PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Rajkovic, A; Hummels, KR; Witzky, A; Erickson, S; Gafken, PR; Whitelegge, JP; Faull, KF; Kearns, DB; Ibba, M				Rajkovic, Andrei; Hummels, Katherine R.; Witzky, Anne; Erickson, Sarah; Gafken, Philip R.; Whitelegge, Julian P.; Faull, Kym F.; Kearns, Daniel B.; Ibba, Michael			Translation Control of Swarming Proficiency in Bacillus subtilis by 5-Amino-pentanolylated Elongation Factor P	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacillus; cell motility; microbiology; posttranslational modification; protein synthesis; translation elongation factor	TRANSFER-RNA SYNTHETASE; RIBOSOME; PATHWAY; PROLINE; GENES; POXA	Elongation factor P (EF-P) accelerates diprolyl synthesis and requires a posttranslational modification to maintain proteostasis. Two phylogenetically distinct EF-P modification pathways have been described and are encoded in the majority of Gram-negative bacteria, but neither is present in Gram-positive bacteria. Prior work suggested that the EF-P-encoding gene (efp) primarily supports Bacillus subtilis swarming differentiation, whereas EF-P in Gram-negative bacteria has a more global housekeeping role, prompting our investigation to determine whether EF-P is modified and how it impacts gene expression in motile cells. We identified a 5-aminopentanol moiety attached to Lys(32) of B. subtilis EF-P that is required for swarming motility. A fluorescent in vivo B. subtilis reporter system identified peptide motifs whose efficient synthesis was most dependent on 5-aminopentanol EF-P. Examination of the B. subtilis genome sequence showed that these EF-P-dependent peptide motifs were represented in flagellar genes. Taken together, these data show that, in B. subtilis, a previously uncharacterized posttranslational modification of EF-P can modulate the synthesis of specific diprolyl motifs present in proteins required for swarming motility.	[Rajkovic, Andrei; Ibba, Michael] Ohio State Univ, Mol Cellular & Dev Biol Program, Columbus, OH 43210 USA; [Rajkovic, Andrei; Ibba, Michael] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Witzky, Anne] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Erickson, Sarah] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA; [Ibba, Michael] Ohio State Univ, Dept Microbiol, 318 W 12th Ave, Columbus, OH 43210 USA; [Hummels, Katherine R.; Kearns, Daniel B.] Indiana Univ, Dept Biol, Bloomington, IN 47305 USA; [Gafken, Philip R.] Fred Hutchinson Canc Res Ctr, Prote Facil, Seattle, WA 98109 USA; [Whitelegge, Julian P.; Faull, Kym F.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA; [Whitelegge, Julian P.; Faull, Kym F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Indiana University System; Indiana University Bloomington; Fred Hutchinson Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Ibba, M (corresponding author), Ohio State Univ, Dept Microbiol, 318 W 12th Ave, Columbus, OH 43210 USA.	ibba.1@osu.edu			National Institutes of Health [P30 CA015704]; M. J. Murdock Charitable Trust; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007757, R01GM065183, T32GM086252, R01GM093030] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M. J. Murdock Charitable Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Yuko Ogata for assistance with collecting mass spectrometry data. We also thank Masaya Fujita, Rebecca Calvo, Eric Vanderpool, and Sampriti Mukherjee for strains and reagents. The Fred Hutchinson Cancer Research Center Proteomics Facility is funded by Cancer Center Support Grant P30 CA015704 from the National Institutes of Health, and the OrbiTrap Fusion used in this research was funded in part by the M. J. Murdock Charitable Trust.	Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Bailly M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-3; Balibar CJ, 2013, CURR MICROBIOL, V67, P293, DOI 10.1007/s00284-013-0363-0; Bullwinkle TJ, 2013, J BIOL CHEM, V288, P4416, DOI 10.1074/jbc.M112.438879; Calvo RA, 2015, J BACTERIOL, V197, P81, DOI 10.1128/JB.02324-14; CARPENTER PB, 1993, MOL MICROBIOL, V7, P735, DOI 10.1111/j.1365-2958.1993.tb01164.x; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; COOPER HL, 1983, P NATL ACAD SCI-BIOL, V80, P1854, DOI 10.1073/pnas.80.7.1854; Courtney CR, 2012, J BACTERIOL, V194, P4619, DOI 10.1128/JB.00444-12; Doerfel LK, 2015, J AM CHEM SOC, V137, P12997, DOI 10.1021/jacs.5b07427; Doherty Geoff P, 2010, BMC Res Notes, V3, P303, DOI 10.1186/1756-0500-3-303; Elgamal S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004553; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gomez SM, 2002, MOL CELL PROTEOMICS, V1, P46, DOI 10.1074/mcp.M100007-MCP200; Harwood C.R., 1990, MOL BIOL METHODS BAC; Hersch SJ, 2014, J BIOL CHEM, V289, P28160, DOI 10.1074/jbc.M114.593277; Hersch SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00180-13; Kearns DB, 2004, MOL MICROBIOL, V52, P357, DOI 10.1111/j.1365-2958.2004.03996.x; Lassak J, 2015, NAT CHEM BIOL, V11, P299, DOI 10.1038/nchembio0415-299d; Mukherjee S, 2014, ANNU REV GENET, V48, P319, DOI 10.1146/annurev-genet-120213-092406; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Ohashi Y, 2003, BIOSCI BIOTECH BIOCH, V67, P2245, DOI 10.1271/bbb.67.2245; Patrick JE, 2008, MOL MICROBIOL, V70, P1166, DOI 10.1111/j.1365-2958.2008.06469.x; Pavlov MY, 2009, P NATL ACAD SCI USA, V106, P50, DOI 10.1073/pnas.0809211106; Peil L, 2012, NAT CHEM BIOL, V8, P695, DOI [10.1038/NCHEMBIO.1001, 10.1038/nchembio.1001]; Rajkovic A, 2015, MBIO, V6, DOI 10.1128/mBio.00823-15; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Sekowska A, 1998, MOL MICROBIOL, V29, P851, DOI 10.1046/j.1365-2958.1998.00979.x; Starosta AL, 2014, CELL REP, V9, P476, DOI 10.1016/j.celrep.2014.09.008; Whitelegge JP, 2007, INT J MASS SPECTROM, V268, P190, DOI 10.1016/j.ijms.2007.08.008; Wohlgemuth I, 2008, J BIOL CHEM, V283, P32229, DOI 10.1074/jbc.M805316200; Woolstenhulme CJ, 2015, CELL REP, V11, P13, DOI 10.1016/j.celrep.2015.03.014; YASBIN RE, 1974, J VIROL, V14, P1343, DOI 10.1128/JVI.14.6.1343-1348.1974; Zhang L, 2008, J AM SOC MASS SPECTR, V19, P1875, DOI 10.1016/j.jasms.2008.08.004; Zou SB, 2012, J BACTERIOL, V194, P413, DOI 10.1128/JB.05864-11; Zou SB, 2011, VIRULENCE, V2, P147, DOI 10.4161/viru.2.2.15039	36	34	35	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					10976	10985		10.1074/jbc.M115.712091	http://dx.doi.org/10.1074/jbc.M115.712091			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27002156	Green Published, hybrid			2022-12-26	WOS:000377042100003
J	Cui, HM; Li, XY; Han, CH; Wang, QE; Wang, HB; Ding, HF; Zhang, JR; Yan, CH				Cui, Hongmei; Li, Xingyao; Han, Chunhua; Wang, Qi-En; Wang, Hongbo; Ding, Han-Fei; Zhang, Junran; Yan, Chunhong			The Stress-responsive Gene ATF3 Mediates Dichotomous UV Responses by Regulating the Tip60 and p53 Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATING TRANSCRIPTION FACTOR-3; NUCLEOTIDE EXCISION-REPAIR; INDUCED APOPTOSIS; HISTONE ACETYLTRANSFERASE; DNA-REPAIR; ACETYLATION; DEGRADATION; BINDING; IRRADIATION; SUPPRESSES	The response to UV irradiation is important for a cell to maintain its genetic integrity when challenged by environmental genotoxins. An immediate early response to UV irradiation is the rapid induction of activating transcription factor 3 (ATF3) expression. Although emerging evidence has linked ATF3 to stress pathways regulated by the tumor suppressor p53 and the histone acetyltransferase Tip60, the role of ATF3 in the UV response remains largely unclear. Here, we report that ATF3 mediated dichotomous UV responses. Although UV irradiation enhanced the binding of ATF3 to Tip60, knockdown of ATF3 expression decreased Tip60 stability, thereby impairing Tip60 induction by UV irradiation. In line with the role of Tip60 in mediating UV-induced apoptosis, ATF3 promoted the death of p53-defective cells in response to UV irradiation. However, ATF3 could also activate p53 and promote p53-mediated DNA repair, mainly through altering histone modifications that could facilitate recruitment of DNA repair proteins (such as DDB2) to damaged DNA sites. As a result, ATF3 rather protected the p53 wild-type cells from UV-induced apoptosis. Our results thus indicate that ATF3 regulates cell fates upon UV irradiation in a p53-dependent manner.	[Cui, Hongmei; Li, Xingyao; Ding, Han-Fei; Yan, Chunhong] Augusta Univ, Med Coll Georgia, Georgia Canc Ctr, Augusta, GA 30912 USA; [Ding, Han-Fei] Augusta Univ, Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA; [Yan, Chunhong] Augusta Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Han, Chunhua; Wang, Qi-En] Ohio State Univ, Dept Radiol, Columbus, OH 43210 USA; [Wang, Hongbo] Yantai Univ, Sch Pharm, Key Lab Mol Pharmacol & Drug Evaluat, Yantai 264005, Peoples R China; [Zhang, Junran] Case Western Reserve Univ, Sch Med, Dept Radiat Oncol, Cleveland, OH 44106 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Ohio; Ohio State University; Yantai University; Case Western Reserve University	Yan, CH (corresponding author), Georgia Canc Ctr, CN2134,1410 Laney Walker Blvd, Augusta, GA 30912 USA.	cyan@augusta.edu	王, 洪波/A-6767-2019; Wang, Hongbo/AHC-7831-2022	王, 洪波/0000-0001-8530-2339; Wang, Hongbo/0000-0001-8530-2339; Ding, Han-Fei/0000-0001-5702-3439; Yan, Chunhong/0000-0002-3974-7991	National Institute of Health [R01CA139107, R01CA164006]; Department of Defense [W81XWH-15-1-0049]; NATIONAL CANCER INSTITUTE [R01CA139107, R01CA164006] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institute of Health grants R01CA139107 and R01CA164006 and Department of Defense Award W81XWH-15-1-0049 (to C. Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe T, 2003, BIOCHEM BIOPH RES CO, V310, P1168, DOI 10.1016/j.bbrc.2003.09.143; Adimoolam S, 2002, P NATL ACAD SCI USA, V99, P12985, DOI 10.1073/pnas.202485699; Amundson SA, 1999, ONCOGENE, V18, P3666, DOI 10.1038/sj.onc.1202676; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Cui HM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7752; Du ZW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001462; Gorrini C, 2007, NATURE, V448, P1063, DOI 10.1038/nature06055; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Hamdi M, 2008, DNA REPAIR, V7, P487, DOI 10.1016/j.dnarep.2007.12.004; Hwang BJ, 1999, P NATL ACAD SCI USA, V96, P424, DOI 10.1073/pnas.96.2.424; Jassim OW, 2003, EMBO J, V22, P5622, DOI 10.1093/emboj/cdg543; Kaidi A, 2013, NATURE, V498, DOI 10.1038/nature12201; Kranz D, 2008, J CELL BIOL, V182, P197, DOI 10.1083/jcb.200712014; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; Legube G, 2002, EMBO J, V21, P1704, DOI 10.1093/emboj/21.7.1704; McKay BC, 2001, ONCOGENE, V20, P6805, DOI 10.1038/sj.onc.1204901; Mo PL, 2010, J BIOL CHEM, V285, P26908, DOI 10.1074/jbc.M110.132597; Niida H, 2010, GENE DEV, V24, P333, DOI 10.1101/gad.1863810; Rubbi CP, 2003, EMBO J, V22, P975, DOI 10.1093/emboj/cdg082; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Squatrito M, 2006, TRENDS CELL BIOL, V16, P433, DOI 10.1016/j.tcb.2006.07.007; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Sun YL, 2005, P NATL ACAD SCI USA, V102, P13182, DOI 10.1073/pnas.0504211102; Sykes SM, 2006, MOL CELL, V24, P841, DOI 10.1016/j.molcel.2006.11.026; Tang Y, 2006, MOL CELL, V24, P827, DOI 10.1016/j.molcel.2006.11.021; Turchi L, 2008, CELL DEATH DIFFER, V15, P1472, DOI 10.1038/cdd.2008.74; Turchi L, 2009, CELL DEATH DIFFER, V16, P728, DOI 10.1038/cdd.2009.2; Tyteca S, 2006, EMBO J, V25, P1680, DOI 10.1038/sj.emboj.7601066; Wang HB, 2012, MOL CELL BIOL, V32, P3190, DOI 10.1128/MCB.00159-12; Wang HB, 2010, J BIOL CHEM, V285, P13201, DOI 10.1074/jbc.M109.058669; Wang QE, 2013, NUCLEIC ACIDS RES, V41, P1722, DOI 10.1093/nar/gks1312; WANG XW, 1995, NAT GENET, V10, P188, DOI 10.1038/ng0695-188; Wang Z, 2015, ONCOGENE, V34, P4975, DOI 10.1038/onc.2014.426; Wei SS, 2014, J BIOL CHEM, V289, P8947, DOI 10.1074/jbc.M113.503755; Yan CH, 2005, EMBO J, V24, P2425, DOI 10.1038/sj.emboj.7600712; Yan CH, 2006, MOL CELL BIOL, V26, P6357, DOI 10.1128/MCB.00311-06; Yan CH, 2006, CELL CYCLE, V5, P926, DOI 10.4161/cc.5.9.2714; Yuan XL, 2013, CANCER RES, V73, P3625, DOI 10.1158/0008-5472.CAN-12-3879	39	16	16	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10847	10857		10.1074/jbc.M115.713099	http://dx.doi.org/10.1074/jbc.M115.713099			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26994140	Green Published, hybrid			2022-12-26	WOS:000377042600034
J	Drylewicz, J; Vrisekoop, N; Mugwagwa, T; de Boer, AB; Otto, SA; Hazenberg, MD; Tesselaar, K; de Boer, RJ; Borghans, JAM				Drylewicz, Julia; Vrisekoop, Nienke; Mugwagwa, Tendai; de Boer, Anne Bregje; Otto, Sigrid A.; Hazenberg, Mette D.; Tesselaar, Kiki; de Boer, Rob J.; Borghans, Jose A. M.			Reconciling Longitudinal Naive T-Cell and TREC Dynamics during HIV-1 Infection	PLOS ONE			English	Article							RECENT THYMIC EMIGRANTS; IMMUNE ACTIVATION; OUTPUT; MAINTENANCE	Naive T cells in untreated HIV-1 infected individuals have a reduced T-cell receptor excision circle (TREC) content. Previous mathematical models have suggested that this is due to increased naive T-cell division. It remains unclear, however, how reduced naive TREC contents can be reconciled with a gradual loss of naive T cells in HIV-1 infection. We performed longitudinal analyses in humans before and after HIV-1 seroconversion, and used a mathematical model to investigate which processes could explain the observed changes in naive T-cell numbers and TRECs during untreated HIV-1 disease progression. Both CD4(+) and CD8(+) naive T-cell TREC contents declined biphasically, with a rapid loss during the first year and a much slower loss during the chronic phase of infection. While naive CD8(+) T-cell numbers hardly changed during follow-up, naive CD4(+) T-cell counts continually declined. We show that a fine balance between increased T-cell division and loss in the peripheral naive T-cell pool can explain the observed short-and long-term changes in TRECs and naive T-cell numbers, especially if T-cell turnover during the acute phase is more increased than during the chronic phase of infection. Loss of thymic output, on the other hand, does not help to explain the biphasic loss of TRECs in HIV infection. The observed longitudinal changes in TRECs and naive T-cell numbers in HIV-infected individuals are most likely explained by a tight balance between increased T-cell division and death, suggesting that these changes are intrinsically linked in HIV infection.	[Drylewicz, Julia; Vrisekoop, Nienke; de Boer, Anne Bregje; Otto, Sigrid A.; Hazenberg, Mette D.; Tesselaar, Kiki; Borghans, Jose A. M.] Univ Med Ctr Utrecht, Dept Immunol, Lab Translat Immunol, Utrecht, Netherlands; [Drylewicz, Julia; Mugwagwa, Tendai; de Boer, Rob J.] Univ Utrecht, Dept Biol, Theoret Biol & Bioinformat, Utrecht, Netherlands; [Vrisekoop, Nienke] Univ Med Ctr Utrecht, Dept Resp Med, Lab Translat Immunol, Utrecht, Netherlands; [Mugwagwa, Tendai] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London WP2 1PG, England; [Hazenberg, Mette D.] Univ Amsterdam, Acad Med Ctr, Dept Hematol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University; Utrecht University Medical Center; Imperial College London; University of Amsterdam	Borghans, JAM (corresponding author), Univ Med Ctr Utrecht, Dept Immunol, Lab Translat Immunol, Utrecht, Netherlands.	J.Borghans@umcutrecht.nl	Drylewicz, Julia/I-4703-2019; de Boer, Rob/B-6050-2011	Drylewicz, Julia/0000-0002-9434-8459; de Boer, Rob/0000-0002-2130-691X; Tesselaar, Kiki/0000-0002-9847-0814; Hazenberg, Mette/0000-0002-5113-0249	AIDS Fonds Netherlands [4025, 4024, 7010]; Netherlands Organization for Scientific Research (NWO) [016.048.603, 917.96.350, 836.07.002]; VIRGO consortium by Dutch government [FES0908]; Netherlands Genomics Initiative [050-060-452]; Center for Infectious Disease Control of the Netherlands National Institute for Public Health and the Environment	AIDS Fonds Netherlands; Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); VIRGO consortium by Dutch government; Netherlands Genomics Initiative; Center for Infectious Disease Control of the Netherlands National Institute for Public Health and the Environment	This research has been funded by AIDS Fonds Netherlands (grants 4025, 4024, 7010), the Netherlands Organization for Scientific Research (NWO, grants 016.048.603, 917.96.350, 836.07.002) and the VIRGO consortium funded by the Dutch government (project number FES0908) and by the Netherlands Genomics Initiative (project number 050-060-452).; The Amsterdam Cohort Studies on HIV infection and AIDS, a collaboration between the Amsterdam Health Service, the Academic Medical Center of the University of Amsterdam, Sanquin Blood Supply Foundation, the University Medical Center Utrecht, and the Jan van Goyen Clinic are part of the Netherlands HIV Monitoring Foundation and financially supported by the Center for Infectious Disease Control of the Netherlands National Institute for Public Health and the Environment.	Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Choudhary SK, 2007, J VIROL, V81, P8838, DOI 10.1128/JVI.02663-06; Clayton F, 1997, GASTROENTEROL CLIN N, V26, P191, DOI 10.1016/S0889-8553(05)70293-4; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; den Braber I, 2012, IMMUNITY, V36, P288, DOI 10.1016/j.immuni.2012.02.006; Dion ML, 2004, IMMUNITY, V21, P757, DOI 10.1016/j.immuni.2004.10.013; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Douek DC, 2001, J IMMUNOL, V167, P6663, DOI 10.4049/jimmunol.167.11.6663; Dutilh BE, 2003, J THEOR BIOL, V224, P351, DOI 10.1016/S0022-5193(03)00172-3; Ganesan A, 2010, J INFECT DIS, V201, P272, DOI 10.1086/649430; Hatzakis A, 2000, LANCET, V355, P599, DOI 10.1016/S0140-6736(99)10311-8; Hazenberg MD, 2003, NAT IMMUNOL, V4, P97, DOI 10.1038/ni0203-97; Hazenberg MD, 2000, NAT MED, V6, P1036, DOI 10.1038/79549; Katsikis PD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002055; Lewin SR, 2002, J IMMUNOL, V169, P4657, DOI 10.4049/jimmunol.169.8.4657; Marchetti G, 2009, HIV MED, V10, P422, DOI 10.1111/j.1468-1293.2009.00710.x; MARGOLICK JB, 1995, NAT MED, V1, P674, DOI 10.1038/nm0795-674; McCune JM, 2001, NATURE, V410, P974, DOI 10.1038/35073648; Meroni L, 1996, AIDS, V10, P23, DOI 10.1097/00002030-199601000-00004; Nobile M, 2004, BLOOD, V104, P470, DOI 10.1182/blood-2003-12-4265; Nokta MA, 2002, AIDS, V16, P2119, DOI 10.1097/00002030-200211080-00003; RABIN RL, 1995, J CLIN INVEST, V95, P2054, DOI 10.1172/JCI117891; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; Sempowski GD, 2005, J CLIN IMMUNOL, V25, P462, DOI 10.1007/s10875-005-5635-4; TAKESHITA S, 1989, EMBO J, V8, P3261, DOI 10.1002/j.1460-2075.1989.tb08486.x; Vrisekoop N, 2008, J IMMUNOL, V181, P1573, DOI 10.4049/jimmunol.181.2.1573; Vrisekoop N, 2008, P NATL ACAD SCI USA, V105, P6115, DOI 10.1073/pnas.0709713105; Vrisekoop N, 2015, AIDS, V29, P2071, DOI 10.1097/QAD.0000000000000822; Westera L, 2015, AGING CELL, V14, P219, DOI 10.1111/acel.12311; Zhang LQ, 1999, J EXP MED, V190, P725, DOI 10.1084/jem.190.5.725	30	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152513	10.1371/journal.pone.0152513	http://dx.doi.org/10.1371/journal.pone.0152513			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010200	Green Published, Green Submitted, gold			2022-12-26	WOS:000372708000147
J	Gros-Balthazard, M; Newton, C; Ivorra, S; Pierre, MH; Pintaud, JC; Terral, JF				Gros-Balthazard, Muriel; Newton, Claire; Ivorra, Sarah; Pierre, Marie-Helene; Pintaud, Jean-Christophe; Terral, Jean-Frederic			The Domestication Syndrome in Phoenix dactylifera Seeds: Toward the Identification of Wild Date Palm Populations	PLOS ONE			English	Article							OLEA-EUROPAEA L.; HISTORICAL BIOGEOGRAPHY; CROP DOMESTICATION; FRUIT; SHAPE; MORPHOMETRY; EVOLUTION; INSIGHTS; OLIVE; MORPHOLOGY	Investigating crop origins is a priority to understand the evolution of plants under domestication, develop strategies for conservation and valorization of agrobiodiversity and acquire fundamental knowledge for cultivar improvement. The date palm(Phoenix dactylifera L.) belongs to the genus Phoenix, which comprises 14 species morphologically very close, sometimes hardly distinguishable. It has been cultivated for millennia in the Middle East and in North Africa and constitutes the keystone of oasis agriculture. Yet, its origins remain poorly understood as no wild populations are identified. Uncultivated populations have been described but they might represent feral, i.e. formerly cultivated, abandoned forms rather than truly wild populations. In this context, this study based on morphometrics applied to 1625 Phoenix seeds aims to (1) differentiate Phoenix species and (2) depict the domestication syndrome observed in cultivated date palm seeds using other Phoenix species as a "wild" reference. This will help discriminate truly wild from feral forms, thus providing new insights into the evolutionary history of this species. Seed size was evaluated using four parameters: length, width, thickness and dorsal view surface. Seed shape was quantified using outline analyses based on the Elliptic Fourier Transform method. The size and shape of seeds allowed an accurate differentiation of Phoenix species. The cultivated date palm shows distinctive size and shape features, compared to other Phoenix species: seeds are longer and elongated. This morphological shift may be interpreted as a domestication syndrome, resulting from the long-term history of cultivation, selection and human-mediated dispersion. Based on seed attributes, some uncultivated date palms from Oman may be identified as wild. This opens new prospects regarding the possible existence and characterization of relict wild populations and consequently for the understanding of the date palm origins. Finally, we here describe a pipeline for the identification of the domestication syndrome in seeds that could be used in other crops.	[Gros-Balthazard, Muriel; Newton, Claire; Ivorra, Sarah; Pierre, Marie-Helene; Terral, Jean-Frederic] Univ Montpellier, Equipe Dynam Biodivers, Inst Sci Evolut, UMR CNRS 5554,IRD EPHE,CC065,Anthropoecol, Pl Eugene Bataillon, F-34095 Montpellier 5, France; [Gros-Balthazard, Muriel; Pintaud, Jean-Christophe] Inst Rech Dev, Equipe DYNADIV, UMR DIADE, 911 Ave Agr, F-34394 Montpellier 5, France; [Newton, Claire] Univ Quebec, Lab Archeol & Patrimoine, 300 Allee Ursulines, Rimouski, PQ G5L 3A1, Canada	UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Quebec	Gros-Balthazard, M (corresponding author), Univ Montpellier, Equipe Dynam Biodivers, Inst Sci Evolut, UMR CNRS 5554,IRD EPHE,CC065,Anthropoecol, Pl Eugene Bataillon, F-34095 Montpellier 5, France.; Gros-Balthazard, M (corresponding author), Inst Rech Dev, Equipe DYNADIV, UMR DIADE, 911 Ave Agr, F-34394 Montpellier 5, France.	muriel.grosb@gmail.com	gros-balthazard, muriel/L-7907-2019	gros-balthazard, muriel/0000-0002-2587-3946; TERRAL, Jean-Frederic/0000-0003-1921-2161; Newton, Claire/0000-0003-3791-3906	Agence Nationale de la Recherche [ANR-06-BLAN-0212-02-PHOENIX, ANR-07-BLAN-003301 - FRUCTIMEDHIS]; French Ministry of Research	Agence Nationale de la Recherche(French National Research Agency (ANR)); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported by the Agence Nationale de la Recherche (http://www.agence-nationale-recherche.fr/): programme blanc, ANR-06-BLAN-0212-02-PHOENIX project (dir. M. Tengberg; WP coordinated by J.-F. Terral) and ANR-07-BLAN-003301 - FRUCTIMEDHIS project (dir. A. Durand; WP coordinated by J.-F. Terral). This work was also supported by PhD fellowships from the French Ministry of Research granted to M.G.-B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alcantara JM, 2003, J EVOLUTION BIOL, V16, P1168, DOI 10.1046/j.1420-9101.2003.00618.x; Auguie B, 2017, GRIDEXTRA MISCELLANE; Aybeke M, 2007, J PLANT BIOL, V50, P387, DOI 10.1007/BF03030673; Ballardini M, 2013, ZOOKEYS, P71, DOI 10.3897/zookeys.365.5725; Barrow Sasha C., 1998, Kew Bulletin, V53, P513, DOI 10.2307/4110478; Beccari O, 1890, MALESIA, V3, P345; Bolmgren K, 2010, OIKOS, V119, P707, DOI 10.1111/j.1600-0706.2009.17944.x; Bonhomme V, 2014, J STAT SOFTW, V56, P1; Bouby L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063195; Breton C, 2009, CR BIOL, V332, P1059, DOI 10.1016/j.crvi.2009.08.001; Burger P, 2011, VEG HIST ARCHAEOBOT, V20, P447, DOI 10.1007/s00334-011-0310-6; Chemisquy MA, 2009, BOT J LINN SOC, V160, P171, DOI 10.1111/j.1095-8339.2009.00968.x; Chen YW, 2004, CROP SCI, V44, P316, DOI 10.2135/cropsci2004.0316; Cope JS, 2012, EXPERT SYST APPL, V39, P7562, DOI 10.1016/j.eswa.2012.01.073; CRAMPTON JS, 1995, LETHAIA, V28, P179, DOI 10.1111/j.1502-3931.1995.tb01611.x; de Caraffa VB, 2002, THEOR APPL GENET, V104, P1209, DOI 10.1007/s00122-002-0883-7; Ferry M, 1990, OPTIONS MEDITERR A, V11, P261; Fuller DQ, 2007, ANN BOT-LONDON, V100, P903, DOI 10.1093/aob/mcm048; Fuller DQ, 2012, BIODIVERSITY IN AGRICULTURE: DOMESTICATION, EVOLUTION, AND SUSTAINABILITY, P110; Gao LZ, 2008, GENETICS, V179, P965, DOI 10.1534/genetics.106.068072; Glemin S, 2009, NEW PHYTOL, V183, P273, DOI 10.1111/j.1469-8137.2009.02884.x; Govaerts R., 2005, World checklist of palms; Gros-Balthazard M, 2013, REV ETHNOECOLOGIE, V4; Gros-Balthazard M, 2013, EMIR J FOOD AGR, V25, P831, DOI 10.9755/ejfa.v25i11.16660; Habib HM, 2011, INT J FOOD SCI NUTR, V62, P544, DOI 10.3109/09637486.2011.558073; HARLAN JR, 1976, CROP SCI, V16, P329, DOI 10.2135/cropsci1976.0011183X001600030004x; Haussmann B. I. G., 2004, Plant Genetic Resources Characterization and Utilization, V2, P3, DOI 10.1079/PGR200430; Henderson S, 2003, PALMS, V47; Henderson SA, 2006, CONSERV GENET, V7, P213, DOI 10.1007/s10592-006-9128-7; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; Lanta V, 2003, PLANT SOIL ENVIRON, V49, P364, DOI 10.17221/4138-PSE; LEVADOUX L., 1956, Annales de l'Amelioration des Plantes, V6, P59; Lutz W, 2001, NATURE, V412, P543, DOI 10.1038/35087589; Mamidi S, 2011, FUNCT PLANT BIOL, V38, P953, DOI 10.1071/FP11124; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Meyer RS, 2012, NEW PHYTOL, V196, P29, DOI 10.1111/j.1469-8137.2012.04253.x; Miller AJ, 2011, AM J BOT, V98, P1389, DOI 10.3732/ajb.1000522; Nakicenovi N, 2000, EMISSIONS SCENARIOS; Newton C, 2014, VEG HIST ARCHAEOBOT, V23, P567, DOI 10.1007/s00334-013-0412-4; Parker IM, 2010, ECON BOT, V64, P161, DOI 10.1007/s12231-010-9121-4; Pintaud JC, 2013, ACTA HORTIC, V994, P19, DOI 10.17660/ActaHortic.2013.994.1; Pintaud Jean-Christophe, 2010, P267; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Renaud S, 2003, J BIOGEOGR, V30, P1617, DOI 10.1046/j.1365-2699.2003.00932.x; Renaud S, 2001, INTRA INTERSPECIFIC, P557; Renaud S, 2012, PALEONTOLOGICAL SOC; Rivera D, 2014, BOT J LINN SOC, V175, P74, DOI 10.1111/boj.12164; ROHLF FJ, 1984, SYST ZOOL, V33, P302, DOI 10.2307/2413076; Rohlf FJ, 1990, SPECIAL PUBLICATION, V2, P167; Rosegrant MW, 2003, SCIENCE, V302, P1917, DOI 10.1126/science.1092958; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; Tengberg M, 2012, J ARID ENVIRON, V86, P139, DOI 10.1016/j.jaridenv.2011.11.022; Tengberg M, 2003, RES ORIGINS DATE PAL, P51; Terral JF, 2012, J BIOGEOGR, V39, P929, DOI 10.1111/j.1365-2699.2011.02649.x; Terral JF, 2010, ANN BOT-LONDON, V105, P443, DOI 10.1093/aob/mcp298; Terral JF, 2004, J BIOGEOGR, V31, P63, DOI 10.1046/j.0305-0270.2003.01019.x; WADDINGTON CH, 1960, GENET RES, V1, P140, DOI 10.1017/S0016672300000136; Wilkin P., 1999, Kew Bulletin, V54, P1, DOI 10.2307/4111020; Willcox G, 2004, J ARCHAEOL SCI, V31, P145, DOI 10.1016/j.jas.2003.07.003; Zohary D, 2012, DOMESTICATION OF PLANTS IN THE OLD WORLD: THE ORIGIN AND SPREAD OF DOMESTICATED PLANTS IN SOUTH-WEST ASIA, EUROPE, AND THE MEDITERRANEAN BASIN, 4TH EDITION, P1, DOI 10.1093/acprof:osobl/9780199549061.001.0001	61	32	32	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152394	10.1371/journal.pone.0152394	http://dx.doi.org/10.1371/journal.pone.0152394			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010707	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708000141
J	Horn, P; Erkilet, G; Veulemans, V; Kropil, P; Schurgers, L; Zeus, T; Heiss, C; Kelm, M; Westenfeld, R				Horn, Patrick; Erkilet, Guesuem; Veulemans, Verena; Kroepil, Patric; Schurgers, Leon; Zeus, Tobias; Heiss, Christian; Kelm, Malte; Westenfeld, Ralf			Microparticle-Induced Coagulation Relates to Coronary Artery Atherosclerosis in Severe Aortic Valve Stenosis	PLOS ONE			English	Article							ENDOTHELIUM-DERIVED MICROPARTICLES; ELEVATION MYOCARDIAL-INFARCTION; CIRCULATING MICROPARTICLES; THROMBIN GENERATION; CALCIFICATION; DISEASE; PROCOAGULANT; INFLAMMATION; ASSOCIATION; MECHANISMS	Background Circulating microparticles (MPs) derived from endothelial cells and blood cells bear procoagulant activity and promote thrombin generation. Thrombin exerts proinflammatory effects mediating the progression of atherosclerosis. Aortic valve stenosis may represent an atherosclerosis-like process involving both the aortic valve and the vascular system. The aim of this study was to investigate whether MP-induced thrombin generation is related to coronary atherosclerosis and aortic valve calcification. Methods In a cross-sectional study of 55 patients with severe aortic valve stenosis, we assessed the coronary calcification score (CAC) as indicator of total coronary atherosclerosis burden, and aortic valve calcification (AVC) by computed tomography. Thrombin-antithrombin complex (TATc) levels were measured as a marker for thrombin formation. Circulating MPs were characterized by flow cytometry according to the expression of established surface antigens and by measuring MP-induced thrombin generation. Results Patients with CAC score below the median were classified as patients with low CAC, patients with CAC Score above the median as high CAC. In patients with high CAC compared to patients with low CAC we detected higher levels of TATc, platelet-derived MPs (PMPs), endothelial-derived MPs (EMPs) and MP-induced thrombin generation. Increased level of PMPs and MP-induced thrombin generation were independent predictors for the severity of CAC. In contrast, AVC Score did not differ between patients with high and low CAC and did neither correlate with MPs levels nor with MP-induced thrombin generation. Conclusion In patients with severe aortic valve stenosis MP-induced thrombin generation was independently associated with the severity of CAC but not AVC indicating different pathomechanisms involved in coronary artery and aortic valve calcification.	[Horn, Patrick; Erkilet, Guesuem; Veulemans, Verena; Zeus, Tobias; Heiss, Christian; Kelm, Malte; Westenfeld, Ralf] Univ Dusseldorf, Fac Med, Div Cardiol Pulmonol & Vasc Med, Dusseldorf, Germany; [Kroepil, Patric] Univ Dusseldorf, Fac Med, Dept Diagnost & Intervent Radiol, Dusseldorf, Germany; [Schurgers, Leon] Maastricht Univ, Cardiovasc Res Inst Maastricht CARIM, Dept Biochem, NL-6200 MD Maastricht, Netherlands; [Kelm, Malte] Univ Dusseldorf, Fac Med, Cardiovasc Res Inst Dusseldorf CARID, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Maastricht University; Heinrich Heine University Dusseldorf	Horn, P (corresponding author), Univ Dusseldorf, Fac Med, Div Cardiol Pulmonol & Vasc Med, Dusseldorf, Germany.	patrick.horn@med.uni-duesseldorf.de	Schurgers, Leon/AAT-7100-2021; Heiss, Christian/AAL-8582-2020	Heiss, Christian/0000-0002-3212-8995; Kelm, Malte/0000-0003-0060-1052; Schurgers, Leon/0000-0001-7867-6957	federal state government of North Rhine-Westphalia; European Union (EFRE-Program "Med in NRW") [005-GW01-235A]; Forschungskommission of the Medical Faculty of the Heinrich-Heine University Duesseldorf	federal state government of North Rhine-Westphalia; European Union (EFRE-Program "Med in NRW"); Forschungskommission of the Medical Faculty of the Heinrich-Heine University Duesseldorf	The study was supported with a restricted grant from the federal state government of North Rhine-Westphalia and the European Union (EFRE-Program "Med in NRW", support code 005-GW01-235A) and funded by the Forschungskommission of the Medical Faculty of the Heinrich-Heine University Duesseldorf to PH.	Alexopoulos N, 2009, NAT REV CARDIOL, V6, P681, DOI 10.1038/nrcardio.2009.165; Amabile N, 2014, EUR HEART J, V35, P2972, DOI 10.1093/eurheartj/ehu153; Bea F, 2006, ARTERIOSCL THROM VAS, V26, P2787, DOI 10.1161/01.ATV.0000246797.05781.ad; Bernard S, 2009, ATHEROSCLEROSIS, V203, P429, DOI 10.1016/j.atherosclerosis.2008.07.039; Borissoff JI, 2012, JACC-CARDIOVASC IMAG, V5, P1201, DOI 10.1016/j.jcmg.2012.01.023; Borissoff JI, 2011, NEW ENGL J MED, V364, P1746, DOI 10.1056/NEJMra1011670; Boulanger CM, 2001, CIRCULATION, V104, P2649, DOI 10.1161/hc4701.100516; Brodsky SV, 2004, AM J PHYSIOL-HEART C, V286, pH1910, DOI 10.1152/ajpheart.01172.2003; Chan KL, 2010, CIRCULATION, V121, P306, DOI 10.1161/CIRCULATIONAHA.109.900027; Del Turco S, 2014, J GERIATR CARDIOL, V11, P13, DOI 10.3969/j.issn.1671-5411.2014.01.008; Diehl P, 2008, THROMB HAEMOSTASIS, V99, P711, DOI 10.1160/TH07-05-0334; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Dimitrow Pawel Petkow, 2009, Atherosclerosis, V204, pe103, DOI 10.1016/j.atherosclerosis.2008.12.029; Erdbrugger U, 2014, CYTOM PART A, V85A, P756, DOI 10.1002/cyto.a.22494; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Henein M, 2015, ATHEROSCLEROSIS, V243, P631, DOI 10.1016/j.atherosclerosis.2015.10.014; Horn P, 2015, EUROINTERVENTION, V10, P1456, DOI 10.4244/EIJY14M10_02; Horn P, 2014, BRIT J NUTR, V111, P1245, DOI 10.1017/S0007114513003693; Horn P, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.003764; Hulsmans M, 2013, CARDIOVASC RES, V100, P7, DOI 10.1093/cvr/cvt161; Jansen F, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001249; Jayachandran M, 2008, AM J PHYSIOL-HEART C, V295, pH931, DOI 10.1152/ajpheart.00193.2008; Kalz J, 2014, J THROMB THROMBOLYS, V37, P45, DOI 10.1007/s11239-013-1026-5; Koos R, 2004, AM J ROENTGENOL, V183, P1813, DOI 10.2214/ajr.183.6.01831813; Lacroix R, 2012, THROMB RES, V129, pS27, DOI 10.1016/j.thromres.2012.02.025; Lee ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035713; Leroyer AS, 2008, J AM COLL CARDIOL, V52, P1302, DOI 10.1016/j.jacc.2008.07.032; Leroyer AS, 2007, J AM COLL CARDIOL, V49, P772, DOI 10.1016/j.jacc.2006.10.053; Mohler ER, 2006, J HEART VALVE DIS, V15, P322; Morel O, 2009, ATHEROSCLEROSIS, V204, P636, DOI 10.1016/j.atherosclerosis.2008.10.039; Nicoll R, 2013, INT J CARDIOL, V167, P322, DOI 10.1016/j.ijcard.2012.06.110; Otto CM, 1999, NEW ENGL J MED, V341, P142, DOI 10.1056/NEJM199907153410302; Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056; Porto I, 2012, EUR HEART J, V33, P2928, DOI 10.1093/eurheartj/ehs065; Rautou PE, 2011, CIRC RES, V109, P593, DOI 10.1161/CIRCRESAHA.110.233163; Rautou PE, 2011, CIRC RES, V108, P335, DOI 10.1161/CIRCRESAHA.110.237420; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Sabatier F, 2009, J CELL MOL MED, V13, P454, DOI 10.1111/j.1582-4934.2008.00639.x; Schiro A, 2014, ATHEROSCLEROSIS, V234, P295, DOI 10.1016/j.atherosclerosis.2014.03.019; Sinning JM, 2011, EUR HEART J, V32, P2034, DOI 10.1093/eurheartj/ehq478; ten Cate H, 2012, THROMB RES, V129, pS38, DOI 10.1016/j.thromres.2012.02.028; Tushuizen ME, 2011, ARTERIOSCL THROM VAS, V31, P4, DOI 10.1161/ATVBAHA.109.200998; van der Meijden PEJ, 2012, J THROMB HAEMOST, V10, P1355, DOI 10.1111/j.1538-7836.2012.04758.x; Wang JG, 2013, J AM COLL CARDIOL, V62, P1442, DOI 10.1016/j.jacc.2013.04.054; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P112, DOI 10.1161/01.ATV.0000191634.13057.15; Wierzbicki A, 1999, J HEART VALVE DIS, V8, P416	46	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151499	10.1371/journal.pone.0151499	http://dx.doi.org/10.1371/journal.pone.0151499			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010400	Green Submitted, Green Published, gold			2022-12-26	WOS:000372708000029
J	Meinert, I; Brown, N; Alt, W				Meinert, Ilka; Brown, Niklas; Alt, Wilfried			Effect of Footwear Modifications on Oscillations at the Achilles Tendon during Running on a Treadmill and Over Ground: A Cross-Sectional Study	PLOS ONE			English	Article							SOFT-TISSUE VIBRATIONS; IMPACT FORCES; MUSCLE-ACTIVITY; HEEL-STRIKE; RUNNERS; TENDINOPATHY; BIOMECHANICS; RESONANCE; STIFFNESS; WALKING	Background Achilles tendon injuries are known to commonly occur in runners. During running repeated impacts are transferred in axial direction along the lower leg, therefore possibly affecting the oscillation behavior of the Achilles tendon. The purpose of the present study was to explore the effects of different footwear modifications and different ground conditions (over ground versus treadmill) on oscillations at the Achilles tendon. Methods Oscillations were measured in 20 male runners using two tri-axial accelerometers. Participants ran in three different shoe types on a treadmill and over ground. Data analysis was limited to stance phase and performed in time and frequency space. Statistical comparison was conducted between oscillations in vertical and horizontal direction, between running shoes and between ground conditions (treadmill versus over ground running). Results Differences in the oscillation behavior could be detected between measurement directions with peak accelerations in the vertical being lower than those in the horizontal direction, p < 0.01. Peak accelerations occurred earlier at the distal accelerometer than at the proximal one, p < 0.01. Average normalized power differed between running shoes (p < 0.01) with harder damping material resulting in higher power values. Little to no power attenuation was found between the two accelerometers. Oscillation behavior of the Achilles tendon is not influenced by ground condition. Conclusion Differences in shoe configurations may lead to variations in running technique and impact forces and therefore result in alterations of the vibration behavior at the Achilles tendon. The absence of power attenuation may have been caused by either a short distance between the two accelerometers or high stiffness of the tendon. High stiffness of the tendon will lead to complete transmission of the signal along the Achilles tendon and therefore no attenuation occurs.	[Meinert, Ilka; Brown, Niklas; Alt, Wilfried] Univ Stuttgart, Inst Sport & Exercise Sci, D-70174 Stuttgart, Germany	University of Stuttgart	Meinert, I (corresponding author), Univ Stuttgart, Inst Sport & Exercise Sci, D-70174 Stuttgart, Germany.	ilka.meinert@inspo.uni-stuttgart.de			Federal Ministry of Economics and Technology [17615N]	Federal Ministry of Economics and Technology(Federal Ministry for Economic Affairs and Energy (BMWi))	This research was supported by the Federal Ministry of Economics and Technology on a basis of the decision by the German Bundestag by grant number 17615N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlGheshyan FN, 2012, COMP GROUND REACTION; Boyer KA, 2006, J BIOMECH, V39, P645, DOI 10.1016/j.jbiomech.2005.01.027; Boyer KA, 2004, J BIOMECH, V37, P1583, DOI 10.1016/j.jbiomech.2004.01.002; Boyer KA, 2006, J BIOMECH ENG-T ASME, V128, P815, DOI 10.1115/1.2354202; Boyer KA, 2007, J BIOMECH, V40, P1877, DOI 10.1016/j.jbiomech.2006.08.008; Cimbala JM, 2013, ANAL FREQUENCY CONTE; Enders H, 2014, J SCI MED SPORT, V17, P218, DOI 10.1016/j.jsams.2013.03.015; Farris DJ, 2012, EUR J APPL PHYSIOL, V112, P653, DOI 10.1007/s00421-011-2019-8; Fu W, 2013, INT J SPORTS MED, V34, P477, DOI 10.1055/s-0032-1327696; Gerlach KE, 2005, MED SCI SPORT EXER, V37, P657, DOI 10.1249/01.MSS.0000158994.29358.71; Girden E.R., 1992, ANOVA REPEATED MEASU, V84; Hong Y, 2012, ISBS C P ARCH MELBOU, P441; JORGENSEN U, 1988, INT J SPORTS MED, V9, P468, DOI 10.1055/s-2007-1025053; Ki-Kwang L, 2005, 7 S FOOTW BIOM CLEV, P7; KOMI PV, 1990, J BIOMECH, V23, P23, DOI 10.1016/0021-9290(90)90038-5; KOMI PV, 1992, CLIN SPORT MED, V11, P521; Lavcanska V, 2005, HUM MOVEMENT SCI, V24, P544, DOI 10.1016/j.humov.2005.08.001; LEES A, 1994, ERGONOMICS, V37, P197, DOI 10.1080/00140139408963638; Lichtwark GA, 2008, J THEOR BIOL, V252, P662, DOI 10.1016/j.jtbi.2008.01.018; Logan S, 2010, J SPORT SCI MED, V9, P147; Lohrer H, 2006, MED TECHNIK, V7, P34; McCrory JL, 1999, MED SCI SPORT EXER, V31, P1374, DOI 10.1097/00005768-199910000-00003; Munteanu SE, 2011, J FOOT ANKLE RES, V4, DOI 10.1186/1757-1146-4-15; NIGG BM, 1987, J BIOMECH, V20, P951, DOI 10.1016/0021-9290(87)90324-1; Nigg BM, 2001, CLIN J SPORT MED, V11, P2, DOI 10.1097/00042752-200101000-00002; NIGG BM, 1995, MED SCI SPORT EXER, V27, P98; NOKES L, 1984, J BIOMED ENG, V6, P223, DOI 10.1016/0141-5425(84)90107-9; Ray A. K., 2004, INFORM TECHNOLOGY PR; Riley PO, 2008, MED SCI SPORT EXER, V40, P1093, DOI 10.1249/MSS.0b013e3181677530; Rosso C, 2012, CLIN J SPORT MED, V22, P483, DOI 10.1097/JSM.0b013e3182639a3e; Wakeling JM, 2003, J BIOMECH, V36, P1761, DOI 10.1016/S0021-9290(03)00216-1; Wakeling JM, 2001, J APPL PHYSIOL, V90, P412, DOI 10.1152/jappl.2001.90.2.412; Wang D, 2015, J ELECTROMYOGR KINES, V25, P495, DOI 10.1016/j.jelekin.2015.03.003; Wang L., 2014, AM J SPORTS SCI MED, V2, P161, DOI [10.12691/ajssm-2-4-8, DOI 10.12691/AJSSM-2-4-8]; Wang TG, 2007, SCAND J MED SCI SPOR, V17, P535, DOI 10.1111/j.1600-0838.2006.00618.x; Zadpoor AA, 2011, CLIN BIOMECH, V26, P23, DOI 10.1016/j.clinbiomech.2010.08.005; Zafar MS, 2009, SPORTS MED ARTHROSC, V17, P190, DOI 10.1097/JSA.0b013e3181b37eb7	37	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152435	10.1371/journal.pone.0152435	http://dx.doi.org/10.1371/journal.pone.0152435			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010929	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708000143
J	Tang, LS; Zhu, HR; Yang, XM; Xie, F; Peng, JT; Jiang, DK; Xie, J; Qi, MY; Yu, L				Tang, Lisha; Zhu, Hengrui; Yang, Xianmei; Xie, Fang; Peng, Jingtao; Jiang, Deke; Xie, Jun; Qi, Meiyan; Yu, Long			Shizukaol D, a Dimeric Sesquiterpene Isolated from Chloranthus serratus, Represses the Growth of Human Liver Cancer Cells by Modulating Wnt Signalling Pathway	PLOS ONE			English	Article							CHEMICAL-CONSTITUENTS; EXPRESSION; APOPTOSIS; JAPONICUS; PRODUCTS; TARGET; PLANTS	Natural products have become sources of developing new drugs for the treatment of cancer. To seek candidate compounds that inhibit the growth of liver cancer, components of Chloranthus serratus were tested. Here, we report that shizukaol D, a dimeric sesquiterpene from Chloranthus serratus, exerted a growth inhibition effect on liver cancer cells in a dose- and time-dependent manner. We demonstrated that shizukaol D induced cells to undergo apoptosis. More importantly, shizukaol D attenuated Wnt signalling and reduced the expression of endogenous Wnt target genes, which resulted in decreased expression of beta-catenin. Collectively, this study demonstrated that shizukaol D inhibited the growth of liver cancer cells by modulating Wnt pathway.	[Tang, Lisha; Zhu, Hengrui; Yang, Xianmei; Xie, Fang; Jiang, Deke; Xie, Jun; Qi, Meiyan; Yu, Long] Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China; [Zhu, Hengrui] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Xie, Fang] Mayo Clin, Rochester, MN 55905 USA; [Peng, Jingtao] Shanghai Jiao Tong Univ, Dept Urol, Shanghai Peoples Hosp 1, Shanghai 200030, Peoples R China; [Jiang, Deke] Univ Chicago, Program Personalized Canc Care, NorthShore Univ HealthSyst, Pritzker Sch Med, Chicago, IL 60637 USA; [Qi, Meiyan] Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Fudan University; The Wistar Institute; Mayo Clinic; Shanghai Jiao Tong University; NorthShore University Health System; University of Chicago; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Jiang, DK; Xie, J; Qi, MY (corresponding author), Fudan Univ, State Key Lab Genet Engn, Sch Life Sci, Shanghai 200433, Peoples R China.; Jiang, DK (corresponding author), Univ Chicago, Program Personalized Canc Care, NorthShore Univ HealthSyst, Pritzker Sch Med, Chicago, IL 60637 USA.; Qi, MY (corresponding author), Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	dekejiang@fudan.edu.cn; xiejun@fudan.edu.cn; qimeiyan@sibs.ac.cn	Jiang, Deke/M-6945-2013		National Key Sci-Tech Special Project of China [2013ZX10002010]; National Natural Science Foundation of China [81301855]; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER	National Key Sci-Tech Special Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Key Sci-Tech Special Project of China (2013ZX10002010) and the National Natural Science Foundation of China (no. 81301855). The funders of this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2010, SURG CLIN N AM, V90, P803, DOI 10.1016/j.suc.2010.04.010; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chiu KY, 2016, CANCER LETT, V373, P174, DOI 10.1016/j.canlet.2015.11.046; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Evason KJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005305; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Filmus J, 2013, FEBS J, V280, P2471, DOI 10.1111/febs.12126; Ford CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054362; Formosa R, 2012, ENDOCR PATHOL, V23, P123, DOI 10.1007/s12022-012-9197-8; HEIDELBERGER C, 1957, NATURE, V179, P663, DOI 10.1038/179663a0; Hu RK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073527; Ichikawa H, 2007, CURR PHARM DESIGN, V13, P3400, DOI 10.2174/138161207782360492; Kang YJ, 2009, J PHARMACOL SCI, V111, P276, DOI 10.1254/jphs.09141FP; KAWABATA J, 1992, PHYTOCHEMISTRY, V31, P1293, DOI 10.1016/0031-9422(92)80281-I; KAWABATA J, 1990, PHYTOCHEMISTRY, V29, P2332, DOI 10.1016/0031-9422(90)83065-9; Koehler A, 2013, DEV BIOL, V383, P132, DOI 10.1016/j.ydbio.2013.08.007; Krupinski J, 2002, NEUROPHARMACOLOGY, V42, P846, DOI 10.1016/S0028-3908(02)00032-1; Kwon OE, 2006, J ETHNOPHARMACOL, V104, P270, DOI 10.1016/j.jep.2005.09.018; Li SY, 2013, CANCER LETT, V340, P247, DOI 10.1016/j.canlet.2012.09.027; Liu H, 2009, inventorsLindenane type sesquiterpenoids, and the preparation method and pharmaceutical application thereof, Patent No. 20091013; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Maher MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010184; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Parody JP, 2010, GROWTH FACTORS, V28, P166, DOI 10.3109/08977190903547863; Ripple MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106257; Sangkhathat S, 2006, INT J ONCOL, V28, P715; Shin HW, 2009, HEPATO-GASTROENTEROL, V56, P208; Tian XH, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-100; Xu YJ, 2007, J NAT PROD, V70, P1987, DOI 10.1021/np070433g; Yuan T, 2008, J NAT PROD, V71, P2021, DOI 10.1021/np800543f; Yuan T, 2012, ORG LETT, V14, P3198, DOI 10.1021/ol301306e; Zhang M, 2013, FITOTERAPIA, V91, P95, DOI 10.1016/j.fitote.2013.08.015; Zhang M, 2012, FITOTERAPIA, V83, P1604, DOI 10.1016/j.fitote.2012.09.009; Zhang M, 2012, J NAT PROD, V75, P694, DOI 10.1021/np200968p	37	21	26	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152012	10.1371/journal.pone.0152012	http://dx.doi.org/10.1371/journal.pone.0152012			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010735	gold, Green Submitted, Green Published			2022-12-26	WOS:000372708000069
J	Tatchley, C; Paton, H; Robertson, E; Minderman, J; Hanley, N; Park, K				Tatchley, Cerian; Paton, Heather; Robertson, Emma; Minderman, Jeroen; Hanley, Nicholas; Park, Kirsty			Drivers of Public Attitudes towards Small Wind Turbines in the UK	PLOS ONE			English	Article							SOCIAL GAP; POWER; EXTINCTION; ENERGY; POLICY	Small Wind Turbines (SWTs) are a growing micro-generation industry with over 870,000 installed units worldwide. No research has focussed on public attitudes towards SWTs, despite evidence the perception of such attitudes are key to planning outcomes and can be a barrier to installations. Here we present the results of a UK wide mail survey investigating public attitudes towards SWTs. Just over half of our respondents, who were predominantly older, white males, felt that SWTs were acceptable across a range of settings, with those on road signs being most accepted and least accepted in hedgerows and gardens. Concern about climate change positively influenced how respondents felt about SWTs. Respondent comments highlight visual impacts and perceptions of the efficiency of this technology are particularly important to this sector of the UK public. Taking this into careful consideration, alongside avoiding locating SWTs in contentious settings such as hedgerows and gardens where possible, may help to minimise public opposition to proposed installations.	[Tatchley, Cerian; Paton, Heather; Robertson, Emma; Park, Kirsty] Univ Stirling, Biol & Environm Sci, Stirling FK9 4LA, Scotland; [Minderman, Jeroen] Sch Biol, Harold Mitchell Bldg, St Andrews, Fife, Scotland; [Hanley, Nicholas] Univ St Andrews, Dept Geog & Sustainable Dev, St Andrews KY16 9AJ, Fife, Scotland	University of Stirling; University of St Andrews; University of St Andrews	Tatchley, C (corresponding author), Univ Stirling, Biol & Environm Sci, Stirling FK9 4LA, Scotland.	c.k.tatchley@stir.ac.uk		Minderman, Jeroen/0000-0002-8451-5540; Hanley, Nick/0000-0002-1362-3499; Park, Kirsty/0000-0001-6080-7197	Natural Environment Research Council [NE/J500434/1]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was funded by a Natural Environment Research Council Studentship (grant reference NE/J500434/1; http://www.nerc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Bell D, 2005, ENVIRON POLIT, V14, P460, DOI 10.1080/09644010500175833; Bell D, 2013, ENVIRON POLIT, V22, P115, DOI 10.1080/09644016.2013.755793; Bergmann A, 2008, ECOL ECON, V65, P616, DOI 10.1016/j.ecolecon.2007.08.011; Bidwell D, 2013, ENERG POLICY, V58, P189, DOI 10.1016/j.enpol.2013.03.010; Braunholtz S., 2003, PUBLIC ATTITUDES WIN; Corp IBM, 2010, IBM SPSS STAT WIND V; De Vaus D., 2002, SURVEYS SOCIAL RES; DECC, 2013, PUBL ATT TRACK WAV 5; DECC, 2011, UK REN EN ROADM; Devine-Wright P, 2005, WIND ENERGY, V8, P125, DOI 10.1002/we.124; Ellis G, 2009, PLAN THEORY PRACT, V10, P521, DOI 10.1080/14649350903441555; Herberlein T.A., 2012, NAVIGATING ENV ATTIT; Jones CR, 2009, ENERG POLICY, V37, P4604, DOI 10.1016/j.enpol.2009.06.015; Minderman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041177; National Records of Scotland, 2012, MID 2011 POP EST SOC; Northern Ireland Statistics and Research Agency, 2012, CENS 2011 POP HOUS E; Norusis MJ, 2011, IBM SPSS STAT 19 ADV; Office for National Statistics, 2012, 2011 CENS ENGL WAL P; Office for National Statistics, 2013, 2011 CENS POP EST SI; Park A, 2012, BRIT SOCIAL ATTITUDE; Park KJ, 2013, J APPL ECOL, V50, P199, DOI 10.1111/jpe.12005; Renewable UK, 2014, STAT IND REP 2014; Renewable UK, 2015, SMALL MED WIND UK MA; Sapsford R., 1996, DATA COLLECTION ANAL; Scarpa R, 2010, ENERG ECON, V32, P129, DOI 10.1016/j.eneco.2009.06.004; Siminski P, 2008, QUAL QUANT, V42, P477, DOI 10.1007/s11135-006-9054-2; Stern N., 2006, REV EC CLIMATE CHANG; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thomas CD, 2012, NATURE, V482, pE4, DOI 10.1038/nature10858; Toke D, 2005, ENERG POLICY, V33, P1527, DOI 10.1016/j.enpol.2004.01.009; Tolonen H, 2006, EUR J EPIDEMIOL, V21, P409, DOI 10.1007/s10654-006-9019-8; Tourangeau R, 2004, ANNU REV PSYCHOL, V55, P775, DOI 10.1146/annurev.psych.55.090902.142040; Warren C.R., 2005, J ENVIRON PLANN MAN, V48, P853, DOI [DOI 10.1080/09640560500294376, 10.1080/09640560500294376]; Warren CR, 2009, SCOT GEOGR J, V125, P97, DOI 10.1080/14702540802712502; Wolsink M, 1988, ENV IMPACT ASSES, V8, P334; Wolsink M, 2007, RENEW SUST ENERG REV, V11, P1188, DOI 10.1016/j.rser.2005.10.005; World Wind Energy Association, 2015, SMALL WIND WORLD REP	39	3	3	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152033	10.1371/journal.pone.0152033	http://dx.doi.org/10.1371/journal.pone.0152033			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3SV	27011356	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000372708000074
J	Hawkins, RXD; Goldstone, RL				Hawkins, Robert X. D.; Goldstone, Robert L.			The Formation of Social Conventions in Real-Time Environments	PLOS ONE			English	Article							COORDINATION; DYNAMICS; EMERGENCE; CONFLICT	Why are some behaviors governed by strong social conventions while others are not? We experimentally investigate two factors contributing to the formation of conventions in a game of impure coordination: the continuity of interaction within each round of play (simultaneous vs. real-time) and the stakes of the interaction (high vs. low differences between payoffs). To maximize efficiency and fairness in this game, players must coordinate on one of two equally advantageous equilibria. In agreement with other studies manipulating continuity of interaction, we find that players who were allowed to interact continuously within rounds achieved outcomes with greater efficiency and fairness than players who were forced to make simultaneous decisions. However, the stability of equilibria in the real-time condition varied systematically and dramatically with stakes: players converged on more stable patterns of behavior when stakes are high. To account for this result, we present a novel analysis of the dynamics of continuous interaction and signaling within rounds. We discuss this previously unconsidered interaction between within-trial and across-trial dynamics as a form of social canalization. When stakes are low in a real-time environment, players can satisfactorily coordinate 'on the fly', but when stakes are high there is increased pressure to establish and adhere to shared expectations that persist across rounds.	[Hawkins, Robert X. D.] Stanford Univ, Dept Psychol, Palo Alto, CA 94304 USA; [Hawkins, Robert X. D.; Goldstone, Robert L.] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA	Stanford University; Indiana University System; Indiana University Bloomington	Hawkins, RXD (corresponding author), Stanford Univ, Dept Psychol, Palo Alto, CA 94304 USA.; Hawkins, RXD (corresponding author), Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA.	rxdh@stanford.edu			National Science Foundation; Stanford Graduate Fellowship; National Science Foundation Research and Evaluation on Education in Science and Engineering [0910218]	National Science Foundation(National Science Foundation (NSF)); Stanford Graduate Fellowship(Stanford University); National Science Foundation Research and Evaluation on Education in Science and Engineering	This work was supported in part by a National Science Foundation Graduate Research Fellowship and Stanford Graduate Fellowship (to RXDH) and National Science Foundation Research and Evaluation on Education in Science and Engineering grant 0910218 (to RLG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CLARENDON LECT EC; Aumann Robert J., 1974, J MATH ECON, V1, P67, DOI 10.1016/0304-4068(74)90037-8; Beer RD, 2000, TRENDS COGN SCI, V4, P91, DOI 10.1016/S1364-6613(99)01440-0; Bicchieri C., 2005, GRAMMAR SOC NATURE D; Binmore K, 2005, NATURAL JUSTICE; Brennan SE, 1996, J EXP PSYCHOL LEARN, V22, P1482, DOI 10.1037/0278-7393.22.6.1482; Caldwell CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043807; Centola D, 2015, P NATL ACAD SCI USA, V112, P1989, DOI 10.1073/pnas.1418838112; David Lewis, 1969, CONVENTION PHILOS ST; Frey S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056416; Friedman D, 2012, AM ECON REV, V102, P337, DOI 10.1257/aer.102.1.337; GARROD S, 1994, COGNITION, V53, P181, DOI 10.1016/0010-0277(94)90048-5; GARROD S, 1987, COGNITION, V27, P181, DOI 10.1016/0010-0277(87)90018-7; Gintis H, 2015, REV BEHAV ECON, V2, P1, DOI 10.1561/105.00000016; Grice H.P, 1975, SYNTAX SEMANTICS, V3, P43; Hawkins RXD, 2015, BEHAV RES METHODS, V47, P966, DOI 10.3758/s13428-014-0515-6; Helbing D, 2005, TRANSPORT SCI, V39, P1, DOI 10.1287/trsc.1040.0108; Helbing D, 2005, ADV COMPLEX SYST, V8, P87, DOI 10.1142/S0219525905000361; Hinton G. E., 1987, Complex Systems, V1, P495; Jackson MO, 2014, P NATL ACAD SCI USA, V111, P10889, DOI 10.1073/pnas.1400826111; Koop GJ, 2011, JUDGM DECIS MAK, V6, P750; Lau SHP, 2008, THEOR DECIS, V65, P153, DOI 10.1007/s11238-008-9100-8; Oprea R, 2014, J ECON BEHAV ORGAN, V108, P212, DOI 10.1016/j.jebo.2014.09.012; Oprea R, 2011, J ECON THEORY, V146, P2206, DOI 10.1016/j.jet.2011.10.014; Rasmusen E, 2006, GAMES INFORM INTRO G; Schotter A, 2003, J POLIT ECON, V111, P498, DOI 10.1086/374187; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Spivey MJ, 2006, CURR DIR PSYCHOL SCI, V15, P207, DOI 10.1111/j.1467-8721.2006.00437.x; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; van Doorn GS, 2014, J THEOR BIOL, V356, P1, DOI 10.1016/j.jtbi.2014.03.019; Vanderschraaf P, 2003, ERKENNTNIS, V59, P311, DOI 10.1023/A:1026046625024; WADDINGTON CH, 1956, EVOLUTION, V10, P1, DOI 10.2307/2406091; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Weber RA, 2003, MANAGE SCI, V49, P400, DOI 10.1287/mnsc.49.4.400.14430	35	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151670	10.1371/journal.pone.0151670	http://dx.doi.org/10.1371/journal.pone.0151670			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3OX	27002729	gold, Green Published, Green Submitted			2022-12-26	WOS:000372697400036
J	Toderici, M; de la Morena-Barrio, ME; Padilla, J; Minano, A; Anton, AI; Iniesta, JA; Herranz, MT; Fernandez, N; Vicente, V; Corral, J				Toderici, Mara; Eugenia de la Morena-Barrio, Maria; Padilla, Jose; Minano, Antonia; Isabel Anton, Ana; Antonio Iniesta, Juan; Teresa Herranz, Maria; Fernandez, Nuria; Vicente, Vicente; Corral, Javier			Identification of Regulatory Mutations in SERPINC1 Affecting Vitamin D Response Elements Associated with Antithrombin Deficiency	PLOS ONE			English	Article							VENOUS THROMBOEMBOLISM; RISK-FACTORS; PROTEIN-S; III GENE; THROMBOSIS; EXPRESSION; REGIONS; MICE; SUPPLEMENTATION; THROMBOPHILIA	Antithrombin is a crucial anticoagulant serpin whose even moderate deficiency significantly increases the risk of thrombosis. Most cases with antithrombin deficiency carried genetic defects affecting exons or flanking regions of SERPINC1. We aimed to identify regulatory mutations inSERPINC1 through sequencing the promoter, intron 1 and 2 of this gene in 23 patients with antithrombin deficiency but without known genetic defects. Three cases with moderate antithrombin deficiency (63-78%) carried potential regulatory mutations. One located 200 bp before the initiation ATG and two in intron 1. These mutations disrupted two out of five potential vitamin D receptor elements (VDRE) identified in SERPINC1 with different software. One genetic defect, c.42-1060_-1057dupTTGA, was a new low prevalent polymorphism (MAF: 0.01) with functional consequences on plasma antithrombin levels. The relevance of the vitamin D pathway on the regulation of SERPINC1 was confirmed in a cell model. Incubation of HepG2 with paricalcitol, a vitamin D analog, increased dose-dependently the levels of SERPINC1transcripts and antithrombin released to the conditioned medium. This study shows further evidence of the transcriptional regulation of SERPINC1 by vitamin D and first describes the functional and pathological relevance of mutations affecting VDRE of this gene. Our study opens new perspectives in the search of new genetic defects involved in antithrombin deficiency and the risk of thrombosis as well as in the design of new antithrombotic treatments.	[Toderici, Mara; Eugenia de la Morena-Barrio, Maria; Padilla, Jose; Minano, Antonia; Isabel Anton, Ana; Vicente, Vicente; Corral, Javier] Univ Murcia, Hosp Univ Morales Meseguer, Ctr Reg Hemodonac, Serv Hematol & Oncol Med,IMIB Arrixaca, Murcia, Spain; [Antonio Iniesta, Juan] Hosp Univ Reina Sofia, Serv Neurol, Murcia, Spain; [Teresa Herranz, Maria] Hosp Univ Morales Meseguer, Serv Med Interna, Murcia, Spain; [Fernandez, Nuria] Hosp Univ Miguel Servet, Serv Hematol & Hemoterapia, Zaragoza, Spain	Hospital Clinico Universitario Virgen de la Arrixaca; Meseguer General University Hospital Morales; University of Murcia; Meseguer General University Hospital Morales; Miguel Servet University Hospital	de la Morena-Barrio, ME (corresponding author), Univ Murcia, Hosp Univ Morales Meseguer, Ctr Reg Hemodonac, Serv Hematol & Oncol Med,IMIB Arrixaca, Murcia, Spain.	uge2985@hotmail.com	Anton, Ana I. I/M-2962-2018; de la Morena-Barrio, ME/AAG-5103-2021; Vicente, Vicente/L-6185-2019	Anton, Ana I. I/0000-0003-1527-6096; de la Morena-Barrio, ME/0000-0001-7426-4947; Vicente, Vicente/0000-0002-4278-3264; Herranz, M. T./0000-0003-4194-4668; PADILLA RUIZ, JOSE/0000-0003-1599-7870; Corral, Javier/0000-0003-0288-1107				Aguila S, 2013, THROMB HAEMOSTASIS, V109, P556, DOI 10.1160/TH12-09-0707; Aihara K, 2004, J BIOL CHEM, V279, P35798, DOI 10.1074/jbc.M404865200; Anton AI, 2009, HAEMATOL-HEMATOL J, V94, P589, DOI 10.3324/haematol.2008.000604; Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; Bjork I, 1997, ADV EXP MED BIOL, V425, P17; Blondon M, 2015, THROMB HAEMOSTASIS, V113, P999, DOI 10.1160/TH14-05-0478; BOCK SC, 1983, NUCLEIC ACIDS RES, V11, P8569, DOI 10.1093/nar/11.24.8569; Brodin EE, 2013, THROMB HAEMOSTASIS, V109, P885, DOI 10.1160/TH12-10-0728; Bucciarelli P, 2012, J THROMB HAEMOST, V10, P1783, DOI 10.1111/j.1538-7836.2012.04858.x; Caspers M, 2012, THROMB HAEMOSTASIS, V108, P247, DOI 10.1160/TH11-12-0875; CHOWDHURY V, 1993, BRIT J HAEMATOL, V84, P656, DOI 10.1111/j.1365-2141.1993.tb03142.x; CONLON MG, 1994, THROMB HAEMOSTASIS, V72, P551; Corral J, 2007, BLOOD, V109, P4258, DOI 10.1182/blood-2006-08-040774; EGEBERG O, 1965, THROMB DIATH HAEMOST, V13, P516, DOI 10.1055/s-0038-1656297; de la Morena-Barrio ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064998; de la Morena-Barrio ME, 2012, THROMB HAEMOSTASIS, V107, P430, DOI 10.1160/TH11-10-0701; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; FernandezRachubinski FA, 1996, J BIOL CHEM, V271, P29502, DOI 10.1074/jbc.271.46.29502; Folsom AR, 2014, J THROMB HAEMOST, V12, P1455, DOI 10.1111/jth.12665; Germain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025581; Hawa NS, 1996, BIOCHEM BIOPH RES CO, V228, P352, DOI 10.1006/bbrc.1996.1665; Hernandez-Espinosa D, 2006, AM J PATHOL, V169, P142, DOI 10.2353/ajpath.2006.051238; Ishiguro K, 2000, J CLIN INVEST, V106, P873, DOI 10.1172/JCI10489; Lindqvist PG, 2013, THROMB HAEMOSTASIS, V109, P787, DOI 10.1160/TH13-03-0235; Liu Y, 2014, BLOOD, V124, P142, DOI 10.1182/blood-2014-03-561027; Luxembourg B, 2011, THROMB HAEMOSTASIS, V105, P635, DOI 10.1160/TH10-08-0538; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Mushunje A, 2004, J THROMB HAEMOST, V2, P2170, DOI 10.1111/j.1538-7836.2004.01047.x; Niessen RWLM, 1996, BIOCHEM J, V318, P263, DOI 10.1042/bj3180263; OCHOA A, 1989, NUCLEIC ACIDS RES, V17, P119, DOI 10.1093/nar/17.1.119; OLDS RJ, 1993, BIOCHEMISTRY-US, V32, P4216, DOI 10.1021/bi00067a008; Perry DJ, 1996, HUM MUTAT, V7, P7, DOI 10.1002/(SICI)1098-1004(1996)7:1<7::AID-HUMU2>3.3.CO;2-A; PROCHOWNIK EV, 1985, NATURE, V316, P845, DOI 10.1038/316845a0; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sheffield WP, 1995, MOL BASIS THROMBOSIS, P355; Targher G, 2012, SEMIN THROMB HEMOST, V38, P114, DOI 10.1055/s-0031-1300957; TREMP GL, 1995, GENE, V156, P199, DOI 10.1016/0378-1119(95)00010-4; Vuckovic BA, 2015, AM J CLIN NUTR, V101, P606, DOI 10.3945/ajcn.114.095398	38	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152159	10.1371/journal.pone.0152159	http://dx.doi.org/10.1371/journal.pone.0152159			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003919	Green Submitted, Green Published, gold			2022-12-26	WOS:000372697400088
J	Zhou, T; Li, CY; Zhao, WN; Wang, XR; Wang, FQ; Sha, JH				Zhou, Tao; Li, Chuyu; Zhao, Wene; Wang, Xinru; Wang, Fuqiang; Sha, Jiahao			MaxReport: An Enhanced Proteomic Result Reporting Tool for MaxQuant	PLOS ONE			English	Article							PEPTIDE IDENTIFICATION; QUANTIFICATION; GUIDELINES; COMPLEX	MaxQuant is a proteomic software widely used for large-scale tandem mass spectrometry data. We have designed and developed an enhanced result reporting tool for MaxQuant, named as MaxReport. This tool can optimize the results of MaxQuant and provide additional functions for result interpretation. MaxReport can generate report tables for protein N-terminal modifications. It also supports isobaric labelling based relative quantification at the protein, peptide or site level. To obtain an overview of the results, MaxReport performs general descriptive statistical analyses for both identification and quantification results. The output results of MaxReport are well organized and therefore helpful for proteomic users to better understand and share their data. The script of MaxReport, which is freely available at http://websdoor.net/bioinfo/maxreport/, is developed using Python code and is compatible across multiple systems including Windows and Linux.	[Zhou, Tao; Li, Chuyu; Wang, Xinru; Sha, Jiahao] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China; [Zhao, Wene; Wang, Fuqiang] Nanjing Med Univ, Analyt & Testing Ctr, Nanjing 210029, Jiangsu, Peoples R China	Nanjing Medical University	Wang, XR (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China.; Wang, FQ (corresponding author), Nanjing Med Univ, Analyt & Testing Ctr, Nanjing 210029, Jiangsu, Peoples R China.	xrwang@njmu.edu.cn; wangfq@njmu.edu.cn	Wang, Xin/GYU-1129-2022; Wang, Xin/AAN-8435-2021; Zhou, Tao/H-1094-2013	Wang, Xin/0000-0002-4457-7376; Zhou, Tao/0000-0003-2219-6385; Wang, Fuqiang/0000-0002-7777-3541; Zhao, Wene/0000-0003-0497-5027	National Natural Science Foundation of China [31400727]; China Postdoctoral Science Foundation [2015M581836]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The work was supported by the National Natural Science Foundation of China (no. 31400727). FW received the funding. The work was also supported by the China Postdoctoral Science Foundation (no. 2015M581836). TZ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arntzen MO, 2011, J PROTEOME RES, V10, P913, DOI 10.1021/pr1009977; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Deutsch EW, 2010, PROTEOMICS, V10, P1150, DOI 10.1002/pmic.200900375; Gatto L, 2014, BBA-PROTEINS PROTEOM, V1844, P42, DOI 10.1016/j.bbapap.2013.04.032; Jones AR, 2008, MOL CELL PROTEOMICS, V7, P2067, DOI 10.1074/mcp.H800010-MCP200; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Martinez-Bartolome S, 2013, J PROTEOMICS, V95, P84, DOI 10.1016/j.jprot.2013.02.026; Perkel JM, 2015, NATURE, V518, P125, DOI 10.1038/518125a; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Shao BB, 2015, J PROTEOMICS, V120, P35, DOI 10.1016/j.jprot.2015.02.015; Spudich GM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-295; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Vaudel M, 2010, PROTEOMICS, V10, P650, DOI 10.1002/pmic.200900481; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang J, 2015, MOL CELL PROTEOMICS, V14, P1104, DOI 10.1074/mcp.M114.045468; Wen B, 2014, PROTEOMICS, V14, P2280, DOI 10.1002/pmic.201300361; Wright JC, 2012, MOL CELL PROTEOMICS, V11, P478, DOI 10.1074/mcp.O111.014522; Zhou T, 2015, J PROTEOMICS; Zhou T, 2015, PROTEOMICS, V15, P1564, DOI 10.1002/pmic.201400248; Zieske LR, 2006, J EXP BOT, V57, P1501, DOI 10.1093/jxb/erj168	23	11	12	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152067	10.1371/journal.pone.0152067	http://dx.doi.org/10.1371/journal.pone.0152067			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003708	Green Published, gold			2022-12-26	WOS:000372697400072
J	Atif, M; Javaid, S; Farooqui, M; Sarwar, MR				Atif, Muhammad; Javaid, Sareema; Farooqui, Maryam; Sarwar, Muhammad Rehan			Rights and Responsibilities of Tuberculosis Patients, and the Global Fund: A Qualitative Study	PLOS ONE			English	Article							EXPERIENCES; AFRICA	Background Implementation of the Charter to protect patients' rights is an important criterion to achieve patient-centered approach and receive financial support from the Global Fund. Our study aims to explore the knowledge of tuberculosis (TB) patients about their rights and responsibilities at the Chest Disease Unit of the Bahawal Victoria Hospital, Bahawalpur, Pakistan. Methods This was a qualitative study. The data from purposefully selected TB patients was collected by in-depth interviews. Eligibility criteria included confirmed diagnosis of TB and enrollment in the TB program. A pilot tested interview protocol was based upon the objectives of the study, and was used uniformly in each interview to maintain the consistency. The sample size was limited by applying the saturation criteria. All interviews were audiotaped and transcribed verbatim. Inductive thematic content analysis was applied to analyze the data and draw conclusions. Results Out of the total 16 patients, four were female, and seven were illiterate. Eight patients were known cases of multi-drug resistant TB. Analysis of the data yielded seven themes; tuberculosis care services, moral support and stigmatization, dignity and privacy, complaints, fear of losing job, information sharing and compliance to the treatment plan, and contribution to eradicate TB. First five represented the rights section while latter two were related to the responsibilities section of the Charter. Conclusion Discriminatory access to TB care services and the right to privacy were two major concerns identified in this study. However, the respondents recognized their responsibilities as a TB patient. To ensure uninterrupted investment from the Global Fund, there is a need to implement fair TB care policies which support human rights-based approach.	[Atif, Muhammad; Javaid, Sareema; Sarwar, Muhammad Rehan] Islamia Univ Bahawalpur, Dept Pharm, Bahawalpur, Punjab, Pakistan; [Farooqui, Maryam] Univ Teknol MARA, Fac Pharm, Bertam Campus, Kepala Batas, Penang, Malaysia	Islamia University of Bahawalpur	Atif, M (corresponding author), Islamia Univ Bahawalpur, Dept Pharm, Bahawalpur, Punjab, Pakistan.	muhammad.atif@iub.edu.pk		Farooqui, Maryam/0000-0002-3380-5855; Sarwar, Muhammad Rehan/0000-0003-4312-9157				Anderson C, 2010, AM J PHARM EDUC, V74, DOI 10.5688/aj7408141; Behzadifar M, 2015, IRAN RED CRESCENT ME, V17, DOI 10.5812/ircmj.17(4)2015.20277; Coyne IT, 1997, J ADV NURS, V26, P623, DOI 10.1046/j.1365-2648.1997.t01-25-00999.x; Cremers AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119861; Dodor E A, 2012, Ghana Med J, V46, P211; Guion LA., 2002, EDIS, V2002; Lewis CP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-190; Dias AAL, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-595; Morse JM, 2000, QUAL HEALTH RES, V10, P3, DOI 10.1177/104973200129118183; Murray EJ, 2013, HEALTH POLICY PLANN, V28, P410, DOI 10.1093/heapol/czs072; Ritchie J., 2003, GUIDE SOCIAL SCI STU, P77; Rundi C, 2010, J HEALTH POPUL NUTR, V28, P114; Slagle T, 2014, BMC INT HEALTH HUM R, V14, DOI 10.1186/s12914-014-0034-7; Starks H, 2007, QUAL HEALTH RES, V17, P1372, DOI 10.1177/1049732307307031; Stop TB Partnership, 2015, TB HUM RIGHTS TASK F; The Global Fund, 2015, TUB HUM RIGHTS INFR; Tuberculosis Coalition for Technical Assistance, 2006, INT STAND TUB CAR; *UNAIDS, 2010, NOND HIV RESP; UNAIDS and TB Care I, TB CAR PAT CTR APPR; United Nations Development Programme, 2015, FACTSH HUM RIGHTS 3; Vukovic DS, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-284; WHO, 2014, GLOB TUB REP 2014; World Care Council, 2006, PAT CHART TUB CAR; World Health Organization, 2009, WHO POL TB INF CONTR; World Health Organization, 2006, THE STOP TB STRAT; World Health Organization, 2015, GLOB TUB REP 2015; World Health Organization, PAK STOP TUB; Zachariah R, 2012, INT J TUBERC LUNG D, V16, P714, DOI 10.5588/ijtld.11.0635	28	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151321	10.1371/journal.pone.0151321	http://dx.doi.org/10.1371/journal.pone.0151321			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3NW	26998830	gold, Green Submitted, Green Published			2022-12-26	WOS:000372694700031
J	Bourdier, T; Cordonnier, T; Kunstler, G; Piedallu, C; Lagarrigues, G; Courbaud, B				Bourdier, Thomas; Cordonnier, Thomas; Kunstler, Georges; Piedallu, Christian; Lagarrigues, Guillaume; Courbaud, Benoit			Tree Size Inequality Reduces Forest Productivity: An Analysis Combining Inventory Data for Ten European Species and a Light Competition Model	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; AREA INCREMENT MODEL; USE EFFICIENCY; PLANT DIVERSITY; STAND STRUCTURE; NORWAY SPRUCE; ASYMMETRIC COMPETITION; STRUCTURAL COMPLEXITY; CONIFEROUS FORESTS; GROWTH	Plant structural diversity is usually considered as beneficial for ecosystem functioning. For instance, numerous studies have reported positive species diversity-productivity relationships in plant communities. However, other aspects of structural diversity such as individual size inequality have been far less investigated. In forests, tree size inequality impacts directly tree growth and asymmetric competition, but consequences on forest productivity are still indeterminate. In addition, the effect of tree size inequality on productivity is likely to vary with species shade-tolerance, a key ecological characteristic controlling asymmetric competition and light resource acquisition. Using plot data from the French National Geographic Agency, we studied the response of stand productivity to size inequality for ten forest species differing in shade tolerance. We fitted a basal area stand production model that included abiotic factors, stand density, stand development stage and a tree size inequality index. Then, using a forest dynamics model we explored whether mechanisms of light interception and light use efficiency could explain the tree size inequality effect observed for three of the ten species studied. Size inequality negatively affected basal area increment for seven out of the ten species investigated. However, this effect was not related to the shade tolerance of these species. According to the model simulations, the negative tree size inequality effect could result both from reduced total stand light interception and reduced light use efficiency. Our results demonstrate that negative relationships between size inequality and productivity may be the rule in tree populations. The lack of effect of shade tolerance indicates compensatory mechanisms between effect on light availability and response to light availability. Such a pattern deserves further investigations for mixed forests where complementarity effects between species are involved. When studying the effect of structural diversity on ecosystem productivity, tree size inequality is a major facet that should be taken into account.	[Bourdier, Thomas; Cordonnier, Thomas; Kunstler, Georges; Lagarrigues, Guillaume; Courbaud, Benoit] Irstea, UR EMGR, Ctr Grenoble, 2 Rue Papeterie BP 76, F-38402 St Martin Dheres, France; [Bourdier, Thomas; Cordonnier, Thomas; Kunstler, Georges; Lagarrigues, Guillaume; Courbaud, Benoit] Univ Grenoble Alpes, F-38402 Grenoble, France; [Piedallu, Christian] AgroParisTech, UMR1092, ENGREF, LERFoB, 14 Rue Girardet,CS14216, FR-54042 Nancy, France	INRAE; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); AgroParisTech	Bourdier, T (corresponding author), Irstea, UR EMGR, Ctr Grenoble, 2 Rue Papeterie BP 76, F-38402 St Martin Dheres, France.; Bourdier, T (corresponding author), Univ Grenoble Alpes, F-38402 Grenoble, France.	thomas.bourdier@irstea.fr	Kunstler, Georges/F-9179-2012; Cordonnier, Thomas/I-2586-2019	Kunstler, Georges/0000-0002-2544-1940; Cordonnier, Thomas/0000-0003-3684-4662	DIVCLIM (DEB); DISTIMACC (BGF) [Ecofor 2014-23]; Irstea; French Environment and Energy Management Agency (ADEME); French Forest National Office (ONF)	DIVCLIM (DEB); DISTIMACC (BGF); Irstea; French Environment and Energy Management Agency (ADEME); French Forest National Office (ONF)	This study was funded by the DIVCLIM (DEB) and DISTIMACC (BGF, no Ecofor 2014-23 http://bgf.gip-ecofor.org/) projects. Thomas Bourdier was funded by a research grant from Irstea and Guillaume Lagarrigues by the French Environment and Energy Management Agency (ADEME) and the French Forest National Office (ONF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmann E, 1970, STUDIES ORGANIC PROD, P506; Bagnaresi U, 2002, FORESTRY, V75, P357, DOI 10.1093/forestry/75.4.357; Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; Binkley D, 2013, FOREST ECOL MANAG, V288, P5, DOI 10.1016/j.foreco.2011.11.002; Binkley D, 2010, FOREST ECOL MANAG, V259, P1704, DOI 10.1016/j.foreco.2009.05.037; Bugmann H, 1998, FOREST ECOL MANAG, V103, P247, DOI 10.1016/S0378-1127(97)00217-X; BUONGIORNO J, 1994, FOREST SCI, V40, P83; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Callaway RM, 1995, BOT REV, V61, P306, DOI 10.1007/BF02912621; Campoe OC, 2013, FOREST ECOL MANAG, V288, P43, DOI 10.1016/j.foreco.2012.05.026; Campoe OC, 2013, FOREST ECOL MANAG, V288, P14, DOI 10.1016/j.foreco.2012.07.035; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Caspersen JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028660; Cordonnier T, 2015, PERSPECT PLANT ECOL, V17, P107, DOI 10.1016/j.ppees.2015.01.001; Courbaud B, 2003, AGR FOREST METEOROL, V116, P1, DOI 10.1016/S0168-1923(02)00254-X; Damgaard C, 2000, ECOLOGY, V81, P1139, DOI 10.1890/0012-9658(2000)081[1139:DIIPSO]2.0.CO;2; De Boeck HJ, 2006, OIKOS, V113, P269, DOI 10.1111/j.2006.0030-1299.14257.x; Duduman G, 2011, FORESTRY, V84, P301, DOI 10.1093/forestry/cpr014; Forrester DI, 2014, FOREST ECOL MANAG, V328, P94, DOI 10.1016/j.foreco.2014.05.026; Gadow K, 2012, CONTINUOUS COVER FOR, DOI [10.1007/978-94-007-2202-6, DOI 10.1007/978-94-007-2202-6]; Gamfeldt L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2328; Gspaltl M, 2013, FOREST ECOL MANAG, V288, P49, DOI 10.1016/j.foreco.2011.11.044; Hardiman BS, 2011, ECOLOGY, V92, P1818, DOI 10.1890/10-2192.1; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Kelty M.J., 1992, ECOLOGY SILVICULTURE; Kiraly I, 2010, BIOL CONSERV, V143, P2063, DOI 10.1016/j.biocon.2010.05.014; Kunstler G, 2011, J ECOL, V99, P300, DOI 10.1111/j.1365-2745.2010.01751.x; Lafond V, 2015, ENVIRON MANAGE, V56, P1118, DOI 10.1007/s00267-015-0557-2; Lafond V, 2014, ANN FOREST SCI, V71, P173, DOI 10.1007/s13595-013-0291-y; Laurans M, 2014, FOREST ECOL MANAG, V329, P79, DOI 10.1016/j.foreco.2014.05.059; le Maire G, 2013, FOREST ECOL MANAG, V288, P31, DOI 10.1016/j.foreco.2012.03.005; Lei XD, 2009, CAN J FOREST RES, V39, P1835, DOI 10.1139/X09-089; Lexerod NL, 2006, FOREST ECOL MANAG, V222, P17, DOI 10.1016/j.foreco.2005.10.046; Liang JJ, 2007, FOREST ECOL MANAG, V243, P116, DOI 10.1016/j.foreco.2007.02.028; Liang JJ, 2005, CAN J FOREST RES, V35, P2368, DOI 10.1139/X05-137; Long JN, 2010, FORESTRY, V83, P121, DOI 10.1093/forestry/cpp033; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; McElhinny C, 2005, FOREST ECOL MANAG, V218, P1, DOI 10.1016/j.foreco.2005.08.034; Messier C, 1998, J VEG SCI, V9, P511, DOI 10.2307/3237266; Monserud RA, 1996, FOREST ECOL MANAG, V80, P57, DOI 10.1016/0378-1127(95)03638-5; Morin X, 2011, ECOL LETT, V14, P1211, DOI 10.1111/j.1461-0248.2011.01691.x; Niinemets U, 2010, ECOL RES, V25, P693, DOI 10.1007/s11284-010-0712-4; Niinemets U, 2006, ECOL MONOGR, V76, P521, DOI 10.1890/0012-9615(2006)076[0521:TTSDAW]2.0.CO;2; O'Hara KL, 2007, FORESTRY, V80, P163, DOI 10.1093/forestry/cpl051; Oliver C.D., 1996, FOREST STAND DYNAMIC; Onoda Y, 2014, J ECOL, V102, P167, DOI 10.1111/1365-2745.12184; Paquette A, 2011, GLOBAL ECOL BIOGEOGR, V20, P170, DOI 10.1111/j.1466-8238.2010.00592.x; Piedallu C, 2011, MAPPING SOIL WATER H; Piedallu C, 2008, AGR FOREST METEOROL, V148, P1696, DOI 10.1016/j.agrformet.2008.06.001; Piedallu C, 2013, GLOBAL ECOL BIOGEOGR, V22, P470, DOI 10.1111/geb.12012; Pokharel B, 2012, FORESTRY, V85, P255, DOI 10.1093/forestry/cpr070; Pommerening A, 2002, FORESTRY, V75, P305, DOI 10.1093/forestry/75.3.305; Pretzsch H, 2005, ECOL STUD-ANAL SYNTH, V176, P41; Pretzsch H., 2010, FOREST DYNAMICS GROW, P664, DOI DOI 10.1007/978-3-540-88307-4; Pretzsch H, 2010, CAN J FOREST RES, V40, P370, DOI 10.1139/X09-195; Ryan MG, 2010, FOREST ECOL MANAG, V259, P1695, DOI 10.1016/j.foreco.2010.01.013; Schutz JP, 2002, FORESTRY, V75, P329, DOI 10.1093/forestry/75.4.329; Schwinning S, 1998, OECOLOGIA, V113, P447, DOI 10.1007/s004420050397; Schwinning S, 1996, ANN BOT-LONDON, V77, P47, DOI 10.1006/anbo.1996.0006; Smith D.M., 1997, PRACTICE SILVICULTUR; Staudhammer CL, 2001, CAN J FOREST RES, V31, P1105, DOI 10.1139/x01-033; THOMAS SC, 1989, OECOLOGIA, V80, P349, DOI 10.1007/BF00379036; TURC L., 1961, Annales Agronomiques, V12, P13; Valbuena R., 2015, DISSERTATION FORESTA, V205, P1; Valbuena R, 2013, CAN J FOREST RES, V43, P1063, DOI 10.1139/cjfr-2013-0147; Valbuena R, 2012, FOREST ECOL MANAG, V276, P185, DOI 10.1016/j.foreco.2012.03.036; Valladares F, 2008, ANNU REV ECOL EVOL S, V39, P237, DOI 10.1146/annurev.ecolsys.39.110707.173506; Vallet P, 2006, FOREST ECOL MANAG, V229, P98, DOI 10.1016/j.foreco.2006.03.013; Vallet P, 2011, J VEG SCI, V22, P932, DOI 10.1111/j.1654-1103.2011.01288.x; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; WYKOFF WR, 1990, FOREST SCI, V36, P1077; Xiao X, 2011, ECOLOGY, V92, P1887, DOI 10.1890/11-0538.1; ZEIDE B, 1985, FOREST ECOL MANAG, V13, P149, DOI 10.1016/0378-1127(85)90031-3; Zhang Y, 2012, J ECOL, V100, P742, DOI 10.1111/j.1365-2745.2011.01944.x	75	77	83	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151852	10.1371/journal.pone.0151852	http://dx.doi.org/10.1371/journal.pone.0151852			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999820	Green Published, Green Submitted, gold			2022-12-26	WOS:000372694700073
J	Liu, JW; Zhao, L; Luo, LM; Liu, MM; Sun, Y; Su, X; Yu, XJ				Liu, Jian-Wei; Zhao, Li; Luo, Li-Mei; Liu, Miao-Miao; Sun, Yue; Su, Xiang; Yu, Xue-Jie			Molecular Evolution and Spatial Transmission of Severe Fever with Thrombocytopenia Syndrome Virus Based on Complete Genome Sequences	PLOS ONE			English	Article							HAEMAPHYSALIS-LONGICORNIS TICKS; HEMORRHAGIC-FEVER; SOUTH-KOREA; EBOLA-VIRUS; CHINA; PHLEBOVIRUS; INTERFERON; IDENTIFICATION; BUNYAVIRIDAE; REASSORTMENT	Severe fever with thrombocytopenia syndrome virus (SFTSV) was a novel tick-borne bunyavirus that caused hemorrhagic fever with a high fatality rate in East Asia. In this study we analyzed the complete genome sequences of 122 SFTSV strains to determine the phylogeny, evolution and reassortment of the virus. We revealed that the evolutionary rate of three genome segments were different, with highest in the S segment and lowest in the L segment. The SFTSV strains were phylogenetically classified into 5 lineages (A, B, C, D and E) with each genome segment. SFTSV strains from China were classified in all 5 lineages, strains from South Korea were classified into 3 lineages (A, D, and E), and all strains from Japan were classified in only linage E. Using the average evolutionary rate of the three genome segments, we found that the extant SFTSV originated 20-87 years ago in the Dabie Mountain area in central China. The viruses were then transmitted to other areas of China, Japan and South Korea. We also found that six SFTSV strains were reassortants. Selection pressure analysis suggested that SFTSV was under purifying selection according to the four genes (RNA-dependent RNA polymerase, glycoprotein, nucleocapsid protein, non-structural protein), and two sites (37, 1033) of glycoproteins were identified as being under strong positive selection. We concluded that SFTSV originated in central China and spread to other places recently and the virus was under purifying selection with high frequency of reassortment.	[Liu, Jian-Wei; Zhao, Li; Luo, Li-Mei; Liu, Miao-Miao; Sun, Yue; Su, Xiang; Yu, Xue-Jie] Shandong Univ, Sch Publ Hlth, Jinan 250100, Shandong, Peoples R China; [Yu, Xue-Jie] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA	Shandong University; University of Texas System; University of Texas Medical Branch Galveston	Yu, XJ (corresponding author), Shandong Univ, Sch Publ Hlth, Jinan 250100, Shandong, Peoples R China.; Yu, XJ (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.	xuyu@utmb.edu	Yu, Xuejie/AAP-9246-2021		Shandong Province Science and Technology Development Program [2014GSF121004]; National Nature Science Foundation of China [31570167]; National Natural Science Funds of China [31570167]	Shandong Province Science and Technology Development Program; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Funds of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from Shandong Province Science and Technology Development Program (2014GSF121004) and a grant from the National Nature Science Foundation of China (31570167).; This study was supported by the National Natural Science Funds of China (31570167), Shandong Province Science and Technology Development Program (2014GSF121004).	Bao CJ, 2011, CLIN INFECT DIS, V53, P1208, DOI 10.1093/cid/cir732; Biek R, 2006, SCIENCE, V311, P538, DOI 10.1126/science.1121360; Bowden TA, 2011, J STRUCT BIOL, V175, P120, DOI 10.1016/j.jsb.2011.03.016; Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594; Carroll SA, 2013, J VIROL, V87, P2608, DOI 10.1128/JVI.03118-12; Denison MR, 2011, RNA BIOL, V8, P270, DOI 10.4161/rna.8.2.15013; Diang SJ, 2014, JPN J INFECT DIS, V67, P1, DOI 10.7883/yoken.67.1; Ding NZ, 2013, VIRUS RES, V178, P543, DOI 10.1016/j.virusres.2013.09.017; Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636; Firth C, 2010, MOL BIOL EVOL, V27, P2038, DOI 10.1093/molbev/msq088; Freire CCM, 2015, SCI REP-UK, V5, DOI 10.1038/srep11353; Fu YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep19563; Gerrard SR, 2004, J VIROL, V78, P8922, DOI 10.1128/JVI.78.16.8922-8926.2004; Huang XY, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003237; Kim KH, 2013, EMERG INFECT DIS, V19, P1892, DOI 10.3201/eid1911.130792; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Lam TTY, 2013, EPIDEMICS-NETH, V5, P1, DOI 10.1016/j.epidem.2012.09.002; Lei XY, 2015, MICROBES INFECT, V17, P149, DOI 10.1016/j.micinf.2014.12.002; Liu J, 2013, J IRON STEEL RES INT, V20, P20, DOI 10.1016/S1006-706X(13)60136-3; Liu Y, 2012, VECTOR-BORNE ZOONOT, V12, P156, DOI 10.1089/vbz.2011.0758; Lopes AM, 2014, VIROLOGY, V468, P104, DOI 10.1016/j.virol.2014.08.002; Luo LM, 2015, EMERG INFECT DIS, V21, P1770, DOI 10.3201/eid2110.150126; Matsuno K, 2013, J VIROL, V87, P3719, DOI 10.1128/JVI.02845-12; McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378; Mourya DT, 2014, J VIROL, V88, P3605, DOI 10.1128/JVI.02617-13; Muniraju M, 2014, EMERG INFECT DIS, V20, P2023, DOI 10.3201/eid2012.140684; Ning YJ, 2015, J VIROL, V89, P4227, DOI 10.1128/JVI.00154-15; Niu GY, 2013, EMERG INFECT DIS, V19, P756, DOI 10.3201/eid1905.120245; Palacios G, 2011, J VIROL, V85, P3811, DOI 10.1128/JVI.02275-10; Park SW, 2014, TICKS TICK-BORNE DIS, V5, P975, DOI 10.1016/j.ttbdis.2014.07.020; Perrone LA, 2007, J VIROL, V81, P884, DOI 10.1128/JVI.01074-06; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Qu BQ, 2012, J VIROL, V86, P8388, DOI 10.1128/JVI.00612-12; Ramsden C, 2009, MOL BIOL EVOL, V26, P143, DOI 10.1093/molbev/msn234; Rodriguez LL, 1998, VIROLOGY, V242, P99, DOI 10.1006/viro.1997.8990; Santiago FW, 2014, J VIROL, V88, P4572, DOI 10.1128/JVI.03021-13; Schrauwen EJA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059889; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Takahashi T, 2014, J INFECT DIS, V209, P816, DOI 10.1093/infdis/jit603; Tong YG, 2015, NATURE, V524, P93, DOI 10.1038/nature14490; Wang J, 2014, EMERG INFECT DIS, V20, P1040, DOI 10.3201/eid2006.140003; Wen HL, 2014, EMERG INFECT DIS, V20, P1, DOI 10.3201/eid2001.120532; Yoshikawa T, 2015, J INFECT DIS, V212, P889, DOI 10.1093/infdis/jiv144; Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095; Zhang L., 2014, HUM VACC IMMUNOTHER, V10, P10, DOI [DOI 10.1371/J0URNAL.P0NE.0111127, DOI 10.2147/NDT.S56020]; Zhang XS, 2013, SCI CHINA LIFE SCI, V56, P697, DOI 10.1007/s11427-013-4518-9; Zhao L, 2012, EMERG INFECT DIS, V18, P963, DOI 10.3201/eid1806.111345	47	23	26	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151677	10.1371/journal.pone.0151677	http://dx.doi.org/10.1371/journal.pone.0151677			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999664	gold, Green Submitted, Green Published			2022-12-26	WOS:000372694700055
J	Primrose, RJ; Zaveri, T; Bakke, AJ; Ziegler, GR; Moskowitz, HR; Hayes, JE				Primrose, Rachel J.; Zaveri, Toral; Bakke, Alyssa J.; Ziegler, Gregory R.; Moskowitz, Howard R.; Hayes, John E.			Drivers of Vaginal Drug Delivery System Acceptability from Internet-Based Conjoint Analysis	PLOS ONE			English	Article							HIV VACCINE ACCEPTABILITY; SEXUAL PLEASURE; CLINICAL-TRIAL; AFRICAN WOMEN; YOUNG-WOMEN; BLACK-WOMEN; MICROBICIDE; PREFERENCES; GEL; FEASIBILITY	Vaginal microbicides potentially empower women to protect themselves from HIV and other sexually transmitted infections (STIs), especially when culture, religion, or social status may prevent them from negotiating condom use. The open literature contains minimal information on factors that drive user acceptability of women's health products or vaginal drug delivery systems. By understanding what women find to be most important with regard to sensory properties and product functionality, developers can iteratively formulate a more desirable product. Conjoint analysis is a technique widely used in market research to determine what combination of elements influence a consumer's willingness to try or use a product. We applied conjoint analysis here to better understand what sexually-active woman want in a microbicide, toward our goal of formulating a product that is highly acceptable to women. Both sensory and non-sensory attributes were tested, including shape, color, wait time, partner awareness, messiness/leakage, duration of protection, and functionality. Heterosexually active women between 18 and 35 years of age in the United States (n = 302) completed an anonymous online conjoint survey using IdeaMap software. Attributes (product elements) were systematically presented in various combinations; women rated these combinations of a 9-point willingness-to-try scale. By coupling systematic combinations and regression modeling, we can estimate the unique appeal of each element. In this population, a multifunctional product (i.e., broad spectrum STI protection, coupled with conception) is far more desirable than a microbicide targeted solely for HIV protection; we also found partner awareness and leakage are potentially strong barriers to use.	[Primrose, Rachel J.; Zaveri, Toral; Bakke, Alyssa J.; Hayes, John E.] Penn State Univ, Sensory Evaluat Ctr, University Pk, PA 16802 USA; [Primrose, Rachel J.; Zaveri, Toral; Bakke, Alyssa J.; Ziegler, Gregory R.; Hayes, John E.] Penn State Univ, Coll Agr Sci, Dept Food Sci, University Pk, PA 16802 USA; [Moskowitz, Howard R.] Mind Genom Associates Inc, White Plains, NY USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hayes, JE (corresponding author), Penn State Univ, Sensory Evaluat Ctr, University Pk, PA 16802 USA.; Hayes, JE (corresponding author), Penn State Univ, Coll Agr Sci, Dept Food Sci, University Pk, PA 16802 USA.	jeh40@psu.edu	Hayes, John E/A-5893-2008	Hayes, John E/0000-0001-9065-6326; Ziegler, Gregory/0000-0002-3881-649X	National Institute of Allergy and Infectious Diseases [R33AI094514]; Mind Genomics Associates, Inc.; Mind Genomics Associates; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI094514] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Mind Genomics Associates, Inc.; Mind Genomics Associates; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant R33AI094514 from the National Institute of Allergy and Infectious Diseases (www.niaid.nih.gov) to JEH and GRZ, and Mind Genomics Associates, Inc. Mind Genomics Associates donated use of the IdeaMap software platform, and provided support in the form of salaries for author HRM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akil A, 2011, DRUG DELIV TRANSL RE, V1, P209, DOI 10.1007/s13346-011-0022-6; [Anonymous], 2014, NAT SURV SEX HLTH BE; [Anonymous], 2014, FACT SHEET MICR; [Anonymous], 2014, PENNS 2013 STAT HLTH; [Anonymous], 2012, GLOB REP UNAIDS REP; Beusterien KM, 2005, VALUE HEALTH, V8, P453, DOI 10.1111/j.1524-4733.2005.00036.x; Centers for Disease Control and Prevention, 2014, HIV AM WOM; Cole AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015111; Colquhoun TA, 2012, J BERRY RES, V2, P45, DOI 10.3233/JBR-2011-027; Devlin B, 2013, ANTIVIR RES, V100, pS3, DOI 10.1016/j.antiviral.2013.09.025; Fetherston SM, 2013, EUR J PHARM SCI, V48, P406, DOI 10.1016/j.ejps.2012.12.002; Foley M, 2009, APPETITE, V52, P554, DOI 10.1016/j.appet.2009.01.006; Giguere R, 2012, CULT HEALTH SEX, V14, P151, DOI 10.1080/13691058.2011.630099; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Green PE, 2001, INTERFACES, V31, pS56, DOI 10.1287/inte.31.3s.56.9676; GREEN PE, 1990, J MARKETING      OCT, P3; Hammett TM, 2000, SEX TRANSM DIS, V27, P119, DOI 10.1097/00007435-200002000-00011; Hoffman S, 2010, ARCH SEX BEHAV, V39, P748, DOI 10.1007/s10508-009-9509-3; Holt BY, 2006, J WOMENS HEALTH, V15, P281, DOI 10.1089/jwh.2006.15.281; Jansen S, 2009, J HOUS BUILT ENVIRON, V24, P271, DOI 10.1007/s10901-009-9149-x; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, LANCET, V378, pE23, DOI 10.1016/S0140-6736(11)61136-7; Kinsler JJ, 2012, AIDS BEHAV, V16, P1436, DOI 10.1007/s10461-011-0045-5; Lee SJ, 2012, INT J STD AIDS, V23, P235, DOI 10.1258/ijsa.2011.011189; Levin LA, 2012, HORTSCIENCE, V47, P1658, DOI 10.21273/HORTSCI.47.11.1658; Li BD, 2013, ANTIVIR RES, V97, P280, DOI 10.1016/j.antiviral.2012.12.024; Li BD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054975; Mahan ED, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105614; Mahan ED, 2011, CONTRACEPTION, V84, P184, DOI 10.1016/j.contraception.2010.11.012; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; MJI-DesignLab, 2014, IDEAMAP R WHIT PLAIN; Morrow K, 2003, J WOMENS HEALTH, V12, P655, DOI 10.1089/154099903322404302; Moskowitz HR, 2012, PHYSIOL BEHAV, V107, P606, DOI 10.1016/j.physbeh.2012.04.009; Moskowitz HR, 2005, CRIT REV FOOD SCI, V45, P165, DOI 10.1080/10408690590956350; Nel AM, 2011, J WOMENS HEALTH, V20, P1207, DOI 10.1089/jwh.2010.2476; Prevention CoDCa, 2014, INC PREV COST SEX TR; Rees H, 2015, C RETR OPP INF CROI; Reiff M, 2008, J WOMENS HEALTH, V17, P1345, DOI 10.1089/jwh.2008.0886; Robertson Angela M, 2013, Glob Public Health, V8, P619, DOI 10.1080/17441692.2012.762412; Rosen M, 2015, CONTRACEPTION; Saulo AA, 2011, FOOD QUAL PREFER, V22, P422, DOI 10.1016/j.foodqual.2011.02.005; Tanner AE, 2008, J ADOLESCENT HEALTH, V43, P349, DOI 10.1016/j.jadohealth.2008.02.017; Tanner A, 2009, J SEX RES, V46, P15, DOI 10.1080/00224490802398407; Terris-Prestholt F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083193; van den Berg JJ, 2014, AIDS BEHAV, V18, P862, DOI 10.1007/s10461-013-0652-4; van der Straten A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089118; Weaver J, 2013, CAN J PUBLIC HEALTH, V104, pE413, DOI 10.17269/cjph.104.3915; WHO, 2012, GLOB INC PREV SEL CU; Zaveri T, 2012, SOC SENS PROF 3 TECH; Zaveri Toral, 2014, Pharmaceutics, V6, P512, DOI 10.3390/pharmaceutics6030512; Zaveri Toral, 2014, Pharmaceutics, V6, P366, DOI 10.3390/pharmaceutics6030366	51	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0150896	10.1371/journal.pone.0150896	http://dx.doi.org/10.1371/journal.pone.0150896			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999009	Green Submitted, gold, Green Published			2022-12-26	WOS:000372694700018
J	Maruyama, Y; Ito, T; Kodama, H; Matsuura, A				Maruyama, Yo; Ito, Toshiyuki; Kodama, Hiroaki; Matsuura, Akira			Availability of Amino Acids Extends Chronological Lifespan by Suppressing Hyper-Acidification of the Environment in Saccharomyces cerevisiae	PLOS ONE			English	Article							MEMBRANE H+-ATPASE; PLASMA-MEMBRANE; OXIDATIVE STRESS; YEAST AMMONIUM; CELL-DEATH; RESTRICTION; TRANSPORT; GROWTH; DETERMINANT; SUPEROXIDE	The chronological lifespan of Saccharomyces cerevisiae represents the duration of cell survival in the postdiauxic and stationary phases. Using a prototrophic strain derived from the standard auxotrophic laboratory strain BY4742, we showed that supplementation of nonessential amino acids to a synthetic defined (SD) medium increases maximal cell growth and extends the chronological lifespan. The positive effects of amino acids can be reproduced by modulating the medium pH, indicating that amino acids contribute to chronological longevity in a cell-extrinsic manner by alleviating medium acidification. In addition, we showed that the amino acid-mediated effects on extension of chronological longevity are independent of those achieved through a reduction in the TORC1 pathway, which is mediated in a cell-intrinsic manner. Since previous studies showed that extracellular acidification causes mitochondrial dysfunction and leads to cell death, our results provide a path to premature chronological aging caused by differences in available nitrogen sources. Moreover, acidification of culture medium is generally associated with culture duration and cell density; thus, further studies are required on cell physiology of auxotrophic yeast strains during the stationary phase because an insufficient supply of essential amino acids may cause alterations in environmental conditions.	[Maruyama, Yo; Ito, Toshiyuki; Kodama, Hiroaki; Matsuura, Akira] Chiba Univ, Grad Sch Adv Integrat Sci, Dept Nanobiol, Inage Ku, Chiba 2638522, Japan; [Matsuura, Akira] Chiba Univ, Mol Chiral Res Ctr, Inage Ku, Chiba 2638522, Japan; [Ito, Toshiyuki] Keiyo Plant Engn Co Ltd, 2-8-8 Ichikawaminami, Ichikawa, Chiba 2720032, Japan	Chiba University; Chiba University	Matsuura, A (corresponding author), Chiba Univ, Grad Sch Adv Integrat Sci, Dept Nanobiol, Inage Ku, Chiba 2638522, Japan.; Matsuura, A (corresponding author), Chiba Univ, Mol Chiral Res Ctr, Inage Ku, Chiba 2638522, Japan.	amatsuur@faculty.chiba-u.jp	Matsuura, Akira/J-3864-2017; Matsuura, Akira/AAO-1572-2021	Matsuura, Akira/0000-0002-2300-7227; Matsuura, Akira/0000-0002-2300-7227	Keiyo Plant Engineering Co., Ltd	Keiyo Plant Engineering Co., Ltd	Keiyo Plant Engineering Co., Ltd provided support in the form of salaries for one of the authors [TI], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the Author Contributions section.	Aerts AM, 2009, FEBS LETT, V583, P113, DOI 10.1016/j.febslet.2008.11.028; Alvers AL, 2009, AGING CELL, V8, P353, DOI 10.1111/j.1474-9726.2009.00469.x; Aris JP, 2013, EXP GERONTOL, V48, P1107, DOI 10.1016/j.exger.2013.01.006; Boeckstaens M, 2008, J BIOL CHEM, V283, P21362, DOI 10.1074/jbc.M801467200; Boeckstaens M, 2007, MOL MICROBIOL, V64, P534, DOI 10.1111/j.1365-2958.2007.05681.x; BRANDRISS MC, 1979, J BACTERIOL, V140, P498, DOI 10.1128/JB.140.2.498-503.1979; BRAUS GH, 1991, MICROBIOL REV, V55, P349, DOI 10.1128/MMBR.55.3.349-370.1991; Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287; Carmelo V, 1996, ARCH MICROBIOL, V166, P315, DOI 10.1007/s002030050389; Carmona-Gutierrez D, 2014, YEAST, V31, P289, DOI 10.1002/yea.3020; Choi JS, 2013, BIOCHEM BIOPH RES CO, V439, P126, DOI 10.1016/j.bbrc.2013.08.014; Cooper T., 1982, MOL BIOL YEAST SACCH, P39, DOI DOI 10.1101/087969180.11B.39; Crepin L, 2012, APPL ENVIRON MICROB, V78, P8102, DOI 10.1128/AEM.02294-12; Dowell RD, 2010, SCIENCE, V328, P469, DOI 10.1126/science.1189015; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; Giannattasio S, 2005, GENE, V354, P93, DOI 10.1016/j.gene.2005.03.030; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; Gomes P, 2007, MECH AGEING DEV, V128, P383, DOI 10.1016/j.mad.2007.04.003; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Holyoak CD, 1996, APPL ENVIRON MICROB, V62, P3158, DOI 10.1128/AEM.62.9.3158-3164.1996; Ito H, 2010, J BIOL CHEM, V285, P34616, DOI 10.1074/jbc.M110.175562; Jakubowski W, 2000, FREE RADICAL BIO MED, V28, P659, DOI 10.1016/S0891-5849(99)00266-X; Jara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086533; Jiang JC, 2000, FASEB J, V14, P2135; JONES JS, 1990, YEAST, V6, P363, DOI 10.1002/yea.320060502; Jones M., 1964, J I BREWING, V70, P307, DOI [10.1002/j.2050-0416.1964.tb01996.x, DOI 10.1002/J.2050-0416.1964.TB01996.X]; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Longo VD, 2012, CELL METAB, V16, P18, DOI 10.1016/j.cmet.2012.06.002; Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Magasanik B., 1992, COLD SPRING HARBOR M, P283; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Murakami CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024530; Ocampo A, 2012, CELL METAB, V16, P55, DOI 10.1016/j.cmet.2012.05.013; Palkova Z, 2002, MOL BIOL CELL, V13, P3901, DOI 10.1091/mbc.E01-12-0149; Pan Y, 2011, CELL METAB, V13, P668, DOI 10.1016/j.cmet.2011.03.018; Pedruzzi I, 2003, MOL CELL, V12, P1607, DOI 10.1016/S1097-2765(03)00485-4; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Rubio-Texeira M, 2012, NAT CHEM BIOL, V8, P400, DOI [10.1038/NCHEMBIO.910, 10.1038/nchembio.910]; Santos J, 2015, ONCOTARGET, V6, P6511, DOI 10.18632/oncotarget.2989; Santos J, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/161986; Santos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037090; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Soga T, 2001, ELECTROPHORESIS, V22, P3418, DOI 10.1002/1522-2683(200109)22:16<3418::AID-ELPS3418>3.0.CO;2-8; Sokolov S, 2006, BBA-BIOENERGETICS, V1757, P1366, DOI 10.1016/j.bbabio.2006.07.005; Suzuki SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017412; Tahara EB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056388; Vachova L, 2005, J CELL BIOL, V169, P711, DOI 10.1083/jcb.200410064; VANDERREST ME, 1995, MICROBIOL REV, V59, P304, DOI 10.1128/MMBR.59.2.304-322.1995; Wacker T, 2014, P NATL ACAD SCI USA, V111, P9995, DOI 10.1073/pnas.1406409111; Weinberger M, 2010, AGING-US, V2, P709, DOI 10.18632/aging.100215	52	16	17	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151894	10.1371/journal.pone.0151894	http://dx.doi.org/10.1371/journal.pone.0151894			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991662	gold, Green Submitted, Green Published			2022-12-26	WOS:000372582800116
J	Matsumoto, N; Ikeda, H; Shigefuku, R; Hattori, N; Watanabe, T; Matsunaga, K; Hiraishi, T; Tamura, T; Noguchi, Y; Fukuda, Y; Ishii, T; Okuse, C; Sato, A; Suzuki, M; Itoh, F				Matsumoto, Nobuyuki; Ikeda, Hiroki; Shigefuku, Ryuta; Hattori, Nobuhiro; Watanabe, Tsunamasa; Matsunaga, Kotaro; Hiraishi, Tetsuya; Tamura, Tomohiro; Noguchi, Yohei; Fukuda, Yasunobu; Ishii, Toshiya; Okuse, Chiaki; Sato, Akira; Suzuki, Michihiro; Itoh, Fumio			Hemoglobin Decrease with Iron Deficiency Induced by Daclatasvir plus Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b	PLOS ONE			English	Article							FERRITIN; AMINOTRANSFERASE; HCV	Background Decreased hemoglobin (Hb) level has been supposed to be a relatively rare side effect of a combination therapy against hepatitis C virus that consists of the NS5A inhibitor daclatasvir (DCV) and the NS3/4A protease inhibitor asunaprevir (ASV). Methods The study was conducted in 75 patients with genotype 1b chronic hepatitis C virus infection who had started combination therapy with DCV and ASV at St. Marianna University School of Medicine Hospital between September 2014 and December 2014. Results Among the patients examined, decreased Hb level by >= 1.5 g/dL from the values at treatment initiation was observed in 11 individuals. This was accompanied by decreased mean corpuscular volume, and iron and ferritin levels. Conclusions These findings suggest that the mechanism of the phenomenon is caused by iron deficiency. The underlying mechanism and clinical impacts will need to be further examined.	[Matsumoto, Nobuyuki; Ikeda, Hiroki; Shigefuku, Ryuta; Hattori, Nobuhiro; Watanabe, Tsunamasa; Matsunaga, Kotaro; Hiraishi, Tetsuya; Tamura, Tomohiro; Noguchi, Yohei; Fukuda, Yasunobu; Ishii, Toshiya; Okuse, Chiaki; Sato, Akira; Suzuki, Michihiro; Itoh, Fumio] St Marianna Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med,Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan	Saint Marianna University	Matsumoto, N (corresponding author), St Marianna Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med,Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	nobu1020@marianna-u.ac.jp	Matsumoto, Nobuyuki/AAK-6459-2020		Research Program on Hepatitis from the Japan Agency for Medical Research and Development, AMED	Research Program on Hepatitis from the Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	This research was partially supported by the Research Program on Hepatitis from the Japan Agency for Medical Research and Development, AMED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was partially supported by the Research Program on Hepatitis from the Japan Agency for Medical Research and Development, AMED.	Busti F, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00083; FINCH CA, 1986, WESTERN J MED, V145, P657; Iwasa M, 2002, HEPATO-GASTROENTEROL, V49, P529; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Kumada H, 2012, J HEPATOL, V56, P78, DOI 10.1016/j.jhep.2011.07.016; LIPSCHITZ DA, 1974, NEW ENGL J MED, V290, P1213, DOI 10.1056/NEJM197405302902201; Manns M, 2014, LANCET, V384, P1597, DOI 10.1016/S0140-6736(14)61059-X; POIGER H, 1979, N-S ARCH PHARMACOL, V306, P89, DOI 10.1007/BF00515599; Polin V, 2013, DIGEST LIVER DIS, V45, P803, DOI 10.1016/j.dld.2013.02.019; Short MW, 2013, AM FAM PHYSICIAN, V87, P98; TAKIKAWA T, 1994, J GASTROENTEROL, V29, P593, DOI 10.1007/BF02365441; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669	12	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151238	10.1371/journal.pone.0151238	http://dx.doi.org/10.1371/journal.pone.0151238			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990758	Green Published, gold, Green Submitted			2022-12-26	WOS:000372582800049
J	Yap, TWC; Gan, HM; Lee, YP; Leow, AHR; Azmi, AN; Francois, F; Perez-Perez, GI; Loke, MF; Goh, KL; Vadivelu, J				Yap, Theresa Wan-Chen; Gan, Han-Ming; Lee, Yin-Peng; Leow, Alex Hwong-Ruey; Azmi, Ahmad Najib; Francois, Fritz; Perez-Perez, Guillermo I.; Loke, Mun-Fai; Goh, Khean-Lee; Vadivelu, Jamuna			Helicobacter pylori Eradication Causes Perturbation of the Human Gut Microbiome in Young Adults	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; GASTRIC EPITHELIAL-CELLS; PLASMA GHRELIN; DIVISION TM7; SP NOV.; COLONIZATION; BACTERIA; OBESITY; ENERGY; HEALTH	Background Accumulating evidence shows that Helicobacter pylori protects against some metabolic and immunological diseases in which the development of these diseases coincide with temporal or permanent dysbiosis. The aim of this study was to assess the effect of H. pylori eradication on the human gut microbiome. Methods As part of the currently on-going ESSAY (Eradication Study in Stable Adults/Youths) study, we collected stool samples from 17 H. pylori-positive young adult (18-30 years-old) volunteers. The same cohort was followed up 6, 12 and 18 months-post H. pylori eradication. The impact of H. pylori on the human gut microbiome pre- and post-eradication was investigated using high throughput 16S rRNA gene (V3-V4 region) sequencing using the Illumina Miseq followed by data analysis using Qiime pipeline. Results We compared the composition and diversity of bacterial communities in the fecal microbiome of the H. pylori-positive volunteers, before and after H. pylori eradication therapy. The 16S rRNA gene was sequenced at an average of 150,000-170,000 reads/sample. The microbial diversity were similar pre- and post-H. pylori eradication with no significant differences in richness and evenness of bacterial species. Despite that the general profile of the gut microbiome was similar pre- and post-eradication, some changes in the bacterial communities at the phylum and genus levels were notable, particularly the decrease in relative abundance of Bacterioidetes and corresponding increase in Firmicutes after H. pylori eradication. The significant increase of short-chain fatty acids (SCFA)-producing bacteria genera could also be associated with increased risk of metabolic disorders. Conclusions Our preliminary stool metagenomics study shows that eradication of H. pylori caused perturbation of the gut microbiome and may indirectly affect the health of human. Clinicians should be aware of the effect of broad spectrum antibiotics used in H. pylori eradication regimen and be cautious in the clinical management of H. pylori infection, particularly in immunocompromised patients.	[Yap, Theresa Wan-Chen; Loke, Mun-Fai; Vadivelu, Jamuna] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia; [Gan, Han-Ming; Lee, Yin-Peng] Monash Univ Malaysia, Sch Sci, Bandar Sunway 47500, Selangor, Malaysia; [Gan, Han-Ming; Lee, Yin-Peng] Monash Univ Malaysia, Genom Facil, Bandar Sunway 47500, Selangor, Malaysia; [Leow, Alex Hwong-Ruey; Azmi, Ahmad Najib; Goh, Khean-Lee] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur 50603, Malaysia; [Azmi, Ahmad Najib] Univ Sains Islam Malaysia, Fac Med & Hlth Sci, Kuala Lumpur 55100, Malaysia; [Francois, Fritz] NYU, Inst Canc, New York, NY 10016 USA; [Francois, Fritz; Perez-Perez, Guillermo I.] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Perez-Perez, Guillermo I.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	Universiti Malaya; Monash University; Monash University Sunway; Monash University; Monash University Sunway; Universiti Malaya; Universiti Sains Islam Malaysia; New York University; New York University; New York University	Vadivelu, J (corresponding author), Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia.	jamuna@ummc.edu.my	Leow, Alex HR/B-1626-2017; Perez, Guillermo Perez/AAJ-3761-2020; VADIVELU, JAMUNARANI S/B-8696-2010; Gan, Han Ming/AAF-9519-2019; Goh, Khean-Lee/B-6404-2009; Loke, Mun Fai/B-1060-2011	Leow, Alex HR/0000-0003-1752-0435; VADIVELU, JAMUNARANI S/0000-0001-7322-3676; Gan, Han Ming/0000-0001-7987-738X; Goh, Khean-Lee/0000-0002-9965-1561; Loke, Mun Fai/0000-0002-3554-5313; Francois, Fritz/0000-0003-4491-2637; Perez Perez, Guillermo/0000-0002-0131-5798	University of Malaya-Ministry of Education (UM-MOE) [UM.C/HIR/MOE/13/4, H-50001-00-A000029]; Diane Belfer Program for Human Microbial Ecology; Knapp Family Fund	University of Malaya-Ministry of Education (UM-MOE); Diane Belfer Program for Human Microbial Ecology; Knapp Family Fund	This study was supported by the University of Malaya-Ministry of Education (UM-MOE) High Impact Research (HIR) Grant UM.C/HIR/MOE/13/4 (HIR Account No: H-50001-00-A000029), by the Diane Belfer Program for Human Microbial Ecology, the C and D fund (anonymous donors), and the Knapp Family Fund.	Amberbir A, 2011, CLIN EXP ALLERGY, V41, P1422, DOI 10.1111/j.1365-2222.2011.03831.x; Amieva MR, 2002, CELL MICROBIOL, V4, P677, DOI 10.1046/j.1462-5822.2002.00222.x; Anini Y, 1999, PFLUG ARCH EUR J PHY, V438, P299, DOI 10.1007/s004240050913; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Brinig MM, 2003, APPL ENVIRON MICROB, V69, P1687, DOI 10.1128/AEM.69.3.1687-1694.2003; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Buffie CG, 2013, NAT REV IMMUNOL, V13, P790, DOI 10.1038/nri3535; Cani PD, 2007, CURR OPIN CLIN NUTR, V10, P729, DOI 10.1097/MCO.0b013e3282efdebb; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Cantarel BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028742; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Chambers ES, 2015, GUT, V64, P1744, DOI 10.1136/gutjnl-2014-307913; Chassard C, 2008, FEMS MICROBIOL ECOL, V66, P496, DOI 10.1111/j.1574-6941.2008.00595.x; Chen Y, 2008, J INFECT DIS, V198, P553, DOI 10.1086/590158; Cherbut C, 1998, AM J PHYSIOL-GASTR L, V275, pG1415, DOI 10.1152/ajpgi.1998.275.6.G1415; Chu YT, 2010, INFECT IMMUN, V78, P4157, DOI 10.1128/IAI.00524-10; Clyne M, 2007, FEMS MICROBIOL LETT, V268, P135, DOI 10.1111/j.1574-6968.2007.00648.x; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; Cummings JH, 1997, NUTRITION, V13, P476, DOI 10.1016/S0899-9007(97)00114-7; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; DiBaise JK, 2012, AM J GASTROENTEROL S, V1, P22, DOI [10.1038/ajgsup.2012.5, DOI 10.1038/AJGSUP.2012.5]; Dinis JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021280; Dubois A, 2007, CELL MICROBIOL, V9, P1108, DOI 10.1111/j.1462-5822.2007.00921.x; Dubourg G, 2013, INT J ANTIMICROB AG, V41, P149, DOI 10.1016/j.ijantimicag.2012.10.012; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; ELLIOTT TSJ, 1990, ALIMENT PHARM THERAP, V4, P227; Endt K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001097; Erejuwa OO, 2014, INT J MOL SCI, V15, P4158, DOI 10.3390/ijms15034158; Finegold SM, 2004, ANAEROBE, V10, P41, DOI 10.1016/j.anaerobe.2003.10.002; Francois F, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-37; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Harris K, 2012, J OBES, V2012, DOI 10.1155/2012/879151; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Hosseini E, 2011, NUTR REV, V69, P245, DOI 10.1111/j.1753-4887.2011.00388.x; Hua J, 1996, MICROBIOS, V87, P103; Hugenholtz P, 2001, APPL ENVIRON MICROB, V67, P411, DOI 10.1128/AEM.67.1.411-419.2001; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Karlsson F, 2013, DIABETES, V62, P3341, DOI 10.2337/db13-0844; Kelly D, 2005, TRENDS IMMUNOL, V26, P326, DOI 10.1016/j.it.2005.04.008; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kuehbacher T, 2008, J MED MICROBIOL, V57, P1569, DOI 10.1099/jmm.0.47719-0; Kumar PS, 2003, J DENT RES, V82, P338, DOI 10.1177/154405910308200503; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Kwok T, 2002, INFECT IMMUN, V70, P2108, DOI 10.1128/IAI.70.4.2108-2120.2002; Le Poul E, 2003, J BIOL CHEM, V278, P25481, DOI 10.1074/jbc.M301403200; Lender N, 2014, ALIMENT PHARM THER, V40, P24, DOI 10.1111/apt.12790; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Liu CX, 2008, INT J SYST EVOL MICR, V58, P1896, DOI 10.1099/ijs.0.65208-0; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Malaty HM, 2010, ADV M C M, P1, DOI 10.1079/9781845935948.0001; Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Menard A, 2016, SYST APPL MICROBIOL; NILIUS M, 1993, ZBL BAKT-INT J MED M, V280, P259; Nwokolo CU, 2003, GUT, V52, P637, DOI 10.1136/gut.52.5.637; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Osawa H, 2008, WORLD J GASTROENTERO, V14, P6327, DOI 10.3748/wjg.14.6327; Ouverney CC, 2003, APPL ENVIRON MICROB, V69, P6294, DOI 10.1128/AEM.69.10.6294-6298.2003; Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101; PETERS DH, 1992, DRUGS, V44, P117, DOI 10.2165/00003495-199244010-00009; Petersen AM, 2003, FEMS IMMUNOL MED MIC, V36, P117, DOI 10.1016/S0928-8244(03)00020-8; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rainey F.A., 2009, BERGEYS MANUAL SYSTE, V3, P921, DOI [10.1007/978-0-387-68489-5_3, DOI 10.1007/978-0-387-68489-5_3]; RAINEY FA, 2009, BERGEYS MANUAL SYSTE, V3, P1016; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543; Schauer D.B., 2001, HELICOBACTER PYLORI; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sonnenberg A, 2013, AM J GASTROENTEROL, V108, P208, DOI 10.1038/ajg.2012.407; Sun J, 2014, GENES DIS, V1, P132, DOI 10.1016/j.gendis.2014.08.001; Szylit O, 1993, World Rev Nutr Diet, V74, P88; Tan GMY, 2015, SCI REP-UK, V5, DOI 10.1038/srep11046; Tan SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000407; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; VanEldere J, 1996, APPL ENVIRON MICROB, V62, P656, DOI 10.1128/AEM.62.2.656-661.1996; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16; Wang YY, 2010, RES J BIOTECHNOL, V5, P5; Wang YH, 2009, EXP BIOL MED, V234, P171, DOI 10.3181/0808-RM-252; Watanabe Y, 2012, APPL ENVIRON MICROB, V78, P511, DOI 10.1128/AEM.06035-11; Weingart V, 2004, J CLIN MICROBIOL, V42, P1319, DOI 10.1128/JCM.42.3.1319-1321.2004; Yap TWC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135771; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	96	79	94	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151893	10.1371/journal.pone.0151893	http://dx.doi.org/10.1371/journal.pone.0151893			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991500	Green Published, gold, Green Submitted			2022-12-26	WOS:000372582800115
J	Aksoy, E; Yigini, Y; Montanarella, L				Aksoy, Ece; Yigini, Yusuf; Montanarella, Luca			Combining Soil Databases for Topsoil Organic Carbon Mapping in Europe	PLOS ONE			English	Article							SPATIAL PREDICTION; ATTRIBUTES	Accuracy in assessing the distribution of soil organic carbon (SOC) is an important issue because of playing key roles in the functions of both natural ecosystems and agricultural systems. There are several studies in the literature with the aim of finding the best method to assess and map the distribution of SOC content for Europe. Therefore this study aims searching for another aspect of this issue by looking to the performances of using aggregated soil samples coming from different studies and land-uses. The total number of the soil samples in this study was 23,835 and they're collected from the "Land Use/Cover Area frame Statistical Survey" (LUCAS) Project (samples from agricultural soil), BioSoil Project (samples from forest soil), and "Soil Transformations in European Catchments" (SoilTrEC) Project (samples from local soil data coming from six different critical zone observatories (CZOs) in Europe). Moreover, 15 spatial indicators (slope, aspect, elevation, compound topographic index (CTI), CORINE land-cover classification, parent material, texture, world reference base (WRB) soil classification, geological formations, annual average temperature, min-max temperature, total precipitation and average precipitation (for years 19601990 and 2000-2010)) were used as auxiliary variables in this prediction. One of the most popular geostatistical techniques, Regression-Kriging (RK), was applied to build the model and assess the distribution of SOC. This study showed that, even though RK method was appropriate for successful SOC mapping, using combined databases was not helpful to increase the statistical significance of the method results for assessing the SOC distribution. According to our results; SOC variation was mainly affected by elevation, slope, CTI, average temperature, average and total precipitation, texture, WRB and CORINE variables for Europe scale in our model. Moreover, the highest average SOC contents were found in the wetland areas; agricultural areas have much lower soil organic carbon content than forest and semi natural areas; Ireland, Sweden and Finland has the highest SOC, on the contrary, Portugal, Poland, Hungary, Spain, Italy have the lowest values with the average 3%.	[Aksoy, Ece] Univ Malaga, European Top Ctr Urban Land Soil, E-29071 Malaga, Spain; [Yigini, Yusuf; Montanarella, Luca] Commiss European Communities, Joint Res Ctr, Inst Environm & Sustainabil, I-21020 Ispra, Italy	Universidad de Malaga; European Commission Joint Research Centre; EC JRC ISPRA Site	Aksoy, E (corresponding author), Univ Malaga, European Top Ctr Urban Land Soil, E-29071 Malaga, Spain.	eceaksoy@hotmail.com	Montanarella, Luca/AAE-7112-2019		European Commission [244118]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission FP 7 Collaborative Project "Soil Transformations in European Catchments" (SoilTrEC) (Grant Agreement no. 244118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksoy E, 2011, P PRAG GOLDSCHM 2011, V75, P418; Aksoy E, 2012, SPATIAL PREDICTION S, P149; Banwart S, 2011, NATURE, V474, P151, DOI 10.1038/474151a; Bernasconi SM, 2011, APPL GEOCHEM, V26, pS279, DOI 10.1016/j.apgeochem.2011.03.080; de Brogniez D, 2015, EUR J SOIL SCI, V66, P121, DOI 10.1111/ejss.12193; Dobos E., 2006, DIGITAL SOIL MAPPING; EEA (European Environment Agency), 2011, CORINE LAND COV 2000; ESDB, 2004, EUR SOIL EUR SOIL BU; Gardi C, 2010, REPORT ACTIVITIES RE, P24744, DOI [10.2788/61018, DOI 10.2788/61018]; Goovaerts P., 1997, GEOSTATISTICS NATURA, P483; Grunwald S., 2010, DIGITAL SOIL MAPPING; Hengl T, 2004, GEODERMA, V120, P75, DOI 10.1016/j.geoderma.2003.08.018; Hengl T, 2007, COMPUT GEOSCI-UK, V33, P1301, DOI 10.1016/j.cageo.2007.05.001; Hiederer R, 2009, JRC SCI TECHNICAL RE; Hiederer R., 2012, EFSA SPATIAL DATA VE; Hiederer R., 2011, EUR24729EN; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Kram P, 2012, APPL GEOCHEM, V27, P1854, DOI 10.1016/j.apgeochem.2012.02.020; Lacarce E, 2009, SOIL USE MANAGE, V25, P57, DOI 10.1111/j.1475-2743.2009.00194.x; Lair GJ, 2011, INT WORKSH DES GLOB; Martino L, 2008, STAT FOCUS, V3; McBratney AB, 2000, GEODERMA, V97, P293, DOI 10.1016/S0016-7061(00)00043-4; Minasny B, 2007, GEODERMA, V140, P324, DOI 10.1016/j.geoderma.2007.04.028; Montanarella L, 2011, LAND QUALITY LAND US; ODEH IOA, 1994, GEODERMA, V63, P197, DOI 10.1016/0016-7061(94)90063-9; ODEH IOA, 1995, GEODERMA, V67, P215, DOI 10.1016/0016-7061(95)00007-B; Panagos P, 2012, LAND USE POLICY, V29, P329, DOI 10.1016/j.landusepol.2011.07.003; Piccini C, 2014, ECOL INDIC, V36, P301, DOI 10.1016/j.ecolind.2013.08.009; Sarmadian F., 2014, Australian Journal of Crop Science, V8, P1216; Sun W, 2012, GEODERMA, V171, P16, DOI 10.1016/j.geoderma.2011.02.010; Szovati I, 2011, FINAL TECHNICAL REPO; Toth G, 2012, EUR SCI TECHNICAL RE; TRANGMAR BB, 1985, ADV AGRON, V38, P45	33	32	32	5	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152098	10.1371/journal.pone.0152098	http://dx.doi.org/10.1371/journal.pone.0152098			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27011357	gold, Green Submitted, Green Published			2022-12-26	WOS:000372708000086
J	Cofer, ZC; Cui, S; EauClaire, SF; Kim, C; Tobias, JW; Hakonarson, H; Loomes, KM; Matthews, RP				Cofer, Zenobia C.; Cui, Shuang; EauClaire, Steven F.; Kim, Cecilia; Tobias, John W.; Hakonarson, Hakon; Loomes, Kathleen M.; Matthews, Randolph P.			Methylation Microarray Studies Highlight PDGFA Expression as a Factor in Biliary Atresia	PLOS ONE			English	Article							DNA METHYLATION; CELLS; ZEBRAFISH; GENE; GENOME; DISEASES; PATHWAY; IDENTIFICATION; OBSTRUCTION; LYMPHOCYTES	Biliary atresia (BA) is a progressive fibro-inflammatory disorder that is the leading indication for liver transplantation in children. Although there is evidence implicating genetic, infectious, environmental, and inflammatory causes, the etiology of BA remains unknown. We have recently reported that cholangiocytes from BA patients showed decreased DNA methylation relative to disease-and non-disease controls, supporting a potential role for DNA hypomethylation in BA etiopathogenesis. In the current study, we examined the methylation status of specific genes in human BA livers using methylation microarray technology. We found global DNA hypomethylation in BA samples as compared to disease-and non-disease controls at specific genetic loci. Hedgehog pathway members, SHH and GLI2, known to be upregulated in BA, were both hypomethylated, validating this approach as an investigative tool. Another region near the PDGFA locus was the most significantly hypomethylated in BA, suggesting potential aberrant expression. Validation assays confirmed increased transcriptional and protein expression of PDGFA in BA livers. We also show that PDGF-A protein is specifically localized to cholangiocytes in human liver samples. Injection of PDGF-AA protein dimer into zebrafish larvae caused biliary developmental and functional defects. In addition, activation of the Hedgehog pathway caused increased expression of PDGF-A in zebrafish larvae, providing a previously unrecognized link between PDGF and the Hedgehog pathway. Our findings implicate DNA hypomethylation as a specific factor in mediating overexpression of genes associated with BA and identify PDGF as a new candidate in BA pathogenesis.	[Cofer, Zenobia C.; Cui, Shuang; EauClaire, Steven F.; Loomes, Kathleen M.; Matthews, Randolph P.] Childrens Hosp Philadelphia, Res Inst, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Kim, Cecilia; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Hakonarson, Hakon; Loomes, Kathleen M.; Matthews, Randolph P.] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Tobias, John W.] Univ Penn, Penn Ctr Biomed Informat, Philadelphia, PA 19104 USA; [Matthews, Randolph P.] Merck Res Labs, 351 N Sumneytown Pike,UG 4D-34, N Wales, PA USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Merck & Company	Loomes, KM (corresponding author), Childrens Hosp Philadelphia, Res Inst, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA.; Loomes, KM (corresponding author), Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA.	loomes@email.chop.edu		EauClaire, Steven/0000-0003-3283-4416	American Liver Foundation; Fred and Suzanne Biesecker Pediatric Liver Center at The Children's Hospital of Philadelphia;  [R01DK090260]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090260] Funding Source: NIH RePORTER	American Liver Foundation; Fred and Suzanne Biesecker Pediatric Liver Center at The Children's Hospital of Philadelphia; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by R01DK090260 to RPM, by the American Liver Foundation to ZCC, and by institutional support to HH for the Children's Hospital of Philadelphia Center for Applied Genomics. The work was also supported by funding from the Fred and Suzanne Biesecker Pediatric Liver Center at The Children's Hospital of Philadelphia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanstad P, 2009, CURR BIOL, V19, P1034, DOI 10.1016/j.cub.2009.04.053; Ader T, 2006, MECH DEVELOP, V123, P177, DOI 10.1016/j.mod.2005.10.003; Bell CG, 2010, BRIEF FUNCT GENOMICS, V9, P477, DOI 10.1093/bfgp/elq026; Bessho K, 2014, HEPATOLOGY, V60, P211, DOI 10.1002/hep.27045; Brindley SM, 2012, HEPATOLOGY, V55, P1130, DOI 10.1002/hep.24807; Burgers WA, 2006, ONCOGENE; Carvalho E, 2005, GASTROENTEROLOGY, V129, P713, DOI 10.1053/j.gastro.205.05.052; Chen LM, 2003, HEPATOLOGY, V38, P567, DOI 10.1053/jhep.2003.50363; Chen WW, 2011, P NATL ACAD SCI USA, V108, P9589, DOI 10.1073/pnas.1017945108; Chen X, 2014, ABSTR APPL ANAL, V2014, P1, DOI DOI 10.1155/2014/956141; Chu AS, 2012, MODERN PATHOL, V25, P751, DOI 10.1038/modpathol.2011.212; Chu J, 2009, HEPATOLOGY, V50, P1656, DOI 10.1002/hep.23157; Cofer ZC, 2014, CURRENT PATHOBIOLOGY, V2, P9; Cui S, 2013, ZEBRAFISH, V10, P177, DOI 10.1089/zeb.2012.0815; Cui S, 2013, GASTROENTEROLOGY, V144, P1107, DOI 10.1053/j.gastro.2013.01.022; Cui SA, 2011, J PEDIATR GASTR NUTR, V52, P339, DOI 10.1097/MPG.0b013e3181ff2e5b; Cui SA, 2011, DEV BIOL, V351, P229, DOI 10.1016/j.ydbio.2010.12.041; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Dennler S, 2009, J BIOL CHEM, V284, P31523, DOI 10.1074/jbc.M109.059964; Dong R, 2012, BIOCHEM BIOPH RES CO, V417, P986, DOI 10.1016/j.bbrc.2011.12.054; Dong R, 2011, PEDIATR RES, V70, P555, DOI 10.1203/PDR.0b013e318232a949; Donnelly JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075225; Donovan J, 2013, FRONT BIOSCI-LANDMRK, V18, P106, DOI 10.2741/4090; EauClaire SF, 2012, DEV BIOL, V365, P434, DOI 10.1016/j.ydbio.2012.03.009; Fingas CD, 2011, HEPATOLOGY, V54, P2076, DOI 10.1002/hep.24588; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; HARPER P, 1990, AUST VET J, V67, P18, DOI 10.1111/j.1751-0813.1990.tb07385.x; Heldin CH, 2014, J NEUROIMMUNE PHARM, V9, P69, DOI 10.1007/s11481-013-9484-2; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Koizumi K, 2012, INT J ONCOL, V40, P983, DOI 10.3892/ijo.2011.1283; KRUGER DH, 1989, CELL BIOPHYS, V15, P87; Laner-Plamberger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075317; Leonhardt J, 2006, PEDIATR SURG INT, V22, P84, DOI 10.1007/s00383-005-1589-0; Liang QY, 2014, GASTROENTEROLOGY, V147, P1350, DOI 10.1053/j.gastro.2014.08.036; Lorent K, 2004, DEVELOPMENT, V131, P5753, DOI 10.1242/dev.01411; Mack CL, 2005, CLIN IMMUNOL, V115, P200, DOI 10.1016/j.clim.2005.01.012; Matthews RP, 2011, HEPATOLOGY, V53, P905, DOI 10.1002/hep.24106; Matthews RP, 2004, DEV BIOL, V274, P245, DOI 10.1016/j.ydbio.2004.06.016; Mavila N, 2014, HEPATOLOGY, V60, P941, DOI 10.1002/hep.27203; Mohanty SK, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-14; Omenetti A, 2011, HEPATOLOGY, V53, P1246, DOI 10.1002/hep.24156; Ren CC, 2012, J BIOL CHEM, V287, P27117, DOI 10.1074/jbc.M112.367680; Sakaguchi TF, 2008, CURR BIOL, V18, P1565, DOI 10.1016/j.cub.2008.08.065; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Shivakumar P, 2004, J CLIN INVEST, V114, P322, DOI 10.1172/jci200421153; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Tan JY, 2002, LIVER, V22, P365, DOI 10.1034/j.1600-0676.2002.01622.x; Watanabe Y, 2015, GENOME RES, V25, P328, DOI 10.1101/gr.175240.114; Xu XJ, 2013, EPIGENETICS-US, V8, P522, DOI 10.4161/epi.24506; Zhang DY, 2004, HEPATOLOGY, V39, P954, DOI 10.1002/hep.20135; Zhang YM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110442	51	14	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151521	10.1371/journal.pone.0151521	http://dx.doi.org/10.1371/journal.pone.0151521			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010479	Green Published, Green Submitted, gold			2022-12-26	WOS:000372708000030
J	Gerloff, NA; Khan, SU; Zanders, N; Balish, A; Haider, N; Islam, A; Chowdhury, S; Rahman, MZ; Haque, A; Hosseini, P; Gurley, ES; Luby, SP; Wentworth, DE; Donis, RO; Sturm-Ramirez, K; Davis, CT				Gerloff, Nancy A.; Khan, Salah Uddin; Zanders, Natosha; Balish, Amanda; Haider, Najmul; Islam, Ausraful; Chowdhury, Sukanta; Rahman, Mahmudur Ziaur; Haque, Ainul; Hosseini, Parviez; Gurley, Emily S.; Luby, Stephen P.; Wentworth, David E.; Donis, Ruben O.; Sturm-Ramirez, Katharine; Davis, C. Todd			Genetically Diverse Low Pathogenicity Avian Influenza A Virus Subtypes Co-Circulate among Poultry in Bangladesh	PLOS ONE			English	Article							HUMAN INFECTION; H5N1 VIRUSES; ORIGIN; SURVEILLANCE; ALIGNMENT; DUCKS	Influenza virus surveillance, poultry outbreak investigations and genomic sequencing were assessed to understand the ecology and evolution of low pathogenicity avian influenza (LPAI) A viruses in Bangladesh from 2007 to 2013. We analyzed 506 avian specimens collected from poultry in live bird markets and backyard flocks to identify influenza A viruses. Virus isolation-positive specimens (n = 50) were subtyped and their coding-complete genomes were sequenced. The most frequently identified subtypes among LPAI isolates were H9N2, H11N3, H4N6, and H1N1. Less frequently detected subtypes included H1N3, H2N4, H3N2, H3N6, H3N8, H4N2, H5N2, H6N1, H6N7, and H7N9. Gene sequences were compared to publicly available sequences using phylogenetic inference approaches. Among the 14 subtypes identified, the majority of viral gene segments were most closely related to poultry or wild bird viruses commonly found in Southeast Asia, Europe, and/or northern Africa. LPAI subtypes were distributed over several geographic locations in Bangladesh, and surface and internal protein gene segments clustered phylogenetically with a diverse number of viral subtypes suggesting extensive reassortment among these LPAI viruses. H9N2 subtype viruses differed from other LPAI subtypes because genes from these viruses consistently clustered together, indicating this subtype is enzootic in Bangladesh. The H9N2 strains identified in Bangladesh were phylogenetically and antigenically related to previous human-derived H9N2 viruses detected in Bangladesh representing a potential source for human infection. In contrast, the circulating LPAI H5N2 and H7N9 viruses were both phylogenetically and antigenically unrelated to H5 viruses identified previously in humans in Bangladesh and H7N9 strains isolated from humans in China. In Bangladesh, domestic poultry sold in live bird markets carried a wide range of LPAI virus subtypes and a high diversity of genotypes. These findings, combined with the seven year timeframe of sampling, indicate a continuous circulation of these viruses in the country.	[Gerloff, Nancy A.; Zanders, Natosha; Balish, Amanda; Wentworth, David E.; Donis, Ruben O.; Sturm-Ramirez, Katharine; Davis, C. Todd] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA; [Khan, Salah Uddin; Haider, Najmul; Islam, Ausraful; Chowdhury, Sukanta; Rahman, Mahmudur Ziaur; Gurley, Emily S.; Luby, Stephen P.; Sturm-Ramirez, Katharine] Icddr B, Dhaka, Bangladesh; [Haque, Ainul] Minist Fisheries & Livestock, Dept Livestock Serv, Dhaka, Bangladesh; [Hosseini, Parviez] EcoHlth Alliance, New York, NY USA	Centers for Disease Control & Prevention - USA; International Centre for Diarrhoeal Disease Research (ICDDR); EcoHealth Alliance	Davis, CT (corresponding author), Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA 30333 USA.	ctdavis@cdc.gov	Khan, Salah Uddin/I-4015-2019; Haider, Najmul/F-6083-2015; Khan, Salah Ud-Din/ABC-5995-2020; Khan, Shahab/GSO-1694-2022; Haider, Najmul/AAH-4290-2020; Gurley, Emily S/B-7903-2010; Islam, Ausraful/AAF-2831-2021; Gerloff, Nancy/C-8955-2015	Khan, Salah Uddin/0000-0001-5928-9257; Haider, Najmul/0000-0002-5980-3460; Gurley, Emily S/0000-0002-8648-9403; Islam, Ausraful/0000-0001-9608-0823; Gerloff, Nancy/0000-0001-5696-8318; Wentworth, David/0000-0002-5190-980X; Luby, Stephen/0000-0001-5385-899X	Government of Bangladesh [PL480]; EcoHealth Alliance; National Institutes of Health/National Science Foundation Ecology and Evolution of Infectious Diseases award from the Fogarty International Center [3R01-TW005869]; Centers for Disease Control; Atlanta Education and Research Foundation; Research Participation Program at the Centers for Disease Control and Prevention (CDC); Oak Ridge Institute for Science and Education; U.S. Department of Energy; Fogarty International Center [3R01-TW005869];  [U01/CI000628]; FOGARTY INTERNATIONAL CENTER [R01TW005869] Funding Source: NIH RePORTER	Government of Bangladesh; EcoHealth Alliance; National Institutes of Health/National Science Foundation Ecology and Evolution of Infectious Diseases award from the Fogarty International Center; Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Atlanta Education and Research Foundation; Research Participation Program at the Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Oak Ridge Institute for Science and Education(General Electric); U.S. Department of Energy(United States Department of Energy (DOE)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Icddr, b is funded by project U01/CI000628 a cooperative agreement with CDC (website TCGwww.cdc.gov;www.icddrb.org). This research was supported by the Government of Bangladesh through grant number PL480. The authors thank the EcoHealth Alliance (www.ecohealthalliance.org) for financial support of staff involved in bird sample collection, which was funded by National Institutes of Health/National Science Foundation Ecology and Evolution of Infectious Diseases award from the Fogarty International Center (3R01-TW005869). This research was supported in part by an appointment to the Research Participation Program at the Centers for Disease Control and Prevention administered by the Oak Ridge Institute for Science and Education through an interagency agreement with the U.S. Department of Energy (www.orau.org). The authors would like to thank the Atlanta Education and Research Foundation for support (www.atlaref.org).; We gratefully acknowledge the authors, and the originating and submitting laboratories of the sequences from GISAID's EpiFluTM Database, which were used in this analysis. This research was supported in part by an appointment to the Research Participation Program at the Centers for Disease Control and Prevention (CDC) administered by the Oak Ridge Institute for Science and Education through an interagency agreement with the U.S. Department of Energy. We would like to thank the Atlanta Education and Research Foundation for support. Icddr,b was funded by project U01CI000628, a cooperative agreement with CDC. We thank the EcoHealth Alliance for financial support of staff involved in sample collection through a NIH/NSF Ecology and Evolution of Infectious Diseases award from the Fogarty International Center (3R01-TW005869). Icddr,b acknowledges with gratitude the commitment of CDC and EcoHealth Alliance to its research efforts. Icddr, b is also grateful to the Governments of Bangladesh, Canada, Sweden and the UK for providing core/unrestricted support. The findings and conclusions in this report are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention or the Agency for Toxic Substances and Disease Registry.	Ahmed SSU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033938; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2013, IDA43400; Banet-Noach C, 2007, AVIAN DIS, V51, P290, DOI 10.1637/7590-040206R1.1; Bangladesh International Centre for Diarrhoeal Disease Research Bangladesh, 2013, HSB (Health Science Bulletin), V11, P1; Brooks WA, 2007, AM J TROP MED HYG, V77, P795, DOI 10.4269/ajtmh.2007.77.795; CDC, 2014, INFL RISK ASS TOOL I; Centers for Disease Control and Prevention (CDC), CDC LAB SUPP INFL SU; Chakma D, 2008, RAPID ASSESSMENT SOC; Chaudhry M, 2015, EMERG INFECT DIS, V21, P673, DOI 10.3201/eid2104.141570; Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; Dolberg F, POULTRY SECTOR COUNT; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Gerloff NA, 2014, VIROLOGY, V450, P297, DOI 10.1016/j.virol.2013.12.023; Gerloff NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068522; Gilbert M, 2010, ECOHEALTH, V7, P448, DOI 10.1007/s10393-010-0672-8; Guan Y, 1999, P NATL ACAD SCI USA, V96, P9363, DOI 10.1073/pnas.96.16.9363; Hall TA, NUCL ACIDS S SER, V41; icddr b, 2015, GOV BANGL ICDDR B RE; International Centre for Diarrhoeal Disease Research Bangladesh/Government of The People's Republic of Bangladesh, 2011, HSB (Health Science Bulletin), V9, P5; Jannat N., 2013, International Journal of Livestock Research, V3, P21; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Khatun A, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-196; Kim JK, 2009, INFLUENZA OTHER RESP, V3, P121, DOI 10.1111/j.1750-2659.2009.00084.x; Kim JA, 2006, VET MICROBIOL, V118, P169, DOI 10.1016/j.vetmic.2006.07.007; Kim LM, 2008, J VET DIAGN INVEST, V20, P414, DOI 10.1177/104063870802000402; Klimov Alexander, 2012, Methods Mol Biol, V865, P25, DOI 10.1007/978-1-61779-621-0_3; Lepage D, AVIBASE 2015; Li CJ, 2005, VIROLOGY, V340, P70, DOI 10.1016/j.virol.2005.06.025; Li Q, 2014, NEW ENGL J MED, V370, P520, DOI 10.1056/NEJMoa1304617; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Mabud MA, 2008, BANGLADESH POPULATIO; Marinova-Petkova A, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.11; Murhekar M, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2013.4.2.008, 10.5365/WPSAR.2013.4.2.008]; Nagarajan S, 2009, VET MICROBIOL, V133, P154, DOI 10.1016/j.vetmic.2008.06.013; Negovetich NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019311; OIE, 2013, HIGHL PATH AV INFL C; OIE, 2014, AV INFL TERR MAN; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pawar SD, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-151; Shi JZ, 2013, CHINESE SCI BULL, V58, P1857, DOI 10.1007/s11434-013-5873-4; Sultana R, 2012, RURAL REMOTE HEALTH, V12; Sung-Hsi Wei J-RY, 2013, HUMAN INFECT AVIAN I; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; WHO, 2015, SIT UPD AV INFL; WHO, ANT GEN CHAR ZOON IN; WHO, 2013, ANT GEN CHAR ZOON IN; WHO/GIP, 2015, CUM NUMB CONF HUM CA; Yuan J, 2013, CLIN INFECT DIS, V57, P1367, DOI 10.1093/cid/cit479	52	28	29	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152131	10.1371/journal.pone.0152131	http://dx.doi.org/10.1371/journal.pone.0152131			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010791	Green Submitted, gold, Green Published			2022-12-26	WOS:000372708000094
J	Kim, DH; Hong, YK; Jeun, SS; Park, YJ; Kim, SW; Cho, JH; Kim, BY; Han, S; Lee, YJ; Hwang, JH; Kim, SW				Kim, Do Hyun; Hong, Yong-Kil; Jeun, Sin-Soo; Park, Yong Jin; Kim, Soo Whan; Cho, Jin Hee; Kim, Boo Young; Han, Sungwoo; Lee, Yong Joo; Hwang, Jae Hyung; Kim, Sung Won			Intranasal Volume Changes Caused by the Endoscopic Endonasal Transsphenoidal Approach and Their Effects on Nasal Functions	PLOS ONE			English	Article							EVALUATION NOSE SCALE; SKULL BASE TUMORS; PITUITARY-ADENOMAS; NASOSEPTAL FLAP; AIR-FLOW; SURGERY; RECONSTRUCTION; SYMPTOMS; ANATOMY	Objective We evaluated postoperative changes in nasal cavity volume and their effects on nasal function and symptoms after endoscopic endonasal transsphenoidal approach for antero-central skull base surgery. Study Design Retrospective chart review at a tertiary referral center. Methods We studied 92 patients who underwent binostril, four-hand, endoscopic endonasal transsphenoidal approach surgery using the bilateral modified nasoseptal rescue flap technique. Pre- and postoperative paranasal computed tomography and the Mimics1 program were used to assess nasal cavity volume changes at three sections. We also performed several pre-and postoperative tests, including the Connecticut Chemosensory Clinical Research Center test, Cross-Cultural Smell Identification Test, Nasal Obstruction Symptoms Evaluation, and Sino-Nasal Outcome Test-20. In addition, a visual analog scale was used to record subjective symptoms. We compared these data with the pre- and postoperative nasal cavity volumes. Results Three-dimensional, objective increases in nasal passage volumes were evident between the inferior and middle turbinates (p<0.001) and between the superior turbinate and choana (p = 0.006) postoperatively. However, these did not correlate with subjectively assessed symptoms (NOSE, SNOT-20 and VAS; all nasal cavity areas; p >= 0.05) or olfactory dysfunction (CCCRC and CCSIT test; all nasal cavity areas; p >= 0.05). Conclusion Skull base tumor surgery via an endoscopic endonasal transsphenoidal approach altered the patients' nasal anatomy, but the changes in nasal cavity volumes did not affect nasal function or symptoms. These results will help surgeons to appropriately expose the surgical field during an endoscopic endonasal transsphenoidal approach.	[Kim, Do Hyun; Park, Yong Jin; Kim, Soo Whan; Cho, Jin Hee; Kim, Boo Young; Han, Sungwoo; Lee, Yong Joo; Hwang, Jae Hyung; Kim, Sung Won] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea; [Hong, Yong-Kil; Jeun, Sin-Soo] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Neurosurg, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Kim, SW (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.	kswent@catholic.ac.kr	Kim, Do Hyun/AAA-2792-2021	Kim, Do Hyun/0000-0002-9248-5572	National Research Foundation of Korea from the Ministry of Science, ICT, and Future Planning [2014R1A2A2A01004325]; Korea Health Industry Development Institute - Ministry of Health and Welfare [HI14C3228]	National Research Foundation of Korea from the Ministry of Science, ICT, and Future Planning; Korea Health Industry Development Institute - Ministry of Health and Welfare	Funding was obtained from a National Research Foundation of Korea grant from the Ministry of Science, ICT, and Future Planning (No. 2014R1A2A2A01004325) and the Korea Health Industry Development Institute funded by the Ministry of Health and Welfare (HI14C3228). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alobid I, 2013, AM J RHINOL ALLERGY, V27, P426, DOI 10.2500/ajra.2013.27.3932; Balaker AE, 2010, SKULL BASE-INTERD AP, V20, P245, DOI 10.1055/s-0030-1249248; CAIN WS, 1988, LARYNGOSCOPE, V98, P83; Cappabianca P, 2002, J NEUROSURG, V97, P293, DOI 10.3171/jns.2002.97.2.0293; Castelnuovo P, 2006, RHINOLOGY, V44, P2; Damm M, 2002, CHEM SENSES, V27, P831, DOI 10.1093/chemse/27.9.831; de Almeida JR, 2011, HEAD NECK-J SCI SPEC, V33, P547, DOI 10.1002/hed.21483; Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021; Dusick JR, 2006, SURG NEUROL, V65, P332, DOI 10.1016/j.surneu.2005.12.010; Eccles R, 2000, ACTA OTO-LARYNGOL, V120, P580, DOI 10.1080/000164800750000388; Escada PA, 2009, EUR ARCH OTO-RHINO-L, V266, P1675, DOI 10.1007/s00405-009-1073-x; Hadad G, 2006, LARYNGOSCOPE, V116, P1882, DOI 10.1097/01.mlg.0000234933.37779.e4; Hornung DE, 1999, ARCH OTOLARYNGOL, V125, P53, DOI 10.1001/archotol.125.1.53; Kahveci OK, 2012, AURIS NASUS LARYNX, V39, P275, DOI 10.1016/j.anl.2011.08.006; Kassam AB, 2008, NEUROSURGERY, V63, P44, DOI 10.1227/01.NEU.0000297074.13423.F5; Kim BY, 2013, LARYNGOSCOPE, V123, P2605, DOI 10.1002/lary.24098; Kim BY, 2014, LARYNGOSCOPE, V124, P2470, DOI 10.1002/lary.24674; Kim BY, 2013, EUR ARCH OTO-RHINO-L, V270, P1355, DOI 10.1007/s00405-012-2226-x; Kim SK, 2013, J BIOMECH, V46, P299, DOI 10.1016/j.jbiomech.2012.11.022; LEOPOLD DA, 1988, LARYNGOSCOPE, V98, P1232; Rivera-Serrano CM, 2011, LARYNGOSCOPE, V121, P990, DOI 10.1002/lary.21419; Rotenberg B, 2010, LARYNGOSCOPE, V120, P1292, DOI 10.1002/lary.20949; Schroeter JD, 2006, J AEROSOL MED, V19, P301, DOI 10.1089/jam.2006.19.301; Shin JH, 2013, J CRANIOFAC SURG, V24, P1569, DOI 10.1097/SCS.0b013e31829a8105; Stewart MG, 2004, OTOLARYNG HEAD NECK, V130, P157, DOI 10.1016/j.otohns.2003.09.016; Strychowsky J, 2011, J OTOLARYNGOL-HEAD N, V40, P175, DOI 10.2310/7070.2011.100118	26	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151531	10.1371/journal.pone.0151531	http://dx.doi.org/10.1371/journal.pone.0151531			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010730	Green Submitted, Green Published, gold			2022-12-26	WOS:000372708000033
J	Liu, KC; Chen, HL; Wang, TN; Shieh, JY				Liu, Kuan-Chun; Chen, Hao-Ling; Wang, Tien-Ni; Shieh, Jeng-Yi			Developing the Observatory Test of Capacity, Performance, and Developmental Disregard (OTCPDD) for Children with Cerebral Palsy	PLOS ONE			English	Article							INDUCED MOVEMENT THERAPY; WORLD ARM USE; BIMANUAL PERFORMANCE; MOTOR-PERFORMANCE; VOAA-DDD; RELIABILITY; VALIDITY; STROKE; SKILLS; HAND	Purpose The purpose of this study was to develop a reliable and valid instrument, named the Observatory Test of Capacity, Performance, and Developmental Disregard (OTCPDD), for measuring the amount and quality of use of affected upper limb functions in the daily routines of children with CP. Methods Forty-eight participants (24 children with CP and 24 matched typically developing children) were recruited. The OTCPDD was administered twice (the spontaneous use condition first, followed by the forced use condition) on children with CP. Their parents were asked to complete the Pediatric Motor Activity Log-Revised (PMAL-R). The internal consistency, the intrarater and interrater reliabilities, and the convergent and discriminate validities were measured. Results The internal consistency (Cronbach's alpha) and the intrarater and interrater reliabilities were higher than 0.9 for all of the OTCPDD scores. The convergent validity was confirmed by significant correlations between the OTCPDD and the PMAL-R. For the discriminant validity, significant differences (p<0.05) were found between children with CP and typically developing children. Conclusions The results support that the OTCPDD is a reliable and valid observation-based assessment. The OTCPDD, which uses bimanual daily living activities, is able to represent the children's general affected hand functions (including capacity, performance, and developmental disregard) in their daily routines.	[Liu, Kuan-Chun; Chen, Hao-Ling; Wang, Tien-Ni] Natl Taiwan Univ, Sch Occupat Therapy, Coll Med, Taipei 10764, Taiwan; [Chen, Hao-Ling; Wang, Tien-Ni; Shieh, Jeng-Yi] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital	Wang, TN (corresponding author), Natl Taiwan Univ, Sch Occupat Therapy, Coll Med, Taipei 10764, Taiwan.; Wang, TN (corresponding author), Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.	tnwang@ntu.edu.tw	Chen, Hao-Ling/AAE-8045-2022	SHIEH, JENG-YI/0000-0002-3906-4269; CHEN, HAO-LING/0000-0001-5972-2778; WANG, TIEN-NI/0000-0001-9096-5815	Ministry of Science and Technology [MOST 103-2314-B-002-008-MY3, MOST 103-2218-E-002-021-]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This project was supported by the Ministry of Science and Technology (MOST 103-2314-B-002-008-MY3 and MOST 103-2218-E-002-021-). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts PB, 2010, NEUROREHAB NEURAL RE, V24, P509, DOI 10.1177/1545968309359767; Aarts PBM, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-145; Aarts Pauline Bm, 2007, Occup Ther Int, V14, P113, DOI 10.1002/oti.229; Chen HL, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0075-8; Fetters Linda, 2006, J Neurol Phys Ther, V30, P142; Greaves S, 2010, DEV MED CHILD NEUROL, V52, P413, DOI 10.1111/j.1469-8749.2009.03561.x; Hoare BJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004149.pub2; Houwink A, 2013, DEV MED CHILD NEUROL, V55, P76, DOI 10.1111/j.1469-8749.2012.04442.x; Houwink A, 2011, RES DEV DISABIL, V32, P2157, DOI 10.1016/j.ridd.2011.07.012; Howard J, 2005, J PAEDIATR CHILD H, V41, P479, DOI 10.1111/j.1440-1754.2005.00687.x; Huang HH, 2014, PEDIATR PHYS THER, V26, P28, DOI 10.1097/PEP.0000000000000008; Jessen C, 1999, ARCH DIS CHILD-FETAL, V80, pF158, DOI 10.1136/fn.80.2.F158; Kennedy J, 2012, PHYS OCCUP THER PEDI, V32, P196, DOI 10.3109/01942638.2011.631101; Oskoui M, 2013, DEV MED CHILD NEUROL, V55, P509, DOI 10.1111/dmcn.12080; Reid S, 2005, 3 REPORT VICTORIAN C; Sakzewski L, 2010, DEV MED CHILD NEUROL, V52, P811, DOI 10.1111/j.1469-8749.2009.03588.x; Smits DW, 2014, ARCH PHYS MED REHAB, V95, P1577, DOI 10.1016/j.apmr.2014.04.013; Speth L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-152; Taub E, 2006, Eura Medicophys, V42, P241; Taub E, 2004, PEDIATRICS, V113, P305, DOI 10.1542/peds.113.2.305; TAUB E, 1993, ARCH PHYS MED REHAB, V74, P347; Uswatte G, 2005, STROKE, V36, P2493, DOI 10.1161/01.STR.0000185928.90848.2e; Uswatte G, 2012, REHABIL PSYCHOL, V57, P149, DOI 10.1037/a0028516; Wang TN, 2013, RES DEV DISABIL, V34, P1044, DOI 10.1016/j.ridd.2012.11.012; Zielinski IM, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-6	25	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151798	10.1371/journal.pone.0151798	http://dx.doi.org/10.1371/journal.pone.0151798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010941	gold, Green Published, Green Submitted			2022-12-26	WOS:000372708000047
J	Murphy, PR; van Moort, ML; Nieuwenhuis, S				Murphy, Peter R.; van Moort, Marianne L.; Nieuwenhuis, Sander			The Pupillary Orienting Response Predicts Adaptive Behavioral Adjustment after Errors	PLOS ONE			English	Article							BRAIN POTENTIALS; PERFORMANCE; TASK; AWARENESS; DILATION; SURPRISE; NEURONS; ACTIVATION; CONFLICT; DOPAMINE	Reaction time (RT) is commonly observed to slow down after an error. This post-error slowing (PES) has been thought to arise from the strategic adoption of a more cautious response mode following deployment of cognitive control. Recently, an alternative account has suggested that PES results from interference due to an error-evoked orienting response. We investigated whether error-related orienting may in fact be a pre-cursor to adaptive post-error behavioral adjustment when the orienting response resolves before subsequent trial onset. We measured pupil dilation, a prototypical measure of autonomic orienting, during performance of a choice RT task with long inter-stimulus intervals, and found that the trial-by-trial magnitude of the error-evoked pupil response positively predicted both PES magnitude and the likelihood that the following response would be correct. These combined findings suggest that the magnitude of the error-related orienting response predicts an adaptive change of response strategy following errors, and thereby promote a reconciliation of the orienting and adaptive control accounts of PES.	[Murphy, Peter R.; van Moort, Marianne L.; Nieuwenhuis, Sander] Leiden Univ, Inst Psychol, Leiden, Netherlands; [Murphy, Peter R.; van Moort, Marianne L.; Nieuwenhuis, Sander] Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands; [van Moort, Marianne L.] Leiden Univ, Dept Educ Sci, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Murphy, PR (corresponding author), Leiden Univ, Inst Psychol, Leiden, Netherlands.; Murphy, PR (corresponding author), Leiden Univ, Leiden Inst Brain & Cognit, Leiden, Netherlands.	murphyp7@tcd.ie	van Moort, Marloes/GZG-8658-2022	van Moort, Marloes/0000-0002-1746-0869; Murphy, Peter R/0000-0003-1963-185X	European Research Council	European Research Council(European Research Council (ERC)European Commission)	This research was supported by a Starting Independent Researcher Grant of the European Research Council awarded to Sander Nieuwenhuis. The funder had no role in study design or analysis, or in preparation of the manuscript.	ANTIKAINEN J, 1983, BIOL PSYCHOL, V17, P131, DOI 10.1016/0301-0511(83)90013-3; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Braem S, 2015, COGN AFFECT BEHAV NE, V15, P374, DOI 10.3758/s13415-014-0333-4; Carp J, 2009, PSYCHOPHYSIOLOGY, V46, P336, DOI 10.1111/j.1469-8986.2008.00773.x; Colzato LS, 2013, NEUROPSYCHOLOGIA, V51, P2600, DOI 10.1016/j.neuropsychologia.2013.07.026; Critchley HD, 2005, NEUROIMAGE, V27, P885, DOI 10.1016/j.neuroimage.2005.05.047; Danielmeier C, 2015, CURR BIOL, V25, P1461, DOI 10.1016/j.cub.2015.04.022; Dudschig C, 2009, BRAIN RES, V1296, P56, DOI 10.1016/j.brainres.2009.08.009; Dutilh G, 2012, J MATH PSYCHOL, V56, P208, DOI 10.1016/j.jmp.2012.04.001; Dutilh G, 2012, ATTEN PERCEPT PSYCHO, V74, P454, DOI 10.3758/s13414-011-0243-2; Forster SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090281; FRIEDMAN D, 1973, ELECTROEN CLIN NEURO, V34, P475, DOI 10.1016/0013-4694(73)90065-5; Hajcak G, 2003, PSYCHOPHYSIOLOGY, V40, P895, DOI 10.1111/1469-8986.00107; Hangya B, 2015, CELL, V162, P1155, DOI 10.1016/j.cell.2015.07.057; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; JANISSE MP, 1977, PUPILLOMETRY; Jentzsch I, 2009, Q J EXP PSYCHOL, V62, P209, DOI 10.1080/17470210802240655; Joshi S, 2016, NEURON, V89, P221, DOI 10.1016/j.neuron.2015.11.028; King JA, 2010, J NEUROSCI, V30, P12759, DOI 10.1523/JNEUROSCI.3274-10.2010; Klein TA, 2007, NEUROIMAGE, V34, P1774, DOI 10.1016/j.neuroimage.2006.11.014; Kloosterman NA, 2015, EUR J NEUROSCI, V41, P1068, DOI 10.1111/ejn.12859; LAMING D, 1979, ACTA PSYCHOL, V43, P199, DOI 10.1016/0001-6918(79)90026-X; Laming DR, 1968, INFORM THEORY CHOICE; Lynn R., 1966, ATTENTION AROUSAL OR; Maher T. F., 1979, ORIENTING REFLEX HUM, P381; Murphy PR, 2014, HUM BRAIN MAPP, V35, P4140, DOI 10.1002/hbm.22466; Nassar MR, 2012, NAT NEUROSCI, V15, P1040, DOI 10.1038/nn.3130; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Nieuwenhuis S, 2011, PSYCHOPHYSIOLOGY, V48, P162, DOI 10.1111/j.1469-8986.2010.01057.x; Notebaert W, 2011, ACTA PSYCHOL, V136, P212, DOI 10.1016/j.actpsy.2010.05.006; Notebaert W, 2009, COGNITION, V111, P275, DOI 10.1016/j.cognition.2009.02.002; Nunez Castellar E, 2010, COGN AFFECT BEHAV NE, V10, P270, DOI DOI 10.3758/CABN.10.2.270; O'Connell RG, 2007, EUR J NEUROSCI, V25, P2571, DOI 10.1111/j.1460-9568.2007.05477.x; O'Connell RG, 2009, J COGNITIVE NEUROSCI, V21, P93, DOI 10.1162/jocn.2009.21008; Preuschoff K, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00115; RABBITT PMA, 1966, J EXP PSYCHOL, V71, P264, DOI 10.1037/h0022853; RABBITT PMA, 1970, ACTA PSYCHOL, V33, P56, DOI 10.1016/0001-6918(70)90122-8; Rajkowski J, 2004, J NEUROPHYSIOL, V92, P361, DOI 10.1152/jn.00673.2003; Sellaro R, 2015, J COGNITIVE NEUROSCI, V27, P2126, DOI 10.1162/jocn_a_00851; Silvetti M, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00160; Silvetti M, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00075; Sokolov E.N., 1963, PERCEPTION CONDITION; Steinborn MB, 2012, Q J EXP PSYCHOL, V65, P624, DOI 10.1080/17470218.2012.660962; Steiner GZ, 2011, PSYCHOPHYSIOLOGY, V48, P1648, DOI 10.1111/j.1469-8986.2011.01271.x; Steinhauer SR, 2004, INT J PSYCHOPHYSIOL, V52, P77, DOI 10.1016/j.ijpsycho.2003.12.005; STEINHAUER SR, 1992, ANN NY ACAD SCI, V658, P182, DOI 10.1111/j.1749-6632.1992.tb22845.x; van den Brink RL, 2014, J NEUROSCI, V34, P11096, DOI 10.1523/JNEUROSCI.4991-13.2014; Van der Borght L, 2016, ACTA PSYCHOL, V164, P34, DOI 10.1016/j.actpsy.2015.12.007; van Driel J, 2012, J NEUROSCI, V32, P16795, DOI 10.1523/JNEUROSCI.0802-12.2012; Van Olst E.H., 1979, ORIENTING REFLEX HUM, P521; Varazzani C, 2015, J NEUROSCI, V35, P7866, DOI 10.1523/JNEUROSCI.0454-15.2015; Wessel JR, 2012, J NEUROSCI, V32, P7528, DOI 10.1523/JNEUROSCI.6352-11.2012; Wessel JR, 2011, J COGNITIVE NEUROSCI, V23, P3021, DOI 10.1162/jocn.2011.21635	53	19	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151763	10.1371/journal.pone.0151763	http://dx.doi.org/10.1371/journal.pone.0151763			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3SV	27010472	Green Published, gold			2022-12-26	WOS:000372708000042
J	Benito, A; Jeffares, D; Palomero, F; Calderon, F; Bai, FY; Bahler, J; Benito, S				Benito, Angel; Jeffares, Daniel; Palomero, Felipe; Calderon, Fernando; Bai, Feng-Yan; Bahler, Jurg; Benito, Santiago			Selected Schizosaccharomyces pombe Strains Have Characteristics That Are Beneficial for Winemaking	PLOS ONE			English	Article							NON-SACCHAROMYCES YEASTS; REMOVING GLUCONIC ACID; MALOLACTIC FERMENTATION; LACHANCEA-THERMOTOLERANS; TORULASPORA-DELBRUECKII; CO-FERMENTATION; BIOGENIC-AMINES; ALCOHOL CONTENT; TABLE WINES; RED	At present, wine is generally produced using Saccharomyces yeast followed by Oenococus bacteria to complete malolactic fermentation. This method has some unsolved problems, such as the management of highly acidic musts and the production of potentially toxic products including biogenic amines and ethyl carbamate. Here we explore the potential of the fission yeast Schizosaccharomyces pombe to solve these problems. We characterise an extensive worldwide collection of S. pombe strains according to classic biochemical parameters of oenological interest. We identify three genetically different S. pombe strains that appear suitable for winemaking. These strains compare favourably to standard Saccharomyces cerevisiae winemaking strains, in that they perform effective malic acid deacidification and significantly reduce levels of biogenic amines and ethyl carbamate precursors without the need for any secondary bacterial malolactic fermentation. These findings indicate that the use of certain S. pombe strains could be advantageous for winemaking in regions where malic acid is problematic, and these strains also show superior performance with respect to food safety.	[Benito, Angel; Palomero, Felipe; Calderon, Fernando; Benito, Santiago] Univ Politecn Madrid, Dept Chem & Food Technol, Madrid, Spain; [Jeffares, Daniel; Bahler, Jurg] UCL, Res Dept Genet Evolut & Environm, London, England; [Bai, Feng-Yan] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China	Universidad Politecnica de Madrid; University of London; University College London; Chinese Academy of Sciences; Institute of Microbiology, CAS	Benito, S (corresponding author), Univ Politecn Madrid, Dept Chem & Food Technol, Madrid, Spain.	santiago.benito@upm.es	Fernandez, Fernando Calderon/AAS-1635-2020; Benito, Santiago/ABH-2117-2020; Bahler, Jurg/B-4572-2009; Bai, Feng-Yan/E-7860-2019; Jeffares, Daniel/N-2632-2018	Bahler, Jurg/0000-0003-4036-1532; Jeffares, Daniel/0000-0001-7320-0706; BENITO SAEZ, SANTIAGO/0000-0002-1674-8246	Wellcome Trust [095598/Z/11/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	Jurg Bahler and Daniel Jeffares were supported by a Wellcome Trust Senior Investigator Award to JB, Grant Number: 095598/Z/11/Z, URL: http://www.wellcome.ac.uk/. The rest of the authors have no support or funding to report. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide-Hidalgo JM, 2007, FOOD CHEM, V103, P572, DOI 10.1016/j.foodchem.2006.09.002; Bai FY, STATE KEY LAB MYCOLO; Belda I, 2015, APPL MICROBIOL BIOT, V99, P1911, DOI 10.1007/s00253-014-6197-2; Bely M, 2008, INT J FOOD MICROBIOL, V122, P312, DOI 10.1016/j.ijfoodmicro.2007.12.023; Benito A, 2015, FOOD TECHNO IN PRESS, DOI 10.17113/ftb.54.02.16.4220; Benito A, 2015, MOLECULES, V20, P9510, DOI 10.3390/molecules20069510; Benito S, 2014, FOOD MICROBIOL, V42, P218, DOI 10.1016/j.fm.2014.03.014; Benito S., 2013, African Journal of Microbiology Research, V7, P3026; Benito S, 2013, EUR FOOD RES TECHNOL, V236, P29, DOI 10.1007/s00217-012-1836-2; Benito S., 2014, ENCY FOOD MICROBIOLO, P365; Benito S., 2015, J FOOD PROCESS TECHN, V6, P9; Benito S, 2015, EUR FOOD RES TECHNOL, V241, P707, DOI 10.1007/s00217-015-2497-8; Benito S, 2014, FOOD TECHNOL BIOTECH, V52, P376; Benito S, 2012, INT J FOOD SCI TECH, V47, P2101, DOI 10.1111/j.1365-2621.2012.03076.x; Bonciani T, 2016, EUR FOOD RES TECHNOL, V242, P899, DOI 10.1007/s00217-015-2596-6; Camarasa C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025147; Clemente-Jimenez JM, 2004, FOOD MICROBIOL, V21, P149, DOI 10.1016/S0740-0020(03)00063-7; Contreras A, 2015, APPL MICROBIOL BIOT, V99, P1885, DOI 10.1007/s00253-014-6193-6; Contreras A, 2014, APPL ENVIRON MICROB, V80, P1670, DOI 10.1128/AEM.03780-13; Cui Xia, 2014, Journal of Food Safety and Quality, V5, P2617; Deak T., 2008, HDB FOOD SPOILAGE YE, P294; Ding S, 2015, YEAST, V32, P317, DOI 10.1002/yea.3053; Fleet GH, 2008, FEMS YEAST RES, V8, P979, DOI 10.1111/j.1567-1364.2008.00427.x; GALLANDER JF, 1977, AM J ENOL VITICULT, V28, P65; Gobbi M, 2014, EUR FOOD RES TECHNOL, V239, P41, DOI 10.1007/s00217-014-2187-y; Gobbi M, 2013, FOOD MICROBIOL, V33, P271, DOI 10.1016/j.fm.2012.10.004; Husnik JI, 2007, AM J ENOL VITICULT, V58, P42; Husnik JI, 2006, METAB ENG, V8, P315, DOI 10.1016/j.ymben.2006.02.003; Hyma KE, 2011, FEMS YEAST RES, V11, P540, DOI 10.1111/j.1567-1364.2011.00746.x; Jansen SC, 2003, ANN ALLERG ASTHMA IM, V91, P233, DOI 10.1016/S1081-1206(10)63523-5; Jeffares DC, 2015, NAT GENET, V47, P235, DOI 10.1038/ng.3215; Jolly N. P., 2006, SOUTH AFRICAN JOURNAL OF ENOLOGY AND VITICULTURE, V27, P15; Jolly NP, 2014, FEMS YEAST RES, V14, P215, DOI 10.1111/1567-1364.12111; Kanny G, 2001, J ALLERGY CLIN IMMUN, V107, P375, DOI 10.1067/mai.2001.112122; Kutyna DR, 2010, TRENDS FOOD SCI TECH, V21, P293, DOI 10.1016/j.tifs.2010.03.004; Lehtonen P, 1996, AM J ENOL VITICULT, V47, P127; Liu YL, 2009, AGR SCI CHINA, V8, P821, DOI 10.1016/S1671-2927(08)60283-7; Lubbers MW, 1996, CAN J MICROBIOL, V42, P132, DOI 10.1139/m96-021; MAYNARD LS, 1962, NATURE, V196, P575, DOI 10.1038/196575a0; Medina K, 2013, FOOD CHEM, V141, P2513, DOI 10.1016/j.foodchem.2013.04.056; Mendes I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066523; Merico A, 2007, FEBS J, V274, P976, DOI 10.1111/j.1742-4658.2007.05645.x; Morales P, 2015, APPL MICROBIOL BIOT, V99, P3993, DOI 10.1007/s00253-014-6321-3; Moreno-Arribas MV, 2008, FOOD MICROBIOL, V25, P875, DOI 10.1016/j.fm.2008.05.004; Palomero F, 2009, FOOD CHEM, V112, P432, DOI 10.1016/j.foodchem.2008.05.098; Parapouli M, 2010, J IND MICROBIOL BIOT, V37, P85, DOI 10.1007/s10295-009-0651-7; Peinado RA, 2005, J AGR FOOD CHEM, V53, P1017, DOI 10.1021/jf048764b; Peinado RA, 2004, J AGR FOOD CHEM, V52, P4529, DOI 10.1021/jf049853r; Peinado RA, 2004, J AGR FOOD CHEM, V52, P493, DOI 10.1021/jf035030a; Peinado RA, 2007, FOOD CHEM, V104, P457, DOI 10.1016/j.foodchem.2006.11.070; Pitt J. I, 1999, FUNGI FOOD SPOILAGE, P459; Pretorius IS, 2002, TRENDS BIOTECHNOL, V20, P426, DOI 10.1016/S0167-7799(02)02049-8; Redzepovic S, 2003, INT J FOOD MICROBIOL, V83, P49, DOI 10.1016/S0168-1605(02)00320-3; RODRIGUEZ SB, 1990, FEMS MICROBIOL LETT, V72, P17, DOI 10.1016/0378-1097(90)90337-P; ROMANO P, 1993, J APPL BACTERIOL, V75, P541, DOI 10.1111/j.1365-2672.1993.tb01592.x; ROMANO P, 1992, J APPL BACTERIOL, V73, P126, DOI 10.1111/j.1365-2672.1992.tb01698.x; Silva S, 2003, AM J ENOL VITICULT, V54, P50; Smit AY, 2013, FOOD BIOPROCESS TECH, V6, P198, DOI 10.1007/s11947-011-0702-8; SNOW PG, 1979, AM J ENOL VITICULT, V30, P45; Su J, 2014, APPL MICROBIOL BIOT, V98, P2395, DOI 10.1007/s00253-014-5508-y; Sumby KM, 2014, APPL MICROBIOL BIOT, V98, P8111, DOI 10.1007/s00253-014-5976-0; Thornton RJ, 1996, FOOD MICROBIOL, V13, P475, DOI 10.1006/fmic.1996.0054; Unterholzner O., 1988, Mitteilungen Klosterneuburg, Rebe und Wein, Obstbau und Fruechteverwertung, V38, P66; Vaughan-Martini, 1998, YEASTS, P107, DOI DOI 10.1016/B978-044481312-1/50017-4; Vaughnan-Martini A., 1999, YEAST TAXONOMIC STUD, P107; YOKOTSUKA K, 1993, AM J ENOL VITICULT, V44, P371; Zheng YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133889; ZIRONI R, 1993, BIOTECHNOL LETT, V15, P235, DOI 10.1007/BF00128311	68	62	65	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151102	10.1371/journal.pone.0151102	http://dx.doi.org/10.1371/journal.pone.0151102			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007548	gold, Green Published, Green Submitted			2022-12-26	WOS:000372701200042
J	Howard, BM; Kornblith, LZ; Cheung, CK; Kutcher, ME; Miyazawa, BY; Vilardi, RF; Cohen, MJ				Howard, Benjamin M.; Kornblith, Lucy Z.; Cheung, Christopher K.; Kutcher, Matthew E.; Miyazawa, Byron Y.; Vilardi, Ryan F.; Cohen, Mitchell J.			Inducing Acute Traumatic Coagulopathy In Vitro: The Effects of Activated Protein C on Healthy Human Whole Blood	PLOS ONE			English	Article							DAMAGE CONTROL RESUSCITATION; ROTATIONAL THROMBOELASTOMETRY; INJURY; COAGULATION; MECHANISM; THROMBELASTOGRAPHY; HYPOPERFUSION	Introduction Acute traumatic coagulopathy has been associated with shock and tissue injury, and may be mediated via activation of the protein C pathway. Patients with acute traumatic coagulopathy have prolonged PT and PTT, and decreased activity of factors V and VIII; they are also hypocoagulable by thromboelastometry (ROTEM) and other viscoelastic assays. To test the etiology of this phenomenon, we hypothesized that such coagulopathy could be induced in vitro in healthy human blood with the addition of activated protein C (aPC). Methods Whole blood was collected from 20 healthy human subjects, and was "spiked" with increasing concentrations of purified human aPC (control, 75, 300, 2000 ng/mL). PT/PTT, factor activity assays, and ROTEM were performed on each sample. Mixed effect regression modeling was performed to assess the association of aPC concentration with PT/PTT, factor activity, and ROTEM parameters. Results In all subjects, increasing concentrations of aPC produced ROTEM tracings consistent with traumatic coagulopathy. ROTEM EXTEM parameters differed significantly by aPC concentration, with stepwise prolongation of clotting time (CT) and clot formation time (CFT), decreased alpha angle (alpha), impaired early clot formation (a10 and a20), and reduced maximum clot firmness (MCF). PT and PTT were significantly prolonged at higher aPC concentrations, with corresponding significant decreases in factor V and VIII activity. Conclusion A phenotype of acute traumatic coagulopathy can be induced in healthy blood by the in vitro addition of aPC alone, as evidenced by viscoelastic measures and confirmed by conventional coagulation assays and factor activity. This may lend further mechanistic insight to the etiology of coagulation abnormalities in trauma, supporting the central role of the protein C pathway. Our findings also represent a model for future investigations in the diagnosis and treatment of acute traumatic coagulopathy.	[Howard, Benjamin M.; Kornblith, Lucy Z.; Cheung, Christopher K.; Miyazawa, Byron Y.; Vilardi, Ryan F.; Cohen, Mitchell J.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Howard, Benjamin M.; Kornblith, Lucy Z.; Cheung, Christopher K.; Miyazawa, Byron Y.; Vilardi, Ryan F.; Cohen, Mitchell J.] San Francisco Gen Hosp, San Francisco, CA 94110 USA; [Kutcher, Matthew E.] Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA USA; [Kutcher, Matthew E.] Presbyterian Univ Hosp, Pittsburgh, PA 15213 USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; UPMC Presbyterian	Howard, BM (corresponding author), Univ Calif San Francisco, Dept Surg, San Francisco, CA USA.; Howard, BM (corresponding author), San Francisco Gen Hosp, San Francisco, CA 94110 USA.	benjamin.howard@ucsf.edu		Kutcher, Matthew/0000-0003-4566-5359	United States Department of Defense [W911NF-10-1-0384]; United States National Institutes of Health [1 UM1HL120877]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [UM1HL120877] Funding Source: NIH RePORTER	United States Department of Defense(United States Department of Defense); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by United States Department of Defense grant W911NF-10-1-0384 (MJC), and United States National Institutes of Health grant 1 UM1HL120877 (MJC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bowbrick VA, 2000, ANESTH ANALG, V90, P1086, DOI 10.1097/00000539-200005000-00015; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Brown JB, 2012, J TRAUMA ACUTE CARE, V73, P1395, DOI 10.1097/TA.0b013e31825b9f05; Campbell JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099181; Campbell JE, 2015, J TRAUMA ACUTE CARE, V78, P955, DOI 10.1097/TA.0000000000000586; Chesebro BB, 2009, SHOCK, V32, P659, DOI 10.1097/SHK.0b013e3181a5a632; Chitlur M, 2014, J THROMB HAEMOST, V12, P103, DOI 10.1111/jth.12458; Cohen MJ, 2013, J TRAUMA ACUTE CARE, V75, pS40, DOI 10.1097/TA.0b013e31828fa43d; Cohen MJ, 2012, ANN SURG, V255, P379, DOI 10.1097/SLA.0b013e318235d9e6; Doran CM, 2010, J TRAUMA, V69, pS40, DOI 10.1097/TA.0b013e3181e4257b; Esmon CT, 2006, SEMIN THROMB HEMOST, V32, P49, DOI 10.1055/s-2006-939554; Esmon CT, 2003, CHEST, V124, p26S, DOI 10.1378/chest.124.3_suppl.26S; Harr JN, 2011, J SURG RES, V170, P319, DOI 10.1016/j.jss.2011.03.047; Hess JR, 2006, TRANSFUSION, V46, P685, DOI 10.1111/j.1537-2995.2006.00816.x; Holcomb JB, 2007, J TRAUMA, V62, P307, DOI 10.1097/TA.0b013e3180324124; Howard BM, 2015, J TRAUMA ACUTE CARE, V79, P1009, DOI 10.1097/TA.0000000000000707; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Keene DD, 2013, CURR OPIN CRIT CARE, V19, P605, DOI 10.1097/MCC.0000000000000021; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P1389, DOI 10.1097/TA.0b013e318270d595; Mackman N, 2005, ARTERIOSCL THROM VAS, V25, P2273, DOI 10.1161/01.ATV.0000183884.06371.52; MacLeod JBA, 2003, J TRAUMA, V55, P39, DOI 10.1097/01.TA.0000075338.21177.EF; Maegele M, 2007, INJURY, V38, P298, DOI 10.1016/j.injury.2006.10.003; Meyer ASP, 2014, J TRAUMA ACUTE CARE, V76, P682, DOI 10.1097/TA.0000000000000134; Nilsson CU, 2008, ACTA ANAESTH SCAND, V52, P1246, DOI 10.1111/j.1399-6576.2008.01735.x; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Raza I, 2013, J THROMB HAEMOST, V11, P307, DOI 10.1111/jth.12078; Rezaie AR, 2001, J BIOL CHEM, V276, P15567, DOI 10.1074/jbc.C100123200; Rizoli SB, 2011, J TRAUMA, V71, pS427, DOI 10.1097/TA.0b013e318232e5ab; SAKATA Y, 1986, BLOOD, V68, P1218; Schreiber MA, 2005, J TRAUMA, V58, P475, DOI 10.1097/01.TA.0000153938.77777.26; Spoerke N, 2010, J TRAUMA, V68, P1106, DOI 10.1097/TA.0b013e3181d86860	35	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0150930	10.1371/journal.pone.0150930	http://dx.doi.org/10.1371/journal.pone.0150930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008408	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000372701200036
J	Liu, XJ; Wei, YL; Li, YN; Li, HY; Yang, X; Yi, YZ; Zhang, ZF				Liu, Xingjian; Wei, Yonglong; Li, Yinu; Li, Haoyang; Yang, Xin; Yi, Yongzhu; Zhang, Zhifang			A Highly Efficient and Simple Construction Strategy for Producing Recombinant Baculovirus Bombyx mori Nucleopolyhedrovirus	PLOS ONE			English	Article							NUCLEAR-POLYHEDROSIS-VIRUS; HIGH-LEVEL EXPRESSION; ESCHERICHIA-COLI; SILKWORM LARVAE; NUCLEOTIDE-SEQUENCE; ENCODED CHITINASE; CATHEPSIN GENES; INSECT CELLS; GENERATION; VECTORS	The silkworm baculovirus expression system is widely used to produce recombinant proteins. Several strategies for constructing recombinant viruses that contain foreign genes have been reported. Here, we developed a novel defective-rescue BmNPV Bacmid (reBmBac) expression system. A CopyControl origin of replication was introduced into the viral genome to facilitate its genetic manipulation in Escherichia coli and to ensure the preparation of large amounts of high quality reBmBac DNA as well as high quality recombinant baculoviruses. The ORF1629, cathepsin and chitinase genes were partially deleted or rendered defective to improve the efficiency of recombinant baculovirus generation and the expression of foreign genes. The system was validated by the successful expression of luciferase reporter gene and porcine interferon.. This system can be used to produce batches of recombinant baculoviruses and target proteins rapidly and efficiently in silkworms.	[Liu, Xingjian; Li, Yinu; Li, Haoyang; Yang, Xin; Zhang, Zhifang] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China; [Wei, Yonglong] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing, Peoples R China; [Yi, Yongzhu] Chinese Acad Agr Sci, Sericultural Res Inst, Zhenjiang, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Agricultural Sciences	Zhang, ZF (corresponding author), Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China.	zhifangzhang@yahoo.com	Liu, Xingjian/ABH-8168-2020	Li, Yinu/0000-0002-9310-8381; Liu, Xingjian/0000-0001-8198-8089; Wei, Yonglong/0000-0001-6152-7963	National High-Tech R&D Program of China ("863" Program) [2011AA100603]; National Program of Key Basic Research project of China ("973" Program) [2012CB114600]; National Natural Sciences Foundation of China [31200275]	National High-Tech R&D Program of China ("863" Program)(National High Technology Research and Development Program of China); National Program of Key Basic Research project of China ("973" Program)(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National High-Tech R&D Program of China ("863" Program, No. 2011AA100603, http://www.863.gov.cn), the National Program of Key Basic Research project of China ("973" Program, 2012CB114600, http://www.973.gov.cn) and the National Natural Sciences Foundation of China (No. 31200275, http://www.nsfc.gov.cn). ZZ received all of the fundings.	Ahrens CH, 1997, VIROLOGY, V229, P381, DOI 10.1006/viro.1997.8448; Airenne KJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng102; AYRES MD, 1994, VIROLOGY, V202, P586, DOI 10.1006/viro.1994.1380; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; BLISSARD GW, 1990, ANNU REV ENTOMOL, V35, P127, DOI 10.1146/annurev.en.35.010190.001015; BURGESS S, 1977, J GEN VIROL, V37, P501, DOI 10.1099/0022-1317-37-3-501; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DIJKMANS R, 1990, NUCLEIC ACIDS RES, V18, P5943; Felberbaum RS, 2015, BIOTECHNOL J, V10, P702, DOI 10.1002/biot.201400438; Ge JY, 2006, ANN NY ACAD SCI, V1081, P246, DOI 10.1196/annals.1373.030; Gomi S, 1999, J GEN VIROL, V80, P1323, DOI 10.1099/0022-1317-80-5-1323; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HARTIG PC, 1991, BIOTECHNIQUES, V11, P310; Hawtin RE, 1997, VIROLOGY, V238, P243, DOI 10.1006/viro.1997.8816; Jarvis DL, 2009, METHOD ENZYMOL, V463, P191, DOI 10.1016/S0076-6879(09)63014-7; Je YH, 2001, BIOTECHNOL LETT, V23, P575; Je YH, 2001, BIOTECHNOL LETT, V23, P1809, DOI 10.1023/A:1012475004212; Kim UJ, 1996, GENOMICS, V34, P213, DOI 10.1006/geno.1996.0268; KITTS PA, 1993, BIOTECHNIQUES, V14, P810; Kruger N J, 1994, Methods Mol Biol, V32, P9; Lee KS, 2006, BIOTECHNOL LETT, V28, P645, DOI 10.1007/s10529-006-0030-7; LUCKOW VA, 1993, J VIROL, V67, P4566, DOI 10.1128/JVI.67.8.4566-4579.1993; Luckow VA, 1991, RECOMBINANT DNA TECH, V97, P97; Luckow Verne A., 1993, Current Opinion in Biotechnology, V4, P564, DOI 10.1016/0958-1669(93)90078-B; Lyznik LA, 1996, NUCLEIC ACIDS RES, V24, P3784, DOI 10.1093/nar/24.19.3784; Merrington CL, 1997, MOL BIOTECHNOL, V8, P283, DOI 10.1007/BF02760782; Motohashi T, 2005, BIOCHEM BIOPH RES CO, V326, P564, DOI 10.1016/j.bbrc.2004.11.060; Noad RJ, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-87; O'Reilly D.R., 1994, BACULOVIRUS EXPRESSI; Park EY, 2008, BIOTECHNOL APPL BIOC, V49, P135, DOI 10.1042/BA20070098; PATEL G, 1992, NUCLEIC ACIDS RES, V20, P97, DOI 10.1093/nar/20.1.97; POSSEE RD, 1991, VIROLOGY, V185, P229, DOI 10.1016/0042-6822(91)90770-C; Possee RD, 2008, BIOTECHNOL BIOENG, V101, P1115, DOI 10.1002/bit.22002; REIS U, 1992, BIO-TECHNOL, V10, P910, DOI 10.1038/nbt0892-910; SENECOFF JF, 1988, J MOL BIOL, V201, P405, DOI 10.1016/0022-2836(88)90147-7; SMITH GE, 1983, MOL CELL BIOL, V3, P2156, DOI 10.1128/MCB.3.12.2156; STALKER DM, 1981, MOL GEN GENET, V181, P8, DOI 10.1007/BF00338997; Summers MD, 1987, A MANUAL OF METHODS; Sun JC, 2010, BIOTECHNOL APPL BIOC, V57, P117, DOI 10.1042/BA20100148; Tuntufye HN, 2011, FEMS MICROBIOL LETT, V325, P140, DOI 10.1111/j.1574-6968.2011.02421.x; Usami A, 2011, J BIOCHEM, V149, P219, DOI 10.1093/jb/mvq138; Wild J, 2002, GENOME RES, V12, P1434, DOI 10.1101/gr.130502; Wu X, 1998, China Patent, Patent No. 981109632; Wu XF, 2001, PROTEIN EXPRES PURIF, V21, P192, DOI 10.1006/prep.2000.1358; Yao LG, 2007, BIOTECHNOL APPL BIOC, V48, P45, DOI 10.1042/BA20070017; Yao LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032510; Zhang Y, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-42; Zhao YG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng006	48	8	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152140	10.1371/journal.pone.0152140	http://dx.doi.org/10.1371/journal.pone.0152140			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008267	Green Published, gold, Green Submitted			2022-12-26	WOS:000372701200095
J	Lonic, D; Pai, BCJ; Yamaguchi, K; Chortrakarnkij, P; Lin, HH; Lo, LJ				Lonic, Daniel; Pai, Betty Chien-Jung; Yamaguchi, Kazuaki; Chortrakarnkij, Peerasak; Lin, Hsiu-Hsia; Lo, Lun-Jou			Computer-Assisted Orthognathic Surgery for Patients with Cleft Lip/Palate: From Traditional Planning to Three-Dimensional Surgical Simulation	PLOS ONE			English	Article							OF-LIFE MEASURE; FACIAL ASYMMETRY; INTRAOPERATIVE NAVIGATION; CRANIOFACIAL MORPHOLOGY; DENTOFACIAL DEFORMITY; SPLINT; ACCURACY; CEPHALOMETRICS; RELIABILITY; PROTOCOL	Background Although conventional two-dimensional (2D) methods for orthognathic surgery planning are still popular, the use of three-dimensional (3D) simulation is steadily increasing. In facial asymmetry cases such as in cleft lip/palate patients, the additional information can dramatically improve planning accuracy and outcome. The purpose of this study is to investigate which parameters are changed most frequently in transferring a traditional 2D plan to 3D simulation, and what planning parameters can be better adjusted by this method. Patients and Methods This prospective study enrolled 30 consecutive patients with cleft lip and/or cleft palate (mean age 18.6 +/- 2.9 years, range 15 to 32 years). All patients received two-jaw single-splint orthognathic surgery. 2D orthodontic surgery plans were transferred into a 3D setting. Severe bony collisions in the ramus area after 2D plan transfer were noted. The position of the maxillo-mandibular complex was evaluated and eventually adjusted. Position changes of roll, midline, pitch, yaw, genioplasty and their frequency within the patient group were recorded as an alternation of the initial 2D plan. Patients were divided in groups of no change from the original 2D plan and changes in one, two, three and four of the aforementioned parameters as well as subgroups of unilateral, bilateral cleft lip/palate and isolated cleft palate cases. Postoperative OQLQ scores were obtained for 20 patients who finished orthodontic treatment. Results 83.3% of 2D plans were modified, mostly concerning yaw (63.3%) and midline (36.7%) adjustments. Yaw adjustments had the highest mean values in total and in all subgroups. Severe bony collisions as a result of 2D planning were seen in 46.7% of patients. Possible asymmetry was regularly foreseen and corrected in the 3D simulation. Conclusion Based on our findings, 3D simulation renders important information for accurate planning in complex cleft lip/palate cases involving facial asymmetry that is regularly missed in conventional 2D planning.	[Lonic, Daniel; Yamaguchi, Kazuaki; Lo, Lun-Jou] Chang Gung Univ, Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Taoyuan, Taiwan; [Lonic, Daniel; Pai, Betty Chien-Jung; Yamaguchi, Kazuaki; Lo, Lun-Jou] Chang Gung Univ, Chang Gung Mem Hosp, Craniofacial Res Ctr, Taoyuan, Taiwan; [Pai, Betty Chien-Jung] Chang Gung Univ, Chang Gung Mem Hosp, Dept Craniofacial Orthodont, Taoyuan, Taiwan; [Chortrakarnkij, Peerasak] Mahidol Univ, Siriraj Hosp, Div Plast Surg, Bangkok 10700, Thailand; [Lin, Hsiu-Hsia] Chang Gung Mem Hosp, Craniofacial Res Ctr, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Mahidol University; Chang Gung Memorial Hospital	Lo, LJ (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Dept Plast & Reconstruct Surg, Taoyuan, Taiwan.; Lo, LJ (corresponding author), Chang Gung Univ, Chang Gung Mem Hosp, Craniofacial Res Ctr, Taoyuan, Taiwan.	lunjoulo@cgmh.org.tw		Lin, Hsiu-Hsia/0000-0002-4252-4182	Chang Gung Memorial Hospital [CMRPG381601-3, CMRPG3B0291-3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was funded by Chang Gung Memorial Hospital, Grants CMRPG381601-3 and CMRPG3B0291-3, cgmh.org.tw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centenero SAH, 2012, J CRANIO MAXILL SURG, V40, P162, DOI 10.1016/j.jcms.2011.03.014; Abuhijleh E, 2014, J ORAL SCI, V56, P165, DOI 10.2334/josnusd.56.165; ALTOBELLI DE, 1993, PLAST RECONSTR SURG, V92, P576, DOI 10.1097/00006534-199309001-00003; Bergeron L, 2008, PLAST RECONSTR SURG, V122, P1535, DOI 10.1097/PRS.0b013e31818820d8; Caloss Ron, 2007, Oral Maxillofac Surg Clin North Am, V19, P287, DOI 10.1016/j.coms.2007.04.006; Chang HW, 2015, J CRANIO MAXILL SURG, V43, P1119, DOI 10.1016/j.jcms.2015.06.009; Chien PC, 2009, DENTOMAXILLOFAC RAD, V38, P262, DOI 10.1259/dmfr/81889955; Cunningham SJ, 2002, COMMUNITY DENT ORAL, V30, P81, DOI 10.1034/j.1600-0528.2002.300201.x; Cunningham ST, 2000, COMMUNITY DENT ORAL, V28, P195, DOI 10.1034/j.1600-0528.2000.280305.x; Silva Maurício Barbosa Guerra da, 2013, Dental Press J. Orthod., V18, P63; Dai JW, 2014, J CRANIOFAC SURG, V25, pE140, DOI 10.1097/SCS.0000000000000414; De Riu G, 2014, BRIT J ORAL MAX SURG, V52, P251, DOI 10.1016/j.bjoms.2013.12.010; FARKAS LG, 1981, ANGLE ORTHOD, V51, P70; Gateno J, 2007, J ORAL MAXIL SURG, V65, P728, DOI 10.1016/j.joms.2006.04.001; Gateno J, 2011, J ORAL MAXIL SURG, V69, P606, DOI 10.1016/j.joms.2010.09.010; Guyuron B, 2008, PLAST RECONSTR SURG, V121, P1015, DOI [10.1097/01.prs.0000305931.98111.c3, 10.1097/01.prs.0000305955.67554.40, 10.1097/01.prs.0000299464.02430.78]; Haas OL, 2015, INT J ORAL MAX SURG, V44, P329, DOI 10.1016/j.ijom.2014.10.025; Halazonetis DJ, 2005, AM J ORTHOD DENTOFAC, V127, P627, DOI 10.1016/j.ajodo.2005.01.004; Hammoudeh JA, 2015, PRS-GLOB OPEN, V3, DOI 10.1097/GOX.0000000000000184; Hernandez-Alfaro F, 2013, INT J ORAL MAX SURG, V42, P1547, DOI 10.1016/j.ijom.2013.03.025; Hsu SSP, 2013, J ORAL MAXIL SURG, V71, P128, DOI 10.1016/j.joms.2012.03.027; Huang C., 2013, ABSTR APPL ANAL, V2013, P1, DOI DOI 10.1016/J.J0MS.2013.08.004; Huang CS, 2013, ORTHOD CRANIOFAC RES, V16, P97, DOI 10.1111/ocr.12010; Hurst C. A., 2007, PLAST RECONSTR SURG, V120, p92e; Kusnoto B, 2007, CLIN PLAST SURG, V34, P417, DOI 10.1016/j.cps.2007.04.005; Kwon TG, 2006, INT J ORAL MAX SURG, V35, P43, DOI 10.1016/j.ijom.2005.04.006; Lee S, 2008, J ORAL MAXIL SURG, V66, P1194, DOI 10.1016/j.joms.2008.01.006; Li B, 2013, BRIT J ORAL MAX SURG, V51, pE239, DOI 10.1016/j.bjoms.2013.03.007; Lin HH, 2015, INT J COMPUT ASS RAD, V10, P2021, DOI 10.1007/s11548-015-1223-0; Lin HH, 2015, J FORMOS MED ASSOC, V114, P300, DOI 10.1016/j.jfma.2015.01.017; Lin HH, 2015, ANN PLAS SURG, V74, pS118, DOI 10.1097/SAP.0000000000000455; Lin HH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117604; Lin HH, 2013, J ORAL MAXIL SURG, V71, P1933, DOI 10.1016/j.joms.2013.06.199; Lonic D, 2016, J FORMOS MED ASSOC, V115, P387, DOI 10.1016/j.jfma.2015.09.002; Maglione M, 2012, INT J DENT, V2012, DOI 10.1155/2012/285693; Meyer-Marcotty P, 2010, AM J ORTHOD DENTOFAC, V137, DOI 10.1016/j.ajodo.2008.11.023; Mori Y, 2011, ORAL MAXILLOFAC SURG, V15, P131, DOI 10.1007/s10006-010-0247-4; Proffit W R, 1998, Int J Adult Orthodon Orthognath Surg, V13, P97; Rinchuse DJ, 2006, AM J ORTHOD DENTOFAC, V129, P299, DOI 10.1016/j.ajodo.2005.03.019; Shehab MF, 2013, OR SURG OR MED OR PA, V115, pE16, DOI 10.1016/j.oooo.2011.09.035; Song WW, 2013, J ORAL MAXIL SURG, V71, P752, DOI 10.1016/j.joms.2012.07.043; Sun Y, 2013, J CRANIOFAC SURG, V24, P1871, DOI 10.1097/SCS.0b013e31829a80d9; Xia JJ, 2007, J ORAL MAXIL SURG, V65, P248, DOI 10.1016/j.joms.2006.10.005; Xia JJ, 2011, J ORAL MAXIL SURG, V69, P2014, DOI 10.1016/j.joms.2011.02.018; Zinser MJ, 2013, J ORAL MAXILLOFAC SU, V71, P2151, DOI DOI 10.1016/J.J0MS.2013.07.007; Zizelmann C, 2012, J ORAL MAXIL SURG, V70, P1944, DOI 10.1016/j.joms.2011.08.025	46	45	48	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152014	10.1371/journal.pone.0152014	http://dx.doi.org/10.1371/journal.pone.0152014			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002726	Green Published, gold, Green Submitted			2022-12-26	WOS:000372697400064
J	Uriarte, JJ; Meirelles, T; del Blanco, DG; Nonaka, PN; Campillo, N; Sarri, E; Navajas, D; Egea, G; Farre, R				Uriarte, Juan J.; Meirelles, Thayna; del Blanco, Darya Gorbenko; Nonaka, Paula N.; Campillo, Noelia; Sarri, Elisabet; Navajas, Daniel; Egea, Gustavo; Farre, Ramon			Early Impairment of Lung Mechanics in a Murine Model of Marfan Syndrome	PLOS ONE			English	Article							IN-VITRO; MICROMECHANICAL PROPERTIES; EXTRACELLULAR-MATRIX; PULMONARY-FUNCTION; TGF-BETA; FIBRILLIN; MICE; PATHOGENESIS; EMPHYSEMA; PRESSURE	Early morbidity and mortality in patients with Marfan syndrome (MFS) -a connective tissue disease caused by mutations in fibrillin-1 gene- are mainly caused by aorta aneurysm and rupture. However, the increase in the life expectancy of MFS patients recently achieved by reparatory surgery promotes clinical manifestations in other organs. Although some studies have reported respiratory alterations in MFS, our knowledge of how this connective tissue disease modifies lung mechanics is scarce. Hence, we assessed whether the stiffness of the whole lung and of its extracellular matrix (ECM) is affected in a well-characterized MFS mouse model (FBN1(C1039G/+)). The stiffness of the whole lung and of its ECM were measured by conventional mechanical ventilation and atomic force microscopy, respectively. We studied 5-week and 9-month old mice, whose ages are representative of early and late stages of the disease. At both ages, the lungs of MFS mice were significantly more compliant than in wild type (WT) mice. By contrast, no significant differences were found in local lung ECM stiffness. Moreover, histopathological lung evaluation showed a clear emphysematous-like pattern in MFS mice since alveolar space enlargement was significantly increased compared with WT mice. These data suggest that the mechanism explaining the increased lung compliance in MFS is not a direct consequence of reduced ECM stiffness, but an emphysema-like alteration in the 3D structural organization of the lung. Since lung alterations in MFS are almost fully manifested at an early age, it is suggested that respiratory monitoring could provide early biomarkers for diagnosis and/or follow-up of patients with the Marfan syndrome.	[Uriarte, Juan J.; Nonaka, Paula N.; Campillo, Noelia; Navajas, Daniel; Farre, Ramon] Univ Barcelona, Fac Med, Unitat Biofis & Bioengn, Barcelona 7, Spain; [Uriarte, Juan J.; Campillo, Noelia; Navajas, Daniel; Farre, Ramon] CIBER Enfermedades Resp, Madrid, Spain; [Meirelles, Thayna; del Blanco, Darya Gorbenko; Sarri, Elisabet; Egea, Gustavo] Univ Barcelona, Dept Biol Cel Lular Immunol & Neurociencies, Barcelona 7, Spain; [Nonaka, Paula N.] Nove Julho Univ, Masters & Doctoral Degree Programs Rehabil Sci, Sao Paulo, Brazil; [Campillo, Noelia; Navajas, Daniel] Inst Bioengn Catalunya, Barcelona, Spain; [Egea, Gustavo] Univ Barcelona, Inst Nanociencies & Nanotecnol, Barcelona 7, Spain; [Egea, Gustavo; Farre, Ramon] Inst Invest Biomed August Pi Sunyer, Barcelona, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona; Universidade Nove de Julho; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Farre, R (corresponding author), Univ Barcelona, Fac Med, Unitat Biofis & Bioengn, Barcelona 7, Spain.; Farre, R (corresponding author), CIBER Enfermedades Resp, Madrid, Spain.; Farre, R (corresponding author), Inst Invest Biomed August Pi Sunyer, Barcelona, Spain.	rfarre@ub.edu	Sarri, Elisabet/AHA-6911-2022; Farre, Ramon/L-2664-2017; Navajas, Daniel/E-4233-2010; Gorbenko del Blanco, Darya/N-6069-2018; Egea, Gustavo/I-2394-2014	Sarri, Elisabet/0000-0002-2435-399X; Farre, Ramon/0000-0002-9084-7824; Campillo, Noelia/0000-0001-9712-3784; Navajas, Daniel/0000-0001-7150-9363; Gorbenko del Blanco, Darya/0000-0002-9674-2388; Egea, Gustavo/0000-0001-5242-150X	National Counsel of Technological and Scientific Development-Science without Borders scholarship program (Brazilian federal government); Fundacio Marato-TV3 [122310]; Fundacion Ramon Areces; Spanish Ministry of Economy and Competitiveness [FIS14-22576, FIS-PI11/00089, BFU2012-33932]	National Counsel of Technological and Scientific Development-Science without Borders scholarship program (Brazilian federal government); Fundacio Marato-TV3; Fundacion Ramon Areces; Spanish Ministry of Economy and Competitiveness(Spanish Government)	Thayna Meirelles and Paula N. Nonaka were supported by fellowships from National Counsel of Technological and Scientific Development-Science without Borders scholarship program (Brazilian federal government). This work was supported by grants of Fundacio Marato-TV3 (122310), Fundacion Ramon Areces, and the Spanish Ministry of Economy and Competitiveness (FIS14-22576, FIS-PI11/00089 and BFU2012-33932).	Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0; Andreu I, 2014, ACTA BIOMATER, V10, P3235, DOI 10.1016/j.actbio.2014.03.034; BATES JHT, 1985, J APPL PHYSIOL, V58, P1840, DOI 10.1152/jappl.1985.58.6.1840; Booth AJ, 2012, AM J RESP CRIT CARE, V186, P866, DOI 10.1164/rccm.201204-0754OC; Canadas V, 2010, NAT REV CARDIOL, V7, P256, DOI 10.1038/nrcardio.2010.30; Cannizzaro V, 2009, RESP PHYSIOL NEUROBI, V165, P61, DOI 10.1016/j.resp.2008.10.006; Cavarra E, 2001, AM J RESP CRIT CARE, V164, P886, DOI 10.1164/ajrccm.164.5.2010032; Chiumello D, 2014, INTENS CARE MED, V40, P1670, DOI 10.1007/s00134-014-3415-4; Cistulli PA, 2001, CHEST, V120, P1455, DOI 10.1378/chest.120.5.1455; Corsico AG, 2014, PANMINERVA MED, V56, P177; Davis MR, 2012, MOL GENET METAB, V107, P635, DOI 10.1016/j.ymgme.2012.07.023; Deb PP, 2014, J TISSUE ENG REGEN M; DIETZ HC, 1991, NATURE, V352, P337, DOI 10.1038/352337a0; Dinwiddie Robert, 2005, Paediatr Respir Rev, V6, P181, DOI 10.1016/j.prrv.2005.06.007; Dyhdalo K, 2011, AM J CLIN PATHOL, V136, P857, DOI 10.1309/AJCP79SNDHGKQFIN; Faffe DS, 2009, PHYSIOL REV, V89, P759, DOI 10.1152/physrev.00019.2007; Ferruzzi J, 2011, CARDIOVASC RES, V92, P287, DOI 10.1093/cvr/cvr195; Giske L, 2003, J REHABIL MED, V35, P221, DOI 10.1080/16501970306095; Gould RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044639; Groves AM, 2013, AM J PHYSIOL-LUNG C, V305, pL555, DOI 10.1152/ajplung.00027.2013; Huang KW, 2007, J APPL PHYSIOL, V102, P1632, DOI 10.1152/japplphysiol.00833.2006; Jacob RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006670; Jensen T, 2012, TISSUE ENG PART C-ME, V18, P632, DOI [10.1089/ten.tec.2011.0584, 10.1089/ten.TEC.2011.0584]; Judge DP, 2004, J CLIN INVEST, V114, P172, DOI 10.1172/JCI200420641; da Palma RK, 2015, RESP PHYSIOL NEUROBI, V207, P58, DOI 10.1016/j.resp.2014.12.013; Knudsen L, 2010, J APPL PHYSIOL, V108, P412, DOI 10.1152/japplphysiol.01100.2009; Koenders MMJF, 2009, J PATHOL, V218, P446, DOI 10.1002/path.2548; Lima BL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014136; Limjunyawong N, 2015, AM J PHYSIOL-LUNG C, V309, pL662, DOI 10.1152/ajplung.00214.2015; Liu F, 2011, JOVE-J VIS EXP, DOI 10.3791/2911; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; Luque T, 2013, ACTA BIOMATER, V9, P6852, DOI 10.1016/j.actbio.2013.02.044; Machado MN, 2014, RESP PHYSIOL NEUROBI, V200, P90, DOI 10.1016/j.resp.2014.06.005; Mariko B, 2011, J PATHOL, V224, P33, DOI 10.1002/path.2840; MECHAM RP, 1991, ANN NY ACAD SCI, V624, P137, DOI 10.1111/j.1749-6632.1991.tb17013.x; Melo E, 2014, J MECH BEHAV BIOMED, V37, P186, DOI 10.1016/j.jmbbm.2014.05.019; Melo E, 2014, TISSUE ENG PART C-ME, V20, P412, DOI [10.1089/ten.tec.2013.0325, 10.1089/ten.TEC.2013.0325]; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng DK, 1999, J PAEDIATR CHILD H, V35, P321, DOI 10.1046/j.1440-1754.1999.00355.x; Nonaka PN, 2014, J BIOMED MATER RES A, V102, P413, DOI 10.1002/jbm.a.34708; Perea-Gil I, 2015, AM J TRANSL RES, V7, P558; Pereira L, 1997, NAT GENET, V17, P218, DOI 10.1038/ng1097-218; Pereira L, 1999, P NATL ACAD SCI USA, V96, P3819, DOI 10.1073/pnas.96.7.3819; Pyeritz RE, 2009, HEART, V95, P173, DOI 10.1136/hrt.2008.160515; Rico F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021914; Robbesom AA, 2008, MODERN PATHOL, V21, P297, DOI 10.1038/modpathol.3801004; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; SALDIVA PHN, 1992, J APPL PHYSIOL, V72, P302, DOI 10.1152/jappl.1992.72.1.302; Sato S, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00146; Sherratt MJ, 2003, J MOL BIOL, V332, P183, DOI 10.1016/S0022-2836(03)00829-5; Silversides CK, 2010, CAN J CARDIOL, V26, pE80, DOI 10.1016/S0828-282X(10)70355-X; STREETEN EA, 1987, CHEST, V91, P408, DOI 10.1378/chest.91.3.408; SUKI B, 1994, J APPL PHYSIOL, V76, P2749, DOI 10.1152/jappl.1994.76.6.2749; Suki B, 2011, COMPREHENSIVE PHYSL; Suki B, 2008, RESP PHYSIOL NEUROBI, V163, P33, DOI 10.1016/j.resp.2008.03.015; Szabari MV, 2012, AM J PHYSIOL-LUNG C, V303, pL567, DOI 10.1152/ajplung.00217.2012; Turner JA, THORAX, V31, P771; Von Kodolitsch Y, 2015, APPL CLIN GENET, V8, P137, DOI 10.2147/TACG.S60472; WOOD JR, 1984, THORAX, V39, P780, DOI 10.1136/thx.39.10.780	60	16	16	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152124	10.1371/journal.pone.0152124	http://dx.doi.org/10.1371/journal.pone.0152124			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003297	gold, Green Published			2022-12-26	WOS:000372697400082
J	Jiang, YH; Jhang, JF; Kuo, HC				Jiang, Yuan-Hong; Jhang, Jia-Fong; Kuo, Hann-Chorng			Revisiting the Role of Potassium Sensitivity Testing and Cystoscopic Hydrodistention for the Diagnosis of Interstitial Cystitis	PLOS ONE			English	Article							HYPERSENSITIVE BLADDER; PATHOGENESIS; EPITHELIUM; EXPRESSION; SYMPTOMS; BIOPSY; WOMEN	Objectives To revisit the diagnostic roles of cystoscopic hydrodistention and the potassium sensitivity test (PST) for the diagnosis of interstitial cystitis (IC). Methods We prospectively enrolled 214 patients clinically diagnosed with IC, 125 non-IC patients who underwent video urodynamic studies and PST, and another 144 non-IC patients who underwent cystoscopic hydrodistention before transurethral surgery. The sensitivity, specificity, and positive and negative predictive values were calculated for the PST and glomerulations after cystoscopic hydrodistention. Results After cystoscopic hydrodistention, glomerulations developed in 211/214 (98.6%) IC patients and 61/144 (42.4%) of the non-IC patients including patients with stones (45/67, 67%), hematuria (2/5, 40%), and stress urinary incontinence (SUI) (6/17, 35%). When positive glomerulation was defined as grade 2 or more, the sensitivity was 61.7%. The PST was positive in 183/214 (85.5%) IC patients and 7/17 (41%) with hypersensitive bladder, 7/32 (22%) with detrusor overactivity, 5/27 (18%) with SUI, 2/21 (10%) with lower urinary tract symptoms, and 2/25 (8%) with bladder outlet obstruction. The PST had a sensitivity of 85.5% and a specificity of 81.6% for diagnosis of IC. IC patients with a positive PST had a significantly smaller urgency sensation capacity, smaller voided volume, and greater bladder pain score. Conclusions Both the PST and glomerulations after hydrodistention are sensitive indicators of IC, but the specificity of glomerulations in the diagnosis of IC is lower than that of the PST. A positive PST is associated with a more hypersensitive bladder and bladder pain, but not the grade of glomerulations in IC patients. Neither test provided 100% diagnostic accuracy for IC, we might select patients into different subgroups based on different PST and hydrodistention results, not for making a diagnosis of IC but for guidance of different treatments.	[Kuo, Hann-Chorng] Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan; Tzu Chi Univ, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University	Kuo, HC (corresponding author), Buddhist Tzu Chi Gen Hosp, Dept Urol, Hualien, Taiwan.	hck@tzuchi.com.tw						Birder LA, 2014, NEUROUROL URODYNAM, V33, P597, DOI 10.1002/nau.22604; Chancellor MB, 2004, UROLOGY, V63, P85, DOI 10.1016/j.urology.2003.10.034; Chung SD, 2011, NEUROUROL URODYNAM, V30, P1300, DOI 10.1002/nau.21057; Engles CD, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2011.10.010; Hanno P, 2010, NEUROUROL URODYNAM, V29, P191, DOI 10.1002/nau.20847; Hanno PM, 1999, J UROLOGY, V161, P553, DOI 10.1016/S0022-5347(01)61948-7; Hanno PM, 2001, UROLOGY, V57, P2, DOI 10.1016/S0090-4295(01)01112-8; Hassan AA, 2007, INT J UROL, V14, P738, DOI 10.1111/j.1442-2042.2007.01821.x; Homma Y, 2014, INT J UROL, V21, P43, DOI 10.1111/iju.12314; Homma Y, 2009, INT J UROL, V16, P597, DOI 10.1111/j.1442-2042.2009.02326.x; HUNNER GL, 1914, T S SURG GYNECOL, V27, P247; Jiang YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110754; Kuo YC, 2012, INT J CLIN PRACT, V66, P146, DOI 10.1111/j.1742-1241.2011.02767.x; Lee JD, 2011, UROLOGY, V78, DOI [10.1016/j.urology.2011.04.055, 10.1016/j.urology.2011.05.050]; Nickel JC, 2004, MED CLIN N AM, V88, P467, DOI 10.1016/S0025-7125(03)00151-2; Nigro DA, 1997, UROLOGY, V49, P86, DOI 10.1016/S0090-4295(99)80337-9; Parsons CL, 2007, UROLOGY, V69, P9, DOI 10.1016/j.urology.2006.03.084; Parsons CL, 2011, BJU INT, V107, P370, DOI 10.1111/j.1464-410X.2010.09843.x; Parsons CL, 2009, J UROLOGY, V182, P432; Parsons CL, 1998, J UROLOGY, V159, P1862, DOI 10.1016/S0022-5347(01)63178-1; PARSONS CL, 1987, J UROLOGY, V138, P513, DOI 10.1016/S0022-5347(17)43243-5; Saban R, 2008, AM J PHYSIOL-RENAL, V295, pF1613, DOI 10.1152/ajprenal.90344.2008; Shie JH, 2013, BJU INT, V111, P638, DOI 10.1111/j.1464-410X.2012.11466.x; Shie JH, 2012, UROLOGY, V79, P750, DOI 10.1016/j.urology.2011.10.045; Shie JH, 2011, BJU INT, V108, pE136, DOI 10.1111/j.1464-410X.2010.09911.x; Tamaki M, 2004, J UROLOGY, V172, P945, DOI 10.1097/01.ju.0000135009.55905.cb; Tomaszewski JE, 2001, UROLOGY, V57, P67, DOI 10.1016/S0090-4295(01)01166-9; Waxman JA, 1998, J UROLOGY, V160, P1663, DOI 10.1016/S0022-5347(01)62376-0; Yamada T, 2007, WORLD J UROL, V25, P407, DOI 10.1007/s00345-007-0174-7	29	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151692	10.1371/journal.pone.0151692	http://dx.doi.org/10.1371/journal.pone.0151692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999787	Green Published, Green Submitted, gold			2022-12-26	WOS:000372694700057
J	Loewen, RT; Brown, EN; Roy, P; Schuman, JS; Sigal, IA; Loewen, NA				Loewen, Ralitsa T.; Brown, Eric N.; Roy, Pritha; Schuman, Joel S.; Sigal, Ian A.; Loewen, Nils A.			Regionally Discrete Aqueous Humor Outflow Quantification Using Fluorescein Canalograms	PLOS ONE			English	Article							HUMAN TRABECULAR MESHWORK; UVEOSCLERAL OUTFLOW; PORCINE EYES; FACILITY; EXPRESSION; PATHWAY; FLUOROPHOTOMETRY; ANGIOGRAPHY; INJECTION; GLAUCOMA	Purpose To visualize and quantify conventional outflow directly in its anatomic location. Methods We obtained fluorescein canalograms in six porcine whole eyes and six porcine anterior segment cultures. Eyes were perfused with a constant pressure of 15 mmHg using media containing 0.017 mg/ml fluorescein. Flow patterns were visualized using a stereo dissecting microscope equipped for fluorescent imaging. Images were captured every 30 seconds for 20 minutes for time lapse analysis. Anterior chamber cultures were imaged again on day three of culture. Canalograms were first analyzed for filling time per quadrant. We then wrote a program to automatically compute focal flow fits for each macropixel and to detect convergent perilimbal flow patterns with macropixels grouped into 3 equal-radial width rings around the cornea. A generalized additive model was used to determine fluorescence changes of individual macropixels. Results The resulting imaging algorithm deployed 1024 macropixels that were fit to determine maximum intensity and time to fill. These individual fits highlighted the focal flow function. In whole eyes, significantly faster flow was seen in the inferonasal (IN) and superonasal (SN) quadrants compared to the superotemporal (ST) and inferotemporal (IT) ones (p<0.05). In anterior chamber cultures, reduced flow on day 1 increased in all quadrants on day 3 except in IT (p<0.05). Perilimbal ring analysis uncovered convergent perilimbal flow. Conclusions An algorithm was developed that analyzes regional and circumferential outflow patterns. This algorithm found flow patterns that changed over time and differ in whole eyes and anterior segment cultures.	[Loewen, Ralitsa T.; Roy, Pritha; Schuman, Joel S.; Sigal, Ian A.; Loewen, Nils A.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA; [Brown, Eric N.] Vanderbilt Univ, Sch Med, Dept Ophthalmol, Nashville, TN 37212 USA; [Loewen, Ralitsa T.; Roy, Pritha; Schuman, Joel S.; Sigal, Ian A.; Loewen, Nils A.] Univ Pittsburgh, Sch Med, Louis J Fox Ctr Vis Restorat, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Vanderbilt University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Loewen, NA (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA.; Loewen, NA (corresponding author), Univ Pittsburgh, Sch Med, Louis J Fox Ctr Vis Restorat, Pittsburgh, PA USA.	loewenna@upmc.edu	Brown, Eric/A-1018-2010; Schuman, Joel/K-7304-2012	Brown, Eric/0000-0002-2641-1890; Schuman, Joel/0000-0002-8885-3766	National Eye Institute [5R01EY013178-16, 2T32EY017271-06A1, EY023966, KO8EY022737]; Research to Prevent Blindness; NATIONAL EYE INSTITUTE [T32EY017271, K08EY022737, P30EY008098, R01EY023966, R01EY013178] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by 5R01EY013178-16 (National Eye Institute; nei.nih.gov) to JSS; Research to Prevent Blindness, Departmental (www.rpbusa.org), to JSS; 2T32EY017271-06A1 (National Eye Institute, nei.nih.gov; IVS Training Program); EY023966 (National Eye Institute, nei.nih.gov) to IAS; and KO8EY022737 (National Eye Institute, nei.nih.gov) to NAL.	Abu-Hassan DW, 2015, STEM CELLS, V33, P751, DOI 10.1002/stem.1885; ASHTON N, 1951, BRIT J OPHTHALMOL, V35, P291, DOI 10.1136/bjo.35.5.291; Barraza RA, 2010, MOL THER, V18, P491, DOI 10.1038/mt.2009.278; BENEDIKT O, 1976, A GRAEF ARCH KLIN EX, V199, P45, DOI 10.1007/BF00660815; Bentzen CF, 1895, GRAEFES ARCH OPHTHAL, V41, P208; BRUBAKER RF, 1985, GRAEF ARCH CLIN EXP, V222, P190, DOI 10.1007/BF02133672; Chung WY, 2015, J KOREAN MED SCI, V30, P716, DOI 10.3346/jkms.2015.30.6.716; Du YQ, 2013, INVEST OPHTH VIS SCI, V54, P1450, DOI 10.1167/iovs.12-11056; FEGHALI JG, 1986, INVEST OPHTH VIS SCI, V27, P1776; Fellman RL, 2014, J GLAUCOMA, V23, P347, DOI 10.1097/IJG.0b013e31827a06d8; Francis AW, 2012, INVEST OPHTH VIS SCI, V53, P5198, DOI 10.1167/iovs.11-9229; Gabelt BT, 2006, EXP EYE RES, V82, P935, DOI 10.1016/j.exer.2005.12.002; Grieshaber MC, 2010, INVEST OPHTH VIS SCI, V51, P1498, DOI 10.1167/iovs.09-4327; Grundeken Maik J, 2015, EuroIntervention, V11 Suppl V, pV44, DOI 10.4244/EIJV11SVA10; HASTIE T, 1987, J AM STAT ASSOC, V82, P371, DOI 10.2307/2289439; Hastie T, 1986, STAT SCI JSTOR; HAYASHI M, 1989, EXP EYE RES, V48, P621, DOI 10.1016/0014-4835(89)90004-3; Jia YL, 2014, OPHTHALMOLOGY, V121, P1322, DOI 10.1016/j.ophtha.2014.01.021; JOHNSON DH, 1987, INVEST OPHTH VIS SCI, V28, P945; Kagemann L, 2010, INVEST OPHTH VIS SCI, V51, P4054, DOI 10.1167/iovs.09-4559; Kaplowitz K, 2014, BRIT J OPHTHALMOL, V98, P579, DOI 10.1136/bjophthalmol-2013-304256; Khare PD, 2008, MOL THER, V16, P97, DOI 10.1038/sj.mt.6300318; Loewen N, 2002, INVEST OPHTH VIS SCI, V43, P3686; Loewen N, 2001, HUM GENE THER, V12, P2109, DOI 10.1089/10430340152677449; MCMENAMIN PG, 1991, J ANAT, V178, P65; Morrison JC, 2005, PROG RETIN EYE RES, V24, P217, DOI 10.1016/j.preteyeres.2004.08.003; MORRISON JC, 1995, INVEST OPHTH VIS SCI, V36, P751; Pau G, 2010, BIOINFORMATICS, V26, P979, DOI 10.1093/bioinformatics/btq046; Sandrian MG, 2012, BRIT J OPHTHALMOL, V96, P1522, DOI 10.1136/bjophthalmol-2012-301904; Schuman JS, 1999, INVEST OPHTH VIS SCI, V40, P1676; Schwalbe G., 1870, ARCH MIKROSK ANAT, V6, P261, DOI DOI 10.1007/BF02955984; Suarez T, 2006, MOL VIS, V12, P1467; Toris CB, 1995, EXP EYE RES, V61, P649, DOI 10.1016/S0014-4835(05)80015-6; TRIPATHI RC, 1971, EXP EYE RES, V12, P311, DOI 10.1016/0014-4835(71)90155-2; Wagner JA, 2004, INVEST OPHTH VIS SCI, V45, P3203, DOI 10.1167/iovs.03-1176; Wang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090690; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Yu SY, 2006, EXP EYE RES, V83, P758, DOI 10.1016/j.exer.2006.03.014; Zeppa Lucio, 2014, JAMA Ophthalmol, V132, P1281, DOI 10.1001/jamaophthalmol.2014.567	39	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151754	10.1371/journal.pone.0151754	http://dx.doi.org/10.1371/journal.pone.0151754			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998833	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000372694700061
J	Zaccaria, E; Cao, R; Wells, JM; van Baarlen, P				Zaccaria, Edoardo; Cao, Rui; Wells, Jerry M.; van Baarlen, Peter			A Zebrafish Larval Model to Assess Virulence of Porcine Streptococcus suis Strains	PLOS ONE			English	Article							COMPARATIVE GENOMIC ANALYSIS; MURAMIDASE-RELEASED PROTEIN; INNATE IMMUNE-RESPONSE; FUNCTIONAL-ANALYSIS; INFECTIOUS-DISEASE; SEROTYPE-2; PATHOGEN; HOST; PIGS; IDENTIFICATION	Streptococcus suis is an encapsulated Gram-positive bacterium, and the leading cause of sepsis and meningitis in young pigs resulting in considerable economic losses in the porcine industry. It is also considered an emerging zoonotic agent. In the environment, both avirulent and virulent strains occur in pigs, and virulent strains appear to cause disease in both humans and pigs. There is a need for a convenient, reliable and standardized animal model to assess S.suis virulence. A zebrafish (Danio rerio) larvae infection model has several advantages, including transparency of larvae, low cost, ease of use and exemption from ethical legislation up to 6 days post fertilization, but has not been previously established as a model for S. suis. Microinjection of different porcine strains of S. suis in zebrafish larvae resulted in highly reproducible dose- and strain-dependent larval death, strongly correlating with presence of the S. suis capsule and to the original virulence of the strain in pigs. Additionally we compared the virulence of the two-component system mutant of ciaRH, which is attenuated for virulence in both mice and pigs in vivo. Infection of larvae with the Delta ciaRH strain resulted in significantly higher survival rate compared to infection with the S10 wild-type strain. Our data demonstrate that zebrafish larvae are a rapid and reliable model to assess the virulence of clinical porcine S. suis isolates.	[Zaccaria, Edoardo; Cao, Rui; Wells, Jerry M.; van Baarlen, Peter] Wageningen Univ, Dept Anim Sci, Host Microbe Interact, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research	van Baarlen, P (corresponding author), Wageningen Univ, Dept Anim Sci, Host Microbe Interact, NL-6700 AP Wageningen, Netherlands.	peter.vanbaarlen@wur.nl	Zaccaria, Edoardo/AAP-9740-2020	van Baarlen, Peter/0000-0003-3530-5472				Allgaier A, 2001, J CLIN MICROBIOL, V39, P445, DOI 10.1128/JCM.39.2.445-453.2001; ARENDS JP, 1988, REV INFECT DIS, V10, P131; Benard EL, 2012, JOVE-J VIS EXP, DOI 10.3791/3781; Carvalho R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016779; Cui C, 2011, METHOD CELL BIOL, V105, P273, DOI 10.1016/B978-0-12-381320-6.00012-6; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; de Greeff A, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-161; Dominguez-Punaro MC, 2007, J IMMUNOL, V179, P1842, DOI 10.4049/jimmunol.179.3.1842; Feng YJ, 2014, VIRULENCE, V5, P477, DOI 10.4161/viru.28595; Ferrando ML, 2015, J INFECT DIS, V212, P95, DOI 10.1093/infdis/jiu813; Fittipaldi N, 2012, FUTURE MICROBIOL, V7, P259, DOI [10.2217/FMB.11.149, 10.2217/fmb.11.149]; Fortier LC, 2013, VIRULENCE, V4, P354, DOI 10.4161/viru.24498; Gottschalk Marcelo, 2007, Animal Health Research Reviews, V8, P29, DOI 10.1017/S1466252307001247; Goyette-Desjardins G, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.45; Harvie EA, 2013, INFECT IMMUN, V81, P110, DOI 10.1128/IAI.00642-12; Herbomel P, 1999, DEVELOPMENT, V126, P3735; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; Ju CX, 2012, J BACTERIOL, V194, P1464, DOI 10.1128/JB.06231-11; Kanther M, 2010, CURR OPIN IMMUNOL, V22, P10, DOI 10.1016/j.coi.2010.01.006; Kim BJ, 2015, MICROB PATHOGENESIS, V79, P57, DOI 10.1016/j.micpath.2015.01.007; Lakkitjaroen N, 2011, J MED MICROBIOL, V60, P1669, DOI 10.1099/jmm.0.034686-0; Lecours MP, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-72; Levraud JP, 2009, INFECT IMMUN, V77, P3651, DOI 10.1128/IAI.00408-09; Li JQ, 2011, VET MICROBIOL, V148, P99, DOI 10.1016/j.vetmic.2010.08.005; Li YJ, 2012, J GENET GENOMICS, V39, P521, DOI 10.1016/j.jgg.2012.07.006; Lieschke GJ, 2001, BLOOD, V98, P3087, DOI 10.1182/blood.V98.10.3087; Lun ZR, 2007, LANCET INFECT DIS, V7, P201, DOI 10.1016/S1473-3099(07)70001-4; Madsen LW, 2002, J VET MED B, V49, P211, DOI 10.1046/j.1439-0450.2002.00491.x; Marini E, 2015, VET MICROBIOL, V178, P99, DOI 10.1016/j.vetmic.2015.04.013; Marois C, 2004, J CLIN MICROBIOL, V42, P3169, DOI 10.1128/JCM.42.7.3169-3175.2004; Meijerink M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035849; Miller JD, 2004, ACTA TROP, V91, P53, DOI 10.1016/j.actatropica.2003.10.020; Nguyen THM, 2008, CLIN INFECT DIS, V46, P659, DOI 10.1086/527385; Smith HE, 1996, INFECT IMMUN, V64, P4409, DOI 10.1128/IAI.64.10.4409-4412.1996; Smith HE, 1999, INFECT IMMUN, V67, P1750; Smith HE, 1997, J CLIN MICROBIOL, V35, P1049, DOI 10.1128/JCM.35.5.1049-1053.1997; Staats JJ, 1997, VET RES COMMUN, V21, P381, DOI 10.1023/A:1005870317757; Stockhammer OW, 2009, J IMMUNOL, V182, P5641, DOI 10.4049/jimmunol.0900082; Suankratay Chusana, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P868; Sullivan C, 2008, FISH SHELLFISH IMMUN, V25, P341, DOI 10.1016/j.fsi.2008.05.005; Tang F, 2013, GENOMICS, V101, P336, DOI 10.1016/j.ygeno.2013.04.005; Tang F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054227; Tang JQ, 2006, PLOS MED, V3, P668, DOI 10.1371/journal.pmed.0030151; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; van der Sar AM, 2006, INFECT IMMUN, V74, P2436, DOI 10.1128/IAI.74.4.2436-2441.2006; van der Sar AM, 2004, TRENDS MICROBIOL, V12, P451, DOI 10.1016/j.tim.2004.08.001; van der Sar AM, 2003, CELL MICROBIOL, V5, P601, DOI 10.1046/j.1462-5822.2003.00303.x; van der Vaart M, 2013, DIS MODEL MECH, V6, P841, DOI 10.1242/dmm.010843; Vecht U, 1996, VET MICROBIOL, V51, P125, DOI 10.1016/0378-1135(96)00028-4; VECHT U, 1992, INFECT IMMUN, V60, P550, DOI 10.1128/IAI.60.2.550-556.1992; Wangkaew S, 2006, J INFECTION, V52, P455, DOI 10.1016/j.jinf.2005.02.012; Watkins EJ, 2001, LANCET, V357, P38, DOI 10.1016/S0140-6736(00)03570-4; Weinert LA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7740; Wertheim HFL, 2009, CLIN INFECT DIS, V48, P617, DOI 10.1086/596763; Wisselink HJ, 2001, VET REC, V148, P473, DOI 10.1136/vr.148.15.473; Wu ZF, 2014, GENE, V535, P156, DOI 10.1016/j.gene.2013.11.044; Wu ZF, 2010, MICROB PATHOGENESIS, V48, P178, DOI 10.1016/j.micpath.2010.02.007; Wu ZF, 2008, MICROB PATHOGENESIS, V45, P159, DOI 10.1016/j.micpath.2008.04.009; Yu HJ, 2006, EMERG INFECT DIS, V12, P914, DOI 10.3201/eid1206.051194; Zhang H, 2010, CURR MICROBIOL, V61, P494, DOI 10.1007/s00284-010-9643-0	60	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151623	10.1371/journal.pone.0151623	http://dx.doi.org/10.1371/journal.pone.0151623			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999052	gold, Green Published			2022-12-26	WOS:000372694700049
J	Becker, MA; Ibrahim, YH; Oh, AS; Fagan, DH; Byron, SA; Sarver, AL; Lee, AV; Shaw, LM; Fan, C; Perou, CM; Yee, D				Becker, Marc A.; Ibrahim, Yasir H.; Oh, Annabell S.; Fagan, Dedra H.; Byron, Sara A.; Sarver, Aaron L.; Lee, Adrian V.; Shaw, Leslie M.; Fan, Cheng; Perou, Charles M.; Yee, Douglas			Insulin Receptor Substrate Adaptor Proteins Mediate Prognostic Gene Expression Profiles in Breast Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-I; PHASE-II; IRS-1; GANITUMAB; CELLS; ACTIVATION; ANTIBODY; SARCOMA; FAMILY; TUMORS	Therapies targeting the type I insulin-like growth factor receptor (IGF-1R) have not been developed with predictive biomarkers to identify tumors with receptor activation. We have previously shown that the insulin receptor substrate (IRS) adaptor proteins are necessary for linking IGF1R to downstream signaling pathways and the malignant phenotype in breast cancer cells. The purpose of this study was to identify gene expression profiles downstream of IGF1R and its two adaptor proteins. IRS-null breast cancer cells (T47D-YA) were engineered to express IRS-1 or IRS-2 alone and their ability to mediate IGF ligand-induced proliferation, motility, and gene expression determined. Global gene expression signatures reflecting IRS adaptor specific and primary vs. secondary ligand response were derived (Early IRS-1, Late IRS-1, Early IRS-2 and Late IRS-2) and functional pathway analysis examined. IRS isoforms mediated distinct gene expression profiles, functional pathways, and breast cancer subtype association. For example, IRS-1/2-induced TGFb2 expression and blockade of TGFb2 abrogated IGF-induced cell migration. In addition, the prognostic value of IRS proteins was significant in the luminal B breast tumor subtype. Univariate and multivariate analyses confirmed that IRS adaptor signatures correlated with poor outcome as measured by recurrence-free and overall survival. Thus, IRS adaptor protein expression is required for IGF ligand responses in breast cancer cells. IRS-specific gene signatures represent accurate surrogates of IGF activity and could predict response to anti-IGF therapy in breast cancer.	[Becker, Marc A.; Ibrahim, Yasir H.; Oh, Annabell S.; Fagan, Dedra H.; Byron, Sara A.; Sarver, Aaron L.; Yee, Douglas] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA; [Lee, Adrian V.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA USA; [Shaw, Leslie M.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Fan, Cheng; Perou, Charles M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA; [Fan, Cheng; Perou, Charles M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Pathol, Chapel Hill, NC 27599 USA; [Becker, Marc A.] Mayo Clin, Ctr Canc, Rochester, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Massachusetts System; University of Massachusetts Worcester; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Mayo Clinic	Yee, D (corresponding author), Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA.	yeexx006@umn.edu	Perou, Charles M/H-9934-2014	Perou, Charles M/0000-0001-9827-2247; Byron, Sara/0000-0003-0093-0374; Lee, Adrian/0000-0001-9917-514X; Yee, Douglas/0000-0002-3387-4009	Breast Cancer Research Foundation-American Association for Cancer Research Grant for Translational Breast Cancer Research [07-60-26]; Department of Defense Predoctoral Traineeship Award [BC073039]; National Cancer Institute Cancer Center Support Grant [P30 077598]; BCRF-AACR Grant for Translational Breast Cancer Research [07-60-26]; NATIONAL CANCER INSTITUTE [P30CA016086, R01CA148761, P50CA058223] Funding Source: NIH RePORTER	Breast Cancer Research Foundation-American Association for Cancer Research Grant for Translational Breast Cancer Research; Department of Defense Predoctoral Traineeship Award(United States Department of Defense); National Cancer Institute Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BCRF-AACR Grant for Translational Breast Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a Breast Cancer Research Foundation-American Association for Cancer Research Grant for Translational Breast Cancer Research 07-60-26 (DY), Department of Defense Predoctoral Traineeship Award BC073039 (MAB), and the National Cancer Institute Cancer Center Support Grant P30 077598.; This work was supported by a BCRF-AACR Grant for Translational Breast Cancer Research 07-60-26 (DY), Department of Defense Predoctoral Traineeship Award BC073039 (MAB), and the National Cancer Institute Cancer Center Support Grant P30 077598. We extend our appreciation to Eva Feldman for the use of the IRS overexpressing SH-EP human neuroblastoma cells.	Byron SA, 2006, BRIT J CANCER, V95, P1220, DOI 10.1038/sj.bjc.6603354; Creighton CJ, 2008, J CLIN ONCOL, V26, P4078, DOI 10.1200/JCO.2007.13.4429; Fagan DH, 2012, CANCER RES, V72, P3372, DOI 10.1158/0008-5472.CAN-12-0684; Jackson JG, 2001, ONCOGENE, V20, P7318, DOI 10.1038/sj.onc.1204920; Jackson JG, 1998, J BIOL CHEM, V273, P9994, DOI 10.1074/jbc.273.16.9994; KALEKO M, 1990, MOL CELL BIOL, V10, P464, DOI 10.1128/MCB.10.2.464; Kim B, 2009, APOPTOSIS, V14, P665, DOI 10.1007/s10495-009-0331-0; Law JH, 2008, CANCER RES, V68, P10238, DOI 10.1158/0008-5472.CAN-08-2755; Ma ZF, 2006, MOL CELL BIOL, V26, P9338, DOI 10.1128/MCB.01032-06; McCaffery I, 2013, CLIN CANCER RES, V19, P4282, DOI 10.1158/1078-0432.CCR-12-1840; Nagle JA, 2004, MOL CELL BIOL, V24, P9726, DOI 10.1128/MCB.24.22.9726-9735.2004; Pankratz SL, 2009, J BIOL CHEM, V284, P2031, DOI 10.1074/jbc.M804776200; Pappo AS, 2011, J CLIN ONCOL, V29, P4541, DOI 10.1200/JCO.2010.34.0000; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Robertson JFR, 2013, LANCET ONCOL, V14, P228, DOI 10.1016/S1470-2045(13)70026-3; SARTORIUS CA, 1994, CANCER RES, V54, P3868; Schwartz GK, 2013, LANCET ONCOL, V14, P371, DOI 10.1016/S1470-2045(13)70049-4; Shaw LM, 2011, CELL CYCLE, V10, P1750, DOI 10.4161/cc.10.11.15824; Shaw LM, 2001, MOL CELL BIOL, V21, P5082, DOI 10.1128/MCB.21.15.5082-5093.2001; Tap WD, 2012, J CLIN ONCOL, V30, P1849, DOI 10.1200/JCO.2011.37.2359; Timmerman LA, 2013, CANCER CELL, V24, P450, DOI 10.1016/j.ccr.2013.08.020; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; WANG LM, 1993, SCIENCE, V261, P1591, DOI 10.1126/science.8372354; Yang YZ, 2014, CANCER RES, V74, P2295, DOI 10.1158/0008-5472.CAN-13-1803; Yee D, 2012, JNCI-J NATL CANCER I, V104, P975, DOI 10.1093/jnci/djs258	26	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150564	10.1371/journal.pone.0150564	http://dx.doi.org/10.1371/journal.pone.0150564			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991655	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000372582800036
J	Janssen, JAMJL; Hofland, LJ; Strasburger, CJ; van den Dungen, ESR; Thevis, M				Janssen, Joseph A. M. J. L.; Hofland, Leo J.; Strasburger, Christian J.; van den Dungen, Elisabeth S. R.; Thevis, Mario			Potency of Full-Length MGF to Induce Maximal Activation of the IGF-I R Is Similar to Recombinant Human IGF-I at High Equimolar Concentrations	PLOS ONE			English	Article							MECHANO-GROWTH-FACTOR; SKELETAL-MUSCLE; INSULIN; PEPTIDE; BIOACTIVITY; PROTEINS; PRODUCT; ANALOGS; BINDING	Aims To compare full-length mechano growth factor (full-length MGF) with human recombinant insulin-like growth factor-I (IGF-I) and human recombinant insulin (HI) in their ability to activate the human IGF-I receptor (IGF-IR), the human insulin receptor (IR-A) and the human insulin receptor-B (IR-B), respectively. In addition, we tested the stimulatory activity of human MGF and its stabilized analog Goldspink-MGF on the IGF-IR. Methods The effects of full-length MGF, IGF-I, human mechano growth factor (MGF), Goldspink-MGF and HI were compared using kinase specific receptor activation (KIRA) bioassays specific for IGF-I, IR-A or IR-B, respectively. These assays quantify activity by measuring auto-phosphorylation of the receptor upon ligand binding. Results IGF-IR: At high equimolar concentrations maximal IGF-IR stimulating effects generated by full-length MGF were similar to that of IGF-I (89-fold vs. 77-fold, respectively). However, EC50 values of IGF-I and full-length MGF for the IGF-I receptor were 0.86 nmol/L (95% CI 0.69-1.07) and 7.83 nmol/L (95% CI: 4.87-12.58), respectively. No IGF-IR activation was observed by human MGF and Goldspink-MGF, respectively. IR-A/IR-B: At high equimolar concentrations similar maximal IR-A stimulating effects were observed for full-length MGF and HI, but maximal IR-B stimulation achieved by full -length MGF was stronger than that by HI (292-fold vs. 98-fold). EC50 values of HI and full-length MGF for the IR-A were 1.13 nmol/L (95% CI 0.69-1.84) and 73.11 nmol/L (42.87-124.69), respectively; for IR-B these values were 1.28 nmol/L (95% CI 0.64-2.57) and 35.10 nmol/L (95% 17.52-70.33), respectively. Conclusions Full-length MGF directly stimulates the IGF-IR. Despite a higher EC50 concentration, at high equimolar concentrations full-length MGF showed a similar maximal potency to activate the IGF-IR as compared to IGF-I. Further research is needed to understand the actions of full-length MGF in vivo and to define the physiological relevance of our in vitro findings.	[Janssen, Joseph A. M. J. L.; Hofland, Leo J.; van den Dungen, Elisabeth S. R.] Erasmus MC, Dept Internal Med, Div Endocrinol, Rotterdam, Netherlands; [Strasburger, Christian J.] Charite, Dept Med Endocrinol Diabet & Nutr Med, D-13353 Berlin, Germany; [Thevis, Mario] German Sport Univ Cologne, Inst Biochem, Ctr Prevent Doping Res, Cologne, Germany	Erasmus University Rotterdam; Erasmus MC; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Sport University Cologne; University of Cologne	Janssen, JAMJL (corresponding author), Erasmus MC, Dept Internal Med, Div Endocrinol, Rotterdam, Netherlands.	j.a.m.j.l.janssen@erasmusmc.nl	Janssen, Joseph A.M.J.L./AAU-5133-2021	Janssen, Joseph A.M.J.L./0000-0002-9363-6408	Federal Ministry of the Interior of the Federal Republic of Germany (Bonn, Germany)	Federal Ministry of the Interior of the Federal Republic of Germany (Bonn, Germany)	The Center for Preventive Doping Research is supported by the Federal Ministry of the Interior of the Federal Republic of Germany (Bonn, Germany)	BASTIAN SEP, 1993, J ENDOCRINOL, V138, P327, DOI 10.1677/joe.0.1380327; Brisson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045588; Brugts MP, 2008, J CLIN ENDOCR METAB, V93, P2539, DOI 10.1210/jc.2007-2454; Chen JW, 2003, AM J PHYSIOL-ENDOC M, V284, pE1149, DOI 10.1152/ajpendo.00410.2002; Dluzniewska J, 2005, FASEB J, V19, P1896, DOI 10.1096/fj.05-3786fje; Durzynska J, 2013, HORM METAB RES, V45, P415, DOI 10.1055/s-0032-1331699; Durzynska J, 2013, ENDOCRINOLOGY, V154, P1215, DOI 10.1210/en.2012-1992; Fornaro M, 2014, AM J PHYSIOL-ENDOC M, V306, pE150, DOI 10.1152/ajpendo.00408.2013; FRANCIS GL, 1992, J MOL ENDOCRINOL, V8, P213, DOI 10.1677/jme.0.0080213; Goldspink G, 2006, INT J BIOCHEM CELL B, V38, P480, DOI 10.1016/j.biocel.2005.10.013; Goldspink G, 2002, STRENGTH POWER SPORT, P231; Goodman HM, 2009, BASIC MEDICAL ENDOCRINOLOGY, 4TH EDITION, P91; Hede MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051152; JENKINS N, 1994, ENZYME MICROB TECH, V16, P354, DOI 10.1016/0141-0229(94)90149-X; Martins KJB, 2013, GROWTH HORM IGF RES, V23, P128, DOI 10.1016/j.ghir.2013.03.002; Matheny RW, 2010, ENDOCRINOLOGY, V151, P865, DOI 10.1210/en.2009-1217; Philippou A, 2014, MOL MED, V20, P202, DOI 10.2119/molmed.2014.00011; Sadick MD, 1999, J PHARMACEUT BIOMED, V19, P883, DOI 10.1016/S0731-7085(98)00144-7; SIEGFRIED JM, 1992, P NATL ACAD SCI USA, V89, P8107, DOI 10.1073/pnas.89.17.8107; Thevis M, 2014, GROWTH HORM IGF RES, V24, P276, DOI 10.1016/j.ghir.2014.10.004; Tomas FM, 1997, J ENDOCRINOL, V155, P377, DOI 10.1677/joe.0.1550377; Varewijck AJ, 2013, DIABETES, V62, P2539, DOI 10.2337/db12-1773; Varewijck AJ, 2013, MOL CELL ENDOCRINOL, V365, P17, DOI 10.1016/j.mce.2012.08.021; Varewijck AJ, 2012, ENDOCR-RELAT CANCER, V19, pF63, DOI 10.1530/ERC-12-0026; Voorhamme D, 2006, MOL BIOTECHNOL, V34, P201, DOI 10.1385/MB:34:2:201; Yang SY, 2002, FEBS LETT, V522, P156, DOI 10.1016/S0014-5793(02)02918-6	26	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150453	10.1371/journal.pone.0150453	http://dx.doi.org/10.1371/journal.pone.0150453			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991004	Green Published, Green Submitted, gold			2022-12-26	WOS:000372582800031
J	O'Connor, C; Lohan, F; Campos, J; Ohlsson, E; Salome, M; Forde, C; Artschwager, R; Liskamp, RM; Cahill, MR; Kiely, PA; Porse, B; Keeshan, K				O'Connor, C.; Lohan, F.; Campos, J.; Ohlsson, E.; Salome, Mara; Forde, C.; Artschwager, R.; Liskamp, R. M.; Cahill, M. R.; Kiely, P. A.; Porse, B.; Keeshan, K.			The presence of C/EBP alpha and its degradation are both required for TRIB2-mediated leukaemia	ONCOGENE			English	Article							BINDING-PROTEIN-ALPHA; CEBPA; MUTATIONS; TRIB2; EXPRESSION; C/EBP-ALPHA-P-30; PROTEASOME; COOPERATE; ABSENCE; COP1	C/EBP alpha (p42 and p30 isoforms) is commonly dysregulated in cancer via the action of oncogenes, and specifically in acute myeloid leukaemia (AML) by mutation. Elevated TRIB2 leads to the degradation of C/EBP alpha p42, leaving p30 intact in AML. Whether this relationship is a cooperative event in AML transformation is not known and the molecular mechanism involved remains elusive. Using mouse genetics, our data reveal that in the complete absence of C/EBP alpha, TRIB2 was unable to induce AML. Only in the presence of C/EBP alpha p42 and p30, were TRIB2 and p30 able to cooperate to decrease the latency of disease. We demonstrate that the molecular mechanism involved in the degradation of C/EBP alpha p42 requires site-specific direct interaction between TRIB2 and C/EBP alpha p42 for the K48-specific ubiquitin-dependent proteasomal degradation of C/EBP alpha p42. This interaction and ubiquitination is dependent on a critical C terminal lysine residue on C/EBP alpha. We show effective targeting of this pathway pharmacologically using proteasome inhibitors in TRIB2-positive AML cells. Together, our data show that excess p30 cooperated with TRIB2 only in the presence of p42 to accelerate AML, and the direct interaction and degradation of C/EBP alpha p42 is required for TRIB2-mediated AML.	[O'Connor, C.; Lohan, F.; Campos, J.; Salome, Mara; Keeshan, K.] Univ Glasgow, Inst Canc Sci, Paul OGorman Leukaemia Res Ctr, 21 Shelley Rd, Glasgow G12 0XB, Lanark, Scotland; [Ohlsson, E.; Porse, B.] Univ Copenhagen, Fac Hlth Sci, Rigshosp, Finsen Lab, Copenhagen, Denmark; [Ohlsson, E.; Porse, B.] Univ Copenhagen, BRIC, Copenhagen, Denmark; [Ohlsson, E.; Porse, B.] Univ Copenhagen, Fac Hlth Sci, Danish Stem Cell Ctr DanStem, Copenhagen, Denmark; [Forde, C.] Univ Coll Cork, Cork, Ireland; [Artschwager, R.; Liskamp, R. M.] Univ Glasgow, Sch Chem, Glasgow, Lanark, Scotland; [Cahill, M. R.] Cork Univ Hosp, Dept Haematol, Cork, Ireland; [Kiely, P. A.] Univ Limerick, Dept Life Sci, Mat & Surface Sci Inst, Limerick, Ireland; [Kiely, P. A.] Univ Limerick, Stokes Inst, Limerick, Ireland	University of Glasgow; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; University College Cork; University of Glasgow; University College Cork; University of Limerick; University of Limerick	Keeshan, K (corresponding author), Univ Glasgow, Inst Canc Sci, Paul OGorman Leukaemia Res Ctr, 21 Shelley Rd, Glasgow G12 0XB, Lanark, Scotland.	Karen.keeshan@glasgow.ac.uk	Keeshan, Karen/L-5615-2013; Salomé, Mara/I-9423-2018; Liskamp, Rob M/I-5889-2012	Keeshan, Karen/0000-0001-7266-0890; Salomé, Mara/0000-0003-3267-650X; Liskamp, Rob M/0000-0001-8897-8975; Porse, Bo/0000-0001-6043-0844; Cahill, Mary R/0000-0002-1655-3078; O'Connor, Caitriona/0000-0002-7638-9804	Kay Kendall foundation [KKL501]; Howat foundation; Cancer UK; Childrens Leukaemia Research Project grant; Science Foundation Ireland Infrastructure award; Mid-Western Cancer Foundation; centre grant from the NovoNordisk Foundation (The Novo Nordisk Foundation Section for Stem Cell Biology in Human Disease); Novo Nordisk Foundation Section for Basic Stem Cell Biology [Porse group] Funding Source: researchfish	Kay Kendall foundation; Howat foundation; Cancer UK; Childrens Leukaemia Research Project grant; Science Foundation Ireland Infrastructure award(Science Foundation Ireland); Mid-Western Cancer Foundation; centre grant from the NovoNordisk Foundation (The Novo Nordisk Foundation Section for Stem Cell Biology in Human Disease); Novo Nordisk Foundation Section for Basic Stem Cell Biology	We thank all the technical staff at the Paul O'Gorman Leukaemia Research Centre. We thank the Cancer Research UK Glasgow Centre (C596/A18076) and the Biological Service Unit facilities at the Cancer Research UK Beatson Institute (C596/A17196) and the Biological Services at the University of Glasgow. We thank Ruaidhri Carmody for reagents and critical review of the work. We thank the Kay Kendall foundation (KKL501) and the Howat foundation for Flow cytometry facility funding. Work in the Keeshan lab was supported by the Howat Foundation and Children with Cancer UK. CO'C was supported by Childrens Leukaemia Research Project grant. PK was supported by Science Foundation Ireland Infrastructure award and the Mid-Western Cancer Foundation. Work in the Porse lab was supported by a centre grant from the NovoNordisk Foundation (The Novo Nordisk Foundation Section for Stem Cell Biology in Human Disease).	Andreu-Vieyra C, 2014, EXPERT OPIN BIOL TH, V14, P1685, DOI 10.1517/14712598.2014.953050; Annamaneni S, 2014, HEMATOLOGY, V19, P42, DOI 10.1179/1607845413Y.0000000081; Bennett KL, 2007, CANCER RES, V67, P4657, DOI 10.1158/0008-5472.CAN-06-4793; Bereshchenko O, 2009, CANCER CELL, V16, P390, DOI 10.1016/j.ccr.2009.09.036; Brouwer AJ, 2012, J MED CHEM, V55, P10995, DOI 10.1021/jm301443r; Carnicer MJ, 2008, ANN HEMATOL, V87, P819, DOI 10.1007/s00277-008-0528-2; Colleran A, 2013, P NATL ACAD SCI USA, V110, P618, DOI 10.1073/pnas.1208446110; Collins C, 2014, P NATL ACAD SCI USA, V111, P9899, DOI 10.1073/pnas.1402238111; Fasan A, 2014, LEUKEMIA, V28, P794, DOI 10.1038/leu.2013.273; Fasan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054365; Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0; Friedman AD, 2015, INT J HEMATOL, V101, P330, DOI 10.1007/s12185-015-1764-6; Geletu M, 2007, BLOOD, V110, P3301, DOI 10.1182/blood-2007-01-071035; Grandinetti KB, 2011, ONCOGENE, V14, P1; Hasemann MS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004079; Hattori T, 2003, ONCOGENE, V22, P1273, DOI 10.1038/sj.onc.1206204; Jin GA, 2007, BLOOD, V109, P3998, DOI 10.1182/blood-2006-08-041202; Keeshan K, 2008, BLOOD CELL MOL DIS, V40, P119, DOI 10.1016/j.bcmd.2007.06.005; Keeshan K, 2006, CANCER CELL, V10, P401, DOI 10.1016/j.ccr.2006.09.012; Keeshan K, 2010, BLOOD, V116, P4948, DOI 10.1182/blood-2009-10-247361; Kirstetter P, 2008, CANCER CELL, V13, P299, DOI 10.1016/j.ccr.2008.02.008; Leroy H, 2005, LEUKEMIA, V19, P329, DOI 10.1038/sj.leu.2403614; Mancini E, 2011, EMBO J, V8, P1; Ohlsson E, 2014, J EXP MED, V211, P5, DOI 10.1084/jem.20130932; Pabst T, 2001, NAT GENET, V27, P263, DOI 10.1038/85820; Pabst T, 2008, J CLIN ONCOL, V26, P5088, DOI 10.1200/JCO.2008.16.5563; Paz-Priel Ido, 2011, Critical Reviews in Oncogenesis, V16, P93; Pulikkan JA, 2010, LEUKEMIA, V24, P914, DOI 10.1038/leu.2010.37; Quintana-Bustamante O, 2012, LEUKEMIA, V26, P1537, DOI 10.1038/leu.2012.38; Rishi L, 2014, BLOOD, V123, P2389, DOI 10.1182/blood-2013-07-511683; Taskesen E, 2011, BLOOD, V117, P2469, DOI 10.1182/blood-2010-09-307280; Trivedi AK, 2007, ONCOGENE, V26, P1789, DOI 10.1038/sj.onc.1209964; Wagner K, 2006, P NATL ACAD SCI USA, V103, P6338, DOI 10.1073/pnas.0508143103; Wouters BJ, 2007, BLOOD, V110, P3706, DOI 10.1182/blood-2007-02-073486; Xu SS, 2014, FEBS LETT, V588, P4334, DOI 10.1016/j.febslet.2014.09.042; Ye M, 2013, NAT CELL BIOL, V15, P385, DOI 10.1038/ncb2698; Yokoyama T, 2012, BLOOD, V119, P2608, DOI 10.1182/blood-2010-12-324806; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	38	22	22	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 6	2016	35	40					5272	5281		10.1038/onc.2016.66	http://dx.doi.org/10.1038/onc.2016.66			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DZ7NO	26996668	Green Submitted, Green Accepted			2022-12-26	WOS:000386053000006
J	Jubierre, L; Soriano, A; Planells-Ferrer, L; Paris-Coderch, L; Tenbaum, SP; Romero, OA; Moubarak, RS; Almazan-Moga, A; Molist, C; Roma, J; Navarro, S; Noguera, R; Sanchez-Cespedes, M; Comella, JX; Palmer, HG; de Toledo, JS; Gallego, S; Segura, MF				Jubierre, L.; Soriano, A.; Planells-Ferrer, L.; Paris-Coderch, L.; Tenbaum, S. P.; Romero, O. A.; Moubarak, R. S.; Almazan-Moga, A.; Molist, C.; Roma, J.; Navarro, S.; Noguera, R.; Sanchez-Cespedes, M.; Comella, J. X.; Palmer, H. G.; Sanchez de Toledo, J.; Gallego, S.; Segura, M. F.			BRG1/SMARCA4 is essential for neuroblastoma cell viability through modulation of cell death and survival pathways	ONCOGENE			English	Article							SWI/SNF COMPLEX; DNA METHYLATION; BRG1 EXPRESSION; INHIBITION; VORINOSTAT; TRIAL; WIDE; PROLIFERATION; CHEMOTHERAPY; TARGETS	Neuroblastoma (NB) is a neoplasm of the sympathetic nervous system, and is the most common solid tumor of infancy. NBs are very heterogeneous, with a clinical course ranging from spontaneous regression to resistance to all current forms of treatment. High-risk patients need intense chemotherapy, and only 30-40% will be cured. Relapsed or metastatic tumors acquire multi-drug resistance, raising the need for alternative treatments. Owing to the diverse mechanisms that are responsible of NB chemoresistance, we aimed to target epigenetic factors that control multiple pathways to bypass therapy resistance. We found that the SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily a, member 4 (SMARCA4/BRG1) was consistently upregulated in advanced stages of NB, with high BRG1 levels being indicative of poor outcome. Loss-of-function experiments in vitro and in vivo showed that BRG1 is essential for the proliferation of NB cells. Furthermore, whole-genome transcriptome analysis revealed that BRG1 controls the expression of key elements of oncogenic pathways such as PI3K/AKT and BCL2, which offers a promising new combination therapy for high-risk NB.	[Jubierre, L.; Soriano, A.; Paris-Coderch, L.; Almazan-Moga, A.; Molist, C.; Roma, J.; Sanchez de Toledo, J.; Gallego, S.; Segura, M. F.] UAB, Lab Translat Res Child & Adolescent Canc, VHIR, Passeig Vall dHebron 119-129, Barcelona 08035, Spain; [Planells-Ferrer, L.; Moubarak, R. S.; Sanchez-Cespedes, M.; Comella, J. X.] UAB, Cell Signaling & Apoptosis Grp, VHIR, Barcelona, Spain; [Tenbaum, S. P.; Palmer, H. G.] VHIO, Stem Cell & Canc Lab, Barcelona, Spain; [Romero, O. A.] Bellvitge Biomed Res Inst IDIBELL Barcelona, Epigenet & Canc Biol Program PEBC, Barcelona, Spain; [Navarro, S.; Noguera, R.] Univ Valencia, Sch Med, Valencia, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Valencia	Segura, MF (corresponding author), UAB, Lab Translat Res Child & Adolescent Canc, VHIR, Passeig Vall dHebron 119-129, Barcelona 08035, Spain.	miguel.segura@vhir.org	Gallego, Soledad/ABI-1334-2020; Palmer, Héctor G./AAG-8332-2019; Segura, Miguel F/J-4749-2013; Soriano, Aroa/J-9105-2016; Jubierre Zapater, Luz/ABD-7848-2021; Comella, Joan/GQA-4279-2022; Romero, Octavio A./AAA-8078-2020; Navarro, Samuel/AAD-2021-2020	Segura, Miguel F/0000-0003-0916-3618; Soriano, Aroa/0000-0001-9659-1471; Jubierre Zapater, Luz/0000-0001-9934-1590; Romero, Octavio A./0000-0003-0229-6530; Navarro, Samuel/0000-0001-5016-5653; Palmer, Hector/0000-0002-9823-5638; Roma, Josep/0000-0001-7692-6123; Gallego, Soledad/0000-0002-4712-9624; Paris Coderch, Laia/0000-0003-2145-5752; Moubarak, Rana/0000-0003-2096-1258	Instituto de Salud Carlos III [CP11/00052, RD12/0036/0016, RD12/0036/0020, RD12/0036/0045, RD12/0036/0012]; European Regional Development Fund (ERDF); Generalitat de Catalunya [2014-SGR-660]; Marie Curie Career Integration Grants	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Regional Development Fund (ERDF)(European Commission); Generalitat de Catalunya(Generalitat de Catalunya); Marie Curie Career Integration Grants	We thank members of the Genomics Facility, Statitstics and Bioinformatic Unit, Pathology Laboratory and the Animal Core Facilities of the Vall d'Hebron Research Institute. We thank Dr Mireia Dunac, Dr Jose R Bayascas and Dr Diego Arango for precious advice. We thank Ms Christine O'Hara for text correction. This work was supported by the Instituto de Salud Carlos III (CP11/00052, RD12/0036/0016, RD12/0036/0020, RD12/0036/0045, RD12/0036/0012) co-financed by the European Regional Development Fund (ERDF), Generalitat de Catalunya 2014-SGR-660 and Marie Curie Career Integration Grants.	Alaminos M, 2004, JNCI-J NATL CANCER I, V96, P1208, DOI 10.1093/jnci/djh224; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bai J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059772; Bai J, 2012, J CANCER RES CLIN, V138, P991, DOI 10.1007/s00432-012-1172-8; Bender A, 2011, ONCOGENE, V30, P494, DOI 10.1038/onc.2010.429; Boix J, 1998, EXP CELL RES, V238, P422, DOI 10.1006/excr.1997.3852; Buckley PG, 2011, INT J CANCER, V128, P2296, DOI 10.1002/ijc.25584; Burke MJ, 2014, AM J HEMATOL, V89, P889, DOI 10.1002/ajh.23778; Buscarlet M, 2014, BLOOD, V123, P1720, DOI 10.1182/blood-2013-02-483495; Charlet J, 2012, BIOCHEM PHARMACOL, V83, P858, DOI 10.1016/j.bcp.2012.01.009; Cheng ZX, 2013, CLIN CANCER RES, V19, P1748, DOI 10.1158/1078-0432.CCR-12-3066; Chesler L, 2006, CANCER RES, V66, P8139, DOI 10.1158/0008-5472.CAN-05-2769; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Fouladi M, 2010, J CLIN ONCOL, V28, P3623, DOI 10.1200/JCO.2009.25.9119; Grau E, 2010, J CANCER RES CLIN, V136, P1415, DOI 10.1007/s00432-010-0796-9; Hummel TR, 2013, PEDIATR BLOOD CANCER, V60, P1452, DOI 10.1002/pbc.24541; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irwin MS, 2015, PEDIATR CLIN N AM, V62, P225, DOI 10.1016/j.pcl.2014.09.015; Kadam S, 2003, MOL CELL, V11, P377, DOI 10.1016/S1097-2765(03)00034-0; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Keshelava N, 1998, CANCER RES, V58, P5396; Kumar HR, 2008, PEDIATR SURG INT, V24, P1229, DOI 10.1007/s00383-008-2245-2; Lamers F, 2012, EUR J CANCER, V48, P3093, DOI 10.1016/j.ejca.2012.01.037; Li Yan, 2006, Zhonghua Nan Ke Xue, V12, P629; Lin H, 2010, BRIT J DERMATOL, V163, P502, DOI 10.1111/j.1365-2133.2010.09851.x; Liu XR, 2014, EUR J CANCER, V50, P2251, DOI 10.1016/j.ejca.2014.05.017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machida Y, 2001, J BIOCHEM, V129, P43, DOI 10.1093/oxfordjournals.jbchem.a002834; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Numata M, 2013, INT J ONCOL, V42, P403, DOI 10.3892/ijo.2012.1723; Opel D, 2007, CANCER RES, V67, P735, DOI 10.1158/0008-5472.CAN-06-2201; Opel D, 2011, CLIN CANCER RES, V17, P3233, DOI 10.1158/1078-0432.CCR-10-2530; Popovic R, 2012, CANCER DISCOV, V2, P405, DOI 10.1158/2159-8290.CD-12-0076; Puissant A, 2013, CANCER DISCOV, V3, P308, DOI 10.1158/2159-8290.CD-12-0418; Romero OA, 2012, EMBO MOL MED, V4, P603, DOI 10.1002/emmm.201200236; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Segura MF, 2013, CANCER RES, V73, P6264, DOI 10.1158/0008-5472.CAN-13-0122-T; Sentani K, 2001, PATHOBIOLOGY, V69, P315, DOI 10.1159/000064638; Shain AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055119; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Su JM, 2011, CLIN CANCER RES, V17, P589, DOI 10.1158/1078-0432.CCR-10-0738; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun A, 2007, PROSTATE, V67, P203, DOI 10.1002/pros.20521; Tse C, 2008, CANCER RES, V68, P3421, DOI 10.1158/0008-5472.CAN-07-5836; Watanabe T, 2011, BRIT J CANCER, V104, P146, DOI 10.1038/sj.bjc.6606018; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wyce A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072967; Yang QW, 2007, CLIN CANCER RES, V13, P3191, DOI 10.1158/1078-0432.CCR-06-2846; Yu AL, 2010, NEW ENGL J MED, V363, P1324, DOI 10.1056/NEJMoa0911123; Yuste VJ, 2001, J BIOL CHEM, V276, P22323, DOI 10.1074/jbc.M100072200; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	55	49	51	0	14	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 29	2016	35	39					5179	5190		10.1038/onc.2016.50	http://dx.doi.org/10.1038/onc.2016.50			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX5PI	26996667				2022-12-26	WOS:000384433000009
J	Vieweg, S; Ansaloni, A; Wang, ZM; Warner, JB; Lashuel, HA				Vieweg, Sophie; Ansaloni, Annalisa; Wang, Zhe-Ming; Warner, John B.; Lashuel, Hilal A.			An Intein-based Strategy for the Production of Tag-free Huntingtin Exon 1 Proteins Enables New Insights into the Polyglutamine Dependence of Httex1 Aggregation and Fibril Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-LIKE FIBRILS; IN-VITRO; GLUTAMINE REPEATS; FUSION PROTEINS; DISEASE; LENGTH; NUCLEAR; CYTOTOXICITY; OLIGOMERS; MECHANISM	The first exon of the Huntingtin protein (Httex1) is one of the most actively studied Htt fragments because its overexpression in R6/2 transgenic mice has been shown to recapitulate several key features of Huntington disease. However, the majority of biophysical studies of Httex1 are based on assessing the structure and aggregation of fusion constructs where Httex1 is fused to large proteins, such as glutathione S-transferase, maltosebinding protein, or thioredoxin, or released in solution upon in situ cleavage of these proteins. Herein, we report an inteinbased strategy that allows, for the first time, the rapid and efficient production of native tag-free Httex1 with polyQ repeats ranging from 7Q to 49Q. Aggregation studies on these proteins enabled us to identify interesting polyQ-length-dependent effects on Httex1 oligomer and fibril formation that were previously not observed using Httex1 fusion proteins or Httex1 proteins produced by in situ cleavage of fusion proteins. Our studies revealed the inability of Httex1-7Q/15Q to undergo amyloid fibril formation and an inverse correlation between fibril length and polyQ repeat length, suggesting possible polyQ length-dependent differences in the structural properties of the Httex1 aggregates. Altogether, our findings underscore the importance of working with tag-free Httex1 proteins and indicate that model systems based on non-native Httex1 sequences may not accurately reproduce the effect of polyQ repeat length and solution conditions on Httex1 aggregation kinetics and structural properties.	[Vieweg, Sophie; Ansaloni, Annalisa; Wang, Zhe-Ming; Warner, John B.; Lashuel, Hilal A.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol & Chem Biol Neurodegenerat, CH-1015 Lausanne, Switzerland; [Lashuel, Hilal A.] HBKU, QBRI, Doha 5825, Qatar	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar	Lashuel, HA (corresponding author), Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Mol & Chem Biol Neurodegenerat, CH-1015 Lausanne, Switzerland.; Lashuel, HA (corresponding author), HBKU, QBRI, Doha 5825, Qatar.	hilal.lashuel@epfl.ch	Lashuel, Hilal/M-3500-2017		CHDI foundation [A_7627]; Swiss National Science Foundation [31003A-146680]	CHDI foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported primarily by grants from the CHDI foundation (A_7627) and the Swiss National Science Foundation (31003A-146680). The authors declare that they have no conflicts of interest with the contents of this article.	Ansaloni A, 2014, ANGEW CHEM INT EDIT, V53, P1928, DOI 10.1002/anie.201307510; Arnesen T, 2010, MOL CELL BIOL, V30, P1898, DOI 10.1128/MCB.01199-09; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bhattacharyya A, 2006, J MOL BIOL, V355, P524, DOI 10.1016/j.jmb.2005.10.053; Bounab Y., 2010, THESIS; Bugg CW, 2012, J BIOL CHEM, V287, P31739, DOI 10.1074/jbc.M112.353839; Bulone D, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000111; Busch A, 2003, J BIOL CHEM, V278, P41452, DOI 10.1074/jbc.M303354200; Chen S, 2001, J MOL BIOL, V311, P173, DOI 10.1006/jmbi.2001.4850; Chen SM, 2001, PROTEIN SCI, V10, P887, DOI 10.1110/ps.42301; Crick SL, 2013, P NATL ACAD SCI USA, V110, P20075, DOI 10.1073/pnas.1320626110; Dahlgren PR, 2005, NANOMED-NANOTECHNOL, V1, P52, DOI 10.1016/j.nano.2004.11.004; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; Dehay B, 2006, J BIOL CHEM, V281, P35608, DOI 10.1074/jbc.M605558200; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Duim WC, 2011, CHEMPHYSCHEM, V12, P2386, DOI 10.1002/cphc.201100392; Fodale V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112262; Georgalis Y, 1998, P NATL ACAD SCI USA, V95, P6118, DOI 10.1073/pnas.95.11.6118; Halliday GM, 1998, EXP NEUROL, V154, P663, DOI 10.1006/exnr.1998.6919; Heiser V, 2000, P NATL ACAD SCI USA, V97, P6739, DOI 10.1073/pnas.110138997; Hollenbach B, 1999, PHILOS T ROY SOC B, V354, P991, DOI 10.1098/rstb.1999.0450; Huntington G, 2003, J NEUROPSYCH CLIN N, V15, P109, DOI 10.1176/appi.neuropsych.15.1.109; Isas JM, 2015, BIOCHEMISTRY-US, V54, P3942, DOI 10.1021/acs.biochem.5b00281; Kar K, 2011, NAT STRUCT MOL BIOL, V18, P328, DOI 10.1038/nsmb.1992; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Landrum E, 2014, J BIOL CHEM, V289, P10254, DOI 10.1074/jbc.C114.552943; Lee JM, 2012, NEUROLOGY, V78, P690, DOI 10.1212/WNL.0b013e318249f683; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Legleiter J, 2009, J BIOL CHEM, V284, P21647, DOI 10.1074/jbc.M109.016923; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MacDonald ME, 2003, NEUROMOL MED, V4, P7, DOI 10.1385/NMM:4:1-2:7; Masino L, 2002, FEBS LETT, V513, P267, DOI 10.1016/S0014-5793(02)02335-9; Miller JP, 2010, NEURON, V67, P199, DOI 10.1016/j.neuron.2010.06.021; Mishra R, 2012, J MOL BIOL, V424, P1, DOI 10.1016/j.jmb.2012.09.011; Monsellier E, 2015, J BIOL CHEM, V290, P2560, DOI 10.1074/jbc.M114.603332; Muchowski PJ, 2000, P NATL ACAD SCI USA, V97, P7841, DOI 10.1073/pnas.140202897; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Nucifora LG, 2012, J BIOL CHEM, V287, P16017, DOI 10.1074/jbc.M111.252577; O'Nuallain B, 2006, METHOD ENZYMOL, V413, P34, DOI 10.1016/S0076-6879(06)13003-7; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; Pieri L, 2012, BIOPHYS J, V102, P2894, DOI 10.1016/j.bpj.2012.04.050; Poirier MA, 2002, J BIOL CHEM, V277, P41032, DOI 10.1074/jbc.M205809200; Rubinsztein DC, 1996, AM J HUM GENET, V59, P16; Sahoo B, 2014, BIOCHEMISTRY-US, V53, P3897, DOI 10.1021/bi500300c; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Singer D, 2010, J PEPT SCI, V16, P358, DOI 10.1002/psc.1252; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Tartari M, 2008, MOL BIOL EVOL, V25, P330, DOI 10.1093/molbev/msm258; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Walters RH, 2009, J MOL BIOL, V393, P978, DOI 10.1016/j.jmb.2009.08.034	60	20	20	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12074	12086		10.1074/jbc.M116.713982	http://dx.doi.org/10.1074/jbc.M116.713982			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27002149	Green Published, hybrid			2022-12-26	WOS:000378092800011
J	Chacon-Fernandez, P; Sauberli, K; Colzani, M; Moreau, T; Ghevaert, C; Barde, YA				Chacon-Fernandez, Pedro; Saeuberli, Katharina; Colzani, Maria; Moreau, Thomas; Ghevaert, Cedric; Barde, Yves-Alain			Brain-derived Neurotrophic Factor in Megakaryocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTORS; FACTOR BDNF; EXPRESSION; RAT; BIOSYNTHESIS; VESICLES; EXERCISE; RELEASE; PEPTIDE; MEMORY	The biosynthesis of endogenous brain-derived neurotrophic factor (BDNF) has thus far been examined in neurons where it is expressed at very low levels, in an activity-dependent fashion. In humans, BDNF has long been known to accumulate in circulating platelets, at levels far higher than in the brain. During the process of blood coagulation, BDNF is released from platelets, which has led to its extensive use as a readily accessible biomarker, under the assumption that serum levels may somehow reflect brain levels. To identify the cellular origin of BDNF in platelets, we established primary cultures of megakaryocytes, the progenitors of platelets, and we found that human and rat megakaryocytes express the BDNF gene. Surprisingly, the pattern of mRNA transcripts is similar to neurons. In the presence of thapsigargin and external calcium, the levels of the mRNA species leading to efficient BDNF translation rapidly increase. Under these conditions, pro-BDNF, the obligatory precursor of biologically active BDNF, becomes readily detectable. Megakaryocytes store BDNF in alpha-granules, with more than 80% of them also containing platelet factor 4. By contrast, BDNF is undetectable in mouse megakaryocytes, in line with the absence of BDNF in mouse serum. These findings suggest that alterations of BDNF levels in human serum as reported in studies dealing with depression or physical exercise may primarily reflect changes occurring in megakaryocytes and platelets, including the ability of the latter to retain and release BDNF.	[Barde, Yves-Alain] Cardiff Univ, Sch Biosci, Sir Martin Evans Bldg, Cardiff CF10 3AX, S Glam, Wales; [Colzani, Maria; Moreau, Thomas; Ghevaert, Cedric] Univ Cambridge, Dept Haematol, Cambridge CB2 0PT, England	Cardiff University; University of Cambridge	Barde, YA (corresponding author), Cardiff Univ, Sch Biosci, Sir Martin Evans Bldg, Cardiff CF10 3AX, S Glam, Wales.	bardey@cardiff.ac.uk		Ghevaert, Cedric/0000-0002-9251-0934; Barde, Yves/0000-0002-7627-461X; Moreau, Thomas/0000-0003-1090-6685; Chacon Fernandez, Pedro Jose/0000-0003-0925-814X	Life Science Research Network Wales through the Welsh Government's Ser Cymru program; National Institute for Health Research [RP-PG-0310-1002]; MRC [MR/L022982/1] Funding Source: UKRI; British Heart Foundation [FS/09/039/27788] Funding Source: researchfish; Medical Research Council [MR/L022982/1, MC_PC_12009] Funding Source: researchfish	Life Science Research Network Wales through the Welsh Government's Ser Cymru program; National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Life Science Research Network Wales, an initiative funded through the Welsh Government's Ser Cymru program, and National Institute for Health Research Grant RP-PG-0310-1002 (to C.G.).	Aatonen MT, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24692; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; Burnouf T, 2012, TRANSFUSION, V52, P1721, DOI 10.1111/j.1537-2995.2011.03494.x; Cheng KT, 2011, ADV EXP MED BIOL, V704, P435, DOI 10.1007/978-94-007-0265-3_24; Cohen S, 2008, J BIOL CHEM, V283, P33793, DOI 10.1074/jbc.X800008200; Day RB, 2014, NAT MED, V20, P1233, DOI 10.1038/nm.3745; Dieni S, 2012, J CELL BIOL, V196, P775, DOI 10.1083/jcb.201201038; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550; Heijnen HFG, 1999, BLOOD, V94, P3791, DOI 10.1182/blood.V94.11.3791.423a22_3791_3799; Hillman EMC, 2014, ANNU REV NEUROSCI, V37, P161, DOI 10.1146/annurev-neuro-071013-014111; Kerschensteiner M, 1999, J EXP MED, V189, P865, DOI 10.1084/jem.189.5.865; KESTIN AS, 1993, CIRCULATION, V88, P1502, DOI 10.1161/01.CIR.88.4.1502; Kolbeck R, 1999, J NEUROCHEM, V72, P1930, DOI 10.1046/j.1471-4159.1999.0721930.x; KOLBECK R, 1994, EUR J BIOCHEM, V225, P995, DOI 10.1111/j.1432-1033.1994.0995b.x; Koppel I, 2015, J NEUROCHEM, V134, P1015, DOI 10.1111/jnc.13124; Kwok SCM, 2013, J OVARIAN RES, V6, DOI 10.1186/1757-2215-6-91; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038; Maynard DM, 2007, J THROMB HAEMOST, V5, P1945, DOI 10.1111/j.1538-7836.2007.02690.x; MCDONALD NQ, 1993, CELL, V73, P421, DOI 10.1016/0092-8674(93)90127-C; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Munkholm K, 2016, MOL PSYCHIATR, V21, P216, DOI 10.1038/mp.2015.54; PARDRIDGE WM, 1994, PHARMACEUT RES, V11, P738, DOI 10.1023/A:1018940732550; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Polyakova M, 2015, J AFFECT DISORDERS, V174, P432, DOI 10.1016/j.jad.2014.11.044; Radka SF, 1996, BRAIN RES, V709, P122, DOI 10.1016/0006-8993(95)01321-0; Snapyan M, 2009, J NEUROSCI, V29, P4172, DOI 10.1523/JNEUROSCI.4956-08.2009; SUTER U, 1991, EMBO J, V10, P2395, DOI 10.1002/j.1460-2075.1991.tb07778.x; Szuhany KL, 2015, J PSYCHIATR RES, V60, P56, DOI 10.1016/j.jpsychires.2014.10.003; West A E, 2014, Handb Exp Pharmacol, V220, P67, DOI 10.1007/978-3-642-45106-5_4; Wetsel WC, 2013, P NATL ACAD SCI USA, V110, P17362, DOI 10.1073/pnas.1314698110; YAMAMOTO H, 1990, J NEUROSCI, V10, P3469; Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244; Zagrebelsky M, 2014, NEUROPHARMACOLOGY, V76, P628, DOI 10.1016/j.neuropharm.2013.05.029; Zeiler M, 2014, MOL CELL PROTEOMICS, V13, P3435, DOI 10.1074/mcp.M114.038513	36	104	108	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					9872	9881		10.1074/jbc.M116.720029	http://dx.doi.org/10.1074/jbc.M116.720029			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	27006395	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000375602800002
J	Kumar, RB; Zhu, L; Idborg, H; Radmark, O; Jakobsson, PJ; Rinaldo-Matthis, A; Hebert, H; Jegerschold, C				Kumar, Ramakrishnan B.; Zhu, Lin; Idborg, Helena; Radmark, Olof; Jakobsson, Per-Johan; Rinaldo-Matthis, Agnes; Hebert, Hans; Jegerschold, Caroline			Structural and Functional Analysis of Calcium Ion Mediated Binding of 5-Lipoxygenase to Nanodiscs	PLOS ONE			English	Article							HUMAN PLATELET 12-LIPOXYGENASE; PURIFIED HUMAN 5-LIPOXYGENASE; ELECTRON-MICROSCOPY; MEMBRANE-PROTEIN; LEUKOTRIENE BIOSYNTHESIS; SUBSTRATE-BINDING; ENZYME-ACTIVITY; PHOSPHATIDYLCHOLINE; BILAYER; DOMAIN	An important step in the production of inflammatory mediators of the leukotriene family is the Ca2+ mediated recruitment of 5 Lipoxygenase (5LO) to nuclear membranes. To study this reaction in vitro, the natural membrane mimicking environment of nanodiscs was used. Nanodiscs with 10.5 nm inner diameter were made with the lipid POPC and membrane scaffolding protein MSP1E3D1. Monomeric and dimeric 5LO were investigated. Monomeric 5LO mixed with Ca2+ and nanodiscs are shown to form stable complexes that 1) produce the expected leukotriene products from arachidonic acid and 2) can be, for the first time, visualised by native gel electrophoresis and negative stain transmission electron micros-copy and 3) show a highest ratio of two 5LO per nanodisc. We interpret this as one 5LO on each side of the disc. The dimer of 5LO is visualised by negative stain transmission electron microscopy and is shown to not bind to nanodiscs. This study shows the advantages of nanodiscs to obtain basic structural information as well as functional information of a complex between a monotopic membrane protein and the membrane.	[Kumar, Ramakrishnan B.; Zhu, Lin; Hebert, Hans; Jegerschold, Caroline] Karolinska Inst, Dept Biosci & Nutr, S-14183 Huddinge, Sweden; [Kumar, Ramakrishnan B.; Zhu, Lin; Hebert, Hans; Jegerschold, Caroline] KTH Royal Inst Technol, Sch Technol & Hlth, S-14183 Huddinge, Sweden; [Idborg, Helena; Jakobsson, Per-Johan] Karolinska Inst, Rheumatol Unit, Dept Med, S-17176 Stockholm, Sweden; [Radmark, Olof; Rinaldo-Matthis, Agnes] Karolinska Inst, Div Physiol Chem 2, Dept Med Biochem & Biophys, S-17165 Stockholm, Sweden	Karolinska Institutet; Royal Institute of Technology; Karolinska Institutet; Karolinska Institutet	Jegerschold, C (corresponding author), Karolinska Inst, Dept Biosci & Nutr, S-14183 Huddinge, Sweden.; Jegerschold, C (corresponding author), KTH Royal Inst Technol, Sch Technol & Hlth, S-14183 Huddinge, Sweden.	caroline.jegerschold@ki.se	Jakobsson, Per-Johan/ABC-5594-2021	Jegerschold, Caroline/0000-0003-2419-6354; Balakrishnan Kumar, Ramakrishnan/0000-0002-1483-6285; Idborg, Helena/0000-0003-4041-4729	Swedish Research Council; Stockholm County Council; KI funds	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); KI funds	The authors thank the Swedish Research Council, Stockholm County Council and KI funds for support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleem AM, 2008, J MOL BIOL, V376, P193, DOI 10.1016/j.jmb.2007.11.086; Aleem AM, 2009, INT J MOL MED, V24, P759, DOI 10.3892/ijmm_00000289; ANTIA NJ, 1967, NATURE, V214, P1028, DOI 10.1038/2141028a0; Balali-Mood K, 2009, BIOCHEMISTRY-US, V48, P2135, DOI 10.1021/bi8017398; Basavarajappa D, 2014, P NATL ACAD SCI USA, V111, P11371, DOI 10.1073/pnas.1410983111; Bayburt TH, 2010, FEBS LETT, V584, P1721, DOI 10.1016/j.febslet.2009.10.024; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; Chen XS, 2001, J BIOL CHEM, V276, P811, DOI 10.1074/jbc.M008203200; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Denisov IG, 2007, J BIOL CHEM, V282, P7066, DOI 10.1074/jbc.M609589200; Eek P, 2012, J BIOL CHEM, V287, P22377, DOI 10.1074/jbc.M112.343285; Gerstmeier J, 2016, FASEB J, V30, P276, DOI 10.1096/fj.15-278010; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Grinkova YV, 2010, PROTEIN ENG DES SEL, V23, P843, DOI 10.1093/protein/gzq060; Hafner AK, 2011, BIOL CHEM, V392, P1097, DOI [10.1515/BC.2011.200, 10.1515/BC-2011-200]; Haeggstrom JZ, 2002, CELL MOL LIFE SCI, V59, P742, DOI 10.1007/s00018-002-8463-1; Hammarberg T, 1999, BIOCHEMISTRY-US, V38, P4441, DOI 10.1021/bi9824700; JAKSCHIK BA, 1980, BIOCHEM BIOPH RES CO, V95, P103, DOI 10.1016/0006-291X(80)90710-X; Jaud S, 2007, BIOPHYS J, V92, P517, DOI 10.1529/biophysj.106.090704; Jiang QX, 2001, J STRUCT BIOL, V133, P119, DOI 10.1006/jsbi.2001.4376; Kobe MJ, 2014, J BIOL CHEM, V289, P8562, DOI 10.1074/jbc.M113.543777; Kucerka N, 2011, BBA-BIOMEMBRANES, V1808, P2761, DOI 10.1016/j.bbamem.2011.07.022; Kulkarni S, 2002, J BIOL CHEM, V277, P13167, DOI 10.1074/jbc.M112393200; Liu YH, 2014, J STRUCT BIOL, V185, P295, DOI 10.1016/j.jsb.2014.01.004; Lu WQ, 2013, ANAL BIOCHEM, V441, P162, DOI 10.1016/j.ab.2013.06.007; MILLER DK, 1990, NATURE, V343, P278, DOI 10.1038/343278a0; NOGUCHI M, 1994, BBA-LIPID LIPID MET, V1215, P300, DOI 10.1016/0005-2760(94)90057-4; NOGUCHI M, 1994, EUR J BIOCHEM, V222, P285, DOI 10.1111/j.1432-1033.1994.tb18867.x; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Pande AH, 2005, BIOPHYS J, V88, P4084, DOI 10.1529/biophysj.104.056788; Pande AH, 2004, BIOCHEMISTRY-US, V43, P14653, DOI 10.1021/bi048775y; PERCIVAL MD, 1992, EUR J BIOCHEM, V210, P109, DOI 10.1111/j.1432-1033.1992.tb17397.x; PUUSTINEN T, 1988, BIOCHIM BIOPHYS ACTA, V960, P261, DOI 10.1016/0005-2760(88)90033-1; Radermacher Michael, 2006, V319, P427; Radmark O., 2014, BIOCH BIOPHYS ACTA; Radmark O, 2010, BIOCHEM BIOPH RES CO, V396, P105, DOI 10.1016/j.bbrc.2010.02.173; Rakonjac M, 2006, P NATL ACAD SCI USA, V103, P13150, DOI 10.1073/pnas.0605150103; Reddy KV, 2000, BIOCHEMISTRY-US, V39, P1840, DOI 10.1021/bi9919246; REID GK, 1990, J BIOL CHEM, V265, P19818; Ritchie TK, 2009, METHOD ENZYMOL, V464, P211, DOI 10.1016/S0076-6879(09)64011-8; Rouzer C A, 1987, Adv Prostaglandin Thromboxane Leukot Res, V17A, P60; Shang WF, 2011, J MOL BIOL, V409, P654, DOI 10.1016/j.jmb.2011.04.035; Skorey KI, 1998, BIOCHEMISTRY-US, V37, P8027, DOI 10.1021/bi980371g; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Wang LG, 2009, NATURE, V461, P292, DOI 10.1038/nature08291; Ward KE, 2012, J LIPID RES, V53, P2656, DOI 10.1194/jlr.M030718; WONG A, 1988, BIOCHEMISTRY-US, V27, P6763, DOI 10.1021/bi00418a018; Zhang L, 2011, J LIPID RES, V52, P175, DOI 10.1194/jlr.D010959; Zhang YY, 2000, BIOCHEM J, V351, P697, DOI 10.1042/0264-6021:3510697; ZHANG YY, 1994, ANAL BIOCHEM, V220, P28, DOI 10.1006/abio.1994.1294	51	7	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152116	10.1371/journal.pone.0152116	http://dx.doi.org/10.1371/journal.pone.0152116			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010627	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708000092
J	Schafer, AA; Domingues, MR; Dahly, DL; Meller, FO; Goncalves, H; Wehrmeister, FC; Assuncao, MCF				Schaefer, Antnio Augusto; Domingues, Marlos Rodrigues; Dahly, Darren Lawrence; Meller, Fernanda Oliveira; Goncalves, Helen; Wehrmeister, Fernando Cesar; Formoso Assuncao, Maria Cecilia			Sleep Duration Trajectories and Body Composition in Adolescents: Prospective Birth Cohort Study	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; MASS INDEX; FOLLOW-UP; OBESITY; CHILDREN; FAT; ASSOCIATION; DEPRIVATION; ADIPOSITY; VALIDITY	We aimed to estimate the association between sleep duration trajectories and body composition in adolescents. We used data from participants of the 1993 Pelotas (Brazil) Birth Cohort Study who were later followed up at age 18 years (response rate of 81.3%). At the time, 3974 adolescents had complete data on body composition, which was assessed by air displacement plethysmography. Sleep duration was self-reported by participants at ages 11 and 18 years. Analyses were sex-stratified. The mean sleep duration at 11 years was 9.7 (SD 1.4) and 8.4 (SD 1.9) at 18 years. Sleep duration was dichotomized as inadequate (< 8 hours/day) or adequate (>= 8 hours/day). Mean body mass, fat mass, and fat-free mass indices at 18 years were 23.4 kg/m(2) (SD 4.5), 6.1 kg/m(2) (SD 3.9) and 17.3 kg/m(2) (SD 2.5), respectively. Girls who reported inadequate sleep duration at 11 years of age, but adequate sleep duration at 18, on average experienced an increase in body mass index (beta = 0.39 z-scores; 95% CI 0.13, 0.65), fat mass index (beta = 0.30 z-scores; 95% CI 0.07, 0.53), and fat free mass index (beta = 0.24 z-scores; 95% CI 0.08, 0.39) compared to those who had adequate sleep duration at both time points. The results suggest that changes in sleep duration across adolescence may impact body composition in later adolescence and that this may differ by sex.	[Schaefer, Antnio Augusto; Meller, Fernanda Oliveira; Goncalves, Helen; Wehrmeister, Fernando Cesar; Formoso Assuncao, Maria Cecilia] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil; [Domingues, Marlos Rodrigues] Univ Fed Pelotas, Postgrad Program Phys Educ, Pelotas, Brazil; [Dahly, Darren Lawrence] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland	Universidade Federal de Pelotas; Universidade Federal de Pelotas; University College Cork	Schafer, AA (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil.	aaschafer@hotmail.com	Gonçalves, Helen/M-1603-2017; Wehrmeister, Fernando/A-3006-2014; Domingues, Marlos R/A-4758-2009; Gonçalves, Helen/P-2381-2018	Gonçalves, Helen/0000-0001-6470-3352; Wehrmeister, Fernando/0000-0001-7137-1747; Domingues, Marlos R/0000-0002-2503-2944; Dahly, Darren/0000-0003-0110-324X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Araujo J, 2012, PEDIATRICS, V130, pE1146, DOI 10.1542/peds.2011-1116; Bernardo Maria Perpeto Socorro Leite, 2009, J. bras. psiquiatr., V58, P231, DOI 10.1590/S0047-20852009000400003; Bibiloni Mdel M, 2013, ISRN OBES, V2013, DOI DOI 10.1155/2013/392747; Bjorge T, 2008, AM J EPIDEMIOL, V168, P30, DOI 10.1093/aje/kwn096; Bogin B., 1999, PATTERNS HUMAN GROWT, V2nd ed.; Brasil. Ministerio da Saude (MS), 2005, PREN PUERP AT QUAL H; Brazilian Institute of Geography and Statistics. IBGE. Brazilian Ministry of Health, 2010, CONS EXP SURV POF 20; Cameron N., 2022, HUMAN GROWTH DEV, V3rd, P177; CARSKADON MA, 1980, SLEEP, V2, P453; Chamorro RA, 2011, REV MED CHILE, V139, P932, DOI [10.4067/S0034-98872011000700017, /S0034-98872011000700017]; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dahl RE, 2002, J ADOLESCENT HEALTH, V31, P175, DOI 10.1016/S1054-139X(02)00506-2; Daniels SR, 2009, INT J OBESITY, V33, pS60, DOI 10.1038/ijo.2009.20; Dollman I, 2007, ACTA PAEDIATR, V96, P1011, DOI 10.1111/j.1651-2227.2007.00278.x; Foti KE, 2011, AM J PREV MED, V41, P596, DOI 10.1016/j.amepre.2011.08.009; Garaulet M, 2011, INT J OBESITY, V35, P1308, DOI 10.1038/ijo.2011.149; Goncalves H, 2014, INT J EPIDEMIOL, V43, P1082, DOI 10.1093/ije/dyu077; Gupta NK, 2002, AM J HUM BIOL, V14, P762, DOI 10.1002/ajhb.10093; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010; Jiang YR, 2015, J PUBLIC HEALTH-UK, V37, P277, DOI 10.1093/pubmed/fdu049; Kimm SYS, 2002, NEW ENGL J MED, V347, P709, DOI 10.1056/NEJMoa003277; Knutson KL, 2005, J PEDIATR-US, V147, P830, DOI 10.1016/j.jpeds.2005.07.019; Knutson KL, 2007, SLEEP MED REV, V11, P163, DOI 10.1016/j.smrv.2007.01.002; Lytle LA, 2013, HEALTH EDUC BEHAV, V40, P362, DOI 10.1177/1090198112451446; Norgan NG, 1997, INT J OBESITY, V21, P738, DOI 10.1038/sj.ijo.0800473; Seegers V, 2011, AM J EPIDEMIOL, V173, P621, DOI 10.1093/aje/kwq389; Silva GE, 2011, SLEEP, V34, P1197, DOI 10.5665/SLEEP.1238; Storfer-Isser A, 2012, PEDIATR OBES, V7, P53, DOI 10.1111/j.2047-6310.2011.00008.x; Taheri S, 2006, ARCH DIS CHILD, V91, P881, DOI 10.1136/adc.2005.093013; Taylor DJ, 2005, J SLEEP RES, V14, P239, DOI 10.1111/j.1365-2869.2005.00467.x; Van Cauter E, 2008, EUR J ENDOCRINOL, V159, pS59, DOI 10.1530/EJE-08-0298; VANITALLIE TB, 1990, AM J CLIN NUTR, V52, P953, DOI 10.1093/ajcn/52.6.953; Veldhuis JD, 2005, ENDOCR REV, V26, P114, DOI 10.1210/er.2003-0038; Victora CG, 2006, REV SAUDE PUBL, V40, P39, DOI 10.1590/S0034-89102006000100008; Wells JCK, 2008, INT J OBESITY, V32, P1042, DOI 10.1038/ijo.2008.37; Wells JCK, 2007, BEST PRACT RES CL EN, V21, P415, DOI 10.1016/j.beem.2007.04.007; Wolfson AR, 2003, SLEEP, V26, P213, DOI 10.1093/sleep/26.2.213; World Health Organization (WHO), 2007, GROWTH REF 5 19 YEAR; Zafon C, 2007, OBES REV, V8, P525, DOI 10.1111/j.1467-789X.2007.00377.x	39	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152348	10.1371/journal.pone.0152348	http://dx.doi.org/10.1371/journal.pone.0152348			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010312	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708000136
J	Ciblis, AS; Butler, ML; Quinn, C; Clare, L; Bokde, ALW; Mullins, PG; McNulty, JP				Ciblis, Aurelia S.; Butler, Marie-Louise; Quinn, Catherine; Clare, Linda; Bokde, Arun L. W.; Mullins, Paul G.; McNulty, Jonathan P.			Current Practice in the Referral of Individuals with Suspected Dementia for Neuroimaging by General Practitioners in Ireland and Wales	PLOS ONE			English	Article							PRIMARY-CARE; DIAGNOSIS	Objectives While early diagnosis of dementia is important, the question arises whether general practitioners (GPs) should engage in direct referrals. The current study investigated current referral practices for neuroimaging in dementia, access to imaging modalities and investigated related GP training in Ireland and North Wales. Methods A questionnaire was distributed to GPs in the programme regions which included approximately two thirds of all GPs in the Republic of Ireland and all general practitioners in North Wales. A total of 2,093 questionnaires were issued. Results 48.6% of Irish respondents and 24.3% of Welsh respondents directly referred patients with suspected dementia for neuroimaging. Irish GPs reported greater direct access to neuroimaging than their Welsh counterparts. A very small percentage of Irish and Welsh GPs (4.7% and 10% respectively) had received training in neuroimaging and the majority who referred patients for neuroimaging were not aware of any dementia-specific protocols for referrals (93.1% and 95% respectively). Conclusions The benefits of direct GP access to neuroimaging investigations for dementia have yet to be established. Our findings suggest that current GP speciality training in Ireland and Wales is deficient in dementia-specific and neuroimaging training with the concern being that inadequate training will lead to inadequate referrals. Further training would complement guidelines and provide a greater understanding of the role and appropriateness of neuroimaging techniques in the diagnosis of dementia.	[Ciblis, Aurelia S.; Butler, Marie-Louise; McNulty, Jonathan P.] Univ Coll Dublin, Sch Med, Dublin 2, Ireland; [Quinn, Catherine; Mullins, Paul G.] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales; [Clare, Linda] Univ Exeter, Sch Psychol, Exeter, Devon, England; [Bokde, Arun L. W.] Univ Dublin Trinity Coll, Inst Neurosci, Dublin 2, Ireland	University College Dublin; Bangor University; University of Exeter; Trinity College Dublin	McNulty, JP (corresponding author), Univ Coll Dublin, Sch Med, Dublin 2, Ireland.	jonathan.mcnulty@ucd.ie	Quinn, Catherine/H-6498-2019	Quinn, Catherine/0000-0001-9553-853X; Clare, Linda/0000-0003-3989-5318; McNulty, Jonathan/0000-0002-1365-8747; Bokde, Arun/0000-0003-0114-4914; Ryan, Marie-Louise/0000-0002-7424-0045	European Regional Development Fund INTERREG 4 A Ireland Wales Programme [087]; Bangor University; University College Dublin; Trinity College Dublin	European Regional Development Fund INTERREG 4 A Ireland Wales Programme; Bangor University; University College Dublin; Trinity College Dublin	This work was part-funded under the European Regional Development Fund INTERREG 4 A Ireland Wales Programme (Project number: 087; www.irelandwales.ie) with matching funding from Bangor University, University College Dublin and Trinity College Dublin. The funding bodies had no role in the study design, data collection, analysis, decision to publish or manuscript preparation.	Ahmad S, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X515386; Alzheimer's Society, 2013, PROGR IMPR DIAGN DEM; Alzheimer's Society, 2012, ONL 37 PER CENT GPS; American College of Radiology, 2015, ACR APPR CRIT; Audit Commission, 2002, FORG ME NOT 2002 DEV; Bermingham S L, 2014, Ont Health Technol Assess Ser, V14, P1; Brooker D, 2014, INT J GERIATR PSYCH, V29, P682, DOI 10.1002/gps.4066; Cahill S, 2008, INT J GERIATR PSYCH, V23, P663, DOI 10.1002/gps.1956; Cahill S, 2006, INT J GERIATR PSYCH, V21, P319, DOI 10.1002/gps.1464; Cahill S., 2012, CREATING EXCELLENCE; Cahill S, 2014, INT PSYCHOGERIATR, V26, P605, DOI 10.1017/S104161021300238X; Cahill S, 2010, INT J GERIATR PSYCH, V25, P912, DOI 10.1002/gps.2597; Ciblis AS, 2016, IRISH J MED SCI, V185, P597, DOI 10.1007/s11845-015-1315-4; Department of Health, 2014, IR NAT DEM STRAT; Department of Health, 2014, PRIV HLTH INS; Downs MG, 1996, INT J GERIATR PSYCH, V11, P937, DOI 10.1002/(SICI)1099-1166(199611)11:11<937::AID-GPS540>3.0.CO;2-0; Foley T, 2014, DEMENTIA DIAGNOSIS M; Health Information and Quality Authority, 2011, REP REC PAT REF GEN; Iliffe S, 2000, AGING MENT HEALTH, V4, P286, DOI 10.1080/713649957; Knapp M, 2007, DEMENTIA INT COMP SU; Menon R, 2011, FAM PRACT, V28, P272, DOI 10.1093/fampra/cmq100; National Health Service England, 2014, ENH SERV SPEC DEM ID; National Health Service Wales, 2013, SNAPSH HLTH N WAL AG; O'Connell H, 2012, NATL DEMENTIA STRATE; O'Riordan M, 2013, ACCESS DIAGNOSTICS K; Office of the Minister for Children and Youth Affairs, 2010, STAT NAT CHILDR 2010; Prince M, 2011, WORLD ALZHEIMER REPO; Rosen B, 2009, HLTH SYST TRANSIT, V11, P1; Scheltens P, 2002, LANCET NEUROL, V1, P13, DOI 10.1016/S1474-4422(02)00002-9; Social Care Institute for Excellence National Institute for Health and clinical Excellence, 2006, NAT CLIN PRACT GUID; The Royal College of Radiologists, 2012, IREFER MAK BEST US C; Thies W, 2013, ALZHEIMERS DEMENT, V9, P208, DOI 10.1016/j.jalz.2013.02.003; Waldemar G, 2007, INT J GERIATR PSYCH, V22, P47, DOI 10.1002/gps.1652; Yi Jiming, 2014, UK PRIV HLTH MARK	34	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151793	10.1371/journal.pone.0151793	http://dx.doi.org/10.1371/journal.pone.0151793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3QJ	27007435	Green Published, Green Submitted, gold			2022-12-26	WOS:000372701200065
J	Wang, W; Hong, JS; Rab, A; Sorscher, EJ; Kirk, KL				Wang, Wei; Hong, Jeong S.; Rab, Andras; Sorscher, Eric J.; Kirk, Kevin L.			Robust Stimulation of W1282X-CFTR Channel Activity by a Combination of Allosteric Modulators	PLOS ONE			English	Article							NUCLEOTIDE-BINDING DOMAINS; CONDUCTANCE REGULATOR CHANNELS; CYSTIC-FIBROSIS PATIENTS; CFTR CHLORIDE CHANNEL; ATP BINDING; PHOSPHORYLATION; PROTEIN; VX-770; DIMERIZATION; POTENTIATOR	W1282X is a common nonsense mutation among cystic fibrosis patients that results in the production of a truncated Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) channel. Here we show that the channel activity of the W1282X-CFTR polypeptide is exceptionally low in excised membrane patches at normally saturating doses of ATP and PKA (single channel open probability (P-O) < 0.01). However, W1282X-CFTR channels were stimulated by two CFTR modulators, the FDA-approved VX-770 and the dietary compound curcumin. Each of these compounds is an allosteric modulator of CFTR gating that promotes channel activity in the absence of the native ligand, ATP. Although W1282X-CFTR channels were stimulated by VX-770 in the absence of ATP their activities remained dependent on PKA phosphorylation. Thus, activated W1282X-CFTR channels should remain under physiologic control by cyclic nucleotide signaling pathways in vivo. VX-770 and curcumin exerted additive effects on W1282X-CFTR channel gating (opening/ closing) in excised patches such that the P-O of the truncated channel approached unity (> 0.9) when treated with both modulators. VX-770 and curcumin also additively stimulated W1282XCFTR mediated currents in polarized FRT epithelial monolayers. In this setting, however, the stimulated W1282X-CFTR currents were smaller than those mediated by wild type CFTR (3-5%) due presumably to lower expression levels or cell surface targeting of the truncated protein. Combining allosteric modulators of different mechanistic classes is worth considering as a treatment option for W1282X CF patients perhaps when coupled with maneuvers to increase expression of the truncated protein.	[Wang, Wei; Hong, Jeong S.; Rab, Andras; Kirk, Kevin L.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA; [Wang, Wei; Hong, Jeong S.; Kirk, Kevin L.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA; [Sorscher, Eric J.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Emory University	Wang, W; Kirk, KL (corresponding author), Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA.; Wang, W; Kirk, KL (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA.	weiwang@uab.edu; klkirk@uab.edu	Rab, András/AAR-7804-2021; Rab, Andras/AAI-9402-2021	Rab, András/0000-0003-2154-0017; Sorscher, Eric J./0000-0001-9341-3354	National Institutes of Health [RO1DK056796, P30DK072482]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056796, P30DK072482] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants RO1DK056796 (awarded to KK) and P30DK072482 (ES as Program Director).	Auerbach A, 2012, J PHYSIOL-LONDON, V590, P93, DOI 10.1113/jphysiol.2011.214684; Berger AL, 2005, P NATL ACAD SCI USA, V102, P455, DOI 10.1073/pnas.0408575102; CHENG SH, 1991, CELL, V66, P1027, DOI 10.1016/0092-8674(91)90446-6; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Eckford PDW, 2012, J BIOL CHEM, V287, P36639, DOI 10.1074/jbc.M112.393637; Galzi JL, 1996, P NATL ACAD SCI USA, V93, P1853, DOI 10.1073/pnas.93.5.1853; Jih KY, 2013, P NATL ACAD SCI USA, V110, P4404, DOI 10.1073/pnas.1215982110; Kerem E, 2014, LANCET RESP MED, V2, P539, DOI 10.1016/S2213-2600(14)70100-6; Kirk KL, 2011, J BIOL CHEM, V286, P12813, DOI 10.1074/jbc.R111.219634; Linde L, 2007, J CLIN INVEST, V117, P683, DOI 10.1172/JCI28523; Mathews CJ, 1998, J PHYSIOL-LONDON, V508, P365, DOI 10.1111/j.1469-7793.1998.365bq.x; Rowe SM, 2011, J MOL MED, V89, P1149, DOI 10.1007/s00109-011-0787-6; SHOSHANI T, 1992, AM J HUM GENET, V50, P222; Sohma Y, 2013, CURR PHARM DESIGN, V19, P3521, DOI 10.2174/13816128113199990320; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang W, 2005, J BIOL CHEM, V280, P23622, DOI 10.1074/jbc.M503118200; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; Wang W, 2010, P NATL ACAD SCI USA, V107, P3888, DOI 10.1073/pnas.0913001107; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Xue XP, 2014, AM J RESP CELL MOL, V50, P805, DOI 10.1165/rcmb.2013-0282OC; Yeh HI, 2015, J GEN PHYSIOL, V145, P47, DOI 10.1085/jgp.201411272	22	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152232	10.1371/journal.pone.0152232	http://dx.doi.org/10.1371/journal.pone.0152232			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007499	gold, Green Submitted, Green Published			2022-12-26	WOS:000372701200114
J	dos Santos, HG; Nunez-Castilla, J; Siltberg-Liberles, J				dos Santos, Helena G.; Nunez-Castilla, Janelle; Siltberg-Liberles, Jessica			Functional Diversification after Gene Duplication: Paralog Specific Regions of Structural Disorder and Phosphorylation in p53, p63, and p73	PLOS ONE			English	Article							INDUCED FIT; PROTEINS; PREDICTION; SEQUENCE; EVOLUTION; FAMILY; DATABASE; GENOME; MDM2; GENERATION	Conformational and functional flexibility promote protein evolvability. High evolvability allows related proteins to functionally diverge and perhaps to neostructuralize. p53 is a multifunctional protein frequently referred to as the Guardian of the Genome-a hub for e.g. incoming and outgoing signals in apoptosis and DNA repair. p53 has been found to be structurally disordered, an extreme form of conformational flexibility. Here, p53, and its paralogs p63 and p73, were studied for further insights into the evolutionary dynamics of structural disorder, secondary structure, and phosphorylation. This study is focused on the post gene duplication phase for the p53 family in vertebrates, but also visits the origin of the protein family and the early domain loss and gain events. Functional divergence, measured by rapid evolutionary dynamics of protein domains, structural properties, and phosphorylation propensity, is inferred across vertebrate p53 proteins, in p63 and p73 from fish, and between the three paralogs. In particular, structurally disordered regions are redistributed among paralogs, but within clades redistribution of structural disorder also appears to be an ongoing process. Despite its deemed importance as the Guardian of the Genome, p53 is indeed a protein with high evolvability as seen not only in rearranged structural disorder, but also in fluctuating domain sequence signatures among lineages.	[dos Santos, Helena G.; Nunez-Castilla, Janelle; Siltberg-Liberles, Jessica] Florida Int Univ, Dept Biol Sci, Biomol Sci Inst, Miami, FL 33199 USA	State University System of Florida; Florida International University	Siltberg-Liberles, J (corresponding author), Florida Int Univ, Dept Biol Sci, Biomol Sci Inst, Miami, FL 33199 USA.	jliberle@fiu.edu		Nunez-Castilla, Janelle/0000-0002-3608-4512				Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Assis R, 2014, MOL BIOL EVOL, V31, P419, DOI 10.1093/molbev/mst217; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Balint E, 1999, ONCOGENE, V18, P3923, DOI 10.1038/sj.onc.1202781; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Belyi VA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001198; Berna L, 2014, GENOME BIOL EVOL, V6, P1724, DOI 10.1093/gbe/evu122; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bornberg-Bauer E, 2005, CELL MOL LIFE SCI, V62, P435, DOI 10.1007/s00018-004-4416-1; Brandt T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047889; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cai QL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-3-r29; Chao CCK, 2015, CLIN CHIM ACTA, V438, P139, DOI 10.1016/j.cca.2014.08.015; Chen YH, 2013, NUCLEIC ACIDS RES, V41, P8368, DOI 10.1093/nar/gkt584; CLORE GM, 1994, SCIENCE, V265, P386, DOI 10.1126/science.8023159; Cohen O, 2010, BIOINFORMATICS, V26, P2914, DOI 10.1093/bioinformatics/btq549; Collavin L, 2010, CELL DEATH DIFFER, V17, P901, DOI 10.1038/cdd.2010.35; Costanzo A, 2014, FEBS LETT, V588, P2590, DOI 10.1016/j.febslet.2014.06.047; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Di Domenico T, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S7-S3; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Fukuchi S, 2012, NUCLEIC ACIDS RES, V40, pD507, DOI 10.1093/nar/gkr884; Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035; Gunasekaran K, 2004, PROTEINS, V57, P433, DOI 10.1002/prot.20232; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Joerger AC, 2014, STRUCTURE, V22, P1301, DOI 10.1016/j.str.2014.07.010; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lane DP, 2011, CELL CYCLE, V10, P4272, DOI 10.4161/cc.10.24.18567; Lane DP, 2010, CELL CYCLE; Lee JC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1933; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; Mayrose I, 2004, MOL BIOL EVOL, V21, P1781, DOI 10.1093/molbev/msh194; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Nedelcu AM, 2007, DEV GENES EVOL, V217, P801, DOI 10.1007/s00427-007-0185-9; Nguyen TA, 2014, HUM MUTAT, V35, P738, DOI 10.1002/humu.22506; Nussinov R, 2014, BIOPHYS CHEM, V186, P22, DOI 10.1016/j.bpc.2013.10.002; Oldfield CJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S1; Popowicz GM, 2008, CELL CYCLE, V7, P2441, DOI 10.4161/cc.6365; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; R Core Team, 2021, R LANGUAGE ENV STAT; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Siltberg-Liberles J, 2011, GENES-BASEL, V2, P748, DOI 10.3390/genes2040748; Siltberg-Liberles J, 2011, MOL BIOL EVOL, V28, P59, DOI 10.1093/molbev/msq291; Slabinski L, 2007, PROTEIN SCI, V16, P2472, DOI 10.1110/ps.073037907; SOUSSI T, 1988, NUCLEIC ACIDS RES, V16, P11383, DOI 10.1093/nar/16.23.11383; Stiewe T, 2007, NAT REV CANCER, V7, P165, DOI 10.1038/nrc2072; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Trost B, 2011, BIOINFORMATICS, V27, P2927, DOI 10.1093/bioinformatics/btr525; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wagner A, 2008, NAT REV GENET, V9, P965, DOI 10.1038/nrg2473; Wu H, 2015, ONCOTARGET, V6, P21479, DOI 10.18632/oncotarget.4086; Xue B, 2013, BBA-PROTEINS PROTEOM, V1834, P725, DOI 10.1016/j.bbapap.2013.01.012; Xue B, 2009, FEBS LETT, V583, P1469, DOI 10.1016/j.febslet.2009.03.070; Yu QF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0078318, 10.1371/journal.pone.0059627]; Zdzalik M, 2010, CELL CYCLE, V9, P4584, DOI 10.4161/cc.9.22.13871	74	15	15	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151961	10.1371/journal.pone.0151961	http://dx.doi.org/10.1371/journal.pone.0151961			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003913	Green Published, gold, Green Submitted			2022-12-26	WOS:000372697400060
J	Kugelman, JR; Rossi, CA; Wiley, MR; Ladner, JT; Nagle, ER; Pfeffer, BP; Garcia, K; Prieto, K; Wada, J; Kuhn, JH; Palacios, G				Kugelman, Jeffrey R.; Rossi, Cynthia A.; Wiley, Michael R.; Ladner, Jason T.; Nagle, Elyse R.; Pfeffer, Bradley P.; Garcia, Karla; Prieto, Karla; Wada, Jiro; Kuhn, Jens H.; Palacios, Gustavo			Informing the Historical Record of Experimental Nonhuman Primate Infections with Ebola Virus: Genomic Characterization of USAMRIID Ebola Virus/H.sapiens-tc/COD/1995/Kikwit-9510621 Challenge Stock "R4368" and Its Replacement "R4415"	PLOS ONE			English	Article							SMALL GLYCOPROTEIN SGP; VARIANTS; RNA; NOMENCLATURE; GUINEA	The creation of licensed medical countermeasures against Select Agents such as Ebola virus (EBOV) is critically dependent on the use of standardized reagents, assays, and animal models. We performed full genome reconstruction, population genomics, contaminant analysis, and characterization of the glycoprotein gene editing site of historical United States Army Medical Research Institute of Infectious Diseases (USAMRIID) nonhuman-primate challenge stock Ebola virus Kikwit "R4368" and its 2014 replacement "R4415." We also provide characterization of the master stock used to create "R4415." The obtained data are essential to understanding the quality of the seed stock reagents used in pivotal animal studies that have been used to inform medical countermeasure development. Furthermore, these data might add to the understanding of the influence of EBOV variant populations on pathogenesis and disease outcome and inform attempts to avoid the evolution of EBOV escape mutants in response to current therapeutics. Finally, as the primary challenge stocks have changed over time, these data will provide a baseline for understanding and correlating past and future animal study results.	[Kugelman, Jeffrey R.; Rossi, Cynthia A.; Wiley, Michael R.; Ladner, Jason T.; Nagle, Elyse R.; Pfeffer, Bradley P.; Garcia, Karla; Prieto, Karla; Palacios, Gustavo] USAMRIID, Frederick, MD USA; [Wada, Jiro; Kuhn, Jens H.] NIAID, Integrated Res Facil Ft Detrick IRF Frederick, NIH, Frederick, MD USA	United States Army Medical Research Institute of Infectious Diseases; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Palacios, G (corresponding author), USAMRIID, Frederick, MD USA.	gustavo.f.palacios.ctr@mail.mil	Kuhn, Jens H./B-7615-2011; Palacios, Gustavo/I-7773-2015; Ladner, Jason/G-3486-2011	Kuhn, Jens H./0000-0002-7800-6045; Palacios, Gustavo/0000-0001-5062-1938; Ladner, Jason/0000-0001-7751-4366; Wiley, Michael/0000-0001-6688-007X	Battelle Memorial Institute; US National Institute of Allergy and Infectious Diseases (NIAID) [HHSN272200700016I]	Battelle Memorial Institute; US National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The content of this publication does not necessarily reflect the views or policies of the US Department of Defense, the US Department of Health and Human Services, the US Department of the Army, or the institutions and companies affiliated with the authors. This work was funded in part through Battelle Memorial Institute's prime contract with the US National Institute of Allergy and Infectious Diseases (NIAID) under Contract No. HHSN272200700016I (J.H.K.). A subcontractor to Battelle Memorial Institute who performed this work is: J.H.K, an employee of Tunnell Government Services, Inc. Tunnell Government Services provided support in the form of salaries, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. All work under contract HHSN272200700016I is performed under the agreement/understanding that it will belong to the client and will be affiliated directly to the NIH/NIAID Integrated Research Facility at Fort Detrick. The specific roles of these authors are articulated in the 'author contributions' section.	Alfson KJ, 2015, J INFECT DIS, V212, pS295, DOI 10.1093/infdis/jiv216; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Barrientos LG, 2004, BIOCHEM BIOPH RES CO, V323, P696, DOI 10.1016/j.bbrc.2004.08.148; Hirschberg R, 2014, VIRUSES-BASEL, V6, P2673, DOI 10.3390/v6072673; Kilgore N, 2012, VIRUSES-BASEL, V4, P2312, DOI 10.3390/v4102312; Kugelman JR, 2015, CELL REP, V12, P2111, DOI 10.1016/j.celrep.2015.08.038; Kugelman JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050316; Kuhn JH, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01178-14; Kuhn JH, 2014, VIRUSES-BASEL, V6, P4760, DOI 10.3390/v6114760; Kuhn JH, 2014, VIRUSES-BASEL, V6, P3663, DOI 10.3390/v6093663; Kuhn JH, 2013, ARCH VIROL, V158, P301, DOI 10.1007/s00705-012-1454-0; Kuhn JH, 2011, BIOSECUR BIOTERROR, V9, P361, DOI 10.1089/bsp.2011.0051; Kuhn JH, 2011, VIRUS TAXONOMY, P665; KUHN JH, 2008, ARCH VIROLOGY S, V20; Ladner JT, 2014, MBIO, V5, DOI 10.1128/mBio.01360-14; Mehedi M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003677; Mehedi M, 2011, J VIROL, V85, P5406, DOI 10.1128/JVI.02190-10; Natl Res Council, 2011, ANIMAL MODELS FOR ASSESSING COUNTERMEASURES TO BIOTERRORISM AGENTS, P1; Sanchez A, 1996, P NATL ACAD SCI USA, V93, P3602, DOI 10.1073/pnas.93.8.3602; Shurtleff AC, 2012, VIRUSES-BASEL, V4, P3511, DOI 10.3390/v4123511; Trefry JC, 2015, VIRUSES-BASEL, V7, P6739, DOI 10.3390/v7122969; Volchkov VE, 1995, VIROLOGY, V214, P421, DOI 10.1006/viro.1995.0052; Volchkova VA, 1998, VIROLOGY, V250, P408, DOI 10.1006/viro.1998.9389; Volchkova VA, 1999, VIROLOGY, V265, P164, DOI 10.1006/viro.1999.0034; Volchkova VA, 2015, J INFECT DIS, V212, pS226, DOI 10.1093/infdis/jiv309; Volchkova VA, 2011, J INFECT DIS, V204, pS941, DOI 10.1093/infdis/jir321; W.H. Organization, 2016, WHO EB SIT REP; Wahl-Jensen V, 2014, VIRAL HEMORRHAGIC FEVERS, P99	28	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0150919	10.1371/journal.pone.0150919	http://dx.doi.org/10.1371/journal.pone.0150919			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002733	Green Published, gold			2022-12-26	WOS:000372697400022
J	Li, XS; Luo, YQ; Yang, HY; Yang, QS; Settele, J; Schweiger, O				Li, Xiushan; Luo, Youqing; Yang, Haiyu; Yang, Qingsen; Settele, Josef; Schweiger, Oliver			On the Ecology and Conservation of Sericinus montelus (Lepidoptera: Papilionidae) - Its Threats in Xiaolongshan Forests Area (China)	PLOS ONE			English	Article							CLIMATE-CHANGE; HABITAT; RESPONSES; IMPACTS	Contents and Methods Here we present a detailed analysis of the life history, mobility and habitat requirements of the butterfly Sericinus montelus on the basis of extensive field observations, experimental breeding, capture-mark-recapture (CMR) and transect surveys. Life History We found that S. montelus has three generations per year and overwinters as pupae on shrub branches in Xiaolongshan. The adults of first generation have a peak of emergence in late April. The second generation emerges at the end of June and the third in early to middle August. Within the study region, larvae of S. montelus are monophagous on Aristolochia contorta. Adults fly slowly and lay eggs in clusters. Key Factors Life tables show that natural enemies and human activities such as mowing, weeding and trampling during the egg and larval stages are key factors causing high mortality, killing up to 43% of eggs and 72% of larvae thereby limiting population growth and recovery. Population Ecology The populations of S. montelus in Xiaolongshan have a rather patchy distribution. According to CMR data, adults fly a maximum distance of 700m within a lifespan of 6 days. The host plant A. contorta, grows along the low banks of fields, irrigation ditches and paths, and can be highly affected by agricultural activities, like mowing, weeding and herding, which impact larval survival. Population Maintenance For S. montelus should mainly focus on reducing agricultural threats to the host plant A. contorta and on increasing habitat connectivity.	[Li, Xiushan; Luo, Youqing] Beijing Forestry Univ, Key Lab Forest Silviculture & Conservat, Minist Educ, Beijing 100083, Peoples R China; [Li, Xiushan] Chinese Res Inst Environm Sci, Biodivers Res Ctr, Beijing 100012, Peoples R China; [Yang, Haiyu] Xiaolongshan Forestry Expt Agcy, Res Inst Forestry Sci, Key Lab Oak Secondary Forest Ecosyst Gansu Prov, Tianshui, Peoples R China; [Yang, Qingsen] Xiaolongshan Forestry Expt Agcy, Stn Forests Dis & Pests Control & Quarantine, Tianshui 741020, Peoples R China; [Settele, Josef; Schweiger, Oliver] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol, D-06120 Halle, Germany; [Settele, Josef] German Ctr Integrat Biodivers Res iDiv, IDiv, Deutsch Pl 5e, D-04103 Leipzig, Germany	Beijing Forestry University; Chinese Research Academy of Environmental Sciences; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ)	Luo, YQ (corresponding author), Beijing Forestry Univ, Key Lab Forest Silviculture & Conservat, Minist Educ, Beijing 100083, Peoples R China.	yqluo@bjfu.edu.cn	Schweiger, Oliver/B-4909-2008; Settele, Josef/A-6371-2009; Li, Xiushan/AAA-3856-2021	Schweiger, Oliver/0000-0001-8779-2335; Settele, Josef/0000-0002-8624-4983; 				An DG, 2002, HIGH PLANTS FLORA XI; [Anonymous], 2009, BUTTERFLIES EUROPE, DOI DOI 10.1111/j.1365-3113.2006.00333.x; BELLOWS TS, 1992, ANNU REV ENTOMOL, V37, P587, DOI 10.1146/annurev.en.37.010192.003103; Chou I, 2000, MONOGRAPHIA RHOPALOC; Dover J, 2009, J INSECT CONSERV, V13, P3, DOI 10.1007/s10841-008-9135-8; Ehrlich P.R., 1984, Symposia of the Royal Entomological Society of London, P25; Fischer Klaus, 1998, Nota Lepidopterologica, V21, P14; Geiger F, 2010, BASIC APPL ECOL, V11, P97, DOI 10.1016/j.baae.2009.12.001; Hanspach J, 2014, ECOGRAPHY, V37, P301, DOI 10.1111/j.1600-0587.2013.00195.x; Koh LP, 2007, J APPL ECOL, V44, P703, DOI 10.1111/j.1365-2664.2007.01324.x; Leidner AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009534; Li XS, 2011, J INSECT CONSERV, V15, P617, DOI 10.1007/s10841-010-9361-8; Li XS, 2010, J INSECT CONSERV, V14, P257, DOI 10.1007/s10841-009-9254-x; Li Xiu-Shan, 2006, Acta Ecologica Sinica, V26, P3184, DOI 10.1016/S1872-2032(06)60049-8; Luo Z.W., 2005, SERICINUS MONTELUS J, V23, P437; Luo ZB, 2011, MORPHOLOGY BIOL CHAR; Luo ZB, 2010, INSECT RES MIDDLE CH, V6, P71; Maes D, 2001, BIOL CONSERV, V99, P263, DOI 10.1016/S0006-3207(00)00182-8; Maes D, 2005, BIOL CONSERV, V123, P177, DOI 10.1016/j.biocon.2004.11.005; Marschalek DA, 2010, J INSECT CONSERV, V14, P721, DOI 10.1007/s10841-010-9302-6; Nilsson SG, 2008, INSECT CONSERV DIVER, V1, P197, DOI 10.1111/j.1752-4598.2008.00027.x; Nowicki P, 2008, ISR J ECOL EVOL, V54, P69, DOI 10.1560/IJEE.54.1.69; Ockinger E, 2010, ECOL LETT, V13, P969, DOI 10.1111/j.1461-0248.2010.01487.x; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Poyry J, 2009, GLOBAL CHANGE BIOL, V15, P732, DOI 10.1111/j.1365-2486.2008.01789.x; Pollard E., 1986, MONITORING ABUNDANCE; Schtickzelle N, 2007, BIOL CONSERV, V136, P651, DOI 10.1016/j.biocon.2007.01.012; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; Schweiger O, 2008, ECOLOGY, V89, P3472, DOI 10.1890/07-1748.1; Schweiger O, 2006, LANDSCAPE ECOL, V21, P989, DOI 10.1007/s10980-005-6057-7; Schweiger O, 2012, GLOBAL ECOL BIOGEOGR, V21, P88, DOI 10.1111/j.1466-8238.2010.00607.x; van Swaay CAM, 2008, BIODIVERS CONSERV, V17, P3455, DOI 10.1007/s10531-008-9491-4; Wang XP, 2007, APPL ENTOMOL ZOOL, V42, P419, DOI 10.1303/aez.2007.419; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; WATANABE M, 1979, Japanese Journal of Ecology, V29, P85; WATANABE M, 1981, RES POPUL ECOL, V23, P74, DOI 10.1007/BF02514094; Wilson Robert J., 2009, P81; Wu CS, 2001, FAUNA SINICA INSECTA, V25, P241; Xu RM., 1987, INSECT POPULATION EC; Yang Darong, 1998, Acta Entomologica Sinica, V41, P48; Yang Qiu-Sheng, 2007, Chinese Bulletin of Entomology, V44, P223; Ye SX, 2002, CHINESE HIGHER PLANT; Zhang XX., 2002, INSECT ECOLOGY FOREC	43	11	11	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0150833	10.1371/journal.pone.0150833	http://dx.doi.org/10.1371/journal.pone.0150833			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002639	gold, Green Published, Green Submitted			2022-12-26	WOS:000372697400021
J	Perilli, MLL; Lima, F; Rodrigues, FHG; Cavalcanti, SMC				Perilli, Miriam L. L.; Lima, Fernando; Rodrigues, Flavio H. G.; Cavalcanti, Sandra M. C.			Can Scat Analysis Describe the Feeding Habits of Big Cats? A Case Study with Jaguars (Panthera onca) in Southern Pantanal, Brazil	PLOS ONE			English	Article							PUMA PUMA-CONCOLOR; FOOD-HABITS; PREDATION; ECOLOGY; PREY; CARNIVORES; LANDSCAPE; PATTERNS; CLUSTERS; FOREST	Large cats feeding habits have been studied through two main methods: scat analysis and the carcasses of prey killed by monitored animals. From November 2001 to April 2004, we studied jaguar predation patterns using GPS telemetry location clusters on a cattle ranch in southern Pantanal. During this period, we recorded 431 carcasses of animals preyed upon by monitored jaguars. Concurrently, we collected 125 jaguar scats opportunistically. We compared the frequencies of prey found through each method. We also compared the prey communities using Bray-Curtis similarity coefficient. These comparisons allowed us to evaluate the use of scat analysis as a means to describe jaguar feeding habits. Both approaches identified prey communities with high similarity (Bray-Curtis coefficient >70). According to either method, jaguars consume three main prey: cattle (Bos taurus), caiman (Caiman yacare) and peccaries (Tayassu pecari and Pecari tajacu). The two methods did not differ in the frequency of the three main prey over dry and wet seasons or years sampled. Our results show that scat analysis is effective and capable of describing jaguar feeding habits.	[Perilli, Miriam L. L.] Univ Fed Vicosa, Dept Biol Geral, Programa Posgrad Ecol, Vicosa, MG, Brazil; [Perilli, Miriam L. L.] Univ Fed Mato Grosso do Sul UFMS, Programa Posgrad Ecol & Conservacao, Campo Grande, MS, Brazil; [Perilli, Miriam L. L.; Rodrigues, Flavio H. G.; Cavalcanti, Sandra M. C.] Inst Conservacao Carnivoros Neotropicais Procarni, Sao Paulo, Brazil; [Lima, Fernando] IPE, Sao Paulo, Brazil; [Lima, Fernando] Univ Estadual Paulista UNESP, Inst Biociencias, Programa Posgrad Ecol & Biodiversidade, Sao Paulo, Brazil; [Rodrigues, Flavio H. G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Mato Grosso do Sul; Universidade de Sao Paulo; Universidade Estadual Paulista; Universidade Federal de Minas Gerais	Perilli, MLL (corresponding author), Univ Fed Vicosa, Dept Biol Geral, Programa Posgrad Ecol, Vicosa, MG, Brazil.; Perilli, MLL (corresponding author), Univ Fed Mato Grosso do Sul UFMS, Programa Posgrad Ecol & Conservacao, Campo Grande, MS, Brazil.; Perilli, MLL (corresponding author), Inst Conservacao Carnivoros Neotropicais Procarni, Sao Paulo, Brazil.	miriamperilli@gmail.com	Rodrigues, Flávio/E-4924-2012; Lima, Fernando/E-8023-2016	Rodrigues, Flávio/0000-0002-4797-0085; Lima, Fernando/0000-0002-8644-9647	Fundacao Grupo Boticario de Protecao a Natureza (Boticario Group Foundation); Wildlife Conservation Society (WCS); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao Grupo Boticario de Protecao a Natureza (Boticario Group Foundation); Wildlife Conservation Society (WCS); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Scat analysis funding was provided by Fundacao Grupo Boticario de Protecao a Natureza (Boticario Group Foundation). Funding for jaguar monitoring was provided by the Wildlife Conservation Society (WCS). Sociedade Civil Mamiraua (SCM) and Fundacao Brasileira para o Desenvolvimento Sustentavel (FBDS - Brazilian Foundation for Sustainable Development) provided administrative and logistical support at the research station. MLLP received scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson CR, 2003, J WILDLIFE MANAGE, V67, P307, DOI 10.2307/3802772; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2003, TECHNOMETRICS; [Anonymous], 2008, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2008.RLTS.T15953A5327466.EN; Aranda M, 1996, STUD NEOTROP FAUNA E, V31, P65, DOI 10.1076/snfe.31.2.65.13334; Bacon MM, 2011, WILDLIFE SOC B, V35, P409, DOI 10.1002/wsb.85; BLOOM SA, 1981, MAR ECOL PROG SER, V5, P125, DOI 10.3354/meps005125; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Carbone C, 2007, PLOS BIOL, V5, P363, DOI 10.1371/journal.pbio.0050022; de Azevedo FCC, 2008, BIOTROPICA, V40, P494, DOI 10.1111/j.1744-7429.2008.00404.x; de Azevedo FCC, 2007, BIOL CONSERV, V137, P391, DOI 10.1016/j.biocon.2007.02.022; Cavalcanti SMC, 2010, J MAMMAL, V91, P722, DOI 10.1644/09-MAMM-A-171.1; Ceballos G., 2005, BIODIVERSITAS, V62, P1; Chinchilla FA, 1997, REV BIOL TROP, V45, P1223; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Crawshaw, 1995, COMP ECOLOGY OCELOT; Crawshaw PG, 2002, JAGUAR NUEVO MILENIO, P223; Dalponte J, 2002, JAGUAR NUEVO MILENIO; de Azevedo FCC, 2007, J WILDLIFE MANAGE, V71, P2379, DOI 10.2193/2006-520; EMMONS LH, 1987, BEHAV ECOL SOCIOBIOL, V20, P271, DOI 10.1007/BF00292180; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Facure KG, 1996, MAMMALIA, V60, P499; Farrell LE, 2000, MOL ECOL, V9, P1583, DOI 10.1046/j.1365-294x.2000.01037.x; Foster RJ, 2010, J ZOOL, V280, P309, DOI 10.1111/j.1469-7998.2009.00663.x; Garla RC, 2001, BIOTROPICA, V33, P691, DOI 10.1111/j.1744-7429.2001.tb00226.x; Gomez-Ortiz Y, 2015, ZOOL STUD, V54, DOI 10.1186/s40555-014-0102-7; Harris MB, 2005, CONSERV BIOL, V19, P714, DOI 10.1111/j.1523-1739.2005.00708.x; Hernandez-SaintMartin AD, 2015, NAT AREA J, V35, P308, DOI 10.3375/043.035.0213; Hoogesteijn R, 2010, WILD FELID MONIT, V3, P1; Desbiez ALJ, 2010, BIOTROPICA, V42, P372, DOI 10.1111/j.1744-7429.2009.00601.x; Knopff KH, 2009, J WILDLIFE MANAGE, V73, P586, DOI 10.2193/2008-294; Legendre P., 2003, NUMERICAL ECOLOGY, VSecond; Leite Y, 2002, JAGUAR NUEVO MILENIO; Loveridge Andrew J., 2010, P161; Martins Q, 2011, J ZOOL, V283, P81, DOI 10.1111/j.1469-7998.2010.00757.x; Morato Ronaldo G., 2002, P91; Novack AJ, 2005, J ZOOL, V267, P167, DOI 10.1017/S0952836905007338; Nunez R, 2000, J ZOOL, V252, P373, DOI 10.1111/j.1469-7998.2000.tb00632.x; Pitman RT, 2012, J ZOOL, V288, P222, DOI 10.1111/j.1469-7998.2012.00945.x; Polisar J, 2003, BIOL CONSERV, V109, P297, DOI 10.1016/S0006-3207(02)00157-X; Quadros J, 2006, REV BRAS ZOOL, V23, P279, DOI 10.1590/S0101-81752006000100023; QUIGLEY HB, 1992, BIOL CONSERV, V61, P149, DOI 10.1016/0006-3207(92)91111-5; Quigley HB, 1987, ECOLOGY CONSERVATION; RABINOWITZ AR, 1986, J ZOOL, V210, P149, DOI 10.1111/j.1469-7998.1986.tb03627.x; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Roemer GW, 2009, BIOSCIENCE, V59, P165, DOI 10.1525/bio.2009.59.2.9; Rosas-Rosas OC, 2008, RANGELAND ECOL MANAG, V61, P554, DOI 10.2111/08-038.1; Ryall KL, 2006, ECOLOGY, V87, P1086, DOI 10.1890/0012-9658(2006)87[1086:ROPTLA]2.0.CO;2; Sanderson EW, 2002, CONSERV BIOL, V16, P58, DOI 10.1046/j.1523-1739.2002.00352.x; SCHALLER GB, 1978, Z SAUGETIERKD, V43, P296; SCHALLER GB, 1980, BIOTROPICA, V12, P161, DOI 10.2307/2387967; Scognamillo D, 2003, J ZOOL, V259, P269, DOI 10.1017/S0952836902003230; Sollmann R, 2013, EUR J WILDLIFE RES, V59, P445, DOI 10.1007/s10344-013-0708-9; Taber AB, 1997, BIOTROPICA, V29, P204, DOI 10.1111/j.1744-7429.1997.tb00025.x; Tambling CJ, 2012, J ZOOL, V286, P102, DOI 10.1111/j.1469-7998.2011.00856.x; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Wachter B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038066; Wallach AD, 2015, OIKOS, V124, P1453, DOI 10.1111/oik.01977; Weckel M, 2006, J ZOOL, V270, P25, DOI 10.1111/j.1469-7998.2006.00106.x; Zar J. H., 1996, BIOSTATISTICAL ANAL	60	16	16	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151814	10.1371/journal.pone.0151814	http://dx.doi.org/10.1371/journal.pone.0151814			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002524	Green Published, gold, Green Submitted			2022-12-26	WOS:000372697400048
J	Steinwender, B; Thrimawithana, AH; Crowhurst, R; Newcomb, RD				Steinwender, Bernd; Thrimawithana, Amali H.; Crowhurst, Ross; Newcomb, Richard D.			Odorant Receptors of the New Zealand Endemic Leafroller Moth Species Planotortrix octo and P. excessana	PLOS ONE			English	Article							SEX-PHEROMONE COMPONENTS; BROWN APPLE MOTH; CTENOPSEUSTIS-OBLIQUANA LEPIDOPTERA; FUNCTIONAL-CHARACTERIZATION; BROWNHEADED LEAFROLLER; EPIPHYAS-POSTVITTANA; EVOLUTION; RESPONSES; ALIGNMENT; QUANTIFICATION	Moths use their sense of smell to find food sources, mating partners and oviposition sites. For this they possess a family of odorant receptors (ORs). Some ORs are used by both sexes whereas others have sex-specific roles. For example, male moths possess ORs specifically tuned to sex pheromones produced by conspecific females. Here we identify sets of ORs from the antennae of New Zealand endemic leafroller moths Planotortrix octo (48 ORs) and P. excessana (47 ORs) using an RNA-Seq approach. Two orthologous ORs show male-biased expression in the adult antennae of both species (OR7 and OR30) and one other OR in each species was female-biased in its expression (PoctOR25, PexcOR14) by qPCR. PAML analysis conducted on male-biased ORs indicated positive selection acting on the male-biased OR7. The fact that OR7 is likely under positive selection, that it is male-biased in its expression and that its orthologue in C. obliquana, CoblOR7, responds to sex pheromone components also utilised by Planotortrix species, suggests that this receptor may also be important in sex pheromone reception in Planotortrix species.	[Steinwender, Bernd; Thrimawithana, Amali H.; Crowhurst, Ross; Newcomb, Richard D.] New Zealand Inst Plant & Food Res Ltd, Auckland, New Zealand; [Steinwender, Bernd; Newcomb, Richard D.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Steinwender, Bernd; Newcomb, Richard D.] Allan Wilson Ctr Mol Ecol & Evolut, Auckland, New Zealand	New Zealand Institute for Plant & Food Research Ltd; University of Auckland; Massey University	Newcomb, RD (corresponding author), New Zealand Inst Plant & Food Res Ltd, Auckland, New Zealand.; Newcomb, RD (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.; Newcomb, RD (corresponding author), Allan Wilson Ctr Mol Ecol & Evolut, Auckland, New Zealand.	Richard.Newcomb@plantandfood.co.nz	Thrimawithana, Amali H/O-4702-2017; Crowhurst, Ross N/N-8892-2017; Newcomb, Richard/C-2067-2009	Thrimawithana, Amali H/0000-0001-6325-2334; Crowhurst, Ross N/0000-0003-0608-2134; Newcomb, Richard/0000-0002-7307-9755	Allan Wilson Centre for Molecular Ecology and Evolution	Allan Wilson Centre for Molecular Ecology and Evolution	We would like to thank Anne Barrington for supplying moths. Funding was provided by the Allan Wilson Centre for Molecular Ecology and Evolution.	Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; Albre J, 2013, J HERED, V104, P627, DOI 10.1093/jhered/est043; Albre J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002489; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson AR, 2009, INSECT BIOCHEM MOLEC, V39, P189, DOI 10.1016/j.ibmb.2008.11.002; Aronesty E., 2011, EA UTILS COMMAND LIN; Bengtsson JM, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00033; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Bradbury Jack W., 1998, pi; Carraher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038391; CLARE GK, 1988, NEW ZEAL J ZOOL, V15, P435, DOI 10.1080/03014223.1988.10422971; Corcoran, 2014, THESIS U AUCKLAND NZ; Corcoran JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128596; CROSBY T K, 1976, New Zealand Journal of Zoology, V3, P69; Davie LC, 2010, ANIM BEHAV, V79, P391, DOI 10.1016/j.anbehav.2009.11.015; Domingue MJ, 2007, J INSECT PHYSIOL, V53, P1063, DOI 10.1016/j.jinsphys.2007.05.013; DUGDALE JS, 1990, NEW ZEAL J ZOOL, V17, P437, DOI 10.1080/03014223.1990.10422943; FOSTER SP, 1986, NATURWISSENSCHAFTEN, V73, P156, DOI 10.1007/BF00367406; FOSTER SP, 1990, J CHEM ECOL, V16, P2461, DOI 10.1007/BF01017469; FOSTER SP, 1987, J CHEM ECOL, V13, P623, DOI 10.1007/BF01880104; FOSTER SP, 1988, BIOCHEM SYST ECOL, V16, P227, DOI 10.1016/0305-1978(88)90102-0; FOSTER SP, 1989, J CHEM ECOL, V15, P457, DOI 10.1007/BF01014692; GALBREATH RA, 1985, Z NATURFORSCH C, V40, P266; Gould F, 2010, P NATL ACAD SCI USA, V107, P8660, DOI 10.1073/pnas.0910945107; Greenberg AJ, 2003, SCIENCE, V302, P1754, DOI 10.1126/science.1090432; Grosse-Wilde E, 2007, EUR J NEUROSCI, V25, P2364, DOI 10.1111/j.1460-9568.2007.05512.x; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Grosse-Wilde E, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00022; Guo S, 2007, MOL BIOL EVOL, V24, P1198, DOI 10.1093/molbev/msm038; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; HANSSON BS, 1989, ENTOMOL EXP APPL, V53, P137, DOI 10.1007/BF00187995; Heinbockel T, 1996, J INSECT PHYSIOL, V42, P565, DOI 10.1016/0022-1910(95)00133-6; Hillier NK, 2011, J CHEM ECOL, V37, P1127, DOI 10.1007/s10886-011-0017-2; Hillier NK, 2004, CHEM SENSES, V29, P499, DOI 10.1093/chemse/bjh052; Jiang XJ, 2014, INSECT BIOCHEM MOLEC, V48, P63, DOI 10.1016/j.ibmb.2014.02.010; Johns SJ, 2005, TRANSMEMBRANE PROTEI; Jordan MD, 2008, INSECT MOL BIOL, V17, P361, DOI 10.1111/j.1365-2583.2008.00812.x; Juretic D, 2002, J CHEM INF COMP SCI, V42, P620, DOI 10.1021/ci010263s; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KOH YH, 1995, ANN ENTOMOL SOC AM, V88, P519, DOI 10.1093/aesa/88.4.519; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Langhoff P, 2009, MOL ECOL RESOUR, V9, P691, DOI 10.1111/j.1755-0998.2009.02537.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lassance JM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-10; Leary GP, 2012, P NATL ACAD SCI USA, V109, P14081, DOI 10.1073/pnas.1204661109; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Linn Charles E. Jr., 1995, P263; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lundin C, 2007, FEBS LETT, V581, P5601, DOI 10.1016/j.febslet.2007.11.007; Mitsuno H, 2008, EUR J NEUROSCI, V28, P893, DOI 10.1111/j.1460-9568.2008.06429.x; Miura N, 2010, INSECT BIOCHEM MOLEC, V40, P64, DOI 10.1016/j.ibmb.2009.12.011; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Newcomb RD, 2015, PHEROMONE COMMUNICTA; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Phelan P.L., 1992, P265; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; ROELOFS WL, 1982, ANNU REV ECOL SYST, V13, P395, DOI 10.1146/annurev.es.13.110182.002143; RUMBO ER, 1983, PHYSIOL ENTOMOL, V8, P195, DOI 10.1111/j.1365-3032.1983.tb00349.x; RUMBO ER, 1981, PHYSIOL ENTOMOL, V6, P87; Sakai R, 2009, INSECT BIOCHEM MOLEC, V39, P62, DOI 10.1016/j.ibmb.2008.10.001; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Shirangi TR, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000168; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; STADELBACHER EA, 1983, EXPERIENTIA, V39, P1174, DOI 10.1007/BF01943168; Steinwender B, 2015, J MOL EVOL, V80, P42, DOI 10.1007/s00239-014-9650-z; Suckling DM, 2010, ANNU REV ENTOMOL, V55, P285, DOI 10.1146/annurev-ento-112408-085311; Symonds MRE, 2008, TRENDS ECOL EVOL, V23, P220, DOI 10.1016/j.tree.2007.11.009; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tunstall NE, 2007, J MOL EVOL, V64, P628, DOI 10.1007/s00239-006-0151-6; Turner CT, 2006, INSECT MOL BIOL, V15, P383, DOI 10.1111/j.1365-2583.2006.00656.x; Wang G, 2011, INSECT MOL BIOL, V20, P125, DOI 10.1111/j.1365-2583.2010.01045.x; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; WEARING C. H., 1991, TORTRICID PESTS THEI, P453; Xue BY, 2007, P NATL ACAD SCI USA, V104, P4467, DOI 10.1073/pnas.0700422104; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; YOUNG H, 1985, Z NATURFORSCH C, V40, P262	81	9	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152147	10.1371/journal.pone.0152147	http://dx.doi.org/10.1371/journal.pone.0152147			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003722	Green Submitted, Green Published, gold			2022-12-26	WOS:000372697400086
J	Tarjan, LM; Tinker, MT				Tarjan, L. Max; Tinker, M. Tim			Permissible Home Range Estimation (PHRE) in Restricted Habitats: A New Algorithm and an Evaluation for Sea Otters	PLOS ONE			English	Article							ENHYDRA-LUTRIS; SPACE USE; SAMPLE-SIZE; SELECTION; BEHAVIOR; MOVEMENT; FOX	Parametric and nonparametric kernel methods dominate studies of animal home ranges and space use. Most existing methods are unable to incorporate information about the underlying physical environment, leading to poor performance in excluding areas that are not used. Using radio-telemetry data from sea otters, we developed and evaluated a new algorithm for estimating home ranges (hereafter Permissible Home Range Estimation, or "PHRE") that reflects habitat suitability. We began by transforming sighting locations into relevant landscape features (for sea otters, coastal position and distance from shore). Then, we generated a bivariate kernel probability density function in landscape space and back-transformed this to geographic space in order to define a permissible home range. Compared to two commonly used home range estimation methods, kernel densities and local convex hulls, PHRE better excluded unused areas and required a smaller sample size. Our PHRE method is applicable to species whose ranges are restricted by complex physical boundaries or environmental gradients and will improve understanding of habitat-use requirements and, ultimately, aid in conservation efforts.	[Tarjan, L. Max; Tinker, M. Tim] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Tinker, M. Tim] US Geol Survey, Western Ecol Res Ctr, Santa Cruz, CA USA	University of California System; University of California Santa Cruz; United States Department of the Interior; United States Geological Survey	Tarjan, LM (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	ltarjan@ucsc.edu	Tinker, Martin T/D-3249-2018	Tinker, Martin T/0000-0002-3314-839X	United States Geological Survey; American Association for the Advancement of Science Pacific Division Alan E. Leviton Student Research Award; Rebecca and Steve Sooy Graduate Fellowship in Marine Mammals; Sigma Xi Grants-in-Aid of Research [G20111015158929]; Friends of Long Marine Laboratory Student Research Award; National Geographic Society Young Explorers Grant [9120-12]; Dr. Earl H. and Ethyl M. Myers Oceanographic and Marine Biology Trust; NSF EEID grant "Roles of marine host cycle and particle aggregation in transmission of zoonotic pathogens in coastal ecosystems" [OCE1065990]; GK-12 Santa Cruz-Watsonville Inquiry-Based Learning in Environmental Sciences [NSF DGE-0947923]; Division Of Graduate Education [0947923] Funding Source: National Science Foundation	United States Geological Survey(United States Geological Survey); American Association for the Advancement of Science Pacific Division Alan E. Leviton Student Research Award; Rebecca and Steve Sooy Graduate Fellowship in Marine Mammals; Sigma Xi Grants-in-Aid of Research; Friends of Long Marine Laboratory Student Research Award; National Geographic Society Young Explorers Grant(National Geographic Society); Dr. Earl H. and Ethyl M. Myers Oceanographic and Marine Biology Trust; NSF EEID grant "Roles of marine host cycle and particle aggregation in transmission of zoonotic pathogens in coastal ecosystems"; GK-12 Santa Cruz-Watsonville Inquiry-Based Learning in Environmental Sciences; Division Of Graduate Education(National Science Foundation (NSF)NSF- Directorate for Education & Human Resources (EHR))	This study would not have been possible without the field and financial support of the United States Geological Survey. Thank you to the following funding sources for supporting field research: the American Association for the Advancement of Science Pacific Division Alan E. Leviton Student Research Award (LMT, http://associations.sou.edu/aaaspd/Students/StudentResearchGrants.html), the Rebecca and Steve Sooy Graduate Fellowship in Marine Mammals (LMT), the Sigma Xi Grants-in-Aid of Research (LMT, G20111015158929, https://www.sigmaxi.org/programs/grants-in-aid), the Friends of Long Marine Laboratory Student Research Award (LMT), the National Geographic Society Young Explorers Grant (LMT, 9120-12, http://www.nationalgeographic.com/explorers/grants-programs/young-explorers/), and the Dr. Earl H. and Ethyl M. Myers Oceanographic and Marine Biology Trust (LMT). The authors thank the National Science Foundation for contributing funds for data analysis via the NSF EEID grant "Roles of marine host cycle and particle aggregation in transmission of zoonotic pathogens in coastal ecosystems" (MTT, OCE1065990, https://www.nsf.gov/funding). Manuscript preparation was partially supported by GK-12 Santa Cruz-Watsonville Inquiry-Based Learning in Environmental Sciences (LMT, NSF DGE-0947923, http://scwibles.ucsc.edu/, https://www.nsf.gov/div/index.jsp?div=DGE).	Ames RA, 1986, SIMULATED TRANSLOCAT; ANDERSON DJ, 1982, ECOLOGY, V63, P103, DOI 10.2307/1937036; Barding EE, 2008, AM MIDL NAT, V159, P394, DOI 10.1674/0003-0031(2008)159[394:RUHEIN]2.0.CO;2; Barry RP, 2011, ECOL MODEL, V222, P1666, DOI 10.1016/j.ecolmodel.2011.02.016; BEKOFF M, 1984, BEHAV RES METH INS C, V16, P32, DOI 10.3758/BF03201046; Bivand R., 2015, **DATA OBJECT**; Blundell GM, 2001, ECOL MONOGR, V71, P469, DOI 10.1890/0012-9615(2001)071[0469:LHREOS]2.0.CO;2; Bodkin JL, 2004, MAR MAMMAL SCI, V20, P305, DOI 10.1111/j.1748-7692.2004.tb01159.x; Boyle SA, 2009, FOLIA PRIMATOL, V80, P33, DOI 10.1159/000201092; BRODY AJ, 1989, WILDLIFE SOC B, V17, P5; Burt W. H., 1943, J MAMMAL, V24, P346, DOI DOI 10.2307/1374834; Calenge C., 2011, HOME RANGE ESTIMATIO, DOI DOI 10.1111/J.1365-2656.2006.01186.X; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; California Department of Fish and Game Bathymetry Project & State of California Teale Data Center GIS Solutions Group, 2002, BD200M V2I; California Department of Forestry and Fire Protection, 2007, CNTY24K09 1 DISS M S; Campos FA, 2009, AM J PHYS ANTHROPOL, V138, P101, DOI 10.1002/ajpa.20908; CAVALLINI P, 1994, ACTA THERIOL, V39, P279, DOI 10.4098/AT.arch.94-31; Dickson BG, 2002, J WILDLIFE MANAGE, V66, P1235, DOI 10.2307/3802956; Duong T, 2014, KS KERNEL SMOOTHING; EBERHARDT LE, 1982, J WILDLIFE MANAGE, V46, P183, DOI 10.2307/3808421; Fayer R, 2004, TRENDS PARASITOL, V20, P531, DOI 10.1016/j.pt.2004.08.008; Fieberg J, 2012, J MAMMAL, V93, P890, DOI 10.1644/11-MAMM-S-172.1; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Getz WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000207; Getz WM, 2004, ECOGRAPHY, V27, P489, DOI 10.1111/j.0906-7590.2004.03835.x; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hedmark E, 2007, WILDLIFE BIOL, V13, P13, DOI 10.2981/0909-6396(2007)13[13:PAMSIW]2.0.CO;2; Hijmans R.J., 2019, GEOGRAPHIC DATA ANAL; Hijmans RJ, 2011, PACKAGE DISMO SPECIE; Horne JS, 2008, ECOL MODEL, V214, P338, DOI 10.1016/j.ecolmodel.2008.02.042; Knight CM, 2009, WILDLIFE RES, V36, P213, DOI 10.1071/WR08032; Larson SD, 2013, CAN J FISH AQUAT SCI, V70, P1498, DOI 10.1139/cjfas-2013-0025; Lucas A, 2014, AMAP ANOTHER MULTIDI; MacDonald DW, 2004, BIOLOGIA, V59, P235; Major RE, 2001, WILDLIFE RES, V28, P565, DOI 10.1071/WR01040; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Miller M. A., 2002, International Journal for Parasitology, V32, P997, DOI 10.1016/S0020-7519(02)00069-3; Mitchell MS, 2012, J MAMMAL, V93, P917, DOI 10.1644/11-MAMM-S-157.1; Monson DH, 2001, J ZOO WILDLIFE MED, V32, P181, DOI 10.1638/1042-7260(2001)032[0181:CAONSO]2.0.CO;2; Moorcroft PR, 2012, J MAMMAL, V93, P903, DOI 10.1644/11-MAMM-S-254.1; Moorcroft PR, 1999, ECOLOGY, V80, P1656, DOI 10.2307/176554; Pattison CA, 1997, SEA OTTER ENHYDRA LU; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Powell RA, 2012, J MAMMAL, V93, P948, DOI 10.1644/11-MAMM-S-177.1; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ralls K, 1996, CAN J ZOOL, V74, P1841, DOI 10.1139/z96-207; REDPATH SM, 1995, J ANIM ECOL, V64, P652, DOI 10.2307/5807; ROSE B, 1982, J HERPETOL, V16, P253, DOI 10.2307/1563718; SAIN SR, 1994, J AM STAT ASSOC, V89, P807, DOI 10.2307/2290906; Seton E.T., 1909, LIFE HIST NO ANIMALS, V1; Silverman B.W., 1986, DENSITY ESTIMATION S; Skern-Mauritzen M, 2011, MAR ECOL PROG SER, V426, P289, DOI 10.3354/meps09027; Slaght JC, 2013, J APPL ECOL, V50, P1350, DOI 10.1111/1365-2664.12143; Thomas DL, 2006, J WILDLIFE MANAGE, V70, P324, DOI 10.2193/0022-541X(2006)70[324:SDATFC]2.0.CO;2; Thometz NM, 2014, J EXP BIOL, V217, P2053, DOI 10.1242/jeb.099739; Tinker MT, 2008, ECOL APPL, V18, P1781, DOI 10.1890/07-0735.1; Tinker MT, 2008, P NATL ACAD SCI USA, V105, P560, DOI 10.1073/pnas.0709263105; Tinker MT, 2006, ECOL APPL, V16, P2293, DOI 10.1890/1051-0761(2006)016[2293:IDDARC]2.0.CO;2; Tinker MT, SEA OTTER P IN PRESS; Vanpe C, 2009, J ANIM ECOL, V78, P42, DOI 10.1111/j.1365-2656.2008.01467.x; Vokoun JC, 2003, N AM J FISH MANAGE, V23, P1020, DOI 10.1577/M02-141; Walter WD, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0039-4; Wand MP., 1994, KERNEL SMOOTHING; White G.C., 1990, ANAL WILDLIFE RADIO; WILLIAMS TD, 1983, J AM VET MED ASSOC, V183, P1290; Winnie JA, 2008, ECOLOGY, V89, P1457, DOI 10.1890/07-0772.1; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423	68	30	30	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0150547	10.1371/journal.pone.0150547	http://dx.doi.org/10.1371/journal.pone.0150547			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003710	gold, Green Published, Green Submitted			2022-12-26	WOS:000372697400016
J	Willner, M; Viermetz, M; Marschner, M; Scherer, K; Braun, C; Fingerle, A; Noel, P; Rummeny, E; Pfeiffer, F; Herzen, J				Willner, Marian; Viermetz, Manuel; Marschner, Mathias; Scherer, Kai; Braun, Christian; Fingerle, Alexander; Noel, Peter; Rummeny, Ernst; Pfeiffer, Franz; Herzen, Julia			Quantitative Three-Dimensional Imaging of Lipid, Protein, and Water Contents via X-Ray Phase-Contrast Tomography	PLOS ONE			English	Article							FATTY LIVER-DISEASE; BREAST-TISSUE CHARACTERIZATION; NEOADJUVANT CHEMOTHERAPY; GRATING INTERFEROMETER; COMPUTED-TOMOGRAPHY; HIGH-RESOLUTION; MEAT; SPECTROSCOPY; CANCER; MICROSTRUCTURE	X-ray phase-contrast computed tomography is an emerging imaging technology with powerful capabilities for three-dimensional (3D) visualization of weakly absorbing objects such as biological soft tissues. This technique is an extension of existing X-ray applications because conventional attenuation-contrast images are simultaneously acquired. The complementary information provided by both the contrast modalities suggests that enhanced material characterization is possible when performing combined data analysis. In this study, we describe how protein, lipid, and water concentrations in each 3D voxel can be quantified by vector decomposition. Experimental results of dairy products, porcine fat and rind, and different human soft tissue types are presented. The results demonstrate the potential of phase-contrast imaging as a new analysis tool. The 3D representations of protein, lipid, and water contents open up new opportunities in the fields of biology, medicine, and food science.	[Willner, Marian; Viermetz, Manuel; Marschner, Mathias; Scherer, Kai; Pfeiffer, Franz; Herzen, Julia] Tech Univ Munich, Dept Phys, Garching, Germany; [Willner, Marian; Viermetz, Manuel; Marschner, Mathias; Scherer, Kai; Pfeiffer, Franz; Herzen, Julia] Tech Univ Munich, Inst Med Engn, Garching, Germany; [Braun, Christian] Univ Munich, Inst Forens Med, Munich, Germany; [Willner, Marian; Fingerle, Alexander; Noel, Peter; Rummeny, Ernst] Tech Univ Munich, Dept Diagnost & Intervent Radiol, D-80290 Munich, Germany	Technical University of Munich; Technical University of Munich; University of Munich; Technical University of Munich	Willner, M (corresponding author), Tech Univ Munich, Dept Phys, Garching, Germany.; Willner, M (corresponding author), Tech Univ Munich, Inst Med Engn, Garching, Germany.; Willner, M (corresponding author), Tech Univ Munich, Dept Diagnost & Intervent Radiol, D-80290 Munich, Germany.	marian.willner@tum.de		Viermetz, Manuel/0000-0002-7332-1900; Noel, Peter/0000-0002-9671-6171	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP); DFG Gottfried Wilhelm Leibniz program; European Research Council (ERC) [StG 240142]; Karlsruhe Nano Micro Facility (KNMF), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT)	DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP)(German Research Foundation (DFG)); DFG Gottfried Wilhelm Leibniz program(German Research Foundation (DFG)); European Research Council (ERC)(European Research Council (ERC)); Karlsruhe Nano Micro Facility (KNMF), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT)	The authors acknowledge financial support through the DFG Cluster of Excellence Munich-Centre for Advanced Photonics (MAP), the DFG Gottfried Wilhelm Leibniz program and the European Research Council (ERC, FP7, StG 240142). M.W. further acknowledges the Graduate School of Information Science in Health (GSISH). This work was carried out with the support of the Karlsruhe Nano Micro Facility (KNMF, www.kit.edu/knmf), a Helmholtz Research Infrastructure at Karlsruhe Institute of Technology (KIT).	Afdhal NH, 2004, AM J GASTROENTEROL, V99, P1160, DOI 10.1111/j.1572-0241.2004.30110.x; Bech M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03209; Bech M, 2010, Z MED PHYS, V20, P7, DOI 10.1016/j.zemedi.2009.11.003; Bravin A, 2013, PHYS MED BIOL, V58, pR1, DOI 10.1088/0031-9155/58/1/R1; Cerussi A, 2007, P NATL ACAD SCI USA, V104, P4014, DOI 10.1073/pnas.0611058104; COLMENERO FJ, 1995, LEBENSM WISS TECHNOL, V28, P481, DOI DOI 10.1006/FSTL.1995.0081; Ding HJ, 2014, RADIOLOGY, V272, P731, DOI 10.1148/radiol.14132732; Donath T, 2010, INVEST RADIOL, V45, P445, DOI 10.1097/RLI.0b013e3181e21866; Einarsdottir H, 2014, INNOV FOOD SCI EMERG, V24, P88, DOI 10.1016/j.ifset.2013.11.003; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Frisullo P, 2009, J FOOD ENG, V94, P283, DOI 10.1016/j.jfoodeng.2009.03.020; Guinee TP, 2013, J DAIRY SCI, V96, P6830, DOI 10.3168/jds.2013-6685; Haka AS, 2005, P NATL ACAD SCI USA, V102, P12371, DOI 10.1073/pnas.0501390102; Herzen J, 2009, OPT EXPRESS, V17, P10010, DOI 10.1364/OE.17.010010; Holme MN, 2014, NAT PROTOC, V9, P1401, DOI 10.1038/nprot.2014.091; Janhoj T, 2006, J TEXTURE STUD, V37, P276, DOI 10.1111/j.1745-4603.2006.00052.x; Kalender WA, 2012, EUR RADIOL, V22, P1, DOI 10.1007/s00330-011-2169-4; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Ligabue G, 2013, QUANT IMAGING MED SU, V3, P192, DOI 10.3978/j.issn.2223-4292.2013.08.01; Machann J, 2003, J MAGN RESON IMAGING, V17, P350, DOI 10.1002/jmri.10255; O'Sullivan A, 1999, INT J DAIRY TECHNOL, V52, P139, DOI 10.1111/j.1471-0307.1999.tb02856.x; Pfeiffer F, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108105; Pfeiffer F, 2006, NAT PHYS, V2, P258, DOI 10.1038/nphys265; Prieto N, 2009, MEAT SCI, V83, P175, DOI 10.1016/j.meatsci.2009.04.016; Reeder SB, 2011, J MAGN RESON IMAGING, V34, P729, DOI 10.1002/jmri.22580; Schreuder TCMA, 2008, WORLD J GASTROENTERO, V14, P2474, DOI 10.3748/wjg.14.2474; Tapfer A, 2012, P NATL ACAD SCI USA, V109, P15691, DOI 10.1073/pnas.1207503109; Togersen G, 1999, MEAT SCI, V51, P97, DOI 10.1016/S0309-1740(98)00106-5; Tromberg BJ, 2005, BREAST CANCER RES, V7, P279, DOI 10.1186/bcr1358; Weitkamp T, 2005, OPT EXPRESS, V13, P6296, DOI 10.1364/OPEX.13.006296; Willner M, 2014, PHYS MED BIOL, V59, P1557, DOI 10.1088/0031-9155/59/7/1557; Willner M, 2013, OPT EXPRESS, V21, P4155, DOI 10.1364/OE.21.004155; WOODARD HQ, 1986, BRIT J RADIOL, V59, P1209, DOI 10.1259/0007-1285-59-708-1209; Wu MG, 2009, J FOOD SCI, V74, pE207, DOI 10.1111/j.1750-3841.2009.01140.x; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Youssef MK, 2010, J FOOD SCI, V75, pS108, DOI 10.1111/j.1750-3841.2009.01475.x; Zanette I, 2011, PHYS STATUS SOLIDI A, V208, P2526, DOI 10.1002/pssa.201184276; Zanette I, 2013, RSC ADV, V3, P19816, DOI 10.1039/c3ra41372a; Zhao YZ, 2012, P NATL ACAD SCI USA, V109, P18290, DOI 10.1073/pnas.1204460109	40	13	13	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151889	10.1371/journal.pone.0151889	http://dx.doi.org/10.1371/journal.pone.0151889			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003308	Green Published, gold			2022-12-26	WOS:000372697400054
J	Gao, XN; Huang, QL; Zhao, ZB; Han, QM; Ke, XW; Qin, HQ; Huang, LL				Gao, Xiaoning; Huang, Qiling; Zhao, Zhibo; Han, Qingmei; Ke, Xiwang; Qin, Huqiang; Huang, Lili			Studies on the Infection, Colonization, and Movement of Pseudomonas syringae pv. actinidiae in Kiwifruit Tissues Using a GFPuv-Labeled Strain	PLOS ONE			English	Article							BACTERIAL CANKER; REAL-TIME; EPIDEMICS; PCR	Kiwifruit bacterial canker, an economically important disease caused by Pseudomonas syringae pv. actinidiae (Psa), has caused severe losses in all major areas of kiwifruit cultivation. Using a GFPuv-labeled strain of Psa, we monitored the invasion, colonization, and movement of the pathogen in kiwifruit twigs, leaves and veins. The pathogen can invade twigs through both wounds and natural openings; the highest number of Psa is obtained in cut tissues. We determined that, following spray inoculation, Psa-GFPuv could infect leaves and cause lesions in the presence and absence of wounds. Light and transmission electron microscopic observations showed that bacterial cells colonize both phloem and xylem vessels. Bacterial infection resulted in marked alterations of host tissues including the disintegration of organelles and degeneration of protoplasts and cell walls. Furthermore, low temperature was conducive to colonization and movement of Psa-GFPuv in kiwifruit tissues. Indeed, the pathogen migrated faster at 4 degrees C than at 16 degrees C or 25 degrees C in twigs. However, the optimum temperature for colonization and movement of Psa in leaf veins was 16 degrees C. Our results, revealing a better understanding of the Psa infection process, might contribute to develop more efficacious disease management strategies.	[Gao, Xiaoning; Huang, Qiling; Zhao, Zhibo; Han, Qingmei; Ke, Xiwang; Qin, Huqiang; Huang, Lili] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China; [Gao, Xiaoning; Huang, Qiling; Zhao, Zhibo; Han, Qingmei; Ke, Xiwang; Qin, Huqiang; Huang, Lili] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Huang, LL (corresponding author), Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China.	huanglili@nwsuaf.edu.cn	Zhao, Zhibo/AAA-3701-2020	Zhao, Zhibo/0000-0001-5043-1384	Fundamental Research Funds for the Central Universities of China [QN2013007]; Natural Science Basic Research Plan in Shaanxi Province of China [2014JQ2-3011]; Education Ministry of China [B07049]	Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Natural Science Basic Research Plan in Shaanxi Province of China; Education Ministry of China(Ministry of Education, China)	This study was supported by the Fundamental Research Funds for the Central Universities of China (No. QN2013007), Natural Science Basic Research Plan in Shaanxi Province of China (No. 2014JQ2-3011), and the 111 project from the Education Ministry of China (No. B07049).	Balestra GM, 2009, AUSTRALAS PLANT DIS, V4, P34, DOI 10.1071/DN09014; Biondi E, 2013, ANN APPL BIOL, V162, P60, DOI 10.1111/aab.12001; Butler MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057464; Cameron A, 2014, PLANT PATHOL, V63, P1, DOI 10.1111/ppa.12066; COLLMER A, 1986, ANNU REV PHYTOPATHOL, V24, P383, DOI 10.1146/annurev.py.24.090186.002123; Donati I, 2014, J BERRY RES, V4, P53, DOI 10.3233/JBR-140073; Everett KR, 2011, AUSTRALAS PLANT DIS, V6, P67, DOI 10.1007/s13314-011-0023-9; Ferrante P, 2015, EUR J PLANT PATHOL, V142, P677, DOI 10.1007/s10658-015-0643-6; Ferrante P, 2015, PLANT PATHOL, V64, P51, DOI 10.1111/ppa.12236; Ferrante P, 2012, J PLANT PATHOL, V94, P455; Froud K. J., 2015, New Zealand Plant Protection, V68, P313; Gallelli A, 2014, PLANT PATHOL, V63, P264, DOI 10.1111/ppa.12082; Gallelli A, 2011, J PLANT PATHOL, V93, P425; [黄其玲 Huang Qiling], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P282; Kang ZS, 2000, MYCOL RES, V104, P1083, DOI 10.1017/S0953756200002495; Ke XW, 2013, AUSTRALAS PLANT PATH, V42, P85, DOI 10.1007/s13313-012-0158-y; Koh Y., 1994, KOREAN J PLANT PATHO, V10, P68; Koh YoungJin, 1996, Korean Journal of Plant Pathology, V12, P324; [刘丽珍 Liu Lizhen], 2007, [灾害学, Journal of Catastrophology], V22, P91; Mazzaglia A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036518; Mazzaglia A, 2011, CAN J PLANT PATHOL, V33, P8, DOI 10.1080/07060661.2010.538556; McCann HC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003503; Qin HuQiang, 2013, Acta Phytophylacica Sinica, V40, P225; Rees-George J, 2010, PLANT PATHOL, V59, P453, DOI 10.1111/j.1365-3059.2010.02259.x; Renzi M, 2012, PHYTOPATHOLOGY, V102, P827, DOI 10.1094/PHYTO-02-12-0019-R; SCORTICHINI M, 1994, PLANT PATHOL, V43, P1035, DOI 10.1111/j.1365-3059.1994.tb01654.x; Scortichini M, 2012, MOL PLANT PATHOL, V13, P631, DOI 10.1111/j.1364-3703.2012.00788.x; SERIZAWA S, 1989, Annals of the Phytopathological Society of Japan, V55, P427, DOI 10.3186/jjphytopath.55.427; Serizawa S, 1993, ANN PHYTOPATHOL SOC, V60, P237; Serizawa Setsuo, 1993, Annals of the Phytopathological Society of Japan, V59, P694, DOI 10.3186/jjphytopath.59.694; Serizawa Setsuo, 1993, Annals of the Phytopathological Society of Japan, V59, P469, DOI 10.3186/jjphytopath.59.469; Serizawa Setsuo, 1993, Annals of the Phytopathological Society of Japan, V59, P452, DOI 10.3186/jjphytopath.59.452; Serizawa Setsuo, 1993, Annals of the Phytopathological Society of Japan, V59, P460, DOI 10.3186/jjphytopath.59.460; Spinelli F, 2011, ACTA HORTIC, P461, DOI 10.17660/ActaHortic.2011.913.61; TAKIKAWA Y, 1989, Annals of the Phytopathological Society of Japan, V55, P437, DOI 10.3186/jjphytopath.55.437; Vanneste JL, 2013, PLANT DIS, V97, P708, DOI 10.1094/PDIS-07-12-0700-RE; Vanneste JL, 2012, NEW ZEAL J CROP HORT, V40, P265, DOI 10.1080/01140671.2012.736084; Vanneste J. L., 2010, New Zealand Plant Protection, V63, P7; von Bodman SB, 2003, ANNU REV PHYTOPATHOL, V41, P455, DOI 10.1146/annurev.phyto.41.052002.095652; Wang ZS., 1992, J SW AGR U SCI CHINA, V6, P500; Young JM, 2012, J PLANT PATHOLOGY S, V1, pS15; Zhao ZB, 2013, J PLANT PATHOL, V95, P155; Zhao ZB, 2015, CROP PROT, V75, P55, DOI 10.1016/j.cropro.2015.05.008	43	31	35	5	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151169	10.1371/journal.pone.0151169	http://dx.doi.org/10.1371/journal.pone.0151169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999596	Green Published, Green Submitted, gold			2022-12-26	WOS:000372694700024
J	Giesbrecht, CJ; O'Rourke, N; Leonova, O; Strehlau, V; Paquet, K; Vila-Rodriguez, F; Panenka, WJ; MacEwan, GW; Smith, GN; Thornton, AE; Honer, WG				Giesbrecht, Chantelle J.; O'Rourke, Norm; Leonova, Olga; Strehlau, Verena; Paquet, Karine; Vila-Rodriguez, Fidel; Panenka, William J.; MacEwan, G. William; Smith, Geoffrey N.; Thornton, Allen E.; Honer, William G.			The Positive and Negative Syndrome Scale (PANSS): A Three-Factor Model of Psychopathology in Marginally Housed Persons with Substance Dependence and Psychiatric Illness	PLOS ONE			English	Article							CONFIRMATORY FACTOR-ANALYSIS; MENTAL-DISORDERS; 5-FACTOR MODEL; SCHIZOPHRENIA; HOMELESS; PREVALENCE; SYMPTOMS; VALIDITY; ADULTS; TIME	Rates of psychopathology are elevated in marginalized and unstably housed persons, underscoring the need for applicable clinical measures for these populations. The Positive and Negative Syndrome Scale (PANSS) is a clinical instrument principally developed for use in schizophrenia to identify the presence and severity of psychopathology symptoms. The current study investigates whether a reliable and valid PANSS factor structure emerges in a marginally housed, heterogeneous sample recruited from the Downtown Eastside of Vancouver where substance use disorders and psychiatric illness are pervasive. Participants (n = 270) underwent structured clinical assessments including the PANSS and then were randomly assigned to either exploratory (EFA) or confirmatory factor analytic (CFA) subsamples. EFA pointed to a novel three factor PANSS. This solution was supported by CFA. All retained items (28 out of 30) load significantly upon hypothesized factors and model goodness of fit analyses are in the acceptable to good range. Each of the three firstorder factor constructs, labeled Psychosis/Disorganized, Negative Symptoms/Hostility, and Insight/Awareness, contributed significantly to measurement of a higher-order psychopathology construct. Further, the latent structure of this 3-factor solution appears temporally consistent over one-year. This PANSS factor structure appears valid and reliable for use in persons with multimorbidity, including substance use disorders. The structure is somewhat distinct from existing solutions likely due to the unique characteristics of this marginally housed sample.	[Giesbrecht, Chantelle J.; Thornton, Allen E.] Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada; [O'Rourke, Norm] Ben Gurion Univ Negev, Dept Publ Hlth, IL-84105 Beer Sheva, Israel; [O'Rourke, Norm] Ben Gurion Univ Negev, Ctr Multidisciplinary Res Aging, IL-84105 Beer Sheva, Israel; [Leonova, Olga; Strehlau, Verena; Paquet, Karine; Vila-Rodriguez, Fidel; Panenka, William J.; MacEwan, G. William; Smith, Geoffrey N.; Honer, William G.] Univ British Columbia, Dept Psychiat, Vancouver, BC, Canada; [Paquet, Karine] Inst Univ Sante Mentale Quebec, Montreal, PQ, Canada	Simon Fraser University; Ben Gurion University; Ben Gurion University; University of British Columbia	Thornton, AE (corresponding author), Simon Fraser Univ, Dept Psychol, Burnaby, BC V5A 1S6, Canada.	aethornt@sfu.ca	O'Rourke, Norm/AAP-5428-2020; Vila, Fidel/L-3463-2019	O'Rourke, Norm/0000-0001-5100-427X; Vila, Fidel/0000-0002-8273-8820; Panenka, William/0000-0001-7143-6512; Thornton, Allen/0000-0002-9942-0122	Canadian Institute of Health Research [CBG-101827]; BC Mental Health and Addictions Services; William and Ada Isabelle Steel Fund	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); BC Mental Health and Addictions Services; William and Ada Isabelle Steel Fund	This research was funded by a grant from the Canadian Institute of Health Research (CBG-101827 to WGH, GNS, AET); BC Mental Health and Addictions Services (to WGH); and the William and Ada Isabelle Steel Fund (to AET, WGH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Benoit C, 2003, SOC SCI MED, V56, P821, DOI 10.1016/S0277-9536(02)00081-3; Bryson G, 1999, SCHIZOPHR RES, V38, P27, DOI 10.1016/S0920-9964(99)00004-3; Byrne BM, 2004, STRUCT EQU MODELING, V11, P272, DOI 10.1207/s15328007sem1102_8; BYRNE BM, 1989, PSYCHOL BULL, V105, P456, DOI 10.1037/0033-2909.105.3.456; Chou PHB, 2012, AGING MENT HEALTH, V16, P145, DOI 10.1080/13607863.2011.602962; Citrome L, 2011, SCHIZOPHR RES, V131, P75, DOI 10.1016/j.schres.2011.05.018; Clark LA, 1995, PSYCHOL ASSESSMENT, V7, P309, DOI 10.1037/1040-3590.7.3.309; Council on Welfare, 2010, NAT COUNC WELF REP; Daneluzzo E, 2002, SCHIZOPHR RES, V56, P129, DOI 10.1016/S0920-9964(01)00277-8; DeVellis R., 2011, SCALE DEV THEORY APP, VXXVI; Eisenberg DP, 2009, PSYCHOPATHOLOGY, V42, P242, DOI 10.1159/000218522; Emsley R, 2003, SCHIZOPHR RES, V61, P47, DOI 10.1016/S0920-9964(02)00302-X; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; Folsom D, 2002, ACTA PSYCHIAT SCAND, V105, P404, DOI 10.1034/j.1600-0447.2002.02209.x; Gicas KM, 2014, J CLIN EXP NEUROPSYC, V36, P1009, DOI 10.1080/13803395.2014.963519; GOLDMAN HH, 1992, AM J PSYCHIAT, V149, P1148; Gomez R, 2014, J PSYCHOPATHOL BEHAV, V36, P308, DOI 10.1007/s10862-013-9391-0; Hall CS, 2004, J GEN INTERN MED, V19, P357, DOI 10.1111/j.1525-1497.2004.30613.x; Jones AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079754; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Koegel P, 1999, MED CARE, V37, P306, DOI 10.1097/00005650-199903000-00010; Loranger A. W, 1999, INT PERSONALITY DISO; Meade AW, 2005, INT J TEST, V5, P279, DOI 10.1207/s15327574ijt0503_6; ORourke Norm, 2013, STEP BY STEP APPROAC; Rapado-Castro M, 2010, J CLIN PSYCHIAT, V71, P327, DOI 10.4088/JCP.08m04845yel; Reichenberg A, 2005, J ABNORM PSYCHOL, V114, P363, DOI 10.1037/0021-843X.114.3.363; Robertson MJ, 2004, AM J PUBLIC HEALTH, V94, P1207, DOI 10.2105/AJPH.94.7.1207; Roe RA, 2014, EUR J WORK ORGAN PSY, V23, P754, DOI 10.1080/1359432X.2013.804177; Stefanovics EA, 2014, COMPR PSYCHIAT, V55, P887, DOI 10.1016/j.comppsych.2014.01.014; Tsai J, 2011, J COMMUNITY PSYCHOL, V39, P76, DOI 10.1002/jcop.20418; Van den Oord EJCG, 2006, SCHIZOPHR RES, V82, P213, DOI 10.1016/j.schres.2005.09.002; van der Gaag M, 2006, SCHIZOPHR RES, V85, P273, DOI 10.1016/j.schres.2006.04.001; Vazquez C, 1997, ACTA PSYCHIAT SCAND, V95, P523, DOI 10.1111/j.1600-0447.1997.tb10141.x; Vila-Rodriguez F, 2013, AM J PSYCHIAT, V170, P1413, DOI 10.1176/appi.ajp.2013.12111439; Wallwork RS, 2012, SCHIZOPHR RES, V137, P246, DOI 10.1016/j.schres.2012.01.031; White L, 1997, PSYCHOPATHOLOGY, V30, P263, DOI 10.1159/000285058	39	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151648	10.1371/journal.pone.0151648	http://dx.doi.org/10.1371/journal.pone.0151648			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3NW	26999280	Green Published, gold, Green Submitted			2022-12-26	WOS:000372694700050
J	Leone, DA; Kozakowski, N; Kornauth, C; Waidacher, T; Neudert, B; Loeffler, AG; Haitel, A; Rees, AJ; Kain, R				Leone, Dario A.; Kozakowski, Nicolas; Kornauth, Christoph; Waidacher, Theresa; Neudert, Barbara; Loeffler, Agnes G.; Haitel, Andrea; Rees, Andrew J.; Kain, Renate			The Phenotypic Characterization of the Human Renal Mononuclear Phagocytes Reveal a Co-Ordinated Response to Injury	PLOS ONE			English	Article							DENDRITIC CELL SUBSETS; GENE-EXPRESSION; IMMUNE-SYSTEM; MACROPHAGES; KIDNEY; MONOCYTES; TISSUE; RESIDENT; ORIGINS; POPULATION	Mammalian tissues contain networks of mononuclear phagocytes (MPh) that sense injury and orchestrate the response to it. In mice, this is affected by distinct populations of dendritic cells (DC), monocytes and macrophages and recent studies suggest the same is true for human skin and intestine but little is known about the kidney. Here we describe the analysis of MPh populations in five human kidneys and show they are highly heterogeneous and contain discrete populations of DC, monocytes and macrophages. These include: plasmacytoid DC (CD303(+)) and both types of conventional DC-cDC1 (CD141(+) cells) and CD2 (CD1c(+) cells); classical, non-classical and intermediate monocytes; and macrophages including a novel population of CD141(+) macrophages clearly distinguishable from cDC1 cells. The relative size of the MPh populations differed between kidneys: the pDC population was bi-modally distributed being less than 2% of DC in two kidneys without severe injury and over 35% in the remaining three with low grade injury in the absence of morphological evidence of inflammation. There were profound differences in the other MPh populations in kidneys with high and low numbers of pDC. Thus, cDC1 cells were abundant (55 and 52.3%) when pDC were sparse and sparse (12.8-12.5%) when pDC were abundant, whereas the proportions of cDC2 cells and classical monocytes increased slightly in pDC high kidneys. We conclude that MPh are highly heterogeneous in human kidneys and that pDC infiltration indicative of low-grade injury does not occur in isolation but is part of a coordinated response affecting all renal DC, monocyte and macrophage populations.	[Leone, Dario A.; Kozakowski, Nicolas; Kornauth, Christoph; Waidacher, Theresa; Neudert, Barbara; Haitel, Andrea; Rees, Andrew J.; Kain, Renate] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria; [Loeffler, Agnes G.] Univ Wisconsin, Surg Pathol, Madison, WI USA	Medical University of Vienna; University of Wisconsin System; University of Wisconsin Madison	Leone, DA (corresponding author), Med Univ Vienna, Clin Inst Pathol, Vienna, Austria.	dario.leone@meduniwien.ac.at; renate.kain@meduniwien.ac.at	Kozakowski, Nicolas/I-1005-2019; Kain, Renate/ACR-4709-2022; Kornauth, Christoph/AAA-3935-2022	Kozakowski, Nicolas/0000-0001-9180-620X; Kain, Renate/0000-0002-2428-543X; Kornauth, Christoph/0000-0003-0443-3498; Leone, Dario Armando/0000-0002-4103-670X	European Union [261382, 238756]; Vienna Science and Technology Fund (WWTF) [LS09-75]	European Union(European Commission); Vienna Science and Technology Fund (WWTF)	The research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreements no 261382 (INTRICATE) and no 238756 (TranSVIR) and was supported by the Vienna Science and Technology Fund (WWTF) project Nr LS09-75.	Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Batal I, 2015, J AM SOC NEPHROLOGY; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Breton G, 2015, J EXP MED, V212, P401, DOI 10.1084/jem.20141441; Cao Q, 2015, J AM SOC NEPHROL, V26, P349, DOI 10.1681/ASN.2013121336; Cavanagh LL, 2002, IMMUNOL CELL BIOL, V80, P448, DOI 10.1046/j.1440-1711.2002.01119.x; Duffield JS, 2011, J AM SOC NEPHROL, V22, P199, DOI 10.1681/ASN.2010121301; Ferenbach D, 2008, KIDNEY INT, V74, P5, DOI 10.1038/ki.2008.189; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Haniffa M, 2012, IMMUNITY, V37, P60, DOI 10.1016/j.immuni.2012.04.012; HART DNJ, 1981, TRANSPLANTATION, V31, P318, DOI 10.1097/00007890-198105010-00003; Heath WR, 2013, NAT IMMUNOL, V14, P978, DOI 10.1038/ni.2680; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Hijdra D, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00339; Howe R, 2009, CLIN IMMUNOL, V131, P317, DOI 10.1016/j.clim.2008.12.003; Iqbal AJ, 2014, BLOOD, V124, pE33, DOI 10.1182/blood-2014-04-568691; John R, 2007, J AM SOC NEPHROL, V18, P2628, DOI 10.1681/ASN.2007030273; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Kassianos AJ, 2013, AM J PHYSIOL-RENAL, V305, pF1391, DOI 10.1152/ajprenal.00318.2013; Kawakami T, 2013, J IMMUNOL, V191, P3358, DOI 10.4049/jimmunol.1300342; Kruger T, 2004, J AM SOC NEPHROL, V15, P613, DOI 10.1097/01.ASN.0000114553.36258.91; Kurts C, 2013, NAT REV IMMUNOL, V13, P738, DOI 10.1038/nri3523; Lee J, 2015, J EXP MED, V212, P385, DOI 10.1084/jem.20141442; Lin SL, 2009, J IMMUNOL, V183, P6733, DOI 10.4049/jimmunol.0901473; McCarthy NE, 2007, CLIN EXP ALLERGY, V37, P72, DOI 10.1111/j.1365-2222.2006.02631.x; McGovern N, 2014, IMMUNITY, V41, P465, DOI 10.1016/j.immuni.2014.08.006; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Nelson PJ, 2012, J AM SOC NEPHROL, V23, P194, DOI 10.1681/ASN.2011070680; Ozaki KS, 2012, KIDNEY INT, V81, P1015, DOI 10.1038/ki.2011.458; Pindjakova J, 2013, J AM SOC NEPHROL, V24, P519, DOI 10.1681/ASN.2013020164; Rogers NM, 2014, NAT REV NEPHROL, V10, P625, DOI 10.1038/nrneph.2014.170; Segerer S, 2008, KIDNEY INT, V74, P37, DOI 10.1038/ki.2008.99; Segura E, 2012, J EXP MED, V209, P653, DOI 10.1084/jem.20111457; Soos TJ, 2006, CX3CR1 INTERSTITIAL; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Teteris SA, 2011, KIDNEY INT, V80, P140, DOI 10.1038/ki.2011.129; Teteris SA, 2012, NEPHROLOGY, V17, P364, DOI 10.1111/j.1440-1797.2012.01581.x; Vigl B, 2011, BLOOD, V118, P205, DOI 10.1182/blood-2010-12-326447; Villadangos JA, 2010, J EXP MED, V207, P1131, DOI 10.1084/jem.20100985; Woltman AM, 2007, KIDNEY INT, V71, P1001, DOI 10.1038/sj.ki.5002187; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Ziegler-Heitbrock L, 2013, FRONTIERS IMMUNOLOGY, P4; Zuidwijk K, 2012, KIDNEY INT, V81, P64, DOI 10.1038/ki.2011.289	48	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151674	10.1371/journal.pone.0151674	http://dx.doi.org/10.1371/journal.pone.0151674			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999595	Green Published, gold, Green Submitted			2022-12-26	WOS:000372694700054
J	Lin, YW; Hussain, M; Avery, PB; Qasim, M; Fang, DL; Wang, LD				Lin, Yongwen; Hussain, Mubasher; Avery, Pasco Bruce; Qasim, Muhammad; Fang, Dalin; Wang, Liande			Volatiles from Plants Induced by Multiple Aphid Attacks Promote Conidial Performance of Lecanicillium lecanii	PLOS ONE			English	Article							METARHIZIUM-ANISOPLIAE; SPORE GERMINATION; FIELD-EVALUATION; PATHOGENICITY; APPRESSORIA; RESPONSES; ECOLOGY; DEFENSE; ARTHROPODS; BEHAVIOR	Herbivore-induced plant volatiles (HIPVs) are clues that help predatory insects search for food. The hypothesis that entomopathogenic fungi, which protect plants, benefit from the release of HIPVs was tested. The plant Arabidopsis thaliana was used as the source of HIPVs. The insect herbivore Lipaphis erysimi (Kaltenbach) was used as the inducer, and the fungal pathogen of the aphid Lecanicillium lecanii was exposed to HIPVs to test our hypothesis. When exposed to aphid-induced A. thaliana volatiles, the mortality of aphids pre-treated with a conidial suspension of L. lecanii, the conidial germination and the appressorial formation were significantly increased compared with the control. The decan-3-ol and 4-methylpentyl isothiocyanate that were detected in the headspace seemed to have positive and negative affection, respectively. Moreover, HIPVs generated from groups of eight aphids per plant promoted significantly increased conidial germination and appressorial formation compared with HIPVs from groups of one, two and four aphids per plant. Our results demonstrated that the pathogenicity of the entomopathogenic fungus L. lecanii was enhanced when exposed to HIPVs and that the HIPVs were affected by the number of insect herbivores that induced them.	[Lin, Yongwen; Hussain, Mubasher; Qasim, Muhammad; Fang, Dalin; Wang, Liande] Fujian Agr & Forestry Univ, Coll Plant Protect, Fuzhou, Peoples R China; [Lin, Yongwen; Hussain, Mubasher; Qasim, Muhammad; Fang, Dalin; Wang, Liande] Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Peoples R China; [Lin, Yongwen; Hussain, Mubasher] Minist Agr, Key Lab Integrated Pest Management Fujian Taiwan, Fuzhou, Peoples R China; [Avery, Pasco Bruce] Univ Florida, Indian River Res & Educ Ctr, Inst Food & Agr Sci, Ft Pierce, FL USA	Fujian Agriculture & Forestry University; Ministry of Agriculture & Rural Affairs; State University System of Florida; University of Florida	Wang, LD (corresponding author), Fujian Agr & Forestry Univ, Coll Plant Protect, Fuzhou, Peoples R China.; Wang, LD (corresponding author), Minist Educ, Key Lab Biopesticide & Chem Biol, Fuzhou, Peoples R China.	wang_liande@126.com	Hussain, Mubasher/N-8785-2017; Qasim, Muhammad/T-9636-2019; Qasim, Muhammad/R-2570-2019	Hussain, Mubasher/0000-0003-0833-7399; Qasim, Muhammad/0000-0002-8063-9140; Wang, Liande/0000-0001-8395-7243	National Nature Science Foundation of China (NSFC) [31371998]; Research Fund for the Doctoral Program of Higher Education of China [20123515110003]	National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	Funding provided by National Nature Science Foundation of China (NSFC) with grant number 31371998(http://www.nsfc.gov.cn/), LDW received the funding and Research Fund for the Doctoral Program of Higher Education of China with grant number 20123515110003(http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm), LDW received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura G, 2005, BBA-MOL CELL BIOL L, V1734, P91, DOI 10.1016/j.bbalip.2005.03.001; Askary H, 1999, J INVERTEBR PATHOL, V74, P1, DOI 10.1006/jipa.1999.4857; Baldwin IT, 2002, CURR OPIN PLANT BIOL, V5, P351, DOI 10.1016/S1369-5266(02)00263-7; Braasch J, 2012, J CHEM ECOL, V38, P1264, DOI 10.1007/s10886-012-0202-y; Bramley GN, 2001, J CHEM ECOL, V27, P1029, DOI 10.1023/A:1010399322861; Brown GC, 1995, ENVIRON ENTOMOL, V24, P1637, DOI 10.1093/ee/24.6.1637; BUTT TM, 1995, MYCOL RES, V99, P945, DOI 10.1016/S0953-7562(09)80754-5; Gonzalez LC, 2012, J FOOD AGRIC ENVIRON, V10, P1142; Chakraborty U, 1995, FOLIA MICROBIOL, V40, P159, DOI 10.1007/BF02815415; Chung SH, 2013, P NATL ACAD SCI USA, V110, P15728, DOI 10.1073/pnas.1308867110; Cory JS, 2006, TRENDS ECOL EVOL, V21, P278, DOI 10.1016/j.tree.2006.02.005; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Truong DH, 2014, ARTHROPOD-PLANT INTE, V8, P317, DOI 10.1007/s11829-014-9311-6; Ekesi S, 2000, BIOCONTROL, V45, P79, DOI 10.1023/A:1009927302916; Elliot SL, 2000, ECOL LETT, V3, P228; Erb M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7273; Farquharson KL, 2008, PLANT CELL, V20, P244, DOI 10.1105/tpc.108.200210; Frost CJ, 2008, PLANT PHYSIOL, V146, P818, DOI 10.1104/pp.107.113027; Gachomo EW, 2010, MOL BIOL REP, V37, P3583, DOI 10.1007/s11033-010-0007-4; Ganassi S, 2010, BIOCONTROL, V55, P299, DOI 10.1007/s10526-009-9250-9; Gourgues M, 2004, MOL MICROBIOL, V51, P619, DOI 10.1046/j.1365-2958.2003.03866.x; HALL RA, 1976, J INVERTEBR PATHOL, V27, P41, DOI 10.1016/0022-2011(76)90026-4; HASSAN AEM, 1989, J INVERTEBR PATHOL, V54, P277, DOI 10.1016/0022-2011(89)90040-2; Hatzipapas P, 2002, MYCOL RES, V106, P1349, DOI 10.1017/S0953756202006792; Hountondji FCC, 2010, TRENDS IN ACAROLOGY, P249, DOI 10.1007/978-90-481-9837-5_40; Hountondji FCC, 2005, J CHEM ECOL, V31, P1003, DOI 10.1007/s10886-005-4244-2; Ishiwari H, 2007, J CHEM ECOL, V33, P1670, DOI 10.1007/s10886-007-9344-8; James DG, 2005, J CHEM ECOL, V31, P481, DOI 10.1007/s10886-005-2020-y; Jones VP, 2011, BIOL CONTROL, V56, P98, DOI 10.1016/j.biocontrol.2010.10.001; Kaplan I, 2012, BIOL CONTROL, V60, P77, DOI 10.1016/j.biocontrol.2011.10.017; Khan ZR, 2008, BIOL CONTROL, V45, P210, DOI 10.1016/j.biocontrol.2007.11.009; Lins JC, 2014, BIOCONTROL, V59, P707, DOI 10.1007/s10526-014-9602-y; Orre GUS, 2010, BIOL CONTROL, V53, P62, DOI 10.1016/j.biocontrol.2009.10.010; Perez-Hedo M, 2015, BIOL CONTROL, V86, P46, DOI 10.1016/j.biocontrol.2015.04.006; Pierik R, 2014, PLANT CELL ENVIRON, V37, P1845, DOI 10.1111/pce.12330; Pineda A, 2013, PLANT CELL ENVIRON, V36, P393, DOI 10.1111/j.1365-3040.2012.02581.x; Quintana-Rodriguez E, 2015, J ECOL, V103, P250, DOI 10.1111/1365-2745.12340; Rodriguez-Saona CR, 2010, PLANT SIGNAL BEHAV, V5, P58, DOI 10.4161/psb.5.1.10160; Rodriguez-Saona CR, 2009, J CHEM ECOL, V35, P163, DOI 10.1007/s10886-008-9579-z; Salamanca J, 2015, BIOL CONTROL, V80, P103, DOI 10.1016/j.biocontrol.2014.10.003; Savchenko T, 2013, PLANT J, V73, P653, DOI 10.1111/tpj.12064; Schwartzberg EG, 2014, FUNCT ECOL, V28, P386, DOI 10.1111/1365-2435.12182; Spence C, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-130; Tajul MI, 2012, EUR J PLANT PATHOL, V132, P91, DOI 10.1007/s10658-011-9851-x; Takano Y, 2001, MOL PLANT MICROBE IN, V14, P1149, DOI 10.1094/MPMI.2001.14.10.1149; Tamiru A, 2015, CAN J ZOOL, V93, P281, DOI 10.1139/cjz-2014-0266; Tan XL, 2014, ENTOMOL EXP APPL, V151, P259, DOI 10.1111/eea.12190; Uefune M, 2013, BIOCONTROL, V58, P187, DOI 10.1007/s10526-012-9483-x; van Veen FJF, 2015, CURR OPIN INSECT SCI, V8, P29, DOI 10.1016/j.cois.2015.02.009; Venkatesan R, 2015, J INDIAN I SCI, V95, P25; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Wang CS, 2007, J BIOL CHEM, V282, P21110, DOI 10.1074/jbc.M609592200; Wang L, 2005, J APPL ENTOMOL, V129, P32, DOI 10.1111/j.1439-0418.2005.00929.x; Weber RWS, 2001, PROTOPLASMA, V216, P101, DOI 10.1007/BF02680137; Yoneya K, 2014, PLANT BIOTECHNOL-NAR, V31, P409, DOI 10.5511/plantbiotechnology.14.0827a	55	28	29	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151844	10.1371/journal.pone.0151844	http://dx.doi.org/10.1371/journal.pone.0151844			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999795	Green Published, gold, Green Submitted			2022-12-26	WOS:000372694700072
J	Marcus, SA; Sidiropoulos, SW; Steinberg, H; Talaat, AM				Marcus, Sarah A.; Sidiropoulos, Sarah W.; Steinberg, Howard; Talaat, Adel M.			CsoR Is Essential for Maintaining Copper Homeostasis in Mycobacterium tuberculosis	PLOS ONE			English	Article							CONTAINING PHAGOSOMES; HYPOXIC RESPONSE; NITRIC-OXIDE; RESISTANCE; EXPRESSION; TRANSPORT; VIRULENCE; SYSTEM; GALAXY; OXYGEN	Mycobacterium tuberculosis, a pathogen infecting one third of the world population, faces numerous challenges within the host, including high levels of copper. We have previously shown that M. tuberculosis CsoR is a copper inducible transcriptional regulator. Here we examined the hypothesis that csoR is necessary for maintaining copper homeostasis and surviving under various stress conditions. With an unmarked csoR knockout strain, we were able to characterize the role of csoR in M. tuberculosis as it faced copper and host stress. Growth under high levels of copper demonstrated that M. tuberculosis survives copper stress significantly better in the absence of csoR. Yet under minimal levels of copper, differential expression analysis revealed that the loss of csoR results in a cell wide hypoxia-type stress response with the induction of the DosR regulon. Despite the stress placed on M. tuberculosis by the loss of csoR, survival of the knockout strain was increased compared to wild type during the early chronic stages of mouse infection, suggesting that csoR could play an active role in modulating M. tuberculosis fitness within the host. Overall, analysis of CsoR provided an increased understanding of the M. tuberculosis copper response with implications for other intracellular pathogens harboring CsoR.	[Marcus, Sarah A.; Sidiropoulos, Sarah W.; Steinberg, Howard; Talaat, Adel M.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Sidiropoulos, Sarah W.] Oakland Community Coll, Auburn Hills, MI USA	University of Wisconsin System; University of Wisconsin Madison	Talaat, AM (corresponding author), Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.	atalaat@wisc.edu		Marcus, Sarah/0000-0002-3795-0806	National Institutes of Health [R21AI090308]; University of Wisconsin-Madison Graduate School [MSN174746]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090308] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin-Madison Graduate School; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work in this report was supported by National Institutes of Health grant R21AI090308 and the University of Wisconsin-Madison Graduate School (MSN174746). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abomoelak B, 2009, J BACTERIOL, V191, P5941, DOI 10.1128/JB.00778-09; Adams LB, 1997, TUBERCLE LUNG DIS, V78, P237, DOI 10.1016/S0962-8479(97)90004-6; Arredondo Miguel, 2005, Molecular Aspects of Medicine, V26, P313, DOI 10.1016/j.mam.2005.07.010; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BESWICK PH, 1976, CHEM-BIOL INTERACT, V14, P347, DOI 10.1016/0009-2797(76)90113-7; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Dicks AP, 1996, CHEM BIOL, V3, P655, DOI 10.1016/S1074-5521(96)90133-7; DOMEK MJ, 1984, APPL ENVIRON MICROB, V48, P289, DOI 10.1128/AEM.48.2.289-293.1984; Festa RA, 2011, MOL MICROBIOL, V79, P133, DOI 10.1111/j.1365-2958.2010.07431.x; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Franzblau SG, 1998, J CLIN MICROBIOL, V36, P362, DOI 10.1128/JCM.36.2.362-366.1998; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gold B, 2008, NAT CHEM BIOL, V4, P609, DOI 10.1038/nchembio.109; Hodgkinson V, 2012, J BIOL CHEM, V287, P13549, DOI 10.1074/jbc.R111.316406; Honaker RW, 2010, J BACTERIOL, V192, P6447, DOI 10.1128/JB.00978-10; Hsu CY, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00236; Ioerger TR, 2010, J BACTERIOL, V192, P3645, DOI 10.1128/JB.00166-10; Kendall SL, 2004, TUBERCULOSIS, V84, P247, DOI 10.1016/j.tube.2003.12.007; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Liu T, 2007, NAT CHEM BIOL, V3, P60, DOI 10.1038/nchembio844; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Neyrolles O, 2015, IMMUNOL REV, V264, P249, DOI 10.1111/imr.12265; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rao MD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.383604; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rowland JL, 2013, J BACTERIOL, V195, P3724, DOI 10.1128/JB.00546-13; Rowland JL, 2012, TUBERCULOSIS, V92, P202, DOI 10.1016/j.tube.2011.12.006; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Schaible UE, 1998, J IMMUNOL, V160, P1290; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Smaldone GT, 2007, MICROBIOL-SGM, V153, P4123, DOI 10.1099/mic.0.2007/011742-0; Spagnolo L, 2004, J BIOL CHEM, V279, P33447, DOI 10.1074/jbc.M404699200; Speer A, 2013, J BACTERIOL, V195, P5133, DOI 10.1128/JB.00763-13; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wagner D, 2005, J IMMUNOL, V174, P1491, DOI 10.4049/jimmunol.174.3.1491; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Ward SK, 2008, J BACTERIOL, V190, P2939, DOI 10.1128/JB.01847-07; Ward SK, 2010, MOL MICROBIOL, V77, P1096, DOI 10.1111/j.1365-2958.2010.07273.x; Wardman P, 1996, RADIAT RES, V145, P523, DOI 10.2307/3579270; White C, 2009, J CELL SCI, V122, P1315, DOI 10.1242/jcs.043216; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wolschendorf F, 2011, P NATL ACAD SCI USA, V108, P1621, DOI 10.1073/pnas.1009261108	50	21	22	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151816	10.1371/journal.pone.0151816	http://dx.doi.org/10.1371/journal.pone.0151816			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999439	gold, Green Submitted, Green Published			2022-12-26	WOS:000372694700067
J	Lindblad, O; Cordero, E; Puissant, A; Macaulay, L; Ramos, A; Kabir, NN; Sun, J; Vallon-Christersson, J; Haraldsson, K; Hemann, MT; Borg, A; Levander, F; Stegmaier, K; Pietras, K; Ronnstrand, L; Kazi, JU				Lindblad, O.; Cordero, E.; Puissant, A.; Macaulay, L.; Ramos, A.; Kabir, N. N.; Sun, J.; Vallon-Christersson, J.; Haraldsson, K.; Hemann, M. T.; Borg, A.; Levander, F.; Stegmaier, K.; Pietras, K.; Ronnstrand, L.; Kazi, J. U.			Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML	ONCOGENE			English	Article							ACUTE MYELOID-LEUKEMIA; FLT3; MUTATIONS; INHIBITORS; KINASE; PKI-587; PKC412; TARGET; PI3K/AKT/MTOR; CYTOGENETICS	Therapy directed against oncogenic FLT3 has been shown to induce response in patients with acute myeloid leukemia (AML), but these responses are almost always transient. To address the mechanism of FLT3 inhibitor resistance, we generated two resistant AML cell lines by sustained treatment with the FLT3 inhibitor sorafenib. Parental cell lines carry the FLT3-ITD (tandem duplication) mutation and are highly responsive to FLT3 inhibitors, whereas resistant cell lines display resistance to multiple FLT3 inhibitors. Sanger sequencing and protein mass-spectrometry did not identify any acquired mutations in FLT3 in the resistant cells. Moreover, sorafenib treatment effectively blocked FLT3 activation in resistant cells, whereas it was unable to block colony formation or cell survival, suggesting that the resistant cells are no longer FLT3 dependent. Gene expression analysis of sensitive and resistant cell lines, as well as of blasts from patients with sorafenib-resistant AML, suggested an enrichment of the PI3K/mTOR pathway in the resistant phenotype, which was further supported by next-generation sequencing and phospho-specific-antibody array analysis. Furthermore, a selective PI3K/mTOR inhibitor, gedatolisib, efficiently blocked proliferation, colony and tumor formation, and induced apoptosis in resistant cell lines. Gedatolisib significantly extended survival of mice in a sorafenib-resistant AML patient-derived xenograft model. Taken together, our data suggest that aberrant activation of the PI3K/mTOR pathway in FLT3-ITD-dependent AML results in resistance to drugs targeting FLT3.	[Lindblad, O.; Cordero, E.; Macaulay, L.; Sun, J.; Pietras, K.; Ronnstrand, L.; Kazi, J. U.] Lund Univ, Dept Lab Med, Div Translat Canc Res, Medicon Village 404 C3, S-22363 Lund, Skane, Sweden; [Lindblad, O.; Macaulay, L.; Sun, J.; Ronnstrand, L.; Kazi, J. U.] Lund Univ, Dept Lab Med, Lund Stem Cell Ctr, Lund, Sweden; [Lindblad, O.] Skane Univ Hosp, Dept Hematol & Vasc Disorders, Lund, Sweden; [Puissant, A.; Stegmaier, K.] Harvard Med Sch, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA USA; [Puissant, A.; Stegmaier, K.] Harvard Med Sch, Boston Childrens Hosp, Boston, MA USA; [Ramos, A.; Hemann, M. T.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kabir, N. N.; Kazi, J. U.] KN Biomed Res Inst, Lab Computat Biochem, Barisal, Bangladesh; [Vallon-Christersson, J.; Haraldsson, K.; Borg, A.] Lund Univ, Dept Oncol & Pathol, Lund, Sweden; [Levander, F.] Lund Univ, Dept Immunotechnol, BILS, Lund, Sweden	Lund University; Lund University; Lund University; Skane University Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT); Lund University; Lund University	Kazi, JU (corresponding author), Lund Univ, Dept Lab Med, Div Translat Canc Res, Medicon Village 404 C3, S-22363 Lund, Skane, Sweden.	kazi.uddin@med.lu.se	Pietras, Kristian/ABG-2097-2021; Pietras, Kristian/ABE-8727-2020; Kazi, Julhash/D-9190-2011	Pietras, Kristian/0000-0001-6738-4705; Vallon-Christersson, Johan/0000-0002-2195-0385; Levander, Fredrik/0000-0002-0710-9792; Ronnstrand, Lars/0000-0003-1275-5809; Kazi, Julhash/0000-0002-0719-5336	Kungliga Fysiografiska Sallskapet i Lund; Ollie and Elof Ericssons Stiftelse; Ake-Wiberg Stiftelse; Lars Hiertas Minne Stiftelse; Stiftelsen Olle Engkvist Byggmastare; Harald Jeanssons Stiftelse and Harald och Greta Jeanssons Stiftelse; Swedish Childhood Cancer Foundation; Crafoord foundation; Stiftelsen Clas Groschinskys Minnesfond; Swedish Cancer Foundation; Swedish Research Council; Region Skane; Research Funds at Skane University Hospital; Gunnar Nilssons Cancer Foundation; NIH [R01CA140292]; NATIONAL CANCER INSTITUTE [R01CA140292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	Kungliga Fysiografiska Sallskapet i Lund; Ollie and Elof Ericssons Stiftelse; Ake-Wiberg Stiftelse; Lars Hiertas Minne Stiftelse; Stiftelsen Olle Engkvist Byggmastare(Swedish Research Council); Harald Jeanssons Stiftelse and Harald och Greta Jeanssons Stiftelse; Swedish Childhood Cancer Foundation(European Commission); Crafoord foundation; Stiftelsen Clas Groschinskys Minnesfond; Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Region Skane; Research Funds at Skane University Hospital; Gunnar Nilssons Cancer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr Peter J Valk at Erasmus University Medical Center for help with AML patient data and Dr David Weinstock for leading the development of a bank of patient-derived xenograft models of leukemia at the DFCI. This research was funded by Kungliga Fysiografiska Sallskapet i Lund (JUK), Ollie and Elof Ericssons Stiftelse (JUK), Ake-Wiberg Stiftelse (JUK), Lars Hiertas Minne Stiftelse (JUK), Stiftelsen Olle Engkvist Byggmastare (JUK), Harald Jeanssons Stiftelse and Harald och Greta Jeanssons Stiftelse (JUK), the Swedish Childhood Cancer Foundation (JUK), the Crafoord foundation (JUK), Stiftelsen Clas Groschinskys Minnesfond (JUK), Swedish Cancer Foundation (LR), Swedish Research Council (LR), Region Skane (LR), the Research Funds at Skane University Hospital (LR), Gunnar Nilssons Cancer Foundation (LR) and the NIH R01CA140292 (KS). JUK is a recipient of Assistant Professorship (forskarassistenttjanst) grant from the Swedish Childhood Cancer Foundation. KP is the Goran & Birgitta Grosskopf Professor of Molecular Medicine at Lund University.	Albers C, 2013, LEUKEMIA, V27, P1416, DOI 10.1038/leu.2013.14; Barrett D, 2012, PEDIATR DRUGS, V14, P299, DOI 10.2165/11594740-000000000-00000; Birkenkamp KU, 2004, LEUKEMIA, V18, P103, DOI 10.1038/sj.leu.2403145; Breitenbuecher F, 2009, BLOOD, V113, P4063, DOI 10.1182/blood-2007-11-126664; Cui J, 2006, CLIN CHIM ACTA, V368, P155, DOI 10.1016/j.cca.2005.12.043; D'Amato V, 2014, BRIT J CANCER, V110, P2887, DOI 10.1038/bjc.2014.241; Frohling S, 2002, BLOOD, V100, P4372, DOI 10.1182/blood-2002-05-1440; Gedaly R, 2012, J SURG RES, V176, P542, DOI 10.1016/j.jss.2011.10.045; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Grabiner BC, 2014, CANCER DISCOV, V4, P554, DOI 10.1158/2159-8290.CD-13-0929; Hakkinen J, 2009, J PROTEOME RES, V8, P3037, DOI 10.1021/pr900189c; Hayakawa F, 2000, ONCOGENE, V19, P624, DOI 10.1038/sj.onc.1203354; Juliusson G, 2009, BLOOD, V113, P4179, DOI 10.1182/blood-2008-07-172007; Kiyoi H, 2005, INT J HEMATOL, V82, P85, DOI 10.1532/IJH97.05066; Knapper S, 2006, BLOOD, V108, P3494, DOI 10.1182/blood-2006-04-015487; Kutok JL, 2011, J CELL MOL MED, V15, P86, DOI 10.1111/j.1582-4934.2009.00925.x; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; Leung AYH, 2013, LEUKEMIA, V27, P260, DOI 10.1038/leu.2012.195; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Mallon R, 2011, CLIN CANCER RES, V17, P3193, DOI 10.1158/1078-0432.CCR-10-1694; Man CH, 2014, BLOOD, V123, P2530, DOI 10.1182/blood-2013-07-512194; Man CH, 2012, BLOOD, V119, P5133, DOI 10.1182/blood-2011-06-363960; Martelli AM, 2011, LEUKEMIA, V25, P1064, DOI 10.1038/leu.2011.46; Masson K, 2009, CELL SIGNAL, V21, P1717, DOI 10.1016/j.cellsig.2009.06.002; Meshinchi S, 2008, BLOOD, V111, P4930, DOI 10.1182/blood-2008-01-117770; Nogami A, 2015, ONCOTARGET, V6, P9189, DOI 10.18632/oncotarget.3279; Puissant A, 2014, CANCER CELL, V25, P226, DOI 10.1016/j.ccr.2014.01.022; Razumovskaya E, 2009, EXP HEMATOL, V37, P979, DOI 10.1016/j.exphem.2009.05.008; Sandhofer N, 2015, LEUKEMIA, V29, P828, DOI 10.1038/leu.2014.305; Sandin M, 2013, MOL CELL PROTEOMICS, V12, P1407, DOI 10.1074/mcp.O112.021907; Sasore T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105280; Schnittger S, 2002, BLOOD, V100, P59, DOI 10.1182/blood.V100.1.59; Sheikhha Mohammad Hasan, 2003, Hematol J, V4, P41, DOI 10.1038/sj.thj.6200224; Smith CC, 2013, BLOOD, V121, P3165, DOI 10.1182/blood-2012-07-442871; Smith CC, 2012, NATURE, V485, P260, DOI 10.1038/nature11016; Stolzel F, 2010, ANN HEMATOL, V89, P653, DOI 10.1007/s00277-009-0889-1; Stone RM, 2005, BLOOD, V105, P54, DOI 10.1182/blood-2004-03-0891; Stone RM, 2015, ASH ANN M, V126, P6, DOI DOI 10.1182/blood.V126.23.6.6; Sun J, 2014, ONCOGENE, V33, P5360, DOI 10.1038/onc.2013.479; Venkatesan AM, 2010, J MED CHEM, V53, P2636, DOI 10.1021/jm901830p; von Bubnoff N, 2009, CANCER RES, V69, P3032, DOI 10.1158/0008-5472.CAN-08-2923; Wang W, 2010, BLOOD, V116, P254, DOI 10.1182/blood-2009-11-254664; Wouters BJ, 2009, BLOOD, V113, P3088, DOI 10.1182/blood-2008-09-179895; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299	45	71	72	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 29	2016	35	39					5119	5131		10.1038/onc.2016.41	http://dx.doi.org/10.1038/onc.2016.41			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX5PI	26999641	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000384433000004
J	Kadamur, G; Ross, EM				Kadamur, Ganesh; Ross, Elliott M.			Intrinsic Pleckstrin Homology (PH) Domain Motion in Phospholipase C- Exposes a G Protein Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; heterotrimeric G protein; phosphatidylinositol signaling; phospholipase C; protein conformation; G; PH domain	BETA-GAMMA-SUBUNITS; CRYSTAL-STRUCTURE; RHO GTPASES; ACTIVATION; C-BETA(2); STIMULATION; G-ALPHA(Q); RECEPTOR; COMPLEX; IDENTIFICATION	Mammalian phospholipase C- (PLC-) isoforms are stimulated by heterotrimeric G protein subunits and members of the Rho GTPase family of small G proteins. Although recent structural studies showed how G(q) and Rac1 bind PLC-, there is a lack of consensus regarding the G binding site in PLC-. Using FRET between cerulean fluorescent protein-labeled G and the Alexa Fluor 594-labeled PLC- pleckstrin homology (PH) domain, we demonstrate that the PH domain is the minimal G binding region in PLC-3. We show that the isolated PH domain can compete with full-length PLC-3 for binding G but not G(q), Using sequence conservation, structural analyses, and mutagenesis, we identify a hydrophobic face of the PLC- PH domain as the G binding interface. This PH domain surface is not solvent-exposed in crystal structures of PLC-, necessitating conformational rearrangement to allow G binding. Blocking PH domain motion in PLC- by cross-linking it to the EF hand domain inhibits stimulation by G without altering basal activity or G(q) response. The fraction of PLC- cross-linked is proportional to the fractional loss of G response. Cross-linked PLC- does not bind G in a FRET-based G-PLC- binding assay. We propose that unliganded PLC- exists in equilibrium between a closed conformation observed in crystal structures and an open conformation where the PH domain moves away from the EF hands. Therefore, intrinsic movement of the PH domain in PLC- modulates G access to its binding site.	Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Mol Biophys Grad Program, Dallas, TX 75390 USA; Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ross, EM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	Elliott.Ross@UTSouthwestern.edu		Ross, Elliott M./0000-0002-0252-8197; Kadamur, Ganesh/0000-0002-7019-1485	National Institutes of Health [R01MG030355]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01MG030355. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barr AJ, 2000, BIOCHEMISTRY-US, V39, P1800, DOI 10.1021/bi992021f; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; Bonacci TM, 2005, J BIOL CHEM, V280, P10174, DOI 10.1074/jbc.M412514200; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; Chan P, 2011, J BIOL CHEM, V286, P2625, DOI 10.1074/jbc.M110.178897; Chidiac P, 1999, J BIOL CHEM, V274, P19639, DOI 10.1074/jbc.274.28.19639; DIETRICH A, 1994, EUR J BIOCHEM, V219, P171, DOI 10.1111/j.1432-1033.1994.tb19927.x; Drin G, 2006, BIOCHEMISTRY-US, V45, P5712, DOI 10.1021/bi052317n; Essen LO, 1996, NATURE, V380, P595, DOI 10.1038/380595a0; Essen LO, 1997, BIOCHEMISTRY-US, V36, P1704, DOI 10.1021/bi962512p; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Gao JM, 2009, NAT STRUCT MOL BIOL, V16, P684, DOI 10.1038/nsmb.1610; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Guo YJ, 2003, J BIOL CHEM, V278, P29995, DOI 10.1074/jbc.M301438200; Hicks SN, 2008, MOL CELL, V31, P383, DOI 10.1016/j.molcel.2008.06.018; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Huang ZW, 2009, NAT STRUCT MOL BIOL, V16, P853, DOI 10.1038/nsmb.1647; Ilkaeva O, 2002, J BIOL CHEM, V277, P4294, DOI 10.1074/jbc.M109612200; Illenberger D, 2003, J BIOL CHEM, V278, P3006, DOI 10.1074/jbc.M208282200; Illenberger D, 1998, EMBO J, V17, P6241, DOI 10.1093/emboj/17.21.6241; Jezyk MR, 2006, NAT STRUCT MOL BIOL, V13, P1135, DOI 10.1038/nsmb1175; Kadamur G, 2013, ANNU REV PHYSIOL, V75, P127, DOI 10.1146/annurev-physiol-030212-183750; KOZASA T, 1995, J BIOL CHEM, V270, P1734, DOI 10.1074/jbc.270.4.1734; LEE E, 1994, METHOD ENZYMOL, V237, P146; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Lyon AM, 2013, NAT STRUCT MOL BIOL, V20, P355, DOI 10.1038/nsmb.2497; Lyon AM, 2011, NAT STRUCT MOL BIOL, V18, P999, DOI 10.1038/nsmb.2095; MAHADEVAN D, 1995, BIOCHEMISTRY-US, V34, P9111, DOI 10.1021/bi00028a021; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Panchenko MP, 1998, J BIOL CHEM, V273, P28298, DOI 10.1074/jbc.273.43.28298; Philip F, 2010, CURR BIOL, V20, P1327, DOI 10.1016/j.cub.2010.06.013; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Ross EM, 2008, CURR BIOL, V18, pR777, DOI 10.1016/j.cub.2008.07.035; Savage JR, 2000, J BIOL CHEM, V275, P30399, DOI 10.1074/jbc.M005120200; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schnabel P, 1998, BIOCHEM J, V330, P461, DOI 10.1042/bj3300461; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; Snyder JT, 2003, J BIOL CHEM, V278, P21099, DOI 10.1074/jbc.M301418200; Tang W, 2006, J BIOL CHEM, V281, P4746, DOI 10.1074/jbc.M510573200; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; Wang TL, 2000, J BIOL CHEM, V275, P7466, DOI 10.1074/jbc.275.11.7466; WU DQ, 1993, J BIOL CHEM, V268, P3704; Zhang W, 2001, J BIOL CHEM, V276, P2503, DOI 10.1074/jbc.M003562200	43	10	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11394	11406		10.1074/jbc.M116.723940	http://dx.doi.org/10.1074/jbc.M116.723940			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27002154	Green Published, hybrid			2022-12-26	WOS:000377042100037
J	Bonetti, D; Camilloni, C; Visconti, L; Longhi, S; Brunori, M; Vendruscolo, M; Gianni, S				Bonetti, Daniela; Camilloni, Carlo; Visconti, Lorenzo; Longhi, Sonia; Brunori, Maurizio; Vendruscolo, Michele; Gianni, Stefano			Identification and Structural Characterization of an Intermediate in the Folding of the Measles Virus X Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ON-PATHWAY INTERMEDIATE; REPLICA-AVERAGED METADYNAMICS; C-TERMINAL DOMAIN; PROTEIN-STRUCTURE; KINETIC-ANALYSIS; DENATURED STATE; 3-STATE MODEL; PDZ DOMAIN; MECHANISM; BINDING	Although most proteins fold by populating intermediates, the transient nature of such states makes it difficult to characterize their structures. In this work we identified and characterized the structure of an intermediate of the X domain of phosphoprotein (P) of measles virus. We obtained this result by a combination of equilibrium and kinetic measurements and NMR chemical shifts used as structural restraints in replica-averaged metadynamics simulations. The structure of the intermediate was then validated by rationally designing four mutational variants predicted to affect the stability of this state. These results provide a detailed view of an intermediate state and illustrate the opportunities offered by a synergistic use of experimental and computational methods to describe non-native states at atomic resolution.	[Bonetti, Daniela; Visconti, Lorenzo; Brunori, Maurizio; Gianni, Stefano] Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Bonetti, Daniela; Visconti, Lorenzo; Brunori, Maurizio; Gianni, Stefano] Univ Roma La Sapienza, Ist Biol & Patol Mol, CNR, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy; [Camilloni, Carlo; Vendruscolo, Michele; Gianni, Stefano] Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England; [Camilloni, Carlo] Tech Univ Munich, Dept Chem, Lichtenbergstr 4, D-85747 Garching, Germany; [Camilloni, Carlo] Tech Univ Munich, Inst Adv Study, Lichtenbergstr 4, D-85747 Garching, Germany; [Longhi, Sonia] Aix Marseille Univ, CNRS, UMR 7257, AFMB, F-13288 Marseille, France; [Longhi, Sonia] CNRS, AFMB UMR 7257, F-13288 Marseille, France	Fondazione Cenci Bolognetti; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; University of Cambridge; Technical University of Munich; Technical University of Munich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Gianni, S (corresponding author), Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy.; Gianni, S (corresponding author), Univ Roma La Sapienza, Ist Biol & Patol Mol, CNR, Dipartimento Sci Biochim A Rossi Fanelli, I-00185 Rome, Italy.; Gianni, S (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	gianni@uniroma1.it	Vendruscolo, Michele/F-5901-2012; Camilloni, Carlo/A-4395-2009; Longhi, Sonia/M-5305-2014	Vendruscolo, Michele/0000-0002-3616-1610; Camilloni, Carlo/0000-0002-9923-8590; Longhi, Sonia/0000-0002-6829-6771	Italian Ministero dell'Istruzione dell'Universita e della Ricerca; Sapienza Universita di Roma [C26A155548]	Italian Ministero dell'Istruzione dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Sapienza Universita di Roma	This work was supported by the Italian Ministero dell'Istruzione dell'Universita e della Ricerca (Progetto di Interesse "Invecchiamento"; to S. G.) and by Sapienza Universita di Roma (C26A155548; to S. G.). The authors declare that they have no conflicts of interest with the contents of this article.	Abascal JLF, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2121687; Bernard C, 2009, FEBS LETT, V583, P1084, DOI 10.1016/j.febslet.2009.03.004; Best RB, 2010, J PHYS CHEM B, V114, P14916, DOI 10.1021/jp108618d; Bourhis JM, 2004, VIRUS RES, V99, P157, DOI 10.1016/j.virusres.2003.11.007; Bourhis JM, 2006, VIROLOGY, V344, P94, DOI 10.1016/j.virol.2005.09.025; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Camilloni C, 2014, J AM CHEM SOC, V136, P8982, DOI 10.1021/ja5027584; Camilloni C, 2013, J CHEM THEORY COMPUT, V9, P5610, DOI 10.1021/ct4006272; Camilloni C, 2012, J AM CHEM SOC, V134, P3968, DOI 10.1021/ja210951z; Capaldi AP, 2001, NAT STRUCT BIOL, V8, P68; Capaldi AP, 2002, NAT STRUCT BIOL, V9, P209, DOI 10.1038/nsb757; Cavalli A, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4793625; D'Urzo A, 2015, J AM SOC MASS SPECTR, V26, P472, DOI 10.1007/s13361-014-1048-z; Dosnon M, 2015, ACS CHEM BIOL, V10, P795, DOI 10.1021/cb5008579; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fu B, 2014, J COMPUT CHEM, V35, P1101, DOI 10.1002/jcc.23588; Gianni S, 2007, BIOPHYS CHEM, V128, P105, DOI 10.1016/j.bpc.2007.04.008; Gianni S, 2010, NAT STRUCT MOL BIOL, V17, P1431, DOI 10.1038/nsmb.1956; Gruebele M, 2002, NAT STRUCT BIOL, V9, P154, DOI 10.1038/nsb0302-154; Ivarsson Y, 2007, J BIOL CHEM, V282, P8568, DOI 10.1074/jbc.M611026200; JACKSON SE, 1991, BIOCHEMISTRY-US, V30, P10428, DOI 10.1021/bi00107a010; Jemth P, 2004, P NATL ACAD SCI USA, V101, P6450, DOI 10.1073/pnas.0401732101; Johansson K, 2003, J BIOL CHEM, V278, P44567, DOI 10.1074/jbc.M308745200; Khorasanizadeh S, 1996, NAT STRUCT BIOL, V3, P193, DOI 10.1038/nsb0296-193; Kingston RL, 2008, J MOL BIOL, V379, P719, DOI 10.1016/j.jmb.2007.12.080; Kohlhoff KJ, 2009, J AM CHEM SOC, V131, P13894, DOI 10.1021/ja903772t; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lindorff-Larsen K, 2005, NATURE, V433, P128, DOI 10.1038/nature03199; MATOUSCHEK A, 1990, NATURE, V346, P440, DOI 10.1038/346440a0; Pace CN, 2000, PROTEINS, P1; PARKER MJ, 1995, J MOL BIOL, V253, P771, DOI 10.1006/jmbi.1995.0590; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Religa TL, 2005, NATURE, V437, P1053, DOI 10.1038/nature04054; Sedlmeier R, 1998, ADV VIRUS RES, V50, P101, DOI 10.1016/S0065-3527(08)60807-6; Travaglini-Allocatelli C, 2005, J BIOL CHEM, V280, P25729, DOI 10.1074/jbc.M502628200; Travaglini-Allocatelli C, 2003, J BIOL CHEM, V278, P41136, DOI 10.1074/jbc.M303990200; Wildegger G, 1997, J MOL BIOL, V270, P294, DOI 10.1006/jmbi.1997.1030; Yegambaram K, 2013, PROTEIN SCI, V22, P1502, DOI 10.1002/pro.2336	38	17	18	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10886	10892		10.1074/jbc.M116.721126	http://dx.doi.org/10.1074/jbc.M116.721126			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27002146	hybrid, Green Published			2022-12-26	WOS:000377042600038
J	Callan, MB; Haskins, ME; Wang, P; Zhou, SZ; High, KA; Arruda, VR				Callan, Mary Beth; Haskins, Mark E.; Wang, Ping; Zhou, Shangzhen; High, Katherine A.; Arruda, Valder R.			Successful Phenotype Improvement following Gene Therapy for Severe Hemophilia A in Privately Owned Dogs	PLOS ONE			English	Article							FACTOR-VIII GENE; LONG-TERM SAFETY; FACTOR-IX; B DOGS; NEUTRALIZING ANTIBODIES; IMMUNE TOLERANCE; LIVER; INHIBITOR; EFFICACY; MUTATION	Severe hemophilia A (HA) is an inherited bleeding disorder characterized by <1% of residual factor VIII (FVIII) clotting activity. The disease affects several mammals including dogs, and, like humans, is associated with high morbidity and mortality. In gene therapy using adeno-associated viral (AAV) vectors, the canine model has been one of the best predictors of the therapeutic dose tested in clinical trials for hemophilia B (factor IX deficiency) and other genetic diseases, such as congenital blindness. Here we report our experience with liver gene therapy with AAV-FVIII in two outbred, privately owned dogs with severe HA that resulted in sustained expression of 1-2% of normal FVIII levels and prevented 90% of expected bleeding episodes. A Thr62Met mutation in the F8 gene was identified in one dog. These data recapitulate the improvement of the disease phenotype in research animals, and in humans, with AAV liver gene therapy for hemophilia B. Our experience is a novel example of the benefits of a relevant preclinical canine model to facilitate both translational studies in humans and improved welfare of privately owned dogs.	[Callan, Mary Beth] Univ Penn, Sch Vet Med, Dept Clin Studies, Philadelphia, PA 19104 USA; [Haskins, Mark E.; Wang, Ping] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Zhou, Shangzhen; High, Katherine A.; Arruda, Valder R.] Childrens Hosp Philadelphia, Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA; [High, Katherine A.; Arruda, Valder R.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [High, Katherine A.] Spark Therapeut, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Arruda, VR (corresponding author), Childrens Hosp Philadelphia, Ctr Cellular & Mol Therapeut, Philadelphia, PA 19104 USA.; Arruda, VR (corresponding author), Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.	arruda@email.chop.edu	High, Katherine A./AAB-9322-2020	High, Katherine/0000-0002-0805-6223	Center for Cellular and Molecular Therapeutics at The Children's Hospital of Philadelphia; NIH [OD 010939]; Companion Animal Research Fund at the University of Pennsylvania School of Veterinary Medicine; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010939] Funding Source: NIH RePORTER	Center for Cellular and Molecular Therapeutics at The Children's Hospital of Philadelphia; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Companion Animal Research Fund at the University of Pennsylvania School of Veterinary Medicine; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the Center for Cellular and Molecular Therapeutics at The Children's Hospital of Philadelphia, NIH OD 010939, and the Companion Animal Research Fund at the University of Pennsylvania School of Veterinary Medicine.	Arruda V, 2015, HARRISONS PRINCIPLES; Astermark J, 1999, BRIT J HAEMATOL, V105, P1109, DOI 10.1046/j.1365-2141.1999.01463.x; Booth CJ, 2010, J THROMB HAEMOST, V8, P2472, DOI 10.1111/j.1538-7836.2010.03978.x; Boutin S, 2010, HUM GENE THER, V21, P704, DOI 10.1089/hum.2009.182; Calcedo R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00341; Crudele JM, 2015, BLOOD, V125, P1553, DOI 10.1182/blood-2014-07-588194; de Brasi C, 2014, HAEMOPHILIA, V20, P54, DOI 10.1111/hae.12409; Demaster A, 2012, HUM GENE THER, V23, P407, DOI 10.1089/hum.2011.106; DiMichele DM, 2002, THROMB HAEMOSTASIS, V87, P52; Evatt BL, 2000, HAEMOPHILIA, V6, P131, DOI 10.1046/j.1365-2516.2000.00417.x; Finn JD, 2010, BLOOD, V116, P5842, DOI 10.1182/blood-2010-06-288001; GILES AR, 1984, BLOOD, V63, P451; Gouw SC, 2007, BLOOD, V109, P4648, DOI 10.1182/blood-2006-11-056291; Hay CRM, 2012, BLOOD, V119, P1335, DOI 10.1182/blood-2011-08-369132; Hough C, 2002, THROMB HAEMOSTASIS, V87, P659, DOI 10.1055/s-0037-1613063; Jiang HY, 2006, BLOOD, V108, P3321, DOI 10.1182/blood-2006-04-017913; Li C, 2012, GENE THER, V19, P288, DOI 10.1038/gt.2011.90; Lisowski L, 2014, NATURE, V506, P382, DOI 10.1038/nature12875; Lozier JN, 2002, P NATL ACAD SCI USA, V99, P12991, DOI 10.1073/pnas.192219599; Manco-Johnson MJ, 2007, NEW ENGL J MED, V357, P535, DOI 10.1056/NEJMoa067659; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mao J, 2013, J GENET SYNDR GEN S1; Masat E, 2013, DISCOV MED, V15, P379; McIntosh J, 2013, BLOOD, V121, P3335, DOI 10.1182/blood-2012-10-462200; Mingozzi F, 2013, GENE THER, V20, P417, DOI 10.1038/gt.2012.55; Mingozzi F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005795; Mount JD, 2002, BLOOD, V99, P2670, DOI 10.1182/blood.V99.8.2670; Nair N, 2014, BLOOD, V123, P3195, DOI 10.1182/blood-2013-10-534032; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Nathwani AC, 2011, MOL THER, V19, P876, DOI 10.1038/mt.2010.274; Nichols TC, 2015, HUM GENE THER CL DEV, V26, P5, DOI 10.1089/humc.2014.153; Nichols TC, 2009, ILAR J, V50, P144, DOI 10.1093/ilar.50.2.144; Niemeyer GP, 2009, BLOOD, V113, P797, DOI 10.1182/blood-2008-10-181479; Oldenburg J, 2015, BLOOD, V125, P2038, DOI 10.1182/blood-2015-01-528414; Porada CD, 2010, J THROMB HAEMOST, V8, P276, DOI 10.1111/j.1538-7836.2009.03697.x; Rost S, 2008, J THROMB HAEMOST, V6, P1996, DOI 10.1111/j.1538-7836.2008.03125.x; Sabatino DE, 2011, MOL THER, V19, P442, DOI 10.1038/mt.2010.240; Sabatino DE, 2009, BLOOD, V114, P4562, DOI 10.1182/blood-2009-05-220327; Siner JI, 2013, BLOOD, V121, P4396, DOI 10.1182/blood-2012-10-464164; Wang LL, 2011, HUM GENE THER, V22, P1389, DOI 10.1089/hum.2011.031; Wight J, 2003, HAEMOPHILIA, V9, P418, DOI 10.1046/j.1365-2516.2003.00780.x	41	15	16	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151800	10.1371/journal.pone.0151800	http://dx.doi.org/10.1371/journal.pone.0151800			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27011017	gold, Green Submitted, Green Published			2022-12-26	WOS:000372708000048
J	Fuentealba, M; Munoz, R; Maturana, P; Krapp, A; Cabrera, R				Fuentealba, Matias; Munoz, Rodrigo; Maturana, Pablo; Krapp, Adriana; Cabrera, Ricardo			Determinants of Cofactor Specificity for the Glucose-6-Phosphate Dehydrogenase from Escherichia coli: Simulation, Kinetics and Evolutionary Studies	PLOS ONE			English	Article							LEUCONOSTOC-MESENTEROIDES GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; MOLECULAR-DYNAMICS; COENZYME SPECIFICITY; FORCE-FIELD; DEHYDROGENASE; PURIFICATION; BINDING; ENZYME; NADP(+); GENE	Glucose 6-Phosphate Dehydrogenases (G6PDHs) from different sources show varying specificities towards NAD(+) and NADP(+) as cofactors. However, it is not known to what extent structural determinants of cofactor preference are conserved in the G6PDH family. In this work, molecular simulations, kinetic characterization of site-directed mutants and phylogenetic analyses were used to study the structural basis for the strong preference towards NADP(+) shown by the G6PDH from Escherichia coli. Molecular Dynamics trajectories of homology models showed a highly favorable binding energy for residues K18 and R50 when interacting with the 2'-phosphate of NADP(+), but the same residues formed no observable interactions in the case of NAD(+). Alanine mutants of both residues were kinetically characterized and analyzed with respect to the binding energy of the transition state, according to the k(cat)/K-M value determined for each cofactor. Whereas both residues contribute to the binding energy of NADP(+), only R50 makes a contribution (about-1 kcal/mol) to NAD(+) binding. In the absence of both positive charges the enzyme was unable to discriminate NADP(+) from NAD(+). Although kinetic data is sparse, the observed distribution of cofactor preferences within the phylogenetic tree is sufficient to rule out the possibility that the known NADP(+)-specific G6PDHs form a monophyletic group. While the beta 1-alpha 1 loop shows no strict conservation of K18, (rather, S and T seem to be more frequent), in the case of the beta 2-alpha 2 loop, different degrees of conservation are observed for R50. Noteworthy is the fact that a K18T mutant is indistinguishable from K18A in terms of cofactor preference. We conclude that the structural determinants for the strict discrimination against NAD(+) in the case of the NADP(+)-specific enzymes have evolved independently through different means during the evolution of the G6PDH family. We further suggest that other regions in the cofactor binding pocket, besides the beta 1-alpha 1 and beta 2-alpha 2 loops, play a role in determining cofactor preference.	[Fuentealba, Matias; Munoz, Rodrigo; Maturana, Pablo; Cabrera, Ricardo] Univ Chile, Fac Ciencias, Lab Bioquim & Biol Mol, Santiago, Chile; [Krapp, Adriana] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Argentina	Universidad de Chile; National University of Rosario	Cabrera, R (corresponding author), Univ Chile, Fac Ciencias, Lab Bioquim & Biol Mol, Santiago, Chile.	ricabrer@uchile.cl		Cabrera, Ricardo/0000-0002-8896-3172; Fuentealba, Matias/0000-0001-7353-4394; Munoz-Gonzalez, Rodrigo/0000-0003-2266-5014; Maturana, Pablo/0000-0003-0686-1605	FONDECYT [1121170]; ANILLO [ACT-1107]	FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); ANILLO(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS)	Support was provided by FONDECYT 1121170 and ANILLO ACT-1107.	ANDERSON BM, 1995, ARCH BIOCHEM BIOPHYS, V321, P94, DOI 10.1006/abbi.1995.1372; Baugh L, 2015, TUBERCULOSIS, V95, P142, DOI 10.1016/j.tube.2014.12.003; CACCIAPUOTI AF, 1977, J BACTERIOL, V132, P555, DOI 10.1128/JB.132.2.555-563.1977; Canback B, 2002, P NATL ACAD SCI USA, V99, P6097, DOI 10.1073/pnas.082112499; Carugo O, 1997, PROTEINS, V28, P10, DOI 10.1002/(SICI)1097-0134(199705)28:1<10::AID-PROT2>3.3.CO;2-R; Churchill CDM, 2009, J PHYS CHEM B, V113, P16046, DOI 10.1021/jp907887y; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cornish-Bowden A., 1979, FUNDAMENTALS ENZYME, DOI 10.1016/C2013-0-04130-8; Dean AM, 1997, P NATL ACAD SCI USA, V94, P3104, DOI 10.1073/pnas.94.7.3104; Engel PC, 2014, NEUROCHEM RES, V39, P426, DOI 10.1007/s11064-013-1089-x; Fersht A., 1999, STRUCTURE MECH PROTE, P349; FIRST EA, 1995, BIOCHEMISTRY-US, V34, P5030, DOI 10.1021/bi00015a014; Haghighi B, 2005, IRAN J SCI TECHNOL A, V29, P71; Hansen T, 2002, FEMS MICROBIOL LETT, V216, P249, DOI 10.1016/S0378-1097(02)01021-2; Holmberg N, 1999, PROTEIN ENG, V12, P851, DOI 10.1093/protein/12.10.851; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iyer RB, 2002, EXTREMOPHILES, V6, P283, DOI 10.1007/s00792-001-0255-2; Kotaka M, 2005, ACTA CRYSTALLOGR D, V61, P495, DOI 10.1107/S0907444905002350; Lee HY, 2006, J GEN APPL MICROBIOL, V52, P147, DOI 10.2323/jgam.52.147; Lessie TG, 1972, J BACTERIOL; LESSMANN D, 1975, EUR J BIOCHEM, V59, P545, DOI 10.1111/j.1432-1033.1975.tb02481.x; Levy H., 1979, GLUCOSE 6 PHOSPHATE; Levy HR, 1996, ARCH BIOCHEM BIOPHYS, V326, P145, DOI 10.1006/abbi.1996.0058; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Naylor CE, 2001, ACTA CRYSTALLOGR D, V57, P635, DOI 10.1107/S0907444901003420; Olavarria K, 2014, MICROBIOL-SGM, V160, P2780, DOI 10.1099/mic.0.082180-0; Olavarria K, 2012, FEBS J, V279, P2296, DOI 10.1111/j.1742-4658.2012.08610.x; OPHEIM D, 1973, J BACTERIOL, V116, P1150, DOI 10.1128/JB.116.3.1150-1159.1973; Paraquat V, 1998, J BACTERIOL, V180, P1741; Paton RS, 2009, J CHEM INF MODEL, V49, P944, DOI 10.1021/ci900009f; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pletnev VZ, 2004, PROTEINS, V57, P294, DOI 10.1002/prot.20205; RAGUNATHAN S, 1994, ARCH BIOCHEM BIOPHYS, V310, P360, DOI 10.1006/abbi.1994.1179; Rauch B, 2010, APPL MICROBIOL BIOT, V88, P711, DOI 10.1007/s00253-010-2779-9; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCOPES RK, 1985, BIOCHEM J, V228, P627, DOI 10.1042/bj2280627; SERRANO L, 1990, BIOCHEMISTRY-US, V29, P9343, DOI 10.1021/bi00492a006; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; STEINBACH RA, 1978, EUR J BIOCHEM, V87, P409, DOI 10.1111/j.1432-1033.1978.tb12390.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vought V, 2000, BIOCHEMISTRY-US, V39, P15012, DOI 10.1021/bi0014610; Wendt UK, 1999, PLANT MOL BIOL, V40, P487, DOI 10.1023/A:1006257230779; Zhao YB, 2011, J COMPUT CHEM, V32, P33, DOI 10.1002/jcc.21595	46	12	12	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152403	10.1371/journal.pone.0152403	http://dx.doi.org/10.1371/journal.pone.0152403			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010804	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708000142
J	Friedman, MA; Bailey, AM; Rondon, MJ; McNerny, EM; Sahar, ND; Kohn, DH				Friedman, Michael A.; Bailey, Alyssa M.; Rondon, Matthew J.; McNerny, Erin M.; Sahar, Nadder D.; Kohn, David H.			Calcium- and Phosphorus-Supplemented Diet Increases Bone Mass after Short-Term Exercise and Increases Bone Mass and Structural Strength after Long-Term Exercise in Adult Mice	PLOS ONE			English	Article							RANDOMIZED CONTROLLED TRIAL; HIGH-IMPACT EXERCISE; YOUNG GROWING RAT; BIOMECHANICAL STRENGTH; CALCIOTROPIC HORMONES; MECHANICAL-PROPERTIES; TREADMILL EXERCISE; PHYSICAL-ACTIVITY; CORTICAL BONE; METABOLISM	Exercise has long-lasting benefits to bone health that may help prevent fractures by increasing bone mass, bone strength, and tissue quality. Long-term exercise of 6-12 weeks in rodents increases bone mass and bone strength. However, in growing mice, a short-term exercise program of 3 weeks can limit increases in bone mass and structural strength, compared to non-exercised controls. Short-term exercise can, however, increase tissue strength, suggesting that exercise may create competition for minerals that favors initially improving tissue-level properties over structural-level properties. It was therefore hypothesized that adding calcium and phosphorus supplements to the diet may prevent decreases in bonemass and structural strength during a short-term exercise program, while leading to greater bone mass and structural strength than exercise alone after a long-term exercise program. A short-term exercise experiment was done for 3 weeks, and a long-term exercise experiment was done for 8 weeks. For each experiment, male 16-week old C57BL/6 mice were assigned to 4 weight-matched groups-exercise and non-exercise groups fed a control or mineral-supplemented diet. Exercise consisted of treadmill running at 12 m/min, 30 min/day for 7 days/week. After 3 weeks, exercised mice fed the supplemented diet had significantly increased tibial tissue mineral content (TMC) and cross-sectional area over exercised mice fed the control diet. After 8 weeks, tibial TMC, cross-sectional area, yield force, and ultimate force were greater from the combined treatments than from either exercise or supplemented diet alone. Serum markers of bone formation (PINP) and resorption (CTX) were both decreased by exercise on day 2. In exercised mice, day 2 PINP was significantly positively correlated with day 2 serum Ca, a correlation that was weaker and negative in non-exercised mice. Increasing dietary mineral consumption during an exercise program increases bonemass after 3 weeks and increases structural strength after 8 weeks, making bones best able to resist fracture.	[Friedman, Michael A.; Bailey, Alyssa M.; Rondon, Matthew J.; McNerny, Erin M.; Sahar, Nadder D.; Kohn, David H.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Kohn, David H.] Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kohn, DH (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.; Kohn, DH (corresponding author), Univ Michigan, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA.	dhkohn@umich.edu	Kohn, David/AAJ-4131-2020; Friedman, Michael A/J-6414-2019	McNerny, Erin/0000-0002-1825-9657; Friedman, Michael/0000-0001-8279-0306	National Institutes of Health [R01-AR052010]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052010] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health R01-AR052010 (DHK).	Bass SL, 2007, J BONE MINER RES, V22, P458, DOI 10.1359/JBMR.061201; Bhatia V, 2008, INDIAN J MED RES, V127, P269; Burr D.B., 2001, MUSCULOSKELETAL FATI; Committee to Review Dietary Reference Intakes for Vitamin D and Calcium Institute of Medicine, 2011, DIETARY REFERENCE IN; Creedon A, 2001, BRIT J NUTR, V86, P453, DOI 10.1079/BJN2001419; Fatayerji D, 1999, J BONE MINER RES, V14, P1203, DOI 10.1359/jbmr.1999.14.7.1203; Fonseca D, 2004, BONE, V35, P489, DOI 10.1016/j.bone.2004.03.031; Fuchs RK, 2002, J PEDIATR-US, V141, P357, DOI 10.1067/mpd.2002.127275; Gala J, 2001, BRIT J NUTR, V86, P521, DOI 10.1079/BJN2001428; Gunter K, 2008, J BONE MINER RES, V23, P986, DOI 10.1359/JBMR.071201; Gunter K, 2008, BONE, V42, P710, DOI 10.1016/j.bone.2008.01.002; HALL DD, 1991, J ANIM SCI, V69, P646; Heaney RP, 2000, OSTEOPOROSIS INT, V11, P985, DOI 10.1007/s001980070020; Honda A, 2008, J APPL PHYSIOL, V105, P849, DOI 10.1152/japplphysiol.00902.2007; Hunt JR, 2008, J NUTR, V138, P1462, DOI 10.1093/jn/138.8.1462; Iuliano-Burns S, 2003, J BONE MINER RES, V18, P156, DOI 10.1359/jbmr.2003.18.1.156; Iwamoto J, 1999, BONE, V24, P163, DOI 10.1016/S8756-3282(98)00189-6; Iwamoto J, 2004, J BONE MINER METAB, V22, P26, DOI 10.1007/s00774-003-0443-5; Kohn DH, 2009, CELLS TISSUES ORGANS, V189, P33, DOI 10.1159/000151452; Lappe JM, 2001, J BONE MINER RES, V16, pS138; Liesegang A, 2005, J ANIM PHYSIOL AN N, V89, P113, DOI 10.1111/j.1439-0396.2005.00548.x; Masuyama R, 2003, J BONE MINER RES, V18, P1217, DOI 10.1359/jbmr.2003.18.7.1217; RAAB DM, 1990, J APPL PHYSIOL, V68, P130, DOI 10.1152/jappl.1990.68.1.130; Somerville JN, 2004, CALCIFIED TISSUE INT, V74, P469, DOI 10.1007/s00223-003-0101-x; Specker B. L., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P338; Standing Committee on the Scientific Evaluation of Dietary Reference Intakes FNB Institute of Medicine, 1997, DIET REF INT CALC PH; TURNER CH, 1993, BONE, V14, P595, DOI 10.1016/8756-3282(93)90081-K; U. S. Department of Health and Human Services, 2004, BONE HEALTH AND OSTE; Umemura Y, 2008, J BONE MINER METAB, V26, P456, DOI 10.1007/s00774-007-0848-7; van Driel Marjolein, 2014, Bonekey Rep, V3, P493, DOI 10.1038/bonekey.2013.227; Wallace JM, 2007, BONE, V40, P1120, DOI 10.1016/j.bone.2006.12.002; Warden SJ, 2007, J BONE MINER RES, V22, P251, DOI 10.1359/JBMR.061107; Welch JM, 2008, BONE, V42, P660, DOI 10.1016/j.bone.2007.12.220; YEH JK, 1990, AM J PHYSIOL, V258, pE263, DOI 10.1152/ajpendo.1990.258.2.E263; YEH JK, 1989, AM J PHYSIOL, V256, pE1, DOI 10.1152/ajpendo.1989.256.1.E1; YEH JK, 1993, AM J PHYSIOL, V264, pE182, DOI 10.1152/ajpendo.1993.264.2.E182	36	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151995	10.1371/journal.pone.0151995	http://dx.doi.org/10.1371/journal.pone.0151995			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008546	gold, Green Published, Green Submitted			2022-12-26	WOS:000372701200085
J	Bailey, K; Yazdi, T; Masharani, U; Tyrrell, B; Butch, A; Schaufele, F				Bailey, Kathy; Yazdi, Tahmineh; Masharani, Umesh; Tyrrell, Blake; Butch, Anthony; Schaufele, Fred			Advantages and Limitations of Androgen Receptor-Based Methods for Detecting Anabolic Androgenic Steroid Abuse as Performance Enhancing Drugs	PLOS ONE			English	Article							BACKDOOR PATHWAY; FLUORESCENT PROTEIN; MODULATORS; SPORTS; TESTOSTERONE; CONSEQUENCES; DEFICIENCY; ACTIVATION; MICROSCOPY; AGENTS	Testosterone (T) and related androgens are performance enhancing drugs (PEDs) abused by some athletes to gain competitive advantage. To monitor unauthorized androgen abuse, doping control programs use mass spectrometry (MS) to detect androgens, synthetic anabolic-androgenic steroids (AASs) and their metabolites in an athlete's urine. AASs of unknown composition will not be detected by these procedures. Since AASs achieve their anabolic effects by activating the Androgen Receptor (AR), cell-based bioassays that measure the effect of a urine sample on AR activity are under investigation as complementary, pan-androgen detection methods. We evaluated an AR BioAssay as a monitor for androgen activity in urine pre-treated with glucuronidase, which releases T from the inactive T-glucuronide that predominates in urine. AR BioAssay activity levels were expressed as 'T-equivalent' concentrations by comparison to a T dose response curve. The T-equivalent concentrations of androgens in the urine of hypogonadal participants supplemented with T (in whom all androgenic activity should arise from T) were quantitatively identical to the T measurements conducted by MS at the UCLA Olympic Analytical Laboratory (0.96 +/- 0.22). All 17 AASs studied were active in the AR BioAssay; other steroids were inactive. 12 metabolites of 10 commonly abused AASs, which are used for MS monitoring of AAS doping because of their prolonged presence in urine, had reduced or no AR BioAssay activity. Thus, the AR BioAssay can accurately and inexpensively monitor T, but its ability to monitor urinary AASs will be limited to a period immediately following doping in which the active AASs remain intact.	[Bailey, Kathy; Yazdi, Tahmineh; Schaufele, Fred] Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Masharani, Umesh; Tyrrell, Blake] Univ Calif San Francisco, Div Endocrinol, San Francisco, CA 94143 USA; [Butch, Anthony] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Schaufele, Fred] Univ Calif San Francisco, Dept Obstet & Gynecol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco	Schaufele, F (corresponding author), Univ Calif San Francisco, Ctr Reprod Sci, San Francisco, CA 94143 USA.; Schaufele, F (corresponding author), Univ Calif San Francisco, Dept Obstet & Gynecol, San Francisco, CA 94143 USA.	fred.schaufele@ucsf.edu			Partnership for Clean Competition; National Institutes of Health [P30 DK63720]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720] Funding Source: NIH RePORTER	Partnership for Clean Competition; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a research grant to FS from the Partnership for Clean Competition (http://www.cleancompetition.org/). Maintenance of microscopy equipment was partially offset with Center grant (P30 DK63720, PI: Michael German) support from the National Institutes of Health (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auchus RJ, 2004, TRENDS ENDOCRIN MET, V15, P432, DOI 10.1016/j.tem.2004.09.004; Basaria S, 2010, J CLIN ENDOCR METAB, V95, P1533, DOI 10.1210/jc.2009-1579; Bhasin S, 2009, CURR OPIN CLIN NUTR, V12, P232, DOI 10.1097/MCO.0b013e32832a3d79; Biason-Lauber A, 2013, MOL CELL ENDOCRINOL, V371, P124, DOI 10.1016/j.mce.2013.01.017; Bowers LD, 2014, CLIN CHEM, V60, P1279, DOI 10.1373/clinchem.2014.226175; Bowers LD, 2009, ANNU REV ANAL CHEM, V2, P485, DOI 10.1146/annurev-anchem-060908-155159; Bowers LD, 2009, STEROIDS, V74, P285, DOI 10.1016/j.steroids.2009.01.007; Bowers LD, 2002, THER DRUG MONIT, V24, P178, DOI 10.1097/00007691-200202000-00028; Cadwallader AB, 2011, J ANAL TOXICOL, V35, P594, DOI 10.1093/anatox/35.9.594; Catlin DH, 2008, J INTERN MED, V264, P99, DOI 10.1111/j.1365-2796.2008.01993.x; Dalton JT, 2013, CURR OPIN SUPPORT PA, V7, P345, DOI 10.1097/SPC.0000000000000015; DEHENNIN L, 1994, J ENDOCRINOL, V142, P353, DOI 10.1677/joe.0.1420353; Elsliger MA, 1999, BIOCHEMISTRY-US, V38, P5296, DOI 10.1021/bi9902182; Fenton MA, 1997, CLIN CANCER RES, V3, P1383; Gao WQ, 2007, DRUG DISCOV TODAY, V12, P241, DOI 10.1016/j.drudis.2007.01.003; Geyer H, 2014, BRIT J SPORT MED, V48, P820, DOI 10.1136/bjsports-2014-093526; Gregory CW, 2001, CANCER RES, V61, P2892; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hartig SM, 2011, METHODS MOL BIOL, V776, P313, DOI 10.1007/978-1-61779-243-4_18; Hebborn P., 2013, SCREENING METHODS PH, V2, P75; Homma K, 2006, J CLIN ENDOCR METAB, V91, P2643, DOI 10.1210/jc.2005-2460; Houtman CJ, 2009, ANAL CHIM ACTA, V637, P247, DOI 10.1016/j.aca.2008.09.037; Johnston L, 2014, MONITORING FUTURE NA, V2; Johnston L. D., 2014, MONITORING FUTURE NA, V1; Jones JO, 2009, ACS CHEM BIOL, V4, P199, DOI 10.1021/cb900024z; Kamrath C, 2012, J CLIN ENDOCR METAB, V97, pE367, DOI 10.1210/jc.2011-1997; Kanayama G, 2010, HORM BEHAV, V58, P111, DOI 10.1016/j.yhbeh.2009.09.006; Kann L, 2014, MMWR SURVEILL SUMM, V63, P1; Kofoed EM, 2010, J BIOL CHEM, V285, P2428, DOI 10.1074/jbc.M109.045203; Kofoed EM, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2940366; Krylova I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063286; Marcelli M, 2006, J CELL BIOCHEM, V98, P770, DOI 10.1002/jcb.20593; Martinez ED, 2006, METHOD ENZYMOL, V414, P37, DOI 10.1016/S0076-6879(06)14003-3; Momaya A, 2015, SPORTS MED, V45, P517, DOI 10.1007/s40279-015-0308-9; Parr MK, 2010, J STEROID BIOCHEM, V121, P528, DOI 10.1016/j.jsbmb.2009.12.008; Pope HG, 2014, ENDOCR REV, V35, P341, DOI 10.1210/er.2013-1058; Rane A, 2012, BRIT J CLIN PHARMACO, V74, P3, DOI 10.1111/j.1365-2125.2012.04294.x; Sagoe D, 2014, ANN EPIDEMIOL, V24, P383, DOI 10.1016/j.annepidem.2014.01.009; Saugy M, 2014, BRIT J SPORT MED, V48, P827, DOI 10.1136/bjsports-2014-093512; Schaufele F, 2005, P NATL ACAD SCI USA, V102, P9802, DOI 10.1073/pnas.0408819102; Schaufele F, 2014, METHODS, V66, P188, DOI 10.1016/j.ymeth.2013.07.040; Schulze JJ, 2008, J CLIN ENDOCR METAB, V93, P2500, DOI 10.1210/jc.2008-0218; Sjoqvist F, 2008, LANCET, V371, P1872, DOI 10.1016/S0140-6736(08)60801-6; Sonneveld E, 2006, TOXICOL SCI, V89, P173, DOI 10.1093/toxsci/kfj009; Sottas PE, 2010, ENDOCRIN METAB CLIN, V39, P59, DOI 10.1016/j.ecl.2009.11.003; Swanson C, 2007, J CLIN ENDOCR METAB, V92, P4878, DOI 10.1210/jc.2007-0359; Szafran AT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003605; Taplin ME, 1999, CANCER RES, V59, P2511; Thevis M, 2015, DRUG TEST ANAL, V7, P1, DOI 10.1002/dta.1769; Wolf S, 2011, ARCH TOXICOL, V85, P285, DOI 10.1007/s00204-010-0590-0; Zhou XE, 2010, J BIOL CHEM, V285, P9161, DOI 10.1074/jbc.M109.085779; Zierau O, 2008, STEROIDS, V73, P1143, DOI 10.1016/j.steroids.2008.04.015	52	12	12	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151860	10.1371/journal.pone.0151860	http://dx.doi.org/10.1371/journal.pone.0151860			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998755	Green Published, Green Submitted, gold			2022-12-26	WOS:000372694700075
J	Banihashemian, SM; Periasamy, V; Tong, GB; Rahman, SA				Banihashemian, Seyedeh Maryam; Periasamy, Vengadesh; Tong, Goh Boon; Rahman, Saadah Abdul			Spectroscopic (UV/VIS, Raman) and Electrophoresis Study of Cytosine-Guanine Oligonucleotide DNA Influenced by Magnetic Field	PLOS ONE			English	Article							CURRENT-VOLTAGE CHARACTERISTICS; GOLD STRUCTURE; BAND-GAP; HYBRIDIZATION; MOLECULES; STRAND; MODEL	Studying the effect of a magnetic field on oligonucleotide DNA can provide a novel DNA manipulation technique for potential application in bioengineering and medicine. In this work, the optical and electrochemical response of a 100 bases oligonucleotides DNA, cytosine-guanine (CG(100)), is investigated via exposure to different magnetic fields (250, 500, 750, and 1000 mT). As a result of the optical response of CG(100) to the magnetic field, the ultra-violet-visible spectrum indicated a slight variation in the band gap of CG(100) of about 0.3 eV. Raman spectroscopy showed a significant deviation in hydrogen and phosphate bonds' vibration after exposure to the magnetic field. Oligonucleotide DNA mobility was investigated in the external electric field using the gel electrophoresis technique, which revealed a small decrease in the migration of CG(100) after exposure to the magnetic field.	[Banihashemian, Seyedeh Maryam; Periasamy, Vengadesh; Tong, Goh Boon; Rahman, Saadah Abdul] Univ Malaya, Dept Phys, Low Dimens Mat Res Ctr, Kuala Lumpur 50603, Malaysia	Universiti Malaya	Banihashemian, SM (corresponding author), Univ Malaya, Dept Phys, Low Dimens Mat Res Ctr, Kuala Lumpur 50603, Malaysia.	banihashemian_physics@yahoo.com	PERIASAMY, VENGADESH/B-9993-2010; RAHMAN, SAADAH BINTI ABDUL/A-8561-2010; GOH, BOON TONG/B-8545-2010	PERIASAMY, VENGADESH/0000-0002-0435-4944; RAHMAN, SAADAH BINTI ABDUL/0000-0002-5738-5920; GOH, BOON TONG/0000-0003-3933-7594	IPPP-BKP [BK003-2015]; UM/MOHE [F000006-21001]; HIR grants [J-21002-73823, UM.C/HIR/MOHE/SC/06]; FRGS grant [FP004/2013A]; BKP grant [BK003-2015]	IPPP-BKP; UM/MOHE; HIR grants; FRGS grant; BKP grant	This research was supported by IPPP-BKP grant BK003-2015, UM/MOHE High Impact Research Grant allocation of F000006-21001, HIR grants (J-21002-73823 and UM.C/HIR/MOHE/SC/06) and FRGS grant (FP004/2013A). S. M. Banihashemian conducted the experiments and took the measurements with advice and consultation from all authors and BK003-2015 is her BKP grant. Set up preparation, picture and redraw of schematic also prepared by Seyedeh Maryam. Saadah Abdul Rahman, Vengadesh Periasamand and Goh Boon Tong helped to prepare the designed set up and all authors contributed to writing, editing and reviewing the paper that UM/MOHE High Impact Research Grant allocation of F000006-21001, HIR grants (J-21002-73823 and UM.C/HIR/MOHE/SC/06) and FRGS grant (FP004/2013A) are their grant respectively.	Ahmad M, 2005, SENSOR ACTUAT A-PHYS, V119, P84, DOI 10.1016/j.sna.2004.09.007; Banihashemian SM, 2013, MOLECULES, V18, P11797, DOI 10.3390/molecules181011797; Bende A, 2011, SOLID STATE COMMUN, V151, P301, DOI 10.1016/j.ssc.2010.12.001; Doyle PS, 2002, SCIENCE, V295, P2237, DOI 10.1126/science.1068420; Epstein JR, 2002, ANAL CHIM ACTA, V469, P3, DOI 10.1016/S0003-2670(02)00030-2; Gabelica V, 2007, J AM CHEM SOC, V129, P4706, DOI 10.1021/ja068440z; Gullu O, 2008, APPL SURF SCI, V254, P5175, DOI 10.1016/j.apsusc.2008.02.019; Hu DS, 2008, CHINESE PHYS LETT, V25, P1822, DOI 10.1088/0256-307X/25/5/081; Iguchi K, 2001, J PHYS SOC JPN, V70, P593, DOI 10.1143/JPSJ.70.593; Khatir NM, 2015, MAT SCI SEMICON PROC, V36, P134, DOI 10.1016/j.mssp.2015.02.085; Khatir NM, 2014, APPL MECH MATER, V554, P155, DOI 10.4028/www.scientific.net/AMM.554.155; Khatir NM, 2014, SENSORS-BASEL, V14, P19229, DOI 10.3390/s141019229; Khatir NM, 2012, ADV MATER RES-SWITZ, V535-537, P1350, DOI 10.4028/www.scientific.net/AMR.535-537.1350; Khatir NM, 2012, SENSORS-BASEL, V12, P3578, DOI 10.3390/s120303578; Khatir NM, 2011, SENSORS-BASEL, V11, P6719, DOI 10.3390/s110706719; Kilina S, 2007, J PHYS CHEM C, V111, P14541, DOI 10.1021/jp070805u; Kumar S, 2005, INDIAN J PURE AP PHY, V43, P609; Martins SAM, 2010, ANAL LETT, V43, P2694, DOI 10.1080/00032711003731431; Muehsam D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061752; Muehsam DJ, 2009, BIOELECTROMAGNETICS, V30, P462, DOI 10.1002/bem.20494; Peter C, 2001, FRESEN J ANAL CHEM, V371, P120, DOI 10.1007/s002160101006; Rogers KR, 2001, ANAL CHIM ACTA, V444, P51, DOI 10.1016/S0003-2670(01)01150-3; Singh TB, 2009, ADV POLYM SCI, P73; Slavicek P, 2009, J AM CHEM SOC, V131, P6460, DOI 10.1021/ja8091246; Song J, 2005, SYNTHETIC MET, V155, P607, DOI 10.1016/j.synthmet.2005.08.011; TAUC J, 1966, PHYS STATUS SOLIDI, V15, P627, DOI 10.1002/pssb.19660150224; Tauc J., 1974, AMORPHOUS LIQUID SEM; Vlassakis J, 2010, PROC SPIE, V7762, DOI 10.1117/12.868284; Wang H, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.016401; Xiu-feng JY-xLJ-tG, 2006, CHINESE J CLIN REHAB, V10, P3; Yang X, 2004, P NATL ACAD SCI USA, V101, P17588, DOI 10.1073/pnas.0405157101; Yousef TA, 2010, J MOL STRUCT, V1035, P307	32	0	0	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0149488	10.1371/journal.pone.0149488	http://dx.doi.org/10.1371/journal.pone.0149488			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999445	gold, Green Submitted, Green Published			2022-12-26	WOS:000372694700008
J	Dileepan, M; Sarver, AE; Rao, SP; Panettieri, RA; Subramanian, S; Kannan, MS				Dileepan, Mythili; Sarver, Anne E.; Rao, Savita P.; Panettieri, Reynold A., Jr.; Subramanian, Subbaya; Kannan, Mathur S.			MicroRNA Mediated Chemokine Responses in Human Airway Smooth Muscle Cells	PLOS ONE			English	Article							NF-KAPPA-B; ALPHA-INDUCED SECRETION; TNF-ALPHA; SEVERE ASTHMA; MESSENGER-RNA; GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; INFLAMMATORY PHENOTYPE; TRANSCRIPTION FACTORS; CD38-DEFICIENT MICE	Airway smooth muscle (ASM) cells play a critical role in the pathophysiology of asthma due to their hypercontractility and their ability to proliferate and secrete inflammatory mediators. microRNAs (miRNAs) are gene regulators that control many signaling pathways and thus serve as potential therapeutic alternatives for many diseases. We have previously shown that miR-708 and miR-140-3p regulate the MAPK and PI3K signaling pathways in human ASM (HASM) cells following TNF-alpha exposure. In this study, we investigated the regulatory effect of these miRNAs on other asthma-related genes. Microarray analysis using the Illumina platform was performed with total RNA extracted from miR-708 (or control miR)-transfected HASM cells. Inhibition of candidate inflammation-associated gene expression was further validated by qPCR and ELISA. The most significant biologic functions for the differentially expressed gene set included decreased inflammatory response, cytokine expression and signaling. qPCR revealed inhibition of expression of CCL11, CXCL10, CCL2 and CXCL8, while the release of CCL11 was inhibited in miR-708-transfected cells. Transfection of cells with miR-140-3p resulted in inhibition of expression of CCL11, CXCL12, CXCL10, CCL5 and CXCL8 and of TNF-alpha-induced CXCL12 release. In addition, expression of RARRES2, CD44 and ADAM33, genes known to contribute to the pathophysiology of asthma, were found to be inhibited in miR-708-transfected cells. These results demonstrate that miR-708 and miR-140-3p exert distinct effects on inflammation-associated gene expression and biological function of ASM cells. Targeting these miRNA networks may provide a novel therapeutic mechanism to down-regulate airway inflammation and ASM proliferation in asthma.	[Dileepan, Mythili; Rao, Savita P.; Kannan, Mathur S.] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Sarver, Anne E.; Subramanian, Subbaya] Univ Minnesota, Surg, Minneapolis, MN USA; [Panettieri, Reynold A., Jr.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Pennsylvania	Kannan, MS (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	kanna001@umn.edu	panettieri, reynold/AAG-9485-2019	Subramanian, Subbaya/0000-0002-2544-480X	National Institutes of Health [P01-HL114471, P30-ES013508]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	RAP received funding from the National Institutes of Health (Grant Numbers: P01-HL114471 and P30-ES013508 to RAP).	Al Heialy S, 2013, AM J RESP CELL MOL, V49, P563, DOI 10.1165/rcmb.2012-0356OC; Alkhouri H, 2014, J Allergy (Cairo), V2014, P875105, DOI 10.1155/2014/875105; Alrashdan YA, 2012, AM J PHYSIOL-LUNG C, V302, pL1118, DOI 10.1152/ajplung.00232.2011; Amiri KI, 2003, PROG NUCLEIC ACID RE, V74, P1, DOI 10.1016/S0079-6603(03)01009-2; Ammit AJ, 2002, AM J RESP CELL MOL, V26, P465, DOI 10.1165/ajrcmb.26.4.4681; Ammit AJ, 2000, AM J RESP CELL MOL, V23, P794, DOI 10.1165/ajrcmb.23.6.4184; Amrani Y, 2001, MOL PHARMACOL, V60, P646; Amrani Y, 1999, J IMMUNOL, V163, P2128; Androlewicz MJ, 1999, IMMUNOL RES, V20, P79, DOI 10.1007/BF02786464; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berkman N, 1996, AM J RESP CRIT CARE, V154, P1804, DOI 10.1164/ajrccm.154.6.8970374; Bondue B, 2011, CYTOKINE GROWTH F R, V22, P331, DOI 10.1016/j.cytogfr.2011.11.004; Brightling CE, 2005, AM J RESP CRIT CARE, V171, P1103, DOI 10.1164/rccm.200409-1220OC; BURD PR, 1995, J EXP MED, V181, P1373, DOI 10.1084/jem.181.4.1373; Burgess JK, 2008, J CELL PHYSIOL, V216, P673, DOI 10.1002/jcp.21450; Chiba S, 2014, EUROPEAN RESP J S58, V44; Chung KF, 2006, EUR J PHARMACOL, V533, P110, DOI 10.1016/j.ejphar.2005.12.059; Clarke DL, 2010, J BIOL CHEM, V285, P29101, DOI 10.1074/jbc.M109.0999952; Cockcroft DW, 2006, J ALLERGY CLIN IMMUN, V118, P551, DOI 10.1016/j.jaci.2006.07.012; Damera G, 2011, BRIT J PHARMACOL, V163, P68, DOI 10.1111/j.1476-5381.2010.01165.x; de Bruin A, 2003, J BIOL CHEM, V278, P42041, DOI 10.1074/jbc.M308105200; Dekkers Bart G J, 2009, Proc Am Thorac Soc, V6, P683, DOI 10.1513/pats.200907-056DP; Deshpande DA, 2005, AM J RESP CELL MOL, V32, P149, DOI 10.1165/rcmb.2004-0243OC; Dileepan M, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0107-0; Dragon S, 2007, AM J PHYSIOL-LUNG C, V292, pL1023, DOI 10.1152/ajplung.00306.2006; Ekman AK, 2011, EUR J PHARMACOL, V652, P145, DOI 10.1016/j.ejphar.2010.11.009; El-Shazly A, 2006, J IMMUNOL, V176, P1860, DOI 10.4049/jimmunol.176.3.1860; Eynott PR, 2003, BRIT J PHARMACOL, V140, P1373, DOI 10.1038/sj.bjp.0705569; Gao YD, 2014, J ASTHMA, V51, P997, DOI 10.3109/02770903.2014.939283; Garantziotis S, 2009, J BIOL CHEM, V284, P11309, DOI 10.1074/jbc.M802400200; Genin P, 2000, J IMMUNOL, V164, P5352, DOI 10.4049/jimmunol.164.10.5352; Ghaffar O, 1999, AM J RESP CRIT CARE, V159, P1933, DOI 10.1164/ajrccm.159.6.9805039; Girodet PO, 2010, ALLERGY, V65, P1004, DOI 10.1111/j.1398-9995.2009.02308.x; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Grunstein MM, 2000, AM J PHYSIOL-LUNG C, V278, pL1154, DOI 10.1152/ajplung.2000.278.6.L1154; Guedes AGP, 2006, AM J PHYSIOL-LUNG C, V291, pL1286, DOI 10.1152/ajplung.00187.2006; Guedes AGP, 2015, CAN J PHYSIOL PHARM, V93, P145, DOI 10.1139/cjpp-2014-0410; Gunst SJ, 2000, EUR RESPIR J, V15, P600, DOI 10.1034/j.1399-3003.2000.15.29.x; Ha Tai-You, 2011, Immune Netw, V11, P11, DOI [10.4110/in.2011.11.3.135, 10.4110/in.2011.11.1.11]; Halwani R, 2011, J IMMUNOL, V186, P4156, DOI 10.4049/jimmunol.1001210; Hart R, 2010, J IMMUNOL, V185, P3728, DOI 10.4049/jimmunol.0902154; Hershenson MB, 2008, ANNU REV PATHOL-MECH, V3, P523, DOI 10.1146/annurev.pathmechdis.1.110304.100213; Hirst Stuart J, 2004, J Allergy Clin Immunol, V114, pS2, DOI 10.1016/j.jaci.2004.04.039; Holgate Stephen T, 2006, Proc Am Thorac Soc, V3, P440, DOI 10.1513/pats.200603-026AW; Hollins F, 2008, J IMMUNOL, V181, P2772, DOI 10.4049/jimmunol.181.4.2772; Hu RX, 2014, FASEB J, V28, P2347, DOI 10.1096/fj.13-247247; Ishikawa T, 2013, EUROPEAN RESP J S57, V42; John AE, 2009, J IMMUNOL, V183, P4682, DOI 10.4049/jimmunol.0803832; John M, 1998, AM J RESP CELL MOL, V18, P84, DOI 10.1165/ajrcmb.18.1.2813; John M, 1997, J IMMUNOL, V158, P1841; Jude JA, 2012, AM J PHYSIOL-LUNG C, V303, pL460, DOI 10.1152/ajplung.00041.2012; Katoh S, 2003, J CLIN INVEST, V111, P1563, DOI 10.1172/JCI200316583; Katoh S, 2007, AM J RESP CRIT CARE, V176, P27, DOI 10.1164/rccm.200608-1243OC; Khan MA, 2013, MULTIDISCIP RESP MED, V8, DOI 10.1186/2049-6958-8-11; Knox AJ, 2001, FASEB J, V15, P2480, DOI 10.1096/fj.01-0256com; Kuhn AR, 2010, AM J RESP CELL MOL, V42, P506, DOI 10.1165/rcmb.2009-0123OC; Lazaar AL, 2001, J IMMUNOL, V166, P155, DOI 10.4049/jimmunol.166.1.155; LAZAAR AL, 1994, J EXP MED, V180, P807, DOI 10.1084/jem.180.3.807; Lazzeri N, 2001, EUR J PHARMACOL, V433, P231, DOI 10.1016/S0014-2999(01)01520-5; Lee IS, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/872142; Lin TY, 2014, CLIN EXP ALLERGY, V44, P1347, DOI 10.1111/cea.12421; Manetsch M, 2012, AM J PHYSIOL-LUNG C, V302, pL838, DOI 10.1152/ajplung.00317.2011; Mariani F, 2015, INFLAMM RES, V64, P85, DOI 10.1007/s00011-014-0792-7; Martinez-Nunez RT, 2011, J BIOL CHEM, V286, P1786, DOI 10.1074/jbc.M110.169367; McKay S, 2000, AM J RESP CELL MOL, V23, P103, DOI 10.1165/ajrcmb.23.1.3765; NOVERAL JP, 1994, AM J PHYSIOL-LUNG C, V267, pL761, DOI 10.1152/ajplung.1994.267.6.L761; Ozier Annaig, 2011, J Allergy (Cairo), V2011, P742710, DOI 10.1155/2011/742710; PANETTIERI RA, 1995, J IMMUNOL, V154, P2358; Paulissen G, 2006, MOL MED, V12, P171, DOI 10.2119/2006-00028.Paulissen; Perez-Zoghbi JF, 2007, AM J PHYSIOL-LUNG C, V293, pL1000, DOI 10.1152/ajplung.00184.2007; Perry MM, 2014, AM J RESP CELL MOL, V50, P7, DOI 10.1165/rcmb.2013-0067OC; Phelan PD, 2002, J ALLERGY CLIN IMMUN, V109, P189, DOI 10.1067/mai.2002.120951; Prefontaine D, 2009, J IMMUNOL, V183, P5094, DOI 10.4049/jimmunol.0802387; Rahman MS, 2006, J IMMUNOL, V177, P4064, DOI 10.4049/jimmunol.177.6.4064; Rajah R, 1999, AM J RESP CELL MOL, V20, P199, DOI 10.1165/ajrcmb.20.2.3148; Redhu NS, 2011, AM J PHYSIOL-LUNG C, V300, pL479, DOI 10.1152/ajplung.00301.2009; Roger T, 1998, BIOCHEM J, V330, P429, DOI 10.1042/bj3300429; Saunders MA, 1997, BRIT J PHARMACOL, V120, P545, DOI 10.1038/sj.bjp.0700998; Singh SR, 2014, ALLERGY, V69, P1189, DOI 10.1111/all.12444; Sutcliffe A, 2006, THORAX, V61, P657, DOI 10.1136/thx.2005.056770; Tan XH, 2012, AM J PHYSIOL-LUNG C, V302, P1700, DOI 10.1152/ajplung.00167.2011; Tatter AL, 2011, J IMMUNOL, V187, P6094, DOI 10.4049/jimmunol.1003507; Tliba O, 2009, ANNU REV PHYSIOL, V71, P509, DOI 10.1146/annurev.physiol.010908.163227; Tsitsiou E, 2012, J ALLERGY CLIN IMMUN, V129, P95, DOI 10.1016/j.jaci.2011.08.011; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Wenzel S, 2012, CLIN EXP ALLERGY, V42, P650, DOI 10.1111/j.1365-2222.2011.03929.x; Wuyts WA, 2003, RESP MED, V97, P811, DOI 10.1016/S0954-6111(03)00036-2; Xu J, 1999, Respirology, V4, P413, DOI 10.1046/j.1440-1843.1999.00214.x; Zhang KQ, 2007, AM J PHYSIOL-LUNG C, V293, pL375, DOI 10.1152/ajplung.00045.2007	89	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0150842	10.1371/journal.pone.0150842	http://dx.doi.org/10.1371/journal.pone.0150842			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998837	Green Published, Green Submitted, gold			2022-12-26	WOS:000372694700016
J	Keys, PW; Wang-Erlandsson, L; Gordon, LJ				Keys, Patrick W.; Wang-Erlandsson, Lan; Gordon, Line J.			Revealing Invisible Water: Moisture Recycling as an Ecosystem Service	PLOS ONE			English	Article							HYDROLOGICAL CYCLE; CONTRASTING ROLES; PRECIPITATION; IRRIGATION; RAINFALL; IMPACT; FOREST; TRANSPIRATION; DEFORESTATION; VULNERABILITY	An ecosystem service is a benefit derived by humanity that can be traced back to an ecological process. Although ecosystem services related to surface water have been thoroughly described, the relationship between atmospheric water and ecosystem services has been mostly neglected, and perhaps misunderstood. Recent advances in land-atmosphere modeling have revealed the importance of terrestrial ecosystems for moisture recycling. In this paper, we analyze the extent to which vegetation sustains the supply of atmospheric moisture and precipitation for downwind beneficiaries, globally. We simulate land-surface evaporation with a global hydrology model and track changes to moisture recycling using an atmospheric moisture budget model, and we define vegetation-regulated moisture recycling as the difference in moisture recycling between current vegetation and a hypothetical desert world. Our results show that nearly a fifth of annual average precipitation falling on land is from vegetation-regulated moisture recycling, but the global variability is large, with many places receiving nearly half their precipitation from this ecosystem service. The largest potential impacts for changes to this ecosystem service are land-use changes across temperate regions in North America and Russia. Likewise, in semi-arid regions reliant on rainfed agricultural production, land-use change that even modestly reduces evaporation and subsequent precipitation, could significantly affect human well-being. We also present a regional case study in the Mato Grosso region of Brazil, where we identify the specific moisture recycling ecosystem services associated with the vegetation in Mato Grosso. We find that Mato Grosso vegetation regulates some internal precipitation, with a diffuse region of benefit downwind, primarily to the south and east, including the La Plata River basin and the megacities of Sao Paulo and Rio de Janeiro. We synthesize our global and regional results into a generalized framework for describing moisture recycling as an ecosystem service. We conclude that future work ought to disentangle whether and how this vegetationregulated moisture recycling interacts with other ecosystem services, so that trade-offs can be assessed in a comprehensive and sustainable manner.	[Keys, Patrick W.; Wang-Erlandsson, Lan; Gordon, Line J.] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Keys, Patrick W.] Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA; [Wang-Erlandsson, Lan] Delft Univ Technol, Fac Civil Engn & Geosci, Dept Water Management, Delft, Netherlands	Stockholm University; Colorado State University; Delft University of Technology	Keys, PW (corresponding author), Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden.; Keys, PW (corresponding author), Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA.	patrick.keys@su.se	Wang-Erlandsson, Lan/V-5999-2019; Keys, Patrick/AAK-1359-2021	Wang-Erlandsson, Lan/0000-0002-7739-5069; Keys, Patrick/0000-0002-7250-1563; Gordon, Line/0000-0002-3520-4340	Swedish Research Council Formas [1364115]; BioCycle Group at Colorado State University	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); BioCycle Group at Colorado State University	The research for this work was supported by The Swedish Research Council Formas, under grant number 1364115. Auxiliary support was provided by Scott Denning and the BioCycle Group at Colorado State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, SOCIAL ECOLOGICAL RE; Ayres MP, 2014, ADV GLOB CHANGE RES, V57, P55, DOI 10.1007/978-94-007-7515-2_4; Bagley JE, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014009; Berger M, 2014, ENVIRON SCI TECHNOL, V48, P4521, DOI 10.1021/es404994t; Brauman KA, 2007, ANNU REV ENV RESOUR, V32, P67, DOI 10.1146/annurev.energy.32.031306.102758; Daily G.C., 1997, NATURES SERVICES SOC, P1; Daily GC, 2008, P NATL ACAD SCI USA, V105, P9455, DOI 10.1073/pnas.0804960105; Dee DP, 2011, Q J ROY METEOR SOC, V137, P553, DOI 10.1002/qj.828; Dirmeyer PA, 1999, J GEOPHYS RES-ATMOS, V104, P19383, DOI 10.1029/1999JD900222; Dominguez F, 2006, J CLIMATE, V19, P1513, DOI 10.1175/JCLI3691.1; Ebbesson J., 2014, SCAND STUD, V59, P259; Ellison D, 2012, GLOBAL CHANGE BIOL, V18, P806, DOI 10.1111/j.1365-2486.2011.02589.x; Falkenmark M., 2007, WATER FOOD WATER LIF, P234; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Gimeno L, 2012, REV GEOPHYS, V50, DOI 10.1029/2012RG000389; Goessling HF, 2011, HYDROL EARTH SYST SC, V15, P3217, DOI 10.5194/hess-15-3217-2011; Gordon LJ, 2010, AGR WATER MANAGE, V97, P512, DOI 10.1016/j.agwat.2009.03.017; Gordon LJ, 2005, P NATL ACAD SCI USA, V102, P7612, DOI 10.1073/pnas.0500208102; Green PA, 2015, GLOBAL ENVIRON CHANG, V34, P108, DOI 10.1016/j.gloenvcha.2015.06.007; Guerry AD, 2015, P NATL ACAD SCI USA, V112, P7348, DOI 10.1073/pnas.1503751112; Guimberteau M, 2012, CLIM DYNAM, V39, P1329, DOI 10.1007/s00382-011-1252-5; Hirota M, 2011, SCIENCE, V334, P232, DOI 10.1126/science.1210657; Jacobi P, 2004, ENVIRON URBAN, V16, P199, DOI 10.1177/095624780401600211; Keys PW, 2014, HYDROL EARTH SYST SC, V18, P3937, DOI 10.5194/hess-18-3937-2014; Keys PW, 2012, BIOGEOSCIENCES, V9, P733, DOI 10.5194/bg-9-733-2012; Kiage LM, 2013, PROG PHYS GEOG, V37, P664, DOI 10.1177/0309133313492543; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; LETTAU H, 1979, MON WEATHER REV, V107, P227, DOI 10.1175/1520-0493(1979)107<0227:AHCATR>2.0.CO;2; Lo MH, 2013, GEOPHYS RES LETT, V40, P301, DOI 10.1002/grl.50108; Maes J, 2015, LANDSCAPE ECOL, V30, P517, DOI 10.1007/s10980-014-0083-2; Makarieva AM, 2014, J HYDROMETEOROL, V15, P411, DOI 10.1175/JHM-D-12-0190.1; McDonald RI, 2014, GLOBAL ENVIRON CHANG, V27, P96, DOI 10.1016/j.gloenvcha.2014.04.022; Morton JF, 2007, P NATL ACAD SCI USA, V104, P19680, DOI 10.1073/pnas.0701855104; Nabinger C, 2000, CAMPOS SO BRAZIL GRA, P355; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Peden D., 2007, WATER FOOD WATER LIF; Pitman AJ, 2012, EARTH SYST DYNAM, V3, P213, DOI 10.5194/esd-3-213-2012; Potschin MB, 2011, PROG PHYS GEOG, V35, P575, DOI 10.1177/0309133311423172; Queiroz C, 2014, FRONT ECOL ENVIRON, V12, P288, DOI 10.1890/120348; Raudsepp-Hearne C, 2010, P NATL ACAD SCI USA, V107, P5242, DOI 10.1073/pnas.0907284107; Rost S, 2008, ADV GEOSCIENCES, V18, P43, DOI [DOI 10.5194/ADGEO-18-43-2008, DOI 10.5194/ADGE0-18-43-2008]; Sacks WJ, 2010, GLOBAL ECOL BIOGEOGR, V19, P607, DOI 10.1111/j.1466-8238.2010.00551.x; Schar C, 1999, J CLIMATE, V12, P722, DOI 10.1175/1520-0442(1999)012<0722:TSPFAP>2.0.CO;2; Shvidenko AZ, 2013, CONTEMP PROBL ECOL+, V6, P683, DOI 10.1134/S199542551307010X; Spera SA, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/6/064010; Spracklen DV, 2015, GEOPHYS RES LETT, V42, P9546, DOI 10.1002/2015GL066063; Stohl A, 1998, ATMOS ENVIRON, V32, P4245, DOI 10.1016/S1352-2310(98)00184-8; Tuinenburg OA, 2014, J HYDROMETEOROL, V15, P1028, DOI 10.1175/JHM-D-13-078.1; Tuinenburg OA, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016221; van der Ent RJ, 2014, EARTH SYST DYNAM, V5, P471, DOI 10.5194/esd-5-471-2014; van der Ent RJ, 2011, ATMOS CHEM PHYS, V11, P1853, DOI 10.5194/acp-11-1853-2011; van der Ent RJ, 2013, WATER RESOUR RES, V49, P3993, DOI 10.1002/wrcr.20296; van der Ent RJ, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009127; Wang-Erlandsson L, 2014, EARTH SYST DYNAM, V5, P441, DOI 10.5194/esd-5-441-2014; Wei JF, 2013, J HYDROMETEOROL, V14, P275, DOI 10.1175/JHM-D-12-079.1; Zambelli Mônica, 2011, Sba Controle & Automação, V22, P598, DOI 10.1590/S0103-17592011000600005; Zemp DC, 2014, ATMOS CHEM PHYS, V14, P13337, DOI 10.5194/acp-14-13337-2014	57	73	73	8	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151993	10.1371/journal.pone.0151993	http://dx.doi.org/10.1371/journal.pone.0151993			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998832	Green Published, gold			2022-12-26	WOS:000372694700091
J	Bogart, E; Myers, CR				Bogart, Eli; Myers, Christopher R.			Multiscale Metabolic Modeling of C4 Plants: Connecting Nonlinear Genome-Scale Models to Leaf-Scale Metabolism in Developing Maize Leaves	PLOS ONE			English	Article							FLUX BALANCE ANALYSIS; C-4 PHOTOSYNTHESIS; BUNDLE-SHEATH; DEVELOPMENTAL DYNAMICS; MESSENGER-RNA; PATHWAY; EVOLUTION; DATABASE; DECARBOXYLATION; PROTEOMICS	C4 plants, such as maize, concentrate carbon dioxide in a specialized compartment surrounding the veins of their leaves to improve the efficiency of carbon dioxide assimilation. Nonlinear relationships between carbon dioxide and oxygen levels and reaction rates are key to their physiology but cannot be handled with standard techniques of constraint-based metabolic modeling. We demonstrate that incorporating these relationships as constraints on reaction rates and solving the resulting nonlinear optimization problem yields realistic predictions of the response of C4 systems to environmental and biochemical perturbations. Using a new genome-scale reconstruction of maize metabolism, we build an 18000-reaction, nonlinearly constrained model describing mesophyll and bundle sheath cells in 15 segments of the developing maize leaf, interacting via metabolite exchange, and use RNA-seq and enzyme activity measurements to predict spatial variation in metabolic state by a novel method that optimizes correlation between fluxes and expression data. Though such correlations are known to be weak in general, we suggest that developmental gradients may be particularly suited to the inference of metabolic fluxes from expression data, and we demonstrate that our method predicts fluxes that achieve high correlation with the data, successfully capture the experimentally observed base-to-tip transition between carbon-importing tissue and carbon-exporting tissue, and include a nonzero growth rate, in contrast to prior results from similar methods in other systems.	[Bogart, Eli; Myers, Christopher R.] Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA; [Bogart, Eli; Myers, Christopher R.] Cornell Univ, Inst Biotechnol, Ithaca, NY USA; [Bogart, Eli] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA	Cornell University; Cornell University; Harvard University; Brigham & Women's Hospital	Myers, CR (corresponding author), Cornell Univ, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA.; Myers, CR (corresponding author), Cornell Univ, Inst Biotechnol, Ithaca, NY USA.	c.myers@cornell.edu	Myers, Christopher R/I-8516-2017		National Science Foundation [IOS-1127017]; Bill and Melinda Gates Foundation	National Science Foundation(National Science Foundation (NSF)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the National Science Foundation (www.nsf.gov) grant IOS-1127017 to CRM and a grant from the Bill and Melinda Gates Foundation (www.gatesfoundation.org) to the International Rice Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker BE, 2015, COMPUT BIOL CHEM, V59, P98, DOI 10.1016/j.compbiolchem.2015.08.002; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Bellasio C, 2014, PLANT CELL ENVIRON, V37, P1046, DOI 10.1111/pce.12194; Bordbar A, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.68; Bornstein BJ, 2008, BIOINFORMATICS, V24, P880, DOI 10.1093/bioinformatics/btn051; Boyd S., 2004, CONVEX OPTIMIZATION; Boyle NR, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-4; Brown R.H., 1999, C4 PLANT BIOL, P473, DOI DOI 10.1016/B978-012614440-6/50015-X; Chang RL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.52; Cheung CYM, 2014, PLANT PHYSIOL, V165, P917, DOI 10.1104/pp.113.234468; Chiu HC, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003695; Chowdhury A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003487; Christin PA, 2009, GENOME BIOL EVOL, V1, P221, DOI 10.1093/gbe/evp020; Colijn C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000489; Cotten C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-32; Covshoff S, 2012, CURR OPIN BIOTECH, V23, P209, DOI 10.1016/j.copbio.2011.12.011; Dal'Molin CGD, 2010, PLANT PHYSIOL, V154, P1871, DOI 10.1104/pp.110.166488; Dal'Molin CGD, 2010, PLANT PHYSIOL, V152, P579, DOI 10.1104/pp.109.148817; Feng XY, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002376; Fernandez-Pozo N, 2014, NUCLEIC ACIDS RES, V39, pD1149; Furbank RT, 2011, J EXP BOT, V62, P3103, DOI 10.1093/jxb/err080; GLPK, 2011, GNU LIN PROGR KIT VE; Grafahrend-Belau E, 2013, PLANT PHYSIOL, V163, P637, DOI 10.1104/pp.113.224006; Griffiths H, 2013, PLANT CELL ENVIRON, V36, P249, DOI 10.1111/j.1365-3040.2012.02585.x; Gutenkunst RN, 2007, SLOPPYCELL; HATCH MD, 1987, BIOCHIM BIOPHYS ACTA, V895, P81, DOI 10.1016/S0304-4173(87)80009-5; Heckmann D, 2013, CELL, V153, P1579, DOI 10.1016/j.cell.2013.04.058; Heinken A, 2013, GUT MICROBES, V4, P28, DOI 10.4161/gmic.22370; Hibberd JM, 2010, ANNU REV PLANT BIOL, V61, P181, DOI 10.1146/annurev-arplant-042809-112238; Hoppe A, 2012, METABOLITES, V2, P614, DOI 10.3390/metabo2030614; HSL, 2013, COLL FORTR COD LARG; Hucka M, 2003, BIOINFORMATICS, V19, P524, DOI 10.1093/bioinformatics/btg015; Jamshidi N, 2010, BIOPHYS J, V98, P175, DOI 10.1016/j.bpj.2009.09.064; Jung S, 2014, NUCLEIC ACIDS RES, V42, pD1237, DOI 10.1093/nar/gkt1012; Kanai R., 1999, C4 PLANT BIOL, P49, DOI [10.5860/choice.36-6275, DOI 10.5860/CHOICE.36-6275, DOI 10.1016/B978-012614440-6/50004-5]; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Khandelwal RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064567; Kromdijk J, 2010, PLANT CELL ENVIRON, V33, P1935, DOI 10.1111/j.1365-3040.2010.02196.x; Latendresse M, 2012, BIOINFORMATICS, V28, P388, DOI 10.1093/bioinformatics/btr681; Lee D, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-73; Lewis NE, 2010, NAT BIOTECHNOL, V28, P1279, DOI 10.1038/nbt.1711; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Machado D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003580; Mahadevan R, 2002, BIOPHYS J, V83, P1331, DOI 10.1016/S0006-3495(02)73903-9; Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002; Majeran W, 2010, PLANT CELL, V22, P3509, DOI 10.1105/tpc.110.079764; Monaco MK, 2014, NUCLEIC ACIDS RES, V42, pD1193, DOI 10.1093/nar/gkt1110; Myers CR, 2007, COMPUT SCI ENG, V9, P34, DOI 10.1109/MCSE.2007.60; Naithani S, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00644; Nelson T, 2011, J EXP BOT, V62, P3039, DOI 10.1093/jxb/err072; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Plant Metabolic Network (PMN), 2014, ENZ FUNCT ANN METH; Plant Metabolic Network (PMN), 2014, PMN DAT CONT STAT; Plant Metabolic Network (PMN), 2013, CORNCYC 4 0; Ponnala L, 2014, PLANT J, V78, P424, DOI 10.1111/tpj.12482; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Sage RF, 2004, NEW PHYTOL, V161, P341, DOI 10.1111/j.1469-8137.2004.00974.x; Sage RF, 2011, J EXP BOT, V62, P3155, DOI 10.1093/jxb/err048; Saha R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021784; Salimi F, 2010, BIOTECHNOL J, V5, P726, DOI 10.1002/biot.201000159; Sandve GK, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003285; Schwender J, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00668; Simons M, 2014, PLANT PHYSIOL, V166, P1659, DOI 10.1104/pp.114.245787; Smallbone K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-6; Stanford NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079195; Stolyar S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100131; Studer AJ, 2014, PLANT PHYSIOL, V165, P608, DOI 10.1104/pp.114.237602; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Tan Y, 2011, METAB ENG, V13, P60, DOI 10.1016/j.ymben.2010.11.001; Tausta SL, 2014, J EXP BOT, V65, P3543, DOI 10.1093/jxb/eru152; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Urbanczyk-Wochniak E, 2007, BIOINFORMATICS, V23, P1418, DOI 10.1093/bioinformatics/btm040; von Caemmerer S, 2003, PHOTOSYNTH RES, V77, P191, DOI 10.1023/A:1025830019591; von Caemmerer S., 2000, BIOCH MODELS LEAF PH; von Caemmerer S, 2012, SCIENCE, V336, P1671, DOI 10.1126/science.1220177; Wachter A, 2006, MATH PROGRAM, V106, P25, DOI 10.1007/s10107-004-0559-y; Wang L, 2014, NAT BIOTECHNOL, V32, P1158, DOI 10.1038/nbt.3019; Wang Y, 2014, J EXP BOT, V65, P3567, DOI 10.1093/jxb/eru058; Wang Y, 2014, PLANT PHYSIOL, V164, P2231, DOI 10.1104/pp.113.230284; Way DA, 2014, J EXP BOT, V65, P3683, DOI 10.1093/jxb/eru205; Wingler A, 1999, PLANT PHYSIOL, V120, P539, DOI 10.1104/pp.120.2.539; Zengler K, 2012, NAT REV MICROBIOL, V10, P366, DOI 10.1038/nrmicro2763; Zhuang K, 2011, ISME J, V5, P305, DOI 10.1038/ismej.2010.117; Zomorrodi AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002363; Zomorrodi AR, 2014, ACS SYNTH BIOL, V3, P247, DOI 10.1021/sb4001307	87	26	26	3	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151722	10.1371/journal.pone.0151722	http://dx.doi.org/10.1371/journal.pone.0151722			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990967	Green Submitted, Green Published, gold			2022-12-26	WOS:000372582800091
J	Lim, M; Roosink, M; Kim, JS; Kim, HW; Lee, EB; Son, KM; Kim, HA; Chung, CK				Lim, Manyoel; Roosink, Meyke; Kim, June Sic; Kim, Hye Won; Lee, Eun Bong; Son, Kyeong Min; Kim, Hyun Ah; Chung, Chun Kee			Augmented Pain Processing in Primary and Secondary Somatosensory Cortex in Fibromyalgia: A Magnetoencephalography Study Using Intra-Epidermal Electrical Stimulation	PLOS ONE			English	Article							EVOKED MAGNETIC-FIELDS; 2ND PAIN; TEMPORAL SUMMATION; CORTICAL RESPONSES; CLINICAL PAIN; FUNCTIONAL CONNECTIVITY; CERVICAL RADICULOPATHY; LASER STIMULATION; FIBER STIMULATION; MODULATION	The aim of this study was to investigate augmented pain processing in the cortical somatosensory system in patients with fibromyalgia (FM). Cortical evoked responses were recorded in FM (n = 19) and healthy subjects (n = 21) using magnetoencephalography after noxious intra-epidermal electrical stimulation (IES) of the hand dorsum (pain rating 6 on a numeric rating scale, perceptually-equivalent). In addition, healthy subjects were stimulated using the amplitude corresponding to the average stimulus intensity rated 6 in patients with FM (intensity-equivalent). Quantitative sensory testing was performed on the hand dorsum or thenar muscle (neutral site) and over the trapezius muscle (tender point), using IES (thresholds, ratings, temporal summation of pain, stimulus-response curve) and mechanical stimuli (threshold, ratings). Increased amplitude of cortical responses was found in patients with FM as compared to healthy subjects. These included the contralateral primary (S1) and bilateral secondary somatosensory cortices (S2) in response to intensity-equivalent stimuli and the contralateral S1 and S2 in response to perceptually-equivalent stimuli. The amplitude of the contralateral S2 response in patients with FM was positively correlated with average pain intensity over the last week. Quantitative sensory testing results showed that patients with FM were more sensitive to painful IES as well as to mechanical stimulation, regardless of whether the stimulation site was the hand or the trapezius muscle. Interestingly, the slope of the stimulus-response relationship as well as temporal summation of pain in response to IES was not different between groups. Together, these results suggest that the observed pain augmentation in response to IES in patients with FM could be due to sensitization or disinhibition of the cortical somatosensory system. Since the S2 has been shown to play a role in higher-order functions, further studies are needed to clarify the role of augmented S2 response in clinical characteristics of FM.	[Lim, Manyoel; Roosink, Meyke; Chung, Chun Kee] Seoul Natl Univ, Coll Med, Neurosci Res Inst, Seoul, South Korea; [Roosink, Meyke] Radboud Univ Nijmegen, Med Ctr, Dept Rehabil, NL-6525 ED Nijmegen, Netherlands; [Kim, June Sic; Chung, Chun Kee] Seoul Natl Univ, Coll Nat Sci, Dept Brain & Cognit Sci, Seoul 151742, South Korea; [Kim, Hye Won; Lee, Eun Bong] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Rheumatol, Seoul 151, South Korea; [Kim, Hye Won] Eulji Univ, Sch Med, Eulji Gen Hosp, Div Rheumatol,Dept Internal Med, Seoul, South Korea; [Son, Kyeong Min; Kim, Hyun Ah] Hallym Univ, Coll Med, Dept Internal Med, Chunchon, South Korea; [Kim, Hyun Ah] Hallym Univ, Sacred Heart Hosp, Dept Internal Med, Div Rheumatol, Anyang, South Korea; [Chung, Chun Kee] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul 110744, South Korea	Seoul National University (SNU); Radboud University Nijmegen; Seoul National University (SNU); Seoul National University (SNU); Eulji University; Hallym University; Hallym University; Seoul National University (SNU); Seoul National University Hospital	Chung, CK (corresponding author), Seoul Natl Univ, Coll Med, Neurosci Res Inst, Seoul, South Korea.; Chung, CK (corresponding author), Seoul Natl Univ, Coll Nat Sci, Dept Brain & Cognit Sci, Seoul 151742, South Korea.	chungc@snu.ac.kr	Song, Young Goo/AGV-5104-2022	Song, Young Goo/0000-0002-0733-4156	National Research Foundation of Korea (NRF) - Korea government (MSIP) [NRF-2014R1A2A1A11049662]	National Research Foundation of Korea (NRF) - Korea government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIP) (NRF-2014R1A2A1A11049662). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Banic B, 2004, PAIN, V107, P7, DOI 10.1016/j.pain.2003.05.001; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Berglund B, 2002, PAIN, V96, P177, DOI 10.1016/S0304-3959(01)00443-2; Blumenstiel K, 2011, CLIN J PAIN, V27, P682, DOI 10.1097/AJP.0b013e3182177654; BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728; Burgmer M, 2009, NEUROIMAGE, V44, P502, DOI 10.1016/j.neuroimage.2008.09.008; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Caetano G, 2010, CEREB CORTEX, V20, P1898, DOI 10.1093/cercor/bhp260; Choi W, 2015, CLIN NEUROPHYSIOL, V126, P1310, DOI 10.1016/j.clinph.2014.10.012; Cook DB, 2004, J RHEUMATOL, V31, P364; Desmeules JA, 2003, ARTHRITIS RHEUM-US, V48, P1420, DOI 10.1002/art.10893; Fallon N, 2013, CLIN NEUROPHYSIOL, V124, P154, DOI 10.1016/j.clinph.2012.06.014; Forss N, 2005, NEUROIMAGE, V24, P132, DOI 10.1016/j.neuroimage.2004.09.032; Geisser ME, 2008, J PAIN, V9, P417, DOI 10.1016/j.jpain.2007.12.006; Gracely RH, 2002, ARTHRITIS RHEUM-US, V46, P1333, DOI 10.1002/art.10225; Gross J, 2013, NEUROIMAGE, V65, P349, DOI 10.1016/j.neuroimage.2012.10.001; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Inui K, 2006, CEREB CORTEX, V16, P355, DOI 10.1093/cercor.bhi114; Inui K, 2003, EUR J NEUROSCI, V18, P2859, DOI 10.1111/j.1460-9568.2003.02995.x; Inui K, 2003, NEUROSCIENCE, V120, P235, DOI 10.1016/S0306-4522(03)00261-6; Inui K, 2002, PAIN, V96, P247, DOI 10.1016/S0304-3959(01)00453-5; Inui K, 2012, J NEUROL NEUROSUR PS, V83, P551, DOI 10.1136/jnnp-2011-301484; Jensen KB, 2013, ARTHRITIS RHEUM-US, V65, P3293, DOI 10.1002/art.38170; Jensen KB, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-32; Jensen KB, 2009, PAIN, V144, P95, DOI 10.1016/j.pain.2009.03.018; Julien N, 2005, PAIN, V114, P295, DOI 10.1016/j.pain.2004.12.032; Kim DJ, 2014, ARTHRITIS RHEUMATOL, V66, P3190, DOI 10.1002/art.38771; Kirveskari E, 2015, EUR J PAIN, V19, P1168, DOI 10.1002/ejp.642; Kosek E, 1997, PAIN, V70, P41, DOI 10.1016/S0304-3959(96)03295-2; Kosek E, 1996, PAIN, V68, P375, DOI 10.1016/S0304-3959(96)03188-0; Lannersten L, 2010, PAIN, V151, P77, DOI 10.1016/j.pain.2010.06.021; Lautenbacher S, 1997, CLIN J PAIN, V13, P189, DOI 10.1097/00002508-199709000-00003; LAUTENBACHER S, 1994, PAIN, V59, P45, DOI 10.1016/0304-3959(94)90046-9; Lim M, 2015, PAIN, V156, P666, DOI 10.1097/j.pain.0000000000000096; Lim M, 2012, NEUROIMAGE, V61, P660, DOI 10.1016/j.neuroimage.2012.04.003; Lim M, 2011, CLIN NEUROPHYSIOL, V122, P2246, DOI 10.1016/j.clinph.2011.03.001; Lorenz J, 1996, EVOKED POTENTIAL, V100, P165, DOI 10.1016/0013-4694(95)00259-6; Maestu C, 2013, CLIN NEUROPHYSIOL, V124, P752, DOI 10.1016/j.clinph.2012.09.015; McDermid AJ, 1996, PAIN, V66, P133, DOI 10.1016/0304-3959(96)03059-X; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Mima T, 1998, J NEUROPHYSIOL, V80, P2215, DOI 10.1152/jn.1998.80.4.2215; Montoya P, 2006, ARTHRITIS RHEUM-US, V54, P1995, DOI 10.1002/art.21910; Motogi J, 2014, NEUROSCI LETT, V570, P69, DOI 10.1016/j.neulet.2014.04.001; Mouraux A, 2010, PAIN, V150, P199, DOI 10.1016/j.pain.2010.04.026; Mouraux A, 2014, NEUROSCI LETT, V561, P69, DOI 10.1016/j.neulet.2013.12.017; Nakata H, 2004, PAIN, V107, P91, DOI 10.1016/j.pain.2003.10.001; Nakata H, 2008, NEUROIMAGE, V42, P858, DOI 10.1016/j.neuroimage.2008.05.017; Nakata H, 2009, NEUROREPORT, V20, P1149, DOI 10.1097/WNR.0b013e32832f81d6; Nielsen LA, 2007, BEST PRACT RES CL RH, V21, P465, DOI 10.1016/j.berh.2007.03.007; Ogino Y, 2005, ANESTHESIOLOGY, V103, P821, DOI 10.1097/00000542-200510000-00021; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Omori S, 2013, CLIN NEUROPHYSIOL, V124, P1422, DOI 10.1016/j.clinph.2013.01.006; Persson AL, 2004, J REHABIL MED, V36, P17, DOI 10.1080/16501970310015218; Petzke F, 2003, PAIN, V105, P403, DOI 10.1016/S0304-3959(03)00204-5; Pfau DB, 2012, CURR PAIN HEADACHE R, P1; Pfau DB, 2009, PAIN, V147, P72, DOI 10.1016/j.pain.2009.08.010; Ploner M, 1999, J NEUROPHYSIOL, V81, P3100, DOI 10.1152/jn.1999.81.6.3100; Pollok B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015804; Potvin S, 2012, PAIN RES TREAT, V2012, DOI 10.1155/2012/938595; PRICE DD, 1977, PAIN, V3, P57, DOI 10.1016/0304-3959(77)90035-5; Price DD, 2002, PAIN, V99, P49, DOI 10.1016/S0304-3959(02)00053-2; Pujol J, 2014, PAIN, V155, P1492, DOI 10.1016/j.pain.2014.04.028; Pujol J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005224; Rhudy JL, 2013, PAIN, V154, P1045, DOI 10.1016/j.pain.2013.03.025; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Schmidt-Wilcke T, 2011, NAT REV RHEUMATOL, V7, P518, DOI 10.1038/nrrheum.2011.98; Schnitzler A, 2000, J CLIN NEUROPHYSIOL, V17, P592, DOI 10.1097/00004691-200011000-00005; Schweinhardt P, 2008, NEUROSCIENTIST, V14, P415, DOI 10.1177/1073858407312521; Seifert F, 2011, CURR OPIN ANESTHESIO, V24, P515, DOI 10.1097/ACO.0b013e32834a1079; Serra J, 2014, ANN NEUROL, V75, P196, DOI 10.1002/ana.24065; Staud R, 2003, PAIN, V101, P167, DOI 10.1016/S0304-3959(02)00325-1; Staud R, 2001, PAIN, V91, P165, DOI 10.1016/S0304-3959(00)00432-2; Staud R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089086; Staud R, 2012, J PAIN, V13, P725, DOI 10.1016/j.jpain.2012.04.006; Staud R, 2011, CURR RHEUMATOL REP, V13, P513, DOI 10.1007/s11926-011-0206-6; Staud R, 2009, RHEUM DIS CLIN N AM, V35, P263, DOI 10.1016/j.rdc.2009.05.006; Tampin B, 2013, EUR J PAIN, V17, P621, DOI 10.1002/j.1532-2149.2012.00227.x; Tampin B, 2012, PAIN, V153, P2403, DOI 10.1016/j.pain.2012.08.007; Taulu S, 2006, PHYS MED BIOL, V51, P1759, DOI 10.1088/0031-9155/51/7/008; Torquati K, 2003, NEUROIMAGE, V20, P1704, DOI 10.1016/S1053-8119(03)00439-7; Uceyler N, 2013, BRAIN, V136, P1857, DOI 10.1093/brain/awt053; Vartiainen NV, 2008, CLIN NEUROPHYSIOL, V119, P2380, DOI 10.1016/j.clinph.2008.06.008; Vierck CJ, 2006, PAIN, V124, P242, DOI 10.1016/j.pain.2006.06.001; Wolfe F, 2012, CLIN EXP RHEUMATOL, V30, pS88	86	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151776	10.1371/journal.pone.0151776	http://dx.doi.org/10.1371/journal.pone.0151776			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992095	Green Published, gold, Green Submitted			2022-12-26	WOS:000372582800100
J	Harprecht, C; Okifo, O; Robbins, KJ; Motwani, T; Alexandrescu, AT; Teschke, CM				Harprecht, Christina; Okifo, Oghenefejiro; Robbins, Kevin J.; Motwani, Tina; Alexandrescu, Andrei T.; Teschke, Carolyn M.			Contextual Role of a Salt Bridge in the Phage P22 Coat Protein I-Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteriophage; nuclear magnetic resonance (NMR); protein folding; protein stability; virus; ionization constant; nanoparticle; procapsid	AMINO-ACID SUBSTITUTIONS; P22 SCAFFOLDING PROTEIN; BACTERIOPHAGE P22; HYDROGEN-EXCHANGE; ASSEMBLY IDENTIFICATION; STAPHYLOCOCCAL NUCLEASE; CAPSID MATURATION; NMR ASSIGNMENTS; VIRAL CAPSIDS; STABILITY	The I-domain is a genetic insertion in the phage P22 coat protein that chaperones its folding and stability. Of 11 acidic residues in the I-domain, seven participate in stabilizing electrostatic interactions with basic residues across elements of secondary structure, fastening the -barrel fold. A hydrogen-bonded salt bridge between Asp-302 and His-305 is particularly interesting as Asp-302 is the site of a temperature-sensitive-folding mutation. The pK(a) of His-305 is raised to 9.0, indicating the salt bridge stabilizes the I-domain by approximate to 4 kcal/mol. Consistently, urea denaturation experiments indicate the stability of the WT I-domain decreases by 4 kcal/mol between neutral and basic pH. The mutants D302A and H305A remove the pH dependence of stability. The D302A substitution destabilizes the I-domain by 4 kcal/mol, whereas H305A had smaller effects, on the order of 1-2 kcal/mol. The destabilizing effects of D302A are perpetuated in the full-length coat protein as shown by a higher sensitivity to protease digestion, decreased procapsid assembly rates, and impaired phage production in vivo. By contrast, the mutants have only minor effects on capsid expansion or stability in vitro. The effects of the Asp-302-His-305 salt bridge are thus complex and context-dependent. Substitutions that abolish the salt bridge destabilize coat protein monomers and impair capsid self-assembly, but once capsids are formed the effects of the substitutions are overcome by new quaternary interactions between subunits.	[Alexandrescu, Andrei T.; Teschke, Carolyn M.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; Univ Connecticut, Dept Chem, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut	Alexandrescu, AT; Teschke, CM (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	andrei.alexandrescu@uconn.edu; carolyn.teschke@uconn.edu			National Institutes of Health [R01 GM076661]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076661] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM076661 (to C. M. T. and A. T. A.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALEXANDRESCU AT, 1994, J MOL BIOL, V242, P527, DOI 10.1006/jmbi.1994.1598; Alexandrescu AT, 1999, J MOL BIOL, V289, P1041, DOI 10.1006/jmbi.1999.2813; Anderson E, 2003, VIROLOGY, V313, P184, DOI 10.1016/S0042-6822(03)00240-X; BAI YW, 1994, PROTEINS, V20, P4, DOI 10.1002/prot.340200103; BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5; Capen CM, 2000, BIOCHEMISTRY-US, V39, P1142, DOI 10.1021/bi991956t; CASJENS S, 1988, J MOL BIOL, V199, P467, DOI 10.1016/0022-2836(88)90618-3; CASJENS S, 1992, J MOL BIOL, V224, P1055, DOI 10.1016/0022-2836(92)90469-Z; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Cortines JR, 2014, J VIROL, V88, P5287, DOI 10.1128/JVI.00036-14; Cortines JR, 2011, VIROLOGY, V421, P1, DOI 10.1016/j.virol.2011.09.005; CREIGHTON TE, 1993, PROTEINS STRUCTURES, P225; Croke RL, 2008, PROTEIN SCI, V17, P1434, DOI 10.1110/ps.033803.107; Croke RL, 2011, PROTEIN SCI, V20, P256, DOI 10.1002/pro.556; D'Lima NG, 2015, J VIROL, V89, P10569, DOI 10.1128/JVI.01629-15; Flenniken ML, 2009, CURR TOP MICROBIOL, V327, P71; FOGUEL D, 1995, BIOCHEMISTRY-US, V34, P1120, DOI 10.1021/bi00004a003; GALISTEO ML, 1993, BIOPHYS J, V65, P227, DOI 10.1016/S0006-3495(93)81073-7; GORDON CL, 1994, J BIOL CHEM, V269, P27941; GORDON CL, 1994, GENETICS, V136, P427; Kang S, 2010, BIOMACROMOLECULES, V11, P2804, DOI 10.1021/bm100877q; KING J, 1978, CELL, V15, P551, DOI 10.1016/0092-8674(78)90023-5; KING J, 1976, PHILOS T ROY SOC B, V276, P37, DOI 10.1098/rstb.1976.0096; KING J, 1973, J MOL BIOL, V80, P697, DOI 10.1016/0022-2836(73)90205-2; Kumar S, 2002, BIOPHYS J, V83, P1595, DOI 10.1016/S0006-3495(02)73929-5; Li YY, 2005, J MOL BIOL, V348, P167, DOI 10.1016/j.jmb.2005.02.045; Liu Z, 2012, CHEM SOC REV, V41, P6178, DOI 10.1039/c2cs35108k; LUMB KJ, 1995, SCIENCE, V268, P436, DOI 10.1126/science.7716550; Newcomer RL, 2015, BIOPHYS J, V109, P2666, DOI 10.1016/j.bpj.2015.11.010; O'Neil A, 2012, BIOMACROMOLECULES, V13, P3902, DOI 10.1021/bm301347x; Pace C N, 1986, Methods Enzymol, V131, P266; Padilla-Meier GP, 2012, J BIOL CHEM, V287, P33766, DOI 10.1074/jbc.M112.393132; Padilla-Meier GP, 2011, J MOL BIOL, V410, P226, DOI 10.1016/j.jmb.2011.05.006; Parent KN, 2004, MOL MICROBIOL, V54, P1036, DOI 10.1111/j.1365-2958.2004.04326.x; Parent KN, 2007, MOL MICROBIOL, V65, P1300, DOI 10.1111/j.1365-2958.2007.05868.x; Parent KN, 2007, J MOL BIOL, V365, P513, DOI 10.1016/j.jmb.2006.09.088; Parent KN, 2006, J MOL BIOL, V359, P1097, DOI 10.1016/j.jmb.2006.03.068; Parent KN, 2012, BIOMATERIALS, V33, P5628, DOI 10.1016/j.biomaterials.2012.04.026; Parent KN, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/4/045004; Parent KN, 2010, STRUCTURE, V18, P390, DOI 10.1016/j.str.2009.12.014; Patterson DP, 2012, ACS NANO, V6, P5000, DOI 10.1021/nn300545z; PREVELIGE PE, 1988, J MOL BIOL, V202, P743, DOI 10.1016/0022-2836(88)90555-4; PREVELIGE PE, 1993, PROG MED VIROL, V40, P206; Rizzo AA, 2014, STRUCTURE, V22, P830, DOI 10.1016/j.str.2014.04.003; Rizzo AA, 2013, BIOMOL NMR ASSIGN, V7, P257, DOI 10.1007/s12104-012-9422-x; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Sheftic SR, 2009, METHOD ENZYMOL, V466, P233, DOI 10.1016/S0076-6879(09)66010-9; Shortle D, 1996, FASEB J, V10, P27, DOI 10.1096/fasebj.10.1.8566543; Suhanovsky MM, 2015, VIROLOGY, V479, P487, DOI 10.1016/j.virol.2015.02.055; Suhanovsky MM, 2013, J BIOL CHEM, V288, P33772, DOI 10.1074/jbc.M113.515312; Teschke CM, 2010, VIROLOGY, V401, P119, DOI 10.1016/j.virol.2010.02.017; Teschke CM, 2003, BIOPHYS J, V84, P2585, DOI 10.1016/S0006-3495(03)75063-2; TESCHKE CM, 1993, BIOCHEMISTRY-US, V32, P10839, DOI 10.1021/bi00091a040; Thurlkill RL, 2006, PROTEIN SCI, V15, P1214, DOI 10.1110/ps.051840806; Tripler TN, 2015, BIOMOL NMR ASSIGN, V9, P333, DOI 10.1007/s12104-015-9604-4; Watson E, 2007, BIOCHEMISTRY-US, V46, P9484, DOI 10.1021/bi700532j; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; WINSTON F, 1979, J BACTERIOL, V137, P433, DOI 10.1128/JB.137.1.433-439.1979; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Zhang Y.Z., 1995, THESIS U PENNSYLVANI; Zhang ZX, 2000, J MOL BIOL, V297, P615, DOI 10.1006/jmbi.2000.3601; Zlotnick A, 2012, VIROLOGY, V428, P64, DOI 10.1016/j.virol.2012.03.017	64	4	4	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11359	11372		10.1074/jbc.M116.716910	http://dx.doi.org/10.1074/jbc.M116.716910			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27006399	Green Published, hybrid			2022-12-26	WOS:000377042100034
J	Nguyen, A; Duquette, N; Mamarbachi, M; Thorin, E				Nguyen, Albert; Duquette, Natacha; Mamarbachi, Maya; Thorin, Eric			Epigenetic Regulatory Effect of Exercise on Glutathione Peroxidase 1 Expression in the Skeletal Muscle of Severely Dyslipidemic Mice	PLOS ONE			English	Article							DNA METHYLATION PATTERNS; CORONARY-ARTERY-DISEASE; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; UNCOUPLING PROTEIN-2; ATHEROSCLEROTIC MICE; PROMOTER METHYLATION; ENDOTHELIAL FUNCTION; PHYSICAL-EXERCISE; NADPH OXIDASES	Exercise is an effective approach for primary and secondary prevention of cardiovascular diseases (CVD) and loss of muscular mass and function. Its benefits are widely documented but incompletely characterized. It has been reported that exercise can induce changes in the expression of antioxidant enzymes including Sod2, Trx1, Prdx3 and Gpx1 and limits the rise in oxidative stress commonly associated with CVD. These enzymes can be subjected to epigenetic regulation, such as DNA methylation, in response to environmental cues. The aim of our study was to determine whether in the early stages of atherogenesis, in young severely dyslipidemic mice lacking LDL receptors and overexpressing human ApoB100 (LDLR-/-; hApoB(+/+)), exercise regulates differentially the expression of antioxidant enzymes by DNA methylation in the skeletal muscles that consume high levels of oxygen and thus generate high levels of reactive oxygen species. Expression of Sod2, Txr1, Prdx3 and Gpx1 was altered by 3 months of exercise and/or severe dyslipidemia in 6-mo dyslipidemic mice. Of these genes, only Gpx1 exhibited changes in DNA methylation associated with dyslipidemia and exercise: we observed both increased DNA methylation with dyslipidemia and a transient decrease in DNA methylation with exercise. These epigenetic alterations are found in the second exon of the Gpx1 gene and occur alongside with inverse changes in mRNA expression. Inhibition of expression by methylation of this specific locus was confirmed in vitro. In conclusion, Gpx1 expression in the mouse skeletal muscle can be altered by both exercise and dyslipidemia through changes in DNA methylation, leading to a fine regulation of free radical metabolism.	[Nguyen, Albert; Thorin, Eric] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Nguyen, Albert; Duquette, Natacha; Mamarbachi, Maya; Thorin, Eric] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Thorin, Eric] Univ Montreal, Fac Med, Dept Surg, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Thorin, E (corresponding author), Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada.; Thorin, E (corresponding author), Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada.; Thorin, E (corresponding author), Univ Montreal, Fac Med, Dept Surg, Montreal, PQ H3C 3J7, Canada.	eric.thorin@umontreal.ca	Thorin, Eric/K-3978-2013	Thorin, Eric/0000-0001-5827-8935	Canadian Institutes of Health Research [14496, 133649]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research operating grant numbers 14496 and 133649 to ET (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessio HM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/950516; Archer SL, 2010, CIRCULATION, V121, P2661, DOI 10.1161/CIRCULATIONAHA.109.916098; Argyropoulos G, 2002, J APPL PHYSIOL, V92, P2187, DOI 10.1152/japplphysiol.00994.2001; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Ballinger SW, 2002, CIRCULATION, V106, P544, DOI 10.1161/01.CIR.0000023921.93743.89; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blankenberg S, 2003, NEW ENGL J MED, V349, P1605, DOI 10.1056/NEJMoa030535; Bolduc V, 2012, AM J PHYSIOL-HEART C, V302, pH1330, DOI 10.1152/ajpheart.01044.2011; Bolduc V, 2011, AM J PHYSIOL-HEART C, V301, pH2081, DOI 10.1152/ajpheart.00706.2011; Bonomini F, 2008, HISTOL HISTOPATHOL, V23, P381, DOI 10.14670/HH-23.381; Brinkmann C, 2013, J PHYSIOL SCI, V63, P1, DOI 10.1007/s12576-012-0237-4; Carrio E, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00019; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Diaz-Vegas A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129882; Do Jee C, 2009, EUR J CANCER, V45, P1282, DOI 10.1016/j.ejca.2008.12.027; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Drouin A, 2011, AM J PHYSIOL-HEART C, V300, pH1032, DOI 10.1152/ajpheart.00410.2010; Drummond GR, 2014, TRENDS ENDOCRIN MET, V25, P452, DOI 10.1016/j.tem.2014.06.012; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Gendron ME, 2010, AM J PHYSIOL-HEART C, V298, pH2062, DOI 10.1152/ajpheart.00532.2009; Hanson M, 2011, PROG BIOPHYS MOL BIO, V106, P272, DOI 10.1016/j.pbiomolbio.2010.12.008; Hochberg Z, 2011, ENDOCR REV, V32, P159, DOI 10.1210/er.2009-0039; Jang YC, 2009, EXP GERONTOL, V44, P256, DOI 10.1016/j.exger.2008.12.006; Jimenez-Chillaron JC, 2012, BIOCHIMIE, V94, P2242, DOI 10.1016/j.biochi.2012.06.012; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Katsiki N, 2009, CLIN NUTR, V28, P3, DOI 10.1016/j.clnu.2008.10.011; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim GH, 2013, ANTIOXID REDOX SIGN, V18, P1920, DOI 10.1089/ars.2012.4926; Kim HS, 2007, DIABETES RES CLIN PR, V77, pS46, DOI 10.1016/j.diabres.2007.01.032; Kulak MV, 2013, ONCOGENE, V32, P4043, DOI 10.1038/onc.2012.400; Laker RC, 2014, DIABETES, V63, P1605, DOI [10.2337/db14-0135, 10.2337/db13-1614]; Lakshmi SVV, 2013, MOL CELL BIOCHEM, V374, P203, DOI 10.1007/s11010-012-1520-7; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Leblond F, 2013, PFLUG ARCH EUR J PHY, V465, P197, DOI 10.1007/s00424-012-1206-8; Ling C, 2014, DRUG DISCOV TODAY, V19, P1015, DOI 10.1016/j.drudis.2014.03.006; Madrigal-Matute J, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/232464; Miao L, 2009, FREE RADICAL BIO MED, V47, P344, DOI 10.1016/j.freeradbiomed.2009.05.018; Min SY, 2012, ANTICANCER RES, V32, P3169; Mofarrahi M, 2008, ANTIOXID REDOX SIGN, V10, P559, DOI 10.1089/ars.2007.1792; Montezano AC, 2015, CAN J CARDIOL, V31, P631, DOI 10.1016/j.cjca.2015.02.008; Nitert MD, 2012, DIABETES, V61, P3322, DOI 10.2337/db11-1653; Oelze M, 2014, HYPERTENSION, V63, P390, DOI 10.1161/HYPERTENSIONAHA.113.01602; Okuda M, 2001, ARTERIOSCL THROM VAS, V21, P1483, DOI 10.1161/hq0901.095550; Ordovas JM, 2010, NAT REV CARDIOL, V7, P510, DOI 10.1038/nrcardio.2010.104; Palmefors H, 2014, ATHEROSCLEROSIS, V235, P150, DOI 10.1016/j.atherosclerosis.2014.04.026; Paneni F, 2013, ATHEROSCLEROSIS, V230, P191, DOI 10.1016/j.atherosclerosis.2013.07.003; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Powers SK, 1999, P NUTR SOC, V58, P1025, DOI 10.1017/S0029665199001342; Rengo G, 2013, AGING CLIN EXP RES, V25, P487, DOI 10.1007/s40520-013-0117-7; Reul JMHM, 2014, FRONT PSYCHIATRY, V5, DOI [10.3389/fpsyt.2014.00005, 10.3389/fpsyt.2004.0005]; Ristow M, 2009, P NATL ACAD SCI USA, V106, P8665, DOI 10.1073/pnas.0903485106; Roden M, 2015, DIABETOLOGIA, V58, P1693, DOI 10.1007/s00125-015-3629-1; Ronn T, 2013, EPIGENOMICS-UK, V5, P603, DOI 10.2217/epi.13.61; Rousset S, 2004, DIABETES, V53, pS130, DOI 10.2337/diabetes.53.2007.S130; Seals DR, 2014, J APPL PHYSIOL, V117, P425, DOI 10.1152/japplphysiol.00362.2014; Sindler AL, 2013, J APPL PHYSIOL, V114, P681, DOI 10.1152/japplphysiol.00341.2012; Siti HN, 2015, VASC PHARMACOL, V71, P40, DOI 10.1016/j.vph.2015.03.005; Sorescu D, 2002, CIRCULATION, V105, P1429, DOI 10.1161/01.CIR.0000012917.74432.66; Stankiewicz AM, 2013, BRAIN RES BULL, V98, P76, DOI 10.1016/j.brainresbull.2013.07.003; Steinhubl SR, 2008, AM J CARDIOL, V101, p14D, DOI 10.1016/j.amjcard.2008.02.003; Sullivan-Gunn MJ, 2011, J CACHEXIA SARCOPENI, V2, P181, DOI 10.1007/s13539-011-0037-3; Szostak J, 2011, CLIN SCI, V121, P91, DOI 10.1042/CS20100520; Tanaka LY, 2015, NITRIC OXIDE-BIOL CH, V45, P7, DOI 10.1016/j.niox.2015.01.003; Turunen MP, 2009, BBA-GEN SUBJECTS, V1790, P886, DOI 10.1016/j.bbagen.2009.02.008; Victor VM, 2009, CURR PHARM DESIGN, V15, P2988, DOI 10.2174/138161209789058093; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; Vuori IM, 2013, MAYO CLIN PROC, V88, P1446, DOI 10.1016/j.mayocp.2013.08.020; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Whitehead NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015354; Wilson AG, 2008, J PERIODONTOL, V79, P1514, DOI 10.1902/jop.2008.080172; Zhao WY, 2006, HYPERTENSION, V48, P637, DOI 10.1161/01.HYP.0000240347.51386.ea; Zhu SK, 2005, CIRCULATION, V112, P1353, DOI 10.1161/CIRCULATIONAHA.104.519025	74	10	10	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151526	10.1371/journal.pone.0151526	http://dx.doi.org/10.1371/journal.pone.0151526			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010651	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708000032
J	Sequeira, JM; Desai, A; Berrocal-Zaragoza, MI; Murphy, MM; Fernandez-Ballart, JD; Quadros, EV				Sequeira, Jeffrey M.; Desai, Ankuri; Berrocal-Zaragoza, Maria I.; Murphy, Michelle M.; Fernandez-Ballart, Joan D.; Quadros, Edward V.			Exposure to Folate Receptor Alpha Antibodies during Gestation and Weaning Leads to Severe Behavioral Deficits in Rats: A Pilot Study	PLOS ONE			English	Article							ACTIVE PLACE AVOIDANCE; NEURAL-TUBE; FOLIC-ACID; FREEZING BEHAVIOR; AUTOANTIBODIES; PREGNANCY; BINDING; MEMORY; AUTOIMMUNITY; ASSOCIATION	The central nervous system continues to develop during gestation and after birth, and folate is an essential nutrient in this process. Folate deficiency and folate receptor alpha autoantibodies (FRa-AuAb) have been associated with pregnancy-related complications and neuro-developmental disorders. In this pilot study, we investigated the effect of exposure to FRa antibodies (Ab) during gestation (GST), the pre-weaning (PRW), and the post weaning (POW) periods on learning and behavior in adulthood in a rat model. In the open field test and novel object recognition task, which examine locomotor activity and anxiety-like behavior, deficits in rats exposed to Ab during gestation and pre-weaning (GST+PRW) included more time spent in the periphery or corner areas, less time in the central area, frequent self-grooming akin to stereotypy, and longer time to explore a novel object compared to a control group; these are all indicative of increased levels of anxiety. In the place avoidance tasks that assess learning and spatial memory formation, only 30% of GST+PRW rats were able to learn the passive place avoidance task. None of these rats learned the active place avoidance task indicating severe learning deficits and cognitive impairment. Similar but less severe deficits were observed in rats exposed to Ab during GST alone or only during the PRW period, suggesting the extreme sensitivity of the fetal as well as the neonatal rat brain to the deleterious effects of exposure to Ab during this period. Behavioral deficits were not seen in rats exposed to antibody post weaning. These observations have implications in the pathology of FRa-AuAb associated with neural tube defect pregnancy, preterm birth and neurodevelopmental disorders including autism.	[Sequeira, Jeffrey M.; Quadros, Edward V.] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11209 USA; [Desai, Ankuri] Suny Downstate Med Ctr, Sch Grad Studies, Brooklyn, NY 11209 USA; [Berrocal-Zaragoza, Maria I.; Murphy, Michelle M.; Fernandez-Ballart, Joan D.] Univ Rovira & Virgili, Prevent Med & Publ Hlth, E-43007 Tarragona, Spain; [Berrocal-Zaragoza, Maria I.; Murphy, Michelle M.; Fernandez-Ballart, Joan D.] Univ Rovira & Virgili, IISPV Fac Med & Hlth Sci, E-43007 Tarragona, Spain	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Universitat Rovira i Virgili; Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV)	Quadros, EV (corresponding author), Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11209 USA.	Edward.quadros@downstate.edu		Murphy, Michelle/0000-0002-6304-6204; Fernandez-Ballart, Joan D./0000-0002-1320-6484	Autism Speaks [8202]	Autism Speaks	Financial support was provided by grant #8202 from Autism Speaks. The funder had no role in the design, data collection, analysis, decision to publish or preparation of the manuscript.	Baki SGA, 2009, BRAIN RES, V1280, P98, DOI 10.1016/j.brainres.2009.05.034; Berrocal-Zaragoza MI, 2014, BRIT J NUTR, V112, P1323, DOI 10.1017/S0007114514002116; Bille C, 2010, PEDIATR RES, V67, P274, DOI 10.1203/PDR.0b013e3181cbd564; Boyles AL, 2011, HUM REPROD, V26, P2232, DOI 10.1093/humrep/der144; Cabrera RM, 2008, J REPROD IMMUNOL, V79, P85, DOI 10.1016/j.jri.2008.08.002; Cimadevilla JM, 2000, J NEUROSCI METH, V102, P155, DOI 10.1016/S0165-0270(00)00288-0; Cimadevilla JM, 2001, BRAIN RES BULL, V54, P559, DOI 10.1016/S0361-9230(01)00448-8; Clancy B, 2007, NEUROINFORMATICS, V5, P79, DOI 10.1385/NI:5:1:79; da Costa M, 2003, BIRTH DEFECTS RES A, V67, P837, DOI 10.1002/bdra.10088; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ferguson SA, 2005, BIRTH DEFECTS RES A, V73, P249, DOI 10.1002/bdra.20111; Frye RE, 2013, MOL PSYCHIATR, V18, P369, DOI 10.1038/mp.2011.175; GILES C, 1966, J CLIN PATHOL, V19, P1, DOI 10.1136/jcp.19.1.1; Gisquet-Verrier P, 1999, BEHAV NEUROSCI, V113, P507, DOI 10.1037/0735-7044.113.3.507; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Hashimoto S, 1999, EUR J PHARMACOL, V378, P23, DOI 10.1016/S0014-2999(99)00441-0; HIBBARD ED, 1965, LANCET, V1, P1254; Kalueff AV, 2004, ACTA NEUROBIOL EXP, V64, P439; Kim JM, 2002, J NUTR, V132, P3418, DOI 10.1093/jn/132.11.3418; Kruman II, 2002, J NEUROSCI, V22, P1752, DOI 10.1523/JNEUROSCI.22-05-01752.2002; Molloy AM, 2009, NEW ENGL J MED, V361, P152, DOI 10.1056/NEJMoa0803783; Momb J, 2013, P NATL ACAD SCI USA, V110, P549, DOI 10.1073/pnas.1211199110; Piedrahita JA, 1999, NAT GENET, V23, P228, DOI 10.1038/13861; Power AE, 2002, BEHAV BRAIN RES, V134, P307, DOI 10.1016/S0166-4328(02)00046-3; Ramaekers VT, 2007, NEUROPEDIATRICS, V38, P276, DOI 10.1055/s-2008-1065354; Ramaekers VT, 2007, NEUROPEDIATRICS, V38, P179, DOI 10.1055/s-2007-991148; Ramaekers VT, 2013, MOL PSYCHIATR, V18, P270, DOI 10.1038/mp.2012.22; Ramaekers VT, 2008, DEV MED CHILD NEUROL, V50, P346, DOI 10.1111/j.1469-8749.2008.02053.x; Ramaekers VT, 2005, NEW ENGL J MED, V352, P1985, DOI 10.1056/NEJMoa043160; Ramaekers VT, 2004, DEV MED CHILD NEUROL, V46, P843, DOI 10.1017/S0012162204001471; Rothenberg SP, 2004, NEW ENGL J MED, V350, P134, DOI 10.1056/NEJMoa031145; SADASIVAN E, 1987, BIOCHIM BIOPHYS ACTA, V925, P36, DOI 10.1016/0304-4165(87)90145-0; Sadasivan E, 2000, GENE, V254, P219, DOI 10.1016/S0378-1119(00)00262-6; Scholl TO, 2000, AM J CLIN NUTR, V71, p1295S, DOI 10.1093/ajcn/71.5.1295s; SMITHELLS RW, 1976, ARCH DIS CHILD, V51, P944, DOI 10.1136/adc.51.12.944; WALD N, 1991, LANCET, V338, P131; WALSH RN, 1976, PSYCHOL BULL, V83, P482, DOI 10.1037/0033-2909.83.3.482; Wesierska M, 2009, NEUROBIOL LEARN MEM, V91, P41, DOI 10.1016/j.nlm.2008.09.005	38	29	29	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152249	10.1371/journal.pone.0152249	http://dx.doi.org/10.1371/journal.pone.0152249			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27011008	Green Published, gold			2022-12-26	WOS:000372708000120
J	Yacoub, E; Ben, B; Mardassi, A				Yacoub, Elhem; Ben, Boutheina; Mardassi, Abdelmoumen			Mm19, a Mycoplasma meleagridis Major Surface Nuclease that Is Related to the RE_AlwI Superfamily of Endonucleases	PLOS ONE			English	Article							CYTOTOXIC NUCLEASE; GENOME SEQUENCE; CULTURED-CELLS; GALLISEPTICUM; STRAIN; GENE; DNA; HYOPNEUMONIAE; METABOLISM; APOPTOSIS	Mycoplasma meleagridis infection is widespread in turkeys, causing poor growth and feathering, airsacculitis, osteodystrophy, and reduction in hatchability. Like most mycoplasma species, M. meleagridis is characterized by its inability to synthesize purine and pyrimidine nucleotides de novo. Consistent with this intrinsic deficiency, we here report the cloning, expression, and characterization of a M. meleagridis gene sequence encoding a major surface nuclease, referred to as Mm 19. Mm 19 consists of a 1941- bp ORF encoding a 646-amino-acid polypeptide with a predicted molecular mass of 74,825 kDa. BLASTP analysis revealed a significant match with the catalytic/dimerization domain of type II restriction enzymes of the RE_AlwI superfamily. This finding is consistent with the genomic location of Mm19 sequence, which dispalys characteristics of a typical type II restriction-modification locus. Like intact M. meleagridis cells, the E. coli-expressed Mm19 fusion product was found to exhibit a nuclease activity against plasmid DNA, double-stranded DNA, single-stranded DNA, and RNA. The Mm19-associated nuclease activity was consistently enhanced with Mg2+ divalent cations, a hallmark of type II restriction enzymes. A rabbit hyperimmune antiserum raised against the bacterially expressed Mm 19 strongly reacted with M. meleagridis intact cells and fully neutralized the surface-bound nuclease activity. Collectively, the results show that M. meleagridis expresses a strong surface-bound nuclease activity, which is the product of a single gene sequence that is related to the RE_AlwI superfamily of endonucleases.	[Yacoub, Elhem; Ben, Boutheina; Mardassi, Abdelmoumen] Univ Tunis, Unit Mycoplasmas, Lab Mol Microbiol Vaccinol & Biotechnol Dev, Inst Pasteur Tunis, El Manar, Tunisia	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Tunis	Mardassi, A (corresponding author), Univ Tunis, Unit Mycoplasmas, Lab Mol Microbiol Vaccinol & Biotechnol Dev, Inst Pasteur Tunis, El Manar, Tunisia.	boutheina.mardassi@pasteur.rns.tn			Tunisian Ministry of Higher Education and Scientific Research	Tunisian Ministry of Higher Education and Scientific Research	Funded by Tunisian Ministry of Higher Education and Scientific Research (http://www.mes.tn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the Tunisian Ministry of Higher Education and Scientific Research. We thank Dr Mehdi Houimel (Laboratory of Veterinary Microbiology, Institut Pasteur de Tunis) for providing M13 phage stocks and Dr Hela Kallel (Unit of Biotechnology Development, Institut Pasteur de Tunis) for providing Vero cell suspensions. Authors thank Dr Pascal Sirand-Pugnet and Pr Alain Blanchard (Mollicutes team, Institut National de la Recherche Agronomique, Bordeaux-France) for their valuable participation in sequencing and bioinformatics analysis of M. meleagridis whole genome. The authors are indebted to Dr Helmi Mardassi (Institut Pasteur de Tunis) for critically reading the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bejaoui-Khiari A, 2010, BMC MICROBIOL, V10, P1; Mardassi BB, 2007, VET MICROBIOL, V119, P31, DOI 10.1016/j.vetmic.2006.08.008; BENABDELMOUMEN B, 1995, AVIAN DIS, V39, P250, DOI 10.2307/1591866; Bendjennat M, 1997, J BACTERIOL, V179, P2210, DOI 10.1128/jb.179.7.2210-2220.1997; Bendjennat M, 1999, INFECT IMMUN, V67, P4456, DOI 10.1128/IAI.67.9.4456-4462.1999; Bizarro CV, 2007, GENET MOL BIOL, V30, P190, DOI 10.1590/S1415-47572007000200005; Browning GF, 2011, VET MICROBIOL, V153, P44, DOI 10.1016/j.vetmic.2011.05.031; Cacciotto C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057775; COWEN BS, 1972, J BACTERIOL, V109, P21, DOI 10.1128/JB.109.1.21-24.1972; Fadiel A, 2007, FRONT BIOSCI-LANDMRK, V12, P2020, DOI 10.2741/2207; Finch Lloyd R., 1992, P211; FREY ML, 1968, AM J VET RES, V29, P2163; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HIRT B, 1967, J MOL BIOL, V26, P365, DOI 10.1016/0022-2836(67)90307-5; Jarvill-Taylor KJ, 1999, J BACTERIOL, V181, P1853, DOI 10.1128/JB.181.6.1853-1860.1999; Jordan FTW, 1990, AVIAN MYCOPLASMOSES, P81; Li LB, 2010, J BACTERIOL, V192, P4876, DOI 10.1128/JB.00401-10; MINION FC, 1986, INFECT IMMUN, V51, P352, DOI 10.1128/IAI.51.1.352-354.1986; MINION FC, 1993, J BACTERIOL, V175, P7842, DOI 10.1128/JB.175.24.7842-7847.1993; MITCHELL A, 1977, J BACTERIOL, V130, P1047, DOI 10.1128/JB.130.3.1047-1054.1977; Paddenberg R, 1998, CELL DEATH DIFFER, V5, P517, DOI 10.1038/sj.cdd.4400380; Paddenberg R, 1996, EUR J CELL BIOL, V71, P105; Papazisi L, 2003, MICROBIOL-SGM, V149, P2307, DOI 10.1099/mic.0.26427-0; Pingoud A, 2001, NUCLEIC ACIDS RES, V29, P3705, DOI 10.1093/nar/29.18.3705; Pollack JD, 1997, CRIT REV MICROBIOL, V23, P269, DOI 10.3109/10408419709115140; RAZIN S, 1978, MICROBIOL REV, V42, P414, DOI 10.1128/MMBR.42.2.414-470.1978; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Rottem S, 2003, PHYSIOL REV, V83, P417, DOI 10.1152/physrev.00030.2002; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sasaki Y, 2010, NUCLEIC ACIDS RES, V30, P5293; Schmidt JA, 2007, J BACTERIOL, V189, P3414, DOI 10.1128/JB.01835-06; Sharma S, 2015, J BACTERIOL, V197, P1549, DOI 10.1128/JB.00034-15; Somarajan SR, 2010, CELL MICROBIOL, V12, P1821, DOI 10.1111/j.1462-5822.2010.01513.x; Stipkovits L, 1996, REV SCI TECH OIE, V15, P1495, DOI 10.20506/rst.15.4.986; Szczepanek SM, 2010, INFECT IMMUN, V78, P1760, DOI 10.1128/IAI.01172-09; Vasconcelos ATR, 2005, J BACTERIOL, V187, P5568, DOI 10.1128/JB.187.16.5568-5577.2005; Wei S, 2012, J BACTERIOL, V194, P547, DOI 10.1128/JB.06297-11; Xu J, 2015, APPL MICROBIOL BIOT, V99, P1859, DOI 10.1007/s00253-014-6185-6; Xu Y, 2001, P NATL ACAD SCI USA, V98, P12990, DOI 10.1073/pnas.241215698; Yacoub E, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00484-15	42	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152171	10.1371/journal.pone.0152171	http://dx.doi.org/10.1371/journal.pone.0152171			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010566	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708000103
J	Cavallini, A; Lippolis, C; Vacca, M; Nardelli, C; Castegna, A; Arnesano, F; Carella, N; Depalo, R				Cavallini, Aldo; Lippolis, Catia; Vacca, Margherita; Nardelli, Claudia; Castegna, Alessandra; Arnesano, Fabio; Carella, Nicola; Depalo, Raffaella			The Effects of Chronic Lifelong Activation of the AHR Pathway by Industrial Chemical Pollutants on Female Human Reproduction	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; HYDROCARBON DIOXIN RECEPTOR; HEAVY-METALS; FOLLICULAR-FLUID; ANTIOXIDANT STATUS; OXIDATIVE STRESS; GRANULOSA-CELLS; GENE BATTERY; LEAD; TARANTO	Environmental chemicals, such as heavy metals, affect female reproductive function. A biological sensor of the signals of many toxic chemical compounds seems to be the aryl hydrocarbon receptor (AHR). Previous studies demonstrated the environmental of heavy metals in Taranto city (Italy), an area that has been influenced by anthropogenic factors such as industrial activities and waste treatments since 1986. However, the impact of these elements on female fertility in this geographic area has never been analyzed. Thus, in the present study, we evaluated the AHR pathway, sex steroid receptor pattern and apoptotic process in granulosa cells (GCs) retrieved from 30 women, born and living in Taranto, and 30 women who are living in non-contaminated areas (control group), who were undergoing in vitro fertilization (IVF) protocol. In follicular fluids (FFs) of both groups the toxic and essential heavy metals, such as chromiun (Cr), Manganese (Mn), iron (Fe), cobalt (Co), nickel (Ni), copper (Cu), zinc (Zn), cadmium (Cd) and lead (Pb), were also analyzed. Higher levels of Cr, Fe, Zn and Pb were found in the FFs of the women from Taranto as compared to the control group, as were the levels of AHR and AHR-dependent cytochrome P450 1A1 and 1B1; while CYP19A1 expression was decreased. The anti-apoptotic process found in the GCs of women fromTaranto was associated with the highest levels of progesterone receptor membrane component 1 (PGRMC1), a novel progesterone receptor, the expression of which is subjected to AHR activated by its highest affinity ligands (e.g., dioxins) or indirectly by other environmental pollutants, such as heavy metals. In conclusion, decreased production of estradiol and decreased number of retrieved mature oocytes found in women from Taranto could be due to chronic exposure to heavy metals, in particular to Cr and Pb.	[Cavallini, Aldo; Lippolis, Catia; Carella, Nicola] IRCCS Saverio de Bellis, Natl Inst Digest Dis, Dept Clin Pathol, Lab Cellular & Mol Biol, Via Turi 27, I-70013 Castellana Grotte, BA, Italy; [Vacca, Margherita; Nardelli, Claudia; Depalo, Raffaella] Univ Hosp Bari, Dept Gen Surg Gynecol Obstet & Anesthesiol, Unit Pathophysiol Human Reprod & Gametes Cryopres, Consorziale, Policlin Piazza Giulio Cesare 11, I-70124 Bari, Italy; [Castegna, Alessandra] Univ Bari A Moro, Dept Biosci Biotechnol & Biopharmaceut, Via E Orabona 4, I-70125 Bari, Italy; [Arnesano, Fabio] Univ Bari A Moro, Dept Chem, Via E Orabona 4, I-70125 Bari, Italy	IRCCS Saverio de Bellis; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro	Cavallini, A (corresponding author), IRCCS Saverio de Bellis, Natl Inst Digest Dis, Dept Clin Pathol, Lab Cellular & Mol Biol, Via Turi 27, I-70013 Castellana Grotte, BA, Italy.	cavaldo@libero.it	castegna, alessandra/AAH-6668-2020; Arnesano, Fabio/C-3066-2016; Depalo, Raffaella/AAK-3583-2020	Arnesano, Fabio/0000-0002-8399-0964; CASTEGNA, Alessandra/0000-0003-0235-6847	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	The funder was Italian Ministry of Health (www.salute.gov.it) for a national project on women's health. The funding was received from RD. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Al-Saleh I, 2008, INT J HYG ENVIR HEAL, V211, P560, DOI 10.1016/j.ijheh.2007.09.005; Aurrekoetxea I, 2010, FERTIL STERIL, V94, P1279, DOI 10.1016/j.fertnstert.2009.05.028; Baba T, 2005, MOL CELL BIOL, V25, P10040, DOI 10.1128/MCB.25.22.10040-10051.2005; Banu SK, 2011, TOXICOL APPL PHARM, V251, P253, DOI 10.1016/j.taap.2011.01.011; Bianco G, 2013, ANAL BIOANAL CHEM, V405, P2405, DOI 10.1007/s00216-013-6706-7; Bloom MS, 2011, REPROD TOXICOL, V31, P164, DOI 10.1016/j.reprotox.2010.11.011; Bruno P, 2000, J CHROMATOGR A, V888, P145, DOI 10.1016/S0021-9673(00)00503-3; Buccolieri A, 2006, MAR CHEM, V99, P227, DOI 10.1016/j.marchem.2005.09.009; Buccolieri A, 2010, ENVIRON MONIT ASSESS, V168, P547, DOI 10.1007/s10661-009-1133-0; Calleja A., 2014, J TOXINS, V1, P1; Carr BI, 2013, J CELL PHYSIOL, V228, P1344, DOI 10.1002/jcp.24291; Cavallini A, 2002, DIGEST DIS SCI, V47, P2720, DOI 10.1023/A:1021053105096; Darwish WS, 2016, J FOOD SCI, V81, pT275, DOI 10.1111/1750-3841.13162; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Depalo R, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-26; Elassar A, 2012, FERTIL STERIL, V97, P572, DOI 10.1016/j.fertnstert.2011.12.026; Elbekai RH, 2007, TOXICOL LETT, V172, P106, DOI 10.1016/j.toxlet.2007.05.009; Hombach-Klonisch S, 2005, CURR MED CHEM, V12, P599, DOI 10.2174/0929867053362857; Kopec AK, 2010, TOXICOL SCI, V118, P286, DOI 10.1093/toxsci/kfq236; Korashy HM, 2005, TOXICOL SCI, V88, P39, DOI 10.1093/toxsci/kfi282; Mangia C, 2013, ENVIRON MONIT ASSESS, V185, P1719, DOI 10.1007/s10661-012-2663-4; Mansouri MR, 2008, HUM MOL GENET, V17, P3776, DOI 10.1093/hmg/ddn274; Marinaccio A, 2011, ANN I SUPER SANITA, V47, P192, DOI 10.4415/ANN_11_02_11; Minervini F, 2005, TOXICOL LETT, V159, P272, DOI 10.1016/j.toxlet.2005.05.017; Nampoothiri LP, 2007, ARCH TOXICOL, V81, P145, DOI 10.1007/s00204-006-0133-x; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; Pascuzzi S, 2013, PROCEDIA ENVIRON SCI, V19, P671, DOI 10.1016/j.proenv.2013.06.076; Pasqualotto EB, 2004, FERTIL STERIL, V81, P973, DOI 10.1016/j.fertnstert.2003.11.021; Peluso JJ, 2014, REPRODUCTION, V147, pR169, DOI 10.1530/REP-13-0582; Peluso JJ, 2009, J CLIN ENDOCR METAB, V94, P2644, DOI 10.1210/jc.2009-0147; Pillai P, 2010, J BIOCHEM MOL TOXIC, V24, P384, DOI 10.1002/jbt.20351; Silberstein T, 2006, J TRACE ELEM MED BIO, V20, P205, DOI 10.1016/j.jtemb.2006.05.001; Silberstein T, 2009, FERTIL STERIL, V91, P1771, DOI 10.1016/j.fertnstert.2008.02.007; Stanley JA, 2011, REPROD TOXICOL, V32, P112, DOI 10.1016/j.reprotox.2011.05.007; Taupeau C, 2003, BIOL REPROD, V68, P1982, DOI 10.1095/biolreprod.102.009894; Veeck LL, 1986, ATLAS HUMAN OOCYTE E; Xie X, 2013, ENVIRON POLLUT, V175, P30, DOI 10.1016/j.envpol.2012.12.013; Younglai EV, 2005, HUM REPROD UPDATE, V11, P43, DOI 10.1093/humupd/dmh055; Younglai EV, 2002, ARCH ENVIRON CON TOX, V43, P121, DOI 10.1007/s00244-001-0048-8	39	19	19	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152181	10.1371/journal.pone.0152181	http://dx.doi.org/10.1371/journal.pone.0152181			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008165	Green Published, gold, Green Submitted			2022-12-26	WOS:000372701200106
J	Kasanova, Z; Hernaus, D; Vaessen, T; Van Amelsvoort, T; Winz, O; Heinzel, A; Pruessner, J; Mottaghy, FM; Collip, D; Myin-Germeys, I				Kasanova, Zuzana; Hernaus, Dennis; Vaessen, Thomas; Van Amelsvoort, Therese; Winz, Oliver; Heinzel, Alexander; Pruessner, Jens; Mottaghy, Felix M.; Collip, Dina; Myin-Germeys, Inez			Early-Life Stress Affects Stress-Related Prefrontal Dopamine Activity in Healthy Adults, but Not in Individuals with Psychotic Disorder	PLOS ONE			English	Article							GLUCOCORTICOID-RECEPTOR GENE; POSITRON-EMISSION-TOMOGRAPHY; ABUSE QUESTIONNAIRE CECA.Q; CHILDHOOD TRAUMA; RELEASE; SCHIZOPHRENIA; CORTEX; RISK; STRIATUM; EXPERIENCE	Early life stress may have a lasting impact on the developmental programming of the dopamine (DA) system implicated in psychosis. Early adversity could promote resilience by calibrating the prefrontal stress-regulatory dopaminergic neurotransmission to improve the individual's fit with the predicted stressful environment. Aberrant reactivity to such match between proximal and distal environments may, however, enhance psychosis disease risk. We explored the combined effects of childhood adversity and adult stress by exposing 12 unmedicated individuals with a diagnosis of non-affective psychotic disorder (NAPD) and 12 healthy controls (HC) to psychosocial stress during an [F-18]fallypride positron emission tomography. Childhood trauma divided into early (ages 0-11 years) and late (12-18 years) was assessed retrospectively using a questionnaire. A significant group x childhood trauma interaction on the spatial extent of stress-related [18F] fallypride displacement was observed in the mPFC for early (b=-8.45, t(1,23) = -3.35, p=.004) and late childhood trauma (b=7.86, t(1,23) = -2.48, p=.023). In healthy individuals, the spatial extent of mPFC DA activity under acute psychosocial stress was positively associated with the severity of early (b=7.23, t(11) = 3.06, p=.016) as well as late childhood trauma (b=-7.86, t(1,23) = -2.48, p=.023). Additionally, a trend-level main effect of early childhood trauma on subjective stress response emerged within this group (b=-.7, t(11) = -2, p=.07), where higher early trauma correlated with lower subjective stress response to the task. In the NAPD group, childhood trauma was not associated with the spatial extent of the tracer displacement in mPFC (b=-1.22, t(11) = -0.67), nor was there a main effect of trauma on the subjective perception of stress within this group (b=.004, t(11) = .01, p=.99). These findings reveal a potential mechanism of neuroadaptation of prefrontal DA transmission to early life stress and suggest its role in resilience and vulnerability to psychosis.	[Kasanova, Zuzana; Vaessen, Thomas; Van Amelsvoort, Therese; Myin-Germeys, Inez] KU Leuven Univ Leuven, Dept Neurosci, Leuven, Belgium; [Hernaus, Dennis; Collip, Dina] Maastricht Univ, Sch Mental Hlth & NeuroSci MHeNS, South Limburg Mental Hlth Res & Teaching Network, Dept Psychiat & Psychol,EURON, NL-6200 MD Maastricht, Netherlands; [Van Amelsvoort, Therese] Univ Amsterdam, Acad Med Ctr, Dept Nucl Med, NL-1105 AZ Amsterdam, Netherlands; [Winz, Oliver; Heinzel, Alexander; Mottaghy, Felix M.] Univ Hosp RWTH Aachen Univ, Dept Nucl Med, Aachen, Germany; [Pruessner, Jens] McGill Univ, Dept Psychiat, Douglas Mental Hlth Inst, Montreal, PQ, Canada; [Mottaghy, Felix M.] Maastricht Univ Hosp, Dept Nucl Med, Maastricht, Netherlands	KU Leuven; Maastricht University; University of Amsterdam; Academic Medical Center Amsterdam; RWTH Aachen University; RWTH Aachen University Hospital; McGill University; Maastricht University; Maastricht University Medical Centre (MUMC)	Kasanova, Z (corresponding author), KU Leuven Univ Leuven, Dept Neurosci, Leuven, Belgium.	zuzana.kasanova@kuleuven.be	Myin Germeys, Inez/HIR-3364-2022; Myin-Germeys, Inez/L-5106-2014; Heinzel, Alexander/G-7725-2017; Mottaghy, Felix/AAU-2673-2020	Myin Germeys, Inez/0000-0002-3731-4930; Heinzel, Alexander/0000-0002-2430-4557; Mottaghy, Felix/0000-0002-7212-6521; Vaessen, Thomas/0000-0002-9300-3117; Kasanova, Zuzana/0000-0002-8795-5373; Hernaus, Dennis/0000-0002-8370-5756; Pruessner, Jens/0000-0002-8582-2980	ERC [309767 - INTERACT]; Maastricht University; Network of European Neuroscience Schools	ERC(European Research Council (ERC)European Commission); Maastricht University; Network of European Neuroscience Schools	This study was supported by an ERC consolidator grant to Inez Myin-Germeys (ERC-2012-StG, project 309767 - INTERACT). Dina Collip and Zuzana Kasanova were supported by a Maastricht University post-doc and pre-doc Kootstra fellowship, respectively. Dennis Hernaus was funded by the Network of European Neuroscience Schools. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE ED, 1989, J NEUROCHEM, V52, P1655, DOI 10.1111/j.1471-4159.1989.tb09224.x; Alpert NM, 2003, NEUROIMAGE, V19, P1049, DOI 10.1016/S1053-8119(03)00186-1; Badgaiyan RD, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00125; Bet PM, 2009, AM J MED GENET B, V150B, P660, DOI 10.1002/ajmg.b.30886; Bifulco A, 2005, BRIT J CLIN PSYCHOL, V44, P563, DOI 10.1348/014466505X35344; Boksa P, 2003, NEUROSCI BIOBEHAV R, V27, P91, DOI 10.1016/S0149-7634(03)00012-5; Butts KA, 2011, P NATL ACAD SCI USA, V108, P18459, DOI 10.1073/pnas.1111746108; Cansino S, 2009, INT J PSYCHOPHYSIOL, V71, P64, DOI 10.1016/j.ijpsycho.2008.07.005; Ceccarini J, 2012, J NUCL MED, V53, P1565, DOI 10.2967/jnumed.111.099416; Christian BT, 2006, NEUROIMAGE, V31, P139, DOI 10.1016/j.neuroimage.2005.11.052; Collip D, 2011, PSYCHOL MED, V41, P2305, DOI 10.1017/S0033291711000602; Collip D, 2011, CNS NEUROSCI THER, V17, P612, DOI 10.1111/j.1755-5949.2010.00213.x; Daskalakis NP, 2013, PSYCHONEUROENDOCRINO, V38, P1858, DOI 10.1016/j.psyneuen.2013.06.008; Eacott MJ, 1999, MEMORY, V7, P279, DOI 10.1080/096582199387922; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Green MJ, 2014, J PSYCHIATR RES, V49, P43, DOI 10.1016/j.jpsychires.2013.10.018; Grunder G, 2003, J NUCL MED, V44, P109; Hermans EJ, 2014, TRENDS NEUROSCI, V37, P304, DOI 10.1016/j.tins.2014.03.006; Hernaus D., 2015, TRANSLATIONAL PSYCHI; Hernaus D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065662; Holtzman CW, 2013, NEUROSCIENCE, V249, P172, DOI 10.1016/j.neuroscience.2012.12.017; Horga G, 2014, JAMA PSYCHIAT, V71, P489, DOI 10.1001/jamapsychiatry.2014.191; Howes OD, 2012, ARCH GEN PSYCHIAT, V69, P776, DOI 10.1001/archgenpsychiatry.2012.169; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Janssen I, 2004, ACTA PSYCHIAT SCAND, V109, P38, DOI 10.1046/j.0001-690X.2003.00217.x; Kaenmaki M, 2010, J NEUROCHEM, V114, P1745, DOI 10.1111/j.1471-4159.2010.06889.x; KEEFE KA, 1990, BRAIN RES, V527, P350, DOI 10.1016/0006-8993(90)91158-D; Kegeles LS, 2010, ARCH GEN PSYCHIAT, V67, P231, DOI 10.1001/archgenpsychiatry.2010.10; Kelleher I, 2013, AM J PSYCHIAT, V170, P734, DOI 10.1176/appi.ajp.2012.12091169; Latagliata EC, 2014, PSYCHOPHARMACOLOGY, V231, P4099, DOI 10.1007/s00213-014-3549-7; Lataster J, 2014, SCHIZOPHRENIA BULL, V40, P66, DOI 10.1093/schbul/sbs187; Lataster J, 2011, NEUROIMAGE, V58, P1081, DOI 10.1016/j.neuroimage.2011.07.030; Matheson SL, 2013, PSYCHOL MED, V43, P225, DOI 10.1017/S0033291712000785; McLaughlin KA, 2013, J AM ACAD CHILD PSY, V52, P815, DOI 10.1016/j.jaac.2013.05.011; Mizrahi R, 2012, BIOL PSYCHIAT, V71, P561, DOI 10.1016/j.biopsych.2011.10.009; Myin-Germeys I, 2007, CLIN PSYCHOL REV, V27, P409, DOI 10.1016/j.cpr.2006.09.005; Nagano-Saito A, 2013, SYNAPSE, V67, P821, DOI 10.1002/syn.21700; Nederhof E, 2012, PHYSIOL BEHAV, V106, P691, DOI 10.1016/j.physbeh.2011.12.008; Pani L, 2000, MOL PSYCHIATR, V5, P14, DOI 10.1038/sj.mp.4000589; Pruessner JC, 2004, J NEUROSCI, V24, P2825, DOI 10.1523/JNEUROSCI.3422-03.2004; Ramsay H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079741; Read J, 2001, PSYCHIATRY, V64, P319, DOI 10.1521/psyc.64.4.319.18602; Roy CA, 2004, J NERV MENT DIS, V192, P343, DOI 10.1097/01.nmd.0000126701.23121.fa; Scornaiencki R, 2009, INT J NEUROPSYCHOPH, V12, P1195, DOI 10.1017/S1461145709000121; Smith N, 2002, SOC PSYCH PSYCH EPID, V37, P572, DOI 10.1007/s00127-002-0589-9; Soliman A, 2008, NEUROPSYCHOPHARMACOL, V33, P2033, DOI 10.1038/sj.npp.1301597; SUDHA S, 1995, PHYSIOL BEHAV, V57, P1061, DOI 10.1016/0031-9384(94)00369-G; van Os J, 2006, ACTA PSYCHIAT SCAND, V113, P91, DOI 10.1111/j.1600-0447.2005.00659.x; van Rossum EFC, 2006, BIOL PSYCHIAT, V59, P681, DOI 10.1016/j.biopsych.2006.02.007; Varese F, 2012, SCHIZOPHRENIA BULL, V38, P661, DOI 10.1093/schbul/sbs050; Ventura R, 2013, CEREB CORTEX, V23, P1606, DOI 10.1093/cercor/bhs145; Walker EF, 1997, PSYCHOL REV, V104, P667, DOI 10.1037/0033-295X.104.4.667; Walker EF, 2013, DEV PSYCHOPATHOL, V25, P1585, DOI 10.1017/S0954579413000783; Watt MJ, 2014, PSYCHOPHARMACOLOGY, V231, P1627, DOI 10.1007/s00213-013-3353-9	54	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0150746	10.1371/journal.pone.0150746	http://dx.doi.org/10.1371/journal.pone.0150746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007554	gold, Green Published, Green Submitted			2022-12-26	WOS:000372701200030
J	Knowler, SP; Berg, HVD; McFadyen, A; La Ragione, RM; Rusbridge, C				Knowler, Susan P.; Berg, Henny V. D.; McFadyen, Angus; La Ragione, Roberto M.; Rusbridge, Clare			Inheritance of Chiari-Like Malformation: Can a Mixed Breeding Reduce the Risk of Syringomyelia?	PLOS ONE			English	Article							KING-CHARLES SPANIELS; OCCIPITAL BONE HYPOPLASIA; CAUDAL CRANIAL FOSSA; I MALFORMATION; CRANIOCERVICAL JUNCTION; SALL1 MUTATIONS; CAVALIER; DOGS; DYSPLASIA; GENETICS	Canine Chiari-like malformation (CM) is a complex abnormality of the skull and craniocervical junction associated with miniaturization and brachycephaly which can result in the spinal cord disease syringomyelia (SM). This study investigated the inheritance of CM in a Griffon Bruxellois (GB) family and feasibility of crossbreeding a brachycephalic CM affected GB with a mesaticephalic normal Australian terrier and then backcrossing to produce individuals free of the malformation and regain GB breed characteristics. The study family cohort (n = 27) included five founder dogs from a previous baseline study of 155 GB which defined CM as a global malformation of the cranium and craniocervical junction with a shortened skull base and increased proximity of the cervical vertebrae to the skull. T1-weighted sagittal DICOM images of the brain and craniocervical junction were analysed for five significant traits (two angles, three lines) identified from the previous study and subsequent Qualitative Trait Loci analysis. Mean measurements for mixed breed, pure-breed and baseline study groups were compared. Results indicated that mixed breed traits posed less risk for CM and SM and were useful to distinguish the phenotype. Moreover on the MR images, the filial relationships displayed by the traits exhibited segregation and those presenting the greatest risk for CM appeared additive towards the severity of the condition. The external phenotypes revealed that by outcrossing breed types and with careful selection of appropriate conformation characteristics in the first generation, it is possible to regain the GB breed standard and reduce the degree of CM. The four GB affected with SM in the study all exhibited reduced caudal skull development compared to their relatives. The craniocervical traits may be useful for quantifying CM and assessing the possibility of SM thus assisting breeders with mate selection. However, such a system requires validation to ensure appropriateness for all breeds at risk.	[Knowler, Susan P.; La Ragione, Roberto M.; Rusbridge, Clare] Univ Surrey, Fac Hlth & Med Sci, Sch Vet Med, Guildford GU2 5XH, Surrey, England; [Berg, Henny V. D.; Rusbridge, Clare] Fitzpatrick Referrals, Godalming, Surrey, England; [McFadyen, Angus] Akm Stats, Glasgow, Lanark, Scotland	University of Surrey	Knowler, SP (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Sch Vet Med, Guildford GU2 5XH, Surrey, England.	s.knowler@surrey.ac.uk	Rusbridge, Clare/A-3794-2019; Rusbridge, Clare/K-6560-2019; Knowler, Susan P/AAL-4595-2021; La Ragione, Roberto M/Q-9916-2017	Rusbridge, Clare/0000-0002-3366-2110; Rusbridge, Clare/0000-0002-3366-2110; Knowler, Susan P/0000-0001-8727-8440; La Ragione, Roberto M/0000-0001-5861-613X	Cavalier Matters Charity [1141674]; Dogs Trust Charity [227523, SC037843]	Cavalier Matters Charity; Dogs Trust Charity	Cavalier Matters Charity Reg No 1141674 funded SPK's doctoral research. The Dogs Trust Charity Reg. No. 227523 & SC037843 contributed towards the cost of leasing the DICOM viewing software package MIMICS 14.12 Materialise (Technologielaan 15 3001 Leuven Belgium). The costs for 12 MRIs and for BVA Grading for 8 dogs were paid by Syringomyelia DNA Research Fund. (http://www.veterinary-neurologist.co.uk/Syringomyelia/DNA_Research/). AKM is an independent statistical consultant operating professionally as a sole trader under the company name of akm-stats and did not receive any salary or other remittance for his contribution in this investigation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken LA, 2009, PEDIATR NEUROL, V40, P449, DOI 10.1016/j.pediatrneurol.2009.01.003; [Anonymous], BVA KC CHIAR MALF SY; [Anonymous], 2011, ACVIM 29 ANN; Boyles AL, 2006, AM J MED GENET A, V140A, P2776, DOI 10.1002/ajmg.a.31546; Buck A, 2001, MECH DEVELOP, V104, P143, DOI 10.1016/S0925-4773(01)00364-1; Calboli FCF, 2008, GENETICS, V179, P593, DOI 10.1534/genetics.107.084954; Cappello R., 2007, AM COLL VET SURG, V36, P389; Carrera I, 2009, AM J VET RES, V70, P340, DOI 10.2460/ajvr.70.3.340; Cerda-Gonzalez S, 2015, J VET INTERN MED, V29, P887, DOI 10.1111/jvim.12604; Cerda-Gonzalez S, 2015, J VET INTERN MED, V29, P882, DOI 10.1111/jvim.12605; Cerda-Gonzalez S, 2009, VET RADIOL ULTRASOUN, V50, P467, DOI 10.1111/j.1740-8261.2009.01571.x; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Cinalli G, 2005, CHILD NERV SYST, V21, P889, DOI 10.1007/s00381-004-1115-z; Collmann H, 2005, CHILD NERV SYST, V21, P902, DOI 10.1007/s00381-004-1116-y; Couturier J, 2008, J SMALL ANIM PRACT, V49, P438, DOI 10.1111/j.1748-5827.2008.00578.x; Crispin S, 2011, VET J, V189, P129, DOI 10.1016/j.tvjl.2011.06.008; Cross HR, 2009, J SMALL ANIM PRACT, V50, P399, DOI 10.1111/j.1748-5827.2009.00799.x; Dixon A., 1997, FUNDAMENTALS CRANIOF; Driver CJ, 2013, VET J, V198, P88, DOI 10.1016/j.tvjl.2013.05.017; Driver CJ, 2010, VET REC, V167, P978, DOI 10.1136/vr.c4109; Driver CJ, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-215; Evans HE, 2012, MILLERS ANATOMY DOG, p4e; Flint G, 2014, SYRINGOMYELIA DISORD, P209; Freeman AC, 2014, J VET INTERN MED, V28, P1551, DOI 10.1111/jvim.12421; Hedhammar AA, 2011, VET J, V189, P141, DOI [10.1016/j.tvjl.2011.06.011, 10.1016/j.tvjl.2011.06.018]; KHLAT M, 1991, EPIDEMIOL REV, V13, P28, DOI 10.1093/oxfordjournals.epirev.a036072; Knowler SP, 2011, VET REC, V169, P681, DOI 10.1136/vr.100062; Knowler SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088120; Kohlhase J, 1999, AM J HUM GENET, V64, P435, DOI 10.1086/302238; Kohlhase J, 2000, HUM MUTAT, V16, P460, DOI 10.1002/1098-1004(200012)16:6<460::AID-HUMU2>3.0.CO;2-4; Kromhout K., 2014, J VET INT MED; Lemay P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089816; Leroy G, 2011, VET J, V189, P177, DOI 10.1016/j.tvjl.2011.06.016; Lewis TW, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-16; Lewis T, 2010, VET J, V183, P345, DOI 10.1016/j.tvjl.2009.10.022; McGreevy PD, 1999, ANIM WELFARE, V8, P329; Milhorat TH, 1999, NEUROSURGERY, V44, P1005, DOI 10.1097/00006123-199905000-00042; Mitchell Thomas J, 2014, Canine Genet Epidemiol, V1, P9, DOI 10.1186/2052-6687-1-9; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.2307/2411226, 10.1111/j.1558-5646.1998.tb01823.x]; Parker JE, 2011, VET REC, V168, DOI 10.1136/vr.d1726; Penderis J, 2013, VET J, V195, P133, DOI 10.1016/j.tvjl.2012.08.026; Rusbridge C, 2007, J SMALL ANIM PRACT, V48, P432, DOI 10.1111/j.1748-5827.2007.00344.x; Rusbridge C, 2006, J SMALL ANIM PRACT, V47, P603, DOI 10.1111/j.1748-5827.2006.00048.x; Rusbridge C, 2004, J VET INTERN MED, V18, P673, DOI 10.1892/0891-6640(2004)18&lt;673:IOOBHC&gt;2.0.CO;2; Rusbridge C, 2003, VET REC, V153, P107, DOI 10.1136/vr.153.4.107; Rusbridge C, 2009, J SMALL ANIM PRACT, V50, P386, DOI 10.1111/j.1748-5827.2009.00744.x; Rusbridge C., 2013, EUR J COMPANION, V23, P70, DOI DOI 10.1111/J.1748-5827.2008.00578.X; Rusbridge C, 2008, VET J, V175, P164, DOI 10.1016/j.tvjl.2006.12.007; Schanker BD, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.6.FOCUS11104; Shaw TA, 2013, VET REC, V172, DOI 10.1136/vr.101082; Shaw TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033660; Speer M C, 2000, Neurosurg Focus, V8, pE12; Stockard Charles Rupert, 1941, GENETIC ENDOCRINE BA; Summers Jennifer F, 2015, Canine Genet Epidemiol, V2, P4, DOI 10.1186/s40575-015-0016-7; Thofner MSS, 2014, J VET INTERN MED, V29; Toldo I, 2014, HEADACHE, V54, P899, DOI 10.1111/head.12341; Wolfe KC, 2010, CAN VET J, V51, P95	57	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151280	10.1371/journal.pone.0151280	http://dx.doi.org/10.1371/journal.pone.0151280			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008271	Green Published, Green Submitted, gold			2022-12-26	WOS:000372701200047
J	Murakami, G				Murakami, Gen			Distinct Effects of Estrogen on Mouse Maternal Behavior: The Contribution of Estrogen Synthesis in the Brain	PLOS ONE			English	Article							MEDIAL PREOPTIC AREA; GENE-EXPRESSION; CORTICOMEDIAL AMYGDALA; GOLDEN-HAMSTER; RECEPTOR; FEMALE; RAT; CONNECTIONS; VASOPRESSIN; EXPERIENCE	Estrogen surge following progesterone withdrawal at parturition plays an important role in initiating maternal behavior in various rodent species. Systemic estrogen treatment shortens the latency to onset of maternal behavior in nulliparous female rats that have not experienced parturition. In contrast, nulliparous laboratory mice show rapid onset of maternal behavior without estrogen treatment, and the role of estrogen still remains unclear. Here the effect of systemic estrogen treatment (for 2 h, 1 day, 3 days, and 7 days) after progesterone withdrawal was examined on maternal behavior of C57BL/6 mice. This estrogen regimen led to different effects on nursing, pup retrieval, and nest building behaviors. Latency to nursing was shortened by estrogen treatment within 2 h. Moreover, pup retrieval and nest building were decreased. mRNA expression was also investigated for estrogen receptor a (ER alpha) and for genes involved in regulating maternal behavior, specifically, the oxytocin receptor (OTR) and vasopressin receptor in the medial amygdala (MeA) and medial preoptic area (MPOA). Estrogen treatment led to decreased ER alpha mRNA in both regions. Although OTR mRNA was increased in the MeA, OTR and vasopressin receptor mRNA were reduced in the MPOA, showing region-dependent transcription regulation. To determine the mechanisms for the actions of estrogen treatment, the contribution of estrogen synthesis in the brain was examined. Blockade of estrogen synthesis in the brain by systemic letrozole treatment in ovariectomized mice interfered with pup retrieval and nest building but not nursing behavior, indicating different contributions of estrogen synthesis to maternal behavior. Furthermore, letrozole treatment led to an increase in ER alpha mRNA in the MeA but not in the MPOA, suggesting that involvement of estrogen synthesis is brain region dependent. Altogether, these results suggest that region-dependent estrogen synthesis leads to differential transcriptional activation due to exogenous estrogen treatment, and thereby results in different effects on maternal behavior.	[Murakami, Gen] Rockefeller Univ, Neurobiol & Behav Lab, 1230 York Ave,Box 275, New York, NY 10065 USA; [Murakami, Gen] Hamamatsu Univ Sch Med, Dept Psychol & Behav Neurosci, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan; [Murakami, Gen] Hamamatsu Univ Sch Med, Dept Regenerat & Infect Pathol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan	Rockefeller University; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Murakami, G (corresponding author), Rockefeller Univ, Neurobiol & Behav Lab, 1230 York Ave,Box 275, New York, NY 10065 USA.; Murakami, G (corresponding author), Hamamatsu Univ Sch Med, Dept Psychol & Behav Neurosci, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.; Murakami, G (corresponding author), Hamamatsu Univ Sch Med, Dept Regenerat & Infect Pathol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	murakami@hama-med.ac.jp			Hamamatsu University School of Medicine project research	Hamamatsu University School of Medicine project research	Funding provided by Hamamatsu University School of Medicine project research.	Bender RA, 2010, CEREB CORTEX, V20, P2985, DOI 10.1093/cercor/bhq047; Bosch OJ, 2008, P NATL ACAD SCI USA, V105, P17139, DOI 10.1073/pnas.0807412105; BRIDGES RS, 1978, HORM BEHAV, V10, P30, DOI 10.1016/0018-506X(78)90022-3; BRIDGES RS, 1984, ENDOCRINOLOGY, V114, P930, DOI 10.1210/endo-114-3-930; Bridges RS, 1996, ADV STUD BEHAV, V25, P215; BROWN TJ, 1994, MOL CELL NEUROSCI, V5, P283, DOI 10.1006/mcne.1994.1033; DOERR HK, 1981, BEHAV NEURAL BIOL, V32, P35, DOI 10.1016/S0163-1047(81)90242-9; DONCARLOS LL, 1995, NEUROREPORT, V6, P2054, DOI 10.1097/00001756-199510010-00024; FLEMING AS, 1981, PHYSIOL BEHAV, V27, P863, DOI 10.1016/0031-9384(81)90054-8; GANDELMAN R, 1973, PHYSIOL BEHAV, V10, P153, DOI 10.1016/0031-9384(73)90101-7; Gonzalez-Mariscal G, 1998, DEV PSYCHOBIOL, V32, P101, DOI 10.1002/(SICI)1098-2302(199803)32:2<101::AID-DEV3>3.0.CO;2-T; HAUSER H, 1985, HORM BEHAV, V19, P454, DOI 10.1016/0018-506X(85)90041-8; Hojo Y, 2009, ENDOCRINOLOGY, V150, P5106, DOI 10.1210/en.2009-0305; JACOBSON CD, 1980, BRAIN RES, V194, P471, DOI 10.1016/0006-8993(80)91226-3; KEVETTER GA, 1981, J COMP NEUROL, V197, P81, DOI 10.1002/cne.901970107; KEVETTER GA, 1981, J COMP NEUROL, V197, P99, DOI 10.1002/cne.901970108; KOCH M, 1989, PHYSIOL BEHAV, V45, P771, DOI 10.1016/0031-9384(89)90293-X; Kretz O, 2004, J NEUROSCI, V24, P5913, DOI 10.1523/JNEUROSCI.5186-03.2004; LAUBER AH, 1991, ENDOCRINOLOGY, V129, P3180, DOI 10.1210/endo-129-6-3180; LEGOASCOGNE C, 1991, J REPROD FERTIL, V93, P609, DOI 10.1530/jrf.0.0930609; LISK RD, 1971, ANIM BEHAV, V19, P606, DOI 10.1016/S0003-3472(71)80118-5; LISK RD, 1969, ANIM BEHAV, V17, P730, DOI 10.1016/S0003-3472(69)80020-5; Litvin Y, 2011, PHYSIOL BEHAV, V103, P393, DOI 10.1016/j.physbeh.2011.03.007; MANN MA, 1983, PHYSIOL BEHAV, V30, P697, DOI 10.1016/0031-9384(83)90165-8; MICELI MO, 1983, BEHAV BRAIN RES, V9, P337, DOI 10.1016/0166-4328(83)90137-7; MOLTZ H, 1970, PHYSIOL BEHAV, V5, P1373, DOI 10.1016/0031-9384(70)90122-8; Murakami G, 2011, EUR J NEUROSCI, V34, P469, DOI 10.1111/j.1460-9568.2011.07761.x; Murakami G, 2006, DRUG METAB REV, V38, P353, DOI 10.1080/03602530600724068; Noirot E, 1972, ADV STUDY BEHAV; NUMAN M, 1980, PHYSIOL BEHAV, V25, P653, DOI 10.1016/0031-9384(80)90367-4; Numan M, 1994, PHYSL REPROD, V2; Numan M., 2003, HORM BR BEHAV; Ogawa S, 1998, ENDOCRINOLOGY, V139, P5070, DOI 10.1210/en.139.12.5070; ORPEN BG, 1987, PHYSIOL BEHAV, V40, P47, DOI 10.1016/0031-9384(87)90184-3; Patel H, 2002, ACTA PHYSIOL SCAND, V176, P177, DOI 10.1046/j.1365-201X.2002.01033.x; PERKINS LM, 1988, ENDOCRINOLOGY, V123, P2675, DOI 10.1210/endo-123-6-2675; Ribeiro AC, 2012, P NATL ACAD SCI USA, V109, P16324, DOI 10.1073/pnas.1214094109; Ribeiro AC, 2009, EUR J NEUROSCI, V29, P795, DOI 10.1111/j.1460-9568.2009.06620.x; Rosenblatt JS, 1995, BEHAV DEV; ROSENBLATT JS, 1985, HDB BEHAV NEUROBIOLO, V7; SIMERLY RB, 1986, J COMP NEUROL, V246, P312, DOI 10.1002/cne.902460304; Solomon N. G., 1997, COOPERATIVE BREEDING; Spiteri T, 2012, BEHAV BRAIN RES, V230, P11, DOI 10.1016/j.bbr.2012.01.048; Stolzenberg DS, 2011, J NEUROENDOCRINOL, V23, P345, DOI 10.1111/j.1365-2826.2011.02112.x; Takayanagi Y, 2005, P NATL ACAD SCI USA, V102, P16096, DOI 10.1073/pnas.0505312102; Ubuka T, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00323; Vierk R, 2012, J NEUROSCI, V32, P8116, DOI 10.1523/JNEUROSCI.5319-11.2012	47	14	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0150728	10.1371/journal.pone.0150728	http://dx.doi.org/10.1371/journal.pone.0150728			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007402	Green Submitted, gold, Green Published			2022-12-26	WOS:000372701200029
J	Paulina-Carabajal, A; Lee, YN; Jacobs, LL				Paulina-Carabajal, Ariana; Lee, Yuong-Nam; Jacobs, Louis L.			Endocranial Morphology of the Primitive Nodosaurid Dinosaur Pawpawsaurus campbelli from the Early Cretaceous of North America	PLOS ONE			English	Article							ANKYLOSAURIAN DINOSAUR; ORNITHISCHIA; EVOLUTION; THEROPODA; ANATOMY; BRAIN; SKULL; REDESCRIPTION; ARCHOSAURIA; REPTILES	Background Ankylosaurs are one of the least explored clades of dinosaurs regarding endocranial anatomy, with few available descriptions of braincase anatomy and even less information on brain and inner ear morphologies. The main goal of this study is to provide a detailed description of the braincase and internal structures of the Early Cretaceous nodosaurid Pawpawsaurus campbelli, based on recently made CT scans. Methodology/Principal Findings The skull of Pawpawsaurus was CT scanned at University of Texas at Austin (UTCT). Three-dimensional models were constructed using Mimics 18.0 (Materialise). The digital data and further processed 3D models revealed inaccessible anatomic structures, allowing a detailed description of the lateral wall of the braincase (obscured by other bones in the articulated skull), and endocranial structures such as the cranial endocast, the most complete inner ear morphology for a nodosaurid, and the interpretation of the airflow system within the nasal cavities. Conslusions/Significance The new information on the endocranial morphology of Pawpawsaurus adds anatomical data to the poorly understand ankylosaur paleoneurology. The new set of data has potential use not only in taxonomy and phylogeny, but also in paleobiological interpretations based on the relative development of sense organs, such as olfaction, hearing and balance.	[Paulina-Carabajal, Ariana] Consejo Nacl Invest Cient & Tecn, Inst Invest Biodiversidad & Medioambiente INIBIOM, San Carlos De Bariloche, Rio Negro, Argentina; [Lee, Yuong-Nam] Seoul Natl Univ, Sch Earth & Environm Sci, Seoul, South Korea; [Jacobs, Louis L.] So Methodist Univ, Roy M Huffington Dept Earth Sci, Dallas, TX 75275 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Seoul National University (SNU); Southern Methodist University	Paulina-Carabajal, A (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Biodiversidad & Medioambiente INIBIOM, San Carlos De Bariloche, Rio Negro, Argentina.	a.paulinacarabajal@conicet.gov.ar		Paulina Carabajal, Ariana/0000-0002-7820-4770; Jacobs, Louis/0000-0002-7735-3678	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2012/1425]; Research Resettlement Fund for the new faculty of Seoul National University; ISEM at Southern Methodist University	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Research Resettlement Fund for the new faculty of Seoul National University; ISEM at Southern Methodist University	Funding for this project was granted by Agencia Nacional de Promocion Cientifica y Tecnologica, PICT 2012/1425 (to APC); by Research Resettlement Fund for the new faculty of Seoul National University (to Y-NL), and ISEM at Southern Methodist University (to LLJ).	Arbour VM, 2015, J ANAT, V227, P514, DOI 10.1111/joa.12363; Arbour VM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006738; Balanoff AM, 2016, J ANAT, V229, P173, DOI 10.1111/joa.12378; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; Bourke JM, 2014, ANAT REC, V297, P2148, DOI 10.1002/ar.23046; Brusatte SL, 2013, B AM MUS NAT HIST, P3; Carabajal AP, 2014, J VERTEBR PALEONTOL, V34, P870, DOI 10.1080/02724634.2014.838174; Carabajal AP, 2012, ANAT REC, V295, P2141, DOI 10.1002/ar.22572; Carpenter K, 2004, CAN J EARTH SCI, V41, P961, DOI 10.1139/E04-043; Carpenter K, 2001, LIFE O PAST, P455; Carpenter K, 2001, LIFE O PAST, P211; Chaterjee S., 1997, RISE BIRDS 25 MILLIO; COOMBS W P JR, 1978, Palaeontology (Oxford), V21, P143; Coombs W.P. Jr, 1978, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V161, P176; Currie P.J., 1997, ENCY DINOSAURS, P81; David R, 2010, CR PALEVOL, V9, P397, DOI 10.1016/j.crpv.2010.07.012; Dong Z.-M., 1993, VERTEBRAT PALASIATIC, V31, P258; Dsi A, 2014, PALAEONTOL ELECTRON, V17, P1; Evans DC, 2009, ANAT REC, V292, P1315, DOI 10.1002/ar.20984; Evans DC, 2005, ACTA PALAEONTOL POL, V50, P617; Evans Susan E., 2008, Contributions to Herpetology, V23, P1; Franzosa J.W., 2004, THESIS U TEXAS; Galton P.M., 1983, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V182, P1; Galton PM, 2001, LIFE O PAST, P103; Georgi JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058517; Gleich O, 2005, NATURWISSENSCHAFTEN, V92, P595, DOI 10.1007/s00114-005-0050-5; Godefroit Pascal, 2000, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V69, P17; Hawakaya H, 2005, J VERTEBR PALEONTOL, V25, P240, DOI 10.1671/0272-4634(2005)025[0240:NAFTCO]2.0.CO;2; Hill RV, 2003, AM MUS NOV, V3395; Holliday CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062806; Hopson J.A., 1979, P39; JACOBS LL, 1991, NEWSL STRATIGR, V24, P35; Jacobs Louis L., 1994, P337; Janensch W, 1935, PALAEONTOGRAPHICA S, V7, P145; JERISON HJ, 1969, AM NAT, V103, P575, DOI 10.1086/282627; Kearney, 2005, J MORPHOL, V264, P1; Knoll F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138233; Knoll F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030060; Knoll F, 2009, ANN PALEONTOL, V95, P165, DOI 10.1016/j.annpal.2009.06.001; Lautenschlager S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052289; Leahey LG, 2015, PEERJ, V3, DOI 10.7717/peerj.1475; Lee YN, 1996, J VERTEBR PALEONTOL, V16, P232, DOI 10.1080/02724634.1996.10011311; MANLEY GA, 1971, NATURE, V230, P506, DOI 10.1038/230506a0; Miyashita T, 2011, J ANAT, V219, P661, DOI 10.1111/j.1469-7580.2011.01427.x; Norman DB, 1996, GEOL MAG, V133, P299, DOI 10.1017/S0016756800009031; Oelrich T. M., 1956, Miscellaneous Publications Museum of Zoology University of Michigan, V94, P1; Osmolska H, 2004, ACTA PALAEONTOL POL, V49, P321; OSMOLSKA H, 1979, Acta Palaeontologica Polonica, V24, P205; Parsons T. S., 1970, P99; PARSONS THOMAS S., 1959, BULL MUS COMP ZOOL HARVARD UNIV, V120, P101; Paulina-Carabajal A, J VERT PALE IN PRESS; Paulina-Carabajal A, 2014, INT PAL C MEND; Paulina-Carabajal A, 2014, SOC VERT PAL ANN M; Pereda Suberbiola J., 1994, NEUES JB GEOLOGIE PA, V191, P173; Porter WR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139215; Romer A, 1956, OSTEOLOGY REPTILES; Salgado L, 2006, GEODIVERSITAS, V28, P119; Sampson S.D., 2007, SOC VERTEBRATE PALEO, V8, P32, DOI DOI 10.1671/0272-4634(2007)27[32:CAOMCT]2.0.CO; Schwenk K, 2008, SENSORY EVOLUTION ON THE THRESHOLD: ADAPTATIONS IN SECONDARILY AQUATIC VERTEBRATES, P65; Sereno PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001230; Sues HD, 2015, J VERTEBR PALEONTOL, V35, DOI 10.1080/02724634.2014.889145; Trotteyn MJ, 2015, 5 C LAT PAL VERT COL; Tumanova T.A., 1987, Trudy Sessii Vsesoyuznogo Paleontologicheskogo Obshchestva, V32, P1; Vickaryous MK, 2004, DINOSAURIA, 2ND EDITION, P363; Vickaryous MK, 2003, ZOOL J LINN SOC-LOND, V137, P157, DOI 10.1046/j.1096-3642.2003.00045.x; Walsh SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067176; Walsh SA, 2009, P ROY SOC B-BIOL SCI, V276, P1355, DOI 10.1098/rspb.2008.1390; Welker KL, 2009, J ANAT, V215, P444, DOI 10.1111/j.1469-7580.2009.01124.x; Witmer LM, 2008, ANAT REC, V291, P1362, DOI 10.1002/ar.20794; Witmer LM, 2008, ANATOMICAL IMAGING: TOWARDS A NEW MORPHOLOGY, P67, DOI 10.1007/978-4-431-76933-0_6; Witmer LM, 2009, ANAT REC, V292, P1266, DOI 10.1002/ar.20983; Witmer Lawrence M., 2008, P117; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; WITMER LM, 1995, J MORPHOL, V225, P269, DOI 10.1002/jmor.1052250304; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Zelenitsky DK, 2009, P ROY SOC B-BIOL SCI, V276, P667, DOI 10.1098/rspb.2008.1075	77	13	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0150845	10.1371/journal.pone.0150845	http://dx.doi.org/10.1371/journal.pone.0150845			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007950	Green Published, gold			2022-12-26	WOS:000372701200033
J	Julovi, SM; Xue, AQ; Thanh, LETN; Gill, AJ; Bulanadi, JC; Patel, M; Waddington, LJ; Rye, KA; Moghaddam, MJ; Smith, RC				Julovi, Sohel M.; Xue, Aiqun; Thanh, Thao N. L. E.; Gill, Anthony J.; Bulanadi, Jerikho C.; Patel, Mili; Waddington, Lynne J.; Rye, Kerry-Anne; Moghaddam, Minoo J.; Smith, Ross C.			Apolipoprotein A-II Plus Lipid Emulsion Enhance Cell Growth via SR-B1 and Target Pancreatic Cancer In Vitro and In Vivo	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; B TYPE-I; SCAVENGER RECEPTOR; SELECTIVE UPTAKE; PROSTATE-CANCER; CHOLESTEROL; PROTEIN; HDL; PROLIFERATION; INHIBITION	Background Apolipoprotein A-II (ApoA-II) is down regulated in the sera of pancreatic ductal adenocarcinoma (PDAC) patients, which may be due to increase utilization of high density lipoprotein (HDL) lipid by pancreatic cancer tissue. This study examined the influence of exogenous ApoA-II on lipid uptake and cell growth in pancreatic cancer (PC) both in vitro and in vivo. Methods Cryo transmission electron microscopy (TEM) examined ApoA-II's influence on morphology of SMOFLipid emulsion. The influence of ApoA-II on proliferation of cancer cell lines was determined by incubating them with lipid+/-ApoA-II and anti-SR-B1 antibody. Lipid was labeled with the fluorophore, DiD, to trace lipid uptake by cancer cells in vitro by confocal microscopy and in vivo in PDAC patient derived xenograft tumours (PDXT) by fluorescence imaging. Scavenger receptor class B type-1(SR-B1) expression in PDAC cell lines and in PDAC PDXT was measured by western blotting and immunohistochemistry, respectively. Results ApoA-II spontaneously converted lipid emulsion into very small unilamellar rHDL like vesicles (rHDL/A-II) and enhanced lipid uptake in PANC-1, CFPAC-1 and primary tumour cells as shown by confocal microscopy. SR-B1 expression was 13.2, 10.6, 3.1 and 2.3 fold higher in PANC-1, MIAPaCa-2, CFPAC-1 and BxPC3 cell lines than the normal pancreatic cell line (HPDE6) and 3.7 fold greater in PDAC tissue than in normal pancreas. ApoA-II plus lipid significantly increased the uptake of labeled lipid and promoted cell growth in PANC-1, MIAPaCa-2, CFPAC-1 and BxPC3 cells which was inhibited by anti SR-B1 antibody. Further, ApoA-II increased the uptake of lipid in xenografts by 3.4 fold. Conclusion Our data suggest that ApoA-II enhance targeting potential of lipid in pancreatic cancer which may have imaging and drug delivery potentialities.	[Julovi, Sohel M.; Xue, Aiqun; Thanh, Thao N. L. E.; Bulanadi, Jerikho C.; Smith, Ross C.] Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Canc Surg Grp, St Leonards, NSW 2065, Australia; [Smith, Ross C.] Royal N Shore Hosp, Dept Gastrointestinal Surg, St Leonards, NSW 2065, Australia; [Gill, Anthony J.] Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Canc Diag & Pathol Res Grp, St Leonards, NSW 2065, Australia; [Bulanadi, Jerikho C.; Moghaddam, Minoo J.] CSIRO, CSIRO Mfg, N Ryde, NSW 2113, Australia; [Waddington, Lynne J.] CSIRO, CSIRO Mfg, Parkville, Vic, Australia; [Patel, Mili; Rye, Kerry-Anne] Univ New S Wales, Fac Med, Ctr Vasc Res, Sydney, NSW 2052, Australia	Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Royal North Shore Hospital; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of New South Wales Sydney	Smith, RC (corresponding author), Univ Sydney, Royal N Shore Hosp, Kolling Inst Med Res, Canc Surg Grp, St Leonards, NSW 2065, Australia.; Smith, RC (corresponding author), Royal N Shore Hosp, Dept Gastrointestinal Surg, St Leonards, NSW 2065, Australia.	ross.smith@sydney.edu.au	Julovi, Sohel/AAQ-4539-2020; Gill, Anthony/D-4215-2015; Gill, Anthony J./M-5015-2019	Gill, Anthony/0000-0002-9447-1967; Julovi, Sohel/0000-0003-0834-2366	CanSur foundation; Ramsay Research Teaching Fund	CanSur foundation; Ramsay Research Teaching Fund	Part of this study was presented and awarded as best poster at New Horizons 2014 and the Scientific Research Meeting, 17th-19th November, 2014. This study has not been published elsewhere or is not under consideration for a publication. The study was supported by the CanSur foundation and partly by the Ramsay Research Teaching Fund but did not have any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. Commercial affiliation of the authors at CSIRO did not play any role in the study and did not have any competing interests relating to employment, consultancy, patents, products in development and marketed products.	Ahmad S, 2006, INT J TOXICOL, V25, P17, DOI 10.1080/10915810500488361; Biswas S, 2012, CANCER METAST REV, V31, P689, DOI 10.1007/s10555-012-9384-6; CALDERON P, 1979, BIOCHIM BIOPHYS ACTA, V574, P379, DOI 10.1016/0005-2760(79)90234-0; Cao WM, 2004, CANCER RES, V64, P1515, DOI 10.1158/0008-5472.CAN-03-0675; Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Connelly MA, 2003, TRENDS ENDOCRIN MET, V14, P467, DOI 10.1016/j.tem.2003.10.002; Czernin J, 2002, ANNU REV MED, V53, P89, DOI 10.1146/annurev.med.53.082901.104028; Daerr WH, 1990, BIOCHIM BIOPHYS ACTA, P1043; de Beer MC, 2001, J BIOL CHEM, V276, P15832, DOI 10.1074/jbc.M100228200; EISENBERG S, 1973, J LIPID RES, V14, P446; Fan YB, 2014, BIOMATERIALS, V35, P7870, DOI 10.1016/j.biomaterials.2014.05.054; Felix K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082755; Gabizon A, 1997, ADV DRUG DELIVER REV, V24, P337, DOI 10.1016/S0169-409X(96)00476-0; GABIZON AA, 1994, HEMATOL ONCOL CLIN N, V8, P431; Gao X, 2012, BIOCHEMISTRY-US, V51, P4633, DOI 10.1021/bi300555d; GOSPODAROWICZ D, 1982, CANCER RES, V42, P3704; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; HO YK, 1978, BLOOD, V52, P1099; Honda K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046908; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Huang H, 2015, WIRES NANOMED NANOBI, V7, P298, DOI 10.1002/wnan.1308; Imachi H, 1999, ENDOCR J, V46, P27, DOI 10.1507/endocrj.46.27; Julovi SM, 2013, MOL MED; Julovi SM, 2011, AM J PATHOL, V179, P2233, DOI 10.1016/j.ajpath.2011.07.024; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; Kim JY, 2009, J SEP SCI, V32, P4161, DOI 10.1002/jssc.200900442; Leon CG, 2010, PROSTATE, V70, P390, DOI 10.1002/pros.21072; OSBORNE CK, 1987, BREAST CANCER RES TR, V9, P111, DOI 10.1007/BF01807363; OSBORNE JC, 1986, METHOD ENZYMOL, V128, P213; PAPAHADJOPOULOS D, 1991, P NATL ACAD SCI USA, V88, P11460, DOI 10.1073/pnas.88.24.11460; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Pussinen PJ, 2000, BIOCHEM J, V349, P559, DOI 10.1042/0264-6021:3490559; Rodrigueza WV, 1999, J BIOL CHEM, V274, P20344, DOI 10.1074/jbc.274.29.20344; RYE KA, 1993, BIOCHIM BIOPHYS ACTA, V1167, P316, DOI 10.1016/0005-2760(93)90235-2; Shahzad MMK, 2011, NEOPLASIA, V13, P309, DOI 10.1593/neo.101372; Silva RAGD, 2007, J BIOL CHEM, V282, P9713, DOI 10.1074/jbc.M610380200; Silver DL, 2001, J BIOL CHEM, V276, P25287, DOI 10.1074/jbc.M101726200; SIPERSTEIN MD, 1984, J LIPID RES, V25, P1462; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Surugau N, 2009, J SEP SCI, V32, P1889, DOI 10.1002/jssc.200900071; Thuahnai ST, 2004, J BIOL CHEM, V279, P12448, DOI 10.1074/jbc.M311718200; Twiddy AL, 2012, PROSTATE, V72, P955, DOI 10.1002/pros.21499; Valacchi G, 2011, ANN NY ACAD SCI, V1229, pE1, DOI 10.1111/j.1749-6632.2011.06205.x; VITOLS S, 1990, P NATL ACAD SCI USA, V87, P2598, DOI 10.1073/pnas.87.7.2598; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WEISWEILER P, 1987, CLIN CHIM ACTA, V169, P249, DOI 10.1016/0009-8981(87)90325-1; Weng W, 1999, J LIPID RES, V40, P1064; Wong MH, 2014, CLIN CANCER RES, V20, P4047, DOI 10.1158/1078-0432.CCR-13-3377; Xue A, 2010, BRIT J CANCER, V103, P391, DOI 10.1038/sj.bjc.6605764; Xue AQ, 2015, PANCREATOLOGY, V15, P397, DOI 10.1016/j.pan.2015.04.008	51	16	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151475	10.1371/journal.pone.0151475	http://dx.doi.org/10.1371/journal.pone.0151475			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002321	Green Published, gold, Green Submitted			2022-12-26	WOS:000372697400033
J	Meunier, CNJ; Dallerac, G; Le Roux, N; Sacchi, S; Levasseur, G; Amar, M; Pollegioni, L; Mothet, JP; Fossier, P				Meunier, Claire N. J.; Dallerac, Glenn; Le Roux, Nicolas; Sacchi, Silvia; Levasseur, Gregoire; Amar, Muriel; Pollegioni, Loredano; Mothet, Jean-Pierre; Fossier, Philippe			D-Serine and Glycine Differentially Control Neurotransmission during Visual Cortex Critical Period	PLOS ONE			English	Article							D-ASPARTATE RECEPTOR; OCULAR DOMINANCE PLASTICITY; EXCITATION-INHIBITION BALANCE; AMINO-ACID OXIDASE; NMDA RECEPTOR; IN-VIVO; SYNAPTIC PLASTICITY; PYRAMIDAL NEURONS; CORTICAL NETWORKS; SITE	N-methyl-D-aspartate receptors (NMDARs) play a central role in synaptic plasticity. Their activation requires the binding of both glutamate and D-serine or glycine as co-agonist. The prevalence of either co-agonist on NMDA-receptor function differs between brain regions and remains undetermined in the visual cortex (VC) at the critical period of postnatal development. Here, we therefore investigated the regulatory role that D-serine and/or glycine may exert on NMDARs function and on synaptic plasticity in the rat VC layer 5 pyramidal neurons of young rats. Using selective enzymatic depletion of D-serine or glycine, we demonstrate that D-serine and not glycine is the endogenous co-agonist of synaptic NMDARs required for the induction and expression of Long Term Potentiation (LTP) at both excitatory and inhibitory synapses. Glycine on the other hand is not involved in synaptic efficacy per se but regulates excitatory and inhibitory neurotransmission by activating strychnine-sensitive glycine receptors, then producing a shunting inhibition that controls neuronal gain and results in a depression of synaptic inputs at the somatic level after dendritic integration. In conclusion, we describe for the first time that in the VC both D-serine and glycine differentially regulate somatic depolarization through the activation of distinct synaptic and extrasynaptic receptors.	[Meunier, Claire N. J.; Le Roux, Nicolas; Amar, Muriel; Fossier, Philippe] Univ Paris 11, Inst Neurosci Paris Saclay NeuroPSI, UMR CNRS 9197, Bat 446, F-91405 Orsay, France; [Dallerac, Glenn; Levasseur, Gregoire; Mothet, Jean-Pierre] Aix Marseille Univ, CNRS CRN2M UMR7286, 51 Bd Pierre Dramard, F-13344 Marseille, France; [Sacchi, Silvia; Pollegioni, Loredano] Univ Insubria, Dipartimento Biotecnol & Sci Vita, Via JH Dunant 3, Varese, Italy; [Sacchi, Silvia; Pollegioni, Loredano] Politecn Milan, ICRM CNR, Ctr Interuniv Biotecnol Prote, Prot Factory, I-20133 Milan, Italy; [Sacchi, Silvia; Pollegioni, Loredano] Univ Insubria, Via Mancinelli 7, Milan, Italy; [Meunier, Claire N. J.; Dallerac, Glenn] Coll France, CNRS UMR 7241, CIRB, INSERM U1050, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of Insubria; Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); Polytechnic University of Milan; University of Insubria; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France	Fossier, P (corresponding author), Univ Paris 11, Inst Neurosci Paris Saclay NeuroPSI, UMR CNRS 9197, Bat 446, F-91405 Orsay, France.; Mothet, JP (corresponding author), Aix Marseille Univ, CNRS CRN2M UMR7286, 51 Bd Pierre Dramard, F-13344 Marseille, France.	jean-pierre.mothet@univ-amu.fr; philippe.fossier@u-psud.fr	Mothet, Jean-Pierre/ABE-3066-2020	POLLEGIONI, LOREDANO/0000-0003-1733-7243; MOTHET, Jean-Pierre/0000-0003-4991-0614	Centre National pour la Recherche Scientifique (CNRS); SANOFI-AVENTIS; Agence Nationale de la Recherche (ANR); CNRS; SANOFI-AVENTIS RD Exploratory Unit; Agence Nationale pour la Recherche [ANR-09-MNPS-022-01]; Universite Aix-Marseille; Fondation pour la Recherche Medicale	Centre National pour la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); SANOFI-AVENTIS(Sanofi-Aventis); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); SANOFI-AVENTIS RD Exploratory Unit; Agence Nationale pour la Recherche(French National Research Agency (ANR)); Universite Aix-Marseille; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This research was supported by grants from the Centre National pour la Recherche Scientifique (CNRS), SANOFI-AVENTIS and Agence Nationale de la Recherche (ANR). CNJM received a studentship from CNRS and SANOFI-AVENTIS RD Exploratory Unit. JPM and GD were supported by Agence Nationale pour la Recherche (Grant number ANR-09-MNPS-022-01), CNRS, Universite Aix-Marseille and Fondation pour la Recherche Medicale (to J-P.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anver H, 2011, NEUROPSYCHOPHARMACOL, V36, P519, DOI 10.1038/npp.2010.183; Aroeira RI, 2011, J NEUROCHEM, V118, P339, DOI 10.1111/j.1471-4159.2011.07197.x; Atkinson BN, 2001, MOL PHARMACOL, V60, P1414, DOI 10.1124/mol.60.6.1414; Basu AC, 2009, MOL PSYCHIATR, V14, P719, DOI 10.1038/mp.2008.130; BECKER CM, 1993, BRAIN RES, V606, P220, DOI 10.1016/0006-8993(93)90988-Y; Bergeron R, 1998, P NATL ACAD SCI USA, V95, P15730, DOI 10.1073/pnas.95.26.15730; Cao ZP, 2007, EXP BRAIN RES, V177, P64, DOI 10.1007/s00221-006-0647-8; Chen RQ, 2011, NEUROPSYCHOPHARMACOL, V36, P1948, DOI 10.1038/npp.2011.86; Cho KKA, 2009, P NATL ACAD SCI USA, V106, P5377, DOI 10.1073/pnas.0808104106; Collingridge GL, 2013, NEUROPHARMACOLOGY, V64, P13, DOI 10.1016/j.neuropharm.2012.06.051; Curcio L, 2013, BRAIN, V136, P1216, DOI 10.1093/brain/awt036; Czepita D, 1996, J NEUROPHYSIOL, V75, P311, DOI 10.1152/jn.1996.75.1.311; Danglot L, 2004, MOL CELL NEUROSCI, V27, P394, DOI 10.1016/j.mcn.2004.05.007; Fantinato S., 2001, ENZYME MICROB TECHNO, V29, P407; Flint AC, 1998, NEURON, V20, P43, DOI 10.1016/S0896-6273(00)80433-X; Fossat P, 2012, CEREB CORTEX, V22, P595, DOI 10.1093/cercor/bhr130; Hagiwara H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062438; Haider B, 2006, J NEUROSCI, V26, P4535, DOI 10.1523/JNEUROSCI.5297-05.2006; HASHIMOTO A, 1995, NEUROSCIENCE, V66, P635, DOI 10.1016/0306-4522(94)00597-X; Higley MJ, 2006, J NEUROSCI, V26, P448, DOI 10.1523/JNEUROSCI.3506-05.2006; Ito K, 2001, NEUROSCI LETT, V303, P95, DOI 10.1016/S0304-3940(01)01709-8; Job V, 2002, J BIOL CHEM, V277, P6985, DOI 10.1074/jbc.M111095200; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; Keck T, 2008, J NEUROSCI, V28, P7359, DOI 10.1523/JNEUROSCI.5618-07.2008; Kim PM, 2005, P NATL ACAD SCI USA, V102, P2105, DOI 10.1073/pnas.0409723102; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Krahe TE, 2010, J NEUROPHYSIOL, V103, P2700, DOI 10.1152/jn.00442.2009; Krasteniakov NV, 2005, EUR J NEUROSCI, V21, P2782, DOI 10.1111/j.1460-9568.2005.04099.x; Le Bail M, 2015, P NATL ACAD SCI USA, V112, pE204, DOI 10.1073/pnas.1416668112; Le Roux N, 2008, EUR J NEUROSCI, V27, P3244, DOI 10.1111/j.1460-9568.2008.06288.x; Le Roux N, 2007, EUR J NEUROSCI, V26, P289, DOI 10.1111/j.1460-9568.2007.05671.x; Le Roux N, 2006, EUR J NEUROSCI, V24, P3507, DOI 10.1111/j.1460-9568.2006.05203.x; Levitt JB, 1997, PLOS ONE, P73; Li Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2779; Li YH, 2008, BRAIN RES, V1190, P49, DOI 10.1016/j.brainres.2007.11.006; Li YH, 2007, J NEUROPHYSIOL, V97, P817, DOI 10.1152/jn.00980.2006; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; Lucas-Meunier E, 2009, CEREB CORTEX, V19, P2411, DOI 10.1093/cercor/bhn258; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Martineau M, 2006, TRENDS NEUROSCI, V29, P481, DOI 10.1016/j.tins.2006.06.008; Molla G, 2000, J BIOL CHEM, V275, P24715, DOI 10.1074/jbc.M908193199; Monier C, 2008, J NEUROSCI METH, V169, P323, DOI 10.1016/j.jneumeth.2007.11.008; Moreau AW, 2010, CEREB CORTEX, V20, P456, DOI 10.1093/cercor/bhp114; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; Pollegioni L, 2007, CELL MOL LIFE SCI, V64, P1373, DOI 10.1007/s00018-007-6558-4; Pratte MS, 2013, J NEUROPHYSIOL, V110, P1346, DOI 10.1152/jn.00127.2013; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; RALL W, 1969, BIOPHYS J, V9, P1483, DOI 10.1016/S0006-3495(69)86467-2; Rosenberg D, 2013, J NEUROSCI, V33, P3533, DOI 10.1523/JNEUROSCI.3836-12.2013; Salling MC, 2014, J NEUROPHYSIOL, V112, P1169, DOI 10.1152/jn.00714.2013; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Song WF, 2006, J NEUROPHYSIOL, V95, P2366, DOI 10.1152/jn.00386.2005; SPRUSTON N, 1994, TRENDS NEUROSCI, V17, P161, DOI 10.1016/0166-2236(94)90094-9; Stevens ER, 2010, NEUROREPORT, V21, P239, DOI 10.1097/WNR.0b013e32833313b7; Tsai G, 2004, P NATL ACAD SCI USA, V101, P8485, DOI 10.1073/pnas.0402662101; Tuckwell HC, 1996, J THEOR BIOL, V181, P25, DOI 10.1006/jtbi.1996.0111; Turpin FR, 2011, NEUROBIOL AGING, V32, P1495, DOI 10.1016/j.neurobiolaging.2009.09.001; Wake K, 2001, NEUROSCI LETT, V297, P25, DOI 10.1016/S0304-3940(00)01658-X; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P721, DOI 10.1073/pnas.96.2.721; Yan XH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041419; Yang KY, 2011, SCI REP-UK, V1, DOI 10.1038/srep00203; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046	69	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151233	10.1371/journal.pone.0151233	http://dx.doi.org/10.1371/journal.pone.0151233			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003418	Green Published, Green Submitted, gold			2022-12-26	WOS:000372697400027
J	Morimoto, S; Remijn, GB; Nakajima, Y				Morimoto, Satoshi; Remijn, Gerard B.; Nakajima, Yoshitaka			Computational-Model-Based Analysis of Context Effects on Harmonic Expectancy	PLOS ONE			English	Article							TONAL CENTERS; MUSIC; CHORDS; ORGANIZATION; FACILITATION; PERCEPTION; HIERARCHY; JUDGMENTS	Expectancy for an upcoming musical chord, harmonic expectancy, is supposedly based on automatic activation of tonal knowledge. Since previous studies implicitly relied on interpretations based on Western music theory, the underlying computational processes involved in harmonic expectancy and how it relates to tonality need further clarification. In particular, short chord sequences which cannot lead to unique keys are difficult to interpret in music theory. In this study, we examined effects of preceding chords on harmonic expectancy from a computational perspective, using stochastic modeling. We conducted a behavioral experiment, in which participants listened to short chord sequences and evaluated the subjective relatedness of the last chord to the preceding ones. Based on these judgments, we built stochastic models of the computational process underlying harmonic expectancy. Following this, we compared the explanatory power of the models. Our results imply that, even when listening to short chord sequences, internally constructed and updated tonal assumptions determine the expectancy of the upcoming chord.	[Morimoto, Satoshi] Kyushu Univ, Grad Sch Design, Dept Design, Fukuoka 812, Japan; [Remijn, Gerard B.; Nakajima, Yoshitaka] Kyushu Univ, Res Ctr Appl Perceptual Sci, Fukuoka 812, Japan; [Remijn, Gerard B.; Nakajima, Yoshitaka] Kyushu Univ, Fac Design, Dept Human Sci, Fukuoka 812, Japan	Kyushu University; Kyushu University; Kyushu University	Morimoto, S (corresponding author), Kyushu Univ, Grad Sch Design, Dept Design, Fukuoka 812, Japan.	satoshi.morimo@gmail.com	Remijn, Gerard/CAF-9960-2022	Remijn, Gerard/0000-0002-8681-9951	Japan Society for the Promotion of Science (JSPS) [KAKENHI 26540145]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Challenging Exploratory Research (KAKENHI 26540145) from the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams WJ, 2004, NAT NEUROSCI, V7, P1057, DOI 10.1038/nn1312; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; BHARUCHA JJ, 1986, J EXP PSYCHOL HUMAN, V12, P403, DOI 10.1037/0096-1523.12.4.403; BHARUCHA JJ, 1987, MUSIC PERCEPT, V5, P1; BHARUCHA JJ, 1987, PERCEPT PSYCHOPHYS, V41, P519, DOI 10.3758/BF03210486; Bigand E, 1997, PERCEPT PSYCHOPHYS, V59, P1098, DOI 10.3758/BF03205524; Bigand E, 1999, J EXP PSYCHOL HUMAN, V25, P184, DOI 10.1037/0096-1523.25.1.184; Bigand E, 2003, J EXP PSYCHOL HUMAN, V29, P159, DOI 10.1037/0096-1523.29.1.159; BUTLER D, 1989, MUSIC PERCEPT, V6, P219; Daw ND, 2006, CURR OPIN NEUROBIOL, V16, P199, DOI 10.1016/j.conb.2006.03.006; Huron D.B., 2006, SWEET ANTICIPATION M; JOHNSON SC, 1967, PSYCHOMETRIKA, V32, P241, DOI 10.1007/BF02289588; Jurafsky Daniel, 2000, SPEECH LANGUAGE PROC, V1st; Koelsch S, 2000, J COGNITIVE NEUROSCI, V12, P520, DOI 10.1162/089892900562183; Koelsch S, 2014, NAT REV NEUROSCI, V15, P170, DOI 10.1038/nrn3666; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; Krumhansl C.L., 1990, COGNITIVE FDN MUSICA, P77; KRUMHANSL CL, 1990, MUSIC PERCEPT, V7, P309; KRUMHANSL CL, 1982, PSYCHOL REV, V89, P334, DOI 10.1037/0033-295X.89.4.334; KRUMHANSL CL, 1982, J EXP PSYCHOL HUMAN, V8, P24, DOI 10.1037/0096-1523.8.1.24; KRUMHANSL CL, 1979, J EXP PSYCHOL HUMAN, V5, P579, DOI 10.1037/0096-1523.5.4.579; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Lee Michael D, 2006, Cogn Sci, V30, P1, DOI 10.1207/s15516709cog0000_69; Meyer L., 1956, EMOTION MEANING MUSI; Miyazaki M, 2006, NAT NEUROSCI, V9, P875, DOI 10.1038/nn1712; Mulder MJ, 2014, NEUROSCIENCE, V277, P872, DOI 10.1016/j.neuroscience.2014.07.031; Pearce MT, 2012, TOP COGN SCI, V4, P625, DOI 10.1111/j.1756-8765.2012.01214.x; Piston W., 1948, HARMONY, V5th ed.; Raphael C, 2004, COMPUT MUSIC J, V28, P45, DOI 10.1162/0148926041790676; Rohrmeier MA, 2012, INT J PSYCHOPHYSIOL, V83, P164, DOI 10.1016/j.ijpsycho.2011.12.010; Sawai K, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00524; SCHMUCKLER MA, 1989, MUSIC PERCEPT, V7, P109; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SHEPARD RN, 1964, J ACOUST SOC AM, V36, P2346, DOI 10.1121/1.1919362; Temperley D., 2007, MUSIC PROBABILITY; THOMPSON WF, 1989, MUSIC PERCEPT, V7, P151; Tillmann B, 2000, PSYCHOL REV, V107, P885, DOI 10.1037/0033-295X.107.4.885; Tillmann B, 2003, J EXP PSYCHOL HUMAN, V29, P470, DOI 10.1037/0096-1523.29.2.470; Tillmann B, 2001, J EXP PSYCHOL HUMAN, V27, P1185, DOI 10.1037//0096-1523.27.5.1185; Tillmann B, 2013, PSYCHOMUSICOL MUSIC, V23, P1, DOI [10.1037/a0030454, DOI 10.1037/A0030454]; Tillmann B, 2008, J EXP PSYCHOL HUMAN, V34, P1031, DOI 10.1037/0096-1523.34.4.1031; Tillmann B, 2006, PSYCHOL RES-PSYCH FO, V70, P345, DOI 10.1007/s00426-005-0222-0; Yoshida W, 2006, NEURON, V50, P781, DOI 10.1016/j.neuron.2006.05.006	43	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151374	10.1371/journal.pone.0151374	http://dx.doi.org/10.1371/journal.pone.0151374			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003807	gold, Green Published, Green Submitted			2022-12-26	WOS:000372697400030
J	Natsume-Kitatani, Y; Mamitsuka, H				Natsume-Kitatani, Yayoi; Mamitsuka, Hiroshi			Classification of Promoters Based on the Combination of Core Promoter Elements Exhibits Different Histone Modification Patterns	PLOS ONE			English	Article							TRANSCRIPTION FACTOR-BINDING; CHROMATIN-STATE; TATA BOX; EXPRESSION; DROSOPHILA; DPE; IDENTIFICATION; INITIATION; ALIGNMENT; MAP	Four different histones (H2A, H2B, H3, and H4; two subunits each) constitute a histone octamer, around which DNA wraps to form histone-DNA complexes called nucleosomes. Amino acid residues in each histone are occasionally modified, resulting in several biological effects, including differential regulation of transcription. Core promoters that encompass the transcription start site have well-conserved DNA motifs, including the initiator (Inr), TATA box, and DPE, which are collectively called the core promoter elements (CPEs). In this study, we systematically studied the associations between the CPEs and histone modifications by integrating the Drosophila Core Promoter Database and time-series ChIP-seq data for histone modifications (H3K4me3, H3K27ac, and H3K27me3) during development in Drosophila melanogaster via the modENCODE project. We classified 96 core promoters into four groups based on the presence or absence of the TATA box or DPE, calculated the histone modification ratio at the core promoter region, and transcribed region for each core promoter. We found that the histone modifications in TATA-less groups were static during development and that the core promoters could be clearly divided into three types: i) core promoters with continuous active marks (H3K4me3 and H3K27ac), ii) core promoters with a continuous inactive mark (H3K27me3) and occasional active marks, and iii) core promoters with occasional histone modifications. Linear regression analysis and non-linear regression by random forest showed that the TATA-containing groups included core promoters without histone modifications, for which the measured RNA expression values were not predictable accurately from the histone modification status. DPE-containing groups had a higher relative frequency of H3K27me3 in both the core promoter region and transcribed region. In summary, our analysis showed that there was a systematic link between the existence of the CPEs and the dynamics, frequency and influence on transcriptional activity of histone modifications.	[Natsume-Kitatani, Yayoi] Japan Sci & Technol Agcy, PRESTO Precursory Res Embryon Sci & Technol, Saitama, Japan; [Mamitsuka, Hiroshi] Kyoto Univ, Inst Chem Res, Bioinformat Ctr, Kyoto 606, Japan; [Natsume-Kitatani, Yayoi] Natl Inst Biomed Innovat Hlth & Nutr, Osaka, Japan	Japan Science & Technology Agency (JST); Kyoto University	Natsume-Kitatani, Y (corresponding author), Japan Sci & Technol Agcy, PRESTO Precursory Res Embryon Sci & Technol, Saitama, Japan.; Natsume-Kitatani, Y (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Osaka, Japan.	natsume@nibiohn.go.jp	Mamitsuka, Hiroshi/R-1110-2016	Mamitsuka, Hiroshi/0000-0002-6607-5617	JST (Japan Science and Technology Agency) PRESTO program; MEXT KAKENHI [24300054]	JST (Japan Science and Technology Agency) PRESTO program; MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JST (Japan Science and Technology Agency) PRESTO program. HM is supported by MEXT KAKENHI #24300054. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziato A., 2008, NATURE ED, V1, P26; [Anonymous], 1957, COLD SPRING HARB SYM; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Benayoun BA, 2014, CELL, V158, P673, DOI 10.1016/j.cell.2014.06.027; Benveniste D, 2014, P NATL ACAD SCI USA, V111, P13367, DOI 10.1073/pnas.1412081111; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Burke TW, 1998, COLD SPRING HARB SYM, V63, P75, DOI 10.1101/sqb.1998.63.75; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Cheng C, 2012, GENOME RES, V22, P1658, DOI 10.1101/gr.136838.111; Cheng C, 2012, NUCLEIC ACIDS RES, V40, P553, DOI 10.1093/nar/gkr752; Crawley MJ, 2005, STAT INTRO USING R; Dong XJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r53; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Juven-Gershon T, 2008, GENE DEV, V22, P2823, DOI 10.1101/gad.1698108; Juven-Gershon T, 2010, DEV BIOL, V339, P225, DOI 10.1016/j.ydbio.2009.08.009; Kadonaga JT, 2012, WIRES DEV BIOL, V1, P40, DOI 10.1002/wdev.21; Karlic R, 2010, P NATL ACAD SCI USA, V107, P2926, DOI 10.1073/pnas.0909344107; Karolchik Donna, 2007, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0104s17; Kavurma MM, 2007, BIOCHEM J, V407, P79, DOI 10.1042/BJ20070380; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kutach AK, 2000, MOL CELL BIOL, V20, P4754, DOI 10.1128/MCB.20.13.4754-4764.2000; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindeman R., 1980, INTRO BIVARIATE MULT; Liu L, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1281; Liu L, 2015, NUCLEIC ACIDS RES, V43, P3873, DOI 10.1093/nar/gkv255; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Negre N, 2011, NATURE, V471, P527, DOI 10.1038/nature09990; Ohler U., 2002, GENOME BIOL, V3, pRESEARCH0087, DOI [10.1186/gb-2002-3-12-research0087, DOI 10.1186/GB-2002-3-12-RESEARCH0087]; Ponjavic J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r78; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Roberts A, 2011, BIOINFORMATICS, V27, P2325, DOI 10.1093/bioinformatics/btr355; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Smith ER, 2008, MOL CELL BIOL, V28, P1041, DOI 10.1128/MCB.01504-07; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Xu SLY, 2014, METHODS MOL BIOL, V1150, P97, DOI 10.1007/978-1-4939-0512-6_5	46	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151917	10.1371/journal.pone.0151917	http://dx.doi.org/10.1371/journal.pone.0151917			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003446	Green Published, Green Submitted, gold			2022-12-26	WOS:000372697400056
J	Szczecinska, M; Sramko, G; Wolosz, K; Sawicki, J				Szczecinska, Monika; Sramko, Gabor; Wolosz, Katarzyna; Sawicki, Jakub			Genetic Diversity and Population Structure of the Rare and Endangered Plant Species Pulsatilla patens (L.) Mill in East Central Europe	PLOS ONE			English	Article							ALLELE FREQUENCY; COMPUTER-PROGRAM; HABITAT QUALITY; SIZE; CONSERVATION; FITNESS; SOFTWARE; DECLINES; MARKERS; FLOW	Pulsatilla patens s.s. is a one of the most endangered plant species in Europe. The present range of this species in Europe is highly fragmented and the size of the populations has been dramatically reduced in the past 50 years. The rapid disappearance of P. patens localities in Europe has prompted the European Commission to initiate active protection of this critically endangered species. The aim of this study was to estimate the degree and distribution of genetic diversity within European populations of this endangered species. We screened 29 populations of P. patens using a set of six microsatellite primers. The results of our study indicate that the analyzed populations are characterized by low levels of genetic diversity (H-o = 0.005) and very high levels of inbreeding (F-IS = 0.90). These results suggest that genetic erosion could be partially responsible for the lower fitness in smaller populations of this species. Private allelic richness was very low, being as low as 0.00 for most populations. Average genetic diversity over loci and mean number of alleles in P. patens populations were significantly correlated with population size, suggesting severe genetic drift. The results of AMOVA point to higher levels of variation within populations than between populations. The results of Structure and PCoA analyses suggest that the genetic structure of the studied P. patens populations fall into three clusters corresponding to geographical regions. The most isolated populations (mostly from Romania) formed a separate group with a homogeneous gene pool located at the southern, steppic part of the distribution range. Baltic, mostly Polish, populations fall into two genetic groups which were not fully compatible with their geographic distribution. Our results indicate the serious genetic depauperation of P. patens in the western part of its range, even hinting at an ongoing extinction vortex. Therefore, special conservation attention is required to maintain the populations of this highly endangered species of European Community interest.	[Szczecinska, Monika; Wolosz, Katarzyna; Sawicki, Jakub] Univ Warmia & Mazury, Dept Bot & Nat Protect, Olsztyn, Poland; [Sramko, Gabor] Univ Debrecen, Dept Bot, Debrecen, Hungary; [Sramko, Gabor] MTA ELTE MTM Ecol Res Grp, Budapest, Hungary; [Sawicki, Jakub] Univ Ostrava, Dept Biol & Ecol, CZ-70103 Ostrava, Czech Republic	University of Warmia & Mazury; University of Debrecen; Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH); University of Ostrava	Szczecinska, M (corresponding author), Univ Warmia & Mazury, Dept Bot & Nat Protect, Olsztyn, Poland.	monika.szczecinska@uwm.edu.pl	Sawicki, Jakub/H-4432-2012; Bilska, Katarzyna/K-2376-2019; Szczecinska, Monika/J-2400-2012; Sramko, Gabor/A-1165-2009	Sawicki, Jakub/0000-0002-4759-8113; Bilska, Katarzyna/0000-0003-2817-2317; Sramko, Gabor/0000-0001-8588-6362; Szczecinska, Monika/0000-0002-5377-4304	Polish National Science Centre [NN 304 364438]; Hungarian Research Fund (OTKA PD) [109686, K108992]	Polish National Science Centre; Hungarian Research Fund (OTKA PD)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This work was supported by the Polish National Science Centre, NN 304 364438, and Hungarian Research Fund (OTKA PD 109686 and K108992).	BARRETT SCH, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P3; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; BILLINGTON HL, 1991, CONSERV BIOL, V5, P115, DOI 10.1111/j.1523-1739.1991.tb00394.x; Biro E, 2015, APPL ECOL ENV RES, V13, P181; BOCK JH, 1975, AM MIDL NAT, V94, P476, DOI 10.2307/2424441; Booy G, 2000, PLANT BIOLOGY, V2, P379, DOI 10.1055/s-2000-5958; Bothwell H, 2013, CONSERV GENET, V14, P467, DOI 10.1007/s10592-012-0411-5; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; Bunnell FL, 2004, CAN J FOREST RES, V34, P2240, DOI [10.1139/x04-102, 10.1139/X04-102]; Channell R, 2000, NATURE, V403, P84, DOI 10.1038/47487; Chapuis MP, 2008, MOL ECOL, V17, P3640, DOI 10.1111/j.1365-294X.2008.03869.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chmura D., 2003, CHRO MY PRZYR OJCZ, V59, P14; Cornuet JM, 1996, GENETICS, V144, P2001; Couvet D, 2002, CONSERV BIOL, V16, P369, DOI 10.1046/j.1523-1739.2002.99518.x; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; de Vere N, 2009, OECOLOGIA, V159, P59, DOI 10.1007/s00442-008-1203-y; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Dostalek T, 2010, CONSERV GENET, V11, P773, DOI 10.1007/s10592-009-9879-z; Duminil J, 2007, AM NAT, V169, P662, DOI 10.1086/513490; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Ehrich D, 2007, MOL ECOL, V16, P2542, DOI 10.1111/j.1365-294X.2007.03299.x; ELLSTRAND NC, 1993, ANNU REV ECOL SYST, V24, P217, DOI 10.1146/annurev.es.24.110193.001245; ERNST M, 1970, POPULATIONS SPECIES; *EUNIS, 2007, SPEC FACTSH PULS PAT; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Diniz JAF, 2009, J BIOGEOGR, V36, P2222, DOI 10.1111/j.1365-2699.2009.02163.x; Fischer M, 1998, J ECOL, V86, P195, DOI 10.1046/j.1365-2745.1998.00246.x; Frankel OH, 1995, CONSERVATION PLANT B, P91; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Frankham R, 2003, CR BIOL, V326, pS22, DOI 10.1016/S1631-0691(03)00023-4; Fraser DF, 2000, P C BIOL MAN SPEC HA, P49; Freeland J. R., 2011, MOL ECOLOGY; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Gaston KJ, 2003, THE STRUCTURE AND DY; Ge S, 1998, INT J PLANT SCI, V159, P351, DOI 10.1086/297556; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hamrick J. L., 1989, PLANT POPULATION GEN, P43; Hensen I, 2005, FLORA, V200, P3, DOI 10.1016/j.flora.2004.05.001; HILL WG, 1986, GENET RES, V48, P41, DOI 10.1017/S0016672300024642; HOFFMANN A, 1997, EXTREME ENVIRONMENTA; HOFFMANN AA, 1994, TRENDS ECOL EVOL, V9, P223, DOI 10.1016/0169-5347(94)90248-8; Hofreiter M, 2004, P NATL ACAD SCI USA, V101, P12963, DOI 10.1073/pnas.0403618101; Hollingsworth PM, 2005, MOL ECOL, V14, P497, DOI 10.1111/j.1365-294X.2005.02431.x; Holub Josef, 2000, Preslia (Prague), V72, P187; Hulten E., 1986, ATLAS N EUROPEAN VAS, V3, P969; HUNTER ML, 1994, CONSERV BIOL, V8, P1163, DOI 10.1046/j.1523-1739.1994.08041163.x; Ilves A, 2013, CONSERV GENET, V14, P661, DOI 10.1007/s10592-013-0459-x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Johansson M, 2007, MOL ECOL, V16, P2693, DOI 10.1111/j.1365-294X.2007.03357.x; Jump AS, 2009, TRENDS ECOL EVOL, V24, P694, DOI 10.1016/j.tree.2009.06.007; Kalamees R, 2005, CAN J BOT, V83, P688, DOI [10.1139/B05-038, 10.1139/b05-038]; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kalliovirta M., 2003, MONITORING THREATENE, P37; Kalliovirta M, 2006, BIODIVERS CONSERV, V15, P3095, DOI 10.1007/s10531-005-5403-z; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kirk H, 2011, INT J MOL SCI, V12, P3966, DOI 10.3390/ijms12063966; Leimu R, 2006, J ECOL, V94, P942, DOI 10.1111/j.1365-2745.2006.01150.x; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; LESKU B, 2014, NATURA 2000 FAJOK ES, P43; Lindell T, 1998, NORD J BOT, V18, P549, DOI 10.1111/j.1756-1051.1998.tb01535.x; Lonn M, 2002, OIKOS, V99, P489, DOI 10.1034/j.1600-0706.2002.11907.x; Lowe A., 2004, ECOLOGICAL GENETICS; Meusel H, 1965, TEXT U KARTEN TEXT U KARTEN, V1; Millar C, 1991, NATURA 2000 HALOZAT, P149; MILLAR CI, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P149; Molnar VA, 2015, APPL ECOL ENV RES, V13, P1097, DOI 10.15666/aeer/1304_10971108; MOURA AE, 2014, MOL BIOL EVOL, V32, DOI DOI 10.1093/MOLBER/MSU058; Neel MC, 2003, CONSERV GENET, V4, P337, DOI 10.1023/A:1024017029933; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Nybom H, 2004, MOL ECOL, V13, P1143, DOI 10.1111/j.1365-294X.2004.02141.x; Nybom Hilde, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P93, DOI 10.1078/1433-8319-00006; O'Grady JJ, 2004, BIOL CONSERV, V118, P513, DOI 10.1016/j.biocon.2003.10.002; Pandey M, 2012, AM J BOT, V99, P690, DOI 10.3732/ajb.1100116; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peterson A, 2008, PLANT ECOL, V198, P101, DOI 10.1007/s11258-007-9388-4; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pilt Indrek, 2002, Proceedings of the Estonian Academy of Sciences Biology Ecology, V51, P242; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Pritchard JK, 2000, GENETICS, V155, P945; Prsa D., 2005, CHRANENE RASTLINY CE; Prusa D, 2005, CONSERVATION BIOL; Pullin AS, 2002, SCHRIFTEN DES VEREIN; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Rasmussen IR, 1992, THE 2000 RED LIST OF, V89, P278; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Roder D, 2006, FLORA, V201, P499, DOI 10.1016/j.flora.2005.11.001; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; RYBKA V, 2005, PLANTS OF THE NATURA; SLATKIN M, 1995, GENETICS, V139, P457; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Smidova A, 2011, FLORA, V206, P151, DOI 10.1016/j.flora.2010.03.003; SOULE ME, 1986, BIOL CONSERV, V35, P19, DOI 10.1016/0006-3207(86)90025-X; Sramko G, 2014, ANN BOT-LONDON, V114, P1609, DOI 10.1093/aob/mcu179; StatSoft I, 2011, STATISTICA DAT AN SO; Szczecinska M, 2013, CONSERV GENET RESOUR, V5, P421, DOI 10.1007/s12686-012-9818-z; Tollefsrud MM, 2009, HEREDITY, V102, P549, DOI 10.1038/hdy.2009.16; Tutin T.G., 1993, FLORA EUROPAEA, V2nd, P264; Uotila Pertti, 1996, Acta Universitatis Upsaliensis Symbolae Botanicae Upsalienses, V31, P205; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; van Zonneveld M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029845; Vergeer P, 2003, J ECOL, V91, P18, DOI 10.1046/j.1365-2745.2003.00736.x; Vinceti B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059987; Vucetich JA, 2003, CONSERV GENET, V4, P639, DOI 10.1023/A:1025671831349; W?jtowicz W., 2000, BIUL OGR BOT, V9, P45; Wang JL, 2004, CONSERV BIOL, V18, P332, DOI 10.1111/j.1523-1739.2004.00440.x; Wojtowicz W., 2004, PORADNIK OCHRONY SIE; Wright LI, 2008, CONSERV GENET, V9, P833, DOI 10.1007/s10592-007-9405-0; WRIGHT S, 1951, ANN EUGENIC, V15, P323; YUZEPCHUK SV, 1937, FLORA USSR, P285; Yuzepchuk SV, 1937, DIE KULTURPFANZE BEI, P285; Zimmermann W, 1962, KRAJOWY PLAN OCHRONY, V3, P93; Zimmermann W, 1963, OECOLOGIA, V103, P99	121	62	69	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151730	10.1371/journal.pone.0151730	http://dx.doi.org/10.1371/journal.pone.0151730			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003296	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000372697400040
J	Xue, Y; Yang, ZY; Wang, XY; Lin, ZP; Li, DX; Su, SF				Xue, Yang; Yang, Zhongyang; Wang, Xiaoyan; Lin, Zhipan; Li, Dunxi; Su, Shaofeng			Tree Biomass Allocation and Its Model Additivity for Casuarina equisetifolia in a Tropical Forest of Hainan Island, China	PLOS ONE			English	Article							BELOW-GROUND BIOMASS; ABOVEGROUND BIOMASS; ALLOMETRIC MODELS; EXPANSION FACTORS; LOBLOLLY-PINE; WOOD DENSITY; EQUATIONS; STAND; DIAMETER; PREDICTIONS	Casuarina equisetifolia is commonly planted and used in the construction of coastal shelter-belt protection in Hainan Island. Thus, it is critical to accurately estimate the tree biomass of Casuarina equisetifolia L. for forest managers to evaluate the biomass stock in Hainan. The data for this work consisted of 72 trees, which were divided into three age groups: young forest, middle-aged forest, and mature forest. The proportion of biomass from the trunk significantly increased with age (P<0.05). However, the biomass of the branch and leaf decreased, and the biomass of the root did not change. To test whether the crown radius (CR) can improve biomass estimates of C. equisetifolia, we introduced CR into the biomass models. Here, six models were used to estimate the biomass of each component, including the trunk, the branch, the leaf, and the root. In each group, we selected one model among these six models for each component. The results showed that including the CR greatly improved the model performance and reduced the error, especially for the young and mature forests. In addition, to ensure biomass additivity, the selected equation for each component was fitted as a system of equations using seemingly unrelated regression (SUR). The SUR method not only gave efficient and accurate estimates but also achieved the logical additivity. The results in this study provide a robust estimation of tree biomass components and total biomass over three groups of C. equisetifolia.	[Xue, Yang; Yang, Zhongyang; Wang, Xiaoyan; Lin, Zhipan; Li, Dunxi; Su, Shaofeng] Forestry Res Inst Hainan Prov, Haikou 57L100, Hainan, Peoples R China		Yang, ZY (corresponding author), Forestry Res Inst Hainan Prov, Haikou 57L100, Hainan, Peoples R China.	yangzy_hk@163.com			State Forestry Bureau research and public service industry [201304320]; Beijing Natural Science Foundation [8152033]; National Natural Science Foundation of China [31400538]	State Forestry Bureau research and public service industry; Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the State Forestry Bureau research and public service industry (No. 201304320), Beijing Natural Science Foundation (No. 8152033), and the National Natural Science Foundation of China (No. 31400538).	Albaugh TJ, 2004, FOREST ECOL MANAG, V192, P3, DOI 10.1016/j.foreco.2004.01.002; Antonio N, 2007, CAN J FOREST RES, V37, P895, DOI 10.1139/X06-276; BASKERVILLE G L, 1972, Canadian Journal of Forest Research, V2, P49, DOI 10.1139/x72-009; Basuki TM, 2009, FOREST ECOL MANAG, V257, P1684, DOI 10.1016/j.foreco.2009.01.027; Bi HQ, 2004, TREES-STRUCT FUNCT, V18, P467, DOI 10.1007/s00468-004-0333-z; Bijak S, 2013, SILVA FENN, V47, DOI 10.14214/sf.963; BORDERS BE, 1989, FOREST SCI, V35, P548; Burkes EC, 2003, FOREST SCI, V49, P224; Canham CD, 1996, CAN J FOREST RES, V26, P1521, DOI 10.1139/x26-171; CANNELL MGR, 1984, FOREST ECOL MANAG, V8, P299, DOI 10.1016/0378-1127(84)90062-8; Case BS, 2008, CAN J FOREST RES, V38, P878, DOI 10.1139/X07-212; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Clutter JL, 1983, TIMBER MANAGEMENT QU; F.S. Popoola, 2012, Journal of forest and environmental science, V28, P63; Fahey TJ, 2010, FRONT ECOL ENVIRON, V8, P245, DOI 10.1890/080169; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Feldpausch TR, 2012, BIOGEOSCIENCES, V9, P3381, DOI 10.5194/bg-9-3381-2012; Goodman RC, 2014, ECOL APPL, V24, P680, DOI 10.1890/13-0070.1; Gower ST, 1996, ECOLOGY, V77, P1750, DOI 10.2307/2265780; Hasenauer H, 1996, FOREST ECOL MANAG, V84, P49, DOI 10.1016/0378-1127(96)03768-1; Huxley J. S., 1936, Nature London, V137, P780, DOI 10.1038/137780b0; Iida Y, 2012, FUNCT ECOL, V26, P274, DOI 10.1111/j.1365-2435.2011.01921.x; Jalkanen A, 2005, ANN FOREST SCI, V62, P845, DOI 10.1051/forest:2005075; Jenkins JC, 2003, FOREST SCI, V49, P12; Ketterings QM, 2001, FOREST ECOL MANAG, V146, P199, DOI 10.1016/S0378-1127(00)00460-6; KOZAK A, 1970, FOREST CHRON, V46, P402, DOI 10.5558/tfc46402-5; Laar A. van, 1982, South African Forestry Journal, P8; LEECH JW, 1984, AUST FOREST RES, V14, P333; Leites LP, 2009, CAN J FOREST RES, V39, P655, DOI 10.1139/X08-205; Levy PE, 2004, FORESTRY, V77, P421, DOI 10.1093/forestry/77.5.421; Li X, 2011, J PLANT BIOL, V54, P33, DOI 10.1007/s12374-010-9140-9; Lie G, 2015, TREES-STRUCT FUNCT, P1; Liu XZ, 2014, FOREST ECOL MANAG, V322, P19, DOI 10.1016/j.foreco.2014.03.020; MacFarlane DW, 2015, FOREST ECOL MANAG, V354, P43, DOI 10.1016/j.foreco.2015.06.038; Makela A, 2006, ECOLOGY, V87, P2967, DOI 10.1890/0012-9658(2006)87[2967:CRIASI]2.0.CO;2; Mbow C, 2014, J FOREST RES-JPN, V19, P340, DOI 10.1007/s10310-013-0414-1; Medhurst JL, 1999, TREES-STRUCT FUNCT, V14, P91, DOI 10.1007/s004680050213; Mendonza LA, 1983, CASUARINA ECOLOGY MA, P53; Mugasha WA, 2013, FOREST ECOL MANAG, V310, P87, DOI 10.1016/j.foreco.2013.08.003; NIKLAS KJ, 1995, ANN BOT-LONDON, V75, P217, DOI 10.1006/anbo.1995.1015; Nogueira EM, 2008, FOREST ECOL MANAG, V256, P990, DOI 10.1016/j.foreco.2008.06.001; Overman Johannes Petrus Maria, 1994, Journal of Tropical Ecology, V10, P207; Pan YD, 2004, CLIMATIC CHANGE, V67, P211, DOI 10.1007/s10584-004-2799-5; Parresol BR, 1999, FOREST SCI, V45, P573; Parresol BR, 2001, CAN J FOREST RES, V31, P865, DOI 10.1139/cjfr-31-5-865; Peichl M, 2007, FOREST ECOL MANAG, V253, P68, DOI 10.1016/j.foreco.2007.07.003; Petersson H, 2012, FOREST ECOL MANAG, V270, P78, DOI 10.1016/j.foreco.2012.01.004; Russell M., 2008, FOREST ECOL MANAG; Ryan MG, 1997, ADV ECOL RES, V27, P213, DOI 10.1016/S0065-2504(08)60009-4; Saint-Andre L, 2005, FOREST ECOL MANAG, V205, P199, DOI 10.1016/j.foreco.2004.10.006; Sanquetta CR, 2015, ANN FOREST SCI, V72, P1099, DOI 10.1007/s13595-015-0497-2; Schroeder P, 1997, FOREST SCI, V43, P424; Segura M, 2005, BIOTROPICA, V37, P2, DOI 10.1111/j.1744-7429.2005.02027.x; Sileshi GW, 2014, FOREST ECOL MANAG, V329, P237, DOI 10.1016/j.foreco.2014.06.026; SNOWDON P, 1991, CAN J FOREST RES, V21, P720, DOI 10.1139/x91-101; Soethe N, 2007, ECOL MODEL, V207, P363, DOI 10.1016/j.ecolmodel.2007.05.007; Tobin B, 2006, FORESTRY, V79, P453, DOI 10.1093/forestry/cpl030; VANLEAR DH, 1995, CAN J FOREST RES, V25, P361, DOI 10.1139/x95-040; Vanninen P, 1996, TREES-STRUCT FUNCT, V10, P231, DOI 10.1007/BF02185674; Wagner RG, 1999, ANN FOREST SCI, V56, P193, DOI 10.1051/forest:19990301; Wang FQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062988, 10.1371/journal.pone.0061792, 10.1371/journal.pone.0069284, 10.1371/journal.pone.0064373, 10.1371/journal.pone.0080480, 10.1371/journal.pone.0078025]; Wang JS, 2013, DENDROBIOLOGY, V70, P13, DOI 10.12657/denbio.070.002; Wang XP, 2008, FOREST ECOL MANAG, V255, P4007, DOI 10.1016/j.foreco.2008.03.055; WARING RH, 1985, ECOLOGY, V66, P889, DOI 10.2307/1940551; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; WIANT HV, 1979, FOREST SCI, V25, P167; [吴春燕 Wu Chunyan], 2014, [东北林业大学学报, Journal of North-East Forestry University], V42, P67; Yang Jenq-Chun, 1995, Bulletin of Taiwan Forestry Research Institute New Series, V10, P195; [杨众养 Yang Zongyang], 2015, [东北林业大学学报, Journal of North-East Forestry University], V43, P36; Yao XL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056537, 10.1371/journal.pone.0054660]; Ye G., 2011, COASTAL ECOSYSTEM CA; Zhang XQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079868; Zhang XQ, 2010, FOREST SCI, V56, P552; Zhang XL, 2014, J CHEM-NY, V2014, DOI 10.1155/2014/249485; Zhong Chong-lu, 2005, Forest Research, V18, P345; Zhou GS, 2002, FOREST ECOL MANAG, V169, P149, DOI 10.1016/S0378-1127(02)00305-5	76	18	19	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151858	10.1371/journal.pone.0151858	http://dx.doi.org/10.1371/journal.pone.0151858			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002822	Green Submitted, Green Published, gold			2022-12-26	WOS:000372697400051
J	Lozada, M; Adamo, PD; Buteler, M; Kuperman, MN				Lozada, Mariana; Adamo, Paola D'; Buteler, Micaela; Kuperman, Marcelo N.			Social Learning in Vespula Germanica Wasps: Do They Use Collective Foraging Strategies?	PLOS ONE			English	Article							STINGLESS BEES HYMENOPTERA; CUE-MEDIATED RECRUITMENT; VISUAL CUES; INFORMATION-TRANSFER; DECISION-MAKING; FOOD SOURCE; VESPIDAE; APIDAE; NEST; COMMUNICATION	Vespula germanica is a social wasp that has become established outside its native range in many regions of the world, becoming a major pest in the invaded areas. In the present work we analyze social communication processes used by V. germanica when exploiting undepleted food sources. For this purpose, we investigated the arrival pattern of wasps at a protein bait and evaluated whether a forager recruited conspecifics in three different situations: foragers were able to return to the nest (full communication), foragers were removed on arrival (communication impeded), or only one forager was allowed to return to the nest (local enhancement restricted). Results demonstrated the existence of recruitment in V. germanica, given that very different patterns of wasp arrivals and a higher frequency of wasp visits to the resource were observed when communication flow between experienced and naive foragers was allowed. Our findings showed that recruitment takes place at a distance from the food source, in addition to local enhancement. When both local enhancement and distant recruitment were occurring simultaneously, the pattern of wasp arrival was exponential. When recruitment occurred only distant from the feeder, the arrival pattern was linear, but the number of wasps arriving was twice as many as when neither communication nor local enhancement was allowed. Moreover, when return to the nest was impeded, wasp arrival at the bait was regular and constant, indicating that naive wasps forage individually and are not spatially aggregated. In conclusion, this is the first study to demonstrate recruitment in V. germanica at a distance from the food source by modelling wasps' arrival to a protein-based resource. In addition, the existence of correlations when communication was allowed and reflected in tandem arrivals indicates that we were not in the presence of random processes.	[Lozada, Mariana; Adamo, Paola D'; Buteler, Micaela] Univ Nacl Comahue, CONICET, INIBIOMA, Quintral 1250, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Kuperman, Marcelo N.] Consejo Nacl Invest Cient & Tecn, San Carlos De Bariloche, Rio Negro, Argentina; [Kuperman, Marcelo N.] Ctr Atom Bariloche CNEA, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina; [Kuperman, Marcelo N.] Inst Balseiro, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Comision Nacional de Energia Atomica (CNEA); Centro Atomico Bariloche; Comision Nacional de Energia Atomica (CNEA); University Nacional Cuyo Mendoza; Instituto Balseiro	Kuperman, MN (corresponding author), Consejo Nacl Invest Cient & Tecn, San Carlos De Bariloche, Rio Negro, Argentina.; Kuperman, MN (corresponding author), Ctr Atom Bariloche CNEA, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina.; Kuperman, MN (corresponding author), Inst Balseiro, RA-8400 San Carlos De Bariloche, Rio Negro, Argentina.	kuperman@cab.cnea.gov.ar	Kuperman, Marcelo N/N-3783-2019	Kuperman, Marcelo N/0000-0003-0935-7949; D'Adamo, Paola/0000-0003-3037-5914	CONICET, Argentina	CONICET, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was funded by CONICET, Argentina.	Aguilar I, 2005, APIDOLOGIE, V36, P313, DOI 10.1051/apido:2005005; Akre R. D., 1986, EC IMPACT CONTROL SO; Akre RD, 1982, SOCIAL INSECTS; [Anonymous], 1971, INSECT SOC; Archer Michael E., 1998, Entomologist's Monthly Magazine, V134, P279; Bartlett MS, 1981, INTRO STOCHASTIC PRO; BECKERS R, 1993, J INSECT BEHAV, V6, P751, DOI 10.1007/BF01201674; BECKERS R, 1990, INSECT SOC, V37, P258, DOI 10.1007/BF02224053; Beggs JR, 2011, BIOCONTROL, V56, P505, DOI 10.1007/s10526-011-9389-z; CAMAZINE S, 1991, J THEOR BIOL, V149, P547, DOI 10.1016/S0022-5193(05)80098-0; COLLETT TS, 1993, P ROY SOC B-BIOL SCI, V252, P129, DOI 10.1098/rspb.1993.0056; D'Adamo P, 2000, INSECT SOC, V47, P289, DOI 10.1007/PL00001717; D'Adamo P, 2003, NEW ZEAL J ZOOL, V30, P171, DOI 10.1080/03014223.2003.9518336; D'Adamo P, 2005, ANN ENTOMOL SOC AM, V98, P236, DOI 10.1603/0013-8746(2005)098[0236:CAFAIT]2.0.CO;2; D'Adamo P, 2007, INSECT SCI, V14, P383, DOI 10.1111/j.1744-7917.2007.00165.x; D'Adamo P, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.10301; D'Adamo P, 2009, ANN ENTOMOL SOC AM, V102, P1109, DOI 10.1603/008.102.0620; EDWARDS R, 1976, Entomologica Germanica, V3, P269; Hrncir M, 2007, BEHAV ECOL SOCIOBIOL, V61, P975, DOI 10.1007/s00265-006-0326-6; Jandt JM, 2005, ETHOLOGY, V111, P641, DOI 10.1111/j.1439-0310.2005.01088.x; JEANNE RL, 1995, J KANSAS ENTOMOL SOC, V68, P279; Jeanne RL, 2009, CONTEMP TOP ENTOMOL, P53; LEHRER M, 1994, J COMP PHYSIOL A, V175, P171, DOI 10.1007/BF00215113; Lozada M, 2009, ENVIRON ENTOMOL, V38, P803, DOI 10.1603/022.038.0333; Lozada M, 2006, J INSECT BEHAV, V19, P591, DOI 10.1007/s10905-006-9045-0; Lozada M, 2014, J PHYSIOL-PARIS, V108, P187, DOI 10.1016/j.jphysparis.2014.05.006; Lozada M, 2011, J INSECT BEHAV, V24, P159, DOI 10.1007/s10905-010-9244-6; MASCHWITZ U, 1974, NATURWISSENSCHAFTEN, V61, P506, DOI 10.1007/BF00622975; Mc Cabe SI, 2010, J COMP PHYSIOL A, V196, P481, DOI 10.1007/s00359-010-0536-2; Mc Cabe SI, 2009, J COMP PHYSIOL A, V195, P113, DOI 10.1007/s00359-008-0391-6; Moreyra S, 2006, AUST J ZOOL, V54, P393, DOI 10.1071/ZO06029; Moreyra S, 2012, ANN ENTOMOL SOC AM, V105, P128, DOI 10.1603/AN11097; Nieh JC, 2004, APIDOLOGIE, V35, P159, DOI 10.1051/apido:2004007; Nieh JC, 2009, ORG INSECTS SOC GENO; Overmyer SL, 1998, BEHAV ECOL SOCIOBIOL, V42, P17, DOI 10.1007/s002650050407; PARRISH MD, 1983, ECOL ENTOMOL, V8, P185, DOI 10.1111/j.1365-2311.1983.tb00497.x; Pasteels J.M., 1987, INDIVIDUAL COLLECTIV; Richter MR, 1999, INSECT SOC, V46, P131, DOI 10.1007/s000400050123; Richter MR, 2000, ANNU REV ENTOMOL, V45, P121, DOI 10.1146/annurev.ento.45.1.121; Santoro D, 2015, INSECT SOC, V62, P207, DOI 10.1007/s00040-015-0395-5; Schmidt VM, 2006, ANIM BEHAV, V72, P1309, DOI 10.1016/j.anbehav.2006.03.023; Schueller Teresa I., 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/585014; Schueller TI, 2010, NATURWISSENSCHAFTEN, V97, P1017, DOI 10.1007/s00114-010-0712-9; Seeley TD, 2000, J COMP PHYSIOL A, V186, P813, DOI 10.1007/s003590000134; SEELEY TD, 1991, BEHAV ECOL SOCIOBIOL, V28, P277, DOI 10.1007/BF00175101; Taylor Benjamin J., 2011, Psyche (Cambridge), V2011, P1, DOI 10.1155/2011/378576; Taylor BJ, 2010, NATURWISSENSCHAFTEN, V97, P1041, DOI 10.1007/s00114-010-0724-5; Thorpe, 1963, LEARNING INSTINCT AN; Wilson-Rankin EE, 2015, BEHAV ECOL SOCIOBIOL, V69, P491, DOI 10.1007/s00265-014-1861-1; Wilson-Rankin EE, 2014, BEHAV ECOL SOCIOBIOL, V68, P1151, DOI 10.1007/s00265-014-1726-7; Zeil J, 1996, J EXP BIOL, V199, P245	51	10	10	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0152080	10.1371/journal.pone.0152080	http://dx.doi.org/10.1371/journal.pone.0152080			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990864	Green Published, gold			2022-12-26	WOS:000372582800130
J	Yu, HL; Gao, Q; Shao, ZQ; Ying, AN; Sun, YY; Liu, JW; Mao, W; Zhang, B				Yu, Hailing; Gao, Qiang; Shao, Zeqiang; Ying, Anning; Sun, Yuyang; Liu, Jingwei; Mao, Wei; Zhang, Bin			Decreasing Nitrogen Fertilizer Input Had Little Effect on Microbial Communities in Three Types of Soils	PLOS ONE			English	Article							BIOMASS; ACIDIFICATION; BARLEY; CARBON	In this study, we examined the influence of different nitrogen (N) application rates (0, 168, 240, 270 and 312 kg N ha(-1)) on soil properties, maize (Zea mays L.) yields and microbial communities of three types of soils (clay, alluvial and sandy soils). Phospholipid fatty acid analysis was used to characterize soil microbial communities. Results indicated that N fertilization significantly decreased microbial biomass in both clay and sandy soils regardless of application rate. These decreases were more likely a result of soil pH decreases induced by N fertilization, especially in the sandy soils. This is supported by structural equation modeling and redundancy analysis results. Nitrogen fertilization also led to significant changes in soil microbial community composition. However, the change differences were gradually dismissed with increase in N application rate. We also observed that N fertilization increased maize yields to the same level regardless of application rate. This suggests that farmers could apply N fertilizers at a lower rate (i.e. 168 kg N ha(-1)), which could achieve high maize yield on one hand while maintain soil microbial functions on the other hand.	[Yu, Hailing; Gao, Qiang; Shao, Zeqiang; Ying, Anning; Sun, Yuyang; Liu, Jingwei; Mao, Wei] Jilin Agr Univ, Coll Resources & Environm, Changchun 130122, Jilin, Peoples R China; [Zhang, Bin] Shenyang Agr Univ, Coll Land & Environm, Shenyang 110161, Liaoning, Peoples R China	Jilin Agricultural University; Shenyang Agricultural University	Gao, Q (corresponding author), Jilin Agr Univ, Coll Resources & Environm, Changchun 130122, Jilin, Peoples R China.; Zhang, B (corresponding author), Shenyang Agr Univ, Coll Land & Environm, Shenyang 110161, Liaoning, Peoples R China.	gyt199962@163.com; bzhang@syau.edu.cn	shao, zeqiang/AAE-2180-2022	shao, zeqiang/0000-0003-3268-4876	Special Fund for Agro-scientific Research in the Public Interest [201103003]; National Natural Science Foundation of China [41401332]; Modern agricultural maize industry technology system [CARS-02]	Special Fund for Agro-scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Modern agricultural maize industry technology system	This work was financially supported by the Special Fund for Agro-scientific Research in the Public Interest (201103003, http://www.moa.gov.cn/), the National Natural Science Foundation of China (41401332, http://www.nsfc.gov.cn/), and the Modern agricultural maize industry technology system (CARS-02, http://www.moa.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balser TC, 2005, BIOGEOCHEMISTRY, V73, P395, DOI 10.1007/s10533-004-0372-y; Barak P, 1997, PLANT SOIL, V197, P61, DOI 10.1023/A:1004297607070; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bohme L, 2005, AGR ECOSYST ENVIRON, V109, P141, DOI 10.1016/j.agee.2005.01.017; Bossio DA, 1998, MICROBIAL ECOL, V36, P1, DOI 10.1007/s002489900087; Burow KR, 2010, ENVIRON SCI TECHNOL, V44, P4988, DOI 10.1021/es100546y; Esperschuetz J, 2007, FEMS MICROBIOL ECOL, V61, P26, DOI 10.1111/j.1574-6941.2007.00318.x; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; Geisseler D, 2014, SOIL BIOL BIOCHEM, V75, P54, DOI 10.1016/j.soilbio.2014.03.023; Guo JH, 2010, SCIENCE, V327, P1008, DOI 10.1126/science.1182570; Hooper D., 2008, EJBRM, V6, P53, DOI [DOI 10.1037/1082[HYPHEN]989X.12.1.58, 10.21427/D79B73]; IUSS Working Group WRB, 2014, WOLRD SOIL RES REP, V106; Kirchmann H, 2013, ACTA AGR SCAND B-S P, V63, P25, DOI 10.1080/09064710.2012.711352; Lu RK, 2000, METHODS SOIL AGROCHI; Lupwayi NZ, 2012, SOIL TILL RES, V118, P139, DOI 10.1016/j.still.2011.11.006; Lupwayi NZ, 2011, AGRON J, V103, P1064, DOI 10.2134/agronj2010.0334; Muller T, 2006, CURR MICROBIOL, V52, P400, DOI 10.1007/s00284-005-0370-x; Omar SA, 1999, FOLIA MICROBIOL, V44, P205, DOI 10.1007/BF02816244; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Ritz K, 2009, ECOL INDIC, V9, P1212, DOI 10.1016/j.ecolind.2009.02.009; Roberts BA, 2011, SOIL SCI, V176, P487, DOI 10.1097/SS.0b013e31822769d3; Rousk J, 2009, APPL ENVIRON MICROB, V75, P1589, DOI 10.1128/AEM.02775-08; Rutherford PM, 2006, SOIL SAMPLING METHOD; Savci S., 2012, International Journal of Environmental Science and Development, V3, P77; SCHWAB AP, 1990, SOIL SCI, V149, P35, DOI 10.1097/00010694-199001000-00004; Six J, 2004, SOIL TILL RES, V79, P7, DOI 10.1016/j.still.2004.03.008; Smith J.L., 1996, SSSA SPEC PUBL, V49, P169, DOI DOI 10.2136/SSSASPECPUB49.C10; Sommers D.W., 1996, METHODS SOIL ANAL; WARDLE DA, 1992, BIOL REV, V67, P321, DOI 10.1111/j.1469-185X.1992.tb00728.x; Yevdokimov I, 2008, BIOL FERT SOILS, V44, P1103, DOI 10.1007/s00374-008-0315-1; Zhang B, 2016, J AGR SCI-CAMBRIDGE, V154, P1051, DOI 10.1017/S0021859615001008; Zhang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066184; Zogg GP, 1997, SOIL SCI SOC AM J, V61, P475, DOI 10.2136/sssaj1997.03615995006100020015x	35	15	18	8	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151622	10.1371/journal.pone.0151622	http://dx.doi.org/10.1371/journal.pone.0151622			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992097	Green Published, gold, Green Submitted			2022-12-26	WOS:000372582800080
J	Carmona, G; Perera, U; Gillett, C; Naba, A; Law, AL; Sharma, VP; Wang, J; Wyckoff, J; Balsamo, M; Mosis, F; De Piano, M; Monypenny, J; Woodman, N; McConnell, RE; Mouneimne, G; Van Hemelrijck, M; Cao, Y; Condeelis, J; Hynes, RO; Gertler, FB; Krause, M				Carmona, G.; Perera, U.; Gillett, C.; Naba, A.; Law, A-L; Sharma, V. P.; Wang, J.; Wyckoff, J.; Balsamo, M.; Mosis, F.; De Piano, M.; Monypenny, J.; Woodman, N.; McConnell, R. E.; Mouneimne, G.; Van Hemelrijck, M.; Cao, Y.; Condeelis, J.; Hynes, R. O.; Gertler, F. B.; Krause, M.			Lamellipodin promotes invasive 3D cancer cell migration via regulated interactions with Ena/VASP and SCAR/WAVE	ONCOGENE			English	Article							ACTIN-FILAMENT ELONGATION; BREAST-CARCINOMA CELLS; ABL-FAMILY KINASES; LEADING-EDGE; INVADOPODIUM FORMATION; EXPRESSION SIGNATURE; FIBROBLAST MOTILITY; MAMMARY-TUMORS; BARBED ENDS; METASTASIS	Cancer invasion is a hallmark of metastasis. The mesenchymal mode of cancer cell invasion is mediated by elongated membrane protrusions driven by the assembly of branched F-actin networks. How deregulation of actin regulators promotes cancer cell invasion is still enigmatic. We report that increased expression and membrane localization of the actin regulator Lamellipodin correlate with reduced metastasis-free survival and poor prognosis in breast cancer patients. In agreement, we find that Lamellipodin depletion reduced lung metastasis in an orthotopic mouse breast cancer model. Invasive 3D cancer cell migration as well as invadopodia formation and matrix degradation was impaired upon Lamellipodin depletion. Mechanistically, we show that Lamellipodin promotes invasive 3D cancer cell migration via both actin-elongating Ena/VASP proteins and the Scar/WAVE complex, which stimulates actin branching. In contrast, Lamellipodin interaction with Scar/WAVE but not with Ena/VASP is required for random 2D cell migration. We identified a phosphorylation-dependent mechanism that regulates selective recruitment of these effectors to Lamellipodin: Abl-mediated Lamellipodin phosphorylation promotes its association with both Scar/WAVE and Ena/VASP, whereas Src-dependent phosphorylation enhances binding to Scar/WAVE but not to Ena/VASP. Through these selective, regulated interactions Lamellipodin mediates directional sensing of epidermal growth factor (EGF) gradients and invasive 3D migration of breast cancer cells. Our findings imply that increased Lamellipodin levels enhance Ena/VASP and Scar/WAVE activities at the plasma membrane to promote 3D invasion and metastasis.	[Carmona, G.; Naba, A.; Wyckoff, J.; Balsamo, M.; McConnell, R. E.; Hynes, R. O.; Gertler, F. B.] MIT, Koch Inst Integrat Canc Res, BLDG 76-361,77 Massachusetts Ave, Cambridge, MA 02139 USA; [Perera, U.; Law, A-L; Mosis, F.; Monypenny, J.; Krause, M.] Kings Coll London, Randall Div Cell & Mol Biophys, New Hunts House,Guys Campus, London SE1 1UL, England; [Gillett, C.; Monypenny, J.; Woodman, N.] Kings Coll London, Res Oncol, Div Canc Studies, Fac Life Sci & Med, London, England; [Sharma, V. P.; Condeelis, J.] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10467 USA; [Sharma, V. P.; Condeelis, J.] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Bronx, NY 10467 USA; [Wang, J.; Cao, Y.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [De Piano, M.; Van Hemelrijck, M.] Kings Coll London, Div Canc Studies, Canc Epidemiol Grp, London, England; [Monypenny, J.] Kings Coll London, Div Canc Studies, Richard Dimbleby Dept Canc Res, London, England; [Mouneimne, G.] Univ Arizona, Ctr Canc, Tucson, AZ USA; [Hynes, R. O.] MIT, Howard Hughes Med Inst, Cambridge, MA USA	Massachusetts Institute of Technology (MIT); University of London; King's College London; University of London; King's College London; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Karolinska Institutet; University of London; King's College London; University of London; King's College London; University of Arizona; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Gertler, FB (corresponding author), MIT, Koch Inst Integrat Canc Res, BLDG 76-361,77 Massachusetts Ave, Cambridge, MA 02139 USA.; Krause, M (corresponding author), Kings Coll London, Randall Div Cell & Mol Biophys, New Hunts House,Guys Campus, London SE1 1UL, England.	fgertler@mit.edu; Matthias.Krause@kcl.ac.uk	Naba, Alexandra/E-6867-2010; Balsamo, Michele/AAJ-3247-2020; Krause, Matthias/D-9814-2013	Naba, Alexandra/0000-0002-4796-5614; Balsamo, Michele/0000-0002-2315-4761; Krause, Matthias/0000-0002-3200-3199; Van Hemelrijck, Mieke/0000-0002-7317-0858	Experimental Cancer Medicine Centre at King's College London; Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award; Ludwig Fund for Cancer Research; King's College Overseas Research PhD Studentship (KORS); National Cancer Institute [U54-CA112967, U54-CA163109]; Ludwig Center for Metastasis Research at MIT; Koch Institute Support Grant from the National Cancer Institute [P30-CA14051]; Biotechnology and Biological Science Research Council, UK [BB/F011431/1, BB/J000590/1, BB/N000226/1]; Wellcome Trust [082907/Z/07/Z]; NATIONAL CANCER INSTITUTE [U54CA163109, P30CA014051, U54CA112967, R01CA150344, P01CA100324] Funding Source: NIH RePORTER; BBSRC [BB/N000226/1, BB/F011431/1, BB/J000590/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J000590/1, BB/F011431/1, BB/N000226/1] Funding Source: researchfish; Medical Research Council [1522273] Funding Source: researchfish	Experimental Cancer Medicine Centre at King's College London; Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award; Ludwig Fund for Cancer Research; King's College Overseas Research PhD Studentship (KORS); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ludwig Center for Metastasis Research at MIT; Koch Institute Support Grant from the National Cancer Institute; Biotechnology and Biological Science Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome Trust); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank members of the Gertler and Krause laboratories for helpful discussions and technical assistance; R Weinberg for his helpful discussions; J Lamar, S Hansen, D Mullins, M Way, C Cepko, D Sabatini, T Koleske and M Hemann for reagents; the Koch Institute Swanson Biotechnology Center - specifically M Griffin (Flow Cytometry Core Facility), E Vasile (Microscopy Core Facility) and K Cormier (Hope Babette Tang Histology Facility) for technical support. D Barry and M Way (LRI, CRICK, UK) for adapting the Image J plugin ADAPT for us to V1.33. Patient samples and data were provided by King's Health Partners Cancer Biobank, London, UK, which is supported by the Experimental Cancer Medicine Centre at King's College London and the Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award. GC received a postdoctoral fellowship from the Ludwig Fund for Cancer Research and UP received a King's College Overseas Research PhD Studentship (KORS). This work was supported by grants from the National Cancer Institute (U54-CA112967 and U54-CA163109), funds from the Ludwig Center for Metastasis Research at MIT (FBG, GC, AN and ROH), the Koch Institute Support Grant P30-CA14051 from the National Cancer Institute, the Biotechnology and Biological Science Research Council, UK (BB/F011431/1; BB/J000590/1; BB/N000226/1) and the Wellcome Trust (082907/Z/07/Z) (MK).	Arjonen A, 2014, J CLIN INVEST, V124, P1069, DOI 10.1172/JCI67280; Bailly M, 1999, J CELL BIOL, V145, P331, DOI 10.1083/jcb.145.2.331; Barry DJ, 2015, J CELL BIOL, V209, P163, DOI 10.1083/jcb.201501081; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bear JE, 2000, CELL, V101, P717, DOI 10.1016/S0092-8674(00)80884-3; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Beaty BT, 2014, EUR J CELL BIOL, V93, P438, DOI 10.1016/j.ejcb.2014.07.003; Bisi S, 2013, CURR OPIN CELL BIOL, V25, P565, DOI 10.1016/j.ceb.2013.04.001; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Breitsprecher D, 2008, EMBO J, V27, P2943, DOI 10.1038/emboj.2008.211; Breitsprecher D, 2011, EMBO J, V30, P456, DOI 10.1038/emboj.2010.348; Chereau D, 2006, J STRUCT BIOL, V155, P195, DOI 10.1016/j.jsb.2006.01.012; Derivery E, 2009, CELL MOTIL CYTOSKEL, V66, P777, DOI 10.1002/cm.20342; Di Modugno F, 2006, CLIN CANCER RES, V12, P1470, DOI 10.1158/1078-0432.CCR-05-2027; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Eccles SA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3493; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Gligorijevic B, 2012, J CELL SCI, V125, P724, DOI 10.1242/jcs.092726; Goswami S, 2005, CANCER RES, V65, P5278, DOI 10.1158/0008-5472.CAN-04-1853; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Hansen SD, 2010, J CELL BIOL, V191, P571, DOI 10.1083/jcb.201003014; HENNIGAN RF, 1994, ONCOGENE, V9, P3591; Iglesias PA, 2008, CURR OPIN CELL BIOL, V20, P35, DOI 10.1016/j.ceb.2007.11.011; Ignatoski KMW, 1999, BREAST CANCER RES TR, V54, P173, DOI 10.1023/A:1006135331912; Insall RH, 2009, DEV CELL, V17, P310, DOI 10.1016/j.devcel.2009.08.012; Janetopoulos C, 2008, FEBS LETT, V582, P2075, DOI 10.1016/j.febslet.2008.04.035; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; Krause M, 2004, DEV CELL, V7, P571, DOI 10.1016/j.devcel.2004.07.024; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Law AL, 2013, J CELL BIOL, V203, P673, DOI 10.1083/jcb.201304051; Lebrand C, 2004, NEURON, V42, P37, DOI 10.1016/S0896-6273(04)00108-4; Lee SLC, 2009, P NATL ACAD SCI USA, V106, P19485, DOI 10.1073/pnas.0909228106; Loi S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-239; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Lyulcheva E, 2008, DEV CELL, V15, P680, DOI 10.1016/j.devcel.2008.09.020; Michael M, 2010, CURR BIOL, V20, P783, DOI 10.1016/j.cub.2010.03.048; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mouneimne G, 2004, J CELL BIOL, V166, P697, DOI 10.1083/jcb.200405156; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; Newsome TP, 2006, CELL MICROBIOL, V8, P233, DOI 10.1111/j.1462-5822.2005.00613.x; Pasic L, 2008, J BIOL CHEM, V283, P9814, DOI 10.1074/jbc.M710475200; Philippar U, 2008, DEV CELL, V15, P813, DOI 10.1016/j.devcel.2008.09.003; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Roussos ET, 2011, NAT REV CANCER, V11, P573, DOI 10.1038/nrc3078; Roussos ET, 2011, J CELL SCI, V124, P2120, DOI 10.1242/jcs.086231; Roussos ET, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2784; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sharma VP, 2013, CURR BIOL, V23, P2079, DOI 10.1016/j.cub.2013.08.044; SYMONS MH, 1991, J CELL BIOL, V114, P503, DOI 10.1083/jcb.114.3.503; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vehlow A, 2013, EMBO J, V32, P2722, DOI 10.1038/emboj.2013.212; Youssef G, 2014, MODERN PATHOL, V27, P361, DOI 10.1038/modpathol.2013.129	58	46	46	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 29	2016	35	39					5155	5169		10.1038/onc.2016.47	http://dx.doi.org/10.1038/onc.2016.47			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX5PI	26996666	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000384433000007
J	Kim, YH; Barclay, JL; He, JJ; Luo, X; O'Neill, HM; Keshvari, S; Webster, JA; Ng, CP; Hutley, LJ; Prins, JB; Whitehead, JP				Kim, Yu-Hee; Barclay, Johanna L.; He, Jingjing; Luo, Xiao; O'Neill, Hayley M.; Keshvari, Sahar; Webster, Julie A.; Ng, Choaping; Hutley, Louise J.; Prins, Johannes B.; Whitehead, Jonathan P.			Identification of carboxypeptidase X (CPX)-1 as a positive regulator of adipogenesis	FASEB JOURNAL			English	Article						obesity; adipocyte; differentiation; extracellular matrix; collagen	METALLOCARBOXYPEPTIDASE GENE FAMILY; ADIPOCYTE DIFFERENTIATION; TRANSCRIPTIONAL REPRESSOR; EXTRACELLULAR-MATRIX; INSULIN-RESISTANCE; ADIPOSE-TISSUE; KEY REGULATOR; PROTEIN; DISCOIDIN; CELLS	Adipose tissue expansion occurs through a combination of hypertrophy of existing adipocytes and generation of new adipocytes via the process of hyperplasia, which involves the proliferation and subsequent differentiation of preadipocytes. Deficiencies in hyperplasia contribute to adipose tissue dysfunction and the association of obesity with chronic cardiometabolic diseases. Thus, increased understanding of hyperplastic pathways may be expected to afford novel therapeutic strategies. We have reported that fibroblast growth factor (FGF)-1 promotes proliferation and differentiation of human preadipocytes and recently demonstrated that bone morphogenetic protein and activin membrane-bound inhibitor (BAMBI) is a central, proximal effector. Herein, we describe the identification and characterization of carboxypeptidase X (CPX)-1, a secreted collagen-binding glycoprotein, as a novel downstream effector in human primary and Simpson-Golabi-Behmel syndrome preadipocytes. CPX-1 expression increased after treatment of preadipocytes with FGF-1, BAMBI knockdown, or induction of differentiation. CPX-1 knockdown compromised preadipocyte differentiation coincident with reduced collagen expression. Furthermore, preadipocytes differentiated on matrix derived from CPX-1 knockdown cells exhibited reduced Glut4 expression and insulin-stimulated glucose uptake. Finally, CPX-1 expression was increased in adipose tissue from obese mice and humans. Collectively, these findings establish CPX-1 as a positive regulator of adipogenesis situated downstream of FGF-1/ BAMBI that may contribute to hyperplastic adipose tissue expansion via affecting extracellular matrix remodeling.	[Kim, Yu-Hee; Barclay, Johanna L.; He, Jingjing; Luo, Xiao; O'Neill, Hayley M.; Keshvari, Sahar; Webster, Julie A.; Ng, Choaping; Hutley, Louise J.; Prins, Johannes B.; Whitehead, Jonathan P.] Univ Queensland, Translat Res Inst, Mater Res Inst, Metab Med Grp, Level 4,37 Kent St, Brisbane, Qld 4102, Australia; [Kim, Yu-Hee] Ewha Womans Univ, Sch Med, Dept Microbiol, Seoul, South Korea; [Luo, Xiao] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Xian, Peoples R China; [O'Neill, Hayley M.] Bond Univ, Inst Hlth & Sport, Robina, Qld, Australia; [Webster, Julie A.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld, Australia	Mater Research; University of Queensland; Ewha Womans University; Xi'an Jiaotong University; Bond University; University of Queensland	Whitehead, JP (corresponding author), Univ Queensland, Translat Res Inst, Mater Res Inst, Metab Med Grp, Level 4,37 Kent St, Brisbane, Qld 4102, Australia.	jon.whitehead@mater.uq.edu.au	Webster, Julie A/N-6081-2015; Prins, Johannes B/M-5884-2013; Prins, Johannes/I-3610-2019; Barclay, Johanna/G-6293-2012	Webster, Julie A/0000-0003-2879-700X; Prins, Johannes B/0000-0001-9497-927X; Prins, Johannes/0000-0001-9497-927X; Barclay, Johanna/0000-0001-5737-1775; Whitehead, Jonathan/0000-0003-3978-3148; Keshvari, Sahar/0000-0002-8116-8889; Kim, Yu-Hee/0000-0002-7804-9264; O'Neill, Hayley/0000-0001-6812-6580	Australian National Health and Medical Research Council Grants [1047625, 511104, 1074074]; Diabetes Australia; Mater Foundation; Australian Government; University of Queensland; National Natural Science Foundation of China	Australian National Health and Medical Research Council Grants(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia; Mater Foundation; Australian Government(Australian GovernmentCGIAR); University of Queensland(University of Queensland); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funding from the Australian National Health and Medical Research Council Grants 1047625 (to J.P.W. and J.B.P.), 511104 (to J.P.W.), and 1074074 (to H.M.O.); Diabetes Australia (to J.P.W.); and the Mater Foundation. The Translational Research Institute is supported by a grant from the Australian Government. Postgraduate research scholarships were awarded from the Australian National Health and Medical Research Council Grant (to J.A.W.); the University of Queensland (to Y.H.K. and S.K.); and the National Natural Science Foundation of China (to J.H. and X.L.). The authors declare no conflicts of interest.	Abderrahim-Ferkoune A, 2004, EXP CELL RES, V293, P219, DOI 10.1016/j.yexcr.2003.10.020; Borza CM, 2014, MATRIX BIOL, V34, P185, DOI 10.1016/j.matbio.2013.12.002; Chang EJ, 2004, FEBS LETT, V564, P166, DOI 10.1016/S0014-5793(04)00338-2; Fischer-Posovszky P, 2008, OBESITY FACTS, V1, P184, DOI 10.1159/000145784; Gagnon A, 2005, EXP CELL RES, V308, P265, DOI 10.1016/j.yexcr.2005.04.031; Gagnon A, 2002, ENDOCRINOLOGY, V143, P2478, DOI 10.1210/en.143.7.2478; Gusinjac A, 2011, METABOLISM, V60, P782, DOI 10.1016/j.metabol.2010.07.028; Gustafson B, 2015, TRENDS ENDOCRIN MET, V26, P193, DOI 10.1016/j.tem.2015.01.006; HE GP, 1995, NATURE, V378, P92, DOI 10.1038/378092a0; Heilbronn L, 2004, INT J OBESITY, V28, pS12, DOI 10.1038/sj.ijo.0802853; Hutley L, 2004, DIABETES, V53, P3097, DOI 10.2337/diabetes.53.12.3097; Kim SW, 2001, J BIOL CHEM, V276, P10199, DOI 10.1074/jbc.M010640200; Kim YH, 2015, BIOCHEM BIOPH RES CO, V468, P894, DOI 10.1016/j.bbrc.2015.11.053; Layne MD, 1998, J BIOL CHEM, V273, P15654, DOI 10.1074/jbc.273.25.15654; Lei YH, 1999, DNA CELL BIOL, V18, P175, DOI 10.1089/104454999315565; Leitinger B, 2014, INT REV CEL MOL BIO, V310, P39, DOI 10.1016/B978-0-12-800180-6.00002-5; Luo X, 2012, DIABETES, V61, P124, DOI 10.2337/db11-0998; Mariman ECM, 2010, CELL MOL LIFE SCI, V67, P1277, DOI 10.1007/s00018-010-0263-4; Newell FS, 2006, FASEB J, V20, P2615, DOI 10.1096/fj.05-5710fje; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; Ro HS, 2007, OBESITY, V15, P288, DOI 10.1038/oby.2007.569; Sapio MR, 2014, PROTEOM CLIN APPL, V8, P327, DOI 10.1002/prca.201300090; Scherer PE, 2006, DIABETES, V55, P1537, DOI 10.2337/db06-0263; Schissel SL, 2009, AM J PATHOL, V174, P818, DOI 10.2353/ajpath.2009.080856; Song DS, 2011, J PERIODONTAL RES, V46, P193, DOI 10.1111/j.1600-0765.2010.01328.x; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; van Tienen FHJ, 2011, INT J OBESITY, V35, P1154, DOI 10.1038/ijo.2010.275; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Wang MY, 2008, P NATL ACAD SCI USA, V105, P6139, DOI 10.1073/pnas.0801981105; WEINER FR, 1989, BIOCHEMISTRY-US, V28, P4094, DOI 10.1021/bi00435a070; Widberg CH, 2009, AM J PHYSIOL-ENDOC M, V296, pE121, DOI 10.1152/ajpendo.90602.2008; Williams AS, 2015, TRENDS ENDOCRIN MET, V26, P357, DOI 10.1016/j.tem.2015.05.006; Xin XN, 1998, DNA CELL BIOL, V17, P897, DOI 10.1089/dna.1998.17.897; Zhang L, 2005, MOL MED, V11, P39, DOI 10.2119/2005-00021.Ro; Zurakowski H, 2007, HORM METAB RES, V39, P575, DOI 10.1055/s-2007-985132	35	13	13	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2528	2540		10.1096/fj.201500107R	http://dx.doi.org/10.1096/fj.201500107R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27006448				2022-12-26	WOS:000379249500008
J	Sigoillot, SM; Bourgeois, F; Karmouch, J; Molgo, J; Dobbertin, A; Chevalier, C; Houlgatte, R; Leger, J; Legay, C				Sigoillot, Severine M.; Bourgeois, Francine; Karmouch, Jennifer; Molgo, Jordi; Dobbertin, Alexandre; Chevalier, Catherine; Houlgatte, Remi; Leger, Jean; Legay, Claire			Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency	FASEB JOURNAL			English	Article						gene profiling; collagen Q; AChR; extracellular matrix; dystroglycan	HEPARIN-BINDING DOMAINS; COLLAGEN-TAILED FORMS; GENE-EXPRESSION; SKELETAL-MUSCLE; ANCHORING ACETYLCHOLINESTERASE; MUSCULAR-DYSTROPHY; SYNAPTIC STRUCTURE; BETA-DYSTROGLYCAN; SUBUNIT; MUTATIONS	The collagen ColQ anchors acetylcholinesterase (AChE) in the synaptic cleft of the neuromuscular junction (NMJ). It also binds MuSK and perlecan/dystroglycan, 2 signaling platforms of the postsynaptic domain. Mutations in ColQ cause a congenital myasthenic syndrome (CMS) with AChE deficiency. Because the absence of AChE does not fully explain the complexity of the syndrome and there is no curative treatment for the disease, we explored additional potential targets of ColQ by conducting a large genetic screening of ColQ-deficient mice, a model for CMS with AChE deficiency, and analyzed their NMJ and muscle phenotypes. We demonstrated that ColQ controls the development and the maturation of the postsynaptic domain by regulating synaptic gene expression. Notably, ColQ deficiency leads to an up-regulation of the 5 subunits of the nicotinic acetylcholine receptor (AChR), leading to mixed mature and immature AChRs at the NMJ of adult mice. ColQ also regulates the expression of extracellular matrix (ECM) components. However, whereas the ECM mRNAs were down-regulated in vitro, compensation seemed to occur in vivo to maintain normal levels of these mRNAs. Finally, ColQ deficiency leads to a general atrophic phenotype and hypoplasia that affect fast muscles. This study points to new specific hallmarks for this CMS.Sigoillot, S. M., Bourgeois, F., Karmouch, J., Molgo, J., Dobbertin, A., Chevalier, C., Houlgatte, R., Leger, J., Legay, C. Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency.	[Sigoillot, Severine M.; Bourgeois, Francine; Karmouch, Jennifer; Dobbertin, Alexandre; Legay, Claire] Univ Paris 05, Sorbonne Paris Cite, CNRS, Ctr Neurophys Physiol & Pathol,Unite Mixte Rech U, F-75006 Paris, France; [Molgo, Jordi] Commissariat Energie Atom & Energies Alternat, Inst Biol & Technol Saclay, Serv Ingn Mol Prot, Gif Sur Yvette, France; [Molgo, Jordi] Univ Paris 11, CNRS, UMR 9197, Inst Neurosci Paris Saclay, Paris, France; [Chevalier, Catherine; Houlgatte, Remi; Leger, Jean] Univ Nantes, Inst Rech Therapeut, Plateforme Genom Integrat, Nantes, France; [Sigoillot, Severine M.] Coll France, CNRS UMR 7241, INSERM U1050, Ctr Interdisciplinary Res Biol, F-75231 Paris, France; [Houlgatte, Remi] Fac Med, INSERM, U954, Vandoeuvre Les Nancy, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; Nantes Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine	Legay, C (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Ctr CNRS, Ctr Neurophys Physiol & Pathol,UMR 8119, 45 Rue St Peres, F-75006 Paris, France.	claire.legay@parisdescartes.fr	Houlgatte, Remi/P-3020-2017		INSERM; Association Francaise contre les Myopathies (AFM); Agence Nationale de la Recherche; Universite Paris Descartes; French Ministry of Research; AFM	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Agence Nationale de la Recherche(French National Research Agency (ANR)); Universite Paris Descartes; French Ministry of Research(Ministry of Research, FranceEuropean Commission); AFM(Association Francaise contre les Myopathies)	The authors thank Eric Krejci and Emmanuelle Girard for providing WT and ColQ<SUP>-/-</SUP> mice and Olivier Bignolais and Audrey Donnart for help with TLDA experiments. This work was funded by grants from INSERM, the Association Francaise contre les Myopathies (AFM; to C. L.), the Agence Nationale de la Recherche, and Universite Paris Descartes. S. M. S. is the recipient of a Ph.D. grant from the French Ministry of Research and AFM. The authors declare no conflicts of interest.	Arikawa-Hirasawa E, 2002, NAT NEUROSCI, V5, P119, DOI 10.1038/nn801; Arredondo J, 2014, HUM GENET, V133, P599, DOI 10.1007/s00439-013-1391-3; Bauche S, 2013, NEUROMUSCULAR DISORD, V23, P998, DOI 10.1016/j.nmd.2013.07.005; Cairns SP, 2015, J PHYSIOL-LONDON, V593, P4713, DOI 10.1113/JP270909; Cartaud A, 2004, J CELL BIOL, V165, P505, DOI 10.1083/jcb.200307164; Ciciliot S, 2013, INT J BIOCHEM CELL B, V45, P2191, DOI 10.1016/j.biocel.2013.05.016; Cote PD, 1999, NAT GENET, V23, P338, DOI 10.1038/15519; Deprez P, 2003, J BIOL CHEM, V278, P23233, DOI 10.1074/jbc.M301384200; Donger C, 1998, AM J HUM GENET, V63, P967, DOI 10.1086/302059; Engel AG, 2007, NEUROTHERAPEUTICS, V4, P252, DOI 10.1016/j.nurt.2007.01.001; Engel AG, 2015, LANCET NEUROL, V14, P420, DOI 10.1016/S1474-4422(14)70201-7; Feng GP, 1999, J CELL BIOL, V144, P1349, DOI 10.1083/jcb.144.6.1349; Folker ES, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00363; FRAIL DE, 1989, NEURON, V2, P1077, DOI 10.1016/0896-6273(89)90232-8; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; Guo YR, 2015, NEUROMUSCULAR DISORD, V25, P257, DOI 10.1016/j.nmd.2014.11.017; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; Hantai D, 2004, CURR OPIN NEUROL, V17, P539, DOI 10.1097/00019052-200410000-00004; Herlitze S, 1996, J PHYSIOL-LONDON, V492, P775, DOI 10.1113/jphysiol.1996.sp021345; Jacobson C, 2001, J CELL BIOL, V152, P435, DOI 10.1083/jcb.152.3.435; Joassard OR, 2015, J NEUROSCI, V35, P10949, DOI 10.1523/JNEUROSCI.1043-15.2015; Kang H, 2014, J NEUROSCI, V34, P6323, DOI 10.1523/JNEUROSCI.4673-13.2014; KATZ B, 1973, J PHYSIOL-LONDON, V231, P549, DOI 10.1113/jphysiol.1973.sp010248; Kharraz Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/965631; Kimbell LM, 2004, J BIOL CHEM, V279, P10997, DOI 10.1074/jbc.M305462200; Krejci E, 1997, J BIOL CHEM, V272, P22840, DOI 10.1074/jbc.272.36.22840; KREJCI E, 1991, EMBO J, V10, P1285, DOI 10.1002/j.1460-2075.1991.tb08070.x; Krejci E, 1999, J NEUROSCI, V19, P10672, DOI 10.1523/JNEUROSCI.19-24-10672.1999; Lashley D, 2010, NEUROLOGY, V74, P1517, DOI 10.1212/WNL.0b013e3181dd43bf; Legay C, 2000, MICROSC RES TECHNIQ, V49, P56, DOI 10.1002/(SICI)1097-0029(20000401)49:1<56::AID-JEMT7>3.0.CO;2-R; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma JJ, 2007, J ORTHOP RES, V25, P1498, DOI 10.1002/jor.20414; Marionneau C, 2005, J PHYSIOL-LONDON, V562, P223, DOI 10.1113/jphysiol.2004.074047; Martin PT, 2003, GLYCOBIOLOGY, V13, p55R, DOI 10.1093/glycob/cwg076; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Mejat A, 2003, ANN NY ACAD SCI, V998, P53, DOI 10.1196/annals.1254.008; Mihaylova V, 2008, BRAIN, V131, P747, DOI 10.1093/brain/awm325; Minic J, 2003, BRIT J PHARMACOL, V138, P177, DOI 10.1038/sj.bjp.0705010; Montanaro F, 1999, J CELL BIOL, V145, P1325, DOI 10.1083/jcb.145.6.1325; Mueller Juliane S., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000427; Nguyen-Huu T, 2005, ANESTHESIOLOGY, V103, P788, DOI 10.1097/00000542-200510000-00017; Nicole S, 2000, NAT GENET, V26, P480, DOI 10.1038/82638; Nicole S, 2014, BRAIN, V137, P2429, DOI 10.1093/brain/awu160; Ohno K, 1998, P NATL ACAD SCI USA, V95, P9654, DOI 10.1073/pnas.95.16.9654; OWENS J, 1993, RECEPTOR CHANNEL, V1, P173; Pavlidis P, 2002, J COMPUT BIOL, V9, P401, DOI 10.1089/10665270252935539; Pitceathly RDS, 2014, CURR OPIN NEUROL, V27, P576, DOI 10.1097/WCO.0000000000000126; Ridgeway AG, 2000, J BIOL CHEM, V275, P41, DOI 10.1074/jbc.275.1.41; Riemersma M, 2015, NEUROLOGY, V84, P2177, DOI 10.1212/WNL.0000000000001615; Ruegg MA, 2011, ANNU REV PHARMACOL, V51, P373, DOI 10.1146/annurev-pharmtox-010510-100537; Salih MAM, 1996, ANN NEUROL, V40, P925, DOI 10.1002/ana.410400617; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; SCHOFIELD JN, 1995, DEV DYNAM, V204, P178, DOI 10.1002/aja.1002040208; Sigoillot SM, 2010, CHEM-BIOL INTERACT, V187, P84, DOI 10.1016/j.cbi.2010.02.007; Sigoillot SM, 2010, J NEUROSCI, V30, P13, DOI 10.1523/JNEUROSCI.4374-09.2010; Spillane J, 2010, J NEUROL NEUROSUR PS, V81, P850, DOI 10.1136/jnnp.2008.169367; Stum M, 2008, HUM MOL GENET, V17, P3166, DOI 10.1093/hmg/ddn213; Stum M, 2006, HUM MUTAT, V27, P1082, DOI 10.1002/humu.20388; Tang HB, 2006, J BIOL CHEM, V281, P3943, DOI 10.1074/jbc.M511317200; Tang HB, 2004, CELL SIGNAL, V16, P551, DOI 10.1016/j.cellsig.2003.09.006; VANDERKLOOT W, 1994, PFLUG ARCH EUR J PHY, V428, P114, DOI 10.1007/BF00374848; Wargon I, 2012, NEUROMUSCULAR DISORD, V22, P318, DOI 10.1016/j.nmd.2011.09.002; Yumoto N, 2005, BIOCHEM BIOPH RES CO, V331, P1522, DOI 10.1016/j.bbrc.2005.04.081	64	16	18	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2382	2399		10.1096/fj.201500162	http://dx.doi.org/10.1096/fj.201500162			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	26993635				2022-12-26	WOS:000376878300027
J	Heinrich, G; Russo, L; Castaneda, TR; Pfeiffer, V; Ghadieh, HE; Ghanem, SS; Wu, JS; Faulkner, LD; Ergun, S; McInerney, MF; Hill, JW; Najjar, SM				Heinrich, Garrett; Russo, Lucia; Castaneda, Tamara R.; Pfeiffer, Verena; Ghadieh, Hilda E.; Ghanem, Simona S.; Wu, Jieshen; Faulkner, Latrice D.; Erguen, Sueleyman; McInerney, Marcia F.; Hill, Jennifer W.; Najjar, Sonia M.			Leptin Resistance Contributes to Obesity in Mice with Null Mutation of Carcinoembryonic Antigen-related Cell Adhesion Molecule 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						fatty acid oxidation; fatty-acid synthase (FAS); insulin resistance; leptin; nuclear magnetic resonance (NMR); CEACAM1; Energy homeostasis; hyperleptinemia; hyperphagia; leptin resistance NIH [; and (to S; M; Najjar); (to J; W; Hill) and	ACTIVATED PROTEIN-KINASE; ACID SYNTHASE INHIBITOR; LOW AEROBIC CAPACITY; INSULIN ACTION; ENERGY-BALANCE; SKELETAL-MUSCLE; POMC NEURONS; FOOD-INTAKE; GLUCOSE-HOMEOSTASIS; HEPATIC STEATOSIS	Carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) promotes hepatic insulin clearance. Consistently, mice with null mutation of Ceacam1 (Cc1(-/-)) exhibit impaired insulin clearance with increased lipid production in liver and redistribution to white adipose tissue, leading to visceral obesity at 2 months of age. When the mutation is propagated on the C57/BL6J genetic background, total fat mass rises significantly with age, and glucose intolerance and systemic insulin resistance develop at 6 months of age. This study was carried out to determine the mechanisms underlying the marked increase in total fat mass in 6-month-old mutants. Indirect calorimetry analysis showed that Cc1(-/-) mice develop hyperphagia and a significant reduction in physical activity, in particular in the early hours of the dark cycle, during which energy expenditure is only slightly lower than in wild-type mice. They also exhibit increased triglyceride accumulation in skeletal muscle, due in part to incomplete fatty acid -oxidation. Mechanistically, hypothalamic leptin signaling is reduced, as demonstrated by blunted STAT3 phosphorylation in coronal sections in response to an intracerebral ventricular injection of leptin. Hypothalamic fatty-acid synthase activity is also elevated in the mutants. Together, the data show that the increase in total fat mass in Cc1(-/-) mice is mainly attributed to hyperphagia and reduced spontaneous physical activity. Although the contribution of the loss of CEACAM1 from anorexigenic proopiomelanocortin neurons in the arcuate nucleus is unclear, leptin resistance and elevated hypothalamic fatty-acid synthase activity could underlie altered energy balance in these mice.	[Heinrich, Garrett; Russo, Lucia; Castaneda, Tamara R.; Ghadieh, Hilda E.; Ghanem, Simona S.; Wu, Jieshen; Faulkner, Latrice D.; McInerney, Marcia F.; Hill, Jennifer W.; Najjar, Sonia M.] Coll Pharm & Pharmaceut Sci, Ctr Diabet & Endocrine Res, Toledo, OH 43614 USA; [Castaneda, Tamara R.; McInerney, Marcia F.] Coll Pharm & Pharmaceut Sci, Dept Med & Biol Chem, Toledo, OH 43614 USA; [Pfeiffer, Verena; Erguen, Sueleyman] Univ Wurzburg, Inst Anat & Zellbiol, D-97070 Wurzburg, Germany; [Najjar, Sonia M.] Ohio Univ, Heritage Coll Osteopath Med, Dept Biomed Sci, Athens, OH 45701 USA	University of Wurzburg; University System of Ohio; Ohio University	Najjar, SM (corresponding author), Ohio Univ, Heritage Coll Osteopath Med, Off Grants & Res, Irvine Hall,Rm 220B,1 Ohio Univ, Athens, OH 45701 USA.	najjar@ohio.edu	Najjar, Sonia M/GXW-2217-2022; Hill, Jennifer/AAD-8415-2019	Hill, Jennifer/0000-0001-7482-9215	National Institutes of Health [R01 DK054254, R01 DK083850, R01 HL112248, R01 HD081792, R15 DK103196]; Wolfe Innovation Fund (University of Toledo Foundation); Deutsche Forschungsgemeinschaft [ER 276/9-1 TI 690/3-1, SFB 688/3 A19]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD081792] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083850, R01DK054254, P30DK020572, R15DK103196] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wolfe Innovation Fund (University of Toledo Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 DK054254, R01 DK083850, and R01 HL112248 (to S.M.N.), R01 HD081792 (to J.W.H.), and R15 DK103196 (to M.F.M.) and in part by the Wolfe Innovation Fund (University of Toledo Foundation) and Deutsche Forschungsgemeinschaft Grants ER 276/9-1 TI 690/3-1 and SFB 688/3 A19 (to S.E). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Share QY, 2015, DIABETES, V64, P2780, DOI 10.2337/db14-1772; Allison MB, 2014, J ENDOCRINOL, V223, pT25, DOI 10.1530/JOE-14-0404; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Bates SH, 2003, NATURE, V421, P856, DOI 10.1038/nature01388; Berglund ED, 2012, J CLIN INVEST, V122, P1000, DOI 10.1172/JCI59816; Cha SH, 2005, P NATL ACAD SCI USA, V102, P14557, DOI 10.1073/pnas.0507300102; Cha SH, 2004, BIOCHEM BIOPH RES CO, V317, P301, DOI 10.1016/j.bbrc.2004.03.026; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Chen AS, 2000, TRANSGENIC RES, V9, P145, DOI 10.1023/A:1008983615045; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; DeAngelis AM, 2008, DIABETES, V57, P2296, DOI 10.2337/db08-0379; Draper S, 2010, BRAIN RES, V1350, P139, DOI 10.1016/j.brainres.2010.03.082; Gao S, 2003, P NATL ACAD SCI USA, V100, P5628, DOI 10.1073/pnas.1031698100; Ghosh Sumona, 2010, Hepat Med, V2010, P69; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Han E, 2001, BIOCHEM J, V355, P417, DOI 10.1042/0264-6021:3550417; Heinrich G, 2010, GASTROENTEROLOGY, V139, P644, DOI 10.1053/j.gastro.2010.03.056; Kim JD, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00480; Kotronen A, 2008, GASTROENTEROLOGY, V135, P122, DOI 10.1053/j.gastro.2008.03.021; Lam DD, 2015, ENDOCRINOLOGY, V156, P1292, DOI 10.1210/en.2014-1373; Lee SJ, 2008, GASTROENTEROLOGY, V135, P2084, DOI 10.1053/j.gastro.2008.08.007; Lester SG, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00116; Luo N, 2011, ENDOCRINOLOGY, V152, P883, DOI 10.1210/en.2010-1135; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; Mul JD, 2012, OBESITY, V20, P612, DOI 10.1038/oby.2011.81; Muoio DM, 1997, DIABETES, V46, P1360, DOI 10.2337/diabetes.46.8.1360; Najjar SM, 2005, CELL METAB, V2, P43, DOI 10.1016/j.cmet.2005.06.001; Najjar SM, 2002, TRENDS ENDOCRIN MET, V13, P240, DOI 10.1016/S1043-2760(02)00608-2; Obici S, 2003, ENDOCRINOLOGY, V144, P5172, DOI 10.1210/en.2003-0999; Obici S, 2002, NAT MED, V8, P1376, DOI 10.1038/nm798; Osborne TF, 2000, J BIOL CHEM, V275, P32379, DOI 10.1074/jbc.R000017200; Patel PR, 2012, DIABETOLOGIA, V55, P763, DOI 10.1007/s00125-011-2388-x; Plum L, 2006, J CLIN INVEST, V116, P1886, DOI 10.1172/JCI27123; Plum L, 2006, J CLIN INVEST, V116, P1761, DOI 10.1172/JCI29063; Poy MN, 2002, NAT GENET, V30, P270, DOI 10.1038/ng840; Ren HX, 2015, DIABETES, V64, P405, DOI 10.2337/db14-0752; SMITH AL, 1991, J INFECT DIS, V163, P879, DOI 10.1093/infdis/163.4.879; Ste Marie L, 2000, P NATL ACAD SCI USA, V97, P12339, DOI 10.1073/pnas.220409497; Tanaka T, 2007, CELL METAB, V5, P395, DOI 10.1016/j.cmet.2007.04.004; Thyfault JP, 2009, J PHYSIOL-LONDON, V587, P1805, DOI 10.1113/jphysiol.2009.169060; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Xu AW, 2005, PLOS BIOL, V3, P2168, DOI 10.1371/journal.pbio.0030415; Xu E, 2009, ENDOCRINOLOGY, V150, P3503, DOI 10.1210/en.2008-1439; Zebhauser R, 2005, GENOMICS, V86, P566, DOI 10.1016/j.ygeno.2005.07.008	46	13	14	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11124	11132		10.1074/jbc.M116.716431	http://dx.doi.org/10.1074/jbc.M116.716431			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27002145	Green Published, hybrid			2022-12-26	WOS:000377042100016
J	Lubarski-Gotliv, I; Asher, C; Dada, LA; Garty, H				Lubarski-Gotliv, Irina; Asher, Carol; Dada, Laura A.; Garty, Haim			FXYD5 Protein Has a Pro-inflammatory Role in Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine induction; inflammation; lipopolysaccharide (LPS); plasma membrane; translocation	TUMOR-NECROSIS-FACTOR; ALVEOLAR FLUID CLEARANCE; KAPPA-B; K-ATPASE; DYSADHERIN; EXPRESSION; RECEPTOR; NA,K-ATPASE; ACTIVATION; TNF	The FXYD proteins are a family of small membrane proteins that share an invariant four amino acid signature motif F-X-Y-D and act as tissue-specific regulatory subunits of the Na,K-ATPase. FXYD5 (also termed dysadherin or RIC) is a structurally and functionally unique member of the FXYD family. As other FXYD proteins, FXYD5 specifically interacts with the Na,K-ATPase and alters its kinetics by increasing V-max. However, unlike other family members FXYD5 appears to have additional functions, which cannot be readily explained by modulation of transport kinetics. Knockdown of FXYD5 in MDA-MB-231 breast cancer cells largely decreases expression and secretion of the chemokine CCL2 (MCP-1). A related effect has also been observed in renal cell carcinoma cells. The current study aims to further characterize the relationship between the expression of FXYD5 and CCL2 secretion. We demonstrate that transfection of M1 epithelial cell line with FXYD5 largely increases lipopolysaccharide (LPS) stimulated CCL2 mRNA and secretion of the translated protein. We have completed a detailed analysis of the molecular events leading to the above response. Our key findings indicate that FXYD5 generates a late response by increasing the surface expression of the TNF receptor, without affecting its total protein level, or mRNA transcription. LPS administration to mice demonstrates induced secretion of CCL2 and TNF in FXYD5-expressing lung peripheral tissue, which suggests a possible role for FXYD5 in normal epithelia during inflammation.	[Lubarski-Gotliv, Irina; Asher, Carol; Garty, Haim] Weizmann Inst Sci, Dept Biol Chem, IL-7610001 Rehovot, Israel; [Dada, Laura A.] Northwestern Univ, Div Pulm & Crit Care Med, Chicago, IL 60611 USA	Weizmann Institute of Science; Northwestern University	Lubarski-Gotliv, I (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	irina.lubarski@weizmann.ac.il			U.S.-Israel Binational Science Foundation; National Institutes of Health [HL113350]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113350] Funding Source: NIH RePORTER	U.S.-Israel Binational Science Foundation(US-Israel Binational Science Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the U.S.-Israel Binational Science Foundation (to L. A. D. and H. G.) and National Institutes of Health Grant HL113350. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abramowitz J, 2003, CIRCULATION, V108, P3048, DOI 10.1161/01.CIR.0000101919.00548.86; Amiot F, 1997, MOL MED, V3, P864, DOI 10.1007/BF03401722; Anand AR, 2009, MOL IMMUNOL, V46, P962, DOI 10.1016/j.molimm.2008.09.022; Azzam ZS, 2002, CIRCULATION, V105, P497, DOI 10.1161/hc0402.102848; Baay M, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/565187; Barwe SP, 2005, MOL BIOL CELL, V16, P1082, DOI 10.1091/mbc.E04-05-0427; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Dmitrieva RI, 2003, J BIOL CHEM, V278, P28160, DOI 10.1074/jbc.M303768200; Dumasius V, 2001, CIRC RES, V89, P907, DOI 10.1161/hh2201.100204; Gaeta ML, 2000, LAB INVEST, V80, P1185, DOI 10.1038/labinvest.3780126; Garty H, 2002, AM J PHYSIOL-RENAL, V283, pF607, DOI 10.1152/ajprenal.00112.2002; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Ino Y, 2002, P NATL ACAD SCI USA, V99, P365, DOI 10.1073/pnas.012425299; Jones SJ, 1999, J IMMUNOL, V162, P1042; Lee HW, 2013, BBA-REV CANCER, V1835, P170, DOI 10.1016/j.bbcan.2012.12.007; Lee YK, 2012, CANCER SCI, V103, P1280, DOI 10.1111/j.1349-7006.2012.02302.x; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Lubarski I, 2005, J BIOL CHEM, V280, P37717, DOI 10.1074/jbc.M506397200; Lubarski I, 2007, AM J PHYSIOL-RENAL, V293, pF1818, DOI 10.1152/ajprenal.00367.2007; Lubarski I, 2014, AM J PHYSIOL-CELL PH, V306, pC1080, DOI 10.1152/ajpcell.00042.2014; Lubarski I, 2011, AM J PHYSIOL-RENAL, V301, pF1270, DOI 10.1152/ajprenal.00142.2011; McConkey DJ, 2000, CANCER RES, V60, P3807; McFarlane SM, 2002, FEBS LETT, V515, P119, DOI 10.1016/S0014-5793(02)02450-X; Mendes SD, 2009, CELL SIGNAL, V21, P1109, DOI 10.1016/j.cellsig.2009.02.025; Miller TJ, 2008, AM J PHYSIOL-LUNG C, V294, pL654, DOI 10.1152/ajplung.00430.2007; Mutlu GM, 2007, J CLIN INVEST, V117, P2952, DOI 10.1172/JCI30639; Nam JS, 2007, CANCER LETT, V255, P161, DOI 10.1016/j.canlet.2007.02.018; Nam JS, 2006, CANCER RES, V66, P7176, DOI 10.1158/0008-5472.CAN-06-0825; Nikas JB, 2013, SCI REP-UK, V3, DOI 10.1038/srep03254; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Rowlands DJ, 2011, J CLIN INVEST, V121, P1986, DOI 10.1172/JCI43839; Schaer DA, 2011, J EXP MED, V208, P1937, DOI 10.1084/jem.20111856; Schuler Y, 2012, INT J CANCER, V130, P288, DOI 10.1002/ijc.25981; Shimamura T, 2004, CANCER RES, V64, P6989, DOI 10.1158/0008-5472.CAN-04-1166; STOOS BA, 1991, KIDNEY INT, V39, P1168, DOI 10.1038/ki.1991.148; TRACEY KJ, 1993, ANNU REV CELL BIOL, V9, P317, DOI 10.1146/annurev.cb.09.110193.001533; Tsuiji H, 2003, GLYCOBIOLOGY, V13, P521, DOI 10.1093/glycob/cwg065; Vagin O, 2006, J BIOL CHEM, V281, P39573, DOI 10.1074/jbc.M606507200; Wang HL, 2007, J IMMUNOL, V179, P1834, DOI 10.4049/jimmunol.179.3.1834; Xaus J, 2000, BLOOD, V95, P3823; Yadav A, 2010, CLIN CHIM ACTA, V411, P1570, DOI 10.1016/j.cca.2010.07.006	41	8	8	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11072	11082		10.1074/jbc.M115.699041	http://dx.doi.org/10.1074/jbc.M115.699041			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27006401	Green Published, hybrid			2022-12-26	WOS:000377042100011
J	Duan, DZ; Zhang, JM; Yao, J; Liu, YP; Fang, JG				Duan, Dongzhu; Zhang, Junmin; Yao, Juan; Liu, Yaping; Fang, Jianguo			Targeting Thioredoxin Reductase by Parthenolide Contributes to Inducing Apoptosis of HeLa Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRESS-MEDIATED APOPTOSIS; OXIDATIVE STRESS; MAMMALIAN THIOREDOXIN; REACTIVE OXYGEN; KAPPA-B; CANCER; EXPRESSION; GLUTATHIONE; INHIBITION; CURCUMIN	Parthenolide (PTL), a major active sesquiterpene lactone from the herbal plant Tanacetum parthenium, has been applied in traditional Chinese medicine for centuries. Although PTL demonstrates potent anticancer efficacy in numerous types of malignant cells, the cellular targets of PTL have not been well defined. We reported here that PTL interacts with both cytosolic thioredoxin reductase (TrxR1) and mitochondrial thioredoxin reductase (TrxR2), two ubiquitous selenocysteine-containing antioxidant enzymes, to elicit reactive oxygen species-mediated apoptosis in HeLa cells. PTL selectively targets the selenocysteine residue in TrxR1 to inhibit the enzyme function, and further shifts the enzyme to an NADPH oxidase to generate superoxide anions, leading to reactive oxygen species accumulation and oxidized thioredoxin. Under the conditions of inhibition of TrxRs in cells, PTL does not cause significant alteration of cellular thiol homeostasis, supporting selective target of TrxRs by PTL. Importantly, overexpression of functional TrxR1 or Trx1 confers protection, whereas knockdown of the enzymes sensitizes cells to PTL treatment. Targeting TrxRs by PTL thus discloses an unprecedented mechanism underlying the biological activity of PTL, and provides deep insights to understand the action of PTL in treatment of cancer.	[Duan, Dongzhu; Zhang, Junmin; Yao, Juan; Liu, Yaping; Fang, Jianguo] Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China; [Duan, Dongzhu; Zhang, Junmin; Yao, Juan; Liu, Yaping; Fang, Jianguo] Lanzhou Univ, Coll Chem & Chem Engn, Lanzhou 730000, Peoples R China; [Duan, Dongzhu] Baoji Univ Arts & Sci, Shannxi Key Lab Phytochem, Baoji 721013, Peoples R China	Lanzhou University; Lanzhou University; Baoji University of Arts & Sciences	Fang, JG (corresponding author), Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China.; Fang, JG (corresponding author), Lanzhou Univ, Coll Chem & Chem Engn, Lanzhou 730000, Peoples R China.	fangjg@lzu.edu.cn	Zhang, Junmin/AAI-5069-2020; Fang, Jianguo/K-8058-2016; Duan, Dongzhu/AAD-1479-2022; Zhang, Junmin/AAI-5133-2020	Zhang, Junmin/0000-0001-5036-5559; Duan, Dongzhu/0000-0001-5635-819X	Natural Science Foundation of China [21572093]; Natural Science Foundation of Gansu Province [145RJZA225]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Gansu Province	This work was supported by Natural Science Foundation of China Grant 21572093 and Natural Science Foundation of Gansu Province Grant 145RJZA225. The authors declare they have no conflicts of interest with the contents of this article.	Anestal K, 2003, J BIOL CHEM, V278, P15966, DOI 10.1074/jbc.M210733200; Arner ESJ, 2009, BBA-GEN SUBJECTS, V1790, P495, DOI 10.1016/j.bbagen.2009.01.014; Arner ESJ, 1999, J MOL BIOL, V292, P1003, DOI 10.1006/jmbi.1999.3085; ARNER ESJ, 1995, J BIOL CHEM, V270, P3479, DOI 10.1074/jbc.270.8.3479; Berggren M, 1996, ANTICANCER RES, V16, P3459; Bindoli A, 2013, ANTIOXID REDOX SIGN, V18, P1557, DOI 10.1089/ars.2012.4655; Cai WQ, 2012, TOXICOL APPL PHARM, V262, P341, DOI 10.1016/j.taap.2012.05.012; Chew EH, 2010, FREE RADICAL BIO MED, V48, P98, DOI 10.1016/j.freeradbiomed.2009.10.028; Citta A, 2014, J MED CHEM, V57, P8849, DOI 10.1021/jm5013165; Citta A, 2013, METALLOMICS, V5, P1006, DOI 10.1039/c3mt20260g; D'Anneo A, 2013, INT J ONCOL, V43, P1895, DOI 10.3892/ijo.2013.2137; Du YT, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.392225; Duan DZ, 2014, FREE RADICAL BIO MED, V70, P182, DOI 10.1016/j.freeradbiomed.2014.02.016; Duan DZ, 2014, FREE RADICAL BIO MED, V69, P15, DOI 10.1016/j.freeradbiomed.2013.12.027; Eriksson SE, 2009, FREE RADICAL BIO MED, V47, P1661, DOI 10.1016/j.freeradbiomed.2009.09.016; Fang JG, 2005, J BIOL CHEM, V280, P25284, DOI 10.1074/jbc.M414645200; Fonrose X, 2007, CANCER RES, V67, P3371, DOI 10.1158/0008-5472.CAN-06-3732; Gallegos A, 1996, CANCER RES, V56, P5765; Gan FF, 2013, ANTIOXID REDOX SIGN, V19, P1149, DOI 10.1089/ars.2012.4909; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Ghantous A, 2013, DRUG DISCOV TODAY, V18, P894, DOI 10.1016/j.drudis.2013.05.005; Gopal YNV, 2009, MOL CANCER THER, V8, P552, DOI 10.1158/1535-7163.MCT-08-0661; Gopal YV, 2007, CHEM BIOL, V14, P813, DOI 10.1016/j.chembiol.2007.06.007; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hanschmann EM, 2013, ANTIOXID REDOX SIGN, V19, P1539, DOI 10.1089/ars.2012.4599; Harris IS, 2015, CANCER CELL, V27, P211, DOI 10.1016/j.ccell.2014.11.019; Hehner SP, 1999, J IMMUNOL, V163, P5617; Hellfritsch J, 2015, ANTIOXID REDOX SIGN, V22, P938, DOI 10.1089/ars.2014.5889; Javvadi P, 2010, CANCER RES, V70, P1941, DOI 10.1158/0008-5472.CAN-09-3025; Johansson L, 2004, NAT METHODS, V1, P61, DOI 10.1038/NMETH707; Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030; Kanzok SM, 2001, SCIENCE, V291, P643, DOI 10.1126/science.291.5504.643; Kim JH, 2005, CANCER RES, V65, P6312, DOI 10.1158/0008-5472.CAN-04-4193; Kim SJ, 2005, CLIN CANCER RES, V11, P8425, DOI 10.1158/1078-0432.CCR-05-0449; Kurdi M, 2007, J CELL PHYSIOL, V212, P424, DOI 10.1002/jcp.21033; Kwok BHB, 2001, CHEM BIOL, V8, P759, DOI 10.1016/S1074-5521(01)00049-7; Lan B, 2015, BIOCHEM BIOPH RES CO, V456, P434, DOI 10.1016/j.bbrc.2014.11.102; Lincoln DT, 2003, ANTICANCER RES, V23, P2425; Liu YP, 2016, CHEM COMMUN, V52, P2296, DOI 10.1039/c5cc09998f; Liu YP, 2014, J MED CHEM, V57, P5203, DOI 10.1021/jm500221p; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; Mitchell DA, 2007, P NATL ACAD SCI USA, V104, P11609, DOI 10.1073/pnas.0704898104; Nalvarte I, 2004, J BIOL CHEM, V279, P54510, DOI 10.1074/jbc.M408494200; Nogueira V, 2013, CLIN CANCER RES, V19, P4309, DOI 10.1158/1078-0432.CCR-12-1424; Kreuger MRO, 2012, ANTI-CANCER DRUG, V23, P883, DOI 10.1097/CAD.0b013e328356cad9; Peng SJ, 2015, FOOD FUNCT, V6, P2813, DOI [10.1039/c5fo00214a, 10.1039/C5FO00214A]; Peng SJ, 2015, J MED CHEM, V58, P5242, DOI 10.1021/acs.jmedchem.5b00410; Qiu X, 2008, BIOORGAN MED CHEM, V16, P8035, DOI 10.1016/j.bmc.2008.07.054; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Shelar SB, 2015, FREE RADICAL BIO MED, V87, P125, DOI 10.1016/j.freeradbiomed.2015.06.029; Soethoudt M, 2014, FREE RADICAL BIO MED, V77, P331, DOI 10.1016/j.freeradbiomed.2014.09.025; Steele AJ, 2006, LEUKEMIA, V20, P1073, DOI 10.1038/sj.leu.2404230; Sun YL, 2010, CANCER RES, V70, P2880, DOI 10.1158/0008-5472.CAN-09-4572; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Welsh SJ, 2002, CANCER RES, V62, P5089; Wen J, 2002, J BIOL CHEM, V277, P38954, DOI 10.1074/jbc.M203842200; Won YK, 2005, CARCINOGENESIS, V26, P2149, DOI 10.1093/carcin/bgi194; Won YK, 2004, CARCINOGENESIS, V25, P1449, DOI 10.1093/carcin/bgh151; Xu Y, 2013, CANCER RES, V73, P4406, DOI 10.1158/0008-5472.CAN-12-4297; Yao J, 2015, J AGR FOOD CHEM, V63, P1521, DOI 10.1021/jf505075n; Yoo MH, 2006, J BIOL CHEM, V281, P13005, DOI 10.1074/jbc.C600012200; Zhang BX, 2015, J MED CHEM, V58, P1795, DOI 10.1021/jm5016507; Zhang JM, 2016, BIOCHEM PHARMACOL, V102, P34, DOI 10.1016/j.bcp.2015.12.004; Zhang LW, 2014, J AM CHEM SOC, V136, P226, DOI 10.1021/ja408792k; Zhang SY, 2004, CANCER LETT, V211, P175, DOI 10.1016/j.canlet.2004.03.033; Zhao L, 2015, FREE RADICAL BIO MED, V82, P29, DOI 10.1016/j.freeradbiomed.2015.01.014; Zhong LW, 2000, J BIOL CHEM, V275, P18121, DOI 10.1074/jbc.M000690200	69	85	87	0	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10021	10031		10.1074/jbc.M115.700591	http://dx.doi.org/10.1074/jbc.M115.700591			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	27002142	Green Published, hybrid			2022-12-26	WOS:000375602800015
J	Chan, PH; Hai, JJ; Chan, EW; Li, WH; Tse, HF; Wong, ICK; Lip, GYH; Siu, CW				Chan, Pak Hei; Hai, Jo Jo; Chan, Esther W.; Li, Wen Hua; Tse, Hung Fat; Wong, Ian C. K.; Lip, Gregory Y. H.; Siu, Chung Wah			Use of the SAMe-TT2R2 Score to Predict Good Anticoagulation Control with Warfarin in Chinese Patients with Atrial Fibrillation: Relationship to Ischemic Stroke Incidence	PLOS ONE			English	Article							QUALITY; RISK; MORTALITY; ASPIRIN; EVENTS; IMPACT	Background The efficacy and safety of warfarin therapy for stroke prevention in atrial fibrillation (AF) depends on the time in therapeutic range (TTR). We aimed to assess the predictive ability of SAMe-TT2R2 score in Chinese AF patients on warfarin, whose TTR is notoriously poor. Methods and Results This is a single-centre retrospective study. Patients with non-valvular AF on warfarin diagnosed between 1997 and 2011 were stratified according to SAMe-TT2R2 score, and TTR was calculated using Rosendaal method. The predictive power of SAMe-TT2R2 scores for good TTR i.e. >70% was assessed. We included 1,428 Chinese patients (mean age 76.2 +/- 8.7 years, 47.5% male) with non-valvular AF on warfarin. The mean and median TTR were 38.2 +/- 24.4% and 38.8% (interquartile range: 17.9% and 56.2%) respectively. TTR decreased progressively with increasing SAMe-TT2R2 score (p = 0.016). When the cut-off value of SAMe-TT2R2 score was set to 2, the sensitivity and specificity to predict TTR<70% were 85.7% and 17.8%, respectively. The corresponding positive and negative predictive values were 10.1% and 92.0%. After a mean follow-up of 4.7 +/- 3.6 years, 338 patients developed an ischemic stroke (4.96%/year). Patients with TTR >= 70% had a lower annual risk of ischemic stroke of 3.67%/year compared with than those with TTR<70% (5.13%/year)(p=0.08). Patients with SAMe-TT2R2 score <= 2 had the lowest risk of annual risk of ischemic stroke (3.49%/year) compared with those with SAMe-TT2R2 score = 3 (4.56%/year), and those with SAMe-TT2R2 score >= 4 (6.41%/year)(p<0.001). There was also a non-significant trend towards more intracranial hemorrhage with increasing SAMe-TT2R2 score. Conclusions The SAMe-TT2R2 score correlates well with TTR in Chinese AF patients, with a score >2 having high sensitivity and negative predictive values for poor TTR. Ischemic stroke risk increased progressively with increasing SAMe-TT2R2 score, consistent with poorer TTRs at high SAMe-TT2R2 scores.	[Chan, Pak Hei; Hai, Jo Jo; Li, Wen Hua; Tse, Hung Fat; Siu, Chung Wah] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China; [Chan, Esther W.; Wong, Ian C. K.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Li, Wen Hua] Sichuan Acad Med Sci, Dept Cardiovasc Ultrasound & Noninvas Cardiol, Chengdu, Sichuan, Peoples R China; [Li, Wen Hua] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [Lip, Gregory Y. H.] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham, W Midlands, England	University of Hong Kong; University of Hong Kong; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; University of Birmingham	Siu, CW (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Div Cardiol, Hong Kong, Hong Kong, Peoples R China.	cwdsiu@hku.hk	Tse, Hung-Fat/C-4426-2009; Siu, Chung Wah/C-6947-2011; Chan, Esther Wai Yin/B-3522-2012	Tse, Hung-Fat/0000-0002-9578-7808; Chan, Esther Wai Yin/0000-0002-7602-9470; Tse, Hung Fat/0000-0003-4665-7887; Wong, Ian Chi Kei/0000-0001-8242-0014				Apostolakis S, 2013, CHEST, V144, P1555, DOI 10.1378/chest.13-0054; Azoulay L, 2014, EUR HEART J, V35, P1881, DOI 10.1093/eurheartj/eht499; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Chiang CE, 2014, THROMB HAEMOSTASIS, V111, P789, DOI 10.1160/TH13-11-0948; Clarkesmith DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074037; De Caterina R, 2013, THROMB HAEMOSTASIS, V110, P1087, DOI 10.1160/TH13-06-0443; Gallego P, 2013, THROMB HAEMOSTASIS, V110, P1189, DOI 10.1160/TH13-07-0556; Hart RG, 2007, ANN INTERN MED, V147, P590, DOI 10.7326/0003-4819-147-8-200710160-00018; Ho CW, 2015, STROKE, V46, P23, DOI 10.1161/STROKEAHA.114.006476; Huang D, 2014, PACE, V37, P1442, DOI 10.1111/pace.12445; Lau KK, 2014, CARDIOL J, V21, P474, DOI 10.5603/CJ.a2014.0034; Lip GYH, 2014, CHEST, V146, P719, DOI 10.1378/chest.13-2976; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Nuhrich JM, 2014, HEART RHYTHM, V11, P1536, DOI 10.1016/j.hrthm.2014.06.002; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Poli D, 2014, INTERN EMERG MED, V9, P443, DOI 10.1007/s11739-014-1065-8; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Schmitt L, 2003, J THROMB THROMBOLYS, V15, P213, DOI 10.1023/B:THRO.0000011377.78585.63; Siu CW, 2014, CIRC-ARRHYTHMIA ELEC, V7, P300, DOI 10.1161/CIRCEP.113.000858; Wan Y, 2008, CIRC-CARDIOVASC QUAL, V1, P84, DOI 10.1161/CIRCOUTCOMES.108.796185	20	30	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0150674	10.1371/journal.pone.0150674	http://dx.doi.org/10.1371/journal.pone.0150674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010633	Green Published, gold			2022-12-26	WOS:000372708000020
J	Hossain, TJ; Harada, Y; Hirayama, H; Tomotake, H; Seko, A; Suzuki, T				Hossain, Tanim Jabid; Harada, Yoichiro; Hirayama, Hiroto; Tomotake, Haruna; Seko, Akira; Suzuki, Tadashi			Structural Analysis of Free N-Glycans in alpha-Gucosidase Mutants of Saccharomyces cerevisiae: Lack of the Evidence for the Occurrence of Catabolic alpha-Glucosidase Acting on the N-Glycans	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; FREE OLIGOSACCHARIDES; LINKED OLIGOSACCHARIDES; D-MANNOSIDASE; II-DEFICIENT; SUGAR CHAINS; YEAST; PEPTIDE	Saccharomyces cerevisiae produces two different alpha-glucosidases, Glucosidase 1 (Gls1) and Glucosidase 2 (Gls2), which are responsible for the removal of the glucose molecules from N-glycans (Glc(3)Man(9)GlcNAc(2)) of glycoproteins in the endoplasmic reticulum. Whether any additional alpha-glucosidases playing a role in catabolizing the glucosylated N-glycans are produced by this yeast, however, remains unknown. We report herein on a search for additional alpha-glucosidases in S. cerevisiae. To this end, the precise structures of cytosolic free N-glycans (FNGs), mainly derived from the peptide:N-glycanase (Png1) mediated deglycosylation of N-glycoproteins were analyzed in the endoplasmic reticulum alpha-glucosidase-deficient mutants. 12 new glucosylated FNG structures were successfully identified through 2-dimentional HPLC analysis. On the other hand, non-glucosylated FNGs were not detected at all under any culture conditions. It can therefore be safely concluded that no catabolic alpha-glucosidases acting on N-glycans are produced by this yeast.	[Hossain, Tanim Jabid; Harada, Yoichiro; Hirayama, Hiroto; Tomotake, Haruna; Suzuki, Tadashi] RIKEN, Syst Glycobiol Res Grp, Max Planck Joint Res Ctr Syst Chem Biol, Glycometabolome Team, Wako, Saitama, Japan; [Hossain, Tanim Jabid; Tomotake, Haruna; Suzuki, Tadashi] Saitama Univ, Grad Sch Sci & Engn, Sakura, Saitama, Japan; [Seko, Akira] Japan Sci & Technol Agcy JST, ERATO Ito Glycotril Project, Wako, Saitama, Japan; [Hossain, Tanim Jabid] Univ Chittagong, Dept Biochem & Mol Biol, Chittagong, Bangladesh; [Harada, Yoichiro] Kagoshima Univ, Dept Syst Biol Thromboregulat, Grad Sch Med & Dent Sci, Kagoshima 890, Japan	RIKEN; Saitama University; Japan Science & Technology Agency (JST); University of Chittagong; Kagoshima University	Suzuki, T (corresponding author), RIKEN, Syst Glycobiol Res Grp, Max Planck Joint Res Ctr Syst Chem Biol, Glycometabolome Team, Wako, Saitama, Japan.; Suzuki, T (corresponding author), Saitama Univ, Grad Sch Sci & Engn, Sakura, Saitama, Japan.	tsuzuki_gm@riken.jp	hirayama, hiroto/HCH-9202-2022; Suzuki, Tadashi/I-4536-2014; Hossain, Tanim Jabid/AAK-5572-2020; Suzuki, Tadashi/AAX-5707-2021	Hossain, Tanim Jabid/0000-0002-0978-2657; Suzuki, Tadashi/0000-0003-1030-7631; Hirayama, Hiroto/0000-0003-1909-9488	Ministry of Education, Culture, Sports, Science and Technolog of Japan [25291030]; RIKEN	Ministry of Education, Culture, Sports, Science and Technolog of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN	This work was supported by a Grant-in-Aid for Scientific Research (B) (grant no. 25291030), Ministry of Education, Culture, Sports, Science and Technolog of Japan.; We thank the members of Glycometabolome Team for fruitful discussions. We express our sincere gratitude to Dr. Yukishige Ito (RIKEN) for kindly allowing us to use an expression vector for endo-alpha-mannosidase. TJH is an International Program Associate (IPA) and financially supported by RIKEN.	[Anonymous], 2009, ESSENTIALS GLYCOBIOL; BELARD M, 1988, BIOCHEM J, V255, P235; CAMIRAND A, 1991, J BIOL CHEM, V266, P15120; Chantret I, 2003, BIOCHEM J, V373, P901, DOI 10.1042/BJ20030384; Chantret I, 2011, J BIOL CHEM, V286, P41786, DOI 10.1074/jbc.M111.251371; Cipollo JF, 2002, GLYCOBIOLOGY, V12, P749, DOI 10.1093/glycob/cwf082; Cipollo JF, 2000, J BIOL CHEM, V275, P4267, DOI 10.1074/jbc.275.6.4267; Dairaku K, 1997, GLYCOBIOLOGY, V7, P579, DOI 10.1093/glycob/7.4.579; Eguchi H, 2002, J BIOCHEM, V131, P477, DOI 10.1093/oxfordjournals.jbchem.a003124; FUJIMOTO K, 1991, J BIOL CHEM, V266, P3571; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Harada Y, 2015, CELL MOL LIFE SCI, V72, P2509, DOI 10.1007/s00018-015-1881-7; Harada Y, 2013, P NATL ACAD SCI USA, V110, P19366, DOI 10.1073/pnas.1312187110; Harada Y, 2013, J BIOL CHEM, V288, P32673, DOI 10.1074/jbc.M113.486985; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hirayama H, 2015, SEMIN CELL DEV BIOL, V41, P110, DOI 10.1016/j.semcdb.2014.11.009; Hirayama H, 2011, GLYCOBIOLOGY, V21, P1341, DOI 10.1093/glycob/cwr073; Hirayama H, 2010, J BIOL CHEM, V285, P12390, DOI 10.1074/jbc.M109.082081; Hitt R, 2004, FEMS YEAST RES, V4, P815, DOI 10.1016/j.femsyr.2004.04.002; Hossain TJ, 2016, BIOSCI BIOTECH BIOCH, V80, P152, DOI 10.1080/09168451.2015.1072464; Hu D, 2009, GLYCOBIOLOGY, V19, P1127, DOI 10.1093/glycob/cwp104; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Jakob CA, 2001, EMBO REP, V2, P423; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LUBAS WA, 1987, J BIOL CHEM, V262, P3775; Matsuo I, 2006, TETRAHEDRON, V62, P8262, DOI 10.1016/j.tet.2006.06.045; MOORE SEH, 1992, J BIOL CHEM, V267, P8443; MOORE SEH, 1990, J BIOL CHEM, V265, P13104; Natsuka S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102219; Romero PA, 1997, GLYCOBIOLOGY, V7, P997, DOI 10.1093/glycob/7.7.997; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Stigliano ID, 2011, MOL BIOL CELL, V22, P1810, DOI 10.1091/mbc.E11-01-0019; Suzuki T, 1998, J BIOL CHEM, V273, P21526, DOI 10.1074/jbc.273.34.21526; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Suzuki T, 2008, ANAL BIOCHEM, V381, P224, DOI 10.1016/j.ab.2008.07.002; Suzuki T, 2014, BIOCHEM BIOPH RES CO, V453, P213, DOI 10.1016/j.bbrc.2014.05.075; Takahashi N, 1997, LAB GUIDE GLYCOCONJU, P295; Totani K, 2006, J BIOL CHEM, V281, P31502, DOI 10.1074/jbc.M605457200; Wilkinson BM, 2006, J BIOL CHEM, V281, P6325, DOI 10.1074/jbc.M510455200; Yanagida K, 1998, J CHROMATOGR A, V800, P187, DOI 10.1016/S0021-9673(97)01109-6	41	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151891	10.1371/journal.pone.0151891	http://dx.doi.org/10.1371/journal.pone.0151891			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010459	Green Submitted, gold, Green Published			2022-12-26	WOS:000372708000054
J	Joustra, SD; Reijntjes, RH; Pereira, AM; Lammers, GJ; Biermasz, NR; Thijs, RD				Joustra, S. D.; Reijntjes, R. H.; Pereira, A. M.; Lammers, G. J.; Biermasz, N. R.; Thijs, R. D.			The Role of the Suprachiasmatic Nucleus in Cardiac Autonomic Control during Sleep	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; RHYTHMS	Background The suprachiasmatic nucleus (SCN) may play an important role in central autonomic control, since its projections connect to (para) sympathetic relay stations in the brainstem and spinal cord. The cardiac autonomic modifications during nighttime may therefore not only result from direct effects of the sleep-related changes in the central autonomic network, but also from endogenous circadian factors as directed by the SCN. To explore the influence of the SCN on autonomic fluctuations during nighttime, we studied heart rate and its variability (HRV) in a clinical model of SCN damage. Methods Fifteen patients in follow-up after surgical treatment for nonfunctioning pituitary macroadenoma (NFMA) compressing the optic chiasm (8 females, 26-65 years old) and fifteen agematched healthy controls (5 females, 30-63 years) underwent overnight ambulatory polysomnography. Eleven patients had hypopituitarism and received adequate replacement therapy. HRV was calculated for each 30-second epoch and corrected for sleep stage, arousals, and gender using mixed effect regression models. Results Compared to controls, patients spent more time awake after sleep onset and in NREM1-sleep, and less in REM-sleep. Heart rate, low (LF) and high frequency (HF) power components and the LF/HF ratio across sleep stages were not significantly different between groups. Conclusions These findings suggest that the SCN does not play a dominant role in cardiac autonomic control during sleep.	[Joustra, S. D.; Pereira, A. M.; Biermasz, N. R.] Leiden Univ, Dept Med, Med Ctr, Div Endocrinol,Ctr Endocrine Tumours Leiden, Leiden, Netherlands; [Reijntjes, R. H.; Lammers, G. J.; Thijs, R. D.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Lammers, G. J.; Thijs, R. D.] Stichting Epilepsie Instellingen Nederland SEIN, Heemstede, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Joustra, SD (corresponding author), Leiden Univ, Dept Med, Med Ctr, Div Endocrinol,Ctr Endocrine Tumours Leiden, Leiden, Netherlands.	sdjoustra@lumc.nl	Biermasz, Nienke/ABE-9436-2021; Pereira, Alberto M./Q-7175-2017; Thijs, Roland D/AGE-5180-2022	Biermasz, Nienke/0000-0001-5817-3594; Pereira, Alberto M./0000-0002-1194-9866; Thijs, Roland D/0000-0003-1435-8970; Reijntjes, Robert/0000-0002-7784-1807; Lammers, Gert Jan/0000-0003-4755-7060	the Netherlands Organisation for Health Research and Development [90700195, 91613125]	the Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	Dr. N.R. Biermasz was supported by the Netherlands Organisation for Health Research and Development (Clinical Fellows 90700195, Veni 91613125).	Biermasz NR, 2011, J CLIN ENDOCR METAB, V96, P1524, DOI 10.1210/jc.2010-2742; Boudreau P, 2013, SLEEP, V36, P1919, DOI 10.5665/sleep.3230; Buijs RM, 2003, J COMP NEUROL, V464, P36, DOI 10.1002/cne.10765; Calandra-Buonaura G, 2016, SLEEP MED REV, V26, P43, DOI 10.1016/j.smrv.2015.05.005; Camm AJ, 1996, CIRCULATION, V93, P1043; Chouchou F, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00402; Deboer T, 2003, NAT NEUROSCI, V6, P1086, DOI 10.1038/nn1122; Dekkers OM, 2007, PITUITARY, V10, P61, DOI 10.1007/s11102-007-0007-0; Fronczek R, 2006, SLEEP, V29, P1444, DOI 10.1093/sleep/29.11.1444; Golombek DA, 2012, PRIMER AUTONOMIC NER, P157; Joustra SD, 2014, J CLIN ENDOCR METAB; Joustra SD, 2014, EUR J ENDOCRINOL; Moore RY, 2007, SLEEP MED, V8, pS27, DOI 10.1016/j.sleep.2007.10.003; Niemeijer ND, 2015, SLEEP, V38, P633, DOI 10.5665/sleep.4586; Raymann RJEM, 2005, AM J PHYSIOL-REG I, V288, pR1589, DOI 10.1152/ajpregu.00492.2004; Raymann RJEM, 2008, BRAIN, V131, P500, DOI 10.1093/brain/awm315; Scheer FAJL, 2001, AM J PHYSIOL-HEART C, V280, pH1391, DOI 10.1152/ajpheart.2001.280.3.H1391; Silvani A, 2013, AM J PHYSIOL-HEART C, V305, pH1683, DOI 10.1152/ajpheart.00554.2013; van der Meijden WP, 2015, J SLEEP RES, V24, P206, DOI 10.1111/jsr.12253; Van Someren EJW, 1999, CHRONOBIOL INT, V16, P505, DOI 10.3109/07420529908998724; Viola AU, 2002, J BIOL RHYTHM, V17, P539, DOI 10.1177/0748730402238236; Weibel L, 1997, AM J PHYSIOL-REG I, V272, pR948, DOI 10.1152/ajpregu.1997.272.3.R948	22	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152390	10.1371/journal.pone.0152390	http://dx.doi.org/10.1371/journal.pone.0152390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010631	Green Published, gold			2022-12-26	WOS:000372708000140
J	Vivacqua, G; Latorre, A; Suppa, A; Nardi, M; Pietracupa, S; Mancinelli, R; Fabbrini, G; Colosimo, C; Gaudio, E; Berardelli, A				Vivacqua, Giorgio; Latorre, Anna; Suppa, Antonio; Nardi, Michela; Pietracupa, Sara; Mancinelli, Romina; Fabbrini, Giovanni; Colosimo, Carlo; Gaudio, Eugenio; Berardelli, Alfredo			Abnormal Salivary Total and Oligomeric Alpha-Synuclein in Parkinson's Disease	PLOS ONE			English	Article							CEREBROSPINAL-FLUID; ELEVATED LEVELS; LEWY BODY; BIOMARKERS; DEMENTIA; MECHANISM; SPECIFICITY; PROGRESSION; SECRETION; CSF	In Parkinson's disease (PD), alpha-synuclein (a-syn) can be detected in biological fluids including saliva. Although previous studies found reduced a-syn total (a-syn(total)) concentration in saliva of PD patients, no studies have previously examined salivary a-syn oligomers (a-syn(olig)) concentrations or assessed the correlation between salivary a-syn(total), a-syn(olig) and clinical features in a large cohort of PD patients. Is well known that a-syn(olig) exerts a crucial neurotoxic effect in PD. We collected salivary samples from 60 PD patients and 40 age-and sex-comparable healthy subjects. PD was diagnosed according to the United Kingdom Brain Bank Criteria. Samples of saliva were analyzed by specific anti-a-syn and anti-oligomeric a-syn ELISA kits. A complete clinical evaluation of each patient was performed using MDS-Unified Parkinson's Disease Rating Scale, Beck Depression Inventory, Montreal Cognitive Assessment and Frontal Assessment Battery. Salivary a-syn(total) was lower, whereas a-syn(olig) was higher in PD patients than healthy subjects. The a-syn(olig)/a-syn(total) ratio was also higher in patients than in healthy subjects. Salivary a-syn(total) concentration negatively correlated with that of a-syn(olig) and correlated with several patients' clinical features. In PD, decreased salivary concentration of a-syn(total) may reflect the reduction of a-syn monomers (a-syn(mon)), as well as the formation of insoluble intracellular inclusions and soluble oligomers. The combined detection of a-syn(total) and a-syn(olig) in the saliva might help the early diagnosis of PD.	[Vivacqua, Giorgio; Latorre, Anna; Suppa, Antonio; Nardi, Michela; Pietracupa, Sara; Fabbrini, Giovanni; Colosimo, Carlo; Berardelli, Alfredo] Univ Roma La Sapienza, Dept Neurol & Psychiat, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Vivacqua, Giorgio; Mancinelli, Romina; Gaudio, Eugenio] Univ Roma La Sapienza, Dept Anat Histol Forens & Locomotor Apparat Sci, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Suppa, Antonio; Fabbrini, Giovanni; Berardelli, Alfredo] Neuromed Inst, Venafro, IS, Italy	Sapienza University Rome; Sapienza University Rome	Berardelli, A (corresponding author), Univ Roma La Sapienza, Dept Neurol & Psychiat, Piazzale Aldo Moro 5, I-00185 Rome, Italy.; Berardelli, A (corresponding author), Neuromed Inst, Venafro, IS, Italy.	alfredo.berardelli@uniroma1.it	Fabbrini, Giovanni/AAC-1875-2020; Colosimo, Carlo/AAY-8552-2020; Suppa, Antonio/K-4803-2016; Latorre, Anna/AAV-5888-2020; Mancinelli, Romina/Y-4540-2018	Colosimo, Carlo/0000-0002-2216-3973; Suppa, Antonio/0000-0001-9903-5550; Latorre, Anna/0000-0001-7103-5209; Vivacqua, Giorgio/0000-0001-6080-7007; Mancinelli, Romina/0000-0003-2040-0581; BERARDELLI, Alfredo/0000-0003-3598-3142; Fabbrini, Giovanni/0000-0001-7614-8771				Al-Nimer MSM, 2014, N AM J MED SCI, V6, P633, DOI 10.4103/1947-2714.147980; Bendor JT, 2013, NEURON, V79, P1044, DOI 10.1016/j.neuron.2013.09.004; Berardelli A, 2013, EUR J NEUROL, V20, P16, DOI 10.1111/ene.12022; Breydo L, 2012, BBA-MOL BASIS DIS, V1822, P261, DOI 10.1016/j.bbadis.2011.10.002; Cersosimo MG, 2009, AUTON NEUROSCI-BASIC, V150, P150, DOI 10.1016/j.autneu.2009.04.004; Cersosimo MG, 2012, NEUROBIOL DIS, V46, P559, DOI 10.1016/j.nbd.2011.10.014; Del Tredici K, 2010, ACTA NEUROPATHOL, V119, P703, DOI 10.1007/s00401-010-0665-2; Devic I, 2010, BRAIN, V134, P1; Dickson DW, 2009, LANCET NEUROL, V8, P1150, DOI 10.1016/S1474-4422(09)70238-8; Donadio V, 2014, NEUROLOGY, V82, P1362, DOI 10.1212/WNL.0000000000000316; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Folgoas E, 2013, NEUROSCI LETT, V551, P62, DOI 10.1016/j.neulet.2013.07.016; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Grathwohl SA, 2013, J NEUROCHEM, V125, P487, DOI 10.1111/jnc.12191; Hall S, 2015, NEUROLOGY, V84, P57, DOI 10.1212/WNL.0000000000001098; Hong DP, 2011, PROTEIN PEPTIDE LETT, V18, P230, DOI 10.2174/092986611794578332; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Hoops S, 2009, NEUROLOGY, V73, P1738, DOI 10.1212/WNL.0b013e3181c34b47; Hu Y, 2015, NEUROLOGY, V84, P888, DOI 10.1212/WNL.0000000000001308; Kaszas B, 2012, PARKINSONISM RELAT D, V18, P553, DOI 10.1016/j.parkreldis.2012.02.010; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Lee HJ, 2014, NAT REV NEUROL, V10, P92, DOI 10.1038/nrneurol.2013.275; Maetzler W, 2014, ACTA NEUROPATHOL, V128, P893, DOI 10.1007/s00401-014-1364-1; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Paleologou KE, 2009, BRAIN, V132, P1093, DOI 10.1093/brain/awn349; Park MJ, 2011, J CLIN NEUROL, V7, P215, DOI 10.3988/jcn.2011.7.4.215; Parnetti L, 2013, NAT REV NEUROL, V9, P131, DOI 10.1038/nrneurol.2013.10; Parnetti L, 2011, MOVEMENT DISORD, V26, P1428, DOI 10.1002/mds.23670; Phillips RJ, 2008, NEUROSCIENCE, V153, P733, DOI 10.1016/j.neuroscience.2008.02.074; Roberts HL, 2015, BIOMOLECULES, V5, P282, DOI 10.3390/biom5020282; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stewart T, 2014, AM J PATHOL, V184, P966, DOI 10.1016/j.ajpath.2013.12.007; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Tolosa E, 2015, BRAIN, V138, P2120, DOI 10.1093/brain/awv164; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Tumilasci OR, 2006, MOVEMENT DISORD, V21, P660, DOI 10.1002/mds.20784; Unterberger U, 2014, CLIN NEUROPATHOL, V33, P329, DOI 10.5414/NP300796; Vekrellis K, 2011, LANCET NEUROL, V10, P1041, DOI 10.1016/S1474-4422(11)70213-7; Visanji NP, 2015, NEUROLOGY, V84, P609, DOI 10.1212/WNL.0000000000001240; Vivacqua G, 2011, J CHEM NEUROANAT, V41, P97, DOI 10.1016/j.jchemneu.2010.12.003; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Xilouri M, 2013, MOL NEUROBIOL, V47, P537, DOI 10.1007/s12035-012-8341-2; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Zange L, 2015, BRAIN, V138, P2310, DOI 10.1093/brain/awv138	45	69	70	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151156	10.1371/journal.pone.0151156	http://dx.doi.org/10.1371/journal.pone.0151156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27011009	gold, Green Published, Green Submitted			2022-12-26	WOS:000372708000024
J	Alves, LGA; Scariot, DB; Guimaraes, RR; Nakamura, CV; Mendes, RS; Ribeiro, HV				Alves, Luiz G. A.; Scariot, Debora B.; Guimaraes, Renato R.; Nakamura, Celso V.; Mendes, Renio S.; Ribeiro, Haroldo V.			Transient Superdiffusion and Long-Range Correlations in the Motility Patterns of Trypanosomatid Flagellate Protozoa	PLOS ONE			English	Article							ANOMALOUS DIFFUSION; ANTIGENIC VARIATION; PROBABILITY-DISTRIBUTIONS; TRANSMISSION; INFECTION	We report on a diffusive analysis of the motion of flagellate protozoa species. These parasites are the etiological agents of neglected tropical diseases: leishmaniasis caused by Leishmania amazonensis and Leishmania braziliensis, African sleeping sickness caused by Trypanosoma brucei, and Chagas disease caused by Trypanosoma cruzi. By tracking the positions of these parasites and evaluating the variance related to the radial positions, we find that their motions are characterized by a short-time transient superdiffusive behavior. Also, the probability distributions of the radial positions are self-similar and can be approximated by a stretched Gaussian distribution. We further investigate the probability distributions of the radial velocities of individual trajectories. Among several candidates, we find that the generalized gamma distribution shows a good agreement with these distributions. The velocity time series have long-range correlations, displaying a strong persistent behavior (Hurst exponents close to one). The prevalence of "universal" patterns across all analyzed species indicates that similar mechanisms may be ruling the motion of these parasites, despite their differences in morphological traits. In addition, further analysis of these patterns could become a useful tool for investigating the activity of new candidate drugs against these and others neglected tropical diseases.	[Alves, Luiz G. A.; Guimaraes, Renato R.; Mendes, Renio S.; Ribeiro, Haroldo V.] Univ Estadual Maringa, Dept Fis, BR-87020900 Maringa, PR, Brazil; [Alves, Luiz G. A.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Alves, Luiz G. A.; Guimaraes, Renato R.; Mendes, Renio S.] CNPq, Natl Inst Sci & Technol Complex Syst, BR-22290180 Rio De Janeiro, RJ, Brazil; [Scariot, Debora B.; Nakamura, Celso V.] Univ Estadual Maringa, Dept Ciencias Basicas Saude, BR-87020900 Maringa, PR, Brazil	Universidade Estadual de Maringa; Northwestern University; Universidade Estadual de Maringa	Alves, LGA (corresponding author), Univ Estadual Maringa, Dept Fis, BR-87020900 Maringa, PR, Brazil.; Alves, LGA (corresponding author), Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.; Alves, LGA (corresponding author), CNPq, Natl Inst Sci & Technol Complex Syst, BR-22290180 Rio De Janeiro, RJ, Brazil.	lgaalves@dfi.uem.br	Nakamura, Celso Vataru/AAA-5620-2019; Ribeiro, Haroldo Valentin/C-8614-2012; Alves, Luiz G A/H-3389-2013; Mendes, Renio/F-9261-2017	Ribeiro, Haroldo Valentin/0000-0002-9532-5195; Alves, Luiz G A/0000-0001-6204-5552; Botura Scariot, Debora/0000-0002-8681-0172	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Araucaria (FA); CNPq [440650/2014-3]; CAPES [99999.006842/2015-01]; RSM [263/2014]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Araucaria (FA)(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FA); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); RSM	This work has been supported by the agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Fundacao Araucaria (FA). HVR is thankful for the financial support of CNPq (grant 440650/2014-3), LGAA is thankful for the financial support of CAPES (grant 99999.006842/2015-01) and RSM gives thanks to FA (grant 263/2014) for partial financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadehrad D, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1003967; Amselem G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037213; [Anonymous], 2015, PARASITES LEISHMANIA; Ballesteros-Rodea G, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/520380; Baron S, 1996, MED MICROBIOLOGY, P1; Barry JD, 2001, ADV PARASIT, V49, P1, DOI 10.1016/S0065-308X(01)49037-3; Bates PA, 2007, INT J PARASITOL, V37, P1097, DOI 10.1016/j.ijpara.2007.04.003; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; Carta JA, 2009, RENEW SUST ENERG REV, V13, P933, DOI 10.1016/j.rser.2008.05.005; de Noya BA, 2015, TRYPANOSOMA CRUZI FO; de Paula, 2006, PHYS CHEM THERMODYNA; De Souza W, 2002, CURR PHARM DESIGN, V8, P269, DOI 10.2174/1381612023396276; Donelson JE, 2003, ACTA TROP, V85, P391, DOI 10.1016/S0001-706X(02)00237-1; Farrar J, 2014, MANSONS TROPICAL INF, pxi, DOI [10.1016/b978-0-7020-5101-2.00094-7, DOI 10.1016/B978-0-7020-5101-2.00094-7]; Forestier CL, 2011, CELL HOST MICROBE, V9, P319, DOI 10.1016/j.chom.2011.03.011; Ginger ML, 2008, NAT REV MICROBIOL, V6, P838, DOI 10.1038/nrmicro2009; Grab DJ, 2008, J NEUROVIROL, V14, P344, DOI 10.1080/13550280802282934; Heddergott N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003023; Hill KL, 2003, EUKARYOT CELL, V2, P200, DOI 10.1128/EC.2.2.200-208.2003; Kantelhardt JW, 2001, PHYSICA A, V295, P441, DOI 10.1016/S0378-4371(01)00144-3; Kennedy PGE, 2004, J CLIN INVEST, V113, P496, DOI 10.1172/JCI200421052; Kiss P, 2008, ENERG CONVERS MANAGE, V49, P2142, DOI 10.1016/j.enconman.2008.02.003; Langousis G, 2014, NAT REV MICROBIOL, V12, P505, DOI 10.1038/nrmicro3274; Lauga E, 2006, BIOPHYS J, V90, P400, DOI 10.1529/biophysj.105.069401; Lythgoe KA, 2007, P NATL ACAD SCI USA, V104, P8095, DOI 10.1073/pnas.0606206104; Makarava N, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042703; Manderson L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000332; Metzler R, 2000, PHYS REP, V339, P1, DOI 10.1016/S0370-1573(00)00070-3; Metzler R, 2014, PHYS CHEM CHEM PHYS, V16, P24128, DOI 10.1039/c4cp03465a; Morgan EC, 2011, ENERG CONVERS MANAGE, V52, P15, DOI 10.1016/j.enconman.2010.06.015; Nigeria, 2015, NEGLECTED TROPICAL D; Nussbaum K, 2010, CURR MED CHEM, V17, P1594, DOI 10.2174/092986710790979953; Pays E, 2004, CURR OPIN MICROBIOL, V7, P369, DOI 10.1016/j.mib.2004.05.001; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Plastino AR, 1995, PHYSICA A, V222, P347, DOI 10.1016/0378-4371(95)00211-1; Reverey JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11690; Richardson LF, 1926, P R SOC LOND A-CONTA, V110, P709, DOI 10.1098/rspa.1926.0043; Rodriguez JA, 2009, P NATL ACAD SCI USA, V106, P19322, DOI 10.1073/pnas.0907001106; Rogers M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000555; Rogers ME, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00223; Rogers ME, 2002, PARASITOLOGY, V124, P495, DOI 10.1017/S0031182002001439; Rozenberg Gillian, 2011, MICROSCOPIC HAEMATOL; Silverberg JL, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.228701; Song LL, 2006, EUR J CELL BIOL, V85, P981, DOI 10.1016/j.ejcb.2006.01.012; Theves M, 2015, EPL-EUROPHYS LETT, V109, DOI 10.1209/0295-5075/109/28007; Theves M, 2013, BIOPHYS J, V105, P1915, DOI 10.1016/j.bpj.2013.08.047; Thurner S, 2003, PHYSICA A, V320, P475, DOI 10.1016/S0378-4371(02)01598-4; TSALLIS C, 1988, J STAT PHYS, V52, P479, DOI 10.1007/BF01016429; Upadhyaya A, 2001, PHYSICA A, V293, P549, DOI 10.1016/S0378-4371(01)00009-7; Uppaluri S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002058; VANDERAUWERA L, 1980, J APPL METEOROL, V19, P819, DOI 10.1175/1520-0450(1980)019<0819:TUOTWT>2.0.CO;2; Wauthier F., 2015, MOTION TRACKING IMAG; ZARLEY JH, 1991, J CLIN INVEST, V88, P1511, DOI 10.1172/JCI115461	53	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152092	10.1371/journal.pone.0152092	http://dx.doi.org/10.1371/journal.pone.0152092			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007779	gold, Green Published, Green Submitted			2022-12-26	WOS:000372701200092
J	Hearn, AJ; Ross, J; Bernard, H; Abu Bakar, S; Hunter, LTB; Macdonald, DW				Hearn, Andrew J.; Ross, Joanna; Bernard, Henry; Abu Bakar, Soffian; Hunter, Luke T. B.; Macdonald, David W.			The First Estimates of Marbled Cat Pardofelis marmorata Population Density from Bornean Primary and Selectively Logged Forest	PLOS ONE			English	Article							LEOPARD NEOFELIS-DIARDI; NON-PANTHERA CATS; NATIONAL-PARK; PROTECTED AREA; HABITAT USE; SABAH; CARNIVORES; RESERVES; SUMATRA	The marbled cat Pardofelis marmorata is a poorly known wild cat that has a broad distribution across much of the Indomalayan ecorealm. This felid is thought to exist at low population densities throughout its range, yet no estimates of its abundance exist, hampering assessment of its conservation status. To investigate the distribution and abundance of marbled cats we conducted intensive, felid-focused camera trap surveys of eight forest areas and two oil palm plantations in Sabah, Malaysian Borneo. Study sites were broadly representative of the range of habitat types and the gradient of anthropogenic disturbance and fragmentation present in contemporary Sabah. We recorded marbled cats from all forest study areas apart from a small, relatively isolated forest patch, although photographic detection frequency varied greatly between areas. No marbled cats were recorded within the plantations, but a single individual was recorded walking along the forest/plantation boundary. We collected sufficient numbers of marbled cat photographic captures at three study areas to permit density estimation based on spatially explicit capture-recapture analyses. Estimates of population density from the primary, lowland Danum Valley Conservation Area and primary upland, Tawau Hills Park, were 19.57 (SD: 8.36) and 7.10 (SD: 1.90) individuals per 100 km(2), respectively, and the selectively logged, lowland Tabin Wildlife Reserve yielded an estimated density of 10.45 (SD: 3.38) individuals per 100 km(2). The low detection frequencies recorded in our other survey sites and from published studies elsewhere in its range, and the absence of previous density estimates for this felid suggest that our density estimates may be from the higher end of their abundance spectrum. We provide recommendations for future marbled cat survey approaches.	[Hearn, Andrew J.; Ross, Joanna; Macdonald, David W.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit WildCRU, S Parks Rd, Oxford, England; [Bernard, Henry] Univ Malaysia Sabah, Inst Trop Biol & Conservat, Kota Kinabalu, Sabah, Malaysia; [Abu Bakar, Soffian] Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia; [Hunter, Luke T. B.] Panthera, New York, NY USA	University of Oxford; Universiti Malaysia Sabah	Hearn, AJ (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit WildCRU, S Parks Rd, Oxford, England.	Andrew.hearn@zoo.ox.ac.uk	Hunter, Luke T.B./H-3324-2019	Hunter, Luke T.B./0000-0001-9653-6544	Darwin Initiative; Recaniti-Kaplan Foundation; Robertson Foundation; Sime Darby Foundation; Clouded Leopard project; Felidae Conservation Fund; Houston Zoo; HG Wills International Trust for Nature Conservation; Panthera AJH; Point Defiance Zoo and Aquarium; Wild About Cats	Darwin Initiative; Recaniti-Kaplan Foundation; Robertson Foundation; Sime Darby Foundation; Clouded Leopard project; Felidae Conservation Fund; Houston Zoo; HG Wills International Trust for Nature Conservation; Panthera AJH; Point Defiance Zoo and Aquarium; Wild About Cats	This research was primarily funded by the Darwin Initiative (https://www.gov.uk/government/groups/the-darwin-initiative) [DWM], Recaniti-Kaplan Foundation to DWM, Robertson Foundation (http://www.robertsonfoundation.org/) [DWM] and Sime Darby Foundation (http://www.yayasansimedarby.com/). The authors received additional funding from Clouded Leopard project (http://www.cloudedleopard.org/) [AJH and JR]; Felidae Conservation Fund (http://felidaefund.org/) [AJH and JR]; Houston Zoo (http://www.houstonzoo.org/) [AJH]; HG Wills International Trust for Nature Conservation [AJH, JR]; Panthera AJH (https://www.panthera.org/); Point Defiance Zoo and Aquarium (http://www.pdza.org/) [AJH] and Wild About Cats [AJH and JR]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernard H, 2013, RAFFLES B ZOOL, V61, P861; Borries C, 2014, RAFFLES B ZOOL, V62, P561; Brodie J, 2012, ORYX, V46, P427, DOI 10.1017/S0030605312000087; Brodie Jedediah, 2011, Small Carnivore Conservation, V44, P1; Chutipong W, 2014, RAFFLES B ZOOL, V62, P521; Costa PM, 1996, AMBIO, V25, P279; Coudrat Camille N.Z., 2014, Cat News, P45; Duckworth J.W., 2014, Cat News, P62; Efford M, 2004, OIKOS, V106, P598, DOI 10.1111/j.0030-1299.2004.13043.x; Gaveau DLA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101654; Goldberg JF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140757; Gopalaswamy AM, 2012, METHODS ECOL EVOL, V3, P1067, DOI 10.1111/j.2041-210X.2012.00241.x; Grassman LI, 2005, J MAMMAL, V86, P29, DOI 10.1644/1545-1542(2005)086&lt;0029:EOTSFI&gt;2.0.CO;2; Grassman Lon I. Jr, 2002, Cat News, V36, P19; Gray Thomas N.E., 2014, Cat News, P19; Guggisberg CAW, 1975, WILD CATS WORLD; Gumal Melvin, 2014, Cat News, P10; Hunter Luke, 2015, P1; Lyngdoh S, 2011, CURR SCI INDIA, V101, P1284; McCarthy JL, 2015, GLOB ECOL CONSERV, V3, P210, DOI 10.1016/j.gecco.2014.11.009; Miettinen J, 2011, GLOBAL CHANGE BIOL, V17, P2261, DOI 10.1111/j.1365-2486.2011.02398.x; Mohamed A, 2009, CAT NEWS, V51, P12; Mohamed A, 2013, J MAMMAL, V94, P82, DOI 10.1644/11-MAMM-A-394.1; Nowell K., 1996, WILD CATS STATUS SUR; Pusparini Wulan, 2014, Cat News, P4; R Development Team, 2014, R LANG ENV STAT COMP; Reynolds G, 2011, PHILOS T R SOC B, V366, P3168, DOI 10.1098/rstb.2011.0154; Ross J., 2015, IUCN RED LIST THREAT; Royle JA, 2008, ECOLOGY, V89, P2281, DOI 10.1890/07-0601.1; Royle JA, 2011, J WILDLIFE MANAGE, V75, P604, DOI 10.1002/jwmg.79; Royle JA, 2009, ECOLOGY, V90, P3233, DOI 10.1890/08-1481.1; Simcharoen Saksit, 2014, Cat News, P31; Sollmann R, 2013, BIOL CONSERV, V159, P405, DOI 10.1016/j.biocon.2012.12.025; Sunquist ME, 2002, WILD CATS WORLD; Suzuki Al, 2015, Cat News, V62, P14; Tempa T, 2013, ORYX, V47, P207, DOI 10.1017/S0030605312001317; Tonkin B.A., 1979, CAT BEHAV PREDATORY; Wearn OR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077598; Willcox Daniel H.A., 2014, Cat News, P53; Wilting A, 2012, ORYX, V46, P423, DOI 10.1017/S0030605311001694; Zaw Than, 2014, Cat News, P24	41	21	24	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151046	10.1371/journal.pone.0151046	http://dx.doi.org/10.1371/journal.pone.0151046			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007219	Green Published, gold, Green Submitted			2022-12-26	WOS:000372701200040
J	Loewen, RT; Roy, P; Parikh, HA; Dang, Y; Schuman, JS; Loewen, NA				Loewen, Ralitsa T.; Roy, Pritha; Parikh, Hardik A.; Dang, Yalong; Schuman, Joel S.; Loewen, Nils A.			Impact of a Glaucoma Severity Index on Results of Trabectome Surgery: Larger Pressure Reduction in More Severe Glaucoma	PLOS ONE			English	Article							AB INTERNO TRABECULECTOMY; OUTCOMES; PROGRESSION; SYSTEMS	Purpose To stratify outcomes of trabectome-mediated ab interno trabeculectomy (AIT) by glaucoma severity using a simple and clinically useful glaucoma index. Based on prior data of trabectome after failed trabeculectomy, we hypothesized that more severe glaucoma might have a relatively more reduced facility compared to mild glaucoma and respond with a larger IOP reduction to trabecular meshwork ablation. Methods Patients with primary open angle glaucoma who had undergone AIT without any other same session surgery and without any second eye surgery during the following 12 months were analyzed. Eyes of patients that had less than 12 months follow up or were diagnosed with neovascular glaucoma were excluded. A glaucoma index (GI) was created to capture glaucoma severity based on visual field, number of preoperative medications, and preoperative IOP. Visual field (VF) was separated into 3 categories: mild, moderate, and advanced (assigned 1, 2, and 3 points, respectively). Preoperative number of medications (meds) was divided into 4 categories: <= 1, 2, 3 or >= 4, and assigned with a value of 1 to 4. Baseline IOP (IOP) was divided into 3 categories: <20 mmHg, 20-29 mmHg, and greater than 30 mmHg and assigned with 1 to 3 points. GI was defined as IOP x meds x VF and separated into 4 groups: <6 (Group 1), 6-12 (Group 2), >12-18 (Group 3) and >18 (Group 4). Linear regression was used to determine if there was an association between GI group and IOP reduction after one year or age, gender, race, diagnosis, cup to disc (C/D) ratio, and Shaffer grade. Results Out of 1340 patients, 843 were included in the analysis. The GI group distribution was GI1 = 164, GI2 = 202, GI3 = 260, and GI4 = 216. Mean IOP reduction after one year was 4.0 +/- 5.4, 6.4 +/- 5.8, 9.0 +/- 7.6, 12.0 +/- 8.0 mmHg for GI groups 1 to 4, respectively. Linear regression showed that IOP reduction was associated with GI group after adjusting for age, gender, race, diagnosis, cup to disc ratio, and Shaffer grade. Each GI group increase of 1 was associated with incremental IOP reductions of 2.95 +/- 0.29 mmHg. Success rate at 12 months was 90%, 77%, 77%, and 71% for GI groups 1 to 4. The log-rank test suggested significant differences between GI groups. Conclusion A simple glaucoma index, GI, was created to capture glaucoma severity and a relative resistance to treatment. A higher GI was associated with a larger IOP reduction in trabectome surgery. This indicates that there is a role for AIT beyond mild glaucoma and ocular hypertension.	[Loewen, Ralitsa T.; Roy, Pritha; Parikh, Hardik A.; Dang, Yalong; Schuman, Joel S.; Loewen, Nils A.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Loewen, NA (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA.	Loewen.nils@gmail.com	Loewen, Nils/E-9946-2014; Schuman, Joel S/M-2389-2019; Schuman, Joel S/K-7304-2012; Dang, Yalong/Q-4156-2017	Loewen, Nils/0000-0001-7167-1213; Schuman, Joel S/0000-0002-8885-3766; Schuman, Joel S/0000-0002-8885-3766; Dang, Yalong/0000-0003-2194-6375	Research to Prevent Blindness; Department of Ophthalmology, University of Pittsburgh; NATIONAL EYE INSTITUTE [K08EY022737] Funding Source: NIH RePORTER	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Department of Ophthalmology, University of Pittsburgh(University of Pittsburgh); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by a Research to Prevent Blindness Departmental Grant and an Individual Grant from the Department of Ophthalmology, University of Pittsburgh. The sponsor or funding organization had no role in the design or conduct of this research.	Buck CJ, 2015, ICD 10 CM 2015 PHYS; Bussel II, 2015, BRIT J OPHTHALMOL, V99, P914, DOI 10.1136/bjophthalmol-2014-305577; Bussel II, 2015, BRIT J OPHTHALMOL, V99, P258, DOI 10.1136/bjophthalmol-2013-304717; Chandrasekaran S, 2006, OPHTHALMOLOGY, V113, P417, DOI 10.1016/j.ophtha.2005.10.050; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; ETHIER CR, 1986, INVEST OPHTH VIS SCI, V27, P1741; Gedde SJ, 2012, AM J OPHTHALMOL, V153, P789, DOI 10.1016/j.ajo.2011.10.026; Heilmann K, 1978, GLAUCOMA CONCEPTIONS; Jea SY, 2012, OPHTHALMOLOGY, V119, P36, DOI 10.1016/j.ophtha.2011.06.046; Kaplowitz K, 2016, BRIT J OPHTHALMOL, V100, P594, DOI 10.1136/bjophthalmol-2015-307131; Kaplowitz K, 2014, BRIT J OPHTHALMOL, V98, P579, DOI 10.1136/bjophthalmol-2013-304256; Krupin T, 2005, OPHTHALMOLOGY, V112, P376, DOI 10.1016/j.ophtha.2004.10.034; Medeiros FA, 2012, INVEST OPHTH VIS SCI, V53, P6939, DOI 10.1167/iovs.12-10345; Mosaed S, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001045; Ng M, 2012, J GLAUCOMA, V21, P551, DOI 10.1097/IJG.0b013e31821dac66; Parikh HA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149384; Ronald L, EYE NET MAGAZINE; Samuelson TW, 2011, OPHTHALMOLOGY, V118, P459, DOI 10.1016/j.ophtha.2010.07.007; Spaeth GL, 2006, SURV OPHTHALMOL, V51, P293, DOI 10.1016/j.survophthal.2006.04.008; Stamper RL, 2009, BECKER SHAFFERS DIAG, P78; Ting JLM, 2012, J CATARACT REFR SURG, V38, P315, DOI 10.1016/j.jcrs.2011.08.043; Vajaranant TS, 2012, AM J OPHTHALMOL, V154, P303, DOI 10.1016/j.ajo.2012.02.024; Wollstein G, 2012, BRIT J OPHTHALMOL, V96, P47, DOI 10.1136/bjo.2010.196907	23	36	36	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151926	10.1371/journal.pone.0151926	http://dx.doi.org/10.1371/journal.pone.0151926			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008637	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000372701200074
J	Borgeraas, H; Hertel, JK; Svingen, GFT; Pedersen, ER; Seifert, R; Nygard, O; Hjelmesaeth, J				Borgeraas, Heidi; Hertel, Jens Kristoffer; Svingen, Gard Frodahl Tveitevag; Pedersen, Eva Ringdal; Seifert, Reinhard; Nygard, Ottar; Hjelmesaeth, Joran			Association between Body Mass Index, Asymmetric Dimethylarginine and Risk of Cardiovascular Events and Mortality in Norwegian Patients with Suspected Stable Angina Pectoris	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; INDUCIBLE NITRIC-OXIDE; ENDOTHELIAL DYSFUNCTION; MYOCARDIAL-INFARCTION; PLASMA-CONCENTRATION; OXIDATIVE STRESS; FOLLOW-UP; HEART; DEATH; WOMEN	Background Asymmetric dimethylarginine (ADMA) is associated with increased risk of atherosclerotic cardiovascular disease and mortality through inhibition of nitrogen oxide (NO) synthesis. As positive correlations between serum concentrations of NO and body mass index (BMI) have been observed, we aimed to explore whether the potential associations between plasma ADMA levels and the risk of acute myocardial infarction (AMI) and mortality were modified by BMI. Methods Multivariable Cox proportional hazard models were used to estimate the hazard ratios (HR) for AMI, cardiovascular death and all-cause mortality according to baseline plasma ADMA levels in 4122 patients with suspected stable angina pectoris. Analyses were subsequently repeated in patients with BMI below (low BMI) or above (high BMI) median. Results A total of 2982 patients (72%) were men. Median (range) age, plasma ADMA level and BMI were 62 (21-88) years, 0.54 (0.10-1.25) mu mol/L and 26.3 (18.5-54.3) kg/m(2), respectively. During a mean (standard deviation) follow-up time of 4.7 (1.4) years, 337 (8%) patients suffered from an AMI, 300 (7%) died, whereof 165 (55%) due to cardiovascular disease. Each 0.1 mu mol/L increment in plasma ADMA level was associated with an increased risk of AMI (HR (95% CI) 1.21 (1.08, 1.35) and cardiovascular death 1.30 (1.13, 1.49) in participants with low BMI only. Interactions were significant for AMI (p = 0.04) and CV death (p = 0.03). BMI did not modify the association between plasma ADMA levels and all-cause mortality. Conclusion Plasma ADMA levels were associated with risk of AMI and cardiovascular death among patients with low BMI only.	[Borgeraas, Heidi; Hertel, Jens Kristoffer; Hjelmesaeth, Joran] Vestfold Hosp Trust, Morbid Obes Ctr, Tonsberg, Norway; [Borgeraas, Heidi; Hjelmesaeth, Joran] Univ Oslo, Inst Clin Med, Dept Endocrinol Morbid Obes & Prevent Med, Oslo, Norway; [Svingen, Gard Frodahl Tveitevag; Pedersen, Eva Ringdal; Nygard, Ottar] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Svingen, Gard Frodahl Tveitevag; Pedersen, Eva Ringdal; Seifert, Reinhard; Nygard, Ottar] Haukeland Hosp, Dept Heart Dis, N-5021 Bergen, Norway; [Nygard, Ottar] Haukeland Hosp, KG Jebsen Ctr Diabet Res, N-5021 Bergen, Norway	University of Oslo; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Borgeraas, H (corresponding author), Vestfold Hosp Trust, Morbid Obes Ctr, Tonsberg, Norway.; Borgeraas, H (corresponding author), Univ Oslo, Inst Clin Med, Dept Endocrinol Morbid Obes & Prevent Med, Oslo, Norway.	heibor@siv.no			Norwegian Ministry of Health and Care Services; Western Norway Regional Health Authority; Department of Heart Disease at Haukeland University Hospital, Bergen; Meltzer Foundation, Bergen, Norway	Norwegian Ministry of Health and Care Services; Western Norway Regional Health Authority; Department of Heart Disease at Haukeland University Hospital, Bergen; Meltzer Foundation, Bergen, Norway	The study was funded by the Norwegian Ministry of Health and Care Services, the Western Norway Regional Health Authority, the Department of Heart Disease at Haukeland University Hospital, Bergen, and the Meltzer Foundation, Bergen, Norway.	Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Albert MA, 2001, JAMA-J AM MED ASSOC, V286, P64, DOI 10.1001/jama.286.1.64; Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; Bleie O, 2004, AM J CLIN NUTR, V80, P641; Boger RH, 2009, CIRCULATION, V119, P1592, DOI 10.1161/CIRCULATIONAHA.108.838268; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Borgeraas H, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-68; Borgeraas H, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/201742; Bredt DS, 1999, FREE RADICAL RES, V31, P577, DOI 10.1080/10715769900301161; Choi JW, 2001, CLIN CHEM, V47, P1106; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Codoner-Franch P, 2011, ATHEROSCLEROSIS, V215, P475, DOI 10.1016/j.atherosclerosis.2010.12.035; Duckelmann C, 2007, ARTERIOSCL THROM VAS, V27, P2037, DOI 10.1161/ATVBAHA.107.147595; Ebbing M, 2008, JAMA-J AM MED ASSOC, V300, P795, DOI 10.1001/jama.300.7.795; Fujii H, 2008, AM J HYPERTENS, V21, P650, DOI 10.1038/ajh.2008.29; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Heitzer T, 2005, ARTERIOSCL THROM VAS, V25, P1174, DOI 10.1161/01.ATV.0000166516.52477.81; Ing DJ, 1999, CIRC RES, V84, P21; Knowles JW, 2000, J CLIN INVEST, V105, P451, DOI 10.1172/JCI8376; Kotamraju S, 2007, CANCER RES, V67, P7386, DOI 10.1158/0008-5472.CAN-07-0993; Krzyzanowska K, 2007, DIABETES CARE, V30, P1834, DOI 10.2337/dc07-0019; Lajer M, 2008, DIABETES CARE, V31, P747, DOI 10.2337/dc07-1762; Lee J, 2012, J DENT RES, V91, P142, DOI 10.1177/0022034511421200; Leong T, 2008, ARTERIOSCL THROM VAS, V28, P961, DOI 10.1161/ATVBAHA.107.156596; Loland KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064774; LOSCALZO J, 1995, PROG CARDIOVASC DIS, V38, P87, DOI 10.1016/S0033-0620(05)80001-5; Lu TM, 2003, EUR HEART J, V24, P1912, DOI 10.1016/j.ehj.2003.08.013; Maas R, 2007, CLIN CHEM, V53, P693, DOI 10.1373/clinchem.2006.081893; Meinitzer A, 2007, CLIN CHEM, V53, P273, DOI 10.1373/clinchem.2006.076711; Mittermayer F, 2006, ARTERIOSCL THROM VAS, V26, P2536, DOI 10.1161/01.ATV.0000242801.38419.48; Muhl H, 1996, EUR J PHARMACOL, V317, P137, DOI 10.1016/S0014-2999(96)00701-7; Nathan C, 1997, J CLIN INVEST, V100, P2417, DOI 10.1172/JCI119782; Nijveldt RJ, 2003, CLIN NUTR, V22, P23, DOI 10.1054/clnu.2002.0613; Olszanecka-Glinianowicz M, 2004, METABOLISM, V53, P1268, DOI 10.1016/j.metabol.2004.07.001; Paik JK, 2015, AGE, V37, DOI 10.1007/s11357-015-9770-4; Pedersen ER, 2010, ATHEROSCLEROSIS, V212, P644, DOI 10.1016/j.atherosclerosis.2010.06.027; PINSKY DJ, 1995, J CLIN INVEST, V95, P677, DOI 10.1172/JCI117713; Qiu CB, 1998, HYPERTENSION, V31, P21, DOI 10.1161/01.HYP.31.1.21; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; Schnabel R, 2005, CIRC RES, V97, P53, DOI 10.1161/01.RES.0000181286.44222.61; Sibal L, 2010, CURR CARDIOL REV, V6, P82, DOI 10.2174/157340310791162659; SRNT Subcommittee on Biochemical Verification, 2002, Nicotine Tob Res, V4, P149, DOI 10.1080/14622200210123581; Svingen GF, 2013, ARTERIOSCLER THROMB; Therneau T.M., 2000, MODELING SURVIVAL DA; Trayhurn P, 2005, BIOCHEM SOC T, V33, P1078, DOI [10.1042/BST0331078, 10.1042/BST20051078]; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Tzanavari T, 2010, CURR DIR AUTOIMMUN, V11, P145, DOI 10.1159/000289203; Zeller M, 2008, ARTERIOSCL THROM VAS, V28, P954, DOI 10.1161/ATVBAHA.108.162768; Zoccali C, 2001, LANCET, V358, P2113, DOI 10.1016/S0140-6736(01)07217-8	51	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152029	10.1371/journal.pone.0152029	http://dx.doi.org/10.1371/journal.pone.0152029			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003294	Green Submitted, Green Published, gold			2022-12-26	WOS:000372697400068
J	Hsu, CE; Lin, TK; Lee, MH; Lee, ST; Chang, CN; Lin, CL; Hsu, YH; Huang, YC; Hsieh, TC; Chang, CJ				Hsu, Chung-En; Lin, Tzu-Kang; Lee, Ming-Hsueh; Lee, Shih-Tseng; Chang, Chen-Nen; Lin, Chih-Lung; Hsu, Yung-Hsin; Huang, Yin-Cheng; Hsieh, Tsung-Che; Chang, Chee-Jen			The Impact of Surgical Experience on Major Intraoperative Aneurysm Rupture and Their Consequences on Outcome: A Multivariate Analysis of 538 Microsurgical Clipping Cases	PLOS ONE			English	Article							UNRUPTURED INTRACRANIAL ANEURYSMS; IN-HOSPITAL MORTALITY; SUBARACHNOID HEMORRHAGE; SURGEON VOLUME; UNITED-STATES; RATES; COMPLICATIONS; SPECIALTY; MORBIDITY	The incidence and associated mortality of major intraoperative rupture (MIOR) in intracranial aneurysm surgery is diverse. One possible reason is that many studies failed to consider and properly adjust the factor of surgical experience in the context. We conducted this study to clarify the role of surgical experience on MIOR and associated outcome. 538 consecutive intracranial aneurysm surgeries performed on 501 patients were enrolled in this study. Various potential predictors of MIOR were evaluated with stratified analysis and multivariate logistic regression. The impact of surgical experience and MIOR on outcome was further studied in a logistic regression model with adjustment of each other. The outcome was evaluated using the Glasgow Outcome Scale one year after the surgery. Surgical experience and preoperative Glasgow Coma Scale (GCS) were identified as independent predictors of MIOR. Experienced neurovascular surgeons encountered fewer cases of MIOR compared to novice neurosurgeons (MIOR, 18/225, 8.0% vs. 50/313, 16.0%, P = 0.009). Inexperience and MIOR were both associated with a worse outcome. Compared to experienced neurovascular surgeons, inexperienced neurosurgeons had a 1.90-fold risk of poor outcome. On the other hand, MIOR resulted in a 3.21-fold risk of unfavorable outcome compared to those without it. Those MIOR cases managed by experienced neurovascular surgeons had a better prognosis compared with those managed by inexperienced neurosurgeons (poor outcome, 4/18, 22% vs. 30/50, 60%, P = 0.013).	[Hsu, Chung-En; Lin, Tzu-Kang; Lee, Shih-Tseng; Chang, Chen-Nen; Hsu, Yung-Hsin; Huang, Yin-Cheng] Chang Gung Mem Hosp Linkou, Dept Neurosurg, Taoyuan, Taiwan; [Hsu, Chung-En; Lin, Tzu-Kang; Lee, Shih-Tseng; Chang, Chen-Nen; Hsu, Yung-Hsin; Huang, Yin-Cheng] Chang Gung Univ, Taoyuan, Taiwan; [Lee, Ming-Hsueh] Chang Gung Mem Hosp Chiayi, Dept Neurosurg, Chiayi, Taiwan; [Lee, Ming-Hsueh] Chang Gung Inst Technol, Chiayi, Taiwan; [Lin, Chih-Lung] Kaohsiung Med Univ Hosp, Dept Neurosurg, Kaohsiung, Taiwan; [Lin, Chih-Lung] Kaohsiung Med Univ, Kaohsiung, Taiwan; [Hsieh, Tsung-Che] St Pauls Hosp, Div Neurosurg, Taoyuan, Taiwan; [Chang, Chee-Jen] Chang Gung Univ, Clin Informat & Med Stat Res Ctr, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Chang Gung University	Lin, TK (corresponding author), Chang Gung Mem Hosp Linkou, Dept Neurosurg, Taoyuan, Taiwan.; Lin, TK (corresponding author), Chang Gung Univ, Taoyuan, Taiwan.	tklin100@cgmh.org.tw			Biostatistical Center for Clinical Research, Chang Gung Memorial Hospital [CLRPG3D0041]	Biostatistical Center for Clinical Research, Chang Gung Memorial Hospital	The authors received no specific funding for this work. Nevertheless, Mr. Yu Jr Lin who assisted in the statistics of this work was supported by grants from Biostatistical Center for Clinical Research, Chang Gung Memorial Hospital (CLRPG3D0041).	Barker FG, 2003, NEUROSURGERY, V52, P995, DOI 10.1227/01.NEU.0000057743.56678.5F; BATJER H, 1986, NEUROSURGERY, V18, P701, DOI 10.1227/00006123-198606000-00004; Berman MF, 2003, STROKE, V34, P2200, DOI 10.1161/01.STR.0000086528.32334.06; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Boogaarts HD, 2014, J NEUROSURG, V120, P605, DOI 10.3171/2013.9.JNS13640; Carter D, 2003, BRIT MED J, V326, P832, DOI 10.1136/bmj.326.7394.832; Chyatte D, 2001, J NEUROSURG, V94, P417, DOI 10.3171/jns.2001.94.3.0417; Cowan JA, 2003, J NEUROSURG, V99, P947, DOI 10.3171/jns.2003.99.6.0947; Cowan JA, 2002, J AM COLL SURGEONS, V195, P814, DOI 10.1016/S1072-7515(02)01345-5; Cowan JA, 2003, NEUROSURGERY, V52, P48, DOI 10.1097/00006123-200301000-00005; Cross DT, 2003, J NEUROSURG, V99, P810, DOI 10.3171/jns.2003.99.5.0810; Davies JM, 2014, NEUROSURGERY, V74, pS7, DOI 10.1227/NEU.0000000000000193; Elijovich L, 2008, STROKE, V39, P1501, DOI 10.1161/STROKEAHA.107.504670; Fridriksson S, 2002, J NEUROSURG, V96, P515, DOI 10.3171/jns.2002.96.3.0515; Hannan EL, 2002, SURGERY, V131, P6, DOI 10.1067/msy.2002.120238; Hattori N, 2007, NEUROL MED-CHIR, V47, P95, DOI 10.2176/nmc.47.95; Hattori NKY, 2007, NEUROL MED CHIR TOKY, V47, P1; Kalkanis SN, 2003, NEUROSURGERY, V52, P1251, DOI 10.1227/01.NEU.0000065129.25359.EE; Lawton MT, 2005, NEUROSURGERY, V57, P9, DOI 10.1227/01.NEU.0000163082.20941.EF; Leipzig TJ, 2005, NEUROSURGERY, V56, P455, DOI 10.1227/01.NEU.0000154697.75300.C2; Lin Tzu-Kang, 2013, Acta Neurol Taiwan, V22, P106; Sandalcioglu IE, 2004, CLIN NEUROL NEUROSUR, V106, P88, DOI 10.1016/j.clineuro.2003.10.011; SCHRAMM J, 1993, SURG NEUROL, V40, P26, DOI 10.1016/0090-3019(93)90165-W; Solomon RA, 1996, STROKE, V27, P13, DOI 10.1161/01.STR.27.1.13; Taylor CL, 1997, J NEUROSURG, V86, P583, DOI 10.3171/jns.1997.86.4.0583; van Lindert EJ, 2001, SURG NEUROL, V56, P151, DOI 10.1016/S0090-3019(01)00547-X; von Meyenfeldt EM, 2012, J THORAC ONCOL, V7, P1170, DOI 10.1097/JTO.0b013e318257cc45; Wong JM, 2012, NEUROSURG FOCUS, V33, DOI 10.3171/2012.7.FOCUS12181; Wouters MWJM, 2012, CANCER-AM CANCER SOC, V118, P1754, DOI 10.1002/cncr.26383; Yasunaga H, 2008, NEUROL MED-CHIR, V48, P531, DOI 10.2176/nmc.48.531	30	26	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151805	10.1371/journal.pone.0151805	http://dx.doi.org/10.1371/journal.pone.0151805			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003926	Green Submitted, gold, Green Published			2022-12-26	WOS:000372697400046
J	de Rooij, MMT; Borlee, F; Smit, LAM; de Bruin, A; Janse, I; Heederik, DJJ; Wouters, IM				de Rooij, Myrna M. T.; Borlee, Floor; Smit, Lidwien A. M.; de Bruin, Arnout; Janse, Ingmar; Heederik, Dick J. J.; Wouters, Inge M.			Detection of Coxiella burnetii in Ambient Air after a Large Q Fever Outbreak	PLOS ONE			English	Article							DAIRY GOAT; SPATIAL VARIATION; NATURAL-HISTORY; PREGNANT GOATS; SHEEP; NETHERLANDS; EPIDEMIC; INFECTION; SAMPLES; FARMS	One of the largest Q fever outbreaks ever occurred in the Netherlands from 2007-2010, with 25 fatalities among 4,026 notified cases. Airborne dispersion of Coxiella burnetii was suspected but not studied extensively at the time. We investigated temporal and spatial variation of Coxiella burnetii in ambient air at residential locations in the most affected area in the Netherlands (the South-East), in the year immediately following the outbreak. One-week average ambient particulate matter < 10 mu m samples were collected at eight locations from March till September 2011. Presence of Coxiella burnetii DNA was determined by quantitative polymerase chain reaction. Associations with various spatial and temporal characteristics were analyzed by mixed logistic regression. Coxiella burnetii DNA was detected in 56 out of 202 samples (28%). Airborne Coxiella burnetii presence showed a clear seasonal pattern coinciding with goat kidding. The spatial variation was significantly associated with number of goats on the nearest goat farm weighted by the distance to the farm (OR per IQR: 1.89, CI: 1.31-2.76). We conclude that in the year after a large Q fever outbreak, temporal variation of airborne Coxiella burnetii is suggestive to be associated with goat kidding, and spatial variation with distance to and size of goat farms. Aerosol measurements show to have potential for source identification and attribution of an airborne pathogen, which may also be applicable in early stages of an outbreak.	[de Rooij, Myrna M. T.; Borlee, Floor; Smit, Lidwien A. M.; Heederik, Dick J. J.; Wouters, Inge M.] Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands; [de Bruin, Arnout; Janse, Ingmar] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Control CIb, Bilthoven, Netherlands	Utrecht University; Netherlands National Institute for Public Health & the Environment	de Rooij, MMT (corresponding author), Univ Utrecht, Inst Risk Assessment Sci, Div Environm Epidemiol, Utrecht, Netherlands.	M.M.T.deRooij@uu.nl	Smit, Lidwien AM/AFC-8689-2022	Smit, Lidwien AM/0000-0003-0292-0946; de Rooij, Myrna Maria Theresia/0000-0002-6560-4839; Heederik, Dick/0000-0002-4550-1437; Wouters, Inge M./0000-0001-7834-9390	ZonMW [Zorg Onderzoek Nederland/ Mediche Wetenschappen] [205520010]	ZonMW [Zorg Onderzoek Nederland/ Mediche Wetenschappen]	The study was financially supported through a research grant of ZonMW [Zorg Onderzoek Nederland/ Mediche Wetenschappen, grant number 205520010, website (http://www.zonmw.nl/en/)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astobiza I, 2011, RES VET SCI, V91, pE58, DOI 10.1016/j.rvsc.2010.11.014; Bouvery NA, 2003, VET RES, V34, P423, DOI 10.1051/vetres:2003017; Brooke RJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-488; Commandeur M, 2014, INT J ENVIRON HEAL R, V24, P137, DOI 10.1080/09603123.2013.800963; de Bruin A, 2013, J APPL MICROBIOL, V114, P1395, DOI 10.1111/jam.12163; de Bruin A, 2011, APPL ENVIRON MICROB, V77, P6516, DOI 10.1128/AEM.05097-11; Dijkstra F, 2012, FEMS IMMUNOL MED MIC, V64, P3, DOI 10.1111/j.1574-695X.2011.00876.x; Duarte ASR, 2015, INT J FOOD MICROBIOL, V195, P48, DOI 10.1016/j.ijfoodmicro.2014.11.024; Dungan RS, 2010, J ANIM SCI, V88, P3693, DOI 10.2527/jas.2010-3094; Eeftens M, 2012, ATMOS ENVIRON, V62, P303, DOI 10.1016/j.atmosenv.2012.08.038; Evstigneeva A. S., 2005, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P57; Gilsdorf A, 2008, EPIDEMIOL INFECT, V136, P1084, DOI 10.1017/S0950268807009533; Gyuranecz M, 2014, EUROSURVEILLANCE, V19, P9, DOI 10.2807/1560-7917.ES2014.19.30.20863; Hatchette T, 2003, VECTOR-BORNE ZOONOT, V3, P11, DOI 10.1089/153036603765627415; Hawker J I, 1998, Commun Dis Public Health, V1, P180; Hermans T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096607; Hogerwerf L, 2012, APPL ENVIRON MICROB, V78, P5410, DOI 10.1128/AEM.00677-12; Hogerwerf L, 2011, EMERG INFECT DIS, V17, P379, DOI 10.3201/eid1703.101157; Jones RM, 2011, J VET DIAGN INVEST, V23, P108, DOI 10.1177/104063871102300118; Jonges M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125401; Klompniaker JO, 2015, SCI TOTAL ENVIRON, V508, P266, DOI 10.1016/j.scitotenv.2014.11.088; Madariaga MG, 2003, LANCET INFECT DIS, V3, P709, DOI 10.1016/S1473-3099(03)00804-1; National Institute for Public Health and the Environment (RIVM), 2015, Q KOORTS Q FEV; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Reedijk M, 2013, EPIDEMIOL INFECT, V141, P2623, DOI 10.1017/S0950268813000460; Roest HIJ, 2011, EPIDEMIOL INFECT, V139, P1, DOI 10.1017/S0950268810002268; Roest HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048949; Sanchez J, 2006, J COMP PATHOL, V135, P108, DOI 10.1016/j.jcpa.2006.06.003; Schimmer B, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-69; Schneeberger PM, 2014, MED MALADIES INFECT, V44, P339, DOI 10.1016/j.medmal.2014.02.006; Schulz J, 2005, DEUT TIERARZTL WOCH, V112, P470; Smit LAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038843; van Asseldonk MAPM, 2013, PREV VET MED, V112, P27, DOI 10.1016/j.prevetmed.2013.06.002; van den Brom R, 2012, VET REC, V170, P310, DOI 10.1136/vr.100304; van den Brom R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121355; van der Hoek W, 2012, ADV EXP MED BIOL, V984, P329, DOI 10.1007/978-94-007-4315-1_17; van der Hoek W, 2011, INT J ENVIRON HEAL R, V21, P441, DOI 10.1080/09603123.2011.574270; van Leuken JPG, 2015, INT J HEALTH GEOGR, V14, DOI 10.1186/s12942-015-0003-y	38	34	34	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151281	10.1371/journal.pone.0151281	http://dx.doi.org/10.1371/journal.pone.0151281			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991094	Green Published, Green Submitted, gold			2022-12-26	WOS:000372582800052
J	Hajna, S; Ross, NA; Joseph, L; Harper, S; Dasgupta, K				Hajna, Samantha; Ross, Nancy A.; Joseph, Lawrence; Harper, Sam; Dasgupta, Kaberi			Neighbourhood Walkability and Daily Steps in Adults with Type 2 Diabetes	PLOS ONE			English	Article							ASSESSING PHYSICAL-ACTIVITY; LAND-USE MIX; ENVIRONMENTAL ATTRIBUTES; CARDIOVASCULAR-DISEASE; WALKING BEHAVIOR; OLDER-ADULTS; SAMPLE-SIZE; ASSOCIATIONS; DEPRESSION; PREVALENCE	Introduction There is evidence that greater neighbourhood walkability (i.e., neighbourhoods with more amenities and well-connected streets) is associated with higher levels of total walking in Europe and in Asia, but it remains unclear if this association holds in the Canadian context and in chronic disease populations. We examined the relationships of different walkability measures to biosensor-assessed total walking (i.e., steps/day) in adults with type 2 diabetes living in Montreal (QC, Canada). Materials and Methods Participants (60.5 +/- 10.4 years; 48.1% women) were recruited through McGill University-affiliated clinics (June 2006 to May 2008). Steps/day were assessed once per season for one year with pedometers. Neighbourhood walkability was evaluated through participant reports, in-field audits, Geographic Information Systems (GIS)-derived measures, and the Walk Score1. Relationships between walkability and daily steps were estimated using Bayesian longitudinal hierarchical linear regression models (n = 131). Results Participants who reported living in the most compared to the least walkable neighbourhoods completed 1345 more steps/day (95% Credible Interval: 718, 1976; Quartiles 4 versus 1). Those living in the most compared to the least walkable neighbourhoods (based on GIS-derived walkability) completed 606 more steps per day (95% CrI: 8, 1203). No statistically significant associations with steps were observed for audit-assessed walkability or the Walk Score1. Conclusions Adults with type 2 diabetes who perceived their neighbourhoods as more walkable accumulated more daily steps. This suggests that knowledge of local neighborhood features that enhance walking is a meaningful predictor of higher levels of walking and an important component of neighbourhood walkability.	[Hajna, Samantha; Ross, Nancy A.; Joseph, Lawrence; Harper, Sam; Dasgupta, Kaberi] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, 1020 Pine Ave West, Montreal, PQ, Canada; [Ross, Nancy A.] McGill Univ, Dept Geog, 805 Sherbrooke St W, Montreal, PQ, Canada; [Joseph, Lawrence; Dasgupta, Kaberi] McGill Univ, Dept Med, Div Clin Epidemiol, Ctr Hlth, 687 Pine Ave W, Montreal, PQ, Canada	McGill University; McGill University; McGill University	Dasgupta, K (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, 1020 Pine Ave West, Montreal, PQ, Canada.; Dasgupta, K (corresponding author), McGill Univ, Dept Med, Div Clin Epidemiol, Ctr Hlth, 687 Pine Ave W, Montreal, PQ, Canada.	kaberi.dasgupta@mcgill.ca	Harper, Sam/A-3406-2008	Harper, Sam/0000-0002-2767-1053; Hajna, Samantha/0000-0002-0431-2787	Canadian Institutes of Health Research (CIHR) [MOP-79275]; CIHR [94431]; Heart and Stroke Foundation of Canada [G-12-000251]; Canadian Institutes of Health Research (CIHR) Doctoral Research Award; Fonds de Recherche Sante Quebec; Fonds de Recherche Sante Quebec (FRSQ) Career Award (Chercheurs Boursier Health and Society); Canada Research Chair program; Fonds de Recherche Sante Quebec (FRSQ) Career Award (Chercheurs Boursier Junior 2)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research (CIHR) Doctoral Research Award(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche Sante Quebec; Fonds de Recherche Sante Quebec (FRSQ) Career Award (Chercheurs Boursier Health and Society); Canada Research Chair program(Canada Research Chairs); Fonds de Recherche Sante Quebec (FRSQ) Career Award (Chercheurs Boursier Junior 2)	This work was supported by an operating grant from the Canadian Institutes of Health Research (CIHR) (KD: MOP-79275), a Catalyst Grant (NAR and KD: 94431) from CIHR, and a grant from the Heart and Stroke Foundation of Canada (KD: G-12-000251). SHajna was supported by a Canadian Institutes of Health Research (CIHR) Doctoral Research Award. KD is supported through a Senior Clinician Scientist Award from the Fonds de Recherche Sante Quebec. NAR was supported by a Fonds de Recherche Sante Quebec (FRSQ) Career Award (Chercheurs Boursier Health and Society). NAR is also supported by the Canada Research Chair program (http://www.chairs-chaires.gc.ca<http://www.chairs-chaires.gc.ca/>). SHarper was supported by a Fonds de Recherche Sante Quebec (FRSQ) Career Award (Chercheurs Boursier Junior 2).; The authors thank Patrick Belisle and Deborah Chan for their assistance with programming and data management, Max Halparin, Alexandre Poisson, and Elizabeth McNamee for conducting the neighbourhood audits, and Max Halparin for conducting the GIS mapping. This work was supported by an operating grant from the Canadian Institutes of Health Research (CIHR) (KD: MOP-79275), a Catalyst Grant (NAR and KD: 94431) from CIHR, and a grant from the Heart and Stroke Foundation of Canada (KD: G-12-000251). SHajna was supported by a Canadian Institutes of Health Research (CIHR) Doctoral Research Award. KD is supported through a Senior Clinician Scientist Award from the Fonds de Recherche Sante Quebec. NAR was supported by a Fonds de Recherche Sante Quebec (FRSQ) Career Award (Chercheurs Boursier Health and Society) and the Canada Research Chair program (http://www.chairs-chaires.gc.ca). SHarper was supported by a Fonds de Recherche Sante Quebec (FRSQ) Career Award (Chercheurs Boursier Junior 2).	Adriaanse MC, 2008, DIABETIC MED, V25, P843, DOI 10.1111/j.1464-5491.2008.02464.x; Anderson RJ, 2001, DIABETES CARE, V24, P1069, DOI 10.2337/diacare.24.6.1069; Aoyagi Y, 2009, SPORTS MED, V39, P423, DOI 10.2165/00007256-200939060-00001; Brownson RC, 2004, AM J PUBLIC HEALTH, V94, P473, DOI 10.2105/AJPH.94.3.473; Brownson RC, 2009, AM J PREV MED, V36, pS99, DOI 10.1016/j.amepre.2009.01.005; Carr LJ, 2011, BRIT J SPORT MED, V45, P1144, DOI 10.1136/bjsm.2009.069609; Carr LJ, 2010, AM J PREV MED, V39, P460, DOI 10.1016/j.amepre.2010.07.007; Casey D, 2010, DIABETIC MED, V27, P79, DOI 10.1111/j.1464-5491.2009.02873.x; Cerin E, 2014, MED SCI SPORT EXER, V46, P2253, DOI 10.1249/MSS.0000000000000367; Christian HE, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-55; Christine PJ, 2015, JAMA INTERN MED, V175, P1311, DOI 10.1001/jamainternmed.2015.2691; Clifton KJ, 2007, LANDSCAPE URBAN PLAN, V80, P95, DOI 10.1016/j.landurbplan.2006.06.008; Dasgupta K, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-1; Dasgupta K, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-7; Dasgupta K, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-81; De Greef K, 2011, HEALTH SOC CARE COMM, V19, P178, DOI 10.1111/j.1365-2524.2010.00958.x; Deshpande AD, 2005, DIABETES CARE, V28, P1012, DOI 10.2337/diacare.28.5.1012; Ding D, 2014, J AGING PHYS ACTIV, V22, P421, DOI [10.1123/japa.2012-0332, 10.1123/JAPA.2012-0332]; DMTI Spatial Inc, 2008, STREET SEGM FIL; DMTI Spatial Inc, 2008, QUEB LAND US FIL; Eriksson U, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-123; FORD ES, 1995, DIABETES CARE, V18, P27, DOI 10.2337/diacare.18.1.27; Frank LD, 2010, BRIT J SPORT MED, V44, P924, DOI 10.1136/bjsm.2009.058701; Frank LD, 2007, SOC SCI MED, V65, P1898, DOI 10.1016/j.socscimed.2007.05.053; Frank LD, 2005, AM J PREV MED, V28, P117, DOI 10.1016/j.amepre.2004.11.001; Frumkin H., 2004, URBAN SPRAWL PUBLIC; Gebel K, 2011, HEALTH PLACE, V17, P519, DOI 10.1016/j.healthplace.2010.12.008; Gilmour Heather, 2007, Health Rep, V18, P45; Guo Y, 2015, AM J ORTHOD DENTOFAC, V147, P146, DOI 10.1016/j.ajodo.2014.10.009; Guo Y, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-100; Hajna S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008964; Hajna S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2082-x; Hajna S, 2013, AM J PREV MED, V44, pE55, DOI 10.1016/j.amepre.2013.01.033; Hamilton SL, 2008, ANN HUM BIOL, V35, P154, DOI 10.1080/03014460801908058; Hoffmann K, 2002, AM J EPIDEMIOL, V156, P862, DOI 10.1093/aje/kwf121; Huebschmann AG, 2011, DIABETES CARE, V34, P1717, DOI 10.2337/dc10-1801; Inoue S, 2011, AM J PREV MED, V40, P566, DOI 10.1016/j.amepre.2010.12.023; Kamada M, 2009, PREV MED, V49, P490, DOI 10.1016/j.ypmed.2009.09.014; Koohsari MJ, 2015, J URBAN HEALTH, V92, P242, DOI 10.1007/s11524-014-9928-x; Koopmans B, 2009, FAM PRACT, V26, P171, DOI 10.1093/fampra/cmp016; Korkiakangas EE, 2009, HEALTH PROMOT INT, V24, P416, DOI 10.1093/heapro/dap031; Leslie E, 2007, HEALTH PLACE, V13, P111, DOI 10.1016/j.healthplace.2005.11.001; Mier Nelda, 2007, Prev Chronic Dis, V4, pA24; Okun A, 1996, PSYCHOL REP, V79, P1059, DOI 10.2466/pr0.1996.79.3.1059; Oliver M, 2010, J PHYS ACT HEALTH, V7, P102, DOI 10.1123/jpah.7.1.102; Public Health Agency of Canada, WHAT CAN HAPP I HAV; Rhodes RE, 2012, PREV MED, V54, P309, DOI 10.1016/j.ypmed.2012.02.014; Rodriguez DA, 2005, MED SCI SPORT EXER, V37, pS572, DOI 10.1249/01.mss.0000185297.72328.ce; Saelens BE, 2003, AM J PUBLIC HEALTH, V93, P1552, DOI 10.2105/AJPH.93.9.1552; Saelens BE, 2003, ANN BEHAV MED, V25, P80, DOI 10.1207/S15324796ABM2502_03; Schneider KL, 2015, MED SCI SPORT EXER, V47, P631, DOI 10.1249/MSS.0000000000000441; Schneider PL, 2004, MED SCI SPORT EXER, V36, P331, DOI 10.1249/01.MSS.0000113486.60548.E9; Schneider PL, 2003, MED SCI SPORT EXER, V35, P1779, DOI 10.1249/01.MSS.0000089342.96098.C4; Schondorf T, 2010, DIABETES VASC DIS RE, V7, P145, DOI 10.1177/1479164109358241; Statistics Canada, 2006, 2006 CAN CENS FIL; Strawbridge WJ, 2002, AM J EPIDEMIOL, V156, P328, DOI 10.1093/aje/kwf047; Taylor LM, 2008, ANN BEHAV MED, V35, P170, DOI 10.1007/s12160-008-9021-3; Thomas N, 2004, POSTGRAD MED J, V80, P287, DOI 10.1136/pgmj.2003.010553; Troped PJ, 2010, AM J PREV MED, V38, P429, DOI 10.1016/j.amepre.2009.12.032; Tudor-Locke C, 2004, ANN BEHAV MED, V28, P158, DOI 10.1207/s15324796abm2803_3; Tudor-Locke C, 2004, SPORTS MED, V34, P281, DOI 10.2165/00007256-200434050-00001; Tudor-Locke C, 2002, SPORTS MED, V32, P795, DOI 10.2165/00007256-200232120-00004; Tudor-Locke Catrine, 2005, Int J Behav Nutr Phys Act, V2, P5, DOI 10.1186/1479-5868-2-5; Tudor-Locke CE, 2002, DIABETES RES CLIN PR, V55, P191, DOI 10.1016/S0168-8227(01)00317-5; Van Dyck D, 2009, HEALTH PLACE, V15, P496, DOI 10.1016/j.healthplace.2008.08.010; Van Vrancken C, 2004, SOUTH MED J, V97, P141, DOI 10.1097/01.SMJ.0000091027.41012.05; Yates T, 2014, LANCET, V383, P1059, DOI 10.1016/S0140-6736(13)62061-9	68	16	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151544	10.1371/journal.pone.0151544	http://dx.doi.org/10.1371/journal.pone.0151544			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1ZE	26991308	Green Published, gold, Green Submitted			2022-12-26	WOS:000372582800073
J	Iwanowycz, S; Wang, JF; Altomare, D; Hui, Y; Fan, DP				Iwanowycz, Stephen; Wang, Junfeng; Altomare, Diego; Hui, Yvonne; Fan, Daping			Emodin Bidirectionally Modulates Macrophage Polarization and Epigenetically Regulates Macrophage Memory	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INFLAMMATORY RESPONSE; MOLECULAR-MECHANISM; TRAINED IMMUNITY; RAT MODEL; ACTIVATION; GAMMA; MONOCYTE; EXPRESSION; PROTEIN	Macrophages are pleiotropic cells capable of performing a broad spectrum of functions. Macrophage phenotypes are classified along a continuum between the extremes of proinflammatory M1 macrophages and anti-inflammatory M2 macrophages. The seemingly opposing functions of M1 and M2 macrophages must be tightly regulated for an effective and proper response to foreign molecules or damaged tissue. Excessive activation of either M1 or M2 macrophages contributes to the pathology of many diseases. Emodin is a Chinese herb-derived compound and has shown potential to inhibit inflammation in various settings. In this study, we tested the ability of emodin to modulate the macrophage response to both M1 and M2 stimuli. Primary mouse macrophages were stimulated with LPS/IFN gamma or IL4 with or without emodin, and the effects of emodin on gene transcription, cell signaling pathways, and histone modifications were examined by a variety of approaches, including microarray, quantitative real-time PCR, Western blotting, chromatin immunoprecipitation, and functional assays. We found that emodin bidirectionally tunes the induction of LPS/IFN gamma- and IL4-responsive genes through inhibiting NF kappa B/IRF5/STAT1 signaling and IRF4/STAT6 signaling, respectively. Thereby, emodin modulates macrophage phagocytosis, migration, and NO production. Furthermore, emodin inhibited the removal of H3K27 trimethylation (H3K27m3) marks and the addition of H3K27 acetylation (H3K27ac) marks on genes required for M1 or M2 polarization of macrophages. In conclusion, our data suggest that emodin is uniquely able to suppress the excessive response of macrophages to both M1 and M2 stimuli and therefore has the potential to restore macrophage homeostasis in various pathologies.	[Iwanowycz, Stephen; Wang, Junfeng; Hui, Yvonne; Fan, Daping] Univ S Carolina, Sch Med, Dept Cell Biol & Anat, 6439 Garners Ferry Rd,Bldg 1,C36, Columbia, SC 29209 USA; [Altomare, Diego] Univ S Carolina, South Carolina Coll Pharm, Dept Drug Discovery & Biomed Sci, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Medical University of South Carolina; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Fan, DP (corresponding author), Univ S Carolina, Sch Med, Dept Cell Biol & Anat, 6439 Garners Ferry Rd,Bldg 1,C36, Columbia, SC 29209 USA.	daping.fan@uscmed.sc.edu	Wang, Junfeng/AAJ-3248-2020		National Institutes of Health [HL116626, AT003961-8455]; National Center for Complementary & Integrative Health [P01AT003961] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116626] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL116626 and AT003961-8455. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Chang Y-C, 2011, EVID-BASED COMPL ALT, V2011; Chawla A, 2010, CIRC RES, V106, P1559, DOI 10.1161/CIRCRESAHA.110.216523; Chu X, 2012, FOOD CHEM TOXICOL, V50, P2368, DOI 10.1016/j.fct.2012.03.076; Deng H, 2013, J BIOL CHEM, V288, P3897, DOI 10.1074/jbc.M112.424390; El Chartouni C, 2010, IMMUNOBIOLOGY, V215, P821, DOI 10.1016/j.imbio.2010.05.031; Fu X, 2014, CLIN EXP PHARMACOL P, V41, P679, DOI 10.1111/1440-1681.12262; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gupta SC, 2014, ARCH BIOCHEM BIOPHYS, V559, P91, DOI 10.1016/j.abb.2014.06.006; Hermansson C, 2014, INT IMMUNOPHARMACOL, V22, P318, DOI 10.1016/j.intimp.2014.07.009; Ifrim DC, 2014, CLIN VACCINE IMMUNOL, V21, P534, DOI 10.1128/CVI.00688-13; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Ivashkiv LB, 2013, TRENDS IMMUNOL, V34, P216, DOI 10.1016/j.it.2012.11.001; Jia XM, 2014, BREAST CANCER RES TR, V148, P291, DOI 10.1007/s10549-014-3164-7; Jia XM, 2014, EXP BIOL MED, V239, P1025, DOI 10.1177/1535370214530247; Karsdal MA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3280; Komohara Y, 2014, CANCER SCI, V105, P1, DOI 10.1111/cas.12314; Kundu JK, 2008, MUTAT RES-REV MUTAT, V659, P15, DOI 10.1016/j.mrrev.2008.03.002; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Le KA, 2011, DIABETES, V60, P2802, DOI 10.2337/db10-1263; Li Y, 2015, IRAN J KIDNEY DIS, V9, P202; Liang QL, 2011, J BIOL CHEM, V286, P26470, DOI 10.1074/jbc.M111.227934; Lin SZ, 2010, CLIN EXP PHARMACOL P, V37, P790, DOI 10.1111/j.1440-1681.2010.05378.x; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Moberas J, 2009, EUR J IMMUNOL, V39, P691, DOI 10.1002/eji.200939262; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Muto A, 2007, MOL CANCER THER, V6, P987, DOI 10.1158/1535-7163.MCT-06-0605; Nahrendorf M, 2013, CIRC RES, V112, P1624, DOI 10.1161/CIRCRESAHA.113.300890; National Toxicology Program, 2001, Natl Toxicol Program Tech Rep Ser, V493, P1; Negishi H, 2005, P NATL ACAD SCI USA, V102, P15989, DOI 10.1073/pnas.0508327102; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Ni QQ, 2014, BIOMED REP, V2, P63, DOI 10.3892/br.2013.178; Ni QQ, 2014, MOL MED REP, V9, P355, DOI 10.3892/mmr.2013.1771; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Sandholt IS, 2009, ANTI-CANCER DRUG, V20, P238, DOI 10.1097/CAD.0b013e328326472e; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Shechter R, 2013, J PATHOL, V229, P332, DOI 10.1002/path.4106; Shehzad A, 2013, BIOFACTORS, V39, P69, DOI 10.1002/biof.1066; Shia CS, 2011, J ETHNOPHARMACOL, V137, P1388, DOI 10.1016/j.jep.2011.08.003; Shrimali D, 2013, CANCER LETT, V341, P139, DOI 10.1016/j.canlet.2013.08.023; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Srinivas G, 2007, MED RES REV, V27, P591, DOI 10.1002/med.20095; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Tomar S, 2016, HEAD NECK-J SCI SPEC, V38, pE694, DOI 10.1002/hed.24072; Tong HF, 2011, ANAT REC, V294, P445, DOI 10.1002/ar.21352; Wang B, 2015, J MATER CHEM B, V3, P3840, DOI 10.1039/c5tb00065c; Wang QX, 2011, INT IMMUNOPHARMACOL, V11, P373, DOI 10.1016/j.intimp.2010.11.018; Wang T, 2015, CHIN J INTEGR MED, V21, P431, DOI 10.1007/s11655-014-1898-z; Whyte CS, 2011, J LEUKOCYTE BIOL, V90, P845, DOI 10.1189/jlb.1110644; Wicks K, 2014, SEMIN IMMUNOL, V26, P341, DOI 10.1016/j.smim.2014.04.006; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xaus J, 1999, IMMUNITY, V11, P103, DOI 10.1016/S1074-7613(00)80085-0; Xiao M, 2014, INT J MOL SCI, V15, P19355, DOI 10.3390/ijms151119355; Xue JH, 2015, CELL PHYSIOL BIOCHEM, V35, P1557, DOI 10.1159/000373971; Xue J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8158; Yang ZT, 2014, INT IMMUNOPHARMACOL, V21, P354, DOI 10.1016/j.intimp.2014.05.019; Zheng Y, 2011, BLOOD, V118, P156, DOI 10.1182/blood-2010-01-266320; Zhou DX, 2014, CELL SIGNAL, V26, P192, DOI 10.1016/j.cellsig.2013.11.004	62	42	48	6	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11491	11503		10.1074/jbc.M115.702092	http://dx.doi.org/10.1074/jbc.M115.702092			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27008857	Green Published, hybrid			2022-12-26	WOS:000377264800003
J	Driskell, LO; Tucker, AM; Woodard, A; Wood, RR; Wood, DO				Driskell, Lonnie O.; Tucker, Aimee M.; Woodard, Andrew; Wood, Raphael R.; Wood, David O.			Fluorescence Activated Cell Sorting of Rickettsia prowazekii-Infected Host Cells Based on Bacterial Burden and Early Detection of Fluorescent Rickettsial Transformants	PLOS ONE			English	Article							MARINER-BASED TRANSPOSON; EPIDEMIC TYPHUS; FLYING SQUIRRELS; ACTIN POLYMERIZATION; UNITED-STATES; PLAQUE-ASSAY; MUTAGENESIS; PROTEIN; EXPRESSION; RESISTANCE	Rickettsia prowazekii, the causative agent of epidemic typhus, is an obligate intracellular bacterium that replicates only within the cytosol of a eukaryotic host cell. Despite the barriers to genetic manipulation that such a life style creates, rickettsial mutants have been generated by transposon insertion as well as by homologous recombination mechanisms. However, progress is hampered by the length of time required to identify and isolate R. prowazekii transformants. To reduce the time required and variability associated with propagation and harvesting of rickettsiae for each transformation experiment, characterized frozen stocks were used to generate electrocompetent rickettsiae. Transformation experiments employing these rickettsiae established that fluorescent rickettsial populations could be identified using a fluorescence activated cell sorter within one week following electroporation. Early detection was improved with increasing amounts of transforming DNA. In addition, we demonstrate that heterogeneous populations of rickettsiae-infected cells can be sorted into distinct sub-populations based on the number of rickettsiae per cell. Together our data suggest the combination of fluorescent reporters and cell sorting represent an important technical advance that will facilitate isolation of distinct R. prowazekii mutants and allow for closer examination of the effects of infection on host cells at various infectious burdens.	[Driskell, Lonnie O.; Tucker, Aimee M.; Woodard, Andrew; Wood, Raphael R.; Wood, David O.] Univ S Alabama, Coll Med, Dept Microbiol & Immunol, Mobile, AL 36688 USA	University of South Alabama	Wood, DO (corresponding author), Univ S Alabama, Coll Med, Dept Microbiol & Immunol, Mobile, AL 36688 USA.	dowood@southalabama.edu			National Institutes of Health, National Institute of Allergy and Infectious Diseases [1R21AI103272, 5R01AI020384]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI103272, R01AI020384] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health, National Institute of Allergy and Infectious Diseases (https://www.niaid.nih.gov/Pages/default.aspx) grants 1R21AI103272 and 5R01AI020384 to DOW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azad AF, 2003, ANN NY ACAD SCI, V990, P734, DOI 10.1111/j.1749-6632.2003.tb07452.x; Azad AF, 1998, EMERG INFECT DIS, V4, P179, DOI 10.3201/eid0402.980205; Baldridge GD, 2005, APPL ENVIRON MICROB, V71, P2095, DOI 10.1128/AEM.71.4.2095-2105.2005; Bechah Y, 2008, LANCET INFECT DIS, V8, P417, DOI 10.1016/S1473-3099(08)70150-6; BOZEMAN FM, 1975, NATURE, V255, P545, DOI 10.1038/255545a0; Burkhardt NY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029511; Chapman AS, 2009, EMERG INFECT DIS, V15, P1005, DOI 10.3201/eid1507.081305; Clark TR, 2011, J BACTERIOL, V193, P4993, DOI 10.1128/JB.05279-11; CORY J, 1974, APPL MICROBIOL, V27, P1157, DOI 10.1128/AEM.27.6.1157-1161.1974; Driskell LO, 2009, INFECT IMMUN, V77, P3244, DOI 10.1128/IAI.00395-09; Gillespie JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002018; Gillespie JJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000266; GIMENEZ DF, 1964, STAIN TECHNOL, V39, P135, DOI 10.3109/10520296409061219; Hackstadt T, 1996, INFECT AGENT DIS, V5, P127; HEINZEN RA, 1993, INFECT IMMUN, V61, P1926, DOI 10.1128/IAI.61.5.1926-1935.1993; Kleba B, 2010, INFECT IMMUN, V78, P2240, DOI 10.1128/IAI.00100-10; Liu ZM, 2007, APPL ENVIRON MICROB, V73, P6644, DOI 10.1128/AEM.01727-07; MCDADE JE, 1969, J BACTERIOL, V99, P910, DOI 10.1128/JB.99.3.910-912.1969; Noriea NF, 2015, MBIO, V6, DOI 10.1128/mBio.00323-15; Policastro PF, 1996, J CLIN MICROBIOL, V34, P1944, DOI 10.1128/JCM.34.8.1944-1948.1996; Prusinski MA, 2014, VECTOR-BORNE ZOONOT, V14, P240, DOI 10.1089/vbz.2013.1392; Qin AP, 2004, APPL ENVIRON MICROB, V70, P2816, DOI 10.1128/AEM.70.5.2816-2822.2004; Rachek LI, 1998, J BACTERIOL, V180, P2118, DOI 10.1128/JB.180.8.2118-2124.1998; Rachek LI, 2000, J BACTERIOL, V182, P3289, DOI 10.1128/JB.182.11.3289-3291.2000; Raoult D, 1997, EMERG INFECT DIS, V3, P357, DOI 10.3201/eid0303.970313; Renesto P, 2002, MICROB PATHOGENESIS, V33, P17, DOI 10.1006/mpat.2002.0508; Reynolds MG, 2003, EMERG INFECT DIS, V9, P1341; SILVERMAN DJ, 1986, ANN INST PASTEUR MIC, V137A, P336, DOI 10.1016/S0769-2609(86)80045-X; SILVERMAN DJ, 1984, INFECT IMMUN, V44, P545, DOI 10.1128/IAI.44.3.545-553.1984; TEYSSEIRE N, 1992, RES MICROBIOL, V143, P821, DOI 10.1016/0923-2508(92)90069-Z; Troyer JM, 1999, INFECT IMMUN, V67, P3308, DOI 10.1128/IAI.67.7.3308-3311.1999; Walker DH, 2009, VACCINE, V27, pD52, DOI 10.1016/j.vaccine.2009.07.045; WINKLER HH, 1976, J BIOL CHEM, V251, P389; WINKLER HH, 1990, ANNU REV MICROBIOL, V44, P131, DOI 10.1146/annurev.mi.44.100190.001023; Wood DO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034715	35	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152365	10.1371/journal.pone.0152365	http://dx.doi.org/10.1371/journal.pone.0152365			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010457	Green Published, Green Submitted, gold			2022-12-26	WOS:000372708000138
J	Jeong, J; Kim, YJ; Yoon, SY; Kim, YJ; Kim, JH; Sohn, KY; Kim, HJ; Han, YH; Chong, S; Kim, JW				Jeong, Jinseon; Kim, Young-Jun; Yoon, Sun Young; Kim, Yong-Jae; Kim, Joo Heon; Sohn, Ki-Young; Kim, Heung-Jae; Han, Yong-Hae; Chong, Saeho; Kim, Jae Wha			PLAG (1-Palmitoyl-2-Linoleoyl-3-Acetyl-rac-Glycerol) Modulates Eosinophil Chemotaxis by Regulating CCL26 Expression from Epithelial Cells	PLOS ONE			English	Article							HUMAN DERMAL FIBROBLASTS; AIRWAY INFLAMMATION; GROWTH-FACTOR; EOTAXIN-3 SECRETION; ASTHMA; STAT6; LUNG; ACTIVATION; INTERLEUKIN-13; IDENTIFICATION	Increased number of eosinophils in the circulation and sputum is associated with the severity of asthma. The respiratory epithelium produces chemokine (C-C motif) ligands (CCL) which recruits and activates eosinophils. A chemically synthesized monoacetyl-diglyceride, PLAG (1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol) is a major constituent in the antlers of Sika deer (Cervus nippon Temminck) which has been used in oriental medicine. This study was aimed to investigate the molecular mechanism of PLAG effect on the alleviation of asthma phenotypes. A549, a human alveolar basal epithelial cell, and HaCaT, a human keratinocyte, were activated by the treatment of interleukin-4 (IL-4), and the expression of chemokines, known to be effective on the induction of eosinophil migration was analyzed by RT-PCR. The expression of IL-4 induced genes was modulated by the co-treatment of PLAG. Especially, CCL26 expression from the stimulated epithelial cells was significantly blocked by PLAG, which was confirmed by ELISA. The transcriptional activity of signal transducer and activator of transcription 6 (STAT6), activated by IL-4 mediated phosphorylation and nuclear translocation, was down-regulated by PLAG in a concentration-dependent manner. In ovalbumin-induced mouse model, the infiltration of immune cells into the respiratory tract was decreased by PLAG administration. Cytological analysis of the isolated bronchoalveolar lavage fluid (BALF) cells proved the infiltration of eosinophils was significantly reduced by PLAG. In addition, PLAG inhibited the migration of murine bone marrow-derived eosinophils, and human eosinophil cell line, EoL-1, which was induced by the addition of A549 culture medium.	[Jeong, Jinseon; Kim, Young-Jun; Kim, Yong-Jae; Kim, Jae Wha] Korea Res Inst Biosci & Biotechnol, Biomed Translat Res Ctr, Daejeon 305806, South Korea; [Jeong, Jinseon; Kim, Jae Wha] Univ Sci & Technol, Dept Funct Genom, Daejeon 305806, South Korea; [Yoon, Sun Young; Sohn, Ki-Young; Kim, Heung-Jae; Han, Yong-Hae; Chong, Saeho] KAIST ICC, ENZYCHEM Lifesci, Daejeon 305732, South Korea; [Kim, Joo Heon] Eulji Univ, Sch Med, Dept Pathol, Daejeon 302120, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Eulji University	Kim, JW (corresponding author), Korea Res Inst Biosci & Biotechnol, Biomed Translat Res Ctr, Daejeon 305806, South Korea.; Kim, JW (corresponding author), Univ Sci & Technol, Dept Funct Genom, Daejeon 305806, South Korea.	wjkim@kribb.re.kr		Kim, Jae Wha/0000-0002-1507-2731	KRIBB Research Initiative Program from Korea Research Institute of Bioscience and Biotechnology [KGM4701511, KGM5251611]; University of Science and Technology [KFM0191511]; ENZYCHEM Lifesciences [IGM0161411, IGM0081511]; KRIBB Research Initiative Program by University of Science and Technology [KGM4701511, KGM5251611]; Contract Based Department Program by University of Science and Technology [KFM0191511]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081511] Funding Source: NIH RePORTER	KRIBB Research Initiative Program from Korea Research Institute of Bioscience and Biotechnology; University of Science and Technology; ENZYCHEM Lifesciences; KRIBB Research Initiative Program by University of Science and Technology; Contract Based Department Program by University of Science and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	1. KRIBB Research Initiative Program (KGM4701511 and KGM5251611) from Korea Research Institute of Bioscience and Biotechnology, http://www.kribb.re.kr. The funder provided support in the form of a research grant for JWK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. 2. Contract Based Department Program (KFM0191511) from University of Science and Technology, http://www.ust.ac.kr. The funder provided support in the form of research grant for JWK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. 3. Grants (IGM0161411 and IGM0081511) from ENZYCHEM Lifesciences, http://www.enzychem.com. The funder provided support in the form of salaries for authors [SYY, KYS, HJK, YHH, SC], and research grant for JWK but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. 4. Enzychem Lifesciences has supplied PLAG. The funder provided research material (PLAG), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This study was supported by the KRIBB Research Initiative Programs (KGM4701511 and KGM5251611), Contract Based Department Program (KFM0191511) by University of Science and Technology, and a grant (IGM0161411 and IGM0081511) from ENZYCHEM Lifesciences.	Banwell ME, 2002, CYTOKINE, V17, P317, DOI 10.1006/cyto.2002.1021; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Bel EH, 2004, CURR OPIN PULM MED, V10, P44, DOI 10.1097/00063198-200401000-00008; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Chae SC, 2004, BIOCHEM BIOPH RES CO, V320, P131, DOI 10.1016/j.bbrc.2004.05.136; Dulkys Y, 2001, J INVEST DERMATOL, V116, P498, DOI 10.1046/j.1523-1747.2001.01299.x; Duvernelle C, 2003, PULM PHARMACOL THER, V16, P181, DOI 10.1016/S1094-5539(03)00051-8; Egesten A, 1996, BLOOD, V87, P3910, DOI 10.1182/blood.V87.9.3910.bloodjournal8793910; GarciaZepeda EA, 1996, J IMMUNOL, V157, P5613; Hoeck J, 2001, J IMMUNOL, V167, P3216, DOI 10.4049/jimmunol.167.6.3216; Hoshino A, 2004, INT IMMUNOL, V16, P1497, DOI 10.1093/intimm/dxh151; Hoshino M, 2001, J ALLERGY CLIN IMMUN, V107, P295, DOI 10.1067/mai.2001.111928; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Kagami S, 2005, CLIN EXP IMMUNOL, V141, P459, DOI 10.1111/j.1365-2249.2005.02875.x; Kay AB, 2004, TRENDS IMMUNOL, V25, P477, DOI 10.1016/j.it.2004.07.006; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Larose MC, 2015, J ALLERGY CLIN IMMUN, V136, P904, DOI 10.1016/j.jaci.2015.02.039; Lezcano-Meza D, 2003, ALLERGY, V58, P1011, DOI 10.1034/j.1398-9995.2003.00174.x; Lovett CJ, 2007, CLIN EXP ALLERGY, V37, P1594, DOI 10.1111/j.1365-2222.2007.02839.x; Matsukura S, 1999, J IMMUNOL, V163, P6876; Moghadam-Kia S, 2010, INT J DERMATOL, V49, P239, DOI 10.1111/j.1365-4632.2009.04322.x; Nakayama T, 2010, J IMMUNOL, V185, P6472, DOI 10.4049/jimmunol.0904126; OPDENAKKER G, 1993, BIOCHEM BIOPH RES CO, V191, P535, DOI 10.1006/bbrc.1993.1251; Pope SM, 2005, J BIOL CHEM, V280, P13952, DOI 10.1074/jbc.M406037200; ROBINSON DS, 1992, NEW ENGL J MED, V326, P298, DOI 10.1056/NEJM199201303260504; Rokudai A, 2006, BIOL PHARM BULL, V29, P1102, DOI 10.1248/bpb.29.1102; Shang XZ, 2002, AM J PATHOL, V161, P257, DOI 10.1016/S0002-9440(10)64177-6; Shin IS, 2014, INT IMMUNOPHARMACOL, V18, P116, DOI 10.1016/j.intimp.2013.11.006; Stokes K, 2015, J IMMUNOL, V194, P2477, DOI 10.4049/jimmunol.1402096; Venge J, 1996, J ALLERGY CLIN IMMUN, V97, P1110, DOI 10.1016/S0091-6749(96)70265-8; Wang J, 2015, IMMUNOL LETT, V163, P173, DOI 10.1016/j.imlet.2014.12.002; Wang Y, 2012, J NUTR BIOCHEM, V23, P602, DOI 10.1016/j.jnutbio.2011.03.003; Yang HO, 2004, BIOL PHARM BULL, V27, P1121, DOI 10.1248/bpb.27.1121; Yoon SY, 2015, IMMUNE NETW, V15, P100, DOI 10.4110/in.2015.15.2.100; Yoshihisa Y, 2011, J INVEST DERMATOL, V131, P925, DOI 10.1038/jid.2010.418; Yuan Q, 2006, EUR J IMMUNOL, V36, P2700, DOI 10.1002/eji.200636112; Zhou L, 2012, BIOORGAN MED CHEM, V20, P750, DOI 10.1016/j.bmc.2011.12.006; Zhou XX, 2012, J IMMUNOL, V188, P6046, DOI 10.4049/jimmunol.1102760	38	16	17	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151758	10.1371/journal.pone.0151758	http://dx.doi.org/10.1371/journal.pone.0151758			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010397	Green Submitted, gold, Green Published			2022-12-26	WOS:000372708000041
J	Kuan, KB; Othman, R; Rahim, KA; Shamsuddin, ZH				Kuan, Khing Boon; Othman, Radziah; Rahim, Khairuddin Abdul; Shamsuddin, Zulkifli H.			Plant Growth-Promoting Rhizobacteria Inoculation to Enhance Vegetative Growth, Nitrogen Fixation and Nitrogen Remobilisation of Maize under Greenhouse Conditions	PLOS ONE			English	Article							WHEAT TRITICUM-AESTIVUM; N-15 ISOTOPE-DILUTION; ZEA-MAYS L.; IDENTIFICATION; RHIZOBIUM; PROSPECTS; BACTERIA	Plant growth-promoting rhizobacteria (PGPR) may provide a biological alternative to fix atmospheric N-2 and delay N remobilisation in maize plant to increase crop yield, based on an understanding that plant-N remobilisation is directly correlated to its plant senescence. Thus, four PGPR strains were selected from a series of bacterial strains isolated from maize roots at two locations in Malaysia. The PGPR strains were screened in vitro for their biochemical plant growth-promoting (PGP) abilities and plant growth promotion assays. These strains were identified as Klebsiella sp. Br1, Klebsiella pneumoniae Fr1, Bacillus pumilus S1r1 and Acinetobacter sp. S3r2 and a reference strain used was Bacillus subtilis UPMB10. All the PGPR strains were tested positive for N-2 fixation, phosphate solubilisation and auxin production by in vitro tests. In a greenhouse experiment with reduced fertiliser-N input (a third of recommended fertiliser-N rate), the N-2 fixation abilities of PGPR in association with maize were determined by N-15 isotope dilution technique at two harvests, namely, prior to anthesis (D-50) and ear harvest (D-65). The results indicated that dry biomass of top, root and ear, total N content and bacterial colonisations in non-rhizosphere, rhizosphere and endosphere of maize roots were influenced by PGPR inoculation. In particular, the plants inoculated with B. pumilus S1r1 generally outperformed those with the other treatments. They produced the highest N-2 fixing capacity of 30.5% (262 mg N-2 fixed plant(-1)) and 25.5% (304 mg N-2 fixed plant(-1)) of the total N requirement of maize top at D-50 and D-65, respectively. N remobilisation and plant senescence in maize were delayed by PGPR inoculation, which is an indicative of greater grain production. This is indicated by significant interactions between PGPR strains and time of harvests for parameters on N uptake and at. % N-15(e) of tassel. The phenomenon is also supported by the lower N content in tassels of maize treated with PGPR, namely, B. pumilus S1r1, K. pneumoniae Fr1, B. subtilis UPMB10 and Acinetobacter sp. S3r2 at D-65 harvest. This study provides evidence that PGPR inoculation, namely, B. pumilus S1r1 can biologically fix atmospheric N-2 and provide an alternative technique, besides plant breeding, to delay N remobilisation in maize plant for higher ear yield (up to 30.9%) with reduced fertiliser-N input.	[Kuan, Khing Boon; Othman, Radziah; Shamsuddin, Zulkifli H.] Univ Putra Malaysia, Fac Agr, Dept Land Management, Serdang 43400, Selangor, Malaysia; [Rahim, Khairuddin Abdul] Agensi Nuklear Malaysia, Agrotechnol & Biosci Div, Bangi, Selangor, Malaysia	Universiti Putra Malaysia; Agensi Nuklear Malaysia	Kuan, KB (corresponding author), Univ Putra Malaysia, Fac Agr, Dept Land Management, Serdang 43400, Selangor, Malaysia.	kbkuan@hotmail.com; zulsham@upm.edu.my			Ministry of Education Malaysia; Universiti Putra Malaysia	Ministry of Education Malaysia(Ministry of Education, Malaysia); Universiti Putra Malaysia	K.B. Kuan was supported by the MyBrain15 and Graduate Research Fellowship scholarships from the Ministry of Education Malaysia and Universiti Putra Malaysia, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda L, 2013, APPL SOIL ECOL, V63, P15, DOI 10.1016/j.apsoil.2012.09.001; BALDANI VLD, 1980, SOIL BIOL BIOCHEM, V12, P433, DOI 10.1016/0038-0717(80)90021-8; Barker AV, 2007, HDB PLANT NUTR, P21; Benizri E, 2001, BIOCONTROL SCI TECHN, V11, P557, DOI 10.1080/09583150120076120; BODDEY RM, 1987, CRC CR REV PLANT SCI, V6, P209, DOI 10.1080/07352688709382251; BODDEY RM, 1995, PLANT SOIL, V174, P195, DOI 10.1007/BF00032247; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; Bremner J. M., 1996, Methods of soil analysis. Part 3 - chemical methods., P1085; Burgmann H, 2005, ENVIRON MICROBIOL, V7, P1711, DOI 10.1111/j.1462-2920.2005.00818.x; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; CLIQUET JB, 1990, PLANT PHYSIOL, V92, P79, DOI 10.1104/pp.92.1.79; CLIQUET JB, 1990, PLANT PHYSIOL, V94, P1547, DOI 10.1104/pp.94.4.1547; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; DANSO SKA, 1993, PLANT SOIL, V152, P25, DOI 10.1007/BF00016331; Diaz C, 2008, PLANT PHYSIOL, V147, P1437, DOI 10.1104/pp.108.119040; Dierolf T, 2001, SOIL FERTILITY KIT T; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Egamberdiyeva D, 2007, APPL SOIL ECOL, V36, P184, DOI 10.1016/j.apsoil.2007.02.005; Gallais A, 2007, CROP SCI, V47, P685, DOI 10.2135/cropsci2006.08.0523; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; HOBEN HJ, 1982, APPL ENVIRON MICROB, V44, P1246, DOI 10.1128/AEM.44.5.1246-1247.1982; Hodge A, 2000, TRENDS PLANT SCI, V5, P304, DOI 10.1016/S1360-1385(00)01656-3; International Atomic Energy Agency (IAEA), 2001, IAEATCS14; James EK, 2000, FIELD CROP RES, V65, P197, DOI 10.1016/S0378-4290(99)00087-8; Kichey T, 2007, FIELD CROP RES, V102, P22, DOI 10.1016/j.fcr.2007.01.002; Koh MC, 1998, MEAT SCI, V48, P275, DOI 10.1016/S0309-1740(97)00104-6; Lugtenberg B, 2009, ANNU REV MICROBIOL, V63, P541, DOI 10.1146/annurev.micro.62.081307.162918; Maathuis Frans J M, 2009, Curr Opin Plant Biol, V12, P250, DOI 10.1016/j.pbi.2009.04.003; Malaysian Agricultural Research and Development Institute (MARDI), 2006, ANGG KOS PENG PEND B; Masclaux-Daubresse C, 2008, PLANT BIOLOGY, V10, P23, DOI 10.1111/j.1438-8677.2008.00097.x; Masclaux-Daubresse C, 2010, ANN BOT-LONDON, V105, P1141, DOI 10.1093/aob/mcq028; Matiru V. N., 2004, African Journal of Biotechnology, V3, P1; McLean E., 1983, METHODS SOIL ANAL PA, V9, P199, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C12; Mehnaz S, 2010, SOIL BIOL BIOCHEM, V42, P1848, DOI 10.1016/j.soilbio.2010.07.003; Ministry of Agriculture and Agro-Based Industry Malaysia, 2014, AGR STAT 2013; Montanez A, 2009, BIOL FERT SOILS, V45, P253, DOI 10.1007/s00374-008-0322-2; Nor HMS, 2012, B TEKNOLOGI MARDI; PIKOVSKAIA R. I., 1948, Mikrobiologiya, V17, P362; Piromyou P, 2011, EUR J SOIL BIOL, V47, P44, DOI 10.1016/j.ejsobi.2010.11.004; Richards LA, 1943, SOIL SCI, V56, P395, DOI 10.1097/00010694-194312000-00001; Sachdev DP, 2009, INDIAN J EXP BIOL, V47, P993; Salon C, 2001, AGRONOMIE, V21, P539, DOI 10.1051/agro:2001143; Schroder JJ, 2000, FIELD CROP RES, V66, P151, DOI 10.1016/S0378-4290(00)00072-1; Shamsuddin ZH, 1995, P 18 MICR MAL SOC MI, P1; Song OR, 2008, BRAZ J MICROBIOL, V39, P151, DOI 10.1590/S1517-838220080001000030; Steel R. G. D., 1980, Principles and procedures of statistics, a biometrical approach.; TA CT, 1992, CROP SCI, V32, P443, DOI 10.2135/cropsci1992.0011183X003200020032x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMAS H, 1993, ANN APPL BIOL, V123, P193, DOI 10.1111/j.1744-7348.1993.tb04086.x; UHART SA, 1995, CROP SCI, V35, P1376, DOI [10.2135/cropsci1995.0011183X003500050020x, 10.2135/cropsci1995.0011183X003500010034x, 10.2135/cropsci1995.0011183X003500050021x]; Wang BX, 2015, BIOMASS BIOENERG, V83, P493, DOI 10.1016/j.biombioe.2015.10.029; Wang DL, 1998, COMMUN SOIL SCI PLAN, V29, P15, DOI 10.1080/00103629809369925; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wu SC, 2005, GEODERMA, V125, P155, DOI 10.1016/j.geoderma.2004.07.003; Yadav J, 2014, EUR J SOIL BIOL, V63, P70, DOI 10.1016/j.ejsobi.2014.05.001; Zakry FAA, 2012, MICROBES ENVIRON, V27, P257, DOI 10.1264/jsme2.ME11309	57	172	185	17	138	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152478	10.1371/journal.pone.0152478	http://dx.doi.org/10.1371/journal.pone.0152478			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27011317	gold, Green Published, Green Submitted			2022-12-26	WOS:000372708000146
J	Li, XH; He, F; Gabelt, BT; Wang, Y; Cai, SP; Cao, JH; Fan, N; Kaufman, PL; Liu, XY				Li, Xiaohong; He, Fen; Gabelt, B'Ann T.; Wang, Yun; Cai, Suping; Cao, Juanhui; Fan, Ning; Kaufman, Paul L.; Liu, Xuyang			Effects of Latanoprost and Bimatoprost on the Expression of Molecules Relevant to Ocular Inflow and Outflow Pathways	PLOS ONE			English	Article							HUMAN CILIARY MUSCLE; OPEN-ANGLE GLAUCOMA; TRABECULAR MESHWORK CELLS; NF-KAPPA-B; INTRAOCULAR-PRESSURE; MATRIX METALLOPROTEINASES; PROSTAGLANDIN ANALOGS; HUMAN EYES; EXTRACELLULAR-MATRIX; CORPUS-LUTEUM	Background and Purpose The intraocular pressure (IOP)-lowering and side effects in response to different prostaglandin F-2 alpha analogues can be variable, but, the underlying basis for this difference remains unknown. This study investigated the differential changes of cellular proteins relevant to IOP-lowering effects of latanoprost and bimatoprost. Methods The human T lymphoblast (MOLT-3) cell line and immortalized human trabecular meshwork (iHTM) cells were studied by quantitative PCR and by immunofluorescence after treatment with either latanoprost or bimatoprost. New Zealand white rabbit eyes were treated topically with each agent and, following euthanasia, anterior segment tissues were studied with immunostaining. Results In cultured MOLT-3 cells, mRNA expression of both c-fos and matrix metalloproteinase 9 increased significantly in response to each agent. In addition, there was little change in tissue inhibitor of metalloproteinase (TIMP)-3 mRNA, but a significant decrease in TIMP-4. Fibronectin mRNA in MOLT-3 cells was down-regulated with bimatoprost, but was up-regulated with latanoprost. Immunofluorescence analysis of iHTM cells showed that intracellular fibronectin was significantly decreased by bimatoprost, but was increased by latanoprost. Both latanoprost and bimatoprost increased mRNA expression of NF-kappa B p65 and decreased that of I kappa B alpha. Aquaporin-1 mRNA expression was significantly down-regulated by bimatoprost. Immunostaining also revealed a significant decrease of aquaporin-1 in the ciliary epithelium of New Zealand white rabbits after bimatoprost treatment. Conclusions Similarities in protein expression produced by latanoprost and bimatoprost in vitro may be relevant to the mechanism for their IOP-lowering effects in vivo. Differences in fibronectin expression and in aquaporin-1 expression in response to each agent may contribute to variability in the IOP-lowering efficacy in some studies.	[Li, Xiaohong] Sichuan Univ, West China Sch Pharm, Minist Educ, Dept Biopharmaceut,Key Lab Drug Targeting & Drug, Chengdu 610064, Peoples R China; [He, Fen] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610064, Peoples R China; [Gabelt, B'Ann T.; Kaufman, Paul L.] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Wang, Yun; Cai, Suping; Cao, Juanhui; Fan, Ning; Liu, Xuyang] Shenzhen Univ, Shenzhen Eye Hosp, Shenzhen Key Lab Ophthalmol, Shenzhen, Peoples R China	Sichuan University; Sichuan University; University of Wisconsin System; University of Wisconsin Madison; Shenzhen University	Liu, XY (corresponding author), Shenzhen Univ, Shenzhen Eye Hosp, Shenzhen Key Lab Ophthalmol, Shenzhen, Peoples R China.	xliu1213@126.com			National Natural Science Foundation of China [NSFC 81270995, 81170851]; Research to Prevent Blindness, Inc, New York, NY; Ocular Physiology Research and Education Foundation, Madison, WI; NATIONAL EYE INSTITUTE [P30EY016665] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research to Prevent Blindness, Inc, New York, NY(Research to Prevent Blindness (RPB)); Ocular Physiology Research and Education Foundation, Madison, WI; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the National Natural Science Foundation of China (NSFC 81270995, 81170851); Research to Prevent Blindness, Inc, New York, NY; Ocular Physiology Research and Education Foundation, Madison, WI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CL, 2002, ANN PHARMACOTHER, V36, P504, DOI 10.1345/aph.1A178; ALEXANDER JP, 1991, INVEST OPHTH VIS SCI, V32, P172; Aung T, 2001, AM J OPHTHALMOL, V131, P636, DOI 10.1016/S0002-9394(00)00943-0; BABIZHAYEV MA, 1989, MECH AGEING DEV, V47, P145, DOI 10.1016/0047-6374(89)90017-1; BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141; Bahler CK, 2008, AM J OPHTHALMOL, V145, P114, DOI 10.1016/j.ajo.2007.09.001; Bradley JMB, 2003, INVEST OPHTH VIS SCI, V44, P5174, DOI 10.1167/iovs.03-0213; Bradley JMB, 1998, INVEST OPHTH VIS SCI, V39, P2649; Brubaker RF, 2001, AM J OPHTHALMOL, V131, P19, DOI 10.1016/S0002-9394(00)00843-6; Cai SP, 2013, MED HYPOTHESES, V80, P32, DOI 10.1016/j.mehy.2012.09.024; Calera MR, 2009, INVEST OPHTH VIS SCI, V50, P2185, DOI 10.1167/iovs.08-2962; Chase AJ, 2002, ARTERIOSCL THROM VAS, V22, P765, DOI 10.1161/01.ATV.0000015078.09208.92; Chen J, 2009, CURR EYE RES, V34, P184, DOI 10.1080/02713680802669781; Cheng JW, 2008, CLIN THER, V30, P622, DOI 10.1016/j.clinthera.2008.04.006; Christiansen GA, 2004, OPHTHALMOLOGY, V111, P1658, DOI 10.1016/j.ophtha.2004.02.006; FLOYD BB, 1985, INVEST OPHTH VIS SCI, V26, P797; Gandolfi SA, 2003, OPHTHALMOLOGY, V110, P609, DOI 10.1016/S0161-6420(02)01891-2; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Guenoun JM, 2005, INVEST OPHTH VIS SCI, V46, P4594, DOI 10.1167/iovs.05-0776; Hamann S, 1998, AM J PHYSIOL-CELL PH, V274, pC1332, DOI 10.1152/ajpcell.1998.274.5.C1332; Lan YQ, 2009, MOL VIS, V15, P1977; Levin MH, 2006, J MEMBRANE BIOL, V210, P105, DOI 10.1007/s00232-005-0849-1; Li XH, 2011, J OCUL PHARMACOL TH, V27, P519, DOI 10.1089/jop.2011.0036; Li XH, 2011, CURR EYE RES, V36, P680, DOI 10.3109/02713683.2011.566979; LINDSEY JD, 1994, INVEST OPHTH VIS SCI, V35, P242; Noecker RS, 2003, AM J OPHTHALMOL, V135, P55, DOI 10.1016/S0002-9394(02)01827-5; Ocklind A, 1998, EXP EYE RES, V67, P179, DOI 10.1006/exer.1998.0508; Oh DJ, 2006, INVEST OPHTH VIS SCI, V47, P953, DOI 10.1167/iovs.05-0516; Ota T, 2005, INVEST OPHTH VIS SCI, V46, P4159, DOI 10.1167/iovs.05-0494; POLANSKY JR, 1979, INVEST OPHTH VIS SCI, V18, P1043; Scherer WJ, 2002, J OCUL PHARMACOL TH, V18, P287, DOI 10.1089/108076802760116205; Shirasuna K, 2007, J REPROD DEVELOP, V53, P1319, DOI 10.1262/jrd.19082; Simmons ST, 2004, ADV THER, V21, P247, DOI 10.1007/BF02850157; Sjoquist B, 2002, SURV OPHTHALMOL, V47, pS6, DOI 10.1016/S0039-6257(02)00302-8; Stamer WD, 2008, EXP EYE RES, V87, P349, DOI 10.1016/j.exer.2008.06.018; Tang-liu DD, 2002, ARV ANN M ABSTR SEAR; Taniguchi K, 2010, REPRODUCTION, V140, P885, DOI 10.1530/REP-10-0240; Toris CB, 2008, SURV OPHTHALMOL, V53, pS107, DOI 10.1016/j.survophthal.2008.08.010; Toris CB, 1997, SURV OPHTHALMOL, V41, pS69, DOI 10.1016/S0039-6257(97)80010-0; Ueda J, 2002, INVEST OPHTH VIS SCI, V43, P1068; van der Valk R, 2009, J CLIN EPIDEMIOL, V62, P1279, DOI 10.1016/j.jclinepi.2008.04.012; Verkman AS, 2003, EXP EYE RES, V76, P137, DOI 10.1016/S0014-4835(02)00303-2; Wan Z, 2007, INVEST OPHTH VIS SCI, V48, P4107, DOI 10.1167/iovs.07-0080; WEINREB RN, 1983, INVEST OPHTH VIS SCI, V24, P1541; Weinreb RN, 2004, INVEST OPHTH VIS SCI, V45, P4368, DOI 10.1167/iovs.04-0413; Weinreb RN, 2002, INVEST OPHTH VIS SCI, V43, P716; Weinreb RN, 2002, SURV OPHTHALMOL, V47, pS53, DOI 10.1016/S0039-6257(02)00306-5; Weinreb RN, 1997, INVEST OPHTH VIS SCI, V38, P2772; Woodward DF, 2010, J OPHTHALMOL, V2010, DOI 10.1155/2010/926192; Yu AL, 2008, INVEST OPHTH VIS SCI, V49, P4872, DOI 10.1167/iovs.07-0984; Yu Man, 2009, BMJ Case Rep, V2009, DOI 10.1136/bcr.08.2008.0618; Yurko-Mauro KA, 1998, AM J PHYSIOL-CELL PH, V275, pC653, DOI 10.1152/ajpcell.1998.275.3.C653; Zhang D, 2002, J GEN PHYSIOL, V119, P561, DOI 10.1085/jgp.20028597; Zhao XJ, 2003, INVEST OPHTH VIS SCI, V44, P1945, DOI 10.1167/iovs.02-0920	54	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151644	10.1371/journal.pone.0151644	http://dx.doi.org/10.1371/journal.pone.0151644			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27011234	Green Submitted, gold, Green Published			2022-12-26	WOS:000372708000037
J	Meng, QC; Rong, XX; Zhang, YM; Wan, XL; Liu, YY; Wang, YZ				Meng, Qing-chun; Rong, Xiao-xia; Zhang, Yi-min; Wan, Xiao-le; Liu, Yuan-yuan; Wang, Yu-zhi			Collaborative Emission Reduction Model Based on Multi-Objective Optimization for Greenhouse Gases and Air Pollutants	PLOS ONE			English	Article								CO2 emission influences not only global climate change but also international economic and political situations. Thus, reducing the emission of CO2, a major greenhouse gas, has become a major issue in China and around the world as regards preserving the environmental ecology. Energy consumption from coal, oil, and natural gas is primarily responsible for the production of greenhouse gases and air pollutants such as SO2 and NOX, which are the main air pollutants in China. In this study, a mathematical multi-objective optimization method was adopted to analyze the collaborative emission reduction of three kinds of gases on the basis of their common restraints in different ways of energy consumption to develop an economic, clean, and efficient scheme for energy distribution. The first part introduces the background research, the collaborative emission reduction for three kinds of gases, the multi-objective optimization, the main mathematical modeling, and the optimization method. The second part discusses the four mathematical tools utilized in this study, which include the Granger causality test to analyze the causality between air quality and pollutant emission, a function analysis to determine the quantitative relation between energy consumption and pollutant emission, a multi-objective optimization to set up the collaborative optimization model that considers energy consumption, and an optimality condition analysis for the multi-objective optimization model to design the optimal-pole algorithm and obtain an efficient collaborative reduction scheme. In the empirical analysis, the data of pollutant emission and final consumption of energies of Tianjin in 1996-2012 was employed to verify the effectiveness of the model and analyze the efficient solution and the corresponding dominant set. In the last part, several suggestions for collaborative reduction are recommended and the drawn conclusions are stated.	[Meng, Qing-chun; Wan, Xiao-le] Shandong Univ, Sch Management, Jinan 250100, Shandong, Peoples R China; [Rong, Xiao-xia] Shandong Univ, Sch Math, Jinan 250100, Shandong, Peoples R China; [Zhang, Yi-min] China Bohai Bank Co Ltd, Tianjin 300204, Peoples R China; [Liu, Yuan-yuan; Wang, Yu-zhi] Shandong Univ, Inst Ecol & Biodivers, Sch Life Sci, Jinan 250100, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Wang, YZ (corresponding author), Shandong Univ, Inst Ecol & Biodivers, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.	wangyuzhi2015@hotmail.com	liu, yuanyuan/GWZ-5838-2022	Wan, Xiao-le/0000-0001-6990-0451	Fundamental Research Funds of Shandong University [2014QY001-05]; National Nature Science Foundation of China (NSFC) [71572096]; China Bohai Bank Co., Ltd.	Fundamental Research Funds of Shandong University; National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); China Bohai Bank Co., Ltd.	This paper is supported by Fundamental Research Funds of Shandong University (Grant no. 2014QY001-05) and National Nature Science Foundation of China (NSFC) (Grant no. 71572096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. China Bohai Bank Co., Ltd. provided support in the form of salaries for authors [Yi-min Zhang], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Antipova E, 2013, ENERGY, V51, P50, DOI 10.1016/j.energy.2013.01.001; Balaman SY, 2014, ENERGY, V74, P928, DOI 10.1016/j.energy.2014.07.073; Bollen J, 2009, RESOUR ENERGY ECON, V31, P161, DOI 10.1016/j.reseneeco.2009.03.001; Filipic B, 2007, INFORM-J COMPUT INFO, V31, P233; Flegiel F, 2015, MATER MANUF PROCESS, V30, P444, DOI 10.1080/10426914.2014.967355; GRANGER CWJ, 1969, ECONOMETRICA, V37, P424, DOI 10.2307/1912791; Hwang C.-L., 1979, MULTIPLE OBJECTIVE D, V164, P21, DOI 10.1007/978-3-642-45511-7_3; IPCC Climate Change, 2022, CLIMATE CHANGE 2022; Johnsen E, 1968, STUDIES MULTIOBJECTI; Koopmans T.C., 1951, ACTIVITY ANAL PRODUC, P33; Kuhn H. W., 1951, P 2 BERK S MATH STAT, P481, DOI DOI 10.1007/BF01582292; [刘胜强 Liu Shengqiang], 2012, [环境科学与技术, Enuivonmental Science and Technology], V35, P168; Luque M, 2015, EXPERT SYST APPL, V42, P2205, DOI 10.1016/j.eswa.2014.10.028; Mao Xian-giang, 2012, China Environmental Science, V32, P748; Qin XL, 2012, THESIS S CHINA U TEC; Rafaj P, 2013, MITIG ADAPT STRAT GL, V18, P801, DOI 10.1007/s11027-012-9390-6; State Statistics Bureau, 2013, CHIN EN STAT YB 2013; Sun RQ, 2003, ENERGY CHINA, V7, P25; Xu CH, 2013, STAT DECISION, V4, P63; Xu GH, 1999, FUNDAMENTAL OPERATIN, P268; Yue CHY, 2003, DECISION MAKING THEO, P151	21	5	5	8	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152057	10.1371/journal.pone.0152057	http://dx.doi.org/10.1371/journal.pone.0152057			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010658	gold, Green Published, Green Submitted			2022-12-26	WOS:000372708000080
J	Talaue, CO; del Rosario, RCH; Pfeiffer, F; Mendoza, ER; Oesterhelt, D				Talaue, Cherryl O.; del Rosario, Ricardo C. H.; Pfeiffer, Friedhelm; Mendoza, Eduardo R.; Oesterhelt, Dieter			Model Construction and Analysis of Respiration in Halobacterium salinarum	PLOS ONE			English	Article							INTRACELLULAR ADENOSINE-TRIPHOSPHATE; ELECTROCHEMICAL PROTON GRADIENT; ELECTRON-TRANSPORT CHAIN; CELL-MEMBRANE; STRAIN NRC-1; HALOBIUM; BIOENERGETICS; PHOTOPHOSPHORYLATION; PH	The archaeon Halobacterium salinarum can produce energy using three different processes, namely photosynthesis, oxidative phosphorylation and fermentation of arginine, and is thus a model organism in bioenergetics. Compared to its bacteriorhodopsin-driven photosynthesis, less attention has been devoted to modeling its respiratory pathway. We created a system of ordinary differential equations that models its oxidative phosphorylation. The model consists of the electron transport chain, the ATP synthase, the potassium uniport and the sodium-proton antiport. By fitting the model parameters to experimental data, we show that the model can explain data on proton motive force generation, ATP production, and the charge balancing of ions between the sodium-proton antiporter and the potassium uniport. We performed sensitivity analysis of the model parameters to determine how the model will respond to perturbations in parameter values. The model and the parameters we derived provide a resource that can be used for analytical studies of the bioenergetics of H. salinarum.	[Talaue, Cherryl O.; del Rosario, Ricardo C. H.; Mendoza, Eduardo R.] Univ Philippines, Inst Math, Quezon City 1101, Philippines; [del Rosario, Ricardo C. H.; Pfeiffer, Friedhelm; Mendoza, Eduardo R.; Oesterhelt, Dieter] Max Planck Inst Biochem, Dept Membrane Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany; [del Rosario, Ricardo C. H.] Broad Inst Harvard & MIT, Cambridge, MA USA	University of the Philippines System; University of the Philippines Diliman; Max Planck Society; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	del Rosario, RCH (corresponding author), Univ Philippines, Inst Math, Quezon City 1101, Philippines.; del Rosario, RCH (corresponding author), Max Planck Inst Biochem, Dept Membrane Biochem, Klopferspitz 18A, D-82152 Martinsried, Germany.; del Rosario, RCH (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA USA.	rcdelros@broadinstitute.org	Pfeiffer, Friedhelm/K-1757-2019	Pfeiffer, Friedhelm/0000-0003-4691-3246	Max-Planck-Society, Germany	Max-Planck-Society, Germany(Max Planck Society)	This work was funded by the Max-Planck-Society, Germany, to Dieter Oesterhelt, Director of the Department of Membrane Biochemistry, Max Planck Institute of Biochemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers SV, 2001, EXTREMOPHILES, V5, P285, DOI 10.1007/s007920100214; Beard DA, 2005, PLOS COMPUT BIOL, V1, P252, DOI 10.1371/journal.pcbi.0010036; Bertram R, 2006, J THEOR BIOL, V243, P575, DOI 10.1016/j.jtbi.2006.07.019; Chou IC, 2009, MATH BIOSCI, V219, P57, DOI 10.1016/j.mbs.2009.03.002; DANON A, 1974, P NATL ACAD SCI USA, V71, P1234, DOI 10.1073/pnas.71.4.1234; del Rosario RCH, 2007, IET SYST BIOL, V1, P207, DOI 10.1049/iet-syb:20070007; del Rosario RCH, 2009, J COMPUT THEOR NANOS, V6, P1965, DOI 10.1166/jctn.2009.1252; del Rosario RCH, 2010, MATH BIOSCI, V225, P68, DOI 10.1016/j.mbs.2010.02.002; DUNDAS IED, 1966, J BACTERIOL, V91, P113, DOI 10.1128/JB.91.1.113-119.1966; Gonzalez O, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000332; HARTMANN R, 1980, P NATL ACAD SCI-BIOL, V77, P3821, DOI 10.1073/pnas.77.7.3821; HARTMANN R, 1977, FEBS LETT, V82, P1, DOI 10.1016/0014-5793(77)80873-9; HARTMANN R, 1977, EUR J BIOCHEM, V77, P325, DOI 10.1111/j.1432-1033.1977.tb11671.x; Klamt S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100191; Koch M, 2005, INVESTIGATIONS HALOB; Koch MK, 2005, MOL MICROBIOL, V55, P1681, DOI 10.1111/j.1365-2958.2005.04516.x; Korzeniewski B, 1996, BIOPHYS CHEM, V57, P143, DOI 10.1016/0301-4622(95)00076-7; KORZENIEWSKI B, 1992, BIOCHIM BIOPHYS ACTA, V1102, P67, DOI 10.1016/0005-2728(92)90066-B; LANYI JK, 1979, J BIOL CHEM, V254, P4750; Magnus G, 1998, AM J PHYSIOL-CELL PH, V274, pC1158, DOI 10.1152/ajpcell.1998.274.4.C1158; MICHEL H, 1980, BIOCHEMISTRY-US, V19, P4607, DOI 10.1021/bi00561a011; MICHEL H, 1980, BIOCHEMISTRY-US, V19, P4615, DOI 10.1021/bi00561a012; MICHEL H, 1976, FEBS LETT, V65, P175, DOI 10.1016/0014-5793(76)80473-5; Muller JA, 2005, J BACTERIOL, V187, P1659, DOI 10.1128/JB.187.5.1659-1667.2005; MURAKAMI N, 1990, ARCH BIOCHEM BIOPHYS, V281, P13, DOI 10.1016/0003-9861(90)90406-O; OESTERHELT D, 1973, FEBS LETT, V36, P72, DOI 10.1016/0014-5793(73)80339-4; Oren A, 1999, MICROBIOL MOL BIOL R, V63, P334, DOI 10.1128/MMBR.63.2.334-348.1999; Pfeiffer F, 2008, GENOMICS, V91, P335, DOI 10.1016/j.ygeno.2008.01.001; Schafer G, 1999, MICROBIOL MOL BIOL R, V63, P570; Sreeramulu K, 1998, J BIOENERG BIOMEMBR, V30, P443, DOI 10.1023/A:1020538129400; Varma A, 1999, PARAMETERIC SENSITIV; Voit E. O., 2000, COMPUTATIONAL ANAL B; WAGNER G, 1978, EUR J BIOCHEM, V89, P169, DOI 10.1111/j.1432-1033.1978.tb20909.x	33	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151839	10.1371/journal.pone.0151839	http://dx.doi.org/10.1371/journal.pone.0151839			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27011330	Green Published, Green Submitted, gold			2022-12-26	WOS:000372708000050
J	Yin, QY; Ge, HX; Liao, CC; Liu, D; Zhang, S; Pan, YH				Yin, Qiuyuan; Ge, Hanxiao; Liao, Chen-Chong; Liu, Di; Zhang, Shuyi; Pan, Yi-Hsuan			Antioxidant Defenses in the Brains of Bats during Hibernation	PLOS ONE			English	Article							OXIDATIVE STRESS; HYDROGEN-PEROXIDE; GROUND-SQUIRREL; MAMMALIAN HIBERNATION; METABOLIC SUPPRESSION; ISCHEMIA-REPERFUSION; MYOTIS-RICKETTI; UP-REGULATION; AROUSAL; NRF2	Hibernation is a strategy used by some mammals to survive a cold winter. Small hibernating mammals, such as squirrels and hamsters, use species- and tissue-specific antioxidant defenses to cope with oxidative insults during hibernation. Little is known about antioxidant responses and their regulatory mechanisms in hibernating bats. We found that the total level of reactive oxygen species (ROS) and reactive nitrogen species (RNS) in the brain of each of the two distantly related hibernating bats M. ricketti and R. ferrumequinum at arousal was lower than that at torpid or active state. We also found that the levels of malondialdehyde (product of lipid peroxidation) of the two hibernating species of bats were significantly lower than those of non-hibernating bats R. leschenaultia and C. sphinx. This observation suggests that bats maintain a basal level of ROS/RNS that does no harm to the brain during hibernation. Results of Western blotting showed that hibernating bats expressed higher amounts of antioxidant proteins than non-hibernating bats and that M. ricketti bats upregulated the expression of some enzymes to overcome oxidative stresses, such as superoxide dismutase, glutathione reductase, and catalase. In contrast, R. ferrumequinum bats maintained a relatively high level of superoxide dismutase 2, glutathione reductase, and thioredoxin-2 throughout the three different states of hibernation cycles. The levels of glutathione (GSH) were higher in M. ricketti bats than in R. ferrumequinum bats and were significantly elevated in R. ferrumequinum bats after torpor. These data suggest that M. ricketti bats use mainly antioxidant enzymes and R. ferrumequinum bats rely on both enzymes and low molecular weight antioxidants (e.g., glutathione) to avoid oxidative stresses during arousal. Furthermore, Nrf2 and FOXOs play major roles in the regulation of antioxidant defenses in the brains of bats during hibernation. Our study revealed strategies used by bats against oxidative insults during hibernation.	[Yin, Qiuyuan; Ge, Hanxiao] E China Normal Univ, Lab Mol Ecol & Evolut, Shanghai Engn Res Ctr Mol Therapeut & New Drug De, Shanghai 200062, Peoples R China; [Liao, Chen-Chong] Natl Yang Ming Univ, Prote Res Ctr, Taipei 112, Taiwan; [Liu, Di; Zhang, Shuyi] E China Normal Univ, State Key Lab Estuarine & Coastal Res, Shanghai 200062, Peoples R China; [Zhang, Shuyi] Shenyang Agr Univ, Coll Anim Sci & Vet Med, Shenyang 110161, Peoples R China; [Pan, Yi-Hsuan] E China Normal Univ, Lab Mol Ecol & Evolut, Sch Life Sci, Shanghai 200062, Peoples R China	East China Normal University; National Yang Ming Chiao Tung University; East China Normal University; Shenyang Agricultural University; East China Normal University	Zhang, S (corresponding author), E China Normal Univ, State Key Lab Estuarine & Coastal Res, Shanghai 200062, Peoples R China.; Zhang, S (corresponding author), Shenyang Agr Univ, Coll Anim Sci & Vet Med, Shenyang 110161, Peoples R China.; Pan, YH (corresponding author), E China Normal Univ, Lab Mol Ecol & Evolut, Sch Life Sci, Shanghai 200062, Peoples R China.	szhang_sau@126.com; yihsuanp@gmail.com	Pan, Yi-Hsuan/ABG-6271-2020	Pan, Yi-Hsuan/0000-0001-5156-9887	National Science Foundation of China [31100273/C030101]; National Natural Science Foundation of China [31172077, 31570382]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Science Foundation of China (No. 31100273/C030101) to YP, and the National Natural Science Foundation of China (Grant Nos. 31172077 and 31570382) to SZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres-Mateos E, 2007, P NATL ACAD SCI USA, V104, P14807, DOI 10.1073/pnas.0703219104; Aquilano K, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00196; Avci E, 2014, PAK J ZOOL, V46, P177; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Borlongan CV, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-31; Brunet-Rossinni AK, 2004, MECH AGEING DEV, V125, P11, DOI 10.1016/j.mad.2003.09.003; Brunet-Rossinni AK, 2004, BIOGERONTOLOGY, V5, P211, DOI 10.1023/B:BGEN.0000038022.65024.d8; Bryan HK, 2013, BIOCHEM PHARMACOL, V85, P705, DOI 10.1016/j.bcp.2012.11.016; Buzadzic B, 1997, COMP BIOCHEM PHYS C, V117, P141, DOI 10.1016/S0742-8413(97)00061-3; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Chen JP, 2007, COMP BIOCHEM PHYS B, V146, P166, DOI 10.1016/j.cbpb.2006.10.095; Cui J, 2011, MOL BIOL EVOL, V28, P1025, DOI 10.1093/molbev/msq286; Dave KR, 2012, COMP BIOCHEM PHYS B, V162, P1, DOI 10.1016/j.cbpb.2012.01.008; Del Rio D, 2005, NUTR METAB CARDIOVAS, V15, P316, DOI 10.1016/j.numecd.2005.05.003; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Drew KL, 2007, J NEUROCHEM, V102, P1713, DOI 10.1111/j.1471-4159.2007.04675.x; Drew KL, 2002, COMP BIOCHEM PHYS C, V133, P483, DOI 10.1016/S1532-0456(02)00118-7; Drew KL, 1999, BRAIN RES, V851, P1, DOI 10.1016/S0006-8993(99)01969-1; Drew KL, 2001, FREE RADICAL BIO MED, V31, P563, DOI 10.1016/S0891-5849(01)00628-1; Eddy SF, 2005, ARCH BIOCHEM BIOPHYS, V435, P103, DOI 10.1016/j.abb.2004.11.020; Fontella F, 2005, NEUROCHEM RES, V30, P105, DOI 10.1007/s11064-004-9691-6; FRERICHS KU, 1994, J CEREBR BLOOD F MET, V14, P193, DOI 10.1038/jcbfm.1994.26; Galano A, 2011, RSC ADV, V1, P1763, DOI 10.1039/c1ra00474c; Geiser F, 2011, INTEGR COMP BIOL, V51, P337, DOI 10.1093/icb/icr042; Harman D, 2006, ANN NY ACAD SCI, V1067, P10, DOI 10.1196/annals.1354.003; Hermes-Lima M., 2001, CELL MOL RESPONSE ST, V2, P263; Huang HJ, 2011, BBA-MOL CELL RES, V1813, P1961, DOI 10.1016/j.bbamcr.2011.01.007; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Keilin D, 1938, PROC R SOC SER B-BIO, V124, P397, DOI 10.1098/rspb.1938.0001; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Lambert AJ, 2007, AGING CELL, V6, P607, DOI 10.1111/j.1474-9726.2007.00312.x; Lee JM, 2003, J BIOL CHEM, V278, P12029, DOI 10.1074/jbc.M211558200; Lee M, 2002, J NEUROCHEM, V82, P867, DOI 10.1046/j.1471-4159.2002.01022.x; Ma J, 2003, J ZOOL, V261, P245, DOI 10.1017/S095283690300414X; Ma YL, 2005, AM J PHYSIOL-REG I, V289, pR1297, DOI 10.1152/ajpregu.00260.2005; Mariani E, 2005, J CHROMATOGR B, V827, P65, DOI 10.1016/j.jchromb.2005.04.023; Maseko BC, 2007, J CHEM NEUROANAT, V34, P80, DOI 10.1016/j.jchemneu.2007.05.004; Morin P, 2008, MOL CELL BIOCHEM, V312, P121, DOI 10.1007/s11010-008-9727-3; Morin PJ, 2007, ARCH BIOCHEM BIOPHYS, V461, P59, DOI 10.1016/j.abb.2007.01.035; Muleme HM, 2006, PHYSIOL BIOCHEM ZOOL, V79, P474, DOI 10.1086/501053; Neuweiler G., 2000, BIOL BATS; Ni ZL, 2010, CAN J PHYSIOL PHARM, V88, P379, DOI 10.1139/Y10-017; Niture SK, 2014, FREE RADICAL BIO MED, V66, P36, DOI 10.1016/j.freeradbiomed.2013.02.008; Ohta H, 2006, COMP BIOCHEM PHYS C, V143, P484, DOI 10.1016/j.cbpc.2006.05.002; Okamoto I, 2006, COMP BIOCHEM PHYS C, V144, P47, DOI 10.1016/j.cbpc.2006.05.003; Osborne PG, 2006, BEHAV BRAIN RES, V168, P208, DOI 10.1016/j.bbr.2005.11.007; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Pamplona R, 2011, AM J PHYSIOL-REG I, V301, pR843, DOI 10.1152/ajpregu.00034.2011; Pan YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062039; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Ruczynski I, 2011, BIOL LETTERS, V7, P153, DOI 10.1098/rsbl.2010.0585; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; Schulz JB, 2000, EUR J BIOCHEM, V267, P4904, DOI 10.1046/j.1432-1327.2000.01595.x; Siegel D, 2004, MOL PHARMACOL, V65, P1238, DOI 10.1124/mol.65.5.1238; Storey KB, 2010, ADV CLIN CHEM, V52, P77, DOI 10.1016/S0065-2423(10)52003-1; Storey KB, 2010, GERONTOLOGY, V56, P220, DOI 10.1159/000228829; Sun Z, 2009, MOL CELL BIOL, V29, P2658, DOI 10.1128/MCB.01639-08; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Theodore M, 2010, FASEB J, V24; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Vucetic M, 2013, FREE RADICAL BIO MED, V65, P916, DOI 10.1016/j.freeradbiomed.2013.08.188; Wilkinson GS, 2002, AGING CELL, V1, P124, DOI 10.1046/j.1474-9728.2002.00020.x; Wu CW, 2014, MOL CELL BIOCHEM, V390, P185, DOI 10.1007/s11010-014-1969-7; Wu JH, 2010, CHEM BIOL DRUG DES, V75, P475, DOI 10.1111/j.1747-0285.2010.00955.x; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; Zhang YJ, 2014, J PROTEOMICS, V105, P266, DOI 10.1016/j.jprot.2014.01.006	69	30	31	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152135	10.1371/journal.pone.0152135	http://dx.doi.org/10.1371/journal.pone.0152135			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010916	Green Published, Green Submitted, gold			2022-12-26	WOS:000372708000095
J	Chen, R; Lu, DR; Xie, ZL; Feng, J; Jia, ZF; Ho, JM; Coote, ML; Wu, YL; Monteiro, MJ; Chung, SH				Chen, Rong; Lu, Derong; Xie, Zili; Feng, Jing; Jia, Zhongfan; Ho, Junming; Coote, Michelle L.; Wu, Yingliang; Monteiro, Michael J.; Chung, Shin-Ho			Peptidomimetic Star Polymers for Targeting Biological Ion Channels	PLOS ONE			English	Article							K+ CHANNEL; AUTOIMMUNE-DISEASES; POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; KV1.3; DENDRIMERS; PEPTIDES; TOXINS; BINDING	Four end-functionalized star polymers that could attenuate the flow of ionic currents across biological ion channels were first de novo designed computationally, then synthesized and tested experimentally on mammalian K+ channels. The 4-arm ethylene glycol conjugate star polymers with lysine or a tripeptide attached to the end of each arm were specifically designed to mimic the action of scorpion toxins on K+ channels. Molecular dynamics simulations showed that the lysine side chain of the polymers physically occludes the pore of Kv1.3, a target for immuno-suppression therapy. Two of the compounds tested were potent inhibitors of Kv1.3. The dissociation constants of these two compounds were computed to be 0.1 mu M and 0.7 mu M, respectively, within 3-fold to the values derived from subsequent experiments. These results demonstrate the power of computational methods in molecular design and the potential of star polymers as a new infinitely modifiable platform for ion channel drug discovery.	[Chen, Rong; Chung, Shin-Ho] Australian Natl Univ, Res Sch Biol, GPO Box 4, Canberra, ACT 2601, Australia; [Lu, Derong; Jia, Zhongfan; Monteiro, Michael J.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia; [Xie, Zili; Feng, Jing; Wu, Yingliang] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Ho, Junming; Coote, Michelle L.] Australian Natl Univ, ARC Ctr Excellence Electromat Sci, Res Sch Chem, GPO Box 4, Canberra, ACT 2601, Australia	Australian National University; University of Queensland; Wuhan University; Australian National University	Chen, R (corresponding author), Australian Natl Univ, Res Sch Biol, GPO Box 4, Canberra, ACT 2601, Australia.; Monteiro, MJ (corresponding author), Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia.	rong.chen@anu.edu.au; m.monteiro@uq.edu.au	Ho, Junming/A-1070-2012; Feng, Jing/C-1729-2018; Coote, Michelle L/B-2267-2010; lu, derong/HCH-1625-2022; Jia, Zhongfan/AAD-2308-2020; Ho, Junming/J-9366-2019; Monteiro, Michael/C-5658-2009	Ho, Junming/0000-0001-9381-924X; Feng, Jing/0000-0001-6726-7912; Coote, Michelle L/0000-0003-0828-7053; Jia, Zhongfan/0000-0001-9690-7288; Ho, Junming/0000-0001-9381-924X; Monteiro, Michael/0000-0001-5624-7115	Australian Research Council; National Health and Medical Research Council of Australia; Medical Advances Without Animals Trust (MAWA)	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Medical Advances Without Animals Trust (MAWA)	This work was supported by grants from the Australian Research Council, the National Health and Medical Research Council of Australia, and The Medical Advances Without Animals Trust (MAWA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagal S, 2013, J MED CHEM, V56, P593, DOI 10.1021/jm3011433; Banerjee A, 2013, ELIFE, V2, DOI 10.7554/eLife.00594; Beeton C, 2006, P NATL ACAD SCI USA, V103, P17414, DOI 10.1073/pnas.0605136103; BONTEMS F, 1991, SCIENCE, V254, P1521, DOI 10.1126/science.1720574; Bourne N, 2000, ANTIMICROB AGENTS CH, V44, P2471, DOI 10.1128/AAC.44.9.2471-2474.2000; Bracci L, 2003, J BIOL CHEM, V278, P46590, DOI 10.1074/jbc.M308615200; Chen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047253; Chen R, 2011, BIOPHYS J, V101, P2652, DOI 10.1016/j.bpj.2011.10.029; Chi V, 2012, TOXICON, V59, P529, DOI 10.1016/j.toxicon.2011.07.016; Dennis A, 2007, BIOCHEM SOC T, V35, P1060, DOI 10.1042/BST0351060; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; England S, 2009, BRIT J PHARMACOL, V158, P1413, DOI 10.1111/j.1476-5381.2009.00437.x; Gordon D, 2013, PHYSIOL REV, V93, P767, DOI 10.1152/physrev.00035.2012; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; Grossfield A., WHAM WEIGHTED HISTOG; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; Jiang YH, 2005, AIDS RES HUM RETROV, V21, P207, DOI 10.1089/aid.2005.21.207; Kaczorowski GJ, 2008, J GEN PHYSIOL, V131, P399, DOI 10.1085/jgp.200709946; Klint JK, 2015, BRIT J PHARMACOL, V172, P2445, DOI 10.1111/bph.13081; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Liu TY, 2013, BIOMACROMOLECULES, V14, P2798, DOI 10.1021/bm400626w; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu DR, 2015, MACROMOLECULES, V48, P1688, DOI 10.1021/acs.macromol.5b00195; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; McGivern Joseph G, 2007, Neuropsychiatr Dis Treat, V3, P69, DOI 10.2147/nedt.2007.3.1.69; Minett MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1795; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Shieh CC, 2000, PHARMACOL REV, V52, P557; Skwarczynski M, 2010, ANGEW CHEM INT EDIT, V49, P5742, DOI 10.1002/anie.201002221; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wulff H, 2003, J CLIN INVEST, V111, P1703, DOI 10.1172/JCI200316921; Zaydman MA, 2012, CHEM REV, V112, P6319, DOI 10.1021/cr300360k	33	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152169	10.1371/journal.pone.0152169	http://dx.doi.org/10.1371/journal.pone.0152169			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007701	Green Published, gold			2022-12-26	WOS:000372701200103
J	Kang, S; Hong, SY				Kang, Sinkyu; Hong, Suk Young			Assessing Seasonal and Inter-Annual Variations of Lake Surface Areas in Mongolia during 2000-2011 Using Minimum Composite MODIS NDVI	PLOS ONE			English	Article							WATER INDEX NDWI; LANDSAT TM; CLASSIFICATION; IMAGES; THRESHOLD; DISASTER	A minimum composite method was applied to produce a 15-day interval normalized difference vegetation index (NDVI) dataset from Moderate Resolution Imaging Spectroradiometer (MODIS) daily 250 m reflectance in the red and near-infrared bands. This dataset was applied to determine lake surface areas in Mongolia. A total of 73 lakes greater than 6.25 km(2)in area were selected, and 28 of these lakes were used to evaluate detection errors. The minimum composite NDVI showed a better detection performance on lake water pixels than did the official MODIS 16-day 250 m NDVI based on a maximum composite method. The overall lake area detection performance based on the 15-day minimum composite NDVI showed -2.5% error relative to the Landsat-derived lake area for the 28 evaluated lakes. The errors increased with increases in the perimeter-to-area ratio but decreased with lake size over 10 km(2). The lake area decreased by -9.3% at an annual rate of -53.7 km(2) yr(-1) during 2000 to 2011 for the 73 lakes. However, considerable spatial variations, such as slight-to-moderate lake area reductions in semi-arid regions and rapid lake area reductions in arid regions, were also detected. This study demonstrated applicability of MODIS 250 m reflectance data for biweekly monitoring of lake area change and diagnosed considerable lake area reduction and its spatial variability in arid and semi-arid regions of Mongolia. Future studies are required for explaining reasons of lake area changes and their spatial variability.	[Kang, Sinkyu] Kangwon Natl Univ, Dept Environm Sci, Chunchon 200701, South Korea; [Hong, Suk Young] Natl Acad Agr Sci, Agr Environm Dept, Wonju 565851, South Korea	Kangwon National University; Rural Development Administration (RDA)	Kang, S (corresponding author), Kangwon Natl Univ, Dept Environm Sci, Chunchon 200701, South Korea.	kangsk@kangwon.ac.kr			Agenda Program of the Rural Development Agency [PJ00997802]; Korea Forest Service [S211212L06301]; Korea Ministry of Environment [2015001370002]	Agenda Program of the Rural Development Agency; Korea Forest Service(Korea Forest Service); Korea Ministry of Environment(Ministry of Environment (ME), Republic of Korea)	This work was supported by grants from the Agenda Program of the Rural Development Agency (PJ00997802), the Korea Forest Service (S211212L06301), and the Korea Ministry of Environment (2015001370002).	Batima P, 2005, AIACC WORKING PAPER, V12, P5; Cai YL, 2005, INT GEOSCI REMOTE SE, P4539; Castaneda C, 2005, J ARID ENVIRON, V63, P497, DOI 10.1016/j.jaridenv.2005.03.021; Chavez PS, 1996, PHOTOGRAMM ENG REM S, V62, P1025; Cretaux JF, 2011, ADV SPACE RES, V47, P1497, DOI 10.1016/j.asr.2011.01.004; Cretaux JF, 2006, CR GEOSCI, V338, P1098, DOI 10.1016/j.crte.2006.08.002; Davaa G, 2008, MONGOLIA ENV HDB, P42; Du Y, 2002, REMOTE SENS ENVIRON, V82, P123, DOI 10.1016/S0034-4257(02)00029-9; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Jang K, 2013, J GEOPHYS RES-ATMOS, V118, P12927, DOI 10.1002/2013JD020639; Kang SY, 2015, J ARID LAND, V7, P146, DOI 10.1007/s40333-014-0081-x; KAWATA Y, 1990, IEEE T GEOSCI REMOTE, V28, P755, DOI 10.1109/TGRS.1990.573015; Komatsu G, 2001, GEOMORPHOLOGY, V39, P83, DOI 10.1016/S0169-555X(00)00095-7; Koponen S, 2002, REMOTE SENS ENVIRON, V79, P51, DOI 10.1016/S0034-4257(01)00238-3; Kummerow C, 1998, J ATMOS OCEAN TECH, V15, P809, DOI 10.1175/1520-0426(1998)015<0809:TTRMMT>2.0.CO;2; Lee EH, 2011, ATMOS ENVIRON, V45, P4611, DOI 10.1016/j.atmosenv.2011.05.065; Lillesand TM, 2004, REMOTE SENSING IMAGE, P574; Liu YB, 2012, INT J REMOTE SENS, V33, P5862, DOI 10.1080/01431161.2012.675452; Ma JZ, 2006, HYDROGEOL J, V14, P1231, DOI 10.1007/s10040-006-0045-0; Ma M, 2007, INT J REMOTE SENS, V28, P5523, DOI 10.1080/01431160601009698; McFeeters SK, 1996, INT J REMOTE SENS, V17, P1425, DOI 10.1080/01431169608948714; Michishita R, 2012, INT J REMOTE SENS, V33, P3373, DOI 10.1080/01431161.2011.611185; Nakayama Y, 2007, ADV SPACE RES, V39, P52, DOI 10.1016/j.asr.2006.02.045; Neupert R F., 1996, POPUL ENVIRON, V20, P413; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ryu Y, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2011GB004053; Scepan J, 1999, PHOTOGRAMM ENG REM S, V65, P1075; Sharkhuu N, 2003, PERMAFROST, VOLS 1 AND 2, P1029; Song C, 2001, REMOTE SENS ENVIRON, V75, P230, DOI 10.1016/S0034-4257(00)00169-3; Sternberg T, 2010, NOMAD PEOPLES, V14, P72, DOI 10.3167/np.2010.140105; Subramaniam S, 2011, IEEE J-STARS, V4, P205, DOI 10.1109/JSTARS.2010.2085032; Tachiiri K, 2008, J ARID ENVIRON, V72, P2251, DOI 10.1016/j.jaridenv.2008.06.015; Tao SL, 2015, P NATL ACAD SCI USA, V112, P2281, DOI 10.1073/pnas.1411748112; Tsogtbaatar J, 2009, UNESCO CHAIR WORKSH, P25; Tsutomu K, 2007, ANN GLACIOL-SER, V46, P185, DOI 10.3189/172756407782871675; UNEP RRC.AP, 2002, STAT ENV MONG 2002; Vermote E, 2008, MODIS LAND SURFACE R; Wang Y, 2008, INT J REMOTE SENS, V29, P293, DOI 10.1080/01431160701253311; Xu HQ, 2006, INT J REMOTE SENS, V27, P3025, DOI 10.1080/01431160600589179; Yang H, 2012, KOREAN J REMOTE SENS, V28, P267, DOI 10.7780/kjrs.2012.28.3.267; Zhao L, 2010, PERMAFROST PERIGLAC, V21, P198, DOI 10.1002/ppp.688	41	9	10	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151395	10.1371/journal.pone.0151395	http://dx.doi.org/10.1371/journal.pone.0151395			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007233	Green Submitted, Green Published, gold			2022-12-26	WOS:000372701200052
J	Sun, LL; Tabaka, M; Hou, S; Li, L; Burdzy, K; Aksimentiev, A; Maffeo, C; Zhang, XZ; Holyst, R				Sun, Lili; Tabaka, Marcin; Hou, Sen; Li, Lin; Burdzy, Krzysztof; Aksimentiev, Aleksei; Maffeo, Christopher; Zhang, Xuzhu; Holyst, Robert			The Hinge Region Strengthens the Nonspecific Interaction between Lac-Repressor and DNA: A Computer Simulation Study	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; NUCLEIC-ACIDS; FORCE-FIELD; PROTEIN; MODELS; RECOGNITION; HEADPIECE; OPERATOR; BINDING; WATER	LacI is commonly used as a model to study the protein-DNA interaction and gene regulation. The headpiece of the lac-repressor (LacI) protein is an ideal system for investigation of nonspecific binding of the whole LacI protein to DNA. The hinge region of the headpiece has been known to play a key role in the specific binding of LacI to DNA, whereas its role in nonspecific binding process has not been elucidated. Here, we report the results of explicit solvent molecular dynamics simulation and continuum electrostatic calculations suggesting that the hinge region strengthens the nonspecific interaction, accounting for up to 50% of the micro-dissociation free energy of LacI from DNA. Consequently, the rate of microscopic dissociation of LacI from DNA is reduced by 2 similar to 3 orders of magnitude in the absence of the hinge region. We find the hinge region makes an important contribution to the electrostatic energy, the salt dependence of electrostatic energy, and the number of salt ions excluded from binding of the LacI-DNA complex.	[Sun, Lili; Tabaka, Marcin; Hou, Sen; Zhang, Xuzhu; Holyst, Robert] Inst Phys Chem PAS, Kasprzaka 44-52, PL-01224 Warsaw, Poland; [Li, Lin] Clemson Univ, Dept Phys, Computat Biophys & Bioinformat, Clemson, SC 29634 USA; [Burdzy, Krzysztof] Univ Washington, Dept Math, Seattle, WA 98195 USA; [Aksimentiev, Aleksei; Maffeo, Christopher] Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA	Polish Academy of Sciences; Institute of Physical Chemistry of the Polish Academy of Sciences; Clemson University; University of Washington; University of Washington Seattle; University of Illinois System; University of Illinois Urbana-Champaign	Holyst, R (corresponding author), Inst Phys Chem PAS, Kasprzaka 44-52, PL-01224 Warsaw, Poland.	rholyst@ichf.edu.pl	Sun, lili/GQH-2057-2022; hou, sen/B-6733-2011	hou, sen/0000-0002-6871-4419; Tabaka, Marcin/0000-0002-6166-2820; Aksimentiev, Aleksei/0000-0002-6042-8442; Zhang, Xuzhu/0000-0002-5530-7611; Holyst, Robert/0000-0002-3211-4286	Interdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw [G53-19]; National Science Center [UMO-2011/02/A/ST3/00143]; Project Sonata [UMO-2012/07/D/ST4/02183]; Direct For Mathematical & Physical Scien [1206276] Funding Source: National Science Foundation	Interdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw; National Science Center(National Science Centre, Poland); Project Sonata; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The calculations were performed in the Interdisciplinary Centre for Mathematical and Computational Modelling, University of Warsaw (Grant Number: G53-19). This work was supported by the National Science Center UMO-2011/02/A/ST3/00143(Maestro grant). S.H. was supported by Project Sonata from UMO-2012/07/D/ST4/02183.	BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Blainey PC, 2009, NAT STRUCT MOL BIOL, V16, P1224, DOI 10.1038/nsmb.1716; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Dahirel V, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.228101; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Furini S, 2013, NUCLEIC ACIDS RES, V41, P3963, DOI 10.1093/nar/gkt099; Furini S, 2010, J PHYS CHEM B, V114, P2238, DOI 10.1021/jp906504m; Givaty O, 2009, J MOL BIOL, V385, P1087, DOI 10.1016/j.jmb.2008.11.016; Gowers DM, 2003, EMBO J, V22, P1410, DOI 10.1093/emboj/cdg125; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064; Kalodimos CG, 2001, P NATL ACAD SCI USA, V98, P6039, DOI 10.1073/pnas.101129898; KARPLUS M, 1983, ANNU REV BIOCHEM, V52, P263, DOI 10.1146/annurev.bi.52.070183.001403; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Lewis M, 2005, CR BIOL, V328, P521, DOI 10.1016/j.crvi.2005.04.004; Li L, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-9; Liu YZ, 2012, J PHYS CHEM B, V116, P12227, DOI 10.1021/jp304796p; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maffeo C, 2012, NUCLEIC ACIDS RES, V40, P3812, DOI 10.1093/nar/gkr1220; Marklund EG, 2013, P NATL ACAD SCI USA, V110, P19796, DOI 10.1073/pnas.1307905110; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; MISRA VK, 1994, J MOL BIOL, V238, P264, DOI 10.1006/jmbi.1994.1286; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; PABO CO, 1992, ANNU REV BIOCHEM, V61, P1053, DOI 10.1146/annurev.bi.61.070192.005201; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ren P, 2002, ABSTR PAP AM CHEM S, V224, pU473; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; Spronk CAEM, 1999, STRUCT FOLD DES, V7, P1483, DOI 10.1016/S0969-2126(00)88339-2; Swint-Kruse L, 2009, CURR OPIN MICROBIOL, V12, P129, DOI 10.1016/j.mib.2009.01.009; Tabaka M, 2014, NUCLEIC ACIDS RES, V42, P727, DOI 10.1093/nar/gkt907; TORRIE GM, 1974, CHEM PHYS LETT, V28, P578, DOI 10.1016/0009-2614(74)80109-0; van Dijk M, 2009, NUCLEIC ACIDS RES, V37, pW235, DOI 10.1093/nar/gkp287; von Hippel PH, 2004, SCIENCE, V305, P350, DOI 10.1126/science.1101270; Wang YM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.048302; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051	38	2	2	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152002	10.1371/journal.pone.0152002	http://dx.doi.org/10.1371/journal.pone.0152002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008630	Green Published, Green Submitted, gold			2022-12-26	WOS:000372701200086
J	Victor, VM; Rovira-Llopis, S; Banuls, C; Diaz-Morales, N; de Maranon, AM; Rios-Navarro, C; Alvarez, A; Gomez, M; Rocha, M; Hernandez-Mijares, A				Victor, Victor M.; Rovira-Llopis, Susana; Banuls, Celia; Diaz-Morales, Noelia; Martinez de Maranon, Arantxa; Rios-Navarro, Cesar; Alvarez, Angeles; Gomez, Marcelino; Rocha, Milagros; Hernandez-Mijares, Antonio			Insulin Resistance in PCOS Patients Enhances Oxidative Stress and Leukocyte Adhesion: Role of Myeloperoxidase	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; LEUKOCYTE/ENDOTHELIAL CELL-INTERACTIONS; GRADE CHRONIC INFLAMMATION; METABOLIC SYNDROME; ENDOTHELIAL DYSFUNCTION; CARDIOVASCULAR RISK; GLYCEMIC CONTROL; WOMEN; NEUTROPHILS; EXPRESSION	Cardiovascular diseases and oxidative stress are related to polycystic ovary syndrome (PCOS) and insulin resistance (IR). We have evaluated the relationship between myeloperoxidase (MPO) and leukocyte activation in PCOS patients according to homeostatic model assessment of IR (HOMA-IR), and have explored a possible correlation between these factors and endocrine and inflammatory parameters. This was a prospective controlled study conducted in an academic medical center. The study population consisted of 101 PCOS subjects and 105 control subjects. We divided PCOS subjects into PCOS non-IR (HOMA-IR<2.5) and PCOS IR (HOMA-IR>2.5). Metabolic and anthropometric parameters, total and mitochondrial reactive oxygen species (ROS) production, MPO levels, interactions between human umbilical vein endothelial cells and leukocytes, adhesion molecules (E-selectin, ICAM-1 and VCAM-1) and proinflammatory cytokines (IL-6 and TNF-alpha) were evaluated. Oxidative stress was observed in PCOS patients, in whom there was an increase in total and mitochondrial ROS production and MPO levels. Enhanced rolling flux and adhesion, and a decrease in polymorphonuclear cell rolling velocity were also detected in PCOS subjects. Increases in IL-6 and TNF-alpha and adhesion molecules (E-selectin, ICAM-1 and VCAM-1) were also observed, particularly in the PCOS IR group, providing evidence that inflammation and oxidative stress are related in PCOS patients. HOMA-IR was positively correlated with hsCRP (p<0.001, r = 0.304), ROS production (p<0.01, r = 0.593), leukocyte rolling flux (p<0.05, r = 0.446), E-selectin (p<0.01, r = 0.436) and IL-6 (p<0.001, r = 0.443). The results show an increase in the rate of ROS and MPO levels in PCOS patients in general, and particularly in those with IR. Inflammation in PCOS induces leukocyte-endothelium interactions and a simultaneous increase in IL-6, TNF-alpha, E-selectin, ICAM-1 and VCAM-1. These conditions are aggravated by the presence of IR.	[Victor, Victor M.; Rovira-Llopis, Susana; Banuls, Celia; Diaz-Morales, Noelia; Martinez de Maranon, Arantxa; Gomez, Marcelino; Rocha, Milagros; Hernandez-Mijares, Antonio] Univ Hosp Doctor Peset, Serv Endocrinol, Fdn Promot Hlth & Biomed Res Valencian Reg FISABI, Valencia, Spain; [Victor, Victor M.; Rovira-Llopis, Susana; Banuls, Celia; Rocha, Milagros; Hernandez-Mijares, Antonio] Univ Valencia, Inst Hlth Res INCLIVA, Valencia, Spain; [Victor, Victor M.; Rios-Navarro, Cesar; Alvarez, Angeles; Rocha, Milagros] Univ Valencia, CIBERehd Dept Pharmacol & Physiol, Valencia, Spain; [Victor, Victor M.] Univ Valencia, Dept Physiol, Valencia, Spain; [Alvarez, Angeles] Univ Valencia, Gen Fdn, Valencia, Spain; [Hernandez-Mijares, Antonio] Univ Valencia, Dept Med, Valencia, Spain	University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Valencia; University of Valencia; University of Valencia; University of Valencia	Victor, VM; Rocha, M; Hernandez-Mijares, A (corresponding author), Univ Hosp Doctor Peset, Serv Endocrinol, Fdn Promot Hlth & Biomed Res Valencian Reg FISABI, Valencia, Spain.; Victor, VM; Rocha, M; Hernandez-Mijares, A (corresponding author), Univ Valencia, Inst Hlth Res INCLIVA, Valencia, Spain.; Victor, VM; Rocha, M (corresponding author), Univ Valencia, CIBERehd Dept Pharmacol & Physiol, Valencia, Spain.; Victor, VM (corresponding author), Univ Valencia, Dept Physiol, Valencia, Spain.; Hernandez-Mijares, A (corresponding author), Univ Valencia, Dept Med, Valencia, Spain.	Victor.Victor@uv.es; milagros.rocha@uv.es; hernandez_antmij@gva.es	Alvarez, Angeles/ABF-4589-2020; victor, victor/Q-4843-2019; Diaz-Morales, Noelia/ABH-3698-2020; Rovira-Llopis, Susana/AAX-8666-2021; de Marañón Peris, Aranzazu Martínez/H-4399-2017; BaÃuls, Celia/H-7359-2017; VICTOR, VICTOR M/I-3270-2015; Cerviño, Alejandro/L-5853-2014; Diaz-Morales, Noelia/H-1978-2015; Ríos-Navarro, Cesar/AAB-3875-2019; Rocha, Milagros/ABE-4931-2020; Rocha, Milagros/I-4987-2015	Rovira-Llopis, Susana/0000-0002-8476-5128; de Marañón Peris, Aranzazu Martínez/0000-0002-4153-0396; BaÃuls, Celia/0000-0001-8077-7642; Cerviño, Alejandro/0000-0001-8014-3279; Diaz-Morales, Noelia/0000-0003-1657-2700; Ríos-Navarro, Cesar/0000-0002-6405-6279; Rocha, Milagros/0000-0003-2923-6546; Rocha, Milagros/0000-0003-2923-6546; VICTOR, VICTOR/0000-0002-3027-3945; Alvarez, Angeles/0000-0002-2301-9746	European Regional Development Fund (ERDF "A way to build Europe"); Ministry of Health of the Valencian Regional Government; Carlos III Health Institute [CES10/030, CP10/0360, FI11/00637, CD14/00043, FI14/00125]; Conselleria de Educacion, Cultura y Deporte [CPI-13-194]; Ministerio de Ciencia e Innovacion [RYC2005-002295];  [PI12/1984];  [PI13/1025];  [PI13/0073];  [PI15/1424];  [CIBERehd CB06/04/0071];  [PROMETEOII2014/035];  [SAF2010/16030];  [UGP-14-93];  [UGP-14-95]	European Regional Development Fund (ERDF "A way to build Europe"); Ministry of Health of the Valencian Regional Government; Carlos III Health Institute(Instituto de Salud Carlos III); Conselleria de Educacion, Cultura y Deporte; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); ; ; ; ; ; ; ; ; 	This study was financed by grants PI12/1984, PI13/1025, PI13/0073, PI15/1424, CIBERehd CB06/04/0071, PROMETEOII2014/035, SAF2010/16030, UGP-14-93, UGP-14-95 and by the European Regional Development Fund (ERDF "A way to build Europe"). VMV and MR are recipients of contracts from the Ministry of Health of the Valencian Regional Government and Carlos III Health Institute (CES10/030 and CP10/0360, respectively). SR-L is the recipient of a predoctoral fellowship from Carlos III Health Institute (FI11/00637). CB is the recipient of a postdoctoral contract from Carlos III Health Institute (CD14/00043). ND-M is the recipient of a predoctoral contract from Carlos III Health Institute (FI14/00125). CR-N was supported by Conselleria de Educacion, Cultura y Deporte (CPI-13-194). AA was supported by Ministerio de Ciencia e Innovacion (Ramon y Cajal program RYC2005-002295 and I3 program).	Anatoliotakis N, 2013, CURR TOP MED CHEM, V13, P115, DOI 10.2174/1568026611313020004; Armeni E, 2013, J HYPERTENS, V31, P1998, DOI 10.1097/HJH.0b013e3283630362; Azziz R, 2004, J CLIN ENDOCR METAB, V89, P453, DOI 10.1210/jc.2003-031122; Baldus S, 2004, FREE RADICAL BIO MED, V37, P902, DOI 10.1016/j.freeradbiomed.2004.06.003; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; Blair SA, 2013, J REPROD MED, V58, P107; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Diamanti-Kandarakis E, 1999, J CLIN ENDOCR METAB, V84, P4006, DOI 10.1210/jc.84.11.4006; Dunaif A, 1997, ENDOCR REV, V18, P774, DOI 10.1210/er.18.6.774; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Ehrmann DA, 2006, J CLIN ENDOCR METAB, V91, P48, DOI 10.1210/jc.2005-1329; Eiserich JP, 2002, SCIENCE, V296, P2391, DOI 10.1126/science.1106830; Escobar-Morreale HF, 2011, FERTIL STERIL, V95, P1048, DOI 10.1016/j.fertnstert.2010.11.036; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gonzalez F, 2006, J ENDOCRINOL, V188, P521, DOI 10.1677/joe.1.06579; Gonzalez F, 2006, J CLIN ENDOCR METAB, V91, P336, DOI 10.1210/jc.2005-1696; Gorudko IV, 2016, ARCH BIOCHEM BIOPHYS, V591, P87, DOI 10.1016/j.abb.2015.12.007; Grundy SM, 2007, J CLIN ENDOCR METAB, V92, P399, DOI 10.1210/jc.2006-0513; Hernandez Mijares A, 2003, MED CLIN BARC, V121, P204; Hernandez-Mijares A, 2013, DIABETES CARE, V36, P1695, DOI 10.2337/dc12-1224; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Klinke A, 2011, BLOOD, V117, P1350, DOI 10.1182/blood-2010-05-284513; Kurdoglu Z, 2012, GYNECOL ENDOCRINOL, V28, P115, DOI 10.3109/09513590.2011.583959; Li Q, 2013, CIRC RES, V113, P418, DOI 10.1161/CIRCRESAHA.113.301074; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Mahalingaiah S, 2015, EXPERT OPIN THER TAR, V19, P1561, DOI 10.1517/14728222.2015.1101067; Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001; Nasiek M, 2004, GYNECOL ENDOCRINOL, V19, P208, DOI 10.1080/09513590400014313; Nussbaum C, 2013, ANTIOXID REDOX SIGN, V18, P692, DOI 10.1089/ars.2012.4783; Orio F, 2005, J CLIN ENDOCR METAB, V90, P2, DOI 10.1210/jc.2004-0628; Palomba S, 2014, J CLIN ENDOCR METAB, V99, P2942, DOI 10.1210/jc.2014-1214; Podrez EA, 1999, J CLIN INVEST, V103, P1547, DOI 10.1172/JCI5549; Prieto D, 2014, CURR VASC PHARMACOL, V12, P412, DOI 10.2174/1570161112666140423221008; Ribeiro AL, 2012, GYNECOL ENDOCRINOL, V28, P3, DOI 10.3109/09513590.2011.579656; Rovira-Llopis S, 2014, ANTIOXID REDOX SIGN, V21, P1759, DOI 10.1089/ars.2014.6030; Rovira-Llopis S, 2013, ANTIOXID REDOX SIGN, V19, P1452, DOI 10.1089/ars.2013.5307; Studen KB, 2013, FRONT HORM RES, V40, P64, DOI 10.1159/000341838; Unubol M, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0115-3; Victor VM, 2011, J CLIN ENDOCR METAB, V96, P3115, DOI 10.1210/jc.2011-0651; Victor VM, 2009, J CLIN ENDOCR METAB, V94, P3505, DOI 10.1210/jc.2009-0466; Vita JA, 2004, CIRCULATION, V110, P1134, DOI 10.1161/01.CIR.0000140262.20831.8F; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; Zhang CX, 2004, DIABETES, V53, P2950, DOI 10.2337/diabetes.53.11.2950; Zhao Y, 2015, J CLIN ENDOCR METAB, V100, P201, DOI 10.1210/jc.2014-2419	44	71	76	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151960	10.1371/journal.pone.0151960	http://dx.doi.org/10.1371/journal.pone.0151960			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007571	Green Published, Green Submitted, gold			2022-12-26	WOS:000372701200078
J	Wang, CY; Ji, LF; Yuan, XH; Jin, Y; Cardona, CJ; Xing, Z				Wang, Chunyang; Ji, Lianfu; Yuan, Xinhui; Jin, Yu; Cardona, Carol J.; Xing, Zheng			Differential Regulation of TLR Signaling on the Induction of Antiviral Interferons in Human Intestinal Epithelial Cells Infected with Enterovirus 71	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; INDUCIBLE GENE-I; NF-KAPPA-B; INNATE IMMUNITY; VIRAL REPLICATION; RESPONSES; PROTEIN; MICE; RECOGNITION; ACTIVATION	Enterovirus 71 (EV71) causes hand-foot-and-mouth disease, which can lead to fatal neurological complications in young children and infants. Few gastrointestinal symptoms are observed clinically, suggesting the presence of a unique immunity to EV71 in the gut. We reported a robust induction of interferons (IFNs) in human intestinal epithelial cells (HT-29), which was suppressed in other types such as RD and HeLa cells. The underlying mechanism for the apparent difference remains obscure. In this study we report that in EV71-infected HT-29 cells, TLR/TRIF signaling was essential to IFN induction; viral replication increased and the induction of IFN-alpha, -beta, -omega, -kappa, and -epsilon decreased markedly in TRIF-silenced HT-29 cells. Importantly, TRIF was degraded by viral 3C(pro) in RD cells, but resisted cleavage, and IRF3 was activated and translocated into the nucleus in HT-29 cells. Taken together, our data suggest that IFNs were induced differentially in human HT-29 cells through an intact TLR/TRIF signaling, which differs from other cell types and may be implicated in viral pathogenesis in EV71 infection.	[Wang, Chunyang; Ji, Lianfu; Yuan, Xinhui; Jin, Yu; Xing, Zheng] Nanjing Univ, Jiangsu Prov Key Lab Med, Sch Med, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Chunyang; Ji, Lianfu; Yuan, Xinhui; Jin, Yu; Xing, Zheng] Nanjing Univ, State Key Lab Pharmaceut Technol, Nanjing 210008, Jiangsu, Peoples R China; [Wang, Chunyang; Ji, Lianfu; Yuan, Xinhui; Jin, Yu] Nanjing Med Univ, Nanjing Childrens Hosp, Nanjing, Jiangsu, Peoples R China; [Cardona, Carol J.; Xing, Zheng] Univ Minnesota Twin Cities, Coll Vet Med, Dept Vet Biomed Sci, St Paul, MN USA	Nanjing University; Nanjing University; Nanjing Medical University; University of Minnesota System; University of Minnesota Twin Cities	Jin, Y; Xing, Z (corresponding author), Nanjing Univ, Jiangsu Prov Key Lab Med, Sch Med, Nanjing 210008, Jiangsu, Peoples R China.; Jin, Y; Xing, Z (corresponding author), Nanjing Univ, State Key Lab Pharmaceut Technol, Nanjing 210008, Jiangsu, Peoples R China.; Jin, Y (corresponding author), Nanjing Med Univ, Nanjing Childrens Hosp, Nanjing, Jiangsu, Peoples R China.; Xing, Z (corresponding author), Univ Minnesota Twin Cities, Coll Vet Med, Dept Vet Biomed Sci, St Paul, MN USA.	jinyuldyy@163.com; zxing@umn.edu	Xing, Zheng/G-8366-2011	Xing, Zheng/0000-0002-7288-0268	National Natural Science Foundation of China [81571993]; Mega Infectious Diseases Program from the Ministry of Science of Technology of China [2014ZX10004001-002]; Natural Science Foundation of Jiangsu Province [BK20141078]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Mega Infectious Diseases Program from the Ministry of Science of Technology of China; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by a funding from National Natural Science Foundation of China (No. 81571993) and a Mega Infectious Diseases Program from the Ministry of Science of Technology of China (Grant No. 2014ZX10004001-002) to Z.X. and a Natural Science Foundation of Jiangsu Province (BK20141078) to Y.J. We thank Ms. Sandy Shanks for her dedicated and excellent work in editing the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Chattopadhyay S, 2014, CYTOKINE GROWTH F R, V25, P533, DOI 10.1016/j.cytogfr.2014.06.002; Chen CS, 2007, J VIROL, V81, P8996, DOI 10.1128/JVI.00236-07; Chi C., 2013, VIRUS RES; Gurtler C, 2013, TRENDS MICROBIOL, V21, P413, DOI 10.1016/j.tim.2013.04.004; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hsiao HB, 2014, J VIROL, V88, P11658, DOI 10.1128/JVI.00867-14; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kuo RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063431; Lei XB, 2013, J VIROL, V87, P1690, DOI 10.1128/JVI.01855-12; Lei XB, 2011, J VIROL, V85, P8811, DOI 10.1128/JVI.00447-11; Lei XB, 2010, J VIROL, V84, P8051, DOI 10.1128/JVI.02491-09; Lester SN, 2014, J MOL BIOL, V426, P1246, DOI 10.1016/j.jmb.2013.11.024; Liu ML, 2005, J GEN VIROL, V86, P3263, DOI 10.1099/vir.0.81195-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lum LCS, 1998, J PEDIATR-US, V133, P795, DOI 10.1016/S0022-3476(98)70155-6; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Sato S, 2003, J IMMUNOL, V171, P4304, DOI 10.4049/jimmunol.171.8.4304; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Takaoka A, 2003, CANCER SCI, V94, P405, DOI 10.1111/j.1349-7006.2003.tb01455.x; Tatematsu M, 2014, BIOCHEM J, V458, P195, DOI 10.1042/BJ20131492; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Uematsu S, 2005, J EXP MED, V201, P915, DOI 10.1084/jem.20042372; Wang B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003231; Wang CY, 2015, VIRUS RES, V197, P75, DOI 10.1016/j.virusres.2014.12.016; Yi LN, 2011, CRIT REV MICROBIOL, V37, P313, DOI 10.3109/1040841X.2011.580723; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851	34	22	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152177	10.1371/journal.pone.0152177	http://dx.doi.org/10.1371/journal.pone.0152177			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007979	gold, Green Submitted, Green Published			2022-12-26	WOS:000372701200105
J	Zheng, LY; Zhao, XL; Zhang, P; Chen, CD; Liu, SJ; Huang, RQ; Zhong, MQ; Wei, CJ; Zhang, YL				Zheng, Liyuan; Zhao, Xianliang; Zhang, Pei; Chen, Chuandao; Liu, Shangjie; Huang, Runqing; Zhong, Mingqi; Wei, Chiju; Zhang, Yueling			Hemocyanin from Shrimp Litopenaeus vannamei Has Antiproliferative Effect against HeLa Cell In Vitro	PLOS ONE			English	Article							KEYHOLE LIMPET HEMOCYANIN; IMMUNE-ENHANCING PROTEINS; CANCER; IDENTIFICATION; APOPTOSIS; PHENOLOXIDASE; BREAST; DEATH; BINDS; MODEL	Hemocyanin (HMC) has been shown to participate in multiple roles of immune defence. In this study, we investigated the antiproliferative effect and underpinning mechanism of HMC from Litopenaeus vannamei in vitro. Sulforhodamine B (SRB) assay indicated that HMC could dramatically inhibit the growth of HeLa cells, but not 293T cells under the same conditions. Moreover, typical morphological features of apoptosis in HeLa cells including the formation of apoptotic body-like vesicles, chromatin condensation and margination were observed by using 4, 6-diamidino-2-phenylindole dihydrochloride (DAPI) staining and fluorescence analysis. An apoptotic DNA ladder from 180 to 300 bp was also detected. Furthermore, 10 variation proteins associated with apoptosis pathway, viz. G3PDH isoforms 1/2 (G3PDH1/2), aldosereductase, ectodemal dysplasia receptor associated death receptor domain isoform CRA_a (EDARADD), heat shock 60kD protein 1 variant 1 (HSP60), heat shock 70kDa protein 5 precursor (HSP70), heat shock protein 90kDa beta member 1 precursor (HSP90), 14-3-3 protein zeta/delta, Ran and ubiquitin activating enzyme E1(UBE1), were identified from HMC-treated HeLa cells by the proteomic and quantitative real-time RT-PCR strategies. Importantly, the reactive oxygen species (ROS), mitochondrial membrane potential (Delta psi m) and caspase-9/3 activities were changed significantly in HMC-treated HeLa cells. Together, the data suggests that L. vannamei HMC mediates antiproliferative properties through the apoptosis mechanism involving the mitochondria triggered pathway.	[Zheng, Liyuan; Zhao, Xianliang; Zhang, Pei; Chen, Chuandao; Liu, Shangjie; Huang, Runqing; Zhong, Mingqi; Zhang, Yueling] Shantou Univ, Dept Biol, Shantou 515063, Peoples R China; [Zheng, Liyuan; Zhao, Xianliang; Zhang, Pei; Chen, Chuandao; Liu, Shangjie; Huang, Runqing; Zhong, Mingqi; Zhang, Yueling] Shantou Univ, Guangdong Prov Key Lab Marine Biotechnol, Shantou 515063, Peoples R China; [Wei, Chiju] Shantou Univ, Res Inst Biomed & Adv Mat, Shantou 515063, Peoples R China	Shantou University; Shantou University; Shantou University	Zhang, YL (corresponding author), Shantou Univ, Dept Biol, Shantou 515063, Peoples R China.; Zhang, YL (corresponding author), Shantou Univ, Guangdong Prov Key Lab Marine Biotechnol, Shantou 515063, Peoples R China.	zhangyl@stu.edu.cn		Xianliang, Zhao/0000-0002-1485-0407	National Natural Science Foundation of China [31372558, 31072237]; New Century Excellent Talents Program of Ministry of Education of China [NCET-11-0922]; Natural Science Foundation of Guangdong Province [S2013010015190, 10251503101000002]; Key Innovation Project of Science and Technology of Guangdong Province College [2012CXZD0025, cxzd1123]; National Key Growth Project of Guangdong Province College [2014GKXM043]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents Program of Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Key Innovation Project of Science and Technology of Guangdong Province College; National Key Growth Project of Guangdong Province College	This work was sponsored by National Natural Science Foundation of China (Nos. 31372558 & 31072237), New Century Excellent Talents Program of Ministry of Education of China (No. NCET-11-0922), Natural Science Foundation of Guangdong Province (Nos. S2013010015190 & 10251503101000002), The Key Innovation Project of Science and Technology of Guangdong Province College (Nos. 2012CXZD0025 & cxzd1123) and The National Key Growth Project of Guangdong Province College (No. 2014GKXM043).	Adachi K, 2005, PIGM CELL RES, V18, P214, DOI 10.1111/j.1600-0749.2005.00232.x; Antonova O, 2014, Z NATURFORSCH C, V69, P325, DOI 10.5560/ZNC.2013-0148; Arancibia A, 2014, EUR J IMMUNOL, V42, P688; Arancibia S, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0087240, 10.1371/journal.pone.0101786]; Arroyo JC, 2004, J CLIN IMMUNOL, V24, P86, DOI 10.1023/B:JOCI.0000018067.71622.fb; Bogdan C, 2007, NAT IMMUNOL, V8, P1029, DOI 10.1038/ni1007-1029; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Cao JS, 2014, MOL IMMUNOL, V57, P263, DOI 10.1016/j.molimm.2013.10.003; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; Coates CJ, 2014, DEV COMP IMMUNOL, V45, P43, DOI 10.1016/j.dci.2014.01.021; Coates CJ, 2013, APOPTOSIS, V18, P1319, DOI 10.1007/s10495-013-0891-x; Decker H, 2007, INTEGR COMP BIOL, V47, P631, DOI 10.1093/icb/icm063; Destoumieux-Garzon D, 2001, J BIOL CHEM, V276, P47070, DOI 10.1074/jbc.M103817200; Dias N, 2005, BIOCHEM PHARMACOL, V70, P1, DOI 10.1016/j.bcp.2005.03.021; Gesheva V, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0034-3; Gesheva V, 2011, FISH SHELLFISH IMMUN, V30, P135, DOI 10.1016/j.fsi.2010.09.018; Giomi F, 2007, GENE, V398, P192, DOI 10.1016/j.gene.2007.02.039; Glazer L, 2013, J EXP BIOL, V216, P1898, DOI 10.1242/jeb.080945; Guncheva M, 2015, RSC ADV, V5, P63345, DOI 10.1039/c5ra12214g; Guo DY, 2011, PARASITOL INT, V60, P242, DOI 10.1016/j.parint.2011.03.005; Jaenicke E, 1999, J BIOL CHEM, V274, P34267, DOI 10.1074/jbc.274.48.34267; Jaenicke E, 2009, DEV COMP IMMUNOL, V33, P1055, DOI 10.1016/j.dci.2009.05.005; Jiang N, 2007, NAT IMMUNOL, V8, P1114, DOI 10.1038/ni1501; Kumar A, 2001, J BIOL CHEM, V276, P2668, DOI 10.1074/jbc.M008356200; Lin MC, 2010, PEPTIDES, V31, P1019, DOI 10.1016/j.peptides.2010.02.023; Liossis SNC, 1997, J IMMUNOL, V158, P5668; Liu C, 2001, INT J CANCER, V129, P1519; Markl J, 2013, BBA-PROTEINS PROTEOM, V1834, P1840, DOI 10.1016/j.bbapap.2013.02.020; McFadden DW, 2003, AM J SURG, V186, P552, DOI 10.1016/j.amjsurg.2003.08.002; Murakawa M, 2001, CELL DEATH DIFFER, V8, P298, DOI 10.1038/sj.cdd.4400811; Nagai T, 2001, J BIOL CHEM, V276, P27166, DOI 10.1074/jbc.M102596200; Neckers L, 2007, CHEM BIOL, V14, P1204, DOI 10.1016/j.chembiol.2007.11.002; OLSSON CA, 1974, J UROLOGY, V111, P173, DOI 10.1016/S0022-5347(17)59919-X; Paul R., 1998, ZOOLOGY, V100, P319; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiao J, 2011, FISH SHELLFISH IMMUN, V31, P736, DOI 10.1016/j.fsi.2011.07.005; Riggs DR, 2005, AM J SURG, V189, P680, DOI 10.1016/j.amjsurg.2004.10.005; Riggs DR, 2002, J SURG RES, V108, P279, DOI 10.1006/jsre.2002.6548; Sagias FG, 2010, CELL TRANSPLANT, V19, P1487, DOI 10.3727/096368910X514620; van Holde KE, 2001, J BIOL CHEM, V276, P15563, DOI 10.1074/jbc.R100010200; vanHolde KE, 1995, ADV PROTEIN CHEM, V47, P1, DOI 10.1016/S0065-3233(08)60545-8; Wilde A, 2009, NAT CELL BIOL, V11, P11, DOI 10.1038/ncb0109-11; Xia F, 2008, CANCER RES, V68, P1826, DOI 10.1158/0008-5472.CAN-07-5279; Youn UJ, 2013, PHYTOTHER RES, V27, P1419, DOI 10.1002/ptr.4893; Zanjani NT, 2016, ANTIMICROB AGENTS CH, V60, P1003, DOI 10.1128/AAC.01738-15; Zhang XB, 2004, ANTIVIR RES, V61, P93, DOI 10.1016/j.antiviral.2003.08.019; Zhang YL, 2006, J PROTEOME RES, V5, P815, DOI 10.1021/pr0503984; Zhang YL, 2004, J EXP MAR BIOL ECOL, V301, P39, DOI 10.1016/j.jembe.2003.09.011; Zhang YL, 2009, FISH SHELLFISH IMMUN, V27, P330, DOI 10.1016/j.fsi.2009.05.017; Zhen-Jun Shao, 2012, Biochem Pharmacol, V84, P507, DOI 10.1016/j.bcp.2012.05.013	51	35	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151801	10.1371/journal.pone.0151801	http://dx.doi.org/10.1371/journal.pone.0151801			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007573	gold, Green Submitted, Green Published			2022-12-26	WOS:000372701200066
J	Cong, LL; Muir, ER; Chen, C; Qian, YS; Liu, JW; Biju, KC; Clark, RA; Li, SL; Duong, TQ				Cong, Linlin; Muir, Eric R.; Chen, Cang; Qian, Yusheng; Liu, Jingwei; Biju, K. C.; Clark, Robert A.; Li, Senlin; Duong, Timothy Q.			Multimodal MRI Evaluation of the MitoPark Mouse Model of Parkinson's Disease	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; IRON-DEPOSITION; ANIMAL-MODELS; COGNITIVE IMPAIRMENT; SUBSTANTIA-NIGRA; BRAIN-TISSUE; DIFFUSION; MICE; DOPAMINE; ATROPHY	The MitoPark mouse, a relatively new genetic model of Parkinson's disease (PD), has a dopaminergic neuron-specific knock-out that inactivates the mitochondrial transcription factor A (Tfam), a protein essential for mitochondrial DNA expression and maintenance. This study used multimodal MRI to characterize the neuroanatomical correlates of PD-related deficits in MitoPark mice, along with functional behavioral tests. Compared with age-matched wild-type animals, MitoPark mice at 30 weeks showed: i) reduced whole-brain volume and increased ventricular volume, indicative of brain atrophy, ii) reduced transverse relaxation time (T-2*) of the substantia nigra and striatum, suggestive of abnormal iron accumulation, iii) reduced apparent diffusion coefficient in the substantia nigra, suggestive of neuronal loss, iv) reduced fractional anisotropy in the corpus callosum and substantia nigra, indicative of white-matter damages, v) cerebral blood flow was not significantly affected, and vi) reduced motor activity in open-field tests, reduced memory in novel object recognition tests, as well as decreased mobility in tail suspension tests, an indication of depression. In sum, MitoPark mice recapitulate changes in many MRI parameters reported in PD patients. Multimodal MRI may prove useful for evaluating neuroanatomical correlates of PD pathophysiology in MitoPark mice, and for longitudinally monitoring disease progression and therapeutic interventions for PD.	[Cong, Linlin; Muir, Eric R.; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA; [Cong, Linlin] Univ Texas San Antonio, Grad Sch Biomed Sci, San Antonio, TX USA; [Muir, Eric R.; Duong, Timothy Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Ophthalmol, San Antonio, TX 78229 USA; [Chen, Cang; Qian, Yusheng; Liu, Jingwei; Biju, K. C.; Clark, Robert A.; Li, Senlin] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Clark, Robert A.; Li, Senlin; Duong, Timothy Q.] South Texas Vet Hlth Care Syst, Dept Vet Affairs, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Muir, ER; Duong, TQ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, San Antonio, TX 78229 USA.; Muir, ER; Duong, TQ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Ophthalmol, San Antonio, TX 78229 USA.; Duong, TQ (corresponding author), South Texas Vet Hlth Care Syst, Dept Vet Affairs, San Antonio, TX USA.	muire@uthscsa.edu; duongt@uthscsa.edu	Duong, Tim/AAL-8357-2021; Liu, Jingwei/AAZ-9739-2021; Clark, Robert/Q-6764-2019	Duong, Tim/0000-0001-6403-2827; Liu, Jingwei/0000-0003-1381-7039; Clark, Robert/0000-0002-4892-3619; Qian, Yusheng/0000-0003-3341-0762; Chandu, Biju/0000-0002-8409-6374	United States (U.S.) Department of Veterans Biomedical Laboratory Research and Development Service [I01BX000737]; William and Ella Owens Medical Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120] Funding Source: NIH RePORTER	United States (U.S.) Department of Veterans Biomedical Laboratory Research and Development Service; William and Ella Owens Medical Research Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	work was supported by Merit Review Award #I01BX000737 from the United States (U.S.) Department of Veterans Biomedical Laboratory Research and Development Service and by a grant from the William and Ella Owens Medical Research Foundation awarded to S.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbier EL, 2005, NMR BIOMED, V18, P499, DOI 10.1002/nbm.979; Baudrexel S, 2010, NEUROIMAGE, V51, P512, DOI 10.1016/j.neuroimage.2010.03.005; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betarbet R, 2002, BIOESSAYS, V24, P308, DOI 10.1002/bies.10067; Beyer MK, 2007, J NEUROL NEUROSUR PS, V78, P254, DOI 10.1136/jnnp.2006.093849; Blesa J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/845618; Boska MD, 2007, NEUROBIOL DIS, V26, P590, DOI 10.1016/j.nbd.2007.02.010; Burton EJ, 2005, MOVEMENT DISORD, V20, P1571, DOI 10.1002/mds.20652; Castagne Vincent, 2011, Curr Protoc Neurosci, VChapter 8, DOI 10.1002/0471142301.ns0810as55; Cicchetti F, 2009, TRENDS PHARMACOL SCI, V30, P475, DOI 10.1016/j.tips.2009.06.005; Cochrane CJ, 2013, NEUROLOGY, V80, P857, DOI 10.1212/WNL.0b013e318284070c; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dexter DT, 2013, FREE RADICAL BIO MED, V62, P132, DOI 10.1016/j.freeradbiomed.2013.01.018; DEXTER DT, 1989, J NEUROCHEM, V52, P1830, DOI 10.1111/j.1471-4159.1989.tb07264.x; Du GW, 2011, MOVEMENT DISORD, V26, P1627, DOI 10.1002/mds.23643; Duty S, 2011, BRIT J PHARMACOL, V164, P1357, DOI 10.1111/j.1476-5381.2011.01426.x; Ekstrand MI, 2007, P NATL ACAD SCI USA, V104, P1325, DOI 10.1073/pnas.0605208103; Ekstrand MI, 2009, PARKINSONISM RELAT D, V15, pS185, DOI 10.1016/S1353-8020(09)70811-9; Fernandez-Seara MA, 2012, NEUROIMAGE, V59, P2743, DOI 10.1016/j.neuroimage.2011.10.033; Firbank M, 2003, NEUROIMAGE, V20, P1309, DOI 10.1016/S1053-8119(03)00364-1; Galter D, 2010, GENES BRAIN BEHAV, V9, P173, DOI 10.1111/j.1601-183X.2009.00542.x; Gattellaro G, 2009, AM J NEURORADIOL, V30, P1222, DOI 10.3174/ajnr.A1556; Good CH, 2011, FASEB J, V25, P1333, DOI 10.1096/fj.10-173625; Graham JM, 2000, BRAIN, V123, P2423, DOI 10.1093/brain/123.12.2423; Halliday GM, 2009, PARKINSONISM RELAT D, V15, pS152, DOI 10.1016/S1353-8020(09)70804-1; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; HERSCOVITCH P, 1985, J CEREBR BLOOD F MET, V5, P65, DOI 10.1038/jcbfm.1985.9; Hunot S, 2003, ANN NEUROL, V53, pS49, DOI 10.1002/ana.10481; JAGUST WJ, 1992, BRAIN, V115, P521, DOI 10.1093/brain/115.2.521; Jenner P, 2008, ANN NEUROL, V64, pS16, DOI 10.1002/ana.21489; Kaidanovich-Beilin O, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-35; Krabbe K, 2005, J NEUROL SCI, V239, P45, DOI 10.1016/j.jns.2005.07.013; Lau JC, 2008, NEUROIMAGE, V42, P19, DOI 10.1016/j.neuroimage.2008.04.252; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lee HM, 2014, PARKINSONISM RELAT D, V20, P622, DOI 10.1016/j.parkreldis.2014.03.009; Li XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071341; Long JA, 2015, J NEUROTRAUM, V32, P598, DOI 10.1089/neu.2014.3563; Melzer TR, 2011, BRAIN, V134, P845, DOI 10.1093/brain/awq377; Mueggler T, 2004, EUR J NEUROSCI, V20, P811, DOI 10.1111/j.1460-9568.2004.03534.x; Muir ER, 2008, MAGN RESON MED, V60, P744, DOI 10.1002/mrm.21721; Nagano-Saito A, 2005, NEUROLOGY, V64, P224, DOI 10.1212/01.WNL.0000149510.41793.50; Nicoletti G, 2006, BRAIN, V129, P2679, DOI 10.1093/brain/awl166; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Peran P, 2010, BRAIN, V133, P3423, DOI 10.1093/brain/awq212; Pyatigorskaya N, 2014, THER ADV NEUROL DISO, V7, P12, DOI 10.1177/1756285613511507; Shen J, 2004, NEURON, V43, P301, DOI 10.1016/j.neuron.2004.07.012; Shen Q, 2015, BRAIN RES, V1599, P126, DOI 10.1016/j.brainres.2014.12.049; Spring S, 2007, NEUROIMAGE, V35, P1424, DOI 10.1016/j.neuroimage.2007.02.023; Sterky FH, 2011, P NATL ACAD SCI USA, V108, P12937, DOI 10.1073/pnas.1103295108; Symonds LL, 1999, J NEUROIMAGING, V9, P201, DOI 10.1111/jon199994201; Vernon AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017269; Wang Y, 2012, AM J NEURORADIOL, V33, P266, DOI 10.3174/ajnr.A2765; Zhan W, 2012, MOVEMENT DISORD, V27, P90, DOI 10.1002/mds.23917; Zhang JQ, 2010, BRAIN RES, V1330, P124, DOI 10.1016/j.brainres.2010.03.036; Zhang KY, 2011, EUR J RADIOL, V77, P269, DOI 10.1016/j.ejrad.2009.07.032	56	14	15	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151884	10.1371/journal.pone.0151884	http://dx.doi.org/10.1371/journal.pone.0151884			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003179	Green Published, Green Submitted, gold			2022-12-26	WOS:000372697400053
J	Hammamieh, R; Muhie, S; Borschel, R; Gautam, A; Miller, SA; Chakraborty, N; Jett, M				Hammamieh, Rasha; Muhie, Seid; Borschel, Richard; Gautam, Aarti; Miller, Stacy-Ann; Chakraborty, Nabarun; Jett, Marti			Temporal Progression of Pneumonic Plague in Blood of Nonhuman Primate: A Transcriptomic Analysis	PLOS ONE			English	Article							YERSINIA-PESTIS CO92; TOLL-LIKE RECEPTORS; MOUSE MODEL; KAPPA-B; BIOLOGICAL AGENTS; IMMUNE-RESPONSE; INNATE IMMUNITY; BUBONIC PLAGUE; INFECTION; EXPRESSION	Early identification of impending illness during widespread exposure to a pathogenic agent offers a potential means to initiate treatment during a timeframe when it would be most likely to be effective and has the potential to identify novel therapeutic strategies. The latter could be critical, especially as antibiotic resistance is becoming widespread. In order to examine pre-symptomatic illness, African green monkeys were challenged intranasally with aerosolized Yersinia pestis strain CO92 and blood samples were collected in short intervals from 45 m till 42 h post-exposure. Presenting one of the first genomic investigations of a NHP model challenged by pneumonic plague, whole genome analysis was annotated in silico and validated by qPCR assay. Transcriptomic profiles of blood showed early perturbation with the number of differentially expressed genes increasing until 24 h. By then, Y. pestis had paralyzed the host defense, as suggested by the functional analyses. Early activation of the apoptotic networks possibly facilitated the pathogen to overwhelm the defense mechanisms, despite the activation of the pro-inflammatory mechanism, toll-like receptors and microtubules at the port-of-entry. The overexpressed transcripts encoding an early pro-inflammatory response particularly manifested in active lymphocytes and ubiquitin networks were a potential deviation from the rodent models, which needs further verification. In summary, the present study recognized a pattern of Y. pestis pathogenesis potentially more applicable to the human system. Independent validation using the complementary omics approach with comprehensive evaluation of the organs, such as lungs which showed early bacterial infection, is essential.	[Hammamieh, Rasha; Muhie, Seid; Gautam, Aarti; Miller, Stacy-Ann; Chakraborty, Nabarun; Jett, Marti] US Army Ctr Environm Hlth Res, Ft Detrick, MD 21702 USA; [Muhie, Seid] NCI, Adv Biomed Ctr, Fredrick Natl Lab Canc Res, Frederick, MD 21702 USA; [Borschel, Richard] Walter Reed Army Med Ctr, Silver Spring, MD 20910 USA; [Gautam, Aarti; Miller, Stacy-Ann; Chakraborty, Nabarun] Geneva Fdn, Ft Detrick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Defense; United States Army	Hammamieh, R (corresponding author), US Army Ctr Environm Hlth Res, Ft Detrick, MD 21702 USA.	Rasha.Hammamieh1.civ@mail.mil		Hammamieh, Rasha/0000-0001-8643-6232	Defense Threat Reduction Agency [TMTI0029_09_WR_T]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by Defense Threat Reduction Agency, Funding #: TMTI0029_09_WR_T received by: MJ and RH.	Agar SL, 2008, MICROBIOL-SGM, V154, P1939, DOI 10.1099/mic.0.2008/017335-0; Agar SL, 2009, MICROBES INFECT, V11, P205, DOI 10.1016/j.micinf.2008.11.009; Amedei A, 2011, J INFECT DEV COUNTR, V5, P628, DOI 10.3855/jidc.1999; Barbaric S, 2001, EMBO J, V20, P4944, DOI 10.1093/emboj/20.17.4944; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Broussard LA, 2001, MOL DIAGN, V6, P323, DOI 10.1054/modi.2001.29155; Bubeck SS, 2007, INFECT IMMUN, V75, P697, DOI 10.1128/IAI.00403-06; Caulfield AJ, 2014, CELL HOST MICROBE, V15, P424, DOI 10.1016/j.chom.2014.03.005; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; Comer JE, 2010, INFECT IMMUN, V78, P5086, DOI 10.1128/IAI.00256-10; Cornez I, 2008, BIOCHEM PHARMACOL, V75, P2122, DOI 10.1016/j.bcp.2008.03.006; Cowan C, 2000, INFECT IMMUN, V68, P4523, DOI 10.1128/IAI.68.8.4523-4530.2000; Davis KJ, 1996, ARCH PATHOL LAB MED, V120, P156; DeClue AE, 2012, VET J, V192, P455, DOI 10.1016/j.tvjl.2011.09.001; Demeure CE, 2012, J INFECT DIS, V205, P134, DOI 10.1093/infdis/jir696; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Durrenberger PF, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-1; Ferrazzi Fulvia, 2005, Appl Bioinformatics, V4, P263, DOI 10.2165/00822942-200504040-00006; Filipovich AH, 2008, IMMUNOL ALLERGY CLIN, V28, P293, DOI 10.1016/j.iac.2008.01.010; Galindo CL, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/914762; Gingras S, 2004, J BIOL CHEM, V279, P54702, DOI 10.1074/jbc.M411043200; Gonzalez RJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004587; Guo RF, 2000, J CLIN INVEST, V106, P1271, DOI 10.1172/JCI10793; Hammamieh R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090425; Heesemann J, 2006, CURR OPIN MICROBIOL, V9, P55, DOI 10.1016/j.mib.2005.10.018; Inglesby TV, 2000, JAMA-J AM MED ASSOC, V283, P2281, DOI 10.1001/jama.283.17.2281; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; KORZENIEWSKI C, 1983, J IMMUNOL METHODS, V64, P313, DOI 10.1016/0022-1759(83)90438-6; Kwit N, 2015, MMWR-MORBID MORTAL W, V64, P918, DOI 10.15585/mmwr.mm6433a6; Lathem WW, 2005, P NATL ACAD SCI USA, V102, P17786, DOI 10.1073/pnas.0506840102; Layton RC, 2011, J MED PRIMATOL, V40, P6, DOI 10.1111/j.1600-0684.2010.00443.x; Levine S, 2002, ANTIMICROB AGENTS CH, V46, P2525, DOI 10.1128/AAC.46.8.2525-2532.2002; Levkau B, 2001, CIRC RES, V88, P282, DOI 10.1161/01.RES.88.3.282; Liu HH, 2009, J BASIC MICROB, V49, P92, DOI 10.1002/jobm.200800027; Magni P, 2008, BIOINFORMATICS, V24, P430, DOI 10.1093/bioinformatics/btm605; Matsumoto H, 2009, CURR OPIN MICROBIOL, V12, P94, DOI 10.1016/j.mib.2008.12.005; O'Brien JM, 2007, AM J MED, V120, P1012, DOI 10.1016/j.amjmed.2007.01.035; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Oleinik NV, 2010, ONCOGENE, V29, P6233, DOI 10.1038/onc.2010.356; Pechous RD, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003679; Perry RD, 1997, CLIN MICROBIOL REV, V10, P35, DOI 10.1128/CMR.10.1.35; Peters KN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003324; Rollins Sarah E, 2003, Am J Clin Pathol, V119 Suppl, pS78; Sebbane F, 2005, AM J PATHOL, V166, P1427, DOI 10.1016/S0002-9440(10)62360-7; Sha J, 2013, MICROB PATHOGENESIS, V55, P39, DOI 10.1016/j.micpath.2012.09.011; Sladek NE, 2002, CANCER CHEMOTH PHARM, V49, P309, DOI 10.1007/s00280-001-0412-4; Smiley ST, 2008, IMMUNOL REV, V225, P256, DOI 10.1111/j.1600-065X.2008.00674.x; Smiley ST, 2007, ADV EXP MED BIOL, V603, P376; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Tourdjman M, 2012, CLIN INFECT DIS, V55, pE58, DOI 10.1093/cid/cis578; Trulzsch K, 2005, J IMMUNOL, V174, P4244, DOI 10.4049/jimmunol.174.7.4244; Uusitalo-Seppala R, 2011, SCAND J INFECT DIS, V43, P883, DOI 10.3109/00365548.2011.600325; Vesanto J, 2000, IEEE T NEURAL NETWOR, V11, P586, DOI 10.1109/72.846731; Webel DM, 1997, J ANIM SCI, V75, P1514; Whitby M, 2002, MED J AUSTRALIA, V176, P605, DOI 10.5694/j.1326-5377.2002.tb04594.x; Wullaert A, 2006, TRENDS IMMUNOL, V27, P533, DOI 10.1016/j.it.2006.09.003; Yang RF, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00157; Zhang Y, 2005, J IMMUNOL, V174, P7939, DOI 10.4049/jimmunol.174.12.7939; Zhou DS, 2006, MICROBES INFECT, V8, P273, DOI 10.1016/j.micinf.2005.06.006	59	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151788	10.1371/journal.pone.0151788	http://dx.doi.org/10.1371/journal.pone.0151788			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003632	Green Published, Green Submitted, gold			2022-12-26	WOS:000372697400043
J	Hymowitz, MB; Chang, D; Feinberg, EB; Roy, S				Hymowitz, Maggie B.; Chang, Donny; Feinberg, Edward B.; Roy, Sayon			Increased Intraocular Pressure and Hyperglycemic Level in Diabetic Patients	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; TRABECULAR MESHWORK CELLS; AQUEOUS-HUMOR DYNAMICS; BEAVER DAM EYE; EXTRACELLULAR-MATRIX; MELLITUS; RISK; EXPRESSION; GLUCOSE	Purpose To determine whether hyperglycemic levels as determined from high hemoglobin A1c (HbA1c) levels influence intraocular pressure (IOP) in patients with non-proliferative diabetic retinopathy (NPDR). Methods A retrospective chart review was performed on subjects with a diagnosis of NPDR and a corresponding HbA1c level measured within 90 days before or after an IOP measurement over a two-year period. Exclusion criteria included a diagnosis of glaucoma or treatment with IOP lowering medications or oral or topical steroids. Results Using 14.5mmHg as a baseline mean value for IOP, 42 subjects had an IOP < 14.5mmHg and mean HbA1c of 8.1 +/- 1.1, while 72 subjects had an IOP >= 14.5mmHg and a mean HbA1c of 9.0 +/- 2.1. Although there was an overlap in the confidence intervals, a significant difference (P = 0.01) in the mean HbA1c level was observed in regression analysis between the two groups. Importantly, diabetic subjects with elevated HbA1c levels rarely (< 1%) exhibited reduced IOP levels. Conclusions Diabetic subjects with elevated HbA1c levels exhibited significantly higher IOPs compared to those with lower HbA1c levels. Findings from this study indicate an association between hyperglycemia and elevated IOP and that poor glycemic control may contribute to increased IOP levels in long-term diabetic patients.	[Hymowitz, Maggie B.; Chang, Donny; Feinberg, Edward B.; Roy, Sayon] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Roy, Sayon] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA	Boston University; Boston University	Roy, S (corresponding author), Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA.; Roy, S (corresponding author), Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA.	sayon@bu.edu			Massachusetts Lions Eye Research Fund, Incorporated	Massachusetts Lions Eye Research Fund, Incorporated	This study was supported by a departmental grant from the Massachusetts Lions Eye Research Fund, Incorporated. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacharach J, 2003, J OCUL PHARMACOL TH, V19, P93, DOI 10.1089/108076803321637618; Bonovas S, 2004, DIABETIC MED, V21, P609, DOI 10.1111/j.1464-5491.2004.01173.x; Chopra V, 2008, OPHTHALMOLOGY, V115, P227, DOI 10.1016/j.ophtha.2007.04.049; DAVIES PD, 1984, EXP EYE RES, V39, P605, DOI 10.1016/0014-4835(84)90060-5; Dickerson JE, 1998, EXP EYE RES, V66, P731, DOI 10.1006/exer.1997.0470; Dielemans I, 1996, OPHTHALMOLOGY, V103, P1271, DOI 10.1016/S0161-6420(96)30511-3; Gabelt BT, 2005, PROG RETIN EYE RES, V24, P612, DOI 10.1016/j.preteyeres.2004.10.003; Guo L, 2005, INVEST OPHTH VIS SCI, V46, P175, DOI 10.1167/iovs.04-0832; Ignat Florica, 2002, Oftalmologia, V55, P43; KAHN HA, 1980, AM J EPIDEMIOL, V111, P769, DOI 10.1093/oxfordjournals.aje.a112955; Kaimbo DKW, 2001, J CLIN EPIDEMIOL, V54, P166, DOI 10.1016/S0895-4356(00)00291-2; KLEIN BEK, 1994, OPHTHALMOLOGY, V101, P1173; KLEIN BEK, 1992, INVEST OPHTH VIS SCI, V33, P2224; Li A-F, 2003, INVESTIGATIVE OPHTHA, V44; Lutjen-Drecoll E, 1999, PROG RETIN EYE RES, V18, P91, DOI 10.1016/S1350-9462(98)00011-1; Mitchell P, 1997, OPHTHALMOLOGY, V104, P712, DOI 10.1016/S0161-6420(97)30247-4; Oshitari T, 2007, AM J OPHTHALMOL, V143, P363, DOI 10.1016/j.ajo.2006.09.033; Pasquale LR, 2006, OPHTHALMOLOGY, V113, P1081, DOI 10.1016/j.ophtha.2006.01.066; Perez-Rico C, 2015, ACTA OPHTHALMOL, V93, pe193, DOI 10.1111/aos.12530; Qureshi Imran Ahmad, 1995, JPMA (Journal of the Pakistan Medical Association), V45, P150; Rombold F, 2005, OPHTHALMOLOGE, V102, P158, DOI 10.1007/s00347-004-1078-1; Sato T, 2002, INVEST OPHTH VIS SCI, V43, P170; Soto I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107291; Tane N, 2007, EXP EYE RES, V84, P832, DOI 10.1016/j.exer.2007.01.002; Toris CB, 1999, AM J OPHTHALMOL, V127, P407, DOI 10.1016/S0002-9394(98)00436-X; Yue BYJT, 1996, SURV OPHTHALMOL, V40, P379; Yun HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107446	27	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151833	10.1371/journal.pone.0151833	http://dx.doi.org/10.1371/journal.pone.0151833			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002725	Green Submitted, Green Published, gold			2022-12-26	WOS:000372697400050
J	Pan, D; Vargas-Morales, O; Zern, B; Anselmo, AC; Gupta, V; Zakrewsky, M; Mitragotri, S; Muzykantov, V				Pan, Daniel; Vargas-Morales, Omayra; Zern, Blaine; Anselmo, Aaron C.; Gupta, Vivek; Zakrewsky, Michael; Mitragotri, Samir; Muzykantov, Vladimir			The Effect of Polymeric Nanoparticles on Biocompatibility of Carrier Red Blood Cells	PLOS ONE			English	Article							BIOTINYLATED ERYTHROCYTES; PLASMINOGEN-ACTIVATOR; DRUG-DELIVERY; INDUCED LYSIS; COMPLEMENT; MEMBRANE; ADSORPTION; BINDING; THROMBOPROPHYLAXIS; BIODISTRIBUTION	Red blood cells (RBCs) can be used for vascular delivery of encapsulated or surface-bound drugs and carriers. Coupling to RBC prolongs circulation of nanoparticles (NP, 200 nm spheres, a conventional model of polymeric drug delivery carrier) enabling their transfer to the pulmonary vasculature without provoking overt RBC elimination. However, little is known about more subtle and potentially harmful effects of drugs and drug carriers on RBCs. Here we devised high-throughput in vitro assays to determine the sensitivity of loaded RBCs to osmotic stress and other damaging insults that they may encounter in vivo (e.g. mechanical, oxidative and complement insults). Sensitivity of these tests is inversely proportional to RBC concentration in suspension and our results suggest that mouse RBCs are more sensitive to damaging factors than human RBCs. Loading RBCs by NP at 1: 50 ratio did not affect RBCs, while 10-50 fold higher NP load accentuated RBC damage by mechanical, osmotic and oxidative stress. This extensive loading of RBC by NP also leads to RBCs agglutination in buffer; however, addition of albumin diminished this effect. These results provide a template for analyses of the effects of diverse cargoes loaded on carrier RBCs and indicate that: i) RBCs can tolerate carriage of NP at doses providing loading of millions of nanoparticles per microliter of blood; ii) tests using protein-free buffers and mouse RBCs may overestimate adversity that may be encountered in humans.	[Pan, Daniel; Vargas-Morales, Omayra; Zern, Blaine; Muzykantov, Vladimir] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Pan, Daniel; Vargas-Morales, Omayra; Zern, Blaine; Muzykantov, Vladimir] Univ Penn, Perelman Sch Med, Ctr Translat Targeted Therapeut & Nanomed, Philadelphia, PA 19104 USA; [Anselmo, Aaron C.; Gupta, Vivek; Zakrewsky, Michael; Mitragotri, Samir] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; [Anselmo, Aaron C.; Gupta, Vivek; Zakrewsky, Michael; Mitragotri, Samir] Univ Calif Santa Barbara, Ctr Bioengn, Santa Barbara, CA 93106 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Muzykantov, V (corresponding author), Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Muzykantov, V (corresponding author), Univ Penn, Perelman Sch Med, Ctr Translat Targeted Therapeut & Nanomed, Philadelphia, PA 19104 USA.	muzykant@mail.med.upenn.edu		Gupta, Vivek/0000-0002-3618-8178; Anselmo, Aaron/0000-0003-3290-7857	National Heart, Lung, and Blood Institute (NHLBI) [R01 HL121134-02, T32 HL07915, T32 HL07748]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL121134, T32HL007748, T32HL007915] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Heart, Lung, and Blood Institute (NHLBI): R01 HL121134-02, Muzykantov, Vladimir R, Drug delivery by carrier erythrocytes; T32 HL07915, Shaddy, Robert E and Levy, Robert J (co-PI), Training in Molecular Therapeutics for Pediatric Cardiology; and T32 HL07748, Fisher, AB (PI) Training in Lung Cell and Molecular Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselmo AC, 2015, BIOMATERIALS, V68, P1, DOI 10.1016/j.biomaterials.2015.07.043; Anselmo AC, 2014, J CONTROL RELEASE, V190, P531, DOI 10.1016/j.jconrel.2014.03.050; Anselmo AC, 2013, ACS NANO, V7, P11129, DOI 10.1021/nn404853z; Atukorale PU, 2015, NANOSCALE, V7, P11420, DOI 10.1039/c5nr01355k; Barodka VM, 2014, BLOOD CELL MOL DIS, V52, P230, DOI 10.1016/j.bcmd.2013.10.004; BARTOSZ G, 1991, GERONTOLOGY, V37, P33, DOI 10.1159/000213251; BECKER PS, 1986, J BIOL CHEM, V261, P4620; Brazile D, 1996, J PHARM SCI, V84, P493; Chambers E, 2007, EXP BIOL MED, V232, P958; Chen LQ, 2015, CHEM RES TOXICOL, V28, P501, DOI 10.1021/tx500479m; CLEMENS MR, 1987, CHEM PHYS LIPIDS, V45, P251, DOI 10.1016/0009-3084(87)90068-5; Cremel M, 2013, INT J PHARMACEUT, V443, P39, DOI 10.1016/j.ijpharm.2012.12.044; Danielyan K, 2008, CIRCULATION, V118, P1442, DOI 10.1161/CIRCULATIONAHA.107.750257; Down LA, 2011, ANN BIOMED ENG, V39, P1632, DOI 10.1007/s10439-011-0262-0; Evans BC, 2013, JOVE-J VIS EXP, DOI 10.3791/50166; Gersh KC, 2011, BLOOD, V117, P4964, DOI 10.1182/blood-2010-10-310409; Godfrin Y, 2012, EXPERT OPIN BIOL TH, V12, P127, DOI 10.1517/14712598.2012.631909; GONZALES R, 1984, CANCER RES, V44, P4137; Grey JL, 2012, BIOCHEMISTRY-US, V51, P6838, DOI 10.1021/bi300693k; Gundersen SI, 2007, BIOTECHNOL BIOENG, V96, P1199, DOI 10.1002/bit.21204; GUTTERIDGE JMC, 1995, CLIN CHEM, V41, P1819; HEBBEL RP, 1990, BLOOD, V76, P1015; Kontos S, 2013, P NATL ACAD SCI USA, V110, pE60, DOI 10.1073/pnas.1216353110; Koshkaryev A, 2013, ADV DRUG DELIVER REV, V65, P24, DOI 10.1016/j.addr.2012.08.009; Kuypers FA, 1998, J HEART VALVE DIS, V7, P387; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Li CM, 2014, ACS APPL MATER INTER, V6, P13956, DOI 10.1021/am503332z; Lin JS, 2015, BBA-GEN SUBJECTS, V1850, P419, DOI 10.1016/j.bbagen.2014.11.016; Liu ZH, 2010, BIOMATERIALS, V31, P3364, DOI 10.1016/j.biomaterials.2010.01.021; Mandal D, 2003, J BIOL CHEM, V278, P52551, DOI 10.1074/jbc.M306914200; Mukthavaram R, 2014, J CONTROL RELEASE, V183, P146, DOI 10.1016/j.jconrel.2014.03.038; Murad KT, 1999, BLOOD, V93, P2121, DOI 10.1182/blood.V93.6.2121.406a30_2121_2127; Murciano JC, 2003, NAT BIOTECHNOL, V21, P891, DOI 10.1038/nbt846; MUZYKANTOV V R, 1985, Journal of Applied Biochemistry, V7, P223; Muzykantov VR, 2010, EXPERT OPIN DRUG DEL, V7, P403, DOI 10.1517/17425241003610633; MUZYKANTOV VR, 1987, AM J PATHOL, V128, P276; MUZYKANTOV VR, 1992, BIOCHIM BIOPHYS ACTA, V1107, P119, DOI 10.1016/0005-2736(92)90336-K; Muzykantov VR, 1996, BIOTECHNOL APPL BIOC, V24, P41; MUZYKANTOV VR, 1993, J IMMUNOL METHODS, V158, P183, DOI 10.1016/0022-1759(93)90212-P; MUZYKANTOV VR, 1991, BIOCHEM J, V273, P393, DOI 10.1042/bj2730393; Muzykantov VR, 1996, ANAL BIOCHEM, V241, P109, DOI 10.1006/abio.1996.0384; MUZYKANTOV VR, 1993, FEBS LETT, V318, P108, DOI 10.1016/0014-5793(93)80002-C; MUZYKANTOV VR, 1992, INT J ARTIF ORGANS, V15, P622, DOI 10.1177/039139889201501010; MUZYKANTOV VR, 1991, FEBS LETT, V280, P112, DOI 10.1016/0014-5793(91)80216-P; Nagababu E, 2013, FREE RADICAL RES, V47, P164, DOI 10.3109/10715762.2012.756138; Nagababu E, 2008, FREE RADICAL RES, V42, P824, DOI 10.1080/10715760802459879; Nagababu E, 2010, LIFE SCI, V86, P133, DOI 10.1016/j.lfs.2009.11.015; Perry JL, 2012, NANO LETT, V12, P5304, DOI 10.1021/nl302638g; Rossi Luiga, 2005, Expert Opin Drug Deliv, V2, P311, DOI 10.1517/17425247.2.2.311; SALLAM AM, 1984, BIORHEOLOGY, V21, P783; Scott MD, 1997, P NATL ACAD SCI USA, V94, P7566, DOI 10.1073/pnas.94.14.7566; Serafini S, 2004, TRANSFUS MED HEMOTH, V31, P92, DOI 10.1159/000078042; Villa CH, 2015, THER DELIV, V6, P795, DOI [10.4155/TDE.15.34, 10.4155/tde.15.34]; WAGNER GM, 1987, BLOOD, V69, P1777; WAUGH RE, 1992, BLOOD, V79, P1351; Yen JH, 2014, J ARTIF ORGANS, V17, P178, DOI 10.1007/s10047-014-0755-3; Zaitsev S, 2006, BLOOD, V108, P1895, DOI 10.1182/blood-2005-11-012336; Zaitsev S, 2012, BLOOD, V119, P4779, DOI 10.1182/blood-2011-12-398149; Zaitsev S, 2010, BLOOD, V115, P5241, DOI 10.1182/blood-2010-01-261610; Zaitzev S, 2010, J PHARMACOL EXP THER, V332, P1022, DOI 10.1124/jpet.109.159194; Zhao YN, 2011, ACS NANO, V5, P1366, DOI 10.1021/nn103077k	61	82	83	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152074	10.1371/journal.pone.0152074	http://dx.doi.org/10.1371/journal.pone.0152074			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003833	Green Published, Green Submitted, gold			2022-12-26	WOS:000372697400073
J	Corbel, A; Baud, D; Chaouch, A; Beney, J; Csajka, C; Panchaud, A				Corbel, Aline; Baud, David; Chaouch, Aziz; Beney, Johnny; Csajka, Chantal; Panchaud, Alice			Utility of an Algorithm to Increase the Accuracy of Medication History in an Obstetrical Setting	PLOS ONE			English	Article							RECONCILIATION; DISCHARGE; ADMISSION; RECORDS; RECALL; DESIGN	Background In an obstetrical setting, inaccurate medication histories at hospital admission may result in failure to identify potentially harmful treatments for patients and/or their fetus(es). Methods This prospective study was conducted to assess average concordance rates between (1) a medication list obtained with a one-page structured medication history algorithm developed for the obstetrical setting and (2) the medication list reported in medical records and obtained by open-ended questions based on standard procedures. Both lists were converted into concordance rate using a best possible medication history approach as the reference (information obtained by patients, prescribers and community pharmacists' interviews). Results The algorithm-based method obtained a higher average concordance rate than the standard method, with respectively 90.2% [CI95% 85.8-94.3] versus 24.6% [CI95% 15.3-34.4] concordance rates (p<0.01). Conclusion Our algorithm-based method strongly enhanced the accuracy of the medication history in our obstetric population, without using substantial resources. Its implementation is an effective first step to the medication reconciliation process, which has been recognized as a very important component of patients' drug safety.	[Corbel, Aline; Csajka, Chantal; Panchaud, Alice] Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland; [Corbel, Aline; Csajka, Chantal; Panchaud, Alice] Univ Lausanne, Geneva, Switzerland; [Baud, David] Univ Lausanne Hosp, Dept Gynecol & Obstet, Lausanne, Switzerland; [Chaouch, Aziz] Univ Lausanne Hosp, Inst Social & Prevent Med, Lausanne, Switzerland; [Beney, Johnny] Valais Hosp, Cent Inst, Div Pharm, Sion, Switzerland; [Csajka, Chantal; Panchaud, Alice] Univ Lausanne Hosp, Div Clin Pharmacol, Lausanne, Switzerland	University of Geneva; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Panchaud, A (corresponding author), Univ Geneva, Sch Pharmaceut Sci, Geneva, Switzerland.	alice.panchaud@chuv.ch	Panchaud, Alice/S-6535-2019	Panchaud, Alice/0000-0001-6086-2401; Csajka, Chantal/0000-0002-0660-082X; Baud, David/0000-0001-9914-6496				Gama H, 2009, PHARMACOEPIDEM DR S, V18, P175, DOI 10.1002/pds.1703; Glintborg B, 2008, BRIT J CLIN PHARMACO, V65, P265, DOI 10.1111/j.1365-2125.2007.03017.x; Greenwald JL, 2010, J HOSP MED, V5, P477, DOI 10.1002/jhm.849; Halapy Henry, 2012, Can J Hosp Pharm, V65, P360; Kimmel SE, 2003, PHARMACOEPIDEM DR S, V12, P1, DOI 10.1002/pds.764; Lau HS, 2000, BRIT J CLIN PHARMACO, V49, P597, DOI 10.1046/j.1365-2125.2000.00204.x; Leguelinel-Blache G, 2014, EUR J INTERN MED, V25, P808, DOI 10.1016/j.ejim.2014.09.012; Lupattelli A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004365; McKibbon KA, 2012, J AM MED INFORM ASSN, V19, P22, DOI 10.1136/amiajnl-2011-000304; Oppermann M, 2013, BRIT J CLIN PHARMACO, V75, P822, DOI 10.1111/j.1365-2125.2012.04388.x; Parlato S, 2010, DEV OUTIL ANAMNESE M; Perennes M, 2012, PRESSE MED, V41, pe77; Poon EG, 2006, J AM MED INFORM ASSN, V13, P581, DOI 10.1197/jamia.M2142; Schnipper JL, 2011, J AM MED INFORM ASSN, V18, P309, DOI 10.1136/amiajnl-2010-000040; Tam VC, 2005, CAN MED ASSOC J, V173, P510, DOI 10.1503/cmaj.045311; Tamblyn R, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-150; Turchin A, 2008, J AM MED INFORM ASSN, V15, P449, DOI 10.1197/jamia.M2561; World Health Organisation, 2012, STAND OP PROT MED RE; World Health Organization, 2013, HIGH 5S PROJ INT REP; World Health Organization, 2007, ASS MED ACC TRANS CA	20	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151205	10.1371/journal.pone.0151205	http://dx.doi.org/10.1371/journal.pone.0151205			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3NW	26999743	Green Published, gold, Green Submitted			2022-12-26	WOS:000372694700026
J	Harron, K; Mok, Q; Hughes, D; Muller-Pebody, B; Parslow, R; Ramnarayan, P; Gilbert, R				Harron, Katie; Mok, Quen; Hughes, Dyfrig; Muller-Pebody, Berit; Parslow, Roger; Ramnarayan, Padmanabhan; Gilbert, Ruth			Generalisability and Cost-Impact of Antibiotic-Impregnated Central Venous Catheters for Reducing Risk of Bloodstream Infection in Paediatric Intensive Care Units in England	PLOS ONE			English	Article							UNCERTAINTY	Background We determined the generalisability and cost-impact of adopting antibiotic-impregnated CVCs in all paediatric intensive care units (PICUs) in England, based on results from a large randomised controlled trial (the CATCH trial; ISRCTN34884569). Methods BSI rates using standard CVCs were estimated through linkage of national PICU audit data (PICANet) with laboratory surveillance data. We estimated the number of BSI averted if PICUs switched from standard to antibiotic-impregnated CVCs by applying the CATCH trial rate-ratio (0.40; 95% CI 0.17,0.97) to the BSI rate using standard CVCs. The value of healthcare resources made available by averting one BSI as estimated from the trial economic analysis was 10,975; pound 95% CI -2,801 pound, 24,751 pound. Results The BSI rate using standard CVCs was 4.58 (95% CI 4.42,4.74) per 1000 CVC-days in 2012. Applying the rate-ratio gave 232 BSI averted using antibiotic CVCs. The additional cost of purchasing antibiotic-impregnated compared with standard CVCs was 36 pound for each child, corresponding to additional costs of 317,916 pound for an estimated 8831 CVCs required in PICUs in 2012. Based on 2012 BSI rates, management of BSI in PICUs cost 2.5 pound million annually (95% uncertainty interval: -160,986 pound, 5,603,005) pound. The additional cost of antibiotic CVCs would be less than the value of resources associated with managing BSI in PICUs with standard BSI rates >1.2 per 1000 CVC-days. Conclusions The cost of introducing antibiotic-impregnated CVCs is less than the cost associated with managing BSIs occurring with standard CVCs. The long-term benefits of preventing BSI could mean that antibiotic CVCs are cost-effective even in PICUs with extremely low BSI rates.	[Harron, Katie; Gilbert, Ruth] UCL, Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England; [Mok, Quen] Great Ormond St Hosp Sick Children, Paediat Intens Care Unit, London WC1N 3JH, England; [Hughes, Dyfrig] Bangor Univ, Ctr Hlth Econ & Med Evaluat, Bangor LL57 2PZ, Gwynedd, Wales; [Muller-Pebody, Berit] Publ Hlth England, 61 Colindale Ave, London NW9 5EQ, England; [Parslow, Roger] Univ Leeds, Leeds LS2 9JT, W Yorkshire, England; [Ramnarayan, Padmanabhan] Great Ormond St Hosp Sick Children, Childrens Acute Transport Serv, London WC1N 3JH, England	University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Bangor University; Public Health England; University of Leeds; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Harron, K (corresponding author), UCL, Inst Child Hlth, 30 Guilford St, London WC1N 1EH, England.	k.harron@ucl.ac.uk	Mok, Quen/AAA-2648-2019; Parslow, Roger/AAV-1477-2020; Ramnarayan, Padmanabhan/AAI-6783-2020; Hughes, Dyfrig/H-5252-2012	Mok, Quen/0000-0003-4807-9275; Ramnarayan, Padmanabhan/0000-0003-0784-8154; Hughes, Dyfrig/0000-0001-8247-7459; Harron, Katie/0000-0002-3418-2856; Muller-Pebody, Berit/0000-0002-8874-480X; Parslow, Roger/0000-0002-3945-5294; Gilbert, Ruth/0000-0001-9347-2709	National Institute of Health Resarch [08/13/47]; Medical Research Council [MR/K006584/1] Funding Source: researchfish	National Institute of Health Resarch; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the National Institute of Health Resarch Health Technology Assessment programme (project number 08/13/47). The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, NHS or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Elella R, 2010, PEDIATR CARDIOL, V31, P483, DOI 10.1007/s00246-009-9624-x; Briggs A, 2005, VALUE HEALTH, V8, P1, DOI 10.1111/j.1524-4733.2005.08101.x; Claxton K, 2005, HEALTH ECON, V14, P339, DOI 10.1002/hec.985; Department of Health, 2007, SAV LIV RED INF DEL; Elward AM, 2005, PEDIATRICS, V115, P868, DOI 10.1542/peds.2004-0256; Gilbert R, 2016, LANCET IN PRESS; Gilbert RE, 2008, CURR OPIN INFECT DIS, V21, P235, DOI 10.1097/QCO.0b013e3282ffd6e0; Harron K, 2015, CRIT CARE M IN PRESS; Harron K, 2014, EVALUATING DATA LINK; Harron K, 2014, INTENS CARE MED, V40, P1916, DOI 10.1007/s00134-014-3516-0; Harron K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085278; Harron K, 2013, INTENS CARE MED, V39, P1080, DOI 10.1007/s00134-013-2841-z; Harron K, 2011, INTENS CARE MED, V37, P1641, DOI 10.1007/s00134-011-2343-9; Hockenhull JC, 2008, HEALTH TECHNOL ASSES, V12, P1; Lakshmi KS, 2007, J TROP PEDIATRICS, V53, P87, DOI 10.1093/tropej/fml073; Nowak JE, 2010, PEDIATR CRIT CARE ME, V11, P579, DOI 10.1097/PCC.0b013e3181d90569; O'Hagan A, 2005, PHARMACOECONOMICS, V23, P529, DOI 10.2165/00019053-200523060-00001; Universities of Leeds and Leicester, 2013, PAED INT CAR AUD NET; Wilson J, 2011, CLIN MICROBIOL INFEC, V17, P451, DOI 10.1111/j.1469-0691.2010.03262.x; Yogaraj JS, 2002, PEDIATRICS, V110, P481, DOI 10.1542/peds.110.3.481	20	16	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151348	10.1371/journal.pone.0151348	http://dx.doi.org/10.1371/journal.pone.0151348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999045	Green Published, Green Accepted, gold			2022-12-26	WOS:000372694700034
J	Martin-Prevel, Y; Allemand, P; Nikiema, L; Ayassou, KA; Ouedraogo, HG; Moursi, M; De Moura, FF				Martin-Prevel, Yves; Allemand, Pauline; Nikiema, Laetitia; Ayassou, Kossiwavi A.; Ouedraogo, Henri Gautier; Moursi, Mourad; De Moura, Fabiana F.			Biological Status and Dietary Intakes of Iron, Zinc and Vitamin A among Women and Preschool Children in Rural Burkina Faso	PLOS ONE			English	Article							SOLUBLE TRANSFERRIN RECEPTOR; YOUNG-CHILDREN; PREGNANT-WOMEN; PLASMA RETINOL; DEFICIENCY; INFLAMMATION; SUPPLEMENTATION; INFECTION; FERRITIN; IMPACT	Background Food-based approaches such as biofortification are meant to sustainably address micronutrient deficiencies in poor settings. Knowing more about micronutrient intakes and deficiencies is a prerequisite to designing and evaluating interventions. Objective The objectives of the study were to assess biological status and dietary intakes of iron, zinc and vitamin A among women and children aged 36-59 months in rural Burkina Faso and to study relationships between intake and status to better inform future food-based interventions. Design A cross-sectional survey was carried out in two rural provinces of Burkina Faso on a random cluster sample of 480 mother-child pairs. Dietary data was obtained by 24-hour recalls repeated on a random sub-selection of 37.5% of subjects to allow calculation of nutrient's probability of adequacy (PA). Biomarkers were measured on a sub-sample of 180 mother-child pairs. Blood samples were analyzed for hemoglobin, serum ferritin, soluble transferrin receptors (sTfR), C-reactive protein, alpha-1-glycoprotein, serum zinc concentration (SZnC) and retinol. For each micronutrient the relationship between biomarker and dietary intake was investigated by multiple linear regression models accounting for inflammatory biomarkers. Results Mean PA for iron, zinc and vitamin A was 0.49, 0.87 and 0.21 among women and 0.61, 0.95 and 0.33 among children, respectively. Prevalence of anemia, corrected low serum ferritin and high sTfR was 37.6%, 4.0% and 77.5% among women and 72.1%, 1.5% and 87.6% among children, respectively. Prevalence of low SZnC and corrected low serum retinol was 39.4% and 12.0% among women and 63.7% and 24.8% among children, respectively. There was a tendency for a positive relationship between vitamin A intakes and serum retinol among women (beta = 0.0003, P = 0.06). Otherwise, no link was found between micronutrients biomarkers and intakes. Conclusion Our study depicted different images of micronutrient deficiencies when based on dietary intakes or biomarkers results, thus highlighting the need for more suitable biomarkers and more precise measures of absorbable micronutrient intakes at the individual level. It thus points to challenges in the design and evaluation of future biofortification or other food-based interventions in rural areas of Burkina Faso.	[Martin-Prevel, Yves; Allemand, Pauline; Ayassou, Kossiwavi A.] Inst Rech Dev, Res Unit Nutripass 204, Montpellier, France; [Nikiema, Laetitia; Ouedraogo, Henri Gautier] Inst Natl Rech Sci Sante, Ouagadougou, Burkina Faso; [Moursi, Mourad; De Moura, Fabiana F.] Int Food Policy Res Inst, HarvestPlus, Washington, DC 20036 USA	Institut de Recherche pour le Developpement (IRD); CGIAR; International Food Policy Research Institute (IFPRI)	Martin-Prevel, Y (corresponding author), Inst Rech Dev, Res Unit Nutripass 204, Montpellier, France.	yves.martin-prevel@ird.fr	Martin-Prevel, Yves/E-7637-2011	Martin-Prevel, Yves/0000-0002-4689-7867; Moursi, Mourad/0000-0002-5071-8534; De Moura, Fabiana F./0000-0001-8176-5352	Institut de Recherche pour le Developpement; Grand Challenges in Global Health; Bill and Melinda Gates Foundation	Institut de Recherche pour le Developpement; Grand Challenges in Global Health; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work is part of the Grand Challenges in Global Health (#9), an initiative of the Bill and Melinda Gates Foundation through a grant to the International Food Policy Research Institute; with additional funds from the Institut de Recherche pour le Developpement.	Ahmed F, 2003, ASIA PAC J CLIN NUTR, V12, P460; [Anonymous], 2011, VIT MIN NUTR INF SYS; Arimond M, 2010, J NUTR, V140, p2059S, DOI 10.3945/jn.110.123414; Arsenault JE, 2014, J NUTR SCI, V3, DOI 10.1017/jns.2014.53; Artacho R, 1997, SCI TOTAL ENVIRON, V205, P159, DOI 10.1016/S0048-9697(97)00196-4; Asakura K, 2009, PUBLIC HEALTH NUTR, V12, P1373, DOI 10.1017/S1368980008004072; Asare GA, 2010, BIOL TRACE ELEM RES, V137, P139, DOI 10.1007/s12011-009-8571-y; Becquey E, 2010, J NUTR, V140, p2079S, DOI 10.3945/jn.110.123356; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Bui VQ, 2013, FOOD NUTR BULL, V34, P143, DOI 10.1177/156482651303400203; Casgrain A, 2012, AM J CLIN NUTR, V96, P768, DOI 10.3945/ajcn.112.040626; Cook JD, 2003, BLOOD, V101, P3359, DOI 10.1182/blood-2002-10-3071; Ribeiro KDD, 2010, J HUM NUTR DIET, V23, P154, DOI 10.1111/j.1365-277X.2009.01026.x; de Pee S, 1998, AM J CLIN NUTR, V68, P1068, DOI 10.1093/ajcn/68.5.1068; Deegan Heather, 2005, J Adolesc Health, V37, P75, DOI 10.1016/j.jadohealth.2004.07.008; Engle-Stone R, 2014, J NUTR, V144, P382, DOI 10.3945/jn.113.188383; Engle-Stone R, 2012, J NUTR, V142, P555, DOI 10.3945/jn.111.148783; Erhardt JG, 2004, J NUTR, V134, P3127, DOI 10.1093/jn/134.11.3127; Food and Agriculture Organization/World Health Organization/United Nations University, 2001, HUM EN REQ; Gegios A, 2010, PLANT FOOD HUM NUTR, V65, P64, DOI 10.1007/s11130-010-0157-5; Gibson R, 2005, PRINCIPLES NUTR ASSE; Gibson RS, 2012, ADV NUTR, V3, P772, DOI 10.3945/an.112.002287; Grant FKE, 2012, J NUTR, V142, P105, DOI 10.3945/jn.111.146316; Hotz C, 2007, FOOD NUTR BULL, V28, pS430, DOI 10.1177/15648265070283S304; Hotz C, 2007, FOOD NUTR BULL, V28, pS271, DOI 10.1177/15648265070282S206; Hotz C, 2012, PUBLIC HEALTH NUTR, V15, P1688, DOI 10.1017/S1368980012000924; Huybregts LF, 2009, MATERN CHILD NUTR, V5, P211, DOI 10.1111/j.1740-8709.2008.00180.x; Icard-Verniere C, 2013, J AGR FOOD CHEM, V61, P10377, DOI 10.1021/jf402612k; Institut Nationalde la Statistique et de la Demographie (INSD) et ICF International, 2012, ENQ DEM SANT IND MUL; Institute Of Medicine, 2001, DIET REF INT VIT A V; Institute Of Medicine, 2000, DIET REF INT APPL DI; International Zinc Nutrition Consultative Group (IZiNCG), 2004, Food Nutr Bull, V25, pS99; Lowe NM, 2012, BRIT J NUTR, V108, P1962, DOI 10.1017/S0007114512004382; Martin-Prevel Y, 2013, ANN NUTR METAB, V63, P215; Moran VH, 2012, NUTRIENTS, V4, P841, DOI 10.3390/nu4080841; Muller O, 2001, BMJ-BRIT MED J, V322, P1567, DOI 10.1136/bmj.322.7302.1567; Nana CP, 2006, PUBLIC HEALTH NUTR, V9, P808, DOI 10.1079/PHN2005911; Nana Constance P., 2005, Food and Nutrition Bulletin, V26, P356; Nikiema L, IRON ZINC P IN PRESS; Ouedraogo C, 2014, MICR FOR GLOB C JUN; Pollard J, 2003, EUR J CLIN NUTR, V57, P988, DOI 10.1038/sj.ejcn.1601634; Righetti AA, 2013, AM J CLIN NUTR, V97, P1364, DOI 10.3945/ajcn.112.050302; Rohner F., 2013, PUBLIC HEALTH NUTR, V15, P1; Rohner F, 2014, PUBLIC HEALTH NUTR, V17, P2016, DOI 10.1017/S136898001300222X; ROIDT L, 1988, AM J EPIDEMIOL, V128, P645, DOI 10.1093/oxfordjournals.aje.a115012; Samuelson G, 1996, ACTA PAEDIATR, V85, P1033, DOI 10.1111/j.1651-2227.1996.tb14212.x; Spodaryk K, 1999, ARCH PHYSIOL BIOCHEM, V107, P361, DOI 10.1076/1381-3455(199912)107:05;1-5;FT361; Swindale A., 2006, FHI 360FANTA; Thane CW, 2004, EUR J CLIN NUTR, V58, P363, DOI 10.1038/sj.ejcn.1601792; Thurnham DI, 2015, J NUTR, V145, p1137S, DOI 10.3945/jn.114.194712; Thurnham DI, 2010, AM J CLIN NUTR, V92, P546, DOI 10.3945/ajcn.2010.29284; Thurnham DI, 2003, LANCET, V362, P2052, DOI 10.1016/S0140-6736(03)15099-4; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Wessells KR, 2012, J PEDIATR-US, V160, P129, DOI 10.1016/j.jpeds.2011.06.051; WHO, 2007, ASS IR STAT POP INCL; WHO, 2011, SERUM RETINOL CONCEN; WHO, 2001, IRON DEFICIENCY ANAE; WHO/FAO, 2004, VIT MIN REQ HUM NUTR, VSecond; Willett W., 2012, NUTR EPIDEMIOLOGY; World Health Organization, 2008, WHO GLOBAL DATABASE; World Health Organization (WHO), 2013, WORLD HLTH REPORT 20; Zagre No l-Marie, 2002, Sante, V12, P38; Zeba AN, 2012, PUBLIC HEALTH NUTR, V15, P2210, DOI 10.1017/S1368980012000729	63	19	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0146810	10.1371/journal.pone.0146810	http://dx.doi.org/10.1371/journal.pone.0146810			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991908	gold, Green Submitted, Green Published			2022-12-26	WOS:000372582800018
J	Vellinga, TT; den Uil, S; Rinkes, IHB; Marvin, D; Ponsioen, B; Alvarez-Varela, A; Fatrai, S; Scheele, C; Zwijnenburg, DA; Snippert, H; Vermeulen, L; Medema, JP; Stockmann, HB; Koster, J; Fijneman, RJA; de Rooij, J; Kranenburg, O				Vellinga, T. T.; den Uil, S.; Rinkes, I. H. B.; Marvin, D.; Ponsioen, B.; Alvarez-Varela, A.; Fatrai, S.; Scheele, C.; Zwijnenburg, D. A.; Snippert, H.; Vermeulen, L.; Medema, J. P.; Stockmann, H. B.; Koster, J.; Fijneman, R. J. A.; de Rooij, J.; Kranenburg, O.			Collagen-rich stroma in aggressive colon tumors induces mesenchymal gene expression and tumor cell invasion	ONCOGENE			English	Article							INTESTINAL EPITHELIAL-CELLS; HUMAN COLORECTAL-CANCER; MOLECULAR SUBTYPES; UP-REGULATION; TGF-BETA; TRANSITION; METASTASIS; SURVIVAL; PROGRAM; MATRIX	Gene expression-based classification systems have identified an aggressive colon cancer subtype with mesenchymal features, possibly reflecting epithelial-to-mesenchymal transition (EMT) of tumor cells. However, stromal fibroblasts contribute extensively to the mesenchymal phenotype of aggressive colon tumors, challenging the notion of tumor EMT. To separately study the neoplastic and stromal compartments of colon tumors, we have generated a stroma gene filter (SGF). Comparative analysis of stroma(high) and stroma(low) tumors shows that the neoplastic cells in stromahigh tumors express specific EMT drivers (ZEB2, TWIST1, TWIST2) and that 98% of differentially expressed genes are strongly correlated with them. Analysis of differential gene expression between mesenchymal and epithelial cancer cell lines revealed that hepatocyte nuclear factor 4 alpha (HNF4 alpha), a transcriptional activator of intestinal (epithelial) differentiation, and its target genes are highly expressed in epithelial cancer cell lines. However, mesenchymal-type cancer cell lines expressed only part of the mesenchymal genes expressed by tumor-derived neoplastic cells, suggesting that external cues were lacking. We found that collagen-I dominates the extracellular matrix in aggressive colon cancer. Mimicking the tumor microenvironment by replacing laminin-rich Matrigel with collagen-I was sufficient to induce tumor-specific mesenchymal gene expression, suppression of HNF4 alpha and its target genes, and collective tumor cell invasion of patient-derived colon tumor organoids. The data connect collagen-rich stroma to mesenchymal gene expression in neoplastic cells and to collective tumor cell invasion. Targeting the tumor-collagen interface may therefore be explored as a novel strategy in the treatment of aggressive colon cancer.	[Vellinga, T. T.; Rinkes, I. H. B.; Marvin, D.; Fatrai, S.; Kranenburg, O.] Univ Med Ctr Utrecht, Ctr Canc, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands; [den Uil, S.; Fijneman, R. J. A.] Vrije Univ Amsterdam, Med Ctr, Dept Pathol, Amsterdam, Netherlands; [den Uil, S.; Stockmann, H. B.; de Rooij, J.] Spaarne Gasthuis, Dept Surg, Haarlem, Netherlands; [Ponsioen, B.; Alvarez-Varela, A.; Scheele, C.; Snippert, H.] Univ Med Ctr Utrecht, Dept Mol Canc Res, Utrecht, Netherlands; [Zwijnenburg, D. A.] Acad Med Ctr Amsterdam, Dept Oncogen, Amsterdam, Netherlands; [Vermeulen, L.; Medema, J. P.; Koster, J.] Acad Med Ctr Amsterdam, Ctr Expt & Mol Med, Amsterdam, Netherlands; [Fijneman, R. J. A.] Netherlands Canc Inst, Dept Pathol, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; Spaarne Hospital; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Netherlands Cancer Institute	Kranenburg, O (corresponding author), Univ Med Ctr Utrecht, Ctr Canc, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	O.kranenburg@umcutrecht.nl	Scheele, Colinda/AAZ-9118-2021; Fijneman, Remond/X-4199-2019; de rooij, johan/C-1325-2019; Vermeulen, Louis/B-7488-2008; Koster, Jan/C-5934-2008	Scheele, Colinda/0000-0001-8999-5451; Fijneman, Remond/0000-0003-2076-5521; Vermeulen, Louis/0000-0002-6066-789X; Koster, Jan/0000-0002-0890-7585; Medema, Jan Paul/0000-0003-3045-2924; Alvarez-Varela, Adrian/0000-0001-5315-3092; Zwijnenburg, Danny/0000-0002-9353-8904				Belt EJT, 2011, EUR J CANCER, V47, P1837, DOI 10.1016/j.ejca.2011.04.025; Boissiere-Michot F, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.29256; Boyd M, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-68; Budinska E, 2013, J PATHOL, V231, P63, DOI 10.1002/path.4212; Caiado F, 2013, CANCER RES, V73, P4233, DOI 10.1158/0008-5472.CAN-13-0085; Calon A, 2015, NAT GENET, V47, P320, DOI 10.1038/ng.3225; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Celesti G, 2013, GASTROENTEROLOGY, V145, P647, DOI 10.1053/j.gastro.2013.05.011; Chanrion M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6005; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Emmink BL, 2014, CANCER RES, V74, P6717, DOI 10.1158/0008-5472.CAN-14-1645; Fatrai S, 2015, GASTROENTEROLOGY, V149, P692, DOI 10.1053/j.gastro.2015.05.003; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Gujral TS, 2014, CELL, V159, P844, DOI 10.1016/j.cell.2014.10.032; Hongo K, 2013, J SURG RES, V182, P75, DOI 10.1016/j.jss.2012.08.034; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang WL, 2011, GASTROENTEROLOGY, V141, P279, DOI 10.1053/j.gastro.2011.04.008; Isella C, 2015, NAT GENET, V47, P312, DOI 10.1038/ng.3224; Jorissen RN, 2009, CLIN CANCER RES, V15, P7642, DOI 10.1158/1078-0432.CCR-09-1431; Julien S, 2012, CLIN CANCER RES, V18, P5314, DOI 10.1158/1078-0432.CCR-12-0372; Loboda A, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-9; Lu J, 2013, CANCER CELL, V23, P171, DOI 10.1016/j.ccr.2012.12.021; Lussier CR, 2008, AM J PHYSIOL-GASTR L, V294, pG418, DOI 10.1152/ajpgi.00418.2007; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Mesker WE, 2007, CELL ONCOL, V29, P387; Mesker WE, 2009, CELL ONCOL, V31, P169, DOI 10.3233/CLO-2009-0478; Miles FL, 2014, MOL CANCER RES, V12, P297, DOI 10.1158/1541-7786.MCR-13-0535; Nishida N, 2012, CLIN CANCER RES, V18, P3054, DOI 10.1158/1078-0432.CCR-11-1078; Perez-Villamil B, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-260; Phillips SM, 2004, BRIT J SURG, V91, P469, DOI 10.1002/bjs.4472; Roepman P, 2014, INT J CANCER, V134, P552, DOI 10.1002/ijc.28387; Sadanandam A, 2014, CELL CYCLE, V13, P353, DOI 10.4161/cc.27769; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Santangelo L, 2011, HEPATOLOGY, V53, P2063, DOI 10.1002/hep.24280; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Schlicker A, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-66; Smith JJ, 2010, GASTROENTEROLOGY, V138, P958, DOI 10.1053/j.gastro.2009.11.005; Smith K, 1999, BRIT J CANCER, V81, P496, DOI 10.1038/sj.bjc.6690721; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Stegmann A, 2006, PHYSIOL GENOMICS, V27, P141, DOI 10.1152/physiolgenomics.00314.2005; Tabibzadeh S, 2002, FRONT BIOSCI-LANDMRK, V7, pD1231; Thomson S, 2011, CLIN EXP METASTAS, V28, P137, DOI 10.1007/s10585-010-9367-3; Wei SC, 2015, NAT CELL BIOL, V17, P678, DOI 10.1038/ncb3157; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yao HS, 2015, MOL CARCINOG; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438	49	67	69	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 6	2016	35	40					5263	5271		10.1038/onc.2016.60	http://dx.doi.org/10.1038/onc.2016.60			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DZ7NO	26996663				2022-12-26	WOS:000386053000005
J	Jager, J; Wang, FF; Fang, B; Lim, HW; Peed, LC; Steger, DJ; Won, KJ; Kharitonenkov, A; Adams, AC; Lazar, MA				Jager, Jennifer; Wang, Fenfen; Fang, Bin; Lim, Hee-Woon; Peed, Lindsey C.; Steger, David J.; Won, Kyoung-Jae; Kharitonenkov, Alexei; Adams, Andrew C.; Lazar, Mitchell A.			The Nuclear Receptor Rev-erb alpha Regulates Adipose Tissue-specific FGF21 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR 21; BETA-KLOTHO; INSULIN-RESISTANCE; TRANSCRIPTION; EXPRESSION; OBESITY; INFLAMMATION; PGC-1-ALPHA; METABOLISM; ACTIVATION	FGF21 is an atypical member of the FGF family that functions as a hormone to regulate carbohydrate and lipid metabolism. Here we demonstrate that the actions of FGF21 in mouse adipose tissue, but not in liver, are modulated by the nuclear receptor Rev-erb alpha, a potent transcriptional repressor. Interrogation of genes induced in the absence of Rev-erba for Rev-erb alpha-binding sites identified beta kappa lotho, an essential coreceptor for FGF21, as a direct target gene of Rev-erba in white adipose tissue but not liver. Rev-erba ablation led to the robust elevated expression of beta kappa lotho. Consequently, the effects of FGF21 were markedly enhanced in the white adipose tissue of mice lacking Rev-erb alpha. A major Rev-erb alpha-controlled enhancer at the Klb locus was also bound by the adipocytic transcription factor peroxisome proliferator-activated receptor (PPAR) gamma, which regulates its activity in the opposite direction. These findings establish Rev-erb alpha as a specific modulator of FGF21 signaling in adipose tissue.	[Jager, Jennifer; Wang, Fenfen; Fang, Bin; Lim, Hee-Woon; Peed, Lindsey C.; Steger, David J.; Won, Kyoung-Jae; Lazar, Mitchell A.] Univ Penn, Div Endocrinol Diabet & Metab, Perelman Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Jager, Jennifer; Wang, Fenfen; Fang, Bin; Lim, Hee-Woon; Peed, Lindsey C.; Steger, David J.; Won, Kyoung-Jae; Lazar, Mitchell A.] Univ Penn, Dept Genet, Perelman Sch Med, Philadelphia, PA 19104 USA; [Jager, Jennifer; Wang, Fenfen; Fang, Bin; Lim, Hee-Woon; Peed, Lindsey C.; Steger, David J.; Won, Kyoung-Jae; Lazar, Mitchell A.] Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kharitonenkov, Alexei] Indiana Univ, Dept Chem, Bloomington, IN 47405 USA; [Adams, Andrew C.] Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Indiana University System; Indiana University Bloomington; Eli Lilly	Lazar, MA (corresponding author), Univ Penn, Div Endocrinol Diabet & Metab, Perelman Sch Med, Dept Med,Smilow Ctr Translat Res 12102, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.; Lazar, MA (corresponding author), Univ Penn, Dept Genet, Perelman Sch Med, Smilow Ctr Translat Res 12102, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.; Lazar, MA (corresponding author), Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Smilow Ctr Translat Res 12102, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	lazar@mail.med.upenn.edu	Lazar, Mitchell A/AAF-3738-2019; Lim, Hee Woong/AAX-6835-2021; Lim, HW/GRY-3517-2022	Lim, Hee Woong/0000-0001-8599-1808; Jager, Jennifer/0000-0003-3740-9742; Won, Kyoung Jae/0000-0002-2924-9630	National Institutes of Health [R01 DK45586, DK49780]; JPB Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049780, P30DK019525, R01DK045586] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01 DK45586 and DK49780, and the JPB Foundation. M. A. L. is a consultant to Lilly, A. K. is a former employee of Lilly, and A. C. A. is a current employee of Lilly. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams AC, 2013, MOL METAB, V2, P205, DOI 10.1016/j.molmet.2013.05.005; Adams AC, 2013, MOL METAB, V2, P31, DOI 10.1016/j.molmet.2012.08.007; Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049977; Anghel SI, 2007, CELL RES, V17, P486, DOI 10.1038/cr.2007.48; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Coskun T, 2008, ENDOCRINOLOGY, V149, P6018, DOI 10.1210/en.2008-0816; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Delezie J, 2012, FASEB J, V26, P3321, DOI 10.1096/fj.12-208751; Ding XS, 2012, CELL METAB, V16, P387, DOI 10.1016/j.cmet.2012.08.002; Duez H, 2010, ARTERIOSCL THROM VAS, V30, P1529, DOI 10.1161/ATVBAHA.110.209098; Estall JL, 2009, P NATL ACAD SCI USA, V106, P22510, DOI 10.1073/pnas.0912533106; Fang B, 2014, CELL, V159, P1140, DOI 10.1016/j.cell.2014.10.022; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Gerhart-Hines Z, 2013, NATURE, V503, P410, DOI 10.1038/nature12642; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hah N, 2013, GENOME RES, V23, P1210, DOI 10.1101/gr.152306.112; HARDING HP, 1995, MOL CELL BIOL, V15, P4791; Harms MJ, 2015, GENE DEV, V29, P298, DOI 10.1101/gad.252734.114; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Ishizuka T, 2003, MOL CELL BIOL, V23, P5122, DOI 10.1128/MCB.23.15.5122-5131.2003; Jager J, 2014, MOL ENDOCRINOL, V28, P490, DOI 10.1210/me.2013-1351; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kharitonenkov A, 2008, J CELL PHYSIOL, V215, P1, DOI 10.1002/jcp.21357; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kharitonenkov A, 2014, MOL METAB, V3, P221, DOI 10.1016/j.molmet.2013.12.003; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Lee JM, 2014, NATURE, V516, P112, DOI 10.1038/nature13961; Liu T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r83; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mathieu P, 2010, CLIN PHARMACOL THER, V87, P407, DOI 10.1038/clpt.2009.311; Moyers JS, 2007, J CELL PHYSIOL, V210, P1, DOI 10.1002/jcp.20847; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Qatanani M, 2007, GENE DEV, V21, P1443, DOI 10.1101/gad.1550907; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schmidt SF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-152; Schupp M, 2009, J BIOL CHEM, V284, P9458, DOI 10.1074/jbc.M809498200; Soccio RE, 2015, CELL, V162, P33, DOI 10.1016/j.cell.2015.06.025; Step SE, 2014, GENE DEV, V28, P1018, DOI 10.1101/gad.237628.114; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Tong X, 2010, J BIOL CHEM, V285, P36401, DOI 10.1074/jbc.M110.172866; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Veniant MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040164; Wang YJ, 2010, J BIOL CHEM, V285, P15668, DOI 10.1074/jbc.M110.102160; Wente W, 2006, DIABETES, V55, P2470, DOI 10.2337/db05-1435; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Wu AL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002669; Yang X, 2007, COLD SPRING HARB SYM, V72, P387, DOI 10.1101/sqb.2007.72.058; Zamir I, 1996, MOL CELL BIOL, V16, P5458; Zhang YX, 2015, SCIENCE, V348, P1488, DOI 10.1126/science.aab3021	63	26	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10867	10875		10.1074/jbc.M116.719120	http://dx.doi.org/10.1074/jbc.M116.719120			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27002153	Green Published, hybrid			2022-12-26	WOS:000377042600036
J	Becher, T; Vogt, B; Kott, M; Schadler, D; Weiler, N; Frerichs, I				Becher, Tobias; Vogt, Barbara; Kott, Matthias; Schaedler, Dirk; Weiler, Norbert; Frerichs, Inez			Functional Regions of Interest in Electrical Impedance Tomography: A Secondary Analysis of Two Clinical Studies	PLOS ONE			English	Article							PRESSURE SUPPORT VENTILATION; LUNG VENTILATION; EIT; INHOMOGENEITY; HETEROGENEITY; RECRUITMENT; VOLUME	Introduction Patients with acute respiratory distress syndrome (ARDS) typically show a high degree of ventilation inhomogeneity, which is associated with morbidity and unfavorable outcomes. Electrical impedance tomography (EIT) is able to detect ventilation inhomogeneity, but it is unclear which method for defining the region of interest (ROI) should be used for this purpose. The aim of our study was to compare the functional region of interest (fROI) method to both the lung area estimation method (LAEM) and no ROI when analysing global parameters of ventilation inhomogeneity. We assumed that a good method for ROI determination would lead to a high discriminatory power for ventilation inhomogeneity, as defined by the area under the receiver operating characteristics curve (AUC), comparing patients suffering from ARDS and control patients without pulmonary pathologies. Methods We retrospectively analysed EIT data from 24 ARDS patients and 12 control patients without pulmonary pathology. In all patients, a standardized low-flow-pressure volume maneuver had been performed and was used for EIT image generation. We compared the AUC for global inhomogeneity (GI) index and coefficient of variation (CV) between ARDS and control patients using all EIT image pixels, the fROI method and the LAEM for ROI determination. Results When analysing all EIT image pixels, we found an acceptable AUC both for the GI index (AUC = 0.76; 95% confidence interval (CI) 0.58-0.94) and the CV (AUC = 0.74; 95% CI 0.55-0.92). With the fROI method, we found a deteriorating AUC with increasing threshold criteria. With the LAEM, we found the best AUC both for the GI index (AUC = 0.89; 95% CI 0.78-1.0) and the CV (AUC = 0.89; 95% CI 0.78-1.0) using a threshold criterion of 50% of the maximum tidal impedance change. Conclusion In the assessment of ventilation inhomogeneity with EIT, functional regions of interest obscure the difference between patients with ARDS and control patients without pulmonary pathologies. The LAEM is preferable to the fROI method when assessing ventilation inhomogeneity.	[Becher, Tobias; Vogt, Barbara; Kott, Matthias; Schaedler, Dirk; Weiler, Norbert; Frerichs, Inez] Univ Med Ctr Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Campus Kiel,Arnold Heller Str 3,Haus 12, D-24105 Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital	Becher, T (corresponding author), Univ Med Ctr Schleswig Holstein, Dept Anesthesiol & Intens Care Med, Campus Kiel,Arnold Heller Str 3,Haus 12, D-24105 Kiel, Germany.	Tobias.Becher@uksh.de	Schädler, Dirk/A-7253-2012; Becher, Tobias/HIR-1888-2022; Lindner, Matthias/O-1961-2018; Frerichs, I./AAT-3685-2021; Becher, Tobias/AAW-8491-2021	Schädler, Dirk/0000-0002-5745-4797; Lindner, Matthias/0000-0003-2647-7790; Frerichs, I./0000-0002-7712-6539; Becher, Tobias/0000-0003-2026-7629				Adler A, 2012, PHYSIOL MEAS, V33, P679, DOI 10.1088/0967-3334/33/5/679; Adler A, 2009, PHYSIOL MEAS, V30, pS35, DOI 10.1088/0967-3334/30/6/S03; Becher T, 2015, PHYSIOL MEAS, V36, P1137, DOI 10.1088/0967-3334/36/6/1137; Becher TH, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0679-6; Blankman P, 2014, ACTA ANAESTH SCAND, V58, P997, DOI 10.1111/aas.12367; Blankman P, 2014, CRIT CARE, V18, DOI 10.1186/cc13866; Costa ELV, 2010, CRIT CARE, V14, DOI 10.1186/cc8901; Costa ELV, 2009, INTENS CARE MED, V35, P1132, DOI 10.1007/s00134-009-1447-y; Cressoni M, 2014, AM J RESP CRIT CARE, V189, P149, DOI 10.1164/rccm.201308-1567OC; Ferrario D, 2012, IEEE T BIO-MED ENG, V59, P3000, DOI 10.1109/TBME.2012.2209116; Frerichs I, 2006, AM J RESP CRIT CARE, V174, P772, DOI 10.1164/rccm.200512-1942OC; Frerichs I, 2014, CURR OPIN CRIT CARE, V20, P323, DOI 10.1097/MCC.0000000000000088; Frerichs I, 2012, J CRIT CARE, V27, P172, DOI 10.1016/j.jcrc.2011.04.008; Mauri T, 2013, CRIT CARE MED; Muders T, 2012, CRIT CARE MED, V40, P903, DOI 10.1097/CCM.0b013e318236f452; Pulletz S, 2008, ACTA ANAESTH SCAND, V52, P1131, DOI 10.1111/j.1399-6576.2008.01706.x; Pulletz S, 2006, PHYSIOL MEAS, V27, pS115, DOI 10.1088/0967-3334/27/5/S10; Pulletz S, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.09.002; Reifferscheid F, 2011, RESPIROLOGY, V16, P523, DOI 10.1111/j.1440-1843.2011.01929.x; Vogt B, 2012, J APPL PHYSIOL, V113, P1154, DOI 10.1152/japplphysiol.01630.2011; Wolf GK, 2013, CRIT CARE MED, V41, P1296, DOI 10.1097/CCM.0b013e3182771516; Zhao Zhanqi, 2014, BMC Res Notes, V7, P82, DOI 10.1186/1756-0500-7-82; Zhao ZQ, 2010, CRIT CARE, V14, DOI 10.1186/cc8860; Zhao ZQ, 2009, INTENS CARE MED, V35, P1900, DOI 10.1007/s00134-009-1589-y; Zick G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072675	25	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152267	10.1371/journal.pone.0152267	http://dx.doi.org/10.1371/journal.pone.0152267			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010320	Green Submitted, gold, Green Published			2022-12-26	WOS:000372708000124
J	Burda, P; Vargova, J; Curik, N; Salek, C; Papadopoulos, GL; Strouboulis, J; Stopka, T				Burda, Pavel; Vargova, Jarmila; Curik, Nikola; Salek, Cyril; Papadopoulos, Giorgio Lucio; Strouboulis, John; Stopka, Tomas			GATA-1 Inhibits PU.1 Gene via DNA and Histone H3K9 Methylation of Its Distal Enhancer in Erythroleukemia	PLOS ONE			English	Article							TRANSCRIPTION FACTOR GATA-1; ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; MYELODYSPLASTIC SYNDROMES; DIFFERENTIATION; EXPRESSION; BINDING; DIVERSIFICATION; LYMPHOCYTES; MACROPHAGE	GATA-1 and PU.1 are two important hematopoietic transcription factors that mutually inhibit each other in progenitor cells to guide entrance into the erythroid or myeloid lineage, respectively. PU.1 controls its own expression during myelopoiesis by binding to the distal URE enhancer, whose deletion leads to acute myeloid leukemia (AML). We herein present evidence that GATA-1 binds to the PU.1 gene and inhibits its expression in human AML-erythroleukemias (EL). Furthermore, GATA-1 together with DNA methyl Transferase I (DNMT1) mediate repression of the PU.1 gene through the URE. Repression of the PU.1 gene involves both DNA methylation at the URE and its histone H3 lysine-K9 methylation and deacetylation as well as the H3K27 methylation at additional DNA elements and the promoter. The GATA-1-mediated inhibition of PU.1 gene transcription in human AML-EL mediated through the URE represents important mechanism that contributes to PU.1 downregulation and leukemogenesis that is sensitive to DNA demethylation therapy.	[Burda, Pavel; Vargova, Jarmila; Curik, Nikola; Stopka, Tomas] Charles Univ Prague, Fac Med 1, Biocev, Prague, Czech Republic; [Burda, Pavel; Vargova, Jarmila; Curik, Nikola; Stopka, Tomas] Charles Univ Prague, Fac Med 1, Pathol Physiol, Prague, Czech Republic; [Burda, Pavel; Curik, Nikola; Salek, Cyril] Inst Hematol & Blood Transfus, CR-12820 Prague, Czech Republic; [Papadopoulos, Giorgio Lucio; Strouboulis, John] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Crete, Greece; [Papadopoulos, Giorgio Lucio] Univ Crete, Dept Biol, Iraklion, Crete, Greece; [Stopka, Tomas] Gen Fac Hosp, Med Dept Hematol 1, Prague, Czech Republic	Charles University Prague; Charles University Prague; Institute of Hematology Prague; Foundation for Research & Technology - Hellas (FORTH); University of Crete; General University Hospital Prague	Stopka, T (corresponding author), Charles Univ Prague, Fac Med 1, Biocev, Prague, Czech Republic.; Stopka, T (corresponding author), Charles Univ Prague, Fac Med 1, Pathol Physiol, Prague, Czech Republic.; Stopka, T (corresponding author), Gen Fac Hosp, Med Dept Hematol 1, Prague, Czech Republic.	tstopka@lf1.cuni.cz	Curik, Nikola/J-6354-2017; Burda, Pavel/K-8219-2017; Vargova, Jarmila/AAO-8636-2020; Strouboulis, John/U-4459-2019; Stopka, Tomáš/D-5864-2017; Salek, Cyril/F-2149-2017	Curik, Nikola/0000-0002-5876-1326; Burda, Pavel/0000-0002-2841-792X; Stopka, Tomáš/0000-0001-7236-6894; Salek, Cyril/0000-0002-0021-3247; Papadopoulos, Giorgio Lucio/0000-0003-0199-0256; Strouboulis, John/0000-0002-6133-2872	 [GACR P301/12/P380]		Primary grant support: GACR P301/12/P380. Institutional: UNCE 204021, Prvouk-P24/LF1/3, SVV-2014-260033, CZ.1.05/1.1.00/02.0109, LQ1604 NPU II, 16-27790A, LH15170. GAUK-84314.	Basova P, 2014, ONCOGENE, V33, P4735, DOI 10.1038/onc.2013.414; Blobel GA, 1998, P NATL ACAD SCI USA, V95, P2061, DOI 10.1073/pnas.95.5.2061; Burda P, 2009, MOL CANCER RES, V7, P1693, DOI 10.1158/1541-7786.MCR-09-0031; Chen GY, 2008, J BIOL CHEM, V283, P34563, DOI 10.1074/jbc.M804271200; Cheng JX, 2013, LEUKEMIA, V27, P1291, DOI 10.1038/leu.2013.45; Choe KS, 2003, CANCER RES, V63, P6363; Chou ST, 2009, BLOOD, V114, P983, DOI 10.1182/blood-2009-03-207944; Curik N, 2012, LEUKEMIA, V26, P1804, DOI 10.1038/leu.2012.47; Dahl R, 2003, BLOOD CELL MOL DIS, V31, P229, DOI 10.1016/S1079-9796(03)00152-9; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Dluhosova M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087448; Fenaux P, 2004, SEMIN HEMATOL, V41, P6, DOI 10.1053/j.seminhematol.2004.02.002; Feng Q, 2001, GENE DEV, V15, P827; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Harigae H, 1998, GENES CELLS, V3, P39, DOI 10.1046/j.1365-2443.1998.00166.x; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Leddin M, 2011, BLOOD, V117, P2827, DOI 10.1182/blood-2010-08-302976; MARTIN DIK, 1990, GENE DEV, V4, P1886, DOI 10.1101/gad.4.11.1886; McIvor Z, 2003, EXP HEMATOL, V31, P39, DOI 10.1016/S0301-472X(02)01017-2; Migliaccio AR, 2003, J EXP MED, V197, P281, DOI 10.1084/jem.20021149; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; MoreauGachelin F, 1996, MOL CELL BIOL, V16, P2453; MOREAUGACHELIN F, 1988, NATURE, V331, P277, DOI 10.1038/331277a0; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Okuno Y, 2005, MOL CELL BIOL, V25, P2832, DOI 10.1128/MCB.25.7.2832-2845.2005; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Papadopoulos GL, 2013, NUCLEIC ACIDS RES, V41, P4938, DOI 10.1093/nar/gkt167; PEVNY L, 1995, DEVELOPMENT, V121, P163; Rodriguez P, 2005, EMBO J, V24, P2354, DOI 10.1038/sj.emboj.7600702; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; ROSS IL, 1994, ONCOGENE, V9, P121; Schonheit J, 2015, J MOL BIOL, V427, P670, DOI 10.1016/j.jmb.2014.08.015; Welch JS, 2012, CELL, V150, P264, DOI 10.1016/j.cell.2012.06.023; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	37	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152234	10.1371/journal.pone.0152234	http://dx.doi.org/10.1371/journal.pone.0152234			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010793	gold, Green Submitted, Green Published			2022-12-26	WOS:000372708000118
J	Del Debbio, CB; Mir, Q; Parameswaran, S; Mathews, S; Xia, XH; Zheng, L; Neville, AJ; Ahmad, I				Del Debbio, Carolina Beltrame; Mir, Qulsum; Parameswaran, Sowmya; Mathews, Saumi; Xia, Xiaohuan; Zheng, Li; Neville, Andrew J.; Ahmad, Iqbal			Notch Signaling Activates Stem Cell Properties of Muller Glia through Transcriptional Regulation and Skp2-mediated Degradation of p27(Kip1)	PLOS ONE			English	Article							PROGENITOR CELLS; SELF-RENEWAL; REGENERATION; RETINA; ADULT; SOX9; DIFFERENTIATION; PROLIFERATION; CYCLE; LOOP	Muller glia (MG), the sole glial cells generated by retinal progenitors, have emerged as a viable cellular target for therapeutic regeneration in degenerative blinding diseases, as they possess dormant stem cell properties. However, the mammalian MG does not display the neurogenic potential of their lower vertebrate counterparts, precluding their practical clinical use. The answer to this barrier may be found in two interlinked processes underlying the neurogenic potential, i.e., the activation of the dormant stem cell properties of MG and their differentiation along the neuronal lineage. Here, we have focused on the former and examined Notch signaling-mediated activation of MG. We demonstrate that one of the targets of Notch signaling is the cyclin-dependent kinase inhibitor (CKI), p27(Kip1), which is highly expressed in quiescent MG. Notch signaling facilitates the activation of MG by inhibiting p27(Kip1) expression. This is likely achieved through the Notch-p27(Kip1) and Notch-Skp2-p27(Kip1) axes, the former inhibiting the expression of p27(Kip1) transcripts and the latter levels of p27(Kip1) proteins by Skp2-mediated proteasomal degradation. Thus, Notch signaling may facilitate re-entry of MG into the cell cycle by inhibiting p27(Kip1) expression both transcriptionally and post-translationally.	[Del Debbio, Carolina Beltrame; Mir, Qulsum; Parameswaran, Sowmya; Mathews, Saumi; Xia, Xiaohuan; Zheng, Li; Neville, Andrew J.; Ahmad, Iqbal] Univ Nebraska Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE USA; [Del Debbio, Carolina Beltrame] Univ Sao Paulo, Inst Biomed Sci, Dept Cell & Dev Biol, Sao Paulo, Brazil; [Parameswaran, Sowmya] Vis Res Fdn, Dept Radheshyam Kanoi Stem Cell Lab, Madras, Tamil Nadu, India	University of Nebraska System; University of Nebraska Medical Center; Universidade de Sao Paulo	Ahmad, I (corresponding author), Univ Nebraska Med Ctr, Dept Ophthalmol & Visual Sci, Omaha, NE USA.	iahmad@unmc.edu	Sowmya, Parameswaran/GZK-8635-2022; mathews, saumi/K-8569-2019	Xia, Xiaohuan/0000-0002-0287-6319; Neville, Andrew/0000-0001-6237-9640	Pearson Foundation; Lincy Foundation; Nebraska Department of Human and Health Services [LB606]; Nebraska Department of Health and Human Services	Pearson Foundation; Lincy Foundation; Nebraska Department of Human and Health Services; Nebraska Department of Health and Human Services	This work was supported by the Pearson Foundation (grant #: private foundation), Lincy Foundation (grant #: private foundation), and the Nebraska Department of Human and Health Services (grant #: LB606). All funding was received by IA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks are due to Puroshotham Reddy and Sharda Paudel for help with experiments and John Sorrentino for critical reading of the manuscript. This work was supported by Pearson Foundation, Lincy Foundation, and Nebraska Department of Health and Human Services.	AHMAD I, 1995, MECH DEVELOP, V53, P73, DOI 10.1016/0925-4773(95)00425-4; Ahmad I, 2011, INVEST OPHTH VIS SCI, V52, P5758, DOI 10.1167/iovs.11-7308; Bernardos RL, 2007, J NEUROSCI, V27, P7028, DOI 10.1523/JNEUROSCI.1624-07.2007; Bernardos RL, 2005, DEV BIOL, V278, P381, DOI 10.1016/j.ydbio.2004.11.018; Bhattacharya S, 2003, INVEST OPHTH VIS SCI, V44, P2764, DOI 10.1167/iovs.02-0899; Bilitou A, 2010, DEV DYNAM, V239, P727, DOI 10.1002/dvdy.22223; Bray S, 2010, CURR TOP DEV BIOL, V92, P253, DOI 10.1016/S0070-2153(10)92008-5; Bringmann A, 2009, PROG RETIN EYE RES, V28, P423, DOI 10.1016/j.preteyeres.2009.07.001; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Das AV, 2006, DEV BIOL, V299, P283, DOI 10.1016/j.ydbio.2006.07.029; Del Bene F, 2008, CELL, V134, P1055, DOI 10.1016/j.cell.2008.07.017; Del Debbio CB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012425; DORSKY RI, 1995, NEURON, V14, P487, DOI 10.1016/0896-6273(95)90305-4; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Dyer MA, 2001, J NEUROSCI, V21, P4259, DOI 10.1523/JNEUROSCI.21-12-04259.2001; Fausett BV, 2008, J NEUROSCI, V28, P1109, DOI 10.1523/JNEUROSCI.4853-07.2008; Fausett BV, 2006, J NEUROSCI, V26, P6303, DOI 10.1523/JNEUROSCI.0332-06.2006; Fischer AJ, 2002, DEVELOPMENT, V129, P2283; Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036; Ghai K, 2010, J NEUROSCI, V30, P3101, DOI 10.1523/JNEUROSCI.4919-09.2010; Goldman D, 2014, NAT REV NEUROSCI, V15, P431, DOI 10.1038/nrn3723; Guruharsha KG, 2012, NAT REV GENET, V13, P654, DOI 10.1038/nrg3272; Hayes S, 2007, DEV BIOL, V312, P300, DOI 10.1016/j.ydbio.2007.09.046; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Hojo M, 2000, DEVELOPMENT, V127, P2515; Hori K, 2013, J CELL SCI, V126, P2135, DOI 10.1242/jcs.127308; Jadhav AP, 2009, PROG RETIN EYE RES, V28, P249, DOI 10.1016/j.preteyeres.2009.05.002; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Lamba DA, 2008, DEV DYNAM, V237, P3016, DOI 10.1002/dvdy.21697; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lenkowski JR, 2014, PROG RETIN EYE RES, V40, P94, DOI 10.1016/j.preteyeres.2013.12.007; Levine EM, 2000, DEV BIOL, V219, P299, DOI 10.1006/dbio.2000.9622; Matsumoto A, 2011, J BIOL CHEM, V286, P13754, DOI 10.1074/jbc.M110.194936; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Muto A, 2009, EXP EYE RES, V89, P549, DOI 10.1016/j.exer.2009.05.006; Namihira M, 2009, DEV CELL, V16, P245, DOI 10.1016/j.devcel.2008.12.014; Nelson BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022817; Ogilvie JM, 1999, J NEUROSCI METH, V87, P57; Ooto S, 2004, P NATL ACAD SCI USA, V101, P13654, DOI 10.1073/pnas.0402129101; Osakada F, 2007, J NEUROSCI, V27, P4210, DOI 10.1523/JNEUROSCI.4193-06.2007; Parameswaran S, 2014, DEVELOPMENT, V141, P4087, DOI 10.1242/dev.107326; Parameswaran S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046734; Poche RA, 2008, J COMP NEUROL, V510, P237, DOI 10.1002/cne.21746; Qin Z, 2009, P NATL ACAD SCI USA, V106, P9310, DOI 10.1073/pnas.0811186106; Raymond PA, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-36; Reichenbach A, 2013, GLIA, V61, P651, DOI 10.1002/glia.22477; Sarmento LM, 2005, J EXP MED, V202, P157, DOI 10.1084/jem.20050559; Satow T, 2001, J NEUROSCI, V21, P1265; Sullivan SA, 1997, DEV GENET, V20, P208, DOI 10.1002/(SICI)1520-6408(1997)20:3<208::AID-DVG4>3.0.CO;2-B; Takeda M, 2008, INVEST OPHTH VIS SCI, V49, P1142, DOI 10.1167/iovs.07-0434; Tanaka H, 2002, J CELL BIOL, V158, P321, DOI 10.1083/jcb.200202071; TELFORD WG, 1991, CELL PROLIFERAT, V24, P447, DOI 10.1111/j.1365-2184.1991.tb01173.x; Vetter ML, 2001, DEV DYNAM, V221, P146, DOI 10.1002/dvdy.1145; Wan J, 2012, DEV CELL, V22, P334, DOI 10.1016/j.devcel.2011.11.020; Yokoi H, 2009, DEV BIOL, V329, P1, DOI 10.1016/j.ydbio.2009.01.002; Zhu MY, 2013, GENE EXPR PATTERNS, V13, P78, DOI 10.1016/j.gep.2012.12.001	56	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152025	10.1371/journal.pone.0152025	http://dx.doi.org/10.1371/journal.pone.0152025			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27011052	Green Published, gold			2022-12-26	WOS:000372708000072
J	Salmon, Y; Buchmann, N; Barnard, RL				Salmon, Yann; Buchmann, Nina; Barnard, Romain L.			Effects of Ontogeny on delta C-13 of Plant- and Soil-Respired CO2 and on Respiratory Carbon Fractionation in C-3 Herbaceous Species	PLOS ONE			English	Article							MICROBIAL BIOMASS-C; ISOTOPE COMPOSITION; ORGANIC-MATTER; PHASEOLUS-VULGARIS; METABOLIC ORIGIN; C-13 DISCRIMINATION; SEASONAL-VARIATION; RICINUS-COMMUNIS; DIEL VARIATIONS; GAS-EXCHANGE	Knowledge gaps regarding potential ontogeny and plant species identity effects on carbon isotope fractionation might lead to misinterpretations of carbon isotope composition (delta C-13) of respired CO2, a widely-used integrator of environmental conditions. In monospecific mesocosms grown under controlled conditions, the delta C-13 of C pools and fluxes and leaf ecophysiological parameters of seven herbaceous species belonging to three functional groups (crops, forage grasses and legumes) were investigated at three ontogenetic stages of their vegetative cycle (young foliage, maximum growth rate, early senescence). Ontogeny-related changes in delta C-13 of leaf-and soil-respired CO2 and C-13/C-12 fractionation in respiration (Delta(R)) were species-dependent and up to 7 parts per thousand, a magnitude similar to that commonly measured in response to environmental factors. At plant and soil levels, changes in delta C-13 of respired CO2 and Delta(R) with ontogeny were related to changes in plant physiological status, likely through ontogeny-driven changes in the C sink to source strength ratio in the above-ground plant compartment. Our data further showed that lower Delta(R) values (i.e. respired CO2 relatively less depleted in C-13) were observed with decreasing net assimilation. Our findings highlight the importance of accounting for ontogenetic stage and plant community composition in ecological studies using stable carbon isotopes.	[Salmon, Yann; Buchmann, Nina; Barnard, Romain L.] Swiss Fed Inst Technol, Inst Agr Sci, Zurich, Switzerland; [Salmon, Yann] Univ Helsinki, Dept Phys, Helsinki, Finland; [Barnard, Romain L.] INRA, UMR Agroecol 1347, F-21034 Dijon, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Helsinki; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne	Salmon, Y (corresponding author), Swiss Fed Inst Technol, Inst Agr Sci, Zurich, Switzerland.	yann.salmon@helsinki.fi	Buchmann, Nina/E-6095-2011; Barnard, Romain L./G-8190-2011	Buchmann, Nina/0000-0003-0826-2980; Barnard, Romain L./0000-0002-6440-1159; Salmon, Yann/0000-0003-4433-4021	Swiss National Science Foundation [3100A0-105273/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This project was supported by the Swiss National Science Foundation (project no3100A0-105273/1 to NB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews JA, 2000, SOIL BIOL BIOCHEM, V32, P699, DOI 10.1016/S0038-0717(99)00206-0; Badeck FW, 2005, RAPID COMMUN MASS SP, V19, P1381, DOI 10.1002/rcm.1912; Barbour MM, 2007, PLANT CELL ENVIRON, V30, P469, DOI 10.1111/j.1365-3040.2007.01634.x; BARNES A, 1979, ANN BOT-LONDON, V43, P487, DOI 10.1093/oxfordjournals.aob.a085659; Bathellier C, 2009, NEW PHYTOL, V181, P387, DOI 10.1111/j.1469-8137.2008.02679.x; Bathellier C, 2008, NEW PHYTOL, V177, P406, DOI 10.1111/j.1469-8137.2007.02246.x; Bowling DR, 2008, NEW PHYTOL, V178, P24, DOI 10.1111/j.1469-8137.2007.02342.x; Brooks PD, 2003, RAPID COMMUN MASS SP, V17, P1924, DOI 10.1002/rcm.1134; Cernusak LA, 2009, FUNCT PLANT BIOL, V36, P199, DOI 10.1071/FP08216; CRAIG H, 1954, J GEOL, V62, P115, DOI 10.1086/626141; Crow SE, 2006, SOIL BIOL BIOCHEM, V38, P3279, DOI 10.1016/j.soilbio.2006.04.007; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; Duranceau M, 1999, PLANT CELL ENVIRON, V22, P515, DOI 10.1046/j.1365-3040.1999.00420.x; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; FARQUHAR GD, 1982, AUST J PLANT PHYSIOL, V9, P121, DOI 10.1071/PP9820121; FARQUHAR GD, 1984, AUST J PLANT PHYSIOL, V11, P539, DOI 10.1071/PP9840539; Franck N, 2006, TREE PHYSIOL, V26, P517, DOI 10.1093/treephys/26.4.517; Gessler A, 2004, PLANT BIOLOGY, V6, P289, DOI 10.1055/s-2004-820878; Gessler A, 2009, NEW PHYTOL, V181, P374, DOI 10.1111/j.1469-8137.2008.02672.x; Gessler A, 2008, PLANT CELL ENVIRON, V31, P941, DOI 10.1111/j.1365-3040.2008.01806.x; Ghashghaie J, 2015, ISOT ENVIRON HEALT S, V51, P93, DOI 10.1080/10256016.2015.1011635; Ghashghaie J, 2014, NEW PHYTOL, V201, P751, DOI 10.1111/nph.12563; Ghashghaie Jaleh, 2003, Phytochemistry Reviews, V2, P145, DOI 10.1023/B:PHYT.0000004326.00711.ca; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; KEELING CD, 1958, GEOCHIM COSMOCHIM AC, V13, P322, DOI 10.1016/0016-7037(58)90033-4; Korner C, 2015, CURR OPIN PLANT BIOL, V25, P107, DOI 10.1016/j.pbi.2015.05.003; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; Lehmeier CA, 2008, PLANT PHYSIOL, V148, P1148, DOI 10.1104/pp.108.127324; Lerch TZ, 2011, BIOGEOCHEMISTRY, V106, P5, DOI 10.1007/s10533-010-9432-7; LLOYD J, 1994, OECOLOGIA, V99, P201, DOI 10.1007/BF00627732; McDowell NG, 2004, GLOBAL CHANGE BIOL, V10, P1767, DOI 10.1111/j.1365-2486.2004.00837.x; Mortazavi B, 2009, PLANT CELL ENVIRON, V32, P1310, DOI 10.1111/j.1365-3040.2009.01999.x; Nogues S, 2004, PLANT PHYSIOL, V136, P3245, DOI 10.1104/pp.104.048470; Ocheltree TW, 2004, J EXP BOT, V55, P2599, DOI 10.1093/jxb/erh263; Pataki DE, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001850; PHELOUNG PC, 1991, AUST J PLANT PHYSIOL, V18, P53, DOI 10.1071/PP9910053; Pons TL, 2009, J EXP BOT, V60, P2217, DOI 10.1093/jxb/erp081; Priault P, 2009, NEW PHYTOL, V181, P400, DOI 10.1111/j.1469-8137.2008.02665.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rascher KG, 2010, TREE PHYSIOL, V30, P1499, DOI 10.1093/treephys/tpq092; ROESKE CA, 1984, BIOCHEMISTRY-US, V23, P6275, DOI 10.1021/bi00320a058; Rolland F, 2002, PLANT CELL, V14, pS185, DOI 10.1105/tpc.010455; Salmon Y, 2011, PLANT CELL ENVIRON, V34, P465, DOI 10.1111/j.1365-3040.2010.02256.x; Schnyder H, 2003, PLANT CELL ENVIRON, V26, P1863, DOI 10.1046/j.1365-3040.2003.01102.x; Sun W, 2009, PLANT CELL ENVIRON, V32, P1390, DOI 10.1111/j.1365-3040.2009.02006.x; Tcherkez G, 2003, PLANT PHYSIOL, V131, P237, DOI 10.1104/pp.013078; Thomas H, 2013, NEW PHYTOL, V197, P696, DOI 10.1111/nph.12047; Ubierna N, 2011, TREE PHYSIOL, V31, P414, DOI 10.1093/treephys/tpr026; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wegener F, 2015, FUNCT PLANT BIOL, V42, P620, DOI 10.1071/FP14152; Werner C, 2011, BIOGEOSCIENCES, V8, P2437, DOI 10.5194/bg-8-2437-2011; Werner RA, 2001, RAPID COMMUN MASS SP, V15, P501, DOI 10.1002/rcm.258; Werner RA, 1999, RAPID COMMUN MASS SP, V13, P1237, DOI 10.1002/(SICI)1097-0231(19990715)13:13<1237::AID-RCM633>3.0.CO;2-C; WU J, 1990, SOIL BIOL BIOCHEM, V22, P1167, DOI 10.1016/0038-0717(90)90046-3; Zeeman MJ, 2008, RAPID COMMUN MASS SP, V22, P3883, DOI 10.1002/rcm.3772	55	3	3	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151583	10.1371/journal.pone.0151583	http://dx.doi.org/10.1371/journal.pone.0151583			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010947	Green Published, Green Submitted, gold			2022-12-26	WOS:000372708000035
J	Abdullah, BM; Zubairi, SI; Huri, HZ; Hairunisa, N; Yousif, E; Basu, RC				Abdullah, Bashar Mudhaffar; Zubairi, Saiful Irwan; Huri, Hasniza Zaman; Hairunisa, Nany; Yousif, Emad; Basu, Roma Choudhury			Polyesters Based on Linoleic Acid for Biolubricant Basestocks: Low-Temperature, Tribological and Rheological Properties	PLOS ONE			English	Article							EPOXIDIZED SOYBEAN OIL; OXIDATIVE STABILITY; LUBRICANT	Presently, plant oils which contain high percentage of linoleic acid 1 are perceived to be a viable alternative to mineral oil for biolubricant applications due to their biodegradability and technical properties. In order to get biodegradable lubricant, triester derivatives compounds (1-5) were synthesized and characterized. The processes involved were monoepoxidation of linoleic acid 2, oxirane ring opening 3, esterification 4 and acylation 5. The structures of the products were confirmed by FTIR, H-1 and C-13-NMR and LC-MS. The results that showed lowest temperature properties were obtained for triester 5, with a pour point value (PP) of -73 degrees C, highest onset temperature (260 degrees C) and lowest volatility at 0.30%. Viscosity index (VI) increased for the ester's synthetic compounds (2, 3, 4, 5), while the PP decreased. This behavior is the result of the increase of the chain length of the branching agents. Triester based linoleic acid has improved properties such as low-temperature and tribological properties. These results will make it feasible for plant oil to be used for biolubricants, fuels in chain saws, transmission oil and brake fluid.	[Abdullah, Bashar Mudhaffar; Huri, Hasniza Zaman; Hairunisa, Nany; Basu, Roma Choudhury] Univ Malaya, Med Ctr, Clin Invest Ctr, 13th Floor Main Tower, Kuala Lumpur, Malaysia; [Zubairi, Saiful Irwan] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Chem Sci & Food Technol, Ukm Bangi, Selangor, Malaysia; [Huri, Hasniza Zaman] Univ Malaya, Fac Med, Dept Pharm, Kuala Lumpur, Malaysia; [Yousif, Emad] Al Nahrain Univ, Coll Sci, Dept Chem, Baghdad, Iraq	Universiti Malaya; Universiti Kebangsaan Malaysia; Universiti Malaya; Al-Nahrain University	Zubairi, SI (corresponding author), Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Chem Sci & Food Technol, Ukm Bangi, Selangor, Malaysia.	saiful-z@ukm.edu.my	Zubairi, Saiful/J-4626-2015; HURI, HASNIZA ZAMAN/B-8612-2010; Zubairi, Saiful Irwan/J-6201-2019; Hairunisa, Nany/AAL-7484-2020	Zubairi, Saiful/0000-0002-1674-9820; HURI, HASNIZA ZAMAN/0000-0002-6423-8515; Hairunisa, Nany/0000-0003-2414-9224	Universiti Kebangsaan Malaysia [TRGS/1/2014/USM/01/3/4, FRGS/2/2013/TK04/UKM/03/1, GGPM-2013-078, LAUREATE-2013-002, 06-01-02-SF1271]; University of Malaya [RP024A-14HTM]	Universiti Kebangsaan Malaysia; University of Malaya(Universiti Malaya)	This work was supported by Universiti Kebangsaan Malaysia (TRGS/1/2014/USM/01/3/4, FRGS/2/2013/TK04/UKM/03/1, GGPM-2013-078 and LAUREATE-2013-002) and University of Malaya (RP024A-14HTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Universiti Kebangsaan Malaysia (TRGS/1/2014/USM/01/3/4, FRGS/2/2013/TK04/UKM/03/1, GGPM-2013-078, 06-01-02-SF1271 and LAUREATE-2013-002) and University of Malaya (RP024A-14HTM) for the financial support and technical assistance on this work.	American Society for Testing Materials, 2011, STAND TEST METH POUR; American Society for Testing Materials, 2011, STAND TEST METH FLAS; Asadauskas S, 1996, LUBR ENG, V52, P877; Cary F., 2007, ADV ORGANIC CHEM A; Castro W, 2005, TRIBOL INT, V38, P321, DOI 10.1016/j.triboint.2004.08.020; Cheng CF, 1998, J AM SOC MASS SPECTR, V9, P840, DOI 10.1016/S1044-0305(98)00053-1; Erhan SZ, 2000, IND CROP PROD, V11, P277, DOI 10.1016/S0926-6690(99)00061-8; Gleghorn JP, 2008, J BIOMECH, V41, P1910, DOI 10.1016/j.jbiomech.2008.03.043; Greenwood JA, 1998, P I MECH ENG J-J ENG, V212, P179, DOI 10.1243/1350650981541994; Hoglund E, 1999, WEAR, V232, P176, DOI 10.1016/s0043-1648(99)00143-x; Hsu FF, 2004, J AM SOC MASS SPECTR, V15, P536, DOI 10.1016/j.jasms.2003.12.007; Hwang HS, 2001, J AM OIL CHEM SOC, V78, P1179, DOI 10.1007/s11745-001-0410-0; Hwang HS, 2003, J AM OIL CHEM SOC, V80, P811, DOI 10.1007/s11746-003-0777-y; Hwang HS, 2006, IND CROP PROD, V23, P311, DOI 10.1016/j.indcrop.2005.09.002; Jankovic M., 2004, HEM IND, V58, P569, DOI [DOI 10.2298/HEMIND0412569J, 10.2298/hemind0412569j]; Kaufmann AJ, 1990, INFORM, V1, P1034; Kosanov J, 2006, MAT SCI ENG A-STRUCT, V427, P274, DOI 10.1016/j.msea.2006.04.090; Kubouchi H, 2002, J AM OIL CHEM SOC, V79, P567, DOI 10.1007/s11746-002-0523-5; Mendez PS, 2009, J MOL STRUC-THEOCHEM, V904, P21, DOI 10.1016/j.theochem.2009.02.023; Nessil A, 2013, ADV TRIBOL, V2013, DOI 10.1155/2013/212568; Orellana-Coca C, 2005, CHEM PHYS LIPIDS, V135, P189, DOI 10.1016/j.chemphyslip.2005.02.014; Ozgulsun A, 2000, J AM OIL CHEM SOC, V77, P105, DOI 10.1007/s11746-000-0017-5; Patil VR, 2014, INT J ADV ENG TECHNO, P01; Rani S, 2014, IND CROP PROD, V65, P328, DOI [10.1016/j.indcrop.2014.12.020, DOI 10.1016/J.INDCR0P.2014.12.020]; Ready JM, 2002, ANGEW CHEM INT EDIT, V41, P1374, DOI 10.1002/1521-3773(20020415)41:8<1374::AID-ANIE1374>3.0.CO;2-8; Reyes EAA, 2011, THESIS U GRANADA GRA; Salih N, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-128; Salimon J, 2012, INT J CHEM ENG, V2012, DOI 10.1155/2012/896598; Salimon J, 2014, CHEM CENT J, V8, DOI 10.1186/1752-153X-8-16; Salimon J, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-429; Salimon J, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/693848; Sharma BK, 2006, J AM OIL CHEM SOC, V83, P129, DOI 10.1007/s11746-006-1185-z; Sharma BK, 2008, BIORESOURCE TECHNOL, V99, P7333, DOI 10.1016/j.biortech.2007.12.057; Sliverstien R., 2005, SPECTROMETRIC IDENTI; Syaima MTS, 2015, RENEW SUST ENERG REV, V44, P669, DOI 10.1016/j.rser.2015.01.005; Yao LX, 2010, J AM OIL CHEM SOC, V87, P937, DOI 10.1007/s11746-010-1574-1; Yunus R., 2003, J OIL PALM RES, V15, P35	37	14	14	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151603	10.1371/journal.pone.0151603	http://dx.doi.org/10.1371/journal.pone.0151603			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008312	Green Submitted, gold, Green Published			2022-12-26	WOS:000372701200059
J	Govindarajan, D; Guan, LM; Meschino, S; Fridman, A; Bagchi, A; Pak, I; ter Meulen, J; Casimiro, DR; Bett, AJ				Govindarajan, Dhanasekaran; Guan, Liming; Meschino, Steven; Fridman, Arthur; Bagchi, Ansu; Pak, Irene; ter Meulen, Jan; Casimiro, Danilo R.; Bett, Andrew J.			A Rapid and Improved Method to Generate Recombinant Dengue Virus Vaccine Candidates	PLOS ONE			English	Article							PROTECTIVE EFFICACY; ATTENUATED VACCINE; IMMUNOGENICITY; CONSTRUCTION; CDNA; RNA; AMPLIFICATION; ANTIBODIES; SAFETY; CLONE	Dengue is one of the most important mosquito-borne infections accounting for severe morbidity and mortality worldwide. Recently, the tetravalent chimeric live attenuated Dengue vaccine Dengvaxia (R) was approved for use in several dengue endemic countries. In general, live attenuated vaccines (LAV) are very efficacious and offer long-lasting immunity against virus-induced disease. Rationally designed LAVs can be generated through reverse genetics technology, a method of generating infectious recombinant viruses from full length cDNA contained in bacterial plasmids. In vitro transcribed (IVT) viral RNA from these infectious clones is transfected into susceptible cells to generate recombinant virus. However, the generation of full-length dengue virus cDNA clones can be difficult due to the genetic instability of viral sequences in bacterial plasmids. To circumvent the need for a single plasmid containing a full length cDNA, in vitro ligation of two or three cDNA fragments contained in separate plasmids can be used to generate a full-length dengue viral cDNA template. However, in vitro ligation of multiple fragments often yields low quality template for IVT reactions, resulting in inconsistent low yield RNA. These technical difficulties make recombinant virus recovery less efficient. In this study, we describe a simple, rapid and efficient method of using LONG-PCR to recover recombinant chimeric Yellow fever dengue (CYD) viruses as potential dengue vaccine candidates. Using this method, we were able to efficiently generate several viable recombinant viruses without introducing any artificial mutations into the viral genomes. We believe that the techniques reported here will enable rapid and efficient recovery of recombinant flaviviruses for evaluation as vaccine candidates and, be applicable to the recovery of other RNA viruses.	[Govindarajan, Dhanasekaran; Guan, Liming; Meschino, Steven; Fridman, Arthur; Bagchi, Ansu; Pak, Irene; Casimiro, Danilo R.; Bett, Andrew J.] Merck & Co Inc, Merck Res Labs, Kenilworth, NJ USA; [ter Meulen, Jan] Immune Design Corp, Seattle, WA USA	Merck & Company	Bett, AJ (corresponding author), Merck & Co Inc, Merck Res Labs, Kenilworth, NJ USA.	andrew_bett@merck.com						Arroyo J, 2004, J VIROL, V78, P12497, DOI 10.1128/JVI.78.22.12497-12507.2004; Barrett ADT, 2001, ANN NY ACAD SCI, V951, P262; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760; Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0; Carvalho A, 2016, EXPERT REV VACCINES; Chambers TJ, 1999, J VIROL, V73, P3095, DOI 10.1128/JVI.73.4.3095-3101.1999; Charlier N, 2004, J VIROL, V78, P7418, DOI 10.1128/JVI.78.14.7418-7426.2004; Coller BAG, 2011, CURR OPIN IMMUNOL, V23, P391, DOI 10.1016/j.coi.2011.03.005; Santos JJD, 2013, MEM I OSWALDO CRUZ, V108, P983, DOI 10.1590/0074-0276130298; Durbin AP, 2010, CURR TOP MICROBIOL, V338, P129, DOI 10.1007/978-3-642-02215-9_10; Eckels KH, 2003, AM J TROP MED HYG, V69, P12, DOI 10.4269/ajtmh.2003.69.12; Govindarajan D, 2015, VACCINE, V33, P4105, DOI 10.1016/j.vaccine.2015.06.067; Guirakhoo F, 2000, J VIROL, V74, P5477, DOI 10.1128/JVI.74.12.5477-5485.2000; Guirakhoo F, 1999, VIROLOGY, V257, P363, DOI 10.1006/viro.1999.9695; Guirakhoo F, 2001, J VIROL, V75, P7290, DOI 10.1128/JVI.75.16.7290-7304.2001; Guy B., 2010, HUM VACCIN, V6, DOI 10.4161.hv.6.9.12739; Halstead SB, 2013, VACCINE, V31, P4501, DOI 10.1016/j.vaccine.2013.06.079; Han JF, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-116; HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830; Lai Ching-Juh, 2003, Adv Virus Res, V61, P469, DOI 10.1016/S0065-3527(03)61013-4; Lindberg AM, 1997, J VIROL METHODS, V65, P191; Lindberg AM, 1999, J VIROL METHODS, V77, P131, DOI 10.1016/S0166-0934(98)00144-X; Polo S, 1997, J VIROL, V71, P5366, DOI 10.1128/JVI.71.7.5366-5374.1997; Puri B, 2000, VIRUS GENES, V20, P57, DOI 10.1023/A:1008160123754; RICE C M, 1989, New Biologist, V1, P285; Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007; Schwartz LM, 2015, VACCINE, V33, P3293, DOI 10.1016/j.vaccine.2015.05.010; SUMIYOSHI H, 1992, J VIROL, V66, P5425, DOI 10.1128/JVI.66.9.5425-5431.1992; Whitehead SS, 2015, EXPERT REV VACCINES, P1; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690	31	4	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152209	10.1371/journal.pone.0152209	http://dx.doi.org/10.1371/journal.pone.0152209			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008550	Green Published, Green Submitted, gold			2022-12-26	WOS:000372701200109
J	Salazar, MFM; Waldner, C; Stookey, J; Bollinger, TK				Salazar, Maria Fernanda Mejia; Waldner, Cheryl; Stookey, Joseph; Bollinger, Trent K.			Infectious Disease and Grouping Patterns in Mule Deer	PLOS ONE			English	Article							CHRONIC WASTING DISEASE; WHITE-TAILED DEER; ELK CERVUS-ELAPHUS; GROUP-SIZE; ODOCOILEUS-HEMIONUS; SOCIAL-ORGANIZATION; PRION TRANSMISSION; BEHAVIOR; DYNAMICS; HABITAT	Infectious disease dynamics are determined, to a great extent, by the social structure of the host. We evaluated sociality, or the tendency to form groups, in Rocky Mountain mule deer (Odocoileus hemionus hemionus) from a chronic wasting disease (CWD) endemic area in Saskatchewan, Canada, to better understand factors that may affect disease transmission. Using group size data collected on 365 radio-collared mule deer (2008-2013), we built a generalized linear mixed model (GLMM) to evaluate whether factors such as CWD status, season, habitat and time of day, predicted group occurrence. Then, we built another GLMM to determine factors associated with group size. Finally, we used 3 measures of group size (typical, mean and median group sizes) to quantify levels of sociality. We found that mule deer showing clinical signs of CWD were less likely to be reported in groups than clinically healthy deer after accounting for time of day, habitat, and month of observation. Mule deer groups were much more likely to occur in February and March than in July. Mixed-sex groups in early gestation were larger than any other group type in any season. Groups were largest and most likely to occur at dawn and dusk, and in open habitats, such as cropland. We discuss the implication of these results with respect to sociobiology and CWD transmission dynamics.	[Salazar, Maria Fernanda Mejia; Bollinger, Trent K.] Univ Saskatchewan, Dept Vet Pathol, Saskatoon, SK, Canada; [Waldner, Cheryl; Stookey, Joseph] Univ Saskatchewan, Dept Large Anim Clin Sci, Saskatoon, SK, Canada; [Bollinger, Trent K.] Canadian Wildlife Hlth Cooperat, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Bollinger, TK (corresponding author), Univ Saskatchewan, Dept Vet Pathol, Saskatoon, SK, Canada.; Bollinger, TK (corresponding author), Canadian Wildlife Hlth Cooperat, Saskatoon, SK, Canada.	trent.bollinger@usask.ca		Waldner, Cheryl/0000-0002-7152-4261	PrioNet Canada a Network of Centres of Excellence of Canada; Saskatchewan Ministry of Environment; Canadian Wildlife Health Cooperative; Consejo Nacional de Ciencia y Tecnologia (CONACyT)	PrioNet Canada a Network of Centres of Excellence of Canada; Saskatchewan Ministry of Environment; Canadian Wildlife Health Cooperative; Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This project was funded primarily by PrioNet Canada a Network of Centres of Excellence of Canada (www.nce-rce.gc.ca). Additional funding and support was provided by Saskatchewan Ministry of Environment (http://environment.gov.sk.ca/) and the Canadian Wildlife Health Cooperative (http://www.ccwhc.ca/). MFMS received a scholarship funding from the Consejo Nacional de Ciencia y Tecnologia (CONACyT) (http://www.conacyt.mx/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman JS, 2009, INTEGR COMP BIOL, V49, P202, DOI 10.1093/icb/icp028; Ager AA, 2003, J MAMMAL, V84, P1076, DOI 10.1644/BBa-020; Alcock J, 2009, ANIMAL BEHAV EVOLUTI; Almberg ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019896; Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Arakawa H, 2010, HORM BEHAV, V57, P330, DOI 10.1016/j.yhbeh.2010.01.002; Barria MA, 2014, EMERG INFECT DIS, V20, P88, DOI 10.3201/eid2001.130858; Behringer DC, 2006, NATURE, V441, P421, DOI 10.1038/441421a; Bender LC, 1996, AM MIDL NAT, V135, P261, DOI 10.2307/2426708; Bishop R.C., 2004, HUM DIMENS WILDL, V9, P181, DOI [10.1080/10871200490479963, DOI 10.1080/10871200490479963]; Body G, 2015, ACTA ETHOL, V18, P101, DOI 10.1007/s10211-014-0190-8; Bouwman KM, 2010, BIOL LETTERS, V6, P462, DOI 10.1098/rsbl.2010.0020; Bowyer RT, 2001, ALCES-N AM MOOSE CON, V37, P371; Brent LJN, 2015, ANIM BEHAV, V103, P211, DOI 10.1016/j.anbehav.2015.01.020; Butler MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126374; Canadian Wildlife Health Cooperative, 2013, CHRON WAST DIS TEST; CLOVER MELVIN R., 1956, CALIFORNIA FISH AND GAME, V42, P199; Conradt L, 2009, AM NAT, V173, P304, DOI 10.1086/596532; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Cross PC, 2007, ECOL APPL, V17, P957, DOI 10.1890/06-1603; Cross PC, 2005, DIS INVASION CONTROL; DEVOS A, 1967, AM MIDL NAT, V77, P390, DOI 10.2307/2423349; Dohoo I., 2009, VET EPIDEMIOLOGICAL, P579; Efron B., 1994, INTRO BOOTSTRAP; GERARD JF, 1995, J THEOR BIOL, V176, P511, DOI 10.1006/jtbi.1995.0217; Gerard JF, 2002, BIOL BULL, V202, P275, DOI 10.2307/1543479; Godfrey Stephanie S., 2013, International Journal for Parasitology Parasites and Wildlife, V2, P235, DOI 10.1016/j.ijppaw.2013.09.001; Gough KC, 2010, PRION, V4, P275, DOI 10.4161/pri.4.4.13678; Grear DA, 2006, J WILDLIFE MANAGE, V70, P546, DOI 10.2193/0022-541X(2006)70[546:DPAHVO]2.0.CO;2; Gross JE, 2001, J WILDLIFE MANAGE, V65, P205, DOI 10.2307/3802899; Gueron S, 1996, J THEOR BIOL, V182, P85, DOI 10.1006/jtbi.1996.0144; HART BL, 1988, NEUROSCI BIOBEHAV R, V12, P123, DOI 10.1016/S0149-7634(88)80004-6; HAWKINS RE, 1970, J WILDLIFE MANAGE, V34, P407, DOI 10.2307/3799027; Hirth DH, 1977, WILDLIFE MONOGR, V53, P3, DOI DOI 10.2307/3830446; Hjeljord O, 2001, ALCES-N AM MOOSE CON, V37, P353; Hughes WOH, 2002, P ROY SOC B-BIOL SCI, V269, P1811, DOI 10.1098/rspb.2002.2113; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Karns GR, 2009, J WILDLIFE DIS, V45, P196, DOI 10.7589/0090-3558-45.1.196; Krumm CE, 2010, BIOL LETTERS, V6, P209, DOI 10.1098/rsbl.2009.0742; Krumm CE, 2005, J WILDLIFE DIS, V41, P503, DOI 10.7589/0090-3558-41.3.503; KUCERA TE, 1978, J MAMMAL, V59, P463, DOI 10.2307/1380224; Kurvers RHJM, 2014, TRENDS ECOL EVOL, V29, P326, DOI 10.1016/j.tree.2014.04.002; LAGORY KE, 1986, BEHAVIOUR, V98, P168, DOI 10.1163/156853986X00955; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lingle S, 2001, ETHOLOGY, V107, P295, DOI 10.1046/j.1439-0310.2001.00664.x; Lingle S, 2003, CAN J ZOOL, V81, P1119, DOI 10.1139/Z03-097; Lingle S, 2000, CAN J ZOOL, V78, P85, DOI 10.1139/cjz-78-1-85; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; Mathiason CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005916; Miller MW, 2006, ECOL APPL, V16, P2208, DOI 10.1890/1051-0761(2006)016[2208:DOPDTI]2.0.CO;2; Miller MW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004019; Miller MW, 2000, J WILDLIFE DIS, V36, P676, DOI 10.7589/0090-3558-36.4.676; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Monello RJ, 2014, J WILDLIFE MANAGE, V78, P214, DOI 10.1002/jwmg.665; Monteith KL, 2007, J WILDLIFE MANAGE, V71, P1712, DOI 10.2193/2005-763; Murtaugh PA, 2009, ECOL LETT, V12, P1061, DOI 10.1111/j.1461-0248.2009.01361.x; Nunn CL, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0115; Nunn CL, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0111; Oraby T, 2014, J THEOR BIOL, V340, P50, DOI 10.1016/j.jtbi.2013.09.003; Otterstatter MC, 2007, OECOLOGIA, V154, P411, DOI 10.1007/s00442-007-0834-8; Potapov A, 2013, ECOL MODEL, V250, P244, DOI 10.1016/j.ecolmodel.2012.11.012; Potapov A, 2012, P ROY SOC B-BIOL SCI, V279, P3139, DOI 10.1098/rspb.2012.0520; Putman R., 1988, NATURAL HIST DEER; Rabe-Hesketh S, 2012, MULTILEVEL LONGITUDI, P687; Reiczigel J, 2005, J PARASITOL, V91, P245, DOI 10.1645/GE-281R1; Reiczigel J, 2016, EUROPEAN J ECOLOGY; Reiczigel J, 2013, QUANTITATIVE PARASIT; Reiczigel J, 2008, ANIM BEHAV, V75, P715, DOI 10.1016/j.anbehav.2007.05.020; Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.1645/0022-3395(2000)086[0228:QPISOH]2.0.CO;2; SAS, 2006, GLIMMIX PROC SAS STA; Semeniuk MB, 2015, MAMMALIA, V79, P131, DOI 10.1515/mammalia-2014-0054; Silbernagel E, 2010, THESIS U SASKATTCHEW; Silbernagel ER, 2011, J WILDLIFE MANAGE, V75, P1453, DOI 10.1002/jwmg.172; SKELTON NK, 2010, THESIS U SASKATCHEWA; Spraker TR, 2002, VET PATHOL, V39, P546, DOI 10.1354/vp.39-5-546; Sullivan L., 2008, ESSENTIAL BIOSTATIST, P175; Time and Date AS, 2014, SWIFT CAN SUNR SUNS; VanderWaal KL, 2013, BEHAV ECOL SOCIOBIOL, V67, P1951, DOI 10.1007/s00265-013-1602-x; Vasilyeva O, 2015, MATH BIOSCI ENG, V12, P209, DOI 10.3934/mbe.2015.12.209; Wasserberg G, 2009, J APPL ECOL, V46, P457, DOI 10.1111/j.1365-2664.2008.01576.x; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Wild MA, 2002, J GEN VIROL, V83, P2629, DOI 10.1099/0022-1317-83-10-2629; WILLIAMS ES, 1993, VET PATHOL, V30, P36, DOI 10.1177/030098589303000105; Williams ES, 2002, REV SCI TECH OIE, V21, P305, DOI 10.20506/rst.21.2.1340; [No title captured]	86	9	9	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0150830	10.1371/journal.pone.0150830	http://dx.doi.org/10.1371/journal.pone.0150830			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007808	gold, Green Published, Green Submitted			2022-12-26	WOS:000372701200032
J	Goncalves, AZ; Oliveira, RS; Oliveira, PS; Romero, GQ				Goncalves, Ana Z.; Oliveira, Rafael S.; Oliveira, Paulo S.; Romero, Gustavo Q.			Species-Specific Effects of Ant Inhabitants on Bromeliad Nutrition	PLOS ONE			English	Article							NEOTROPICAL ANT; NITROGEN FLUXES; URSUS-ARCTOS; PLANT; MUTUALISM; FORMICIDAE; PREDATORS; ECOLOGY; MARINE; FOREST	Predator activities may lead to the accumulation of nutrients in specific areas of terrestrial habitats where they dispose of prey carcasses. In their feeding sites, predators may increase nutrient availability in the soil and favor plant nutrition and growth. However, the translocation of nutrients from one habitat to another may depend on predator identity and diet, as well as on the amount of prey intake. Here we used isotopic (N-15) and physiological methods in greenhouse experiments to evaluate the effects of the identity of predatory ants (i.e., the consumption of prey and nest sites) on the nutrition and growth of the bromeliad Quesnelia arvensis. We showed that predatory ants with protein-based nutrition (i.e., Odontomachus hastatus, Gnamptogenys moelleri) improved the performance of their host bromeliads (i.e., increased foliar N, production of soluble proteins and growth). On the other hand, the contribution of Camponotus crassus for the nutritional status of bromeliads did not differ from bromeliads without ants, possibly because this ant does not have arthropod prey as a preferred food source. Our results show, for the first time, that predatory ants can translocate nutrients from one habitat to another within forests, accumulating nutrients in their feeding sites that become available to bromeliads. Additionally, we highlight that ant contribution to plant nutrition may depend on predator identity and its dietary requirements. Nest debris may be especially important for epiphytic and terrestrial bromeliads in nutrient-poor environments.	[Goncalves, Ana Z.] Univ Estadual Campinas UNICAMP, Inst Biol, Posgrad Ecol, CP 6109, BR-13083970 Campinas, SP, Brazil; [Oliveira, Rafael S.] Univ Estadual Campinas UNICAMP, Inst Biol, Dept Biol Vegetal, CP 6109, BR-13083970 Campinas, SP, Brazil; [Oliveira, Paulo S.; Romero, Gustavo Q.] Univ Estadual Campinas UNICAMP, Inst Biol, Dept Biol Anim, CP 6109, BR-13083970 Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas	Goncalves, AZ (corresponding author), Univ Estadual Campinas UNICAMP, Inst Biol, Posgrad Ecol, CP 6109, BR-13083970 Campinas, SP, Brazil.	zangirolame@gmail.com	Oliveira, Rafael S/B-3422-2013; Gonçalves, Ana Z/AAR-8968-2020; Romero, Gustavo Q/H-8974-2012; Romero, Gustavo Q/N-1896-2019; Gonçalves, Ana Z./E-6735-2016; Oliveira, Paulo S./E-1910-2013	Oliveira, Rafael S/0000-0002-6392-2526; Gonçalves, Ana Z/0000-0002-9036-8831; Romero, Gustavo Q/0000-0003-3736-4759; Romero, Gustavo Q/0000-0003-3736-4759; Gonçalves, Ana Z./0000-0002-9036-8831; 	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo scholarship [2011/10137-8]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [2010/17204-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo scholarship; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo scholarship to A.Z. Goncalves (2011/10137-8), and by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico research grants to P.S. Oliveira, G.Q. Romero and R.S. Oliveira (2010/17204-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson B, 2003, OIKOS, V102, P221, DOI 10.1034/j.1600-0706.2003.12478.x; Anderson B, 2002, OECOLOGIA, V132, P369, DOI 10.1007/s00442-002-0998-1; Barneix AJ, 1996, J PLANT PHYSIOL, V149, P358; Benzing D., 1990, J TROP ECOL, V8, P55, DOI [10.1017/S0266467400006088, DOI 10.1017/S0266467400006088]; BENZING DH, 2000, BROMELIACEAE PROFILE; Bluthgen N, 2000, INSECT SOC, V47, P313, DOI 10.1007/PL00001722; Bouchard SS, 2000, ECOLOGY, V81, P2305, DOI 10.1890/0012-9658(2000)081[2305:STABTO]2.0.CO;2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Camargo RX, 2012, J INSECT SCI, V12, DOI 10.1673/031.012.4801; Camargo RX, 2002, THESIS U ESTADUAL CA; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cogni R, 2004, INSECT SOC, V51, P123, DOI 10.1007/s00040-003-0711-3; Davidson DW, 2003, SCIENCE, V300, P969, DOI 10.1126/science.1082074; DEJEAN A, 1995, BIOTROPICA, V27, P57, DOI 10.2307/2388903; Ellis AG, 1996, OECOLOGIA, V106, P478, DOI 10.1007/BF00329705; Ellison AM, 2001, TRENDS ECOL EVOL, V16, P623, DOI 10.1016/S0169-5347(01)02269-8; Endres L, 2003, PLANT PHYSIOL BIOCH, V41, P181, DOI 10.1016/S0981-9428(02)00025-6; Fischer RC, 2003, J ECOL, V91, P126, DOI 10.1046/j.1365-2745.2003.00747.x; Gibernau M, 2007, BIOL J LINN SOC, V91, P341, DOI 10.1111/j.1095-8312.2007.00799.x; GIVNISH TJ, 1984, AM NAT, V124, P479, DOI 10.1086/284289; Goncalves AZ, 2014, BIOTROPICA, V46, P170, DOI 10.1111/btp.12086; Goncalves AZ, 2011, ANN BOT-LONDON, V107, P1047, DOI 10.1093/aob/mcr047; Hilderbrand GV, 1999, OECOLOGIA, V121, P546, DOI 10.1007/s004420050961; Hocking MD, 2011, SCIENCE, V331, P1609, DOI 10.1126/science.1201079; Holtgrieve GW, 2009, ECOL RES, V24, P1125, DOI 10.1007/s11284-009-0591-8; HUXLEY C, 1980, BIOL REV, V55, P321, DOI 10.1111/j.1469-185X.1980.tb00696.x; Inselsbacher E, 2007, NEW PHYTOL, V175, P311, DOI 10.1111/j.1469-8137.2007.02098.x; Kempf WW, 1972, STUD ENTOMOL, V15, P1; Kolb GS, 2015, ECOSYSTEMS, V18, P643, DOI 10.1007/s10021-015-9853-1; Lattke John E., 1995, Journal of Hymenoptera Research, V4, P137; Leroy C, 2013, ANN BOT-LONDON, V112, P919, DOI 10.1093/aob/mct147; Leroy C, 2012, ANN BOT-LONDON, V109, P145, DOI 10.1093/aob/mcr253; Martins Susian Christian, 2015, Geoderma Regional, V5, P106, DOI 10.1016/j.geodrs.2015.04.005; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Ngai JT, 2006, SCIENCE, V314, P963, DOI 10.1126/science.1132598; Oliveira PS, 2011, INSECT SOC, V58, P207, DOI 10.1007/s00040-010-0138-6; Oliveira PS, 2004, NATURWISSENSCHAFTEN, V91, P557, DOI 10.1007/s00114-004-0585-x; Pereira CG, 2012, P NATL ACAD SCI USA, V109, P1154, DOI 10.1073/pnas.1114199109; Phillips DL, 2001, OECOLOGIA, V127, P171, DOI 10.1007/s004420000578; RICOGRAY V, 1989, AM J BOT, V76, P603, DOI 10.2307/2444355; Rodrigues PAP, 2014, BEHAV PROCESS, V109, P48, DOI 10.1016/j.beproc.2014.06.007; Romero GQ, 2006, ECOLOGY, V87, P803, DOI 10.1890/0012-9658(2006)87[803:BSIHPN]2.0.CO;2; Romero GQ, 2010, J ANIM ECOL, V79, P1122, DOI 10.1111/j.1365-2656.2010.01716.x; Romero GQ, 2010, OECOLOGIA, V162, P941, DOI 10.1007/s00442-009-1533-4; Rudolf VHW, 2014, P ROYAL SOC B, V281, P1; Schmitz OJ, 2010, ECOL LETT, V13, P1199, DOI 10.1111/j.1461-0248.2010.01511.x; Schulze W, 1997, OECOLOGIA, V112, P464, DOI 10.1007/s004420050333; Sendoya SF, 2009, AM NAT, V174, P134, DOI 10.1086/599302; TRESEDER KK, 1995, NATURE, V375, P137, DOI 10.1038/375137a0	49	19	19	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152113	10.1371/journal.pone.0152113	http://dx.doi.org/10.1371/journal.pone.0152113			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002980	Green Submitted, gold, Green Published			2022-12-26	WOS:000372697400080
J	Li, X; Li, XY; Zhu, ZL; Huang, PW; Zhuang, ZX; Liu, JJ; Gao, W; Liu, YP; Huang, HY				Li, Xuan; Li, Xiyi; Zhu, Zhiliang; Huang, Peiwu; Zhuang, Zhixiong; Liu, Jianjun; Gao, Wei; Liu, Yinpin; Huang, Haiyan			Poly(ADP-Ribose) Glycohydrolase (PARG) Silencing Suppresses Benzo(a)pyrene Induced Cell Transformation	PLOS ONE			English	Article							DNA-DAMAGE; CARCINOGENESIS; POLYMERASE-1; INHIBITION; METABOLISM; PROTECTS; REPAIR; GENE	Benzo(a) pyrene (BaP) is a ubiquitously distributed environmental pollutant and known carcinogen, which can induce malignant transformation in rodent and human cells. Poly(ADPribose) glycohydrolase (PARG), the primary enzyme that catalyzes the degradation of poly (ADP-ribose) (PAR), has been known to play an important role in regulating DNA damage repair and maintaining genomic stability. Although PARG has been shown to be a downstream effector of BaP, the role of PARG in BaP induced carcinogenesis remains unclear. In this study, we used the PARG-deficient human bronchial epithelial cell line (shPARG) as a model to examine how PARG contributed to the carcinogenesis induced by chronic BaP exposure under various concentrations (0, 10, 20 and 40 mu M). Our results showed that PARG silencing dramatically reduced DNA damages, chromosome abnormalities, and micronuclei formations in the PARG-deficient human bronchial epithelial cells compared to the control cells (16HBE cells). Meanwhile, the wound healing assay showed that PARG silencing significantly inhibited BaP-induced cell migration. Furthermore, silencing of PARG significantly reduced the volume and weight of tumors in Balb/c nude mice injected with BaP induced transformed human bronchial epithelial cells. This was the first study that reported evidences to support an oncogenic role of PARG in BaP induced carcinogenesis, which provided a new perspective for our understanding in BaP exposure induced cancer.	[Li, Xuan; Huang, Peiwu; Zhuang, Zhixiong; Liu, Jianjun; Gao, Wei; Liu, Yinpin; Huang, Haiyan] Shenzhen Ctr Dis Control & Prevent, Key Lab Modern Toxicol Shenzhen, Shenzhen, Guangdong, Peoples R China; [Li, Xiyi] Guangxi Med Univ, Sch Publ Hlth, Guangxi, Peoples R China; [Zhu, Zhiliang] Baoan Ctr Dis Control & Prevent, Dept Occupat Dis Prevent, Guangzhou, Guangdong, Peoples R China	Shenzhen Center for Disease Control & Prevention (SZCDC); Guangxi Medical University	Huang, HY (corresponding author), Shenzhen Ctr Dis Control & Prevent, Key Lab Modern Toxicol Shenzhen, Shenzhen, Guangdong, Peoples R China.	hhy424@126.com			NSFC [81001261, 81370080, 81273127]; Future Industry Special Project of Shenzhen [ZDSYS20140509101335476]; Shenzhen Science and Technology Development Fund Project [JCYJ20130329103949642]	NSFC(National Natural Science Foundation of China (NSFC)); Future Industry Special Project of Shenzhen; Shenzhen Science and Technology Development Fund Project	This study was supported by NSFC (Project No: 81001261, 81370080 and 81273127) in the study design and data collection. The Future Industry Special Project of Shenzhen (No. ZDSYS20140509101335476) was funded for analysis. The Shenzhen Science and Technology Development Fund Project (Project No: JCYJ20130329103949642) was funded for publish.	Ame JC, 1999, J BIOL CHEM, V274, P17860, DOI 10.1074/jbc.274.25.17860; Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Andreassi Maria Grazia, 2004, Cardiovasc Ultrasound, V2, P25, DOI 10.1186/1476-7120-2-25; Asaithamby A, 2011, MUTAT RES-FUND MOL M, V711, P87, DOI 10.1016/j.mrfmmm.2010.11.002; Blenn C, 2006, BIOCHEM J, V396, P419, DOI 10.1042/BJ20051696; BROCHU G, 1994, BBA-GENE STRUCT EXPR, V1219, P342, DOI 10.1016/0167-4781(94)90058-2; Cohen SM, 2011, TOXICOL SCI, V120, pS76, DOI 10.1093/toxsci/kfq365; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; Erdelyi K, 2009, FASEB J, V23, P3553, DOI 10.1096/fj.09-133264; Fathers C, 2012, CELL CYCLE, V11, P990, DOI 10.4161/cc.11.5.19482; Fauzee NJS, 2012, PATHOL ONCOL RES, V18, P191, DOI 10.1007/s12253-011-9428-1; Fenech M, 2003, MUTAT RES-GEN TOX EN, V534, P65, DOI 10.1016/S1383-5718(02)00249-8; Feng XX, 2013, INT J ONCOL, V42, P749, DOI 10.3892/ijo.2012.1740; Feng XX, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-48; Fisher AEO, 2007, MOL CELL BIOL, V27, P5597, DOI 10.1128/MCB.02248-06; Fujihara H, 2009, CURR CANCER DRUG TAR, V9, P953, DOI 10.2174/156800909790192419; Gagne JP, 2006, CURR OPIN CELL BIOL, V18, P145, DOI 10.1016/j.ceb.2006.02.013; GELBOIN HV, 1980, PHYSIOL REV, V60, P1107, DOI 10.1152/physrev.1980.60.4.1107; Gurung RL, 2010, GENOME INTEGR, V1, P1; Han ZY, 2014, TOXICOL LETT, V225, P275, DOI 10.1016/j.toxlet.2013.12.008; HEIDELBERGER C, 1983, MUTAT RES, V114, P283, DOI 10.1016/0165-1110(83)90036-2; Huang HY, 2012, EXP CELL RES, V318, P682, DOI 10.1016/j.yexcr.2012.01.007; Huang HY, 2015, AM J CANCER RES, V5, P155; Huang HY, 2014, BIOCHEM BIOPH RES CO, V452, P708, DOI 10.1016/j.bbrc.2014.08.146; Ji WD, 2008, CARCINOGENESIS, V29, P1267, DOI 10.1093/carcin/bgn012; Koh DW, 2004, P NATL ACAD SCI USA, V101, P17699, DOI 10.1073/pnas.0406182101; Li M, 2015, ONCOGENE, V34, P3349, DOI 10.1038/onc.2014.295; Li QZ, 2012, CELL PHYSIOL BIOCHEM, V29, P361, DOI 10.1159/000338491; Lin WS, 1997, J BIOL CHEM, V272, P11895, DOI 10.1074/jbc.272.18.11895; Min W, 2010, CARCINOGENESIS, V31, P2058, DOI 10.1093/carcin/bgq205; Min W, 2009, FRONT BIOSCI-LANDMRK, V14, P1619, DOI 10.2741/3329; Nkrumah-Elie YM, 2012, FOOD CHEM TOXICOL, V50, P2524, DOI 10.1016/j.fct.2012.04.010; Shirai H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.133; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Vodicka P, 2015, CARCINOGENESIS; Zhang C, 2015, BMB REP, V48, P354, DOI 10.5483/BMBRep.2015.48.6.012	37	4	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151172	10.1371/journal.pone.0151172	http://dx.doi.org/10.1371/journal.pone.0151172			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003318	Green Published, Green Submitted, gold			2022-12-26	WOS:000372697400026
J	Paiva, VH; Fagundes, AI; Romao, V; Gouveia, C; Ramos, JA				Paiva, Vitor H.; Fagundes, Ana I.; Romao, Vera; Gouveia, Catia; Ramos, Jaime A.			Population-Scale Foraging Segregation in an Apex Predator of the North Atlantic	PLOS ONE			English	Article							PELAGIC SEABIRD; AZORES ARCHIPELAGO; ROUND DISTRIBUTION; STABLE-ISOTOPES; MAXIMUM-ENTROPY; MANX SHEARWATER; STORM-PETREL; MOVEMENTS; TRACKING; ECOLOGY	In this work we investigated the between-colony spatial, behavioural and trophic segregation of two sub-populations of the elusive Macaronesian shearwaters Puffinus baroli breeding only similar to 340 km apart in Cima Islet (Porto Santo Island) and Selvagem Grande Island. Global location sensing (gls) loggers were used in combination with the trophic ecology of tracked individuals, inferred from the isotopic signatures of wing feathers. Results suggest that these two Macaronesian shearwater sub-populations do segregate during the non-breeding period in some 'sub-population-specific' regions, by responding to different oceanographic characteristics (habitat modelling). Within these disparate areas, both sub-populations behave differently (at-sea activity) and prey on disparate trophic niches (stable isotope analysis). One hypothesis would be that each sub-population have evolved and adapted to feed on particular and 'sub-population-specific' resources, and the segregation observed at the three different levels (spatial, behavioural and trophic) might be in fact a result of such adaptation, from the emergence of 'cultural foraging patterns'. Finally, when comparing to the results of former studies reporting on the spatial, behavioural and trophic choices of Macaronesian shearwater populations breeding on Azores and Canary Islands, we realized the high ecological plasticity of this species inhabiting and foraging over the North-East Atlantic Ocean.	[Paiva, Vitor H.; Romao, Vera; Ramos, Jaime A.] Univ Coimbra, Dept Life Sci, MARE Marine & Environm Sci Ctr, P-3004517 Coimbra, Portugal; [Fagundes, Ana I.; Gouveia, Catia] SPEA, Travessa das Torres 2A 1, P-9060314 Funchal, Madeira, Portugal	Universidade de Coimbra	Paiva, VH (corresponding author), Univ Coimbra, Dept Life Sci, MARE Marine & Environm Sci Ctr, P-3004517 Coimbra, Portugal.	vitorpaiva@ci.uc.pt	Ramos, Jaime/B-6616-2018; Paiva, Vitor Hugo/GRX-9179-2022; Paiva, Vitor H./J-1092-2019	Ramos, Jaime/0000-0002-9533-987X; Paiva, Vitor H./0000-0001-6368-9579	EU [NAT/PT/000041]; British Ornithologists' Union; Fundacao para a Ciencia e Tecnologia [SFRH/BPD/63825/2009, SFRH/BPD/85024/2012]	EU(European Commission); British Ornithologists' Union; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	Financial support for the fieldwork on Cima Islet was provided by the EU project LIFE09 NAT/PT/000041. Fieldwork on Selvagem Grande was partially funded by a small grant from the British Ornithologists' Union (2011). VHP received postdoctoral grants given by 'Fundacao para a Ciencia e Tecnologia' (SFRH/BPD/63825/2009 and SFRH/BPD/85024/2012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afan I, 2014, MAR BIOL, V161, P657, DOI 10.1007/s00227-013-2368-4; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Bates D., 2013, LME4 LINEAR MIXED EF; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Camphuysen CJ, 2005, AFR J MAR SCI, V27, P427, DOI 10.2989/18142320509504101; Catry P, 2013, ECOLOGY, V94, P1230, DOI 10.1890/12-2177.1; Catry P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026079; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Edren SMC, 2010, ECOGRAPHY, V33, P698, DOI 10.1111/j.1600-0587.2009.05901.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Fort J, 2012, FRONT ECOL ENVIRON, V10, P237, DOI 10.1890/110194; Frederiksen M, 2012, DIVERS DISTRIB, V18, P530, DOI 10.1111/j.1472-4642.2011.00864.x; Fridolfsson AK, 1999, J AVIAN BIOL, V30, P116, DOI 10.2307/3677252; Graham BS, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P299, DOI 10.1007/978-90-481-3354-3_14; Gremillet D, 2004, MAR ECOL PROG SER, V268, P265, DOI 10.3354/meps268265; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Inger R, 2008, IBIS, V150, P447, DOI 10.1111/j.1474-919X.2008.00839.x; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; Kubetzki U, 2009, MAR ECOL PROG SER, V391, P257, DOI 10.3354/meps08254; Longhurst A.R., 2010, ECOLOGICAL GEOGRAPHY; Lorenzo JA, 2003, ATLAS AVES NIDIFICAN; Louzao M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035728; Roscales JL, 2011, MAR ECOL PROG SER, V434, P1, DOI 10.3354/meps09211; Mackley EK, 2010, MAR ECOL PROG SER, V406, P291, DOI 10.3354/meps08532; Mann K.H., 2005, DYNAMICS MARINE ECOS, V3rd ed., P163; Monteiro LR, 1996, BIOL CONSERV, V78, P319, DOI 10.1016/S0006-3207(96)00037-7; Monteiro LR, 1999, WATERBIRDS, V22, P358, DOI 10.2307/1522111; Monteiro LR, 1996, COLON WATERBIRD, V19, P82, DOI 10.2307/1521810; Monzon-Arguello C, 2009, J EXP MAR BIOL ECOL, V373, P79, DOI 10.1016/j.jembe.2009.03.007; Morato T, 2008, MAR ECOL PROG SER, V357, P23, DOI 10.3354/meps07269; Muller MS, 2014, CURR ZOOL, V60, P631, DOI 10.1093/czoolo/60.5.631; Navarro J, 2013, DEEP SEA RES 2, P1, DOI 10.1016/j.dsr2.2013.01.031; Navarro J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062897; Neves VC, 2012, MAR ECOL PROG SER, V452, P269, DOI 10.3354/meps09670; Oliveira P, 1995, POPULATION SIZE BREE; Paiva VH, 2013, MAR ECOL PROG SER, V477, P15, DOI 10.3354/meps10180; Paiva VH, 2010, OIKOS, V119, P1423, DOI 10.1111/j.1600-0706.2010.18294.x; Paiva VH, 2010, MAR BIOL, V157, P1385, DOI 10.1007/s00227-010-1417-5; Paiva VH, 2010, ZOOLOGY, V113, P47, DOI 10.1016/j.zool.2009.05.003; Paiva VH, 2010, MAR ECOL PROG SER, V398, P259, DOI 10.3354/meps08319; Peron C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072713; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pikitch EK, 2014, FISH FISH, V15, P43, DOI 10.1111/faf.12004; Pinet P, 2011, MAR ECOL PROG SER, V423, P291, DOI 10.3354/meps08971; Quillfeldt P, 2005, MAR ECOL PROG SER, V295, P295, DOI 10.3354/meps295295; Quillfeldt P, 2013, J BIOGEOGR, V40, P430, DOI 10.1111/jbi.12008; R Core Team, 2013, R LANG ENV STAT COMP; Ramirez I, 2013, MAR ECOL PROG SER, V476, P269, DOI 10.3354/meps10083; Ramos JA, 1997, CONDOR, V99, P634, DOI 10.2307/1370475; Ramos JA, 2015, DEEP-SEA RES PT I, V104, P60, DOI 10.1016/j.dsr.2015.07.001; Ramos R, 2013, DIVERS DISTRIB, V19, P1284, DOI 10.1111/ddi.12088; Ramos R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040822; Reiertsen TK, 2014, MAR ECOL PROG SER, V509, P289, DOI 10.3354/meps10825; Rodriguez A, 2012, IBIS, V154, P167, DOI 10.1111/j.1474-919X.2011.01175.x; Santos RS, 1995, AQUAT CONSERV, V5, P311, DOI 10.1002/aqc.3270050406; Somes CJ, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003767; Sousa FM, 2008, REMOTE SENS ENVIRON, V112, P2817, DOI 10.1016/j.rse.2008.01.014; Tremblay Y, 2009, MAR ECOL PROG SER, V391, P153, DOI 10.3354/meps08146; Verbruggen H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068337; Votier SC, 2011, MAR BIOL, V158, P355, DOI 10.1007/s00227-010-1563-9; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1; Werner AC, 2014, AUK, V131, P265, DOI 10.1642/AUK-13-172.1; Zino F., 2011, BIRDING WORLD, V24, P216	67	7	7	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151340	10.1371/journal.pone.0151340	http://dx.doi.org/10.1371/journal.pone.0151340			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003687	gold, Green Submitted, Green Published			2022-12-26	WOS:000372697400029
J	Wu, FX; He, Y; Di, HT; Sun, YM; Pan, RR; Yu, WF; Liu, RY				Wu, Fei-xiang; He, Yan; Di, Hui-ting; Sun, Yu-ming; Pan, Rui-rui; Yu, Wei-feng; Liu, Renyu			An Engineered Endomorphin-2 Gene for Morphine Withdrawal Syndrome	PLOS ONE			English	Article							SPINAL SUBARACHNOID SPACE; INJECTION-DRUG USERS; ADENOVIRAL VECTORS; NEUROPATHIC PAIN; BETA-ENDORPHIN; ENZYMATIC DEGRADATION; ADDICTION TREATMENT; CLINICAL-TRIAL; SAFETY PROFILE; THERAPY	An optimal therapeutics to manage opioid withdrawal syndrome is desired for opioid addiction treatment. Down-regulation of endogenous endomorphin-2 (EM2) level in the central nervous system after continuous morphine exposure was observed, which suggested that increase of EM2 could be an alternative novel method for opioid dependence. As a short peptide, the short half-life of EM2 limits its clinical usage through conventional administration. In the present study, we engineered an EM2 gene using a signal peptide of mouse growth factor for an out-secretory expression of EM2 and an adenovirus as a vector, which ultimately sustained the release of EM-2. After administration of the adenovirus in central nervous system, a sustained increase of EM2 level in the cerebral spinal fluid (CSF) was observed along with a reduction of morphine withdrawal syndrome. These findings suggest that the engineered EM2 gene delivered to the central nervous system could be a novel therapeutics for withdrawal syndrome in opioid dependent subjects.	[Wu, Fei-xiang; Di, Hui-ting; Sun, Yu-ming; Pan, Rui-rui; Yu, Wei-feng] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Anesthesiol & Intens Care, Shanghai 200438, Peoples R China; [Wu, Fei-xiang; Liu, Renyu] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [He, Yan] Dongfang Hosp, Dept Anesthesiol, Fujian 354200, Peoples R China	Naval Medical University; University of Pennsylvania; Pennsylvania Medicine	Yu, WF (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Dept Anesthesiol & Intens Care, Shanghai 200438, Peoples R China.; Liu, RY (corresponding author), Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.	ywf808@sohu.com; liur@uphs.upenn.edu	Yu, Wei/GZL-3831-2022		National Natural Science Foundation of China [30901403]; National Institutes of Health (NIH) [K08-GM-093115]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM093115] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Natural Science Foundation of China (no. 30901403, PI, WFY); National Institutes of Health (NIH, K08-GM-093115) (PI: RYL).	BIAN D, 1995, NEUROREPORT, V6, P1981, DOI 10.1097/00001756-199510010-00007; Brunetti-Pierri N, 2008, GENE THER, V15, P553, DOI 10.1038/gt.2008.14; Cao HB, 2004, VIRAL IMMUNOL, V17, P327, DOI 10.1089/0882824041857111; Capasso A, 2002, PROG NEURO-PSYCHOPH, V26, P313, DOI 10.1016/S0278-5846(01)00274-3; Dalbey RE, 1997, PROTEIN SCI, V6, P1129, DOI 10.1002/pro.5560060601; FARRELL M, 1994, BMJ-BRIT MED J, V309, P997, DOI 10.1136/bmj.309.6960.997; Finegold AA, 1999, HUM GENE THER, V10, P1251, DOI 10.1089/10430349950018238; Fukunaga Y, 1998, JPN J PHARMACOL, V78, P455, DOI 10.1254/jjp.78.455; Gao Y, 2006, CELL MOL NEUROBIOL, V26, P357, DOI 10.1007/s10571-006-9050-z; Gartry CC, 2009, HARM REDUCT J, V6, DOI 10.1186/1477-7517-6-2; Gupta DS, 2007, J PHARMACOL EXP THER, V321, P635, DOI 10.1124/jpet.106.118505; Hau VS, 2002, J PHARM SCI-US, V91, P2140, DOI 10.1002/jps.10202; He Y, 2011, BRAIN RES, V1422, P13, DOI 10.1016/j.brainres.2011.07.063; Honda T, 2007, BIOORGAN MED CHEM, V15, P3883, DOI 10.1016/j.bmc.2007.03.009; Ishii K, 2000, EXP NEUROL, V166, P90, DOI 10.1006/exnr.2000.7491; Johnson RE, 2000, NEW ENGL J MED, V343, P1290, DOI 10.1056/NEJM200011023431802; Karila L, 2008, AM J PSYCHIAT, V165, P400, DOI 10.1176/appi.ajp.2007.07071103; Knappskog S, 2007, J BIOTECHNOL, V128, P705, DOI 10.1016/j.jbiotec.2006.11.026; Liu HM, 2007, BIOORGAN MED CHEM, V15, P1694, DOI 10.1016/j.bmc.2006.12.007; MALDONADO R, 1992, NEUROPHARMACOLOGY, V31, P1231, DOI 10.1016/0028-3908(92)90051-P; Manzoni P, 2006, DEVIANT BEHAV, V27, P351, DOI 10.1080/01639620600605705; March JC, 2006, EUR ADDICT RES, V12, P33, DOI 10.1159/000088581; Mata Marina, 2004, Curr Neurol Neurosci Rep, V4, P1, DOI 10.1007/s11910-004-0001-0; Mattick RP, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002209.pub2; Mayer P, 2006, PHARMACOGENET GENOM, V16, P1, DOI 10.1097/01.fpc.0000182781.87932.0d; Miller CL, 2006, SUBST USE MISUSE, V41, P199, DOI 10.1080/10826080500391795; Milligan ED, 1999, J NEUROSCI METH, V90, P81, DOI 10.1016/S0165-0270(99)00075-8; Muhammad AKMG, 2012, HUM GENE THER METHOD, V23, P271, DOI 10.1089/hgtb.2012.060; Okada Y, 2012, INT J MED CHEM, V2012, DOI 10.1155/2012/715123; Oviedo-Joekes E, 2009, NEW ENGL J MED, V361, P777, DOI 10.1056/NEJMoa0810635; Peter A, 1999, J CHROMATOGR A, V846, P39, DOI 10.1016/S0021-9673(99)00146-6; Pohl M, 2001, EUR J PHARMACOL, V429, P39, DOI 10.1016/S0014-2999(01)01304-8; Przewlocka B, 1999, EUR J PHARMACOL, V367, P189, DOI 10.1016/S0014-2999(98)00956-X; Puntel M, 2013, TOXICOL APPL PHARM, V268, P318, DOI 10.1016/j.taap.2013.02.001; Robles E, 2002, J SUBST ABUSE TREAT, V23, P409, DOI 10.1016/S0740-5472(02)00274-X; St George JA, 2003, GENE THER, V10, P1135, DOI 10.1038/sj.gt.3302071; Stevens RC, 2003, JAIDS-J ACQ IMM DEF, V33, P650, DOI 10.1097/00126334-200308150-00016; Storkson RV, 1996, J NEUROSCI METH, V65, P167, DOI 10.1016/0165-0270(95)00164-6; Sugimoto-Watanabe A, 1999, JPN J PHARMACOL, V81, P264, DOI 10.1254/jjp.81.264; Termorshuizen F, 2005, DRUG ALCOHOL DEPEN, V79, P231, DOI 10.1016/j.drugalcdep.2005.01.013; Tseng LF, 2000, J PHARMACOL EXP THER, V292, P576; Vigezzi P, 2006, J SUBST ABUSE TREAT, V31, P3, DOI 10.1016/j.jsat.2006.03.007; Volpers C, 2004, J GENE MED, V6, pS164, DOI 10.1002/jgm.496; Wilson S P, 2000, Curr Rev Pain, V4, P445; Wood E, 2005, SUBST USE MISUSE, V40, P1153, DOI 10.1081/JA-200042287; Wu FX, 2012, INT J CLIN EXP PATHO, V5, P914; Wu FX, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/406435; Xiao H, 2009, BRAIN RES, V1271, P74, DOI 10.1016/j.brainres.2009.02.084; Zadina JE, 1997, NATURE, V386, P499, DOI 10.1038/386499a0	49	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0149877	10.1371/journal.pone.0149877	http://dx.doi.org/10.1371/journal.pone.0149877			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003293	Green Published, Green Submitted, gold			2022-12-26	WOS:000372697400012
J	Ban, CX; Zhong, L; Wang, T; Zhu, MJ; Wang, JH; Zhang, ZL; Wang, Z; Su, N; Liu, YY; Shi, YC; Xiao, SF; Li, X				Ban, Chun-xia; Zhong, Li; Wang, Tao; Zhu, Min-jie; Wang, Jing-hua; Zhang, Zhen-lian; Wang, Zhe; Su, Ning; Liu, Yuan-yuan; Shi, Yan-chen; Xiao, Shi-fu; Li, Xia			Enhanced Diabetes Susceptibility in Community Dwelling Han Elders Carrying the Apolipoprotein E 3/3 Genotype	PLOS ONE			English	Article							E GENE POLYMORPHISM; CARDIOVASCULAR RISK; LIPID PROFILE; ASSOCIATION; DISEASE; ALLELE; APOE; POPULATION; PREVALENCE; MELLITUS	Despite Apolipoprotein E (ApoE) being one of the main apolipoproteins in the blood, the association between its genotype and the high cholesterol or blood glucose levels commonly seen in clinical practice is inconclusive. Such research is also lacking in the Han population. The aim of this study was to investigate the association between APOE genotype, diabetes, and plasma glucose and lipid levels. We included 243 community-dwelling elderly residents in this study. Participant APOE genotypes were assessed and were simultaneously tested for weight, height, blood glucose, triglycerides, cholesterol, and high- and low-density lipoprotein. In addition, gender, age, years of education, cognitive function, and medical history was recorded. Subjects were divided into 3 groups based on APOE genotype: APOE epsilon 2 group (epsilon 2/epsilon 2 and epsilon 2/3), APOE epsilon 3 group (epsilon 3/epsilon 3), and APOE epsilon 4 group (epsilon 2/epsilon 4, epsilon 3/epsilon 4 and epsilon 4/epsilon 4). Comparisons between groups were conducted for the incidence of diabetes, high blood pressure, and dementia, as well as for differences in body-mass index, fasting plasma glucose, and blood lipids. The APOE epsilon 3/epsilon 3 genotype exhibited the highest frequency (70.4%) among the subjects. Participants in the APOE epsilon 3 group demonstrated significantly higher levels of fasting plasma glucose than those in the APOE epsilon 2 and APOE epsilon 4 groups (P<0.05). The APOE epsilon 3 group had slightly higher abnormal fasting plasma glucose values than did the APOE epsilon 2 group (P = 0.065). Furthermore, the APOE3 genotype was significantly correlated with both fasting plasma glucose level and glucose abnormality (P<0.05) and trended toward statistically significant correlation with diabetes (P = 0.082). The correlation between APOE2 and low low-density lipoprotein levels also approached statistical significance (P = 0.052). Thus, elderly community dwelling residents of Han ethnicity carrying the APOE epsilon 3/epsilon 3 genotype might have higher plasma glucose levels and a higher occurrence of diabetes.	[Ban, Chun-xia; Wang, Tao; Zhu, Min-jie; Wang, Jing-hua; Su, Ning; Liu, Yuan-yuan; Shi, Yan-chen; Xiao, Shi-fu; Li, Xia] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Dept Psychogeriatr, Shanghai 200030, Peoples R China; [Zhong, Li; Zhang, Zhen-lian; Wang, Zhe] Xiamen Univ, Coll Med, Inst Neurosci, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Xiamen, Peoples R China	Shanghai Jiao Tong University; Xiamen University	Xiao, SF; Li, X (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Dept Psychogeriatr, Shanghai 200030, Peoples R China.	xiaoshifu@msn.com; ja_1023@aliyun.com		Zhong, Li/0000-0003-3815-6484	National Key Project for IND [2012ZX09303-303]; National Natural Science Foundation of China [81101007]; Shanghai Science & Technology Committee [15411961400]	National Key Project for IND; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science & Technology Committee(Shanghai Science & Technology Committee)	This work was financially supported mostly by the grants from National Key Project for IND (No. 2012ZX09303-303, SFX, http://www.most.gov.cn/), partially supported from National Natural Science Foundation of China (No. 81101007, XL, http://www.nsfc.gov.cn/) and the Shanghai Science & Technology Committee (No. 15411961400, XL, http://www.stcsm.gov.cn/).	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Alberti KGMM, 2007, DIABETIC MED, V24, P451, DOI 10.1111/j.1464-5491.2007.02157.x; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; de Freitas RGA, 2015, ARQ BRAS CARDIOL, V104, P468, DOI 10.5935/abc.20150036; Anthopoulos PG, 2010, MOL GENET METAB, V100, P283, DOI 10.1016/j.ymgme.2010.03.008; Bojar I, 2015, ANN AGR ENV MED, V22, P313, DOI 10.5604/12321966.1152086; Cedazo-Minguez A, 2007, J CELL MOL MED, V11, P1227, DOI 10.1111/j.1582-4934.2007.00130.x; Chaudhary R, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-36; Chen XF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143157; Colagiuri S, 2005, DIABETOLOGIA, V48, P1459, DOI 10.1007/s00125-005-1843-y; Duman BS, 2004, DIABETES NUTR METAB, V17, P267; HALLMAN DM, 1991, AM J HUM GENET, V49, P338; Hu G, 2013, EUR J PREV CARDIOL, V20, P89, DOI 10.1177/1741826711428242; Igbavboa U, 2005, J NEUROL SCI, V229, P225, DOI 10.1016/j.jns.2004.11.037; Jochemsen HM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.016; KATZMAN R, 1988, J CLIN EPIDEMIOL, V41, P971, DOI 10.1016/0895-4356(88)90034-0; Lin SK, 2004, ANN CLIN LAB SCI, V34, P443; Linhartova PB, 2015, ARCH ORAL BIOL, V60, P456, DOI 10.1016/j.archoralbio.2014.10.003; Mazzotti DR, 2014, GENE, V535, P370, DOI 10.1016/j.gene.2013.11.040; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mondadori CRA, 2007, CEREB CORTEX, V17, P1934, DOI 10.1093/cercor/bhl103; Ostchega Y, 2007, J AM GERIATR SOC, V55, P1056, DOI 10.1111/j.1532-5415.2007.01215.x; RALL SC, 1992, J INTERN MED, V231, P653, DOI 10.1111/j.1365-2796.1992.tb01254.x; Sapkota B, 2015, J DIABETES COMPLICAT, V29, P1191, DOI 10.1016/j.jdiacomp.2015.07.025; Scuteri A, 2005, AM J PHYSIOL-ENDOC M, V289, pE322, DOI 10.1152/ajpendo.00408.2004; Serrano-Pozo A, 2015, ANN NEUROL, V77, P917, DOI 10.1002/ana.24369; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; SIEST G, 1995, CLIN CHEM, V41, P1068; Tao QQ, 2014, CLIN INTERV AGING, V9, P1063, DOI 10.2147/CIA.S62554; Wang H, 2011, DIABETES CARE, V34, P1952, DOI 10.2337/dc11-0329; Windler E, 2005, ATHEROSCLEROSIS SUPP, V6, P11, DOI 10.1016/j.atherosclerosissup.2005.06.003; Xiao Shifu, 2013, Shanghai Arch Psychiatry, V25, P91, DOI 10.3969/j.issn.1002-0829.2013.02.005; Yousuf FA, 2015, PAK J PHARM SCI, V28, P1439; Zhan XH, 2015, EXP THER MED, V9, P469, DOI 10.3892/etm.2014.2097; Zheng YX, 2009, CLIN CARDIOL, V32, P491, DOI 10.1002/clc.20605; Zhu H, 2015, MINERVA CARDIOANGIOL	36	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151336	10.1371/journal.pone.0151336	http://dx.doi.org/10.1371/journal.pone.0151336			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998902	Green Published, gold			2022-12-26	WOS:000372694700032
J	Farooqi, A; Adamsson, M; Serenius, F; Hagglof, B				Farooqi, A.; Adamsson, M.; Serenius, F.; Hagglof, B.			Executive Functioning and Learning Skills of Adolescent Children Born at Fewer than 26 Weeks of Gestation	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; EXTREMELY PRETERM CHILDREN; ACTIVE PERINATAL MANAGEMENT; SCHOOL-AGE OUTCOMES; FTF 5; MATHEMATICS DIFFICULTIES; ACADEMIC ATTAINMENT; PROCESSING SPEED; 15 QUESTIONNAIRE; WORKING-MEMORY	Aims To assess the cognitive and behavioral aspects of executive functioning (EF) and learning skills in extremely preterm (EPT) children compared with term control children aged 10 to 15 years. Methods A total of 132 of 134 (98% of all eligible survivors) EPT children born at the 2 Swedish regional tertiary care centers from 1992 to 1998 (mean age = 12 years, mean birth weight = 718 g, and mean gestational age = 24.4 weeks) and 103 matched term controls were assessed. General intelligence was assessed using the Wechsler Intelligence Scale for Children (WISC-III-R), and cognitive aspects of EF were analyzed using EF-sensitive sub-scales of the WISC-III-R and Tower test of the Delis-Kaplan Executive Function Scale (D-KEFS). Behaviors related to EF and learning skills were assessed using the Five to Fifteen questionnaire, which is a validated parent and teacher instrument. Academic performance in school was assessed by teachers' responses on Achenbach's Teachers Report Form. Analyses performed included multivariate analyses of covariance (ANCOVA and MANCOVA) and logistic regression analyses. Results The EPT children displayed significant deficits in cognitive aspects of EF compared with the controls, exhibiting decreases on the order of 0.9 SD to 1.2 SD for tasks of verbal conceptual reasoning, verbal and non-verbal working memory, processing speed and planning ability (P < 0.001 for all). After excluding the children with major neurosensory impairment (NSI) or a Full Scale intelligence quotient (FSIQ) of < 70, significant differences were observed on all tests. Compared with controls, parents and teachers of EPT children reported significantly more EF-related behavioral problems. MANCOVA of teacher-reported learning skills in children with FSIQ > 70 and without major NSI revealed no interactions, but significant main effects were observed for the behavioral composite executive function score, group status (EPT vs control) and FSIQ, for which all effect sizes were medium to large. The corresponding findings of MANCOVA of the parent-reported learning skills were very similar. According to the teachers' ratings, the EPT children were less well adjusted to the school environment. Conclusion EPT children born in the 1990s who received active perinatal care are at an increased risk of executive dysfunction, even after excluding children with significant neurodevelopmental disabilities. Even mild to moderate executive dysfunctions has a significant impact on learning skills. These findings suggest the need for timely interventions that address specific cognitive vulnerabilities and executive dysfunctions.	[Farooqi, A.; Adamsson, M.] Umea Univ, Inst Clin Sci, Pediat, Umea, Sweden; [Serenius, F.] Uppsala Univ, Dept Womens & Childrens Hlth, Uppsala, Sweden; [Hagglof, B.] Umea Univ, Inst Clin Sci Child & Adolescent Psychiat, Umea, Sweden	Umea University; Uppsala University; Umea University	Farooqi, A (corresponding author), Umea Univ, Inst Clin Sci, Pediat, Umea, Sweden.	aijaz.farooqi@umu.se			ALF - Vasterbotten; Umea univesrity [ALF-VLL 67971]; Vastebotten county council, Sweden [ALF-VLL 67971]; Jerringfonden	ALF - Vasterbotten; Umea univesrity; Vastebotten county council, Sweden; Jerringfonden	The work was was funded by the ALF - Vasterbotten, jointly funded by Umea univesrity and Vastebotten county council, Sweden, grant no. ALF-VLL 67971 (agreement concerning reasearch and education of doctors), and Jerringfonden. The funders had no role in study design, data collection and analysis, or decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2012, DEV MED CHILD NEUROL, V54, P247, DOI 10.1111/j.1469-8749.2011.04150.x; Aarnoudse-Moens CSH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055994; Achenbach T.M., 1991, MANUAL YOUTH SELF RE; Anderson P, 2003, JAMA-J AM MED ASSOC, V289, P3264, DOI 10.1001/jama.289.24.3264; Anderson PJ, 2008, SEMIN PERINATOL, V32, P51, DOI 10.1053/j.semperi.2007.12.009; Anderson PJ, 2004, PEDIATRICS, V114, P50, DOI 10.1542/peds.114.1.50; [Anonymous], 2004, EUR CHILD ADOLESC S3, V13, pIII/50; Aylward GP, 2005, J DEV BEHAV PEDIATR, V26, P427, DOI 10.1097/00004703-200512000-00008; Berntsson L, 2000, THESIS NORDIC SCH PU; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Blennow M, 2009, JAMA-J AM MED ASSOC, V301, P2225, DOI 10.1001/jama.2009.771; Bohm B, 2002, DEV MED CHILD NEUROL, V44, P508; Botting N, 1998, DEV MED CHILD NEUROL, V40, P652; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crijnen AAM, 1999, AM J PSYCHIAT, V156, P569; Delis C. D., 2001, DELIS KAPLAN EXECUTI; Dennis M, 2009, J INT NEUROPSYCH SOC, V15, P331, DOI 10.1017/S1355617709090481; Farooqi A, 2013, ACTA PAEDIATR, V102, P625, DOI 10.1111/apa.12219; Gioia GA, 2001, PSYCHOLOGICAL AND DEVELOPMENTAL ASSESSMENT, P317; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Guarini A, 2006, WORLD J PEDIATR, V2, P102; Hakansson S, 2004, PEDIATRICS, V114, P58, DOI 10.1542/peds.114.1.58; Holsti A, 1990, CHRONIC CONDIT UNPUB; Holsti A, NEURODEVELOPME UNPUB; Huppi PS, 1998, ANN NEUROL, V43, P224, DOI 10.1002/ana.410430213; Hutchinson EA, 2013, PEDIATRICS, V131, pE1053, DOI 10.1542/peds.2012-2311; Inder TE, 1999, ANN NEUROL, V46, P755, DOI 10.1002/1531-8249(199911)46:5<755::AID-ANA11>3.0.CO;2-0; Isaacs EB, 2001, BRAIN, V124, P1701, DOI 10.1093/brain/124.9.1701; Johnson S, 2009, ARCH DIS CHILD-FETAL, V94, pF283, DOI 10.1136/adc.2008.152793; Johnson S, 2011, DEV NEUROPSYCHOL, V36, P74, DOI 10.1080/87565641.2011.540541; Johnson S, 2010, J AM ACAD CHILD PSY, V49, P453, DOI 10.1016/j.jaac.2010.02.002; Johnson S, 2009, PEDIATRICS, V124, pE249, DOI 10.1542/peds.2008-3743; Kadesjo B, 2004, EUR CHILD ADOLES PSY, V13, P3, DOI 10.1007/s00787-004-3002-2; Kohen DE, 1997, J DEV BEHAV PEDIATR, V18, P295, DOI 10.1097/00004703-199710000-00003; Korkman M, 2004, EUR CHILD ADOLES PSY, V13, P31, DOI 10.1007/s00787-004-3005-z; LeFevre JA, 2010, CHILD DEV, V81, P1753, DOI 10.1111/j.1467-8624.2010.01508.x; Litt J, 2005, J LEARN DISABIL-US, V38, P130, DOI 10.1177/00222194050380020301; Litt JS, 2012, ACTA PAEDIATR, V101, P1240, DOI 10.1111/j.1651-2227.2012.02790.x; Locascio G, 2010, J LEARN DISABIL-US, V43, P441, DOI 10.1177/0022219409355476; Marlow N, 2007, PEDIATRICS, V120, P793, DOI 10.1542/peds.2007-0440; Marsal K, 1996, ACTA PAEDIATR, V85, P843, DOI 10.1111/j.1651-2227.1996.tb14164.x; McKinstry RC, 2002, NEUROLOGY, V59, P824, DOI 10.1212/WNL.59.6.824; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Moore Tamanna, 2012, BMJ, V345, pe7961, DOI 10.1136/bmj.e7961; Mulder H, 2011, BRIT J EDUC PSYCHOL, V81, P147, DOI 10.1348/000709910X505527; Mulder H, 2010, ARCH DIS CHILD-FETAL, V95, pF267, DOI 10.1136/adc.2009.167965; Mulder H, 2009, DEV NEUROPSYCHOL, V34, P393, DOI 10.1080/87565640902964524; Pritchard VE, 2009, EARLY HUM DEV, V85, P215, DOI 10.1016/j.earlhumdev.2008.10.004; Rubinsten O, 2009, TRENDS COGN SCI, V13, P92, DOI 10.1016/j.tics.2008.11.002; Serenius F, 2004, ACTA PAEDIATR, V93, P1090, DOI [10.1111/j.1651-2227.2004.tb02722.x, 10.1080/08035250410027760]; Serenius F, 2004, ACTA PAEDIATR, V93, P1081, DOI [10.1080/08035250410027751, 10.1111/j.1651-2227.2004.tb02721.x]; Serenius F, 2013, JAMA-J AM MED ASSOC, V309, P1810, DOI 10.1001/jama.2013.3786; Shum D, 2008, ARCH CLIN NEUROPSYCH, V23, P103, DOI 10.1016/j.acn.2007.08.006; Simms V, 2013, ARCH DIS CHILD-FETAL, V98, pF457, DOI 10.1136/archdischild-2013-303777; Simms V, 2013, PEDIATR RES, V73, P236, DOI 10.1038/pr.2012.157; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Taylor HG, 2009, DEV DISABIL RES REV, V15, P52, DOI 10.1002/ddrr.51; Taylor HG, 2000, CHILD DEV, V71, P1495, DOI 10.1111/1467-8624.00242; Taylor HG, 2002, CHILD NEUROPSYCHOL, V8, P163, DOI 10.1076/chin.8.3.163.13500; TAYLOR HG, 1995, J PEDIATR PSYCHOL, V20, P703, DOI 10.1093/jpepsy/20.6.703; Thuy ML, 2011, PEDIATRICS, V127, pE639, DOI 10.1542/peds.2010-1421; Trillingsgaard A, 2004, EUR CHILD ADOLES PSY, V13, P39, DOI 10.1007/s00787-004-3006-y; Wechsler D., 1999, WECHSLER INTELLIGENC, V1	63	31	32	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151819	10.1371/journal.pone.0151819	http://dx.doi.org/10.1371/journal.pone.0151819			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3NW	26999522	Green Published, Green Submitted, gold			2022-12-26	WOS:000372694700068
J	Jokela, M; Huovinen, S; Raheem, O; Lindfors, M; Palmio, J; Penttila, S; Udd, B				Jokela, Manu; Huovinen, Sanna; Raheem, Olayinka; Lindfors, Mikaela; Palmio, Johanna; Penttila, Sini; Udd, Bjarne			Distinct Muscle Biopsy Findings in Genetically Defined Adult-Onset Motor Neuron Disorders	PLOS ONE			English	Article								The objective of this study was to characterize and compare muscle histopathological findings in 3 different genetic motor neuron disorders. We retrospectively re-assessed muscle biopsy findings in 23 patients with autosomal dominant lower motor neuron disease caused by p.G66V mutation in CHCHD10 (SMAJ), 10 X-linked spinal and bulbar muscular atrophy (SBMA) and 11 autosomal dominant c9orf72-mutated amyotrophic lateral sclerosis (c9ALS) patients. Distinct large fiber type grouping consisting of non-atrophic type IIA muscle fibers were 100% specific for the late-onset spinal muscular atrophies (SMAJ and SBMA) and were never observed in c9ALS. Common, but less specific findings included small groups of highly atrophic rounded type IIA fibers in SMAJ/SBMA, whereas in c9ALS, small group atrophies consisting of small-caliber angular fibers involving both fiber types were more characteristic. We also show that in the 2 slowly progressive motor neuron disorders (SMAJ and SBMA) the initial neurogenic features are often confused with considerable secondary "myopathic" changes at later disease stages, such as rimmed vacuoles, myofibrillar aggregates and numerous fibers reactive for fetal myosin heavy chain (dMyHC) antibodies. Based on our findings, muscle biopsy may be valuable in the diagnostic work-up of suspected motor neuron disorders in order to avoid a false ALS diagnosis in patients without clear findings of upper motor neuron lesions.	[Jokela, Manu] Turku Univ Hosp, Div Clin Neurosci, FIN-20520 Turku, Finland; [Jokela, Manu] Univ Turku, Turku, Finland; [Jokela, Manu; Raheem, Olayinka; Lindfors, Mikaela; Palmio, Johanna; Penttila, Sini; Udd, Bjarne] Tampere Univ Hosp, Dept Neurol, Neuromuscular Res Ctr, Tampere, Finland; [Jokela, Manu; Raheem, Olayinka; Lindfors, Mikaela; Palmio, Johanna; Penttila, Sini; Udd, Bjarne] Univ Tampere, FIN-33101 Tampere, Finland; [Huovinen, Sanna] Tampere Univ Hosp, Dept Pathol, Fimlab Labs, Tampere, Finland; [Udd, Bjarne] Vasa Cent Hosp, Dept Neurol, Vaasa, Finland; [Udd, Bjarne] Univ Helsinki, Dept Med Genet, Folkhalsan Inst Genet, Helsinki, Finland	University of Turku; University of Turku; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Vaasa Central Hospital; University of Helsinki	Jokela, M (corresponding author), Turku Univ Hosp, Div Clin Neurosci, FIN-20520 Turku, Finland.; Jokela, M (corresponding author), Univ Turku, Turku, Finland.; Jokela, M (corresponding author), Tampere Univ Hosp, Dept Neurol, Neuromuscular Res Ctr, Tampere, Finland.	mejoke@utu.fi		Huovinen, Sanna/0000-0001-7659-7921	Folkhalsan Genetic Institute; Tampere University Hospital	Folkhalsan Genetic Institute; Tampere University Hospital	The study was funded by research grants from Folkhalsan Genetic Institute and Tampere University Hospital Research Funds (BU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baloh RH, 2007, MUSCLE NERVE, V36, P107, DOI 10.1002/mus.20755; Bannwarth S, 2014, BRAIN, V137, P2329, DOI 10.1093/brain/awu138; Dubowitz V, 2013, MUSCLE BIOPSY PRACTI, V4th, P16; Johnson JO, 2014, NAT NEUROSCI, V17, P664, DOI 10.1038/nn.3688; Malena A, 2013, ACTA NEUROPATHOL, V126, P109, DOI 10.1007/s00401-013-1122-9; Mascorro J, 2007, METHOD MOL BIOL, P19; Palmio J, 2015, J NEUROL NE IN PRESS; Penttila S, 2015, ANN NEUROL, V77, P163, DOI 10.1002/ana.24319; Penttila S, 2014, NEUROMUSCULAR DISORD, V24, P259, DOI 10.1016/j.nmd.2013.11.010; Raheem O, 2010, ACTA NEUROPATHOL, V119, P495, DOI 10.1007/s00401-010-0643-8; Vogel H, 2013, MUSCLE DISEASE: PATHOLOGY AND GENETICS, 2ND EDITION, P68	11	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151376	10.1371/journal.pone.0151376	http://dx.doi.org/10.1371/journal.pone.0151376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999347	Green Submitted, Green Published, gold			2022-12-26	WOS:000372694700036
J	Tuand, K; Stijnen, P; Volders, K; Declercq, J; Nuytens, K; Meulemans, S; Creemers, J				Tuand, Krizia; Stijnen, Pieter; Volders, Karolien; Declercq, Jeroen; Nuytens, Kim; Meulemans, Sandra; Creemers, John			Nuclear Localization of the Autism Candidate Gene Neurobeachin and Functional Interaction with the NOTCH1 Intracellular Domain Indicate a Role in Regulating Transcription	PLOS ONE			English	Article							KINASE ANCHOR PROTEIN; COPY NUMBER VARIANTS; AGGREGATED PROTEINS; BEACH-DOMAIN; MUTATIONS; HOMOLOG; EXPRESSION; RUGOSE; INVOLVEMENT; TRAFFICKING	Background Neurobeachin (NBEA) is an autism spectrum disorders (ASD) candidate gene. NBEA deficiency affects regulated secretion, receptor trafficking, synaptic architecture and protein kinase A (PKA)-mediated phosphorylation. NBEA is a large multidomain scaffolding protein. From N-to C-terminus, NBEA has a concanavalin A-like lectin domain flanked by armadillo repeats (ACA), an A-kinase anchoring protein domain that can bind to PKA, a domain of unknown function (DUF1088) and a BEACH domain, preceded by a pleckstrin homology-like domain and followed by WD40 repeats (PBW). Although most of these domains mediate protein-protein interactions, no interaction screen has yet been performed. Methods Yeast two-hybrid screens with the ACA and PBW domain modules of NBEA gave a list of interaction partners, which were analyzed for Gene Ontology (GO) enrichment. Neuro-2a cells were used for confocal microscopy and nuclear extraction analysis. NOTCH-mediated transcription was studied with luciferase reporter assays and qRT-PCR, combined with NBEA knockdown or overexpression. Results Both domain modules showed a GO enrichment for the nucleus. PBW almost exclusively interacted with transcription regulators, while ACA interacted with a number of PKA substrates. NBEA was partially localized in the nucleus of Neuro-2a cells, albeit much less than in the cytoplasm. A nuclear localization signal was found in the DUF1088 domain, which was shown to contribute to the nuclear localization of an EGFP-DPBW fusion protein. Yeast two-hybrid identified the Notch1 intracellular domain as a physical interactor of the PBW domain and a role for NBEA as a negative regulator in Notch-mediated transcription was demonstrated. Conclusion Defining novel interaction partners of conserved NBEA domain modules identified a role for NBEA as transcriptional regulator in the nucleus. The physical interaction of NBEA with NOTCH1 is most relevant for ASD pathogenesis because NOTCH signaling is essential for neural development.	[Tuand, Krizia; Stijnen, Pieter; Volders, Karolien; Declercq, Jeroen; Nuytens, Kim; Meulemans, Sandra; Creemers, John] Katholieke Univ Leuven, Dept Human Genet, Leuven, Belgium; [Tuand, Krizia; Volders, Karolien; Nuytens, Kim] Katholieke Univ Leuven, Leuven Autism Res Consortium LAuRes, Leuven, Belgium	KU Leuven; KU Leuven	Creemers, J (corresponding author), Katholieke Univ Leuven, Dept Human Genet, Leuven, Belgium.	john.creemers@med.kuleuven.be	Tuand, Krizia/AAF-7888-2019; Tuand, Krizia/E-1657-2015	Tuand, Krizia/0000-0003-2670-5415; Tuand, Krizia/0000-0003-2670-5415; stijnen, pieter/0000-0002-3047-6902	Research Fund - Flanders (FWO) [1187213N]; Steunfonds Marguerite-Marie Delacroix	Research Fund - Flanders (FWO)(FWO); Steunfonds Marguerite-Marie Delacroix	The work of Krizia Tuand is supported by the Research Fund - Flanders (FWO; 1187213N; www.fwo.be) and the "Steunfonds Marguerite-Marie Delacroix" (www.fondsmmdelacroix.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson ER, 2011, DEVELOPMENT, V138, P3593, DOI 10.1242/dev.063610; Anney R, 2010, HUM MOL GENET, V19, P4072, DOI 10.1093/hmg/ddq307; Bailey A, 1998, BRAIN, V121, P889, DOI 10.1093/brain/121.5.889; Ball JR, 2005, CHROMOSOMA, V114, P319, DOI 10.1007/s00412-005-0019-3; Barrett S, 1999, AM J MED GENET, V88, P609; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Burgess A, 2009, BIOINFORMATICS, V25, P1219, DOI 10.1093/bioinformatics/btp151; Castermans D, 2003, J MED GENET, V40, P352, DOI 10.1136/jmg.40.5.352; Castermans D, 2010, HUM MOL GENET, V19, P1368, DOI 10.1093/hmg/ddq013; Celestino-Soper PBS, 2011, HUM MOL GENET, V20, P4360, DOI 10.1093/hmg/ddr363; Chen L, 2000, P NATL ACAD SCI USA, V97, P11557, DOI 10.1073/pnas.190133497; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Correia C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112399; Cullinane AR, 2013, TRAFFIC, V14, P749, DOI 10.1111/tra.12069; De Rubeis S, 2014, NATURE, V515, P209, DOI 10.1038/nature13772; de Souza N, 2007, DEVELOPMENT, V134, P691, DOI 10.1242/dev.02767; del Pino I, 2011, BIOCHEM BIOPH RES CO, V412, P435, DOI 10.1016/j.bbrc.2011.07.110; Farzana F, 2016, MOL NEUROBIOL, V53, P2112, DOI 10.1007/s12035-015-9164-8; Filimonenko M, 2010, MOL CELL, V38, P265, DOI 10.1016/j.molcel.2010.04.007; Fromont-Racine M, 1997, NAT GENET, V15, P57; Gadad Bharathi S, 2013, Autism Res Treat, V2013, P731935, DOI 10.1155/2013/731935; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Garcia-Cazorla A, 2014, HUM MUTAT, V35, P470, DOI 10.1002/humu.22513; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Han JD, 1997, J BIOL CHEM, V272, P26611, DOI 10.1074/jbc.272.42.26611; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hormozdiari F, 2015, GENOME RES, V25, P142, DOI 10.1101/gr.178855.114; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hsieh JJD, 1996, MOL CELL BIOL, V16, P952; Hwang JY, 2014, INT J BIOCHEM CELL B, V47, P118, DOI 10.1016/j.biocel.2013.11.021; Janssens V, 2008, TRENDS BIOCHEM SCI, V33, P113, DOI 10.1016/j.tibs.2007.12.004; Jogl G, 2002, EMBO J, V21, P4785, DOI 10.1093/emboj/cdf502; Kageyama R, 2005, EXP CELL RES, V306, P343, DOI 10.1016/j.yexcr.2005.03.015; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Kaminsky EB, 2011, GENET MED, V13, P777, DOI 10.1097/GIM.0b013e31822c79f9; Kong SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049475; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lauks J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039420; Lee KE, 2014, P NATL ACAD SCI USA, V111, P2794, DOI 10.1073/pnas.1308758111; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Miller AC, 2015, CURR BIOL, V25, P16, DOI 10.1016/j.cub.2014.10.071; Moreno CS, 2001, J BIOL CHEM, V276, P24253, DOI 10.1074/jbc.M102398200; Nair R, 2013, J CELL BIOL, V200, P61, DOI 10.1083/jcb.201207113; Nakahara J, 2009, J CLIN INVEST, V119, P169, DOI 10.1172/JCI35440; Niesmann K, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1565; Novarino G, 2012, SCIENCE, V338, P394, DOI 10.1126/science.1224631; Nuytens K, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-43; Nuytens K, 2013, NEUROBIOL DIS, V51, P144, DOI 10.1016/j.nbd.2012.11.004; O'Roak BJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6595; Orosco LA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5692; Reddy KS, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-3; Reiser M, 2014, AUSTIN J CLIN IMMUNO, V1, P1; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schreiber SL, 2002, GENESIS, V33, P141, DOI 10.1002/gene.10102; Seno MMG, 2011, BRAIN RES, V1380, P85, DOI 10.1016/j.brainres.2010.09.046; Shamloula HK, 2002, GENETICS, V161, P693; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith M, 2002, CYTOGENET GENOME RES, V98, P233, DOI 10.1159/000071040; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stolt CC, 2006, DEV CELL, V11, P697, DOI 10.1016/j.devcel.2006.08.011; Su YH, 2004, J NEUROSCI, V24, P3627, DOI 10.1523/JNEUROSCI.4644-03.2004; Taylor MK, 2007, DEVELOPMENT, V134, P2435, DOI 10.1242/dev.005520; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Volders K, 2012, J NEUROSCI, V32, P15193, DOI 10.1523/JNEUROSCI.6424-11.2012; Wang HB, 2000, J NEUROCHEM, V75, P644, DOI 10.1046/j.1471-4159.2000.0750644.x; Wang XL, 2000, J NEUROSCI, V20, P8551; Wech I, 2005, CELL DEATH DIFFER, V12, P145, DOI 10.1038/sj.cdd.4401538; Welch EJ, 2010, MOL INTERV, V10, P86, DOI 10.1124/mi.10.2.6; Yamamoto A, 2011, AUTOPHAGY, V7, P346, DOI 10.4161/auto.7.3.14234; Yatim A, 2012, MOL CELL, V48, P445, DOI 10.1016/j.molcel.2012.08.022; Yoon K, 2005, NAT NEUROSCI, V8, P709, DOI 10.1038/nn1475; Zeidan-Chulia F, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.227	75	18	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151954	10.1371/journal.pone.0151954	http://dx.doi.org/10.1371/journal.pone.0151954			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999814	Green Published, gold, Green Submitted			2022-12-26	WOS:000372694700088
J	Chandramouleeswaran, PM; Shen, DW; Lee, AJ; Benitez, A; Dods, K; Gambanga, F; Wilkins, BJ; Merves, J; Noah, Y; Toltzis, S; Yearley, JH; Spergel, JM; Nakagawa, H; Malefyt, RD; Muir, AB; Wang, ML				Chandramouleeswaran, Prasanna M.; Shen, Dawen; Lee, Anna J.; Benitez, Alain; Dods, Kara; Gambanga, Fiona; Wilkins, Benjamin J.; Merves, Jamie; Noah, Yuliana; Toltzis, Sarit; Yearley, Jennifer H.; Spergel, Jonathan M.; Nakagawa, Hiroshi; Malefyt, Rene deWaal; Muir, Amanda B.; Wang, Mei-Lun			Preferential Secretion of Thymic Stromal Lymphopoietin (TSLP) by Terminally Differentiated Esophageal Epithelial Cells: Relevance to Eosinophilic Esophagitis (EoE)	PLOS ONE			English	Article							ORAL VISCOUS BUDESONIDE; SQUAMOUS DIFFERENTIATION; ELEMENTAL DIET; MOUSE MODELS; EXPRESSION; INFLAMMATION; ASTHMA; TOLERANCE; CHILDREN; FLUTICASONE	Eosinophilic esophagitis (EoE) is a chronic Th2 and food antigen-mediated disease characterized by esophageal eosinophilic infiltration. Thymic stromal lymphopoetin (TSLP), an epithelial derived cytokine which bridges innate and Th2-type adaptive immune responses in other allergic conditions, is overexpressed in esophageal biopsies of EoE subjects. However, the triggers of TSLP expression in the esophageal epithelium are unknown. The objective of the current study was to characterize TSLP expression in human esophageal epithelium in EoE in vivo and to determine the role of food antigens upon epithelial TSLP expression in vitro. Using immunohistochemistry (IHC), we localized TSLP in esophageal biopsies of active EoE (>= 15 eos/hpf), inactive EoE (<15 eos/hpf) and non-EoE control subjects, and found that TSLP expression was restricted to the differentiated suprabasal layer of the epithelium in actively inflamed EoE biopsies. Consistent with these results in vivo, inducible TSLP protein secretion was higher in CaCl2 differentiated telomerase-immortalized esophageal epithelial cells (EPC2-hTERT) compared to undifferentiated cells of the basal phenotype, following stimulation with the TLR3 ligand poly(I:C). To determine whether food antigens could directly induce epithelial TSLP secretion, differentiated and undifferentiated primary esophageal epithelial cells from EoE and non-EoE subjects were challenged with food antigens clinically relevant to EoE: Chicken egg ovalbumin (OVA), wheat, and milk proteins beta-lactoglobulin (blg) and beta-casein. Food antigens failed to induce TSLP secretion by undifferentiated cells; in contrast, only OVA induced TSLP secretion in differentiated epithelial cells from both EoE and control cell lines, an effect abolished by budesonide and NF-kappa b inhibition. Together, our study shows that specific food antigens can trigger innate immune mediated esophageal TSLP secretion, suggesting that esophageal epithelial cells at the barrier surface may play a significant role in the pathogenesis of EoE by regulating TSLP expression.	[Chandramouleeswaran, Prasanna M.; Shen, Dawen; Lee, Anna J.; Benitez, Alain; Dods, Kara; Gambanga, Fiona; Merves, Jamie; Noah, Yuliana; Toltzis, Sarit; Muir, Amanda B.; Wang, Mei-Lun] Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA; [Merves, Jamie; Yearley, Jennifer H.; Muir, Amanda B.; Wang, Mei-Lun] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wilkins, Benjamin J.] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yearley, Jennifer H.; Malefyt, Rene deWaal] Merck Res Labs, Dept Immunol, Palo Alto, CA 94304 USA; [Spergel, Jonathan M.] Childrens Hosp Philadelphia, Div Allergy & Immunol, Philadelphia, PA 19104 USA; [Nakagawa, Hiroshi] Univ Penn, Dept Med, Div Gastroenterol, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Merck & Company; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Muir, AB; Wang, ML (corresponding author), Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA 19104 USA.; Muir, AB; Wang, ML (corresponding author), Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.	muira@email.chop.edu; wangm@email.chop.edu		de Waal Malefyt, Rene/0000-0002-2663-383X; Spergel, Jonathan/0000-0002-4658-5353	NIH [R01 DK087789, R01 DK087789-02S1, 1K08DK106444-01]; Abbott Nutrition United States [1013]; AGA Donald and June Castell Award; Molecular Pathology and Imaging Core of the National Institute of Diabetes and Digestive and Kidney Diseases Center Grant [DK-50306]; Rare Disease Clinical Research Network (RDCRN), an initiative of the Office of Rare Disease Research (ORDR), NCATS [U54 AI117804]; NCATS; NIAID; NIDDK;  [K08 DK099379]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI117804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306, K08DK099379, K08DK106444, R01DK087789] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Abbott Nutrition United States; AGA Donald and June Castell Award; Molecular Pathology and Imaging Core of the National Institute of Diabetes and Digestive and Kidney Diseases Center Grant; Rare Disease Clinical Research Network (RDCRN), an initiative of the Office of Rare Disease Research (ORDR), NCATS; NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH R01 DK087789 (to MLW and JMS) and R01 DK087789-02S1 (to MLW); Abbott Nutrition United States (Project 1013, to MLW); ABM is supported by NIH 1K08DK106444-01 and the AGA Donald and June Castell Award; BJW is supported by K08 DK099379. The work is also supported by the Molecular Pathology and Imaging Core of the National Institute of Diabetes and Digestive and Kidney Diseases Center Grant DK-50306. In addition this study is supported in part by the U54 AI117804, which is part of the Rare Disease Clinical Research Network (RDCRN), an initiative of the Office of Rare Disease Research (ORDR), NCATS, and is funded through collaboration between NCATS, NIAID and NIDDK, which have collectively resulted in the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceves SS, 2007, AM J GASTROENTEROL, V102, P2271, DOI 10.1111/j.1572-0241.2007.01379.x; Al-Shami A, 2005, J EXP MED, V202, P829, DOI 10.1084/jem.20050199; Allakhverdi Z, 2007, J EXP MED, V204, P253, DOI 10.1084/jem.20062211; Arora AS, 2004, CLIN GASTROENTEROL H, V2, P523, DOI 10.1016/S1542-3565(04)00236-8; Biancheri P, 2015, GUT BMJ PUBLISHING G, DOI [10. 1136/g ugn1-2014-308876, DOI 10.1136/G]; Birmingham JM, 2013, J ASTHMA, V50, P122, DOI 10.3109/02770903.2012.753455; Blanchard C, 2011, J ALLERGY CLIN IMMUN, V127, P208, DOI 10.1016/j.jaci.2010.10.039; Blanchard C, 2010, J IMMUNOL, V184, P4033, DOI 10.4049/jimmunol.0903069; Blazquez AB, 2010, GASTROENTEROLOGY, V139, P1301, DOI 10.1053/j.gastro.2010.06.055; Cheng E, 2013, GUT, V62, P824, DOI 10.1136/gutjnl-2012-302250; Cornelissen LH, 2007, SKIN RES TECHNOL, V13, P369, DOI 10.1111/j.1600-0846.2007.00239.x; Dohil R, 2010, GASTROENTEROLOGY, V139, P418, DOI 10.1053/j.gastro.2010.05.001; Ek A, 1999, ALLERGY, V54, P691, DOI 10.1034/j.1398-9995.1999.00087.x; Foerg C, 2007, PHARM RES-DORDR, V24, P628, DOI 10.1007/s11095-006-9212-1; Fornasa G, 2015, J ALLERGY CLIN IMMUN, V136, P413, DOI 10.1016/j.jaci.2015.04.011; Gulati N, 2013, J INVEST DERMATOL, V133, P2640, DOI 10.1038/jid.2013.190; Harada H, 2003, MOL CANCER RES, V1, P729; Harada M, 2009, AM J RESP CELL MOL, V40, P368, DOI 10.1165/rcmb.2008-0041OC; Holgate ST, 2007, TRENDS IMMUNOL, V28, P248, DOI 10.1016/j.it.2007.04.007; JETTEN AM, 1989, EXP CELL RES, V182, P622, DOI 10.1016/0014-4827(89)90264-4; Jyonouchi S, 2014, CLIN EXP ALLERGY, V44, P58, DOI 10.1111/cea.12201; Kagalwalla AF, 2006, CLIN GASTROENTEROL H, V4, P1097, DOI 10.1016/j.cgh.2006.05.026; Kalabis J, 2012, NAT PROTOC, V7, P235, DOI 10.1038/nprot.2011.437; KASTURI L, 1993, EXP CELL RES, V205, P84, DOI 10.1006/excr.1993.1061; Kato A, 2007, J IMMUNOL, V179, P1080, DOI 10.4049/jimmunol.179.2.1080; Lee HC, 2007, P NATL ACAD SCI USA, V104, P914, DOI 10.1073/pnas.0607305104; Leyva-Castillo JM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3847; Li DQ, 2011, J ALLERGY CLIN IMMUN, V128, P1318, DOI 10.1016/j.jaci.2011.06.041; Liacouras C, 2011, J ALLERGY CLIN IMMUN, V128, P3, DOI 10.1016/j.jaci.2011.02.040; Lim DM, 2009, AM J PHYSIOL-GASTR L, V297, pG1172, DOI 10.1152/ajpgi.00065.2009; Lin CF, 2007, ACTA OTO-LARYNGOL, V127, P395, DOI 10.1080/00016480601089416; Liu YJ, 2007, J ALLERGY CLIN IMMUN, V120, P238, DOI 10.1016/j.jaci.2007.06.004; Liu YJ, 2009, ADV IMMUNOL, V101, P1, DOI 10.1016/S0065-2776(08)01001-8; Lopez-Souza N, 2004, AM J PHYSIOL-LUNG C, V286, pL373, DOI 10.1152/ajplung.00300.2003; Markowitz JE, 2003, AM J GASTROENTEROL, V98, P777, DOI 10.1111/j.1572-0241.2003.07390.x; Masterson JC, 2014, GUT, V63, P43, DOI 10.1136/gutjnl-2012-303631; Matsuda A, 2010, INVEST OPHTH VIS SCI, V51, P151, DOI 10.1167/iovs.09-4183; Mishra A, 2002, J IMMUNOL, V168, P2464, DOI 10.4049/jimmunol.168.5.2464; Mishra A, 2007, J LEUKOCYTE BIOL, V81, P916, DOI 10.1189/jlb.1106653; Muir AB, 2013, EXP CELL RES, V319, P850, DOI 10.1016/j.yexcr.2012.12.002; Nials AT, 2008, DIS MODEL MECH, V1, P213, DOI 10.1242/dmm.000323; Noti M, 2013, NAT MED, V19, P1005, DOI 10.1038/nm.3281; Ohashi S, 2010, GASTROENTEROLOGY, V139, P2113, DOI 10.1053/j.gastro.2010.08.040; Peterson KA, 2013, AM J GASTROENTEROL, V108, P759, DOI 10.1038/ajg.2012.468; Radoja N, 2006, PHYSIOL GENOMICS, V27, P65, DOI 10.1152/physiolgenomics.00031.2006; Roth-Walter F, 2008, ALLERGY, V63, P882, DOI 10.1111/j.1398-9995.2008.01673.x; Rothenberg ME, 2010, NAT GENET, V42, P289, DOI 10.1038/ng.547; Sherrill JD, 2010, J ALLERGY CLIN IMMUN, V126, P160, DOI 10.1016/j.jaci.2010.04.037; Smolinski KN, 2002, GENOMICS, V79, P875, DOI 10.1006/geno.2002.6775; Spergel JM, 2012, J ALLERGY CLIN IMMUN, V130, P461, DOI 10.1016/j.jaci.2012.05.021; Straumann A, 2010, GASTROENTEROLOGY, V139, P1526, DOI 10.1053/j.gastro.2010.07.048; Takai T, 2012, ALLERGOL INT, V61, P3, DOI 10.2332/allergolint.11-RAI-0395; Tang MLK, 2013, PEDIAT ALLERG IMM-UK, V24, P512, DOI 10.1111/pai.12100; Taylor BC, 2009, J EXP MED, V206, P655, DOI 10.1084/jem.20081499; Teitelbaum JE, 2002, GASTROENTEROLOGY, V122, P1216, DOI 10.1053/gast.2002.32998; Tunis MC, 2012, J ALLERGY CLIN IMMUN, V130, P705, DOI 10.1016/j.jaci.2012.04.011; Vu AT, 2011, J INVEST DERMATOL, V131, P2205, DOI 10.1038/jid.2011.185; Wang XQ, 2013, J INFLAMM RES, V6, P109, DOI 10.2147/JIR.S43736; Wangi JK, 2008, CELL MOL IMMUNOL, V5, P99, DOI 10.1038/cmi.2008.12; Xie Y, 2012, J DERMATOL SCI, V66, P233, DOI 10.1016/j.jdermsci.2012.03.007; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1247, DOI 10.1681/ASN.2010060616; Zhang F, 2011, CLIN EXP IMMUNOL, V164, P256, DOI 10.1111/j.1365-2249.2011.04328.x; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247	63	26	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150968	10.1371/journal.pone.0150968	http://dx.doi.org/10.1371/journal.pone.0150968			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992000	Green Published, gold, Green Submitted			2022-12-26	WOS:000372582800039
J	Chen, WP; Li, QK; Fan, YT; Li, DC; Jiang, L; Qiu, PN; Tang, LL				Chen, Weiping; Li, Qiken; Fan, Yongtian; Li, Dechuan; Jiang, Lai; Qiu, Pengnian; Tang, Lilong			Factors Predicting Difficulty of Laparoscopic Low Anterior Resection for Rectal Cancer with Total Mesorectal Excision and Double Stapling Technique	PLOS ONE			English	Article							RECTOSIGMOID CARCINOMA; COLORECTAL-CANCER; SURGERY; COLECTOMY; SURVIVAL; BENEFIT; SAFETY; TRIAL; COLON; TIME	Background Laparoscopic sphincter-preserving low anterior resection for rectal cancer is a surgery demanding great skill. Immense efforts have been devoted to identifying factors that can predict operative difficulty, but the results are inconsistent. Objective Our study was conducted to screen patients' factors to build models for predicting the operative difficulty using well controlled data. Method We retrospectively reviewed records of 199 consecutive patients who had rectal cancers 5-8 cm from the anal verge. All underwent laparoscopic sphincter-preserving low anterior resections with total mesorectal excision (TME) and double stapling technique (DST). Data of 155 patients from one surgeon were utilized to build models to predict standardized end-points (operative time, blood loss) and postoperative morbidity. Data of 44 patients from other surgeons were used to test the predictability of the built models. Results Our results showed prior abdominal surgery, preoperative chemoradiotherapy, tumor distance to anal verge, interspinous distance, and BMI were predictors for the standardized operative times. Gender and tumor maximum diameter were related to the standardized blood loss. Temporary diversion and tumor diameter were predictors for postoperative morbidity. The model constructed for the operative time demonstrated excellent predictability for patients from different surgeons. Conclusions With a well-controlled patient population, we have built a predictable model to estimate operative difficulty. The standardized operative time will make it possible to significantly increase sample size and build more reliable models to predict operative difficulty for clinical use.	[Chen, Weiping; Li, Qiken; Fan, Yongtian; Li, Dechuan; Jiang, Lai; Qiu, Pengnian] Zhejiang Canc Hosp, Dept Colorectal Surg, Hangzhou 310022, Zhejiang, Peoples R China; [Tang, Lilong] Zhejiang Canc Hosp, Dept Radiol, Hangzhou 310022, Zhejiang, Peoples R China	Zhejiang Cancer Hospital; Zhejiang Cancer Hospital	Chen, WP (corresponding author), Zhejiang Canc Hosp, Dept Colorectal Surg, Hangzhou 310022, Zhejiang, Peoples R China.	cwp819@yahoo.com	Chen, Wei/GZK-7348-2022		Zhejiang Medical Technology and Education [2011RCA010]	Zhejiang Medical Technology and Education	This work is supported by Zhejiang Medical Technology and Education (2011RCA010).; We greatly appreciate critical data interpretation and manuscript review by Dr. Shihua Wang of Departments of Cancer Biology, Wake Forest University School of Medicine. We are also grateful to Ms. Kristin Best for her proof reading of this manuscript. This work is supported by Zhejiang Medical Technology and Education (2011RCA010).	Akagi T, 2012, SURG LAPARO ENDO PER, V22, P52, DOI 10.1097/SLE.0b013e31824019fc; Akiyoshi T, 2009, SURGERY, V146, P483, DOI 10.1016/j.surg.2009.03.030; Akiyoshi T, 2009, J GASTROINTEST SURG, V13, P521, DOI 10.1007/s11605-008-0744-z; American Cancer Society, 2015, CANC FACTS FIG 2015; American Cancer Society, 2011, GLOB CANC FACTS FIG; Baik SH, 2008, ANN SURG ONCOL, V15, P721, DOI 10.1245/s10434-007-9706-z; Center MM, 2009, CANCER EPIDEM BIOMAR, V18, P1688, DOI 10.1158/1055-9965.EPI-09-0090; Denost Q, 2013, COLORECTAL DIS, V15, P463, DOI 10.1111/codi.12026; Denost Q, 2012, SURG ENDOSC, V26, P1878, DOI 10.1007/s00464-011-2119-x; Folkesson J, 2005, J CLIN ONCOL, V23, P5644, DOI 10.1200/JCO.2005.08.144; Franko Jan, 2006, JSLS, V10, P169; Gu J, 2006, DIS COLON RECTUM, V49, P1517, DOI 10.1007/s10350-006-0665-4; Hamabe A, 2014, J GASTROINTEST SURG, V18, P977, DOI 10.1007/s11605-014-2463-y; Havel PJ, 1996, NAT MED, V2, P949, DOI 10.1038/nm0996-949b; Ishihara S, 2014, TECH COLOPROCTOL, V18, P247, DOI 10.1007/s10151-013-1048-1; Ishihara S, 2011, HEPATO-GASTROENTEROL, V58, P756; Jin KT, 2014, INT J CLIN EXP MED, V7, P4635; Killeen T, 2010, SURG ENDOSC, V24, P2974, DOI 10.1007/s00464-010-1075-1; KOTANI K, 1994, INT J OBESITY, V18, P207; Kuroyanagi H, 2008, SURG ENDOSC, V22, P557, DOI 10.1007/s00464-007-9626-9; Lacy AM, 2002, LANCET, V359, P2224, DOI 10.1016/S0140-6736(02)09290-5; Laurent C, 2009, ANN SURG, V250, P54, DOI 10.1097/SLA.0b013e3181ad6511; Leung KL, 2004, LANCET, V363, P1187, DOI 10.1016/S0140-6736(04)15947-3; Liu SZ, 2015, CHINESE J CANCER RES, V27, P22, DOI 10.3978/j.issn.1000-9604.2015.02.01; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Nussbaum DP, 2015, J GASTROINTEST SURG, V19, P124, DOI 10.1007/s11605-014-2614-1; Ogiso S, 2011, SURG ENDOSC, V25, P1907, DOI 10.1007/s00464-010-1485-0; Peeters KCMJ, 2007, ANN SURG, V246, P693, DOI 10.1097/01.sla.0000257358.56863.ce; Petrelli NJ, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju376; Poylin V, 2014, ANN SURG ONCOL, V21, P3587, DOI 10.1245/s10434-014-3703-9; Seki Y, 2007, SURG ENDOSC, V21, P929, DOI 10.1007/s00464-006-9084-9; Targarona EM, 2008, ANN SURG, V247, P642, DOI 10.1097/SLA.0b013e3181612c6a; Wang C, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-44; Yeh CY, 2005, ANN SURG, V241, P9, DOI 10.1097/01.sla.0000150067.99651.6a; Yeo H, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju362	35	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151773	10.1371/journal.pone.0151773	http://dx.doi.org/10.1371/journal.pone.0151773			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992004	Green Submitted, gold, Green Published			2022-12-26	WOS:000372582800099
J	Cova, I; Clerici, F; Rossi, A; Cucumo, V; Ghiretti, R; Maggiore, L; Pomati, S; Galimberti, D; Scarpini, E; Mariani, C; Caracciolo, B				Cova, Ilaria; Clerici, Francesca; Rossi, Annalia; Cucumo, Valentina; Ghiretti, Roberta; Maggiore, Laura; Pomati, Simone; Galimberti, Daniela; Scarpini, Elio; Mariani, Claudio; Caracciolo, Barbara			Weight Loss Predicts Progression of Mild Cognitive Impairment to Alzheimer's Disease	PLOS ONE			English	Article							BODY-MASS INDEX; RATING-SCALE; DEMENTIA; DIAGNOSIS; CONSENSUS; ILLNESS; LEPTIN	Background Weight loss is common in people with Alzheimer's disease (AD) and it could be a marker of impending AD in Mild Cognitive Impairment (MCI) and improve prognostic accuracy, if accelerated progression to AD would be shown. Aims To assess weight loss as a predictor of dementia and AD in MCI. Methods One hundred twenty-five subjects with MCI (age 73.8 +/- 7.1 years) were followed for an average of 4 years. Two weight measurements were carried out at a minimum time interval of one year. Dementia was defined according to DSM-IV criteria and AD according to NINCDS-ADRDA criteria. Weight loss was defined as a >= 4% decrease in baseline weight. Results Fifty-three (42.4%) MCI progressed to dementia, which was of the AD-type in half of the cases. Weight loss was associated with a 3.4-fold increased risk of dementia (95% CI = 1.5-6.9) and a 3.2-fold increased risk of AD (95% CI = 1.4-8.3). In terms of years lived without disease, weight loss was associated to a 2.3 and 2.5 years earlier onset of dementia and AD. Conclusions Accelerated progression towards dementia and AD is expected when weight loss is observed in MCI patients. Weight should be closely monitored in elderly with mild cognitive impairment.	[Cova, Ilaria; Clerici, Francesca; Rossi, Annalia; Cucumo, Valentina; Ghiretti, Roberta; Maggiore, Laura; Pomati, Simone; Mariani, Claudio] Univ Milan, Luigi Sacco Hosp, Biomed & Clin Sci Dept, Ctr Res & Treatment Cognit Dysfunct, Milan, Italy; [Galimberti, Daniela; Scarpini, Elio] Univ Milan, Fdn Ca Granda, IRCCS Osped Policlin, Neurol Unit,Dept Pathophysiol & Transplantat, Milan, Italy; [Caracciolo, Barbara] Karolinska Inst, Aging Res Ctr, Dept Neurobiol Hlth Care Sci & Soc, Stockholm, Sweden; [Caracciolo, Barbara] Karolinska Inst, Stockholm Gerontol Res Ctr, Stockholm, Sweden	University of Milan; Luigi Sacco Hospital; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Karolinska Institutet; Karolinska Institutet	Cova, I (corresponding author), Univ Milan, Luigi Sacco Hosp, Biomed & Clin Sci Dept, Ctr Res & Treatment Cognit Dysfunct, Milan, Italy.	ilaria.cova@unimi.it	Galimberti, Daniela/N-7209-2019; Pomati, Simone/AAP-5414-2021; Cova, Ilaria/K-9454-2016; Scarpini, Elio/K-6547-2016	Galimberti, Daniela/0000-0002-9284-5953; Cova, Ilaria/0000-0001-7831-6791; Pomati, Simone/0000-0001-8930-6361; Scarpini, Elio/0000-0002-6395-2119				American Psychiatric Association DSM-IV, 1994, DSM 4 DIAGN STAT MAN; [Anonymous], 1987, Ital J Neurol Sci, VSuppl 8, P1; Besser LM, 2014, ALZ DIS ASSOC DIS, V28, P36, DOI 10.1097/WAD.0000000000000005; Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016; Capitani E, 1997, J CLIN EXP NEUROPSYC, V19, P795, DOI 10.1080/01688639708403761; Caracciolo B, 2011, J NEUROL NEUROSUR PS, V82, P788, DOI 10.1136/jnnp.2010.225003; Clerici F, 2012, DEMENT GERIATR COGN, V34, P235, DOI 10.1159/000343776; Cooper C, 2015, AM J PSYCHIAT, V172, P323, DOI 10.1176/appi.ajp.2014.14070878; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Devanand DP, 2000, AM J PSYCHIAT, V157, P1399, DOI 10.1176/appi.ajp.157.9.1399; EVANS WJ, 1993, J NUTR, V123, P465, DOI 10.1093/jn/123.suppl_2.465; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gillette-Guyonnet S, 2000, AM J CLIN NUTR, V71, p637S; GREEN MW, 1995, PSYCHOL MED, V25, P1003, DOI 10.1017/S0033291700037491; Guerin O, 2005, AM J CLIN NUTR, V82, P435, DOI 10.1093/ajcn/82.2.435; Harvey J, 2005, BIOCHEM SOC T, V33, P1029, DOI 10.1042/BST0331029; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Johnson DK, 2006, ARCH NEUROL-CHICAGO, V63, P1312, DOI 10.1001/archneur.63.9.1312; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; MARIANI C, 1991, CLIN NEUROPATHOL, V10, P171; Mauri M, 2012, FUNCT NEUROL, V27, P49; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mitchell AJ, 2009, ACTA PSYCHIAT SCAND, V119, P252, DOI 10.1111/j.1600-0447.2008.01326.x; Neary D, 1998, NEUROLOGY, V51, P1546, DOI 10.1212/WNL.51.6.1546; Patra SK, 2012, CLIN CHIM ACTA, V413, P1025, DOI 10.1016/j.cca.2011.12.008; Petersen RC, 2014, J INTERN MED, V275, P214, DOI 10.1111/joim.12190; Power DA, 2001, DEMENT GERIATR COGN, V12, P167, DOI 10.1159/000051252; Qi Y, 2004, NAT MED, V10, P524, DOI 10.1038/nm1029; Quintanilla RA, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.02.007; Rebeck GW, 2010, J BIOL CHEM, V285, P7440, DOI 10.1074/jbc.M109.083915; ROMAN GC, 1993, NEUROLOGY, V43, P250, DOI 10.1212/WNL.43.2.250; Salvi F, 2008, J AM GERIATR SOC, V56, P1926, DOI 10.1111/j.1532-5415.2008.01935.x; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Sergi G, 2013, P NUTR SOC, V72, P160, DOI 10.1017/S0029665112002753; Sobow T, 2014, EUR J CLIN NUTR, V68, P1216, DOI 10.1038/ejcn.2014.167; Speakman JR, 2004, AGING CELL, V3, P87, DOI 10.1111/j.1474-9728.2004.00097.x; Stewart R, 2005, ARCH NEUROL-CHICAGO, V62, P55, DOI 10.1001/archneur.62.1.55; Sullivan PG, 2005, PROG NEURO-PSYCHOPH, V29, P407, DOI 10.1016/j.pnpbp.2004.12.007; Tracy AL, 2001, BEHAV BRAIN RES, V127, P13, DOI 10.1016/S0166-4328(01)00364-3; Visser M, 2002, J GERONTOL A-BIOL, V57, pM326, DOI 10.1093/gerona/57.5.M326; Volicer L, 2013, J AM MED DIR ASSOC, V14, P417, DOI 10.1016/j.jamda.2012.12.004; Wahlund LO, 2001, STROKE, V32, P1318, DOI 10.1161/01.STR.32.6.1318; Waite L, 1999, ALZ DIS ASSOC DIS, V13, P34, DOI 10.1097/00002093-199903000-00005; Wallace DC, 1997, SCI AM, V277, P40, DOI 10.1038/scientificamerican0897-40; White H, 1996, J AM GERIATR SOC, V44, P265, DOI 10.1111/j.1532-5415.1996.tb00912.x; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Wysokinski A, 2015, AGE, V37, DOI 10.1007/s11357-015-9821-x; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	50	47	48	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151710	10.1371/journal.pone.0151710	http://dx.doi.org/10.1371/journal.pone.0151710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990757	Green Published, gold, Green Submitted			2022-12-26	WOS:000372582800089
J	Forcato, C; Bavassi, L; De Pino, G; Fernandez, RS; Villarreal, MF; Pedreira, ME				Forcato, Cecilia; Bavassi, Luz; De Pino, Gabriela; Sebastian Fernandez, Rodrigo; Fabiana Villarreal, Mirta; Eugenia Pedreira, Maria			Differential Left Hippocampal Activation during Retrieval with Different Types of Reminders: An fMRI Study of the Reconsolidation Process	PLOS ONE			English	Article							MEMORY RECONSOLIDATION; DECLARATIVE MEMORY; PROTEIN-SYNTHESIS; EXTINCTION; HUMANS; INVOLVEMENT; MISMATCH; AMYGDALA; TIME	Consolidated memories return to a labile state after the presentation of cues (reminders) associated with acquisition, followed by a period of stabilization (reconsolidation). However not all cues are equally effective in initiating the process, unpredictable cues triggered it, predictable cues do not. We hypothesize that the different effects observed by the different reminder types on memory labilization-reconsolidation depend on a differential neural involvement during reminder presentation. To test it, we developed a declarative task and compared the efficacy of three reminder types in triggering the process in humans (Experiment 1). Finally, we compared the brain activation patterns between the different conditions using functional magnetic resonance imaging (fMRI) (Experiment 2). We confirmed that the unpredictable reminder is the most effective in initiating the labilization-reconsolidation process. Furthermore, only under this condition there was differential left hippocampal activation during its presentation. We suggest that the left hippocampus is detecting the incongruence between actual and past events and allows the memory to be updated.	[Forcato, Cecilia; Bavassi, Luz; Sebastian Fernandez, Rodrigo; Eugenia Pedreira, Maria] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular,CONICET, Lab Neurobiol Mem,Inst Fisiol Biol Mol & Neurocie, Buenos Aires, DF, Argentina; [De Pino, Gabriela; Fabiana Villarreal, Mirta] Consejo Nacl Invest Cient & Tecn, Fdn Lucha Enfermedades Neurol Infancia, RA-1033 Buenos Aires, DF, Argentina; [De Pino, Gabriela] Univ Nacl San Martin, Escuela Ciencia & Tecnol, Ctr Univ Imagenes Med, Buenos Aires, DF, Argentina; [Fabiana Villarreal, Mirta] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fis, RA-1428 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Pedreira, ME (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular,CONICET, Lab Neurobiol Mem,Inst Fisiol Biol Mol & Neurocie, Buenos Aires, DF, Argentina.	mpedreira@fbmc.fcen.uba.ar	Fernández, Rodrigo S/AAP-3748-2021; Fernandez, Rodrigo/GRF-1350-2022	Fernández, Rodrigo S/0000-0002-0213-9108; Bavassi, Luz/0000-0001-7839-3973; FORCATO, CECILIA/0000-0002-5954-4008	Agencia Nacional de Promocion Cientifica y Tecnologica [PICT2010-0391, PICT2013-0412]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT)	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnologica (http://www.agencia.mincyt.gob.ar/) PICT2010-0391 and PICT2013-0412 (MEP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren T, 2012, SCIENCE, V337, P1550, DOI 10.1126/science.1223006; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brett M, 2002, NEUROIMAGE, V16, pS497, DOI DOI 10.1016/S1053-8119(02)90010-8; Crone EA, 2006, CEREB CORTEX, V16, P475, DOI 10.1093/cercor/bhi127; Dudai Y, 2012, ANNU REV NEUROSCI, V35, P227, DOI 10.1146/annurev-neuro-062111-150500; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Forcato C, 2007, LEARN MEMORY, V14, P295, DOI 10.1101/lm.486107; Forcato C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061688; Foricato C, 2009, NEUROBIOL LEARN MEM, V91, P50, DOI 10.1016/j.nlm.2008.09.011; Friston KJ, 2000, NEUROIMAGE, V12, P196, DOI 10.1006/nimg.2000.0609; Hupbach A, 2008, LEARN MEMORY, V15, P574, DOI 10.1101/lm.1022308; Inda MC, 2011, J NEUROSCI, V31, P1635, DOI 10.1523/JNEUROSCI.4736-10.2011; Kleiner M, 2007, PERCEPTION, V36, P14; Kumaran D, 2007, J NEUROSCI, V27, P8517, DOI 10.1523/JNEUROSCI.1677-07.2007; Kumaran D, 2006, PLOS BIOL, V4, P2372, DOI 10.1371/journal.pbio.0040424; Lee JLC, 2008, NAT NEUROSCI, V11, P1264, DOI 10.1038/nn.2205; Lee JLC, 2009, TRENDS NEUROSCI, V32, P413, DOI 10.1016/j.tins.2009.05.002; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Pedreira ME, 2004, LEARN MEMORY, V11, P579, DOI 10.1101/lm.76904; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Rodriguez MLC, 2013, NEUROPHARMACOLOGY, V64, P432, DOI 10.1016/j.neuropharm.2012.06.059; Rossion B, 2003, NEUROIMAGE, V19, P877, DOI 10.1016/S1053-8119(03)00105-8; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Schiller D, 2013, P NATL ACAD SCI USA, V110, P20040, DOI 10.1073/pnas.1320322110; Schwabe L, 2012, BIOL PSYCHIAT, V71, P380, DOI 10.1016/j.biopsych.2011.10.028; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; St Jacques PL, 2013, P NATL ACAD SCI USA, V110, P19671, DOI 10.1073/pnas.1319630110; Stoeckel C, 2009, CORTEX, V45, P1091, DOI 10.1016/j.cortex.2008.12.004; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001	34	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151381	10.1371/journal.pone.0151381	http://dx.doi.org/10.1371/journal.pone.0151381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991776	Green Published, Green Submitted, gold			2022-12-26	WOS:000372582800057
J	Xu, XM; Chao, J; Cheng, XL; Wang, R; Sun, BJ; Wang, HM; Luo, SB; Xu, XW; Wu, TQ; Li, Y				Xu, Xiaomei; Chao, Juan; Cheng, Xueli; Wang, Rui; Sun, Baojuan; Wang, Hengming; Luo, Shaobo; Xu, Xiaowan; Wu, Tingquan; Li, Ying			Mapping of a Novel Race Specific Resistance Gene to Phytophthora Root Rot of Pepper (Capsicum annuum) Using Bulked Segregant Analysis Combined with Specific Length Amplified Fragment Sequencing Strategy	PLOS ONE			English	Article							QTL ANALYSIS; MAP; CONSTRUCTION	Phytophthora root rot caused by Phytophthora capsici (P. capsici) is a serious limitation to pepper production in Southern China, with high temperature and humidity. Mapping PRR resistance genes can provide linked DNA markers for breeding PRR resistant varieties by molecular marker-assisted selection (MAS). Two BC1 populations and an F-2 population derived from a cross between P. capsici-resistant accession, Criollo de Morelos 334 (CM334) and P. capsici-susceptible accession, New Mexico Capsicum Accession 10399 (NMCA10399) were used to investigate the genetic characteristics of PRR resistance. PRR resistance to isolate Byl4 (race 3) was controlled by a single dominant gene, PhR10, that was mapped to an interval of 16.39Mb at the end of the long arm of chromosome 10. Integration of bulked segregant analysis (BSA) and Specific Length Amplified Fragment sequencing (SLAF-seq) provided an efficient genetic mapping strategy. Ten polymorphic Simple Sequence Repeat (SSR) markers were found within this region and used to screen the genotypes of 636 BC1 plants, delimiting PhR10 to a 2.57 Mb interval between markers P52-11-21 (1.5 cM away) and P52-11-41 (1.1 cM). A total of 163 genes were annotated within this region and 31 were predicted to be associated with disease resistance. PhR10 is a novel race specific gene for PRR, and this paper describes linked SSR markers suitable for marker-assisted selection of PRR resistant varieties, also laying a foundation for cloning the resistance gene.	[Xu, Xiaomei; Chao, Juan; Cheng, Xueli; Wang, Rui; Sun, Baojuan; Wang, Hengming; Luo, Shaobo; Xu, Xiaowan; Wu, Tingquan; Li, Ying] Guangdong Acad Agr Sci, Vegetable Res Inst, Guangzhou, Guangdong, Peoples R China; [Xu, Xiaomei; Chao, Juan; Cheng, Xueli; Wang, Rui; Sun, Baojuan; Luo, Shaobo; Wu, Tingquan] Guangdong Key Lab New Technol Res Vegetables, Guangzhou, Guangdong, Peoples R China	Guangdong Academy of Agricultural Sciences	Li, Y (corresponding author), Guangdong Acad Agr Sci, Vegetable Res Inst, Guangzhou, Guangdong, Peoples R China.	390020225@qq.com			Guangdong Natural Science Foundation [2014A030310321]; Guangdong Academy of Agricultural Sciences Dean Fund [201304]; Guangzhou Science and Technology Program key projects [2014Y2-00112]; Guangdong Science and Technology Project [2015B0202009, 2014A020208045]; Common key technology research of Guangdong Lingnan characteristic vegetable Crossbreeding [2012A020100006]	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong Academy of Agricultural Sciences Dean Fund; Guangzhou Science and Technology Program key projects; Guangdong Science and Technology Project; Common key technology research of Guangdong Lingnan characteristic vegetable Crossbreeding	Support was provided by: Guangdong Natural Science Foundation (2014A030310321) XMX; Guangdong Academy of Agricultural Sciences Dean Fund (201304) XMX; Guangzhou Science and Technology Program key projects (2014Y2-00112) YL; Guangdong Science and Technology Project (2015B0202009) YL; Common key technology research of Guangdong Lingnan characteristic vegetable Crossbreeding (2012A020100006) SBL; and Guangdong Science and Technology Project (2014A020208045) XWX.	Abe A, 2012, NAT BIOTECHNOL, V30, P174, DOI 10.1038/nbt.2095; Allen GC, 2006, NAT PROTOC, V1, P2320, DOI 10.1038/nprot.2006.384; Bonnet J, 2007, THEOR APPL GENET, V115, P253, DOI 10.1007/s00122-007-0561-x; BOSLAND PW, 1991, PLANT DIS, V75, P1048, DOI 10.1094/PD-75-1048; Chague V, 1997, THEOR APPL GENET, V95, P671, DOI 10.1007/s001220050611; Ribeiro CSD, 2012, J AM SOC HORTIC SCI, V137, P421; Glosier BR, 2008, EUPHYTICA, V162, P23, DOI 10.1007/s10681-007-9532-1; Hai THT, 2013, EUR J PLANT PATHOL, V135, P289, DOI 10.1007/s10658-012-0085-3; Hausbeck MK, 2004, PLANT DIS, V88, P1292, DOI 10.1094/PDIS.2004.88.12.1292; Hill JT, 2013, GENOME RES, V23, P687, DOI 10.1101/gr.146936.112; Huang Q, 2014, THEOR APPL GENET, V127, P843, DOI 10.1007/s00122-014-2261-7; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim HJ, 2008, THEOR APPL GENET, V118, P15, DOI 10.1007/s00122-008-0873-5; Kim S, 2014, NAT GENET, V46, P270, DOI 10.1038/ng.2877; Kiraly L, 2007, J PHYTOPATHOL, V155, P385, DOI 10.1111/j.1439-0434.2007.01264.x; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lefebvre V, 1996, THEOR APPL GENET, V93, P503, DOI 10.1007/BF00417941; Leonian LH, 1922, PHYTOPATHOLOGY, V12, P401; Li B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1086; Li Qiang, 2005, Yichuan, V27, P808; Li ZhiJun, 2007, Journal of South China Agricultural University, V28, P50; Liu WY, 2014, THEOR APPL GENET, V127, P2503, DOI 10.1007/s00122-014-2394-8; Liu WY., 2006, COMP GENETICS RESIST; Mallard S, 2013, MOL BREEDING, V32, P349, DOI 10.1007/s11032-013-9875-3; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Minamiyama Y, 2007, BREEDING SCI, V57, P129, DOI 10.1270/jsbbs.57.129; Monroy-Barbosa A, 2008, J AM SOC HORTIC SCI, V133, P825, DOI 10.21273/JASHS.133.6.825; Ogundiwin EA, 2005, GENOME, V48, P698, DOI 10.1139/G05-028; ORTEGA RG, 1991, PLANT BREEDING, V107, P50, DOI 10.1111/j.1439-0523.1991.tb00527.x; Piquemal J, 2005, THEOR APPL GENET, V111, P1514, DOI 10.1007/s00122-005-0080-6; Qi ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104871; Quirin EA, 2005, THEOR APPL GENET, V110, P605, DOI 10.1007/s00122-004-1874-7; Reeves G, 2013, PHYTOPATHOLOGY, V103, P472, DOI 10.1094/PHYTO-09-12-0242-R; Sugita T, 2006, BREEDING SCI, V56, P137, DOI 10.1270/jsbbs.56.137; Sun XW, 2013, PLOS ONE, V3; Sy O, 2005, J AM SOC HORTIC SCI, V130, P75, DOI 10.21273/JASHS.130.1.75; Thabuis A, 2003, THEOR APPL GENET, V106, P1473, DOI 10.1007/s00122-003-1206-3; Truong HTH, 2012, PLANT PATHOL, V61, P48, DOI 10.1111/j.1365-3059.2011.02483.x; Van Tassell CP, 2008, NAT METHODS, V5, P247, DOI 10.1038/NMETH.1185; Walker SJ, 1999, J AM SOC HORTIC SCI, V124, P14, DOI 10.21273/JASHS.124.1.14; Wei QZ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1158; Xia C, 2015, EUPHYTICA, V202, P35, DOI 10.1007/s10681-014-1202-5; Xu FF, 2015, PLOS ONE, V3; Xu XW, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00768; Yi B, 2006, THEOR APPL GENET, V113, P643, DOI 10.1007/s00122-006-0328-9; Zhang YX, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-141	46	37	42	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151401	10.1371/journal.pone.0151401	http://dx.doi.org/10.1371/journal.pone.0151401			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992080	gold, Green Published, Green Submitted			2022-12-26	WOS:000372582800060
J	Um, JW; Choii, G; Park, D; Kim, D; Jeon, S; Kang, H; Mori, T; Papadopoulos, T; Yoo, T; Lee, Y; Kim, E; Tabuchi, K; Ko, J				Um, Ji Won; Choii, Gayoung; Park, Dongseok; Kim, Dongwook; Jeon, Sangmin; Kang, Hyeyeon; Mori, Takuma; Papadopoulos, Theofilos; Yoo, Taesun; Lee, Yeunkum; Kim, Eunjoon; Tabuchi, Katsuhiko; Ko, Jaewon			IQ Motif and SEC7 Domain-containing Protein 3 (IQSEC3) Interacts with Gephyrin to Promote Inhibitory Synapse Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTOR; NEUROLIGIN 2; COLLYBISTIN; ARF6; TRANSMISSION; MAINTENANCE; MOLECULES; BRAG2	Gephyrin is a central scaffold protein that mediates development, function, and plasticity of mammalian inhibitory synapses by interacting with various inhibitory synaptic proteins. Here, we show that IQSLC3, a guanine nucleotide exchange factor for ARE6, directly interacts with gephyrin, an interaction that is critical for the inhibitory synapse localization of IQSEC3. Overexpression of IQSEC3 increases inhibitory, but not excitatory, synapse density in a guanine nucleotide exchange factor activity-dependent manner. Conversely, knockdown of IQSEC3 decreases size of gephyrin cluster without altering gephyrin puncta density. Collectively, these data reveal that IQSEC3 acts together with gephyrin to regulate inhibitory synapse development.	[Um, Ji Won; Choii, Gayoung; Jeon, Sangmin; Ko, Jaewon] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Biochem, Seoul 120749, South Korea; [Um, Ji Won; Park, Dongseok; Kim, Dongwook; Kang, Hyeyeon] Yonsei Univ, Coll Med, Dept Physiol, Seoul 120752, South Korea; [Um, Ji Won; Park, Dongseok; Kim, Dongwook; Kang, Hyeyeon] Yonsei Univ, Coll Med, PLUS Project Med Sci BK21, Seoul 120752, South Korea; [Mori, Takuma; Tabuchi, Katsuhiko] Shinshu Univ, Sch Med, Matsumoto, Nagano 3908621, Japan; [Papadopoulos, Theofilos] Univ Med Gottingen, Dept Mol Biol, D-37075 Gottingen, Germany; [Yoo, Taesun; Kim, Eunjoon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon 305701, South Korea; [Lee, Yeunkum; Kim, Eunjoon] Ctr Synapt Brain Dysfunct, Inst Basic Sci, Daejeon 305701, South Korea; [Ko, Jaewon] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Yonsei University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Shinshu University; University of Gottingen; Korea Advanced Institute of Science & Technology (KAIST); Institute for Basic Science - Korea (IBS); Japan Science & Technology Agency (JST)	Ko, J (corresponding author), Yonsei Univ, Ctr Sci Res, Coll Life Sci & Biotechnol, Dept Biochem, 134 Shinchon Dong,S421, Seoul 120749, South Korea.	jaewonko@yonsei.ac.kr	Mori, Takuma/AFS-0267-2022; Mori, Takuma/GMX-3581-2022; Kim, Eunjoon/C-1566-2011	Mori, Takuma/0000-0002-4195-2804; Mori, Takuma/0000-0002-4195-2804; Papadopoulos, Theofilos/0000-0002-0684-2407; Park, Dongseok/0000-0003-0065-7945	National Research Foundation of Korea - Ministry of Science and Future Planning [2014051826, NRF-2015R1C1A2A01052176]; Yonsei University Future-leading Research Initiative; National Research Foundation of Korea - Ministry of Education, Science and Technology [NRF-2013R1A6A3A04061338]; Deutsche Forschungsgemeinschaft [PA2087/1-3]; Institute for Basic Science [IBS-R002-D1]; Japan Science and Technology Agency PRESTO; Brain Korea 21 PLUS Program	National Research Foundation of Korea - Ministry of Science and Future Planning; Yonsei University Future-leading Research Initiative; National Research Foundation of Korea - Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of KoreaNational Research Foundation of Korea); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Institute for Basic Science; Japan Science and Technology Agency PRESTO(Japan Science & Technology Agency (JST)); Brain Korea 21 PLUS Program	This work was supported in part by the National Research Foundation of Korea funded by the Ministry of Science and Future Planning Grants 2014051826 (to J. K.) and NRF-2015R1C1A2A01052176 (to J. W. U.), Yonsei University Future-leading Research Initiative of 2014 (to J. K.), Yonsei University Future-leading Research Initiative of 2015 (to J. W. U.), National Research Foundation of Korea funded by the Ministry of Education, Science and Technology Grant NRF-2013R1A6A3A04061338 (to J. W. U.), Deutsche Forschungsgemeinschaft Grant PA2087/1-3 (to T. P.), the Institute for Basic Science Grant IBS-R002-D1 (to E. K.), Japan Science and Technology Agency PRESTO (to K. T.), and in part by the Brain Korea 21 PLUS Program. The authors declare that they have no conflicts of interest with the contents of this article.	Arancibia-Carcamo I. Lorena, 2006, V43, P25, DOI 10.1007/017; Choi S, 2006, J NEUROSCI, V26, P4811, DOI 10.1523/JNEUROSCI.4182-05.2006; Choii G, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.5; Fritschy JM, 2012, CELL MOL LIFE SCI, V69, P2485, DOI 10.1007/s00018-012-0926-4; Fukaya M, 2011, J NEUROCHEM, V116, P1122, DOI 10.1111/j.1471-4159.2010.07167.x; Gibson JR, 2009, J NEUROSCI, V29, P13883, DOI 10.1523/JNEUROSCI.2457-09.2009; Hiester KG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082084; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; Ko J, 2003, J NEUROSCI, V23, P1667; Ko J, 2015, TRENDS MOL MED, V21, P256, DOI 10.1016/j.molmed.2015.01.004; Ko J, 2011, J CELL BIOL, V194, P323, DOI 10.1083/jcb.201101072; Ko JW, 2006, NEURON, V50, P233, DOI 10.1016/j.neuron.2006.04.005; Krueger DD, 2012, CURR OPIN NEUROBIOL, V22, P412, DOI 10.1016/j.conb.2012.02.012; Mok H, 2002, J NEUROSCI, V22, P5253; Morishige M, 2008, NAT CELL BIOL, V10, P85, DOI 10.1038/ncb1672; Myers KR, 2012, J NEUROSCI, V32, P11716, DOI 10.1523/JNEUROSCI.1942-12.2012; Papadopoulos T, 2008, MOL CELL NEUROSCI, V39, P161, DOI 10.1016/j.mcn.2008.06.006; Papadopoulos T, 2007, EMBO J, V26, P3888, DOI 10.1038/sj.emboj.7601819; Papadopoulos Theofilos, 2011, Front Cell Neurosci, V5, P11, DOI 10.3389/fncel.2011.00011; Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023; Saiyed T, 2007, J BIOL CHEM, V282, P5625, DOI 10.1074/jbc.M610290200; Sakagami H, 2013, J COMP NEUROL, V521, P860, DOI 10.1002/cne.23206; Scholz R, 2010, NEURON, V66, P768, DOI 10.1016/j.neuron.2010.05.003; Shoubridge C, 2010, NAT GENET, V42, P486, DOI 10.1038/ng.588; Specht CG, 2013, NEURON, V79, P308, DOI 10.1016/j.neuron.2013.05.013; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Tyagarajan SK, 2014, NAT REV NEUROSCI, V15, P141, DOI 10.1038/nrn3670; West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744; Woo J, 2013, J CELL BIOL, V201, P929, DOI 10.1083/jcb.201209132	29	19	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10119	10130		10.1074/jbc.M115.712893	http://dx.doi.org/10.1074/jbc.M115.712893			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	27002143	Green Published, hybrid			2022-12-26	WOS:000375602800023
J	Browne, EP; Letham, B; Rudin, C				Browne, Edward P.; Letham, Benjamin; Rudin, Cynthia			A Computational Model of Inhibition of HIV-1 by Interferon-Alpha	PLOS ONE			English	Article							BOUND-CONSTRAINED OPTIMIZATION; PLASMACYTOID DENDRITIC CELLS; DYNAMICS IN-VIVO; PRODUCTIVE INFECTION; VIRUS-INFECTION; VIRAL DYNAMICS; KINETICS; PROGRESSION; ALGORITHM; RESPONSES	Type 1 interferons such as interferon-alpha (IFN alpha) inhibit replication of Human immunodeficiency virus (HIV-1) by upregulating the expression of genes that interfere with specific steps in the viral life cycle. This pathway thus represents a potential target for immune based therapies that can alter the dynamics of host-virus interactions to benefit the host. To obtain a deeper mechanistic understanding of how IFN alpha impacts spreading HIV-1 infection, we modeled the interaction of HIV-1 with CD4 T cells and IFN alpha as a dynamical system. This model was then tested using experimental data from a cell culture model of spreading HIV-1 infection. We found that a model in which IFN alpha induces reversible cellular states that block both early and late stages of HIV-1 infection, combined with a saturating rate of conversion to these states, was able to successfully fit the experimental dataset. Sensitivity analysis showed that the potency of inhibition by IFN alpha was particularly dependent on specific network parameters and rate constants. This model will be useful for designing new therapies targeting the IFN alpha network in HIV-1-infected individuals, as well as potentially serving as a template for understanding the interaction of IFNa with other viruses.	[Browne, Edward P.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Letham, Benjamin; Rudin, Cynthia] MIT, Ctr Operat Res, Cambridge, MA 02139 USA; [Rudin, Cynthia] MIT, Alfred P Sloan Sch Management, Cambridge, MA 02139 USA; [Rudin, Cynthia] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Browne, EP (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ebrowne@mit.edu			Army Research Office grant [W911NF-15-1-0155]	Army Research Office grant	This work was supported by an Army Research Office grant to Cynthia Rudin (W911NF-15-1-0155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo MM, 2014, J INFECT DIS, V209, pS86, DOI 10.1093/infdis/jiu175; Althaus CL, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003871; Archin NM, 2014, NAT REV MICROBIOL, V12, P750, DOI 10.1038/nrmicro3352; Asmuth DM, 2010, J INFECT DIS, V201, P1686, DOI 10.1086/652420; Azzoni L, 2013, J INFECT DIS, V207, P213, DOI 10.1093/infdis/jis663; Barr SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000007; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Bhutta ZA, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-21; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Cecilia D, 1998, J VIROL, V72, P6988, DOI 10.1128/JVI.72.9.6988-6996.1998; Ciupe SM, 2007, P NATL ACAD SCI USA, V104, P5050, DOI 10.1073/pnas.0603626104; Crouse J, 2015, NAT REV IMMUNOL, V15, P231, DOI 10.1038/nri3806; Dahari H, 2009, J VIROL, V83, P6383, DOI 10.1128/JVI.02612-08; Fenton-May AE, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-146; Fraietta JA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003658; FU XY, 1990, P NATL ACAD SCI USA, V87, P8555, DOI 10.1073/pnas.87.21.8555; Gervaix A, 1997, P NATL ACAD SCI USA, V94, P4653, DOI 10.1073/pnas.94.9.4653; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Hardy GAD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056527; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; HUDDLESTONE JR, 1979, NATURE, V282, P417, DOI 10.1038/282417a0; Iwasaki A, 2012, ANNU REV MICROBIOL, V66, P177, DOI 10.1146/annurev-micro-092611-150203; Jacquelin B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004241; Kane M, 2013, NATURE, V502, P563, DOI 10.1038/nature12653; Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; LEVY DE, 1988, GENE DEV, V2, P383, DOI 10.1101/gad.2.4.383; Li MQ, 2012, NATURE, V491, P125, DOI 10.1038/nature11433; Manion M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030306; Meier A, 2009, NAT MED, V15, P955, DOI 10.1038/nm.2004; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Pawelek KA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002588; Perelson AS, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-96; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Powers KA, 2003, SEMIN LIVER DIS, V23, P13; Prakash A, 2005, J BIOL CHEM, V280, P18651, DOI 10.1074/jbc.M501289200; Saenz RA, 2010, J VIROL, V84, P3974, DOI 10.1128/JVI.02078-09; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stafford MA, 2000, J THEOR BIOL, V203, P285, DOI 10.1006/jtbi.2000.1076; Sterling TR, 2001, NEW ENGL J MED, V344, P720, DOI 10.1056/NEJM200103083441003; Talal AH, 2006, HEPATOLOGY, V43, P943, DOI 10.1002/hep.21136; VENZON DJ, 1988, J R STAT SOC C-APPL, V37, P87, DOI 10.2307/2347496; WESTERVELT P, 1991, P NATL ACAD SCI USA, V88, P3097, DOI 10.1073/pnas.88.8.3097; Zhu CY, 1997, ACM T MATH SOFTWARE, V23, P550, DOI 10.1145/279232.279236	47	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152316	10.1371/journal.pone.0152316	http://dx.doi.org/10.1371/journal.pone.0152316			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010978	Green Published, Green Submitted, gold			2022-12-26	WOS:000372708000131
J	Wang, W; Lu, H; Yang, DW; Sothea, K; Jiao, Y; Gao, B; Peng, XT; Pang, ZG				Wang, Wei; Lu, Hui; Yang, Dawen; Sothea, Khem; Jiao, Yang; Gao, Bin; Peng, Xueting; Pang, Zhiguo			Modelling Hydrologic Processes in the Mekong River Basin Using a Distributed Model Driven by Satellite Precipitation and Rain Gauge Observations	PLOS ONE			English	Article							CLIMATE; VARIABILITY; IMPACTS	The Mekong River is the most important river in Southeast Asia. It has increasingly suffered from water-related problems due to economic development, population growth and climate change in the surrounding areas. In this study, we built a distributed Geomorphology-Based Hydrological Model (GBHM) of the Mekong River using remote sensing data and other publicly available data. Two numerical experiments were conducted using different rainfall data sets as model inputs. The data sets included rain gauge data from the Mekong River Commission (MRC) and remote sensing rainfall data from the Tropic Rainfall Measurement Mission (TRMM 3B42V7). Model calibration and validation were conducted for the two rainfall data sets. Compared to the observed discharge, both the gauge simulation and TRMM simulation performed well during the calibration period (1998-2001). However, the performance of the gauge simulation was worse than that of the TRMM simulation during the validation period (2002-2012). The TRMM simulation is more stable and reliable at different scales. Moreover, the calibration period was changed to 2, 4, and 8 years to test the impact of the calibration period length on the two simulations. The results suggest that longer calibration periods improved the GBHM performance during validation periods. In addition, the TRMM simulation is more stable and less sensitive to the calibration period length than is the gauge simulation. Further analysis reveals that the uneven distribution of rain gauges makes the input rainfall data less representative and more heterogeneous, worsening the simulation performance. Our results indicate that remotely sensed rainfall data may be more suitable for driving distributed hydrologic models, especially in basins with poor data quality or limited gauge availability.	[Wang, Wei; Lu, Hui; Peng, Xueting] Tsinghua Univ, Minist Educ, Key Lab Earth Syst Modeling, Beijing 100084, Peoples R China; [Wang, Wei; Lu, Hui; Peng, Xueting] Tsinghua Univ, Ctr Earth Syst Sci, Beijing 100084, Peoples R China; [Lu, Hui] Joint Ctr Global Change Studies, Beijing, Peoples R China; [Yang, Dawen; Jiao, Yang] Tsinghua Univ, Dept Hydraul Engn, Beijing 100084, Peoples R China; [Sothea, Khem] Mekong River Commiss Secretariat MRCS OSP, Phnom Penh, Cambodia; [Gao, Bin] China Univ Geosci, Sch Water Resources & Environm, Beijing, Peoples R China; [Pang, Zhiguo] Inst Water Resources & Hydropower Res, Ctr Remote Sensing, Beijing, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; China University of Geosciences; China Institute of Water Resources & Hydropower Research	Lu, H (corresponding author), Tsinghua Univ, Minist Educ, Key Lab Earth Syst Modeling, Beijing 100084, Peoples R China.; Lu, H (corresponding author), Tsinghua Univ, Ctr Earth Syst Sci, Beijing 100084, Peoples R China.; Lu, H (corresponding author), Joint Ctr Global Change Studies, Beijing, Peoples R China.	luhui@tsinghua.edu.cn	Lu, Hui/H-4349-2011; wang, wei/HGC-8000-2022	Lu, Hui/0000-0003-1640-239X; Wang, Wei/0000-0002-3297-7161; JIAO, Yang/0000-0001-5875-6677	National Basic Research Program of China [2015CB953703]; National "863" Program of China [2012AA12A309]; National Natural Science Foundation of China [51109111, 41371328, 51190092]; Tsinghua University Initiative Research Program [2011081132]; Beijing Higher Education Young Elite Teacher Project [YETP0132]	National Basic Research Program of China(National Basic Research Program of China); National "863" Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University Initiative Research Program; Beijing Higher Education Young Elite Teacher Project	This work was jointly supported by the National Basic Research Program of China (2015CB953703), the National "863" Program of China (2012AA12A309), the National Natural Science Foundation of China (51109111, 41371328 and 51190092), Tsinghua University Initiative Research Program (2011081132), and the Beijing Higher Education Young Elite Teacher Project (YETP0132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Most of satellite-based data set is provided by International Scientific & Technical Data Mirror Site, Computer Network Information Center, CAS. The computation of this work is supported by Tsinghua National Laboratory for Information Science and Technology. The author would like thank the Mekong River Commission and China Meteorological Data Sharing Service System for providing in situ data. The first Author would also acknowledge Pauline Lovell and Arthur Cracknell for their kind help and comments on this paper.	Boegh E, 2004, J HYDROL, V287, P279, DOI 10.1016/j.jhydrol.2003.10.018; Cai YC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120026; Cong ZT, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR006852; Cook BI, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017708; Costa-Cabral MC, 2008, HYDROL PROCESS, V22, P1731, DOI 10.1002/hyp.6740; Cronin R, 2009, SURVIVAL, V51, P147, DOI 10.1080/00396330903461716; Eastham J., 2008, MEKONG RIVER BASIN W; Fortin JP, 2001, J HYDROL ENG, V6, P91, DOI 10.1061/(ASCE)1084-0699(2001)6:2(91); GAO B, 2008, J CHINA HYDROLOGY, V28, P40; Hoanh C., 2010, IMPACTS CLIMATE CHAN; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; Kingston DG, 2011, HYDROL EARTH SYST SC, V15, P1459, DOI 10.5194/hess-15-1459-2011; Kite G, 2001, J HYDROL, V253, P1, DOI 10.1016/S0022-1694(01)00396-1; Li Z, 2015, J HYDROMETEOROL, V16, P407, DOI 10.1175/JHM-D-14-0105.1; Loveland TR, 2000, INT J REMOTE SENS, V21, P1303, DOI 10.1080/014311600210191; Mekong River Commission, 2010, STAT BAS REP 2010; Mekong River Commission, 2005, OV HYDR MEK BAS; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Nijssen B, 2001, CLIMATIC CHANGE, V50, P143, DOI 10.1023/A:1010616428763; Nijssen B, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2003JD003497; Peng B, 2014, IEEE J-STARS, V7, P3915, DOI 10.1109/JSTARS.2014.2320756; Refsgaard JC, 1997, J HYDROL, V198, P69, DOI 10.1016/S0022-1694(96)03329-X; Schmugge TJ, 2002, ADV WATER RESOUR, V25, P1367, DOI 10.1016/S0309-1708(02)00065-9; Sneddon C, 2006, POLIT GEOGR, V25, P181, DOI 10.1016/j.polgeo.2005.11.002; Tang LH, 2011, J HYDROL, V409, P172, DOI 10.1016/j.jhydrol.2011.08.015; Tian F, 2006, HYDROL EARTH SYST SC, V10, P619, DOI 10.5194/hess-10-619-2006; Valeriano OCS, 2010, J HYDROL ENG, V15, P580, DOI 10.1061/(ASCE)HE.1943-5584.0000212; Vastila K, 2010, J WATER CLIM CHANGE, V1, P67, DOI 10.2166/wcc.2010.008; Xu J., 2008, J CHINA HYDROL, V28, P32; Xu XY, 2013, HYDROL RES, V44, P940, DOI 10.2166/nh.2013.144; Yang D, 2002, HYDROLOG SCI J, V47, P49, DOI 10.1080/02626660209492907; Yang DaWen, 2002, Mathematical models of small watershed hydrology and applications, P259; Yang DW, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002763; Yang DW, 2004, HYDROL PROCESS, V18, P3119, DOI 10.1002/hyp.5752; Yang DW, 2003, HYDROL PROCESS, V17, P2855, DOI 10.1002/hyp.1438; Yang DW, 1997, P HYDRAULIC ENG, V41, P105, DOI [10.2208/prohe.41.105, DOI 10.2208/PROHE.41.105]; Yang DW, P 2000 ANN C JAP SOC, P200; Yang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112725	38	67	70	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152229	10.1371/journal.pone.0152229	http://dx.doi.org/10.1371/journal.pone.0152229			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010692	Green Submitted, gold, Green Published			2022-12-26	WOS:000372708000117
J	Bo, L; Jiang, S; Xie, YQ; Kan, HD; Song, WM; Zhao, JZ				Bo, Liang; Jiang, Shuo; Xie, Yuquan; Kan, Haidong; Song, Weimin; Zhao, Jinzhuo			Effect of Vitamin E and Omega-3 Fatty Acids on Protecting Ambient PM2.5-Induced Inflammatory Response and Oxidative Stress in Vascular Endothelial Cells	PLOS ONE			English	Article							PARTICULATE MATTER EXPOSURE; AIR-POLLUTION; CIRCULATING BIOMARKERS; SYSTEMIC INFLAMMATION; FINE; SUPPLEMENTATION; DYSFUNCTION; INCREASES; DISEASES; INJURY	Although the mechanisms linking cardiopulmonary diseases to ambient fine particles (PM2.5) are still unclear, inflammation and oxidative stress play important roles in PM2.5-induced injury. It is well known that inflammation and oxidative stress could be restricted by vitamin E (Ve) or omega-3 fatty acids (O-3 FA) consumption. This study investigated the effects of Ve and O-3 FA on PM2.5-induced inflammation and oxidative stress in vascular endothelial cells. The underlying mechanisms linking PM2.5 to vascular endothelial injury were also explored. Human umbilical vein endothelial cells (HUVECs) were treated with 50 mu g/mL PM2.5 in the presence or absence of different concentrations of Ve and O-3 FA. The inflammatory cytokines and oxidative stress markers were determined. The results showed that Ve induced a significant decrease in PM2.5-induced inflammation and oxidative stress. Malondialdehyde (MDA) in supernatant and reactive oxygen species (ROS) in cytoplasm decreased by Ve, while the superoxide dismutase (SOD) activity elevated. The inflammatory cytokines interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) also reduced by Ve. Moreover, O-3 FA played the same role on decreasing the inflammation and oxidative stress. IL-6 and TNF-a expressions were significantly lower in combined Ve with O-3 FA than treatment with Ve or O-3 FA alone. The Ve and O-3 FA intervention might abolish the PM2.5-induced oxidative stress and inflammation in vascular endothelial cells. There might be an additive effect of these two nutrients in mediating the PM2.5-induced injury in vascular endothelial cells. The results suggested that inflammation and oxidative stress might be parts of the mechanisms linking PM2.5 to vascular endothelial injury.	[Bo, Liang; Jiang, Shuo; Kan, Haidong; Song, Weimin; Zhao, Jinzhuo] Fudan Univ, Sch Publ Hlth, Dept Environm Hlth, Shanghai 200032, Peoples R China; [Bo, Liang; Jiang, Shuo; Kan, Haidong; Song, Weimin; Zhao, Jinzhuo] Fudan Univ, Key Lab Publ Hlth Safety, Shanghai 200032, Peoples R China; [Xie, Yuquan] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Cardiol, Shanghai 200092, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University	Zhao, JZ (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Environm Hlth, Shanghai 200032, Peoples R China.; Zhao, JZ (corresponding author), Fudan Univ, Key Lab Publ Hlth Safety, Shanghai 200032, Peoples R China.	jinzhuozhao@fudan.edu.cn	Song, Weimin/AAJ-5415-2020; Kan, Haidong/AGU-0328-2022	Song, Weimin/0000-0003-1376-2293; 	nutrition research fund of Chinese Nutrition Society [2014-012]; National Natural Science Foundation of China [91543119]	nutrition research fund of Chinese Nutrition Society; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grant from the nutrition research fund of Chinese Nutrition Society (No. 2014-012), and the National Natural Science Foundation of China (No. 91543119).	Angelini DJ, 2006, AM J PHYSIOL-LUNG C, V291, pL1232, DOI 10.1152/ajplung.00109.2006; Behbod B, 2013, OCCUP ENVIRON MED, V70, P761, DOI 10.1136/oemed-2013-101498; Bonetti PO, 2003, ARTERIOSCL THROM VAS, V23, P168, DOI 10.1161/01.ATV.0000051384.43104.FC; BRETT J, 1989, J EXP MED, V169, P1977, DOI 10.1084/jem.169.6.1977; Bulger EM, 2003, SHOCK, V19, P99, DOI 10.1097/00024382-200302000-00001; Cachon BF, 2014, ENVIRON POLLUT, V185, P340, DOI 10.1016/j.envpol.2013.10.026; Chandran PA, 2014, IMMUNOPHARMACOL IMMU, P1; Davel AP, 2012, TOXICOLOGY, V295, P39, DOI 10.1016/j.tox.2012.02.004; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Delfino RJ, 2008, ENVIRON HEALTH PERSP, V116, P898, DOI 10.1289/ehp.11189; Delfino RJ, 2011, AIR QUAL ATMOS HLTH, V4, P37, DOI 10.1007/s11869-010-0095-2; Dhalla NS, 2000, J HYPERTENS, V18, P655, DOI 10.1097/00004872-200018060-00002; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; GOLDFARB AH, 1993, MED SCI SPORT EXER, V25, P232; Gurgueira SA, 2002, ENVIRON HEALTH PERSP, V110, P749, DOI 10.1289/ehp.02110749; Kurhanewicz N, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0054-4; Liu CQ, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/s12989-014-0053-5; MCCORD JM, 1978, ANN INTERN MED, V89, P122, DOI 10.7326/0003-4819-89-1-122; Nigam A, 2014, J AM COLL CARDIOL, V64, P1441, DOI 10.1016/j.jacc.2014.07.956; Nurkiewicz TR, 2006, ENVIRON HEALTH PERSP, V114, P412, DOI 10.1289/ehp.8413; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Ozkaya D, 2011, CELL BIOCHEM FUNCT, V29, P287, DOI 10.1002/cbf.1749; ROMIEU I, 2008, PMID, V179, DOI DOI 10.1183/09031936.00128106; Samet JM, 2001, AM J RESP CRIT CARE, V164, P819, DOI 10.1164/ajrccm.164.5.2008003; Sekikawa A, 2008, J AM COLL CARDIOL, V52, P417, DOI 10.1016/j.jacc.2008.03.047; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Stafoggia M, 2014, ENVIRON HEALTH PERSP, V122, P919, DOI 10.1289/ehp.1307301; van Eeden SF, 2002, J TOXICOL ENV HEAL A, V65, P1597, DOI 10.1080/00984100290071685; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Zhao JZ, 2012, TOXICOL LETT, V208, P225, DOI 10.1016/j.toxlet.2011.11.012; Zhao JZ, 2011, HUM EXP TOXICOL, V30, P1828, DOI 10.1177/0960327111401050	32	55	63	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152216	10.1371/journal.pone.0152216	http://dx.doi.org/10.1371/journal.pone.0152216			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007186	Green Published, gold			2022-12-26	WOS:000372701200112
J	Sharp, JD; Singh, AK; Park, ST; Lyubetskaya, A; Peterson, MW; Gomes, ALC; Potluri, LP; Raman, S; Galagan, JE; Husson, RN				Sharp, Jared D.; Singh, Atul K.; Park, Sang Tae; Lyubetskaya, Anna; Peterson, Matthew W.; Gomes, Antonio L. C.; Potluri, Lakshmi-Prasad; Raman, Sahadevan; Galagan, James E.; Husson, Robert N.			Comprehensive Definition of the SigH Regulon of Mycobacterium tuberculosis Reveals Transcriptional Control of Diverse Stress Responses	PLOS ONE			English	Article							CHIP-SEQ; IMMUNOPATHOLOGY; SEQUENCE; NETWORK	Expression of SigH, one of 12 Mycobacterium tuberculosis alternative sigma factors, is induced by heat, oxidative and nitric oxide stresses. SigH activation has been shown to increase expression of several genes, including genes involved in maintaining redox equilibrium and in protein degradation. However, few of these are known to be directly regulated by SigH. The goal of this project is to comprehensively define the Mycobacterium tuberculosis genes and operons that are directly controlled by SigH in order to gain insight into the role of SigH in regulating M. tuberculosis physiology. We used ChIP-Seq to identify in vivo SigH binding sites throughout the M. tuberculosis genome, followed by quantification of SigH-dependent expression of genes linked to these sites and identification of SigH-regulated promoters. We identified 69 SigH binding sites, which are located both in intergenic regions and within annotated coding sequences in the annotated M. tuberculosis genome. 41 binding sites were linked to genes that showed greater expression following heat stress in a SigH-dependent manner. We identified several genes not previously known to be regulated by SigH, including genes involved in DNA repair, cysteine biosynthesis, translation, and genes of unknown function. Experimental and computational analysis of SigH-regulated promoter sequences within these binding sites identified strong consensus -35 and -10 promoter sequences, but with tolerance for non-consensus bases at specific positions. This comprehensive identification and validation of SigH-regulated genes demonstrates an extended SigH regulon that controls an unexpectedly broad range of stress response functions.	[Sharp, Jared D.; Singh, Atul K.; Potluri, Lakshmi-Prasad; Husson, Robert N.] Boston Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Sharp, Jared D.; Singh, Atul K.; Potluri, Lakshmi-Prasad; Husson, Robert N.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Park, Sang Tae; Raman, Sahadevan; Galagan, James E.] Boston Univ, Natl Emerging Infect Dis Labs, Boston, MA 02118 USA; [Lyubetskaya, Anna; Gomes, Antonio L. C.; Galagan, James E.] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Galagan, James E.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Peterson, Matthew W.; Galagan, James E.] Boston Univ, Dept Microbiol, Boston, MA 02215 USA; [Sharp, Jared D.] Affinivax, Cambridge, MA 02139 USA; [Park, Sang Tae] Macrogen Clin Lab, Rockville, MD 20850 USA; [Lyubetskaya, Anna] Beth Israel Deaconess Med Ctr, Bioinformat Program, Boston, MA 02115 USA; [Gomes, Antonio L. C.] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Raman, Sahadevan] Brigham & Womens Hosp, Div Rheumatol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Boston University; Boston University; Boston University; Boston University; Harvard University; Beth Israel Deaconess Medical Center; Columbia University; Harvard University; Brigham & Women's Hospital	Husson, RN (corresponding author), Boston Childrens Hosp, Div Infect Dis, Boston, MA 02115 USA.; Husson, RN (corresponding author), Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA.; Galagan, JE (corresponding author), Boston Univ, Natl Emerging Infect Dis Labs, Boston, MA 02118 USA.; Galagan, JE (corresponding author), Boston Univ, Bioinformat Program, Boston, MA 02215 USA.; Galagan, JE (corresponding author), Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.; Galagan, JE (corresponding author), Boston Univ, Dept Microbiol, Boston, MA 02215 USA.	jgalag@bu.edu; robert.husson@childrens.harvard.edu	Potluri, Lakshmi-Prasad/D-3318-2013; Husson, Robert/Y-7288-2019	Potluri, Lakshmi-Prasad/0000-0001-5260-6678; Galagan, James/0000-0003-0542-3291; Lyubetskaya, Anna/0000-0003-2485-3924; Raman, Sahadevan/0000-0001-5309-8169; Gomes, Antonio LC/0000-0003-3790-3724	National Institute of Allergy and Infectious Diseases [R01AI37901]; Boston Children's Hospital internal funding; National Institute of General Medical Sciences [R01GM114812]; National Institutes of Health [T32HD055148]; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200800059C]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD055148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI037901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114812] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Boston Children's Hospital internal funding; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of Allergy and Infectious Diseases R01AI37901 to RNH; Boston Children's Hospital internal funding (no grant number) to RNH; and National Institute of General Medical Sciences R01GM114812 to JEG. JDS was supported in part by National Institutes of Health training grant T32HD055148. This project was funded in part with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract no. HHSN272200800059C to JEG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z., 2001, HIGH THROUGHPUT QUAN; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Burns KE, 2005, J AM CHEM SOC, V127, P11602, DOI 10.1021/ja053476x; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Dutta NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028958; Fitzgerald DM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004649; Galagan J, 2013, CURR TOP MICROBIOL, V363, P43, DOI 10.1007/82_2012_257; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Ghosh P, 2013, INFECT IMMUN, V81, P2242, DOI 10.1128/IAI.01273-12; Gomes ALC, 2014, GENOME RES, V24, P1686, DOI 10.1101/gr.161711.113; Hartkoorn RC, 2012, J BACTERIOL, V194, P2001, DOI 10.1128/JB.06692-11; Helmann JD, 1999, CURR OPIN MICROBIOL, V2, P135, DOI 10.1016/S1369-5274(99)80024-1; Hsu LM, 2002, BBA-GENE STRUCT EXPR, V1577, P191, DOI 10.1016/S0167-4781(02)00452-9; Kahramanoglou C, 2014, NUCLEIC ACIDS RES, V42, P8320, DOI 10.1093/nar/gku548; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Kaushal D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9533; Klotzsche M, 2009, NUCLEIC ACIDS RES, V37, P1778, DOI 10.1093/nar/gkp015; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; LONETTO MA, 1994, P NATL ACAD SCI USA, V91, P7573, DOI 10.1073/pnas.91.16.7573; Manganelli R, 2002, MOL MICROBIOL, V45, P365, DOI 10.1046/j.1365-2958.2002.03005.x; Manganelli R, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.MGM2-0007-2013; Mehra S, 2012, J INFECT DIS, V205, P1203, DOI 10.1093/infdis/jis102; Minch KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6829; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; Paget MSB, 2001, MOL MICROBIOL, V42, P1007, DOI 10.1046/j.1365-2958.2001.02675.x; Paget MSB, 2001, MOL MICROBIOL, V39, P1036, DOI 10.1046/j.1365-2958.2001.02298.x; Park ST, 2008, P NATL ACAD SCI USA, V105, P13105, DOI 10.1073/pnas.0801143105; Raman S, 2001, J BACTERIOL, V183, P6119, DOI 10.1128/JB.183.20.6119-6125.2001; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rodrigue S, 2006, FEMS MICROBIOL REV, V30, P926, DOI 10.1111/j.1574-6976.2006.00040.x; Song T, 2008, J BACTERIOL, V190, P2227, DOI 10.1128/JB.01642-07; Song TS, 2003, MOL MICROBIOL, V50, P949, DOI 10.1046/j.1365-2958.2003.03739.x; Stewart GR, 2002, MICROBIOL-SGM, V148, P3129, DOI 10.1099/00221287-148-10-3129; Via LE, 2008, INFECT IMMUN, V76, P2333, DOI 10.1128/IAI.01515-07	38	23	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152145	10.1371/journal.pone.0152145	http://dx.doi.org/10.1371/journal.pone.0152145			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003599	Green Published, gold, Green Submitted			2022-12-26	WOS:000372697400085
J	Ju, CR; Chen, M; Zhang, JH; Lin, ZY; Chen, RC				Ju, Chun-rong; Chen, Miao; Zhang, Jian-heng; Lin, Zhi-ya; Chen, Rong-chang			Higher Plasma Myostatin Levels in Cor Pulmonale Secondary to Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							RIGHT-VENTRICULAR DYSFUNCTION; BRAIN NATRIURETIC PEPTIDE; SKELETAL-MUSCLE ATROPHY; ECHOCARDIOGRAPHIC-ASSESSMENT; HEART-FAILURE; EXPRESSION; GROWTH; HYPERTENSION; MYOCARDIUM; GUIDELINES	Objective To analyze plasma myostatin levels and investigate their relationship with right ventricular (RV) function in patients with cor pulmonale secondary to chronic obstructive pulmonary disease (COPD). Methods The study recruited 81 patients with advanced COPD and 40 age-matched controls. The patients were divided into two groups: those with cor pulmonale and those without. Echocardiography was used to evaluate RV function and morphology, and the value of tricuspid annular plane systolic excursion (TAPSE) less than 16 mm was considered RV dysfunction. Plasma myostatin levels were analyzed by enzyme-linked immunosorbent assay, and B-type natriuretic peptide (BNP) levels were analyzed as a comparison of myostatin. Results The data detected cor pulmonale in 39/81 patients, with the mean value of TAPSE of 14.3 mm. Plasma myostatin levels (ng/mL) were significantly higher in patients with cor pulmonale (16.68 +/- 2.95) than in those without (13.56 +/- 3.09), and much higher than in controls (8.79 +/- 2.79), with each p<0.01. Significant differences were also found in plasma BNP levels among the three groups (p<0.05). Multivariate regression analysis suggested that myostatin levels were significantly correlated with the values of TAPSE and RV myocardium performance index among the COPD patients, and that BNP levels were significantly correlated only with systolic pulmonary arterial pressure, with each p<0.05. Conclusions Plasma myostatin levels are increased in COPD patients who have cor pulmonale. Stronger correlations of plasma myostatin levels with echocardiographic indexes of the right heart suggest that myostatin might be superior to BNP in the early diagnosis of cor pulmonale in COPD.	[Ju, Chun-rong; Chen, Miao; Zhang, Jian-heng; Lin, Zhi-ya; Chen, Rong-chang] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease	Chen, RC (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	chenrc_1234@163.com			Chinese Natural Science Foundation [81100034]; Guangdong Provincial Natural Science Foundation [2015A030313457]; American Thoracic Society	Chinese Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Science Foundation(National Natural Science Foundation of Guangdong Province); American Thoracic Society	This work was funded by Chinese Natural Science Foundation Program (Grant 81100034) and Guangdong Provincial Natural Science Foundation Program (2015A030313457).; We thank the MECOR faculty, especially Prof Sonia Buist and Dr Jeffrey Curtis for their generous help during project preparation. The manuscript was developed at MECOR CHINA sponsored by the American Thoracic Society. This study was supported by both the Chinese Natural Science Foundation Program (Grant 81100034) and Guangdong Provincial Natural Science Foundation Program (2015A030313457). The authors thank Xiao-lu Bao, who is the director of Guangzhou Old Age Association, for coordinating and contributing to the recruitment of healthy controls in this study.	Bin Yap L, 2004, CHEST, V126, P1330, DOI 10.1378/chest.126.4.1330; Bish LT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010230; Budev MM, 2003, SEMIN RESP CRIT CARE, V24, P233; Casserly B, 2009, DRUG DES DEV THER, V3, P269; Chua S, 2009, EUR J ECHOCARDIOGR, V10, P619, DOI 10.1093/ejechocard/jep013; Damy T, 2012, J CARD FAIL, V18, P216, DOI 10.1016/j.cardfail.2011.12.003; Fisher MR, 2009, AM J RESP CRIT CARE, V179, P615, DOI 10.1164/rccm.200811-1691OC; Forfia PR, 2006, AM J RESP CRIT CARE, V174, P1034, DOI 10.1164/rccm.200604-547OC; Freixa X, 2013, EUR RESPIR J, V41, P784, DOI 10.1183/09031936.00222511; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; George I, 2010, EUR J HEART FAIL, V12, P444, DOI 10.1093/eurjhf/hfq039; Granton John, 2008, Anesthesiol Clin, V26, P337, DOI 10.1016/j.anclin.2008.01.010; Grignola JC, 2006, INT J CARDIOL, V113, P25, DOI 10.1016/j.ijcard.2005.10.012; Gruson D, 2012, PEPTIDES, V33, P351, DOI 10.1016/j.peptides.2011.12.017; Gruson D, 2011, EUR J HEART FAIL, V13, P734, DOI 10.1093/eurjhf/hfr024; Heineke J, 2010, CIRCULATION, V121, P419, DOI 10.1161/CIRCULATIONAHA.109.882068; Hilde JM, 2013, J AM COLL CARDIOL, V62, P1103, DOI 10.1016/j.jacc.2013.04.091; Ho SY, 2006, HEART, V92, pI2, DOI 10.1136/hrt.2005.077875; Hoiseth AD, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-97; Jespersen J, 2006, SCAND J MED SCI SPOR, V16, P74, DOI 10.1111/j.1600-0838.2005.00498.x; Ju CR, 2012, RESP MED, V106, P102, DOI 10.1016/j.rmed.2011.07.016; Jurcut R, 2010, EUR J ECHOCARDIOGR, V11, P81, DOI 10.1093/ejechocard/jep234; Kolb TM, 2012, CARDIOL CLIN, V30, P243, DOI 10.1016/j.ccl.2012.03.005; Lee-Chiong TL, 2003, SEMIN RESP CRIT CARE, V24, P263; Lenk K, 2009, EUR J HEART FAIL, V11, P342, DOI 10.1093/eurjhf/hfp020; Leuchte HH, 2005, CHEST, V128, P2368, DOI 10.1378/chest.128.4.2368; Mckoy G, 2007, CARDIOVASC RES, V74, P304, DOI 10.1016/j.cardiores.2007.02.023; McNally EM, 2004, NEW ENGL J MED, V350, P2642, DOI 10.1056/NEJMp048124; Morissette MR, 2006, CIRC RES, V99, P15, DOI 10.1161/01.RES.0000231290.45676.d4; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Radom-Aizik S, 2013, PEDIATR RES, V74, P111, DOI 10.1038/pr.2013.80; Rafacho BPM, 2011, CELL PHYSIOL BIOCHEM, V27, P305, DOI 10.1159/000327957; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Sabit R, 2010, RESP MED, V104, P1171, DOI 10.1016/j.rmed.2010.01.020; Sharma M, 1999, J CELL PHYSIOL, V180, P1; Shujaat Adil, 2007, Int J Chron Obstruct Pulmon Dis, V2, P273; Shyu KG, 2006, EUR J CLIN INVEST, V36, P713, DOI 10.1111/j.1365-2362.2006.01718.x; Tulevski II, 2001, HEART, V86, P27, DOI 10.1136/heart.86.1.27; Ventetuolo Corey E, 2012, Pulm Circ, V2, P379, DOI 10.4103/2045-8932.101657; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wang RW, 2008, J ENDOCRINOL, V197, P85, DOI 10.1677/JOE-07-0596; Weitzenblum E, 2003, HEART, V89, P225, DOI 10.1136/heart.89.2.225; Wintgens KF, 2012, CLIN CHIM ACTA, V413, P1288, DOI 10.1016/j.cca.2012.04.023; Zachwieja J J, 1999, J Gravit Physiol, V6, P11; Zangiabadi A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/739674	45	4	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0150838	10.1371/journal.pone.0150838	http://dx.doi.org/10.1371/journal.pone.0150838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998756	Green Submitted, Green Published, gold			2022-12-26	WOS:000372694700015
J	Mayer-Scholl, A; Murugaiyan, J; Neumann, J; Bahn, P; Reckinger, S; Nockler, K				Mayer-Scholl, Anne; Murugaiyan, Jayaseelan; Neumann, Jennifer; Bahn, Peter; Reckinger, Sabine; Noeckler, Karsten			Rapid Identification of the Foodborne Pathogen Trichinella spp. by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry	PLOS ONE			English	Article							MIXED INFECTION; TRICHINOSIS; SPIRALIS; ANIMALS; PCR	Human trichinellosis occurs through consumption of raw or inadequately processed meat or meat products containing larvae of the parasitic nematodes of the genus Trichinella. Currently, nine species and three genotypes are recognized, of which T. spiralis, T. britovi and T. pseudospiralis have the highest public health relevance. To date, the differentiation of the larvae to the species and genotype level is based primarily on molecular methods, which can be relatively time consuming and labor intensive. Due to its rapidness and ease of use a matrix assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS) reference spectra database using Trichinella strains of all known species and genotypes was created. A formicacid/acetonitrile protein extraction was carried out after pooling 10 larvae of each Trichinella species and genotype. Each sample was spotted 9 times using a-cyano 4-hydoxy cinnamic acid matrix and a MicroFlex LT mass spectrometer was used to acquire 3 spectra (m/z 2000 to 20000 Da) from each spot resulting in 27 spectra/species or genotype. Following the spectra quality assessment, Biotyper software was used to create a main spectra library (MSP) representing nine species and three genotypes of Trichinella. The evaluation of the spectra generated by MALDI-TOF MS revealed a classification which was comparable to the results obtained by molecular methods. Also, each Trichinella species utilized in this study was distinct and distinguishable with a high confidence level. Further, different conservation methods such as freezing and conservation in alcohol and the host species origin of the isolated larvae did not have a significant influence on the generated spectra. Therefore, the described MALDI-TOF MS can successfully be implemented for both genus and species level identification and represents a major step forward in the use of this technique in foodborne parasitology.	[Mayer-Scholl, Anne; Neumann, Jennifer; Bahn, Peter; Reckinger, Sabine; Noeckler, Karsten] Fed Inst Risk Assessment, Dept Biol Safety, Berlin, Germany; [Murugaiyan, Jayaseelan] Free Univ Berlin, Ctr Infect Med, Inst Anim Hyg & Environm Hlth, Berlin, Germany	Federal Institute for Risk Assessment; Free University of Berlin	Mayer-Scholl, A (corresponding author), Fed Inst Risk Assessment, Dept Biol Safety, Berlin, Germany.	anne.mayer-scholl@bfr.bund.de	Murugaiyan, Jayaseelan/D-4619-2009	Murugaiyan, Jayaseelan/0000-0002-1924-2988				FAO WHO, 2014, REP JOINT FAO WHO EX; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Gamble HR, 2000, VET PARASITOL, V93, P393, DOI 10.1016/S0304-4017(00)00354-X; Gottstein B, 2009, CLIN MICROBIOL REV, V22, P127, DOI 10.1128/CMR.00026-08; Hoppenheit A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002305; IQACA, ESS QUAL ASS STAND T; Krivokapich SJ, 2012, INT J PARASITOL, V42, P903, DOI 10.1016/j.ijpara.2012.07.009; La Grange LJ, 2014, ONDERSTEPOORT J VET, V81; Liciardi M, 2009, VET PARASITOL, V161, P345, DOI 10.1016/j.vetpar.2009.01.013; Mayer-Scholl A, 2014, VET PARASITOL, V203, P247, DOI 10.1016/j.vetpar.2014.01.015; Murrell KD, 2011, EMERG INFECT DIS, V17, P2194, DOI 10.3201/eid1712.110896; Murugaiyan J, 2012, CLIN MICROBIOL INFEC, V18, P461, DOI 10.1111/j.1469-0691.2011.03593.x; Nockler K, 2006, VET PARASITOL, V137, P364, DOI 10.1016/j.vetpar.2006.01.031; Pozio E, 2007, VET PARASITOL, V149, P3, DOI 10.1016/j.vetpar.2007.07.002; Pozio Edoardo, 2003, Methods Mol Biol, V216, P299; Pozio E, 2009, INFECT GENET EVOL, V9, P606, DOI 10.1016/j.meegid.2009.03.003; Richter C, 2012, J MED MICROBIOL, V61, P1409, DOI 10.1099/jmm.0.042606-0; Trichinellosis, 2012, TRICHINELLOSIS; Wieser A, 2012, APPL MICROBIOL BIOT, V93, P965, DOI 10.1007/s00253-011-3783-4; Zarlenga DS, 2006, P NATL ACAD SCI USA, V103, P7354, DOI 10.1073/pnas.0602466103; Zarlenga DS, 1999, INT J PARASITOL, V29, P1859, DOI 10.1016/S0020-7519(99)00107-1	21	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0152062	10.1371/journal.pone.0152062	http://dx.doi.org/10.1371/journal.pone.0152062			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999436	Green Published, Green Submitted, gold			2022-12-26	WOS:000372694700097
J	Nam, SK; Yun, S; Koh, J; Kwak, Y; Seo, AN; Park, KU; Kim, DW; Kang, SB; Kim, WH; Lee, HS				Nam, Soo Kyung; Yun, Sumi; Koh, Jiwon; Kwak, Yoonjin; Seo, An Na; Park, Kyoung Un; Kim, Duck-Woo; Kang, Sung-Bum; Kim, Woo Ho; Lee, Hye Seung			BRAF, PIK3CA, and HER2 Oncogenic Alterations According to KRAS Mutation Status in Advanced Colorectal Cancers with Distant Metastasis	PLOS ONE			English	Article							ANTI-EGFR THERAPY; MONOCLONAL-ANTIBODIES; ACQUIRED-RESISTANCE; KOREAN PATIENTS; PI3K PATHWAY; CARCINOMA; HETEROGENEITY; NRAS; IMPACT	Background Anti-EGFR antibody-based treatment is an important therapeutic strategy for advanced colorectal cancer (CRC); despite this, several mutations-including KRAS, BRAF, and PIK3CA mutations, and HER2 amplification-are associated with the mechanisms underlying the development of resistance to anti-EGFR therapy. The aim of our study was to investigate the frequencies and clinical implications of these genetic alterations in advanced CRC. Methods KRAS, BRAF, and PIK3CA mutations were determined by Cobas real-time polymerase chain reaction (PCR) in 191 advanced CRC patients with distant metastasis. Microsatellite instability (MSI) status was determined by a fragmentation assay and HER2 amplification was assessed by silver in situ hybridization. In addition, KRAS mutations were investigated by the Sanger sequencing method in 97 of 191 CRC cases. Results Mutations in KRAS, BRAF, and PIK3CA were found in 104 (54.5%), 6 (3.1%), and 25 (13.1%) cases of advanced CRC, respectively. MSI-high status and HER2 amplification were observed in 3 (1.6%) and 16 (8.4%) cases, respectively. PIK3CA mutations were more frequently found in KRAS mutant type (18.3%) than KRAS wild type (6.9%) (P = 0.020). In contrast, HER2 amplifications and BRAF mutations were associated with KRAS wild type with borderline significance (P = 0.052 and 0.094, respectively). In combined analyses with KRAS, BRAF and HER2 status, BRAF mutations or HER2 amplifications were associated with the worst prognosis in the wild type KRAS group (P = 0.004). When comparing the efficacy of detection methods, the results of real time PCR analysis revealed 56 of 97 (57.7%) CRC cases with KRAS mutations, whereas Sanger sequencing revealed 49 cases (50.5%). Conclusions KRAS mutations were found in 54.5% of advanced CRC patients. Our results support that subgrouping using PIK3CA and BRAF mutation or HER2 amplification status, in addition to KRAS mutation status, is helpful for managing advanced CRC patients.	[Nam, Soo Kyung; Yun, Sumi; Kwak, Yoonjin; Lee, Hye Seung] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam, South Korea; [Yun, Sumi; Koh, Jiwon; Kwak, Yoonjin; Kim, Woo Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Seo, An Na] Kyungpook Natl Univ, Sch Med, Kyungpook Natl Univ Hosp, Dept Pathol, Daegu, South Korea; [Park, Kyoung Un] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Lab Med, Songnam, South Korea; [Kim, Duck-Woo; Kang, Sung-Bum] Seoul Natl Univ, Bundang Hosp, Dept Surg, Songnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Kyungpook National University; Kyungpook National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Lee, HS (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam, South Korea.	hye2@snu.ac.kr	Lee, Hye Seung/G-6419-2011; Park, Kyoung Un/J-5473-2012	Lee, Hye Seung/0000-0002-1667-7986; Park, Kyoung Un/0000-0002-2402-7633	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C1813]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1813, https://www.khidi.or.kr/eps). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcila M, 2011, J MOL DIAGN, V13, P64, DOI 10.1016/j.jmoldx.2010.11.005; Baldus SE, 2010, CLIN CANCER RES, V16, P790, DOI 10.1158/1078-0432.CCR-09-2446; Cantwell-Dorris ER, 2011, MOL CANCER THER, V10, P385, DOI 10.1158/1535-7163.MCT-10-0799; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Er TK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/591867; Heppner BI, 2014, BRIT J CANCER, V111, P1977, DOI 10.1038/bjc.2014.483; Imamura Y, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-135; Kawazoe A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1276-z; Kim B, 2014, WORLD J GASTROENTERO, V20, P4370, DOI 10.3748/wjg.v20.i15.4370; Kim Jung Ho, 2014, Korean J Pathol, V48, P276, DOI 10.4132/KoreanJPathol.2014.48.4.276; Kim MJ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-347; Kumler I, 2014, CANCER TREAT REV, V40, P259, DOI 10.1016/j.ctrv.2013.09.002; Lee S, 2012, VIRCHOWS ARCH, V460, P141, DOI 10.1007/s00428-011-1180-0; Leto SM, 2014, J MOL MED, V92, P709, DOI 10.1007/s00109-014-1161-2; Ma BB, 2015, ASIA-PAC J CLIN ONCO, V11, P160, DOI 10.1111/ajco.12342; Mao C, 2012, ANN ONCOL, V23, P1518, DOI 10.1093/annonc/mdr464; Martin V, 2013, BRIT J CANCER, V108, P668, DOI 10.1038/bjc.2013.4; Misale S, 2014, CANCER DISCOV, V4, P1269, DOI 10.1158/2159-8290.CD-14-0462; Misale S, 2012, NATURE, V486, P532, DOI 10.1038/nature11156; Neumann J, 2013, VIRCHOWS ARCH, V463, P509, DOI 10.1007/s00428-013-1450-0; Normanno N, 2015, ANN ONCOL, V26, P1710, DOI 10.1093/annonc/mdv176; Oh JR, 2012, FAM CANCER, V11, P459, DOI 10.1007/s10689-012-9536-4; Oliveira C, 2007, ONCOGENE, V26, P158, DOI 10.1038/sj.onc.1209758; Sahin IH, 2013, J CANCER, V4, P320, DOI 10.7150/jca.3619; Seo AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098528; Shaib W, 2013, J GASTROINTEST ONCOL, V4, P308, DOI 10.3978/j.issn.2078-6891.2013.029; Temraz S, 2015, INT J MOL SCI, V16, P22976, DOI 10.3390/ijms160922976; Van Cutsem E, 2011, J CLIN ONCOL, V29, P2011, DOI 10.1200/JCO.2010.33.5091; van Krieken JHJM, 2008, VIRCHOWS ARCH, V453, P417, DOI 10.1007/s00428-008-0665-y; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645; Yokota T, 2012, ANTI-CANCER AGENT ME, V12, P163, DOI 10.2174/187152012799014968; Yonesaka K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002442; Zhang J, 2011, GASTROENTEROLOGY, V141, P50, DOI 10.1053/j.gastro.2011.05.010	34	34	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151865	10.1371/journal.pone.0151865	http://dx.doi.org/10.1371/journal.pone.0151865			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991109	Green Published, Green Submitted, gold			2022-12-26	WOS:000372582800112
J	Oji, S; Nicolussi, EM; Kaufmann, N; Zeka, B; Schanda, K; Fujihara, K; Illes, Z; Dahle, C; Reindl, M; Lassmann, H; Bradl, M				Oji, Satoru; Nicolussi, Eva-Maria; Kaufmann, Nathalie; Zeka, Bleranda; Schanda, Kathrin; Fujihara, Kazuo; Illes, Zsolt; Dahle, Charlotte; Reindl, Markus; Lassmann, Hans; Bradl, Monika			Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ENTIRE C1QR(2)S(2) COMPLEX; NECROSIS-FACTOR FAMILY; CELL-ACTIVATING FACTOR; BLOOD-BRAIN-BARRIER; C VIRUS-INFECTION; MULTIPLE-SCLEROSIS; IFN-BETA; CEREBROSPINAL-FLUID; STIMULATED GENES	Neuromyelitis optica (NMO) is an acute inflammatory disease of the central nervous system (CNS) which predominantly affects spinal cord and optic nerves. Most patients harbor pathogenic autoantibodies, the so-called NMO-IgGs, which are directed against the water channel aquaporin 4 (AQP4) on astrocytes. When these antibodies gain access to the CNS, they mediate astrocyte destruction by complement-dependent and by antibody-dependent cellular cytotoxicity. In contrast to multiple sclerosis (MS) patients who benefit from therapies involving type I interferons (I-IFN), NMO patients typically do not profit from such treatments. How is I-IFN involved in NMO pathogenesis? To address this question, we made gene expression profiles of spinal cords from Lewis rat models of experimental neuromyelitis optica (ENMO) and experimental autoimmune encephalomyelitis (EAE). We found an upregulation of I-IFN signature genes in EAE spinal cords, and a further upregulation of these genes in ENMO. To learn whether the local I-IFN signature is harmful or beneficial, we induced ENMO by transfer of CNS antigen-specific T cells and NMO-IgG, and treated the animals with I-IFN at the very onset of clinical symptoms, when the blood-brain barrier was open. With this treatment regimen, we could amplify possible effects of the I-IFN induced genes on the transmigration of infiltrating cells through the blood brain barrier, and on lesion formation and expansion, but could avoid effects of I-IFN on the differentiation of pathogenic T and B cells in the lymph nodes. We observed that I-IFN treated ENMO rats had spinal cord lesions with fewer T cells, macrophages/activated microglia and activated neutrophils, and less astrocyte damage than their vehicle treated counterparts, suggesting beneficial effects of I-IFN.	[Oji, Satoru; Nicolussi, Eva-Maria; Kaufmann, Nathalie; Zeka, Bleranda; Lassmann, Hans; Bradl, Monika] Med Univ Vienna, Dept Neuroimmunol, Ctr Brain Res, Vienna, Austria; [Schanda, Kathrin; Reindl, Markus] Med Univ Innsbruck, Dept Clin Neurol, A-6020 Innsbruck, Austria; [Fujihara, Kazuo] Tohoku Univ, Grad Sch Med, Dept Multiple Sclerosis Therapeut, Sendai, Miyagi 980, Japan; [Fujihara, Kazuo] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan; [Illes, Zsolt] Univ Southern Denmark, Dept Neurol, Odense, Denmark; [Dahle, Charlotte] Linkoping Univ, Dept Clin Immunol & Transfus Med, Linkoping, Sweden; [Dahle, Charlotte] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	Medical University of Vienna; Medical University of Innsbruck; Tohoku University; Tohoku University; University of Southern Denmark; Linkoping University; Linkoping University	Bradl, M (corresponding author), Med Univ Vienna, Dept Neuroimmunol, Ctr Brain Res, Vienna, Austria.	monika.bradl@meduniwien.ac.at	Oji, Satoru/AAX-4144-2021; Lassmann, Hans/Z-2269-2019; Reindl, Markus/ABE-5880-2020	Lassmann, Hans/0000-0001-8617-5052; Reindl, Markus/0000-0003-2817-1402; Kaufmann, Nathalie/0000-0002-4823-6923; Illes, Zsolt/0000-0001-9655-0450	Austrian Science Fund [P25240-B24]; Austrian Ministry of Science, Research and Economy (BIGWIG-MS); Ministry of Education, Culture, Sports, Science and Technology of Japan; Alumni Association of Saitama Medical University; Austrian Science Fund (FWF) [P 25240] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Ministry of Science, Research and Economy (BIGWIG-MS); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Alumni Association of Saitama Medical University; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (grant number P25240-B24 to MB), by the Austrian Ministry of Science, Research and Economy (BIGWIG-MS to HL and MR), by Grants-in-aid for Scientific Research of the Ministry of Education, Culture, Sports, Science and Technology of Japan to KF, and by a travel grant from the Alumni Association of Saitama Medical University to SO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonelli A, 2014, WORLD J DIABETES, V5, P586, DOI 10.4239/wjd.v5.i5.586; Asgari N, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/713519; Austin BA, 2005, J IMMUNOL, V175, P1100, DOI 10.4049/jimmunol.175.2.1100; Axtell RC, 2011, TRENDS IMMUNOL, V32, P272, DOI 10.1016/j.it.2011.03.008; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; BARNUM SR, 1992, BIOCHEM J, V287, P595, DOI 10.1042/bj2870595; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Bergman CM, 2012, J IMMUNOL, V188, P6001, DOI 10.4049/jimmunol.1101898; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Borysiewicz E, 2009, J NEUROSCI RES, V87, P1565, DOI 10.1002/jnr.21968; Boutros T, 1997, J NEUROCHEM, V69, P939; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Brand-Schieber E, 2004, BRAIN RES, V1007, P178, DOI 10.1016/j.brainres.2003.12.051; Brendecke SM, 2012, J LEUKOCYTE BIOL, V92, P479, DOI 10.1189/jlb.0112043; Brodsky LI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000584; Bulwin GC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001576; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Carter RH, 2005, ARTHRITIS RHEUM-US, V52, P3943, DOI 10.1002/art.21489; Chabot S, 1997, J CLIN INVEST, V100, P604, DOI 10.1172/JCI119571; Chen CH, 1998, IMMUNOLOGY, V95, P648; Chen CH, 1998, CLIN IMMUNOL IMMUNOP, V87, P68, DOI 10.1006/clin.1997.4515; Chen F, 2013, J CEREBR BLOOD F MET, V33, P1041, DOI 10.1038/jcbfm.2013.45; Chihara N, 2011, P NATL ACAD SCI USA, V108, P3701, DOI 10.1073/pnas.1017385108; COLLINS JM, 1985, CANC DRUG DEL, V2, P247, DOI 10.1089/cdd.1985.2.247; Das A, 2014, J VIROL, V88, P3103, DOI 10.1128/JVI.03202-13; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; de Weerd NA, 2012, IMMUNOL CELL BIOL, V90, P483, DOI 10.1038/icb.2012.9; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Domingues HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015531; Du J, 1998, NEUROSCIENCE, V84, P37, DOI 10.1016/S0306-4522(97)00519-8; Durelli L, 2009, ANN NEUROL, V65, P499, DOI 10.1002/ana.21652; Elinav E, 2011, IMMUNITY, V34, P665, DOI 10.1016/j.immuni.2011.05.007; Esser J, 2010, BIOCHEM J, V425, P265, DOI 10.1042/BJ20090856; Feng X, 2011, J NEUROL SCI; Giannattasio G, 2011, J IMMUNOL, V187, P1486, DOI 10.4049/jimmunol.1003669; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; Gveric D, 1999, NEUROPATH APPL NEURO, V25, P215; Harmel J, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0247-3; Hasham A, 2013, J AUTOIMMUN, V44, P61, DOI 10.1016/j.jaut.2013.04.002; He XS, 2006, HEPATOLOGY, V44, P352, DOI 10.1002/hep.21267; Hilkens CMU, 2003, J IMMUNOL, V171, P5255, DOI 10.4049/jimmunol.171.10.5255; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; Howe CL, 2014, GLIA, V62, P692, DOI 10.1002/glia.22635; Howie D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073610; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hultcrantz M, 2007, VIROLOGY, V367, P92, DOI 10.1016/j.virol.2007.05.010; Indraccolo S, 2007, J IMMUNOL, V178, P1122, DOI 10.4049/jimmunol.178.2.1122; Inglis HR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048555; Ittah M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1912; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jacob A, 2012, MULT SCLER J, V18, P1801, DOI 10.1177/1352458512443994; Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006; Jonsson MV, 2005, J CLIN IMMUNOL, V25, P189, DOI 10.1007/s10875-005-4091-5; Kalie E, 2008, J BIOL CHEM, V283, P32925, DOI 10.1074/jbc.M806019200; Kalinke U, 2012, IMMUNOL CELL BIOL, V90, P505, DOI 10.1038/icb.2012.8; Khan TH, 2014, J IMMUNOL, V193, P3644, DOI 10.4049/jimmunol.1400620; Khorooshi R, 2015, ACTA NEUROPATHOL, V130, P107, DOI 10.1007/s00401-015-1418-z; Khorooshi R, 2013, EXP NEUROL, V247, P744, DOI 10.1016/j.expneurol.2013.02.005; Kim SG, 2003, BIOCHEM PHARMACOL, V65, P923, DOI 10.1016/S0006-2952(02)01614-3; Kocur M, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0192-4; Kozovska ME, 1999, NEUROLOGY, V53, P1692, DOI 10.1212/WNL.53.8.1692; Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990; Krumbholz M, 2008, BRAIN, V131, P1455, DOI 10.1093/brain/awn077; Lanford RE, 2006, HEPATOLOGY, V43, P961, DOI 10.1002/hep.21167; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Le Jan S, 2006, FEBS LETT, V580, P3395, DOI 10.1016/j.febslet.2006.05.011; Leaman DW, 2003, J INTERF CYTOK RES, V23, P745, DOI 10.1089/107999003772084860; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Major MB, 2004, J BIOL CHEM, V279, P5278, DOI 10.1074/jbc.M311517200; Mangioni D, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-56; Matus-Nicodemos R, 2011, J IMMUNOL, V186, P2164, DOI 10.4049/jimmunol.1003236; McCarthy MK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00021; McGlasson S, 2015, NAT REV NEUROL, V11, P515, DOI 10.1038/nrneurol.2015.143; Mendoza P, 2014, CURR MOL MED, V14, P235, DOI 10.2174/1566524014666140128111347; Messmer-Blust AF, 2010, MOL BIOL CELL, V21, P2514, DOI 10.1091/mbc.E09-04-0344; Nakamura N, 2014, NATURE, V509, P240, DOI 10.1038/nature13133; Ni W, 1997, BRAIN RES, V769, P97, DOI 10.1016/S0006-8993(97)00676-8; Nicolussi EM, 2009, NEUROBIOL DIS, V35, P24, DOI 10.1016/j.nbd.2009.03.010; Okenwa C, 2013, J IMMUNOL, V191, P2589, DOI 10.4049/jimmunol.1300466; Oliveira TL, 2014, ACTA REUMATOL PORT, V39, P327; Onodera Y, 2012, J CELL BIOL, V197, P983, DOI 10.1083/jcb.201201065; Ortuno-Sahagun D, 2010, HIPPOCAMPUS; Owens T, 2014, GLIA, V62, P339, DOI 10.1002/glia.22608; Palace J, 2010, ARCH NEUROL-CHICAGO, V67, P1016, DOI 10.1001/archneurol.2010.188; Papadopoulos MC, 2014, NAT REV NEUROL, V10, P493, DOI 10.1038/nrneurol.2014.141; Papeix C, 2007, MULT SCLER, V13, P256, DOI 10.1177/1352458506070732; Park OK, 2010, J NEUROL SCI, V294, P7, DOI 10.1016/j.jns.2010.04.013; Pashenkov M, 2001, BRAIN, V124, P480, DOI 10.1093/brain/124.3.480; Paun A, 2008, J BIOL CHEM, V283, P14295, DOI 10.1074/jbc.M800501200; PIDDLESDEN S, 1991, CLIN EXP IMMUNOL, V83, P245; Pohl M, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-85; Pohl M, 2011, ACTA NEUROPATHOL, V122, P21, DOI 10.1007/s00401-011-0824-0; Prehaud C, 2005, J VIROL, V79, P12893, DOI 10.1128/JVI.79.20.12893-12904.2005; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Raison CL, 2009, BIOL PSYCHIAT, V65, P296, DOI 10.1016/j.biopsych.2008.08.010; Ramgolam VS, 2009, J IMMUNOL, V183, P5418, DOI 10.4049/jimmunol.0803227; Ramsauer K, 2007, P NATL ACAD SCI USA, V104, P2849, DOI 10.1073/pnas.0610944104; Rani MRS, 2007, J LEUKOCYTE BIOL, V82, P1353, DOI 10.1189/jlb.0507273; Ratelade J, 2013, ACTA NEUROPATHOL, V126, P699, DOI 10.1007/s00401-013-1172-z; Redig AJ, 2009, J BIOL CHEM, V284, P10301, DOI 10.1074/jbc.M807254200; Ross TM, 2004, J NEUROIMMUNOL, V151, P66, DOI 10.1016/j.jneuroim.2004.02.011; Saadoun S, 2012, ANN NEUROL, V71, P323, DOI 10.1002/ana.22686; Sarasin-Filipowicz M, 2008, P NATL ACAD SCI USA, V105, P7034, DOI 10.1073/pnas.0707882105; Satoh J, 2008, NEUROPATHOLOGY, V28, P561, DOI 10.1111/j.1440-1789.2008.00915.x; Savarin C, 2013, ASN NEURO, V5, DOI 10.1042/AN20130033; Schick N, 2004, J BIOL CHEM, V279, P38787, DOI 10.1074/jbc.M312581200; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Sene D, 2007, RHEUMATOLOGY, V46, P65, DOI 10.1093/rheumatology/kel177; Shimizu J, 2010, NEUROLOGY, V75, P1423, DOI 10.1212/WNL.0b013e3181f8832e; Shimizu Y, 2008, J NEUROL, V255, P305, DOI 10.1007/s00415-007-0730-5; Strokin M, 2007, J NEUROCHEM, V102, P1771, DOI 10.1111/j.1471-4159.2007.04663.x; Strokin M, 2011, AM J PHYSIOL-CELL PH, V300, pC542, DOI 10.1152/ajpcell.00428.2010; Sun-Wada GH, 2009, J CELL SCI, V122, P2504, DOI 10.1242/jcs.050443; Takata Y, 2007, ARTHRITIS RHEUM-US, V56, P30, DOI 10.1002/art.22262; Takeyama K, 2003, J BIOL CHEM, V278, P21930, DOI 10.1074/jbc.M301157200; Tanaka M, 2009, EUR NEUROL, V62, P167, DOI 10.1159/000227277; Tecchio C, 2004, BLOOD, V103, P3837, DOI 10.1182/blood-2003-08-2806; Teige I, 2003, J IMMUNOL, V170, P4776, DOI 10.4049/jimmunol.170.9.4776; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Toubi E, 2006, J AUTOIMMUN, V27, P134, DOI 10.1016/j.jaut.2006.07.005; Usmani N, 2014, J NEUROL, V261, P240, DOI 10.1007/s00415-013-7202-x; Uzawa A, 2010, EUR J NEUROL, V17, P672, DOI 10.1111/j.1468-1331.2009.02897.x; Uzawa A, 2010, MULT SCLER J, V16, P1443, DOI 10.1177/1352458510379247; Vaknin-Dembinsky A, 2010, MULT SCLER, V16, P1453, DOI 10.1177/1352458510380416; Veldhuis TB, 2003, J CEREBR BLOOD F MET, V23, P1060, DOI 10.1097/01.WCB.0000080701.47016.24; Wagner E, 2010, NAT REV DRUG DISCOV, V9, P43, DOI 10.1038/nrd3011; Wang HH, 2012, J CLIN IMMUNOL, V32, P1007, DOI 10.1007/s10875-012-9709-9; Wang J, 2008, MOL PSYCHIATR, V13, P293, DOI 10.1038/sj.mp.4002013; Wang KC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098192; Witwer KW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008129; WOODS JW, 1993, J EXP MED, V178, P1935, DOI 10.1084/jem.178.6.1935; Wu LJ, 2009, STROKE, V40, P2973, DOI 10.1161/STROKEAHA.109.551747; Xu X, 2013, MOL CELLS, V36, P322, DOI 10.1007/s10059-013-0114-x; Xu Y, 2011, NEUROL SCI; Yamasaki Masayoshi, 2012, Rinsho Shinkeigaku, V52, P19; Yokoyama T, 2010, J PERIODONTAL RES, V45, P780, DOI 10.1111/j.1600-0765.2010.01300.x; Zeka B, 2015, ACTA NEUROPATHOL, V130, P783, DOI 10.1007/s00401-015-1501-5; Zhang H, 2011, ANN NEUROL, V70, P943, DOI 10.1002/ana.22551; Zheng H, 2011, MOL CELL BIOL, V31, P710, DOI 10.1128/MCB.01154-10	145	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151244	10.1371/journal.pone.0151244	http://dx.doi.org/10.1371/journal.pone.0151244			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990978	Green Published, Green Submitted, gold			2022-12-26	WOS:000372582800051
J	Thayer, KM; Beyer, GA				Thayer, Kelly M.; Beyer, George A.			Energetic Landscape of MDM2-p53 Interactions by Computational Mutagenesis of the MDM2-p53 Interaction	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITORS; TUMOR-SUPPRESSOR P53; IN-VIVO; P53-HDM2 INTERACTION; PEPTIDE INHIBITORS; ONCOPROTEIN MDM2; PROTEIN; CANCER; CELLS; DISCOVERY	The ubiquitin ligase MDM2, a principle regulator of the tumor suppressor p53, plays an integral role in regulating cellular levels of p53 and thus a prominent role in current cancer research. Computational analysis used MUMBO to rotamerize the MDM2-p53 crystal structure 1YCR to obtain an exhaustive search of point mutations, resulting in the calculation of the Delta Delta G comprehensive energy landscape for the p53-bound regulator. The results herein have revealed a set of residues R65-E69 on MDM2 proximal to the p53 hydrophobic binding pocket that exhibited an energetic profile deviating significantly from similar residues elsewhere in the protein. In light of the continued search for novel competitive inhibitors for MDM2, we discuss possible implications of our findings on the drug discovery field.	[Thayer, Kelly M.] Dept Chem, 124 Raymond Ave, Poughkeepsie, NY 12604 USA; [Beyer, George A.] Vassar Coll, Biochem Program, 124 Raymond Ave, Poughkeepsie, NY 12604 USA; [Thayer, Kelly M.] Wesleyan Univ, Hall Atwater Labs, Middletown, CT 06459 USA	Vassar College; Wesleyan University	Thayer, KM (corresponding author), Dept Chem, 124 Raymond Ave, Poughkeepsie, NY 12604 USA.; Thayer, KM (corresponding author), Wesleyan Univ, Hall Atwater Labs, Middletown, CT 06459 USA.	kthayer@wesleyan.edu						Allen JG, 2009, J MED CHEM, V52, P7044, DOI 10.1021/jm900681h; Almerico AM, 2012, BIOCHEM BIOPH RES CO, V424, P341, DOI 10.1016/j.bbrc.2012.06.138; Anil B, 2013, ACTA CRYSTALLOGR D, V69, P1358, DOI 10.1107/S0907444913004459; Aragam NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062427; Aziz MH, 2011, ONCOGENE, V30, P4678, DOI 10.1038/onc.2011.185; Beck B, 2006, QSAR COMB SCI, V25, P527, DOI 10.1002/qsar.200540300; Bizzarri AR, 2011, PHYS CHEM CHEM PHYS, V13, P2738, DOI 10.1039/c0cp01474e; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BUESORAMOS CE, 1993, BLOOD, V82, P2617; Chao CCK, 2015, CLIN CHIM ACTA, V438, P139, DOI 10.1016/j.cca.2014.08.015; Chee SMQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104914; Chen HB, 2011, DRUG DISCOV TODAY, V16, P354, DOI 10.1016/j.drudis.2010.02.009; Chen JZ, 2011, J MOL GRAPH MODEL, V30, P46, DOI 10.1016/j.jmgm.2011.06.003; Chene P, 2002, FEBS LETT, V529, P293, DOI 10.1016/S0014-5793(02)03362-8; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Cinatl J, 2014, BIOCHEM SOC T, V42, P752, DOI 10.1042/BST20140035; Dastidar SG, 2008, J AM CHEM SOC, V130, P13514, DOI 10.1021/ja804289g; DeLano WL, PYMOLMOLECULAR GRAPH; Ding K, 2006, J MED CHEM, V49, P3432, DOI 10.1021/jm051122a; Ding Q, 2013, DISCOVERY RG7388 POT, P4; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Furet P, 2012, BIOORG MED CHEM LETT, V22, P3498, DOI 10.1016/j.bmcl.2012.03.083; Garcia PB, 2014, SEMIN CELL DEV BIOL, V27, P74, DOI 10.1016/j.semcdb.2013.12.014; Grasberger BL, 2005, J MED CHEM, V48, P909, DOI 10.1021/jm049137g; Graves B, 2012, P NATL ACAD SCI USA, V109, P11788, DOI 10.1073/pnas.1203789109; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hoe KK, 2014, NAT REV DRUG DISCOV, V13, P217, DOI 10.1038/nrd4236; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hu GD, 2010, J COMPUT AID MOL DES, V24, P687, DOI 10.1007/s10822-010-9366-0; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Javid J, 2015, TUMOR BIOL, V36, P5425, DOI 10.1007/s13277-015-3208-6; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Khoury K, 2012, CURR PHARM DESIGN, V18, P4668, DOI 10.2174/138161212802651580; Koblish HK, 2006, MOL CANCER THER, V5, P160, DOI 10.1158/1535-7163.MCT-05-0199; Komarova EA, 1997, EMBO J, V16, P1391, DOI 10.1093/emboj/16.6.1391; Kritzer JA, 2004, J AM CHEM SOC, V126, P9468, DOI 10.1021/ja031625a; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Liu XR, 2013, NUCLEIC ACIDS RES, V41, P6034, DOI 10.1093/nar/gkt305; MacCallum DE, 1996, ONCOGENE, V13, P2575; MARCHETTI A, 1995, J PATHOL, V175, P31, DOI 10.1002/path.1711750106; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; McEvoy J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042739; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; Michaelis M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.35; Michaelis M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.129; Millard M, 2011, SMALL MOL INHIBITORS; Moller MB, 2002, HISTOPATHOLOGY, V41, P322, DOI 10.1046/j.1365-2559.2002.01506.x; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Nag S, 2014, CURR MED CHEM, V21, P553, DOI 10.2174/09298673113206660325; Okorokov AL, 2009, CURR OPIN STRUC BIOL, V19, P197, DOI 10.1016/j.sbi.2009.02.003; OLINER JD, 1993, NATURE, V362, P857, DOI 10.1038/362857a0; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Popowicz GM, 2011, ANGEW CHEM INT EDIT, V50, P2680, DOI 10.1002/anie.201003863; Popowicz GM, 2010, CELL CYCLE, V9, P1104, DOI 10.4161/cc.9.6.10956; PURDIE CA, 1994, ONCOGENE, V9, P603; REIFENBERGER G, 1993, CANCER RES, V53, P2736; Rew Y, 2014, J MED CHEM, V57, P6332, DOI 10.1021/jm500627s; Stiebritz MT, 2006, ACTA CRYSTALLOGR D, V62, P648, DOI 10.1107/S0907444906013333; Stiebritz MT, 2010, J MOL BIOL, V403, P371, DOI 10.1016/j.jmb.2010.07.055; Tao WK, 1999, P NATL ACAD SCI USA, V96, P3077, DOI 10.1073/pnas.96.6.3077; Unni S, 2012, NIH PUBLIC ACCESS, V32, P1488, DOI [10.1002/jcc.21720.Web, DOI 10.1002/JCC.21720.WEB]; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wasylyk C, 1999, ONCOGENE, V18, P1921, DOI 10.1038/sj.onc.1202528; Wei SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062564; Zhang ZM, 2014, ACS MED CHEM LETT, V5, P124, DOI 10.1021/ml400359z; Zhao YJ, 2013, J AM CHEM SOC, V135, P7223, DOI 10.1021/ja3125417; Zhong HZ, 2005, PROTEINS, V58, P222, DOI 10.1002/prot.20275	71	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0147806	10.1371/journal.pone.0147806	http://dx.doi.org/10.1371/journal.pone.0147806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992014	Green Published, Green Submitted, gold			2022-12-26	WOS:000372582800019
J	Zhang, DJ; Lees, RS; Xi, ZY; Bourtzis, K; Gilles, JRL				Zhang, Dongjing; Lees, Rosemary Susan; Xi, Zhiyong; Bourtzis, Kostas; Gilles, Jeremie R. L.			Combining the Sterile Insect Technique with the Incompatible Insect Technique: III-Robust Mating Competitiveness of Irradiated Triple Wolbachia-Infected Aedes albopictus Males under Semi-Field Conditions	PLOS ONE			English	Article							DENGUE VECTOR MOSQUITO; CYTOPLASMIC INCOMPATIBILITY; GENETIC MANIPULATION; DIELDRIN TREATMENT; GAMMA-RADIATION; FITNESS; ERADICATION; PERFORMANCE; RELEASE; DIPTERA	Combination of the sterile insect technique with the incompatible insect technique is considered to be a safe approach to control Aedes albopictus populations in the absence of an accurate and scalable sex separation system or genetic sexing strain. Our previous study has shown that the triple Wolbachia-infected Ae. albopictus strain (wAlbA, wAlbB and wPip) was suitable for mass rearing and females could be completely sterilized as pupae with a radiation dose of at least 28 Gy. However, whether this radiation dose can influence the mating competitiveness of the triple infected males was still unknown. In this study we aimed to evaluate the effects of irradiation on the male mating competitiveness of the triple infected strain under laboratory and semi-field conditions. The results herein indicate that irradiation with a lower, female-sterilizing dose has no negative impact on the longevity of triple infected males while a reduced lifespan was observed in the wild type males (wAlbA and wAlbB) irradiated with a higher male-sterilizing dose, in small cages. At different sterile: fertile release ratios in small cages, triple-infected males induced 39.8, 81.6 and 87.8% sterility in a wild type female population at 1:1, 5:1 and 10:1 release ratios, respectively, relative to a fertile control population. Similarly, irradiated triple infected males induced 31.3, 70.5 and 89.3% sterility at 1:1, 5:1 and 10:1 release ratios, respectively, again relative to the fertile control. Under semi-field conditions at a 5:1 release ratio, relative to wild type males, the mean male mating competitiveness index of 28 Gy irradiated triple-infected males was significantly higher than 35 Gy irradiated wild type males, while triple infected males showed no difference in mean mating competitiveness to either irradiated triple-infected or irradiated wild type males. An unexpected difference was also observed in the relative male mating competitiveness of the triple infected strain after irradiation at 28 Gy dose in small vs large cages, with a higher male mating competitiveness index calculated from results of experiments in the large cages. Based on these results, we consider that the male mating performance of the triple infected strain after irradiation at 28 Gy, a dose required for complete female sterility and the avoidance of population replacement, is approximately equal to that of the wild type males under semi-field conditions. Though field evaluation is required, this suggests that the triple infected strain is suitable for irradiation and release as part of a combined SIT-IIT approach to Ae. albopictus control.	[Zhang, Dongjing; Xi, Zhiyong] Sun Yat Sen Univ Michigan State Univ Joint Ctr Ve, Zhongshan Sch Med, Guangzhou, Guangdong, Peoples R China; [Zhang, Dongjing; Lees, Rosemary Susan; Bourtzis, Kostas; Gilles, Jeremie R. L.] Insect Pest Control Lab, Joint FAO IAEA Div Nucl Tech Food & Agr, Vienna, Austria; [Xi, Zhiyong] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA	Sun Yat Sen University; Food & Agriculture Organization of the United Nations (FAO); International Atomic Energy Agency; Michigan State University	Gilles, JRL (corresponding author), Insect Pest Control Lab, Joint FAO IAEA Div Nucl Tech Food & Agr, Vienna, Austria.	J.Gilles@iaea.org	Xi, Zhiyong/AAD-7936-2022; Lees, Rosemary Susan/H-3425-2019	Xi, Zhiyong/0000-0001-7786-012X; Lees, Rosemary Susan/0000-0002-4232-9125	National Institutes of Health/National Institute of Allergy and Infectious Disease [R01AI080597]; Chinese Ministry of Education [311030]; Guangdong Innovative Research Team Program [2011S009]; Scientific and Technological Leading Talents of Guangzhou Development District [2013L-P116]; Foundation for the NIH through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080597] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Chinese Ministry of Education(Ministry of Education, China); Guangdong Innovative Research Team Program; Scientific and Technological Leading Talents of Guangzhou Development District; Foundation for the NIH through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research in Prof. Zhiyong Xi's laboratory was supported by the National Institutes of Health/National Institute of Allergy and Infectious Disease R01AI080597, the Key Project of Chinese Ministry of Education (No. 311030), Guangdong Innovative Research Team Program (No. 2011S009), Scientific and Technological Leading Talents of Guangzhou Development District (No. 2013L-P116) and a grant from the Foundation for the NIH through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation.; The authors would like to thank David Damiens, Hanano Yamada, Maiga Hamidou and Minlin Zheng for collecting the GUA females in the large cages in the greenhouse at IPCL. Research in Prof. Zhiyong Xi's laboratory was supported by the National Institutes of Health/National Institute of Allergy and Infectious Disease R01AI080597, the Key Project of Chinese Ministry of Education (No. 311030), Guangdong Innovative Research Team Program (No. 2011S009), Scientific and Technological Leading Talents of Guangzhou Development District (No. 2013L-P116) and a grant from the Foundation for the NIH through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation.	ABDELMALEK AA, 1966, J ECON ENTOMOL, V59, P672, DOI 10.1093/jee/59.3.672; Andreasen MH, 2005, MED VET ENTOMOL, V19, P238, DOI 10.1111/j.1365-2915.2005.00565.x; Atyame CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119288; Balestrino F, 2010, J MED ENTOMOL, V47, P581, DOI 10.1603/ME09272; Bellini R, 2013, J MED ENTOMOL, V50, P94, DOI 10.1603/ME11058; Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562; Benedict MQ, 2003, TRENDS PARASITOL, V19, P349, DOI 10.1016/S1471-4922(03)00144-2; Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0; Blagrove MSC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002152; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Bourtzis K., 2006, INSECT SYMBIOSIS VOL, V2, P225, DOI DOI 10.1201/9781420005936.CH14; Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004; Boyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042040; Brelsfoard CL, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-38; Carrieri M, 2011, J MED ENTOMOL, V48, P1214, DOI 10.1603/ME10230; Chambers EW, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001271; Chapman T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000273; CRAIG GB, 1967, SCIENCE, V156, P1499, DOI 10.1126/science.156.3781.1499; Damiens D, 2013, J MED ENTOMOL, V50, P314, DOI 10.1603/ME12058; Dyck VA, 2005, STERILE INSECT QUALI, P269; Enserink M, 2014, SCIENCE, V344, P678, DOI 10.1126/science.344.6185.678; FAO/IAEA/USDA, 2019, PROD QUAL CONTR STER; FRIED M, 1971, J ECON ENTOMOL, V64, P869, DOI 10.1093/jee/64.4.869; Gasperi G, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001836; Gilles JRL, 2014, ACTA TROP, V132, pS178, DOI 10.1016/j.actatropica.2013.08.015; Helinski MEH, 2008, J MED ENTOMOL, V45, P698, DOI 10.1603/0022-2585(2008)45[698:MCOMAA]2.0.CO;2; Helinski MEH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-41; Helinski MEH, 2008, REPROD BIOL INDUCED, V11, P166; Helinski MEH, 2012, AM J TROP MED HYG, V86, P635, DOI 10.4269/ajtmh.2012.11-0225; Jin X, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.3; Joshi D, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-336; KNIPLING EF, 1968, B WORLD HEALTH ORGAN, V38, P421; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0; Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011; Madakacherry O, 2014, ACTA TROP, V132, pS124, DOI 10.1016/j.actatropica.2013.11.020; Maiga H, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-460; Moretti R, 2013, MED VET ENTOMOL, V27, P377, DOI 10.1111/j.1365-2915.2012.01061.x; O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797; Oliva CF, 2014, ACTA TROP, V132, pS12, DOI 10.1016/j.actatropica.2013.11.021; Oliva CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078884; Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414; Ponlawat A, 2009, AM J TROP MED HYG, V80, P395, DOI 10.4269/ajtmh.2009.80.395; Rendon P, 2004, J ECON ENTOMOL, V97, P1547, DOI 10.1603/0022-0493-97.5.1547; Segoli M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003294; SHARMA VP, 1978, J ECON ENTOMOL, V71, P449, DOI 10.1093/jee/71.3.449; Sow A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037124; Xi ZY, 2006, P R SOC B, V273, P1317, DOI 10.1098/rspb.2005.3405; Yamada H, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-318; Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135194; Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121126	51	107	112	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151864	10.1371/journal.pone.0151864	http://dx.doi.org/10.1371/journal.pone.0151864			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990981	Green Submitted, Green Published, gold			2022-12-26	WOS:000372582800111
J	Rajasekaran, D; Jariwala, N; Mendoza, RG; Robertson, CL; Akiel, MA; Dozmorov, M; Fisher, PB; Sarkar, D				Rajasekaran, Devaraja; Jariwala, Nidhi; Mendoza, Rachel G.; Robertson, Chadia L.; Akiel, Maaged A.; Dozmorov, Mikhail; Fisher, Paul B.; Sarkar, Devanand			Staphylococcal Nuclease and Tudor Domain Containing 1 (SND1 Protein) Promotes Hepatocarcinogenesis by Inhibiting Monoglyceride Lipase (MGLL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCELLULAR-CARCINOMA; MONOACYLGLYCEROL LIPASE; COMPONENT; INSIGHTS; CANCER; IDENTIFICATION; ANGIOGENESIS; ABERRATIONS; METASTASIS; DOWNSTREAM	Staphylococcal nuclease and tudor domain containing 1 (SND1) is overexpressed in multiple cancers, including hepatocellular carcinoma (HCC), and functions as an oncogene. This study was carried out to identify novel SND1-interacting proteins to better understand its molecular mechanism of action. SND1-interacting proteins were identified by a modified yeast two-hybrid assay. Protein-protein interaction was confirmed by co-immunoprecipitation analysis. Monoglyceride lipase (MGLL) expression was analyzed by quantitative RT-PCR, Western blot, and immunohistochemistry. MGLL-overexpressing clones were analyzed for cell proliferation and cell cycle analysis and in vivo tumorigenesis in nude mice. MGLL was identified as an SND1-interacting protein. Interaction of SND1 with MGLL resulted in ubiquitination and proteosomal degradation of MGLL. MGLL expression was detected in normal human hepatocytes and mouse liver, although it was undetected in human HCC cell lines. An inverse correlation between SND1 and MGLL levels was identified in a human HCC tissue microarray as well as in the TCGA database. Forced overexpression of MGLL in human HCC cells resulted in marked inhibition in cell proliferation with a significant delay in cell cycle progression and a marked decrease in tumor growth in nude mouse xenograft assays. MGLL overexpression inhibited Akt activation that is independent of enzymatic activity of MGLL and overexpression of a constitutively active Akt rescued cells from inhibition of proliferation and restored normal cell cycle progression. This study unravels a novel mechanism of SND1 function and identifies MGLL as a unique tumor suppressor for HCC. MGLL might function as a homeostatic regulator of Akt restraining its activation.	[Rajasekaran, Devaraja; Jariwala, Nidhi; Mendoza, Rachel G.; Robertson, Chadia L.; Akiel, Maaged A.; Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, Dept Human & Mol Genet, 1220 East Broad St,POB 980035, Richmond, VA 23298 USA; [Dozmorov, Mikhail] Virginia Commonwealth Univ, Dept Biostat, Richmond, VA 23298 USA; [Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Fisher, Paul B.; Sarkar, Devanand] Virginia Commonwealth Univ, VCU Inst Mol Med, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Sarkar, D (corresponding author), Virginia Commonwealth Univ, Dept Human & Mol Genet, 1220 East Broad St,POB 980035, Richmond, VA 23298 USA.	devanand.sarkar@vcuhealth.org	Dozmorov, Mikhail/B-1374-2009; Akiel, Maaged/B-5109-2014	Dozmorov, Mikhail/0000-0002-0086-8358; Akiel, Maaged/0000-0002-0211-2837	James S. McDonnell Foundation; NCI from National Institutes of Health [R01 CA138540, R21 CA183954, R01 CA134721]; National Foundation for Cancer Research; NIDDK from National Institutes of Health [T32DK007150]; NATIONAL CANCER INSTITUTE [R21CA183954, R01CA138540, R01CA134721] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007150] Funding Source: NIH RePORTER	James S. McDonnell Foundation; NCI from National Institutes of Health; National Foundation for Cancer Research; NIDDK from National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by The James S. McDonnell Foundation, NCI Grants R01 CA138540 and R21 CA183954 (to D. S.) and R01 CA134721 (to P. B. F.) from National Institutes of Health, and the National Foundation for Cancer Research (to P. B. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by NIDDK Grant T32DK007150 from National Institutes of Health.	Blanco MA, 2011, J BIOL CHEM, V286, P19982, DOI 10.1074/jbc.M111.240077; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; Guo F, 2014, CELL REP, V8, P1704, DOI 10.1016/j.celrep.2014.08.033; Hashimoto K, 2004, MODERN PATHOL, V17, P617, DOI 10.1038/modpathol.3800107; Jariwala N, 2015, INT J ONCOL, V46, P465, DOI 10.3892/ijo.2014.2766; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Kuruma H, 2009, AM J PATHOL, V174, P2044, DOI 10.2353/ajpath.2009.080776; Labar G, 2010, CHEMBIOCHEM, V11, P218, DOI 10.1002/cbic.200900621; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li CL, 2008, NUCLEIC ACIDS RES, V36, P3579, DOI 10.1093/nar/gkn236; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Patil MA, 2005, CARCINOGENESIS, V26, P2050, DOI 10.1093/carcin/bgi178; Paukku K, 2003, MOL ENDOCRINOL, V17, P1805, DOI 10.1210/me.2002-0256; Pek JW, 2012, DEVELOPMENT, V139, P2255, DOI 10.1242/dev.073304; Petrenko AB, 2014, BEHAV BRAIN RES, V271, P51, DOI 10.1016/j.bbr.2014.05.063; Quiroga AD, 2012, BBA-MOL CELL BIOL L, V1821, P762, DOI 10.1016/j.bbalip.2011.09.007; Rajasekaran D, 2015, ONCOTARGET, V6, P26266, DOI 10.18632/oncotarget.4656; Santhekadur PK, 2014, FEBS OPEN BIO, V4, P353, DOI 10.1016/j.fob.2014.03.012; Santhekadur PK, 2012, J BIOL CHEM, V287, P13952, DOI 10.1074/jbc.M111.321646; Srivastava J, 2014, CANCER RES, V74, P4364, DOI 10.1158/0008-5472.CAN-14-0421; Srivastava J, 2012, HEPATOLOGY, V56, P1782, DOI 10.1002/hep.25868; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Sun H, 2013, ONCOGENE, V32, P234, DOI 10.1038/onc.2012.34; Sundstrom JF, 2009, NAT CELL BIOL, V11, P1347, DOI 10.1038/ncb1979; Tsuchiya N, 2007, CANCER RES, V67, P9568, DOI 10.1158/0008-5472.CAN-06-2707; Villanueva A, 2007, SEMIN LIVER DIS, V27, P55, DOI 10.1055/s-2006-960171; Wan LL, 2014, CANCER CELL, V26, P92, DOI 10.1016/j.ccr.2014.04.027; Yang J, 2002, EMBO J, V21, P4950, DOI 10.1093/emboj/cdf463; Yoo BK, 2011, HEPATOLOGY, V53, P1538, DOI 10.1002/hep.24216; Yoo BK, 2009, J CLIN INVEST, V119, P465, DOI 10.1172/JCI36460; Yu L, 2015, CANCER RES, V75, P1275, DOI 10.1158/0008-5472.CAN-14-2387; Zhu YT, 2014, NAT METHODS, V11, P599, DOI 10.1038/nmeth.2956	33	26	26	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10736	10746		10.1074/jbc.M116.715359	http://dx.doi.org/10.1074/jbc.M116.715359			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26997225	hybrid, Green Published			2022-12-26	WOS:000377042600025
J	Ledger, AEW; Scurr, ED; Hughes, J; Macdonald, A; Wallace, T; Thomas, K; Wilson, R; Leach, MO; Schmidt, MA				Ledger, Araminta E. W.; Scurr, Erica D.; Hughes, Julie; Macdonald, Alison; Wallace, Toni; Thomas, Karen; Wilson, Robin; Leach, Martin O.; Schmidt, Maria A.			Comparison of Dixon Sequences for Estimation of Percent Breast Fibroglandular Tissue	PLOS ONE			English	Article							WATER-FAT SEPARATION; MAMMOGRAPHIC DENSITY; CANCER RISK; WOMEN; VOLUME	Objectives To evaluate sources of error in the Magnetic Resonance Imaging (MRI) measurement of percent fibroglandular tissue (% FGT) using two-point Dixon sequences for fat-water separation. Methods Ten female volunteers (median age: 31 yrs, range: 23-50 yrs) gave informed consent following Research Ethics Committee approval. Each volunteer was scanned twice following repositioning to enable an estimation of measurement repeatability from high-resolution gradient-echo (GRE) proton-density (PD)-weighted Dixon sequences. Differences in measures of % FGT attributable to resolution, T-1 weighting and sequence type were assessed by comparison of this Dixon sequence with low-resolution GRE PD-weighted Dixon data, and against gradient-echo (GRE) or spin-echo (SE) based T-1-weighted Dixon datasets, respectively. Results % FGT measurement from high-resolution PD-weighted Dixon sequences had a coefficient of repeatability of +/- 4.3%. There was no significant difference in % FGT between high-resolution and low-resolution PD-weighted data. Values of % FGT from GRE and SE T-1-weighted data were strongly correlated with that derived from PD-weighted data (r = 0.995 and 0.96, respectively). However, both sequences exhibited higher mean % FGT by 2.9% (p < 0.0001) and 12.6%(p < 0.0001), respectively, in comparison with PD-weighted data; the increase in % FGT from the SE T-1-weighted sequence was significantly larger at lower breast densities. Conclusion Although measurement of % FGT at low resolution is feasible, T-1 weighting and sequence type impact on the accuracy of Dixon-based % FGT measurements; Dixon MRI protocols for % FGT measurement should be carefully considered, particularly for longitudinal or multicentre studies.	[Ledger, Araminta E. W.; Leach, Martin O.; Schmidt, Maria A.] Inst Canc Res, CR UK Canc Imaging Ctr, London SW3 6JB, England; [Ledger, Araminta E. W.; Leach, Martin O.; Schmidt, Maria A.] Royal Marsden NHS Fdn Trust, London, England; [Scurr, Erica D.; Hughes, Julie; Macdonald, Alison; Wallace, Toni; Wilson, Robin] Royal Marsden NHS Fdn Trust, Dept Radiol, London, England; [Thomas, Karen] Royal Marsden NHS Fdn Trust, Clin Res & Dev, London, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust	Leach, MO (corresponding author), Inst Canc Res, CR UK Canc Imaging Ctr, London SW3 6JB, England.; Leach, MO (corresponding author), Royal Marsden NHS Fdn Trust, London, England.	Martin.Leach@icr.ac.uk	leach, martin o/C-2248-2008	leach, martin o/0000-0002-0756-5368	Cancer Research UK (CR UK); Engineering and Physical Sciences Research Council (EPSRC); Royal Marsden National Health Service (NHS) Foundation Trust; Medical Research Council (MRC) & Department of Health [C1060/A10334, C1060/A16464]; NIHR Transitional Research Fellowship [TRF-2013-06-003]; Cancer Research UK (CR UK) and Engineering; Cancer Imaging Centre at The Institute of Cancer Research (ICR); National Institute of Health Research (NIHR) Biomedical Research Centre; Clinical Research Facility in Imaging; EPSRC [EP/E035736/1] Funding Source: UKRI; MRC [G0701533] Funding Source: UKRI; Cancer Research UK [16464] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/E035736/1] Funding Source: researchfish; Medical Research Council [G0701533] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10162, TRF-2013-06-003] Funding Source: researchfish	Cancer Research UK (CR UK)(Cancer Research UK); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Marsden National Health Service (NHS) Foundation Trust; Medical Research Council (MRC) & Department of Health(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Transitional Research Fellowship; Cancer Research UK (CR UK) and Engineering; Cancer Imaging Centre at The Institute of Cancer Research (ICR); National Institute of Health Research (NIHR) Biomedical Research Centre(National Institute for Health Research (NIHR)); Clinical Research Facility in Imaging; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study presents independent research which received Cancer Research UK (CR UK) and Engineering and Physical Sciences Research Council (EPSRC) support to the Cancer Imaging Centre at The Institute of Cancer Research (ICR) and The Royal Marsden National Health Service (NHS) Foundation Trust in association with the Medical Research Council (MRC) & Department of Health C1060/A10334, C1060/A16464 and NHS funding to the National Institute of Health Research (NIHR) Biomedical Research Centre and the Clinical Research Facility in Imaging, and NIHR Transitional Research Fellowship TRF-2013-06-003 awarded to Dr Araminta EW Ledger. Prof. Martin O Leach is an NIHR Senior Investigator. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study presents independent research which received Cancer Research UK (CR UK) and Engineering and Physical Sciences Research Council (EPSRC) support to the Cancer Imaging Centre at The Institute of Cancer Research (ICR) and The Royal Marsden National Health Service (NHS) Foundation Trust in association with the Medical Research Council (MRC) & Department of Health C1060/A10334, C1060/A16464 and NHS funding to the National Institute of Health Research (NIHR) Biomedical Research Centre and the Clinical Research Facility in Imaging, and NIHR Transitional Research Fellowship TRF-2013-06-003 awarded to Dr Araminta EW Ledger. Prof. Martin O Leach is an NIHR Senior Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr Karen Thomas, one of the authors, has significant statistical expertise; the authors would also like to acknowledge Dr Matthew Orton for helpful statistical discussion.	Aliu SO, 2014, TRANSL ONCOL, V7, P130, DOI 10.1593/tlo.13841; Boyd N, 2009, LANCET ONCOL, V10, P569, DOI 10.1016/S1470-2045(09)70078-6; Boyd NF, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2942; Boyd NF, 2010, JNCI-J NATL CANCER I, V102, P1224, DOI 10.1093/jnci/djq239; Byng JW, 1998, RADIOGRAPHICS, V18, P1587, DOI 10.1148/radiographics.18.6.9821201; Chang DHE, 2011, MED PHYS, V38, P5961, DOI 10.1118/1.3646756; Clendenen TV, 2013, J MAGN RESON IMAGING, V38, P474, DOI 10.1002/jmri.24002; Eggers H, 2011, MAGN RESON MED, V65, P96, DOI 10.1002/mrm.22578; Eng-Wong J, 2008, CANCER EPIDEM BIOMAR, V17, P1696, DOI 10.1158/1055-9965.EPI-07-2752; Ertas G, 2010, IFMBE PROC, V25, P1893; Graham SJ, 1996, BRIT J CANCER, V73, P162, DOI 10.1038/bjc.1996.30; Graham SJ, 1995, JMRI-J MAGN RESON IM, V5, P695, DOI 10.1002/jmri.1880050613; Khazen M, 2008, CANCER EPIDEM BIOMAR, V17, P2268, DOI 10.1158/1055-9965.EPI-07-2547; Klifa C, 2004, P ANN INT IEEE EMBS, V26, P1667; Klifa C, 2010, MAGN RESON IMAGING, V28, P8, DOI 10.1016/j.mri.2009.05.040; Lu LJW, 2012, PHYS MED BIOL, V57, P6903, DOI 10.1088/0031-9155/57/21/6903; Ma JF, 2004, MAGN RESON MED, V52, P415, DOI 10.1002/mrm.20146; Ma JF, 2008, J MAGN RESON IMAGING, V28, P543, DOI 10.1002/jmri.21492; McCormack VA, 2006, CANCER EPIDEM BIOMAR, V15, P1159, DOI 10.1158/1055-9965.EPI-06-0034; Nie K, 2008, MED PHYS, V35, P5253, DOI 10.1118/1.3002306; POON CS, 1989, MAGN RESON IMAGING, V7, P369, DOI 10.1016/0730-725X(89)90486-4; Reeder SB, 2007, J MAGN RESON IMAGING, V25, P644, DOI 10.1002/jmri.20831; Roulston MS, 1999, PHYSICA D, V125, P285, DOI 10.1016/S0167-2789(98)00269-3; Saranathan M, 2014, J MAGN RESON IMAGING, V40, P1392, DOI 10.1002/jmri.24490; Sickles EA, 2013, ACR BI RADS ATLAS BR; Skippage P, 2013, BREAST J, V19, P79, DOI 10.1111/tbj.12046; Tagliafico A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099027; Thompson DJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2447; Wang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081653; Wei J, 2004, MED PHYS, V31, P933, DOI 10.1118/1.1668512; Wengert GJ, 2015, INVEST RADIOL, V50, P73, DOI 10.1097/RLI.0000000000000102; Yang IY, 2014, J MAGN RESON IMAGING, V39, P217, DOI 10.1002/jmri.24126; Yao JH, 2005, PROC SPIE, V5747, P1942, DOI 10.1117/12.594671; Yu HZ, 2008, MAGN RESON MED, V60, P1122, DOI 10.1002/mrm.21737	34	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152152	10.1371/journal.pone.0152152	http://dx.doi.org/10.1371/journal.pone.0152152			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27011312	Green Published, Green Submitted, gold			2022-12-26	WOS:000372708000098
J	Uchida, Y; Uchida, Y; Shimoyama, E; Hiruta, N; Kishimoto, T; Watanabe, S				Uchida, Yasumi; Uchida, Yasuto; Shimoyama, Ei; Hiruta, Nobuyuki; Kishimoto, Toshihiko; Watanabe, Soichiro			Pericoronary Adipose Tissue as Storage and Supply Site for Oxidized Low-Density Lipoprotein in Human Coronary Plaques	PLOS ONE			English	Article							ATHEROSCLEROTIC LESIONS; ARTERY-DISEASE; LDL; MACROPHAGES	Objectives It is generally believed that low-density lipoprotein enters the vascular wall from its lumen and oxidized (oxLDL), after which it plays an important role in atherosclerosis. Because voluminous epicardial adipose tissue is a risk factor for coronary events, there is a possibility that the pericoronary adipose tissue (PCAT), which is a part of epicardial adipose tissue, acts as a risk factor by supplying oxLDL to the coronary arterial wall. The present study was performed whether PCAT stores and supplies oxLDL to the coronary wall. Methods Localization of oxLDL in PCAT and its relation to plaque morphology were examined by immunohistochemical techniques in 27 epicardial coronary arteries excised from 9 human autopsy cases. Results OxLDL deposited in all PCAT of the studied cases. The percent (%) incidence of oxLDL in the intima of 25 normal segment, 19 white plaques, 15 yellow plaques without necrotic core (NC) and 10 yellow plaques with NC, was 32, 84, 93 (p<0.05 vs normal segments and yellow plaques with NC), and 30, respectively. OxLDL deposited either in dotted or diffuse pattern. Double immunohistochemical staining revealed that the dotted oxLDL was that contained in CD68(+)-macrophages. The oxLDL-containing macrophages were observed in the interstitial space but not inside of the vasa vasorum, and they traversed PCAT, adventitia, external and internal elastic laminae, suggesting their migration towards the intima. Diffuse oxLDL deposits were observed in 17 preparations, the majority of which were co-localized with the vasa vasorum in outer or in both inner and outer halves of intima, and rarely in the inner half alone. Conclusions The results suggested that PCAT is a supply source of oxLDL to coronary intima and acts as a risk factor for coronary events, that oxLDL increasingly deposits in the intima with plaque growth and decreases after plaque maturation, and therefore molecular therapies targeting the PCAT before plaque growth could be effective in preventing human coronary atherosclerosis.	[Uchida, Yasumi] Japanese Fdn Cardiovasc Res, Funabashi, Chiba, Japan; [Uchida, Yasumi] Tokyo Jikei Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Uchida, Yasuto] Tsukuba Mem Hosp, Dept Cardiol, Tsukuba, Ibaraki, Japan; [Shimoyama, Ei] Funabashi Futawa Hosp, Dept Pathol, Funabashi, Chiba, Japan; [Hiruta, Nobuyuki] Toho Univ, Sakura Med Ctr, Dept Pathol, Sakura, Japan; [Kishimoto, Toshihiko; Watanabe, Soichiro] Toho Univ, Fac Sci, Dept Biomol Sci, Funabashi, Chiba 274, Japan	Jikei University; Toho University; Toho University	Uchida, Y (corresponding author), Japanese Fdn Cardiovasc Res, Funabashi, Chiba, Japan.; Uchida, Y (corresponding author), Tokyo Jikei Univ, Sch Med, Dept Cardiol, Tokyo, Japan.	uchida73@ta2.so-net.ne.jp						Bourlier V, 2008, CIRCULATION, V117, P806, DOI 10.1161/CIRCULATIONAHA.107.724096; BOYD HC, 1989, AM J PATHOL, V135, P815; Chen JH, 2009, ARTERIOSCL THROM VAS, V29, P92, DOI 10.1161/ATVBAHA.108.174599; Cho KH, 2009, BMB REP, V42, P393, DOI 10.5483/BMBRep.2009.42.7.393; De Paoli F, 2014, CIRC J, V78, P1775, DOI 10.1253/circj.CJ-14-0621; Donne D, 1985, J BIOL CHEM, V260, P2891; FUSTER V, 1992, NEW ENGL J MED, V326, P242, DOI 10.1056/NEJM199201233260406; Halvorsen B, 2008, PROG CARDIOVASC DIS, V51, P183, DOI 10.1016/j.pcad.2008.09.001; Holness CL, 1993, BLOOD, V15, P1603; Li J, 2015, INT J CLIN EXP PATHO, V8, P11386; Li W, 1998, ARTERIOSCL THROM VAS, V18, P177, DOI 10.1161/01.ATV.18.2.177; Libby P., 2015, HEART DIS, P873; Matsuura E, 2008, AUTOIMMUN REV, V7, P558, DOI 10.1016/j.autrev.2008.04.018; Park YM, 2009, J CLIN INVEST, V119, P136, DOI 10.1172/JCI35535; Peng ZY, 2011, MOL CELL BIOCHEM, V351, P243, DOI 10.1007/s11010-011-0731-7; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Romijn MA, 2015, ATHEROSCLEROSIS, V242, P161, DOI 10.1016/j.atherosclerosis.2015.07.005; Shah PK, 2009, CARDIOVASC DRUG THER, V23, P31, DOI 10.1007/s10557-008-6147-2; Szasz T, 2012, CLIN SCI, V122, P1, DOI 10.1042/CS20110151; Tada Y, 2014, EXPERT OPIN INV DRUG, V23, P149, DOI 10.1517/13543784.2014.855196; Takahashi Kiyoshi, 2002, Medical Electron Microscopy, V35, P179, DOI 10.1007/s007950200023; Toth PP, 2010, J CLIN LIPIDOL, V4, P359, DOI 10.1016/j.jacl.2010.08.002; UCHIDA Y, 1995, AM HEART J, V130, P1114, DOI 10.1016/0002-8703(95)90216-3; Uchida Y, 1995, ATLAS CARDIOANGIOSCO, P164; Uchida Y, 2001, CORONARY ANGIOSCOPY, P11; Uchida Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055188; Uchida Y, 2010, JACC-CARDIOVASC IMAG, V3, P398, DOI 10.1016/j.jcmg.2009.09.030; Verhagen SN, 2011, ATHEROSCLEROSIS, V214, P3, DOI 10.1016/j.atherosclerosis.2010.05.034; Yamada H, 2015, J CARDIOL, V65, P2, DOI 10.1016/j.jjcc.2014.07.004; Yoshida H, 2011, CHIMICA ACTA, V411, P1875	30	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0150862	10.1371/journal.pone.0150862	http://dx.doi.org/10.1371/journal.pone.0150862			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010927	Green Published, gold			2022-12-26	WOS:000372708000023
J	Zhou, Y; Dong, GC; Tao, YJ; Chen, C; Yang, B; Wu, Y; Yang, ZF; Liang, GH; Wang, BH; Wang, YL				Zhou, Yong; Dong, Guichun; Tao, Yajun; Chen, Chen; Yang, Bin; Wu, Yue; Yang, Zefeng; Liang, Guohua; Wang, Baohe; Wang, Yulong			Mapping Quantitative Trait Loci Associated with Toot Traits Using Sequencing-Based Genotyping Chromosome Segment Substitution Lines Derived from 9311 and Nipponbare in Rice (Oryza sativa L.)	PLOS ONE			English	Article							ROOT-SYSTEM ARCHITECTURE; GRAIN-YIELD; GENETIC-IMPROVEMENT; DROUGHT RESISTANCE; WATER-DEFICIT; UPLAND RICE; QTL; IDENTIFICATION; POPULATION; GROWTH	Identification of quantitative trait loci (QTLs) associated with rice root morphology provides useful information for avoiding drought stress and maintaining yield production under the irrigation condition. In this study, a set of chromosome segment substitution lines derived from 9311 as the recipient and Nipponbare as donor, were used to analysis root morphology. By combining the resequencing-based bin-map with a multiple linear regression analysis, QTL identification was conducted on root number (RN), total root length (TRL), root dry weight (RDW), maximum root length (MRL), root thickness (RTH), total absorption area (TAA) and root vitality (RV), using the CSSL population grown under hydroponic conditions. A total of thirty-eight QTLs were identified: six for TRL, six for RDW, eight for the MRL, four for RTH, seven for RN, two for TAA, and five for RV. Phenotypic effect variance explained by these QTLs ranged from 2.23% to 37.08%, and four single QTLs had more than 10% phenotypic explanations on three root traits. We also detected the correlations between grain yield (GY) and root traits, and found that TRL, RTH and MRL had significantly positive correlations with GY. However, TRL, RDW and MRL had significantly positive correlations with biomass yield (BY). Several QTLs identified in our population were co-localized with some loci for grain yield or biomass. This information may be immediately exploited for improving rice water and fertilizer use efficiency for molecular breeding of root system architectures.	[Zhou, Yong; Dong, Guichun; Tao, Yajun; Chen, Chen; Yang, Bin; Wu, Yue; Yang, Zefeng; Liang, Guohua; Wang, Yulong] Yangzhou Univ, Jiangsu Key Lab Crop Genet & Physiol, Coinnovat Ctr Modern Prod Technol Grain Crops, Key Lab Plant Funct Gen,Minist Educ, Yangzhou 225009, Jiangsu, Peoples R China; [Wang, Baohe] Lixiahe Agr Res Inst Jiangsu Prov, Yangzhou 225007, Jiangsu, Peoples R China	Yangzhou University	Wang, YL (corresponding author), Yangzhou Univ, Jiangsu Key Lab Crop Genet & Physiol, Coinnovat Ctr Modern Prod Technol Grain Crops, Key Lab Plant Funct Gen,Minist Educ, Yangzhou 225009, Jiangsu, Peoples R China.; Wang, BH (corresponding author), Lixiahe Agr Res Inst Jiangsu Prov, Yangzhou 225007, Jiangsu, Peoples R China.	wangbhyznks@126.com; ylwang@yzu.edu.cn		Yang, Zefeng/0000-0002-3465-8594	973 program [2013CBA01405]; National Natural Science Foundation of China [31271679, 31471458]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by grants from the 973 program (2013CBA01405), the National Natural Science Foundation of China (31271679, 31471458), and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Arai-Sanoh Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05563; Bouman B.A., 2007, RICE FEEDING BILLION; CHAMPOUX MC, 1995, THEOR APPL GENET, V90, P969, DOI 10.1007/BF00222910; Chloupek O, 2006, THEOR APPL GENET, V112, P779, DOI 10.1007/s00122-005-0147-4; Chung PJ, 2009, PLANT J, V59, P764, DOI 10.1111/j.1365-313X.2009.03908.x; Coudert Y, 2010, TRENDS PLANT SCI, V15, P219, DOI 10.1016/j.tplants.2010.01.008; Courtois B, 2003, EUPHYTICA, V134, P335, DOI 10.1023/B:EUPH.0000004987.88718.d6; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; Courtois B, 2009, RICE, V2, P115, DOI 10.1007/s12284-009-9028-9; Dai GuiJin, 2008, Journal of Shenyang Agricultural University, V39, P515; de Dorlodot S, 2007, TRENDS PLANT SCI, V12, P474, DOI 10.1016/j.tplants.2007.08.012; Dixit S, 2012, THEOR APPL GENET, V125, P155, DOI 10.1007/s00122-012-1823-9; Dong GuiChun, 2011, Scientia Agricultura Sinica, V44, P4570; Gowda VRP, 2011, FIELD CROP RES, V122, P1, DOI 10.1016/j.fcr.2011.03.001; Hao W, 2009, J INTEGR PLANT BIOL, V51, P500, DOI 10.1111/j.1744-7909.2009.00822.x; Hittalmani S, 2003, THEOR APPL GENET, V107, P679, DOI 10.1007/s00122-003-1269-1; Huang J, 2013, PLANTA, V237, P1227, DOI 10.1007/s00425-013-1838-8; Inukai Y, 2005, PLANT CELL, V17, P1387, DOI 10.1105/tpc.105.030981; Kamoshita A, 2002, CROP SCI, V42, P255, DOI 10.2135/cropsci2002.0255; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; Kitomi Y, 2008, PLANT ROOT, V2, P19, DOI 10.3117/plantroot.2.19; Kraiser T, 2011, J EXP BOT, V62, P1455, DOI 10.1093/jxb/erq425; Li M, 2011, THEOR APPL GENET, V123, P411, DOI 10.1007/s00122-011-1593-9; Liang YS, 2013, GENE, V526, P331, DOI 10.1016/j.gene.2013.04.010; LILLEY JM, 1994, FIELD CROP RES, V37, P205, DOI 10.1016/0378-4290(94)90099-X; Liu SP, 2009, CELL RES, V19, P1110, DOI 10.1038/cr.2009.70; MacMillan K, 2006, THEOR APPL GENET, V113, P953, DOI 10.1007/s00122-006-0357-4; Marzougui S, 2012, THEOR APPL GENET, V124, P893, DOI 10.1007/s00122-011-1753-y; Morita Y, 2007, PLANT CELL PHYSIOL, V48, P540, DOI 10.1093/pcp/pcm024; Nakamura A, 2006, PLANT J, V46, P297, DOI 10.1111/j.1365-313X.2006.02693.X; Obara M, 2010, THEOR APPL GENET, V121, P535, DOI 10.1007/s00122-010-1328-3; OTOOLE JC, 1987, ADV AGRON, V41, P91, DOI 10.1016/S0065-2113(08)60803-2; Price AH, 2002, FIELD CROP RES, V76, P25, DOI 10.1016/S0378-4290(02)00010-2; Price AH, 1997, THEOR APPL GENET, V95, P143, DOI 10.1007/s001220050542; Qi YH, 2012, NEW PHYTOL, V193, P109, DOI 10.1111/j.1469-8137.2011.03910.x; Samejima H, 2004, SOIL SCI PLANT NUTR, V50, P545, DOI 10.1080/00380768.2004.10408511; Sandhu N, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-104; Steele KA, 2013, THEOR APPL GENET, V126, P101, DOI 10.1007/s00122-012-1963-y; Uga Y, 2013, NAT GENET, V45, P1097, DOI 10.1038/ng.2725; Uga Y, 2012, THEOR APPL GENET, V124, P75, DOI 10.1007/s00122-011-1688-3; Uga Y, 2011, J EXP BOT, V62, P2485, DOI 10.1093/jxb/erq429; Uga Y, 2010, MOL BREEDING, V26, P533, DOI 10.1007/s11032-010-9450-0; Venuprasad R, 2002, EUPHYTICA, V128, P293, DOI 10.1023/A:1021281428957; Venuprasad R, 2009, THEOR APPL GENET, V120, P177, DOI 10.1007/s00122-009-1168-1; Wan XY, 2004, THEOR APPL GENET, V110, P71, DOI 10.1007/s00122-004-1744-3; Wang JK, 2006, GENET RES, V88, P93, DOI 10.1017/S0016672306008408; Wang XF, 2011, MOL PLANT, V4, P289, DOI 10.1093/mp/ssq068; Wu WeiMing, 2005, Chinese Journal of Rice Science, V19, P174; Xiao L.T, 2005, PLANT PHYSL EXPT TEC, P61; Xing YZ, 2002, THEOR APPL GENET, V105, P248, DOI 10.1007/s00122-002-0952-y; Xu JJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-656; Yadav R, 1997, THEOR APPL GENET, V94, P619, DOI 10.1007/s001220050459; Yamamoto T, 2000, GENETICS, V154, P885; YAMBAO EB, 1992, J EXP BOT, V43, P925, DOI 10.1093/jxb/43.7.925; Yang CM, 2004, AGR WATER MANAGE, V70, P67, DOI 10.1016/j.agwat.2004.05.003; Ye GY, 2010, THEOR APPL GENET, V121, P741, DOI 10.1007/s00122-010-1345-2; Yue B, 2006, GENETICS, V172, P1213, DOI 10.1534/genetics.105.045062; Zhang H, 2011, J GENET GENOMICS, V38, P603, DOI 10.1016/j.jgg.2011.11.004; Zhang JDL G.P, 1982, EXPT METHOD PLANT PH, P52; Zhao HM, 2015, PLANT CELL ENVIRON, V38, P2208, DOI 10.1111/pce.12467; Zhao Y, 2009, PLANT CELL, V21, P736, DOI 10.1105/tpc.108.061655; Zheng BS, 2003, THEOR APPL GENET, V107, P1505, DOI 10.1007/s00122-003-1390-1	62	12	15	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151796	10.1371/journal.pone.0151796	http://dx.doi.org/10.1371/journal.pone.0151796			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010823	gold, Green Published, Green Submitted			2022-12-26	WOS:000372708000046
J	Atkinson, SC; Jupiter, SD; Adams, VM; Ingram, JC; Narayan, S; Klein, CJ; Possingham, HP				Atkinson, Scott C.; Jupiter, Stacy D.; Adams, Vanessa M.; Ingram, J. Carter; Narayan, Siddharth; Klein, Carissa J.; Possingham, Hugh P.			Prioritising Mangrove Ecosystem Services Results in Spatially Variable Management Priorities	PLOS ONE			English	Article							POPULATION-DENSITY; BIODIVERSITY; RISK; COMMUNITIES; VALUATION; FORESTS; VULNERABILITY; CHALLENGES; IMPACT; FUTURE	Incorporating the values of the services that ecosystems provide into decision making is becoming increasingly common in nature conservation and resource management policies, both locally and globally. Yet with limited funds for conservation of threatened species and ecosystems there is a desire to identify priority areas where investment efficiently conserves multiple ecosystem services. We mapped four mangrove ecosystems services (coastal protection, fisheries, biodiversity, and carbon storage) across Fiji. Using a cost-effectiveness analysis, we prioritised mangrove areas for each service, where the effectiveness was a function of the benefits provided to the local communities, and the costs were associated with restricting specific uses of mangroves. We demonstrate that, although priority mangrove areas (top 20%) for each service can be managed at relatively low opportunity costs (ranging from 4.5 to 11.3% of overall opportunity costs), prioritising for a single service yields relatively low co-benefits due to limited geographical overlap with priority areas for other services. None-the-less, prioritisation of mangrove areas provides greater overlap of benefits than if sites were selected randomly for most ecosystem services. We discuss deficiencies in the mapping of ecosystems services in data poor regions and how this may impact upon the equity of managing mangroves for particular services across the urban-rural divide in developing countries. Finally we discuss how our maps may aid decision-makers to direct funding for mangrove management from various sources to localities that best meet funding objectives, as well as how this knowledge can aid in creating a national mangrove zoning scheme.	[Atkinson, Scott C.; Adams, Vanessa M.; Possingham, Hugh P.] Univ Queensland, Sch Biol Sci, Ctr Biodivers & Conservat Sci, ARC Ctr Excellence Environm Decis, St Lucia, Qld, Australia; [Jupiter, Stacy D.] Wildlife Conservat Soc, Melanesia Program, Suva, Fiji; [Ingram, J. Carter] Wildlife Conservat Soc, Global Conservat Program, New York, NY USA; [Narayan, Siddharth] Univ Calif Santa Barbara, NCEAS, Santa Barbara, CA 93106 USA; [Klein, Carissa J.] Univ Queensland, Sch Geog Planning & Environm Management, St Lucia, Qld, Australia	University of Queensland; Wildlife Conservation Society; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; University of Queensland	Atkinson, SC (corresponding author), Univ Queensland, Sch Biol Sci, Ctr Biodivers & Conservat Sci, ARC Ctr Excellence Environm Decis, St Lucia, Qld, Australia.	s.atkinson@uq.edu.au	BITOUN, RACHEL Elisabeth/AAC-9538-2021; Klein, Carissa J/F-1632-2011; Atkinson, Scott Consaul/F-8406-2016; Possingham, Hugh/B-1337-2008; Adams, Vanessa M./A-3834-2012; POSSINGHAM, HUGH/R-8310-2019	BITOUN, RACHEL Elisabeth/0000-0002-3614-9910; Klein, Carissa J/0000-0002-6299-6451; Atkinson, Scott Consaul/0000-0001-5995-0199; Possingham, Hugh/0000-0001-7755-996X; Adams, Vanessa M./0000-0002-3509-7901; POSSINGHAM, HUGH/0000-0001-7755-996X; Jupiter, Stacy/0000-0001-9742-1677	David and Lucile Packard Foundation [2013-38757]; Australian Research Council; University of Queensland Postdoctoral Research Fellowship; Australian Research Council [DP140100733]	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Australian Research Council(Australian Research Council); University of Queensland Postdoctoral Research Fellowship(University of Queensland); Australian Research Council(Australian Research Council)	Funding for this study was supported by a grant from the David and Lucile Packard Foundation (#2013-38757) to the Wildlife Conservation Society, with contributions from members of the SNaP Coastal Defences working group. SCA, VMA, and HPP acknowledge Australian Research Council Laureate funding. CJK was supported by a University of Queensland Postdoctoral Research Fellowship and a Discovery Grant from the Australian Research Council (DP140100733). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; Anderson BJ, 2009, J APPL ECOL, V46, P888, DOI 10.1111/j.1365-2664.2009.01666.x; [Anonymous], 2015, WETLANDS HUMAN HLTH; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Barbier EB, 2008, SCIENCE, V319, P321, DOI 10.1126/science.1150349; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; BENNETT EL, 1993, BIODIVERS CONSERV, V2, P359, DOI 10.1007/BF00114040; Bhandari A, 2002, ROAD COST KNOWLEDGE; Brinkman R.M., 2006, THESIS J COOK U; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; Danielsen F, 2005, SCIENCE, V310, P643, DOI 10.1126/science.1118387; Das S, 2009, P NATL ACAD SCI USA, V106, P7357, DOI 10.1073/pnas.0810440106; Davies ZG, 2011, J APPL ECOL, V48, P1125, DOI 10.1111/j.1365-2664.2011.02021.x; Donato DC, 2011, NAT GEOSCI, V4, P293, DOI [10.1038/ngeo1123, 10.1038/NGEO1123]; Duarte CM, 2013, NAT CLIM CHANGE, V3, P961, DOI [10.1038/nclimate1970, 10.1038/NCLIMATE1970]; Eigenbrod F, 2010, J APPL ECOL, V47, P377, DOI 10.1111/j.1365-2664.2010.01777.x; Ellison AM, 2008, J SEA RES, V59, P2, DOI 10.1016/j.seares.2007.05.003; FAO, 2007, WORLDS MANGR 1980 20; Faulkner Stephen, 2004, Urban Ecosystems, V7, P89, DOI 10.1023/B:UECO.0000036269.56249.66; Feagin RA, 2010, CONSERV LETT, V3, P1, DOI 10.1111/j.1755-263X.2009.00087.x; Geller HS, 1981, ANNEX 3 MEASURING CO; Gilman Eric, 2006, PACIFIC ISLAND MANGR; Gorokhovich Y, 2006, REMOTE SENS ENVIRON, V104, P409, DOI 10.1016/j.rse.2006.05.012; GRASS Development Team, 2012, GEOGRAPHIC RESOURCES; Gret-Regamey A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112601; Hamilton SE, 2014, CREATION HIGH SPATIO; Harborne AR, 2006, ADV MAR BIOL, V50, P57, DOI 10.1016/S0065-2881(05)50002-6; Hauck J, 2013, ECOSYST SERV, V4, P25, DOI 10.1016/j.ecoser.2012.11.003; IFRC, 2011, BREAK WAV IMP AN COA; Jenkins AP, 2011, ENVIRON BIOL FISH, V91, P261, DOI 10.1007/s10641-011-9776-4; Jenkins AP, 2010, AQUAT CONSERV, V20, P224, DOI 10.1002/aqc.1086; Jones HP, 2012, NAT CLIM CHANGE, V2, P504, DOI 10.1038/NCLIMATE1463; Kerr AM, 2007, BIOSCIENCE, V57, P102, DOI 10.1641/B570202; Klein CJ, 2012, ECOL APPL, V22, P1246, DOI 10.1890/11-1718.1; Kossoy A., 2009, STATE TRENDS CARBON, P24; Lal P, 2003, OCEAN COAST MANAGE, V46, P823, DOI 10.1016/S0964-5691(03)00062-0; Lal PN., 2009, EC COSTS 2009 FLOODS; Lange GM, 2009, OCEAN COAST MANAGE, V52, P521, DOI 10.1016/j.ocecoaman.2009.08.005; Lavorel S, 2011, J ECOL, V99, P135, DOI 10.1111/j.1365-2745.2010.01753.x; Lee SY, 2006, AUSTRAL ECOL, V31, P149, DOI 10.1111/j.1442-9993.2006.01581.x; Loomis JB, 2006, ECOL ECON, V60, P343, DOI 10.1016/j.ecolecon.2006.05.006; Lovelock CE, 2015, NATURE, V526, P559, DOI 10.1038/nature15538; Mace GM, 2012, TRENDS ECOL EVOL, V27, P19, DOI 10.1016/j.tree.2011.08.006; Malinga R, 2015, ECOSYST SERV, V13, P57, DOI 10.1016/j.ecoser.2015.01.006; Marois Darryl E., 2015, International Journal of Biodiversity Science Ecosystem Services & Management, V11, P71, DOI 10.1080/21513732.2014.997292; Martin-Lopez B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038970; Martinez-Harms MJ, 2015, BIOL CONSERV, V184, P229, DOI 10.1016/j.biocon.2015.01.024; Mazda Yoshihiro, 2006, Wetlands Ecology and Management, V14, P365, DOI 10.1007/s11273-005-5388-0; McInnes KL, 2011, J COASTAL RES, P1121; McIvor A, 2012, 1 NAT CONS WETL INT; McLeod E., 2006, MANAGING MANGROVES R, P64; Mimura N, 1998, J COASTAL RES, V14, P37; MMC, 2013, MANGR MAN PLAN FIJ 2; Mukherjee S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086731; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Narsey W., 2011, REPORT 2008 09 HOUSE; Naylor R, 1998, ENVIRON DEV ECON, V3; Pascal N., 2013, EC VALUATION MANGROV; PCRAFI, 2014, BUILDINGS; PCRAFI, 2014, TAK BUILD REPL COST; PCRAFI, 2014, LAND TYP; Peduzzi P, 2009, NAT HAZARD EARTH SYS, V9, P1149, DOI 10.5194/nhess-9-1149-2009; Plieninger T, 2013, LAND USE POLICY, V33, P118, DOI 10.1016/j.landusepol.2012.12.013; Plummer ML, 2009, FRONT ECOL ENVIRON, V7, P38, DOI 10.1890/080091; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Quinn P, 2013, NAT HAZARDS, V65, P1227, DOI 10.1007/s11069-012-0379-y; Rao NS, 2012, COMP ANAL ECOSYSTEM; Reyers B, 2012, BIOSCIENCE, V62, P503, DOI 10.1525/bio.2012.62.5.12; Richardson L, 2015, ECOL ECON, V115, P51, DOI 10.1016/j.ecolecon.2014.02.018; Rodriguez E, 2006, PHOTOGRAMM ENG REM S, V72, P249, DOI 10.14358/PERS.72.3.249; Rodriguez JP, 2006, ECOL SOC, V11; Salem ME, 2012, SUSTAINABILITY-BASEL, V4, P359, DOI 10.3390/su4030359; Sanchirico JN, 2009, THEOR ECOL-NETH, V2, P67, DOI 10.1007/s12080-008-0034-0; Schulp CJE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109643; Shi KF, 2014, REMOTE SENS LETT, V5, P358, DOI 10.1080/2150704X.2014.905728; Sinha CC, 2002, PACIFIC TOURISM REV; Spalding MD, 2014, CONSERV LETT, V7, P293, DOI 10.1111/conl.12074; Spalding MD, 2014, MANGROVES COASTAL RE; Spurgeon J., 2004, EC VALUATION CORAL R; Teh LCL, 2009, MAR POLICY, V33, P807, DOI 10.1016/j.marpol.2009.03.001; Tischendorf L, 2005, ECOL SOC, V10; Troy A, 2006, ECOL ECON, V60, P435, DOI 10.1016/j.ecolecon.2006.04.007; USACE, 2013, COAST RISK RED RES; USAID, 2009, AD COAST CLIM CHANG; Valiela I, 2001, BIOSCIENCE, V51, P807, DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; van Maanen B, 2015, P ROY SOC A-MATH PHY, V471, DOI 10.1098/rspa.2015.0115; Warren-Rhodes K, 2011, ENVIRON CONSERV, V38, P485, DOI 10.1017/S0376892911000373; Watling D., 1985, MANGROVE MANAGEMENT; WHO, 2007, WHO TECH REP SER, V935, P1; Wilson KA, 2010, ECOL APPL, V20, P1721, DOI 10.1890/09-1051.1; WTTC, 2014, EC IMP 2014 SING; Zhang KQ, 2012, ESTUAR COAST SHELF S, V102, P11, DOI 10.1016/j.ecss.2012.02.021	94	31	31	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151992	10.1371/journal.pone.0151992	http://dx.doi.org/10.1371/journal.pone.0151992			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008421	gold, Green Published, Green Submitted			2022-12-26	WOS:000372701200084
J	Sei, JJ; Waters, RA; Kenney, M; Barlow, JW; Golde, WT				Sei, Janet J.; Waters, Ryan A.; Kenney, Mary; Barlow, John W.; Golde, William T.			Effect of Foot-and-Mouth Disease Virus Infection on the Frequency, Phenotype and Function of Circulating Dendritic Cells in Cattle	PLOS ONE			English	Article							ANTIBODY-RESPONSE; SWINE; INTERFERON; LYMPHOPENIA; EXPRESSION; MATURATION; COMPLEXES; MONOCYTES; SUBSETS; ANTIGEN	Foot-and-mouth disease virus (FMDV) is a highly contagious virus that causes one of the most devastating diseases in cloven-hoofed animals. Disease symptoms develop within 2 to 3 days of exposure and include fever and vesicular lesions on the tongue and hooves. Dendritic cells (DC) play an essential role in protective immune responses against pathogens. Therefore, investigating their role during FMDV infection would lead to a better understanding of host-pathogen interactions. In this study, following infection of cattle with FMDV, we investigated the frequency and function of conventional (cDC) and plasmacytoid DC (pDC) in blood by using multi-color flow cytometry. We show that the frequency of cDC and pDC increased following FMDV infection and peaked 3 to 4 days post-infection. During peak viremia, the cattle became lymphopenic, the expression of MHC class II molecules on cDC and pDC was dramatically down-regulated, the processing of exogenous antigen by cDC and pDC was impaired, and there was an increase in IL-10 production by DC and monocytes. Notably, after clearance of FMDV from the blood, MHC class II expression returned to pre-infection levels. Altogether, our study demonstrates that in cattle, FMDV inhibits the function of DC, thereby retarding the initiation of adaptive immune responses, potentially enhancing virus shedding during the acute phase of infection.	[Sei, Janet J.; Waters, Ryan A.; Kenney, Mary; Golde, William T.] ARS, Plum Isl Anim Dis Ctr, USDA, Greenport, NY USA; [Sei, Janet J.; Barlow, John W.] Univ Vermont, Dept Anim & Vet Sci, Burlington, VT USA; [Sei, Janet J.] Merck & Co Inc, Kenilworth, NJ USA; [Waters, Ryan A.] Pirbright Inst, Pirbright, England	United States Department of Agriculture (USDA); University of Vermont; Merck & Company; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Golde, WT (corresponding author), ARS, Plum Isl Anim Dis Ctr, USDA, Greenport, NY USA.	William.Golde@ARS.USDA.GOV	Ibrahim, Essam Hassan/G-1960-2018	Ibrahim, Essam Hassan/0000-0003-0130-2257	US Department of Agriculture, Agricultural Research Service [CRIS 1940-32000-057-00D]; US Department of Homeland Security, Science and Technology Directorate IAA [HQPM-13-X-00110]; National Science Foundation [0965346]	US Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); US Department of Homeland Security, Science and Technology Directorate IAA; National Science Foundation(National Science Foundation (NSF))	This work was supported by the US Department of Agriculture, Agricultural Research Service, (http://www.ars.usda.gov/) CRIS 1940-32000-057-00D (W.T.G.); US Department of Homeland Security, Science and Technology Directorate (http://www.dhs.gov/science-and-technology) IAA #HQPM-13-X-00110 (W.T.G.); and National Science Foundation (http://www.nsf.gov/bio/bread) grant #0965346, under the BREAD program (J.W.B. and W.T.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai FW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000610; Bajer AA, 2003, J LEUKOCYTE BIOL, V73, P100, DOI 10.1189/jlb.0302128; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bautista EA, 2005, J VIROL, V79, P4838, DOI 10.1128/JVI.79.8.4838-4847.2005; Bautista EM, 2003, VET IMMUNOL IMMUNOP, V92, P61, DOI 10.1016/S0165-2427(03)00004-7; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Chen LJ, 2012, RES VET SCI, V93, P529, DOI 10.1016/j.rvsc.2011.06.026; Diaz-San Segundo F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005659; Golde WT, 2005, VACCINE, V23, P5775, DOI 10.1016/j.vaccine.2005.07.043; Gonzalez-Cano P, 2014, DEV COMP IMMUNOL, V44, P378, DOI 10.1016/j.dci.2014.01.014; Grubman MJ, 2004, CLIN MICROBIOL REV, V17, P465, DOI 10.1128/CMR.17.2.465-493.2004; Guzylack-Piriou L, 2006, EUR J IMMUNOL, V36, P1674, DOI 10.1002/eji.200635866; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Heath WR, 2001, ANNU REV IMMUNOL, V19, P47, DOI 10.1146/annurev.immunol.19.1.47; Iwasaki A, 2007, ANNU REV IMMUNOL, V25, P381, DOI 10.1146/annurev.immunol.25.022106.141634; Joshi G, 2009, VACCINE, V27, P6656, DOI 10.1016/j.vaccine.2009.08.107; Juleff N, 2009, J VIROL, V83, P3626, DOI 10.1128/JVI.02613-08; Kamath AT, 2000, J IMMUNOL, V165, P6762, DOI 10.4049/jimmunol.165.12.6762; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Koppelman B, 1997, IMMUNITY, V7, P861, DOI 10.1016/S1074-7613(00)80404-5; Malavige GN, 2011, IMMUNOLOGY, V135, P58; Malavige GN, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-341; Martin-Fontecha Alfonso, 2009, Handb Exp Pharmacol, P31, DOI 10.1007/978-3-540-71029-5_2; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Merad M, 2009, BLOOD, V113, P3418, DOI 10.1182/blood-2008-12-180646; Mirkovitch J, 2006, VET IMMUNOL IMMUNOP, V114, P1, DOI 10.1016/j.vetimm.2006.06.004; Nfon CK, 2008, VIRAL IMMUNOL, V21, P68, DOI 10.1089/vim.2007.0097; Nfon CK, 2010, VIRAL IMMUNOL, V23, P29, DOI 10.1089/vim.2009.0078; Ostrowski M, 2005, J IMMUNOL, V175, P3971, DOI 10.4049/jimmunol.175.6.3971; Pacheco JM, 2010, CLIN VACCINE IMMUNOL, V17, P550, DOI 10.1128/CVI.00429-09; Perez-Martin E, 2012, J VIROL, V86, P4477, DOI 10.1128/JVI.06683-11; Pinchuk LM, 2003, COMP IMMUNOL MICROB, V26, P233, DOI 10.1016/S0147-9571(02)00061-9; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Sanz-Parra A, 1998, J GEN VIROL, V79, P433, DOI 10.1099/0022-1317-79-3-433; Segundo FDS, 2006, J VIROL, V80, P2369, DOI 10.1128/JVI.80.5.2369-2379.2006; Sei JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109273; SIGAL LJ, 1992, VET IMMUNOL IMMUNOP, V30, P431, DOI 10.1016/0165-2427(92)90111-3; Song S, 2013, DEV COMP IMMUNOL, V39, P265, DOI 10.1016/j.dci.2012.10.001; Spears M, 2011, CLIN EXP ALLERGY, V41, P665, DOI 10.1111/j.1365-2222.2010.03692.x; Suchanek O, 2010, CELL IMMUNOL, V266, P40, DOI 10.1016/j.cellimm.2010.08.010; Suradhat S, 2003, J GEN VIROL, V84, P453, DOI 10.1099/vir.0.18698-0; Toka FN, 2011, J IMMUNOL, V186, P4853, DOI 10.4049/jimmunol.1003599; Urban BC, 2006, INFECT IMMUN, V74, P6700, DOI 10.1128/IAI.00861-06; Werling D, 1999, J LEUKOCYTE BIOL, V66, P50, DOI 10.1002/jlb.66.1.50; Wijewardana V, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001235; Windsor MA, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-108	46	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152192	10.1371/journal.pone.0152192	http://dx.doi.org/10.1371/journal.pone.0152192			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008425	Green Published, gold, Green Submitted			2022-12-26	WOS:000372701200108
J	Su, MM; Guo, L; Tao, YL; Zhang, YJ; Wan, FH; Chu, D				Su, Ming-Ming; Guo, Lei; Tao, Yun-Li; Zhang, You-Jun; Wan, Fang-Hao; Chu, Dong			Effects of Host Plant Factors on the Bacterial Communities Associated with Two Whitefly Sibling Species	PLOS ONE			English	Article							TABACI HEMIPTERA ALEYRODIDAE; BEMISIA-TABACI; MICROBIAL COMMUNITIES; INSECTICIDE SUSCEPTIBILITY; HOMOPTERA ALEYRODIDAE; CULTURABLE BACTERIA; BIOTYPE; IDENTIFICATION; DIVERSITY; VIRUS	Background Although discrepancy in the specific traits and ecological characteristics of Bemisia tabaci between species are partially attributed to the B. tabaci-associated bacteria, the factors that affect the diversity of B. tabaci-associated bacteria are not well-understood. We used the metagenomic approach to characterize the B. tabaci-associated bacterial community because the approach is an effective tool to identify the bacteria. Methodology and Results To investigate the effects of the host plant and a virus, tomato yellow leaf curl virus (TYLCV), on the bacterial communities of B. tabaci sibling species B and Q, we analyzed the bacterial communities associated with whitefly B and Q collected from healthy cotton, healthy tomato, and TYLCV-infected tomato. The analysis used miseq-based sequencing of a variable region of the bacterial 16S rDNA gene. For the bacteria associated with B. tabaci, we found that the influence of the host plant species was greater than that of the whitefly cryptic species. With further analysis of host plants infected with the TYLCV, the virus had no significant effects on the B. tabaci-associated bacterial community. Conclusions The effects of different plant hosts and TYLCV-infection on the diversity of B. tabaci-associated bacterial communities were successfully analyzed in this study. To explain why B. tabaci sibling species with different host ranges differ in performance, the analysis of the bacterial community may be essential to the explanation.	[Su, Ming-Ming; Guo, Lei; Tao, Yun-Li; Wan, Fang-Hao; Chu, Dong] Qingdao Agr Univ, Coll Agron & Plant Protect, Key Lab Integrated Crop Pest Management Shandong, Qingdao 266109, Peoples R China; [Wan, Fang-Hao] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100081, Peoples R China; [Zhang, You-Jun] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Dept Plant Protect, Beijing 100081, Peoples R China	Qingdao Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS	Chu, D (corresponding author), Qingdao Agr Univ, Coll Agron & Plant Protect, Key Lab Integrated Crop Pest Management Shandong, Qingdao 266109, Peoples R China.	chinachudong@qau.edu.cn	Chu, Dong/AAS-3914-2020; CHU, DONG/AAI-1892-2020; Zhang, Youjun/AAY-7948-2020	Chu, Dong/0000-0001-5716-4979; Zhang, Youjun/0000-0003-3508-6695	High-Level Talents Fund of Qingdao Agricultural University [631212]; National Natural Science Foundation of China [31272105]; Science and Technology Development Planning Program of Qingdao [13-1-3-108-nsh]; Taishan Mountain Scholar Constructive Engineering Foundation of Shandong	High-Level Talents Fund of Qingdao Agricultural University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Development Planning Program of Qingdao; Taishan Mountain Scholar Constructive Engineering Foundation of Shandong	This research was supported by the High-Level Talents Fund of Qingdao Agricultural University (631212), the National Natural Science Foundation of China (31272105), the Science and Technology Development Planning Program of Qingdao (13-1-3-108-nsh), and the Taishan Mountain Scholar Constructive Engineering Foundation of Shandong.	Anderson KE, 2012, MOL ECOL, V21, P2282, DOI 10.1111/j.1365-294X.2011.05464.x; Ateyyat Mazen A., 2009, Jordan Journal of Biological Sciences, V2, P139; Ateyyat MA, 2010, TURK J AGRIC FOR, V34, P225, DOI 10.3906/tar-0902-35; Baumann P., 2005, BIOL BACTERIOCYTE, V59, P155, DOI DOI 10.1146/ANNUREV.MICR0.59.030804.121041; Bing XL, 2013, INSECT SCI, V20, P194, DOI 10.1111/j.1744-7917.2012.01522.x; Boykin LM, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-228; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Broderick NA, 2004, APPL ENVIRON MICROB, V70, P293, DOI 10.1128/AEM.70.1.293-300.2004; Brown JK, 2000, VIRUS RES, V71, P233, DOI 10.1016/S0168-1702(00)00221-5; Brumin M, 2011, INSECT SCI, V18, P57, DOI 10.1111/j.1744-7917.2010.01396.x; Castle SJ, 2009, B ENTOMOL RES, V99, P263, DOI 10.1017/S0007485308006329; Chandler JA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002272; Chiel E, 2007, B ENTOMOL RES, V97, P407, DOI 10.1017/S0007485307005159; Chu D, 2011, B ENTOMOL RES, V101, P477, DOI 10.1017/S0007485311000083; Chu D, 2012, J ECON ENTOMOL, V105, P242, DOI 10.1603/EC11039; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Davidson EW, 2000, FLA ENTOMOL, V83, P159, DOI 10.2307/3496151; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Fang YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100423; Firdaus S, 2013, INSECT SCI, V20, P723, DOI 10.1111/1744-7917.12001; Ghanim M, 2009, PEST MANAG SCI, V65, P939, DOI 10.1002/ps.1795; Gnankine O, 2013, INSECT CONSERV DIVER, V6, P411, DOI 10.1111/j.1752-4598.2012.00206.x; Gottlieb Y, 2010, J VIROL, V84, P9310, DOI 10.1128/JVI.00423-10; Gueguen G, 2010, MOL ECOL, V19, P4365, DOI 10.1111/j.1365-294X.2010.04775.x; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hui XA, 2006, CAN J MICROBIOL, V52, P1085, DOI 10.1139/W06-064; Indiragandhi P, 2010, J KOREAN SOC APPL BI, V53, P605, DOI 10.3839/jksabc.2010.093; Jing XF, 2014, MOL ECOL, V23, P1433, DOI 10.1111/mec.12637; Jiravanichpaisal P, 2006, IMMUNOBIOLOGY, V211, P213, DOI 10.1016/j.imbio.2005.10.015; Jones RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061218; Kontsedalov S, 2008, PEST MANAG SCI, V64, P789, DOI 10.1002/ps.1595; Liang P, 2007, PEST MANAG SCI, V63, P365, DOI 10.1002/ps.1346; Liu BM, 2013, J VIROL, V87, P4929, DOI 10.1128/JVI.03571-12; Liu SS, 2012, J INTEGR AGR, V11, P176, DOI 10.1016/S2095-3119(12)60002-1; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mahadav A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-342; Mansaray A, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.0101; Osei-Poku J, 2012, MOL ECOL, V21, P5138, DOI 10.1111/j.1365-294X.2012.05759.x; Pan HP, 2013, ENVIRON ENTOMOL, V42, P74, DOI 10.1603/EN12114; Pan Huipeng, 2013, Commun Integr Biol, V6, pe23397, DOI 10.4161/cib.23397; Pan HP, 2013, SCI REP-UK, V3, DOI 10.1038/srep02230; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034817; Pan HP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030760; Partida-Martinez LP, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00100; Priya NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030768; Roopa HK, 2014, META GENE, V2, P114, DOI 10.1016/j.mgene.2013.11.002; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Singh ST, 2012, INFECT GENET EVOL, V12, P411, DOI 10.1016/j.meegid.2012.01.015; Staubach F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070749; Tajebe LS, 2015, ANN APPL BIOL, V166, P297, DOI 10.1111/aab.12183; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Vodovar N, 2005, P NATL ACAD SCI USA, V102, P11414, DOI 10.1073/pnas.0502240102; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767; Xie W, 2011, PEST MANAG SCI, V67, P87, DOI 10.1002/ps.2037; Zang LS, 2006, ENTOMOL EXP APPL, V121, P221, DOI 10.1111/j.1570-8703.2006.00482.x	57	15	21	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152183	10.1371/journal.pone.0152183	http://dx.doi.org/10.1371/journal.pone.0152183			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008327	Green Submitted, Green Published, gold			2022-12-26	WOS:000372701200107
J	Crespo, A; Rodrigues, M; Telletxea, I; Ibanez, R; Diez, F; Tobar, JF; Arizaga, J				Crespo, Arine; Rodrigues, Marcos; Telletxea, Ibon; Ibanez, Ruben; Diez, Felipe; Tobar, Joseba F.; Arizaga, Juan			No Habitat Selection during Spring Migration at a Meso-Scale Range across Mosaic Landscapes: A Case Study with the Woodcock (Scolopax rusticola)	PLOS ONE			English	Article							EURASIAN WOODCOCK; REED WARBLERS; STOPOVER; BEHAVIOR; MIGRANT; ECOLOGY; SUCCESS; SITES; NORTH; LOADS	Success of migration in birds in part depends on habitat selection. Overall, it is still poorly known whether there is habitat selection amongst landbird migrants moving across landscapes. Europe is chiefly covered by agro-forestry mosaic landscapes, so migratory species associated to either agricultural landscapes or woodland habitats should theoretically find suitable stopover sites along migration. During migration from wintering to breeding quarters, woodcocks (Scolopax rusticola) tagged with PTT satellite-tracking transmitters were used to test for the hypothesis that migrants associated to agro-forest habitats have no habitat selection during migration, at a meso-scale level. Using a GIS platform we extracted at a meso-scale range habitat cover at stopover localities. Results obtained from comparisons of soil covers between points randomly selected and true stopover localities sites revealed, as expected, the species may not select for particular habitats at a meso-scale range, because the habitat (or habitats) required by the species can be found virtually everywhere on their migration route. However, those birds stopping over in places richer in cropland or mosaic habitats including both cropland and forest and with proportionally less closed forest stayed for longer than in areas with lower surfaces of cropland and mosaic and more closed forest. This suggests that areas rich in cropland or mosaic habitat were optimal.	[Crespo, Arine; Arizaga, Juan] Aranzadi Sci Soc, Dept Ornithol, Zorroagagaina 11, E-20014 Donostia S Sebastian, Spain; [Rodrigues, Marcos] Univ Zaragoza, Dept Geog & Land Management, IUCA, GEOFOREST Grp, Pedro Cerbuna 12, E-50009 Zaragoza, Spain; [Telletxea, Ibon; Ibanez, Ruben; Diez, Felipe; Tobar, Joseba F.] Club Cazadores Becada, Avda Schulz 8,4 Dcha, E-33208 Gijon, Asturias, Spain		Arizaga, J (corresponding author), Aranzadi Sci Soc, Dept Ornithol, Zorroagagaina 11, E-20014 Donostia S Sebastian, Spain.	jarizaga@aranzadi.eus	Rodrigues, Marcos/L-7931-2014	Rodrigues, Marcos/0000-0002-0477-0796; Arizaga, Juan/0000-0003-1911-4078	Government of Gipuzkoa; Government of Cataluna; Government of Baleares; Government of Bizkaia; Government of Navarra; FEDENCA; IREC (CSIC-University of Castilla-La Mancha); Microwave Telemetry Inc.; Urdaibai Bird Center-Sociedad de Ciencias Aranzadi; Club de Cazadores de Becada (CCB); CAM	Government of Gipuzkoa; Government of Cataluna; Government of Baleares; Government of Bizkaia; Government of Navarra; FEDENCA; IREC (CSIC-University of Castilla-La Mancha); Microwave Telemetry Inc.; Urdaibai Bird Center-Sociedad de Ciencias Aranzadi; Club de Cazadores de Becada (CCB); CAM	This work was funded by: Regional Councils or Governments of Gipuzkoa, Cataluna, Baleares, Bizkaia and Navarra; FEDENCA, IREC (CSIC-University of Castilla-La Mancha), Microwave Telemetry Inc., Urdaibai Bird Center-Sociedad de Ciencias Aranzadi, Club de Cazadores de Becada (CCB), CAM. Funders had no role in the design of this work, data collection, data analysis, decision to publish, or preparation of this manuscript.	Alerstam T, 1990, BIRD MIGRATION PHYSL, P331, DOI [DOI 10.1007/978-3-642-74542-3_22., 10.1007/978-3-642-74542-3_22]; Andueza M, 2014, ARDEOLA, V61, P269, DOI 10.13157/arla.61.2.2014.269; Arizaga J, 2015, EUR J WILDLIFE RES, V61, P407, DOI 10.1007/s10344-015-0908-6; Arizaga J, 2015, J ORNITHOL, V156, P515, DOI 10.1007/s10336-014-1152-7; Baldock, 1990, AGR HABITAT LOSS EUR; Barton K., MUMIN MULTIMODEL INF; Berthold P, 2001, AUK, V2nd; Biebach H., 1990, P352; Bolshakov C, 2003, IBIS, V145, P106, DOI 10.1046/j.1474-919X.2003.00128.x; Brana F, 2013, ACTA ORNITHOL, V48, P27, DOI 10.3161/000164513X669973; Brana F, 2010, ANN ZOOL FENN, V47, P206, DOI 10.5735/086.047.0305; Burnham K. P., 1998, MODEL SELECTION INFE; Cerasale DJ, 2010, AUK, V127, P636, DOI 10.1525/auk.2010.09124; Chernetsov N., 2012, PASSERINE MIGRATION; Chernetsov N, 2006, WILSON J ORNITHOL, V118, P364, DOI 10.1676/04-134.1; Conklin JR, 2012, J AVIAN BIOL, V43, P252, DOI 10.1111/j.1600-048X.2012.05606.x; Costantini D, 2013, CURR ZOOL, V59, P697, DOI 10.1093/czoolo/59.6.697; Cramp S., 1980, BIRDS W PALEARCTIC, V2; Dierschke V, 2003, J ORNITHOL, V144, P33, DOI 10.1007/BF02465515; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Duriez O, 2005, IBIS, V147, P519, DOI 10.1111/j.1474-919x.2005.00423.x; Duriez O, 2005, BIOL CONSERV, V122, P479, DOI 10.1016/j.biocon.2004.08.011; ELLEGREN H, 1992, Ringing and Migration, V13, P1; FRANSSON T, 1995, J AVIAN BIOL, V26, P39, DOI 10.2307/3677211; Fuller R.J., 2012, BIRDS HABITAT RELATI; GUDMUNDSSON GA, 1991, IBIS, V133, P140, DOI 10.1111/j.1474-919X.1991.tb04825.x; Guzman JL, 2013, THESIS U CASTILLA MA; Hedenstrom A, 1997, J THEOR BIOL, V189, P227, DOI 10.1006/jtbi.1997.0505; Herrera JM, 2014, J BIOGEOGR, V41, P700, DOI 10.1111/jbi.12236; Hoodless Andrew, 1995, British Birds, V88, P578; Hoodless AN, 2007, IBIS, V149, P234, DOI 10.1111/j.1474-919X.2007.00725.x; Inger R, 2010, J ANIM ECOL, V79, P974, DOI 10.1111/j.1365-2656.2010.01712.x; KENWARD RE, 1978, J ANIM ECOL, V47, P449, DOI 10.2307/3793; Ktitorov P, 2010, BEHAV ECOL SOCIOBIOL, V64, P1135, DOI 10.1007/s00265-010-0929-9; Lindstrom A, 2010, J AVIAN BIOL, V41, P154, DOI 10.1111/j.1600-048X.2009.04810.x; Machado AL, 2008, WILDLIFE BIOL, V14, P129, DOI 10.2981/0909-6396(2008)14[129:DAHPOE]2.0.CO;2; Martell MS, 2001, CONDOR, V103, P715, DOI 10.1650/0010-5422(2001)103[0715:FMRTAW]2.0.CO;2; Martin TE, 1995, ECOLOGY MANAGEMENT N; Mayor SJ, 2009, ECOSCIENCE, V16, P238, DOI 10.2980/16-2-3238; Newton I, 2004, IBIS, V146, P197, DOI 10.1111/j.1474-919X.2004.00293.x; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Onrubia A, 2003, ATLAS AVES REPROD ES, P258; Overdijk O, 2012, AQUAT CONSERV, V22, P695, DOI 10.1002/aqc.2275; Piersma Theunis, 2005, P262; Prop J, 1998, NORSK POLARINST SKRI, P175; R Core Team, 2014, R LANG ENV STAT COMP; Revelle W., 2014, PSYCH PROCEDURES PER; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Tsiakiris R, 2009, ENVIRON MANAGE, V44, P874, DOI 10.1007/s00267-009-9359-8	49	2	2	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0149790	10.1371/journal.pone.0149790	http://dx.doi.org/10.1371/journal.pone.0149790			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002975	Green Published, gold			2022-12-26	WOS:000372697400010
J	Cuenca, M; Pfister, SP; Buschor, S; Bayramova, F; Hernandez, SB; Cava, F; Kuru, E; Van Nieuwenhze, MS; Brun, YV; Coelho, FM; Hapfelmeier, S				Cuenca, Miguelangel; Pfister, Simona P.; Buschor, Stefanie; Bayramova, Firuza; Hernandez, Sara B.; Cava, Felipe; Kuru, Erkin; Van Nieuwenhze, Michael S.; Brun, Yves V.; Coelho, Fernanda M.; Hapfelmeier, Siegfried			D-Alanine-Controlled Transient Intestinal Mono-Colonization with Non-Laboratory-Adapted Commensal E. coli Strain HS	PLOS ONE			English	Article							D-AMINO ACIDS; ESCHERICHIA-COLI; IN-SITU; MICROBIOTA; PEPTIDOGLYCAN; RESISTANCE; RESPONSES; DYNAMICS; DISEASE; MICE	Soon after birth the mammalian gut microbiota forms a permanent and collectively highly resilient consortium. There is currently no robust method for re-deriving an already microbially colonized individual again-germ-free. We previously developed the in vivo growth-incompetent E. coli K-12 strain HA107 that is auxotrophic for the peptidoglycan components D-alanine (D-Ala) and meso-diaminopimelic acid (Dap) and can be used to transiently associate germ-free animals with live bacteria, without permanent loss of germ-free status. Here we describe the translation of this experimental model from the laboratory-adapted E. coli K-12 prototype to the better gut-adapted commensal strain E. coli HS. In this genetic background it was necessary to complete the D-Ala auxotrophy phenotype by additional knockout of the hypothetical third alanine racemase metC. Cells of the resulting fully auxotrophic strain assembled a peptidoglycan cell wall of normal composition, as long as provided with D-Ala and Dap in the medium, but could not proliferate a single time after D-Ala/Dap removal. Yet, unsupplemented bacteria remained active and were able to complete their cell cycle with fully sustained motility until immediately before autolytic death. Also in vivo, the transiently colonizing bacteria retained their ability to stimulate a live-bacteria-specific intestinal Immunoglobulin (Ig) A response. Full D-Ala auxotrophy enabled rapid recovery to again-germ-free status. E. coli HS has emerged from human studies and genomic analyses as a paradigm of benign intestinal commensal E. coli strains. Its reversibly colonizing derivative may provide a versatile research tool for mucosal bacterial conditioning or compound delivery without permanent colonization.	[Cuenca, Miguelangel; Pfister, Simona P.; Buschor, Stefanie; Bayramova, Firuza; Coelho, Fernanda M.; Hapfelmeier, Siegfried] Univ Bern, Inst Infect Dis, Bern, Switzerland; [Cuenca, Miguelangel; Pfister, Simona P.; Buschor, Stefanie] Univ Bern, Grad Sch GCB, Bern, Switzerland; [Hernandez, Sara B.; Cava, Felipe] Umea Univ, Dept Mol Biol, Lab Mol Infect Med Sweden, Umea, Sweden; [Kuru, Erkin; Van Nieuwenhze, Michael S.] Indiana Univ, Dept Chem, Bloomington, IN USA; [Kuru, Erkin; Brun, Yves V.] Indiana Univ, Dept Biol, Bloomington, IN USA	University of Bern; University of Bern; Umea University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Hapfelmeier, S (corresponding author), Univ Bern, Inst Infect Dis, Bern, Switzerland.	siegfried.hapfelmeier@ifik.unibe.ch	VanNieuwenhze, Michael/B-5120-2018; Hapfelmeier, Siegfried/B-6005-2011; Hernandez, Sara B./M-2986-2019; Hernandez, Sara/L-2220-2017; Cava, Felipe/L-2082-2017	VanNieuwenhze, Michael/0000-0001-6093-5949; Hapfelmeier, Siegfried/0000-0002-6913-7932; Hernandez, Sara B./0000-0002-8349-360X; Hernandez, Sara/0000-0002-8349-360X; Cava, Felipe/0000-0001-5995-718X; Brun, Yves/0000-0002-9289-1909; Cuenca, Miguelangel/0000-0003-3435-9102	Swiss National Science Foundation [310030_138452]; ERC Starting Grant from the European Research Council under the European Union's Seventh Framework Programme [281904]; Molecular Infection Medicine Sweden; Knut and Alice Wallenberg Foundation [KAW 2012-0184]; Kempe foundation [JCK-1422]; Swedish Research Council [K201457X-22450-01-5]; Boehringer Ingelheim Foundation; Alfonso Martin Escudero Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113172] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ERC Starting Grant from the European Research Council under the European Union's Seventh Framework Programme; Molecular Infection Medicine Sweden; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Kempe foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Boehringer Ingelheim Foundation(Boehringer Ingelheim); Alfonso Martin Escudero Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	SH was supported by the Swiss National Science Foundation (http://www.snf.ch; Grant 310030_138452) and an ERC Starting Grant from the European Research Council (http://erc.europa.eu) under the European Union's Seventh Framework Programme (FP/2007-2013), ERC Grant Agreement 281904. The FC laboratory received funding support by Molecular Infection Medicine Sweden (http://www.mims.umu.se), Knut and Alice Wallenberg Foundation (https://www.wallenberg.com/kaw/en; grant KAW 2012-0184), Kempe foundation (http://www.kempe.com; grant JCK-1422) and the Swedish Research Council (http://www.vr.se; grant K201457X-22450-01-5). SB was supported by a Boehringer Ingelheim Foundation (https://www.bifonds.de) PhD scholarship. SBH was supported by an Alfonso Martin Escudero Foundation (http://www.fundame.org) postdoctoral scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias CA, 2000, MICROBIOL-SGM, V146, P1727, DOI 10.1099/00221287-146-7-1727; Balmer ML, 2014, J IMMUNOL, V193, P5273, DOI 10.4049/jimmunol.1400762; Balmer ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008618; Browning DF, 2013, MOL MICROBIOL, V87, P939, DOI 10.1111/mmi.12144; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Curtiss R, 1980, US Patent, Patent No. [US4190495 A, 4190495]; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; DUCLUZEAU R, 1986, ANN INST PASTEUR MIC, V137A, P79, DOI 10.1016/S0769-2609(86)80007-2; Espaillat A, 2014, ACTA CRYSTALLOGR D, V70, P79, DOI 10.1107/S1399004713024838; Faith JJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008051; Fritz JH, 2012, NATURE, V481, P199, DOI 10.1038/nature10698; Giraudoux P., 2015, R PACKAGE VERSION 1; Glover WA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007316; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; Kuru E, 2015, NAT PROTOC, V10, P33, DOI 10.1038/nprot.2014.197; Kuru E, 2012, ANGEW CHEM INT EDIT, V51, P12519, DOI 10.1002/anie.201206749; LEVINE MM, 1978, LANCET, V1, P1119; Macpherson AJ, 2015, MUCOSAL IMMUNOL, V8, P476, DOI 10.1038/mi.2014.113; Macpherson A. J., 2009, ENCY MICROBIOLOGY, P237; MARFEY P, 1984, CARLSBERG RES COMMUN, V49, P591, DOI 10.1007/BF02908688; Nam SH, 2011, J BACTERIOL, V193, P1014, DOI [10.1128/JB.01394-10, 10.1128/JB.01027-10]; R Development Core Team, 2014, R LANG ENV STAT COMP; Radkov AD, 2013, J BACTERIOL, V195, P5016, DOI 10.1128/JB.00761-13; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Rautava S, 2012, NAT REV GASTRO HEPAT, V9, P565, DOI 10.1038/nrgastro.2012.144; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; RICHAUD C, 1993, J BIOL CHEM, V268, P26827; Schultz M, 2008, INFLAMM BOWEL DIS, V14, P1012, DOI 10.1002/ibd.20377; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; WELLS CL, 1978, NATURE, V274, P397, DOI 10.1038/274397a0; Wickham H, 2015, R PACKAGE VERSION 0; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yao ZZ, 2012, MOL CELL, V48, P705, DOI 10.1016/j.molcel.2012.09.016	35	8	8	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151872	10.1371/journal.pone.0151872	http://dx.doi.org/10.1371/journal.pone.0151872			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002976	Green Submitted, Green Published, gold			2022-12-26	WOS:000372697400052
J	Hyona, J; Ekholm, M				Hyona, Jukka; Ekholm, Miia			Background Speech Effects on Sentence Processing during Reading: An Eye Movement Study	PLOS ONE			English	Article							SHORT-TERM-MEMORY; WORKING-MEMORY; INDIVIDUAL-DIFFERENCES; IRRELEVANT SPEECH; DISRUPTION; INTELLIGIBILITY; MANIPULATIONS; COMPREHENSION; INTERFERENCE; DISTRACTION	Effects of background speech on reading were examined by playing aloud different types of background speech, while participants read long, syntactically complex and less complex sentences embedded in text. Readers' eye movement patterns were used to study online sentence comprehension. Effects of background speech were primarily seen in rereading time. In Experiment 1, foreign-language background speech did not disrupt sentence processing. Experiment 2 demonstrated robust disruption in reading as a result of semantically and syntactically anomalous scrambled background speech preserving normal sentence-like intonation. Scrambled speech that was constructed from the text to-be read did not disrupt reading more than scrambled speech constructed from a different, semantically unrelated text. Experiment 3 showed that scrambled speech exacerbated the syntactic complexity effect more than coherent background speech, which also interfered with reading. Experiment 4 demonstrated that both semantically and syntactically anomalous speech produced no more disruption in reading than semantically anomalous but syntactically correct background speech. The pattern of results is best explained by a semantic account that stresses the importance of similarity in semantic processing, but not similarity in semantic content, between the reading task and background speech.	[Hyona, Jukka] Univ Turku, Dept Psychol, Turku, Finland; [Ekholm, Miia] Stockholm South Gen Hosp Sodersjukhuset, Stockholm, Sweden	University of Turku	Hyona, J (corresponding author), Univ Turku, Dept Psychol, Turku, Finland.	hyona@utu.fi	Hyönä, Jukka/K-5280-2019	Hyönä, Jukka/0000-0002-5950-3361				Baddeley A.D., 1974, MOTIV ADV RES THEORY, V8, P47, DOI [DOI 10.1016/S0079-7421(08)60452-1, 10.1016/S0079-7421(08)60452-1]; Baddeley A. D, 1986, WORKING MEMORY; Banbury S, 1998, BRIT J PSYCHOL, V89, P499, DOI 10.1111/j.2044-8295.1998.tb02699.x; Bell R, 2012, J EXP PSYCHOL LEARN, V38, P1542, DOI 10.1037/a0028459; Boyle R, 1996, Q J EXP PSYCHOL-A, V49, P398, DOI 10.1080/027249896392702; Caplan D, 1999, BEHAV BRAIN SCI, V22, P77; Cauchard F, 2012, APPL COGNITIVE PSYCH, V26, P381, DOI 10.1002/acp.1837; Cowan N, ATTENTION MEMORY INT; Emberson LL, 2010, PSYCHOL SCI, V21, P1383, DOI 10.1177/0956797610382126; Gathercole S. E., 1993, WORKING MEMORY LANGU; Gibson E, 1998, COGNITION, V68, P1, DOI 10.1016/S0010-0277(98)00034-1; Gordon PC, 2001, J EXP PSYCHOL LEARN, V27, P1411, DOI 10.1037/0278-7393.27.6.1411; Haapakangas A, 2014, APPL ACOUST, V86, P1, DOI 10.1016/j.apacoust.2014.04.018; Hakulinen A., 1980, SUOMEN TEKSTILAUSEID; Halin N, 2014, J EXP PSYCHOL-APPL, V20, P69, DOI 10.1037/xap0000002; HEMFORTH B, 1993, PROCEEDINGS OF THE FIFTEENTH ANNUAL CONFERENCE OF THE COGNITIVE SCIENCE SOCIETY, P539; HOLMES VM, 1981, J VERB LEARN VERB BE, V20, P417, DOI 10.1016/S0022-5371(81)90533-8; Hughes RW, 2007, J EXP PSYCHOL LEARN, V33, P1050, DOI 10.1037/0278-7393.33.6.1050; Humphries C, 2005, HUM BRAIN MAPP, V26, P128, DOI 10.1002/hbm.20148; Hyona J, 1997, Q J EXP PSYCHOL-A, V50, P841; Hyona J, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P313, DOI 10.1016/B978-044451020-4/50018-9; Hyona J, 2002, J EDUC PSYCHOL, V94, P44, DOI 10.1037//0022-0663.94.1.44; Inhoff AW, 2004, PSYCHON B REV, V11, P320, DOI 10.3758/BF03196577; Johnston M, 2002, AUST J PSYCHOL, V54, P54; JONES D, 1992, Q J EXP PSYCHOL-A, V44, P645, DOI 10.1080/14640749208401304; JONES DM, 1990, APPL COGNITIVE PSYCH, V4, P89, DOI 10.1002/acp.2350040203; KING J, 1991, J MEM LANG, V30, P580, DOI 10.1016/0749-596X(91)90027-H; Kliegl R., 1999, CONSTRAINTS LANGUAGE, P137, DOI [10.1007/0-306-46902-2_6, DOI 10.1007/0-306-46902-2_]; LECOMPTE DC, 1995, PSYCHON B REV, V2, P391, DOI 10.3758/BF03210978; Liversedge S. P., 1998, EYE GUIDANCE READING, P55, DOI DOI 10.1016/B978-008043361-5/50004-3; MACWHINNEY B, 1988, COGNITION, V29, P95, DOI 10.1016/0010-0277(88)90034-0; Marsh JE, 2008, J MEM LANG, V58, P682, DOI 10.1016/j.jml.2007.05.002; Marsh JE, 2014, MEM COGNITION, V42, P1285, DOI 10.3758/s13421-014-0438-6; Marsh JE, 2009, COGNITION, V110, P23, DOI 10.1016/j.cognition.2008.08.003; Martin R., 1994, NEUROPSYCHOLOGY, V8, P506, DOI [10.1037/0894-4105.8.4.506, DOI 10.1037/0894-4105.8.4.506]; MARTIN RC, 1988, J MEM LANG, V27, P382, DOI 10.1016/0749-596X(88)90063-0; MARTIN RC, 1994, J MEM LANG, V33, P83, DOI 10.1006/jmla.1994.1005; MURRAY WS, 1988, Q J EXP PSYCHOL-A, V40, P693, DOI 10.1080/14640748808402294; Oswald CJP, 2000, MEMORY, V8, P345, DOI 10.1080/09658210050117762; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; RAYNER K, 1975, COGNITIVE PSYCHOL, V7, P65, DOI 10.1016/0010-0285(75)90005-5; Robison MK, 2015, APPL COGNITIVE PSYCH, V29, P680, DOI 10.1002/acp.3150; Sorqvist P, 2015, CURR DIR PSYCHOL SCI; Sorqvist P, 2010, MEMORY, V18, P310, DOI 10.1080/09658211003601530; Sorqvist P, 2010, J ENVIRON PSYCHOL, V30, P112, DOI 10.1016/j.jenvp.2009.11.004; Sorqvist P, 2010, APPL COGNITIVE PSYCH, V24, P67, DOI 10.1002/acp.1543; van Gompel RPG, 2001, J MEM LANG, V45, P225, DOI 10.1006/jmla.2001.2773; Venetjoki N, 2006, ERGONOMICS, V49, P1068, DOI 10.1080/00140130600679142	48	15	18	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152133	10.1371/journal.pone.0152133	http://dx.doi.org/10.1371/journal.pone.0152133			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3OX	27003410	gold, Green Published, Green Submitted			2022-12-26	WOS:000372697400083
J	Liao, Y; Gilmour, S; Shibuya, K				Liao, Yi; Gilmour, Stuart; Shibuya, Kenji			Health Insurance Coverage and Hypertension Control in China: Results from the China Health and Nutrition Survey	PLOS ONE			English	Article							BLOOD-PRESSURE; CHRONIC DISEASE; UNITED-STATES; COUNTRIES	Background China has rapidly expanded health insurance coverage over the past decade but its impact on hypertension control is not well known. We analyzed factors associated with hypertension and the impact of health insurance on the management of hypertension in China from 1991 to 2009. Methods and Findings We used individual-level data from the China Health and Nutrition Survey (CHNS) for blood pressure, BMI, and other socio-economic variables. We employed multi-level logistic regression models to estimate the factors associated with prevalence and management of hypertension. We also estimated the effects of health insurance on management of hypertension using propensity score matching. We found that prevalence of hypertension increased from 23.8% (95% CI: 22.5-25.1%) in 1991 to 31.5% (28.5-34.7%) in 2009. The proportion of hypertensive patients aware of their condition increased from 31.7%(28.7-34.9%) to 51.1% (45.1-57.0%). The proportion of diagnosed hypertensive patients in treatment increased by 35.5% in the 19 years, while the proportion of those in treatment with controlled blood pressure remained low. Among diagnosed hypertensives, health insurance increased the probability of receiving treatment by 28.7% (95% CI: 10.6-46.7%) compared to propensity-matched individuals not covered by health insurance. Conclusions Hypertension continues to be a major health threat in China and effective control has not improved over time despite large improvements in awareness and treatment access. This suggests problems in treatment quality, medication adherence and patient understanding of the condition. Improvements in hypertension management, quality of medical care for those at high risk, and better health insurance packages are needed.	[Liao, Yi; Gilmour, Stuart; Shibuya, Kenji] Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan	University of Tokyo	Liao, Y (corresponding author), Univ Tokyo, Dept Global Hlth Policy, Tokyo, Japan.	liaoyi.pku@gmail.com		Shibuya, Kenji/0000-0003-2528-7530	Japan Ministry of Health and Welfare [H25-chikyukibo-ippan-007, H27-chikyukibo-shitei-004]; Ministry of Education, Culture, Sports, Science and Technology [22390130]; National Institute of Nutrition and Food Safety; China Center for Disease Control and Prevention; Carolina Population Center; University of North Carolina at Chapel Hill; NIH [R01-HD30880, DK056350, R01-HD38700]; Fogarty International Center, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD030880] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER	Japan Ministry of Health and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Nutrition and Food Safety; China Center for Disease Control and Prevention; Carolina Population Center; University of North Carolina at Chapel Hill; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported in part by grants from the Japan Ministry of Health and Welfare (H25-chikyukibo-ippan-007 and H27-chikyukibo-shitei-004) and the Ministry of Education, Culture, Sports, Science and Technology (Grant-in-aid for scientific research A, grant number 22390130). The funders had no influence over the content of the research or the decision to publish.; This study was supported in part by grants from the Japan Ministry of Health and Welfare (H25-chikyukibo-ippan-007 and H27-chikyukibo-shitei-004) and the Ministry of Education, Culture, Sports, Science and Technology (Grant-in-aid for scientific research A, grant number 22390130). The funders had no influence over the content of the research or the decision to publish. We are grateful to the National Institute of Nutrition and Food Safety, China Center for Disease Control and Prevention, Carolina Population Center, the University of North Carolina at Chapel Hill, the NIH (R01-HD30880, DK056350, and R01-HD38700) and the Fogarty International Center, NIH for financial support for the CHNS data collection and analysis files from 1989 to 2006 and both parties plus the China-Japan Friendship Hospital, Ministry of Health for support for CHNS 2009 and future surveys.	Anderson CAM, 2010, J AM DIET ASSOC, V110, P736, DOI 10.1016/j.jada.2010.02.007; Barber SL, 2010, HLTH INSURANCE SYSTE, P1; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Biao Y, 2011, INT C HUM HLTH BIOM, V2011, P852; Black HR, 2001, HYPERTENSION, V37, P12, DOI 10.1161/01.HYP.37.1.12; Bramlage P, 2010, J CLIN HYPERTENS, V12, P666, DOI 10.1111/j.1751-7176.2010.00322.x; Duru OK, 2007, AM J HYPERTENS, V20, P348, DOI 10.1016/j.amjhyper.2006.11.007; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065938; Hagihara A, 2001, HEALTH POLICY, V58, P231, DOI 10.1016/S0168-8510(01)00171-3; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Ikeda N, 2008, B WORLD HEALTH ORGAN, V86, P978; Ikeda N, 2014, B WORLD HEALTH ORGAN, V92, P10, DOI 10.2471/BLT.13.121954; Institute for Health Metrics and Evaluation, GBD ARR DIAGR 2013; Izzo JL, 2000, HYPERTENSION, V35, P1021, DOI 10.1161/01.HYP.35.5.1021; Lei XY, 2012, CHINA ECON REV, V23, P105, DOI 10.1016/j.chieco.2011.08.004; Li Jian-xin, 2013, Zhonghua Yu Fang Yi Xue Za Zhi, V47, P301; Li L, 2008, CHINESE HLTH EC, V27, P26; Liu LS, 2010, ZHONGHUA XIN XUE GUA, V201139, P579; Ma JS, 2005, CHINESE J PREVENTIVE, V39, P311; Ma JT, 2012, CHINA STAT YB 2012; Parry J, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e248; Popkin BM, 2010, INT J EPIDEMIOL, V39, P1435, DOI 10.1093/ije/dyp322; Song YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068599; STAMLER R, 1993, J HUM HYPERTENS, V7, P429; Sun Q, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-42; World Bank, OFF EXCH RAT; Xiao HM, 2005, CHINESE J CLIN REHAB, V31, P30; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yip W, 2009, SOC SCI MED, V68, P201, DOI 10.1016/j.socscimed.2008.09.066	29	15	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152091	10.1371/journal.pone.0152091	http://dx.doi.org/10.1371/journal.pone.0152091			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3OX	27002634	Green Published, gold, Green Submitted			2022-12-26	WOS:000372697400077
J	Mitchell, EJ; McCallum, S; Dewar, D; Maxwell, DJ				Mitchell, Emma J.; McCallum, Sarah; Dewar, Deborah; Maxwell, David J.			Corticospinal and Reticulospinal Contacts on Cervical Commissural and Long Descending Propriospinal Neurons in the Adult Rat Spinal Cord; Evidence for Powerful Reticulospinal Connections	PLOS ONE			English	Article							CHOLERA-TOXIN; VENTROLATERAL FUNICULUS; HORSERADISH-PEROXIDASE; QUADRUPEDAL LOCOMOTION; VESTIBULOSPINAL TRACT; RETICULAR-FORMATION; NEONATAL RAT; SUBUNIT-B; PHA-L; CAT	Descending systems have a crucial role in the selection of motor output patterns by influencing the activity of interneuronal networks in the spinal cord. Commissural interneurons that project to the contralateral grey matter are key components of such networks as they coordinate left-right motor activity of fore and hind-limbs. The aim of this study was to determine if corticospinal (CST) and reticulospinal (RST) neurons make significant numbers of axonal contacts with cervical commissural interneurons. Two classes of commissural neurons were analysed: 1) local commissural interneurons (LCINs) in segments C4-5;2) long descending propriospinal neurons (LDPNs) projecting from C4 to the rostral lumbar cord. Commissural interneurons were labelled with Fluorogold and CST and RST axons were labelled by injecting the b subunit of cholera toxin in the forelimb area of the primary somatosensory cortex or the medial longitudinal fasciculus respectively. The results show that LCINs and LDPNs receive few contacts from CST terminals but large numbers of contacts are formed by RST terminals. Use of vesicular glutamate and vesicular GABA transporters revealed that both types of cell received about 80% excitatory and 20% inhibitory RST contacts. Therefore the CST appears to have a minimal influence on LCINs and LDPNs but the RST has a powerful influence. This suggests that left-right activity in the rat spinal cord is not influenced directly via CST systems but is strongly controlled by the RST pathway. Many RST neurons have monosynaptic input from corticobulbar pathways therefore this pathway may provide an indirect route from the cortex to commissural systems. The corticoreticulospinal- commissural system may also contribute to functional recovery following damage to the CST as it has the capacity to deliver information from the cortex to the spinal cord in the absence of direct CST input.	[Mitchell, Emma J.; McCallum, Sarah; Dewar, Deborah; Maxwell, David J.] Univ Glasgow, Coll Med Vet Med & Life Sci, Inst Neurosci & Psychol, Spinal Cord Grp, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Maxwell, DJ (corresponding author), Univ Glasgow, Coll Med Vet Med & Life Sci, Inst Neurosci & Psychol, Spinal Cord Grp, Glasgow G12 8QQ, Lanark, Scotland.	David.Maxwell@Glasgow.ac.uk			Medical Research Council; Neurosciences Foundation, Glasgow	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Neurosciences Foundation, Glasgow	EM funded by PhD Studentship from Medical Research Council (http://www.mrc.ac.uk/). Additional support from Neurosciences Foundation, Glasgow (http://neurosciencesfoundation.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSTERMARK B, 1987, BRAIN RES, V404, P382, DOI 10.1016/0006-8993(87)91400-4; ALSTERMARK B, 1991, EXP BRAIN RES, V84, P561; ALSTERMARK B, 1991, EXP BRAIN RES, V84, P569; ALSTERMARK B, 1987, BRAIN RES, V404, P395, DOI 10.1016/0006-8993(87)91402-8; ALSTERMARK B, 1985, EXP BRAIN RES, V59, P353; Alstermark B, 2004, J NEUROPHYSIOL, V91, P1832, DOI 10.1152/jn.00820.2003; ALSTERMARK B, 1990, EXP BRAIN RES, V80, P96, DOI 10.1007/BF00228851; Angelucci A, 1996, J NEUROSCI METH, V65, P101, DOI 10.1016/0165-0270(95)00155-7; Bachmann LC, 2014, J NEUROSCI, V34, P3378, DOI 10.1523/JNEUROSCI.4384-13.2014; Ballion B, 2001, EUR J NEUROSCI, V14, P1727, DOI 10.1046/j.0953-816x.2001.01794.x; Bannatyne BA, 2009, J PHYSIOL-LONDON, V587, P379, DOI 10.1113/jphysiol.2008.159129; Bannatyne BA, 2003, EUR J NEUROSCI, V18, P2273, DOI 10.1046/j.1460-9568.2003.02973.x; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; BOLTON PS, 1991, NEUROREPORT, V2, P743, DOI 10.1097/00001756-199112000-00003; Brockett EG, 2013, NEUROSCIENCE, V240, P83, DOI 10.1016/j.neuroscience.2013.02.039; Brosamle C, 1997, J COMP NEUROL, V386, P293, DOI 10.1002/(SICI)1096-9861(19970922)386:2<293::AID-CNE9>3.0.CO;2-X; CASALE EJ, 1988, J COMP NEUROL, V278, P275, DOI 10.1002/cne.902780210; CAVADA C, 1984, BRAIN RES, V308, P123, DOI 10.1016/0006-8993(84)90923-5; CHEN S, 1995, BRAIN RES, V674, P107, DOI 10.1016/0006-8993(95)00020-Q; Du Beau A, 2012, NEUROSCIENCE, V227, P67, DOI 10.1016/j.neuroscience.2012.09.037; ERICSON H, 1988, J NEUROSCI METH, V24, P225, DOI 10.1016/0165-0270(88)90167-7; HUISMAN AM, 1981, BRAIN RES, V209, P271, DOI 10.1016/0006-8993(81)90153-0; Huma Z, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00040; Jankowska E, 2006, NEUROSCIENTIST, V12, P67, DOI 10.1177/1073858405283392; Jankowska E, 2003, J NEUROSCI, V23, P1867; JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9; Juvin L, 2005, J NEUROSCI, V25, P6025, DOI 10.1523/JNEUROSCI.0696-05.2005; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Lemon RN, 2008, ANNU REV NEUROSCI, V31, P195, DOI 10.1146/annurev.neuro.31.060407.125547; LIANG F, 1991, J COMP NEUROL, V311, P356, DOI 10.1002/cne.903110306; Matsuyama K, 1997, J COMP NEUROL, V377, P234; Matsuyama K, 2004, PROG BRAIN RES, V143, P239, DOI 10.1016/S0079-6123(03)43024-0; Matsuyama K, 2004, J COMP NEUROL, V474, P546, DOI 10.1002/cne.20131; Matsuyama K, 1999, J COMP NEUROL, V410, P413; McKenna JE, 2000, J COMP NEUROL, V419, P286, DOI 10.1002/(SICI)1096-9861(20000410)419:3<286::AID-CNE2>3.0.CO;2-3; NEAFSEY EJ, 1986, BRAIN RES REV, V11, P77, DOI 10.1016/0165-0173(86)90011-1; Ni YC, 2014, J NEUROSCI, V34, P9404, DOI 10.1523/JNEUROSCI.1771-14.2014; NYBERGHANSEN R, 1964, J COMP NEUROL, V122, P369, DOI 10.1002/cne.901220307; Olave MJ, 2003, J NEUROSCI, V23, P6837; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; PETRAS J. M., 1967, BRAIN RES, V6, P275, DOI 10.1016/0006-8993(67)90196-5; Quinlan KA, 2007, J NEUROSCI, V27, P6521, DOI 10.1523/JNEUROSCI.1618-07.2007; Reed WR, 2008, NEUROSCIENCE, V151, P505, DOI 10.1016/j.neuroscience.2007.10.025; Reed WR, 2009, BRAIN RES, V1302, P76, DOI 10.1016/j.brainres.2009.09.049; SHINODA Y, 1992, J COMP NEUROL, V316, P151, DOI 10.1002/cne.903160203; Sivertsen MS, 2016, J COMP NEUROL, V524, P1270, DOI 10.1002/cne.23904; Sivertsen MS, 2014, J NEUROPHYSIOL, V112, P1628, DOI 10.1152/jn.00820.2013; Soteropoulos DS, 2013, J NEUROSCI, V33, P9614, DOI 10.1523/JNEUROSCI.0269-13.2013; Soteropoulos DS, 2012, J PHYSIOL-LONDON, V590, P4011, DOI 10.1113/jphysiol.2011.225169; Stepien AE, 2010, NEURON, V68, P456, DOI 10.1016/j.neuron.2010.10.019; Stokke MF, 2002, J COMP NEUROL, V446, P349, DOI 10.1002/cne.10211; SUGIUCHI Y, 1992, NEUROSCI LETT, V145, P221, DOI 10.1016/0304-3940(92)90027-5; Todd AJ, 1997, J NEUROSCI METH, V73, P149, DOI 10.1016/S0165-0270(97)02222-X; VALTSCHANOFF JG, 1993, EXP BRAIN RES, V93, P95; WILSON VJ, 1978, PHYSIOL REV, V58, P80, DOI 10.1152/physrev.1978.58.1.80; Zaaimi B, 2012, BRAIN, V135, P2277, DOI 10.1093/brain/aws115; ZEMLAN FP, 1978, EXP NEUROL, V62, P298, DOI 10.1016/0014-4886(78)90059-6	57	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0152094	10.1371/journal.pone.0152094	http://dx.doi.org/10.1371/journal.pone.0152094			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999665	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000372694700100
J	Hong, JY; Han, K; Shin, DH; Chun, EM				Hong, Jae-Young; Han, Kyungdo; Shin, Dong-Hyup; Chun, Eun Mi			Quality of Life Analysis and Smoking Correlation in Symptomatic Spine Osteoarthritis: A Nationwide Health Survey Analysis of an Elderly Population with EQ-5D	PLOS ONE			English	Article							HIP OSTEOARTHRITIS; KNEE OSTEOARTHRITIS; GENERAL-POPULATION; PREVALENCE; ASSOCIATION; OVERWEIGHT; ARTHRITIS; HISTORY; IMPACT; COHORT	Objectives To analyze quality of life in people with symptomatic spine osteoarthritis (OA) using the results of a cross-sectional, nationwide survey. Materials and Methods This study used data from the Fifth Korean National Health and Nutrition Examination Survey (KNHANES V-5; 2010-2012). After excluding ineligible subjects, the total number of subjects in the study was 8,963, including 4,091 males and 4,872 females. All participants reported disabilities related to spine OA. Plain radiographs of the spine were taken for all participants. Results Age, sex, smoking, drinking, education, and income level were significantly related to spine OA morbidity (P<0.05). OA morbidity was significantly higher in female ex-smokers (OR; 2.94, P<0.05). Quality of life (EQ-5D: L1 similar to 5) was significantly compromised in the group with spine OA compared to the group without spine OA (P<0.05). Overall, LQ 1, 2, 3, 4, and 5 domain scores were significantly higher in the group with spine OA (P<0.05). In the group with spine OA, quality of life was reduced on more than three questions for 34.3% of the group (EQ-5D: grade >= 2); on two questions, for 18.5% of the group; and on one question, for 11.1% of the group. Mental stress, melancholy, and suicidal thinking were also more common in the group with spine OA (P<0.05). The group with radiographic spine OA but without symptoms did not have compromised EQ-5D scores, whereas the group with radiographic OA and symptoms showed a significantly reduced quality of life. Conclusions Quality of life was significantly reduced in the group with symptomatic spine OA in a large cross-sectional analysis. Physicians should consider quality of life in the treatment of patients with spine OA	[Hong, Jae-Young; Shin, Dong-Hyup] Korea Univ, Ansan Hosp, Dept Orthoped, Ansan, South Korea; [Han, Kyungdo] Catholic Univ, Coll Med, Dept Biostat, Seoul, South Korea; [Chun, Eun Mi] Ewha Womans Univ, Div Pulm & Crit Care Med, Dept Internal Med, Mokdong Hosp, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Catholic University of Korea; Ewha Womans University	Chun, EM (corresponding author), Ewha Womans Univ, Div Pulm & Crit Care Med, Dept Internal Med, Mokdong Hosp, Seoul, South Korea.	cem@ewha.ac.kr						Akmal M, 2004, SPINE, V29, P568, DOI 10.1097/01.BRS.0000101422.36419.D8; Amin S, 2007, ANN RHEUM DIS, V66, P18, DOI 10.1136/ard.2006.056697; ANDERSON JJ, 1988, AM J EPIDEMIOL, V128, P179, DOI 10.1093/oxfordjournals.aje.a114939; Andrianakos AA, 2006, J RHEUMATOL, V33, P2507; Blagojevic M, 2010, OSTEOARTHR CARTILAGE, V18, P24, DOI 10.1016/j.joca.2009.08.010; Chung JH, 2014, NPJ PRIM CARE RESP M, V24, DOI 10.1038/npjpcrm.2014.94; Ding CH, 2007, ARTHRITIS RHEUM-US, V56, P1521, DOI 10.1002/art.22591; Dominick Kelli L, 2004, Health Qual Life Outcomes, V2, P5; Eisele M, 2015, BRIT J GEN PRACT, V65, pE716, DOI 10.3399/bjgp15X687337; Ernest S, 2001, P 26 ANN SAS US GROU, P222; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; Geryk LL, 2015, CLIN EXP RHEUMATOL, V33, P366; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; Gullihorn L, 2005, J ORTHOP TRAUMA, V19, P17, DOI 10.1097/00005131-200501000-00004; Hill CL, 1999, J RHEUMATOL, V26, P2029; Hui M, 2011, ANN RHEUM DIS, V70, P1231, DOI 10.1136/ard.2010.142323; Hung MC, 2015, J OCCUP REHABIL, V25, P387, DOI 10.1007/s10926-014-9547-0; Hunter DJ, 2009, MED CLIN N AM, V93, P127, DOI [10.1016/j.rdc.2008.05.008, 10.1016/j.mcna.2008.07.009]; Hwang IC, 2015, ASIA-PAC J PUBLIC HE, V27, P4; Jordan JM, 2007, J RHEUMATOL, V34, P172; Jorgensen KT, 2011, OSTEOARTHR CARTILAGE, V19, P1176, DOI 10.1016/j.joca.2011.07.009; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kent S, 2015, MED DECIS MAKING, V35, P902, DOI 10.1177/0272989X15584921; Kim C, 2014, ARTHRITIS RHEUMATOL, V66, P3013, DOI 10.1002/art.38795; Kim KH, 2013, SUPPORT CARE CANCER, V21, P3471, DOI 10.1007/s00520-013-1939-8; Kim Y, 2014, EPIDEMIOL HLTH, V30; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Leicht H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070018; Muraki S, 2010, OSTEOARTHR CARTILAGE, V18, P1227, DOI 10.1016/j.joca.2010.06.001; Nelson AE, 2013, ARTHRITIS RHEUM-US, V65, P373, DOI 10.1002/art.37775; Nho SJ, 2013, J AM ACAD ORTHOP SUR, V21, pS1, DOI 10.5435/JAAOS-21-07-S1; Oda H, 2004, J ORTHOP SCI, V9, P135, DOI 10.1007/s00776-003-0759-y; Pereira D, 2011, OSTEOARTHR CARTILAGE, V19, P1270, DOI 10.1016/j.joca.2011.08.009; Ramsey SD, 2015, J CLIN ONCOLOGY, V33; Sandmark H, 1999, ANN RHEUM DIS, V58, P151, DOI 10.1136/ard.58.3.151; TEPPER S, 1993, AM J EPIDEMIOL, V137, P1081, DOI 10.1093/oxfordjournals.aje.a116611; Turkiewicz A, 2014, OSTEOARTHR CARTILAGE, V22, P1826, DOI 10.1016/j.joca.2014.07.015; Turkiewicz A, 2015, RHEUMATOLOGY, V54, P827, DOI 10.1093/rheumatology/keu409; Yu ST, 2015, QUAL LIFE RES, V24, P2541, DOI 10.1007/s11136-015-0978-7	39	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151315	10.1371/journal.pone.0151315	http://dx.doi.org/10.1371/journal.pone.0151315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1ZE	26991429	Green Submitted, Green Published, gold			2022-12-26	WOS:000372582800054
J	Song, GJ; Ji, ZZ				Song, GuangJia; Ji, ZhenZhou			Novel Duplicate Address Detection with Hash Function	PLOS ONE			English	Article								Duplicate address detection (DAD) is an important component of the address resolution protocol (ARP) and the neighbor discovery protocol (NDP). DAD determines whether an IP address is in conflict with other nodes. In traditional DAD, the target address to be detected is broadcast through the network, which provides convenience for malicious nodes to attack. A malicious node can send a spoofing reply to prevent the address configuration of a normal node, and thus, a denial-of-service attack is launched. This study proposes a hash method to hide the target address in DAD, which prevents an attack node from launching destination attacks. If the address of a normal node is identical to the detection address, then its hash value should be the same as the "Hash_64" field in the neighboring solicitation message. Consequently, DAD can be successfully completed. This process is called DAD-h. Simulation results indicate that address configuration using DAD-h has a considerably higher success rate when under attack compared with traditional DAD. Comparative analysis shows that DAD-h does not require third-party devices and considerable computing resources; it also provides a lightweight security resolution.	[Song, GuangJia; Ji, ZhenZhou] Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150006, Peoples R China	Harbin Institute of Technology	Song, GJ (corresponding author), Harbin Inst Technol, Sch Comp Sci & Technol, Harbin 150006, Peoples R China.	35059899@QQ.com			National Natural Science Foundation of China [61173024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (grant no. 61173024), http://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsa'deh A., 2012, 2012 International Conference on Information Networking (ICOIN 2012), P257, DOI 10.1109/ICOIN.2012.6164388; AlSa'deh A, 2011, IEEE INT CONF NETWOR, P299, DOI 10.1109/ICON.2011.6168492; Arkko J., 2005, 3971 IETF RFC; Aura Tuomas, 2005, CRYPTOGRAPHICALLY GE; Bagnulo M., 2006, CRYPTOGRAPHICALLY GE; Bagnulo M, 2013, IEEE COMMUN MAG, V51, P66, DOI 10.1109/MCOM.2013.6495763; Beck F., 2007, P INT MULT COMP GLOB, P57; Cheshire S., 2008, IPV4 ADDRESS CONFLIC; D. C. Plummer, ETHERNET ADDRESS RES; Garcia-Martinez A, 2012, IEEE COMMUN LETT, V16, P1900, DOI 10.1109/LCOMM.2012.100812.121517; Heuse M, THC IPV6 ATTACK TOOL; Kevin R, 2011, TCP IP ILLUSTRATED, V1; Kim PS, 2013, ENG LET, V21, P68; LI ZM, 2008, P INT S IEEE COMP SC, P277, DOI DOI 10.1109/ISCSCT.2008.62; Narten T., 2001, 3041 RFC, DOI DOI 10.17487/RFC3041; Narten T., 2007, PRIVACY EXTENSIONS S; Narten T., NEIGHBOR DISCOVERY I; Netze Heise, 2008, SOURCE ADDRESS VALID; Nikander Pekka, 2004, IPV6 NEIGHBOR DISCOV; Rafiee H., 2012, 2012 International Conference on Information Networking (ICOIN 2012), P269, DOI 10.1109/ICOIN.2012.6164390; Rehman SU, 2015, INT J SECUR APPL, V9, P77, DOI 10.14257/ijsia.2015.9.11.08; Seo Karen, 2005, SECURITY ARCHITECTUR; Shigei Noritaka, 2012, IAENG International Journal of Computer Science, V39, P321; Stinson D. R., 2005, CRYPTOGRAPHY THEORY; Thomson S., 2007, RFC, V4862, P1; Tseng CC, 2006, IEEE INTERNET COMPUT, V10, P50, DOI 10.1109/MIC.2006.131; Yu-xuan Hong, 2011, Proceedings of the 2011 Fifth International Conference on Innovative Mobile and Internet Services in Ubiquitous Computing (IMIS), P353, DOI 10.1109/IMIS.2011.121	27	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151612	10.1371/journal.pone.0151612	http://dx.doi.org/10.1371/journal.pone.0151612			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991901	Green Published, gold, Green Submitted			2022-12-26	WOS:000372582800078
J	Young, SK; Baird, TD; Wek, RC				Young, Sara K.; Baird, Thomas D.; Wek, Ronald C.			Translation Regulation of the Glutamyl-prolyl-tRNA Synthetase Gene EPRS through Bypass of Upstream Open Reading Frames with Noncanonical Initiation Codons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; INTEGRATED STRESS-RESPONSE; RIBOSOMAL ENTRY SITE; MAMMALIAN-CELLS; QUALITY-CONTROL; MESSENGER-RNAS; PHOSPHORYLATION; METABOLISM; ACTIVATION; EXPRESSION	In the integrated stress response, phosphorylation of eIF2 alpha. (eIF2 alpha-P) reduces protein synthesis while concomitantly promoting preferential translation of specific transcripts associated with stress adaptation. Translation of the glutamyl-prolyl-tRNA synthetase gene EPRS is enhanced in response to eIF2 alpha-P. To identify the underlying mechanism of translation control, we employed biochemical approaches to determine the regulatory features by which upstream ORFs (uORFs) direct downstream translation control and expression of the EPRS coding region. Our findings reveal that translation of two inhibitory uORE's encoded by noncanonical CUG and UUG initiation codons in the EPRS mRNA 5'-leader serve to dampen levels of translation initiation at the EPRS coding region. By a mechanism suggested to involve increased translation initiation stringency during stress-induced eIF2 alpha-P, we observed facilitated ribosome bypass of these uORFs, allowing for increased translation of the EPRS coding region. Importantly, EPRS protein expression is enhanced through this preferential translation mechanism in response to multiple known activators of eIF2 alpha-P and likely serves to facilitate stress adaptation in response to a variety of cellular stresses. The rules presented here for the regulated ribosome bypass of noncanonical initiation codons in the EPRS 5'-leader add complexity into the nature of uORF-mediated translation control mechanisms during eIF2 alpha-P and additionally illustrate the roles that previously unexamined uORFs with noncanonical initiation codons can play in modulating gene expression.	[Young, Sara K.; Baird, Thomas D.; Wek, Ronald C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Wek, RC (corresponding author), Indiana Univ, Sch Med, Dept Biochem & Mol Biol, 635 Barnhill Dr, Indianapolis, IN 46202 USA.	rwek@iu.edu		Young-Baird, Sara/0000-0002-8915-3139; Baird, Thomas/0000-0002-0280-9984	National Institutes of Health [GM049164]; Ralph W. and Grace M. Showalter Research Trust Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049164] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ralph W. and Grace M. Showalter Research Trust Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM049164 (to R. C. W.) and the Ralph W. and Grace M. Showalter Research Trust Fund. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baird TD, 2014, MOL BIOL CELL, V25, P1686, DOI 10.1091/mbc.E14-02-0704; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Bullwinkle T, 2014, ANNU REV GENET, V48, P149, DOI 10.1146/annurev-genet-120213-092101; Bullwinkle TJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02501; Cho SC, 2007, MOL CELL BIOL, V27, P368, DOI 10.1128/MCB.00814-06; Gao XW, 2015, NAT METHODS, V12, P147, DOI 10.1038/nmeth.3208; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Iacono M, 2005, GENE, V349, P97, DOI 10.1016/j.gene.2004.11.041; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Keller TL, 2012, NAT CHEM BIOL, V8, P311, DOI [10.1038/NCHEMBIO.790, 10.1038/nchembio.790]; Kim YK, 2002, BIOCHEM BIOPH RES CO, V297, P224, DOI 10.1016/S0006-291X(02)02154-X; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; Lee S, 2012, P NATL ACAD SCI USA, V109, pE2424, DOI 10.1073/pnas.1207846109; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Narasimhan J, 2004, J BIOL CHEM, V279, P22820, DOI 10.1074/jbc.M402228200; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Peng W, 2012, SCI TRANSL MED, V4; Starck SR, 2016, SCIENCE, V351, DOI 10.1126/science.aad3867; Teske BF, 2013, MOL BIOL CELL, V24, P2477, DOI 10.1091/mbc.E13-01-0067; Teske BF, 2011, METHOD ENZYMOL, V490, P333, DOI 10.1016/B978-0-12-385114-7.00019-2; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Young SK, 2015, J BIOL CHEM, V290, P28257, DOI 10.1074/jbc.M115.693184; Zaborske JM, 2009, J BIOL CHEM, V284, P25254, DOI 10.1074/jbc.M109.000877; Zhou DH, 2008, J BIOL CHEM, V283, P7064, DOI 10.1074/jbc.M708530200; Zhou HH, 2013, NATURE, V494, P121, DOI 10.1038/nature11774	34	22	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10824	10835		10.1074/jbc.M116.722256	http://dx.doi.org/10.1074/jbc.M116.722256			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27002157	Green Published, hybrid			2022-12-26	WOS:000377042600032
J	Gudnadottir, TA; Bateman, BT; Hernadez-Diaz, S; Luque-Fernandez, MA; Valdimarsdottir, U; Zoega, H				Gudnadottir, Thuridur A.; Bateman, Brian T.; Hernadez-Diaz, Sonia; Luque-Fernandez, Miguel Angel; Valdimarsdottir, Unnur; Zoega, Helga			Body Mass Index, Smoking and Hypertensive Disorders during Pregnancy: A Population Based Case-Control Study	PLOS ONE			English	Article							NHLBI WORKING GROUP; RISK-FACTORS; GESTATIONAL HYPERTENSION; CIGARETTE-SMOKING; NULLIPAROUS WOMEN; PREECLAMPSIA; STATES; OBESITY	While obesity is an indicated risk factor for hypertensive disorders of pregnancy, smoking during pregnancy has been shown to be inversely associated with the development of pre-eclampsia and gestational hypertension. The purpose of this study was to investigate the combined effects of high body mass index and smoking on hypertensive disorders during pregnancy. This was a case-control study based on national registers, nested within all pregnancies in Iceland 1989-2004, resulting in birth at the Landspitali University Hospital. Cases (n = 500) were matched 1:2 with women without a hypertensive diagnosis who gave birth in the same year. Body mass index (kg/m(2)) was based on height and weight at 10-15 weeks of pregnancy. We used logistic regression models to calculate odds ratios and corresponding 95% confidence intervals as measures of association, adjusting for potential con-founders and tested for additive and multiplicative interactions of body mass index and smoking. Women's body mass index during early pregnancy was positively associated with each hypertensive outcome. Compared with normal weight women, the multivariable adjusted odds ratio for any hypertensive disorder was 1.8 (95% confidence interval, 1.32.3) for overweight women and 3.1 (95% confidence interval, 2.2-4.3) for obese women. The odds ratio for any hypertensive disorder with obesity was 3.9 (95% confidence interval 1.8-8.6) among smokers and 3.0 (95% confidence interval 2.1-4.3) among non-smokers. The effect estimates for hypertensive disorders with high body mass index appeared more pronounced among smokers than non-smokers, although the observed difference was not statistically significant. Our findings may help elucidate the complicated interplay of these lifestyle-related factors with the hypertensive disorders during pregnancy.	[Gudnadottir, Thuridur A.; Valdimarsdottir, Unnur; Zoega, Helga] Univ Iceland, Fac Med, Ctr Publ Hlth Sci, Reykjavik, Iceland; [Bateman, Brian T.] Harvard Univ, Sch Med, Dept Anesthesia Crit Care & Pain Med, Massachusetts Gen Hosp, Boston, MA USA; [Bateman, Brian T.] Harvard Univ, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Dept Med,Med Sch, Boston, MA 02115 USA; [Hernadez-Diaz, Sonia; Luque-Fernandez, Miguel Angel; Valdimarsdottir, Unnur] Harvard Univ, Dept Epidemiol, TH Chan Sch Publ Hlth, Boston, MA 02115 USA	University of Iceland; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Zoega, H (corresponding author), Univ Iceland, Fac Med, Ctr Publ Hlth Sci, Reykjavik, Iceland.	helgaz@hi.is	FERNANDEZ, MIGUEL ANGEL LUQUE/AAZ-5017-2020; FERNANDEZ, MIGUEL ANGEL LUQUE/AAK-7183-2021; FERNANDEZ, MIGUEL ANGEL LUQUE/L-4053-2015	FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; Valdimarsdottir, Unnur/0000-0001-5382-946X	Icelandic Centre for Research; START - Reintegration fellowship [130814-051]; Eunice Kennedy Shriver National Institute of Child Health & Human Development of National Institutes of Health (Bethesda, Maryland, United States) [K08HD075831]; US National Institute of Mental Health [R01MH100216]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K08HD075831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100216] Funding Source: NIH RePORTER	Icelandic Centre for Research; START - Reintegration fellowship; Eunice Kennedy Shriver National Institute of Child Health & Human Development of National Institutes of Health (Bethesda, Maryland, United States); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	HZ and TAG received financial support for this study from the Icelandic Centre for Research, START - Reintegration fellowship (#130814-051), http://www.rannis.is/. BTB was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health (Bethesda, Maryland, United States) under award number K08HD075831, https://www.nichd.nih.gov/Pages/index.aspx. SHD was supported by grant R01MH100216 from the US National Institute of Mental Health, https://www.nimh.nih.gov/index.shtml. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript. The authors did not receive financial support from any other organization for the submitted work.	Bateman BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036171; Bhattacharya S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-168; Bjarnadottir RI, 2013, NAT BIRTH REG REP 20; Bodnar LM, 2005, ANN EPIDEMIOL, V15, P475, DOI 10.1016/j.annepidem.2004.12.008; Boyd HA, 2013, AM J EPIDEMIOL, V178, P1611, DOI 10.1093/aje/kwt189; Catov JM, 2007, INT J EPIDEMIOL, V36, P412, DOI 10.1093/ije/dyl271; Directorate of Health, 2008, PREN CAR HLTH WOM NO; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Engel SM, 2013, EPIDEMIOLOGY, V24, P379, DOI 10.1097/EDE.0b013e3182873a73; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Hammoud AO, 2005, AM J OBSTET GYNECOL, V192, P1856, DOI 10.1016/j.ajog.2004.12.057; Hardardottir H, 2012, CLIN GUIDELINES SCRE; Harmon Q, 2014, 27 ANN M SPER SOC PE; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Kim SY, 2007, OBESITY, V15, P986, DOI 10.1038/oby.2007.621; KLONOFFCOHEN H, 1993, OBSTET GYNECOL, V81, P541; Kuklina EV, 2009, OBSTET GYNECOL, V113, P1299, DOI 10.1097/AOG.0b013e3181a45b25; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Lisonkova S, 2014, 27 ANN M SPER SOC PE; Martin J.A., 2010, NATL VITAL STAT REP, V59, P1; Martin JA, 2010, NATL VITAL STAT REP, V58, P1, DOI 10.1007/s10995-007-0177-4; Ness RB, 2008, AM J EPIDEMIOL, V168, P427, DOI 10.1093/aje/kwn140; O'Brien TE, 2003, EPIDEMIOLOGY, V14, P368, DOI 10.1097/00001648-200305000-00020; Pagano M., 2018, PRINCIPLES BIOSTATIS; Roberts JM, 2003, HYPERTENSION, V41, P437, DOI 10.1161/01.HYP.0000054981.03589.E9; Roberts JM, 2003, HYPERTENS PREGNANCY, V22, P109, DOI 10.1081/PRG-120016792; Ros HS, 1998, AM J EPIDEMIOL, V147, P1062; Sibai BM, 1997, AM J OBSTET GYNECOL, V177, P1003, DOI 10.1016/S0002-9378(97)70004-8; Sigurbjornsdottir GB, 2000, CHANG SERV WOM DEL P; Stone CD, 2007, J PERINAT MED, V35, P28, DOI 10.1515/JPM.2007.003; Valensise H, 2008, HYPERTENSION, V52, P873, DOI 10.1161/HYPERTENSIONAHA.108.117358; Villar J, 2006, AM J OBSTET GYNECOL, V194, P921, DOI 10.1016/j.ajog.2005.10.813; Wikstrom AK, 2010, HYPERTENSION, V55, P1254, DOI 10.1161/HYPERTENSIONAHA.109.147082; World Health Organization, 2006, GLOB DAT BOD MASS IN	34	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152187	10.1371/journal.pone.0152187	http://dx.doi.org/10.1371/journal.pone.0152187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010734	Green Published, Green Accepted, gold			2022-12-26	WOS:000372708000105
J	Liu, LR; Wang, YY; Yan, R; Li, S; Shi, MJ; Xiao, Y; Guo, B				Liu, Lirong; Wang, Yuanyuan; Yan, Rui; Li, Shuang; Shi, Mingjun; Xiao, Ying; Guo, Bing			Oxymatrine Inhibits Renal Tubular EMT Induced by High Glucose via Upregulation of SnoN and Inhibition of TGF-beta 1/Smad Signaling Pathway	PLOS ONE			English	Article							UBIQUITIN-DEPENDENT DEGRADATION; TO-MESENCHYMAL TRANSITION; TGF-BETA; OBSTRUCTIVE NEPHROPATHY; DIABETIC-NEPHROPATHY; NEGATIVE REGULATORS; TUMOR-METASTASIS; DOWN-REGULATION; FIBROSIS; EXPRESSION	Transforming growth factor-beta 1 (TGF-beta 1) signaling has been shown to play a critical role in the development of diabetic nephropathy (DN). The nuclear transcription co-repressor Ski-related novel protein N (SnoN) is an important negative regulator of TGF-beta 1/Smad signal transduction, and subsequent biological responses including tubule epithelial-mesenchymal transition (EMT), extracellular matrix accumulation and tubulointerstitial fibrosis. Oxymatrine (OM) is an alkaloid extracted from the Chinese herb Sophora japonica and has been demonstrated to prevent fibrosis. However, the anti-fibrosis effect of OM in DN is still unclear. In this study, we cultured normal rat renal tubular epithelial cells (NRK52Es) in high glucose and high glucose plus OM, and detected the expression of E-cadherin, alpha-SMA, FN, TGF-beta 1, SnoN, Arkadia, p-Smad2 and p-Smad3 and poly-ubiquitination of SnoN. The results showed that E-cadherin and SnoN expression in NRK52Es decreased significantly, but poly-ubiquitination of SnoN, TGF-beta 1, alpha-SMA, FN, Arkadia, p-Smad2 and p-Smad3 expression significantly increased due to high glucose stimulation, which could be almost completely reversed by OM, suggesting that OM may alleviate EMT induced by high glucose via upregulating SnoN expression and inhibiting TGF-beta 1/Smad signaling pathway activation. Hence, OM could be a novel therapeutic for DN.	[Liu, Lirong] Guizhou Med Univ, Dept Clin Hematol, Affiliated Hosp, Guiyang, Guizhou, Peoples R China; [Wang, Yuanyuan; Li, Shuang; Shi, Mingjun; Xiao, Ying; Guo, Bing] Guizhou Med Univ, Dept Pathophysiol, Guiyang, Guizhou, Peoples R China; [Yan, Rui] Guizhou Med Univ, Dept Nephrol, Affiliated Hosp, Guiyang, Guizhou, Peoples R China	Guizhou Medical University; Guizhou Medical University; Guizhou Medical University	Guo, B (corresponding author), Guizhou Med Univ, Dept Pathophysiol, Guiyang, Guizhou, Peoples R China.	guobingbs@126.com	wang, yuanyuan/AAY-2671-2020	wang, yuanyuan/0000-0002-6693-643X; guo, bing/0000-0001-8998-2597	National Natural Science Foundation of China [81160094, 81460144]; special project for Traditional Chinese medicine research and development of Guizhou Province [[2012] 5037]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); special project for Traditional Chinese medicine research and development of Guizhou Province	This work was supported by the National Natural Science Foundation of China (Grant Nos. 81160094 and 81460144), and the special project for Traditional Chinese medicine research and development of Guizhou Province (Grant No. [2012] 5037).	Bonventre JV, 2012, SEMIN NEPHROL, V32, P452, DOI 10.1016/j.semnephrol.2012.07.008; Bottinger EP, 2007, SEMIN NEPHROL, V27, P309, DOI 10.1016/j.semnephrol.2007.02.009; Briones-Orta MA, 2006, BIOCHEM BIOPH RES CO, V341, P889, DOI 10.1016/j.bbrc.2006.01.041; Briones-Orta MA, 2013, CANCER RES, V73, P1800, DOI 10.1158/0008-5472.CAN-12-1916; Cao CX, 2007, BIOCHEM BIOPH RES CO, V353, P509, DOI 10.1016/j.bbrc.2006.12.057; Chen XH, 2008, BASIC CLIN PHARMACOL, V103, P278, DOI 10.1111/j.1742-7843.2008.00287.x; Deheuninck J, 2009, CELL RES, V19, P47, DOI 10.1038/cr.2008.324; Deng ZY, 2009, CHINESE MED J-PEKING, V122, P1449, DOI 10.3760/cma.j.issn.0366-6999.2009.12.018; Fan DL, 2012, INT J DERMATOL, V51, P463, DOI 10.1111/j.1365-4632.2011.05234.x; Fujita H, 2004, AM J PHYSIOL-RENAL, V286, pF120, DOI 10.1152/ajprenal.00351.2002; Fukasawa H, 2004, P NATL ACAD SCI USA, V101, P8687, DOI 10.1073/pnas.0400035101; Gu LJ, 2013, CHEM PHARM BULL, V61, P688, DOI 10.1248/cpb.c13-00066; Herbach N, 2012, PATHOLOGE, V33, P318, DOI 10.1007/s00292-012-1637-1; Hills CE, 2011, CYTOKINE GROWTH F R, V22, P131, DOI 10.1016/j.cytogfr.2011.06.002; Hills CE, 2010, AM J NEPHROL, V31, P68, DOI 10.1159/000256659; Inoue Y, 2008, CANCER SCI, V99, P2107, DOI 10.1111/j.1349-7006.2008.00925.x; Javelaud D, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-2; Koinuma D, 2003, EMBO J, V22, P6458, DOI 10.1093/emboj/cdg632; Kolset SO, 2012, J HISTOCHEM CYTOCHEM, V60, P976, DOI 10.1369/0022155412465073; Krakowski AR, 2005, P NATL ACAD SCI USA, V102, P12437, DOI 10.1073/pnas.0504107102; Lan HY, 2011, INT J BIOL SCI, V7, P1056, DOI 10.7150/ijbs.7.1056; Le Scolan E, 2008, CANCER RES, V68, P3277, DOI 10.1158/0008-5472.CAN-07-6793; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Liu L, 2012, INT J MOL MED, V29, P815, DOI 10.3892/ijmm.2012.923; [刘丽荣 Liu Lirong], 2013, [中国病理生理杂志, Chinese Journal of Pathophysiology], V29, P2152; Liu RX, 2012, KIDNEY BLOOD PRESS R, V35, P517, DOI 10.1159/000339172; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Lu LG, 2003, WORLD J GASTROENTERO, V9, P2480; Luo KX, 2004, CURR OPIN GENET DEV, V14, P65, DOI 10.1016/j.gde.2003.11.003; Mason RM, 2003, J AM SOC NEPHROL, V14, P1358, DOI 10.1097/01.ASN.0000065640.77499.D7; Mavrakis KJ, 2007, PLOS BIOL, V5, P586, DOI 10.1371/journal.pbio.0050067; Miyazono K, 2011, J BIOCHEM, V149, P1, DOI 10.1093/jb/mvq133; Moustakas A, 2013, MOL CELL, V51, P555, DOI 10.1016/j.molcel.2013.08.034; Nagano Y, 2007, J BIOL CHEM, V282, P20492, DOI 10.1074/jbc.M701294200; Pot I, 2008, CURR MOL MED, V8, P319, DOI 10.2174/156652408784533797; Satirapoj B, 2013, ADV EXP MED BIOL, V771, P107; Shen XC, 2011, J ASIAN NAT PROD RES, V13, P215, DOI 10.1080/10286020.2010.550883; Shi GF, 2005, WORLD J GASTROENTERO, V11, P268, DOI 10.3748/wjg.v11.i2.268; Sun YM, 2013, BIOCHEM BIOPH RES CO, V433, P359, DOI 10.1016/j.bbrc.2013.02.120; Tan RY, 2006, J AM SOC NEPHROL, V17, P2781, DOI 10.1681/ASN.2005101055; Tang FC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021208; Togawa A, 2003, AM J PATHOL, V163, P1645, DOI 10.1016/S0002-9440(10)63521-3; Wang YP, 2011, ANTIVIR RES, V89, P227, DOI 10.1016/j.antiviral.2011.01.005; Wu XL, 2008, WORLD J GASTROENTERO, V14, P2100, DOI 10.3748/wjg.14.2100; Yu XH, 2004, CHINESE MED J-PEKING, V117, P1856; Zhou XM, 2012, ORGANOGENESIS, V8, P18, DOI 10.4161/org.19332	46	24	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151986	10.1371/journal.pone.0151986	http://dx.doi.org/10.1371/journal.pone.0151986			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010330	gold, Green Submitted, Green Published			2022-12-26	WOS:000372708000064
J	Ma, ZY; Su, J; Guo, TT; Jin, MM; Li, X; Lei, ZH; Hou, YL; Li, XL; Jia, CC; Zhang, Z; Ahmed, E				Ma, Zhiyu; Su, Juan; Guo, Tingting; Jin, Mengmeng; Li, Xiang; Lei, Zhihai; Hou, Yuanlong; Li, Xiaoliang; Jia, Cuicui; Zhang, Zheng; Ahmed, Ejlal			Neuromedin B and Its Receptor: Gene Cloning, Tissue Distribution and Expression Levels of the Reproductive Axis in Pigs	PLOS ONE			English	Article							GASTRIN-RELEASING-PEPTIDE; BOMBESIN-RELATED PEPTIDES; INHIBITORY HORMONE GNIH; PITUITARY-THYROID AXIS; SPINAL-CORD; DISEASE STATES; CDNA CLONING; RATS; MICE; HYPOTHALAMUS	Neuromedin B is one member of a family of bombesin-like peptides, which performs a variety of physiological functions via their receptor (NMBR) in most mammals. However, the genes encoding NMB and NMBR and their functions especially reproduction of the pigs are currently not fully understood. To research the physiological functions of NMB, we cloned and analyzed the NMB and NMBR genes, and systematically investigated the expression levels of NMB and NMBR mRNA using relative real-time PCR and the distribution of NMBR by immunohistochemistry (IHC). Experimental results show that the sequences of the amino acid and gene of NMB and NMBR were highly conservative and homology in many species, Significantly, the relative RT-PCR results revealed that NMB was mainly expressed in the central nervous system (CNS), whereas NMBR is highly expressed in peripheral tissues and organs, such as endocrine tissues, glands and reproductive organs. The IHC results show that NMBR positive cells were widely distributed in the body, such as respiratory and circulatory system, digestive system, urogenital system, in lymphatic organs and in the endocrine system. We also systematically investigated expression levels of NMB and NMBR in the reproductive axis using relative real-time PCR. In sow estrous cycle, the hypothalamic levels of both NMB and NMBR mRAN were similar, but the expression levels of the pituitary were negatively correlated. Expression levels in the ovarian system are lowest in metestrus phases and highest in proestrus and estrus phases. In boar post-natal development stages, the hypothalamic, pituitary and testicular levels of NMB and NMBR mRNAs showed developmental changes on postnatal day 30, 60, 90 and 120. Taken together, this study provided molecular and morphological data necessary for further research of physiological function of NMB/NMBR system in the pigs.	[Ma, Zhiyu; Su, Juan; Guo, Tingting; Jin, Mengmeng; Li, Xiang; Lei, Zhihai; Hou, Yuanlong; Li, Xiaoliang; Jia, Cuicui; Zhang, Zheng; Ahmed, Ejlal] Nanjing Agr Univ, Coll Vet Med, Nanjing 210095, Jiangsu, Peoples R China	Nanjing Agricultural University	Lei, ZH (corresponding author), Nanjing Agr Univ, Coll Vet Med, Nanjing 210095, Jiangsu, Peoples R China.	lei55062@163.com			National Nature Science Foundation of China [31372388]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [280100745113]; Postgraduate Scientific Research Innovation Program of Jiangsu Common Higher Education Institutions	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Postgraduate Scientific Research Innovation Program of Jiangsu Common Higher Education Institutions	This work was supported by the National Nature Science Foundation of China (31372388) and received financial support from the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) (280100745113) and the Postgraduate Scientific Research Innovation Program of Jiangsu Common Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedard T, 2007, BEHAV BRAIN RES, V179, P133, DOI 10.1016/j.bbr.2007.01.021; Boughton CK, 2013, REGUL PEPTIDES, V187, P6, DOI 10.1016/j.regpep.2013.10.002; CORJAY MH, 1991, J BIOL CHEM, V266, P18771; Fleming MS, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-52; Gonzalez N, 2008, CURR OPIN ENDOCRINOL, V15, P58, DOI 10.1097/MED.0b013e3282f3709b; Hoggard N, 2007, J MOL ENDOCRINOL, V39, P199, DOI 10.1677/JME-07-0071; Ionescu VA, 2011, BRAIN RES BULL, V84, P244, DOI 10.1016/j.brainresbull.2010.12.011; Iwasa T, 2012, INT J DEV NEUROSCI, V30, P31, DOI 10.1016/j.ijdevneu.2011.10.003; Jensen RT, 2008, PHARMACOL REV, V60, P1, DOI 10.1124/pr.107.07108; KRANE IM, 1988, J BIOL CHEM, V263, P13317; Kullmann FA, 2013, NEUROPEPTIDES, V47, P305, DOI 10.1016/j.npep.2013.08.003; LADENHEIM EE, 1994, EUR J PHARMACOL, V271, pR7, DOI 10.1016/0014-2999(94)90291-7; Li X, 2012, PEPTIDES, V36, P176, DOI 10.1016/j.peptides.2012.05.008; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MALENDOWICZ LK, 1995, EXP TOXICOL PATHOL, V47, P31, DOI 10.1016/S0940-2993(11)80279-4; Merali Z, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00193; Merali Z, 2006, J NEUROSCI, V26, P10387, DOI 10.1523/JNEUROSCI.1219-06.2006; MINAMINO N, 1985, BIOCHEM BIOPH RES CO, V130, P685, DOI 10.1016/0006-291X(85)90471-1; MINAMINO N, 1983, BIOCHEM BIOPH RES CO, V114, P541, DOI 10.1016/0006-291X(83)90814-8; Ohki-Hamazaki H, 2000, PROG NEUROBIOL, V62, P297, DOI 10.1016/S0301-0082(00)00004-6; Ohki-Hamazaki H, 1999, J NEUROSCI, V19, P948; Ohki-Hamazaki H, 2005, INT J DEV BIOL, V49, P293, DOI 10.1387/ijdb.041954ho; OhkiHamazaki H, 1997, BRAIN RES, V762, P165, DOI 10.1016/S0006-8993(97)00380-6; Oliveira KJ, 2014, REGUL PEPTIDES, V194, P30, DOI 10.1016/j.regpep.2014.10.002; Oliveira KJ, 2006, J MOL ENDOCRINOL, V36, P73, DOI 10.1677/jme.1.01892; Pailhoux E, 2001, J REP FER S, P65; Park HJ, 2009, EXP CELL RES, V315, P3359, DOI 10.1016/j.yexcr.2009.08.009; Reubi JC, 2002, CLIN CANCER RES, V8, P1139; Roesler R, 2012, REV NEUROSCIENCE, V23, P571, DOI 10.1515/revneuro-2012-0046; Sano H, 2004, GENOMICS, V84, P139, DOI 10.1016/j.ygeno.2004.01.008; Sayegh AI, 2013, PROG MOL BIOL TRANSL, V114, P343, DOI 10.1016/B978-0-12-386933-3.00010-8; Soede NM, 2011, ANIM REPROD SCI, V124, P251, DOI 10.1016/j.anireprosci.2011.02.025; Su J, 2008, RES VET SCI, V85, P315, DOI 10.1016/j.rvsc.2007.12.007; Su PY, 2011, J PHARMACOL EXP THER, V337, P822, DOI 10.1124/jpet.111.178970; WADA E, 1990, J NEUROSCI, V10, P2917; WADA E, 1991, NEURON, V6, P421, DOI 10.1016/0896-6273(91)90250-4; Wang Jian, 2008, Chinese Journal of Clinical Healthcare, V11, P126; Yao Y, 2009, NEUROPEPTIDES, V43, P465, DOI 10.1016/j.npep.2009.09.003; Zhang WS, 2011, BIOL REPROD, V84, P113, DOI 10.1095/biolreprod.110.085746; Zhang Weishe, 2009, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V34, P531	40	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151871	10.1371/journal.pone.0151871	http://dx.doi.org/10.1371/journal.pone.0151871			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010315	Green Published, Green Submitted, gold			2022-12-26	WOS:000372708000052
J	Sayers, SR; Reimann, F; Gribble, FM; Parker, H; Zac-Varghese, S; Bloom, SR; Foretz, M; Viollet, B; Rutter, GA				Sayers, Sophie R.; Reimann, Frank; Gribble, Fiona M.; Parker, Helen; Zac-Varghese, Sagen; Bloom, Stephen R.; Foretz, Marc; Viollet, Benoit; Rutter, Guy A.			Proglucagon Promoter Cre-Mediated AMPK Deletion in Mice Increases Circulating GLP-1 Levels and Oral Glucose Tolerance	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; ACTIVATED PROTEIN-KINASE; BETA-CELLS; ALPHA-CELLS; SECRETION; LKB1; METFORMIN; METABOLISM; INSULIN; CARBOHYDRATE	Background Enteroendocrine L-cells synthesise and release the gut hormone glucagon-like peptide-1 (GLP-1) in response to food transit. Deletion of the tumour suppressor kinase LKB1 from proglucagon-expressing cells leads to the generation of intestinal polyps but no change in circulating GLP-1 levels. Here, we explore the role of the downstream kinase AMP-activated protein kinase (AMPK) in these cells. Method Loss of AMPK from proglucagon-expressing cells was achieved using a preproglucagon promoter-driven Cre (iGluCre) to catalyse recombination of floxed alleles of AMPK alpha 1 and alpha 2. Oral and intraperitoneal glucose tolerance were measured using standard protocols. L-cell mass was measured by immunocytochemistry. Hormone and peptide levels were measured by electrochemical-based luminescence detection or radioimmunoassay. Results Recombination with iGluCre led to efficient deletion of AMPK from intestinal L-and pancreatic alpha-cells. In contrast to mice rendered null for LKB1 using the same strategy, mice deleted for AMPK displayed an increase (WT: 0.05 +/- 0.01, KO: 0.09 +/- 0.02%, p<0.01) in L-cell mass and elevated plasma fasting (WT: 5.62 +/- 0.800 pg/ml, KO: 14.5 +/- 1.870, p<0.01) and fed (WT: 15.7 +/- 1.48pg/ml, KO: 22.0 +/- 6.62, p<0.01) GLP-1 levels. Oral, but not intraperitoneal, glucose tolerance was significantly improved by AMPK deletion, whilst insulin and glucagon levels were unchanged despite an increase in alpha to beta cell ratio (WT: 0.23 +/- 0.02, KO: 0.33 +/- 0.03, p<0.01). Conclusion AMPK restricts L-cell growth and GLP-1 secretion to suppress glucose tolerance. Targeted inhibition of AMPK in L-cells may thus provide a new therapeutic strategy in some forms of type 2 diabetes.	[Sayers, Sophie R.; Rutter, Guy A.] Univ London Imperial Coll Sci Technol & Med, Dept Cell Biol & Funct Genom, London W12 ONN, England; [Reimann, Frank; Gribble, Fiona M.; Parker, Helen] Univ Cambridge, Wellcome Trust, MRC Inst Metab Sci, Hills Rd, Cambridge CB2 0QQ, England; [Zac-Varghese, Sagen; Bloom, Stephen R.] Univ London Imperial Coll Sci Technol & Med, Dept Investigat Med, London W12 ONN, England; [Foretz, Marc; Viollet, Benoit] Inst Cochin, INSERM, U1016, F-75014 Paris, France; [Foretz, Marc; Viollet, Benoit] CNRS, UMR8104, F-75014 Paris, France; [Foretz, Marc; Viollet, Benoit] Univ Paris 05, Sorbonne Paris Cite, F-75014 Paris, France	Imperial College London; University of Cambridge; Wellcome Trust Sanger Institute; Imperial College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Rutter, GA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Cell Biol & Funct Genom, London W12 ONN, England.	g.rutter@imperial.ac.uk	Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017; FORETZ, Marc/O-7334-2017	Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; FORETZ, Marc/0000-0001-7017-9032; Rutter, Guy/0000-0001-6360-0343; Gribble, Fiona/0000-0002-4232-2898; Reimann, Frank/0000-0001-9399-6377	Wellcome Trust [WT098424AIA]; MRC [MR/J0003042/1]; Royal Society; Merck Sharp & Dohme (MSD)/European Foundation for the Study of Diabetes (EFSD); Innovative Medicines Initiative Joint Undertaking [155005]; European Union; European Federation of Pharmaceutical Industries and Associations (EFPIA) companies; Astra Zeneca, under IMIDIA consortium; Biotechnology and Biological Sciences Research Council [BB/J015873/1] Funding Source: researchfish; Medical Research Council [MR/K001981/1, MC_UU_12012/3] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10080, NF-SI-0507-10337] Funding Source: researchfish; Wellcome Trust [106263/Z/14/Z] Funding Source: researchfish; BBSRC [BB/J015873/1] Funding Source: UKRI; MRC [MC_UU_12012/3, MR/K001981/1] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); Merck Sharp & Dohme (MSD)/European Foundation for the Study of Diabetes (EFSD); Innovative Medicines Initiative Joint Undertaking; European Union(European Commission); European Federation of Pharmaceutical Industries and Associations (EFPIA) companies; Astra Zeneca, under IMIDIA consortium; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	GAR was supported by a Wellcome Trust (http://www.wellcome.ac.uk/) Senior Investigator Award (WT098424AIA), an MRC (http://www.mrc.ac.uk/) Programme Grant (MR/J0003042/1) and a Royal Society (https://royalsociety.org/) Wolfson Research Merit Award. SZ-V received a Merck Sharp & Dohme (MSD)/European Foundation for the Study of Diabetes (EFSD, http://www.europeandiabetesfoundation.org/) award. This work was also supported by the Innovative Medicines Initiative (http://www.imi.europa.eu/index_en.html) Joint Undertaking under Grant Agreement 155005 (IMIDIA), resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and European Federation of Pharmaceutical Industries and Associations (EFPIA) companies. Financial support was provided by the pharmaceutical company, Astra Zeneca, under the terms of the IMIDIA consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beguin P, 1999, EMBO J, V18, P4722, DOI 10.1093/emboj/18.17.4722; Cohen D, 2007, MOL BIOL CELL, V18, P2203, DOI 10.1091/mbc.E07-02-0095; Cryer PE, 2002, DIABETES NUTR METAB, V15, P330; da Silva Xavier Gabriela, 2003, Biochem J, V371, P761, DOI 10.1042/BJ20021812; Donath MY, 2013, DIABETES CARE, V36, pS145, DOI 10.2337/dcS13-2015; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Drucker DJ, 2015, DIABETES, V64, P317, DOI 10.2337/db14-1514; Duca FA, 2015, NAT MED, V21, P506, DOI 10.1038/nm.3787; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Fu A, 2009, CELL METAB, V10, P285, DOI 10.1016/j.cmet.2009.08.008; GIARDIELLO FM, 1987, NEW ENGL J MED, V316, P1511, DOI 10.1056/NEJM198706113162404; Granot Z, 2009, CELL METAB, V10, P296, DOI 10.1016/j.cmet.2009.08.010; Gribble FM, 2015, ANN REV PHYSL; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Heller RS, 1995, AM J PHYSIOL-GASTR L, V269, pG852, DOI 10.1152/ajpgi.1995.269.6.G852; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Hodson DJ, 2014, DIABETES, V63, P3009, DOI 10.2337/db13-1607; Hodson DJ, 2013, J CLIN INVEST, V123, P4182, DOI 10.1172/JCI68459; Hoist JJ, 2013, CURR OPIN PHARMACOL, V13, P983, DOI 10.1016/j.coph.2013.09.014; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kennedy HJ, 1999, J BIOL CHEM, V274, P13281, DOI 10.1074/jbc.274.19.13281; Kim MH, 2014, J ENDOCRINOL, V220, P117, DOI 10.1530/JOE-13-0381; Kusakai G, 2004, J EXP CLIN CANC RES, V23, P263; Lamont BJ, 2012, J CLIN INVEST, V122, P388, DOI 10.1172/JCI42497; Leclerc I, 2011, DIABETOLOGIA, V54, P125, DOI 10.1007/s00125-010-1929-z; Leech CA, 2011, PROG BIOPHYS MOL BIO, V107, P236, DOI 10.1016/j.pbiomolbio.2011.07.005; Light PE, 2002, MOL ENDOCRINOL, V16, P2135, DOI 10.1210/me.2002-0084; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Meier JJ, 2015, DIABETOLOGIA, V58, P1745, DOI 10.1007/s00125-015-3608-6; Monteverde T, 2015, FEBS J; Mulherin AJ, 2011, ENDOCRINOLOGY, V152, P4610, DOI 10.1210/en.2011-1485; MULLER WA, 1970, NEW ENGL J MED, V283, P109, DOI 10.1056/NEJM197007162830301; Murlin JR, 1923, J BIOL CHEM, V56, P253; Namiki T, 2011, P NATL ACAD SCI USA, V108, P6597, DOI 10.1073/pnas.1007694108; Olsen HL, 2005, ENDOCRINOLOGY, V146, P4861, DOI 10.1210/en.2005-0800; Parker HE, 2012, DIABETOLOGIA, V55, P2445, DOI 10.1007/s00125-012-2585-2; Parker HE, 2014, EXP PHYSIOL, V99, P1116, DOI 10.1113/expphysiol.2014.079764; Ravier MA, 2010, METHODS MOL BIOL, V633, P171, DOI 10.1007/978-1-59745-019-5_12; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Soedling H, 2015, MOL METAB, V4, P619, DOI 10.1016/j.molmet.2015.06.007; Stapleton D, 1997, FEBS LETT, V409, P452, DOI 10.1016/S0014-5793(97)00569-3; Steinert RE, 2015, INT J OBES LOND; Sun G, 2010, DIABETOLOGIA, V53, P924, DOI 10.1007/s00125-010-1692-1; Sun G, 2015, MOL METAB, V4, P277, DOI 10.1016/j.molmet.2015.01.006; Trabelsi MS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8629; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Yasuda N, 2002, BIOCHEM BIOPH RES CO, V298, P779, DOI 10.1016/S0006-291X(02)02565-2; Zac-Varghese S, 2014, DIS MODEL MECH, V7, P1275, DOI 10.1242/dmm.014720	52	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0149549	10.1371/journal.pone.0149549	http://dx.doi.org/10.1371/journal.pone.0149549			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010458	Green Submitted, Green Published, gold			2022-12-26	WOS:000372708000018
J	Boddum, K; Hansen, MH; Jennum, PJ; Kornum, BR				Boddum, Kim; Hansen, Mathias Hvidtfelt; Jennum, Poul Jorgen; Kornum, Birgitte Rahbek			Cerebrospinal Fluid Hypocretin-1 (Orexin-A) Level Fluctuates with Season and Correlates with Day Length	PLOS ONE			English	Article							DORSAL RAPHE NUCLEUS; AFFECTIVE-DISORDER; PHYSICAL-ACTIVITY; OREXIN/HYPOCRETIN NEURONS; DIURNAL-VARIATION; LIGHT; NARCOLEPSY; PREVALENCE; ACTIVATION; DEPRESSION	The hypocretin/orexin neuropeptides (hcrt) are key players in the control of sleep and wakefulness evidenced by the fact that lack of hcrt leads to the sleep disorder Narcolepsy Type 1. Sleep disturbances are common in mood disorders, and hcrt has been suggested to be poorly regulated in depressed subjects. To study seasonal variation in hcrt levels, we obtained data on hcrt-1 levels in the cerebrospinal fluid (CSF) from 227 human individuals evaluated for central hypersomnias at a Danish sleep center. The samples were taken over a 4 year timespan, and obtained in the morning hours, thus avoiding impact of the diurnal hcrt variation. Hcrt-1 concentration was determined in a standardized radioimmunoassay. Using biometric data and sleep parameters, a multivariate regression analysis was performed. We found that the average monthly CSF hcrt-1 levels varied significantly across the seasons following a sine wave with its peak in the summer (June-July). The amplitude was 19.9 pg hcrt/mL [12.8-26.9] corresponding to a 10.6% increase in midsummer compared to winter. Factors found to significantly predict the hcrt-1 values were day length, presence of snow, and proximity to the Christmas holiday season. The hcrt-1 values from January were much higher than predicted from the model, suggestive of additional factors influencing the CSF hcrt-1 levels such as social interaction. This study provides evidence that human CSF hcrt-1 levels vary with season, correlating with day length. This finding could have implications for the understanding of winter tiredness, fatigue, and seasonal affective disorder. This is the first time a seasonal variation of hcrt-1 levels has been shown, demonstrating that the hcrt system is, like other neurotransmitter systems, subjected to long term modulation.	[Boddum, Kim; Kornum, Birgitte Rahbek] Rigshosp, Dept Clin Biochem, Mol Sleep Lab, Glostrup, Denmark; [Hansen, Mathias Hvidtfelt; Jennum, Poul Jorgen; Kornum, Birgitte Rahbek] Rigshosp, Dept Clin Neurophysiol, Danish Ctr Sleep Med, Glostrup, Denmark	Rigshospitalet; Rigshospitalet	Kornum, BR (corresponding author), Rigshosp, Dept Clin Biochem, Mol Sleep Lab, Glostrup, Denmark.; Kornum, BR (corresponding author), Rigshosp, Dept Clin Neurophysiol, Danish Ctr Sleep Med, Glostrup, Denmark.	birgitte.kornum@regionh.dk	Kornum, Birgitte Rahbek/K-9193-2015	Kornum, Birgitte Rahbek/0000-0002-2515-9451; Hvidtfelt Hansen, Mathias/0000-0002-7488-123X	Lundbeckfunden; Lundbeck Foundation [R105-2011-9362] Funding Source: researchfish	Lundbeckfunden; Lundbeck Foundation(Lundbeckfonden)	Funding for this work came from Lundbeckfunden, http://www.lundbeckfonden.com. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adidharma W, 2012, NEUROSCIENCE, V220, P201, DOI 10.1016/j.neuroscience.2012.06.020; Blouin AM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2461; BOOKER JM, 1992, AM J PSYCHIAT, V149, P1176; Brundin L, 2009, J AFFECT DISORDERS, V113, P179, DOI 10.1016/j.jad.2008.04.011; Dam H, 1998, ACTA PSYCHIAT SCAND, V97, P1, DOI 10.1111/j.1600-0447.1998.tb09954.x; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; de Lecea L, 2012, PROG BRAIN RES, V198, P15, DOI 10.1016/B978-0-444-59489-1.00003-3; Deats SP, 2014, NEUROSCIENCE, V272, P252, DOI 10.1016/j.neuroscience.2014.04.069; Flores A, 2014, NEUROPSYCHOPHARMACOL, V39, P2732, DOI 10.1038/npp.2014.146; Grady SP, 2006, SLEEP, V29, P295, DOI 10.1093/sleep/29.3.295; HAJEK M, 1989, EUR ARCH PSY CLIN N, V238, P203, DOI 10.1007/BF00381466; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Hjorth MF, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-808; Horvath TL, 2005, CELL METAB, V1, P279, DOI 10.1016/j.cmet.2005.03.003; Jalewa J, 2014, BEHAV BRAIN RES, V272, P196, DOI 10.1016/j.bbr.2014.05.030; Knudsen S, 2010, SLEEP, V33, P169, DOI 10.1093/sleep/33.2.169; Kolle E, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-36; Liu RJ, 2002, J NEUROSCI, V22, P9453; Marston OJ, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-19; McGregor R, 2011, J NEUROSCI, V31, P15455, DOI 10.1523/JNEUROSCI.4017-11.2011; Mignot E, 2002, ARCH NEUROL-CHICAGO, V59, P1553, DOI 10.1001/archneur.59.10.1553; Modell JG, 2005, BIOL PSYCHIAT, V58, P658, DOI 10.1016/j.biopsych.2005.07.021; Murray G, 2009, LONGITUDINAL INVESTI; Partinen M, 2014, LANCET NEUROL, V13, P600, DOI 10.1016/S1474-4422(14)70075-4; Peyron C, 1998, J NEUROSCI, V18, P9996; Plazzi G, 2011, SLEEP MED REV, V15, P187, DOI 10.1016/j.smrv.2010.05.002; Praschak-Rieder N, 2008, ARCH GEN PSYCHIAT, V65, P1072, DOI 10.1001/archpsyc.65.9.1072; Rao Y, 2007, J CLIN INVEST, V117, P4022, DOI 10.1172/JCI32829; ROSEN LN, 1990, PSYCHIAT RES, V31, P131, DOI 10.1016/0165-1781(90)90116-M; Sakurai T, 2005, NEURON, V46, P297, DOI 10.1016/j.neuron.2005.03.010; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Sakurai T., 2014, ROLE OREXIN MOTIVATE, P15, DOI [10.1038/nrn3837, DOI 10.1038/NRN3837]; Salomon RM, 2003, BIOL PSYCHIAT, V54, P96, DOI 10.1016/S0006-3223(02)01740-7; SARRIAS MJ, 1989, BIOL PSYCHIAT, V26, P695, DOI 10.1016/0006-3223(89)90104-2; Sateia MJ, 2014, CHEST, V146, P1387, DOI 10.1378/chest.14-0970; Tsujino N, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00028; Tucker P, 2007, PUBLIC HEALTH, V121, P909, DOI 10.1016/j.puhe.2007.04.009; Winkler D, 2005, BIOL PSYCHIAT, V58, P331, DOI 10.1016/j.biopsych.2005.01.031; Wu FZ, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/872547; Wu MF, 2011, ARCH ITAL BIOL, V149, P492, DOI 10.4449/aib.v149i4.1315; Wu MF, 2002, AM J PHYSIOL-REG I, V283, pR1079, DOI 10.1152/ajpregu.00207.2002	41	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151288	10.1371/journal.pone.0151288	http://dx.doi.org/10.1371/journal.pone.0151288			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008404	Green Submitted, Green Published, gold			2022-12-26	WOS:000372701200048
J	Burns, F; Eaton, MA; Barlow, KE; Beckmann, BC; Brereton, T; Brooks, DR; Brown, PMJ; Al Fulaij, N; Gent, T; Henderson, I; Noble, DG; Parsons, M; Powney, GD; Roy, HE; Stroh, P; Walker, K; Wilkinson, JW; Wotton, SR; Gregory, RD				Burns, Fiona; Eaton, Mark A.; Barlow, Kate E.; Beckmann, Bjorn C.; Brereton, Tom; Brooks, David R.; Brown, Peter M. J.; Al Fulaij, Nida; Gent, Tony; Henderson, Ian; Noble, David G.; Parsons, Mark; Powney, Gary D.; Roy, Helen E.; Stroh, Peter; Walker, Kevin; Wilkinson, John W.; Wotton, Simon R.; Gregory, Richard D.			Agricultural Management and Climatic Change Are the Major Drivers of Biodiversity Change in the UK	PLOS ONE			English	Article							SPECIES RICHNESS; CONSERVATION; GRASSLANDS; DECLINES; RANGE; MOTHS	Action to reduce anthropogenic impact on the environment and species within it will be most effective when targeted towards activities that have the greatest impact on biodiversity. To do this effectively we need to better understand the relative importance of different activities and how they drive changes in species' populations. Here, we present a novel, flexible framework that reviews evidence for the relative importance of these drivers of change and uses it to explain recent alterations in species' populations. We review drivers of change across four hundred species sampled from a broad range of taxonomic groups in the UK. We found that species' population change (similar to 1970-2012) has been most strongly impacted by intensive management of agricultural land and by climatic change. The impact of the former was primarily deleterious, whereas the impact of climatic change to date has been more mixed. Findings were similar across the three major taxonomic groups assessed (insects, vascular plants and vertebrates). In general, the way a habitat was managed had a greater impact than changes in its extent, which accords with the relatively small changes in the areas occupied by different habitats during our study period, compared to substantial changes in habitat management. Of the drivers classified as conservation measures, low-intensity management of agricultural land and habitat creation had the greatest impact. Our framework could be used to assess the relative importance of drivers at a range of scales to better inform our policy and management decisions. Furthermore, by scoring the quality of evidence, this framework helps us identify research gaps and needs.	[Burns, Fiona; Eaton, Mark A.; Wotton, Simon R.; Gregory, Richard D.] RSPB Ctr Conservat Sci, Sandy, Beds, England; [Barlow, Kate E.] Bat Conservat Trust, London, England; [Beckmann, Bjorn C.; Powney, Gary D.; Roy, Helen E.] Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Brereton, Tom; Parsons, Mark] Butterfly Conservat, Wareham, Dorset, England; [Brooks, David R.] Rothamsted Res, Dept AgroEcol, Harpenden, Herts, England; [Brown, Peter M. J.] Anglia Ruskin Univ, Cambridge, England; [Al Fulaij, Nida] Peoples Trust Endangered Species, London, England; [Gent, Tony; Wilkinson, John W.] Amphibian & Reptile Conservat, Bournemouth, Dorset, England; [Henderson, Ian; Noble, David G.] British Trust Ornithol, Thetford, England; [Stroh, Peter; Walker, Kevin] Bot Soc Britain & Ireland, Bristol, Avon, England	Royal Society for Protection of Birds; UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Anglia Ruskin University; British Trust for Ornithology	Burns, F; Eaton, MA (corresponding author), RSPB Ctr Conservat Sci, Sandy, Beds, England.	fiona.burns@rspb.org.uk; mark.eaton@rspb.org.uk	Roy, Helen/A-1488-2010	Gregory, Richard/0000-0002-7419-5053; Brown, Peter Michael James/0000-0002-6163-4504; Powney, Gary/0000-0003-3313-7786	Natural Environment Research Council [ceh020009] Funding Source: researchfish; NERC [ceh020009] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		AMAR A, 2006, 169 BTO; [Anonymous], 2011, UK NAT EC ASS; Barlow K, 2013, LIT REV POTENTIAL DR; Beckmann BC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130488; Bright JA, 2015, AGR ECOSYST ENVIRON, V203, P69, DOI 10.1016/j.agee.2015.01.021; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Burns F, 2013, STATE NATURE REPORTT; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Carey PD, 2008, RESULTS 2007 COUNTRY; Carvell C, 2006, BIOL CONSERV, V132, P481, DOI 10.1016/j.biocon.2006.05.008; Chadd R., 2010, SILENT SUMMER STATE, P556, DOI [10.1017/CBO9780511778230.033, DOI 10.1017/CBO9780511778230.033]; Cham S, 2014, ATLAS DRAGONFLIES BR; Dicks L.V., 2013, FARMLAND CONSERVATIO; Duraiappah A. K., 2005, MILLENNIUM ECOSYSTEM; Eaton MA, 2015, BIODIVERSITY, P1; Eglington S, 2014, UNDERSTANDING UNPUB; Eglington SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030407; Fowler D, 2012, REV TRANSBOUNDARY AI; Fox R, 2014, J APPL ECOL, V51, P949, DOI 10.1111/1365-2664.12256; Fox R, 2013, INSECT CONSERV DIVER, V6, P5, DOI 10.1111/j.1752-4598.2012.00186.x; Franco AMA, 2006, GLOBAL CHANGE BIOL, V12, P1545, DOI 10.1111/j.1365-2486.2006.01180.x; FULLER RM, 1987, BIOL CONSERV, V40, P281, DOI 10.1016/0006-3207(87)90121-2; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hiley JR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2310; JNCC, 2014, BIOD IND 2014 C5 BIR; Kleijn D, 2011, TRENDS ECOL EVOL, V26, P474, DOI 10.1016/j.tree.2011.05.009; Mace GM, 2014, SCIENCE, V345, P1558, DOI 10.1126/science.1254704; Morecroft M., 2013, TERRESTRIAL BIODIVER; Pachauri R.K., 2014, CONTRIBUTION WORKING; Pearce-Higgins JW, 2015, NATURAL ENGLAND COMM, V175; Preston C.D., 2002, CHANGING FLORA UK DE; R Core Development Team, 2004, R LANG ENV STAT COMP; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Roy HE, 2012, DIVERS DISTRIB, V18, P717, DOI 10.1111/j.1472-4642.2012.00883.x; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Salafsky N, 2008, CONSERV BIOL, V22, P897, DOI 10.1111/j.1523-1739.2008.00937.x; Smeets E., 1999, ENV INDICATORS TYPOL; Sparks TH, 1996, FOREST ECOL MANAG, V80, P197, DOI 10.1016/0378-1127(95)03639-3; Stevens CJ, 2010, FUNCT ECOL, V24, P478, DOI 10.1111/j.1365-2435.2009.01663.x; Stevens MHH, 2006, J ECOL, V94, P58, DOI 10.1111/j.1365-2745.2005.01091.x; Sutherland WJ, 2006, J APPL ECOL, V43, P617, DOI 10.1111/j.1365-2664.2006.01188.x; Thomas JA, 2015, BIOL J LINNEAN SOC; Tittensor DP, 2014, SCIENCE, V346, P241, DOI 10.1126/science.1257484; Vaughan IP, 2014, GLOBAL CHANGE BIOL, V20, P2725, DOI 10.1111/gcb.12616; Vickery JA, 2014, IBIS, V156, P1, DOI 10.1111/ibi.12118; Wallisdevries MF, 2006, GLOBAL CHANGE BIOL, V12, P1620, DOI 10.1111/j.1365-2486.2006.01202.x; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054	47	51	54	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151595	10.1371/journal.pone.0151595	http://dx.doi.org/10.1371/journal.pone.0151595			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007973	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000372701200057
J	Segura, DF; Nussenbaum, AL; Viscarret, MM; Devescovi, F; Bachmann, GE; Corley, JC; Ovruski, SM; Cladera, JL				Segura, Diego F.; Nussenbaum, Ana L.; Viscarret, Mariana M.; Devescovi, Francisco; Bachmann, Guillermo E.; Corley, Juan C.; Ovruski, Sergio M.; Cladera, Jorge L.			Innate Host Habitat Preference in the Parasitoid Diachasmimorpha longicaudata: Functional Significance and Modifications through Learning	PLOS ONE			English	Article							ANASTREPHA-FRATERCULUS DIPTERA; MEDITERRANEAN FRUIT-FLY; EGG LOAD DYNAMICS; CERATITIS-CAPITATA; HYMENOPTERA-BRACONIDAE; INFOCHEMICAL USE; PLANT SELECTION; TEPHRITIDAE; HERBIVORE; SIZE	Parasitoids searching for polyphagous herbivores can find their hosts in a variety of habitats. Under this scenario, chemical cues from the host habitat (not related to the host) represent poor indicators of host location. Hence, it is unlikely that naive females show a strong response to host habitat cues, which would become important only if the parasitoids learn to associate such cues to the host presence. This concept does not consider that habitats can vary in profitability or host nutritional quality, which according to the optimal foraging theory and the preference-performance hypothesis (respectively) could shape the way in which parasitoids make use of chemical cues from the host habitat. We assessed innate preference in the fruit fly parasitoid Diachasmimorpha longicaudata among chemical cues from four host habitats (apple, fig, orange and peach) using a Y-tube olfactometer. Contrary to what was predicted, we found a hierarchic pattern of preference. The parasitism rate realized on these fruit species and the weight of the host correlates positively, to some extent, with the preference pattern, whereas preference did not correlate with survival and fecundity of the progeny. As expected for a parasitoid foraging for generalist hosts, habitat preference changed markedly depending on their previous experience and the abundance of hosts. These findings suggest that the pattern of preference for host habitats is attributable to differences in encounter rate and host quality. Host habitat preference seems to be, however, quite plastic and easily modified according to the information obtained during foraging.	[Segura, Diego F.; Nussenbaum, Ana L.; Devescovi, Francisco; Bachmann, Guillermo E.; Cladera, Jorge L.] INTA, CICVyA, IGEAF, Lab Genet Insectos Importancia Econ, Hurlingham, Argentina; [Segura, Diego F.; Nussenbaum, Ana L.; Devescovi, Francisco; Bachmann, Guillermo E.] Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina; [Viscarret, Mariana M.] INTA, CICVyA, IMyZA, Insectario Invest Lucha Biol, Hurlingham, Argentina; [Corley, Juan C.] INTA EEA Bariloche, Grp Ecol Poblac Insectos, San Carlos De Bariloche, Rio Negro, Argentina; [Ovruski, Sergio M.] CCT Tucuman CONICET, PROIMI Biotecnol, Div Control Biol Plagas, San Miguel De Tucuman, Tucuman, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Instituto Nacional de Tecnologia Agropecuaria (INTA); Instituto Nacional de Tecnologia Agropecuaria (INTA)	Segura, DF (corresponding author), INTA, CICVyA, IGEAF, Lab Genet Insectos Importancia Econ, Hurlingham, Argentina.; Segura, DF (corresponding author), Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina.	segura.diego@inta.gob.ar	Nussenbaum, Ana Laura/AAT-7037-2020	Nussenbaum, Ana Laura/0000-0003-1795-1980; Segura, Diego Fernando/0000-0003-2927-9028; Ovruski, Sergio M./0000-0002-0137-4499	Fondo para la Investigacion Cientifica y Tecnologica [PICT 2010-1324]; CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECNICAS, PIP	Fondo para la Investigacion Cientifica y Tecnologica; CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECNICAS, PIP(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	The work was supported by the following: Fondo para la Investigacion Cientifica y Tecnologica, PICT 2010-1324 (http://www.agencia.mincyt.gob.ar/frontend/agencia/fondo/foncyt); and CONSEJO NACIONAL DE INVESTIGACIONES CIENTIFICAS Y TECNICAS, PIP 2011-2013 (www.conicet.gov.ar).	[Anonymous], 1992, FRUIT FLIES EC SIGNI; Belda C, 2010, BIOL CONTROL, V54, P29, DOI 10.1016/j.biocontrol.2010.02.005; Benelli G, 2012, BIOCONTROL, V57, P767, DOI 10.1007/s10526-012-9456-0; Benrey B, 1997, ECOLOGY, V78, P987, DOI 10.2307/2265852; Birke A, 2011, J ECON ENTOMOL, V104, P1204, DOI 10.1603/EC11042; Blaul B, 2011, P ROY SOC B-BIOL SCI, V278, P3286, DOI 10.1098/rspb.2011.0001; Bukovinszky T, 2012, J INSECT PHYSIOL, V58, P367, DOI 10.1016/j.jinsphys.2011.12.017; Carrasco M, 2005, ENVIRON ENTOMOL, V34, P576, DOI 10.1603/0046-225X-34.3.576; CHARNOV EL, 1988, AM NAT, V132, P707, DOI 10.1086/284883; Chinajariyawong A, 2000, RAFFLES B ZOOL, V48, P71; Cicero L, 2012, PHYSIOL ENTOMOL, V37, P177, DOI 10.1111/j.1365-3032.2012.00833.x; Cicero L, 2011, J INSECT PHYSIOL, V57, P1471, DOI 10.1016/j.jinsphys.2011.07.014; Clarke AR, 2005, ANNU REV ENTOMOL, V50, P293, DOI 10.1146/annurev.ento.50.071803.130428; Cortesero AM, 1997, J CHEM ECOL, V23, P1589, DOI 10.1023/B:JOEC.0000006424.41365.0d; CROFT P, 1995, ENTOMOL EXP APPL, V74, P121, DOI 10.1007/BF02383003; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; DENNO RF, 1990, ECOLOGY, V71, P124, DOI 10.2307/1940253; Devescovi F, 2015, AGR FOREST ENTOMOL, V17, P325, DOI 10.1111/afe.12111; Dicke M, 1999, HERBIVORES: BETWEEN PLANTS AND PREDATORS, P483; Dicke M, 2010, TRENDS PLANT SCI, V15, P167, DOI 10.1016/j.tplants.2009.12.002; Dicke M, 2009, PLANT CELL ENVIRON, V32, P654, DOI 10.1111/j.1365-3040.2008.01913.x; Dukas R, 2000, BEHAV ECOL, V11, P536, DOI 10.1093/beheco/11.5.536; Eben A, 2000, ENVIRON ENTOMOL, V29, P87, DOI 10.1603/0046-225X-29.1.87; Ero MM, 2012, AGR FOREST ENTOMOL, V14, P101, DOI 10.1111/j.1461-9563.2011.00545.x; Ero MM, 2011, AUST J ENTOMOL, V50, P234, DOI 10.1111/j.1440-6055.2011.00821.x; Fathi SAA, 2012, BIOCONTROL, V57, P49, DOI 10.1007/s10526-011-9373-7; Geervliet JBF, 1998, ENTOMOL EXP APPL, V86, P241, DOI 10.1023/A:1003186706517; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Gols R, 2008, J CHEM ECOL, V34, P132, DOI 10.1007/s10886-008-9429-z; Gols R, 2009, PHYTOCHEM REV, V8, P187, DOI 10.1007/s11101-008-9104-6; Gripenberg S, 2010, ECOL LETT, V13, P383, DOI 10.1111/j.1461-0248.2009.01433.x; Hackermann J, 2007, J ANIM ECOL, V76, P376, DOI 10.1111/j.1365-2656.2006.01206.x; Harvey JA, 2005, ENTOMOL EXP APPL, V117, P1, DOI 10.1111/j.1570-7458.2005.00348.x; HARVEY JA, 1994, ECOLOGY, V75, P1420, DOI 10.2307/1937465; Harvey JA, 2004, ECOL ENTOMOL, V29, P35, DOI 10.1111/j.0307-6946.2004.00568.x; Harvey JA, 2015, ECOL ENTOMOL, V40, P114, DOI 10.1111/een.12165; Harvey JA, 2011, J CHEM ECOL, V37, P1081, DOI 10.1007/s10886-011-0024-3; Hoffmeister TS, 1999, ETHOLOGY, V105, P223, DOI 10.1046/j.1439-0310.1999.00361.x; JAENIKE J, 1978, THEOR POPUL BIOL, V14, P350, DOI 10.1016/0040-5809(78)90012-6; Jandricic SE, 2014, BIOL CONTROL, V76, P28, DOI 10.1016/j.biocontrol.2014.04.007; Kerguelen V, 1998, J INSECT BEHAV, V11, P221, DOI 10.1023/A:1021095907381; LEVINS R, 1969, Ecology (Washington D C), V50, P910, DOI 10.2307/1933709; LEWIS WJ, 1990, NATURE, V348, P635, DOI 10.1038/348635a0; LEYVA JL, 1991, ENVIRON ENTOMOL, V20, P1469, DOI 10.1093/ee/20.5.1469; Li XW, 2014, APPL ENTOMOL ZOOL, V49, P67, DOI 10.1007/s13355-013-0225-z; Luhring KA, 2004, BIOL CONTROL, V30, P382, DOI 10.1016/j.biocontrol.2004.01.008; Mavrikakis PG, 2000, ENVIRON ENTOMOL, V29, P1180, DOI 10.1603/0046-225X-29.6.1180; Mayhew PJ, 1998, P ROY SOC B-BIOL SCI, V265, P383, DOI 10.1098/rspb.1998.0306; Mayhew PJ, 1997, OIKOS, V79, P417, DOI 10.2307/3546884; MESSING RH, 1992, ENVIRON ENTOMOL, V21, P1189, DOI 10.1093/ee/21.5.1189; Ngumbi E, 2009, J CHEM ECOL, V35, P1009, DOI 10.1007/s10886-009-9700-y; Ode PJ, 2006, ANNU REV ENTOMOL, V51, P163, DOI 10.1146/annurev.ento.51.110104.151110; Ode PJ, 2004, OIKOS, V104, P388, DOI 10.1111/j.0030-1299.2004.12323.x; Ovrusiu SM, 2007, BIOCONTROL SCI TECHN, V17, P1079, DOI 10.1080/09583150701661620; Ovruski S, 2012, BIOCONTROL SCI TECHN, V22, P187, DOI 10.1080/09583157.2011.648167; Ovruski Sergio M., 2003, Rev. Soc. Entomol. Argent., V62, P49; Patt JM, 1999, ENTOMOL EXP APPL, V90, P1, DOI 10.1023/A:1003554332259; Rivero A, 2000, ECOL ENTOMOL, V25, P467, DOI 10.1046/j.1365-2311.2000.00276.x; Rutledge CE, 1999, BIOL CONTROL, V16, P144, DOI 10.1006/bcon.1999.0745; Rwomushana I, 2008, ANN ENTOMOL SOC AM, V101, P331, DOI 10.1603/0013-8746(2008)101[331:HPAHPP]2.0.CO;2; Sarfraz RM, 2012, BIOL CONTROL, V62, P38, DOI 10.1016/j.biocontrol.2012.03.004; Sato M, 2000, J INSECT BEHAV, V13, P263, DOI 10.1023/A:1007796400186; Segura DF, 2006, ANN ENTOMOL SOC AM, V99, P70, DOI 10.1603/0013-8746(2006)099[0070:RAOCCA]2.0.CO;2; Segura DF, 2007, ANIM BEHAV, V74, P131, DOI 10.1016/j.anbehav.2006.12.005; Segura Diego F, 2004, Ecol. austral, V14, P3; Segura DF, 2012, ENTOMOL EXP APPL, V143, P164, DOI 10.1111/j.1570-7458.2012.01246.x; SEQUEIRA R, 1992, ECOLOGY, V73, P183, DOI 10.2307/1938730; Silva JWP, 2007, BIOL CONTROL, V41, P304, DOI 10.1016/j.biocontrol.2007.03.005; SIVINSKI J, 1991, ENTOMOPHAGA, V36, P447, DOI 10.1007/BF02377951; StatSoft Inc., 2000, STAT WIND PROGR MAN; Steidle JLM, 2003, ENTOMOL EXP APPL, V108, P133, DOI 10.1046/j.1570-7458.2003.00080.x; Stephens D.W., 1986, pi; Stireman JO, 2002, J INSECT BEHAV, V15, P689, DOI 10.1023/A:1020752024329; Stoepler TM, 2011, ECOL ENTOMOL, V36, P724, DOI 10.1111/j.1365-2311.2011.01322.x; Suarez L., 2014, Natural Science, V6, P664, DOI 10.4236/ns.2014.69066; Takemoto H, 2012, ANIM BEHAV, V83, P1491, DOI 10.1016/j.anbehav.2012.03.023; Tentelier C, 2005, ECOL ENTOMOL, V30, P739, DOI 10.1111/j.0307-6946.2005.00735.x; Tentelier C, 2007, J ANIM ECOL, V76, P1, DOI 10.1111/j.1365-2656.2006.01171.x; TERAN H R, 1977, Revista Agronomica del Noroeste Argentino, V14, P17; THOMPSON JN, 1988, ECOLOGY, V69, P893, DOI 10.2307/1941238; Turlings TCJ, 2004, ADVANCES IN INSECT CHEMICAL ECOLOGY, P21, DOI 10.1017/CBO9780511542664.003; TURLINGS TCJ, 1995, P NATL ACAD SCI USA, V92, P4169, DOI 10.1073/pnas.92.10.4169; TURLINGS TCJ, 1990, SCIENCE, V250, P1251, DOI 10.1126/science.250.4985.1251; Turlings Ted C. J., 1993, P51; Uefune M, 2010, BIOL CONTROL, V54, P19, DOI 10.1016/j.biocontrol.2010.02.008; vansAlphen JJM, 1986, INSECT PARASITOIDS, P23; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; Viscarret MM, 2006, BIOL CONTROL, V36, P147, DOI 10.1016/j.biocontrol.2005.08.009; VISSER ME, 1994, J ANIM ECOL, V63, P963, DOI 10.2307/5273; WACKERS FL, 1994, BIOL CONTROL, V4, P105, DOI 10.1006/bcon.1994.1018; WHARTON RA, 1983, ANN ENTOMOL SOC AM, V76, P721, DOI 10.1093/aesa/76.4.721; Wyckhuys KAG, 2007, ENTOMOL EXP APPL, V123, P149, DOI 10.1111/j.1570-7458.2007.00532.x	92	25	25	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152222	10.1371/journal.pone.0152222	http://dx.doi.org/10.1371/journal.pone.0152222			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007298	Green Published, gold			2022-12-26	WOS:000372701200113
J	Chew, BH; Vos, R; Mohd-Sidik, S; Rutten, GEHM				Chew, Boon-How; Vos, Rimke; Mohd-Sidik, Sherina; Rutten, Guy E. H. M.			Diabetes-Related Distress, Depression and Distress-Depression among Adults with Type 2 Diabetes Mellitus in Malaysia	PLOS ONE			English	Article							COMMON MENTAL-DISORDERS; EMOTIONAL DISTRESS; GLYCEMIC CONTROL; PSYCHOLOGICAL DISTRESS; ANXIETY DISORDERS; SYMPTOMS; PEOPLE; ASSOCIATION; ADHERENCE; PATIENT	Type 2 diabetes mellitus (T2DM) brings about an increasing psychosocial problem in adult patients. Prevalence data on and associated factors of diabetes related distress (DRD) and depression have been lacking in Asia. This study aimed to examine the prevalence of DRD and depression, and their associated factors in Asian adult T2DM patients. This study was conducted in three public health clinics measuring DRD (Diabetes Distress Scale, DDS), and depression (Patient Health Questionnaire, PHQ). Patients who were at least 30 years of age, had T2DM for more than one year, with regular follow-up and recent laboratory results (<3 months) were consecutively recruited. Associations between DRD, depression and the combination DRD-depression with demographic and clinical characteristics were analysed using generalized linear models. From 752 invited people, 700 participated (mean age 56.9 years, 52.8% female, 52.9% Malay, 79.1% married). Prevalence of DRD and depression were 49.2% and 41.7%, respectively. Distress and depression were correlated, spearman's r = 0.50. Patients with higher DRD were younger (OR 0.995, 95% CI 0.996 to 0.991), Chinese (OR 1.2, 95% CI 1.04 to 1.29), attending Dengkil health clinic (OR 1.1, 95% CI 1.00 to 1.22) and had higher scores on the PHQ (OR 1.1, 95% CI 1.04 to 1.06). Depression was less likely in the unmarried compared to divorced/separately living and those attending Dengkil health clinic, but more likely in patients with microvascular complications (OR 1.4, 95% CI 1.06 to 1.73) and higher DDS (OR 1.03, 95% CI 1.02 to 1.03). For the combination of DRD and depression, unemployment (OR 4.7, 95% CI 1.02 to 21.20) had positive association, whereas those under medical care at the Salak health clinics (OR 0.28, 95% CI 0.12 to 0.63), and those with a blood pressure > 130/80 mmHg (OR 0.53, 95% CI 0.32 to 0.89) were less likely to experience both DRD and depression. DRD and depression were common and correlated in Asian adults with T2DM at primary care level. Socio-demographic more than clinical characteristics were related to DRD and depression.	[Chew, Boon-How] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Family Med, Serdang 43400, Selangor, Malaysia; [Chew, Boon-How; Vos, Rimke; Rutten, Guy E. H. M.] Univ Med Ctr Utrecht, Dept Gen Practice, Julius Ctr Hlth Sci & Primary Care, Huispost Str 6-131,POB 85500, NL-3508 GA Utrecht, Netherlands; [Mohd-Sidik, Sherina] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Psychiat, Serdang 43400, Selangor, Malaysia	Universiti Putra Malaysia; Utrecht University; Utrecht University Medical Center; Universiti Putra Malaysia	Chew, BH (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Family Med, Serdang 43400, Selangor, Malaysia.; Chew, BH (corresponding author), Univ Med Ctr Utrecht, Dept Gen Practice, Julius Ctr Hlth Sci & Primary Care, Huispost Str 6-131,POB 85500, NL-3508 GA Utrecht, Netherlands.	chewboonhow@gmail.com	Vos, Rimke C/Y-6460-2018; Chew, Boon How/GPS-9821-2022; Chew, Boon-How/B-2385-2010	Vos, Rimke C/0000-0003-1074-6255; Chew, Boon-How/0000-0002-8627-6248; Mohd Sidik, Sherina/0000-0001-6754-6145	Research University Grants Scheme 2 [RUGS/04-02-2105RU]; Sepang District health Office; Petaling District health Office	Research University Grants Scheme 2; Sepang District health Office; Petaling District health Office	BHC received funding for this study from the Research University Grants Scheme 2 (grant number: RUGS/04-02-2105RU), http://www.rmc.upm.edu.my/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We record our acknowledgment also to Dr. Al-Qazaz HK et al., Morisky et al., World Health Organization, Polonsky et al., Sherina Mohd-Sidik and Xiaonan Yu for the use of the different versions of the MMAS-8, WHOQOL-BREF, DDS-17 and PHQ-9 questionnaires. We also like to acknowledge the Sepang and Petaling District health Offices and officers for their support in this study. We thank the Director General of Health for his permission to publish this report. We thank Dr. Firdaus Mukhtar, Dr. Nor-Kasmawati Jamaludin and Dr. Fuziah Paimin for their input during the study planning and assistance in data collection. Lastly, we would like to thank all the clinic staffs for facilitating the data collection.	Ahola AJ, 2013, DIABETIC MED, V30, P413, DOI 10.1111/dme.12105; Aikens JE, 2012, DIABETES CARE, V35, P2472, DOI 10.2337/dc12-0181; Ali S, 2006, DIABETIC MED, V23, P1165, DOI 10.1111/j.1464-5491.2006.01943.x; Anderson RJ, 2002, INT J PSYCHIAT MED, V32, P235, DOI 10.2190/KLGD-4H8D-4RYL-TWQ8; August KJ, 2013, J FAM PSYCHOL, V27, P712, DOI 10.1037/a0034181; Browne JL, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003384; Burns KK, 2013, DIABETIC MED, V30, P778, DOI 10.1111/dme.12239; Chew B H, 2015, Malays Fam Physician, V10, P22; Chew B H, 2013, Med J Malaysia, V68, P397; Chew BH, 2015, INT J DIABETES DEV C, P1; Chew BH, 2015, PATIENT PREFER ADHER, V9, P639, DOI 10.2147/PPA.S81612; Dalsgaard EM, 2014, DIABETOLOGIA, V57, P710, DOI 10.1007/s00125-014-3165-4; Das-Munshi J, 2007, PSYCHOSOM MED, V69, P543, DOI 10.1097/PSY.0b013e3180cc3062; de Groot M, 2001, PSYCHOSOM MED, V63, P619, DOI 10.1097/00006842-200107000-00015; Delahanty LM, 2007, DIABETIC MED, V24, P48, DOI 10.1111/j.1464-5491.2007.02028.x; Dimitraki G, 2014, INT J BEHAV MED, V21, P230, DOI 10.1007/s12529-013-9296-z; Donkin L, 2006, PSYCHOL HEALTH, V21, P421, DOI 10.1080/14768320500329292; Egede LE, 2012, CURR PSYCHIAT REP, V14, P15, DOI 10.1007/s11920-011-0240-0; Feisul M. I., 2013, NATL DIABETES REGIST; Fisher L, 2008, DIABETIC MED, V25, P1096, DOI 10.1111/j.1464-5491.2008.02533.x; Fisher L, 2014, DIABETIC MED, V31, P764, DOI 10.1111/dme.12428; Fisher L, 2012, DIABETES CARE, V35, P259, DOI 10.2337/dc11-1572; Fisher L, 2010, DIABETES CARE, V33, P23, DOI 10.2337/dc09-1238; Fleer J, 2013, DIABETIC MED, V30, P88, DOI 10.1111/dme.12001; Franks MM, 2012, FAM SYST HEALTH, V30, P154, DOI 10.1037/a0028614; Gallo JJ, 2005, AM J GERIAT PSYCHIAT, V13, P748, DOI 10.1176/appi.ajgp.13.9.748; Gariepy G, 2013, J PSYCHOSOM RES, V75, P147, DOI 10.1016/j.jpsychores.2013.05.009; Gask L, 2011, CHRONIC ILLN, V7, P239, DOI 10.1177/1742395311403636; Gentili P, 2001, DIABETES NUTR METAB, V14, P140; Hermanns N, 2005, DIABETIC MED, V22, P293, DOI 10.1111/j.1464-5491.2005.01414.x; Holt RIG, 2014, DIABETES CARE, V37, P2067, DOI 10.2337/dc13-2134; Hosoya T, 2012, INTERNAL MED, V51, P263, DOI 10.2169/internalmedicine.51.5768; Iida M, 2013, J SOC PERS RELAT, V30, P293, DOI 10.1177/0265407512455308; Ismail K, 2000, AM J EPIDEMIOL, V152, P651, DOI 10.1093/aje/152.7.651; Karlsen B, 2012, J ADV NURS, V68, P391, DOI 10.1111/j.1365-2648.2011.05751.x; Kasteleyn MJ, 2015, DIABET MED; Kaur G, 2013, BMC FAM PRACT, V14, DOI 10.1186/1471-2296-14-69; Kneckt MC, 2001, J CLIN PERIODONTOL, V28, P175, DOI 10.1034/j.1600-051x.2001.028002175.x; Koch T, 1999, J CLIN NURS, V8, P712, DOI 10.1046/j.1365-2702.1999.00320.x; Kokoszka A, 2009, EUR PSYCHIAT, V24, P425, DOI 10.1016/j.eurpsy.2009.04.002; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lee S, 2006, DIABETES RES CLIN PR, V74, P282, DOI 10.1016/j.diabres.2006.03.026; Li CY, 2009, INT J PUBLIC HEALTH, V54, P43, DOI 10.1007/s00038-009-0006-1; Lloyd C., 2005, Diabetes Spectrum, V18, P121, DOI 10.2337/diaspect.18.2.121; Low LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147127; Mimi O, 2011, Malays Fam Physician, V6, P19; Misra R, 2008, J DIABETES COMPLICAT, V22, P217, DOI 10.1016/j.jdiacomp.2006.09.002; Mohamed R, 2012, INT J COLLAB RES INT, V4, P1589; Pibernik-Okanovic M, 2008, DIABETIC MED, V25, P1252, DOI 10.1111/j.1464-5491.2008.02553.x; Polonsky WH, 2005, DIABETES CARE, V28, P626, DOI 10.2337/diacare.28.3.626; Rane K, 2011, DIABETES RES CLIN PR, V93, P371, DOI 10.1016/j.diabres.2011.05.009; Rasmussen NH, 2013, PRIM CARE DIABETES, V7, P213, DOI 10.1016/j.pcd.2013.04.006; REPORT OF A WHO CONSULTATION, 1999, 992 WHO; Rintala TM, 2013, J FAM NURS, V19, P3, DOI 10.1177/1074840712471899; Rutten GEHM, 2014, LANCET DIABETES ENDO, V2, P191, DOI 10.1016/S2213-8587(13)70122-0; Sherina M S, 2012, Med J Malaysia, V67, P309; Skinner TC, 2010, DIABETIC MED, V27, P965, DOI 10.1111/j.1464-5491.2010.03028.x; Stoop CH, 2014, DIABETIC MED, V31, P1252, DOI 10.1111/dme.12472; Stuckey HL, 2014, DIABETES CARE, V37, P2466, DOI 10.2337/dc13-2536; Talley NJ, 2001, AM J GASTROENTEROL, V96, P1033; Ting RZW, 2011, DIABETES CARE, V34, P1094, DOI 10.2337/dc10-1612; Tsujii S, 2012, DIABETIC MED, V29, P1451, DOI 10.1111/j.1464-5491.2012.03647.x; Wardian J, 2014, SOC WORK HEALTH CARE, V53, P364, DOI 10.1080/00981389.2014.884038; West Christina, 2002, Br J Community Nurs, V7, P606; Yu XN, 2012, COMPR PSYCHIAT, V53, P95, DOI 10.1016/j.comppsych.2010.11.002; Zhang J, 2013, NEUROPSYCH DIS TREAT, V9, P1289, DOI 10.2147/NDT.S49798	66	56	58	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152095	10.1371/journal.pone.0152095	http://dx.doi.org/10.1371/journal.pone.0152095			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3OX	27002728	Green Submitted, Green Published, gold			2022-12-26	WOS:000372697400078
J	Li, M; Ye, T; Wang, XX; Li, X; Qiang, O; Yu, T; Tang, CW; Liu, R				Li, Mao; Ye, Ting; Wang, Xiao-Xia; Li, Xian; Qiang, Ou; Yu, Tao; Tang, Cheng-Wei; Liu, Rui			Effect of Octreotide on Hepatic Steatosis in Diet-Induced Obesity in Rats	PLOS ONE			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; HIGH-FAT DIET; APOLIPOPROTEIN B100; SOMATOSTATIN ANALOGS; INSULIN-RESISTANCE; SREBP ACTIVITY; LIVER-DISEASE; DOUBLE-BLIND; WEIGHT-LOSS; APO-B	Background Non-alcoholic fatty liver disease (NAFLD) caused by liver lipid dysregulation is linked to obesity. Somatostatin (SST) and its analogs have been used to treat pediatric hypothalamic obesity. However, the application of such drugs for the treatment of NAFLD has not been evaluated. Objective This study aimed to investigate the expression levels of important regulators of hepatic lipid metabolism and the possible effect of the SST analog octreotide on these regulators. Methods SD rats were assigned to a control group and a high-fat diet group. Obese rats from the high-fat diet group were further divided into the obese and octreotide-treated groups. The body weight, plasma SST, fasting plasma glucose (FPG), insulin, triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and free fatty acid (FFA) levels were measured. Hepatic steatosis was evaluated based on the liver TG content, HE staining and oil red O staining. The SREBP-1c, ACC1, FAS, MTP, apoB and ADRP expression levels in the liver were also determined by RT-PCR, qRT-PCR, western blot or ELISA. Results The obese rats induced by high-fat diet expressed more SREBP-1c, FAS and ADRP but less MTP protein in the liver than those of control rats, whereas octreotide intervention reversed these changes and increased the level of apoB protein. Compared to the control group, obese rats showed increased liver ACC1, SREBP-1c and apoB mRNA levels, whereas octreotide-treated rats showed decreased mRNA levels of apoB and SREBP-1c. This was accompanied by increased body weight, liver TG contents, FPG, TG, TC, LDL-C, FFA, insulin and derived homeostatic model assessment (HOMA) values. Octreotide intervention significantly decreased these parameters. Compared to the control group, the obese group showed a decreasing trend on plasma SST levels, which were significantly increased by the octreotide intervention. Conclusion Octreotide can ameliorate hepatic steatosis in obese rats, possibly by decreasing hepatic lipogenesis and increasing TG export from hepatocytes.	[Li, Mao; Ye, Ting; Wang, Xiao-Xia; Li, Xian; Qiang, Ou; Yu, Tao; Liu, Rui] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Div Peptides Related Human Dis, Chengdu 610064, Peoples R China; [Li, Mao; Ye, Ting; Wang, Xiao-Xia; Yu, Tao; Tang, Cheng-Wei] Sichuan Univ, West China Hosp, Dept Gastroenterol, Chengdu 610064, Peoples R China; [Li, Mao] Chongqing Inst Accid & Emergency Med, Chongqing Emergency Med Ctr, Dept Internal Med, Chongqing, Peoples R China	Sichuan University; Sichuan University	Liu, R (corresponding author), Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Div Peptides Related Human Dis, Chengdu 610064, Peoples R China.	lrui60@163.com			National Natural Science Foundation of China [30870919]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The project was supported by National Natural Science Foundation of China. The grant number was No. 30870919 and Rui Liu received the funding. Rui Liu had an important role in study design, decision to publish, and preparation of the manuscript.	Ahmed MH, 2007, DRUG DISCOV TODAY, V12, P740, DOI 10.1016/j.drudis.2007.07.009; Bakillah A, 2003, FRONT BIOSCI-LANDMRK, V8, pD294; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Chang XX, 2010, J LIPID RES, V51, P2504, DOI 10.1194/jlr.M001958; Daemen S, 2013, GENES NUTR, V8, P289, DOI 10.1007/s12263-013-0342-x; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Figarola JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083801; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gambino R, 2007, HEPATOLOGY, V45, P1097, DOI 10.1002/hep.21631; Gordon DA, 2000, BBA-MOL CELL BIOL L, V1486, P72, DOI 10.1016/S1388-1981(00)00049-4; Gusarova V, 2003, J BIOL CHEM, V278, P48051, DOI 10.1074/jbc.M306898200; Guturu P, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/212865; Higuchi N, 2011, EXP THER MED, V2, P1077, DOI 10.3892/etm.2011.328; Huang W, 2013, NUTRITION, V29, P1259, DOI 10.1016/j.nut.2013.01.013; Hussain MM, 2003, J LIPID RES, V44, P22, DOI 10.1194/jlr.R200014-JLR200; Jung UJ, 2014, INT J MOL SCI, V15, P6184, DOI 10.3390/ijms15046184; Kohjima M, 2007, INT J MOL MED, V20, P351; Lam TKT, 2007, NAT MED, V13, P171, DOI 10.1038/nm1540; Lazo M, 2013, AM J EPIDEMIOL, V178, P38, DOI 10.1093/aje/kws448; Leung GK, 2000, J BIOL CHEM, V275, P7515, DOI 10.1074/jbc.275.11.7515; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; Li XH, 1997, J LIPID RES, V38, P1277; Li XW, 2014, J STEROID BIOCHEM, V143, P174, DOI 10.1016/j.jsbmb.2014.02.009; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Liu R, 2013, EUR J NUTR, V52, P1067, DOI 10.1007/s00394-012-0413-6; Lui R, 2003, CHIN J PUBLIC HLTH, V5, P563; Lustig RH, 2006, INT J OBESITY, V30, P331, DOI 10.1038/sj.ijo.0803074; Lustig RH, 2003, J CLIN ENDOCR METAB, V88, P2586, DOI 10.1210/jc.2002-030003; Magnusson B, 2006, ARTERIOSCL THROM VAS, V26, P1566, DOI 10.1161/01.ATV.0000223345.11820.da; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; Moon YA, 2012, CELL METAB, V15, P240, DOI 10.1016/j.cmet.2011.12.017; Olofsson SO, 2000, TRENDS CARDIOVAS MED, V10, P338, DOI 10.1016/S1050-1738(01)00071-8; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Quesada H, 2009, INT J OBESITY, V33, P1007, DOI 10.1038/ijo.2009.136; Rolo AP, 2012, FREE RADICAL BIO MED, V52, P59, DOI 10.1016/j.freeradbiomed.2011.10.003; Rutledge AC, 2010, BIOCHEM CELL BIOL, V88, P251, DOI [10.1139/O09-168, 10.1139/o09-168]; Shiomi M, 2001, EUR J PHARMACOL, V431, P127, DOI 10.1016/S0014-2999(01)01419-4; Silva AP, 2005, EUR J ENDOCRINOL, V152, P887, DOI 10.1530/eje.1.01914; Solinas G, 2015, MOL METAB, V4, P367, DOI 10.1016/j.molmet.2015.03.004; Sundaram M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-35; Tran K, 2002, J BIOL CHEM, V277, P31187, DOI 10.1074/jbc.M200249200; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; [王重建 Wang Chongjian], 2005, [华中科技大学学报. 医学版, Journal of Huazhong University of Science and Technology], V34, P65; Wang ZX, 2002, J MATH MED, V15, P125; Yu Tao, 2014, Wei Sheng Yan Jiu, V43, P186; Yue JTY, 2012, CIRC RES, V110, P1345, DOI [10.1161/CIRCRESAHA.112.268276, 10.1161/circresaha.112.268276]; Zambre Y, 1999, BIOCHEM PHARMACOL, V57, P1159, DOI 10.1016/S0006-2952(99)00010-6; Zhang L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117008	49	13	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152085	10.1371/journal.pone.0152085	http://dx.doi.org/10.1371/journal.pone.0152085			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002331	gold, Green Published, Green Submitted			2022-12-26	WOS:000372697400075
J	Richter, JN; Hochner, B; Kuba, MJ				Richter, Jonas N.; Hochner, Binyamin; Kuba, Michael J.			Pull or Push? Octopuses Solve a Puzzle Problem	PLOS ONE			English	Article							TACTILE DISCRIMINATION; INDIVIDUAL VARIATION; VULGARIS LAMARCK; ARM MOVEMENTS; CEPHALOPODS; COGNITION; INNOVATION; MEMORY; EVOLUTION; SYSTEM	Octopuses have large brains and exhibit complex behaviors, but relatively little is known about their cognitive abilities. Here we present data from a five-level learning and problem-solving experiment. Seven octopuses (Octopus vulgaris) were first trained to open an L shaped container to retrieve food (level 0). After learning the initial task all animals followed the same experimental protocol, first they had to retrieve this L shaped container, presented at the same orientation, through a tight fitting hole in a clear Perspex partition (level 1). This required the octopuses to perform both pull and release or push actions. After reaching criterion the animals advanced to the next stage of the test, which would be a different consistent orientation of the object (level 2) at the start of the trial, an opaque barrier (level 3) or a random orientation of the object (level 4). All octopuses were successful in reaching criterion in all levels of the task. At the onset of each new level the performance of the animals dropped, shown as an increase in working times. However, they adapted quickly so that overall working times were not significantly different between levels. Our findings indicate that octopuses show behavioral flexibility by quickly adapting to a change in a task. This can be compared to tests in other species where subjects had to conduct actions comprised of a set of motor actions that cannot be understood by a simple learning rule alone.	[Richter, Jonas N.; Hochner, Binyamin; Kuba, Michael J.] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Neurobiol, Givat Ram, Israel; [Richter, Jonas N.] Max Planck Florida Inst, Jupiter, FL USA	Hebrew University of Jerusalem; Max Planck Society	Kuba, MJ (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Neurobiol, Givat Ram, Israel.	michi.kuba@lobster.ls.huji.ac.il	Kuba, Michael J/AAE-7934-2022; Kuba, Michael/ABH-8394-2020	Kuba, Michael J/0000-0003-2688-736X; 	European Commission [231608, 287728]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission under the 7th Framework Programme in the theme of the Future and Emerging Technologies (FET, OCTOPUS IP, FP7-ICT 2007.8.5, FET) [231608]-www.octopus.eu<http://www.octopus.eu>; and STIFFness controllable Flexible and Learn-able manipulator for surgical Operations [STIFF-FLOP] FP7-ICT-2011-7 Project Number 287728 (http://www.stiff-flop.eu/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN A, 1986, MAR BEHAV PHYSIOL, V12, P81, DOI 10.1080/10236248609378636; Alves C, 2008, COGN PROCESS, V9, P239, DOI 10.1007/s10339-007-0192-9; Anderson Roland C., 2010, Ferrantia, V59, P8; Benson-Amram S, 2012, P ROY SOC B-BIOL SCI, V279, P4087, DOI 10.1098/rspb.2012.1450; Boal JG, 2011, VIE MILIEU, V61, P203; Boal JG, 1996, BIOL REV, V71, P157, DOI 10.1111/j.1469-185X.1996.tb00746.x; Boogert NJ, 2008, ANIM BEHAV, V75, P1509, DOI 10.1016/j.anbehav.2007.09.033; BOYCOTT BB, 1955, PROC R SOC SER B-BIO, V143, P449, DOI 10.1098/rspb.1955.0024; Boyle PR, 1986, NEURAL CONTROL CEPHA; Budelmann BU, 1995, CEPHALOPOD NEUROBIOL; Chittka L, 2009, CURR BIOL, V19, pR995, DOI 10.1016/j.cub.2009.08.023; DEWS PB, 1959, J EXP ANAL BEHAV, V2, P57, DOI 10.1901/jeab.1959.2-57; Emery NJ, 2006, PHILOS T R SOC B, V361, P23, DOI 10.1098/rstb.2005.1736; FELLOWS BJ, 1967, PSYCHOL BULL, V67, P87, DOI 10.1037/h0024098; FIORITO G, 1990, BEHAV NEURAL BIOL, V53, P217, DOI 10.1016/0163-1047(90)90441-8; Fiorito G, 2014, INVERTEBR NEUROSCI, V14, P13, DOI 10.1007/s10158-013-0165-x; Fiorito Graziano, 1998, Animal Cognition, V1, P107, DOI 10.1007/s100710050015; Forsythe JW, 1997, J EXP MAR BIOL ECOL, V209, P15, DOI 10.1016/S0022-0981(96)00057-3; Giurfa M, 2013, TRENDS NEUROSCI, V36, P285, DOI 10.1016/j.tins.2012.12.011; Greenberg Russell, 2003, P175; Griffin AS, 2015, ANIM BEHAV, V100, P84, DOI 10.1016/j.anbehav.2014.11.012; Griffin AS, 2014, ANIM BEHAV, V92, P221, DOI 10.1016/j.anbehav.2014.04.009; Griffin AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084907; Gutfreund Y, 1996, J NEUROSCI, V16, P7297; Gutfreund Y, 2006, BIOL BULL-US, V211, P212, DOI 10.2307/4134544; Gutnick T, 2011, CURR BIOL, V21, P460, DOI 10.1016/j.cub.2011.01.052; Hanlon RT, 1996, CEPHALOPOD BEHAV; Hochner B, 2006, BIOL BULL-US, V210, P308, DOI 10.2307/4134567; Hochner Binyamin, 2010, Front Biosci (Schol Ed), V2, P764; HOLLARD VD, 1982, SCIENCE, V218, P804, DOI 10.1126/science.7134976; Hvorecny LM, 2007, ANIM COGN, V10, P449, DOI 10.1007/s10071-007-0085-4; Kuba M.J., 2006, INT J COMP PSYCHOL, V19, P426; Kuba MJ, 2006, J COMP PSYCHOL, V120, P184, DOI 10.1037/0735-7036.120.3.184; Kuba MJ, 2010, ANIM COGN, V13, P507, DOI 10.1007/s10071-009-0301-5; Kummer H., 1985, T ROYAL SOC LONDON B, V308, P203, DOI DOI 10.1098/RSTB.1985.0020; Lefebvre L, 2011, BIOL LETTERS, V7, P631, DOI 10.1098/rsbl.2010.0556; Manrique HM, 2013, ANIM BEHAV, V85, P195, DOI 10.1016/j.anbehav.2012.10.026; MATHER JA, 1991, J COMP PHYSIOL A, V168, P491, DOI 10.1007/BF00199609; Mather JA, 2008, AM MALACOL BULL, V24, P51, DOI 10.4003/0740-2783-24.1.51; Mather JA, 2012, CURR ZOOL, V58, P597, DOI 10.1093/czoolo/58.4.597; MUNTZ WRA, 1970, Q J EXP PSYCHOL, V22, P82, DOI 10.1080/00335557043000005; Overington SE, 2011, BEHAV PROCESS, V87, P274, DOI 10.1016/j.beproc.2011.06.002; PACKARD A, 1972, BIOL REV, V47, P241, DOI 10.1111/j.1469-185X.1972.tb00975.x; Perry CJ, 2013, WILEY INTERDISCIPLIN; Pronk R, 2010, J EXP BIOL, V213, P1035, DOI 10.1242/jeb.040675; Reader S.M., 2003, ANIMAL INNOVATION; Reader SM, 2007, BEHAV BRAIN SCI, V30, P420, DOI 10.1017/S0140525X07002518; Reader SM, 2003, ANIM BIOL, V53, P147, DOI 10.1163/157075603769700340; Richter JN, 2015, J EXP BIOL, V218, P1069, DOI 10.1242/jeb.115915; ROBERTSON JD, 1994, P ROY SOC B-BIOL SCI, V256, P269, DOI 10.1098/rspb.1994.0080; Sanders G.D., 1975, INVERTEBRATE LEARNIN; SCHILLER PH, 1949, J COMP PHYSIOL PSYCH, V42, P220, DOI 10.1037/h0056879; Seed AM, 2013, CURR BIOL, V23, pR67, DOI 10.1016/j.cub.2012.11.043; Shomrat T, 2008, CURR BIOL, V18, P337, DOI 10.1016/j.cub.2008.01.056; Sih A, 2012, PHILOS T R SOC B, V367, P2762, DOI 10.1098/rstb.2012.0216; Sumbre G, 2005, NATURE, V433, P595, DOI 10.1038/433595a; Sumbre G, 2001, SCIENCE, V293, P1845, DOI 10.1126/science.1060976; Taylor AH, 2010, P ROY SOC B-BIOL SCI, V277, P2637, DOI 10.1098/rspb.2010.0285; Tebbich S, 2007, ANIM COGN, V10, P225, DOI 10.1007/s10071-006-0061-4; Thornton A, 2012, PHILOS T R SOC B, V367, P2773, DOI 10.1098/rstb.2012.0214; VILLANUEVA R, 1995, NATURE, V377, P107, DOI 10.1038/377107a0; Villanueva R, 2008, OCEANOGR MAR BIOL, V46, P105; Wells M.J., 1978, OCTOPUS PHYSL BEHAV, V1st; WELLS MJ, 1961, J EXP BIOL, V38, P811; WELLS MJ, 1964, J EXP BIOL, V41, P621; WELLS MJ, 1957, J EXP BIOL, V34, P131; WELLS MJ, 1964, J EXP BIOL, V41, P433; YOUNG JZ, 1991, BIOL BULL, V180, P200, DOI 10.2307/1542389; Young JZ, 1963, P ZOOLOGICAL SOC LON; Young JZ, 1983, P ROY SOC LOND B BIO, V219, P135	70	25	25	2	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152048	10.1371/journal.pone.0152048	http://dx.doi.org/10.1371/journal.pone.0152048			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003439	gold, Green Published, Green Submitted			2022-12-26	WOS:000372697400070
J	Asadi-Eydivand, M; Solati-Hashjin, M; Shafiei, SS; Mohammadi, S; Hafezi, M; Abu Osman, NA				Asadi-Eydivand, Mitra; Solati-Hashjin, Mehran; Shafiei, Seyedeh Sara; Mohammadi, Sepideh; Hafezi, Masoud; Abu Osman, Noor Azuan			Structure, Properties, and In Vitro Behavior of Heat-Treated Calcium Sulfate Scaffolds Fabricated by 3D Printing	PLOS ONE			English	Article							3-DIMENSIONAL SCAFFOLDS; ENGINEERING SCAFFOLDS; MECHANICAL-PROPERTIES; BONE SCAFFOLDS; FILL DEFECTS; TISSUE; DESIGN; PHOSPHATE; BIOMATERIALS; DELIVERY	The ability of inkjet-based 3D printing (3DP) to fabricate biocompatible ceramics has made it one of the most favorable techniques to generate bone tissue engineering (BTE) scaffolds. Calcium sulfates exhibit various beneficial characteristics, and they can be used as a promising biomaterial in BTE. However, low mechanical performance caused by the brittle character of ceramic materials is the main weakness of 3DP calcium sulfate scaffolds. Moreover, the presence of certain organic matters in the starting powder and binder solution causes products to have high toxicity levels. A post-processing treatment is usually employed to improve the physical, chemical, and biological behaviors of the printed scaffolds. In this study, the effects of heat treatment on the structural, mechanical, and physical characteristics of 3DP calcium sulfate prototypes were investigated. Different microscopy and spectroscopy methods were employed to characterize the printed prototypes. The in vitro cytotoxicity of the specimens was also evaluated before and after heat treatment. Results showed that the as-printed scaffolds and specimens heat treated at 300 degrees C exhibited severe toxicity in vitro but had almost adequate strength. By contrast, the specimens heat treated in the 500 degrees C-1000 degrees C temperature range, although non-toxic, had insufficient mechanical strength, which was mainly attributed to the exit of the organic binder before 500 degrees C and the absence of sufficient densification below 1000 degrees C. The sintering process was accelerated at temperatures higher than 1000 degrees C, resulting in higher compressive strength and less cytotoxicity. An anhydrous form of calcium sulfate was the only crystalline phase existing in the samples heated at 500 degrees C-1150 degrees C. The formation of calcium oxide caused by partial decomposition of calcium sulfate was observed in the specimens heat treated at temperatures higher than 1200 degrees C. Although considerable improvements in cell viability of heat-treated scaffolds were observed in this study, the mechanical properties were not significantly improved, requiring further investigations. However, the findings of this study give a better insight into the complex nature of the problem in the fabrication of synthetic bone grafts and scaffolds via post-fabrication treatment of 3DP calcium sulfate prototypes.	[Asadi-Eydivand, Mitra; Hafezi, Masoud; Abu Osman, Noor Azuan] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia; [Solati-Hashjin, Mehran; Mohammadi, Sepideh] Amirkabir Univ Technol, Biomed Engn Fac, Tehran 15914, Iran; [Solati-Hashjin, Mehran] Amirkabir Univ Technol, Biomat Ctr Excellence, Tehran 15914, Iran; [Shafiei, Seyedeh Sara] Natl Inst Genet Engn & Biotechnol, Stem Cell & Regenerat Med Grp, Tehran 14965161, Iran	Universiti Malaya; Amirkabir University of Technology; Amirkabir University of Technology	Abu Osman, NA (corresponding author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur 50603, Malaysia.; Solati-Hashjin, M (corresponding author), Amirkabir Univ Technol, Biomed Engn Fac, Tehran 15914, Iran.; Solati-Hashjin, M (corresponding author), Amirkabir Univ Technol, Biomat Ctr Excellence, Tehran 15914, Iran.	solati@aut.ac.ir; azuan@um.edu.my	Solati-Hashjin, Mehran/X-8822-2019; Asadi-Eydivand, Mitra/H-4092-2019; ABU OSMAN, NOOR AZUAN/B-9265-2010; Shafiei, Seyedeh Sara/R-7755-2017; Hafezi, Masoud/K-3589-2013	Solati-Hashjin, Mehran/0000-0002-1187-1237; Asadi-Eydivand, Mitra/0000-0002-7809-7880; ABU OSMAN, NOOR AZUAN/0000-0002-2853-4421; Shafiei, Seyedeh Sara/0000-0002-4517-5969; Hafezi, Masoud/0000-0002-7199-3180	University of Malaya [UM.C/HIR/MOHE/ENG/14 D000014-16001]	University of Malaya(Universiti Malaya)	This study was supported by High Impact Research Grant UM.C/HIR/MOHE/ENG/14 D000014-16001 from the University of Malaya.	Aghajani F, 2004, DENT MATER J, V23, P373, DOI 10.4012/dmj.23.373; Amini AR, 2012, CRITICAL REV BIOMEDI, V40; Asadi-Eydivand M, 2016, ROBOT CIM-INT MANUF, V37, P57, DOI 10.1016/j.rcim.2015.06.005; Athanasiou KA, 2000, TISSUE ENG, V6, P361, DOI 10.1089/107632700418083; Bateman J, 2005, J PERIODONTOL, V76, P1833, DOI 10.1902/jop.2005.76.11.1833; Bergmann C, 2010, J EUR CERAM SOC, V30, P2563, DOI 10.1016/j.jeurceramsoc.2010.04.037; Blom A, 2007, CURR ORTHOPAED, V21, P280, DOI 10.1016/j.cuor.2007.06.005; Bohner M, 2011, ACTA BIOMATER, V7, P478, DOI 10.1016/j.actbio.2010.08.008; Bose S, 2013, MATER TODAY, V16, P496, DOI 10.1016/j.mattod.2013.11.017; Brand RA, 2012, CLIN ORTHOP RELAT R, V470, P3628, DOI 10.1007/s11999-012-2571-5; Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2; Butscher A, 2011, ACTA BIOMATER, V7, P907, DOI 10.1016/j.actbio.2010.09.039; Chen A. A., 2007, BIOMEMS BIOMEDICAL N, P23; Chia HN, 2015, J BIOL ENG, V9, DOI 10.1186/s13036-015-0001-4; Doty HA, 2014, J MATER SCI-MATER M, V25, P1449, DOI 10.1007/s10856-014-5167-7; Farzadi A, 2014, EFFECT LAYER THICKNE, DOI [10.1371/journal.pone.0108252, DOI 10.1371/JOURNAL.PONE.0108252]; Farzadi A, 2015, CERAM INT, V41, P8320, DOI 10.1016/j.ceramint.2015.03.004; Fereshteh Z, 2015, MAT SCI ENG C-MATER, V54, P50, DOI 10.1016/j.msec.2015.05.011; Frascati J., 2007, THESIS U CENTRAL FLO; Furth ME, 2007, BIOMATERIALS, V28, P5068, DOI 10.1016/j.biomaterials.2007.07.042; Galeta T, 2013, MATER TEHNOL, V47, P781; Gbureck U, 2007, ADV FUNCT MATER, V17, P3940, DOI 10.1002/adfm.200700019; Gentile P, 2014, INT J MOL SCI, V15, P3640, DOI 10.3390/ijms15033640; Guo BL, 2015, REGEN BIOMATER, V2, P47, DOI 10.1093/rb/rbu016; Hollinger J.O., 2011, INTRO BIOMATERALS; Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6; Impens D., 2015, THESIS U WINDSOR; Insights P., BONE REGENERATION CA; Kameda T, 1998, BIOCHEM BIOPH RES CO, V245, P419, DOI 10.1006/bbrc.1998.8448; Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2; Kassim B, 2014, AUST DENT J, V59, P48, DOI 10.1111/adj.12098; Khalyfa A, 2007, J MATER SCI-MATER M, V18, P909, DOI 10.1007/s10856-006-0073-2; Lam CXF, 2002, MAT SCI ENG C-BIO S, V20, P49, DOI 10.1016/S0928-4931(02)00012-7; Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9; Lichte P, 2011, INJURY, V42, P569, DOI 10.1016/j.injury.2011.03.033; Lien SM, 2009, ACTA BIOMATER, V5, P670, DOI 10.1016/j.actbio.2008.09.020; Liu C, 2007, CHEM ENG RES DES, V85, P1051, DOI 10.1205/cherd06196; Mazzoli A, 2015, RAPID PROTOTYPING J, V21, P386, DOI 10.1108/RPJ-04-2013-0040; Munch E, 2008, JOM-US, V60, P54, DOI 10.1007/s11837-008-0072-5; Murphy CM, 2010, BIOMATERIALS, V31, P461, DOI 10.1016/j.biomaterials.2009.09.063; Nyan M, 2007, J PHARMACOL SCI, V104, P384, DOI 10.1254/jphs.SC0070184; Park YB, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/5/055007; Pattanayak DK, 2007, MAT SCI ENG C-BIO S, V27, P684, DOI 10.1016/j.msec.2006.06.021; PELTIER LF, 1957, ANN SURG, V146, P61, DOI 10.1097/00000658-195707000-00007; Pina S, 2015, ADV MATER, V27, P1143, DOI 10.1002/adma.201403354; Polo-Corrales L, 2014, J NANOSCI NANOTECHNO, V14, P15, DOI 10.1166/jnn.2014.9127; Rajzer I, 2014, MAT SCI ENG C-MATER, V44, P183, DOI 10.1016/j.msec.2014.08.017; Rauschmann MA, 2005, BIOMATERIALS, V26, P2677, DOI 10.1016/j.biomaterials.2004.06.045; Rauschmann M, 2010, EUR SPINE J, V19, P887, DOI 10.1007/s00586-010-1279-z; Razak S.I.A., 2012, INT J BASIC APPL SCI, V12, P31, DOI DOI 10.4028/WWW.SCIENTIFIC.NET/JBBTE.10.95; Sadeghpour S, 2014, CERAM INT, V40, P16107, DOI 10.1016/j.ceramint.2014.07.039; Sadiasa A, 2014, J BIOMAT SCI-POLYM E, V25, P150, DOI 10.1080/09205063.2013.846633; Shen Y, 2014, ACS APPL MATER INTER, V6, P12177, DOI 10.1021/am501448t; Sottosanti J, 1992, Compendium, V13, P226; Suwanprateeb J, 2010, J MATER SCI-MATER M, V21, P419, DOI 10.1007/s10856-009-3883-1; Swift W.M., 1976, DECOMPOSITION CALCIU; Technology NIoSa, 2011, 2 PYRR INFR SPECTR; Technology NIoSa, 2011, WAT INFR SPECTR; Thomas M. V., 2005, J LONG TERM EFFECTS, V15; Thomas MV, 2009, J BIOMED MATER RES B, V88B, P597, DOI 10.1002/jbm.b.31269; Utela B., 2008, J MANUF PROCESS, V10, P96, DOI [DOI 10.1016/J.JMAPRO.2009.03.002, 10.1016/j.jmapro.2009.03.002]; Vorndran E, 2011, ADV APPL CERAM, V110, P476, DOI 10.1179/1743676111Y.0000000030; Vorndran E, 2015, MRS BULL, V40, P127, DOI 10.1557/mrs.2015.326; Wu SL, 2014, MAT SCI ENG R, V80, P1, DOI 10.1016/j.mser.2014.04.001; Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645; Yang SF, 2002, TISSUE ENG, V8, P1, DOI 10.1089/107632702753503009; Zhou Z, 2012, ISRN BIOMATERIALS, P2013; Zhou ZX, 2014, MAT SCI ENG C-MATER, V38, P1, DOI 10.1016/j.msec.2014.01.027	68	45	45	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151216	10.1371/journal.pone.0151216	http://dx.doi.org/10.1371/journal.pone.0151216			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999789	gold, Green Published, Green Submitted			2022-12-26	WOS:000372694700027
J	Clark, AL; Maruyama, S; Sano, S; Accorsi, A; Girgenrath, M; Walsh, K; Naya, FJ				Clark, Amanda L.; Maruyama, Sonomi; Sano, Soichi; Accorsi, Anthony; Girgenrath, Mahasweta; Walsh, Kenneth; Naya, Francisco J.			miR-410 and miR-495 Are Dynamically Regulated in Diverse Cardiomyopathies and Their Inhibition Attenuates Pathological Hypertrophy	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; HUMAN HEART; MICRORNAS; EXPRESSION; GENE; ACTIVATION; CLUSTER; MEF2; DYSFUNCTION; DEFICIENCY	Noncoding RNAs have emerged as important modulators in cardiac development and pathological remodeling. Recently, we demonstrated that regulation of the Gtl2-Dio3 noncoding RNA locus is dependent on the MEF2 transcription factor in cardiac muscle, and that two of its encoded miRNAs, miR-410 and miR-495, induce robust cardiomyocyte proliferation. Given the possibility of manipulating the expression of these miRNAs to repair the damaged heart by stimulating cardiomyocyte proliferation, it is important to determine whether the Gtl2-Dio3 noncoding RNAs are regulated in cardiac disease and whether they function downstream of pathological cardiac stress signaling. Therefore, we examined expression of the above miRNAs processed from the Gtl2-Dio3 locus in various cardiomyopathies. These noncoding RNAs were upregulated in all cardiac disease models examined including myocardial infarction (MI) and chronic angiotensin II (Ang II) stimulation, and in the cardiomyopathies associated with muscular dystrophies. Consistent with these observations, we show that the Gtl2-Dio3 proximal promoter is activated by stress stimuli in cardiomyocytes and requires MEF2 for its induction. Furthermore, inhibiting miR-410 or miR-495 in stressed cardiomyocytes attenuated the hypertrophic response. Thus, the Gtl2-Dio3 noncoding RNA locus is a novel marker of cardiac disease and modulating the activity of its encoded miRNAs may mitigate pathological cardiac remodeling in these diseases.	[Clark, Amanda L.; Naya, Francisco J.] Boston Univ, Dept Biol, Program Cell & Mol Biol, 5 Cummington St, Boston, MA 02215 USA; [Maruyama, Sonomi; Sano, Soichi; Walsh, Kenneth] Boston Univ, Sch Med, Whitaker Cardiovasc Inst, Boston, MA 02118 USA; [Accorsi, Anthony; Girgenrath, Mahasweta] Boston Univ, Coll Hlth & Rehabil Sci, Dept Hlth Sci, Boston, MA 02215 USA	Boston University; Boston University; Boston University	Naya, FJ (corresponding author), Boston Univ, Dept Biol, Program Cell & Mol Biol, 5 Cummington St, Boston, MA 02215 USA.	fnaya@bu.edu			National Institutes of Health [HL073304, HL120160, HL131006]; Cure CMD, Struggle Against Muscular Dystrophy (SAM); Muscular Dystrophy Association [218938]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL131006, R01HL073304, R01HL120160] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cure CMD, Struggle Against Muscular Dystrophy (SAM); Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the National Institutes of Health HL073304 to FJN, HL120160 and HL131006 to KW, and Cure CMD, Struggle Against Muscular Dystrophy (SAM) and Muscular Dystrophy Association (218938) to MG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the National Institutes of Health HL073304 to FJN, HL120160 and HL131006 to KW, and Cure CMD, Struggle Against Muscular Dystrophy (SAM) and Muscular Dystrophy Association (218938) to MG. We thank members of the Naya laboratory for critical reading of the manuscript.	Benetatos L, 2013, CELL MOL LIFE SCI, V70, P795, DOI 10.1007/s00018-012-1080-8; Carboni N, 2011, MUSCLE NERVE, V44, P826, DOI 10.1002/mus.22228; Chugh SS, 2003, CARDIOVASC RES, V57, P477, DOI 10.1016/S0008-6363(02)00703-4; Clark AL, 2015, J BIOL CHEM, V290, P23162, DOI 10.1074/jbc.M115.672659; Czubryt MP, 2004, RECENT PROG HORM RES, V59, P105, DOI 10.1210/rp.59.1.105; Da Rocha ST, 2008, TRENDS GENET, V24, P306, DOI 10.1016/j.tig.2008.03.011; Das PP, 2015, CELL REP, V12, P1456, DOI 10.1016/j.celrep.2015.07.053; Duan DS, 2006, HUM MOL GENET, V15, pR253, DOI 10.1093/hmg/ddl180; Finsterer J, 2014, NAT REV CARDIOL, V11, P168, DOI 10.1038/nrcardio.2013.213; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Hagan JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004352; Hashemi S, 2015, CELL DEATH DISCOV, V1, DOI 10.1038/cddiscovery.2015.19; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Janssen R, 2013, ENDOCRINOLOGY, V154, P1973, DOI 10.1210/en.2012-2017; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Kim S, 2000, PHARMACOL REV, V52, P11; Kim Y, 2008, J CLIN INVEST, V118, P124, DOI 10.1172/JCI33255; Kumar A, 2011, HUM MOL GENET, V20, P2333, DOI 10.1093/hmg/ddr126; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Lu JR, 2000, P NATL ACAD SCI USA, V97, P4070, DOI 10.1073/pnas.080064097; McCalmon SA, 2010, CIRC RES, V106, P952, DOI 10.1161/CIRCRESAHA.109.209007; McNally EM, 2007, ANNU REV MED, V58, P75, DOI 10.1146/annurev.med.58.011706.144703; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; Neppl RL, 2014, GENES DIS, V1, P18, DOI 10.1016/j.gendis.2014.06.003; Prat-Vidal C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054785; Shibata R, 2004, NAT MED, V10, P1384, DOI 10.1038/nm1137; Shibata R, 2007, J MOL CELL CARDIOL, V42, P1065, DOI 10.1016/j.yjmcc.2007.03.808; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Snyder CM, 2013, DEVELOPMENT, V140, P31, DOI 10.1242/dev.081851; Song GS, 2008, NUCLEIC ACIDS RES, V36, P5727, DOI 10.1093/nar/gkn567; Spyrou N, 1998, AM HEART J, V136, P474, DOI 10.1016/S0002-8703(98)70222-4; Thum T, 2008, CARDIOVASC RES, V79, P562, DOI 10.1093/cvr/cvn137; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Yang KC, 2012, J MOL CELL CARDIOL, V53, P101, DOI 10.1016/j.yjmcc.2012.04.012; Zhao J, 2010, MOL CELL, V40, P939, DOI 10.1016/j.molcel.2010.12.011; Zhou YL, 2010, DEVELOPMENT, V137, P2643, DOI 10.1242/dev.045724	38	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151515	10.1371/journal.pone.0151515	http://dx.doi.org/10.1371/journal.pone.0151515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999812	gold, Green Published, Green Submitted			2022-12-26	WOS:000372694700043
J	Kennedy, MW; Crowell, CR; Villano, M; Schmiedeler, JP				Kennedy, Michael W.; Crowell, Charles R.; Villano, Michael; Schmiedeler, James P.			Effects of Filtering the Center of Pressure Feedback Provided in Visually Guided Mediolateral Weight Shifting	PLOS ONE			English	Article							POSTURAL CONTROL; STIFFNESS CONTROL; GRAVITY MOTIONS; STROKE PATIENTS; BALANCE; BIOFEEDBACK; IMPROVES; THERAPY; BEARING; STANCE	Thirty healthy adults completed a mediolateral weight-shifting balance task in which they were instructed to shift their weight to visually displayed target regions. A model-based filter and three different moving average filters employing 10, 34, and 58 samples were applied to the center of pressure visual feedback that guided the activity. The effects of filter selection on both the displayed feedback and the shift performance were examined in terms of shift time and non-minimum phase behavior. Shift time relates to feedback delay and shift speed, whereas non-minimum phase behavior relates to the force applied in shift initiation. Results indicated that increasing the number of samples in moving average filters (indicative of stronger filtering) significantly increases shift speed and shift initiation force. These effects indicate that careful selection and documentation of data filtering is warranted in future work and suggest opportunities for strategic filtering of visual feedback in clinical weight-shifting balance activities in order to improve outcomes based on such feedback.	[Kennedy, Michael W.; Schmiedeler, James P.] Univ Notre Dame, Dept Aerosp & Mech Engn, Notre Dame, IN 46556 USA; [Crowell, Charles R.; Villano, Michael] Univ Notre Dame, Dept Psychol, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Kennedy, MW (corresponding author), Univ Notre Dame, Dept Aerosp & Mech Engn, Notre Dame, IN 46556 USA.	michaelwkennedy@gmail.com	Villano, Michael Anthony/AAH-4760-2021; /B-9681-2012	/0000-0002-1692-4414	National Institutes of Health [UL1 RR 02576]; National Science Foundation [IIS-1117706]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Institutes of Health (http://www.nih.gov/): #UL1 RR 02576 to JPS, and the National Science Foundation (http://www.nsf.gov/): #IIS-1117706 to JPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudrahem S, 2009, EXP BRAIN RES, V195, P145, DOI 10.1007/s00221-009-1761-1; Caron O, 1997, J BIOMECH, V30, P1169, DOI 10.1016/S0021-9290(97)00094-8; Cheng PT, 2004, CLIN REHABIL, V18, P747, DOI 10.1191/0269215504cr778oa; Clark RA, 2010, GAIT POSTURE, V31, P307, DOI 10.1016/j.gaitpost.2009.11.012; Dault MC, 2003, HUM MOVEMENT SCI, V22, P221, DOI 10.1016/S0167-9457(03)00034-4; de Haart M, 2005, ARCH PHYS MED REHAB, V86, P755, DOI 10.1016/j.apmr.2004.10.010; de Oliveira CB, 2008, J REHABIL RES DEV, V45, P1215, DOI 10.1682/JRRD.2007.09.0150; de Vries EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098494; Geiger RA, 2001, PHYS THER, V81, P995, DOI 10.1093/ptj/81.4.995; Geurts ACH, 2005, GAIT POSTURE, V22, P267, DOI 10.1016/j.gaitpost.2004.10.002; Goldie PA, 1996, CLIN BIOMECH, V11, P333, DOI 10.1016/0268-0033(96)00014-9; Hatzitaki V, 2007, EXP BRAIN RES, V182, P525, DOI 10.1007/s00221-007-1007-z; HOCKING RR, 1976, BIOMETRICS, V32, P1, DOI 10.2307/2529336; Kennedy M, 2011, 13 INT C E HLTH NETW, DOI [10.1109/HEALTH.2011.6026735, DOI 10.1109/HEALTH.2011.6026735]; Kennedy MW, 2014, GAIT POSTURE, V40, P134, DOI 10.1016/j.gaitpost.2014.03.011; Kennedy MW, 2013, EXP BRAIN RES, V230, P117, DOI 10.1007/s00221-013-3634-x; Marigold DS, 2006, GAIT POSTURE, V23, P249, DOI 10.1016/j.gaitpost.2005.03.001; Patton JL, 2000, EXP BRAIN RES, V135, P117, DOI 10.1007/s002210000500; Rougier P, 2000, J MOTOR BEHAV, V32, P405, DOI 10.1080/00222890009601390; Rougier P, 2005, EXP BRAIN RES, V165, P193, DOI 10.1007/s00221-005-2288-8; Rougier P, 2003, CLIN BIOMECH, V18, P341, DOI 10.1016/S0268-0033(03)00003-2; Rougier PR, 2012, TOP STROKE REHABIL, V19, P1, DOI 10.1310/tsr1901-1; Stanton R, 2011, J PHYSIOTHER, V57, P145, DOI 10.1016/S1836-9553(11)70035-2; Van Peppen RPS, 2006, J REHABIL MED, V38, P3, DOI 10.1080/16501970500344902; Walker C, 2000, PHYS THER, V80, P886, DOI 10.1093/ptj/80.9.886; Winter D., 2009, BIOMECHANICS MOTOR C, V4th; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Winter DA, 2001, J NEUROPHYSIOL, V85, P2630, DOI 10.1152/jn.2001.85.6.2630; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; Yeh TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091554; Zijlstra A, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-58	31	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151393	10.1371/journal.pone.0151393	http://dx.doi.org/10.1371/journal.pone.0151393			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991996	Green Published, Green Submitted, gold			2022-12-26	WOS:000372582800059
J	Mora-Navarro, C; Mendez-Vega, J; Caraballo-Leon, J; Lee, MR; Palecek, S; Torres-Lugo, M; Ortiz-Bermudez, P				Mora-Navarro, Camilo; Mendez-Vega, Janet; Caraballo-Leon, Jean; Lee, Myung-ryul; Palecek, Sean; Torres-Lugo, Madeline; Ortiz-Bermudez, Patricia			Hydrophobicity of Antifungal beta-Peptides Is Associated with Their Cytotoxic Effect on In Vitro Human Colon Caco-2 and Liver HepG2 Cells	PLOS ONE			English	Article							CANDIDA-ALBICANS; LIQUID-CHROMATOGRAPHY; AMPHOTERICIN-B; RELEVANCE; BIOFILMS; LIBRARY; MODEL; ASSAY	The widespread distribution of fungal infections, with their high morbidity and mortality rate, is a global public health problem. The increase in the population of immunocompromised patients combined with the selectivity of currents treatments and the emergence of drug-resistant fungal strains are among the most imperative reasons to develop novel antifungal formulations. Antimicrobial beta-peptides are peptidomimetics of natural antimicrobial peptides (AMPs), which have been proposed as developmental platforms to enhance the AMPs selectivity and biostability. Their tunability allows the design of sequences with remarkable activity against a wide spectrum of microorganisms such as the human pathogenic Candida spp., both in planktonic and biofilm morphology. However, the beta-peptide's effect on surrounding host cells remains greatly understudied. Assessments have mainly relied on the extent of hemolysis that a candidate peptide is able to cause. This work investigated the in vitro cytotoxicity of various beta-peptides in the Caco-2 and HepG2 mammalian cell lines. Results indicated that the cytotoxic effect of the beta-peptides was influenced by cell type and was also correlated to structural features of the peptide such as hydrophobicity. We found that the selectivity of the most hydrophobic beta-peptide was 2-3 times higher than that of the least hydrophobic one, for both cell types according to the selectivity index parameter (IC50/MIC). The IC50 of Caco-2 and HepG2 increased with hydrophobicity, which indicates the importance of testing putative therapeutics on different cell types. We report evidence of peptide-cell membrane interactions in Caco-2 and HepG2 using a widely studied beta-peptide against C. albicans.	[Mora-Navarro, Camilo; Mendez-Vega, Janet; Caraballo-Leon, Jean; Torres-Lugo, Madeline; Ortiz-Bermudez, Patricia] Univ Puerto Rico, Dept Chem Engn, Mayaguez Campus, Mayaguez, PR USA; [Lee, Myung-ryul; Palecek, Sean] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI USA	University of Puerto Rico; University of Puerto Rico Mayaguez; University of Wisconsin System; University of Wisconsin Madison	Ortiz-Bermudez, P (corresponding author), Univ Puerto Rico, Dept Chem Engn, Mayaguez Campus, Mayaguez, PR USA.	patricia.ortiz3@upr.edu	Caraballo-León, Jean/P-6424-2019	Caraballo-León, Jean/0000-0002-7067-2131; Lee, Myung-Ryul/0000-0002-9111-2969; Mora-Navarro, Camilo/0000-0001-6863-8068	National Science Foundation Division of Material Research through the Partnership for Research and Education in Materials Program [DMR-0934115]; NIH [1R01 AI092225]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092225] Funding Source: NIH RePORTER	National Science Foundation Division of Material Research through the Partnership for Research and Education in Materials Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the National Science Foundation Division of Material Research, Grant DMR-0934115, through the Partnership for Research and Education in Materials Program to POB and MTL. This work was also supported by NIH grant 1R01 AI092225 to SPP. The funders participated in the design and conception of the experiments, data analysis, decision to publish and manuscript development.	Alvarez-Berrios MP, 2013, INT J NANOMED, V8, P1003, DOI 10.2147/IJN.S38842; Bhat UG, 2010, MOL CANCER THER, V9, P1688, DOI 10.1158/1535-7163.MCT-09-0919; Bjorklund E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087542; Brown GD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004404; Bruggemann RJM, 2009, CLIN INFECT DIS, V48, P1441, DOI 10.1086/598327; Cabrele C, 2014, J MED CHEM, V57, P9718, DOI 10.1021/jm5010896; CONRADI RA, 1991, PHARMACEUT RES, V8, P1453, DOI 10.1023/A:1015825912542; Domenech M, 2013, ACS NANO, V7, P5091, DOI 10.1021/nn4007048; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gerets HHJ, 2012, CELL BIOL TOXICOL, V28, P69, DOI 10.1007/s10565-011-9208-4; Giuliani A, 2007, CENT EUR J BIOL, V2, P1, DOI 10.2478/s11535-007-0010-5; Gupta N, 1996, RADIAT RES, V145, P636, DOI 10.2307/3579284; Inselmann G, 2002, Eur J Intern Med, V13, P288, DOI 10.1016/S0953-6205(02)00065-1; Karlsson AJ, 2006, J AM CHEM SOC, V128, P12630, DOI 10.1021/ja064630y; Karlsson AJ, 2009, ACS CHEM BIOL, V4, P567, DOI 10.1021/cb900093r; Kaufmann SH, 2003, ONCOGENE, V22, P7414, DOI 10.1038/sj.onc.1206945; Kontoyiannis DP, 2010, CLIN INFECT DIS, V50, P1091, DOI 10.1086/651263; Lakshminarayanan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087730; Lee MR, 2014, ACS CHEM BIOL, V9, P1613, DOI 10.1021/cb500203e; Lestner JM, 2010, ANTIMICROB AGENTS CH, V54, P3432, DOI 10.1128/AAC.01586-09; McKim JM, 2010, COMB CHEM HIGH T SCR, V13, P188, DOI 10.2174/138620710790596736; MEEK JL, 1980, P NATL ACAD SCI-BIOL, V77, P1632, DOI 10.1073/pnas.77.3.1632; Menez C, 2006, ANTIMICROB AGENTS CH, V50, P3793, DOI 10.1128/AAC.00837-06; Mora-Navarro C, 2015, J PEPT SCI, V21, P853, DOI 10.1002/psc.2827; Murray JK, 2006, J COMB CHEM, V8, P58, DOI 10.1021/cc0501099; Murray JK, 2005, ORG LETT, V7, P1517, DOI 10.1021/ol0501727; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; Pauletti GM, 1997, PHARMACEUT RES, V14, P164, DOI 10.1023/A:1012040425146; Protopopova M, 2005, J ANTIMICROB CHEMOTH, V56, P968, DOI 10.1093/jac/dki319; Raguse TL, 2002, J AM CHEM SOC, V124, P12774, DOI 10.1021/ja0270423; Raman N, 2014, J CONTROL RELEASE, V191, P54, DOI 10.1016/j.jconrel.2014.05.026; Sahu SC, 2014, J APPL TOXICOL, V34, P1226, DOI 10.1002/jat.3065; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; SchmiedlinRen P, 1997, MOL PHARMACOL, V51, P741, DOI 10.1124/mol.51.5.741; van der Weerden NL, 2013, CELL MOL LIFE SCI, V70, P3545, DOI 10.1007/s00018-013-1260-1; World Health Organization, 2014, ANT RES GLOB REP SUR; Zhao M, 2000, FEBS LETT, V485, P104, DOI 10.1016/S0014-5793(00)02195-5; Zhou JH, 2013, TOXIN REV, V32, P60, DOI 10.3109/15569543.2013.852108	38	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0149271	10.1371/journal.pone.0149271	http://dx.doi.org/10.1371/journal.pone.0149271			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992117	Green Published, Green Submitted, gold			2022-12-26	WOS:000372582800020
J	Watkins, HA; Chakravarthy, M; Abhayawardana, RS; Gingell, JJ; Garelja, M; Pardamwar, M; McElhinney, JMWR; Lathbridge, A; Constantine, A; Harris, PWR; Yuen, TY; Brimble, MA; Barwell, J; Poyner, DR; Woolley, MJ; Conner, AC; Pioszak, AA; Reynolds, CA; Hay, DL				Watkins, Harriet A.; Chakravarthy, Madhuri; Abhayawardana, Rekhati S.; Gingell, Joseph J.; Garelja, Michael; Pardamwar, Meenakshi; McElhinney, James M. W. R.; Lathbridge, Alex; Constantine, Arran; Harris, Paul W. R.; Yuen, Tsz-Ying; Brimble, Margaret A.; Barwell, James; Poyner, David R.; Woolley, Michael J.; Conner, Alex C.; Pioszak, Augen A.; Reynolds, Christopher A.; Hay, Debbie L.			Receptor Activity-modifying Proteins 2 and 3 Generate Adrenomedullin Receptor Subtypes with Distinct Molecular Properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREDICTING POCKET DRUGGABILITY; FAST INTERACTION REFINEMENT; PHASE PEPTIDE-SYNTHESIS; CLASS-B GPCRS; CALCITONIN-RECEPTOR; COUPLED RECEPTORS; HEART-FAILURE; WEB SERVER; TRANSMEMBRANE HELICES; EXTRACELLULAR LOOPS	Adrenomedullin (AM) is a peptide hormone with numerous effects in the vascular systems. AM signals through the AM(1) and AM(2) receptors formed by the obligate heterodimerization of a G protein-coupled receptor, the calcitonin receptor-like receptor (CLR), and receptor activity-modifying proteins 2 and 3 (RAMP2 and RAMP3), respectively. These different CLR-RAMP interactions yield discrete receptor pharmacology and physiological effects. The effective design of therapeutics that target the individual AM receptors is dependent on understanding the molecular details of the effects of RAMPs on CLR. To understand the role of RAMP2 and -3 on the activation and conformation of the CLR subunit of AM receptors, we mutated 68 individual amino acids in the juxtamembrane region of CLR, a key region for activation of AM receptors, and determined the effects on cAMP signaling. Sixteen CLR mutations had differential effects between the AM(1) and AM(2) receptors. Accompanying this, independent molecular modeling of the full-length AM-bound AM(1) and AM(2) receptors predicted differences in the binding pocket and differences in the electrostatic potential of the two AM receptors. Druggability analysis indicated unique features that could be used to develop selective small molecule ligands for each receptor. The interaction of RAMP2 or RAMP3 with CLR induces conformational variation in the juxtamembrane region, yielding distinct binding pockets, probably via an allosteric mechanism. These subtype-specific differences have implications for the design of therapeutics aimed at specific AM receptors and for understanding the mechanisms by which accessory proteins affect G protein-coupled receptor function.	[Watkins, Harriet A.; Chakravarthy, Madhuri; Abhayawardana, Rekhati S.; Gingell, Joseph J.; Garelja, Michael; Hay, Debbie L.] Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand; [Watkins, Harriet A.; Gingell, Joseph J.; Harris, Paul W. R.; Yuen, Tsz-Ying; Brimble, Margaret A.; Hay, Debbie L.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1010, New Zealand; [Harris, Paul W. R.; Yuen, Tsz-Ying; Brimble, Margaret A.] Univ Auckland, Sch Chem Sci, Auckland 1010, New Zealand; [Pardamwar, Meenakshi; McElhinney, James M. W. R.; Lathbridge, Alex; Constantine, Arran; Reynolds, Christopher A.] Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England; [Barwell, James; Poyner, David R.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Woolley, Michael J.; Conner, Alex C.] Univ Birmingham, Sch Clin & Expt Med, Birmingham B15 2TT, W Midlands, England; [Pioszak, Augen A.] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA	University of Auckland; University of Auckland; University of Auckland; University of Essex; Aston University; University of Birmingham; University of Oklahoma System; University of Oklahoma Health Sciences Center	Hay, DL (corresponding author), Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand.; Reynolds, CA (corresponding author), Univ Essex, Sch Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England.	reync@essex.ac.uk; dl.hay@auckland.ac.nz	Hay, Debbie L/D-4441-2009; Reynolds, Christopher/G-1036-2010	Hay, Debbie L/0000-0002-9558-5122; McElhinney, James/0000-0003-0987-4364; Garelja, Michael/0000-0001-5332-1236; Poyner, David R/0000-0003-1590-112X; Reynolds, Christopher/0000-0001-9267-5141; Chakravarthy, Madhuri/0000-0002-4146-0121; Gingell, Joseph/0000-0002-8733-7639	Biotechnology and Biological Sciences Research Council [BB/M006883/1, BB/M007529/1, BB/M000176/1]; National Heart Foundation of New Zealand; Maurice and Phyllis Paykel Trust; Maurice Wilkins Centre for Molecular Biodiscovery; British Heart Foundation [FS/05/054, PG/12/59/29795]; BBSRC [BB/M000176/1, BB/M006883/1, BB/M007529/1] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104251] Funding Source: NIH RePORTER	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Heart Foundation of New Zealand; Maurice and Phyllis Paykel Trust; Maurice Wilkins Centre for Molecular Biodiscovery; British Heart Foundation(British Heart Foundation); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Biotechnology and Biological Sciences Research Council Grants BB/M006883/1 (to C. A. R.) and BB/M007529/1 and BB/M000176/1 (to D. P.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the National Heart Foundation of New Zealand, the Maurice and Phyllis Paykel Trust, and the Maurice Wilkins Centre for Molecular Biodiscovery.; Supported by British Heart Foundation Grant FS/05/054.; Supported by British Heart Foundation Grant PG/12/59/29795.	Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Bailey RJ, 2007, BRIT J PHARMACOL, V151, P678, DOI 10.1038/sj.bjp.0707246; Bailey RJ, 2006, PEPTIDES, V27, P1367, DOI 10.1016/j.peptides.2005.11.014; Baldwin JM, 1997, J MOL BIOL, V272, P144, DOI 10.1006/jmbi.1997.1240; Barrick CJ, 2012, J MOL CELL CARDIOL, V52, P165, DOI 10.1016/j.yjmcc.2011.10.021; Barwell J, 2011, BBA-MOL CELL RES, V1813, P1906, DOI 10.1016/j.bbamcr.2011.06.005; Booe JM, 2015, MOL CELL, V58, P1040, DOI 10.1016/j.molcel.2015.04.018; Borrel A, 2015, J CHEM INF MODEL, V55, P882, DOI 10.1021/ci5006004; Bortolato A, 2014, BRIT J PHARMACOL, V171, P3132, DOI 10.1111/bph.12689; Burley DS, 2007, HEART FAIL REV, V12, P279, DOI 10.1007/s10741-007-9029-y; Callenberg KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012722; Caron KM, 2001, P NATL ACAD SCI USA, V98, P615, DOI 10.1073/pnas.021548898; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Conner AC, 2005, MOL PHARMACOL, V67, P20, DOI 10.1124/mol.67.1.20; Dackor RT, 2006, MOL CELL BIOL, V26, P2511, DOI 10.1128/MCB.26.7.2511-2518.2006; Dackor R, 2007, J BIOL CHEM, V282, P18094, DOI 10.1074/jbc.M703544200; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Dupuis J, 2005, CLIN SCI, V109, P97, DOI 10.1042/CS20040357; Garland SL, 2013, J BIOMOL SCREEN, V18, P947, DOI 10.1177/1087057113498418; Gingell J. J., 2016, CELL DISCOV IN PRESS; Gingell JJ, 2010, PEPTIDES, V31, P1400, DOI 10.1016/j.peptides.2010.03.027; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Harikumar KG, 2009, BIOCHEMISTRY-US, V48, P11773, DOI 10.1021/bi901326k; Harris PWR, 2011, TETRAHEDRON LETT, V52, P6024, DOI 10.1016/j.tetlet.2011.09.010; Harris PWR, 2008, INT J PEPT RES THER, V14, P387, DOI 10.1007/s10989-008-9149-9; Hollenstein K, 2014, TRENDS PHARMACOL SCI, V35, P12, DOI 10.1016/j.tips.2013.11.001; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hussein HA, 2015, NUCLEIC ACIDS RES, V43, pW436, DOI 10.1093/nar/gkv462; Jacobson MP, 2004, PROTEINS, V55, P351, DOI 10.1002/prot.10613; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Kataoka Y, 2010, J CARDIOVASC PHARM, V56, P413, DOI 10.1097/FJC.0b013e3181f15b45; Kato J, 2015, EUR J PHARMACOL, V764, P140, DOI 10.1016/j.ejphar.2015.06.061; Kenakin T. P., 2014, PHARM PRIMER TECHNIQ, P181; Koole C, 2012, J BIOL CHEM, V287, P3642, DOI 10.1074/jbc.M111.309328; Koth CM, 2012, P NATL ACAD SCI USA, V109, P14393, DOI 10.1073/pnas.1206734109; Kozakov D, 2010, PROTEINS, V78, P3124, DOI 10.1002/prot.22835; Lainchbury JG, 1999, HYPERTENSION, V34, P70, DOI 10.1161/01.HYP.34.1.70; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee SM, 2016, J BIOL CHEM, V291, P8686, DOI 10.1074/jbc.M115.713628; Li XF, 2010, PROTEINS, V78, P3189, DOI 10.1002/prot.22770; Liang LH, 2009, HYPERTENSION, V54, P1254, DOI 10.1161/HYPERTENSIONAHA.109.129783; Lock A, 2014, BBA-BIOMEMBRANES, V1838, P3036, DOI 10.1016/j.bbamem.2014.08.019; Manuela C, 2014, PEPTIDES, V55, P13, DOI 10.1016/j.peptides.2014.01.028; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Miller LJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217901; Monaghan P, 2008, BIOCHEMISTRY-US, V47, P5889, DOI 10.1021/bi800122f; Nagaya N, 2000, HEART, V84, P653, DOI 10.1136/heart.84.6.653; Nishikimi T, 2013, CURR PROTEIN PEPT SC, V14, P256, DOI 10.2174/13892037113149990045; Perez-Castells J, 2012, BIOPOLYMERS, V97, P45, DOI 10.1002/bip.21700; Poyner DR, 2002, PHARMACOL REV, V54, P233, DOI 10.1124/pr.54.2.233; Qi T, 2013, BRIT J PHARMACOL, V168, P644, DOI 10.1111/j.1476-5381.2012.02197.x; Qi T, 2008, MOL PHARMACOL, V74, P1059, DOI 10.1124/mol.108.047142; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Roy A, 2014, J BIOMOL STRUCT DYN, V32, P364, DOI 10.1080/07391102.2013.770371; Runge S, 2008, J BIOL CHEM, V283, P11340, DOI 10.1074/jbc.M708740200; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; SITKOFF D, 1994, BIOPHYS CHEM, V51, P397, DOI 10.1016/0301-4622(94)00062-X; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Taddese B, 2014, PLANT PHYSIOL, V164, P287, DOI 10.1104/pp.113.228874; Tadokoro K, 2003, REGUL PEPTIDES, V112, P71, DOI 10.1016/s0167-0115(03)00024-7; Vohra S, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0846; Volkamer A, 2012, BIOINFORMATICS, V28, P2074, DOI 10.1093/bioinformatics/bts310; Wang DF, 2005, ABSTR PAP AM CHEM S, V230, pU1360; Wang JG, 2007, BIOORGAN MED CHEM, V15, P374, DOI 10.1016/j.bmc.2006.09.050; Watkins HA, 2014, BRIT J PHARMACOL, V171, P772, DOI 10.1111/bph.12508; Watkins HA, 2012, DRUG DISCOV TODAY, V17, P1006, DOI 10.1016/j.drudis.2012.05.005; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; Wong CP, 2012, WORLD J CARDIOL, V4, P206, DOI 10.4330/wjc.v4.i6.206; Woolley MJ, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0589; Wootten D, 2016, MOL PHARMACOL, V89, P335, DOI 10.1124/mol.115.101246; Wootten D, 2013, P NATL ACAD SCI USA, V110, P5211, DOI 10.1073/pnas.1221585110; Yamauchi A, 2014, J MOL CELL CARDIOL, V77, P73, DOI 10.1016/j.yjmcc.2014.09.017; Yang LL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8859; Yoshizawa T, 2013, HYPERTENSION, V61, P341, DOI 10.1161/HYPERTENSIONAHA.111.00647	79	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11657	11675		10.1074/jbc.M115.688218	http://dx.doi.org/10.1074/jbc.M115.688218			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27013657	hybrid, Green Accepted, Green Published			2022-12-26	WOS:000377264800017
J	Guo, H; Foncea, R; O'Byrne, SM; Jiang, HF; Zhang, YY; Deis, JA; Blaner, WS; Bernlohr, DA; Chen, XL				Guo, Hong; Foncea, Rocio; O'Byrne, Sheila M.; Jiang, Hongfeng; Zhang, Yuanyuan; Deis, Jessica A.; Blaner, William S.; Bernlohr, David A.; Chen, Xiaoli			Lipocalin 2, a Regulator of Retinoid Homeostasis and Retinoid-mediated Thermogenic Activation in Adipose Tissue	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adipose tissue; cytokine; energy metabolism; lipid metabolism; retinoid; lipocalin 2	UNCOUPLING PROTEIN GENE; BINDING-PROTEIN; VITAMIN-A; INSULIN-RESISTANCE; HUMAN PLASMA; IN-VITRO; ACID; RECEPTOR; EXPRESSION; METABOLISM	We have recently characterized the role of lipocalin 2 (Lcn2) as a new adipose-derived cytokine in the regulation of adaptive thermogenesis via a non-adrenergic pathway. Herein, we explored a potential non-adrenergic mechanism by which Lcn2 regulates thermogenesis and lipid metabolism. We found that Lcn2 is a retinoic acid target gene, and retinoic acid concurrently stimulated UCP1 and Lcn2 expression in adipocytes. Lcn2 KO mice exhibited a blunted effect of all-trans-retinoic acid (ATRA) on body weight and fat mass, lipid metabolism, and retinoic acid signaling pathway activation in adipose tissue under the high fat diet-induced obese condition. We further demonstrated that Lcn2 is required for the full action of ATRA on the induction of UCP1 and PGC-1 expression in brown adipocytes and the restoration of cold intolerance in Lcn2 KO mice. Interestingly, we discovered that Lcn2 KO mice have decreased levels of retinoic acid and retinol in adipose tissue. The protein levels of STRA6 responsible for retinol uptake were significantly decreased in adipose tissue. The retinol transporter RBP4 was increased in adipose tissue but decreased in the circulation, suggesting the impairment of RBP4 secretion in Lcn2 KO adipose tissue. Moreover, Lcn2 deficiency abolished the ATRA effect on RBP4 expression in adipocytes. All the data suggest that the decreased retinoid level and action are associated with impaired retinol transport and storage in adipose tissue in Lcn2 KO mice. We conclude that Lcn2 plays a critical role in regulating metabolic homeostasis of retinoids and retinoid-mediated thermogenesis in adipose tissue.	[Guo, Hong; Zhang, Yuanyuan; Deis, Jessica A.; Chen, Xiaoli] Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN 55108 USA; [Foncea, Rocio; Bernlohr, David A.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA; [O'Byrne, Sheila M.; Jiang, Hongfeng; Blaner, William S.] Columbia Univ Coll Phys & Surg, Dept Med, 630 W 168th St, New York, NY 10032 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Columbia University	Chen, XL (corresponding author), Univ Minnesota, Dept Food Sci & Nutr, St Paul, MN 55108 USA.; Bernlohr, DA (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, St Paul, MN 55108 USA.; Blaner, WS (corresponding author), Columbia Univ Coll Phys & Surg, Dept Med, 630 W 168th St, New York, NY 10032 USA.	wsb2@columbia.edu; BERNL001@umn.edu; xlchen@umn.edu	jiang, hongfeng/I-6188-2013	Guo, Hong/0000-0001-8024-7086	National Institutes of Health from NIDDK [R01DK080743, P30DK050456]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068437, P30DK050456, T32DK083250, R01DK080743] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants R01DK080743 from NIDDK (to X. C.) and P30DK050456 from NIDDK (to Minnesota Obesity Center). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALVAREZ R, 1995, J BIOL CHEM, V270, P5666, DOI 10.1074/jbc.270.10.5666; Barua AB, 1998, MOL BIOTECHNOL, V10, P167, DOI 10.1007/BF02760863; Berry DC, 2012, BBA-MOL CELL BIOL L, V1821, P168, DOI 10.1016/j.bbalip.2011.07.002; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Blaner WS, 2007, CELL METAB, V5, P164, DOI 10.1016/j.cmet.2007.02.006; BLANER WS, 1989, ENDOCR REV, V10, P308, DOI 10.1210/edrv-10-3-308; Bonet ML, 2000, J ENDOCRINOL, V166, P511, DOI 10.1677/joe.0.1660511; Breustedt DA, 2006, BBA-PROTEINS PROTEOM, V1764, P161, DOI 10.1016/j.bbapap.2005.12.006; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Collins S, 2010, INT J OBESITY, V34, pS28, DOI 10.1038/ijo.2010.180; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P327, DOI 10.1016/S0167-4838(00)00169-2; FLOWER DR, 1993, PROTEIN SCI, V2, P753, DOI 10.1002/pro.5560020507; GarayRojas E, 1996, GENE, V170, P173, DOI 10.1016/0378-1119(95)00896-9; Guo H, 2013, ENDOCRINOLOGY, V154, P3525, DOI 10.1210/en.2013-1289; Guo H, 2010, DIABETES, V59, P1376, DOI 10.2337/db09-1735; Isken A, 2008, CELL METAB, V7, P258, DOI 10.1016/j.cmet.2008.01.009; Jin DZ, 2011, FASEB J, V25, P754, DOI 10.1096/fj.10-165175; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kiernan UA, 2002, BIOCHEM BIOPH RES CO, V297, P401, DOI 10.1016/S0006-291X(02)02212-X; Kim SC, 2014, HEPATOLOGY, V59, P1750, DOI 10.1002/hep.26699; Kumar MV, 1999, J LIPID RES, V40, P824; KURLANDSKY SB, 1995, J BIOL CHEM, V270, P17850, DOI 10.1074/jbc.270.30.17850; LALONDE JM, 1994, FASEB J, V8, P1240, DOI 10.1096/fasebj.8.15.8001736; Larose M, 1996, J BIOL CHEM, V271, P31533, DOI 10.1074/jbc.271.49.31533; Bonet ML, 2012, BBA-MOL CELL BIOL L, V1821, P177, DOI 10.1016/j.bbalip.2011.06.001; Marzan CV, 2011, DEV BIOL, V349, P125, DOI 10.1016/j.ydbio.2010.10.018; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; Mercader J, 2006, ENDOCRINOLOGY, V147, P5325, DOI 10.1210/en.2006-0760; Nedelkov D, 2005, P NATL ACAD SCI USA, V102, P10852, DOI 10.1073/pnas.0500426102; Nelson AM, 2008, J CLIN INVEST, V118, P1468, DOI 10.1172/JCI33869; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pino-Lagos K, 2010, BIOFACTORS, V36, P430, DOI 10.1002/biof.117; Puigserver P, 1996, BIOCHEM J, V317, P827, DOI 10.1042/bj3170827; Rabelo R, 1996, ENDOCRINOLOGY, V137, P3488, DOI 10.1210/en.137.8.3488; Ravussin E, 2011, ANNU REV NUTR, V31, P33, DOI 10.1146/annurev-nutr-072610-145209; REPA JJ, 1993, P NATL ACAD SCI USA, V90, P7293, DOI 10.1073/pnas.90.15.7293; Sears IB, 1996, MOL CELL BIOL, V16, P3410; Serra F, 1999, INT J OBESITY, V23, P650, DOI 10.1038/sj.ijo.0800897; Shen F, 2006, J BIOL CHEM, V281, P24138, DOI 10.1074/jbc.M604597200; Strom K, 2009, FASEB J, V23, P2307, DOI 10.1096/fj.08-120923; SUNDARESAN PR, 1967, J NUTR, V92, P474, DOI 10.1093/jn/92.4.474; Teruel T, 2003, J BIOL CHEM, V278, P263, DOI 10.1074/jbc.M207200200; TSUTSUMI C, 1992, J BIOL CHEM, V267, P1805; Valverde AM, 2003, J BIOL CHEM, V278, P10221, DOI 10.1074/jbc.M209363200; Villarroya F, 2013, CELL METAB, V17, P638, DOI 10.1016/j.cmet.2013.02.020; Wei SH, 1997, J BIOL CHEM, V272, P14159, DOI 10.1074/jbc.272.22.14159; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang Q, 2012, ENDOCRINOLOGY, V153, P1519, DOI 10.1210/en.2011-1750; Zhang JH, 2008, MOL ENDOCRINOL, V22, P1416, DOI 10.1210/me.2007-0420; Zhang YY, 2014, J BIOL CHEM, V289, P22063, DOI 10.1074/jbc.M114.559104; Ziouzenkova O, 2008, FEBS LETT, V582, P32, DOI 10.1016/j.febslet.2007.11.081	52	30	31	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11216	11229		10.1074/jbc.M115.711556	http://dx.doi.org/10.1074/jbc.M115.711556			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27008859	hybrid, Green Published			2022-12-26	WOS:000377042100023
J	Timpano, S; Uniacke, J				Timpano, Sara; Uniacke, James			Human Cells Cultured under Physiological Oxygen Utilize Two Cap-binding Proteins to recruit Distinct mRNAs for Translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARTIAL-PRESSURE; HUMAN TISSUES; CANCER-CELLS; LIFE-SPAN; HYPOXIA; HIF-1-ALPHA; HIF-2-ALPHA; EXPRESSION; PROMOTES; AFFINITY	Translation initiation is a focal point of translational control and requires the binding of eIF4E to the 5' cap of mRNA. Under conditions of extreme oxygen depletion (hypoxia), human cells repress eIF4E and switch to an alternative cap-dependent translation mediated by a homolog of eIF4E, eIF4E2. This homolog forms a complex with the oxygen-regulated hypoxia-inducible factor 2 alpha and can escape translation repression. This complex mediates cap-dependent translation under cell culture conditions of 1% oxygen (to mimic tumor microenvironments), whereas eIF4E mediates cap-dependent translation at 21% oxygen (ambient air). However, emerging evidence suggests that culturing cells in ambient air, or "normoxia," is far from physiological or "normal." In fact, oxygen in human tissues ranges from 1-11% or "physioxia." Here we show that two distinct modes of cap-dependent translation initiation are active during physioxia and act on separate pools of mRNAs. The oxygen-dependent activities of eIF4E and eIF4E2 are elucidated by observing their polysome association and the status of mammalian target of rapamycin complex 1 (eIF4E-dependent) or hypoxiainducible factor 2 alpha expression (eIF4E2-dependent). We have identified oxygen conditions where eIF4E is the dominant cap binding protein (21% normoxia or standard cell culture conditions), where eIF4E2 is the dominant cap-binding protein (1% hypoxia or ischemic diseases and cancerous tumors), and where both cap-binding proteins act simultaneously to initiate the translation of distinct mRNAs (1-11% physioxia or during development and stem cell differentiation). These data suggest that the physioxic proteome is generated by initiating translation of mRNAs via two distinct but complementary cap-binding proteins.	[Timpano, Sara; Uniacke, James] Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada	University of Guelph	Uniacke, J (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, 50 Stone Rd E, Guelph, ON N1G 2W1, Canada.	juniacke@uoguelph.ca			Ontario Ministry of Research and Innovation; Natural Sciences and Engineering Council of Canada [04807]; Queen Elizabeth II Graduate Scholarship in Science and Technology	Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Queen Elizabeth II Graduate Scholarship in Science and Technology	This work was funded by Ontario Ministry of Research and Innovation and the Natural Sciences and Engineering Council of Canada Grant 04807 (to J. U.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a Queen Elizabeth II Graduate Scholarship in Science and Technology.	Atkuri KR, 2007, P NATL ACAD SCI USA, V104, P4547, DOI 10.1073/pnas.0611732104; Brooks AJ, 2004, BRIT J ANAESTH, V92, P735, DOI 10.1093/bja/aeh112; Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gleadle J., 2001, HYPOXIA, P3; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; Gray NK, 2000, EMBO J, V19, P4723, DOI 10.1093/emboj/19.17.4723; Harrison JS, 2002, BLOOD, V99, P394, DOI 10.1182/blood.V99.1.394; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Ho JJD, 2016, CELL REP, V14, P1293, DOI 10.1016/j.celrep.2016.01.036; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Joshi B, 2004, EUR J BIOCHEM, V271, P2189, DOI 10.1111/j.1432-1033.2004.04149.x; Le QT, 2006, CLIN CANCER RES, V12, P1507, DOI 10.1158/1078-0432.CCR-05-2049; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Morita M, 2012, MOL CELL BIOL, V32, P3585, DOI 10.1128/MCB.00455-12; Muller M, 2002, ANAESTHESIA, V57, P110, DOI 10.1046/j.0003-2409.2001.02363.x; Muller M, 1998, ANESTH ANALG, V87, P474, DOI 10.1097/00000539-199808000-00045; Newby D, 2005, PLACENTA, V26, P353, DOI 10.1016/j.placenta.2004.07.002; Okumura F, 2007, GENE DEV, V21, P255, DOI 10.1101/gad.1521607; PACKER L, 1977, NATURE, V267, P423, DOI 10.1038/267423a0; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Rankin EB, 2008, ONCOGENE, V27, P5354, DOI 10.1038/onc.2008.160; Richardson RS, 2006, J PHYSIOL-LONDON, V571, P415, DOI 10.1113/jphysiol.2005.102327; RICHTER A, 1972, J NATL CANCER I, V49, P1705, DOI 10.1093/jnci/49.6.1705; Rouschop KMA, 2011, RADIOTHER ONCOL, V99, P385, DOI 10.1016/j.radonc.2011.05.047; Shatsky IN, 2014, CRIT REV BIOCHEM MOL, V49, P164, DOI 10.3109/10409238.2014.887051; SONENBERG N, 1979, P NATL ACAD SCI USA, V76, P4345, DOI 10.1073/pnas.76.9.4345; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Uniacke J, 2014, CANCER RES, V74, P1379, DOI 10.1158/0008-5472.CAN-13-2278; Uniacke J, 2012, NATURE, V486, P126, DOI 10.1038/nature11055; Wiesener MS, 2002, FASEB J, V16, P271, DOI 10.1096/fj.02-0445fje; Yi TF, 2013, J BIOL CHEM, V288, P18732, DOI 10.1074/jbc.M113.471466; Zuberek J, 2007, RNA, V13, P691, DOI 10.1261/rna.453107	36	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10772	10782		10.1074/jbc.M116.717363	http://dx.doi.org/10.1074/jbc.M116.717363			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27002144	Green Published, hybrid			2022-12-26	WOS:000377042600028
J	Yagura, K; Shinoda, K; Matsumoto, S; Terauchi, G; Watanabe, E; Matsumoto, H; Akiyama, G; Mizota, A; Miyake, Y				Yagura, Kazuma; Shinoda, Kei; Matsumoto, Soiti; Terauchi, Gaku; Watanabe, Emiko; Matsumoto, Harue; Akiyama, Goichi; Mizota, Atsushi; Miyake, Yozo			Intraoperative Electroretinograms before and after Core Vitrectomy	PLOS ONE			English	Article							VITREOUS TEMPERATURE; CLOSED VITRECTOMY; HYPOTHERMIA; SURGERY; POTENTIALS; READINGS; HUMANS; EYE	Purpose To evaluate retinal function by intraoperative electroretinograms (ERGs) before and after core vitrectomy. Design Retrospective consecutive case series. Method Full-field photopic ERGs were recorded prior to the beginning and just after core vitrectomy using a sterilized contact lens electrode in 20 eyes that underwent non-complicated vitreous surgery. A light-emitted diode was embedded into the contact lens, and a stimulus of 150 ms on and 350 ms off at 2 Hz was delivered. The amplitudes and latencies of the a-, b-, and d-waves, photopic negative response (PhNR), and oscillatory potentials (OPs) were analyzed. The intraocular temperature at the mid-vitreous was measured at the beginning and just after the surgery with a thermoprobe. Results The intraocular temperature was 33.2 +/- 1.3 degrees C before and 29.4 +/- 1.7 degrees C after the vitrectomy. The amplitudes of the PhNR and OPs were significantly smaller after surgery, and the latencies of all components were prolonged after the surgery. These changes were not significantly correlated with the changes of the temperature. Conclusion Retinal function is reduced just after core vitrectomy in conjunction with significant temperature reduction. The differences in the degree of alterations of each ERG component suggests different sensitivity of each type of retinal neuron.	[Yagura, Kazuma; Shinoda, Kei; Matsumoto, Soiti; Terauchi, Gaku; Watanabe, Emiko; Matsumoto, Harue; Akiyama, Goichi; Mizota, Atsushi] Teikyo Univ, Sch Med, Dept Ophthalmol, Itabashi Ku, Tokyo 173, Japan; [Matsumoto, Soiti; Matsumoto, Harue] Matsumoto Eye Clin, Awa Cho, Awa, Tokushima, Japan; [Akiyama, Goichi] Akiyama Eye Clin, Kita Ku, Tokyo, Japan; [Miyake, Yozo] Aichi Med Univ, Nagakute, Aichi 48011, Japan	Teikyo University; Aichi Medical University	Shinoda, K (corresponding author), Teikyo Univ, Sch Med, Dept Ophthalmol, Itabashi Ku, Tokyo 173, Japan.	shinodak@med.teikyo-u.ac.jp	Shinoda, Kei/ABC-7993-2020	Shinoda, Kei/0000-0002-1543-9345	Ministry of Education, Culture, Sports, Science and Technology, Japan; Ministry of Health, Labor, and Welfare, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	KS received support by the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by the Ministry of Health, Labor, and Welfare, Japan.	BRESNICK GH, 1984, ARCH OPHTHALMOL-CHIC, V102, P1307, DOI 10.1001/archopht.1984.01040031057023; HANITZSCH R, 1966, VISION RES, V6, P261, DOI 10.1016/0042-6989(66)90060-5; Hayreh SS, 2004, EXP EYE RES, V78, P723, DOI 10.1016/S0014-4835(03)00214-8; HORIGUCHI M, 1991, ARCH OPHTHALMOL-CHIC, V109, P1127, DOI 10.1001/archopht.1991.01080080087035; Iguchi Y, 2014, INVEST OPHTH VIS SCI, V55, P2344, DOI 10.1167/iovs.13-13065; Javaheri M, 2007, RETINA-J RET VIT DIS, V27, P87, DOI 10.1097/01.iae.0000256665.79487.a4; Kong H, 2003, DOC OPHTHALMOL, V106, P239, DOI 10.1023/A:1022988332578; Lachapelle P, 1996, VISION RES, V36, P339, DOI 10.1016/0042-6989(95)00126-3; Landers MB, 2012, RETINA-J RET VIT DIS, V32, P172, DOI 10.1097/IAE.0b013e31821c3ee0; Miyake Y, 1998, GRAEF ARCH CLIN EXP, V236, P13, DOI 10.1007/s004170050036; MIYAKE Y, 1991, ARCH OPHTHALMOL-CHIC, V109, P1123, DOI 10.1001/archopht.1991.01080080083034; Mizota A, 2002, INVEST OPHTH VIS SCI, V43, P3754; Naoi N, 1995, ACTA OPHTHALMOL SCAN, V73, P521; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Quinones-Hinojosa A, 2003, NEUROSURGERY, V52, P1178, DOI 10.1227/01.NEU.0000057836.64972.A0; Romano MR, 2013, CURR EYE RES, V38, P371, DOI 10.3109/02713683.2012.745160; TAZAWA Y, 1972, INVEST OPHTH VISUAL, V11, P691; WOLIN LR, 1964, ARCH OPHTHALMOL-CHIC, V72, P521; Zhao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065555	19	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152052	10.1371/journal.pone.0152052	http://dx.doi.org/10.1371/journal.pone.0152052			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010332	Green Submitted, Green Published, gold			2022-12-26	WOS:000372708000076
J	Veguilla, V; Lopez-Gatell, H; Lopez-Martinez, I; Aparicio-Antonio, R; Barrera-Badillo, G; Rojo-Medina, J; Gross, FL; Jefferson, SN; Katz, JM; Hernandez-Avila, M; Alpuche-Aranda, CM				Veguilla, Vic; Lopez-Gatell, Hugo; Lopez-Martinez, Irma; Aparicio-Antonio, Rodrigo; Barrera-Badillo, Gisela; Rojo-Medina, Julieta; Gross, Felicia Liaini; Jefferson, Stacie N.; Katz, Jacqueline M.; Hernandez-Avila, Mauricio; Alpuche-Aranda, Celia M.			A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1) pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic	PLOS ONE			English	Article							SEROLOGIC ASSAYS; H1N1 VIRUS; SEROPREVALENCE	Background The 2009 H1N1 influenza pandemic initially affected Mexico from April 2009 to July 2010. By August 2010, a fourth of the population had received the monovalent vaccine against the pandemic virus (A(H1N1) pdm09). To assess the proportion of the Mexican population who remained potentially susceptible to infection throughout the summer of 2010, we estimated the population seroprevalence to A(H1N1) pdm09 in a serosurvey of blood donors. Methods We evaluated baseline cross-reactivity to the pandemic strain and set the threshold for seropositivity using pre-pandemic (2005-2008) stored serum samples and sera from confirmed A(H1N1) pdm09 infected individuals. Between June and September 2010, a convenience sample serosurvey of adult blood donors, children, and adolescents was conducted in six states of Mexico. Sera were tested by the microneutralization (MN) and hemagglutination inhibition (HI) assays, and regarded seropositive if antibody titers were equal or exceeded 1: 40 for MN and 1: 20 for HI. Age-standardized seroprevalence were calculated using the 2010 National Census population. Results Sera from 1,484 individuals were analyzed; 1,363 (92%) were blood donors, and 121 (8%) children or adolescents aged <= 19 years. Mean age (standard deviation) was 31.4 (11.5) years, and 276 (19%) were women. A total of 516 (35%) participants declared history of influenza vaccination after April 2009. The age-standardized seroprevalence to A(H1N1) pdm09 was 48% by the MN and 41% by the HI assays, respectively. The youngest quintile, aged 1 to 22 years, had the highest the seroprevalence; 61% (95% confidence interval [CI]: 56, 66%) for MN, and 56% (95% CI: 51, 62%) for HI. Conclusions Despite high transmission of A(H1N1) pdm09 observed immediately after its emergence and extensive vaccination, over a half of the Mexican population remained potentially susceptible to A(H1N1) pdm09 infection. Subsequent influenza seasons with high transmission of A(H1N1) pdm09, as 2011-2012 and 2013-2014, are compatible with these findings.	[Veguilla, Vic; Gross, Felicia Liaini; Jefferson, Stacie N.; Katz, Jacqueline M.] Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Lopez-Gatell, Hugo] Secretaria Salud Mexico, Direcc Gen Adjunta Epidemiol, Mexico City, DF, Mexico; [Lopez-Martinez, Irma; Aparicio-Antonio, Rodrigo; Barrera-Badillo, Gisela] Inst Diagnost & Referencia Epidemiol, Dept Virol, Lab Virus Resp, Mexico City, DF, Mexico; [Rojo-Medina, Julieta] Secretaria Salud Mexico, Ctr Nacl Transfus Sanguinea, Mexico City, DF, Mexico; [Hernandez-Avila, Mauricio] Secretaria Salud Mexico, Subsecretaria Prevenc & Promoc Salud, Mexico City, DF, Mexico; [Alpuche-Aranda, Celia M.] Inst Diagnost & Referencia Epidemiol, Direcc Gen Adjunta, Mexico City, DF, Mexico; [Alpuche-Aranda, Celia M.] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico; [Hernandez-Avila, Mauricio] Inst Nacl Salud Publ, Direcc Gen, Cuernavaca, Morelos, Mexico	Centers for Disease Control & Prevention - USA; Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica	Alpuche-Aranda, CM (corresponding author), Inst Diagnost & Referencia Epidemiol, Direcc Gen Adjunta, Mexico City, DF, Mexico.; Alpuche-Aranda, CM (corresponding author), Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico.	celia.alpuche@insp.mx						Achonu C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026427; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P229; Broberg E, 2011, CLIN VACCINE IMMUNOL, V18, P1205, DOI 10.1128/CVI.05072-11; Chowell G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041069; Chowell G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000436; Davila J., 2014, PLOS CURR-TREE LIFE, V6, DOI [10.1371/currents.outbreaks.a855a92f19db1d90ca955f5e908d6631, DOI 10.1371/CURRENTS.OUTBREAKS.A855A92F19DB1D90CA955F5E908D6631, DOI 10.1371/CURRENTS.0UTBREAKS.A855A92F19DB1D90CA955F5E908D6631]; Direccion General de Epidemiologia Secretaria de Salud, 2009, PERF EP PAND INFL A, P1; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Elizondo-Montemayor L, 2011, INT J INFECT DIS, V15, pE781, DOI 10.1016/j.ijid.2011.07.002; Glatman-Freedman A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050228; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Katz JM, 2011, EXPERT REV ANTI-INFE, V9, P669, DOI [10.1586/ERI.11.51, 10.1586/eri.11.51]; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Van Kerkhove MD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000275; van Kerkhove MD, 2013, INFLUENZA OTHER RESP, V7, P872, DOI DOI 10.1111/IRV.12074; Veguilla V, 2011, J CLIN MICROBIOL, V49, P2210, DOI 10.1128/JCM.00229-11; Wood JM, 2012, VACCINE, V30, P210, DOI 10.1016/j.vaccine.2011.11.019	17	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0150428	10.1371/journal.pone.0150428	http://dx.doi.org/10.1371/journal.pone.0150428			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003409	Green Published, Green Submitted, gold			2022-12-26	WOS:000372697400013
J	Chrisman, SD; Waite, CB; Scoville, AG; Carnell, L				Chrisman, Steven D.; Waite, Christopher B.; Scoville, Alison G.; Carnell, Lucinda			C. elegans Demonstrates Distinct Behaviors within a Fixed and Uniform Electric Field	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; OLFACTORY NEURONS; ODOR DISCRIMINATION; CIRCUIT; ELECTRORECEPTION; TEMPERATURE; THERMOTAXIS; CHEMOTAXIS; ASYMMETRY; GENETICS	C. elegans will orient and travel in a straight uninterrupted path directly towards the negative pole of a DC electric field. We have sought to understand the strategy worms use to navigate to the negative pole in a uniform electric field that is fixed in both direction and magnitude. We examined this behavior by quantifying three aspects of electrotaxis behavior in response to different applied field strengths: the mean approach trajectory angles of the animals' tracks, turning behavior (pirouettes) and average population speeds. We determined that C. elegans align directly to the negative pole of an electric field at sub-preferred field strength and alter approach trajectories at higher field strengths to maintain taxis within a preferred range we have calculated to be similar to 5V/cm. We sought to identify the sensory neurons responsible for the animals' tracking to a preferred field strength. eat-4 mutant animals defective in glutamatergic signaling of the amphid sensory neurons are severely electrotaxis defective and ceh-36 mutant animals, which are defective in the terminal differentiation of two types of sensory neurons, AWC and ASE, are partially defective in electrotaxis. To further elucidate the role of the AWC neurons, we examined the role of each of the pair of AWC neurons (AWC(OFF) and AWC(ON)), which are functionally asymmetric and express different genes. nsy-5/inx-19 mutant animals, which express both neurons as AWC(OFF), are severely impaired in electrotaxis behavior while nsy-1 mutants, which express both neurons as AWC(ON), are able to differentiate field strengths required for navigation to a specific field strength within an electric field. We also tested a strain with targeted genetic ablation of AWC neurons and found that these animals showed only slight disruption of directionality and turning behavior. These results suggest a role for AWC neurons in which complete loss of function is less disruptive than loss of functional asymmetry in electrotaxis behavior within a uniform fixed field.	[Chrisman, Steven D.; Waite, Christopher B.; Scoville, Alison G.; Carnell, Lucinda] Cent Washington Univ, Dept Biol Sci, Ellensburg, WA USA; [Chrisman, Steven D.] Cent Washington Univ, Dept Nutr Exercise & Hlth Sci, Ellensburg, WA USA; [Waite, Christopher B.] Virginia Commonwealth Univ, Med Ctr, Dept Physiol & Biophys, Richmond, VA USA	Central Washington University; Central Washington University; Virginia Commonwealth University	Carnell, L (corresponding author), Cent Washington Univ, Dept Biol Sci, Ellensburg, WA USA.	carnelll@cwu.edu			Central Washington University College of the Science, Provost's Office; Science Honors Research Program; NIH Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Central Washington University College of the Science, Provost's Office; Science Honors Research Program; NIH Office of Research Infrastructure Programs; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding was provided by Central Washington University College of the Science, Provost's Office (LC), and the Science Honors Research Program (SDC). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We especially would like to thank Dr. Michael Jackson of the CWU Physics Department for many valuable discussions and Dr. Andrew Davies for comments on the manuscript. Some strains were provided by the CGC, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). We also thank Dr. Joshua Kaplan (Massachusetts General Hospital/Harvard University, Boston, MA) and Dr. Joy Alcedo (Wayne State University, Detroit, MI) for strains.	[Anonymous], 2013, LSMEANS LEAST SQUARE; AVERY L, 1993, GENETICS, V133, P897; BARGMANN CI, 1993, ANNU REV NEUROSCI, V16, P47, DOI 10.1146/annurev.ne.16.030193.000403; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Beverly M, 2011, J NEUROSCI, V31, P11718, DOI 10.1523/JNEUROSCI.1098-11.2011; Biron D, 2008, P NATL ACAD SCI USA, V105, P11002, DOI 10.1073/pnas.0805004105; Bodznick D, 1999, J EXP BIOL, V202, P1357; BRENNER S, 1974, GENETICS, V77, P71; BULLOCK TH, 1983, BRAIN RES REV, V6, P25, DOI 10.1016/0165-0173(83)90003-6; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; Choi S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005359; Chuang CF, 2007, CELL, V129, P787, DOI 10.1016/j.cell.2007.02.052; Clark DA, 2007, J NEUROPHYSIOL, V97, P1903, DOI 10.1152/jn.00892.2006; Clarke D, 2013, SCIENCE, V340, P66, DOI 10.1126/science.1230883; Cornils A, 2011, DEVELOPMENT, V138, P1183, DOI 10.1242/dev.060905; CROLL N A, 1975, P71, DOI 10.1016/S0065-308X(08)60319-X; Croll NA, CAN J ZOOL, P894; Czech-Damal NU, 2013, J COMP PHYSIOL A, V199, P555, DOI 10.1007/s00359-012-0780-8; Gabel CV, 2007, J NEUROSCI, V27, P7586, DOI 10.1523/JNEUROSCI.0775-07.2007; Gillis JA, 2012, DEVELOPMENT, V139, P3142, DOI 10.1242/dev.084046; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Huang SLB, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-24; Kempster RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052551; Kim D, 2011, J EXP BIOL, V214, P1554, DOI 10.1242/jeb.052092; Koga M, 2004, J MOL BIOL, V336, P579, DOI 10.1016/j.jmb.2003.12.037; Kuhara A, 2008, SCIENCE, V320, P803, DOI 10.1126/science.1148922; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Lanjuin A, 2003, DEV CELL, V5, P621, DOI 10.1016/S1534-5807(03)00293-4; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Lockery SR, 2011, CURR OPIN NEUROBIOL, V21, P782, DOI 10.1016/j.conb.2011.06.009; Luo LJ, 2006, J EXP BIOL, V209, P4652, DOI 10.1242/jeb.02590; Newland PL, 2008, J EXP BIOL, V211, P3682, DOI 10.1242/jeb.019901; O'Halloran DM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000761; Ohnishi N, 2011, EMBO J, V30, P1376, DOI 10.1038/emboj.2011.13; Peters RC, 2007, BIOL REV, V82, P361, DOI 10.1111/j.1469-185X.2007.00015.x; Pettigrew JD, 1999, J EXP BIOL, V202, P1447; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Pinheiro J., 2019, NLME LINEAR NONLINEA; Ramot D, 2008, NAT NEUROSCI, V11, P908, DOI 10.1038/nn.2157; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Ryu WS, 2002, J NEUROSCI, V22, P5727; Sagasti A, 2001, CELL, V105, P221, DOI 10.1016/S0092-8674(01)00313-0; Serrano-Saiz E, 2013, CELL, V155, P659, DOI 10.1016/j.cell.2013.09.052; Shanley LJ, 2006, J CELL SCI, V119, P4741, DOI 10.1242/jcs.03248; SUKUL NC, 1978, J NEMATOL, V10, P314; Suzuki H, 2008, NATURE, V454, P114, DOI 10.1038/nature06927; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Tsunozaki M, 2008, NEURON, V59, P959, DOI 10.1016/j.neuron.2008.07.038; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; Werner KM, 2014, J BIOL CHEM, V289, P26566, DOI 10.1074/jbc.M114.573832; Wes PD, 2001, NATURE, V410, P698, DOI 10.1038/35070581	57	12	14	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151320	10.1371/journal.pone.0151320	http://dx.doi.org/10.1371/journal.pone.0151320			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998749	Green Published, Green Submitted, gold			2022-12-26	WOS:000372694700030
J	Leite, GC; Oliveira, MS; Perdigao-Neto, LV; Rocha, CKD; Guimaraes, T; Rizek, C; Levin, AS; Costa, SF				Leite, Gleice Cristina; Oliveira, Maura Salaroli; Perdigao-Neto, Lauro Vieira; Dias Rocha, Cristiana Kamia; Guimaraes, Thais; Rizek, Camila; Levin, Anna Sara; Costa, Silvia Figueiredo			Antimicrobial Combinations against Pan-Resistant Acinetobacter baumannii Isolates with Different Resistance Mechanisms	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; IN-VITRO ACTIVITY; TIME-KILL; CARBAPENEM; COLISTIN; DISSEMINATION; FOSFOMYCIN; SYNERGY; STRAINS; VANCOMYCIN	The study investigated the effect of antibiotic combinations against 20 clinical isolates of A. baumannii (seven colistin-resistant and 13 colistin-susceptible) with different resistance mechanisms. Clinical data, treatment, and patient mortality were evaluated. The following methods were used: MIC, PCRs, and outer membrane protein (OMP) analysis. Synergy was investigated using the checkerboard and time-kill methods. Clonality was evaluated by PFGE. Based on clonality, the whole genome sequence of six A. baumannii isolates was analyzed. All isolates were resistant to meropenem, rifampicin, and fosfomycin. OXA-23 and OXA-143 were the most frequent carbapenemases found. Four isolates showed loss of a 43kDa OMP. The colistin-susceptible isolates belonged to different clones and showed the highest synergistic effect with fosfomycin-amikacin. Among colistin-resistant isolates, the highest synergistic effect was observed with the combinations of colistin-rifampicin followed by colistin-vancomycin. All colistin-resistant isolates harbored bla(OXA-23-like) and belonged to CC113. Clinical and demographic data were available for 18 of 20 patients. Fourteen received treatment and eight patients died during treatment. The most frequent site of infection was the blood in 13 of 14 patients. Seven patients received vancomycin plus an active drug against A. baumannii; however, mortality did not differ in this group. The synergistic effect was similar for colistin-susceptible isolates of distinct clonal origin presenting with the same resistance mechanism. Overall mortality and death during treatment was high, and despite the high synergism in vitro with vancomycin, death did not differ comparing the use or not of vancomycin plus an active drug against A. baumannii.	[Leite, Gleice Cristina; Oliveira, Maura Salaroli; Perdigao-Neto, Lauro Vieira; Levin, Anna Sara; Costa, Silvia Figueiredo] Univ Sao Paulo, Dept Infect Dis, Sao Paulo, Brazil; [Leite, Gleice Cristina; Perdigao-Neto, Lauro Vieira; Dias Rocha, Cristiana Kamia; Rizek, Camila; Levin, Anna Sara; Costa, Silvia Figueiredo] LIM 54, Sao Paulo, Brazil; [Oliveira, Maura Salaroli; Perdigao-Neto, Lauro Vieira; Levin, Anna Sara; Costa, Silvia Figueiredo] Hosp Clin FMUSP, Sao Paulo, Brazil; [Guimaraes, Thais] Univ Sao Paulo, Dept Infect Control, Hosp Clin, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Costa, SF (corresponding author), Univ Sao Paulo, Dept Infect Dis, Sao Paulo, Brazil.; Costa, SF (corresponding author), LIM 54, Sao Paulo, Brazil.; Costa, SF (corresponding author), Hosp Clin FMUSP, Sao Paulo, Brazil.	costasilviaf@ig.com.br	Costa, Silvia F/K-4768-2012; Figueiredo Costa, silvia/ABC-7704-2021; Levin, Anna S/C-8831-2012; Guimarães, Thais/C-7134-2014; Neto, Lauro V Perdigao/S-2351-2016; Levin, Anna S./AAJ-1712-2021	Costa, Silvia F/0000-0003-1087-752X; Figueiredo Costa, silvia/0000-0003-1087-752X; Levin, Anna S/0000-0003-2427-8368; Guimarães, Thais/0000-0002-7282-5453; Neto, Lauro V Perdigao/0000-0002-7681-8090; Levin, Anna S./0000-0003-2427-8368	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (GCL) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (SFC).	Agodi A, 2014, J HOSP INFECT, V86, P260, DOI 10.1016/j.jhin.2014.02.001; Aydemir H, 2013, EPIDEMIOL INFECT, V141, P1214, DOI 10.1017/S095026881200194X; Bishburg E, 2009, INT J ANTIMICROB AG, V34, P395, DOI 10.1016/j.ijantimicag.2009.06.021; Biswas S, 2007, NAT STRUCT MOL BIOL, V14, P1108, DOI 10.1038/nsmb1304; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonapace CR, 2002, DIAGN MICR INFEC DIS, V44, P363, DOI 10.1016/S0732-8893(02)00473-X; Bonapace CR, 2000, DIAGN MICR INFEC DIS, V38, P43, DOI 10.1016/S0732-8893(00)00163-2; Carvalho KR, 2009, INT J ANTIMICROB AG, V34, P25, DOI 10.1016/j.ijantimicag.2008.12.009; Chevreux B., 1999, COMPUTER SCI BIOL P, P45; Climaco EC, 2013, INFECT GENET EVOL, V19, P127, DOI 10.1016/j.meegid.2013.06.024; Clinical and Laboratory Standards Institute, 2013, M100S23 CLIN LAB STA; Coelho-Souza T, 2013, CLIN MICROBIOL INFEC, V19, pE241, DOI 10.1111/1469-0691.12145; Custovic Amer, 2014, Med Arch, V68, P402, DOI 10.5455/medarh.2014.68.402-406; Cavalcanti FLD, 2013, DIAGN MICR INFEC DIS, V77, P250, DOI 10.1016/j.diagmicrobio.2013.07.022; ELIOPOULOS GM, 1996, ANTIBIOTICS LAB MED, P330; European Committee on Antimicrobial Susceptibility Testing, 2013, EUR COMM ANT SUSC TE; Falagas ME, 2009, INT J ANTIMICROB AG, V34, P111, DOI 10.1016/j.ijantimicag.2009.03.009; Fu YQ, 2010, J ANTIMICROB CHEMOTH, V65, P644, DOI 10.1093/jac/dkq027; Gales AC, 2006, CLIN MICROBIOL INFEC, V12, P315, DOI 10.1111/j.1469-0691.2005.01351.x; Garnacho-Montero J, 2013, CHEMOTHERAPY, V59, P225, DOI 10.1159/000356004; Giamarellos-Bourboulis EJ, 2001, DIAGN MICR INFEC DIS, V40, P117, DOI 10.1016/S0732-8893(01)00258-9; Gordon NC, 2010, ANTIMICROB AGENTS CH, V54, P5316, DOI 10.1128/AAC.00922-10; Grosso F, 2011, J ANTIMICROB CHEMOTH, V66, P62, DOI 10.1093/jac/dkq406; Gusatti CD, 2012, BRAZ J MICROBIOL, V43, P243, DOI [10.1590/S1517-83822012000100027, 10.1590/S1517-838220120001000027]; Higgins PG, 2009, ANTIMICROB AGENTS CH, V53, P5035, DOI 10.1128/AAC.00856-09; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kim CK, 2010, DIAGN MICR INFEC DIS, V68, P432, DOI 10.1016/j.diagmicrobio.2010.07.014; Kim Uh Jin, 2014, Chonnam Med J, V50, P37, DOI 10.4068/cmj.2014.50.2.37; Koh TH, 2007, J ANTIMICROB CHEMOTH, V59, P627, DOI 10.1093/jac/dkl544; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lee Y, 2012, J APPL MICROBIOL, V112, P1207, DOI 10.1111/j.1365-2672.2012.05283.x; Lu CL, 2011, ANTIMICROB AGENTS CH, V55, P4295, DOI 10.1128/AAC.00349-11; Lu PL, 2009, J ANTIMICROB CHEMOTH, V63, P641, DOI 10.1093/jac/dkn553; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Martins N, 2013, MICROB DRUG RESIST, V19, P216, DOI 10.1089/mdr.2012.0174; Mendes RE, 2007, J CLIN MICROBIOL, V45, P544, DOI 10.1128/JCM.01728-06; Mostachio AK, 2012, INT J ANTIMICROB AG, V39, P396, DOI 10.1016/j.ijantimicag.2012.01.021; Nigro SJ, 2012, J ANTIMICROB CHEMOTH, V67, P1342, DOI 10.1093/jac/dks037; O'Hara JA, 2013, ANTIMICROB AGENTS CH, V57, P2103, DOI 10.1128/AAC.02501-12; Petersen PJ, 2006, J ANTIMICROB CHEMOTH, V57, P573, DOI 10.1093/jac/dki477; Pillai S. K., 2005, ANTIMICROBIAL COMBIN; Principe L, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-18; Rossi F, 2009, J MED MICROBIOL, V58, P1522, DOI 10.1099/jmm.0.011080-0; Santimaleeworagun W, 2011, SE ASIAN J TROP MED, V42, P890; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Shahcheraghi F, 2011, IRAN J MICROBIOL, V3, P68; Stietz MS, 2013, INFECT GENET EVOL, V14, P294, DOI 10.1016/j.meegid.2012.12.020; Sirijatuphat R, 2014, ANTIMICROB AGENTS CH, V58, P5598, DOI 10.1128/AAC.02435-13; Ramirez MS, 2013, CURR MICROBIOL, V67, P9, DOI 10.1007/s00284-013-0326-5; Tognim MCB, 2004, INT J INFECT DIS, V8, P284, DOI 10.1016/j.ijid.2003.11.009; Vidaillac C, 2012, ANTIMICROB AGENTS CH, V56, P4856, DOI 10.1128/AAC.05996-11; Wei WJ, 2016, J CHEMOTHERAPY, V28, P159, DOI 10.1179/1973947815Y.0000000030; Werneck JS, 2011, J ANTIMICROB CHEMOTH, V66, P452, DOI 10.1093/jac/dkq462; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004; Zhang YJ, 2013, EXP THER MED, V5, P1737, DOI 10.3892/etm.2013.1039	56	55	57	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151270	10.1371/journal.pone.0151270	http://dx.doi.org/10.1371/journal.pone.0151270			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998609	Green Published, Green Submitted, gold			2022-12-26	WOS:000372694700029
J	Wang, CB; Dollard, SC; Amin, MM; Bialek, SR				Wang, Chengbin; Dollard, Sheila C.; Amin, Minal M.; Bialek, Stephanie R.			Cytomegalovirus IgM Seroprevalence among Women of Reproductive Age in the United States	PLOS ONE			English	Article							BLOOD-DONORS; INFECTION; AVIDITY; ANTIBODIES; PREGNANCY	Cytomegalovirus (CMV) IgM indicates recent active CMV infection. CMV IgM seroprevalence is a useful marker for prevalence of transmission. Using data from the National Health and Nutrition Examination Survey (NHANES) III 1988-1994, we present estimates of CMV IgM prevalence by race/ethnicity, provide a comparison of IgM seroprevalence among all women and among CMV IgG positive women, and explore factors possibly associated with IgM seroprevalence, including socioeconomic status and exposure to young children. There was no difference in IgM seroprevalence by race/ethnicity among all women (3.1%, 2.2%, and 1.6% for non-Hispanic white, non-Hispanic black and Mexican American, respectively; P = 0.11). CMV IgM seroprevalence decreased significantly with increasing age in non-Hispanic black women (P<0.001 for trend) and marginally among Mexican American women (P = 0.07), while no apparent trend with age was seen in non-Hispanic white women (P = 0.99). Among 4001 IgG+ women, 118 were IgM+, resulting in 4.9% IgM seroprevalence. In IgG+ women, IgM seroprevalence varied significantly by age (5.3%, 7.3%, and 3.7% for women of 12-19, 20-29, and 30-49 years; P = 0.04) and race/ethnicity (6.1%, 2.7%, and 2.0% for non-Hispanic white, non-Hispanic black, and Mexican American; P<0.001). The factors reported associated with IgG seroprevalence were not associated with IgM seroprevalence. The patterns of CMV IgM seroprevalence by age, race/ethnicity, and IgG serostatus may help understanding the epidemiology of congenital CMV infection as a consequence of vertical transmission and are useful for identifying target populations for intervention to reduce CMV transmission.	[Wang, Chengbin; Dollard, Sheila C.; Amin, Minal M.; Bialek, Stephanie R.] Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Wang, CB (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA USA.	cwang1@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Bate SL, 2010, CLIN INFECT DIS, V50, P1439, DOI 10.1086/652438; Bowen EF, 1996, AIDS, V10, pS37; Cannon MJ, 2009, J CLIN VIROL, V46, pS6, DOI 10.1016/j.jcv.2009.09.002; Centers for Disease Control and Prevention, NHANES 3 CYT IGG IGM; Centers for Disease Control and Prevention. National Center for Health Statistics (NCHS), 1988, AN REP GUID 3 NAT HL; Das B, 2014, TRANSFUS APHER SCI, V50, P438, DOI 10.1016/j.transci.2014.02.022; Dollard SC, 2011, CLIN VACCINE IMMUNOL, V18, P1895, DOI 10.1128/CVI.05228-11; Kaneko M, 2013, J PERINATOL, V33, P831, DOI 10.1038/jp.2013.87; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Leruez-Ville M, 2013, CLIN INFECT DIS, V56, P1428, DOI 10.1093/cid/cit059; Mwintshi K, 2007, EXPERT REV ANTI-INFE, V5, P295, DOI 10.1586/14787210.5.2.295; PASS RF, 1987, NEW ENGL J MED, V316, P1366, DOI 10.1056/NEJM198705283162203; Prince HE, 2014, CLIN VACCINE IMMUNOL, V21, P1377, DOI 10.1128/CVI.00487-14; Qi Y, 2015, 5 INT CONG CMV C APR; Seo S, 2009, KOREAN J LAB MED, V29, P557, DOI 10.3343/kjlm.2009.29.6.557; Souza MA, 2010, REV SOC BRAS MED TRO, V43, P359, DOI 10.1590/S0037-86822010000400004; Staras SAS, 2008, SEX TRANSM DIS, V35, P472, DOI 10.1097/OLQ.0b013e3181644b70; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Uysal A, 2012, ARCH GYNECOL OBSTET, V286, P605, DOI 10.1007/s00404-012-2353-z; Wang CB, 2011, CLIN INFECT DIS, V52, pE11, DOI 10.1093/cid/ciq085; Wreghitt TG, 2003, CLIN INFECT DIS, V37, P1603, DOI 10.1086/379711	21	13	13	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151996	10.1371/journal.pone.0151996	http://dx.doi.org/10.1371/journal.pone.0151996			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990759	gold, Green Published			2022-12-26	WOS:000372582800129
J	Gopal, U; Gonzalez-Gronow, M; Pizzo, SV				Gopal, Udhayakumar; Gonzalez-Gronow, Mario; Pizzo, Salvatore Vincent			Activated alpha(2)-Macroglobulin Regulates Transcriptional Activation of c-MYC Target Genes through Cell Surface GRP78 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COOH-TERMINAL DOMAIN; PROSTATE-CANCER; HISTONE H3; MONOCLONAL-ANTIBODY; TUMOR-CELLS; GROWTH; PHOSPHORYLATION; LIGATION; EXPRESSION; PROLIFERATION	Activated alpha(2)-macroglobulin (alpha M-2*) signals predominantly through cell surface GRP78 (CS-GRP78) to promote proliferation and survival of cancer cells; however, the molecular mechanism remains obscure. c-MYC is an essential transcriptional regulator that controls cell proliferation. We hypothesize that alpha M-2*/CS-GRP78-evoked key signaling events are required for transcriptional activation of c-MYC target genes. Activation of CS-GRP78 by alpha M-2* requires ligation of the GRP78 primary amino acid sequence (Leu(98)-Leu(115)). After stimulation with alpha M-2*, CS-GRP78 signaling activates 3-phosphoinositide-dependent protein kinase-1 (PDK1) to induce phosphorylation of PLK1, which in turn induces c-MYC transcription. We demonstrate that PLK1 binds directly to c-MYC and promotes its transcriptional activity by phosphorylating Ser(62). Moreover, activated c-MYC is recruited to the E-boxes of target genes FOSLI and ID2 by phosphorylating histone H3 at Ser(10). In addition, targeting the carboxyl-terminal domain of CS-GRP78 with a mAb suppresses transcriptional activation of c-MYC target genes and impairs cell proliferation. This work demonstrates that alpha M-2*JCS-GRP78 acts as an upstream regulator of the PDK1/PLK1 signaling axis to modulate c-MYC transcription and its target genes, suggesting a therapeutic strategy for targeting c-MYC-associated malignant progression.	[Gopal, Udhayakumar; Gonzalez-Gronow, Mario; Pizzo, Salvatore Vincent] Duke Univ, Dept Pathol, Med Ctr, Box 3712, Durham, NC 27710 USA	Duke University	Pizzo, SV (corresponding author), Duke Univ, Dept Pathol, Med Ctr, Box 3712, Durham, NC 27710 USA.	salvatore.pizzo@duke.edu	Gopal, Udhayakumar/K-9092-2019	gopal, Udhayakumar/0000-0003-2110-0601				Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; BORTH W, 1992, FASEB J, V6, P3345, DOI 10.1096/fasebj.6.15.1281457; Cannell IG, 2010, P NATL ACAD SCI USA, V107, P5375, DOI 10.1073/pnas.0910015107; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; Cole MD, 2008, NAT REV MOL CELL BIO, V9, P810, DOI 10.1038/nrm2467; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; de Ridder GG, 2012, MELANOMA RES, V22, P225, DOI 10.1097/CMR.0b013e32835312fd; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; Hann SR, 2006, SEMIN CANCER BIOL, V16, P288, DOI 10.1016/j.semcancer.2006.08.004; Hofheinz RD, 2010, CLIN CANCER RES, V16, P4666, DOI 10.1158/1078-0432.CCR-10-0318; King L, 2001, PROTEIN EXPRES PURIF, V22, P148, DOI 10.1006/prep.2001.1424; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lin YG, 2015, ONCOGENE, V34, P5418, DOI 10.1038/onc.2015.4; Liu R, 2013, CLIN CANCER RES, V19, P6802, DOI 10.1158/1078-0432.CCR-13-1106; Liu SJ, 2009, CANCER RES, V69, P8742, DOI 10.1158/0008-5472.CAN-09-1541; Luo SZ, 2006, MOL CELL BIOL, V26, P5688, DOI 10.1128/MCB.00779-06; Mandelin J, 2015, P NATL ACAD SCI USA, V112, P3776, DOI 10.1073/pnas.1500128112; Misra UK, 2009, J CELL BIOCHEM, V106, P381, DOI 10.1002/jcb.22016; Misra UK, 2006, J BIOL CHEM, V281, P13694, DOI 10.1074/jbc.M511694200; Misra UK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051735; Misra UK, 2011, J BIOL CHEM, V286, P1248, DOI 10.1074/jbc.M110.129767; Misra UK, 2010, CANCER BIOL THER, V9, P142, DOI 10.4161/cbt.9.2.10422; Misra UK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088373; Misra UK, 2009, MOL CANCER THER, V8, P1350, DOI 10.1158/1535-7163.MCT-08-0990; Mo LH, 2015, MOL CANCER THER, V14, P747, DOI 10.1158/1535-7163.MCT-14-0579; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Peifer C, 2008, CHEMMEDCHEM, V3, P1810, DOI 10.1002/cmdc.200800195; Pootrakul L, 2006, CLIN CANCER RES, V12, P5987, DOI 10.1158/1078-0432.CCR-06-0133; Rasche L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063414; Rauschert N, 2008, LAB INVEST, V88, P375, DOI 10.1038/labinvest.2008.2; Roller C, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00010; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Shani G, 2008, MOL CELL BIOL, V28, P666, DOI 10.1128/MCB.01716-07; Sinnreich O, 2004, PROSTATE, V61, P201, DOI 10.1002/pros.20062; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tan J, 2013, CANCER DISCOV, V3, P1156, DOI 10.1158/2159-8290.CD-12-0595; Tan J, 2010, CANCER CELL, V18, P459, DOI 10.1016/j.ccr.2010.10.021; Xiao GQ, 1999, MOL BRAIN RES, V72, P121, DOI 10.1016/S0169-328X(99)00188-6; Zhang C, 2014, ONCOGENE, V33, P5582, DOI 10.1038/onc.2013.505; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	47	26	27	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10904	10915		10.1074/jbc.M115.708131	http://dx.doi.org/10.1074/jbc.M115.708131			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27002159	hybrid, Green Published			2022-12-26	WOS:000377042600040
J	Denguezli, M; Daldoul, H; Harrabi, I; Gnatiuc, L; Coton, S; Burney, P; Tabka, Z				Denguezli, Meriam; Daldoul, Hager; Harrabi, Imed; Gnatiuc, Louisa; Coton, Sonia; Burney, Peter; Tabka, Zouhair			COPD in Nonsmokers: Reports from the Tunisian Population-Based Burden of Obstructive Lung Disease Study	PLOS ONE			English	Article							INDOOR AIR-POLLUTION; PULMONARY-DISEASE; NEVER-SMOKERS; RESPIRATORY SYMPTOMS; REFERENCE VALUES; RISK-FACTORS; PREVALENCE; DIAGNOSIS; SMOKING; STATEMENT	Background It's currently well known that smoking and increasing age constitute the most important risk factors for chronic obstructive pulmonary disease (COPD). However, little is known about COPD among nonsmokers. The present study aimed to investigate prevalence, risk factors and the profiles of COPD among nonsmokers based on the Tunisian Burden of Obstructive Lung Disease (BOLD) study. Methods 807 adults aged 40 years+ were randomly selected from the general population. We collected information about history of respiratory disease, risk factors for COPD and quality of life. Post-bronchodilator spirometry was performed for assessment of COPD. COPD diagnostic was based on the post-bronchodilator FEV1/FVC ratio, according to the Global Initiative for Obstructive Lung Disease (GOLD) guidelines. The lower limit of normal (LLN) was determined as an alternative threshold for the FEV1/FVC ratio. Results and Conclusions Among 485 nonsmokers, 4.7% met the criteria for GOLD grade I and higher COPD. These proportions were similar even when the LLN was used as a threshold. None of the nonsmokers with COPD reported a previous doctor diagnosis of COPD compared to 7.1% of smokers. Nonsmokers accounted for 45.1% of the subjects fulfilling the GOLD spirometric criteria of COPD. Nonsmokers were predominately men and reported more asthma problems than obstructed smokers. Among nonsmokers significantly more symptoms and higher co-morbidity were found among those with COPD. Increasing age, male gender, occupational exposure, lower body mass index and a previous diagnosis of asthma are associated with increased risk for COPD in nonsmokers. This study confirms previous evidence that nonsmokers comprise a substantial proportion of individuals with COPD. Nonsmokers with COPD have a specific profile and should, thus, receive far greater attention to prevent and treat chronic airway obstruction.	[Denguezli, Meriam; Daldoul, Hager; Tabka, Zouhair] Fac Med Ibn El Jazzar, Physiol Lab, Sousse, Tunisia; [Harrabi, Imed] Univ Hosp Farhat Hached, Dept Epidemiol, Sousse, Tunisia; [Gnatiuc, Louisa; Coton, Sonia; Burney, Peter] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Royal Brompton Campus, London, England	Universite de Sousse; Universite de Sousse; Hopital Farhat Hached; Imperial College London	Denguezli, M (corresponding author), Fac Med Ibn El Jazzar, Physiol Lab, Sousse, Tunisia.	myriam_denguezli2@yahoo.fr	, tabka/AAI-1383-2019	, tabka/0000-0002-8854-8286; Gnatiuc Friedrichs, Louisa/0000-0002-0641-2220; Denguezli, Meriam/0000-0002-4583-1145; Burney, Peter/0000-0001-8635-5678	Wellcome Trust [085790/Z/08/Z]; Boerhringer Ingelheim (Sousse, Tunisia)	Wellcome Trust(Wellcome TrustEuropean Commission); Boerhringer Ingelheim (Sousse, Tunisia)	The BOLD Study is funded by a grant from the Wellcome Trust (085790/Z/08/Z). Additional local support for BOLD sites was provided by Boerhringer Ingelheim (Sousse, Tunisia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 2006, GOLD WORKSH; [Anonymous], GOLD WORKSH; Aryal S, 2014, INT J CHRONIC OBSTR, V9, P1145, DOI 10.2147/COPD.S54476; Balmes J, 2003, AM J RESP CRIT CARE, V167, P787, DOI 10.1164/rccm.167.5.787; Behrendt CE, 2005, CHEST, V128, P1239, DOI 10.1378/chest.128.3.1239; Ben Abdallah FC, 2011, WORLD ALLERGY ORGAN, V4, P6; Birring SS, 2002, AM J RESP CRIT CARE, V166, P1078, DOI 10.1164/rccm.200203-245OC; Bridevaux PO, 2010, EUR RESPIR J, V36, P1259, DOI 10.1183/09031936.00004110; Brutsche MH, 2006, THORAX, V61, P671, DOI 10.1136/thx.2005.052241; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Buist A Sonia, 2005, COPD, V2, P277, DOI 10.1081/COPD-200057610; Celli BR, 2005, AM J MED, V118, P1364, DOI 10.1016/j.amjmed.2005.06.041; Celli BR, 2003, EUR RESPIR J, V22, P268, DOI 10.1183/09031936.03.00075102; Chakrabarti B, 2011, INT J CHRONIC OBSTR, V6, P543, DOI 10.2147/COPD.S24113; Daldoul H, 2013, INT J ENV RES PUB HE, V10, P7257, DOI 10.3390/ijerph10127257; David GL, 2005, THORAX, V60, P1052, DOI 10.1136/thx.2005.042960; Echave-Sustaeta JM, 2014, INT J CHRONIC OBSTR, V9, P1307, DOI 10.2147/COPD.S71849; Eisner MD, 2010, AM J RESP CRIT CARE, V182, P693, DOI 10.1164/rccm.200811-1757ST; Ekici A, 2005, ENVIRON RES, V99, P93, DOI 10.1016/j.envres.2005.01.004; Enright PL, 2005, EUR RESP MON, V31, P1, DOI DOI 10.1183/1025448X.00031001; Ezzati M, 2001, LANCET, V358, P619, DOI 10.1016/S0140-6736(01)05777-4; Feenstra TL, 2001, AM J RESP CRIT CARE, V164, P590, DOI 10.1164/ajrccm.164.4.2003167; Fukuchi Y, 2004, RESPIROLOGY, V9, P458, DOI 10.1111/j.1440-1843.2004.00637.x; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hansen JE, 2007, CHEST, V131, P349, DOI 10.1378/chest.06-1349; Hardie JA, 2002, EUR RESPIR J, V20, P1117, DOI 10.1183/09031936.02.00023202; HARKEMA JR, 1993, TOXICOL LETT, V68, P251, DOI 10.1016/0378-4274(93)90136-L; Hunninghake GM, 2009, NEW ENGL J MED, V361, P2599, DOI 10.1056/NEJMoa0904006; Juul K, 2006, AM J RESP CRIT CARE, V173, P858, DOI 10.1164/rccm.200509-1387OC; Kurmi OP, 2010, THORAX, V65, P221, DOI 10.1136/thx.2009.124644; Lamprecht B, 2011, CHEST, V139, P752, DOI 10.1378/chest.10-1253; Lee SJ, 2015, INT J CHRONIC OBSTR, V10, P497, DOI 10.2147/COPD.S77662; Lindberg A, 2006, CHEST, V129, P879, DOI 10.1378/chest.129.4.879; Lindstrom M, 2001, CHEST, V119, P852, DOI 10.1378/chest.119.3.852; Lundback B, 2009, COPD, V6, P263, DOI 10.1080/15412550903061483; Mannino DM, 2008, CHEST, V133, P333, DOI 10.1378/chest.07-2485; Mannino DM, 2007, THORAX, V62, P237, DOI 10.1136/thx.2006.068379; Miravitlles M, 2005, RESP MED, V99, P985, DOI 10.1016/j.rmed.2005.01.012; National Heart Lung and Blood Institute and World Health Organization, GLOB IN CHRON OBSTR; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Pena VS, 2000, CHEST, V118, P981, DOI 10.1378/chest.118.4.981; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Shahab L, 2006, THORAX, V61, P1043, DOI 10.1136/thx.2006.064410; SHORE S, 1995, AM J RESP CRIT CARE, V151, P1931, DOI 10.1164/ajrccm.151.6.7767542; Silva GE, 2004, CHEST, V126, P59, DOI 10.1378/chest.126.1.59; Stanojevic S, 2010, EUR RESPIR J, V36, P12, DOI 10.1183/09031936.00143209; Turner MC, 2007, AM J RESP CRIT CARE, V176, P285, DOI 10.1164/rccm.200612-1792OC; Wood AM, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-130; Young RP, 2007, EUR RESPIR J, V30, P616, DOI 10.1183/09031936.00021707; Zhang J, 2014, INT J CHRONIC OBSTR, V9, P57, DOI 10.2147/COPD.S52416; Zhong N, 2007, AM J RESP CRIT CARE, V176, P753, DOI 10.1164/rccm.200612-1749OC; Zhou Y, 2009, EUR RESPIR J, V33, P509, DOI 10.1183/09031936.00084408	53	17	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151981	10.1371/journal.pone.0151981	http://dx.doi.org/10.1371/journal.pone.0151981			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010214	Green Published, gold			2022-12-26	WOS:000372708000063
J	Witkowski, TA; Grice, AN; Stinnett, DB; Wells, WK; Peterson, MA; Hare, JM				Witkowski, Travis A.; Grice, Alison N.; Stinnett, DeAnna B.; Wells, Whitney K.; Peterson, Megan A.; Hare, Janelle M.			UmuDAb: An Error-Prone Polymerase Accessory Homolog Whose N-Terminal Domain Is Required for Repression of DNA Damage Inducible Gene Expression in Acinetobacter baylyi	PLOS ONE			English	Article							ESCHERICHIA-COLI; LEXA REPRESSOR; PROTEIN; RECA; PURIFICATION; MUTAGENESIS; BAUMANNII	In many bacteria, the DNA damage response induces genes (SOS genes) that were repressed by LexA. LexA represses transcription by binding to SOS promoters via a helixturn-helix motif in its N-terminal domain (NTD). Upon DNA damage, LexA cleaves itself and allows induction of transcription. In Acinetobacter baumannii and Acinetobacter baylyi, multiple genes are induced by DNA damage, and although the Acinetobacter genus lacks LexA, a homolog of the error-prone polymerase subunit UmuD, called UmuDAb, regulates some DNA damage-induced genes. The mechanism of UmuDAb regulation has not been determined. We constructed UmuDAb mutant strains of A. baylyi to test whether UmuDAb mediates gene regulation through LexA-like repressor actions consisting of relief of repression through self-cleavage after DNA damage. Real-time quantitative PCR experiments in both a null umuDAb mutant and an NTD mutant showed that the DNA damage-inducible, UmuDAb-regulated gene ddrR was highly expressed even in the absence of DNA damage. Protein modeling identified a potential LexA-like helix-turn-helix structure in the UmuDAb NTD, which when disrupted, also relieved ddrR and umuDAb repression under non-inducing conditions. Mutations in a putative SOS box in the shared umuDAb-ddrR promoter region similarly relieved these genes' repression under non-inducing conditions. Conversely, cells possessing a cleavage-deficient UmuDAb were unable to induce gene expression after MMC-mediated DNA damage. This evidence of a UmuDAb repressor mechanism was contrasted with the failure of umuDAb to complement an Escherichia coli umuD mutant for UmuD error-prone DNA replication activity. Similarly, A. baumannii null umuDAb mutant cells did not have a reduced UmuD(2)'UmuC-mediated mutation rate after DNA damage, suggesting that although this UmuDAb protein may have evolved from a umuDC operon in this genus, it now performs a LexA-like repressor function for a sub-set of DNA damage-induced genes.	[Witkowski, Travis A.; Grice, Alison N.; Stinnett, DeAnna B.; Wells, Whitney K.; Peterson, Megan A.; Hare, Janelle M.] Morehead State Univ, Dept Biol & Chem, Morehead, KY 40351 USA; [Witkowski, Travis A.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Grice, Alison N.] Univ Colorado Denver, Dept Off Informat Technol, Technol Support Serv, Anschutz Med Campus, Aurora, CO USA	Morehead State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Hare, JM (corresponding author), Morehead State Univ, Dept Biol & Chem, Morehead, KY 40351 USA.	jm.hare@moreheadstate.edu	Hare, Janelle/AAG-1144-2019	Hare, Janelle/0000-0001-5482-8143	National Institutes of Health [R15GM085722]; Kentucky Biomedical Research Infrastructure Network through the National Institutes of Health [P20GM103436]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103436, R15GM085722] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Biomedical Research Infrastructure Network through the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by a National Institutes of Health grant (R15GM085722) and a Kentucky Biomedical Research Infrastructure Network award through the National Institutes of Health grant (P20GM103436). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda J, 2014, ANTIMICROB AGENTS CH, V58, P1771, DOI 10.1128/AAC.02346-13; Aranda J, 2013, J BACTERIOL, V195, P5577, DOI 10.1128/JB.00853-13; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BATTISTA JR, 1990, PROG CLIN BIOL RES, V340, P169; Butala M, 2009, CELL MOL LIFE SCI, V66, P82, DOI 10.1007/s00018-008-8378-6; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Giese KC, 2008, J MOL BIOL, V377, P148, DOI 10.1016/j.jmb.2007.12.025; Hare JM, 2006, APPL ENVIRON MICROB, V72, P4036, DOI 10.1128/AEM.02774-05; Hare JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093861; Hare JM, 2012, FEMS MICROBIOL LETT, V334, P57, DOI 10.1111/j.1574-6968.2012.02618.x; Hare JM, 2012, MICROBIOL-SGM, V158, P601, DOI 10.1099/mic.0.054668-0; HORII T, 1981, CELL, V27, P515, DOI 10.1016/0092-8674(81)90393-7; LAMERICHS RMJN, 1989, P NATL ACAD SCI USA, V86, P6863, DOI 10.1073/pnas.86.18.6863; LITTLE JW, 1984, P NATL ACAD SCI-BIOL, V81, P1375, DOI 10.1073/pnas.81.5.1375; LITTLE JW, 1981, P NATL ACAD SCI-BIOL, V78, P4199, DOI 10.1073/pnas.78.7.4199; LITTLE JW, 1982, CELL, V29, P11, DOI 10.1016/0092-8674(82)90085-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mohana-Borges R, 2000, J BIOL CHEM, V275, P4708, DOI 10.1074/jbc.275.7.4708; Nair R, 2008, METHODS MOL BIOL, V484, P435, DOI 10.1007/978-1-59745-398-1_27; Norton MD, 2013, J BACTERIOL, V195, P1335, DOI 10.1128/JB.02176-12; Opperman T, 1999, P NATL ACAD SCI USA, V96, P9218, DOI 10.1073/pnas.96.16.9218; Rauch PJG, 1996, MICROBIOL-UK, V142, P1025, DOI 10.1099/00221287-142-4-1025; Robinson A, 2010, MICROBIOL MOL BIOL R, V74, P273, DOI 10.1128/MMBR.00048-09; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; SCHNARR M, 1991, BIOCHIMIE, V73, P423, DOI 10.1016/0300-9084(91)90109-E; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; WOODGATE R, 1989, P NATL ACAD SCI USA, V86, P7301, DOI 10.1073/pnas.86.19.7301; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Zhang APP, 2010, NATURE, V466, P883, DOI 10.1038/nature09200	30	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152013	10.1371/journal.pone.0152013	http://dx.doi.org/10.1371/journal.pone.0152013			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010837	Green Submitted, Green Published, gold			2022-12-26	WOS:000372708000070
J	Giles, C; Ndi, O; Barton, MD; Vanniasinkam, T				Giles, Carla; Ndi, Olasumbo; Barton, Mary D.; Vanniasinkam, Thiru			An Adenoviral Vector Based Vaccine for Rhodococcus equi	PLOS ONE			English	Article							VIRULENCE-ASSOCIATED PROTEIN; CYTOTOXIC T-LYMPHOCYTES; TUBERCULOSIS VACCINE; IMMUNE-RESPONSES; PROTECTIVE IMMUNITY; EXPRESSING VAPA; ADULT HORSES; MICE; INFECTION; FOALS	Rhodococcus equi is a respiratory pathogen which primarily infects foals and is endemic on farms around the world with 50% mortality and 80% morbidity in affected foals. Unless detected early and treated appropriately the disease can be fatal. Currently, there is no vaccine available to prevent this disease. For decades researchers have endeavoured to develop an effective vaccine to no avail. In this study a novel human adenoviral vector vaccine for R. equi was developed and tested in the mouse model. This vaccine generated a strong antibody and cytokine response and clearance of R. equi was demonstrated following challenge. These results show that this vaccine could potentially be developed further for use as a vaccine to prevent R. equi disease in foals.	[Giles, Carla; Ndi, Olasumbo; Barton, Mary D.] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Vanniasinkam, Thiru] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW, Australia	University of South Australia; Charles Sturt University	Vanniasinkam, T (corresponding author), Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW, Australia.	tvanniasinkam@csu.edu.au	Vanniasinkam, Thiru/W-2137-2018	Vanniasinkam, Thiru/0000-0001-9318-3982	Rural Industries Research and Development Corporation [PRJ-004862]	Rural Industries Research and Development Corporation	TV and MDB received Funding for this project which was generously provided by the Rural Industries Research and Development Corporation, project number PRJ-004862 (http://www.rirdc.gov.au/).	Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; BARTON MD, 1981, J CLIN MICROBIOL, V13, P219, DOI 10.1128/JCM.13.1.219-221.1981; Berger A, 2000, BRIT MED J, V321, P424, DOI 10.1136/bmj.321.7258.424; Berghaus LJ, 2014, VET IMMUNOL IMMUNOP, V160, P41, DOI 10.1016/j.vetimm.2014.03.010; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Bowersock TL, 2000, ANTIMICROB AGENTS CH, V44, P1367, DOI 10.1128/AAC.44.5.1367-1369.2000; Burton AJ, 2013, EMERG INFECT DIS, V19, P282, DOI 10.3201/eid1902.121210; Cauchard S, 2011, VACCINE, V30, P95, DOI 10.1016/j.vaccine.2011.10.026; CHIRINOTREJO JM, 1987, CAN J VET RES, V51, P444; Darrah PA, 2004, J IMMUNOL, V173, P1914, DOI 10.4049/jimmunol.173.3.1914; Dawson TRMY, 2010, VET IMMUNOL IMMUNOP, V135, P1, DOI 10.1016/j.vetimm.2009.12.004; Draper SJ, 2010, NAT REV MICROBIOL, V8, P62, DOI 10.1038/nrmicro2240; Fischer L, 2002, VACCINE, V20, P3485, DOI 10.1016/S0264-410X(02)00344-4; Giguere S, 2011, J VET INTERN MED, V25, P1221, DOI 10.1111/j.1939-1676.2011.00804.x; Giguere S, 2011, J VET INTERN MED, V25, P1209, DOI 10.1111/j.1939-1676.2011.00835.x; Giguere S, 1999, INFECT IMMUN, V67, P5041; Giles C, 2015, EQUINE VET J, V47, P510, DOI 10.1111/evj.12310; Gonzalez-Iglesias P, 2014, VET MICROBIOL, V172, P256, DOI 10.1016/j.vetmic.2014.03.026; Gonzalez-Juarrero M, 2002, CELL IMMUNOL, V220, P13, DOI 10.1016/S0008-8749(03)00010-8; Haghighi HR, 2005, VET IMMUNOL IMMUNOP, V104, P215, DOI 10.1016/j.vetimm.2004.12.006; Hammond JM, 2000, VACCINE, V18, P1040, DOI 10.1016/S0264-410X(99)00347-3; Harris SP, 2011, VET IMMUNOL IMMUNOP, V141, P312, DOI 10.1016/j.vetimm.2011.03.015; Jones AL, 2013, ANTON LEEUW INT J G, V103, P1405, DOI 10.1007/s10482-013-9924-2; Jones AL, 2013, ANTON LEEUW INT J G, V103, P655, DOI 10.1007/s10482-012-9850-8; Kagina BMN, 2014, VACCINE, V32, P5908, DOI 10.1016/j.vaccine.2014.09.001; KANALY ST, 1995, INFECT IMMUN, V63, P3037, DOI 10.1128/IAI.63.8.3037-3041.1995; Kanaly ST, 1996, INFECT IMMUN, V64, P1126, DOI 10.1128/IAI.64.4.1126-1132.1996; Letek M, 2008, J BACTERIOL, V190, P5797, DOI 10.1128/JB.00468-08; Liu HM, 2014, J CLIN MICROBIOL, V52, P703, DOI 10.1128/JCM.02925-13; Lopez AM, 2003, VACCINE, V21, P3815, DOI 10.1016/S0264-410X(03)00329-3; Muscatello G, 2012, VET J, V192, P20, DOI 10.1016/j.tvjl.2011.08.014; Oliveira AF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008644; Patton KM, 2005, INFECT IMMUN, V73, P2083, DOI 10.1128/IAI.73.4.2083-2093.2005; Pei Y, 2007, VET MICROBIOL, V125, P100, DOI 10.1016/j.vetmic.2007.05.007; Phumoonna T, 2008, VACCINE, V26, P2457, DOI 10.1016/j.vaccine.2008.03.015; PRESCOTT JF, 1991, CLIN MICROBIOL REV, V4, P20, DOI 10.1128/CMR.4.1.20-34.1991; Prescott JF, 1997, VET MICROBIOL, V56, P213, DOI 10.1016/S0378-1135(97)00090-4; PRESCOTT JF, 1980, CAN J COMP MED, V44, P280; Ren J, 2003, VET MICROBIOL, V94, P167, DOI 10.1016/S0378-1135(03)00099-3; ROWBOTHAM TJ, 1977, J GEN MICROBIOL, V100, P231, DOI 10.1099/00221287-100-2-231; Russell DA, 2004, J BACTERIOL, V186, P5576, DOI 10.1128/JB.186.17.5576-5584.2004; Sambrook J, 1989, MOL CLONING; Sturgill TL, 2014, VACCINE, V32, P1362, DOI 10.1016/j.vaccine.2014.01.032; Sturgill TL, 2011, VET IMMUNOL IMMUNOP, V140, P237, DOI 10.1016/j.vetimm.2010.12.012; TAKAI S, 1991, J CLIN MICROBIOL, V29, P2887, DOI 10.1128/JCM.29.12.2887-2889.1991; Takai S, 1999, FEMS IMMUNOL MED MIC, V24, P1; Takai S, 1996, J CLIN MICROBIOL, V34, P1034, DOI 10.1128/JCM.34.4.1034-1037.1996; TAKAI S, 1991, J CLIN MICROBIOL, V29, P439, DOI 10.1128/JCM.29.3.439-443.1991; TAKAI S, 1995, FEMS IMMUNOL MED MIC, V11, P181, DOI 10.1111/j.1574-695X.1995.tb00115.x; Tameris M, 2015, VACCINE, V33, P2944, DOI 10.1016/j.vaccine.2015.03.070; TAN C, 1995, CAN J VET RES, V59, P51; Vanniasinkam T, 2005, INT J MED MICROBIOL, V294, P437, DOI 10.1016/j.ijmm.2004.09.011; Wang YJ, 1997, J VIROL, V71, P3677, DOI 10.1128/JVI.71.5.3677-3683.1997; Whitehead AE, 2012, VET IMMUNOL IMMUNOP, V145, P479, DOI 10.1016/j.vetimm.2011.10.011; Woods A, 1994, LAB HISTOPATHOLOGY C; Xiang ZQ, 1996, VIROLOGY, V219, P220, DOI 10.1006/viro.1996.0239; Yamshchikov AV, 2010, LANCET INFECT DIS, V10, P350, DOI 10.1016/S1473-3099(10)70068-2	57	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152149	10.1371/journal.pone.0152149	http://dx.doi.org/10.1371/journal.pone.0152149			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008624	Green Accepted, gold, Green Published			2022-12-26	WOS:000372701200098
J	Knaster, P; Estlander, AM; Karlsson, H; Kaprio, J; Kalso, E				Knaster, Peter; Estlander, Ann-Mari; Karlsson, Hasse; Kaprio, Jaakko; Kalso, Eija			Diagnosing Depression in Chronic Pain Patients: DSM-IV Major Depressive Disorder vs. Beck Depression Inventory (BDI)	PLOS ONE			English	Article							OLDER-ADULTS; BACK-PAIN; SYMPTOMS; PREVALENCE; VALIDITY	Background Diagnosing depression in chronic pain is challenging due to overlapping somatic symptoms. In questionnaires, such as the Beck Depression Inventory (BDI), responses may be influenced more by pain than by the severity of depression. In addition, previous studies have suggested that symptoms of negative self-image, a key element in depression, are uncommon in chronic pain-related depression. The object of this study is to assess the relationship of the somatic and cognitive-emotional items of BDI with the diagnosis of depression, pain intensity, and disability. Methods One hundred consecutive chronic pain patients completed the Structured Clinical Interview for DSM Disorders (SCID) for the diagnosis of major depressive disorder (MDD) according to DSM-IV. Two subscales of BDI (negative view of self and somatic-physical function) were created according to the factor model presented by Morley. Results In the regression analysis, the somatic-physical function factor associated with MDD, while the negative view of self factor did not. Patients with MDD had higher scores in several of the BDI items when analysed separately. Insomnia and weight loss were not dependent on the depression diagnosis. Limitations The relatively small sample size and the selected patient sample limit the generalisability of the results. Conclusions Somatic symptoms of depression are also common in chronic pain and should not be excluded when diagnosing depression in pain patients. Regardless of the assessment method, diagnosing depression in chronic pain remains a challenge and requires careful interpretation of symptoms.	[Knaster, Peter; Estlander, Ann-Mari; Kalso, Eija] Helsinki Univ Hosp, Dept Anaesthesiol Intens Care & Pain Med, Pain Clin, Helsinki, Finland; [Knaster, Peter; Estlander, Ann-Mari; Kalso, Eija] Univ Helsinki, Helsinki, Finland; [Karlsson, Hasse] Univ Turku, Dept Clin Sci, Turku, Finland; [Kaprio, Jaakko] Univ Helsinki, Fac Med, Helsinki, Finland; [Kaprio, Jaakko] Univ Helsinki, Inst Mol Med, Helsinki, Finland	University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Turku; University of Helsinki; University of Helsinki	Knaster, P (corresponding author), Helsinki Univ Hosp, Dept Anaesthesiol Intens Care & Pain Med, Pain Clin, Helsinki, Finland.; Knaster, P (corresponding author), Univ Helsinki, Helsinki, Finland.	peter.knaster@dr.com	Kaprio, Jaakko/A-1820-2008	Kaprio, Jaakko/0000-0002-3716-2455; Kalso, Eija/0000-0002-4899-605X; Karlsson, Hasse/0000-0002-4992-1893	Signe and Ane Gyllenberg Foundation; Founfation for Psychiatric Research; Wilhelm and Else Stockmann Foundation (Helsinki); Finnish Association for the Study of Pain; Helsinki University Central Hospital Research Funds	Signe and Ane Gyllenberg Foundation; Founfation for Psychiatric Research; Wilhelm and Else Stockmann Foundation (Helsinki); Finnish Association for the Study of Pain; Helsinki University Central Hospital Research Funds	Funded by Grants from the Signe and Ane Gyllenberg Foundation (stiftelsen@gyllenbergs.fi), the Founfation for Psychiatric Research (psykiatrian.tutkimussaatio@psy.fi), the Wilhelm and Else Stockmann Foundation (Tempelgatan 1 a 17/Stockmann Karl, 00100 Helsinki), the Finnish Association for the Study of Pain (http://www.suomenkivuntutkimusyhdistys.fi), and Helsinki University Central Hospital Research Funds (http://www.hyksinstituutti.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikens JE, 1999, J BEHAV MED, V22, P127, DOI 10.1023/A:1018731415172; Akechi T, 2003, PSYCHOSOMATICS, V44, P244, DOI 10.1176/appi.psy.44.3.244; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Arnow BA, 2006, PSYCHOSOM MED, V68, P262, DOI 10.1097/01.psy.0000204851.15499.fc; Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beck AT, 1970, DEPRESSION CAUSES TR, pxiv; CAVANAUGH S, 1983, PSYCHOSOMATICS, V24, P809, DOI 10.1016/S0033-3182(83)73151-8; Demyttenaere K, 2006, J AFFECT DISORDERS, V92, P185, DOI 10.1016/j.jad.2006.01.007; Dionne CE, 1997, J CLIN EPIDEMIOL, V50, P31, DOI 10.1016/S0895-4356(96)00313-7; Estlander AM, 2008, PAIN, V140, P387, DOI 10.1016/j.pain.2008.09.015; First M.B., 1996, STRUCTURED CLIN INTE, DOI DOI 10.1037/T07827-000; Forkmann T, 2009, J PSYCHOSOM RES, V67, P347, DOI 10.1016/j.jpsychores.2009.04.003; KATHOL RG, 1990, AM J PSYCHIAT, V147, P1021; KATHOL RG, 1990, PSYCHOSOMATICS, V31, P434, DOI 10.1016/S0033-3182(90)72140-8; KEARNS NP, 1982, BRIT J PSYCHIAT, V141, P45, DOI 10.1192/bjp.141.1.45; Knaster P, 2012, GEN HOSP PSYCHIAT, V34, P46, DOI 10.1016/j.genhosppsych.2011.09.004; Koenig HG, 1997, AM J PSYCHIAT, V154, P1376; KOENIG HG, 1995, J AM GERIATR SOC, V43, P472, DOI 10.1111/j.1532-5415.1995.tb06091.x; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lustman PJ, 1997, PSYCHOSOM MED, V59, P24, DOI 10.1097/00006842-199701000-00004; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; Morley S, 2002, PAIN, V99, P289, DOI 10.1016/S0304-3959(02)00137-9; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Pincus T, 2001, PSYCHOL BULL, V127, P599, DOI 10.1037//0033-2909.127.5.599; Sanz J, 1998, PSICOTHEMA, V10, P303; Simon GE, 2006, PSYCHOL MED, V36, P27, DOI 10.1017/S0033291705006136; Steer RA, 1997, PSYCHOL REP, V80, P443, DOI 10.2466/pr0.1997.80.2.443; Tang NKY, 2006, PSYCHOL MED, V36, P575, DOI 10.1017/S0033291705006859; WESLEY AL, 1991, SPINE, V16, pS213, DOI 10.1097/00007632-199106001-00007; Wilson KG, 2001, PAIN, V91, P227, DOI 10.1016/S0304-3959(00)00440-1; Wothke J.L, 1999, AMOS 4 0 USERS GUIDE	34	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151982	10.1371/journal.pone.0151982	http://dx.doi.org/10.1371/journal.pone.0151982			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3QJ	27008161	Green Published, gold, Green Submitted			2022-12-26	WOS:000372701200082
J	Luo, JY; Zhang, S; Wang, L; Lv, LM; Wang, CY; Li, CH; Zhu, XZ; Zhou, ZG; Cui, JJ				Luo, Jun-Yu; Zhang, Shuai; Wang, Li; Lv, Li-Min; Wang, Chun-Yi; Li, Chun-Hua; Zhu, Xiang-Zhen; Zhou, Zhi-Guo; Cui, Jin-Jie			The Distribution and Host Shifts of Cotton-Melon Aphids in Northern China	PLOS ONE			English	Article							POPULATION GENETIC SOFTWARE; GOSSYPII GLOVER; SEXUAL REPRODUCTION; GENOTYPIC DATA; DIVERSITY; DIFFERENTIATION; RESISTANCE; PROGRAM	Aphis gossypii Glover (Hemiptera: Aphididae) is a serious pest of cotton in northern China. A microsatellite analysis was used to characterize the genetic structure of A. gossypii populations from different geographic, host plant, and seasonal populations in 2014. Among 906 individuals, 507 multilocus genotypes were identified, with genotypic richness values of 0.07-1.00 for the populations. We observed moderate levels of genetic differentiation among geographic populations (F-ST = 0.103; 95% confidence interval: 0.065-0.145) and host plant populations (F-ST = 0.237; 95% confidence interval: 0.187-0.296). A Mantel test of isolation by distance revealed no significant correlations between Slatkin's linearized F-ST and the natural logarithm of geographic distance. A Bayesian analysis of population genetic structures identified three clusters. An analysis of molecular variance revealed significant differences among the three clusters (F = 0.26596, P < 0.0001), among seasons (F = 0.04244, P = 0.00381), and among host populations (F = 0.12975, P = 0.0029). Thus, the A. gossypii populations in northern China exhibit considerable genotypic diversity. Additionally, our findings indicated that the 31 analyzed populations could be classified as one of three host biotypes (i.e., cotton, cucumber, and pomegranate biotypes). There were also clear seasonal effects on population genetic structure diversity among aphids collected from Anyang.	[Luo, Jun-Yu; Zhou, Zhi-Guo] Nanjing Agr Univ, Minist Agr, Key Lab Crop Physiol & Ecol, Nanjing 210095, Jiangsu, Peoples R China; [Luo, Jun-Yu; Zhang, Shuai; Wang, Li; Lv, Li-Min; Wang, Chun-Yi; Li, Chun-Hua; Zhu, Xiang-Zhen; Cui, Jin-Jie] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Zhou, ZG (corresponding author), Nanjing Agr Univ, Minist Agr, Key Lab Crop Physiol & Ecol, Nanjing 210095, Jiangsu, Peoples R China.; Cui, JJ (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang 455000, Henan, Peoples R China.	giscott@njau.edu.cn; cuijinjie@126.com		Zhang, Shuai/0000-0003-3646-1522	Transgenic Major Projects program of the Ministry of Science and Technology, China [2016ZX08011-002]; National Natural Science Foundation of China [31572015]	Transgenic Major Projects program of the Ministry of Science and Technology, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the Transgenic Major Projects program of the Ministry of Science and Technology, China (2016ZX08011-002) and the National Natural Science Foundation of China (31572015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaud-Haond S, 2007, MOL ECOL NOTES, V7, P15, DOI 10.1111/j.1471-8286.2006.01522.x; Blackman R.L., 2000, J ECON ENTOMOL, V2; Brevault T, 2008, AGR FOREST ENTOMOL, V10, P215, DOI 10.1111/j.1461-9563.2008.00377.x; Carletto J, 2009, MOL ECOL, V18, P2198, DOI 10.1111/j.1365-294X.2009.04190.x; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Charaabi K, 2008, B ENTOMOL RES, V98, P333, DOI 10.1017/S0007485307005585; Chen YZ, 2013, PEST MANAG SCI, V69, P938, DOI 10.1002/ps.3455; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ebert TA, 1997, SOUTHWEST ENTOMOL, V22, P116; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferrari Roberto, 1994, IF (Informatore Fitopatologico), V44, P59; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Guillemaud T, 2003, HEREDITY, V91, P143, DOI 10.1038/sj.hdy.6800292; GULDEMOND JA, 1994, ENVIRON ENTOMOL, V23, P1235, DOI 10.1093/ee/23.5.1235; Harrison JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017524; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Komazaki S, 2011, ENTOMOL EXP APPL, V140, P171, DOI 10.1111/j.1570-7458.2011.01145.x; Li ZQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083180; Liu XiangDong, 2002, Agricultural Sciences in China, V1, P1211; Lombaert E, 2009, ENTOMOL EXP APPL, V133, P46, DOI 10.1111/j.1570-7458.2009.00904.x; Papura D, 2003, HEREDITY, V90, P397, DOI 10.1038/sj.hdy.6800262; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; Razmjou J, 2010, ENTOMOL EXP APPL, V134, P191, DOI 10.1111/j.1570-7458.2009.00951.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rubiano-Rodriguez JA, 2014, B ENTOMOL RES, V104, P182, DOI 10.1017/S000748531300062X; Sunnucks P, 1997, MOL ECOL, V6, P1059, DOI 10.1046/j.1365-294X.1997.00280.x; Thomas S, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-47; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vanlerberghe-Masutti F, 1998, MOL ECOL, V7, P905, DOI 10.1046/j.1365-294x.1998.00421.x; Vanlerberghe-Masutti F, 1999, MOL ECOL, V8, P693, DOI 10.1046/j.1365-294x.1999.00876.x; Wang L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146345; Wu KM, 2003, ENVIRON ENTOMOL, V32, P312, DOI 10.1603/0046-225X-32.2.312; Wu ZS, 2004, ANN ENTOMOL SOC AM, V97, P209, DOI 10.1603/0013-8746(2004)097[0209:TSAICA]2.0.CO;2; Xia J., 1997, THESIS WAGENINGEN U	38	7	7	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152103	10.1371/journal.pone.0152103	http://dx.doi.org/10.1371/journal.pone.0152103			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002824	Green Published, gold, Green Submitted			2022-12-26	WOS:000372697400079
J	Ali, HO; Stavik, B; Myklebust, CF; Andersen, E; Dahm, AEA; Iversen, N; Sandset, PM; Skretting, G				Ali, Huda Omar; Stavik, Benedicte; Myklebust, Christiane Filion; Andersen, Elisabeth; Dahm, Anders E. A.; Iversen, Nina; Sandset, Per Morten; Skretting, Grethe			Oestrogens Downregulate Tissue Factor Pathway Inhibitor through Oestrogen Response Elements in the 5 '-Flanking Region	PLOS ONE			English	Article							LIPOPROTEIN-ASSOCIATED COAGULATION; BREAST-CANCER CELLS; RECEPTOR BINDING; TRANSCRIPTIONAL ACTIVATION; GENE-EXPRESSION; HALF-SITE; ALPHA; DNA; IDENTIFICATION; PROMOTER	Oestrogens influence the pathology and development of hormone-sensitive breast cancers. Tissue factor pathway inhibitor (TFPI) has been shown to be associated with breast cancer pathogenesis. Recently, we found TFPI mRNA levels to be significantly reduced by oestrogens in a breast cancer cell line (MCF7), a process mediated through the oestrogen receptor alpha (ERa). The aim of the present study was to investigate the mechanism(s) by which oestrogens may regulate TFPI at the transcriptional level. The TFPI 5'-flanking region contains three oestrogen response element (ERE) half-sites at positions -845, -769 and -50. Constructs containing the wild type or mutated ERE half-sites of the TFPI 5'-flanking region were generated in a luciferase reporter gene vector and transiently co-transfected with an ERa expression vector into HEK293 cells and subsequently treated with oestrogens. We found that luciferase activity was significantly downregulated after oestrogen stimulation in cells transfected with the wild type construct, an effect that was abolished by mutating either ERE half-sites. Electrophoretic mobility shift assay suggested direct and specific interaction of ERa with the ERE half-sites in the TFPI 5'-flanking region. Chromatin immunoprecipitation showed that ERa was recruited to the region -899 to -578 of the TFPI 5'-flanking region in vivo, where the ERE half-sites -845 and -769 are located. Our results indicate that ERa can interact with all three ERE half-sites in the TFPI 5'-flanking region and thus participate in the repression of oestrogen mediated TFPI transcription in breast cancer cells.	[Ali, Huda Omar; Stavik, Benedicte; Myklebust, Christiane Filion; Andersen, Elisabeth; Sandset, Per Morten; Skretting, Grethe] Oslo Univ Hosp, Dept Haematol, Oslo, Norway; [Ali, Huda Omar; Stavik, Benedicte; Myklebust, Christiane Filion; Andersen, Elisabeth; Dahm, Anders E. A.; Sandset, Per Morten; Skretting, Grethe] Oslo Univ Hosp, Internal Med Res Inst, Oslo, Norway; [Ali, Huda Omar; Andersen, Elisabeth; Dahm, Anders E. A.; Sandset, Per Morten] Univ Oslo, Inst Clin Med, Oslo, Norway; [Dahm, Anders E. A.] Akershus Univ Hosp, Dept Haematol, Nordbyhagen, Norway; [Iversen, Nina] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Skretting, G (corresponding author), Oslo Univ Hosp, Dept Haematol, Oslo, Norway.; Skretting, G (corresponding author), Oslo Univ Hosp, Internal Med Res Inst, Oslo, Norway.	grethe.skretting@medisin.uio.no	Dahm, Anders Erik Astrup/N-4260-2019; Stavik, Benedicte/U-3406-2017; Sandset, Per Morten/J-8141-2019	Stavik, Benedicte/0000-0003-3341-9847; Sandset, Per Morten/0000-0001-5556-8099; Dahm, Anders Erik Astrup/0000-0003-4477-3526; Andersen, Elisabeth/0000-0003-2902-2003				Ali HO, 2014, THROMB RES, V134, P138, DOI 10.1016/j.thromres.2014.04.004; Anderson I, 2000, BIOCHEMISTRY-US, V39, P3842, DOI 10.1021/bi9924516; Bajaj MS, 2001, THROMB HAEMOSTASIS, V86, P959; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Dahl JA, 2007, STEM CELLS, V25, P1037, DOI 10.1634/stemcells.2006-0430; Das D, 2004, MOL ENDOCRINOL, V18, P2616, DOI 10.1210/me.2004-0125; DeNardo DG, 2005, MOL ENDOCRINOL, V19, P362, DOI 10.1210/me.2004-0267; Eilertsen AL, 2007, THROMB RES, V120, P371, DOI 10.1016/j.thromres.2006.10.013; Enmark E, 1997, J CLIN ENDOCR METAB, V82, P4258, DOI 10.1210/jc.82.12.4258; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; FURLOW JD, 1993, J BIOL CHEM, V268, P12519; GIRARD TJ, 1989, NATURE, V338, P518, DOI 10.1038/338518a0; GOSDEN JR, 1986, CYTOGENET CELL GENET, V43, P218, DOI 10.1159/000132325; Hall JM, 2005, MOL INTERV, V5, P343, DOI 10.1124/mi.5.6.7; Hart K, 2008, MUTAT RES-GEN TOX EN, V656, P14, DOI 10.1016/j.mrgentox.2008.06.013; Jakacka M, 2001, J BIOL CHEM, V276, P13615, DOI 10.1074/jbc.M008384200; Joshi SR, 2011, MOL ENDOCRINOL, V25, P980, DOI 10.1210/me.2010-0302; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Liu W, 2007, THROMB HAEMOSTASIS, V97, P839, DOI 10.1160/TH06-09-0536; Martini PGV, 2001, ENDOCRINOLOGY, V142, P3493, DOI 10.1210/en.142.8.3493; Mason CE, 2010, NUCLEIC ACIDS RES, V38, P2355, DOI 10.1093/nar/gkp1188; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; MURDOCH FE, 1990, BIOCHEMISTRY-US, V29, P8377, DOI 10.1021/bi00488a026; Nekoo AA, 2008, THROMB RES, V121, P813, DOI 10.1016/j.thromres.2007.08.012; Ozers MS, 1997, J BIOL CHEM, V272, P30405, DOI 10.1074/jbc.272.48.30405; Petit L, 1999, THROMB RES, V95, P255, DOI 10.1016/S0049-3848(99)00040-7; Petz LN, 2000, MOL ENDOCRINOL, V14, P972, DOI 10.1210/me.14.7.972; Porter W, 1997, MOL ENDOCRINOL, V11, P1569, DOI 10.1210/me.11.11.1569; Reynolds N, 2013, DEVELOPMENT, V140, P505, DOI 10.1242/dev.083105; Safe S, 2001, VITAM HORM, V62, P231, DOI 10.1016/S0083-6729(01)62006-5; Skretting G, 2010, BIOCHEM BIOPH RES CO, V397, P106, DOI 10.1016/j.bbrc.2010.05.078; Stavik B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-357; Stavik B, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-5; Stender JD, 2010, MOL CELL BIOL, V30, P3943, DOI 10.1128/MCB.00118-10; VANDERLOGT CPE, 1991, BIOCHEMISTRY-US, V30, P1571, DOI 10.1021/bi00220a018; Wood JP, 2014, BLOOD, V123, P2934, DOI 10.1182/blood-2013-11-512764; Yang Q, 2012, ENDOCRINOLOGY, V153, P3170, DOI 10.1210/en.2011-2045	38	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0152114	10.1371/journal.pone.0152114	http://dx.doi.org/10.1371/journal.pone.0152114			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999742	Green Published, gold, Green Submitted			2022-12-26	WOS:000372694700101
J	Bai, L; Li, QW; Li, LM; Lin, Y; Zhao, SH; Wang, WR; Wang, R; Li, YQ; Yuan, JB; Wang, CJ; Wang, ZF; Fan, JL; Liu, EQ				Bai, Liang; Li, Qianwei; Li, Lingmei; Lin, Yan; Zhao, Sihai; Wang, Weirong; Wang, Rong; Li, Yongqin; Yuan, Jiangbei; Wang, Chengjian; Wang, Zhongfu; Fan, Jianglin; Liu, Enqi			Plasma High-Mannose and Complex/Hybrid N-Glycans Are Associated with Hypercholesterolemia in Humans and Rabbits	PLOS ONE			English	Article							MASS-SPECTROMETRY; GLYCOSYLATION; GLYCOMICS; CANCER; INFLAMMATION; EXPRESSION; BINDING	N-glycans play important roles in various pathophysiological processes and can be used as clinical diagnosis markers. However, plasma N-glycans change and their pathophysiological significance in the setting of hypercholesterolemia, a major risk factor for atherosclerosis, is unknown. Here, we collected plasma from both hypercholesterolemic patients and cholesterol-fed hypercholesterolemic rabbits, and determined the changes in the whole-plasma N-glycan profile by electrospray ionization mass spectrometry. We found that both the hypercholesterolemic patients and rabbits showed a dramatic change in their plasma glycan profile. Compared with healthy subjects, the hypercholesterolemic patients exhibited higher plasma levels of a cluster of high-mannose and complex/hybrid N-glycans (mainly including undecorated or sialylated glycans), whereas only a few fucosylated or fucosylated and sialylated N-glycans were increased. Additionally, cholesterol-fed hypercholesterolemic rabbits also displayed increased plasma levels of high-mannose in addition to high complex/hybrid N-glycan levels. The whole-plasma glycan profiles revealed that the plasma N-glycan levels were correlated with the plasma cholesterol levels, implying that N-glycans may be a target for treatment of hypercholesterolemia.	[Bai, Liang; Li, Qianwei; Lin, Yan; Zhao, Sihai; Wang, Weirong; Wang, Rong; Liu, Enqi] Xi An Jiao Tong Univ, Cardiovasc Res Ctr, Res Inst Atherosclerot Dis, Xian 710061, Shaanxi, Peoples R China; [Bai, Liang; Li, Qianwei; Lin, Yan; Zhao, Sihai; Wang, Weirong; Wang, Rong; Liu, Enqi] Xi An Jiao Tong Univ, Hlth Sci Ctr, Lab Anim Ctr, Xian 710061, Shaanxi, Peoples R China; [Li, Lingmei; Yuan, Jiangbei; Wang, Chengjian; Wang, Zhongfu] NW Univ Xian, Coll Life Sci, Educ Minist, Key Lab Resource Biol & Biotechnol Western China, Xian 710069, Peoples R China; [Li, Yongqin] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Cardiol, Xian 710004, Shaanxi, Peoples R China; [Fan, Jianglin] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Pathol, Yamanashi 4093898, Japan	Xi'an Jiaotong University; Xi'an Jiaotong University; Northwest University Xi'an; Xi'an Jiaotong University; University of Yamanashi	Liu, EQ (corresponding author), Xi An Jiao Tong Univ, Cardiovasc Res Ctr, Res Inst Atherosclerot Dis, Xian 710061, Shaanxi, Peoples R China.; Liu, EQ (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Lab Anim Ctr, Xian 710061, Shaanxi, Peoples R China.; Wang, ZF (corresponding author), NW Univ Xian, Coll Life Sci, Educ Minist, Key Lab Resource Biol & Biotechnol Western China, Xian 710069, Peoples R China.	wangzhf@nwu.edu.cn; liuenqi@mail.xjtu.edu.cn	liu, enqi/S-7771-2019; Yuan, Jiangbei/HHZ-8184-2022	Zhao, Sihai/0000-0002-5845-6639; Fan, Jianglin/0000-0002-1737-6130; Liu, Enqi/0000-0002-2092-3158; Wang, Rong/0000-0002-9947-4307	National Natural Science Foundation of China [81070250, 81200207]; Public Service Platform Grant from Shaanxi Province [2014FWPT-07]; Grants-in-Aid for Scientific Research [25670190] Funding Source: KAKEN	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Service Platform Grant from Shaanxi Province; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partly supported by the National Natural Science Foundation of China (81070250, 81200207) and a Public Service Platform Grant from Shaanxi Province (2014FWPT-07).	Alaupovic P, 1991, ADV EXP MED BIOL, V285, P299; An HJ, 2009, CURR OPIN CHEM BIOL, V13, P601, DOI 10.1016/j.cbpa.2009.08.015; [Anonymous], [No title captured]; [Anonymous], 2009, ESSENTIALS GLYCOBIOL; Banuls C, 2012, CLIN CHIM ACTA, V413, P251, DOI 10.1016/j.cca.2011.09.047; Barone R, 2009, MASS SPECTROM REV, V28, P517, DOI 10.1002/mas.20201; Chacko BK, 2011, J BIOL CHEM, V286, P38738, DOI 10.1074/jbc.M111.247981; Chen CC, 2010, REJUV RES, V13, P439, DOI 10.1089/rej.2009.0992; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Fan J, 2014, PHARM THER; FIEDLER K, 1995, CELL, V81, P309, DOI 10.1016/0092-8674(95)90380-1; Freeze HH, 2005, CURR OPIN STRUC BIOL, V15, P490, DOI 10.1016/j.sbi.2005.08.010; Furukawa Kiyoshi, 1992, Current Opinion in Biotechnology, V3, P554, DOI 10.1016/0958-1669(92)90085-W; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Garner B, 2001, GLYCOBIOLOGY, V11, P791, DOI 10.1093/glycob/11.10.791; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Hatakeyama S, 2013, SCI WORLD J, DOI 10.1155/2013/268407; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Igl W, 2011, MOL BIOSYST, V7, P1852, DOI 10.1039/c0mb00095g; Jensen MK, 2014, NAT REV ENDOCRINOL, V10, P659, DOI 10.1038/nrendo.2014.155; Jiang K, 2014, J AGR FOOD CHEM, V62, P7245, DOI 10.1021/jf501352j; Kaprio T, 2015, MOL CELL PROTEOMICS, V14, P277, DOI 10.1074/mcp.M114.041632; Kataoka H, 2000, J BIOL CHEM, V275, P6573, DOI 10.1074/jbc.275.9.6573; Kelly Shawn C, 2014, S D Med, V67, P320; Knezevic A, 2010, GLYCOBIOLOGY, V20, P959, DOI 10.1093/glycob/cwq051; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Matthijsen RA, 2009, CIRCULATION, V119, P2188, DOI 10.1161/CIRCULATIONAHA.108.830661; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Pabst M, 2011, PROTEOMICS, V11, P631, DOI 10.1002/pmic.201000517; Paszek MJ, 2014, NATURE, V511, P319, DOI 10.1038/nature13535; Qian YF, 2012, GLYCOCONJUGATE J, V29, P399, DOI 10.1007/s10719-012-9408-z; Renkonen J, 2002, AM J PATHOL, V161, P543, DOI 10.1016/S0002-9440(10)64210-1; Ruhaak LR, 2011, J PROTEOME RES, V10, P1667, DOI 10.1021/pr1009959; Ryden I, 2002, CLIN CHIM ACTA, V317, P221, DOI 10.1016/S0009-8981(01)00803-8; Sano M, 2012, GLYCOBIOLOGY, V22, P714, DOI 10.1093/glycob/cws010; Scott DW, 2012, ARTERIOSCL THROM VAS, V32, pE51, DOI 10.1161/ATVBAHA.112.253203; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; Wang CJ, 2014, J PROTEOME RES, V13, P372, DOI 10.1021/pr4010647; Wang CJ, 2013, ANALYST, V138, P5344, DOI 10.1039/c3an00931a; Wang YL, 2014, HISTOL HISTOPATHOL, V29, P1593, DOI 10.14670/HH-29.1593	40	6	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0146982	10.1371/journal.pone.0146982	http://dx.doi.org/10.1371/journal.pone.0146982			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999365	gold, Green Submitted, Green Published			2022-12-26	WOS:000372694700007
J	Baiocchini, A; Montaldo, C; Conigliaro, A; Grimaldi, A; Correani, V; Mura, F; Ciccosanti, F; Rotiroti, N; Brenna, A; Montalbano, M; D'Offizi, G; Capobianchi, MR; Alessandro, R; Piacentini, M; Schinina, ME; Maras, B; Del Nonno, F; Tripodi, M; Mancone, C				Baiocchini, Andrea; Montaldo, Claudia; Conigliaro, Alice; Grimaldi, Alessio; Correani, Virginia; Mura, Francesco; Ciccosanti, Fabiola; Rotiroti, Nicolina; Brenna, Alessia; Montalbano, Marzia; D'Offizi, Gianpiero; Capobianchi, Maria Rosaria; Alessandro, Riccardo; Piacentini, Mauro; Schinina, Maria Eugenia; Maras, Bruno; Del Nonno, Franca; Tripodi, Marco; Mancone, Carmine			Extracellular Matrix Molecular Remodeling in Human Liver Fibrosis Evolution	PLOS ONE			English	Article							VI COLLAGEN; EXPRESSION; TISSUE; PROTEIN; MICE	Chronic liver damage leads to pathological accumulation of ECM proteins (liver fibrosis). Comprehensive characterization of the human ECM molecular composition is essential for gaining insights into the mechanisms of liver disease. To date, studies of ECM remodeling in human liver diseases have been hampered by the unavailability of purified ECM. Here, we developed a decellularization method to purify ECM scaffolds from human liver tissues. Histological and electron microscopy analyses demonstrated that the ECM scaffolds, devoid of plasma and cellular components, preserved the three-dimensional ECM structure and zonal distribution of ECM components. This method has been then applied on 57 liver biopsies of HCV-infected patients at different stages of liver fibrosis according to METAVIR classification. Label-free nLC-MS/MS proteomics and computation biology were performed to analyze the ECM molecular composition in liver fibrosis progression, thus unveiling protein expression signatures specific for the HCV-related liver fibrotic stages. In particular, the ECM molecular composition of liver fibrosis was found to involve dynamic changes in matrix stiffness, flexibility and density related to the dysregulation of predominant collagen, elastic fibers and minor components with both structural and signaling properties. This study contributes to the understanding of the molecular bases underlying ECM remodeling in liver fibrosis and suggests new molecular targets for fibrolytic strategies.	[Baiocchini, Andrea; Montaldo, Claudia; Grimaldi, Alessio; Ciccosanti, Fabiola; Rotiroti, Nicolina; Brenna, Alessia; Montalbano, Marzia; D'Offizi, Gianpiero; Capobianchi, Maria Rosaria; Piacentini, Mauro; Del Nonno, Franca; Tripodi, Marco; Mancone, Carmine] IRCCS, Natl Inst Infect Dis L Spallanzani, Via Portuense 292, I-00149 Rome, Italy; [Conigliaro, Alice; Tripodi, Marco; Mancone, Carmine] Univ Roma La Sapienza, Dept Cellular Biotechnol & Haematol, Via Regina Elena 324, I-00161 Rome, Italy; [Conigliaro, Alice; Tripodi, Marco; Mancone, Carmine] Fdn Cenci Bolognetti, Ist Pasteur, Via Regina Elena 324, I-00161 Rome, Italy; [Correani, Virginia; Schinina, Maria Eugenia; Maras, Bruno] Univ Roma La Sapienza, Dipartimento Sci Biochim, Ple Aldo Moro 5, I-00185 Rome, Italy; [Mura, Francesco] Univ Roma La Sapienza, Dipartimento Chim, Ple Aldo Moro 5, I-00185 Rome, Italy; [Alessandro, Riccardo] Univ Palermo, Dipartimento Biopatol & Biotecnol Med, Via Divisi 83, I-90133 Palermo, Italy; [Alessandro, Riccardo] Natl Res Council Italy, IBIM, Palermo, Italy; [Piacentini, Mauro] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy	IRCCS Lazzaro Spallanzani; Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome; University of Palermo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); University of Rome Tor Vergata	Tripodi, M; Mancone, C (corresponding author), IRCCS, Natl Inst Infect Dis L Spallanzani, Via Portuense 292, I-00149 Rome, Italy.; Tripodi, M; Mancone, C (corresponding author), Univ Roma La Sapienza, Dept Cellular Biotechnol & Haematol, Via Regina Elena 324, I-00161 Rome, Italy.; Tripodi, M; Mancone, C (corresponding author), Fdn Cenci Bolognetti, Ist Pasteur, Via Regina Elena 324, I-00161 Rome, Italy.	tripodi@bce.uniroma1.it; carmine.mancone@uniroma1.it	Mura, Francesco/AAD-5114-2020; Ciccosanti, Fabiola/B-5284-2017; Tripodi, Marco/ABO-1160-2022; Piacentini, Mauro/I-2411-2016; Conigliaro, Alice/L-5590-2019; Montaldo, Claudia/B-5055-2017; Tripodi, Marco/F-1143-2011; Conigliaro, Alice/J-8717-2016	Mura, Francesco/0000-0001-8490-9438; Ciccosanti, Fabiola/0000-0003-0481-6878; Tripodi, Marco/0000-0001-6135-971X; Piacentini, Mauro/0000-0003-2919-1296; Conigliaro, Alice/0000-0002-3037-835X; Montaldo, Claudia/0000-0001-6487-7176; Tripodi, Marco/0000-0001-6135-971X; Conigliaro, Alice/0000-0002-3037-835X; Capobianchi, Maria Rosaria/0000-0003-3465-0071; Mancone, Carmine/0000-0002-9569-5030	MIUR Ministero dell'Universita e Ricerca Scientifica (FIRB) [RBFR12NSCF]; Ministero della Salute (Ricerca Corrente), Associazione Italiana per la Ricerca sul Cancro (AIRC); CNIS (Research Center for the Nanotechnology Applied to the Engineering of Sapienza University of Rome)	MIUR Ministero dell'Universita e Ricerca Scientifica (FIRB); Ministero della Salute (Ricerca Corrente), Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); CNIS (Research Center for the Nanotechnology Applied to the Engineering of Sapienza University of Rome)	This work was supported by grants from MIUR Ministero dell'Universita e Ricerca Scientifica (FIRB 2012, codice progetto RBFR12NSCF), and Ministero della Salute (Ricerca Corrente), Associazione Italiana per la Ricerca sul Cancro (AIRC).; We are deeply grateful to Ms. Andrea Baker (INMI Rome, Italy) for the editing. We would like to thank Prof. Marco Rossi and CNIS (Research Center for the Nanotechnology Applied to the Engineering of Sapienza University of Rome) for their support.	Baptista PM, 2011, HEPATOLOGY, V53, P604, DOI 10.1002/hep.24067; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bracht T, 2015, J PROTEOME RES, V14, P2278, DOI 10.1021/acs.jproteome.5b00053; Chen W, 2014, HUM PATHOL, V45, P160, DOI 10.1016/j.humpath.2013.08.015; Corchero J, 2004, INT J EXP PATHOL, V85, P295, DOI 10.1111/j.0959-9673.2004.00397.x; Crapo PM, 2011, BIOMATERIALS, V32, P3233, DOI 10.1016/j.biomaterials.2011.01.057; Defamie V, 2015, ONCOGENE, V34, P4098, DOI 10.1038/onc.2014.339; Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736; GRIFFITHS MR, 1992, HISTOPATHOLOGY, V21, P335, DOI 10.1111/j.1365-2559.1992.tb00404.x; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Ikegawa S, 2000, CYTOGENET CELL GENET, V90, P291, DOI 10.1159/000056791; KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995; Kielty CM, 2002, J CELL SCI, V115, P2817; Kinnman N, 2000, SCAND J GASTROENTERO, V35, P1294, DOI 10.1080/003655200453656; Lorena D, 2004, LAB INVEST, V84, P203, DOI 10.1038/labinvest.3700023; MARTINEZHERNANDEZ A, 1984, LAB INVEST, V51, P57; Menghini R, 2009, GASTROENTEROLOGY, V136, P663, DOI 10.1053/j.gastro.2008.10.079; Montaldo C, 2014, PROTEOMICS, V14, P1107, DOI 10.1002/pmic.201300422; Naba A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-518; Oike Y, 2003, P NATL ACAD SCI USA, V100, P9494, DOI 10.1073/pnas.1531901100; Pellicoro A, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S26; Rashid ST, 2012, J PROTEOME RES, V11, P4052, DOI 10.1021/pr3000927; SANDERSON N, 1995, P NATL ACAD SCI USA, V92, P2572, DOI 10.1073/pnas.92.7.2572; SCHUPPAN D, 1990, J BIOL CHEM, V265, P8823; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Uygun BE, 2010, NAT MED, V16, P814, DOI 10.1038/nm.2170; Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193	27	125	128	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151736	10.1371/journal.pone.0151736	http://dx.doi.org/10.1371/journal.pone.0151736			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998606	Green Published, Green Submitted, gold			2022-12-26	WOS:000372694700059
J	van Lummel, RC; Walgaard, S; Hobert, MA; Maetzler, W; van Dieen, JH; Galindo-Garre, F; Terwee, CB				van Lummel, Rob C.; Walgaard, Stefan; Hobert, Markus A.; Maetzler, Walter; van Dieen, Jaap H.; Galindo-Garre, Francisca; Terwee, Caroline B.			Intra-Rater, Inter-Rater and Test-Retest Reliability of an Instrumented Timed Up and Go (iTUG) Test in Patients with Parkinson's Disease	PLOS ONE			English	Article							FUNCTIONAL REACH; STAND; PERFORMANCE; VALIDITY; BALANCE; PEOPLE	Background The "Timed Up and Go" (TUG) is a widely used measure of physical functioning in older people and in neurological populations, including Parkinson's Disease. When using an inertial sensor measurement system (instrumented TUG [iTUG]), the individual components of the iTUG and the trunk kinematics can be measured separately, which may provide relevant additional information. Objective The aim of this study was to determine intra-rater, inter-rater and test-retest reliability of the iTUG in patients with Parkinson's Disease. Methods Twenty eight PD patients, aged 50 years or older, were included. For the iTUG the DynaPort Hybrid (McRoberts, The Hague, The Netherlands) was worn at the lower back. The device measured acceleration and angular velocity in three directions at a rate of 100 samples/s. Patients performed the iTUG five times on two consecutive days. Repeated measurements by the same rater on the same day were used to calculate intra-rater reliability. Repeated measurements by different raters on the same day were used to calculate intra-rater and inter-rater reliability. Repeated measurements by the same rater on different days were used to calculate test-retest reliability. Results Nineteen ICC values (15%) were >= 0.9 which is considered as excellent reliability. Sixty four ICC values (49%) were >= 0.70 and <0.90 which is considered as good reliability. Thirty one ICC values (24%) were >= 0.50 and < 0.70, indicating moderate reliability. Sixteen ICC values (12%) were >= 0.30 and < 0.50 indicating poor reliability. Two ICT values (2%) were < 0.30 indicating very poor reliability. Conclusions In conclusion, in patients with Parkinson's disease the intra-rater, inter-rater, and test-retest reliability of the individual components of the instrumented TUG (iTUG) was excellent to good for total duration and for turning durations, and good to low for the sub durations and for the kinematics of the SiSt and StSi. The results of this fully automated analysis of instrumented TUG movements demonstrate that several reliable TUG parameters can be identified that provide a basis for a more precise, quantitative use of the TUG test, in clinical practice.	[van Lummel, Rob C.; Walgaard, Stefan] McRoberts BV, The Hague, Netherlands; [van Lummel, Rob C.; van Dieen, Jaap H.] Vrije Univ Amsterdam, Dept Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [Hobert, Markus A.; Maetzler, Walter] Univ Tubingen, Ctr Neurol, Tubingen, Germany; [Hobert, Markus A.; Maetzler, Walter] Univ Tubingen, Dept Neurodegenerat, Hertie Inst Clin Brain Res, Tubingen, Germany; [Hobert, Markus A.; Maetzler, Walter] German Ctr Neurodegenerat Dis, DZNE, Tubingen, Germany; [Galindo-Garre, Francisca; Terwee, Caroline B.] Vrije Univ Amsterdam, Med Ctr, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Galindo-Garre, Francisca; Terwee, Caroline B.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	van Lummel, RC (corresponding author), McRoberts BV, The Hague, Netherlands.; van Lummel, RC (corresponding author), Vrije Univ Amsterdam, Dept Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	r.vanlummel@mcroberts.nl	van Dieen, Jaap/B-3937-2013; Maetzler, Walter/A-6796-2011; Maetzler, Walter/AAE-5831-2020; Hobert, Markus A./AAR-3234-2020	van Dieen, Jaap/0000-0002-7719-5585; Maetzler, Walter/0000-0002-5945-4694; Maetzler, Walter/0000-0002-5945-4694; Hobert, Markus A./0000-0002-7558-8107; Terwee, Caroline/0000-0003-4570-2826				Ahlskog JE, 2001, MOVEMENT DISORD, V16, P448, DOI 10.1002/mds.1090; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Botolfsen P, 2008, PHYSIOTHER RES INT, V13, P94, DOI 10.1002/pri.394; Brusse KJ, 2005, PHYS THER, V85, P134, DOI 10.1093/ptj/85.2.134; Buchman AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086262; de Vet HCW, 2011, MEASUREMENT MED PRAC; de Vet HCW, 2006, J CLIN EPIDEMIOL, V59, P1033, DOI 10.1016/j.jclinepi.2005.10.015; Herman T, 2014, EXP BRAIN RES, V232, P713, DOI 10.1007/s00221-013-3778-8; Lin MR, 2004, J AM GERIATR SOC, V52, P1343, DOI 10.1111/j.1532-5415.2004.52366.x; Martinez-Martin P, 1997, CLIN NEUROPHARMACOL, P13; MATHIAS S, 1986, ARCH PHYS MED REHAB, V67, P387; McGraw KO, 1996, PSYCHOL METHODS, V1, P390, DOI 10.1037//1082-989X.1.4.390; Mirelman A, 2014, J AM GERIATR SOC, V62, P673, DOI 10.1111/jgs.12734; Morris S, 2001, PHYS THER, V81, P810, DOI 10.1093/ptj/81.2.810; O'Suilleabhain P, 2001, J NEUROL NEUROSUR PS, V71, P607, DOI 10.1136/jnnp.71.5.607; Podsiadlo D, J AM GERIATR, P142; Reichmann H, 2010, NEURODEGENER DIS, V7, P284, DOI 10.1159/000314478; Rispens SM, 2014, GAIT POSTURE, V40, P187, DOI 10.1016/j.gaitpost.2014.03.182; Rockwood K, 2000, J GERONTOL A-BIOL, V55, pM70; Salarian A, 2010, IEEE T NEUR SYS REH, V18, P303, DOI 10.1109/TNSRE.2010.2047606; Schoppen T, 1999, ARCH PHYS MED REHAB, V80, P825, DOI 10.1016/S0003-9993(99)90234-4; Van Lummel RC, 2013, GAIT POSTURE, V38, P153, DOI 10.1016/j.gaitpost.2012.10.008; van Lummel RC, 2012, PHYSIOL MEAS, V33, P1855, DOI 10.1088/0967-3334/33/11/1855; Weiss A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068885; Weiss A, 2010, MED ENG PHYS, V32, P119, DOI 10.1016/j.medengphy.2009.10.015; Williamson R, 2001, MED BIOL ENG COMPUT, V39, P294, DOI 10.1007/BF02345283; Yeung TSM, 2008, J ORTHOP SPORT PHYS, V38, P410, DOI [10.2519/jospt.2008.2657, 10.519/jospt.2008.2657]; Zampieri C, 2010, J NEUROL NEUROSUR PS, V81, P171, DOI 10.1136/jnnp.2009.173740	28	42	42	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151881	10.1371/journal.pone.0151881	http://dx.doi.org/10.1371/journal.pone.0151881			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999051	Green Published, gold, Green Submitted			2022-12-26	WOS:000372694700079
J	Andersen, LE; Doyle, AS; del Granado, S; Ledezma, JC; Medinaceli, A; Valdivia, M; Weinhold, D				Andersen, Lykke E.; Doyle, Anna Sophia; del Granado, Susana; Ledezma, Juan Carlos; Medinaceli, Agnes; Valdivia, Montserrat; Weinhold, Diana			Net Carbon Emissions from Deforestation in Bolivia during 1990-2000 and 2000-2010: Results from a Carbon Bookkeeping Model	PLOS ONE			English	Article							LAND-USE CHANGE; ORGANIC-CARBON; SOIL; SEQUESTRATION; EROSION; CO2	Accurate estimates of global carbon emissions are critical for understanding global warming. This paper estimates net carbon emissions from land use change in Bolivia during the periods 1990-2000 and 2000-2010 using a model that takes into account deforestation, forest degradation, forest regrowth, gradual carbon decomposition and accumulation, as well as heterogeneity in both above ground and below ground carbon contents at the 10 by 10 km grid level. The approach permits detailed maps of net emissions by region and type of land cover. We estimate that net CO2 emissions from land use change in Bolivia increased from about 65 million tons per year during 1990-2000 to about 93 million tons per year during 2000-2010, while CO2 emissions per capita and per unit of GDP have remained fairly stable over the sample period. If we allow for estimated biomass increases in mature forests, net CO2 emissions drop to close to zero. Finally, we find these results are robust to alternative methods of calculating emissions.	[Andersen, Lykke E.; Doyle, Anna Sophia; del Granado, Susana; Medinaceli, Agnes; Valdivia, Montserrat] Inst Adv Dev Studies INESAD, CEEMA, La Paz, Bolivia; [Andersen, Lykke E.] Univ Privada Boliviana, La Paz, Bolivia; [Ledezma, Juan Carlos] Conservat Int Bolivia, La Paz, Bolivia; [Weinhold, Diana] Univ London London Sch Econ & Polit Sci, Houghton St, London WC2A 2AE, England	University of London; London School Economics & Political Science	Andersen, LE (corresponding author), Inst Adv Dev Studies INESAD, CEEMA, La Paz, Bolivia.; Andersen, LE (corresponding author), Univ Privada Boliviana, La Paz, Bolivia.	landersen@inesad.edu.bo		Weinhold, Diana/0000-0002-0002-9378	Danida [104.Bolivia.813-203.LPB]; International Development Research Centre through Think Tank Initiative grant [107871-001]	Danida; International Development Research Centre through Think Tank Initiative grant	Some of the authors are benefiting from core funds given to INESAD by Danida (grant no. 104.Bolivia.813-203.LPB) and the International Development Research Centre through Think Tank Initiative grant no. 107871-001. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Achard F, 2014, GLOBAL CHANGE BIOL, V20, P2540, DOI 10.1111/gcb.12605; ANDERSEN L.E., 2002, DYNAMICS DEFORESTATI; Araujo C, 2009, ECOL ECON, V68, P2461, DOI 10.1016/j.ecolecon.2008.12.015; Asosiacion de productores de oleaginosas y trigo, 2010, AS PROD OL TRIG MEM; Baccini A, 2012, NAT CLIM CHANGE, V2, P182, DOI [10.1038/NCLIMATE1354, 10.1038/nclimate1354]; Baker JM, 2007, AGR ECOSYST ENVIRON, V118, P1, DOI 10.1016/j.agee.2006.05.014; Berenguer E, 2014, GLOBAL CHANGE BIOL, V20, P3713, DOI 10.1111/gcb.12627; Berhe A, 2005, SOIL DEGRADATION SOI; Brienen RJW, 2015, NATURE, V519, P344, DOI 10.1038/nature14283; DeFries RS, 2002, P NATL ACAD SCI USA, V99, P14256, DOI 10.1073/pnas.182560099; Derpsch Rolf, 2010, International Journal of Agricultural and Biological Engineering, V3, P1, DOI 10.3965/j.issn.1934-6344.2010.01.001-025; Food and Agriculture Organization of the United Nations, 2010, 163 UN FAO; Food and Agriculture Organization of the United Nations International Institute for Applied Systems Analysis International Soil Reference and Information Centre Institute of Soil Science-Chinese Academy of Sciences Joint Research Centre of the European Commission, 2013, HARM WORLD DAT VERS; Gardi C., 2015, SOIL ATLAS LATIN AM; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Harris NL, 2012, SCIENCE, V336, P1573, DOI 10.1126/science.1217962; Houghton RA, 2010, TELLUS B, V62, P337, DOI 10.1111/j.1600-0889.2010.00473.x; Houghton R. A., 2001, ORNLCDIAC131 US DEP, DOI [10.3334/CDIAC/lue.ndp050,2001, DOI 10.3334/CDIAC/LUE.NDP050]; Houghton RA, 2003, TELLUS B, V55, P378, DOI 10.1034/j.1600-0889.2003.01450.x; HOUGHTON RA, 1983, ECOL MONOGR, V53, P235, DOI 10.2307/1942531; Ibarnegaray V., 2014, COMMUNITY BASED FIRE; Ibisch Pierre, 2003, BIODIVERSIDAD RIQUEZ; IPCC, 2006, IPCC GUID NAT GREENH, P83; Killeen TJ, 2008, ECOL SOC, V13; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R, 2003, ENVIRON INT, V29, P437, DOI 10.1016/S0160-4120(02)00192-7; Li DJ, 2012, NEW PHYTOL, V195, P172, DOI 10.1111/j.1469-8137.2012.04150.x; Loarie SR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037526; Ministerio de Medio Ambiente y Agua Sala de Observacion Bolivia de la Organizacion del Tratado de Cooperacion Amazonica, 2015, MEM TECN MAP BOSQ 20; Oskarsson H, 2004, CATENA, V56, P225, DOI 10.1016/j.catena.2003.10.013; Phillips OL, 2008, PHILOS T R SOC B, V363, P1819, DOI 10.1098/rstb.2007.0033; Rada OP, 2009, 2 COMUNICACION NACL; Ramankutty N, 2007, GLOBAL CHANGE BIOL, V13, P51, DOI 10.1111/j.1365-2486.2006.01272.x; Reis E, 2000, CARBON EMISSIONS DEF, V02; Schlesinger W.H., 1986, CHANGES SOIL CARBON, P194, DOI DOI 10.1007/978-1-4757-1915-4_11; Schlesinger W.H., 1995, BIOTIC FEEDBACKS GLO, V1st, P159; Servicio Nacional de Areas Protegidas, 2013, DEF REG BOSQ BOL SUS; Smith SV, 2001, GLOBAL BIOGEOCHEM CY, V15, P697, DOI 10.1029/2000GB001341; Song XP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126754; Stallard RF, 1998, GLOBAL BIOGEOCHEM CY, V12, P231, DOI 10.1029/98GB00741; UNEP, 2013, EM GAP REP 2013 UNEP; Wang X., 2014, PLOS ONE, V9, DOI [DOI 10.1371/journal.pone.0096299, 10.1371/journal.pone.0096299]; Weinhold D, 2015, GLOBAL ENVIRON CHANG, V35, P391, DOI 10.1016/j.gloenvcha.2015.09.013	43	6	9	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151241	10.1371/journal.pone.0151241	http://dx.doi.org/10.1371/journal.pone.0151241			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990865	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000372582800050
J	Li, WJ; Wang, CC; Shi, ZJ; Wei, Y; Zhou, HL; Deng, K				Li, Wenjie; Wang, Changcheng; Shi, Zejin; Wei, Yi; Zhou, Huailai; Deng, Kun			The Description of Shale Reservoir Pore Structure Based on Method of Moments Estimation	PLOS ONE			English	Article							DENSITY-FUNCTIONAL THEORY; GAS-RESERVOIR; SIZE DISTRIBUTION; SICHUAN BASIN; SURFACE-AREA; BARNETT; ADSORPTION; USANS/SANS; MICROSCOPY; MUDROCKS	Shale has been considered as good gas reservoir due to its abundant interior nanoscale pores. Thus, the study of the pore structure of shale is of great significance for the evaluation and development of shale oil and gas. To date, the most widely used approaches for studying the shale pore structure include image analysis, radiation and fluid invasion methods. The detailed pore structures can be studied intuitively by image analysis and radiation methods, but the results obtained are quite sensitive to sample preparation, equipment performance and experimental operation. In contrast, the fluid invasion method can be used to obtain information on pore size distribution and pore structure, but the relative simple parameters derived cannot be used to evaluate the pore structure of shale comprehensively and quantitatively. To characterize the nanoscale pore structure of shale reservoir more effectively and expand the current research techniques, we proposed a new method based on gas adsorption experimental data and the method of moments to describe the pore structure parameters of shale reservoir. Combined with the geological mixture empirical distribution and the method of moments estimation principle, the new method calculates the characteristic parameters of shale, including the mean pore size ((x) over tilde), standard deviation (sigma), skewness (S-k) and variation coefficient (c). These values are found by reconstructing the grouping intervals of observation values and optimizing algorithms for eigenvalues. This approach assures a more effective description of the characteristics of nanoscale pore structures. Finally, the new method has been applied to analyze the Yanchang shale in the Ordos Basin (China) and Longmaxi shale from the Sichuan Basin (China). The results obtained well reveal the pore characteristics of shale, indicating the feasibility of this new method in the study of the pore structure of shale reservoir.	[Li, Wenjie; Wang, Changcheng; Shi, Zejin; Deng, Kun] Chengdu Univ Technol, Coll Energy Resources, Chengdu, Peoples R China; [Wang, Changcheng; Shi, Zejin; Zhou, Huailai; Deng, Kun] Chengdu Univ Technol, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China; [Wei, Yi] Daqing Oil Field Co, Res Inst Explorat & Dev, Daqing, Peoples R China; [Zhou, Huailai] Chengdu Univ Technol, Coll Geophys, Chengdu, Peoples R China	Chengdu University of Technology; Chengdu University of Technology; Chengdu University of Technology	Wang, CC (corresponding author), Chengdu Univ Technol, Coll Energy Resources, Chengdu, Peoples R China.; Wang, CC (corresponding author), Chengdu Univ Technol, State Key Lab Oil & Gas Reservoir Geol & Exploita, Chengdu, Peoples R China.	wcc-126@163.com		Li, Wenjie/0000-0001-6463-4131	National Natural Science Foundation of China [41272129, 41204091]; Daqing Oil Field Company	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Daqing Oil Field Company	This study supports from the National Natural Science Foundation of China (Grant Numbers 41272129 and 41204091) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Daqing Oil Field Company provided support in the form of a salary for author YW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Al Hinai A, 2014, J UNCONV OIL GAS RES, V8, P1, DOI 10.1016/j.juogr.2014.06.002; BARRETT EP, 1951, J AM CHEM SOC, V73, P373, DOI 10.1021/ja01145a126; Chalmers GR, 2012, AAPG BULL, V96, P1099, DOI 10.1306/10171111052; Chalmers GRL, 2007, INT J COAL GEOL, V70, P223, DOI 10.1016/j.coal.2006.05.001; [陈尚斌 Chen Shangbin], 2012, [煤炭学报, Journal of China Coal Society], V37, P438; China National Petroleum Corporation, 1996, 61541995 SYT CHIN NA; Clarkson CR, 2013, FUEL, V103, P606, DOI 10.1016/j.fuel.2012.06.119; [耳闯 Er Chuang], 2013, [石油与天然气地质, Oil & Gas Geology], V34, P708; EVANS R, 1984, PHYS REV LETT, V52, P557, DOI 10.1103/PhysRevLett.52.557; General Administration of Quality Aupervision Inspection and Quarantine of the People's Republic of China Standardization Administration of the People's Republic of China, 2008, 20082165022008 GBT G; Gregg SJ, 1982, ADSORPTION SURFACE A; Groen JC, 2003, MICROPOR MESOPOR MAT, V60, P1, DOI 10.1016/S1387-1811(03)00339-1; HORVATH G, 1983, J CHEM ENG JPN, V16, P470, DOI 10.1252/jcej.16.470; Javadpour F, 2012, J CAN PETROL TECHNOL, V51, P236, DOI 10.2118/161015-PA; Javadpour F, 2009, J CAN PETROL TECHNOL, V48, P16, DOI 10.2118/09-08-16-DA; Kuila U, 2013, GEOPHYS PROSPECT, V61, P341, DOI 10.1111/1365-2478.12028; Li GN, 2001, PETROL GEOL, V22, P324; Liu SG, 2011, ACTA PETROL SIN, V27, P2239; Liu WQ, 2014, SCI TECH ENG, V14, P11; Loucks RG, 2012, AAPG BULL, V96, P1071, DOI 10.1306/08171111061; Loucks RG, 2009, J SEDIMENT RES, V79, P848, DOI 10.2110/jsr.2009.092; [罗超 Luo Chao], 2014, [地质科技情报, Geological Science and Techology Information], V33, P93; Luo Z.T., 1986, PORE STRUCTURE RESER; Musa Muhammad Afiq Aizuddin, 2011, Journal of Applied Sciences, V11, P3650, DOI 10.3923/jas.2011.3650.3654; Neimark AV, 2009, CARBON, V47, P1617, DOI 10.1016/j.carbon.2009.01.050; Quantachrome, 2009, QUADRASORB SI QUADR; Ravikovitch PI, 2006, LANGMUIR, V22, P11171, DOI 10.1021/la0616146; Ross DJK, 2009, MAR PETROL GEOL, V26, P916, DOI 10.1016/j.marpetgeo.2008.06.004; Ruppert LF, 2013, ENERG FUEL, V27, P772, DOI 10.1021/ef301859s; Seiichi Kondo, 2005, ADSORPTION SCI; SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603; Slatt RM, 2011, AAPG BULL, V95, P2017, DOI 10.1306/03301110145; Sondergeld CH, 2010, UNC GAS C 23 25 FEB; Tiwari P, 2013, FUEL, V107, P547, DOI 10.1016/j.fuel.2013.01.006; [王长城 Wang Changcheng], 2003, [成都理工大学学报. 自然科学版, Journal of Chengdu University of Technology.Science & Technonogy Edition], V30, P280; [王香增 Wang Xiangzeng], 2014, [石油勘探与开发, Petroleum Exploration and Development], V41, P294; [杨峰 Yang Feng], 2014, [天然气地球科学, Natural Gas Geoscience], V25, P618; Yang F, 2014, FUEL, V115, P378, DOI 10.1016/j.fuel.2013.07.040; [杨峰 Yang Feng], 2013, [石油学报, Acta Petrolei Sinica], V34, P301; [杨侃 Yang Kan], 2013, [煤炭学报, Journal of China Coal Society], V38, P817; Zeng Qiu-nan, 2013, Special Oil & Gas Reservoirs, V20, P23, DOI 10.3969/j.issn.1006-6535.2013.01.006; [曾维特 Zeng Weite], 2014, [煤炭学报, Journal of China Coal Society], V39, P1118; [钟太贤 Zhong Taixian], 2012, [天然气工业, Natural Gas Industry], V32, P1; [朱如凯 Zhu Rukai], 2013, [古地理学报, Journal of Palaeogeography], V15, P615; Zou C, 2013, UNCONVENTIONAL PETROLEUM GEOLOGY, P1; Zou CN, 2011, ACTA PETROL SIN, V27, P1857	46	8	8	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151631	10.1371/journal.pone.0151631	http://dx.doi.org/10.1371/journal.pone.0151631			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992168	Green Published, gold, Green Submitted			2022-12-26	WOS:000372582800081
J	Lin, XB; Hou, LJ; Liu, M; Li, XF; Yin, GY; Zheng, YL; Deng, FY				Lin, Xianbiao; Hou, Lijun; Liu, Min; Li, Xiaofei; Yin, Guoyu; Zheng, Yanling; Deng, Fengyu			Gross Nitrogen Mineralization in Surface Sediments of the Yangtze Estuary	PLOS ONE			English	Article							AMMONIA-OXIDIZING BACTERIA; MICROBIAL BIOMASS; WATER INTERFACE; INTERTIDAL SEDIMENTS; N MINERALIZATION; SOIL-NITROGEN; RIVER ESTUARY; EAST CHINA; NITRIFICATION RATES; SEASONAL-VARIATION	Nitrogen mineralization is a key biogeochemical process transforming organic nitrogen to inorganic nitrogen in estuarine and coastal sediments. Although sedimentary nitrogen mineralization is an important internal driver for aquatic eutrophication, few studies have investigated sedimentary nitrogen mineralization in these environments. Sediment-slurry incubation experiments combined with N-15 isotope dilution technique were conducted to quantify the potential rates of nitrogen mineralization in surface sediments of the Yangtze Estuary. The gross nitrogen mineralization (GNM) rates ranged from 0.02 to 5.13 mg N kg(-1) d(-1) in surface sediments of the study area. The GNM rates were generally higher in summer than in winter, and the relative high rates were detected mainly at sites near the north branch and frontal edge of this estuary. The spatial and temporal distributions of GNM rates were observed to depend largely on temperature, salinity, sedimentary organic carbon and nitrogen contents, and extracellular enzyme (urease and L-glutaminase) activities. The total mineralized nitrogen in the sediments of the Yangtze Estuary was estimated to be about 6.17 x 10(5) t N yr(-1), and approximately 37% of it was retained in the estuary. Assuming the retained mineralized nitrogen is totally released from the sediments into the water column, which contributed 12-15% of total dissolved inorganic nitrogen (DIN) sources in this study area. This result indicated that the mineralization process is a significant internal nitrogen source for the overlying water of the Yangtze Estuary, and thus may contribute to the estuarine and coastal eutrophication.	[Lin, Xianbiao; Liu, Min; Li, Xiaofei; Yin, Guoyu; Zheng, Yanling] E China Normal Univ, Coll Geog Sci, Shanghai 200241, Peoples R China; [Hou, Lijun; Deng, Fengyu] E China Normal Univ, State Key Lab Estuarine & Coastal Res, Shanghai 200062, Peoples R China	East China Normal University; East China Normal University	Liu, M (corresponding author), E China Normal Univ, Coll Geog Sci, Shanghai 200241, Peoples R China.; Hou, LJ (corresponding author), E China Normal Univ, State Key Lab Estuarine & Coastal Res, Shanghai 200062, Peoples R China.	ljhou@sklec.ecnu.edu.cn; mliu@geo.ecnu.edu.cn	Li, xiaofei/GXF-7187-2022; Yin, Guoyu/H-3393-2016	Yin, Guoyu/0000-0002-8949-3731; xianbiao, lin/0000-0003-4549-158X	National Natural Science Foundation [41322002, 41371451, 41130525, 41271114, 41071135]; Program for New Century Excellent Talents in University (NCET); State Key Laboratory of Estuarine and Coastal Research	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University (NCET)(Program for New Century Excellent Talents in University (NCET)); State Key Laboratory of Estuarine and Coastal Research	This work was together funded by the National Natural Science Foundation (Nos. 41322002, 41371451, 41130525, 41271114 and 41071135), the Program for New Century Excellent Talents in University (NCET), and the State Key Laboratory of Estuarine and Coastal Research.; This work was together funded by the National Natural Science Foundation (Nos. 41322002, 41371451, 41130525, 41271114 and 41071135), the Program for New Century Excellent Talents in University (NCET), and the State Key Laboratory of Estuarine and Coastal Research. We also thank Wayne S. Gardner and the anonymous reviewers for their constructive suggestions on a preliminary draft of the manuscript.	Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Bai JH, 2012, CLEAN-SOIL AIR WATER, V40, P1099, DOI 10.1002/clen.201200055; Bedard-Haughn A, 2013, NUTR CYCL AGROECOSYS, V95, P159, DOI 10.1007/s10705-013-9555-z; Benbi DK, 2002, BIOL FERT SOILS, V35, P168, DOI 10.1007/s00374-002-0456-6; Bengtsson G, 2003, SOIL BIOL BIOCHEM, V35, P143, DOI 10.1016/S0038-0717(02)00248-1; Bricker SB, 2008, HARMFUL ALGAE, V8, P21, DOI 10.1016/j.hal.2008.08.028; Cabrita MT, 2000, MAR ECOL PROG SER, V202, P51, DOI 10.3354/meps202051; Cabrita MT, 1997, INORGANIC NITROGEN D; Chai C, 2006, HYDROBIOLOGIA, V563, P313, DOI 10.1007/s10750-006-0021-7; Chen YT, 2012, WETLANDS, V32, P579, DOI 10.1007/s13157-012-0295-7; Cloern James E., 1999, Aquatic Ecology, V33, P3, DOI 10.1023/A:1009952125558; Corre MD, 2002, SOIL BIOL BIOCHEM, V34, P445, DOI 10.1016/S0038-0717(01)00198-5; Cui J, 2012, SOIL TILL RES, V123, P50, DOI 10.1016/j.still.2012.03.009; Dai ZJ, 2011, ENVIRON SCI TECHNOL, V45, P223, DOI 10.1021/es103026a; Deng FY, 2015, J GEOPHYS RES-BIOGEO, V120, P1521, DOI 10.1002/2015JG003007; Denis L, 2001, OCEANOL ACTA, V24, P85, DOI 10.1016/S0399-1784(00)01130-0; Di HJ, 2000, AUST J SOIL RES, V38, P213, DOI 10.1071/SR99005; Dunn RJK, 2012, ESTUAR COAST SHELF S, V113, P272, DOI 10.1016/j.ecss.2012.08.016; FRANKENBERGER WT, 1991, BIOL FERT SOILS, V11, P1, DOI 10.1007/BF00335825; Franzluebbers AJ, 2001, SOIL BIOL BIOCHEM, V33, P1103, DOI 10.1016/S0038-0717(01)00016-5; Gao HF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095011; Grenz C, 2010, MAR POLLUT BULL, V61, P399, DOI 10.1016/j.marpolbul.2010.06.014; Hou LJ, 2011, APPL GEOCHEM, V26, P2260, DOI 10.1016/j.apgeochem.2011.08.008; Hou LJ, 2013, J GEOPHYS RES-BIOGEO, V118, P1237, DOI 10.1002/jgrg.20108; Hou LJ, 2012, CONT SHELF RES, V35, P86, DOI 10.1016/j.csr.2012.01.004; Howarth RW, 2008, HARMFUL ALGAE, V8, P14, DOI 10.1016/j.hal.2008.08.015; Huang Q, 2006, REG ENVIRON CHANGE, V6, P125, DOI 10.1007/s10113-005-0001-x; Huygens D, 2013, SSSA BOOK S, V10, P553, DOI 10.2136/sssabookser10.c30; Jin XB, 2012, BIOL FERT SOILS, V48, P363, DOI 10.1007/s00374-011-0631-8; Kalvelage T, 2013, NAT GEOSCI, V6, P228, DOI [10.1038/ngeo1739, 10.1038/NGEO1739]; Keuskamp JA, 2013, SOIL BIOL BIOCHEM, V57, P822, DOI 10.1016/j.soilbio.2012.08.007; Kim TW, 2011, SCIENCE, V334, P505, DOI 10.1126/science.1206583; Kirkham D., 1954, SOIL SCI SOC AM P, V18, P33, DOI DOI 10.2136/SSSAJ1954.03615995001800010009X; Kristensen E, 2000, AQUAT MICROB ECOL, V22, P199, DOI 10.3354/ame022199; Li XA, 2010, STUDIES NUTR BUDGETS, P61; Li Xiang, 2014, ScientificWorldJournal, V2014, P540496, DOI 10.1155/2014/540496; Li XA, 2011, CHIN J OCEANOL LIMN, V29, P762, DOI 10.1007/s00343-011-0505-9; Liu H, 2010, ESTUAR COAST SHELF S, V86, P322, DOI 10.1016/j.ecss.2009.04.020; Liu M, 2006, MAR POLLUT BULL, V52, P1625, DOI 10.1016/j.marpolbul.2006.06.008; Liu SM, 2005, PROG OCEANOGR, V66, P66, DOI 10.1016/j.pocean.2005.03.009; Matheson FE, 2003, BIOL FERT SOILS, V38, P129, DOI 10.1007/s00374-003-0640-3; McCarthy MJ, 2008, ESTUAR COAST, V31, P521, DOI 10.1007/s12237-008-9041-z; Mermillod-Blondin F, 2005, J EXP MAR BIOL ECOL, V315, P187, DOI 10.1016/j.jembe.2004.09.013; Mishra S, 2005, BIOL FERT SOILS, V42, P45, DOI 10.1007/s00374-005-0863-6; Muruganandam S, 2009, SOIL SCI SOC AM J, V73, P751, DOI 10.2136/sssaj2008.0231; Noe GB, 2013, BIOGEOCHEMISTRY, V114, P225, DOI 10.1007/s10533-012-9805-1; Pratihary AK, 2009, ESTUAR COAST SHELF S, V85, P387, DOI 10.1016/j.ecss.2009.08.012; Regehr A, 2015, PLANT SOIL, V391, P353, DOI 10.1007/s11104-015-2438-0; Rietz DN, 2003, SOIL BIOL BIOCHEM, V35, P845, DOI 10.1016/S0038-0717(03)00125-1; Roberts KL, 2012, LIMNOL OCEANOGR, V57, P1427, DOI 10.4319/lo.2012.57.5.1427; Schutt M, 2014, SOIL BIOL BIOCHEM, V69, P320, DOI 10.1016/j.soilbio.2013.11.014; de B MIS, 2015, MAR POLLUT BULL, V91, P483, DOI 10.1016/j.marpolbul.2014.10.028; Silva RG, 2005, NUTR CYCL AGROECOSYS, V71, P259, DOI 10.1007/s10705-004-6378-y; Sinsabaugh RL, 2000, SOIL BIOL BIOCHEM, V32, P2095, DOI 10.1016/S0038-0717(00)00102-4; Xu H, 2013, ESTUAR COAST SHELF S, V127, P59, DOI 10.1016/j.ecss.2013.04.020; Xu ZH, 2008, J SOIL SEDIMENT, V8, P99, DOI 10.1065/jss2008.02.276; Yao P, 2014, CONT SHELF RES, V91, P1, DOI 10.1016/j.csr.2014.08.010; Yin GY, 2014, ENVIRON SCI TECHNOL, V48, P9555, DOI 10.1021/es501261s; Zaman M, 2004, BIOL FERT SOILS, V39, P269, DOI 10.1007/s00374-003-0716-0; Zaman M, 1999, SOIL USE MANAGE, V15, P188, DOI 10.1111/j.1475-2743.1999.tb00087.x; Zaman M, 1999, BIOL FERT SOILS, V29, P178, DOI 10.1007/s003740050542; Zhang J, 2007, PROG OCEANOGR, V74, P449, DOI 10.1016/j.pocean.2007.04.019; Zhang JB, 2012, EUR J SOIL SCI, V63, P75, DOI 10.1111/j.1365-2389.2011.01410.x; Zhang L, 2014, J EARTH SCI-CHINA, V25, P197, DOI 10.1007/s12583-014-0413-y; Zhao Y, 2015, ENVIRON SCI POLLUT R, V22, P17975, DOI 10.1007/s11356-015-4873-0; Zheng YL, 2014, APPL ENVIRON MICROB, V80, P408, DOI 10.1128/AEM.03035-13; Zheng YL, 2013, APPL MICROBIOL BIOT, V97, P8351, DOI 10.1007/s00253-012-4512-3; Zhu C, 2011, ESTUAR COAST SHELF S, V93, P182, DOI 10.1016/j.ecss.2010.08.001; Zhu H.F., 1988, PROCESS DYNAMICS GEO, P166; Zhu TB, 2013, BIOL FERT SOILS, V49, P323, DOI 10.1007/s00374-012-0725-y	70	31	34	10	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151930	10.1371/journal.pone.0151930	http://dx.doi.org/10.1371/journal.pone.0151930			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991904	gold, Green Published, Green Submitted			2022-12-26	WOS:000372582800118
J	Sun, GY; Zhou, ZP; Liu, X; Gai, KX; Liu, QQ; Cha, J; Kaleri, FN; Wang, Y; He, Q				Sun, Guangyan; Zhou, Zhipeng; Liu, Xiao; Gai, Kexin; Liu, Qingqing; Cha, Joonseok; Kaleri, Farah Naz; Wang, Ying; He, Qun			Suppression of WHITE COLLAR-independent frequency Transcription by Histone H3 Lysine 36 Methyltransferase SET-2 Is Necessary for Clock Function in Neurospora	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						circadian rhythm; clock gene; gene transcription; histone modification; Neurospora; SET-2 pathway; WC-independent frq	NEGATIVE FEEDBACK LOOP; CIRCADIAN CLOCK; GENE-EXPRESSION; DNA METHYLATION; LIGHT RESPONSES; PROTEIN; CRASSA; CHROMATIN; PHOSPHORYLATION; RHYTHMS	The circadian system in Neurospora is based on the transcriptional/translational feedback loops and rhythmic frequency (frq) transcription requires the WHITE COLLAR (WC) complex. Our previous paper has shown that frq could be transcribed in a WC-independent pathway in a strain lacking the histone H3K36 methyltransferase, SET-2 (su(var)3-9-enhancer-of-zeste-trithorax-2) (1), but the mechanism was unclear. Here we disclose that loss of histone H3K36 methylation, due to either deletion of SET-2 or H3K36R mutation, results in arrhythmic frq transcription and loss of overt rhythmicity. Histone acetylation at frq locus increases in set-2(KO) mutant. Consistent with these results, loss of H3K36 methylation readers, histone deacetylase RPD-3 (reduced potassium dependence 3) or EAF-3 (essential SAS-related acetyltransferase-associated factor 3), also leads to hyperacetylation of histone at frq locus and WC-independent frq expression, suggesting that proper chromatin modification at frq locus is required for circadian clock operation. Furthermore, a mutant strain with three amino acid substitutions (histone H3 lysine 9, 14, and 18 to glutamine) was generated to mimic the strain with hyperacetylation state of histone H3. H3K9QK14QK18Q mutant exhibits the same defective clock phenotype as rpd-3(KO) mutant. Our results support a scenario in which H3K36 methylation is required to establish a permissive chromatin state for circadian frq transcription by maintaining proper acetylation status at frq locus.	[Sun, Guangyan; Zhou, Zhipeng; Liu, Xiao; Gai, Kexin; Liu, Qingqing; Kaleri, Farah Naz; Wang, Ying; He, Qun] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Sun, Guangyan; Zhou, Zhipeng; Liu, Xiao; Gai, Kexin; Liu, Qingqing; Kaleri, Farah Naz; Wang, Ying; He, Qun] China Agr Univ, Coll Biol Sci, MOA Key Lab Soil Microbiol, Beijing 100193, Peoples R China; [Zhou, Zhipeng] China Agr Univ, Coll Agr & Biotechnol, Beijing 100193, Peoples R China; [Cha, Joonseok] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	China Agricultural University; China Agricultural University; China Agricultural University; University of Texas System; University of Texas Southwestern Medical Center Dallas	He, Q (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.	qunhe@cau.edu.cn	liu, qingqing/HHD-0360-2022; Cha, Joonseok/AAE-9918-2020; Liu, Qing/GWC-9222-2022		State Key Program of National Natural Science of China [31330004]; National Basic Research Program of China [2012CB947600]	State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This project was supported by grants from a project supported by the State Key Program of National Natural Science of China (31330004) and National Basic Research Program of China (973 Program) Grant (2012CB947600) (to Q. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Adhvaryu KK, 2005, EUKARYOT CELL, V4, P1455, DOI 10.1128/EC.4.8.1455-1464.2005; ARONSON BD, 1994, P NATL ACAD SCI USA, V91, P7683, DOI 10.1073/pnas.91.16.7683; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Baker CL, 2012, FEMS MICROBIOL REV, V36, P95, DOI 10.1111/j.1574-6976.2011.00288.x; Belden WJ, 2007, MOL CELL, V25, P587, DOI 10.1016/j.molcel.2007.01.010; Belden WJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002166; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Cha J, 2013, EMBO REP, V14, P923, DOI 10.1038/embor.2013.131; Cheng P, 2002, MOL CELL BIOL, V22, P517, DOI 10.1128/MCB.22.2.517-524.2002; Cheng P, 2001, P NATL ACAD SCI USA, V98, P7408, DOI 10.1073/pnas.121170298; Collett MA, 2001, MOL CELL BIOL, V21, P2619, DOI 10.1128/MCB.21.8.2619-2628.2001; Crosthwaite SK, 1997, SCIENCE, V276, P763, DOI 10.1126/science.276.5313.763; Curtis AM, 2004, J BIOL CHEM, V279, P7091, DOI 10.1074/jbc.M311973200; Dunlap JC, 2006, J BIOL CHEM, V281, P28489, DOI 10.1074/jbc.R600018200; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Froehlich AC, 2003, P NATL ACAD SCI USA, V100, P5914, DOI 10.1073/pnas.1030057100; Garceau NY, 1997, CELL, V89, P469, DOI 10.1016/S0092-8674(00)80227-5; Gooch VD, 2008, EUKARYOT CELL, V7, P28, DOI 10.1128/EC.00257-07; He Q, 2003, EMBO J, V22, P4421, DOI 10.1093/emboj/cdg425; He Q, 2006, GENE DEV, V20, P2552, DOI 10.1101/gad.1463506; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; He QY, 2002, SCIENCE, V297, P840, DOI 10.1126/science.1072795; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Liu X, 2015, MOL CELL BIOL, V35, P2088, DOI 10.1128/MCB.00709-14; Liu Y, 2006, EUKARYOT CELL, V5, P1184, DOI 10.1128/EC.00133-06; Loros JJ, 2001, ANNU REV PHYSIOL, V63, P757, DOI 10.1146/annurev.physiol.63.1.757; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Raduwan H, 2013, J BIOL CHEM, V288, P8380, DOI 10.1074/jbc.M112.359935; Smith KM, 2010, GENETICS, V186, P1207, DOI 10.1534/genetics.110.123315; Smolle M, 2012, NAT STRUCT MOL BIOL, V19, P884, DOI 10.1038/nsmb.2312; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; Wang JY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001232; Xu H, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001132; Xue ZH, 2014, NATURE, V514, P650, DOI 10.1038/nature13671; Yang SL, 2014, NUCLEIC ACIDS RES, V42, P6183, DOI 10.1093/nar/gku261; Yang YH, 2002, GENE DEV, V16, P994, DOI 10.1101/gad.965102; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zhao YB, 2010, J BIOL CHEM, V285, P4355, DOI 10.1074/jbc.M109.034710; Zhou M, 2013, NATURE, V495, P111, DOI 10.1038/nature11833; Zhou ZP, 2013, P NATL ACAD SCI USA, V110, pE4867, DOI 10.1073/pnas.1315133110; Zhou ZP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002712	51	8	9	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11055	11063		10.1074/jbc.M115.711333	http://dx.doi.org/10.1074/jbc.M115.711333			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27002152	Green Published, hybrid			2022-12-26	WOS:000377042100009
J	Wong, BH; Chan, JP; Cazenave-Gassiot, A; Poh, RW; Foo, JC; Galam, DLA; Ghosh, S; Nguyen, LN; Barathi, VA; Yeo, SW; Luu, CD; Wenk, MR; Silver, DL				Wong, Bernice H.; Chan, Jia Pei; Cazenave-Gassiot, Amaury; Poh, Rebecca W.; Foo, Juat Chin; Galam, Dwight L. A.; Ghosh, Sujoy; Nguyen, Long N.; Barathi, Veluchamy A.; Yeo, Sia W.; Luu, Chi D.; Wenk, Markus R.; Silver, David L.			Mfsd2a Is a Transporter for the Essential omega-3 Fatty Acid Docosahexaenoic Acid (DHA) in Eye and Is Important for Photoreceptor Cell Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL-PIGMENT EPITHELIUM; BRAIN; EXPRESSION; PHAGOCYTOSIS; PERICYTES; DISEASE; ORGANIZATION; CLONING; HEALTH; VEGF	Eye photoreceptor membrane discs in outer rod segments are highly enriched in the visual pigment rhodopsin and the omega-3 fatty acid docosahexaenoic acid (DHA). The eye acquires DHA from blood, but transporters for DHA uptake across the blood-retinal barrier or retinal pigment epithelium have not been identified. Mfsd2a is a newly described sodium-dependent lysophosphatidylcholine (LPC) symporter expressed at the blood-brain barrier that transports LPCs containing DHA and other long-chain fatty acids. LPC transport via Mfsd2a has been shown to be necessary for human brain growth. Here we demonstrate that Mfsd2a is highly expressed in retinal pigment epithelium in embryonic eye, before the development of photoreceptors, and is the primary site of Mfsd2a expression in the eye. Eyes from whole body Mfsd2a-deficient (KO) mice, but not endothelium-specific Mfsd2a-deficient mice, were DHA-deficient and had significantly reduced LPC/DHA transport in vivo. Fluorescein angiography indicated normal blood-retinal barrier function. Histological and electron microscopic analysis indicated that Mfsd2a KO mice exhibited a specific reduction in outer rod segment length, disorganized outer rod segment discs, and mislocalization of and reduction in rhodopsin early in postnatal development without loss of photoreceptors. Minor photoreceptor cell loss occurred in adult Mfsd2a KO mice, but electroretinography indicated visual function was normal. The developing eyes of Mfsd2a KO mice had activated microglia and up-regulation of lipogenic and cholesterogenic genes, likely adaptations to loss of LPC transport. These findings identify LPC transport via Mfsd2a as an important pathway for DHA uptake in eye and for development of photoreceptor membrane discs.	[Wong, Bernice H.; Chan, Jia Pei; Galam, Dwight L. A.; Ghosh, Sujoy; Silver, David L.] Duke Natl Univ Singapore, Grad Sch Med, Signature Res Program Cardiovasc & Metab Disorder, 8 Coll Rd, Singapore 169857, Singapore; [Ghosh, Sujoy] Duke Natl Univ Singapore, Grad Sch Med, Ctr Computat Biol, 8 Coll Rd, Singapore 169857, Singapore; [Barathi, Veluchamy A.] Duke Natl Univ Singapore, Grad Sch Med, ACP Ophthalmol, 8 Coll Rd, Singapore 169857, Singapore; [Cazenave-Gassiot, Amaury; Foo, Juat Chin; Wenk, Markus R.] Natl Univ Singapore, Dept Biochem, 8 Med Dr,Block MD 7, Singapore 117597, Singapore; [Poh, Rebecca W.] Carl Zeiss Pte Ltd, Microscopy Business Grp, 50 Kaki Bukit Pl,05-01, Singapore 415926, Singapore; [Nguyen, Long N.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, 5 Sci Dr 2,Bldg MD4,Level 1-03A, Singapore 117545, Singapore; [Barathi, Veluchamy A.; Yeo, Sia W.; Luu, Chi D.] Singapore Eye Res Inst, 11 Third Hosp Ave, Singapore 168751, Singapore; [Barathi, Veluchamy A.] Natl Univ Singapore, Yong Loo Lin Sch Med, 1E Kent Ridge Rd 119228,NUHS Tower Block,Level 11, Singapore 117597, Singapore; [Luu, Chi D.] Ctr Eye Res Australia, Level 1,32 Gisborne St, East Melbourne, Vic 3002, Australia	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Carl Zeiss AG; National University of Singapore; National University of Singapore; Singapore National Eye Center; National University of Singapore; Centre for Eye Research Australia	Silver, DL (corresponding author), Duke Natl Univ Singapore, Grad Sch Med, Signature Res Program Cardiovasc & Metab Disorder, 8 Coll Rd, Singapore 169857, Singapore.	david.silver@duke-nus.edu.sg	Nguyen, Long/AAY-6172-2021; foo, juat chin/AAH-8931-2019; Ghosh, Sujoy/I-3729-2017; Cazenave-Gassiot, Amaury/E-4536-2014	foo, juat chin/0000-0002-9189-4585; Ghosh, Sujoy/0000-0002-7601-165X; Cazenave-Gassiot, Amaury/0000-0002-3050-634X; Nguyen, Long N/0000-0002-9857-2239; Galam, Dwight Lark/0000-0002-1158-1969; Wong, Bernice/0000-0001-8981-1376; Luu, Chi/0000-0002-7604-7097	Singapore Ministry of Health National Medical Research Council [CBRG/069/2014]; Singapore Ministry of Education Tier2 Grant [MOE2014-T2-2-018]; National Medical Research Council [NMRC/CG/SERI/2013]	Singapore Ministry of Health National Medical Research Council(Ministry of Health-SingaporeNational Medical Research Council, Singapore); Singapore Ministry of Education Tier2 Grant(Ministry of Education, Singapore); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Singapore Ministry of Health National Medical Research Council Grant CBRG/069/2014 (to D. L. S.), the Singapore Ministry of Education Tier2 Grant MOE2014-T2-2-018 (to D. L. S.), and National Medical Research Council Grant NMRC/CG/SERI/2013 (to V. A. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Alakbarzade V, 2015, NAT GENET, V47, P814, DOI 10.1038/ng.3313; Amadio M, 2016, PHARMACOL RES, V103, P253, DOI 10.1016/j.phrs.2015.11.027; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; Ben-Zvi A, 2014, NATURE, V509, P507, DOI 10.1038/nature13324; Berger JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050629; BOSCH E, 1993, J HISTOCHEM CYTOCHEM, V41, P253, DOI 10.1177/41.2.8419462; Burgoyne T, 2015, P NATL ACAD SCI USA, V112, P15922, DOI 10.1073/pnas.1509285113; Byrne LC, 2015, MOL THER, V23, P290, DOI 10.1038/mt.2014.181; Castoreno AB, 2005, P NATL ACAD SCI USA, V102, P13129, DOI 10.1073/pnas.0506716102; Chertov AO, 2011, J BIOL CHEM, V286, P34700, DOI 10.1074/jbc.M111.279752; Cho HP, 1999, J BIOL CHEM, V274, P471, DOI 10.1074/jbc.274.1.471; Cho HP, 1999, J BIOL CHEM, V274, P37335, DOI 10.1074/jbc.274.52.37335; Croset M, 2000, BIOCHEM J, V345, P61, DOI 10.1042/0264-6021:3450061; CUNHAVAZ J, 1979, SURV OPHTHALMOL, V23, P279, DOI 10.1016/0039-6257(79)90158-9; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Ding JD, 2015, J CELL BIOL, V211, P495, DOI 10.1083/jcb.201508093; Ethayathulla AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4009; Ferrari S, 2011, CURR GENOMICS, V12, P238, DOI 10.2174/138920211795860107; FLIESLER SJ, 1983, PROG LIPID RES, V22, P79; Guemez-Gamboa A, 2015, NAT GENET, V47, P809, DOI 10.1038/ng.3311; Harris JJ, 2012, NEURON, V75, P762, DOI 10.1016/j.neuron.2012.08.019; Kidd PM, 2007, ALTERN MED REV, V12, P207; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200; Lindsay KJ, 2014, P NATL ACAD SCI USA, V111, P15579, DOI 10.1073/pnas.1412441111; Mustafi D, 2013, FASEB J, V27, P4585, DOI 10.1096/fj.13-237537; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Price BA, 2011, INVEST OPHTH VIS SCI, V52, P9728, DOI 10.1167/iovs.11-8654; Robinson R, 2011, INVEST OPHTH VIS SCI, V52, P7423, DOI 10.1167/iovs.11-7912; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; STEINBERG RH, 1985, DOC OPHTHALMOL, V60, P327, DOI 10.1007/BF00158922; Tual-Chalot S, 2013, JOVE-J VIS EXP, DOI 10.3791/50546; Volland S, 2015, P NATL ACAD SCI USA, V112, P14870, DOI 10.1073/pnas.1516309112; Wang YS, 2012, CELL, V151, P1332, DOI 10.1016/j.cell.2012.10.042; Weisinger HS, 2002, LIPIDS, V37, P759, DOI 10.1007/s11745-002-0958-3; Winkler EA, 2011, NAT NEUROSCI, V14, P1398, DOI 10.1038/nn.2946; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; YOUNG RW, 1976, INVEST OPHTH VISUAL, V15, P700	41	81	84	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10501	10514		10.1074/jbc.M116.721340	http://dx.doi.org/10.1074/jbc.M116.721340			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27008858	Green Published, hybrid			2022-12-26	WOS:000377042600006
J	Angelini, M; Calbi, M; Ferrari, A; Sbriscia-Fioretti, B; Franca, M; Gallese, V; Umilta, MA				Angelini, Monica; Calbi, Marta; Ferrari, Annachiara; Sbriscia-Fioretti, Beatrice; Franca, Michele; Gallese, Vittorio; Umilta, Maria Alessandra			Proactive Control Strategies for Overt and Covert Go/NoGo Tasks: An Electrical Neuroimaging Study	PLOS ONE			English	Article							SUPPLEMENTARY MOTOR AREA; RESPONSE-INHIBITION; CORTEX; PERFORMANCE; SELECTION; PREMOTOR	Proactive and reactive inhibition are generally intended as mechanisms allowing the withholding or suppression of overt movements. Nonetheless, inhibition could also play a pivotal role during covert actions (i.e., potential motor acts not overtly performed, despite the activation of the motor system), such as Motor Imagery (MI). In a previous EEG study, we analyzed cerebral activities reactively triggered during two cued Go/NoGo tasks, requiring execution or withholding of overt or covert imagined actions, respectively. This study revealed activation of pre-supplementary motor area (pre-SMA) and right inferior frontal gyrus (rIFG), key nodes of the network underpinning reactive inhibition of overt responses in NoGo trials, also during MI enactment, enabling the covert nature of the imagined motor response. Taking into account possible proactive engagement of inhibitory mechanisms by cue signals, for an exhaustive interpretation of these previous findings in the present study we analyzed EEG activities elicited during the preparatory phase of our cued overt and covert Go/NoGo tasks. Our results demonstrate a substantial overlap of cerebral areas activated during proactive recruitment and subsequent reactive implementation of motor inhibition in both overt and covert actions; also, different involvement of pre-SMA and rIFG emerged, in accord with the intended type (covert or overt) of incoming motor responses. During preparation of the overt Go/NoGo task, the cue is encoded in a pragmatic mode, as it primes the possible overt motor response programs in motor and premotor cortex and, through preactivation of a pre-SMA-related decisional mechanism, it triggers a parallel preparation for successful response selection and/or inhibition during the response phase. Conversely, the preparatory strategy for the covert Go/NoGo task is centered on priming of an inhibitory mechanism in rIFG, tuned to the instructed covert modality of motor performance and instantiated during subsequent MI, which allows the imagined response to remain a potential motor act.	[Angelini, Monica; Calbi, Marta; Ferrari, Annachiara; Franca, Michele; Gallese, Vittorio] Univ Parma, Unit Physiol, Dept Neurosci, I-43100 Parma, Italy; [Sbriscia-Fioretti, Beatrice] Univ Parma, Azienda Osped, I-43100 Parma, Italy; [Umilta, Maria Alessandra] Univ Parma, Dept Pharm, I-43100 Parma, Italy	University of Parma; University of Parma; University Hospital of Parma; University of Parma	Angelini, M (corresponding author), Univ Parma, Unit Physiol, Dept Neurosci, I-43100 Parma, Italy.	monicaterina@yahoo.it	Gallese, Vittorio/ABD-5097-2021; França, Michele/GQA-6034-2022	Gallese, Vittorio/0000-0003-4815-3607; Calbi, Marta/0000-0001-7555-0611; Umilta', Maria Alessandra/0000-0003-0180-6818	Chiesi Foundation	Chiesi Foundation(Chiesi Pharmaceuticals Inc)	This work was supported by a grant from Chiesi Foundation to VG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson EJ, 2008, NEUROIMAGE, V40, P838, DOI 10.1016/j.neuroimage.2007.10.046; Angelini M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126800; Aron AR, 2014, TRENDS COGN SCI, V18, P177, DOI 10.1016/j.tics.2013.12.003; Aron AR, 2011, BIOL PSYCHIAT, V69, pE55, DOI 10.1016/j.biopsych.2010.07.024; Bari A, 2013, PROG NEUROBIOL, V108, P44, DOI 10.1016/j.pneurobio.2013.06.005; Boulinguez P, 2008, J NEUROPHYSIOL, V99, P1572, DOI 10.1152/jn.01198.2007; Brunet D, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/813870; Carter CS, 1999, REV NEUROSCIENCE, V10, P49; Chen XM, 2010, J NEUROSCI, V30, P14657, DOI 10.1523/JNEUROSCI.2669-10.2010; Chikazoe J, 2009, J NEUROSCI, V29, P15870, DOI 10.1523/JNEUROSCI.3645-09.2009; Duque J, 2010, J NEUROSCI, V30, P3793, DOI 10.1523/JNEUROSCI.5722-09.2010; Fallgatter AJ, 1997, BRAIN TOPOGR, V9, P295, DOI 10.1007/BF01464484; Grezes J, 2001, HUM BRAIN MAPP, V12, P1, DOI 10.1002/1097-0193(200101)12:1<1::AID-HBM10>3.0.CO;2-V; GUTHRIE D, 1991, PSYCHOPHYSIOLOGY, V28, P240, DOI 10.1111/j.1469-8986.1991.tb00417.x; Isoda M, 2007, NAT NEUROSCI, V10, P240, DOI 10.1038/nn1830; Jaffard M, 2007, BRAIN RES, V1179, P106, DOI 10.1016/j.brainres.2007.08.032; Jeannerod M, 1995, CURR OPIN NEUROBIOL, V5, P727, DOI 10.1016/0959-4388(95)80099-9; KALASKA JF, 1995, CEREB CORTEX, V5, P410, DOI 10.1093/cercor/5.5.410; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Macuga KL, 2012, NEUROIMAGE, V59, P2798, DOI 10.1016/j.neuroimage.2011.09.083; Majid DSA, 2013, J NEUROSCI, V33, P13259, DOI 10.1523/JNEUROSCI.5651-12.2013; Manly BFJ., 2017, RANDOMIZATION MONTE, DOI 10.1201/9781315273075; Menendez RGD, 2001, BRAIN TOPOGR, V14, P131, DOI 10.1023/A:1012944913650; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; Mirabella G, 2011, J NEUROPHYSIOL, V106, P1454, DOI 10.1152/jn.00995.2010; Mostofsky SH, 2008, J COGNITIVE NEUROSCI, V20, P751, DOI 10.1162/jocn.2008.20500; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Nachev P, 2007, NEUROIMAGE, V36, pT155, DOI 10.1016/j.neuroimage.2007.03.034; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PERRIN F, 1987, ELECTROEN CLIN NEURO, V66, P75, DOI 10.1016/0013-4694(87)90141-6; Spinelli L, 2000, BRAIN TOPOGR, V13, P115, DOI 10.1023/A:1026607118642; Stuphorn Veit, 2012, Front Neuroeng, V5, P9, DOI 10.3389/fneng.2012.00009; Sumner P, 2008, NEUROSCIENTIST, V14, P474, DOI 10.1177/1073858408314435; Swann NC, 2012, NEUROIMAGE, V59, P2860, DOI 10.1016/j.neuroimage.2011.09.049; Talairach J., 1988, COPLANAR STEREOTAXIC; Van Belle J, 2014, NEUROIMAGE, V103, P65, DOI 10.1016/j.neuroimage.2014.09.014; Zandbelt BB, 2013, HUM BRAIN MAPP, V34, P2015, DOI 10.1002/hbm.22047	37	9	10	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152188	10.1371/journal.pone.0152188	http://dx.doi.org/10.1371/journal.pone.0152188			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010832	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000372708000106
J	Czajka, AA; Wojcicka, A; Kubiak, A; Kotlarek, M; Bakula-Zalewska, E; Koperski, L; Wiechno, W; Jazdzewski, K				Czajka, Agnieszka Anna; Wojcicka, Anna; Kubiak, Anna; Kotlarek, Marta; Bakula-Zalewska, Elwira; Koperski, Lukasz; Wiechno, Wieslaw; Jazdzewski, Krystian			Family of microRNA-146 Regulates RAR beta in Papillary Thyroid Carcinoma	PLOS ONE			English	Article							RETINOIC ACID RECEPTOR; BREAST-CANCER CELLS; LUNG-CANCER; CLINICAL-IMPLICATIONS; GROWTH-INHIBITION; INDUCED DIFFERENTIATION; GENE-EXPRESSION; APOPTOSIS; LINES; SYMPORTER	Retinoic acid is a promising tool in adjuvant cancer therapies, including refractory thyroid cancer, and its biological role is mediated by the retinoic acid receptor beta (RAR beta). However, expression of RAR beta is lowered in papillary thyroid carcinoma (PTC), contributing to promotion of tumor growth and inefficiency of retinoic acid and radioactive iodine treatment. The causes of aberrant RARB expression are largely unknown. We hypothesized that the culpable mechanisms include the action of microRNAs from the miR-146 family, previously identified as significantly upregulated in PTC tumors. To test this hypothesis, we assessed the expression of RARB as well as miR-146a-5p and miR-146b-5p in 48 PTC tumor/normal tissue pairs by Taqman assay to reveal that the expression of RARB was 3.28-fold decreased, and miR-146b-5p was 28.9-fold increased in PTC tumors. Direct interaction between miRs and RARB was determined in the luciferase assay and further confirmed in cell lines, where overexpression of miR-146a-5p and miR-146b-5p caused a 31% and 33% decrease in endogenous RARB mRNA levels. Inhibition of miR-146a and miR-146b resulted in 62.5% and 45.4% increase of RARB, respectively, and a concomitant decrease in proliferation rates of thyroid cancer cell lines, analyzed in xCELLigence system. We showed that two microRNAs of the miR-146 family directly regulate RARB. Inhibition of miRs resulted in restoration of RARB expression and decreased rates of proliferation of thyroid cancer cells. By restoring RARB levels, microRNA inhibitors may become part of an adjuvant therapy in thyroid cancer patients.	[Czajka, Agnieszka Anna; Wojcicka, Anna; Kubiak, Anna; Kotlarek, Marta; Jazdzewski, Krystian] Med Univ Warsaw, Genom Med, Warsaw, Poland; [Czajka, Agnieszka Anna; Wojcicka, Anna; Kubiak, Anna; Kotlarek, Marta; Jazdzewski, Krystian] Univ Warsaw, Lab Human Canc Genet, Ctr New Technol, CENT, Warsaw, Poland; [Bakula-Zalewska, Elwira] Maria Sklodowska Curie Mem Canc Ctr, Dept Pathol, Inst Oncol, Warsaw, Poland; [Koperski, Lukasz] Med Univ Warsaw, Dept Pathol, Warsaw, Poland; [Wiechno, Wieslaw] Med Univ Warsaw, Dept Gen & Thorac Surg, Warsaw, Poland	Medical University of Warsaw; University of Warsaw; Maria Sklodowska-Curie National Research Institute of Oncology; Medical University of Warsaw; Medical University of Warsaw	Jazdzewski, K (corresponding author), Med Univ Warsaw, Genom Med, Warsaw, Poland.; Jazdzewski, K (corresponding author), Univ Warsaw, Lab Human Canc Genet, Ctr New Technol, CENT, Warsaw, Poland.	krystian.jazdzewski@wum.edu.pl	Jazdzewski, Krystian/A-2938-2008; Wojcicka, Anna/K-4134-2012; Koperski, Lukasz/U-4594-2018	Jazdzewski, Krystian/0000-0001-5327-6332; Wojcicka, Anna/0000-0001-5803-6397; Koperski, Lukasz/0000-0001-8163-1813	Polish National Science Centre [2012/07/N/NZ3/01515]; Ministry of Science and Higher Education [0525/IP1/2015/73]; Foundation for Polish Science [7/2011]; European Union European Regional Development Fund; European Union [FP7-REGPOT-2012-CT2012-316254-BASTION]; Laboratory of Genomic Medicine participates in Bastion	Polish National Science Centre; Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); European Union European Regional Development Fund(European Commission); European Union(European Commission); Laboratory of Genomic Medicine participates in Bastion	This work was supported by: Polish National Science Centre grant 2012/07/N/NZ3/01515 (to AAC) (www.nauka.gov.pl); Ministry of Science and Higher Education grant 0525/IP1/2015/73 (to AW) (www.nauka.gov.pl); Foundation for Polish Science, Programme TEAM 7/2011, co-financed by the European Union European Regional Development Fund (to KJ) (www.fnp.org.pl); The Laboratory of Genomic Medicine participates in Bastion, a programme financed by the European Union (FP7-REGPOT-2012-CT2012-316254-BASTION).	ATENCIA R, 1994, EXP CELL RES, V214, P663, DOI 10.1006/excr.1994.1304; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bhaijee F, 2011, ENDOCR PATHOL, V22, P126, DOI 10.1007/s12022-011-9170-y; Carpi A, 2010, J CELL PHYSIOL, V224, P612, DOI 10.1002/jcp.22187; Chang YS, 2004, YONSEI MED J, V45, P435, DOI 10.3349/ymj.2004.45.3.435; Damle N, 2011, INDIAN J NUCL MED, V26, P196, DOI [10.4103/0972-3919.103997, 10.4103/0972-3919.106707]; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Feng QH, 2010, EXP MOL PATHOL, V88, P287, DOI 10.1016/j.yexmp.2010.01.002; GERADTS J, 1993, CELL GROWTH DIFFER, V4, P799; Handkiewicz-Junak D, 2009, THYROID RES, V2, DOI 10.1186/1756-6614-2-8; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Hoftijzer HC, 2009, EUR J ENDOCRINOL, V160, P631, DOI 10.1530/EJE-08-0812; HOULE B, 1993, P NATL ACAD SCI USA, V90, P985, DOI 10.1073/pnas.90.3.985; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jazdzewski K, 2011, J CLIN ENDOCR METAB, V96, pE546, DOI 10.1210/jc.2010-1594; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Jeong HJ, 2006, NUCL MED BIOL, V33, P875, DOI 10.1016/j.nucmedbio.2006.07.004; Kimura ET, 2003, CANCER RES, V63, P1454; Kogai T, 2000, P NATL ACAD SCI USA, V97, P8519, DOI 10.1073/pnas.140217197; Kroll TG, 2002, AM J PATHOL, V160, P1941, DOI 10.1016/S0002-9440(10)61142-X; Li C, 1998, CANCER LETT, V124, P205, DOI 10.1016/S0304-3835(97)00475-8; Li Y, 1998, INT J CANCER, V75, P88, DOI 10.1002/(SICI)1097-0215(19980105)75:1<88::AID-IJC14>3.0.CO;2-9; Liu XX, 2011, P NATL ACAD SCI USA, V108, P774, DOI 10.1073/pnas.1011845108; Liu Y, 1996, MOL CELL BIOL, V16, P1138; Ines FM, 2014, J CELL MOL MED, V18, P1113, DOI 10.1111/jcmm.12256; Oridate N, 1996, CLIN CANCER RES, V2, P855; Schmutzler C, 2004, EUR J ENDOCRINOL, V150, P547, DOI 10.1530/eje.0.1500547; SEEWALDT VL, 1995, CELL GROWTH DIFFER, V6, P1077; Si SP, 1996, EXP CELL RES, V223, P102, DOI 10.1006/excr.1996.0062; Simon D, 2002, EUR J NUCL MED MOL I, V29, P775, DOI 10.1007/s00259-001-0737-6; Swierniak M, 2013, J CLIN ENDOCR METAB, V98, pE1401, DOI 10.1210/jc.2013-1214; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tang M, 2014, ASIAN PAC J CANCER P, V15, P1859, DOI 10.7314/APJCP.2014.15.4.1859; Weber E, 1999, INT J CANCER, V80, P935, DOI 10.1002/(SICI)1097-0215(19990315)80:6<935::AID-IJC21>3.0.CO;2-E; Wolf G, 1996, FASEB J, V10, P1102, DOI 10.1096/fasebj.10.9.8801174; WYLLIE FS, 1993, MOL CARCINOGEN, V7, P83, DOI 10.1002/mc.2940070205; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Xing MZ, 2008, OTOLARYNG CLIN N AM, V41, P1135, DOI 10.1016/j.otc.2008.07.001; Zhang YF, 2007, NUCL MED COMMUN, V28, P251, DOI 10.1097/MNM.0b013e3280708ebf	39	40	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151968	10.1371/journal.pone.0151968	http://dx.doi.org/10.1371/journal.pone.0151968			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27011326	Green Submitted, gold, Green Published			2022-12-26	WOS:000372708000062
J	Menegon, M; Bardaji, A; Martinez-Espinosa, F; Botto-Menezes, C; Ome-Kaius, M; Mueller, I; Betuela, I; Arevalo-Herrera, M; Kochar, S; Kochar, SK; Jaju, P; Hans, D; Chitnis, C; Padilla, N; Castellanos, ME; Ortiz, L; Sanz, S; Piqueras, M; Desai, M; Mayor, A; del Portillo, H; Menendez, C; Severini, C				Menegon, Michela; Bardaji, Azucena; Martinez-Espinosa, Flor; Botto-Menezes, Camila; Ome-Kaius, Maria; Mueller, Ivo; Betuela, Inoni; Arevalo-Herrera, Myriam; Kochar, Swati; Kochar, Sanjay K.; Jaju, Puneet; Hans, Dhiraj; Chitnis, Chetan; Padilla, Norma; Eugenia Castellanos, Maria; Ortiz, Lucia; Sanz, Sergi; Piqueras, Mireia; Desai, Meghna; Mayor, Alfredo; del Portillo, Hernando; Menendez, Clara; Severini, Carlo			Microsatellite Genotyping of Plasmodium vivax Isolates from Pregnant Women in Four Malaria Endemic Countries	PLOS ONE			English	Article							GENETIC DIVERSITY; POPULATION-STRUCTURE; CONGENITAL MALARIA; NATURAL-SELECTION; FALCIPARUM; MARKERS; TRANSMISSION; INFECTION; RELAPSES; EPIDEMIOLOGY	Plasmodium vivax is the most widely distributed human parasite and the main cause of human malaria outside the African continent. However, the knowledge about the genetic variability of P. vivax is limited when compared to the information available for P. falciparum. We present the results of a study aimed at characterizing the genetic structure of P. vivax populations obtained from pregnant women from different malaria endemic settings. Between June 2008 and October 2011 nearly 2000 pregnant women were recruited during routine antenatal care at each site and followed up until delivery. A capillary blood sample from the study participants was collected for genotyping at different time points. Seven P. vivax microsatellite markers were used for genotypic characterization on a total of 229 P. vivax isolates obtained from Brazil, Colombia, India and Papua New Guinea. In each population, the number of alleles per locus, the expected heterozygosity and the levels of multilocus linkage disequilibrium were assessed. The extent of genetic differentiation among populations was also estimated. Six microsatellite loci on 137 P. falciparum isolates from three countries were screened for comparison. The mean value of expected heterozygosity per country ranged from 0.839 to 0.874 for P. vivax and from 0.578 to 0.758 for P. falciparum. P. vivax populations were more diverse than those of P. falciparum. In some of the studied countries, the diversity of P. vivax population was very high compared to the respective level of endemicity. The level of inter-population differentiation was moderate to high in all P. vivax and P. falciparum populations studied.	[Menegon, Michela; Severini, Carlo] Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy; [Bardaji, Azucena; Mueller, Ivo; Sanz, Sergi; Piqueras, Mireia; Mayor, Alfredo; del Portillo, Hernando; Menendez, Clara] Univ Barcelona, Barcelona Ctr Int Hlth Res CRESIB, Hosp Clin, Barcelona, Spain; [Martinez-Espinosa, Flor; Botto-Menezes, Camila] Fundacao Med Trop Amazonas Dr Heitor Vieira Doura, Gerencia Malaria, Manaus, Amazonas, Brazil; [Botto-Menezes, Camila] Univ Estado Amazonas, Manaus, Amazonas, Brazil; [Ome-Kaius, Maria; Mueller, Ivo; Betuela, Inoni] Papua New Guinea Inst Med Res, POB 60, Goroka, Papua N Guinea; [Mueller, Ivo] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Arevalo-Herrera, Myriam] Univ Valle, Ctr Int Vacunas, Fac Hlth, Cali, Colombia; [Kochar, Swati; Kochar, Sanjay K.] Sardar Patel Med Coll, Bikaner, India; [Jaju, Puneet; Hans, Dhiraj; Chitnis, Chetan] Int Ctr Genet Engn & Biotechnol, Malaria Grp, New Delhi, India; [Padilla, Norma; Eugenia Castellanos, Maria; Ortiz, Lucia] Univ Valle Guatemala, Ctr Estudios Salud, Guatemala City, Guatemala; [Desai, Meghna] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Parasit Dis & Malaria, Atlanta, GA USA; [del Portillo, Hernando] Inst Catalana Rec & Estudis Avancats, Barcelona, Spain	Istituto Superiore di Sanita (ISS); ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Universidade do Estado do Amazonas; PNG Institute Of Medical Research; Walter & Eliza Hall Institute; Universidad del Valle; Sardar Patel Medical College, Bikaner; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; Universidad del Valle de Guatemala; Centers for Disease Control & Prevention - USA; ICREA	Severini, C (corresponding author), Ist Super Sanita, Dept Infect Parasit & Immunomediated Dis, Viale Regina Elena 299, I-00161 Rome, Italy.	carlo.severini@iss.it	Padilla, Norma/AFK-6645-2022; Alonso, Azucena Bardají/V-5978-2018; Bardají, Azucena/AAE-9145-2019; Padilla, Norma/AAG-4945-2022; Mayor, Alfredo/H-7488-2017; Sanz, Sergi/AAY-7211-2020; Menéndez, Clara/Q-3446-2016; SEVERINI, CARLO/C-4977-2016; Castellanos, Maria Eugenia/N-5807-2019; del Portillo Obando, Hernando A/L-2131-2014	Alonso, Azucena Bardají/0000-0002-5135-0540; Mayor, Alfredo/0000-0003-3890-2897; Menéndez, Clara/0000-0002-2641-6907; SEVERINI, CARLO/0000-0002-6545-0278; Castellanos, Maria Eugenia/0000-0002-8181-6321; Arevalo, Myriam/0000-0002-3434-9425; del Portillo Obando, Hernando A/0000-0002-5278-3452; Chitnis, Chetan/0000-0002-8773-9865; Sanz Bravo, Sergi/0000-0001-5010-4527	EU [FP7-HEALTH-201588]; Malaria in Pregnancy Consortium; Bill and Melinda Gates Foundation; ICREA Funding Source: Custom	EU(European Commission); Malaria in Pregnancy Consortium; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); ICREA(ICREA)	The PregVax collaborative project was an EU-FP7 funded programme (FP7-HEALTH-201588). This research was also supported by the Malaria in Pregnancy Consortium, which is funded through a grant from the Bill and Melinda Gates Foundation to the Liverpool School of Tropical Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082553; de Brito CFA, 2011, MEM I OSWALDO CRUZ, V106, P12, DOI 10.1590/S0074-02762011000900003; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Arango EM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-392; Arnott A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-14; Carvalho BO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-178; Cattamanchi A, 2003, AM J TROP MED HYG, V68, P133, DOI 10.4269/ajtmh.2003.68.133; Chen NH, 2007, J INFECT DIS, V195, P934, DOI 10.1086/512242; de Araujo FCF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049871; Dolmazon V, 2008, ACTA TROP, V107, P37, DOI 10.1016/j.actatropica.2008.04.012; Escalante AA, 1998, GENETICS, V149, P189; Escalante AA, 2015, AM J TROP MED HYG, V93, P79, DOI 10.4269/ajtmh.15-0005; Castellanos ME, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-411; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gray KA, 2013, SOLOMON ISLANDS MALA, V12, P429, DOI DOI 10.1186/1475-2875-12-429; Gunawardena S, 2014, PARASITOLOGY, V141, P880, DOI 10.1017/S0031182013002278; Hamid Muzamil M Abdel, 2013, N Am J Med Sci, V5, P95, DOI 10.4103/1947-2714.107524; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; HUGHES MK, 1995, MOL BIOCHEM PARASIT, V71, P99, DOI 10.1016/0166-6851(95)00037-2; Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241; Imwong M, 2012, J INFECT DIS, V205, P680, DOI 10.1093/infdis/jir806; Iwagami M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001592; Jennison C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003634; Joshi Hema, 2003, Journal of Vector Borne Diseases, V40, P78; Karunaweera ND, 2007, MOL ECOL NOTES, V7, P172, DOI 10.1111/j.1471-8286.2006.01534.x; Koepfli C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003872; Koepfli C, 2009, J INFECT DIS, V199, P1074, DOI 10.1086/597303; Martinez-Espinosa FE, 2004, MEM I OSWALDO CRUZ, V99, P19, DOI 10.1590/S0074-02762004000100003; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Neafsey DE, 2012, NAT GENET, V44, P1046, DOI 10.1038/ng.2373; Nkhoma SC, 2013, MOL ECOL, V22, P273, DOI 10.1111/mec.12099; Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2; Noviyanti R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003739; Orjuela-Sanchez P, 2013, EXP PARASITOL, V134, P318, DOI 10.1016/j.exppara.2013.03.029; Pumpaibool T, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-155; Rezende AM, 2010, TROP MED INT HEALTH, V15, P718, DOI 10.1111/j.1365-3156.2010.02535.x; Rodriguez-Morales AJ, 2006, AM J TROP MED HYG, V74, P755, DOI 10.4269/ajtmh.2006.74.755; SHOLAPURKAR SL, 1988, T ROY SOC TROP MED H, V82, P376, DOI 10.1016/0035-9203(88)90124-1; Singh N, 2003, ANN TROP MED PARASIT, V97, P875, DOI 10.1179/000349803225002688; Singh N, 1999, B WORLD HEALTH ORGAN, V77, P567; Singh N, 2012, INDIA MALAR J, V11, P274, DOI DOI 10.1186/1475-2875-11-274; Su XZ, 2007, NAT REV GENET, V8, P497, DOI 10.1038/nrg2126; Su XZ, 1996, GENOMICS, V33, P430, DOI 10.1006/geno.1996.0218; Takem EN, 2013, MEDITERR J HEMATOL I, V5, DOI 10.4084/MJHID.2013.010; Thanapongpichat S, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-275; Veron V, 2009, EXP PARASITOL, V121, P346, DOI 10.1016/j.exppara.2008.12.012; Wright S., 1978, EVOLUTION GENETIC PO; Yalcindag E, 2012, P NATL ACAD SCI USA, V109, P511, DOI 10.1073/pnas.1119058109	51	8	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152447	10.1371/journal.pone.0152447	http://dx.doi.org/10.1371/journal.pone.0152447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27011010	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000372708000144
J	Nicholls, S; Pong-Wong, R; Mitchard, L; Harley, R; Archibald, A; Dick, A; Bailey, M				Nicholls, Susan; Pong-Wong, Ricardo; Mitchard, Louisa; Harley, Ross; Archibald, Alan; Dick, Andrew; Bailey, Michael			Genome-Wide Analysis in Swine Associates Corneal Graft Rejection with Donor-Recipient Mismatches in Three Novel Histocompatibility Regions and One Locus Homologous to the Mouse H-3 Locus	PLOS ONE			English	Article							MINIATURE SWINE; ALLOGRAFT-REJECTION; ANTIGENS; TRANSPLANTATION; COMPLEX; GENES; IDENTIFICATION; GENOTYPE	In rodents, immune responses to minor histocompatibility antigens are the most important drivers of corneal graft rejection. However, this has not been confirmed in humans or in a large animal model and the genetic loci are poorly characterised, even in mice. The gene sequence data now available for a range of relevant species permits the use of genome-wide association (GWA) techniques to identify minor antigens associated with transplant rejection. We have used this technique in a pre-clinical model of corneal transplantation in semi-inbred NIH minipigs and Babraham swine to search for novel minor histocompatibility loci and to determine whether rodent findings have wider applicability. DNA from a cohort of MHC-matched and MHC-mismatched donors and recipients was analysed for single nucleotide polymorphisms (SNPs). The level of SNP homozygosity for each line was assessed. Genome-wide analysis of the association of SNP disparities with rejection was performed using log-likelihood ratios. Four genomic blocks containing four or more SNPs significantly linked to rejection were identified (on chromosomes 1, 4, 6 and 9), none at the location of the MHC. One block of 36 SNPs spanned a region that exhibits conservation of synteny with the mouse H-3 histocompatibility locus and contains the pig homologue of the mouse Zfp106 gene, which encodes peptide epitopes known to mediate corneal graft rejection. The other three regions are novel minor histocompatibility loci. The results suggest that rejection can be predicted from SNP analysis prior to transplant in this model and that a similar GWA analysis is merited in humans.	[Nicholls, Susan; Dick, Andrew] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Pong-Wong, Ricardo; Archibald, Alan] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Edinburgh EH9 1QH, Midlothian, Scotland; [Pong-Wong, Ricardo; Archibald, Alan] Univ Edinburgh, RD SVS, Edinburgh, Midlothian, Scotland; [Mitchard, Louisa; Harley, Ross; Bailey, Michael] Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England; [Dick, Andrew] Univ Bristol, Sch Cellular & Mol Med, Bristol, Avon, England; [Dick, Andrew] Moorfields Eye Hosp NHS Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr, London, England; [Dick, Andrew] UCL Inst Ophthalmol, London, England	University of Bristol; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Bristol; University of Bristol; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London	Nicholls, S (corresponding author), Univ Bristol, Sch Clin Sci, Bristol, Avon, England.; Bailey, M (corresponding author), Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England.	s.m.nicholls@bris.ac.uk; michael.bailey@bris.ac.uk		Dick, Andrew/0000-0002-0742-3159; Archibald, Alan/0000-0001-9213-1830; Pong-Wong, Ricardo/0000-0001-9808-2742	Medical Research Council [G0600835]; Biotechnology and Biological Sciences Research Council; National Eye Research Centre Fellowship [RJ3311]; UK Medical Research Council; BBSRC Institute Strategic Programme grants; BBSRC National Capability Grant; National Eye Research Council fellowship; Biotechnology and Biological Sciences Research Council [BBS/E/D/20211550, BBS/E/D/20310000, BBS/E/D/20211553] Funding Source: researchfish; BBSRC [BBS/E/D/20310000, BBS/E/D/20211553, BBS/E/D/20211550] Funding Source: UKRI; MRC [G0600835] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Eye Research Centre Fellowship; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC Institute Strategic Programme grants(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC National Capability Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Eye Research Council fellowship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council G0600835 (www.mrc.ac.uk/) to SN MB AD RH, the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk/) to AA RP-W and the National Eye Research Centre Fellowship RJ3311 to SN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding support was from the UK Medical Research Council. SN was supported by a National Eye Research Council fellowship. ALA, RPW were supported by BBSRC Institute Strategic Programme grants. ARK-Genomics is supported by a BBSRC National Capability Grant. We thank Dr Joanna Murrell for withdrawal of blood for SNP analysis.	CHURCHILL GA, 1994, GENETICS, V138, P963; Fuchimoto Y, 2001, TRANSPLANTATION, V72, P122, DOI 10.1097/00007890-200107150-00024; GRAFF RJ, 1985, J IMMUNOL, V135, P2842; Haskova Z, 2003, TRANSPLANTATION, V75, P1368, DOI 10.1097/01.TP.0000063708.26443.3B; Kreisel D, 2013, TRANSPL INT, V26, P2, DOI 10.1111/j.1432-2277.2012.01549.x; McDonald J.H., 2014, HDB BIOL STAT; Nicholls SM, 2012, LAB ANIM-UK, V46, P59, DOI 10.1258/la.2011.011026; NICHOLLS SM, 1995, EYE, V9, P208, DOI 10.1038/eye.1995.41; NICHOLLS SM, 1991, INVEST OPHTH VIS SCI, V32, P2729; Nicholls Susan M, 2012, Invest Ophthalmol Vis Sci, V53, P3183, DOI 10.1167/iovs.11-9106; O'Brien RP, 2013, CLIN TRANSPLANT, V27, P379, DOI 10.1111/ctr.12093; Oostvogels R, 2014, HAEMATOLOGICA, V99, P1854, DOI 10.3324/haematol.2014.109801; PENNINGTON LR, 1981, TRANSPLANTATION, V32, P315, DOI 10.1097/00007890-198110000-00011; PERARNAU B, 1990, NATURE, V346, P751, DOI 10.1038/346751a0; Ramos AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006524; ROOPENIAN DC, 1980, IMMUNOGENETICS, V10, P333, DOI 10.1007/BF01561583; ROOPENIAN DC, 1989, IMMUNOGENETICS, V30, P335, DOI 10.1007/BF02425273; ROSENGARD BR, 1992, J IMMUNOL, V149, P1099; SACHS DH, 1976, TRANSPLANTATION, V22, P559, DOI 10.1097/00007890-197612000-00004; Sano Y, 1996, Transpl Immunol, V4, P53, DOI 10.1016/S0966-3274(96)80035-9; Signer EN, 1999, RES VET SCI, V67, P207, DOI 10.1053/rvsc.1999.0310; Simpson E, 2002, TRANSPL IMMUNOL, V10, P115, DOI 10.1016/S0966-3274(02)00057-6; Sindhi R, 2008, GASTROENTEROLOGY, V135, P830, DOI 10.1053/j.gastro.2008.05.080; Spaapen RM, 2009, CLIN CANCER RES, V15, P7137, DOI 10.1158/1078-0432.CCR-09-1914; Surquin M, 2002, J IMMUNOL, V169, P500, DOI 10.4049/jimmunol.169.1.500; Zuberi AR, 1998, IMMUNITY, V9, P687, DOI 10.1016/S1074-7613(00)80666-4	26	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152155	10.1371/journal.pone.0152155	http://dx.doi.org/10.1371/journal.pone.0152155			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010211	Green Published, Green Submitted, gold			2022-12-26	WOS:000372708000099
J	Tran, H; Wu, XW; Tithi, S; Sun, MA; Xie, HH; Zhang, LQ				Tran, Hong; Wu, Xiaowei; Tithi, Saima; Sun, Ming-An; Xie, Hehuang; Zhang, Liqing			A Bayesian Assignment Method for Ambiguous Bisulfite Short Reads	PLOS ONE			English	Article							DNA METHYLATION; ALIGNMENT	DNA methylation is an epigenetic modification critical for normal development and diseases. The determination of genome-wide DNA methylation at single-nucleotide resolution is made possible by sequencing bisulfite treated DNA with next generation high-throughput sequencing. However, aligning bisulfite short reads to a reference genome remains challenging as only a limited proportion of them (around 50-70%) can be aligned uniquely; a significant proportion, known as multireads, are mapped to multiple locations and thus discarded from downstream analyses, causing financial waste and biased methylation inference. To address this issue, we develop a Bayesian model that assigns multireads to their most likely locations based on the posterior probability derived from information hidden in uniquely aligned reads. Analyses of both simulated data and real hairpin bisulfite sequencing data show that our method can effectively assign approximately 70% of the multireads to their best locations with up to 90% accuracy, leading to a significant increase in the overall mapping efficiency. Moreover, the assignment model shows robust performance with low coverage depth, making it particularly attractive considering the prohibitive cost of bisulfite sequencing. Additionally, results show that longer reads help improve the performance of the assignment model. The assignment model is also robust to varying degrees of methylation and varying sequencing error rates. Finally, incorporating prior knowledge on mutation rate and context specific methylation level into the assignment model increases inference accuracy. The assignment model is implemented in the BAM-ABS package and freely available at https://github.com/zhanglabvt/BAM_ABS.	[Tran, Hong; Tithi, Saima; Zhang, Liqing] Virginia Polytech Inst & State Univ, Dept Comp Sci, Virginia Tech, Blacksburg, VA 24061 USA; [Wu, Xiaowei] Virginia Polytech Inst & State Univ, Dept Stat, Virginia Tech, Blacksburg, VA 24061 USA; [Sun, Ming-An; Xie, Hehuang] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Virginia Tech, Blacksburg, VA 24061 USA; [Xie, Hehuang] Virginia Polytech Inst & State Univ, Dept Biol Sci, Virginia Tech, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Zhang, LQ (corresponding author), Virginia Polytech Inst & State Univ, Dept Comp Sci, Virginia Tech, Blacksburg, VA 24061 USA.	lqzhang@cs.vt.edu	Sun, Mingan/D-7141-2019; Tithi, Saima Sultana/AAF-4088-2020	Sun, Mingan/0000-0002-4661-3027; 				Chatterjee A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks150; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Guo JU, 2014, NAT NEUROSCI, V17, P215, DOI 10.1038/nn.3607; Guo WL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-774; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Laird CD, 2004, P NATL ACAD SCI USA, V101, P204, DOI 10.1073/pnas.2536758100; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lim JQ, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r82, 10.1186/gb-2012-13-10-R82]; Liu YP, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r61; Lorincz MC, 2001, P NATL ACAD SCI USA, V98, P10034, DOI 10.1073/pnas.201392598; Porter J, 2014, COMP ADV BIO MED SCI; Tran Hong, 2014, Advances in Bioinformatics, V2014, P472045, DOI 10.1155/2014/472045; Xi YP, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-10-S1-S58, 10.1186/1471-2105-10-232]; Zhao L, 2014, GENOME RES, V24, P1296, DOI 10.1101/gr.163147.113; Zhao Z, 2002, GENOME RES, V12, P1679, DOI 10.1101/gr.287302; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	22	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151826	10.1371/journal.pone.0151826	http://dx.doi.org/10.1371/journal.pone.0151826			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27011215	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708000049
J	Gaczynska, M; Karpowicz, P; Stuart, CE; Norton, MG; Teckman, JH; Marszal, E; Osmulski, PA				Gaczynska, Maria; Karpowicz, Przemyslaw; Stuart, Christine E.; Norton, Malgorzata G.; Teckman, Jeffrey H.; Marszal, Ewa; Osmulski, Pawel A.			AFM Imaging Reveals Topographic Diversity of Wild Type and Z Variant Polymers of Human alpha(1)-Proteinase Inhibitor	PLOS ONE			English	Article							LOOP-SHEET POLYMERIZATION; ALPHA(1)-ANTITRYPSIN DEFICIENCY; SERPIN POLYMERIZATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ALPHA-1-ANTITRYPSIN DEFICIENCY; CONFORMATIONAL DISEASE; ENDOPLASMIC-RETICULUM; MASS-SPECTROMETRY; MOLECULAR-BASIS	alpha(1)-Proteinase inhibitor (antitrypsin) is a canonical example of the serpin family member that binds and inhibits serine proteases. The natural metastability of serpins is crucial to carry out structural rearrangements necessary for biological activity. However, the enhanced metastability of the mutant Z variant of antitrypsin, in addition to folding defect, may substantially contribute to its polymerization, a process leading to incurable serpinopathy. The metastability also impedes structural studies on the polymers. There are no crystal structures of Z monomer or any kind of polymers larger than engineered wild type (WT) trimer. Our understanding of polymerization mechanisms is based on biochemical data using in vitro generated WT oligomers and molecular simulations. Here we applied atomic force microscopy (AFM) to compare topography of monomers, in vitro formed WT oligomers, and Z type polymers isolated from transgenic mouse liver. We found the AFM images of monomers closely resembled an antitrypsin outer shell modeled after the crystal structure. We confirmed that the Z variant demonstrated higher spontaneous propensity to dimerize than WT monomers. We also detected an unexpectedly broad range of different types of polymers with periodicity and topography depending on the applied method of polymerization. Short linear oligomers of unit arrangement similar to the Z polymers were especially abundant in heat-treated WT preparations. Long linear polymers were a prominent and unique component of liver extracts. However, the liver preparations contained also multiple types of oligomers of topographies undistinguishable from those found in WT samples polymerized with heat, low pH or guanidine hydrochloride treatments. In conclusion, we established that AFM is an excellent technique to assess morphological diversity of antitrypsin polymers, which is important for etiology of serpinopathies. These data also support previous, but controversial models of in vivo polymerization showing a surprising diversity of polymer topography.	[Gaczynska, Maria; Karpowicz, Przemyslaw; Osmulski, Pawel A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Stuart, Christine E.; Norton, Malgorzata G.; Marszal, Ewa] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD USA; [Teckman, Jeffrey H.] St Louis Univ, Sch Med, Cardinal Glennon Childrens Med Ctr, Dept Pediat & Biochem, St Louis, MO USA; [Karpowicz, Przemyslaw] Univ Gdansk, Dept Med Chem, PL-80952 Gdansk, Poland	University of Texas System; University of Texas Health San Antonio; US Food & Drug Administration (FDA); Saint Louis University; Fahrenheit Universities; University of Gdansk	Osmulski, PA (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA.	Osmulski@uthscsa.edu	Osmulski, Pawel/C-7751-2019; Karpowicz, Przemysław/HGU-5893-2022	Osmulski, Pawel/0000-0002-5359-9200; Karpowicz, Przemyslaw/0000-0003-4912-3709; Teckman, Jeffrey/0000-0002-4870-2621	Alpha-1 Foundation; Texas Higher Education Coordinating Board Norman Hackerman Advanced Research Program; Morrison Foundation; Research Participation Program at the Center for Biologics Evaluation and Research; U.S. Department of Energy; U.S. Food and Drug Administration	Alpha-1 Foundation; Texas Higher Education Coordinating Board Norman Hackerman Advanced Research Program; Morrison Foundation; Research Participation Program at the Center for Biologics Evaluation and Research; U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Food and Drug Administration	The research was supported by the Alpha-1 Foundation Pilot Grant to MG and EM (alpha-1foundation.org), the Texas Higher Education Coordinating Board Norman Hackerman Advanced Research Program (www.arpatp.com) and the Morrison Foundation to PAO, and in part by the Research Participation Program at the Center for Biologics Evaluation and Research administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and the U.S. Food and Drug Administration to CES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JK, 2005, HEPATOLOGY, V41, P160, DOI 10.1002/hep.20508; Benning LN, 2004, PROTEIN SCI, V13, P1859, DOI 10.1110/ps.04715304; Berthelier V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126256; CARLSON JA, 1989, J CLIN INVEST, V83, P1183, DOI 10.1172/JCI113999; CARRELL RW, 1994, STRUCTURE, V2, P257, DOI 10.1016/S0969-2126(00)00028-9; Dunstone MA, 2011, CRYSTALLOGRAPHY SERP; Edrey YH, 2013, AMYLOID BETA LONGEST; Ekeowa UI, 2010, P NATL ACAD SCI USA, V107, P17146, DOI 10.1073/pnas.1004785107; Elliott PR, 2000, PROTEIN SCI, V9, P1274, DOI 10.1110/ps.9.7.1274; Gaczynska M, 2008, CURR OPIN COLLOID IN, V13, P351, DOI 10.1016/j.cocis.2008.01.004; Gaczynska M, 2011, METHODS MOL BIOL, V736, P117, DOI 10.1007/978-1-61779-105-5_9; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gooptu B, 2009, EUR RESPIR J, V34, P475, DOI 10.1183/09031936.00096508; Gooptu B, 2014, TRENDS MOL MED, V20, P116, DOI 10.1016/j.molmed.2013.10.007; Gooptu B, 2009, J MOL BIOL, V387, P857, DOI 10.1016/j.jmb.2009.01.069; Huntington JA, 2011, J THROMB HAEMOST, V9, P26, DOI 10.1111/j.1538-7836.2011.04360.x; Huntington JA, 2011, SERPIN POLYM IN VITR; Huntington JA, 2010, BIOL CHEM, V391, P973, DOI 10.1515/BC.2010.085; Janciauskiene SM, 2011, RESP MED, V105, P1129, DOI 10.1016/j.rmed.2011.02.002; Knaupp AS, 2013, PLOS ONE, P8; Lara C, 2012, BIOMACROMOLECULES, V13, P4213, DOI 10.1021/bm301481v; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; LOMAS DA, 1993, J BIOL CHEM, V268, P15333; LOMAS DA, 1994, CLIN SCI, V86, P489, DOI 10.1042/cs0860489; Marcus NY, 2010, HEPATOL RES, V40, P641, DOI 10.1111/j.1872-034X.2010.00663.x; Marszal E, 2003, J BIOL CHEM, V278, P19611, DOI 10.1074/jbc.M210720200; Marszal E, 2006, ARCH BIOCHEM BIOPHYS, V453, P123, DOI 10.1016/j.abb.2006.03.006; Maurice N, 2012, CTS-CLIN TRANSL SCI, V5, P289, DOI 10.1111/j.1752-8062.2011.00363.x; Nelson DR, 2012, CLIN GASTROENTEROL H, V10, P575, DOI 10.1016/j.cgh.2011.12.028; Nyon MP, 2015, PROTEIN SCI, V24, P1301, DOI 10.1002/pro.2706; Nyon MP, 2012, STRUCTURE, V20, P504, DOI 10.1016/j.str.2012.01.012; Ordonez A, 2015, FASEB J, V29, P2667, DOI 10.1096/fj.14-267351; Ordonez A, 2013, HEPATOLOGY, V57, P2049, DOI 10.1002/hep.26173; Pearce MC, 2007, FEBS J, V274, P3622, DOI 10.1111/j.1742-4658.2007.05897.x; Rosenzweig R, 2008, NAT STRUCT MOL BIOL, V15, P573, DOI 10.1038/nsmb.1427; Rudnick DA, 2004, HEPATOLOGY, V39, P1048, DOI 10.1002/hep.20118; Stockley RA, 2014, TRENDS MOL MED, V20, P105, DOI 10.1016/j.molmed.2013.11.006; Takehara S, 2009, J MOL BIOL, V388, P11, DOI 10.1016/j.jmb.2009.03.007; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V279, pG961, DOI 10.1152/ajpgi.2000.279.5.G961; Teckman JH, 2002, AM J PHYSIOL-GASTR L, V283, pG1156, DOI 10.1152/ajpgi.00041.2002; Tsutsui Y, 2008, J BIOL CHEM, V283, P30804, DOI 10.1074/jbc.M804048200; Tuder Rubin M, 2010, Proc Am Thorac Soc, V7, P381, DOI 10.1513/pats.201002-020AW; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Yamasaki M, 2008, NATURE, V455, P1255, DOI 10.1038/nature07394; Yamasaki M, 2011, EMBO REP, V12, P1011, DOI 10.1038/embor.2011.171; Yamasaki M, 2010, J BIOL CHEM, V285, P30752, DOI 10.1074/jbc.M110.156042; Zhang QW, 2008, J MOL BIOL, V376, P1348, DOI 10.1016/j.jmb.2007.12.050; Zhou A, 2008, J MOL BIOL, V375, P36, DOI 10.1016/j.jmb.2007.10.055	48	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151902	10.1371/journal.pone.0151902	http://dx.doi.org/10.1371/journal.pone.0151902			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008547	Green Submitted, gold, Green Published			2022-12-26	WOS:000372701200073
J	Lo, HC; Hung, CY; Huang, FH; Su, TC; Lee, CH				Lo, Hui-Chen; Hung, Ching-Yi; Huang, Fu-Huan; Su, Tzu-Cheng; Lee, Chien-Hsing			The Nitric Oxide Synthase Inhibitor N-G-Nitro-L-Arginine Methyl Ester Diminishes the Immunomodulatory Effects of Parental Arginine in Rats with Subacute Peritonitis	PLOS ONE			English	Article							L-NAME; IMMUNE-RESPONSE; IN-VIVO; SEPSIS; PERMEABILITY; NUTRITION; MODEL	The combined treatment of parenteral arginine and the nitric oxide synthase inhibitor N-G-nitro-L-arginine methyl ester (L-NAME) have been shown to improve liver function and systemic inflammation in subacute peritonitic rats. Here, we investigated the effects of single and combined parenteral arginine and L-NAME treatments on leukocyte and splenocyte immunity. Male Wistar rats were subjected to cecal punctures and were intravenously given total parenteral nutrition solutions with or without arginine and/or L-NAME supplementations for 7 days. Non-surgical and sham-operated rats with no cecal puncture were given a chow diet and parenteral nutrition, respectively. Parenteral feeding elevated the white blood cell numbers and subacute peritonitis augmented the parenteral nutrition-induced alterations in the loss of body weight gain, splenomegaly, and splenocyte decreases. Parenteral arginine significantly increased the B-leukocyte level, decreased the natural killer T (NKT)-leukocyte and splenocyte levels, alleviated the loss in body weight gain and total and cytotoxic T-splenocyte levels, and attenuated the increases in plasma nitrate/nitrite and interferon-gamma production by T-splenocytes. L-NAME infusion significantly decreased NKT-leukocyte level, tumor-necrosis factor (TNF)-alpha production by T-splenocytes and macrophages, and interferon-gamma production by T-leukocytes, monocytes, and T-splenocytes, as well as increased interleukin-6 production by T-leukocytes andmonocytes and nitrate/nitrite production by T-leukocytes. Combined treatment significantly decreased plasma nitrate/nitrite, the NKT-leukocyte level, and TNF-alpha production by T-splenocytes. Parenteral arginine may attenuate immune impairment and L-NAME infusion may augment leukocyte proinflammatory response, eliminate splenocyte proinflammatory and T-helper 1 responses, and diminish arginine-induced immunomodulation in combined treatment in subacute peritonitic rats.	[Lo, Hui-Chen] Fu Jen Catholic Univ, Dept Nutr Sci, New Taipei, Taiwan; [Hung, Ching-Yi; Huang, Fu-Huan; Lee, Chien-Hsing] China Med Univ, Childrens Hosp, Dept Surg, Div Gen Pediat Surg, Taichung, Taiwan; [Su, Tzu-Cheng] Changhua Christian Hosp, Dept Pathol, Changhua, Taiwan; [Lee, Chien-Hsing] China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan	Fu Jen Catholic University; China Medical University Taiwan; Changhua Christian Hospital; China Medical University Taiwan	Lee, CH (corresponding author), China Med Univ, Childrens Hosp, Dept Surg, Div Gen Pediat Surg, Taichung, Taiwan.; Lee, CH (corresponding author), China Med Univ, Sch Chinese Med, Coll Chinese Med, Taichung, Taiwan.	hsing27566@gmail.com	Lo, Hui-Chen/AAN-5906-2021	Huang, Fu Huan/0000-0002-2747-2900	Changhua Christian Hospital [102-CCH-IRP-025]	Changhua Christian Hospital	This work was supported by 102-CCH-IRP-025, Changhua Christian Hospital.	Angus DC, 2011, JAMA-J AM MED ASSOC, V305, P1469, DOI 10.1001/jama.2011.438; Avontuur JAM, 1998, CHEST, V113, P1640, DOI 10.1378/chest.113.6.1640; Chang YS, 2006, J KOREAN MED SCI, V21, P965, DOI 10.3346/jkms.2006.21.6.965; Chen YH, 2012, JPEN-PARENTER ENTER, V36, P741, DOI 10.1177/0148607111429793; Cui L, 1999, J NUTR, V129, P792, DOI 10.1093/jn/129.4.792; Dioguardi FS, 2011, J NUTRIGENET NUTRIGE, V4, P90, DOI 10.1159/000327777; Dong J, 2013, PERITON DIALYSIS INT, V33, P28, DOI 10.3747/pdi.2011.00236; Ferrier ML, 2001, KIDNEY INT, V60, P2343, DOI 10.1046/j.1523-1755.2001.00050.x; Fukatsu K, 1997, J SURG RES, V68, P79, DOI 10.1006/jsre.1997.5018; Granger DL, 1996, METHOD ENZYMOL, V268, P142; Hirose T, 2014, CLIN NUTR, V33, P179, DOI 10.1016/j.clnu.2013.11.017; Hsiao CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042467; Hsiao CC, 2011, BIOL PHARM BULL, V34, P177, DOI 10.1248/bpb.34.177; Ishikawa K, 2011, CRIT CARE MED, V39, P770, DOI 10.1097/CCM.0b013e318206c1fb; Kalil AC, 2006, CURR OPIN CRIT CARE, V12, P303, DOI 10.1097/01.ccx.0000235206.92697.bf; Krauss H, 2011, CHINESE J PHYSIOL, V54, P7, DOI 10.4077/CJP.2011.AMK011; Lee CH, 2013, J SURG RES, V181, P99, DOI 10.1016/j.jss.2012.05.089; Lo HC, 2010, PEDIATR SURG INT, V26, P625, DOI 10.1007/s00383-010-2582-9; Luiking YC, 2007, CRIT CARE MED, V35, pS557, DOI 10.1097/01.CCM.0000279191.44730.A2; Luiking YC, 2012, AM J PHYSIOL-ENDOC M, V303, pE1177, DOI 10.1152/ajpendo.00284.2012; Mourad FH, 1996, GUT, V39, P539, DOI 10.1136/gut.39.4.539; Ni J, 2005, PERITON DIALYSIS INT, V25, pS11; Riche F, 2013, CRIT CARE, V17, DOI 10.1186/cc12895; SHOU J, 1994, AM J SURG, V167, P145, DOI 10.1016/0002-9610(94)90065-5; Stahl W, 2010, SHOCK, V34, P321, DOI 10.1097/SHK.0b013e3181d758b5; Stupnisek M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123454; TAO RC, 1979, J NUTR, V109, P904, DOI 10.1093/jn/109.5.904; Tisljar M, 2011, COLLEGIUM ANTROPOL, V35, P547; Villalpando S, 2006, AM J CLIN NUTR, V84, P197, DOI 10.1093/ajcn/84.1.197; Wanten GJA, 2015, JPEN-PARENTER ENTER, V39, p33S, DOI 10.1177/0148607115595973; Wijnands KAP, 2015, NUTRIENTS, V7, P1426, DOI 10.3390/nu7031426; Yeh CL, 2002, NUTRITION, V18, P631, DOI 10.1016/S0899-9007(02)00809-2	32	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151973	10.1371/journal.pone.0151973	http://dx.doi.org/10.1371/journal.pone.0151973			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007815	gold, Green Published, Green Submitted			2022-12-26	WOS:000372701200080
J	Niimi, M; Hashimoto, K; Kakuda, W; Miyano, S; Momosaki, R; Ishima, T; Abo, M				Niimi, Masachika; Hashimoto, Kenji; Kakuda, Wataru; Miyano, Satoshi; Momosaki, Ryo; Ishima, Tamaki; Abo, Masahiro			Role of Brain-Derived Neurotrophic Factor in Beneficial Effects of Repetitive Transcranial Magnetic Stimulation for Upper Limb Hemiparesis after Stroke	PLOS ONE			English	Article							MOTOR RECOVERY; BDNF; POLYMORPHISM; ASSOCIATION; MECHANISMS; PROBDNF	Background Repetitive transcranial magnetic stimulation (rTMS) can improve upper limb hemiparesis after stroke but the mechanism underlying its efficacy remains elusive. rTMS seems to alter brain-derived neurotrophic factor (BDNF) and such effect is influenced by BDNF gene polymorphism. Objectives To investigate the molecular effects of rTMS on serum levels of BDNF, its precursor proBDNF and matrix metalloproteinase-9 (MMP-9) in poststroke patients with upper limb hemiparesis. Methods Poststroke patients with upper limb hemiparesis were studied. Sixty-two patients underwent rehabilitation plus rTMS combination therapy and 33 patients underwent rehabilitation monotherapy without rTMS for 14 days at our hospital. One Hz rTMS was applied over the motor representation of the first dorsal interosseous muscle on the non-lesional hemisphere. Fugl-Meyer Assessment and Wolf Motor Function (WMFT) were used to evaluate motor function on the affected upper limb before and after intervention. Blood samples were collected for analysis of BDNF polymorphism and measurement of BDNF, proBDNF and MMP-9 levels. Results Two-week combination therapy increased BDNF and MMP-9 serum levels, but not serum proBDNF. Serum BDNF and MMP-9 levels did not correlate with motor function improvement, though baseline serum proBDNF levels correlated negatively and significantly with improvement in WMFT (rho = -0.422, p = 0.002). The outcome of rTMS therapy was not altered by BDNF gene polymorphism. Conclusions The combination therapy of rehabilitation plus low-frequency rTMS seems to improve motor function in the affected limb, by activating BDNF processing. BDNF and its precursor proBDNF could be potentially suitable biomarkers for poststroke motor recovery.	[Niimi, Masachika; Kakuda, Wataru; Momosaki, Ryo; Abo, Masahiro] Jikei Univ, Sch Med, Dept Rehabil Med, Tokyo, Japan; [Hashimoto, Kenji; Ishima, Tamaki] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan; [Miyano, Satoshi] Tokyo Gen Hosp, Dept Rehabil Med, Tokyo, Japan	Jikei University; Chiba University	Abo, M (corresponding author), Jikei Univ, Sch Med, Dept Rehabil Med, Tokyo, Japan.	abo@jikei.ac.jp	Momosaki, Ryo/H-6486-2018; Hashimoto, Kenji/I-5800-2015	Momosaki, Ryo/0000-0003-3274-3952; Abo, Masahiro/0000-0001-6701-4974; Hashimoto, Kenji/0000-0002-8892-0439				Abo M, 2014, INT J STROKE, V9, P607, DOI 10.1111/ijs.12100; Castren E, 2014, Handb Exp Pharmacol, V220, P461, DOI 10.1007/978-3-642-45106-5_17; Chang WH, 2014, BRAIN STIMUL, V7, P553, DOI 10.1016/j.brs.2014.03.008; Cheeran B, 2008, J PHYSIOL-LONDON, V586, P5717, DOI 10.1113/jphysiol.2008.159905; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; Hashimoto K, 2004, BRAIN RES REV, V45, P104, DOI 10.1016/j.brainresrev.2004.02.003; Hashimoto K, 2015, EUR ARCH PSY CLIN N, V265, P83, DOI 10.1007/s00406-014-0557-x; Hashimoto K, 2014, BRIT J PSYCHIAT, V205, P410, DOI 10.1192/bjp.205.5.410; Hashimoto K, 2014, JAMA NEUROL, V71, P653, DOI 10.1001/jamaneurol.2013.6414; Hashimoto K, 2013, PROG NEUROBIOL, V100, P15, DOI 10.1016/j.pneurobio.2012.09.001; Hashimoto K, 2010, PSYCHIAT CLIN NEUROS, V64, P341, DOI 10.1111/j.1440-1819.2010.02113.x; Itoh K, 2005, AM J MED GENET B, V132B, P70, DOI 10.1002/ajmg.b.30097; Itoh K, 2004, AM J MED GENET B, V124B, P61, DOI 10.1002/ajmg.b.20078; Lefaucheur JP, 2014, CLIN NEUROPHYSIOL, V125, P2150, DOI 10.1016/j.clinph.2014.05.021; Levin R, 2015, J PSYCHIATR RES, V61, P188, DOI 10.1016/j.jpsychires.2014.12.007; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Ludemann-Podubecka J, 2015, PROG BRAIN RES, V218, P281, DOI 10.1016/bs.pbr.2014.12.001; Maeda F, 2000, CLIN NEUROPHYSIOL, V111, P800, DOI 10.1016/S1388-2457(99)00323-5; Mirowska-Guzel D, 2013, NEUROREHABILITATION, V32, P573, DOI 10.3233/NRE-130879; Muller-Dahlhaus F, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00050; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Sodersten K, 2014, J AFFECT DISORDERS, V160, P1, DOI 10.1016/j.jad.2014.01.009; Takeuchi N, 2005, STROKE, V36, P2681, DOI 10.1161/01.STR.0000189658.51972.34; VILLARDITA C, 1985, CORTEX, V21, P627, DOI 10.1016/S0010-9452(58)80010-6; Wang HY, 2011, J NEUROSCI, V31, P11044, DOI 10.1523/JNEUROSCI.2125-11.2011; Ward NS, 2004, ARCH NEUROL-CHICAGO, V61, P1844, DOI 10.1001/archneur.61.12.1844; Wolf SL, 2001, STROKE, V32, P1635, DOI 10.1161/01.STR.32.7.1635; Yoshida T., 2012, OPEN CLIN CHEM J, V5, P7, DOI [10.2174/1874241601205010007, DOI 10.2174/1874241601205010007]; Yoshida T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042676; Yukimasa T, 2006, PHARMACOPSYCHIATRY, V39, P52, DOI 10.1055/s-2006-931542; Zanardini R, 2006, J AFFECT DISORDERS, V91, P83, DOI 10.1016/j.jad.2005.12.029	33	32	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152241	10.1371/journal.pone.0152241	http://dx.doi.org/10.1371/journal.pone.0152241			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007747	Green Submitted, Green Published, gold			2022-12-26	WOS:000372701200116
J	Tan, TRM; Hoi, KM; Zhang, PQ; Ng, SK				Tan, Tessa Rui Min; Hoi, Kong Meng; Zhang, Peiqing; Ng, Say Kong			Characterization of a Polyethylene Glycol-Amphotericin B Conjugate Loaded with Free AMB for Improved Antifungal Efficacy	PLOS ONE			English	Article							SIZE-EXCLUSION CHROMATOGRAPHY; FUNGAL-INFECTIONS; DRUG-DELIVERY; PROTEINS; BINDING; TOXICITY; STEROL; YEAST	Amphotericin B (AMB) is a highly hydrophobic antifungal, whose use is limited by its toxicity and poor solubility. To improve its solubility, AMB was reacted with a functionalized polyethylene glycol (PEG), yielding soluble complex AmB-PEG formulations that theoretically comprise of chemically conjugated AMB-PEG and free AMB that is physically associated with the conjugate. Reverse-phase chromatography and size exclusion chromatography methods using HPLC were developed to separate conjugated AMB-PEG and free AmB, enabling the further characterization of these formulations. Using HPLC and dynamic light scattering analyses, it was observed that the AMB-PEG 2 formulation, having a higher molar ratio of 2 AMB: 1 PEG, possesses more free AMB and has relatively larger particle diameters compared to the AMB-PEG 1 formulation, that consists of 1 AMB: 1 PEG. The identity of the conjugate was also verified using mass spectrometry. AMB-PEG 2 demonstrates improved antifungal efficacy relative to AMB-PEG 1, without a concurrent increase in in vitro toxicity to mammalian cells, implying that the additional loading of free AMB in the AMB-PEG formulation can potentially increase its therapeutic index. Compared to unconjugated AMB, AMB-PEG formulations are less toxic to mammalian cells in vitro, even though their MIC50 values are comparatively higher in a variety of fungal strains tested. Our in vitro results suggest that AMB-PEG 2 formulations are two times less toxic than unconjugated AMB with antifungal efficacy on Candida albicans and Cryptococcus neoformans.	[Tan, Tessa Rui Min; Hoi, Kong Meng; Zhang, Peiqing; Ng, Say Kong] ASTAR, Bioproc Technol Inst, Singapore, Singapore; [Zhang, Peiqing] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117595, Singapore; [Ng, Say Kong] Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); National University of Singapore; National University of Singapore	Ng, SK (corresponding author), ASTAR, Bioproc Technol Inst, Singapore, Singapore.; Ng, SK (corresponding author), Natl Univ Singapore, Fac Sci, Dept Pharm, Singapore 117548, Singapore.	ng_say_kong@bti.a-star.edu.sg			Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore	Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Biomedical Research Council of A*STAR (Agency for Science, Technology and Research), Singapore.	Adams Monica, 2004, J Pharm Pharm Sci, V7, P1; Al-Abdely HM, 1998, ANTIMICROB AGENTS CH, V42, P2542, DOI 10.1128/AAC.42.10.2542; Anderson TM, 2014, NAT CHEM BIOL, V10, P400, DOI 10.1038/nchembio.1496; BARWICZ J, 1992, ANTIMICROB AGENTS CH, V36, P2310, DOI 10.1128/AAC.36.10.2310; Bekersky I, 2002, ANTIMICROB AGENTS CH, V46, P834, DOI 10.1128/AAC.46.3.834-840.2002; Cagnoni PJ, 2000, J CLIN ONCOL, V18, P2476, DOI 10.1200/JCO.2000.18.12.2476; Charvalos E, 2006, J ANTIMICROB CHEMOTH, V57, P236, DOI 10.1093/jac/dki455; CLSI, 2008, M27A3 CLSI; Conover CD, 2003, BIOCONJUGATE CHEM, V14, P661, DOI 10.1021/bc0256594; Cybulska B, 2000, ACTA BIOCHIM POL, V47, P121, DOI 10.18388/abp.2000_4069; Ellis D, 2002, J ANTIMICROB CHEMOTH, V49, P7, DOI 10.1093/jac/49.suppl_1.7; Espada R, 2008, BIOMED CHROMATOGR, V22, P402, DOI 10.1002/bmc.947; Falk R, 1999, ANTIMICROB AGENTS CH, V43, P1975, DOI 10.1128/AAC.43.8.1975; Fridkin SK, 1996, CLIN MICROBIOL REV, V9, P499, DOI 10.1128/CMR.9.4.499; Gabrielson JP, 2007, J PHARM SCI-US, V96, P268, DOI 10.1002/jps.20760; Gray KC, 2012, P NATL ACAD SCI USA, V109, P2234, DOI 10.1073/pnas.1117280109; Graybill JR, 1998, ANTIMICROB AGENTS CH, V42, P147, DOI 10.1128/AAC.42.1.147; Greenwald RB, 2003, ADV DRUG DELIVER REV, V55, P217, DOI 10.1016/S0169-409X(02)00180-1; Hermanson GT, 2013, BIOCONJUGATE TECHNIQUES, 3RD EDITION, P1; Hong P, 2012, J LIQ CHROMATOGR R T, V35, P2923, DOI 10.1080/10826076.2012.743724; KHOO SH, 1994, J ANTIMICROB CHEMOTH, V33, P203, DOI 10.1093/jac/33.2.203; KUNITANI M, 1991, J CHROMATOGR, V588, P125, DOI 10.1016/0021-9673(91)85014-7; Kunji ERS, 2008, METHODS, V46, P62, DOI 10.1016/j.ymeth.2008.10.020; Lemke A, 2005, APPL MICROBIOL BIOT, V68, P151, DOI 10.1007/s00253-005-1955-9; Moen MD, 2009, DRUGS, V69, P361, DOI 10.2165/00003495-200969030-00010; Molek JR, 2006, BIOTECHNOL BIOENG, V95, P474, DOI 10.1002/bit.21020; Olson JA, 2008, ANTIMICROB AGENTS CH, V52, P259, DOI 10.1128/AAC.00870-07; Ostrosky-Zeichner L, 2003, CLIN INFECT DIS, V37, P415, DOI 10.1086/376634; Palacios DS, 2011, P NATL ACAD SCI USA, V108, P6733, DOI 10.1073/pnas.1015023108; Pecora R, 1985, BER BUNSEN PHYS CHEM, DOI DOI 10.1002/BBPC.19870910455; SABRA R, 1990, DRUG SAFETY, V5, P94, DOI 10.2165/00002018-199005020-00003; Sedlak M, 2001, BIOORG MED CHEM LETT, V11, P2833, DOI 10.1016/S0960-894X(01)00532-7; Sedlak M, 2007, BIOORGAN MED CHEM, V15, P4069, DOI 10.1016/j.bmc.2007.03.083; Stulik K, 2003, J BIOCHEM BIOPH METH, V56, P1, DOI 10.1016/S0165-022X(03)00053-8; Tiphine M, 1999, Transpl Infect Dis, V1, P273; Torrado JJ, 2008, J PHARM SCI-US, V97, P2405, DOI 10.1002/jps.21179; Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0; Wei GT, 1999, ANAL CHEM, V71, P2085, DOI 10.1021/ac990044u; Wilcock BC, 2013, J AM CHEM SOC, V135, P8488, DOI 10.1021/ja403255s; YAMASHITA K, 1995, J AM CHEM SOC, V117, P6249, DOI 10.1021/ja00128a011	40	15	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152112	10.1371/journal.pone.0152112	http://dx.doi.org/10.1371/journal.pone.0152112			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008086	Green Published, Green Submitted, gold			2022-12-26	WOS:000372701200094
J	Mukhamedshina, YO; Garanina, EE; Masgutova, GA; Galieva, LR; Sanatova, ER; Chelyshev, YA; Rizvanov, AA				Mukhamedshina, Yana O.; Garanina, Ekaterina E.; Masgutova, Galina A.; Galieva, Luisa R.; Sanatova, Elvira R.; Chelyshev, Yurii A.; Rizvanov, Albert A.			Assessment of Glial Scar, Tissue Sparing, Behavioral Recovery and Axonal Regeneration following Acute Transplantation of Genetically Modified Human Umbilical Cord Blood Cells in a Rat Model of Spinal Cord Contusion	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; FUNCTIONAL RECOVERY; GENE-THERAPY; INJURY; VEGF	Objective and Methods This study investigated the potential for protective effects of human umbilical cord blood mononuclear cells (UCB-MCs) genetically modified with the VEGF and GNDF genes on contusion spinal cord injury (SCI) in rats. An adenoviral vector was constructed for targeted delivery of VEGF and GDNF to UCB-MCs. Using a rat contusion SCI model we examined the efficacy of the construct on tissue sparing, glial scar severity, the extent of axonal regeneration, recovery of motor function, and analyzed the expression of the recombinant genes VEGF and GNDF in vitro and in vivo. Results Transplantation of UCB-MCs transduced with adenoviral vectors expressing VEGF and GDNF at the site of SCI induced tissue sparing, behavioral recovery and axonal regeneration comparing to the other constructs tested. The adenovirus encoding VEGF and GDNF for transduction of UCB-MCs was shown to be an effective and stable vehicle for these cells in vivo following the transplantation into the contused spinal cord. Conclusion Our results show that a gene delivery using UCB-MCs-expressing VEGF and GNDF genes improved both structural and functional parameters after SCI. Further histological and behavioral studies, especially at later time points, in animals with SCI after transplantation of genetically modified UCB-MCs (overexpressing VEGF and GDNF genes) will provide additional insight into therapeutic potential of such cells.	[Mukhamedshina, Yana O.; Garanina, Ekaterina E.; Masgutova, Galina A.; Galieva, Luisa R.; Sanatova, Elvira R.; Rizvanov, Albert A.] Kazan Volga Reg Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia; [Chelyshev, Yurii A.] Kazan State Med Univ, Dept Histol, Kazan, Russia	Kazan Federal University; Kazan State Medical University	Rizvanov, AA (corresponding author), Kazan Volga Reg Fed Univ, Inst Fundamental Med & Biol, Kazan, Russia.	rizvanov@gmail.com	Chelyshev, Yuri/P-9412-2015; Rizvanov, Albert/H-4486-2013; Cherenkova, Ekateruna/D-5136-2014; Akhmetzyanova, Elvira/Q-8062-2017	Rizvanov, Albert/0000-0002-9427-5739; Akhmetzyanova, Elvira/0000-0002-5751-6759	Russian Foundation [15-0407527, 14-04-31246]; Russian Federation [MK-4020.2015.7]; Ministry of Education of Russia [RFMEFI59414X0003]; Interdisciplinary Center for Analytical Microscopy; Pharmaceutical Research and Education Center, Kazan (Volga Region) Federal University, Kazan, Russia	Russian Foundation(Russian Foundation for Basic Research (RFBR)); Russian Federation(Russian Federation); Ministry of Education of Russia; Interdisciplinary Center for Analytical Microscopy; Pharmaceutical Research and Education Center, Kazan (Volga Region) Federal University, Kazan, Russia	The study was supported by grants 15-0407527 (A.A. Rizvanov) and 14-04-31246 (Y.O. Mukhamedshina) from Russian Foundation for Basic Research. Y.O. Mukhamedshina was supported by a Presidential Grant for government support of young scientists (PhD) from the Russian Federation (MK-4020.2015.7). This work was performed in accordance with Program of Competitive Growth of Kazan Federal University and a subsidy allocated to Kazan Federal University for the state assignment in the sphere of scientific activities. Some of the experiments were conducted using equipment at the Interdisciplinary Center for Collective Use of Kazan Federal University supported by Ministry of Education of Russia (ID RFMEFI59414X0003), Interdisciplinary Center for Analytical Microscopy, and Pharmaceutical Research and Education Center, Kazan (Volga Region) Federal University, Kazan, Russia.	Antonic A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001738; Barbour HR, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-106; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Cheng H, 2002, J NEUROSCI RES, V69, P397, DOI 10.1002/jnr.10303; Deng LX, 2011, EXP NEUROL, V229, P238, DOI 10.1016/j.expneurol.2011.02.001; Gluckman E, 2000, CURR OPIN HEMATOL, V7, P353, DOI 10.1097/00062752-200011000-00006; Ikeda Y, 2004, HYPERTENS RES, V27, P119, DOI 10.1291/hypres.27.119; Islamov RR, 2004, NEUROREPORT, V15, P2117, DOI 10.1097/00001756-200409150-00024; Islamov RR, 2015, CURR GENE THER, V15, P266, DOI 10.2174/1566523215666150126122317; Jin H, 2009, SPINE, V34, pE952, DOI 10.1097/BRS.0b013e3181c4af80; Jones LL, 2001, J PHYSIOL-LONDON, V533, P83, DOI 10.1111/j.1469-7793.2001.0083b.x; Kim HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004987; Kuh SU, 2005, ACTA NEUROCHIR, V147, P985, DOI 10.1007/s00701-005-0538-y; Lebedev SV, 2008, B EXP BIOL MED+, V146, P489, DOI 10.1007/s10517-009-0328-2; Lin Wei-Ting, 2013, PLoS ONE, V8, P1; Lutton C, 2012, J NEUROTRAUM, V29, P957, DOI 10.1089/neu.2010.1423; Mackenzie F, 2012, DEVELOPMENT, V139, P1371, DOI 10.1242/dev.072348; Mills CD, 2007, MOL CELL NEUROSCI, V36, P185, DOI 10.1016/j.mcn.2007.06.011; Mukhamedshina YO, 2016, SPINAL CORD, V54, P347, DOI 10.1038/sc.2015.161; Mukhamedshina YO, 2012, CELLULAR TRANSPLANTA, V7, P125; Park S, 2012, EURASIP J ADV SIG PR, DOI 10.1186/1687-6180-2012-36; Rodrigues LP, 2012, BRAZ J MED BIOL RES, V45, P49, DOI 10.1590/S0100-879X2011007500162; Rosenstein JM, 1998, P NATL ACAD SCI USA, V95, P7086, DOI 10.1073/pnas.95.12.7086; Sondell M, 1999, J NEUROSCI, V19, P5731, DOI 10.1523/JNEUROSCI.19-14-05731.1999; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Weiss ML, 2006, STEM CELL REV, V2, P155, DOI 10.1007/s12015-006-0022-y; Yan Hui-bo, 2009, Zhonghua Wai Ke Za Zhi, V47, P1817; Zhang LQ, 2009, GLIA, V57, P1178, DOI 10.1002/glia.20840	28	20	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151745	10.1371/journal.pone.0151745	http://dx.doi.org/10.1371/journal.pone.0151745			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003408	Green Submitted, gold, Green Published			2022-12-26	WOS:000372697400041
J	Storrie, S; Longbottom, D; Barlow, PG; Wheelhouse, N				Storrie, Skye; Longbottom, David; Barlow, Peter G.; Wheelhouse, Nick			MAPK Activation Is Essential for Waddlia chondrophila Induced CXCL8 Expression in Human Epithelial Cells	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS INFECTION; ABORTED BOVINE FETUS; INTERLEUKIN-8; RECEPTOR; RICKETTSIA; SAMPLES; NOD1	Background Waddlia chondrophila (W. chondrophila) is an emerging agent of respiratory and reproductive disease in humans and cattle. The organism is a member of the order Chlamydiales, and shares many similarities at the genome level and in growth studies with other well-characterised zoonotic chlamydial agents, such as Chlamydia abortus (C. abortus). The current study investigated the growth characteristics and innate immune responses of human and ruminant epithelial cells in response to infection with W. chondrophila. Methods Human epithelial cells (HEp2) were infected with W. chondrophila for 24h. CXCL8 release was significantly elevated in each of the cell lines by active-infection with live W. chondrophila, but not by exposure to UV-killed organisms. Inhibition of either p38 or p42/44 MAPK significantly inhibited the stimulation of CXCL8 release in each of the cell lines. To determine the pattern recognition receptor through which CXCL8 release was stimulated, wildtype HEK293 cells which express no TLR2, TLR4, NOD2 and only negligible NOD1 were infected with live organisms. A significant increase in CXCL8 was observed. Conclusions/Significance W. chondrophila actively infects and replicates within both human and ruminant epithelial cells stimulating CXCL8 release. Release of CXCL8 is significantly inhibited by inhibition of either p38 or p42/44 MAPK indicating a role for this pathway in the innate immune response to W. chondrophila infection. W. chondrophila stimulation of CXCL8 secretion in HEK293 cells indicates that TLR2, TLR4, NOD2 and NOD1 receptors are not essential to the innate immune response to infection.	[Storrie, Skye; Longbottom, David; Wheelhouse, Nick] Moredun Res Inst, Pentlands Sci Pk, Edinburgh EH26 0PZ, Midlothian, Scotland; [Barlow, Peter G.; Wheelhouse, Nick] Edinburgh Napier Univ, Sch Life Sport & Social Sci, Sighthill Campus, Edinburgh EH11 4BN, Midlothian, Scotland	Moredun Research Institute; Edinburgh Napier University	Wheelhouse, N (corresponding author), Edinburgh Napier Univ, Sch Life Sport & Social Sci, Sighthill Campus, Edinburgh EH11 4BN, Midlothian, Scotland.	n.wheelhouse@napier.ac.uk	Longbottom, David/GWZ-8448-2022; Barlow, Peter/O-4078-2019	Longbottom, David/0000-0003-0086-8443; Barlow, Peter/0000-0002-6516-9312; Wheelhouse, Nick/0000-0002-2803-0055; Molodiuc, Veaceslav/0000-0002-3014-4203	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS); Industrial partnership award - Biotechnology and Biological Sciences Research Council (BBSRC); Zoetis [BB/J015083/1]; BBSRC [BB/J015083/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J015083/1] Funding Source: researchfish	Scottish Government Rural and Environment Science and Analytical Services Division (RESAS); Industrial partnership award - Biotechnology and Biological Sciences Research Council (BBSRC); Zoetis; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Scottish Government Rural and Environment Science and Analytical Services Division (RESAS, http://www.scotland.gov.uk) and through the Industrial partnership award awarded by the Biotechnology and Biological Sciences Research Council (BBSRC, http://www.bbsrc.ac.uk/) and Zoetis (grant no. BB/J015083/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aistleitner K, 2015, ENVIRON MICROBIOL, V17, P1397, DOI 10.1111/1462-2920.12621; Baud D, 2007, EMERG INFECT DIS, V13, P1239, DOI 10.3201/eid1308.070315; Bertelli C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010890; Buchholz KR, 2008, INFECT IMMUN, V76, P3150, DOI 10.1128/IAI.00104-08; Buchholz KR, 2007, INFECT IMMUN, V75, P5924, DOI 10.1128/IAI.01029-07; Buchholz KR, 2006, CELL MICROBIOL, V8, P1768, DOI 10.1111/j.1462-5822.2006.00747.x; DILBECK PM, 1990, J CLIN MICROBIOL, V28, P814, DOI 10.1128/JCM.28.4.814-816.1990; Dille S, 2015, INFECT IMMUN, V83, P3268, DOI 10.1128/IAI.00322-15; Fukuda EY, 2005, INFECT IMMUN, V73, P4017, DOI 10.1128/IAI.73.7.4017-4024.2005; Haider S, 2008, FEMS MICROBIOL LETT, V281, P198, DOI 10.1111/j.1574-6968.2008.01099.x; Hii CS, 2008, J INFECT DIS, V197, P1537, DOI 10.1086/587905; Jacquier N, 2015, CHEM BIOL, V22, P1217, DOI 10.1016/j.chembiol.2015.08.009; Kebbi-Beghdadi C, 2011, MICROBES INFECT, V13, P566, DOI 10.1016/j.micinf.2011.01.020; KOCAN KM, 1990, J BACTERIOL, V172, P5949, DOI 10.1128/jb.172.10.5949-5955.1990; Krull M, 2004, INFECT IMMUN, V72, P6615, DOI 10.1128/IAI.72.11.6615-6621.2004; Lienard J, 2011, J CLIN MICROBIOL, V49, P2637, DOI 10.1128/JCM.00114-11; Verweij SP, 2015, MICROBES INFECT; Welter-Stahl L, 2006, CELL MICROBIOL, V8, P1047, DOI 10.1111/j.1462-5822.2006.00686.x; Wheelhouse N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102386; Wheelhouse N, 2009, J REPROD IMMUNOL, V80, P49, DOI 10.1016/j.jri.2008.12.003; Zhou H, 2013, SCI CHINA LIFE SCI, V56, P460, DOI 10.1007/s11427-013-4470-8	21	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152193	10.1371/journal.pone.0152193	http://dx.doi.org/10.1371/journal.pone.0152193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002636	Green Published, gold, Green Submitted			2022-12-26	WOS:000372697400091
J	Evans, NJ; Bayliss, AL; Reale, V; Evans, PD				Evans, Nicholas J.; Bayliss, Asha L.; Reale, Vincenzina; Evans, Peter D.			Characterisation of Signalling by the Endogenous GPER1 (GPR30) Receptor in an Embryonic Mouse Hippocampal Cell Line (mHippoE-18)	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; ESTROGEN-RECEPTOR; ADENYLYL-CYCLASE; EXPRESSION; RESPONSES; AGONIST; G-PROTEIN-COUPLED-RECEPTOR-30; 17-BETA-ESTRADIOL; IDENTIFICATION; ALDOSTERONE	Estrogen can modulate neuronal development and signalling by both genomic and non-genomic pathways. Many of its rapid, non-genomic effects on nervous tissue have been suggested to be mediated via the activation of the estrogen sensitive G-protein coupled receptor (GPER1 or GPR30). There has been much controversy over the cellular location, signalling properties and endogenous activators of GPER1. Here we describe the pharmacology and signalling properties of GPER1 in an immortalized embryonic hippocampal cell line, mHippoE-18. This cell line does not suffer fromthe inherent problems associated with the study of this receptor in native tissue or the problems associated with heterologously expression in clonal cell lines. In mHippoE-18 cells, 17 beta-Estradiol can mediate a dose-dependent rapid potentiation of forskolin- stimulated cyclic AMP levels but does not appear to activate the ERK1/2 pathway. The effect of 17 beta-Estradiol can bemimicked by the GPER1 agonist, G1, and also by tamoxifen and ICI 182,780 which activate GPER1 in a variety of other preparations. The response is not mimicked by the application of the classical estrogen receptor agonists, PPT, (an ER alpha agonist) or DPN, (an ER beta agonist), further suggesting that this effect of 17 beta-Estradiol is mediated through the activation of GPER1. However, after exposure of the cells to the GPER1 specific antagonists, G15 and G36, the stimulatory effects of the above agonists are replaced by dose-dependent inhibitions of forskolin-stimulated cyclic AMP levels. This inhibitory effect is mimicked by aldosterone in a dose-dependent way even in the absence of the GPER1 antagonists. The results are discussed in terms of possible "Biased Antagonism" whereby the antagonists change the conformation of the receptor resulting in changes in the agonist induced coupling of the receptor to different secondmessenger pathways.	[Evans, Nicholas J.; Bayliss, Asha L.; Reale, Vincenzina; Evans, Peter D.] Babraham Inst, Signalling Lab, Cambridge CB22 3AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Evans, PD (corresponding author), Babraham Inst, Signalling Lab, Cambridge CB22 3AT, England.	peter.evans@babraham.ac.uk		Evans, Nicholas/0000-0002-7419-7761	Wellcome Trust Vacation Scholarship; BBSRC through the Babraham Institute; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C194] Funding Source: researchfish; BBSRC [BBS/E/B/0000C194] Funding Source: UKRI	Wellcome Trust Vacation Scholarship(Wellcome Trust); BBSRC through the Babraham Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	NJE was supported by a Wellcome Trust Vacation Scholarship. ALB, VR and PDE were supported via the BBSRC through the Babraham Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airriess CN, 1997, BRIT J PHARMACOL, V122, P191, DOI 10.1038/sj.bjp.0701348; Akama KT, 2013, J BIOL CHEM, V288, P6438, DOI 10.1074/jbc.M112.412478; Ashton AW, 2015, MOL ENDOCRINOL, V29, P1144, DOI 10.1210/ME.2014-1410; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Balmanno K, 1999, ONCOGENE, V18, P3085, DOI 10.1038/sj.onc.1202647; Barton M, 2015, TRENDS ENDOCRIN MET, V26, P396, DOI 10.1016/j.tem.2015.05.005; Bayliss A, 2013, J NEUROCHEM, V125, P37, DOI 10.1111/jnc.12158; Bayliss AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080833; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Broselid S, 2014, J BIOL CHEM, V289, P22117, DOI 10.1074/jbc.M114.566893; Burman C, 2010, INVERTEBR NEUROSCI, V10, P93, DOI 10.1007/s10158-010-0111-0; Burman C, 2009, J NEUROCHEM, V111, P26, DOI 10.1111/j.1471-4159.2009.06295.x; Cheng SB, 2014, MOL CELL ENDOCRINOL, V382, P950, DOI 10.1016/j.mce.2013.11.005; Cheng SB, 2011, J BIOL CHEM, V286, P22441, DOI 10.1074/jbc.M111.224071; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Dennis MK, 2011, J STEROID BIOCHEM, V127, P358, DOI 10.1016/j.jsbmb.2011.07.002; Dennis MK, 2009, NAT CHEM BIOL, V5, P421, DOI 10.1038/nchembio.168; EASON MG, 1992, J BIOL CHEM, V267, P15795; Evans PD, 1995, PROG BRAIN RES, V106, P259; Evans PD, 2014, GEN COMP ENDOCR, V195, P157, DOI 10.1016/j.ygcen.2013.10.015; Filardo EJ, 2012, ENDOCRINOLOGY, V153, P2953, DOI 10.1210/en.2012-1061; Filardo EJ, 2005, TRENDS ENDOCRIN MET, V16, P362, DOI 10.1016/j.tem.2005.08.005; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; FRASER CM, 1989, J BIOL CHEM, V264, P11754; Funakoshi T, 2006, BIOCHEM BIOPH RES CO, V346, P904, DOI 10.1016/j.bbrc.2006.05.191; Gingerich S, 2010, NEUROSCIENCE, V170, P54, DOI 10.1016/j.neuroscience.2010.06.076; Gros R, 2013, AM J PHYSIOL-CELL PH, V304, pC532, DOI 10.1152/ajpcell.00203.2012; Gros R, 2011, HYPERTENSION, V57, P442, DOI 10.1161/HYPERTENSIONAHA.110.161653; Hammond R, 2011, PSYCHONEUROENDOCRINO, V36, P182, DOI 10.1016/j.psyneuen.2010.07.007; Insel PA, 2003, CELL MOL NEUROBIOL, V23, P305, DOI 10.1023/A:1023684503883; Kelly MJ, 2015, MOL ENDOCRINOL, V29, P645, DOI 10.1210/me.2014-1397; KENAKIN T, 1995, TRENDS PHARMACOL SCI, V16, P232, DOI 10.1016/S0165-6147(00)89032-X; Kenakin T, 2013, BRIT J PHARMACOL, V168, P554, DOI 10.1111/j.1476-5381.2012.02223.x; Lebesgue D, 2009, J NEUROENDOCRINOL, V21, P743, DOI 10.1111/j.1365-2826.2009.01893.x; Lebesgue D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008642; Lindsey SH, 2014, STEROIDS, V81, P99, DOI 10.1016/j.steroids.2013.10.017; Matsuda KI, 2008, NEUROSCI LETT, V441, P94, DOI 10.1016/j.neulet.2008.05.108; Micevych PE, 2012, NEUROENDOCRINOLOGY, V96, P103, DOI 10.1159/000338400; MUNIRATHINAM G, 1994, PHARMACOL BIOCHEM BE, V48, P813, DOI 10.1016/0091-3057(94)90352-2; Noel SD, 2009, MOL ENDOCRINOL, V23, P349, DOI 10.1210/me.2008-0299; Pang Y, 2008, ENDOCRINOLOGY, V149, P3410, DOI 10.1210/en.2007-1663; Peyton C, 2011, BIOL REPROD, V85, P42, DOI 10.1095/biolreprod.110.088765; Prossnitz ER, 2015, PHARMACOL REV, V67, P505, DOI 10.1124/pr.114.009712; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Ruiz-Palmero I, 2013, MOL CELL ENDOCRINOL, V372, P105, DOI 10.1016/j.mce.2013.03.018; Sanden C, 2011, MOL PHARMACOL, V79, P400, DOI 10.1124/mol.110.069500; Sellers K, 2015, FRONT NEUROENDOCRIN, V36, P72, DOI 10.1016/j.yfrne.2014.08.001; Srivastava DP, 2013, J NEUROENDOCRINOL, V25, P1219, DOI 10.1111/jne.12071; Srivastava DP, 2013, NEUROSCIENCE, V239, P17, DOI 10.1016/j.neuroscience.2012.12.004; Srivastava DP, 2005, J NEUROSCI, V25, P6145, DOI 10.1523/JNEUROSCI.1005-05.2005; Swatton JE, 2004, EUR J NEUROSCI, V19, P2711, DOI 10.1111/j.0953-816X.2004.03365.x; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Toran-Allerand CD, 2002, J NEUROSCI, V22, P8391; Toran-Allerand CD, 2004, ENDOCRINOLOGY, V145, P1069, DOI 10.1210/en.2003-1462; Violin JD, 2014, TRENDS PHARMACOL SCI, V35, P308, DOI 10.1016/j.tips.2014.04.007; Waters EM, 2015, J NEUROSCI, V35, P2384, DOI 10.1523/JNEUROSCI.1298-14.2015; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; WOOLLEY CS, 1994, J NEUROSCI, V14, P7680	58	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0152138	10.1371/journal.pone.0152138	http://dx.doi.org/10.1371/journal.pone.0152138			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998610	Green Published, Green Submitted, gold			2022-12-26	WOS:000372694700104
J	Liu, F; Zheng, H; Tong, W; Li, GX; Tian, Q; Liang, C; Li, LW; Zheng, XC; Tong, GZ				Liu, Fei; Zheng, Hao; Tong, Wu; Li, Guo-Xin; Tian, Qing; Liang, Chao; Li, Li-Wei; Zheng, Xu-Chen; Tong, Guang-Zhi			Identification and Analysis of Novel Viral and Host Dysregulated MicroRNAs in Variant Pseudorabies Virus-Infected PK15 Cells	PLOS ONE			English	Article							MESSENGER-RNA TARGETS; GENOMIC CHARACTERIZATION; EXPRESSION; REPLICATION; RECOGNITION; SUPPRESSION; EMERGENCE; LATENCY; MIR-132; CHINA	Pseudorabies (PR) is one of the most devastating diseases in the pig industry. To identify changes in microRNA (miRNA) expression and post-transcriptional regulatory responses to PRV infection in porcine kidney epithelial (PK15) cells, we sequenced a small RNA (sRNA) library prepared from infected PK15 cells and compared it to a library prepared from uninfected cells using Illumina deep sequencing. Here we found 25 novel viral miRNAs by high-throughput sequencing and 20 of these miRNAs were confirmed through stem-loop RT-qPCR. Intriguingly, unlike the usual miRNAs encoded by the alpha-herpesviruses, which are found clustered in the large latency transcript (LLT), these novel viral miRNAs are throughout the PRV genome like beta-herpesviruses. Viral miRNAs are predicted to target multiple genes and form a complex regulatory network. GO analysis on host targets of viral miRNAs were involved in complex cellular processes, including the metabolic pathway, biological regulation, stimulus response, signaling process and immune response. Moreover, 13 host miRNAs were expressed with significant difference after infection with PRV: 8 miRNAs were up-regulated and 5 miRNAs were down-regulated, which may affect viral replication in host cell. Our results provided new insight into the characteristic of miRNAs in response to PRV infection, which is significant for further study of these miRNAs function.	[Liu, Fei; Zheng, Hao; Tong, Wu; Li, Guo-Xin; Tian, Qing; Liang, Chao; Li, Li-Wei; Zheng, Xu-Chen; Tong, Guang-Zhi] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Dept Swine Infect Dis, Shanghai, Peoples R China; [Zheng, Hao; Tong, Wu; Li, Guo-Xin; Tong, Guang-Zhi] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS	Tong, GZ (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Dept Swine Infect Dis, Shanghai, Peoples R China.; Tong, GZ (corresponding author), Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China.	gztong@shvri.ac.cn			Shanghai Municipal Natural Science Foundation [14ZR1448900]; Shanghai city agriculture science and technology key project [2015,1-7]; National Nonprofit Institute Research Grant of CATAS-ITBB [2014JB02]	Shanghai Municipal Natural Science Foundation; Shanghai city agriculture science and technology key project; National Nonprofit Institute Research Grant of CATAS-ITBB	This work was supported by the Shanghai Municipal Natural Science Foundation (No. 14ZR1448900), the Shanghai city agriculture science and technology key project (2015,1-7), and the National Nonprofit Institute Research Grant of CATAS-ITBB (No. 2014JB02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An TQ, 2013, EMERG INFECT DIS, V19, P1749, DOI 10.3201/eid1911.130177; Anselmo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017374; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boss IW, 2009, TRENDS MICROBIOL, V17, P544, DOI 10.1016/j.tim.2009.09.002; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Cullen BR, 2011, CURR OPIN VIROL, V1, P211, DOI 10.1016/j.coviro.2011.04.003; Cullen BR, 2009, NATURE, V457, P421, DOI 10.1038/nature07757; Grey F, 2008, MED MICROBIOL IMMUN, V197, P261, DOI 10.1007/s00430-007-0070-1; Grey F, 2007, PLOS PATHOG, V3, P1593, DOI 10.1371/journal.ppat.0030163; Grey F, 2015, J GEN VIROL, V96, P739, DOI 10.1099/vir.0.070862-0; Hook L, 2014, CURR OPIN VIROL, V7, P40, DOI 10.1016/j.coviro.2014.03.015; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Klupp BG, 2004, J VIROL, V78, P424, DOI 10.1128/JVI.78.1.424-440.2004; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lei XF, 2010, NAT CELL BIOL, V12, P193, DOI 10.1038/ncb2019; Lin XZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016224; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Luo YZ, 2014, VET MICROBIOL, V174, P107, DOI 10.1016/j.vetmic.2014.09.003; Mahjoub N, 2015, J VIROL, V89, P428, DOI 10.1128/JVI.02181-14; MCGEOCH DJ, 1995, J MOL BIOL, V247, P443, DOI 10.1006/jmbi.1995.0152; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Motsch N, 2014, RNA BIOL, V4; Mulik S, 2012, AM J PATHOL, V181, P525, DOI 10.1016/j.ajpath.2012.04.014; Nachmani D, 2009, CELL HOST MICROBE, V5, P376, DOI 10.1016/j.chom.2009.03.003; Qiu J, 2014, P NATL ACAD SCI USA, V111, P11157, DOI 10.1073/pnas.1406136111; Samols MA, 2007, PLOS PATHOG, V3, P611, DOI 10.1371/journal.ppat.0030065; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang S, 2011, J VIROL, V85, P4501, DOI 10.1128/JVI.01997-10; Tang S, 2009, J VIROL, V83, P1433, DOI 10.1128/JVI.01723-08; Timoneda O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086965; Tong W, 2015, VET MICROBIOL, V181, P236, DOI 10.1016/j.vetmic.2015.09.021; Umbach JL, 2009, J VIROL, V83, P10677, DOI 10.1128/JVI.01185-09; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Varkonyi-Gasic E, 2011, METHODS MOL BIOL, V744, P145, DOI 10.1007/978-1-61779-123-9_10; Wu R, 2013, J VET SCI, V14, P363, DOI 10.4142/jvs.2013.14.3.363; Wu YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030988; Yang JS, 2015, TUMOR BIOL, V36, P3035, DOI 10.1007/s13277-014-2938-1; Ye C, 2015, VIROLOGY, V483, P32, DOI 10.1016/j.virol.2015.04.013; Yu XL, 2014, EMERG INFECT DIS, V20, P102, DOI 10.3201/eid2001.130531; Yuan Q., 1987, CHIN J PREV VET MED, V3, P10; Zhang GL, 2010, ANTIVIR RES, V88, P169, DOI 10.1016/j.antiviral.2010.08.008; Ziegelbauer JM, 2009, NAT GENET, V41, P130, DOI 10.1038/ng.266	45	13	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151546	10.1371/journal.pone.0151546	http://dx.doi.org/10.1371/journal.pone.0151546			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998839	Green Submitted, Green Published, gold			2022-12-26	WOS:000372694700046
J	Wijckmans, E; Nys, M; Debaveye, S; Brams, M; Pardon, E; Willegems, K; Bertrand, D; Steyaert, J; Efremov, R; Ulens, C				Wijckmans, Eveline; Nys, Mieke; Debaveye, Sarah; Brams, Marijke; Pardon, Els; Willegems, Katrien; Bertrand, Daniel; Steyaert, Jan; Efremov, Rouslan; Ulens, Chris			Functional and Biochemical Characterization of Alvinella pompejana Cys-Loop Receptor Homologues	PLOS ONE			English	Article							GATED ION-CHANNEL; NICOTINIC ACETYLCHOLINE-RECEPTOR; X-RAY-STRUCTURE; SIZE-EXCLUSION CHROMATOGRAPHY; CRYSTAL-STRUCTURE; MEMBRANE-PROTEINS; GLYCINE RECEPTOR; EUKARYOTIC THERMOPHILE; CHLORIDE CHANNEL; SCREENING METHOD	Cys-loop receptors are membrane spanning ligand-gated ion channels involved in fast excitatory and inhibitory neurotransmission. Three-dimensional structures of these ion channels, determined by X-ray crystallography or electron microscopy, have revealed valuable information regarding the molecular mechanisms underlying ligand recognition, channel gating and ion conductance. To extend and validate the current insights, we here present promising candidates for further structural studies. We report the biochemical and functional characterization of Cys-loop receptor homologues identified in the proteome of Alvinella pompejana, an extremophilic, polychaete annelid found in hydrothermal vents at the bottom of the Pacific Ocean. Seven homologues were selected, named Alpo1-7. Five of them, Alpo2-6, were unidentified prior to this study. Two-electrode voltage clamp experiments revealed that wild type Alpo5 and Alpo6, both sharing remarkably high sequence identity with human glycine receptor a subunits, are anion-selective channels that can be activated by glycine, GABA and taurine. Furthermore, upon expression in insect cells fluorescence size-exclusion chromatography experiments indicated that four homologues, Alpo1, Alpo4, Alpo6 and Alpo7, can be extracted out of the membrane by a wide variety of detergents while maintaining their oligomeric state. Finally, large-scale purification efforts of Alpo1, Alpo4 and Alpo6 resulted in milligram amounts of biochemically stable and monodisperse protein. Overall, our results establish the evolutionary conservation of glycine receptors in annelids and pave the way for future structural studies.	[Wijckmans, Eveline; Nys, Mieke; Debaveye, Sarah; Brams, Marijke; Ulens, Chris] Univ Leuven, Dept Cellular & Mol Med, Lab Struct Neurobiol, Leuven, Belgium; [Pardon, Els; Willegems, Katrien; Steyaert, Jan; Efremov, Rouslan] Vrije Univ Brussel, Struct Biol Brussels, Brussels, Belgium; [Pardon, Els; Willegems, Katrien; Steyaert, Jan; Efremov, Rouslan] VIB, Struct Biol Res Ctr, Brussels, Belgium; [Bertrand, Daniel] HiQscreen, Geneva, Switzerland	KU Leuven; Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB)	Nys, M (corresponding author), Univ Leuven, Dept Cellular & Mol Med, Lab Struct Neurobiol, Leuven, Belgium.	mieke.nys@med.kuleuven.be	Nys, Mieke/AAC-2859-2019; steyaert, jan/GQP-7811-2022; Steyaert, Jan/H-4662-2011; Efremov, Rouslan/P-9085-2015	Steyaert, Jan/0000-0002-3825-874X; Efremov, Rouslan/0000-0001-7516-8658; Nys, Mieke/0000-0003-3976-8538; Pardon, Els/0000-0002-2466-0172; Willegems, Katrien/0000-0003-1346-3701	KU Leuven Onderzoekstoelage [OT/13/095]; Fonds voor Wetenschappelijk Onderzoek (FWO)-Vlaanderen [G.0939.11, G.0762.13]; Agency for Innovation by Science and Technology in Flanders (IWT) [131118]; Industrieel Onderzoeksfonds (IOF) in Flanders; INSTRUCT, part of the European Strategy Forum on Research Infrastructures (ESFRI); Hercules Foundation Flanders; HiQscreen	KU Leuven Onderzoekstoelage(KU Leuven); Fonds voor Wetenschappelijk Onderzoek (FWO)-Vlaanderen(FWO); Agency for Innovation by Science and Technology in Flanders (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Industrieel Onderzoeksfonds (IOF) in Flanders; INSTRUCT, part of the European Strategy Forum on Research Infrastructures (ESFRI); Hercules Foundation Flanders; HiQscreen	Financial support was from KU Leuven Onderzoekstoelage OT/13/095 and Fonds voor Wetenschappelijk Onderzoek (FWO)-Vlaanderen, http://www.fwo.be/en/, G.0939.11, G.0762.13 to CU. EW is a recipient of a fellowship from the Agency for Innovation by Science and Technology in Flanders (IWT), 131118, http://www.iwt.be/. EP is supported by the Industrieel Onderzoeksfonds (IOF) in Flanders. We thank INSTRUCT, part of the European Strategy Forum on Research Infrastructures (ESFRI) and the Hercules Foundation Flanders for their support to the Nanobody discovery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. HiQscreen provided support in the form of salary for author DB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abskharon RNN, 2014, J AM CHEM SOC, V136, P937, DOI 10.1021/ja407527p; Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amlacher S, 2011, CELL, V146, P277, DOI 10.1016/j.cell.2011.06.039; Baulac S, 2001, NAT GENET, V28, P46, DOI 10.1038/88254; BERTRAND D, 1990, P NATL ACAD SCI USA, V87, P1993, DOI 10.1073/pnas.87.5.1993; BIENZ M, 1982, CELL, V29, P811, DOI 10.1016/0092-8674(82)90443-3; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bowie JU, 2001, CURR OPIN STRUC BIOL, V11, P397, DOI 10.1016/S0959-440X(00)00223-2; Bowser DN, 2002, P NATL ACAD SCI USA, V99, P15170, DOI 10.1073/pnas.212320199; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Cheng H, 2015, ACTA PHARMACOL SIN, V36, P1013, DOI 10.1038/aps.2015.34; Chevaldonne P, 2000, MAR ECOL PROG SER, V208, P293, DOI 10.3354/meps208293; COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F; Debont T, 1996, NEUROSCI RES, V24, P201, DOI 10.1016/0168-0102(95)00982-5; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Gagniere N, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-634; Geertsma ER, 2015, NAT STRUCT MOL BIOL, V22, P803, DOI 10.1038/nsmb.3091; Gensler S, 2001, EUR J BIOCHEM, V268, P2209, DOI 10.1046/j.1432-1327.2001.02093.x; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Hattori M, 2012, STRUCTURE, V20, P1293, DOI 10.1016/j.str.2012.06.009; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hohn M, 2007, J STRUCT BIOL, V157, P47, DOI 10.1016/j.jsb.2006.07.003; Holder T, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-2; Huang X, 2015, NATURE, V526, P277, DOI 10.1038/nature14972; Juneja P, 2014, J BIOL CHEM, V289, P15130, DOI 10.1074/jbc.M113.525576; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Li P, 2002, FEBS LETT, V528, P77, DOI 10.1016/S0014-5793(02)03245-3; Lorentzen E, 2005, NAT STRUCT MOL BIOL, V12, P575, DOI 10.1038/nsmb952; Mancusso R, 2011, METHODS, V55, P324, DOI 10.1016/j.ymeth.2011.07.008; Migita K, 2013, J PHARMACOL SCI, V121, P84, DOI 10.1254/jphs.12222SC; Millar NS, 2009, NEUROPHARMACOLOGY, V56, P237, DOI 10.1016/j.neuropharm.2008.07.041; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Moraga-Cid G, 2015, P NATL ACAD SCI USA, V112, P2865, DOI 10.1073/pnas.1417864112; Nishino A, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-6; Oddo S, 2006, J PHYSIOL-PARIS, V99, P172, DOI 10.1016/j.jphysparis.2005.12.080; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Rees DC, 2001, METHOD ENZYMOL, V334, P423; Saint Jan DD, 2001, J PHYSIOL-LONDON, V535, P741; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Schnizler K, 2005, J BIOL CHEM, V280, P16254, DOI 10.1074/jbc.M411759200; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Shan Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028105; Shin DS, 2009, J MOL BIOL, V385, P1534, DOI 10.1016/j.jmb.2008.11.031; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Spurny R, 2012, P NATL ACAD SCI USA, V109, pE3028, DOI 10.1073/pnas.1208208109; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Thompson AJ, 2010, Q REV BIOPHYS, V43, P449, DOI 10.1017/S0033583510000168; Tol MB, 2013, J BIOL CHEM, V288, P5756, DOI 10.1074/jbc.M112.422287; Vincent A, 2001, LANCET, V357, P2122, DOI 10.1016/S0140-6736(00)05186-2; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101	58	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151183	10.1371/journal.pone.0151183	http://dx.doi.org/10.1371/journal.pone.0151183			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999666	Green Published, Green Submitted, gold			2022-12-26	WOS:000372694700025
J	Chen, WM; Li, SS; Li, JW; Zhou, W; Wu, SH; Xu, SM; Cui, K; Zhang, DD; Liu, B				Chen, Weimin; Li, Shanshan; Li, Jinwei; Zhou, Wen; Wu, Shouhai; Xu, Shengmei; Cui, Ke; Zhang, Donna D.; Liu, Bo			Artemisitene activates the Nrf2-dependent antioxidant response and protects against bleomycin-induced lung injury	FASEB JOURNAL			English	Article						Nrf2 activator; Keap1-Nrf2 pathway; oxidative damage	NRF2-KEAP1 SIGNALING PATHWAY; TRANSCRIPTION FACTOR NRF2; CANCER CHEMOPREVENTION; OXIDATIVE STRESS; KEAP1; MECHANISM; FIBROSIS; SYSTEM; LIGASE; MICE	The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) is a crucial regulator of the cellular antioxidant response and xenobiotic metabolism. Activation of the Nrf2 signaling pathway has been demonstrated to confer protection against environmental insults and prevent disease or inhibit the progression of diseases related to oxidative stress. In an attempt to identify novel improved Nrf2 inducers for systemic protection against tissue damage by environmental insults, we identified art emisitene as a novel Nrf2 activator using antioxidant responsive element luciferase assay in MDA-MB-231 cells. Further studies suggest that art emisitene activates Nrf2 by decreasing Nrf2 ubiquitination and increasing its stability. In Nrf2 wild-type mice, systemic administration of artemisitene strongly inhibits bleomycin-induced lung damage. Artemisitene represents a novel class of Nrf2 inducer, and artemisitene-based therapeutic approach targeting Nrf2 may also provide antioxidant protection for humans against tissue damage by toxic chemicals.	[Chen, Weimin; Li, Shanshan; Li, Jinwei; Zhou, Wen; Wu, Shouhai; Xu, Shengmei; Cui, Ke; Liu, Bo] Guangdong Prov Acad Chinese Med Sci, Guangzhou Univ Chinese Med, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China; [Zhang, Donna D.] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ USA; [Liu, Bo] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai, Peoples R China	Guangzhou University of Chinese Medicine; University of Arizona; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Chen, WM (corresponding author), Guangzhou Univ Chinese Med, Affiliated Hosp 2, Ctr Regenerat & Translat Med, Guangzhou 510006, Guangdong, Peoples R China.; Chen, WM (corresponding author), Guangdong Prov Acad Chinese Med Sci, Guangzhou 510006, Guangdong, Peoples R China.	wmchen8@yahoo.com			National Natural Science Foundation of China [81473294, 81202398]; Chinese Ministry of Science and Technology [2013CB966902]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	This study is supported by the National Natural Science Foundation of China (Nos. 81473294 and 81202398), and a grant from Chinese Ministry of Science and Technology (2013CB966902). The authors declare no conflicts of interest.	Chan KM, 1999, P NATL ACAD SCI USA, V96, P12731, DOI 10.1073/pnas.96.22.12731; Chapple SJ, 2012, INT J BIOCHEM CELL B, V44, P1315, DOI 10.1016/j.biocel.2012.04.021; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Cullinan SB, 2004, MOL CELL BIOL, V24, P8477, DOI 10.1128/MCB.24.19.8477-8486.2004; Du Y, 2008, ENVIRON HEALTH PERSP, V116, P1154, DOI 10.1289/ehp.11464; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Harvey CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002042; Hayes JD, 2010, ANTIOXID REDOX SIGN, V13, P1713, DOI 10.1089/ars.2010.3221; Hoshino T, 2009, AM J RESP CELL MOL, V41, P661, DOI 10.1165/rcmb.2008-0182OC; Huaux F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064341; Jaramillo MC, 2013, GENE DEV, V27, P2179, DOI 10.1101/gad.225680.113; Jeong WS, 2006, ANTIOXID REDOX SIGN, V8, P99, DOI 10.1089/ars.2006.8.99; Jiang T, 2014, KIDNEY INT, V85, P333, DOI 10.1038/ki.2013.343; Jiang T, 2009, TOXICOL APPL PHARM, V240, P8, DOI 10.1016/j.taap.2009.06.010; Kilic T, 2014, INFLAMMATION, V37, P1167, DOI 10.1007/s10753-014-9841-1; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Li QK, 2011, J HUM GENET, V56, P230, DOI 10.1038/jhg.2010.172; Ma JL, 2012, MOL CELL BIOL, V32, P1506, DOI 10.1128/MCB.06271-11; Nishinaka T, 2007, TOXICOL LETT, V170, P238, DOI 10.1016/j.toxlet.2007.03.011; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Ren DM, 2011, P NATL ACAD SCI USA, V108, P1433, DOI 10.1073/pnas.1014275108; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Tao S, 2014, CANCER RES, V74, P7430, DOI 10.1158/0008-5472.CAN-14-1439; Tao SS, 2013, ANTIOXID REDOX SIGN, V19, P1647, DOI 10.1089/ars.2012.5117; Tong KI, 2006, BIOL CHEM, V387, P1311, DOI 10.1515/BC.2006.164; Villeneuve NF, 2010, ANTIOXID REDOX SIGN, V13, P1699, DOI 10.1089/ars.2010.3211; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Wang XJ, 2014, FREE RADICAL BIO MED, V70, P68, DOI 10.1016/j.freeradbiomed.2014.02.010; Weiskirchen R, 2009, FRONT BIOSCI, V14, P4992, DOI 10.2741/3583; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004; Zhang DD, 2006, DRUG METAB REV, V38, P769, DOI 10.1080/03602530600971974; Zhang DD, 2013, ANTIOXID REDOX SIGN, V19, P517, DOI 10.1089/ars.2012.5118; Zhang DD, 2010, ANTIOXID REDOX SIGN, V13, P1623, DOI 10.1089/ars.2010.3301; Zheng HT, 2011, DIABETES, V60, P3055, DOI 10.2337/db11-0807; Zheng Y, 2012, TOXICOL APPL PHARM, V265, P292, DOI 10.1016/j.taap.2012.08.028	39	26	27	1	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2500	2510		10.1096/fj.201500109R	http://dx.doi.org/10.1096/fj.201500109R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27006451				2022-12-26	WOS:000379249500006
J	Perry, RJ; Borders, CB; Cline, GW; Zhang, XM; Alves, TC; Petersen, KF; Rothman, DL; Kibbey, RG; Shulman, GI				Perry, Rachel J.; Borders, Candace B.; Cline, Gary W.; Zhang, Xian-Man; Alves, Tiago C.; Petersen, Kitt Falk; Rothman, Douglas L.; Kibbey, Richard G.; Shulman, Gerald I.			Propionate Increases Hepatic Pyruvate Cycling and Anaplerosis and Alters Mitochondrial Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TCA CYCLE; GLUCONEOGENESIS; LIVER; RATS; CARBOXYLASE; FLUXES; REVERSIBILITY; HYPOGLYCEMIA; SPECIFICITY; ZONATION	In mammals, pyruvate kinase (PK) plays a key role in regulating the balance between glycolysis and gluconeogenesis; however, in vivo regulation of PK flux by gluconeogenic hormones and substrates is poorly understood. To this end, we developed a novel NMR-liquid chromatography/tandem-mass spectrometry (LC-MS/MS) method to directly assess pyruvate cycling relative to mitochondrial pyruvate metabolism (VPyr-Cyc/V-Mito) in vivo using [3-C-13] lactate as a tracer. Using this approach, VPyr-Cyc/V-Mito was only 6% in overnight fasted rats. In contrast, when propionate was infused simultaneously at doses previously used as a tracer, it increased VPyr-Cyc/V-Mito by 20-30-fold, increased hepatic TC Ametabolite concentrations 2-3-fold, and increased endogenous glucose production rates by 20-100%. The physiologic stimuli, glucagon and epinephrine, both increased hepatic glucose production, but only glucagon suppressed VPyr-Cyc/V-Mito. These data show that under fasting conditions, when hepatic gluconeogenesis is stimulated, pyruvate recycling is relatively low in liver compared with V-Mito flux and that liver metabolism, in particular pyruvate cycling, is sensitive to propionate making it an unsuitable tracer to assess hepatic glycolytic, gluconeogenic, and mitochondrial metabolism in vivo.	[Perry, Rachel J.; Borders, Candace B.; Cline, Gary W.; Zhang, Xian-Man; Alves, Tiago C.; Petersen, Kitt Falk; Kibbey, Richard G.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06519 USA; [Kibbey, Richard G.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06519 USA; [Rothman, Douglas L.] Yale Univ, Sch Med, Dept Radiol & Biomed Imaging, 333 Cedar St, New Haven, CT 06519 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06519 USA; [Rothman, Douglas L.] Yale Univ, Dept Biomed Engn, New Haven, CT 06519 USA; [Petersen, Kitt Falk; Shulman, Gerald I.] Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-1017 Copenhagen, Denmark	Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Novo Nordisk Foundation; University of Copenhagen	Kibbey, RG; Shulman, GI (corresponding author), Yale Univ, Sch Med, Dept Internal Med, 333 Cedar St, New Haven, CT 06519 USA.; Kibbey, RG; Shulman, GI (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06519 USA.; Shulman, GI (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06519 USA.; Shulman, GI (corresponding author), Univ Copenhagen, Novo Nordisk Fdn Ctr Basic Metab Res, DK-1017 Copenhagen, Denmark.	richard.kibbey@yale.edu; gerald.shulman@yale.edu	Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668; Perry, Rachel/0000-0003-0748-8064	National Institutes of Health [R01 DK-40936, P30 DK-45735, U24 DK-059635, T32 DK-101019, R01 NS-087568, R01 DK-056886, R01 DK-092606, R01 DK-093959, R01 AG-23686, UL1 TR-000142]; Gilead Sciences; Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056886, R01DK092606, T32DK101019, R01DK093959, R01DK040936, P30DK034989, P30DK045735, U24DK059635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS087568] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023686] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gilead Sciences(Gilead Sciences); Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants R01 DK-40936, P30 DK-45735, U24 DK-059635, T32 DK-101019, R01 NS-087568, R01 DK-056886, R01 DK-092606, R01 DK-093959, R01 AG-23686, and UL1 TR-000142, Gilead Sciences, and the Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alves TC, 2015, CELL METAB, V22, P936, DOI 10.1016/j.cmet.2015.08.021; Alves TC, 2011, HEPATOLOGY, V53, P1175, DOI 10.1002/hep.24170; Befroy DE, 2014, NAT MED, V20, P98, DOI 10.1038/nm.3415; Browning JD, 2012, AM J PHYSIOL-ENDOC M, V303, pE1304, DOI 10.1152/ajpendo.00306.2012; Burgess SC, 2003, ANAL BIOCHEM, V312, P228, DOI 10.1016/S0003-2697(02)00465-7; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Burgess SC, 2015, NAT MED, V21, P108, DOI 10.1038/nm.3789; Hasenour CM, 2015, AM J PHYSIOL-ENDOC M, V309, pE191, DOI 10.1152/ajpendo.00003.2015; HILTUNEN JK, 1981, BIOCHIM BIOPHYS ACTA, V678, P115, DOI 10.1016/0304-4165(81)90054-4; Jin ES, 2005, AM J PHYSIOL-ENDOC M, V288, pE654, DOI 10.1152/ajpendo.00365.2004; Jin ES, 2004, ANAL BIOCHEM, V327, P149, DOI 10.1016/j.ab.2003.12.036; Jones JG, 1998, AM J PHYSIOL-ENDOC M, V275, pE843, DOI 10.1152/ajpendo.1998.275.5.E843; JUNGERMANN K, 1987, Diabetes Metabolism Reviews, V3, P269; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; Kumashiro N, 2013, DIABETES, V62, P2183, DOI 10.2337/db12-1311; Mravec B, 2008, ANN NY ACAD SCI, V1148, P196, DOI 10.1196/annals.1410.010; Perry RJ, 2014, NAT MED, V20, P759, DOI 10.1038/nm.3579; PETERSEN KF, 1995, METABOLISM, V44, P1380, DOI 10.1016/0026-0495(95)90133-7; POWELL AM, 1993, J CLIN INVEST, V92, P2667, DOI 10.1172/JCI116883; Previs SF, 2015, AM J PHYSIOL-ENDOC M, V309, pE727, DOI 10.1152/ajpendo.00216.2015; Puchowicz MA, 1999, AM J PHYSIOL-ENDOC M, V277, pE1022, DOI 10.1152/ajpendo.1999.277.6.E1022; Purmal C, 2014, AM J PHYSIOL-HEART C, V307, pH1134, DOI 10.1152/ajpheart.00407.2014; Reszko AE, 2003, J BIOL CHEM, V278, P34959, DOI 10.1074/jbc.M302013200; Satapati S, 2015, J CLIN INVEST, V125, P4447, DOI 10.1172/JCI82204; SCRUTTON MC, 1974, J BIOL CHEM, V249, P7057; Shi ZQ, 1996, ENDOCRINOLOGY, V137, P3193, DOI 10.1210/en.137.8.3193; Sunny NE, 2011, CELL METAB, V14, P804, DOI 10.1016/j.cmet.2011.11.004; Vatner DF, 2013, AM J PHYSIOL-ENDOC M, V305, pE89, DOI 10.1152/ajpendo.00573.2012	28	46	47	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					12161	12170		10.1074/jbc.M116.720631	http://dx.doi.org/10.1074/jbc.M116.720631			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27002151	hybrid, Green Published			2022-12-26	WOS:000378092800018
J	Einholm, AP; Nielsen, HN; Holm, R; Toustrup-Jensen, MS; Vilsen, B				Einholm, Anja P.; Nielsen, Hang N.; Holm, Rikke; Toustrup-Jensen, Mads S.; Vilsen, Bente			Importance of a Potential Protein Kinase A Phosphorylation Site of Na+, K+-ATPase and Its Interaction Network for Na+ Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							4TH TRANSMEMBRANE SEGMENT; CRYSTAL-STRUCTURE; ADENOSINE-TRIPHOSPHATE; INORGANIC-PHOSPHATE; ALPHA-SUBUNIT; SODIUM; NA+,K+-ATPASE; MUTATION; AFFINITY; PUMP	The molecular mechanism underlying PKA-mediated regulation of Na+, K+ -ATPase was explored in mutagenesis studies of the potential PKA site at Ser-938 and surrounding charged residues. The phosphomimetic mutations S938D/E interfered with Na+ binding from the intracellular side of the membrane, whereas Na+ binding from the extracellular side was unaffected. The reduction of Na+ affinity is within the range expected for physiological regulation of the intracellular Na+ concentration, thus supporting the hypothesis that PKA-mediated phosphorylation of Ser-938 regulates Na+, K+ -ATPase activity in vivo. Ser938 is located in the intracellular loop between transmembrane segments M8 and M9. An extended bonding network connects this loop with M10, the C terminus, and the Na+ binding region. Charged residues Asp-997, Glu-998, Arg-1000, and Lys-1001 in M10, participating in this bonding network, are crucial to Na+ interaction. Replacement of Arg-1005, also located in the vicinity of Ser-938, with alanine, lysine, methionine, or serine resulted in wild type-like Na+ and K+ affinities and catalytic turnover rate. However, when combined with the phosphomimetic mutation S938E only lysine substitution of Arg-1005 was compatible with Na+, K+-ATPase function, and the Na+ affinity of this double mutant was reduced even more than in single mutant S938E. This result indicates that the positive side chain of Arg-1005 or the lysine substituent plays a mechanistic role as interaction partner of phosphorylated Ser-938, transducing the phosphorylation signal into a reduced affinity of Na+ site III. Electrostatic interaction of Glu-998 is of minor importance for the reduction of Na+ affinity by phosphomimetic S938E as revealed by combining S938E with E998A.	[Einholm, Anja P.; Nielsen, Hang N.; Holm, Rikke; Toustrup-Jensen, Mads S.; Vilsen, Bente] Aarhus Univ, Dept Biomed, Ole Worms Alle 4,Bldg 1160, DK-8000 Aarhus C, Denmark	Aarhus University	Einholm, AP (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms Alle 4,Bldg 1160, DK-8000 Aarhus C, Denmark.	ape@biomed.au.dk		Vilsen, Bente/0000-0002-4727-9382; Toustrup-Jensen, Mads Schak/0000-0003-2064-5861	Danish Medical Research Council, L'Oreal Denmark; Novo Nordisk Foundation; Riisfort Foundation; Lundbeck Foundation; Lundbeck Foundation [R118-2012-11726] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0013409] Funding Source: researchfish	Danish Medical Research Council, L'Oreal Denmark(L'Oreal Group); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Riisfort Foundation; Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported in part by grants from the Danish Medical Research Council, L'Oreal Denmark, the Novo Nordisk Foundation, the Riisfort Foundation, and the Lundbeck Foundation. The authors declare that they have no conflict of interest with the contents of this article.	ALBERS RW, 1967, ANNU REV BIOCHEM, V36, P727, DOI 10.1146/annurev.bi.36.070167.003455; Azarias G, 2013, J BIOL CHEM, V288, P2734, DOI 10.1074/jbc.M112.425785; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; Beuschlein F, 2013, NAT GENET, V45, P440, DOI 10.1038/ng.2550; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cheng XJ, 1997, AM J PHYSIOL-CELL PH, V273, pC893, DOI 10.1152/ajpcell.1997.273.3.C893; Codina J, 2006, J AM SOC NEPHROL, V17, P1833, DOI 10.1681/ASN.2006010032; Despa S, 2005, CIRC RES, V97, P252, DOI 10.1161/01.RES.0000176532.97731.e5; Einholm AP, 2007, J BIOL CHEM, V282, P23854, DOI 10.1074/jbc.M702259200; Einholm AP, 2010, J BIOL CHEM, V285, P26245, DOI 10.1074/jbc.M110.123976; Fernandez DM, 2008, HEADACHE, V48, P101, DOI [10.1111/j.1526-4610.2007.00848, 10.1111/j.1526-4610.2007.00848.x]; FISONE G, 1994, J BIOL CHEM, V269, P9368; Frame S, 2001, MOL CELL, V7, P1321, DOI 10.1016/S1097-2765(01)00253-2; GARRAHAN PJ, 1967, J PHYSIOL-LONDON, V192, P217, DOI 10.1113/jphysiol.1967.sp008297; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; GLYNN IM, 1993, J PHYSIOL-LONDON, V462, P1; Heinzen EL, 2014, LANCET NEUROL, V13, P503, DOI 10.1016/S1474-4422(14)70011-0; Holm R, 2015, J BIOL CHEM, V290, P9801, DOI 10.1074/jbc.M114.625509; Jen JC, 2007, J NEUROL NEUROSUR PS, V78, P523, DOI 10.1136/jnnp.2006.103267; JEWELL EA, 1991, J BIOL CHEM, V266, P16925; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; JORGENSEN PL, 1974, BIOCHIM BIOPHYS ACTA, V356, P36, DOI 10.1016/0005-2736(74)90292-2; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; KAPLAN JH, 1980, NATURE, V288, P587, DOI 10.1038/288587a0; KARLISH SJD, 1978, BIOCHIM BIOPHYS ACTA, V527, P115, DOI 10.1016/0005-2744(78)90261-9; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; POST RL, 1969, J GEN PHYSIOL, V54, pS306, DOI 10.1085/jgp.54.1.306; POST RL, 1972, J BIOL CHEM, V247, P6530; Poulsen H, 2012, J BIOL CHEM, V287, P15959, DOI 10.1074/jbc.M112.340406; Poulsen H, 2010, FEBS LETT, V584, P2589, DOI 10.1016/j.febslet.2010.04.035; Shinoda T, 2009, NATURE, V459, P446, DOI 10.1038/nature07939; Sweadner KJ, 2001, AM J PHYSIOL-CELL PH, V280, pC1017, DOI 10.1152/ajpcell.2001.280.4.C1017; TANIGUCHI K, 1975, J BIOL CHEM, V250, P3010; Therien AG, 2000, AM J PHYSIOL-CELL PH, V279, pC541, DOI 10.1152/ajpcell.2000.279.3.C541; Toustrup-Jensen M, 2001, BIOCHEMISTRY-US, V40, P5521, DOI 10.1021/bi002367m; Toustrup-Jensen MS, 2014, J BIOL CHEM, V289, P3186, DOI 10.1074/jbc.M113.543272; Toustrup-Jensen MS, 2009, J BIOL CHEM, V284, P18715, DOI 10.1074/jbc.M109.015099; VILSEN B, 1992, FEBS LETT, V314, P301, DOI 10.1016/0014-5793(92)81494-7; Vilsen B, 1997, BIOCHEMISTRY-US, V36, P13312, DOI 10.1021/bi971030q; Woods AS, 2005, J PROTEOME RES, V4, P1397, DOI 10.1021/pr050077s; YODA S, 1986, J BIOL CHEM, V261, P1147	42	10	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10934	+		10.1074/jbc.M115.701201	http://dx.doi.org/10.1074/jbc.M115.701201			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27013656	hybrid, Green Published			2022-12-26	WOS:000377042600042
J	Girardi, E; Wang, J; Zajonc, DM				Girardi, Enrico; Wang, Jing; Zajonc, Dirk M.			Structure of an alpha-Helical Peptide and Lipopeptide Bound to the Nonclassical Major Histocompatibility Complex (MHC) Class I Molecule CD1d	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID ANTIGEN PRESENTATION; T-CELL-RECEPTOR; MOUSE CD1; NKT CELLS; RECOGNITION; BINDING; ACTIVATION; PROTEINS	Mouse CD1d is a nonclassical MHC molecule able to present lipids and glycolipids to a specialized subset of T cells known as natural killer T cells. The antigens presented by CD1d have been shown to cover a broad range of chemical structures and to follow precise rules determining the potency of the antigen in the context of T cell activation. Together with lipids, initial reports suggested that CD1d can also bind and present hydrophobic peptides with (F/W)XX(I/L/M)XXVV. However, the exact location of peptide binding and the molecular basis for the required motif are currently unknown. Here we present the crystal structure of the first peptide identified to bind CD1d, p99, and show that it binds in the antigen-binding groove of CD1d in a manner compatible with its presentation to T cell receptors. Interestingly, the peptide adopts an alpha-helical conformation, which orients the motif residues toward its deep binding groove, therefore explaining the molecular requirements for peptide binding. Moreover, we demonstrate that a lipopeptide version of the same peptide is able to bind CD1d in a similar conformation, identifying another class of molecules binding this antigen-presenting molecule.	[Girardi, Enrico; Wang, Jing; Zajonc, Dirk M.] La Jolla Inst Allergy & Immunol, Div Cell Biol, 9420 Athena Circle, La Jolla, CA 92037 USA; [Zajonc, Dirk M.] Univ Ghent, Fac Med & Hlth Sci, Dept Internal Med, B-9000 Ghent, Belgium	La Jolla Institute for Immunology; Ghent University	Zajonc, DM (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, 9420 Athena Circle, La Jolla, CA 92037 USA.	dzajonc@lji.org	Girardi, Enrico/AAD-2260-2020; Girardi, Enrico/L-4033-2014	Girardi, Enrico/0000-0003-3508-2723; Girardi, Enrico/0000-0003-3508-2723	National Institutes of Health [AI107318]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI107318] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI107318 (to D. M. Z.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams EJ, 2013, ANNU REV IMMUNOL, V31, P529, DOI 10.1146/annurev-immunol-032712-095912; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Brossay L, 1998, IMMUNOL REV, V163, P139, DOI 10.1111/j.1600-065X.1998.tb01193.x; CASTANO AR, 1995, SCIENCE, V269, P223, DOI 10.1126/science.7542403; CEASE KB, 1986, J EXP MED, V164, P1779, DOI 10.1084/jem.164.5.1779; Cho S, 2005, VIROLOGY, V337, P242, DOI 10.1016/j.virol.2005.04.020; Cox D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005325; DELISI C, 1985, P NATL ACAD SCI USA, V82, P7048, DOI 10.1073/pnas.82.20.7048; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fox LM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000228; Girardi E, 2012, IMMUNOL REV, V250, P167, DOI 10.1111/j.1600-065X.2012.01166.x; Gunther S, 2010, P NATL ACAD SCI USA, V107, P22219, DOI 10.1073/pnas.1014708107; GUO HC, 1992, NATURE, V360, P364, DOI 10.1038/360364a0; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; Lee DJ, 1998, J EXP MED, V187, P433, DOI 10.1084/jem.187.3.433; Liu YW, 2011, J CLIN INVEST, V121, P249, DOI 10.1172/JCI43964; MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.iy.13.040195.003103; McMurtrey C, 2016, ELIFE, V5, DOI 10.7554/eLife.12556; Moll M, 2010, BLOOD, V116, P1876, DOI 10.1182/blood-2009-09-243667; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Paletta D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143449; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sullivan BA, 2010, J IMMUNOL, V184, P141, DOI 10.4049/jimmunol.0902880; Tangri S, 1998, P NATL ACAD SCI USA, V95, P14314, DOI 10.1073/pnas.95.24.14314; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Wang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047989; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zajonc DM, 2007, CURR TOP MICROBIOL, V314, P27; Zajonc DM, 2005, NAT IMMUNOL, V6, P810, DOI 10.1038/ni1224; Zajonc DM, 2005, J EXP MED, V202, P1517, DOI 10.1084/jem.20051625; ZHANG WG, 1992, P NATL ACAD SCI USA, V89, P8403, DOI 10.1073/pnas.89.17.8403; Zhou DP, 2004, SCIENCE, V303, P523, DOI 10.1126/science.1092009	35	9	14	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10677	10683		10.1074/jbc.M115.702118	http://dx.doi.org/10.1074/jbc.M115.702118			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27006394	Green Published, hybrid			2022-12-26	WOS:000377042600020
J	Reid, WC; Casas, R; Papadakis, GZ; Muthusamy, S; Lee, DE; Ibrahim, WG; Nair, A; Koziol, D; Maric, D; Hammoud, DA				Reid, William C.; Casas, Rafael; Papadakis, Georgios Z.; Muthusamy, Siva; Lee, Dianne E.; Ibrahim, Wael G.; Nair, Anand; Koziol, Deloris; Maric, Dragan; Hammoud, Dima A.			Neurobehavioral Abnormalities in the HIV-1 Transgenic Rat Do Not Correspond to Neuronal Hypometabolism on F-18-FDG-PET	PLOS ONE			English	Article							VITAMIN-A-DEFICIENCY; MOTOR DEFICITS; EXPRESSION; MODEL; HABITUATION; BEHAVIOR; MEMORY; BRAIN; TIME; PET	Motor and behavioral abnormalities are common presentations among individuals with HIV-1 associated neurocognitive disorders (HAND). We investigated whether longitudinal motor and behavioral performance in the HIV-1 transgenic rat (Tg), a commonly used neuro-HIV model, corresponded to in vivo neuronal death/dysfunction, by using rotarod and open field testing in parallel to [F-18] 2-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET). We demonstrated that age-matched non-Tg wild type (WT) rats outperformed the HIV-1 Tg rats at most time points on rotarod testing. Habituation to rotarod occurred at 8 weeks of age (fifth weekly testing session) in the WT rats but it never occurred in the Tg rats, suggesting deficits in motor learning. Similarly, in open field testing, WT rats outperformed the Tg rats at most time points, suggesting defective exploratory/motor behavior and increased emotionality in the Tg rat. Despite the neurobehavioral abnormalities, there were no concomitant deficits in F-18-FDG uptake in Tg rats on PET compared to age-matched WT rats and no significant longitudinal loss of FDG uptake in either group. The negative PET findings were confirmed using C-14-Deoxy-D-glucose autoradiography in 32 week-old Tg and WT rats. We believe that the neuropathology in the HIV-1 Tg rat is more likely a consequence of neuronal dysfunction rather than overt neurodegeneration/neuronal cell death, similar to what is seen in HIV-positive patients in the post-ART era.	[Reid, William C.; Casas, Rafael; Papadakis, Georgios Z.; Lee, Dianne E.; Ibrahim, Wael G.; Nair, Anand; Hammoud, Dima A.] NIH, Ctr Infect Dis Imaging CIDI Radiol & Imaging Sci, Bldg 10, Bethesda, MD 20892 USA; [Koziol, Deloris] NIH, Biostat & Clin Epidemiol Serv, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA; [Maric, Dragan] NINDS, DIR, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Hammoud, DA (corresponding author), NIH, Ctr Infect Dis Imaging CIDI Radiol & Imaging Sci, Bldg 10, Bethesda, MD 20892 USA.	hammoudd@cc.nih.gov	Hammoud, Dima A/C-2286-2015	Hammoud, Dima/0000-0001-7406-7871	Center of Infectious Disease Imaging (CIDI); Radiology and Imaging Sciences (RIS); Clinical Center, National Institutes of Health (Intramural Program); CLINICAL CENTER [ZIACL090037] Funding Source: NIH RePORTER	Center of Infectious Disease Imaging (CIDI); Radiology and Imaging Sciences (RIS); Clinical Center, National Institutes of Health (Intramural Program)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CLINICAL CENTER	Center of Infectious Disease Imaging (CIDI), Radiology and Imaging Sciences (RIS), Clinical Center, National Institutes of Health (Intramural Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AB, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-13; ARCHER J, 1973, ANIM BEHAV, V21, P205, DOI 10.1016/S0003-3472(73)80065-X; Bandaru VVR, 2007, NEUROLOGY, V68, P1481, DOI 10.1212/01.wnl.0000260610.79853.47; Chang SL, 2006, AM J INFECT DIS, V2, P98; Davinelli S, 2014, BIOGERONTOLOGY, V15, P449, DOI 10.1007/s10522-014-9511-6; DENENBERG VH, 1969, ANN NY ACAD SCI, V159, P852, DOI 10.1111/j.1749-6632.1969.tb12983.x; Fueger BJ, 2006, J NUCL MED, V47, P999; Guo M, 2012, CURR HIV RES, V10, P463, DOI 10.2174/157016212802138715; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; HINKIN CH, 1995, J NEUROPSYCH CLIN N, V7, P180; Jang DP, 2009, BEHAV BRAIN RES, V203, P43, DOI 10.1016/j.bbr.2009.04.020; June HL, 2009, J NEUROVIROL, V15, P380, DOI 10.3109/13550280903350200; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P247, DOI 10.1016/0149-7634(81)90005-1; Kemppainen J, 2005, J PHYSIOL-LONDON, V568, P323, DOI 10.1113/jphysiol.2005.091355; Lashomb AL, 2009, J NEUROVIROL, V15, P14, DOI 10.1080/13550280802232996; Lee DE, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0390-9; Lee DE, 2014, MOL IMAGING, V13, DOI 10.2310/7290.2014.00031; Lentz MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105752; Mann A, 2015, MOVEMENT DISORDERS G; Moran LM, 2013, EXP NEUROL, V239, P139, DOI 10.1016/j.expneurol.2012.10.008; Moran LM, 2014, J NEUROIMMUNE PHARM, V9, P508, DOI 10.1007/s11481-014-9539-z; Moran LM, 2013, J NEUROIMMUNE PHARM, V8, P988, DOI 10.1007/s11481-013-9472-6; Moran LM, 2012, CURR HIV RES, V10, P415, DOI 10.2174/157016212802138788; Nemeth CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108399; Pang XS, 2014, J NEUROIMMUNE PHARM, V9, P413, DOI 10.1007/s11481-014-9538-0; Peng JS, 2010, J NEUROIMMUNOL, V218, P94, DOI 10.1016/j.jneuroim.2009.09.014; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Rao JS, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-101; Reid W, 2001, P NATL ACAD SCI USA, V98, P9271, DOI 10.1073/pnas.161290298; Reid WC, 2016, J NEUROIMMUNOL, V292, P116, DOI 10.1016/j.jneuroim.2016.01.022; Repunte-Canonigo V, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-26; Robillard KR, 2014, BIOCHEM BIOPH RES CO, V444, P531, DOI 10.1016/j.bbrc.2014.01.092; Rottenberg DA, 1996, J NUCL MED, V37, P1133; Sarkar S, 2013, ALCOHOL CLIN EXP RES, V37, pE70, DOI 10.1111/j.1530-0277.2012.01860.x; Schouten J, 2011, AIDS, V25, P561, DOI 10.1097/QAD.0b013e3283437f9a; Sestakova Natalia, 2013, Interdiscip Toxicol, V6, P126, DOI 10.2478/intox-2013-0020; Shirakawa T, 2013, TOXICOL SCI, V133, P13, DOI 10.1093/toxsci/kft036; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; Towgood KJ, 2013, HUM BRAIN MAPP, V34, P2484, DOI 10.1002/hbm.22078; Vigorito M, 2007, J NEUROIMMUNE PHARM, V2, P319, DOI 10.1007/s11481-007-9078-y; Vigorito M, 2015, BRAIN BEHAV IMMUN, V48, P336, DOI 10.1016/j.bbi.2015.02.020; Vigorito M, 2013, J NEUROVIROL, V19, P157, DOI 10.1007/s13365-013-0154-1; von Giesen HJ, 2000, ARCH NEUROL-CHICAGO, V57, P1601, DOI 10.1001/archneur.57.11.1601; Zhang LB, 2012, NPG ASIA MATER, V4, DOI 10.1038/am.2012.14	45	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152265	10.1371/journal.pone.0152265	http://dx.doi.org/10.1371/journal.pone.0152265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010205	Green Submitted, gold, Green Published			2022-12-26	WOS:000372708000123
J	Bouillon, C; Leandri, R; Desch, L; Ernst, A; Bruno, C; Cerf, C; Chiron, A; Souchay, C; Burguet, A; Jimenez, C; Sagot, P; Fauque, P				Bouillon, Celine; Leandri, Roger; Desch, Laurent; Ernst, Alexandra; Bruno, Celine; Cerf, Charline; Chiron, Alexandra; Souchay, Celine; Burguet, Antoine; Jimenez, Clement; Sagot, Paul; Fauque, Patricia			Does Embryo Culture Medium Influence the Health and Development of Children Born after In Vitro Fertilization?	PLOS ONE			English	Article							INTRACYTOPLASMIC SPERM INJECTION; PREIMPLANTATION MOUSE EMBRYOS; ASSISTED REPRODUCTION; DEVELOPMENT INVENTORY; GENE-EXPRESSION; BIRTH-WEIGHT; DUTCH FAMINE; IVF; AMMONIUM; CONCEPTION	In animal studies, extensive data revealed the influence of culture medium on embryonic development, foetal growth and the behaviour of offspring. However, this impact has never been investigated in humans. For the first time, we investigated in depth the effects of embryo culture media on health, growth and development of infants conceived by In Vitro Fertilization until the age of 5 years old. This single-centre cohort study was based on an earlier randomized study. During six months, in vitro fertilization attempts (No. 371) were randomized according to two media (Single Step Medium-SSM group) or Global medium (Global group). This randomized study was stopped prematurely as significantly lower pregnancy and implantation rates were observed in the SSM group. Singletons (No. 73) conceived in the randomized study were included (42 for Global and 31 for SSM). The medical data for gestational, neonatal and early childhood periods were extracted from medical records and parental interviews (256 variables recorded). The developmental profiles of the children in eight domains (social, self-help, gross motor, fine motor, expressive language, language comprehension, letter knowledge and number knowledge - 270 items) were compared in relation to the culture medium. The delivery rate was significantly lower in the SSM group than in the Global group (p<0.05). The culture medium had no significant effect on birthweight, risk of malformation (minor and major), growth and the frequency of medical concerns. However, the children of the Global group were less likely than those of the SSM group to show developmental problems (p=0.002), irrespective of the different domains. In conclusion, our findings showed that the embryo culture medium may have an impact on further development.	[Bouillon, Celine] Ctr Hosp Reg Univ Tours, Serv Med & Biol Reprod, Tours, France; [Leandri, Roger] Hop Paule de Viguier, Ctr Assistance Med Procreat, Grp Rech Fertil Humaine, EA 3694, Toulouse, France; [Desch, Laurent; Bruno, Celine; Fauque, Patricia] Univ Bourgogne, Lab Biol Reprod, Hop Dijon, Equipe GAD,Genet Anomalies Dev,EA 4271, Dijon, France; [Ernst, Alexandra; Cerf, Charline; Souchay, Celine] Univ Bourgogne, LEAD, CNRS, UMR 5022,Pole AAFE, Dijon, France; [Chiron, Alexandra] SELAFA BIOFFICE Clin Jean Villar, Lab Biol Reprod, Brugge, France; [Burguet, Antoine] Univ Bourgogne, Hop Dijon, Serv Pediat, Dijon, France; [Jimenez, Clement] Univ Bordeaux, Inst Malad Neurodegenerat, CNRS, Serv Biol Reprod,CECOS,UMR 5293, Bordeaux, France; [Sagot, Paul] Univ Bourgogne, Hop Dijon, Serv Gynecol Obstet Med Foetale & Steril Conjugal, Dijon, France; [Ernst, Alexandra] Univ Liege, Dept Psychol Cognit & Behav, Liege, Belgium; [Souchay, Celine] Univ Grenoble, Lab Psychol & Neurocognit, CNRS, UMR 5105, Grenoble, France	CHU Tours; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU Dijon Bourgogne; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Bourgogne; CHU Dijon Bourgogne; Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Dijon Bourgogne; Universite de Bourgogne; University of Liege; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie	Fauque, P (corresponding author), Univ Bourgogne, Lab Biol Reprod, Hop Dijon, Equipe GAD,Genet Anomalies Dev,EA 4271, Dijon, France.	patricia.fauque@chu-dijon.fr	Ernst, Alexandra/AAE-7337-2019; Souchay, Céline/AAH-1993-2021	burguet, antoine/0000-0001-5140-2884; Souchay, Celine/0000-0001-9041-0123; Leandri, Roger Dominique/0000-0002-9140-3264; Ernst, Alexandra/0000-0001-6555-546X; desch, laurent/0000-0002-2526-6548				Berning Emily J, 2013, J Amino Acids, V2013, P240537, DOI 10.1155/2013/240537; Biggers JD, 2004, REPROD BIOMED ONLINE, V9, P59, DOI 10.1016/S1472-6483(10)62111-6; Bowen JR, 1998, LANCET, V351, P1529, DOI 10.1016/S0140-6736(98)10168-X; Ceelen M, 2009, HUM REPROD, V24, P2788, DOI 10.1093/humrep/dep273; CHAFFEE CA, 1991, J ABNORM CHILD PSYCH, V19, P65, DOI 10.1007/BF00910565; de Rooij SR, 2010, P NATL ACAD SCI USA, V107, P16881, DOI 10.1073/pnas.1009459107; de Waal E, 2015, HUM MOL GENET, V24, P6975, DOI 10.1093/hmg/ddv400; Devreker F, 1999, HUM REPROD, V14, P2350, DOI 10.1093/humrep/14.9.2350; Doig KB, 1999, J PEDIATR-US, V135, P358, DOI 10.1016/S0022-3476(99)70134-4; Dumoulin JC, 2010, HUM REPROD, V25, P605, DOI 10.1093/humrep/dep456; Duyme M, 2011, CLIN PEDIATR, V50, P636, DOI 10.1177/0009922811398390; Ecker DJ, 2004, P NATL ACAD SCI USA, V101, P1595, DOI 10.1073/pnas.0306846101; el Hajj N, 2013, FERTIL STERIL, V99, P632, DOI 10.1016/j.fertnstert.2012.12.044; EUROCAT, 2013, GUID 1 4 REF DOC INS; Fauque P, 2010, HUM MOL GENET, V19, P1779, DOI 10.1093/hmg/ddq059; Feinberg JI, 2015, INT J EPIDEMIOL, V44, P1199, DOI 10.1093/ije/dyv028; Fernandez-Gonzalez R, 2004, P NATL ACAD SCI USA, V101, P5880, DOI 10.1073/pnas.0308560101; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Hart R, 2013, HUM REPROD UPDATE, V19, P232, DOI 10.1093/humupd/dms062; Hassani F, 2013, INT J FERTIL STERIL, V7, P108; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; Kleijkers SHM, 2014, HUM REPROD, V29, P661, DOI 10.1093/humrep/deu025; Knoester M, 2008, FERTIL STERIL, V90, P289, DOI 10.1016/j.fertnstert.2007.06.090; Lane M, 2003, BIOL REPROD, V69, P1109, DOI 10.1095/biolreprod.103.018093; LANE M, 1994, J REPROD FERTIL, V102, P305, DOI 10.1530/jrf.0.1020305; Leslie GI, 2003, HUM REPROD, V18, P2067, DOI 10.1093/humrep/deg408; Mann MRW, 2004, DEVELOPMENT, V131, P3727, DOI 10.1242/dev.01241; Mantikou E, 2013, HUM REPROD UPDATE, V19, P210, DOI 10.1093/humupd/dms061; Market-Velker BA, 2010, BIOL REPROD, V83, P938, DOI 10.1095/biolreprod.110.085480; Morbeck DE, 2014, J ASSIST REPROD GEN, V31, P1703, DOI 10.1007/s10815-014-0349-2; Morbeck DE, 2014, FERTIL STERIL, V102, P759, DOI 10.1016/j.fertnstert.2014.05.043; Nekkebroeck J, 2008, HUM REPROD, V23, P1560, DOI 10.1093/humrep/den033; Nelissen EC, 2012, HUM REPROD, V27, P1966, DOI 10.1093/humrep/des145; Painter RC, 2006, AM J CLIN NUTR, V84, P322; Ponjaert-Kristoffersen I, 2005, PEDIATRICS, V115, pE283, DOI 10.1542/peds.2004-1445; Rinaudo P, 2004, REPRODUCTION, V128, P301, DOI 10.1530/rep.1.00297; Schwarzer C, 2012, HUM REPROD, V27, P2627, DOI 10.1093/humrep/des223; Simmons RA, 2009, PEDIATR CLIN N AM, V56, P449, DOI 10.1016/j.pcl.2009.03.004; Soderstrom-Anttila V, 2006, HUM REPROD, V21, P1508, DOI 10.1093/humrep/dei503; Stein AD, 2007, AM J CLIN NUTR, V85, P869, DOI 10.1093/ajcn/85.3.869; Vandentorren S, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-58; Velazquez MA, 2015, DOMEST ANIM ENDOCRIN, V51, P27, DOI 10.1016/j.domaniend.2014.10.003; Vendittelli F, 2008, GYNECOL OBSTET FERTI, V36, P1091, DOI 10.1016/j.gyobfe.2008.08.010; Vermeiden JPW, 2013, FERTIL STERIL, V99, P642, DOI 10.1016/j.fertnstert.2013.01.125; Wale PL, 2016, HUM REPROD UPDATE, V22, P2, DOI 10.1093/humupd/dmv034; Wale PL, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109256; Wen J, 2012, FERTIL STERIL, V97, P1331, DOI 10.1016/j.fertnstert.2012.02.053; Whitelaw N, 2014, HUM REPROD, V29, P1452, DOI 10.1093/humrep/deu094; Zander DL, 2006, BIOL REPROD, V74, P288, DOI 10.1095/biolreprod.105.046235; Zandstra H, 2015, HUM REPROD, V30, P530, DOI 10.1093/humrep/deu346; Zhao QH, 2013, INT J MOL SCI, V14, P6556, DOI 10.3390/ijms14046556	51	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0150857	10.1371/journal.pone.0150857	http://dx.doi.org/10.1371/journal.pone.0150857			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008092	Green Published, gold			2022-12-26	WOS:000372701200034
J	Deeney, JT; Belkina, AC; Shirihai, OS; Corkey, BE; Denis, GV				Deeney, Jude T.; Belkina, Anna C.; Shirihai, Orian S.; Corkey, Barbara E.; Denis, Gerald V.			BET Bromodomain Proteins Brd2, Brd3 and Brd4 Selectively Regulate Metabolic Pathways in the Pancreatic beta-Cell	PLOS ONE			English	Article							MITOTIC CHROMOSOMES; NUCLEAR ANTIGEN; NILE RED; INHIBITION; DROSOPHILA; GENE; CHROMATIN; LEUKEMIA; OBESITY; CANCER	Displacement of Bromodomain and Extra-Terminal (BET) proteins from chromatin has promise for cancer and inflammatory disease treatments, but roles of BET proteins in metabolic disease remain unexplored. Small molecule BET inhibitors, such as JQ1, block BET protein binding to acetylated lysines, but lack selectivity within the BET family (Brd2, Brd3, Brd4, Brdt), making it difficult to disentangle contributions of each family member to transcriptional and cellular outcomes. Here, we demonstrate multiple improvements in pancreatic beta-cells upon BET inhibition with JQ1 or BET-specific siRNAs. JQ1 (50-400 nM) increases insulin secretion from INS-1 cells in a concentration dependent manner. JQ1 increases insulin content in INS-1 cells, accounting for increased secretion, in both rat and human islets. Higher concentrations of JQ1 decrease intracellular triglyceride stores in INS-1 cells, a result of increased fatty acid oxidation. Specific inhibition of both Brd2 and Brd4 enhances insulin transcription, leading to increased insulin content. Inhibition of Brd2 alone increases fatty acid oxidation. Overlapping yet discrete roles for individual BET proteins in metabolic regulation suggest new isoform-selective BET inhibitors may be useful to treat insulin resistant/diabetic patients. Results imply that cancer and diseases of chronic inflammation or disordered metabolism are related through shared chromatin regulatory mechanisms.	[Deeney, Jude T.; Shirihai, Orian S.; Corkey, Barbara E.] Evans Biomed Res Ctr, Obes Res Ctr, Endocrinol Sect, Dept Med, 650 Albany St,X804, Boston, MA 02118 USA; [Deeney, Jude T.; Shirihai, Orian S.; Corkey, Barbara E.] Boston Univ, Sch Med, 650 Albany St,X804, Boston, MA 02118 USA; [Belkina, Anna C.] Boston Univ, Sch Med, Flow Cytometry Core Facil, 650 Albany St,X326, Boston, MA 02118 USA; [Denis, Gerald V.] Canc Res Ctr, Dept Pharmacol & Expt Therapeut, 72 East Concord St,K520, Boston, MA 02118 USA; [Denis, Gerald V.] Canc Res Ctr, Sect Hematol Oncol, 72 East Concord St,K520, Boston, MA 02118 USA; [Denis, Gerald V.] Boston Univ, Sch Med, 72 East Concord St,K520, Boston, MA 02118 USA	Boston University; Boston University; Boston University	Denis, GV (corresponding author), Canc Res Ctr, Dept Pharmacol & Expt Therapeut, 72 East Concord St,K520, Boston, MA 02118 USA.; Denis, GV (corresponding author), Canc Res Ctr, Sect Hematol Oncol, 72 East Concord St,K520, Boston, MA 02118 USA.; Denis, GV (corresponding author), Boston Univ, Sch Med, 72 East Concord St,K520, Boston, MA 02118 USA.	gdenis@bu.edu	Belkina, Anna C/F-4816-2014	Belkina, Anna C/0000-0001-7967-6254; Denis, Gerald/0000-0001-9886-0401; Deeney, Jude/0000-0003-0988-9419	National Institutes of Health [DK090455, U01 CA182898, DK035914, PO1 DK46200]; Juvenile Diabetes Foundation [198230]; Zoltan Kohn Endowment; Evans Foundation Pilot Grant; CTSA [UL1 TR000157, UL1 TR001430, U54 TR001012]; NATIONAL CANCER INSTITUTE [U01CA182898] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [U54TR001012, UL1TR001430, UL1TR000157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK090455, R01DK074778, R37DK035914, R56DK035914, R01DK035914, P30DK046200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Foundation(Juvenile Diabetes Research Foundation); Zoltan Kohn Endowment; Evans Foundation Pilot Grant; CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health (DK090455 and U01 CA182898, GVD; DK035914, BEC/OOS; PO1 DK46200, BEC), Juvenile Diabetes Foundation Grant 198230, BEC; the Zoltan Kohn Endowment, BEC; Evans Foundation Pilot Grant, JTD; CTSA grants UL1 TR000157, UL1 TR001430 and U54 TR001012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballestas ME, 1999, SCIENCE, V284, P641, DOI 10.1126/science.284.5414.641; Banerjee C, 2012, J LEUKOCYTE BIOL, V92, P1147, DOI 10.1189/jlb.0312165; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Baud MGJ, 2014, SCIENCE, V346, P638, DOI 10.1126/science.1249830; BECK S, 1992, J DNA SEQ MAPP, V2, P203; Belkina AC, 2014, J LEUKOCYTE BIOL, V95, P451, DOI 10.1189/jlb.1112588; Belkina AC, 2013, J IMMUNOL, V190, P3670, DOI 10.4049/jimmunol.1202838; Belkina AC, 2012, NAT REV CANCER, V12, P465, DOI 10.1038/nrc3256; Ben Sahra I, 2010, MOL CANCER THER, V9, P1092, DOI 10.1158/1535-7163.MCT-09-1186; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CHUA P, 1995, MOL CELL BIOL, V15, P3685; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Denis GV, 2010, DISCOV MED, V10, P489; Denis Gerald V., 2008, P545; Denis GV, 2000, CELL GROWTH DIFFER, V11, P417; Denis GV, 1996, GENE DEV, V10, P261, DOI 10.1101/gad.10.3.261; Denis GV, 2001, FRONT BIOSCI, V6, pD849, DOI 10.2741/Denis; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; DIGAN ME, 1986, DEV BIOL, V114, P161, DOI 10.1016/0012-1606(86)90392-1; Dunphy EL, 2000, MOL CELL BIOL, V20, P1134, DOI 10.1128/MCB.20.4.1134-1139.2000; Erion KA, 2015, J BIOL CHEM, V290, P16191, DOI 10.1074/jbc.M114.620351; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Fong C. Y., 2015, NATURE; FOWLER SD, 1987, J LIPID RES, V28, P1225; French CA, 2008, ONCOGENE, V27, P2237, DOI 10.1038/sj.onc.1210852; French CA, 2003, CANCER RES, V63, P304; Fu WX, 2014, ELIFE, V3, DOI 10.7554/eLife.04631; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Greenwald RJ, 2004, BLOOD, V103, P1475, DOI 10.1182/blood-2003-06-2116; HAYNES SR, 1992, NUCLEIC ACIDS RES, V20, P2603, DOI 10.1093/nar/20.10.2603; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jeanmougin F, 1997, TRENDS BIOCHEM SCI, V22, P151, DOI 10.1016/S0968-0004(97)01042-6; Jiang YW, 1998, P NATL ACAD SCI USA, V95, P8538, DOI 10.1073/pnas.95.15.8538; Kelpe CL, 2003, J BIOL CHEM, V278, P30015, DOI 10.1074/jbc.M302548200; Korb E, 2015, NAT NEUROSCI; Kuras L, 2003, P NATL ACAD SCI USA, V100, P13887, DOI 10.1073/pnas.2036346100; Lehuen A, 2015, NEW ENGL J MED, V372, P778, DOI 10.1056/NEJMcibr1414708; LYGEROU Z, 1994, NUCLEIC ACIDS RES, V22, P5332, DOI 10.1093/nar/22.24.5332; Maruyama T, 2002, MOL CELL BIOL, V22, P6509, DOI 10.1128/MCB.22.18.6509-6520.2002; MAZO AM, 1990, P NATL ACAD SCI USA, V87, P2112, DOI 10.1073/pnas.87.6.2112; Mazur PK, 2015, NAT MED, V21, P1163, DOI 10.1038/nm.3952; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Mirguet O, 2013, J MED CHEM, V56, P7501, DOI 10.1021/jm401088k; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Platt GM, 1999, J VIROL, V73, P9789, DOI 10.1128/JVI.73.12.9789-9795.1999; Prentki M, 1996, DIABETES, V45, P273, DOI 10.2337/diabetes.45.3.273; Saadeh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030200; Sinha A, 2005, BIOCHEM J, V387, P257, DOI 10.1042/BJ20041793; TAMKUN JW, 1992, CELL, V68, P561, DOI 10.1016/0092-8674(92)90191-E; Toyama R, 2008, DEV DYNAM, V237, P1636, DOI 10.1002/dvdy.21576; Wang F, 2013, VITAM HORM, V91, P49, DOI 10.1016/B978-0-12-407766-9.00003-1; Wang FN, 2010, BIOCHEM J, V425, P71, DOI 10.1042/BJ20090928; Winston F, 1999, NAT STRUCT BIOL, V6, P601, DOI 10.1038/10640; Xiao Y, 2015, RHEUMATOLOGY OXFORD; Zhao YJ, 2013, J MED CHEM, V56, P7498, DOI 10.1021/jm4014407; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	58	47	49	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151329	10.1371/journal.pone.0151329	http://dx.doi.org/10.1371/journal.pone.0151329			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008626	Green Submitted, gold, Green Published			2022-12-26	WOS:000372701200050
J	Dummer, B; Ristau, K; Traunspurger, W				Duemmer, Birgit; Ristau, Kai; Traunspurger, Walter			Varying Patterns on Varying Scales: A Metacommunity Analysis of Nematodes in European Lakes	PLOS ONE			English	Article							FRESH-WATER NEMATODES; SEED SIZE; DISPERSAL; COMMUNITY; CONNECTIVITY; INVERTEBRATES; COLONIZATION; ORGANISMS; DIVERSITY; FRAMEWORK	Ecological community patterns are often extremely complex and the factors with the greatest influence on community structure have yet to be identified. In this study we used the elements of metacommunity structure (EMS) framework to characterize the metacommunities of freshwater nematodes in 16 European lakes at four geographical scales (radius ranging from 80 m to 360 km). The site characteristics associated with site scores indicative of the structuring gradient were identified using Spearman rank correlations. The metacommunities of the 174 nematode species included in this analysis mostly had a coherent pattern. The degree of turnover increased with increasing scale. Ordination scores correlated with geographical variables on the larger scales and with the trophic state index on a regional scale. The association of the structuring gradient with spatial variables and the scale-dependent increase in turnover showed that nematode dispersal was limited. The different metacommunity patterns identified at the increasing geographical scales suggested different, scale-related mechanisms of species distribution, with species sorting dominating on smaller and mass effects on larger geographical scales.	[Duemmer, Birgit; Ristau, Kai; Traunspurger, Walter] Univ Bielefeld, Anim Ecol, D-33615 Bielefeld, North Rhine Wes, Germany	University of Bielefeld	Dummer, B (corresponding author), Univ Bielefeld, Anim Ecol, D-33615 Bielefeld, North Rhine Wes, Germany.	birgit.duemmer@uni-bielefeld.de			Deutsche Forschungsgemeinschaft; Open Access Publication Fund of Bielefeld University	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publication Fund of Bielefeld University	We acknowledge support for the article processing charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of Bielefeld University.	Brown BL, 2010, J ANIM ECOL, V79, P571, DOI 10.1111/j.1365-2656.2010.01668.x; Bruun HH, 2006, OIKOS, V113, P402, DOI 10.1111/j.2006.0030-1299.14114.x; CARLSON RE, 1977, LIMNOL OCEANOGR, V22, P361, DOI 10.4319/lo.1977.22.2.0361; Chase JM, 2002, NATURE, V416, P427, DOI 10.1038/416427a; Cottenie K, 2003, FRESHWATER BIOL, V48, P823, DOI 10.1046/j.1365-2427.2003.01050.x; CULLEN DJ, 1973, NATURE, V242, P323, DOI 10.1038/242323a0; Dallas T, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00071.1; Dallas T, 2014, ECOGRAPHY, V37, P402, DOI 10.1111/j.1600-0587.2013.00695.x; Fenchel T, 2004, BIOSCIENCE, V54, P777, DOI 10.1641/0006-3568(2004)054[0777:TUOSSP]2.0.CO;2; Flach PZS, 2012, FUND APPL LIMNOL, V180, P249, DOI 10.1127/1863-9135/2012/0182; Fontaneto D, 2005, HYDROBIOLOGIA, V542, P131, DOI 10.1007/s10750-004-5495-6; Forbes AE, 2002, OIKOS, V96, P433, DOI 10.1034/j.1600-0706.2002.960305.x; Frisch D, 2007, AQUAT SCI, V69, P568, DOI 10.1007/s00027-007-0915-0; Giere O, 2009, MEIOBENTHOLOGY MICRO, DOI 10.1007/978-3-540-68661-3; Hajek M, 2011, J BIOGEOGR, V38, P1683, DOI 10.1111/j.1365-2699.2011.02503.x; Heino J, 2015, ECOL EVOL, V5, P1525, DOI 10.1002/ece3.1460; Heino J, 2012, OIKOS, V121, P537, DOI 10.1111/j.1600-0706.2011.19715.x; Henriques-Silva R, 2013, ECOLOGY, V94, P627, DOI 10.1890/12-0683.1; Hoagland BW, 1997, OIKOS, V78, P23, DOI 10.2307/3545796; Hodda M, 2006, FRESHWATER NEMATODES: ECOLOGY AND TAXONOMY, P179, DOI 10.1079/9780851990095.0179; Keith SA, 2011, OIKOS, V120, P302, DOI 10.1111/j.1600-0706.2010.18775.x; Kneitel JM, 2003, AM NAT, V162, P165, DOI 10.1086/376585; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Leibold MA, 2002, OIKOS, V97, P237, DOI 10.1034/j.1600-0706.2002.970210.x; MAGUIRE B, 1963, ECOL MONOGR, V33, P161, DOI 10.2307/1948560; McSorley R, 2003, FLA ENTOMOL, V86, P138, DOI 10.1653/0015-4040(2003)086[0138:AONTEE]2.0.CO;2; Moens T, 2006, FRESHWATER NEMATODES: ECOLOGY AND TAXONOMY, P105, DOI 10.1079/9780851990095.0105; Morisita M., 1971, Researches Popul Ecol Kyoto Univ, V13, P1, DOI 10.1007/BF02522010; Mouquet N., 2005, METACOMMUNITIES SPAT, P237; Pfannkuche O., 1988, P134; Presley SJ, 2010, OIKOS, V119, P908, DOI 10.1111/j.1600-0706.2010.18544.x; Presley SJ, 2010, GLOBAL ECOL BIOGEOGR, V19, P185, DOI 10.1111/j.1466-8238.2009.00505.x; Presley SJ, 2009, OECOLOGIA, V160, P781, DOI 10.1007/s00442-009-1341-x; Ptatscheck C, 2015, NEMATOLOGY, V17, P911, DOI 10.1163/15685411-00002913; Ristau K, 2015, ECOL INDIC, V53, P196, DOI 10.1016/j.ecolind.2015.01.010; Ristau K, 2011, HYDROBIOLOGIA, V663, P121, DOI 10.1007/s10750-010-0564-5; Seinhorst J. W., 1959, Nematologica, V4, P67; Seinhorst J. W., 1962, MARINE ECOLOGY PROGR, V8, P195; Soininen J, 2007, ECOSCIENCE, V14, P146, DOI 10.2980/1195-6860(2007)14[146:NNADOP]2.0.CO;2; Soons MB, 2008, J ECOL, V96, P619, DOI 10.1111/j.1365-2745.2008.01372.x; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; Thompson R, 2006, J ANIM ECOL, V75, P476, DOI 10.1111/j.1365-2656.2006.01068.x; Traunspurger W, 2006, FRESHWATER NEMATODES: ECOLOGY AND TAXONOMY, P46, DOI 10.1079/9780851990095.0046; Traunspurger W, 2002, FRESHWATER MEIOFAUNA: BIOLOGY AND ECOLOGY, P63; Traunspurger W, 1997, VIE MILIEU, V47, P1; Van De Meutter F, 2007, ECOLOGY, V88, P1687, DOI 10.1890/06-0333.1; Van der Gucht K, 2007, P NATL ACAD SCI USA, V104, P20404, DOI 10.1073/pnas.0707200104; Vanschoenwinkel B, 2008, OIKOS, V117, P125, DOI 10.1111/j.2007.0030-1299.16349.x; Vanschoenwinkel B, 2007, OIKOS, V116, P1255, DOI 10.1111/j.2007.0030-1299.15860.x; Yanoviak SP, 1999, SELBYANA, P106; YEATES GW, 1993, J NEMATOL, V25, P315; Zullini A, 2014, NEMATOLOGY, V16, P1, DOI 10.1163/15685411-00002779	52	14	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151866	10.1371/journal.pone.0151866	http://dx.doi.org/10.1371/journal.pone.0151866			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008422	Green Published, Green Submitted, gold			2022-12-26	WOS:000372701200072
J	Lloyd, JD				Lloyd, John D.			Phenotypic Variation in Mangrove Cuckoo (Coccyzus minor) across Its Geographic Range	PLOS ONE			English	Article								Mangrove Cuckoo (Coccyzus minor) exhibits substantial phenotypic variation across its geographic range, but the significance of this variation for taxonomy remains unresolved. Using measurements of bill size and ventral color recorded from 274 museum specimens, I found that variation in these traits was clinal. No named subspecies was reciprocally diagnosable from all others, and none was distinguishable from the nominate form, such that previously recognized subspecific distinctions are invalid. Greatest differences in phenotype occurred between populations in Florida, the Bahamas, and the Greater Antilles-characteristically small-billed-and those in the Lesser Antilles, which had larger bills. Phenotypically intermediate individuals on the geographically intermediate islands of Barbuda and Antigua linked these two extremes. Individuals intermediate in bill size and color also characterized populations from throughout the remainder of the range in northern South America and Middle America. Mechanisms maintaining the fairly pronounced phenotypic differences between nearby populations of Greater and Lesser Antillean birds are unknown, yet the geographic proximity of these populations suggests that they probably persist despite occasional gene flow, and may be adaptive.	[Lloyd, John D.] Vermont Ctr Ecostudies, Norwich, VT USA; [Lloyd, John D.] Ecostudies Inst, Mt Vernon, WA USA		Lloyd, JD (corresponding author), Vermont Ctr Ecostudies, Norwich, VT USA.; Lloyd, JD (corresponding author), Ecostudies Inst, Mt Vernon, WA USA.	jlloyd@vtecostudies.org		Lloyd, John/0000-0002-9143-3789				AMADON DEAN, 1949, CONDOR, V51, P250, DOI 10.2307/1364805; Amadon Dean, 1992, Bulletin of the British Ornithologists' Club, V112A, P11; American Ornithologists' Union, 1983, CHECK LIST N AM BIRD; Bangs Outram, 1907, Proceedings of the Biological Society of Washington, V20; BANKS R C, 1991, Caribbean Journal of Science, V27, P54; BROWN WL, 1956, SYST ZOOL, V5, P49, DOI 10.2307/2411924; Charrad M, 2014, J STAT SOFTW, V61, P1; Clark AH, 1905, P BOSTON SOC NATURAL, V32, P203; Clements JF, 2014, EBIRD CLEMENTS CHECK; Cruz A, 1975, STUD FAUNA CURACAO, V46, P109; FAABORG J, 1980, AUK, V97, P624; Gleffe JD, 2006, ORNITOL NEOTROP, V17, P271; Grant PR, 2006, SCIENCE, V313, P224, DOI 10.1126/science.1128374; GRANT PR, 1965, EVOLUTION, V19, P355, DOI 10.1111/j.1558-5646.1965.tb01727.x; Greenberg R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040933; Harper David G. C., 1994, Ringing and Migration, V15, P84; Hughes JM, 2010, BIRDS N AM; Kornerup A, 1963, METHUEN HDB COLOUR; LECK CF, 1972, WILSON BULL, V84, P498; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Lloyd JD, 2013, NEOTROPICAL BIRDS ON; Lovette IJ, 1998, AUK, V115, P890, DOI 10.2307/4089508; Oksanen J, 2022, R PACKAGE VERSION; Patten MA, 2002, AUK, V119, P26, DOI 10.1642/0004-8038(2002)119[0026:DVMDOS]2.0.CO;2; Paynter R. A. Jr., 1955, Bulletin of the Peabody Museum, VNo. 9, P1; Peters JL., 1940, CHECK LIST BIRDS WOR, V4; Raffaele H., 1998, GUIDE BIRDS W INDIES; Ridgway R, 1916, B US NATL MUSEUM, V50, P1, DOI DOI 10.5962/BHL.TITLE.54021; Ridgway R., 1902, B US NATL MUS, V50, P1; Riley JH, 1904, SMITHSONIAN MISCELLA, V47, P277; van ROSSEM A. J., 1934, BULL MUS COMP ZOOL, V77, P385; Venables WN., 2002, MODERN APPL STAT S 4; WUNDERLE JM, 1981, HERPETOLOGICA, V37, P104; [No title captured]; [No title captured]	35	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152141	10.1371/journal.pone.0152141	http://dx.doi.org/10.1371/journal.pone.0152141			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008380	gold, Green Submitted, Green Published			2022-12-26	WOS:000372701200096
J	Lozano-Ojalvo, D; Molina, E; Lopez-Fandino, R				Lozano-Ojalvo, Daniel; Molina, Elena; Lopez-Fandino, Rosina			Regulation of Exacerbated Immune Responses in Human Peripheral Blood Cells by Hydrolysed Egg White Proteins	PLOS ONE			English	Article							BALB/C MOUSE MODEL; IN-VITRO; ALLERGIC SENSITIZATION; ENZYMATIC-HYDROLYSIS; SOYBEAN ISOFLAVONES; IGE-BINDING; MAST-CELLS; PEPTIDES; MICE; IMMUNOTHERAPY	The anti-allergic potential of egg white protein hydrolysates (from ovalbumin, lysozyme and ovomucoid) was evaluated as their ability to hinder cytokine and IgE production by Th2-skewed human peripheral blood mononuclear cells (PBMCs), as well as the release of proinflammatory factors and generation of reactive oxygen species from Th1-stimulated peripheral blood leukocytes (PBLs). The binding to IgE of egg allergic patients was determined and the peptides present in the hydrolysates were identified. The hydrolysates with alcalase down-regulated the production of Th2-biased cytokines and the secretion of IgE to the culture media of Th2-skewed PBMCs, and they significantly neutralized oxidative stress in PBLs. The hydrolysates of ovalbumin and ovomucoid with pepsin helped to re-establish the Th1/Th2 balance in Th2-biased PBMCs, while they also inhibited the release of pro-inflammatory mediators and reduced oxidative stress in PBLs treated with inflammatory stimuli. The hydrolysates with alcalase, in addition to equilibrating Th2 differentiation, exhibited a low IgE-binding. Therefore, they would elicit mild allergic reactions while retaining T cell-stimulating abilities, which might correlate with an anti-allergic benefit.	[Lozano-Ojalvo, Daniel; Molina, Elena; Lopez-Fandino, Rosina] CSIC UAM, Inst Invest Ciencias Alimentac CIAL, Nicolas Cabrera 9, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UAM - Instituto de Investigacion en Ciencias de la Alimentacion (CIAL)	Lopez-Fandino, R (corresponding author), CSIC UAM, Inst Invest Ciencias Alimentac CIAL, Nicolas Cabrera 9, Madrid 28049, Spain.	rosina.lopez@csic.es	López-Fandiño, Rosina/H-4132-2012; Molina, Elena/H-4055-2012; Lozano-Ojalvo, Daniel/AAH-6261-2019; Lozano-Ojalvo, Daniel/AAH-6278-2019	López-Fandiño, Rosina/0000-0002-6979-9258; Molina, Elena/0000-0001-7918-7768; Lozano-Ojalvo, Daniel/0000-0002-3524-2929; Lozano-Ojalvo, Daniel/0000-0002-3524-2929	Ministerio de Economia y Competitividad (MINECO, Spain) [AGL2014-59771-R]; Ministerio de Educacion, Cultura y Deporte (MECD, Spain)	Ministerio de Economia y Competitividad (MINECO, Spain); Ministerio de Educacion, Cultura y Deporte (MECD, Spain)(German Research Foundation (DFG))	Financial support was received from the project AGL2014-59771-R from Ministerio de Economia y Competitividad (MINECO, Spain). DL-O is recipient of a FPU fellowship from Ministerio de Educacion, Cultura y Deporte (MECD, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes PJ, 2011, IMMUNOL REV, V242, P31, DOI 10.1111/j.1600-065X.2011.01020.x; Benede S, 2014, J AGR FOOD CHEM, V62, P152, DOI 10.1021/jf404226w; Benede S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080810; Berin MC, 2013, CURR BIOL, V23, pR389, DOI 10.1016/j.cub.2013.02.043; Brix S, 2003, J ALLERGY CLIN IMMUN, V112, P1216, DOI 10.1016/j.jaci.2003.08.047; Cecilia M, 2008, J ALLERGY CLIN IMMUN, V121, P1311, DOI 10.1016/j.jaci.2008.04.023; Chicon R, 2006, J DAIRY RES, V73, P121, DOI 10.1017/S0022029905001664; Cosentino M, 2008, J ETHNOPHARMACOL, V116, P501, DOI 10.1016/j.jep.2007.12.014; Davalos A, 2004, J FOOD PROTECT, V67, P1939, DOI 10.4315/0362-028X-67.9.1939; Hacini-Rachinel F, 2014, INT ARCH ALLERGY IMM, V164, P64, DOI 10.1159/000363110; HANSEN MB, 1989, J IMMUNOL METHODS, V119, P203, DOI 10.1016/0022-1759(89)90397-9; Holvoet S, 2013, INT ARCH ALLERGY IMM, V161, P142, DOI 10.1159/000343703; Jaervinen KM, 2007, ALLERGY, V62, P758, DOI 10.1111/j.1398-9995.2007.01332.x; Jimenez-Saiz R, 2014, MOL NUTR FOOD RES, V58, P614, DOI 10.1002/mnfr.201300442; Jimenez-Saiz R, 2013, FOOD HYDROCOLLOID, V30, P597, DOI 10.1016/j.foodhyd.2012.07.014; Kulis M, 2012, J ALLERGY CLIN IMMUN, V130, P716, DOI 10.1016/j.jaci.2012.05.044; Lopez-Exposito I, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-35; Masilamani M, 2012, IMMUNOL RES, V54, P95, DOI 10.1007/s12026-012-8331-5; Masilamani M, 2011, J ALLERGY CLIN IMMUN, V128, P1242, DOI 10.1016/j.jaci.2011.05.009; Mine Y, 2004, J AGR FOOD CHEM, V52, P1088, DOI 10.1021/jf0345752; Moldaver D, 2011, ALLERGY, V66, P784, DOI 10.1111/j.1398-9995.2011.02610.x; Nwaru BI, 2014, ALLERGY, V69, P992, DOI 10.1111/all.12423; Palomares O, 2010, EUR J IMMUNOL, V40, P1232, DOI 10.1002/eji.200940045; Park BK, 2013, J NUTR BIOCHEM, V24, P868, DOI 10.1016/j.jnutbio.2012.05.007; Pascal M, 2013, CLIN EXP ALLERGY, V43, P116, DOI 10.1111/cea.12014; Richard N, 2005, MOL NUTR FOOD RES, V49, P431, DOI 10.1002/mnfr.200400099; ROUSSET F, 1991, J EXP MED, V173, P705, DOI 10.1084/jem.173.3.705; Rupa P, 2012, ALLERGY, V67, P74, DOI 10.1111/j.1398-9995.2011.02724.x; Samaranayaka AGP, 2011, J FUNCT FOODS, V3, P229, DOI 10.1016/j.jff.2011.05.006; Sicherer SH, 2011, J ALLERGY CLIN IMMUN, V127, P594, DOI 10.1016/j.jaci.2010.11.044; Singh A, 2011, CLIN EXP ALLERGY, V41, P1346, DOI 10.1111/j.1365-2222.2011.03773.x; Untersmayr E, 2007, J ALLERGY CLIN IMMUN, V119, P711, DOI 10.1016/j.jaci.2006.10.039; van den Elsen LWJ, 2013, CLIN EXP ALLERGY, V43, P798, DOI 10.1111/cea.12111; van den Elsen LWJ, 2013, BRIT J NUTR, V109, P1821, DOI 10.1017/S0007114512003959; Yang M, 2010, CLIN EXP ALLERGY, V40, P668, DOI 10.1111/j.1365-2222.2009.03442.x; Yang M, 2009, J AGR FOOD CHEM, V57, P2241, DOI 10.1021/jf803372b; Yano S, 2007, EUR J NUTR, V46, P257, DOI 10.1007/s00394-007-0658-7; You SJ, 2010, FOOD RES INT, V43, P848, DOI 10.1016/j.foodres.2009.12.004; Zaknun D, 2012, INT ARCH ALLERGY IMM, V157, P113, DOI 10.1159/000329137; Zuercher AW, 2010, CLIN EXP ALLERGY, V40, P942, DOI 10.1111/j.1365-2222.2010.03460.x	40	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151813	10.1371/journal.pone.0151813	http://dx.doi.org/10.1371/journal.pone.0151813			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007699	gold, Green Published, Green Submitted			2022-12-26	WOS:000372701200067
J	Qekwana, DN; Oguttu, JW; Venter, D; Odoi, A				Qekwana, Daniel Nenene; Oguttu, James Wabwire; Venter, Dries; Odoi, Agricola			Disparities in Beef Tapeworm Identification Rates in the Abattoirs of Gauteng Province, South Africa: A Descriptive Epidemiologic Study	PLOS ONE			English	Article							TAENIA-SAGINATA CYSTICERCOSIS; BOVINE CYSTICERCOSIS; FEEDLOT CATTLE; PREVALENCE; OUTBREAK; DAIRY	Background Bovine Taenia saginata cysticercus infections (also called bovine cysticercosis or beef measles) is usually diagnosed in cattle only during post-mortem meat inspection. The aim of this study was to investigate the identification rates of these infections in and to identify predictors/determinants of variations in the identification rates in abattoirs in Gauteng province, South Africa. Methods Retrospective data for over 1.4 million cattle carcasses inspected in 26 abattoirs between January 2010 and December 2013 were used for the study. The identification rates (proportion of bovine Taenia saginata cysticercus positive carcasses) were computed and generalized estimating equations used to identify predictors/determinants of identification rates. Results The overall identification rate was 0.70% (95% CI: 0.45, 0.95). Significantly (p< 0.05) lower rates were reported during summer (0.55%) than other seasons. Some geographic areas reported significantly (p<0.05) higher rates than others. The identification rates in high throughput abattoirs was significantly (p<0.05) higher (RR: 9.4; 95% CI: 4.7-19.1) than in low throughput abattoirs. Similarly, the identification rates among animals from feedlots were significantly (p<0.05) higher (RR: 1.6; 95% CI: 1.7-3.5) than those from non-feedlot sources. No significant (p>0.05) association was identified between identification rates and either the number of meat inspectors per abattoir or the provider of inspection services. Conclusion Although no significant association was found between identification rates and provider of inspection services, follow-up studies will need to be done to specifically investigate the potential conflict of interest arising from the fact that abattoir owners hire meat inspection services directly. Capture of abattoir surveillance data needs to include farm address and for each case to be reported separately. Finally, information on the type of identified cysts (alive or calcified) need to be collected to help better estimate risk to consumers. This study provides useful baseline data to guide future studies, surveillance and control efforts.	[Qekwana, Daniel Nenene; Odoi, Agricola] Univ Pretoria, Fac Vet Sci, Dept Paraclin Sci, Sect Vet Publ Hlth, ZA-0002 Pretoria, South Africa; [Oguttu, James Wabwire] Univ S Africa, Coll Agr & Environm Sci, Dept Agr & Anim Hlth, Johannesburg, South Africa; [Venter, Dries] Vet Serv Directory, Gauteng Dept Agr & Rural Dev, Pretoria, South Africa; [Odoi, Agricola] Univ Tennessee, Coll Vet Med, Biomed & Diagnost Sci, Knoxville, TN USA	University of Pretoria; University of South Africa; University of Tennessee System; University of Tennessee Knoxville; UT Institute of Agriculture	Odoi, A (corresponding author), Univ Pretoria, Fac Vet Sci, Dept Paraclin Sci, Sect Vet Publ Hlth, ZA-0002 Pretoria, South Africa.; Odoi, A (corresponding author), Univ Tennessee, Coll Vet Med, Biomed & Diagnost Sci, Knoxville, TN USA.	aodoi@utk.edu	Odoi, Agricola/I-9532-2019; Oguttu, James W/F-4670-2014; Qekwana, Nenene/AAP-7454-2020	Odoi, Agricola/0000-0001-5050-6737; Oguttu, James W/0000-0001-6810-4437; Qekwana, Nenene/0000-0002-4609-5151				Allepuz A, 2009, VET PARASITOL, V159, P43, DOI 10.1016/j.vetpar.2008.09.027; Boone I, 2007, PREV VET MED, V82, P1, DOI 10.1016/j.prevetmed.2007.05.002; Cabaret J, 2002, VET RES, V33, P575, DOI 10.1051/vetres:2002040; COLLIER L, 1998, TOPLEY WILSONS MICRO; Department of Agriculture F Fisheries, 2012, PROP MEAT INSP SERV; Dorny P, 2007, VET PARASITOL, V149, P22, DOI 10.1016/j.vetpar.2007.07.004; Dorny P, 2000, VET PARASITOL, V88, P43, DOI 10.1016/S0304-4017(99)00196-X; Dupuy C., 2012, CONTRIBUTION MEAT IN, V9, P53; Dupuy C, 2015, FOOD CONTROL, V47, P348, DOI 10.1016/j.foodcont.2014.07.025; Dupuy C, 2014, VET PARASITOL, V203, P65, DOI 10.1016/j.vetpar.2014.02.054; Dyson LL, 2009, WATER SA, V35, P627; Dzoma Blessing M., 2011, Journal of Human Ecology, V36, P9; Ebel E, 1994, P 8 INT C AN HYG 199; Eichenberger RM, 2013, INT J PARASITOL, V43, P853, DOI 10.1016/j.ijpara.2013.05.011; Eichenberger RM, 2011, FOOD CONTROL, V22, P989, DOI 10.1016/j.foodcont.2010.11.033; Garedaghi Y., 2011, American Journal of Animal and Veterinary Sciences, V6, P121, DOI 10.3844/ajavsp.2011.121.124; Geysen D, 2007, J FOOD PROTECT, V70, P236, DOI 10.4315/0362-028X-70.1.236; Jenkins DJ, 2013, AUST VET J, V91, P89, DOI 10.1111/avj.12023; Karanikas ID, 2007, T ROY SOC TROP MED H, V101, P527, DOI 10.1016/j.trstmh.2006.07.004; Lees W, 2002, CAN VET J, V43, P227; Patel NM, 2007, WORLD J GASTROENTERO, V13, P5540, DOI 10.3748/wjg.v13.i41.5540; Scandrett B, 2009, VET PARASITOL, V164, P223, DOI 10.1016/j.vetpar.2009.05.015; SLONKA GF, 1978, AM J TROP MED HYG, V27, P101, DOI 10.4269/ajtmh.1978.27.101; Sungirai M, 2014, TROP ANIM HEALTH PRO, V46, P623, DOI 10.1007/s11250-014-0538-0; Terefe Y, 2014, ONDERSTEPOORT J VET, V81, DOI 10.4102/ojvr.v81i1.676; YODER DR, 1994, J AM VET MED ASSOC, V205, P45	26	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151725	10.1371/journal.pone.0151725	http://dx.doi.org/10.1371/journal.pone.0151725			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008629	Green Published, gold			2022-12-26	WOS:000372701200062
J	Zapalski, MK; Berkowski, B; Wrzolek, T				Zapalski, Mikolaj K.; Berkowski, Blazej; Wrzolek, Tomasz			Tabulate Corals after the Frasnian/Famennian Crisis: A Unique Fauna from the Holy Cross Mountains, Poland	PLOS ONE			English	Article							YAVORSKIA TABULATA; GROWTH-PATTERN; TRIMEROCEPHALUS; BRACHIOPODS; ARDENNES; EXAMPLE; KOWALA; REGION; MIDDLE	Famennian tabulate corals were very rare worldwide, and their biodiversity was relatively low. Here we report a unique tabulate fauna from the mid-and late Famennian of the western part of the Holy Cross Mountains (Kowala and Ostrowka), Poland. We describe eight species (four of them new, namely ? Michelinia vinni sp. nov., Thamnoptychia mistiaeni sp. nov., Syringopora kowalensis sp. nov. and Syringopora hilarowiczi sp. nov.); the whole fauna consists of ten species (two others described in previous papers). These corals form two assemblages-the lower, mid-Famennian with Thamnoptychia and the upper, late Famennian with representatives of genera ? Michelinia, Favosites, Syringopora and ? Yavorskia. The Famennian tabulates from Kowala represent the richest Famennian assemblage appearing after the F/F crisis (these faunas appear some 10 Ma after the extinction event). Corals described here most probably inhabited deeper water settings, near the limit between euphotic and disphotic zones or slightly above. At generic level, these faunas show similarities to other Devonian and Carboniferous faunas, which might suggest their ancestry to at least several Carboniferous lineages. Tabulate faunas described here represent new recruits (the basin of the Holy Cross mountains was not a refuge during the F/F crisis) and have no direct evolutionary linkage to Frasnian faunas from Kowala. The colonization of the seafloor took place in two separate steps: first was monospecific assemblage of Thamnoptychia, and later came the diversified Favosites-Syringopora-Michelinia fauna.	[Zapalski, Mikolaj K.] Univ Warsaw, Fac Geol, Warsaw, Poland; [Berkowski, Blazej] Adam Mickiewicz Univ, Inst Geol, Poznan, Poland; [Wrzolek, Tomasz] Univ Silesia, Fac Earth Sci, Sosnowiec, Poland	University of Warsaw; Adam Mickiewicz University; University of Silesia in Katowice	Zapalski, MK (corresponding author), Univ Warsaw, Fac Geol, Warsaw, Poland.	m.zapalski@uw.edu.pl	Zapalski, Mikolaj/D-6359-2017; Berkowski, Blazej/A-1244-2008	Zapalski, Mikolaj/0000-0002-9853-3707; Berkowski, Blazej/0000-0001-7249-0182; Wrzolek, Tomasz/0000-0002-1467-8969	University of Warsaw, Faculty of Geology; Adam Mickiewicz University, Faculty of Geographical and Geological Sciences	University of Warsaw, Faculty of Geology; Adam Mickiewicz University, Faculty of Geographical and Geological Sciences	The research has been funded by the University of Warsaw, Faculty of Geology (funding for MKZ) and Adam Mickiewicz University, Faculty of Geographical and Geological Sciences (funding for BB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELKA Z., 2008, GEOLOGY CENTRAL EURO, P383, DOI DOI 10.1144/CEV1P.8; BERKOWSKI B, 1991, Acta Palaeontologica Polonica, V36, P255; Berkowski Blazej, 2002, Palaeontologia Polonica, V61, P3; Berkowski B, 2014, LETHAIA, V47, P176, DOI 10.1111/let.12048; Berkowski Blazej, 2001, Bulletin of the Tohoku University Museum, V1, P285; Copper P, 2002, PALAEOGEOGR PALAEOCL, V181, P27, DOI 10.1016/S0031-0182(01)00472-2; Coronado I, 2015, PALAEONTOLOGY, V58, P111, DOI 10.1111/pala.12127; Czarnocki J., 1989, PRACE PANSTWOWEGO I, V127, P5; De Vleeschouwer D, 2013, EARTH PLANET SC LETT, V365, P25, DOI 10.1016/j.epsl.2013.01.016; Denayer J, 2014, J ASIAN EARTH SCI, V79, P345, DOI 10.1016/j.jseaes.2013.10.012; Dubatolov VN, 1977, T I GIEOLOGII GIEOFI, V336, P3; Dubatolov VN, 1963, POZDENSILURIISKIE DE; Dzik J., 1997, ACTA PALAEONTOLOGICA, V47, P565; Dzik Jerzy, 2006, Palaeontologia Polonica, V63, P1; Feist Raimund, 1994, Courier Forschungsinstitut Senckenberg, V169, P195; Gerth H., 1921, PALAONTOLOGIE TIMOR, V11, P67; Halamski AT, 2009, ACTA PALAEONTOL POL, V54, P289, DOI 10.4202/app.2007.0066; Hill D., 1981, TREATISE INVERTEBRAT, pF430; Hubert BLM, 2007, ACTA GEOL POL, V57, P223; JOHNSON JG, 1985, GEOL SOC AM BULL, V96, P567, DOI 10.1130/0016-7606(1985)96<567:DEFIE>2.0.CO;2; Kin A, 2013, ZOOTAXA, V3626, P345, DOI 10.11646/zootaxa.3626.3.3; Kowala Malec J., 1995, 13 INT C CARB PERM A, P15; Kozur H., 1991, GEOL PALAONT MITT IN, V3, P25; Kuhn A, 1995, GEOL Q, V39, P43; LAFUSTE J, 1988, GEOBIOS-LYON, V21, P515, DOI 10.1016/S0016-6995(88)80048-2; Malec J, 2014, GEOL Q, V58, P217, DOI 10.7306/gq.1142; Marynowski L, 2000, SEDIMENT GEOL, V137, P187, DOI 10.1016/S0037-0738(00)00157-3; Marynowski L, 2007, GEOL MAG, V144, P569, DOI 10.1017/S0016756807003317; Marynowski L, 2012, PALAEOGEOGR PALAEOCL, V346, P66, DOI 10.1016/j.palaeo.2012.05.020; Marynowski L, 2010, GEOL MAG, V147, P527, DOI 10.1017/S0016756809990835; May Andreas, 2006, Bulletin of Geosciences, V81, P163, DOI 10.3140/bull.geosci.2006.03.163; Motus Mari-Ann, 2006, Proceedings of the Estonian Academy of Sciences Geology, V55, P24; NELSON SJ, 1962, J PALEONTOL, V36, P953; Nowinski A., 1992, ACTA PALAENTOL POL, V37, P183; Nowinski A., 1976, PALAEONTOLOGIA POLON, V35, P3; OGG JG, 1987, INITIAL REPORTS DEEP, V93, P1305; Olempska E, 1997, ACTA PALAEONTOL POL, V42, P291; Pisarzowska A, 2006, ACTA PALAEONTOL POL, V51, P609; Poty E, 1999, PALAEOGEOGR PALAEOCL, V154, P11, DOI 10.1016/S0031-0182(99)00084-X; Radwanski A, 2009, ACTA GEOL POL, V59, P459; Rozkowska M., 1969, Acta Palaeontologica Polonica, V14, P5; SHILO N A, 1984, Annales de la Societe Geologique de Belgique, V107, P137; SIMAKOV K V, 1983, Annales de la Societe Geologique de Belgique, V106, P335; Sokolov BS, 1952, CHAST 4 DEVON RUSSKO; STASINSKA A, 1973, Acta Geologica Polonica, V23, P83; STASINSKA ANNA, 1958, ACTA PALEONTOL POLONICA, V3, P161; SZULCZEWSKI M, 1971, Acta Geologica Polonica, V21, P1; SZULCZEWSKI M, 1973, Acta Geologica Polonica, V23, P15; SZULCZEWSKI M, 1978, Acta Geologica Polonica, V28, P283; Szulczewski M, 1996, SEDIMENT GEOL, V106, P21, DOI 10.1016/0037-0738(95)00145-X; Szulczewski M., 1995, 13 INT C CARB PERM G, P18; Szulczewski M., 1995, GEOL Q, V39, P471; Talent JA, 1986, SENCKENBERG LETH, V69, P315; TCHUDINOVA II, 1974, J PALEONTOL, V48, P124; Tchudinova II., 1970, NOVYE VIDY PALIEOZOI, P97; Tchudinova II, 1986, SOSTAV SISTEMA FILOG; Tourneur F., 1985, THESIS U CATHOLIQUE; Weyer D., 1997, CORAL RES B, V5, P247; Weyer D., 1976, HB GEOLOGIE, V7-8, P353; Wood R. A., 1999, REEF EVOLUTION; Zapalski MK, 2007, B SOC GEOL FR, V178, P383, DOI 10.2113/gssgfbull.178.5.383; Zapalski MK, 2008, ACTA GEOL POL, V58, P321; Zapalski MK, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2663; Zapalski MK, 2013, LETHAIA, V46, P223, DOI 10.1111/let.12005; Zapalski MK, 2012, SPEC PAP PALAEONTOL, P5; Zapalski MK, 2012, ACTA GEOL POL, V62, P197; Zapalski MK, 2012, PALAEONTOLOGY, V55, P697, DOI 10.1111/j.1475-4983.2012.01141.x; Zapalski MK, 2011, GEODIVERSITAS, V33, P541, DOI 10.5252/g2011n4a1	68	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0149767	10.1371/journal.pone.0149767	http://dx.doi.org/10.1371/journal.pone.0149767			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007689	Green Published, Green Submitted, gold			2022-12-26	WOS:000372701200019
J	Kong, BS; Im, SJ; Lee, YJ; Cho, YH; Do, YR; Byun, JW; Ku, CR; Lee, EJ				Kong, Byung Soo; Im, Soo Jung; Lee, Yang Jong; Cho, Yoon Hee; Do, Yu Ri; Byun, Jung Woo; Ku, Cheol Ryong; Lee, Eun Jig			Vasculoprotective Effects of 3-Hydroxybenzaldehyde against VSMCs Proliferation and ECs Inflammation	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELL; MATRIX METALLOPROTEINASE-2 EXPRESSION; MIGRATION; ATHEROSCLEROSIS; DEHYDROGENASE; INHIBITORS	3-hydroxybenzaldehyde (3-HBA) is a precursor compound for phenolic compounds like Protocatechuic aldehyde (PCA). From recent reports, PCA has shown vasculoprotective potency, but the effects of 3-HBA remain unclear. The aim of this study is to investigate the vasculoprotective effects of 3-HBA in endothelial cells, vascular smooth muscle cells and various animal models. We tested effects of 3-HBA in both vitro and vivo. 3-HBA showed that it prevents PDGF-induced vascular smooth muscle cells (VSMCs) migration and proliferation from MTS, BrdU assays and inhibition of AKT phosphorylation. It arrested S and G0/G1 phase of VSMC cell cycle in PI staining and it also showed inhibited expression levels of Rb1 and CD1. In human umbilical vein endothelial cells (HUVECs), 3-HBA inhibited inflammatory markers and signaling molecules (VCAM-1, ICAM-1, p-NF-kappa B and p-p38). For ex vivo, 3-HBA has shown dramatic effects in suppressing the sprouting from aortic ring of Spargue Dawley (SD) rats. In vivo data supported the vasculoprotective effects of 3-HBA as it inhibited angiogenesis from Matrigel Plug assay in C57BL6mouse, prevented ADP-induced thrombus generation, increased blood circulation after formation of thrombus, and attenuated neointima formation induced by common carotid artery balloon injury of SD rats. 3-HBA, a novel therapeutic agent, has shown vasculoprotective potency in both in vitro and in vivo.	[Kong, Byung Soo; Im, Soo Jung; Lee, Yang Jong; Byun, Jung Woo] Yonsei Univ, Brain Korea PLUS Project Med Sci 21, Seoul 120749, South Korea; [Kong, Byung Soo; Im, Soo Jung; Lee, Yang Jong; Cho, Yoon Hee; Do, Yu Ri; Byun, Jung Woo; Ku, Cheol Ryong; Lee, Eun Jig] Yonsei Univ, Coll Med, Endocrinol, Inst Endocrine Res, Seoul, South Korea	Yonsei University; Yonsei University; Yonsei University Health System	Lee, EJ (corresponding author), Yonsei Univ, Coll Med, Endocrinol, Inst Endocrine Res, Seoul, South Korea.	ejlee423@yuhs.ac		Ku, Cheol Ryong/0000-0001-8693-9630; Lee, Eun Jig/0000-0002-9876-8370; Kong, ByungSoo/0000-0002-7916-7422	Korea Health 21 Research and Development Project, Ministry of Health & Welfare, Republic of Korea [A085136]	Korea Health 21 Research and Development Project, Ministry of Health & Welfare, Republic of Korea	This work was supported by a grant (A085136) from the Korea Health 21 Research and Development Project, Ministry of Health & Welfare, Republic of Korea (http://www.nrf.re.kr/nrf).	[Anonymous], 2006, INT J TOXICOL, V25, P11, DOI 10.1080/10915910600716612; Arican D, 2013, ORG LETT, V15, P2582, DOI 10.1021/ol400510j; Barradas S, 2012, ORG LETT, V14, P5952, DOI 10.1021/ol302858r; Cai XL, 2014, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2014-96; Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6; Chen S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122577; Chistiakov DA, 2015, ACTA PHYSIOL, V214, P33, DOI 10.1111/apha.12466; Choi YS, 2009, BLOOD, V114, P3117, DOI 10.1182/blood-2009-02-203372; Cui Y, 2014, MOL CELL BIOCHEM, V393, P255, DOI 10.1007/s11010-014-2068-5; FORRESTER PI, 1972, BIOCHEMISTRY-US, V11, P1108, DOI 10.1021/bi00756a026; Frantz S, 2005, CIRC RES, V96, P15, DOI 10.1161/01.RES.0000153188.68898.ac; Furuno K, 2002, BIOL PHARM BULL, V25, P19, DOI 10.1248/bpb.25.19; Gao J, 2008, J BIOMOL SCREEN, V13, P648, DOI 10.1177/1087057108320545; Han HS, 2014, ENDOCRINOL METAB, V29, P435, DOI 10.3803/EnM.2014.29.4.435; Jeong HJ, 2006, BIOORG MED CHEM LETT, V16, P5576, DOI 10.1016/j.bmcl.2006.08.031; Jeong JY, 2013, ENDOCRINOL METAB, V28, P288, DOI 10.3803/EnM.2013.28.4.288; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; KLUWE WM, 1983, FOOD CHEM TOXICOL, V21, P245, DOI 10.1016/0278-6915(83)90055-8; Kong BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113242; Lee HJ, 2014, CURR MED CHEM, V21, P3095, DOI 10.2174/0929867321666140601195940; Ma L, 2015, EUR J PHARMACOL, V755, P102, DOI 10.1016/j.ejphar.2015.02.039; Ma YL, 2014, INT J MOL SCI, V15, P16611, DOI 10.3390/ijms150916611; MARSELOS M, 1988, TOXICOL APPL PHARM, V95, P339, DOI 10.1016/0041-008X(88)90170-6; Melian A, 1999, AM J PATHOL, V155, P775, DOI 10.1016/S0002-9440(10)65176-0; Miyabe M, 2014, CARDIOVASC RES, V103, P111, DOI 10.1093/cvr/cvu105; Moon CY, 2012, BIOCHEM BIOPH RES CO, V423, P116, DOI 10.1016/j.bbrc.2012.05.092; Rauch BH, 2000, FEBS LETT, V481, P3, DOI 10.1016/S0014-5793(00)01957-8; Rocha GM, 2001, P NATL ACAD SCI USA, V98, P5317, DOI 10.1073/pnas.091057698; Sabir M, 2014, CELL ONCOL, V37, P203, DOI 10.1007/s13402-014-0173-9; Seo MH, 2014, ENDOCRINOL METAB, V29, P427, DOI 10.3803/EnM.2014.29.4.427; Singh V, 2015, BRIT J NUTR, V113, P100, DOI 10.1017/S0007114514003195; Song W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111093; Thanigaimalai P, 2010, BIOORG MED CHEM LETT, V20, P2991, DOI 10.1016/j.bmcl.2010.02.067; Wang M, 2013, BIOORG MED CHEM LETT, V23, P524, DOI 10.1016/j.bmcl.2012.11.031; Wang RS, 2002, DRUG METAB DISPOS, V30, P69, DOI 10.1124/dmd.30.1.69; Xu SX, 2015, THROMB RES, V135, P137, DOI 10.1016/j.thromres.2014.10.034; Yi L, 2012, BIOCHIMIE, V94, P2035, DOI 10.1016/j.biochi.2012.05.027; Yoo SJ, 2014, ENDOCRINOL METAB, V29, P356, DOI 10.3803/EnM.2014.29.3.356; Yu X, 2015, CURR VASC PHARM; Zhang WC, 2015, CARDIOVASC RES, V106, P453, DOI 10.1093/cvr/cvv110	40	18	18	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0149394	10.1371/journal.pone.0149394	http://dx.doi.org/10.1371/journal.pone.0149394			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002821	gold, Green Submitted, Green Published			2022-12-26	WOS:000372697400009
J	Lewin, GR; Johnson, AL; Soto, RDM; Perry, K; Book, AJ; Horn, HA; Pinto-Tomas, AA; Currie, CR				Lewin, Gina R.; Johnson, Amanda L.; Moreira Soto, Rolando D.; Perry, Kailene; Book, Adam J.; Horn, Heidi A.; Pinto-Tomas, Adrian A.; Currie, Cameron R.			Cellulose-Enriched Microbial Communities from Leaf-Cutter Ant (Atta colombica) Refuse Dumps Vary in Taxonomic Composition and Degradation Ability	PLOS ONE			English	Article							SP-NOV.; CUTTING ANT; CD-HIT; BACTERIAL; DIVERSITY; DISCOVERY; DECOMPOSITION; BIODIVERSITY; HERBIVORY; DIGESTION	Deconstruction of the cellulose in plant cell walls is critical for carbon flow through ecosystems and for the production of sustainable cellulosic biofuels. Our understanding of cellulose deconstruction is largely limited to the study of microbes in isolation, but in nature, this process is driven by microbes within complex communities. In Neotropical forests, microbes in leaf-cutter ant refuse dumps are important for carbon turnover. These dumps consist of decaying plant material and a diverse bacterial community, as shown here by electron microscopy. To study the portion of the community capable of cellulose degradation, we performed enrichments on cellulose using material from five Atta colombica refuse dumps. The ability of enriched communities to degrade cellulose varied significantly across refuse dumps. 16S rRNA gene amplicon sequencing of enriched samples identified that the community structure correlated with refuse dump and with degradation ability. Overall, samples were dominated by Bacteroidetes, Gammaproteobacteria, and Betaproteobacteria. Half of abundant operational taxonomic units (OTUs) across samples were classified within genera containing known cellulose degraders, including Acidovorax, the most abundant OTU detected across samples, which was positively correlated with cellulolytic ability. A representative Acidovorax strain was isolated, but did not grow on cellulose alone. Phenotypic and compositional analyses of enrichment cultures, such as those presented here, help link community composition with cellulolytic ability and provide insight into the complexity of community-based cellulose degradation.	[Lewin, Gina R.; Johnson, Amanda L.; Perry, Kailene; Book, Adam J.; Currie, Cameron R.] Univ Wisconsin, Dept Energy, Great Lakes Bioenergy Res Ctr, Madison, WI USA; [Lewin, Gina R.; Johnson, Amanda L.; Perry, Kailene; Book, Adam J.; Horn, Heidi A.; Currie, Cameron R.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Moreira Soto, Rolando D.; Pinto-Tomas, Adrian A.] Univ Costa Rica, Ctr Invest Estruct Microscop, San Jose, Costa Rica; [Moreira Soto, Rolando D.] Univ Costa Rica, Ctr Invest Enfermedades Trop, San Jose, Costa Rica; [Pinto-Tomas, Adrian A.] Univ Costa Rica, Fac Med, Dept Bioquim, San Jose, Costa Rica; [Pinto-Tomas, Adrian A.] Univ Costa Rica, Ctr Invest Biol Celular & Mol, San Jose, Costa Rica	United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Universidad Costa Rica; Universidad Costa Rica; Universidad Costa Rica; Universidad Costa Rica	Currie, CR (corresponding author), Univ Wisconsin, Dept Energy, Great Lakes Bioenergy Res Ctr, Madison, WI USA.; Currie, CR (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.	currie@bact.wisc.edu	Lewin, Gina/ADZ-5997-2022	Lewin, Gina/0000-0002-1189-6696	Great Lakes Bioenergy Research Center [Department of Energy, Office of Science, Biological and Environmental Research] [DE-FC02-07ER64494]; National Science Foundation [DGE-1256259, DEB-0747002, MCB-0702025]; National Institutes of Health [National Research Service Award] [T32 GM07215]; UW-Madison's Hilldale Undergraduate/Faculty Research Fellowship; University of Costa Rica; Costa Rican Ministry of Science and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007215] Funding Source: NIH RePORTER; Division Of Environmental Biology [0747002] Funding Source: National Science Foundation	Great Lakes Bioenergy Research Center [Department of Energy, Office of Science, Biological and Environmental Research](United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health [National Research Service Award](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UW-Madison's Hilldale Undergraduate/Faculty Research Fellowship; University of Costa Rica; Costa Rican Ministry of Science and Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Great Lakes Bioenergy Research Center [Department of Energy, Office of Science, Biological and Environmental Research DE-FC02-07ER64494, http://science.energy.gov/ber/]; the National Science Foundation [DGE-1256259 to GRL, DEB-0747002, and MCB-0702025, http://www.nsf.gov/]; the National Institutes of Health [National Research Service Award T32 GM07215, http://www.nih.gov/]; the UW-Madison's Hilldale Undergraduate/Faculty Research Fellowship to ALJ and CRC [http://awards.advising.wisc.edu/hilldale-undergraduatefaculty-research-fellowship/]; and support from the University of Costa Rica [http://www.ucr.ac.cr/] and the Costa Rican Ministry of Science and Technology [https://www.micit.go.cr/] to RDMS and AAPT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgaier M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008812; An DS, 2005, INT J SYST EVOL MICR, V55, P1625, DOI 10.1099/ijs.0.63695-0; Aylward FO, 2012, ISME J, V6, P1688, DOI 10.1038/ismej.2012.10; Berlemont R, 2013, APPL ENVIRON MICROB, V79, P1545, DOI 10.1128/AEM.03305-12; Book AJ, 2014, APPL ENVIRON MICROB, V80, P4692, DOI 10.1128/AEM.01133-14; Brumm PJ, 2013, BIOFUELS-UK, V4, P669, DOI 10.4155/BFS.13.44; Brunecky R, 2013, SCIENCE, V342, P1513, DOI 10.1126/science.1244273; Choi JH, 2010, INT J SYST EVOL MICR, V60, P2715, DOI 10.1099/ijs.0.019661-0; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Costa AN, 2008, J VEG SCI, V19, P849, DOI 10.3170/2008-8-18461; DeAngelis KM, 2012, MBIO, V3, DOI 10.1128/mBio.00249-11; DeAngelis KM, 2010, BIOENERG RES, V3, P146, DOI 10.1007/s12155-010-9089-z; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Eichorst SA, 2013, ENVIRON MICROBIOL, V15, P2573, DOI 10.1111/1462-2920.12159; ELNAKEEB MA, 1963, APPL MICROBIOL, V11, P75, DOI 10.1128/AEM.11.2.75-77.1963; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gladden John M, 2011, Appl Environ Microbiol, V77, P5804, DOI 10.1128/AEM.00032-11; Hattenschwiler S, 2011, CR BIOL, V334, P393, DOI 10.1016/j.crvi.2011.03.001; HAINES BL, 1978, BIOTROPICA, V10, P270, DOI 10.2307/2387679; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hanshew AS, 2013, J MICROBIOL METH, V95, P149, DOI 10.1016/j.mimet.2013.08.007; Hart AG, 2002, BEHAV ECOL, V13, P224, DOI 10.1093/beheco/13.2.224; Herz H, 2007, BIOTROPICA, V39, P476, DOI 10.1111/j.1744-7429.2007.00283.x; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Hudson TM, 2009, SOIL BIOL BIOCHEM, V41, P1088, DOI 10.1016/j.soilbio.2009.02.014; Jesus ED, 2009, ISME J, V3, P1004, DOI 10.1038/ismej.2009.47; Kato S, 2008, MICROB ECOL, V56, P403, DOI 10.1007/s00248-007-9357-4; Khianngam S, 2012, INT J SYST EVOL MICR, V62, P1921, DOI 10.1099/ijs.0.032607-0; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; LEMBECK WJ, 1967, APPL MICROBIOL, V15, P300, DOI 10.1128/AEM.15.2.300-303.1967; Li P, 2009, 2008 INTERNATIONAL WORKSHOP ON EDUCATION TECHNOLOGY AND TRAINING AND 2008 INTERNATIONAL WORKSHOP ON GEOSCIENCE AND REMOTE SENSING, VOL 2, PROCEEDINGS,, P344, DOI 10.1109/ETTandGRS.2008.117; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Magurran A.E, 2004, MEASURING BIOL DIVER; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Mendes LW, 2015, MICROB ECOL, V70, P255, DOI 10.1007/s00248-014-0559-2; Miller M.A., 2010, P GAT COMP ENV WORKS; Moreira-Soto RD, ULTRASTRUCTURAL MICR; Nielsen UN, 2011, EUR J SOIL SCI, V62, P105, DOI 10.1111/j.1365-2389.2010.01314.x; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Poulsen M, 2014, P NATL ACAD SCI USA, V111, P14500, DOI 10.1073/pnas.1319718111; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; Reichenbach H, 2006, PROKARYOTES, V7, P549, DOI DOI 10.1007/0-387-30747-8_20; Riederer A, 2011, APPL ENVIRON MICROB, V77, P1243, DOI 10.1128/AEM.02008-10; Rivas R, 2006, INT J SYST EVOL MICR, V56, P2777, DOI 10.1099/ijs.0.64480-0; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Schlesner H., 2006, PROKARYOTES, V7, P881, DOI [10.1007/0-387-30747-8_37, DOI 10.1007/0-387-30747-8_37, DOI 10.1007/0-387-30747-8]; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schneiker S, 2007, NAT BIOTECHNOL, V25, P1281, DOI 10.1038/nbt1354; Schulein M, 1997, J BIOTECHNOL, V57, P71, DOI 10.1016/S0168-1656(97)00090-4; Scott JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009922; Scott JJ, 2011, MICROBIAL COMMUNITY; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Suen G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001129; Takasuka TE, 2013, SCI REP-UK, V3, DOI 10.1038/srep01030; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; VANCE I, 1980, J GEN MICROBIOL, V117, P235; Voelskow H., 1988, FORUM MIKROBIOL, V6, P273; Wang CM, 2008, LETT APPL MICROBIOL, V47, P46, DOI 10.1111/j.1472-765X.2008.02385.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WEBER NA, 1966, SCIENCE, V153, P587, DOI 10.1126/science.153.3736.587; WEIMER PJ, 1990, APPL ENVIRON MICROB, V56, P2421, DOI 10.1128/AEM.56.8.2421-2429.1990; Weon HY, 2009, INT J SYST EVOL MICR, V59, P1685, DOI 10.1099/ijs.0.004838-0; Willems A, 2001, BERGEYS MANUAL DETER, P696; Wilson DB, 2011, CURR OPIN MICROBIOL, V14, P259, DOI 10.1016/j.mib.2011.04.004; Zhou YZ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05288; Zhu LF, 2014, INT J SYST EVOL MICR, V64, P3964, DOI 10.1099/ijs.0.066605-0	73	18	20	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151840	10.1371/journal.pone.0151840	http://dx.doi.org/10.1371/journal.pone.0151840			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999749	Green Published, Green Submitted, gold			2022-12-26	WOS:000372694700071
J	Rong, YKS; Golic, MM; Golic, KG				Rong, Yikang S.; Golic, Mary M.; Golic, Kent G.			The pugilist(Dominant) Mutation of Drosophila melanogaster: A Simple-Sequence Repeat Disorder Reveals Localized Transport in the Eye	PLOS ONE			English	Article							XANTHINE DEHYDROGENASE; GENE; EXPRESSION; NEURODEGENERATION; HETEROCHROMATIN; RECOMBINATION; TRANSGENESIS; PHENOTYPE; DELETIONS; WINGLESS	The pugilist-Dominant mutation results from fusion of a portion of the gene encoding the trifunctional Methylene Tetrahydrofolate Dehydrogenase (E.C.1.5.1.5, E.C.3.5.4.9, E.C.6.3.4.3) to approximately one kb of a heterochromatic satellite repeat. Expression of this fusion gene results in an unusual ring pattern of pigmentation around the eye. We carried out experiments to determine the mechanism for this pattern. By using FLP-mediated DNA mobilization to place different pug(D) transgenes at pre-selected sites we found that variation in repeat length makes a strong contribution to variability of the pug phenotype. This variation is manifest primarily as differences in the thickness of the pigmented ring. We show that similar phenotypic variation can also be achieved by changing gene copy number. We found that the pug(D) pattern is not controlled by wingless, which is normally expressed in a similar ring pattern. Finally, we found that physical injury to a pug(D) eye can lead to pigment deposition in parts of the eye that would not have been pigmented in the absence of injury. Our results are consistent with a model in which a metabolite vital for pigment formation is imported from the periphery of the eye, and pug(D) limits the extent of its transport towards the center of the eye, thus revealing the existence of a hitherto unknown mechanism of localized transport in the eye.	[Rong, Yikang S.; Golic, Mary M.; Golic, Kent G.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Rong, Yikang S.] Sun Yat Sen Univ, Sch Life Sci, Guangzho, Peoples R China	Utah System of Higher Education; University of Utah; Sun Yat Sen University	Golic, KG (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	golic@biology.utah.edu			National Institutes of Health, National Institute of General Medical Sciences [R01 GM065604]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065604] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by National Institutes of Health, National Institute of General Medical Sciences, R01 GM065604 to KGG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaire M, 1998, STRUCTURE, V6, P173, DOI 10.1016/S0969-2126(98)00019-7; Ashburner M., 2004, DROSOPHILA LAB HDB; Brunner E, 1999, DEV BIOL, V206, P178, DOI 10.1006/dbio.1998.9136; Cadigan KM, 1996, DEVELOPMENT, V122, P2801; Curtis C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r262; Davidson FF, 1998, NATURE, V391, P587, DOI 10.1038/35385; Gendrin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069742; Golic MM, 1997, NUCLEIC ACIDS RES, V25, P3665, DOI 10.1093/nar/25.18.3665; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Gruenewald C, 2009, FREE RADICAL BIO MED, V46, P1668, DOI 10.1016/j.freeradbiomed.2009.03.025; HAY BA, 1994, DEVELOPMENT, V120, P2121; Horn C, 2005, P NATL ACAD SCI US; KURKULOS M, 1994, GENETICS, V136, P1001; La Spada AR, 2010, NAT REV GENET, V11, P247, DOI 10.1038/nrg2748; LAURIEAHLBERG CC, 1987, GENETICS, V115, P129; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; LOHE AR, 1993, GENETICS, V134, P1149; Malmanche N, 2004, GENETICS, V168, P2011, DOI 10.1534/genetics.104.033134; MONTELL I, 1992, BIOCHEM GENET, V30, P61, DOI 10.1007/BF00554428; Oberstein A, 2005, NAT METHODS, V2, P583, DOI 10.1038/NMETH775; PAQUES F, 1993, GENETICS, V135, P469; Phillips JP, 1980, OMMOCHROMES PTERIDIN; REAUME AG, 1989, GENETICS, V123, P503; REAUME AG, 1991, GENETICS, V129, P1099; ROBERTSON HM, 1988, GENETICS, V118, P461; Rong YS, 1998, GENETICS, V150, P1551; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Scherzer CR, 2003, HUM MOL GENET, V12, P2457, DOI 10.1093/hmg/ddg265; Siegal ML, 1996, GENETICS, V144, P715; Siegal ML, 1998, P NATL ACAD SCI USA, V95, P15513, DOI 10.1073/pnas.95.26.15513; SPRADLING AC, 1983, CELL, V34, P47, DOI 10.1016/0092-8674(83)90135-6; TIONG SYK, 1989, BIOCHEM GENET, V27, P333, DOI 10.1007/BF00554168; Tomlinson A, 2003, DEV CELL, V5, P799, DOI 10.1016/S1534-5807(03)00326-5; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Venken KJT, 2007, DEVELOPMENT, V134, P3571, DOI 10.1242/dev.005686; Weber AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034745	36	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151377	10.1371/journal.pone.0151377	http://dx.doi.org/10.1371/journal.pone.0151377			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999432	gold, Green Submitted, Green Published			2022-12-26	WOS:000372694700037
J	Suchan, T; Pitteloud, C; Gerasimova, NS; Kostikova, A; Schmid, S; Arrigo, N; Pajkovic, M; Ronikier, M; Alvarez, N				Suchan, Tomasz; Pitteloud, Camille; Gerasimova, Nadezhda S.; Kostikova, Anna; Schmid, Sarah; Arrigo, Nils; Pajkovic, Mila; Ronikier, Michal; Alvarez, Nadir			Hybridization Capture Using RAD Probes (hyRAD), a New Tool for Performing Genomic Analyses on Collection Specimens	PLOS ONE			English	Article							ULTRACONSERVED ELEMENTS; POPULATION; ENRICHMENT; DISCOVERY; SOFTWARE; PATTERNS; FORMAT; DAMAGE	In the recent years, many protocols aimed at reproducibly sequencing reduced-genome subsets in non-model organisms have been published. Among them, RAD-sequencing is one of the most widely used. It relies on digesting DNA with specific restriction enzymes and performing size selection on the resulting fragments. Despite its acknowledged utility, this method is of limited use with degraded DNA samples, such as those isolated from museum specimens, as these samples are less likely to harbor fragments long enough to comprise two restriction sites making possible ligation of the adapter sequences (in the case of double-digest RAD) or performing size selection of the resulting fragments (in the case of single-digest RAD). Here, we address these limitations by presenting a novel method called hybridization RAD (hyRAD). In this approach, biotinylated RAD fragments, covering a random fraction of the genome, are used as baits for capturing homologous fragments from genomic shotgun sequencing libraries. This simple and cost-effective approach allows sequencing of orthologous loci even from highly degraded DNA samples, opening new avenues of research in the field of museum genomics. Not relying on the restriction site presence, it improves among-sample loci coverage. In a trial study, hyRAD allowed us to obtain a large set of orthologous loci from fresh and museum samples from a non-model butterfly species, with a high proportion of single nucleotide polymorphisms present in all eight analyzed specimens, including 58-year-old museum samples. The utility of the method was further validated using 49 museum and fresh samples of a Palearctic grasshopper species for which the spatial genetic structure was previously assessed using mtDNA amplicons. The application of the method is eventually discussed in a wider context. As it does not rely on the restriction site presence, it is therefore not sensitive to among-sample loci polymorphisms in the restriction sites that usually causes loci dropout. This should enable the application of hyRAD to analyses at broader evolutionary scales.	[Suchan, Tomasz; Pitteloud, Camille; Schmid, Sarah; Arrigo, Nils; Pajkovic, Mila; Alvarez, Nadir] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Gerasimova, Nadezhda S.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Gerasimova, Nadezhda S.; Kostikova, Anna] InsideDNA Ltd, London, England; [Ronikier, Michal] Polish Acad Sci, Inst Bot, Krakow, Poland	University of Lausanne; Lomonosov Moscow State University; Polish Academy of Sciences	Suchan, T; Alvarez, N (corresponding author), Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland.	tomasz.suchan@unil.ch; nadir.alvarez@unil.ch	Alvarez, Nadir/AAM-2228-2021; Alvarez, Nadir/B-4318-2010; Suchan, Tomasz/B-7765-2016; Gerasimova, Nadezhda S/A-8454-2014	Alvarez, Nadir/0000-0002-0729-166X; Alvarez, Nadir/0000-0002-0729-166X; Suchan, Tomasz/0000-0002-0811-8754; Gerasimova, Nadezhda S/0000-0002-5048-0378; Ronikier, Michal/0000-0001-7652-6787	Swiss National Science Foundation [PP00P3_144870, PZ00P3_148224]; Societe Academique Vaudoise (Switzerland); Switzerland through the Swiss Contribution to the enlarged European Union (Polish-Swiss Research Program) [PSPB-161/2010]; InsideDNA Ltd	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Societe Academique Vaudoise (Switzerland); Switzerland through the Swiss Contribution to the enlarged European Union (Polish-Swiss Research Program); InsideDNA Ltd	N. Alvarez and N. Arrigo were funded by Swiss National Science Foundation grants (PP00P3_144870, and PZ00P3_148224, respectively). TS was supported by a grant from the Societe Academique Vaudoise (Switzerland). The work was financially supported by a grant from Switzerland through the Swiss Contribution to the enlarged European Union (Polish-Swiss Research Program, project no. PSPB-161/2010). InsideDNA Ltd provided support in the form of salary for NSG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2015, OPENWETWARE CONTR HY; Arnold B, 2013, MOL ECOL, V22, P3179, DOI 10.1111/mec.12276; Aronesty E., 2011, DATABASE GOOGLE CODE; Auton A, 2015, VCFTOOLS DATABASE; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bi K, 2013, MOL ECOL, V22, P6018, DOI 10.1111/mec.12516; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Briggs AW, 2007, P NATL ACAD SCI USA, V104, P14616, DOI 10.1073/pnas.0704665104; Briggs AW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1163; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Chepelev I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp507; Cronn R, 2012, AM J BOT, V99, P291, DOI 10.3732/ajb.1100356; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Cruaud A, 2014, MOL BIOL EVOL, V31, P1272, DOI 10.1093/molbev/msu063; Davey JW, 2013, MOL ECOL, V22, P3151, DOI 10.1111/mec.12084; Davey JW, 2011, NAT REV GENET, V12, P499, DOI 10.1038/nrg3012; Dent R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036889, 10.1371/journal.pone.0037135]; Eaton DAR, 2014, BIOINFORMATICS, V30, P1844, DOI 10.1093/bioinformatics/btu121; Eaton DAR, 2013, SYST BIOL, V62, P689, DOI 10.1093/sysbio/syt032; Ellegren H, 2014, TRENDS ECOL EVOL, V29, P51, DOI 10.1016/j.tree.2013.09.008; Faircloth BC, 2015, MOL ECOL RESOUR, V15, P489, DOI 10.1111/1755-0998.12328; Faircloth BC, 2012, SYST BIOL, V61, P717, DOI 10.1093/sysbio/sys004; FASTX-Toolkit, 2015, FASTX TOOLK DAT; Flouri T, 2015, VSEARCH GITHUB REPOS, DOI DOI 10.5281/ZENODO.15524; Garrison E., 2012, ARXIV PREP ARXIV, V1207, P3907, DOI [10.48550/arXiv.1207.3907, DOI 10.48550/ARXIV.1207.3907]; Gautier M, 2013, MOL ECOL, V22, P3165, DOI 10.1111/mec.12089; Gilbert MTP, 2003, AM J HUM GENET, V72, P48, DOI 10.1086/345379; Hipp AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093975; Jones JC, 2013, MOL ECOL, V22, P2986, DOI 10.1111/mec.12269; Jones MR, 2016, MOL ECOL, V25, P185, DOI 10.1111/mec.13304; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kindler E, 2012, MOL PHYLOGENET EVOL, V65, P695, DOI 10.1016/j.ympev.2012.07.025; Krueger F., 2015, TRIM GALORE WRAPPER; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leache AD, 2015, GENOME BIOL EVOL, V7, P706, DOI 10.1093/gbe/evv026; Lemmon AR, 2012, SYST BIOL, V61, P727, DOI 10.1093/sysbio/sys049; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lischer HEL, 2012, BIOINFORMATICS, V28, P298, DOI 10.1093/bioinformatics/btr642; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Mason VC, 2011, GENOME RES, V21, P1695, DOI 10.1101/gr.120196.111; Mastretta-Yanes A, 2015, MOL ECOL RESOUR, V15, P28, DOI 10.1111/1755-0998.12291; McCormack JE, 2013, MOL PHYLOGENET EVOL, V66, P526, DOI 10.1016/j.ympev.2011.12.007; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Orlando L, 2015, NAT REV GENET, V16, P395, DOI 10.1038/nrg3935; Picard tools, 2015, PIC TOOLS DAT; Puritz JB, 2014, MOL ECOL, V23, P5937, DOI 10.1111/mec.12965; Puritz JB, 2014, PEERJ, V2, DOI 10.7717/peerj.431; QGIS Development Team, 2009, QGIS GEOGR INF SYST; Raj A, 2014, GENETICS, V197, P573, DOI 10.1534/genetics.114.164350; Rowe KC, 2011, MOL ECOL RESOUR, V11, P1082, DOI 10.1111/j.1755-0998.2011.03052.x; Rubin BER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033394; Ruby JG, 2013, G3-GENES GENOM GENET, V3, P865, DOI 10.1534/g3.113.005967; Staats M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028448; Stiller M, 2006, P NATL ACAD SCI USA, V103, P13578, DOI 10.1073/pnas.0605327103; Sulonen AM, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r94; Tin MMY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096793; Tsangaras K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109101; vcflib Garrison E., 2015, VCFLIB DATABASE; Wagner CE, 2013, MOL ECOL, V22, P787, DOI 10.1111/mec.12023; Wandeler P, 2007, TRENDS ECOL EVOL, V22, P634, DOI 10.1016/j.tree.2007.08.017	62	93	94	0	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151651	10.1371/journal.pone.0151651	http://dx.doi.org/10.1371/journal.pone.0151651			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999359	Green Published, gold			2022-12-26	WOS:000372694700051
J	Duran, BEL; Duncan, DS; Oates, LG; Kucharik, CJ; Jackson, RD				Duran, Brianna E. L.; Duncan, David S.; Oates, Lawrence G.; Kucharik, Christopher J.; Jackson, Randall D.			Nitrogen Fertilization Effects on Productivity and Nitrogen Loss in Three Grass-Based Perennial Bioenergy Cropping Systems	PLOS ONE			English	Article							TRACE-GAS FLUXES; SOUTHERN WISCONSIN; BIOMASS PRODUCTION; SOIL RESPIRATION; PLANT DIVERSITY; SWITCHGRASS; BIODIVERSITY; CLIMATE; USA; AGRICULTURE	Nitrogen (N) fertilization can greatly improve plant productivity but needs to be carefully managed to avoid harmful environmental impacts. Nutrient management guidelines aimed at reducing harmful forms of N loss such as nitrous oxide (N2O) emissions and nitrate (NO3-) leaching have been tailored for many cropping systems. The developing bioenergy industry is likely to make use of novel cropping systems, such as polycultures of perennial species, for which we have limited nutrient management experience. We studied how a switchgrass (Panicum virgatum) monoculture, a 5-species native grass mixture and an 18-species restored prairie responded to annual fertilizer applications of 56 kg N ha(-1) in a field-scale agronomic trial in south-central Wisconsin over a 2-year period. We observed greater fertilizer-induced N2O emissions and sub-rooting zone NO3- concentrations in the switchgrass monoculture than in either polyculture. Fertilization increased aboveground net primary productivity in the polycultures, but not in the switchgrass monoculture. Switchgrass was generally more productive, while the two polycultures did not differ from each other in productivity or N loss. Our results highlight differences between polycultures and a switchgrass monoculture in responding to N fertilization.	[Duran, Brianna E. L.; Duncan, David S.; Oates, Lawrence G.; Kucharik, Christopher J.; Jackson, Randall D.] Univ Wisconsin, Dept Agron, 1575 Linden Dr, Madison, WI 53706 USA; [Duran, Brianna E. L.; Duncan, David S.; Oates, Lawrence G.; Kucharik, Christopher J.; Jackson, Randall D.] Univ Wisconsin, DOE Great Lakes Bioenergy Res Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison	Oates, LG (corresponding author), Univ Wisconsin, Dept Agron, 1575 Linden Dr, Madison, WI 53706 USA.; Oates, LG (corresponding author), Univ Wisconsin, DOE Great Lakes Bioenergy Res Ctr, Madison, WI USA.	oates@wisc.edu	Oates, Lawrence G/G-6354-2011; Jackson, Randall/AAE-5573-2022	Kucharik, Christopher/0000-0002-0400-758X; Oates, Lawrence/0000-0003-4829-7600	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science) [DE-FC02-07ER64494]; DOE OBP Office of Energy Efficiency and Renewable Energy [DE-AC05-76RL01830]; Water Sustainability and Climate Program of the National Science Foundation [DEB-1038759]; Multi-State Hatch Grant [WISO1420]; UW Department of Agronomy; D.C. Smith Wisconsin Distinguished Graduate Fellowship; Division Of Earth Sciences [1038759] Funding Source: National Science Foundation	DOE Great Lakes Bioenergy Research Center (DOE BER Office of Science)(United States Department of Energy (DOE)); DOE OBP Office of Energy Efficiency and Renewable Energy(United States Department of Energy (DOE)); Water Sustainability and Climate Program of the National Science Foundation; Multi-State Hatch Grant; UW Department of Agronomy; D.C. Smith Wisconsin Distinguished Graduate Fellowship; Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded in part by the DOE Great Lakes Bioenergy Research Center (https://www.glbrc.org/)(DOE BER Office of Science DE-FC02-07ER64494; http://science.energy.gov/) and DOE OBP Office of Energy Efficiency and Renewable Energy (DE-AC05-76RL01830; http://energy.gov/eere/office-energy-efficiency-renewable-energy), the Water Sustainability and Climate Program of the National Science Foundation (DEB-1038759), a Multi-State Hatch Grant (#WISO1420), the UW Department of Agronomy, and the D.C. Smith Wisconsin Distinguished Graduate Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Beale CV, 1997, BIOMASS BIOENERG, V12, P419, DOI 10.1016/S0961-9534(97)00016-0; Cameron KC, 2013, ANN APPL BIOL, V162, P145, DOI 10.1111/aab.12014; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Davidson E. A., 1991, Microbial production and consumption of greenhouse gases: methane, nitrogen oxides, and halomethanes., P219; de Vries BJM, 2007, ENERG POLICY, V35, P2590, DOI 10.1016/j.enpol.2006.09.002; Dobbie KE, 2003, GLOBAL CHANGE BIOL, V9, P204, DOI 10.1046/j.1365-2486.2003.00563.x; Duran BEL, 2013, SOIL SCI SOC AM J, V77, P1601, DOI 10.2136/sssaj2013.01.0023; Elzinga C.L., 1998, 17301 BUR LAND MAN; Epstein HE, 1998, BIOGEOCHEMISTRY, V42, P145, DOI 10.1023/A:1005959001235; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Frank DA, 2009, ECOLOGY, V90, P1512, DOI 10.1890/08-0789.1; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Grogan P, 1999, ECOSYSTEMS, V2, P451, DOI 10.1007/s100219900093; Hong CO, 2014, BIOENERG RES, V7, P777, DOI 10.1007/s12155-014-9484-y; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; IPCC, 2006, ENERGY, V2; Jach-Smith LC, 2015, AGR ECOSYST ENVIRON, V204, P62, DOI 10.1016/j.agee.2015.02.006; Jackson RB, 1996, OECOLOGIA, V108, P389, DOI 10.1007/BF00333714; Jungers JM, 2015, BIOENERG RES, V8, P279, DOI 10.1007/s12155-014-9525-6; Kaye JP, 1997, TRENDS ECOL EVOL, V12, P139, DOI 10.1016/S0169-5347(97)01001-X; Kucharik CJ, 2006, GLOBAL CHANGE BIOL, V12, P122, DOI 10.1111/j.1365-2486.2005.01053.x; Laboski C.A.M., 2012, NUTR APPL GUIDELINES; Lenth R. V., 2013, ISMEANS LEAST SQUARE; Liang C, 2013, SOIL BIOL BIOCHEM, V57, P939, DOI 10.1016/j.soilbio.2012.09.006; Liang C, 2012, APPL SOIL ECOL, V54, P24, DOI 10.1016/j.apsoil.2011.11.015; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Miesel JR, 2012, BIOMASS BIOENERG, V36, P121, DOI 10.1016/j.biombioe.2011.10.018; Mississippi River/Gulf of Mexico Watershed Nutrient Task Force, 2009, MOV FORW GULF HYP AN; Mitchell R, 2008, BIOFUEL BIOPROD BIOR, V2, P530, DOI 10.1002/bbb.106; Niklaus PA, 2006, PLANT SOIL, V282, P83, DOI 10.1007/s11104-005-5230-8; NOAA, 2012, NAT WEATH SERV MILW; Oates LG, 2015, GCB BIOENERGY; Oelmann Y, 2007, SOIL SCI SOC AM J, V71, P720, DOI 10.2136/sssaj2006.0205; Palmborg C, 2005, OIKOS, V110, P271, DOI 10.1111/j.0030-1299.2005.13673.x; Parrish DJ, 2005, CRIT REV PLANT SCI, V24, P423, DOI 10.1080/07352680500316433; Pedersen AR, 2010, EUR J SOIL SCI, V61, P888, DOI 10.1111/j.1365-2389.2010.01291.x; Pedersen A.R., 2012, HMR FLUX ESTIMATION; Perlack, 2011, BILLION TON UPDATE B; Pinheiro J, 2020, R PACKAGE VERSION 31; Rabalais NN, 2001, J ENVIRON QUAL, V30, P320, DOI 10.2134/jeq2001.302320x; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Robertson GP, 2008, SCIENCE, V322, P49, DOI 10.1126/science.1161525; Robertson GP, 2013, BIOGEOCHEMISTRY, V114, P41, DOI 10.1007/s10533-012-9802-4; Robertson GP, 2000, SCIENCE, V289, P1922, DOI 10.1126/science.289.5486.1922; Robertson GP, 1999, LT EC RES NETWK SER, V2, P106; Rustad LE, 2000, BIOGEOCHEMISTRY, V48, P1, DOI 10.1023/A:1006255431298; Sanderson MA, 2008, INT J MOL SCI, V9, P768, DOI 10.3390/ijms9050768; Stehfest E, 2006, NUTR CYCL AGROECOSYS, V74, P207, DOI 10.1007/s10705-006-9000-7; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Vilain G, 2014, NUTR CYCL AGROECOSYS, V98, P169, DOI 10.1007/s10705-014-9604-2; Vogel KP, 2002, AGRON J, V94, P413, DOI 10.2134/agronj2002.0413; Wang D, 2010, GCB BIOENERGY, V2, P16, DOI 10.1111/j.1757-1707.2010.01035.x; Weigelt A, 2009, BIOGEOSCIENCES, V6, P1695, DOI 10.5194/bg-6-1695-2009; Zegada-Lizarazu W, 2010, BIOFUEL BIOPROD BIOR, V4, P674, DOI 10.1002/bbb.242	55	31	32	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151919	10.1371/journal.pone.0151919	http://dx.doi.org/10.1371/journal.pone.0151919			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991790	Green Published, Green Submitted, gold			2022-12-26	WOS:000372582800117
J	Nybakken, GE; Bala, R; Gratzinger, D; Jones, CD; Zehnder, JL; Bangs, CD; Cherry, A; Warnke, RA; Natkunam, Y				Nybakken, Grant E.; Bala, Rajeev; Gratzinger, Dita; Jones, Carol D.; Zehnder, James L.; Bangs, Charles D.; Cherry, Athena; Warnke, Roger A.; Natkunam, Yasodha			Isolated Follicles Enriched for Centroblasts and Lacking t(14;18)/BCL2 in Lymphoid Tissue: Diagnostic and Clinical Implications	PLOS ONE			English	Article							SITU FOLLICULAR LYMPHOMA; MANTLE CELL LYMPHOMA; IN-SITU; B-CELLS; BCL-2/IGH REARRANGEMENT; HEALTHY-INDIVIDUALS; CLONAL EVOLUTION; GERMINAL-CENTERS; BLOOD; TRANSLOCATION	We sought to address the significance of isolated follicles that exhibit atypical morphologic features that may be mistaken for lymphoma in a background of reactive lymphoid tissue. Seven cases that demonstrated centroblast-predominant isolated follicles and absent BCL2 staining in otherwise-normal lymph nodes were studied. Four of seven cases showed clonal B-cell proliferations amid a polyclonal B cell background; all cases lacked the IGH-BCL2 translocation and BCL2 protein expression. Although three patients had invasive breast carcinoma at other sites, none were associated with systemic lymphoma up to 44 months after diagnosis. The immunoarchitectural features of these highly unusual cases raise the question of whether a predominance of centroblasts and/or absence of BCL2 expression could represent a precursor lesion or atypical reactive phenomenon. Differentiating such cases from follicular lymphoma or another mimic is critical, lest patients with indolent proliferations be exposed to unnecessarily aggressive treatment.	[Nybakken, Grant E.; Bala, Rajeev; Gratzinger, Dita; Jones, Carol D.; Zehnder, James L.; Bangs, Charles D.; Cherry, Athena; Warnke, Roger A.; Natkunam, Yasodha] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Stanford University	Natkunam, Y (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	yaso@stanford.edu	Natkunam, Yasodha/L-5454-2015	Natkunam, Yasodha/0000-0002-9816-1018; Gratzinger, Dita/0000-0002-9182-8123	NATIONAL CANCER INSTITUTE [P01CA049605] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA049605] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Advani R, 2004, J CLIN ONCOL, V22, P1454, DOI 10.1200/JCO.2004.10.086; Ardeshna KM, 2003, LANCET, V362, P516, DOI 10.1016/S0140-6736(03)14110-4; Attygalle AD, 2004, BLOOD, V104, P3343, DOI 10.1182/blood-2004-01-0385; BELL DA, 1995, JNCI-J NATL CANCER I, V87, P223, DOI 10.1093/jnci/87.3.223; Bonzheim I, 2011, BLOOD, V118, P3442, DOI 10.1182/blood-2011-07-368944; Carbone A, 2012, LEUKEMIA LYMPHOMA, V53, P603, DOI 10.3109/10428194.2011.624229; Carbone A, 2012, HEMATOL ONCOL, V30, P1, DOI 10.1002/hon.993; Carbone A, 2011, AM J HEMATOL, V86, pE66, DOI 10.1002/ajh.22169; Carbone A, 2011, AM J CLIN PATHOL, V136, P481, DOI 10.1309/AJCPDSG2J5IBEYFB; Carbone A, 2011, BLOOD, V117, P3954, DOI 10.1182/blood-2010-10-299628; Cheung MC, 2009, LEUKEMIA, V23, P1176, DOI 10.1038/leu.2009.9; Cong PJ, 2002, BLOOD, V99, P3376, DOI 10.1182/blood.V99.9.3376; Dolken G, 1996, J CLIN ONCOL, V14, P1333; Dolken Gottfried, 2008, J Natl Cancer Inst Monogr, P44, DOI 10.1093/jncimonographs/lgn005; Handa T, 2011, INT J SURG PATHOL, V19, P521, DOI 10.1177/1066896909350174; Jegalian AG, 2011, BLOOD, V118, P2976, DOI 10.1182/blood-2011-05-355255; JI WZ, 1995, CANCER RES, V55, P2876; Jiang XY, 2010, BLOOD, V116, P5217, DOI 10.1182/blood-2010-04-281568; Ladetto M, 2003, J CLIN ONCOL, V21, P1398, DOI 10.1200/JCO.2003.07.070; Leich E, 2011, BLOOD, V118, P5550, DOI 10.1182/blood-2011-06-361972; LIMPENS J, 1995, BLOOD, V85, P2528, DOI 10.1182/blood.V85.9.2528.bloodjournal8592528; LIMPENS J, 1991, ONCOGENE, V6, P2271; LIU YF, 1994, P NATL ACAD SCI USA, V91, P8910, DOI 10.1073/pnas.91.19.8910; Mamessier E, 2014, HAEMATOLOGICA, V99, P481, DOI 10.3324/haematol.2013.094474; MCDONNELL TJ, 1991, NATURE, V349, P254, DOI 10.1038/349254a0; Montes-Moreno S, 2010, HISTOPATHOLOGY, V56, P658, DOI 10.1111/j.1365-2559.2010.03529.x; Nam-Cha SH, 2008, HISTOPATHOLOGY, V52, P436, DOI 10.1111/j.1365-2559.2008.02965.x; Pillai RK, 2013, HAEMATOLOGICA, V98, P1571, DOI 10.3324/haematol.2013.085506; Roullet MR, 2010, AM J CLIN PATHOL, V133, P584, DOI 10.1309/AJCP5RT4MRSDGKSX; Sapunar F, 2000, LEUKEMIA LYMPHOMA, V37, P163, DOI 10.3109/10428190009057640; Schmidt J, 2014, LEUKEMIA, V28, P1103, DOI 10.1038/leu.2013.307; Schmitt C, 2006, LEUKEMIA RES, V30, P745, DOI 10.1016/j.leukres.2005.10.001; Schuler F, 2009, INT J CANCER, V124, P958, DOI 10.1002/ijc.23958; Sotomayor EA, 2007, EXP MOL PATHOL, V83, P254, DOI 10.1016/j.yexmp.2007.03.001; Summers KE, 2001, J CLIN ONCOL, V19, P420, DOI 10.1200/JCO.2001.19.2.420; Swerdlow SH, 2008, WHO CLASSIFICATION T; Temmins C, 2011, APPL IMMUNOHISTO M M, V19, P266, DOI 10.1097/PAI.0b013e3181f89a4d	37	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151735	10.1371/journal.pone.0151735	http://dx.doi.org/10.1371/journal.pone.0151735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991267	Green Published, gold, Green Submitted			2022-12-26	WOS:000372582800093
J	Son, HS; Lee, YS; Im, YJ; Kim, SW; Chi, BH; Han, SW				Son, Hee Seo; Lee, Yong Seung; Im, Young Jae; Kim, Sang Woon; Chi, Byung Hoon; Han, Sang Won			Can Hypertrophy of the Contralateral Testis Predict the Absence of a Viable Testis in Infancy with Cryptorchidism: A Prospective Analysis	PLOS ONE			English	Article							INHIBIN-B LEVELS; TESTICULAR VOLUME; UNDESCENDED TESTES; NONPALPABLE TESTIS; BOYS; ULTRASONOGRAPHY; TESTOSTERONE; GONADOTROPIN; ORCHIDOMETER; MONORCHISM	This prospective study aimed to evaluate whether Contralateral compensatory testicular hypertrophy (CTH) is valid as a predictive tool for a non-viable testis in children aged between 6 and 18 months, and whether CTH is affected by mini-puberty. Seventy-two testes from 60 boys aged between 6 and 18 months were categorized into three groups: 24 testes contralateral to surgically removed non-viable testes (NVTs), 24 testes contralateral to surgically corrected undescended testes (UDTs), and 24 testes from a normal controls. Contralateral testicular length and volume were measured with ultrasonography and compared among the groups. Group 1 (NVT) had a significantly longer length and larger volume than group 2 (UDT). The length and volume of each group among three developmental periods (6-10, 10-14, and 14-18 months) were also analyzed. In the controls, the length was significantly larger at 6-10 months than at 10-14 months in accordance with previously reported changes in testicular size due to the effect of "mini-puberty." The volume of controls showed a similar pattern, though without statistical significance. However, this pattern was not observed in the NVT and UDT groups. A receiver operating curve revealed that a testicular length of 16.1 mm or a volume of 0.59 ml had the highest sensitivity and specificity for predicting NVTs. The CTH was also found to be valid as a predictive tool for a NVT in children of ages 6 to 18 months, as the effect of mini-puberty appeared to be absent in the NVT and UDT groups. However, the cut-off values were less than those of previous reports. The proper cut-off level according to the age and measurement method should be applied in this developmental period.	[Lee, Yong Seung] Yonsei Univ, Coll Med, Dept Urol, Seoul, South Korea; Yonsei Univ, Coll Med, Urol Sci Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, YS (corresponding author), Yonsei Univ, Coll Med, Dept Urol, Seoul, South Korea.	asforthelord@yuhs.ac		Son, Hee Seo/0000-0001-7198-7816; Lee, Yong Seung/0000-0003-3778-9888; Kim, Sang Woon/0000-0002-5790-1948; Han, Sang Won/0000-0003-0941-1300				Andersson AM, 1998, J CLIN ENDOCR METAB, V83, P675, DOI 10.1210/jc.83.2.675; Bouvattier C, 2002, J CLIN ENDOCR METAB, V87, P29, DOI 10.1210/jc.87.1.29; Braga LH, 2014, J PEDIATR UROL, V10, P693, DOI 10.1016/j.jpurol.2014.05.011; Crofton PM, 2002, CLIN ENDOCRINOL, V56, P215, DOI 10.1046/j.0300-0664.2001.01448.x; GENDREL D, 1980, J PEDIATR-US, V97, P217, DOI 10.1016/S0022-3476(80)80477-X; Grumbach MM, 2005, J CLIN ENDOCR METAB, V90, P3122, DOI 10.1210/jc.2004-2465; Hamza AF, 2001, EUR J PEDIATR SURG, V11, P173, DOI 10.1055/s-2001-15484; Hodhod A, 2016, J PEDIATR UROL, V12, DOI 10.1016/j.jpurol.2015.06.010; HUFF DS, 1992, J UROLOGY, V148, P627, DOI 10.1016/S0022-5347(17)36673-9; Hurwitz RS, 2001, J UROLOGY, V165, P588, DOI 10.1097/00005392-200102000-00077; JOB JC, 1988, HORM RES, V30, P167, DOI 10.1159/000181055; KEIZERSCHRAMA SMPFD, 1988, J CLIN ENDOCR METAB, V66, P159; KOFF SA, 1991, J UROLOGY, V146, P632, DOI 10.1016/S0022-5347(17)37877-1; Kolon TF, 2014, J UROLOGY, V192, P337, DOI 10.1016/j.juro.2014.05.005; Kuijper EAM, 2008, HUM REPROD, V23, P792, DOI 10.1093/humrep/den021; LARON Z, 1980, FERTIL STERIL, V33, P297; Lin CC, 2009, J ANDROL, V30, P685, DOI 10.2164/jandrol.108.006460; Main KM, 2006, J CLIN ENDOCR METAB, V91, P2732, DOI 10.1210/jc.2005-2443; Ritzen EM, 2007, ACTA PAEDIATR, V96, P638, DOI 10.1111/j.1651-2227.2006.00159.x; MULLER J, 1983, INT J ANDROL, V6, P143, DOI 10.1111/j.1365-2605.1983.tb00333.x; Raivio T, 2003, J CLIN ENDOCR METAB, V88, P2597, DOI 10.1210/jc.2002-021676; Sakamoto H, 2007, UROLOGY, V69, P152, DOI 10.1016/j.urology.2006.09.012; Sakamoto H, 2007, UROLOGY, V69, P158, DOI 10.1016/j.urology.2006.09.013; Shibata Y, 2010, UROLOGY, V76, P78, DOI 10.1016/j.urology.2010.02.043; Snodgrass WT, 2007, J UROLOGY, V178, P1718, DOI 10.1016/j.juro.2007.05.089; Suomi AM, 2006, J CLIN ENDOCR METAB, V91, P953, DOI 10.1210/jc.2004-2318; Thorup J, 2015, J UROLOGY, V193, P1632, DOI 10.1016/j.juro.2014.10.110	27	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151528	10.1371/journal.pone.0151528	http://dx.doi.org/10.1371/journal.pone.0151528			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990979	gold, Green Published, Green Submitted			2022-12-26	WOS:000372582800071
J	Muller, A; Eller, J; Albrecht, F; Prochnow, P; Kuhlmann, K; Bandow, JE; Slusarenko, AJ; Leichert, LIO				Mueller, Alexandra; Eller, Jakob; Albrecht, Frank; Prochnow, Pascal; Kuhlmann, Katja; Bandow, Julia Elisabeth; Slusarenko, Alan John; Leichert, Lars Ingo Ole			Allicin Induces Thiol Stress in Bacteria through S-Allylmercapto Modification of Protein Cysteines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; HEAT-SHOCK RESPONSE; ESCHERICHIA-COLI; ANTIBACTERIAL PRINCIPLE; ISOCITRATE LYASE; MODE; IDENTIFICATION; THIOREDOXIN; ANTIOXIDANT; GLUTATHIONE	Allicin (diallyl thiosulfinate) from garlic is a highly potent natural antimicrobial substance. It inhibits growth of a variety of microorganisms, among them antibiotic-resistant strains. However, the precise mode of action of allicin is unknown. Here, we show that growth inhibition of Escherichia coli during allicin exposure coincides with a depletion of the glutathione pool and S-allylmercapto modification of proteins, resulting in overall decreased total sulfhydryl levels. This is accompanied by the induction of the oxidative and heat stress response. We identified and quantified the allicin-induced modification S-allylmercaptocysteine for a set of cytoplasmic proteins by using a combination of label-free mass spectrometry and differential isotope-coded affinity tag labeling of reduced and oxidized thiol residues. Activity of isocitrate lyase AceA, an S-allylmercapto-modified candidate protein, is largely inhibited by allicin treatment in vivo. Allicin-induced protein modifications trigger protein aggregation, which largely stabilizes RpoH and thereby induces the heat stress response. At sublethal concentrations, the heat stress response is crucial to overcome allicin stress. Our results indicate that the mode of action of allicin is a combination of a decrease of glutathione levels, unfolding stress, and inactivation of crucial metabolic enzymes through S-allylmercapto modification of cysteines.	[Mueller, Alexandra; Eller, Jakob; Leichert, Lars Ingo Ole] Ruhr Univ Bochum, Inst Biochem & Pathobiochem Microbial Biochem, D-44780 Bochum, Germany; [Prochnow, Pascal; Bandow, Julia Elisabeth] Ruhr Univ Bochum, Angew Mikrobiol, D-44780 Bochum, Germany; [Kuhlmann, Katja] Ruhr Univ Bochum, Med Proteom Ctr, D-44780 Bochum, Germany; [Albrecht, Frank; Slusarenko, Alan John] Rhein Westfal Tech Hsch Aachen Univ, Dept Plant Physiol, D-52056 Aachen, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum; RWTH Aachen University	Leichert, LIO (corresponding author), Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Microbial Biochem, Univ Str 150, D-44780 Bochum, Germany.	lars.leichert@ruhr-uni-bochum.de	Slusarenko, Alan/AAD-2785-2020; Leichert, Lars I./B-4762-2009; Bandow, Julia/K-8854-2012	Leichert, Lars I./0000-0002-5666-9681; Bandow, Julia/0000-0003-4100-8829; Baumann, Alexandra/0000-0002-6527-5262	Deutsche Forschungsgemeinschaft under German Research Foundation [LE 2905/1-1, SPP1710]; European Research Council (ERC) under the European Union [281384-FuMe]; Ruhr University Research SchoolPLUS; Richtlinien zur Forderung des wissenschaftlichen Nachwuchses der Rheinisch-Westfalischen Technischen Hochschule Aachen (RFwN); Rheinisch-Westfalische Technische Hochschule Aachen (RWTH); German Federal state of North Rhine-Westphalia	Deutsche Forschungsgemeinschaft under German Research Foundation(German Research Foundation (DFG)); European Research Council (ERC) under the European Union(European Research Council (ERC)); Ruhr University Research SchoolPLUS; Richtlinien zur Forderung des wissenschaftlichen Nachwuchses der Rheinisch-Westfalischen Technischen Hochschule Aachen (RFwN); Rheinisch-Westfalische Technische Hochschule Aachen (RWTH); German Federal state of North Rhine-Westphalia	This work was supported in part by Deutsche Forschungsgemeinschaft Grant LE 2905/1-1 under Priority Program SPP1710 of the German Research Foundation and by the European Research Council (ERC) under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC Grant Agreement 281384-FuMe (to L. I. O. L.). This manuscript was written in part during a paper writing retreat sponsored by the Ruhr University Research SchoolPLUS. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by Richtlinien zur Forderung des wissenschaftlichen Nachwuchses der Rheinisch-Westfalischen Technischen Hochschule Aachen (RFwN) and Rheinisch-Westfalische Technische Hochschule Aachen (RWTH).; Supported by funding from the German Federal state of North Rhine-Westphalia "Translation innovativer Antibiotika aus NRW."	Albada HB, 2012, BEILSTEIN J ORG CHEM, V8, P1753, DOI 10.3762/bjoc.8.200; Ankri S, 1999, MICROBES INFECT, V1, P125, DOI 10.1016/S1286-4579(99)80003-3; Appel E, 2010, ANTIMICROB AGENTS CH, V54, P898, DOI 10.1128/AAC.01267-09; Arsene F, 2000, INT J FOOD MICROBIOL, V55, P3, DOI 10.1016/S0168-1605(00)00206-3; Aslund F, 1999, P NATL ACAD SCI USA, V96, P6161, DOI 10.1073/pnas.96.11.6161; ASLUND F, 1994, P NATL ACAD SCI USA, V91, P9813, DOI 10.1073/pnas.91.21.9813; Banerjee SK, 2003, PHYTOTHER RES, V17, P97, DOI 10.1002/ptr.1281; Borlinghaus J, 2014, MOLECULES, V19, P12591, DOI 10.3390/molecules190812591; Cai Y, 2007, J ANTIBIOT, V60, P335, DOI 10.1038/ja.2007.45; Cavallito CJ, 1944, J AM CHEM SOC, V66, P1950, DOI 10.1021/ja01239a048; Cavallito CJ, 1944, J AM CHEM SOC, V66, P1952, DOI 10.1021/ja01239a049; Cavallo L, 2003, NUCLEIC ACIDS RES, V31, P3364, DOI 10.1093/nar/gkg601; CHELL RM, 1978, BIOCHEM J, V173, P165, DOI 10.1042/bj1730165; Cotgreave IA, 2002, METHOD ENZYMOL, V348, P175, DOI 10.1016/S0076-6879(02)48636-3; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Curtis H, 2004, PHYSIOL MOL PLANT P, V65, P79, DOI 10.1016/j.pmpp.2004.11.006; Cutler RR, 2004, BRIT J BIOMED SCI, V61, P71, DOI 10.1080/09674845.2004.11732646; DERMAN AI, 1993, SCIENCE, V262, P1744, DOI 10.1126/science.8259521; ELLMORE GS, 1994, AM J BOT, V81, P89, DOI 10.2307/2445567; FELDBERG RS, 1988, ANTIMICROB AGENTS CH, V32, P1763, DOI 10.1128/AAC.32.12.1763; FREEMAN F, 1995, J AGR FOOD CHEM, V43, P2332, DOI 10.1021/jf00057a004; GHANNOUM MA, 1988, J GEN MICROBIOL, V134, P2917; Gruhlke MCH, 2010, FREE RADICAL BIO MED, V49, P1916, DOI 10.1016/j.freeradbiomed.2010.09.019; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; KOSOWER NS, 1995, METHOD ENZYMOL, V251, P123, DOI 10.1016/0076-6879(95)51116-4; LANCASTER JE, 1981, PLANT SCI LETT, V22, P169, DOI 10.1016/0304-4211(81)90139-5; Lawson LD, 2005, J AGR FOOD CHEM, V53, P6254, DOI 10.1021/jf050536+; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Leichert LIO, 2003, J BACTERIOL, V185, P1967, DOI 10.1128/JB.185.6.1967-1975.2003; MIRELMAN D, 1987, J INFECT DIS, V156, P243, DOI 10.1093/infdis/156.1.243; Miron T, 2000, BBA-BIOMEMBRANES, V1463, P20, DOI 10.1016/S0005-2736(99)00174-1; Muller A, 2013, J BACTERIOL, V195, P2807, DOI 10.1128/JB.00127-13; Neidhardt F. C., 1996, ESCHERICHIA COLI SAL, P14; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Obrist M, 2005, J BACTERIOL, V187, P3807, DOI 10.1128/JB.187.11.3807-3813.2005; Rabinkov A, 2000, BBA-MOL CELL RES, V1499, P144, DOI 10.1016/S0167-4889(00)00119-1; Rabinkov A, 1998, BBA-GEN SUBJECTS, V1379, P233, DOI 10.1016/S0304-4165(97)00104-9; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Rao R., 1949, P INDIAN ACAD SCI B, V29, P148; Rivlin RS, 2001, J NUTR, V131, p951S, DOI 10.1093/jn/131.3.951S; ROBERTSON AGS, 1995, BIOCHEM J, V305, P239, DOI 10.1042/bj3050239; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sone M, 1997, J BIOL CHEM, V272, P6174, DOI 10.1074/jbc.272.10.6174; Stoll A., 2006, ADV ENZYMOLOGY RELAT, V11, P377; STORZ G, 1990, SCIENCE, V248, P189, DOI 10.1126/science.2183352; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wallock-Richards D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112726; Wenzel M, 2013, ACS CHEM BIOL, V8, P1442, DOI 10.1021/cb4000844; Wenzel M, 2011, ANTIMICROB AGENTS CH, V55, P2590, DOI 10.1128/AAC.00078-11; WILLS ED, 1956, BIOCHEM J, V63, P514, DOI 10.1042/bj0630514; YAMADA Y, 1977, ANTIMICROB AGENTS CH, V11, P743, DOI 10.1128/AAC.11.4.743; Zhang H, 2009, PROTEINS, V76, P617, DOI 10.1002/prot.22375; Zhou JD, 2013, NUCLEIC ACIDS RES, V41, pD613, DOI 10.1093/nar/gks1235	53	79	83	3	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11477	11490		10.1074/jbc.M115.702308	http://dx.doi.org/10.1074/jbc.M115.702308			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27008862	Green Published, hybrid			2022-12-26	WOS:000377264800002
J	Bourguignon, LYW; Wong, G; Shiina, M				Bourguignon, Lilly Y. W.; Wong, Gabriel; Shiina, Marisa			Up-regulation of Histone Methyltransferase, DOT1L, by Matrix Hyaluronan Promotes MicroRNA-10 Expression Leading to Tumor Cell Invasion and Chemoresistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ALDEHYDE DEHYDROGENASE; GENE-EXPRESSION; CD44; METHYLATION; PROGRESSION; LEUKEMIA; RECEPTOR; MARKER; SENSITIVITY	Human head and neck squamous cell carcinoma is a solid tumor malignancy associated with major morbidity and mortality. In this study, we determined that human head and neck squamous cell carcinoma-derived HSC-3 cells contain a sub-population of cancer stem cells (CSCs) characterized by a high level of CD44v3 and aldehyde dehydrogenase-1 (ALDH1) expression. Importantly, matrix hyaluronan (HA) induces the up-regulation of stem cell markers that display the hallmark CSC properties. Histone methyltransferase, DOT1L, is also up-regulated by HA in CSCs (isolated from HSC-3 cells). Further analyses indicate that the stimulation of microRNA-10b (miR-10b) expression is DOT1L-specific and HA/CD44-dependent in CSCs. This process subsequently results in the overexpression of RhoGTPases and survival proteins leading to tumor cell invasion and cisplatin resistance. Treatment of CSCs with DOT1L-specific small interfering RNAs (siRNAs) effectively blocks HA/CD44-mediated expression of DOT1L, miR-10b production, and RhoGTPase/survival protein up-regulation as well as reduces tumor cell invasion and enhances chemosensitivity. CSCs were also transfected with a specific anti-miR-10b inhibitor to silence miR-10b expression and block its target functions. Our results demonstrate that the anti-miR-10 inhibitor not only decreases RhoGTPase/survival protein expression and tumor cell invasion, but also increases chemosensitivity in HA-treated CSCs. Taken together, these findings strongly support the contention that histone methyltransferase, DOT1L-associated epigenetic changes induced by HA play pivotal roles in miR-10 production leading to up-regulation of RhoGTPase and survival proteins. All of these events are critically important for the acquisition of cancer stem cell properties, including self-renewal, tumor cell invasion, and chemotherapy resistance in HA/CD44-activated head and neck cancer.	Univ Calif San Francisco, Dept Med, Endocrine Unit, 4150 Clement St, San Francisco, CA 94121 USA; San Francisco VA Med Ctr, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Bourguignon, LYW (corresponding author), Univ Calif San Francisco, San Francisco Med Ctr, Dept Med, 4150 Clement St, San Francisco, CA 94121 USA.	lilly.bourguignon@ucsf.edu			Veterans Affairs Merit Review Award RR [D-1I01 RX000601]; Veterans Affairs Merit Review Award BLR [D-5I01 BX000628]; National Institutes of Health from USPHS [R01 CA66163]; Department of Defense; NATIONAL CANCER INSTITUTE [R01CA066163] Funding Source: NIH RePORTER; Veterans Affairs [I01RX000601, I01BX000628] Funding Source: NIH RePORTER	Veterans Affairs Merit Review Award RR(US Department of Veterans Affairs); Veterans Affairs Merit Review Award BLR(US Department of Veterans Affairs); National Institutes of Health from USPHS; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by Veterans Affairs Merit Review Awards RR and D-1I01 RX000601 and BLR and D-5I01 BX000628, National Institutes of Health Grant R01 CA66163 from USPHS, and a Department of Defense grant. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Astachov L, 2011, FRONT BIOSCI-LANDMRK, V16, P261, DOI 10.2741/3687; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernt KM, 2011, CANCER CELL, V20, P66, DOI 10.1016/j.ccr.2011.06.010; Bourguignon LYW, 2012, ONCOGENE, V31, P149, DOI 10.1038/onc.2011.222; Bourguignon LYW, 2014, ADV CANCER RES, V123, P255, DOI 10.1016/B978-0-12-800092-2.00010-1; Bourguignon Lilly Y W, 2012, Small GTPases, V3, P53, DOI 10.4161/sgtp.19110; Bourguignon LYW, 2010, J BIOL CHEM, V285, P36721, DOI 10.1074/jbc.M110.162305; Bourguignon LYW, 2009, J BIOL CHEM, V284, P2657, DOI 10.1074/jbc.M806708200; Bradford CR, 2003, HEAD NECK-J SCI SPEC, V25, P654, DOI 10.1002/hed.10274; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Chen YC, 2009, BIOCHEM BIOPH RES CO, V385, P307, DOI 10.1016/j.bbrc.2009.05.048; Choudhary M, 2007, STEM CELLS, V25, P3045, DOI 10.1634/stemcells.2007-0296; Clay MR, 2010, HEAD NECK-J SCI SPEC, V32, P1195, DOI 10.1002/hed.21315; Daigle SR, 2013, BLOOD, V122, P1017, DOI 10.1182/blood-2013-04-497644; Daigle SR, 2011, CANCER CELL, V20, P53, DOI 10.1016/j.ccr.2011.06.009; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Guessous F, 2013, J NEURO-ONCOL, V112, P153, DOI 10.1007/s11060-013-1047-0; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Haylock DN, 2006, REGEN MED, V1, P437, DOI 10.2217/17460751.1.4.437; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Janzen CJ, 2006, MOL CELL, V23, P497, DOI 10.1016/j.molcel.2006.06.027; Kato T, 2000, HEAD NECK-J SCI SPEC, V22, P748, DOI 10.1002/1097-0347(200012)22:8<748::AID-HED2>3.3.CO;2-Y; Kim W, 2012, J BIOL CHEM, V287, P5588, DOI 10.1074/jbc.M111.328138; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Mack B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003360; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; San-Segundo PA, 2000, MOL BIOL CELL, V11, P3601, DOI 10.1091/mbc.11.10.3601; SCREATON GR, 1992, P NATL ACAD SCI USA, V89, P12160, DOI 10.1073/pnas.89.24.12160; Seton-Rogers S, 2009, NAT REV CANCER, V9, P610, DOI 10.1038/nrc2719; Shiga H, 2000, HEAD NECK-J SCI SPEC, V22, P599, DOI 10.1002/1097-0347(200009)22:6<599::AID-HED9>3.0.CO;2-M; Shiina M., 2015, INT J CELL BIOL, V2015; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sun X, 2014, ONCOGENE, V33, P4967, DOI [10.1038/onc.2013.492, 10.1038/onc.2014.224]; Toole BP, 2002, AM J PATHOL, V161, P745, DOI 10.1016/S0002-9440(10)64232-0; UNDERHILL C, 1992, J CELL SCI, V103, P293; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang SJ, 2011, AM J PATHOL, V178, P956, DOI 10.1016/j.ajpath.2010.11.077; Wang SJ, 2009, LARYNGOSCOPE, V119, P1518, DOI 10.1002/lary.20506; WHEATLEY SC, 1995, CELL ADHES COMMUN, V3, P217, DOI 10.3109/15419069509081288	42	47	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10571	10585		10.1074/jbc.M115.700021	http://dx.doi.org/10.1074/jbc.M115.700021			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27002147	Green Published, hybrid			2022-12-26	WOS:000377042600012
J	Andriotis, VME; Saalbach, G; Waugh, R; Field, RA; Smith, AM				Andriotis, Vasilios M. E.; Saalbach, Gerhard; Waugh, Robbie; Field, Robert A.; Smith, Alison M.			The Maltase Involved in Starch Metabolism in Barley Endosperm Is Encoded by a Single Gene	PLOS ONE			English	Article							PI-ALPHA-GLUCOSIDASE; LIMIT DEXTRINASE; SUBSTRATE-SPECIFICITY; DEBRANCHING ENZYME; BETA-AMYLASE; DEGRADATION; THERMOSTABILITY; RECOGNITION; GRANULES; SEQUENCE	During germination and early seedling growth of barley (Hordeumvulgare), maltase is responsible for the conversion of maltose produced by starch degradation in the endosperm to glucose for seedling growth. Despite the potential relevance of this enzyme for malting and the production of alcoholic beverages, neither the nature nor the role of maltase is fully understood. Although only one gene encoding maltase has been identified with certainty, there is evidence for the existence of other genes and for multiple forms of the enzyme. It has been proposed that maltase may be involved directly in starch granule degradation as well as in maltose hydrolysis. The aim of our work was to discover the nature of maltase in barley endosperm. We used ion exchange chromatography to fractionate maltase activity from endosperm of young seedlings, and we partially purified activity for protein identification. We compared maltase activity in wild-type barley and transgenic lines with reduced expression of the previously-characterised maltase gene Agl97, and we used genomic and transcriptomic information to search for further maltase genes. We show that all of the maltase activity in the barley endosperm can be accounted for by a single gene, Agl97. Multiple forms of the enzyme most likely arise from proteolysis and other post-translational modifications.	[Andriotis, Vasilios M. E.; Saalbach, Gerhard; Field, Robert A.; Smith, Alison M.] John Innes Ctr, Norwich Res Pk, Norwich, Norfolk, England; [Waugh, Robbie] James Hutton Inst, Invergowrie, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; James Hutton Institute	Smith, AM (corresponding author), John Innes Ctr, Norwich Res Pk, Norwich, Norfolk, England.	alison.smith@jic.ac.uk		Andriotis, Vasilios/0000-0003-2304-843X; Field, Rob/0000-0001-8574-0275	Biotechnology and Biological Sciences Research Council (BBSRC, UK) Crop Improvement Research Club [BB/I017291/1]; BBSRC Institute Strategic Programme [BB/J004561/1]; BBSRC [BBS/E/J/000C0618, BB/I017291/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0618, BB/I017291/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC, UK) Crop Improvement Research Club; BBSRC Institute Strategic Programme(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by the Biotechnology and Biological Sciences Research Council (BBSRC, UK) Crop Improvement Research Club through grant BB/I017291/1 to AMS, RAF and RW, and by a BBSRC Institute Strategic Programme Grant BB/J004561/1 to the John Innes Centre. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. The funders approved the work prior to submission for publication.	Asano N, 2003, GLYCOBIOLOGY, V13, p93R, DOI 10.1093/glycob/cwg090; Bamforth CW, 2009, J CEREAL SCI, V50, P353, DOI 10.1016/j.jcs.2009.03.001; Barba-Espin G, 2014, PLANT PHYSIOL, V164, P951, DOI 10.1104/pp.113.233163; Bathgate GN, 2011, J I BREWING, V117, P33, DOI 10.1002/j.2050-0416.2011.tb00440.x; Bobalova J, 2010, EUR FOOD RES TECHNOL, V230, P665, DOI 10.1007/s00217-009-1205-y; Clark SE, 2004, PROTEIN ENG DES SEL, V17, P245, DOI 10.1093/protein/gzh028; Clark SE, 2003, PLANT PHYSIOL BIOCH, V41, P798, DOI 10.1016/S0981-9428(03)00118-9; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Evans DE, 2009, ADV TOP SCI TECH CHI, P143, DOI 10.1007/978-3-642-01279-2_6; Evans DE, 2008, J AM SOC BREW CHEM, V66, P223, DOI 10.1094/ASBCJ-2008-0909-02; Finnie C, 2011, PROTEOMICS, V11, P1595, DOI 10.1002/pmic.201000656; Finnie C, 2009, J PROTEOMICS, V72, P315, DOI 10.1016/j.jprot.2008.12.001; Frandsen TP, 1998, PLANT MOL BIOL, V37, P1, DOI 10.1023/A:1005925819741; Frandsen TP, 2000, PLANT PHYSIOL, V123, P275, DOI 10.1104/pp.123.1.275; Hazell BW, 1999, J IND MICROBIOL BIOT, V22, P627, DOI 10.1038/sj.jim.2900672; IM H, 1995, CARBOHYD RES, V277, P145, DOI 10.1016/0008-6215(95)00212-C; Kristensen M, 1999, BBA-PROTEIN STRUCT M, V1431, P538, DOI 10.1016/S0167-4838(99)00077-1; Ling AR, 1923, BIOCHEM J, V17, P593, DOI 10.1042/bj0170593; Matsumoto T, 2011, PLANT PHYSIOL, V156, P20, DOI 10.1104/pp.110.171579; Mayer KFX, 2012, NATURE, V491, P711, DOI 10.1038/nature11543; Moreno-Risueno MA, 2007, PLANT J, V51, P352, DOI 10.1111/j.1365-313X.2007.03146.x; Muralikrishna G, 2005, CARBOHYD POLYM, V60, P163, DOI 10.1016/j.carbpol.2004.12.002; Muslin EH, 2003, J AM SOC BREW CHEM, V61, P142; Muslin EH, 2002, PROTEIN ENG, V15, P29, DOI 10.1093/protein/15.1.29; Naested H, 2006, PROTEIN EXPRES PURIF, V46, P56, DOI 10.1016/j.pep.2005.10.008; Osman AM, 2002, J I BREWING, V108, P204, DOI 10.1002/j.2050-0416.2002.tb00542.x; Phaweni P, 1993, J AM SOC BREW CHEM, V51; Ritchie SM, 2002, PHYSIOL PLANTARUM, V115, P342, DOI 10.1034/j.1399-3054.2002.1150303.x; Robert X, 2003, STRUCTURE, V11, P973, DOI 10.1016/S0969-2126(03)00151-5; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SISSONS MJ, 1994, J CEREAL SCI, V19, P161, DOI 10.1006/jcrs.1994.1022; Stanley D, 2011, PLANT PHYSIOL, V155, P932, DOI 10.1104/pp.110.168328; STARK JR, 1987, J I BREWING, V93, P108, DOI 10.1002/j.2050-0416.1987.tb04485.x; SUN Z, 1990, PLANT PHYSIOL, V94, P320, DOI 10.1104/pp.94.1.320; SUN ZT, 1991, ARCH BIOCHEM BIOPHYS, V284, P298, DOI 10.1016/0003-9861(91)90299-X; Tanaka Y, 2006, P 23 INT CARB S WHIS; Tibbot BK, 1998, PLANT MOL BIOL, V38, P379, DOI 10.1023/A:1006006203372; Tibbot BK, 1996, PLANT MOL BIOL, V30, P229, DOI 10.1007/BF00020110; Vester-Christensen MB, 2010, J MOL BIOL, V403, P739, DOI 10.1016/j.jmb.2010.09.031; Xie Z, 2006, PLANT J, V46, P231, DOI 10.1111/j.1365-313X.2006.02694.x	40	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151642	10.1371/journal.pone.0151642	http://dx.doi.org/10.1371/journal.pone.0151642			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27011041	Green Published, gold			2022-12-26	WOS:000372708000036
J	Cordeiro, OG; Chypre, M; Brouard, N; Rauber, S; Alloush, F; Romera-Hernandez, M; Benezech, C; Li, Z; Eckly, A; Coles, MC; Rot, A; Yagita, H; Leon, C; Ludewig, B; Cupedo, T; Lanza, F; Mueller, CG				Cordeiro, Olga G.; Chypre, Melanie; Brouard, Nathalie; Rauber, Simon; Alloush, Farouk; Romera-Hernandez, Monica; Benezech, Cecile; Li, Zhi; Eckly, Anita; Coles, Mark C.; Rot, Antal; Yagita, Hideo; Leon, Catherine; Ludewig, Burkhard; Cupedo, Tom; Lanza, Francois; Mueller, Christopher G.			Integrin-Alpha IIb Identifies Murine Lymph Node Lymphatic Endothelial Cells Responsive to RANKL	PLOS ONE			English	Article							FIBROBLASTIC RETICULAR CELLS; HEMATOPOIETIC PROGENITORS; EXPRESSION; CD41; BETA; MICE; MAINTENANCE; ANTIBODY; DEFINES	Microenvironment and activation signals likely imprint heterogeneity in the lymphatic endothelial cell (LEC) population. Particularly LECs of secondary lymphoid organs are exposed to different cell types and immune stimuli. However, our understanding of the nature of LEC activation signals and their cell source within the secondary lymphoid organ in the steady state remains incomplete. Here we show that integrin alpha 2b (ITGA2b), known to be carried by platelets, megakaryocytes and hematopoietic progenitors, is expressed by a lymph node subset of LECs, residing in medullary, cortical and subcapsular sinuses. In the subcapsular sinus, the floor but not the ceiling layer expresses the integrin, being excluded from ACKR4(+) LECs but overlapping with MAdCAM-1 expression. ITGA2b expression increases in response to immunization, raising the possibility that heterogeneous ITGA2b levels reflect variation in exposure to activation signals. We show that alterations of the level of receptor activator of NF-kappa B ligand (RANKL), by overexpression, neutralization or deletion from stromal marginal reticular cells, affected the proportion of ITGA2b(+) LECs. Lymph node LECs but not peripheral LECs express RANK. In addition, we found that lymphotoxin-beta receptor signaling likewise regulated the proportion of ITGA2b(+) LECs. These findings demonstrate that stromal reticular cells activate LECs via RANKL and support the action of hematopoietic cell-derived lymphotoxin.	[Cordeiro, Olga G.; Chypre, Melanie; Rauber, Simon; Alloush, Farouk; Mueller, Christopher G.] Univ Strasbourg, Lab Immunopathol & Therapeut Chem, Inst Biol Mol & Cellulaire, CNRS,UPR 3572,MEDALIS, Strasbourg, France; [Chypre, Melanie] Prestwick Chem, Blvd Gonthier Andernach,Parc Innovat, F-67400 Illkirch Graffenstaden, France; [Brouard, Nathalie; Eckly, Anita; Leon, Catherine; Lanza, Francois] Univ Strasbourg, Etab Francais Sang Alsace, Federat Med Translat, INSERM,UMR S949,Fac Med, Strasbourg, France; [Romera-Hernandez, Monica; Cupedo, Tom] Erasmus Univ, Dept Hematol, Med Ctr, Rotterdam, Netherlands; [Benezech, Cecile] Univ Edinburgh, Queens Med Res Inst, BHF Ctr Cardiovasc Sci, Edinburgh, Midlothian, Scotland; [Li, Zhi; Coles, Mark C.; Rot, Antal] Univ York, Dept Biol, Ctr Immunol & Infect, York YO10 5DD, N Yorkshire, England; [Yagita, Hideo] Juntendo Univ, Dept Immunol, Sch Med, Tokyo 1138421, Japan; [Ludewig, Burkhard] Kantonspital St Gallen, Inst Immunobiol, CH-9007 St Gallen, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Erasmus University Rotterdam; Erasmus MC; University of Edinburgh; University of York - UK; Juntendo University; Kantonsspital St. Gallen	Mueller, CG (corresponding author), Univ Strasbourg, Lab Immunopathol & Therapeut Chem, Inst Biol Mol & Cellulaire, CNRS,UPR 3572,MEDALIS, Strasbourg, France.	c.mueller@cnrs-ibmc.unistra.fr	Cupedo, Tom/GQQ-0614-2022; Léon, Catherine/G-6473-2015; leon, catherine/ABB-5242-2020; Rauber, Simon/L-6550-2019; Lanza, Francois/H-9252-2016	Léon, Catherine/0000-0002-8597-9929; leon, catherine/0000-0002-8597-9929; Rauber, Simon/0000-0001-8306-9334; Lanza, Francois/0000-0002-5802-4748; Benezech, Cecile/0000-0002-2613-1418; Li, Zhi/0000-0002-0583-1116; Rot, Antal/0000-0002-9730-6166; Mueller, Christopher/0000-0002-4119-2729	FP7-MC-ITN [289720]; Prestwick Chemical; German-French University program; IDEX-University of Strasbourg international PhD program; Centre National pour la Recherche Scientifique; Agence Nationale pour la Recherche [ANR-10-LABX-0034, ANR-11-EQPX-022]	FP7-MC-ITN; Prestwick Chemical; German-French University program; IDEX-University of Strasbourg international PhD program; Centre National pour la Recherche Scientifique; Agence Nationale pour la Recherche(French National Research Agency (ANR))	O.C. and M.R.-H. were supported by FP7-MC-ITN No. 289720 "Stroma", M.C. by Prestwick Chemical, S.R. by the German-French University program and F.A. by the IDEX-University of Strasbourg international PhD program. The study has received financial support by the Centre National pour la Recherche Scientifique and the Agence Nationale pour la Recherche (Program "Investissements d'Avenir", ANR-10-LABX-0034 MEDALIS; ANR-11-EQPX-022) to C.G.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder, Prestwick Chemical (commercial company), provided support in the form of salary for author Melanie Chypre, but did not have additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Bazigou E, 2009, DEV CELL, V17, P175, DOI 10.1016/j.devcel.2009.06.017; Benezech C, 2014, BLOOD, V123, P3200, DOI 10.1182/blood-2013-03-489286; Bergmeier W, 2002, CYTOMETRY, V48, P80, DOI 10.1002/cyto.10114; Berlanga O, 2005, EXP HEMATOL, V33, P403, DOI 10.1016/j.exphem.2005.01.011; Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Boisset JC, 2013, BIOL OPEN, V2, P525, DOI 10.1242/bio.20133715; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; Chypre M, 2016, IMMUNOL LETT, V171, P5, DOI 10.1016/j.imlet.2016.01.003; Cohen JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087740; Duheron V, 2011, P NATL ACAD SCI USA, V108, P5342, DOI 10.1073/pnas.1013054108; Eckly A, 2012, METHODS MOL BIOL, V788, P175, DOI 10.1007/978-1-61779-307-3_13; Emambokus NR, 2003, IMMUNITY, V19, P33, DOI 10.1016/S1074-7613(03)00173-0; Ettinger R, 1996, P NATL ACAD SCI USA, V93, P13102, DOI 10.1073/pnas.93.23.13102; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Furuya M, 2010, J IMMUNOL, V185, P5769, DOI 10.4049/jimmunol.1002226; Gekas C, 2013, BLOOD, V121, P4463, DOI 10.1182/blood-2012-09-457929; Hess E, 2012, J IMMUNOL, V188, P1245, DOI 10.4049/jimmunol.1101513; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Kamijo S, 2006, BIOCHEM BIOPH RES CO, V347, P124, DOI 10.1016/j.bbrc.2006.06.098; Katakai T, 2008, J IMMUNOL, V181, P6189, DOI 10.4049/jimmunol.181.9.6189; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; LEFKOVITS J, 1995, NEW ENGL J MED, V332, P1553, DOI 10.1056/NEJM199506083322306; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Lowell CA, 2011, METHODS MOL BIOL, V757, P369, DOI 10.1007/978-1-61779-166-6_22; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Mitjavila-Garcia MT, 2002, DEVELOPMENT, V129, P2003; Mueller CG, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00261; Nieswandt B, 1999, BLOOD, V94, P684, DOI 10.1182/blood.V94.2.684; Onder L, 2012, BLOOD, V120, P4675, DOI 10.1182/blood-2012-03-416859; Perrault C, 2001, THROMB HAEMOSTASIS, V86, P1238, DOI 10.1055/s-0037-1616057; Ruddell A, 2003, AM J PATHOL, V163, P2233, DOI 10.1016/S0002-9440(10)63581-X; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Sugiyama M, 2012, INT IMMUNOL, V24, P369, DOI 10.1093/intimm/dxs002; Tewalt EF, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00305; Ulvmar MH, 2014, NAT IMMUNOL, V15, P623, DOI 10.1038/ni.2889; Voisin B, 2014, EXP DERMATOL, V23, P354, DOI 10.1111/exd.12373; Wang YC, 2012, P NATL ACAD SCI USA, V109, P16143, DOI 10.1073/pnas.1208253109; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yoshida H, 2002, IMMUNITY, V17, P823, DOI 10.1016/S1074-7613(02)00479-X; Zhang JH, 2007, EXP HEMATOL, V35, P490, DOI 10.1016/j.exphem.2006.11.011	40	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151848	10.1371/journal.pone.0151848	http://dx.doi.org/10.1371/journal.pone.0151848			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010197	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000372708000051
J	Oqani, RK; Lin, T; Lee, JE; Choi, KM; Shin, HY; Jin, DI				Oqani, Reza K.; Lin, Tao; Lee, Jae Eun; Choi, Ki Myung; Shin, Hyun Young; Jin, Dong Il			P-TEFb Kinase Activity Is Essential for Global Transcription, Resumption of Meiosis and Embryonic Genome Activation in Pig	PLOS ONE			English	Article							RNA-POLYMERASE-II; GERMINAL VESICLE OOCYTES; CELL-CYCLE PROGRESSION; C-TERMINAL DOMAIN; RIBOSOMAL-RNA; MOUSE OOCYTES; PORCINE EMBRYOS; IN-VITRO; PREIMPLANTATION EMBRYOS; NUCLEAR MATURATION	Positive transcription elongation factor b (P-TEFb) is a RNA polymerase II carboxyl-terminal domain (Pol II CTD) kinase that phosphorylates Ser2 of the CTD and promotes the elongation phase of transcription. Despite the fact that P-TEFb has role in many cellular processes, the role of this kinase complex remains to be understood in mammalian early developmental events. In this study, using immunocytochemical analyses, we found that the P-TEFb components, CDK9, Cyclin T1 and Cyclin T2 were localized to nuclear speckles, as well as in nucleolar-like bodies in pig germinal vesicle oocytes. Using nascent RNA labeling and small molecule inhibitors, we showed that inhibition of CDK9 activity abolished the transcription of GV oocytes globally. Moreover, using fluorescence in situ hybridization, in absence of CDK9 kinase activity the production of ribosomal RNAs was impaired. We also presented the evidences indicating that P-TEFb kinase activity is essential for resumption of oocyte meiosis and embryo development. Treatment with CDK9 inhibitors resulted in germinal vesicle arrest in maturing oocytes in vitro. Inhibition of CDK9 kinase activity did not interfere with in vitro fertilization and pronuclear formation. However, when in vitro produced zygotes were treated with CDK9 inhibitors, their development beyond the 4-cell stage was impaired. In these embryos, inhibition of CDK9 abrogated global transcriptional activity and rRNA production. Collectively, our data suggested that P-TEFb kinase activity is crucial for oocyte maturation, embryo development and regulation of RNA transcription in pig.	[Oqani, Reza K.; Lin, Tao; Lee, Jae Eun; Shin, Hyun Young; Jin, Dong Il] Chungnam Natl Univ, Dept Anim Sci & Biotechnol, Res Ctr Transgen Cloned Pigs, Taejon 305764, South Korea; [Choi, Ki Myung] Optipharm Inc, Cheongju 361954, Chungbuk, South Korea	Chungnam National University	Jin, DI (corresponding author), Chungnam Natl Univ, Dept Anim Sci & Biotechnol, Res Ctr Transgen Cloned Pigs, Taejon 305764, South Korea.	dijin@cnu.ac.kr		Lin, Tao/0000-0001-9100-6042	BioGreen 21 Program of Rural Development Administration [PJ01119601]; Bio-industry Technology Development Program [IPET312060-5]; Ministry of Agriculture, Food and Rural Affairs, Republic of Korea; Optipharm Inc.	BioGreen 21 Program of Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Bio-industry Technology Development Program; Ministry of Agriculture, Food and Rural Affairs, Republic of Korea; Optipharm Inc.	This work was supported by the BioGreen 21 Program of the Rural Development Administration (grant no. PJ01119601) and the Bio-industry Technology Development Program (grant no. IPET312060-5), the Ministry of Agriculture, Food and Rural Affairs, Republic of Korea. Optipharm Inc. provided support in the form of salary for author KMC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.; This work was supported by the BioGreen 21 Program of the Rural Development Administration (grant no. PJ01119601) and the Bio-industry Technology Development Program (grant no. IPET312060-5), the Ministry of Agriculture, Food and Rural Affairs, Republic of Korea.	Abe K, 2010, J REPROD DEVELOP, V56, P502, DOI 10.1262/jrd.10-068A; Adhikari D, 2012, HUM MOL GENET, V21, P2476, DOI 10.1093/hmg/dds061; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Barnetova I, 2012, MOL REPROD DEV, V79, P697, DOI 10.1002/mrd.22077; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; BIGGIOGERA M, 1989, J HISTOCHEM CYTOCHEM, V37, P1371, DOI 10.1177/37.9.2768807; Bjerregaard B, 2004, BIOL REPROD, V70, P867, DOI 10.1095/biolreprod.103.021683; Bjerregaard B, 2007, MOL REPROD DEV, V74, P35, DOI 10.1002/mrd.20594; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Bouchoux C, 2004, NUCLEIC ACIDS RES, V32, P5851, DOI 10.1093/nar/gkh927; Bouniol-Baly C, 1999, BIOL REPROD, V60, P580, DOI 10.1095/biolreprod60.3.580; Bradsher J, 2002, MOL CELL, V10, P819, DOI 10.1016/S1097-2765(02)00678-0; Bres V, 2008, CURR OPIN CELL BIOL, V20, P334, DOI 10.1016/j.ceb.2008.04.008; Burger K, 2013, J BIOL CHEM, V288, P21173, DOI 10.1074/jbc.M113.483719; Burger K, 2010, J BIOL CHEM, V285, P12416, DOI 10.1074/jbc.M109.074211; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen RC, 2004, J BIOL CHEM, V279, P4153, DOI 10.1074/jbc.M310044200; Cmarko D, 2000, HISTOCHEM CELL BIOL, V113, P181, DOI 10.1007/s004180050437; Conroy A, 2009, CANCER CHEMOTH PHARM, V64, P723, DOI 10.1007/s00280-008-0921-5; Coordes B, 2015, EUKARYOT CELL, V14, P86, DOI 10.1128/EC.00106-14; Dahlberg O, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004971; De La Fuente R, 2006, DEV BIOL, V292, P1, DOI 10.1016/j.ydbio.2006.01.008; Devaiah BN, 2013, TRANSCR-AUSTIN, V4, P13, DOI 10.4161/trns.22542; Dow EC, 2010, J CELL PHYSIOL, V224, P84, DOI 10.1002/jcp.22096; DUNDR M, 1993, EXP CELL RES, V208, P275, DOI 10.1006/excr.1993.1247; Farin CE, 2007, ANIM REPROD SCI, V98, P97, DOI 10.1016/j.anireprosci.2006.10.007; FULKA J, 1986, J REPROD FERTIL, V77, P281, DOI 10.1530/jrf.0.0770281; Gargano B, 2007, CELL CYCLE, V6, P2031, DOI 10.4161/cc.6.16.4554; Ginisty H, 1998, EMBO J, V17, P1476, DOI 10.1093/emboj/17.5.1476; Gordon V, 2010, MOL ENDOCRINOL, V24, P2267, DOI 10.1210/me.2010-0238; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Heidemann M, 2013, BBA-GENE REGUL MECH, V1829, P55, DOI 10.1016/j.bbagrm.2012.08.013; Hernandez-Verdun D, 2010, WIRES RNA, V1, P415, DOI 10.1002/wrna.39; Herrmann CH, 2001, J CELL SCI, V114, P1491; Hirose Y, 2007, J BIOCHEM, V141, P601, DOI 10.1093/jb/mvm090; HOZAK P, 1994, J CELL SCI, V107, P639; Hyttel P, 2000, BIOL REPROD, V63, P1848, DOI 10.1095/biolreprod63.6.1848; Iben S, 2002, CELL, V109, P297, DOI 10.1016/S0092-8674(02)00729-8; JARRELL VL, 1991, BIOL REPROD, V44, P62, DOI 10.1095/biolreprod44.1.62; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; KASTROP PMM, 1991, MOL REPROD DEV, V28, P249, DOI 10.1002/mrd.1080280306; Kohoutek J, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-19; Lam F, 2014, ONCOTARGET, V5, P7691, DOI 10.18632/oncotarget.2296; Liang K, 2015, MOL CELL BIOL, V35, P928, DOI 10.1128/MCB.01426-14; Lin CY, 2002, CURR BIOL, V12, P2142, DOI 10.1016/S0960-9822(02)01389-1; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; MEINECKE B, 1993, J REPROD FERTIL, V98, P195; Ochs RL, 1998, METHOD CELL BIOL, V53, P303; Oqani RK, 2013, DEV DYNAM, V242, P16, DOI 10.1002/dvdy.23901; Oqani RK, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-33; Parfenov VN, 2000, J CELL BIOCHEM, V77, P654, DOI 10.1002/(SICI)1097-4644(20000615)77:4<654::AID-JCB13>3.3.CO;2-W; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Prather R S, 2009, Soc Reprod Fertil Suppl, V66, P165; PuvionDutilleul F, 1997, CHROMOSOMA, V105, P496, DOI 10.1007/s004120050211; Radhakrishnan SK, 2006, CELL CYCLE, V5, P519, DOI 10.4161/cc.5.5.2514; Raju U, 2003, CANCER RES, V63, P3263; Schindler K, 2012, P NATL ACAD SCI USA, V109, pE2215, DOI 10.1073/pnas.1120517109; Schlosser I, 2003, NUCLEIC ACIDS RES, V31, P6148, DOI 10.1093/nar/gkg794; Schmerwitz UK, 2011, ARTERIOSCL THROM VAS, V31, P280, DOI 10.1161/ATVBAHA.110.213934; Schneider DA, 2006, P NATL ACAD SCI USA, V103, P12707, DOI 10.1073/pnas.0605686103; Shim EY, 2002, GENE DEV, V16, P2135, DOI 10.1101/gad.999002; Shishova KV, 2015, DEV BIOL, V397, P267, DOI 10.1016/j.ydbio.2014.11.022; SIMON M, 1989, REPROD NUTR DEV, V29, P533, DOI 10.1051/rnd:19890502; Simone C, 2002, ONCOGENE, V21, P4137, DOI 10.1038/sj.onc.1205493; Solc P, 2010, MOL HUM REPROD, V16, P654, DOI 10.1093/molehr/gaq034; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; Stephan F, 2004, J BIOL CHEM, V279, P25251, DOI 10.1074/jbc.M401867200; Tan JH, 2009, MOL HUM REPROD, V15, P1, DOI 10.1093/molehr/gan069; Ueshima S, 2014, BIOCHEM BIOPH RES CO, V443, P22, DOI 10.1016/j.bbrc.2013.11.039; Viuff D, 2002, BIOL REPROD, V66, P629, DOI 10.1095/biolreprod66.3.629; Wang KQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030128; WANSINK DG, 1993, J CELL BIOL, V122, P283, DOI 10.1083/jcb.122.2.283; WESTENDORF JM, 1994, P NATL ACAD SCI USA, V91, P714, DOI 10.1073/pnas.91.2.714; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Zuccotti M, 2011, HUM REPROD UPDATE, V17, P525, DOI 10.1093/humupd/dmr009	79	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152254	10.1371/journal.pone.0152254	http://dx.doi.org/10.1371/journal.pone.0152254			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27011207	Green Submitted, gold, Green Published			2022-12-26	WOS:000372708000121
J	Greatorex, ZF; Olson, SH; Singhalath, S; Silithammavong, S; Khammavong, K; Fine, AE; Weisman, W; Douangngeun, B; Theppangna, W; Keatts, L; Gilbert, M; Karesh, WB; Hansel, T; Zimicki, S; O'Rourke, K; Joly, DO; Mazet, JAK				Greatorex, Zoe F.; Olson, Sarah H.; Singhalath, Sinpakone; Silithammavong, Soubanh; Khammavong, Kongsy; Fine, Amanda E.; Weisman, Wendy; Douangngeun, Bounlom; Theppangna, Watthana; Keatts, Lucy; Gilbert, Martin; Karesh, William B.; Hansel, Troy; Zimicki, Susan; O'Rourke, Kathleen; Joly, Damien O.; Mazet, Jonna A. K.			Wildlife Trade and Human Health in Lao PDR: An Assessment of the Zoonotic Disease Risk in Markets	PLOS ONE			English	Article							INFLUENZA-VIRUS; FRUIT BATS; RESERVOIRS; SARS; CORONAVIRUS; H5N1	Although the majority of emerging infectious diseases can be linked to wildlife sources, most pathogen spillover events to people could likely be avoided if transmission was better understood and practices adjusted to mitigate risk. Wildlife trade can facilitate zoonotic disease transmission and represents a threat to human health and economies in Asia, highlighted by the 2003 SARS coronavirus outbreak, where a Chinese wildlife market facilitated pathogen transmission. Additionally, wildlife trade poses a serious threat to biodiversity. Therefore, the combined impacts of Asian wildlife trade, sometimes termed bush meat trade, on public health and biodiversity need assessing. From 2010 to 2013, observational data were collected in Lao PDR from markets selling wildlife, including information on volume, form, species and price of wildlife; market biosafety and visitor origin. The potential for traded wildlife to host zoonotic diseases that pose a serious threat to human health was then evaluated at seven markets identified as having high volumes of trade. At the seven markets, during 21 observational surveys, 1,937 alive or fresh dead mammals ( approximately 1,009 kg) were observed for sale, including mammals from 12 taxonomic families previously documented to be capable of hosting 36 zoonotic pathogens. In these seven markets, the combination of high wildlife volumes, high risk taxa for zoonoses and poor biosafety increases the potential for pathogen presence and transmission. To examine the potential conservation impact of trade in markets, we assessed the status of 33,752 animals observed during 375 visits to 93 markets, under the Lao PDR Wildlife and Aquatic Law. We observed 6,452 animals listed by Lao PDR as near extinct or threatened with extinction. The combined risks of wildlife trade in Lao PDR to human health and biodiversity highlight the need for a multi-sector approach to effectively protect public health, economic interests and biodiversity.	[Greatorex, Zoe F.; Olson, Sarah H.; Singhalath, Sinpakone; Silithammavong, Soubanh; Khammavong, Kongsy; Fine, Amanda E.; Weisman, Wendy; Keatts, Lucy; Gilbert, Martin; Karesh, William B.; Hansel, Troy; Joly, Damien O.] Wildlife Conservat Soc, Wildlife Hlth & Hlth Policy Program, Bronx, NY USA; [Olson, Sarah H.] Univ Wisconsin, Ctr Sustainabil & Global Environm, Madison, WI USA; [Douangngeun, Bounlom; Theppangna, Watthana] Natl Anim Hlth Lab, Dept Livestock & Fisheries, Viangchan, Laos; [Zimicki, Susan; O'Rourke, Kathleen] FHI360, Washington, DC USA; [Mazet, Jonna A. K.] Univ Calif Davis, Sch Vet Med, Hlth Inst 1, Davis, CA 95616 USA; [Weisman, Wendy] Ctr Social Innovat, New York, NY USA; [Karesh, William B.] EcoHlth Alliance, New York, NY USA; [Joly, Damien O.] Metabiota Inc, Nanaimo, BC, Canada	Wildlife Conservation Society; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Davis; EcoHealth Alliance	Greatorex, ZF; Olson, SH (corresponding author), Wildlife Conservat Soc, Wildlife Hlth & Hlth Policy Program, Bronx, NY USA.; Olson, SH (corresponding author), Univ Wisconsin, Ctr Sustainabil & Global Environm, Madison, WI USA.	zoegreatorex@hotmail.com; solson@wcs.org	Karesh, William/AAU-9084-2020	Karesh, William/0000-0001-6042-2860; Gilbert, Martin/0000-0002-9930-4383	Wildlife Conservation Society	Wildlife Conservation Society	This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT (http://www.predict.global) and PREVENT projects; additional funding was provided by the Wildlife Conservation Society.	Blasdell Kim, 2009, Kasetsart Journal Natural Sciences, V43, P94; Bourgeois Luthi N, 2012, DESK REV EXPOSURE HU; Center for Disease Control and Prevention, 2003, 52 MMWR; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; CLENDON K, 2001, ROLE FOREST FOOD RES; Cowlishaw G, 2005, J APPL ECOL, V42, P460, DOI 10.1111/j.1365-2664.2005.01046.x; Dautartas AM, 2009, EFFECT VARIOUS COVER; Duckworth W, 1999, WILDLIFE LAO PDR 199; EFSA, 2007, EFSA J, V578, P1; Foppes J, 2001, NONTIMBER FOREST PRO; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Guarner J, 2004, EMERG INFECT DIS, V10, P426, DOI 10.3201/eid1003.030878; Haglund W. D, 1997, FORENSIC TAPHONOMY P; Hai W., 2004, ASIAN ECON PAP, V3, P57, DOI [10.1162/1535351041747905, DOI 10.1162/1535351041747905]; Hansel Troy, 2004, Natural History Bulletin of the Siam Society, V52, P195; International Food Safety Authorities Network (INFOSAN), 2005, HIGHLY PATHOGENIC H5; Johnson A., 2012, LINKING SUSTAINABLE; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; JUSTE J, 1995, J APPL ECOL, V32, P454, DOI 10.2307/2404644; Kadoorie Farm and Botanic Garden, 2004, WILD AN TRAD MON SEL; Kamins AO, 2011, BIOL CONSERV, V144, P3000, DOI 10.1016/j.biocon.2011.09.003; Karesh WB, 2005, EMERG INFECT DIS, V11, P1000; Lam WK, 2003, RESPIROLOGY, V8, pS2, DOI 10.1046/j.1440-1843.2003.00516.x; Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102; Lau W, 1997, REPORTS BIODIVERSITY; Leroy EM, 2005, NATURE, V438, P575, DOI 10.1038/438575a; Leroy EM, 2009, VECTOR-BORNE ZOONOT, V9, P723, DOI 10.1089/vbz.2008.0167; Levinson J, 2013, EMERG INFECT DIS, V19, P743, DOI 10.3201/eid1905.121042; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Li YB, 2011, EMERG INFECT DIS, V17, P265, DOI 10.3201/eid1702.100732; Luby SP, 2009, CLIN INFECT DIS, V49, P1743, DOI 10.1086/647951; Magnino S, 2009, INT J FOOD MICROBIOL, V134, P163, DOI 10.1016/j.ijfoodmicro.2009.07.001; Megyesi M, 2001, EFFECTS TEMPERATURE; Mills JN, 1998, EMERG INFECT DIS, V4, P529, DOI 10.3201/eid0404.980403; Nash S. V, 1997, FIN FEATHER SCALE SK; Olival KJ, 2013, EMERG INFECT DIS, V19, P270, DOI 10.3201/eid1902.120524; Pavlin BI, 2009, EMERG INFECT DIS, V15, P1721, DOI [10.3201/eid1511.090467, 10.3201/eid1511.090419]; Peeters M, 2002, EMERG INFECT DIS, V8, P451, DOI 10.3201/eid0805.010522; Radomyos Prayong, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P498; Saez AM, 2015, EMBO MOL MED, V7, P17, DOI 10.15252/emmm.201404792; Salter R, 1993, NOTES OBSERVATIONS W; Shepherd C, 2007, ASSESSMENT WILDLIFE, V21; Sinclair R, 2008, APPL ENVIRON MICROB, V74, P555, DOI 10.1128/AEM.02167-07; Smith KM, 2012, PLOS ONE, V7, P71, DOI 10.1371/journal.pone.0029505; Song HS, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-40; Srikosamatara Sompoad, 1992, Natural History Bulletin of the Siam Society, V40, P1; The World Bank, 2015, LAO PDR DATA; TRAFFIC, 2008, WHAT DRIV WILDL TRAD; Tu CC, 2004, EMERG INFECT DIS, V10, P2244, DOI 10.3201/eid1012.040520; Van Borm S, 2005, EMERG INFECT DIS, V11, P702, DOI 10.3201/eid1105.050211; Vongkhamsao V., 2006, IMPORTANCE ROLE VALU	51	37	37	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0150666	10.1371/journal.pone.0150666	http://dx.doi.org/10.1371/journal.pone.0150666			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008628	Green Published, gold, Green Submitted			2022-12-26	WOS:000372701200026
J	Gumuchian, ST; Pelaez, S; Delisle, VC; Carrier, ME; Jewett, LR; El-Baalbaki, G; Fortune, C; Hudson, M; Impens, A; Korner, A; Persmann, J; Kwakkenbos, L; Bartlett, SJ; Thombs, BD				Gumuchian, Stephanie T.; Pelaez, Sandra; Delisle, Vanessa C.; Carrier, Marie-Eve; Jewett, Lisa R.; El-Baalbaki, Ghassan; Fortune, Catherine; Hudson, Marie; Impens, Ann; Koerner, Annett; Persmann, Jennifer; Kwakkenbos, Linda; Bartlett, Susan J.; Thombs, Brett D.			Exploring Sources of Emotional Distress among People Living with Scleroderma: A Focus Group Study	PLOS ONE			English	Article							SYSTEMIC-SCLEROSIS; DEPRESSIVE SYMPTOMS; DISEASE; HEALTH; PREVALENCE; EXPERIENCE; WOMEN	Background Systemic sclerosis, or scleroderma, is a chronic and rare connective tissue disease with negative physical and psychological implications. Sources of emotional distress and the impact they have on the lives of people with scleroderma are not well understood. Objectives To gain an in-depth understanding of the emotional experiences and sources of emotional distress for women and men living with scleroderma through focus group discussions. Methods Three semi-structured focus group discussions were conducted (two in English, one in French) with a total of 22 people with scleroderma recruited through the Scleroderma Society of Ontario in Hamilton, Ontario and a scleroderma clinic in Montreal, Canada. Interviews were recorded, transcribed, and then coded for emerging themes using thematic inductive analysis. Results Core themes representing sources of emotional distress were identified, including: (a) facing a new reality; (b) the daily struggle of living with scleroderma; (c) handling work, employment and general financial burden; (d) changing family roles; (e) social interactions; and (f) navigating the health care system. Collectively, these themes refer to the stressful journey of living with scleroderma including the obstacles faced and the emotional experiences beginning prior to receiving a diagnosis and continuing throughout the participants' lives. Conclusion Scleroderma was portrayed as being an unpredictable and overwhelming disease, resulting in many individuals experiencing multiple sources of emotional distress. Interventions and supportive resources need to be developed to help individuals with scleroderma and people close to them manage and cope with the emotional aspects of the disease.	[Gumuchian, Stephanie T.; Kwakkenbos, Linda; Thombs, Brett D.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Gumuchian, Stephanie T.; Pelaez, Sandra; Delisle, Vanessa C.; Carrier, Marie-Eve; Jewett, Lisa R.; Hudson, Marie; Koerner, Annett; Kwakkenbos, Linda; Thombs, Brett D.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Pelaez, Sandra] Ctr Hosp Univ St Justine, Ctr Rech, Montreal, PQ, Canada; [Pelaez, Sandra; Delisle, Vanessa C.; Jewett, Lisa R.; Koerner, Annett; Thombs, Brett D.] McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada; [El-Baalbaki, Ghassan; Persmann, Jennifer] Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada; [Fortune, Catherine] Scleroderma Soc Ontario, Hamilton, ON, Canada; [Hudson, Marie; Bartlett, Susan J.; Thombs, Brett D.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Impens, Ann] Midwestern Univ, Inst Hlth Innovat, Downers Grove, IL 60515 USA; [Kwakkenbos, Linda] Radboud Univ Nijmegen, Inst Behav Sci, Clin Psychol, NL-6525 ED Nijmegen, Netherlands; [Bartlett, Susan J.] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Sch Nursing, Montreal, PQ, Canada	McGill University; Lady Davis Institute; McGill University; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; McGill University; University of Quebec; University of Quebec Montreal; McGill University; Midwestern University; Radboud University Nijmegen; McGill University; McGill University; McGill University; McGill University	Thombs, BD (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.; Thombs, BD (corresponding author), McGill Univ, Dept Educ & Counselling Psychol, Montreal, PQ, Canada.; Bartlett, SJ (corresponding author), McGill Univ, Ctr Hlth, Montreal, PQ, Canada.; Thombs, BD (corresponding author), McGill Univ, Dept Psychol, Montreal, PQ, Canada.; Thombs, BD (corresponding author), McGill Univ, Sch Nursing, Montreal, PQ, Canada.	susan.bartlett@mcgill.ca; brett.thombs@mcgill.ca	Kwakkenbos, Linda/GXH-2756-2022; Bartlett, Susan J./J-9864-2012; Bartlett, Susan Joan/AAD-4103-2020; impens, ann/AAN-8764-2021	Kwakkenbos, Linda/0000-0002-1573-4504; Bartlett, Susan Joan/0000-0001-9755-2490; 	Canadian Institutes of Health Research (CIHR) Emerging Team Grant for Rare Diseases [TR3-119192]; CIHR; Scleroderma Society of Ontario; Scleroderma Society of Canada; Sclerodermie Quebec; Fonds de recherche du Quebec Sante (FRQS) Master's Research Award; CIHR Doctoral Research Awards; CIHR Banting Postdoctoral Fellowship; Fonds de recherche du Quebec Sante (FRQS) Clinical Research Award; Arthritis Society	Canadian Institutes of Health Research (CIHR) Emerging Team Grant for Rare Diseases; CIHR(Canadian Institutes of Health Research (CIHR)); Scleroderma Society of Ontario; Scleroderma Society of Canada; Sclerodermie Quebec; Fonds de recherche du Quebec Sante (FRQS) Master's Research Award; CIHR Doctoral Research Awards(Canadian Institutes of Health Research (CIHR)); CIHR Banting Postdoctoral Fellowship(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec Sante (FRQS) Clinical Research Award; Arthritis Society	This study was funded by a Canadian Institutes of Health Research (CIHR) Emerging Team Grant for Rare Diseases (PI, Thombs; TR3-119192) to support the Scleroderma Patient-centered Intervention Network (SPIN). In addition to CIHR funding, SPIN has received institutional contributions from the Lady Davis Institute for Medical Research of the Jewish General Hospital, Montreal, Canada and from McGill University, Montreal, Canada. SPIN has also received support from the Scleroderma Society of Ontario, the Scleroderma Society of Canada, and Sclerodermie Quebec. Ms. Gumuchian was supported by a Fonds de recherche du Quebec Sante (FRQS) Master's Research Award. Ms. Delisle and Ms. Jewett were supported by CIHR Doctoral Research Awards. Dr. Kwakkenbos was supported by a CIHR Banting Postdoctoral Fellowship. Dr Hudson was supported by a Fonds de recherche du Quebec Sante (FRQS) Clinical Research Award. Dr. Thombs was supported by an Investigator Salary Award from the Arthritis Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin K, 2011, PSYCHOL HEALTH MED, V16, P304, DOI 10.1080/13548506.2010.540250; Barbour R., 2007, DOING FOCUS GROUPS; Barnes J, 2012, CURR OPIN RHEUMATOL, V24, P165, DOI 10.1097/BOR.0b013e32834ff2e8; Baubet Thierry, 2011, Presse Med, V40, pe111, DOI 10.1016/j.lpm.2010.09.019; Benrud-Larson LM, 2003, HEALTH PSYCHOL, V22, P130, DOI 10.1037/0278-6133.22.2.130; Bernatsky S, 2003, ARTHRIT CARE RES, V61, P400; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Chen HY, 2010, J CLIN NURS, V19, P234, DOI 10.1111/j.1365-2702.2009.02896.x; Cinar FI, 2012, RHEUMATOL INT, V32, P3573, DOI 10.1007/s00296-011-2230-2; Creswell J, 2012, QUALITATIVE INQUIRY; Downe-Wamboldt B, 1992, Health Care Women Int, V13, P313; European Organisation for Rare Diseases, 2005, RAR DIS UND THIS PUB; Gergen K. J., 2009, RELATIONAL BEING SEL; Haukeland YB, 2015, J PEDIATR PSYCHOL; Holstein, 2011, HDB INTERVIEW RES CO, P628, DOI 10.4135/9781412973588.n36; Hoogeboom TJ, 2012, BMJ OPEN, V2, DOI [10.1136/bmjopen-2012-001161, 10.1136/bmjopen-2013-003563]; Hudson M, 2009, J RHEUMATOL, V36, P1226, DOI 10.3899/jrheum.081057; Jayasekara RS, 2012, NURS OUTLOOK, V60, P411, DOI 10.1016/j.outlook.2012.02.001; Jewett LR, 2012, RHEUMATOLOGY; Joachim G, 2003, J ADV NURS, V42, P598, DOI 10.1046/j.1365-2648.2003.02663.x; Kelly B., 2003, RES COLL CONTEXT, P49; Kidd PS, 2000, QUAL HEALTH RES, V10, P293, DOI 10.1177/104973200129118453; Kole A, 2009, VOICE 12000 PATIENTS; Kvale S., 2009, INTERVIEWS LEARNING; Kwakkenbos L, 2015, RHEUM DIS CLIN N AM, V41, P519, DOI 10.1016/j.rdc.2015.04.010; Kwakkenbos L, 2012, J PSYCHOSOM RES, V72, P199, DOI 10.1016/j.jpsychores.2011.12.005; Leeds-Hurwitz W., 2006, ENGAGING THEORIES FA, P229, DOI DOI 10.4135/9781452204420.N15; Legendre U, 2005, JOINT BONE SPINE, V72, P408, DOI 10.1016/j.jbspin.2003.11.008; Liamputtong Pranee, 2011, FOCUS GROUP METHODOL; Manno RL, 2011, J RHEUMATOL, V38, P1317, DOI 10.3899/jrheum.100956; Morgan D.L, 1996, FOCUS GROUPS QUALITA; Mozzetta A, 2008, J EUR ACAD DERMATOL, V22, P336, DOI 10.1111/j.1468-3083.2007.02426.x; Muhr T, 2013, ATLAS TI 7 MACINTOSH; Newton EG, 2012, QUAL HEALTH RES, V22, P1195, DOI 10.1177/1049732312449207; Patton M, 2015, QUALITATIVE RES EVLU; Roca RP, 1996, ARTHRITIS RHEUM, V39, P1035, DOI 10.1002/art.1780390623; Schieppati A, 2008, LANCET, V371, P2039, DOI 10.1016/S0140-6736(08)60872-7; Stamm TA, 2011, ANN RHEUM DIS, V70, P1074, DOI 10.1136/ard.2010.148767; Suarez-Almazor ME, 2007, J RHEUMATOL, V34, P1718; Thombs BD, 2012, CLIN EXP RHEUMATOL, V30, pS23; Thombs BD, 2008, ARTHRIT RHEUM-ARTHR, V59, P504, DOI 10.1002/art.23524; Thombs BD, 2010, ARTHRIT CARE RES, V62, P1181, DOI 10.1002/acr.20187; Vaismoradi M, 2013, NURS HEALTH SCI, V15, P398, DOI 10.1111/nhs.12048; van Lankveld WGJM, 2007, RHEUMATOLOGY, V46, P872, DOI 10.1093/rheumatology/kem008	44	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152419	10.1371/journal.pone.0152419	http://dx.doi.org/10.1371/journal.pone.0152419			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008209	Green Submitted, Green Published, gold			2022-12-26	WOS:000372701200119
J	Ramon, M; Miellet, S; Dzieciol, AM; Konrad, BN; Dresler, M; Caldara, R				Ramon, Meike; Miellet, Sebastien; Dzieciol, Anna M.; Konrad, Boris Nikolai; Dresler, Martin; Caldara, Roberto			Super-Memorizers Are Not Super-Recognizers	PLOS ONE			English	Article							EXPERT OBJECT RECOGNITION; MEDIAL TEMPORAL-LOBE; FACE RECOGNITION; FACIAL EXPRESSIONS; MEMORY; PROSOPAGNOSIA; HIPPOCAMPUS; INVERSION; PERCEPTION; ADULTHOOD	Humans have a natural expertise in recognizing faces. However, the nature of the interaction between this critical visual biological skill and memory is yet unclear. Here, we had the unique opportunity to test two individuals who have had exceptional success in the World Memory Championships, including several world records in face-name association memory. We designed a range of face processing tasks to determine whether superior/expert face memory skills are associated with distinctive perceptual strategies for processing faces. Superior memorizers excelled at tasks involving associative face-name learning. Nevertheless, they were as impaired as controls in tasks probing the efficiency of the face system: face inversion and the other-race effect. Super memorizers did not show increased hippocampal volumes, and exhibited optimal generic eye movement strategies when they performed complex multi-item face-name associations. Our data show that the visual computations of the face system are not malleable and are robust to acquired expertise involving extensive training of associative memory.	[Ramon, Meike; Caldara, Roberto] Univ Fribourg, Dept Psychol, Rue PA de Faucigny 2, CH-1700 Fribourg, Switzerland; [Miellet, Sebastien] Bournemouth Univ, Dept Psychol, Talbot Campus, Poole BH12 5BB, Dorset, England; [Dzieciol, Anna M.] UCL Inst Child Hlth, Cognit Neurosci & Neuropsychiat Sect, 30 Guilford St, London WC1N 1EH, England; [Konrad, Boris Nikolai; Dresler, Martin] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Kapittelweg 29, NL-6525 EN Nijmegen, Netherlands; [Dresler, Martin] Max Planck Inst Psychiat, Kraepelinstr 2-10, D-80804 Munich, Germany	University of Fribourg; Bournemouth University; University of London; University College London; Radboud University Nijmegen; Max Planck Society	Ramon, M (corresponding author), Univ Fribourg, Dept Psychol, Rue PA de Faucigny 2, CH-1700 Fribourg, Switzerland.	meike.ramon@unifr.ch	Dresler, Martin/A-9507-2014; Ramon, Meike/ABA-6335-2021; Miellet, Sebastien/AFL-6215-2022; Ramon, Meike/GWM-8082-2022; Ramon, Meike/R-5687-2017	Dresler, Martin/0000-0001-7441-3818; Ramon, Meike/0000-0001-5753-5493; Miellet, Sebastien/0000-0002-3519-033X; Ramon, Meike/0000-0001-5753-5493; Caldara, Roberto/0000-0002-8260-9949	Veni grant of the Netherlands Organisation for Scientific Research (NWO)	Veni grant of the Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by a Veni grant of the Netherlands Organisation for Scientific Research (NWO).	Al-Aidroos N, 2012, P NATL ACAD SCI USA, V109, P14675, DOI 10.1073/pnas.1202095109; [Anonymous], 1998, THE KAROLINSKA DIREC; [Anonymous], 2001, AS FAC IM DAT; Avidan G, 2011, NEUROPSYCHOLOGIA, V49, P2541, DOI 10.1016/j.neuropsychologia.2011.05.002; Bainbridge W, 2014, J VISION, P163; Bilalic M, 2007, INTELLIGENCE, V35, P457, DOI 10.1016/j.intell.2006.09.005; Blais C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003022; Bobak AK, 2017, Q J EXP PSYCHOL, V70, P201, DOI 10.1080/17470218.2016.1161059; Bobak AK, 2016, APPL COGNITIVE PSYCH, V30, P81, DOI 10.1002/acp.3170; Bobak AK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148148; Boggan AL, 2012, J EXP PSYCHOL GEN, V141, P37, DOI 10.1037/a0024236; Bonner L, 2003, PERCEPTION, V32, P1159, DOI 10.1068/p5021; Boutet I, 2006, MEM COGNITION, V34, P854, DOI 10.3758/BF03193432; Bower B, 2012, SCI NEWS, V182, P14, DOI [10.1002/scin.5591821317, DOI 10.1002/SCIN.5591821317]; BOWER GH, 1974, J EXP PSYCHOL, V103, P751, DOI 10.1037/h0037190; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bruce V, 2001, J EXP PSYCHOL-APPL, V7, P207, DOI 10.1037/1076-898X.7.3.207; Bruce V., 1994, VIS COGN, V1, P141, DOI [DOI 10.1080/13506289408402299, 10.1080/13506289408402299]; Busigny T, 2010, CORTEX, V46, P965, DOI 10.1016/j.cortex.2009.07.004; Busigny T, 2010, NEUROPSYCHOLOGIA, V48, P2051, DOI 10.1016/j.neuropsychologia.2010.03.026; Caldara R, 2006, PERCEPTION, V35, P659, DOI 10.1068/p5360; Caldara R, 2011, BEHAV RES METHODS, V43, P864, DOI 10.3758/s13428-011-0092-x; Campitelli G, 2008, LEARN INDIVID DIFFER, V18, P446, DOI 10.1016/j.lindif.2007.11.006; CAREY S, 1992, PHILOS T ROY SOC B, V335, P95, DOI 10.1098/rstb.1992.0012; Charness N, 2001, MEM COGNITION, V29, P1146, DOI 10.3758/BF03206384; CHASE WG, 1973, COGNITIVE PSYCHOL, V4, P55, DOI 10.1016/0010-0285(73)90004-2; CHASE WG, 1981, COGNITIVE SKILLS THE, P141; Chauvin A, 2005, J VISION, V5, P659, DOI 10.1167/5.9.1; Chua EF, 2007, HIPPOCAMPUS, V17, P1071, DOI 10.1002/hipo.20340; Chung M. K., 2005, PARTIAL CORRELATION; Cooper JM, 2015, CEREB CORTEX, V25, P1469, DOI 10.1093/cercor/bht332; Crawford JR, 2002, NEUROPSYCHOLOGIA, V40, P1196, DOI 10.1016/S0028-3932(01)00224-X; Davachi L, 2006, CURR OPIN NEUROBIOL, V16, P693, DOI 10.1016/j.conb.2006.10.012; de Heering A, 2010, DEVELOPMENTAL SCI, V13, P181, DOI 10.1111/j.1467-7687.2009.00876.x; de Heering A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002317; DeGutis J, 2014, BRAIN, V137, P1781, DOI 10.1093/brain/awu062; DeGutis JM, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00561; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; Dowsett AJ, 2016, Q J EXP PSYCHOL, V69, P1, DOI 10.1080/17470218.2015.1017513; Dresler M, 2013, BEHAV BRAIN SCI, V36, P616, DOI 10.1017/S0140525X13001301; Duchaine B, 2006, NEUROPSYCHOLOGIA, V44, P576, DOI 10.1016/j.neuropsychologia.2005.07.001; Duchaine B, 2007, COGN NEUROPSYCHOL, V24, P419, DOI 10.1080/02643290701380491; Eichenbaum H, 2004, NEURON, V44, P109, DOI 10.1016/j.neuron.2004.08.028; Fan JE, 2013, COGNITION, V129, P292, DOI 10.1016/j.cognition.2013.06.007; Farah MJ, 2000, COGNITIVE NEUROPSYCH, V17, P117, DOI 10.1080/026432900380526; Feingold GA, 1914, J AM INST CRIM LAW C, V5, P39, DOI 10.2307/1133283; Gauthier I, 2002, J EXP PSYCHOL HUMAN, V28, P431, DOI 10.1037//0096-1523.28.2.431; Gauthier I, 1998, VISION RES, V38, P2401, DOI 10.1016/S0042-6989(97)00442-2; Gill D, 2014, PSYCHOL SCI, V25, P1079, DOI 10.1177/0956797614522274; Gobet F, 2007, DEV PSYCHOL, V43, P159, DOI 10.1037/0012-1649.43.1.159; GORDON P, 1984, BRIT J PSYCHOL, V75, P1, DOI 10.1111/j.2044-8295.1984.tb02784.x; Graham KS, 2010, NEUROPSYCHOLOGIA, V48, P831, DOI 10.1016/j.neuropsychologia.2010.01.001; GRONINGER LD, 1995, MEMORY, V3, P147, DOI 10.1080/09658219508258963; Groninger LD, 2000, AM J PSYCHOL, V113, P199, DOI 10.2307/1423728; Groninger L, 2006, AM J PSYCHOL, V119, P175, DOI 10.2307/20445333; Jack RE, 2012, P NATL ACAD SCI USA, V109, P7241, DOI 10.1073/pnas.1200155109; Jaffe E, 2014, APS OBSERVER; Jiang F, 2011, VIS COGN, V19, P1003, DOI 10.1080/13506285.2011.604360; Kensinger EA, 2011, NEUROPSYCHOLOGIA, V49, P663, DOI 10.1016/j.neuropsychologia.2011.01.017; Konar Y, 2010, PSYCHOL SCI, V21, P38, DOI 10.1177/0956797609356508; Kuefner D, 2008, J EXP PSYCHOL HUMAN, V34, P811, DOI 10.1037/0096-1523.34.4.811; Laguesse R, 2012, J VISION, V12, DOI 10.1167/12.10.14; Lee ACH, 2005, Q J EXP PSYCHOL-B, V58, P300, DOI 10.1080/02724990444000168; Lee ACH, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00091; Leone MJ, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00047; Magnotta VA, 2002, COMPUT MED IMAG GRAP, V26, P251, DOI 10.1016/S0895-6111(02)00011-3; Maguire EA, 2003, HIPPOCAMPUS, V13, P250, DOI 10.1002/hipo.10087; Maguire EA, 2003, NAT NEUROSCI, V6, P90, DOI 10.1038/nn988; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; MALPASS RS, 1969, J PERS SOC PSYCHOL, V13, P330, DOI 10.1037/h0028434; Martin C, 2013, CURR BIOL, V23, pR731, DOI 10.1016/j.cub.2013.08.027; MCCARTY DL, 1980, J EXP PSYCHOL-HUM L, V6, P145, DOI 10.1037/0278-7393.6.2.145; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Miellet S, 2014, PERCEPTION, V43, P451, DOI 10.1068/p7682; Miellet S, 2011, PSYCHOL SCI, V22, P1518, DOI 10.1177/0956797611424290; Nyberg L, 2003, P NATL ACAD SCI USA, V100, P13728, DOI 10.1073/pnas.1735487100; Olsen RK, 2015, J NEUROSCI, V35, P5342, DOI 10.1523/JNEUROSCI.3987-14.2015; Pantelis PC, 2008, MEM COGNITION, V36, P1182, DOI 10.3758/MC.36.6.1182; PATTERSON KE, 1977, J EXP PSYCHOL-HUM L, V3, P406, DOI 10.1037/0278-7393.3.4.406; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Reingold EM, 2011, OXFORD HDB EYE MOVEM, P528, DOI DOI 10.1093/OXFORDHB/9780199539789.013.0029; RHODES G, 1989, BRIT J PSYCHOL, V80, P313, DOI 10.1111/j.2044-8295.1989.tb02323.x; Richoz AR, 2015, CORTEX, V65, P50, DOI 10.1016/j.cortex.2014.11.015; Righi G, 2004, J VISION; Rossion B, 2010, PERCEPTION, V39, P173, DOI 10.1068/p6270; Russell R, 2012, NEUROPSYCHOLOGIA, V50, P334, DOI 10.1016/j.neuropsychologia.2011.12.004; Russell R, 2009, PSYCHON B REV, V16, P252, DOI 10.3758/PBR.16.2.252; Searcy JH, 1999, MEM COGNITION, V27, P538, DOI 10.3758/BF03211547; Shakeshaft NG, 2015, P NATL ACAD SCI USA, V112, P12887, DOI 10.1073/pnas.1421881112; Sheridan H, 2014, J VISION; Sheridan H, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00941; Sugita Y, 2008, P NATL ACAD SCI USA, V105, P394, DOI 10.1073/pnas.0706079105; van Belle G, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00020; Vizioli L, 2010, P NATL ACAD SCI USA, V107, P20081, DOI 10.1073/pnas.1005751107; Vizioli L, 2010, J VISION, V10, DOI 10.1167/10.1.15; Wang JX, 2014, SCIENCE, V345, P1054, DOI 10.1126/science.1252900; Watier N, 2012, MEMORY, V20, P73, DOI 10.1080/09658211.2011.637935; Westerberg CE, 2012, HUM BRAIN MAPP, V33, P1717, DOI 10.1002/hbm.21316; White D, 2014, PSYCHON B REV, V21, P100, DOI 10.3758/s13423-013-0475-3; WILDING J, 1994, BRIT J PSYCHOL, V85, P231, DOI 10.1111/j.2044-8295.1994.tb02520.x; WILDING J, 1994, BRIT J PSYCHOL, V85, P501, DOI 10.1111/j.2044-8295.1994.tb02537.x; Wilding J. M., 1997, SUPERIOR MEMORY; Wilding JM, 2006, CAMBRIDGE HANDBOOK OF EXPERTISE AND EXPERT PERFORMANCE, P539; Williams CC, 2007, MEM COGNITION, V35, P1977, DOI 10.3758/BF03192930; Wilmer JB, 2010, P NATL ACAD SCI USA, V107, P5238, DOI 10.1073/pnas.0913053107; Worthen JB, 2011, ESSAYS COGN PSYCHOL, P1; YESAVAGE JA, 1984, EXP AGING RES, V10, P55, DOI 10.1080/03610738408258543; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; Zatorre RJ, 2012, NAT NEUROSCI, V15, P528, DOI 10.1038/nn.3045; Zeineh MM, 2003, SCIENCE, V299, P577, DOI 10.1126/science.1077775; Zhu Q, 2010, CURR BIOL, V20, P137, DOI 10.1016/j.cub.2009.11.067	111	17	17	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0150972	10.1371/journal.pone.0150972	http://dx.doi.org/10.1371/journal.pone.0150972			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3QJ	27008627	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000372701200038
J	Shin, KJ; Nakakido, R; Horie, S; Managi, S				Shin, Kong Joo; Nakakido, Ryo; Horie, Shinya; Managi, Shunsuke			The Effects of Community Attachment and Information Seeking on Displaced Disaster Victims' Decision Making	PLOS ONE			English	Article							SYSTEMIC MODEL; MASS SOCIETY; PLACE; TIES	This paper uses original survey data of the Great East Japan earthquake disaster victims to examine their decision to apply for the temporary housing as well as the timing of application. We assess the effects of victims' attachment to their locality as well as variation in victims' information seeking behavior. We additionally consider various factors such as income, age, employment and family structure that are generally considered to affect the decision to choose temporary housing as victims' solution for their displacement. Empirical results indicate that, ceteris paribus, as the degree of attachment increases, victims are more likely to apply for the temporary housing but attachment does not affect the timing of application. On the other hand, the victims who actively seek information and are able to collect higher quality information are less likely to apply for the temporary housing and if they do apply then they apply relatively later.	[Shin, Kong Joo; Managi, Shunsuke] Kyushu Univ, Dept Urban & Environm Engn, Sch Engn, Fukuoka 812, Japan; [Nakakido, Ryo] Tohoku Univ, Grad Sch Environm Studies, Sendai, Miyagi 980, Japan; [Horie, Shinya] Kobe Univ, Dept Econ, Kobe, Hyogo 657, Japan	Kyushu University; Tohoku University; Kobe University	Shin, KJ (corresponding author), Kyushu Univ, Dept Urban & Environm Engn, Sch Engn, Fukuoka 812, Japan.	kjshin@doc.kyushu-u.ac.jp	Managi, Shunsuke/G-1740-2013	Managi, Shunsuke/0000-0001-7883-1427	Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT) [26000001]; Ministry of Environment [S14]	Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Environment(Ministry of Environment (ME), Republic of Korea)	This research is supported by the Ministry of Education, Culture, Sports, Science and Technology in Japan (MEXT) under a Specially Promoted Research grant (grant number 26000001, http://www.jsps.go.jp/english/e-grants/) and Ministry of Environment under S14.	Aldrich DP, 2014, AM BEHAV SCI; Aldrich DP, 2012, BUILDING RESILIENCE, DOI 10.7208/chicago/9780226012896.001.0001; Aldrich DP, 2015, ITS WHO YOU KNOW FAC; Beggs JJ, 1996, RURAL SOCIOL, V61, P407, DOI 10.1111/j.1549-0831.1996.tb00626.x; Botterell A, 1996, EMERGENCY INFORM INF; Boyle MP, 2004, JOURNALISM MASS COMM, V81, P155, DOI 10.1177/107769900408100111; Brehm JM, 2006, AM BEHAV SCI, V50, P142, DOI 10.1177/0002764206290630; Cheng AS, 2003, SOC NATUR RESOUR, V16, P87, DOI 10.1080/08941920309199; GOUDY WJ, 1990, RURAL SOCIOL, V55, P178, DOI 10.1111/j.1549-0831.1990.tb00679.x; Gruntfest E., 1998, INT J MASS EMERGENCI, V16, P55; Hagar C, 2009, TECHNOLOGY INFORM SO; Hidalgo MC, 2001, J ENVIRON PSYCHOL, V21, P273, DOI 10.1006/jevp.2001.0221; Hirayama Y, 2000, HOUSING STUD, V15, P111, DOI 10.1080/02673030082504; Horie S, 2014, WHY DO PEOPLE STAY L; Hummon D. M., 1992, PLACE ATTACHMENT, P253; Johnson C, 2007, DISASTERS, V31, P435, DOI 10.1111/j.1467-7717.2007.01018.x; Kariya N, 2003, J I SOCIAL SAFETY SC, P309; KASARDA JD, 1974, AM SOCIOL REV, V39, P328, DOI 10.2307/2094293; Kimura R, 2004, J SOCIAL SAFETY SCI, V6, P241; Kitayama SE, 1994, EMOTION CULTURE EMPI; Kruger L. E., 1996, UNDERSTANDING PLACE; Low Setha M., 1992, PLACE ATTACHMENT, P165; Mesch GS, 1998, ENVIRON BEHAV, V30, P504, DOI 10.1177/001391659803000405; Omizu T, 2013, CORROBORATIVE EVIDEN; Quarantelli E. L., 1997, DISASTER PREV MANAG, V6, P94, DOI [10.1108/09653569710164053, DOI 10.1108/09653569710164053]; Revival Investigation Committee JAfaIS, 2011, INT VIS TEMP HOUS IW; SAMPSON RJ, 1988, AM SOCIOL REV, V53, P766, DOI 10.2307/2095822; Schneider R., 2002, DISASTER PREV MANAG, V11, P141, DOI DOI 10.1108/09653560210426821; Shklovski I, 2008, P 2008 ACM C COMP SU, P127; SHUMAKER S. A., 1983, ENV PSYCHOL DIRECTIO, V2, P19; Tatsuki S, 2002, P 2 WORKSH COMP STUD, P23; WILLIAMS DR, 1992, LEISURE SCI, V14, P29, DOI 10.1080/01490409209513155; Woldoff RA, 2002, SOC FORCES, V81, P87, DOI 10.1353/sof.2002.0065	33	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151928	10.1371/journal.pone.0151928	http://dx.doi.org/10.1371/journal.pone.0151928			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3QJ	27007117	gold, Green Published, Green Submitted			2022-12-26	WOS:000372701200075
J	Aia, P; Kal, M; Lavu, E; John, LN; Johnson, K; Coulter, C; Ershova, J; Tosas, O; Zignol, M; Ahmadova, S; Islam, T				Aia, Paul; Kal, Margaret; Lavu, Evelyn; John, Lucy N.; Johnson, Karen; Coulter, Chris; Ershova, Julia; Tosas, Olga; Zignol, Matteo; Ahmadova, Shalala; Islam, Tauhid			The Burden of Drug-Resistant Tuberculosis in Papua New Guinea: Results of a Large Population-Based Survey	PLOS ONE			English	Article							WESTERN PROVINCE	Background Reliable estimates of the burden of multidrug-resistant tuberculosis (MDR-TB) are crucial for effective control and prevention of tuberculosis (TB). Papua New Guinea (PNG) is a high TB burden country with limited information on the magnitude of the MDR-TB problem. Methods A cross-sectional study was conducted in four PNG provinces: Madang, Morobe, National Capital District and Western Province. Patient sputum samples were tested for rifampicin resistance by the Xpert MTB/RIF assay and those showing the presence of resistance underwent phenotypic susceptibility testing to first-and second-line anti-TB drugs including streptomycin, isoniazid, rifampicin, ethambutol, pyrazinamide, ofloxacin, amikacin, kanamycin and capreomycin. Results Among 1,182 TB patients enrolled in the study, MDR-TB was detected in 20 new (2.7%; 95% confidence intervals [CI] 1.1-4.3%) and 24 previously treated (19.1%; 95% CI: 8.5-29.8%) TB cases. No case of extensively drug-resistant TB (XDR-TB) was detected. Thirty percent (6/20) of new and 33.3%(8/24) of previously treated cases with MDR-TB were detected in a single cluster in Western Province. Conclusion In PNG the proportion of MDR-TB in new cases is slightly lower than the regional average of 4.4% (95% CI: 2.6-6.3%). A large proportion of MDR-TB cases were identified from a single hospital in Western Province, suggesting that the prevalence of MDR-TB across the country is heterogeneous. Future surveys should further explore this finding. The survey also helped strengthening the use of smear microscopy and Xpert MTB/RIF testing as diagnostic tools for TB in the country.	[Aia, Paul; Kal, Margaret; Lavu, Evelyn; John, Lucy N.] Natl Dept Hlth, Port Moresby, Papua N Guinea; [Johnson, Karen] Hlth & HIV Implementat Serv Provider, Abt JTA, Port Moresby, Papua N Guinea; [Coulter, Chris] Pathol Queensland, Queensland Mycobacterium Reference Lab, Herston, Qld, Australia; [Ershova, Julia] Ctr Dis Control & Prevent CDC, Atlanta, GA USA; [Tosas, Olga] Guys & St Thomas NHS Fdn Trust, London, England; [Zignol, Matteo] WHO, Global TB Programme, CH-1211 Geneva, Switzerland; [Ahmadova, Shalala] WHO, Western Pacific Reg Off, Stop TB & Leprosy Eliminat, Manila, Philippines; [Islam, Tauhid] WHO, Port Moresby, Papua N Guinea	Centers for Disease Control & Prevention - USA; Guy's & St Thomas' NHS Foundation Trust; World Health Organization; WHO Western Pacific Regional Office; World Health Organization; World Health Organization	Islam, T (corresponding author), WHO, Port Moresby, Papua N Guinea.	islamt@wpro.who.int			Australian Government's aid program through the Australian High Commission PNG; Global Fund to Fight AIDS, Tuberculosis and Malaria	Australian Government's aid program through the Australian High Commission PNG(Australian Government); Global Fund to Fight AIDS, Tuberculosis and Malaria	The study was made possible with funding from the Australian Government's aid program through the Australian High Commission PNG and supported by the Global Fund to Fight AIDS, Tuberculosis and Malaria, technical assistance of WHO's Global TB Programme.	[Anonymous], 2014, ANN REP 2013 GOV PAP; Ballif M, INSIGHT GENETI UNPUB; Cross GB, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-93; Department of Health Government of Papua New Guinea, 2011, PNG NATL TUBERCULOSI; Falzon D, 2011, EUR RESPIR J, V38, P516, DOI 10.1183/09031936.00073611; Gilpin CM, 2008, MED J AUSTRALIA, V188, P148, DOI 10.5694/j.1326-5377.2008.tb01557.x; Islam T, 2014, W PAC SURVEILL RESPO, P5; Ley SD, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0307-2; Simpson G, 2011, INT J TUBERC LUNG D, V15, P551, DOI 10.5588/ijtld.10.0347; WHO, 2015, 132015 WHOHTMTB; World Health Organization, 2015, WHOHTMTB201522; World Health Organization, 2011, WHOHTMTB20113; World Health Organization (WHO), 2009, WHOHTMTB2009420	13	34	36	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0149806	10.1371/journal.pone.0149806	http://dx.doi.org/10.1371/journal.pone.0149806			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003160	gold, Green Submitted, Green Published			2022-12-26	WOS:000372697400011
J	Harel, A; Ceccarelli, A; Farrell, C; Fabian, M; Howard, J; Riley, C; Miller, A; Lublin, F; Inglese, M				Harel, Asaff; Ceccarelli, Antonia; Farrell, Colleen; Fabian, Michelle; Howard, Jonathan; Riley, Claire; Miller, Aaron; Lublin, Fred; Inglese, Matilde			Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; COGNITIVE IMPAIRMENT; INTRACORTICAL LESIONS; DIAGNOSTIC-CRITERIA; GUIDELINES; 3T	Previous studies comparing phase sensitive inversion recovery (PSIR) to double inversion recovery (DIR) have demonstrated that use of PSIR improves cross-sectional in vivo detection of cortical lesions (CL) in multiple sclerosis. We studied the utility of PSIR in detection/characterization of accrual of CL over time in a 1-year longitudinal study in primary progressive multiple sclerosis (PPMS) compared to DIR. PSIR and DIR images were acquired with 3T magnetic resonance imaging (MRI) in 25 patients with PPMS and 19 healthy controls at baseline, and after 1 year in 20 patients with PPMS. CL were classified as intracortical, leucocortical or juxtacortical. Lesion counts and volumes were calculated for both time points from both sequences and compared. Correlations with measures of physical and cognitive disability were determined as well as new CL counts and volumes. Compared to DIR, PSIR led to detection of a higher number of CL involving a larger proportion of patients with PPMS both cross-sectionally (p = 0.006, 88%) and longitudinally (p = 0.007, 95%), and led to the reclassification of a third of CL seen on DIR at each time point. Interestingly, PSIR was more sensitive to new CL accumulation over time compared to DIR. PSIR is a promising technique to monitor cortical damage and disease progression in patients with PPMS over a short-term follow-up.	[Harel, Asaff; Ceccarelli, Antonia; Farrell, Colleen; Fabian, Michelle; Miller, Aaron; Lublin, Fred; Inglese, Matilde] Mt Sinai Hosp, Dept Neurol, New York, NY 10029 USA; [Inglese, Matilde] Mt Sinai Hosp, Dept Radiol, New York, NY 10029 USA; [Inglese, Matilde] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Farrell, Colleen; Fabian, Michelle; Miller, Aaron; Lublin, Fred; Inglese, Matilde] Icahn Sch Med Mt Sinai, Corinne Goldsmith Dickinson Ctr MS, New York, NY 10029 USA; [Howard, Jonathan] NYU, Dept Neurol, Langone Med Ctr, New York, NY 10016 USA; [Riley, Claire] Columbia Univ, Dept Neurol, Neurol Inst New York, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; New York University; NYU Langone Medical Center; Columbia University	Inglese, M (corresponding author), Mt Sinai Hosp, Dept Neurol, New York, NY 10029 USA.; Inglese, M (corresponding author), Mt Sinai Hosp, Dept Radiol, New York, NY 10029 USA.; Inglese, M (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA.; Inglese, M (corresponding author), Icahn Sch Med Mt Sinai, Corinne Goldsmith Dickinson Ctr MS, New York, NY 10029 USA.	matilde.inglese@mssm.edu	Lublin, Fred/L-8405-2017; ceccarelli, antonia/N-9563-2019; Inglese, Matilde/AAH-3189-2020	ceccarelli, antonia/0000-0002-1628-5667; Inglese, Matilde/0000-0002-9610-0297; Howard, Jonathan/0000-0003-2658-3219	Novartis Pharmaceuticals Corporation [CFTY20DUSNC15T]; National MS Society NMSS [RG 5120A3/1]; Noto Foundation	Novartis Pharmaceuticals Corporation(Novartis); National MS Society NMSS(National Multiple Sclerosis Society); Noto Foundation	Funding was provided by Novartis Pharmaceuticals Corporation CFTY20DUSNC15T to MI; National MS Society NMSS RG 5120A3/1 to MI; and Noto Foundation to MI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedict RHB, 2006, J INT NEUROPSYCH SOC, V12, P549, DOI 10.1017/S1355617706060723; Calabrese M, 2010, NEUROLOGY, V75, P1234, DOI 10.1212/WNL.0b013e3181f5d4da; Calabrese M, 2009, NEUROLOGY, V72, P1330, DOI 10.1212/WNL.0b013e3181a0fee5; Calabrese M, 2007, ARCH NEUROL-CHICAGO, V64, P1416, DOI 10.1001/archneur.64.10.1416; Calabrese M, 2009, ARCH NEUROL-CHICAGO, V66, P1144, DOI 10.1001/archneurol.2009.174; Ceccarelli A, 2012, CURR OPIN NEUROL, V25, P402, DOI 10.1097/WCO.0b013e328354f63f; Etemadifar M, 2011, EUR J RADIOL, V80, pE104, DOI 10.1016/j.ejrad.2010.05.018; Geurts JJG, 2011, NEUROLOGY, V76, P418, DOI 10.1212/WNL.0b013e31820a0cc4; Geurts JJG, 2005, AM J NEURORADIOL, V26, P572; Geurts JJG, 2005, RADIOLOGY, V236, P254, DOI 10.1148/radiol.2361040450; Ghassemi R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085741; Inglese M, 2010, BRAIN, V133, P847, DOI 10.1093/brain/awp334; Kidd D, 1999, BRAIN, V122, P17, DOI 10.1093/brain/122.1.17; Kuchling J, 2014, MULT SCLER J, V20, P1866, DOI 10.1177/1352458514531084; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; MILLER DH, 1991, J NEUROL NEUROSUR PS, V54, P683, DOI 10.1136/jnnp.54.8.683; Nelson F, 2007, AM J NEURORADIOL, V28, P1645, DOI 10.3174/ajnr.A0645; Nelson F, 2011, MULT SCLER J, V17, P1122, DOI 10.1177/1352458511405561; Papadopoulou A, 2013, MULT SCLER J, V19, P1290, DOI 10.1177/1352458513475490; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Rinaldi F, 2010, NEUROL SCI, V31, P235, DOI 10.1007/s10072-010-0368-4; Rocca MA, 2012, J NEUROL, V259, P611, DOI 10.1007/s00415-011-6195-6; Roosendaal SD, 2009, MULT SCLER, V15, P708, DOI 10.1177/1352458509102907; Ruggieri S, 2015, JAMA NEUROL, V72, P1466, DOI 10.1001/jamaneurol.2015.1897; Seewann A, 2011, MULT SCLER J, V17, P1202, DOI 10.1177/1352458511406575; Sethi V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078879; Sethi V, 2012, J NEUROL NEUROSUR PS, V83, P877, DOI 10.1136/jnnp-2012-303023; Stevenson VL, 2000, J NEUROL NEUROSUR PS, V68, P713, DOI 10.1136/jnnp.68.6.713; Wattjes MP, 2007, AM J NEURORADIOL, V28, P54	30	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152180	10.1371/journal.pone.0152180	http://dx.doi.org/10.1371/journal.pone.0152180			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002529	gold, Green Submitted, Green Published			2022-12-26	WOS:000372697400090
J	Preusse, M; Theis, FJ; Mueller, NS				Preusse, Martin; Theis, Fabian J.; Mueller, Nikola S.			miTALOS v2: Analyzing Tissue Specific microRNA Function	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; TRANSCRIPTOME-WIDE IDENTIFICATION; RNA-BINDING PROTEIN; HEPATOCELLULAR-CARCINOMA; TARGET; EXPRESSION; LIVER; GENE; PROLIFERATION; PROGRESSION	MicroRNAs are involved in almost all biological processes and have emerged as regulators of signaling pathways. We show that miRNA target genes and pathway genes are not uniformly expressed across human tissues. To capture tissue specific effects, we developed a novel methodology for tissue specific pathway analysis of miRNAs. We incorporated the most recent and highest quality miRNA targeting data (TargetScan and StarBase), RNA-seq based gene expression data (EBI Expression Atlas) and multiple new pathway data sources to increase the biological relevance of the predicted miRNA-pathway associations. We identified new potential roles of miR-199a-3p, miR-199b-3p and the miR-200 family in hepatocellular carcinoma, involving the regulation of metastasis through MAPK and Wnt signaling. Also, an association of miR-571 and Notch signaling in liver fibrosis was proposed. To facilitate data update and future extensions of our tool, we developed a flexible database backend using the graph database neo4j. The new backend as well as the novel methodology were included in the updated miTALOS v2, a tool that provides insights into tissue specific miRNA regulation of biological pathways. miTALOS v2 is available at http://mips.helmholtz-muenchen.de/mitalos.	[Preusse, Martin; Theis, Fabian J.; Mueller, Nikola S.] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Computat Biol, Neuherberg, Germany; [Preusse, Martin] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Diabet & Regenerat Res, Neuherberg, Germany; [Theis, Fabian J.] Tech Univ Munich, Inst Math Sci, D-80290 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Mueller, NS (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Computat Biol, Neuherberg, Germany.	nikola.mueller@helmholtz-muenchen.de	Theis, Fabian J/ABD-5212-2021; Mueller, Nikola/I-6366-2013; Preusse, Martin/B-3716-2013	Theis, Fabian J/0000-0002-2419-1943; Mueller, Nikola/0000-0001-8659-4548; Preusse, Martin/0000-0003-4789-0592	Deutsche Forschungsgemeinschaft [InKoMBio: FKZ TH 900/3-2, PsyCourse: FI 981/9-1]; ERC	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission)	This work was supported by Deutsche Forschungsgemeinschaft (InKoMBio: FKZ TH 900/3-2) to MP, an ERC starting grant award (LatentCauses) to FJT and Deutsche Forschungsgemeinschaft (PsyCourse: FI 981/9-1) to NSM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Bonet F, 2015, DEV DYNAM, V244, P1259, DOI 10.1002/dvdy.24309; Callegari E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073964; Chen HC, 2012, LAB INVEST, V92, P676, DOI 10.1038/labinvest.2011.201; Chen R, 2008, ONCOGENE, V27, P4712, DOI 10.1038/onc.2008.112; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cho S, 2013, NUCLEIC ACIDS RES, V41, pD252, DOI 10.1093/nar/gks1168; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Cui QH, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100089; de Brevern AG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/904541; Duan ZF, 2011, MOL CANCER THER, V10, P1337, DOI 10.1158/1535-7163.MCT-11-0096; Fan X, 2015, BRIEF BIOINFORM, V16, P780, DOI 10.1093/bib/bbu044; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hou J, 2011, CANCER CELL, V19, P232, DOI 10.1016/j.ccr.2011.01.001; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Humphries B, 2015, ONCOTARGET, V6, P6472, DOI 10.18632/oncotarget.3052; Huynh H, 2003, BMC GASTROENTEROL, V3, DOI 10.1186/1471-230X-3-19; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jiang YG, 2007, INT J UROL, V14, P1034, DOI 10.1111/j.1442-2042.2007.01866.x; Jouili S, 2013, 2013 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM), P708, DOI 10.1109/SocialCom.2013.106; Jungkamp AC, 2011, MOL CELL, V44, P828, DOI 10.1016/j.molcel.2011.11.009; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Li JY, 2013, INT CONF MEAS, P1, DOI 10.1109/ICMTMA.2013.11; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Morell CM, 2014, J HEPATOL, V60, P885, DOI 10.1016/j.jhep.2013.11.028; Murakami Y, 2006, ONCOGENE, V25, P2537, DOI 10.1038/sj.onc.1209283; Noetel A, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00049; Petryszak R, 2014, NUCLEIC ACIDS RES, V42, pD926, DOI 10.1093/nar/gkt1270; Rinck A, 2013, RNA BIOL, V10, P1125, DOI 10.4161/rna.24955; Roderburg C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032999; Schmidt CM, 1997, BIOCHEM BIOPH RES CO, V236, P54, DOI 10.1006/bbrc.1997.6840; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Song JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110074; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sweetwyne MT, 2014, KIDNEY INT SUPPL, V4, P91, DOI 10.1038/kisup.2014.17; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Vicknair C., 2010, P 48 ANN SE REG C AP, P1, DOI 10.1145/1900008.1900067; Vidigal JA, 2015, TRENDS CELL BIOL, V25, P137, DOI 10.1016/j.tcb.2014.11.004; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Wu C, 2014, NUCLEIC ACIDS RES, V42, pW107, DOI 10.1093/nar/gku409; Wu ZQ, 2012, P NATL ACAD SCI USA, V109, P16654, DOI 10.1073/pnas.1205822109; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yang J, 2014, FEBS LETT, V588, P3218, DOI 10.1016/j.febslet.2014.07.003; Yuan Y, 2015, P NATL ACAD SCI USA, V112, P3158, DOI 10.1073/pnas.1413896112	55	47	47	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151771	10.1371/journal.pone.0151771	http://dx.doi.org/10.1371/journal.pone.0151771			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998997	Green Published, Green Submitted, gold			2022-12-26	WOS:000372694700063
J	Wakisaka, M; Nagao, T; Yoshinari, M				Wakisaka, Masanori; Nagao, Tetsuhiko; Yoshinari, Mototaka			Sodium Glucose Cotransporter 2 (SGLT2) Plays as a Physiological Glucose Sensor and Regulates Cellular Contractility in Rat Mesangial Cells	PLOS ONE			English	Article							ANGIOTENSIN-II; INTESTINAL NA+/GLUCOSE; ALTERED CONTRACTILITY; TRANSPORT; MECHANISM; EXCHANGE; PROTEIN; PREVENTION; COLLAGEN; CALCIUM	Purpose Mesangial cells play an important role in regulating glomerular filtration by altering their cellular tone. We report the presence of a sodium glucose cotransporter (SGLT) in rat mesangial cells. This study in rat mesangial cells aimed to evaluate the expression and role of SGLT2. Methods The SGLT2 expression in rat mesangial cells was assessed by Western blotting and reverse transcription-polymerase chain reaction (RT-PCR). Changes in the mesangial cell surface area at different glucose concentrations and the effects of extracellular Na+ and Ca2+ and of SGLT and Na+/Ca2+ exchanger (NCX) inhibitors on cellular size were determined. The cellular sizes and the contractile response were examined during a 6-day incubation with high glucose with or without phlorizin, an SGLT inhibitor. Results Western blotting revealed an SGLT2 band, and RT-PCR analysis of SGLT2 revealed the predicted 422-bp band in both rat mesangial and renal proximal tubular epithelial cells. The cell surface area changed according to the extracellular glucose concentration. The glucose-induced contraction was abolished by the absence of either extracellular Na+ or Ca2+ and by SGLT and NCX inhibitors. Under the high glucose condition, the cell size decreased for 2 days and increased afterwards; these cells did not contract in response to angiotensin II, and the SGLT inhibitor restored the abolished contraction. Conclusions These data suggest that SGLT2 is expressed in rat mesangial cells, acts as a normal physiological glucose sensor and regulates cellular contractility in rat mesangial cells.	[Wakisaka, Masanori] Wakisaka Naika Clin Internal Med, Fukuoka, Japan; [Nagao, Tetsuhiko] Midori No Clin, Fukuoka, Japan; [Yoshinari, Mototaka] Yoshinari Int Med Clin, Fukuoka, Japan		Wakisaka, M (corresponding author), Wakisaka Naika Clin Internal Med, Fukuoka, Japan.	wakisakanaika@nag.bbiq.jp		Nagao, Tetsuhiko/0000-0001-7241-418X; Wakisaka, Masanori/0000-0002-1373-4287				ANDERSON WP, 1990, KIDNEY INT, V38, pS109; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Bankir L, 2015, AM J PHYSIOL-RENAL, V309, pF2, DOI 10.1152/ajprenal.00614.2014; BARNETT R, 1986, CIRC RES, V59, P529, DOI 10.1161/01.RES.59.5.529; BERS DM, 1988, J MOL CELL CARDIOL, V20, P405, DOI 10.1016/S0022-2828(88)80132-9; DeFronzo RA, 2012, DIABETES OBES METAB, V14, P5, DOI 10.1111/j.1463-1326.2011.01511.x; Derylo B, 1998, DIABETOLOGIA, V41, P507, DOI 10.1007/s001250050939; Donnelly SM, 1996, BIOCHEM CELL BIOL, V74, P355, DOI 10.1139/o96-038; Dunlop ME, 2000, KIDNEY INT, V57, P464, DOI 10.1046/j.1523-1755.2000.t01-1-00866.x; GARCIAESCRIBANO C, 1993, KIDNEY INT, V43, P324, DOI 10.1038/ki.1993.50; Gaughan JP, 1999, AM J PHYSIOL, V277, pH14; Gembardt F, 2014, AM J PHYSIOL-RENAL, V307, pF317, DOI 10.1152/ajprenal.00145.2014; Gnudi L., 2015, NEPHROL DIAL TRANSPL; Gnudi L, 2007, J AM SOC NEPHROL, V18, P2226, DOI 10.1681/ASN.2006121362; Hammes HP, 2005, HORM METAB RES, V37, pS39, DOI 10.1055/s-2005-861361; HEDIGER MA, 1989, P NATL ACAD SCI USA, V86, P5748, DOI 10.1073/pnas.86.15.5748; Hummel CS, 2011, AM J PHYSIOL-CELL PH, V300, pC14, DOI 10.1152/ajpcell.00388.2010; HURST RD, 1995, DIABETES, V44, P759, DOI 10.2337/diabetes.44.7.759; ICHIKAWA I, 1982, KIDNEY INT, pS109; Inoki K, 1999, KIDNEY INT, V55, P1704, DOI 10.1046/j.1523-1755.1999.00438.x; JOHANSSON B, 1987, J CARDIOVASC PHARM, V10, pS75, DOI 10.1097/00005344-198710001-00015; KADOR PF, 1988, ARCH OPHTHALMOL-CHIC, V106, P1099, DOI 10.1001/archopht.1988.01060140255036; Kamouchi M, 2011, CELL MOL NEUROBIOL, V31, P175, DOI 10.1007/s10571-010-9605-x; KANAI Y, 1994, J CLIN INVEST, V93, P397, DOI 10.1172/JCI116972; KANAMORI A, 1994, LIFE SCI, V55, pPL365, DOI 10.1016/0024-3205(94)00762-4; KLIP A, 1987, FEBS LETT, V224, P224, DOI 10.1016/0014-5793(87)80452-0; Lonigro AJ, 1996, DIABETES, V45, pS38, DOI 10.2337/diab.45.1.S38; Mackenzie B, 1996, J BIOL CHEM, V271, P32678, DOI 10.1074/jbc.271.51.32678; Mashburn NA, 1999, AM J PHYSIOL-RENAL, V276, pF574, DOI 10.1152/ajprenal.1999.276.4.F574; MELZER W, 1995, BBA-REV BIOMEMBRANES, V1241, P59, DOI 10.1016/0304-4157(94)00014-5; Osei SY, 1999, HYPERTENSION, V33, P559, DOI 10.1161/01.HYP.33.1.559; Ouardani M, 1997, EUR J CELL BIOL, V73, P232; RABITO CA, 1980, J MEMBRANE BIOL, V54, P31, DOI 10.1007/BF01875374; Rhoads DB, 1998, J BIOL CHEM, V273, P9510, DOI 10.1074/jbc.273.16.9510; SIMONSON MS, 1990, J CLIN INVEST, V85, P790, DOI 10.1172/JCI114505; Terami N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100777; Touyz RM, 1996, HYPERTENSION, V27, P1097, DOI 10.1161/01.HYP.27.5.1097; Trachtman H, 1997, J AM SOC NEPHROL, V8, P1276; TURNER RJ, 1982, AM J PHYSIOL, V242, pF406, DOI 10.1152/ajprenal.1982.242.4.F406; Ueta M, 2004, KIDNEY INT, V65, P961, DOI 10.1111/j.1523-1755.2004.00474.x; Unlap MT, 2000, AM J PHYSIOL-RENAL, V279, pF177, DOI 10.1152/ajprenal.2000.279.1.F177; Wakisaka M, 1997, BBA-MOL BASIS DIS, V1362, P87, DOI 10.1016/S0925-4439(97)00071-9; Wakisaka M, 2001, CIRC RES, V88, P1183, DOI 10.1161/hh1101.091265; WAKISAKA M, 1995, DIABETOLOGIA, V38, P291; WAKISAKA M, 1994, DIABETES, V43, P95, DOI 10.2337/diabetes.43.1.95; Wakisaka M, 1999, BIOCHIM BIOPHYS ACTA, P1453; Wright EM, 2001, AM J PHYSIOL-RENAL, V280, pF10, DOI 10.1152/ajprenal.2001.280.1.F10; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; YOU GF, 1995, J BIOL CHEM, V270, P29365, DOI 10.1074/jbc.270.49.29365	49	21	21	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151585	10.1371/journal.pone.0151585	http://dx.doi.org/10.1371/journal.pone.0151585			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999015	Green Published, gold, Green Submitted			2022-12-26	WOS:000372694700048
J	Wei, CQ; Ni, WT; Cai, XJ; Zhao, J; Cui, JC				Wei, Chuanqi; Ni, Wentao; Cai, Xuejiu; Zhao, Jin; Cui, Junchang			Evaluation of Trimethoprim/Sulfamethoxazole (SXT), Minocycline, Tigecycline, Moxifloxacin, and Ceftazidime Alone and in Combinations for SXT-Susceptible and SXT-Resistant Stenotrophomonas maltophilia by In Vitro Time-Kill Experiments	PLOS ONE			English	Article							TRIMETHOPRIM-SULFAMETHOXAZOLE; ANTIBIOTIC COMBINATIONS; PHARMACOKINETICS; PHARMACODYNAMICS; GLYCYLCYCLINE; MONOTHERAPY	Background The optimal therapy for infections caused by Stenotrophomonas maltophilia (S. maltophilia) has not yet been established. The objective of our study was to evaluate the efficacy of trimethoprim/sulfamethoxazole (SXT), minocycline, tigecycline, moxifloxacin, levofloxacin, ticarcillin-clavulanate, polymyxin E, chloramphenicol, and ceftazidime against clinical isolated S. maltophilia strains by susceptibility testing and carried out time-kill experiments in potential antimicrobials. Methods The agar dilution method was used to test susceptibility of nine candidate antimicrobials, and time-killing experiments were carried out to evaluate the efficacy of SXT, minocycline, tigecycline, moxifloxacin, levofloxacin, and ceftazidime both alone and in combinations at clinically relevant antimicrobial concentrations. Results The susceptibility to SXT, minocycline, tigecycline, moxifloxacin, levofloxacin, ticarcillin-clavulanate, chloramphenicol, polymyxin E, and ceftazidime were 93.8%, 95.0%, 83.8%, 80.0%, 76.3%, 76.3%, 37.5%, 22.5%, and 20.0% against 80 clinical consecutively isolated strains, respectively. Minocycline and tigecycline showed consistent active against 22 SXT-resistant strains. However, resistance rates were high in the remaining antimicrobial agents against SXT-resistant strains. In time-kill experiments, there were no synergisms in most drug combinations in time-kill experiments. SXT plus moxifloxacin displayed synergism when strains with low moxifloxacin MICs. Moxifloxacin plus Minocycline and moxifloxacin plus tigecycline displayed synergism in few strains. No antagonisms were found in these combinations. Overall, compared with single drug, the drug combinations demonstrated lower bacterial concentrations. Some combinations showed bactericidal activity. Conclusions In S. maltophilia infections, susceptibility testing suggests that minocycline and SXT may be considered first-line therapeutic choices while tigecycline, moxifloxacin, levofloxacin, and ticarcillin-clavulanate may serve as second-line choices. Ceftazidime, colistin, and chloramphenicol show poor active against S. maltophilia. However, monotherapy is inadequate in infection management, especially in case of immunocompromised patients. Combination therapy, especially SXT plus moxifloxacin, may benefit than monotherapy in inhibiting or killing S. maltophilia.	[Wei, Chuanqi; Ni, Wentao; Zhao, Jin; Cui, Junchang] Chinese Peoples Liberat Army Gen Hosp, Dept Resp Dis, Beijing 100853, Peoples R China; [Cai, Xuejiu] Chinese Peoples Liberat Army, Guangzhou Army Command, Guangzhou Gen Hosp, Dept Resp Dis, Guangzhou 510010, Guangdong, Peoples R China	Chinese People's Liberation Army General Hospital	Cui, JC (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Resp Dis, Beijing 100853, Peoples R China.	guoguoyoumeng@163.com	Ni, Wentao/HDN-9973-2022	Zhao, Jin/0000-0001-6902-9408	National Natural Science Foundation of China [81371855]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81371855). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2015, M100S25 CLSI; Sanchez MB, 2015, ANTIMICROB AGENTS CH, V59, P4347, DOI 10.1128/AAC.00714-15; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Denton M, 1998, CLIN MICROBIOL REV, V11, P57, DOI 10.1128/CMR.11.1.57; Falagas ME, 2008, J ANTIMICROB CHEMOTH, V62, P889, DOI 10.1093/jac/dkn301; Giamarellos-Bourboulis EJ, 2002, ANTIMICROB AGENTS CH, V46, P3997, DOI 10.1128/AAC.46.12.3997-3999.2002; Hand E, 2016, J ANTIMICROB CHEMOTH; JUNG AC, 1994, ARCH INTERN MED, V154, P2402, DOI 10.1001/archinte.154.21.2402; LEROY A, 1984, ANTIMICROB AGENTS CH, V25, P638, DOI 10.1128/AAC.25.5.638; Levison ME, 2009, INFECT DIS CLIN N AM, V23, P791, DOI 10.1016/j.idc.2009.06.008; Looney WJ, 2009, LANCET INFECT DIS, V9, P312, DOI 10.1016/S1473-3099(09)70083-0; Meagher AK, 2005, DIAGN MICR INFEC DIS, V52, P165, DOI 10.1016/j.diagmicrobio.2005.05.006; Ni WT, 2015, INT J ANTIMICROB AG, V45, P8, DOI 10.1016/j.ijantimicag.2014.10.002; Noskin GA, 2005, CLIN INFECT DIS, V41, pS303, DOI 10.1086/431672; Pillai SK, 2005, ANTIBIOTICS LAB MED, V5, P365; POULOS CD, 1995, ANTIMICROB AGENTS CH, V39, P2220, DOI 10.1128/AAC.39.10.2220; Rodvold KA, 2001, PHARMACOTHERAPY, V21, p233S, DOI 10.1592/phco.21.16.233S.33992; Sader HS, 2014, INT J ANTIMICROB AG, V43, P328, DOI 10.1016/j.ijantimicag.2014.01.007; Sanford Jay P., SANFORD GUIDE ANTIMI, P86; Tangden T, 2014, ANTIMICROB AGENTS CH, V58, P1757, DOI 10.1128/AAC.00741-13; Wang YL, 2014, ANTIMICROB AGENTS CH, V58, P176, DOI 10.1128/AAC.01324-13; Wei CQ, 2015, INFECT DIS-NOR, V47, P846, DOI 10.3109/23744235.2015.1064542; Zelenitsky SA, 2005, DIAGN MICR INFEC DIS, V51, P39, DOI 10.1016/j.diagmicrobio.2004.09.002	23	38	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0152132	10.1371/journal.pone.0152132	http://dx.doi.org/10.1371/journal.pone.0152132			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999818	Green Published, Green Submitted, gold			2022-12-26	WOS:000372694700103
J	Jeon, HW; Park, JK; Song, KY; Sung, SW				Jeon, Hyun Woo; Park, Jae Kil; Song, Kyo Young; Sung, Sook Whan			High Intrathoracic Anastomosis with Thoracoscopy Is Safe and Feasible for Treatment of Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							MINIMALLY INVASIVE ESOPHAGECTOMY; IVOR-LEWIS ESOPHAGECTOMY; OUTCOMES; CANCER	Background Minimally invasive esophagectomy (MIE) has the potential to reduce the morbidity and mortality of esophageal cancer surgery. Esophageal squamous cell carcinoma (ESCC) has a high incidence of earlier lymphatic spread and is usually located more proximal to the incisor than esophageal adenocarcinoma; consequently, the anastomosis should be made more proximal in the thorax or in the neck. We adopted the proximal intrathoracic anastomotic technique using thoracoscopy for mid-to-lower ESCC. Methods From October 2010 to August 2014, fifty-eight consecutive patients underwent MIE for ESCC. After laparoscopic gastric tubing, thoracoscopic esophageal resection and reconstruction were performed using a 28-mm circular stapler following radical mediastinal lymph node dissection. We tried to make an anastomosis at the apex of the chest. Postoperative outcomes, including overall survival and recurrence, were assessed. Results The mean patient age was 64.3 +/- 9 years. The mean operative time was 371.8 +/- 51.6 minutes, and the duration of the thorax procedure was 254.8 +/- 38.3 minutes. The mean number of lymph nodes dissected was 31 +/- 11.7. The mean intensive care unit (ICU) stay and hospital stay were 3.5 +/- 8.2 hours and 13.6 +/- 7.4 days, respectively. The level of anastomosis was 22.3 +/- 1.8cm from the incisor. One patient died of uncontrolled sepsis due to necrosis of the gastric graft. Two patients developed small contained leakage. Nine patients exhibited distant metastasis during the follow-up period. Conclusion Thoracoscopic intrathoracic anastomosis at the proximal esophagus is feasible and safe.	[Jeon, Hyun Woo; Park, Jae Kil; Sung, Sook Whan] Catholic Univ Korea, Seoul St Marys Hosp, Dept Thorac & Cardiovasc Surg, Coll Med, Seoul, South Korea; [Song, Kyo Young] Catholic Univ Korea, Seoul St Marys Hosp, Dept Surg, Coll Med, Seoul, South Korea; [Jeon, Hyun Woo] Catholic Univ Korea, Dept Thorac & Cardiovasc Surg, Bucheon St Marys Hosp, Coll Med, Bucheon, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Sung, SW (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Thorac & Cardiovasc Surg, Coll Med, Seoul, South Korea.	swsung@catholic.ac.kr						Hsu PK, 2014, WORLD J SURG, V38, P402, DOI 10.1007/s00268-013-2265-5; Jeon H-W, 2013, HIGH THORACOSCOPIC I; Kim K, 2013, SURG LAPARO ENDO PER, V23, P303, DOI 10.1097/SLE.0b013e31828b8841; Luketich JD, 2015, ANN SURG, V261, P702, DOI 10.1097/SLA.0000000000000993; Luketich JD, 2012, ANN SURG, V256, P95, DOI 10.1097/SLA.0b013e3182590603; Luketich JD, 2003, ANN SURG, V238, P486, DOI 10.1097/01.sla.0000089858.40725.68; Maas KW, 2012, SURG ENDOSC, V26, P1795, DOI 10.1007/s00464-012-2149-z; Palazzo F, 2015, J AM COLL SURGEONS, V220, P672, DOI 10.1016/j.jamcollsurg.2014.12.023; Park SY, 2013, YONSEI MED J, V54, P381, DOI 10.3349/ymj.2013.54.2.381; Rindani R, 1999, AUST NZ J SURG, V69, P187, DOI 10.1046/j.1440-1622.1999.01520.x; Shen YX, 2012, J GASTROINTEST SURG, V16, P715, DOI 10.1007/s11605-012-1824-7; Siewert JR, 2007, SEMIN RADIAT ONCOL, V17, P38, DOI 10.1016/j.semradonc.2006.09.007; Stiles BM, 2010, ANN THORAC SURG, V90, P1805, DOI 10.1016/j.athoracsur.2010.06.085; Tapias LF, 2012, DIS ESOPHAGUS, V25, P449, DOI 10.1111/j.1442-2050.2011.01269.x; Tapias LF, 2016, ANN THORAC SURG, V101, P1097, DOI 10.1016/j.athoracsur.2015.09.062	15	7	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152151	10.1371/journal.pone.0152151	http://dx.doi.org/10.1371/journal.pone.0152151			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27011160	Green Published, Green Submitted, gold			2022-12-26	WOS:000372708000097
J	Mello, TJ; de Oliveira, AA				Mello, Thayna Jeremias; de Oliveira, Alexandre Adalardo			Making a Bad Situation Worse: An Invasive Species Altering the Balance of Interactions between Local Species	PLOS ONE			English	Article							SEEDLING ESTABLISHMENT; DRY-FOREST; FACILITATION; GERMINATION; ALLELOPATHY; COMPETITION; ECOLOGY; GROWTH; TREE	Biological invasions pose a significant threat to biodiversity, especially on oceanic islands. One of the primary explanations for the success of plant invaders is direct suppression of competitors. However, indirect interactions can also be important, although they are often overlooked in studies on biological invasion. The shrub Leucaena leucocephala is a widespread island invader with putative allelopathic effects on the germination and growth of other species. We quantified the impact of Leucaena on plant communities richness on an oceanic Brazilian island and, through nursery experiments, investigated the potential for allelopathic effects on the germination of Erythrina velutina, a native species that is often absent from stands of Leucaena. Additionally, in a manipulative field experiment, we examined the direct and indirect effects (mediated by the native species Capparis flexuosa) of the invader on the development of Erythrina. The species richness in invaded sites was lower than in uninvaded sites, and Capparis was the only native species that was frequently present in invaded sites. In the nursery experiments, we found no evidence that Leucaena affects the germination of Erythrina. In the field experiments, the odds of Erythrina germination were lower in the presence of Leucaena litter, but higher in the presence of Leucaena trees. However, the survival and growth of Erythrina were considerably inhibited by the presence of Leucaena trees. The isolated effect of native Capparis on the germination and growth of Erythrina varied from positive to neutral. However, when Capparis and Leucaena were both present, their combined negative effects on Erythrina were worse than the effect of Leucaena alone, which may be attributed to indirect effects. This study provides the first empirical evidence that the balance of the interactions between native species can shift from neutral/positive to negative in the presence of an exotic species.	[Mello, Thayna Jeremias; de Oliveira, Alexandre Adalardo] Univ Sao Paulo, Dept Ecol, Sao Paulo, SP, Brazil; [Mello, Thayna Jeremias] Inst Chico Mendes Conservacao Biodiversidade, Fernando de Noronha Marine Natl Pk, Fernando De Noronha, PE, Brazil	Universidade de Sao Paulo	de Oliveira, AA (corresponding author), Univ Sao Paulo, Dept Ecol, Sao Paulo, SP, Brazil.	adalardo@usp.br	de Oliveira, Alexandre Adalardo/G-8830-2012; Oliveira, Alexandre/ABH-1255-2020	de Oliveira, Alexandre Adalardo/0000-0001-5526-8109; Oliveira, Alexandre/0000-0001-5526-8109	Fundacao Grupo Boticario de Protecao a Natureza [0923-20112]; ICMBio [PEM-011.028]; ICMBio; Fundacao Boticario funds	Fundacao Grupo Boticario de Protecao a Natureza; ICMBio; ICMBio; Fundacao Boticario funds	The authors acknowledge the financial support provided by Fundacao Grupo Boticario de Protecao a Natureza (0923-20112) and ICMBio (PEM-011.028). ICMBio provides fellowship for TJM and Fundacao Boticario funds for field and experiments expenses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert Peter, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P52, DOI 10.1078/1433-8319-00004; Alves R. J. V., 2006, ILHAS OCEANICAS BRAS, P83; [Anonymous], 2008, ER CRIST GALL L FAB; [Anonymous], 2014, R LANG ENV STAT COMP; Atwater DZ, 2011, PLANT ECOL, V212, P1655, DOI 10.1007/s11258-011-9938-7; Batistella M, 1996, ACTA BOT BRAS, V10, P223, DOI DOI 10.1590/S0102-33061996000200003; Bolker B., 2014, BBMLE TOOLS GEN MAXI; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brooker RW, 2008, J ECOL, V96, P18, DOI 10.1111/j.1365-2745.2007.01295.x; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Callaway RM, 1997, ECOLOGY, V78, P1958, DOI 10.1890/0012-9658(1997)078[1958:CAFASA]2.0.CO;2; CHOU CH, 1986, J CHEM ECOL, V12, P1431, DOI 10.1007/BF01012362; Colon SM, 2006, BIOTROPICA, V38, P354, DOI 10.1111/j.1744-7429.2006.00159.x; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Demuner Valdir G., 2008, Boletim do Museu de Biologia Mello Leitao Nova Serie, V24, P101; Freitas AMM., 2007, FLORA FANEROGAMICA A; Grove S, 2012, PLANT ECOL, V213, P1869, DOI 10.1007/s11258-012-0079-4; Hata K, 2010, J FOREST RES-JPN, V15, P384, DOI 10.1007/s10310-010-0199-4; Hierro JL, 2003, PLANT SOIL, V256, P29, DOI 10.1023/A:1026208327014; Holmgren Milena, 1997, Ecology (Washington D C), V78, P1966, DOI 10.1890/0012-9658(1997)078[1966:TIOFAC]2.0.CO;2; Inderjit, 2003, PLANT SOIL, V256, P1, DOI 10.1023/A:1026242418333; Inderjit, 1997, BOT REV, V63, P221, DOI 10.1007/BF02857949; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; Jurado E, 1998, FOREST ECOL MANAG, V105, P151, DOI 10.1016/S0378-1127(97)00276-4; Kueffer C, 2010, PERSPECT PLANT ECOL, V12, P145, DOI 10.1016/j.ppees.2009.06.002; Lowe S, 2000, INVASIVE SPECIES SPE, P83; Machado Manoela Schiavon, 2013, Hoehnea, V40, P473; Manly B.F.J., 2006, RANDOMIZATION BOOTST, V3rd, DOI DOI 10.1201/9781315273075; McIntire EJB, 2014, NEW PHYTOL, V201, P403, DOI 10.1111/nph.12478; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Moura FDBP, 2013, J ARID ENVIRON, V90, P67, DOI 10.1016/j.jaridenv.2012.10.010; Peguero G, 2012, PLANT ECOL, V213, P1945, DOI 10.1007/s11258-011-0014-0; PRASAD MNV, 1994, J CHEM ECOL, V20, P1689, DOI 10.1007/BF02059890; Rejmanek M, 1996, ECOLOGY, V77, P1655, DOI 10.2307/2265768; Ridenour WM, 2001, OECOLOGIA, V126, P444, DOI 10.1007/s004420000533; Ridley HN., 1890, J LINNEAN SOC BOT, V27, P1, DOI DOI 10.1111/J.1095-8339.1890.TB00800.X; Rizvi SJH, 1999, CRIT REV PLANT SCI, V18, P773, DOI 10.1080/07352689991309487; Sax DF, 2008, P NATL ACAD SCI USA, V105, P11490, DOI 10.1073/pnas.0802290105; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Silva MC, 1987, ACTA BOT BRAS, V1, P257, DOI 10.1590/S0102-33061987000300024; Smith T, 1990, PROGR THEORETICAL VE, DOI [10.1007/978-94-009-1934-1, DOI 10.1007/978-94-009-1934-1]; SURESH K K, 1987, International Tree Crops Journal, V4, P109; Svenning JC, 2004, ECOLOGY, V85, P2526, DOI 10.1890/03-0396; Teixeira W, 2011, ARQUIPELAGO FERNANDO; Therneau T. M., 2015, PACKAGE SURVIVAL ANA; TILMAN D, 1987, AM NAT, V129, P769, DOI 10.1086/284672; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; White EM, 2006, DIVERS DISTRIB, V12, P443, DOI 10.1111/j.1366-9516.2006.00265.x; WOOTTON JT, 1994, ANNU REV ECOL SYST, V25, P443, DOI 10.1146/annurev.es.25.110194.002303	49	6	6	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152070	10.1371/journal.pone.0152070	http://dx.doi.org/10.1371/journal.pone.0152070			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010846	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708000082
J	Paina, C; Byrne, SL; Studer, B; Rognli, OA; Asp, T				Paina, Cristiana; Byrne, Stephen L.; Studer, Bruno; Rognli, Odd Arne; Asp, Torben			Using a Candidate Gene-Based Genetic Linkage Map to Identify QTL for Winter Survival in Perennial Ryegrass	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; FESTUCA-PRATENSIS HUDS.; LOW-TEMPERATURE TOLERANCE; LOLIUM-PERENNE; FLOWERING TIME; ARABIDOPSIS-THALIANA; VERNALIZATION RESPONSE; NUCLEOTIDE DIVERSITY; BRACHYPODIUM-DISTACHYON	Important agronomical traits in perennial ryegrass (Lolium perenne) breeding programs such as winter survival and heading date, are quantitative traits that are generally controlled by multiple loci. Individually, these loci have relatively small effects. The aim of this study was to develop a candidate gene based Illumina GoldenGate 1,536-plex assay, containing single nucleotide polymorphism markers designed from transcripts involved in response to cold acclimation, vernalization, and induction of flowering. The assay was used to genotype a mapping population that we have also phenotyped for winter survival to complement the heading date trait previously mapped in this population. A positive correlation was observed between strong vernalization requirement and winter survival, and some QTL for winter survival and heading date overlapped on the genetic map. Candidate genes were located in clusters along the genetic map, some of which co-localized with QTL for winter survival and heading date. These clusters of candidate genes may be used in candidate gene based association studies to identify alleles associated with winter survival and heading date.	[Paina, Cristiana; Byrne, Stephen L.; Asp, Torben] Aarhus Univ, Dept Mol Biol & Genet, Sci & Technol, Slagelse, Denmark; [Studer, Bruno] Swiss Fed Inst Technol, Inst Agr Sci, Zurich, Switzerland; [Rognli, Odd Arne] Norwegian Univ Life Sci, Dept Plant & Environm Sci, As, Norway	Aarhus University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Norwegian University of Life Sciences	Asp, T (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Sci & Technol, Slagelse, Denmark.	torben.asp@mbg.au.dk	Studer, Bruno/O-2237-2017; Byrne, Stephen/L-3572-2019	Byrne, Stephen/0000-0002-1179-2272; Studer, Bruno/0000-0001-8795-0719; Paina, Cristiana/0000-0001-7124-1280	Ministry of Food, Agriculture and Fisheries of Denmark [3304-FVFP-09-B-002]	Ministry of Food, Agriculture and Fisheries of Denmark	This work was supported by the Ministry of Food, Agriculture and Fisheries of Denmark, grant number 3304-FVFP-09-B-002.	Alm V, 2003, THEOR APPL GENET, V108, P25, DOI 10.1007/s00122-003-1399-5; Alm V, 2011, THEOR APPL GENET, V123, P369, DOI 10.1007/s00122-011-1590-z; Andersen JR, 2006, PLANT MOL BIOL, V60, P481, DOI 10.1007/s11103-005-4815-1; [Anonymous], 2010, R LANG ENV STAT COMP; Arends D, 2010, BIOINFORMATICS, V26, P2990, DOI 10.1093/bioinformatics/btq565; Armstead IP, 2008, NEW PHYTOL, V178, P559, DOI 10.1111/j.1469-8137.2008.02413.x; Armstead IP, 2005, NEW PHYTOL, V167, P239, DOI 10.1111/j.1469-8137.2005.01392.x; Armstead IP, 2004, THEOR APPL GENET, V108, P822, DOI 10.1007/s00122-003-1495-6; Atwell S, 2010, NATURE, V465, P627, DOI 10.1038/nature08800; Barre P, 2009, GRASS FORAGE SCI, V64, P310, DOI 10.1111/j.1365-2494.2009.00696.x; Branca A, 2011, P NATL ACAD SCI USA, V108, pE864, DOI 10.1073/pnas.1104032108; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Burritt DJ, 2012, CURRENT FRONTIERS IN CRYOPRESERVATION, P415; Byrne S, 2009, EUPHYTICA, V166, P61, DOI 10.1007/s10681-008-9831-1; Byrne SL, 2015, PLANT J, V84, P816, DOI 10.1111/tpj.13037; Chen A., 2012, INT J ANTENN PROPAG, P1, DOI DOI 10.1371/J0URNAL.PGEN.1003134; Deng WW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6882; Dhillon T, 2010, PLANT PHYSIOL, V153, P1846, DOI 10.1104/pp.110.159079; Dubcovsky J, 2006, PLANT MOL BIOL, V60, P469, DOI 10.1007/s11103-005-4814-2; Ergon A, 2006, THEOR APPL GENET, V112, P232, DOI 10.1007/s00122-005-0115-z; Farrell JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103567; Fe D, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2163-3; Fe D, 2015, CROP SCI, V55, P631, DOI 10.2135/cropsci2014.06.0441; Fiil A, 2011, PLANT SCI, V180, P228, DOI 10.1016/j.plantsci.2010.08.015; Finnegan EJ, 2005, PLANT J, V44, P420, DOI 10.1111/j.1365-313X.2005.02541.x; Francia E, 2004, THEOR APPL GENET, V108, P670, DOI 10.1007/s00122-003-1468-9; GALIBA G, 1995, THEOR APPL GENET, V90, P1174, DOI 10.1007/BF00222940; Hare PD, 1999, J EXP BOT, V50, P413, DOI 10.1093/jexbot/50.333.413; HAYES PM, 1993, GENOME, V36, P66, DOI 10.1139/g93-009; HEIDE OM, 1994, NEW PHYTOL, V128, P347, DOI 10.1111/j.1469-8137.1994.tb04019.x; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Huo NX, 2011, THEOR APPL GENET, V123, P455, DOI 10.1007/s00122-011-1598-4; Hyten DL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-38; Jensen LB, 2005, THEOR APPL GENET, V110, P527, DOI 10.1007/s00122-004-1865-8; Ken-ichi T, 2007, P 26 M EUCARPIA MED, P284; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kikuchi R, 2012, J EXP BOT, V63, P773, DOI 10.1093/jxb/err299; Kobayashi F, 2005, J EXP BOT, V56, P887, DOI 10.1093/jxb/eri081; Lacomme C, 1996, PLANT MOL BIOL, V30, P995, DOI 10.1007/BF00020810; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee EJ, 2010, PLANT CELL, V22, P3489, DOI 10.1105/tpc.110.077958; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Limin AE, 2006, PLANTA, V224, P360, DOI 10.1007/s00425-006-0219-y; Lunn JE, 2006, BIOCHEM J, V397, P139, DOI 10.1042/BJ20060083; McKenzie J. S., 1988, Alfalfa and alfalfa improvement, P259; Oliver SN, 2013, J EXP BOT, V64, P2413, DOI 10.1093/jxb/ert095; Paina C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107365; Pfeifer M, 2013, PLANT PHYSIOL, V161, P571, DOI 10.1104/pp.112.207282; Ream TS, 2014, PLANT PHYSIOL, V164, P694, DOI 10.1104/pp.113.232678; Ren Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029453; Rognli O.A., 2013, PLANT MICROBE ADAPTA, P197, DOI [10.1007/978-1-4614-8253-6_17, DOI 10.1007/978-1-4614-8253-6_17]; Sato K, 2009, THEOR APPL GENET, V119, P613, DOI 10.1007/s00122-009-1071-9; Shinozuka H, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-101; Shirasawa K, 2010, DNA RES, V17, P381, DOI 10.1093/dnares/dsq024; Sim S, 2005, THEOR APPL GENET, V110, P1011, DOI 10.1007/s00122-004-1916-1; Simpson JT, 2014, BIOINFORMATICS, V30, P1228, DOI 10.1093/bioinformatics/btu023; Skot L, 2007, GENETICS, V177, P535, DOI 10.1534/genetics.107.071522; Skot L, 2011, PLANT PHYSIOL, V155, P1013, DOI 10.1104/pp.110.169870; Studer B, 2008, THEOR APPL GENET, V117, P781, DOI 10.1007/s00122-008-0819-y; Studer B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-140; Studer B, 2009, MOL BREEDING, V24, P191, DOI 10.1007/s11032-009-9291-x; Sutka J, 1999, THEOR APPL GENET, V99, P199, DOI 10.1007/s001220051225; Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-125; Tang HB, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0573-1; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Toth B, 2003, THEOR APPL GENET, V107, P509, DOI 10.1007/s00122-003-1275-3; VanOoijen WJ, 2006, JOINMAP 4 SOFTWARE C; von Zitzewitz J, 2005, PLANT MOL BIOL, V59, P449, DOI 10.1007/s11103-005-0351-2; von Zitzewitz J, 2011, PLANT GENOME-US, V4, P76, DOI 10.3835/plantgenome2010.12.0030; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wahl V, 2013, SCIENCE, V339, P704, DOI 10.1126/science.1230406; Xing Y, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-43; Xiong YW, 2007, MOL BREEDING, V19, P125, DOI 10.1007/s11032-006-9050-1; Yamada T, 2004, CROP SCI, V44, P925, DOI 10.2135/cropsci2004.0925; Yamada T, 2005, P 2005 JAP IND APPL, P43; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305	77	10	10	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152004	10.1371/journal.pone.0152004	http://dx.doi.org/10.1371/journal.pone.0152004			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010567	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000372708000067
J	Mutschelknaus, L; Peters, C; Winkler, K; Yentrapalli, R; Heider, T; Atkinson, MJ; Moertl, S				Mutschelknaus, Lisa; Peters, Carsten; Winkler, Klaudia; Yentrapalli, Ramesh; Heider, Theresa; Atkinson, Michael John; Moertl, Simone			Exosomes Derived from Squamous Head and Neck Cancer Promote Cell Survival after Ionizing Radiation	PLOS ONE			English	Article							MESSENGER-RNAS; MICROVESICLES; MICRORNAS; MICROENVIRONMENT; PROLIFERATION; MECHANISM; THERAPY	Exosomes are nanometer-sized extracellular vesicles that are believed to function as intercellular communicators. Here, we report that exosomes are able to modify the radiation response of the head and neck cancer cell lines BHY and FaDu. Exosomes were isolated from the conditioned medium of irradiated as well as non-irradiated head and neck cancer cells by serial centrifugation. Quantification using NanoSight technology indicated an increased exosome release from irradiated compared to non-irradiated cells 24 hours after treatment. To test whether the released exosomes influence the radiation response of other cells the exosomes were transferred to non-irradiated and irradiated recipient cells. We found an enhanced uptake of exosomes isolated from both irradiated and non-irradiated cells by irradiated recipient cells compared to non-irradiated recipient cells. Functional analyses by exosome transfer indicated that all exosomes (from non-irradiated and irradiated donor cells) increase the proliferation of non-irradiated recipient cells and the survival of irradiated recipient cells. The survival-promoting effects are more pronounced when exosomes isolated from irradiated compared to non-irradiated donor cells are transferred. A possible mechanism for the increased survival after irradiation could be the increase in DNA doublestrand break repair monitored at 6, 8 and 10 h after the transfer of exosomes isolated from irradiated cells. This is abrogated by the destabilization of the exosomes. Our results demonstrate that radiation influences both the abundance and action of exosomes on recipient cells. Exosomes transmit prosurvival effects by promoting the proliferation and radioresistance of head and neck cancer cells. Taken together, this study indicates a functional role of exosomes in the response of tumor cells to radiation exposure within a therapeutic dose range and encourages that exosomes are useful objects of study for a better understanding of tumor radiation response.	[Mutschelknaus, Lisa; Winkler, Klaudia; Yentrapalli, Ramesh; Heider, Theresa; Atkinson, Michael John; Moertl, Simone] Helmholtz Zentrum mUNCHEN, German Res Ctr Environm Hlth, Inst Radiat Biol, Neuherberg, Germany; [Peters, Carsten] Tech Univ Munich, Dept Chem, D-80290 Munich, Germany; [Atkinson, Michael John] Tech Univ Munich, Radiat Biol, D-80290 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; Technical University of Munich	Moertl, S (corresponding author), Helmholtz Zentrum mUNCHEN, German Res Ctr Environm Hlth, Inst Radiat Biol, Neuherberg, Germany.	moertl@helmholtz-muenchen.de	Atkinson, Michael J/E-5537-2011; Moertl, Simone/M-7353-2014; Atkinson, Michael/AAU-5127-2020; Yentrapalli, Ramesh/N-3509-2019	Atkinson, Michael J/0000-0003-3358-2089; Moertl, Simone/0000-0003-0644-0878; Atkinson, Michael/0000-0003-3358-2089; Yentrapalli, Ramesh/0000-0001-6292-4792				Adelstein DJ, 2003, J CLIN ONCOL, V21, P92, DOI 10.1200/JCO.2003.01.008; Al-Mayah A, 2015, MUTAT RES-FUND MOL M, V772, P38, DOI 10.1016/j.mrfmmm.2014.12.007; Al-Mayah AHJ, 2012, RADIAT RES, V177, P539, DOI 10.1667/RR2868.1; Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Arscott WT, 2013, TRANSL ONCOL, V6, P638, DOI 10.1593/tlo.13640; Battke C, 2011, CANCER IMMUNOL IMMUN, V60, P639, DOI 10.1007/s00262-011-0979-5; Chen WX, 2014, TUMOR BIOL, V35, P9649, DOI 10.1007/s13277-014-2242-0; Chiba M, 2012, ONCOL REP, V28, P1551, DOI 10.3892/or.2012.1967; Ciravolo V, 2012, J CELL PHYSIOL, V227, P658, DOI 10.1002/jcp.22773; Corcoran C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050999; Crescitelli R, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.20677; de Jong OG, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18396; Dutta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097580; Eldh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015353; Hazawa M, 2014, BIOCHEM BIOPH RES CO, V446, P1165, DOI 10.1016/j.bbrc.2014.03.067; Jella KK, 2014, RADIAT RES, V181, P138, DOI 10.1667/RR13337.1; King TL, 2012, AM J PHYSIOL-REG I, V302, pR1219, DOI 10.1152/ajpregu.00028.2012; Kraemer A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077484; Kraemer A, 2011, RADIAT RES, V176, P575, DOI 10.1667/RR2638.1; Lehmann BD, 2008, CANCER RES, V68, P7864, DOI 10.1158/0008-5472.CAN-07-6538; Mineo M, 2012, ANGIOGENESIS, V15, P33, DOI 10.1007/s10456-011-9241-1; O'Leary VB, 2015, CELL REP, V11, P474, DOI 10.1016/j.celrep.2015.03.043; Park JE, 2010, MOL CELL PROTEOMICS, V9, P1085, DOI 10.1074/mcp.M900381-MCP200; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Raimondo S, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0086-x; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Thery C, 2001, CURRENT PROTOCOLS IN; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang JH, 2014, BLOOD, V124, P555, DOI 10.1182/blood-2014-03-562439; Wysoczynski M, 2009, INT J CANCER, V125, P1595, DOI 10.1002/ijc.24479; Xiao H, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0064-8; Yang L, 2013, MOL MED REP, V8, P1272, DOI 10.3892/mmr.2013.1634	32	105	110	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152213	10.1371/journal.pone.0152213	http://dx.doi.org/10.1371/journal.pone.0152213			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27006994	Green Published, Green Submitted, gold			2022-12-26	WOS:000372701200111
J	Doltra, A; Hartmann, A; Stawowy, P; Goubergrits, L; Kuehne, T; Wellnhofer, E; Gebker, R; Schneeweis, C; Schnackenburg, B; Esler, M; Fleck, E; Kelle, S				Doltra, Adelina; Hartmann, Arthur; Stawowy, Philipp; Goubergrits, Leonid; Kuehne, Titus; Wellnhofer, Ernst; Gebker, Rolf; Schneeweis, Christopher; Schnackenburg, Bernhard; Esler, Murray; Fleck, Eckart; Kelle, Sebastian			Effects of Renal Denervation on Renal Artery Function in Humans: Preliminary Study	PLOS ONE			English	Article							TREATMENT-RESISTANT HYPERTENSION; SYMPATHETIC DENERVATION; VASCULAR-LESIONS; NERVE ABLATION; CATHETER; NONRESPONDERS; STENOSIS	Aim To study the effects of RD on renal artery wall function non-invasively using magnetic resonance. Methods and Results 32 patients undergoing RD were included. A 3.0 Tesla magnetic resonance of the renal arteries was performed before RD and after 6-month. We quantified the vessel sharpness of both renal arteries using a quantitative analysis tool (Soap-Bubble1). In 17 patients we assessed the maximal and minimal cross-sectional area of both arteries, peak velocity, mean flow, and renal artery distensibility. In a subset of patients wall shear stress was assessed with computational flow dynamics. Neither renal artery sharpness nor renal artery distensibility differed significantly. A significant increase in minimal and maximal areas (by 25.3%, p = 0.008, and 24.6%, p = 0.007, respectively), peak velocity (by 16.9%, p = 0.021), and mean flow (by 22.4%, p = 0.007) was observed after RD. Wall shear stress significantly decreased (by 25%, p = 0.029). These effects were observed in blood pressure responders and non-responders. Conclusions RD is not associated with adverse effects at renal artery level, and leads to an increase in cross-sectional areas, velocity and flow and a decrease in wall shear stress.	[Doltra, Adelina; Hartmann, Arthur; Stawowy, Philipp; Wellnhofer, Ernst; Gebker, Rolf; Schneeweis, Christopher; Fleck, Eckart; Kelle, Sebastian] Deutsch Herzzentrum Berlin, Dept Internal Med Cardiol, Berlin, Germany; [Goubergrits, Leonid; Kuehne, Titus] Charite, Biofluid Mech Lab, D-13353 Berlin, Germany; [Goubergrits, Leonid; Kuehne, Titus] Deutsch Herzzentrum Berlin, Dept Congenital Heart Dis & Paediat Cardiol, Berlin, Germany; [Kuehne, Titus; Gebker, Rolf; Kelle, Sebastian] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany; [Schnackenburg, Bernhard] Philips Healthcare, Clin Sci, Hamburg, Germany; [Esler, Murray] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	German Heart Center Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Heart Center Berlin; German Centre for Cardiovascular Research; Philips; Philips Healthcare; Baker Heart and Diabetes Institute	Kelle, S (corresponding author), Deutsch Herzzentrum Berlin, Dept Internal Med Cardiol, Berlin, Germany.; Kelle, S (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany.	kelle@dhzb.de	Kelle, Sebastian/ABH-7348-2020; Goubergrits, Leonid/AAB-2332-2022	Goubergrits, Leonid/0000-0002-1961-3179; Kelle, Sebastian/0000-0001-8105-6599; Kuehne, Titus/0000-0003-1631-4824	European Society of Cardiology; Philips Healthcare	European Society of Cardiology; Philips Healthcare	AD was supported by a Research Grant from the European Society of Cardiology (2013). Philips Healthcare provided support in the form of salaries for authors (BS), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Daugherty SL, 2012, CIRCULATION, V125, P1635, DOI 10.1161/CIRCULATIONAHA.111.068064; Doltra A, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001353; Esler MD, 2010, LANCET, V376, P1903, DOI 10.1016/S0140-6736(10)62039-9; Etienne A, 2002, MAGNET RESON MED, V48, P658, DOI 10.1002/mrm.10253; Gatehouse PD, 2005, EUR RADIOL, V15, P2172, DOI 10.1007/s00330-005-2829-3; Goubergrits L, 2013, ANN BIOMED ENG, V41, P2575, DOI 10.1007/s10439-013-0879-2; Ierna S, 2013, INT J CARDIOL, V165, pE35, DOI 10.1016/j.ijcard.2012.10.056; Kaltenbach B, 2012, J AM COLL CARDIOL, V60, P2694, DOI 10.1016/j.jacc.2012.09.027; Krum H, 2014, LANCET, V383, P622, DOI 10.1016/S0140-6736(13)62192-3; Krum H, 2009, LANCET, V373, P1275, DOI 10.1016/S0140-6736(09)60566-3; Lambert T, CATHETER CARDIOVASC, V81, pE255, DOI 10.1002/ccd.24753; Lambert T, 2015, AM J CARDIOL, V115, P1545, DOI 10.1016/j.amjcard.2015.02.055; Mahfoud F, 2014, EUR HEART J, V35, P2224, DOI 10.1093/eurheartj/ehu093; Mahfoud F, 2013, EUR HEART J, V34, P2149, DOI 10.1093/eurheartj/eht154; Mahfoud F, 2012, HYPERTENSION, V60, P419, DOI 10.1161/HYPERTENSIONAHA.112.193870; Oppo K, 1998, RADIOLOGY, V208, P453, DOI 10.1148/radiology.208.2.9680575; Prochnau D, 2013, INT J CARDIOL, V167, P588, DOI 10.1016/j.ijcard.2012.09.224; Rippy MK, 2011, CLIN RES CARDIOL, V100, P1095, DOI 10.1007/s00392-011-0346-8; Sakakura K, 2014, J AM COLL CARDIOL, V64, P635, DOI 10.1016/j.jacc.2014.03.059; Schmid A, 2016, CARDIOVASC INTER RAD, V39, P426, DOI 10.1007/s00270-015-1192-2; Schubert S, 2014, INT J CARDIOL, V177, pE172, DOI 10.1016/j.ijcard.2014.08.112; Steigerwald K, 2012, J HYPERTENS, V30, P2230, DOI 10.1097/HJH.0b013e32835821e5; Templin C, 2013, EUR HEART J, V34, P2141, DOI 10.1093/eurheartj/eht141; Tsioufis C, 2014, EUROINTERVENTION, V9, P27, DOI [10.4244/EIJV919A175, 10.4244/EIJV9I9A175]; VANBORTEL LM, 1995, HYPERTENSION, V26, P531, DOI 10.1161/01.HYP.26.3.531; Versaci F, 2014, INT J CARDIOL, V175, P370, DOI 10.1016/j.ijcard.2014.04.252; Vonend O, 2012, LANCET, V380, P778, DOI 10.1016/S0140-6736(12)61145-3; Wellnhofer E, 2010, ATHEROSCLEROSIS, V213, P475, DOI 10.1016/j.atherosclerosis.2010.09.007; Zhang ZH, 2014, J CLIN HYPERTENS, V16, P599, DOI 10.1111/jch.12367	30	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0150662	10.1371/journal.pone.0150662	http://dx.doi.org/10.1371/journal.pone.0150662			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003912	Green Published, Green Submitted, gold			2022-12-26	WOS:000372697400018
J	Geng, HH; Li, R; Su, YM; Xiao, J; Pan, M; Cai, XX; Ji, XP				Geng, Hai-Hua; Li, Rui; Su, Ya-Min; Xiao, Jie; Pan, Min; Cai, Xing-Xing; Ji, Xiao-Ping			The Circular RNA Cdr1as Promotes Myocardial Infarction by Mediating the Regulation of miR-7a on Its Target Genes Expression	PLOS ONE			English	Article							INDUCED APOPTOSIS; TRANSCRIPTION; PATHWAY	Objectives Recent studies have demonstrated the role of Cdr1as (or CiRS-7), one of the well-identified circular RNAs (circRNAs), as a miR-7a/b sponge or inhibitor in brain tissues or islet cells. This study aimed to investigate the presence of Cdr1as/miR-7a pathway in cardiomyocytes, and explore the mechanism underlying the function of miR-7a in protecting against myocardial infarction (MI)-induced apoptosis. Methods Mouse MI injury model was established and evaluated by infarct size determination. Real-time PCR was performed to quantify the expression of Cdr1as and miR-7a in cardiomyocytes. Cell apoptosis was determined by caspase-3 activity analysis and flow cytometry assays with Annexin V/PI staining. Transfection of Cdr1as overexpressing plasmid and miR-7a mimic were conducted for gain-of-function studies. Luciferase reporter assay and western blot analysis were performed to verity potential miR-7a targets. Results Cdr1as and miR-7a were both upregulated in MI mice with increased cardiac infarct size, or cardiomyocytes under hypoxia treatment. Cdr1as overexpression in MCM cells promoted cell apoptosis, but was then reversed by miR-7a overexpression. The SP1 was identified as a new miR-7a target, in line with previously identified PARP, while miR-7a-induced decrease of cell apoptosis under hypoxia treatment was proven to be inhibited by PARP-SP1 overexpression. Moreover, Cdr1as overexpression in vivo increased cardiac infarct size with upregulated expression of PARP and SP1, while miR-7a overexpression reversed these changes. Conclusions Cdr1as also functioned as a powerful miR-7a sponge in myocardial cells, and showed regulation on the protective role of miR-7a in MI injury, involving the function of miR-7a targets, PARP and SP1.	[Geng, Hai-Hua; Li, Rui; Xiao, Jie; Ji, Xiao-Ping] Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250012, Shandong, Peoples R China; [Geng, Hai-Hua; Li, Rui; Xiao, Jie; Ji, Xiao-Ping] Shandong Univ, Qilu Hosp, Chinese Minist Hlth, Jinan 250012, Shandong, Peoples R China; [Su, Ya-Min; Pan, Min; Cai, Xing-Xing] Nantong Univ, Affiliated Hosp, Dept Cardiol, Nantong 226001, Jiangsu, Peoples R China	Shandong University; Shandong University; Nantong University	Ji, XP (corresponding author), Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan 250012, Shandong, Peoples R China.; Ji, XP (corresponding author), Shandong Univ, Qilu Hosp, Chinese Minist Hlth, Jinan 250012, Shandong, Peoples R China.	Jixping@163.com		Pan, Min/0000-0001-9508-4849				CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; Chavakis E, 2010, CIRCULATION, V121, P325, DOI 10.1161/CIRCULATIONAHA.109.901405; Cho HJ, 2012, MOL THER, V20, P1750, DOI 10.1038/mt.2012.109; Danan M, 2011, NUCLEIC ACIDS RES; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Eltzschig HK, 2009, BLOOD, V113, P224, DOI 10.1182/blood-2008-06-165746; Fan F, 2013, CURR PHARM DESIGN, V19, P4865, DOI 10.2174/13816128113199990325; Guo JU, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0409-z; Hansen TB, 2013, CANCER RES, V73, P5609, DOI 10.1158/0008-5472.CAN-13-1568; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; Hierlihy AM, 2002, FEBS LETT, V530, P239, DOI 10.1016/S0014-5793(02)03477-4; Jeck WR, 2014, NAT BIOTECHNOL, V32, P453, DOI 10.1038/nbt.2890; Kavurma MM, 2002, J BIOL CHEM, V277, P36244, DOI 10.1074/jbc.M200463200; Kazi AA, 2009, BIOL REPROD, V81, P378, DOI 10.1095/biolreprod.109.076117; Kos A, 1986, HEPATITIS DELTA VIRU; Kurrelmeyer KM, 2000, P NATL ACAD SCI USA, V97, P5456, DOI 10.1073/pnas.070036297; Li B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090096; Li LH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145766; Li N, 2012, INVEST OPHTH VIS SCI, V53, P1670, DOI 10.1167/iovs.11-8670; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; Meloni M, 2013, MOL THER, V21, P1390, DOI 10.1038/mt.2013.89; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nicolas FE, 2011, METHODS MOL BIOL, V732, P139, DOI 10.1007/978-1-61779-083-6_11; Qian L, 2011, J EXP MED, V208, P549, DOI 10.1084/jem.20101547; Read DE, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-56; Ren J, 2009, TOXICOL LETT, V187, P149, DOI 10.1016/j.toxlet.2009.02.019; SANGER HL, 1976, P NATL ACAD SCI USA, V73, P3852, DOI 10.1073/pnas.73.11.3852; Saraste A, 1997, CIRCULATION, V95, P320; Steele Robert, 2010, Genes Cancer, V1, P381; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Wang Hong-Ju, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P345; Wang PL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090859; Xu HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12453; Yang GD, 2012, J CELL PHYSIOL, V227, P3192, DOI 10.1002/jcp.24006; Zhang GD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135339; Zhao YJ, 2009, CHINESE MED J-PEKING, V122, P1322, DOI 10.3760/cma.j.issn.0366-6999.2009.11.016	40	287	320	2	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151753	10.1371/journal.pone.0151753	http://dx.doi.org/10.1371/journal.pone.0151753			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998750	Green Submitted, Green Published, gold			2022-12-26	WOS:000372694700060
J	Reacher, M; Verlander, NQ; Roddick, I; Trundle, C; Brown, N; Farrington, M; Jones, P				Reacher, Mark; Verlander, Neville Q.; Roddick, Iain; Trundle, Cheryl; Brown, Nicholas; Farrington, Mark; Jones, Philip			Excess Mortality Attributable to Clostridium difficile and Risk Factors for Infection in an Historic Cohort of Hospitalised Patients Followed Up in the United Kingdom Death Register	PLOS ONE			English	Article							DIARRHEA; DISEASE; MORBIDITY; BURDEN; EUROPE; RATES	Methods We compared time from hospital admission to death in a probability sample of 100 Clostridium difficile infected cases and a probability sample of 98 non-cases admitted to an English teaching hospital between 2005 and 2007 with follow up in the UK national death register using survival analysis. Results Clostridium difficile infection was associated with a 50% increased risk of death (Hazard Ratio 1.51 (95% CI: 1.05-2.19 p = 0.03) at between five to eight years in Cox Regression analysis adjusting for age, sex, Charlson comorbidity index, diagnosis of a malignant condition and insertion of a nasogastric tube during admission. Acquisition of Clostridium difficile infection was independently associated with an almost six fold higher odds of being admitted with a diagnosis of infection of any other type (OR 5.79 (2.19, 15.25) p<0.001). Conclusions Our results strongly support continued priority being given to improve prevention and treatment of Clostridium difficile infection in the English National Health Service particularly in patients admitted with an infection. Our results may be applicable to other health systems.	[Reacher, Mark; Roddick, Iain] Cambridge Inst Publ Hlth, Publ Hlth England, Natl Infect Serv, Field Epidemiol Serv, Cambridge, England; [Reacher, Mark; Trundle, Cheryl; Brown, Nicholas; Farrington, Mark] Addenbrookes Hosp, Clin Microbiol & Publ Hlth Lab, Publ Hlth England, Cambridge, England; [Verlander, Neville Q.] Publ Hlth England, Natl Infect Serv, Stat Modelling & Econ Dept, Stat Unit, London, England; [Jones, Philip] Ipswich Hosp, Dept Med Microbiol, Ipswich, Suffolk, England	Public Health England; University of Cambridge; Addenbrooke's Hospital; Public Health England; University of Cambridge; Public Health England; Ipswich Hospital NHS Trust; Ipswich Hospital	Reacher, M (corresponding author), Cambridge Inst Publ Hlth, Publ Hlth England, Natl Infect Serv, Field Epidemiol Serv, Cambridge, England.; Reacher, M (corresponding author), Addenbrookes Hosp, Clin Microbiol & Publ Hlth Lab, Publ Hlth England, Cambridge, England.	mhr28@cam.ac.uk	Reacher, Mark/Y-6979-2018	Reacher, Mark/0000-0001-6871-7903; Brown, Nicholas/0000-0002-6657-300X				ALTMAN DG, 1999, PRACTICAL STAT MED R, P74; ARONSSON B, 1987, EUR J CLIN MICROBIOL, V6, P352, DOI 10.1007/BF02017639; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Corporation Stata, STAT STAT SOFTW; Delaney JAC, 2007, EMERG INFECT DIS, V13, P761, DOI 10.3201/eid1305.061124; Department of Health, 2012, UPD GUID DIAGN REP C; EAMES M, 1993, BRIT MED J, V307, P1097, DOI 10.1136/bmj.307.6912.1097; Goorhuis A, 2007, CLIN INFECT DIS, V45, P695, DOI 10.1086/520984; Greenland, 1998, MODERN EPIDEMIOLOGY, P47; HEARD SR, 1988, EPIDEMIOL INFECT, V100, P63, DOI 10.1017/S0950268800065560; Hota SS, 2012, EMERG INFECT DIS, V18, P305, DOI [10.3201/eid1802.101611, 10.3201/eid1802.111611]; Hughes GJ, 2013, J HOSP INFECT, V84, P227, DOI 10.1016/j.jhin.2012.12.018; Huisman M, 2013, EPIDEMIOL REV, V35, P84, DOI 10.1093/epirev/mxs010; Karas JA, 2010, J INFECTION, V61, P1, DOI 10.1016/j.jinf.2010.03.025; Karas JA, 2010, INFECT DIS REP; Levy MM, 2001, INTENS CARE MED, V29, P530, DOI DOI 10.1007/S00134-003-1662-X; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Miller MA, 2002, INFECT CONT HOSP EP, V23, P137, DOI 10.1086/502023; National Institute for Health and Care Excellence, 2014, FAEC MICR TRANSPL RE; Pepin J, 2005, CAN MED ASSOC J, V173, P1037, DOI 10.1503/cmaj.050978; Pepin J, 2004, CAN MED ASSOC J, V171, P466, DOI 10.1503/cmaj.1041104; Public Health England, 2015, ANN EP COMM MAND MRS; Schmid D, 2014, J INFECT PUBLIC HEAL, V7, P133, DOI 10.1016/j.jiph.2013.07.010; Stolley PD, 1982, CASE CONTROL STUDIES, P69; Thielman NM, 2010, MANDELL DOUGLAS BENN, P1375; UK government Department for Communities and Local Government, 2014, ENGL IND DEPR; Wiegand PN, 2012, J HOSP INFECT, V81, P1, DOI 10.1016/j.jhin.2012.02.004; Wilcox M, 2015, UPDATE GUIDANCE MANA; World Health Organisation, 2019, INT STAT CLASS DIS R, V11th	30	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0149983	10.1371/journal.pone.0149983	http://dx.doi.org/10.1371/journal.pone.0149983			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999613	Green Published, Green Submitted, gold			2022-12-26	WOS:000372694700010
J	Ribeiro, JMC; Martin-Martin, I; Arca, B; Calvo, E				Ribeiro, Jose M. C.; Martin-Martin, Ines; Arca, Bruno; Calvo, Eric			A Deep Insight into the Sialome of Male and Female Aedes aegypti Mosquitoes	PLOS ONE			English	Article							YELLOW-FEVER MOSQUITO; SALIVARY-GLAND TRANSCRIPTS; TRANSPOSABLE ELEMENTS; ANOPHELES-STEPHENSI; XANTHURENIC ACID; MALARIA VECTOR; SIALOKININ-I; GENE; VIRUS; SIALOTRANSCRIPTOME	Only adult female mosquitoes feed on blood, while both genders take sugar meals. Accordingly, several compounds associated with blood feeding (i.e. vasodilators, anti-clotting, anti-platelets) are found only in female glands, while enzymes associated with sugar feeding or antimicrobials (such as lysozyme) are found in the glands of both sexes. We performed de novo assembly of reads from adult Aedes aegypti female and male salivary gland libraries (285 and 90 million reads, respectively). By mapping back the reads to the assembled contigs, plus mapping the reads from a publicly available Ae. aegypti library from adult whole bodies, we identified 360 transcripts (including splice variants and alleles) overexpressed tenfold or more in the glands when compared to whole bodies. Moreover, among these, 207 were overexpressed fivefold or more in female vs. male salivary glands, 85 were near equally expressed and 68 were overexpressed in male glands. We call in particular the attention to C-type lectins, angiopoietins, female-specific Antigen 5, the 9.7 kDa, 12-14 kDa, 23.5 kDa, 62/34 kDa, 4.2 kDa, proline-rich peptide, SG8, 8.7 kDa family and SGS fragments: these polypeptides are all of unknown function, but due to their overexpression in female salivary glands and putative secretory nature they are expected to affect host physiology. We have also found many transposons (some of which novel) and several endogenous viral transcripts (probably acquired by horizontal transfer) which are overexpressed in the salivary glands and may play some role in tissue-specific gene regulation or represent a mechanism of virus interference. This work contributes to a near definitive catalog of male and female salivary gland transcripts from Ae. aegypti, which will help to direct further studies aiming at the functional characterization of the many transcripts with unknown function and the understanding of their role in vector-host interaction and pathogen transmission.	[Ribeiro, Jose M. C.; Martin-Martin, Ines; Calvo, Eric] NIAID, Lab Malaria & Vector Res, Sect Vector Biol, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Arca, Bruno] Univ Roma La Sapienza, Dept Publ Hlth & Infect Dis, Parasitol Sect, Piazzale Aldo Moro 5, I-00185 Rome, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Sapienza University Rome	Ribeiro, JMC (corresponding author), NIAID, Lab Malaria & Vector Res, Sect Vector Biol, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jribeiro@nih.gov	Martin Martin, Ines/I-9358-2012; Calvo, Eric/ABB-4935-2021; Arca, Bruno/C-8383-2012	Martin Martin, Ines/0000-0002-0956-7324; Calvo, Eric/0000-0001-7880-2730; Ribeiro, Jose/0000-0002-9107-0818; Arca, Bruno/0000-0002-4029-0984	EU [228421]; MIUR (PRIN) [2010C2LKKJ_004]; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000810] Funding Source: NIH RePORTER	EU(European Commission); MIUR (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	BA was supported by funds from the EU grant INFRAVEC (228421) and from MIUR (PRIN 2010-2011, SKINFLAM, 2010C2LKKJ_004); EC, IMM and JMCR by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA.	Arca B, 2005, J EXP BIOL, V208, P3971, DOI 10.1242/jeb.01849; Baker DA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-296; Beerntsen BT, 1999, INSECT MOL BIOL, V8, P459, DOI 10.1046/j.1365-2583.1999.00141.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Calvo E, 2008, INSECT BIOCHEM MOLEC, V38, P499, DOI 10.1016/j.ibmb.2007.12.006; Calvo E, 2006, INSECT BIOCHEM MOLEC, V36, P570, DOI 10.1016/j.ibmb.2006.04.005; Chagas AC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-875; CHAMPAGNE DE, 1994, P NATL ACAD SCI USA, V91, P138, DOI 10.1073/pnas.91.1.138; CHAMPAGNE DE, 1995, P NATL ACAD SCI USA, V92, P694, DOI 10.1073/pnas.92.3.694; Cowley M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003234; Crabtree MB, 2003, ARCH VIROL, V148, P1095, DOI 10.1007/s00705-003-0019-7; Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0; De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5; Edwards JF, 1998, J MED ENTOMOL, V35, P261, DOI 10.1093/jmedent/35.3.261; Francischetti IMB, 2002, J EXP BIOL, V205, P2429; Garcia GE, 1998, J BIOL CHEM, V273, P12003, DOI 10.1074/jbc.273.20.12003; Gibbs GM, 2008, ENDOCR REV, V29, P865, DOI 10.1210/er.2008-0032; Gifford WD, 2013, TRENDS CELL BIOL, V23, P218, DOI 10.1016/j.tcb.2013.01.001; Grossman G.L., 1993, Insect Molecular Biology, V1, P223, DOI 10.1111/j.1365-2583.1993.tb00095.x; Grossman GL, 1997, INSECT BIOCHEM MOLEC, V27, P769, DOI 10.1016/S0965-1748(97)00063-5; Hajnicka V, 2000, PARASITE IMMUNOL, V22, P201, DOI 10.1046/j.1365-3024.2000.00296.x; Hirai M, 2001, BIOCHEM BIOPH RES CO, V287, P859, DOI 10.1006/bbrc.2001.5675; Howe EA, 2011, BIOINFORMATICS, V27, P3209, DOI 10.1093/bioinformatics/btr490; Jiang XF, 2015, GENOME BIOL EVOL, V7, P1914, DOI 10.1093/gbe/evv115; JONES LD, 1990, T ROY SOC TROP MED H, V84, P846, DOI 10.1016/0035-9203(90)90104-M; Juhn J, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-1; Jurka J., 2011, REPBASE REPORTS, V11, P1039; Karim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028525; King JG, 2011, J BIOL CHEM, V286, P40824, DOI 10.1074/jbc.M111.280552; Korochkina S, 2006, CELL MICROBIOL, V8, P163, DOI 10.1111/j.1462-5822.2005.00611.x; LABUDA M, 1993, EXPERIENTIA, V49, P802, DOI 10.1007/BF01923553; Lehane M.J., 2005, BIOL BLOOD SUCKING I, V2nd; Loomans HJ, 1998, J INFECT DIS, V177, P812, DOI 10.1086/517816; Marinotti O, 1996, COMP BIOCHEM PHYS B, V113, P675, DOI 10.1016/0305-0491(95)02035-7; MARINOTTI O, 1990, J INSECT PHYSIOL, V36, P545, DOI 10.1016/0022-1910(90)90021-7; Megy K, 2012, NUCLEIC ACIDS RES, V40, pD729, DOI 10.1093/nar/gkr1089; Nascimento EP, 2000, ARCH INSECT BIOCHEM, V43, P9, DOI 10.1002/(SICI)1520-6327(200001)43:1&lt;9::AID-ARCH2&gt;3.0.CO;2-2; Nuttall PA, 2009, FRONT BIOSCI-LANDMRK, V14, P2466, DOI 10.2741/3390; Peng Z, 2007, PROTEIN PEPTIDE LETT, V14, P975, DOI 10.2174/092986607782541088; PIMENTEL GE, 1990, COMP BIOCHEM PHYS B, V96, P549, DOI 10.1016/0305-0491(90)90054-W; R Core Team, 2021, R LANGUAGE ENV STAT; RIBEIRO JMC, 1984, COMP BIOCHEM PHYS B, V79, P81, DOI 10.1016/0305-0491(84)90081-6; RIBEIRO JMC, 1992, J EXP BIOL, V165, P61; Ribeiro JMC, 2003, INSECT BIOCHEM MOLEC, V33, P13, DOI 10.1016/S0965-1748(02)00078-4; Ribeiro JMC, 2001, J EXP BIOL, V204, P2001; Ribeiro JMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-6; Ribeiro JMC, 2014, INSECT BIOCHEM MOLEC, V44, P23, DOI 10.1016/j.ibmb.2013.10.006; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; ROSSIGNOL PA, 1982, J INSECT PHYSIOL, V28, P579, DOI 10.1016/0022-1910(82)90054-3; ROSSIGNOL PA, 1986, COMP BIOCHEM PHYS B, V83, P819, DOI 10.1016/0305-0491(86)90153-7; Salvemini M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-41; Schneider BS, 2008, T ROY SOC TROP MED H, V102, P400, DOI 10.1016/j.trstmh.2008.01.024; Schneider BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011704; Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74; Shukla JN, 2010, J GENET, V89, P341, DOI 10.1007/s12041-010-0046-6; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Stark KR, 1995, EXP PARASITOL, V81, P321, DOI 10.1006/expr.1995.1123; Styer LM, 2011, J VIROL, V85, P1517, DOI 10.1128/JVI.01112-10; Thangamani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012137; Titus RG, 2006, PARASITE IMMUNOL, V28, P131, DOI 10.1111/j.1365-3024.2006.00807.x; Valenzuela JG, 2002, INSECT BIOCHEM MOLEC, V32, P1101, DOI 10.1016/S0965-1748(02)00047-4; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Warnes GR, 2015, GPLOTS VARIOUS R PRO, V2; Xie YL, 2014, BIOINFORMATICS, V30, P1660, DOI 10.1093/bioinformatics/btu077	67	45	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151400	10.1371/journal.pone.0151400	http://dx.doi.org/10.1371/journal.pone.0151400			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999592	Green Published, gold, Green Submitted			2022-12-26	WOS:000372694700039
J	Harlan, BA; Pehar, M; Sharma, DR; Beeson, G; Beeson, CC; Vargas, MR				Harlan, Benjamin A.; Pehar, Mariana; Sharma, Deep R.; Beeson, Gyda; Beeson, Craig C.; Vargas, Marcelo R.			Enhancing NAD(+) Salvage Pathway Reverts the Toxicity of Primary Astrocytes Expressing Amyotrophic Lateral Sclerosis-linked Mutant Superoxide Dismutase 1 (SOD1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTOR-NEURON DEGENERATION; NICOTINAMIDE RIBOSIDE; NRF2 ACTIVATION; MOUSE MODEL; METABOLISM; SIRT3; BIOSYNTHESIS; LOCALIZATION; MITOCHONDRIA; INHIBITION	Nicotinamide adenine dinucleotide (NAD(+)) participates in redox reactions and NAD(+)-dependent signaling pathways. Although the redox reactions are critical for efficient mitochondrial metabolism, they are not accompanied by any net consumption of the nucleotide. On the contrary, NAD(+)-dependent signaling processes lead to its degradation. Three distinct families of enzymes consume NAD(+) as substrate: poly(ADP-ribose) polymerases, ADP-ribosyl cyclases (CD38 and CD157), and sirtuins (SIRT1-7). Because all of the above enzymes generate nicotinamide as a byproduct, mammalian cells have evolved an NAD(+) salvage pathway capable of resynthesizing NAD(+) from nicotinamide. Overexpression of the rate-limiting enzyme in this pathway, nicotinamide phosphoribosyltransferase, increases total and mitochondrial NAD(+) levels in astrocytes. Moreover, targeting nicotinamide phosphoribosyltransferase to the mitochondria also enhances NAD(+) salvage pathway in astrocytes. Supplementation with the NAD(+) precursors nicotinamide mononucleotide and nicotinamide riboside also increases NAD(+) levels in astrocytes. Amyotrophic lateral sclerosis (ALS) is caused by the progressive degeneration of motor neurons in the spinal cord, brain stem, and motor cortex. Superoxide dismutase 1 (SOD1) mutations account for up to 20% of familial ALS and 1-2% of apparently sporadic ALS cases. Primary astrocytes isolated from mutant human superoxide dismutase 1-overexpressing mice as well as human post-mortem ALS spinal cord-derived astrocytes induce motor neuron death in co-culture. Increasing total and mitochondrial NAD(+) content in ALS astrocytes increases oxidative stress resistance and reverts their toxicity toward co-cultured motor neurons. Taken together, our results suggest that enhancing the NAD(+) salvage pathway in astrocytes could be a potential therapeutic target to prevent astrocyte-mediated motor neuron death in ALS.	[Harlan, Benjamin A.; Pehar, Mariana; Sharma, Deep R.; Vargas, Marcelo R.] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Basic Sci Bldg,Rm 358,MSC 509,173 Ashley Ave, Charleston, SC 29425 USA; [Beeson, Gyda; Beeson, Craig C.] Med Univ S Carolina, South Carolina Coll Pharm Drug Discovery & Biomed, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina	Vargas, MR (corresponding author), Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Basic Sci Bldg,Rm 358,MSC 509,173 Ashley Ave, Charleston, SC 29425 USA.	vargasm@musc.edu		Harlan, Benjamin/0000-0001-9026-543X	National Institutes of Health from the Extramural Research Facilities Program of the National Center for Research Resources [C06 RR015455]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089640] Funding Source: NIH RePORTER	National Institutes of Health from the Extramural Research Facilities Program of the National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Mathias Ziegler for the mitoPARP and mitoEGFP plasmids. We also thank the depositing laboratories of the SIRT1 and SIRT3 plasmids. This work utilized a facility constructed with support from National Institutes of Health Grant C06 RR015455 from the Extramural Research Facilities Program of the National Center for Research Resources to the Medical University of South Carolina.	Aksoy P, 2006, BIOCHEM BIOPH RES CO, V345, P1386, DOI 10.1016/j.bbrc.2006.05.042; Al-Chalabi A, 2012, ACTA NEUROPATHOL, V124, P339, DOI 10.1007/s00401-012-1022-4; Bai P, 2015, MOL CELL, V58, P947, DOI 10.1016/j.molcel.2015.01.034; Bai P, 2012, CELL METAB, V16, P290, DOI 10.1016/j.cmet.2012.06.016; Bai P, 2011, CELL METAB, V13, P461, DOI 10.1016/j.cmet.2011.03.004; Bao JJ, 2010, J CELL BIOCHEM, V110, P238, DOI 10.1002/jcb.22531; Barile M, 1996, BIOCHEM MOL BIOL INT, V38, P297; Bause AS, 2013, EXP GERONTOL, V48, P634, DOI 10.1016/j.exger.2012.08.007; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Berger F, 2004, TRENDS BIOCHEM SCI, V29, P111, DOI 10.1016/j.tibs.2004.01.007; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Canto C, 2013, MOL ASPECTS MED, V34, P1168, DOI 10.1016/j.mam.2013.01.004; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Di Stefano M, 2013, FEBS J, V280, P4711, DOI 10.1111/febs.12433; Dittenhafer-Reed KE, 2015, CELL METAB, V21, P637, DOI 10.1016/j.cmet.2015.03.007; Dolle C, 2010, CELL MOL LIFE SCI, V67, P433, DOI 10.1007/s00018-009-0190-4; Feldman JL, 2012, J BIOL CHEM, V287, P42419, DOI 10.1074/jbc.R112.378877; Felici R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076938; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Imai S, 2014, TRENDS CELL BIOL, V24, P464, DOI 10.1016/j.tcb.2014.04.002; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Li W, 2015, METHODS MOL BIOL, V1241, P39, DOI 10.1007/978-1-4939-1875-1_4; LOWRY OH, 1961, J BIOL CHEM, V236, P2756; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Mayo L, 2008, J IMMUNOL, V181, P92, DOI 10.4049/jimmunol.181.1.92; Mecleiros DM, 2008, METHODS, V46, P288, DOI 10.1016/j.ymeth.2008.09.026; Meyer K, 2014, P NATL ACAD SCI USA, V111, P829, DOI 10.1073/pnas.1314085111; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Niere M, 2008, MOL CELL BIOL, V28, P814, DOI 10.1128/MCB.01766-07; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Partida-Sanchez S, 2007, ADV EXP MED BIOL, V590, P171; Pehar M, 2016, MOL CELL PROTEOMICS, V15, P493, DOI 10.1074/mcp.M115.049288; Pehar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103438; Pittelli M, 2010, J BIOL CHEM, V285, P34106, DOI 10.1074/jbc.M110.136739; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Pryde KR, 2011, J BIOL CHEM, V286, P18056, DOI 10.1074/jbc.M110.186841; Qiu XL, 2010, CELL METAB, V12, P662, DOI 10.1016/j.cmet.2010.11.015; Ravits J, 2013, AMYOTROPH LAT SCL FR, V14, P5, DOI 10.3109/21678421.2013.778548; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Ruddick Jon P., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406000068; Schlicker C, 2008, J MOL BIOL, V382, P790, DOI 10.1016/j.jmb.2008.07.048; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Song WJ, 2013, NEUROBIOL DIS, V51, P72, DOI 10.1016/j.nbd.2012.07.004; Stein LR, 2012, TRENDS ENDOCRIN MET, V23, P420, DOI 10.1016/j.tem.2012.06.005; Tang KS, 2010, GLIA, V58, P446, DOI 10.1002/glia.20936; Tesla R, 2012, P NATL ACAD SCI USA, V109, P17016, DOI 10.1073/pnas.1213960109; VanLinden MR, 2015, J BIOL CHEM, V290, P27644, DOI 10.1074/jbc.M115.654129; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Vargas MR, 2006, J NEUROCHEM, V97, P687, DOI 10.1111/j.1471-4159.2006.03742.x; Vargas MR, 2005, J BIOL CHEM, V280, P25571, DOI 10.1074/jbc.M501920200; Wang G, 2014, CELL, V158, P1324, DOI 10.1016/j.cell.2014.07.040; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Watanabe S, 2014, MOL BRAIN, V7, DOI 10.1186/s13041-014-0062-1; Wilhelm F, 2011, J NEUROSCI RES, V89, P1956, DOI 10.1002/jnr.22638; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Ying WH, 2001, P NATL ACAD SCI USA, V98, P12227, DOI 10.1073/pnas.211202598; Yu W, 2012, J BIOL CHEM, V287, P14078, DOI 10.1074/jbc.M112.355206	72	58	60	2	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10836	10846		10.1074/jbc.M115.698779	http://dx.doi.org/10.1074/jbc.M115.698779			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27002158	Green Published, hybrid			2022-12-26	WOS:000377042600033
J	Shepherd, LD; de Lange, PJ; Cox, S; McLenachan, PA; Roskruge, NR; Lockhart, PJ				Shepherd, Lara D.; de Lange, Peter J.; Cox, Simon; McLenachan, Patricia A.; Roskruge, Nick R.; Lockhart, Peter J.			Evidence of a Strong Domestication Bottleneck in the Recently Cultivated New Zealand Endemic Root Crop, Arthropodium cirratum (Asparagaceae)	PLOS ONE			English	Article							POPULATION-GROWTH; SEQUENCE DATA; DNA; PLANT; MITOCHONDRIAL; COLONIZATION; DIVERSITY; SOFTWARE; GENETICS; ORGANIZATION	We use chloroplast DNA sequencing to examine aspects of the pre-European Maori cultivation of an endemic New Zealand root crop, Arthropodium cirratum (rengarenga). Researching the early stages of domestication is not possible for the majority of crops, because their cultivation began many thousands of years ago and/or they have been substantially altered by modern breeding methods. We found high levels of genetic variation and structuring characterised the natural distribution of A. cirratum, while the translocated populations only retained low levels of this diversity, indicating a strong bottleneck even at the early stages of this species' cultivation. The high structuring detected at four chloroplast loci within the natural A. cirratum range enabled the putative source(s) of the translocated populations to be identified as most likely located in the eastern Bay of Plenty/East Cape region. The high structuring within A. cirratum also has implications for the conservation of genetic diversity within this species, which has undergone recent declines in both its natural and translocated ranges.	[Shepherd, Lara D.] Museum New Zealand Te Papa Tongarewa, Wellington, New Zealand; [Shepherd, Lara D.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Shepherd, Lara D.; Cox, Simon; McLenachan, Patricia A.; Lockhart, Peter J.] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand; [de Lange, Peter J.] Dept Conservat, Terr Ecosyst, Sci & Capabil Grp, Newton, MA, New Zealand; [Roskruge, Nick R.] Massey Univ, Inst Agr & Environm, Palmerston North, New Zealand	Victoria University Wellington; Massey University; Massey University	Shepherd, LD (corresponding author), Museum New Zealand Te Papa Tongarewa, Wellington, New Zealand.; Shepherd, LD (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.; Shepherd, LD (corresponding author), Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand.	Lara.Shepherd@tepapa.govt.nz	de Lange, Peter/V-1338-2018	de Lange, Peter/0000-0001-6699-7083; Shepherd, Lara/0000-0002-7136-0017	Royal Society of New Zealand [RDF-MNZ1201]; Royal Society of New Zealand's Marsden Fund [MAU0709]	Royal Society of New Zealand(Royal Society of New Zealand); Royal Society of New Zealand's Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	This study was funded by a Rutherford Discovery Fellowship from the Royal Society of New Zealand (contract number RDF-MNZ1201) to LDS and the Royal Society of New Zealand's Marsden Fund (contract number MAU0709). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf F, 2013, CONSERV GENET, V2nd; ANDERSON A, 1991, ANTIQUITY, V65, P767, DOI 10.1017/S0003598X00080510; ANDERSON AJ, 1990, ARCHAEOL OCEAN, V25, P37, DOI DOI 10.1002/J.1834-4453.1990.TB00228.X; Anderson AJ, 1997, AUSTR ARCHAEOLOGIST, P440; Anderson Atholl, 1997, Archaeology in Oceania, V32, P39; Armstrong TTJ, 2005, BOT J LINN SOC, V149, P229, DOI 10.1111/j.1095-8339.2005.00437.x; Atherton RA, J R SOC N Z IN PRESS; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Besnard G, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2833; Buckley TR, 2013, BIOL J LINN SOC, V108, P361, DOI 10.1111/j.1095-8312.2012.02009.x; Clarkson BD, 1991, BOT OF ROTORUA; Colenso W., 1880, T NZ I, V13, P3; Conran JG, 2015, BOT J LINN SOC, V178, P394, DOI 10.1111/boj.12284; Cox P. A., 1991, ISLANDS PLANTS POLYN; Cox SJL, 2010, THESIS MASSEY U; Crowe A, 2004, FIELD GUIDE NATIVE E; Dellicour S, 2014, MOL ECOL RESOUR, V14, P647, DOI 10.1111/1755-0998.12200; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Ersts PJ, 2015, GEOGRAPHIC DISTANCE; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fu YX, 1997, GENETICS, V147, P915; Furey L, 2015, B AUCKLAND MUS, V20, P511; Furey L., 2006, 2006 MAORI GARDENING; Gerbault P, 2014, P NATL ACAD SCI USA, V111, P6159, DOI 10.1073/pnas.1400425111; Gross BL, 2014, AM J BOT, V101, P1770, DOI 10.3732/ajb.1400297; HARPENDING HC, 1994, HUM BIOL, V66, P591; Harris GF, 1996, J POLYNESIAN SOC, V105, P271; Heenan PB, 2004, NEW ZEAL J BOT, V42, P233, DOI 10.1080/0028825X.2004.9512900; Kassa MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039563; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larson G, 2014, P NATL ACAD SCI USA, V111, P6139, DOI 10.1073/pnas.1323964111; LEACH BF, 1986, NZ J ARCHAEOLOGY, V8, P143; Leach H, 2005, J POLYNESIAN SOC, V114, P7; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MCGLONE MS, 1985, NEW ZEAL J BOT, V23, P723, DOI 10.1080/0028825X.1985.10434240; Metcalfe L, 2007, PROPAGATION NZ NATIV; Meyer RS, 2012, NEW PHYTOL, V196, P29, DOI 10.1111/j.1469-8137.2012.04253.x; Miller A, 2005, P NATL ACAD SCI USA, V102, P12801, DOI 10.1073/pnas.0505447102; Miller AJ, 2011, AM J BOT, V98, P1389, DOI 10.3732/ajb.1000522; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Pons O, 1996, GENETICS, V144, P1237; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Reid I., 2009, INTRO PLANT LIFE NZ; Riley, 1994, MAORI HEALING HERBAL; Robles HN, 2015, THESIS LOUISIANA STA; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Roskruge N., 2014, RAUWARU PROVERBIAL G; Scott C., 2008, NZ J ARCHAEOL, V29, P57; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shepherd LD, 2011, J PLANT RES, V124, P311, DOI 10.1007/s10265-010-0379-5; Sheppard PJ, 2011, J ARCHAEOL SCI, V38, P45, DOI 10.1016/j.jas.2010.08.007; SLATKIN M, 1991, GENETICS, V129, P555; Smissen RD, 2010, AUST SYST BOT, V23, P371, DOI 10.1071/SB10023; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Thorsen MJ, 2009, PERSPECT PLANT ECOL, V11, P285, DOI 10.1016/j.ppees.2009.06.001; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Walter R, 2010, ANTIQUITY, V84, P497, DOI 10.1017/S0003598X00066734; WARDLE P., 1963, NEW ZEALAND JOUR BOT, V1, P3; Wegmann D, 2006, GENETICS, V174, P2009, DOI 10.1534/genetics.106.062851; Wilmshurst JM, 2011, P NATL ACAD SCI USA, V108, P1815, DOI 10.1073/pnas.1015876108; Yen D, 1990, NGA MAHI MAORI WAO N; Zeder MA, 2006, DOCUMENTING DOMESTICATION: NEW GENETIC AND ARCHAEOLOGICAL PARADIGMS, P1; Zeder MA, 2006, EVOL ANTHROPOL, V15, P105, DOI 10.1002/evan.20101; Zeder MA, 2015, P NATL ACAD SCI USA, V112, P3191, DOI 10.1073/pnas.1501711112; Zhou Wei, 2012, Plant Diversity and Resources, V34, P187, DOI 10.3724/SP.J.1143.2012.11169	69	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152455	10.1371/journal.pone.0152455	http://dx.doi.org/10.1371/journal.pone.0152455			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27011209	gold, Green Submitted, Green Published			2022-12-26	WOS:000372708000145
J	Yang, HM; Boldrini, JL; Fassoni, AC; Freitas, LFS; Gomez, MC; de Lima, KKB; Andrade, VR; Freitas, ARR				Yang, Hyun Mo; Boldrini, Jose Luiz; Fassoni, Artur Cesar; Souza Freitas, Luiz Fernando; Gomez, Miller Ceron; Barboza de Lima, Karla Katerine; Andrade, Valmir Roberto; Ribas Freitas, Andre Ricardo			Fitting the Incidence Data from the City of Campinas, Brazil, Based on Dengue Transmission Modellings Considering Time-Dependent Entomological Parameters	PLOS ONE			English	Article							AEDES-AEGYPTI; SEASONAL PATTERN; ACQUIRED-IMMUNITY; ABUNDANCE; TEMPERATURE; POPULATION; ALBOPICTUS; ARGENTINA; CULICIDAE; DIPTERA	Four time-dependent dengue transmission models are considered in order to fit the incidence data from the City of Campinas, Brazil, recorded from October 1st 1995 to September 30th 2012. The entomological parameters are allowed to depend on temperature and precipitation, while the carrying capacity and the hatching of eggs depend only on precipitation. The whole period of incidence of dengue is split into four periods, due to the fact that the model is formulated considering the circulation of only one serotype. Dengue transmission parameters from human to mosquito and mosquito to human are fitted for each one of the periods. The time varying partial and overall effective reproduction numbers are obtained to explain the incidence of dengue provided by the models.	[Yang, Hyun Mo; Boldrini, Jose Luiz; Fassoni, Artur Cesar; Souza Freitas, Luiz Fernando; Gomez, Miller Ceron; Barboza de Lima, Karla Katerine] Univ Estadual Campinas UNICAMP, Inst Matemat & Comp Cient IMECC, Campinas, SP, Brazil; [Andrade, Valmir Roberto] Superintendencia Controle Endemias SUCEN, Campinas, SP, Brazil; [Ribas Freitas, Andre Ricardo] Coordenadoria Vigilancia Sanitaria COVISA, Campinas, SP, Brazil; [Fassoni, Artur Cesar] Univ Fed Itajuba UNIFEI, IMC, Itajuba, MG, Brazil	Universidade Estadual de Campinas; Universidade Federal de Itajuba	Yang, HM (corresponding author), Univ Estadual Campinas UNICAMP, Inst Matemat & Comp Cient IMECC, Campinas, SP, Brazil.	hyunyang@ime.unicamp.br	Fassoni, Artur/V-5740-2017; Freitas, André Ricardo Ribas/L-1969-2016; Yang, Hyun M/K-6873-2014; Boldrini, Jose Luiz/K-9138-2014	Fassoni, Artur/0000-0002-3634-0061; Freitas, André Ricardo Ribas/0000-0003-0291-7771; Yang, Hyun M/0000-0002-1711-363X; Barboza de Lima, Karla/0000-0001-5867-2828; Boldrini, Jose Luiz/0000-0003-4293-7611; Ceron Gomez, Miller/0000-0002-2689-495X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2009/15098-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP (2009/15098-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baruah Sangeeta, 2012, Asian Journal of Experimental Biological Sciences, V3, P559; de Lima VLC, 2007, CAD SAUDE PUBLICA, V23, P669, DOI 10.1590/S0102-311X2007000300025; Dickerson AK, 2012, P NATL ACAD SCI USA, V109, P9822, DOI 10.1073/pnas.1205446109; Esteva L, 2015, J BIOL SYST, V23, P527, DOI 10.1142/S0218339015500278; Garcia-Rejon JE, 2011, AM J TROP MED HYG, V84, P489, DOI 10.4269/ajtmh.2011.10-0654; Lindsay SW, 1996, ANN TROP MED PARASIT, V90, P573, DOI 10.1080/00034983.1996.11813087; Madi M, 2012, MALAYSIAN J SCI, V31; Micieli MV, 2003, MEM I OSWALDO CRUZ, V98, P659, DOI 10.1590/S0074-02762003000500013; Monath T. P., 1989, ARBOVIRUSES EPIDEMIO, VV; MOORE CG, 1978, AM J TROP MED HYG, V27, P1225, DOI 10.4269/ajtmh.1978.27.1225; TOMA T, 1982, MOSQ NEWS, V42, P179; Vezzani D, 2004, MEM I OSWALDO CRUZ, V99, P351, DOI 10.1590/S0074-02762004000400002; Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040; Yang HM, 2009, EPIDEMIOL INFECT, V137, P1179, DOI 10.1017/S0950268809002052; Yang H.M., 2014, ECOLOGICAL MODELLING, P39, DOI [10.1007/978-3-319- 06877-0_3, DOI 10.1007/978-3-319-06877-0_3]; Yang HM, 1997, J THEOR BIOL, V188, P495, DOI 10.1006/jtbi.1997.0479; Yang HM, 1999, J THEOR BIOL, V196, P473, DOI 10.1006/jtbi.1998.0837; Yang HM, 2012, APPL MATH IRVINE, V3, P293, DOI [10.4236/am.2012.33045, DOI 10.4236/AM.2012.33045]; Yang HM., 2014, APPL MATH, V5, P2696, DOI [10.4236/am.2014.517257, DOI 10.4236/AM.2014.517257]; Yang Hyun Mo, 1998, Journal of Biological Systems, V6, P187, DOI 10.1142/S0218339098000145; Yang HM, 2011, BIOSYSTEMS, V103, P360, DOI 10.1016/j.biosystems.2010.11.002	21	15	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152186	10.1371/journal.pone.0152186	http://dx.doi.org/10.1371/journal.pone.0152186			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010654	Green Published, Green Submitted, gold			2022-12-26	WOS:000372708000104
J	Perez-Tasigchana, RF; Leon-Munoz, LM; Lopez-Garcia, E; Banegas, JR; Rodriguez-Artalejo, F; Guallar-Castillon, P				Perez-Tasigchana, Raul F.; Leon-Munoz, Luz M.; Lopez-Garcia, Esther; Banegas, Jose R.; Rodriguez-Artalejo, Fernando; Guallar-Castillon, Pilar			Mediterranean Diet and Health-Related Quality of Life in Two Cohorts of Community-Dwelling Older Adults	PLOS ONE			English	Article							FOOD-FREQUENCY QUESTIONNAIRE; SPANISH VERSION; PHYSICAL-ACTIVITY; REFERENCE VALUES; MENTAL-HEALTH; POPULATION; ADHERENCE; CONSUMPTION; MORTALITY; SURVIVAL	Introduction In older adults, the Mediterranean diet is associated with lower risk of chronic diseases, but its association with health-related quality of life (HRQL) is still uncertain. This study assessed the association between the Mediterranean diet and HRQL in 2 prospective cohorts of individuals aged >= 60 years in Spain. Methods The UAM-cohort (n = 2376) was selected in 2000/2001 and followed-up through 2003. At baseline, diet was collected with a food frequency questionnaire, which was used to develop an 8-item index of Mediterranean diet (UAM-MDP). The Seniors-ENRICA cohort (n = 1911) was recruited in 2008/2010 and followed-up through 2012. At baseline, a diet history was used to obtain food consumption. Mediterranean diet adherence was measured with the PREDIMED score and the Trichopoulou's Mediterranean Diet Score (MSD). HRQL was assessed, at baseline and at the end of follow-up, with the physical and mental component summaries (PCS and MCS) of the SF-36 questionnaire in the UAM-cohort, and the SF-12v.2 questionnaire in the Seniors-ENRICA cohort. Analyses were conducted with linear regression, and adjusted for the main confounders including baseline HRQL. Results In the UAM-cohort, no significant associations between the UAM-MDP and the PCS or the MCS were found. In the Seniors-ENRICA cohort, a higher PREDIMED score was associated with a slightly better PCS; when compared with the lowest tertile of PREDIMED score, the beta coefficient (95% confidence interval) for PCS was 0.55 (-0.48 to 1.59) in the second tertile, and 1.34 (0.21 to 2.47) in the highest tertile. However, the PREDIMED score was non-significantly associated with a better MCS score. The MSD did not show an association with either the PCS or the MCS. Conclusions No clinically relevant association was found between the Mediterranean diet and HRQL in older adults in Spain.	[Perez-Tasigchana, Raul F.; Leon-Munoz, Luz M.; Lopez-Garcia, Esther; Banegas, Jose R.; Rodriguez-Artalejo, Fernando; Guallar-Castillon, Pilar] Univ Autonoma Madrid IdiPaz, Dept Prevent Med & Publ Hlth, Madrid, Spain		Guallar-Castillon, P (corresponding author), Univ Autonoma Madrid IdiPaz, Dept Prevent Med & Publ Hlth, Madrid, Spain.	mpilar.guallar@uam.es	Stefanadis, Christodoulos/ABH-2232-2020; Lopez-Garcia, Esther/A-8894-2019; Guallar-Castillon, Pilar/F-1533-2016; León-Muñoz, Luz M/H-8275-2017	Stefanadis, Christodoulos/0000-0001-5974-6454; Guallar-Castillon, Pilar/0000-0003-4759-6713; 	Sanofi-Aventis; FIS [09/162, PI11/01379, PI12/1166]; Catedra UAM de Epidemiologia y Control del Riesgo Cardiovascular; National Government of Ecuador through the National Institution of Higher Education, Science, Technology and Innovation-SENESCYT	Sanofi-Aventis(Sanofi-Aventis); FIS(Instituto de Salud Carlos III); Catedra UAM de Epidemiologia y Control del Riesgo Cardiovascular; National Government of Ecuador through the National Institution of Higher Education, Science, Technology and Innovation-SENESCYT	Baseline data collection of the ENRICA-Seniors cohort was funded by Sanofi-Aventis. Data collection during follow-up was funded by FIS a grant 09/162 (Ministry of Health of Spain). Specific funding for this analysis was obtained from FIS grants PI11/01379 and PI12/1166 (Ministry of Health of Spain), and from the "Catedra UAM de Epidemiologia y Control del Riesgo Cardiovascular". RFP-T received a grant from the National Government of Ecuador through the National Institution of Higher Education, Science, Technology and Innovation-SENESCYT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO J, 1995, MED CLIN-BARCELONA, V104, P771; Alonso J, 1998, MED CLIN-BARCELONA, V111, P410; Alonso J., 2000, MANUAL PUNTUACION VE; Amarantos E, 2001, J GERONTOL A-BIOL, V56, P54, DOI 10.1093/gerona/56.suppl_2.54; [Anonymous], 1997, Int J Epidemiol, V26 Suppl 1, pS91; Bach-Faig A, 2011, PUBLIC HEALTH NUTR, V14, P2274, DOI 10.1017/S1368980011002515; Balboa-Castillo T, 2011, AM J PREV MED, V40, P39, DOI 10.1016/j.amepre.2010.10.005; Banegas JR, 2002, J HYPERTENS, V20, P2157, DOI 10.1097/00004872-200211000-00014; Bonaccio M, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003003; Chrysohoou C, 2004, J AM COLL CARDIOL, V44, P152, DOI 10.1016/j.jacc.2004.03.039; Dean M, 2008, APPETITE, V50, P308, DOI 10.1016/j.appet.2007.08.007; Domenech M, 2014, HYPERTENSION, V64, P69, DOI 10.1161/HYPERTENSIONAHA.113.03353; Esposito K, 2004, JAMA-J AM MED ASSOC, V292, P1440, DOI 10.1001/jama.292.12.1440; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Fernandez-Ballarth JD, 2010, BRIT J NUTR, V103, P1808, DOI 10.1017/S0007114509993837; Fito M, 2007, ARCH INTERN MED, V167, P1195, DOI 10.1001/archinte.167.11.1195; Grunert KG, 2007, APPETITE, V49, P486, DOI 10.1016/j.appet.2007.03.010; Guallar-Castillon P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086074; Guallar-Castillon P, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e363; Sanchez PH, 2012, EUR J CLIN NUTR, V66, P360, DOI 10.1038/ejcn.2011.146; Hislop TG, 2006, J CLIN ONCOL, V24, P2311, DOI 10.1200/JCO.2005.04.3042; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Leon-Munoz LM, 2005, INT J OBESITY, V29, P1385, DOI 10.1038/sj.ijo.0803049; Leon-Munoz LM, 2014, J AM MED DIR ASS; Lopez-Garcia E, 2003, MED CLIN-BARCELONA, V120, P568, DOI 10.1157/13046436; Lopez-Garcia E, 2014, J ACAD NUTR DIET; Martinez-Gomez D, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-47; MARTINMORENO JM, 1993, INT J EPIDEMIOL, V22, P512, DOI 10.1093/ije/22.3.512; Munoz MA, 2009, BRIT J NUTR, V101, P1821, DOI 10.1017/S0007114508143598; Myint PK, 2007, PUBLIC HEALTH NUTR, V10, P34, DOI 10.1017/S1368980007222608; Plaisted CS, 1999, J AM DIET ASSOC, V99, pS84, DOI 10.1016/S0002-8223(99)00421-6; Pols MA, 1997, INT J EPIDEMIOL, V26, pS181, DOI 10.1093/ije/26.suppl_1.S181; Poulose SM, 2014, J NUTR, V144, p561S, DOI 10.3945/jn.113.184838; Rienks J, 2013, EUR J CLIN NUTR, V67, P75, DOI 10.1038/ejcn.2012.193; Rodriguez-Artalejo F, 2011, REV ESP CARDIOL, V64, P876, DOI 10.1016/j.recesp.2011.05.019; Sanchez-Villegas A, 2009, ARCH GEN PSYCHIAT, V66, P1090, DOI 10.1001/archgenpsychiatry.2009.129; Schiepers OJG, 2010, PROSTAG LEUKOTR ESS, V83, P31, DOI 10.1016/j.plefa.2010.02.030; Schmidt S, 2012, MED CLIN-BARCELONA, V139, P613, DOI 10.1016/j.medcli.2011.10.024; Schroder H, 2011, J NUTR, V141, P1140, DOI 10.3945/jn.110.135566; Silvers KM, 2002, PUBLIC HEALTH NUTR, V5, P427, DOI 10.1079/PHN2001308; Sofi F, 2014, PUBLIC HEALTH NUTR, V17, P2769, DOI 10.1017/S1368980013003169; Sorensen M, 1999, J SPORT SCI, V17, P369, DOI 10.1080/026404199365885; Trichopoulou A, 2007, EUR J EPIDEMIOL, V22, P871, DOI 10.1007/s10654-007-9190-6; Trichopoulou A, 2005, BMJ-BRIT MED J, V330, P991, DOI 10.1136/bmj.38415.644155.8F; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Vilagut G, 2008, MED CLIN-BARCELONA, V130, P726, DOI 10.1157/13121076; Wardle J, 2000, AM J MED, V108, P547, DOI 10.1016/S0002-9343(00)00330-2; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003	48	31	32	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151596	10.1371/journal.pone.0151596	http://dx.doi.org/10.1371/journal.pone.0151596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008160	Green Published, Green Submitted, gold			2022-12-26	WOS:000372701200058
J	Matsudaira, K; Oka, H; Kikuchi, N; Haga, Y; Sawada, T; Tanaka, S				Matsudaira, Ko; Oka, Hiroyuki; Kikuchi, Norimasa; Haga, Yuri; Sawada, Takayuki; Tanaka, Sakae			Psychometric Properties of the Japanese Version of the STarT Back Tool in Patients with Low Back Pain	PLOS ONE			English	Article							PRIMARY-CARE; SCREENING TOOL; IMPACT BACK; MANAGEMENT	Background and Objective The STarT Back Tool uses prognostic indicators to classify patients with low back pain into three risk groups to guide early secondary prevention in primary care. The present study aimed to evaluate the psychometric properties of the Japanese version of the tool (STarT-J). Methods An online survey was conducted among Japanese patients with low back pain aged 20-64 years. Reliability was assessed by examining the internal consistency of the overall and psychosocial subscales using Cronbach's alpha coefficients. Spearman's correlation coefficients were used to evaluate the concurrent validity between the STarT-J total score/psychosocial subscore and standard reference questionnaires. Discriminant validity was evaluated by calculating the area under the curves (AUCs) for the total and psychosocial subscale scores against standard reference cases. Known-groups validity was assessed by examining the relationship between low back pain-related disability and STarT-J scores. Results The analysis included data for 2000 Japanese patients with low back pain; the mean (standard deviation [SD]) age was 47.7 (9.3) years, and 54.1% were male. The mean (SD) STarT-J score was 2.2 (2.1). The Cronbach's alpha coefficient was 0.75 for the overall scale and 0.66 for the psychosocial subscale. Spearman's correlation coefficients ranged from 0.30 to 0.59, demonstrating moderate to strong concurrent validity. The AUCs for the total score ranged from 0.65 to 0.83, mostly demonstrating acceptable discriminative ability. For known-groups validity, participants with more somatic symptoms had higher total scores. Those in higher STarT-J risk groups had experienced more low back pain-related absences. Conclusions The overall STarT-J scale was internally consistent and had acceptable concurrent, discriminant, and known-groups validity. The STarT-J can be used with Japanese patients with low back pain.	[Matsudaira, Ko; Oka, Hiroyuki] Univ Tokyo, Fac Med, Dept Med Res & Management Musculoskeletal Pain, 22nd Century Med & Res Ctr,Bunkyo Ku, Tokyo 113, Japan; [Kikuchi, Norimasa; Haga, Yuri; Sawada, Takayuki] Clin Study Support Inc, Nagoya, Aichi, Japan; [Kikuchi, Norimasa; Sawada, Takayuki] Aichi Med Univ, Sch Med, Dept Publ Hlth, Nagakute, Aichi 48011, Japan; [Tanaka, Sakae] Univ Tokyo, Dept Orthopaed Surg, Bunkyo Ku, Tokyo, Japan	University of Tokyo; Aichi Medical University; University of Tokyo	Matsudaira, K (corresponding author), Univ Tokyo, Fac Med, Dept Med Res & Management Musculoskeletal Pain, 22nd Century Med & Res Ctr,Bunkyo Ku, Tokyo 113, Japan.	kohart801@gmail.com	Tanaka, Sakae/Y-3061-2019	Tanaka, Sakae/0000-0001-9210-9414	Clinical Study Support, Inc.	Clinical Study Support, Inc.	The authors received no specific funding for this work. Clinical Study Support, Inc. provided support in the form of salaries for authors NK, YH and TS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abedi M, MAN THER; Aebischer B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132068; [Anonymous], 2013, J MUSCULOSKELET PAIN; Axen I, 2013, BEST PRACT RES CL RH, V27, P601, DOI 10.1016/j.berh.2013.10.004; Azimi P, 2014, J ORTHOP SCI, V19, P213, DOI 10.1007/s00776-013-0506-y; Bruyere O, 2014, SPINE, V39, pE123, DOI 10.1097/BRS.0000000000000062; Buchbinder R, 2013, BEST PRACT RES CL RH, V27, P575, DOI 10.1016/j.berh.2013.10.007; Cohen J.E., 1988, STAT POWER ANAL BEHA; DEROGATIS LR, 1983, PSYCHOL MED, V13, P595, DOI 10.1017/S0033291700048017; Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508; Dionne CE, 2008, SPINE, V33, P95, DOI 10.1097/BRS.0b013e31815e7f94; Dunn KM, 2013, BEST PRACT RES CL RH, V27, P591, DOI 10.1016/j.berh.2013.09.007; Foster NE, 2014, ANN FAM MED, V12, P102, DOI 10.1370/afm.1625; Foster NE, 2013, BEST PRACT RES CL RH, V27, P649, DOI 10.1016/j.berh.2013.10.005; GUILLEMIN F, 1993, J CLIN EPIDEMIOL, V46, P1417, DOI 10.1016/0895-4356(93)90142-N; Hasenbring M, 2001, SCHMERZ, V15, P442, DOI 10.1007/s004820100030; Higashi A, 1996, Nihon Shokakibyo Gakkai Zasshi, V93, P884; Hill JC, 2008, ARTHRIT RHEUM-ARTHR, V59, P632, DOI 10.1002/art.23563; Hill JC, 2011, LANCET, V378, P1560, DOI 10.1016/S0140-6736(11)60937-9; Hill JC, 2011, PHYS THER, V91, P712, DOI 10.2522/ptj.20100280; Kikuchi N, J ORTHOP SCI; Koes BW, 2001, SPINE, V26, P2504, DOI 10.1097/00007632-200111150-00022; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Main CJ, 2012, PHYSIOTHERAPY, V98, P110, DOI 10.1016/j.physio.2011.03.003; Matsudaira K., 2013, RINSHO SEIKEIGEKA, V48, P13; Matsudaira K, 2012, SEIKEI GEKA, V63, P149; Matsudaira K, 2014, J ORTHOP SCI, V19, P26, DOI 10.1007/s00776-013-0471-5; Matsuoka H., 2007, SHINSHIN IGAKU, V47, P95, DOI DOI 10.15064/jjpm.47.2_95; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Pilz B, 2014, BRAZ J PHYS THER, V18, P453, DOI 10.1590/bjpt-rbf.2014.0028; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Pincus T, 2013, BEST PRACT RES CL RH, V27, P625, DOI 10.1016/j.berh.2013.09.010; Sowden G, 2012, FAM PRACT, V29, P50, DOI 10.1093/fampra/cmr037; Suzukamo Y, 2001, QOL EVALUATION HDB C, P8; Suzukamo Yoshimi, 2003, J Orthop Sci, V8, P543, DOI 10.1007/s00776-003-0679-x; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	38	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152019	10.1371/journal.pone.0152019	http://dx.doi.org/10.1371/journal.pone.0152019			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002823	Green Published, Green Submitted, gold			2022-12-26	WOS:000372697400065
J	Aamelfot, M; Christiansen, DH; Dale, OB; McBeath, A; Benestad, SL; Falk, K				Aamelfot, Maria; Christiansen, Debes H.; Dale, Ole Bendik; McBeath, Alastair; Benestad, Sylvie L.; Falk, Knut			Localised Infection of Atlantic Salmon Epithelial Cells by HPR0 Infectious Salmon Anaemia Virus	PLOS ONE			English	Article							TIME RT-PCR; HEMAGGLUTININ GENE; MONOCLONAL-ANTIBODY; ISAV; EXPRESSION; INTERFERON; TRANSCRIPT; RECEPTOR; ENCODES; DISEASE	Infectious salmon anaemia (ISA) is an important, systemic viral disease of farmed Atlantic salmon, Salmo salar L. Endothelial cells are the main target cells for highly virulent HPR-deleted ISA virus (ISAV) types. Here we examine the pathogenesis of non-virulent ISAV HPR0 infections, presenting evidence of an epithelial tropism for this virus type, including actual infection and replication in the epithelial cells. Whereas all HPR0 RT-qPCR positive gills prepared for cryosection tested positive by immunohistochemistry (IHC) and immunofluorescent labelling, only 21% of HPR0 RT-qPCR positive formalin-fixed paraffin-embedded gills were IHC positive, suggesting different methodological sensitivities. Only specific epithelial cell staining was observed and no staining was observed in endothelial cells of positive gills. Furthermore, using an ISAV segment 7 RT-PCR assay, we demonstrated splicing of HPR0, suggesting initial activation of the replication machinery in the epithelial gill cells. Immunological responses were investigated by the expression of interferon-related genes (e.g. Mx and gamma IP) and by ELISA for presence of anti-ISAV antibodies on samples taken sequentially over several months during an episode of transient HPR0 infection. All fish revealed a variable, but increased expression of the immunological markers in comparison to normal healthy fish. Taken together, we conclude that HPR0 causes a localized epithelial infection of Atlantic salmon.	[Aamelfot, Maria; Dale, Ole Bendik; Benestad, Sylvie L.; Falk, Knut] Norwegian Vet Inst, Oslo, Norway; [Christiansen, Debes H.] Food & Vet Author, Torshavn, Faroe Islands, Denmark; [McBeath, Alastair] Dept Agr & Fisheries Scotland, Marine Lab, Marine Scotland Sci, Aberdeen, Scotland	Norwegian Veterinary Institute; Marine Scotland Science (MSS)	Falk, K (corresponding author), Norwegian Vet Inst, Oslo, Norway.	knut.falk@vetinst.no	Dale, Ole Bendik/ABB-6276-2021; Falk, Knut/D-2952-2012	Falk, Knut/0000-0002-9830-3493	Norwegian Research Council [207024]; Norwegian Seafood Research Fund [901051]; European Community; Faroese Research Council	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Seafood Research Fund; European Community(European Commission); Faroese Research Council	This work was supported by The Norwegian Research Council (http://www.forskningsradet.no/prognett-havbruk/Forside/1226994216892) HAVBRUK project no. 207024, The Norwegian Seafood Research Fund (http://www.fhf.no) project no. 901051, The European Community's Seventh Framework Programme (FP7, 2007-2013), and The Faroese Research Council (http://www.gransking.fo). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aamelfot M, 2014, J FISH DIS, V37, P291, DOI 10.1111/jfd.12225; Aamelfot M, 2015, VET RES, V46, DOI 10.1186/s13567-015-0265-1; Aamelfot M, 2013, J ANAT, V222, P547, DOI 10.1111/joa.12033; Aamelfot M, 2012, J VIROL, V86, P10571, DOI 10.1128/JVI.00047-12; Aspehaug V, 2004, VIRUS RES, V106, P51, DOI 10.1016/j.virusres.2004.06.001; Biering E, 2002, DIS AQUAT ORGAN, V49, P117, DOI 10.3354/dao049117; Christiansen DH, 2011, J GEN VIROL, V92, P909, DOI 10.1099/vir.0.027094-0; Cook-Versloot M, 2004, B EUR ASSOC FISH PAT, V24, P203; Cunningham CO, 2002, BULL EUR ASSN FISH P, V22, P366; Dufour JH, 2002, J IMMUNOL, V168, P3195, DOI 10.4049/jimmunol.168.7.3195; Falk K, 1998, DIS AQUAT ORGAN, V34, P77, DOI 10.3354/dao034077; Fourrier M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142020; Hellebo A, 2004, J VIROL, V78, P3055, DOI 10.1128/JVI.78.6.3055-3062.2004; Hetland DL, 2010, FISH SHELLFISH IMMUN, V28, P30, DOI 10.1016/j.fsi.2009.09.011; Kibenge FSB, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-88; Laing KJ, 2004, DEV COMP IMMUNOL, V28, P443, DOI 10.1016/j.dci.2003.09.006; Lauscher A, 2011, VACCINE, V29, P6392, DOI 10.1016/j.vaccine.2011.04.074; Lyngstad TM, 2011, EPIDEMICS-NETH, V3, P1, DOI 10.1016/j.epidem.2010.11.001; Lyngstad TM, 2012, DIS AQUAT ORGAN, V101, P197, DOI 10.3354/dao02520; McBeath A, 2015, J FISH DIS, V38, P3, DOI 10.1111/jfd.12253; McBeath AJA, 2007, FISH SHELLFISH IMMUN, V22, P230, DOI 10.1016/j.fsi.2006.05.004; McBeath A, 2013, J VIROL METHODS, V187, P65, DOI 10.1016/j.jviromet.2012.09.007; McBeath AJA, 2014, VET RES, V45, DOI 10.1186/s13567-014-0083-x; McBeath AJA, 2009, DIS AQUAT ORGAN, V87, P161, DOI 10.3354/dao02128; Mjaaland S, 2002, VIROLOGY, V304, P379, DOI 10.1006/viro.2002.1658; Nylund A, 2003, DIS AQUAT ORGAN, V56, P11, DOI 10.3354/dao056011; O'Farrell C, 2002, J VIROL, V76, P8040, DOI 10.1128/JVI.76.16.8040-8049.2002; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Weli SC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-5	29	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151723	10.1371/journal.pone.0151723	http://dx.doi.org/10.1371/journal.pone.0151723			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999815	Green Published, Green Submitted, gold			2022-12-26	WOS:000372694700058
J	Badenes, SM; Fernandes, TG; Cordeiro, CSM; Boucher, S; Kuninger, D; Vemuri, MC; Diogo, MM; Cabral, JMS				Badenes, Sara M.; Fernandes, Tiago G.; Cordeiro, Claudia S. M.; Boucher, Shayne; Kuninger, David; Vemuri, Mohan C.; Diogo, Maria Margarida; Cabral, Joaquim M. S.			Defined Essential 8 (TM) Medium and Vitronectin Efficiently Support Scalable Xeno-Free Expansion of Human Induced Pluripotent Stem Cells in Stirred Microcarrier Culture Systems	PLOS ONE			English	Article							TERM SELF-RENEWAL; SUSPENSION-CULTURE; IPS CELLS; ES CELLS; DIFFERENTIATION; BIOREACTORS; PROPAGATION; DERIVATION; SURFACES; LAMININ	Human induced pluripotent stem (hiPS) cell culture using Essential 8 (TM) xeno-free medium and the defined xeno-free matrix vitronectin was successfully implemented under adherent conditions. This matrix was able to support hiPS cell expansion either in coated plates or on polystyrene-coated microcarriers, while maintaining hiPS cell functionality and pluripotency. Importantly, scale-up of the microcarrier-based system was accomplished using a 50 mL spinner flask, under dynamic conditions. A three-level factorial design experiment was performed to identify optimal conditions in terms of a) initial cell density b) agitation speed, and c) to maximize cell yield in spinner flask cultures. A maximum cell yield of 3.5 is achieved by inoculating 55,000 cells/cm(2) of microcarrier surface area and using 44 rpm, which generates a cell density of 1.4x10(6) cells/mL after 10 days of culture. After dynamic culture, hiPS cells maintained their typical morphology upon re-plating, exhibited pluripotency-associated marker expression as well as tri-lineage differentiation capability, which was verified by inducing their spontaneous differentiation through embryoid body formation, and subsequent downstream differentiation to specific lineages such as neural and cardiac fates was successfully accomplished. In conclusion, a scalable, robust and cost-effective xeno-free culture system was successfully developed and implemented for the scale-up production of hiPS cells.	[Badenes, Sara M.; Fernandes, Tiago G.; Cordeiro, Claudia S. M.] Univ Lisbon, Dept Bioengn, P-1699 Lisbon, Portugal; [Badenes, Sara M.; Fernandes, Tiago G.; Cordeiro, Claudia S. M.] Univ Lisbon, Inst Bioengn & Biosci, Inst Super Tecn, P-1699 Lisbon, Portugal; [Boucher, Shayne; Kuninger, David; Vemuri, Mohan C.; Diogo, Maria Margarida; Cabral, Joaquim M. S.] Thermo Fisher Sci, Life Sci Solut, Cell Biol, Frederick, MD USA	Universidade de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico; Thermo Fisher Scientific	Fernandes, TG (corresponding author), Univ Lisbon, Dept Bioengn, P-1699 Lisbon, Portugal.; Fernandes, TG (corresponding author), Univ Lisbon, Inst Bioengn & Biosci, Inst Super Tecn, P-1699 Lisbon, Portugal.	tfernandes@tecnico.ulisboa.pt	Cabral, Joaquim M S/G-2052-2010; Diogo, Margarida/ABF-4341-2020; Fernandes, Tiago G./C-3865-2009; Badenes, Sara/F-6897-2014	Cabral, Joaquim M S/0000-0002-2405-5845; Fernandes, Tiago G./0000-0002-4651-2832; Badenes, Sara/0000-0001-6507-536X; Diogo, Maria Margarida/0000-0002-6270-4455	Fundacao para a Ciencia e Tecnologia (FCT, Portugal) [SFRH/BPD/74449/2010, SFRH/BPD/86316/2012]; FCT [UID/BIO/04565/2013, MITP-TB/ECE/0013/2013]	Fundacao para a Ciencia e Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	Sara M. Badenes and Tiago G. Fernandes acknowledge Fundacao para a Ciencia e Tecnologia (FCT, Portugal, http://www.fct.pt) for financial support (SFRH/BPD/74449/2010, SFRH/BPD/86316/2012, respectively). Funding was received by iBB - Institute for Bioengineering and Biosciences (UID/BIO/04565/2013) from FCT. This work was also partially funded by FCT through project CARDIOSTEM-Engineered cardiac tissues and stem cell-based therapies for cardiovascular applications (MITP-TB/ECE/0013/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no current external funding sources for this study.	Badenes Sara M, 2015, Methods Mol Biol, V1283, P23, DOI 10.1007/7651_2014_106; Barbosa HSC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038963; Bardy J, 2013, TISSUE ENG PART C-ME, V19, P166, DOI [10.1089/ten.TEC.2012.0146, 10.1089/ten.tec.2012.0146]; Beers J, 2012, NAT PROTOC, V7, P2029, DOI 10.1038/nprot.2012.130; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; Carlson J, 2008, J AM ASSOC LAB ANIM, V47, P80; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen AKL, 2011, STEM CELL RES, V7, P97, DOI 10.1016/j.scr.2011.04.007; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Chen VC, 2012, STEM CELL RES, V8, P388, DOI 10.1016/j.scr.2012.02.001; Cormier JT, 2006, TISSUE ENG, V12, P3233, DOI 10.1089/ten.2006.12.3233; Fan YJ, 2015, STEM CELL REV REP, V11, P96, DOI 10.1007/s12015-014-9544-x; Fernandes AM, 2009, BRAZ J MED BIOL RES, V42, P515, DOI 10.1590/S0100-879X2009000600007; Heng BC, 2012, STEM CELLS DEV, V21, P1701, DOI 10.1089/scd.2011.0509; Hunt MM, 2014, TISSUE ENG PART C-ME, V20, P76, DOI [10.1089/ten.TEC.2013.0040, 10.1089/ten.tec.2013.0040]; Jin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050880; Jing DH, 2010, CELL TRANSPLANT, V19, P1397, DOI 10.3727/096368910X513955; Kirouac DC, 2008, CELL STEM CELL, V3, P369, DOI 10.1016/j.stem.2008.09.001; Krawetz R, 2010, TISSUE ENG PART C-ME, V16, P573, DOI [10.1089/ten.tec.2009.0228, 10.1089/ten.TEC.2009.0228]; Lam ATL, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt498; Lambshead Jack W, 2013, Cell Regen, V2, P7, DOI 10.1186/2045-9769-2-7; Lei YG, 2013, P NATL ACAD SCI USA, V110, pE5039, DOI 10.1073/pnas.1309408110; Li JA, 2010, BIOINTERPHASES, V5, pFA132, DOI 10.1116/1.3525804; Lock LT, 2009, TISSUE ENG PT A, V15, P2051, DOI 10.1089/ten.tea.2008.0455; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Marinho PA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09834; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629; Miranda CC, 2015, BIOTECHNOL J, V10, P1612, DOI 10.1002/biot.201400846; Miyazaki T, 2008, BIOCHEM BIOPH RES CO, V375, P27, DOI 10.1016/j.bbrc.2008.07.111; Nagata S., 1975, MIXING PRINCIPLES AP, P24; Nie Y, 2009, BIOTECHNOL PROGR, V25, P20, DOI 10.1002/btpr.110; Marinho PAN, 2013, TISSUE ENG PART C-ME, V19, P146, DOI [10.1089/ten.tec.2012.0141, 10.1089/ten.TEC.2012.0141]; Oh SKW, 2009, STEM CELL RES, V2, P219, DOI 10.1016/j.scr.2009.02.005; Olmer R, 2010, STEM CELL RES, V5, P51, DOI 10.1016/j.scr.2010.03.005; Phillips BW, 2008, J BIOTECHNOL, V138, P24, DOI 10.1016/j.jbiotec.2008.07.1997; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Rodrigues CAV, 2011, BIOTECHNOL ADV, V29, P815, DOI 10.1016/j.biotechadv.2011.06.009; Serra M, 2011, PLOS ONE, V6; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; STATHOPOULOS NA, 1985, BIOTECHNOL BIOENG, V27, P1021, DOI 10.1002/bit.260270713; Storm MP, 2010, BIOTECHNOL BIOENG, V107, P683, DOI 10.1002/bit.22850; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wang Y, 2013, STEM CELL RES, V11, P1103, DOI 10.1016/j.scr.2013.07.011; Want AJ, 2012, REGEN MED, V7, P71, DOI [10.2217/RME.11.101, 10.2217/rme.11.101]; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yamasaki S, 2014, PLOS ONE, V9	48	43	44	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151264	10.1371/journal.pone.0151264	http://dx.doi.org/10.1371/journal.pone.0151264			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999816	Green Published, gold, Green Submitted			2022-12-26	WOS:000372694700028
J	Dawood, F; Loo, CK				Dawood, Farhan; Loo, Chu Kiong			View-Invariant Visuomotor Processing in Computational Mirror Neuron System for Humanoid	PLOS ONE			English	Article							SELF; IMITATION; MOTOR; ORGANIZATION; REPRESENTATIONS; RECOGNITION; PERCEPTION	Mirror neurons are visuo-motor neurons found in primates and thought to be significant for imitation learning. The proposition that mirror neurons result from associative learning while the neonate observes his own actions has received noteworthy empirical support. Selfexploration is regarded as a procedure by which infants become perceptually observant to their own body and engage in a perceptual communication with themselves. We assume that crude sense of self is the prerequisite for social interaction. However, the contribution of mirror neurons in encoding the perspective from which the motor acts of others are seen have not been addressed in relation to humanoid robots. In this paper we present a computational model for development of mirror neuron system for humanoid based on the hypothesis that infants acquire MNS by sensorimotor associative learning through self-exploration capable of sustaining early imitation skills. The purpose of our proposed model is to take into account the view-dependency of neurons as a probable outcome of the associative connectivity between motor and visual information. In our experiment, a humanoid robot stands in front of a mirror (represented through self-image using camera) in order to obtain the associative relationship between his own motor generated actions and his own visual body-image. In the learning process the network first forms mapping from each motor representation onto visual representation from the self-exploratory perspective. Afterwards, the representation of the motor commands is learned to be associated with all possible visual perspectives. The complete architecture was evaluated by simulation experiments performed on DARwIn-OP humanoid robot.	[Dawood, Farhan; Loo, Chu Kiong] Univ Malaya, Dept Artificial Intelligence, Kuala Lumpur, Malaysia	Universiti Malaya	Loo, CK (corresponding author), Univ Malaya, Dept Artificial Intelligence, Kuala Lumpur, Malaysia.	ckloo.um@um.edu.my	Loo, Chu Kiong/AAI-5093-2021; Dawood, Farhan/G-9105-2011; Loo, Chu Kiong/F-4360-2011	Loo, Chu Kiong/0000-0001-7867-2665; Dawood, Farhan/0000-0002-6968-1671; Loo, Chu Kiong/0000-0001-7867-2665	High Impact Research MoE from the Ministry of Education Malaysia [UM.C/625/1/HIR/MOHE/FCSIT/10]	High Impact Research MoE from the Ministry of Education Malaysia	This research is supported by High Impact Research MoE Grant UM.C/625/1/HIR/MOHE/FCSIT/10 from the Ministry of Education Malaysia.	AMSTERDAM B, 1972, DEV PSYCHOBIOL, V5, P297, DOI 10.1002/dev.420050403; [Anonymous], [No title captured]; Arbib M. A., 2006, P 6 INT C EV LANG, P3; Arbib Michael A., 2008, MIND SOC, V7, P43, DOI DOI 10.1007/S11299-007-0041-7; ASCHERSLEBEN G, 2006, PSYCHOL SCI, V48, P405, DOI DOI 10.1111/J.1467-7687.2008.00736.X; BAHRICK LE, 1985, DEV PSYCHOL, V21, P963, DOI 10.1037/0012-1649.21.6.963; Barakova EI, 2007, LECT NOTES COMPUT SC, V4528, P389; Bekoff M, 2004, TRENDS ECOL EVOL, V19, P176, DOI 10.1016/j.tree.2003.12.010; Billard A., 2008, SPRINGER HDB ROBOTIC, P1371, DOI DOI 10.1007/978-3-540-30301-5_60; Bonaiuto J, 2010, BIOL CYBERN, V102, P341, DOI 10.1007/s00422-010-0371-0; Brand M, 2002, LECT NOTES COMPUT SC, V2350, P707; Caggiano V, 2009, SCIENCE, V324, P403, DOI 10.1126/science.1166818; Carlin JD, 2011, CURR BIOL, V21, P1817, DOI 10.1016/j.cub.2011.09.025; Carpenter G. A., 2010, ADAPTIVE RESONANCE T; Chaminade T, 2008, BRAIN RES BULL, V75, P775, DOI 10.1016/j.brainresbull.2008.01.016; Chersi F, 2012, IEEE T AUTON MENT DE, V4, P204, DOI 10.1109/TAMD.2012.2200250; Chin TJ, 2007, IEEE T IMAGE PROCESS, V16, P1662, DOI 10.1109/TIP.2007.896668; Cook R, 2014, BEHAV BRAIN SCI, V37, P177, DOI 10.1017/S0140525X13000903; Corballis MC, 2010, BRAIN LANG, V112, P25, DOI 10.1016/j.bandl.2009.02.002; Craigherol L, 2007, PROG BRAIN RES, V164, P39, DOI 10.1016/S0079-6123(07)64003-5; Cuijpers RH, 2006, NEURAL NETWORKS, V19, P311, DOI 10.1016/j.neunet.2006.02.004; Dawood F, 2014, ROB INT INF STRUCT S, P1; Dawood F., 2013, NEUR NETW IJCNN 2013, P1; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Franzius M, 2007, PLOS COMPUT BIOL, V3, P1605, DOI 10.1371/journal.pcbi.0030166; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; GALLUP GG, 1970, SCIENCE, V167, P86, DOI 10.1126/science.167.3914.86; Gold K, 2009, ROBOT AUTON SYST, V57, P384, DOI 10.1016/j.robot.2008.07.006; Goodale M.A., 1990, VISION ACTION CONTRO, P163; Heyes C, 2001, TRENDS COGN SCI, V5, P253, DOI 10.1016/S1364-6613(00)01661-2; Heyes C.M., 2007, SENSORIMOTOR FDN HIG; Jellema T, 2006, NEUROPSYCHOLOGIA, V44, P1535, DOI 10.1016/j.neuropsychologia.2006.01.020; Keysers C, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0175; Kulic Dana, 2009, 2009 IEEE International Conference on Robotics and Automation (ICRA), P3166, DOI 10.1109/ROBOT.2009.5152266; Kuniyoshi Y, 2003, IEEE INT CONF ROBOT, P3132; Levy A, 2000, IEEE T IMAGE PROCESS, V9, P1371, DOI 10.1109/83.855432; LEWIS M, 1989, CHILD DEV, V60, P146, DOI 10.1111/j.1467-8624.1989.tb02704.x; Liwicki S., 2012, P AS C COMP VIS, P162; Liwicki S, 2012, IEEE T NEUR NET LEAR, V23, P1624, DOI 10.1109/TNNLS.2012.2208654; LOGOTHETIS NK, 1995, CEREB CORTEX, V5, P270, DOI 10.1093/cercor/5.3.270; Marshall PJ, 2015, TRENDS COGN SCI, V19, P499, DOI 10.1016/j.tics.2015.06.012; Meier F, 2012, P 15 INT C ART INT S; MELTZOFF AN, 1977, SCIENCE, V198, P75, DOI 10.1126/science.198.4312.75; Meltzoff AN, 1997, EARLY DEV PARENTING, V6, P179, DOI 10.1002/(SICI)1099-0917(199709/12)6:3/4<179::AID-EDP157>3.0.CO;2-R; Meltzoff AN, 2007, ACTA PSYCHOL, V124, P26, DOI 10.1016/j.actpsy.2006.09.005; Nagai Y., 2011, P 2011 IEEE INT C DE, V2, P1, DOI [DOI 10.1109/DEVLRN.2011.6037335, 10.1109/DEVLRN.2011.6037335]; Nelissen K, 2011, J NEUROSCI, V31, P3743, DOI 10.1523/JNEUROSCI.4803-10.2011; Nicolescu M. N., 2003, PROC 2 INT JOINT C A, P241, DOI DOI 10.1145/860575.860614; Oztop E, 2002, BIOL CYBERN, V87, P116, DOI 10.1007/s00422-002-0318-1; Oztop E, 2006, NEURAL NETWORKS, V19, P254, DOI 10.1016/j.neunet.2006.02.002; PERRETT DI, 1991, EXP BRAIN RES, V86, P159; Pfeifer R., 2006, BODY SHAPES WAY WE T; Piaget J., 2013, PLAY DREAMS IMITATIO, V25; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rizzolatti, 2005, MONKEY BRAIN HUMAN B, P213; Rizzolatti G, 2001, NEURON, V31, P889, DOI 10.1016/S0896-6273(01)00423-8; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Rochat P, 1998, BRIT J DEV PSYCHOL, V16, P139, DOI 10.1111/j.2044-835X.1998.tb00914.x; Ross DA, 2008, INT J COMPUT VISION, V77, P125, DOI 10.1007/s11263-007-0075-7; Rozzi S, 2008, EUR J NEUROSCI, V28, P1569, DOI 10.1111/j.1460-9568.2008.06395.x; Saegusa R, 2014, IEEE T NEUR NET LEAR, V25, P183, DOI 10.1109/TNNLS.2013.2271793; Schaal S, 1999, TRENDS COGN SCI, V3, P233, DOI 10.1016/S1364-6613(99)01327-3; Shawe-Taylor J., 2004, KERNEL METHODS PATTE; Slater A, 1998, EXP BRAIN RES, V123, P90, DOI 10.1007/s002210050548; Tani J, 2004, NEURAL NETWORKS, V17, P1273, DOI 10.1016/j.neunet.2004.05.007; Tessitore G, 2010, BIOL CYBERN, V103, P471, DOI 10.1007/s00422-010-0415-5; Thill S, 2011, COGN COMPUT, V3, P525, DOI 10.1007/s12559-011-9108-1; Umilta MA, 2001, NEURON, V31, P155, DOI 10.1016/S0896-6273(01)00337-3; von Hofsten C, 2004, TRENDS COGN SCI, V8, P266, DOI 10.1016/j.tics.2004.04.002; Webots, COMM MOB ROB SIM SOF; Wiskott L, 2002, NEURAL COMPUT, V14, P715, DOI 10.1162/089976602317318938	75	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0152003	10.1371/journal.pone.0152003	http://dx.doi.org/10.1371/journal.pone.0152003			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998923	Green Published, Green Submitted, gold			2022-12-26	WOS:000372694700092
J	Lee, M; Ahn, J				Lee, Marvin; Ahn, Jaehong			Effects of Central Corneal Stromal Thickness and Epithelial Thickness on Intraocular Pressure Using Goldmann Applanation and Non-Contact Tonometers	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; OCULAR HYPERTENSION; GLAUCOMA; AGE; REDUCTION; TRIAL	Purpose To investigate whether corneal thickness parameters measured by optical coherence tomography (OCT), such as central corneal thickness (CCT), central corneal stromal thickness (CCST), and central corneal epithelial thickness (CCET), influence the intraocular pressure (IOP) difference measured by Goldmann applanation tonometry (GAT) and non-contact tonometry (NCT). Methods In total, 50 eyes from 50 subjects without glaucomatous defects were included in this retrospective, cross-sectional study. We measured IOP using GAT and NCT and calculated the difference between the two methods. CCT was measured by a Cirrus HD-OCT device using anterior segment imaging. The basement membrane of the epithelium, which was seen as a high-reflection line in the OCT image, was taken as a reference line to measure CCST and CCET. Results The mean IOP measured by GAT and NCT was 16.7 +/- 3.0 and 18.1 +/- 3.8 mmHg, respectively. The mean IOP difference was 1.5 +/- 1.7 mmHg, and the IOP measured by NCT was 8.4% +/- 11.3% higher than that measured by GAT. The CCET and CCST were 57.9 +/- 5.6 and 501.7 +/- 33.8 mu m, respectively. CCT showed a positive correlation with both GAT IOP (r = 0.648, P < 0.001) and NCT IOP (r = 0.676, P < 0.001). Although CCST showed a significant correlation with GAT IOP and NCT IOP, CCET did not. The difference between GAT IOP and NCT IOP increased with CCT (r = 0.333, P = 0.018), and CCET was positively correlated with the IOP difference between GAT and NCT (r = 0.435, P = 0.002). Conclusions IOP increased with greater CCT, and CCST seemed to have a more important role than CCET. CCET also increased with greater CCT, and this may be a possible explanation for the increasing difference in IOP between GAT and NCT with increasing CCT.	[Lee, Marvin] DMC Bundang Jesaeng Gen Hosp, Dept Ophthalmol, Songnam, South Korea; [Ahn, Jaehong] Ajou Univ, Sch Med, Dept Ophthalmol, Suwon 441749, South Korea	Ajou University	Lee, M (corresponding author), DMC Bundang Jesaeng Gen Hosp, Dept Ophthalmol, Songnam, South Korea.	mvejhw@dmc.or.kr						Alward WL, 1998, AM J OPHTHALMOL, V126, P498; Argus WA, 1995, OPHTHALMOLOGY, V102, P1810, DOI 10.1016/S0161-6420(95)30790-7; Broman AT, 2007, J GLAUCOMA, V16, P581, DOI 10.1097/IJG.0b013e3180640f40; Calabuig-Goena M, 2015, CURRENT EYE RES, P1; Desai SP, 2002, EYE, V16, P675, DOI 10.1038/sj.eye.6700129; EHLERS N, 1975, ACTA OPHTHALMOL, V53, P34; FORBES M, 1974, ARCH OPHTHALMOL-CHIC, V91, P134, DOI 10.1001/archopht.1974.03900060140012; GOLDMANN H, 1957, Ophthalmologica, V134, P221; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Huang JH, 2013, OPHTHALMOLOGY, V120, P1951, DOI 10.1016/j.ophtha.2013.02.022; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Kuerten D, 2015, GRAEF ARCH CLIN EXP, V253, P1105, DOI 10.1007/s00417-015-2998-y; Li Y, 2012, OPHTHALMOLOGY, V119, P2425, DOI 10.1016/j.ophtha.2012.06.023; Liu J, 2005, J CATARACT REFR SURG, V31, P146, DOI 10.1016/j.jcrs.2004.09.031; MOSELEY MJ, 1989, EYE, V3, P332, DOI 10.1038/eye.1989.48; Moseley MJ, 1993, EYE LOND 1, V7, P127; Nam SM, 2010, OPHTHALMOLOGY, V117, P2096, DOI 10.1016/j.ophtha.2010.03.002; Nomura H, 2002, CURR EYE RES, V24, P81, DOI 10.1076/ceyr.24.2.81.8161; Randleman JB, 2003, OPHTHALMOLOGY, V110, P267, DOI 10.1016/S0161-6420(02)01727-X; Regine F, 2006, OPHTHAL PHYSL OPT, V26, P33, DOI 10.1111/j.1475-1313.2005.00341.x; Stelzer R, 1973, Albrecht Von Graefes Arch Klin Exp Ophthalmol, V189, P33, DOI 10.1007/BF00411123; Tonnu PA, 2005, BRIT J OPHTHALMOL, V89, P851, DOI 10.1136/bjo.2004.056622; WHITACRE MM, 1993, SURV OPHTHALMOL, V38, P1, DOI 10.1016/0039-6257(93)90053-A; Wollensak G, 2003, J CATARACT REFR SURG, V29, P1780, DOI 10.1016/S0886-3350(03)00407-3; Yang YJ, 2014, INVEST OPHTH VIS SCI, V55, P5032, DOI 10.1167/iovs.13-13831; Zhang Yang, 2009, Zhonghua Yan Ke Za Zhi, V45, P713	26	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151868	10.1371/journal.pone.0151868	http://dx.doi.org/10.1371/journal.pone.0151868			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998838	Green Published, Green Submitted, gold			2022-12-26	WOS:000372694700076
J	Tang, HJ; Hsieh, CF; Chang, PC; Chen, JJ; Lin, YH; Lai, CC; Chao, CM; Chuang, YC				Tang, Hung-Jen; Hsieh, Cheng-Fang; Chang, Ping-Chin; Chen, Jyh-Jou; Lin, Yu-Hsiu; Lai, Chih-Cheng; Chao, Chien-Ming; Chuang, Yin-Ching			Clinical Significance of Community- and Healthcare-Acquired Carbapenem-Resistant Enterobacteriaceae Isolates	PLOS ONE			English	Article							NONSUSCEPTIBLE KLEBSIELLA-PNEUMONIAE; ESCHERICHIA-COLI; UNITED-STATES; RISK-FACTORS; EPIDEMIOLOGY; TAIWAN; INFECTIONS; MULTICENTER; BACTEREMIA; PREVENTION	This study was conducted to investigate the clinical significance, manifestations, microbiological characteristics and outcomes of carbapenem-resistant Enterobacteriaceae (wCRE) isolates, and compare the clinical features of community-and healthcare-acquired CRE isolates. A total of 78 patients were identified to have CRE. Klebsiella pneumoniae was the most common pathogens (n = 42, 53.8%), followed by Enterobacter cloacae (n = 24, 30.8%), and Escherichia coli (n = 11, 14.1%). Most of the patients acquired CRE from healthcare settings (n = 55, 70.5%), and other cases got CRE from community settings (n = 23, 29.5%). Nine cases (11.5%) were classified as CRE colonization. Among the remaining 69 cases of CRE infections, pneumonia (n = 28, 40.6%) was the most common type of infections, followed by urinary tract infection (n = 24, 34.8%), and intra-abdominal infection (n = 16, 23.2%). The patients acquired CRE from community settings were more likely to be elderly, female, and had more urinary tract infections than from healthcare settings. In contrast, the patients acquired CRE from healthcare settings had more intra-abdominal infections, intra-abdominal surgery, and presence of indwelling device than from community settings. In conclusion, community-acquired CRE are not rare, and their associated clinical presentations are different from healthcare-acquired CRE.	[Tang, Hung-Jen] Chi Mei Med Ctr, Dept Med, Tainan, Taiwan; [Tang, Hung-Jen] Chia Nan Univ Pharm & Sci, Dept Hlth & Nutr, Tainan, Taiwan; [Hsieh, Cheng-Fang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Geriatr & Gerontol, Kaohsiung, Taiwan; [Hsieh, Cheng-Fang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan; [Chang, Ping-Chin; Chen, Jyh-Jou; Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Lin, Yu-Hsiu] Chi Mei Med Ctr, Comm Infect Control, Tainan, Taiwan; [Lai, Chih-Cheng; Chao, Chien-Ming] Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan; [Chao, Chien-Ming] Min Hwei Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan; [Chuang, Yin-Ching] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan	Chi Mei Hospital; Chia Nan University of Pharmacy & Science; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Chi Mei Hospital; Chi Mei Hospital; Chi Mei Hospital; Chi Mei Hospital	Chao, CM (corresponding author), Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan.; Chao, CM (corresponding author), Min Hwei Coll Hlth Care Management, Dept Nursing, Tainan, Taiwan.	ccm870958@yahoo.com.tw	Hsieh, Cheng-Fang/AAD-6950-2019	Hsieh, Cheng-Fang/0000-0002-9101-0233				Bhargava A, 2014, INFECT CONT HOSP EP, V35, P398, DOI 10.1086/675614; Chang YY, 2015, J MICROBIOL IMMUNOL, V48, P219, DOI 10.1016/j.jmii.2014.05.010; CLSI, 2012, M100S22 CLSI; CLSI, 2018, METHODS DILUTION ANT; Freeman R, 2015, J ANTIMICROB CHEMOTH, V70, P1212, DOI 10.1093/jac/dku500; Guh AY, 2014, EXPERT REV ANTI-INFE, V12, P565, DOI 10.1586/14787210.2014.902306; Gupta N, 2011, CLIN INFECT DIS, V53, P60, DOI 10.1093/cid/cir202; Kritsotakis EI, 2011, J ANTIMICROB CHEMOTH, V66, P1383, DOI 10.1093/jac/dkr116; Lai CC, 2013, J FORMOS MED ASSOC, V112, P492, DOI 10.1016/j.jfma.2012.09.021; Lazarovitch T, 2015, INFECT CONT HOSP EP, V36, P1283, DOI 10.1017/ice.2015.186; Lee CH, 2010, ANTIMICROB AGENTS CH, V54, P5395, DOI 10.1128/AAC.00083-10; Lee GC, 2013, ANN PHARMACOTHER, V47, P1115, DOI 10.1177/1060028013503120; Ling ML, 2015, ANTIMICROB RESIST IN, V4, DOI 10.1186/s13756-015-0066-3; Liu SW, 2012, J MICROBIOL IMMUNOL, V45, P113, DOI 10.1016/j.jmii.2011.09.026; Liu YF, 2008, J ANTIMICROB CHEMOTH, V61, P1020, DOI 10.1093/jac/dkn049; Ma L, 2013, J MED MICROBIOL, V62, P101, DOI 10.1099/jmm.0.050492-0; Patel N, 2011, J ANTIMICROB CHEMOTH, V66, P1600, DOI 10.1093/jac/dkr156; Schechner V, 2011, INFECT CONT HOSP EP, V32, P497, DOI 10.1086/659762; Sheng WH, 2013, ANTIMICROB AGENTS CH, V57, P2981, DOI 10.1128/AAC.00971-12; Tan CK, 2010, J INFECTION, V61, P34, DOI 10.1016/j.jinf.2010.04.007; Temkin E, 2014, ANN NY ACAD SCI, V1323, P22, DOI 10.1111/nyas.12537; Thaden JT, 2014, INFECT CONT HOSP EP, V35, P978, DOI 10.1086/677157; Wang JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121668; Xu YL, 2015, J THORAC DIS, V7, P376, DOI 10.3978/j.issn.2072-1439.2014.12.33; Yamamoto M, 2014, CRIT CARE, V18, DOI 10.1186/cc13949; Yang FC, 2012, J CLIN MICROBIOL, V50, P223, DOI 10.1128/JCM.01263-11	26	32	34	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151897	10.1371/journal.pone.0151897	http://dx.doi.org/10.1371/journal.pone.0151897			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999356	gold, Green Published, Green Submitted			2022-12-26	WOS:000372694700081
J	Trachsel, S; Sun, DP; SanVicente, FM; Zheng, HJ; Atlin, GN; Suarez, EA; Babu, R; Zhang, XC				Trachsel, Samuel; Sun, Dapeng; SanVicente, Felix M.; Zheng, Hongjian; Atlin, Gary N.; Suarez, Edgar Antonio; Babu, Raman; Zhang, Xuecai			Identification of QTL for Early Vigor and Stay-Green Conferring Tolerance to Drought in Two Connected Advanced Backcross Populations in Tropical Maize (Zea mays L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ANTHESIS-SILKING INTERVAL; GRAIN-YIELD; SECONDARY TRAITS; 8 CYCLES; STRESS; SELECTION; NITROGEN; IMPROVEMENT; ENVIRONMENTS	We aimed to identify quantitative trait loci (QTL) for secondary traits related to grain yield (GY) in two BC1F2:3 backcross populations (LPSpop and DTPpop) under well-watered (4 environments; WW) and drought stressed (6; DS) conditions to facilitate breeding efforts towards drought tolerant maize. GY reached 5.6 and 5.8 t/ha underWWin the LPSpop and the DTPpop, respectively. Under DS, grain yield was reduced by 65% (LPSpop) to 59% (DTPpop) relative to WW. GY was strongly associated with the normalized vegetative index (NDVI; r ranging from 0.61 to 0.96) across environmental conditions and with an early flowering under drought stressed conditions (r ranging from -0.18 to -0.25) indicative of the importance of early vigor and drought escape for GY. Out of the 105 detected QTL, 53 were overdominant indicative of strong heterosis. For 14 out of 18 detected vigor QTL, as well as for eight flowering time QTL the trait increasing allele was derived from CML491. Collocations of early vigor QTL with QTL for stay green (bin 2.02, WW, LPSpop; 2.07, DS, DTPpop), the number of ears per plant (bins 2.02, 2.05, WW, LPSpop; 5.02, DS, LPSpop) and GY (bin 2.07, WW, DTPpop; 5.04, WW, LPSpop), reinforce the importance of the observed correlations. LOD scores for early vigor QTL in these bins ranged from 2.2 to 11.25 explaining 4.6 (additivity: +0.28) to 19.9% (additivity: +0.49) of the observed phenotypic variance. A strong flowering QTL was detected in bin 2.06 across populations and environmental conditions explaining 26-31.3% of the observed phenotypic variation (LOD: 13-17; additivity: 0.1-0.6d). Improving drought tolerance while at the same time maintaining yield potential could be achieved by combining alleles conferring early vigor from the recurrent parent with alleles advancing flowering from the donor. Additionally bin 8.06 (DTPpop) harbored a QTL for GY under WW(additivity: 0.27 t/ha) and DS (additivity: 0.58 t/ha). R-2 ranged from 0 (DTPpop, WW) to 26.54% (LPSpop, DS) for NDVI, 18.6 (LPSpop, WW) to 42.45% (LPSpop, DS) for anthesis and from 0 (DTPpop, DS) to 24.83% (LPSpop, WW) for GY. Lines out-yielding the best check by 32.5% (DTPpop, WW) to 60% (DTPpop, DS) for all population-by-irrigation treatment combination (except LPSpop, WW) identified are immediately available for the use by breeders.	[Trachsel, Samuel; SanVicente, Felix M.; Atlin, Gary N.; Suarez, Edgar Antonio; Zhang, Xuecai] CIMMYT, Int Maize & Wheat Improvement Ctr, Int Apdo Postal 6-641, Mexico City 06600, DF, Mexico; [Babu, Raman] CIMMYT, ICRISAT Campus, Hyderabad 502324, Andhra Pradesh, India; [Sun, Dapeng; Zheng, Hongjian] SAAS, Shanghai 201106, Peoples R China	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT)	Trachsel, S (corresponding author), CIMMYT, Int Maize & Wheat Improvement Ctr, Int Apdo Postal 6-641, Mexico City 06600, DF, Mexico.	s.trachsel@cgiar.org		ZHANG, XUECAI/0000-0001-5498-6387	CGIAR research program on climate change, agriculture and food security (CCAFS)	CGIAR research program on climate change, agriculture and food security (CCAFS)	This study was funded by the CGIAR research program on climate change, agriculture and food security (CCAFS).	Almeida GD, 2014, MOL BREEDING, V34, P701, DOI 10.1007/s11032-014-0068-5; Almeida GD, 2013, THEOR APPL GENET, V126, P583, DOI 10.1007/s00122-012-2003-7; Araus JL, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00305; Araus JL, 2008, CRIT REV PLANT SCI, V27, P377, DOI 10.1080/07352680802467736; Babu R, 2005, THEOR APPL GENET, V111, P888, DOI 10.1007/s00122-005-0011-6; Banziger M, 2002, FIELD CROP RES, V75, P223, DOI 10.1016/S0378-4290(02)00028-X; Banziger M., 2000, BREEDING DROUGHT NIT; Betran FJ, 2003, FIELD CROP RES, V83, P51, DOI 10.1016/S0378-4290(03)00061-3; Bolanos J, 1996, FIELD CROP RES, V48, P65, DOI 10.1016/0378-4290(96)00036-6; BOLANOS J, 1993, FIELD CROP RES, V31, P253, DOI 10.1016/0378-4290(93)90065-U; BOLANOS J, 1993, FIELD CROP RES, V31, P269, DOI 10.1016/0378-4290(93)90066-V; Borras L, 2003, ANN BOT-LONDON, V91, P857, DOI 10.1093/aob/mcg090; Borrell A, 2001, ANN APPL BIOL, V138, P91, DOI 10.1111/j.1744-7348.2001.tb00088.x; Borrell AK, 2000, CROP SCI, V40, P1295, DOI 10.2135/cropsci2000.4051295x; Cai HG, 2012, PLANT BREEDING, V131, P502, DOI 10.1111/j.1439-0523.2012.01963.x; Cairns J, 2012, J INTEGR PLANT BIOL, V54, P14; Cairns JE, 2013, CROP SCI, V53, P1335, DOI 10.2135/cropsci2012.09.0545; Campos H, 2004, FIELD CROP RES, V90, P19, DOI 10.1016/j.fcr.2004.07.003; *CIMMYT APPL MOL G, 2003, LAB PROT, P7; Collins NC, 2008, PLANT PHYSIOL, V147, P469, DOI 10.1104/pp.108.118117; Cooper M, 1994, PLANT ADAPTATION CRO, P193; Dill CL, 1997, GENETICS, V147, P1367; Edmeades G.O., 1997, RECENT ADV BREEDING; Edmeades GO, 1999, CROP SCI, V39, P1306, DOI 10.2135/cropsci1999.3951306x; Edmeades GO, 2000, CSSA SPEC PUBL, P43; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fischer RAT, 2010, CROP SCI, V50, pS85, DOI 10.2135/cropsci2009.10.0564; Frascaroli E, 2007, GENETICS, V176, P625, DOI 10.1534/genetics.106.064493; Frascaroli E, 2009, THEOR APPL GENET, V118, P993, DOI 10.1007/s00122-008-0956-3; Gasura E, 2013, CROP SCI, V53, P2295, DOI 10.2135/cropsci2013.01.0032; Gilmour SJ, 2004, PLANT MOL BIOL, V54, P767, DOI 10.1023/B:PLAN.0000040902.06881.d4; Glaubitz JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090346; Grieder C, 2014, PLANT SOIL, V377, P295, DOI 10.1007/s11104-013-1997-1; Hammer GL, 2009, CROP SCI, V49, P299, DOI 10.2135/cropsci2008.03.0152; Hao Z, 2010, J INTEGR PLANT BIOL, V53, P641; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Lobell DB, 2011, NAT CLIM CHANGE, V1, P42, DOI [10.1038/nclimate1043, 10.1038/NCLIMATE1043]; Messmer R, 2011, FIELD CROP RES, V124, P93, DOI 10.1016/j.fcr.2011.06.010; Messmer R, 2009, THEOR APPL GENET, V119, P913, DOI 10.1007/s00122-009-1099-x; MILES CD, 1974, PLANT PHYSIOL, V53, P589, DOI 10.1104/pp.53.4.589; Monneveux P, 2006, CROP SCI, V46, P180, DOI 10.2135/cropsci2005.04-0034; MUCHOW RC, 1990, FIELD CROP RES, V23, P145, DOI 10.1016/0378-4290(90)90109-O; Poland JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032253; Ribaut JM, 2010, CURR OPIN PLANT BIOL, V13, P213, DOI 10.1016/j.pbi.2009.12.011; Ribaut JM, 2007, J EXP BOT, V58, P351, DOI 10.1093/jxb/erl214; Ruta N, 2010, THEOR APPL GENET, V120, P621, DOI 10.1007/s00122-009-1180-5; STUBER CW, 1987, CROP SCI, V27, P639, DOI 10.2135/cropsci1987.0011183X002700040006x; Tanksley SD, 1996, THEOR APPL GENET, V92, P191, DOI 10.1007/BF00223376; Trachsel S, 2010, MOL BREEDING, V25, P91, DOI 10.1007/s11032-009-9310-y; Trachsel S, 2016, CROP SCI IN PRESS; Trachsel S, 2009, THEOR APPL GENET, V119, P1413, DOI 10.1007/s00122-009-1144-9; Tuberosa R, 2003, PLANT SOIL, V255, P35, DOI 10.1023/A:1026146615248; Tuberosa R, 2002, PLANT MOL BIOL, V48, P697, DOI 10.1023/A:1014897607670; Tuberosa R, 2002, ANN BOT-LONDON, V89, P941, DOI 10.1093/aob/mcf134; Uribelarrea M, 2002, CROP SCI, V42, P1910, DOI 10.2135/cropsci2002.1910; Varshney RK, 2011, TRENDS PLANT SCI, V16, P363, DOI 10.1016/j.tplants.2011.03.004; Wang LJ, 2013, J GENET GENOMICS, V40, P307, DOI 10.1016/j.jgg.2013.04.004; Weber VS, 2012, CROP SCI, V52, P1011, DOI 10.2135/cropsci2011.09.0486; Zhang X, 2015, HEREDITY, V114, P291, DOI 10.1038/hdy.2014.99	59	31	32	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0149636	10.1371/journal.pone.0149636	http://dx.doi.org/10.1371/journal.pone.0149636			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999525	gold, Green Published, Green Submitted			2022-12-26	WOS:000372694700009
J	Wang, M; Cribb, B; Clarke, AR; Hanan, J				Wang, Ming; Cribb, Bronwen; Clarke, Anthony R.; Hanan, Jim			A Generic Individual-Based Spatially Explicit Model as a Novel Tool for Investigating Insect-Plant Interactions: A Case Study of the Behavioural Ecology of Frugivorous Tephritidae	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA HUBNER; TRYONI FROGGATT DIPTERA; FRUIT-FLIES; PEST-MANAGEMENT; MOVEMENT; FLY; PATTERN; ARCHITECTURE; DYNAMICS; POPULATIONS	Computational modelling of mechanisms underlying processes in the real world can be of great value in understanding complex biological behaviours. Uptake in general biology and ecology has been rapid. However, it often requires specific data sets that are overly costly in time and resources to collect. The aim of the current study was to test whether a generic behavioural ecology model constructed using published data could give realistic outputs for individual species. An individual-based model was developed using the Pattern-Oriented Modelling (POM) strategy and protocol, based on behavioural rules associated with insect movement choices. Frugivorous Tephritidae (fruit flies) were chosen because of economic significance in global agriculture and the multiple published data sets available for a range of species. The Queensland fruit fly (Qfly), Bactrocera tryoni, was identified as a suitable individual species for testing. Plant canopies with modified architecture were used to run predictive simulations. A field study was then conducted to validate our model predictions on how plant architecture affects fruit flies' behaviours. Characteristics of plant architecture such as different shapes, e.g., closed-canopy and vase-shaped, affected fly movement patterns and time spent on host fruit. The number of visits to host fruit also differed between the edge and centre in closed-canopy plants. Compared to plant architecture, host fruit has less contribution to effects on flies' movement patterns. The results from this Dmodel, combined with our field study and published empirical data suggest that placing fly traps in the upper canopy at the edge should work best. Such a modelling approach allows rapid testing of ideas about organismal interactions with environmental substrates in silico rather than in vivo, to generate new perspectives. Using published data provides a saving in time and resources. Adjustments for specific questions can be achieved by refinement of parameters based on targeted experiments.	[Wang, Ming; Hanan, Jim] Univ Queensland, QAAFI, Brisbane, Qld, Australia; [Cribb, Bronwen] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld, Australia; [Cribb, Bronwen] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Clarke, Anthony R.] Queensland Univ Technol, Sch Earth Environm & Biol Sci, Brisbane, Qld 4001, Australia; [Clarke, Anthony R.] Plant Biosecur Cooperat Res Ctr, Bruce, ACT, Australia	University of Queensland; University of Queensland; University of Queensland; Queensland University of Technology (QUT)	Hanan, J (corresponding author), Univ Queensland, QAAFI, Brisbane, Qld, Australia.	j.hanan@uq.edu.au	Clarke, Anthony R/B-5143-2011; Hanan, Jim/A-3692-2010	Clarke, Anthony R/0000-0002-8165-3032; Hanan, Jim/0000-0002-0358-8693; Wang, Ming/0000-0003-1457-5713	Plant Biosecurity Cooperative Research Centre [CRC3066]	Plant Biosecurity Cooperative Research Centre	BC and ARC received funding support from the Plant Biosecurity Cooperative Research Centre (http://www.pbcrc.com.au/), through project CRC3066 "Creating a novel lure and kill device for Queensland fruit fly". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aben J, 2014, J APPL ECOL, V51, P693, DOI 10.1111/1365-2664.12224; ALLAN P, 1993, AUST J EXP AGR, V33, P781, DOI 10.1071/EA9930781; ALUJA M, 1993, J CHEM ECOL, V19, P2671, DOI 10.1007/BF00980700; ALUJA M, 1989, ENVIRON ENTOMOL, V18, P1, DOI 10.1093/ee/18.1.1; Augusiak J, 2014, ECOL MODEL, V280, P117, DOI 10.1016/j.ecolmodel.2013.11.009; Balagawi S, 2014, J APPL ENTOMOL, V138, P510, DOI 10.1111/jen.12100; Balagawi S, 2012, AUST J ENTOMOL, V51, P279, DOI 10.1111/j.1440-6055.2012.00863.x; Benelli G, 2014, J PEST SCI, V87, P385, DOI 10.1007/s10340-014-0577-3; Campbell JE, 1996, AUST J EXP AGR, V36, P489, DOI 10.1071/EA9960489; Carter N, 2015, ECOL MODEL, V312, P347, DOI 10.1016/j.ecolmodel.2015.06.008; Casas J, 1997, BEHAV ECOL, V8, P37, DOI 10.1093/beheco/8.1.37; Clarke AR, 2011, ANN APPL BIOL, V158, P26, DOI 10.1111/j.1744-7348.2010.00448.x; Cribb BW, 2010, ARTHROPOD-PLANT INTE, V4, P165, DOI 10.1007/s11829-010-9097-0; Dalby-Ball G, 2000, AUST J ENTOMOL, V39, P201, DOI 10.1046/j.1440-6055.2000.00167.x; Dalby-Ball G, 2002, GEN APPL ENTOMOLOGY, V32, P29; Daniel Claudia, 2014, Insects, V5, P564, DOI 10.3390/insects5030564; Di Ventura B, 2006, NATURE, V443, P527, DOI 10.1038/nature05127; Dong YC, 2014, J PEST SCI, V87, P647, DOI 10.1007/s10340-014-0605-3; Dyer AG, 2014, ECOL MODEL, V277, P119, DOI 10.1016/j.ecolmodel.2014.01.009; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Grimm V, 2015, ECOLOGICAL MODELLING; Grimm V, 2006, ECOL MODEL, V198, P115, DOI 10.1016/j.ecolmodel.2006.04.023; Grimm V, 2012, PHILOS T R SOC B, V367, P298, DOI 10.1098/rstb.2011.0180; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Guttal V, 2012, ECOL LETT, V15, P1158, DOI 10.1111/j.1461-0248.2012.01840.x; Hanan J, 2002, COMPUT ELECTRON AGR, V35, P255, DOI 10.1016/S0168-1699(02)00022-4; HENDRICHS J, 1990, ANN ENTOMOL SOC AM, V83, P632, DOI 10.1093/aesa/83.3.632; HOLBROOK FR, 1969, J ECON ENTOMOL, V62, P962, DOI 10.1093/jee/62.4.962; Kaspi R, 1999, FUNCT ECOL, V13, P539, DOI 10.1046/j.1365-2435.1999.00344.x; Kubicek A, 2015, ECOL COMPLEX, V22, P178, DOI 10.1016/j.ecocom.2015.03.005; Lenth R., 2019, Journal of Statistical Software, V60, P1; LINDENMAYER A, 1968, J THEOR BIOL, V18, P280, DOI 10.1016/0022-5193(68)90079-9; Liu C, 2013, ECOL MODEL, V248, P92, DOI 10.1016/j.ecolmodel.2012.09.016; Martin KR, 2013, AUTOPHAGY, V9, P74, DOI 10.4161/auto.22532; Masoudi-Nejad A, 2015, SEMINARS CANC BIOL; Paini D. R., 2015, PLOS ONE, V10; Pe'er G, 2013, OIKOS, V122, P1483, DOI 10.1111/j.1600-0706.2013.00198.x; Perkins LE, 2010, B ENTOMOL RES, V100, P591, DOI 10.1017/S0007485309990654; Perkins LE, 2009, ARTHROPOD-PLANT INTE, V3, P173, DOI 10.1007/s11829-009-9069-4; Perkins LE, 2008, ARTHROPOD-PLANT INTE, V2, P197, DOI 10.1007/s11829-008-9047-2; PROKOPY RJ, 1984, AM SCI, V72, P41; PRUSINKIEWICZ P, 1990, ALGORITHMIC BEAUTY P; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Raghu S, 2004, J INSECT BEHAV, V17, P179, DOI 10.1023/B:JOIR.0000028568.90719.2a; Railsback S.F., 2011, AGENT BASED INDIVIDU; ROBACKER DC, 1990, J ECON ENTOMOL, V83, P412, DOI 10.1093/jee/83.2.412; Simon S, 2007, PEST TECHNOL, V1, P33; Skirvin DJ, 2004, ECOL MODEL, V171, P301, DOI 10.1016/j.ecolmodel.2003.07.007; Verdeny-Vilalta O, 2015, OIKOS, V124, P337, DOI 10.1111/oik.01557; Vinatier F, 2011, METHODS ECOL EVOL, V2, P11, DOI 10.1111/j.2041-210X.2010.00059.x; Wang M, 2015, MODSIM2015, P375; Wang Z, 2015, SEMINARS CANC BIOL; Wiegand T, 2003, OIKOS, V100, P209, DOI 10.1034/j.1600-0706.2003.12027.x; Wilensky U., NETLOGO; Wood KA, 2015, J APPL ECOLOGY; Yuan RC, 2005, HORTSCIENCE, V40, P2011, DOI 10.21273/HORTSCI.40.7.2011; Zurell D, 2014, OIKOS	57	6	7	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151777	10.1371/journal.pone.0151777	http://dx.doi.org/10.1371/journal.pone.0151777			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999285	gold, Green Published, Green Submitted			2022-12-26	WOS:000372694700065
J	Otto, MC; Afshin, A; Micha, R; Khatibzadeh, S; Fahimi, S; Singh, G; Danaei, G; Sichieri, R; Monteiro, CA; Louzada, MLC; Ezzati, M; Mozaffarian, D				Otto, Marcia C. de Oliveira; Afshin, Ashkan; Micha, Renata; Khatibzadeh, Shahab; Fahimi, Saman; Singh, Gitanjali; Danaei, Goodarz; Sichieri, Rosely; Monteiro, Carlos A.; Louzada, Maria L. C.; Ezzati, Majid; Mozaffarian, Dariush		Global Burden Dis Injuries Risk; Nutr Chronic Dis Expert Grp	The Impact of Dietary and Metabolic Risk Factors on Cardiovascular Diseases and Type 2 Diabetes Mortality in Brazil	PLOS ONE			English	Article							HOUSEHOLD FOOD AVAILABILITY; SYSTEMATIC ANALYSIS; BURDEN; HEALTH; TRENDS; PREVALENCE	Background Trends in food availability and metabolic risk factors in Brazil suggest a shift toward unhealthy dietary patterns and increased cardiometabolic disease risk, yet little is known about the impact of dietary and metabolic risk factors on cardiometabolic mortality in Brazil. Methods Based on data from Global Burden of Disease (GBD) Study, we used comparative risk assessment to estimate the burden of 11 dietary and 4 metabolic risk factors on mortality due to cardiovascular diseases and diabetes in Brazil in 2010. Information on national diets and metabolic risks were obtained from the Brazilian Household Budget Survey, the Food and Agriculture Organization database, and large observational studies including Brazilian adults. Relative risks for each risk factor were obtained from meta-analyses of randomized trials or prospective cohort studies; and disease-specific mortality from the GBD 2010 database. We quantified uncertainty using probabilistic simulation analyses, incorporating uncertainty in dietary and metabolic data and relative risks by age and sex. Robustness of findings was evaluated by sensitivity to varying feasible optimal levels of each risk factor. Results In 2010, high systolic blood pressure (SBP) and suboptimal diet were the largest contributors to cardiometabolic deaths in Brazil, responsible for 214,263 deaths (95% uncertainty interval [UI]: 195,073 to 233,936) and 202,949 deaths (95% UI: 194,322 to 211,747), respectively. Among individual dietary factors, low intakes of fruits and whole grains and high intakes of sodium were the largest contributors to cardiometabolic deaths. For premature cardiometabolic deaths (before age 70 years, representing 40% of cardiometabolic deaths), the leading risk factors were suboptimal diet (104,169 deaths; 95% UI: 99,964 to 108,002), high SBP (98,923 deaths; 95% UI: 92,912 to 104,609) and high body-mass index (BMI) (42,643 deaths; 95% UI: 40,161 to 45,111). Conclusion suboptimal diet, high SBP, and high BMI are major causes of cardiometabolic death in Brazil, informing priorities for policy initiatives.	[Otto, Marcia C. de Oliveira] Univ Texas Hlth Sci Ctr Houston, Div Epidemiol Human Genet & Environm Sci, Sch Publ Hlth, Houston, TX 77030 USA; [Afshin, Ashkan; Micha, Renata; Singh, Gitanjali; Mozaffarian, Dariush] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [Khatibzadeh, Shahab; Fahimi, Saman; Danaei, Goodarz] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, 665 Huntington Ave, Boston, MA 02115 USA; [Micha, Renata] Agr Univ Athens, Dept Food Sci & Human Nutr, GR-11855 Athens, Greece; [Sichieri, Rosely] Univ Estado Rio De Janeiro, Dept Epidemiol, Rio De Janeiro, RJ, Brazil; [Monteiro, Carlos A.; Louzada, Maria L. C.] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo, SP, Brazil; [Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Fac Med, Sch Publ Hlth, London, England	University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Tufts University; Harvard University; Harvard T.H. Chan School of Public Health; Agricultural University of Athens; Universidade do Estado do Rio de Janeiro; Universidade de Sao Paulo; Imperial College London	Otto, MC (corresponding author), Univ Texas Hlth Sci Ctr Houston, Div Epidemiol Human Genet & Environm Sci, Sch Publ Hlth, Houston, TX 77030 USA.	marcia.c.otto@uth.tmc.edu	Pekcan, A Gulden/AAI-6040-2021; Mozaffarian, Dariush/ABC-2822-2020; Bjerregaard, Peter/ABD-8894-2020; Calleja, Neville/E-3895-2019; Louzada, Maria Laura C/G-1851-2012; Duarte, Graziela Biude Silva/Q-7728-2016; Fisberg, Regina Mara/Q-6494-2019; Fisberg, Regina M/C-4069-2012; Monteiro, Carlos Augusto/F-9892-2012; Castetbon, Katia/F-2686-2017; , Sahar/L-7112-2013; Veerman, Lennert/A-9973-2011; Thorsdottir, Inga/M-3260-2015; Nagalla, Balakrishna/GRR-4393-2022	Pekcan, A Gulden/0000-0002-2037-3037; Bjerregaard, Peter/0000-0001-7153-8447; Calleja, Neville/0000-0003-1800-2103; Fisberg, Regina Mara/0000-0002-4490-9035; Fisberg, Regina M/0000-0002-4490-9035; Monteiro, Carlos Augusto/0000-0002-3777-1533; , Sahar/0000-0003-0705-8013; Naska, Androniki/0000-0002-1610-1813; Orfanos, Philippos/0000-0002-9949-3137; Haerpfer, Christian/0000-0002-7350-9049; Waskiewicz, Anna/0000-0001-5091-2145; Farzadfar, Farshad/0000-0001-8288-4046; Veerman, Lennert/0000-0002-3206-8232; Thorsdottir, Inga/0000-0002-2946-287X; Nagalla, Balakrishna/0000-0002-5613-0942; Ding, Eric/0000-0002-5881-8097; Sibai, Abla/0000-0002-1851-5606	National Heart, Lung and Blood Institute of the National Institutes of Health [R01HL085710]; Bunge LLC; Swiss Re; National Heart, Lung, and Blood Institute of the National Institutes of Health [R21 HL109924]; USAID; NIH [R01-HD38700]; Higher School of Economics and Pension Fund of Russia; University of North Carolina Population Center [5 R24 HD050924]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD050924] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038700] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL109924, R01HL085710] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Bunge LLC; Swiss Re; National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); USAID(United States Agency for International Development (USAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Higher School of Economics and Pension Fund of Russia; University of North Carolina Population Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Otto was supported by the National Heart, Lung and Blood Institute of the National Institutes of Health under award number R01HL085710 and by unrestricted educational grants from Bunge LLC and from Swiss Re, which had no role in the study design, data collection and analysis, or data interpretation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Dr. Otto was supported by the National Heart, Lung and Blood Institute of the National Institutes of Health under award number R01HL085710 and by unrestricted educational grants from Bunge LLC and from Swiss Re. Dr. Mozaffarian was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health (R21 HL109924). Dr. Mozaffarian reports ad hoc honoraria or consulting from Bunge, Haas Avocado Board, Nutrition Impact, Amarin, Astra Zeneca, Boston Heart Diagnostics, GOED, and Life Sciences Research Organization; and scientific advisory boards, Unilever North America and Elysium Health.r This work was undertaken as part of the Global Burden of Diseases, Injuries, and Risk Factors Study. The results in this paper are prepared independently of the final estimates of the Global Burden of Diseases, Injuries, and Risk Factors study. We thank the Russia Longitudinal Monitoring Survey Phase 2, funded by the USAID and NIH (R01-HD38700), Higher School of Economics and Pension Fund of Russia, and the University of North Carolina Population Center (5 R24 HD050924) (Source: "Russia Longitudinal Monitoring survey, RLMS-HSE"), conducted by HSE and ZAO "Demoscope" together with Carolina Population Center, University of North Carolina at Chapel Hill and the Institute of Sociology RAS (RLMS-HSE sites: http//.www.cpc.unc.edu/projects/rlms, http://www.hse.ru/org/hse/rlms) for sharing data with us. We thank Barbara Bowman, MS, PhD, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA; Patricia Constante Jamie, PhD, School of Public Health, University of Sao Paulo, Sao Paolo, Brazil; Karen Lock, PhD, London School of Hygiene and Tropical Medicine, London, UK; and Joceline Pomerleau, PhD, London School of Hygiene and Tropical Medicine, London, UK for advising and guidance on initial search strategy. We thank Louise Dekker, MSc, Jenna Golan, MPH, Shadi Kalantarian, MD, MPH, Liesbeth Smit, PhD, and Georgina Waweru Harvard School of Public Health, Boston, MA, USA for assistance with data collection.	Afshin A, 2013, CIRCULATION S, V127, pAMP21; Afshin A, 2014, AM J CLIN NUTR, V100, P278, DOI 10.3945/ajcn.113.076901; Bezerra IN, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-74; Martins APB, 2013, REV SAUDE PUBL, V47, P656, DOI 10.1590/S0034-8910.2013047004968; Chor D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127382; Conde WL, 2014, AM J CLIN NUTR, V100, p1617S, DOI 10.3945/ajcn.114.084764; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; GBD study, 2008, GLOB BURD DIS INJ RI; Hu FB, 2008, OBESITY EPIDEMIOLOGY; Instituto Brasileiro de Geografia e Estatistica (IBGE), 2011, PESQ ORC FAM 2008 20; James WPT, 2004, COMP QUANTIFICATION, P497; Khatibzadeh S., 2012, CIRCULATION, V125; Levy D, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001336; Levy RB, 2012, REV SAUDE PUBL, V46, P6, DOI 10.1590/S0034-89102011005000088; Levy-Costa RB, 2005, REV SAUDE PUBL, V39, P530, DOI 10.1590/S0034-89102005000400003; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Lock K., 2004, COMP QUANTIFICATION, P597; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Micha R, 2012, EUR J CLIN NUTR, V66, P119, DOI 10.1038/ejcn.2011.147; Ministerio da Saude Brasil, 2015, INF SAUD 2013; Ministry of Health B, 2011, STRAT ACT PLAN TACKL; Monteiro CA, 2007, AM J PUBLIC HEALTH, V97, P1808, DOI 10.2105/AJPH.2006.099630; Mozaffarian D, 2006, NEW ENGL J MED, V354, P1601, DOI 10.1056/NEJMra054035; Mozaffarian D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000252; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Picon RV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048255; Schmidt MI, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-123; Schmidt MI, 2011, LANCET, V377, P1949, DOI 10.1016/S0140-6736(11)60135-9; Singh GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124845; Singh GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065174; Souza AD, 2013, REV SAUDE PUBL, V47, pS190, DOI 10.1590/S0034-89102013000700005; Stevens G, 2008, PLOS MED, V5, P900, DOI 10.1371/journal.pmed.0050125; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	38	31	32	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151503	10.1371/journal.pone.0151503	http://dx.doi.org/10.1371/journal.pone.0151503			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990765	Green Published, gold, Green Submitted			2022-12-26	WOS:000372582800069
J	Garibaldi, F; Falcone, E; Trisciuoglio, D; Colombo, T; Lisek, K; Walerych, D; Del Sal, G; Paci, P; Bossi, G; Piaggio, G; Gurtner, A				Garibaldi, F.; Falcone, E.; Trisciuoglio, D.; Colombo, T.; Lisek, K.; Walerych, D.; Del Sal, G.; Paci, P.; Bossi, G.; Piaggio, G.; Gurtner, A.			Mutant p53 inhibits miRNA biogenesis by interfering with the microprocessor complex	ONCOGENE			English	Article							MICRORNA BIOGENESIS; CELL-PROLIFERATION; CANCER; GAIN; EXPRESSION; PROTEINS; RNA; SUPPRESSES; MECHANISMS; MIGRATION	Downregulation of microRNAs (miRNAs) is commonly observed in cancers and promotes tumorigenesis suggesting that miRNAs may function as tumor suppressors. However, the mechanism through which miRNAs are regulated in cancer, and the connection between oncogenes and miRNA biogenesis remain poorly understood. The TP53 tumor-suppressor gene is mutated in half of human cancers resulting in an oncogene with gain-of-function activities. Here we demonstrate that mutant p53 (mutp53) oncoproteins modulate the biogenesis of a subset of miRNAs in cancer cells inhibiting their post-transcriptional maturation. Interestingly, among these miRNAs several are also downregulated in human tumors. By confocal, co-immunoprecipitation and RNA-chromatin immunoprecipitation experiments, we show that endogenous mutp53 binds and sequesters RNA helicases p72/82 from the microprocessor complex, interfering with Drosha-pri-miRNAs association. In agreement with this, the overexpression of p72 leads to an increase of mature miRNAs levels. Moreover, functional experiments demonstrate the oncosuppressive role of mutp53-dependent miRNAs (miR-517a, -519a, -218, -105). Our study highlights a previously undescribed mechanism by which mutp53 interferes with Drosha-p72/82 association leading, at least in part, to miRNA deregulation observed in cancer.	[Garibaldi, F.; Falcone, E.; Trisciuoglio, D.; Bossi, G.; Piaggio, G.; Gurtner, A.] Regina Elena Inst Canc Res, Translat Res Area, Dept Res Adv Diagnost & Technol Innovat, Rome, Italy; [Colombo, T.; Paci, P.] CNR, Inst Syst Anal & Comp Sci Antonio Ruberti, Rome, Italy; [Colombo, T.; Paci, P.] SysBio Ctr Syst Biol, Rome, Italy; [Lisek, K.; Walerych, D.; Del Sal, G.] Area Sci Pk Padriciano, Lab Nazl CIB, Trieste, Italy; [Lisek, K.; Del Sal, G.] Univ Trieste, Dipartimento Sci Vita, Trieste, Italy; [Bossi, G.] Regina Elena Inst Canc Res, Lab Med Phys & Expert Syst, Dept Res Adv Diagnost & Technol Innovat, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Consiglio Nazionale delle Ricerche (CNR); Istituto di Analisi dei Sistemi ed Informatica "Antonio Ruberti" (IASI-CNR); University of Trieste; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena	Bossi, G; Piaggio, G; Gurtner, A (corresponding author), Regina Elena Inst Canc Res, Translat Res Area, Via Elio Chianesi 53, I-00144 Rome, Italy.	bossi@ifo.it; piaggio@ifo.it; gurtner@ifo.it	Piaggio, Giulia/AAD-7336-2022; Piaggio, Giulia/J-7214-2018; Bossi, Gianluca/B-9394-2017; gurtner, aymone/AAB-8843-2020; Bossi, Gianluca/ABH-6846-2020; trisciuoglio, daniela/AAL-4002-2021; Lisek, Kamil/J-5785-2016; Gurtner, Aymone/J-7217-2018; Colombo, Teresa/P-2959-2018; Trisciuoglio, Daniela/H-2131-2016	Piaggio, Giulia/0000-0003-2114-1892; Bossi, Gianluca/0000-0002-2947-1063; gurtner, aymone/0000-0002-7661-9059; Bossi, Gianluca/0000-0002-2947-1063; Lisek, Kamil/0000-0002-2406-8830; Gurtner, Aymone/0000-0002-7661-9059; Colombo, Teresa/0000-0003-2415-7507; Walerych, Dawid/0000-0002-8440-1375; Trisciuoglio, Daniela/0000-0002-7007-7914; DEL SAL, GIANNINO/0000-0003-2185-6003	Fondazione Umberto Veronesi Fellowship; FEBS postdoctoral fellowship; AIRC [MFAG 11752, IG 13234, 10016]; Italian Ministry of Health	Fondazione Umberto Veronesi Fellowship(Fondazione Umberto Veronesi); FEBS postdoctoral fellowship; AIRC(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health(Ministry of Health, Italy)	We thank Dr Vittorio Sartorelli for the p72 expression vector, Dr Silvia Bacchetti and Silvia Soddu for interesting discussions on the manuscript, Maria Pia Gentileschi for technical advice, Daniela Bona for secretary assistance. Aymone Gurtner and Gianluca Bossi were supported by a Fondazione Umberto Veronesi Fellowship; Dawid Walerych was a recipient of the FEBS postdoctoral fellowship. This work has been supported by grant from AIRC to AG (MFAG 11752); from AIRC to GP (IG 13234); from AIRC (Special Program Molecular Clinical Oncology '5 per mille') (grant no. 10016) to GDS and from Italian Ministry of Health to GDS.	Abdelmohsen K, 2010, CELL CYCLE, V9, P1354, DOI 10.4161/cc.9.7.11164; Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Bates GJ, 2005, EMBO J, V24, P543, DOI 10.1038/sj.emboj.7600550; Borralho PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023787; Bossi G, 2006, ONCOGENE, V25, P304, DOI 10.1038/sj.onc.1209026; Bossi G, 2008, CELL CYCLE, V7, P1870, DOI 10.4161/cc.7.12.6161; Braicu C, 2013, MOL CELL BIOCHEM, V381, P61, DOI 10.1007/s11010-013-1688-5; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Carleton M, 2007, CELL CYCLE, V6, P2127, DOI 10.4161/cc.6.17.4641; Cha ST, 2010, CANCER RES, V70, P2675, DOI 10.1158/0008-5472.CAN-09-2448; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; Donehower LA, 2009, NAT REV CANCER, V9, P830, DOI 10.1038/nrc2731; Dong P, 2013, ONCOGENE, V32, P3286, DOI 10.1038/onc.2012.334; Donzelli S, 2012, CELL DEATH DIFFER, V19, P1038, DOI 10.1038/cdd.2011.190; Fabbri M, 2007, EXPERT OPIN BIOL TH, V7, P1009, DOI 10.1517/14712598.7.7.1009; Feng XL, 2014, CANCER LETT, V344, P166, DOI 10.1016/j.canlet.2013.11.004; Fuller-Pace FV, 2013, BBA-GENE REGUL MECH, V1829, P756, DOI 10.1016/j.bbagrm.2013.03.004; Fuller-Pace FV, 2011, FUTURE ONCOL, V7, P239, DOI 10.2217/FON.11.1; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Garufi A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.163; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; Gostissa M, 2004, J BIOL CHEM, V279, P48013, DOI 10.1074/jbc.M310801200; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Gurtner A, 2010, J BIOL CHEM, V285, P14160, DOI 10.1074/jbc.M109.094813; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Hermeking H, 2012, NAT REV CANCER, V12, P613, DOI 10.1038/nrc3318; Kawai S, 2012, J CELL BIOL, V197, P201, DOI 10.1083/jcb.201110008; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Liu RF, 2013, CANCER LETT, V329, P164, DOI 10.1016/j.canlet.2012.10.027; Lujambio A, 2012, NATURE, V482, P347, DOI 10.1038/nature10888; Marasa BS, 2010, AGING-US, V2, P333, DOI 10.18632/aging.100159; Masciarelli S, 2014, ONCOGENE, V33, P1601, DOI 10.1038/onc.2013.106; Mori M, 2014, CELL, V156, P893, DOI 10.1016/j.cell.2013.12.043; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Muller PAJ, 2014, J BIOL CHEM, V289, P122, DOI 10.1074/jbc.M113.502138; Neilsen PM, 2013, ONCOGENE, V32, P2992, DOI 10.1038/onc.2012.305; Nohata N, 2012, ONCOTARGET, V3, P9; Pinho FG, 2013, CANCER RES, V73, P5936, DOI 10.1158/0008-5472.CAN-13-0158; Subramanian M, 2015, ONCOGENE, V34, P1094, DOI 10.1038/onc.2014.46; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Trisciuoglio D, 2012, CLIN CANCER RES, V18, P475, DOI 10.1158/1078-0432.CCR-11-0579; Tu YY, 2013, CANCER RES, V73, P6046, DOI 10.1158/0008-5472.CAN-13-0358; Ubertini V, 2015, ONCOGENE, V34, P2493, DOI 10.1038/onc.2014.191; Uhlmann-Schiffler H, 2002, J BIOL CHEM, V277, P1066, DOI 10.1074/jbc.M107535200; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Wang W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.97; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wu LF, 2011, FEBS LETT, V585, P1322, DOI 10.1016/j.febslet.2011.03.067; Yamakuchi M, 2010, P NATL ACAD SCI USA, V107, P6334, DOI 10.1073/pnas.0911082107; Yoshitomi T, 2011, ONCOL REP, V25, P1661, DOI 10.3892/or.2011.1253; Zhang J, 2013, ONCOGENE, V32, P61, DOI 10.1038/onc.2012.28; Zhang MX, 2012, FEBS LETT, V586, P3508, DOI 10.1016/j.febslet.2012.08.007	60	31	32	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL	2016	35	29					3760	3770		10.1038/onc.2016.51	http://dx.doi.org/10.1038/onc.2016.51			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS4LS	26996669				2022-12-26	WOS:000380753200002
J	Ali, SR; Singh, AK; Laezza, F				Ali, Syed R.; Singh, Aditya K.; Laezza, Fernanda			Identification of Amino Acid Residues in Fibroblast Growth Factor 14 (FGF14) Required for Structure-Function Interactions with Voltage-gated Sodium Channel Nav1.6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid; electrophysiology; fibroblast growth factor (FGF); ion channel; protein-protein interaction; FGF14; Nav1; 6; hot spots; split-luciferase assay; voltage-gated sodium channels	FACTOR HOMOLOGOUS FACTOR; PROTEIN-PROTEIN INTERACTIONS; THERAPEUTIC TARGETS; ANTIEPILEPTIC DRUGS; CRYSTAL-STRUCTURE; MODULATION; PHARMACOLOGY; EPILEPSY; COMPLEX; FIBROBLAST-GROWTH-FACTOR-14	The voltage-gated Na+ (Nav) channel provides the basis for electrical excitability in the brain. This channel is regulated by a number of accessory proteins including fibroblast growth factor 14 (FGF14), a member of the intracellular FGF family. In addition to forming homodimers, FGF14 binds directly to the Nav1.6 channel C-tail, regulating channel gating and expression, properties that are required for intrinsic excitability in neurons. Seeking amino acid residues with unique roles at the protein-protein interaction interface (PPI) of FGF14Nav1.6, we engineered model-guided mutations of FGF14 and validated their impact on the FGF14Nav1.6 complex and the FGF14:FGF14 dimer formation using a luciferase assay. Divergence was found in the beta-9 sheet of FGF14 where an alanine (Ala) mutation of Val-160 impaired binding to Nav1.6 but had no effect on FGF14:FGF14 dimer formation. Additional analysis revealed also a key role of residues Lys-74/Ile-76 at the N-terminal of FGF14 in the FGF14Nav1.6 complex and FGF14:FGF14 dimer formation. Using whole-cell patch clamp electrophysiology, we demonstrated that either the FGF14(V160A) or the FGF14(K74A/I76A) mutation was sufficient to abolish the FGF14-dependent regulation of peak transient Na+ currents and the voltage-dependent activation and steady-state inactivation of Nav1.6; but only V160A with a concomitant alanine mutation at Tyr-158 could impede FGF14-dependent modulation of the channel fast inactivation. Intrinsic fluorescence spectroscopy of purified proteins confirmed a stronger binding reduction of FGF14(V160A) to the Nav1.6 C-tail compared with FGF14(K74A/I76A). Altogether these studies indicate that the beta-9 sheet and the N terminus of FGF14 are well positioned targets for drug development of PPI-based allosteric modulators of Nav channels.	[Ali, Syed R.; Singh, Aditya K.; Laezza, Fernanda] Univ Texas Med Branch, Dept Pharmacol & Toxicol, 301 Univ Blvd, Galveston, TX 77555 USA; [Ali, Syed R.] Univ Texas Med Branch, Pharmacol & Toxicol Grad Program, Galveston, TX 77555 USA; [Laezza, Fernanda] Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA; [Laezza, Fernanda] Univ Texas Med Branch, Addict Res Ctr, Galveston, TX 77555 USA; [Laezza, Fernanda] Univ Texas Med Branch, Ctr Environm Toxicol, Galveston, TX 77555 USA; [Laezza, Fernanda] Univ Texas Med Branch, Ctr Biomed Engn, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Laezza, F (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, 301 Univ Blvd, Galveston, TX 77555 USA.	felaezza@utmb.edu	Laezza, Fernanda/X-4076-2019; Laezza, Fernanda/L-6019-2016	Laezza, Fernanda/0000-0003-1141-1852; Laezza, Fernanda/0000-0003-1141-1852; Singh, Aditya/0000-0001-7549-8163	National Institutes of Health from NIGMS (Keck Center for Interdisciplinary Bioscience Training of the Gulf Coast Consortia) [R01MH095995, 1 T32 GM089657-04]; John Sealy Memorial Endowment Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM089657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095995] Funding Source: NIH RePORTER	National Institutes of Health from NIGMS (Keck Center for Interdisciplinary Bioscience Training of the Gulf Coast Consortia); John Sealy Memorial Endowment Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grants R01MH095995 (to F. L.) and 1 T32 GM089657-04 (to S. R. A.) from NIGMS (a training fellowship from the Keck Center for Interdisciplinary Bioscience Training of the Gulf Coast Consortia). This work was also supported by the John Sealy Memorial Endowment Fund (to F. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ali S, 2014, CNS NEUROL DISORD-DR, V13, P1559, DOI 10.2174/1871527313666141126103309; Bath KG, 2013, EPILEPSY BEHAV, V26, P427, DOI 10.1016/j.yebeh.2012.10.031; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; Catterall WA, 2014, EXP PHYSIOL, V99, P35, DOI 10.1113/expphysiol.2013.071969; Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204; Chahine M, 2008, CNS NEUROL DISORD-DR, V7, P144, DOI 10.2174/187152708784083830; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; Claes L, 2001, AM J HUM GENET, V68, P1327, DOI 10.1086/320609; Clare JJ, 2000, DRUG DISCOV TODAY, V5, P506, DOI 10.1016/S1359-6446(00)01570-1; Cohen M, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000470; Cusdin FS, 2008, TRAFFIC, V9, P17, DOI 10.1111/j.1600-0854.2007.00673.x; Denac H, 2000, N-S ARCH PHARMACOL, V362, P453, DOI 10.1007/s002100000319; Dib-Hajj SD, 2009, PAIN MED, V10, P1260, DOI 10.1111/j.1526-4637.2009.00719.x; Dib-Hajj SD, 2009, BRAIN RES REV, V60, P65, DOI 10.1016/j.brainresrev.2008.12.005; Drendall CI, 2010, PROTEIN EXPRES PURIF, V70, P196, DOI 10.1016/j.pep.2009.12.003; Eijkelkamp N, 2012, BRAIN, V135, P2585, DOI 10.1093/brain/aws225; Emmett MR, 2014, NEUROPSYCHOPHARMACOL, V39, P5, DOI 10.1038/npp.2013.156; Farber NB, 2002, MOL PSYCHIATR, V7, P726, DOI 10.1038/sj.mp.4001087; Goetz R, 2009, J BIOL CHEM, V284, P17883, DOI 10.1074/jbc.M109.001842; Goldin AL, 2000, NEURON, V28, P365, DOI 10.1016/S0896-6273(00)00116-1; Gregoret LM, 1998, FOLD DES, V3, P119, DOI 10.1016/S1359-0278(98)00017-0; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hsu WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117246; Jiang L, 2002, J BIOL CHEM, V277, P37732, DOI 10.1074/jbc.M204514200; Laedermann CJ, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-19; Laezza F, 2009, MOL CELL NEUROSCI, V42, P90, DOI 10.1016/j.mcn.2009.05.007; Lampert A, 2010, PFLUG ARCH EUR J PHY, V460, P249, DOI 10.1007/s00424-009-0779-3; Large CH, 2011, J PHARMACOL EXP THER, V338, P100, DOI 10.1124/jpet.110.178475; Leterrier C, 2010, NEUROSCI LETT, V486, P92, DOI 10.1016/j.neulet.2010.08.079; Liu CJ, 2003, J BIOL CHEM, V278, P1029, DOI 10.1074/jbc.M207074200; Liu CJ, 2001, J BIOL CHEM, V276, P18925, DOI 10.1074/jbc.M101606200; Lou JY, 2005, J PHYSIOL-LONDON, V569, P179, DOI 10.1113/jphysiol.2005.097220; Mantegazza M, 2005, P NATL ACAD SCI USA, V102, P18177, DOI 10.1073/pnas.0506818102; Mantegazza M, 2010, LANCET NEUROL, V9, P413, DOI 10.1016/S1474-4422(10)70059-4; Marban E, 1998, J PHYSIOL-LONDON, V508, P647, DOI 10.1111/j.1469-7793.1998.647bp.x; Moller M, 2002, BIOCHEM MOL BIOL EDU, V30, P175, DOI 10.1002/bmb.2002.494030030035; Mullen SA, 2009, ARCH NEUROL-CHICAGO, V66, P21, DOI 10.1001/archneurol.2008.559; Musa H, 2015, P NATL ACAD SCI USA, V112, P12528, DOI 10.1073/pnas.1516430112; Ochiai K, 2011, FEBS LETT, V585, P1771, DOI 10.1016/j.febslet.2011.05.027; Olsen SK, 2003, J BIOL CHEM, V278, P34226, DOI 10.1074/jbc.M303183200; Papale LA, 2010, J BIOL CHEM, V285, P16553, DOI 10.1074/jbc.M109.090084; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pitteri S, 2010, DIS MARKERS, V28, P233, DOI [10.1155/2010/270859, 10.3233/DMA-2010-0696]; Post RM, 1998, NEUROPSYCHOPHARMACOL, V19, P206, DOI 10.1016/S0893-133X(98)00020-7; Prakriya M, 2000, NEURON, V26, P671, DOI 10.1016/S0896-6273(00)81203-9; Probst V, 2003, J AM COLL CARDIOL, V41, P643, DOI 10.1016/S0735-1097(02)02864-4; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Rodriguez-Murillo L, 2014, NEUROPSYCHOPHARMACOL, V39, P934, DOI 10.1038/npp.2013.293; Rush AM, 2006, EUR J NEUROSCI, V23, P2551, DOI 10.1111/j.1460-9568.2006.04789.x; Savio-Galimberti E, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00124; Schoorlemmer J, 2001, CURR BIOL, V11, P793, DOI 10.1016/S0960-9822(01)00232-9; Shavkunov A, 2012, ASSAY DRUG DEV TECHN, V10, P148, DOI 10.1089/adt.2011.413; Shavkunov AS, 2015, METHODS MOL BIOL, V1278, P497, DOI 10.1007/978-1-4939-2425-7_33; Shavkunov AS, 2013, J BIOL CHEM, V288, P19370, DOI 10.1074/jbc.M112.445924; Stoilova-McPhie S., 2013, AUSTIN J PHARM THER, V1, ppii5; Tang ZL, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0347-1; Teiwes J, 2007, AM J HYPERTENS, V20, P109, DOI 10.1016/j.amjhyper.2006.05.022; Tempia F, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00205; Theile JW, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00054; Tobi D, 2000, PROTEINS, V41, P40, DOI 10.1002/1097-0134(20001001)41:1<40::AID-PROT70>3.0.CO;2-U; van Swieten JC, 2003, AM J HUM GENET, V72, P191, DOI 10.1086/345488; Verbeek EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037384; Wang CJ, 2012, STRUCTURE, V20, P1167, DOI 10.1016/j.str.2012.05.001; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 2002, NEURON, V35, P25, DOI 10.1016/S0896-6273(02)00744-4; Wildburger NC, 2015, MOL CELL PROTEOMICS, V14, P1288, DOI 10.1074/mcp.M114.040055; Wittmack EK, 2004, J NEUROSCI, V24, P6765, DOI 10.1523/JNEUROSCI.1628-04.2004; Woods CG, 2015, EUR J HUM GENET, V23, P561, DOI [10.1038/ejhg.2014.166, 10.1038/ejhg.2015.163]; Wright GEB, 2015, CLIN GENET, V88, P342, DOI 10.1111/cge.12652; Xiao ML, 2007, MOL CELL NEUROSCI, V34, P366, DOI 10.1016/j.mcn.2006.11.020; Yu FH, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-207	72	22	22	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11268	11284		10.1074/jbc.M115.703868	http://dx.doi.org/10.1074/jbc.M115.703868			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	26994141	Green Published, hybrid			2022-12-26	WOS:000377042100027
J	Shimo, T; Matsumoto, K; Takabatake, K; Aoyama, E; Takebe, Y; Ibaragi, S; Okui, T; Kurio, N; Takada, H; Obata, K; Pang, P; Iwamoto, M; Nagatsuka, H; Sasaki, A				Shimo, Tsuyoshi; Matsumoto, Kenichi; Takabatake, Kiyofumi; Aoyama, Eriko; Takebe, Yuichiro; Ibaragi, Soichiro; Okui, Tatsuo; Kurio, Naito; Takada, Hiroyuki; Obata, Kyoichi; Pang, Pai; Iwamoto, Masahiro; Nagatsuka, Hitoshi; Sasaki, Akira			The Role of Sonic Hedgehog Signaling in Osteoclastogenesis and Jaw Bone Destruction	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; CANCER; PROLIFERATION; INVASION; GROWTH; MICROENVIRONMENT; METASTASIS; INHIBITION; EXPRESSION; RECEPTORS	Sonic hedgehog (SHH) and its signaling have been identified in several human cancers, and increased levels of its expression appear to correlate with disease progression and metastasis. However, the role of SHH in bone destruction associated with oral squamous cell carcinomas is still unclear. In this study we analyzed SHH expression and the role played by SHH signaling in gingival carcinoma-induced jawbone destruction. From an analysis of surgically resected lower gingival squamous cell carcinoma mandible samples, we found that SHH was highly expressed in tumor cells that had invaded the bone matrix. On the other hand, the hedgehog receptor Patched and the signaling molecule Gli-2 were highly expressed in the osteoclasts and the progenitor cells. SHH stimulated osteoclast formation and pit formation in the presence of the receptor activator for nuclear factor-kappa B ligand (RANKL) in CD11b(+) mouse bone marrow cells. SHH upregulated phosphorylation of ERK1/2 and p38 MAPK, NFATc1, tartrate-resistant acid phosphatase (TRAP), and Cathepsin K expression in RAW264.7 cells. Our results suggest that tumor-derived SHH stimulated the osteoclast formation and bone resorption in the tumor jawbone microenvironment.	[Shimo, Tsuyoshi; Matsumoto, Kenichi; Ibaragi, Soichiro; Okui, Tatsuo; Kurio, Naito; Takada, Hiroyuki; Obata, Kyoichi; Pang, Pai; Sasaki, Akira] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral & Maxillofacial Surg, Kita Ku, 2-5-1 Shikata Cho, Okayama, Japan; [Takabatake, Kiyofumi; Takebe, Yuichiro; Nagatsuka, Hitoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral Pathol & Med, Kita Ku, 2-5-1 Shikata Cho, Okayama, Japan; [Aoyama, Eriko] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Adv Res Ctr Oral & Craniofacial Sci, Kita Ku, 2-5-1 Shikata Cho, Okayama, Japan; [Iwamoto, Masahiro] Thomas Jefferson Univ, Dept Orthopaed Surg, Philadelphia, PA 19107 USA; [Iwamoto, Masahiro] Childrens Hosp Philadelphia, Res Inst, Div Orthoped Surg, Philadelphia, PA 19104 USA	Okayama University; Okayama University; Okayama University; Jefferson University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Shimo, T (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Oral & Maxillofacial Surg, Kita Ku, 2-5-1 Shikata Cho, Okayama, Japan.	shimotsu@md.okayama-u.ac.jp	Shimo, Tsuyoshi/AAT-8358-2020	Shimo, Tsuyoshi/0000-0002-7811-2366	Ministry of Education, Culture, Sports, Science, and Technology of Japan [18689049, 26293428]; Grants-in-Aid for Scientific Research [26293428] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by a Grant-in-Aid for Young Scientists (A)(18689049 https://kaken.nii.ac.jp/d/p/18689049.ja.html) (to T.S.) and a Grant-in-Aid for Scientific Research (B) (26293428, https://kaken.nii.ac.jp/d/p/26293428.ja.html) (to T.S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Atkinson PJ, 2009, J NEUROCHEM, V108, P1539, DOI 10.1111/j.1471-4159.2009.05900.x; Bilodeau EA, 2011, HEAD NECK PATHOL, V5, P216, DOI 10.1007/s12105-011-0264-0; Choi SW, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-35; Cotton M, 2009, CELL SIGNAL, V21, P1045, DOI 10.1016/j.cellsig.2009.02.008; Das S, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/298623; Denker SP, 2002, CURR OPIN CELL BIOL, V14, P214, DOI 10.1016/S0955-0674(02)00304-6; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Ebrahimi A, 2011, CANCER-AM CANCER SOC, V117, P4460, DOI 10.1002/cncr.26032; Esposito M, 2014, PHARMACOL THERAPEUT, V141, P222, DOI 10.1016/j.pharmthera.2013.10.006; Fried D, 2014, HEAD NECK-J SCI SPEC, V36, P776, DOI 10.1002/hed.23367; Heller E, 2012, CANCER RES, V72, P897, DOI 10.1158/0008-5472.CAN-11-2681; Honami T, 2012, ORAL ONCOL, V48, P49, DOI 10.1016/j.oraloncology.2011.08.026; Horikiri Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076785; Hurchla MA, 2012, ONCOIMMUNOLOGY, V1, P1411, DOI 10.4161/onci.21060; Ichiki T, 2011, NEUROPEPTIDES, V45, P239, DOI 10.1016/j.npep.2011.03.006; Johnson RW, 2011, CANCER RES, V71, P822, DOI 10.1158/0008-5472.CAN-10-2993; Kominsky SL, 2008, CANCER RES, V68, P1261, DOI 10.1158/0008-5472.CAN-07-6122; Lee JH, 2009, J BIOL CHEM, V284, P13725, DOI 10.1074/jbc.M806941200; Lin TL, 2012, ONCOTARGETS THER, V5, P47, DOI 10.2147/OTT.S21957; Liu HY, 2014, EXP DERMATOL, V23, P896, DOI 10.1111/exd.12556; MAGGI CA, 1993, J AUTON PHARMACOL, V13, P23, DOI 10.1111/j.1474-8673.1993.tb00396.x; Nishimaki H, 2004, BIOCHEM BIOPH RES CO, V314, P313, DOI 10.1016/j.bbrc.2003.12.097; Nishimori H, 2012, J BIOL CHEM, V287, P20037, DOI 10.1074/jbc.M112.353094; Olechnowicz SWZ, 2014, CANCER RES, V74, P1625, DOI 10.1158/0008-5472.CAN-13-2645; Osawa H, 2006, BIOCHEM BIOPH RES CO, V344, P680, DOI 10.1016/j.bbrc.2006.03.188; Rougerie P, 2013, IMMUNOLOGICAL REV, V256; Shimo T, 2004, DEV DYNAM, V229, P607, DOI 10.1002/dvdy.20009; Sterling JA, 2006, CANCER RES, V66, P7548, DOI 10.1158/0008-5472.CAN-06-0452; Theunissen JW, 2009, CANCER RES, V69, P6007, DOI 10.1158/0008-5472.CAN-09-0756; Waning DL, 2014, CLIN CANCER RES, V20, P3071, DOI 10.1158/1078-0432.CCR-13-1590; Weilbaecher KN, 2011, NAT REV CANCER, V11, P411, DOI 10.1038/nrc3055; Yan M, 2011, ORAL ONCOL, V47, P504, DOI 10.1016/j.oraloncology.2011.03.027; Young B, 2006, DEV BIOL, V299, P272, DOI 10.1016/j.ydbio.2006.07.028; Zunich SM, 2012, MOL CANCER, P1130	34	16	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151731	10.1371/journal.pone.0151731	http://dx.doi.org/10.1371/journal.pone.0151731			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007126	Green Published, gold, Green Submitted			2022-12-26	WOS:000372701200063
J	Dinkins, JB; Smith, KT; Beck, JL; Kirol, CP; Pratt, AC; Conover, MR				Dinkins, Jonathan B.; Smith, Kurt T.; Beck, Jeffrey L.; Kirol, Christopher P.; Pratt, Aaron C.; Conover, Michael R.			Microhabitat Conditions in Wyoming's Sage-Grouse Core Areas: Effects on Nest Site Selection and Success	PLOS ONE			English	Article							HABITAT; PREDATION; SAGEBRUSH; SURVIVAL; FITNESS	The purpose of our study was to identify microhabitat characteristics of greater sage-grouse (Centrocercus urophasianus) nest site selection and survival to determine the quality of sage-grouse habitat in 5 regions of central and southwest Wyoming associated with Wyoming's Core Area Policy. Wyoming's Core Area Policy was enacted in 2008 to reduce human disturbance near the greatest densities of sage-grouse. Our analyses aimed to assess sage-grouse nest selection and success at multiple micro-spatial scales. We obtained microhabitat data from 928 sage-grouse nest locations and 819 random microhabitat locations from 2008-2014. Nest success was estimated from 924 nests with survival data. Sage-grouse selected nests with greater sagebrush cover and height, visual obstruction, and number of small gaps between shrubs (gap size >= 0.5 m and <1.0 m), while selecting for less bare ground and rock. With the exception of more small gaps between shrubs, we did not find any differences in availability of these microhabitat characteristics between locations within and outside of Core Areas. In addition, we found little supporting evidence that sage-grouse were selecting different nest sites in Core Areas relative to areas outside of Core. The Kaplan-Meier nest success estimate for a 27-day incubation period was 42.0% (95% CI: 38.4-45.9%). Risk of nest failure was negatively associated with greater rock and more medium-sized gaps between shrubs (gap size >= 2.0 m and <3.0 m). Within our study areas, Wyoming's Core Areas did not have differing microhabitat quality compared to outside of Core Areas. The close proximity of our locations within and outside of Core Areas likely explained our lack of finding differences in microhabitat quality among locations within these landscapes. However, the Core Area Policy is most likely to conserve high quality habitat at larger spatial scales, which over decades may have cascading effects on microhabitat quality available between areas within and outside of Core Areas.	[Dinkins, Jonathan B.; Smith, Kurt T.; Beck, Jeffrey L.; Kirol, Christopher P.; Pratt, Aaron C.] Univ Wyoming, Dept Ecosyst Sci & Management, Laramie, WY 82071 USA; [Conover, Michael R.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA	University of Wyoming; Utah System of Higher Education; Utah State University	Dinkins, JB (corresponding author), Univ Wyoming, Dept Ecosyst Sci & Management, Laramie, WY 82071 USA.	jdinkins@uwyo.edu			American Colloid Company; Anadarko Petroleum Corporation; Bates Hole Working Group; Bighorn Basin Working Group; South-Central Working Group; Southwest Working Group; Wind River/Sweetwater River Local Sage-Grouse Working Group; Jack H. Berryman Institute; Lincoln County Predator Management Board; Margaret and Sam Kelly Ornithological Research Fund; Predatory Animal District of Sweetwater County; School of Energy Resources and Wyoming Reclamation and Restoration Center at the University of Wyoming; Uinta County Predator Management Board; Utah Agricultural Experiment Station; Wyoming Animal Damage Management Board; Wyoming Sage-grouse Conservation Fund of the Wyoming Game and Fish Department; Wyoming Wildlife and Natural Resource Trust; State of Wyoming Legislature through the Wyoming Wildlife and Natural Resource Trust on behalf of the Wyoming Sage-Grouse Implementation Team	American Colloid Company; Anadarko Petroleum Corporation; Bates Hole Working Group; Bighorn Basin Working Group; South-Central Working Group; Southwest Working Group; Wind River/Sweetwater River Local Sage-Grouse Working Group; Jack H. Berryman Institute; Lincoln County Predator Management Board; Margaret and Sam Kelly Ornithological Research Fund; Predatory Animal District of Sweetwater County; School of Energy Resources and Wyoming Reclamation and Restoration Center at the University of Wyoming; Uinta County Predator Management Board; Utah Agricultural Experiment Station; Wyoming Animal Damage Management Board; Wyoming Sage-grouse Conservation Fund of the Wyoming Game and Fish Department; Wyoming Wildlife and Natural Resource Trust; State of Wyoming Legislature through the Wyoming Wildlife and Natural Resource Trust on behalf of the Wyoming Sage-Grouse Implementation Team	Research funding was provided by: American Colloid Company; Anadarko Petroleum Corporation; Bates Hole, Bighorn Basin, South-Central, Southwest, and Wind River/Sweetwater River Local Sage-Grouse Working Groups; Jack H. Berryman Institute; Lincoln County Predator Management Board; Margaret and Sam Kelly Ornithological Research Fund; Predatory Animal District of Sweetwater County; School of Energy Resources and Wyoming Reclamation and Restoration Center at the University of Wyoming; Uinta County Predator Management Board; Utah Agricultural Experiment Station; Wyoming Animal Damage Management Board; Wyoming Sage-grouse Conservation Fund of the Wyoming Game and Fish Department; Wyoming Wildlife and Natural Resource Trust. Funding for analysis and publication of this paper was provided by the State of Wyoming Legislature through the Wyoming Wildlife and Natural Resource Trust on behalf of the Wyoming Sage-Grouse Implementation Team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge CL, 2007, ECOL APPL, V17, P508, DOI 10.1890/05-1871; Aldridge CL, 2008, ISR J ECOL EVOL, V54, P389, DOI 10.1560/IJEE.54.3-4.389; Anderson D. R., 2008, MODEL BASED INFERENC; [Anonymous], 2014, RMRSGTR326 USDA FOR; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Boyd C.S., 2014, J RANGELAND APPL, V1, P58; Braun C. E., 1998, P W ASS STATE FISH W, V78, P139; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; CANFIELD R. H., 1941, JOUR FOREST, V39, P388; Coates PS, 2010, J WILDLIFE MANAGE, V74, P240, DOI 10.2193/2009-047; Connelly J. W., 1994, W160R19 ID DEP FISH; Connelly JW, 2011, STUD AVIAN BIOL, P53; CONNELLY JW, 1991, J WILDLIFE MANAGE, V55, P521, DOI 10.2307/3808984; Connelly JW, 2003, U IDAHO EXPT STATION, V80; Conover MR, 2010, CONDOR, V112, P331, DOI 10.1525/cond.2010.090172; Conover MR, 2007, PREDATOR PREY DYNAMI; Copeland HE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067261; COX DR, 1972, J R STAT SOC B, V34, P187; Dalke P.D., 1963, J WILDLIFE MANAGE, V27, P810; DAUBENMIRE R., 1959, NORTHWEST SCI, V33, P43; Dinkins JB, 2014, CAN J ZOOL, V92, P319, DOI 10.1139/cjz-2013-0263; Dinkins J. B., 2013, THESIS UTAH STATE U; Dinkins JB, 2014, CONDOR, V116, P629, DOI 10.1650/CONDOR-13-163.1; Doherty KE, 2014, WILDLIFE BIOL, V20, P320, DOI 10.2981/wlb.00004; Doherty KE, 2011, STUD AVIAN BIOL, P505; Doherty KE, 2010, J WILDLIFE MANAGE, V74, P1544, DOI 10.2193/2009-043; ENG ROBERT L., 1955, JOUR WILDLIFE MANAGEMENT, V19, P267, DOI 10.2307/3796862; GIESEN K M, 1982, Wildlife Society Bulletin, V10, P224; GREGG MA, 1994, J WILDLIFE MANAGE, V58, P162, DOI 10.2307/3809563; GRIFFITH B, 1988, WILDLIFE SOC B, V16, P206; Hagen CA, 2011, STUD AVIAN BIOL, P95; Holloran MJ, 2005, J WILDLIFE MANAGE, V69, P638, DOI 10.2193/0022-541X(2005)069[0638:GSNHSA]2.0.CO;2; Holloran MRJ, 2005, CONDOR, V107, P742, DOI 10.1650/7749.1; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Kaczor NW, 2008, THESIS S DAKOTA STAT; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kirol CP, 2015, ECOL APPL, V25, P968, DOI 10.1890/13-1152.1; Kirol CP, 2012, CONDOR, V114, P75, DOI 10.1525/cond.2012.110024; Kolada EJ, 2009, J WILDLIFE MANAGE, V73, P1333, DOI 10.2193/2008-338; Manly B.F.J., 2002, RESOURCE SELECTION A; Memmott KL, 1998, J RANGE MANAGE, V51, P547, DOI 10.2307/4003374; Musil DD, 2011, STUD AVIAN BIOL, P119; Northwest GAP Analysis Project, 2008, LAND COV DAT GAP AN; Patterson R.L., 1952, SAGE GROUSE WYOMING; R Core Team, 2021, R LANGUAGE ENV STAT; ROBEL RI, 1970, J RANGE MANAGE, V23, P295, DOI 10.2307/3896225; Rodemaker EJ, 2006, MAPPING LAND COVER T; Schroeder M.A., 1999, Birds of North America, V425, P1; State of Wyoming. Office of Governor Freudenthal, 2008, STAT WYOM EX DEP EX; Therneau T.M., 2000, MODELING SURVIVAL DA; Thomas DL, 2006, J WILDLIFE MANAGE, V70, P324, DOI 10.2193/0022-541X(2006)70[324:SDATFC]2.0.CO;2; WAKKINEN WL, 1992, WILDLIFE SOC B, V20, P425; WALLESTAD R, 1974, J WILDLIFE MANAGE, V38, P630, DOI 10.2307/3800029; Wambolt CL, 2006, WILDLIFE SOC B, V34, P440, DOI 10.2193/0091-7648(2006)34[440:EOMSAT]2.0.CO;2; Webb Stephen L., 2012, Ecological Processes, V1	56	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0150798	10.1371/journal.pone.0150798	http://dx.doi.org/10.1371/journal.pone.0150798			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002531	Green Published, gold			2022-12-26	WOS:000372697400020
J	Holloway, KA; Rosella, L; Henry, D				Holloway, Kathleen Anne; Rosella, Laura; Henry, David			The Impact of WHO Essential Medicines Policies on Inappropriate Use of Antibiotics	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE; INTEGRATED MANAGEMENT; BACTERIAL-RESISTANCE; CHILDHOOD ILLNESS; IMPROVE; COUNTRIES; EPIDEMIOLOGY; GUIDELINES; DRUG; CARE	Background Inappropriate overuse of antibiotics contributes to antimicrobial resistance (AMR), yet policy implementation to reduce inappropriate antibiotic use is poor in low and middle-income countries. Aims To determine whether public sector inappropriate antibiotic use is lower in countries reporting implementation of selected essential medicines policies. Materials and Methods Results from independently conducted antibiotic use surveys in countries that did, and did not report implementation of policies to reduce inappropriate antibiotic prescribing, were compared. Survey data on four validated indicators of inappropriate antibiotic use and 16 self-reported policy implementation variables from WHO databases were extracted. The average difference for indicators between countries reporting versus not reporting implementation of specific policies was calculated. For 16 selected policies we regressed the four antibiotic use variables on the numbers of policies the countries reported implementing. Results Data were available for 55 countries. Of 16 policies studied, four (having a national Ministry of Health unit on promoting rational use of medicines, a national drug information centre and provincial and hospital drugs and therapeutics committees) were associated with statistically significant reductions in antibiotic use of >= 20% in upper respiratory infection (URTI). A national strategy to contain antibiotic resistance was associated with a 30% reduction in use of antibiotics in acute diarrheal illness. Policies seemed to be associated with greater effects in antibiotic use for URTI and diarrhea compared with antibiotic use in all patients. There were negative correlations between the numbers of policies reported implemented and the percentage of acute diarrhoea cases treated with antibiotics (r = -0.484, p = 0.007) and the percentage of URTI cases treated with antibiotics (r = -0.472, p = 0.005). Major study limitations were the reliance on self-reported policy implementation data and antibiotic use data from linited surveys. Conclusions Selected essential medicines policies were associated with lower antibiotic use in low and middle income countries.	[Holloway, Kathleen Anne] WHO, Dept Hlth Syst Dev, Reg Off SouthEast Asia, New Delhi, India; [Rosella, Laura; Henry, David] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Epidemiol, Toronto, ON, Canada	World Health Organization; University of Toronto	Holloway, KA (corresponding author), WHO, Dept Hlth Syst Dev, Reg Off SouthEast Asia, New Delhi, India.	kaholloway54@gmail.com	Henry, David/AAU-4650-2020; Henry, David/L-3895-2017	Henry, David/0000-0001-7169-7704; Henry, David/0000-0003-2934-2242	WHO Geneva	WHO Geneva(World Health Organization)	WHO Geneva funded collection of primary data on medicines policies and creation of the WHO medicines use database. However, WHO had no role in study design, data collection and analysis of secondary data on medicines policies and use, the decision to publish, nor preparation of the manuscript.	Bavestrello L, 2002, REV MED CHILE, V130, P1265; Chen W, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-211; Francke AL, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-38; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; Harbarth S, 2005, EMERG INFECT DIS, V11, P794, DOI 10.3201/eid1106.050167; Holloway KA, 2013, TROP MED INT HEALTH, V18, P656, DOI 10.1111/tmi.12123; Holloway KA, 2011, WHOBEMPMIE201122; Holloway KA, 2009, TROP MED INT HEALTH, V14, P1; Holloway KA, 2015, PAEDIATR INT CHILD H, V35, P5, DOI 10.1179/2046905514Y.0000000115; Holloway KA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001724; Holloway Kathleen Anne, 2011, Expert Rev Clin Pharmacol, V4, P335, DOI 10.1586/ecp.11.14; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Institute of Medicine, 1998, MICROBIAL THREATS HL; Jaffer B., 2007, WHO NGO TECHN BRIEF; Levy SB, 2005, ADV DRUG DELIVER REV, V57, P1446, DOI 10.1016/j.addr.2005.04.001; Livermore DM, 2003, CLIN INFECT DIS, V36, pS11, DOI 10.1086/344654; Logez S, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-136; Lu CY, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-75; Molstad S, 2008, LANCET INFECT DIS, V8, P125, DOI 10.1016/S1473-3099(08)70017-3; Okeke IN, 2005, LANCET INFECT DIS, V5, P568, DOI 10.1016/S1473-3099(05)70217-6; Park S, 2005, HEALTH POLICY PLANN, V20, P302, DOI 10.1093/heapol/czi033; Parrino TA, 2005, PHARMACOTHERAPY, V25, P289, DOI 10.1592/phco.25.2.289.56951; Radyowijati A, 2003, SOC SCI MED, V57, P733, DOI 10.1016/S0277-9536(02)00422-7; Ratanawijitrasin S, 2001, SOC SCI MED, V53, P831, DOI 10.1016/S0277-9536(00)00390-7; Rowe AK, 2009, AM J PUBLIC HEALTH, V99, P837, DOI 10.2105/AJPH.2008.134411; Sabuncu E, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000084; SCORE, 2004, RES SENS ISS EUR ROA; Shorr AF, 2007, PHARMACOECONOMICS, V25, P751, DOI 10.2165/00019053-200725090-00004; Sketris IS, 2009, J POPUL THER CLIN PH, V16, pE103; Teng C L, 2006, Med J Malaysia, V61, P323; Trap B, 2002, HEALTH POLICY PLANN, V17, P288, DOI 10.1093/heapol/17.3.288; Vang C, 2006, EUR J CLIN PHARMACOL, V62, P57, DOI 10.1007/s00228-005-0069-8; WHO, 2005, WHOPSM20051; WHO, 1985, RAT US DRUGS C EXP; WHO, 2001, WHOCSRDRS20012; World Health Organisation, 2002, WHO POL PERSP MED, V5; World Health Organization, 2015, A6820 WHO; World Health Organization, 2006, US IND MEAS COUNTR P; World Health Organization, 2007, WHOTCM20072; World Health Organization, 1993, INVESTIGATE DRUG USE; World Health Organization, 2009, MED US PRIM CAR DEV; World Health Organization, 2010, WHOEMPMPC20101	42	40	43	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152020	10.1371/journal.pone.0152020	http://dx.doi.org/10.1371/journal.pone.0152020			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3OX	27002977	Green Published, gold, Green Submitted			2022-12-26	WOS:000372697400066
J	Klebow, S; Hahn, M; Nikoalev, A; Wunderlich, FT; Hovelmeyer, N; Karbach, SH; Waisman, A				Klebow, Sabrina; Hahn, Matthias; Nikoalev, Alexei; Wunderlich, F. Thomas; Hoevelmeyer, Nadine; Karbach, Susanne H.; Waisman, Ari			IL-6 Signaling in Myelomonocytic Cells Is Not Crucial for the Development of IMQ-Induced Psoriasis	PLOS ONE			English	Article							DELTA-T-CELLS; SKIN INFLAMMATION; EPIDERMAL HYPERPLASIA; AUTOIMMUNE-DISEASES; PLAQUE-FORMATION; IMIQUIMOD; INTERLEUKIN-6; TOCILIZUMAB; RECEPTOR; MODEL	Psoriasis is an autoimmune skin disease that is associated with aberrant activity of immune cells and keratinocytes. In mice, topical application of TLR7/8 agonist IMQ leads to a skin disorder resembling human psoriasis. Recently, it was shown that the IL-23/IL-17 axis plays a deciding role in the pathogenesis of human psoriasis, as well as in the mouse model of IMQ-induced psoriasis-like skin disease. A consequence of IL-17A production in the skin includes increased expression and production of IL-6, resulting in the recruitment of neutrophils and other myelomonocytic cells to the site of inflammation. To further investigate and characterize the exact role of IL-6 signaling in myelomonocytic cells during experimental psoriasis, we generated mice lacking the IL-6 receptor alpha specifically in myelomonocytic cells (IL-6R alpha Delta(myel)). Surprisingly, disease susceptibility of these mice was not affected in this model. Our study shows that classical IL-6 signaling in myelomonocytic cells does not play an essential role for disease development of IMQ-induced psoriasis-like skin disease.	[Klebow, Sabrina; Hahn, Matthias; Nikoalev, Alexei; Hoevelmeyer, Nadine; Karbach, Susanne H.; Waisman, Ari] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, D-55122 Mainz, Germany; [Wunderlich, F. Thomas] Max Planck Inst Metab Res, Cologne, Germany; [Karbach, Susanne H.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med 2, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Waisman, A (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Mol Med, D-55122 Mainz, Germany.	waisman@uni-mainz.de	Karbach, Susanne/X-8136-2019; Waisman, Ari/C-7383-2015; Karbach, Susanne/GPC-8804-2022	Waisman, Ari/0000-0003-4304-8234; Hovelmeyer, Nadine/0000-0002-1807-4556	German Research Foundation (DFG) [CRC/TRR 156 (TPC01), KA 4035/1-1]; Stiftung Mainzer Herz; program MAIFOR from the University of Mainz	German Research Foundation (DFG)(German Research Foundation (DFG)); Stiftung Mainzer Herz; program MAIFOR from the University of Mainz	Research was supported by the German Research Foundation (DFG) grants CRC/TRR 156 (TPC01) to AW and KA 4035/1-1 to SHK. SHK research was also supported by the Stiftung Mainzer Herz and the program MAIFOR from the University of Mainz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becher B, 2012, NAT MED, V18, P1748, DOI 10.1038/nm.3016; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Camporeale A, 2012, FRONT BIOSCI-LANDMRK, V17, P2306, DOI 10.2741/4054; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Croxford AL, 2014, J INVEST DERMATOL, V134, P728, DOI 10.1038/jid.2013.404; Danilenko DM, 2008, VET PATHOL, V45, P563, DOI 10.1354/vp.45-4-563; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; El Malki K, 2013, J INVEST DERMATOL, V133, P441, DOI 10.1038/jid.2012.318; Fielding CA, 2008, J IMMUNOL, V181, P2189, DOI 10.4049/jimmunol.181.3.2189; Flutter B, 2013, EUR J IMMUNOL, V43, P3138, DOI 10.1002/eji.201343801; Gilliet M, 2004, ARCH DERMATOL, V140, P1490, DOI 10.1001/archderm.140.12.1490; GROSSMAN RM, 1989, P NATL ACAD SCI USA, V86, P6367, DOI 10.1073/pnas.86.16.6367; Ho LJ, 2015, BIOCHEM PHARMACOL, V97, P16, DOI 10.1016/j.bcp.2015.06.009; Hughes M, 2013, RHEUMATOLOGY, V52, P1728, DOI 10.1093/rheumatology/kes432; Hvid H, 2008, INT IMMUNOL, V20, P1097, DOI 10.1093/intimm/dxn068; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Johnson-Huang LM, 2012, DIS MODEL MECH, V5, P423, DOI 10.1242/dmm.009092; Lindroos J, 2011, J INVEST DERMATOL, V131, P1110, DOI 10.1038/jid.2010.432; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Mabuchi T, 2011, J IMMUNOL, V187, P5026, DOI 10.4049/jimmunol.1101817; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007; Neurath MF, 2011, CYTOKINE GROWTH F R, V22, P83, DOI 10.1016/j.cytogfr.2011.02.003; Palmou-Fontana N, 2014, DERMATOLOGY, V228, P311, DOI 10.1159/000362266; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Roller A, 2012, J IMMUNOL, V189, P4612, DOI 10.4049/jimmunol.1103173; Rose S, 2012, CYTOM PART A, V81A, P343, DOI 10.1002/cyto.a.22012; Rose-John S, 2007, EXPERT OPIN THER TAR, V11, P613, DOI 10.1517/14728222.11.5.613; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Saggini A, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/964069; Sano S, 2005, NAT MED, V11, P43, DOI 10.1038/nm1162; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Tanaka T, 2011, FEBS LETT, V585, P3699, DOI 10.1016/j.febslet.2011.03.023; Tortola L, 2012, J CLIN INVEST, V122, P3965, DOI 10.1172/JCI63451; Toruniowa B, 1995, ANN NY ACAD SCI, V762, P432; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Waisman A, 2012, NEW ENGL J MED, V366, P1251, DOI 10.1056/NEJMe1201071; Walter A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2566; Wang XP, 2004, J INVEST DERMATOL, V123, P124, DOI 10.1111/j.0022-202X.2004.22736.x; Wendling D, 2012, J RHEUMATOL, V39, P657, DOI 10.3899/jrheum.111166; Wenzel P, 2011, CIRCULATION, V124, P1370, DOI 10.1161/CIRCULATIONAHA.111.034470; Wohn C, 2013, P NATL ACAD SCI USA, V110, P10723, DOI 10.1073/pnas.1307569110; Wunderlich FT, 2010, CELL METAB, V12, P237, DOI 10.1016/j.cmet.2010.06.011; Yao X, 2014, PHARMACOL THERAPEUT, V141, P125, DOI 10.1016/j.pharmthera.2013.09.004; Yoshiki R, 2014, J INVEST DERMATOL, V134, P1912, DOI 10.1038/jid.2014.98; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	50	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151913	10.1371/journal.pone.0151913	http://dx.doi.org/10.1371/journal.pone.0151913			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999594	gold, Green Published, Green Submitted			2022-12-26	WOS:000372694700084
J	Marcinkiewicz, MM; Baker, ST; Wu, JC; Hubert, TL; Wolfson, MR				Marcinkiewicz, Mariola M.; Baker, Sandy T.; Wu, Jichuan; Hubert, Terrence L.; Wolfson, Marla R.			A Novel Approach for Ovine Primary Alveolar Epithelial Type II Cell Isolation and Culture from Fresh and Cryopreserved Tissue Obtained from Premature and Juvenile Animals	PLOS ONE			English	Article							SURFACTANT PROTEIN-B; AIR-LIQUID INTERFACE; DIFFERENTIATED FUNCTION; NATRIURETIC-PEPTIDE; RESPIRATORY-FAILURE; IN-VITRO; LUNG; MAINTENANCE; EXPRESSION; GENE	The in vivo ovine model provides a clinically relevant platform to study cardiopulmonary mechanisms and treatments of disease; however, a robust ovine primary alveolar epithelial type II (ATII) cell culture model is lacking. The objective of this study was to develop and optimize ovine lung tissue cryopreservation and primary ATII cell culture methodologies for the purposes of dissecting mechanisms at the cellular level to elucidate responses observed in vivo. To address this, we established in vitro submerged and air-liquid interface cultures of primary ovine ATII cells isolated from fresh or cryopreserved lung tissues obtained from mechanically ventilated sheep (128 days gestation-6 months of age). Presence, abundance, and mRNA expression of surfactant proteins was assessed by immunocytochemistry, Western Blot, and quantitative PCR respectively on the day of isolation, and throughout the 7 day cell culture study period. All biomarkers were significantly greater from cells isolated from fresh than cryopreserved tissue, and those cultured in air-liquid interface as compared to submerged culture conditions at all time points. Surfactant protein expression remained in the air-liquid interface culture system while that of cells cultured in the submerged system dissipated over time. Despite differences in biomarker magnitude between cells isolated from fresh and cryopreserved tissue, cells isolated from cryopreserved tissue remained metabolically active and demonstrated a similar response as cells from fresh tissue through 72 hr period of hyperoxia. These data demonstrate a cell culture methodology using fresh or cryopreserved tissue to support study of ovine primary ATII cell function and responses, to support expanded use of biobanked tissues, and to further understanding of mechanisms that contribute to in vivo function of the lung.	[Marcinkiewicz, Mariola M.; Baker, Sandy T.; Wu, Jichuan; Hubert, Terrence L.; Wolfson, Marla R.] Temple Univ, Katz Sch Med, Dept Thorac Med & Surg, Philadelphia, PA 19122 USA; [Wolfson, Marla R.] Temple Univ, Katz Sch Med, Dept Physiol Pediat & Med, Philadelphia, PA 19122 USA; [Marcinkiewicz, Mariola M.; Baker, Sandy T.; Wu, Jichuan; Hubert, Terrence L.; Wolfson, Marla R.] Temple Univ, Katz Sch Med, Ctr Inflammat Translat & Clin Lung Res, Philadelphia, PA 19122 USA; [Marcinkiewicz, Mariola M.; Baker, Sandy T.; Wu, Jichuan; Hubert, Terrence L.; Wolfson, Marla R.] Temple Univ, Katz Sch Med, CENTRe Collaborat Environm & Neonatal Therapeut, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Wolfson, MR (corresponding author), Temple Univ, Katz Sch Med, Dept Thorac Med & Surg, Philadelphia, PA 19122 USA.; Wolfson, MR (corresponding author), Temple Univ, Katz Sch Med, Dept Physiol Pediat & Med, Philadelphia, PA 19122 USA.; Wolfson, MR (corresponding author), Temple Univ, Katz Sch Med, Ctr Inflammat Translat & Clin Lung Res, Philadelphia, PA 19122 USA.; Wolfson, MR (corresponding author), Temple Univ, Katz Sch Med, CENTRe Collaborat Environm & Neonatal Therapeut, Philadelphia, PA 19122 USA.	marla.wolfson@temple.edu			Department of Defense/Office of Naval Research [N000141210597/N000141210810]; Discovery Laboratories, Inc.	Department of Defense/Office of Naval Research(Office of Naval ResearchUnited States Department of Defense); Discovery Laboratories, Inc.	This work was supported by the Department of Defense/Office of Naval Research N000141210597/N000141210810 (MRW) and Discovery Laboratories, Inc. (MRW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beers MF, 2005, ANNU REV PHYSIOL, V67, P663, DOI 10.1146/annurev.physiol.67.040403.101937; Bjarnadottir H, 2005, J BIOTECHNOL, V117, P173, DOI 10.1016/j.jbiotec.2005.01.016; CLARK JC, 1995, P NATL ACAD SCI USA, V92, P7794, DOI 10.1073/pnas.92.17.7794; Creuwels LAJM, 1997, LUNG, V175, P1, DOI 10.1007/PL00007554; D'Angelis CA, 2008, PEDIATR RES, V63, P239, DOI 10.1203/PDR.0b013e318163a215; D'Angelis CA, 2006, HISTOCHEM CELL BIOL, V126, P317, DOI 10.1007/s00418-006-0159-4; DiVincenti L, 2014, J AM ASSOC LAB ANIM, V53, P439; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; Dobbs LG, 1997, AM J PHYSIOL-LUNG C, V273, pL347, DOI 10.1152/ajplung.1997.273.2.L347; EVANS MJ, 1975, EXP MOL PATHOL, V22, P142, DOI 10.1016/0014-4800(75)90059-3; Fuchs S, 2003, CELL TISSUE RES, V311, P31, DOI 10.1007/s00441-002-0653-5; Gonzales LW, 2002, AM J PHYSIOL-LUNG C, V283, pL940, DOI 10.1152/ajplung.00127.2002; Gonzales LW, 2001, PEDIATR PATHOL MOL M, V20, P387, DOI 10.1080/15513810109168622; Grek CL, 2009, EXP LUNG RES, V35, P155, DOI 10.1080/01902140802495870; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lenz AG, 2014, AM J RESP CELL MOL, V51, P526, DOI 10.1165/rcmb.2013-0479OC; Lenz AG, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/652632; LILEY HG, 1988, BIOCHIM BIOPHYS ACTA, V961, P86, DOI 10.1016/0005-2760(88)90133-6; Lin S, 1996, J BIOL CHEM, V271, P19689, DOI 10.1074/jbc.271.33.19689; Mancia A, 2012, COMP BIOCHEM PHYS C, V155, P136, DOI 10.1016/j.cbpc.2011.04.002; Marquez-Curtis LA, 2015, CRYOBIOLOGY, V71, P181, DOI 10.1016/j.cryobiol.2015.07.003; Mason R J, 1983, Curr Probl Clin Biochem, V13, P24; Melton KR, 2003, AM J PHYSIOL-LUNG C, V285, pL543, DOI 10.1152/ajplung.00011.2003; Pezzulo AA, 2011, AM J PHYSIOL-LUNG C, V300, pL25, DOI 10.1152/ajplung.00256.2010; Rice WR, 2002, AM J PHYSIOL-LUNG C, V283, pL256, DOI 10.1152/ajplung.00302.2001; Scheerlinck JPY, 2008, TRENDS BIOTECHNOL, V26, P259, DOI 10.1016/j.tibtech.2008.02.002; SHANNON JM, 1987, BIOCHIM BIOPHYS ACTA, V931, P143, DOI 10.1016/0167-4889(87)90200-X; SHANNON JM, 1990, AM J RESP CELL MOL, V2, P183, DOI 10.1165/ajrcmb/2.2.183; Shannon JM, 2001, AM J RESP CELL MOL, V24, P235, DOI 10.1165/ajrcmb.24.3.4302; SHANNON JM, 1992, AM J PHYSIOL, V262, pL427, DOI 10.1152/ajplung.1992.262.4.L427; Shetty SK, 2012, AM J RESP CELL MOL, V47, P474, DOI 10.1165/rcmb.2011-0390OC; SPAIN CL, 1987, PEDIATR RES, V21, P5, DOI 10.1203/00006450-198701000-00002; STONE KC, 1992, AM J RESP CELL MOL, V6, P235, DOI 10.1165/ajrcmb/6.2.235; Strober W, 2001, Curr Protoc Immunol, VAppendix 3, p3B, DOI 10.1002/0471142735.ima03bs21; SUWABE A, 1991, AM J RESP CELL MOL, V5, P80, DOI 10.1165/ajrcmb/5.1.80; Tichopad A, 2003, MOL CELL PROBE, V17, P5, DOI 10.1016/S0890-8508(02)00114-7; Tokieda K, 1997, AM J PHYSIOL-LUNG C, V273, pL875, DOI 10.1152/ajplung.1997.273.4.L875; WHITSETT JA, 1995, PHYSIOL REV, V75, P749, DOI 10.1152/physrev.1995.75.4.749; Wolfson MR, 2008, ASAIO J, V54, P256, DOI 10.1097/MAT.0b013e318168fef0; Wolfson MR, 2012, PEDIATR RES, V72, P375, DOI 10.1038/pr.2012.96; WOLFSON MR, 1988, J APPL PHYSIOL, V65, P1436, DOI 10.1152/jappl.1988.65.3.1436; Xu XS, 1998, AM J RESP CELL MOL, V18, P168, DOI 10.1165/ajrcmb.18.2.2824; Yano T, 2000, AM J PHYSIOL-LUNG C, V279, pL1146, DOI 10.1152/ajplung.2000.279.6.L1146	43	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0152027	10.1371/journal.pone.0152027	http://dx.doi.org/10.1371/journal.pone.0152027			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999050	Green Published, Green Submitted, gold			2022-12-26	WOS:000372694700094
J	Summa, A; Vannozzi, G; Bergamini, E; Iosa, M; Morelli, D; Cappozzo, A				Summa, Aurora; Vannozzi, Giuseppe; Bergamini, Elena; Iosa, Marco; Morelli, Daniela; Cappozzo, Aurelio			Multilevel Upper Body Movement Control during Gait in Children with Cerebral Palsy	PLOS ONE			English	Article							GROSS MOTOR FUNCTION; WALKING; STABILITY; TRUNK; ACCELERATIONS; YOUNG; HEAD; DISPLACEMENT; RELIABILITY; FREQUENCY	Upper body movements during walking provide information about balance control and gait stability. Typically developing (TD) children normally present a progressive decrease of accelerations from the pelvis to the head, whereas children with cerebral palsy (CP) exhibit a general increase of upper body accelerations. However, the literature describing how they are transmitted from the pelvis to the head is lacking. This study proposes a multilevel motion sensor approach to characterize upper body accelerations and how they propagate from pelvis to head in children with CP, comparing with their TD peers. Two age-and gender-matched groups of 20 children performed a 10m walking test at self-selected speed while wearing three magneto-inertial sensors located at pelvis, sternum, and head levels. The root mean square value of the accelerations at each level was computed in a local anatomical frame and its variation from lower to upper levels was described using attenuation coefficients. Between-group differences were assessed performing an ANCOVA, while the mutual dependence between acceleration components and the relationship between biomechanical parameters and typical clinical scores were investigated using Regression Analysis and Spearman's Correlation, respectively (alpha = 0.05). New insights were obtained on how the CP group managed the transmission of accelerations through the upper body. Despite a significant reduction of the acceleration from pelvis to sternum, children with CP do not compensate for large accelerations, which are greater than in TD children. Furthermore, those with CP showed negative sternum-to-head attenuations, in agreement with the documented rigidity of the head-trunk system observed in this population. In addition, the estimated parameters proved to correlate with the scores used in daily clinical practice. The proposed multilevel approach was fruitful in highlighting CP-TD gait differences, supported the in-field quantitative gait assessment in children with CP and might prove beneficial to designing innovative intervention protocols based on pelvis stabilization.	[Summa, Aurora; Vannozzi, Giuseppe; Bergamini, Elena; Cappozzo, Aurelio] Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Interuniv Ctr Bioengn Human Neuromusculoskeletal, Piazza Lauro De Bosis 15, I-00135 Rome, Italy; [Iosa, Marco; Morelli, Daniela] Fdn Santa Lucia IRCCS, Via Ardeatina 306, I-00179 Rome, Italy	Foro Italico University of Rome; IRCCS Santa Lucia	Vannozzi, G (corresponding author), Univ Rome Foro Italico, Dept Movement Human & Hlth Sci, Interuniv Ctr Bioengn Human Neuromusculoskeletal, Piazza Lauro De Bosis 15, I-00135 Rome, Italy.	giuseppe.vannozzi@uniroma4.it	Vannozzi, Giuseppe/G-9897-2013; Bergamini, Elena/AAC-1555-2019; Morelli, Daniela/L-2114-2018; Iosa, Marco/B-9531-2012; Iosa, Marco/AAC-1693-2022	Vannozzi, Giuseppe/0000-0002-2359-6076; Bergamini, Elena/0000-0002-9055-3981; Morelli, Daniela/0000-0001-5797-7451; 	Italian Ministry of Economic Development; University of Rome "Foro Italico"	Italian Ministry of Economic Development(Ministry of Economic Development, Italy); University of Rome "Foro Italico"	The study was financially supported by the Italian Ministry of Economic Development (ICE-CRUI agreement, call 2010, SIVAM project) and by the University of Rome "Foro Italico" (PR_2013, DeMOS project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armitage P., 1985, STAT METHODS MED RES; Bax M, 2005, DEV MED CHILD NEUROL, V47, P571, DOI 10.1017/S001216220500112X; Berthoz A, 1994, HEAD BODY COORDINATI; Berthoz A, 2015, DEV MED CHILD NEUROL, V57, P15, DOI 10.1111/dmcn.12690; Brandes M, 2006, GAIT POSTURE, V24, P482, DOI 10.1016/j.gaitpost.2005.12.006; Bruijn SM, 2013, RES DEV DISABIL, V34, P1689, DOI 10.1016/j.ridd.2013.02.011; Cappa P, 2008, GAIT POSTURE, V28, P615, DOI 10.1016/j.gaitpost.2008.04.013; CAPPOZZO A, 1981, J BIOMECH, V14, P411, DOI 10.1016/0021-9290(81)90059-2; CAPPOZZO A, 1982, J BIOMECH, V15, P599, DOI 10.1016/0021-9290(82)90071-9; Chambers Henry G, 2002, J Am Acad Orthop Surg, V10, P222; DeLuca PA, 1997, J PEDIATR ORTHOPED, V17, P608, DOI 10.1097/00004694-199709000-00007; Hanna SE, 2009, DEV MED CHILD NEUROL, V51, P295, DOI 10.1111/j.1469-8749.2008.03196.x; Heyrman L, 2013, GAIT POSTURE, V38, P770, DOI 10.1016/j.gaitpost.2013.03.019; Heyrman L, 2014, RES DEV DISABIL, V35, P2044, DOI 10.1016/j.ridd.2014.04.031; HOF AL, 1996, GAIT POSTURE, V4, P222; Hsue BJ, 2009, GAIT POSTURE, V29, P465, DOI 10.1016/j.gaitpost.2008.11.007; Innman V, 1981, HUMAN WALKING; Iosa M, 2012, RES DEV DISABIL, V33, P129, DOI 10.1016/j.ridd.2011.08.031; Kang HG, 2009, GAIT POSTURE, V30, P260, DOI 10.1016/j.gaitpost.2009.05.003; Kavanagh JJ, 2004, GAIT POSTURE, V20, P291, DOI 10.1016/j.gaitpost.2003.10.004; Kavanagh JJ, 2006, J BIOMECH, V39, P2863, DOI 10.1016/j.jbiomech.2005.09.012; Masci I, 2013, GAIT POSTURE, V37, P570, DOI 10.1016/j.gaitpost.2012.09.017; Massaad F, 2004, DEV MED CHILD NEUROL, V46, P674, DOI 10.1017/s0012162204001136; Mazza C, 2010, GAIT POSTURE, V31, P429, DOI 10.1016/j.gaitpost.2010.01.012; Mazza C, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-30; Menz HB, 2003, GAIT POSTURE, V18, P35, DOI 10.1016/S0966-6362(02)00159-5; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Romkes J, 2007, J PEDIATR ORTHOP B, V16, P175, DOI 10.1097/BPB.0b013e32801405bf; Rosenbaum P, 2007, DEV MED CHILD NEUROL, V109, P8, DOI DOI 10.1111/J.1469-8749.2007.TB12610.X; RUSSELL DJ, 1989, DEV MED CHILD NEUROL, V31, P341; Saether R, 2014, RES DEV DISABIL, V35, P1773, DOI 10.1016/j.ridd.2014.02.011; Schweizer K, 2014, CLIN BIOMECH, V29, P387, DOI 10.1016/j.clinbiomech.2014.02.005; Vaughan CL, 2003, EXP BRAIN RES, V153, P123, DOI 10.1007/s00221-003-1635-x; Wang TM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143967; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd	35	23	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151792	10.1371/journal.pone.0151792	http://dx.doi.org/10.1371/journal.pone.0151792			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999362	gold, Green Published, Green Submitted			2022-12-26	WOS:000372694700066
J	Vasconcelos, BHB; Souza, GS; Barroso, TGCP; Silveira, LCL; Sousa, RCM; Callegari, B; Xavier, MB				Vasconcelos, Beatriz Helena B.; Souza, Givago S.; Barroso, Tatiana G. C. P.; Silveira, Luiz Carlos L.; Sousa, Rita Catarina M.; Callegari, Bianca; Xavier, Marilia B.			Barefoot Plantar Pressure Indicates Progressive Neurological Damage in Patients with Human T-Cell Lymphotropic Virus Type 1 Infection	PLOS ONE			English	Article							TROPICAL SPASTIC PARAPARESIS; HTLV-I; LEUKEMIA; FEATURES; RISK	Background The human T-Cell Lymphotropic Virus Type 1 (HTLV-1) is a retrovirus associated with neurological alterations; individuals with HTLV-1 infection may develop HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP). Frequent neurological complaints include foot numbness and leg weakness. In this study, we compared the distribution of the body weight on different areas of the foot in HTLV-1 patients with HAM/TSP, asymptomatic HTLV-1 patients, and healthy individuals. Methodology We studied 36 HTLV-1 infected patients, who were divided in two groups of 18 patients each based on whether or not they had been diagnosed with HAM/TSP, and 17 control subjects. The evaluation included an interview on the patient's clinical history and examinations of the patient's reflexes, foot skin tactile sensitivity, and risk of falling. The pressure distribution on different areas of the foot was measured with baropodometry, using a pressure platform, while the patients had their eyes open or closed. Main Findings The prevalence of neurological disturbances-altered reflexes and skin tactile sensitivity and increased risk of falling-was higher in HTLV-1 HAM/TSP patients than in HTLV-1 asymptomatic patients. The medium and maximum pressure values were higher in the forefoot than in the midfoot and hindfoot in both HTLV-1 groups. In addition, the pressure on the hindfoot was lower in HAM/TSP patients compared to control subjects. Conclusions The neurological disturbances associated with HTLV-1 infection gradually worsened from HTLV-1 asymptomatic patients to HAM/TSP patients. Baropodometry is a valuable tool to establish the extent of neurological damage in patients suffering from HTLV-1 infection.	[Vasconcelos, Beatriz Helena B.; Xavier, Marilia B.] Univ Estado Para, Belem, Para, Brazil; [Souza, Givago S.; Barroso, Tatiana G. C. P.; Silveira, Luiz Carlos L.; Sousa, Rita Catarina M.; Xavier, Marilia B.] Fed Univ Para, Nucleo Med Trop, BR-66059 Belem, Para, Brazil; [Souza, Givago S.; Silveira, Luiz Carlos L.] Fed Univ Para, Inst Ciencias Biol, BR-66059 Belem, Para, Brazil; [Silveira, Luiz Carlos L.] Univ Ceuma, Sao Luis, Maranhao, Brazil; [Callegari, Bianca] Fed Univ Para, Inst Ciencias Saude, BR-66059 Belem, Para, Brazil	Universidade do Estado do Para (UEPA); Universidade Federal do Para; Universidade Federal do Para; Universidade Ceuma; Universidade Federal do Para	Callegari, B (corresponding author), Fed Univ Para, Inst Ciencias Saude, BR-66059 Belem, Para, Brazil.	callegaribi@uol.com.br	Callegari, Bianca/G-3605-2016; Souza, Givago/W-6393-2019	Callegari, Bianca/0000-0001-9151-3896; Souza, Givago/0000-0002-4525-3971	Para Amazon Research Support Foundation (FAPESPA) [180/2012]; CAPES/COFECUBE [819-14]; Brazilian National Council for Scientific and Technological Development (CNPq) [486545/2012-1]; CAPES	Para Amazon Research Support Foundation (FAPESPA)(Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); CAPES/COFECUBE; Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This research was supported by the following grants: Para Amazon Research Support Foundation (FAPESPA) number180/2012; CAPES/COFECUBE research grant number 819-14 and Brazilian National Council for Scientific and Technological Development (CNPq) number 486545/2012-1. BHBV is the recipient of a CAPES fellowship for graduate students. LCLS is a CNPq research fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaut V.A.C.O., 2014, PHYS THER RES, V4, P99; AYRES M., 2003, BIOESTAT3 0 APLICACO; BHIGJEE AI, 1990, BRAIN, V113, P1307, DOI 10.1093/brain/113.5.1307; Carneiro-Proietti Anna Bárbara F., 2002, Rev. Soc. Bras. Med. Trop., V35, P499, DOI 10.1590/S0037-86822002000500013; Cunha EFD, 2013, BRAZ J MED HUM HLTH, V1, P19; DEARAUJO A, 1993, ACTA NEUROL SCAND, V88, P59; Dias GAS, 2015, SPINAL CORD, P1; Donaghue VM, 1997, ORTHOPAEDIC PHYSICAL, V6, P1509; Franzoi AC, 2007, SPINAL CORD, V45, P64, DOI 10.1038/sj.sc.3101919; Gotuzzo E, 2004, CLIN INFECT DIS, V39, P939, DOI 10.1086/423957; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; KITAOKA HB, 1995, FOOT ANKLE INT, V16, P492, DOI 10.1177/107110079501600806; Lannes P, 2006, REV NEUROSCI, V14, P153; Macedo MC, 2013, BRAZ J MED HUM HLTH, V1, DOI [10.17267/2317-3386bjmhh.v1i2.168, DOI 10.17267/2317-3386BJMHH.V1I2.168]; Monteiro VA, 1999, THESIS PONTIFICIA U; Orland JR, 2003, NEUROLOGY, V61, P1588, DOI 10.1212/01.WNL.0000096011.92542.DA; Osame M, 2002, J NEUROVIROL, V8, P359, DOI 10.1080/13550280260422668; OSAME M, 1986, LANCET, V1, P1031; Rosario JLP, 2014, J BODYW MOV THER, V18, P215, DOI 10.1016/j.jbmt.2013.05.016; Reiss DB, 2014, RETROVIROLOGY S1, V11, pP51; Ribas João Gabriel Ramos, 2002, Rev. Soc. Bras. Med. Trop., V35, P377, DOI 10.1590/S0037-86822002000400015; Santos Fred Luciano Neves, 2005, J. Bras. Patol. Med. Lab., V41, P105, DOI 10.1590/S1676-24442005000200008; Satou Y, 2013, REV MED VIROL, V23, P269, DOI 10.1002/rmv.1745; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Souza A, 2012, REV SOC BRAS MED TRO, V45, P545, DOI 10.1590/S0037-86822012000500002; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Tipismana M, 2008, SUBACUTE PROGR HTLV; UCHIYAMA T, 1977, BLOOD, V50, P481, DOI 10.1182/blood.V50.3.481.481; UNSONG O, 2008, NEUROL CLIN, V26, P781, DOI DOI 10.1016/J.NCL.2008.03.008; van Sickels N. J., 2013, HUNTERS TROPICAL MED, P375; Verdonck K, 2007, LANCET INFECT DIS, V7, P266, DOI 10.1016/S1473-3099(07)70081-6; VERNANT JC, 1987, ANN NEUROL, V21, P123, DOI 10.1002/ana.410210204; Vianna DL, 2006, Braz. J. Phys. Ther., V10, P339, DOI 10.1590/S1413-35552006000300014; WHO, 1989, WEEKLY EPIDEMIOLOGIC, P382; Yamano Y, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00389; Zunt JR, 1999, NEUROLOGY, V53, P386, DOI 10.1212/WNL.53.2.386	36	6	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151855	10.1371/journal.pone.0151855	http://dx.doi.org/10.1371/journal.pone.0151855			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998608	gold, Green Published, Green Submitted			2022-12-26	WOS:000372694700074
J	Bedoya-Lopez, A; Estrada, K; Sanchez-Flores, A; Ramirez, OT; Altamirano, C; Segovia, L; Miranda-Rios, J; Trujillo-Roldan, MA; Valdez-Cruz, NA				Bedoya-Lopez, Andrea; Estrada, Karel; Sanchez-Flores, Alejandro; Ramirez, Octavio T.; Altamirano, Claudia; Segovia, Lorenzo; Miranda-Rios, Juan; Trujillo-Roldan, Mauricio A.; Valdez-Cruz, Norma A.			Effect of Temperature Downshift on the Transcriptomic Responses of Chinese Hamster Ovary Cells Using Recombinant Human Tissue Plasminogen Activator Production Culture	PLOS ONE			English	Article							CONNECTS FANCONI-ANEMIA; B-MYB; GENE-EXPRESSION; DOWN-REGULATION; DIFFERENTIAL EXPRESSION; ANTIBODY-PRODUCTION; INTERFERON-GAMMA; MAMMALIAN-CELLS; COLD SHOCK; RNA-SEQ	Recombinant proteins are widely used as biopharmaceuticals, but their production by mammalian cell culture is expensive. Hence, improvement of bioprocess productivity is greatly needed. A temperature downshift (TDS) from 37 degrees C to 28-34 degrees C is an effective strategy to expand the productive life period of cells and increase their productivity (q(p)). Here, TDS in Chinese hamster ovary (CHO) cell cultures, initially grown at 37 degrees C and switched to 30 degrees C during the exponential growth phase, resulted in a 1.6-fold increase in the qp of recombinant human tissue plasminogen activator (rh-tPA). The transcriptomic response using next-generation sequencing (NGS) was assessed to characterize the cellular behavior associated with TDS. A total of 416 (q > 0.8) and 3,472 (q > 0.9) differentially expressed transcripts, with more than a 1.6-fold change at 24 and 48 h post TDS, respectively, were observed in cultures with TDS compared to those at constant 37 degrees C. In agreement with the extended cell survival resulting from TDS, transcripts related to cell growth arrest that controlled cell proliferation without the activation of the DNA damage response, were differentially expressed. Most upregulated genes were related to energy metabolism in mitochondria, mitochondrial biogenesis, central metabolism, and avoidance of apoptotic cell death. The gene coding for rh-tPA was not differentially expressed, but fluctuations were detected in the transcripts encoding proteins involved in the secretory machinery, particularly in glycosylation. Through NGS the dynamic processes caused by TDS were assessed in this biological system.	[Bedoya-Lopez, Andrea; Miranda-Rios, Juan; Trujillo-Roldan, Mauricio A.; Valdez-Cruz, Norma A.] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Mol & Biotecnol, Mexico City 04510, DF, Mexico; [Estrada, Karel; Sanchez-Flores, Alejandro] Univ Nacl Autonoma Mexico, Inst Biotecnol, Unidad Univ Apoyo Bioinformat, Cuernavaca 62191, Morelos, Mexico; [Ramirez, Octavio T.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62191, Morelos, Mexico; [Altamirano, Claudia] Pontificia Univ Catolica Valparaiso, Escuela Ingn Bioquim, Valparaiso, Chile; [Segovia, Lorenzo] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca 62191, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Pontificia Universidad Catolica de Valparaiso; Universidad Nacional Autonoma de Mexico	Valdez-Cruz, NA (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Biol Mol & Biotecnol, Mexico City 04510, DF, Mexico.	adri@biomedicas.unam.mx	Miranda Ríos, Juan/ABB-7767-2021; Valdez-Cruz, Norma A./AAH-9584-2020; Trujillo-Roldán, Mauricio/B-3961-2014; Segovia, Lorenzo/A-5206-2008; Sanchez-Flores, Alejandro/L-9454-2016	Valdez-Cruz, Norma A./0000-0002-8581-1173; Trujillo-Roldán, Mauricio/0000-0002-7497-4452; Segovia, Lorenzo/0000-0002-4291-4711; Altamirano, Claudia/0000-0002-6389-086X; Bedoya, Andrea/0000-0001-7804-5055; Sanchez-Flores, Alejandro/0000-0003-0476-3139	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [220795, 104951-Z, 178528]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (PAPIIT-UNAM) [IN-210013, IN-209113]; CONACYT-Mexico	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (PAPIIT-UNAM); CONACYT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was partially financed by Consejo Nacional de Ciencia y Tecnologia (CONACyT, www.conacyt.mx/, projects 220795, 104951-Z, 178528), and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (PAPIIT-UNAM, www.dgapa.unam.mx, projects IN-210013 and IN-209113). ABL, thanks the "Programa de Doctorado en Ciencias Biomedicas", UNAM, and the scholarship from CONACYT-Mexico. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackland ML, 2003, LAB INVEST, V83, P435, DOI 10.1097/01.LAB.0000059927.97515.FD; Ahn WS, 2008, BIOTECHNOL BIOENG, V101, P1234, DOI 10.1002/bit.22006; Al-Fageeh MB, 2006, BIOCHEM J, V397, P247, DOI 10.1042/BJ20060166; Alexa A, 2010, TOPGO TOPGO ENRICHME; Altamirano C, 2001, BIOTECHNOL PROGR, V17, P1032, DOI 10.1021/bp0100981; Altamirano C, 2006, ELECT J BIOTECHNOL, V9; Andersen DC, 2000, BIOTECHNOL BIOENG, V70, P25, DOI 10.1002/1097-0290(20001005)70:1<25::AID-BIT4>3.0.CO;2-Q; Aritomi M, 1997, J BIOL CHEM, V272, P27886, DOI 10.1074/jbc.272.44.27886; ARSURA M, 1992, BLOOD, V79, P2708; Baik JY, 2006, BIOTECHNOL BIOENG, V93, P361, DOI 10.1002/bit.20717; Becker J, 2011, J BIOTECHNOL, V156, P227, DOI 10.1016/j.jbiotec.2011.09.014; Beltran E, 2011, P NATL ACAD SCI USA, V108, P12461, DOI 10.1073/pnas.1018941108; Bhaijee F, 2011, ANN DIAGN PATHOL, V15, P69, DOI 10.1016/j.anndiagpath.2010.12.001; Bi JX, 2004, BIOTECHNOL BIOENG, V85, P741, DOI 10.1002/bit.20025; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Butler M, 2014, CURR OPIN BIOTECH, V30, P107, DOI 10.1016/j.copbio.2014.06.010; Chuppa S, 1997, BIOTECHNOL BIOENG, V55, P328, DOI 10.1002/(SICI)1097-0290(19970720)55:2<328::AID-BIT10>3.0.CO;2-D; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Danno S, 1997, BIOCHEM BIOPH RES CO, V236, P804, DOI 10.1006/bbrc.1997.7059; Daugherty M, 2002, J BIOL CHEM, V277, P21431, DOI 10.1074/jbc.M201708200; Doolan P, 2012, BIOTECHNOL J, V7, P516, DOI 10.1002/biot.201100255; Durchdewald M, 2009, HISTOL HISTOPATHOL, V24, P14451, DOI 10.14670/HH-24.1451; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Fadloun A, 2008, ONCOGENE, V27, P477, DOI 10.1038/sj.onc.1210657; Fogolin MB, 2004, J BIOTECHNOL, V109, P179, DOI 10.1016/j.jbiotec.2003.10.035; Fomina-Yadlin D, 2015, J BIOTECHNOL, V212, P106, DOI 10.1016/j.jbiotec.2015.08.025; Fox SR, 2005, BIOTECHNOL APPL BIOC, V41, P255, DOI 10.1042/BA20040066; Fox SR, 2004, BIOTECHNOL BIOENG, V85, P177, DOI 10.1002/bit.10861; Gawlitzek M, 2009, BIOTECHNOL BIOENG, V103, P1164, DOI 10.1002/bit.22348; Gettmann J, 2013, BMC P S6, V7, pP5; Gibson L, 1996, ONCOGENE, V13, P665; Gilles C, 1999, J CELL SCI, V112, P4615; Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8; Hammond S, 2012, BIOTECHNOL BIOENG, V109, P528, DOI 10.1002/bit.23322; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hendrick V, 2001, CYTOTECHNOLOGY, V36, P71, DOI 10.1023/A:1014088919546; Huang JH, 2005, CIRCULATION, V112, P76, DOI 10.1161/CIRCULATIONAHA.105.535740; Ilmjarv S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku158; Irminger-Finger I, 1998, J CELL BIOL, V143, P1329, DOI 10.1083/jcb.143.5.1329; Ishida N, 1999, J BIOCHEM, V126, P68, DOI 10.1093/oxfordjournals.jbchem.a022437; Jagya N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087835; Kantardjieff A, 2010, J BIOTECHNOL, V145, P143, DOI 10.1016/j.jbiotec.2009.09.008; Kaufmann H, 1999, BIOTECHNOL BIOENG, V63, P573, DOI 10.1002/(SICI)1097-0290(19990605)63:5<573::AID-BIT7>3.0.CO;2-Y; Kenyon J, 2007, NUCLEIC ACIDS RES, V35, P7557, DOI 10.1093/nar/gkm1064; Khanna KK, 1998, NAT GENET, V20, P398, DOI 10.1038/3882; Kou TC, 2011, J BIOSCI BIOENG, V111, P365, DOI 10.1016/j.jbiosc.2010.11.016; Kumar N, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-42; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; LAM EWF, 1993, EMBO J, V12, P2705, DOI 10.1002/j.1460-2075.1993.tb05932.x; Latham KE, 1996, ONCOGENE, V13, P1161; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Lefeber DJ, 2009, AM J HUM GENET, V85, P76, DOI 10.1016/j.ajhg.2009.06.006; Lewis NE, 2013, NAT BIOTECHNOL, V31, P759, DOI 10.1038/nbt.2624; LIN D, 1994, P NATL ACAD SCI USA, V91, P10079, DOI 10.1073/pnas.91.21.10079; Liu WL, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-146; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeda Y, 2000, EMBO J, V19, P2475, DOI 10.1093/emboj/19.11.2475; Marchant RJ, 2008, MOL BIOTECHNOL, V39, P69, DOI 10.1007/s12033-008-9032-0; Matijasevic Z, 1998, ONCOL RES, V10, P605; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Sanchez-Mora RM, 2012, J MOL NEUROSCI, V47, P582, DOI 10.1007/s12031-011-9687-z; Meza JE, 1999, J BIOL CHEM, V274, P5659, DOI 10.1074/jbc.274.9.5659; Misra S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-50; Murray J, 2003, J BIOL CHEM, V278, P13619, DOI 10.1074/jbc.C300064200; Nagasawa K, 2007, EMBO REP, V8, P483, DOI 10.1038/sj.embor.7400933; Neutelings T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069687; Odet F, 2011, BIOL REPROD, V85, P556, DOI 10.1095/biolreprod.111.091546; Oguchi S, 2006, CYTOTECHNOLOGY, V52, P199, DOI 10.1007/s10616-007-9059-2; Ohnishi T, 1998, ONCOGENE, V16, P1507, DOI 10.1038/sj.onc.1201663; Oliveira-Ferrer L, 2014, BRIT J CANCER, V110, P753, DOI 10.1038/bjc.2013.774; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Pistoni M, 2010, EMBO J, V29, P1215, DOI 10.1038/emboj.2010.16; QUELLE DE, 1995, CELL, V83, P993; Reynolds MR, 2014, ONCOGENE, V33, P556, DOI 10.1038/onc.2012.635; Richard H, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq041; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rojas-Rivera D, 2012, CELL DEATH DIFFER, V19, P1013, DOI 10.1038/cdd.2011.189; Roobol A, 2011, BIOCHEM J, V435, P499, DOI 10.1042/BJ20101303; Roobol A, 2009, FEBS J, V276, P286, DOI 10.1111/j.1742-4658.2008.06781.x; Rupp O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085568; Rutter JL, 2003, ONCOGENE, V22, P4444, DOI 10.1038/sj.onc.1206564; SALA A, 1992, P NATL ACAD SCI USA, V89, P10415, DOI 10.1073/pnas.89.21.10415; Sanchez-Flores A, 2014, CURR TOP MED CHEM, V14, P398, DOI 10.2174/1568026613666131204142353; Sano T, 2002, PATHOL INT, V52, P375, DOI 10.1046/j.1440-1827.2002.01359.x; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Schmitt E, 2000, BIOCHEM BIOPH RES CO, V270, P868, DOI 10.1006/bbrc.2000.2537; Schulze A, 2005, J MOL BIOL, V354, P1021, DOI 10.1016/j.jmb.2005.10.020; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Silvaggi NR, 2006, J BIOL CHEM, V281, P14918, DOI 10.1074/jbc.M601505200; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Sou SN, 2015, BIOTECHNOL BIOENG, V112, P1165, DOI 10.1002/bit.25524; Stancic A, 2013, J EXP BIOL, V216, P4233, DOI 10.1242/jeb.089334; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; Swiderek H, 2007, BIOTECHNOL BIOENG, V98, P616, DOI 10.1002/bit.21445; Tao KP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021602; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Templeton N, 2013, BIOTECHNOL BIOENG, V110, P2013, DOI 10.1002/bit.24858; Tomasini R, 2003, J BIOL CHEM, V278, P37722, DOI 10.1074/jbc.M301979200; Tripathi MK, 2005, J BIOL CHEM, V280, P17163, DOI 10.1074/jbc.M501375200; Trummer E, 2006, BIOTECHNOL BIOENG, V94, P1033, DOI 10.1002/bit.21013; Vergara M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144224; Vergara M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093865; Vishwanathan N, 2015, BIOTECHNOL BIOENG, V112, P965, DOI 10.1002/bit.25513; Wuest DM, 2012, BIOTECHNOL ADV, V30, P629, DOI 10.1016/j.biotechadv.2011.10.010; Wulhfard S, 2008, BIOTECHNOL PROGR, V24, P458, DOI 10.1021/bp070286c; Xia ZP, 2012, ASIAN J ANDROL, V14, P884, DOI 10.1038/aja.2012.71; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Yee JC, 2009, BIOTECHNOL BIOENG, V102, P246, DOI 10.1002/bit.22039; Yoon SK, 2006, J BIOTECHNOL, V122, P463, DOI 10.1016/j.jbiotec.2005.09.010; Yoon SK, 2003, BIOTECHNOL BIOENG, V82, P289, DOI 10.1002/bit.10566; Zhang HY, 2014, CARCINOGENESIS, V35, P1863, DOI 10.1093/carcin/bgu113; Zhang XP, 2012, PROTEIN CELL, V3, P790, DOI 10.1007/s13238-012-2069-7	116	40	40	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151529	10.1371/journal.pone.0151529	http://dx.doi.org/10.1371/journal.pone.0151529			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991106	Green Published, Green Submitted, gold			2022-12-26	WOS:000372582800072
J	de Wijk, RA; Maaskant, AJ; Polet, IA; Holthuysen, NTE; van Kleef, E; Vingerhoeds, MH				de Wijk, Rene A.; Maaskant, Anna J.; Polet, Ilse A.; Holthuysen, Nancy T. E.; van Kleef, Ellen; Vingerhoeds, Monique H.			An In-Store Experiment on the Effect of Accessibility on Sales of Wholegrain and White Bread in Supermarkets	PLOS ONE			English	Article							GRAIN INTAKE; FOOD; CONSUMPTION; CHILDREN; HEALTH	Even though whole grain foods have various health benefits, consumers have been found not to eat enough of them. Nudging interventions are built on the premise that food purchases and consumption are strongly influenced by the environment in which decisions are made. Little research has been conducted to examine the influence of a small and inexpensive nudging intervention on bread choices in a real-life supermarket context. An in-store experiment was conducted in two six-week periods in two supermarkets to investigate the effects of accessibility on consumers' purchase of healthier whole grain and other types of bread. In the high accessibility condition, healthier bread was placed in a more convenient location for the shopper on the left side of the shelves where it was encountered first. In the low accessibility condition, it was placed on the right side. There were consistent significant differences in sales between supermarkets, types of bread, day of the week, but not between low and high accessibility. Additional research is needed to better understand the effects of convenience and accessibility on bread choices.	[de Wijk, Rene A.; Maaskant, Anna J.; Polet, Ilse A.; Holthuysen, Nancy T. E.; Vingerhoeds, Monique H.] Wageningen UR Food & Biobased Res, Wageningen, Netherlands; [van Kleef, Ellen] Wageningen Univ, Mkt & Consumer Behaviour Grp, NL-6700 AP Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research	de Wijk, RA (corresponding author), Wageningen UR Food & Biobased Res, Wageningen, Netherlands.	Rene.deWijk@wur.nl	van Kleef, Ellen/B-7789-2009	van Kleef, Ellen/0000-0002-8797-6983	Dutch Bakery Centre; Ministry of Economic Affairs [AF12104]	Dutch Bakery Centre; Ministry of Economic Affairs	This project received financial support from the Dutch Bakery Centre and the Ministry of Economic Affairs (grant number AF12104; http://www.tki-agrifood.nl/projectengalerij/2012/pps-2012gezondheid-basisvoedingsmiddelen-engedragsinterventies.jpg). Neither organization had any role in the design, analysis, or writing of this article.	Arvola A, 2007, J CEREAL SCI, V46, P197, DOI 10.1016/j.jcs.2007.06.001; Aune D, 2013, EUR J EPIDEMIOL, V28, P845, DOI 10.1007/s10654-013-9852-5; Breugelmans E, 2007, MARKET LETT, V18, P117, DOI 10.1007/s11002-006-9002-x; Desmet P, 1998, INT J RES MARK, V15, P443, DOI 10.1016/S0167-8116(98)00018-4; Devlin NF, 2012, BRIT J NUTRN, V11, P1; Drewnowski A, 2010, AM J CLIN NUTR, V91, p1095S, DOI 10.3945/ajcn.2010.28450D; Driessen CE, 2014, OBES REV, V15, P968, DOI 10.1111/obr.12224; Guldborg Hansen P, 2016, ANN REV PUBLIC HLTH, V37; Hanks AS, 2012, J PUBLIC HEALTH-UK, V34, P370, DOI 10.1093/pubmed/fds003; Hollands GJ, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1218; Inman JJ, 2009, J MARKETING, V73, P19, DOI 10.1509/jmkg.73.5.19; Ji MF, 2007, J CONSUM PSYCHOL, V17, P261, DOI 10.1016/S1057-7408(07)70037-2; Jonnalagadda SS, 2011, J NUTR, V141, p1011S, DOI 10.3945/jn.110.132944; Mattei J, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0109-9; McMackin E, 2013, PUBLIC HEALTH NUTR, V16, P743, DOI 10.1017/S1368980012003205; Moss M., 2013, NEW YORK TIMES; Quigley M, 2013, MED LAW REV, V21, P588, DOI 10.1093/medlaw/fwt022; Sandvik P, 2014, FOOD NUTR RES, V58, DOI 10.3402/fnr.v58.24024; Slavin J, 2003, P NUTR SOC, V62, P129, DOI 10.1079/PNS2002221; Steffen LM, 2003, AM J EPIDEMIOL, V158, P243, DOI 10.1093/aje/kwg146; Thaler R.H., 2021, NUDGE FINAL EDITION; Thane CW, 2005, BRIT J NUTR, V94, P825, DOI 10.1079/BJN20051557; Thorndike AN, 2012, AM J PUBLIC HEALTH, V102, P527, DOI 10.2105/AJPH.2011.300391; van Kleef E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-906; van Kleef E, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1072; Wansink B., 2014, SLIM DESIGN MINDLESS; Wansink B, 2007, ENVIRON BEHAV, V39, P106, DOI 10.1177/0013916506295573; Wansink B, 2015, PSYCHOL MARKET, V32, P486, DOI 10.1002/mar.20794; Wansink B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077055; Worsley A., 2003, British Food Journal, V105, P695, DOI 10.1108/00070700310506245	30	37	37	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151915	10.1371/journal.pone.0151915	http://dx.doi.org/10.1371/journal.pone.0151915			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3SV	27010704	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708000057
J	Duvvari, MR; van de Ven, JPH; Geerlings, MJ; Saksens, NTM; Bakker, B; Henkes, A; Neveling, K; del Rosario, M; Westra, D; van den Heuvel, LPWJ; Schick, T; Fauser, S; Boon, CJF; Hoyng, CB; de Jong, EK; den Hollander, AI				Duvvari, Maheswara R.; van de Ven, Johannes P. H.; Geerlings, Maartje J.; Saksens, Nicole T. M.; Bakker, Bjorn; Henkes, Arjen; Neveling, Kornelia; del Rosario, Marisol; Westra, Dineke; van den Heuvel, Lambertus P. W. J.; Schick, Tina; Fauser, Sascha; Boon, Camiel J. F.; Hoyng, Carel B.; de Jong, Eiko K.; den Hollander, Anneke I.			Whole Exome Sequencing in Patients with the Cuticular Drusen Subtype of Age-Related Macular Degeneration	PLOS ONE			English	Article							BASAL LAMINAR DRUSEN; EXTRACELLULAR-MATRIX; BRUCHS MEMBRANE; GRADING SYSTEM; HIGH-RISK; CFH GENE; DISEASE; MUTATION; RARE; CLASSIFICATION	Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in elderly people worldwide. Cuticular drusen (CD) is a clinical subtype of AMD, which typically displays an earlier age at onset, and has a strong genetic component. Genetic studies support a role for rare sequence variants in CD susceptibility, and rare sequence variants in the CFH gene have been identified in 8.8% of CD cases. To further explore the role of rare variants in CD, we performed whole exome sequencing (WES) in 14 affected members of six families and 12 sporadic cases with CD. We detected rare sequence variants in CFH and FBLN5, which previously were shown to harbor rare variants in patients with CD. In addition, we detected heterozygous rare sequence variants in several genes encoding components of the extracellular matrix (ECM), including FBLN1, FBLN3/EFEMP1, FBLN5, FBLN6/HMCN1, FBN2, and COL15A1. Two rare pathogenic variants were identified in the COL15A1 gene: one in a sporadic case and another was found to segregate in a family with six affected individuals with CD. In addition, two rare pathogenic variants were identified in the FGL1 gene in three unrelated CD cases. These findings suggest that alterations in the ECM and in the coagulation pathway may play a role in the pathogenesis of CD. The identified candidate genes require further analyses in larger cohorts to confirm their role in the CD subtype of AMD. No evidence was found of rare sequence variants in a single gene that segregate with CD in the six families, suggesting that the disease is genetically heterogeneous.	[Duvvari, Maheswara R.; van de Ven, Johannes P. H.; Geerlings, Maartje J.; Saksens, Nicole T. M.; Bakker, Bjorn; Henkes, Arjen; Boon, Camiel J. F.; Hoyng, Carel B.; de Jong, Eiko K.; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands; [Henkes, Arjen; Neveling, Kornelia; del Rosario, Marisol; den Hollander, Anneke I.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Westra, Dineke; van den Heuvel, Lambertus P. W. J.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat Nephrol, NL-6525 ED Nijmegen, Netherlands; [Schick, Tina; Fauser, Sascha] Univ Hosp Cologne, Dept Ophthalmol, Cologne, Germany; [Boon, Camiel J. F.] Leiden Univ, Med Ctr, Dept Ophthalmol, Leiden, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Cologne; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands.; den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands.	Anneke.denHollander@radboudumc.nl	Hollander, Anneke den/N-4911-2014; Geerlings, Maartje/P-3338-2019; van den Heuvel, Lambertus/AAM-1772-2021; de Jong, Eiko/P-3407-2015; Geerlings, Maartje/P-8309-2015; van den Heuvel, L.P.W.J./H-8044-2014; Bakker, Bjorn/E-2842-2016; Boon, CJF/P-7534-2014	Geerlings, Maartje/0000-0003-1164-3573; van den Heuvel, Lambertus/0000-0003-3917-6727; de Jong, Eiko/0000-0001-6520-0407; Geerlings, Maartje/0000-0003-1164-3573; van den Heuvel, L.P.W.J./0000-0003-3917-6727; Boon, CJF/0000-0002-6737-7932	Netherlands Organization for Scientific Research (Vidi Innovational Research Award) [016.096.309]; Foundation Fighting Blindness USA [C-GE-0811-0548-RAD04]; European Research Council under the European Union's Seventh Framework Programme (FP) / ERC [310644]	Netherlands Organization for Scientific Research (Vidi Innovational Research Award); Foundation Fighting Blindness USA; European Research Council under the European Union's Seventh Framework Programme (FP) / ERC(European Research Council (ERC))	This study was supported by the Netherlands Organization for Scientific Research (Vidi Innovational Research Award 016.096.309) and the Foundation Fighting Blindness USA (grant C-GE-0811-0548-RAD04). The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013) / ERC grant agreement n. 310644 (MACULA).	BIRD AEC, 1995, SURV OPHTHALMOL, V39, P367, DOI 10.1016/S0039-6257(05)80092-X; Booij JC, 2010, THESIS; Boon CJE, 2008, AM J HUM GENET, V82, P516, DOI 10.1016/j.ajhg.2007.11.007; Boon CJF, 2013, PROG RETIN EYE RES, V37, P90, DOI 10.1016/j.preteyeres.2013.08.003; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Chong NHV, 2005, AM J PATHOL, V166, P241, DOI 10.1016/S0002-9440(10)62248-1; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Duvvari MR, 2015, MOL VIS, V21, P285; Duvvari MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094165; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Grassi MA, 2007, ARCH OPHTHALMOL-CHIC, V125, P93, DOI 10.1001/archopht.125.1.93; Hayward C, 2003, HUM MOL GENET, V12, P2657, DOI 10.1093/hmg/ddg289; KLEIN R, 1991, OPHTHALMOLOGY, V98, P1128; Li DQ, 2000, J BIOL CHEM, V275, P22339, DOI 10.1074/jbc.M000519200; Lotery AJ, 2006, HUM MUTAT, V27, P568, DOI 10.1002/humu.20344; Malek G, 2006, BRIT J OPHTHALMOL, V90, P1080, DOI 10.1136/bjo.2006.098715; Mullins RF, 2000, FASEB J, V14, P835, DOI 10.1096/fasebj.14.7.835; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nita M, 2014, MED SCI MONITOR, V20, P1003, DOI 10.12659/MSM.889887; Ratnapriya R, 2014, HUM MOL GENET; Raychaudhuri S, 2011, NAT GENET, V43, P1232, DOI 10.1038/ng.976; Rijken DC, 2006, BIOCHEM BIOPH RES CO, V350, P191, DOI 10.1016/j.bbrc.2006.09.018; Russell SR, 2000, AM J OPHTHALMOL, V129, P205, DOI 10.1016/S0002-9394(99)00345-1; Saksens NTM, 2014, INVEST OPHTH VIS SCI, V55, P7085, DOI 10.1167/iovs.14-14659; Saksens NT, 2016, JAMA OPHTHALMOL, P1; Sivaprasad S, 2005, CLIN EXP OPHTHALMOL, V33, P518, DOI 10.1111/j.1442-9071.2005.01074.x; Stone EM, 1999, NAT GENET, V22, P199, DOI 10.1038/9722; Stone EM, 2004, NEW ENGL J MED, V351, P346, DOI 10.1056/NEJMoa040833; Swaroop A, 2009, ANNU REV GENOM HUM G, V10, P19, DOI 10.1146/annurev.genom.9.081307.164350; van de Ven JPH, 2013, NAT GENET, V45, P813, DOI 10.1038/ng.2640; van de Ven JPH, 2012, ARCH OPHTHALMOL-CHIC, V130, P1038, DOI 10.1001/archophthalmol.2012.265; van de Ven JPH, 2012, MOL VIS, V18, P2271; van de Ven JPH, 2012, AM J OPHTHALMOL, V154, P560, DOI 10.1016/j.ajo.2012.03.012; WEBER BHF, 1994, NAT GENET, V8, P352, DOI 10.1038/ng1294-352; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; YAMAMOTO T, 1993, BIOCHEM BIOPH RES CO, V193, P681, DOI 10.1006/bbrc.1993.1678; Yu Y, 2014, HUM MOL GENET, V23, P5283, DOI 10.1093/hmg/ddu226; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598	39	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152047	10.1371/journal.pone.0152047	http://dx.doi.org/10.1371/journal.pone.0152047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007659	gold, Green Published			2022-12-26	WOS:000372701200091
J	Kleckova, I; Klecka, J				Kleckova, Irena; Klecka, Jan			Facing the Heat: Thermoregulation and Behaviour of Lowland Species of a Cold-Dwelling Butterfly Genus, Erebia	PLOS ONE			English	Article							CLIMATE-CHANGE; MOUNTAIN BUTTERFLIES; LOCAL ADAPTATION; THERMAL NICHES; HABITAT USE; PLASTICITY; RESPONSES; ALPINE; CONSERVATION; LEPIDOPTERA	Understanding the potential of animals to immediately respond to changing temperatures is imperative for predicting the effects of climate change on biodiversity. Ectothermic animals, such as insects, use behavioural thermoregulation to keep their body temperature within suitable limits. It may be particularly important at warm margins of species occurrence, where populations are sensitive to increasing air temperatures. In the field, we studied thermal requirements and behavioural thermoregulation in low-altitude populations of the Satyrinae butterflies Erebia aethiops, E. euryale and E. medusa. We compared the relationship of individual body temperature with air and microhabitat temperatures for the low-altitude Erebia species to our data on seven mountain species, including a high-altitude population of E. euryale, studied in the Alps. We found that the grassland butterfly E. medusa was well adapted to the warm lowland climate and it was active under the highest air temperatures and kept the highest body temperature of all species. Contrarily, the woodland species, E. aethiops and a low-altitude population of E. euryale, kept lower body temperatures and did not search for warm microclimates as much as other species. Furthermore, temperature-dependence of daily activities also differed between the three low-altitude and the mountain species. Lastly, the different responses to ambient temperature between the low-and high-altitude populations of E. euryale suggest possible local adaptations to different climates. We highlight the importance of habitat heterogeneity for long-term species survival, because it is expected to buffer climate change consequences by providing a variety of microclimates, which can be actively explored by adults. Alpine species can take advantage of warm microclimates, while low-altitude grassland species may retreat to colder microhabitats to escape heat, if needed. However, we conclude that lowland populations of woodland species may be more severely threatened by climate warming because of the unavailability of relatively colder microclimates.	[Kleckova, Irena; Klecka, Jan] Acad Sci Czech Republic, Inst Entomol, Ctr Biol, Lab Integrat Ecol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Kleckova, I (corresponding author), Acad Sci Czech Republic, Inst Entomol, Ctr Biol, Lab Integrat Ecol, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.	irena.slamova@gmail.com	Klecka, Jan/H-7874-2014; Kleckova, Irena/K-8626-2015	Klecka, Jan/0000-0003-0633-3896; Kleckova, Irena/0000-0002-9333-213X	Czech Science Foundation [GP14-10035P, GA14-33733S]	Czech Science Foundation(Grant Agency of the Czech Republic)	Both JK and IK are supported by the Czech Science Foundation (project GP14-10035P and GA14-33733S; http://www.gacr.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, IUCN RED LIST THREAT, DOI DOI 10.2305/IUCN.UK.2010-1.RLTS; Araujo MB, 2013, ECOL LETT, V16, P1206, DOI 10.1111/ele.12155; Ashton S, 2009, ECOL ENTOMOL, V34, P437, DOI 10.1111/j.1365-2311.2008.01068.x; Benes J, 2002, MOTYLI CESKE REPUBLI, VII; Bennett NL, 2015, OIKOS, V124, P41, DOI 10.1111/oik.01490; Besold J, 2015, J ZOOL SYST EVOL RES, V53, P67, DOI 10.1111/jzs.12076; BOGERT CM, 1949, EVOLUTION, V3, P195, DOI 10.2307/2405558; Buckley LB, 2015, FUNCT ECOL, V29, P1038, DOI 10.1111/1365-2435.12406; Castaneda LE, 2013, AM NAT, V182, P249, DOI 10.1086/671057; Chown SL, 2010, CLIM RES, V43, P3, DOI 10.3354/cr00879; De Groot M, 2009, EUR J ENTOMOL, V106, P77, DOI 10.14411/eje.2009.012; Ellers J, 2004, BIOL J LINN SOC, V82, P79, DOI 10.1111/j.1095-8312.2004.00319.x; Foster SA, 2013, ANIM BEHAV, V85, P1061, DOI 10.1016/j.anbehav.2013.02.008; Franzen M, 2012, BIODIVERS CONSERV, V21, P517, DOI 10.1007/s10531-011-0197-7; Gunderson AR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0401; Illan JG, 2012, ECOL ENTOMOL, V37, P134, DOI 10.1111/j.1365-2311.2012.01345.x; Habel JC, 2010, ACTA ZOOL ACAD SCI H, V56, P383; Hoffmann AA, 2013, FUNCT ECOL, V27, P934, DOI 10.1111/j.1365-2435.2012.02036.x; Huey RB, 2003, AM NAT, V161, P357, DOI 10.1086/346135; Huey RB, 2009, P ROY SOC LOND B BIO; Karl I, 2011, GLOBAL CHANGE BIOL, V17, P676, DOI 10.1111/j.1365-2486.2010.02277.x; Karl I, 2009, ECOGRAPHY, V32, P488, DOI 10.1111/j.1600-0587.2008.05660.x; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Kjaersgaard A, 2015, ANIM BEHAV, V99, P123, DOI 10.1016/j.anbehav.2014.11.003; Kleckova I, 2015, MOL PHYLOGENET EVOL, V92, P255, DOI 10.1016/j.ympev.2015.06.012; Kleckova I, 2014, J THERM BIOL, V41, P50, DOI 10.1016/j.jtherbio.2014.02.002; Konvicka M, 2003, GLOBAL ECOL BIOGEOGR, V12, P403, DOI 10.1046/j.1466-822X.2003.00053.x; Konvicka M, 2002, BIOLOGIA, V57, P223; LAMB RJ, 1985, CAN ENTOMOL, V117, P727, DOI 10.4039/Ent117727-6; Lawson CR, 2014, CONSERV LETT, V7, P111, DOI 10.1111/conl.12036; Lawson CR, 2012, J APPL ECOL, V49, P552, DOI 10.1111/j.1365-2664.2011.02098.x; Marschalek DA, 2010, J INSECT CONSERV, V14, P721, DOI 10.1007/s10841-010-9302-6; Mercader RJ, 2008, ECOL ENTOMOL, V33, P537, DOI 10.1111/j.1365-2311.2008.01001.x; Merckx T, 2006, OIKOS, V113, P226, DOI 10.1111/j.2006.0030-1299.14501.x; Mitchell KA, 2013, NATURWISSENSCHAFTEN, V100, P281, DOI 10.1007/s00114-013-1023-8; Moritz C, 2012, PHILOS T R SOC B, V367, P1680, DOI 10.1098/rstb.2012.0018; Munoz MM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2433; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pellissier L, 2013, GLOBAL ECOL BIOGEOGR, V22, P933, DOI 10.1111/geb.12057; Pena C, 2015, BIOL J LINN SOC, V116, P449, DOI 10.1111/bij.12597; Pitteloud C, ECOLOGICAL CHARACTER; R Core Team, 2013, R LANG ENV STAT COMP; Radchuk V, 2013, J ANIM ECOL, V82, P275, DOI 10.1111/j.1365-2656.2012.02029.x; Roth T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082490; Samietz J, 2005, J EVOLUTION BIOL, V18, P1087, DOI 10.1111/j.1420-9101.2005.00893.x; Sanborn AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029368; Sanborn AF, 2011, J THERM BIOL, V36, P150, DOI 10.1016/j.jtherbio.2011.01.002; Scalercio S, 2014, J INSECT CONSERV, V18, P643, DOI 10.1007/s10841-014-9669-x; Schmitt T, 2004, MOL ECOL, V13, P21, DOI 10.1046/j.1365-294X.2004.02020.x; SHERMAN PW, 1973, J COMP PHYSIOL, V83, P25, DOI 10.1007/BF00694570; Slamova I, 2013, INSECT CONSERV DIVER, V6, P243, DOI 10.1111/j.1752-4598.2012.00212.x; Slamova I, 2011, J INSECT BEHAV, V24, P230, DOI 10.1007/s10905-010-9250-8; Sonderegger P, 2005, ERBIEN SCHWEIZ LEPID; Stuhldreher G, 2014, J INSECT CONSERV, V18, P965, DOI 10.1007/s10841-014-9704-y; Stuhldreher G, 2014, ENTOMOL EXP APPL, V151, P270, DOI 10.1111/eea.12193; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; Turlure C., 2014, JEWELS MIST SYNOPSIS, P67; Turlure C, 2010, GLOBAL CHANGE BIOL, V16, P1883, DOI 10.1111/j.1365-2486.2009.02133.x; van Swaay C., 1999, RED DATA BOOK EUROPE, V99; Vellend M, 2007, J ECOL, V95, P565, DOI 10.1111/j.1365-2745.2007.01233.x; Vila R, 2011, P ROY SOC LOND B BIO; Vrba P, 2012, CRYOLETTERS, V33, P251; Wilson RJ, 2005, ECOL LETT, V8, P1138, DOI 10.1111/j.1461-0248.2005.00824.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zuk M, 2014, ANIM BEHAV, V92, P333, DOI 10.1016/j.anbehav.2014.02.032; [No title captured]	67	21	22	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0150393	10.1371/journal.pone.0150393	http://dx.doi.org/10.1371/journal.pone.0150393			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008409	Green Published, Green Submitted, gold			2022-12-26	WOS:000372701200024
J	Moss, P; Whitnell, J; Wright, A				Moss, Penny; Whitnell, Jasmine; Wright, Anthony			Quantitative and Qualitative Responses to Topical Cold in Healthy Caucasians Show Variance between Individuals but High Test-Retest Reliability	PLOS ONE			English	Article							NEUROPATHIC PAIN SYMPTOMS; WHIPLASH INJURY; THRESHOLDS; SENSITIZATION; HYPERALGESIA; DISORDERS; HEAT; SEX	Increased sensitivity to cold may be a predictor of persistent pain, but cold pain threshold is often viewed as unreliable. This study aimed to determine the within-subject reliability and between-subject variance of cold response, measured comprehensively as cold pain threshold plus pain intensity and sensation quality at threshold. A test-retest design was used over three sessions, one day apart. Response to cold was assessed at four sites (thenar eminence, volar forearm, tibialis anterior, plantar foot). Cold pain threshold was measured using a Medoc thermode and standard method of limits. Intensity of pain at threshold was rated using a 10cm visual analogue scale. Quality of sensation at threshold was quantified with indices calculated from subjects' selection of descriptors from a standard McGill Pain Questionnaire. Within-subject reliability for each measure was calculated with intra-class correlation coefficients and between-subject variance was evaluated as group coefficient of variation percentage (CV%). Gender and site comparisons were also made. Forty-five healthy adults participated: 20 male, 25 female; mean age 29 (range 18-56) years. All measures at all four test sites showed high within-subject reliability: cold pain thresholds r = 0.92-0.95; pain rating r = 0.93-0.97; McGill pain quality indices r = 0.87-0.85. In contrast, all measures showed wide between-subject variance (CV% between 51.4% and 92.5%). Upper limb sites were consistently more sensitive than lower limb sites, but equally reliable. Females showed elevated cold pain thresholds, although similar pain intensity and quality to males. Females were also more reliable and showed lower variance for all measures. Thus, although there was clear population variation, response to cold for healthy individuals was found to be highly reliable, whether measured as pain threshold, pain intensity or sensation quality. A comprehensive approach to cold response testing therefore may add validity and improve acceptance of this potentially important pain measure.	[Moss, Penny; Whitnell, Jasmine; Wright, Anthony] Curtin Univ Technol, Sch Physiotherapy & Exercise Sci, Perth, WA, Australia	Curtin University	Moss, P (corresponding author), Curtin Univ Technol, Sch Physiotherapy & Exercise Sci, Perth, WA, Australia.	p.moss@curtin.edu.au						Ahmad S, 2014, PAIN MED, V15, P857, DOI 10.1111/pme.12374; Backonja M, 2013, PAIN, V154, P1807, DOI 10.1016/j.pain.2013.05.047; BOECKSTYNS MEH, 1989, PAIN, V38, P29, DOI 10.1016/0304-3959(89)90069-9; Burckhardt CS, 2003, ARTH RHEUMAT ARTH CA, V49, pS96, DOI [DOI 10.1002/ART.11440, 10.1002/art.11440]; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; Fillingim RB, 2009, J PAIN, V10, P447, DOI 10.1016/j.jpain.2008.12.001; Freeman R, 2014, PAIN, V155, P367, DOI 10.1016/j.pain.2013.10.023; FRUHSTORFER H, 1976, J NEUROL NEUROSUR PS, V39, P1071, DOI 10.1136/jnnp.39.11.1071; Geber C, 2011, PAIN, V152, P548, DOI 10.1016/j.pain.2010.11.013; Goldsmith R, 2012, MANUAL THER, V17, P402, DOI 10.1016/j.math.2012.02.014; Grafton KV, 2005, CLIN J PAIN, V21, P73, DOI 10.1097/00002508-200501000-00009; Heldestad V, 2010, CLIN NEUROPHYSIOL, V121, P1878, DOI 10.1016/j.clinph.2010.03.055; Hochman JR, 2013, OSTEOARTHR CARTILAGE, V21, P1236, DOI 10.1016/j.joca.2013.06.023; Kelly KG, 2005, MUSCLE NERVE, V32, P179, DOI 10.1002/mus.20355; Knutti IA, 2014, NEUROSCI LETT, V579, P157, DOI 10.1016/j.neulet.2014.07.023; Law LAF, 2008, PAIN, V140, P254, DOI 10.1016/j.pain.2008.08.014; Lee YC, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3306; Martin Vincent T, 2009, Gend Med, V6 Suppl 2, P168, DOI 10.1016/j.genm.2009.03.006; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Moloney NA, 2012, J REHABIL RES DEV, V49, P191, DOI 10.1682/JRRD.2011.03.0044; Moloney NA, 2011, MUSCLE NERVE, V44, P547, DOI 10.1002/mus.22121; Moss P, 2011, EUROP J PAIN S, V5, P128; Neziri AY, 2011, EUR J PAIN, V15, P376, DOI 10.1016/j.ejpain.2010.08.011; O'Sullivan P, 2014, MANUAL THER, V19, P311, DOI 10.1016/j.math.2014.03.006; Pfau DB, 2009, PAIN, V147, P72, DOI 10.1016/j.pain.2009.08.010; Rahim-Williams B, 2012, PAIN MED, V13, P522, DOI 10.1111/j.1526-4637.2012.01336.x; Ritchie C, 2013, PAIN, V154, P2198, DOI 10.1016/j.pain.2013.07.001; Rolke R, 2006, PAIN, V123, P231, DOI 10.1016/j.pain.2006.01.041; Rowell LN, 2011, EUR J PAIN, V15, P764, DOI 10.1016/j.ejpain.2010.11.016; Sand T, 2010, CEPHALALGIA, V30, P904, DOI 10.1177/0333102409356023; Smith BW, 2008, PAIN, V140, P420, DOI 10.1016/j.pain.2008.09.018; Steinmetz A, 2013, ARCH PHYS MED REHAB, V94, P2523, DOI 10.1016/j.apmr.2013.04.019; Sterling M, 2003, PAIN, V104, P509, DOI 10.1016/S0304-3959(03)00078-2; Sterling M, 2012, PAIN, V153, P1727, DOI 10.1016/j.pain.2012.05.004; Thorn BE, 2004, CLIN J PAIN, V20, P275, DOI 10.1097/00002508-200409000-00001; Wasner GL, 2008, CLIN NEUROPHYSIOL, V119, P2389, DOI 10.1016/j.clinph.2008.07.223; Wylde V, 2011, OSTEOARTHR CARTILAGE, V19, P655, DOI 10.1016/j.joca.2011.02.009	37	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151972	10.1371/journal.pone.0151972	http://dx.doi.org/10.1371/journal.pone.0151972			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007696	Green Published, gold, Green Submitted			2022-12-26	WOS:000372701200079
J	Retory, Y; Niedzialkowski, P; de Picciotto, C; Bonay, M; Petitjean, M				Retory, Yann; Niedzialkowski, Pauline; de Picciotto, Carole; Bonay, Marcel; Petitjean, Michel			New Respiratory Inductive Plethysmography (RIP) Method for Evaluating Ventilatory Adaptation during Mild Physical Activities	PLOS ONE			English	Article							VALIDATION; SLEEP; CAGE	The pneumotachometer is currently the most accepted device to measure tidal breathing, however, it requires the use of a mouthpiece and thus alteration of spontaneous ventilation is implied. Respiratory inductive plethysmography (RIP), which includes two belts, one thoracic and one abdominal, is able to determine spontaneous tidal breathing without the use of a facemask or mouthpiece, however, there are a number of as yet unresolved issues. In this study we aimed to describe and validate a new RIP method, relying on a combination of thoracic RIP and nasal pressure signals taking into account that exercise-induced body movements can easily contaminate RIP thoracic signals by generating tissue motion artifacts. A custom-made time domain algorithm that relies on the elimination of low amplitude artifacts was applied to the raw thoracic RIP signal. Determining this tidal ventilation allowed comparisons between the RIP signal and simultaneously-recorded airflow signals from a calibrated pneumotachometer (PT). We assessed 206 comparisons from 30 volunteers who were asked to breathe spontaneously at rest and during walking on the spot. Comparisons between RIP signals processed by our algorithm and PT showed highly significant correlations for tidal volume (Vt), inspiratory (Ti) and expiratory times (Te). Moreover, bias calculated using the Bland and Altman method were reasonably low for Vt and Ti (0.04 L and 0.02 s, respectively), and acceptable for Te (<0.1 s) and the intercept from regression relationships (0.01 L, 0.06 s, 0.17 s respectively). The Ti/Ttot and Vt/Ti ratios obtained with the two methods were also statistically correlated. We conclude that our methodology (filtering by our algorithm and calibrating with our calibration procedure) for thoracic RIP renders this technique sufficiently accurate to evaluate tidal ventilation variation at rest and during mild to moderate physical activity.	[Retory, Yann; Bonay, Marcel; Petitjean, Michel] TITAN, Lab Physiol, End Icap, INSERM,U1179, Montigny Le Bretonneux, France; [Retory, Yann; Bonay, Marcel; Petitjean, Michel] Univ Versailles St Quentin Yvelines, UFR Sci Sante, Montigny Le Bretonneux, France; [Retory, Yann; Niedzialkowski, Pauline; de Picciotto, Carole; Bonay, Marcel; Petitjean, Michel] Hop Ambroise Pare, AP HP, Grp Hosp Paris Ile de France Ouest, Serv Physiol Explorat Fonct, Boulogne, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP	Petitjean, M (corresponding author), TITAN, Lab Physiol, End Icap, INSERM,U1179, Montigny Le Bretonneux, France.; Petitjean, M (corresponding author), Univ Versailles St Quentin Yvelines, UFR Sci Sante, Montigny Le Bretonneux, France.; Petitjean, M (corresponding author), Hop Ambroise Pare, AP HP, Grp Hosp Paris Ile de France Ouest, Serv Physiol Explorat Fonct, Boulogne, France.	michel.petitjean134@gmail.com	Bonay, Marcel/ABG-2039-2020	Bonay, Marcel/0000-0003-1446-7456	Institut National de la Sante et de la Recherche Medical [U1179]; Fonds de Dotation de Recherche en Sante Respiratoire; LVL Medical	Institut National de la Sante et de la Recherche Medical; Fonds de Dotation de Recherche en Sante Respiratoire; LVL Medical	This study was supported by Institut National de la Sante et de la Recherche Medical (U1179 Inserm, Laboratoire de Physiologie TITAN), and by funding from the Fonds de Dotation de Recherche en Sante Respiratoire and LVL Medical. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brown K, 1998, EUR RESPIR J, V12, P935, DOI 10.1183/09031936.98.12040935; Collop NA, 2011, J CLIN SLEEP MED, V7, P531, DOI 10.5664/JCSM.1328; D'Agostino RB, 1986, GOODNESS OF FIT TECH; Gastinger S, 2010, EUR J APPL PHYSIOL, V109, P1179, DOI 10.1007/s00421-010-1463-1; Gastinger S, 2014, JPEN-PARENTER ENTER, V38, P926, DOI 10.1177/0148607114530432; Grossman P, 2010, BIOL PSYCHOL, V84, P121, DOI 10.1016/j.biopsycho.2010.02.008; Hollier CA, 2014, RESP PHYSIOL NEUROBI, V194, P15, DOI 10.1016/j.resp.2014.01.014; Kaplan V, 2000, EUR RESPIR J, V15, P570, DOI 10.1034/j.1399-3003.2000.15.24.x; Keenan DB, 2005, BIOMED SCI INSTRUM, V41, P37; KONNO K, 1967, J APPL PHYSIOL, V22, P407, DOI 10.1152/jappl.1967.22.3.407; Liu SP, 2013, ANN BIOMED ENG, V41, P1003, DOI 10.1007/s10439-013-0742-5; Pepin V, 2007, THORAX, V62, P291, DOI 10.1136/thx.2006.065540; PEREZ W, 1985, J APPL PHYSIOL, V59, P1515, DOI 10.1152/jappl.1985.59.5.1515; Raoufy MR, 2013, RESPIROLOGY, V18, P108, DOI 10.1111/j.1440-1843.2012.02251.x; White BM, 2013, MED PHYS, V40, DOI 10.1118/1.4805099; Witt JD, 2006, RESP PHYSIOL NEUROBI, V154, P389, DOI 10.1016/j.resp.2006.01.010; Zhang ZB, 2012, SENSORS-BASEL, V12, P13167, DOI 10.3390/s121013167	18	27	27	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151983	10.1371/journal.pone.0151983	http://dx.doi.org/10.1371/journal.pone.0151983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008313	Green Submitted, Green Published, gold			2022-12-26	WOS:000372701200083
J	Solstad, RG; Li, C; Isaksson, J; Johansen, J; Svenson, J; Stensvag, K; Haug, T				Solstad, Runar Gjerp; Li, Chun; Isaksson, Johan; Johansen, Jostein; Svenson, Johan; Stensvag, Klara; Haug, Tor			Novel Antimicrobial Peptides EeCentrocins 1, 2 and EeStrongylocin 2 from the Edible Sea Urchin Echinus esculentus Have 6-Br-Trp Post-Translational Modifications	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; STRONGYLOCENTROTUS-PURPURATUS; MOLECULAR-BASIS; CELOMIC FLUID; HYAS-ARANEUS; SPIDER CRAB; PROTEIN; GREEN; ORGANIZATION; ECHINODERM	The global problem of microbial resistance to antibiotics has resulted in an urgent need to develop new antimicrobial agents. Natural antimicrobial peptides are considered promising candidates for drug development. Echinoderms, which rely on innate immunity factors in the defence against harmful microorganisms, are sources of novel antimicrobial peptides. This study aimed to isolate and characterise antimicrobial peptides from the Edible sea urchin Echinus esculentus. Using bioassay-guided purification and cDNA cloning, three antimicrobial peptides were characterised from the haemocytes of the sea urchin; two heterodimeric peptides and a cysteine-rich peptide. The peptides were named EeCentrocin 1 and 2 and EeStrongylocin 2, respectively, due to their apparent homology to the published centrocins and strongylocins isolated from the green sea urchin Strongylocentrotus droebachiensis. The two centrocin-like peptides EeCentrocin 1 and 2 are intramolecularly connected via a disulphide bond to form a heterodimeric structure, containing a cationic heavy chain of 30 and 32 amino acids and a light chain of 13 amino acids. Additionally, the light chain of EeCentrocin 2 seems to be N-terminally blocked by a pyroglutamic acid residue. The heavy chains of EeCentrocins 1 and 2 were synthesised and shown to be responsible for the antimicrobial activity of the natural peptides. EeStrongylocin 2 contains 6 cysteines engaged in 3 disulphide bonds. A fourth peptide (Ee4635) was also discovered but not fully characterised. Using mass spectrometric and NMR analyses, EeCentrocins 1 and 2, EeStrongylocin 2 and Ee4635 were all shown to contain post-translationally brominated Trp residues in the 6 position of the indole ring.	[Solstad, Runar Gjerp; Li, Chun; Stensvag, Klara; Haug, Tor] UiT Arctic Univ Norway, Norwegian Coll Fishery Sci, Fac Biosci Fisheries & Econ, Tromso, Norway; [Isaksson, Johan; Johansen, Jostein; Svenson, Johan] UiT Arctic Univ Norway, Dept Chem, Fac Sci & Technol, Tromso, Norway; [Svenson, Johan] Mat & Surfaces SP Tech Res Inst Sweden, Dept Chem, Boras, Sweden	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; SP Technical Research Institute of Sweden	Solstad, RG; Haug, T (corresponding author), UiT Arctic Univ Norway, Norwegian Coll Fishery Sci, Fac Biosci Fisheries & Econ, Tromso, Norway.	Runar.g.solstad@uit.no; Tor.haug@uit.no	Haug, Tor/I-8163-2019; Isaksson, Johan/G-9292-2016; Haug, Tor/J-2498-2017	Haug, Tor/0000-0003-1104-5813; Isaksson, Johan/0000-0001-6287-7594; Haug, Tor/0000-0003-1104-5813; Stensvag, Klara/0000-0002-4717-6711; Solstad, Runar Gjerp/0000-0003-3463-6034	Research Council of Norway [208546]	Research Council of Norway(Research Council of Norway)	This work was supported by the Research Council of Norway (http://www.forskningsradet.no) project XBioPepS (grant number 208546) where TH and JS are partners and KS is the project leader. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beauregard KA, 2001, ADV EXP MED BIOL, V484, P55; Bjorn C, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-67; Boucher HW, 2009, CLIN INFECT DIS, V48, P1, DOI 10.1086/595011; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; BUSBY WH, 1987, J BIOL CHEM, V262, P8532; Chan DI, 2006, BBA-BIOMEMBRANES, V1758, P1184, DOI 10.1016/j.bbamem.2006.04.006; Chattopadhyay S, 2006, PROTEINS, V64, P524, DOI 10.1002/prot.20963; Chen TB, 2005, REGUL PEPTIDES, V128, P75, DOI 10.1016/j.regpep.2004.12.022; Craig AG, 1997, J BIOL CHEM, V272, P4689, DOI 10.1074/jbc.272.8.4689; Craik DJ, 2013, CHEM BIOL DRUG DES, V81, P136, DOI 10.1111/cbdd.12055; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dick LW, 2007, BIOTECHNOL BIOENG, V97, P544, DOI 10.1002/bit.21260; EDMAN P, 1967, EUR J BIOCHEM, V1, P80, DOI 10.1111/j.1432-1033.1967.tb00047.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gross PS, 2000, IMMUNOGENETICS, V51, P1034, DOI 10.1007/s002510000234; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Haug T, 2002, J INVERTEBR PATHOL, V81, P94, DOI 10.1016/S0022-2011(02)00153-2; Haug T, 2002, FISH SHELLFISH IMMUN, V12, P371, DOI 10.1006/fsim.2001.0378; INOUYE M, 1991, ENZYME, V45, P314, DOI 10.1159/000468904; Jiravanichpaisal P, 2007, DEV COMP IMMUNOL, V31, P441, DOI 10.1016/j.dci.2006.08.002; JOLLES J, 1975, EUR J BIOCHEM, V54, P19, DOI 10.1111/j.1432-1033.1975.tb04108.x; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; Keller R, 2004, THE COMPUTER AIDED R; Li C, 2010, ISJ-INVERT SURVIV J, V7, P132; Li C, 2008, DEV COMP IMMUNOL, V32, P1430, DOI 10.1016/j.dci.2008.06.013; Li C, 2015, DEV COMP IMMUNOL, V49, P190, DOI 10.1016/j.dci.2014.11.002; Li C, 2010, DEV COMP IMMUNOL, V34, P959, DOI 10.1016/j.dci.2010.04.004; Li C, 2010, DEV COMP IMMUNOL, V34, P286, DOI 10.1016/j.dci.2009.10.006; Loker ES, 2004, IMMUNOL REV, V198, P10, DOI 10.1111/j.0105-2896.2004.0117.x; Maltseva A.L., 2004, Vestnik Sankt-Peterburgskogo Universiteta Seriya 3 Biologiya, V4, P101; [Мальцева А.Л. Malzeva A.L.], 2007, [Вестник Санкт-Петербургского университета. Серия 3: Биология, Vestnik Sankt-Peterburgskogo universiteta. Seriya 3: Biologiya], P85; Matsuzaki K, 2009, BBA-BIOMEMBRANES, V1788, P1687, DOI 10.1016/j.bbamem.2008.09.013; Mayer AMS, 2011, COMP BIOCHEM PHYS C, V153, P191, DOI 10.1016/j.cbpc.2010.08.008; Oren Z, 1998, BIOPOLYMERS, V47, P451; Oren Z, 1999, BIOCHEM J, V341, P501, DOI 10.1042/0264-6021:3410501; Patiny L, 2013, J CHEM INF MODEL, V53, P1223, DOI 10.1021/ci300563h; Paulsen VS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053326; Pereira DM, 2014, DYES PIGMENTS, V111, P124, DOI 10.1016/j.dyepig.2014.06.011; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.2005.04515.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saude ACM, 2014, INT J NANOMED, V9, P5055, DOI 10.2147/IJN.S66300; Saugar JM, 2006, ANTIMICROB AGENTS CH, V50, P1251, DOI 10.1128/AAC.50.4.1251-1256.2006; Schillaci D, 2010, J APPL MICROBIOL, V108, P17, DOI 10.1111/j.1365-2672.2009.04394.x; SERVICE M, 1984, COMP BIOCHEM PHYS B, V79, P161, DOI 10.1016/0305-0491(84)90008-7; SHIGENAGA T, 1990, J BIOL CHEM, V265, P21350; Shinnar AE, 2003, BIOORG CHEM, V31, P425, DOI 10.1016/S0045-2068(03)00080-4; Smith LC, 2006, ISJ-INVERT SURVIV J, V3, P25; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Sperstad SV, 2009, MOL IMMUNOL, V46, P2604, DOI 10.1016/j.molimm.2009.05.002; Sperstad SV, 2009, DEV COMP IMMUNOL, V33, P583, DOI 10.1016/j.dci.2008.10.010; Splith K, 2011, EUR BIOPHYS J BIOPHY, V40, P387, DOI 10.1007/s00249-011-0682-7; Stabili L, 1996, COMP BIOCHEM PHYS B, V113, P639, DOI 10.1016/0305-0491(95)02080-2; Strom MB, 2003, J MED CHEM, V46, P1567, DOI 10.1021/jm0340039; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tasiemski A, 2007, DEV COMP IMMUNOL, V31, P749, DOI 10.1016/j.dci.2006.11.003; Taylor SW, 2000, J BIOL CHEM, V275, P38417, DOI 10.1074/jbc.M006762200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tossi A, 2000, BIOPOLYMERS, V55, P4; Uhlig T., 2014, EUPA OPEN PROTEOMICS, V4, P58, DOI [10.1016/j.euprot.2014.05.003, DOI 10.1016/J.EUPROT.2014.05.003]; Wagner C, 2012, HDB MARINE NATURAL P, P977; Wang GS, 2009, NUCLEIC ACIDS RES, V37, pD933, DOI 10.1093/nar/gkn823; Wang KR, 2013, PEPTIDES, V39, P80, DOI 10.1016/j.peptides.2012.11.002; WARDLAW AC, 1978, J INVERTEBR PATHOL, V32, P25, DOI 10.1016/0022-2011(78)90170-2; Wieprecht T, 1997, BIOCHEMISTRY-US, V36, P6124, DOI 10.1021/bi9619987; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478; Zhao XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066557; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	71	28	29	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151820	10.1371/journal.pone.0151820	http://dx.doi.org/10.1371/journal.pone.0151820			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007817	Green Submitted, Green Published, gold			2022-12-26	WOS:000372701200068
J	Taylor, RM; Sunde, RA				Taylor, Rachel M.; Sunde, Roger A.			Selenoprotein Transcript Level and Enzyme Activity as Biomarkers for Selenium Status and Selenium Requirements in the Turkey (Meleagris gallopavo)	PLOS ONE			English	Article							GLUTATHIONE-PEROXIDASE-ACTIVITY; NUTRITIONAL MUSCULAR-DYSTROPHY; MESSENGER-RNA LEVELS; SULFUR AMINO ACIDS; DIETARY SELENIUM; VITAMIN-E; RATS; CHICK; DEFICIENCY; RODENTS	The current National Research Council (NRC) selenium (Se) requirement for the turkey is 0.2 mu g Se/g diet. The sequencing of the turkey selenoproteome offers additional molecular biomarkers for assessment of Se status. To determine dietary Se requirements using selenoprotein transcript levels and enzyme activities, day-old male turkey poults were fed a Se-deficient diet supplemented with graded levels of Se (0, 0.025, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.75, 1.0 mu g Se/g diet) as selenite, and 12.5X the vitamin E requirement. Poults fed less than 0.05 mu g Se/g diet had a significantly reduced rate of growth, indicating the Se requirement for growth in young male poults is 0.05 mu g Se/g diet. Se deficiency decreased plasma GPX3 (glutathione peroxidase), liver GPX1, and liver GPX4 activities to 2, 3, and 7%, respectively, of Se-adequate levels. Increasing Se supplementation resulted in well-defined plateaus for all blood, liver and gizzard enzyme activities and mRNA levels, showing that these selenoprotein biomarkers could not be used as biomarkers for supernutritional-Se status. Using selenoenzyme activity, minimum Se requirements based on red blood cell GPX1, plasma GPX3, and pancreas and liver GPX1 activities were 0.29-0.33 mu g Se/g diet. qPCR analyses using all 10 dietary Se treatments for all 24 selenoprotein transcripts (plus SEPHS1) in liver, gizzard, and pancreas found that only 4, 4, and 3 transcripts, respectively, were significantly down-regulated by Se deficiency and could be used as Se biomarkers. Only GPX3 and SELHmRNA were down regulated in all 3 tissues. For these transcripts, minimum Se requirements were 0.07-0.09 mu g Se/g for liver, 0.06-0.15 mu g Se/g for gizzard, and 0.13-0.18 mu g Se/g for pancreas, all less than enzyme-based requirements. Panels based onmultiple Se-regulated transcripts were effective in identifying Se deficiency. These results show that the NRC turkey dietary Se requirement should be raised to 0.3 mu g Se/g diet.	[Taylor, Rachel M.; Sunde, Roger A.] Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Sunde, RA (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	sunde@nutrisci.wisc.edu			National Institute of Food and Agriculture, United States Department of Agriculture [233618, 1004389]; Wisconsin Alumni Foundation [12046295]	National Institute of Food and Agriculture, United States Department of Agriculture(United States Department of Agriculture (USDA)); Wisconsin Alumni Foundation	This Research was supported by the National Institute of Food and Agriculture, United States Department of Agriculture (www.csrees.usda.gov), Hatch projects 233618 and 1004389, and by the Wisconsin Alumni Foundation (http://www.uwalumni.com) Selenium Nutrition Research Fund (No. 12046295).	Applegate TJ, 2014, J APPL POULTRY RES, V23, P567, DOI 10.3382/japr.2014-00980; Barnes KM, 2009, J NUTR, V139, P199, DOI 10.3945/jn.108.098624; Brown M. B., 1979, J AM STAT ASSOC, V69, P364, DOI [DOI 10.2307/2285659, DOI 10.1080/01621459.1974.10482955]; CANTOR AH, 1982, POULTRY SCI, V61, P478, DOI 10.3382/ps.0610478; CANTOR AH, 1978, POULTRY SCI, V57, P1337, DOI 10.3382/ps.0571337; Fischer J, 2008, BRIT POULTRY SCI, V49, P583, DOI 10.1080/00071660802337258; GRIES CL, 1972, J NUTR, V102, P1287, DOI 10.1093/jn/102.10.1287; Hadley KB, 1997, TRACE ELEMENTS IN MAN AND ANIMALS - 9, P59; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Hill KE, 1997, ANAL BIOCHEM, V253, P123, DOI 10.1006/abio.1997.2373; Huang JQ, 2015, FREE RADICAL BIO MED, V83, P129, DOI 10.1016/j.freeradbiomed.2015.01.033; LAWRENCE RA, 1974, EXP EYE RES, V18, P563, DOI 10.1016/0014-4835(74)90062-1; Lei XG, 1998, J NUTR, V128, P130, DOI 10.1093/jn/128.1.130; LEI XG, 1995, J NUTR, V125, P1438; Li J, 2016, PLOS ONE, DOI 10.1371/journal.pone.0164235.g007; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mariotti M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033066; Mueller AS, 2009, J ANIM PHYSIOL AN N, V93, P313, DOI 10.1111/j.1439-0396.2008.00849.x; National Research Council, 1994, NUTR REQ POULTR; OH SH, 1976, J ANIM SCI, V42, P977, DOI 10.2527/jas1976.424977x; Olson GE, 2010, AM J PHYSIOL-RENAL, V298, pF1244, DOI 10.1152/ajprenal.00662.2009; OMAYE ST, 1974, J NUTR, V104, P747, DOI 10.1093/jn/104.6.747; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raines AM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-26; SCOTT ML, 1966, ANN NY ACAD SCI, V138, P82; SCOTT ML, 1967, J NUTR, V91, P573, DOI 10.1093/jn/91.4.573; Steel R.G., 1980, PRINCIPLES PROCEDURE, P481; Sunde RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129801; Sunde RA, 2011, ADV NUTR, V2, P138, DOI 10.3945/an.110.000240; Sunde RA, 2010, EXP BIOL MED, V235, P1046, DOI 10.1258/ebm.2010.010111; Sunde RA, 2010, J NUTR BIOCHEM, V21, P665, DOI 10.1016/j.jnutbio.2009.11.012; Sunde RA, 2010, EXP BIOL MED, V235, P23, DOI 10.1258/ebm.2009.009262; Sunde RA, 2009, BIOSCIENCE REP, V29, P329, DOI 10.1042/BSR20080146; THOMPSON KM, 1995, J NUTR, V125, P864; WALTER ED, 1963, J NUTR, V80, P327, DOI 10.1093/jn/80.3.327; Weiss SL, 1996, J NUTR, V126, P2260, DOI 10.1093/jn/126.9.2260; Weiss SL, 1997, J NUTR BIOCHEM, V8, P85, DOI 10.1016/S0955-2863(96)00178-7; [No title captured]	39	21	22	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151665	10.1371/journal.pone.0151665	http://dx.doi.org/10.1371/journal.pone.0151665			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008545	gold, Green Published, Green Submitted			2022-12-26	WOS:000372701200061
J	Velentzis, LS; Banks, E; Sitas, F; Salagame, U; Tan, EH; Canfell, K				Velentzis, Louiza S.; Banks, Emily; Sitas, Freddy; Salagame, Usha; Tan, Eng Hooi; Canfell, Karen			Use of Menopausal Hormone Therapy and Bioidentical Hormone Therapy in Australian Women 50 to 69 Years of Age: Results from a National, Cross-Sectional Study	PLOS ONE			English	Article							HEALTH; TRENDS	Menopausal Hormone Therapy (MHT) use in Australia fell by 55% from 2001 to 2005, following the release of large-scale findings on its risks and benefits. Comprehensive national data, including information on overall prevalence of MHT use as well as information on duration of use in Australia have not been reported since the 2004-5 National Health Survey, when 11% of women aged 45+ years were estimated to be current MHT users. No national data are available on prevalence of use of "bioidentical" hormone therapy (BHT). The objective of this study was to determine recent prevalence of MHT and BHT use. A cross-sectional, national, age-stratified, population survey was conducted in 2013. Eligible women, aged 50-69 years, resident in Australia were randomly sampled in 5-year age groups from the Medicare enrolment database (Australia's universal health scheme). The response rate was 22% based on return of completed questionnaires, and analyses were restricted to 4,389 women within the specified age range. The estimated population-weighted prevalence of current use of MHT was 13% (95% CI 12-14), which was broadly similar to the previously reported national figures in 2004-5, suggesting that the use of MHT in Australia has largely stabilised over the past decade. A total of 39% and 20% of current-users with an intact uterus reported use of oestrogen-progestagen MHT and oestrogen-only MHT, respectively, whereas 77% of hysterectomised current-users used oestrogen-only MHT. Almost three-quarters of current-users [population-weighted prevalence 9% (95% CI 8-10)] had used MHT for >= 5 years. In regard to BHT, estimated population-weighted prevalence of ever use was 6% (95% CI 6-7) and 2% (95% CI 2-3) for current use. The population-weighted prevalence of MHT and BHT combined, in current users in their fifties and sixties was 15% (95% CI 14-16). These data provide a recent national "snapshot" of Australian women's use of both conventional MHT and of BHT.	[Velentzis, Louiza S.; Salagame, Usha; Canfell, Karen] NSW Canc Council, Canc Res Div, Sydney, NSW, Australia; [Banks, Emily] Australian Natl Univ, Res Sch Populat Hlth, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia; [Sitas, Freddy; Canfell, Karen] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Tan, Eng Hooi] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Canfell, Karen] Univ New S Wales, Lowy Canc Res Ctr, Sydney, NSW, Australia	Cancer Council New South Wales; Australian National University; University of Sydney; National University of Singapore; University of New South Wales Sydney	Velentzis, LS (corresponding author), NSW Canc Council, Canc Res Div, Sydney, NSW, Australia.	louizav@nswcc.org.au		Canfell, Karen/0000-0002-6443-6618; Banks, Emily/0000-0002-4617-1302; Tan, Eng Hooi/0000-0003-4470-2736; Sitas, Freddy/0000-0001-9679-1481	Cancer Council NSW; National Medical Research Council Australia [APP1082989, APP1042717]	Cancer Council NSW(Cancer Council New South Wales); National Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia)	The study was funded by Cancer Council NSW. The funding source had no involvement in the study design, analysis, and interpretation of results, writing of the manuscript or the decision to submit for publication. KC and EB receive salary support from the National Medical Research Council Australia (APP1082989 and APP1042717, respectively).	Australian Bureau of Statistics, 2012, POP AG SEX TABL; Australian Bureau of Statistics, 2001, NAT HLTH SURV SUMM R; Australian Drug Evaluation Committee, 2004, ADEC SUMM STAT HRT; Australian Statistics on Medicine, 2011, PHARM BEN SCHEM; Banks E, 2001, J Epidemiol Biostat, V6, P357; Banks E., 2014, MED FOR WOMEN; Beral V, 2005, LANCET, V365, P1543, DOI 10.1016/S0140-6736(05)66455-0; Beral V, 2011, JNCI-J NATL CANCER I, V103, P1; Canfell K, 2008, MED J AUSTRALIA, V188, P641, DOI 10.5694/j.1326-5377.2008.tb01821.x; Canfell K, 2009, BREAST CANCER RES TR, V117, P671, DOI 10.1007/s10549-009-0331-3; Gartoulla P, 2015, MED J AUSTRALIA, V203, P146, DOI 10.5694/mja14.01723; Iftikhar S, 2011, J WOMENS HEALTH, V20, P559, DOI 10.1089/jwh.2009.1915; International Survey Associates, 2006, THEOR CAS EXAMPL; Jordan SJ, 2015, AUST NZ J PUBL HEAL, V39, P441, DOI 10.1111/1753-6405.12444; Maclennan A H, 2004, Cochrane Database Syst Rev, pCD002978, DOI 10.1002/14651858.CD002978.pub2; MacLennan AH, 2009, CLIMACTERIC, V12, P122, DOI 10.1080/13697130802666251; NPS MedicineWise website, 2016, THER CHOIC MEN SYMPT; Peng WB, 2014, MATURITAS, V79, P340, DOI 10.1016/j.maturitas.2014.08.002; Pinkerton JV, 2015, MENOPAUSE, V22, P926, DOI 10.1097/GME.0000000000000420; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Salagame U, 2015, INT J CANC; Taylor AW, 2006, AUST NZ J OBSTET GYN, V46, P128, DOI 10.1111/j.1479-828X.2006.00542.x; UK Medicines and Healthcare products Regulatory Agency (UKMHRA), 2007, HORM REPL THER UPD A; United States Department of Health and Human Services Food and Drug Administration, 2016, DRAFT GUIDANCE; United States Department of Health and Human Services Food and Drug Administration US, US REP LTD FDA SURV; Whelan Anne Marie, 2011, Pharmacy Pract (Granada), V9, P16	26	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0146494	10.1371/journal.pone.0146494	http://dx.doi.org/10.1371/journal.pone.0146494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008039	Green Published, Green Submitted, gold			2022-12-26	WOS:000372701200010
J	Afema, JA; Byarugaba, DK; Shah, DH; Atukwase, E; Nambi, M; Sischo, WM				Afema, Josephine A.; Byarugaba, Denis K.; Shah, Devendra H.; Atukwase, Esther; Nambi, Maria; Sischo, William M.			Potential Sources and Transmission of Salmonella and Antimicrobial Resistance in Kampala, Uganda	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI O157-H7; TANDEM REPEAT ANALYSIS; VARIABLE-NUMBER; GLOBAL BURDEN; INFECTIONS; DISEASE; EPIDEMIOLOGY; SURVEILLANCE	In sub-Saharan Africa, non-typhoidal Salmonellae (NTS) cause invasive disease particularly in children and HIV infected adults, but the disease epidemiology is poorly understood. Between 2012 and 2013, we investigated NTS sources and transmission in Kampala. We detected Salmonella in 60% of the influent and 60% of the effluent samples from a wastewater treatment plant and 53.3% of the influent and 10% of the effluent samples from waste stabilization ponds that serve the human population; 40.9% of flush-water samples from ruminant slaughterhouses, 6.6% of the poultry fecal samples from live bird markets and 4% of the fecal samples from swine at slaughter; and in 54.2% of the water samples from a channel that drains storm-water and effluents from the city. We obtained 775 Salmonella isolates, identified 32 serovars, and determined resistance to 15 antimicrobials. We genotyped common serovars using multiple-locus variable number tandem repeats analysis or pulsed-field gel electrophoresis. In addition, we analyzed 49 archived NTS isolates from asymptomatic livestock and human clinical cases. Salmonella from ruminant and swine sources were mostly pan-susceptible (95%) while poultry isolates were generally more resistant. Salmonella Kentucky isolated from poultry exhibited extensive drug resistance characterized by resistance to 10 antimicrobials. Interestingly, similar genotypes of S. Kentucky but with less antimicrobial resistance (AMR) were found in poultry, human and environmental sources. The observed AMR patterns could be attributed to host or management factors associated with production. Alternatively, S. Kentucky may be prone to acquiring AMR. The factors driving AMR remain poorly understood and should be elucidated. Overall, shared genotypes and AMR phenotypes were found in NTS from human, livestock and environmental sources, suggesting zoonotic and environmental transmissions most likely occur. Information from this study could be used to control NTS transmission.	[Afema, Josephine A.; Sischo, William M.] Washington State Univ, Coll Vet Med, Dept Vet Clin Sci, Pullman, WA 99164 USA; [Byarugaba, Denis K.; Atukwase, Esther; Nambi, Maria] Makerere Univ, Coll Vet Med & Anim Resources & Biosecur, Dept Biomol Resources & Biolab Sci, Kampala, Uganda; [Shah, Devendra H.] Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA	Washington State University; Makerere University; Washington State University	Afema, JA (corresponding author), Washington State Univ, Coll Vet Med, Dept Vet Clin Sci, Pullman, WA 99164 USA.	jaafema@vetmed.wsu.edu	Shah, Devendra H./S-4965-2016	Shah, Devendra H./0000-0001-6365-7868; Byarugaba, Denis K./0000-0002-4175-5659; Azikuru Afema, Josephine/0000-0003-3630-1772	United States Department of Agriculture Formula [3924-1027]; USAID Higher Education for Development; North Dakota State University [2530-0407]	United States Department of Agriculture Formula(United States Department of Agriculture (USDA)); USAID Higher Education for Development(United States Agency for International Development (USAID)); North Dakota State University	This work was supported by United States Department of Agriculture Formula Funds 3924-1027 (WMS), USAID Higher Education for Development subcontract with North Dakota State University 2530-0407. The funders had no role in study design, data collection and analysis, decision to publish or manuscript preparation.	Afema JA, 2015, ZOONOSES PUBLIC HLTH, V62, P506, DOI 10.1111/zph.12172; Ao TT, 2015, EMERG INFECT DIS, V21, P941, DOI 10.3201/eid2106.140999; Bachou H, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-160; BAUER AW, 1966, AM J CLIN PATHOL, V45, P493; Berge ACB, 2006, J APPL MICROBIOL, V101, P1309, DOI 10.1111/j.1365-2672.2006.03031.x; Boxrud D, 2007, J CLIN MICROBIOL, V45, P536, DOI 10.1128/JCM.01595-06; Boyer TC, 2012, ANTIBIOTIC RESISTANC; Byarugaba DK, 2004, INT J ANTIMICROB AG, V24, P105, DOI 10.1016/j.ijantimicag.2004.02.015; CDC, 2013, NAT ANT RES MON SYST; Cho S, 2007, FEMS MICROBIOL LETT, V275, P16, DOI 10.1111/j.1574-6968.2007.00875.x; Clinical and Laboratory Standards Institute (CLSI), 2012, M100S22 CLIN LAB S S; Collins LindaM., 2010, LATENT CLASS LATENT, DOI DOI 10.1002/9780470567333; Dhanani AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137697; Elgroud R, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/352029; Fashae K, 2010, J INFECT DEV COUNTR, V4, P484, DOI 10.3855/jidc.909; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; Francisco A, 2012, BMC BIOINFORMATICS, P13; Galanis E, 2006, EMERG INFECT DIS, V12, P381, DOI 10.3201/eid1203.050854; Gordon MA, 2011, CURR OPIN INFECT DIS, V24, P484, DOI 10.1097/QCO.0b013e32834a9980; Grimont P.A.D., 2007, AESTHETICS COSMETIC, P9; Hale CR, 2012, CLIN INFECT DIS, V54, pS472, DOI 10.1093/cid/cis051; Haley BJ, 2009, APPL ENVIRON MICROB, V75, P1248, DOI 10.1128/AEM.01648-08; Hendriksen RS, 2013, J CLIN MICROBIOL, V51, P284, DOI 10.1128/JCM.02227-12; Hoelzer K, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-34; Ikwap K, 2014, PREV VET MED, V115, P39, DOI 10.1016/j.prevetmed.2014.03.009; Kagambega A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-253; Kansiime F., 1999, WASTEWATER TREATMENT; Kariuki S, 2006, J MED MICROBIOL, V55, P585, DOI 10.1099/jmm.0.46375-0; Kariuki S, 2002, FEMS IMMUNOL MED MIC, V33, P165, DOI 10.1111/j.1574-695X.2002.tb00587.x; Keddy KH, 2009, J INFECT DEV COUNTR, V3, P585, DOI 10.3855/jidc.549; Kerouanton A, 2007, FOODBORNE PATHOG DIS, V4, P293, DOI 10.1089/fpd.2007.0090; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Lanza ST, 2007, STRUCT EQU MODELING, V14, P671, DOI 10.1080/10705510701575602; Le Hello S, 2013, LANCET INFECT DIS, V13, P672, DOI 10.1016/S1473-3099(13)70124-5; Le Hello S, 2011, J INFECT DIS, V204, P675, DOI 10.1093/infdis/jir409; Letema S, 2012, ENVIRON ENG SCI, V29, P291, DOI 10.1089/ees.2011.0063; Leung AKC, 2005, J NATL MED ASSOC, V97, P281; Lindstedt BA, 2004, J MICROBIOL METH, V59, P163, DOI 10.1016/j.mimet.2004.06.014; Lindstedt BA, 2003, J CLIN MICROBIOL, V41, P1469, DOI 10.1128/JCM.41.4.1469-1479.2003; Mahero M, 2013, CLIN MICROBIOL, V2, P128, DOI [10.4172/2327-5073.1000128, DOI 10.4172/2327-5073.1000128]; Majowicz SE, 2010, CLIN INFECT DIS, V50, P882, DOI 10.1086/650733; Matagi SV, 2002, ENVIRON MONIT ASSESS, V77, P121, DOI 10.1023/A:1015860820467; Mather AE, 2012, P ROY SOC B-BIOL SCI, V279, P1630, DOI 10.1098/rspb.2011.1975; MORINIGO MA, 1993, J APPL BACTERIOL, V74, P330, DOI 10.1111/j.1365-2672.1993.tb03033.x; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rickert-Hartman R, 2014, EMERG INFECT DIS, V20, P910, DOI 10.3201/eid2005.131575; SANDERSON MW, 1995, J CLIN MICROBIOL, V33, P2616, DOI 10.1128/JCM.33.10.2616-2619.1995; Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904; Tennant SM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000621; UBOS, 2014, NATL POPULATION HOUS; Vincent V, 2007, FOODBORNE PATHOG DIS, V4, P375, DOI 10.1089/fpd.2007.0025; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003; Yoshida C, 2007, J MICROBIOL METH, V70, P261, DOI 10.1016/j.mimet.2007.04.018	53	33	33	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0152130	10.1371/journal.pone.0152130	http://dx.doi.org/10.1371/journal.pone.0152130			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999788	Green Submitted, Green Published, gold			2022-12-26	WOS:000372694700102
J	Dietrich, M; Tjale, MA; Weyer, J; Kearney, T; Seamark, ECJ; Nel, LH; Monadjem, A; Markotter, W				Dietrich, Muriel; Tjale, Mabotse A.; Weyer, Jacqueline; Kearney, Teresa; Seamark, Ernest C. J.; Nel, Louis H.; Monadjem, Ara; Markotter, Wanda			Diversity of Bartonella and Rickettsia spp. in Bats and Their Blood-Feeding Ectoparasites from South Africa and Swaziland	PLOS ONE			English	Article							FLIES NYCTERIBIIDAE; RESERVOIR HOSTS; INFECTION; GRAHAMII; BORRELIA; PATIENT; DNA	In addition to several emerging viruses, bats have been reported to host multiple bacteria but their zoonotic threats remain poorly understood, especially in Africa where the diversity of bats is important. Here, we investigated the presence and diversity of Bartonella and Rickettsia spp. in bats and their ectoparasites (Diptera and Siphonaptera) collected across South Africa and Swaziland. We collected 384 blood samples and 14 ectoparasites across 29 different bat species and found positive samples in four insectivorous and two frugivorous bat species, as well as their Nycteribiidae flies. Phylogenetic analyses revealed diverse Bartonella genotypes and one main group of Rickettsia, distinct from those previously reported in bats and their ectoparasites, and for some closely related to human pathogens. Our results suggest a differential pattern of host specificity depending on bat species. Bartonella spp. identified in bat flies and blood were identical supporting that bat flies may serve as vectors. Our results represent the first report of bat-borne Bartonella and Rickettsia spp. in these countries and highlight the potential role of bats as reservoirs of human bacterial pathogens.	[Dietrich, Muriel; Tjale, Mabotse A.; Nel, Louis H.; Markotter, Wanda] Univ Pretoria, Dept Microbiol & Plant Pathol, ZA-0002 Pretoria, South Africa; [Weyer, Jacqueline] Natl Inst Communicable Dis, Natl Hlth Lab Serv, Johannesburg, South Africa; [Weyer, Jacqueline] Univ Pretoria, ZA-0002 Pretoria, South Africa; [Kearney, Teresa] Ditsong Natl Museum Nat Hist, Pretoria, South Africa; [Kearney, Teresa] Univ Witwatersrand, Johannesburg, South Africa; [Seamark, Ernest C. J.] AfricanBats, Kloofsig, South Africa; [Seamark, Ernest C. J.] Univ Pretoria, Ctr Wildlife Management, ZA-0002 Pretoria, South Africa; [Monadjem, Ara] Univ Swaziland, Kwaluseni, Eswatini	University of Pretoria; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Pretoria; University of Witwatersrand; University of Pretoria	Markotter, W (corresponding author), Univ Pretoria, Dept Microbiol & Plant Pathol, ZA-0002 Pretoria, South Africa.	wanda.markotter@up.ac.za	Nel, Louis H/F-1001-2012; Monadjem, Ara/K-7279-2014	Nel, Louis H/0000-0001-8963-0153; Monadjem, Ara/0000-0003-1906-4023; Markotter, Wanda/0000-0002-7550-0080; Dietrich, Muriel/0000-0002-2665-7970; Kearney, Teresa/0000-0002-0050-4060; Seamark, Ernest C. J./0000-0001-9741-9147	National Research Foundation (NRF) of South Africa [78566, ABI3500, 91496, 92524]; Poliomyelitis Research Foundation (PRF) [12/14]; National Research Foundation, South Africa (NRF) [N00595]	National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa); Poliomyelitis Research Foundation (PRF); National Research Foundation, South Africa (NRF)(National Research Foundation - South Africa)	This work is based on the research supported in part by a number of grants from the National Research Foundation (NRF) of South Africa (Grant UID: 78566 (NRF RISP grant for the ABI3500) and Grant UID 91496 and 92524) and the Poliomyelitis Research Foundation (PRF) (Grant number 12/14). MD's postdoctoral fellowship is funded by the National Research Foundation, South Africa (NRF - N00595).	ACR, 2014, AFR CHIR REP 2014; Anti P, 2015, EMERG INFECT DIS, V21, P1418, DOI 10.3201/eid2108.142015; Bai Y, 2011, EMERG INFECT DIS, V17, P1269, DOI 10.3201/eid1707.101867; Billeter SA, 2012, PARASITOLOGY, V139, P324, DOI 10.1017/S0031182011002113; Brook CE, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003532; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; D'Auria SRN, 2010, VECTOR-BORNE ZOONOT, V10, P459, DOI 10.1089/vbz.2009.0070; DALY JS, 1993, J CLIN MICROBIOL, V31, P872, DOI 10.1128/JCM.31.4.872-881.1993; Dick CW, 2007, ECOL ENTOMOL, V32, P446, DOI 10.1111/j.1365-2311.2007.00836.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Judson SD, 2015, ZOONOSES PUBLIC HLTH, V62, P609, DOI 10.1111/zph.12188; Kamani J, 2014, VECTOR-BORNE ZOONOT, V14, P625, DOI 10.1089/vbz.2013.1541; Kerkhoff FT, 1999, J CLIN MICROBIOL, V37, P4034, DOI 10.1128/JCM.37.12.4034-4038.1999; Kosoy M, 2010, EMERG INFECT DIS, V16, P1875, DOI 10.3201/eid1612.100601; Lin EY, 2010, EMERG INFECT DIS, V16, P500, DOI 10.3201/eid1603.081673; Loftis AD, 2005, J MED ENTOMOL, V42, P473, DOI 10.1603/0022-2585(2005)042[0473:DORBAB]2.0.CO;2; Morse SF, 2012, INFECT GENET EVOL, V12, P1717, DOI 10.1016/j.meegid.2012.06.009; Muhldorfer K, 2013, ZOONOSES PUBLIC HLTH, V60, P93, DOI 10.1111/j.1863-2378.2012.01536.x; Oksi J, 2013, J CLIN MICROBIOL, V51, P2781, DOI 10.1128/JCM.00910-13; Anh PH, 2015, EMERG INFECT DIS, V21, P1266, DOI 10.3201/eid2107.141760; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pretorius AM, 2004, INT J SYST EVOL MICR, V54, P1959, DOI 10.1099/ijs.0.03033-0; Pretorius AM, 2004, EMERG INFECT DIS, V10, P125; Serratrice J, 2003, REV MED INTERNE, V24, P629, DOI 10.1016/S0248-8663(03)00224-8; Socolovschi C, 2012, EMERG INFECT DIS, V18, P1966, DOI 10.3201/eid1812.111237; TAYLOR P. J., 2010, BATS SO CENTRAL AFRI; Tortosa P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075215; Trataris AN, 2012, P C SO AFR CTR INF D; Veikkolainen V, 2014, EMERG INFECT DIS, V20, P960, DOI 10.3201/eid2006.130956; Walker DH, 2008, NAT REV MICROBIOL, V6, P375, DOI 10.1038/nrmicro1866; Wilkinson DA, 2016, APPL ENVIRON MICROB, V82, P1778, DOI 10.1128/AEM.03505-15; Wolfel R, 2008, INT J MED MICROBIOL, V298, P368, DOI 10.1016/j.ijmm.2007.11.009	33	32	36	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0152077	10.1371/journal.pone.0152077	http://dx.doi.org/10.1371/journal.pone.0152077			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999518	Green Submitted, Green Published, gold			2022-12-26	WOS:000372694700098
J	Nissink, JWM; Bista, M; Breed, J; Carter, N; Embrey, K; Read, J; Winter-Holt, JJ				Nissink, J. Willem M.; Bista, Michal; Breed, Jason; Carter, Nikki; Embrey, Kevin; Read, Jonathan; Winter-Holt, Jon J.			MTH1 Substrate Recognition-An Example of Specific Promiscuity	PLOS ONE			English	Article							HUMAN MUTT HOMOLOG; PROTEINS; CANCER; DNA; REPAIR; PK(A)	MTH1 (NUDT1) is an oncologic target involved in the prevention of DNA damage. We investigate the way MTH1 recognises its substrates and present substrate-bound structures of MTH1 for 8-oxo-dGTP and 8-oxo-rATP as examples of novel strong and weak binding substrate motifs. Investigation of a small set of purine-like fragments using 2D NMR resulted in identification of a fragment with weak potency. The protein-ligand X-Ray structure of this fragment provides insight into the role of water molecules in substrate selectivity. Wider fragment screening by NMR resulted in three new protein structures exhibiting alternative binding configurations to the key Asp-Asp recognition element of the protein. These inhibitor binding modes demonstrate that MTH1 employs an intricate yet promiscuous mechanism of substrate anchoring through its Asp-Asp pharmacophore. The structures suggest that water-mediated interactions convey selectivity towards oxidized substrates over their non-oxidised counterparts, in particular by stabilization of a water molecule in a hydrophobic environment through hydrogen bonding. These findings may be useful in the design of inhibitors of MTH1.	[Nissink, J. Willem M.; Winter-Holt, Jon J.] AstraZeneca, Chem Oncol Innovat Med & Early Dev Biotech Unit, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England; [Nissink, J. Willem M.; Winter-Holt, Jon J.] Alderley Pk, Macclesfield SK10 4TG, Cheshire, England; [Bista, Michal; Breed, Jason; Carter, Nikki; Read, Jonathan] AstraZeneca, Discovery Sci Innovat Med & Early Dev Biotech Uni, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England; [Embrey, Kevin] AstraZeneca, Discovery Sci Innovat Med & Early Dev Biotech Uni, Alderley Pk, Macclesfield SK10 4TG, Cheshire, England	AstraZeneca; AstraZeneca; AstraZeneca	Nissink, JWM (corresponding author), AstraZeneca, Chem Oncol Innovat Med & Early Dev Biotech Unit, Unit 310,Darwin Bldg,Cambridge Sci Pk,Milton Rd, Cambridge CB4 0WG, England.; Nissink, JWM (corresponding author), Alderley Pk, Macclesfield SK10 4TG, Cheshire, England.	willem.nissink@astrazeneca.com	Nissink, J. Willem M./C-1507-2010	Nissink, J. Willem M./0000-0003-2572-9140; Bista, Michal/0000-0001-9237-1199	AstraZeneca	AstraZeneca(AstraZeneca)	All authors were employees of Astrazeneca at the time of writing. AstraZeneca provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Duddy WJ, 2004, PROTEIN SCI, V13, P3051, DOI 10.1110/ps.04920904; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujikawa K, 1999, J BIOL CHEM, V274, P18201, DOI 10.1074/jbc.274.26.18201; Fujikawa K, 2001, NUCLEIC ACIDS RES, V29, P449, DOI 10.1093/nar/29.2.449; FURUICHI M, 1994, GENOMICS, V24, P485, DOI 10.1006/geno.1994.1657; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Isom DG, 2010, P NATL ACAD SCI USA, V107, P16096, DOI 10.1073/pnas.1004213107; Jang YH, 2002, CHEM RES TOXICOL, V15, P1023, DOI 10.1021/tx010146r; KAKUMA T, 1995, J BIOL CHEM, V270, P25942, DOI 10.1074/jbc.270.43.25942; Kamiya H, 2004, J MOL BIOL, V336, P843, DOI 10.1016/j.jmb.2003.12.060; Kamiya H, 2006, J BIOCHEM, V140, P843, DOI 10.1093/jb/mvj214; Kamiya H, 2010, MUTAT RES-GEN TOX EN, V703, P32, DOI 10.1016/j.mrgentox.2010.06.003; Kimple AJ, 2010, METHODS MOL BIOL, V627, P91, DOI 10.1007/978-1-60761-670-2_5; Kimsey IJ, 2015, NATURE, V519, P315, DOI 10.1038/nature14227; Leatherbarrow RJ, 2008, GRAFIT, P605; Marian CM, 2007, J PHYS CHEM A, V111, P1545, DOI 10.1021/jp068620v; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Okochi E, 2002, JPN J CANCER RES, V93, P501, DOI 10.1111/j.1349-7006.2002.tb01284.x; Parker AR, 2003, J BIOL CHEM, V278, P47937, DOI 10.1074/jbc.M306598200; Parker AR, 2002, CANCER RES, V62, P7230; Patel A, 2015, ONCOGENE, V34, P2586, DOI 10.1038/onc.2014.195; Roversi P, 2000, ACTA CRYSTALLOGR D, V56, P1316, DOI 10.1107/S0907444900008490; Sakai Y, 2002, J BIOL CHEM, V277, P8579, DOI 10.1074/jbc.M110566200; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; SEPIOL J, 1976, Z NATURFORSCH C, V31, P361; Streib M, 2014, ANGEW CHEM INT EDIT, V53, P305, DOI 10.1002/anie.201307849; Svensson LM, 2011, FEBS LETT, V585, P2617, DOI 10.1016/j.febslet.2011.07.017; Tan KP, 2013, NUCLEIC ACIDS RES, V41, pW314, DOI 10.1093/nar/gkt503; TOPAL MD, 1982, P NATL ACAD SCI-BIOL, V79, P2211, DOI 10.1073/pnas.79.7.2211; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xu P, 2003, J BIOL CHEM, V278, P48422, DOI 10.1074/jbc.M307888200	36	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151154	10.1371/journal.pone.0151154	http://dx.doi.org/10.1371/journal.pone.0151154			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999531	Green Published, gold, Green Submitted			2022-12-26	WOS:000372694700023
J	Nlend, AEN; Motaze, AN; Tetang, SM; Zeudja, C; Ngantcha, M; Tejiokem, M				Nlend, Anne Esther Njom; Motaze, Annie Nga; Tetang, Suzie Moyo; Zeudja, Cecile; Ngantcha, Marcus; Tejiokem, Mathurin			Preterm Birth and Low Birth Weight after In Utero Exposure to Antiretrovirals Initiated during Pregnancy in Yaounde, Cameroon	PLOS ONE			English	Article								Background Effects of antiretroviral therapy (ART) on birth outcomes remain controversial. Objective To assess the impact of antenatal exposure to ART on the occurrence of preterm birth (PTB) and low birth weight (LBW). Methods A cross-sectional study conducted at the Essos Hospital Center in Yaounde from 2008 to 2011 among HIV vertically exposed infants with two distinct maternal antiretroviral experiences: monotherapy group (Zidovudine, ZDV) and the combination ART group (cART). Mothers already receiving cART before pregnancy were ineligible. In both groups, events of PTB (<37 weeks) and LBW (<2,500g) were analyzed using univariate and multivariate logistic regression; with p<0.05 considered statistically significant. Results Of the 760 infants, 481 were born from cART-exposed mothers against 279 from maternal-ZDV. Median maternal CD4 count was 378 [interquartile range (IQR): 253-535] cells/mm(3). Median duration of ART at onset of delivery was 13 [IQR: 10-17] weeks. In the cART-group, 64.9% (312/481) of mothers were exposed to Zidovudine/Lamuvidine/Nevirapine and only 2% (9/481) were on protease inhibitor-based regimens. Events of PTB were not significantly higher in the cART-group compared to the ZDV-group (10.2% vs. 6.4% respectively, p = 0.08), while onsets of LBW were significantly found in the cART-group compared to ZDV-group (11.6% vs. 7.2% respectively, p = 0.05). Other factors (parity, maternal age at delivery or CD4 cell count) were not associated with PTB. Conclusion cART, initiated during pregnancy, would be an independent factor of LBW. In the era of option B+ (lifelong ART to all HIV-pregnant women), further studies would guide towards measures limiting onsets of LBW.	[Nlend, Anne Esther Njom; Motaze, Annie Nga; Tetang, Suzie Moyo; Zeudja, Cecile] Natl Social Insurance Fund Hosp, Essos Hosp Ctr, Dept Pediat, Yaounde, Cameroon; [Tejiokem, Mathurin] Ctr Pasteur Cameroon, Epidemiol & Publ Hlth Unit, Yaounde, Cameroon		Nlend, AEN (corresponding author), Natl Social Insurance Fund Hosp, Essos Hosp Ctr, Dept Pediat, Yaounde, Cameroon.	anne.njom@gmail.com	NLEND, ANNE ESTHER NJOM/AAZ-8748-2020		French "Fondation GlaxoSmithKline"	French "Fondation GlaxoSmithKline"	We are thankful to the French "Fondation GlaxoSmithKline" for the supportive grant for the follow up of this perinatal cohort.	Aaron E, 2012, INFECT DIS OBSTET GY; Ackerman W, 2013, J NIPPON MED SCH, V80, P90, DOI 10.1272/jnms.80.90; Alemu Mazengia F, 2013, INT J, V1, P31; [Anonymous], 2020, HIGH POSS COST COVID; Dos Reis HLB, 2015, REV INST MED TROP SP, V57, P111, DOI 10.1590/S0036-46652015000200003; Briand N, 2009, AIDS, V23, P1235, DOI 10.1097/QAD.0b013e32832be0df; Browne JL, 2015, JAIDS-J ACQ IMM DEF, V70, P91, DOI 10.1097/QAI.0000000000000686; Chen JY, 2012, J INFECT DIS, V206, P1695, DOI 10.1093/infdis/jis553; Darak S, 2013, AIDS PATIENT CARE ST, V27, P163, DOI 10.1089/apc.2012.0401; Dola CP, 2012, J PERINAT MED, V40, P51, DOI 10.1515/JPM.2011.111; Ekouevi DK, 2008, AIDS, V22, P1815, DOI 10.1097/QAD.0b013e32830b8ab9; Marazzi MC, 2011, AIDS, V25, P1611, DOI 10.1097/QAD.0b013e3283493ed0; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Ministry of Public Health, 2009, REC US ANT DRUGS PRE; Ndirangu J, 2012, HUM REPROD, V27, P1846, DOI 10.1093/humrep/des090; Nielsen-Saines K, 2012, PEDIATRICS, V129, pE1525, DOI 10.1542/peds.2011-2340; Nlend AEN, 2012, J TROP PEDIATRICS, V58, P297, DOI 10.1093/tropej/fmr100; Olagbuji BN, 2010, ARCH GYNECOL OBSTET, V281, P991, DOI 10.1007/s00404-009-1186-x; Papp E, 2015, J INFECT DIS, V211, P10, DOI 10.1093/infdis/jiu393; Patel K, 2010, J INFECT DIS, V201, P1035, DOI 10.1086/651232; Phiri K, 2015, PEDIATR INFECT DIS J, V34, pE169, DOI 10.1097/INF.0000000000000712; Powis KM, 2011, J INFECT DIS, V204, P506, DOI 10.1093/infdis/jir307; Senise JF, 2011, AIDS REV, V13, P198; Sibiude J, 2015, EXPERT OPIN DRUG SAF, V14, P643, DOI 10.1517/14740338.2015.1019462; Sturt AS, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008440; Tchetgen EJT, 2015, EPIDEMIOLOGY, V26, P473, DOI 10.1097/EDE.0000000000000317; Thorne C, 2004, AIDS, V18, P2337, DOI 10.1097/00002030-200411190-00019; Turner AN, 2013, JAIDS-J ACQ IMM DEF, V64, P392, DOI 10.1097/QAI.0b013e3182a2d13c; van der Merwe K, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-42; Watts DH, 2012, J INFECT DIS, V206, P1639, DOI 10.1093/infdis/jis581; World Health Organization, 2010, ANT DURGS TREAT PREG; Young S, 2012, PLOS ONE, V8	32	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0150565	10.1371/journal.pone.0150565	http://dx.doi.org/10.1371/journal.pone.0150565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999744	Green Published, Green Submitted, gold			2022-12-26	WOS:000372694700012
J	Mazzorana, M; Hussain, R; Sorensen, T				Mazzorana, Marco; Hussain, Rohanah; Sorensen, Thomas			Ca-Dependent Folding of Human Calumenin	PLOS ONE			English	Article							EF-HAND PROTEIN; CALCIUM-BINDING; ENDOPLASMIC-RETICULUM; CA2+-BINDING PROTEIN; STRUCTURAL-CHANGES; CALSEQUESTRIN; PREDICTION; SKELETAL; WEB; COOPERATIVITY	Human calumenin (hCALU) is a six EF-hand protein belonging to the CREC family. As other members of the family, it is localized in the secretory pathway and regulates the activity of SERCA2a and of the ryanodine receptor in the endoplasmic reticulum (ER). We have studied the effects of Ca2+ binding to the protein and found it to attain a more compact structure upon ion binding. Circular Dichroism (CD) measurements suggest a major rearrangement of the protein secondary structure, which reversibly switches from disordered at low Ca2+ concentrations to predominantly alpha-helical when Ca2+ is added. SAXS experiments confirm the transition from an unfolded to a compact structure, which matches the structural prediction of a trilobal fold. Overall our experiments suggest that calumenin is a Ca2+ sensor, which folds into a compact structure, capable of interacting with its molecular partners, when Ca2+ concentration within the ER reaches the millimolar range.	[Mazzorana, Marco; Hussain, Rohanah; Sorensen, Thomas] Diamond Light Source Ltd, Div Life Sci, Harwell Sci & Innovat Campus, Didcot, Oxon, England	Diamond Light Source	Mazzorana, M; Sorensen, T (corresponding author), Diamond Light Source Ltd, Div Life Sci, Harwell Sci & Innovat Campus, Didcot, Oxon, England.	marco.mazzorana@diamond.ac.uk; thomas.sorensen@diamond.ac.uk	Sørensen, Thomas Lykke-Møller/AAA-7052-2020	Mazzorana, Marco/0000-0001-9414-4547; Sorensen, Thomas Lykke-Moller/0000-0003-3873-3499	Diamond Light Source; OPPF	Diamond Light Source; OPPF	This work was supported by Diamond Light Source. The funder provided support in the form of salaries for authors [MM, RH, TS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.; The authors wish to thank the OPPF for their support with the cloning and expression of the protein and Dr. Gemma Harris for the assistance with SPR and SEC-MALS experimens. We owe a special acknowledgement to the staff of beamlines B21, I22 and B23 of Diamond Light Source, in particular Dr. Robert P. Rambo help with SAXS data collection and analysis and Dr. Giuliano Siligardi for the insightful suggestions and scientific discussion. We thank Diamond Light Source for beamtime on B23 (SM-10526), I22 (SM-3999) and B21 (SM-10528).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Assenberg R, 2008, ACTA CRYSTALLOGR F, V64, P258, DOI 10.1107/S1744309108004557; Bal NC, 2011, BIOCHEM J, V435, P391, DOI 10.1042/BJ20101771; Beard NA, 2004, PROG BIOPHYS MOL BIO, V85, P33, DOI 10.1016/j.pbiomolbio.2003.07.001; Bitto E, 2009, PROTEINS, V76, P477, DOI 10.1002/prot.22362; FINN BE, 1995, NAT STRUCT BIOL, V2, P777, DOI 10.1038/nsb0995-777; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Hidalgo C, 1996, BIOPHYS J, V71, P2130, DOI 10.1016/S0006-3495(96)79413-4; Honore B, 2000, FEBS LETT, V466, P11, DOI 10.1016/S0014-5793(99)01780-9; Hussain R, 2015, J SYNCHROTRON RADIAT, V22, P465, DOI 10.1107/S1600577514028161; IIDA S, 1986, J BIOCHEM-TOKYO, V99, P1765, DOI 10.1093/oxfordjournals.jbchem.a135654; IKEMOTO N, 1974, J BIOL CHEM, V249, P2357; Jung DH, 2006, BIOCHEM BIOPH RES CO, V343, P34, DOI 10.1016/j.bbrc.2006.02.115; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kojetin DJ, 2006, NAT STRUCT MOL BIOL, V13, P641, DOI 10.1038/nsmb1112; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kumar A, 2013, MOL BIOSYST, V9, P1949, DOI 10.1039/c3mb25588c; Kursula P, 2014, ACTA CRYSTALLOGR D, V70, P24, DOI 10.1107/S1399004713024437; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; LINSE S, 1995, PROTEIN SCI, V4, P1038, DOI 10.1002/pro.5560040602; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Perez J, 2001, J MOL BIOL, V308, P721, DOI 10.1006/jmbi.2001.4611; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rogstam A, 2007, BIOCHEM J, V401, P353, DOI 10.1042/BJ20060918; Romanov RA, 2015, EMBO J, V34, P36, DOI 10.15252/embj.201488977; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sahoo SK, 2008, MOL CELLS, V26, P265; Sahoo SK, 2010, BMB REP, V43, P158, DOI 10.5483/BMBRep.2010.43.3.158; Sahoo SK, 2009, J BIOL CHEM, V284, P31109, DOI 10.1074/jbc.M109.031989; Sanchez EJ, 2012, J BIOL CHEM, V287, P11592, DOI 10.1074/jbc.M111.335075; Siligardi G, 2002, J BIOL CHEM, V277, P20151, DOI 10.1074/jbc.M201287200; Slabinski L, 2007, BIOINFORMATICS, V23, P3403, DOI 10.1093/bioinformatics/btm477; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Suzuki N, 2014, J BIOCHEM, V155, P281, DOI 10.1093/jb/mvu003; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Vorum H, 1998, BBA-PROTEIN STRUCT M, V1386, P121, DOI 10.1016/S0167-4838(98)00089-2; Yabe D, 1998, GENOMICS, V49, P331, DOI 10.1006/geno.1998.5245; Yabe D, 1997, J BIOL CHEM, V272, P18232, DOI 10.1074/jbc.272.29.18232; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758	42	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151547	10.1371/journal.pone.0151547	http://dx.doi.org/10.1371/journal.pone.0151547			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991433	gold, Green Submitted, Green Published			2022-12-26	WOS:000372582800074
J	Zanotta, N; Tornesello, ML; Annunziata, C; Stellato, G; Buonaguro, FM; Comar, M				Zanotta, Nunzia; Tornesello, Maria Lina; Annunziata, Clorinda; Stellato, Giovanni; Buonaguro, Franco Maria; Comar, Manola			Candidate Soluble Immune Mediators in Young Women with High-Risk Human Papillomavirus Infection: High Expression of Chemokines Promoting Angiogenesis and Cell Proliferation	PLOS ONE			English	Article							DENDRITIC CELLS; CANCER; TUMOR; RESPONSES; TYPE-16; ASSOCIATION; PERSISTENCE; ACTIVATION; RECEPTORS; PATHWAYS	Background The causal interpretation of cervical immune response to Human Papillomavirus (HPV) infection is complex and poorly characterized mainly due to the delicate balance that exists between viral infection, increase of inflammatory cytokines and host risk factors. This study aims to explore the significance of cervical immune mediators associated to cell survival, angiogenesis and interaction with immune response, in predicting the risk to develop HPV-related intraepithelial lesions. Methods A panel of 48 cytokines and growth factors were explored in a selected cohort of 168 immunocompetent women including 88 diagnosed with low (LSIL) or high (HSIL) squamous intraepithelial lesions of the cervix and 80 with normal cervical cytology (NIL). HPV genotyping was performed by Linear Array HPV test and the soluble concentration of 48 immune molecules was analyzed using the Bio-Plex platform. Results The prevalence of single HR-HPV infection was 30% in NIL and 100% in LSIL and HSIL women. The expression of 13 cytokines, including interleukins IL-6, IL-3, IL-12p40, IL-12p70, IL-16, IL-18, LIF, of chemokines CCL7 (MCP-3), CXCL9 (MIG), CXCL12 (SDF-1 alpha) and of the tropic factors VEGF, G-CSF, M-CSF were significantly associated with the presence of infection, with levels being higher in women with precancerous lesions compared to NIL HPV negative women. Only the growth factor GM-CSF was positively associated with the cytological abnormalities. Conclusions The ability of HR-HPV to escape from innate immune recognition and to orchestrate the production of specific inflammatory and growth factors, involved in early inflammatory response and in the cell-proliferating phase of intraepithelial damage, was documented in women before the development of cervical lesions.	[Zanotta, Nunzia; Comar, Manola] Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy; [Tornesello, Maria Lina; Annunziata, Clorinda; Buonaguro, Franco Maria] Ist Nazl Tumori IRCCS Fond Pascale, Mol Biol & Viral Oncol Div, Naples, Italy; [Stellato, Giovanni] Ist Nazl Tumori IRCCS Fond Pascale, Div Gynecol Oncol, Naples, Italy; [Comar, Manola] Univ Trieste, Dept Med Sci, Trieste, Italy	IRCCS Burlo Garofolo; IRCCS Fondazione Pascale; IRCCS Fondazione Pascale; University of Trieste	Comar, M (corresponding author), Inst Maternal & Child Hlth IRCCS Burlo Garofolo, Trieste, Italy.; Comar, M (corresponding author), Univ Trieste, Dept Med Sci, Trieste, Italy.	manola.comar@burlo.trieste.it	Zanotta, Nunzia/K-4539-2016; Buonaguro, Franco M./T-6028-2019; Comar, Manola/K-4613-2016; Tornesello, Maria Lina/A-1964-2008; Maria, Buonaguro Franco/AAF-4888-2019; Annunziata, Clorinda/K-3886-2018; COMAR, Manola/K-4613-2016	Zanotta, Nunzia/0000-0002-6458-1946; Buonaguro, Franco M./0000-0002-7491-7220; Comar, Manola/0000-0001-6310-3320; Tornesello, Maria Lina/0000-0002-3523-3264; Annunziata, Clorinda/0000-0002-9580-8330; COMAR, Manola/0000-0002-9487-861X	Italian Health Ministry IRCCS-"Burlo Garofolo," Trieste, Italy [09/12]	Italian Health Ministry IRCCS-"Burlo Garofolo," Trieste, Italy	The present study has been supported by a grant from Italian Health Ministry (Current research 09/12) IRCCS-"Burlo Garofolo," Trieste, Italy.	Alcocer-Gonzalez JM, 2006, VIRAL IMMUNOL, V19, P481, DOI 10.1089/vim.2006.19.481; Arbyn M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092615; Azar KK, 2004, HUM PATHOL, V35, P1376, DOI 10.1016/j.humpath.2004.08.012; Bais AG, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/24147; Castle PE, 2001, CANCER EPIDEM BIOMAR, V10, P1021; Chang YH, 2010, CANCER-AM CANCER SOC, V116, P4800, DOI 10.1002/cncr.25224; Comar M, 2013, J CLIN VIROL, V58, P479, DOI 10.1016/j.jcv.2013.07.001; Conesa-Zamora P, 2002, NAT REV CANCER, V2, P59; Conesa-Zamora P, 2013, GYNECOL ONCOL, V131, P480, DOI 10.1016/j.ygyno.2013.08.025; Deligeoroglou Efthimios, 2013, Infect Dis Obstet Gynecol, V2013, P540850, DOI 10.1155/2013/540850; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Hasan UA, 2007, J IMMUNOL, V178, P3186, DOI 10.4049/jimmunol.178.5.3186; Hasan UA, 2013, J EXP MED, V210, P1369, DOI 10.1084/jem.20122394; Hazelbag S, 2001, GYNECOL ONCOL, V83, P235, DOI 10.1006/gyno.2001.6378; Heikkila K, 2008, EUR J CANCER, V44, P937, DOI 10.1016/j.ejca.2008.02.047; Hubert P, 2005, J PATHOL, V206, P346, DOI 10.1002/path.1771; Hubert P, 1999, AM J PATHOL, V154, P775, DOI 10.1016/S0002-9440(10)65324-2; Hussain SK, 2013, INT J CANCER, V133, P201, DOI 10.1002/ijc.28000; Jaafar F, 2009, AM J PATHOL, V175, P1525, DOI 10.2353/ajpath.2009.090295; Kanodia S, 2007, CURR CANCER DRUG TAR, V7, P79, DOI 10.2174/156800907780006869; Karim R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017848; Kryczek I, 2007, AM J PHYSIOL-CELL PH, V292, pC987, DOI 10.1152/ajpcell.00406.2006; Lee SJ, 2015, VACCINE, V33, P1549, DOI 10.1016/j.vaccine.2015.02.019; Liu Y, 2011, CANCER GENE THER, V18, P407, DOI 10.1038/cgt.2011.8; Majka M, 2006, FOLIA HISTOCHEM CYTO, V44, P155; Miller LS, 2007, J INVEST DERMATOL, V127, P262, DOI 10.1038/sj.jid.5700559; Molling JW, 2007, INT J CANCER, V121, P1749, DOI 10.1002/ijc.22894; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Munoz N, 2000, J CLIN VIROL, V19, P1, DOI 10.1016/S1386-6532(00)00125-6; Nasu K, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/976024; Nees M, 2001, J VIROL, V75, P4283, DOI 10.1128/JVI.75.9.4283-4296.2001; Perea SE, 2000, INT J MOL MED, V5, P661; Ren CX, 2013, EUR J CANCER, V49, P3889, DOI 10.1016/j.ejca.2013.07.140; Rositch AF, 2013, INT J CANCER, V133, P1271, DOI 10.1002/ijc.27828; Scott ME, 2009, INT J CANCER, V124, P1379, DOI 10.1002/ijc.24117; Sheu BC, 2001, J IMMUNOL, V167, P2972, DOI 10.4049/jimmunol.167.5.2972; Sheu BC, 2007, J OBSTET GYNAECOL RE, V33, P103, DOI 10.1111/j.1447-0756.2007.00492.x; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Stanley M, 2006, VACCINE, V24, P16, DOI 10.1016/j.vaccine.2005.09.002; Stanley MA, 2012, CLIN MICROBIOL REV, V25, P215, DOI 10.1128/CMR.05028-11; Strickler HD, 2014, VIRAL IMMUNOL, V27, P20, DOI 10.1089/vim.2013.0097; Tindle RW, 2002, NAT REV CANCER, V2, P59, DOI 10.1038/nrc700; Tommasino M, 2014, SEMIN CANCER BIOL, V26, P13, DOI 10.1016/j.semcancer.2013.11.002; Tornesello ML, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/519619; Torres-Poveda K, 2014, WORLD J CLIN ONCOL, V5, P753, DOI 10.5306/wjco.v5.i4.753; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Walentowicz-Sadlecka M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084629; Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064; Bosch FX, 2013, VACCINE, V31, pH1, DOI [10.1016/j.vaccine.2013.10.003, 10.1016/j.vaccine.2013.07.026]; Yang K, 2005, IMMUNITY, V23, P465, DOI 10.1016/j.immuni.2005.09.016	50	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151851	10.1371/journal.pone.0151851	http://dx.doi.org/10.1371/journal.pone.0151851			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990868	Green Published, gold, Green Submitted			2022-12-26	WOS:000372582800110
J	Lee, I; Maniar, K; Lydon, JP; Kim, JJ				Lee, Il; Maniar, K.; Lydon, J. P.; Kim, J. J.			Akt regulates progesterone receptor B-dependent transcription and angiogenesis in endometrial cancer cells	ONCOGENE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MEDROXYPROGESTERONE ACETATE; GLUCOCORTICOID-RECEPTOR; GENE-EXPRESSION; DOWN-REGULATION; STROMAL CELLS; YOUNG-WOMEN; CARCINOMA; 14-3-3-SIGMA; 14-3-3-PROTEINS	Progestins have long been used clinically for the treatment of endometrial cancers; however, the response rates to progestin therapy vary and the molecular mechanisms behind progestin insensitivity are poorly understood. We hypothesized that in PTEN-mutated endometrial cancers, hyperactive Akt signaling downregulates progesterone receptor B (PRB) transcriptional activity, leading to overall impaired progestin responses. We report that inhibition of Akt with the Akt inhibitor, MK-2206 (MK), in conjunction with progestin (R5020) treatment, is sufficient to upregulate a subset of PRB target genes in Ishikawa cells stably expressing PRB (PRB-Ishikawa). Through gene ontology analysis of Akt-regulated PRB target genes, angiogenesis was found to be the principle process regulated by Akt-PRB. To further interrogate the mechanism by which Akt modulates PRB transcriptional activity, ChIP-Mass spectrometry was performed to identify potential cofactors that differentially interact with PRB in the presence of R5020 and MK+R5020. 14-3-3 sigma was identified as a protein enriched in the MK+R5020 data set, and it was demonstrated that 14-3-3 sigma is required for the upregulation in PRB target gene expression following inhibition of Akt. To determine the ramifications of MK+R5020 treatment on angiogenesis, in vitro assays were performed and combinatorial MK+R5020 treatment significantly decreased endothelial cell invasion and tube formation more than MK or R5020 treatment alone. Furthermore, we found that combinatorial MK-2206+progesterone treatments decreased angiogenesis and proliferation in the Pten(d/d) conditional mouse model of endometrial cancer. Taken together, these findings suggest that a combinatorial therapeutic approach utilizing Akt inhibitors with progestins may improve the efficacy of progestin therapy for the treatment of endometrial cancer.	[Lee, Il; Kim, J. J.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Div Reprod Sci Med,Dept Obstet & Gynecol, Chicago, IL 60611 USA; [Maniar, K.] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Lydon, J. P.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; Feinberg School of Medicine; Baylor College of Medicine	Kim, JJ (corresponding author), Northwestern Univ, OB GYN, 303 E Super St Lurie 4-117, Chicago, IL 60611 USA.	j-kim4@northwestern.edu		Lee, Irene/0000-0002-5749-9389; Kim, J Julie/0000-0001-9834-8213	Robert H. Lurie Comprehensive Cancer Center of Northwestern University; NIH/NICHD [R01HD042311]; NIH/NCI [T32CA09560, R01CA155513]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042311] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA155513, P30CA060553, T32CA009560] Funding Source: NIH RePORTER	Robert H. Lurie Comprehensive Cancer Center of Northwestern University; NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to acknowledge the Northwestern Genomics Core Facility, the Northwestern Proteomics Core Facility, and the Northwestern Next Generation Sequencing Core Facility. We would also like to thank members of the Kim laboratory for technical assistance and insightful discussion and review of the manuscript. This work is supported by NIH/NCI training grant T32CA09560 (IIL), Malkin Scholars Program from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University (IIL), NIH/NICHD grant R01HD042311 (JPL) and NIH/NCI grant R01CA155513 (JJK).	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Bansal N, 2009, CANCER CONTROL, V16, P8, DOI 10.1177/107327480901600102; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Clarke CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035859; Dai D, 2002, CANCER RES, V62, P881; Dai DH, 2001, AM J OBSTET GYNECOL, V184, P790, DOI 10.1067/mob.2001.113844; Daikoku T, 2008, CANCER RES, V68, P5619, DOI 10.1158/0008-5472.CAN-08-1274; Erkanli S, 2010, INT J GYNECOL CANCER, V20, P1170, DOI 10.1111/IGC.0b013e3181e94f5a; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gibson DA, 2015, HUM REPROD, V30, P1290, DOI 10.1093/humrep/dev067; Goddard LM, 2014, CELL, V156, P549, DOI 10.1016/j.cell.2013.12.025; Goto T, 2008, ONCOGENE, V27, P9, DOI 10.1038/sj.onc.1210626; Gu CO, 2011, CANCER SCI, V102, P557, DOI 10.1111/j.1349-7006.2010.01829.x; Hsu SP, 2008, CELL MOL LIFE SCI, V65, P3839, DOI 10.1007/s00018-008-8441-3; Lebovic DI, 2000, HUM REPROD, V15, P67, DOI 10.1093/humrep/15.suppl_3.67; De Vries-van Leeuwen IJ, 2013, P NATL ACAD SCI USA, V110, P8894, DOI 10.1073/pnas.1220809110; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodygin D, 2004, ONCOGENE, V23, P9034, DOI 10.1038/sj.onc.1208004; Mhawech P, 2005, MODERN PATHOL, V18, P340, DOI 10.1038/modpathol.3800240; Mohammed H, 2013, CELL REP, V3, P342, DOI 10.1016/j.celrep.2013.01.010; Nakayama H, 2005, PATHOL INT, V55, P707, DOI 10.1111/j.1440-1827.2005.01900.x; National Cancer Institute, 2015, SEER STAT FACT SHEET, V2015; Okada H, 2011, FERTIL STERIL, V96, P786, DOI 10.1016/j.fertnstert.2011.06.048; Pant A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041593; Park JY, 2015, ONCOLOGIST, V20, P270, DOI 10.1634/theoncologist.2013-0445; Quayle SN, 2007, CANCER LETT, V254, P137, DOI 10.1016/j.canlet.2007.03.003; Ramirez PT, 2004, GYNECOL ONCOL, V95, P133, DOI 10.1016/j.ygyno.2004.06.045; Razandi M, 2000, J BIOL CHEM, V275, P38540, DOI 10.1074/jbc.M007555200; Rubel CA, 2012, MOL ENDOCRINOL, V26, P1428, DOI 10.1210/me.2011-1355; Sefton EC, 2013, ENDOCRINOLOGY, V154, P4046, DOI 10.1210/en.2013-1389; Shifren JL, 1996, J CLIN ENDOCR METAB, V81, P3112, DOI 10.1210/jc.81.8.3112; Smid-Koopman E, 2003, J SOC GYNECOL INVEST, V10, P49, DOI 10.1016/S1071-5576(02)00217-4; Takano M, 2007, MOL ENDOCRINOL, V21, P2334, DOI 10.1210/me.2007-0058; Thigpen JT, 1999, J CLIN ONCOL, V17, P1736, DOI 10.1200/JCO.1999.17.6.1736; Titus MA, 2009, CLIN CANCER RES, V15, P7571, DOI 10.1158/1078-0432.CCR-08-1976; Ushijima K, 2007, J CLIN ONCOL, V25, P2798, DOI 10.1200/JCO.2006.08.8344; Vasquez YM, 2015, MOL ENDOCRINOL, V29, P421, DOI 10.1210/me.2014-1292; Wakui H, 1997, J BIOL CHEM, V272, P8153, DOI 10.1074/jbc.272.13.8153; Winter S, 2008, EMBO J, V27, P88, DOI 10.1038/sj.emboj.7601954; Yang S, 2011, TRENDS ENDOCRIN MET, V22, P145, DOI 10.1016/j.tem.2011.01.005; Zilliacus J, 2001, MOL ENDOCRINOL, V15, P501, DOI 10.1210/me.15.4.501	41	25	26	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 29	2016	35	39					5191	5201		10.1038/onc.2016.56	http://dx.doi.org/10.1038/onc.2016.56			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DX5PI	26996671	Green Accepted			2022-12-26	WOS:000384433000010
J	Deredge, D; Li, JW; Johnson, KA; Wintrode, PL				Deredge, Daniel; Li, Jiawen; Johnson, Kenneth A.; Wintrode, Patrick L.			Hydrogen/Deuterium Exchange Kinetics Demonstrate Long Range Allosteric Effects of Thumb Site 2 Inhibitors of Hepatitis C Viral RNA-dependent RNA Polymerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 REVERSE-TRANSCRIPTASE; VIRUS NS5B POLYMERASE; NONNUCLEOSIDE INHIBITORS; CRYSTAL-STRUCTURE; HYDROGEN-EXCHANGE; MECHANISM; BINDING; INITIATION; DYNAMICS; PROTEIN	New nonnucleoside analogs are being developed as part of a multi-drug regimen to treat hepatitis C viral infections. Particularly promising are inhibitors that bind to the surface of the thumb domain of the viral RNA-dependent RNA polymerase (NS5B). Numerous crystal structures have been solved showing small molecule non-nucleoside inhibitors bound to the hepatitis C viral polymerase, but these structures alone do not define the mechanism of inhibition. Our prior kinetic analysis showed that nonnucleoside inhibitors binding to thumb site-2 (NNI2) do not block initiation or elongation of RNA synthesis; rather, they block the transition from the initiation to elongation, which is thought to proceed with significant structural rearrangement of the enzyme-RNA complex. Here we have mapped the effect of three NNI2 inhibitors on the conformational dynamics of the enzyme using hydrogen/deuterium exchange kinetics. All three inhibitors rigidify an extensive allosteric network extending > 40 angstrom from the binding site, thus providing a structural rationale for the observed disruption of the transition from distributive initiation to processive elongation. The two more potent inhibitors also suppress slow cooperative unfolding in the fingers extension-thumb interface and primer grip, which may contribute their stronger inhibition. These results establish that NNI2 inhibitors act through long range allosteric effects, reveal important conformational changes underlying normal polymerase function, and point the way to the design of more effective allosteric inhibitors that exploit this new information.	[Deredge, Daniel; Wintrode, Patrick L.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 20 North Pine St, Baltimore, MD 21201 USA; [Li, Jiawen; Johnson, Kenneth A.] Univ Texas Austin, Inst Cell & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA	University System of Maryland; University of Maryland Baltimore; University of Texas System; University of Texas Austin	Wintrode, PL (corresponding author), Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, 20 North Pine St, Baltimore, MD 21201 USA.; Johnson, KA (corresponding author), Univ Texas Austin, Inst Cell & Mol Biol, Dept Mol Biosci, Austin, TX 78712 USA.	kajohnson@mail.utexas.edu; pwintrod@rx.umaryland.edu			National Institutes of Health [1R01AI110577]; University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center [SOP1841-IQB2014]; Welch Foundation [F-1604]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110577] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center; Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R01AI110577 (NIAID; to K. A. J.). This work was also supported by the University of Maryland Baltimore, School of Pharmacy Mass Spectrometry Center (SOP1841-IQB2014) and by the Welch Foundation (F-1604; to K. A. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ago H, 1999, STRUCTURE, V7, P1417, DOI 10.1016/S0969-2126(00)80031-3; Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210; Boyce SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084808; Bressanelli S, 1999, P NATL ACAD SCI USA, V96, P13034, DOI 10.1073/pnas.96.23.13034; Caillet-Saguy C, 2011, J MOL BIOL, V414, P370, DOI 10.1016/j.jmb.2011.10.001; Canales E, 2012, BIOORG MED CHEM LETT, V22, P4288, DOI 10.1016/j.bmcl.2012.05.025; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; Cherry AL, 2015, J VIROL, V89, P2052, DOI 10.1128/JVI.01106-14; Chinnaswamy S, 2008, J BIOL CHEM, V283, P20535, DOI 10.1074/jbc.M801490200; Davis BC, 2013, PROTEINS, V81, P40, DOI 10.1002/prot.24154; Engen JR, 1997, BIOCHEMISTRY-US, V36, P14384, DOI 10.1021/bi971635m; Guttman M, 2013, J AM SOC MASS SPECTR, V24, P1906, DOI 10.1007/s13361-013-0727-5; Hang JQ, 2009, J BIOL CHEM, V284, P15517, DOI 10.1074/jbc.M808889200; Harrus D, 2010, J BIOL CHEM, V285, P32906, DOI 10.1074/jbc.M110.151316; Hawse WF, 2012, J IMMUNOL, V188, P5819, DOI 10.4049/jimmunol.1200952; Hong Z, 2001, VIROLOGY, V285, P6, DOI 10.1006/viro.2001.0948; Houde D, 2011, J PHARM SCI-US, V100, P2071, DOI 10.1002/jps.22432; Jin ZN, 2012, J BIOL CHEM, V287, P10674, DOI 10.1074/jbc.M111.325530; Lazerwith SE, 2014, J MED CHEM, V57, P1893, DOI 10.1021/jm401420j; Lesburg CA, 1999, NAT STRUCT BIOL, V6, P937; Li H, 2009, J MED CHEM, V52, P1255, DOI 10.1021/jm8014537; Li J., 2016, J BIOL CHEM, V291; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Morgan Christopher R, 2009, Curr Protoc Protein Sci, VChapter 17, DOI 10.1002/0471140864.ps1706s58; Mosley RT, 2012, J VIROL, V86, P6503, DOI 10.1128/JVI.00386-12; Muir AJ, 2015, CLIN GASTROENTEROL H, V13, P2166, DOI 10.1016/j.cgh.2015.07.015; Persson F, 2015, P NATL ACAD SCI USA, V112, P10383, DOI 10.1073/pnas.1506079112; Rand KD, 2006, J BIOL CHEM, V281, P23018, DOI 10.1074/jbc.M602968200; Rigat K, 2010, ANTIVIR RES, V88, P197, DOI 10.1016/j.antiviral.2010.08.014; Seckler JM, 2011, BIOPHYS J, V100, P144, DOI 10.1016/j.bpj.2010.11.004; Seckler JM, 2009, BIOCHEMISTRY-US, V48, P7646, DOI 10.1021/bi900790x; Shi ZS, 2006, CURR OPIN STRUC BIOL, V16, P686, DOI 10.1016/j.sbi.2006.10.011; SPENCE RA, 1995, SCIENCE, V267, P988, DOI 10.1126/science.7532321; Wales TE, 2015, BIOCHEMISTRY-US, V54, P6382, DOI 10.1021/acs.biochem.5b00875; West GM, 2011, STRUCTURE, V19, P1424, DOI 10.1016/j.str.2011.08.001; Winquist J, 2013, ANTIVIR RES, V97, P356, DOI 10.1016/j.antiviral.2012.12.027; Xue WW, 2014, ANTIVIR RES, V104, P40, DOI 10.1016/j.antiviral.2014.01.006; Zhang J, 2010, STRUCTURE, V18, P1332, DOI 10.1016/j.str.2010.07.007	38	18	18	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10078	10088		10.1074/jbc.M115.708370	http://dx.doi.org/10.1074/jbc.M115.708370			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	27006396	hybrid, Green Published			2022-12-26	WOS:000375602800020
J	Castelain, M; Duviau, MP; Canette, A; Schmitz, P; Loubiere, P; Cocaign-Bousquet, M; Piard, JC; Mercier-Bonin, M				Castelain, Mickael; Duviau, Marie-Pierre; Canette, Alexis; Schmitz, Philippe; Loubiere, Pascal; Cocaign-Bousquet, Muriel; Piard, Jean-Christophe; Mercier-Bonin, Muriel			The Nanomechanical Properties of Lactococcus lactis Pili Are Conditioned by the Polymerized Backbone Pilin	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; ACID BACTERIA; ESCHERICHIA-COLI; OPTICAL TWEEZERS; P-PILI; FORCE SPECTROSCOPY; SORTASE; SURFACE; MICROSCOPY; EXTENSION	Pili produced by Lactococcus lactis subsp. lactis are putative linear structures consisting of repetitive subunits of the major pilin PilB that forms the backbone, pilin PilA situated at the distal end of the pilus, and an anchoring pilin PilC that tethers the pilus to the peptidoglycan. We determined the nanomechanical properties of pili using optical-tweezers force spectroscopy. Single pili were exposed to optical forces that yielded force-versus-extension spectra fitted using the Worm-Like Chain model. Native pili subjected to a force of 0-200 pN exhibit an inextensible, but highly flexible ultrastructure, reflected by their short persistence length. We tested a panel of derived strains to understand the functional role of the different pilins. First, we found that both the major pilin PilB and sortase C organize the backbone into a full-length organelle and dictate the nanomechanical properties of the pili. Second, we found that both PilA tip pilin and PilC anchoring pilin were not essential for the nanomechanical properties of pili. However, PilC maintains the pilus on the bacterial surface and may play a crucial role in the adhesion-and biofilm-forming properties of L. lactis.	[Castelain, Mickael; Duviau, Marie-Pierre; Schmitz, Philippe; Loubiere, Pascal; Cocaign-Bousquet, Muriel; Mercier-Bonin, Muriel] Univ Toulouse, INSA, UPS, INP,LISBP, 135 Ave Rangueil, F-31077 Toulouse, France; [Castelain, Mickael; Duviau, Marie-Pierre; Schmitz, Philippe; Loubiere, Pascal; Cocaign-Bousquet, Muriel; Mercier-Bonin, Muriel] INRA, Ingn Syst Biol & Proc UMR792, F-31400 Toulouse, France; [Castelain, Mickael; Duviau, Marie-Pierre; Schmitz, Philippe; Loubiere, Pascal; Cocaign-Bousquet, Muriel; Mercier-Bonin, Muriel] CNRS, UMR5504, F-31400 Toulouse, France; [Canette, Alexis; Piard, Jean-Christophe] Univ Paris Saclay, Micalis Inst, INRA, AgroParisTech, F-78350 Jouy En Josas, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Castelain, M (corresponding author), Univ Toulouse, INSA, UPS, INP,LISBP, 135 Ave Rangueil, F-31077 Toulouse, France.; Castelain, M (corresponding author), INRA, Ingn Syst Biol & Proc UMR792, F-31400 Toulouse, France.; Castelain, M (corresponding author), CNRS, UMR5504, F-31400 Toulouse, France.	mickael.castelain@insa-toulouse.fr	MERCIER-BONIN, Muriel/AAO-5286-2021; Castelain, Mickaël/A-9647-2011	Castelain, Mickaël/0000-0002-0256-7663; Canette, Alexis/0000-0002-2750-6568	INRA-CEPIA Division	INRA-CEPIA Division	This work was supported by INRA-CEPIA Division grant ANS 2011-2012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre-Cebollada J, 2010, J BIOL CHEM, V285, P11235, DOI 10.1074/jbc.M110.102962; Andersson M, 2011, J OPTICS-UK, V13, DOI 10.1088/2040-8978/13/4/044020; Andersson M, 2008, CHEMPHYSCHEM, V9, P221, DOI 10.1002/cphc.200700389; Andersson M, 2006, BIOPHYS J, V91, P2717, DOI 10.1529/biophysj.106.087429; Ashkin A, 1997, P NATL ACAD SCI USA, V94, P4853, DOI 10.1073/pnas.94.10.4853; Axner O, 2010, SPRINGER SER CHEM PH, V96, P337, DOI 10.1007/978-3-642-02597-6_18; Bouchiat C, 1999, BIOPHYS J, V76, P409, DOI 10.1016/S0006-3495(99)77207-3; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Castelain M, 2015, IN PRESS; Castelain M, 2011, EUR BIOPHYS J BIOPHY, V40, P305, DOI 10.1007/s00249-010-0648-1; Castelain M, 2010, EUR BIOPHYS J BIOPHY, V39, P1105, DOI 10.1007/s00249-009-0552-8; Castelain M, 2009, CHEMPHYSCHEM, V10, P1533, DOI 10.1002/cphc.200900195; Chen YS, 2013, J APPL MICROBIOL, V115, P125, DOI 10.1111/jam.12199; Chen YS, 2005, LETT APPL MICROBIOL, V40, P195, DOI 10.1111/j.1472-765X.2005.01653.x; Cozzi R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125875; Craig L, 2004, NAT REV MICROBIOL, V2, P363, DOI 10.1038/nrmicro885; Czerwinski F, 2009, OPT EXPRESS, V17, P13255, DOI 10.1364/OE.17.013255; Dieye Y, 2010, APPL ENVIRON MICROB, V76, P7332, DOI 10.1128/AEM.00928-10; Nguyen DTL, 2013, INT J FOOD MICROBIOL, V163, P19, DOI 10.1016/j.ijfoodmicro.2013.01.024; Fallman E, 2004, BIOSENS BIOELECTRON, V19, P1429, DOI 10.1016/j.bios.2003.12.029; Fallman E, 2005, EMBO REP, V6, P52, DOI 10.1038/sj.embor.7400310; Fernandez L, 2013, PHARMACOL RES, V69, P1, DOI 10.1016/j.phrs.2012.09.001; GONG MF, 1992, J MOL BIOL, V228, P735, DOI 10.1016/0022-2836(92)90860-M; Gutierrez-Mendez N, 2010, CAN J MICROBIOL, V56, P432, DOI [10.1139/w10-026, 10.1139/W10-026]; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Hung TT, 2004, MOL MICROBIOL, V53, P251, DOI 10.1111/j.1365-2958.2004.04117.x; Jeffrey B, 2003, AM J PHYSIOL-GASTR L, V285, pG907, DOI 10.1152/ajpgi.00062.2003; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Kang HJ, 2012, CURR OPIN STRUC BIOL, V22, P200, DOI 10.1016/j.sbi.2012.01.009; Kang HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015969; Kelly WJ, 1998, INT J FOOD MICROBIOL, V45, P85, DOI 10.1016/S0168-1605(98)00135-4; Kline KA, 2009, J BACTERIOL, V191, P3237, DOI 10.1128/JB.01837-08; Klinth JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038548; Klinth JE, 2012, EUR BIOPHYS J BIOPHY, V41, P285, DOI 10.1007/s00249-011-0784-2; Liu SN, 2011, FOOD RES INT, V44, P643, DOI 10.1016/j.foodres.2010.12.034; Lugmaier RA, 2008, EUR BIOPHYS J BIOPHY, V37, P111, DOI 10.1007/s00249-007-0183-x; Magnusson J, 2002, INT J SYST EVOL MICR, V52, P831, DOI 10.1099/00207713-52-3-831; Mahamdeh M, 2011, OPT EXPRESS, V19, P11759, DOI 10.1364/OE.19.011759; Maier B, 2005, CURR OPIN MICROBIOL, V8, P344, DOI 10.1016/j.mib.2005.04.002; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; Meyrand M, 2013, MOL CELL PROTEOMICS, V12, P3935, DOI 10.1074/mcp.M113.029066; Miller E, 2006, BIOPHYS J, V91, P3848, DOI 10.1529/biophysj.106.088989; Mortezaei N, 2015, BIOPHYS J, V109, P49, DOI 10.1016/j.bpj.2015.05.022; Mortezaei N, 2015, MOL MICROBIOL, V95, P116, DOI 10.1111/mmi.12847; Mu XQ, 2002, J BACTERIOL, V184, P4868, DOI 10.1128/JB.184.17.4868-4874.2002; Nambiar R, 2004, BIOPHYS J, V87, P1972, DOI 10.1529/biophysj.103.037697; Oxaran V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050989; Pang HL, 2012, J MICROBIOL, V50, P63, DOI 10.1007/s12275-012-1284-5; Papasergi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018747; Phillips R., 2012, PHYS BIOL CELL; Prajapati J.B., 2003, HIST FERMENTED FOODS; Pralle A, 1999, MICROSC RES TECHNIQ, V44, P378, DOI 10.1002/(SICI)1097-0029(19990301)44:5<378::AID-JEMT10>3.0.CO;2-Z; Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4; Remaut H, 2004, CURR OPIN STRUC BIOL, V14, P161, DOI 10.1016/j.sbi.2004.03.004; Reunanen J, 2012, APPL ENVIRON MICROB, V78, P2337, DOI 10.1128/AEM.07047-11; Rheinlaender J, 2012, EUR BIOPHYS J BIOPHY, V41, P561, DOI 10.1007/s00249-012-0818-4; SALAMA MS, 1995, J DAIRY SCI, V78, P1004, DOI 10.3168/jds.S0022-0302(95)76716-9; SKINNER DR, 1972, J PHYS E SCI INSTRUM, V5, P237, DOI 10.1088/0022-3735/5/3/015; Smith SP, 1999, AM J PHYS, V67, P26, DOI 10.1119/1.19187; Smith WD, 2010, J BACTERIOL, V192, P4651, DOI 10.1128/JB.00071-10; Sullan RMA, 2014, NANOSCALE, V6, P1134, DOI 10.1039/c3nr05462d; Swierczynski A, 2006, J BACTERIOL, V188, P6318, DOI 10.1128/JB.00606-06; Thomas WE, 2002, CELL, V109, P913, DOI 10.1016/S0092-8674(02)00796-1; Tohno M, 2012, ANIM SCI J, V83, P111, DOI 10.1111/j.1740-0929.2011.00923.x; Tolic-Norrelykke SF, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2356852; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Tripathi P, 2013, ACS NANO, V7, P3685, DOI 10.1021/nn400705u; VANLOOSDRECHT MCM, 1990, AQUAT SCI, V52, P103, DOI 10.1007/BF00878244; Wang B, 2013, BIOPHYS J, V104, P2051, DOI 10.1016/j.bpj.2013.04.002; YANAGAWA R, 1968, JPN J VET RES, V16, P31; Yang J, 2010, J DAIRY SCI, V93, P3136, DOI 10.3168/jds.2009-2898	75	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152053	10.1371/journal.pone.0152053	http://dx.doi.org/10.1371/journal.pone.0152053			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010408	gold, Green Published, Green Submitted			2022-12-26	WOS:000372708000077
J	Ghanouni, A; Meisel, SF; Hersch, J; Waller, J; Wardle, J; Renzi, C				Ghanouni, Alex; Meisel, Susanne F.; Hersch, Jolyn; Waller, Jo; Wardle, Jane; Renzi, Cristina			Information on 'Overdiagnosis' in Breast Cancer Screening on Prominent United Kingdom- and Australia-Oriented Health Websites	PLOS ONE			English	Article							PROGRAM	Objectives Health-related websites are an important source of information for the public. Increasing public awareness of overdiagnosis and ductal carcinoma in situ (DCIS) in breast cancer screening may facilitate more informed decision-making. This study assessed the extent to which such information was included on prominent health websites oriented towards the general public, and evaluated how it was explained. Design Cross-sectional study. Setting Websites identified through Google searches in England (United Kingdom) and New South Wales (Australia) for "breast cancer screening" and further websites included based on our prior knowledge of relevant organisations. Main Outcomes Content analysis was used to determine whether information on overdiagnosis or DCIS existed on each site, how the concepts were described, and what statistics were used to quantify overdiagnosis. Results After exclusions, ten UK websites and eight Australian websites were considered relevant and evaluated. They originated from charities, health service providers, government agencies, and an independent health organisation. Most contained some information on overdiagnosis (and/or DCIS). Descriptive information was similar across websites. Among UK websites, statistical information was often based on estimates from the Independent UK Panel on Breast Cancer Screening; the most commonly provided statistic was the ratio of breast cancer deaths prevented to overdiagnosed cases (1:3). A range of other statistics was included, such as the yearly number of overdiagnosed cases and the proportion of women screened who would be overdiagnosed. Information on DCIS and statistical information was less common on the Australian websites. Conclusions Online information about overdiagnosis has become more widely available in 2015-16 compared with the limited accessibility indicated by older research. However, there may be scope to offer more information on DCIS and overdiagnosis statistics on Australian websites. Moreover, the variability in how estimates are presented across UK websites may be confusing for the general public.	[Ghanouni, Alex; Meisel, Susanne F.; Waller, Jo; Wardle, Jane; Renzi, Cristina] UCL, Hlth Behav Res Ctr, Dept Epidemiol & Publ Hlth, 1-19 Torrington Pl, London WC1E 6BT, England; [Hersch, Jolyn] Univ Sydney, Sch Publ Hlth, Edward Ford Bldg, Sydney, NSW 2006, Australia	University of London; University College London; University of Sydney	Renzi, C (corresponding author), UCL, Hlth Behav Res Ctr, Dept Epidemiol & Publ Hlth, 1-19 Torrington Pl, London WC1E 6BT, England.	c.renzi@ucl.ac.uk	Hersch, Jolyn/H-7153-2013; Waller, Jo/C-1705-2008	Hersch, Jolyn/0000-0001-5225-6639; Waller, Jo/0000-0003-4025-9132	programme grant from Cancer Research UK [C1418/A14134]; Cancer Research UK [14134] Funding Source: researchfish	programme grant from Cancer Research UK; Cancer Research UK(Cancer Research UK)	The current study was supported by a programme grant from Cancer Research UK awarded to Prof Jane Wardle (C1418/A14134). Cancer Research UK was not involved in the design of this study; the collection, analysis, or interpretation of the results; in the writing of the manuscript; or in the decision to submit for publication.	Basch CH, 2014, J CANCER EDUC, V30, P699; Bewley S, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6894; Cancer Research UK, 2008, CANC RES UKS STRAT 2; Duffy SW, 2010, J MED SCREEN, V17, P25, DOI 10.1258/jms.2009.009094; Fereday J., 2006, INT J QUAL METH, V5, P80, DOI [DOI 10.1177/160940690600500107, 10.1177/160940690600500107]; Geller BM, 2007, J CANCER EDUC, V22, P25, DOI 10.1007/BF03174371; Glasziou P, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4247; Hersch J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f158; Jorgensen KJ, 2004, BMJ-BRIT MED J, V328, P148, DOI 10.1136/bmj.328.7432.148; Lipkus IM, 2001, MED DECIS MAKING, V21, P37, DOI 10.1177/0272989X0102100105; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Moynihan R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007436; NHS Breast Screening Programme, NHS BREAST SCREEN HE; OFCOM, HOUS PEN BROADB; Petrescu P., 2014, GOOGLE ORGANIC CTR S; Pew Research Center, HLTH FACT SHEET 2015; Richards M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6843; Statista, MARK SHAR HELD LEAD; Waller J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002703	19	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152279	10.1371/journal.pone.0152279	http://dx.doi.org/10.1371/journal.pone.0152279			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010593	Green Published, Green Submitted, gold			2022-12-26	WOS:000372708000127
J	Gonzalez, AL; Teixido, J; Borrell, JI; Estrada-Tejedor, R				Gonzalez, Alex L.; Teixido, Jordi; Borrell, Jose I.; Estrada-Tejedor, Roger			On the Applicability of Elastic Network Models for the Study of RNA CUG Trinucleotide Repeat Overexpansion	PLOS ONE			English	Article							MYOTONIC-DYSTROPHY TYPE-1; MOLECULAR-DYNAMICS SIMULATIONS; BIOACTIVE SMALL MOLECULES; PROTEIN DYNAMICS; NUCLEIC-ACIDS; FORCE-FIELDS; TAR RNA; MUSCLEBLIND; BINDING; FOCI	Non-coding RNAs play a pivotal role in a number of diseases promoting an aberrant sequestration of nuclear RNA-binding proteins. In the particular case of myotonic dystrophy type 1 (DM1), a multisystemic autosomal dominant disease, the formation of large non-coding CUG repeats set up long-tract hairpins able to bind muscleblind-like proteins (MBNL), which trigger the deregulation of several splicing events such as cardiac troponin T (cTNT) and insulin receptor's, among others. Evidence suggests that conformational changes in RNA are determinant for the recognition and binding of splicing proteins, molecular modeling simulations can attempt to shed light on the structural diversity of CUG repeats and to understand their pathogenic mechanisms. Molecular dynamics (MD) are widely used to obtain accurate results at atomistic level, despite being very time consuming, and they contrast with fast but simplified coarse-grained methods such as Elastic Network Model (ENM). In this paper, we assess the application of ENM (traditionally applied on proteins) for studying the conformational space of CUG repeats and compare it to conventional and accelerated MD conformational sampling. Overall, the results provided here reveal that ANM can provide useful insights into dynamic rCUG structures at a global level, and that their dynamics depend on both backbone and nucleobase fluctuations. On the other hand, ANM fail to describe local U-U dynamics of the rCUG system, which require more computationally expensive methods such as MD. Given that several limitations are inherent to both methods, we discuss here the usefulness of the current theoretical approaches for studying highly dynamic RNA systems such as CUG trinucleotide repeat overexpansions.	[Gonzalez, Alex L.; Teixido, Jordi; Borrell, Jose I.; Estrada-Tejedor, Roger] URL, IQS, GEM, Barcelona 08017, Catalonia, Spain	Universitat Ramon Llull; Institut Quimic de Sarria	Estrada-Tejedor, R (corresponding author), URL, IQS, GEM, Barcelona 08017, Catalonia, Spain.	roger.estrada@iqs.url.edu	González, Alex/GYU-3220-2022; Teixidó, Jordi/M-1005-2013; Borrell, Jose I./M-1646-2013; Estrada-Tejedor, Roger/R-5326-2018	Teixidó, Jordi/0000-0002-2720-9811; Borrell, Jose I./0000-0001-9409-2919; Estrada-Tejedor, Roger/0000-0002-2983-0492	La Marato Foundation [100231]; Secretaria d'Universitats i Recerca - Generalitat de Catalunya; Fundacio La Marato de TV3	La Marato Foundation; Secretaria d'Universitats i Recerca - Generalitat de Catalunya; Fundacio La Marato de TV3	This work was supported by La Marato Foundation [project id. 100231, to JIB] (http://www.tv3.cat/marato/) and by the Secretaria d'Universitats i Recerca - Generalitat de Catalunya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thankfully acknowledge the support of Fundacio La Marato de TV3 and Secretaria d'Universitats i Recerca-Generalitat de Catalunya, the technical assistance of IUCT and Universitat de Valencia and the resources provided by Barcelona Supercomputing Center-Centro Nacional de Supercomputacion (BSC-RES). The authors also thank the anonymous reviewers for their constructive comments.	Bakan A, 2011, BIOINFORMATICS, V27, P1575, DOI 10.1093/bioinformatics/btr168; Bakan A, 2011, BIOCOMPUT-PAC SYM, P181; Bose D, 2012, ANGEW CHEM INT EDIT, V51, P1019, DOI 10.1002/anie.201106455; Broda M, 2005, BIOCHEMISTRY-US, V44, P10873, DOI 10.1021/bi0502339; BRUSCHWEILER R, 1995, J CHEM PHYS, V102, P3396, DOI 10.1063/1.469213; Case DA, 2014, AMBER 14; Childs-Disney JL, 2014, ACS CHEM BIOL, V9, P538, DOI 10.1021/cb4007387; Childs-Disney JL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3044; CLARAGE JB, 1995, P NATL ACAD SCI USA, V92, P3288, DOI 10.1073/pnas.92.8.3288; Cleary JD, 2014, CURR OPIN GENET DEV, V26, P6, DOI 10.1016/j.gde.2014.03.002; Coonrod LA, 2012, BIOCHEMISTRY-US, V51, P8330, DOI 10.1021/bi300829w; Das A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003521; Davidson A, 2011, NUCLEIC ACIDS RES, V39, P248, DOI 10.1093/nar/gkq713; deLorimier E, 2014, NUCLEIC ACIDS RES, V42, P12768, DOI 10.1093/nar/gku941; Doruker P, 2000, PROTEINS, V40, P512, DOI 10.1002/1097-0134(20000815)40:3<512::AID-PROT180>3.3.CO;2-D; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Fuglebakk E, 2015, BBA-GEN SUBJECTS, V1850, P911, DOI 10.1016/j.bbagen.2014.09.021; Ho TH, 2005, J CELL SCI, V118, P2923, DOI 10.1242/jcs.02404; Iyer RR, 2015, ANNU REV BIOCHEM, V84, P199, DOI 10.1146/annurev-biochem-060614-034010; Jiang H, 2004, HUM MOL GENET, V13, P3079, DOI 10.1093/hmg/ddh327; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Kiliszek A, 2009, NUCLEIC ACIDS RES, V37, P4149, DOI 10.1093/nar/gkp350; Kino Y, 2004, HUM MOL GENET, V13, P495, DOI 10.1093/hmg/ddh056; Krzyzosiak WJ, 2012, NUCLEIC ACIDS RES, V40, P11, DOI 10.1093/nar/gkr729; Kumar A, 2011, BIOCHEMISTRY-US, V50, P9928, DOI 10.1021/bi2013068; Kumar A, 2013, GENE, V522, P226, DOI 10.1016/j.gene.2013.03.059; Lee JE, 2009, BIOCHEM SOC T, V37, P1281, DOI 10.1042/BST0371281; Longman C, 2006, J ROY COLL PHYS EDIN, V36, P51; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Magnus M, 2014, RNA BIOL, V11, P522, DOI 10.4161/rna.28826; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Meireles L, 2011, PROTEIN SCI, V20, P1645, DOI 10.1002/pro.711; Michalowski S, 1999, NUCLEIC ACIDS RES, V27, P3534, DOI 10.1093/nar/27.17.3534; Mooers BHM, 2005, P NATL ACAD SCI USA, V102, P16626, DOI 10.1073/pnas.0505873102; Mu YG, 2006, BIOPHYS J, V90, P391, DOI 10.1529/biophysj.105.069559; Mulders SAM, 2010, HUM MOL GENET, V19, pR90, DOI 10.1093/hmg/ddq161; Nalavade R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.276; Orellana L, 2010, J CHEM THEORY COMPUT, V6, P2910, DOI 10.1021/ct100208e; Parkesh R, 2011, BIOCHEMISTRY-US, V50, P599, DOI 10.1021/bi101896j; Pascale L, 2013, NUCLEIC ACIDS RES, V41, P5851, DOI 10.1093/nar/gkt237; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Pinamonti G, 2015, NUCLEIC ACIDS RES, V43, P7260, DOI 10.1093/nar/gkv708; Ranum LPW, 2004, AM J HUM GENET, V74, P793, DOI 10.1086/383590; Romo TD, 2011, PROTEINS, V79, P23, DOI 10.1002/prot.22855; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sagui C, 2004, J CHEM PHYS, V120, P73, DOI 10.1063/1.1630791; Sato Yoshiteru, 2004, Nucleic Acids Symp Ser (Oxf), P117; Setny P, 2013, J CHEM THEORY COMPUT, V9, P5460, DOI 10.1021/ct400814n; Stelzer AC, 2011, NAT CHEM BIOL, V7, P553, DOI [10.1038/NCHEMBIO.596, 10.1038/nchembio.596]; Tamjar J, 2012, J BIOMOL STRUCT DYN, V30, P505, DOI 10.1080/07391102.2012.687517; Toukmaji A, 2000, J CHEM PHYS, V113, P10913, DOI 10.1063/1.1324708; Udd B, 2006, Neuromuscul Disord, V16, P403, DOI 10.1016/j.nmd.2006.03.010; Velagapudi SP, 2014, NAT CHEM BIOL, V10, P291, DOI [10.1038/NCHEMBIO.1452, 10.1038/nchembio.1452]; Warf MB, 2007, RNA, V13, P2238, DOI 10.1261/rna.610607; Wheeler TM, 2009, SCIENCE, V325, P336, DOI 10.1126/science.1173110; Wong CH, 2014, J AM CHEM SOC, V136, P6355, DOI 10.1021/ja5012146; Yang L, 2009, P NATL ACAD SCI USA, V106, P12347, DOI 10.1073/pnas.0902159106; Yildirim I, 2013, J AM CHEM SOC, V135, P3528, DOI 10.1021/ja3108627; Yildirim I, 2011, J PHYS CHEM B, V115, P9261, DOI 10.1021/jp2016006; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601; Zimmermann MT, 2014, RNA, V20, P792, DOI 10.1261/rna.041269.113	63	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152049	10.1371/journal.pone.0152049	http://dx.doi.org/10.1371/journal.pone.0152049			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010216	gold, Green Published, Green Submitted			2022-12-26	WOS:000372708000075
J	Marceau, K; De Araujo-Greecher, M; Miller, ES; Massey, SH; Mayes, LC; Ganiban, JM; Reiss, D; Shaw, DS; Leve, LD; Neiderhiser, JM				Marceau, Kristine; De Araujo-Greecher, Marielena; Miller, Emily S.; Massey, Suena H.; Mayes, Linda C.; Ganiban, Jody M.; Reiss, David; Shaw, Daniel S.; Leve, Leslie D.; Neiderhiser, Jenae M.			The Perinatal Risk Index: Early Risks Experienced by Domestic Adoptees in the United States	PLOS ONE			English	Article							MENTAL-HEALTH; PREGNANCY; SCHIZOPHRENIA; COMPLICATIONS; CONSEQUENCES; ADOLESCENCE; CESSATION; EXPOSURE; CORTISOL; CHILDREN	We aimed to assess comprehensively the prevalence of perinatal risks experienced by a potentially high-risk yet understudied population of children domestically adopted in the United States. Data are from participant report and medical records from mothers (n = 580) who completed a domestic adoption placement with nonrelatives at or near birth (Mean placement age = 7 days). We describe a comprehensive measure of perinatal risks, including divergences from previous assessment tools and the incorporation of multiple reporters, and report the prevalence of various types of perinatal risks. The prevalence of each specific risk factor was generally low, although several risks were more prevalent in this sample than estimates from nationally representative publicly available data. Nearly the entire sample (99%) experienced some type of risk exposure. Birth mothers who placed their children for adoption domestically in the US experience higher levels of perinatal risks than the national average, but not for all specific types of risk. Thus, the developmental trajectories of children adopted domestically may systematically differ from the general population to the extent that these specific perinatal risks impact development.	[Marceau, Kristine] Brown Univ, Rhode Isl Hosp, Providence, RI 02903 USA; [De Araujo-Greecher, Marielena; Neiderhiser, Jenae M.] Penn State Univ, University Pk, PA 16802 USA; [Miller, Emily S.; Massey, Suena H.] Northwestern Univ, Evanston, IL USA; [Mayes, Linda C.; Reiss, David] Yale Univ, New Haven, CT USA; [Ganiban, Jody M.] George Washington Univ, Washington, DC USA; [Shaw, Daniel S.] Univ Pittsburgh, Pittsburgh, PA USA; [Leve, Leslie D.] Univ Oregon, Eugene, OR 97403 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Northwestern University; Yale University; George Washington University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Oregon	Marceau, K (corresponding author), Brown Univ, Rhode Isl Hosp, Providence, RI 02903 USA.; Neiderhiser, JM (corresponding author), Penn State Univ, University Pk, PA 16802 USA.	Kristine_Marceau@brown.edu; jenaemn@psu.edu	Marceau, Kristine/AAU-5587-2020; Massey, Suena H/AAX-5551-2021	Marceau, Kristine/0000-0002-8924-6597; Massey, Suena/0000-0003-4941-6499	National Institute of Child Health and Human Development [R01 HD042608]; National Institute on Drug Abuse, NIH, U.S. PHS; National Institute on Drug Abuse [R01 DA020585, T32 DA016184]; National Institute of Mental Health; OBSSR, NIH, U.S. PHS; National Institute on Mental Health [T32 MH019927];  [NIH-5K12HD050121-09];  [K23DA037913]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R56HD042608, K12HD050121] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH019927, R01MH092118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K01DA039288, R01DA020585, T32DA016184, K23DA037913] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute on Drug Abuse, NIH, U.S. PHS; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OBSSR, NIH, U.S. PHS; National Institute on Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This project was supported by grant R01 HD042608 from the National Institute of Child Health and Human Development and the National Institute on Drug Abuse, NIH, U.S. PHS (PI Years 1-5: David Reiss, MD; PI Years 6-10: Leslie Leve, PhD) and by grant R01 DA020585 from the National Institute on Drug Abuse, the National Institute of Mental Health and OBSSR, NIH, U.S. PHS (PI: Jenae Neiderhiser, Ph.D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development or the National Institutes of Health. Dr. Marceau was supported by the National Institute on Drug Abuse (T32 DA016184) and National Institute on Mental Health (T32 MH019927). Dr. Miller is supported by NIH-5K12HD050121-09. Dr. Massey is supported by grant K23DA037913.	BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Beck A, 1993, BECK ANXIETY INVETOR; Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Caspi A, 1996, INT J METHOD PSYCH, V6, P101, DOI 10.1002/(SICI)1234-988X(199607)6:2<101::AID-MPR156>3.3.CO;2-E; Coussons-Read ME, 2013, OBSTET MED, V6, P52, DOI 10.1177/1753495X12473751; Gaysina D, 2013, JAMA PSYCHIAT, V70, P956, DOI 10.1001/jamapsychiatry.2013.127; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Irner TB, 2012, CHILD NEUROPSYCHOL, V18, P521, DOI 10.1080/09297049.2011.628309; Jackson M, 2011, OBSTET GYNECOL, V118, P803, DOI 10.1097/AOG.0b013e31822f1b50; KOTELCHUCK M, 1994, AM J PUBLIC HEALTH, V84, P1414, DOI 10.2105/AJPH.84.9.1414; Lee HC, 2010, ACTA PAEDIATR, V99, P1785, DOI 10.1111/j.1651-2227.2010.01935.x; Leve LD, 2013, DEV PSYCHOL, V49, P1045, DOI 10.1037/a0029390; Leve LD, 2013, TWIN RES HUM GENET, V16, P412, DOI 10.1017/thg.2012.126; Luke B, 2007, HUM REPROD, V22, P1264, DOI 10.1093/humrep/del522; Maisels M. J., 2012, CARE JAUNDICED NEONA, P97; Marceau K, 2015, BEHAV GENET, V45, P268, DOI 10.1007/s10519-014-9689-z; Marceau K, 2013, STRESS, V16, P607, DOI 10.3109/10253890.2013.825766; Marceau K, 2013, INT J BEHAV DEV, V37, P366, DOI 10.1177/0165025413489378; Martin JA, 2013, NATL VITAL STAT REPO, V62, P1; Massey SH, 2012, ADDICT BEHAV, V37, P956, DOI 10.1016/j.addbeh.2012.04.002; Massey SH, 2011, AM J ADDICTION, V20, P143, DOI 10.1111/j.1521-0391.2010.00110.x; McNamara TK, AM J OBSTET GYNECOL, V193, P1981, DOI [10.1016/j.ajog.2005.04.053, DOI 10.1016/J.AJOG.2005.04.053]; MCNEIL TF, 1994, J PSYCHIAT RES, V28, P519, DOI 10.1016/0022-3956(94)90042-6; MCNEIL TF, 1995, EPIDEMIOL REV, V17, P107, DOI 10.1093/oxfordjournals.epirev.a036165; O'Connor TG, 2005, BIOL PSYCHIAT, V58, P211, DOI 10.1016/j.biopsych.2005.03.032; Olson JE, 1997, AM J EPIDEMIOL, V145, P58; Rasmussen KM, 2009, CURR OPIN OBSTET GYN, V21, P521, DOI 10.1097/GCO.0b013e328332d24e; Raznahan A, 2012, P NATL ACAD SCI USA, V109, P11366, DOI 10.1073/pnas.1203350109; Robinson M, 2008, J CHILD PSYCHOL PSYC, V49, P1118, DOI 10.1111/j.1469-7610.2008.01955.x; Thornton A, 1988, SOCIOL METHODOL, V18, P37; Truong YN, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.027; Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P237, DOI 10.1016/j.neubiorev.2004.10.007; Williams JHG, 2007, EUR CHILD ADOLES PSY, V16, P243, DOI 10.1007/s00787-006-0596-6	33	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0150486	10.1371/journal.pone.0150486	http://dx.doi.org/10.1371/journal.pone.0150486			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010541	Green Submitted, gold, Green Published, Green Accepted			2022-12-26	WOS:000372708000019
J	Pothasin, P; Compton, SG; Wangpakapattanawong, P				Pothasin, Pornwiwan; Compton, Stephen G.; Wangpakapattanawong, Prasit			Seasonality of Leaf and Fig Production in Ficus squamosa, a Fig Tree with Seeds Dispersed by Water	PLOS ONE			English	Article							RECENT CLIMATE-CHANGE; DRY FOREST TREES; REPRODUCTIVE PHENOLOGY; TROPICAL FOREST; DIOECIOUS FIGS; WASP; POLLINATORS; EVOLUTION; MUTUALISM; RESPONSES	The phenology of plants reflects selection generated by seasonal climatic factors and interactions with other plants and animals, within constraints imposed by their phylogenetic history. Fig trees (Ficus) need to produce figs year-round to support their short-lived fig wasp pollinators, but this requirement is partially de-coupled in dioecious species, where female trees only develop seeds, not pollinator offspring. This allows female trees to concentrate seed production at more favorable times of the year. Ficus squamosa is a riparian species whose dispersal is mainly by water, rather than animals. Seeds can float and travel in long distances. We recorded the leaf and reproductive phenology of 174 individuals for three years in Chiang Mai, Northern Thailand. New leaves were produced throughout the year. Fig production occurred year-round, but with large seasonal variations that correlated with temperature and rainfall. Female and male trees initiated maximal fig crops at different times, with production in female trees confined mainly to the rainy season and male figs concentrating fig production in the preceding months, but also often bearing figs continually. Ficus squamosa concentrates seed production by female plants at times when water levels are high, favouring dispersal by water, and asynchronous flowering within male trees allow fig wasps to cycle there, providing them with potential benefits by maintaining pollinators for times when female figs become available to pollinate.	[Pothasin, Pornwiwan; Wangpakapattanawong, Prasit] Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai 50000, Thailand; [Compton, Stephen G.] Univ Leeds, Sch Biol, Leeds LS2 9JT, W Yorkshire, England; [Compton, Stephen G.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa; [Wangpakapattanawong, Prasit] Chiang Mai Univ, World Agroforestry Ctr ICRAF, Knowledge Support Ctr Greater Mekong Subreg KSC G, Fac Social Sci, POB 267,CMU PO, Chiang Mai 50000, Thailand	Chiang Mai University; University of Leeds; Rhodes University; Chiang Mai University	Wangpakapattanawong, P (corresponding author), Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai 50000, Thailand.; Wangpakapattanawong, P (corresponding author), Chiang Mai Univ, World Agroforestry Ctr ICRAF, Knowledge Support Ctr Greater Mekong Subreg KSC G, Fac Social Sci, POB 267,CMU PO, Chiang Mai 50000, Thailand.	prasitwang@yahoo.com		Compton, Stephen/0000-0002-1247-8058	Office of the higher education commission; PERDO-Climate change program	Office of the higher education commission; PERDO-Climate change program	This study was supported by the Office of the higher education commission and PERDO-Climate change program.	[Anonymous], 2012, METEOROLOGICAL DATA; Anstett MC, 1997, TRENDS ECOL EVOL, V12, P94, DOI 10.1016/S0169-5347(96)10064-1; Badeck FW, 2004, NEW PHYTOL, V162, P295, DOI 10.1111/j.1469-8137.2004.01059.x; Bain A, 2014, ACTA OECOL, V57, P124, DOI 10.1016/j.actao.2013.10.004; Ballestrini Caín, 2011, Braz. J. Plant Physiol., V23, P113, DOI 10.1590/S1677-04202011000200003; Berg C.C., 1992, Verhandelingen der Koninklijke Nederlandse Akademie van Wetenschappen Afdeling Natuurkunde Tweede Reeks, V89, P1; Berg CC, 2011, FLORA OF THAILAND, V10; Berg CC., 2005, FLORA MALESIANA, V17, P1, DOI DOI 10.1663/0007-196X(2006)58[; Boedeltje G, 2004, J ECOL, V92, P786, DOI 10.1111/j.0022-0477.2004.00906.x; Boochabun K, 2004, J GEOL SOC INDIA, V64, P503; BORCHERT R, 1994, ECOLOGY, V75, P1437, DOI 10.2307/1937467; BRONSTEIN JL, 1989, EXPERIENTIA, V45, P601, DOI 10.1007/BF01975676; BRONSTEIN JL, 1992, AM MIDL NAT, V128, P397, DOI 10.2307/2426473; Cascaes MF, 2013, AN ACAD BRAS CIENC, V85, P1449, DOI 10.1590/0001-37652013105112; Caspers H. C. G., VAS STEENIS RHEOPHYT; Cook JM, 2003, TRENDS ECOL EVOL, V18, P241, DOI 10.1016/S0169-5347(03)00062-4; CORLETT RT, 1987, BIOTROPICA, V19, P122, DOI 10.2307/2388733; Corner E., 1965, CHECK LIST FICUS ASI; Cornille A, FLORAL VOLATILES POL, P1471, DOI [10.1098/rspb.2011.1972, DOI 10.1098/RSPB.2011.1972]; Cruaud A, 2012, SYST BIOL, V61, P1029, DOI 10.1093/sysbio/sys068; Davies TJ, 2013, J ECOL, V101, P1520, DOI 10.1111/1365-2745.12154; Devi AF, 2013, TREES-STRUCT FUNCT, V27, P985, DOI 10.1007/s00468-013-0850-8; DHAILA S, 1995, ECOL RES, V10, P151, DOI 10.1007/BF02347937; Dransfield J., 1992, B LINSTITUT FRANCAIS, V2, P415; Elliott S, 2006, GLOBAL ECOL BIOGEOGR, V15, P248, DOI 10.1111/j.1466-822x.2006.00213.x; Fenner Michael, 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P78, DOI 10.1078/1433-8319-00053; Forrest J, 2010, PHILOS T R SOC B, V365, P3101, DOI 10.1098/rstb.2010.0145; GALIL J, 1973, Gardens' Bulletin (Singapore), V26, P303; GALIL J, 1968, ECOLOGY, V49, P259, DOI 10.2307/1934454; Haine ER, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-83; Harrison RD, 2000, ECOL RES, V15, P47, DOI 10.1046/j.1440-1703.2000.00319.x; Harrison RD, 2003, OIKOS, V100, P628, DOI 10.1034/j.1600-0706.2003.11829.x; Harrison RD, 2005, 77 WAYS BE FIG OVERV, P111; Herre EA, 1996, J BIOGEOGR, V23, P593, DOI 10.1111/j.1365-2699.1996.tb00020.x; Hossaert-McKey M, 2001, AM J BOT, V88, P685, DOI 10.2307/2657069; JANZEN DH, 1979, ANNU REV ECOL SYST, V10, P13, DOI 10.1146/annurev.es.10.110179.000305; Jousselin E, 2008, ONE FIG BIND THEM AL; Kerdelhue C, 2000, ECOLOGY, V81, P2832, DOI 10.1890/0012-9658(2000)081[2832:CCESOO]2.0.CO;2; KJELLBERG F, 1989, EXPERIENTIA, V45, P653, DOI 10.1007/BF01975682; Kjellberg F MG, 1987, INSECTS PLANTS; Kovach W, 2010, ORIANA; Kuaraksa C, 2013, RESTOR ECOL, V21, P86, DOI 10.1111/j.1526-100X.2011.00853.x; Kuaraksa C, 2012, FOREST ECOL MANAG, V265, P82, DOI 10.1016/j.foreco.2011.10.022; Lieth H, 1970, ECOL STUD ANAL SYNTH, V1, P29; Liu GX, 2015, J PLANT ECOL, V8, P197, DOI 10.1093/jpe/rtv022; Lopez-Vaamonde C, 2001, MOL PHYLOGENET EVOL, V21, P55, DOI 10.1006/mpev.2001.0993; Machado CA, 2005, P NATL ACAD SCI USA, V102, P6558, DOI 10.1073/pnas.0501840102; Maxwell JF, 2001, VEGETATION VASCULAR, V5; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Moe AM, 2011, BIOL J LINN SOC, V103, P546, DOI 10.1111/j.1095-8312.2011.01669.x; Moegenburg Susan, 2003, Palms, V47, P16; Morellato LPCA L.F., 2010, APPL CIRCULAR STAT P; Naiman R.J., 2010, RIPARIA ECOLOGY CONS; NEWSTROM LE, 1994, BIOTROPICA, V26, P141, DOI 10.2307/2388804; Nilsson C, 2010, ROLE HYDROCHORY STRU; Nomura N, 2006, FUNCTIONAL CONSEQUEN; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Patel A, 2000, ECOLOGY, V81, P2850, DOI 10.1890/0012-9658(2000)081[2850:CORSIT]2.0.CO;2; Patel A, 1998, OECOLOGIA, V115, P391, DOI 10.1007/s004420050533; Pothasin P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108945; RAMIREZ W, 1969, SCIENCE, V163, P580, DOI 10.1126/science.163.3867.580; Ramos FN, 2005, CAN J BOT, V83, P1305, DOI 10.1139/b05-106; Rivera G, 2002, TREES-STRUCT FUNCT, V16, P445, DOI 10.1007/s00468-002-0185-3; Sakai S, 2001, POPUL ECOL, V43, P77, DOI 10.1007/PL00012018; Santisuk T., 1988, ACCOUNT VEGETATION N; SCHNEIDER RL, 1988, ECOLOGY, V69, P1055, DOI 10.2307/1941261; Silva IA, 2011, ANN FOREST SCI, V68, P1207, DOI 10.1007/s13595-011-0071-5; Singh KP, 2005, CURR SCI INDIA, V88, P1820; Smitinand T., 1989, FLORISTIC INVENTORY, P63; Spencer H, 1996, J BIOGEOGR, V23, P467, DOI 10.1111/j.1365-2699.1996.tb00008.x; Team R. D. C, 2011, R LANG ENV STAT COMP; Thies W, 2004, OIKOS, V104, P362, DOI 10.1111/j.0030-1299.2004.12747.x; VANSCHAIK CP, 1993, ANNU REV ECOL SYST, V24, P353, DOI 10.1146/annurev.es.24.110193.002033; Visser ME, 2005, P ROY SOC B-BIOL SCI, V272, P2561, DOI 10.1098/rspb.2005.3356; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; WIEBES JT, 1979, ANNU REV ECOL SYST, V10, P1, DOI 10.1146/annurev.es.10.110179.000245; Zhang GM, 2006, BIOTROPICA, V38, P334, DOI 10.1111/j.1744-7429.2006.00150.x; Zimmerman D.W., 2010, UNDERSTANDING STAT, V2, P267, DOI [10.1207/S15328031US0204_03, DOI 10.1207/S15328031US0204_03]	79	5	6	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152380	10.1371/journal.pone.0152380	http://dx.doi.org/10.1371/journal.pone.0152380			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010540	Green Published, gold			2022-12-26	WOS:000372708000139
J	Su, Y; Blazey, TM; Owen, CJ; Christensen, JJ; Friedrichsen, K; Joseph-Mathurin, N; Wang, Q; Hornbeck, RC; Ances, BM; Snyder, AZ; Cash, LA; Koeppe, RA; Klunk, WE; Galasko, D; Brickman, AM; McDade, E; Ringman, JM; Thompson, PM; Saykin, AJ; Ghetti, B; Sperling, RA; Johnson, KA; Salloway, SP; Schofield, PR; Masters, CL; Villemagne, VL; Fox, NC; Forster, S; Chen, KW; Reiman, EM; Xiong, CJ; Marcus, DS; Weiner, MW; Morris, JC; Bateman, RJ; Benzinger, TLS				Su, Yi; Blazey, Tyler M.; Owen, Christopher J.; Christensen, Jon J.; Friedrichsen, Karl; Joseph-Mathurin, Nelly; Wang, Qing; Hornbeck, Russ C.; Ances, Beau M.; Snyder, Abraham Z.; Cash, Lisa A.; Koeppe, Robert A.; Klunk, William E.; Galasko, Douglas; Brickman, Adam M.; McDade, Eric; Ringman, John M.; Thompson, Paul M.; Saykin, Andrew J.; Ghetti, Bernardino; Sperling, Reisa A.; Johnson, Keith A.; Salloway, Stephen P.; Schofield, Peter R.; Masters, Colin L.; Villemagne, Victor L.; Fox, Nick C.; Foerster, Stefan; Chen, Kewei; Reiman, Eric M.; Xiong, Chengjie; Marcus, Daniel S.; Weiner, Michael W.; Morris, John C.; Bateman, Randall J.; Benzinger, Tammie L. S.		Dominantly Inherited Alzheimer Net	Quantitative Amyloid Imaging in Autosomal Dominant Alzheimer's Disease: Results from the DIAN Study Group	PLOS ONE			English	Article							PARTIAL-VOLUME CORRECTION; WHITE-MATTER REFERENCE; GRAPHICAL ANALYSIS; PET; GENE; QUANTIFICATION; IMPLEMENTATION; VARIABILITY; MUTATION; TRIALS	Amyloid imaging plays an important role in the research and diagnosis of dementing disorders. Substantial variation in quantitative methods to measure brain amyloid burden exists in the field. The aim of this work is to investigate the impact of methodological variations to the quantification of amyloid burden using data from the Dominantly Inherited Alzheimer's Network (DIAN), an autosomal dominant Alzheimer's disease population. Cross-sectional and longitudinal [C-11]-Pittsburgh Compound B (PiB) PET imaging data from the DIAN study were analyzed. Four candidate reference regions were investigated for estimation of brain amyloid burden. A regional spread function based technique was also investigated for the correction of partial volume effects. Cerebellar cortex, brain-stem, and white matter regions all had stable tracer retention during the course of disease. Partial volume correction consistently improves sensitivity to group differences and longitudinal changes over time. White matter referencing improved statistical power in the detecting longitudinal changes in relative tracer retention; however, the reason for this improvement is unclear and requires further investigation. Full dynamic acquisition and kinetic modeling improved statistical power although it may add cost and time. Several technical variations to amyloid burden quantification were examined in this study. Partial volume correction emerged as the strategy that most consistently improved statistical power for the detection of both longitudinal changes and across-group differences. For the autosomal dominant Alzheimer's disease population with PiB imaging, utilizing brainstem as a reference region with partial volume correction may be optimal for current interventional trials. Further investigation of technical issues in quantitative amyloid imaging in different study populations using different amyloid imaging tracers is warranted.	[Su, Yi; Blazey, Tyler M.; Owen, Christopher J.; Christensen, Jon J.; Friedrichsen, Karl; Joseph-Mathurin, Nelly; Wang, Qing; Hornbeck, Russ C.; Cash, Lisa A.; Marcus, Daniel S.; Benzinger, Tammie L. S.] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Ances, Beau M.; Snyder, Abraham Z.; McDade, Eric; Morris, John C.; Bateman, Randall J.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Koeppe, Robert A.] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA; [Klunk, William E.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Galasko, Douglas] Univ Calif San Diego, La Jolla, CA 92093 USA; [Brickman, Adam M.] Columbia Univ, New York, NY USA; [Ringman, John M.] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA; [Thompson, Paul M.] Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA; [Saykin, Andrew J.; Ghetti, Bernardino] Indiana Univ, Dept Radiol, Indianapolis, IN 46204 USA; [Sperling, Reisa A.; Johnson, Keith A.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA; [Salloway, Stephen P.] Butler Hosp, Providence, RI 02906 USA; [Salloway, Stephen P.] Brown Univ, Providence, RI 02912 USA; [Schofield, Peter R.] Univ New S Wales, Neurosci Res Australia, Sydney, NSW, Australia; [Schofield, Peter R.] Univ New S Wales, Sch Med Sci, Sydney, NSW, Australia; [Masters, Colin L.; Villemagne, Victor L.] Florey Inst, Parkville, Vic, Australia; [Masters, Colin L.; Villemagne, Victor L.] Univ Melbourne, Parkville, Vic 3052, Australia; [Fox, Nick C.] Inst Neurol, Dememtia Res Ctr, Queen Sq, London WC1N 3BG, England; [Foerster, Stefan] Tech Univ Munich, Deutsch Zentrum Neurodegenerat Erkrankungen DZNE, D-80290 Munich, Germany; [Foerster, Stefan] Tech Univ Munich, Dept Nucl Med, D-80290 Munich, Germany; [Chen, Kewei; Reiman, Eric M.] Banner Hlth, Banner Alzheimers Inst, 901 E Willetta St, Phoenix, AZ USA; [Xiong, Chengjie] Washington Univ, Sch Med, Div Biostat, St Louis, MO 63110 USA; [Weiner, Michael W.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA	Washington University (WUSTL); Washington University (WUSTL); University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego; Columbia University; University of Southern California; University of Southern California; Indiana University System; Indiana University-Purdue University Indianapolis; Harvard University; Harvard Medical School; Massachusetts General Hospital; Butler Hospital Rhode Island; Brown University; Neuroscience Research Australia; University of New South Wales Sydney; University of New South Wales Sydney; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of London; University College London; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; Technical University of Munich; University of Munich; Banner Research; Banner Health; Banner Alzheimer's Institute; Washington University (WUSTL); University of California System; University of California San Francisco	Su, Y (corresponding author), Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA.	suy@mir.wustl.edu	Benzinger, Tammie/L-6104-2013; Thompson, Paul M/C-4194-2018; Villemagne, Victor/AAC-5406-2019; Fox, Nick C/B-1319-2009; Saykin, Andrew/A-1318-2007; Schofield, Peter/C-9669-2011	Benzinger, Tammie/0000-0002-8114-0552; Thompson, Paul M/0000-0002-4720-8867; Villemagne, Victor/0000-0002-5832-9875; Fox, Nick C/0000-0002-6660-657X; Friedrichsen, Karl/0000-0002-9233-1418; Saykin, Andrew/0000-0002-1376-8532; Joseph-Mathurin, Nelly/0000-0002-9735-5152; Klunk, William/0000-0001-5512-0251; Schofield, Peter/0000-0003-2967-9662; Masters, Colin/0000-0003-3072-7940; Bateman, Randall/0000-0002-7729-1702	Knight Alzheimer's Disease Research Center; Washington University Institute of Clinical and Translational Sciences; National Institute of Health [UL1TR000448]; National Institute of Neurological Disorders and Stroke [P30NS048056]; National Institute of Ageing [P01AG026276, U19AG032438, P50AG005681, P01AG003991]; NIHR Queen Square Dementia Biomedical Research Unit; National Institute for Health Research [NF-SI-0513-10134] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS080675, P30NS048056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG026276, P01AG003991, U19AG032438, UF1AG032438, P50AG005142, P50AG005681, P50AG005131] Funding Source: NIH RePORTER	Knight Alzheimer's Disease Research Center; Washington University Institute of Clinical and Translational Sciences; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Ageing(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIHR Queen Square Dementia Biomedical Research Unit; National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	YS received funds from the Knight Alzheimer's Disease Research Center (http://knightadrc.wustl.edu/) pilot award, Washington University Institute of Clinical and Translational Sciences (http://icts.wustl.edu/) Pilot Grant supported by the Clinical and Translational Science Award (CTSA) program (https://www.ctsacentral.org/) of National Institute of Health (http://www.nih.gov/): UL1TR000448. AZS and DSM received funds from National Institute of Neurological Disorders and Stroke (http://www.ninds.nih.gov/): P30NS048056; JCM and TLSB received funds from National Institute of Ageing (http://www.nia.nih.gov/): P01AG026276, U19AG032438, P50AG005681, P01AG003991. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the altruism of the DIAN participants and their families and contributions of the DIAN research. We acknowledge the DIAN genetics core for APOE genotype and mutation status; the DIAN clinical core for providing CDR status; and the DIAN biostatistics, informatics, neuropathology, and biomarker cores for their assistance in the DIAN project. We acknowledge each of the participating sites (list follows in alphabetical order) and their staff for their contributions to this study (see DIAN website (www.DIAN-info.org) for a list of DIAN sites and other DIAN related information). We also acknowledge Alzheimer's Disease Cooperative Study (ADCS) for coordination of clinical and neuropsychological evaluations and monitoring of the acquisition of imaging studies and collection of biological fluids; Mayo Clinic Rochester for MRI site training and standardization; University of Michigan for PET site training and standardization; and San Francisco Veteran's Administration Medical Center and Alzheimer's Disease Neuroimaging Initiative (ADNI) for the assistance in the conduct of project research. Support was also provided by the NIHR Queen Square Dementia Biomedical Research Unit.	Aisen PS, 2011, NEUROLOGY, V76, P280, DOI 10.1212/WNL.0b013e318207b1b9; Aisen PS, 2009, ALZHEIMERS RES THER, V1, DOI 10.1186/alzrt2; Alzheimers Assoc, 2015, ALZHEIMERS DEMENT, V11, P332, DOI 10.1016/j.jalz.2015.02.003; Bateman RJ, 2012, NEW ENGL J MED, V367, P795, DOI 10.1056/NEJMoa1202753; Benzinger TLS, 2013, P NATL ACAD SCI USA, V110, pE4502, DOI 10.1073/pnas.1317918110; Bilgel M, 2015, NEUROIMAGE, V119, P152, DOI 10.1016/j.neuroimage.2015.06.063; Brendel M, 2015, NEUROIMAGE, V108, P450, DOI 10.1016/j.neuroimage.2014.11.055; Chen KW, 2015, J NUCL MED, V56, P560, DOI 10.2967/jnumed.114.149732; Edison P, 2012, NEUROIMAGE, V60, P1716, DOI 10.1016/j.neuroimage.2012.01.099; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Joshi A, 2012, J NUCL MED, V53, DOI 10.2967/jnumed.111.090340; Lammertsma AA, 1996, NEUROIMAGE, V4, P153, DOI 10.1006/nimg.1996.0066; Landau SM, 2015, J NUCL MED, V56, P567, DOI 10.2967/jnumed.114.148981; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Lippa CF, 1996, NEUROLOGY, V46, P406, DOI 10.1212/WNL.46.2.406; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834, DOI 10.1097/00004647-199609000-00008; Lopresti BJ, 2005, J NUCL MED, V46, P1959; Mann DMA, 2001, AM J PATHOL, V158, P2165, DOI 10.1016/S0002-9440(10)64688-3; Meltzer CC, 1999, J NUCL MED, V40, P2053; Mills SM, 2013, REV NEUROL-FRANCE, V169, P737, DOI 10.1016/j.neurol.2013.07.017; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris John C, 2012, Clin Investig (Lond), V2, P975; Panin VY, 2006, IEEE T MED IMAGING, V25, P907, DOI 10.1109/TMI.2006.876171; Pastor P, 2003, ANN NEUROL, V54, P163, DOI 10.1002/ana.10636; Raniga P, 2008, ACAD RADIOL, V15, P1376, DOI 10.1016/j.acra.2008.07.006; Reiman EM, 2011, J ALZHEIMERS DIS, V26, P321, DOI 10.3233/JAD-2011-0059; Rousset OG, 2008, J NUCL MED, V49, P1097, DOI 10.2967/jnumed.107.048330; Schneider LS, 2014, J INTERN MED, V275, P251, DOI 10.1111/joim.12191; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Soret M, 2007, J NUCL MED, V48, P932, DOI 10.2967/jnumed.106.035774; Sperling RA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007941; Su Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122920; Su Y, 2015, NEUROIMAGE, V107, P55, DOI 10.1016/j.neuroimage.2014.11.058; Su Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073377; Su Y, 2013, J CEREBR BLOOD F MET, V33, P115, DOI 10.1038/jcbfm.2012.143; Thomas BA, 2011, EUR J NUCL MED MOL I, V38, P1104, DOI 10.1007/s00259-011-1745-9; Tohka J, 2008, NEUROIMAGE, V39, P1570, DOI 10.1016/j.neuroimage.2007.10.038; van Berckel BNM, 2013, J NUCL MED, V54, P1570, DOI 10.2967/jnumed.112.113654	41	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152082	10.1371/journal.pone.0152082	http://dx.doi.org/10.1371/journal.pone.0152082			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010959	Green Published, gold, Green Accepted			2022-12-26	WOS:000372708000083
J	Vresak, M; Olesen, MH; Gislum, R; Bavec, F; Jorgensen, JR				Vresak, Martina; Olesen, Merete Halkjaer; Gislum, Rene; Bavec, Franc; Jorgensen, Johannes Ravn			The Use of Image-Spectroscopy Technology as a Diagnostic Method for Seed Health Testing and Variety Identification	PLOS ONE			English	Article							WHEAT; DEOXYNIVALENOL	Application of rapid and time-efficient health diagnostic and identification technology in the seed industry chain could accelerate required analysis, characteristic description and also ultimately availability of new desired varieties. The aim of the study was to evaluate the potential of multispectral imaging and single kernel near-infrared spectroscopy (SKNIR) for determination of seed health and variety separation of winter wheat (Triticum aestivum L.) and winter triticale (Triticosecale Wittm. & Camus). The analysis, carried out in autumn 2013 at AU-Flakkebjerg, Denmark, included nine winter triticale varieties and 27 wheat varieties provided by the Faculty of Agriculture and Life Sciences Maribor, Slovenia. Fusarium sp. and black point disease-infected parts of the seed surface could successfully be distinguished from uninfected parts with use of a multispectral imaging device (405-970 nm wavelengths). SKNIR was applied in this research to differentiate all 36 involved varieties based on spectral differences due to variation in the chemical composition. The study produced an interesting result of successful distinguishing between the infected and uninfected parts of the seed surface. Furthermore, the study was able to distinguish between varieties. Together these components could be used in further studies for the development of a sorting model by combining data from multispectral imaging and SKNIR for identifying disease (s) and varieties.	[Vresak, Martina; Bavec, Franc] Univ Maribor, Fac Agr & Life Sci, Inst Organ Farming, Pivola, Hoce, Slovenia; [Olesen, Merete Halkjaer; Gislum, Rene; Jorgensen, Johannes Ravn] Aarhus Univ, Fac Sci & Technol, Dept Agroecol, Slagelse, Denmark	University of Maribor; Aarhus University	Vresak, M (corresponding author), Univ Maribor, Fac Agr & Life Sci, Inst Organ Farming, Pivola, Hoce, Slovenia.	tinavresak@gmail.com	Jørgensen, Johannes Ravn/E-9797-2016; Jørgensen, Johannes Ravn/M-1273-2019	Jørgensen, Johannes Ravn/0000-0003-3133-2350; Gislum, Rene/0000-0002-1432-4781	CORE ORGANIC II FUNDING BODIES (Ministry of Agriculture, Forestry and Food, Slovenia) [2330-12-000120]; FP7 ERA-NET project CORE ORGANIC II (Coordinating European Transitional Research Organic Food and Farming Systems) [249667]	CORE ORGANIC II FUNDING BODIES (Ministry of Agriculture, Forestry and Food, Slovenia); FP7 ERA-NET project CORE ORGANIC II (Coordinating European Transitional Research Organic Food and Farming Systems)	With gratitude, this work was supported by the international COBRA (Coordinating organic plant breeding activities for diversity) project provided by the CORE ORGANIC II FUNDING BODIES (Ministry of Agriculture, Forestry and Food, Slovenia, Agreement No. 2330-12-000120 led by Prof. Dr. Franc Bavec and Ministry of Environment and Food of Denmark) being partners of the FP7 ERA-NET project CORE ORGANIC II (Coordinating European Transitional Research Organic Food and Farming Systems, project No. 249667). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelet LE, 2014, TALANTA, V121, P288, DOI 10.1016/j.talanta.2013.12.038; Bauriegel E, 2011, COMPUT ELECTRON AGR, V75, P304, DOI 10.1016/j.compag.2010.12.006; Dammer KH, 2011, CROP PROT, V30, P420, DOI 10.1016/j.cropro.2010.12.015; ISTA, 2009, INT RUL SEED TEST; Jaillais B, 2011, PLANTA, V233, P1147, DOI 10.1007/s00425-011-1369-0; Khodadadi M, 2011, AUST J CROP SCI, V5, P17; Khoshroo A., 2014, Agricultural Communications, V2, P17; Mahesh S, 2008, BIOSYST ENG, V101, P50, DOI 10.1016/j.biosystemseng.2008.05.017; Mathur SB, 2003, COMMON LAB SEED HLTH; Menesatti P, 2013, BIOSYST ENG, V114, P289, DOI 10.1016/j.biosystemseng.2013.01.004; Nielsen JP, 2003, CEREAL CHEM, V80, P274, DOI 10.1094/CCHEM.2003.80.3.274; Olesen MH, 2011, SEED SCI TECHNOL, V39, P140, DOI 10.15258/sst.2011.39.1.12; Olesen MH, 2012, THESIS AARHUS U, P123; Pearson T., 2013, J AGR SCI TECHNOL, V2, P45, DOI [10.7726/ajast.2013.1004, DOI 10.7726/AJAST.2013.1004]; Peiris KHS, 2010, CEREAL CHEM, V87, P511, DOI 10.1094/CCHEM-01-10-0006; Peiris KHS, 2009, J NEAR INFRARED SPEC, V17, P213, DOI 10.1255/jnirs.846; Sandeep Varma V., 2013, INT J RES AGR SCI, V1, P30; Shahin M. A., 2012, Journal of Food Measurement and Characterization, V6, P3; Shrestha S, 2015, SENSORS-BASEL, V15, P4496, DOI 10.3390/s150204496; van Bueren ETL, 2011, NJAS-WAGEN J LIFE SC, V58, P193, DOI 10.1016/j.njas.2010.04.001; Wegulo SN, 2008, CAN J PLANT SCI, V88, P1087, DOI 10.4141/CJPS08053; Williams P, 2010, J NEAR INFRARED SPEC, V18, P49, DOI 10.1255/jnirs.858; Zhang XL, 2012, SENSORS-BASEL, V12, P17234, DOI 10.3390/s121217234	23	17	20	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152011	10.1371/journal.pone.0152011	http://dx.doi.org/10.1371/journal.pone.0152011			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010656	Green Published, Green Submitted, gold			2022-12-26	WOS:000372708000068
J	Wei, SN; Zhang, M; Yu, Y; Lan, XX; Yao, F; Yan, X; Chen, L; Hatch, GM				Wei, Shengnan; Zhang, Ming; Yu, Yang; Lan, Xiaoxin; Yao, Fan; Yan, Xin; Chen, Li; Hatch, Grant M.			Berberine Attenuates Development of the Hepatic Gluconeogenesis and Lipid Metabolism Disorder in Type 2 Diabetic Mice and in Palmitate-Incubated HepG2 Cells through Suppression of the HNF-4 alpha miR122 Pathway	PLOS ONE			English	Article							CIRCULATING MICRORNA BIOMARKERS; IN-VIVO; EXPRESSION; RECEPTOR; MIR-122; CHOLESTEROL; HNF4-ALPHA; ACTIVATION; AMPK	Berberine (BBR) has been shown to exhibit protective effects against diabetes and dyslipidemia. Previous studies have indicated that BBR modulates lipid metabolism and inhibits hepatic gluconeogensis by decreasing expression of Hepatocyte Nuclear Factor-4 alpha (HNF-4 alpha). However, the mechanism involved in this process was unknown. In the current study, we examined the mechanism of how BBR attenuates hepatic gluconeogenesis and the lipid metabolism alterations observed in type 2 diabetic (T2D) mice and in palmitate (PA)-incubated HepG2 cells. Treatment with BBR for 4 weeks improve all biochemical parameters compared to T2D mice. Treatment of T2D mice for 4 weeks or treatment of PA-incubated HepG2 cells for 24 h with BBR decreased expression of HNF-4 alpha and the microRNA miR122, the key gluconeogenesis enzymes Phosphoenolpyruvate carboxykinase (PEPCK) and Glucose-6-phosphatase (G6Pase) and the key lipid metabolism proteins Sterol response element binding protein-1 (SREBP-1), Fatty acid synthase-1 (FAS-1) and Acetyl-Coenzyme A carboxylase (ACC alpha) and increased Carnitine palmitoyltransferase-1(CPT-1) compared to T2D mice or PA-incubated HepG2 cells. Expression of HNF-4 alpha in HepG2 cells increased expression of gluconeogenic and lipid metabolism enzymes and BBR treatment or knock down of miR122 attenuated the effect of HNF-4 alpha expression. In contrast, BBR treatment did not alter expression of gluconeogenic and lipid metabolism enzymes in HepG2 cells with knockdown of HNF-4 alpha. In addition, miR122 mimic increased expression of gluconeogenic and lipid metabolism enzymes in HepG2 cells with knockdown of HNF-4 alpha. These data indicate that miR122 is a critical regulator in the downstream pathway of HNF-4 alpha in the regulation of hepatic gluconeogenesis and lipid metabolism in HepG2 cells. The effect of BBR on hepatic gluconeogenesis and lipid metabolism is mediated through HNF-4 alpha and is regulated downstream of miR122. Our data provide new evidence to support HNF-4 alpha and miR122 regulated hepatic gluconeogenesis and lipid metabolism as promising therapeutic targets for the treatment of T2D.	[Wei, Shengnan; Zhang, Ming; Yu, Yang; Lan, Xiaoxin; Yao, Fan; Yan, Xin; Chen, Li] Jilin Univ, Sch Nursing, Coll Basic Med Sci, Dept Pharmacol, Changchun 130023, Jilin, Peoples R China; [Zhang, Ming; Hatch, Grant M.] Univ Manitoba, Dept Pharmacol & Therapeut Biochem & Med Genet, DREAM, Childrens Hosp,Res Inst Manitoba, Winnipeg, MB, Canada	Jilin University; University of Manitoba; Children's Hospital Research Institute of Manitoba	Chen, L (corresponding author), Jilin Univ, Sch Nursing, Coll Basic Med Sci, Dept Pharmacol, Changchun 130023, Jilin, Peoples R China.	chen_lab@163.com	Yu, Yang/GZG-4493-2022; Zhang, Ming/E-4888-2016	Yu, Yang/0000-0002-2480-7306; 	National Natural Science Foundation of China [81200598]; Young Scholars Program of Norman Bethune Health Science Center of JiLin University [2013201011]; Heart and Stroke Foundation of Canada [G-14-0005708]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Young Scholars Program of Norman Bethune Health Science Center of JiLin University; Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	This work was conducted in Preclinical Pharmacology R&D Center of Jilin Province and Key Lab of Traditional Medicine for Diabetes of Jilin Province. This work was supported by National Natural Science Foundation of China (81200598), Young Scholars Program of Norman Bethune Health Science Center of JiLin University (2013201011) and the Heart and Stroke Foundation of Canada (G-14-0005708). G.M.H. is a Canada Research Chair in Molecular Cardiolipin Metabolism.	Ansell Benjamin J, 2005, Curr Atheroscler Rep, V7, P29, DOI 10.1007/s11883-005-0072-7; Assmann G, 1991, Fortschr Med, V109, P361; Benatti RO, 2014, BRIT J NUTR, V111, P2112, DOI 10.1017/S0007114514000579; Boussageon R, 2014, DIABETES METAB, V40, P169, DOI 10.1016/j.diabet.2013.12.010; Chantarangsi W., 2014, BIOCH CELL BIOL, P1, DOI [10.1002/bimj.201300244, DOI 10.1002/BIMJ.201300244]; Donlo IC, 2009, MED CLIN-BARCELONA, V132, P217, DOI 10.1016/j.medcli.2008.07.021; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Iliopoulos D, 2010, J LIPID RES, V51, P1513, DOI 10.1194/jlr.M004812; Indira M, 2015, Indian J Dent Res, V26, P271, DOI 10.4103/0970-9290.162883; Isaacsohn JL, 2004, AM J CARDIOL, V93, p49C, DOI 10.1016/j.amjcard.2004.02.007; Kong WJ, 2008, METABOLISM, V57, P1029, DOI 10.1016/j.metabol.2008.01.037; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Kroh EM, 2010, METHODS, V50, P298, DOI 10.1016/j.ymeth.2010.01.032; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Li JX, 2000, GENE DEV, V14, P464; Li W, 2012, FITOTERAPIA, V83, P192, DOI 10.1016/j.fitote.2011.10.011; Li XY, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0629-3; Li ZY, 2011, J HEPATOL, V55, P602, DOI 10.1016/j.jhep.2010.12.023; Li Z, 2014, BIOL PHARM BULL, V37, P1766, DOI 10.1248/bpb.b14-00412; Liu LH, 2014, TUMOR BIOL, V35, P12245, DOI 10.1007/s13277-014-2533-5; Mitchell SMS, 2002, MOL GENET METAB, V76, P148, DOI 10.1016/S1096-7192(02)00027-6; Mogilenko DA, 2009, BIOCHEMISTRY-US, V48, P11950, DOI 10.1021/bi9015742; Niu CS, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-20; Oliveira K.G., 2015, MED MICROBIOL IMMUNO; SLADEK FM, 1990, GENE DEV, V4, P2353, DOI 10.1101/gad.4.12b.2353; Stoffel M, 1997, P NATL ACAD SCI USA, V94, P13209, DOI 10.1073/pnas.94.24.13209; SVEDBERG J, 1990, DIABETES, V39, P570, DOI 10.2337/diabetes.39.5.570; Xia XA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016556; Xie L, 2011, CLIN BIOCHEM, V44, P216, DOI 10.1016/j.clinbiochem.2010.11.002; Yan HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134172; Zhang H, 2010, METABOLISM, V59, P285, DOI 10.1016/j.metabol.2009.07.029; ZHANG MF, 1989, ACTA PHARM SINIC, V10, P174; Zhang M, 2012, MOL CELL ENDOCRINOL, V363, P122, DOI 10.1016/j.mce.2012.08.006; Zhao L, 2014, CHIN J INTEGR MED; Zhao W, 2008, BIOMED PHARMACOTHER, V62, P730, DOI 10.1016/j.biopha.2008.01.007	37	47	55	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152097	10.1371/journal.pone.0152097	http://dx.doi.org/10.1371/journal.pone.0152097			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27011261	Green Submitted, Green Published, gold			2022-12-26	WOS:000372708000085
J	Calvo-Iglesias, J; Perez-Estevez, D; Lorenzo-Abalde, S; Sanchez-Correa, B; Quiroga, MI; Fuentes, JM; Gonzalez-Fernandez, A				Calvo-Iglesias, Juan; Perez-Estevez, Daniel; Lorenzo-Abalde, Silvia; Sanchez-Correa, Beatriz; Isabel Quiroga, Maria; Fuentes, Jose M.; Gonzalez-Fernandez, Africa			Characterization of a Monoclonal Antibody Directed against Mytilus spp Larvae Reveals an Antigen Involved in Shell Biomineralization	PLOS ONE			English	Article							EXTRAPALLIAL FLUID PROTEIN; PEARL OYSTER; MATRIX PROTEINS; GALLOPROVINCIALIS LARVAE; ELECTROPHORETIC TRANSFER; POLYACRYLAMIDE-GELS; CALCIUM-BINDING; MOLLUSK; IDENTIFICATION; TISSUES	The M22.8 monoclonal antibody (mAb) developed against an antigen expressed at the mussel larval and postlarval stages of Mytilus galloprovincialis was studied on adult samples. Antigenic characterization by Western blot showed that the antigen MSP22.8 has a restricted distribution that includes mantle edge tissue, extrapallial fluid, extrapallial fluid hemocytes, and the shell organic matrix of adult samples. Other tissues such as central mantle, gonadal tissue, digestive gland, labial palps, foot, and byssal retractor muscle did not express the antigen. Immunohistochemistry assays identified MSP22.8 in cells located in the outer fold epithelium of the mantle edge up to the pallial line. Flow cytometry analysis showed that hemocytes from the extrapallial fluid also contain the antigen intracellularly. Furthermore, hemocytes from hemolymph have the ability to internalize the antigen when exposed to a cell-free extrapallial fluid solution. Our findings indicate that hemocytes could play an important role in the biomineralization process and, as a consequence, they have been included in a model of shell formation. This is the first report concerning a protein secreted by the mantle edge into the extrapallial space and how it becomes part of the shell matrix framework in M. galloprovincialis mussels.	[Calvo-Iglesias, Juan; Lorenzo-Abalde, Silvia; Sanchez-Correa, Beatriz; Gonzalez-Fernandez, Africa] Univ Vigo, Immunol Biomed Res Ctr CINBIO, Vigo 36310, Spain; [Calvo-Iglesias, Juan; Lorenzo-Abalde, Silvia; Sanchez-Correa, Beatriz; Gonzalez-Fernandez, Africa] Univ Vigo, Inst Biomed Res Vigo IBIV, Vigo 36310, Spain; [Perez-Estevez, Daniel] NanoImmunoTech, R&D Deparment, Vigo, Spain; [Isabel Quiroga, Maria] Univ Santiago de Compostela, Fac Vet, Vet Clin Sci, Lugo, Spain; [Fuentes, Jose M.] Ctr Invest Marinas CIMA, Conselleria Medio Rural & Mar, Vilanova De Arousa, Spain	Universidade de Vigo; CINBIO; Universidade de Vigo; Universidade de Santiago de Compostela	Calvo-Iglesias, J (corresponding author), Univ Vigo, Immunol Biomed Res Ctr CINBIO, Vigo 36310, Spain.; Calvo-Iglesias, J (corresponding author), Univ Vigo, Inst Biomed Res Vigo IBIV, Vigo 36310, Spain.	xoanci@hotmail.com	González-Fernández, África/E-2641-2012; Quiroga, María Isabel/L-1376-2014	González-Fernández, África/0000-0002-9226-4825; Gonzalez-Fernandez, Africa/0000-0001-5906-3901; Quiroga, Maria Isabel/0000-0001-6832-7665; Perez Estevez, Daniel/0000-0002-1238-8028	Xunta de Galicia (Grupo con potencial de crecimiento) [GPC2013-005]; BIOCAPS project - European Commission [FP7- 316265, FP7/REGPOT-2012-2013.1]	Xunta de Galicia (Grupo con potencial de crecimiento)(Xunta de Galicia); BIOCAPS project - European Commission	This work was supported by the Xunta de Galicia (Grupo con potencial de crecimiento GPC2013-005). The authors also thank the BIOCAPS project (grant agreement no. FP7- 316265) funded by the European Commission under the 7th Framework Programme (FP7/REGPOT-2012-2013.1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abalde SL, 2003, AQUACULTURE, V219, P545, DOI 10.1016/S0044-8486(02)00658-0; Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; BIELEFELD U, 1993, J MOLLUS STUD, V59, P323, DOI 10.1093/mollus/59.3.323; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Canesi L, 2002, MICROSC RES TECHNIQ, V57, P469, DOI 10.1002/jemt.10100; Crenshaw M. A., 1980, MECH SHELL FORMATION; CRENSHAW MA, 1972, BIOL BULL, V143, P506, DOI 10.2307/1540180; Currey JD, 1999, J EXP BIOL, V202, P3285; Dalbeck P, 2006, EUR J MINERAL, V18, P601, DOI 10.1127/0935-1221/2006/0018-0601; Donaghy L, 2009, FISH SHELLFISH IMMUN, V27, P296, DOI 10.1016/j.fsi.2009.05.010; Feng QL, 2000, J MATER SCI, V35, P3337, DOI 10.1023/A:1004843900161; HARE PE, 1963, SCIENCE, V139, P216, DOI 10.1126/science.139.3551.216; Hattan SJ, 2001, J BIOL CHEM, V276, P4461, DOI 10.1074/jbc.M006803200; JACKSON AP, 1988, PROC R SOC SER B-BIO, V234, P415, DOI 10.1098/rspb.1988.0056; Jackson DJ, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-40; Johnstone MB, 2008, J EXP ZOOL PART B, V310B, P227, DOI 10.1002/jez.b.21206; Jolly C, 2004, MAR BIOTECHNOL, V6, P541, DOI 10.1007/s10126-004-3129-7; KNIPRATH E, 1981, ZOOL SCR, V10, P61, DOI 10.1111/j.1463-6409.1981.tb00485.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu C, 2015, SCI REPORTS, V5; Lorenzo-Abalde S, 2005, AQUACULTURE, V250, P736, DOI 10.1016/j.aquaculture.2005.05.039; Lowenstam HA, 1989, BIOMINERALIZATION; Ma ZJ, 2007, J BIOL CHEM, V282, P23253, DOI 10.1074/jbc.M700001200; Mann S, 2001, BIOMINERALIZATION; Marie B, 2012, P NATL ACAD SCI USA, V109, P20986, DOI 10.1073/pnas.1210552109; Marie B, 2011, J MOL EVOL, V72, P531, DOI 10.1007/s00239-011-9451-6; Marin F, 2004, CR PALEVOL, V3, P469, DOI 10.1016/j.crpv.2004.07.009; Marin F, 2000, J BIOL CHEM, V275, P20667, DOI 10.1074/jbc.M003006200; Marin F, 2008, CURR TOP DEV BIOL, V80, P209, DOI 10.1016/S0070-2153(07)80006-8; Marin Frederic, 2012, Front Biosci (Schol Ed), V4, P1099; MISOGIANES MJ, 1979, ANAL BIOCHEM, V100, P324, DOI 10.1016/0003-2697(79)90236-7; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; Moura G, 2000, COMP BIOCHEM PHYS B, V125, P293, DOI 10.1016/S0305-0491(99)00192-3; Mutvei H., 1980, P49; Naganuma T, 2006, MOL DIVERS, V10, P607, DOI 10.1007/s11030-006-9051-3; Nair PS, 1998, BIOL BULL, V195, P43, DOI 10.2307/1542774; Perez D, 2009, AQUACULTURE, V294, P86, DOI 10.1016/j.aquaculture.2009.05.020; PIETRZAK JE, 1976, HYDROBIOLOGIA, V50, P89, DOI 10.1007/BF00016846; Saleuddin A.S.M., 1983, P199; Simkiss K, 1989, BIOMINERALIZATION CE, P231; Sudo S, 1997, NATURE, V387, P563, DOI 10.1038/42391; Suzuki M, 2011, CHEMBIOCHEM, V12, P2478, DOI 10.1002/cbic.201100317; Takeuchi T, 2006, MAR BIOTECHNOL, V8, P52, DOI 10.1007/s10126-005-5037-x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tsukamoto D, 2004, BIOCHEM BIOPH RES CO, V320, P1175, DOI 10.1016/j.bbrc.2004.06.072; Wada K., 1980, P79; Wang XT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066522; WEINER S, 1986, CRC CR REV BIOCH MOL, V20, P365, DOI 10.3109/10409238609081998; WEINER S, 1977, J EXP MAR BIOL ECOL, V30, P45, DOI 10.1016/0022-0981(77)90026-0; WHEELER AP, 1987, COMP BIOCHEM PHYS B, V87, P953, DOI 10.1016/0305-0491(87)90418-4; Wilbur K. M., 1983, MOLLUSCA 1, P236; WILBUR KM, 1952, BIOL BULL, V103, P269, DOI 10.2307/1538451; Yin Y, 2005, BIOCHEMISTRY-US, V44, P10720, DOI 10.1021/bi0505565; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413	54	7	7	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152210	10.1371/journal.pone.0152210	http://dx.doi.org/10.1371/journal.pone.0152210			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008638	Green Published, gold, Green Submitted			2022-12-26	WOS:000372701200110
J	Nyberg, C; Karlsson, T; Hillered, L; Stridsberg, M; Engstrom, ER				Nyberg, Christoffer; Karlsson, Torbjorn; Hillered, Lars; Stridsberg, Mats; Engstrom, Elisabeth Ronne			The Early Endocrine Stress Response in Experimental Subarachnoid Hemorrhage	PLOS ONE			English	Article							PITUITARY-ADRENAL-FUNCTION; ACUTE-PHASE; CHROMOGRANIN-A; CORTISOL; PLASMA; MECHANISMS; DYNAMICS; NEURONS; DISEASE; SPACE	Introduction In patients with severe illness, such as aneurysmal subarachnoid hemorrhage (SAH), a physiologic stress response is triggered. This includes activation of the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic nervous system. The aim of this study was to investigate the very early responses of these systems. Methods A porcine animal model of aneurysmal SAH was used. In this model, blood is injected slowly to the basal cisterns above the anterior skull base until the cerebral perfusion pressure is 0 mm Hg. Sampling was done from blood and urine at -10, +15, +75 and +135 minutes from time of induction of SAH. Analyses of adrenocorticotropic hormone (ACTH), cortisol, aldosterone, catecholamines and chromogranin-A were performed. Results Plasma ACTH, serum cortisol and plasma aldosterone increased in the samples following induction of SAH, and started to decline after 75 minutes. Urine cortisol also increased after SAH. Urine catecholamines and their metabolites were found to increase after SAH. Many samples were however below detection level, not allowing for statistical analysis. Plasma chromogranin-A peaked at 15 minutes after SAH, and thereafter decreased. Conclusions The endocrine stress response after aneurysmal SAH was found to start within 15 minutes in the HPA axis with early peak values of ACTH, cortisol and aldosterone. The fact that the concentrations of the HPA axis hormones decreased 135 minutes after SAH may suggest that a similar pattern exists in SAH patients, thus making it difficult to catch these early peak values. There were also indications of early activation of the sympathetic nervous system, but the small number of valid samples made interpretation difficult.	[Nyberg, Christoffer; Hillered, Lars; Engstrom, Elisabeth Ronne] Uppsala Univ, Dept Neurosci, Sect Neurosurg, Uppsala, Sweden; [Karlsson, Torbjorn] Uppsala Univ, Dept Surg Sci, Sect Anesthesiol & Intens Care, Uppsala, Sweden; [Stridsberg, Mats] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	Nyberg, C (corresponding author), Uppsala Univ, Dept Neurosci, Sect Neurosurg, Uppsala, Sweden.	christoffer.nyberg@neuro.uu.se			Uppsala University Hospital	Uppsala University Hospital	The study was supported financially by Uppsala University Hospital grants for clinical research.	Bendel S, 2008, CRIT CARE, V12, DOI 10.1186/cc7084; CRYER PE, 1991, AM J PHYSIOL, V260, pE243, DOI 10.1152/ajpendo.1991.260.2.E243; DILRAJ A, 1992, NEUROSURGERY, V31, P42, DOI 10.1227/00006123-199207000-00007; Dimopoulou I, 2004, STROKE, V35, P2884, DOI 10.1161/01.STR.0000147716.45571.45; Ebersberger A, 1997, J NEUROPHYSIOL, V77, P3122, DOI 10.1152/jn.1997.77.6.3122; Ebersberger A, 1999, PAIN, V81, P283, DOI 10.1016/S0304-3959(99)00017-2; Espiner EA, 2002, CLIN ENDOCRINOL, V56, P629, DOI 10.1046/j.1365-2265.2002.01285.x; Hansen-Schwartz J, 2004, NEUROCRIT CARE, V1, P235, DOI 10.1385/NCC:1:2:235; HJEMDAHL P, 1979, LIFE SCI, V25, P131, DOI 10.1016/0024-3205(79)90384-9; JENKINS JS, 1969, BRIT MED J, V4, P707, DOI 10.1136/bmj.4.5685.707; Kreitschmann-Andermahr I, 2003, J NEUROL NEUROSUR PS, V74, P1133, DOI 10.1136/jnnp.74.8.1133; Lanterna LA, 2013, J STROKE CEREBROVASC, V22, pE189, DOI 10.1016/j.jstrokecerebrovasdis.2012.11.002; Lindgren C, 2013, ACTA ANAESTH SCAND, V57, P452, DOI 10.1111/aas.12014; Naredi S, 2000, STROKE, V31, P901, DOI 10.1161/01.STR.31.4.901; Naredi S, 2006, INTENS CARE MED, V32, P1955, DOI 10.1007/s00134-006-0408-y; Nyberg C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099904; Poll EM, 2013, STRESS, V16, P153, DOI 10.3109/10253890.2012.697946; Poll EM, 2010, J NEUROTRAUM, V27, P189, DOI 10.1089/neu.2009.1014; Stridsberg M, 2000, J ENDOCRINOL, V165, P703, DOI 10.1677/joe.0.1650703; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Venkataraman S, 2007, REV ENDOCR METAB DIS, V8, P365, DOI 10.1007/s11154-007-9058-9; Zetterling M, 2011, BRIT J NEUROSURG, V25, P684, DOI 10.3109/02688697.2011.584638	22	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151457	10.1371/journal.pone.0151457	http://dx.doi.org/10.1371/journal.pone.0151457			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007694	Green Submitted, Green Published, gold			2022-12-26	WOS:000372701200055
J	Ponert, J; Travnicek, P; Vuong, TB; Rybkova, R; Suda, J				Ponert, Jan; Travnicek, Pavel; Truong Ba Vuong; Rybkova, Romana; Suda, Jan			A New Species of Cleisostoma (Orchidaceae) from the Hon Ba Nature Reserve in Vietnam: A Multidisciplinary Assessment	PLOS ONE			English	Article							NECTAR SUGAR COMPOSITION; AERIDINAE ORCHIDACEAE; MOLECULAR PHYLOGENETICS; FLORAL NECTAR; CLASSIFICATION; POLLINATION; EVOLUTION; NUCLEAR; SYSTEMATICS; MORPHOLOGY	A new species, Cleisostoma yersinii J. Ponert & Vuong, is described and illustrated based on the material collected in the Hon Ba Nature Reserve in southern Vietnam. In addition to conventional (macro) morphological examination we comparatively investigated root and leaf anatomy (using light and fluorescent microscopy), assessed nectar characteristics (using HPLC analysis), determined nuclear genome size (using DNA flow cytometry) and reconstructed phylogenetic relationships (using nrITS sequences). Cleisostoma yersinii differs from its putative closest relative C. birmanicum in wider and shorter leaves, larger flowers, distinct lip with S-shaped tip of the mid-lobe, and a shallow spur with two large nectar sacks separated by prominent calli and septum. Nectar is sucrose-dominant and very rich in sugars. Stomata are developed on both sides of the leaf and have prominent hyperstomatal chambers and substomatal cavities. Roots with well-developed exodermis and tracheoidal idioblasts are covered by a two-layer Vanda-type velamen. Chloroplasts occur not only in the cortex but are also abundant in the stele. Mean 1C-value was estimated to 2.57 pg DNA. An updated identification key is provided for SE Asian sections and all Vietnamese species of Cleisostoma.	[Ponert, Jan; Rybkova, Romana] Prague Bot Garden, Prague, Czech Republic; [Ponert, Jan] Charles Univ Prague, Fac Sci, Dept Expt Plant Biol, Prague, Czech Republic; [Ponert, Jan; Travnicek, Pavel; Suda, Jan] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Travnicek, Pavel; Suda, Jan] Acad Sci Czech Republic, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Truong Ba Vuong] Inst Trop Biol, Linh Trung Ward, Ho Chi Minh City, Vietnam	Charles University Prague; Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Ponert, J (corresponding author), Prague Bot Garden, Prague, Czech Republic.; Ponert, J (corresponding author), Charles Univ Prague, Fac Sci, Dept Expt Plant Biol, Prague, Czech Republic.; Ponert, J (corresponding author), Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic.	ponert@natur.cuni.cz	Ponert, Jan/S-2083-2017; Truong, Vuong/AAY-8913-2021; Travnicek, Pavel/G-9028-2012	Ponert, Jan/0000-0003-3827-8086; Truong, Vuong/0000-0003-3452-8455; Travnicek, Pavel/0000-0002-5806-1645	Charles University in Prague [GAUK 1598214]; Czech Science Foundation [P506/12/1320]; Ministry of Education, Youth and Sports of the Czech Republic [NPU1: LO1417]	Charles University in Prague; Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	Laboratory research was supported by the Charles University in Prague (project GAUK 1598214), Czech Science Foundation (project P506/12/1320) and Ministry of Education, Youth and Sports of the Czech Republic (project NPU1: LO1417). Special thanks belong to Prague Botanical Garden for sponsoring the research in the Hon Ba Nature Reserve. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; [Anonymous], 2009, LANG ENV STAT COMP; [Anonymous], 2015, WORLD CHECKLIST ORCH; AVERYANOV L. V., 2009, ADV NATURAL SCI, V10, P353; Averyanov L.V., 2006, KOMAROVIA, V4, P1; Averyanov L.V., 2003, J SCI HANOI NAT SCI, V19, P1; Averyanov LV, 2003, UPDATED CHECKLIST OR; Averyanov LV, 2003, KOMAROVIA, V3, P1; Averyanov LV, 2013, ORCHIDS CUC PHUONG N; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Canto A, 2012, ANN BOT-LONDON, V110, P1173, DOI 10.1093/aob/mcs183; Canto A, 2008, AM J BOT, V95, P315, DOI 10.3732/ajb.95.3.315; Carlsward BS, 2006, AM J BOT, V93, P770, DOI 10.3732/ajb.93.5.770; Carlsward BS, 2014, GENERA ORCHIDACEARUM; Chalcoff VR, 2006, ANN BOT-LONDON, V97, P413, DOI 10.1093/aob/mcj043; Chase MW, 2015, BOT J LINN SOC, V177, P151, DOI 10.1111/boj.12234; Chomicki G, 2014, FLORA, V209, P88, DOI 10.1016/j.flora.2014.01.001; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DAS S, 1992, BANGLADESH J BOTANY, V21, P65; Doleel J., 2007, FLOW CYTOMETRY PLANT, DOI [10.1002/9783527610921, DOI 10.1002/9783527610921]; Ehlers BK, 1997, FLORA, V192, P223, DOI 10.1016/S0367-2530(17)30787-9; Fan J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101557; Farkas A, 2012, SCI WORLD J, DOI 10.1100/2012/138579; Figueroa C, 2008, ANN BOT-LONDON, V101, P509, DOI 10.1093/aob/mcm328; Freudenstein JV, 2015, ANN BOT-LONDON, V115, P665, DOI 10.1093/aob/mcu253; Freudenstein JV, 1999, AM J BOT, V86, P225, DOI 10.2307/2656939; Gijbels P, 2015, PLANT ECOL EVOL, V148, P153, DOI 10.5091/plecevo.2015.914; Gijbels P, 2014, J ECOL, V102, P136, DOI 10.1111/1365-2745.12183; GUNDERSEN HJG, 1977, J MICROSC-OXFORD, V111, P219, DOI 10.1111/j.1365-2818.1977.tb00062.x; Herrera CM, 2008, ECOLOGY, V89, P2369, DOI 10.1890/08-0241.1; Herrera CM, 2006, AM J BOT, V93, P575, DOI 10.3732/ajb.93.4.575; Hidayat T, 2005, J PLANT RES, V118, P271, DOI 10.1007/s10265-005-0217-3; Hidayat T, 2012, J TEKNOL, V59, P87; JEFFREY DC, 1970, NEW PHYTOL, V69, P187, DOI 10.1111/j.1469-8137.1970.tb04062.x; Jersakova J, 2013, BOT J LINN SOC, V172, P95, DOI 10.1111/boj.12027; Kim W, 2011, P NATL ACAD SCI USA, V108, P16618, DOI 10.1073/pnas.1108642108; Kocyan A, 2014, GENERA ORCHIDACEARUM; Kocyan A, 2008, MOL PHYLOGENET EVOL, V48, P422, DOI 10.1016/j.ympev.2008.02.017; Kocyan A, 2014, PHYTOTAXA, V161, P61, DOI 10.11646/phytotaxa.161.1.3; KRAMER CY, 1956, BIOMETRICS, V12, P307, DOI 10.2307/3001469; KUBINOVA L, 1994, J EXP BOT, V45, P119, DOI 10.1093/jxb/45.1.119; KURZWEIL H, 1995, BOT J LINN SOC, V117, P171, DOI 10.1006/bojl.1995.0013; LANZA J, 1995, OECOLOGIA, V102, P113, DOI 10.1007/BF00333318; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132777; Lin WI, 2014, NATURE, V508, P546, DOI DOI 10.1038/NATURE13082; Martins DJ, 2007, AM J BOT, V94, P650, DOI 10.3732/ajb.94.4.650; Muller Kai, 2005, Appl Bioinformatics, V4, P65; Pokorny T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113823; PONERT J, 2014, LANKESTERIANA, V14, P123; POREMBSKI S, 1988, NORD J BOT, V8, P117, DOI 10.1111/j.1756-1051.1988.tb00491.x; PRIDGEON AM, 1983, AM J BOT, V70, P1365, DOI 10.2307/2443427; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schuiteman A, 2011, BOT J LINN SOC, V167, P344, DOI 10.1111/j.1095-8339.2011.01183.x; SEIDENFADEN G, 1975, DAN BOT ARK, V29, P1; SEIDENFADEN G, 1970, BOT TIDSSKR, V65, P313; Seidenfaden G, 1992, OPERA BOT, V114, P1; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Stern WL, 2001, BOT J LINN SOC, V136, P153, DOI 10.1111/j.1095-8339.2001.tb00564.x; Stern WL., 2014, ANATOMY MONOCOTYLEDO, VX; Swarts ND, 2009, ANN BOT-LONDON, V104, P543, DOI 10.1093/aob/mcp025; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tremblay RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102859; Tsukaya H, 2011, SYST BOT, V36, P49, DOI 10.1600/036364411X553117; Vojtiskova L, 2006, HYDROBIOLOGIA, V563, P73, DOI 10.1007/s10750-005-0929-3; WILLIAMS NH, 1979, BOT J LINN SOC, V78, P41, DOI 10.1111/j.1095-8339.1979.tb02185.x; Willmer P., 2011, POLLINATION FLORAL E; Wolff D, 2006, ANN BOT-LONDON, V97, P767, DOI 10.1093/aob/mcl033; Wood J., 2014, GENERA ORCHIDACEARUM; Xinqi C, 2015, ORCHIDACEAE FLORA CH; Zou LH, 2015, MOL PHYLOGENET EVOL, V85, P247, DOI 10.1016/j.ympev.2015.02.014; Zwickl DJ., 2006, THESIS; [No title captured]	73	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0150631	10.1371/journal.pone.0150631	http://dx.doi.org/10.1371/journal.pone.0150631			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008538	Green Published, gold			2022-12-26	WOS:000372701200025
J	Rowse, EG; Harris, S; Jones, G				Rowse, Elizabeth G.; Harris, Stephen; Jones, Gareth			The Switch from Low-Pressure Sodium to Light Emitting Diodes Does Not Affect Bat Activity at Street Lights	PLOS ONE			English	Article							ACOUSTIC IDENTIFICATION; DARK SIDE; POLLUTION; IMPACTS; CHALLENGES; BEHAVIOR; NIGHT	We used a before-after-control-impact paired design to examine the effects of a switch from low-pressure sodium (LPS) to light emitting diode (LED) street lights on bat activity at twelve sites across southern England. LED lights produce broad spectrum 'white' light compared to LPS street lights that emit narrow spectrum, orange light. These spectral differences could influence the abundance of insects at street lights and thereby the activity of the bats that prey on them. Most of the bats flying around the LPS lights were aerial-hawking species, and the species composition of bats remained the same after the switch-over to LED. We found that the switch-over from LPS to LED street lights did not affect the activity (number of bat passes), or the proportion of passes containing feeding buzzes, of those bat species typically found in close proximity to street lights in suburban environments in Britain. This is encouraging from a conservation perspective as many existing street lights are being, or have been, switched to LED before the ecological consequences have been assessed. However, lighting of all spectra studied to date generally has a negative impact on several slow-flying bat species, and LED lights are rarely frequented by these 'light-intolerant' bat species.	[Rowse, Elizabeth G.; Harris, Stephen; Jones, Gareth] Univ Bristol, Sch Biol Sci, Life Sci Bldg,24 Tyndall Ave, Bristol BS8 1TQ, Avon, England	University of Bristol	Rowse, EG (corresponding author), Univ Bristol, Sch Biol Sci, Life Sci Bldg,24 Tyndall Ave, Bristol BS8 1TQ, Avon, England.	liz.rowse@bristol.ac.uk		Jones, Gareth/0000-0002-1904-3735	Natural Environment Research Council [NE/K500823/1]; Natural Environment Research Council [1507353] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The project was funded by a studentship from the Natural Environment Research Council, grant number NE/K500823/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG., 1999, PRACTICAL STAT MED R; BELL GP, 1980, CAN J ZOOL, V58, P1876, DOI 10.1139/z80-256; Bezak P, 2008, ENVIRON SCI-TOKYO, V5, P161, DOI [DOI 10.1080/15693430802055524, 10.1080/15693430802055524]; BLAKE D, 1994, J ZOOL, V234, P453, DOI 10.1111/j.1469-7998.1994.tb04859.x; Boldogh S, 2007, ACTA CHIROPTEROL, V9, P527, DOI 10.3161/1733-5329(2007)9[527:TEOTIO]2.0.CO;2; Britton ARC, 1997, J ZOOL, V241, P503, DOI 10.1111/j.1469-7998.1997.tb04842.x; Cinzano P, 2001, MON NOT R ASTRON SOC, V328, P689, DOI 10.1046/j.1365-8711.2001.04882.x; Cowan T, 2009, ENTOMOL EXP APPL, V131, P148, DOI 10.1111/j.1570-7458.2009.00838.x; Davies TW, 2013, GLOBAL CHANGE BIOL, V19, P1417, DOI 10.1111/gcb.12166; De Almeida A, 2014, RENEW SUST ENERG REV, V34, P30, DOI 10.1016/j.rser.2014.02.029; Downs NC, 2003, BIOL CONSERV, V111, P247, DOI 10.1016/S0006-3207(02)00298-7; Eisenbeis Gerhard, 2006, P281; Elvidge CD, 2010, SENSORS-BASEL, V10, P3961, DOI 10.3390/s100403961; FENTON MB, 1976, CAN J ZOOL, V54, P526, DOI 10.1139/z76-059; Frank Kenneth D., 2006, P305; Gaisler J, 1998, J ZOOL, V244, P439, DOI 10.1111/j.1469-7998.1998.tb00048.x; Gaston KJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0133; Gaston KJ, 2015, ENVIRON REV, V23, P14, DOI 10.1139/er-2014-0041; Gaston KJ, 2012, J APPL ECOL, V49, P1256, DOI 10.1111/j.1365-2664.2012.02212.x; Gorresen PM, 2015, ACTA CHIROPTEROL, V17, P193, DOI 10.3161/15081109ACC2015.17.1.017; Hale JD, 2015, GLOBAL CHANGE BIOL, V21, P2467, DOI 10.1111/gcb.12884; Hassel F., 2011, NATUR LANDSCHAFT, V86, P298; Holker F, 2010, ECOL SOC, V15; Hothorn T, 2008, J STAT SOFTW, V28, P1; Institution of Lighting Engineers, 2007, 22 I LIGHT ENG; Jagerbrand AK, 2015, SUSTAINABILITY-BASEL, V7, P1028, DOI 10.3390/su7011028; Jakle John A., 2001, CITY LIGHTS ILLUMINA; JONES G, 1994, PHILOS T R SOC B, V346, P445, DOI 10.1098/rstb.1994.0161; Jung K, 2010, J MAMMAL, V91, P144, DOI [10.1644/08-MAMM-A-313R.1, 10.1644/08-MAMM-A-313R.1.]; Kyba CCM, 2015, SCI REP-UK, V5, DOI 10.1038/srep08409; Kyba CCM, 2013, LANDSCAPE ECOL, V28, P1637, DOI 10.1007/s10980-013-9936-3; Lacoeuilhe A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103042; Land MF, 2002, ANIMAL EYES; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Mathews F, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0124; McDonald TL, 2000, J AGRIC BIOL ENVIR S, V5, P262, DOI 10.2307/1400453; Muirhead-Thomson RC., 1991, TRAP RESPONSES FLYIN, V1st edn, DOI DOI 10.1007/s13355-015-0390-3; Navara KJ, 2007, J PINEAL RES, V43, P215, DOI 10.1111/j.1600-079X.2007.00473.x; NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Parsons S, 2000, J EXP BIOL, V203, P2641; Pawson SM, 2014, ECOL APPL, V24, P1561, DOI 10.1890/14-0468.1; R Core Team, 2021, R LANGUAGE ENV STAT; Royal Commission on Environmental Pollution, 2009, ART LIGHT ENV; Russ J, 2021, BAT CALLS BRITAIN EU; RYDELL J, 1992, FUNCT ECOL, V6, P744, DOI 10.2307/2389972; Rydell J, 1996, OIKOS, V76, P243, DOI 10.2307/3546196; Rydell J, 1995, SYM ZOOL S, P291; Rydell Jens, 2006, P43; Schubert EF, 2005, SCIENCE, V308, P1274, DOI 10.1126/science.1108712; Schwarz CJ, 2014, COURSE NOTES BEGINNI; Stebbings RE, 1995, BIOL J LINN SOC, V56, P103, DOI 10.1111/j.1095-8312.1995.tb01125.x; STEWARTOATEN A, 1986, ECOLOGY, V67, P929, DOI 10.2307/1939815; Stone EL, 2012, GLOBAL CHANGE BIOL, V18, P2458, DOI 10.1111/j.1365-2486.2012.02705.x; Stone EL, 2015, MAMM BIOL, V80, P213, DOI 10.1016/j.mambio.2015.02.004; Stone EL, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0127; Stone EL, 2009, CURR BIOL, V19, P1123, DOI 10.1016/j.cub.2009.05.058; UNDERWOOD AJ, 1991, AUST J MAR FRESH RES, V42, P569, DOI 10.1071/MF9910569; Vaughan N, 1997, MAMMAL REV, V27, P77, DOI 10.1111/j.1365-2907.1997.tb00373.x; Vaughan Nancy, 1997, Bioacoustics, V7, P189; Wakefield A, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150291; Walters CL, 2012, J APPL ECOL, V49, P1064, DOI 10.1111/j.1365-2664.2012.02182.x; Williams G, 2009, CORNWALL FUTURE LIGH	63	26	27	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0150884	10.1371/journal.pone.0150884	http://dx.doi.org/10.1371/journal.pone.0150884			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008274	Green Published, Green Submitted, gold			2022-12-26	WOS:000372701200035
J	Van Loon, AF; Te Brake, B; Van Huijgevoort, MHJ; Dijksma, R				Van Loon, Anne F.; Te Brake, Bram; Van Huijgevoort, Marjolein H. J.; Dijksma, Roel			Hydrological Classification, a Practical Tool for Mangrove Restoration	PLOS ONE			English	Article							MEKONG DELTA; FORESTS; REHABILITATION; MANAGEMENT; EVOLUTION; DYNAMICS; FUTURE; SEA; HYDRODYNAMICS; BIODIVERSITY	Mangrove restoration projects, aimed at restoring important values of mangrove forests after degradation, often fail because hydrological conditions are disregarded. We present a simple, but robust methodology to determine hydrological suitability for mangrove species, which can guide restoration practice. In 15 natural and 8 disturbed sites (i.e. disused shrimp ponds) in three case study regions in south-east Asia, water levels were measured and vegetation species composition was determined. Using an existing hydrological classification for mangroves, sites were classified into hydrological classes, based on duration of inundation, and vegetation classes, based on occurrence of mangrove species. For the natural sites hydrological and vegetation classes were similar, showing clear distribution of mangrove species from wet to dry sites. Application of the classification to disturbed sites showed that in some locations hydrological conditions had been restored enough for mangrove vegetation to establish, in some locations hydrological conditions were suitable for various mangrove species but vegetation had not established naturally, and in some locations hydrological conditions were too wet for any mangrove species (natural or planted) to grow. We quantified the effect that removal of obstructions such as dams would have on the hydrology and found that failure of planting at one site could have been prevented. The hydrological classification needs relatively little data, i.e. water levels for a period of only one lunar tidal cycle without additional measurements, and uncertainties in the measurements and analysis are relatively small. For the study locations, the application of the hydrological classification gave important information about how to restore the hydrology to suitable conditions to improve natural regeneration or to plant mangrove species, which could not have been obtained by estimating elevation only. Based on this research a number of recommendations are given to improve the effectiveness of mangrove restoration projects.	[Van Loon, Anne F.] Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England; [Van Loon, Anne F.] Univ Birmingham, Birmingham Inst Forest Res BIFoR, Birmingham, W Midlands, England; [Te Brake, Bram] Eijkelkamp Soil & Water, Giesbeek, Netherlands; [Te Brake, Bram; Van Huijgevoort, Marjolein H. J.; Dijksma, Roel] Wageningen Univ, Hydrol & Quantitat Water Management Grp, NL-6700 AP Wageningen, Netherlands; [Van Huijgevoort, Marjolein H. J.] Princeton Univ, Program Atmospher & Ocean Sci, Princeton, NJ 08544 USA	University of Birmingham; University of Birmingham; Wageningen University & Research; National Oceanic Atmospheric Admin (NOAA) - USA; Princeton University	Van Loon, AF (corresponding author), Univ Birmingham, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England.; Van Loon, AF (corresponding author), Univ Birmingham, Birmingham Inst Forest Res BIFoR, Birmingham, W Midlands, England.	a.f.vanloon@bham.ac.uk	Van Loon, Anne/ADL-7862-2022	Van Loon, Anne F./0000-0003-2308-0392				Agoramoorthy G, 2012, ENVIRON SCI TECHNOL, V46, P3625, DOI 10.1021/es300923j; Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; Andradi-Brown DA, 2013, ENVIRON EVID, V2, DOI 10.1186/2047-2382-2-20; [Anonymous], 2014, J MAR ISL CULT, DOI DOI 10.1016/J.IMIC.2014.11.002; Aucan Jerome, 2000, Wetlands Ecology and Management, V8, P223, DOI 10.1023/A:1008459814925; Balke T, 2011, MAR ECOL PROG SER, V440, P1, DOI 10.3354/meps09364; Binh T. N. K. D., 2005, Environment Development and Sustainability, V7, P519, DOI 10.1007/s10668-004-6001-z; Bosire JO, 2008, AQUAT BOT, V89, P251, DOI 10.1016/j.aquabot.2008.03.010; Bosire JO, 2003, AQUAT BOT, V76, P267, DOI 10.1016/S0304-3770(03)00054-8; Brockmeyer R.E. Jr, 1997, Wetlands Ecology and Management, V4, P93, DOI 10.1007/BF01876231; Chapman V. J., 1976, MANGROVE VEGETATION, V6, P12; Chien NV, 2003, CASE STUDY CAN GIO M; Clarke PJ, 2014, MAR FRESHWATER RES, V65, P930, DOI 10.1071/MF13326; Crase B, 2013, GLOBAL ECOL BIOGEOGR, V22, P806, DOI 10.1111/geb.12063; Dent D., 1992, Advances in Soil Science, V17, P79; Di Nitto D, 2014, BIOGEOSCIENCES, V11, P857, DOI 10.5194/bg-11-857-2014; Dijksma R, 2010, TROPICAL DELTAS COAS, V9, P384; Eijkelkamp, 2014, GROUND WAT MON COMM; Ellison AM, 2000, J ECOL, V88, P813, DOI 10.1046/j.1365-2745.2000.00500.x; Elster C, 2000, FOREST ECOL MANAG, V131, P201, DOI 10.1016/S0378-1127(99)00214-5; Erftemeijer PL, 1999, P ECOTONE 8 SEM ENH, P23; Field CB, 1998, GLOBAL ECOL BIOGEOGR, V7, P3, DOI 10.2307/2997693; Friess DA, 2014, GLOBAL ECOL BIOGEOGR, V23, P715, DOI 10.1111/geb.12140; Friess DA, 2012, BIOL REV, V87, P346, DOI 10.1111/j.1469-185X.2011.00198.x; Gastaldo RA, 2010, INT J COAL GEOL, V83, P162, DOI 10.1016/j.coal.2010.01.005; Gilman E, 2007, ESTUAR COAST, V30, P641, DOI 10.1007/BF02841961; Gopal B, 2013, AQUAT SCI, V75, P39, DOI 10.1007/s00027-011-0247-y; Gowing JW, 2006, COMPR ASSESS WAT MAN, V2, P48, DOI 10.1079/9781845931070.0048; Hall D., 2004, Journal of Agrarian Change, V4, P315, DOI 10.1111/j.1471-0366.2004.00081.x; Hong, 1993, MANGROVEVIETNAM; Horstman EM, 2015, GEOMORPHOLOGY, V228, P244, DOI 10.1016/j.geomorph.2014.08.011; Horstman EM, 2013, CONT SHELF RES, V71, P52, DOI 10.1016/j.csr.2013.10.002; Idris M., 2008, COASTAL MARINE SCI, V32, P1; Isyrini R, 2012, AS C SUST EN ENV OFF, P361; Kairo JG, 2001, S AFR J BOT, V67, P383, DOI 10.1016/S0254-6299(15)31153-4; Krauss KW, 2008, AQUAT BOT, V89, P105, DOI 10.1016/j.aquabot.2007.12.014; Krauss KW, 2006, HYDROBIOLOGIA, V569, P311, DOI 10.1007/s10750-006-0139-7; Lee SY, 2014, GLOBAL ECOL BIOGEOGR, V23, P726, DOI 10.1111/geb.12155; Lewis III RR, 2006, 5 STEPS SUCCESSFUL E; Lewis R.R., 2009, COASTAL WETLANDS INT, P787, DOI 10.1016/C2018-0-02302-6; Lewis RR, 2005, ECOL ENG, V24, P403, DOI 10.1016/j.ecoleng.2004.10.003; Marchand M., 2008, MANGROVE RESTORATION; Matsui N, 2010, WETL ECOL MANAG, V18, P233, DOI 10.1007/s11273-009-9162-6; Matthijs S., 1999, Mangroves and Salt Marshes, V3, P243, DOI 10.1023/A:1009971023277; MAZDA Y, 1995, HYDROBIOLOGIA, V295, P51, DOI 10.1007/BF00029110; MAzDA Y, 2007, ROLE PHYS PROCESSES; Mazda Yoshihiro, 2005, Wetlands Ecology and Management, V13, P647, DOI 10.1007/s11273-005-0613-4; Miyagi T, 2013, ISME MANGROVE ECOSYS, V6; Moore RD, 2009, GEOMORPHOLOGY, V103, P588, DOI 10.1016/j.geomorph.2008.08.003; Murdiyarso D, 2015, NAT CLIM CHANGE, V5, P1089, DOI [10.1038/nclimate2734, 10.1038/NCLIMATE2734]; Nam VN, 1999, IDENTIFYING PLANTS M; Polidoro BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010095; Primavera J. H., 2008, Wetlands Ecology and Management, V16, P345, DOI 10.1007/s11273-008-9101-y; Punwong P, 2013, PALAEOGEOGR PALAEOCL, V379, P54, DOI 10.1016/j.palaeo.2013.04.004; Punwong P, 2013, QUATERN INT, V298, P4, DOI 10.1016/j.quaint.2013.02.007; Richards DR, 2016, P NATL ACAD SCI USA, V113, P344, DOI 10.1073/pnas.1510272113; Samson MS, 2008, AMBIO, V37, P234, DOI 10.1579/0044-7447(2008)37[234:GPOPMI]2.0.CO;2; Sassi MG, 2012, J GEOPHYS RES-EARTH, V117, DOI 10.1029/2012JF002448; Shalisman A, 2014, IMPORTANCE UPTIME; Sidik AS, 2008, S CHIN SEA C 2008 S; Stevenson N J, 1999, INT PERSPECTIVE WETL, P277, DOI DOI 10.1007/978-94-011-4683-8_28; Storms JEA, 2005, SEDIMENT GEOL, V180, P149, DOI 10.1016/j.sedgeo.2005.08.003; Te Brake B, 2008, THESIS WAGENINGEN U; Tomlinson P.B., 1986, BOT MANGOVES; Tong PHS, 2004, INT J REMOTE SENS, V25, P4795, DOI 10.1080/01431160412331270858; Tri N, 2000, CAN GIO MANGROVE BIO; Tuan L. D., 2002, CAN GIO MANGROVE BIO; Tuan V., 2012, CAN GIO MANGROVE BIO; Valiela I, 2001, BIOSCIENCE, V51, P807, DOI 10.1641/0006-3568(2001)051[0807:MFOOTW]2.0.CO;2; Van der Lely C, 2012, THESIS WAGENINGEN U; van Loon AF, 2007, AQUAT BOT, V87, P80, DOI 10.1016/j.aquabot.2007.02.001; Van TT, 2015, ACTA OECOL, V63, P71, DOI 10.1016/j.actao.2014.11.007; Vietnam National Committee, 1998, CAN GIO MAN IN PRESS; Vogt J, 2013, GLOBAL PLANET CHANGE, V110, P249, DOI 10.1016/j.gloplacha.2011.09.002; Wassmann R, 2004, CLIMATIC CHANGE, V66, P89, DOI 10.1023/B:CLIM.0000043144.69736.b7; Watson J. G., 1928, MANGROVE FORESTS MAL, V6; Winterwerp JC, 2013, WETLANDS, V33, P515, DOI 10.1007/s13157-013-0409-x; WOLANSKI E, 1992, HYDROBIOLOGIA, V247, P141, DOI 10.1007/BF00008214; WOLANSKI E, 1980, AUST J MAR FRESH RES, V31, P431, DOI 10.1071/MF9800431; Wolanski E, 1993, TROPICAL MANGROVE EC, P43; Zaldivar-Jimenez M. A., 2010, Ecological Restoration, V28, P333; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248	82	27	27	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0150302	10.1371/journal.pone.0150302	http://dx.doi.org/10.1371/journal.pone.0150302			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008277	Green Published, gold, Green Submitted			2022-12-26	WOS:000372701200023
J	Tawara, S; Tatsumi, T; Iio, S; Kobayashi, I; Shigekawa, M; Hikita, H; Sakamori, R; Hiramatsu, N; Miyoshi, E; Takehara, T				Tawara, Seiichi; Tatsumi, Tomohide; Iio, Sadaharu; Kobayashi, Ichizou; Shigekawa, Minoru; Hikita, Hayato; Sakamori, Ryotaro; Hiramatsu, Naoki; Miyoshi, Eiji; Takehara, Tetsuo			Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA DEVELOPMENT; SIMPLE NONINVASIVE INDEX; VIRUS-INFECTION; NONCIRRHOTIC PATIENTS; INTERFERON THERAPY; PANCREATIC-CANCER; ALPHA-FETOPROTEIN; VIRAL-HEPATITIS; CLINICAL-USE; CELL-LINES	Fucosylated haptoglobin (Fuc-Hpt) and Mac-2 binding protein (Mac-2 bp) are identified as cancer biomarkers, based on the results from a glyco-proteomic analysis. Recently, we reported that these glyco-biomarkers were associated with liver fibrosis and/ or ballooning hepatocytes in patients with nonalcoholic fatty liver disease (NAFLD). We evaluated the ability of these glycoproteins to estimate liver fibrosis in 317 patients with chronic hepatitis C. We measured the serum Fuc-Hpt and Mac-2 bp levels using a lectin-antibody ELISA and ELISA, respectively. The serum levels of both Fuc-Hpt and Mac-2 bp increased with the progression of liver fibrosis. The multivariate analysis revealed that Mac-2 bp was an independent factor associated with moderate liver fibrosis (F >= 2). In contrast, Fuc-Hpt was an independent factor associated with advanced liver fibrosis (F >= 3). In terms of evaluating liver fibrosis, the serum levels of these glycomarkers were correlated with well-known liver fibrosis indexes, such as the aspartate aminotransferase to platelet ratio index (APRI) and Fibrosis-4 (FIB4) index. An assay that combined the APRI or FIB4 index and the Fuc-Hpt or Mac-2 bp levels increased the AUC value for diagnosing hepatic fibrosis. Interestingly, the cumulative incidence of hepatocellular carcinoma (HCC) was significantly higher in the patients with elevated serum levels of Fuc-Hpt and Mac-2 bp. In conclusion, both Fuc-Hpt and Mac-2 bp could be useful glyco-biomarkers of liver fibrosis and predictors of HCC in patients with chronic hepatitis C.	[Tawara, Seiichi; Tatsumi, Tomohide; Shigekawa, Minoru; Hikita, Hayato; Sakamori, Ryotaro; Hiramatsu, Naoki; Takehara, Tetsuo] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka, Japan; [Iio, Sadaharu] Hyogo Prefectural Nishinomiya Hosp, Dept Gastroenterol Med, Nishinomiya, Hyogo, Japan; [Kobayashi, Ichizou] Higashiosaka City Gen Hosp, Dept Gastroenterol Med, Higashiosaka, Osaka, Japan; [Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Suita, Osaka, Japan	Osaka University; Osaka University	Tatsumi, T; Takehara, T (corresponding author), Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka, Japan.	tatsumit@gh.med.osaka-u.ac.jp; takehara@gh.med.osaka-u.ac.jp	Sakamori, Ryotaro/B-4406-2014	Sakamori, Ryotaro/0000-0002-1580-607X	Ministry of Health, Labour and Welfare of Japan; Japan Agency for Medical Research and Development; Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for Research Program on Hepatitis from the Ministry of Health, Labour and Welfare of Japan, and Japan Agency for Medical Research and Development, and this study was supported by a research program of the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2015, J GASTROENTEROL, V50, P776, DOI 10.1007/s00535-014-1007-2; Asahina Y, 2013, HEPATOLOGY, V58, P1253, DOI 10.1002/hep.26442; Asazawa H, 2015, CLIN CHEM LAB MED, V53, P95, DOI 10.1515/cclm-2014-0427; Cooper S, 1999, IMMUNITY, V10, P439, DOI 10.1016/S1074-7613(00)80044-8; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; FREI A, 1984, HEPATOLOGY, V4, P830, DOI 10.1002/hep.1840040505; Grassadonia A, 2002, GLYCOCONJUGATE J, V19, P551, DOI 10.1023/B:GLYC.0000014085.00706.d4; Hadziyannis SJ, 2004, ANN INTERN MED, V140, P346, DOI 10.7326/0003-4819-140-5-200403020-00010; Hu JX, 2013, EXP THER MED, V5, P181, DOI 10.3892/etm.2012.768; Hu SX, 2009, J CLIN GASTROENTEROL, V43, P758, DOI 10.1097/MCG.0b013e31818be17c; Iacovazzi PA, 2008, IMMUNOPHARM IMMUNOT, V30, P687, DOI 10.1080/08923970802278177 ; Ichida F, 1996, INT HEPATOL COMMUN, V6, P112, DOI 10.1016/S0928-4346(96)00325-8; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Inohara H, 1996, CANCER RES, V56, P4530; Kamada Y, 2013, PROTEOM CLIN APPL, V7, P648, DOI 10.1002/prca.201200137; Kamada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066328; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lin ZH, 2011, HEPATOLOGY, V53, P726, DOI 10.1002/hep.24105; McCaughan GW, 2004, GUT, V53, P318, DOI 10.1136/gut.2003.026393; Miyoshi E, 2008, J BIOCHEM, V143, P725, DOI 10.1093/jb/mvn011; Nakagawa T, 2006, J BIOL CHEM, V281, P29797, DOI 10.1074/jbc.M605697200; Narisada M, 2008, BIOCHEM BIOPH RES CO, V377, P792, DOI 10.1016/j.bbrc.2008.10.061; Okuyama N, 2006, INT J CANCER, V118, P2803, DOI 10.1002/ijc.21728; Ozaki Y, 2002, CANCER, V95, P1954, DOI 10.1002/cncr.10899; Oze T, 2011, J GASTROENTEROL, V46, P944, DOI 10.1007/s00535-011-0403-0; Patel K, 2003, J GASTROEN HEPATOL, V18, P253, DOI 10.1046/j.1440-1746.2003.02930.x; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; Przybylo M, 2007, BBA-GEN SUBJECTS, V1770, P1427, DOI 10.1016/j.bbagen.2007.05.006; Sasaki T, 1998, EMBO J, V17, P1606, DOI 10.1093/emboj/17.6.1606; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Tamaki N, 2014, J GASTROENTEROL, V49, P1495, DOI 10.1007/s00535-013-0914-y; Tateyama M, 2011, J GASTROENTEROL, V46, P92, DOI 10.1007/s00535-010-0293-6; Toshima T, 2015, J GASTROENTEROL, V50, P76, DOI 10.1007/s00535-014-0946-y; Toyoda H, 2015, J GASTROEN HEPATOL, V30, P1183, DOI 10.1111/jgh.12915; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; YAMADA S, 1992, CLIN BIOCHEM, V25, P467, DOI 10.1016/0009-9120(92)90150-Q; Yamasaki K, 2014, HEPATOLOGY, V60, P1563, DOI 10.1002/hep.27305; Yoshida H, 1999, ANN INTERN MED, V131, P174, DOI 10.7326/0003-4819-131-3-199908030-00003	38	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151828	10.1371/journal.pone.0151828	http://dx.doi.org/10.1371/journal.pone.0151828			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002630	Green Published, Green Submitted, gold			2022-12-26	WOS:000372697400049
J	Errahhali, ME; Errahhali, ME; Abda, N; Bellaoui, M				Errahhali, Manal Elidrissi; Errahhali, Mounia Elidrissi; Abda, Naima; Bellaoui, Mohammed			Exploring Geographic Variability in Cancer Prevalence in Eastern Morocco: A Retrospective Study over Eight Years	PLOS ONE			English	Article							SOUTH-WALES AUSTRALIA; MAMMOGRAPHY USE; PROSTATE-CANCER; TRENDS; CHINA	Background Malignant diseases have been believed to be more common in some areas of Eastern Morocco, but until now, cancer patterns have not been reported for this region. In this paper we present for the first time the cancer prevalence analysis in Eastern Morocco. Methods Cross-sectional study carried out among all patients diagnosed and/or treated with cancer at the Hassan II Regional Oncology Center (ROC) since it was established in October 2005 until December 2012. The ROC is the only hospital specialized in cancer care in Eastern Morocco. Results A total of 8,508 cases of cancer were registered among residents in Eastern Morocco, with a female to male ratio of 2.1. The mean age at diagnosis was 53.9 +/- 15.2 years (median age = 53 years). Thus, unlike in Western countries, cancer in Eastern Morocco afflicts younger population. The areas of Eastern Morocco did not differ significantly by mean age at diagnosis (p = 0.061). However, these regions differed significantly by sex ratio (p < 0.001). The highest sex ratio was observed in Figuig, with a female to male ratio of 3.1 (75.4% of the registered case were females), followed respectively by Taourirt, Oujda-Angad, Berkane, Nador-Driouch and Jerada. Clear variation in the distribution of cancer types between areas of Eastern Morocco was observed, both in males and females (p < 0.001). Furthermore, the areas of Eastern Morocco differed significantly by cancer prevalence (p < 0.001). The highest age-standardized five-year prevalence proportion was observed in Oujda-Angad with 420.2 per 100,000, followed respectively by Berkane (311.4), Jerada (287.8), Taourirt (269.3), Nador-Driouch (213.6) and Figuig (194.4). Trends in the five-year prevalence proportions decreased in Oujda-Angad, Berkane and Jerada throughout the study period, while an increasing trend was observed in Nador-Driouch, Taourirt and Figuig. Conclusions For the first time, our study presents the pattern and distribution of diagnosed cancers in Eastern Morocco. Our study illustrates substantial differences in cancer patterns between areas of Eastern Morocco. These findings are important for cancer control and highlight the need to develop program aiming at controlling and preventing the spread of major cancer sites in Eastern Morocco, particularly in areas with increased cancer prevalence rates.	[Errahhali, Manal Elidrissi; Errahhali, Mounia Elidrissi; Abda, Naima; Bellaoui, Mohammed] Univ Mohammed First, Fac Med & Pharm Oujda, Med Biol Unit, Oujda, Morocco	Mohammed First University of Oujda	Bellaoui, M (corresponding author), Univ Mohammed First, Fac Med & Pharm Oujda, Med Biol Unit, Oujda, Morocco.	bmbellaoui@gmail.com		Bellaoui, Mohammed/0000-0001-7508-4550; Abda, Naima/0000-0002-6702-4977				Baade PD, 2013, PROSTATE INT, V1, P47, DOI 10.12954/PI.12014; Bouchbika Z, 2013, PAN AFR MED J, V16, DOI 10.11604/pamj.2013.16.31.2791; Bray F, 2013, INT J CANCER, V132, P1133, DOI 10.1002/ijc.27711; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Chen JG, 2006, INT J CANCER, V119, P1447, DOI 10.1002/ijc.21952; Corrarino JE, 2015, JNP-J NURSE PRACT, V11, P790, DOI 10.1016/j.nurpra.2015.05.016; Crocetti E, 2013, BRIT J CANCER, V109, P219, DOI 10.1038/bjc.2013.311; Curado MP, 2007, CANC INCIDENCE 5 CON, VIX; DPRF, 2014, SANT CHIFFR 2012; Ellison LF, 2012, HLTH REP, V23, pB1; Engholm G, 2010, ACTA ONCOL, V49, P725, DOI 10.3109/02841861003782017; Engholm GFJ, 2015, NORDCAN CANC INCIDEN; Esteve J, 1994, IARC Sci Publ, P1; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fritz AG., 2000, INT CLASSIFICATION D, V3rd; Guzzinati S, 2012, CANCER CAUSE CONTROL, V23, P1497, DOI 10.1007/s10552-012-0025-8; Han B, 2003, J AM GERIATR SOC, V51, P203, DOI 10.1046/j.1532-5415.2003.51059.x; HCP, 2012, MON REG E MOR 2012; IARC UK CR, 2014, WORLD CANC FACTSH; *INT AG RES CANC, 2012, GLOBOCAN 2012; John U, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1807-7; Kapp JM, 2009, BREAST CANCER RES TR, V113, P327, DOI 10.1007/s10549-008-9919-2; Lam JO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146185; Lee DS, 2007, EXPERT OPIN THER TAR, V11, P757, DOI 10.1517/14728222.11.6.757; Linn Mary Morse, 2007, Urol Nurs, V27, P481; Maddams J, 2012, BRIT J CANCER, V107, P1195, DOI 10.1038/bjc.2012.366; Micheli A, 2002, ANN ONCOL, V13, P840, DOI 10.1093/annonc/mdf127; Missaoui N, 2010, INT J CANCER, V127, P2669, DOI 10.1002/ijc.25490; Nahar Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107675; Percy C., 1990, INT CLASSIFICATION D; Sahraoui S, 2013, INT RES J, V1, P35; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Stewart B. W., 2003, World Cancer Report; Tazi MA, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.338; Vineis P, 2014, LANCET, V383, P549, DOI 10.1016/S0140-6736(13)62224-2; Yu XQ, 2015, CANCER EPIDEMIOL, V39, P534, DOI 10.1016/j.canep.2015.05.007; Yu XQ, 2015, CANCER EPIDEMIOL, V39, P29, DOI 10.1016/j.canep.2014.11.009; Zheng RS, 2016, CANCER LETT, V370, P33, DOI 10.1016/j.canlet.2015.10.003	39	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151987	10.1371/journal.pone.0151987	http://dx.doi.org/10.1371/journal.pone.0151987			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998751	gold, Green Published, Green Submitted			2022-12-26	WOS:000372694700090
J	Poupel, O; Moyat, M; Groizeleau, J; Antunes, LCS; Gribaldo, S; Msadek, T; Dubrac, S				Poupel, Olivier; Moyat, Mati; Groizeleau, Julie; Antunes, Luisa C. S.; Gribaldo, Simonetta; Msadek, Tarek; Dubrac, Sarah			Transcriptional Analysis and Subcellular Protein Localization Reveal Specific Features of the Essential WalKR System in Staphylococcus aureus	PLOS ONE			English	Article							YYCFG 2-COMPONENT SYSTEM; SENSOR HISTIDINE KINASE; SIGNAL-TRANSDUCTION PATHWAY; GRAM-POSITIVE BACTERIA; STREPTOCOCCUS-PNEUMONIAE R6; BACILLUS-SUBTILIS; LISTERIA-MONOCYTOGENES; RESPONSE-REGULATOR; ESCHERICHIA-COLI; CELL-DIVISION	The WalKR two-component system, controlling cell wall metabolism, is highly conserved among Bacilli and essential for cell viability. In Staphylococcus aureus, walR and walK are followed by three genes of unknown function: walH, walI and walJ. Sequence analysis and transcript mapping revealed a unique genetic structure for this locus in S. aureus: the last gene of the locus, walJ, is transcribed independently, whereas transcription of the tetra-cistronic walRKHI operon occurred from two independent promoters located upstream from walR. Protein topology analysis and protein-protein interactions in E. coli as well as subcellular localization in S. aureus allowed us to show that WalH and WalI are membrane-bound proteins, which associate with WalK to form a complex at the cell division septum. While these interactions suggest that WalH and WalI play a role in activity of the WalKR regulatory pathway, deletion of walH and/or walI did not have a major effect on genes whose expression is strongly dependent on WalKR or on associated phenotypes. No effect of WalH or WalI was seen on tightly controlled WalKR regulon genes such as sle1 or saouhsc_00773, which encodes a CHAP-domain amidase. Of the genes encoding the two major S. aureus autolysins, AtlA and Sle1, only transcription of atlA was increased in the Delta walH or Delta walI mutants. Likewise, bacterial autolysis was not increased in the absence of WalH and/or WalI and biofilm formation was lowered rather than increased. Our results suggest that contrary to their major role as WalK inhibitors in B. subtilis, the WalH and WalI proteins have evolved a different function in S. aureus, where they are more accessory. A phylogenomic analysis shows a striking conservation of the 5 gene wal cluster along the evolutionary history of Bacilli, supporting the key importance of this signal transduction system, and indicating that the walH and walI genes were lost in the ancestor of Streptococcaceae, leading to their atypical 3 wal gene cluster, walRKJ.	[Poupel, Olivier; Moyat, Mati; Groizeleau, Julie; Msadek, Tarek; Dubrac, Sarah] Inst Pasteur, Biol Gram Posit Pathogens, Dept Microbiol, Paris, France; [Poupel, Olivier; Moyat, Mati; Groizeleau, Julie; Msadek, Tarek; Dubrac, Sarah] CNRS, ERL3526, Paris, France; [Antunes, Luisa C. S.; Gribaldo, Simonetta] Inst Pasteur, Mol Biol Gene Extremophiles, Dept Microbiol, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Msadek, T; Dubrac, S (corresponding author), Inst Pasteur, Biol Gram Posit Pathogens, Dept Microbiol, Paris, France.; Msadek, T; Dubrac, S (corresponding author), CNRS, ERL3526, Paris, France.	tmsadek@pasteur.fr; sdubrac@pasteur.fr	gribaldo, simonetta/AAW-4377-2020	gribaldo, simonetta/0000-0002-7662-021X; Sarah, Dubrac/0000-0002-9810-5390; Moyat, Mati/0000-0002-9233-5320	Institut Pasteur Transversal Research Program [336]; Agence Nationale de la Recherche [ANR-09-MIEN-0010 GRABIRON, ANR-08-ALIA-0011 NABAB]	Institut Pasteur Transversal Research Program; Agence Nationale de la Recherche(French National Research Agency (ANR))	Support was provided by Institut Pasteur Transversal Research Program No. 336 [http://www.pasteur.fr]; Agence Nationale de la Recherche, Grant ANR-08-ALIA-0011 NABAB [http://www.agencenationale-recherche.fr/]; and Agence Nationale de la Recherche, Grant ANR-09-MIEN-0010 GRABIRON [http://www.agence-nationale-recherche.fr/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyev MF, 1999, J MOL BIOL, V285, P1503, DOI 10.1006/jmbi.1998.2412; Archambaud C, 2005, MOL MICROBIOL, V56, P383, DOI 10.1111/j.1365-2958.2005.04551.x; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Beaume M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010725; Beltrame CO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138924; Biller SJ, 2011, J BACTERIOL, V193, P896, DOI 10.1128/JB.00594-10; Bisicchia P, 2007, MOL MICROBIOL, V65, P180, DOI 10.1111/j.1365-2958.2007.05782.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Charpentier E, 2004, APPL ENVIRON MICROB, V70, P6076, DOI 10.1128/AEM.70.10.6076-6085.2004; Criscuolo A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-210; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Dautin N, 2000, J BACTERIOL, V182, P7060, DOI 10.1128/JB.182.24.7060-7066.2000; Delaune A, 2012, INFECT IMMUN, V80, P3438, DOI 10.1128/IAI.00195-12; Delaune A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017054; Dhiman A, 2015, BIOCHEM BIOPH RES CO, V459, P623, DOI 10.1016/j.bbrc.2015.02.159; Dubrac S, 2004, J BACTERIOL, V186, P1175, DOI 10.1128/JB.186.4.1175-1181.2004; Dubrac S, 2008, ADV EXP MED BIOL, V631, P214, DOI 10.1007/978-0-387-78885-2_15; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; Dubrac S, 2008, MOL MICROBIOL, V70, P1307, DOI 10.1111/j.1365-2958.2008.06483.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Even S, 2006, J BACTERIOL, V188, P2184, DOI 10.1128/JB.188.6.2184-2197.2006; Falord M, 2012, ANTIMICROB AGENTS CH, V56, P1047, DOI 10.1128/AAC.05054-11; Falord M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021323; Fukuchi K, 2000, MICROBIOL-UK, V146, P1573, DOI 10.1099/00221287-146-7-1573; Fukushima T, 2008, MOL MICROBIOL, V69, P621, DOI 10.1111/j.1365-2958.2008.06308.x; Fukushima T, 2011, MOL MICROBIOL, V79, P503, DOI 10.1111/j.1365-2958.2010.07464.x; Gardete S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002505; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Herbert S, 2010, INFECT IMMUN, V78, P2877, DOI 10.1128/IAI.00088-10; Hiron A, 2011, MOL MICROBIOL, V81, P602, DOI 10.1111/j.1365-2958.2011.07735.x; Howden BP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002359; Jansen A, 2007, INT J MED MICROBIOL, V297, P205, DOI 10.1016/j.ijmm.2007.02.002; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kajimura J, 2005, MOL MICROBIOL, V58, P1087, DOI 10.1111/j.1365-2958.2005.04881.x; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Karimova G, 2009, J BACTERIOL, V191, P333, DOI 10.1128/JB.00331-08; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Martin PK, 1999, J BACTERIOL, V181, P3666, DOI 10.1128/JB.181.12.3666-3673.1999; McEvoy CRE, 2013, ANTIMICROB AGENTS CH, V57, P3240, DOI 10.1128/AAC.00279-13; Miller JH., 1972, EXPT MOL GENETICS; Mwangi MM, 2007, P NATL ACAD SCI USA, V104, P9451, DOI 10.1073/pnas.0609839104; Ng WL, 2005, J BACTERIOL, V187, P7444, DOI 10.1128/JB.187.21.7444-7459.2005; Ng WL, 2004, MICROBIOL-SGM, V150, P3096, DOI 10.1099/mic.0.27550-0; Ng WL, 2004, MOL MICROBIOL, V53, P1161, DOI 10.1111/j.1365-2958.2004.04196.x; Ng WL, 2003, MOL MICROBIOL, V50, P1647, DOI 10.1046/j.1365-2958.2003.03806.x; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Pontinen A, 2015, APPL ENVIRON MICROB, V81, P3994, DOI 10.1128/AEM.00626-15; RAYCHAUDHURI D, 1985, J BACTERIOL, V164, P1337, DOI 10.1128/JB.164.3.1337-1349.1985; SABELNIKOV AG, 1995, J MOL BIOL, V250, P144, DOI 10.1006/jmbi.1995.0366; Santelli E, 2007, J BACTERIOL, V189, P3290, DOI 10.1128/JB.01937-06; Sastalla I, 2009, APPL ENVIRON MICROB, V75, P2099, DOI 10.1128/AEM.02066-08; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Senadheera MD, 2007, J BACTERIOL, V189, P1451, DOI 10.1128/JB.01161-06; Shoji M, 2011, ANTIMICROB AGENTS CH, V55, P3870, DOI 10.1128/AAC.01563-10; Sleator RD, 2005, CLIN MICROBIOL INFEC, V11, P599, DOI 10.1111/j.1469-0691.2005.01176.x; Stack HM, 2005, APPL ENVIRON MICROB, V71, P4241, DOI 10.1128/AEM.71.8.4241-4247.2005; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; SULLIVAN MA, 1984, GENE, V29, P21, DOI 10.1016/0378-1119(84)90161-6; Szurmant H, 2006, PROTEIN SCI, V15, P929, DOI 10.1110/ps.052064406; Szurmant H, 2005, J BACTERIOL, V187, P5419, DOI 10.1128/JB.187.15.5419-5426.2005; Szurmant H, 2008, P NATL ACAD SCI USA, V105, P5891, DOI 10.1073/pnas.0800247105; Szurmant H, 2007, J BACTERIOL, V189, P3280, DOI 10.1128/JB.01936-06; Takahashi J, 2002, MICROBIOL IMMUNOL, V46, P601, DOI 10.1111/j.1348-0421.2002.tb02741.x; Turck M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030403; Vidaillac C, 2013, J INFECT DIS, V208, P67, DOI 10.1093/infdis/jit127; Wagner C, 2002, INFECT IMMUN, V70, P6121, DOI 10.1128/IAI.70.11.6121-6128.2002; Wang LS, 2004, NUCLEIC ACIDS RES, V32, P3689, DOI 10.1093/nar/gkh694; Yang HJ, 2013, DNA REPAIR, V12, P334, DOI 10.1016/j.dnarep.2013.02.002; Yang HJ, 2011, DNA REPAIR, V10, P1121, DOI 10.1016/j.dnarep.2011.08.009; Yang HJ, 2011, MOL MICROBIOL, V79, P1276, DOI 10.1111/j.1365-2958.2011.07519.x	71	16	16	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151449	10.1371/journal.pone.0151449	http://dx.doi.org/10.1371/journal.pone.0151449			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999783	Green Published, gold			2022-12-26	WOS:000372694700042
J	D'Brot, A; Kurtz, P; Regan, E; Jakubowski, B; Abrams, JM				D'Brot, A.; Kurtz, P.; Regan, E.; Jakubowski, B.; Abrams, J. M.			A platform for interrogating cancer-associated p53 alleles This article has been corrected since Advance Online Publication and a corrigendum is also printed in this issue	ONCOGENE			English	Article							MUTANT P53; DROSOPHILA-MELANOGASTER; NUCLEAR-BODIES; MOUSE MODELS; CELL-DEATH; GAIN; PROTEIN; ACTIVATION; APOPTOSIS; NETWORK	p53 is the most frequently mutated gene in human cancer. Compelling evidence argues that full transformation involves loss of growth suppression encoded by wild-type p53 together with poorly understood oncogenic activity encoded by missense mutations. Furthermore, distinguishing disease alleles from natural polymorphisms is an important clinical challenge. To interrogate the genetic activity of human p53 variants, we leveraged the Drosophila model as an in vivo platform. We engineered strains that replace the fly p53 gene with human alleles, producing a collection of stocks that are, in effect, 'humanized' for p53 variants. Like the fly counterpart, human p53 transcriptionally activated a biosensor and induced apoptosis after DNA damage. However, all humanized strains representing common alleles found in cancer patients failed to complement in these assays. Surprisingly, stimulus-dependent activation of hp53 occurred without stabilization, demonstrating that these two processes can be uncoupled. Like its fly counterpart, hp53 formed prominent nuclear foci in germline cells but cancer-associated p53 variants did not. Moreover, these same mutant alleles disrupted hp53 foci and inhibited biosensor activity, suggesting that these properties are functionally linked. Together these findings establish a functional platform for interrogating human p53 alleles and suggest that simple phenotypes could be used to stratify disease variants.	[D'Brot, A.; Kurtz, P.; Abrams, J. M.] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA; [Regan, E.] Univ Texas Southwestern Med Ctr Dallas, Dept Phys Therapy, Dallas, TX 75390 USA; [Jakubowski, B.] Univ Texas Southwestern Med Ctr Dallas, Southwestern Med Sch, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Abrams, JM (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	john.abrams@utsouthwestern.edu		D'Brot, Alejandro/0000-0002-9885-0702	NIH [GM072124, GM115682, S10 RR029731-01]; Welch Foundation [1-1865]; Ellison Medical Foundation; CPRIT [RP110076]; NRSA [F31 GM108472-03]; NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029731] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM108472, R01GM072124, R56GM072124, R01GM115682] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); Ellison Medical Foundation(Lawrence Ellison Foundation); CPRIT; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge Melissa O'neal for help cloning constructs for humanized lines and Akash Patel for help with crosses to make humanized lines. We are grateful to Anne Dejean for the dSmt3/dSUMO antibody and to Michael Buszczak for the coilin and Ism11 antibodies. We thank Kate Luby-Phelps, Abhijit Bugde and the Live Cell Imaging Facility at UT Southwestern for help with confocal imaging, deconvolution and Imaris. We also thank Po Chen, Nichole Link, Annika Wylie, Gianella Garcia-Hughes, Mike Buszczak, Robin Hiesinger and Helmut Kramer for discussion, advice and comments. This work was supported by the NIH (GM072124) and (GM115682), the Welch Foundation (1-1865), the Ellison Medical Foundation and CPRIT (RP110076) as well as NRSA (F31 GM108472-03) to Paula Kurtz and NIH (S10 RR029731-01) to Kate Luby-Phelps.	ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Abrams JM, 2002, CELL, V110, P403, DOI 10.1016/S0092-8674(02)00904-2; Akdemir F, 2007, ONCOGENE, V26, P5184, DOI 10.1038/sj.onc.1210328; Attrill H, 2016, NUCLEIC ACIDS RES, V44, pD786, DOI 10.1093/nar/gkv1046; Bom APDA, 2012, J BIOL CHEM, V287, P28152, DOI 10.1074/jbc.M112.340638; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Brooks CL, 2010, CELL RES, V20, P614, DOI 10.1038/cr.2010.53; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Fogal V, 2000, EMBO J, V19, P6185, DOI 10.1093/emboj/19.22.6185; Freed-Pastor WA, 2012, GENE DEV, V26, P1268, DOI 10.1101/gad.190678.112; Freed-Pastor WA, 2012, CELL, V148, P244, DOI 10.1016/j.cell.2011.12.017; Godfrey AC, 2009, RNA, V15, P1661, DOI 10.1261/rna.1518009; Hanel W, 2013, CELL DEATH DIFFER, V20, P898, DOI 10.1038/cdd.2013.17; Haupt S, 2009, CANCER RES, V69, P4818, DOI 10.1158/0008-5472.CAN-08-4010; Joerger AC, 2007, ONCOGENE, V26, P2226, DOI 10.1038/sj.onc.1210291; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Lehembre F, 2000, MOL CELL BIOL, V20, P1072, DOI 10.1128/MCB.20.3.1072-1082.2000; Liu JL, 2009, MOL BIOL CELL, V20, P1661, DOI 10.1091/mbc.E08-05-0525; Lu WJ, 2010, SCIENCE, V328, P1278, DOI 10.1126/science.1185640; Lu WJ, 2009, NAT REV CANCER, V9, P758, DOI 10.1038/nrc2732; Lubin R, 1995, CLIN CANCER RES, V1, P1463; Mauri F, 2008, J BIOL CHEM, V283, P20848, DOI 10.1074/jbc.M710186200; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; Monk AC, 2012, CELL TISSUE RES, V350, P385, DOI 10.1007/s00441-012-1479-4; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Quon KC, 2001, GENE DEV, V15, P2917, DOI 10.1101/gad.949001; Schoborg T, 2013, J CELL BIOL, V202, P261, DOI 10.1083/jcb.201304181; Schumacher B, 2005, CELL, V120, P357, DOI 10.1016/j.cell.2004.12.009; Soussi T, 2007, ONCOGENE, V26, P2145, DOI 10.1038/sj.onc.1210280; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Tritarelli A, 2004, MOL BIOL CELL, V15, P3751, DOI 10.1091/mbc.E03-12-0900; Valente LJ, 2013, CELL REP, V3, P1339, DOI 10.1016/j.celrep.2013.04.012; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wei QX, 2012, NAT PROTOC, V7, P1145, DOI 10.1038/nprot.2012.042; Wong KB, 1999, P NATL ACAD SCI USA, V96, P8438, DOI 10.1073/pnas.96.15.8438; Wylie A, 2014, ELIFE, V3, DOI 10.7554/eLife.01530; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; Yamaguchi M, 1999, ONCOGENE, V18, P6767, DOI 10.1038/sj.onc.1203113	42	8	8	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 12	2017	36	2					286	291		10.1038/onc.2016.48	http://dx.doi.org/10.1038/onc.2016.48			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EK5AA	26996664	Green Accepted			2022-12-26	WOS:000393938100013
J	McGarvey, JC; Xiao, KH; Bowman, SL; Mamonova, T; Zhang, QM; Bisello, A; Sneddon, WB; Ardura, JA; Jean-Alphonse, F; Vilardaga, JP; Puthenveedu, MA; Friedman, PA				McGarvey, Jennifer C.; Xiao, Kunhong; Bowman, Shanna L.; Mamonova, Tatyana; Zhang, Qiangmin; Bisello, Alessandro; Sneddon, W. Bruce; Ardura, Juan A.; Jean-Alphonse, Frederic; Vilardaga, Jean-Pierre; Puthenveedu, Manojkumar A.; Friedman, Peter A.			Actin-Sorting Nexin 27 (SNX27)-Retromer Complex Mediates Rapid Parathyroid Hormone Receptor Recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endosome; G protein-coupled receptor (GPCR); parathyroid hormone; receptor recycling; sorting nexin (SNX)	PROTEIN-COUPLED RECEPTOR; ETHYLMALEIMIDE-SENSITIVE FACTOR; PDZ-DOMAIN; MOLECULAR-DYNAMICS; RETROMER COMPLEX; TRAFFICKING; MEMBRANE; BINDING; INTERNALIZATION; PTH	The G protein-coupled parathyroid hormone receptor (PTHR) regulates mineral-ion homeostasis and bone remodeling. Upon parathyroid hormone (PTH) stimulation, the PTHR internalizes into early endosomes and subsequently traffics to the retromer complex, a sorting platform on early endosomes that promotes recycling of surface receptors. The C terminus of the PTHR contains a type I PDZ ligand that binds PDZ domain-containing proteins. Mass spectrometry identified sorting nexin 27 (SNX27) in isolated endosomes as a PTHR binding partner. PTH treatment enriched endosomal PTHR. SNX27 contains a PDZ domain and serves as a cargo selector for the retromer complex. VPS26, VPS29, and VPS35 retromer subunits were isolated with PTHR in endosomes from cells stimulated with PTH. Molecular dynamics and protein binding studies establish that PTHR and SNX27 interactions depend on the PDZ recognition motif in PTHR and the PDZ domain of SNX27. Depletion of either SNX27 or VPS35 or actin depolymerization decreased the rate of PTHR recycling following agonist stimulation. Mutating the PDZ ligand of PTHR abolished the interaction with SNX27 but did not affect the overall rate of recycling, suggesting that PTHR may directly engage the retromer complex. Coimmunoprecipitation and overlay experiments show that both intact and mutated PTHR bind retromer through the VPS26 protomer and sequentially assemble a ternary complex with PTHR and SNX27. SNX27-independent recycling may involve N-ethylmaleimide-sensitive factor, which binds both PDZ intact and mutant PTHRs. We conclude that PTHR recycles rapidly through at least two pathways, one involving the ASRT complex of actin, SNX27, and retromer and another possibly involving N-ethylmaleimide-sensitive factor.	[McGarvey, Jennifer C.; Xiao, Kunhong; Mamonova, Tatyana; Zhang, Qiangmin; Bisello, Alessandro; Sneddon, W. Bruce; Ardura, Juan A.; Jean-Alphonse, Frederic; Vilardaga, Jean-Pierre; Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Lab GPCR Biol, Pittsburgh, PA 15261 USA; [Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15261 USA; [Bowman, Shanna L.; Puthenveedu, Manojkumar A.] Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA; [Ardura, Juan A.] San Pablo CEU Univ, Sch Med, Madrid 28668, Spain	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University; San Pablo CEU University	Friedman, PA (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, E1356 Thomas E Starzl Biomed Sci Tower,200 Lothro, Pittsburgh, PA 15261 USA.	paf10@pitt.edu	Ardura, Juan Antonio/F-3378-2017; Puthenveedu, Manojkumar A/A-3795-2016; Xiao, Kunhong/AAG-4275-2020	Ardura, Juan Antonio/0000-0002-2827-3364; Xiao, Kunhong/0000-0002-1069-1226; McGarvey, Jennifer/0000-0001-8782-267X; Vilardaga, Jean-Pierre/0000-0002-1217-1435; JEAN-ALPHONSE, Frederic/0000-0002-7380-5825	National Institutes of Health [DK069998, DK054171, DK105811, DK087688, GM117425, DK102495]; National Science Foundation [1517776]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105811, R01DK102495, R01DK069998, R01DK087688, R01DK054171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants DK069998, DK054171, and DK105811 (to P. A. F.); DK087688 and GM117425 (to M. A. P.); and DK102495 (to J. P. V.). This work was also supported by National Science Foundation Grant 1517776 (to M. A. P.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alonso V, 2013, MOL ENDOCRINOL, V27, P558, DOI 10.1210/me.2012-1404; Alonso V, 2011, J BONE MINER RES, V26, P2923, DOI 10.1002/jbmr.494; Ardura JA, 2011, J BIOL CHEM, V286, P35020, DOI 10.1074/jbc.M111.264978; Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Balana B, 2011, P NATL ACAD SCI USA, V108, P5831, DOI 10.1073/pnas.1018645108; Bauch C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088529; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bowman SL, 2015, METHOD CELL BIOL, V130, P333, DOI 10.1016/bs.mcb.2015.05.007; Bowman SL, 2015, CELL REP, V10, P1925, DOI 10.1016/j.celrep.2015.02.045; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Case D, 2006, AMBER 9; Case D.A., 2022, AMBER 2020; Chan ASM, 2016, MOL BIOL CELL, V27, P1367, DOI 10.1091/mbc.E15-12-0851; Chaudhary S, 2012, NAT PROTOC, V7, P453, DOI 10.1038/nprot.2011.453; Chauvin S, 2002, MOL ENDOCRINOL, V16, P2720, DOI 10.1210/me.2002-0049; Cheloha RW, 2015, NAT REV ENDOCRINOL, V11, P712, DOI 10.1038/nrendo.2015.139; Cong M, 2001, J BIOL CHEM, V276, P45145, DOI 10.1074/jbc.M106087200; Conway RR, 2001, J CELL PHYSIOL, V189, P341, DOI 10.1002/jcp.10028; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Derivery E, 2009, DEV CELL, V17, P712, DOI 10.1016/j.devcel.2009.09.010; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Feinstein TN, 2013, J BIOL CHEM, V288, P27849, DOI 10.1074/jbc.M112.445098; Feinstein TN, 2011, NAT CHEM BIOL, V7, P278, DOI 10.1038/nchembio.545; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Ferrari SL, 1999, J BIOL CHEM, V274, P29968, DOI 10.1074/jbc.274.42.29968; Gage RM, 2005, J BIOL CHEM, V280, P3305, DOI 10.1074/jbc.M406934200; Gallon M, 2014, P NATL ACAD SCI USA, V111, pE3604, DOI 10.1073/pnas.1410552111; Garrido JL, 2009, MOL ENDOCRINOL, V23, P2048, DOI 10.1210/me.2008-0436; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Ghai R, 2013, P NATL ACAD SCI USA, V110, pE643, DOI 10.1073/pnas.1216229110; Ghai R, 2011, P NATL ACAD SCI USA, V108, P7763, DOI 10.1073/pnas.1017110108; Gidon A, 2014, NAT CHEM BIOL, V10, P707, DOI [10.1038/NCHEMBIO.1589, 10.1038/nchembio.1589]; Gomez TS, 2009, DEV CELL, V17, P699, DOI 10.1016/j.devcel.2009.09.009; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Haft CR, 2000, MOL BIOL CELL, V11, P4105, DOI 10.1091/mbc.11.12.4105; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Harbour ME, 2010, J CELL SCI, V123, P3703, DOI 10.1242/jcs.071472; Helfer E, 2013, BIOL CELL, V105, P191, DOI 10.1111/boc.201200038; Hierro A, 2007, NATURE, V449, P1063, DOI 10.1038/nature06216; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; HUANG ZM, 1995, J BIOL CHEM, V270, P151, DOI 10.1074/jbc.270.1.151; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Kahsai AW, 2014, NAT PROTOC, V9, P1301, DOI 10.1038/nprot.2014.075; Kotowski SJ, 2011, NEURON, V71, P278, DOI 10.1016/j.neuron.2011.05.036; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Lee S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10939; Lin TB, 2015, J NEUROSCI, V35, P14943, DOI 10.1523/JNEUROSCI.2587-15.2015; Linardopoulou EV, 2007, PLOS GENET, V3, P2477, DOI 10.1371/journal.pgen.0030237; Mahon MJ, 2009, MOL ENDOCRINOL, V23, P1691, DOI 10.1210/me.2009-0164; Mayle KM, 2012, BBA-GEN SUBJECTS, V1820, P264, DOI 10.1016/j.bbagen.2011.09.009; Miesenbock Gero, 2012, Cold Spring Harb Protoc, V2012, P213, DOI 10.1101/pdb.ip067827; Nakagawa T, 2013, J MEMBRANE BIOL, V246, P571, DOI 10.1007/s00232-013-9571-6; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Peng Y, 2014, PROTEOM CLIN APPL, V8, P554, DOI 10.1002/prca.201400043; Puthenveedu MA, 2010, CELL, V143, P761, DOI 10.1016/j.cell.2010.10.003; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; Rojas R, 2007, MOL CELL BIOL, V27, P1112, DOI 10.1128/MCB.00156-06; Romero G, 2011, ADV PHARMACOL, V62, P279, DOI 10.1016/B978-0-12-385952-5.00003-8; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Ryu JK, 2015, SCIENCE, V347, P1485, DOI 10.1126/science.aaa5267; Seaman MNJ, 2012, J CELL SCI, V125, P4693, DOI 10.1242/jcs.103440; Shi H, 2006, NAT STRUCT MOL BIOL, V13, P540, DOI 10.1038/nsmb1103; Sneddon WB, 2004, ENDOCRINOLOGY, V145, P2815, DOI 10.1210/en.2003-1185; Sneddon WB, 2003, J BIOL CHEM, V278, P43787, DOI 10.1074/jbc.M306019200; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Srivastava A, 2015, TRENDS ENDOCRIN MET, V26, P628, DOI 10.1016/j.tem.2015.09.001; Steinberg F, 2013, NAT CELL BIOL, V15, P461, DOI 10.1038/ncb2721; Syme CA, 2005, J BIOL CHEM, V280, P11281, DOI 10.1074/jbc.M413393200; Tawfeek HAW, 2004, AM J PHYSIOL-ENDOC M, V286, pE704, DOI 10.1152/ajpendo.00404.2003; Tawfeek HAW, 2002, MOL ENDOCRINOL, V16, P1, DOI 10.1210/me.16.1.1; Temkin P, 2011, NAT CELL BIOL, V13, P715, DOI 10.1038/ncb2252; Tsvetanova NG, 2015, J BIOL CHEM, V290, P6689, DOI 10.1074/jbc.R114.617951; Tsvetanova NG, 2014, NAT CHEM BIOL, V10, P1061, DOI 10.1038/nchembio.1665; Valdes JL, 2011, J BIOL CHEM, V286, P39403, DOI 10.1074/jbc.M111.260802; van Dam EM, 2002, J BIOL CHEM, V277, P48876, DOI 10.1074/jbc.M206271200; van Weering JRT, 2014, SEMIN CELL DEV BIOL, V31, P40, DOI 10.1016/j.semcdb.2014.03.015; Vilardaga JP, 2014, NAT CHEM BIOL, V10, P700, DOI [10.1038/nchembio.1611, 10.1038/NCHEMBIO.1611]; Vilardaga JP, 2011, CELL MOL LIFE SCI, V68, P1, DOI 10.1007/s00018-010-0465-9; Vilardaga JP, 2002, J BIOL CHEM, V277, P8121, DOI 10.1074/jbc.M110433200; Vistein R, 2013, P NATL ACAD SCI USA, V110, P15289, DOI 10.1073/pnas.1306340110; Walther C, 2013, PROG MOL BIOL TRANSL, V118, P93, DOI 10.1016/B978-0-12-394440-5.00004-8; Wang B, 2008, MOL BIOL CELL, V19, P1637, DOI 10.1091/mbc.E07-11-1114; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang YY, 2007, MOL PHARMACOL, V72, P429, DOI 10.1124/mol.107.037747; Wassmer T, 2009, DEV CELL, V17, P110, DOI 10.1016/j.devcel.2009.04.016; Zimmerman SP, 2013, BIOCHEM J, V455, P95, DOI 10.1042/BJ20121755	90	48	48	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					10986	11002		10.1074/jbc.M115.697045	http://dx.doi.org/10.1074/jbc.M115.697045			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27008860	Green Published, hybrid			2022-12-26	WOS:000377042100004
J	Braun, J; Meixner, A; Brachner, A; Foisner, R				Braun, Juliane; Meixner, Arabella; Brachner, Andreas; Foisner, Roland			The GIY-YIG Type Endonuclease Ankyrin Repeat and LEM Domain-Containing Protein 1 (ANKLE1) Is Dispensable for Mouse Hematopoiesis	PLOS ONE			English	Article							NEGATIVE BREAST-CANCER; DNA-DAMAGE; STEM-CELLS; REPAIR; MICE; RECOMBINATION; SUSCEPTIBILITY; 19P13	Ankyrin repeat and LEM-domain containing protein 1 (ANKLE1) is a GIY-YIG endonuclease with unknown functions, mainly expressed in mouse hematopoietic tissues. To test its potential role in hematopoiesis we generated Ankle1-deficient mice. Ankle1(Delta/Delta) mice are viable without any detectable phenotype in hematopoiesis. Neither hematopoietic progenitor cells, myeloid and lymphoid progenitors, nor B and T cell development in bone marrow, spleen and thymus, are affected in Ankle1(Delta/Delta)-mice. Similarly embryonic stress erythropoiesis in liver and adult erythropoiesis in bone marrow and spleen appear normal. To test whether ANKLE1, like the only other known GIY-YIG endonuclease in mammals, SLX1, may contribute to Holliday junction resolution during DNA repair, Ankle1-deficient cells were exposed to various DNA-damage inducing agents. However, lack of Ankle1 did not affect cell viability and, unlike depletion of Slx1, Ankle1-deficiency did not increase sister chromatid exchange in Bloom helicase-depleted cells. Altogether, we show that lack of Ankle1 does neither affect mouse hematopoiesis nor DNA damage repair in mouse embryonic fibroblasts, indicating a redundant or non-essential function of ANKLE1 in mouse.	[Braun, Juliane; Brachner, Andreas; Foisner, Roland] Med Univ Vienna, MFPL, Dept Med Biochem, Vienna Bioctr VBC, Vienna, Austria; [Meixner, Arabella] Austrian Acad Sci, IMBA Inst Mol Biotechnol, A-1010 Vienna, Austria	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Brachner, A; Foisner, R (corresponding author), Med Univ Vienna, MFPL, Dept Med Biochem, Vienna Bioctr VBC, Vienna, Austria.	andreas.brachner@univie.ac.at; roland.foisner@meduniwien.ac.at	Foisner, Roland/AAD-1833-2019; Brachner, Andreas/AAE-5037-2020	Brachner, Andreas/0000-0002-9465-8561; Foisner, Roland/0000-0003-4734-4647	Austrian Science Fund (FWF) [P22569-B09]; Herzfelder'sche Familienstiftung; doctoral program grant from University of Vienna [I031-B]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Herzfelder'sche Familienstiftung; doctoral program grant from University of Vienna	This work was supported by the Austrian Science Fund (FWF grant P22569-B09) to RF, and the Herzfelder'sche Familienstiftung to AB. JB was supported by a doctoral program grant I031-B from the University of Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostinho A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003591; Antoniou AC, 2010, NAT GENET, V42, P885, DOI 10.1038/ng.669; Barton LJ, 2015, CURR OPIN CELL BIOL, V34, P1, DOI 10.1016/j.ceb.2015.03.005; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bayani Jane, 2005, Curr Protoc Cell Biol, VChapter 22, DOI 10.1002/0471143030.cb2207s25; Bey EA, 2006, J CELL PHYSIOL, V209, P604, DOI 10.1002/jcp.20783; Bolton KL, 2010, NAT GENET, V42, P880, DOI 10.1038/ng.666; Brachner A, 2012, J CELL SCI, V125, P1048, DOI 10.1242/jcs.098392; Brachner A, 2011, BIOCHEM SOC T, V39, P1735, DOI 10.1042/BST20110724; Caddle LB, 2008, MOL CELL BIOL, V28, P2295, DOI 10.1128/MCB.02139-07; Cai ML, 2001, EMBO J, V20, P4399, DOI 10.1093/emboj/20.16.4399; Castor D, 2013, MOL CELL, V52, P221, DOI 10.1016/j.molcel.2013.08.036; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Dendouga N, 2005, MOL CELL BIOL, V25, P7569, DOI 10.1128/MCB.25.17.7569-7579.2005; Dittrich CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0024555; Dunin-Horkawicz S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-98; Dymecki SM, 1996, P NATL ACAD SCI USA, V93, P6191, DOI 10.1073/pnas.93.12.6191; Guzman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092444; Johar AS, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0525-x; Kwon TH, 2012, BIOCHEM BIOPH RES CO, V424, P189, DOI 10.1016/j.bbrc.2012.06.113; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Lyashenko N, 2011, NAT CELL BIOL, V13, P753, DOI 10.1038/ncb2260; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Paulson RF, 2011, CURR OPIN HEMATOL, V18, P139, DOI 10.1097/MOH.0b013e32834521c8; Prasher JM, 2005, EMBO J, V24, P861, DOI 10.1038/sj.emboj.7600542; Rooney S, 2002, MOL CELL, V10, P1379, DOI 10.1016/S1097-2765(02)00755-4; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Saito TT, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003586; Sarbajna S, 2014, TRENDS BIOCHEM SCI, V39, P409, DOI 10.1016/j.tibs.2014.07.003; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Stevens KN, 2011, CANCER RES, V71, P6240, DOI 10.1158/0008-5472.CAN-11-1266; Wagner N, 2007, INT REV CYTOL, V261, P1, DOI 10.1016/S0074-7696(07)61001-8; Wilson KL, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000554; Wyatt HDM, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a023192	36	8	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152278	10.1371/journal.pone.0152278	http://dx.doi.org/10.1371/journal.pone.0152278			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010503	Green Published, Green Submitted, gold			2022-12-26	WOS:000372708000126
J	Goldsmith, G; Rathinavelan, T; Yathindra, N				Goldsmith, Gunaseelan; Rathinavelan, Thenmalarchelvi; Yathindra, Narayanarao			Selective Preference of Parallel DNA Triplexes Is Due to the Disruption of Hoogsteen Hydrogen Bonds Caused by the Severe Nonisostericity between the G*GC and T*AT Triplets	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATION; NUCLEIC-ACID STRUCTURES; AMBER FORCE-FIELD; HELIX FORMATION; FORMING OLIGONUCLEOTIDES; HUMAN GENOME; CENTER-DOT; MASS-SPECTROMETRY; BINDING PROTEINS; MIXED SEQUENCES	Implications of DNA, RNA and RNA. DNA hybrid triplexes in diverse biological functions, diseases and therapeutic applications call for a thorough understanding of their structure-function relationships. Despite exhaustive studies mechanistic rationale for the discriminatory preference of parallel DNA triplexes with G*GC & T*AT triplets still remains elusive. Here, we show that the highest nonisostericity between the G*GC & T*AT triplets imposes extensive stereochemical rearrangements contributing to context dependent triplex destabilisation through selective disruption of Hoogsteen scheme of hydrogen bonds. MD simulations of nineteen DNA triplexes with an assortment of sequence milieu reveal for the first time fresh insights into the nature and extent of destabilization from a single (non-overlapping), double (overlapping) and multiple pairs of nonisosteric base triplets (NIBTs). It is found that a solitary pair of NIBTs, feasible either at a G*GC/T*AT or T*AT/G*GC triplex junction, does not impinge significantly on triplex stability. But two overlapping pairs of NIBTs resulting from either a T*AT or a G*GC interruption disrupt Hoogsteen pair to a noncanonical mismatch destabilizing the triplex by similar to 10 to 14 kcal/mol, implying that their frequent incidence in multiples, especially, in short sequences could even hinder triplex formation. The results provide (i) an unambiguous and generalised mechanistic rationale for the discriminatory trait of parallel triplexes, including those studied experimentally (ii) clarity for the prevalence of antiparallel triplexes and (iii) comprehensive perspectives on the sequence dependent influence of nonisosteric base triplets useful in the rational design of TFO's against potential triplex target sites.	[Goldsmith, Gunaseelan; Rathinavelan, Thenmalarchelvi; Yathindra, Narayanarao] Biotech Pk, Inst Bioinformat & Appl Biotechnol, Elect City Phase 1, Bangalore, Karnataka, India; [Goldsmith, Gunaseelan] Manipal Univ, Manipal, Karnataka, India; [Rathinavelan, Thenmalarchelvi] Indian Inst Technol Hyderabad, Dept Biotechnol, Kandi, Telangana State, India	Manipal Academy of Higher Education (MAHE); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Hyderabad	Yathindra, N (corresponding author), Biotech Pk, Inst Bioinformat & Appl Biotechnol, Elect City Phase 1, Bangalore, Karnataka, India.	yathindra@ibab.ac.in			Department of Electronics and Information Technology, Government of India, under 'Centre of Excellence for Research and Teaching in Bioinformatics' [DIT-R&D-BIO/15(7)/2007]; Department of IT, BT and S&T, Government of Karnataka, India	Department of Electronics and Information Technology, Government of India, under 'Centre of Excellence for Research and Teaching in Bioinformatics'; Department of IT, BT and S&T, Government of Karnataka, India	This work was supported by an institutional grant to IBAB from the Department of Electronics and Information Technology, Government of India, under 'Centre of Excellence for Research and Teaching in Bioinformatics' [DIT-R&D-BIO/15(7)/2007] and Department of IT, BT and S&T, Government of Karnataka, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agazie YM, 1996, BIOCHEM J, V316, P461, DOI 10.1042/bj3160461; Aghamollaei H, 2015, J INFECT PUBLIC HEAL, V8, P314, DOI 10.1016/j.jiph.2015.03.003; Akiyama T, 1996, P NATL ACAD SCI USA, V93, P12122, DOI 10.1073/pnas.93.22.12122; Ananth P, 2013, RNA, V19, P1038, DOI 10.1261/rna.036905.112; [Anonymous], 2005, INS 2 2005L; ARNOTT S, 1974, J MOL BIOL, V88, P509, DOI 10.1016/0022-2836(74)90498-7; Arya DP, 2011, ACCOUNTS CHEM RES, V44, P134, DOI 10.1021/ar100113q; Asensio JL, 1998, J MOL BIOL, V275, P811, DOI 10.1006/jmbi.1997.1520; BEAL PA, 1991, SCIENCE, V251, P1360, DOI 10.1126/science.2003222; Bednarski D, 2006, CHEMBIOCHEM, V7, P1715, DOI 10.1002/cbic.200600141; BEHE MJ, 1995, NUCLEIC ACIDS RES, V23, P689, DOI 10.1093/nar/23.4.689; Bissler JJ, 2007, FRONT BIOSCI-LANDMRK, V12, P4536, DOI 10.2741/2408; Brodin P, 1999, NUCLEIC ACIDS RES, V27, P3029, DOI 10.1093/nar/27.15.3029; Brown JA, 2012, P NATL ACAD SCI USA, V109, P19202, DOI 10.1073/pnas.1217338109; Brunger AT, 1996, X PLOR VER 3 851; Burrell MR, 2010, METHODS MOL BIOL, V613, P257, DOI 10.1007/978-1-60327-418-0_16; Buske FA, 2013, BIOINFORMATICS, V29, P1895, DOI 10.1093/bioinformatics/btt315; Buske FA, 2011, RNA BIOL, V8, P427, DOI 10.4161/rna.8.3.14999; Case D. A., 2012, AMBER 13; Case DA, 2012, AMBER 12; Chakravorty DK, 2014, ADV PROTEIN CHEM STR, V96, P181, DOI 10.1016/bs.apcsb.2014.06.009; Chandler SP, 1996, BIOCHEMISTRY-US, V35, P15038, DOI 10.1021/bi9609679; Chin JY, 2007, FRONT BIOSCI-LANDMRK, V12, P4288, DOI 10.2741/2388; Chin JY, 2009, MOL CARCINOGEN, V48, P389, DOI 10.1002/mc.20501; Chou MY, 2010, NUCLEIC ACIDS RES, V38, P1676, DOI 10.1093/nar/gkp1107; CHUBB JM, 1992, TRENDS BIOTECHNOL, V10, P132, DOI 10.1016/0167-7799(92)90195-2; CLARENC JP, 1994, NUCLEOS NUCLEOT NUCL, V13, P799, DOI 10.1080/15257779408013279; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; deBizemont T, 1996, NUCLEIC ACIDS RES, V24, P1136, DOI 10.1093/nar/24.6.1136; Devi G, 2015, WIRES RNA, V6, P111, DOI 10.1002/wrna.1261; Diviacco S, 2001, FASEB J, V15, P2660, DOI 10.1096/fj.01-0440com; Drsata T, 2014, J PHYS CHEM LETT, V5, P3831, DOI 10.1021/jz501826q; Duca M, 2008, NUCLEIC ACIDS RES, V36, P5123, DOI 10.1093/nar/gkn493; DURLAND RH, 1991, BIOCHEMISTRY-US, V30, P9246, DOI 10.1021/bi00102a017; Eick A, 2010, BIOCONJUGATE CHEM, V21, P1105, DOI 10.1021/bc100107n; FRANKKAMENETSKII MD, 1995, ANNU REV BIOCHEM, V64, P65, DOI 10.1146/annurev.bi.64.070195.000433; GIOVANNANGELI C, 1992, P NATL ACAD SCI USA, V89, P8631, DOI 10.1073/pnas.89.18.8631; Gohlke H, 2004, J COMPUT CHEM, V25, P238, DOI 10.1022/jcc.10379; Gondeau C, 2000, J BIOMOL STRUCT DYN, V17, P879, DOI 10.1080/07391102.2000.10506576; Goni JR, 2004, NUCLEIC ACIDS RES, V32, P354, DOI 10.1093/nar/gkh188; Grossmann TN, 2007, ANGEW CHEM INT EDIT, V46, P5223, DOI 10.1002/anie.200700289; Guillonneau F, 2001, NUCLEIC ACIDS RES, V29, P2427, DOI 10.1093/nar/29.11.2427; Guo MH, 2015, J BIOL CHEM, V290, P5174, DOI 10.1074/jbc.M114.634923; HAMPEL KJ, 1993, BIOCHEMISTRY-US, V32, P1072, DOI 10.1021/bi00055a012; Hart K, 2012, J CHEM THEORY COMPUT, V8, P348, DOI 10.1021/ct200723y; Hegarat N, 2014, FEBS J, V281, P1417, DOI 10.1111/febs.12714; Holder IT, 2015, NUCL ACIDS RES; Holland JA, 1996, NUCLEIC ACIDS RES, V24, P2841, DOI 10.1093/nar/24.14.2841; Hou XHH, 2015, MOL THER-METH CLIN D, V2, DOI 10.1038/mtm.2014.62; Idili A, 2014, J AM CHEM SOC, V136, P5836, DOI 10.1021/ja500619w; Ishida H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101951; Islam B, 2015, NUCLEIC ACIDS RES, V43, P8673, DOI 10.1093/nar/gkv785; Jain A, 2008, BIOCHIMIE, V90, P1117, DOI 10.1016/j.biochi.2008.02.011; Jain A, 2010, BIOCHEMISTRY-US, V49, P6992, DOI 10.1021/bi100795m; Jakobsen U, 2013, BIOCONJUGATE CHEM, V24, P1485, DOI 10.1021/bc300690m; Jenjaroenpun P, 2015, NUCLEIC ACIDS RES, V43, pD110, DOI 10.1093/nar/gku970; Jenjaroenpun P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S3-S9; Jimenez-Garcia E, 1998, J BIOL CHEM, V273, P24640, DOI 10.1074/jbc.273.38.24640; Johannsen MW, 2014, CHEM COMMUN, V50, P551, DOI 10.1039/c3cc45917a; Keppler MD, 1997, NUCLEIC ACIDS RES, V25, P4644, DOI 10.1093/nar/25.22.4644; Khan N, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004162; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Krepl M, 2012, J CHEM THEORY COMPUT, V8, P2506, DOI 10.1021/ct300275s; Kroner C, 2013, CHEM-EUR J, V19, P15879, DOI 10.1002/chem.201303098; Kukreti S, 1997, NUCLEIC ACIDS RES, V25, P4264, DOI 10.1093/nar/25.21.4264; Kusic J, 2010, MOL BIOL REP, V37, P2317, DOI 10.1007/s11033-009-9735-8; Lexa M, 2011, BIOINFORMATICS, V27, P2510, DOI 10.1093/bioinformatics/btr439; Liberles DA, 1996, P NATL ACAD SCI USA, V93, P9510, DOI 10.1073/pnas.93.18.9510; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; MACAYA R, 1992, J MOL BIOL, V225, P755, DOI 10.1016/0022-2836(92)90399-5; MACAYA RF, 1991, SCIENCE, V254, P270, DOI 10.1126/science.1925581; MACAYA RF, 1992, J AM CHEM SOC, V114, P781, DOI 10.1021/ja00028a067; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; MAYFIELD C, 1994, BIOCHEMISTRY-US, V33, P3358, DOI 10.1021/bi00177a029; McCrate NE, 2006, NUCLEIC ACIDS RES, V34, P5361, DOI 10.1093/nar/gkl580; MCSHAN WM, 1992, J BIOL CHEM, V267, P5712; Mitton Fry RM, 2010, SCIENCE, V330, P1244, DOI [10.1126/science.1195858, DOI 10.1126/SCIENCE.1195858]; Mondal T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8743; Moradi M, 2013, NUCLEIC ACIDS RES, V41, P33, DOI 10.1093/nar/gks1003; Mura C, 2008, NUCLEIC ACIDS RES, V36, P4941, DOI 10.1093/nar/gkn473; Musso M, 1998, BIOCHEMISTRY-US, V37, P3086, DOI 10.1021/bi9717486; Nelson LD, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-38; NOONBERG SB, 1995, NUCLEIC ACIDS RES, V23, P1956, DOI 10.1093/nar/23.11.1956; Noy A, 2005, J AM CHEM SOC, V127, P4910, DOI 10.1021/ja043293v; Noy A, 2007, NUCLEIC ACIDS RES, V35, P3330, DOI 10.1093/nar/gkl1135; O'Leary VB, 2015, CELL REP, V11, P474, DOI 10.1016/j.celrep.2015.03.043; Ohno M, 2002, CHROMOSOMA, V111, P201, DOI 10.1007/s00412-002-0198-0; Ohshima K, 1998, J BIOL CHEM, V273, P14588, DOI 10.1074/jbc.273.23.14588; Ojha RP, 2003, NUCLEIC ACIDS RES, V31, P6373, DOI 10.1093/nar/gkg796; Ojha RP, 2002, J BIOMOL STRUCT DYN, V20, P107; Perez A, 2007, BIOPHYS J, V92, P3817, DOI 10.1529/biophysj.106.097782; Petrov AS, 2004, BIOPHYS J, V87, P3954, DOI 10.1529/biophysj.104.043752; RADHAKRISHNAN I, 1991, J MOL BIOL, V221, P1403, DOI 10.1016/0022-2836(91)90941-X; RADHAKRISHNAN I, 1993, STRUCTURE, V1, P135, DOI 10.1016/0969-2126(93)90028-F; RAGHUNATHAN G, 1993, BIOCHEMISTRY-US, V32, P455, DOI 10.1021/bi00053a009; Rao JE, 2001, J MOL BIOL, V307, P1161, DOI 10.1006/jmbi.2001.4553; Rathinavelan T, 2006, BIOPOLYMERS, V82, P443, DOI [10.1002/bip.20484, 10.1002/BIP.20484]; Rathinavelan T, 2005, FEBS J, V272, P4055, DOI 10.1111/j.1742-4658.2005.04817.x; Riechert-Krause F, 2013, BIOCHEMISTRY-US, V52, P41, DOI 10.1021/bi301381h; Rogers Faye A., 2013, Yale Journal of Biology and Medicine, V86, P471; Rusling DA, 2012, ACS NANO, V6, P3604, DOI 10.1021/nn300718z; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Scaria PV, 1996, BIOCHEMISTRY-US, V35, P10985, DOI 10.1021/bi960966g; SEKHARUDU CY, 1993, J BIOMOL STRUCT DYN, V11, P225, DOI 10.1080/07391102.1993.10508723; Shefer K, 2007, MOL CELL BIOL, V27, P2130, DOI 10.1128/MCB.01826-06; Singh RP, 2013, BIOPHYS J, V105, P2820, DOI [10.1016/j.bpj.2013.10.021, 10.1016/j.bpj.2013.10.02]; Soyfer V.N., 1996, TRIPLE HELICAL NUCL; Sponer J, 2012, METHODS, V57, P25, DOI 10.1016/j.ymeth.2012.04.005; SUN JS, 1991, CR ACAD SCI III-VIE, V313, P585; Sun JS, 1996, CURR OPIN STRUC BIOL, V6, P327, DOI 10.1016/S0959-440X(96)80051-0; SVINARCHUK F, 1995, NUCLEIC ACIDS RES, V23, P3831, DOI 10.1093/nar/23.19.3831; Tateishi-Karimata H, 2014, SCI REP-UK, V4, DOI 10.1038/srep03593; Thenmalarchelvi R, 2005, NUCLEIC ACIDS RES, V33, P43, DOI 10.1093/nar/gki143; Van Dyke Mw, 2013, OA Mol Oncol, V1, P5; Vollmer S, 2015, CHEMISTRY; Vuyisich M, 2000, NUCLEIC ACIDS RES, V28, P2369, DOI 10.1093/nar/28.12.2369; Wang E., 1999, OXFORD HDB NUCL ACID, P355; Wheatley EG, 2012, BIOPHYS J, V102, P552, DOI 10.1016/j.bpj.2011.11.4023; Wilusz JE, 2012, GENE DEV, V26, P2392, DOI 10.1101/gad.204438.112; Xi DM, 2014, CHEM COMMUN, V50, P9547, DOI 10.1039/c4cc03925d; Xiao ZY, 2015, ANALYST, V140, P7322, DOI 10.1039/c5an01371b; Xu NS, 2012, ANAL CHEM, V84, P2562, DOI 10.1021/ac202796v; Yang MQ, 2015, ANAL CHEM, V87, P5854, DOI 10.1021/acs.analchem.5b01233; Zgarbova M, 2013, J CHEM THEORY COMPUT, V9, P2339, DOI 10.1021/ct400154j; Zgarbova M, 2011, J CHEM THEORY COMPUT, V7, P2886, DOI 10.1021/ct200162x; Zheng J, 2013, CHEM COMMUN, V49, P6915, DOI 10.1039/c3cc42962h; Zheng J, 2012, J AM CHEM SOC, V134, P19957, DOI 10.1021/ja308875r; Zhu XL, 2010, BIOSENS BIOELECTRON, V25, P2135, DOI 10.1016/j.bios.2010.02.017	128	8	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152102	10.1371/journal.pone.0152102	http://dx.doi.org/10.1371/journal.pone.0152102			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010368	Green Submitted, Green Published, gold			2022-12-26	WOS:000372708000089
J	Homolka, S; Ubben, T; Niemann, S				Homolka, Susanne; Ubben, Tanja; Niemann, Stefan			High Sequence Variability of the ppE18 Gene of Clinical Mycobacterium tuberculosis Complex Strains Potentially Impacts Effectivity of Vaccine Candidate M72/AS01E	PLOS ONE			English	Article							DIVERSITY; IMMUNOGENICITY; TRANSMISSION; MTB72F/AS02A; EFFICACY; LINEAGE; HUMANS; GAMBIA; FAMILY	The development of an effective vaccine is urgently needed to fight tuberculosis (TB) which is still the leading cause of death from a single infectious agent worldwide. One of the promising vaccine candidates M72/AS01E consists of two proteins subunits PepA and PPE18 coded by Rv0125 and Rv1196. However, preliminary data indicate a high level of sequence variability among clinical Mycobacterium tuberculosis complex (MTBC) strains that might have an impact on the vaccine efficacy. To further investigate this finding, we determined ppE18 sequence variability in a well-characterized reference collection of 71 MTBC strains from 23 phylogenetic lineages representing the global MTBC diversity. In total, 100 sequence variations consisting of 96 single nucleotide polymorphisms (SNPs), three insertions and one deletion were detected resulting in 141 variable positions distributed over the entire gene. The majority of SNPs detected were non-synonymous (n = 68 vs. n = 28 synonymous). Strains from animal adapted lineages, e.g., M. bovis, showed a significant higher diversity than the human pathogens such as M. tuberculosis Haarlem. SNP patterns specific for different lineages as well as for deeper branches in the phylogeny could be identified. The results of our study demonstrate a high variability of the ppE18 gene even in the N-terminal domains that is normally highly conserved in ppe genes. As the N-terminal region interacts with TLR2 receptor inducing a protective anti-inflammatory immune response, genetic heterogeneity has a potential impact on the vaccine efficiency, however, this has to be investigated in future studies.	[Homolka, Susanne; Ubben, Tanja; Niemann, Stefan] Res Ctr Borstel, Mol & Expt Mycobacteriol, Schleswig Holstein, Germany; [Niemann, Stefan] German Ctr Infect Res DZIF, Partner Site Borstel, Schleswig Holstein, Germany	German Center for Infection Research	Homolka, S (corresponding author), Res Ctr Borstel, Mol & Expt Mycobacteriol, Schleswig Holstein, Germany.	shomolka@fz-borstel.de	Niemann, Stefan/C-9327-2011	Niemann, Stefan/0000-0002-6604-0684				Ahmed A, 2015, IUBMB LIFE, V67, P414, DOI 10.1002/iub.1387; Bhat KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052601; Brandt L, 2004, INFECT IMMUN, V72, P6622, DOI 10.1128/IAI.72.11.6622-6632.2004; Cobey S, 2014, ANN NY ACAD SCI, V1320, P1, DOI 10.1111/nyas.12493; Cohen T, 2008, P NATL ACAD SCI USA, V105, P16302, DOI 10.1073/pnas.0808746105; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Coscolla M, 2014, SEMIN IMMUNOL, V26, P431, DOI 10.1016/j.smim.2014.09.012; Davila J, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/208371; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; Frick M, 2014, TUBERCULOSIS VACCINE; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Gehre F, 2013, EMERG INFECT DIS, V19, P1598, DOI 10.3201/eid1910.121023; Hebert AM, 2007, INFECT IMMUN, V75, P5798, DOI 10.1128/IAI.00335-07; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Karboul A, 2008, J BACTERIOL, V190, P7838, DOI 10.1128/JB.00827-08; Leroux-Roels I, 2013, VACCINE, V31, P2196, DOI 10.1016/j.vaccine.2012.05.035; Marais BJ, 2010, LANCET, V375, P2179, DOI 10.1016/S0140-6736(10)60554-5; McNamara LA, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-18; Merker M, 2015, NAT GENET, V47, P242, DOI 10.1038/ng.3195; Montagnani C, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-S1-S2; Mortier MC, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0119-7; Mustafa AS, 2006, INFECT IMMUN, V74, P4566, DOI 10.1128/IAI.01660-05; Nair S, 2011, J IMMUNOL, V186, P5413, DOI 10.4049/jimmunol.1000773; Nair S, 2009, J IMMUNOL, V183, P6269, DOI 10.4049/jimmunol.0901367; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Reed SG, 2009, P NATL ACAD SCI USA, V106, P2301, DOI 10.1073/pnas.0712077106; Reiling N, 2013, MBIO, V4, DOI 10.1128/mBio.00250-13; Ribeiro SCM, 2014, J CLIN MICROBIOL, V52, P2615, DOI 10.1128/JCM.00498-14; Sampson SL, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/497203; Sherman DR, 2011, NAT GENET, V43, P400, DOI 10.1038/ng.815; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Stavrum R, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-309; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Von Eschen K, 2009, HUM VACCINES, V5, P475, DOI 10.4161/hv.8570; Warner DF, 2015, TRENDS MICROBIOL, V23, P14, DOI 10.1016/j.tim.2014.10.005; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; WHO, 2014, GLOB TUB REP 2014; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; World Health Organisation, STOP TB PARTN GLOB P	40	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152200	10.1371/journal.pone.0152200	http://dx.doi.org/10.1371/journal.pone.0152200			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27011018	Green Published, Green Submitted, gold			2022-12-26	WOS:000372708000108
J	Hwang, IS; Huang, CY				Hwang, Ing-Shiou; Huang, Cheng-Ya			Neural Correlates of Task Cost for Stance Control with an Additional Motor Task: Phase-Locked Electroencephalogram Responses	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; WORKING-MEMORY TASK; DUAL-TASK; POSTURAL CONTROL; RESOURCE-ALLOCATION; THETA OSCILLATIONS; CORTICAL ACTIVITY; PERFORMANCE; ATTENTION; BRAIN	With appropriate reallocation of central resources, the ability to maintain an erect posture is not necessarily degraded by a concurrent motor task. This study investigated the neural control of a particular postural-suprapostural procedure involving brain mechanisms to solve crosstalk between posture and motor subtasks. Participants completed a single posture task and a dual-task while concurrently conducting force-matching and maintaining a tilted stabilometer stance at a target angle. Stabilometer movements and event-related potentials (ERPs) were recorded. The added force-matching task increased the irregularity of postural response rather than the size of postural response prior to force-matching. In addition, the added force-matching task during stabilometer stance led to marked topographic ERP modulation, with greater P2 positivity in the frontal and sensorimotor-parietal areas of the N1-P2 transitional phase and in the sensorimotor-parietal area of the late P2 phase. The time-frequency distribution of the ERP primary principal component revealed that the dual-task condition manifested more pronounced delta (1-4 Hz) and beta (13-35 Hz) synchronizations but suppressed theta activity (4-8 Hz) before force-matching. The dual-task condition also manifested coherent fronto-parietal delta activity in the P2 period. In addition to a decrease in postural regularity, this study reveals spatio-temporal and temporal-spectral reorganizations of ERPs in the fronto-sensorimotor-parietal network due to the added suprapostural motor task. For a particular set of postural-suprapostural task, the behavior and neural data suggest a facilitatory role of autonomous postural response and central resource expansion with increasing interregional interactions for task-shift and planning the motor-suprapostural task.	[Hwang, Ing-Shiou] Natl Cheng Kung Univ, Dept Phys Therapy, Coll Med, Tainan 701, Taiwan; [Hwang, Ing-Shiou] Natl Cheng Kung Univ, Inst Allied Hlth Sci, Coll Med, Tainan 701, Taiwan; [Huang, Cheng-Ya] Natl Taiwan Univ, Sch & Grad Inst Phys Therapy, Coll Med, Taipei 100, Taiwan; [Huang, Cheng-Ya] Natl Taiwan Univ Hosp, Phys Therapy Ctr, Taipei 100, Taiwan	National Cheng Kung University; National Cheng Kung University; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Huang, CY (corresponding author), Natl Taiwan Univ, Sch & Grad Inst Phys Therapy, Coll Med, Taipei 100, Taiwan.; Huang, CY (corresponding author), Natl Taiwan Univ Hosp, Phys Therapy Ctr, Taipei 100, Taiwan.	rcyhuang@ntu.edu.tw		HUANG, CHENG-YA/0000-0001-6946-2105	Ministry of Science and Technology, ROC [MOST 103-2314-B-002 -007 -MY3]; Ministry of Science and Technology, R.O.C. Taiwan [MOST 103-2314-B-002-007 -MY3]	Ministry of Science and Technology, ROC; Ministry of Science and Technology, R.O.C. Taiwan	This research was supported by a grant from the Ministry of Science and Technology, ROC, under grant no. MOST 103-2314-B-002 -007 -MY3 (https://www.most.gov.tw/en/public). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a grant from the Ministry of Science and Technology, R.O.C. Taiwan, under grant no. MOST 103-2314-B-002-007 -MY3	Adkin AL, 2008, NEUROSCI LETT, V435, P120, DOI 10.1016/j.neulet.2008.02.018; Baumann MA, 2009, J NEUROSCI, V29, P6436, DOI 10.1523/JNEUROSCI.5479-08.2009; Bernat EM, 2007, INT J PSYCHOPHYSIOL, V64, P62, DOI 10.1016/j.ijpsycho.2006.07.015; Borg FG, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-38; Caldwell JA, 2003, CLIN NEUROPHYSIOL, V114, P23, DOI 10.1016/S1388-2457(02)00283-3; Cavanaugh JT, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-42; Cocchi L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028301; Donker SF, 2007, EXP BRAIN RES, V181, P1, DOI 10.1007/s00221-007-0905-4; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Gladwin TE, 2005, BIOL PSYCHOL, V68, P309, DOI 10.1016/j.biopsycho.2004.06.004; Graimann B, 2006, PROG BRAIN RES, V159, P79, DOI 10.1016/S0079-6123(06)59006-5; Gruendler TOJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025591; Harmony T, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00083; Hartley AA, 2011, BRAIN COGNITION, V75, P281, DOI 10.1016/j.bandc.2011.01.004; Hikosaka O, 2010, TRENDS COGN SCI, V14, P154, DOI 10.1016/j.tics.2010.01.006; Huang CY, 2014, BEHAV BRAIN RES, V274, P95, DOI 10.1016/j.bbr.2014.07.054; Huang CY, 2013, HUM BRAIN MAPP, V34, P635, DOI 10.1002/hbm.21460; Huang CY, 2010, J ELECTROMYOGR KINES, V20, P413, DOI 10.1016/j.jelekin.2009.06.003; Hulsdunker T, 2015, NEUROSCI LETT, V592, P1, DOI 10.1016/j.neulet.2015.02.049; Huster RJ, 2013, INT J PSYCHOPHYSIOL, V87, P217, DOI 10.1016/j.ijpsycho.2012.08.001; Iyer A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000444; Kida T, 2004, CLIN NEUROPHYSIOL, V115, P2616, DOI 10.1016/j.clinph.2004.06.013; Kida T, 2012, EXP BRAIN RES, V216, P575, DOI 10.1007/s00221-011-2961-z; Kieffaber PD, 2005, PSYCHOPHYSIOLOGY, V42, P56, DOI 10.1111/j.1469-8986.2005.00262.x; Kirmizi-Alsan E, 2006, BRAIN RES, V1104, P114, DOI 10.1016/j.brainres.2006.03.010; Kline JE, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00288; Klingberg T, 2000, PROG BRAIN RES, V126, P95; Kok A, 1997, BIOL PSYCHOL, V45, P19, DOI 10.1016/S0301-0511(96)05221-0; Kuczynski M, 2011, J SPORT SCI, V29, P539, DOI 10.1080/02640414.2010.544046; Lacour M, 2008, NEUROPHYSIOL CLIN, V38, P411, DOI 10.1016/j.neucli.2008.09.005; Lavallee CF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096159; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Maki BE, 2007, J NEURAL TRANSM, V114, P1279, DOI 10.1007/s00702-007-0764-y; Mazaheri M, 2010, GAIT POSTURE, V31, P116, DOI 10.1016/j.gaitpost.2009.09.009; McNevin N, 2013, RES Q EXERCISE SPORT, V84, P96, DOI 10.1080/02701367.2013.762321; Mitra S, 2004, HUM MOVEMENT SCI, V23, P1, DOI 10.1016/j.humov.2004.03.003; Mitra S, 2004, J EXP PSYCHOL HUMAN, V30, P28, DOI 10.1037/0096-1523.30.1.28; Mizuno K, 2012, NEUROPSYCHOLOGIA, V50, P1998, DOI 10.1016/j.neuropsychologia.2012.04.025; Mochizuki G, 2008, CLIN NEUROPHYSIOL, V119, P1626, DOI 10.1016/j.clinph.2008.03.020; Mouraux A, 2008, MAGN RESON IMAGING, V26, P1041, DOI 10.1016/j.mri.2008.01.011; Muller MLTM, 2007, EXP BRAIN RES, V183, P447, DOI 10.1007/s00221-007-1065-2; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Murray MM, 2004, NEUROIMAGE, V21, P125, DOI 10.1016/j.neuroimage.2003.09.035; NASHNER LM, 1985, BEHAV BRAIN SCI, V8, P135, DOI 10.1017/S0140525X00020008; Nurwulan NR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134230; Paul I, 2003, J CLIN NEUROPHYSIOL, V20, P351, DOI 10.1097/00004691-200309000-00007; Phillips JM, 2014, CEREB CORTEX, V24, P1996, DOI 10.1093/cercor/bht050; Remaud A, 2012, J MOTOR BEHAV, V44, P329, DOI 10.1080/00222895.2012.708680; Riley MA, 1999, HUM MOVEMENT SCI, V18, P795, DOI 10.1016/S0167-9457(99)00041-X; Salo E, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00102; Santangelo V, 2013, HUM BRAIN MAPP, V34, P158, DOI 10.1002/hbm.21430; Sauseng P, 2006, EXP BRAIN RES, V170, P295, DOI 10.1007/s00221-005-0211-y; Schubert T, 2008, FRONT BIOSCI-LANDMRK, V13, P3569, DOI 10.2741/2950; Serrien DJ, 2009, NEUROPSYCHOLOGIA, V47, P139, DOI 10.1016/j.neuropsychologia.2008.08.004; Serrien DJ, 2009, HUM BRAIN MAPP, V30, P523, DOI 10.1002/hbm.20518; Serrien DJ, 2004, EXP BRAIN RES, V157, P79, DOI 10.1007/s00221-003-1822-9; Sibley KM, 2010, EXP BRAIN RES, V203, P533, DOI 10.1007/s00221-010-2257-8; Sipp AR, 2013, J NEUROPHYSIOL, V110, P2050, DOI 10.1152/jn.00744.2012; Slobounov S, 2009, EXP BRAIN RES, V199, P1, DOI 10.1007/s00221-009-1956-5; Slobounov SM, 2013, NEUROSCI LETT, V547, P6, DOI 10.1016/j.neulet.2013.05.001; Stins JF, 2011, HUM MOVEMENT SCI, V30, P190, DOI 10.1016/j.humov.2010.05.013; Stoffregen TA, 1999, J EXP PSYCHOL HUMAN, V25, P1641; Sveistrup H, 1996, J MOTOR BEHAV, V28, P58, DOI 10.1080/00222895.1996.9941734; Weeks DL, 2003, GERONTOLOGY, V49, P225, DOI 10.1159/000070402; Woollacott M, 2002, GAIT POSTURE, V16, P1, DOI 10.1016/S0966-6362(01)00156-4; Zhao Y, 2014, NEUROSCIENCE, V262, P92, DOI 10.1016/j.neuroscience.2013.12.052	68	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151906	10.1371/journal.pone.0151906	http://dx.doi.org/10.1371/journal.pone.0151906			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010634	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708000056
J	Bhalala, US; Hemani, M; Shah, M; Kim, B; Gu, B; Cruz, A; Arunachalam, P; Tian, E; Yu, C; Punnoose, J; Chen, S; Petrillo, C; Brown, A; Munoz, K; Kitchen, G; Lam, T; Bosemani, T; Huisman, TAGM; Allen, RH; Acharya, S				Bhalala, Utpal S.; Hemani, Malvi; Shah, Meehir; Kim, Barbara; Gu, Brian; Cruz, Angelo; Arunachalam, Priya; Tian, Elli; Yu, Christine; Punnoose, Joshua; Chen, Steven; Petrillo, Christopher; Brown, Alisa; Munoz, Karina; Kitchen, Grant; Lam, Taylor; Bosemani, Thangamadhan; Huisman, Thierry A. G. M.; Allen, Robert H.; Acharya, Soumyadipta			Defining Optimal Head-Tilt Position of Resuscitation in Neonates and Young Infants Using Magnetic Resonance Imaging Data	PLOS ONE			English	Article							UPPER AIRWAY; OBSTRUCTION; GUIDELINES	Head-tilt maneuver assists with achieving airway patency during resuscitation. However, the relationship between angle of head-tilt and airway patency has not been defined. Our objective was to define an optimal head-tilt position for airway patency in neonates (age: 0-28 days) and young infants (age: 29 days-4 months). We performed a retrospective study of head and neck magnetic resonance imaging (MRI) of neonates and infants to define the angle of head-tilt for airway patency. We excluded those with an artificial airway or an airway malformation. We defined head-tilt angle a priori as the angle between occipito-ophisthion line and ophisthion-C7 spinous process line on the sagittal MR images. We evaluated medical records for Hypoxic Ischemic Encephalopathy (HIE) and exposure to sedation during MRI. We analyzed MRI of head and neck regions of 63 children (53 neonates and 10 young infants). Of these 63 children, 17 had evidence of airway obstruction and 46 had a patent airway on MRI. Also, 16/63 had underlying HIE and 47/63 newborn infants had exposure to sedative medications during MRI. In spontaneously breathing and neurologically depressed newborn infants, the head-tilt angle (median +/- SD) associated with patent airway (125.3 degrees +/- 11.9 degrees) was significantly different from that of blocked airway (108.2 degrees +/- 17.1 degrees) (Mann Whitney U-test, p = 0.0045). The logistic regression analysis showed that the proportion of patent airways progressively increased with an increasing head-tilt angle, with >95% probability of a patent airway at head-tilt angle 144-150 degrees.	[Bhalala, Utpal S.; Shah, Meehir] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA; [Hemani, Malvi; Kim, Barbara; Gu, Brian; Cruz, Angelo; Arunachalam, Priya; Tian, Elli; Yu, Christine; Punnoose, Joshua; Chen, Steven; Petrillo, Christopher; Brown, Alisa; Munoz, Karina; Kitchen, Grant; Lam, Taylor; Allen, Robert H.; Acharya, Soumyadipta] Johns Hopkins Univ, Dept Biomed Engn, Ctr Biomed Innovat & Design, Baltimore, MD USA; [Bosemani, Thangamadhan; Huisman, Thierry A. G. M.] Johns Hopkins Univ, Dept Radiol & Radiol Sci, Div Pediat Radiol & Pediat Neuroradiol, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Bhalala, US (corresponding author), Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA.	ubhalal1@jhmi.edu	Huisman, Thierry/GYD-4734-2022		Johns Hopkins University PURA grant	Johns Hopkins University PURA grant	This work was supported by Johns Hopkins University PURA grant.	Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; Bhutta ZA, 2006, BMJ-BRIT MED J, V333, P839, DOI 10.1136/bmj.38979.379641.68; de Caen AR, 2015, CIRCULATION, V132, pS526, DOI 10.1161/CIR.0000000000000266; GREENE DG, 1961, JAMA-J AM MED ASSOC, V176, P570, DOI 10.1001/jama.1961.03040200006002; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; Reber A, 1999, ANESTHESIOLOGY, V90, P1617, DOI 10.1097/00000542-199906000-00018; RUBEN H, 1960, LANCET, V1, P849; SAFAR P, 1959, J APPL PHYSIOL, V14, P760, DOI 10.1152/jappl.1959.14.5.760; SAFAR P, 1958, JAMA-J AM MED ASSOC, V167, P335, DOI 10.1001/jama.1958.72990200026008c; Tonkin SL, 1998, J ROY SOC MED, V91, P310, DOI 10.1177/014107689809100608; Upadhyay A, 2011, PRINCIPLES PEDIAT NE, P503; Von Ungern-Sternberg BS, 2005, PEDIATR ANESTH, V15, P181, DOI 10.1111/j.1460-9592.2004.01534.x; WILSON SL, 1980, J APPL PHYSIOL, V48, P500, DOI 10.1152/jappl.1980.48.3.500; Wyckoff MH, 2015, CIRCULATION, V132, pS543, DOI 10.1161/CIR.0000000000000267	15	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151789	10.1371/journal.pone.0151789	http://dx.doi.org/10.1371/journal.pone.0151789			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003759	Green Published, Green Submitted, gold			2022-12-26	WOS:000372697400044
J	Davis, J; Brazil, N				Davis, Jason; Brazil, Noli			Migration, Remittances and Nutrition Outcomes of Left-Behind Children: A National-Level Quantitative Assessment of Guatemala	PLOS ONE			English	Article							INTERNATIONAL REMITTANCES; MIGRANT REMITTANCES; US MIGRATION; WOMENS WORK; HOUSEHOLD; IMPACT; INEQUALITY; NETWORKS; GROWTH; EXPENDITURE	Historically, Guatemalans have suffered high rates of poverty and malnutrition while nearly ten percent of their population resides abroad. Many Guatemalan parents use economic migration, mainly international migration to the United States, as a means to improve the human capital prospects of their children. However, as this investigation shows, the timing of migration events in relation to left-behind children's ages has important, often negative and likely permanent, repercussions on the physical development of their children. To illustrate these dynamics, this investigation uses an instrumental variables framework to disentangle the countervailing effects of Guatemalan fathers' absences due to migration from concomitant remittances on left-behind children's growth outcomes. Based on national-level data collected in 2000, the investigation reveals that the international migration of a father in the previous year is correlated with a 22.1% lower length/height-for-age z-score for the average left-behind child aged <= 3. In contrast, the receipt of remittance income has no influence on the physical stature of a child, which may indicate that migrant fathers with young children are not able to achieve economic success soon enough during their ventures abroad to fully ameliorate the harmful effects caused by their absences.	[Davis, Jason] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA; [Brazil, Noli] Univ So Calif, Spatial Sci Inst, Los Angeles, CA USA	University of North Carolina; University of North Carolina Chapel Hill; University of Southern California	Davis, J (corresponding author), Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA.	jdavis36@live.unc.edu			Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [K99 HD079586, T32 HD007168, R24 HD050924]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007168, P2CHD050924, R00HD079586, R24HD050924, K99HD079586] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research received support from a Pathway to Independence Award (K99 HD079586), a Population Research Training grant (T32 HD007168) and a Population Research Infrastructure Program grant (R24 HD050924), awarded to the Carolina Population Center by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). NICHD played no role in study design; data collection, analysis, and interpretation; manuscript preparation; or whether and where to publish this work.	Adams RH, 2006, J AFR ECON, V15, P396, DOI 10.1093/jafeco/ejl028; Adams RH, 2010, WORLD DEV, V38, P1626, DOI 10.1016/j.worlddev.2010.03.003; Anton JI, 2010, INT MIGR REV, V44, P269, DOI 10.1111/j.1747-7379.2010.00806.x; Baez J., 2008, DOES MORE MEAN BETTE; Beaton G, 1990, APPROPRIATE USES ANT; Becker G., 1974, EC FAMILY MARRIAGE C, P81, DOI DOI 10.1086/260166; BECKER GS, 1976, J POLIT ECON, V84, pS143, DOI 10.1086/260536; Bierbaum R.M., 2010, WORLD DEV REPORT 201; Buis ML, 2011, STATA J, V11, P315, DOI 10.1177/1536867X1101100211; Bureau of Labor Statistics. Occupational employment statistics, OCC EMPL STAT; Carletto C, 2011, FOOD POLICY, V36, P16, DOI 10.1016/j.foodpol.2010.08.002; CARLSON ED, 1985, DEMOGRAPHY, V22, P61, DOI 10.2307/2060986; Carrington WJ, 1996, AM ECON REV, V86, P909; Curran SR, 2003, DEMOGRAPHY, V40, P289, DOI 10.2307/3180802; Davis J., 2010, INT MIGRATION REMITT; Davis J, 2010, POPUL ENVIRON, V32, P216, DOI 10.1007/s11111-010-0128-7; de Brauw A, 2011, FOOD POLICY, V36, P88, DOI 10.1016/j.foodpol.2010.08.001; De Onis M, 2006, WHO CHILD GROWTH STA; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; DELATORRE A, 1987, INT MIGR REV, V21, P728, DOI 10.2307/2546619; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Frank R, 2005, SOC FORCES, V83, P919, DOI 10.1353/sof.2005.0031; Gao Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-56; Goldstein S., 1983, MIGRATION FERTILITY; Gross R., 2000, SCN NEWS, V20, P20; Hallman K, 2006, MULTIPLE DISADVANTAG; Hamilton ER, 2009, POPUL RES POLICY REV, V28, P123, DOI 10.1007/s11113-008-9097-2; Hildebrandt N, 2005, ECONOMIA, V6, P257, DOI 10.1353/eco.2006.0009; IOM, 2004, ENC NAC IMP REM FAM; IOM, 2011, ENC REM 2010 NIN AD; IOM, 2003, ENC NAC EM INT GUAT; Kanaiaupuni SM, 1999, DEMOGRAPHY, V36, P339, DOI 10.2307/2648057; LESLIE J, 1988, WORLD DEV, V16, P1341, DOI 10.1016/0305-750X(88)90209-4; LEVINE NE, 1988, ETHNOLOGY, V27, P231, DOI 10.2307/3773519; LUCAS REB, 1985, J POLIT ECON, V93, P901, DOI 10.1086/261341; Marini A, 2003, MALNUTRITION POVERTY; MARTORELL R, 1995, J NUTR, V125, pS1060; McKay D., 2007, MOBILITIES, V2, P175, DOI DOI 10.1080/17450100701381532; Mckenzie D, 2007, J DEV ECON, V84, P1, DOI 10.1016/j.jdeveco.2006.11.003; McKenzie D, 2010, REV ECON STAT, V92, P811, DOI 10.1162/REST_a_00032; McKenzie D, 2010, J EUR ECON ASSOC, V8, P913; McKenzie DJ, 2005, J POPUL ECON, V18, P229, DOI 10.1007/s00148-005-0224-7; Menjivar C, 2007, SOC SCI QUART, V88, P1243, DOI 10.1111/j.1540-6237.2007.00501.x; Milman A, 2005, J NUTR, V135, P1415, DOI 10.1093/jn/135.6.1415; Mohapatra S., 2011, OUTLOOK REMITTANCE F; Munshi K, 2003, Q J ECON, V118, P549, DOI 10.1162/003355303321675455; Nobles JE, 2007, EFFECTS MEXICAN MIGR; Osili UO, 2004, ECON DEV CULT CHANGE, V52, P821, DOI 10.1086/420903; Ponce J, 2011, INT MIGR REV, V45, P727, DOI 10.1111/j.1747-7379.2011.00864.x; POPKIN BM, 1980, ECOL FOOD NUTR, V9, P1, DOI 10.1080/03670244.1980.9990579; Roodman D, 2009, 168 CTR GLOB DEV, V168, P1; Schmeer K, 2009, SOC SCI MED, V69, P1281, DOI 10.1016/j.socscimed.2009.07.030; STARK O, 1988, ECON DEV CULT CHANGE, V36, P465, DOI 10.1086/451670; STEPHEN EH, 1992, INT MIGR REV, V26, P67, DOI 10.2307/2546937; Stephen L., 2005, GENDER CLASS ETHNICI; Stillman S, 2012, ECON INQ, V50, P62, DOI 10.1111/j.1465-7295.2009.00284.x; Stoll D., 2012, MIGRATION FEVER MICR; Taylor JE, 1996, J DEV STUD, V32, P899, DOI 10.1080/00220389608422445; Toyama N, 2001, J TROP PEDIATRICS, V47, P179, DOI 10.1093/tropej/47.3.179; TUCKER K, 1988, SOC SCI MED, V26, P605, DOI 10.1016/0277-9536(88)90024-X; United Nations Children's Fund, 2007, PROGR CHILDR WORLD F; Vanwey LK, 2004, DEMOGRAPHY, V41, P739, DOI 10.1353/dem.2004.0039; WHO, 2006, WHO CHILD GROWTH STA; Woodruff C, 2007, J DEV ECON, V82, P509, DOI 10.1016/j.jdeveco.2006.03.006; World Health Organization, GROWTH REF 5 19 YEAR; World Health Organization, 2012, GLOB HLTH OBS DAT RE; Yang D, 2007, WORLD BANK ECON REV, V21, P219, DOI 10.1093/wber/lhm003	67	14	14	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152089	10.1371/journal.pone.0152089	http://dx.doi.org/10.1371/journal.pone.0152089			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3OX	27002528	Green Published, gold, Green Submitted			2022-12-26	WOS:000372697400076
J	Fernandes, CS; Batalha, MA; Bichuette, ME				Fernandes, Camile Sorbo; Batalha, Marco Antonio; Bichuette, Maria Elina			Does the Cave Environment Reduce Functional Diversity?	PLOS ONE			English	Article							TERRESTRIAL ISOPODS CRUSTACEA; ONISCIDEA; HABITATS; BRAZIL; RULES	Caves are not colonised by all taxa present in the surface species pool, due to absence of light and the tendency to food limitation when compared to surface communities. Under strong species sorting during colonisation and later by the restrictive environmental filter, traits that are not adaptive in subterranean habitats may be filtered out. We tested whether cave communities were assembled by the restrictive regime propitiated by permanent darkness or by competitive exclusion due to resource scarcity. When compared to surface communities, the restrictive subterranean regime would lead to lower functional diversity and phenotypic clustering inside the caves, and the opposite should be expected in the case of competitive exclusion. Using isopods (Oniscidea) as model taxa, we measured several niche descriptors of taxa from surface and cave habitats, used a multivariate measure of functional diversity, and compared their widths. We found phenotypic overdispersion and higher functional diversity in cave taxa when compared to surface taxa. On the one hand, the dry climate outside of caves hampered the survival of several taxa and their ecological strategies, not viable under severe desiccation risk, culminating in the clustering of functional traits. In contrast, this restriction does not occur inside of caves, where isopods find favourable conditions under lower predation pressures and more amenable environmental parameters that allow occupation and subsequent diversification. Our results showed that, at least for some taxa, caves may not be such a harsh environment as previously thought. The high functional diversity we found inside caves adds an additional reason for the conservation of these sensitive environments.	[Fernandes, Camile Sorbo; Bichuette, Maria Elina] Univ Fed Sao Carlos, Dept Ecol & Evolutionary Biol, POB 676, BR-13565905 Sao Carlos, SP, Brazil; [Batalha, Marco Antonio] Univ Fed Sao Carlos, Dept Bot, POB 676, BR-13565905 Sao Carlos, SP, Brazil	Universidade Federal de Sao Carlos; Universidade Federal de Sao Carlos	Fernandes, CS (corresponding author), Univ Fed Sao Carlos, Dept Ecol & Evolutionary Biol, POB 676, BR-13565905 Sao Carlos, SP, Brazil.	camilesorbofernandes@yahoo.com.br	Bichuette, Maria Elina/C-5262-2013; Batalha, Marco A/C-9113-2012; Batalha, Marco Antonio/P-1102-2019	Bichuette, Maria Elina/0000-0002-9515-4832; Batalha, Marco A/0000-0002-8236-8022; Batalha, Marco Antonio/0000-0002-8236-8022	Coordination for the Improvement of Higher Education Personnel (CAPES); Postgraduate Program on Ecology and Natural Resources from Federal University of Sao Carlos (PPG-ERN UFSCar); Fapesp [2008/05678-7, 2010/08459-4, 2008/57949-4]; Brazilian National Council for Scientific and Technological Development (CNPq); CNPq [573802/2008-4]	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Postgraduate Program on Ecology and Natural Resources from Federal University of Sao Carlos (PPG-ERN UFSCar); Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The first author (CSF) was supported by a PhD fellowship granted by the Coordination for the Improvement of Higher Education Personnel (CAPES: http://www.capes.gov.br/). The field samples were supported by the Postgraduate Program on Ecology and Natural Resources from Federal University of Sao Carlos (PPG-ERN UFSCar: http://www.ppgern.ufscar.br/) and by Fapesp (http://www.fapesp.br/) numbers 2008/05678-7; 2010/08459-4.; We are grateful to the Brazilian National Council for Scientific and Technological Development (CNPq), for the productivity fellowship granted to the second author; to Dr AMPM Dias, coordinator of the National Institute of Science and Technology of the Hymenoptera Parasitoids from Brazilian Southeast Region (INCT Hympar Sudeste, Fapesp grant 2008/57949-4 and CNPq grant 573802/2008-4), for the scanning electron microscope; to Dr LBDR Fernandes, biologist at the Department of Ecology and Evolutionary Biology of the Federal University of Sao Carlos, for taking the scanning electron microscope images; to Dr E Trajano, for the donation of some specimens; to Dr. Ivanklin S. Campos-Filho and Dr. Paula B. Araujo for the help in our taxonomic doubts and for receiving the material for identification and description. To BS Brito, JE Gallao, N Hattori, FD Passos, D Pedroso, B Rantin, PP Rizzato, D Sansone, RC Santos, RH Santos, T Scatolini, L Senna-Horta, LB Simoes, JS Souza, E Trajano, DM Von-Schimonsky, T Zepon, for the help in field; and to JE Gallao and PP Rizzato, for comments on the manuscript.	Ab'Saber A.N, 1977, GEOMORFOLOGIA, V52, P1, DOI DOI 10.3897/ZOOKEYS.150.2109; Barr TC, 1968, EVOLUTIONARY BIOL, V2, P72; Bichuette ME, 2013, AN 32 C BRAS ESP SOC, P95; Bichuette ME, 2004, RES ENC BRAS EST CAR, P20; Bini LM, 2006, DIVERS DISTRIB, V12, P475, DOI 10.1111/j.1366-9516.2006.00286.x; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Campos IS, 2014, ZOOL J LINN SOC-LOND, V172, P360, DOI 10.1111/zoj12172; Cardoso P, 2012, INT J SPELEOL, V41, P83, DOI 10.5038/1827-806X.41.1.9; Christiansen K., 1962, Memoires Spelunca, VNo. 2, P76; Culver D. C., 2009, BIOL CAVES OTHER SUB, P40; Culver DC, 2010, J CRUSTACEAN BIOL, V30, P68, DOI 10.1651/09-3156.1; Diamond J.M, 1975, ECOLOGY EVOLUTION CO; Fiser C, 2012, BIOL LETTERS, V8, P578, DOI 10.1098/rsbl.2012.0125; Gallao JE, 2012, NAT CONSERVACAO, V10, P83, DOI 10.4322/natcon.2012.014; Gibert J, 2002, BIOSCIENCE, V52, P473, DOI 10.1641/0006-3568(2002)052[0473:SEATFB]2.0.CO;2; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Haddad A, 2007, TECNICAS MICROSCOPIA, V3rd; Holdich D.M., 1984, Symposia of the Zoological Society of London, P9; HOLDICH DM, 1974, J ZOOL, V172, P469; Hornung Elisabeth, 2011, Terrestrial Arthropod Reviews, V4, P95, DOI 10.1163/187498311X576262; HOWARTH FG, 1993, AM NAT, V142, pS65, DOI 10.1086/285523; Howarth FG, 2012, ENCY CAVES, P230; Hutchinson G.E., 1959, AM NAT, V93, P342; Jongman RHG, 1995, DATA ANAL COMMUNITY; Karmann I, 1979, ESPELEO TEMA, V14, P43; KEDDY PA, 1992, J VEG SCI, V3, P157, DOI 10.2307/3235676; Langecker TG, 2000, ECOSYSTEMS WORLD 30, P17; Maire E, 2015, GLOBAL ECOL BIOGEOGR, V24, P728, DOI 10.1111/geb.12299; Moura VM, 2008, O CARSTE, V20, P76; Palacios-Vargas JG, 2013, TECNICAS ATUAIS ESTU; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Pipan T, 2012, BIOL J LINN SOC, V107, P1, DOI 10.1111/j.1095-8312.2012.01964.x; POULSON TL, 1969, SCIENCE, V165, P971; Quadros AF, 2008, REV BRAS ZOOL, V25, P58, DOI 10.1590/S0101-81752008000100009; R Core Team, 2020, R LANG ENV STAT COMP; Schmalfuss H., 1984, Symposia of the Zoological Society of London, P49; SCHMALFUSS H, 1978, ZOOMORPHOLOGIE, V91, P263, DOI 10.1007/BF00999815; Simoes Luiza Bertelli, 2013, Subterranean Biology, V11, P55, DOI 10.3897/subtbiol.11.5981; Swenson NG, 2014, USE R, P1, DOI 10.1007/978-1-4614-9542-0; Taiti S, 2003, ENCY CAVES KARST SCI, P547; Tilman D, 2000, NATURE, V405, P208, DOI 10.1038/35012217; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; TRAJANO E, 2012, ESPELEO TEMA, V23, P13; TRAJANO E., 2012, ENCY CAVES, P295, DOI DOI 10.1016/B978-0-12-383832-2.00040-2; Trajano E, 2003, O CARSTE, V15, P114; Trajano E., 2012, ENCY CAVES, P275, DOI DOI 10.1016/B978-0-12-383832-2.00035-9; Trajano Eleonora, 2009, Subterranean Biology, V7, P1; Trontelj P, 2012, EVOLUTION, V66, P3852, DOI 10.1111/j.1558-5646.2012.01734.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; WEIHER E, 1995, OIKOS, V74, P159, DOI 10.2307/3545686; Wilkens H, 2011, HEREDITY, V106, P707, DOI 10.1038/hdy.2010.105; Zimmer M, 2002, BIOL REV, V77, P455, DOI 10.1017/S1464793102005912	53	27	28	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151958	10.1371/journal.pone.0151958	http://dx.doi.org/10.1371/journal.pone.0151958			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003837	Green Submitted, Green Published, gold			2022-12-26	WOS:000372697400059
J	Stressler, T; Ewert, J; Merz, M; Funk, J; Claaen, W; Lutz-Wahl, S; Schmidt, H; Kuhn, A; Fischer, L				Stressler, Timo; Ewert, Jacob; Merz, Michael; Funk, Joshua; Claaen, Wolfgang; Lutz-Wahl, Sabine; Schmidt, Herbert; Kuhn, Andreas; Fischer, Lutz			A Novel Glutamyl (Aspartyl)-Specific Aminopeptidase A from Lactobacillus delbrueckii with Promising Properties for Application	PLOS ONE			English	Article							PURIFICATION; HYDROLYSIS	Lactic acid bacteria (LAB) are auxotrophic for a number of amino acids. Thus, LAB have one of the strongest proteolytic systems to acquit their amino acid requirements. One of the intracellular exopeptidases present in LAB is the glutamyl (aspartyl) specific aminopeptidase (PepA; EC 3.4.11.7). Most of the PepA enzymes characterized yet, belonged to Lactococcus lactis sp., but no PepA from a Lactobacillus sp. has been characterized so far. In this study, we cloned a putative pepA gene from Lb. delbrueckii ssp. lactis DSM 20072 and characterized it after purification. For comparison, we also cloned, purified and characterized PepA from Lc. lactis ssp. lactis DSM 20481. Due to the low homology between both enzymes (30%), differences between the biochemical characteristics were very likely. This was confirmed, for example, by the more acidic optimum pH value of 6.0 for Lb-PepA compared to pH 8.0 for Lc-PepA. In addition, although the optimum temperature is quite similar for both enzymes (Lb-PepA: 60 degrees C; Lc-PepA: 65 degrees C), the temperature stability after three days, 20 degrees C below the optimum temperature, was higher for Lb-PepA (60% residual activity) than for Lc-PepA (2% residual activity). EDTA inhibited both enzymes and the strongest activation was found for CoCl2, indicating that both enzymes are metallopeptidases. In contrast to Lc-PepA, disulfide bond-reducing agents such as dithiothreitol did not inhibit Lb-PepA. Finally, Lb-PepA was not product-inhibited by L-Glu, whereas Lc-PepA showed an inhibition.	[Stressler, Timo; Ewert, Jacob; Merz, Michael; Claaen, Wolfgang; Lutz-Wahl, Sabine; Fischer, Lutz] Univ Hohenheim, Inst Food Sci & Biotechnol, Dept Biotechnol & Enzyme Sci, Stuttgart, Germany; [Funk, Joshua; Schmidt, Herbert] Univ Hohenheim, Inst Food Sci & Biotechnol, Dept Food Microbiol & Hyg, Stuttgart, Germany; [Kuhn, Andreas] Univ Hohenheim, Inst Microbiol, Stuttgart, Germany	University Hohenheim; University Hohenheim; University Hohenheim	Stressler, T (corresponding author), Univ Hohenheim, Inst Food Sci & Biotechnol, Dept Biotechnol & Enzyme Sci, Stuttgart, Germany.	t.stressler@uni-hohenheim.de		Merz, Michael/0000-0002-1975-8175; Schmidt, Herbert/0000-0001-6046-4198				Aaslyng MD, 1998, J AGR FOOD CHEM, V46, P5225, DOI 10.1021/jf9806816; Altermann E, 2005, P NATL ACAD SCI USA, V102, P3906, DOI 10.1073/pnas.0409188102; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bacon CL, 1994, INT DAIRY J, V4, P503, DOI 10.1016/0958-6946(94)90022-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brena Beatriz M., 2006, V22, P15; Caplice E, 1999, INT J FOOD MICROBIOL, V50, P131, DOI 10.1016/S0168-1605(99)00082-3; Carr FJ, 2002, CRIT REV MICROBIOL, V28, P281, DOI 10.1080/1040-840291046759; EXTERKATE FA, 1987, APPL ENVIRON MICROB, V53, P577, DOI 10.1128/AEM.53.3.577-583.1987; Girono L, 2000, TRENDS BIOTECHNOL, V18, P339, DOI 10.1016/S0167-7799(00)01472-4; GISH W, 1993, NAT GENET, V3, P266, DOI 10.1038/ng0393-266; IANSON KJA, 1995, MICROBIOL-UK, V141, P2873, DOI 10.1099/13500872-141-11-2873; Kim D, 2010, BIOCHEM BIOPH RES CO, V391, P431, DOI 10.1016/j.bbrc.2009.11.075; Kleerebezem M, 2003, CURR OPIN BIOTECH, V14, P232, DOI 10.1016/S0958-1669(03)00033-8; Kunji ERS, 1996, ANTON LEEUW INT J G, V70, P187, DOI 10.1007/BF00395933; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Mayo B., 2010, BIOTECHNOLOGY LACTIC, P3, DOI DOI 10.1002/9780813820866.CH1; Merz M., 2015, EUR FOOD RES TECHNOL, V241, P1; Merz M, 2016, J SCI FOOD AGR, V96, P3358, DOI 10.1002/jsfa.7515; Merz M, 2015, BIOCHEM ENG J, V99, P114, DOI 10.1016/j.bej.2015.03.019; Merza M, 2015, J MOL CATAL B-ENZYM, V122, P218, DOI 10.1016/j.molcatb.2015.09.010; NIKKILA P, 1995, J GEN APPL MICROBIOL, V41, P327, DOI 10.2323/jgam.41.327; NIVEN GW, 1991, J GEN MICROBIOL, V137, P1207, DOI 10.1099/00221287-137-5-1207; Rios GM, 2004, J MEMBRANE SCI, V242, P189, DOI 10.1016/j.memsci.2003.06.004; Rombouts I, 2009, J CHROMATOGR A, V1216, P5557, DOI 10.1016/j.chroma.2009.05.066; SALES MGR, 1995, AM J CLIN NUTR, V62, P87, DOI 10.1093/ajcn/62.1.87; Sambrook J., 2001, MOL CLONING LAB MANU; Schlichtherle-Cerny H, 2002, J AGR FOOD CHEM, V50, P1515, DOI 10.1021/jf010989o; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stressler T, 2014, J MOL CATAL B-ENZYM, V108, P103, DOI 10.1016/j.molcatb.2014.07.006; Stressler T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070055; Stressler T, 2012, AMB EXPRESS, V2, DOI 10.1186/2191-0855-2-39; TAN PST, 1991, APPL ENVIRON MICROB, V57, P3593, DOI 10.1128/AEM.57.12.3593-3599.1991	33	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152139	10.1371/journal.pone.0152139	http://dx.doi.org/10.1371/journal.pone.0152139			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003449	Green Published, Green Submitted, gold			2022-12-26	WOS:000372697400084
J	Wu, PS; Feldman, AS; Rosas-Salazar, C; James, K; Escobar, G; Gebretsadik, T; Li, SX; Carroll, KN; Walsh, E; Mitchel, E; Das, S; Kumar, R; Yu, C; Dupont, WD; Hartert, TV				Wu, Pingsheng; Feldman, Amy S.; Rosas-Salazar, Christian; James, Kristina; Escobar, Gabriel; Gebretsadik, Tebeb; Li, Sherian Xu; Carroll, Kecia N.; Walsh, Eileen; Mitchel, Edward; Das, Suman; Kumar, Rajesh; Yu, Chang; Dupont, William D.; Hartert, Tina V.			Relative Importance and Additive Effects of Maternal and Infant Risk Factors on Childhood Asthma	PLOS ONE			English	Article							LONG-TERM IMPACTS; GUT MICROBIOTA; CESAREAN-SECTION; INTESTINAL MICROBIOTA; ANTIBIOTIC-TREATMENT; VIRUS-INFECTION; EXPOSURE; CHILDREN; DELIVERY; OLIGOSACCHARIDES	Background Environmental exposures that occur in utero and during early life may contribute to the development of childhood asthma through alteration of the human microbiome. The objectives of this study were to estimate the cumulative effect and relative importance of environmental exposures on the risk of childhood asthma. Methods We conducted a population-based birth cohort study of mother-child dyads who were born between 1995 and 2003 and were continuously enrolled in the PRIMA (Prevention of RSV: Impact on Morbidity and Asthma) cohort. The individual and cumulative impact of maternal urinary tract infections (UTI) during pregnancy, maternal colonization with group B streptococcus (GBS), mode of delivery, infant antibiotic use, and older siblings at home, on the risk of childhood asthma were estimated using logistic regression. Dose-response effect on childhood asthma risk was assessed for continuous risk factors: number of maternal UTIs during pregnancy, courses of infant antibiotics, and number of older siblings at home. We further assessed and compared the relative importance of these exposures on the asthma risk. In a subgroup of children for whom maternal antibiotic use during pregnancy information was available, the effect of maternal antibiotic use on the risk of childhood asthma was estimated. Results Among 136,098 singleton birth infants, 13.29% developed asthma. In both univariate and adjusted analyses, maternal UTI during pregnancy (odds ratio [OR] 1.2, 95% confidence interval [CI] 1.18, 1.25; adjusted OR [AOR] 1.04, 95% CI 1.02, 1.07 for every additional UTI) and infant antibiotic use (OR 1.21, 95% CI 1.20, 1.22; AOR 1.16, 95% CI 1.15, 1.17 for every additional course) were associated with an increased risk of childhood asthma, while having older siblings at home (OR 0.92, 95% CI 0.91, 0.93; AOR 0.85, 95% CI 0.84, 0.87 for each additional sibling) was associated with a decreased risk of childhood asthma, in a dose-dependent manner. Compared with vaginal delivery, C-section delivery increased odds of childhood asthma by 34% (OR 1.34, 95% CI 1.29, 1.39) in the univariate analysis and 11% after adjusting for other environmental exposures and covariates (AOR 1.11, 95% CI 1.06, 1.15). Maternal GBS was associated with a significant increased risk of childhood asthma in the univariate analysis (OR 1.27, 95% CI 1.19, 1.35), but not in the adjusted analysis (AOR 1.03, 95% CI 0.96, 1.10). In the subgroup analysis of children whose maternal antibiotic use information was available, maternal antibiotic use was associated with an increased risk of childhood asthma in a similar dose-dependent manner in the univariate and adjusted analyses (OR 1.13, 95% CI 1.12, 1.15; AOR 1.06, 95% CI 1.05, 1.08 for every additional course). Compared with infants with the lowest number of exposures (no UTI during pregnancy, vaginal delivery, at least five older siblings at home, no antibiotics during infancy), infants with the highest number of exposures (at least three UTIs during pregnancy, C-section delivery, no older siblings, eight or more courses of antibiotics during infancy) had a 7.77 fold increased odds of developing asthma (AOR: 7.77, 95% CI: 6.25, 9.65). Lastly, infant antibiotic use had the greatest impact on asthma risk compared with maternal UTI during pregnancy, mode of delivery and having older siblings at home. Conclusion Early-life exposures, maternal UTI during pregnancy (maternal antibiotic use), mode of delivery, infant antibiotic use, and having older siblings at home, are associated with an increased risk of childhood asthma in a cumulative manner, and for those continuous variables, a dose-dependent relationship. Compared with in utero exposures, exposures occurring during infancy have a greater impact on the risk of developing childhood asthma.	[Wu, Pingsheng; Feldman, Amy S.; Hartert, Tina V.] Vanderbilt Univ, Sch Med, Div Allergy Pulm & Crit Care Med, Dept Med, Nashville, TN 37212 USA; [Wu, Pingsheng; Feldman, Amy S.; Hartert, Tina V.] Vanderbilt Univ, Sch Med, Ctr Asthma & Environm Sci Res, Nashville, TN 37212 USA; [Wu, Pingsheng; Gebretsadik, Tebeb; Yu, Chang; Dupont, William D.] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA; [Rosas-Salazar, Christian; Carroll, Kecia N.] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37212 USA; [James, Kristina] Peninsula Allergy & Asthma Ctr, Soldotna, AK USA; [Escobar, Gabriel] Kaiser Permanente Med Care Program, Oakland, CA USA; [Escobar, Gabriel; Li, Sherian Xu; Walsh, Eileen] Kaiser Permanente No Calif, Div Res, Perinatal Res Unit, Oakland, CA USA; [Mitchel, Edward] Vanderbilt Univ, Sch Med, Dept Hlth Policy, Nashville, TN 37212 USA; [Das, Suman] J Craig Venter Inst, Rockville, MD USA; [Kumar, Rajesh] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Kumar, Rajesh] Northwestern Univ, Chicago, IL 60611 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Kaiser Permanente; Kaiser Permanente; Vanderbilt University; J. Craig Venter Institute; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University	Wu, PS (corresponding author), Vanderbilt Univ, Sch Med, Div Allergy Pulm & Crit Care Med, Dept Med, Nashville, TN 37212 USA.; Wu, PS (corresponding author), Vanderbilt Univ, Sch Med, Ctr Asthma & Environm Sci Res, Nashville, TN 37212 USA.; Wu, PS (corresponding author), Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN 37212 USA.	pingsheng.wu@vanderbilt.edu	Das, Suman/ABB-7273-2020; Rosas-Salazar, Christian/AAC-8571-2021	Das, Suman/0000-0003-2496-9724; Rosas-Salazar, Christian/0000-0001-6644-5780; Kumar, Rajesh/0000-0002-1962-7108	Agency for Healthcare Research and Quality [R01 HS018454]; NIH [K24 AI 077930]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI110819, K24AI077930] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the Agency for Healthcare Research and Quality [R01 HS018454; to TVH] and NIH [K24 AI 077930; to TVH]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Alm B, 2008, PEDIATRICS, V121, P697, DOI 10.1542/peds.2007-1232; Azad MB, 2013, ALLERGY ASTHMA CL IM, V9, DOI 10.1186/1710-1492-9-15; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bager P, 2008, CLIN EXP ALLERGY, V38, P634, DOI 10.1111/j.1365-2222.2008.02939.x; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Barile D, 2013, CURR OPIN BIOTECH, V24, P214, DOI 10.1016/j.copbio.2013.01.008; Biasucci G, 2010, EARLY HUM DEV, V86, pS13, DOI 10.1016/j.earlhumdev.2010.01.004; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Colombo DF, 2006, AM J OBSTET GYNECOL, V194, P466, DOI 10.1016/j.ajog.2005.07.098; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Escobar GJ, 2013, J PEDIATR INFECT DIS, V2, P205, DOI 10.1093/jpids/pit007; Funkhouser LJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001631; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Hanson LA, 2003, ANN ALLERG ASTHMA IM, V90, P59, DOI 10.1016/S1081-1206(10)61662-6; Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019; Harrell FE, 2015, SPRINGER SER STAT, P1, DOI 10.1007/978-3-319-19425-7_1; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2013, CURR ALLERGY ASTHMA; Huang YJ, 2015, J ALLERGY CLIN IMMUN, V135, P25, DOI 10.1016/j.jaci.2014.11.011; Huang Yvonne J, 2014, Ann Am Thorac Soc, V11 Suppl 1, pS48, DOI 10.1513/AnnalsATS.201306-187MG; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Isolauri E, 2012, GASTROENTEROL CLIN N, V41, P747, DOI 10.1016/j.gtc.2012.08.007; Isolauri E, 2012, J PAEDIATR CHILD H, V48, P1, DOI 10.1111/j.1440-1754.2012.02489.x; Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Kozyrskyj AL, 2007, CHEST, V131, P1753, DOI 10.1378/chest.06-3008; Magnus MC, 2011, AM J EPIDEMIOL, V174, P1275, DOI 10.1093/aje/kwr242; Malveaux FJ, 2009, PEDIATRICS, V123, pS129, DOI 10.1542/peds.2008-2233B; Marra F, 2009, PEDIATRICS, V123, P1003, DOI 10.1542/peds.2008-1146; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Midodzi WK, 2010, J ASTHMA, V47, P7, DOI 10.3109/02770900903380996; Moeller AH, 2013, GUT MICROBES, V4, P403, DOI 10.4161/gmic.26039; Myles I, 2013, J IMMUNOL, V190; Ownby DR, 2002, JAMA-J AM MED ASSOC, V288, P963, DOI 10.1001/jama.288.8.963; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Penders J, 2007, GUT, V56, P661, DOI 10.1136/gut.2006.100164; Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824; R Core Team, 2013, R LANG ENV STAT COMP; Risnes KR, 2011, AM J EPIDEMIOL, V173, P310, DOI 10.1093/aje/kwq400; Roduit C, 2009, THORAX, V64, P107, DOI 10.1136/thx.2008.100875; Shilts MH, 2015, MICROB ECOL; Sjolund M, 2003, ANN INTERN MED, V139, P483, DOI 10.7326/0003-4819-139-6-200309160-00011; Stensballe LG, 2013, J PEDIATR-US, V162, P832, DOI 10.1016/j.jpeds.2012.09.049; Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x; Tollanes MC, 2008, J PEDIATR-US, V153, P112, DOI 10.1016/j.jpeds.2008.01.029; Torrazza RM, 2011, J PERINATOL, V31, pS29, DOI 10.1038/jp.2010.172; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Vael C, 2009, CURR OPIN PEDIATR, V21, P794, DOI 10.1097/MOP.0b013e328332351b; Vaishampayan PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/gbe/evp057; Valles Y, 2012, CLIN MICROBIOL INFEC, V18, P21, DOI 10.1111/j.1469-0691.2012.03876.x; Wakefield DB, 2006, PEDIATR PULM, V41, P962, DOI 10.1002/ppul.20476; Ward RE, 2006, APPL ENVIRON MICROB, V72, P4497, DOI 10.1128/AEM.02515-05; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Wu PS, 2008, AM J RESP CRIT CARE, V178, P1123, DOI 10.1164/rccm.200804-579OC	59	45	47	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151705	10.1371/journal.pone.0151705	http://dx.doi.org/10.1371/journal.pone.0151705			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002979	gold, Green Submitted, Green Published			2022-12-26	WOS:000372697400038
J	Maestri, R; Patterson, BD				Maestri, Renan; Patterson, Bruce D.			Patterns of Species Richness and Turnover for the South American Rodent Fauna	PLOS ONE			English	Article							LATITUDINAL DIVERSITY GRADIENT; SPATIAL-ANALYSIS; BETA-DIVERSITY; DIVERSIFICATION; PHYLOGENY; MAMMALS; CONSERVATISM; BIOGEOGRAPHY; RANGES; RATES	Understanding the spatial distribution of species sheds light on the group's biogeographical history, offers clues to the drivers of diversity, and helps to guide conservation strategies. Here, we compile geographic range information for South America's diverse rodents, whose 14 families comprise similar to 50% of the continent's mammalian species. The South American rodent fauna is dominated by independent and temporally staggered radiations of caviomorph and sigmodontine groups. We mapped species richness and turnover of all rodents and the principal clades to identify the main predictors of diversity patterns. Species richness was highest in the Andes, with a secondary hotspot in Atlantic Forest and some regions of considerable richness in Amazonia. Differences in richness were evident between the caviomorphs and sigmodontines, the former showing the greatest richness in tropical forests whereas the latter show-and largely determine-the all-rodent pattern. Elevation was the main predictor of sigmodontine richness, whereas temperature was the principal variable correlated with richness of caviomorphs. Across clades, species turnover was highest along the Andes and was best explained by elevational relief. In South America, the effects of the familiar latitudinal gradient in species richness are mixed with a strong longitudinal effect, triggered by the importance of elevation and the position of the Andes. Both latitudinal and elevational effects help explain the complicated distribution of rodent diversity across the continent. The continent's restricted-range species-those seemingly most vulnerable to localized disturbance-are mostly distributed along the Andes and in Atlantic Forest, with the greatest concentration in Ecuador. Both the Andes and Atlantic Forest are known hotspots for other faunal and floral components. Contrasting patterns of the older caviomorph and younger sigmodontine radiations underscore the interplay of both historical and ecological factors in determining present-day diversity patterns.	[Maestri, Renan] Univ Fed Rio Grande do Sul, Programa Posgrad Ecol, BR-91501970 Porto Alegre, RS, Brazil; [Patterson, Bruce D.] Field Museum Nat Hist, Integrat Res Ctr, Chicago, IL 60605 USA	Universidade Federal do Rio Grande do Sul; Field Museum of Natural History (Chicago)	Maestri, R (corresponding author), Univ Fed Rio Grande do Sul, Programa Posgrad Ecol, BR-91501970 Porto Alegre, RS, Brazil.	renanmaestri@gmail.com	Maestri, Renan/L-2637-2015; Patterson, Bruce D/O-5068-2019	Maestri, Renan/0000-0001-9134-2943; Patterson, Bruce D/0000-0002-2249-7260	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES foundation) [4087/14-3]; Barbara E. Brown Fund for Mammal Research (FMNH)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES foundation)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Barbara E. Brown Fund for Mammal Research (FMNH)	RM thanks Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES foundation) for the sandwich fellowship, process number 4087/14-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Primary thanks are due the systematists and biogeographers who are responsible for refining species limits and geographic ranges in South America. We also thank Jessica Mohlman for her work compiling species ranges from the accounts in [27], funded by the Barbara E. Brown Fund for Mammal Research (FMNH).	Amori G, 2013, MAMMALIA, V77, P1, DOI 10.1515/mammalia-2012-0050; [Anonymous], 2012, BONES CLONES BIOMES; Badgley C, 2010, ECOGRAPHY, V33, P220, DOI 10.1111/j.1600-0587.2010.06282.x; Barton K., 2013, MUMIN MULTI MODEL IN; Baselga A, 2013, BETAPART PARTITIONIN; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Begon M, 2006, ECOLOGY INDIVIDUALS, V4th; Borcard D, 2002, ECOL MODEL, V153, P51, DOI 10.1016/S0304-3800(01)00501-4; Bromham L, 2003, J EVOLUTION BIOL, V16, P200, DOI 10.1046/j.1420-9101.2003.00526.x; Buckley LB, 2010, P ROY SOC B-BIOL SCI, V277, P2131, DOI 10.1098/rspb.2010.0179; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Diniz JAF, 2005, GLOBAL ECOL BIOGEOGR, V14, P177, DOI 10.1111/j.1466-822X.2005.00147.x; Fabre PH, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-88; GRAVES GR, 1988, AUK, V105, P47, DOI 10.1093/auk/105.1.47; Gross J., 2003, R NEWS, V3, P13; Hawkins BA, 2003, ECOLOGY, V84, P1608, DOI 10.1890/0012-9658(2003)084[1608:PAHAPO]2.0.CO;2; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; IUCN, 2010, IUCN REDL THREAT SPE; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Jetz W, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001292; KAUFMAN DM, 1995, J MAMMAL, V76, P322, DOI 10.2307/1382344; Kerkhoff AJ, 2014, P NATL ACAD SCI USA, V111, P8125, DOI 10.1073/pnas.1308932111; Kier G, 2009, P NATL ACAD SCI USA, V106, P9322, DOI 10.1073/pnas.0810306106; Leite RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100687; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Lessa EP, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00039; Lopez-Gonzalez C, 2015, ECOGRAPHY, V38, P261, DOI 10.1111/ecog.00813; Mares M.A., 1982, Pymatuning Laboratory of Ecology Special Publications, V6, P393; McKnight MW, 2007, PLOS BIOL, V5, P2424, DOI 10.1371/journal.pbio.0050272; Melo AS, 2009, ECOGRAPHY, V32, P226, DOI 10.1111/j.1600-0587.2008.05502.x; Musser GG, 2005, MAMMAL SPECIES WORLD, P1; Ojeda R.A., 2013, ENCY BIODIVERSITY, P582, DOI [10.1016/B978-0-12-384719-5.00353-1, DOI 10.1016/B978-0-12-384719-5.00353-1]; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Parada A, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0440-z; Parada A, 2013, MOL PHYLOGENET EVOL, V66, P960, DOI 10.1016/j.ympev.2012.12.001; Patterson BD, 1999, J MAMMAL, V80, P345, DOI 10.2307/1383284; Patterson Bruce D., 2000, Diversity and Distributions, V6, P145, DOI 10.1046/j.1472-4642.2000.00080.x; Patterson BD, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00044; Patterson Bruce D., 2012, P351; Patton J.L., 1990, P355; Patton J.L., 2015, MAMMALS S AM, V2; PATTON JL, 1992, EVOLUTION, V46, P174, DOI 10.1111/j.1558-5646.1992.tb01992.x; R Core Team, 2016, R FDN STAT COMP; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; Pereira MJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069245; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Rangel TFLVB, 2006, GLOBAL ECOL BIOGEOGR, V15, P321, DOI 10.1111/j.1466-822x.2006.00237.x; Rodriguez P, 2004, ECOGRAPHY, V27, P547, DOI 10.1111/j.0906-7590.2004.03788.x; ROHDE K, 1992, OIKOS, V65, P514, DOI 10.2307/3545569; Rowe DL, 2010, J BIOGEOGR, V37, P305, DOI 10.1111/j.1365-2699.2009.02190.x; Ruggiero A, 2004, ECOGRAPHY, V27, P401, DOI 10.1111/j.0906-7590.2004.03801.x; RUGGIERO A, 1994, J BIOGEOGR, V21, P545, DOI 10.2307/2845657; Ruggiero A, 1998, J BIOGEOGR, V25, P1093, DOI 10.1046/j.1365-2699.1998.00253.x; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; SIMPSON GG, 1964, SYST ZOOL, V13, P57, DOI 10.2307/2411825; Sokal RR, 1998, BIOL J LINN SOC, V65, P41, DOI 10.1111/j.1095-8312.1998.tb00350.x; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Stevens RD, 2013, BIOTROPICA, V45, P764, DOI 10.1111/btp.12056; Tamma K, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0289-1; TERBORGH J, 1974, BIOSCIENCE, V24, P715, DOI 10.2307/1297090; TERBORGH J, 1971, Ecology (Washington D C), V52, P23, DOI 10.2307/1934735; Tognelli MF, 2004, ECOGRAPHY, V27, P427, DOI 10.1111/j.0906-7590.2004.03732.x; Upham NS, 2012, MOL PHYLOGENET EVOL, V63, P417, DOI 10.1016/j.ympev.2012.01.020; Upham NS., 2015, BIOL CAVIOMORPH RODE, P63; Vilela JF, 2014, J ZOOL SYST EVOL RES, V52, P249, DOI 10.1111/jzs.12057; Voss RS, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)421<0001:ANSOTR>2.0.CO;2; Vucetich MG, 2015, BIOL CAVIOMORPH RODE, P11; Willig MR, 2016, J TROP ECOL, V32, P421, DOI 10.1017/S0266467415000589; Willig MR, 2003, BAT ECOLOGY, P580; WRIGHT DH, 1983, OIKOS, V41, P496, DOI 10.2307/3544109	72	41	56	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151895	10.1371/journal.pone.0151895	http://dx.doi.org/10.1371/journal.pone.0151895			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999278	Green Published, gold, Green Submitted			2022-12-26	WOS:000372694700080
J	Roth, I; Campbell, H; Rubio, C; Vennin, C; Wilson, M; Wiles, A; Williams, G; Woolley, A; Timpson, P; Berridge, MV; Fleming, N; Baird, M; Braithwaite, AW				Roth, I.; Campbell, H.; Rubio, C.; Vennin, C.; Wilson, M.; Wiles, A.; Williams, G.; Woolley, A.; Timpson, P.; Berridge, M. V.; Fleming, N.; Baird, M.; Braithwaite, A. W.			The Delta 133p53 isoform and its mouse analogue Delta 122p53 promote invasion and metastasis involving pro-inflammatory molecules interleukin-6 and CCL2	ONCOGENE			English	Article							RENAL-CELL CARCINOMA; P53 ISOFORMS; ANGIOGENESIS; EXPRESSION; CANCER; INHIBITOR; MIGRATION; MOTILITY; MUTANT	A number of naturally occurring isoforms of the tumour suppressor protein p53 have been discovered, which appear to have differing roles in tumour prevention or promotion. We are investigating the tumour-promoting activities of the Delta 133p53 isoform using our mouse model of Delta 133p53 (Delta 122p53). Here, we report that tumours from Delta 122p53 homozygous mice show evidence of invasion and metastasis and that Delta 122p53 promotes migration though a 3-dimensional collagen matrix. We also show that Delta 122p53 and Delta 133p53 promote cell migration in scratch wound and Transwell assays, similar to the 'gain-of-function' phenotypes seen with mutant p53. Using the well-defined B16 mouse melanoma metastatic model, we show that Delta 122p53 leads to faster generation of lung metastases. The increased migratory phenotypes are dependent on secreted factors, including the cytokine interleukin-6 and the chemokine CCL2. We propose that Delta 122p53 (and Delta 133p53) acts in a similar manner to 'gain-of-function' mutant p53 proteins to promote migration, invasion and metastasis, which may contribute to poor survival in patients with Delta 133p53-expressing tumours.	[Roth, I.; Wilson, M.; Wiles, A.; Williams, G.; Woolley, A.; Fleming, N.; Baird, M.; Braithwaite, A. W.] Univ Otago, Dunedin Sch Med, Dept Pathol, 58 Hanover St, Dunedin, New Zealand; [Roth, I.; Baird, M.; Braithwaite, A. W.] Univ Auckland, Sch Biol Sci, Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand; [Campbell, H.; Rubio, C.; Braithwaite, A. W.] Univ Sydney, Childrens Med Res Inst, Sydney, NSW, Australia; [Vennin, C.; Timpson, P.] Garvan Inst Med Res, Sydney, NSW, Australia; [Berridge, M. V.] Malaghan Inst Med Res, Wellington, New Zealand	University of Otago; University of Auckland; Children's Medical Research Institute - Australia; University of Sydney; Garvan Institute of Medical Research; Malaghan Institute; Victoria University Wellington	Braithwaite, AW (corresponding author), Univ Otago, Dunedin Sch Med, Dept Pathol, 58 Hanover St, Dunedin, New Zealand.	antony.braithwaite@otago.ac.nz	Timpson, Paul/A-9429-2016	Berridge, Michael/0000-0003-2619-7473; Vennin, Claire/0000-0001-9088-4177; Timpson, Paul/0000-0002-5514-7080	Health Research Council of New Zealand; Marsden Fund; Maurice Wilkins Centre for Molecular Biodiscovery; Cancer Council NSW; National Health and Medical Research Council	Health Research Council of New Zealand(Health Research Council of New Zealand); Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Maurice Wilkins Centre for Molecular Biodiscovery; Cancer Council NSW(Cancer Council New South Wales); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Health Research Council of New Zealand, Marsden Fund, Maurice Wilkins Centre for Molecular Biodiscovery, Cancer Council NSW and National Health and Medical Research Council.	Alexandrova A, 2000, ONCOGENE, V19, P5826, DOI 10.1038/sj.onc.1203944; Anensen N, 2006, CLIN CANCER RES, V12, P3985, DOI 10.1158/1078-0432.CCR-05-1970; Avery-Kiejda KA, 2008, CLIN CANCER RES, V14, P1659, DOI 10.1158/1078-0432.CCR-07-1422; Bernard H, 2013, ONCOGENE, V32, P2150, DOI 10.1038/onc.2012.242; BLAY JY, 1992, CANCER RES, V52, P3317; Boldrup L, 2007, EUR J CANCER, V43, P617, DOI 10.1016/j.ejca.2006.10.019; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Bystry RS, 2001, NAT IMMUNOL, V2, P1126, DOI 10.1038/ni735; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; DAVATELIS G, 1988, J EXP MED, V167, P1939, DOI 10.1084/jem.167.6.1939; FIDLER IJ, 1973, NATURE-NEW BIOL, V242, P148, DOI 10.1038/newbio242148a0; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; Gadea G, 2002, EMBO J, V21, P2373, DOI 10.1093/emboj/21.10.2373; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Gudkov Andrei V, 2011, Genes Cancer, V2, P503, DOI 10.1177/1947601911409747; Guo FK, 2004, ONCOGENE, V23, P5577, DOI 10.1038/sj.onc.1207752; Guo FK, 2003, J BIOL CHEM, V278, P14414, DOI 10.1074/jbc.M300341200; Hafsi H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-134; Hofstetter G, 2010, ONCOGENE, V29, P1997, DOI 10.1038/onc.2009.482; JOHNSON RK, 1979, INT J RADIAT ONCOL, V5, P1605, DOI 10.1016/0360-3016(79)90782-X; Marcel V, 2011, CELL DEATH DIFFER, V18, P1815, DOI 10.1038/cdd.2011.120; Muller PAJ, 2011, J CELL BIOL, V192, P209, DOI 10.1083/jcb.201009059; Muller PAJ, 2009, CELL, V139, P1327, DOI 10.1016/j.cell.2009.11.026; Nutthasirikul N, 2013, INT J ONCOL, V42, P1181, DOI 10.3892/ijo.2013.1818; RASTINEJAD F, 1989, CELL, V56, P345, DOI 10.1016/0092-8674(89)90238-9; Ravi R, 2000, GENE DEV, V14, P34; Senturk S, 2014, P NATL ACAD SCI USA, V111, pE3287, DOI 10.1073/pnas.1321640111; Slatter TL, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.149; Slatter TL, 2011, BLOOD, V117, P5166, DOI 10.1182/blood-2010-11-321851; Song W, 2009, CHINESE MED J-PEKING, V122, P921, DOI 10.3760/cma.j.issn.0366-6999.2009.08.008; Timpson P, 2011, JOVE-J VIS EXP, DOI 10.3791/3089	33	23	23	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 22	2016	35	38					4981	4989		10.1038/onc.2016.45	http://dx.doi.org/10.1038/onc.2016.45			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DW9GT	26996665				2022-12-26	WOS:000383965300003
J	Plotner, M; Over, H; Carpenter, M; Tomasello, M				Ploetner, Maria; Over, Harriet; Carpenter, Malinda; Tomasello, Michael			What Is a Group? Young Children's Perceptions of Different Types of Groups and Group Entitativity	PLOS ONE			English	Article							INTERGROUP ATTITUDES; INTUITIVE THEORIES; EVOLUTION; REPRESENTATIONS; COLLABORATION; COOPERATION; CATEGORIES; VARIETIES; LANGUAGE; PEOPLE	To date, developmental research on groups has focused mainly on in-group biases and intergroup relations. However, little is known about children's general understanding of social groups and their perceptions of different forms of group. In this study, 5- to 6-year-old children were asked to evaluate prototypes of four key types of groups: an intimacy group (friends), a task group (people who are collaborating), a social category (people who look alike), and a loose association (people who coincidently meet at a tram stop). In line with previous work with adults, the vast majority of children perceived the intimacy group, task group, and social category, but not the loose association, to possess entitativity, that is, to be a 'real group.' In addition, children evaluated group member properties, social relations, and social obligations differently in each type of group, demonstrating that young children are able to distinguish between different types of in-group relations. The origins of the general group typology used by adults thus appear early in development. These findings contribute to our knowledge about children's intuitive understanding of groups and group members' behavior.	[Ploetner, Maria; Carpenter, Malinda; Tomasello, Michael] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Over, Harriet] Univ York, York YO10 5DD, N Yorkshire, England; [Carpenter, Malinda] Univ St Andrews, St Andrews, Fife, Scotland	Max Planck Society; University of York - UK; University of St Andrews	Plotner, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.	maria_ploetner@eva.mpg.de		Carpenter, Malinda/0000-0003-3983-2034; Over, Harriet/0000-0001-9461-043X	ESRC [ES/K006702/1]	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	We thank the ESRC for supporting H. Over (grant number ES/K006702/1) and Roger Mundry for help with statistical analyses.	Aboud F., 1988, CHILDREN PREJUDICE; Adams DC, 1996, ANIM BEHAV, V51, P733, DOI 10.1006/anbe.1996.0077; Bennett M, 2008, DEVELOPMENTAL SCI, V11, P69, DOI 10.1111/j.1467-7687.2007.00642.x; Bennett M, 2011, INFANT CHILD DEV, V20, P353, DOI 10.1002/icd.741; Bigler RS, 2006, ADV CHILD DEV BEHAV, V34, P39, DOI 10.1016/S0065-2407(06)80004-2; BRATMAN ME, 1992, PHILOS REV, V101, P327, DOI 10.2307/2185537; CAMPBELL DT, 1958, BEHAV SCI, V3, P14, DOI 10.1002/bs.3830030103; Diesendruck G, 2006, CHILD DEV, V77, P539, DOI 10.1111/j.1467-8624.2006.00889.x; Diesendruck G, 2011, CHILD DEV PERSPECT, V5, P189, DOI 10.1111/j.1750-8606.2010.00156.x; Diesendruck G, 2011, COGNITIVE DEV, V26, P118, DOI 10.1016/j.cogdev.2010.11.001; Dunham Y, 2008, TRENDS COGN SCI, V12, P248, DOI 10.1016/j.tics.2008.04.006; Dunham Y, 2014, J SOC ISSUES, V70, P81, DOI 10.1111/josi.12048; Dunham Y, 2011, CHILD DEV, V82, P793, DOI 10.1111/j.1467-8624.2011.01577.x; Fiske A.P., 1991, STRUCTURES SOCIAL LI; FISKE AP, 1992, PSYCHOL REV, V99, P689, DOI 10.1037/0033-295X.99.4.689; Gelman SA, 2004, TRENDS COGN SCI, V8, P404, DOI 10.1016/j.tics.2004.07.001; Giraudoux P., 2013, PGIRMESS DATA ANAL E; Graefenhain M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073039; Grafenhain M, 2009, DEV PSYCHOL, V45, P1430, DOI 10.1037/a0016122; Hamann K, 2012, CHILD DEV, V83, P137, DOI 10.1111/j.1467-8624.2011.01695.x; Hamann K, 2011, NATURE, V476, P328, DOI 10.1038/nature10278; Hamilton DL, 1998, APP SOC RES, P47; Harasty A. S., 1996, HDB MOTIVATION COGNI, V3, P347; Hirschfeld LA, 2001, PERS SOC PSYCHOL REV, V5, P107, DOI 10.1207/S15327957PSPR0502_2; Kalish CW, 2008, CHILD DEV, V79, P577, DOI 10.1111/j.1467-8624.2008.01144.x; Kinzler KD, 2007, P NATL ACAD SCI USA, V104, P12577, DOI 10.1073/pnas.0705345104; Kinzler KD, 2011, COGNITION, V119, P1, DOI 10.1016/j.cognition.2010.10.019; Kinzler KD, 2009, SOC COGNITION, V27, P623, DOI 10.1521/soco.2009.27.4.623; Lickel B, 2000, J PERS SOC PSYCHOL, V78, P223, DOI 10.1037/0022-3514.78.2.223; Lickel B, 2006, J EXP SOC PSYCHOL, V42, P28, DOI 10.1016/j.jesp.2005.01.007; Lickel B, 2001, PERS SOC PSYCHOL REV, V5, P129, DOI 10.1207/S15327957PSPR0502_4; Livesley W.J., 1973, PERSON PERCEPTION CH; Manly BFJ, 1997, RANDOMIZATION BOOTST; McGlothlin H, 2005, BRIT J DEV PSYCHOL, V23, P227, DOI 10.1348/026151005x26101; McGlothlin H, 2006, CHILD DEV, V77, P1375, DOI 10.1111/j.1467-8624.2006.00941.x; MCGRAW KO, 1989, J GENET PSYCHOL, V150, P251, DOI 10.1080/00221325.1989.9914595; Misch A, 2014, J EXP CHILD PSYCHOL, V126, P19, DOI 10.1016/j.jecp.2014.02.008; Moore C, 2009, PSYCHOL SCI, V20, P944, DOI 10.1111/j.1467-9280.2009.02378.x; Nesdale D., 2007, CONT PERSPECTIVES SO, P213; Olson KR, 2008, COGNITION, V108, P222, DOI 10.1016/j.cognition.2007.12.003; Patterson MM, 2006, CHILD DEV, V77, P847, DOI 10.1111/j.1467-8624.2006.00906.x; Plotner M, 2015, J EXP CHILD PSYCHOL, V139, P161, DOI 10.1016/j.jecp.2015.05.008; Quintana SM, 1998, APPL PREV PSYCHOL, V7, P27, DOI 10.1016/S0962-1849(98)80020-6; Rhodes M, 2013, CHILD DEV PERSPECT, V7, P12, DOI 10.1111/cdep.12007; Rhodes M, 2012, CHILD DEV, V83, P1900, DOI 10.1111/j.1467-8624.2012.01835.x; Shutts K, 2013, J COGN DEV, V14, P35, DOI 10.1080/15248372.2011.638686; Svirydzenka N, 2010, EUR J SOC PSYCHOL, V40, P611, DOI 10.1002/ejsp.761; Tomasello M, 2012, CURR ANTHROPOL, V53, P673, DOI 10.1086/668207; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Warneken F, 2006, CHILD DEV, V77, P640, DOI 10.1111/j.1467-8624.2006.00895.x; Waxman SR, 2010, EUR J SOC PSYCHOL, V40, P593, DOI 10.1002/ejsp.732; Zar JH, 1999, BIOSTATISTICAL ANAL	52	23	23	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152001	10.1371/journal.pone.0152001	http://dx.doi.org/10.1371/journal.pone.0152001			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3SV	27010484	gold, Green Accepted, Green Published			2022-12-26	WOS:000372708000066
J	Pulford, BD; Krockow, EM; Colman, AM; Lawrence, CL				Pulford, Briony D.; Krockow, Eva M.; Colman, Andrew M.; Lawrence, Catherine L.			Social Value Induction and Cooperation in the Centipede Game	PLOS ONE			English	Article							VALUE ORIENTATION; BACKWARD INDUCTION; MOTIVATION; PREFERENCES; COMPETITION; FAIRNESS; DILEMMAS; OUTCOMES; ISSUES; MODEL	The Centipede game provides a dynamic model of cooperation and competition in repeated dyadic interactions. Two experiments investigated psychological factors driving cooperation in 20 rounds of a Centipede game with significant monetary incentives and anonymous and random re-pairing of players after every round. The main purpose of the research was to determine whether the pattern of strategic choices observed when no specific social value orientation is experimentally induced-the standard condition in all previous investigations of behavior in the Centipede and most other experimental games-is essentially individualistic, the orthodox game-theoretic assumption being that players are individualistically motivated in the absence of any specific motivational induction. Participants in whom no specific state social value orientation was induced exhibited moderately non-cooperative play that differed significantly from the pattern found when an individualistic orientation was induced. In both experiments, the neutral treatment condition, in which no orientation was induced, elicited competitive behavior resembling behavior in the condition in which a competitive orientation was explicitly induced. Trait social value orientation, measured with a questionnaire, influenced cooperation differently depending on the experimentally induced state social value orientation. Cooperative trait social value orientation was a significant predictor of cooperation and, to a lesser degree, experimentally induced competitive orientation was a significant predictor of non-cooperation. The experimental results imply that the standard assumption of individualistic motivation in experimental games may not be valid, and that the results of such investigations need to take into account the possibility that players are competitively motivated.	[Pulford, Briony D.; Krockow, Eva M.; Colman, Andrew M.; Lawrence, Catherine L.] Univ Leicester, Dept Neurosci Psychol & Behav, Leicester, Leics, England; [Lawrence, Catherine L.] Bangor Univ, Sch Psychol, Bangor, Gwynedd, Wales	University of Leicester; Bangor University	Pulford, BD (corresponding author), Univ Leicester, Dept Neurosci Psychol & Behav, Leicester, Leics, England.	bdp5@le.ac.uk	Colman, Andrew M./CBO-8743-2022; Pulford, Briony D/C-1709-2009; Colman, Andrew M./A-3322-2008	Colman, Andrew M./0000-0003-0499-3479; Pulford, Briony D/0000-0001-8636-9957; Colman, Andrew M./0000-0003-0499-3479; Krockow, Eva Maria/0000-0001-8748-9897	Leicester Judgment and Decision Making Endowment Fund [RM43G0176]	Leicester Judgment and Decision Making Endowment Fund	The research reported in this article was supported by the Leicester Judgment and Decision Making Endowment Fund http://www2.le.ac.uk/departments/psychology/research/JDMSP/leicester-judgment-and-decision-making-endowment-fund (Grant RM43G0176) to BDP and AMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann KA, 2016, J CONFLICT RESOLUT, V60, P340, DOI 10.1177/0022002714541854; Ames DR, 2008, J PERS SOC PSYCHOL, V95, P1541, DOI 10.1037/a0013334; Arnsperger C, 2003, ERKENNTNIS, V59, P157, DOI 10.1023/A:1024630228818; Au W. T, 2004, CONT PSYCHOL RES SOC, P71; AUMANN RJ, 1995, GAME ECON BEHAV, V8, P6, DOI 10.1016/S0899-8256(05)80015-6; Aumann RJ, 1998, GAME ECON BEHAV, V23, P97, DOI 10.1006/game.1997.0605; Balliet D, 2009, GROUP PROCESS INTERG, V12, P533, DOI 10.1177/1368430209105040; Bardsley N., 2010, EXPT EC RETHINKING R; Beersma B, 1999, INT J CONFL MANAGE, V10, P385, DOI 10.1108/eb022831; BEM DJ, 1979, J PERS SOC PSYCHOL, V37, P833, DOI 10.1037/0022-3514.37.6.833; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; BINMORE K, 1987, ECON PHILOS, V3, P179, DOI 10.1017/S0266267100002893; Bisgaard S., 2011, TIME SERIES ANAL FOR; Bogaert S, 2008, BRIT J SOC PSYCHOL, V47, P453, DOI 10.1348/014466607X244970; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; Burnham T, 2000, J ECON BEHAV ORGAN, V43, P57, DOI 10.1016/S0167-2681(00)00108-6; Busemeyer JR, 2009, J MATH PSYCHOL, V53, P126, DOI 10.1016/j.jmp.2008.12.007; Chatfield C., 2003, ANAL TIME SERIES INT, V6, DOI 10.4324/9780203491683; COHEN J, 1983, APPL PSYCH MEAS, V7, P249, DOI 10.1177/014662168300700301; Colman AM, 2011, J MATH PSYCHOL, V55, P166, DOI 10.1016/j.jmp.2011.02.001; Cubitt R. P., 1998, Experimental Economics, V1, P115, DOI 10.1023/A:1026435508449; Droste E, 2003, MATH SOC SCI, V46, P291, DOI 10.1016/S0165-4896(03)00065-9; ELGAMAL MA, 1993, J AM STAT ASSOC, V88, P428, DOI 10.2307/2290321; Ellingsen T, 2012, GAME ECON BEHAV, V76, P117, DOI 10.1016/j.geb.2012.05.007; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Feinberg M, 2012, J PERS SOC PSYCHOL, V102, P81, DOI 10.1037/a0025403; Fey M, 1996, INT J GAME THEORY, V25, P269, DOI 10.1007/BF02425258; GRIESINGER DW, 1973, BEHAV SCI, V18, P173, DOI 10.1002/bs.3830180305; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Hilbig BE, 2013, EUR J PERSONALITY, V27, P319, DOI 10.1002/per.1856; IEDEMA J, 1994, J SOC PSYCHOL, V134, P771, DOI 10.1080/00224545.1994.9923012; Krockow EM, 2015, GAMES, V6, P262, DOI [10.3390/g6030262, DOI 10.3390/G6030262]; Lee JW, 2008, J RISK UNCERTAINTY, V36, P19, DOI 10.1007/s11166-007-9028-3; Levitt SD, 2011, AM ECON REV, V101, P975, DOI 10.1257/aer.101.2.975; Malhotra D, 2010, ORGAN BEHAV HUM DEC, V111, P139, DOI 10.1016/j.obhdp.2009.11.005; MCCLINTOCK CG, 1989, J APPL SOC PSYCHOL, V19, P353, DOI 10.1111/j.1559-1816.1989.tb00060.x; MCCLINTOCK CG, 1972, BEHAV SCI, V17, P438, DOI 10.1002/bs.3830170505; MCKELVEY RD, 1992, ECONOMETRICA, V60, P803, DOI 10.2307/2951567; MESSICK DM, 1968, J EXP SOC PSYCHOL, V4, P1, DOI 10.1016/0022-1031(68)90046-2; Murphy RO, 2014, PERS SOC PSYCHOL REV, V18, P13, DOI 10.1177/1088868313501745; Murphy RO, 2011, JUDGM DECIS MAK, V6, P771; Nagel R, 1998, J MATH PSYCHOL, V42, P356, DOI 10.1006/jmps.1998.1225; Piff PK, 2010, J PERS SOC PSYCHOL, V99, P771, DOI 10.1037/a0020092; Pulford BD., 2017, DECISION-INDIA, V4, P102, DOI [10.1037/dec0000057, DOI 10.1037/DEC0000057]; RABIN M, 1993, AM ECON REV, V83, P1281; ROSENTHAL RW, 1981, J ECON THEORY, V25, P92, DOI 10.1016/0022-0531(81)90018-1; Rusbult CE, 2003, ANNU REV PSYCHOL, V54, P351, DOI 10.1146/annurev.psych.54.101601.145059; Shumway R.H., 2006, TIME SERIES ANAL ITS; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Spielberger Charles D., 1966, ANXIETY BEHAV, p361?398, DOI DOI 10.1016/B978-1-4832-3131-0.50019-6; STARMER C, 1991, AM ECON REV, V81, P971; Van Lange P. A. M., 2000, EUROPEAN REV SOCIAL, V11, P297, DOI DOI 10.1080/14792772043000068; Van Lange PAM, 1999, J PERS SOC PSYCHOL, V77, P337, DOI 10.1037/0022-3514.77.2.337; Van Lange PAM, 2007, BASIC APPL SOC PSYCH, V29, P375, DOI 10.1080/01973530701665223; VanLange PAM, 1997, J PERS SOC PSYCHOL, V73, P733, DOI 10.1037/0022-3514.73.4.733; von Neumann J., 1947, THEORY GAMES EC BEHA, V2nd ed; WEINGART LR, 1993, J APPL PSYCHOL, V78, P504, DOI 10.1037/0021-9010.78.3.504; White AE, 2013, J PERS SOC PSYCHOL, V105, P924, DOI 10.1037/a0033808; Yamagishi T, 2013, ORGAN BEHAV HUM DEC, V120, P260, DOI 10.1016/j.obhdp.2012.06.002; Yanovitzky I., 2008, SAGE SOURCEBOOK ADV, P89	60	9	9	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152352	10.1371/journal.pone.0152352	http://dx.doi.org/10.1371/journal.pone.0152352			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3SV	27010385	Green Submitted, gold, Green Published			2022-12-26	WOS:000372708000137
J	Sinyangwe, C; Graham, K; Nicholas, S; King, R; Mukupa, S; Kallander, K; Counihan, H; Montague, M; Tibenderana, J; Hamade, P				Sinyangwe, Chomba; Graham, Kirstie; Nicholas, Sarala; King, Rebecca; Mukupa, Samuel; Kaellander, Karin; Counihan, Helen; Montague, Mark; Tibenderana, James; Hamade, Prudence			Assessing the Quality of Care for Pneumonia in Integrated Community Case Management: A Cross-Sectional Mixed Methods Study	PLOS ONE			English	Article							HEALTH WORKERS; SIAYA DISTRICT; CHILDREN; VOLUNTEERS; MORTALITY	Background Pneumonia is the leading infectious cause of mortality in children under five worldwide. Community-level interventions, such as integrated community case management, have great potential to reduce the burden of pneumonia, as well as other diseases, especially in remote populations. However, there are still questions as to whether community health workers (CHW) are able to accurately assess symptoms of pneumonia and prescribe appropriate treatment. This research addresses limitations of previous studies using innovative methodology to assess the accuracy of respiratory rate measurement by CHWs and provides new evidence on the quality of care given for children with symptoms of pneumonia. It is one of few that assesses CHW performance in their usual setting, with independent re-examination by experts, following a considerable period of time post-training of CHWs. Methods In this cross-sectional mixed methods study, 1,497 CHW consultations, conducted by 90 CHWs in two districts of Luapula province, Zambia, were directly observed, with measurement of respiratory rate for children with suspected pneumonia recorded by video. Using the video footage, a retrospective reference standard assessment of respiratory rate was conducted by experts. Counts taken by CHWs were compared against the reference standard and appropriateness of the treatment prescribed by CHWs was assessed. To supplement observational findings, three focus group discussions and nine in depth interviews with CHWs were conducted. Results and Conclusion The findings support existing literature that CHWs are capable of measuring respiratory rates and providing appropriate treatment, with 81% and 78% agreement, respectively, between CHWs and experts. Accuracy in diagnosis could be strengthened through further training and the development of improved diagnostic tools appropriate for resource-poor settings.	[Sinyangwe, Chomba; Mukupa, Samuel] Malaria Consortium, Mansa, Luapula Provinc, Zambia; [Graham, Kirstie; Nicholas, Sarala; Kaellander, Karin; Counihan, Helen; Hamade, Prudence] Malaria Consortium, London, England; [King, Rebecca] Univ Leeds, Nuffield Ctr Int Hlth & Dev, Leeds, W Yorkshire, England; [Montague, Mark; Tibenderana, James] Malaria Consortium, Kampala, Uganda	University of Leeds	Counihan, H (corresponding author), Malaria Consortium, London, England.	h.counihan@malariaconsortium.org	Tibenderana, James Kananura/M-2272-2018	Tibenderana, James Kananura/0000-0002-0755-4597; Kallander, Karin/0000-0002-5778-5780	UK aid from UK government; Global Affairs Canada [M012955-001]; CIDA; Department for International Development (DFID) [201025] Funding Source: researchfish	UK aid from UK government(CGIAR); Global Affairs Canada(CGIAR); CIDA; Department for International Development (DFID)	The study was conducted through COMDIS-HSD (http://comdis-hsd.leeds.ac.uk), a research programme consortium funded by UK aid from the UK government (www.gov.uk/government/organisations/department-for-international-development). KG, MM, SN, PH and RK were funded through this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research study was conducted alongside implementation of iCCM in Luapula Province in Zambia funded by CIDA (now Global Affairs Canada, www.international.gc.ca) from 2009-2013 (grant number M012955-001). CS, SM and HC were funded through this grant. Some of the activities and materials for the study were therefore supported by funding from CIDA.	BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Cardemil CV, 2012, AM J TROP MED HYG, V87, P127, DOI 10.4269/ajtmh.2012.12-0389; CURTALE F, 1995, SOC SCI MED, V40, P1117, DOI 10.1016/0277-9536(94)00172-P; Das JK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-S3-S29; Druetz T, 2013, HLTH POLICY PLAN, V30, P253, DOI DOI 10.1093/; Earl-Slater A, 2002, HDB CLIN TRIALS OTHE; Floyd J, 2015, NATURE, V528, pS53, DOI 10.1038/nature16043; Hadi A, 2003, B WORLD HEALTH ORGAN, V81, P183; Halcomb EJ, 2006, APPL NURS RES, V19, P38, DOI 10.1016/j.apnr.2005.06.001; Kallander K, 2006, T ROY SOC TROP MED H, V100, P956, DOI 10.1016/j.trstmh.2005.11.004; Kalyango JN, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-282; Kelly JM, 2001, AM J PUBLIC HEALTH, V91, P1617, DOI 10.2105/AJPH.91.10.1617; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Mukanga D, 2011, TROP MED INT HEALTH, V16, P1234, DOI 10.1111/j.1365-3156.2011.02831.x; Noordam AC, 2015, HEALTH POLICY PLANN, V30, P696, DOI 10.1093/heapol/czu047; PRINGLE M, 1990, BRIT J GEN PRACT, V40, P455; Republic of Zambia Central Statistical Office, 2011, ZAMB 2010 CENS POP H; Rowe SY, 2006, INT J QUAL HEALTH C, V18, P299, DOI 10.1093/intqhc/mzl009; Rowe SY, 2007, T ROY SOC TROP MED H, V101, P188, DOI 10.1016/j.trstmh.2006.02.023; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; SIMOES EAF, 1991, ARCH DIS CHILD, V66, P1199, DOI 10.1136/adc.66.10.1199; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; WHO U, 2004, WHO UNICEF JOINT STA; World Health Organization, 2012, EQ FOC STRAT IMPR AC; World Health Organization and UNICEF, 2009, GLOB ACT PLAN PREV C	25	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152204	10.1371/journal.pone.0152204	http://dx.doi.org/10.1371/journal.pone.0152204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3SV	27011331	gold, Green Published			2022-12-26	WOS:000372708000110
J	Wang, X; Liu, ZL; Weber, SA; Zhang, XP				Wang, Xu; Liu, Z. Lewis; Weber, Scott A.; Zhang, Xiaoping			Two New Native beta-Glucosidases from Clavispora NRRL Y-50464 Confer Its Dual Function as Cellobiose Fermenting Ethanologenic Yeast	PLOS ONE			English	Article							NEUROSPORA-CRASSA; SUBSTRATE-SPECIFICITY; PURIFICATION; FERMENTATION; CELLULOSE; BIOMASS; SACCHARIFICATION; MICROORGANISMS; HYDROLYSIS; STRAIN	Yeast strain Clavispora NRRL Y-50464 is able to produce cellulosic ethanol from lignocellulosic materials without addition of external beta-glucosidase by simultaneous saccharification and fermentation. A beta-glucosidase BGL1 protein from this strain was recently reported supporting its cellobiose utilization capability. Here, we report two additional new beta-glucosidase genes encoding enzymes designated as BGL2 and BGL3 from strain NRRL Y-50464. Quantitative gene expression was analyzed and the gene function of BGL2 and BGL3 was confirmed by heterologous expression using cellobiose as a sole carbon source. Each gene was cloned and partially purified protein obtained separately for direct enzyme assay using varied substrates. Both proteins showed the highest specific activity at pH 5 and relatively strong affinity with a K-m of 0.08 and 0.18 mM for BGL2 and BGL3, respectively. The optimum temperature was found to be 50 degrees C for BGL2 and 55 degrees C for BGL3. Both proteins were able to hydrolyze 1,4 oligosaccharides evaluated in this study. They also showed a strong resistance to glucose product inhibition with a K-i of 61.97 and 38.33 mM for BGL2 and BGL3, respectively. While BGL3 was sensitive showing a significantly reduced activity to 4% ethanol, BGL2 demonstrated tolerance to ethanol. Its activity was enhanced in the presence of ethanol but reduced at concentrations greater than 16%. The presence of the fermentation inhibitors furfural and HMF did not affect the enzyme activity. Our results suggest that a beta-glucosidase gene family exists in Clavispora NRRL Y-50464 with at least three members in this group that validate its cellobiose hydrolysis functions for lower-cost cellulosic ethanol production. Results of this study confirmed the cellobiose hydrolysis function of strain NRRL Y-50464, and further supported this dual functional yeast as a candidate for lower-cost cellulosic ethanol production and next-generation biocatalyst development in potential industrial applications.	[Wang, Xu; Zhang, Xiaoping] Sichuan Agr Univ, Chengdu, Peoples R China; [Wang, Xu; Liu, Z. Lewis; Weber, Scott A.] ARS, Bioenergy Res Unit, Natl Ctr Agr Utilizat Res, USDA, Peoria, IL 61604 USA	Sichuan Agricultural University; United States Department of Agriculture (USDA)	Liu, ZL (corresponding author), ARS, Bioenergy Res Unit, Natl Ctr Agr Utilizat Res, USDA, Peoria, IL 61604 USA.	ZLewis.Liu@ars.usda.gov			ARS [ARS-0427438] Funding Source: Federal RePORTER	ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)		Baffi MA, 2013, APPL BIOCHEM BIOTECH, V171, P1681, DOI 10.1007/s12010-013-0471-0; Barbagallo RN, 2004, ENZYME MICROB TECH, V35, P58, DOI 10.1016/j.enzmictec.2004.03.005; Berka RM, 2011, NAT BIOTECHNOL, V29, P922, DOI 10.1038/nbt.1976; Cairns JRK, 2010, CELL MOL LIFE SCI, V67, P3389, DOI 10.1007/s00018-010-0399-2; Chapla D, 2015, J BIOBASED MATER BIO, V9, P1; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Dan S, 2000, J BIOL CHEM, V275, P4973, DOI 10.1074/jbc.275.7.4973; Decker CH, 2001, APPL MICROBIOL BIOT, V55, P157, DOI 10.1007/s002530000462; den Haan R, 2015, CURR OPIN BIOTECH, V33, P32, DOI 10.1016/j.copbio.2014.10.003; Eyzaguirre J., 2005, HDB CARBOHYDRATE ENG; Gong YX, 2014, J GEN APPL MICROBIOL, V60, P198, DOI 10.2323/jgam.60.198; GROVER AK, 1977, BIOCHIM BIOPHYS ACTA, V482, P98, DOI 10.1016/0005-2744(77)90358-8; HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309; Hildebrand A, 2015, APPL ENVIRON MICROB, V81, P597, DOI 10.1128/AEM.02885-14; Hong JF, 2014, WORLD J MICROB BIOT, V30, P2985, DOI 10.1007/s11274-014-1726-9; Jeya M, 2010, APPL MICROBIOL BIOT, V86, P1473, DOI 10.1007/s00253-009-2395-8; Jung YR, 2012, J IND ENG CHEM, V18, P702, DOI 10.1016/j.jiec.2011.11.133; Kawai R, 2004, CARBOHYD RES, V339, P2851, DOI 10.1016/j.carres.2004.09.019; Liu M, 2012, BIOCHEM ENG J, V68, P1, DOI 10.1016/j.bej.2012.07.003; Liu ZL, 2007, J MICROBIOL METH, V68, P486, DOI 10.1016/j.mimet.2006.10.014; Liu ZL, 2015, BIOENERG RES, V8, P1203, DOI 10.1007/s12155-014-9575-9; Liu ZL, 2013, BIOENERG RES, V6, P65, DOI 10.1007/s12155-012-9236-9; Liu ZL, 2012, BIORESOURCE TECHNOL, V104, P410, DOI 10.1016/j.biortech.2011.10.099; Liu ZL, 2009, J BIOTECHNOL, V143, P10, DOI 10.1016/j.jbiotec.2009.06.006; Liu ZL, 2014, United States Patent, Patent No. [8,673,604, 8673604]; Luo ZC, 2014, APPL BIOCHEM BIOTECH, V174, P772, DOI 10.1007/s12010-014-1108-7; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Nam KH, 2008, PROTEINS, V73, P788, DOI 10.1002/prot.22199; Olofsson K, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-7; Parisutham V, 2011, APPL MICROBIOL BIOT, V92, P125, DOI [10.1007/s00253-011-3434-9, DOI 10.1007/S00253-011-3434-9]; Leite RSR, 2008, ENZYME MICROB TECH, V43, P391, DOI 10.1016/j.enzmictec.2008.07.006; Riou C, 1998, APPL ENVIRON MICROB, V64, P3607; Saha BC, 2008, J BIOBASED MATER BIO, V2, P210, DOI 10.1166/jbmb.2008.412; Sambrook J., 2001, MOL CLONING LAB MANU; Sarah R., 2007, World Applied Sciences Journal, V2, P315; Singhania RR, 2013, BIORESOURCE TECHNOL, V127, P500, DOI 10.1016/j.biortech.2012.09.012; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanzila Shahzadi, 2014, Advances in Bioscience and Biotechnology, V5, P426; Thongpoo P, 2013, BBA-GEN SUBJECTS, V1830, P2739, DOI 10.1016/j.bbagen.2012.11.014; Tiwari P, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/203735; Varghese JN, 1999, STRUCTURE, V7, P179, DOI 10.1016/S0969-2126(99)80024-0; Wentrup C, 2015, ANGEW CHEM INT EDIT, V54, P5702, DOI 10.1002/anie.201412431; Wu WH, 2013, ARCH MICROBIOL, V195, P823, DOI 10.1007/s00203-013-0931-5; Wu WH, 2013, ENZYME MICROB TECH, V52, P184, DOI 10.1016/j.enzmictec.2012.12.010; Yan SM, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-177; Yoshida E, 2009, ACTA CRYSTALLOGR F, V65, P1190, DOI 10.1107/S1744309109042948; Zechel DL, 2003, BIOCHEMISTRY-US, V42, P7195, DOI 10.1021/bi034329j	47	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151293	10.1371/journal.pone.0151293	http://dx.doi.org/10.1371/journal.pone.0151293			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27011316	Green Published, gold			2022-12-26	WOS:000372708000026
J	Lu, MC; Chang, SC; Huang, KY; Koo, M; Lai, NS				Lu, Ming-Chi; Chang, Shou-Chih; Huang, Kuang-Yung; Koo, Malcolm; Lai, Ning-Sheng			Higher Risk of Thyroid Disorders in Young Patients with Type 1 Diabetes: A 12-Year Nationwide, Population-Based, Retrospective Cohort Study	PLOS ONE			English	Article							JOINT GENETIC SUSCEPTIBILITY; AUTOIMMUNE-THYROIDITIS; CHINESE CHILDREN; ADOLESCENTS; DISEASE; HYPOTHYROIDISM; EPIDEMIOLOGY; GENDER; AGE	Background The association between type 1 diabetes and thyroid autoimmunity has been studied in various populations, but seldom on Taiwanese children and adolescents. Therefore, the aim of this study was to examine the incidence of autoimmune thyroid disorders in Taiwanese children and adolescent patients with type 1 diabetes, based on data from a nationwide, population-based, health claims database. Methods Using Taiwan's National Health Insurance Research Database, we identified 3,652 patients with type 1 diabetes between 2000 and 2012. A comparison cohort was assembled, which consisted of five patients without type 1 diabetes, based on frequency matching for sex and 3-year age interval, for each patient with type 1 diabetes. Both groups were followed until diagnosis of thyroid disorders or the end of the follow-up period. Poisson regression models were used to calculate incidence rate ratios for the thyroid disorders between the type 1 diabetes cohort and the comparison cohort. Results Simple and unspecified goiter (International Classification of Diseases, 9th Revision, Clinical Modification [ICD-9-CM] code 240), thyrotoxicosis (ICD-9-CM code 242), unspecified hypothyroidism (ICD-9-CM code 244.9), and thyroiditis (ICD-9-CM code 245) showed significantly higher incidences in the type 1 diabetes cohort compared with the control cohort, with incidence rate ratios of 2.74, 6.95, 6.54, 16.07, respectively. Conclusions Findings from this nationwide, population-based cohort study showed that the incidences of autoimmune thyroid disorders were significantly higher in Taiwanese children and adolescents with type 1 diabetes compared with those without the disease.	[Lu, Ming-Chi; Huang, Kuang-Yung; Lai, Ning-Sheng] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Allergy Immunol & Rheumatol, Chiayi 62247, Taiwan; [Lu, Ming-Chi; Huang, Kuang-Yung; Lai, Ning-Sheng] Tzu Chi Univ, Sch Med, Hualien 97004, Taiwan; [Chang, Shou-Chih] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Pediat, Chiayi 62247, Taiwan; [Koo, Malcolm] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Med Res, Chiayi 62247, Taiwan; [Koo, Malcolm] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 3G3, Canada	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; University of Toronto	Lai, NS (corresponding author), Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Allergy Immunol & Rheumatol, Chiayi 62247, Taiwan.; Lai, NS (corresponding author), Tzu Chi Univ, Sch Med, Hualien 97004, Taiwan.; Koo, M (corresponding author), Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Dept Med Res, Chiayi 62247, Taiwan.; Koo, M (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 3G3, Canada.	m.koo@utoronto.ca; tzuchilai@gmail.com	Koo, Malcolm/AAE-5822-2020	Koo, Malcolm/0000-0002-9242-9167				Administration NHR, 2016, NAT HLTH INS RES DAT; [Anonymous], 2015, DIABETES CARE, V38, pS1, DOI 10.2337/dc15-S001; Bando Y, 2002, EXP CLIN ENDOCR DIAB, V110, P408, DOI 10.1055/s-2002-36427; Cade WT, 2008, PHYS THER, V88, P1322, DOI 10.2522/ptj.20080008; Chuang LM, 1996, CLIN ENDOCRINOL, V45, P631, DOI 10.1046/j.1365-2265.1996.00857.x; Riquetto ADC, 2015, DIABETES RES CLIN PR, V110, pE9, DOI 10.1016/j.diabres.2015.07.003; Danne T, 2007, ARCH DIS CHILD, V92, P1015, DOI 10.1136/adc.2006.094904; Denzer C, 2013, EUR J ENDOCRINOL, V168, P601, DOI 10.1530/EJE-12-0703; Fortunato RS, 2014, J ENDOCRINOL, V221, pR31, DOI 10.1530/JOE-13-0588; Franklyn JA, 2012, LANCET, V379, P1155, DOI 10.1016/S0140-6736(11)60782-4; Franzese A, 2000, DIABETES CARE, V23, P1201, DOI 10.2337/diacare.23.8.1201; Goodwin G, 2006, DIABETES CARE, V29, P1397, DOI 10.2337/dc06-0098; Huber A, 2008, ENDOCR REV, V29, P697, DOI 10.1210/er.2008-0015; Jacobson DL, 1997, CLIN IMMUNOL IMMUNOP, V84, P223, DOI 10.1006/clin.1997.4412; Johnson JL., 2006, DIABETES SPECTRUM, V19, P148, DOI [10.2337/diaspect.19.3.148, DOI 10.2337/DIASPECT.19.3.148]; Kakleas K, 2015, AUTOIMMUN REV, V14, P781, DOI 10.1016/j.autrev.2015.05.002; Kordonouri O, 2005, ARCH DIS CHILD, V90, P411, DOI 10.1136/adc.2004.056424; Kordonouri O, 2002, DIABETES CARE, V25, P1346, DOI 10.2337/diacare.25.8.1346; Lin WH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086172; Nandi-Munshi D, 2015, PEDIATR NEUROL, V52, P373, DOI 10.1016/j.pediatrneurol.2014.12.005; Ngo ST, 2014, FRONT NEUROENDOCRIN, V35, P347, DOI 10.1016/j.yfrne.2014.04.004; Omar MA, 2014, ALEX J MED, V50, P77, DOI 10.1016/j.ajme.2013.09.001; Park Yong Soo, 2000, Korean Journal of Internal Medicine, V15, P202; Patterson C, 2014, DIABETES RES CLIN PR, V103, P161, DOI 10.1016/j.diabres.2013.11.005; Piatkowska Ewa, 2011, Pediatr Endocrinol Diabetes Metab, V17, P173; Triolo TM, 2011, DIABETES CARE, V34, P1211, DOI 10.2337/dc10-1756; TSAI WY, 1993, DIABETES CARE, V16, P1314, DOI 10.2337/diacare.16.9.1314; Villano MJB, 2009, J CLIN ENDOCR METAB, V94, P1458, DOI 10.1210/jc.2008-2193; WONG GWK, 1993, DIABETES CARE, V16, P1315, DOI 10.2337/diacare.16.9.1315	29	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152168	10.1371/journal.pone.0152168	http://dx.doi.org/10.1371/journal.pone.0152168			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007574	Green Published, gold, Green Submitted			2022-12-26	WOS:000372701200102
J	Pinter, D; Beckmann, C; Koini, M; Pirker, E; Filippini, N; Pichler, A; Fuchs, S; Fazekas, F; Enzinger, C				Pinter, Daniela; Beckmann, Christian; Koini, Marisa; Pirker, Eva; Filippini, Nicola; Pichler, Alexander; Fuchs, Siegrid; Fazekas, Franz; Enzinger, Christian			Reproducibility of Resting State Connectivity in Patients with Stable Multiple Sclerosis	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; WORKING-MEMORY; FMRI; ACTIVATION; NETWORK; ASSOCIATION; DYSFUNCTION; IMPAIRMENT; PATTERNS; MOTOR	Given increasing efforts to use resting-state fMRI (rfMRI) as a biomarker of disease progression in multiple sclerosis (MS) we here explored the reproducibility of longitudinal rfMRI over three months in patients with clinically and radiologically stable MS. To pursue this aim, two approaches were applied in nine rfMRI networks: First, the intraclass correlation coefficient (ICC 3,1) was assessed for the mean functional connectivity maps across the entire network and a region of interest (ROI). Second, the ratio of overlap between Z-thresholded connectivity maps for each network was assessed. We quantified between-session functional reproducibility of rfMRI for 20 patients with stable MS and 14 healthy controls (HC). Nine rfMRI networks (RSNs) were examined at baseline and after 3 months of followup: three visual RSNs, the default-mode network, sensorimotor-, auditory-, executive control, and the left and right fronto-parietal RSN. ROI analyses were constrained to thresholded overlap masks for each individual (Z>0) at baseline and follow-up. In both stable MS and HC mean functional connectivity across the entire network did not reach acceptable ICCs for several networks (ICC<0.40) but we found a high reproducibility of ROI ICCs and of the ratio of overlap. ROI ICCs of all nine networks were between 0.98 and 0.99 for HC and ranged from 0.88 to 0.99 in patients with MS, respectively. The ratio of overlap for all networks was similar for both groups, ranging from 0.60 to 0.75. Our findings attest to a high reproducibility of rfMRI networks not only in HC but also in patients with stable MS when applying ROI analysis. This supports the utility of rfMRI to monitor functional changes related to disease progression or therapeutic interventions in MS.	[Pinter, Daniela; Koini, Marisa; Pirker, Eva; Pichler, Alexander; Fuchs, Siegrid; Fazekas, Franz; Enzinger, Christian] Med Univ Graz, Dept Neurol, Graz, Austria; [Beckmann, Christian] Radboud Univ Nijmegen, Donders Inst, Cognit Neurosci Dept, NL-6525 ED Nijmegen, Netherlands; [Beckmann, Christian] Radboud Univ Nijmegen, Ctr Cognit Neuroimaging, NL-6525 ED Nijmegen, Netherlands; [Filippini, Nicola] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford Ctr Funct MRI Brain, Oxford, England; [Enzinger, Christian] Med Univ Graz, Dept Radiol, Div Neuroradiol, Graz, Austria	Medical University of Graz; Radboud University Nijmegen; Radboud University Nijmegen; University of Oxford; Medical University of Graz	Pinter, D (corresponding author), Med Univ Graz, Dept Neurol, Graz, Austria.	daniela.pinter@medunigraz.at	Filippini, Nicola/H-6869-2013; Filippini, Nicola/Q-5250-2019; Beckmann, Christian F./E-6374-2012	Filippini, Nicola/0000-0003-1513-5269; Filippini, Nicola/0000-0003-1513-5269; Beckmann, Christian F./0000-0002-3373-3193; Pinter, Daniela/0000-0003-3138-5225	Biogen Idec.; HDH Wills Charitable Trust; UK Wellcome Trust; Dutch Organisation for Scientific Research NOW	Biogen Idec.(Biogen); HDH Wills Charitable Trust; UK Wellcome Trust(Wellcome Trust); Dutch Organisation for Scientific Research NOW	This study was supported by an unrestricted research grant provided by Biogen Idec. The sponsor had no influence on the design, data collection, analysis and interpretation of the results. NF is funded by the HDH Wills 1965 Charitable Trust. CFB acknowledges funding from the UK Wellcome Trust and the Dutch Organisation for Scientific Research NOW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2006, NEUROIMAGE, V29, P1000, DOI 10.1016/j.neuroimage.2005.08.010; Bosnell R, 2008, NEUROIMAGE, V42, P603, DOI 10.1016/j.neuroimage.2008.05.005; Caceres A, 2009, NEUROIMAGE, V45, P758, DOI 10.1016/j.neuroimage.2008.12.035; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Chou YH, 2012, AM J NEURORADIOL, V33, P833, DOI 10.3174/ajnr.A2894; Clement F, 2009, HUM BRAIN MAPP, V30, P4033, DOI 10.1002/hbm.20827; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Cruz-Gomez AJ, 2013, MULT SCLER, V2013, DOI 10.1177/; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Eaton KP, 2008, NEUROIMAGE, V41, P311, DOI 10.1016/j.neuroimage.2008.02.033; Enzinger C, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00056; Enzinger C, 2012, NEUROLOGY, V79, P1416, DOI 10.1212/WNL.0b013e31826d600d; Faivre A, 2012, MULT SCLER J, V18, P1251, DOI 10.1177/1352458511435930; Filippi M, 2013, J NEUROL, V260, P1709, DOI 10.1007/s00415-012-6695-z; Filippi M, 2012, LANCET NEUROL, V11, P349, DOI 10.1016/S1474-4422(12)70003-0; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Forsyth JK, 2014, NEUROIMAGE, V97, P41, DOI 10.1016/j.neuroimage.2014.04.027; Griffanti L, 2016, NEUROIMAGE, V124, P704, DOI 10.1016/j.neuroimage.2015.09.021; H?rting, 2000, WECHSLER GEDACHTNIST; Janssen AL, 2013, NEUROPSYCHOLOGIA, P1, DOI [10.1016/j.neuropsychologia.2013.08.010, DOI 10.1016/J.NEUROPSYCHOL0GIA.2013.08.010]; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jovicich J, 2016, NEUROIMAGE, V124, P442, DOI 10.1016/j.neuroimage.2015.07.010; Kristo G, 2014, HUM BRAIN MAPP, V35, P340, DOI 10.1002/hbm.22180; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Langdon DW, 2011, CURR OPIN NEUROL, V24, P244, DOI 10.1097/WCO.0b013e328346a43b; Lee JN, 2010, NEUROIMAGE, V49, P1282, DOI 10.1016/j.neuroimage.2009.09.072; Loitfelder M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093715; Marshall I, 2004, RADIOLOGY, V233, P868, DOI 10.1148/radiol.2333031782; McGonigle DJ, 2000, NEUROIMAGE, V11, P708, DOI 10.1006/nimg.2000.0562; Meindl T, 2010, HUM BRAIN MAPP, V31, P237, DOI 10.1002/hbm.20860; Plummer DL., 1992, REV NEU RORADIOL, V5, P489, DOI 10.1177/197140099200500413; Poldrack RA, 2011, HDB FUNCTIONAL MRI D; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Pugliatti M, 2006, EUR J NEUROL, V13, P700, DOI 10.1111/j.1468-1331.2006.01342.x; Raemaekers M, 2007, NEUROIMAGE, V36, P532, DOI 10.1016/j.neuroimage.2007.03.061; Rao S, 1990, MANUAL BRIEF REPEATA; Rocca MA, 2015, LANCET NEUROL, V14, P302, DOI 10.1016/S1474-4422(14)70250-9; Rombouts SARB, 1998, MAGN RESON IMAGING, V16, P105, DOI 10.1016/S0730-725X(97)00253-1; Sacco R, 2013, MULT SCLER INT, V2013, DOI 10.1155/2013/857807; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Zuo XN, 2014, NEUROSCI BIOBEHAV R, V45, P100, DOI 10.1016/j.neubiorev.2014.05.009; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080	47	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152158	10.1371/journal.pone.0152158	http://dx.doi.org/10.1371/journal.pone.0152158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007237	Green Published, gold, Green Submitted			2022-12-26	WOS:000372701200100
J	Sa-Nguanmoo, P; Posuwan, N; Vichaiwattana, P; Vuthitanachot, V; Saelao, S; Foonoi, M; Fakthongyoo, A; Makaroon, J; Srisingh, K; Asawarachun, D; Owatanapanich, S; Wutthiratkowit, N; Tohtubtiang, K; Vongpunsawad, S; Yoocharoen, P; Poovorawan, Y				Sa-nguanmoo, Pattaratida; Posuwan, Nawarat; Vichaiwattana, Preeyaporn; Vuthitanachot, Viboonsak; Saelao, Siriporn; Foonoi, Monthana; Fakthongyoo, Apinya; Makaroon, Jamorn; Srisingh, Klaita; Asawarachun, Duangporn; Owatanapanich, Somchai; Wutthiratkowit, Norra; Tohtubtiang, Kraisorn; Vongpunsawad, Sompong; Yoocharoen, Pornsak; Poovorawan, Yong			Declining Trend of Hepatitis A Seroepidemiology in Association with Improved Public Health and Economic Status of Thailand	PLOS ONE			English	Article							UNITED-STATES; VIRUS; SEROPREVALENCE; VACCINATION; INFECTION; OUTBREAK; ANTIBODY; STRAINS; AGE	Hepatitis A virus (HAV) is transmitted via the fecal-oral route from contaminated food or water. As part of the most recent survey of viral hepatitis burden in Thailand, we analyzed the current seroprevalence of HAV in the country and compared with data dating back to 1971. From March to October, 2014, a total of 4,260 individuals between one month and 71 years of age from different geographical regions (North = 961; Central = 1,125; Northeast = 1,109; South = 1,065) were screened for anti-HAV IgG antibody using an automated chemi-luminescent microparticle immunoassay. Overall, 34.53% (1,471/4,260) possessed anti-HAV IgG antibody, and the age-standardized seroprevalence was 48.6%. Seroprevalence rates were 27.3% (North), 30.8% (Central), 33.8%(Northeast) and 45.8%(South) and were markedly lower than in the past studies especially among younger age groups. The overall trend showed an increase in the age by which 50% of the population were anti-HAV IgG antibody: 4.48 years (1971-1972), 6 (1976), 12.49 (1990), 36.02 (2004) and 42.03 (2014). This suggests that Thailand is transitioning from low to very low HAV endemicity. Lower prevalence of HAV correlated with improved healthcare system as measured by decreased infant mortality rate and improved national economy based on increased GDP per capita. The aging HAV immuno-naive population may be rendered susceptible to potential HAV outbreaks similar to those in industrialized countries and may benefit from targeted vaccination of high-risk groups.	[Sa-nguanmoo, Pattaratida; Posuwan, Nawarat; Vichaiwattana, Preeyaporn; Vongpunsawad, Sompong; Poovorawan, Yong] Chulalongkorn Univ, Fac Med, Dept Pediat, Ctr Excellence Clin Virol, Bangkok 10330, Thailand; [Vuthitanachot, Viboonsak; Saelao, Siriporn] Chumphae Hosp, Khon Kaen, Thailand; [Foonoi, Monthana; Fakthongyoo, Apinya] Uttaradit Hosp, Mueang Uttaradit, Uttaradit, Thailand; [Makaroon, Jamorn] Laplae Hosp, Laplae, Uttaradit, Thailand; [Srisingh, Klaita] Naresuan Univ Hosp, Mueang Phitsanulok, Phitsanulok, Thailand; [Asawarachun, Duangporn] Phra Nakhon Si Ayutthaya Hosp, Phra Nakhon Si Ayutthaya, Thailand; [Owatanapanich, Somchai] King Narai Hosp, Mueang Lop Buri, Lop Buri, Thailand; [Wutthiratkowit, Norra] Narathiwat Ratchanakarin Hosp, Mueang Narathiwat, Narathiwat, Thailand; [Tohtubtiang, Kraisorn] Trang Hosp, Mueang Trang, Trang, Thailand; [Yoocharoen, Pornsak] Minist Publ Hlth, Dept Dis Control, Bur Epidemiol, Mueang Nonthaburi, Nonthaburi, Thailand	Chulalongkorn University; Ministry of Public Health - Thailand	Poovorawan, Y (corresponding author), Chulalongkorn Univ, Fac Med, Dept Pediat, Ctr Excellence Clin Virol, Bangkok 10330, Thailand.	Yong.P@chula.ac.th	ภู่วรวรรณ, ศนพ.ยง/GZK-8615-2022	vongpunsawad, sompong/0000-0001-7520-8728	National Research Council of Thailand (NRCT); National Research University Project, Office of Higher Education Commission [WCU-58-006-HR]; Research Chair Grant from the National Science and Technology Development Agency; Chulalongkorn University Centenary Academic Development Project [CU56-HR01]; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University [RES560530093]; Outstanding Professor of Thailand Research Fund [DPG5480002]; Center of Excellence in Clinical Virology, Chulalongkorn University [GCE58-014-30-004]; King Chulalongkorn Memorial Hospital; Postdoctoral Fellowship under Rachadapisaek Sompote Fund, the Graduate School, Chulalongkorn University	National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT)); National Research University Project, Office of Higher Education Commission; Research Chair Grant from the National Science and Technology Development Agency; Chulalongkorn University Centenary Academic Development Project; Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University(Chulalongkorn University); Outstanding Professor of Thailand Research Fund; Center of Excellence in Clinical Virology, Chulalongkorn University(Chulalongkorn University); King Chulalongkorn Memorial Hospital(Chulalongkorn University); Postdoctoral Fellowship under Rachadapisaek Sompote Fund, the Graduate School, Chulalongkorn University	This work was supported by the National Research Council of Thailand (NRCT), the National Research University Project, Office of Higher Education Commission (WCU-58-006-HR), the Research Chair Grant from the National Science and Technology Development Agency, Chulalongkorn University Centenary Academic Development Project (CU56-HR01), Ratchadaphiseksomphot Endowment Fund of Chulalongkorn University (RES560530093), the Outstanding Professor of Thailand Research Fund (DPG5480002), the Center of Excellence in Clinical Virology, Chulalongkorn University (GCE58-014-30-004) and King Chulalongkorn Memorial Hospital. This research is also supported by the Postdoctoral Fellowship under Rachadapisaek Sompote Fund, the Graduate School, Chulalongkorn University to Pattaratida Sa-nguanmoo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, Wkly Epidemiol Rec, V87; [Anonymous], 2013, VACCINE, V31, P285, DOI 10.1016/j.vaccine.2012.10.102; Bureau of Epidemiology Department of Disease Control Ministry of Public Health Thailand. Hepatitis A, 2015, HEP A; BURKE D S, 1980, Southeast Asian Journal of Tropical Medicine and Public Health, V11, P415; BURKE DS, 1981, AM J EPIDEMIOL, V113, P245, DOI 10.1093/oxfordjournals.aje.a113093; Chatproedprai S, 2007, ANN TROP MED PARASIT, V101, P61, DOI 10.1179/136485907X157040; COHEN JI, 1987, J VIROL, V61, P50, DOI 10.1128/JVI.61.1.50-59.1987; D'Andrea L, 2015, INT J MOL SCI, V16, P6842, DOI 10.3390/ijms16046842; Daniels Danni, 2009, Morbidity and Mortality Weekly Report, V58, P1; Dentinger CM, 2001, J INFECT DIS, V183, P1273, DOI 10.1086/319688; Gossner CM, 2014, EURO SURVEILL, V19; Hepatitis A, 2000, WKLY EPIDEMIOL REC, V75, P38; Hollinger FB, 2013, FIELDS VIROLOGY, P550; Jacobsen KH, 2010, VACCINE, V28, P6653, DOI 10.1016/j.vaccine.2010.08.037; Jacobsen KH, 2004, EPIDEMIOL INFECT, V132, P1005, DOI 10.1017/S0950268804002857; Kunasol Prayura, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P255; Lima LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102925; Lopez EL, 2015, PEDIATR INFECT DIS J, V34, P417, DOI 10.1097/INF.0000000000000605; Ly KN, 2015, J INFECT DIS, V212, P176, DOI 10.1093/infdis/jiu834; MELNICK JL, 1995, J INFECT DIS, V171, pS2, DOI 10.1093/infdis/171.Supplement_1.S2; Montano-Remacha C, 2014, EURO SURVEILL, V19; Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646; Pinto RM, 2012, FUTURE MICROBIOL, V7, P331, DOI [10.2217/FMB.12.5, 10.2217/fmb.12.5]; POOVORAWAN Y, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P35; ROBERTSON BH, 1992, J GEN VIROL, V73, P1365, DOI 10.1099/0022-1317-73-6-1365; Stene-Johansen K, 2007, J MED VIROL, V79, P356, DOI 10.1002/jmv.20781; Suwantika AA, 2013, EXPERT REV VACCINES, V12, P1479, DOI 10.1586/14760584.2013.851008; Teppakdee Anchalee, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P118; The World Bank, 2015, MORT RAT INF PER 100; The World Bank, 2015, GDP PER CAPT CURR US; Vaughan G, 2014, INFECT GENET EVOL, V21, P227, DOI 10.1016/j.meegid.2013.10.023; Wheeler C, 2005, NEW ENGL J MED, V353, P890, DOI 10.1056/NEJMoa050855	32	18	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151304	10.1371/journal.pone.0151304	http://dx.doi.org/10.1371/journal.pone.0151304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008531	Green Published, gold, Green Submitted			2022-12-26	WOS:000372701200049
J	Chu, LY; Wang, YF; Cheng, HH; Kuo, CC; Wu, KK				Chu, Ling-Yun; Wang, Yi-Fu; Cheng, Huei-Hsuan; Kuo, Cheng-Chin; Wu, Kenneth K.			Endothelium-Derived 5-Methoxytryptophan Protects Endothelial Barrier Function by Blocking p38 MAPK Activation	PLOS ONE			English	Article							VE-CADHERIN; TRYPTOPHAN-HYDROXYLASE; VASCULAR-PERMEABILITY; TNF-ALPHA; TYROSINE PHOSPHORYLATION; MONOLAYER PERMEABILITY; ADHERENS JUNCTIONS; CELL PERMEABILITY; EXPRESSION; KINASE	The endothelial junction is tightly controlled to restrict the passage of blood cells and solutes. Disruption of endothelial barrier function by bacterial endotoxins, cytokines or growth factors results in inflammation and vascular damage leading to vascular diseases. We have identified 5-methoxytryptophan (5-MTP) as an anti-inflammatory factor by metabolomic analysis of conditioned medium of human fibroblasts. Here we postulated that endothelial cells release 5-MTP to protect the barrier function. Conditioned medium of human umbilical vein endothelial cells (HUVECs) prevented endothelial hyperpermeability and VE-cadherin downregulation induced by VEGF, LPS and cytokines. We analyzed the metabolomic profile of HUVEC conditioned medium and detected 5-MTP but not melatonin, serotonin or their catabolites, which was confirmed by enzyme-linked immunosorbent assay. Addition of synthetic pure 5-MTP preserved VE-cadherin and maintained barrier function despite challenge with pro-inflammatory mediators. Tryptophan hydroxylase-1, an enzyme required for 5-MTP biosynthesis, was downregulated in HUVECs by pro-inflammatory mediators and it was accompanied by reduction of 5-MTP. 5-MTP protected VE-cadherin and prevented endothelial hyperpermeability by blocking p38 MAPK activation. A chemical inhibitor of p38 MAPK, SB202190, exhibited a similar protective effect as 5-MTP. To determine whether 5-MTP prevents vascular hyperpermeability in vivo, we evaluated the effect of 5-MTP administration on LPS-induced murine microvascular permeability with Evans blue. 5-MTP significantly prevented Evans blue dye leakage. Our findings indicate that 5-MTP is a new class of endothelium-derived molecules which protects endothelial barrier function by blocking p38 MAPK.	[Chu, Ling-Yun; Cheng, Huei-Hsuan; Kuo, Cheng-Chin; Wu, Kenneth K.] China Med Univ Hosp, Metabol Med Res Ctr, Taichung, Taiwan; [Wang, Yi-Fu; Kuo, Cheng-Chin; Wu, Kenneth K.] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Wang, Yi-Fu] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan; [Cheng, Huei-Hsuan] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kuo, Cheng-Chin; Wu, Kenneth K.] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Wu, Kenneth K.] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan; [Wu, Kenneth K.] Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; National Health Research Institutes - Taiwan; National Tsing Hua University; China Medical University Taiwan; China Medical University Taiwan; National Tsing Hua University; National Tsing Hua University	Wu, KK (corresponding author), China Med Univ Hosp, Metabol Med Res Ctr, Taichung, Taiwan.; Wu, KK (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan.; Wu, KK (corresponding author), China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan.; Wu, KK (corresponding author), Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan.; Wu, KK (corresponding author), Natl Tsing Hua Univ, Inst Biotechnol, Hsinchu, Taiwan.	kkgo@nhri.org.tw			Ministry of Science and Technology of Taiwan [MOST 103-2321-B-400-005, 103-2321-B-039-003]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by the Ministry of Science and Technology of Taiwan grants MOST 103-2321-B-400-005 (to CCK), and 103-2321-B-039003 (to KKW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam AP, 2010, J BIOL CHEM, V285, P7045, DOI 10.1074/jbc.M109.079277; Borbiev T, 2004, AM J PHYSIOL-LUNG C, V287, pL911, DOI 10.1152/ajplung.00372.2003; Broman MT, 2006, CIRC RES, V98, P73, DOI 10.1161/01.RES.0000198387.44395.e9; Cash CD, 1998, GEN PHARMACOL, V30, P569, DOI 10.1016/S0306-3623(97)00308-X; Cheng HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088507; Cheng HH, 2012, P NATL ACAD SCI USA, V109, P13231, DOI 10.1073/pnas.1209919109; Chu LY, 2015, PROSTAG OTH LIPID M, V118, P19, DOI 10.1016/j.prostaglandins.2015.04.006; Cowan CE, 2010, CIRC RES, V107, P959, DOI 10.1161/CIRCRESAHA.110.219592; DARMON MC, 1988, J NEUROCHEM, V51, P312, DOI 10.1111/j.1471-4159.1988.tb04871.x; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dejana E, 2012, CURR OPIN HEMATOL, V19, P218, DOI 10.1097/MOH.0b013e3283523e1c; Deng WG, 2002, FASEB J, V16, P1286, DOI 10.1096/fj.01-0844fje; Deng WG, 2006, BLOOD, V108, P518, DOI 10.1182/blood-2005-09-3691; Dong FY, 2014, BIOCHEM BIOPH RES CO, V450, P447, DOI 10.1016/j.bbrc.2014.05.140; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Goldberg PL, 2002, AM J PHYSIOL-LUNG C, V282, pL146, DOI 10.1152/ajplung.2002.282.1.L146; Gong P, 2008, J BIOL CHEM, V283, P13437, DOI 10.1074/jbc.M707986200; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Kiemer AK, 2002, CIRC RES, V90, P874, DOI 10.1161/01.RES.0000017068.58856.F3; Koss M, 2006, J IMMUNOL, V176, P1218, DOI 10.4049/jimmunol.176.2.1218; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Liou JY, 2006, ARTERIOSCL THROM VAS, V26, P1481, DOI 10.1161/01.ATV.0000223875.14120.93; Liu TG, 2012, J CELL PHYSIOL, V227, P1438, DOI 10.1002/jcp.22859; LOVENBERG W, 1967, SCIENCE, V155, P217, DOI 10.1126/science.155.3759.217; Mace T, 2005, EMBO J, V24, P3235, DOI 10.1038/sj.emboj.7600799; Min JK, 2005, J IMMUNOL, V175, P531, DOI 10.4049/jimmunol.175.1.531; Ni W, 2008, BRIT J PHARMACOL, V154, P663, DOI 10.1038/bjp.2008.111; Niwa K, 2001, FREE RADICAL RES, V35, P519, DOI 10.1080/10715760100301531; Nwariaku FE, 2002, SHOCK, V18, P82, DOI 10.1097/00024382-200207000-00015; Rahman MS, 2009, NEUROSCIENCE, V158, P751, DOI 10.1016/j.neuroscience.2008.10.029; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Takekawa M, 2000, EMBO J, V19, P6517, DOI 10.1093/emboj/19.23.6517; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; Walther DJ, 2003, SCIENCE, V299, P76, DOI 10.1126/science.1078197; Weis S, 2004, J CELL BIOL, V167, P223, DOI 10.1083/jcb.200408130; Wu KK, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-17; Xing JJ, 2010, MICROVASC RES, V79, P56, DOI 10.1016/j.mvr.2009.11.006; Yang D, 2010, CARDIOVASC RES, V85, P520, DOI 10.1093/cvr/cvp323; Yuan XC, 2011, J PINEAL RES, V51, P220, DOI 10.1111/j.1600-079X.2011.00882.x	42	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152166	10.1371/journal.pone.0152166	http://dx.doi.org/10.1371/journal.pone.0152166			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002329	Green Published, gold, Green Submitted			2022-12-26	WOS:000372697400089
J	Morioka, MS; Kitazume, M; Osaki, K; Wood, J; Tanaka, Y				Morioka, Masaki Suimye; Kitazume, Miwako; Osaki, Ken; Wood, Jonathan; Tanaka, Yujiro			Filling in the Gap of Human Chromosome 4: Single Molecule Real Time Sequencing of Macrosatellite Repeats in the Facioscapulohumeral Muscular Dystrophy Locus	PLOS ONE			English	Article							HUMAN GENOME; D4Z4; DNA	A majority of facioscapulohumeral muscular dystrophy (FSHD) is caused by contraction of macrosatellite repeats called D4Z4 that are located in the subtelomeric region of human chromosome 4q35. Sequencing the FSHD locus has been technically challenging due to its long size and nearly identical nature of repeat elements. Here we report sequencing and partial assembly of a BAC clone carrying an entire FSHD locus by a single molecule real time (SMRT) sequencing technology which could produce long reads up to about 18 kb containing D4Z4 repeats. De novo assembly by Hierarchical Genome Assembly Process 1 (HGAP.1) yielded a contig of 41 kb containing all but a part of the most distal D4Z4 element. The validity of the sequence model was confirmed by an independent approach employing anchored multiple sequence alignment by Kalign using reads containing unique flanking sequences. Our data will provide a basis for further optimization of sequencing and assembly conditions of D4Z4.	[Morioka, Masaki Suimye] Tokyo Med & Dent Univ, Med Res Inst, Dept Bioinformat, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan; [Kitazume, Miwako; Osaki, Ken] Tomy Digital Biol, Bunkyo Ku, SF Bldg 7F,1-4-6 Nezu, Tokyo 1130031, Japan; [Wood, Jonathan] Wellcome Trust Sanger Inst, Genome Reference Consortium, Genome Reference Informat T135, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England; [Tanaka, Yujiro] Tokyo Med & Dent Univ, Grad Sch Biomed Sci, Genome Struct & Regulat, Chiyoda Ku, 2-3-10 Kandasurugadai, Tokyo 1010062, Japan; [Tanaka, Yujiro] Tokyo Med & Dent Univ, Med Res Inst, Dept Biochem Genet, Chiyoda Ku, 2-3-10 Kandasurugadai, Tokyo 1010062, Japan	Tokyo Medical & Dental University (TMDU); Wellcome Trust Sanger Institute; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Tanaka, Y (corresponding author), Tokyo Med & Dent Univ, Grad Sch Biomed Sci, Genome Struct & Regulat, Chiyoda Ku, 2-3-10 Kandasurugadai, Tokyo 1010062, Japan.; Tanaka, Y (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Biochem Genet, Chiyoda Ku, 2-3-10 Kandasurugadai, Tokyo 1010062, Japan.	yujirotanaka@gmail.com			Ministry of Health, Labour, and Welfare in Japan [H24-Neuro, Muscle-General-004]; Ministry of Education, Culture, Sports, Science Technology [26460408]	Ministry of Health, Labour, and Welfare in Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The study was supported by a grant from the Ministry of Health, Labour, and Welfare in Japan (www.mhlw.go.jp) to YT (H24-Neuro, Muscle-General-004), and a grant from the Ministry of Education, Culture, Sports, Science & Technology (www.mext.go.jp) in Japan to YT (26460408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cabianca DS, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.035; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chaisson MJP, 2015, NATURE, V517, P608, DOI 10.1038/nature13907; de Koning APJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002384; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Huddleston J, 2014, GENOME RES, V24, P688, DOI 10.1101/gr.168450.113; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; Lemmers RJLF, 2012, NAT GENET, V44, P1370, DOI 10.1038/ng.2454; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; LYLE R, 1995, GENOMICS, V28, P389, DOI 10.1006/geno.1995.1166; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Osoegawa K, 2001, GENOME RES, V11, P483, DOI 10.1101/gr.169601; Rossi M, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-8; Schaap M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-143; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Statland JM, 2011, CURR OPIN NEUROL, V24, P423, DOI 10.1097/WCO.0b013e32834959af; Steinberg KM, 2014, GENOME RES, V24, P2066, DOI 10.1101/gr.180893.114; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26	20	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151963	10.1371/journal.pone.0151963	http://dx.doi.org/10.1371/journal.pone.0151963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002334	Green Published, Green Submitted, gold			2022-12-26	WOS:000372697400061
J	Kawahara, M; Hasegawa, N; Takaku, H				Kawahara, Mamoru; Hasegawa, Nozomi; Takaku, Hiroshi			Murine Splenic Natural Killer Cells Do Not Develop Immunological Memory after Re-Encounter with Mycobacterium bovis BCG	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; BACILLUS-CALMETTE-GUERIN; HUMAN NK CELLS; INTERFERON-GAMMA; ADAPTIVE IMMUNITY; IFN-GAMMA; T-CELLS; TUBERCULOSIS; INNATE; RESISTANCE	Several lines of evidence have recently suggested that natural killer (NK) cells develop immunological memory against viral infections. However, there is no apparent evidence that NK cells acquire specific memory against Mycobacterium bovis bacillus Calmette-Guerin (BCG), the only currently licensed vaccine for preventing tuberculosis. In the present study, we investigated whether murine splenic NK cells can be activated by BCG in a dendritic cell (DC)-independent or -dependent manner, and furthermore examined whether these NK cells acquire specific memory following BCG vaccination. NK cells isolated from spleens of BCG-immunized mice produced interferon (IFN). through direct BCG stimulation in the absence of antigen-presenting cells; however, NK cells from control animals similarly directly responded to BCG, and the response level was not statistically significant between the immunized and the naive NK cells. When purified NK cells that had been exposed to BCG were cocultured with RAW murine macrophages infected with BCG, the antibacterial activity of the macrophages was strongly enhanced; however, its level was similar to that by naive NK cells, which had not been exposed to BCG. When splenocytes harvested from BCG-immunized mice were stimulated with purified protein derivative (PPD) derived from Mycobacterium tuberculosis, a specific IFN. response was clearly observed, mainly attributed to NK cells and memory CD4(+) T cells. To investigate whether these NK cells as well as the T cells are activated by cell-cell interaction with DCs presenting mycobacterial antigens, NK cells isolated from BCG-immunized mice were cocultured with splenocytes harvested from naive mice in the presence of PPD stimulation. However, no IFN. response was found in the NK cells. These results suggest that murine splenic NK cells do not develop BCG-specific immunological memory in either a DC-independent or -dependent manner.	[Kawahara, Mamoru] Japan BCG Lab, Dept Res & Dev, Tokyo, Japan; [Kawahara, Mamoru; Hasegawa, Nozomi; Takaku, Hiroshi] Chiba Inst Technol, Dept Life & Environm Sci, Narashino, Chiba 275, Japan; [Takaku, Hiroshi] Chiba Inst Technol, Res Inst, Narashino, Chiba 275, Japan	Chiba Institute of Technology; Chiba Institute of Technology	Kawahara, M (corresponding author), Japan BCG Lab, Dept Res & Dev, Tokyo, Japan.; Kawahara, M (corresponding author), Chiba Inst Technol, Dept Life & Environm Sci, Narashino, Chiba 275, Japan.	kawahara@bcg.gr.jp			Supporting Program for Creating University Ventures from the Japan Science and Technology Agency; Research and Development Program for New Bioindustry Initiatives from the Ministry of Agriculture, Forestry and Fisheries of Japan	Supporting Program for Creating University Ventures from the Japan Science and Technology Agency; Research and Development Program for New Bioindustry Initiatives from the Ministry of Agriculture, Forestry and Fisheries of Japan	This work was supported in part by a grant from the Supporting Program for Creating University Ventures from the Japan Science and Technology Agency (www.jst.go.jp/) (HT) and a grant from the Research and Development Program for New Bioindustry Initiatives from the Ministry of Agriculture, Forestry and Fisheries of Japan (www.maff.go.jp/) (HT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadie V, 2005, BLOOD, V106, P1843, DOI 10.1182/blood-2005-03-1281; Abdul-Careem MF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032821; Akazawa T, 2004, CANCER RES, V64, P757, DOI 10.1158/0008-5472.CAN-03-1518; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; Biron CA, 2001, CURR OPIN IMMUNOL, V13, P458, DOI 10.1016/S0952-7915(00)00241-7; Chalifour A, 2004, BLOOD, V104, P1778, DOI 10.1182/blood-2003-08-2820; Cook KD, 2014, CRIT REV IMMUNOL, V34, P359, DOI 10.1615/CritRevImmunol.2014010604; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; DENIS M, 1991, J LEUKOCYTE BIOL, V49, P380, DOI 10.1002/jlb.49.4.380; Feng CG, 2006, J IMMUNOL, V177, P7086, DOI 10.4049/jimmunol.177.10.7086; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Fu XY, 2011, IMMUNOLOGY, V134, P41, DOI 10.1111/j.1365-2567.2011.03464.x; Gillard GO, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002141; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; HAVELL EA, 1989, J IMMUNOL, V143, P2894; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Junqueira-Kipnis AP, 2003, J IMMUNOL, V171, P6039, DOI 10.4049/jimmunol.171.11.6039; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Korbel DS, 2004, INT J PARASITOL, V34, P1517, DOI 10.1016/j.ijpara.2004.10.006; Marcenaro E, 2008, INT IMMUNOL, V20, P1155, DOI 10.1093/intimm/dxn073; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Paust S, 2010, IMMUNOL REV, V235, P286, DOI 10.1111/j.0105-2896.2010.00906.x; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Portevin D, 2012, CELL MICROBIOL, V14, P1734, DOI 10.1111/j.1462-5822.2012.01834.x; Rahim MMA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00145; Reeves RK, 2015, NAT IMMUNOL, V16, P927, DOI 10.1038/ni.3227; Schaible UE, 1998, J IMMUNOL, V160, P1290; SCHARTON TM, 1993, J EXP MED, V178, P567, DOI 10.1084/jem.178.2.567; Sun JC, 2011, J IMMUNOL, V186, P1891, DOI 10.4049/jimmunol.1003035; Sun JC, 2009, EUR J IMMUNOL, V39, P2059, DOI 10.1002/eji.200939435; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Tascon RE, 1998, INFECT IMMUN, V66, P830, DOI 10.1128/IAI.66.2.830-834.1998; Tsuji S, 2000, INFECT IMMUN, V68, P6883, DOI 10.1128/IAI.68.12.6883-6890.2000; Uehori J, 2003, INFECT IMMUN, V71, P4238, DOI 10.1128/IAI.71.8.4238-4249.2003; Via LE, 1998, J CELL SCI, V111, P897	38	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0152051	10.1371/journal.pone.0152051	http://dx.doi.org/10.1371/journal.pone.0152051			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999357	Green Published, Green Submitted, gold			2022-12-26	WOS:000372694700096
J	Kim, JY; Goo, YK; Zo, YG; Ji, SY; Trimarsanto, H; To, S; Clark, TG; Price, RN; Auburn, S				Kim, Jung-Yeon; Goo, Youn-Kyoung; Zo, Young-Gun; Ji, So-Young; Trimarsanto, Hidayat; To, Sheren; Clark, Taane G.; Price, Ric N.; Auburn, Sarah			Further Evidence of Increasing Diversity of Plasmodium vivax in the Republic of Korea in Recent Years	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENETIC DIVERSITY; MICROSATELLITE DIVERSITY; TRANSMISSION DYNAMICS; MALARIA PARASITES; NATURAL-SELECTION; INFECTIONS; MARKERS; FALCIPARUM; SPECTRUM	Background Vivax malaria was successfully eliminated from the Republic of Korea (ROK) in the late 1970s but re-emerged in 1993. Two decades later as the ROK enters the final stages of malaria elimination, dedicated surveillance of the local P. vivax population is critical. We apply a population genetic approach to gauge P. vivax transmission dynamics in the ROK between 2010 and 2012. Methodology/Principal Findings P. vivax positive blood samples from 98 autochthonous cases were collected from patients attending health centers in the ROK in 2010 (n = 27), 2011 (n = 48) and 2012 (n = 23). Parasite genotyping was undertaken at 9 tandem repeat markers. Although not reaching significance, a trend of increasing population diversity was observed from 2010 (H-E = 0.50 +/- 0.11) to 2011 (H-E = 0.56 +/- 0.08) and 2012 (H-E = 0.60 +/- 0.06). Conversely, linkage disequilibrium declined during the same period: I-AS = 0.15 in 2010 (P = 0.010), 0.09 in 2011 (P = 0.010) and 0.05 in 2012 (P = 0.010). In combination with data from other ROK studies undertaken between 1994 and 2007, our results are consistent with increasing parasite divergence since re-emergence. Polyclonal infections were rare (3% infections) suggesting that local out-crossing alone was unlikely to explain the increased divergence. Cases introduced from an external reservoir may therefore have contributed to the increased diversity. Aside from one isolate, all infections carried a short MS20 allele (142 or 149 bp), not observed in other studies in tropical endemic countries despite high diversity, inferring that these regions are unlikely reservoirs. Conclusions Whilst a number of factors may explain the observed population genetic trends, the available evidence suggests that an external geographic reservoir with moderate diversity sustains the majority of P. vivax infection in the ROK, with important implications for malaria elimination.	[Kim, Jung-Yeon; Goo, Youn-Kyoung; Ji, So-Young] Osong Hlth Technol Adm, Korea CDC, Natl Inst Hlth, Div Malaria & Parasit Dis, 2 Ro, Osong, South Korea; [Goo, Youn-Kyoung] Kyungpook Natl Univ, Sch Med, Dept Parasitol & Trop Med, Daegu 700422, South Korea; [Zo, Young-Gun] Sungkyunkwan Univ, Sch Med, Dept Mol Parasitol, Suwon 440746, Gyeonggi Do, South Korea; [Zo, Young-Gun] Samsung Biomed Res Inst, Ctr Mol Med, Suwon 440746, Gyeonggi Do, South Korea; [Trimarsanto, Hidayat] Eijkman Inst Mol Biol, Jl Diponegoro 69, Jakarta 10430, Indonesia; [Trimarsanto, Hidayat] Agcy Assessment & Applicat Technol, Jl MH Thamrin 8, Jakarta 10340, Indonesia; [To, Sheren; Price, Ric N.; Auburn, Sarah] Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT 0810, Australia; [To, Sheren; Price, Ric N.; Auburn, Sarah] Charles Darwin Univ, Darwin, NT 0810, Australia; [Clark, Taane G.] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Keppel St, London WC1E 7HT, England; [Clark, Taane G.] Univ London London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England; [Price, Ric N.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England	Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Kyungpook National University; Sungkyunkwan University (SKKU); Samsung; Eijkman Institute; Agency for the Assessment & Application of Technology (BPPT); Charles Darwin University; Menzies School of Health Research; Charles Darwin University; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Oxford	Kim, JY (corresponding author), Osong Hlth Technol Adm, Korea CDC, Natl Inst Hlth, Div Malaria & Parasit Dis, 2 Ro, Osong, South Korea.; Auburn, S (corresponding author), Menzies Sch Hlth Res, Global & Trop Hlth Div, Darwin, NT 0810, Australia.; Auburn, S (corresponding author), Charles Darwin Univ, Darwin, NT 0810, Australia.	jykim-malaria@nih.go.kr; Sarah.Auburn@menzies.edu.au	Clark, Taane G./AAM-2570-2020; Auburn, Sarah/N-2266-2013	Clark, Taane G./0000-0001-8985-9265; Auburn, Sarah/0000-0002-4638-536X; Price, Richard/0000-0003-2000-2874; Trimarsanto, Hidayat/0000-0003-2436-8283	APMEN Small Project Grant [107-05]; Wellcome Trust [091625]; APMEN; Medical Research Council UK [MR/K000551/1, MR/M01360X/1]; MRC [MR/K000551/1, MR/M01360X/1] Funding Source: UKRI; Medical Research Council [MR/M01360X/1, MR/K000551/1] Funding Source: researchfish	APMEN Small Project Grant; Wellcome Trust(Wellcome TrustEuropean Commission); APMEN; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study has been an output of the Asia Pacific Malaria Elimination Network (APMEN). The study was funded by an APMEN Small Project Grant awarded to JYK (No. 107-05). SA, HT and RNP are funded by the Wellcome Trust [Wellcome Trust Senior Research Fellow in Clinical Science (091625) awarded to RNP]. SA is also part-funded by APMEN. TGC is funded by the Medical Research Council UK (Grant no. MR/K000551/1 and MR/M01360X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082553; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 1999, PARASITOLOGY, V119, P113, DOI 10.1017/S0031182099004552; Anstey NM, 2012, ADV PARASIT, V80, P151, DOI 10.1016/B978-0-12-397900-1.00003-7; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Chai In-Ho, 1994, Korean Journal of Parasitology, V32, P195, DOI 10.3347/kjp.1994.32.3.195; Cho Shin-Hyeong, 2002, Korean Journal of Parasitology, V40, P139, DOI 10.3347/kjp.2002.40.3.139; Choi YK, 2010, AM J TROP MED HYG, V82, P426, DOI 10.4269/ajtmh.2010.09-0245; Conway DJ, 1999, P NATL ACAD SCI USA, V96, P4506, DOI 10.1073/pnas.96.8.4506; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ferreira MU, 2007, J INFECT DIS, V195, P1218, DOI 10.1086/512685; Ferreira MU, 2014, TRENDS PARASITOL, V30, P465, DOI 10.1016/j.pt.2014.08.003; Getachew S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140780; Gething PW, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001814; Goo YK, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0803-3; Gray KA, 2013, SOLOMON ISLANDS MALA, V12, P429, DOI DOI 10.1186/1475-2875-12-429; Gunawardena S, 2014, PARASITOLOGY, V141, P880, DOI 10.1017/S0031182013002278; Gunawardena S, 2010, AM J TROP MED HYG, V82, P235, DOI 10.4269/ajtmh.2010.09-0588; Han ET, 2011, PARASITOL RES, V109, P1571, DOI 10.1007/s00436-011-2413-5; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; Havryliuk T, 2009, MEM I OSWALDO CRUZ, V104, P67, DOI 10.1590/S0074-02762009000100011; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Honma H, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-257; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Imwong M, 2007, INT J PARASITOL, V37, P1013, DOI 10.1016/j.ijpara.2007.02.010; Iwagami M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002522; Iwagami M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001592; Iwagami M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-184; Jennison C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003634; Ju HL, 2013, ACTA TROP, V125, P67, DOI 10.1016/j.actatropica.2012.09.016; Kang Jung-Mi, 2012, Malar J, V11, P206, DOI 10.1186/1475-2875-11-206; Karunaweera ND, 2008, GENE, V410, P105, DOI 10.1016/j.gene.2007.11.022; Kim JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039645; Koepfli C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003872; Koepfli C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066041; Koepfli C, 2009, J INFECT DIS, V199, P1074, DOI 10.1086/597303; Lee SW, 2009, AM J TROP MED HYG, V81, P600, DOI 10.4269/ajtmh.2009.09-0102; Liu YB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-262; Menegon M, 2014, INFECT GENET EVOL, V27, P244, DOI 10.1016/j.meegid.2014.07.029; Noviyanti R, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003739; Orjuela-Sanchez P, 2013, EXP PARASITOL, V134, P318, DOI 10.1016/j.exppara.2013.03.029; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Park JW, 2009, KOREAN J PARASITOL, V47, pS39, DOI 10.3347/kjp.2009.47.S.S39; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Price RN, 2014, LANCET INFECT DIS, V14, P982, DOI 10.1016/S1473-3099(14)70855-2; Pritchard JK, 2000, GENETICS, V155, P945; Rezende AM, 2009, AM J TROP MED HYG, V80, P729, DOI 10.4269/ajtmh.2009.80.729; Rodrigues PT, 2014, AM J TROP MED HYG, V90, P1102, DOI 10.4269/ajtmh.13-0588; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schousboe ML, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-392; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Sutton PL, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-447; Tibayrenc M, 2014, ADV PARASIT, V84, P253, DOI 10.1016/B978-0-12-800099-1.00005-3; Van den Eede P, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-151; Van den Eede P, 2010, AM J TROP MED HYG, V82, P223, DOI 10.4269/ajtmh.2010.09-0458; WHO, 2013, WORLD MALARIA REPORT 2013, P1	58	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151514	10.1371/journal.pone.0151514	http://dx.doi.org/10.1371/journal.pone.0151514			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990869	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000372582800070
J	Pintor, AFV; Schwarzkopf, L; Krockenberger, AK				Pintor, Anna F. V.; Schwarzkopf, Lin; Krockenberger, Andrew K.			Extensive Acclimation in Ectotherms Conceals Interspecific Variation in Thermal Tolerance Limits	PLOS ONE			English	Article							TEMPERATURE-ACCLIMATION; LOCOMOTOR PERFORMANCE; CLIMATIC VARIABILITY; BODY-TEMPERATURE; LIZARDS; RANGE; MODEL; METABOLISM; RESPONSES; GRADIENT	Species' tolerance limits determine their capacity to tolerate climatic extremes and limit their potential distributions. Interspecific variation in thermal tolerances is often proposed to indicate climatic vulnerability and is, therefore, the subject of many recent meta-studies on differential capacities of species from climatically different habitats to deal with climate change. Most studies on thermal tolerances do not acclimate animals or use inconsistent, and insufficient, acclimation times, limiting our knowledge of the shape, duration and extent of acclimation responses. Consequently patterns in thermal tolerances observed in meta-analyses, based on data from the literature are based on inconsistent, partial acclimation and true trends may be obscured. In this study we describe time-course of complete acclimation of critical thermal minima in the tropical ectotherm Carlia longipes and compare it to the average acclimation response of other reptiles, estimated from published data, to assess how much acclimation time may contribute to observed differences in thermal limits. Carlia longipes decreased their lower critical thermal limits by 2.4 degrees C and completed 95% of acclimation in 17 weeks. Wild populations did not mirror this acclimation process over the winter. Other reptiles appear to decrease cold tolerance more quickly (95% in 7 weeks) and to a greater extent, with an estimated average acclimation response of 6.1 degrees C. However, without data on tolerances after longer acclimation times available, our capacity to estimate final acclimation state is very limited. Based on the subset of data available for meta-analysis, much of the variation in cold tolerance observed in the literature can be attributed to acclimation time. Our results indicate that (i) acclimation responses can be slow and substantial, even in tropical species, and (ii) interspecific differences in acclimation speed and extent may obscure trends assessed in some meta-studies. Cold tolerances of wild animals are representative of cumulative responses to recent environments, while lengthy acclimation is necessary for controlled comparisons of physiological tolerances. Measures of inconsistent, intermediate acclimation states, as reported by many studies, represent neither the realised nor the potential tolerance in that population, are very likely underestimates of species' physiological capacities and may consequently be of limited value.	[Pintor, Anna F. V.; Krockenberger, Andrew K.] James Cook Univ, Ctr Trop Biodivers & Climate Change, Coll Marine & Environm Sci, Cairns, Qld 4878, Australia; [Schwarzkopf, Lin] James Cook Univ, Ctr Trop Biodivers & Climate Change, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Pintor, AFV (corresponding author), James Cook Univ, Ctr Trop Biodivers & Climate Change, Coll Marine & Environm Sci, Cairns, Qld 4878, Australia.	Anna.Pintor@my.jcu.edu.au	Schwarzkopf, Lin/C-1242-2012	Schwarzkopf, Lin/0000-0002-1009-670X; Krockenberger, Andrew/0000-0003-2872-9939	James Cook University; Centre for Tropical Biodiversity and Climate Change; National Climate Change Adaptation Research Facility; Skyrail Rainforest Foundation	James Cook University; Centre for Tropical Biodiversity and Climate Change; National Climate Change Adaptation Research Facility; Skyrail Rainforest Foundation	Funding was provided by James Cook University (http://www.jcu.edu.au/; AFVP), the Centre for Tropical Biodiversity and Climate Change (https://research.jcu.edu.au/ctbcc; AKK), the National Climate Change Adaptation Research Facility (https://www.nccarf.edu.au/; AFVP), and the Skyrail Rainforest Foundation (http://www.skyrailfoundation.org/; AFVP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; ALEKSIUK M, 1976, COPEIA, P170, DOI 10.2307/1443787; Andersson M, 2010, AUSTRAL ECOL, V35, P294, DOI 10.1111/j.1442-9993.2009.02035.x; Andrews RM, 2012, BIOL J LINN SOC, V106, P851, DOI 10.1111/j.1095-8312.2012.01901.x; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; [Anonymous], 2014, R LANG ENV STAT COMP; Bates D., 2011, PACKAGE LME4 LINEAR, V1; BELEHRADEK J, 1957, ANNU REV PHYSIOL, V19, P59, DOI 10.1146/annurev.ph.19.030157.000423; BLEM CR, 1990, COMP BIOCHEM PHYS A, V97, P259, DOI 10.1016/0300-9629(90)90182-R; BOGERT CM, 1949, EVOLUTION, V3, P195, DOI 10.2307/2405558; BRATTSTROM BAYARD H., 1962, PHYSIOL ZOOL, V35, P148; Buckley LB, 2015, FUNCTIONAL ECOLOGY, DOI [10.1111/365-2435, DOI 10.1111/365-2435]; Burton P, 1998, STAT MED, V17, P1261, DOI 10.1002/(SICI)1097-0258(19980615)17:11<1261::AID-SIM846>3.0.CO;2-Z; Calosi P, 2010, J ANIM ECOL, V79, P194, DOI 10.1111/j.1365-2656.2009.01611.x; Clusella-Trullas S, 2014, J COMP PHYSIOL B, V184, P5, DOI 10.1007/s00360-013-0776-x; Corn M.J., 1971, J Herpet, V5, P17, DOI 10.2307/1562838; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; GOLDSTEIN H, 1986, BIOMETRIKA, V73, P43; Gunderson AR, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0401; Holt RD, 2003, EVOL ECOL RES, V5, P159; Huey R. B., 1990, STRESS PROTEINS BIOL; Huey RB, 2009, P ROY SOC B-BIOL SCI, V276, P1939, DOI 10.1098/rspb.2008.1957; HUTCHISON V H, 1970, Herpetologica, V26, P1; Hutchison V. H., 1961, Physiological Zoology, V84, P92; HUTCHISON VH, 1979, AM ZOOL, V19, P367; KATTAN GH, 1989, PHYSIOL ZOOL, V62, P593, DOI 10.1086/physzool.62.2.30156187; KAUFMANN JS, 1989, PHYSIOL ZOOL, V62, P1047, DOI 10.1086/physzool.62.5.30156195; Kearney M, 2004, ECOLOGY, V85, P3119, DOI 10.1890/03-0820; Kearney M, 2008, ECOGRAPHY, V31, P423, DOI 10.1111/j.0906-7590.2008.05457.x; Kimura MT, 2004, OECOLOGIA, V140, P442, DOI 10.1007/s00442-004-1605-4; LAYNE JR, 1982, J THERM BIOL, V7, P139, DOI 10.1016/0306-4565(82)90002-X; Lutterschmidt WI, 1997, CAN J ZOOL, V75, P1561, DOI 10.1139/z97-783; MURRISH DE, 1968, COMP BIOCHEM PHYSIOL, V27, P329, DOI 10.1016/0010-406X(68)90775-5; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Pinheiro J, 2020, R PACKAGE VERSION 31; Pintor AFV, 2015, ECOL MONOGR, V85, P643, DOI 10.1890/14-1510.1; Ramlov H, 2000, HUM REPROD, V15, P26, DOI 10.1093/humrep/15.suppl_5.26; SHINE R, 1979, AM NAT, V113, P905, DOI 10.1086/283444; Shine R, 1999, J EVOLUTION BIOL, V12, P918, DOI 10.1046/j.1420-9101.1999.00093.x; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; STEVENS GC, 1992, AM NAT, V140, P893, DOI 10.1086/285447; STOREY KB, 1992, ANNU REV PHYSIOL, V54, P619, DOI 10.1146/annurev.physiol.54.1.619; Sunday JM, 2014, P NATL ACAD SCI USA, V111, P5610, DOI 10.1073/pnas.1316145111; Sunday JM, 2012, NAT CLIM CHANGE, V2, P686, DOI 10.1038/NCLIMATE1539; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Terblanche JS, 2007, P ROY SOC B-BIOL SCI, V274, P2935, DOI 10.1098/rspb.2007.0985; TSUJI JS, 1988, PHYSIOL ZOOL, V61, P241, DOI 10.1086/physzool.61.3.30161237; Vickers M, 2011, AM NAT, V177, P452, DOI 10.1086/658150; WHEELER PE, 1986, J THERM BIOL, V11, P161, DOI 10.1016/0306-4565(86)90041-0; Xu XF, 2006, COMP BIOCHEM PHYS A, V143, P118, DOI 10.1016/j.cbpa.2005.11.004; Yang J, 2008, J COMP PHYSIOL B, V178, P343, DOI 10.1007/s00360-007-0227-7	52	36	36	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150408	10.1371/journal.pone.0150408	http://dx.doi.org/10.1371/journal.pone.0150408			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990769	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000372582800029
J	Taher, M; Nakao, S; Zandi, S; Melhorn, MI; Hayes, KC; Hafezi-Moghadam, A				Taher, Mahdi; Nakao, Shintaro; Zandi, Souska; Melhorn, Mark I.; Hayes, K. C.; Hafezi-Moghadam, Ali			Phenotypic transformation of intimal and adventitial lymphatics in atherosclerosis: a regulatory role for soluble VEGF receptor 2	FASEB JOURNAL			English	Article						lymphangiogenesis; LYVE-1; podoplanin; macrophages; VEGF-C	E-DEFICIENT MICE; VASA VASORUM NEOVASCULARIZATION; LYMPHANGIOGENIC FACTORS; PLAQUE PROGRESSION; ANGIOGENESIS; INFLAMMATION; ATHEROGENESIS; MECHANISMS; EXPRESSION; ARTERIES	The role of lymphatics in atherosclerosis is not yet understood. Here, we investigate lymphatic growth dynamics and marker expression in atherosclerosis in apolipoprotein E-deficient (apoE(-/-)) mice. The prolymphangiogenic growth factor, VEGF-C, was elevated in atherosclerotic aortic walls. Despite increased VEGF-C, we found that adventitial lymphatics regress during the course of formation of atherosclerosis (P < 0.01). Similar to lymphatic regression, the number of lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1(+)) macrophages decreased in the aortic adventitia of apoE(-/-) mice with atherosclerosis (P < 0.01). Intimal lymphatics in the atherosclerotic lesions exhibited an atypical phenotype, with the expression of podoplanin and VEGF receptor 3 (VEGFR-3) but not of LYVE-1 and prospero homeobox protein 1. In the aortas of atherosclerotic animals, we found markedly increased soluble VEGFR-2. We hypothesized that the elevated soluble VEGFR-2 that was found in the aortas of apoE(-/-) mice with atherosclerosis binds to and diminishes the activity of VEGF-C. This trapping mechanism explains, despite increased VEGF-C in the atherosclerotic aortas, how adventitial lymphatics regress. Lymphatic regression impedes the drainage of lipids, growth factors, inflammatory cytokines, and immune cells. Insufficient lymphatic drainage could thus exacerbate atherosclerosis formation. Our study contributes new insights to previously unknown dynamic changes of adventitial lymphatics. Targeting soluble VEGFR-2 in atherosclerosis may provide a new strategy for the liberation of endogenous VEGF-C and the prevention of lymphatic regression.	[Taher, Mahdi; Nakao, Shintaro; Zandi, Souska; Melhorn, Mark I.; Hafezi-Moghadam, Ali] Brigham & Womens Hosp, Ctr Excellence Funct & Mol Imaging, 75 Francis St, Boston, MA 02115 USA; [Taher, Mahdi; Nakao, Shintaro; Zandi, Souska; Melhorn, Mark I.; Hafezi-Moghadam, Ali] Massachusetts Eye & Ear Infirm, Dept Radiol, Boston, MA 02114 USA; [Taher, Mahdi; Nakao, Shintaro; Zandi, Souska; Melhorn, Mark I.; Hafezi-Moghadam, Ali] Massachusetts Eye & Ear Infirm, Angiogenesis Lab, Boston, MA 02114 USA; [Taher, Mahdi; Nakao, Shintaro; Zandi, Souska; Melhorn, Mark I.; Hafezi-Moghadam, Ali] Harvard Med Sch, Dept Ophthalmol, Boston, MA USA; [Taher, Mahdi] Charite, Med Ctr, Inst Biochem, Berlin, Germany; [Hayes, K. C.] Brandeis Univ, Dept Biol, Waltham, MA 02254 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Brandeis University	Hafezi-Moghadam, A (corresponding author), Brigham & Womens Hosp, 45 Francis St, Boston, MA 02115 USA.	ahm@bwh.harvard.edu		Hafezi-Moghadam, Ali/0000-0002-5336-0697; Taher, Mahdi/0000-0001-8454-9751; Zandi, Souska/0000-0001-9351-4278	DP3 IMPACT award from U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant [DK108238]; DiaComp award; German Academic Exchange Service-DAAD; Bausch Lomb; Japan Eye Bank Association; Tear Film and Ocular Surface Society Young Investigator Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP3DK108238] Funding Source: NIH RePORTER	DP3 IMPACT award from U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant; DiaComp award; German Academic Exchange Service-DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Bausch Lomb; Japan Eye Bank Association; Tear Film and Ocular Surface Society Young Investigator Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank the Malaysian Palm Oil Board. This work was supported by a DP3 IMPACT award from U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant DK108238; a DiaComp award (to A.H.-M.); an overseas doctoral fellowship from the German Academic Exchange Service-DAAD (to M.T.); an overseas Research Fellowship Award from Bausch & Lomb; a fellowship award from the Japan Eye Bank Association; and a Tear Film and Ocular Surface Society Young Investigator Fellowship (to S.N.).	Aspelund A, 2016, CIRC RES, V118, P515, DOI 10.1161/CIRCRESAHA.115.306544; Cueni LN, 2010, BLOOD, V116, P4376, DOI 10.1182/blood-2010-04-278564; Donners MPC, 2010, ARTERIOSCL THROM VAS, V30, P2188, DOI 10.1161/ATVBAHA.110.213124; Drechsler M, 2015, ARTERIOSCL THROM VAS, V35, P1050, DOI 10.1161/ATVBAHA.114.304649; Du F, 2014, ARTERIOSCL THROM VAS, V34, P759, DOI 10.1161/ATVBAHA.113.302701; Grzegorek I, 2014, LYMPHAT RES BIOL, V12, P222, DOI 10.1089/lrb.2013.0048; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Johnson LA, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702889200; Kholova I, 2011, EUR J CLIN INVEST, V41, P487, DOI 10.1111/j.1365-2362.2010.02431.x; Klotz L, 2015, NATURE, V522, P62, DOI 10.1038/nature14483; Kutkut I, 2015, EUR J CLIN INVEST, V45, P100, DOI 10.1111/eci.12372; Langheinrich AC, 2006, ARTERIOSCL THROM VAS, V26, P347, DOI 10.1161/01.ATV.0000196565.38679.6d; Liu ZL, 2014, NUCL MED BIOL, V41, P785, DOI 10.1016/j.nucmedbio.2014.08.004; Llodra J, 2004, P NATL ACAD SCI USA, V101, P11779, DOI 10.1073/pnas.0403259101; Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Missiou A, 2010, CIRCULATION, V121, P2033, DOI 10.1161/CIRCULATIONAHA.109.895037; Moulton KS, 1999, CIRCULATION, V99, P1726, DOI 10.1161/01.CIR.99.13.1726; Moulton KS, 2003, P NATL ACAD SCI USA, V100, P4736, DOI 10.1073/pnas.0730843100; Nakano T, 2005, HUM PATHOL, V36, P330, DOI 10.1016/j.humpath.2005.01.001; Nakao S, 2012, FASEB J, V26, P808, DOI 10.1096/fj.11-183897; Nakao S, 2011, AM J PATHOL, V178, P1913, DOI 10.1016/j.ajpath.2011.01.011; Nakao S, 2011, BLOOD, V117, P1081, DOI 10.1182/blood-2010-02-267427; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tanaka K, 2011, ATHEROSCLEROSIS, V215, P366, DOI 10.1016/j.atherosclerosis.2011.01.016; Veerman KJ, 2013, ATHEROSCLEROSIS, V227, P250, DOI 10.1016/j.atherosclerosis.2013.01.018; Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18; Vuorio T, 2014, ARTERIOSCL THROM VAS, V34, P1162, DOI 10.1161/ATVBAHA.114.302528; Zheng W, 2014, J CLIN INVEST, V124, P878, DOI 10.1172/JCI71603	30	18	20	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2490	2499		10.1096/fj.201500112	http://dx.doi.org/10.1096/fj.201500112			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27006449	Green Published			2022-12-26	WOS:000379249500005
J	Yang, Q; Wang, LX				Yang, Qiang; Wang, Lai-Xi			Mammalian-1,6-Fucosyltransferase (FUT8) Is the Sole Enzyme Responsible for the N-Acetylglucosaminyltransferase I-independent Core Fucosylation of High-mannose N-Glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						erythropoietin; fucosyltransferase; glycoprotein; glycoprotein biosynthesis; glycosylation	PERFORMANCE LIQUID-CHROMATOGRAPHY; CHEMOENZYMATIC SYNTHESIS; GLYCOPROTEIN-SYNTHESIS; HEPATOMA-CELLS; RAT-LIVER; L-FUCOSE; OLIGOSACCHARIDES; GLYCOSYLATION; TRANSFERASE; ERYTHROPOIETIN	Understanding the biosynthetic pathway of protein glycosylation in various expression cell lines is important for controlling and modulating the glycosylation profiles of recombinant glycoproteins. We found that expression of erythropoietin (EPO) in a HEK293S N-acetylglucosaminyltransferase I (GnT I)(-/-) cell line resulted in production of the Man(5)GlcNAc(2) glycoforms, in which more than 50% were core-fucosylated, implicating a clear GnT I-independent core fucosylation pathway. Expression of GM-CSF and the ectodomain of FcIIIA receptor led to approximate to 30% and 3% core fucosylation, suggesting that the level of core fucosylation also depends on the nature of the recombinant proteins. To elucidate the GnT I-independent core fucosylation pathway, we generated a stable HEK293S GnT I-/- cell line with either knockdown or overexpression of FUT8 by a highly efficient lentivirus-mediated gene transfer approach. We found that the EPO produced from the FUT8 knockdown cell line was the pure Man(5)GlcNAc(2) glycoform, whereas that produced from the FUT8-overexpressing cell line was found to be fully core-fucosylated oligomannose glycan (Man(5)GlcNAc(2)Fuc). These results provide direct evidence that FUT8, the mammalian 1,6-fucosyltransferase, is the sole enzyme responsible for the GnT I-independent core fucosylation pathway. The production of the homogeneous core-fucosylated Man(5)GlcNAc(2) glycoform of EPO in the FUT8-overexpressed HEK293S GnT I-/- cell line represents the first example of production of fully core-fucosylated high-mannose glycoforms.	[Yang, Qiang; Wang, Lai-Xi] Univ Maryland, Dept Chem & Biochem, 8051 Regents Dr,3500 Chem Bldg, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Wang, LX (corresponding author), Univ Maryland, Dept Chem & Biochem, 8051 Regents Dr,3500 Chem Bldg, College Pk, MD 20742 USA.	wang518@umd.edu	wang, xl/Y-8251-2019; wang, xiao/HGB-7081-2022; Wang, Lai-Xi/E-8790-2019; Wang, Xin/AAN-8435-2021; Wang, Xin/GYU-1129-2022; Wang, Lai-Xi/E-8755-2019	wang, xiao/0000-0002-4088-3341; Wang, Lai-Xi/0000-0003-4293-5819; Wang, Xin/0000-0002-4457-7376; 	National Institutes of Health [R01 GM080374]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080374] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM080374. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Crispin M, 2006, GLYCOBIOLOGY, V16, P748, DOI 10.1093/glycob/cwj119; Dalziel M, 2014, SCIENCE, V343, P37, DOI 10.1126/science.1235681; DELORME E, 1992, BIOCHEMISTRY-US, V31, P9871, DOI 10.1021/bi00156a003; Dwek RA, 1996, CHEM REV, V96, P683, DOI 10.1021/cr940283b; Endo T, 1996, EUR J BIOCHEM, V236, P579, DOI 10.1111/j.1432-1033.1996.t01-1-00579.x; Faid V, 2006, GLYCOBIOLOGY, V16, P440, DOI 10.1093/glycob/cwj081; Hacker DL, 2013, PROTEIN EXPRES PURIF, V92, P67, DOI 10.1016/j.pep.2013.09.001; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; HOWARD DR, 1982, J BIOL CHEM, V257, P861; Huang W, 2012, J AM CHEM SOC, V134, P12308, DOI 10.1021/ja3051266; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Juliant S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110422; Kamoda S, 2005, J PROTEOME RES, V4, P146, DOI 10.1021/pr049825o; Kittur FS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076468; Li L, 2015, CHEM SCI, V6, P5652, DOI 10.1039/c5sc02025e; LIN AI, 1994, GLYCOBIOLOGY, V4, P895, DOI 10.1093/glycob/4.6.895; LONGMORE GD, 1982, CARBOHYD RES, V100, P365, DOI 10.1016/S0008-6215(00)81049-6; Miyoshi E, 1999, CANCER RES, V59, P2237; Oberbek A, 2011, BIOTECHNOL BIOENG, V108, P600, DOI 10.1002/bit.22968; Ohta M, 2001, J CHROMATOGR A, V910, P1, DOI 10.1016/S0021-9673(00)01116-X; Osumi D, 2009, CANCER SCI, V100, P888, DOI 10.1111/j.1349-7006.2009.01125.x; Packer NH, 1998, GLYCOCONJUGATE J, V15, P737, DOI 10.1023/A:1006983125913; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13419, DOI 10.1073/pnas.212519299; Rodriguez-Diaz J, 2011, APPL ENVIRON MICROB, V77, P703, DOI 10.1128/AEM.01906-10; SCHACHTER H, 1983, CAN J BIOCHEM CELL B, V61, P1049, DOI 10.1139/o83-134; SHAO MC, 1994, CARBOHYD RES, V251, P163, DOI 10.1016/0008-6215(94)84283-3; TAKAHASHI T, 1983, J BIOL CHEM, V258, P2819; VOYNOW JA, 1991, J BIOL CHEM, V266, P21572; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wang LX, 2014, CHEM BIOL, V21, P51, DOI 10.1016/j.chembiol.2014.01.001; Wang LX, 2012, ACS CHEM BIOL, V7, P110, DOI 10.1021/cb200429n; WILSON JR, 1976, BIOCHEM BIOPH RES CO, V72, P909, DOI 10.1016/S0006-291X(76)80218-5	32	33	34	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11064	11071		10.1074/jbc.M116.720789	http://dx.doi.org/10.1074/jbc.M116.720789			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27008861	Green Published, hybrid			2022-12-26	WOS:000377042100010
J	Babinsky, VN; Hannan, FM; Gorvin, CM; Howles, SA; Nesbit, MA; Rust, N; Hanyaloglu, AC; Hu, JX; Spiegel, AM; Thakker, RV				Babinsky, Valerie N.; Hannan, Fadil M.; Gorvin, Caroline M.; Howles, Sarah A.; Nesbit, M. Andrew; Rust, Nigel; Hanyaloglu, Aylin C.; Hu, Jianxin; Spiegel, Allen M.; Thakker, Rajesh V.			Allosteric Modulation of the Calcium-sensing Receptor Rectifies Signaling Abnormalities Associated with G-protein alpha-11 Mutations Causing Hypercalcemic and Hypocalcemic Disorders	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL HYPOCALCIURIC HYPERCALCEMIA; ACTIVATING MUTATIONS; MUTANT RECEPTORS; CINACALCET; DOMAIN; CELLS; HYPOPARATHYROIDISM; IDENTIFICATION; TRANSDUCTION; KIDNEY	Germline loss- and gain-of-function mutations of G-protein alpha-11 (G alpha(11)), which couples the calcium-sensing receptor (CaSR) to intracellular calcium (Ca-i(2+)) signaling, lead to familial hypocalciuric hypercalcemia type 2 (FHH2) and autosomal dominant hypocalcemia type 2 (ADH2), respectively, whereas somatic Gall mutations mediate uveal melanoma development by constitutively up-regulating MAPK signaling. Cinacalcet and NPS-2143 are allosteric CaSR activators and inactivators, respectively, that ameliorate signaling disturbances associated with CaSR mutations, but their potential to modulate abnormalities of the downstream Gall protein is unknown. This study investigated whether cinacalcet and NPS-2143 may rectify Ca-i(2+) alterations associated with FHH2- and ADH2-causing Got, mutations, and evaluated the influence of germline gain of-function Gall mutations on MAPK signaling by measuring ERK phosphorylation, and assessed the effect of NPS-2143 on a uveal melanoma Gall mutant. WT and mutant G alpha(11) proteins causing FHH2, ADH2 or uveal melanoma were transfected in CaSR-expressing HEK293 cells, and Ca-i(2+) and ERK phosphorylation responses measured by flow-cytometry and Alphascreen immunoassay following exposure to extracellular Ca2+ (Ca-0(2+)) and allosteric modulators. Cinacalcet and NPS-2143 rectified the Ca-i(2+) responses of FHH2- and ADH2-associated G alpha(11) loss and gain-of-function mutations, respectively. ADH2-causing	[Babinsky, Valerie N.; Hannan, Fadil M.; Gorvin, Caroline M.; Howles, Sarah A.; Nesbit, M. Andrew; Thakker, Rajesh V.] Univ Oxford, Radcliffe Dept Med, S Parks Rd, Oxford OX3 7LJ, England; [Hannan, Fadil M.] Univ Liverpool, Dept Musculoskeletal Biol, Liverpool L69 3GA, Merseyside, England; [Nesbit, M. Andrew] Univ Ulster, Biomed Sci Res Inst, Coleraine BT52 1SA, Londonderry, North Ireland; [Rust, Nigel] Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England; [Hanyaloglu, Aylin C.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Inst Reprod Biol & Dev, London W12 0NN, England; [Hu, Jianxin] NIDDK, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; [Spiegel, Allen M.] Albert Einstein Coll Med, Bronx, NY 10461 USA	University of Oxford; University of Liverpool; Ulster University; University of Oxford; Imperial College London; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Yeshiva University; Albert Einstein College of Medicine	Thakker, RV (corresponding author), Churchill Hosp, Acad Endocrine Unit, Radcliffe Dept Med, OCDEM, Oxford OX3 7LJ, England.	rajesh.thakker@ndm.ox.ac.uk	Gorvin, Caroline/T-2406-2019	Gorvin, Caroline/0000-0002-1361-9174; Thakker, Rajesh/0000-0002-1438-3220; Hannan, Fadil/0000-0002-2975-5170; /0000-0003-4206-737X; Howles, Sarah/0000-0001-6342-0895	United Kingdom Medical Research Council (MRC) [G9825289, G1000467]; National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme; European Commission [FP7-264663]; Medical Research Council [G1000467, MR/K006312/1, G9825289] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10091, CL-2015-13-005] Funding Source: researchfish; Wellcome Trust [106995/Z/15/Z] Funding Source: researchfish; MRC [MR/K006312/1, G1000467, G9825289] Funding Source: UKRI	United Kingdom Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme(National Institute for Health Research (NIHR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the United Kingdom Medical Research Council (MRC) Programme Grants G9825289 and G1000467 (to M. A. N., F. M. H., C. M. G., and R. V. T), and National Institute for Health Research (NIHR) Oxford Biomedical Research Centre Programme (to M. A. N. and R. V. T.); European Commission Seventh Framework Programme (FP7-264663) (to V. N. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or NIHR (UK).	Bai M, 1996, J BIOL CHEM, V271, P19537, DOI 10.1074/jbc.271.32.19537; Breitwieser GE, 2001, AM J PHYSIOL-CELL PH, V280, pC1412, DOI 10.1152/ajpcell.2001.280.6.C1412; BROWN EM, 1991, PHYSIOL REV, V71, P371, DOI 10.1152/physrev.1991.71.2.371; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Davey AE, 2012, ENDOCRINOLOGY, V153, P1232, DOI 10.1210/en.2011-1426; Dong BZ, 2015, J BONE MINER RES, V30, P1980, DOI 10.1002/jbmr.2551; Fang Y, 1999, METHOD ENZYMOL, V302, P207, DOI 10.1016/S0076-6879(99)02020-0; Festen-Spanjer B, 2008, CLIN ENDOCRINOL, V68, P324, DOI 10.1111/j.1365-2265.2007.03027.x; Gannon AW, 2014, J CLIN ENDOCR METAB, V99, P7, DOI 10.1210/jc.2013-2834; Gowen M, 2000, J CLIN INVEST, V105, P1595, DOI 10.1172/JCI9038; Hannan FM, 2015, HUM MOL GENET, V24, P5079, DOI 10.1093/hmg/ddv226; Hannan FM, 2015, ENDOCRINOLOGY, V156, P3114, DOI 10.1210/en.2015-1269; Hannan FM, 2013, BEST PRACT RES CL EN, V27, P359, DOI 10.1016/j.beem.2013.04.007; Hannan FM, 2012, HUM MOL GENET, V21, P2768, DOI 10.1093/hmg/dds105; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Hu JX, 2005, J BIOL CHEM, V280, P5113, DOI 10.1074/jbc.M413403200; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Leach K, 2013, ENDOCRINOLOGY, V154, P1105, DOI 10.1210/en.2012-1887; Leach K, 2012, ENDOCRINOLOGY, V153, P4304, DOI 10.1210/en.2012-1449; Letz S, 2010, J CLIN ENDOCR METAB, V95, pE229, DOI 10.1210/jc.2010-0651; Li D, 2014, J CLIN ENDOCR METAB, V99, pE1774, DOI 10.1210/jc.2014-1029; Mannstadt M, 2013, NEW ENGL J MED, V368, P2532, DOI 10.1056/NEJMc1300278; Miedlich SU, 2004, J BIOL CHEM, V279, P7254, DOI 10.1074/jbc.M307191200; Nemeth EF, 2004, J PHARMACOL EXP THER, V308, P627, DOI 10.1124/jpet.103.057273; Nesbit MA, 2013, NEW ENGL J MED, V368, P2476, DOI 10.1056/NEJMoa1300253; Nesbit MA, 2013, NAT GENET, V45, P93, DOI 10.1038/ng.2492; Newey PJ, 2013, NEW ENGL J MED, V369, P2012, DOI 10.1056/NEJMoa1307557; Pearce SHS, 1996, J CLIN INVEST, V98, P1860, DOI 10.1172/JCI118987; Pearce SHS, 1996, NEW ENGL J MED, V335, P1115, DOI 10.1056/NEJM199610103351505; Radhika V, 2001, ONCOGENE, V20, P1607, DOI 10.1038/sj.onc.1204274; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Riccardi D, 2010, AM J PHYSIOL-RENAL, V298, pF485, DOI 10.1152/ajprenal.00608.2009; Rus R, 2008, J CLIN ENDOCR METAB, V93, P4797, DOI 10.1210/jc.2008-1076; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; WU DQ, 1992, J BIOL CHEM, V267, P1811	35	27	29	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10876	10885		10.1074/jbc.M115.696401	http://dx.doi.org/10.1074/jbc.M115.696401			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	26994139	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000377042600037
J	Cuevas-Velazquez, CL; Saab-Rincon, G; Reyes, JL; Covarrubias, AA				Cuevas-Velazquez, Cesar L.; Saab-Rincon, Gloria; Luis Reyes, Jose; Covarrubias, Alejandra A.			The Unstructured N-terminal Region of Arabidopsis Group 4 Late Embryogenesis Abundant (LEA) Proteins Is Required for Folding and for Chaperone-like Activity under Water Deficit	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY DISORDERED PROTEINS; IN-VITRO; SECONDARY STRUCTURE; CIRCULAR-DICHROISM; FORMING PROPERTIES; ESCHERICHIA-COLI; EXCLUDED-VOLUME; BINDING; PEPTIDES; THALIANA	Late embryogenesis abundant (LEA) proteins are a conserved group of proteins widely distributed in the plant kingdom that participate in the tolerance to water deficit of different plant species. In silico analyses indicate that most LEA proteins are structurally disordered. The structural plasticity of these proteins opens the question of whether water deficit modulates their conformation and whether these possible changes are related to their function. In this work, we characterized the secondary structure of Arabidopsis group 4 LEA proteins. We found that they are disordered in aqueous solution, with high intrinsic potential to fold into alpha-helix. We demonstrate that complete dehydration is not required for these proteins to sample ordered structures because milder water deficit and macromolecular crowding induce high alpha-helix levels in vitro, suggesting that prevalent conditions under water deficit modulate their conformation. We also show that the N-terminal region, conserved across all group 4 LEA proteins, is necessary and sufficient for conformational transitions and that their protective function is confined to this region, suggesting that folding into alpha-helix is required for chaperone-like activity under water limitation. We propose that these proteins can exist as different conformers, favoring functional diversity, a moonlighting property arising from their structural dynamics.	[Cuevas-Velazquez, Cesar L.; Luis Reyes, Jose; Covarrubias, Alejandra A.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Biol Mol Plantas, Cuernavaca 62250, Morelos, Mexico; [Saab-Rincon, Gloria] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca 62250, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Covarrubias, AA (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Biol Mol Plantas, Cuernavaca 62250, Morelos, Mexico.	crobles@ibt.unam.mx	Saab-RIncon, Gloria/AFO-4892-2022	Saab-RIncon, Gloria/0000-0002-5251-1000; Cuevas-Velazquez, Cesar/0000-0002-6629-6444	Direccion General de Apoyo al Personal Academico/Programa de Apoyo a Proyectos de Investigation e Innovation Tecnologica PAPIIT, Universidad Nacional Autonoma de Mexico [IN208212]; Consejo Nacional de Ciencia y Tecnologia [132258, 221448]; Consejo Nacional de Ciencia y Tecnologia doctoral fellowship	Direccion General de Apoyo al Personal Academico/Programa de Apoyo a Proyectos de Investigation e Innovation Tecnologica PAPIIT, Universidad Nacional Autonoma de Mexico; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Nacional de Ciencia y Tecnologia doctoral fellowship	This work was partially supported by Grants IN208212 from the Direccion General de Apoyo al Personal Academico/Programa de Apoyo a Proyectos de Investigation e Innovation Tecnologica PAPIIT, Universidad Nacional Autonoma de Mexico and Grants 132258 and 221448 from the Consejo Nacional de Ciencia y Tecnologia. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a Consejo Nacional de Ciencia y Tecnologia doctoral fellowship.	Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Borcherds W, 2014, NAT CHEM BIOL, V10, P1000, DOI 10.1038/nchembio.1668; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Campos F, 2006, BIOCHEM BIOPH RES CO, V342, P406, DOI 10.1016/j.bbrc.2006.01.151; Campos F, 2011, PROTEIN EXPRES PURIF, V80, P47, DOI 10.1016/j.pep.2011.06.007; Cheng JL, 2005, DATA MIN KNOWL DISC, V11, P213, DOI 10.1007/s10618-005-0001-y; Cino EA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049876; Cuevas-Velazquez CL, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00583; Dang NX, 2014, PLANTA, V240, P325, DOI 10.1007/s00425-014-2089-z; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Garay-Arroyo A, 2000, J BIOL CHEM, V275, P5668, DOI 10.1074/jbc.275.8.5668; Goyal K, 2003, J BIOL CHEM, V278, P12977, DOI 10.1074/jbc.M212007200; Haaning S, 2008, J BIOL CHEM, V283, P31142, DOI 10.1074/jbc.M805024200; Hughes S, 2011, PROTEIN SCI, V20, P42, DOI 10.1002/pro.534; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Hundertmark M, 2012, BIOCHEM BIOPH RES CO, V417, P122, DOI 10.1016/j.bbrc.2011.11.067; Hundertmark M, 2011, BBA-BIOMEMBRANES, V1808, P446, DOI 10.1016/j.bbamem.2010.09.010; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Lee SH, 2012, CURR PROTEIN PEPT SC, V13, P34, DOI 10.2174/138920312799277974; Liu GB, 2011, PLANT CELL PHYSIOL, V52, P994, DOI 10.1093/pcp/pcr052; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Luo PZ, 1997, BIOCHEMISTRY-US, V36, P8413, DOI 10.1021/bi9707133; MCCUBBIN WD, 1985, CAN J BIOCHEM CELL B, V63, P803, DOI 10.1139/o85-102; Minton AP, 1997, CURR OPIN BIOTECH, V8, P65, DOI 10.1016/S0958-1669(97)80159-0; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Mittag T, 2008, P NATL ACAD SCI USA, V105, P17772, DOI 10.1073/pnas.0809222105; Mouillon JM, 2006, PLANT PHYSIOL, V141, P638, DOI 10.1104/pp.106.079848; Mouillon JM, 2008, PLANT PHYSIOL, V148, P1925, DOI 10.1104/pp.108.124099; MUNOZ V, 1994, NAT STRUCT BIOL, V1, P399, DOI 10.1038/nsb0694-399; Olvera-Carrillo Y, 2011, PLANT SIGNAL BEHAV, V6, P586, DOI 10.4161/psb.6.4.15042; Olvera-Carrillo Y, 2010, PLANT PHYSIOL, V154, P373, DOI 10.1104/pp.110.158964; Popova AV, 2011, BBA-BIOMEMBRANES, V1808, P1879, DOI 10.1016/j.bbamem.2011.03.009; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Reichmann D, 2012, CELL, V148, P947, DOI 10.1016/j.cell.2012.01.045; Reyes JL, 2005, PLANT CELL ENVIRON, V28, P709, DOI 10.1111/j.1365-3040.2005.01317.x; Reyes JL, 2008, PLANT CELL ENVIRON, V31, P1781, DOI 10.1111/j.1365-3040.2008.01879.x; Rivera-Najera LY, 2014, J BIOL CHEM, V289, P31995, DOI 10.1074/jbc.M114.583369; Rogers JM, 2014, J AM CHEM SOC, V136, P5197, DOI 10.1021/ja4125065; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shih MD, 2012, PLANT SCI, V196, P152, DOI 10.1016/j.plantsci.2012.07.012; Shih MD, 2010, PLANT CELL PHYSIOL, V51, P395, DOI 10.1093/pcp/pcq005; Shimizu T, 2010, BIOCHEMISTRY-US, V49, P1093, DOI 10.1021/bi901745f; Soulages JL, 2002, PLANT PHYSIOL, V128, P822, DOI 10.1104/pp.010521; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Sun XL, 2013, PLANT CELL, V25, P38, DOI 10.1105/tpc.112.106062; Szasz C, 2011, BIOCHEMISTRY-US, V50, P5834, DOI [10.1021/bi200365J, 10.1021/bi200365j]; Tapley TL, 2009, P NATL ACAD SCI USA, V106, P5557, DOI 10.1073/pnas.0811811106; Tolleter D, 2007, PLANT CELL, V19, P1580, DOI 10.1105/tpc.107.050104; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Tompa P, 2010, BIOCHEM CELL BIOL, V88, P167, DOI [10.1139/O09-163, 10.1139/o09-163]; Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; ZIMMERMAN SB, 1991, J MOL BIOL, V222, P599, DOI 10.1016/0022-2836(91)90499-V; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	60	46	50	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10893	10903		10.1074/jbc.M116.720318	http://dx.doi.org/10.1074/jbc.M116.720318			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27006402	Green Published, hybrid			2022-12-26	WOS:000377042600039
J	Ruszkowski, M; Dauter, Z				Ruszkowski, Milosz; Dauter, Zbigniew			Structural Studies of Medicago truncatula Histidinol Phosphate Phosphatase from Inositol Monophosphatase Superfamily Reveal Details of Penultimate Step of Histidine Biosynthesis in Plants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUTATIVE TARGET; MOLECULAR-CLONING; ESCHERICHIA-COLI; LITHIUM; MYOINOSITOL; PATHWAY; MECHANISM; BINDING; DEHYDROGENASE; PROTEINS	The penultimate enzyme in the histidine biosynthetic pathway catalyzes dephosphorylation of L-histidinol 1-phosphate (HOLP) into L-histidinol. The recently discovered in Arabidopsis thaliana plant-type histidinol phosphate phosphatase (HPP) shares no homology with the two other HPP superfamilies known previously in prokaryotes and resembles myo-inositol monophosphatases (IMPases). In this work, identification of an HPP enzyme from a model legume, Medicago truncatula (MtHPP) was based on the highest sequence identity to A. thaliana enzyme. Biochemical assays confirmed that MtHPP was able to cleave inorganic phosphate from HOLP but not from D-myo-inositol-1-phosphate, the main substrate of IMPases. Dimers of MtHPP, determined by size exclusion chromatography, in the presence of CO2 or formaldehyde form mutual, methylene-bridged cross-links between Lys(158) and Cys(245) residues. Four high resolution crystal structures, namely complexes with HOLP (substrate), L-histidinol (product), and PO43- (by-product) as well as the structure showing the cross-linking between two MtHPP molecules, provide detailed structural information on the enzyme. Based on the crystal structures, the enzymatic reaction mechanism of IMPases is accustomed to fit the data for MtHPP. The enzymatic reaction, which requires Mg2+ cations, is catalyzed mainly by amino acid residues from the N-terminal domain. The C-terminal domain, sharing little identity with IMPases, is responsible for the substrate specificity (i.e. allows the enzyme to distinguish between HOLP and D-myo-inositol-1-phosphate). Structural features, mainly the presence of a conserved Asp(246), allow MtHPP to bind HOLP specifically.	[Ruszkowski, Milosz; Dauter, Zbigniew] NCI, Synchrotron Radiat Res Sect, MCL, NIH, Argonne, IL 60439 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ruszkowski, M (corresponding author), NCI, Synchrotron Radiat Res Sect, MCL, S Cass Ave 9700,Bldg 202,Rm Q-141, Argonne, IL 60439 USA.	mruszkowski@anl.gov		Ruszkowski, Milosz/0000-0002-4415-3100	United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL CANCER INSTITUTE [ZIABC010378] Funding Source: NIH RePORTER	United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We gratefully acknowledge Dr. Joanna Banasiak for assistance with identification of the MTHPP gene. We are also thankful to Dr. Jerry Alexandratos, who performed LC-MS studies at the Biophysics Resource in the Structural Biophysics Laboratory, National Cancer Institute at Frederick. Diffraction data were collected at the (i) SER-CAT beamline 22-ID at the Advanced Photon Source, Argonne National Laboratory, supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract W-31-109-Eng-38 and (ii) Structural Biology Center at the Advanced Photon Source, operated by UChicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	Akashi H, 2002, P NATL ACAD SCI USA, V99, P3695, DOI 10.1073/pnas.062526999; Alifano P, 1996, MICROBIOL REV, V60, P44, DOI 10.1128/MMBR.60.1.44-69.1996; Allen KN, 2004, TRENDS BIOCHEM SCI, V29, P495, DOI 10.1016/j.tibs.2004.07.008; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P127, DOI 10.1016/S0968-0004(98)01189-X; BAKER GR, 1991, BIOORG MED CHEM LETT, V1, P193, DOI 10.1016/S0960-894X(00)80250-4; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; BONE R, 1992, P NATL ACAD SCI USA, V89, P10031, DOI 10.1073/pnas.89.21.10031; BONE R, 1994, BIOCHEMISTRY-US, V33, P9460, DOI 10.1021/bi00198a011; BONE R, 1994, BIOCHEMISTRY-US, V33, P9468, DOI 10.1021/bi00198a012; Brilli M, 2004, J MOL EVOL, V58, P225, DOI 10.1007/s00239-003-2547-x; BUCHWALD SL, 1984, J AM CHEM SOC, V106, P4916, DOI 10.1021/ja00329a048; COLE AG, 1994, J CHEM SOC CHEM COMM, P1139, DOI 10.1039/c39940001139; de Beer TAP, 2014, NUCLEIC ACIDS RES, V42, pD292, DOI 10.1093/nar/gkt940; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Eicher T., 2003, CHEM HETEROCYCLES ST; El Malki F, 1998, PLANT MOL BIOL, V37, P1013, DOI 10.1023/A:1006007125448; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fauroux CMJ, 1999, J AM CHEM SOC, V121, P8385, DOI 10.1021/ja991939r; Fujimori K, 1998, MOL GEN GENET, V259, P216, DOI 10.1007/s004380050807; Fujimori K, 1998, PLANT PHYSIOL, V118, P275, DOI 10.1104/pp.118.1.275; Fujimori K, 1998, FEBS LETT, V428, P229, DOI 10.1016/S0014-5793(98)00535-3; Ghodge SV, 2013, BIOCHEMISTRY-US, V52, P1101, DOI 10.1021/bi301496p; Gill R, 2005, ACTA CRYSTALLOGR D, V61, P545, DOI 10.1107/S0907444905004038; GREASLEY PJ, 1994, EUR J BIOCHEM, V222, P453, DOI 10.1111/j.1432-1033.1994.tb18885.x; GREASLEY PJ, 1993, FEBS LETT, V331, P114, DOI 10.1016/0014-5793(93)80308-H; HALLCHER LM, 1980, J BIOL CHEM, V255, P896; HAUSER M, 1995, PLANT PHYSIOL, V108, P1059, DOI 10.1104/pp.108.3.1059; HELDT HW, 1973, BIOCHIM BIOPHYS ACTA, V314, P224, DOI 10.1016/0005-2728(73)90137-0; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Hwang HJ, 2014, BIOCHEM BIOPH RES CO, V445, P78, DOI 10.1016/j.bbrc.2014.01.152; Ingle RA, 2005, PLANT CELL, V17, P2089, DOI 10.1105/tpc.104.030577; Ingle Robert A, 2011, Arabidopsis Book, V9, pe0141, DOI 10.1199/tab.0141; Ishijima S, 2003, ARCH BIOCHEM BIOPHYS, V412, P126, DOI 10.1016/S0003-9861(03)00038-9; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim Y, 2011, METHODS, V55, P12, DOI 10.1016/j.ymeth.2011.07.010; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Koslowsky S, 2008, PLANT BIOTECHNOL J, V6, P281, DOI 10.1111/j.1467-7652.2007.00314.x; Kowiel M, 2014, ACTA CRYSTALLOGR D, V70, P3290, DOI 10.1107/S1399004714024572; Kramer U, 1996, NATURE, V379, P635, DOI 10.1038/379635a0; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lahiri SD, 2003, SCIENCE, V299, P2067, DOI 10.1126/science.1082710; LANG PF, 2010, J CHEM SOC DA, V39, P7786, DOI DOI 10.1039/C0DT00401D; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Le Coq D, 1999, J BACTERIOL, V181, P3277, DOI 10.1128/JB.181.10.3277-3280.1999; Lee HS, 2008, J BACTERIOL, V190, P2629, DOI 10.1128/JB.01722-07; LEECH AP, 1993, EUR J BIOCHEM, V212, P693, DOI 10.1111/j.1432-1033.1993.tb17707.x; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Marineo S, 2008, CURR MICROBIOL, V56, P6, DOI 10.1007/s00284-007-9014-7; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Metz B, 2004, J BIOL CHEM, V279, P6235, DOI 10.1074/jbc.M310752200; Miller DJ, 2000, CHEMBIOCHEM, V1, P262, DOI 10.1002/1439-7633(20001117)1:4<262::AID-CBIC262>3.0.CO;2-#; Mormann S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-205; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NAGAI A, 1991, ARCH BIOCHEM BIOPHYS, V284, P127, DOI 10.1016/0003-9861(91)90274-M; NAGAI A, 1991, P NATL ACAD SCI USA, V88, P4133, DOI 10.1073/pnas.88.10.4133; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nourbakhsh A, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00725; PENNY DE, 1983, J CHEM SOC FARAD T 1, V79, P2103, DOI 10.1039/f19837902103; Petersen LN, 2010, PLANT PHYSIOL, V152, P1186, DOI 10.1104/pp.109.150805; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; POLLACK SJ, 1993, EUR J BIOCHEM, V217, P281, DOI 10.1111/j.1432-1033.1993.tb18244.x; POLLACK SJ, 1994, P NATL ACAD SCI USA, V91, P5766, DOI 10.1073/pnas.91.13.5766; Rangarajan ES, 2006, J BIOL CHEM, V281, P37930, DOI 10.1074/jbc.M604916200; Rees JD, 2009, PLANT BIOTECHNOL J, V7, P499, DOI 10.1111/j.1467-7652.2009.00419.x; Ruszkowski M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00869; Saudek V, 1996, EUR J BIOCHEM, V240, P288, DOI 10.1111/j.1432-1033.1996.0288h.x; Seligmann H, 2003, J MOL EVOL, V56, P151, DOI 10.1007/s00239-002-2388-z; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Stepansky A, 2006, AMINO ACIDS, V30, P121, DOI 10.1007/s00726-005-0246-1; Swire J, 2007, J MOL EVOL, V64, P558, DOI 10.1007/s00239-006-0206-8; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang HB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-312; Thaller MC, 1998, PROTEIN SCI, V7, P1647, DOI 10.1002/pro.5560070722; Torabinejad J, 2009, PLANT PHYSIOL, V150, P951, DOI 10.1104/pp.108.135129; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; WIATER A, 1971, ACTA BIOCHIM POL, V18, P299; Wilkie J, 1996, J CHEM SOC PERK T 2, P783, DOI 10.1039/p29960000783; WILKIE J, 1995, J CHEM SOC PERK T 1, P2709, DOI 10.1039/p19950002709; WLODEK L, 1988, ACTA BIOCHIM POL, V35, P307; WONG YS, 1981, PHYTOCHEMISTRY, V20, P1831, DOI 10.1016/0031-9422(81)84014-9; YOUNG VR, 1994, J NUTR, V124, pS1517, DOI 10.1093/jn/124.suppl_8.1517S	85	14	14	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					9960	9973		10.1074/jbc.M115.708727	http://dx.doi.org/10.1074/jbc.M115.708727			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26994138	Green Published, hybrid			2022-12-26	WOS:000375602800011
J	Finne, LB; Christensen, JO; Knardahl, S				Finne, Live Bakke; Christensen, Jan Olav; Knardahl, Stein			Psychological and Social Work Factors as Predictors of Mental Distress and Positive Affect: A Prospective, Multilevel Study	PLOS ONE			English	Article							EFFORT-REWARD IMBALANCE; ORGANIZATIONAL JUSTICE; PSYCHOSOCIAL FACTORS; JOB DEMANDS; PSYCHOMETRIC PROPERTIES; NEGATIVE AFFECTIVITY; DISABILITY PENSION; ABILITY INDEX; HEALTH; DEPRESSION	Occupational health research has mainly addressed determinants of negative health effects, typically employing individual-level self-report data. The present study investigated individual-and department-level (means of each work unit) effects of psychological/social work factors on mental distress and positive affect. Employees were recruited from 63 Norwegian organizations, representing a wide variety of job types. A total of 4158 employees, in 918 departments, responded at baseline and at follow-up two years later. Multilevel linear regressions estimated individual-and department-level effects simultaneously, and accounted for clustering of data. Baseline exposures and average exposures over time ([T1+T2]/2) were tested. All work factors; decision control, role conflict, positive challenge, support from immediate superior, fair leadership, predictability during the next month, commitment to organization, rumors of change, human resource primacy, and social climate, were related to mental distress and positive affect at the individual and department level. However, analyses of baseline exposures adjusted for baseline outcome, demonstrated significant associations at the individual level only. Baseline "rumors of change" was related to mental distress only and baseline "predictability during the next month" was not a statistical significant predictor of either outcome when adjusted for outcome at baseline. Psychological and social work factors were generally related to mental distress and positive affect in a mirrored way. Impact of exposures seemed most pervasive at the individual level. However, department-level relations were also discovered. Supplementing individual-level measures with aggregated measures may increase understanding of working conditions influence on employees health and well-being. Organizational improvements focusing on the work factors in the current study should be able to reduce distress and enhance positive affect. Furthermore, both targeting individual employees and redesigning working conditions at the work unit level seems important.	[Finne, Live Bakke; Christensen, Jan Olav; Knardahl, Stein] Natl Inst Occupat Hlth, Dept Work Psychol & Physiol, Oslo, Norway		Finne, LB (corresponding author), Natl Inst Occupat Hlth, Dept Work Psychol & Physiol, Oslo, Norway.	live.b.finne@stami.no	Christensen, Jan Olav/AAS-1031-2020	Christensen, Jan Olav/0000-0001-5530-7526	Norwegian Research Council [185209]; National Institute of Occupational Health in Norway	Norwegian Research Council(Research Council of NorwayEuropean Commission); National Institute of Occupational Health in Norway	This study was funded by the Norwegian Research Council (grant number: 185209), http://www.forskningsradet.no/en/Home_page/1177315753906. The recipient of the funding was the National Institute of Occupational Health in Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen CH, 2001, WHY LAGGED DEPENDENT; Armstrong BG, 1998, OCCUP ENVIRON MED, V55, P651, DOI 10.1136/oem.55.10.651; Babyak MA, 2009, EVID-BASED MENT HEAL, V12, P68, DOI 10.1136/ebmh.12.3.68; Bakker A.B., 2007, J MANAGE PSYCHOL, V22 (3), P309, DOI [10.1108/02683940710733115, DOI 10.1108/02683940710733115]; Barsade SG, 2002, ADMIN SCI QUART, V47, P644, DOI 10.2307/3094912; BEEHR TA, 1978, PERS PSYCHOL, V31, P665, DOI 10.1111/j.1744-6570.1978.tb02118.x; Bliese P.D., 2000, MULTILEVEL THEORY RE, P349; Bliese Paul D, 2002, J Occup Health Psychol, V7, P265, DOI 10.1037/1076-8998.7.3.265; Bliese PD, 2004, ORGAN RES METHODS, V7, P400, DOI 10.1177/1094428104268542; Blom V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075387; Bonde JPE, 2008, OCCUP ENVIRON MED, V65, P438, DOI 10.1136/oem.2007.038430; Christensen JO, 2010, PAIN, V151, P162, DOI 10.1016/j.pain.2010.07.001; Christensen KB, 2005, J OCCUP ENVIRON MED, V47, P933, DOI 10.1097/01.jom.0000172864.16001.85; Clark C, 2012, PSYCHOL MED, V42, P829, DOI 10.1017/S0033291711001759; Clausen T, 2010, APPL PSYCHOL-HLTH WE, V2, P182, DOI 10.1111/j.1758-0854.2010.01031.x; Crawford ER, 2010, J APPL PSYCHOL, V95, P834, DOI 10.1037/a0019364; Dalgard OS, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-27; Dallner M., 2000, VALIDATION GEN NORDI; de Jonge J, 1999, HUM RELAT, V52, P95, DOI 10.1177/001872679905200106; De Lange AH, 2004, WORK STRESS, V18, P149, DOI 10.1080/02678370412331270860; de Lange Annet H, 2003, J Occup Health Psychol, V8, P282, DOI 10.1037/1076-8998.8.4.282; de Zwart BCH, 2002, OCCUP MED-OXFORD, V52, P177, DOI 10.1093/occmed/52.4.177; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Diez-Roux AV, 1998, AM J PUBLIC HEALTH, V88, P216, DOI 10.2105/AJPH.88.2.216; Dormann C, 2002, J OCCUP ORGAN PSYCH, V75, P33, DOI 10.1348/096317902167630; Edwards JR, 2000, PSYCHOL METHODS, V5, P155, DOI 10.1037//1082-989X.5.2.155; Elovainio M, 2000, J Occup Health Psychol, V5, P269, DOI 10.1037/1076-8998.5.2.269; Elovainio M, 2013, SOC SCI MED, V91, P39, DOI 10.1016/j.socscimed.2013.05.008; Emdad R, 2013, INT ARCH OCC ENV HEA, V86, P709, DOI 10.1007/s00420-012-0813-1; Finne LB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102514; Ford MT, 2014, WORK STRESS, V28, P9, DOI 10.1080/02678373.2013.877096; Furlan AD, 2012, J OCCUP REHABIL, V22, P312, DOI 10.1007/s10926-011-9340-2; Glymour MM, 2005, AM J EPIDEMIOL, V162, P267, DOI 10.1093/aje/kwi187; Grynderup MB, 2012, SCAND J WORK ENV HEA, V38, P527, DOI 10.5271/sjweh.3316; Hernan MA, 2004, EPIDEMIOLOGY, V15, P615, DOI 10.1097/01.ede.0000135174.63482.43; Huppert FA, 2003, BRIT J HEALTH PSYCH, V8, P107, DOI 10.1348/135910703762879246; Ilmarinen J, 2007, OCCUP MED-OXFORD, V57, P160, DOI 10.1093/occmed/kqm008; Ilmarinen J, 2009, SCAND J WORK ENV HEA, V35, P1; Jahkola, 1998, WORK ABILITY INDEX; Juvani A, 2014, SCAND J WORK ENV HEA, V40, P266, DOI 10.5271/sjweh.3402; Karasek R, 1998, J Occup Health Psychol, V3, P322, DOI 10.1037/1076-8998.3.4.322; Karasek R, 1990, HLTH WORK STRESS PRO; Kivimaki M, 2003, PSYCHOL MED, V33, P319, DOI 10.1017/S0033291702006591; Kolstad HA, 2011, AM J EPIDEMIOL, V173, P94, DOI 10.1093/aje/kwq318; Kouvonen A, 2008, AM J EPIDEMIOL, V167, P1143, DOI 10.1093/aje/kwn067; Lazarus R.S., 1984, EMOTION ADAPTATION; Lazarus R.S., 1995, OCCUPATIONAL STRESS, P3; Ludtke O, 2009, CONTEMP EDUC PSYCHOL, V34, P120, DOI 10.1016/j.cedpsych.2008.12.001; Marchand Alain, 2010, J Occup Health, V52, P176; Mather L, 2015, J OCCUP ENVIRON MED, V57, P858, DOI 10.1097/JOM.0000000000000504; MILLER KI, 1986, ACAD MANAGE J, V29, P727, DOI 10.2307/255942; MOORMAN RH, 1991, J APPL PSYCHOL, V76, P845, DOI 10.1037/0021-9010.76.6.845; Muthen L.K., 2010, MPLUS USERS GUIDE; Ndjaboue R, 2012, OCCUP ENVIRON MED, V69, P694, DOI 10.1136/oemed-2011-100595; Netterstrom B, 2008, EPIDEMIOL REV, V30, P118, DOI 10.1093/epirev/mxn004; Nieuwenhuijsen K, 2010, OCCUP MED-OXFORD, V60, P277, DOI 10.1093/occmed/kqq081; Podsakoff PM, 2003, J APPL PSYCHOL, V88, P879, DOI 10.1037/0021-9010.88.5.879; Radkiewicz P, 2005, INT CONGR SER, V1280, P304, DOI 10.1016/j.ics.2005.02.089; Raftery AE, 1995, SOCIOL METHODOL, V25, P111, DOI 10.2307/271063; Raudenbush SW, 2002, HIERARCHICAL LINEAR; Rickels K, 1976, Prim Care, V3, P751; Rugulies R, 2012, SCAND J WORK ENV HEA, V38, P187, DOI 10.5271/sjweh.3296; Rydstedt LW, 2013, EUR J PSYCHOL, V9, P93, DOI 10.5964/ejop.v9i1.537; Samuelsson A, 2013, SCAND J WORK ENV HEA, V39, P351, DOI 10.5271/sjweh.3338; Schaufeli WB, 2008, APPL PSYCHOL-INT REV, V57, P173, DOI 10.1111/j.1464-0597.2007.00285.x; SCHEIER MF, 1985, HEALTH PSYCHOL, V4, P219, DOI 10.1037/0278-6133.4.3.219; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Siegrist J, 2004, SOC SCI MED, V58, P1483, DOI 10.1016/S0277-9536(03)00351-4; Siegrist J, 2008, EUR ARCH PSY CLIN N, V258, P115, DOI 10.1007/s00406-008-5024-0; Sogaard AJ, 2003, NOR EPIDEMIOL, V13, P279, DOI DOI 10.5324/NJE.V13I2.296; Spector PE, 2000, J ORGAN BEHAV, V21, P79, DOI 10.1002/(SICI)1099-1379(200002)21:1<79::AID-JOB964>3.0.CO;2-G; Stansfeld S, 2006, SCAND J WORK ENV HEA, V32, P443, DOI 10.5271/sjweh.1050; Strand BH, 2003, NORD J PSYCHIAT, V57, P113, DOI 10.1080/08039480310000932; Tubre TC, 2000, J MANAGE, V26, P155, DOI 10.1177/014920630002600104; Tuomi K, 1997, SCAND J WORK ENV HEA, V23, P66; Wang JL, 2011, AM J EPIDEMIOL, V174, P125, DOI 10.1093/aje/kwr094; Wannstrom I, 2009, SCAND J PSYCHOL, V50, P231, DOI 10.1111/j.1467-9450.2008.00697.x; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WATSON D, 1988, J ABNORM PSYCHOL, V97, P346, DOI 10.1037/0021-843X.97.3.346; Weinberg A, 2000, LANCET, V355, P533, DOI 10.1016/S0140-6736(99)07366-3	81	17	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152220	10.1371/journal.pone.0152220	http://dx.doi.org/10.1371/journal.pone.0152220			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3SV	27010369	gold, Green Published, Green Submitted			2022-12-26	WOS:000372708000113
J	Lopez, M; Bollag, RJ; Yu, JC; Isales, CM; Eroglu, A				Lopez, Melany; Bollag, Roni J.; Yu, Jack C.; Isales, Carlos M.; Eroglu, Ali			Chemically Defined and Xeno-Free Cryopreservation of Human Adipose-Derived Stem Cells	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; BONE-MARROW; STROMAL CELLS; MOUSE OOCYTES; SACCHAROMYCES-CEREVISIAE; PROTECTIVE ACTION; TREHALOSE; TISSUE; SURVIVAL; DIFFERENTIATION	The stromal compartment of adipose tissue harbors multipotent cells known as adipose-derived stem cells (ASCs). These cells can differentiate into various lineages including osteogenic, chrondrogenic, adipogenic, and neurogenic; this cellular fraction may be easily obtained in large quantities through a clinically safe liposuction procedure. Therefore, ASCs offer exceptional opportunities for tissue engineering and regenerative medicine. However, current practices involving ASCs typically use fetal bovine serum(FBS)-based cryopreservation solutions that are associated with risks of immunological reactions and of transmitting infectious diseases and prions. To realize clinical applications of ASCs, serum- and xeno-free defined cryopreservation methods are needed. To this end, an animal product-free chemically defined cryopreservation medium was formulated by adding two antioxidants (reduced glutathione and ascorbic acid 2-phosphate), two polymers (PVA and ficoll), two permeating cryoprotectants (ethylene glycol and dimethylsulfoxide), a disaccharide (trehalose), and a calcium chelator (EGTA) to HEPES-buffered DMEM/F12. To limit the number of experimental groups, the concentration of trehalose, both polymers, and EGTA was fixed while the presence of the permeating CPAs and antioxidants was varied. ASCs suspended either in different versions of the defined medium or in the conventional undefined cryopreservation medium (10% dimethylsulfoxide+10% DMEM/F12+80% serum) were cooled to -70 degrees C at 1 degrees C/min before being plunged into liquid nitrogen. Samples were thawed either in air or in a water bath at 37 degrees C. The presence of antioxidants along with 3.5% concentration of each penetrating cryoprotectant improved the freezing outcome to the level of the undefined cryopreservation medium, but the plating efficiency was still lower than that of unfrozen controls. Subsequently, increasing the concentration of both permeating cryoprotectants to 5% further improved the plating efficiency to the level of unfrozen controls. Moreover, ASCs cryopreserved in this defined medium retained their multipotency and chromosomal normality. These results are of significance for tissue engineering and clinical applications of stem cells.	[Lopez, Melany; Isales, Carlos M.; Eroglu, Ali] Augusta Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, Augusta, GA USA; [Bollag, Roni J.] Augusta Univ, Med Coll Georgia, Dept Pathol, Augusta, GA USA; [Yu, Jack C.] Augusta Univ, Med Coll Georgia, Dept Surg, Augusta, GA USA; [Isales, Carlos M.] Augusta Univ, Med Coll Georgia, Orthopaed Surg, Augusta, GA USA; [Eroglu, Ali] Augusta Univ, Med Coll Georgia, Dept Obstet & Gynecol, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Eroglu, A (corresponding author), Augusta Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, Augusta, GA USA.; Eroglu, A (corresponding author), Augusta Univ, Med Coll Georgia, Dept Obstet & Gynecol, Augusta, GA USA.	aeroglu@gru.edu	Isales, Carlos/J-9902-2013	Isales, Carlos/0000-0002-4480-3484	Xytex Cryo International;  [P01 AG036675]; NATIONAL INSTITUTE ON AGING [P01AG036675] Funding Source: NIH RePORTER	Xytex Cryo International; ; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by Xytex Cryo International and a program project grant (P01 AG036675). The partial support of Xytex Cryo International does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	ALI J, 1993, J REPROD FERTIL, V99, P471, DOI 10.1530/jrf.0.0990471; ALVAREZ JG, 1992, J ANDROL, V13, P232; [Anonymous], 2014, AESTHET SURG J S, V34, p1S; Ashjian PH, 2003, PLAST RECONSTR SURG, V111, P1922, DOI 10.1097/01.PRS.0000055043.62589.05; Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200; Bilodeau JF, 2000, MOL REPROD DEV, V55, P282, DOI 10.1002/(SICI)1098-2795(200003)55:3&lt;282::AID-MRD6&gt;3.0.CO;2-7; Brooke G, 2009, BRIT J HAEMATOL, V144, P571, DOI 10.1111/j.1365-2141.2008.07492.x; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; CARROLL J, 1993, BIOL REPROD, V48, P606, DOI 10.1095/biolreprod48.3.606; Chen QF, 2004, J EXP BIOL, V207, P3125, DOI 10.1242/jeb.01133; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; Cui L, 2007, BIOMATERIALS, V28, P5477, DOI 10.1016/j.biomaterials.2007.08.042; De Rosa A, 2009, TISSUE ENG PART C-ME, V15, P659, DOI [10.1089/ten.tec.2008.0674, 10.1089/ten.TEC.2008.0674]; Dinara S, 2001, HUM REPROD, V16, P1976, DOI 10.1093/humrep/16.9.1976; Erdag G, 2002, CRYOBIOLOGY, V44, P218, DOI 10.1016/S0011-2240(02)00023-8; Eroglu A, 2005, FERTIL STERIL, V84, pS56, DOI 10.1016/j.fertnstert.2005.07.133; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; Eroglu A, 2002, FERTIL STERIL, V77, P152, DOI 10.1016/S0015-0282(01)02959-4; Eroglu A, 2010, CRYOBIOLOGY, V60, pS54, DOI 10.1016/j.cryobiol.2009.07.001; Eroglu A, 2009, BIOL REPROD, V80, P70, DOI 10.1095/biolreprod.108.070383; Garcia-Olmo D, 2005, DIS COLON RECTUM, V48, P1416, DOI 10.1007/s10350-005-0052-6; GIBBS CJ, 1985, NEW ENGL J MED, V313, P734, DOI 10.1056/NEJM198509193131207; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Gimble JM, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt19; Goh BC, 2007, J TISSUE ENG REGEN M, V1, P322, DOI 10.1002/term.35; Gonzalez-Rey E, 2010, ANN RHEUM DIS, V69, P241, DOI 10.1136/ard.2008.101881; Grisendi G, 2010, CYTOTHERAPY, V12, P466, DOI 10.3109/14653241003649510; Guilak F, 2006, J CELL PHYSIOL, V206, P229, DOI 10.1002/jcp.20463; Gupta MK, 2010, FERTIL STERIL, V93, P2602, DOI 10.1016/j.fertnstert.2010.01.043; GUTIERREZ A, 1993, THERIOGENOLOGY, V39, P1111, DOI 10.1016/0093-691X(93)90010-3; Halme DG, 2006, NEW ENGL J MED, V355, P1730, DOI 10.1056/NEJMhpr063086; Heiskanen A, 2007, STEM CELLS, V25, P197, DOI 10.1634/stemcells.2006-0444; Herdeiro RS, 2006, BBA-GEN SUBJECTS, V1760, P340, DOI 10.1016/j.bbagen.2006.01.010; Huang JYJ, 2006, CELL PRESERV TECHNOL, V4, P149, DOI 10.1089/cpt.2006.4.149; Karran G, 1996, HUM REPROD, V11, P2681; KASAI M, 1981, J REPROD FERTIL, V63, P175, DOI 10.1530/jrf.0.0630175; KASAI M, 1990, J REPROD FERTIL, V89, P91, DOI 10.1530/jrf.0.0890091; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Keskintepe L, 2007, TRANSGENIC RES, V16, P751, DOI 10.1007/s11248-007-9125-8; Lane M, 2002, HUM REPROD, V17, P2686, DOI 10.1093/humrep/17.10.2686; LEVINE H, 1988, J CHEM SOC FARAD T 1, V84, P2619, DOI 10.1039/f19888402619; Limaye LS, 1997, STEM CELLS, V15, P353, DOI 10.1002/stem.150353; LOVELOCK JE, 1959, NATURE, V183, P1394, DOI 10.1038/1831394a0; Mackensen A, 2000, CANCER IMMUNOL IMMUN, V49, P152, DOI 10.1007/s002620050614; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Matthes G, 1987, Folia Haematol Int Mag Klin Morphol Blutforsch, V114, P482; MAZUR P, 1963, J GEN PHYSIOL, V47, P347, DOI 10.1085/jgp.47.2.347; MAZUR P, 1972, EXP CELL RES, V71, P345, DOI 10.1016/0014-4827(72)90303-5; Meucci E, 1997, AMINO ACIDS, V12, P373, DOI 10.1007/BF01373017; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Nambu M, 2007, WOUND REPAIR REGEN, V15, P505, DOI 10.1111/j.1524-475X.2007.00258.x; Niemeyer P, 2008, CYTOTHERAPY, V10, P784, DOI 10.1080/14653240802419302; Nowshari MA, 2000, THERIOGENOLOGY, V53, P1157, DOI 10.1016/S0093-691X(00)00260-0; Pu Lee L Q, 2004, Aesthet Surg J, V24, P536, DOI 10.1016/j.asj.2004.09.002; Puissant N, 2005, BRIT J HAEMATOL, V129, P118, DOI 10.1111/j.1365-2141.2005.05409.x; Safford KM, 2002, BIOCHEM BIOPH RES CO, V294, P371, DOI 10.1016/S0006-291X(02)00469-2; Selvaggi TA, 1997, BLOOD, V89, P776, DOI 10.1182/blood.V89.3.776; Sharma S, 2011, REJUV RES, V14, P641, DOI 10.1089/rej.2011.1186; Singer MA, 1998, TRENDS BIOTECHNOL, V16, P460, DOI 10.1016/S0167-7799(98)01251-7; SolaPenna M, 1997, EUR J BIOCHEM, V248, P24, DOI 10.1111/j.1432-1033.1997.00024.x; SOMERO GN, 1986, AM J PHYSIOL, V251, pR197, DOI 10.1152/ajpregu.1986.251.2.R197; Szurek EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027604; Thirumala S, 2010, J TISSUE ENG REGEN M, V4, P224, DOI 10.1002/term.232; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Wowk B, 2000, CRYOBIOLOGY, V40, P228, DOI 10.1006/cryo.2000.2243; Yanez R, 2006, STEM CELLS, V24, P2582, DOI 10.1634/stemcells.2006-0228; Yoshimura K, 2006, J CELL PHYSIOL, V208, P64, DOI 10.1002/jcp.20636; Yu G, 2011, METHODS MOL BIOL, V702, P17, DOI 10.1007/978-1-61737-960-4_2; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	69	18	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152161	10.1371/journal.pone.0152161	http://dx.doi.org/10.1371/journal.pone.0152161			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010403	Green Submitted, Green Published, gold			2022-12-26	WOS:000372708000101
J	Kulkarni, H; Mamtani, M; Peralta, J; Almeida, M; Dyer, TD; Goring, HH; Johnson, MP; Duggirala, R; Mahaney, MC; Olvera, RL; Almasy, L; Glahn, DC; Williams-Blangero, S; Curran, JE; Blangero, J				Kulkarni, Hemant; Mamtani, Manju; Peralta, Juan; Almeida, Marcio; Dyer, Thomas D.; Goring, Harald H.; Johnson, Matthew P.; Duggirala, Ravindranath; Mahaney, Michael C.; Olvera, Rene L.; Almasy, Laura; Glahn, David C.; Williams-Blangero, Sarah; Curran, Joanne E.; Blangero, John			Soluble Forms of Intercellular and Vascular Cell Adhesion Molecules Independently Predict Progression to Type 2 Diabetes in Mexican American Families	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; ENDOTHELIAL DYSFUNCTION; INSULIN-RESISTANCE; E-SELECTIN; ELEVATED CONCENTRATIONS; SERUM CONCENTRATIONS; CIRCULATING LEVELS; OXIDATIVE STRESS; INFLAMMATION; MARKERS	Objective While the role of type 2 diabetes (T2D) in inducing endothelial dysfunction is fairly well-established the etiological role of endothelial dysfunction in the onset of T2D is still a matter of debate. In the light of conflicting evidence in this regard, we conducted a prospective study to determine the association of circulating levels of soluble intercellular adhesion molecule 1 (sICAM-1) and soluble vessel cell adhesion molecule 1 (sVCAM-1) with incident T2D. Methods Data from this study came from 1,269 Mexican Americans of whom 821 initially T2D-free individuals were longitudinally followed up in the San Antonio Family Heart Study. These individuals were followed for 9752.95 person-years for development of T2D. Prospective association of sICAM-1 and sVCAM-1 with incident T2D was studied using Kaplan-Meier survival plots and mixed effects Cox proportional hazards modeling to account for related-ness among study participants. Incremental value of adhesion molecule biomarkers was studied using integrated discrimination improvement (IDI) and net reclassification improvement (NRI) indexes. Results Decreasing median values for serum concentrations of sICAM-1 and sVCAM-1 were observed in the following groups in this order: individuals with T2D at baseline, individuals who developed T2D during follow-up, individuals with prediabetes at baseline and normal glucose tolerant (NGT) individuals who remained T2D-free during follow-up. Top quartiles for sICAM-1 and sVCAM-1 were strongly and significantly associated with homeostatic model of assessment-insulin resistance (HOMA-IR). Mixed effects Cox proportional hazards modeling revealed that after correcting for important clinical confounders, high sICAM-1 and sVCAM-1 concentrations were associated with 2.52 and 1.99 times faster progression to T2D as compared to low concentrations, respectively. Individuals with high concentrations for both sICAM-1 and sVCAM-1 progressed to T2D 3.42 times faster than those with low values for both sICAM-1 and sVCAM-1. The results were similar in women in reproductive age group and the remainder of the cohort. Inclusion of sICAM-1 and sVCAM-1 in predictive models significantly improved reclassification and discrimination. The majority of these results were seen even when the analyses were restricted to NGT individuals. Conclusion Serum concentrations of sICAM-1 and sVCAM-1 independently and additively predict future T2D and represent important candidate biomarkers of T2D.	[Kulkarni, Hemant; Mamtani, Manju; Peralta, Juan; Almeida, Marcio; Dyer, Thomas D.; Goring, Harald H.; Johnson, Matthew P.; Duggirala, Ravindranath; Mahaney, Michael C.; Almasy, Laura; Williams-Blangero, Sarah; Curran, Joanne E.; Blangero, John] Univ Texas Brownsville, Rio Grande Valley Sch Med, South Texas Diabet & Obes Inst, Brownsville, TX 78520 USA; [Olvera, Rene L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, San Antonio, TX 78229 USA; [Glahn, David C.] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Glahn, David C.] Hartford Hosp, Inst Living, Olin Neuropsychiat Res Ctr, Hartford, CT 06115 USA	University of Texas System; University of Texas Rio Grande Valley; University of Texas System; University of Texas Health San Antonio; Yale University; Hartford Hospital	Kulkarni, H (corresponding author), Univ Texas Brownsville, Rio Grande Valley Sch Med, South Texas Diabet & Obes Inst, Brownsville, TX 78520 USA.	hemant.kulkarni@utrgv.edu	Almasy, Laura/V-3156-2019; Blangero, John/ABA-7175-2021; Kulkarni, Hemant/AEM-5750-2022	Blangero, John/0000-0001-6250-5723; Peralta, Juan Manuel/0000-0002-8811-5579; Curran, Joanne/0000-0002-6898-155X	National Institutes of Health (NIH) [R01 DK082610, R01 HL045522, R01 MH078143, R01 MH078111, R01 MH083824]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078111, R01MH078143, R01MH083824] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by National Institutes of Health (NIH) grants R01 DK082610, R01 HL045522, R01 MH078143, R01 MH078111 and R01 MH083824. The funders had no role in the conduct, interpretation and publication of the results.	Adela R, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/490842; Albertini JP, 1998, DIABETES CARE, V21, P1008, DOI 10.2337/diacare.21.6.1008; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; Balsan GA, 2015, REV ASSOC MED BRAS, V61, P72, DOI 10.1590/1806-9282.61.01.072; Begic I, 2012, MED GLAS, V9, P32; Berezin AE, 2016, DIABETES METAB SYND, V10, pS154, DOI 10.1016/j.dsx.2015.09.016; Bonello N, 2002, HUM REPROD, V17, P2272, DOI 10.1093/humrep/17.9.2272; Boulbou MS, 2005, INT J CARDIOL, V98, P39, DOI 10.1016/j.ijcard.2003.07.037; Carbone F, 2015, CURR DRUG TARGETS, V16, P295, DOI 10.2174/1389450115666141109213439; Chao C, 2010, ARCH INTERN MED, V170, P1557, DOI 10.1001/archinternmed.2010.312; Chen NG, 1999, J CLIN ENDOCR METAB, V84, P3485, DOI 10.1210/jc.84.10.3485; Dallmeier D, 2012, J AM HEART ASSOC, V1, DOI DOI 10.1161/JAHA.112.000869; Matheus ASD, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/653789; Del Turco S, 2013, CURR PHARM DESIGN, V19, P2420, DOI 10.2174/1381612811319130010; Demerath E, 2001, ANN HUM BIOL, V28, P664, DOI 10.1080/03014460110048530; Eringa EC, 2013, REV ENDOCR METAB DIS, V14, P39, DOI 10.1007/s11154-013-9239-7; Fagard RH, 2009, PRIM CARE DIABETES, V3, P205, DOI 10.1016/j.pcd.2009.09.003; Fasching P, 1996, J CLIN ENDOCR METAB, V81, P4313, DOI 10.1210/jc.81.12.4313; Gardner AW, 2015, J VASC SURG, V61, P1249, DOI 10.1016/j.jvs.2014.02.045; Gibbons Gary H, 2004, J Clin Hypertens (Greenwich), V6, P11, DOI 10.1111/j.1524-6175.2004.03562.x; Haffner SM, 1997, DIABETES CARE, V20, P1087, DOI 10.2337/diacare.20.7.1087; Hak AE, 2001, J CLIN ENDOCR METAB, V86, P4398, DOI 10.1210/jc.86.9.4398; Hartge Martin M, 2007, Diab Vasc Dis Res, V4, P84; Houghton JL, 2002, J AM COLL CARDIOL, V39, P1314, DOI 10.1016/S0735-1097(02)01781-3; Kent JW, 2007, ATHEROSCLEROSIS, V195, P367, DOI 10.1016/j.atherosclerosis.2006.10.005; Kent JW, 2004, DIABETES, V53, P2691, DOI 10.2337/diabetes.53.10.2691; Kissebah AH, 2000, P NATL ACAD SCI USA, V97, P14478, DOI 10.1073/pnas.97.26.14478; LEEUWENBERG JFM, 1992, IMMUNOLOGY, V77, P543; MacCluer JW, 1999, NUTR REV, V57, pS59, DOI 10.1111/j.1753-4887.1999.tb01790.x; Marfella R, 2000, CIRCULATION, V101, P2247, DOI 10.1161/01.CIR.101.19.2247; Matsumoto K, 2002, ATHEROSCLEROSIS, V161, P243, DOI 10.1016/S0021-9150(01)00757-2; Matsumoto K, 2002, DIABETIC MED, V19, P822, DOI 10.1046/j.1464-5491.2002.00799.x; Meigs JB, 2006, DIABETES, V55, P530, DOI 10.2337/diabetes.55.02.06.db05-1041; Meigs JB, 2004, JAMA-J AM MED ASSOC, V291, P1978, DOI 10.1001/jama.291.16.1978; Mitchell BD, 1996, CIRCULATION, V94, P2159, DOI 10.1161/01.CIR.94.9.2159; Morris AA, 2012, METAB SYNDR RELAT D, V10, P252, DOI 10.1089/met.2011.0117; Nowak M, 2008, CLIN EXP MED, V8, P159, DOI 10.1007/s10238-008-0173-z; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Polovina MM, 2014, POSTGRAD MED, V126, P38, DOI 10.3810/pgm.2014.03.2739; Price DT, 1999, AM J MED, V107, P85, DOI 10.1016/S0002-9343(99)00153-9; Rossi R, 2005, DIABETES CARE, V28, P702, DOI 10.2337/diacare.28.3.702; Saku K, 1999, JPN CIRC J, V63, P19, DOI 10.1253/jcj.63.19; Somigliana E, 1996, HUM REPROD, V11, P1190; Song YQ, 2007, DIABETES, V56, P1898, DOI 10.2337/db07-0250; Stranges S, 2008, OBESITY, V16, P1370, DOI 10.1038/oby.2008.59; Therneau T, 2012, COXME MIXED EFFECTS; Thorand B, 2006, ARTERIOSCL THROM VAS, V26, P398, DOI 10.1161/01.ATV.0000198392.05307.aa; Vigano P, 2000, OBSTET GYNECOL, V95, P115, DOI 10.1016/S0029-7844(99)00465-2; Voruganti VS, 2008, J MOL MED, V86, P303, DOI 10.1007/s00109-007-0273-3; Wallen NH, 1999, EUR HEART J, V20, P1039; Wei XM, 2015, DIABETES RES CLIN PR, V107, P9, DOI 10.1016/j.diabres.2014.09.019; Weyer C, 2002, ATHEROSCLEROSIS, V161, P233, DOI 10.1016/S0021-9150(01)00626-8; Zeitler H, 1997, Eur J Med Res, V2, P389; Zhao JH, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S127	54	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151177	10.1371/journal.pone.0151177	http://dx.doi.org/10.1371/journal.pone.0151177			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007680	gold, Green Published, Green Submitted			2022-12-26	WOS:000372701200043
J	Levy-Tzedek, S; Maidenbaum, S; Amedi, A; Lackner, J				Levy-Tzedek, S.; Maidenbaum, S.; Amedi, A.; Lackner, J.			Aging and Sensory Substitution in a Virtual Navigation Task	PLOS ONE			English	Article							AGE-DIFFERENCES; SPATIAL MEMORY; COGNITION; LOCALIZATION; ENVIRONMENT; BEHAVIOR; EYECANE; SYSTEMS; DEVICE	Virtual environments are becoming ubiquitous, and used in a variety of contexts-from entertainment to training and rehabilitation. Recently, technology for making them more accessible to blind or visually impaired users has been developed, by using sound to represent visual information. The ability of older individuals to interpret these cues has not yet been studied. In this experiment, we studied the effects of age and sensory modality (visual or auditory) on navigation through a virtual maze. We added a layer of complexity by conducting the experiment in a rotating room, in order to test the effect of the spatial bias induced by the rotation on performance. Results from 29 participants showed that with the auditory cues, it took participants a longer time to complete the mazes, they took a longer path length through the maze, they paused more, and had more collisions with the walls, compared to navigation with the visual cues. The older group took a longer time to complete the mazes, they paused more, and had more collisions with the walls, compared to the younger group. There was no effect of room rotation on the performance, nor were there any significant interactions among age, feedback modality and room rotation. We conclude that there is a decline in performance with age, and that while navigation with auditory cues is possible even at an old age, it presents more challenges than visual navigation.	[Levy-Tzedek, S.] Ben Gurion Univ Negev, Dept Phys Therapy, Recanati Sch Community Hlth Profess, IL-84105 Beer Sheva, Israel; [Levy-Tzedek, S.] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Maidenbaum, S.; Amedi, A.] Hebrew Univ Jerusalem, Fac Med, Inst Med Res Israel Canada, Dept Med Neurobiol, Jerusalem, Israel; [Amedi, A.] Hebrew Univ Jerusalem, Fac Humanities, Dept Cognit Sci, Jerusalem, Israel; [Amedi, A.] Univ Paris 06, Inst Vis, Univ Sorbonne, Paris, France; [Lackner, J.] Brandeis Univ, Dept Physiol, Ashton Graybiel Spatial Orientat Lab, Waltham, MA USA	Ben Gurion University; Ben Gurion University; Hebrew University of Jerusalem; Hebrew University of Jerusalem; UDICE-French Research Universities; Sorbonne Universite; Brandeis University	Levy-Tzedek, S (corresponding author), Ben Gurion Univ Negev, Dept Phys Therapy, Recanati Sch Community Hlth Profess, IL-84105 Beer Sheva, Israel.; Levy-Tzedek, S (corresponding author), Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel.	Shelly@bgu.ac.il	Maidenbaum, Shachar/K-4277-2019; Levy-Tzedek, Shelly/E-8612-2017	Maidenbaum, Shachar/0000-0002-2078-3896; Amedi, Amir/0000-0001-5042-2533	Brandeis-Leir foundation; Brandeis-Bronfman foundation; Helmsley Charitable Trust through the Agricultural, Biological and Cognitive Robotics Center of the Ben-Gurion University of the Negev; Promobilia Foundation	Brandeis-Leir foundation; Brandeis-Bronfman foundation; Helmsley Charitable Trust through the Agricultural, Biological and Cognitive Robotics Center of the Ben-Gurion University of the Negev; Promobilia Foundation	The Brandeis-Leir foundation (SL, AA, JL) and the Brandeis-Bronfman foundation (SL, JL) provided funding for this experiment. The research was partially supported by the Helmsley Charitable Trust through the Agricultural, Biological and Cognitive Robotics Center of the Ben-Gurion University of the Negev (SL). The support of the Promobilia Foundation is gratefully acknowledged (SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auvray M, 2007, PERCEPTION, V36, P416, DOI 10.1068/p5631; Boot WR, 2011, FRONT PSYCHOL, P2; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Bushara KO, 1999, NAT NEUROSCI, V2, P759, DOI 10.1038/11239; Byrne P, 2007, PSYCHOL REV, V114, P340, DOI 10.1037/0033-295X.114.2.340; Carriot J, 2011, EXP BRAIN RES, V209, P415, DOI 10.1007/s00221-011-2567-5; Dehaene S, 2010, NEUROIMAGE, V49, P1837, DOI 10.1016/j.neuroimage.2009.09.024; Goeke C, 2015, SCI REPORTS, P5; Hartshorne Joshua K, 2015, PSYCHOL SCI; HIMANN JE, 1988, MED SCI SPORT EXER, V20, P161, DOI 10.1249/00005768-198820020-00010; Iaria G, 2009, BEHAV BRAIN RES, V196, P187, DOI 10.1016/j.bbr.2008.08.040; Kimura T, 2007, ANTHROPOL SCI, V115, P67, DOI 10.1537/ase.060309; Lackner JR, 2010, EXP BRAIN RES, V202, P513, DOI 10.1007/s00221-009-2149-y; Lahav O, 2008, VIRTUAL REHABILITATI, V2008; Levy-Tzedek S, 2012, RESTOR NEUROL NEUROS, V30, P313, DOI 10.3233/RNN-2012-110219; Levy-Tzedek S, 2012, SCI REPORTS, P2; Levy-Tzedek S, 2014, FRONTIERS NEUROSCIEN, P8; Li SC, 2001, TRENDS COGN SCI, V5, P479, DOI 10.1016/S1364-6613(00)01769-1; Lin FR, 2011, J GERONTOL A-BIOL, V66, P582, DOI 10.1093/gerona/glr002; Liu YC, 2001, ERGONOMICS, V44, P425, DOI 10.1080/00140130010011369; Loomis JM, 2012, ATTEN PERCEPT PSYCHO, V74, P1260, DOI 10.3758/s13414-012-0311-2; Mahmood O, 2009, BEHAV BRAIN RES, V205, P88, DOI 10.1016/j.bbr.2009.08.001; Maidenbaum S, 2014, MULTISENS RES, V27, P379, DOI 10.1163/22134808-00002463; Maidenbaum S, 2014, RESTOR NEUROL NEUROS, V32, P813, DOI 10.3233/RNN-130351; Maidenbaum S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072555; Merabet LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044958; Moffat SD, 2006, NEUROBIOL AGING, V27, P965, DOI 10.1016/j.neurobiolaging.2005.05.011; Moffat SD, 2009, NEUROPSYCHOL REV, V19, P478, DOI 10.1007/s11065-009-9120-3; Moffat SD, 2001, NEUROBIOL AGING, V22, P787, DOI 10.1016/S0197-4580(01)00251-2; Ouda L, 2015, CELL TISSUE RES, P1; Park D. C., 2000, BASIC MECH ACCOUNTIN; Proulx MJ, 2016, RESTOR NEUROL NEUROS, V34, P29, DOI 10.3233/RNN-150541; Rodgers M Kirk, 2012, Neurobiol Aging, V33, DOI 10.1016/j.neurobiolaging.2010.07.021; Rosenbaum RS, 2004, HIPPOCAMPUS, V14, P826, DOI 10.1002/hipo.10218; SHULL PETER B., 2015, J NEUROENG REHABIL, V12, P1, DOI DOI 10.1186/S12984-015-0055-Z; Smith K, 2012, UNIVERSAL ACCESS INF, V11, P387, DOI 10.1007/s10209-011-0254-8; Spence I, 2010, REV GEN PSYCHOL, V14, P92, DOI 10.1037/a0019491; Stenfelt S, 2009, SCAND J PSYCHOL, V50, P385, DOI 10.1111/j.1467-9450.2009.00748.x; Westin T., 2010, ADV GAME ACCESSIBILI, P400; White GR., 2008, P 3 INT C DIG INT ME; Wilkniss SM, 1997, PSYCHOL AGING, V12, P372, DOI 10.1037/0882-7974.12.2.372; Yan JH, 1998, EXP AGING RES, V24, P155	42	16	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151593	10.1371/journal.pone.0151593	http://dx.doi.org/10.1371/journal.pone.0151593			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007812	Green Published, gold, Green Submitted			2022-12-26	WOS:000372701200056
J	Nistal-Villan, E; Poutou, J; Rodriguez-Garcia, E; Bunuales, M; Carte-Abad, B; Prieto, J; Gonzalez-Aseguinolaza, G; Hernandez-Alcoceba, R; Larrea, E				Nistal-Villan, Estanislao; Poutou, Joanna; Rodriguez-Garcia, Estefania; Bunuales, Maria; Carte-Abad, Beatriz; Prieto, Jesus; Gonzalez-Aseguinolaza, Gloria; Hernandez-Alcoceba, Ruben; Larrea, Esther			A Versatile Vector for In Vivo Monitoring of Type I Interferon Induction and Signaling	PLOS ONE			English	Article							FEVER VIRUS-INFECTION; HAMSTER MESOCRICETUS-AURATUS; EXPRESSION; GENE; MICE; SYSTEM; ALPHA; CELLS; ACTIVATION; MONOCYTES	Development of reporter systems for in vivo examination of IFN-beta induction or signaling of type I interferon (IFN-I) pathways is of great interest in order to characterize biological responses to different inducers such as viral infections. Several reporter mice have been developed to monitor the induction of both pathways in response to different agonists. However, alternative strategies that do not require transgenic mice breeding have to date not been reported. In addition, detection of these pathways in vivo in animal species other than mice has not yet been addressed. Herein we describe a simple method based on the use of an adeno-associated viral vector (AAV8-3xIRF-ISRE-Luc) containing an IFN-beta induction and signaling-sensitive promoter sequence controlling the expression of the reporter gene luciferase. This vector is valid for monitoring IFN-I responses in vivo elicited by diverse stimuli in different organs. Intravenous administration of the vector in C57BL/6 mice and Syrian hamsters was able to detect activation of the IFN pathway in the liver upon systemic treatment with different pro-inflammatory agents and infection with Newcastle disease virus (NDV). In addition, intranasal instillation of AAV8-3xIRF-ISRE-Luc showed a rapid and transient IFN-I response in the respiratory tract of mice infected with the influenza A/PR8/34 virus lacking the NS1 protein. In comparison, this response was delayed and exacerbated in mice infected with influenza A/PR/8 wild type virus. In conclusion, the AAV8-3xIRF-ISRE-Luc vector offers the possibility of detecting IFN-I activation in response to different stimuli and in different animal models with no need for reporter transgenic animals.	[Nistal-Villan, Estanislao; Poutou, Joanna; Rodriguez-Garcia, Estefania; Bunuales, Maria; Carte-Abad, Beatriz; Prieto, Jesus; Gonzalez-Aseguinolaza, Gloria; Hernandez-Alcoceba, Ruben] Univ Navarra, Ctr Appl Med Res CIMA, Gene Therapy & Regulat Gene Express Program, E-31080 Pamplona, Spain; [Larrea, Esther] Univ Navarra, Inst Salud Trop, E-31080 Pamplona, Spain; [Nistal-Villan, Estanislao; Poutou, Joanna; Rodriguez-Garcia, Estefania; Bunuales, Maria; Carte-Abad, Beatriz; Prieto, Jesus; Gonzalez-Aseguinolaza, Gloria; Hernandez-Alcoceba, Ruben; Larrea, Esther] IdiSNA Navarra Inst Hlth Res, Pamplona, Spain; [Nistal-Villan, Estanislao] Univ CEU San Pablo, Microbiol Sect, Dept Pharmaceut & Hlth Sci, Fac Pharm, Campus Monteprincipe, Madrid, Spain	University of Navarra; University of Navarra; San Pablo CEU University	Hernandez-Alcoceba, R (corresponding author), Univ Navarra, Ctr Appl Med Res CIMA, Gene Therapy & Regulat Gene Express Program, E-31080 Pamplona, Spain.; Larrea, E (corresponding author), Univ Navarra, Inst Salud Trop, E-31080 Pamplona, Spain.; Hernandez-Alcoceba, R; Larrea, E (corresponding author), IdiSNA Navarra Inst Hlth Res, Pamplona, Spain.	rubenh@unav.es; elarrea@unav.es	Gonzalez-Aseguinolaza, Gloria/H-9928-2015; Nistal-Villán, Estanislao/AAM-8029-2020; Buñuales, María/P-2146-2019; Larrea, Esther/L-7586-2014; Nistal-Villan, Estanislao/GWM-7994-2022	Gonzalez-Aseguinolaza, Gloria/0000-0002-1600-4562; Nistal-Villán, Estanislao/0000-0003-2458-8833; Buñuales, María/0000-0002-9588-9214; Larrea, Esther/0000-0002-1443-6513; Poutou Paumier, Yoanna/0000-0002-7830-6371; Prieto, Jesus/0000-0002-1091-9593; Rodriguez Garcia, Estefania/0000-0002-0578-6212	Spanish Department of Science [SAF2012-39504, SAF2012-39578]; Spanish MINECO fellowship [JCI-2011-09179]; ISCIII; FEDER [PI11/01534]; European Marie-Curie [IRG-2010-277172]	Spanish Department of Science(Spanish Government); Spanish MINECO fellowship; ISCIII(Instituto de Salud Carlos III); FEDER(European Commission); European Marie-Curie(European Commission)	This work was funded by grants SAF2012-39504 (to RH) and SAF2012-39578 (to GG) from the Spanish Department of Science; Spanish MINECO fellowship JCI-2011-09179 and by the ISCIII, cofounded by FEDER, grant number PI11/01534 and the European Marie-Curie IRG-2010-277172 (to EN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranda F, 2011, CANCER RES, V71, P3214, DOI 10.1158/0008-5472.CAN-10-3259; Berraondo P, 2009, EUR J PHARM SCI, V37, P418, DOI 10.1016/j.ejps.2009.03.013; Bunuales M, 2012, HUM GENE THER, V23, P1258, DOI 10.1089/hum.2012.043; Chenuaud P, 2004, MOL THER, V9, P410, DOI 10.1016/j.ymthe.2003.12.015; Fioravanti J, 2011, HEPATOLOGY, V53, P1864, DOI 10.1002/hep.24306; Garcia-Sastre A, 1998, J VIROL, V72, P8550; Geiss G, 2001, J BIOL CHEM, V276, P30178, DOI 10.1074/jbc.C100137200; GrageGriebenow E, 1996, J LEUKOCYTE BIOL, V60, P389, DOI 10.1002/jlb.60.3.389; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Iankov ID, 2006, J VIROL, V80, P8530, DOI 10.1128/JVI.00593-06; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Jia WZ, 2008, MOL IMMUNOL, V45, P2419, DOI 10.1016/j.molimm.2007.11.011; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Kumar R, 2012, APPL BIOCHEM BIOTECH, V167, P2005, DOI 10.1007/s12010-012-9700-1; Larrea E, 2006, GUT, V55, P1188, DOI 10.1136/gut.2005.070060; Larrea E, 2014, GUT, V63, P665, DOI 10.1136/gutjnl-2012-304377; Li GY, 2008, INT J CLIN EXP PATHO, V1, P169; Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277; Manicassamy B, 2010, P NATL ACAD SCI USA, V107, P11531, DOI 10.1073/pnas.0914994107; Morrey JD, 2004, ANTIVIR RES, V63, P41, DOI 10.1016/j.antiviral.2004.02.005; Nistal-Villan E, 2015, J INNATE IMMUN, V7, P466, DOI 10.1159/000375262; Paessler S, 2004, J INFECT DIS, V189, P2072, DOI 10.1086/383246; Paneda A, 2011, HUM GENE THER, V22, P999, DOI 10.1089/hum.2010.190; Paneda A, 2009, HUM GENE THER, V20, P908, DOI 10.1089/hum.2009.031; Poupiot J, 2011, METHODS MOL BIOL, V709, P63, DOI 10.1007/978-1-61737-982-6_4; Pulverer JE, 2010, J VIROL, V84, P8626, DOI 10.1128/JVI.00303-10; Rajsbaum R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003059; Ronnblom L, 2006, ARTHRITIS RHEUM-US, V54, P408, DOI 10.1002/art.21571; Sbrana E, 2006, AM J TROP MED HYG, V74, P1084, DOI 10.4269/ajtmh.2006.74.1084; Scheu S, 2008, P NATL ACAD SCI USA, V105, P20416, DOI 10.1073/pnas.0808537105; Schmid S, 2010, J BIOL CHEM, V285, P42013, DOI 10.1074/jbc.M110.165936; Simmons DJ, 1997, J BIOMED MATER RES, V34, P393, DOI 10.1002/(SICI)1097-4636(19970305)34:3<393::AID-JBM14>3.0.CO;2-H; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; TANAKA N, 1993, MOL CELL BIOL, V13, P4531, DOI 10.1128/MCB.13.8.4531; Tesh RB, 2001, J INFECT DIS, V183, P1431, DOI 10.1086/320199; Unzu C, 2011, MOL THER, V19, P243, DOI 10.1038/mt.2010.210; Vanrell L, 2011, MOL THER, V19, P1245, DOI 10.1038/mt.2011.37	38	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152031	10.1371/journal.pone.0152031	http://dx.doi.org/10.1371/journal.pone.0152031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007218	Green Published, gold			2022-12-26	WOS:000372701200088
J	Bigorgne, AE; John, B; Ebrahimkhani, MR; Shimizu-Albergine, M; Campbell, JS; Crispe, IN				Bigorgne, Amelie E.; John, Beena; Ebrahimkhani, Mohammad R.; Shimizu-Albergine, Masami; Campbell, Jean S.; Crispe, Ian N.			TLR4-Dependent Secretion by Hepatic Stellate Cells of the Neutrophil-Chemoattractant CXCL1 Mediates Liver Response to Gut Microbiota	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; ENDOTHELIAL-CELLS; INTESTINAL MICROBIOTA; IMMUNE-RESPONSES; TLR4; INFILTRATION; CHEMOKINE; FIBROSIS; MICE	Background & Aims The gut microbiota significantly influences hepatic immunity. Little is known on the precise mechanism by which liver cells mediate recognition of gut microbes at steady state. Here we tested the hypothesis that a specific liver cell population was the sensor and we aimed at deciphering the mechanism by which the activation of TLR4 pathway would mediate liver response to gut microbiota. Methods Using microarrays, we compared total liver gene expression in WT versus TLR4 deficient mice. We performed in situ localization of the major candidate protein, CXCL1. With an innovative technique based on cell sorting, we harvested enriched fractions of KCs, LSECs and HSCs from the same liver. The cytokine secretion profile was quantified in response to low levels of LPS (1ng/mL). Chemotactic activity of stellate cell-derived CXCL1 was assayed in vitro on neutrophils upon TLR4 activation. Results TLR4 deficient liver had reduced levels of one unique chemokine, CXCL1 and subsequent decreased of neutrophil counts. Depletion of gut microbiota mimicked TLR4 deficient phenotype, i.e., decreased neutrophils counts in the liver. All liver cells were responsive to low levels of LPS, but hepatic stellate cells were the major source of chemotactic levels of CXCL1. Neutrophil migration towards secretory hepatic stellate cells required the TLR4 dependent secretion of CXCL1. Conclusions Showing the specific activation of TLR4 and the secretion of one major functional chemokine-CXCL1, the homolog of human IL-8-, we elucidate a new mechanism in which Hepatic Stellate Cells play a central role in the recognition of gut microbes by the liver at steady state.	[Bigorgne, Amelie E.; John, Beena; Ebrahimkhani, Mohammad R.; Crispe, Ian N.] Seattle Biomed Res Inst, 307 North Westlake Ave, Seattle, WA 98109 USA; [Shimizu-Albergine, Masami; Campbell, Jean S.; Crispe, Ian N.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [John, Beena] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Ebrahimkhani, Mohammad R.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Shimizu-Albergine, Masami] Univ Washington, Dept Pharmacol, Med Ctr, Seattle, WA 98195 USA; [Crispe, Ian N.] Univ Washington, Dept Pathol, Med Ctr, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle; University of Pennsylvania; Massachusetts Institute of Technology (MIT); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bigorgne, AE (corresponding author), Seattle Biomed Res Inst, 307 North Westlake Ave, Seattle, WA 98109 USA.	amelie.bigorgne@inserm.fr		Campbell, Jean/0000-0002-9187-2204; Ebrahimkhani, Mo R./0000-0001-5753-6779	National Institute of Allergy and Infectious Diseases, National Institutes of Health [1R01AI072049]; INC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072049] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); INC; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases, National Institutes of Health Grant #1R01AI072049. INC received the funding.	Bigorgne A.E., 2010, GASTROENTEROL RES PR, V2010; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Craciun FL, 2010, J IMMUNOL, V185, P6930, DOI 10.4049/jimmunol.1002300; Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007; Duerkop BA, 2009, IMMUNITY, V31, P368, DOI 10.1016/j.immuni.2009.08.009; Dunham RM, 2013, J IMMUNOL, V190, P2009, DOI 10.4049/jimmunol.1201937; Henao-Mejia J, 2013, ADV IMMUNOL, V117, P73, DOI 10.1016/B978-0-12-410524-9.00003-7; John B, 2005, J IMMUNOL, V175, P1643, DOI 10.4049/jimmunol.175.3.1643; John B, 2007, HEPATOLOGY, V45, P178, DOI 10.1002/hep.21446; Knolle PA, 2001, TRENDS IMMUNOL, V22, P432, DOI 10.1016/S1471-4906(01)01957-3; Le Roy T, 2012, GUT, V0, P1; Lisbonne M, 2011, EUR J IMMUNOL, V41, P1720, DOI 10.1002/eji.201041006; Lu YZ, 2012, LAB INVEST, V92, P783, DOI 10.1038/labinvest.2012.11; Lunz JG, 2007, HEPATOLOGY, V46, P1946, DOI 10.1002/hep.21906; Maher JJ, 1998, AM J PHYSIOL-GASTR L, V275, pG847, DOI 10.1152/ajpgi.1998.275.4.G847; Mencin A, 2009, GUT, V58, P704, DOI 10.1136/gut.2008.156307; Mosher B, 2001, J SURG RES, V99, P201, DOI 10.1006/jsre.2001.6217; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Quigley EMM, 2013, J HEPATOL, V58, P1020, DOI 10.1016/j.jhep.2012.11.023; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Sabroe I, 2003, J IMMUNOL, V170, P5268, DOI 10.4049/jimmunol.170.10.5268; Schwabe RF, 2006, GASTROENTEROLOGY, V130, P1886, DOI 10.1053/j.gastro.2006.01.038; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; SHIRATORI Y, 1994, BIOCHEM BIOPH RES CO, V203, P1398, DOI 10.1006/bbrc.1994.2340; Stefanovic L, 2005, EXP BIOL MED, V230, P573, DOI 10.1177/153537020523000809; Tillack K, 2012, J IMMUNOL, V188, P3150, DOI 10.4049/jimmunol.1103414; Uhrig A, 2005, J LEUKOCYTE BIOL, V77, P626, DOI 10.1189/jlb.0604332; Wang FL, 2013, NANOSCALE RES LETT, V8, P1, DOI 10.1186/1556-276X-8-284; Winau F, 2007, IMMUNITY, V26, P117, DOI 10.1016/j.immuni.2006.11.011; Zhu Q, 2012, J HEPATOL, V56, P893, DOI 10.1016/j.jhep.2011.11.013	30	26	28	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151063	10.1371/journal.pone.0151063	http://dx.doi.org/10.1371/journal.pone.0151063			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002851	Green Published, Green Submitted, gold			2022-12-26	WOS:000372697400023
J	Hanzlicek, GA; Raghavan, RK; Ganta, RR; Anderson, GA				Hanzlicek, Gregg A.; Raghavan, Ram K.; Ganta, Roman R.; Anderson, Gary A.			Bayesian Space-Time Patterns and Climatic Determinants of Bovine Anaplasmosis	PLOS ONE			English	Article							LONE STAR TICK; MODEL; DISEASE; MAXIMUM; RISK	The space-time pattern and environmental drivers (land cover, climate) of bovine anaplasmosis in the Midwestern state of Kansas was retrospectively evaluated using Bayesian hierarchical spatio-temporal models and publicly available, remotely-sensed environmental covariate information. Cases of bovine anaplasmosis positively diagnosed at Kansas State Veterinary Diagnostic Laboratory (n = 478) between years 2005-2013 were used to construct the models, which included random effects for space, time and space-time interaction effects with defined priors, and fixed-effect covariates selected a priori using an univariate screening procedure. The Bayesian posterior median and 95% credible intervals for the space-time interaction term in the best-fitting covariate model indicated a steady progression of bovine anaplasmosis over time and geographic area in the state. Posterior median estimates and 95% credible intervals derived for covariates in the final covariate model indicated land surface temperature (minimum), relative humidity and diurnal temperature range to be important risk factors for bovine anaplasmosis in the study. The model performance measured using the Area Under the Curve (AUC) value indicated a good performance for the covariate model (>0.7). The relevance of climatological factors for bovine anaplasmosis is discussed.	[Hanzlicek, Gregg A.; Raghavan, Ram K.; Anderson, Gary A.] Kansas State Univ, Coll Vet Med, Kansas State Vet Diagnost Lab, Manhattan, KS 66506 USA; [Hanzlicek, Gregg A.; Raghavan, Ram K.; Anderson, Gary A.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Raghavan, Ram K.; Ganta, Roman R.] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Ctr Excellence Vector Borne Dis, Manhattan, KS 66506 USA	Kansas State University; Kansas State University; Kansas State University	Raghavan, RK (corresponding author), Kansas State Univ, Coll Vet Med, Kansas State Vet Diagnost Lab, Manhattan, KS 66506 USA.; Raghavan, RK (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.; Raghavan, RK (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Ctr Excellence Vector Borne Dis, Manhattan, KS 66506 USA.	rkraghavan@vet.k-state.edu		Raghavan, Ram/0000-0002-2657-3398				[Anonymous], 2013, BAYESIAN DIS MAPPING; Beckham TR., 2015, VECTOR-BORNE ZOONOT, V15, P453; Berger KA, 2013, INT J REMOTE SENS, V34, P73, DOI 10.1080/01431161.2012.705447; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Braganza K, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019998; Cressie N., 1992, TERRA NOVA, V4, P613, DOI DOI 10.1111/J.1365-3121.1992.TB00605.X; Fan Jerome, 2006, CJEM, V8, P19; Goodin DouglasG., 2004, CLIMATE WEATHER ATLA; HAIR JA, 1975, J MED ENTOMOL, V12, P37, DOI 10.1093/jmedent/12.1.37; Hayhoe K, 2015, CLIMATE CHANGE MIDWE; Jonsson NN, 2000, VET J, V160, P87; KARL TR, 1991, GEOPHYS RES LETT, V18, P2253, DOI 10.1029/91GL02900; KARL TR, 1993, B AM METEOROL SOC, V74, P1007, DOI 10.1175/1520-0477(1993)074<1007:ANPORG>2.0.CO;2; Knorr-Held L, 1998, STAT MED, V17, P2045, DOI 10.1002/(SICI)1097-0258(19980930)17:18<2045::AID-SIM943>3.0.CO;2-P; KOCAN KM, 1981, AM J VET RES, V42, P15; Kocan KM, 2010, CURRENT CHALLENGES M; Land Processes Distributed Active Archive Center, MODIS OV; McGarigal K., 2012, TECH REP; Potgieter F. T., 2004, Infectious diseases of livestock, Volume One, P594; Raghavan RK, 2016, VECTOR-BORNE ZOONOT, V16, P205, DOI 10.1089/vbz.2015.1837; Raghavan RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100850; Raghavan RK, 2014, VECTOR-BORNE ZOONOT, V14, P486, DOI 10.1089/vbz.2013.1496; Rodgers SE, 2007, J MED ENTOMOL, V44, P372, DOI 10.1603/0022-2585(2007)44[372:DOETSA]2.0.CO;2; Rynkiewicz EC, 2014, EXP APPL ACAROL, V64, P109, DOI 10.1007/s10493-014-9798-7; Savage HM, 2013, AM J TROP MED HYG, V89, P445, DOI 10.4269/ajtmh.13-0209; Schoof J., 2013, CLIMATE CHANGE MIDWE, V146, P146; SCHWARTZ MD, 1995, ANN ASSOC AM GEOGR, V85, P553, DOI 10.1111/j.1467-8306.1995.tb01812.x; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Springer YP, 2015, AM J TROP MED HYG, V93, P875, DOI 10.4269/ajtmh.15-0330; Suss J, 2008, J TRAVEL MED, V15, P39, DOI 10.1111/j.1708-8305.2007.00176.x; White JW, 2008, AGR FOREST METEOROL, V148, P1574, DOI 10.1016/j.agrformet.2008.05.017; White JW, 2011, AGRON J, V103, P1242, DOI 10.2134/agronj2011.0038; Wimberly MC, 2008, GLOBAL ECOL BIOGEOGR, V17, P189, DOI 10.1111/j.1466-8238.2007.00353.x; Yoder JA, 2012, INT J ACAROL, V38, P334, DOI 10.1080/01647954.2011.647073	35	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151924	10.1371/journal.pone.0151924	http://dx.doi.org/10.1371/journal.pone.0151924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003596	Green Submitted, Green Published, gold			2022-12-26	WOS:000372697400057
J	Itonaga, M; Matsuzaki, I; Warigaya, K; Tamura, T; Shimizu, Y; Fujimoto, M; Kojima, F; Ichinose, M; Murata, S				Itonaga, Masahiro; Matsuzaki, Ibu; Warigaya, Kenji; Tamura, Takaaki; Shimizu, Yuki; Fujimoto, Masakazu; Kojima, Fumiyoshi; Ichinose, Masao; Murata, Shin-ichi			Novel Methodology for Rapid Detection of KRAS Mutation Using PNA-LNA Mediated Loop-Mediated Isothermal Amplification	PLOS ONE			English	Article							K-RAS MUTATIONS; POLYMERASE-CHAIN-REACTION; COLORECTAL-CANCER; SENSITIVE DETECTION; PANCREATIC-CANCER; LUNG-CANCER; PCR; ASSAY; DNA; FLUORESCENCE	Detecting point mutation of human cancer cells quickly and accurately is gaining in importance for pathological diagnosis and choice of therapeutic approach. In the present study, we present novel methodology, peptide nucleic acid-locked nucleic acid mediated loop-mediated isothermal amplification (PNA-LNA mediated LAMP), for rapid detection of KRAS mutation using advantages of both artificial DNA and LAMP. PNA-LNA mediated LAMP reactions occurred under isothermal temperature conditions of with 4 primary primers set for the target regions on the KRAS gene, clamping PNA probe that was complimentary to the wild type sequence and LNA primers complementary to the mutated sequences. PNA-LNA mediated LAMP was applied for cDNA from 4 kinds of pancreatic carcinoma cell lines with or without KRAS point mutation. The amplified DNA products were verified by naked-eye as well as a real-time PCR equipment. By PNA-LNA mediated LAMP, amplification of wild type KRAS DNA was blocked by clamping PNA probe, whereas, mutant type KRAS DNA was significantly amplified within 50 min. Mutant alleles could be detected in samples which diluted until 0.1% of mutant-to-wild type ratio. On the other hand, mutant alleles could be reproducibly with a mutant-to-wild type ratio of 30% by direct sequencing and of 1% by PNA-clamping PCR. The limit of detection (LOD) of PNA-LNA mediated LAMP was much lower than the other conventional methods. Competition of LNA clamping primers complementary to two different subtypes (G12D and G12V) of mutant KRAS gene indicated different amplification time depend on subtypes of mutant cDNA. PNA-LNA mediated LAMP is a simple, rapid, specific and sensitive methodology for the detection of KRAS mutation.	[Itonaga, Masahiro; Matsuzaki, Ibu; Warigaya, Kenji; Tamura, Takaaki; Shimizu, Yuki; Fujimoto, Masakazu; Kojima, Fumiyoshi; Murata, Shin-ichi] Wakayama Med Univ, Dept Human Pathol, Wakayama, Japan; [Itonaga, Masahiro; Ichinose, Masao] Wakayama Med Univ, Dept Internal Med 2, Wakayama, Japan	Wakayama Medical University; Wakayama Medical University	Murata, S (corresponding author), Wakayama Med Univ, Dept Human Pathol, Wakayama, Japan.	smurata@wakayama-med.ac.jp	Itonaga, Masahiro/AAK-6905-2021; Ichinose, Masao/HAB-1645-2022					Anderson SM, 2011, EXPERT REV MOL DIAGN, V11, P635, DOI [10.1586/erm.11.42, 10.1586/ERM.11.42]; Anker P, 1997, GASTROENTEROLOGY, V112, P1114, DOI 10.1016/S0016-5085(97)70121-5; Badolo A, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-227; Bournet B, 2009, ENDOSCOPY, V41, P552, DOI 10.1055/s-0029-1214717; DEMERS DB, 1995, NUCLEIC ACIDS RES, V23, P3050, DOI 10.1093/nar/23.15.3050; Dieterle CP, 2004, CLIN CANCER RES, V10, P641, DOI 10.1158/1078-0432.CCR-1355-02; EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0; Goto M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072; HANVEY JC, 1992, SCIENCE, V258, P1481, DOI 10.1126/science.1279811; Hirsch FR, 2001, CLIN CANCER RES, V7, P5; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kyger EM, 1998, ANAL BIOCHEM, V260, P142, DOI 10.1006/abio.1998.2687; Li JY, 2013, J VIROL METHODS, V193, P583, DOI 10.1016/j.jviromet.2013.07.059; Minnucci G, 2012, HAEMATOL-HEMATOL J, V97, P1394, DOI 10.3324/haematol.2011.056184; MOTOJIMA K, 1991, AM J GASTROENTEROL, V86, P1784; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; NIELSEN PE, 1991, SCIENCE, V254, P1497, DOI 10.1126/science.1962210; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Ogino S, 2013, MODERN PATHOL, V26, P465, DOI 10.1038/modpathol.2012.214; Ogura T, 2013, J GASTROENTEROL, V48, P640, DOI 10.1007/s00535-012-0664-2; Pan L, 2015, PEST MANAG SCI, V71, P123, DOI 10.1002/ps.3777; Parida M, 2004, J CLIN MICROBIOL, V42, P257, DOI 10.1128/JCM.42.1.257-263.2004; Srivastava S, 2001, CLIN CANCER RES, V7, P1118; Sun XY, 2002, NAT BIOTECHNOL, V20, P186, DOI 10.1038/nbt0202-186; Taback B, 2004, INT J CANCER, V111, P409, DOI 10.1002/ijc.20268; Thiede C, 1996, NUCLEIC ACIDS RES, V24, P983, DOI 10.1093/nar/24.5.983; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Tsujimoto M, 2007, CLIN CANCER RES, V13, P4807, DOI 10.1158/1078-0432.CCR-06-2512; Uemura N, 2008, J MED MICROBIOL, V57, P50, DOI 10.1099/jmm.0.47216-0; Wen Pan J-YW, 2011, J ANIMAL VET ADV, V10; Whitcombe D, 1999, NAT BIOTECHNOL, V17, P804, DOI 10.1038/11751; Yoneda A, 2014, J SURG RES, V187, pE1, DOI 10.1016/j.jss.2013.01.001	32	40	44	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151654	10.1371/journal.pone.0151654	http://dx.doi.org/10.1371/journal.pone.0151654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999437	Green Published, Green Submitted, gold			2022-12-26	WOS:000372694700052
J	Ramachandran, G; Tennant, SM; Boyd, MA; Wang, JY; Tulapurkar, ME; Pasetti, MF; Levine, MM; Simon, R				Ramachandran, Girish; Tennant, Sharon M.; Boyd, Mary A.; Wang, Jin Y.; Tulapurkar, Mohan E.; Pasetti, Marcela F.; Levine, Myron M.; Simon, Raphael			Functional Activity of Antibodies Directed towards Flagellin Proteins of Non-Typhoidal Salmonella	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; INVASIVE NONTYPHOIDAL SALMONELLA; ELECTRON CRYOMICROSCOPY; CONJUGATE VACCINE; ATOMIC MODEL; INFECTION; PROTECTION; FEVER; VIRULENCE; MACROPHAGES	Non-typhoidal Salmonella (NTS) serovars Typhimurium and Enteritidis are major causes of invasive bacterial infections in children under 5 years old in sub-Saharan Africa, with case fatality rates of similar to 20%. There are no licensed NTS vaccines for humans. Vaccines that induce antibodies against a Salmonella Typhi surface antigen, Vi polysaccharide, significantly protect humans against typhoid fever, establishing that immune responses to Salmonella surface antigens can be protective. Flagella proteins, abundant surface antigens in Salmonella serovars that cause human disease, are also powerful immunogens, but the functional capacity of elicited anti-flagellar antibodies and their role in facilitating bacterial clearance has been unclear. We examined the ability of anti-flagellar antibodies to mediate microbial killing by immune system components in-vitro and assessed their role in protecting mice against invasive Salmonella infection. Polyclonal (hyperimmune sera) and monoclonal antibodies raised against phase 1 flagellin proteins of S. Enteritidis and S. Typhimurium facilitated bacterial uptake and killing of the homologous serovar pathogen by phagocytes. Polyclonal anti-flagellar antibodies accompanied by complement also achieved direct bacterial killing. Serum bactericidal activity was restricted to Salmonella serovars expressing the same flagellin used as immunogen. Notably, individual anti-flagellin monoclonal antibodies with complement were not bactericidal, but this biological activity was restored when different monoclonal anti-flagellin antibodies were combined. Passive transfer immunization with a monoclonal IgG antibody specific for phase 1 flagellin from S. Typhimurium protected mice against lethal challenge with a representative African invasive S. Typhimurium strain. These findings have relevance for the use of flagellin proteins in NTS vaccines, and confirm the role of anti-flagellin antibodies as mediators of protective immunity.	[Ramachandran, Girish; Tennant, Sharon M.; Boyd, Mary A.; Wang, Jin Y.; Pasetti, Marcela F.; Levine, Myron M.; Simon, Raphael] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA; [Ramachandran, Girish; Tennant, Sharon M.; Wang, Jin Y.; Tulapurkar, Mohan E.; Levine, Myron M.; Simon, Raphael] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Boyd, Mary A.; Pasetti, Marcela F.; Levine, Myron M.] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA; [Tulapurkar, Mohan E.] Univ Maryland, Sch Med, Div Pulm & Crit Care, Baltimore, MD 21201 USA; [Boyd, Mary A.] US FDA, Silver Spring, MD USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Food & Drug Administration (FDA)	Simon, R (corresponding author), Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.; Simon, R (corresponding author), Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA.	rsimon@medicine.umaryland.edu	tulapurkar, mohan/F-1926-2015	tulapurkar, mohan/0000-0002-2476-5417; Pasetti, Marcela/0000-0003-0894-4009	Middle Atlantic RCE Program, NIAID/NIH [2 U54 AI057168]; UK Wellcome Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057168] Funding Source: NIH RePORTER	Middle Atlantic RCE Program, NIAID/NIH; UK Wellcome Trust(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Middle Atlantic RCE Program, NIAID/NIH 2 U54 AI057168 and a Strategic Translation Grant from the UK Wellcome Trust (MML PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaniz RC, 2006, J IMMUNOL, V177, P3983, DOI 10.4049/jimmunol.177.6.3983; ANDERSON TR, 1987, INFECT IMMUN, V55, P3204, DOI 10.1128/IAI.55.12.3204-3206.1987; Ault A, 2013, VACCINE, V31, P5879, DOI 10.1016/j.vaccine.2013.09.041; Bergman MA, 2005, INFECT IMMUN, V73, P7226, DOI 10.1128/IAI.73.11.7226-7235.2005; Bobat S, 2011, EUR J IMMUNOL, V41, P1606, DOI 10.1002/eji.201041089; Boyd MA, 2014, CLIN VACCINE IMMUNOL, V21, P712, DOI 10.1128/CVI.00115-14; CARSIOTIS M, 1984, INFECT IMMUN, V46, P814, DOI 10.1128/IAI.46.3.814-818.1984; Casadevall A, 1998, TRENDS MICROBIOL, V6, P102, DOI 10.1016/S0966-842X(98)01208-6; Feasey NA, 2012, LANCET, V379, P2489, DOI 10.1016/S0140-6736(11)61752-2; FELIX A, 1951, J HYG-CAMBRIDGE, V49, P92, DOI 10.1017/S0022172400015394; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Gil-Cruz C, 2009, P NATL ACAD SCI USA, V106, P9803, DOI 10.1073/pnas.0812431106; Gondwe EN, 2010, P NATL ACAD SCI USA, V107, P3070, DOI 10.1073/pnas.0910497107; Hiriart Y, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-640; Ikeda JS, 2001, INFECT IMMUN, V69, P3021, DOI 10.1128/IAI.69.5.3021-3030.2001; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; KLUGMAN KP, 1987, LANCET, V2, P1165; LEVINE MM, 1978, AM J TROP MED HYG, V27, P795, DOI 10.4269/ajtmh.1978.27.795; Levy H, 2008, J CLIN MICROBIOL, V46, P1861, DOI 10.1128/JCM.00109-08; Lindberg A., 1984, METHOD MICROBIOL, V15, P1, DOI DOI 10.1016/S0580-9517(08)70457-4; McSorley SJ, 2000, J IMMUNOL, V164, P986, DOI 10.4049/jimmunol.164.2.986; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Mohan VK, 2015, CLIN INFECT DIS, V61, P393, DOI 10.1093/cid/civ295; Schmitt CK, 2001, INFECT IMMUN, V69, P5619, DOI 10.1128/IAI.69.9.5619-5625.2001; Simon R, 2014, PROTEIN EXPRES PURIF, V102, P1, DOI 10.1016/j.pep.2014.07.005; Simon R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064680; Simon R, 2011, INFECT IMMUN, V79, P4240, DOI 10.1128/IAI.05484-11; Simon R, 2011, VACCINE, V29, P5094, DOI 10.1016/j.vaccine.2011.05.022; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; SVENSON SB, 1979, INFECT IMMUN, V25, P863, DOI 10.1128/IAI.25.3.863-872.1979; Tapia MD, 2015, CLIN INFECT DIS, V61, pS332, DOI 10.1093/cid/civ729; Tennant SM, 2011, INFECT IMMUN, V79, P4175, DOI 10.1128/IAI.05278-11; Tennant SM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000621; WATSON DC, 1992, INFECT IMMUN, V60, P4679, DOI 10.1128/IAI.60.11.4679-4686.1992; WEINSTEIN DL, 1984, INFECT IMMUN, V46, P819, DOI 10.1128/IAI.46.3.819-825.1984; Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830; Yonekura K, 2005, STRUCTURE, V13, P407, DOI 10.1016/j.str.2005.02.003	37	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151875	10.1371/journal.pone.0151875	http://dx.doi.org/10.1371/journal.pone.0151875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998925	Green Published, Green Submitted, gold			2022-12-26	WOS:000372694700077
J	Wang, QH; Zhao, ZJ; Zhang, XX; Li, XL; Zhu, M; Li, PP; Yang, ZQ; Wang, Y; Yan, GY; Shang, H; Cao, YM; Fan, Q; Cui, LW				Wang, Qinghui; Zhao, Zhenjun; Zhang, Xuexing; Li, Xuelian; Zhu, Min; Li, Peipei; Yang, Zhaoqing; Wang, Ying; Yan, Guiyun; Shang, Hong; Cao, Yaming; Fan, Qi; Cui, Liwang			Naturally Acquired Antibody Responses to Plasmodium vivax and Plasmodium falciparum Merozoite Surface Protein 1 (MSP1) C-Terminal 19 kDa Domains in an Area of Unstable Malaria Transmission in Southeast Asia	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSES; BLOOD-STAGE ANTIGENS; SERUM ANTIBODIES; VACCINE CANDIDATE; CLINICAL MALARIA; 19-KILODALTON DOMAIN; ENDEMIC AREA; REDUCED RISK; IGG ISOTYPE; PROTECTION	Understanding naturally acquired immunity to infections caused by Plasmodia in different malaria endemicity settings is needed for better vaccine designs and for exploring antibody responses as a proxy marker of malaria transmission intensity. This study investigated the sero-epidemiology of malaria along the international border between China and Myanmar, where malaria elimination action plans are in place. This study recruited 233 P. vivax and 156 P. falciparum infected subjects with acute malaria at the malaria clinics and hospitals. In addition, 93 and 67 healthy individuals from the same endemic region or from non-endemic region, respectively, were used as controls. Acute malaria infections were identified by microscopy. Anti-recombinant PfMSP1(19) and PvMSP1(19) antibody levels were measured by ELISA. Antibody responses to respective MSP1(19) were detected in 50.9% and 78.2% patients with acute P. vivax and P. falciparum infections, respectively. There were cross-reacting antibodies in Plasmodium patients against these two recombinant proteins, though we could not exclude the possibility of submicroscopic mixed-species infections. IgG1, IgG3 and IgG4 were the major subclasses. Interestingly, 43.2% of the healthy endemic population also had antibodies against PfMSP1(19), whereas only 3.9% of this population had antibodies against PvMSP1(19). Higher antibody levels were correlated with age and parasite density, but not with season, gender or malaria history. Both total IgG and individual IgG subclasses underwent substantial declines during the convalescent period in three months. This study demonstrated that individuals in a hypoendemic area with coexistence of P. vivax and P. falciparum can mount rapid antibody responses against both PfMSP1(19) and PvMSP1(19). The significantly higher proportion of responders to PfMSP119 in the healthy endemic population indicates higher prevalence of P. falciparum in the recent past. Specific antibodies against PvMSP1(19) could serve as a marker of recent exposure to P. vivax in epidemiological studies.	[Wang, Qinghui; Zhang, Xuexing; Cao, Yaming] China Med Univ, Coll Basic Med Sci, Dept Immunol, Shenyang 110001, Liaoning, Peoples R China; [Zhao, Zhenjun; Li, Peipei; Fan, Qi] Dalian Inst Biotechnol, Dalian, Liaoning, Peoples R China; [Li, Xuelian] China Med Univ, Sch Publ Hlth, Dept Epidemiol, Shenyang 110001, Liaoning, Peoples R China; [Zhu, Min] China Med Univ, Sch Humanities & Social Sci, Shenyang 110001, Liaoning, Peoples R China; [Yang, Zhaoqing] Kunming Med Univ, Dept Pathogen Biol & Immunol, Kunming, Peoples R China; [Wang, Ying] Third Mil Med Univ, Inst Trop Med, Chongqing, Peoples R China; [Yan, Guiyun] Univ Calif Irvine, Program Publ Hlth, Irvine, CA USA; [Shang, Hong] China Med Univ, Hosp 1, Dept Lab Med, Shenyang 110001, Liaoning, Peoples R China; [Cui, Liwang] Penn State Univ, Dept Entomol, 501 ASI Bldg, University Pk, PA 16802 USA	China Medical University; China Medical University; China Medical University; Kunming Medical University; Army Medical University; University of California System; University of California Irvine; China Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Cao, YM (corresponding author), China Med Univ, Coll Basic Med Sci, Dept Immunol, Shenyang 110001, Liaoning, Peoples R China.; Fan, Q (corresponding author), Dalian Inst Biotechnol, Dalian, Liaoning, Peoples R China.; Cui, LW (corresponding author), Penn State Univ, Dept Entomol, 501 ASI Bldg, University Pk, PA 16802 USA.	ymcao@mail.cmu.edu.cn; qifan10001@163.com; luc2@psu.edu			National Institutes of Health, USA [U19AI089672, R01 AI099611]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099611, U19AI089672] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grants U19AI089672 to LC and R01 AI099611 to YC from the National Institutes of Health, USA.	Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; Achary KG, 2014, PARASITE IMMUNOL, V36, P485, DOI 10.1111/pim.12121; Afridi S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-308; Ak Mucide, 1998, Southeast Asian Journal of Tropical Medicine and Public Health, V29, P685; Akpogheneta OJ, 2010, PARASITE IMMUNOL, V32, P296, DOI 10.1111/j.1365-3024.2009.01193.x; AlYaman F, 1996, AM J TROP MED HYG, V54, P443, DOI 10.4269/ajtmh.1996.54.443; Aucan C, 2000, INFECT IMMUN, V68, P1252, DOI 10.1128/IAI.68.3.1252-1258.2000; BLACKMAN MJ, 1990, J EXP MED, V172, P379, DOI 10.1084/jem.172.1.379; Braga TM, 2002, AM J TROP MED HYG, V66, P461, DOI 10.4269/ajtmh.2002.66.461; Branch OH, 1998, AM J TROP MED HYG, V58, P211, DOI 10.4269/ajtmh.1998.58.211; Branch OH, 2000, J INFECT DIS, V181, P1746, DOI 10.1086/315424; Chuangchaiya S, 2010, CLIN EXP IMMUNOL, V160, P233, DOI 10.1111/j.1365-2249.2009.04075.x; COOPER JA, 1993, PARASITOL TODAY, V9, P50, DOI 10.1016/0169-4758(93)90031-A; Cui LW, 2012, ACTA TROP, V121, P227, DOI 10.1016/j.actatropica.2011.02.016; DALY TM, 1993, INFECT IMMUN, V61, P2462, DOI 10.1128/IAI.61.6.2462-2467.1993; DELPORTILLO HA, 1991, P NATL ACAD SCI USA, V88, P4030, DOI 10.1073/pnas.88.9.4030; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Dutta S, 2005, INFECT IMMUN, V73, P5936, DOI 10.1128/IAI.73.9.5936-5944.2005; EGAN AF, 1995, INFECT IMMUN, V63, P456, DOI 10.1128/IAI.63.2.456-466.1995; Egan AF, 1996, J INFECT DIS, V173, P765, DOI 10.1093/infdis/173.3.765; Egan AF, 1999, PARASITE IMMUNOL, V21, P133, DOI 10.1046/j.1365-3024.1999.00209.x; Fernandez-Becerra C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-29; Ferreira AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105828; Fowkes FJI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000218; FREEMAN RR, 1983, J EXP MED, V158, P1647, DOI 10.1084/jem.158.5.1647; Greenhouse B, 2011, J INFECT DIS, V204, P19, DOI 10.1093/infdis/jir223; GROUX H, 1990, RES IMMUNOL, V141, P529, DOI 10.1016/0923-2494(90)90021-P; JEFFERY GM, 1966, B WORLD HEALTH ORGAN, V35, P873; John CC, 2005, AM J TROP MED HYG, V73, P222, DOI 10.4269/ajtmh.2005.73.222; John CC, 2004, J IMMUNOL, V173, P666, DOI 10.4049/jimmunol.173.1.666; Ladeia-Andrade S, 2007, MEM I OSWALDO CRUZ, V102, P943, DOI 10.1590/S0074-02762007000800009; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Li NN, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-361; Lourembam SD, 2012, VACCINE, V30, P767, DOI 10.1016/j.vaccine.2011.11.069; Mazumdar S, 2010, INFECT IMMUN, V78, P872, DOI 10.1128/IAI.00427-09; Mehrizi AA, 2011, ACTA TROP, V119, P84, DOI 10.1016/j.actatropica.2011.04.012; Mehrizi AA, 2009, ACTA TROP, V112, P1, DOI 10.1016/j.actatropica.2009.05.016; Metzger WG, 2003, PARASITE IMMUNOL, V25, P307, DOI 10.1046/j.1365-3024.2003.00636.x; Morais CG, 2005, PARASITOL RES, V95, P420, DOI 10.1007/s00436-005-1314-x; Nagao Y, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-113; Nebie I, 2008, INFECT IMMUN, V76, P759, DOI 10.1128/IAI.01147-07; Nogueira PA, 2006, INFECT IMMUN, V74, P2726, DOI 10.1128/IAI.74.5.2726-2733.2006; Noland GS, 2008, INFECT IMMUN, V76, P5721, DOI 10.1128/IAI.00591-08; Okech BA, 2004, INFECT IMMUN, V72, P1557, DOI 10.1128/IAI.72.3.1557-1567.2004; Olotu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032929; Omosun YO, 2005, ACTA TROP, V95, P233, DOI 10.1016/j.actatropica.2005.06.019; Pan D, 2010, ACTA TROP, V116, P200, DOI 10.1016/j.actatropica.2010.08.004; Park JW, 2001, CLIN DIAGN LAB IMMUN, V8, P14, DOI 10.1128/CDLI.8.1.14-20.2001; Pitabut Nada, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P1; Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030; Putaporntip C, 2002, P NATL ACAD SCI USA, V99, P16348, DOI 10.1073/pnas.252348999; Riccio EKP, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-326; RILEY EM, 1992, PARASITE IMMUNOL, V14, P321, DOI 10.1111/j.1365-3024.1992.tb00471.x; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; Rzepczyk CM, 1997, INFECT IMMUN, V65, P1098, DOI 10.1128/IAI.65.3.1098-1100.1997; Sachdeva S, 2004, INFECT IMMUN, V72, P5775, DOI 10.1128/IAI.72.10.5775-5782.2004; Shi YP, 1996, INFECT IMMUN, V64, P2716, DOI 10.1128/IAI.64.7.2716-2723.1996; Snounou G, 2004, TRENDS PARASITOL, V20, P333, DOI 10.1016/j.pt.2004.05.004; Soares IS, 1999, MOL MED, V5, P459; Soares IS, 1999, ACTA TROP, V72, P13, DOI 10.1016/S0001-706X(98)00078-3; Soares IS, 1999, AM J TROP MED HYG, V60, P357, DOI 10.4269/ajtmh.1999.60.357; Soares IS, 1997, INFECT IMMUN, V65, P1606, DOI 10.1128/IAI.65.5.1606-1614.1997; Soe S, 2004, INFECT IMMUN, V72, P247, DOI 10.1128/IAI.72.1.247-252.2004; Soyer OU, 2013, ALLERGY, V68, P161, DOI 10.1111/all.12085; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Taylor RR, 1998, AM J TROP MED HYG, V58, P406, DOI 10.4269/ajtmh.1998.58.406; Tongren JE, 2006, INFECT IMMUN, V74, P257, DOI 10.1128/IAI.74.1.257-264.2006; Torres KJ, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-173; Valderrama-Aguirre A, 2005, AM J TROP MED HYG, V73, P16, DOI 10.4269/ajtmh.2005.73.16; Versiani FG, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/965841; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wilson DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027705; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; Woodberry T, 2008, J INFECT DIS, V198, P134, DOI 10.1086/588711; Yeom JS, 2008, J PARASITOL, V94, P1410, DOI 10.1645/GE-1484.1; Zakeri S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-257; Zeyrek FY, 2008, AM J TROP MED HYG, V78, P729, DOI 10.4269/ajtmh.2008.78.729	77	17	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151900	10.1371/journal.pone.0151900	http://dx.doi.org/10.1371/journal.pone.0151900			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999435	Green Submitted, Green Published, gold			2022-12-26	WOS:000372694700082
J	Lyons, B; Ravulapalli, R; Lanoue, J; Lugo, MR; Dutta, D; Carlin, S; Merrill, AR				Lyons, Bronwyn; Ravulapalli, Ravikiran; Lanoue, Jason; Lugo, Miguel R.; Dutta, Debajyoti; Carlin, Stephanie; Merrill, A. Rod			Scabin, a Novel DNA-acting ADP-ribosyltransferase from Streptomyces scabies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacterial toxin; bioinformatics; crystallography; DNA binding protein; enzyme kinetics; fluorescence; molecular modeling	APOPTOSIS-INDUCING PROTEIN; IOTA-TOXIN; RIBOSYLATION; MECHANISM; INHIBITORS; BOTULINUM; INSIGHTS; ENZYME; DOMAIN	A bioinformatics strategy was used to identify Scabin, a novel DNA-targeting enzyme from the plant pathogen 87.22 strain of Streptomyces scabies. Scabin shares nearly 40% sequence identity with the Pierisin family of mono-ADP-ribosyltransferase toxins. Scabin was purified to homogeneity as a 22-kDa single-domain enzyme and was shown to possess high NAD(+)-glycohydrolase (K-m(NAD) = 68 +/- 3 m; k(cat) = 94 +/- 2 min(-1)) activity with an RSQXE motif; it was also shown to target deoxyguanosine and showed sigmoidal enzyme kinetics (K-0.5(deoxyguanosine) = 302 +/- 12 m; k(cat) = 14 min(-1)). Mass spectrometry analysis revealed that Scabin labels the exocyclic amino group on guanine bases in either single-stranded or double-stranded DNA. Several small molecule inhibitors were identified, and the most potent compounds were found to inhibit the enzyme activity with K-i values ranging from 3 to 24 m. PJ34, a well known inhibitor of poly-ADP-ribosyltransferases, was shown to be the most potent inhibitor of Scabin. Scabin was crystallized, representing the first structure of a DNA-targeting mono-ADP-ribosyltransferase enzyme; the structures of the apo-form (1.45 ) and with two inhibitors (P6-E, 1.4 ; PJ34, 1.6 ) were solved. These x-ray structures are also the first high resolution structures of the Pierisin subgroup of the mono-ADP-ribosyltransferase toxin family. A model of Scabin with its DNA substrate is also proposed.	[Lyons, Bronwyn; Ravulapalli, Ravikiran; Lanoue, Jason; Lugo, Miguel R.; Carlin, Stephanie; Merrill, A. Rod] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [Dutta, Debajyoti] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2R3, Canada	University of Guelph; University of Alberta	Merrill, AR (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	rmerrill@uoguelph.ca	Dutta, Debajyoti/AGT-3216-2022; Lanoue, Jason/AAF-3363-2020; Merrill, Rod/M-8313-2014; Dutta, Debajyoti/E-2798-2018	Dutta, Debajyoti/0000-0003-0403-2192; Dutta, Debajyoti/0000-0003-0403-2192; Lanoue, Jason/0000-0002-8935-5718	Canadian Institutes of Health Research [MOP-106661]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (Grant MOP-106661 to A. R. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AKTORIES K, 1988, EUR J BIOCHEM, V172, P445, DOI 10.1111/j.1432-1033.1988.tb13908.x; Armstrong S, 2001, ANAL BIOCHEM, V292, P26, DOI 10.1006/abio.2001.5052; BARBIERI JT, 1989, INFECT IMMUN, V57, P3549, DOI 10.1128/IAI.57.11.3549-3554.1989; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fieldhouse RJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001029; Fieldhouse RJ, 2008, TRENDS BIOCHEM SCI, V33, P546, DOI 10.1016/j.tibs.2008.08.003; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Goyer C, 1997, PLANT DIS, V81, P901, DOI 10.1094/PDIS.1997.81.8.901; Han SI, 2001, J MOL BIOL, V305, P95, DOI 10.1006/jmbi.2000.4292; Healey A, 2014, PLANT METHODS, V10, DOI 10.1186/1746-4811-10-21; Holbourn KP, 2006, FEBS J, V273, P4579, DOI 10.1111/j.1742-4658.2006.05442.x; Jorgensen R, 2005, NATURE, V436, P979, DOI 10.1038/nature03871; Jorgensen R, 2008, J BIOL CHEM, V283, P10671, DOI 10.1074/jbc.M710008200; Joshi MV, 2010, MOL MICROBIOL, V77, P252, DOI 10.1111/j.1365-2958.2010.07206.x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krska D, 2015, J BIOL CHEM, V290, P1639, DOI 10.1074/jbc.M114.589846; Labute P, 2010, J CHEM INF MODEL, V50, P792, DOI 10.1021/ci900508k; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lerat S, 2009, MOL PLANT PATHOL, V10, P579, DOI [10.1111/J.1364-3703.2009.00561.X, 10.1111/j.1364-3703.2009.00561.x]; Lesnick ML, 2001, MOL MICROBIOL, V39, P1464, DOI 10.1046/j.1365-2958.2001.02360.x; Lugo M. R., 2016, J BIOMOL STRUCT DYN, V26, P1; Lugo MR, 2015, J BIOMOL STRUCT DYN, V33, P2452, DOI 10.1080/07391102.2014.1000972; Lugo MR, 2015, J MOL RECOGNIT, V28, P539, DOI 10.1002/jmr.2469; Masignani V, 2004, INT J MED MICROBIOL, V293, P471, DOI 10.1078/1438-4221-00296; Nakano T, 2015, CURR TOP MICROBIOL, V384, P127, DOI 10.1007/82_2014_416; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Parikh SL, 2004, BIOCHEMISTRY-US, V43, P1204, DOI 10.1021/bi035907z; Ravulapalli R, 2015, BIOCHEMISTRY-US, V54, P5920, DOI 10.1021/acs.biochem.5b00921; Reinert DJ, 2006, J MOL BIOL, V357, P1226, DOI 10.1016/j.jmb.2006.01.025; Sakurai J, 2003, ADV ENZYME REGUL, V43, P361, DOI 10.1016/S0065-2571(02)00044-4; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Simon NC, 2014, NAT REV MICROBIOL, V12, P599, DOI 10.1038/nrmicro3310; Takamura-Enya T, 2001, P NATL ACAD SCI USA, V98, P12414, DOI 10.1073/pnas.221444598; Tsurumura T, 2013, P NATL ACAD SCI USA, V110, P4267, DOI 10.1073/pnas.1217227110; Turgeon Z, 2011, ANTIMICROB AGENTS CH, V55, P983, DOI 10.1128/AAC.01164-10; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Visschedyk D, 2012, J BIOL CHEM, V287, P41089, DOI 10.1074/jbc.M112.412809; Visschedyk DD, 2010, J BIOL CHEM, V285, P13525, DOI 10.1074/jbc.M109.077339; Vogelsgesang M, 2007, N-S ARCH PHARMACOL, V374, P347, DOI 10.1007/s00210-006-0113-y; Watanabe M, 1999, P NATL ACAD SCI USA, V96, P10608, DOI 10.1073/pnas.96.19.10608; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yates SP, 2006, TRENDS BIOCHEM SCI, V31, P123, DOI 10.1016/j.tibs.2005.12.007; Yates SP, 2005, BIOCHEM J, V385, P667, DOI 10.1042/BJ20041480	45	36	37	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 20	2016	291	21					11198	11215		10.1074/jbc.M115.707653	http://dx.doi.org/10.1074/jbc.M115.707653			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MT	27002155	hybrid, Green Published			2022-12-26	WOS:000377042100022
J	Leung, A; Trac, C; Du, J; Natarajan, R; Schones, DE				Leung, Amy; Trac, Candi; Du, Juan; Natarajan, Rama; Schones, Dustin E.			Persistent Chromatin Modifications Induced by High Fat Diet	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM PERSISTENCE; REGULATORY ELEMENTS; FOLLOW-UP; EPIGENETICS; OBESITY; MECHANISMS; ALIGNMENT; PATTERNS; REVEALS; LIVERS	Obesity is a highly heritable complex disease that results from the interaction of multiple genetic and environmental factors. Formerly obese individuals are susceptible to metabolic disorders later in life, even after lifestyle changes are made to mitigate the obese state. This is reminiscent of the metabolic memory phenomenon originally observed for persistent complications in diabetic patients, despite subsequent glycemic control. Epigenetic modifications represent a potential mediator of this observed memory. We previously demonstrated that a high fat diet leads to changes in chromatin accessibility in the mouse liver. The regions of greatest chromatin changes in accessibility are largely strain-dependent, indicating a genetic component in diet-induced chromatin alterations. We have now examined the persistence of diet-induced chromatin accessibility changes upon diet reversal in two strains of mice. We find that a substantial fraction of loci that undergo chromatin accessibility changes with a high fat diet remains in the remodeled state after diet reversal in C57BL/6J mice. In contrast, the vast majority of diet-induced chromatin accessibility changes in A/J mice are transient. Our data also indicate that the persistent chromatin accessibility changes observed in C57BL/6J mice are associated with specific transcription factors and histone post-translational modifications. The persistent loci identified here are likely to be contributing to the overall phenotype and are attractive targets for therapeutic intervention.	[Leung, Amy; Trac, Candi; Du, Juan; Natarajan, Rama; Schones, Dustin E.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet Complicat & Metab, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Du, Juan; Natarajan, Rama; Schones, Dustin E.] City Hope Natl Med Ctr, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope	Schones, DE (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet Complicat & Metab, 1500 E Duarte Rd, Duarte, CA 91010 USA.	dschones@coh.org		Leung, Amy/0000-0002-5175-430X	National Institutes of Health [K22HL101950, T32DK007571-24, 1K01DK104993, R01HL106089, RO1DK065073]; Schaeffer Endowment funds; National Institutes of Health under NO [P30CA33572]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K22HL101950, R01HL106089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065073, K01DK104993, T32DK007571] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Schaeffer Endowment funds; National Institutes of Health under NO; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants K22HL101950 (to D. E. S.), T32DK007571-24 (to A. L.), 1K01DK104993 (to A. L), and R01HL106089 and RO1DK065073 and Schaeffer Endowment funds (to R. N.). Research reported in this publication included work performed in the Pathology and Integrative Genomics Cores of the City of Hope supported by National Institutes of Health under NO Award P30CA33572. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson JW, 2001, AM J CLIN NUTR, V74, P579; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Cooper ME, 2010, CIRC RES, V107, P1403, DOI 10.1161/CIRCRESAHA.110.223552; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fradin D, 2011, J NUTR METAB, V2011, DOI 10.1155/2011/647514; Genuth S, 2002, JAMA-J AM MED ASSOC, V287, P2563; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Guo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005370; Guo YR, 2013, MOL CELL PROTEOMICS, V12, P3744, DOI 10.1074/mcp.M113.027441; Hicks SC, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0679-0; Hill-Baskin AE, 2009, HUM MOL GENET, V18, P2975, DOI 10.1093/hmg/ddp236; Hoek-van den Hil EF, 2015, GENES NUTR, V10, DOI 10.1007/s12263-015-0469-z; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jayaraman S, 2011, EPIGENOMICS-UK, V3, P639, DOI [10.2217/EPI.11.78, 10.2217/epi.11.78]; Keating ST, 2015, CIRC RES, V116, P715, DOI 10.1161/CIRCRESAHA.116.303936; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; KRAMER FM, 1989, INT J OBESITY, V13, P123; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leung A, 2014, J BIOL CHEM, V289, P23557, DOI 10.1074/jbc.M114.581439; Leung A, 2013, CIRC RES, V113, P266, DOI 10.1161/CIRCRESAHA.112.300849; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Littlejohns B, 2014, CELL PHYSIOL BIOCHEM, V34, P1090, DOI 10.1159/000366323; Littlejohns B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100579; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Meng ZX, 2015, CELL REP, V13, P1658, DOI 10.1016/j.celrep.2015.10.033; Noma K, 2001, SCIENCE, V293, P1150, DOI 10.1126/science.1064150; Podrini C, 2015, FASEB J, V29, P1676, DOI 10.1096/fj.14-262717; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Rosenbaum M, 2008, AM J CLIN NUTR, V88, P906, DOI 10.1093/ajcn/88.4.906; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schones DE, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-23; Simon JA, 2013, MOL CELL, V49, P808, DOI 10.1016/j.molcel.2013.02.013; Simon JM, 2012, NAT PROTOC, V7, P256, DOI 10.1038/nprot.2011.444; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Sookoian S, 2015, WORLD J GASTROENTERO, V21, P711, DOI 10.3748/wjg.v21.i3.711; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; Stefflova K, 2013, CELL, V154, P530, DOI 10.1016/j.cell.2013.07.007; Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043; Sumithran P, 2011, NEW ENGL J MED, V365, P1597, DOI 10.1056/NEJMoa1105816; Takamura T, 2008, OBESITY, V16, P2601, DOI 10.1038/oby.2008.419; Tsompana M, 2014, EPIGENET CHROMATIN, V7, DOI 10.1186/1756-8935-7-33; White JK, 2013, CELL, V154, P452, DOI 10.1016/j.cell.2013.06.022; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992	48	46	47	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10446	10455		10.1074/jbc.M115.711028	http://dx.doi.org/10.1074/jbc.M115.711028			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27006400	hybrid, Green Published			2022-12-26	WOS:000377042600002
J	Li, EF; Wang, G; Xiao, JL; Ling, J; Yang, YH; Xie, BY				Li, Erfeng; Wang, Gang; Xiao, Jiling; Ling, Jian; Yang, Yuhong; Xie, Bingyan			A SIX1 Homolog in Fusarium oxysporum f. sp conglutinans Is Required for Full Virulence on Cabbage	PLOS ONE			English	Article							I-3-MEDIATED RESISTANCE; EFFECTOR; PROTEINS; IDENTIFICATION; PATHOGENICITY; COLONIZATION; TOMATO	Fusarium oxysporum is a soil-born fungus that induces wilt and root rot on a variety of plants. F. oxysporum f. sp. conglutinans (Foc) can cause wilt disease on cabbage. This study showed that a homolog of SIX1 protein in the Arabidopsis infecting isolate Fo5176 (Fo5176-SIX1) had four isoforms in the conidia of Foc by proteomic analysis. Thus, we analyzed the roles of protein Foc-SIX1. Gene expression analysis showed that, compared to the expression in mycelia, dramatically altered expression of Foc-SIX1 could be detected after infecting cabbages, and Foc-SIX1 was highly expressed in conidia under axenic culture condition. Furthermore, we knocked out the Foc-SIX1 gene and found that Foc-Delta SIX1 mutants had significantly reduced virulence compared with wild type isolate, and full virulence was restored by complementation of Foc-Delta SIX1 mutants with Foc-SIX1. Thus, we concluded that SIX1 in Foc was required for full virulence on cabbage. We also complemented Foc-Delta SIX1 with SIX1 gene in F. oxysporum f. sp. lycopersici (Fol) and found Foc-Delta SIX1::Fol-SIX1 mutants did not affect the virulence of Foc-Delta SIX1. The results confirmed that Fol-SIX1 was not capable of replacing the role of Foc-SIX1 in Foc on the disease symptom development of cabbage. The roles of Fol-SIX1 on virulence might rely on host specificity.	[Li, Erfeng; Wang, Gang; Ling, Jian; Yang, Yuhong; Xie, Bingyan] Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100081, Peoples R China; [Xiao, Jiling] Hunan Watermelon & Muskmelon Inst, Changsha 410125, Hunan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS	Xie, BY (corresponding author), Chinese Acad Agr Sci, Inst Vegetables & Flowers, Beijing 100081, Peoples R China.	lrfcaas@gmail.com			National Natural Science Foundation of China [31272003]; National Key Technology RD Program [2012BAD19B06]; National Staple Vegetable Industry Technology System Construction Project [CARS-25-B-01]; Special Fund for Agro-scientific Research in the Public Interest [200903049-04]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology RD Program(National Key Technology R&D Program); National Staple Vegetable Industry Technology System Construction Project; Special Fund for Agro-scientific Research in the Public Interest	This work was funded by the National Natural Science Foundation of China (31272003), [http://www.nsfc.gov.cn/], to YHY; National Key Technology R&D Program (2012BAD19B06), [http://program.most.gov.cn/], to BYX; National Staple Vegetable Industry Technology System Construction Project (CARS-25-B-01), to BYX; Special Fund for Agro-scientific Research in the Public Interest (200903049-04), to BYX. The funders had roles in study design, data collection and analysis, decision to publish and preparation of the manuscript.; The work in the ministry of agriculture key laboratory of genetic improvement of horticultural crops was and is supported in part by grants from the National Natural Science Foundation of China (No. 31272003), the National Key Technology R&D Program (No. 2012BAD19B06), the Special Fund for Agro-scientific Research in the Public Interest (No. 200903049-04) and the National Staple Vegetable Industry Technology System Construction Project (No. CARS-25-B-01). The authors declared no conflicts of interest.	Beaubois E, 2007, PLANT CELL ENVIRON, V30, P834, DOI 10.1111/j.1365-3040.2007.01669.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Catlett N.L., 2003, FUNGAL GENET NEWSL, V50, P9, DOI DOI 10.4148/1941-4765.1150; Fu J, 2006, FUNGAL GENET BIOL, V43, P200, DOI 10.1016/j.fgb.2005.09.007; Gawehns F, 2014, MOL PLANT MICROBE IN, V27, P336, DOI 10.1094/MPMI-11-13-0330-R; Houterman PM, 2009, PLANT J, V58, P970, DOI 10.1111/j.1365-313X.2009.03838.x; Houterman PM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000061; Li E, 2011, CHINA VEGETABLES, V14; Li EF, 2015, SCI REP-UK, V5, DOI 10.1038/srep13663; Li EF, 2015, EUR J PLANT PATHOL, V141, P597, DOI 10.1007/s10658-014-0567-6; Lv H, 2011, ACTA HORTICULTURAE S, V5; Lv HH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1094; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; Pu XM, 2014, FEMS MICROBIOL LETT, V355, P142, DOI 10.1111/1574-6968.12461; Rep M, 2005, FEMS MICROBIOL LETT, V253, P19, DOI 10.1016/j.femsle.2005.09.014; Rep M, 2005, MOL PLANT MICROBE IN, V18, P15, DOI 10.1094/MPMI-18-0015; Rep M, 2004, MOL MICROBIOL, V53, P1373, DOI 10.1111/j.1365-2958.2004.04177.x; Rep M, 2002, PLANT PHYSIOL, V130, P904, DOI 10.1104/pp.007427; Shen SH, 2003, PROTEOMICS, V3, P527, DOI 10.1002/pmic.200390066; Shimizu M, 2015, THEOR APPL GENET, V128, P119, DOI 10.1007/s00122-014-2416-6; Smith E.F., 1899, SCI AM SUPPL, V48, P1981; Son H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002310; Takken F, 2010, MOL PLANT PATHOL, V11, P309, DOI 10.1111/j.1364-3703.2009.00605.x; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Thatcher LF, 2012, MOL PLANT MICROBE IN, V25, P180, DOI 10.1094/MPMI-08-11-0212; TURGEON BG, 1987, MOL CELL BIOL, V7, P3297, DOI 10.1128/MCB.7.9.3297; van der Does HC, 2008, FUNGAL GENET BIOL, V45, P1257, DOI 10.1016/j.fgb.2008.06.002; Wang XC, 2007, ELECTROPHORESIS, V28, P3976, DOI 10.1002/elps.200600805; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	29	35	36	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152273	10.1371/journal.pone.0152273	http://dx.doi.org/10.1371/journal.pone.0152273			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010418	Green Submitted, Green Published, gold			2022-12-26	WOS:000372708000125
J	Kesaniemi, JE; Heikkinen, L; Knott, KE				Kesaniemi, Jenni E.; Heikkinen, Liisa; Knott, K. Emily			DNA Methylation and Potential for Epigenetic Regulation in Pygospio elegans	PLOS ONE			English	Article							GENOME-WIDE; DEVELOPMENTAL MODE; GENETIC-STRUCTURE; PATTERNS; POLYCHAETE; CPG; EXPRESSION; AMPLIFICATION; POLYMORPHISM; POECILOGONY	Transitions in developmental mode are common evolutionarily, but how and why they occur is not understood. Developmental mode describes larval phenotypes, including morphology, ecology and behavior of larvae, which typically are generalized across different species. The polychaete worm Pygospio elegans is one of few species polymorphic in developmental mode, with multiple larval phenotypes, providing a possibility to examine the potential mechanisms allowing transitions in developmental mode. We investigated the presence of DNA methylation in P. elegans, and, since maternal provisioning is a key factor determining eventual larval phenotype, we compared patterns of DNA methylation in females during oogenesis in this species. We demonstrate that intragenic CpG site DNA methylation and many relevant genes necessary for DNA methylation occur in P. elegans. Methylation-sensitive AFLP analysis showed that gravid females with offspring differing in larval developmental mode have significantly different methylation profiles and that the females with benthic larvae and non-reproductive females from the same location also differ in their epigenetic profiles. Analysis of CpG sites in transcriptome data supported our findings of DNA methylation in this species and showed that CpG observed/expected ratios differ among females gravid with embryos destined to different developmental modes. The differences in CpG site DNA methylation patterns seen among the samples suggest a potential for epigenetic regulation of gene expression (through DNA methylation) in this species.	[Kesaniemi, Jenni E.; Heikkinen, Liisa; Knott, K. Emily] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland; [Kesaniemi, Jenni E.] Univ Oulu, Dept Ecol, Oulu, Finland	University of Jyvaskyla; University of Oulu	Kesaniemi, JE (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla, Finland.	jenni.kesaniemi@gmail.com		Kesaniemi, Jenni/0000-0001-8328-558X; Knott, Karelyn Emily/0000-0003-2564-1560	Academy of Finland [263951]; University of Jyvaskyla	Academy of Finland(Academy of Finland); University of Jyvaskyla	This work was funded by the Academy of Finland (KEK, project number 263951) and an International mobility grant from the University of Jyvaskyla (to JEK).	Amarasinghe HE, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2502; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; Bonasio R, 2012, CURR BIOL, V22, P1755, DOI 10.1016/j.cub.2012.07.042; Colgan DJ, 2008, ZOOL STUD, V47, P338; del Gaudio R, 1999, FEBS LETT, V460, P380, DOI 10.1016/S0014-5793(99)01379-4; delGaudio R, 1997, FEBS LETT, V417, P48, DOI 10.1016/S0014-5793(97)01262-3; Dowen RH, 2012, P NATL ACAD SCI USA, V109, pE2183, DOI 10.1073/pnas.1209329109; Dubin MJ, 2015, ELIFE, V4, DOI 10.7554/eLife.05255; Elango N, 2008, MOL BIOL EVOL, V25, P1602, DOI 10.1093/molbev/msn110; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; Fatemi M, 2006, J CELL SCI, V119, P3033, DOI 10.1242/jcs.03099; Field LM, 2000, BIOCHEM J, V349, P863, DOI 10.1042/bj3490863; Field LM, 2004, INSECT MOL BIOL, V13, P109, DOI 10.1111/j.0962-1075.2004.00470.x; Flores K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-480; Fneich S, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-167; Foret S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-472; Gavery MR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-483; Gibson G, 2012, GENET RES INT, V2012, DOI 10.1155/2012/392903; GUDMUNDSSON H, 1985, J MAR BIOL ASSOC UK, V65, P93, DOI 10.1017/S0025315400060835; Hendrich B, 2003, TRENDS GENET, V19, P269, DOI 10.1016/S0168-9525(03)00080-5; Herrera CM, 2010, NEW PHYTOL, V187, P867, DOI 10.1111/j.1469-8137.2010.03298.x; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Johnson LJ, 2010, HEREDITY, V105, P113, DOI 10.1038/hdy.2010.25; Kesaniemi JE, 2012, ECOL EVOL, V2, P994, DOI 10.1002/ece3.226; Kesaniemi JE, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-12; Kesaniemi JE, 2012, INTEGR COMP BIOL, V52, P181, DOI 10.1093/icb/ics064; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Knott KE, 2012, INTEGR COMP BIOL, V52, P120, DOI 10.1093/icb/ics037; Lyko F, 2011, TRENDS GENET, V27, P127, DOI 10.1016/j.tig.2011.01.003; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; Marsh AG, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00173; Mazzio EA, 2012, EPIGENETICS-US, V7, P119, DOI 10.4161/epi.7.2.18764; Moran P, 2013, AQUACULTURE, V392, P77, DOI 10.1016/j.aquaculture.2013.02.006; Moran P, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-86; Morgan TS, 1999, MAR ECOL PROG SER, V178, P121, DOI 10.3354/meps178121; Nabel CS, 2011, SCIENCE, V333, P1229, DOI 10.1126/science.1211917; Navarro-Martin L, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002447; Pastor WA, 2013, NAT REV MOL CELL BIO, V14, P341, DOI 10.1038/nrm3589; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perez-Figueroa A, 2013, MOL ECOL RESOUR, V13, P522, DOI 10.1111/1755-0998.12064; ReynaLopez GE, 1997, MOL GEN GENET, V253, P703, DOI 10.1007/s004380050374; Schulz B, 2013, MOL ECOL RESOUR, V13, P642, DOI 10.1111/1755-0998.12100; Sheldon CC, 1999, PLANT CELL, V11, P445, DOI 10.1105/tpc.11.3.445; Shimizu TS, 1997, GENE, V205, P103, DOI 10.1016/S0378-1119(97)00542-8; Simmen MW, 1999, SCIENCE, V283, P1164, DOI 10.1126/science.283.5405.1164; SIMPSON VJ, 1986, NUCLEIC ACIDS RES, V14, P6711, DOI 10.1093/nar/14.16.6711; Smith CR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042433; Smith G, 2015, MOL BIOL EVOL, V32, P888, DOI 10.1093/molbev/msu344; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Suzuki MM, 2007, GENOME RES, V17, P625, DOI 10.1101/gr.6163007; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatra GS, 2000, PHYSIOL PLANTARUM, V109, P313, DOI 10.1034/j.1399-3054.2000.100313.x; Tweedie S, 1997, MOL CELL BIOL, V17, P1469, DOI 10.1128/MCB.17.3.1469; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang X, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003872; Wojciechowski M, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140110; Xu F, 2010, CURR MED CHEM, V17, P4052, DOI 10.2174/092986710793205372; Xu ML, 2000, PLANT MOL BIOL REP, V18, P361, DOI 10.1007/BF02825064; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	60	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151863	10.1371/journal.pone.0151863	http://dx.doi.org/10.1371/journal.pone.0151863			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008314	gold, Green Published, Green Submitted			2022-12-26	WOS:000372701200071
J	Syvertsson, S; Vischer, NOE; Gao, YQ; Hamoen, LW				Syvertsson, Simon; Vischer, Norbert O. E.; Gao, Yongqiang; Hamoen, Leendert W.			When Phase Contrast Fails: ChainTracer and NucTracer, Two ImageJ Methods for Semi-Automated Single Cell Analysis Using Membrane or DNA Staining	PLOS ONE			English	Article							BACILLUS-SUBTILIS; POPULATION HETEROGENEITY; EPIGENETIC INHERITANCE; ESCHERICHIA-COLI; STATE	Within bacterial populations, genetically identical cells often behave differently. Single-cell measurement methods are required to observe this heterogeneity. Flow cytometry and fluorescence light microscopy are the primary methods to do this. However, flow cytometry requires reasonably strong fluorescence signals and is impractical when bacteria grow in cell chains. Therefore fluorescence light microscopy is often used to measure population heterogeneity in bacteria. Automatic microscopy image analysis programs typically use phase contrast images to identify cells. However, many bacteria divide by forming a cross-wall that is not detectable by phase contrast. We have developed 'ChainTracer', a method based on the ImageJ plugin ObjectJ. It can automatically identify individual cells stained by fluorescent membrane dyes, and measure fluorescence intensity, chain length, cell length, and cell diameter. As a complementary analysis method we developed 'NucTracer', which uses DAPI stained nucleoids as a proxy for single cells. The latter method is especially useful when dealing with crowded images. The methods were tested with Bacillus subtilis and Lactococcus lactis cells expressing a GFP-reporter. In conclusion, ChainTracer and NucTracer are useful single cell measurement methods when bacterial cells are difficult to distinguish with phase contrast.	[Syvertsson, Simon; Hamoen, Leendert W.] Newcastle Univ, Ctr Bacterial Cell Biol, Richardson Rd, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Vischer, Norbert O. E.; Gao, Yongqiang; Hamoen, Leendert W.] Univ Amsterdam, Swammerdam Inst Life Sci, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands	Newcastle University - UK; University of Amsterdam	Hamoen, LW (corresponding author), Newcastle Univ, Ctr Bacterial Cell Biol, Richardson Rd, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England.; Hamoen, LW (corresponding author), Univ Amsterdam, Swammerdam Inst Life Sci, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands.	l.w.hamoen@uva.nl	t, lf/AAJ-4924-2020; GAO, YQ/AAD-8468-2022	Gao, Yongqiang/0000-0002-5871-8651; Hamoen, Leendert/0000-0001-9251-1403	Biotechnology and Biological Sciences Research Council (BBSRC); Stichting voor de Technische Wetenschappen (STW) Vici grant [12128]	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Stichting voor de Technische Wetenschappen (STW) Vici grant	SS was supported by a Biotechnology and Biological Sciences Research Council (BBSRC) Ph.D. studentship. NOEV and LWH were supported by a Stichting voor de Technische Wetenschappen (STW) Vici (12128) grant.	ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen R, 2009, J BACTERIOL, V191, P5775, DOI 10.1128/JB.00521-09; Cozy LM, 2010, MOL MICROBIOL, V76, P273, DOI 10.1111/j.1365-2958.2010.07112.x; HARWOOD CR, MOL BIOL METHODS BAC; Kearns DB, 2005, GENE DEV, V19, P3083, DOI 10.1101/gad.1373905; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; Maamar H, 2005, MOL MICROBIOL, V56, P615, DOI 10.1111/j.1365-2958.2005.04592.x; MARQUEZMAGANA LM, 1994, J BACTERIOL, V176, P2427; Pandey R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058972; Piersma S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068696; Robert L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.12; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Smits WK, 2005, MOL MICROBIOL, V56, P604, DOI 10.1111/j.1365-2958.2005.04488.x; Solopova A, 2014, P NATL ACAD SCI USA, V111, P7427, DOI 10.1073/pnas.1320063111; Veening JW, 2008, P NATL ACAD SCI USA, V105, P4393, DOI 10.1073/pnas.0700463105; Vlamakis H, 2008, GENE DEV, V22, P945, DOI 10.1101/gad.1645008	20	9	9	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151267	10.1371/journal.pone.0151267	http://dx.doi.org/10.1371/journal.pone.0151267			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008090	Green Published, Green Submitted, gold			2022-12-26	WOS:000372701200046
J	Yang, YJ; Chen, LH; Li, N; Zhang, QF				Yang, Yuanjun; Chen, Lihua; Li, Ning; Zhang, Qiufen			Effect of Root Moisture Content and Diameter on Root Tensile Properties	PLOS ONE			English	Article							STRENGTH; REINFORCEMENT; RESISTANCE; CELLULOSE; WATER; SHAPE	The stabilization of slopes by vegetation has been a topical issue for many years. Root mechanical characteristics significantly influence soil reinforcement; therefore it is necessary to research into the indicators of root tensile properties. In this study, we explored the influence of root moisture content on tensile resistance and strength with different root diameters and for different tree species. Betula platyphylla, Quercus mongolica, Pinus tabulae-formis, and Larix gmelinii, the most popular tree species used for slope stabilization in the rocky mountainous areas of northern China, were used in this study. A tensile test was conducted after root samples were grouped by diameter and moisture content. The results showedthat: 1) root moisture content had a significant influence on tensile properties; 2) slightly loss of root moisture content could enhance tensile strength, but too much loss of water resulted in weaker capacity for root elongation, and consequently reduced tensile strength; 3) root diameter had a strong positive correlation with tensile resistance; and 4) the roots of Betula platyphylla had the best tensile properties when both diameter and moisture content being controlled. These findings improve our understanding of root tensile properties with root size and moisture, and could be useful for slope stabilization using vegetation.	[Yang, Yuanjun; Chen, Lihua; Li, Ning; Zhang, Qiufen] Beijing Forest Univ, Sch Water & Soil Conservat, Minist Educ, Key Lab Soil & Water Conservat & Desertificat Com, Beijing, Peoples R China	Beijing Forestry University	Chen, LH (corresponding author), Beijing Forest Univ, Sch Water & Soil Conservat, Minist Educ, Key Lab Soil & Water Conservat & Desertificat Com, Beijing, Peoples R China.	chenlihua_bjfu@163.com			National Science and Technology Pillar Program [2015BAD07B03]	National Science and Technology Pillar Program	This study is funded by the National Science and Technology Pillar Program (NO. 2015BAD07B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bischetti GB, 2005, PLANT SOIL, V278, P11, DOI 10.1007/s11104-005-0605-4; Chen LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093066; Cofie P, 2001, SOIL TILL RES, V63, P51, DOI 10.1016/S0167-1987(01)00225-2; De Baets S, 2008, PLANT SOIL, V305, P207, DOI 10.1007/s11104-008-9553-0; Genet M, 2005, PLANT SOIL, V278, P1, DOI 10.1007/s11104-005-8768-6; Gray DH, 1996, BIOTECHNICAL SOIL BI; Gu XL, 2014, FRONT STRUCT CIV ENG, V8, P308, DOI 10.1007/s11709-014-0266-6; Gyssels G, 2005, PROG PHYS GEOG, V29, P189, DOI 10.1191/0309133305pp443ra; Hales TC, 2009, J GEOPHYS RES-EARTH, V114, DOI 10.1029/2008JF001168; Huang QG, 2006, CHINESE J APPL ECOLO, V13, P519, DOI 10.13287/j.1001-9332.2002.0123; [姜志强 Jiang Zhiqiang], 2004, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V23, P2133; Liu XiuPing, 2006, Journal of Beijing Forestry University, V28, P67; Lu ChunJuan, 2013, Transactions of the Chinese Society of Agricultural Engineering, V29, P69; [吕春娟 Lv Chunjuan], 2011, [水土保持学报, Journal of Soil and Water Conservation], V25, P17; Lv CJ, 2012, THESIS BEIJING FORES; Mao Z, 2014, PLANT SOIL, V381, P249, DOI 10.1007/s11104-014-2116-7; Nilaweera N.S., 1999, B ENG GEOL ENVIRON, V57, P337, DOI [10.1007/s100640050056, DOI 10.1007/S100640050056]; Osman N, 2006, ECOL ENG, V28, P90, DOI 10.1016/j.ecoleng.2006.04.004; Roering JJ, 2003, CAN GEOTECH J, V40, P237, DOI 10.1139/T02-113; Schroeder WL, 1984, WORKSH SLOP STAB PRO, P43; Sidle RC, 2001, HYDROL PROCESS, V15, P1675, DOI 10.1002/hyp.233; Simon A, 2002, EARTH SURF PROC LAND, V27, P527, DOI 10.1002/esp.325; Stokes A., 2002, Plant roots: the hidden half, P175; Stokes A, 2008, SLOPE STABILITY EROS, P65, DOI [DOI 10.1007/978-1-4020-6676-4_4, 10.1007/978-1-4020-6676-4_4]; Stokes A, 2007, DEV PLANT SOIL SCI, V103, P165; Tokyay M, 1997, CEMENT CONCRETE RES, V27, P1281, DOI 10.1016/S0008-8846(97)00104-X; TURMANINA V. I., 1965, BYUL MOSKOV OBSHCHEST ISPYTATE LEI PRIRODY OTD BIOL, V70, P36; Vergani C, 2012, ECOL ENG, V46, P43, DOI 10.1016/j.ecoleng.2012.04.036; [王萍花 WANG Pinghua], 2011, [水土保持通报, Bulletin of Soil and Water Conservation], V31, P154; Watson Alex J., 2004, New Zealand Journal of Forestry Science, V34, P344; WU TH, 1976, 5 OH STAT U DEP CIV, P94; Zhang CB, 2014, GEOMORPHOLOGY, V206, P196, DOI 10.1016/j.geomorph.2013.09.024; Zhang CB, 2010, ECOL ENG, V36, P19, DOI 10.1016/j.ecoleng.2009.09.005; Zhang CB, 2014, J ARID LAND, V6, P601, DOI 10.1007/s40333-014-0004-x; Zhang CB, 2012, TREES-STRUCT FUNCT, V26, P1577, DOI 10.1007/s00468-012-0732-5; Zhu HaiLi, 2009, Transactions of the Chinese Society of Agricultural Engineering, V25, P40; Zhu QingKe, 2002, Journal of Beijing Forestry University, V24, P64	37	39	41	13	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151791	10.1371/journal.pone.0151791	http://dx.doi.org/10.1371/journal.pone.0151791			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003872	Green Published, gold, Green Submitted			2022-12-26	WOS:000372697400045
J	Kumar, S; Lanckacker, E; Dentener, M; Bracke, K; Provoost, S; De Grove, K; Brusselle, G; Wouters, E; Maes, T; Joos, G				Kumar, Smitha; Lanckacker, Ellen; Dentener, Mieke; Bracke, Ken; Provoost, Sharen; De Grove, Katrien; Brusselle, Guy; Wouters, Emiel; Maes, Tania; Joos, Guy			Aggravation of Allergic Airway Inflammation by Cigarette Smoke in Mice Is CD44-Dependent	PLOS ONE			English	Article							HYALURONAN-BINDING PROTEINS; INDUCED MURINE MODEL; DENDRITIC CELL; LUNG INFLAMMATION; CD44 ISOFORMS; ASTHMA; SENSITIZATION; ACTIVATION; EXPRESSION; DEPOSITION	Background Although epidemiological studies reveal that cigarette smoke (CS) facilitates the development and exacerbation of allergic asthma, these studies offer limited information on the mechanisms involved. The transmembrane glycoprotein CD44 is involved in cell adhesion and acts as a receptor for hyaluronic acid and osteopontin. We aimed to investigate the role of CD44 in a murine model of CS-facilitated allergic airway inflammation. Methods Wild type (WT) and CD44 knock-out (KO) mice were exposed simultaneously to house dust mite (HDM) extract and CS. Inflammatory cells, hyaluronic acid (HA) and osteopontin (OPN) levels were measured in bronchoalveolar lavage fluid (BALF). Proinflammatory mediators, goblet cell metaplasia and peribronchial eosinophilia were assessed in lung tissue. T-helper (Th) 1, Th2 and Th17 cytokine production was evaluated in mediastinal lymph node cultures. Results In WT mice, combined HDM/CS exposure increased the number of inflammatory cells and the levels of HA and OPN in BALF and Th2 cytokine production in mediastinal lymph nodes compared to control groups exposed to phosphate buffered saline (PBS)/CS, HDM/Air or PBS/Air. Furthermore, HDM/CS exposure significantly increased goblet cell metaplasia, peribronchial eosinophilia and inflammatory mediators in the lung. CD44 KO mice exposed to HDM/CS had significantly fewer inflammatory cells in BALF, an attenuated Th2 cytokine production, as well as decreased goblet cells and peribronchial eosinophils compared to WT mice. In contrast, the levels of inflammatory mediators were similar or higher than in WT mice. Conclusion We demonstrate for the first time that the aggravation of pulmonary inflammation upon combined exposure to allergen and an environmental pollutant is CD44-dependent. Data from this murine model of concomitant exposure to CS and HDM might be of importance for smoking allergic asthmatics.	[Kumar, Smitha; Lanckacker, Ellen; Bracke, Ken; Provoost, Sharen; De Grove, Katrien; Brusselle, Guy; Maes, Tania; Joos, Guy] Ghent Univ Hosp, Dept Resp Med, Lab Translat Res Obstruct Pulm Dis, Ghent, Belgium; [Dentener, Mieke; Wouters, Emiel] Univ Hosp Maastricht, Nutr & Toxicol Res Inst Maastricht NUTRIM, Dept Resp Med, Maastricht, Netherlands	Ghent University; Ghent University Hospital; Maastricht University; Maastricht University Medical Centre (MUMC)	Maes, T (corresponding author), Ghent Univ Hosp, Dept Resp Med, Lab Translat Res Obstruct Pulm Dis, Ghent, Belgium.	Tania.Maes@Ugent.be	Wouters, Emiel/ABD-6200-2021; Maes, Tania/M-8675-2016; Bracke, Ken R/GSN-7630-2022	Maes, Tania/0000-0002-3037-6928; Bracke, Ken R/0000-0001-5906-4605; Brusselle, Guy/0000-0001-7021-8505	Concerted Research Initiative of the Ghent University [BOF/GOA 01251504]; Interuniversity Attraction Poles (IUAP)-Belgian Science Policy [P6/35, P7/30]; Fund for Scientific Research Flanders-Belgium (FWO Vlaanderen) [G.0329.11N]	Concerted Research Initiative of the Ghent University; Interuniversity Attraction Poles (IUAP)-Belgian Science Policy; Fund for Scientific Research Flanders-Belgium (FWO Vlaanderen)(FWO)	This study was funded by Concerted Research Initiative of the Ghent University Project BOF/GOA 01251504, Interuniversity Attraction Poles (IUAP)-Belgian Science Policy P6/35 and P7/30 and Fund for Scientific Research Flanders-Belgium (FWO Vlaanderen; Research Project G.0329.11N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUSQUET J, 1991, J ALLERGY CLIN IMMUN, V88, P649, DOI 10.1016/0091-6749(91)90159-L; Bracke KR, 2010, AM J RESP CELL MOL, V42, P753, DOI 10.1165/rcmb.2008-0424OC; Bullens DMA, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-135; Cheng G, 2013, GLYCOBIOLOGY, V23, P43, DOI 10.1093/glycob/cws122; Cheng G, 2011, MATRIX BIOL, V30, P126, DOI 10.1016/j.matbio.2010.12.003; Dentener MA, 2005, THORAX, V60, P114, DOI 10.1136/thx.2003.020842; Do Y, 2004, J IMMUNOTHER, V27, P1, DOI 10.1097/00002371-200401000-00001; Gaffin JM, 2009, CURR OPIN ALLERGY CL, V9, P128, DOI 10.1097/ACI.0b013e32832678b0; Garantziotis S, 2009, J BIOL CHEM, V284, P11309, DOI 10.1074/jbc.M802400200; Gueders MM, 2009, INFLAMM RES, V58, P845, DOI 10.1007/s00011-009-0054-2; Haegel-Kronenberger H, 1998, J IMMUNOL, V161, P3902; Hillas G, 2013, CYTOKINE, V61, P251, DOI 10.1016/j.cyto.2012.10.002; Hollingsworth JW, 2007, AM J RESP CELL MOL, V37, P248, DOI 10.1165/rcmb.2006-0363OC; Isacke CM, 2002, INT J BIOCHEM CELL B, V34, P718, DOI 10.1016/S1357-2725(01)00166-2; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; Katoh S, 2003, J CLIN INVEST, V111, P1563, DOI 10.1172/JCI200316583; Katoh S, 2010, CLIN EXP IMMUNOL, V161, P233, DOI 10.1111/j.1365-2249.2010.04165.x; Katoh S, 2007, AM J RESP CRIT CARE, V176, P27, DOI 10.1164/rccm.200608-1243OC; Katoh S, 2011, EUR J IMMUNOL, V41, P3198, DOI 10.1002/eji.201141521; Klagas I, 2009, EUR RESPIR J, V34, P616, DOI 10.1183/09031936.00070808; Konno S, 2011, CLIN EXP ALLERGY, V41, P1360, DOI 10.1111/j.1365-2222.2011.03775.x; Lackie PM, 1997, AM J RESP CELL MOL, V16, P14, DOI 10.1165/ajrcmb.16.1.8998074; Lanckacker EA, 2013, EUR RESPIR J, V41, P1189, DOI 10.1183/09031936.00096612; Lennon FE, 2011, AM J PHYSIOL-LUNG C, V301, pL137, DOI 10.1152/ajplung.00071.2010; Liang JR, 2011, J ALLERGY CLIN IMMUN, V128, P403, DOI 10.1016/j.jaci.2011.04.006; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Moerloose KB, 2005, AM J RESP CRIT CARE, V172, P168, DOI 10.1164/rccm.200409-1174OC; Molet S, 2001, J ALLERGY CLIN IMMUN, V108, P430, DOI 10.1067/mai.2001.117929; Nakae S, 2002, IMMUNITY, V17, P375, DOI 10.1016/S1074-7613(02)00391-6; Nakano H, 2012, MUCOSAL IMMUNOL, V5, P53, DOI 10.1038/mi.2011.47; NOBLE PW, 1993, J CLIN INVEST, V91, P2368, DOI 10.1172/JCI116469; Pauwels NS, 2011, EUR RESPIR J, V38, P1019, DOI 10.1183/09031936.00158110; Salvi SS, 2001, AM J RESP CRIT CARE, V164, P1343, DOI 10.1164/ajrccm.164.8.2103080; Schnyder-Candrian S, 2006, J EXP MED, V203, P2715, DOI 10.1084/jem.20061401; Scott DA, 2000, BIOMARKERS, V5, P240, DOI 10.1080/135475000230406; Siegelman MH, 1999, J LEUKOCYTE BIOL, V66, P315, DOI 10.1002/jlb.66.2.315; Stapleton M, 2011, J AM BOARD FAM MED, V24, P313, DOI 10.3122/jabfm.2011.03.100180; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; Thomson NC, 2009, CURR OPIN PULM MED, V15, P39, DOI 10.1097/MCP.0b013e32831da894; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Uchakina ON, 2013, CLIN IMMUNOL, V146, P56, DOI 10.1016/j.clim.2012.11.002; van der Windt GJW, 2011, AM J RESP CELL MOL, V44, P377, DOI 10.1165/rcmb.2010-0158OC; van der Windt GJW, 2010, AM J PATHOL, V177, P2483, DOI 10.2353/ajpath.2010.100562; Van Hove CL, 2009, INT ARCH ALLERGY IMM, V149, P195, DOI 10.1159/000199715; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vermaelen K, 2004, CYTOM PART A, V61A, P170, DOI 10.1002/cyto.a.20064; Vermaelen K, 2003, AM J RESP CELL MOL, V29, P405, DOI 10.1165/rcmb.2003-0008OC; Weiss JM, 1997, J CELL BIOL, V137, P1137, DOI 10.1083/jcb.137.5.1137; Willart MAM, 2012, J EXP MED, V209, P1505, DOI 10.1084/jem.20112691	49	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151113	10.1371/journal.pone.0151113	http://dx.doi.org/10.1371/journal.pone.0151113			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999446	Green Submitted, gold, Green Published			2022-12-26	WOS:000372694700022
J	Kim, W; Park, H; Seo, S				Kim, Woonsu; Park, Hyesun; Seo, Seongwon			Global Metabolic Reconstruction and Metabolic Gene Evolution in the Cattle Genome	PLOS ONE			English	Article							MEAT QUALITY TRAITS; SEGMENTAL DUPLICATIONS; BISPHOSPHOGLYCERATE MUTASE; SUPEROXIDE-DISMUTASE; PLACENTAL EXPRESSION; BOVINE; GENERATION; SEQUENCE; DATABASE; GROWTH	The sequence of cattle genome provided a valuable opportunity to systematically link genetic and metabolic traits of cattle. The objectives of this study were 1) to reconstruct genome-scale cattle-specific metabolic pathways based on the most recent and updated cattle genome build and 2) to identify duplicated metabolic genes in the cattle genome for better understanding of metabolic adaptations in cattle. A bioinformatic pipeline of an organism for amalgamating genomic annotations from multiple sources was updated. Using this, an amalgamated cattle genome database based on UMD_3.1, was created. The amalgamated cattle genome database is composed of a total of 33,292 genes: 19,123 consensus genes between NCBI and Ensembl databases, 8,410 and 5,493 genes only found in NCBI or Ensembl, respectively, and 266 genes from NCBI scaffolds. A metabolic reconstruction of the cattle genome and cattle pathway genome database (PGDB) was also developed using Pathway Tools, followed by an intensive manual curation. The manual curation filled or revised 68 pathway holes, deleted 36 metabolic pathways, and added 23 metabolic pathways. Consequently, the curated cattle PGDB contains 304 metabolic pathways, 2,460 reactions including 2,371 enzymatic reactions, and 4,012 enzymes. Furthermore, this study identified eight duplicated genes in 12 metabolic pathways in the cattle genome compared to human and mouse. Some of these duplicated genes are related with specific hormone biosynthesis and detoxifications. The updated genome-scale metabolic reconstruction is a useful tool for understanding biology and metabolic characteristics in cattle. There has been significant improvements in the quality of cattle genome annotations and the MetaCyc database. The duplicated metabolic genes in the cattle genome compared to human and mouse implies evolutionary changes in the cattle genome and provides a useful information for further research on understanding metabolic adaptations of cattle.	[Kim, Woonsu; Park, Hyesun; Seo, Seongwon] Chungnam Natl Univ, Dept Anim Biosyst Sci, Daejeon, South Korea	Chungnam National University	Seo, S (corresponding author), Chungnam Natl Univ, Dept Anim Biosyst Sci, Daejeon, South Korea.	swseo@cnu.kr	Seo, Seongwon/E-9687-2013	Seo, Seongwon/0000-0002-4131-0545	Basic Science Research Program through the National Research Foundation of Korea (NRF) [NRF-2010-0022865]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This research was supported by Basic Science Research Program (NRF-2010-0022865) through the National Research Foundation of Korea (NRF) funded by the Ministry. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala R, 2016, NUCLEIC ACIDS RES, V44, pD7, DOI [10.1093/nar/gkv1290, 10.1093/nar/gku1130]; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; BEITZ DC, 1985, J ANIM SCI, V61, P1; Boeke JD, 1991, CURR OPIN CELL BIOL, V3, P502, DOI 10.1016/0955-0674(91)90079-E; Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkm900, 10.1093/nar/gkt1103]; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Craft CM, 1999, MOL BRAIN RES, V65, P44, DOI 10.1016/S0169-328X(98)00336-2; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Dunner S, 2013, LIVEST SCI, V154, P34, DOI 10.1016/j.livsci.2013.02.020; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Gu M, 2009, PLACENTA, V30, P919, DOI 10.1016/j.placenta.2009.08.005; Guillemin N, 2011, J PROTEOMICS, V75, P352, DOI 10.1016/j.jprot.2011.07.026; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; HODGSON EK, 1975, BIOCHEMISTRY-US, V14, P5294, DOI 10.1021/bi00695a010; Hough MA, 2003, STRUCTURE, V11, P937, DOI 10.1016/S0969-2126(03)00155-2; Hoyer JD, 2004, AM J HEMATOL, V75, P205, DOI 10.1002/ajh.20014; Hubisz MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017034; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Karp PD, 2011, ARCH TOXICOL, V85, P1015, DOI 10.1007/s00204-011-0705-2; Karp PD, 2010, BRIEF BIOINFORM, V11, P40, DOI 10.1093/bib/bbp043; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Kim JJ, 2003, J ANIM SCI, V81, P1933; Klein DC, 2006, CHRONOBIOL INT, V23, P5, DOI 10.1080/07420520500545839; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liu GE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-571; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Meader S, 2010, GENOME RES, V20, P675, DOI 10.1101/gr.096966.109; Mulquiney PJ, 1999, BIOCHEM J, V342, P567, DOI 10.1042/0264-6021:3420567; Oltjen JW, 1996, J ANIM SCI, V74, P1406; Pavlicek J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-154; Poolman MG, 2006, IEE P SYST BIOL, V153, P379, DOI 10.1049/ip-syb:20060012; Pritlove DC, 2006, PLACENTA, V27, P924, DOI 10.1016/j.placenta.2005.08.010; RECNY MA, 1982, J BIOL CHEM, V257, P2878; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scheer Maurice, 2011, Nucleic Acids Res, V39, pD670, DOI 10.1093/nar/gkq1089; Schomerus C, 2004, J NEUROENDOCRINOL, V16, P741, DOI 10.1111/j.1365-2826.2004.01228.x; Seo S, 2013, ANIMAL, V7, P172, DOI 10.1017/S1751731111002588; Seo S, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-33; Sevane N, 2014, MOL BIOL REP, V41, P4721, DOI 10.1007/s11033-014-3343-y; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Temperley ND, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-62; Wang YL, 2004, J BIOL CHEM, V279, P39132, DOI 10.1074/jbc.M405982200; WILLIAMS F, 1961, J BIOL CHEM, V236, pPC36; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	51	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150974	10.1371/journal.pone.0150974	http://dx.doi.org/10.1371/journal.pone.0150974			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992093	Green Published, gold, Green Submitted			2022-12-26	WOS:000372582800040
J	Dries, DR; Zhu, Y; Brooks, MM; Forero, DA; Adachi, M; Cenik, B; West, JM; Han, YH; Yu, C; Arbella, J; Nordin, A; Adolfsson, R; Del-Favero, J; Lu, QR; Callaerts, P; Birnbaum, SG; Yu, G				Dries, Daniel R.; Zhu, Yi; Brooks, Mieu M.; Forero, Diego A.; Adachi, Megumi; Cenik, Basar; West, James M.; Han, Yu-Hong; Yu, Cong; Arbella, Jennifer; Nordin, Annelie; Adolfsson, Rolf; Del-Favero, Jurgen; Lu, Q. Richard; Callaerts, Patrick; Birnbaum, Shari G.; Yu, Gang			Loss of Nicastrin from Oligodendrocytes Results in Hypomyelination and Schizophrenia with Compulsive Behavior	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE; ALZHEIMERS-DISEASE; WHITE-MATTER; MICE; DISORDERS; MATURATION; RECEPTOR; GENE; ASSOCIATION; MOUSE	The biological underpinnings and the pathological lesions of psychiatric disorders are centuries-old questions that have yet to be understood. Recent studies suggest that schizophrenia and related disorders likely have their origins in perturbed neurodevelopment and can result from a large number of common genetic variants or multiple, individually rare genetic alterations. It is thus conceivable that key neurodevelopmental pathways underline the various genetic changes and the still unknown pathological lesions in schizophrenia. Here, we report that mice defective of the nicastrin subunit of gamma-secretase in oligodendrocytes have hypomyelination in the central nervous system. These mice have altered dopamine signaling and display profound abnormal phenotypes reminiscent of schizophrenia. In addition, we identify an association of the nicastrin gene with a human schizophrenia cohort. These observations implicate gamma-secretase and its mediated neurodevelopmental pathways in schizophrenia and provide support for the "myelination hypothesis" of the disease. Moreover, by showing that schizophrenia and obsessive-compulsive symptoms could be modeled in animals wherein a single genetic factor is altered, our work provides a biological basis that schizophrenia with obsessive-compulsive disorder is a distinct subtype of schizophrenia.	[Dries, Daniel R.; Zhu, Yi; Brooks, Mieu M.; Cenik, Basar; West, James M.; Han, Yu-Hong; Yu, Cong; Yu, Gang] Univ Texas SW Med Ctr Dallas, Dept Neurosci, 6000 Harry Hines Blvd, Dallas, TX 75390 USA; [Adachi, Megumi; Birnbaum, Shari G.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Lu, Q. Richard] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Dries, Daniel R.; Arbella, Jennifer] Juniata Coll, Dept Chem, Huntingdon, PA 16652 USA; [Forero, Diego A.] Univ Antonio Narino, Sch Med, Biomed Sci Res Grp, Lab NeuroPsychiat Genet, Bogota 3794, Colombia; [Nordin, Annelie; Adolfsson, Rolf] Umea Univ, Dept Clin Sci, Div Psychiat, SE-90187 Umea, Sweden; [Del-Favero, Jurgen] Univ Antwerp, VIB Dept Mol Genet, Appl Mol Genom Unit, B-2610 Antwerp, Belgium; [Lu, Q. Richard] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Cincinnati, OH 45229 USA; [Callaerts, Patrick] Katholieke Univ Leuven, VIB Ctr Biol Dis, Ctr Human Genet, Lab Behav & Dev Genet, B-3000 Leuven, Belgium	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Universidad Antonio Narino; Umea University; Flanders Institute for Biotechnology (VIB); University of Antwerp; Cincinnati Children's Hospital Medical Center; Flanders Institute for Biotechnology (VIB); KU Leuven	Yu, G (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.	gang.yu@utsouthwestern.edu	Forero, Diego A./O-9981-2019; Callaerts, Patrick/I-8118-2013; Forero, Diego/GPX-2849-2022; Adachi, Megumi/M-7746-2017	Forero, Diego A./0000-0001-9175-3363; Forero, Diego/0000-0001-9175-3363; Adachi, Megumi/0000-0003-3404-6640; Callaerts, Patrick/0000-0003-4530-4561; Adolfsson, Rolf/0000-0001-9785-8473; /0000-0002-8114-7615	National Institute of Neurological Disorders and Stroke [R01 NS079796]; National Institute on Aging [F32 AG031625]; Hartwell Foundation; Fund for Scientific Research Flanders; Industrial Research Fund; University of Antwerp, Belgium; Swedish Medical Research Council [K2001-21X-10412-09A]; County Council of Vasterbotten and Norrbotten, Sweden; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS072427, R37NS096359, R01NS075243, R01NS079796] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG031625] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Hartwell Foundation; Fund for Scientific Research Flanders(FWO); Industrial Research Fund; University of Antwerp, Belgium; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); County Council of Vasterbotten and Norrbotten, Sweden; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institute of Neurological Disorders and Stroke Grant R01 NS079796, by the National Institute on Aging Grant F32 AG031625), by the Hartwell Foundation, by the Fund for Scientific Research Flanders, by the Industrial Research Fund, by the Special Research Fund of the University of Antwerp, Belgium, by Swedish Medical Research Council Grant K2001-21X-10412-09A, and the County Council of Vasterbotten and Norrbotten, Sweden. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Autry AE, 2011, NATURE, V475, P91, DOI 10.1038/nature10130; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BERRIOS GE, 1989, COMPR PSYCHIAT, V30, P283, DOI 10.1016/0010-440X(89)90052-7; Blobel CR, 2009, EXP CELL RES, V315, P671, DOI 10.1016/j.yexcr.2008.10.011; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Bottas A, 2005, J PSYCHIATR NEUROSCI, V30, P187; Buckley PF, 2009, SCHIZOPHRENIA BULL, V35, P383, DOI 10.1093/schbul/sbn135; Casey BJ, 2013, ANNU REV MED, V64, P427, DOI 10.1146/annurev-med-052611-130408; Coolen MW, 2005, NEURON, V45, P497, DOI 10.1016/j.neuron.2004.12.054; De Strooper B, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006304; Dejaegere T, 2008, P NATL ACAD SCI USA, V105, P9775, DOI 10.1073/pnas.0800507105; Dries DR, 2008, CURR ALZHEIMER RES, V5, P132, DOI 10.2174/156720508783954695; Dries DR, 2009, J BIOL CHEM, V284, P29714, DOI 10.1074/jbc.M109.038737; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Fields RD, 2008, TRENDS NEUROSCI, V31, P361, DOI 10.1016/j.tins.2008.04.001; Greer JM, 2002, NEURON, V33, P23, DOI 10.1016/S0896-6273(01)00564-5; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Jaaro-Peled H, 2009, TRENDS NEUROSCI, V32, P485, DOI 10.1016/j.tins.2009.05.007; Kuroda K, 2011, HUM MOL GENET, V20, P4666, DOI 10.1093/hmg/ddr400; Lai C, 2004, BIOCHEM BIOPH RES CO, V314, P535, DOI 10.1016/j.bbrc.2003.12.131; Meier IB, 2012, J INT NEUROPSYCH SOC, V18, P414, DOI 10.1017/S1355617712000227; Mi S, 2011, NAT MED, V17, P816, DOI 10.1038/nm.2373; Murray PS, 2012, NEUROBIOL AGING, V33, P2807, DOI 10.1016/j.neurobiolaging.2012.02.015; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; Nieuwenhuis S, 2011, NAT NEUROSCI, V14, P1105, DOI 10.1038/nn.2886; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Romberg C, 2013, BRAIN RES BULL, V92, P49, DOI 10.1016/j.brainresbull.2012.02.007; Roy K, 2007, P NATL ACAD SCI USA, V104, P8131, DOI 10.1073/pnas.0702157104; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Shmelkov SV, 2010, NAT MED, V16, P598, DOI 10.1038/nm.2125; Simon VM, 2000, EUR NEUROPSYCHOPHARM, V10, P159, DOI 10.1016/S0924-977X(00)00070-5; Spalletta G, 2012, J ALZHEIMERS DIS, V29, P761, DOI 10.3233/JAD-2012-111886; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Tabuchi K, 2009, J NEUROSCI, V29, P7290, DOI 10.1523/JNEUROSCI.1320-09.2009; Takahashi N, 2011, PROG NEUROBIOL, V93, P13, DOI 10.1016/j.pneurobio.2010.09.004; Venken T, 2007, HUM MUTAT, V28, P1156, DOI 10.1002/humu.20582; Wang BX, 2010, SCIENCE, V330, P1065, DOI 10.1126/science.1196284; Welch JM, 2007, NATURE, V448, P894, DOI 10.1038/nature06104; Xin M, 2005, J NEUROSCI, V25, P1354, DOI 10.1523/JNEUROSCI.3034-04.2005; Young-Pearse TL, 2010, J NEUROSCI, V30, P10431, DOI 10.1523/JNEUROSCI.1445-10.2010; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	48	10	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11647	11656		10.1074/jbc.M116.715078	http://dx.doi.org/10.1074/jbc.M116.715078			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	27008863	Green Published, hybrid			2022-12-26	WOS:000377264800016
J	He, L; Chang, E; Peng, J; An, H; McMillin, SM; Radovick, S; Stratakis, CA; Wondisford, FE				He, Ling; Chang, Evan; Peng, Jinghua; An, Hongying; McMillin, Sara M.; Radovick, Sally; Stratakis, Constantine A.; Wondisford, Fredric E.			Activation of the cAMP-PKA pathway Antagonizes Metformin Suppression of Hepatic Glucose Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; GENETIC-VARIATION; COACTIVATOR P300; AMPK ACTIVATION; GLUCAGON; ALPHA; PHOSPHORYLATION; HYPERGLYCEMIA; HYPERGLUCAGONEMIA; GLUCONEOGENESIS	Metformin is the most commonly prescribed oral anti-diabetic agent worldwide. Surprisingly, about 35% of diabetic patients either lack or have a delayed response to metformin treatment, and many patients become less responsive to metformin over time. It remains unknown how metformin resistance or insensitivity occurs. Recently, we found that therapeutic metformin concentrations suppressed glucose production in primary hepatocytes through AMPK; activation of the cAMP-PKA pathway negatively regulates AMPK activity by phosphorylating AMPK alpha subunit at Ser-485, which in turn reduces AMPK activity. In this study, we find that metformin failed to suppress glucose production in primary hepatocytes with constitutively activated PKA and did not improve hyperglycemia in mice with hyperglucagonemia. Expression of the AMPK alpha 1(S485A) mutant, which is unable to be phosphorylated by PKA, increased both AMPK alpha activation and the suppression of glucose production in primary hepatocytes treated with metformin. Intriguingly, salicylate/aspirin prevents the phosphorylation of AMPK alpha at Ser-485, blocks cAMP-PKA negative regulation of AMPK, and improves metformin resistance. We propose that aspirin/salicylate may augment metformin's hepatic action to suppress glucose production.	[He, Ling; Chang, Evan; Peng, Jinghua; An, Hongying] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Metab, Baltimore, MD 21287 USA; [McMillin, Sara M.; Wondisford, Fredric E.] Rutgers Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08901 USA; [Radovick, Sally] Rutgers Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ 08901 USA; [Stratakis, Constantine A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Endocrinol & Genet, Bethesda, MD 20892 USA	Johns Hopkins University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	He, L (corresponding author), Div Metab, 600 N Wolfe St,CMSC10-113, Baltimore, MD 21287 USA.	heling@jhmi.edu	Stratakis, Constantine/AAP-4745-2020		National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health [R00DK085142, R01DK107641, R01DK063349]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK085142, R01DK063349, R01DK107641] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institutes of Health: R00DK085142 (to L. H.), R01DK107641 (to L. H.), and R01DK063349 (to F. E. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	An HY, 2016, J ENDOCRINOL, V228, pR97, DOI 10.1530/JOE-15-0447; Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; BARON AD, 1987, DIABETES, V36, P274, DOI 10.2337/diabetes.36.3.274; Burcelin R, 1996, DIABETES METAB, V22, P373; Cao J, 2014, J BIOL CHEM, V289, P20435, DOI 10.1074/jbc.M114.567271; CONSOLI A, 1992, DIABETES CARE, V15, P430, DOI 10.2337/diacare.15.3.430; Cook MN, 2007, DIABETIC MED, V24, P350, DOI 10.1111/j.1464-5491.2007.02078.x; Djouder N, 2010, EMBO J, V29, P469, DOI 10.1038/emboj.2009.339; Ford RJ, 2015, BIOCHEM J, V468, P125, DOI 10.1042/BJ20150125; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; He L, 2014, J ENDOCRINOL, V221, P363, DOI 10.1530/JOE-14-0084; He L, 2012, J BIOL CHEM, V287, P32069, DOI 10.1074/jbc.M112.385864; He L, 2009, CELL, V137, P635, DOI 10.1016/j.cell.2009.03.016; HERMANN LS, 1990, DIABETES CARE, V13, P37, DOI 10.2337/diacare.13.3.37; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; Hurley RL, 2006, J BIOL CHEM, V281, P36662, DOI 10.1074/jbc.M606676200; Inzucchi SE, 2012, DIABETES CARE, V35, P1364, DOI 10.2337/dc12-0413; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kirschner LS, 2005, CANCER RES, V65, P4506, DOI 10.1158/0008-5472.CAN-05-0580; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Meng SM, 2015, J BIOL CHEM, V290, P3793, DOI 10.1074/jbc.M114.604421; MILLER JD, 1983, DIABETES, V32, P439, DOI 10.2337/diabetes.32.5.439; Ning JY, 2011, ENDOCRINOLOGY, V152, P3143, DOI 10.1210/en.2011-0155; Pawlyk AC, 2014, DIABETES, V63, P2590, DOI 10.2337/db13-1367; REAVEN GM, 1987, J CLIN ENDOCR METAB, V64, P106, DOI 10.1210/jcem-64-1-106; Shu Y, 2008, CLIN PHARMACOL THER, V83, P273, DOI 10.1038/sj.clpt.6100275; Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558; Song WJ, 2011, CELL METAB, V13, P308, DOI 10.1016/j.cmet.2011.02.002; UNGER RH, 1970, J CLIN INVEST, V49, P837, DOI 10.1172/JCI106297; UNGER RH, 1985, DIABETOLOGIA, V28, P574, DOI 10.1007/BF00281991; Webb GC, 2002, DIABETES, V51, P398, DOI 10.2337/diabetes.51.2.398; Witters LA, 2001, J CLIN INVEST, V108, P1105, DOI 10.1172/JCI200114178; Wondisford AR, 2014, J BIOL CHEM, V289, P4326, DOI 10.1074/jbc.M113.540500; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	35	26	27	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10562	10570		10.1074/jbc.M116.719666	http://dx.doi.org/10.1074/jbc.M116.719666			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27002150	Green Published, hybrid			2022-12-26	WOS:000377042600011
J	Bilardi, J; Walker, S; McNair, R; Mooney-Somers, J; Temple-Smith, M; Bellhouse, C; Fairley, C; Chen, M; Bradshaw, C				Bilardi, Jade; Walker, Sandra; McNair, Ruth; Mooney-Somers, Julie; Temple-Smith, Meredith; Bellhouse, Clare; Fairley, Christopher; Chen, Marcus; Bradshaw, Catriona			Women's Management of Recurrent Bacterial Vaginosis and Experiences of Clinical Care: A Qualitative Study	PLOS ONE			English	Article							OVER-THE-COUNTER; PRETERM DELIVERY; GENITAL-TRACT; PREVALENCE; LESBIANS; INFECTION; BEHAVIORS; SEX	Background Few data are available on how women manage recurring bacterial vaginosis (BV) and their experiences of the clinical care of this condition. This study aimed to explore women's recurrent BV management approaches and clinical care experiences, with a view to informing and improving the clinical management of BV. Methods A descriptive, social constructionist approach was chosen as the framework for the study. Thirty-five women of varying sexual orientation who had experienced recurrent BV in the past 5 years took part in semi-structured interviews. Results The majority of women reported frustration and dissatisfaction with current treatment regimens and low levels of satisfaction with the clinical management of BV. Overall, women disliked taking antibiotics regularly, commonly experienced adverse side effects from treatment and felt frustrated at having symptoms recur quite quickly after treatment. Issues in clinical care included inconsistency in advice, misdiagnosis and inappropriate diagnostic approaches and insensitive or dismissive attitudes. Women were more inclined to report positive clinical experiences with sexual health physicians than primary care providers. Women's frustrations led most to try their own self-help remedies and lifestyle modifications in an attempt to treat symptoms and prevent recurrences, including well-known risk practices such as douching. Conclusion In the face of considerable uncertainty about the cause of BV, high rates of recurrence, unacceptable treatment options and often insensitive and inconsistent clinical management, women are trying their own self-help remedies and lifestyle modifications to prevent recurrences, often with little effect. Clinical management of BV could be improved through the use of standardised diagnostic approaches, increased sensitivity and understanding of the impact of BV, and the provision of evidence based advice about known BV related risk factors.	[Bilardi, Jade; Walker, Sandra; Bellhouse, Clare; Fairley, Christopher; Chen, Marcus; Bradshaw, Catriona] Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia; [Bilardi, Jade; Walker, Sandra; Bellhouse, Clare; Fairley, Christopher; Chen, Marcus; Bradshaw, Catriona] Alfred Hosp, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Bilardi, Jade; McNair, Ruth; Temple-Smith, Meredith] Univ Melbourne, Dept Gen Practice, Melbourne, Vic, Australia; [Mooney-Somers, Julie] Univ Sydney, Ctr Values Eth & Law Med, Sydney, NSW 2006, Australia; [Bradshaw, Catriona] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia	Monash University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Sydney; University of Melbourne	Bilardi, J (corresponding author), Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia.; Bilardi, J (corresponding author), Alfred Hosp, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia.; Bilardi, J (corresponding author), Univ Melbourne, Dept Gen Practice, Melbourne, Vic, Australia.	jbilardi@mshc.org.au	McNair, Ruth P/B-3027-2012; Mooney-Somers, Julie/D-1824-2010	Christopher, Fairley/0000-0001-9081-1664; Mooney-Somers, Julie/0000-0003-4047-3403; McNair, Ruth/0000-0002-4738-8781; Bilardi, Jade/0000-0003-0461-2605; bradshaw, catriona/0000-0002-6643-5678	National Health and Medical Research Council [1013135]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Dr. Jade Bilardi is in receipt of a National Health and Medical Research Council Early Career Fellowship (No. 1013135).	Allsworth JE, 2007, OBSTET GYNECOL, V109, P114, DOI 10.1097/01.AOG.0000247627.84791.91; Anderson Matthew R, 2005, MedGenMed, V7, P61; Bailey JV, 2004, SEX TRANSM DIS, V31, P691, DOI 10.1097/01.olq.0000143093.70899.68; Berger BJ, 1995, CLIN INFECT DIS, V21, P1402, DOI 10.1093/clinids/21.6.1402; Bilardi J, 2015, WORLD STI HIV 2015 C; Bilardi JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074378; Boskey ER, 2005, ALTERN THER HEALTH M, V11, P38; Bradshaw CS, 2014, J INFECT DIS, V209, P1562, DOI 10.1093/infdis/jit664; Bradshaw CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057688; Bradshaw CS, 2006, J INFECT DIS, V193, P1478, DOI 10.1086/503780; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Centers for Disease control and Prevention, BACT VAG CDC FACT SH; Chapple A, 2000, J REPROD INFANT PSYC, V18, P309, DOI 10.1080/713683045; EASMON CSF, 1992, GENITOURIN MED, V68, P134; Eschenbach DA, 2007, CLIN INFECT DIS, V44, P220, DOI 10.1086/509584; Evans AL, 2007, SEX TRANSM INFECT, V83, P470, DOI 10.1136/sti.2006.022277; Ferris DG, 2002, OBSTET GYNECOL, V99, P419, DOI 10.1016/S0029-7844(01)01759-8; Fethers K, 2000, SEX TRANSM INFECT, V76, P345, DOI 10.1136/sti.76.5.345; Gribch C, 2013, QUALITATIVE DATA ANA; Guedou FA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-208; HAY PE, 1994, BRIT MED J, V308, P295, DOI 10.1136/bmj.308.6924.295; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; Holzman C, 2001, AM J PUBLIC HEALTH, V91, P1664, DOI 10.2105/AJPH.91.10.1664; Hutchinson KB, 2007, SEX TRANSM DIS, V34, P671, DOI 10.1097/01.olq.0000258435.34879.da; Irving G, 1998, SEX TRANSM INFECT, V74, P334, DOI 10.1136/sti.74.5.334; Johnson SR, 2010, J LOW GENIT TRACT DI, V14, P287, DOI 10.1097/LGT.0b013e3181d85bb7; Karasz A, 2003, SOC SCI MED, V56, P1013, DOI 10.1016/S0277-9536(02)00092-8; Klebanoff MA, 2010, SEX TRANSM DIS, V37, P94, DOI 10.1097/OLQ.0b013e3181bc063c; Lamont RF, 2000, INT J STD AIDS, V11, P495, DOI 10.1258/0956462001916371; Landers DV, 2004, AM J OBSTET GYNECOL, V190, P1004, DOI 10.1016/j.ajog.2004.02.015; Langsford MJ, 2001, FAM PRACT, V18, P253, DOI 10.1093/fampra/18.3.253; Marrazzo JM, 2010, SEX TRANSM DIS, V37, P335, DOI 10.1097/OLQ.0b013e3181ca3cac; Nyirjesy P, 1997, OBSTET GYNECOL, V90, P50, DOI 10.1016/S0029-7844(97)00242-1; ODowd T, 1996, BRIT J GEN PRACT, V46, P415; Parma M, 2014, ALTERN THER HEALTH M, V20, P52; Payne SC, 2010, J AM ACAD NURSE PRAC, V22, P101, DOI 10.1111/j.1745-7599.2009.00474.x; Schwiertz Andreas, 2006, Ann Clin Microbiol Antimicrob, V5, P4, DOI 10.1186/1476-0711-5-4; Sewankambo N, 1997, LANCET, V350, P546, DOI 10.1016/S0140-6736(97)01063-5; Sobel JD, 1997, NEW ENGL J MED, V337, P1896, DOI 10.1056/NEJM199712253372607; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Verstraelen H, 2009, BACT VAG UPD DIAGN T; Wiesenfeld HC, 1999, AM J OBSTET GYNECOL, V181, P39, DOI 10.1016/S0002-9378(99)70433-3	42	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151794	10.1371/journal.pone.0151794	http://dx.doi.org/10.1371/journal.pone.0151794			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3SV	27010725	Green Published, gold			2022-12-26	WOS:000372708000045
J	Jitoboam, K; Phaonakrop, N; Libsittikul, S; Thepparit, C; Roytrakul, S; Smith, DR				Jitoboam, Kunlakanya; Phaonakrop, Narumon; Libsittikul, Sirikwan; Thepparit, Chutima; Roytrakul, Sittiruk; Smith, Duncan R.			Actin Interacts with Dengue Virus 2 and 4 Envelope Proteins	PLOS ONE			English	Article							HOST-CELLS; IDENTIFICATION; ENTRY; RECEPTOR; BINDING; GLYCOPROTEIN; INFECTION; COLOCALIZATION; ORGANIZATION; REPLICATION	Dengue virus (DENV) remains a significant public health problem in many tropical and subtropical countries worldwide. The DENV envelope (E) protein is the major antigenic determinant and the protein that mediates receptor binding and endosomal fusion. In contrast to some other DENV proteins, relatively few cellular interacting proteins have been identified. To address this issue a co-immuoprecipitation strategy was employed. The predominant co-immunoprecipitating proteins identified were actin and actin related proteins, however the results suggested that actin was the only bona fide interacting partner. Actin was shown to interact with the E protein of DENV 2 and 4, and the interaction between actin and DENV E protein was shown to occur in a truncated DENV consisting of only domains I and II. Actin was shown to decrease during infection, but this was not associated with a decrease in gene transcription. Actin-related proteins also showed a decrease in expression during infection that was not transcriptionally regulated. Cytoskeletal reorganization was not observed during infection, suggesting that the interaction between actin and E protein has a cell type specific component.	[Jitoboam, Kunlakanya; Libsittikul, Sirikwan; Thepparit, Chutima; Smith, Duncan R.] Mahidol Univ, Inst Mol Biosci, Salaya Campus,25-25 Phuttamonton Sai 4, Salaya, Nakorn Pathom, Thailand; [Phaonakrop, Narumon; Roytrakul, Sittiruk] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, 113 Thailand Sci Pk,Phahonyothin Rd, Khlong Luang, Pathum Thani, Thailand; [Smith, Duncan R.] Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Salaya Campus,25-25 Phuttamonton Sai 4, Salaya, Nakorn Pathom, Thailand	Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University	Smith, DR (corresponding author), Mahidol Univ, Inst Mol Biosci, Salaya Campus,25-25 Phuttamonton Sai 4, Salaya, Nakorn Pathom, Thailand.; Smith, DR (corresponding author), Mahidol Univ, Ctr Emerging & Neglected Infect Dis, Salaya Campus,25-25 Phuttamonton Sai 4, Salaya, Nakorn Pathom, Thailand.	duncan_r_smith@hotmail.com	Smith, Duncan R/C-6891-2011; Thepparit, Chutima/GLN-5662-2022	Smith, Duncan R/0000-0002-6592-9852; Roytrakul, Sittiruk/0000-0003-3696-8390	Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Thailand Research Fund [RTA5780009, IRG5780009]; Mahidol University; Royal Golden Jubilee PhD Scholarship; Thailand Graduate Institute of Science and Technology (TGIST)	Office of the Higher Education Commission; Mahidol University under the National Research Universities Initiative; Thailand Research Fund(Thailand Research Fund (TRF)); Mahidol University; Royal Golden Jubilee PhD Scholarship; Thailand Graduate Institute of Science and Technology (TGIST)	This work was supported by grants from the Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative, the Thailand Research Fund (RTA5780009 and IRG5780009) and Mahidol University. KJ is supported by a Royal Golden Jubilee PhD Scholarship, SL is supported by a Thailand Graduate Institute of Science and Technology (TGIST) Ph.D. scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Acosta EG, 2008, J GEN VIROL, V89, P474, DOI 10.1099/vir.0.83357-0; Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Choukhi A, 1998, J VIROL, V72, P3851, DOI 10.1128/JVI.72.5.3851-3858.1998; Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004; Fischl W, 2011, CURR OPIN MICROBIOL, V14, P470, DOI 10.1016/j.mib.2011.07.012; French AP, 2008, NAT PROTOC, V3, P619, DOI 10.1038/nprot.2008.31; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; HENCHAL EA, 1985, AM J TROP MED HYG, V34, P162, DOI 10.4269/ajtmh.1985.34.162; Huerta V, 2016, J PROTEOMICS, V131, P205, DOI 10.1016/j.jprot.2015.11.003; Jindadamrongwech S, 2004, ARCH VIROL, V149, P915, DOI 10.1007/s00705-003-0263-x; Jirakanwisal K, 2015, COMP IMMUNOL MICROB, V43, P28, DOI 10.1016/j.cimid.2015.10.001; Kanlaya R, 2009, J PROTEOME RES, V8, P2551, DOI 10.1021/pr900060g; Klomporn P, 2011, VIROLOGY, V409, P189, DOI 10.1016/j.virol.2010.10.010; Kuadkitkan A, 2010, VIROLOGY, V406, P149, DOI 10.1016/j.virol.2010.07.015; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Leecharoenkiat A, 2011, BLOOD CELL MOL DIS, V47, P143, DOI 10.1016/j.bcmd.2011.06.005; Limjindaporn T, 2009, BIOCHEM BIOPH RES CO, V379, P196, DOI 10.1016/j.bbrc.2008.12.070; Mairiang D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053535; MANDL CW, 1989, J VIROL, V63, P564, DOI 10.1128/JVI.63.2.564-571.1989; Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100; Otteken A, 1996, J BIOL CHEM, V271, P97, DOI 10.1074/jbc.271.1.97; Panyasrivanit M, 2009, J GEN VIROL, V90, P448, DOI 10.1099/vir.0.005355-0; Rattanachuen W, 2011, AFR J MICROBIOL RES, V5, P117; Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z; Rungruengphol C, 2015, MICROB PATHOGENESIS, V86, P18, DOI 10.1016/j.micpath.2015.07.003; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Sithisarn P, 2003, J MED VIROL, V71, P532, DOI 10.1002/jmv.10520; Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160; Smith DR, 2012, INSECT MOL BIOL, V21, P1, DOI 10.1111/j.1365-2583.2011.01098.x; Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004; Upanan S, 2008, J VIROL METHODS, V151, P325, DOI 10.1016/j.jviromet.2008.05.001; Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005; Wang Jue, 2010, Sarcoma, V2010, P454792, DOI 10.1155/2010/454792; Yang J, 2013, MICROBES INFECT, V15, P310, DOI 10.1016/j.micinf.2013.01.004	37	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151951	10.1371/journal.pone.0151951	http://dx.doi.org/10.1371/journal.pone.0151951			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010925	gold, Green Published, Green Submitted			2022-12-26	WOS:000372708000059
J	Liu, AF; Zhao, FB; Wang, J; Zhao, Y; Luo, ZZ; Gao, Y; Shi, J				Liu, Aifen; Zhao, Fengbo; Wang, Jing; Zhao, Yin; Luo, Zhenzhao; Gao, Yan; Shi, Jing			Regulation of TRPM7 Function by IL-6 through the JAK2-STAT3 Signaling Pathway	PLOS ONE			English	Article							SOLUBLE INTERLEUKIN-6; CHANNEL ACTIVITY; NEURONAL DEATH; RECEPTOR; KINASE; PROTEIN; CELLS; APOPTOSIS; MAGNESIUM; GP130	Aims Previous studies have demonstrated that expression of the TRPM7 channel, which may induce delayed cell death by mediating calcium influx, is precisely regulated. However, functional regulation of TRPM7 channels by endogenous molecules has not been elucidated. The proinflammatory cytokine IL-6 contributes to regulation of Ca2+ influx in cerebral ischemia, but the role of IL-6 in regulating TRPM7 functioning is unknown. Thus, we here investigated the interaction between IL-6 and TRPM7 channels and the relevant mechanisms. Materials and Methods Using whole-cell patch-clamping, we first investigated the effect of IL-6 on TRPM7-like currents in primary cultured cortical neurons. Next, TRPM7-overexpressing HEK293 cells were used to confirm the effect of IL-6/sIL-6R on TRPM7. Finally, we used specific signaling pathway inhibitors to investigate the signaling pathways involved. Results IL-6 or IL-6/sIL-6R dose-dependently inhibited inward TRPM7 currents, in both primary cultured neurons and HEK293 cells overexpressing TRPM7. In intracellular Mg2+-free conditions, extracellular Ca2+ or the a-kinase domain of TRPM7 did not participate in this regulation. The inhibitory effect of IL-6 on TRPM7 could be blocked by specific inhibitors of the JAK2-STAT3 pathway, but not of the PI3K, ERK1/2, or PLC pathways. Conclusions IL-6 inhibits the inward TRPM7 current via the JAK2-STAT3 signaling pathway.	[Liu, Aifen; Zhao, Fengbo; Wang, Jing; Zhao, Yin; Luo, Zhenzhao; Gao, Yan; Shi, Jing] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Neurobiol, Wuhan 430074, Hubei, Peoples R China; [Liu, Aifen; Zhao, Fengbo] Nantong Univ, Basic Med Res Ctr, Coll Med, Nantong, Jiangsu, Peoples R China	Huazhong University of Science & Technology; Nantong University	Shi, J (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Neurobiol, Wuhan 430074, Hubei, Peoples R China.	sj@mails.tjmu.edu.cn	Zhao, Yin/AAA-5891-2019		National Natural Science Foundation of China [31171029, 31471015, 81300564]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China [31171029 to JS, 31471015 to JS, and 81300564 to AL].; We thank Loren W. Runnels (Department of Pharmacology, Rutgers-Robert Wood Johnson Medical School, Piscataway, NJ, USA) for the gift of the expression vectors (pcDNA5/FRT/TO) containing amino-terminal hemagglutinin (HA)-tagged murine TRPM7 or TRPM Delta Kin, which was produced by changing the TCG codon, encoding serine 1501, into a stop codon. This study was supported by grants 31171029, 31471015 and 81300564 from the National Natural Science Foundation of China.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Bhavsar SK, 2014, AM J PHYSIOL-CELL PH, V306, pC374, DOI 10.1152/ajpcell.00320.2013; Chokshi R, 2012, AM J PHYSIOL-CELL PH, V302, pC1004, DOI 10.1152/ajpcell.00422.2011; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Hosseinzadeh Z, 2014, AM J PHYSIOL-CELL PH, V306, pC1041, DOI 10.1152/ajpcell.00209.2013; Hosseinzadeh Z, 2011, CELL PHYSIOL BIOCHEM, V28, P693, DOI 10.1159/000335763; Inoue K, 2009, CARDIOVASC RES, V83, P547, DOI 10.1093/cvr/cvp153; Jiang XP, 2003, J BIOL CHEM, V278, P42867, DOI 10.1074/jbc.M304487200; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Kallen KJ, 2002, BBA-MOL CELL RES, V1592, P323, DOI 10.1016/S0167-4889(02)00325-7; Kollet O, 1999, BLOOD, V94, P923, DOI 10.1182/blood.V94.3.923.415k08_923_931; Kraakman MJ, 2015, CELL METAB, V21, P403, DOI 10.1016/j.cmet.2015.02.006; Langeslag M, 2007, J BIOL CHEM, V282, P232, DOI 10.1074/jbc.M605300200; Li CK, 2015, EXPERT OPIN THER TAR, V19, P879, DOI 10.1517/14728222.2015.1021781; Li XN, 2014, ACTA NEUROPSYCHIATR, V26, P170, DOI 10.1017/neu.2013.49; Ma SH, 2012, J PHYSIOL SCI, V62, P385, DOI 10.1007/s12576-012-0215-x; Matsushita M, 2005, J BIOL CHEM, V280, P20793, DOI 10.1074/jbc.M413671200; Muller-Newen G, 1998, J IMMUNOL, V161, P6347; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nelson TE, 2004, EUR J NEUROSCI, V20, P2387, DOI 10.1111/j.1460-9568.2004.03706.x; NOVICK D, 1992, CYTOKINE, V4, P6, DOI 10.1016/1043-4666(92)90029-Q; Peng YP, 2005, NEUROSCI LETT, V374, P192, DOI 10.1016/j.neulet.2004.10.069; Qiu AW, 2013, NEUROENDOCRINOL LETT, V34, P529; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Ryazanov AG, 2002, FEBS LETT, V514, P26, DOI 10.1016/S0014-5793(02)02299-8; Sanchez RN, 2003, INVEST OPHTH VIS SCI, V44, P4006, DOI 10.1167/iovs.03-0040; Shimizu S, 2014, EUR J PHARMACOL, V742, P22, DOI 10.1016/j.ejphar.2014.08.023; Strassburger M, 2008, EUR J PHARMACOL, V592, P55, DOI 10.1016/j.ejphar.2008.06.099; Suzuki S, 2009, J CEREBR BLOOD F MET, V29, P464, DOI 10.1038/jcbfm.2008.141; Takahashi E, 2004, CIRC RES, V94, P1242, DOI 10.1161/01.RES.0000126405.38858.BC; Takezawa R, 2004, P NATL ACAD SCI USA, V101, P6009, DOI 10.1073/pnas.0307565101; TAMURA T, 1993, P NATL ACAD SCI USA, V90, P11924, DOI 10.1073/pnas.90.24.11924; Tian SL, 2007, NEUROSCI LETT, V419, P93, DOI 10.1016/j.neulet.2007.04.020; Wei WL, 2007, P NATL ACAD SCI USA, V104, P16323, DOI 10.1073/pnas.0701149104; Wolf FI, 2010, CELL CYCLE, V9, P3399, DOI 10.4161/cc.9.17.13072; Xia W, 2015, NEURAL REGEN RES, V10, P610, DOI 10.4103/1673-5374.155436; Yao X, 2014, PHARMACOL THERAPEUT, V141, P125, DOI 10.1016/j.pharmthera.2013.09.004; Yee NS, 2011, DIS MODEL MECH, V4, P240, DOI 10.1242/dmm.004564; Zeng Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119912; Zhang J, 2011, J BIOL CHEM, V286, P20194, DOI 10.1074/jbc.M110.148494; Zhao Y, 2015, MOL NEUROBIOL, V51, P729, DOI 10.1007/s12035-014-8781-y	44	11	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152120	10.1371/journal.pone.0152120	http://dx.doi.org/10.1371/journal.pone.0152120			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010689	Green Submitted, Green Published, gold			2022-12-26	WOS:000372708000093
J	Shridhar, PB; Noll, LW; Shi, XR; Cernicchiaro, N; Renter, DG; Bai, J; Nagaraja, TG				Shridhar, Pragathi B.; Noll, Lance W.; Shi, Xiaorong; Cernicchiaro, Natalia; Renter, David G.; Bai, J.; Nagaraja, T. G.			Escherichia coli O104 in Feedlot Cattle Feces: Prevalence, Isolation and Characterization	PLOS ONE			English	Article							MULTIPLEX PCR; VIRULENCE FACTORS; STRAINS; OUTBREAK; GENES; IDENTIFICATION; EXPRESSION; SEROTYPES; SEQUENCE; GERMANY	Escherichia coli O104:H4, an hybrid pathotype of Shiga toxigenic and enteroaggregative E. coli, involved in a major foodborne outbreak in Germany in 2011, has not been detected in cattle feces. Serogroup O104 with H type other than H4 has been reported to cause human illnesses, but their prevalence and characteristics in cattle have not been reported. Our objectives were to determine the prevalence of E. coli O104 in feces of feedlot cattle, by culture and PCR detection methods, and characterize the isolated strains. Rectal fecal samples from a total of 757 cattle originating from 29 feedlots were collected at a Midwest commercial slaughter plant. Fecal samples, enriched in E. coli broth, were subjected to culture and PCR methods of detection. The culture method involved immunomagnetic separation with O104-specific beads and plating on a selective chromogenic medium, followed by serogroup confirmation of pooled colonies by PCR. If pooled colonies were positive for the wzx(O104) gene, then colonies were tested individually to identify wzx(O104)-positive serogroup and associated genes of the hybrid strains. Extracted DNA from feces were also tested by a multiplex PCR to detect wzx(O104)-positive serogroup and associated major genes of the O104 hybrid pathotype. Because wzx(O104) has been shown to be present in E. coli O8/O9/O9a, wzx(O104)-positive isolates and extracted DNA from fecal samples were also tested by a PCR targeting wbdD(O8/O9/O9a), a gene specific for E. coli O8/O9/O9a serogroups. Model-adjusted prevalence estimates of E. coli O104 (positive for wzx(O104) and negative for wbdD(O8/O9/O9a)) at the feedlot level were 5.7% and 21.2%, and at the sample level were 0.5% and 25.9% by culture and PCR, respectively. The McNemar's test indicated that there was a significant difference (P < 0.01) between the proportions of samples that tested positive for wzx(O104) and samples that were positive for wzx(O104), but negative for wbdD(O8/O9/O9a) by PCR and culture methods. A total of 143 isolates, positive for the wzx(O104), were obtained in pure culture from 146 positive fecal samples. Ninety-two of the 143 isolates (64.3%) also tested positive for the wbdD(O8/O9/O9a), indicating that only 51 (35.7%) isolates truly belonged to the O104 serogroup (positive for wzx(O104) and negative for wbdD(O8/O9/O9a)). All 51 isolates tested negative for eae, and 16 tested positive for stx1 gene of the subtype 1c. Thirteen of the 16 stx1-positive O104 isolates were from one feedlot. The predominant serotype was O104:H7. Pulsed-field gel electrophoresis analysis indicated that stx1-positive O104:H7 isolates had 62.4% homology to the German outbreak strain and 67.9% to 77.5% homology to human diarrheagenic O104:H7 strains. The 13 isolates obtained from the same feedlot were of the same PFGE subtype with 100% Dice similarity. Although cattle do not harbor the O104:H4 pathotype, they do harbor and shed Shiga toxigenic O104 in the feces and the predominant serotype was O104:H7.	[Shridhar, Pragathi B.; Noll, Lance W.; Shi, Xiaorong; Cernicchiaro, Natalia; Renter, David G.; Nagaraja, T. G.] Kansas State Univ, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA; [Bai, J.] Kansas State Univ, Vet Diagnost Lab, Manhattan, KS 66506 USA	Kansas State University; Kansas State University	Nagaraja, TG (corresponding author), Kansas State Univ, Dept Diagnost Med & Pathobiol, Manhattan, KS 66506 USA.	tnagaraj@vet.k-state.edu	Bai, Jianfa/M-7830-2019	Bai, Jianfa/0000-0002-0021-3036; Renter, David/0000-0002-9959-0674	National Institute of Food and Agriculture, U. S. Department of Agriculture [2012-68003-30155]	National Institute of Food and Agriculture, U. S. Department of Agriculture(United States Department of Agriculture (USDA))	This material is based upon work that is supported by the National Institute of Food and Agriculture, U. S. Department of Agriculture, under award number 2012-68003-30155 (to TGN). The funders had no role in study design, data collection and analysis, decision to publish, or presentation of the manuscript.	Amezquita-Lopez BA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051565; Auvray F, 2012, VET MICROBIOL, V158, P443, DOI 10.1016/j.vetmic.2012.02.029; Bai JF, 2012, FOODBORNE PATHOG DIS, V9, P541, DOI 10.1089/fpd.2011.1082; Bai JF, 2010, J MICROBIOL METH, V82, P85, DOI 10.1016/j.mimet.2010.05.003; Baranzoni GM, 2014, INT J FOOD MICROBIOL, V173, P99, DOI 10.1016/j.ijfoodmicro.2013.12.020; Beutin L, 2007, APPL ENVIRON MICROB, V73, P4769, DOI 10.1128/AEM.00873-07; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Blanco A, 2004, J CLIN MICROBIOL, V42, P645, DOI 10.1128/JCM.42.2.645-651.2004; Blanco M, 2003, J CLIN MICROBIOL, V41, P1351, DOI 10.1128/JCM.41.4.1351-1356.2003; Cleary J, 2004, MICROBIOL-SGM, V150, P527, DOI 10.1099/mic.0.26740-0; Delannoy S, 2012, J CLIN MICROBIOL, V50, P3485, DOI 10.1128/JCM.01656-12; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Feng P, 2001, J CLIN MICROBIOL, V39, P24, DOI 10.1128/JCM.39.1.24-28.2001; Friedrich AW, 2003, J CLIN MICROBIOL, V41, P2448, DOI 10.1128/JCM.41.6.2448-2453.2003; GAMIAN A, 1993, J BACTERIOL, V175, P1508, DOI 10.1128/JB.175.5.1508-1513.1993; Hao WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033971; Hussein HS, 2007, J ANIM SCI, V85, pE63, DOI 10.2527/jas.2006-421; Karch H, 2012, EMBO MOL MED, V4, P841, DOI 10.1002/emmm.201201662; KEDZIERSKA B, 1978, EUR J BIOCHEM, V91, P545, DOI 10.1111/j.1432-1033.1978.tb12708.x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Makela P, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3129; Manna SK, 2010, J APPL MICROBIOL, V108, P658, DOI 10.1111/j.1365-2672.2009.04460.x; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Miko A, 2013, INT J MED MICROBIOL, V303, P410, DOI 10.1016/j.ijmm.2013.05.006; Moriel DG, 2012, MBIO, V3, DOI 10.1128/mBio.00118-12; NATARO JP, 1993, INFECT IMMUN, V61, P1126, DOI 10.1128/IAI.61.3.1126-1131.1993; Noll LW, 2015, PLOS ONE IN PRESS; Paddock ZD, 2013, APPL ENVIRON MICROB, V79, P3522, DOI 10.1128/AEM.00246-13; Posse B, 2008, FEMS MICROBIOL LETT, V282, P124, DOI 10.1111/j.1574-6968.2008.01121.x; Scheutz F, 2012, J CLIN MICROBIOL, V50, P2951, DOI 10.1128/JCM.00860-12; Sekse C, 2011, APPL ENVIRON MICROB, V77, P4949, DOI 10.1128/AEM.00189-11; Tau NP, 2012, EMERG INFECT DIS, V18, P1314, DOI 10.3201/eid1808.111616; Wang L, 2001, GENE, V270, P231, DOI 10.1016/S0378-1119(01)00471-1; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Wieler LH, 2011, GUT PATHOG, V3, DOI 10.1186/1757-4749-3-17	35	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152101	10.1371/journal.pone.0152101	http://dx.doi.org/10.1371/journal.pone.0152101			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010226	Green Submitted, gold, Green Published			2022-12-26	WOS:000372708000088
J	Yan, JJ; Zhang, JB; Sun, KY; Chang, D; Bai, SQ; Shen, YX; Huang, LK; Zhang, J; Zhang, Y; Dong, YH				Yan, Jiajun; Zhang, Jianbo; Sun, Kaiyan; Chang, Dan; Bai, Shiqie; Shen, Yixin; Huang, Linkai; Zhang, Jin; Zhang, Yu; Dong, Yanhai			Ploidy Level and DNA Content of Erianthus arundinaceus as Determined by Flow Cytometry and the Association with Biological Characteristics	PLOS ONE			English	Article							PERENNIAL RYEGRASS; CHROMOSOME-NUMBERS; RETZ. JESWIET; AFLP MARKERS; GENOME; ACCESSIONS; HYBRIDS; TRAITS; SIZE	Erianthus arundinaceus is not only an important germplasm resource for sugarcane breeding but also a potential bioenergy plant. Making clear the distribution of the chromosome ploidy of wild E. arundinaceus in china is the premise of the research and utilization of this species. Therefore, the objectives of this study were to determine the ploidy level and DNA content of the 55 E. arundinaceus accessions using flow cytometry and to identify the correlation between ploidy and phenotypic traits. Among the 55 accessions, four tetraploids and 51 hexaploids were identified. The four tetraploids originated from Mengma Yunnan, Shuangjiang Yunnan, Gaozhou Guangdong and Chengle Sichuan. The mean DNA content was 4.82 pg/2C for the tetraploid and 7.30 pg/2C for the hexaploid plants. The ploidy was negatively correlated with cellulose content and positively correlated (P < 0.05) with plant height, stem diameter, leaf width, dry weight per plant, fresh weight per plant and hemicellulose content. However, ploidy was not correlated with leaf length, tiller number and the ratio of dry weight and fresh weight. This study will be useful for revealing the distribution of the ploidy of wild E. arundinaceus in Chin, traits markers analysis, and utilization of this species, such as cultivar improvement and sugarcane breeding in the future.	[Yan, Jiajun; Zhang, Jianbo; Sun, Kaiyan; Chang, Dan; Bai, Shiqie; Zhang, Jin; Zhang, Yu] Sichuan Acad Grassland Sci, Chengdu, Sichuan, Peoples R China; [Sun, Kaiyan; Shen, Yixin] Nanjing Agr Univ, Dept Grassland Sci, Anim Sci & Technol Coll, Nanjing, Jiangsu, Peoples R China; [Chang, Dan; Huang, Linkai; Dong, Yanhai] Sichuan Agr Univ, Dept Grassland Sci, Anim Sci & Technol Coll, Yaan, Sichuan, Peoples R China	Nanjing Agricultural University; Sichuan Agricultural University	Bai, SQ (corresponding author), Sichuan Acad Grassland Sci, Chengdu, Sichuan, Peoples R China.; Shen, YX (corresponding author), Nanjing Agr Univ, Dept Grassland Sci, Anim Sci & Technol Coll, Nanjing, Jiangsu, Peoples R China.	baishiqie@126.com; yxshen@njau.edu.cn			National Natural Science Foundation of China [31302026]; National High-Tech R&D Program of China (863 Program) [2012AA101801-01]; earmarked fund for China Agriculture Research System [CARS35-35]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech R&D Program of China (863 Program)(National High Technology Research and Development Program of China); earmarked fund for China Agriculture Research System	This work was supported by the National Natural Science Foundation of China (#31302026), National High-Tech R&D Program of China (863 Program, #2012AA101801-01), and the earmarked fund for China Agriculture Research System (#CARS35-35). SQ Bai received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P229, DOI [10.1007/BF02672073, DOI 10.1007/BF02672073]; Barker RE, 2001, SEED SCI TECHNOL, V29, P493; BERDING N, 1980, Hawaiian Planters' Record, V59, P87; Bonos SA, 2002, CROP SCI, V42, P192, DOI 10.2135/cropsci2002.0192; Cai Q, 2005, PLANT SCI, V169, P976, DOI 10.1016/j.plantsci.2005.07.002; Cai Qing, 2002, Southwest China Journal of Agricultural Sciences, V15, P16; Deng GT, 2013, J PLANT GENETIC RESO, V2; Deng ZH, 2010, AGR SCI CHINA, V9, P1271, DOI 10.1016/S1671-2927(09)60216-9; Denis M, 2013, TREE GENET GENOMES, V9, P927, DOI [10.1007/s11295-013-0606-z, 10.1007/s11295-012-0528-1]; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Greilhuber J, 2006, PLANT BIOLOGY, V8, P770, DOI 10.1055/s-2006-924101; He, 1997, J YUNNAN AGR U, V12, P253; Johnston JS, 1999, AM J BOT, V86, P609, DOI 10.2307/2656569; KAMEMOTO H., 1964, PAC SCI, V18, P104; Kole C, 2011, WILD CROP RELATIVES, P97; LACKEY JA, 1980, AM J BOT, V67, P595, DOI 10.2307/2442301; Leitch IJ, 2005, ANN BOT-LONDON, V95, P207, DOI 10.1093/aob/mci014; Li Han, 2009, Acta Horticulturae Sinica, V36, P605; Liang ZX, 2011, GENETIC DIVERSITY BI; Liu J, 2013, EURASIP J WIREL COMM, DOI 10.1186/1687-1499-2013-29; Ming R, 2006, PL BRED RE, V27, P15; Mukherjee S. K, 1957, BOT GAZ, V119, P55, DOI DOI 10.1086/335962; Nagai C, 1983, SOMACLONAL VARIETIES, P9; Nair Narayana V., 2006, Cytologia (Tokyo), V71, P107, DOI 10.1508/cytologia.71.107; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Peterson DG, 2002, GENOME RES, V12, P795, DOI 10.1101/gr.226102; Piperidis N, 2010, GENOME, V53, P331, DOI [10.1139/G10-010, 10.1139/g10-010]; Richardson MD, 2007, CROP SCI, V47, P83, DOI 10.2135/cropsci2006.04.0221; Salama H, NAHRWERT MILCHPRODUK, P148; Sari N, 1999, SCI HORTIC-AMSTERDAM, V82, P265, DOI 10.1016/S0304-4238(99)00077-1; Serapiglia MJ, 2015, BIOENERG RES, V8, P259, DOI 10.1007/s12155-014-9521-x; Sreenivasan TV, 1989, SUGARCANE VARIETAL I, P177; Sreenivasan TV, 1989, SUGARCANE VARIETAL I, P194; Tew Thomas L., 2008, P249, DOI 10.1007/978-0-387-70805-8_9; Uwatoko N, 2011, GRASSL SCI, V57, P231, DOI 10.1111/j.1744-697X.2011.00234.x; Wang Y, 2009, HORTSCIENCE, V44, P2049, DOI 10.21273/HORTSCI.44.7.2049; WEEDIN JF, 1978, AM J BOT, V65, P531, DOI 10.2307/2442586; Wu JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110390; Wu YQ, 2006, CROP SCI, V46, P917, DOI 10.2135/cropsci2005.08.0256; Xiao FH, 1994, SUGARCANE, V1, P22; Zlesak DC, 2005, EUPHYTICA, V141, P281, DOI 10.1007/s10681-005-7512-x	42	26	30	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151948	10.1371/journal.pone.0151948	http://dx.doi.org/10.1371/journal.pone.0151948			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010798	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708000058
J	Moch, M; Windoffer, R; Schwarz, N; Pohl, R; Omenzetter, A; Schnakenberg, U; Herb, F; Chaisaowong, K; Merhof, D; Ramms, L; Fabris, G; Hoffmann, B; Merkel, R; Leube, RE				Moch, Marcin; Windoffer, Reinhard; Schwarz, Nicole; Pohl, Raphaela; Omenzetter, Andreas; Schnakenberg, Uwe; Herb, Fabian; Chaisaowong, Kraisorn; Merhof, Dorit; Ramms, Lena; Fabris, Gloria; Hoffmann, Bernd; Merkel, Rudolf; Leube, Rudolf E.			Effects of Plectin Depletion on Keratin Network Dynamics and Organization	PLOS ONE			English	Article							INTERMEDIATE-FILAMENT PROTEINS; ALPHA-6-BETA-4 INTEGRIN; CROSS-TALK; IN-VITRO; CYTOSKELETON; HEMIDESMOSOMES; MIGRATION; BINDING; CELLS; ACTIN	The keratin intermediate filament cytoskeleton protects epithelial cells against various types of stress and is involved in fundamental cellular processes such as signaling, differentiation and organelle trafficking. These functions rely on the cell type-specific arrangement and plasticity of the keratin system. It has been suggested that these properties are regulated by a complex cycle of assembly and disassembly. The exact mechanisms responsible for the underlying molecular processes, however, have not been clarified. Accumulating evidence implicates the cytolinker plectin in various aspects of the keratin cycle, i.e., by acting as a stabilizing anchor at hemidesmosomal adhesion sites and the nucleus, by affecting keratin bundling and branching and by linkage of keratins to actin filament and microtubule dynamics. In the present study we tested these hypotheses. To this end, plectin was downregulated by shRNA in vulvar carcinoma-derived A431 cells. As expected, integrin beta 4-and BPAG-1-positive hemidesmosomal structures were strongly reduced and cytosolic actin stress fibers were increased. In addition, integrins alpha 3 and beta 1 were reduced. The experiments furthermore showed that loss of plectin led to a reduction in keratin filament branch length but did not alter overall mechanical properties as assessed by indentation analyses using atomic force microscopy and by displacement analyses of cytoplasmic superparamagnetic beads using magnetic tweezers. An increase in keratin movement was observed in plectin-depleted cells as was the case in control cells lacking hemidesmosome-like structures. Yet, keratin turnover was not significantly affected. We conclude that plectin alone is not needed for keratin assembly and disassembly and that other mechanisms exist to guarantee proper keratin cycling under steady state conditions in cultured single cells.	[Moch, Marcin; Windoffer, Reinhard; Schwarz, Nicole; Pohl, Raphaela; Leube, Rudolf E.] Rhein Westfal TH Aachen, Inst Mol & Cellular Anat, Aachen, Germany; [Omenzetter, Andreas; Schnakenberg, Uwe] Rhein Westfal TH Aachen, Inst Mat Elect Engn 1, Aachen, Germany; [Herb, Fabian; Chaisaowong, Kraisorn; Merhof, Dorit] Rhein Westfal TH Aachen, Inst Imaging & Comp Vis, Aachen, Germany; [Ramms, Lena; Fabris, Gloria; Hoffmann, Bernd; Merkel, Rudolf] Forschungszentrum Julich, Inst Complex Syst, D-52425 Julich, Germany; [Chaisaowong, Kraisorn] King Mongkuts Univ Technol North Bangkok, Bangkok, Thailand	RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; Helmholtz Association; Research Center Julich; King Mongkuts University of Technology North Bangkok	Leube, RE (corresponding author), Rhein Westfal TH Aachen, Inst Mol & Cellular Anat, Aachen, Germany.	rleube@ukaachen.de	Merhof, Dorit/AAV-7892-2021; Schwarz, Nicole/ABC-8096-2020; Moch, Marcin/GWC-7292-2022; Merkel, Rudolf/G-3647-2013	Moch, Marcin/0000-0003-2143-5292; Merkel, Rudolf/0000-0003-3178-3282; Schnakenberg, Uwe/0000-0002-2251-0605; Windoffer, Reinhard/0000-0003-1403-5880; Leube, Rudolf/0000-0002-5519-7379; Schwarz, Nicole/0000-0001-7888-6970; Hoffmann, Bernd/0000-0002-3803-8835	German Research Foundation [LE 566/18-1, LE 566/22-1, WI 1731/8-1]; Excellence Initiative of the German federal government; Excellence Initiative of the German state government; RWTH ERS Boost-Fund [OPBF071]; IZKF, Uniklinik RWTH Aachen University; EU [642866]	German Research Foundation(German Research Foundation (DFG)); Excellence Initiative of the German federal government; Excellence Initiative of the German state government; RWTH ERS Boost-Fund; IZKF, Uniklinik RWTH Aachen University; EU(European Commission)	Funded by 1. German Research Foundation, http://www.dfg.de/en/, LE 566/18-1, RE, 2. German Research Foundation, http://www.dfg.de/en/, LE 566/22-1, REL, 3. German Research Foundation, http://www.dfg.de/en/, WI 1731/8-1, RW, 4. Excellence Initiative of the German federal and state governments, http://www.dfg.de/en/research_funding/programmes/excellence_initiative/, RWTH ERS Boost-Fund 2013 OPBF071, US, 5. IZKF, Uniklinik RWTH Aachen University, http://www.medizin.rwth-aachen.de/cms/Medizin/Die_Fakultaet/Einrichtungen/similar to dgun/IZKF_Aachen/?lidx=1, Boost Fund, REF and RW, 6. IZKF, Uniklinik RWTH Aachen University, http://www.medizin.rwth-aachen.de/cms/Medizin/Die_Fakultaet/Einrichtungen/similar to dgun/IZKF_ Aachen/?lidx=1, TP1, REL and RW, and 7. EU # 2020-MSCA-ITN InCeM, http://ec.europa.eu/programmes/horizon2020/en/h2020-section/mariesklodowska-curie-actions, 642866, REL, RW. None of the funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andra K, 1997, GENE DEV, V11, P3143, DOI 10.1101/gad.11.23.3143; Boczonadi V, 2007, EXP CELL RES, V313, P3579, DOI 10.1016/j.yexcr.2007.07.005; Bonakdar N, 2015, EXP CELL RES, V331, P331, DOI 10.1016/j.yexcr.2014.10.001; Bouameur JE, 2014, J INVEST DERMATOL, V134, P2776, DOI 10.1038/jid.2014.255; Bouameur JE, 2014, J INVEST DERMATOL, V134, P885, DOI 10.1038/jid.2013.498; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BRULET P, 1980, P NATL ACAD SCI-BIOL, V77, P4113, DOI 10.1073/pnas.77.7.4113; Burgstaller G, 2010, MOL BIOL CELL, V21, P3362, DOI 10.1091/mbc.E10-02-0094; CHOU CF, 1993, J CELL SCI, V105, P433; de Pereda JM, 2009, EMBO J, V28, P1180, DOI 10.1038/emboj.2009.48; DELWEL GO, 1994, MOL BIOL CELL, V5, P203, DOI 10.1091/mbc.5.2.203; DIPERSIO CM, 1995, J CELL SCI, V108, P2321; Feng X, 2015, J CELL BIOL, V209, P59, DOI 10.1083/jcb.201408079; FOISNER R, 1988, J CELL BIOL, V106, P723, DOI 10.1083/jcb.106.3.723; Geerts D, 1999, J CELL BIOL, V147, P417, DOI 10.1083/jcb.147.2.417; Herberich Gerlind, 2014, MULTIDIMENSIONAL IMA; Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214; HERTLE MD, 1991, DEVELOPMENT, V112, P193; HIEDA Y, 1992, J CELL BIOL, V116, P1497, DOI 10.1083/jcb.116.6.1497; Iwatsuki H, 2010, ACTA HISTOCHEM CYTOC, V43, P19, DOI 10.1267/ahc.10009; Jefferson JJ, 2004, NAT REV MOL CELL BIO, V5, P542, DOI 10.1038/nrm1425; Kolsch A, 2010, J CELL SCI, V123, P2266, DOI 10.1242/jcs.068080; Kollmannsberger P, 2011, SOFT MATTER, V7, P3127, DOI 10.1039/c0sm00833h; Koster J, 2004, MOL BIOL CELL, V15, P1211, DOI 10.1091/mbc.E03-09-0697; Kreidberg JA, 2000, CURR OPIN CELL BIOL, V12, P548, DOI 10.1016/S0955-0674(00)00130-7; Kroger C, 2013, J CELL BIOL, V201, P681, DOI 10.1083/jcb.201208162; Leube Rudolf E, 2011, Bioarchitecture, V1, P39; Long HA, 2006, J CELL SCI, V119, P5147, DOI 10.1242/jcs.03304; Loschke F, 2015, CURR OPIN CELL BIOL, V32, P56, DOI 10.1016/j.ceb.2014.12.006; Margadant C, 2009, J CELL SCI, V122, P278, DOI 10.1242/jcs.029108; Marinkovich MP, 2007, NAT REV CANCER, V7, P370, DOI 10.1038/nrc2089; Moch M, 2013, P NATL ACAD SCI USA, V110, P10664, DOI 10.1073/pnas.1306020110; NIESSEN CM, 1994, EXP CELL RES, V211, P360, DOI 10.1006/excr.1994.1099; Nievers MG, 2000, J CELL SCI, V113, P963; Osmanagic-Myers S, 2006, J CELL BIOL, V174, P557, DOI 10.1083/jcb.200605172; Pan XO, 2013, CURR OPIN CELL BIOL, V25, P47, DOI 10.1016/j.ceb.2012.10.018; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Ramms L, 2013, P NATL ACAD SCI USA, V110, P18513, DOI 10.1073/pnas.1313491110; Rezniczek GA, 1998, J CELL BIOL, V141, P209, DOI 10.1083/jcb.141.1.209; Sailer M, 2010, MICROSC MICROANAL, V16, P462, DOI 10.1017/S1431927610093657; Seltmann K, 2013, J INVEST DERMATOL, V133, P181, DOI 10.1038/jid.2012.256; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Szabo S, 2015, J HEPATOL, V62, P1357, DOI 10.1016/j.jhep.2015.01.007; Toivola DM, 2010, TRENDS CELL BIOL, V20, P79, DOI 10.1016/j.tcb.2009.11.004; Tsuruta D, 2011, J DERMATOL SCI, V62, P1, DOI 10.1016/j.jdermsci.2011.01.005; Walko G, 2015, CELL TISSUE RES, V360, P363, DOI 10.1007/s00441-014-2061-z; Werner NS, 2004, MOL BIOL CELL, V15, P990, DOI 10.1091/mbc.E03-09-0687; Wiche G, 2015, CURR OPIN CELL BIOL, V32, P21, DOI 10.1016/j.ceb.2014.10.002; Wiche Gerhard, 2011, Bioarchitecture, V1, P14; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Windoffer R, 2006, J CELL BIOL, V173, P341, DOI 10.1083/jcb.200511124; Windoffer R, 1999, J CELL SCI, V112, P4521; Windoffer R, 2011, J CELL BIOL, V194, P669, DOI 10.1083/jcb.201008095; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yang YM, 1996, CELL, V86, P655, DOI 10.1016/S0092-8674(00)80138-5	55	19	19	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0149106	10.1371/journal.pone.0149106	http://dx.doi.org/10.1371/journal.pone.0149106			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007410	gold, Green Published, Green Submitted			2022-12-26	WOS:000372701200017
J	Saber, A; van der Wekken, AJ; Kerner, GSMA; van den Berge, M; Timens, W; Schuuring, E; ter Elst, A; van den Berg, A; Hiltermann, TJN; Groen, HJM				Saber, Ali; van der Wekken, Anthonie J.; Kerner, Gerald S. M. A.; van den Berge, Maarten; Timens, Wim; Schuuring, Ed; ter Elst, Arja; van den Berg, Anke; Hiltermann, T. Jeroen N.; Groen, Harry J. M.			Chronic Obstructive Pulmonary Disease Is Not Associated with KRAS Mutations in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CIGARETTE-SMOKE; SEX-DIFFERENCES; GENE-MUTATIONS; RISK-FACTORS; EGFR; COPD; ADENOCARCINOMA; SUSCEPTIBILITY; EXPRESSION	Mutations in epithelial growth factor receptor (EGFR), as well as in the EGFR downstream target KRAS are frequently observed in non-small cell lung cancer (NSCLC). Chronic obstructive pulmonary disease (COPD), an independent risk factor for developing NSCLC, is associated with an increased activation of EGFR. In this study we determined presence of EGFR and KRAS hotspot mutations in 325 consecutive NSCLC patients subjected to EGFR and KRAS mutation analysis in the diagnostic setting and for whom the pulmonary function has been determined at time of NSCLC diagnosis. Information about age at diagnosis, sex, smoking status, forced vital capacity (FVC) and forced expiratory volume in 1 sec (FEV1) was collected. Chronic obstructive pulmonary disease(COPD) was defined according to 2013 GOLD criteria. Chi-Square, student t-test and multivariate logistic regression were used to analyze the data. A total of 325 NSCLC patients were included, 193 with COPD and 132 without COPD. COPD was not associated with presence of KRAS hotspot mutations, while EGFR mutations were significantly higher in non-COPD NSCLC patients. Both female gender (HR 2.61; 95% CI: 1.56-4.39; p<0.001) and smoking (HR 4.10; 95% CI: 1.14-14.79; p = 0.03) were associated with KRAS mutational status. In contrast, only smoking (HR 0.11; 95% CI: 0.04-0.32; p<0.001) was inversely associated with EGFR mutational status. Smoking related G>T and G>C transversions were significantly more frequent in females (86.2%) than in males (61.5%) (p = 0.008). The exon 19del mutation was more frequent in non-smokers (90%) compared to current or past smokers (36.8%). In conclusion, KRAS mutations are more common in females and smokers, but are not associated with COPD-status in NSCLC patients. EGFR mutations are more common in non-smoking NSCLC patients.	[Saber, Ali; Timens, Wim; Schuuring, Ed; ter Elst, Arja; van den Berg, Anke] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [van der Wekken, Anthonie J.; Kerner, Gerald S. M. A.; van den Berge, Maarten; Hiltermann, T. Jeroen N.; Groen, Harry J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, Groningen, Netherlands	University of Groningen; University of Groningen	Groen, HJM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pulm Dis, Groningen, Netherlands.	h.j.m.groen@umcg.nl	Timens, Wim/K-5570-2013; van der Wekken, Anthonie/AAE-2328-2021; Groen, Harry/AAP-2242-2021; , HiltermannTJN/ABA-9144-2021; van den Berg, Anke/H-1718-2011	Timens, Wim/0000-0002-4146-6363; van den Berg, Anke/0000-0002-8894-2638; van der Wekken, Anthonie/0000-0001-7175-0026; van den Berge, Maarten/0000-0002-9336-7340; Saber, Ali/0000-0002-7110-6860				Ahrendt SA, 2001, CANCER, V92, P1525, DOI 10.1002/1097-0142(20010915)92:6<1525::AID-CNCR1478>3.0.CO;2-H; Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Blons H, 2006, AM J SURG PATHOL, V30, P1309, DOI 10.1097/01.pas.0000213285.65907.31; Brenner DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017479; Denholm R, 2014, AM J RESP CRIT CARE, V190, P549, DOI 10.1164/rccm.201402-0338OC; Dogan S, 2012, CLIN CANCER RES, V18, P6169, DOI 10.1158/1078-0432.CCR-11-3265; Edwards MR, 2009, PHARMACOL THERAPEUT, V121, P1, DOI 10.1016/j.pharmthera.2008.09.003; Eklund BM, 2012, TOB INDUC DIS, V10, DOI 10.1186/1617-9625-10-17; Filosto S, 2012, MOL CANCER THER, V11, P795, DOI 10.1158/1535-7163.MCT-11-0698; Ganesan S, 2013, THORAX, V68, P131, DOI 10.1136/thoraxjnl-2012-201719; Henschke CI, 2006, JAMA-J AM MED ASSOC, V296, P180; Kerner GSMA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070346; Khan EM, 2008, FASEB J, V22, P910, DOI 10.1096/fj.06-7729com; Li M, 2009, ONCOL REP, V22, P1013, DOI 10.3892/or_00000529; Lim JU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142306; Ma ESK, 2012, ACTA CYTOL, V56, P661, DOI 10.1159/000343606; MacNee W, 2000, CHEST, V117, p303S, DOI 10.1378/chest.117.5_suppl_1.303S-a; Maki-Nevala S, 2014, J THORAC ONCOL, V9, P886, DOI 10.1097/JTO.0000000000000132; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Moghaddam SJ, 2009, AM J RESP CELL MOL, V40, P443, DOI 10.1165/rcmb.2008-0198OC; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Mollerup S, 2006, INT J CANCER, V119, P741, DOI 10.1002/ijc.21891; Okudela K, 2010, PATHOL INT, V60, P651, DOI 10.1111/j.1440-1827.2010.02580.x; Piperdi B, 2012, DRUGS, V72, P11, DOI 10.2165/1163018-S0-000000000-00000; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; Powell HA, 2013, J THORAC ONCOL, V8, P6, DOI 10.1097/JTO.0b013e318274a7dc; Puddicombe SM, 2000, FASEB J, V14, P1362, DOI 10.1096/fj.14.10.1362; Reinmuth N, 2008, LUNG CANCER, V62, P193, DOI 10.1016/j.lungcan.2008.03.011; Riely GJ, 2008, CLIN CANCER RES, V14, P5731, DOI 10.1158/1078-0432.CCR-08-0646; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Saber A., 2015, CANC TREATMENT COMMU, V143, P23, DOI [DOI 10.1016/j.ctrc.2015.03.005, 10.1016/j.ctrc.2015.03.005]; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Sunaga N, 2013, ONCOGENE, V32, P4034, DOI 10.1038/onc.2012.402; Suzuki M, 2010, ANN SURG ONCOL, V17, P878, DOI 10.1245/s10434-009-0739-3; Travis W, 2004, WHO CLASSIFICATION T; Tyner JW, 2006, J CLIN INVEST, V116, P309, DOI 10.1172/JCI25167; Uppstad H, 2011, LUNG CANCER, V71, P264, DOI 10.1016/j.lungcan.2010.09.006; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Yao HW, 2009, CURR OPIN PHARMACOL, V9, P375, DOI 10.1016/j.coph.2009.06.009; Young RP, 2009, EUR RESPIR J, V34, P380, DOI 10.1183/09031936.00144208; Zang EA, 1996, JNCI-J NATL CANCER I, V88, P183, DOI 10.1093/jnci/88.3-4.183	42	7	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152317	10.1371/journal.pone.0152317	http://dx.doi.org/10.1371/journal.pone.0152317			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008036	Green Submitted, gold, Green Published			2022-12-26	WOS:000372701200118
J	Wong, RSY; Ismail, NA				Wong, Rowena Syn Yin; Ismail, Noor Azina			An Application of Bayesian Approach in Modeling Risk of Death in an Intensive Care Unit	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; HOSPITAL MORTALITY; ACUTE PHYSIOLOGY; APACHE IV; REGRESSION; VALIDATION; ADMISSION; PATIENT; SAPS-3	Background and Objectives There are not many studies that attempt to model intensive care unit (ICU) risk of death in developing countries, especially in South East Asia. The aim of this study was to propose and describe application of a Bayesian approach in modeling in-ICU deaths in a Malaysian ICU. Methods This was a prospective study in a mixed medical-surgery ICU in a multidisciplinary tertiary referral hospital in Malaysia. Data collection included variables that were defined in Acute Physiology and Chronic Health Evaluation IV (APACHE IV) model. Bayesian Markov Chain Monte Carlo (MCMC) simulation approach was applied in the development of four multivariate logistic regression predictive models for the ICU, where the main outcome measure was in-ICU mortality risk. The performance of the models were assessed through overall model fit, discrimination and calibration measures. Results from the Bayesian models were also compared against results obtained using frequentist maximum likelihood method. Results The study involved 1,286 consecutive ICU admissions between January 1, 2009 and June 30, 2010, of which 1,111 met the inclusion criteria. Patients who were admitted to the ICU were generally younger, predominantly male, with low co-morbidity load and mostly under mechanical ventilation. The overall in-ICU mortality rate was 18.5% and the overall mean Acute Physiology Score (APS) was 68.5. All four models exhibited good discrimination, with area under receiver operating characteristic curve (AUC) values approximately 0.8. Calibration was acceptable (Hosmer-Lemeshow p-values > 0.05) for all models, except for model M3. Model M1 was identified as the model with the best overall performance in this study. Conclusion Four prediction models were proposed, where the best model was chosen based on its overall performance in this study. This study has also demonstrated the promising potential of the Bayesian MCMC approach as an alternative in the analysis and modeling of in-ICU mortality outcomes.	[Wong, Rowena Syn Yin; Ismail, Noor Azina] Univ Malaya, Fac Econ & Adm, Dept Appl Stat, Kuala Lumpur, Malaysia	Universiti Malaya	Ismail, NA (corresponding author), Univ Malaya, Fac Econ & Adm, Dept Appl Stat, Kuala Lumpur, Malaysia.	nazina@um.edu.my	ISMAIL, NOOR AZINA/B-5341-2010	ISMAIL, NOOR AZINA/0000-0001-8032-2162	University of Malaya [RG138/09HTM]	University of Malaya(Universiti Malaya)	This work was supported by the University of Malaya (www.um.edu.my) Grant RG138/09HTM Assessment of Performance of the Scoring Systems at an Interdisciplinary ICU, received by NAI. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedrick EJ, 1997, AM STAT, V51, P211, DOI 10.2307/2684890; Brier G. W., 1950, MONTHLY WEATHER REVI, V78, P1, DOI DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2; Chen MH, 1999, J ROY STAT SOC B, V61, P223, DOI 10.1111/1467-9868.00173; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Congdon P, 2005, WILEY SER PROBAB ST, P1, DOI 10.1002/0470092394; Gerds TA, 2008, BIOMETRICAL J, V50, P457, DOI 10.1002/bimj.200810443; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Higgins TL, 2007, CRIT CARE MED, V35, P827, DOI 10.1097/01.CCM.0000257337.63529.9F; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; KAY R, 1987, BIOMETRIKA, V74, P495, DOI 10.1093/biomet/74.3.495; Kazembe LN, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-6; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Letchuman GR, 2010, MED J MALAYSIA, V65, P180; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Manan MMA, 2012, IATSS RES, V36, P30, DOI 10.1016/j.iatssr.2012.02.005; Metnitz PGH, 2005, INTENS CARE MED, V31, P1336, DOI 10.1007/s00134-005-2762-6; Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5; Nazaimoon WMW, 2013, DIABETIC MED, V30, P825, DOI 10.1111/dme.12161; SCHWARTZ S, 1981, CRIT CARE MED, V9, P625, DOI 10.1097/00003246-198109000-00001; Siegelaar SE, 2011, CRIT CARE, V15, DOI 10.1186/cc10440; Siegelaar SE, 2010, CRIT CARE, V14, DOI 10.1186/cc8881; Souza Aparecida D. P., 2004, Pesqui. Oper., V24, P253, DOI 10.1590/S0101-74382004000200003; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Steyerberg EW, 2003, J CLIN EPIDEMIOL, V56, P441, DOI 10.1016/S0895-4356(03)00047-7; Tong JMG, MALAYSIAN REGISTRY I; Vincent JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8866; Vogenberg FR, 2009, AM HEALTH DRUG BENEF, V2, P218; Wong RSY, 2015, ANN ACAD MED SINGAP, V44, P127; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	30	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151949	10.1371/journal.pone.0151949	http://dx.doi.org/10.1371/journal.pone.0151949			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007413	Green Submitted, Green Published, gold			2022-12-26	WOS:000372701200077
J	Berisha, S; Han, J; Shahid, M; Han, YC; Witschey, WRT				Berisha, Sebastian; Han, Joyce; Shahid, Mohammed; Han, Yuchi; Witschey, Walter R. T.			Measurement of Myocardial T-1 rho with a Motion Corrected, Parametric Mapping Sequence in Humans	PLOS ONE			English	Article							TISSUE CHARACTERIZATION; INVERSION-RECOVERY; IN-VIVO; INFARCTION; TIME; T-1; COMPENSATION; ARTIFACTS; ECHO; B-0	Purpose To develop a robust T-1 rho magnetic resonance imaging (MRI) sequence for assessment of myocardial disease in humans. Materials and Methods We developed a breath-held T-1 rho mapping method using a single-shot, T-1 rho-prepared balanced steady-state free-precession (bSSFP) sequence. The magnetization trajectory was simulated to identify sources of T-1 rho error. To limit motion artifacts, an optical flow-based image registration method was used to align T-1 rho images. The reproducibility and accuracy of these methods was assessed in phantoms and 10 healthy subjects. Results are shown in 1 patient with pre-ventricular contractions (PVCs), 1 patient with chronic myocardial infarction (MI) and 2 patients with hypertrophic cardiomyopathy (HCM). Results In phantoms, the mean bias was 1.0 +/- 2.7 msec (100 msec phantom) and 0.9 +/- 0.9 msec (60 msec phantom) at 60 bpm and 2.2 +/- 3.2 msec (100 msec) and 1.4 +/- 0.9 msec (60 msec) at 80 bpm. The coefficient of variation (COV) was 2.2 (100 msec) and 1.3 (60 msec) at 60 bpm and 2.6 (100 msec) and 1.4 (60 msec) at 80 bpm. Motion correction improved the alignment of T-1 rho images in subjects, as determined by the increase in Dice Score Coefficient (DSC) from 0.76 to 0.88. T-1 rho reproducibility was high (COV < 0.05, intra-class correlation coefficient (ICC) = 0.85-0.97). Mean myocardial T-1 rho value in healthy subjects was 63.5 +/- 4.6 msec. There was good correspondence between late-gadolinium enhanced (LGE) MRI and increased T-1 rho relaxation times in patients. Conclusion Single-shot, motion corrected, spin echo, spin lock MRI permits 2D T-1 rho mapping in a breath-hold with good accuracy and precision.	[Berisha, Sebastian; Shahid, Mohammed; Witschey, Walter R. T.] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [Han, Joyce; Han, Yuchi] Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Witschey, WRT (corresponding author), Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA.	witschey@mail.med.upenn.edu	Han, Q. Joyce/GLR-1652-2022	Han, Q. Joyce/0000-0001-7089-1767	National Institutes of Health [NHLBI R00-HL108157]; Mr. and Mrs. Thomas B. McCabe Fund; National Center for Research Resources [UL1RR024134]; National Center for Advancing Translational Sciences [UL1TR000003]; Institute for Translational Medicine and Therapeutics' (ITMAT) Transdisciplinary Program in Translational Medicine and Therapeutics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL108157] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mr. and Mrs. Thomas B. McCabe Fund; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Institute for Translational Medicine and Therapeutics' (ITMAT) Transdisciplinary Program in Translational Medicine and Therapeutics; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Institutes of Health NHLBI R00-HL108157 and the Mr. and Mrs. Thomas B. McCabe Fund. The project described was supported by the National Center for Research Resources, Grant UL1RR024134, and is now at the National Center for Advancing Translational Sciences, Grant UL1TR000003. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This work was also supported in part by the Institute for Translational Medicine and Therapeutics' (ITMAT) Transdisciplinary Program in Translational Medicine and Therapeutics (http://www.itmat.upenn.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya M, 2014, MAGN RESON MED; Brox T, 2004, LECT NOTES COMPUT SC, V2034, P25, DOI 10.1007/978-3-540-24673-2_3; Bruce D, IJCAI 81 P 7 INT JOI; Bruhn A, 2005, INT J COMPUT VISION, V61, P211, DOI 10.1023/B:VISI.0000045324.43199.43; Chen WT, 2011, MAGN RESON IMAGING, V29, P608, DOI 10.1016/j.mri.2011.02.002; Dixon WT, 1996, MAGNET RESON MED, V36, P90, DOI 10.1002/mrm.1910360116; Fleiss JL, 1999, DESIGN ANAL CLIN EXP; Han JQ, 2015, J CARDIOVASC MAGN S1, V17, pP22; Han Q, 2014, J CARDIOVASC MAGN S1, V16, pP70; Han Y, 2014, CURR CARDIOVASC IMAG, V7, DOI 10.1007/s12410-013-9248-7; HORN BKP, 1981, ARTIF INTELL, V17, P185, DOI 10.1016/0004-3702(81)90024-2; Huber S, 2006, J MAGN RESON IMAGING, V24, P1040, DOI 10.1002/jmri.20720; Liu C, 2009, PIXELS EXPLORING NEW; Murase K, 2011, MAGN RESON IMAGING, V29, P126, DOI 10.1016/j.mri.2010.07.003; Musthafa HSN, 2013, MAGN RESON MED, V69, P1389, DOI 10.1002/mrm.24382; Muthupillai R, 2004, RADIOLOGY, V232, P606, DOI 10.1148/radiol.2322030334; Roujol S, 2014, MAGN RESON MED, P1; Scheffler K, 2001, MAGNET RESON MED, V45, P720, DOI 10.1002/mrm.1097; van Oorschot JWM, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/s12968-014-0104-y; von Knobelsdorff-Brenkenhoff F, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-53; Wang C, 2015, J CARDIOL, P00090; Wang DJJ, 2010, ESTIMATION PERFUSION, V1295, P1289; Witschey WRT, 2008, J MAGN RESON IMAGING, V28, P744, DOI 10.1002/jmri.21444; Witschey WRT, 2007, MAGN RESON MED, V57, P2, DOI 10.1002/mrm.21134; Witschey WRT, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-37; Witschey WRT, 2010, MAGN RESON MED, V64, P1454, DOI 10.1002/mrm.22543; Witschey WRT, 2007, J MAGN RESON, V186, P75, DOI 10.1016/j.jmr.2007.01.015; Xue H, 2013, MAGN RESON MED, V69, P1408, DOI 10.1002/mrm.24385; Xue H, 2012, MAGN RESON MED, V67, P1644, DOI 10.1002/mrm.23153	29	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151144	10.1371/journal.pone.0151144	http://dx.doi.org/10.1371/journal.pone.0151144			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003184	Green Published, gold, Green Submitted			2022-12-26	WOS:000372697400025
J	Karimi, S; Ahl, D; Vagesjo, E; Holm, L; Phillipson, M; Jonsson, H; Roos, S				Karimi, Shokoufeh; Ahl, David; Vagesjo, Evelina; Holm, Lena; Phillipson, Mia; Jonsson, Hans; Roos, Stefan			In Vivo and In Vitro Detection of Luminescent and Fluorescent Lactobacillus reuteri and Application of Red Fluorescent mCherry for Assessing Plasmid Persistence	PLOS ONE			English	Article							LACTOCOCCUS-LACTIS; ESCHERICHIA-COLI; HOST-RANGE; PROBIOTIC LACTOBACILLI; CHROMOPHORE MATURATION; PROMISCUOUS PLASMID; GENE-EXPRESSION; GUT MICROBIOTA; STABILITY; EVOLUTION	Lactobacillus reuteri is a symbiont that inhabits the gastrointestinal (GI) tract of mammals, and several strains are used as probiotics. After introduction of probiotic strains in a complex ecosystem like the GI tract, keeping track of them is a challenge. The main objectives of this study were to introduce reporter proteins that would enable in vivo and in vitro detection of L. reuteri and increase knowledge about its interactions with the host. We describe for the first time cloning of codon-optimized reporter genes encoding click beetle red luciferase (CBRluc) and red fluorescent protein mCherry in L. reuteri strains ATCC PTA 6475 and R2LC. The plasmid persistence of mCherry-expressing lactobacilli was evaluated by both flow cytometry (FCM) and conventional plate count (PC), and the plasmid loss rates measured by FCM were lower overall than those determined by PC. Neutralization of pH and longer induction duration significantly improved the mCherry signal. The persistency, dose-dependent signal intensity and localization of the recombinant bacteria in the GI tract of mice were studied with an in vivo imaging system (IVIS), which allowed us to detect fluorescence from 6475-CBRluc-mCherry given at a dose of 1x10(10) CFU and luminescence signals at doses ranging from 1x10(5) to 1x10(10) CFU. Both 6475-CBRluc-mCherry and R2LC-CBRluc were localized in the colon 1 and 2 h after ingestion, but the majority of the latter were still found in the stomach, possibly reflecting niche specificity for R2LC. Finally, an in vitro experiment showed that mCherry-producing R2LC adhered efficiently to the intra cellular junctions of cultured IPEC-J2 cells. In conclusion, the two reporter genes CBRluc and mCherry were shown to be suitable markers for biophotonic imaging (BPI) of L. reuteri and may provide useful tools for future studies of in vivo and in vitro interactions between the bacteria and the host.	[Karimi, Shokoufeh; Jonsson, Hans; Roos, Stefan] Swedish Univ Agr Sci, Dept Microbiol, Uppsala BioCtr, Uppsala, Sweden; [Ahl, David; Vagesjo, Evelina; Holm, Lena; Phillipson, Mia] Uppsala Univ, Dept Med Cell Biol, Biomed Ctr, Uppsala, Sweden	Swedish University of Agricultural Sciences; Uppsala University	Karimi, S (corresponding author), Swedish Univ Agr Sci, Dept Microbiol, Uppsala BioCtr, Uppsala, Sweden.	shokoufeh.karimi@slu.se		Phillipson, Mia/0000-0002-2387-0266; Roos, Stefan/0000-0002-1606-1794	Biogaia AB	Biogaia AB	This work was funded by Biogaia AB, www.biogaia.se. The company has only financially sponsored the project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson TR, 2009, J PEDIATR GASTR NUTR, V49, P349, DOI 10.1097/MPG.0b013e31818f091b; Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; Bahl ML, 2004, FEMS MICROBIOL LETT, V232, P45, DOI 10.1016/S0378-1097(04)00015-1; Bingle LEH, 2001, CURR OPIN MICROBIOL, V4, P194, DOI 10.1016/S1369-5274(00)00188-0; Bonot S, 2010, APPL ENVIRON MICROB, V76, P378, DOI 10.1128/AEM.01125-09; BOUMA JE, 1988, NATURE, V335, P351, DOI 10.1038/335351a0; Bourgois JJ, 2001, J BIOENERG BIOMEMBR, V33, P353, DOI 10.1023/A:1010615508916; Boyle EC, 2003, CURR OPIN CELL BIOL, V15, P633, DOI 10.1016/S0955-0674(03)00099-1; Britton RA, 2014, J CELL PHYSIOL, V229, P1822, DOI 10.1002/jcp.24636; BRON S, 1988, PLASMID, V19, P231, DOI 10.1016/0147-619X(88)90041-8; Casas Ivan A., 2000, Microbial Ecology in Health and Disease, V12, P247; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Cooper TF, 2000, P NATL ACAD SCI USA, V97, P12643, DOI 10.1073/pnas.220077897; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Daniel C, 2013, APPL ENVIRON MICROB, V79, P1086, DOI 10.1128/AEM.03221-12; De Gelder L, 2008, GENETICS, V178, P2179, DOI 10.1534/genetics.107.084475; De Gelder L, 2007, MICROBIOL-SGM, V153, P452, DOI 10.1099/mic.0.2006/001784-0; Deane SM, 2004, J BACTERIOL, V186, P2123, DOI 10.1128/JB.186.7.2123-2133.2004; Dinleyici EC, 2014, ACTA PAEDIATR, V103, pe300, DOI 10.1111/apa.12617; Doherty Geoff P, 2010, BMC Res Notes, V3, P303, DOI 10.1186/1756-0500-3-303; FABIA R, 1993, SCAND J GASTROENTERO, V28, P155, DOI 10.3109/00365529309096063; Foucault ML, 2010, APPL ENVIRON MICROB, V76, P264, DOI 10.1128/AEM.01686-09; Francavilla R, 2014, J CLIN GASTROENTEROL, V48, P407, DOI 10.1097/MCG.0000000000000007; Gheysens O, 2009, METHODS, V48, P139, DOI 10.1016/j.ymeth.2009.03.013; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; Hebisch E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075991; Hemarajata P, 2013, THER ADV GASTROENTER, V6, P39, DOI 10.1177/1756283X12459294; HOLO H, 1989, APPL ENVIRON MICROB, V55, P3119, DOI 10.1128/AEM.55.12.3119-3123.1989; Hsieh FC, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-35; Hughes JM, 2012, MBIO, V3, DOI 10.1128/mBio.00077-12; Hummel S, 2012, APPL ENVIRON MICROB, V78, P1140, DOI 10.1128/AEM.06983-11; Iizuka R, 2011, ANAL BIOCHEM, V414, P173, DOI 10.1016/j.ab.2011.03.036; Indrio F, 2014, JAMA PEDIATR, V168, P228, DOI 10.1001/jamapediatrics.2013.4367; KIEWIET R, 1993, APPL ENVIRON MICROB, V59, P358, DOI 10.1128/AEM.59.2.358-364.1993; Landete JM, 2015, APPL MICROBIOL BIOT, V99, P6865, DOI 10.1007/s00253-015-6770-3; Lau BTC, 2013, PLASMID, V70, P353, DOI 10.1016/j.plasmid.2013.07.007; Lebeer S, 2008, MICROBIOL MOL BIOL R, V72, P728, DOI 10.1128/MMBR.00017-08; Lee MS, 2012, FOOD SCI BIOTECHNOL, V21, P917, DOI 10.1007/s10068-012-0120-3; Leisner M, 2007, MOL MICROBIOL, V63, P1806, DOI 10.1111/j.1365-2958.2007.05628.x; LENSKI RE, 1987, J BACTERIOL, V169, P5314, DOI 10.1128/jb.169.11.5314-5316.1987; LENSKI RE, 1994, J BACTERIOL, V176, P3140, DOI 10.1128/jb.176.11.3140-3147.1994; Levkovich T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053867; Lin YP, 2008, INFLAMM BOWEL DIS, V14, P1068, DOI 10.1002/ibd.20448; Loftie-Eaton W, 2014, APPL ENVIRON MICROB, V80, P5439, DOI 10.1128/AEM.00793-14; Macdonald PJ, 2012, ANAL BIOCHEM, V421, P291, DOI 10.1016/j.ab.2011.10.040; Martinez I, 2015, CELL REP, V11, P527, DOI 10.1016/j.celrep.2015.03.049; Mccabe LR, 2013, J CELL PHYSIOL, V228, P1793, DOI 10.1002/jcp.24340; Miyawaki A, 2003, CURR OPIN CHEM BIOL, V7, P557, DOI 10.1016/S1367-5931(03)00097-8; MODI RI, 1991, EVOLUTION, V45, P656, DOI 10.1111/j.1558-5646.1991.tb04336.x; MOLIN G, 1992, ANTON LEEUW INT J G, V61, P167, DOI 10.1007/BF00584223; Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251; NOACK D, 1981, MOL GEN GENET, V184, P121, DOI 10.1007/BF00271207; O'Hara AM, 2006, IMMUNOLOGY, V118, P202, DOI 10.1111/j.1365-2567.2006.02358.x; Oh PL, 2010, ISME J, V4, P377, DOI 10.1038/ismej.2009.123; PALOHEIMO M, 1992, APPL MICROBIOL BIOT, V36, P584; Perez-Burgos A, 2015, J PHYSIOL-LONDON, V593, P3943, DOI 10.1113/JP270229; Ponciano JM, 2007, GENETICS, V176, P957, DOI 10.1534/genetics.106.061937; Rhee KJ, 2011, GUT MICROBES, V2, P34, DOI 10.4161/gmic.2.1.14882; Rud I, 2006, MICROBIOL-SGM, V152, P1011, DOI 10.1099/mic.0.28599-0; Ruiz PA, 2005, IMMUNOLOGY, V115, P441, DOI 10.1111/j.1365-2567.2005.02176.x; Schreiber O, 2009, AM J PHYSIOL-GASTR L, V296, pG534, DOI 10.1152/ajpgi.90470.2008; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shu XK, 2006, BIOCHEMISTRY-US, V45, P9639, DOI 10.1021/bi060773l; Sorensen SJ, 2005, NAT REV MICROBIOL, V3, P700, DOI 10.1038/nrmicro1232; Sorvig E, 2005, MICROBIOL-SGM, V151, P2439, DOI 10.1099/mic.0.28084-0; Sota M, 2010, ISME J, V4, P1568, DOI 10.1038/ismej.2010.72; Spinler JK, 2008, ANAEROBE, V14, P166, DOI 10.1016/j.anaerobe.2008.02.001; Tannock GW, 1992, LACTIC ACID BACTERIA, P21; Thomas CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031951; Thomas CM, 2000, MOL MICROBIOL, V37, P485, DOI 10.1046/j.1365-2958.2000.02006.x; Valeur N, 2004, APPL ENVIRON MICROB, V70, P1176, DOI 10.1128/AEM.70.2.1176-1181.2004; van Pijkeren JP, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks147; Walter J, 2011, P NATL ACAD SCI USA, V108, P4645, DOI 10.1073/pnas.1000099107; Yang FJ, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0372-1	75	29	31	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151969	10.1371/journal.pone.0151969	http://dx.doi.org/10.1371/journal.pone.0151969			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002525	Green Published, gold, Green Submitted			2022-12-26	WOS:000372697400062
J	Wijesekera, TP; Saurabh, S; Dauwalder, B				Wijesekera, Thilini P.; Saurabh, Sumit; Dauwalder, Brigitte			Juvenile Hormone Is Required in Adult Males for Drosophila Courtship	PLOS ONE			English	Article							BINDING-PROTEIN; NEURAL CIRCUITRY; LIGAND-BINDING; MANDUCA-SEXTA; TAKEOUT GENE; FAT-BODY; MELANOGASTER; BEHAVIOR; FRUITLESS; HEMOLYMPH	Juvenile Hormone (JH) has a prominent role in the regulation of insect development. Much less is known about its roles in adults, although functions in reproductive maturation have been described. In adult females, JH has been shown to regulate egg maturation and mating. To examine a role for JH in male reproductive behavior we created males with reduced levels of Juvenile Hormone Acid O-Methyl Transferase (JHAMT) and tested them for courtship. JHAMT regulates the last step of JH biosynthesis in the Corpora Allata (CA), the organ of JH synthesis. Males with reduced levels of JHAMT showed a reduction in courtship that could be rescued by application of Methoprene, a JH analog, shortly before the courtship assays were performed. In agreement with this, reducing JHAMT conditionally in mature flies led to courtship defects that were rescuable by Methoprene. The same result was also observed when the CA were conditionally ablated by the expression of a cellular toxin. Our findings demonstrate that JH plays an important physiological role in the regulation of male mating behavior.	[Wijesekera, Thilini P.; Saurabh, Sumit; Dauwalder, Brigitte] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Wijesekera, Thilini P.] Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA; [Wijesekera, Thilini P.] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA	University of Houston System; University of Houston; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Dauwalder, B (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX USA.	bdauwalder@uh.edu	Saurabh, Sumit/ABD-8993-2020	Sumit Saurabh, Sumit/0000-0001-7661-1914	National Science Foundation [IOS-0919697]	National Science Foundation(National Science Foundation (NSF))	This study was supported by the National Science Foundation (nsf.gov) Grant number IOS-0919697. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2001, GENETICS, V158, P1569; Argue KJ, 2013, HORM BEHAV, V64, P589, DOI 10.1016/j.yhbeh.2013.08.018; BELLEN HJ, 1992, DEVELOPMENT, V114, P787; Bilen J, 2013, P NATL ACAD SCI USA, V110, P18321, DOI 10.1073/pnas.1318119110; BOWNES M, 1983, J EMBRYOL EXP MORPH, V75, P241; Cachero S, 2010, CURR BIOL, V20, P1589, DOI 10.1016/j.cub.2010.07.045; Charles JP, 2011, P NATL ACAD SCI USA, V108, P21128, DOI 10.1073/pnas.1116123109; DAI JD, 1991, DEV BIOL, V144, P309, DOI 10.1016/0012-1606(91)90424-2; Dauwalder B, 2002, GENE DEV, V16, P2879, DOI 10.1101/gad.1010302; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Dubrovsky EB, 2002, INSECT BIOCHEM MOLEC, V32, P1555, DOI 10.1016/S0965-1748(02)00076-0; Gilbert LI, 2000, INSECT BIOCHEM MOLEC, V30, P617, DOI 10.1016/S0965-1748(00)00034-5; GLINKA AV, 1995, INSECT BIOCHEM MOLEC, V25, P775, DOI 10.1016/0965-1748(94)00098-3; GOODMAN W, 1978, MOL CELL ENDOCRINOL, V11, P225, DOI 10.1016/0303-7207(78)90010-2; GREENSPAN RJ, 1995, SCI AM, V272, P72, DOI 10.1038/scientificamerican0495-72; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Lazareva AA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030016; Li YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028269; Manoli DS, 2005, NATURE; McGuire SE, 2004, TRENDS GENET, V20, P384, DOI 10.1016/j.tig.2004.06.012; Niwa R, 2008, INSECT BIOCHEM MOLEC, V38, P714, DOI 10.1016/j.ibmb.2008.04.003; NOWOCK J, 1975, GEN COMP ENDOCR, V27, P230, DOI 10.1016/0016-6480(75)90238-5; OZYHAR A, 1987, EUR J BIOCHEM, V162, P675, DOI 10.1111/j.1432-1033.1987.tb10690.x; POSTLETHWAIT JH, 1974, BIOL BULL-US, V147, P119, DOI 10.2307/1540573; Riddiford LM, 2010, DEVELOPMENT, V137, P1117, DOI 10.1242/dev.037218; Rideout EJ, 2010, NAT NEUROSCI, V13, P458, DOI 10.1038/nn.2515; RINGO J, 1992, BEHAV GENET, V22, P469, DOI 10.1007/BF01066616; Sarov-Blat L, 2000, CELL, V101, P647, DOI 10.1016/S0092-8674(00)80876-4; Sheng ZT, 2008, ARCH INSECT BIOCHEM, V69, P143, DOI 10.1002/arch.20268; SHTORCH A, 1995, ARCH INSECT BIOCHEM, V30, P195, DOI 10.1002/arch.940300209; SLITER TJ, 1987, INSECT BIOCHEM, V17, P161, DOI 10.1016/0020-1790(87)90156-9; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; TOMPKINS L, 1990, J NEUROGENET, V6, P221, DOI 10.3109/01677069009107112; TROWELL SC, 1992, COMP BIOCHEM PHYS B, V103, P795, DOI 10.1016/0305-0491(92)90196-X; Truman JW, 2007, INSECT BIOCHEM MOLEC, V37, P761, DOI 10.1016/j.ibmb.2007.05.011; Villella A, 2008, ADV GENET, V62, P67, DOI 10.1016/S0065-2660(08)00603-2; WILSON TG, 1986, DEV BIOL, V118, P190, DOI 10.1016/0012-1606(86)90087-4; Wilson TG, 2003, INSECT BIOCHEM MOLEC, V33, P1167, DOI 10.1016/j.ibmb.2003.06.007; WOJTASEK H, 1995, BIOCHEMISTRY-US, V34, P5234, DOI 10.1021/bi00015a037; Yamamoto R, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-85; Yu JY, 2010, CURR BIOL, V20, P1602, DOI 10.1016/j.cub.2010.08.025	42	34	34	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151912	10.1371/journal.pone.0151912	http://dx.doi.org/10.1371/journal.pone.0151912			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003411	gold, Green Published, Green Submitted			2022-12-26	WOS:000372697400055
J	Nanda, N; Dhawan, DK; Bhatia, A; Mahmood, A; Mahmood, S				Nanda, Neha; Dhawan, Devinder K.; Bhatia, Alka; Mahmood, Akhtar; Mahmood, Safrun			Doxycycline Promotes Carcinogenesis & Metastasis via Chronic Inflammatory Pathway: An In Vivo Approach	PLOS ONE			English	Article							NF-KAPPA-B; COLORECTAL-CANCER CELLS; HUMAN BREAST-CANCER; METABOLIC-ACTIVATION; TUMOR BURDEN; COLON-CANCER; MATRIX-METALLOPROTEINASE-9; MODEL; MICE; PROGRESSION	Background Doxycycline (DOX) exhibits anti-inflammatory, anti-tumor, and pro-apoptotic activity and is being tested in clinical trials as a chemotherapeutic agent for several cancers, including colon cancer. Materials & Methods In the current study, the chemotherapeutic activity of doxycycline was tested in a rat model of colon carcinogenesis, induced by colon specific cancer promoter, 1,2, dimethylhydrazine (DMH) as well as study the effect of DOX-alone on a separate group of rats. Results Doxycycline administration in DMH-treated rats (DMH-DOX) unexpectedly increased tumor multiplicity, stimulated progression of colonic tumor growth from adenomas to carcinomas and revealed metastasis in small intestine as determined by macroscopic and histopathological analysis. DOX-alone treatment showed markedly enhanced chronic inflammation and reactive hyperplasia, which was dependent upon the dose of doxycycline administered. Moreover, immunohistochemical analysis revealed evidence of inflammation and anti-apoptotic action of DOX by deregulation of various biomarkers. Conclusion These results suggest that doxycycline caused chronic inflammation in colon, small intestine injury, enhanced the efficacy of DMH in tumor progression and provided a mechanistic link between doxycycline-induced chronic inflammation and tumorigenesis. Ongoing studies thus may need to focus on the molecular mechanisms of doxycycline action, which lead to its inflammatory and tumorigenic effects.	[Nanda, Neha; Bhatia, Alka; Mahmood, Safrun] Postgrad Inst Med Educ & Res, Dept Expt Med & Biotechnol, Chandigarh 160012, India; [Nanda, Neha; Dhawan, Devinder K.] Panjab Univ, Dept Biophys, Chandigarh 160014, India; [Mahmood, Akhtar] Panjab Univ, Dept Biochem, Chandigarh 160014, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Panjab University; Panjab University	Mahmood, S (corresponding author), Postgrad Inst Med Educ & Res, Dept Expt Med & Biotechnol, Chandigarh 160012, India.; Dhawan, DK (corresponding author), Panjab Univ, Dept Biophys, Chandigarh 160014, India.	dhawan@pu.ac.in; mahmoodpgi@gmail.com			Indian Council of Medical Research (ICMR), New Delhi, India, [3/1/3/JRF-2009/MPD-74]	Indian Council of Medical Research (ICMR), New Delhi, India,(Indian Council of Medical Research (ICMR))	The authors would like to thank Indian Council of Medical Research (ICMR), New Delhi, India, (Reference No-3/1/3/JRF-2009/MPD-74) for financial support to the research work. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkaya P, 2009, HUM REPROD, V24, P1900, DOI 10.1093/humrep/dep106; American Cancer Society, 2014, COL CANC FACTS FIG 2; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Chadha VD, 2007, MOL CELL BIOCHEM, V304, P101, DOI 10.1007/s11010-007-9490-x; Chen XW, 2005, INT J CANCER, V116, P52, DOI 10.1002/ijc.20997; Cooks T, 2013, CANCER CELL, V23, P634, DOI 10.1016/j.ccr.2013.03.022; Dance-Barnes ST, 2009, CARCINOGENESIS, V30, P1016, DOI 10.1093/carcin/bgp082; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Duivenvoorden WCM, 2007, BRIT J CANCER, V96, P1526, DOI 10.1038/sj.bjc.6603740; Duivenvoorden WCM, 2002, CANCER RES, V62, P1588; Dursun D, 2001, AM J OPHTHALMOL, V132, P8, DOI 10.1016/S0002-9394(01)00913-8; Fainaru O, 2008, FASEB J, V22, P3728, DOI 10.1096/fj.08-110494; FIALA ES, 1987, J CANCER RES CLIN, V113, P145, DOI 10.1007/BF00391436; Fife R S, 1998, Adv Dent Res, V12, P94; Fischer A. H., 2008, CSH PROTOC, V3; Fujioka S, 2004, MOL CELL BIOL, V24, P7806, DOI 10.1128/MCB.24.17.7806-7819.2004; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Jubb AM, 2006, NAT REV CANCER, V6, P626, DOI 10.1038/nrc1946; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kovacs Z, 2011, NEUROCHEM INT, V59, P563, DOI 10.1016/j.neuint.2011.06.016; LIOTTA LA, 1980, NATURE, V284, P67, DOI 10.1038/284067a0; Liu XD, 2008, J IMMUNOL, V181, P449, DOI 10.4049/jimmunol.181.1.449; Loughery J., 2013, BIODISCOVERY, V8, pe8946, DOI [10.7750/BioDiscovery.2013.8.1, DOI 10.7750/BI0DISC0VERY.2013.8.1]; Malhotra P, 2013, TUMOR BIOL, V34, P1901, DOI 10.1007/s13277-013-0734-y; Megaraj V, 2014, CHEM RES TOXICOL, V27, P656, DOI 10.1021/tx4004769; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Mouratidis PXE, 2007, INT J CANCER, V120, P743, DOI 10.1002/ijc.22303; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Onoda T, 2006, INT J CANCER, V118, P1309, DOI 10.1002/ijc.21447; Onoda T, 2004, J LAB CLIN MED, V143, P207, DOI 10.1016/j.lab.2003.12.012; Panico A, 2015, MEDCHEMCOMM, V6, P823, DOI 10.1039/c4md00556b; Pettan-Brewer C, 2012, AM J CANCER RES, V2, P168; Pozzi A, 2002, ONCOGENE, V21, P272, DOI 10.1038/sj.onc.1205045; Rui LX, 2011, NAT IMMUNOL, V12, P933, DOI 10.1038/ni.2094; Sagar J, 2010, CLIN MED INSIGHTS-TH, V2, P133; Sagar J, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-31; Schmidt A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00051; Shostak K, 2015, TRENDS MOL MED, V21, P385, DOI 10.1016/j.molmed.2015.04.001; Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220; Soler AP, 1999, CARCINOGENESIS, V20, P1425, DOI 10.1093/carcin/20.8.1425; Sun BC, 2007, EXP BIOL MED, V232, P1300, DOI 10.3181/0705-RM-145; Tahan Veysel, 2008, Cases J, V1, P144, DOI 10.1186/1757-1626-1-144; Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801; Veeramachaneni N., 2003, J SURG RES, V114, P251; Walker SR, 2014, CANCERS, V6, P958, DOI 10.3390/cancers6020958; Wang F, 2015, MOL CANCER, V14, DOI 10.1186/s12943-014-0274-0; Webster GA, 1999, MOL CELL BIOL, V19, P3485; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015	51	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151539	10.1371/journal.pone.0151539	http://dx.doi.org/10.1371/journal.pone.0151539			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998758	Green Published, gold			2022-12-26	WOS:000372694700045
J	Slancarova, J; Bartonova, A; Zapletal, M; Kotilinek, M; Fric, ZF; Micevski, N; Kati, V; Konvicka, M				Slancarova, Jana; Bartonova, Alena; Zapletal, Michal; Kotilinek, Milan; Fric, Zdenek Faltynek; Micevski, Nikola; Kati, Vasiliki; Konvicka, Martin			Life History Traits Reflect Changes in Mediterranean Butterfly Communities Due to Forest Encroachment	PLOS ONE			English	Article							AGRICULTURAL LAND ABANDONMENT; PLANT-COMMUNITIES; SPECIES RICHNESS; LANDSCAPE; CLIMATE; EUROPE; DIVERSITY; RESPONSES; HABITAT; LEPIDOPTERA	The biodiversity of the Southern Balkans, part of the Mediterranean global biodiversity hotspot, is threatened by land use intensification and abandonment, the latter causing forest encroachment of formerly open habitats. We investigated the impact of forest encroachment on butterfly species richness, community species composition and the representation of life history traits by repeated seasonal visits of 150 one-hectare sites in five separate regions in three countries-Greece, Bulgaria, and the Republic of Macedonia (FYROM-the Former Yugoslav Republic of Macedonia)-10 replicates for each habitat type of grasslands, open formations and scrub forest within each region. Grasslands and open formations sites hosted in average more species and more red-listed species than scrub forest, while no pattern was found for numbers of Mediterranean species. As shown by ordination analyses, each of the three habitat types hosted distinct butterfly communities, with Mediterranean species inclining either towards grasslands or open formations. Analysing the representation of life history traits revealed that successional development from grasslands and open formations towards scrub forest shifts the community composition towards species overwintering in earlier stages, having fewer generations per year, and inhabiting large European or Eurosiberian (e. g. northern) ranges; it decreases the representation of Mediterranean endemics. The loss of grasslands and semi-open formations due to forest encroachment thus threatens exactly the species that should be the focus of conservation attention in the Mediterranean region, and innovative conservation actions to prevent ongoing forest encroachment are badly needed.	[Slancarova, Jana; Bartonova, Alena; Zapletal, Michal; Kotilinek, Milan; Konvicka, Martin] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Slancarova, Jana; Bartonova, Alena; Zapletal, Michal; Fric, Zdenek Faltynek; Konvicka, Martin] CAS, Inst Entomol, Ctr Biol, Ceske Budejovice, Czech Republic; [Micevski, Nikola] Macedonian Entomol Soc ENTOMAK, Skopje, North Macedonia; [Kati, Vasiliki] Univ Patras, Dept Environm & Nat Resources Management, Agrinion, Greece	University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of Patras	Slancarova, J; Konvicka, M (corresponding author), Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic.; Slancarova, J; Konvicka, M (corresponding author), CAS, Inst Entomol, Ctr Biol, Ceske Budejovice, Czech Republic.	slancaro@mail.com; konva333@gmail.com	Liparova, Jana/H-7748-2012; Kati, Vassiliki I/AAB-9418-2020; Konvicka, Martin/H-1446-2014; Bartonova, Alena Suchackova/ABH-7498-2020; FALTYNEK, FRIC ZDENEK/H-1468-2014	Kati, Vassiliki I/0000-0003-3357-4556; Bartonova, Alena Suchackova/0000-0001-6298-2466; FALTYNEK, FRIC ZDENEK/0000-0002-3611-8022	University of South Bohemia [114/2012/P, 168/2013/P]; Institute of Entomology: The Xerxes Society; Explorer Club; Biology Centre CAS, Institute of Vertebrate Biology [CZ.1.07/2.4.00/17.0138]; University of South Bohemia, University of South Bohemia [144/2010/P]; Biology Centre CAS, Institute of Entomology [14-33733S]; Grant Agency of the Czech Republic	University of South Bohemia; Institute of Entomology: The Xerxes Society; Explorer Club; Biology Centre CAS, Institute of Vertebrate Biology; University of South Bohemia, University of South Bohemia; Biology Centre CAS, Institute of Entomology; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This work was supported by University of South Bohemia: 114/2012/P, 168/2013/P, (https://gaju.jcu.cz/) to JS; Biology Centre CAS, Institute of Entomology: The Xerxes Society 2012 (http://www.xerces.org/joan-dewind-award/) to JS; Explorer Club 2013 (https://explorersclub.org/expeditions/funding/2013_grant_awardees) to JS; Biology Centre CAS, Institute of Vertebrate Biology: CZ.1.07/2.4.00/17.0138 (http://www.ivb.cz/institute.html) to JS; University of South Bohemia: 144/2010/P, University of South Bohemia (http://gaju.jcu.cz/) to MK; and Biology Centre CAS, Institute of Entomology: 14-33733S, The Grant Agency of the Czech Republic (www.gacr.cz) to MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, FAUNA EUROPAEA VERSI; Bartonova A, 2014, EUR J ENTOMOL, V111, P543, DOI 10.14411/eje.2014.060; Blondel J., 1999, Biology and wildlife of the Mediterranean region.; Borschig C, 2013, BASIC APPL ECOL, V14, P547, DOI 10.1016/j.baae.2013.09.002; Bunce RGH, 1998, ENVIRON CONSERV, V25, P219, DOI 10.1017/S0376892998000277; Carnicer J, 2013, GLOBAL ECOL BIOGEOGR, V22, P6, DOI 10.1111/j.1466-8238.2012.00762.x; Cizek L, 2006, ECOL ENTOMOL, V31, P337, DOI 10.1111/j.1365-2311.2006.00783.x; Cizek O, 2012, J INSECT CONSERV, V16, P215, DOI 10.1007/s10841-011-9407-6; Coreau A, 2007, LANDSCAPE ECOL, V22, P747, DOI 10.1007/s10980-006-9074-2; Cremene C, 2005, CONSERV BIOL, V19, P1606, DOI 10.1111/j.1523-1739.2005.00084.x; Debussche M, 1999, GLOBAL ECOL BIOGEOGR, V8, P3, DOI 10.1046/j.1365-2699.1999.00316.x; Dennis RLH, 2004, ECOL ENTOMOL, V29, P12, DOI 10.1111/j.1365-2311.2004.00572.x; Dobson M, 1998, MAMMAL REV, V28, P77, DOI 10.1046/j.1365-2907.1998.00027.x; Dover JW, 2011, J INSECT CONSERV, V15, P523, DOI 10.1007/s10841-010-9331-1; Dover JW, 2010, J INSECT CONSERV, V14, P413, DOI 10.1007/s10841-010-9267-5; Farris E, 2010, J NAT CONSERV, V18, P258, DOI 10.1016/j.jnc.2009.11.003; GARCIABARROS E, 1988, ECOL ENTOMOL, V13, P391, DOI 10.1111/j.1365-2311.1988.tb00371.x; Grill A, 2005, BIODIVERS CONSERV, V14, P1281, DOI 10.1007/s10531-004-1661-4; Grill A, 2003, BIOL CONSERV, V114, P427, DOI 10.1016/S0006-3207(03)00070-3; Grove AT., 2003, NATURE MEDITERRANEAN; Hadjigeorgiou I, 2005, LIVEST PROD SCI, V96, P51, DOI 10.1016/j.livprodsci.2005.05.016; Kadlec T, 2012, J INSECT CONSERV, V16, P275, DOI 10.1007/s10841-011-9414-7; Kati V, 2004, BIOL CONSERV, V115, P33, DOI 10.1016/S0006-3207(03)00091-0; Knop E, 2006, J APPL ECOL, V43, P120, DOI 10.1111/j.1365-2664.2005.01113.x; Konvicka M, 1999, J INSECT CONSERV, V3, P211, DOI 10.1023/A:1009641618795; Leingartner A, 2014, OECOLOGIA, V175, P613, DOI 10.1007/s00442-014-2917-7; Lopez-Villalta JS, 2010, B INSECTOL, V63, P161; MacDonald D, 2000, J ENVIRON MANAGE, V59, P47, DOI 10.1006/jema.1999.0335; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Metzger MJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P549, DOI 10.1111/j.1466-822x.2005.00190.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Ohwaki A, 2007, BIODIVERS CONSERV, V16, P1521, DOI 10.1007/s10531-006-9042-9; Pamperis LN, 1997, BUTTERFLIES GREECE; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Sanchez-Rodriguez J. F., 1995, Journal of the Lepidopterists' Society, V49, P192; Schoville SD, 2009, MOL ECOL, V18, P3471, DOI 10.1111/j.1365-294X.2009.04287.x; Settele J, 2009, ECOLOGY BUTTERFLIES, P315; Sirami C, 2007, DIVERS DISTRIB, V13, P42, DOI 10.1111/j.1472-4642.2006.00297.x; Slamova I, 2013, INSECT CONSERV DIVER, V6, P243, DOI 10.1111/j.1752-4598.2012.00212.x; Slancarova J, 2015, J INSECT CONSERV, V19, P823, DOI 10.1007/s10841-015-9801-6; Stefanescu C, 2004, J BIOGEOGR, V31, P905, DOI 10.1111/j.1365-2699.2004.01088.x; Stefanescu C, 2005, BIOL CONSERV, V126, P234, DOI 10.1016/j.biocon.2005.05.010; Stefanescu C, 2011, ECOGRAPHY, V34, P353, DOI 10.1111/j.1600-0587.2010.06264.x; Stefanescu C, 2011, J INSECT CONSERV, V15, P83, DOI 10.1007/s10841-010-9325-z; Steffan-Dewenter I, 1997, OECOLOGIA, V109, P294, DOI 10.1007/s004420050087; Steiner Roland, 2000, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), V606, P1; Stoate C, 2009, J ENVIRON MANAGE, V91, P22, DOI 10.1016/j.jenvman.2009.07.005; Strijker D, 2005, BASIC APPL ECOL, V6, P99, DOI 10.1016/j.baae.2005.01.001; Suggitt AJ, 2012, BIOL LETTERS, V8, P590, DOI 10.1098/rsbl.2012.0112; Tansley A.G., 1926, AIMS METHODS STUDY V; Ter Braak C.J.F., 2013, CANOCO 5 WINDOWS REL; The R Core Team, 2012, R VERS 2 15 2; Tolman T, 2009, COLLINS BUTTERFLY GU; van der Leeuw S. E., 2004, DYNAMICS MEDITERRANE, P121; Van Dyck H, 2009, CONSERV BIOL, V23, P957, DOI 10.1111/j.1523-1739.2009.01175.x; Van Swaay C., 2013, 112013136 EUR ENV AG, DOI [10.2800/89760, DOI 10.2800/89760]; van Swaay Chris, 2010, pi; van Swaay CAM, 2008, BIODIVERS CONSERV, V17, P3455, DOI 10.1007/s10531-008-9491-4; Zakkak S, 2014, J INSECT CONSERV, V18, P599, DOI 10.1007/s10841-014-9663-3; Zakkak S, 2014, J NAT CONSERV, V22, P157, DOI 10.1016/j.jnc.2013.11.001; Zografou K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087245; Zografou K, 2009, J INSECT CONSERV, V13, P505, DOI 10.1007/s10841-008-9198-6	62	20	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0152026	10.1371/journal.pone.0152026	http://dx.doi.org/10.1371/journal.pone.0152026			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999008	Green Published, gold, Green Submitted			2022-12-26	WOS:000372694700093
J	Lim, HD; Kim, MH; Lee, CY; Namgung, U				Lim, Hee-Don; Kim, Min-Hee; Lee, Chan-Yong; Namgung, Uk			Anti-Inflammatory Effects of Acupuncture Stimulation via the Vagus Nerve	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; SOLITARY TRACT; BRAIN-STEM; ENDOTOXEMIA; NUCLEUS; NEURONS; PATHWAY; ELECTROACUPUNCTURE; ACTIVATION; RECEPTORS	Although acupuncture therapy is widely used in traditional Asian medicine for the treatment of diverse internal organ disorders, its underlying biological mechanisms are largely unknown. Here, we investigated the functional involvement of acupuncture stimulation (AS) in the regulation of inflammatory responses. TNF-alpha production in mouse serum, which was induced by lipopolysaccharide (LPS) administration, was decreased by manual acupuncture (MAC) at the zusanli acupoint (stomach36, ST36). In the spleen, TNF-alpha mRNA and protein levels were also downregulated by MAC and were recovered by using a splenic neurectomy and a vagotomy. c-Fos, which was induced in the nucleus tractus solitarius (NTS) and dorsal motor nucleus of the vagus nerve (DMV) by LPS and electroacupuncture (EAC), was further increased by focal administration of the AMPA receptor blocker CNQX and the purinergic receptor antagonist PPADS. TNF-alpha levels in the spleen were decreased by CNQX and PPADS treatments, implying the involvement of inhibitory neuronal activity in the DVC. In unanesthetized animals, both MAC and EAC generated c-Fos induction in the DVC neurons. However, MAC, but not EAC, was effective in decreasing splenic TNF-alpha production. These results suggest that the therapeutic effects of acupuncture may be mediated through vagal modulation of inflammatory responses in internal organs.	[Lim, Hee-Don; Kim, Min-Hee; Namgung, Uk] Daejeon Univ, Dept Oriental Med, Daejeon, South Korea; [Lee, Chan-Yong] Daejeon Univ, Dept Microbiol & Biotechnol, Daejeon, South Korea	Daejeon University; Daejeon University	Namgung, U (corresponding author), Daejeon Univ, Dept Oriental Med, Daejeon, South Korea.	unamgung@dju.kr			Basic Science Research Programs through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [2013056735]; Ministry of Education [2013011219]	Basic Science Research Programs through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning; Ministry of Education	This work was supported by grants from the Basic Science Research Programs through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (2013056735) and by the Ministry of Education (2013011219), URL: www.nrf.re.kr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Basic Science Research Programs through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (2013056735) and by the Ministry of Education (2013011219).	Andersson U, 2012, J EXP MED, V209, P1057, DOI 10.1084/jem.20120571; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bratton BO, 2012, EXP PHYSIOL, V97, P1180, DOI 10.1113/expphysiol.2011.061531; Buijs RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003152; Burnstock G, 2014, SCIENCE, V346, pS23; Cailotto C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087785; Cano G, 2001, J COMP NEUROL, V439, P1, DOI 10.1002/cne.1331; Chang IA, 2013, J ACUPUNCT MERIDIAN, V6, P89, DOI 10.1016/j.jams.2012.12.004; Chang IA, 2012, FASEB J, V26, P2401, DOI 10.1096/fj.11-199018; Chiu IM, 2012, NAT NEUROSCI, V15, P1063, DOI 10.1038/nn.3144; Goldman N, 2010, NAT NEUROSCI, V13, P883, DOI 10.1038/nn.2562; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Hermann GE, 2008, NEUROSCIENTIST, V14, P53, DOI 10.1177/1073858407305725; Illes P, 2012, NEUROSCIENTIST, V18, P422, DOI 10.1177/1073858411418524; Iwa M, 2006, AM J PHYSIOL-GASTR L, V290, pG285, DOI 10.1152/ajpgi.00068.2005; Janig W, 2006, INTEGRATIVE ACTION OF THE AUTONOMIC NERVOUS SYSTEM: NEUROBIOLOGY OF HOMEOSTASIS, P1; Kavoussi B, 2007, INTEGR CANCER THER, V6, P251, DOI 10.1177/1534735407305892; Kim MH, 2012, J ACUPUNCT MERIDIAN, V5, P148, DOI [10.1016/j.jams.2012.05.002/, 10.1016/j.jams.2012.05.002]; Kim SY, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1086; Langevin HM, 2001, FASEB J, V15, P2275, DOI 10.1096/fj.01-0015hyp; Leake R., 1999, INTEGR MED, V1, P107; LUX G, 1994, GUT, V35, P1026, DOI 10.1136/gut.35.8.1026; Martelli D, 2014, AUTON NEUROSCI-BASIC, V182, P65, DOI 10.1016/j.autneu.2013.12.007; McDougal DH, 2011, J NEUROSCI, V31, P14037, DOI 10.1523/JNEUROSCI.2855-11.2011; MENETREY D, 1987, J COMP NEUROL, V255, P439, DOI 10.1002/cne.902550310; Nishijo K, 1997, NEUROSCI LETT, V227, P165, DOI 10.1016/S0304-3940(97)00337-6; Noguchi E, 2010, AUTON NEUROSCI-BASIC, V156, P15, DOI 10.1016/j.autneu.2010.06.010; Pavlov VA, 2006, P NATL ACAD SCI USA, V103, P5219, DOI 10.1073/pnas.0600506103; Potts JT, 2006, EXP PHYSIOL, V91, P59, DOI 10.1113/expphysiol.2005.032227; Rosas-Ballina M, 2008, P NATL ACAD SCI USA, V105, P11008, DOI 10.1073/pnas.0803237105; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Taniguchi T, 2005, MINI-REV MED CHEM, V5, P241, DOI 10.2174/1389557053175407; Toney GM, 2000, J APPL PHYSIOL, V88, P2062, DOI 10.1152/jappl.2000.88.6.2062; Torres-Rosas R, 2014, NAT MED, V20, P291, DOI 10.1038/nm.3479; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Travagli RA, 2006, ANNU REV PHYSIOL, V68, P279, DOI 10.1146/annurev.physiol.68.040504.094635; Xu GY, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2009.01354.x; Yang FL, 2007, SHOCK, V28, P309, DOI 10.1097/shk.0b013e31803dd04d; Yin JY, 2010, AUTON NEUROSCI-BASIC, V157, P31, DOI 10.1016/j.autneu.2010.03.007; Zagon A, 2001, EUR J NEUROSCI, V13, P781, DOI 10.1046/j.0953-816x.2000.01445.x	41	75	88	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151882	10.1371/journal.pone.0151882	http://dx.doi.org/10.1371/journal.pone.0151882			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991319	gold, Green Published, Green Submitted			2022-12-26	WOS:000372582800113
J	Dey, A; Shree, S; Pandey, SK; Tripathi, RP; Ramachandran, R				Dey, Abhishek; Shree, Sonal; Pandey, Sarvesh Kumar; Tripathi, Rama Pati; Ramachandran, Ravishankar			Crystal Structure of Mycobacterium tuberculosis H37Rv AldR (Rv2779c), a Regulator of the ald Gene DNA BINDING AND IDENTIFICATION OF SMALL MOLECULE INHIBITORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENCODING ALANINE DEHYDROGENASE; MYCOBACTERIUM-TUBERCULOSIS; ESCHERICHIA-COLI; LRP/ASNC FAMILY; STRUCTURE VALIDATION; EFFECTOR-BINDING; PROTEIN; FL11; LRP; RECOGNITION	Here we report the crystal structure of M. tuberculosis AldR (Rv2779c) showing that the N-terminal DNA-binding domains are swapped, forming a dimer, and four dimers are assembled into an octamer through crystal symmetry. The C-terminal domain is involved in oligomeric interactions that stabilize the oligomer, and it contains the effector-binding sites. The latter sites are 30-60% larger compared with homologs like MtbFFRP (Rv3291c) and can consequently accommodate larger molecules. MtbAldR binds to the region upstream to the ald gene that is highly up-regulated in nutrient-starved tuberculosis models and codes for L-alanine dehydrogenase (MtbAld; Rv2780). Further, the MtbAldR-DNA complex is inhibited upon binding of Ala, Tyr, Trp and Asp to the protein. Studies involving a ligand-binding site G131T mutant show that the mutant forms a DNA complex that cannot be inhibited by adding the amino acids. Comparative studies suggest that binding of the amino acids changes the relative spatial disposition of the DNA-binding domains and thereby disrupt the protein-DNA complex. Finally, we identified small molecules, including a tetrahydroquinoline carbonitrile derivative (S010-0261), that inhibit the MtbAldR-DNA complex. The latter molecules represent the very first inhibitors of a feast/famine regulatory protein from any source and set the stage for exploring MtbAldR as a potential anti-tuberculosis target.	[Dey, Abhishek; Shree, Sonal; Ramachandran, Ravishankar] Cent Drug Res Inst, CSIR, Mol & Struct Biol Div, Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India; [Pandey, Sarvesh Kumar; Tripathi, Rama Pati] Cent Drug Res Inst, CSIR, Med & Proc Chem Div, Sitapur Rd, Lucknow 226031, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Ramachandran, R (corresponding author), Cent Drug Res Inst, CSIR, Mol & Struct Biol Div, Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India.	r_ravishankar@cdri.res.in	Shree, Sonal/AAE-9442-2020; Dey, Abhishek/AAA-4517-2022	Shree, Sonal/0000-0002-5665-8157; Dey, Abhishek/0000-0002-3899-1124	Council of Scientific and Industrial Research (CSIR), India [BSC0104, BSC0121]; Indian Council of Medical Research; University Grants Commission; CSIR	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); University Grants Commission(University Grants Commission, India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was funded by Council of Scientific and Industrial Research (CSIR), India, vide Grants BSC0104 (SPLenDID) and BSC0121 (GENESIS). This paper bears the CDRI communication number 9203. The authors declare that they have no conflicts of interest with the contents of this article.r Recipient of a fellowship from the Indian Council of Medical Research.r Recipient of a fellowship from the University Grants Commission.r Recipient of a fellowship from CSIR.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Beloin C, 2003, J BIOL CHEM, V278, P5333, DOI 10.1074/jbc.M207489200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; CALVO JM, 1994, MICROBIOL REV, V58, P466, DOI 10.1128/MMBR.58.3.466-490.1994; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; de los Rios S, 2007, J MOL BIOL, V366, P1589, DOI 10.1016/j.jmb.2006.12.032; Deng WY, 2011, J CELL BIOCHEM, V112, P2655, DOI 10.1002/jcb.23193; Dey A, 2014, ACTA CRYSTALLOGR F, V70, P97, DOI 10.1107/S2053230X13033128; Ducati RG, 2007, CURR DRUG TARGETS, V8, P423, DOI 10.2174/138945007780059004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Giffin MM, 2012, J BACTERIOL, V194, P1045, DOI 10.1128/JB.05914-11; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Hasan S, 2006, PLOS COMPUT BIOL, V2, P539, DOI 10.1371/journal.pcbi.0020061; Jeong JA, 2015, J BACTERIOL, V197, P3142, DOI 10.1128/JB.00453-15; Jeong JA, 2013, J BACTERIOL, V195, P3610, DOI 10.1128/JB.00482-13; Kumarevel T, 2008, NUCLEIC ACIDS RES, V36, P4808, DOI 10.1093/nar/gkn456; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; NEWMAN EB, 1992, CELL, V68, P617, DOI 10.1016/0092-8674(92)90135-Y; Parish T, 2002, MICROBIOL-SGM, V148, P3069, DOI 10.1099/00221287-148-10-3069; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Schwaiger R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-40; Shrivastava T, 2007, NUCLEIC ACIDS RES, V35, P7324, DOI 10.1093/nar/gkm850; Shrivastava T, 2009, J MOL BIOL, V392, P1007, DOI 10.1016/j.jmb.2009.07.084; Singh P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026629; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Tani TH, 2002, P NATL ACAD SCI USA, V99, P13471, DOI 10.1073/pnas.212510999; Thaw P, 2006, NUCLEIC ACIDS RES, V34, P1439, DOI 10.1093/nar/gkl009; Tina KG, 2007, NUCLEIC ACIDS RES, V35, pW473, DOI 10.1093/nar/gkm423; Tripathi SM, 2008, PROTEINS, V72, P1089, DOI 10.1002/prot.22101; Tripathi SM, 2006, J MOL BIOL, V362, P877, DOI 10.1016/j.jmb.2006.08.019; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yamada M, 2009, PROTEINS, V74, P520, DOI 10.1002/prot.22269; Yokoyama K, 2006, FEMS MICROBIOL REV, V30, P89, DOI 10.1111/j.1574-6976.2005.00005.x; Yokoyama K, 2007, STRUCTURE, V15, P1542, DOI 10.1016/j.str.2007.10.015; Yokoyama K, 2009, NUCLEIC ACIDS RES, V37, P4407, DOI 10.1093/nar/gkp378	37	13	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 3	2016	291	23					11967	11980		10.1074/jbc.M115.700484	http://dx.doi.org/10.1074/jbc.M115.700484			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DO9GJ	27006398	Green Published, hybrid			2022-12-26	WOS:000378092800002
J	Kouzoukas, DE; Ma, F; Meyer-Siegler, KL; Westlund, KN; Hunt, DE; Vera, PL				Kouzoukas, Dimitrios E.; Ma, Fei; Meyer-Siegler, Katherine L.; Westlund, Karin N.; Hunt, David E.; Vera, Pedro L.			Protease-Activated Receptor 4 Induces Bladder Pain through High Mobility Group Box-1	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; INTERSTITIAL CYSTITIS; HMGB1; MICE; HYPERSENSITIVITY; PANCREATITIS; EXPRESSION; MODELS; URINE; RATS	Pain is the significant presenting symptom in Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS). Activation of urothelial protease activated receptor 4 (PAR4) causes pain through release of urothelial macrophage migration inhibitory factor (MIF). High Mobility Group Box-1 (HMGB1), a chromatin-binding protein, mediates bladder pain (but not inflammation) in an experimental model (cyclophosphamide) of cystitis. To determine if PAR4-induced bladder hypersensitivity depends on HMGB1 downstream, we tested whether: 1) bladder PAR4 stimulation affected urothelial HMGB1 release; 2) blocking MIF inhibited urothelial HMGB1 release; and 3) blocking HMGB1 prevented PAR4-induced bladder hypersensitivity. HMGB1 release was examined in immortalized human urothelial cultures (UROtsa) exposed to PAR4-activating peptide (PAR4-AP; 100 mu M; 2 hours) or scrambled control peptide. Female C57BL/6 mice, pretreated with a HMGB1 inhibitor (glycyrrhizin: 50 mg/kg; ip) or vehicle, received intravesical PAR4-AP or a control peptide (100 mu M; 1 hour) to determine 1) HMGB1 levels at 1 hour in the intravesical fluid (released HMGB1) and urothelium, and 2) abdominal hypersensitivity to von Frey filament stimulation 24 hours later. We also tested mice pretreated with a MIF blocker (ISO-1: 20 mg/kg; ip) to determine whether MIF mediated PAR4-induced urothelial HMGB1 release. PAR4-AP triggered HMGB1 release from human (in vitro) and mice (in vivo) urothelial cells. Intravesical PAR4 activation elicited abdominal hypersensitivity in mice that was prevented by blocking HMGB1. MIF inhibition prevented PAR4-mediated HMGB1 release from mouse urothelium. Urothelial MIF and HGMB1 represent novel targets for therapeutic intervention in bladder pain conditions.	[Kouzoukas, Dimitrios E.; Ma, Fei; Westlund, Karin N.; Hunt, David E.; Vera, Pedro L.] Lexington Vet Affairs Med Ctr, Res & Dev, Lexington, KY USA; [Meyer-Siegler, Katherine L.] St Petersburg Coll, Dept Nat Sci, St Petersburg, FL USA; [Ma, Fei; Westlund, Karin N.; Vera, Pedro L.] Univ Kentucky, Dept Physiol, Lexington, KY USA; [Vera, Pedro L.] Univ Kentucky, Dept Surg, Lexington, KY USA; [Kouzoukas, Dimitrios E.] Univ Kentucky, Saha Cardiovasc Res Ctr, Lexington, KY USA; [Kouzoukas, Dimitrios E.] Loyola Univ Chicago, Dept Mol Pharmacol & Therapeut, Maywood, IL USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center; University of Kentucky; University of Kentucky; University of Kentucky; Loyola University Chicago	Vera, PL (corresponding author), Lexington Vet Affairs Med Ctr, Res & Dev, Lexington, KY USA.; Vera, PL (corresponding author), Univ Kentucky, Dept Physiol, Lexington, KY USA.; Vera, PL (corresponding author), Univ Kentucky, Dept Surg, Lexington, KY USA.	pedro.vera@va.gov	Kouzoukas, Dimitrios/AAH-4616-2020; Vera, Pedro/AAE-1514-2021; Kouzoukas, Dimitrios E/D-4964-2013; Kouzoukas, Dimitrios/N-6575-2019; Westlund, Karin/R-6960-2019	Kouzoukas, Dimitrios E/0000-0002-1922-670X; Kouzoukas, Dimitrios/0000-0002-1922-670X; Westlund High, Karin/0000-0002-7388-4834	National Institutes of Health [DK0093496]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK093496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by funding from the National Institutes of Health (DK0093496; P.L.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalave NM, 2014, MOL MED, V20, P569, DOI 10.2119/molmed.2014.00176; Agalave NM, 2014, PAIN, V155, P1802, DOI 10.1016/j.pain.2014.06.007; Al-Abed Y, 2005, J BIOL CHEM, V280, P36541, DOI 10.1074/jbc.C500243200; Allette YM, 2014, BRAIN BEHAV IMMUN, V42, P169, DOI 10.1016/j.bbi.2014.06.199; Berry SH, 2011, J UROLOGY, V186, P540, DOI 10.1016/j.juro.2011.03.132; BOUCHER W, 1995, BRIT J UROL, V76, P94, DOI 10.1111/j.1464-410X.1995.tb07840.x; D'Andrea MR, 2003, AM J PATHOL, V162, P907, DOI 10.1016/S0002-9440(10)63886-2; Fry CH, 2010, NEUROUROL URODYNAM, V29, P603, DOI 10.1002/nau.20903; Guerios SD, 2006, NEUROSCI LETT, V392, P193, DOI 10.1016/j.neulet.2005.09.026; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; Kato J, 2015, PROG MOL BIOL TRANSL, V131, P251, DOI 10.1016/bs.pmbts.2014.11.014; Kokkola R, 2002, ARTHRITIS RHEUM, V46, P2598, DOI 10.1002/art.10540; Kouzoukas DE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127628; Kuromitsu S, 2008, SCAND J UROL NEPHROL, V42, P455, DOI 10.1080/00365590802025881; Meyer-Siegler KL, 2004, J INTERF CYTOK RES, V24, P55, DOI 10.1089/107999004772719918; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Rossi MR, 2001, ENVIRON HEALTH PERSP, V109, P801, DOI 10.1289/ehp.01109801; Roundy Lindsi McCoard, 2013, Adv Biosci Biotechnol, V4, P1; Rudick CN, 2010, J INFECT DIS, V201, P1240, DOI 10.1086/651275; Schober A, 2008, J MOL MED, V86, P761, DOI 10.1007/s00109-008-0334-2; Shibasaki M, 2010, PAIN, V149, P514, DOI 10.1016/j.pain.2010.03.023; Tanaka J, 2014, NEUROPHARMACOLOGY, V79, P112, DOI 10.1016/j.neuropharm.2013.11.003; Tong W, 2010, BIOCHEM BIOPH RES CO, V395, P572, DOI 10.1016/j.bbrc.2010.04.086; Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189; Vera PL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015904; Vera PL, 2010, NEUROUROL URODYNAM, V29, P1451, DOI 10.1002/nau.20878; Wang YS, 2015, PAIN PHYSICIAN, V18, pE615; Westropp JL, 2002, J UROLOGY, V167, P694, DOI 10.1016/S0022-5347(01)69129-8; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648; Yasuda T, 2006, PANCREAS, V33, P359, DOI 10.1097/01.mpa.0000236741.15477.8b; Zhao PS, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00067	31	17	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152055	10.1371/journal.pone.0152055	http://dx.doi.org/10.1371/journal.pone.0152055			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010488	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708000078
J	Li, KJ; Yu, Y; Sun, S; Liu, Y; Garg, S; Kaul, SC; Lei, ZF; Gao, R; Wadhwa, R; Zhang, ZY				Li, Kejuan; Yu, Yue; Sun, Shuang; Liu, Ye; Garg, Sukant; Kaul, Sunil C.; Lei, Zhongfang; Gao, Ran; Wadhwa, Renu; Zhang, Zhenya			Functional Characterisation of Anticancer Activity in the Aqueous Extract of Helicteres angustifolia L. Roots	PLOS ONE			English	Article							CANCER-CELLS; LEAF EXTRACT; HNRNP-K; TUMOR; IDENTIFICATION; CONSTITUENTS; ASHWAGANDHA; DERIVATIVES; INDUCTION; APOPTOSIS	Helicteres angustifolia L. is a shrub that forms a common ingredient of several cancer treatment recipes in traditional medicine system both in China and Laos. In order to investigate molecular mechanisms of its anticancer activity, we prepared aqueous extract of Helicteres angustifolia L. Roots (AQHAR) and performed several in vitro assays using human normal fibroblasts (TIG-3) and osteosarcoma (U2OS). We found that AQHAR caused growth arrest/apoptosis of U2OS cells in a dose-dependent manner. It showed no cytotoxicity to TIG-3 cells at doses up to 50 mu g/ml. Biochemical, imaging and cell cycle analyses revealed that it induces ROS signaling and DNA damage response selectively in cancer cells. The latter showed upregulation of p53, p21 and downregulation of Cyclin B1 and phospho-Rb. Furthermore, AQHAR-induced apoptosis was mediated by increase in pro-apoptotic proteins including cleaved PARP, caspases and Bax. Anti-apoptotic protein Bcl-2 showed decrease in AQHAR-treated U2OS cells. In vivo xenograft tumor assays in nude mice revealed dose-dependent suppression of tumor growth and lung metastasis with no toxicity to the animals suggesting that AQHAR could be a potent and safe natural drug for cancer treatment.	[Li, Kejuan; Yu, Yue; Sun, Shuang; Liu, Ye; Lei, Zhongfang; Zhang, Zhenya] Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan; [Li, Kejuan; Yu, Yue; Garg, Sukant; Kaul, Sunil C.; Wadhwa, Renu] Natl Inst Adv Ind Sci & Technol, Drug Discovery & Assets Innovat Lab, DAILAB, Cent 5-41,1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan; [Garg, Sukant; Wadhwa, Renu] Univ Tsukuba, Sch Integrat & Global Majors, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan; [Gao, Ran] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100021, Peoples R China	University of Tsukuba; National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS	Zhang, ZY (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.; Wadhwa, R (corresponding author), Natl Inst Adv Ind Sci & Technol, Drug Discovery & Assets Innovat Lab, DAILAB, Cent 5-41,1-1-1 Higashi, Tsukuba, Ibaraki 3058565, Japan.; Wadhwa, R (corresponding author), Univ Tsukuba, Sch Integrat & Global Majors, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	renu-wadhwa@aist.go.jp; zhang.zhenya.fu@u.tsukuba.ac.jp	Yu, Yue/AAM-9329-2020; Lei, Zhongfang/V-8241-2019; Wadhwa, Renu/L-8898-2018; Kaul, Sunil C/L-8671-2018; Lei, Zhongfang/B-3611-2014	Yu, Yue/0000-0002-7620-6078; Lei, Zhongfang/0000-0002-0479-6179; Wadhwa, Renu/0000-0001-8248-5192; Kaul, Sunil C/0000-0002-0046-3916; Gao, Ran/0000-0001-8712-429X; Liu, Ye/0000-0002-4845-6643	Institute of Laboratory Animal Science, CAMSPUMC [DWS201402]; National Institute of Advanced Industrial Science & Technology (AIST) Special Research Fund	Institute of Laboratory Animal Science, CAMSPUMC; National Institute of Advanced Industrial Science & Technology (AIST) Special Research Fund	The study was supported by grants from the Institute of Laboratory Animal Science, CAMS&PUMC (DWS201402) to RG and National Institute of Advanced Industrial Science & Technology (AIST) Special Research Fund to SCK and RW.	Achliya GS, 2004, J ETHNOPHARMACOL, V90, P229, DOI 10.1016/j.jep.2003.09.037; CHEN CM, 1990, PHYTOCHEMISTRY, V29, P980, DOI 10.1016/0031-9422(90)80061-K; Chen WL, 2006, PHYTOCHEMISTRY, V67, P1041, DOI 10.1016/j.phytochem.2006.03.005; Chen ZT, 2006, CHEM PHARM BULL, V54, P1605, DOI 10.1248/cpb.54.1605; CHEN ZT, 1994, HETEROCYCLES, V38, P1399, DOI 10.3987/COM-94-6710; Chiu NY, 1995, ILLUSTRATED MED PLAN, V1, P104; Collins A, 2003, CANCER LETT, V189, P49, DOI 10.1016/S0304-3835(02)00502-5; Ding HM, 2009, NUTR CANCER, V61, P348, DOI 10.1080/01635580802567158; Duangmano S, 2012, J ONCOL, V2012, DOI 10.1155/2012/601682; Duangmano S, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-185; Efferth T, 2007, CURR MED CHEM, V14, P2024; Gao R, 2013, J BIOL CHEM, V288, P15046, DOI 10.1074/jbc.M113.466136; Inoue A, 2007, P NATL ACAD SCI USA, V104, P8983, DOI 10.1073/pnas.0607595104; Jiangsu New Medical College (JNMC), 1986, DICT CHIN HERB MED, P178; Kavitha K., 2006, Indian Journal of Pharmacology, V38, P185; Li D, 2007, J PHARMACOL SCI, V103, P56, DOI 10.1254/jphs.FPJ06016X; Li KJ, 2016, J TAIWAN INST CHEM E, V61, P75, DOI 10.1016/j.jtice.2015.12.022; Li KJ, 2015, J ETHNOPHARMACOL, V172, P61, DOI 10.1016/j.jep.2015.06.007; Navarro J, 1997, FREE RADICAL BIO MED, V22, P1203, DOI 10.1016/S0891-5849(96)00554-0; OLIVE PL, 1990, RADIAT RES, V122, P86, DOI 10.2307/3577587; Pan MH, 2008, CHEM BIODIVERS, V5, P565, DOI 10.1002/cbdv.200890053; Piccirillo S, 2009, J BIOL CHEM, V284, P27721, DOI 10.1074/jbc.M109.014837; Ryu J, 2014, J BIOL CHEM, V289, P24832, DOI 10.1074/jbc.M114.565929; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Sharma Arishya, 2012, Methods Mol Biol, V920, P613, DOI 10.1007/978-1-61779-998-3_40; Sreelatha S, 2011, FOOD CHEM TOXICOL, V49, P1270, DOI 10.1016/j.fct.2011.03.006; Stewart BS, WORLD CANCER REPORT, V9283204298; Vojnovic B, 2003, HIGH SENSITIVITY HIG; Wadhwa R, 2006, INT J CANCER, V118, P2973, DOI 10.1002/ijc.21773; Wadhwa R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077189; Wang GC, 2012, FITOTERAPIA, V83, P1643, DOI 10.1016/j.fitote.2012.09.016; Widodo N, 2008, CANCER LETT, V262, P37, DOI 10.1016/j.canlet.2007.11.037; Widodo N, 2007, CLIN CANCER RES, V13, P2298, DOI 10.1158/1078-0432.CCR-06-0948; Widodo N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013536; Yoo JY, 2010, J GENE MED, V12, P586, DOI 10.1002/jgm.1471	35	14	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152017	10.1371/journal.pone.0152017	http://dx.doi.org/10.1371/journal.pone.0152017			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010955	Green Submitted, Green Published, gold			2022-12-26	WOS:000372708000071
J	Mao, XJ; Banta, JT; Ke, BL; Jiang, H; He, JC; Liu, C; Wang, JH				Mao, Xinjie; Banta, James T.; Ke, Bilian; Jiang, Hong; He, Jichang; Liu, Che; Wang, Jianhua			Wavefront Derived Refraction and Full Eye Biometry in Pseudophakic Eyes	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; SPECTRAL-DOMAIN OCT; CILIARY MUSCLE THICKNESS; INTRAOCULAR-LENS; ANTERIOR SEGMENT; AXIAL LENGTH; ACCOMMODATION; ABERRATIONS; ULTRASOUND; AGREEMENT	Purpose To assess wavefront derived refraction and full eye biometry including ciliary muscle dimension and full eye axial geometry in pseudophakic eyes using spectral domain OCT equipped with a Shack-Hartmann wavefront sensor. Methods Twenty-eight adult subjects (32 pseudophakic eyes) having recently undergone cataract surgery were enrolled in this study. A custom system combining two optical coherence tomography systems with a Shack-Hartmann wavefront sensor was constructed to image and monitor changes in whole eye biometry, the ciliary muscle and ocular aberration in the pseudophakic eye. A Badal optical channel and a visual target aligning with the wavefront sensor were incorporated into the system for measuring the wavefront-derived refraction. The imaging acquisition was performed twice. The coefficients of repeatability (CoR) and intraclass correlation coefficient (ICC) were calculated. Results Images were acquired and processed successfully in all patients. No significant difference was detected between repeated measurements of ciliary muscle dimension, full-eye biometry or defocus aberration. The CoR of full-eye biometry ranged from 0.36% to 3.04% and the ICC ranged from 0.981 to 0.999. The CoR for ciliary muscle dimensions ranged from 12.2% to 41.6% and the ICC ranged from 0.767 to 0.919. The defocus aberrations of the two measurements were 0.443 +/- 0.534 D and 0.447 +/- 0.586 D and the ICC was 0.951. Conclusions The combined system is capable of measuring full eye biometry and refraction with good repeatability. The system is suitable for future investigation of pseudoaccommodation in the pseudophakic eye.	[Mao, Xinjie; Ke, Bilian] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Peoples R China; [Mao, Xinjie; Banta, James T.; Jiang, Hong; Liu, Che; Wang, Jianhua] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Ke, Bilian] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Ophthalmol, Shanghai 200030, Peoples R China; [He, Jichang] New England Coll Optometry, Boston, MA USA	Wenzhou Medical University; Bascom Palmer Eye Institute; University of Miami; Shanghai Jiao Tong University	Wang, JH (corresponding author), Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA.	jwang3@med.miami.edu		Banta, James/0000-0002-7222-0462	National Institutes of Health [EY021012, EY021336]; National Institutes of Health Center Grant [P30 EY014801]; Research to Prevent Blindness (RPB); Wenzhou Medical University; NATIONAL EYE INSTITUTE [P30EY014801, R21EY021336, R21EY021012] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Center Grant; Research to Prevent Blindness (RPB)(Research to Prevent Blindness (RPB)); Wenzhou Medical University; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by research grants in part from the National Institutes of Health EY021012, EY021336, National Institutes of Health Center Grant P30 EY014801, and Research to Prevent Blindness (RPB). Visiting scholar activity (XJM) was supported by Wenzhou Medical University.	Alderson A, 2011, OPHTHAL PHYSL OPT, V31, P100, DOI 10.1111/j.1475-1313.2010.00794.x; Alio JL, 2011, J CATARACT REFR SURG, V37, P241, DOI 10.1016/j.jcrs.2010.08.043; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Charman WN, 2008, CLIN EXP OPTOM, V91, P207, DOI 10.1111/j.1444-0938.2008.00256.x; CHENG HM, 1991, OPTOMETRY VISION SCI, V68, P976, DOI 10.1097/00006324-199112000-00013; Cleary G, 2010, J CATARACT REFR SURG, V36, P762, DOI 10.1016/j.jcrs.2009.11.025; Dai CX, 2012, OPT EXPRESS, V20, P6109, DOI 10.1364/OE.20.006109; DELLER JFP, 1947, PROC R SOC SER B-BIO, V134, P456, DOI 10.1098/rspb.1947.0025; Eleftheriadis H, 2003, BRIT J OPHTHALMOL, V87, P960, DOI 10.1136/bjo.87.8.960; Fan SH, 2015, OSLI RETINA, V46, P186, DOI 10.3928/23258160-20150213-25; Fledelius HC, 1997, ULTRASOUND MED BIOL, V23, P365, DOI 10.1016/S0301-5629(96)00213-X; Fukuyama M, 1999, OPHTHALMOLOGY, V106, P1178, DOI 10.1016/S0161-6420(99)90259-2; Grulkowski I, 2013, OPHTHALMOLOGY, V120, P2184, DOI 10.1016/j.ophtha.2013.04.007; Grulkowski I, 2012, BIOMED OPT EXPRESS, V3, P2733, DOI 10.1364/BOE.3.002733; Hamidzada WA, 1999, VET RADIOL ULTRASOUN, V40, P502, DOI 10.1111/j.1740-8261.1999.tb00382.x; He JC, 2000, VISION RES, V40, P41, DOI 10.1016/S0042-6989(99)00156-X; He JC, 2014, OPT EXPRESS, V22, P9764, DOI 10.1364/OE.22.009764; HITZENBERGER CK, 1991, INVEST OPHTH VIS SCI, V32, P616; Ide T, 2010, OPHTHAL SURG LAS IM, V41, P250, DOI 10.3928/15428877-20100303-15; Jeong HW, 2012, OPT EXPRESS, V20, P19148, DOI 10.1364/OE.20.019148; Kriechbaum K, 2005, OPHTHALMOLOGY, V112, P453, DOI 10.1016/j.ophtha.2004.09.021; Kumar DA, 2013, J CATARACT REFR SURG, V39, P1017, DOI 10.1016/j.jcrs.2013.01.039; Leng T, 2008, OPHTHAL SURG LAS IM, V39, pS132, DOI 10.3928/15428877-20080715-08; Lesiewska-Junk H, 2000, J CATARACT REFR SURG, V26, P562, DOI 10.1016/S0886-3350(99)00407-1; Lewis HA, 2012, OPTOMETRY VISION SCI, V89, P727, DOI 10.1097/OPX.0b013e318253de7e; LIANG JZ, 1994, J OPT SOC AM A, V11, P1949, DOI 10.1364/JOSAA.11.001949; Lossing LA, 2012, OPTOMETRY VISION SCI, V89, P719, DOI 10.1097/OPX.0b013e318252cadc; Misra M, 1987, Indian J Ophthalmol, V35, P17; Read SA, 2010, OPTOMETRY VISION SCI, V87, P656, DOI 10.1097/OPX.0b013e3181e87dd3; Ruggeri M, 2012, BIOMED OPT EXPRESS, V3, P1506, DOI 10.1364/BOE.3.001506; Schmid GF, 2003, J BIOMED OPT, V8, P655, DOI 10.1117/1.1606461; Shao YL, 2013, BIOMED OPT EXPRESS, V4, P466, DOI 10.1364/BOE.4.000466; Shi GH, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.12.120501; Strenk SA, 2010, J CATARACT REFR SURG, V36, P235, DOI 10.1016/j.jcrs.2009.08.029; Tao AZ, 2013, BIOMED OPT EXPRESS, V4, P1031, DOI 10.1364/BOE.4.001031; Thibos LN, 2002, J OPT SOC AM A, V19, P2329, DOI 10.1364/JOSAA.19.002329; Turuwhenua J, 2010, OPHTHAL PHYSL OPT, V30, P43, DOI 10.1111/j.1475-1313.2009.00692.x; Wang H, 1996, Zhonghua Yan Ke Za Zhi, V32, P291; Wang H, 2008, OPT LETT, V33, P2632, DOI 10.1364/OL.33.002632; Wolffsohn JS, 2010, J REFRACT SURG, V26, P858, DOI 10.3928/1081597X-20100114-04; Yuan YM, 2013, INVEST OPHTH VIS SCI, V54, P7028, DOI 10.1167/iovs.13-11893; Zhong JG, 2014, AM J OPHTHALMOL, V157, P412, DOI 10.1016/j.ajo.2013.09.033	42	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152293	10.1371/journal.pone.0152293	http://dx.doi.org/10.1371/journal.pone.0152293			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010674	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708000128
J	Weber, K; Lau, EF; Stillerman, B; Kuperberg, GR				Weber, Kirsten; Lau, Ellen F.; Stillerman, Benjamin; Kuperberg, Gina R.			The Yin and the Yang of Prediction: An fMRI Study of Semantic Predictive Processing	PLOS ONE			English	Article							INFERIOR PREFRONTAL CORTEX; BRAIN POTENTIAL ANALYSIS; LANGUAGE COMPREHENSION; SENTENCE COMPREHENSION; PSYCHOPHYSIOLOGICAL INTERACTIONS; EFFECTIVE CONNECTIVITY; NEURAL MECHANISMS; COGNITIVE CONTROL; LEXICAL DECISION; MULTIPLE ASPECTS	Probabilistic prediction plays a crucial role in language comprehension. When predictions are fulfilled, the resulting facilitation allows for fast, efficient processing of ambiguous, rapidly-unfolding input; when predictions are not fulfilled, the resulting error signal allows us to adapt to broader statistical changes in this input. We used functional Magnetic Resonance Imaging to examine the neuroanatomical networks engaged in semantic predictive processing and adaptation. We used a relatedness proportion semantic priming paradigm, in which we manipulated the probability of predictions while holding local semantic context constant. Under conditions of higher (versus lower) predictive validity, we replicate previous observations of reduced activity to semantically predictable words in the left anterior superior/middle temporal cortex, reflecting facilitated processing of targets that are consistent with prior semantic predictions. In addition, under conditions of higher (versus lower) predictive validity we observed significant differences in the effects of semantic relatedness within the left inferior frontal gyrus and the posterior portion of the left superior/middle temporal gyrus. We suggest that together these two regions mediated the suppression of unfulfilled semantic predictions and lexico-semantic processing of unrelated targets that were inconsistent with these predictions. Moreover, under conditions of higher (versus lower) predictive validity, a functional connectivity analysis showed that the left inferior frontal and left posterior superior/middle temporal gyrus were more tightly interconnected with one another, as well as with the left anterior cingulate cortex. The left anterior cingulate cortex was, in turn, more tightly connected to superior lateral frontal cortices and subcortical regions-a network that mediates rapid learning and adaptation and that may have played a role in switching to a more predictive mode of processing in response to the statistical structure of the wider environmental context. Together, these findings highlight close links between the networks mediating semantic prediction, executive function and learning, giving new insights into how our brains are able to flexibly adapt to our environment.	[Weber, Kirsten; Lau, Ellen F.; Stillerman, Benjamin; Kuperberg, Gina R.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA; [Weber, Kirsten; Lau, Ellen F.; Stillerman, Benjamin; Kuperberg, Gina R.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA; [Weber, Kirsten; Lau, Ellen F.; Stillerman, Benjamin; Kuperberg, Gina R.] Tufts Univ, Dept Psychol, Medford, MA 02155 USA; [Weber, Kirsten; Lau, Ellen F.; Stillerman, Benjamin; Kuperberg, Gina R.] Tufts Univ, Ctr Cognit Sci, Medford, MA 02155 USA; [Weber, Kirsten] Max Planck Inst Psycholinguist, Nijmegen, Netherlands; [Lau, Ellen F.] Univ Maryland, Dept Linguist, College Pk, MD 20742 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Tufts University; Tufts University; Max Planck Society; University System of Maryland; University of Maryland College Park	Weber, K (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA USA.; Weber, K (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA USA.; Weber, K (corresponding author), Tufts Univ, Dept Psychol, Medford, MA 02155 USA.; Weber, K (corresponding author), Tufts Univ, Ctr Cognit Sci, Medford, MA 02155 USA.; Weber, K (corresponding author), Max Planck Inst Psycholinguist, Nijmegen, Netherlands.	kirsten.weber@mpi.nl	Weber, Kirsten/U-5244-2018	Weber, Kirsten/0000-0001-8192-2207	National Institutes of Health [R01MH071635, F32HD063221]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD063221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071635] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institutes of Health (grants R01MH071635 to GK and F32HD063221 to EL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Badre D, 2008, TRENDS COGN SCI, V12, P193, DOI 10.1016/j.tics.2008.02.004; Badre D, 2009, NAT REV NEUROSCI, V10, P659, DOI 10.1038/nrn2667; Baggio G, 2011, LANG COGNITIVE PROC, V26, P1338, DOI 10.1080/01690965.2010.542671; Baumgaertner A, 2002, NEUROIMAGE, V16, P736, DOI 10.1006/nimg.2002.1134; Bedny M, 2008, CEREB CORTEX, V18, P2574, DOI 10.1093/cercor/bhn018; Bedny M, 2007, BRAIN RES, V1146, P101, DOI 10.1016/j.brainres.2006.10.012; Behrens TEJ, 2007, NAT NEUROSCI, V10, P1214, DOI 10.1038/nn1954; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brown CM, 2000, BRAIN LANG, V72, P158, DOI 10.1006/brln.1999.2284; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; Burock MA, 2000, HUM BRAIN MAPP, V11, P249, DOI 10.1002/1097-0193(200012)11:4<249::AID-HBM20>3.3.CO;2-X; Cardillo ER, 2004, J COGNITIVE NEUROSCI, V16, P1552, DOI 10.1162/0898929042568523; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Catani M, 2007, P NATL ACAD SCI USA, V104, P17163, DOI 10.1073/pnas.0702116104; Courville AC, 2006, TRENDS COGN SCI, V10, P294, DOI 10.1016/j.tics.2006.05.004; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; DEGROOT AMB, 1984, Q J EXP PSYCHOL-A, V36, P253, DOI 10.1080/14640748408402158; Dejerine J., 1901, ANATOMIE CTR NERVEUX, Vvol 2; DeLong KA, 2005, NAT NEUROSCI, V8, P1117, DOI 10.1038/nn1504; DeLong KA, 2014, LANG LINGUIST COMPAS, V8, P631, DOI 10.1111/lnc3.12093; den Ouden DB, 2012, NEUROIMAGE, V59, P815, DOI 10.1016/j.neuroimage.2011.07.057; DENHEYER K, 1985, ACTA PSYCHOL, V60, P25, DOI 10.1016/0001-6918(85)90011-3; Dien J, 2008, BRAIN RES, V1229, P179, DOI 10.1016/j.brainres.2008.06.107; Dominey PF, 2009, CORTEX, V45, P1012, DOI 10.1016/j.cortex.2009.03.007; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; ELMAN JL, 1990, COGNITIVE SCI, V14, P179, DOI 10.1207/s15516709cog1402_1; Erb J, 2013, J NEUROSCI, V33, P10688, DOI 10.1523/JNEUROSCI.4596-12.2013; Federmeier KD, 2007, BRAIN RES, V1146, P75, DOI 10.1016/j.brainres.2006.06.101; Federmeier KD, 2007, PSYCHOPHYSIOLOGY, V44, P491, DOI 10.1111/j.1469-8986.2007.00531.x; Fine AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077661; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Glasser MF, 2008, CEREB CORTEX, V18, P2471, DOI 10.1093/cercor/bhn011; Gold BT, 2006, J NEUROSCI, V26, P6523, DOI 10.1523/JNEUROSCI.0808-06.2006; Griffiths TL, 2008, CAMB HANDB PSYCHOL, P59; Hagoort P, 2004, SCIENCE, V304, P438, DOI 10.1126/science.1095455; Henson R, 2001, NEUROIMAGE, V13, pS683; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; HOLCOMB PJ, 1988, BRAIN LANG, V35, P66, DOI 10.1016/0093-934X(88)90101-0; Hon N, 2012, NEUROIMAGE, V59, P655, DOI 10.1016/j.neuroimage.2011.06.093; Ide JS, 2013, J NEUROSCI, V33, P2039, DOI 10.1523/JNEUROSCI.2201-12.2013; Jaeger TF, 2013, COGNITION, V127, P57, DOI 10.1016/j.cognition.2012.10.013; KEEFE DE, 1990, MEM COGNITION, V18, P289, DOI 10.3758/BF03213882; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kleinschmidt DF, 2015, PSYCHOL REV, V122, P148, DOI 10.1037/a0038695; Kotz SA, 2002, NEUROIMAGE, V17, P1761, DOI 10.1006/nimg.2002.1316; Kotz SA, 2009, CORTEX, V45, P982, DOI 10.1016/j.cortex.2009.02.010; Kruschke JK, 2008, LEARN BEHAV, V36, P210, DOI 10.3758/LB.36.3.210; Kuperberg G. R., 2013, UNRAVELING READING C, P176; Kuperberg GR, 2008, HUM BRAIN MAPP, V29, P544, DOI 10.1002/hbm.20419; Kuperberg GR, 2008, NEUROIMAGE, V40, P367, DOI 10.1016/j.neuroimage.2007.10.009; Kuperberg GR, 2007, BRAIN RES, V1146, P23, DOI 10.1016/j.brainres.2006.12.063; Kuperberg GR, 2006, NEUROIMAGE, V33, P343, DOI 10.1016/j.neuroimage.2006.06.001; Kuperberg GR, 2016, LANG COGN NEUROSCI, V31, P32, DOI 10.1080/23273798.2015.1102299; Kuperberg GR, 2003, COGNITIVE BRAIN RES, V17, P117, DOI 10.1016/S0926-6410(03)00086-7; Kutas M., 2011, PREDICTIONBRAIN US, P190, DOI DOI 10.1093/ACPROF:OSO/9780195395518.003.0065; Lau EF, 2014, CEREBRAL CORTEX; Lau EF, 2013, J NEUROSCI, V 33, P17174, DOI 10.1523/JNEUROSCI.1018-13.2013; Lau EF, 2013, J COGNITIVE NEUROSCI, V25, P484, DOI 10.1162/jocn_a_00328; Lau EF, 2008, NAT REV NEUROSCI, V9, P920, DOI 10.1038/nrn2532; Lee CL, 2006, BRAIN RES, V1081, P191, DOI 10.1016/j.brainres.2006.01.058; Martin A, 2007, ANNU REV PSYCHOL, V58, P25, DOI 10.1146/annurev.psych.57.102904.190143; Mason RA, 2007, BRAIN RES, V1146, P115, DOI 10.1016/j.brainres.2007.02.076; Mazaika PK, 2009, ARTREPAIR; McLaren DG, 2012, NEUROIMAGE, V61, P1277, DOI 10.1016/j.neuroimage.2012.03.068; MILBERG W, 1987, BRAIN LANG, V31, P138, DOI 10.1016/0093-934X(87)90065-4; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Mozes S, 2011, ARTIFACT DETECTION T; Munte TF, 2008, NEURON, V59, P677, DOI 10.1016/j.neuron.2008.08.015; Mummery CJ, 2000, ANN NEUROL, V47, P36; Neely J. H., 1991, BASIC PROCESSES READ, P264, DOI DOI 10.1016/J.BRAINRES.2007.05.058; NEELY JH, 1989, J EXP PSYCHOL LEARN, V15, P1003, DOI 10.1037/0278-7393.15.6.1003; Nelson DL, 2004, BEHAV RES METH INS C, V36, P402, DOI 10.3758/BF03195588; Norris D, 2008, PSYCHOL REV, V115, P357, DOI 10.1037/0033-295X.115.2.357; Novick JM, 2010, LANG LINGUIST COMPAS, V4, P906, DOI 10.1111/j.1749-818x.2010.00244.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osterhout L, 2012, CAMBRIDGE HDB PSYCHO, P365, DOI [10.1017/CBO9781139029377.025, DOI 10.1017/CBO9781139029377.025]; Papoutsi M, 2011, NEUROIMAGE, V58, P656, DOI 10.1016/j.neuroimage.2011.06.036; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Perfors A, 2011, COGNITION, V120, P302, DOI 10.1016/j.cognition.2010.11.015; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Petrides M., 2000, BRAIN MAPPING SYSTEM, P159; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Rilling JK, 2008, NAT NEUROSCI, V11, P426, DOI 10.1038/nn2072; Rissman J, 2003, J COGNITIVE NEUROSCI, V15, P1160, DOI 10.1162/089892903322598120; Robinson G, 2005, COGN NEUROPSYCHOL, V22, P661, DOI 10.1080/02643290442000239; Robinson G, 1998, BRAIN, V121, P77, DOI 10.1093/brain/121.1.77; Rodd JM, 2012, CEREB CORTEX, V22, P1761, DOI 10.1093/cercor/bhr252; Rodd JM, 2005, CEREB CORTEX, V15, P1261, DOI 10.1093/cercor/bhi009; Rogers TT, 2008, BEHAV BRAIN SCI, V31, P689, DOI 10.1017/S0140525X0800589X; Rossell SL, 2001, NEUROPSYCHOLOGIA, V39, P1167, DOI 10.1016/S0028-3932(01)00049-5; Rumelhart G.E., 1986, PARALLEL DISTRIBUTED, P318, DOI DOI 10.1016/B978-1-4832-1446-7.50035-2; Rushworth MFS, 2004, TRENDS COGN SCI, V8, P410, DOI 10.1016/j.tics.2004.07.009; Segaert K, 2013, NEUROPSYCHOLOGIA, V51, P59, DOI 10.1016/j.neuropsychologia.2012.11.006; SEIDENBERG MS, 1984, MEM COGNITION, V12, P315, DOI 10.3758/BF03198291; Snijders TM, 2010, NEUROIMAGE, V52, P1633, DOI 10.1016/j.neuroimage.2010.05.035; Swaab TY, 1998, NEUROPSYCHOLOGIA, V36, P737, DOI 10.1016/S0028-3932(97)00174-7; Thompson-Schill SL, 1999, NEURON, V23, P513, DOI 10.1016/S0896-6273(00)80804-1; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Turken AU, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00001; TWEEDY JR, 1977, MEM COGNITION, V5, P84, DOI 10.3758/BF03209197; Ulrich M, 2013, J COGNITIVE NEUROSCI, V25, P2216, DOI 10.1162/jocn_a_00449; Van Petten C, 2012, INT J PSYCHOPHYSIOL, V83, P176, DOI 10.1016/j.ijpsycho.2011.09.015; Visser M, 2010, J COGNITIVE NEUROSCI, V22, P1083, DOI 10.1162/jocn.2009.21309; Wahl M, 2008, NEURON, V59, P695, DOI 10.1016/j.neuron.2008.07.011; Wheatley T, 2005, J COGNITIVE NEUROSCI, V17, P1871, DOI 10.1162/089892905775008689; Wlotko EW, 2012, NEUROIMAGE, V62, P356, DOI 10.1016/j.neuroimage.2012.04.054; Wlotko EW, 2012, PSYCHOPHYSIOLOGY, V49, P770, DOI 10.1111/j.1469-8986.2012.01366.x; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Xiang HD, 2010, CEREB CORTEX, V20, P549, DOI 10.1093/cercor/bhp119; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Yu AJ, 2009, J EXP PSYCHOL HUMAN, V35, P700, DOI 10.1037/a0013553; Zempleni MZ, 2007, NEUROIMAGE, V34, P1270, DOI 10.1016/j.neuroimage.2006.09.048	118	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0148637	10.1371/journal.pone.0148637	http://dx.doi.org/10.1371/journal.pone.0148637			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010386	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708000017
J	Bossu, J; Beauchene, J; Estevez, Y; Duplais, C; Clair, B				Bossu, Julie; Beauchene, Jacques; Estevez, Yannick; Duplais, Christophe; Clair, Bruno			New Insights on Wood Dimensional Stability Influenced by Secondary Metabolites: The Case of a Fast-Growing Tropical Species Bagassa guianensis Aubl.	PLOS ONE			English	Article							MICROFIBRIL ANGLE; EXTRACTIVES; SHRINKAGE; HEARTWOOD; GRAVITY; STRESS; FIBER	Challenging evaluation of tropical forest biodiversity requires the reporting of taxonomic diversity but also the systematic characterization of wood properties in order to discover new promising species for timber industry. Among wood properties, the dimensional stability is regarded as a major technological characteristic to validate whether a wood species is adapted to commercial uses. Cell structure and organization are known to influence the drying shrinkage making wood density and microfibrils angle markers of choice to predict wood dimensional stability. On the contrary the role of wood extractive content remains unclear. This work focuses on the fast-growing tropical species Bagassa guianensis and we report herein a correlation between heartwood drying shrinkage and extractive content. Chemical extractions and shrinkage experiments were performed on separate wood twin samples to better evaluate correctly how secondary metabolites influence the wood shrinkage behaviour. Extractive content were qualitatively and quantitatively analysed using HPLC and NMR spectroscopy. We found that B guianensis heartwood has a homogeneous low shrinkage along its radius that could not be explained only by its basic density. In fact the low drying shrinkage is correlated to the high extractive content and a corrected model to improve the prediction of wood dimensional stability is presented. Additionally NMR experiments conducted on sapwood and heartwood extracts demonstrate that secondary metabolites biosynthesis occurs in sapwood thus revealing B. guianensis as a Juglans-Type heartwood formation. This work demonstrates that B. guianensis, a fast-growing species associated with high durability and high dimensional stability, is a good candidate for lumber production and commercial purposes.	[Bossu, Julie; Beauchene, Jacques; Estevez, Yannick; Duplais, Christophe; Clair, Bruno] Univ Guyane, Univ Antilles, INRA, CNRS,UMR EcoFoG,AgroParisTech,Cirad, F-97310 Kourou, France	AgroParisTech; CIRAD; Centre National de la Recherche Scientifique (CNRS); Universite des Antilles; INRAE	Bossu, J (corresponding author), Univ Guyane, Univ Antilles, INRA, CNRS,UMR EcoFoG,AgroParisTech,Cirad, F-97310 Kourou, France.	juliebossu@hotmail.fr	Clair, Bruno/B-7503-2013; BEAUCHENE, Jacques/AAN-4909-2020; Duplais, Christophe/E-3668-2017	Clair, Bruno/0000-0002-4093-9034; BEAUCHENE, Jacques/0000-0003-4578-3670; Duplais, Christophe/0000-0003-0926-9885	Investissement d'Avenir Grant of the ANR [CEBA: ANR-10-LABX-25-01]; CNRS-INSIS; European Social Fund (FSE); Labex CEBA award; INSIS award; European Social Founds award	Investissement d'Avenir Grant of the ANR(French National Research Agency (ANR)); CNRS-INSIS; European Social Fund (FSE)(European Social Fund (ESF)); Labex CEBA award; INSIS award; European Social Founds award	This work was supported by Investissement d'Avenir Grant of the ANR (CEBA: ANR-10-LABX-25-01). JB received a doctoral fellowship from the CNRS-INSIS and the European Social Fund (FSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Eric Nicolini (CIRAD-AMAP) and Onoefe NGwete (CIRAD-ECOFOG) for their help in trees identification and field work. This research project has been financially supported by the Labex CEBA, INSIS and European Social Founds awards.	Abe H, 2005, IAWA J, V26, P161, DOI 10.1163/22941932-90000108; Adamopoulos S, 2002, HOLZ ROH WERKST, V60, P377, DOI 10.1007/s00107-002-0329-6; Barnett JR, 2004, BIOL REV, V79, P461, DOI 10.1017/S1464793103006377; CHAFE SC, 1986, WOOD SCI TECHNOL, V20, P293, DOI 10.1007/BF00351583; Clair B, 2003, HOLZFORSCHUNG, V57, P189, DOI 10.1515/HF.2003.028; Clair B, 2012, HOLZFORSCHUNG, V66, P349, DOI [10.1515/hf.2011.159, 10.1515/HF.2011.159]; Cote W.A., 1968, PRINCIPLES WOOD SCI, DOI [10.1007/978-3-642-87928-9_5, 10.1007/978-3-642-87928-9_1, DOI 10.1007/978-3-642-87928-9_1]; De Filippis L, 1998, TREES-STRUCT FUNCT, V12, P377; de Moura LF, 2006, WOOD FIBER SCI, V38, P166; Dejardin A, 2010, CR BIOL, V333, P325, DOI 10.1016/j.crvi.2010.01.010; Donaldson L, 2008, IAWA J, V29, P345, DOI 10.1163/22941932-90000192; Flores O, 2006, ACTA OECOL, V29, P141, DOI 10.1016/j.actao.2005.08.007; Gilbert B, 2006, ECOLOGY, V87, P1281, DOI 10.1890/0012-9658(2006)87[1281:LHTITT]2.0.CO;2; Groemping U, 2006, RELATIVE IMPORTANCE, V17, P27; HARRIS JM, 1965, HOLZFORSCHUNG, V19, P144, DOI 10.1515/hfsg.1965.19.5.144; Hernandez RE, 2007, WOOD MATER SCI ENG, V2, P45, DOI 10.1080/17480270701538425; Kampe A, 2013, PLANT CELL MONOGR, V20, P71, DOI 10.1007/978-3-642-36491-4_3; Koponen S, 1998, SIGNIFICANCE MICROFI, P348; KRYLA JM, 1980, WOOD SCI, V13, P18; MANTANIS GI, 1994, WOOD SCI TECHNOL, V28, P119, DOI 10.1007/BF00192691; Nakada R, 2012, TREE PHYSIOL, V32, P1497, DOI 10.1093/treephys/tps108; Newlin JA, 1919, REPORT FOREST SERVIC, V676, P60; R Core Team, 2021, R LANGUAGE ENV STAT; Royer M, 2012, INT BIODETER BIODEGR, V70, P55, DOI 10.1016/j.ibiod.2011.10.016; Royer M, 2010, PHYTOCHEMISTRY, V71, P1708, DOI 10.1016/j.phytochem.2010.06.020; Stamm A.J., 1942, T AM SOC MECH ENG, V64, P379; Stamm AJ, 1935, IND ENG CHEM, V27, P401, DOI 10.1021/ie50304a011; Stamm AJ, 1952, WOOD CHEM, V2, P691; Taylor F. W., 1974, Weed Science, V6, P396; Walker JCF, 1993, PRIMARY WOOD PROCESS, P95; Williamson GB, 2010, AM J BOT, V97, P519, DOI 10.3732/ajb.0900243; Yamamoto H, 2001, WOOD SCI TECHNOL, V35, P167, DOI 10.1007/s002260000074; Yin JP, 2015, WOOD SCI TECHNOL, V49, P987, DOI 10.1007/s00226-015-0741-9	33	19	19	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0150777	10.1371/journal.pone.0150777	http://dx.doi.org/10.1371/journal.pone.0150777			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007687	Green Published, gold, Green Submitted			2022-12-26	WOS:000372701200031
J	Romera-Cardenas, G; Thomas, LM; Lopez-Cobo, S; Garcia-Cuesta, EM; Long, EO; Reyburn, HT				Romera-Cardenas, Gema; Thomas, L. Michael; Lopez-Cobo, Sheila; Garcia-Cuesta, Eva M.; Long, Eric O.; Reyburn, Hugh T.			Ionomycin Treatment Renders NK Cells Hyporesponsive	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; MHC CLASS-I; COMPLEX CLASS-I; SELF-TOLERANCE; T-CELLS; TRANSCRIPTIONAL ANALYSIS; MEDIATED CYTOTOXICITY; FUNCTIONAL-ANALYSIS; SIGNALING PATHWAYS; VIRAL-INFECTION	Natural killer cells are cytotoxic lymphocytes important in immune responses to cancer and multiple pathogens. However, chronic activation of NK cells can induce a hyporesponsive state. The molecular basis of the mechanisms underlying the generation and maintenance of this hyporesponsive condition are unknown, thus an easy and reproducible mechanism able to induce hyporesponsiveness on human NK cells would be very useful to gain understanding of this process. Human NK cells treated with ionomycin lose their ability to degranulate and secrete IFN-gamma in response to a variety of stimuli, but IL-2 stimulation can compensate these defects. Apart from reductions in the expression of CD11a/CD18, no great changes were observed in the activating and inhibitory receptors expressed by these NK cells, however their transcriptional signature is different to that described for other hyporesponsive lymphocytes.	[Romera-Cardenas, Gema; Lopez-Cobo, Sheila; Garcia-Cuesta, Eva M.; Reyburn, Hugh T.] CSIC, CNB, Madrid, Spain; [Thomas, L. Michael; Long, Eric O.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Romera-Cardenas, Gema] Univ Porto, Inst Invest & Inovacao Saude i3S, Rua Campo Alegre 823, P-4100 Oporto, Portugal	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto	Reyburn, HT (corresponding author), CSIC, CNB, Madrid, Spain.	htreyburn@cnb.csic.es	García-Cuesta, Eva M./J-6600-2017; Long, Eric O/G-5475-2011; Reyburn, Hugh T/B-4338-2009	García-Cuesta, Eva M./0000-0003-2311-4353; Long, Eric O/0000-0002-7793-3728; Reyburn, Hugh T/0000-0003-2855-1595	Fondo de Investigacion Sanitaria [PI11/00298, PI08/1701]; MINECO [SAF2014-58752-R]; CSIC; EMBO Short term fellowship; National Institutes of Health, National Institute of Allergy and Infectious Disease; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000525] Funding Source: NIH RePORTER	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); MINECO(Spanish Government); CSIC; EMBO Short term fellowship(European Molecular Biology Organization (EMBO)); National Institutes of Health, National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the Fondo de Investigacion Sanitaria (PI11/00298 and PI08/1701), MINECO (SAF2014-58752-R) (to HTR), a JAE Predoc studentship from the CSIC and an EMBO Short term fellowship (to GRC) and the Intramural Research Program at the National Institutes of Health, National Institute of Allergy and Infectious Disease (to LMT and EOL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS SI, 1986, CELL IMMUNOL, V101, P558, DOI 10.1016/0008-8749(86)90166-8; Ardolino M, 2014, J CLIN INVEST, V124, P4781, DOI 10.1172/JCI74337; Babor F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00027; Barber DF, 2004, J IMMUNOL, V173, P3653, DOI 10.4049/jimmunol.173.6.3653; BEVERLY B, 1992, INT IMMUNOL, V4, P661, DOI 10.1093/intimm/4.6.661; Brown ACN, 2012, BLOOD, V120, P3729, DOI 10.1182/blood-2012-05-429977; Bryceson YT, 2010, METHODS MOL BIOL, V612, P335, DOI 10.1007/978-1-60761-362-6_23; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Burshtyn DN, 2010, METHODS MOL BIOL, V612, P89, DOI 10.1007/978-1-60761-362-6_7; Calabia-Linares C, 2011, J CELL SCI, V124, P820, DOI 10.1242/jcs.078832; Chaix J, 2008, J IMMUNOL, V181, P1627, DOI 10.4049/jimmunol.181.3.1627; Coudert JD, 2005, BLOOD, V106, P1711, DOI 10.1182/blood-2005-03-0918; Crozat K, 2011, BLOOD, V117, P2874, DOI 10.1182/blood-2010-10-315457; Dybkaer K, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-230; Elliott JM, 2010, J EXP MED, V207, P2073, DOI 10.1084/jem.20100986; FINEGOLD I, 1967, J IMMUNOL, V99, P839; GILLIS S, 1980, J EXP MED, V152, P1709, DOI 10.1084/jem.152.6.1709; Guia S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001608; Hanna J, 2004, J IMMUNOL, V173, P6547, DOI 10.4049/jimmunol.173.11.6547; Hoglund P, 2010, NAT REV IMMUNOL, V10, P724, DOI 10.1038/nri2835; Jewett A, 1996, J IMMUNOL, V156, P907; Johansson MH, 1997, J EXP MED, V186, P353, DOI 10.1084/jem.186.3.353; Joncker NT, 2010, J EXP MED, V207, P2065, DOI 10.1084/jem.20100570; Joncker NT, 2009, J IMMUNOL, V182, P4572, DOI 10.4049/jimmunol.0803900; JONDAL M, 1975, INT J CANCER, V15, P596, DOI 10.1002/ijc.2910150409; Kim HS, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002754; Kim HS, 2010, IMMUNITY, V32, P175, DOI 10.1016/j.immuni.2010.02.004; KLEIN E, 1968, CANCER RES, V28, P1300; LANIER LL, 1991, J IMMUNOL, V146, P4421; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Mamessier E, 2011, J CLIN INVEST, V121, P3609, DOI 10.1172/JCI45816; Mazumdar B, 2013, EUR J IMMUNOL, V43, P1345, DOI 10.1002/eji.201243215; Montelli TCB, 2001, ARQ NEURO-PSIQUIAT, V59, P6, DOI 10.1590/S0004-282X2001000100003; Morlino G, 2014, MOL CELL BIOL, V34, P1412, DOI 10.1128/MCB.01177-13; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Peracoli MTS, 1999, ARQ NEURO-PSIQUIAT, V57, P539, DOI 10.1590/S0004-282X1999000400001; PERUSSIA B, 1987, NAT IMMUN CELL GROW, V6, P171; PLAUT M, 1973, J IMMUNOL, V111, P389; Pradeu T, 2013, NAT REV IMMUNOL, V13, P764, DOI 10.1038/nri3521; Prinz PU, 2014, INT J CANCER, V135, P1832, DOI 10.1002/ijc.28837; PROSS HF, 1976, INT J CANCER, V18, P593, DOI 10.1002/ijc.2910180508; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Reiners KS, 2013, MOL THER, V21, P895, DOI 10.1038/mt.2013.14; Ruggeri L, 2002, SCIENCE, V295, P2097, DOI 10.1126/science.1068440; Ruggeri L, 1999, BLOOD, V94, P333, DOI 10.1182/blood.V94.1.333.413a31_333_339; Sarkar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064835; Schietinger A, 2012, SCIENCE, V335, P723, DOI 10.1126/science.1214277; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schwartz RH, 2003, ANNU REV IMMUNOL, V21, P305, DOI 10.1146/annurev.immunol.21.120601.141110; Shifrin N, 2014, SEMIN IMMUNOL, V26, P138, DOI 10.1016/j.smim.2014.02.007; SLEZAK SE, 1989, J IMMUNOL METHODS, V117, P205, DOI 10.1016/0022-1759(89)90142-7; Thomas LM, 2013, J IMMUNOL, V191, P3981, DOI 10.4049/jimmunol.1301159; Tripathy SK, 2008, J EXP MED, V205, P1829, DOI 10.1084/jem.20072446; Vales-Gomez M, 2008, CANCER RES, V68, P1546, DOI 10.1158/0008-5472.CAN-07-2973; VANKOOYK Y, 1991, J CELL BIOL, V112, P345, DOI 10.1083/jcb.112.2.345; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Yokoyama WM, 2006, IMMUNOL REV, V214, P143, DOI 10.1111/j.1600-065X.2006.00458.x; Yoon JC, 2011, J VIROL, V85, P12557, DOI 10.1128/JVI.00838-11; Zamai L, 1998, J EXP MED, V188, P2375, DOI 10.1084/jem.188.12.2375	61	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0150998	10.1371/journal.pone.0150998	http://dx.doi.org/10.1371/journal.pone.0150998			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007115	gold, Green Submitted, Green Published			2022-12-26	WOS:000372701200039
J	Souza, RS; Diaz-Albiter, HM; Dillon, VM; Dillon, RJ; Genta, FA				Souza, Raquel Santos; Diaz-Albiter, Hector Manuel; Dillon, Vivian Maureen; Dillon, Rod J.; Genta, Fernando Ariel			Digestion of Yeasts and Beta-1,3-Glucanases in Mosquito Larvae: Physiological and Biochemical Considerations	PLOS ONE			English	Article							AEDES-AEGYPTI; ANOPHELES-GAMBIAE; ENZYMES; DIPTERA; GUT; EXPRESSION; FOOD; COMPARTMENTALIZATION; BIOSYNTHESIS; MICROBIOTA	Aedes aegypti larvae ingest several kinds of microorganisms. In spite of studies regarding mosquito digestion, little is known about the nutritional utilization of ingested cells by larvae. We investigated the effects of using yeasts as the sole nutrient source for A. aegypti larvae. We also assessed the role of beta-1,3-glucanases in digestion of live yeast cells. Beta-1,3-glucanases are enzymes which hydrolyze the cell wall beta-1,3-glucan polyssacharide. Larvae were fed with cat food (controls), live or autoclaved Saccharomyces cerevisiae cells and larval weight, time for pupation and adult emergence, larval and pupal mortality were measured. The presence of S. cerevisiae cells inside the larval gut was demonstrated by light microscopy. Beta-1,3-glucanase was measured in dissected larval samples. Viability assays were performed with live yeast cells and larval gut homogenates, with or without addition of competing beta-1,3-glucan. A. aegypti larvae fed with yeast cells were heavier at the 4th instar and showed complete development with normal mortality rates. Yeast cells were efficiently ingested by larvae and quickly killed (10% death in 2h, 100% in 48h). Larvae showed beta-1,3-glucanase in head, gut and rest of body. Gut beta-1,3-glucanase was not derived from ingested yeast cells. Gut and rest of body activity was not affected by the yeast diet, but head homogenates showed a lower activity in animals fed with autoclaved S. cerevisiae cells. The enzymatic lysis of live S. cerevisiae cells was demonstrated using gut homogenates, and this activity was abolished when excess beta-1,3-glucan was added to assays. These results show that live yeast cells are efficiently ingested and hydrolyzed by A. aegypti larvae, which are able to fully-develop on a diet based exclusively on these organisms. Beta-1,3-glucanase seems to be essential for yeast lytic activity of A. aegypti larvae, which possess significant amounts of these enzyme in all parts investigated.	[Souza, Raquel Santos; Diaz-Albiter, Hector Manuel; Genta, Fernando Ariel] Fiocruz MS, Inst Oswaldo Cruz, Lab Insect Biochem & Physiol, 4365 Brasil Av,Leonidas Deane Bldg,Room 207, BR-21040360 Rio De Janeiro, Brazil; [Dillon, Vivian Maureen] Univ Liverpool, Inst Integrat Biol, Biosci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England; [Dillon, Rod J.] Univ Lancaster, Div Biomed & Life Sci, Furness Bldg, Lancaster LA1 4YG, England; [Dillon, Rod J.; Genta, Fernando Ariel] Natl Inst Sci & Technol Mol Entomol, Ctr Hlth Sci, 373 Carlos Chagas Filho Av,Bldg D,Room 5, BR-21941590 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; University of Liverpool; Lancaster University	Genta, FA (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Insect Biochem & Physiol, 4365 Brasil Av,Leonidas Deane Bldg,Room 207, BR-21040360 Rio De Janeiro, Brazil.; Genta, FA (corresponding author), Natl Inst Sci & Technol Mol Entomol, Ctr Hlth Sci, 373 Carlos Chagas Filho Av,Bldg D,Room 5, BR-21941590 Rio De Janeiro, Brazil.	genta@ioc.fiocruz.br	Genta, Fernando/F-1791-2011	Genta, Fernando/0000-0001-9558-1116; Diaz-Albiter, Hector/0000-0003-2937-0569	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/110.760/2013]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [573959/2008-0, 400607/2012-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [1273/2011]; Science Without Borders Program by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq Young Talent Fellowship) [400584/2012-3]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES Parasitology program) [1273/2011]; National Institute of Science and Technology for Molecular Entomology (CNPq) [573959/2008-0]; Science Without Borders Program (Special Visitant Researcher Fellowship, CNPq) [400607/2012-3]; FIOCRUZ; CAPES; CNPq; FAPERJ	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Science Without Borders Program by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq Young Talent Fellowship)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES Parasitology program); National Institute of Science and Technology for Molecular Entomology (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Science Without Borders Program (Special Visitant Researcher Fellowship, CNPq); FIOCRUZ; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	FAG was funded by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, http://www.faperj.br/), grant number E-26/110.760/2013, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, http://www.cnpq.br/), grant number 573959/2008-0) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, http://www.capes.gov.br/), grant number 1273/2011. RJD was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, http://www.cnpq.br/), grant number 400607/2012-3. HMD was funded by funded by the Science Without Borders Program by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq Young Talent Fellowship, http://www.cnpq.br/), grant number 400584/2012-3). RSS was funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES Parasitology program, http://www.capes.gov.br/), grant number 1273/2011. RJD, VMD and FAG are staff members from their respective departments, and were funded by the National Institute of Science and Technology for Molecular Entomology (CNPq grant number 573959/2008-0) and by Science Without Borders Program (Special Visitant Researcher Fellowship, CNPq number 400607/2012-3). FAG was funded by FIOCRUZ, CAPES, CNPq and FAPERJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, FRONT PHYSIOL, DOI DOI 10.3389/fphys.2014.00276; Ashburner M., 1989, DROSOPHILA LAB HDB; AVISSAR YJ, 1994, J AM MOSQUITO CONTR, V10, P45; Borovsky D, 2003, IUBMB LIFE, V55, P435, DOI 10.1080/15216540310001597721; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bragatto I, 2010, INSECT BIOCHEM MOLEC, V40, P861, DOI 10.1016/j.ibmb.2010.08.006; Bulmer MS, 2009, P NATL ACAD SCI USA, V106, P12652, DOI 10.1073/pnas.0904063106; Carvalho DO, 2014, ACTA TROP, V132, pS170, DOI 10.1016/j.actatropica.2013.09.023; Chen XG, 2008, ADV GENET, V64, P19, DOI 10.1016/S0065-2660(08)00802-X; Clements N., 2000, BIOL MOSQUITOES; Coon KL, 2014, MOL ECOL, V23, P2727, DOI 10.1111/mec.12771; DAFFRE S, 1994, MOL GEN GENET, V242, P152, DOI 10.1007/BF00391008; Dillon RJ, 2004, ANNU REV ENTOMOL, V49, P71, DOI 10.1146/annurev.ento.49.061802.123416; Douglas AE, 2014, J MOL BIOL, V426, P3830, DOI 10.1016/j.jmb.2014.04.005; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Ferreira AHP, 2001, INSECT BIOCHEM MOLEC, V31, P1065, DOI 10.1016/S0965-1748(01)00054-6; Genta FA, 2003, INSECT BIOCHEM MOLEC, V33, P1085, DOI 10.1016/S0965-1748(03)00121-8; Genta FA, 2007, BBA-PROTEINS PROTEOM, V1774, P1079, DOI 10.1016/j.bbapap.2007.07.006; Genta FA, 2009, INSECT BIOCHEM MOLEC, V39, P861, DOI 10.1016/j.ibmb.2009.10.003; Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442; HO BC, 1992, J MED ENTOMOL, V29, P960, DOI 10.1093/jmedent/29.6.960; Joy TK, 2010, EXP GERONTOL, V45, P685, DOI 10.1016/j.exger.2010.04.009; Kay B, 1999, CURR OPIN INFECT DIS, V12, P425, DOI 10.1097/00001432-199910000-00003; KHAWALED K, 1992, J INVERTEBR PATHOL, V59, P186, DOI 10.1016/0022-2011(92)90031-X; Lucena SA, 2013, ANAL BIOCHEM, V434, P39, DOI 10.1016/j.ab.2012.10.032; Lucena SA, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-51; Luz PM, 2009, EPIDEMIOL INFECT, V137, P1203, DOI 10.1017/S0950268808001799; Maciel-de-Freitas R, 2012, MEM I OSWALDO CRUZ, V107, P828, DOI 10.1590/S0074-02762012000600021; MERRITT RW, 1990, J AM MOSQUITO CONTR, V6, P35; Moraes CS, 2012, J INSECT PHYSIOL, V58, P1136, DOI 10.1016/j.jinsphys.2012.05.015; Muniaraj M, 2012, TROP BIOMED, V29, P646; Nathan MB, 2007, RECENT EPIDEMIOLOGIC, P30; Orlean P, 2012, GENETICS, V192, P775, DOI 10.1534/genetics.112.144485; Oviedo MN, 2008, INSECT MOL BIOL, V17, P61, DOI 10.1111/j.1365-2583.2008.00779.x; Pauchet Y, 2009, J BIOL CHEM, V284, P2214, DOI 10.1074/jbc.M806204200; Paz S., 2015, PHILOS T R SOC LON B, V370, DOI DOI 10.1098/RSTB.2013.0561.20130561; ROMBOUTS FM, 1976, EUR J BIOCHEM, V63, P121, DOI 10.1111/j.1432-1033.1976.tb10214.x; Ruiz-Herrera J, 1991, Antonie Van Leeuwenhoek, V60, P72; Sandven P, 1999, J CLIN MICROBIOL, V37, P3731, DOI 10.1128/JCM.37.11.3731-3732.1999; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Soares TS, 2011, GENE, V489, P70, DOI 10.1016/j.gene.2011.08.018; Souza-Neto JA, 2003, COMP BIOCHEM PHYS A, V136, P717, DOI 10.1016/S1095-6433(03)00224-1; Steyn A, 2016, MICROBIAL E IN PRESS; Takken W, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-345; Terra, 2005, COMPREHENSIVE MOL IN, P171, DOI [10.1016/B0-44-451924-6/00053-3, DOI 10.1016/B0-44-451924-6/00053-3]; TERRA WR, 1994, COMP BIOCHEM PHYS B, V109, P1, DOI 10.1016/0305-0491(94)90141-4; Timmermann SE, 1996, ENTOMOL EXP APPL, V80, P173, DOI 10.1007/BF00194752; Venancio TM, 2009, INSECT MOL BIOL, V18, P33, DOI 10.1111/j.1365-2583.2008.00845.x; Villegas LM, 2014, MEM I OSWALDO CRUZ, V109, P672, DOI 10.1590/0074-0276140194; WALKER ED, 1988, J MED ENTOMOL, V25, P551, DOI 10.1093/jmedent/25.6.551; Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008; Yahouedo GA, 2014, ACTA TROP, V132, pS96, DOI 10.1016/j.actatropica.2013.11.014	52	14	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151403	10.1371/journal.pone.0151403	http://dx.doi.org/10.1371/journal.pone.0151403			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007411	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000372701200053
J	Kumar, S; Rathkolb, B; Kemter, E; Sabrautzki, S; Michel, D; Adler, T; Becker, L; Beckers, J; Busch, DH; Garrett, L; Hans, W; Holter, SM; Horsch, M; Klingenspor, M; Klopstock, T; Racz, I; Rozman, J; Panesso, ILV; Vernaleken, A; Zimmer, A; Fuchs, H; Gailus-Durner, V; de Angelis, MH; Wolf, E; Aigner, B				Kumar, Sudhir; Rathkolb, Birgit; Kemter, Elisabeth; Sabrautzki, Sibylle; Michel, Dian; Adler, Thure; Becker, Lore; Beckers, Johannes; Busch, Dirk H.; Garrett, Lillian; Hans, Wolfgang; Hoelter, Sabine M.; Horsch, Marion; Klingenspor, Martin; Klopstock, Thomas; Racz, Ildiko; Rozman, Jan; Panesso, Ingrid Liliana Vargas; Vernaleken, Alexandra; Zimmer, Andreas; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe; Wolf, Eckhard; Aigner, Bernhard			Generation and Standardized, Systemic Phenotypic Analysis of Pou3f3(L423P) Mutant Mice	PLOS ONE			English	Article							MOUSE MUTAGENESIS PROJECT; KIDNEY-DISEASE; CRUCIAL ROLES; MUTATION; GENES; EXPRESSION; UROMODULIN; MODELS; BRN-1	Increased levels of blood plasma urea were used as phenotypic parameter for establishing novel mouse models for kidney diseases on the genetic background of C3H inbred mice in the phenotype-driven Munich ENU mouse mutagenesis project. The phenotypically recessive mutant line HST011 was established and further analyzed. The causative mutation was detected in the POU domain, class 3 transcription factor 3 (Pou3f3) gene, which leads to the amino acid exchange Pou3f3(L423P) thereby affecting the conserved homeobox domain of the protein. Pou3f3 homozygous knockout mice are published and show perinatal death. Line Pou3f3(L423P) is a viable mouse model harboring a homozygous Pou3f3 mutation. Standardized, systemic phenotypic analysis of homozygous mutants was carried out in the German Mouse Clinic. Main phenotypic changes were low body weight and a state of low energy stores, kidney dysfunction and secondary effects thereof including low bone mineralization, multiple behavioral and neurological defects including locomotor, vestibular, auditory and nociceptive impairments, as well as multiple subtle changes in immunological parameters. Genome-wide transcriptome profiling analysis of kidney and brain of Pou3f3(L423P) homozygous mutants identified significantly regulated genes as compared to wild-type controls.	[Kumar, Sudhir; Rathkolb, Birgit; Kemter, Elisabeth; Wolf, Eckhard; Aigner, Bernhard] Ludwig Maximilians Univ Munchen, Mol Anim Breeding & Biotechnol, D-81377 Munich, Germany; [Kumar, Sudhir; Rathkolb, Birgit; Kemter, Elisabeth; Wolf, Eckhard; Aigner, Bernhard] Ludwig Maximilians Univ Munchen, Lab Funct Genome Anal LAFUGA, Gene Ctr, D-81377 Munich, Germany; [Sabrautzki, Sibylle; Michel, Dian; Adler, Thure; Becker, Lore; Beckers, Johannes; Hans, Wolfgang; Horsch, Marion; Rozman, Jan; Panesso, Ingrid Liliana Vargas; Vernaleken, Alexandra; Fuchs, Helmut; Gailus-Durner, Valerie; de Angelis, Martin Hrabe] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, German Mouse Clin, Inst Expt Genet, D-85764 Neuherberg, Germany; [Adler, Thure; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Beckers, Johannes; de Angelis, Martin Hrabe] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Chair Expt Genet, D-85350 Freising Weihenstephan, Germany; [Garrett, Lillian; Hoelter, Sabine M.] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Dev Genet, D-85764 Neuherberg, Germany; [Klingenspor, Martin; Rozman, Jan] Tech Univ Munich, Else Kroner Fresenius Ctr, Mol Nutr Med, D-85350 Freising Weihenstephan, Germany; [Klopstock, Thomas; Panesso, Ingrid Liliana Vargas; Vernaleken, Alexandra] Ludwig Maximilians Univ Munchen, Friedrich Baur Inst, Dept Neurol, D-80336 Munich, Germany; [Klopstock, Thomas; Panesso, Ingrid Liliana Vargas; de Angelis, Martin Hrabe] Univ Hosp Munich, German Ctr Vertigo & Balance Disorders, Campus Grosshadern, D-81377 Munich, Germany; [Racz, Ildiko; Zimmer, Andreas] Univ Bonn, Dept Psychiat, Mol Neurobiol Lab, D-53105 Bonn, Germany	University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; University of Munich; University of Bonn	Aigner, B (corresponding author), Ludwig Maximilians Univ Munchen, Mol Anim Breeding & Biotechnol, D-81377 Munich, Germany.; Aigner, B (corresponding author), Ludwig Maximilians Univ Munchen, Lab Funct Genome Anal LAFUGA, Gene Ctr, D-81377 Munich, Germany.	b.aigner@gen.vetmed.uni-muenchen.de	Zimmer, Andreas/B-8357-2009; Hölter, Sabine M./N-5868-2014; Klingenspor, Martin/D-6930-2011; Wolf, Eckhard/AAT-7500-2021; Becker, Lore/AAJ-1203-2020; Klingenspor, Martin/K-5033-2019; Rozman, Jan/A-2540-2010; Beckers, Johannes/K-7237-2012; de Angelis, Martin Hrabe/F-5531-2012; Gailus-Durner, Valerie/M-7337-2014	Hölter, Sabine M./0000-0003-4878-5241; Klingenspor, Martin/0000-0002-4502-6664; Wolf, Eckhard/0000-0002-0430-9510; Becker, Lore/0000-0002-6890-4984; Rozman, Jan/0000-0002-8035-8904; Beckers, Johannes/0000-0001-7874-3822; de Angelis, Martin Hrabe/0000-0002-7898-2353; Garrett, Lillian/0000-0003-4880-7076; Kemter, Elisabeth/0000-0001-7785-7502; Aigner, Bernhard/0000-0003-1644-2711	German Federal Ministry of Education and Research; German Center for Vertigo and Balance Disorders [01 EO 0901]; GMC (NGFN-Plus grants) [01GS0850, 01GS0851, 01GS0853, 01GS0854, 01GS0869, 01KX1012]; Initiative and Networking Fund of the Helmholtz Association [HA-215]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Center for Vertigo and Balance Disorders; GMC (NGFN-Plus grants); Initiative and Networking Fund of the Helmholtz Association	This work has been funded by the German Federal Ministry of Education and Research to the German Center for Diabetes Research (DZD), the German Center for Vertigo and Balance Disorders (grant 01 EO 0901) and to the GMC (NGFN-Plus grants No. 01GS0850, 01GS0851, 01GS0853, 01GS0854, 01GS0869; Infrafrontier grant 01KX1012), and by the Initiative and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Research in an Ageing Society (HA-215).	Aigner B, 2007, AM J PHYSIOL-RENAL, V292, pF1560, DOI 10.1152/ajprenal.00213.2006; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Dheedene A, 2014, MOL SYNDROMOL, V5, P32, DOI 10.1159/000356060; Friedrich RP, 2005, MOL CELL BIOL, V25, P1821, DOI 10.1128/MCB.25.5.1821-1829.2005; Fuchs H, 2012, MAMM GENOME, V23, P611, DOI 10.1007/s00335-012-9415-1; Fuchs H, 2011, METHODS, V53, P120, DOI 10.1016/j.ymeth.2010.08.006; Gailus-Durner V, 2005, NAT METHODS, V2, P403, DOI 10.1038/nmeth0605-403; Gailus-Durner Valerie, 2009, V530, P463, DOI 10.1007/978-1-59745-471-1_25; Haluszczak C, 2009, J EXP MED, V206, P435, DOI 10.1084/jem.20081829; HARA Y, 1992, P NATL ACAD SCI USA, V89, P3280, DOI 10.1073/pnas.89.8.3280; Horsch M, 2008, PROTEOMICS, V8, P1248, DOI 10.1002/pmic.200700725; HRABE DE ANGELIS M, 2007, MOUSE BIOMEDICAL RES, P225; Kemter E, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0068-0; Kemter E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078337; Kemter E, 2013, HUM MOL GENET, V22, P4148, DOI 10.1093/hmg/ddt263; Kemter E, 2010, AM J PHYSIOL-RENAL, V298, pF1405, DOI 10.1152/ajprenal.00522.2009; Kemter E, 2009, AM J PHYSIOL-RENAL, V297, pF1391, DOI 10.1152/ajprenal.00261.2009; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; Mutai H, 2009, DEV NEUROBIOL, V69, P913, DOI 10.1002/dneu.20746; Nakai S, 2003, DEVELOPMENT, V130, P4751, DOI 10.1242/dev.00666; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; Rathkolb B, 2000, MAMM GENOME, V11, P543, DOI 10.1007/s003350010104; Rozman J, 2014, MAMM GENOME, V25, P497, DOI 10.1007/s00335-014-9532-0; Sugitani Y, 2002, GENE DEV, V16, P1760, DOI 10.1101/gad.978002; Sumiyama K, 1996, J MOL EVOL, V43, P170, DOI 10.1007/PL00006075; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0	27	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0150472	10.1371/journal.pone.0150472	http://dx.doi.org/10.1371/journal.pone.0150472			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003440	Green Published, Green Submitted, gold			2022-12-26	WOS:000372697400014
J	Livingstone, IAT; Tarbert, CM; Giardini, ME; Bastawrous, A; Middleton, D; Hamilton, R				Livingstone, I. A. T.; Tarbert, C. M.; Giardini, M. E.; Bastawrous, A.; Middleton, D.; Hamilton, R.			Photometric Compliance of Tablet Screens and Retro-Illuminated Acuity Charts As Visual Acuity Measurement Devices	PLOS ONE			English	Article							CONTRAST SENSITIVITY	Mobile technology is increasingly used to measure visual acuity. Standards for chart-based acuity tests specify photometric requirements for luminance, optotype contrast and luminance uniformity. Manufacturers provide some photometric data but little is known about tablet performance for visual acuity testing. This study photometrically characterised seven tablet computers (iPad, Apple inc.) and three ETDRS (Early Treatment Diabetic Retinopathy Study) visual acuity charts with room lights on and off, and compared findings with visual acuity measurement standards. Tablet screen luminance and contrast were measured using nine points across a black and white checkerboard test screen at five arbitrary brightness levels. ETDRS optotypes and adjacent white background luminance and contrast were measured. All seven tablets (room lights off) exceeded the most stringent requirement for mean luminance(>= 120 cd/m(2)) providing the nominal brightness setting was above 50%. All exceeded contrast requirement (Weber >= 90%) regardless of brightness setting, and five were marginally below the required luminance uniformity threshold (L-min/L-max >= 80%). Re-assessing three tablets with room lights on made little difference to mean luminance or contrast, and improved luminance uniformity to exceed the threshold. The three EDTRS charts (room lights off) had adequate mean luminance (>= 120 cd/m(2)) and Weber contrast (>= 90%), but all three charts failed to meet the luminance uniformity standard (L-min/L-max >= 80%). Two charts were operating beyond manufacturer's recommended lamp replacement schedule. With room lights on, chart mean luminance and Weber contrast increased, but two charts still had inadequate luminance uniformity. Tablet computers showed less inter-device variability, higher contrast, and better luminance uniformity than charts in both lights-on and lights-off environments, providing brightness setting was >50%. Overall, iPad tablets matched or marginally out-performed ETDRS charts in terms of photometric compliance with high contrast acuity standards.	[Livingstone, I. A. T.] NHS Greater Glasgow & Clyde, Dept Ophthalmol, Glasgow, Lanark, Scotland; [Livingstone, I. A. T.] NHS Greater Glasgow & Clyde, Glasgow Ctr Ophthalm Res, Glasgow, Lanark, Scotland; [Livingstone, I. A. T.; Hamilton, R.] Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Tarbert, C. M.; Middleton, D.; Hamilton, R.] NHS Greater Glasgow & Clyde, Dept Clin Phys, Glasgow, Lanark, Scotland; [Giardini, M. E.] Univ Strathclyde, Dept Biomed Engn, Glasgow, Lanark, Scotland; [Bastawrous, A.] London Sch Hyg & Trop Med, Dept Clin Res, Int Ctr Eye Hlth, London WC1, England	University of Glasgow; University of Strathclyde; University of London; London School of Hygiene & Tropical Medicine	Livingstone, IAT (corresponding author), NHS Greater Glasgow & Clyde, Dept Ophthalmol, Glasgow, Lanark, Scotland.; Livingstone, IAT (corresponding author), NHS Greater Glasgow & Clyde, Glasgow Ctr Ophthalm Res, Glasgow, Lanark, Scotland.; Livingstone, IAT (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	iain.livingstone@nhs.net	Hamilton, Ruth/H-4253-2011; Giardini, Mario/C-3552-2008	Hamilton, Ruth/0000-0002-0855-9533; Giardini, Mario/0000-0003-4849-9683; Middleton, Duncan/0000-0003-2909-0049	Queen Elizabeth Diamond Jubilee Trust; MRC [G1001934] Funding Source: UKRI; Medical Research Council [G1001934] Funding Source: researchfish; Fight for Sight [1310/11] Funding Source: researchfish	Queen Elizabeth Diamond Jubilee Trust; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Fight for Sight	IL was funded in part by the Queen Elizabeth Diamond Jubilee Trust. URL: http://jubileetribute.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Association of Physicists in Medicine Task Group 18, 2005, 03 AAPM IM INF SUBC; [Anonymous], PERS HLTH CAR 2020 F; Aslam TM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0239; Bastawrous A, 2012, EYE, V26, P343, DOI 10.1038/eye.2012.6; Bastawrous A, 2015, JAMA OPHTHALMOLOGY; Black JM, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002730; British Standards Institution, 2003, 427412003 BS; Buhren J, 2006, OPTOMETRY VISION SCI, V83, P290, DOI 10.1097/01.opx.0000216100.93302.2d; Dorr M, 2013, INVEST OPHTH VIS SCI, V54, P7266, DOI 10.1167/iovs.13-11743; HAUSER B, 1992, KLIN MONATSBL AUGENH, V200, P105, DOI 10.1055/s-2008-1045721; Health C for D and R, MOB MED APPL; International Committee for Display Metrology, 2013, INF DISPL MEAS STAND; International Council of Ophthalmology, RES VIS AC MEAS STAN; Johnson CA, 1995, OPTOMETRY VISION SCI, V72, P864, DOI 10.1097/00006324-199512000-00004; Kollbaum PS, 2014, OPTOMETRY VISION SCI, V91, P291, DOI 10.1097/OPX.0000000000000158; Lin TP, 2015, J PARKINSON DIS, V5, P125, DOI 10.3233/JPD-140470; Livingstone IAT, 2014, IEEE ENG MED BIO, P2189, DOI 10.1109/EMBC.2014.6944052; Norgett Y, 2014, J VISION, V14, DOI 10.1167/14.12.23; research2guidance, 2013, MOB HLTH MARK TRENDS, V3; Ruamviboonsuk Paisan, 2012, J Med Assoc Thai, V95 Suppl 3, pS109; SHEEDY JE, 1984, AM J OPTOM PHYS OPT, V61, P595; Tahir HJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095074; Tsui Irena, 2014, J Diabetes Sci Technol, V8, P845, DOI 10.1177/1932296814529637; World Health Organization, UN EYE HLTH GLOB ACT; Zhang ZT, 2013, J TELEMED TELECARE, V19, P55, DOI 10.1177/1357633X12474964	25	10	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0150676	10.1371/journal.pone.0150676	http://dx.doi.org/10.1371/journal.pone.0150676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002333	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000372697400019
J	Langie, SAS; Szic, KSV; Declerck, K; Traen, S; Koppen, G; Van Camp, G; Schoeters, G; Vanden Berghe, W; De Boever, P				Langie, Sabine A. S.; Szic, Katarzyna Szarc vel; Declerck, Ken; Traen, Sophie; Koppen, Gudrun; Van Camp, Guy; Schoeters, Greet; Vanden Berghe, Wim; De Boever, Patrick			Whole-Genome Saliva and Blood DNA Methylation Profiling in Individuals with a Respiratory Allergy	PLOS ONE			English	Article							EPIGENOME-WIDE ASSOCIATION; CHILDHOOD ASTHMA; GROWTH-FACTOR; T-CELLS; EXPOSURE; DIAGNOSTICS; PATTERNS; SAMPLES; TISSUE; BETA	The etiology of respiratory allergies (RA) can be partly explained by DNA methylation changes caused by adverse environmental and lifestyle factors experienced early in life. Longitudinal, prospective studies can aid in the unravelment of the epigenetic mechanisms involved in the disease development. High compliance rates can be expected in these studies when data is collected using non-invasive and convenient procedures. Saliva is an attractive biofluid to analyze changes in DNA methylation patterns. We investigated in a pilot study the differential methylation in saliva of RA (n = 5) compared to healthy controls (n = 5) using the Illumina Methylation 450K BeadChip platform. We evaluated the results against the results obtained in mononuclear blood cells from the same individuals. Differences in methylation patterns from saliva and mononuclear blood cells were clearly distinguishable (P-Adj<0.001 and vertical bar Delta beta vertical bar 0.2), though the methylation status of about 96% of the cg-sites was comparable between peripheral blood mononuclear cells and saliva. When comparing RA cases with healthy controls, the number of differentially methylated sites (DMS) in saliva and blood were 485 and 437 (P<0.05 and vertical bar Delta beta vertical bar>0.1), respectively, of which 216 were in common. The methylation levels of these sites were significantly correlated between blood and saliva. The absolute levels of methylation in blood and saliva were confirmed for 3 selected DMS in the PM20D1, STK32C, and FGFR2 genes using pyrosequencing analysis. The differential methylation could only be confirmed for DMS in PM20D1 and STK32C genes in saliva. We show that saliva can be used for genome-wide methylation analysis and that it is possible to identify DMS when comparing RA cases and healthy controls. The results were replicated in blood cells of the same individuals and confirmed by pyrosequencing analysis. This study provides proof-of-concept for the applicability of saliva-based whole-genome methylation analysis in the field of respiratory allergy.	[Langie, Sabine A. S.; Szic, Katarzyna Szarc vel; Traen, Sophie; Koppen, Gudrun; Schoeters, Greet; De Boever, Patrick] Flemish Inst Technol Res VITO, Environm Risk & Hlth Unit, Mol, Belgium; [Szic, Katarzyna Szarc vel; Declerck, Ken; Vanden Berghe, Wim] Univ Antwerp, Lab Prot Chem Prote & Epigenet Signaling PPES, Antwerp, Belgium; [Szic, Katarzyna Szarc vel; Declerck, Ken; Schoeters, Greet; Vanden Berghe, Wim] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium; [Van Camp, Guy] Univ Antwerp, Ctr Med Genet, Lab Canc Res & Clin Oncol, Edegem, Belgium; [Schoeters, Greet] Univ Southern Denmark, Inst Publ Hlth, Dept Environm Med, Odense, Denmark; [De Boever, Patrick] Hasselt Univ, Ctr Environm Sci, Diepenbeek, Belgium	VITO; University of Antwerp; University of Antwerp; University of Antwerp; University of Southern Denmark; Hasselt University	Langie, SAS (corresponding author), Flemish Inst Technol Res VITO, Environm Risk & Hlth Unit, Mol, Belgium.	sabine.langie@vito.be	Berghe, Wim Vanden/S-6425-2018; De Boever, Patrick/AAA-8387-2019; Vanden Berghe, Wim/HGE-4696-2022; Langie, Sabine A/Q-2917-2017; Van Camp, Guy/F-3386-2013; Koppen, Gudrun/Q-4011-2018	Berghe, Wim Vanden/0000-0003-0161-7355; De Boever, Patrick/0000-0002-5197-8215; Langie, Sabine A/0000-0003-3288-7331; Van Camp, Guy/0000-0001-5105-9000; Schoeters, Greta/0000-0002-6556-4814; Declerck, Ken/0000-0001-8104-8054	AXA Research Fund; Cefic-LRI Innovative Science Award	AXA Research Fund(AXA Research Fund); Cefic-LRI Innovative Science Award	SL is the beneficiary of a post-doctoral grant from the AXA Research Fund and the Cefic-LRI Innovative Science Award 2013.	Adalsteinsson BT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046705; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Assenov Y, 2014, NAT METHODS, V11, P1138, DOI [10.1038/NMETH.3115, 10.1038/nmeth.3115]; Begin P, 2014, ALLERGY ASTHMA CL IM, V10, DOI 10.1186/1710-1492-10-27; Birnboim HC, 2008, PDWP011; Bolstad B, 2005, BIOINFORMATICS COMPU; Bonne NJ, 2012, GENOME MED, V4, DOI 10.1186/gm383; Brunst KJ, 2013, J ALLERGY CLIN IMMUN, V131, P592, DOI 10.1016/j.jaci.2012.10.042; Cortessis VK, 2012, HUM GENET, V131, P1565, DOI 10.1007/s00439-012-1189-8; Delaleu N, 2015, ARTHRITIS RHEUMATOL, V67, P1084, DOI 10.1002/art.39015; Everson TM, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0213-8; Feinberg AP, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001262; Gaffin JM, 2014, CLIN EXP ALLERGY, V44, P681, DOI 10.1111/cea.12219; Gomez-Uriz AM, 2015, HUM MOL GENET, V24, P1432, DOI 10.1093/hmg/ddu559; Goode MR, 2014, JOVE-J VIS EXP, DOI 10.3791/51697; Gunawardhana LP, 2014, PEDIATR PULM, V49, P852, DOI 10.1002/ppul.22930; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31; Kang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016161; Koestler DC, 2013, EPIGENETICS-US, V8, P816, DOI 10.4161/epi.25430; Koni AC, 2011, INT J OBESITY, V35, pS113, DOI 10.1038/ijo.2011.43; Kunikata T, 2005, NAT IMMUNOL, V6, P524, DOI 10.1038/ni1188; Little FF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084449; Lowe R, 2013, EPIGENETICS-US, V8, P445, DOI 10.4161/epi.24362; Mathers JC, 2010, ADV GENET, V71, P3, DOI [10.1016/B978-0-12-380864-6.00001-8, 10.1016/S0065-2660(10)71001-4]; Michel S, 2013, ALLERGY, V68, P355, DOI 10.1111/all.12097; Nie S, 2014, LAB CHIP, V14, P1087, DOI 10.1039/c3lc51303c; Njau F, 2009, MICROBES INFECT, V11, P1002, DOI 10.1016/j.micinf.2009.07.006; Ollikainen M, 2010, HUM MOL GENET, V19, P4176, DOI 10.1093/hmg/ddq336; Park HK, 2008, ALLERGY, V63, P447, DOI 10.1111/j.1398-9995.2007.01593.x; Pascual M, 2011, EPIGENETICS-US, V6, P1131, DOI 10.4161/epi.6.9.16061; Perera F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004488; Qin HJ, 2011, P NATL ACAD SCI USA, V108, P2016, DOI 10.1073/pnas.1019082108; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Schafer CA, 2014, MONOGR ORAL SCI, V24, P88, DOI 10.1159/000358791; Schneider E, 2010, NUCLEIC ACIDS RES, V38, P3880, DOI 10.1093/nar/gkq126; Sebastian T, 2014, CLIN CHIM ACTA, V429, P198, DOI 10.1016/j.cca.2013.12.009; Shah S, 2015, ANN ALLERG ASTHMA IM, V114, P63, DOI 10.1016/j.anai.2014.09.012; Shikhagaie MM, 2014, CLIN EXP ALLERGY, V44, P184, DOI 10.1111/cea.12176; Sly PD, 2011, CURR OPIN ALLERGY CL, V11, P24, DOI 10.1097/ACI.0b013e328342309d; Smith AK, 2015, AM J MED GENET B, V168, P36, DOI 10.1002/ajmg.b.32278; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Suderman M, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-13; Teschendorff AE, 2013, BIOINFORMATICS, V29, P189, DOI 10.1093/bioinformatics/bts680; Thompson TM, 2013, BEHAV GENET, V43, P168, DOI 10.1007/s10519-012-9579-1; Tsitsiou E, 2012, J ALLERGY CLIN IMMUN, V129, P95, DOI 10.1016/j.jaci.2011.08.011; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Wilson RH, 2012, NAT MED, V18, P1705, DOI 10.1038/nm.2920; World Health Organization, 2007, GLOB SURV PREV CONTR; Wren ME, 2015, CLIN THER, V37, P529, DOI 10.1016/j.clinthera.2015.02.022; Wu HC, 2014, EPIGENETICS-US, V9, P929, DOI 10.4161/epi.28902; Yoshizawa JM, 2013, CLIN MICROBIOL REV, V26, P781, DOI 10.1128/CMR.00021-13	53	36	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151109	10.1371/journal.pone.0151109	http://dx.doi.org/10.1371/journal.pone.0151109			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999364	Green Published, gold			2022-12-26	WOS:000372694700021
J	Song, J; Tanida, M; Shibamoto, T; Zhang, T; Wang, MF; Kuda, Y; Kurata, Y				Song, Jie; Tanida, Mamoru; Shibamoto, Toshishige; Zhang, Tao; Wang, Mofei; Kuda, Yuhichi; Kurata, Yasutaka			The Role of Lumbar Sympathetic Nerves in Regulation of Blood Flow to Skeletal Muscle during Anaphylactic Hypotension in Anesthetized Rats	PLOS ONE			English	Article							NITRIC-OXIDE; VASOCONSTRICTION; SHOCK; ANTAGONISTS; INHIBITION; MECHANISMS; RESPONSES; SYSTEM	During hypovolemic shock, skeletal muscle blood flow could be redistributed to vital organs via vasoconstriction in part evoked by activation of the innervating sympathetic nerve activity. However, it is not well known whether this mechanism operates during anaphylactic shock. We determined the femoral artery blood flow (FBF) and lumbar sympathetic nerve activity (LSNA) mainly regulating the hindquater muscle blood flow during anaphylactic hypotension in anesthetized rats. Anesthetized Sprague-Dawley rats were randomly allocated to the following groups (n = 7/group): (1) non-sensitized, (2) anaphylaxis, (3) anaphylaxis-lumbar sympathectomy (LS) and (4) anaphylaxis-sinoaortic denervation (SAD) groups. Anaphylaxis was induced by an intravenous injection of the ovalbumin antigen to the sensitized rats. The systemic arterial pressure (SAP), heart rate (HR), central venous pressure (CVP), FBF and LSNA were continuously measured. In the anaphylaxis group, LSNA and HR increased, while SAP and FBF decreased after antigen injection. In the anaphylaxis-SAD group, LSNA did not significantly change during the early phase, but the responses of SAP and FBF were similar to those in the anaphylaxis group. In the anaphylaxis-LS group, both FBF and SAP decreased similarly to the anaphylaxis group during anaphylactic hypotension. These results indicated that LSNA increased via baroreceptor reflex, but this sympathoexcitation or LS did not affect antigen-induced decreases in FBF or SAP. Lumbar sympathetic nerves are not involved in regulation of the blood flow to the hindlimb or systemic blood pressure during anaphylactic hypotension in anesthetized rats.	[Song, Jie; Tanida, Mamoru; Shibamoto, Toshishige; Zhang, Tao; Wang, Mofei; Kuda, Yuhichi; Kurata, Yasutaka] Kanazawa Med Univ, Dept Physiol 2, Uchinada, Ishikawa 9200293, Japan; [Song, Jie] China Japan Friendship Hosp, Dept Anesthesiol, Beijing 100029, Peoples R China; [Zhang, Tao] China Med Univ, Affiliated Hosp 4, Dept Colorectal & Hernia Surg, Shenyang 110032, Peoples R China; [Wang, Mofei] China Med Univ, Affiliated Hosp 4, Dept Diabet Surg, Shenyang 110032, Peoples R China	Kanazawa Medical University; China-Japan Friendship Hospital; China Medical University; China Medical University	Tanida, M; Shibamoto, T (corresponding author), Kanazawa Med Univ, Dept Physiol 2, Uchinada, Ishikawa 9200293, Japan.	mtanida@kanazawa-med.ac.jp; shibamo@kanazawa-med.ac.jp			Kanazawa Medical University [S2013-1]; Mishima Kaiun Memorial Foundation [11]; Takeda Science Foundation; Grants-in-Aid for Scientific Research [16K09767] Funding Source: KAKEN	Kanazawa Medical University; Mishima Kaiun Memorial Foundation(Mishima Kaiun Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study is supported by grants from Grant for Promoted Research from Kanazawa Medical University (MT, S2013-1, http://www.kanazawa-med.ac.jp/kenkyu/publication.html), from Mishima Kaiun Memorial Foundation (MT, No11, http://www.mishima-kaiun.or.jp/assist/2147.html) and from Takeda Science Foundation (MT, http://www.takeda-sci.or.jp/business/doc/2013_list.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1990, EUROPEAN RESPIRATORY; BARON R, 1988, J COMP NEUROL, V275, P460, DOI 10.1002/cne.902750310; BAYORH MA, 1985, PROSTA LEUKOTR MED, V17, P229, DOI 10.1016/0262-1746(85)90110-6; BRANTIGAN JW, 1974, J APPL PHYSIOL, V37, P117, DOI 10.1152/jappl.1974.37.1.117; Coney AM, 2003, J PHYSIOL-LONDON, V549, P613, DOI 10.1113/jphysiol.2003.042267; Dewachter P, 2005, ANESTHESIOLOGY, V103, P40, DOI 10.1097/00000542-200507000-00010; Hui YQ, 2004, CIRCULATION, V110, P3360, DOI 10.1161/01.CIR.0000147775.50954.AA; Jendzjowsky NG, 2013, J APPL PHYSIOL, V115, P97, DOI 10.1152/japplphysiol.00250.2013; KAPIN MA, 1985, AM J PHYSIOL, V249, pH430, DOI 10.1152/ajpheart.1985.249.2.H430; Kemp SF, 2002, J ALLERGY CLIN IMMUN, V110, P341, DOI 10.1067/mai.2002.126811; MATHISON R, 1992, BRIT J PHARMACOL, V106, P263, DOI 10.1111/j.1476-5381.1992.tb14326.x; Miki K, 2004, J PHYSIOL-LONDON, V557, P261, DOI 10.1113/jphysiol.2003.055525; MITSUHATA H, 1995, J CLIN IMMUNOL, V15, P277, DOI 10.1007/BF01541317; Moreira TS, 2011, BRAZ J MED BIOL RES, V44, P883, DOI 10.1590/S0100-879X2011000900009; OFFNER B, 1994, J APPL PHYSIOL, V77, P173, DOI 10.1152/jappl.1994.77.1.173; Potas JR, 2004, AUTON NEUROSCI-BASIC, V112, P25, DOI 10.1016/j.autneu.2004.03.004; Shibamoto T, 2005, AM J PHYSIOL-HEART C, V289, pH1436, DOI 10.1152/ajpheart.00368.2005; SMEDEGARD G, 1979, ACTA PHYSIOL SCAND, V106, P191, DOI 10.1111/j.1748-1716.1979.tb06389.x; Sun LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113945; Thomas GD, 1998, J PHYSIOL-LONDON, V506, P817, DOI 10.1111/j.1469-7793.1998.817bv.x; VATNER SF, 1974, J CLIN INVEST, V54, P225, DOI 10.1172/JCI107757; Wang MF, 2015, EXP LUNG RES, V41, P324, DOI 10.3109/01902148.2015.1032448; Wang M, 2014, EUR J PHARMACOL, V731, P38, DOI 10.1016/j.ejphar.2014.03.012; Wang MF, 2013, AM J PHYSIOL-REG I, V305, pR900, DOI 10.1152/ajpregu.00120.2013; Zhang W, 2013, IN VIVO, V27, P485; Zhang W, 2012, AM J PHYSIOL-REG I, V302, pR1191, DOI 10.1152/ajpregu.00695.2011; Zhang W, 2011, ANESTHESIOLOGY, V114, P614, DOI 10.1097/ALN.0b013e31820b8d34	27	6	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0150882	10.1371/journal.pone.0150882	http://dx.doi.org/10.1371/journal.pone.0150882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998924	Green Published, gold, Green Submitted			2022-12-26	WOS:000372694700017
J	Clemente, NS; Ugarte-Gil, C; Solorzano, N; Maguina, C; Moore, D				Clemente, Nuria Sanchez; Ugarte-Gil, Cesar; Solorzano, Nelson; Maguina, Ciro; Moore, David			An Outbreak of Bartonella bacilliformis in an Endemic Andean Community	PLOS ONE			English	Article							EPIDEMIOLOGY	Background Bartonellosis affects small Andean communities in Peru, Colombia and Ecuador. Research in this area has been limited. Methods Retrospective review of 191 cases of bartonellosis managed in Caraz District Hospital, Peru, during the last outbreak (2003). Results The majority of cases (65%) were 14 years old and younger. There was a peak in acute cases after the rainy season; chronic cases presented more constantly throughout the year. The sensitivity of blood smear against blood culture in acute disease was 25%. The most commonly used treatment for chronic disease was rifampicin; chloramphenicol was used to treat most acute cases. Complications arose in 6.8% and there were no deaths. Conclusions Diagnostic and treatment algorithms for acute and chronic bartonellosis have been developed without a strong evidence base. Preparation of ready-to-go operational research protocols for future outbreaks would strengthen the evidence base for diagnostic and treatment strategies and enhance opportunities for control.	[Clemente, Nuria Sanchez; Moore, David] London Sch Hyg & Trop Med, London WC1, England; [Ugarte-Gil, Cesar; Maguina, Ciro] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Lima, Peru; [Solorzano, Nelson] Hosp San Juan Dios, Caraz, Peru	University of London; London School of Hygiene & Tropical Medicine; Universidad Peruana Cayetano Heredia	Clemente, NS (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	nuriasanchezclemente@gmail.com	Ugarte-Gil, Cesar/E-6074-2013; Clemente, Nuria Sanchez/AAL-4309-2020	Ugarte-Gil, Cesar/0000-0002-2833-9087; 	London School of Hygiene and Tropical Medicine; Wellcome Trust [092691/Z10/Z]	London School of Hygiene and Tropical Medicine; Wellcome Trust(Wellcome TrustEuropean Commission)	NSC received a travel stipend from the London School of Hygiene and Tropical Medicine. DM received support from the support of the Wellcome Trust (grant 092691/Z10/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DM acknowledges the support of the Wellcome Trust (grant 092691/Z10/Z)	Angelakis E, 2008, J ANTIMICROB CHEMOTH, V61, P1252, DOI 10.1093/jac/dkn094; [Anonymous], 1992, REV MED HEREDIANA; [Anonymous], 1996, REV NEUROPSIQUIATR; [Anonymous], 1998, REV MED HEREDIANA; Blazes DL, 2013, EMERG INFECT DIS, V19, P1111, DOI 10.3201/eid1907.121718; BREÑA CHÁVEZ Judith Patricia, 2006, Rev Med Hered, V17, P122; Chamberlin J, 2002, J INFECT DIS, V186, P983, DOI 10.1086/344054; Chinga-Alayo E, 2004, T ROY SOC TROP MED H, V98, P116, DOI 10.1016/S0035-9203(03)00017-8; Clemente NS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001819; Direccion Regional de Salud Ancash (Peru), 2015, B EP SEM, P38; GRAY GC, 1990, AM J TROP MED HYG, V42, P215, DOI 10.4269/ajtmh.1990.42.215; Maguina Ciro, 1997, Rev Gastroenterol Peru, V17, P31; Maguina C, 2009, CLIN DERMATOL, V27, P271, DOI 10.1016/j.clindermatol.2008.10.006; Maguiña Vargas Ciro, 2008, Acta méd. peruana, V25, P30; Maguina Vargas C., 1998, BARTONELLOSIS ENFERM, P89; Maguiña Vargas Ciro, 2008, Rev Med Hered, V19, P36; Ministerio de Salud, 1998, DOCTR NORM PROC CONT; Minnick MF, 2003, ANTIMICROBIAL AGENTS, V47; Peru Ministerio de Salud, 2006, NORM TECN SAL AT BAR; SCHULTZ MG, 1968, AM J TROP MED HYG, V17, P503, DOI 10.4269/ajtmh.1968.17.503; Tarazona F Augusto, 2006, Rev. perú. med. exp. salud publica, V23, P188	21	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150525	10.1371/journal.pone.0150525	http://dx.doi.org/10.1371/journal.pone.0150525			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991495	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000372582800035
J	Hall, A; Kingsford, M				Hall, April; Kingsford, Michael			Predators Exacerbate Competitive Interactions and Dominance Hierarchies between Two Coral Reef Fishes	PLOS ONE			English	Article							HABITAT DEGRADATION; DENSITY-DEPENDENCE; INTERSPECIFIC COMPETITION; POPULATION REGULATION; SELECTIVE MORTALITY; HUMBUG DAMSELFISH; HIGH DIVERSITY; PREY REFUGES; SIZE; RECRUITMENT	Predation and competition are critical processes influencing the ecology of organisms, and can play an integral role in shaping coral reef fish communities. This study compared the relative and interacting effects of competition and predation on two competing species of coral reef fish, Pomacentrus amboinensis and P. moluccensis (Pomacentridae), using a multifactorial experiment. Fish were subjected to the sight and smell of a known predator (Pseudochromis fuscus), the presence of the heterospecific competitor (i.e., P. amboinensis vs. P. moluccensis), or a combination of the two for a period of 19 days. The sub-lethal effects of predator/competitor treatments were compared with controls; a combination of otolith microstructure analysis and observations were used to determine otolith growth patterns and behaviour. We predicted that the stress of competition and/or predation would result in strong sub-lethal impacts, and act synergistically on growth and behavioural patterns. We found strong evidence to support this prediction, but only for P. amboinensis, which suffered reductions in growth in both predator and competitor treatments, with the largest reductions occurring when subjected to both predation and competition concurrently. There was strong evidence of asymmetrical competition between the two damselfish species, with P. moluccensis as the dominant competitor, displaying strong aggressive behaviour towards P. amboinensis. Growth reductions for P. amboinensis in predator/competitor treatments appeared to come about primarily due to increases in shelter seeking behaviour, which significantly reduced the foraging rates of individuals compared with controls. These data highlight the importance of predator/competitor synergisms in influencing key behaviours and demographic parameters for juvenile coral reef fishes.	[Hall, April] James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia; James Cook Univ, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Hall, A (corresponding author), James Cook Univ, Coll Marine & Environm Sci, Townsville, Qld 4811, Australia.	april.hall3110@gmail.com	Kingsford, Michael J/C-2015-2008	Kingsford, Michael J/0000-0003-1704-6198; Hall, April/0000-0003-3672-2761	ARC Centre of Excellence for Coral Reef Studies grant	ARC Centre of Excellence for Coral Reef Studies grant(Australian Research Council)	All funding was from an ARC Centre of Excellence for Coral Reef Studies grant to Michael Kingsford.	Baumann H, 2011, HELGOLAND MAR RES, V65, P425, DOI 10.1007/s10152-011-0255-2; Beschta RL, 2009, BIOL CONSERV, V142, P2401, DOI 10.1016/j.biocon.2009.06.015; Beukers JS, 1998, OECOLOGIA, V114, P50, DOI 10.1007/s004420050419; Boaden AE, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00292.1; Bonin MC, 2009, CORAL REEFS, V28, P265, DOI 10.1007/s00338-008-0451-y; Bosiger YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034535; Bostrom-Einarsson L, 2014, ECOLOGY, V95, P3056; Bostrom-Einarsson L, 2013, J EXP MAR BIOL ECOL, V448, P85, DOI 10.1016/j.jembe.2013.06.017; CALEY MJ, 1993, MAR BIOL, V117, P33, DOI 10.1007/BF00346423; Cappuccino Naomi, 1995, P3, DOI 10.1016/B978-012159270-7/50002-6; CARR MH, 1995, MAR ECOL PROG SER, V124, P31, DOI 10.3354/meps124031; Chase JM, 2002, ECOL LETT, V5, P302, DOI 10.1046/j.1461-0248.2002.00315.x; COATES D, 1980, J ANIM ECOL, V49, P335, DOI 10.2307/4292; Cohen J.E., 1988, STAT POWER ANAL BEHA; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Connell SD, 1998, MAR ECOL PROG SER, V169, P251, DOI 10.3354/meps169251; Connell SD, 1996, MAR BIOL, V126, P347, DOI 10.1007/BF00347459; Cooke SJ, 2003, CAN J ZOOL, V81, P699, DOI 10.1139/Z03-044; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; DAYTON PK, 1971, ECOL MONOGR, V41, P351, DOI 10.2307/1948498; DOHERTY P, 1994, SCIENCE, V263, P935, DOI 10.1126/science.263.5149.935; Feeney WE, 2012, CORAL REEFS, V31, P909, DOI 10.1007/s00338-012-0894-z; Figueira WF, 2008, OECOLOGIA, V156, P215, DOI 10.1007/s00442-008-0985-2; FORRESTER GE, 1991, ANIM BEHAV, V42, P701, DOI 10.1016/S0003-3472(05)80116-2; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; Green BS, 2009, REV-METHODS TECHNOL, V11, P1, DOI 10.1007/978-1-4020-5775-5_1; Gurevitch J, 2000, AM NAT, V155, P435, DOI 10.1086/303337; HAMBRIGHT KD, 1991, ARCH HYDROBIOL, V121, P389; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Hixon M.A., 2002, CORAL REEF FISHES DY; Hixon MA, 2005, ECOLOGY, V86, P2847, DOI 10.1890/04-1455; HIXON MA, 1993, ECOL MONOGR, V63, P77, DOI 10.2307/2937124; Hixon MA, 1997, SCIENCE, V277, P946, DOI 10.1126/science.277.5328.946; HIXON MA, 1991, THEOR POPUL BIOL, V39, P178, DOI 10.1016/0040-5809(91)90035-E; Hixon MA, 2012, ECOL MONOGR, V82, P467, DOI 10.1890/11-1525.1; Holbrook SJ, 2003, OECOLOGIA, V135, P532, DOI 10.1007/s00442-003-1220-9; Holbrook SJ, 2002, ECOLOGY, V83, P2855, DOI 10.2307/3072021; Holmes TH, 2011, ANIM BEHAV, V81, P543, DOI 10.1016/j.anbehav.2010.11.019; Holmes TH, 2010, MAR ECOL PROG SER, V399, P273, DOI 10.3354/meps08337; JEFFRIES MJ, 1984, BIOL J LINN SOC, V23, P269, DOI 10.1111/j.1095-8312.1984.tb00145.x; Jennings S, 1997, CORAL REEFS, V16, P71, DOI 10.1007/s003380050061; Jones Geoffrey P., 2002, P221, DOI 10.1016/B978-012615185-5/50013-X; JONES GP, 1988, J EXP MAR BIOL ECOL, V123, P115, DOI 10.1016/0022-0981(88)90164-5; Killen SS, 2006, MAR ECOL PROG SER, V321, P255, DOI 10.3354/meps321255; Kingsford MJ, 2011, CORAL REEFS, V30, P203, DOI 10.1007/s00338-010-0692-4; Lonnstedt OM, 2013, SCI REP-UK, V3, DOI 10.1038/srep02259; Lonnstedt OM, 2012, P ROY SOC B-BIOL SCI, V279, P2091, DOI 10.1098/rspb.2011.2516; Mathuru AS, 2012, CURR BIOL, V22, P538, DOI 10.1016/j.cub.2012.01.061; McCormick MI, 2010, CORAL REEFS, V29, P537, DOI 10.1007/s00338-010-0620-7; McCormick MI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042590; McCormick MI, 2012, P ROY SOC B-BIOL SCI, V279, P3899, DOI 10.1098/rspb.2012.0854; McCormick MI, 2006, J FISH BIOL, V68, P969, DOI 10.1111/j.1095-8649.2006.00982.x; McCormick MI, 1998, AUST J ECOL, V23, P258, DOI 10.1111/j.1442-9993.1998.tb00729.x; Mitchell MD, 2013, FUNCT ECOL, V27, P299, DOI 10.1111/1365-2435.12043; Mitchell MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015764; Morales-Nin B, 2000, FISH RES, V46, P53, DOI 10.1016/S0165-7836(00)00133-8; PITCHER CR, 1988, CORAL REEFS, V7, P105, DOI 10.1007/BF00300969; Rizzari JR, 2014, OIKOS, V123, P829, DOI 10.1111/oik.01318; Ruttenberg BI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021062; SALE PF, 1977, AM NAT, V111, P337, DOI 10.1086/283164; SALE PF, 1988, CORAL REEFS, V7, P117, DOI 10.1007/BF00300971; SIH A, 1985, ANNU REV ECOL SYST, V16, P269, DOI 10.1146/annurev.es.16.110185.001413; Sogard SM, 1997, B MAR SCI, V60, P1129; Villegas-Hernandez H, 2008, AQUAT BIOL, V1, P249, DOI 10.3354/ab00026; Walsh SM, 2012, J FISH BIOL, V80, P519, DOI 10.1111/j.1095-8649.2011.03209.x; Webster MS, 2004, ECOLOGY, V85, P986, DOI 10.1890/02-0576; Webster MS, 2000, MAR ECOL PROG SER, V196, P187, DOI 10.3354/meps196187; Webster MS, 2002, OECOLOGIA, V131, P52, DOI 10.1007/s00442-001-0860-x; WERNER EE, 1983, ECOLOGY, V64, P1540, DOI 10.2307/1937508; Williamson DH, 2004, ENVIRON CONSERV, V31, P149, DOI 10.1017/S0376892904001262; WOOTTON JT, 1992, ECOLOGY, V73, P981, DOI 10.2307/1940174	71	7	7	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151778	10.1371/journal.pone.0151778	http://dx.doi.org/10.1371/journal.pone.0151778			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992169	gold, Green Published, Green Accepted			2022-12-26	WOS:000372582800101
J	Melese, M; Jerene, D; Alem, G; Seid, J; Belachew, F; Kassie, Y; Habte, D; Negash, S; Ayana, G; Girma, B; Haile, YK; Hiruy, N; Suarez, PG				Melese, Muluken; Jerene, Degu; Alem, Genetu; Seid, Jemal; Belachew, Feleke; Kassie, Yewulsew; Habte, Dereje; Negash, Solomon; Ayana, Gonfa; Girma, Belaineh; Haile, Yared K.; Hiruy, Nebiyu; Suarez, Pedro G.			Decentralization of Acid Fast Bacilli(AFB) External Quality Assurance Using Blind Rechecking for Sputum Smear Microscopy in Ethiopia	PLOS ONE			English	Article							ASSESSMENT GUIDELINES; TUBERCULOSIS; LABORATORIES; ENSURE	Introduction Ethiopia achieved a rapid expansion of TB microscopic centers for acid fast bacilli (AFB). However, external quality assurance (EQA) services were, until recently, limited to few regional and sub-regional laboratories. In this paper, we describe the decentralization experience and the result of EQA using random blinded rechecking. Materials and Methods The routine EQA quarterly report was compiled and analyzed. A positive result by the microscopic center while the EQA center reported negative result is categorized as false positive (FP). A negative result by the microscopic center while the EQA center reported positive is considered false negative (FN). The reading of EQA centers was considered a gold standard to compute the sensitivity, specificity, positive predictive (PPV) and negative predictive values (NPV) of the readings of microscopic centers. Results We decentralized sputum smear AFB EQA from 4 Regional Laboratories (RRLs) to 82 EQA centers and enrolled 956 health facilities in EQA schemes. Enrollment of HFs in EQA was gradual because it required training and mentoring laboratory professionals, institutionalizing internal QA measures, equipping all HFs to perform diagnosis, and establishing more EQA centers. From 2012 to 2014 (Phase I), the FP rate declined from 0.6% to 0.2% and FN fell from as high as 7.6% to 1.6% in supported health facilities (HFs). In HFs that joined in Phase II, FN rates ranged from 5.6 to 7.3%. The proportion of HFs without errors has increased from 77.9% to 90.5% in Phase I HFs and from 82.9% to 86.9% in Phase II HFs. Overall sensitivity and specificity were 95.0% and 99.7%, respectively. PPV and NPV were 93.3% and 99.7%, respectively. Conclusion Decentralizing blinded rechecking of sputum smear microscopy is feasible in low-income settings. While a comprehensive laboratory improvement strategy enhanced the quality of microscopy, laboratory professionals' capacity in slide reading and smear quality requires continued support.	[Melese, Muluken; Jerene, Degu; Seid, Jemal; Kassie, Yewulsew; Habte, Dereje; Negash, Solomon; Girma, Belaineh; Hiruy, Nebiyu] Management Sci Hlth, Help Ethiopia Address Low Performance TB HEAL TB, Addis Ababa, Ethiopia; [Alem, Genetu] Amhara Reg Hlth Bur, Bahir Dar, Ethiopia; [Belachew, Feleke] Oromia Reg Reference Lab, Addis Ababa, Ethiopia; [Ayana, Gonfa] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia; [Haile, Yared K.] USAID, Addis Ababa, Ethiopia; [Suarez, Pedro G.] Management Sci Hlth, Ctr Hlth Serv, Arlington, VA USA	United States Agency for International Development (USAID)	Melese, M (corresponding author), Management Sci Hlth, Help Ethiopia Address Low Performance TB HEAL TB, Addis Ababa, Ethiopia.	mmelese@msh.org	Suarez, Pedro G/AAD-2278-2019	Suarez, Pedro G/0000-0001-9825-1761; Habte, Dereje/0000-0002-4720-4188	United States Agency for International Development(USAID) through HEAL TB [AID-663-A-11-00011]	United States Agency for International Development(USAID) through HEAL TB(United States Agency for International Development (USAID))	United States Agency for International Development(USAID) supported this work through HEAL TB, under cooperative agreement number AID-663-A-11-00011. The contents of the article are the responsibility of the authors alone and do not necessarily reflect the views of USAID or the US government.	Chiang CY, 2005, J FORMOS MED ASSOC, V104, P502; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Ethiopian Health and Nutrition Research Institute Federal Ministry of Health, 2009, GUID QUAL ASS SMEAR; Gilpin C, 2007, INT J TUBERC LUNG D, V11, P946; Jekel JF, 2007, EPIDEMIOLOGY BIOSTAT; Kumar V, 2009, INT J TUBERC LUNG D, V13, P1183; Kusznierz GF, 2004, INT J TUBERC LUNG D, V8, P1234; Manyazewal T, 2013, DIAGN MICR INFEC DIS, V75, P55, DOI 10.1016/j.diagmicrobio.2012.09.020; Martinez A, 2005, INT J TUBERC LUNG D, V9, P301; Martinez-Guarneros A, 2003, INT J TUBERC LUNG D, V7, P516; Mundy CJF, 2002, INT J TUBERC LUNG D, V6, P47; Otero L, 2011, INT J TUBERC LUNG D, V15, P211; Patel Nilesh D, 2012, Indian J Tuberc, V59, P12; Ridderhof JC, 2007, B WORLD HEALTH ORGAN, V85, P354, DOI 10.2471/BLT.06.039081; Selvakumar N, 2003, INT J TUBERC LUNG D, V7, P1077; Van Deun A, 2005, INT J TUBERC LUNG D, V9, P355; Van Deun A, 1998, INT J TUBERC LUNG D, V2, P756; Van Rie A, 2008, J CLIN MICROBIOL, V46, P897, DOI 10.1128/JCM.01553-07; World Health Organization, 2002, KNCV INT UN TUB LUNG; World Health Organization, 2006, WHOHTMTB2006368; World Health Organization (WHO), 1998, WHO TUB HDB; Wu MH, 2009, INT J TUBERC LUNG D, V13, P606; Yip CW, 2012, INT J TUBERC LUNG D, V16, P398, DOI 10.5588/ijtld.11.0330	23	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151366	10.1371/journal.pone.0151366	http://dx.doi.org/10.1371/journal.pone.0151366			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991651	Green Submitted, Green Published, gold			2022-12-26	WOS:000372582800056
J	Aghamohammadzadeh, R; Zhang, YY; Stephens, TE; Arons, E; Zaman, P; Polach, KJ; Matar, M; Yung, LM; Yu, PB; Bowman, FP; Opotowsky, AR; Waxman, AB; Loscalzo, J; Leopold, JA; Maron, BA				Aghamohammadzadeh, Reza; Zhang, Ying-Yi; Stephens, Thomas E.; Arons, Elena; Zaman, Paula; Polach, Kevin J.; Matar, Majed; Yung, Lai-Ming; Yu, Paul B.; Bowman, Frederick P.; Opotowsky, Alexander R.; Waxman, Aaron B.; Loscalzo, Joseph; Leopold, Jane A.; Maron, Bradley A.			Up-regulation of the mammalian target of rapamycin complex 1 subunit Raptor by aldosterone induces abnormal pulmonary artery smooth muscle cell survival patterns to promote pulmonary arterial hypertension	FASEB JOURNAL			English	Article						vascular remodeling; pulmonary vascular disease; kinase signaling	INSULIN-RESISTANCE; S6 KINASE; RECEPTOR; APOPTOSIS; PROLIFERATION; ACTIVATION; IMPROVES; PROTEIN; MTORC1; PHOSPHORYLATION	Activation of the mammalian target of rapamycin complex 1 (mTORC1) subunit Raptor induces cell growth and is a downstream target of Akt. Elevated levels of aldosterone activate Akt, and, in pulmonary arterial hypertension (PAH), correlate with pulmonary arteriole thickening, which suggests that mTORC1 regulation by aldosterone may mediate adverse pulmonary vascular remodeling. We hypothesized that aldosterone-Raptor signaling induces abnormal pulmonary artery smooth muscle cell (PASMC) survival patterns to promote PAH. Remodeled pulmonary arterioles from SU-5416/hypoxia-PAH rats and monocrotaline-PAH rats with hyperaldosteronism expressed increased levels of the Raptor target, p70S6K, which provided a basis for investigating aldosterone-Raptor signaling in human PASMCs. Aldosterone (10(-9) to 10(-7) M) increased Akt/mTOR/Raptor to activate p70S6K and increase proliferation, viability, and apoptosis resistance in PASMCs. In PASMCs transfected with Raptor-small interfering RNA or treated with spironolactone/eplerenone, aldosterone or pulmonary arterial plasma from patients with PAH failed to increase p70S6K activation or to induce cell survival in vitro. Optimal inhibition of pulmonary arteriole Raptor was achieved by treatment with Staramine-monomethoxy polyethylene glycol that was formulated with Raptor-small interfering RNA plus spironolactone in vivo, which decreased arteriole muscularization and pulmonary hypertension in 2 experimental animal models of PAH in vivo. Up-regulation of mTORC1 by aldosterone is a critical pathobiologic mechanism that controls PASMC survival to promote hypertrophic vascular remodeling and PAH.	[Aghamohammadzadeh, Reza; Zhang, Ying-Yi; Stephens, Thomas E.; Arons, Elena; Zaman, Paula; Yung, Lai-Ming; Yu, Paul B.; Bowman, Frederick P.; Opotowsky, Alexander R.; Loscalzo, Joseph; Leopold, Jane A.; Maron, Bradley A.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA USA; [Waxman, Aaron B.] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, Boston, MA USA; [Polach, Kevin J.; Matar, Majed] Cels Corp, Lawrenceville, NJ USA; [Opotowsky, Alexander R.] Boston Childrens Hosp, Dept Cardiol, Boston, MA USA; [Maron, Bradley A.] Boston Vet Affairs Healthcare Syst, Dept Cardiol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital	Maron, BA (corresponding author), 77 Ave Louis Pasteur,NRB Rm 0630-N, Boston, MA 02115 USA.	bmaron@partners.org	Waxman, Aaron/I-8659-2019; Yu, Paul B./J-7540-2019; Waxman, Aaron/L-7450-2019; Loscalzo, Joseph/ABD-8980-2021; Opotowsky, Alexander/AAL-1481-2020	Waxman, Aaron/0000-0001-7797-0361; Yu, Paul B./0000-0003-2145-4944; Opotowsky, Alexander/0000-0002-6107-2281; Aghamohammadzadeh, Reza/0000-0002-6058-9078; Bowman, Frederick/0000-0001-8143-879X	British Heart Foundation; C.R.T Fellowship [FS/10/42/28372]; U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) [1K08HL11207-01A1]; American Heart Association Grant [AHA 15GRNT25080016]; Pulmonary Hypertension Association; Cardiovascular Medical Research and Education Fund (CMREF); Klarman Foundation at Brigham and Women's Hospital; Gilead Young Scholars Foundation; Dunlevie Family Fund; NIH NHLBI Grant [1U01HL125215-01, R37 HL061795, HL108630, U54HL119145, PPGHL048743]; Gilead Sciences; Actelion Pharmaceuticals; British Heart Foundation [FS/10/42/28372] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL125215, U01HL108630, U54HL119145, R01HL131910, K08HL111207, R37HL061795, R01HL139613] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); C.R.T Fellowship; U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Grant(American Heart Association); Pulmonary Hypertension Association; Cardiovascular Medical Research and Education Fund (CMREF); Klarman Foundation at Brigham and Women's Hospital; Gilead Young Scholars Foundation; Dunlevie Family Fund; NIH NHLBI Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Gilead Sciences(Gilead Sciences); Actelion Pharmaceuticals; British Heart Foundation(British Heart Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the British Heart Foundation and a C.R.T Fellowship (FS/10/42/28372) (to R.A.); the U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) Grant 1K08HL11207-01A1, American Heart Association Grant AHA 15GRNT25080016, the Pulmonary Hypertension Association, the Cardiovascular Medical Research and Education Fund (CMREF), the Klarman Foundation at Brigham and Women's Hospital, and the Gilead Young Scholars Foundation (to B.A.M.); by the Dunlevie Family Fund (to A.R.O.); by NIH NHLBI Grant 1U01HL125215-01 (to J.A.L.); and by NIH NHLBI Grants R37 HL061795, HL108630 (MAPGEN), U54HL119145, and PPGHL048743 (to J.L.). B.A.M. is involved with investigator-initiated research that is supported by Gilead Sciences. A.R.O. is involved with investigator-initiated research that is supported by Actelion Pharmaceuticals.	Abe K, 2010, CIRCULATION, V121, P2747, DOI 10.1161/CIRCULATIONAHA.109.927681; Bockmeyer CL, 2012, J HEART LUNG TRANSPL, V31, P764, DOI 10.1016/j.healun.2012.03.010; Chen XP, 2016, CIRCULATION, V133, P82, DOI 10.1161/CIRCULATIONAHA.115.016133; Duan YH, 2015, AMINO ACIDS, V47, P857, DOI 10.1007/s00726-015-1937-x; Fattori R, 2003, LANCET, V361, P247, DOI 10.1016/S0140-6736(03)12275-1; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; French CJ, 2009, FASEB J, V23, P1177, DOI 10.1096/fj.08-116509; Frump AL, 2015, AM J PHYSIOL-LUNG C, V308, pL873, DOI 10.1152/ajplung.00006.2015; Galie N, 2008, CIRCULATION, V117, P3010, DOI 10.1161/CIRCULATIONAHA.107.742510; Gerasimovskaya EV, 2005, J BIOL CHEM, V280, P1838, DOI 10.1074/jbc.M409466200; Goncharov DA, 2014, CIRCULATION, V129, P864, DOI 10.1161/CIRCULATIONAHA.113.004581; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hansmann G, 2007, CIRCULATION, V115, P1275, DOI 10.1161/CIRCULATIONAHA.106.663120; HEI YJ, 1994, J BIOL CHEM, V269, P7816; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Jia GH, 2014, AM J PHYSIOL-REG I, V307, pR1198, DOI 10.1152/ajpregu.00262.2014; Kirsch T, 2013, HYPERTENSION, V61, P501, DOI 10.1161/HYPERTENSIONAHA.111.196832; Krymskaya VP, 2011, FASEB J, V25, P1922, DOI 10.1096/fj.10-175018; Lee CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116393; Lee JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015394; Li LX, 2015, INT J MOL MED, V36, P316, DOI 10.3892/ijmm.2015.2224; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maron BA, 2015, CIRCULATION, V131, P2079, DOI 10.1161/CIRCULATIONAHA.114.006980; Maron BA, 2014, CIRCULATION, V130, P168, DOI 10.1161/CIRCULATIONAHA.113.007690; Maron BA, 2013, EUR J HEART FAIL, V15, P277, DOI 10.1093/eurjhf/hfs173; Maron BA, 2012, CIRCULATION, V126, P963, DOI 10.1161/CIRCULATIONAHA.112.094722; Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848; McLendon JM, 2015, J CONTROL RELEASE, V210, P67, DOI 10.1016/j.jconrel.2015.05.261; McMurtry MS, 2005, J CLIN INVEST, V115, P1479, DOI 10.1172/JCI23203; McMurtry MS, 2004, CIRC RES, V95, P830, DOI 10.1161/01.RES.0000145360.16770.9f; Mill C, 2014, ARTERIOSCL THROM VAS, V34, P2449, DOI 10.1161/ATVBAHA.114.303922; Oshiro N, 2014, J BIOL CHEM, V289, P2658, DOI 10.1074/jbc.M113.528505; PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x; Preston IR, 2013, AM J PHYSIOL-LUNG C, V304, pL678, DOI 10.1152/ajplung.00300.2012; Ranchoux B, 2015, CIRCULATION, V131, P1006, DOI 10.1161/CIRCULATIONAHA.114.008750; Sakurabayashi-Kitade S, 2009, ATHEROSCLEROSIS, V206, P54, DOI 10.1016/j.atherosclerosis.2009.01.039; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Seyfarth HJ, 2013, PULM CIRC, V3, P632, DOI 10.1086/674311; Sherajee SJ, 2012, ARTERIOSCL THROM VAS, V32, P257, DOI 10.1161/ATVBAHA.111.240697; Su HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062399; Taraseviciene-Stewart L, 2001, FASEB J, V15, P427, DOI 10.1096/fj.00-0343com; Thompson AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085495; Wallace E, 2015, AM J RESP CRIT CARE, V191, P1432, DOI 10.1164/rccm.201412-2148OC; Wang B, 2015, CELL PHYSIOL BIOCHEM, V35, P116, DOI 10.1159/000369680; Wang L, 2013, PULM CIRC, V3, P654, DOI 10.1086/674310; Wang W, 2014, J CELL PHYSIOL, V229, P2117, DOI 10.1002/jcp.24670; White K, 2015, EMBO MOL MED, V7, P695, DOI 10.15252/emmm.201404511	48	34	36	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2511	2527		10.1096/fj.201500042	http://dx.doi.org/10.1096/fj.201500042			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27006450	Green Published			2022-12-26	WOS:000379249500007
J	Rasheedi, S; Shun, MC; Serrao, E; Sowd, GA; Qian, J; Hao, CL; Dasgupta, T; Engelman, AN; Skowronski, J				Rasheedi, Sheeba; Shun, Ming-Chieh; Serrao, Erik; Sowd, Gregory A.; Qian, Juan; Hao, Caili; Dasgupta, Twishasri; Engelman, Alan N.; Skowronski, Jacek			The Cleavage and Polyadenylation Specificity Factor 6 (CPSF6) Subunit of the Capsid-recruited Pre-messenger RNA Cleavage Factor I (CFIm) Complex Mediates HIV-1 Integration into Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MESSENGER-RNA; STRUCTURAL BASIS; DNA INTEGRATION; NUCLEAR IMPORT; SPLICING FACTORS; SR PROTEINS; 3 END; LEDGF/P75; INFECTION	HIV-1 favors integration into active genes and gene-enriched regions of host cell chromosomes, thus maximizing the probability of provirus expression immediately after integration. This requires cleavage and polyadenylation specificity factor 6 (CPSF6), a cellular protein involved in pre-mRNA 3' end processing that binds HIV-1 capsid and connects HIV-1 preintegration complexes to intranuclear trafficking pathways that link integration to transcriptionally active chromatin. CPSF6 together with CPSF5 and CPSF7 are known subunits of the cleavage factor I (CFIm) 3' end processing complex; however, CPSF6 could participate in additional protein complexes. The molecular mechanisms underpinning the role of CPSF6 in HIV-1 infection remain to be defined. Here, we show that a majority of cellular CPSF6 is incorporated into the CFIm complex. HIV-1 capsid recruits CFIm in a CPSF6-dependent manner, which suggests that the CFIm-complex mediates the known effects of CPSF6 in HIV-1 infection. To dissect the roles of CPSF6 and other CFIm complex subunits in HIV-1 infection, we analyzed virologic and integration site targeting properties of a CPSF6 variant with mutations that prevent its incorporation into CFIm. We show, somewhat surprisingly, that CPSF6 incorporation into CFIm is not required for its ability to direct preferential HIV-1 integration into genes. The CPSF5 and CPSF7 subunits appear to have only a minor, if any, role in this process even though they appear to facilitate CPSF6 binding to capsid. Thus, CPSF6 alone controls the key molecular interactions that specify HIV-1 preintegration complex trafficking to active chromatin.	[Rasheedi, Sheeba; Shun, Ming-Chieh; Qian, Juan; Hao, Caili; Dasgupta, Twishasri; Skowronski, Jacek] Case Western Reserve Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Serrao, Erik; Sowd, Gregory A.; Engelman, Alan N.] Dana Farber Canc Inst, Dept Canc Immunol & Virol, Boston, MA 02215 USA	Case Western Reserve University; Harvard University; Dana-Farber Cancer Institute	Skowronski, J (corresponding author), Case Western Reserve Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.	jacek.skowronski@case.edu			National Institutes of Health [P50 GM082251]; National Institutes of Health Center for AIDS Research [P30 AI036219]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007245, P30AI036219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Center for AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P50 GM082251 (to A. N. E. and J. S.). Shared resources at Case Western Reserve University are supported by National Institutes of Health Center for AIDS Research Grant P30 AI036219. The authors declare that they have no conflicts of interest with the contents of this article.	Ambrose Z, 2012, J VIROL, V86, P4708, DOI 10.1128/JVI.05887-11; Bhattacharya A, 2014, P NATL ACAD SCI USA, V111, P18625, DOI 10.1073/pnas.1419945112; Byeon IJL, 2009, CELL, V139, P780, DOI 10.1016/j.cell.2009.10.010; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Chin CR, 2015, CELL REP, V13, P1717, DOI 10.1016/j.celrep.2015.10.036; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Dantonel JC, 1997, NATURE, V389, P399, DOI 10.1038/38763; De Iaco A, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-20; Dettwiler S, 2004, J BIOL CHEM, V279, P35788, DOI 10.1074/jbc.M403927200; Di Nunzio F, 2013, VIROLOGY, V440, P8, DOI 10.1016/j.virol.2013.02.008; Ferris AL, 2010, P NATL ACAD SCI USA, V107, P3135, DOI 10.1073/pnas.0914142107; Fricke T, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-46; Gres AT, 2015, SCIENCE, V349, P99, DOI 10.1126/science.aaa5936; Gruber AR, 2012, RNA BIOL, V9, P1405, DOI 10.4161/rna.22570; Hori T, 2013, J VIROL, V87, P7726, DOI 10.1128/JVI.00124-13; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Hulme AE, 2011, P NATL ACAD SCI USA, V108, P9975, DOI 10.1073/pnas.1014522108; Katahira J, 2013, NUCLEIC ACIDS RES, V41, P7060, DOI 10.1093/nar/gkt414; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Koh Y, 2013, J VIROL, V87, P648, DOI 10.1128/JVI.01148-12; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Lee K, 2012, J VIROL, V86, P3851, DOI 10.1128/JVI.06607-11; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Maertens GN, 2014, P NATL ACAD SCI USA, V111, P2728, DOI 10.1073/pnas.1320755111; Marshall HM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001340; Martin G, 2010, RNA, V16, P1646, DOI 10.1261/rna.2164210; Matreyek KA, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0090-z; Matreyek KA, 2011, J VIROL, V85, P7818, DOI 10.1128/JVI.00325-11; Millevoi S, 2006, EMBO J, V25, P4854, DOI 10.1038/sj.emboj.7601331; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Ocwieja KE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001313; Pornillos O, 2010, J MOL BIOL, V401, P985, DOI 10.1016/j.jmb.2010.06.042; Price AJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004459; Price AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002896; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruegsegger U, 1996, J BIOL CHEM, V271, P6107; Schaller T, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002439; Schrijvers R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002558; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Shun MC, 2008, J VIROL, V82, P11555, DOI 10.1128/JVI.01561-08; Singh PK, 2015, GENE DEV, V29, P2287, DOI 10.1101/gad.267609.115; Sowd GA, 2016, P NATL ACAD SCI USA, V113, pE1054, DOI 10.1073/pnas.1524213113; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Yan JP, 2013, J BIOL CHEM, V288, P10406, DOI 10.1074/jbc.M112.443796; Yang Q, 2011, STRUCTURE, V19, P368, DOI 10.1016/j.str.2010.12.021; Yang Q, 2010, P NATL ACAD SCI USA, V107, P10062, DOI 10.1073/pnas.1000848107; Zhang RN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015620	53	33	33	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 27	2016	291	22					11809	11819		10.1074/jbc.M116.721647	http://dx.doi.org/10.1074/jbc.M116.721647			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN7NZ	26994143	Green Published, hybrid			2022-12-26	WOS:000377264800030
J	Lu, L; Lin, CD; Yan, ZJ; Wang, S; Zhang, YH; Wang, SH; Wang, JL; Liu, C; Chen, JF				Lu, Ling; Lin, ChangDong; Yan, ZhanJun; Wang, Shu; Zhang, YouHua; Wang, ShiHui; Wang, JunLei; Liu, Cui; Chen, JianFeng			Kindlin-3 Is Essential for the Resting alpha 4 beta 1 Integrin-mediated Firm Cell Adhesion under Shear Flow Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKOCYTE ADHESION; DEFICIENCY-III; OUTSIDE-IN; T-CELLS; COACTIVATOR KINDLIN-3; DIVALENT-CATIONS; STRUCTURAL BASIS; ACTIVATION; AFFINITY; BINDING	Integrin-mediated rolling and firm cell adhesion are two critical steps in leukocyte trafficking. Integrin alpha 4 beta 1 mediates a mixture of rolling and firm cell adhesion on vascular cell adhesion molecule-1 (VCAM-1) when in its resting state but only supports firm cell adhesion upon activation. The transition from rolling to firm cell adhesion is controlled by integrin activation. Kindlin-3 has been shown to bind to integrin tails and trigger integrin activation via inside-out signaling. However, the role of kindlin-3 in regulating resting alpha 4 beta 1-mediated cell adhesion is not well characterized. Herein we demonstrate that kindlin-3 was required for the resting alpha 4 beta 1-mediated firm cell adhesion but not rolling adhesion. Knockdown of kindlin-3 significantly decreased the binding of kindlin-3 to beta 1 and down regulated the binding affinity of the resting alpha 4 beta 1 to soluble VCAM-1. Notably, it converted the resting alpha 4 beta 1-mediated firm cell adhesion to rolling adhesion on VCAM-1 substrates, increased cell rolling velocity, and impaired the stability of cell adhesion. By contrast, firm cell adhesion mediated by Mn2+ activated alpha 4 beta 1 was barely affected by knockdown of kindlin-3. Structurally, lack of kindlin-3 led to a more bent conformation of the resting alpha 4 beta 1. Thus, kindlin-3 plays an important role in maintaining a proper conformation of the resting alpha 4 beta 1 to mediate both rolling and firm cell adhesion. Defective kindlin-3 binding to the resting alpha 4 beta 1 leads to a transition from firm to rolling cell adhesion on VCAM-1, implying its potential role in regulating the transition between integrin-mediated rolling and firm cell adhesion.	[Lu, Ling; Lin, ChangDong; Wang, Shu; Zhang, YouHua; Wang, ShiHui; Wang, JunLei; Liu, Cui; Chen, JianFeng] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol,CAS Ctr Excellence Mol Ce, Shanghai 200031, Peoples R China; [Yan, ZhanJun] Soochow Univ, Affiliated Hosp 2, Suzhou 215004, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Soochow University - China	Chen, JF (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.	jfchen@sibcb.ac.cn		Lin, ChangDong/0000-0002-6766-3699	National Basic Research Program of China [2014CB541905]; National Natural Science Foundation of China [31525016, 31190061, 31271487]; Personalized Medicines Molecular Signature-based Drug Discovery and Development; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA12000000]; Chinese Academy of Sciences/State Administration of Foreign Experts Affairs International Partnership Program for Creative Research Teams; Science and Technology Commission of Shanghai Municipality [11JC1414200]; Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Personalized Medicines Molecular Signature-based Drug Discovery and Development; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese Academy of Sciences/State Administration of Foreign Experts Affairs International Partnership Program for Creative Research Teams(Chinese Academy of Sciences); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program	This work was supported by National Basic Research Program of China Grant 2014CB541905; National Natural Science Foundation of China Grants 31525016, 31190061, and 31271487; Personalized Medicines Molecular Signature-based Drug Discovery and Development; Strategic Priority Research Program of the Chinese Academy of Sciences Grant XDA12000000; the Chinese Academy of Sciences/State Administration of Foreign Experts Affairs International Partnership Program for Creative Research Teams; Science and Technology Commission of Shanghai Municipality Grant 11JC1414200; and the Sanofi-Aventis-Shanghai Institutes for Biological Sciences scholarship program. The authors declare that they have no conflicts of interest with the contents of this article.	Arnaout MA, 2005, ANNU REV CELL DEV BI, V21, P381, DOI 10.1146/annurev.cellbio.21.090704.151217; Askari JA, 2010, J CELL BIOL, V188, P891, DOI 10.1083/jcb.200907174; Banno A, 2008, BIOCHEM SOC T, V36, P229, DOI 10.1042/BST0360229; BERLIN C, 1995, CELL, V80, P413, DOI 10.1016/0092-8674(95)90491-3; Bialkowska K, 2010, J BIOL CHEM, V285, P18640, DOI 10.1074/jbc.M109.085746; Calderwood DA, 2004, BIOCHEM SOC T, V32, P434, DOI 10.1042/BST0320434; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Chen C, 1999, J IMMUNOL, V162, P1084; Chen JF, 2003, NAT STRUCT BIOL, V10, P995, DOI 10.1038/nsb1011; Chen J, 2006, P NATL ACAD SCI USA, V103, P13062, DOI 10.1073/pnas.0605666103; Chen X, 2010, P NATL ACAD SCI USA, V107, P14727, DOI 10.1073/pnas.1008663107; Chigaev A, 2003, J BIOL CHEM, V278, P38174, DOI 10.1074/jbc.M210472200; Cohen SJ, 2013, BLOOD, V122, P2609, DOI 10.1182/blood-2013-04-495036; de Chateau M, 2001, BIOCHEMISTRY-US, V40, P13972, DOI 10.1021/bi011582f; Dixit N, 2012, J IMMUNOL, V189, P5954, DOI 10.4049/jimmunol.1201638; Harburger DS, 2009, J BIOL CHEM, V284, P11485, DOI 10.1074/jbc.M809233200; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; Hyduk SJ, 2011, J IMMUNOL, V187, P4360, DOI 10.4049/jimmunol.1003725; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kahner BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034056; Karakose E, 2010, J CELL SCI, V123, P2353, DOI 10.1242/jcs.064600; KASSNER PD, 1993, J EXP MED, V178, P649, DOI 10.1084/jem.178.2.649; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Lefort CT, 2012, BLOOD, V119, P4275, DOI 10.1182/blood-2011-08-373118; Leitinger B, 2000, BBA-MOL CELL RES, V1498, P91, DOI 10.1016/S0167-4889(00)00086-0; Liao ZJ, 2015, BLOOD, V125, P1995, DOI 10.1182/blood-2014-09-603035; Lim YC, 2000, MICROCIRCULATION, V7, P201, DOI 10.1038/sj.mn.7300103; Liu SC, 2000, J CELL SCI, V113, P3563; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Malinin NL, 2010, BLOOD, V115, P4011, DOI 10.1182/blood-2009-10-239269; Malinin NL, 2009, NAT MED, V15, P313, DOI 10.1038/nm.1917; Manevich-Mendelson E, 2009, BLOOD, V114, P2344, DOI 10.1182/blood-2009-04-218636; McDowall A, 2010, BLOOD, V115, P4834, DOI 10.1182/blood-2009-08-238709; Meller J, 2012, J THROMB HAEMOST, V10, P1397, DOI 10.1111/j.1538-7836.2012.04768.x; Moretti F, 2010, EUR J CELL BIOL, V89, P51; Moretti FA, 2013, P NATL ACAD SCI USA, V110, P17005, DOI 10.1073/pnas.1316032110; Moser M, 2008, NAT MED, V14, P325, DOI 10.1038/nm1722; Moser M, 2009, SCIENCE, V324, P895, DOI 10.1126/science.1163865; Moser M, 2009, NAT MED, V15, P300, DOI 10.1038/nm.1921; MOULD AP, 1995, J BIOL CHEM, V270, P26270, DOI 10.1074/jbc.270.44.26270; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Pan YP, 2010, P NATL ACAD SCI USA, V107, P21388, DOI 10.1073/pnas.1015487107; Rose DM, 2000, BLOOD, V95, P602, DOI 10.1182/blood.V95.2.602; Salas A, 2002, J BIOL CHEM, V277, P50255, DOI 10.1074/jbc.M209822200; Shimaoka M, 2004, CURR TOP MED CHEM, V4, P1485, DOI 10.2174/1568026043387575; Sun H, 2014, DEV CELL, V30, P61, DOI 10.1016/j.devcel.2014.05.002; Svensson L, 2009, NAT MED, V15, P306, DOI 10.1038/nm.1931; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; TAKADA Y, 1993, J BIOL CHEM, V268, P17597; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Theodosiou M, 2016, ELIFE, V5, DOI 10.7554/eLife.10130; Tidswell M, 1997, J IMMUNOL, V159, P1497; Ussar S, 2006, EXP CELL RES, V312, P3142, DOI 10.1016/j.yexcr.2006.06.030; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Ye F, 2013, CURR BIOL, V23, P2288, DOI 10.1016/j.cub.2013.09.050; Ye F, 2011, CURR OPIN HEMATOL, V18, P356, DOI 10.1097/MOH.0b013e3283497f09; Yue J, 2013, J BIOL CHEM, V288, P14228, DOI 10.1074/jbc.M113.462630; Zhang K, 2012, CELL ADHES MIGR, V6, P20, DOI 10.4161/cam.18702	60	10	11	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 6	2016	291	19					10363	10371		10.1074/jbc.M116.717694	http://dx.doi.org/10.1074/jbc.M116.717694			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DL4KB	26994136	Green Published, hybrid			2022-12-26	WOS:000375602800041
J	Dhiman, S; Yadav, K; Rabha, B; Goswami, D; Hazarika, S; Tyagi, V				Dhiman, Sunil; Yadav, Kavita; Rabha, Bipul; Goswami, Diganta; Hazarika, S.; Tyagi, Varun			Evaluation of Insecticides Susceptibility and Malaria Vector Potential of Anopheles annularis s.l. and Anopheles vagus in Assam, India	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; KNOCKDOWN RESISTANCE; DIPTERA-CULICIDAE; SINGLE MUTATION; GAMBIAE; MOSQUITOS; AREAS; DISTRICT; BORDER; DDT	During the recent past, development of DDT resistance and reduction to pyrethroid susceptibility among the malaria vectors has posed a serious challenge in many Southeast Asian countries including India. Current study presents the insecticide susceptibility and knockdown data of field collected Anopheles annularis sensu lato and An. vagus mosquito species from endemic areas of Assam in northeast India. Anopheles annularis s.l. and An. vagus adult females were collected from four randomly selected sentinel sites in Orang primary health centre (OPHC) and Balipara primary health centre (BPHC) areas, and used for testing susceptibility to DDT, malathion, deltamethrin and lambda-cyhalothrin. After insecticide susceptibility tests, mosquitoes were subjected to VectorTest (TM) assay kits to detect the presence of malaria sporozoite in the mosquitoes. An. annularis s.l. was completely susceptible to deltamethrin, lambda-cyhalothrin and malathion in both the study areas. An. vagus was highly susceptible to deltamethrin in both the areas, but exhibited reduced susceptibility to lambda-cyhalothrin in BPHC. Both the species were resistant to DDT and showed very high KDT50 and KDT99 values for DDT. Probit model used to calculate the KDT50 and KDT99 values did not display normal distribution of percent knock-down with time for malathion in both the mosquito species in OPHC (p<0.05) and An. vagus in BPHC (chi(2) = 25.3; p = 0.0), and also for deltamethrin to An. vagus in BPHC area (chi(2) = 15.4; p = 0.004). Minimum infection rate (MIR) of Plasmodium sporozoite for An. vagus was 0.56 in OPHC and 0.13 in BPHC, while for An. annularis MIR was found to be 0.22 in OPHC. Resistance management strategies should be identified to delay the expansion of resistance. Testing of field caught Anopheles vectors from different endemic areas for the presence of malaria sporozoite may be useful to ensure their role in malaria transmission.	[Dhiman, Sunil; Yadav, Kavita; Rabha, Bipul; Goswami, Diganta; Hazarika, S.; Tyagi, Varun] Def Res Lab, Div Med Entomol, Tezpur 784001, Assam, India	Defence Research & Development Organisation (DRDO); Defence Research Laboratory (DRL)	Dhiman, S (corresponding author), Def Res Lab, Div Med Entomol, Tezpur 784001, Assam, India.	sunildhiman81@gmail.com	Dhiman, Sunil/AAQ-3735-2021	Dhiman, Sunil/0000-0003-4547-6603; Yadav, Kavita/0000-0002-3082-6060				Agossa FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145207; Alam MS, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-15; [Anonymous], 2013, ISRN COMPUT MATH, DOI DOI 10.1155/2013/262863; [Anonymous], 2006, PESTICIDES THEIR APP; Bashar K, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-442; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-111; Betson M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-187; Brooke BD, 2008, T ROY SOC TROP MED H, V102, P524, DOI 10.1016/j.trstmh.2008.01.001; Chouaibou MS, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-214; Coleman M, 2015, P NATL ACAD SCI USA, V112, P8573, DOI 10.1073/pnas.1507782112; Dev V, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P239, DOI 10.5772/55215; Dhiman S, 2014, J INFECT PUBLIC HEAL, V7, P457, DOI 10.1016/j.jiph.2014.06.002; Dhiman S, 2014, J VECTOR DIS, V51, P133; Dhiman S, 2012, PATHOG GLOB HEALTH, V106, P177, DOI 10.1179/2047773212Y.0000000012; Dhiman S, 2010, SE ASIAN J TROP MED, V41, P1279; Edi CVA, 2012, EMERG INFECT DIS, V18, P1508, DOI 10.3201/eid1809.120262; Kumar D, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-450; Mishra AK, 2012, J VECTOR DIS, V49, P39; Mitchell SN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092662; Nath MJ, 2013, PUBLIC HEALTH, V127, P572, DOI 10.1016/j.puhe.2013.02.007; Ndiath MO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031943; Ndiath MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097700; Nkya TE, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-28; Nwane P, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-163; Prakash A, 2004, ANN TROP MED PARASIT, V98, P559, DOI 10.1179/000349804225021361; Protopopoff N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-149; Puntener W., 1981, MANUAL FIELD TRIALS, V2nd ed.; Raghavendra K, 2010, INDIAN J MED RES, V132, P260; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Riveron JM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r27; Rueda LM, 2011, TROP BIOMED, V28, P181; Ryan JR, 2001, MED VET ENTOMOL, V15, P225, DOI 10.1046/j.1365-2915.2001.00296.x; Sattabongkot J, 2004, J MED ENTOMOL, V41, P209, DOI 10.1603/0022-2585-41.2.209; Shetty V, 2013, PEST MANAG SCI, V69, P257, DOI 10.1002/ps.3383; Singh OP, 2015, J MED ENTOMOL, V52, P24, DOI 10.1093/jme/tju013; Tikar SN, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.8501; Verhaeghen K, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-59; WHO, 2013, WHO TECH REP SER, V984, P1; WHO, 1998, WHOCDSCPCMAL9812; WHO, 2007, SEARO TECHN PUBL, V57, P17; Xu TL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-54; Yadav K, 2016, J ARTHROPOD IN PRESS; Yadav K, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0754-0; Yadav K, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-19; Yadav K, 2012, INT J GEOGR INF SCI, V26, P123, DOI 10.1080/13658816.2011.576678	45	9	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151786	10.1371/journal.pone.0151786	http://dx.doi.org/10.1371/journal.pone.0151786			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010649	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708000044
J	Hasegawa, K; Tanaka, S; Fujiki, F; Morimoto, S; Nakano, K; Kinoshita, H; Okumura, A; Fujioka, Y; Urakawa, R; Nakajima, H; Tatsumi, N; Nakata, J; Takashima, S; Nishida, S; Tsuboi, A; Oka, Y; Oji, Y; Miyoshi, E; Hirata, T; Kumanogoh, A; Sugiyama, H; Hosen, N				Hasegawa, Kana; Tanaka, Satomi; Fujiki, Fumihiro; Morimoto, Soyoko; Nakano, Katsuhiko; Kinoshita, Hiroko; Okumura, Atsushi; Fujioka, Yuka; Urakawa, Rika; Nakajima, Hiroko; Tatsumi, Naoya; Nakata, Jun; Takashima, Satoshi; Nishida, Sumiyuki; Tsuboi, Akihiro; Oka, Yoshihiro; Oji, Yusuke; Miyoshi, Eiji; Hirata, Takako; Kumanogoh, Atsushi; Sugiyama, Haruo; Hosen, Naoki			Glycosylation Status of CD43 Protein Is Associated with Resistance of Leukemia Cells to CTL-Mediated Cytolysis	PLOS ONE			English	Article							WT1 PEPTIDE VACCINATION; CANCER; IDENTIFICATION; LEUKOSIALIN; EXPRESSION; EFFICIENT; MOLECULE; EPITOPE; SYSTEM	To improve cancer immunotherapy, it is important to understand how tumor cells counteract immune-surveillance. In this study, we sought to identify cell-surface molecules associated with resistance of leukemia cells to cytotoxic T cell (CTL)-mediated cytolysis. To this end, we first established thousands of monoclonal antibodies (mAbs) that react with MLL/AF9 mouse leukemia cells. Only two of these mAbs, designated R54 and B2, bound preferentially to leukemia cells resistant to cytolysis by a tumor cell antigen-specific CTLs. The antigens recognized by these mAbs were identified by expression cloning as the same protein, CD43, although their binding patterns to subsets of hematopoietic cells differed significantly from each other and from a pre-existing pan-CD43mAb, S11. The epitopes of R54 and B2, but not S11, were sialidase-sensitive and expressed at various levels on leukemia cells, suggesting that binding of R54 or B2 is associated with the glycosylation status of CD43. R54(high) leukemia cells, which are likely to express sialic acid-rich CD43, were highly resistant to CTL-mediated cytolysis. In addition, loss of CD43 in leukemia cells or neuraminidase treatment of leukemia cells sensitized leukemia cells to CTL-mediated cell lysis. These results suggest that sialic acid-rich CD43, which harbors multiple sialic acid residues that impart a net negative surface charge, protects leukemia cells from CTL-mediated cell lysis. Furthermore, R54(high) or B2(high) leukemia cells preferentially survived in vivo in the presence of adaptive immunity. Taken together, these results suggest that the glycosylation status of CD43 on leukemia is associated with sensitivity to CTL-mediated cytolysis in vitro and in vivo. Thus, regulation of CD43 glycosylation is a potential strategy for enhancing CTL-mediated immunotherapy.	[Hasegawa, Kana; Fujiki, Fumihiro; Nakajima, Hiroko; Oka, Yoshihiro] Osaka Univ, Dept Canc Immunol, Grad Sch Med, Suita, Osaka, Japan; [Hasegawa, Kana; Tanaka, Satomi; Morimoto, Soyoko; Nakano, Katsuhiko; Kinoshita, Hiroko; Okumura, Atsushi; Fujioka, Yuka; Urakawa, Rika; Tatsumi, Naoya; Miyoshi, Eiji; Sugiyama, Haruo] Osaka Univ, Dept Funct Diagnost Sci, Grad Sch Med, Suita, Osaka, Japan; [Nakata, Jun; Tsuboi, Akihiro] Osaka Univ, Dept Canc Immunotherapy, Grad Sch Med, Suita, Osaka, Japan; [Takashima, Satoshi; Nishida, Sumiyuki; Oka, Yoshihiro; Kumanogoh, Atsushi] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka, Japan; [Oka, Yoshihiro; Kumanogoh, Atsushi] Osaka Univ, Dept Immunopathol, Immunol Frontier Res Ctr WP1, Suita, Osaka, Japan; [Oji, Yusuke; Hosen, Naoki] Osaka Univ, Dept Canc Stem Cell Biol, Grad Sch Med, Suita, Osaka, Japan; [Hirata, Takako] Shiga Univ Med Sci, Dept Fundamental Biosci, Otsu, Shiga 52021, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Osaka University; Shiga University of Medical Science	Hosen, N (corresponding author), Osaka Univ, Dept Canc Stem Cell Biol, Grad Sch Med, Suita, Osaka, Japan.	hnaoki@imed3.med.osaka-u.ac.jp	Okumura, Atsushi/E-8012-2015	Okumura, Atsushi/0000-0002-7779-3059; Nakata, Jun/0000-0002-7494-1204; Hirata, Takako/0000-0002-1740-6168	Ministry of Education, Culture, Sports, Science and Technology of Japan [23130509]; Grants-in-Aid for Scientific Research [26461404] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research (Grants 23130509) (to N.H.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ARDMAN B, 1992, P NATL ACAD SCI USA, V89, P5001, DOI 10.1073/pnas.89.11.5001; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Carlow DA, 1999, J IMMUNOL, V163, P1441; CYSTER JG, 1991, EMBO J, V10, P893, DOI 10.1002/j.1460-2075.1991.tb08022.x; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Hasegawa K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144594; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Jeon YK, 2011, CANCER IMMUNOL IMMUN, V60, P1697, DOI 10.1007/s00262-011-1066-7; Keilholz U, 2009, BLOOD, V113, P6541, DOI 10.1182/blood-2009-02-202598; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; MCFARLAND TA, 1995, J IMMUNOL, V154, P1097; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; NATHAN C, 1993, J CELL BIOL, V122, P243, DOI 10.1083/jcb.122.1.243; Oka Y, 2004, P NATL ACAD SCI USA, V101, P13885, DOI 10.1073/pnas.0405884101; Rezvani K, 2008, BLOOD, V111, P236, DOI 10.1182/blood-2007-08-108241; Rouas-Freiss N, 2003, SEMIN CANCER BIOL, V13, P325, DOI 10.1016/S1044-579X(03)00023-3; Santamaria M, 1996, CANCER RES, V56, P3526; Slany RK, 1998, MOL CELL BIOL, V18, P122, DOI 10.1128/MCB.18.1.122; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Stockton BM, 1998, IMMUNITY, V8, P373, DOI 10.1016/S1074-7613(00)80542-7; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Tuccillo FM, 2014, MOL CANCER THER, V13, P752, DOI 10.1158/1535-7163.MCT-13-0651; Wu JD, 2004, J CLIN INVEST, V114, P560, DOI 10.1172/JCI200422206	24	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152326	10.1371/journal.pone.0152326	http://dx.doi.org/10.1371/journal.pone.0152326			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27011118	Green Published, gold			2022-12-26	WOS:000372708000132
J	Phillipou, A; Rossell, SL; Gurvich, C; Hughes, ME; Castle, DJ; Nibbs, RG; Abel, LA				Phillipou, Andrea; Rossell, Susan Lee; Gurvich, Caroline; Hughes, Matthew Edward; Castle, David Jonathan; Nibbs, Richard Grant; Abel, Larry Allen			Saccadic Eye Movements in Anorexia Nervosa	PLOS ONE			English	Article							OBSESSIVE-COMPULSIVE DISORDER; EVENT-RELATED FMRI; MONKEY SUPERIOR COLLICULUS; VISUALLY GUIDED SACCADES; ANTISACCADE TASK; FIXATION CELLS; SCHIZOPHRENIA; INHIBITION; ABNORMALITIES; PERFORMANCE	Background Anorexia Nervosa (AN) has a mortality rate among the highest of any mental illness, though the factors involved in the condition remain unclear. Recently, the potential neurobiological underpinnings of the condition have become of increasing interest. Saccadic eye movement tasks have proven useful in our understanding of the neurobiology of some other psychiatric illnesses as they utilise known brain regions, but to date have not been examined in AN. The aim of this study was to investigate whether individuals with AN differ from healthy individuals in performance on a range of saccadic eye movements tasks. Methods 24 females with AN and 25 healthy individuals matched for age, gender and premorbid intelligence participated in the study. Participants were required to undergo memory-guided and self-paced saccade tasks, and an interleaved prosaccade/antisaccade/no-go saccade task while undergoing functional magnetic resonance imaging (fMRI). Results AN participants were found to make prosaccades of significantly shorter latency than healthy controls. AN participants also made an increased number of inhibitory errors on the memory-guided saccade task. Groups did not significantly differ in antisaccade, no-go saccade or self-paced saccade performance, or fMRI findings. Discussion The results suggest a potential role of GABA in the superior colliculus in the psychopathology of AN.	[Phillipou, Andrea; Abel, Larry Allen] Univ Melbourne, Dept Optometry & Vis Sci, Melbourne, Vic, Australia; [Phillipou, Andrea; Castle, David Jonathan] Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia; [Phillipou, Andrea] Austin Hosp, Dept Mental Hlth, Heidelberg, Vic 3084, Australia; [Rossell, Susan Lee; Hughes, Matthew Edward; Nibbs, Richard Grant] Swinburne Univ Technol, Brain & Psychol Sci Res Ctr, Hawthorn, Vic, Australia; [Rossell, Susan Lee; Gurvich, Caroline] Monash Univ, Monash Alfred Psychiat Res Ctr, Clayton, Vic, Australia; [Rossell, Susan Lee; Castle, David Jonathan] St Vincents Hosp, Dept Psychiat, Fitzroy, Vic 3065, Australia; [Castle, David Jonathan] Australian Catholic Univ, Fac Hlth Sci, Fitzroy, Vic, Australia	University of Melbourne; University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Swinburne University of Technology; Monash University; St Vincent's Hospital Melbourne; Australian Catholic University	Phillipou, A (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Melbourne, Vic, Australia.; Phillipou, A (corresponding author), Univ Melbourne, Dept Psychiat, Melbourne, Vic, Australia.; Phillipou, A (corresponding author), Austin Hosp, Dept Mental Hlth, Heidelberg, Vic 3084, Australia.	ap@unimelb.edu.au	Gurvich, Caroline/AAB-9115-2019	Gurvich, Caroline/0000-0002-5663-3419; Hughes, Matthew/0000-0001-5057-5556; Rossell, Susan/0000-0002-7415-8252	Jack Brockhoff Foundation [3410]; Dick and Pip Smith Foundation; Australian Postgraduate Award; David Hay Memorial Fund Award	Jack Brockhoff Foundation; Dick and Pip Smith Foundation; Australian Postgraduate Award(Australian Government); David Hay Memorial Fund Award	This research was supported by the Jack Brockhoff Foundation (LA, SR, DC, AP, grant number: 3410); the Dick and Pip Smith Foundation (AP, LA, SR, DC); an Australian Postgraduate Award (AP) and the David Hay Memorial Fund Award (AP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5; Brenner CA, 2001, PSYCHOPHYSIOLOGY, V38, P399, DOI 10.1017/S0048577201992200; Brown MRG, 2006, NEUROIMAGE, V33, P644, DOI 10.1016/j.neuroimage.2006.07.002; CLEMENTZ BA, 1994, J ABNORM PSYCHOL, V103, P277, DOI 10.1037/0021-843X.103.2.277; DeSouza JFX, 2003, J NEUROPHYSIOL, V89, P1016, DOI 10.1152/jn.00562.2002; Fairburn CG, 2008, COGNITIVE BEHAV THER; Ford KA, 2005, J NEUROPHYSIOL, V94, P429, DOI 10.1152/jn.00471.2004; Gluscher J., 2008, CONTRAST WEIGHTS FLE; Gurvich CT, 2008, NEUROREPORT, V19, P1435, DOI 10.1097/WNR.0b013e32830e4622; Hafed ZM, 2009, SCIENCE, V323, P940, DOI 10.1126/science.1166112; Harris EC, 1998, BRIT J PSYCHIAT, V173, P11, DOI 10.1192/bjp.173.1.11; Hutton SB, 2006, PSYCHOPHYSIOLOGY, V43, P302, DOI 10.1111/j.1469-8986.2006.00403.x; Keedy SK, 2006, PSYCHIAT RES-NEUROIM, V146, P199, DOI 10.1016/j.pscychresns.2006.01.003; Kloft L, 2011, PSYCHOPHYSIOLOGY, V48, P755, DOI 10.1111/j.1469-8986.2010.01138.x; Lennertz L, 2012, EUR ARCH PSY CLIN N, V262, P625, DOI 10.1007/s00406-012-0311-1; Maruff P, 1999, PSYCHOL MED, V29, P1377, DOI 10.1017/S0033291799008843; McDowell JE, 2002, BIOL PSYCHIAT, V51, P216, DOI 10.1016/S0006-3223(01)01204-5; McDowell JE, 1997, EXP BRAIN RES, V115, P333, DOI 10.1007/PL00005702; Moeller S, 2010, MAGN RESON MED, V63, P1144, DOI 10.1002/mrm.22361; Muller N, 1999, EUR ARCH PSY CLIN N, V249, P7, DOI 10.1007/s004060050059; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P576, DOI 10.1152/jn.1993.70.2.576; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P559, DOI 10.1152/jn.1993.70.2.559; Phillipou A, 2014, INVESTIGATI IN PRESS; Phillipou A, 2014, AUST NZ J PSYCHIAT, V48, P128, DOI 10.1177/0004867413509693; Raemaekers M, 2002, ARCH GEN PSYCHIAT, V59, P313, DOI 10.1001/archpsyc.59.4.313; Reilly JL, 2005, BIOL PSYCHIAT, V57, P145, DOI 10.1016/j.biopsych.2004.10.024; Rosenberg DR, 1997, J PSYCHIATR NEUROSCI, V22, P29; Rosenberg DR, 1997, ARCH GEN PSYCHIAT, V54, P831; ROYBYRNE PP, 1993, PSYCHOPHARMACOLOGY, V110, P85, DOI 10.1007/BF02246954; SCHILLER PH, 1987, J NEUROPHYSIOL, V57, P1033, DOI 10.1152/jn.1987.57.4.1033; Schmechtig A, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.109; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Spengler D, 2006, PSYCHIAT RES, V143, P77, DOI 10.1016/j.psychres.2005.08.020; SULLIVAN PF, 1995, AM J PSYCHIAT, V152, P1073; Thiel A, 1995, AM J PSYCHIAT; TIEN AY, 1992, AM J PSYCHIAT, V149, P641; Van Der Wee NJ, 2006, PSYCHOL MED, V36, P1321, DOI 10.1017/S0033291706007926; Wechsler D., 2001, WECHSLER TEST ADULT	38	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152338	10.1371/journal.pone.0152338	http://dx.doi.org/10.1371/journal.pone.0152338			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3SV	27010196	Green Published, gold			2022-12-26	WOS:000372708000135
J	Qiu, XN; Zhang, JY; Shi, WH; Liu, S; Kang, MY; Chu, HY; Wu, DM; Tong, N; Gong, WD; Tao, GQ; Zhao, QH; Qiang, FL; Zhu, HX; Wu, Q; Wang, ML; Zhang, ZD				Qiu, Xiaonan; Zhang, Jinyue; Shi, Weihong; Liu, Sang; Kang, Meiyun; Chu, Haiyan; Wu, Dongmei; Tong, Na; Gong, Weida; Tao, Guoquan; Zhao, Qinghong; Qiang, Fulin; Zhu, Haixia; Wu, Qin; Wang, Meilin; Zhang, Zhengdong			Circulating MicroRNA-26a in Plasma and Its Potential Diagnostic Value in Gastric Cancer	PLOS ONE			English	Article							SERUM; BIOMARKER; MIR-378; PROGRESSION; CA-19-9; CEA	Background In the past decades, a good deal of studies has provided the possibility of the circulating microRNAs (miRNAs) as noninvasive biomarkers for cancer diagnosis. The aim of our study was to detect the levels of circulating miRNAs in tissues and plasmas of gastric cancer (GC) patients and evaluate their diagnostic value. Methods Tissue samples were collected from 85 GC patients. Plasma samples were collected from 285 GC patients and 285 matched controls. Differentially expressed miRNAs were filtered with by Agilent Human miRNA Microarray and TaqMan low density array (TLDA) with pooled samples, followed by the quantitative reverse transcription polymerase chain reaction (qRT-PCR) validation. Receiver operating characteristic (ROC) curves were structured to evaluate the diagnostic accuracy of the miRNAs. The plasma level of miR-26a in GC patients of different clinical stages was compared. Results Four miRNAs (miR-26a, miR-142-3p, miR-148a, and miR-195) revealed coincidentally decreased levels in tissue and plasma of the GC patients compared with controls, and ROC curves were constructed to demonstrate that miR-26a had a highest area under the ROC curve (AUC) of 0.882. Furthermore, miR-26a was stably detected in the plasma of GC patients with different clinical characteristics. Conclusion Plasma miR-26a may provide a novel and stable marker of gastric cancer.	[Qiu, Xiaonan; Liu, Sang; Kang, Meiyun; Chu, Haiyan; Wu, Dongmei; Tong, Na; Zhu, Haixia; Wang, Meilin; Zhang, Zhengdong] Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Dept Environm Genom, Nanjing, Jiangsu, Peoples R China; [Qiu, Xiaonan; Liu, Sang; Kang, Meiyun; Chu, Haiyan; Wu, Dongmei; Tong, Na; Wang, Meilin; Zhang, Zhengdong] Nanjing Med Univ, Dept Genet Toxicol, Key Lab Modern Toxicol, Minist Educ,Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China; [Zhang, Jinyue; Shi, Weihong; Wu, Qin] Yancheng Insititute Hlth Sci, Dept Med Technol, Yancheng, Peoples R China; [Gong, Weida] Yixing Canc Hosp, Dept Gen Surg, Yixing, Peoples R China; [Tao, Guoquan] Nanjing Med Univ, Huai An Peoples Hosp 1, Dept Gen Surg, Huaian, Peoples R China; [Zhao, Qinghong] Nanjing Med Univ, Affiliated Hosp 2, Dept Gen Surg, Nanjing, Jiangsu, Peoples R China; [Qiang, Fulin; Zhu, Haixia] Nantong Tumor Hosp, Core Lab, Nantong, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Wang, ML; Zhang, ZD (corresponding author), Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Dept Environm Genom, Nanjing, Jiangsu, Peoples R China.; Wang, ML; Zhang, ZD (corresponding author), Nanjing Med Univ, Dept Genet Toxicol, Key Lab Modern Toxicol, Minist Educ,Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China.; Wu, Q (corresponding author), Yancheng Insititute Hlth Sci, Dept Med Technol, Yancheng, Peoples R China.	hhwuq@163.com; mwang@njmu.edu.cn; drzdzhang@gmail.com	zhang, zheng/HCH-9684-2022		National Natural Science Foundation of China [81230068, 81373091, 81302502, 81302490, 81473049]; Natural Science Foundation of Jiangsu Province [BK2012842, BK20130641]; Key Program for Basic Research of Jiangsu Provincial Department of Education [12KJA330002]; Specialized Research Fund for the Doctoral Program of Higher education of China [20130092120063]; Jiangsu Provincial Training Programs of Innovation and Entrepreneurship for Undergraduates [201412682004Y]; Jiangsu Provincial Science and Technology Innovation Team; Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Key Program for Basic Research of Jiangsu Provincial Department of Education; Specialized Research Fund for the Doctoral Program of Higher education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Jiangsu Provincial Training Programs of Innovation and Entrepreneurship for Undergraduates; Jiangsu Provincial Science and Technology Innovation Team; Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine)	This study was partly supported by National Natural Science Foundation of China (81230068, 81373091, 81302502, 81302490, and 81473049), Natural Science Foundation of Jiangsu Province (BK2012842 and BK20130641), the Key Program for Basic Research of Jiangsu Provincial Department of Education (12KJA330002), Specialized Research Fund for the Doctoral Program of Higher education of China (20130092120063), Jiangsu Provincial Training Programs of Innovation and Entrepreneurship for Undergraduates (201412682004Y), Jiangsu Provincial Science and Technology Innovation Team, and the Priority Academic Program Development of Jiangsu Higher Education Institutions (Public Health and Preventive Medicine).	Ai J, 2010, BIOCHEM BIOPH RES CO, V391, P73, DOI 10.1016/j.bbrc.2009.11.005; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; Carpelan-Holmstrom M, 2002, ANTICANCER RES, V22, P2311; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Deng M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072662; Fei BJ, 2012, ONCOL RES, V20, P557, DOI 10.3727/096504013X13775486749254; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Habbe N, 2009, CANCER BIOL THER, V8, P340, DOI 10.4161/cbt.8.4.7338; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Hu ZB, 2012, CARCINOGENESIS, V33, P828, DOI 10.1093/carcin/bgs030; Ichikawa D, 2012, GASTROENTEROLOGY, V142, P1074, DOI 10.1053/j.gastro.2012.03.008; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang XM, 2015, INT J CANCER, V136, P854, DOI 10.1002/ijc.29041; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Leonov G, 2015, INT J BIOCHEM CELL B, V69, P75, DOI 10.1016/j.biocel.2015.10.006; Li GM, 2008, CELL RES, V18, P1, DOI 10.1038/cr.2008.9; Liu HS, 2012, CANCER LETT, V316, P196, DOI 10.1016/j.canlet.2011.10.034; Liu R, 2012, CLIN CHEM, V58, P610, DOI 10.1373/clinchem.2011.172767; Liu R, 2011, EUR J CANCER, V47, P784, DOI 10.1016/j.ejca.2010.10.025; Mar-Aguilar F, 2013, DIS MARKERS, V34, P163, DOI [10.1155/2013/259454, 10.3233/DMA-120957]; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Nonaka R, 2014, ONCOL REP, V32, P2354, DOI 10.3892/or.2014.3515; Oh HK, 2011, CLIN CANCER RES, V17, P2657, DOI 10.1158/1078-0432.CCR-10-3152; Redova M, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-55; Schneider J, 2003, ANTICANCER RES, V23, P5089; Si HY, 2013, J CANCER RES CLIN, V139, P223, DOI 10.1007/s00432-012-1315-y; Takei Y, 2011, CANCER RES, V71, P1442, DOI 10.1158/0008-5472.CAN-10-2530; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wang SZ, 2014, MUTAT RES-FUND MOL M, V769, P35, DOI 10.1016/j.mrfmmm.2014.07.002; Winter J, 2011, METHODS MOL BIOL, V676, P3, DOI 10.1007/978-1-60761-863-8_1; Xiao BX, 2009, CLIN CHIM ACTA, V400, P97, DOI 10.1016/j.cca.2008.10.021; Yang N, 2008, CANCER RES, V68, P10307, DOI 10.1158/0008-5472.CAN-08-1954; Zhang Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep09401; Zhu C, 2014, BRIT J CANCER, V110, P2291, DOI 10.1038/bjc.2014.119	40	31	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151345	10.1371/journal.pone.0151345	http://dx.doi.org/10.1371/journal.pone.0151345			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010210	gold, Green Published, Green Submitted			2022-12-26	WOS:000372708000027
J	Tosello, F; Guala, A; Leone, D; Camporeale, C; Bruno, G; Ridolfi, L; Veglio, F; Milan, A				Tosello, Francesco; Guala, Andrea; Leone, Dario; Camporeale, Carlo; Bruno, Giulia; Ridolfi, Luca; Veglio, Franco; Milan, Alberto			Central Pressure Appraisal: Clinical Validation of a Subject-Specific Mathematical Model	PLOS ONE			English	Article							CENTRAL BLOOD-PRESSURE	Introduction Current evidence suggests that aortic blood pressure has a superior prognostic value with respect to brachial pressure for cardiovascular events, but direct measurement is not feasible in daily clinical practice. Aim The aim of the present study is the clinical validation of a multiscale mathematical model for non-invasive appraisal of central blood pressure from subject-specific characteristics. Methods A total of 51 young male were selected for the present study. Aortic systolic and diastolic pressure were estimated with a mathematical model and were compared to the most-used non-invasive validated technique (SphygmoCor device, AtCor Medical, Australia). SphygmoCor was calibrated through diastolic and systolic brachial pressure obtained with a sphygmomanometer, while model inputs consist of brachial pressure, height, weight, age, left-ventricular end-systolic and end-diastolic volumes, and data from a pulse wave velocity study. Results Model-estimated systolic and diastolic central blood pressures resulted to be significantly related to SphygmoCor-assessed central systolic (r = 0.65 p <0.0001) and diastolic (r = 0.84 p<0.0001) blood pressures. The model showed a significant overestimation of systolic pressure (+7.8 (-2.2;14) mmHg, p = 0.0003) and a significant underestimation of diastolic values (-3.2(-7.5;1.6), p = 0.004), which imply a significant overestimation of central pulse pressure. Interestingly, model prediction errors mirror the mean errors reported in large meta-analysis characterizing the use of the SphygmoCor when non-invasive calibration is performed. Conclusion In conclusion, multi-scale mathematical model predictions result to be significantly related to SphygmoCor ones. Model-predicted systolic and diastolic aortic pressure resulted in difference of less than 10 mmHg in the 51% and 84% of the subjects, respectively, when compared with SphygmoCor-obtained pressures.	[Tosello, Francesco; Leone, Dario; Bruno, Giulia; Veglio, Franco; Milan, Alberto] Univ Turin, Dept Med Sci, Div Internal Med, Hypertens Unit,Univ Hosp AOU Citta Salute & Sci T, Turin, Italy; [Guala, Andrea; Camporeale, Carlo; Ridolfi, Luca] Politecn Torino, DIATI, Turin, Italy	University of Turin; Polytechnic University of Turin	Milan, A (corresponding author), Univ Turin, Dept Med Sci, Div Internal Med, Hypertens Unit,Univ Hosp AOU Citta Salute & Sci T, Turin, Italy.	alberto.milan@gmail.com	Leone, Dario/AAB-6992-2021; Leone, Dario/AAC-1775-2021; Milan, Alberto/AAG-9783-2019; Guala, Andrea/L-9857-2019; Camporeale, Carlo/I-1247-2019	Leone, Dario/0000-0002-2904-3130; Milan, Alberto/0000-0002-8863-8572; Guala, Andrea/0000-0002-5006-8164; Camporeale, Carlo/0000-0002-7311-6018; Tosello, Francesco/0000-0001-9182-7916	Ministry of Health (Italy) (Ricerca Sanitaria Finalizzata) [2013 - GR-2013-02356887]; Italian Ministry of Health (Ricerca Sanitaria Finalizzata) [2013-GR-2013-02356887]	Ministry of Health (Italy) (Ricerca Sanitaria Finalizzata); Italian Ministry of Health (Ricerca Sanitaria Finalizzata)	This work was supported by Ministry of Health (Italy) (Ricerca Sanitaria Finalizzata 2013 - GR-2013-02356887). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research has been funded by the Italian Ministry of Health (Ricerca Sanitaria Finalizzata 2013-GR-2013-02356887).	Agabiti-Rosei E, 2007, HYPERTENSION, V50, P154, DOI 10.1161/HYPERTENSIONAHA.107.090068; Bollache E, 2014, J BIOMECH, V47, P424, DOI 10.1016/j.jbiomech.2013.11.009; Cheng HM, 2013, INT J CARDIOL, V167, P1867, DOI 10.1016/j.ijcard.2012.04.155; Guala A, 2015, MECCANICA, V1, P1; Guala A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139211; Guala A, 2015, ANN BIOMED ENG, V43, P222, DOI 10.1007/s10439-014-1163-9; Lang RM, 2006, EUR J ECHOCARDIOGR, V7, P79, DOI 10.1016/j.euje.2005.12.014; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Mancia G, 2013, EUR HEART J, V34, P2159, DOI 10.1093/eurheartj/eht151; McEniery CM, 2014, EUR HEART J, V35, P1719, DOI 10.1093/eurheartj/eht565; Milan A, 2007, J HYPERTENS, V25, P1655, DOI 10.1097/HJH.0b013e3281ddb0a0; Mynard JP, 2014, AM J PHYSIOL-HEART C, V306, pH517, DOI 10.1152/ajpheart.00603.2013; NEWTON RG, 1967, APPLIED STATISTICS, V16, P51; Pauca AL, 2001, HYPERTENSION, V38, P932, DOI 10.1161/hy1001.096106; Reymond P, 2011, AM J PHYSIOL-HEART C, V301, pH1173, DOI 10.1152/ajpheart.00821.2010; Roman MJ, 2007, HYPERTENSION, V50, P197, DOI 10.1161/HYPERTENSIONAHA.107.089078; Roman MJ, 2014, HYPERTENSION, V63, P1148, DOI 10.1161/HYPERTENSIONAHA.114.03361; Safar ME, 2002, HYPERTENSION, V39, P735, DOI 10.1161/hy0202.098325; Shih YT, 2011, AM J HYPERTENS, V24, P1312, DOI 10.1038/ajh.2011.146; Smulyan H, 2003, HYPERTENSION, V42, P150, DOI 10.1161/01.HYP.0000084051.34269.A9	20	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151523	10.1371/journal.pone.0151523	http://dx.doi.org/10.1371/journal.pone.0151523			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010562	Green Published, gold			2022-12-26	WOS:000372708000031
J	Asare, EO; Tompkins, AM; Bomblies, A				Asare, Ernest Ohene; Tompkins, Adrian Mark; Bomblies, Arne			A Regional Model for Malaria Vector Developmental Habitats Evaluated Using Explicit, Pond-Resolving Surface Hydrology Simulations	PLOS ONE			English	Article							ANOPHELES-GAMBIAE-S.S.; SPATIAL-DISTRIBUTION; MOSQUITO LARVAE; ENVIRONMENTAL-FACTORS; CRUST FORMATION; SANDY SOILS; EL-NINO; TRANSMISSION; CLIMATE; DYNAMICS	Dynamical malaria models can relate precipitation to the availability of vector breeding sites using simple models of surface hydrology. Here, a revised scheme is developed for the VECTRI malaria model, which is evaluated alongside the default scheme using a two year simulation by HYDREMATS, a 10 metre resolution, village-scale model that explicitly simulates individual ponds. Despite the simplicity of the two VECTRI surface hydrology parametrization schemes, they can reproduce the sub-seasonal evolution of fractional water coverage. Calibration of the model parameters is required to simulate the mean pond fraction correctly. The default VECTRI model tended to overestimate water fraction in periods subject to light rainfall events and underestimate it during periods of intense rainfall. This systematic error was improved in the revised scheme by including the a parametrization for surface run-off, such that light rainfall below the initial abstraction threshold does not contribute to ponds. After calibration of the pond model, the VECTRI model was able to simulate vector densities that compared well to the detailed agent based model contained in HYDREMATS without further parameter adjustment. Substituting local rain-gauge data with satellite-retrieved precipitation gave a reasonable approximation, raising the prospects for regional malaria simulations even in data sparse regions. However, further improvements could be made if a method can be derived to calibrate the key hydrology parameters of the pond model in each grid cell location, possibly also incorporating slope and soil texture.	[Asare, Ernest Ohene] Kwame Nkrumah Univ Sci & Technol, Dept Phys, Kumasi, Ghana; [Asare, Ernest Ohene; Tompkins, Adrian Mark] Abdus Salam Int Ctr Theoret Phys ICTP, Trieste, Italy; [Bomblies, Arne] Univ Vermont, Sch Engn, 33 Colchester Ave, Burlington, VT 05405 USA	Kwame Nkrumah University Science & Technology; Abdus Salam International Centre for Theoretical Physics (ICTP); University of Vermont	Asare, EO (corresponding author), Kwame Nkrumah Univ Sci & Technol, Dept Phys, Kumasi, Ghana.; Asare, EO (corresponding author), Abdus Salam Int Ctr Theoret Phys ICTP, Trieste, Italy.	eoheneasare@gmail.com	Tompkins, Adrian M/N-6472-2013	Tompkins, Adrian M/0000-0003-0975-6691; Asare, Ernest/0000-0003-4078-8755	Italian government's funds-in-trust programme; ICTP PhD Sandwich Training and Educational Programme (STEP); European Union [266327]; QWeCI (Quantifying Weather and Climate Impacts on health in developing countries) [243964]	Italian government's funds-in-trust programme; ICTP PhD Sandwich Training and Educational Programme (STEP); European Union(European Commission); QWeCI (Quantifying Weather and Climate Impacts on health in developing countries)	EOA was funded by two International Centre of Theoretical Physics (ICTP) programme, namely the Italian government's funds-in-trust programme and the ICTP PhD Sandwich Training and Educational Programme (STEP). The study was also partly funded by two European Union Seventh Framework Programmes projects: HEALTHY FUTURES under the grant agreement number 266327 and QWeCI (Quantifying Weather and Climate Impacts on health in developing countries) under the grant agreement number 243964.	Ageep TB, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-123; Asare EO, 2015, GEOSPATIAL HLT UNPUB; Awolola T. S., 2007, Journal of Vector Borne Diseases, V44, P241; Beven K, 2006, J HYDROL, V320, P18, DOI 10.1016/j.jhydrol.2005.07.007; Bogh C, 2007, AM J TROP MED HYG, V76, P875; Bomblies A, 2012, CLIMATIC CHANGE, V112, P673, DOI 10.1007/s10584-011-0230-6; Bomblies A, 2009, ECOHEALTH, V6, P426, DOI 10.1007/s10393-010-0274-5; Bomblies A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-223; Bomblies A, 2008, WATER RESOUR RES, V44, DOI 10.1029/2008WR006917; Depinay JMO, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-29; Desconnets JC, 1997, J HYDROL, V188, P155; Favreau G, 2009, WATER RESOUR RES, V45, DOI 10.1029/2007WR006785; Fillinger U, 2004, TROP MED INT HEALTH, V9, P1274, DOI 10.1111/j.1365-3156.2004.01335.x; Garmendia A, 2010, LIMNETICA, V29, P145; Gianotti RL, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007567; Gimnig JE, 2001, J MED ENTOMOL, V38, P282, DOI 10.1603/0022-2585-38.2.282; Githeko AK, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-107; Hayashi M, 2000, J HYDROL, V237, P74, DOI 10.1016/S0022-1694(00)00300-0; Herman A, 1997, INT J REMOTE SENS, V18, P2147, DOI 10.1080/014311697217800; Himeidan YE, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-234; HOOGMOED WB, 1984, SOIL TILL RES, V4, P5, DOI 10.1016/0167-1987(84)90013-8; Hoshen MB, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-32; Huffman GJ, 2007, J HYDROMETEOROL, V8, P38, DOI 10.1175/JHM560.1; IDSO SB, 1981, WATER RESOUR BULL, V17, P46; Iguchi T, 2000, J APPL METEOROL, V39, P2038, DOI 10.1175/1520-0450(2001)040<2038:RPAFTT>2.0.CO;2; Imbahale SS, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-81; Kelly-Hope LA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-268; Kilian AHD, 1999, T ROY SOC TROP MED H, V93, P22, DOI 10.1016/S0035-9203(99)90165-7; Koenraadt CJM, 2004, ACTA TROP, V90, P141, DOI 10.1016/j.actatropica.2003.11.007; Leduc C, 2001, J HYDROL, V243, P43, DOI 10.1016/S0022-1694(00)00403-0; Lindsay SW, 2000, LANCET, V355, P989, DOI 10.1016/S0140-6736(00)90022-9; LOVE T, 2004, AM MET SOC C APPL CL; Lowe R, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-416; Lunde TM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-28; Majambere S, 2008, AM J TROP MED HYG, V79, P19, DOI 10.4269/ajtmh.2008.79.19; Martin-Rosales W, 2003, CR GEOSCI, V335, P461, DOI 10.1016/S1631-0713(03)00059-2; Minakawa N, 2005, J MED ENTOMOL, V42, P295, DOI 10.1603/0022-2585(2005)042[0295:RBOOAG]2.0.CO;2; Minakawa N, 1999, AM J TROP MED HYG, V61, P1010, DOI 10.4269/ajtmh.1999.61.1010; Minakawa N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032725; Minke AG, 2010, WETLANDS, V30, P541, DOI 10.1007/s13157-010-0044-8; Molineaux L, 1980, RES EPIDEMIOLOGY CON; Montosi E, 2012, HYDROL EARTH SYST SC, V16, P2759, DOI 10.5194/hess-16-2759-2012; Murphy JM, 2004, NATURE, V430, P768, DOI 10.1038/nature02771; Mutuku FM, 2006, AM J TROP MED HYG, V74, P54, DOI 10.4269/ajtmh.2006.74.54; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Oesterholt MJAM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-98; Paaijmans KP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001146; Patz JA, 1998, TROP MED INT HEALTH, V3, P818, DOI 10.1046/j.1365-3156.1998.00309.x; POLLARD D, 1995, GLOBAL PLANET CHANGE, V10, P129, DOI 10.1016/0921-8181(94)00023-7; Ramier D, 2009, J HYDROL, V375, P204, DOI 10.1016/j.jhydrol.2008.12.002; Sattler MA, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-4; Shaman J, 2002, EMERG INFECT DIS, V8, P6; Soti V, 2010, HYDROL EARTH SYST SC, V14, P1449, DOI 10.5194/hess-14-1449-2010; Stainforth DA, 2005, NATURE, V433, P403, DOI 10.1038/nature03301; STROOSNIJDER L, 1984, SOIL TILL RES, V4, P321, DOI 10.1016/0167-1987(84)90032-1; Thomson MC, 2006, NATURE, V439, P576, DOI 10.1038/nature04503; Tompkins AM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-65; USDA S, 1972, NAT ENG HDB; Yamana TK, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009744	59	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0150626	10.1371/journal.pone.0150626	http://dx.doi.org/10.1371/journal.pone.0150626			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003834	Green Published, gold, Green Submitted			2022-12-26	WOS:000372697400017
J	He, JJ; Ma, J; Elsheikha, HM; Song, HQ; Zhou, DH; Zhu, XQ				He, Jun-Jun; Ma, Jun; Elsheikha, Hany M.; Song, Hui-Qun; Zhou, Dong-Hui; Zhu, Xing-Quan			Proteomic Profiling of Mouse Liver following Acute Toxoplasma gondii Infection	PLOS ONE			English	Article							IFN-GAMMA; MURINE MACROPHAGES; GENE-EXPRESSION; HOST-RESISTANCE; SUPPRESSION; MODULATION; INDUCTION; IMMUNITY; FIBROBLASTS; ACTIVATION	Toxoplasma gondii remains a global public health problem. However, its pathophysiology is still not-completely understood particularly the impact of infection on host liver metabolism. We performed iTRAQ-based proteomic analysis to evaluate early liver protein responses in BALB/c mice following infection with T. gondii PYS strain (genotype ToxoDB#9) infection. Our data revealed modification of protein expression in key metabolic pathways, as indicated by the upregulation of immune response and downregulation of mitochondrial respiratory chain, and the metabolism of fatty acids, lipids and xenobiotics. T. gondii seems to hijack host PPAR signaling pathway to downregulate the metabolism of fatty acids, lipids and energy in the liver. The metabolism of over 400 substances was affected by the downregulation of genes involved in xenobiotic metabolism. The top 10 transcription factors used by upregulated genes were Stat2, Stat1, Irf2, Irf1, Sp2, Egr1, Stat3, Klf4, Elf1 and Gabpa, while the top 10 transcription factors of downregulated genes were Hnf4A, Ewsr1, Fli1, Hnf4g, Nr2f1, Pparg, Rxra, Hnf1A, Foxa1 and Foxo1. These findings indicate global reprogramming of the metabolism of the mouse liver after acute T. gondii infection. Functional characterization of the altered proteins may enhance understanding of the host responses to T. gondii infection and lead to the identification of new therapeutic targets.	[He, Jun-Jun; Ma, Jun; Song, Hui-Qun; Zhou, Dong-Hui; Zhu, Xing-Quan] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou 730046, Gansu, Peoples R China; [Ma, Jun] Hunan Agr Univ, Coll Vet Med, Changsha 410128, Hunan, Peoples R China; [Elsheikha, Hany M.] Univ Nottingham, Sch Vet Med & Sci, Fac Med & Hlth Sci, Sutton Bonington Campus, Loughborough LE12 5RD, Leics, England	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Hunan Agricultural University; University of Nottingham	Zhou, DH; Zhu, XQ (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, Key Lab Vet Parasitol Gansu Prov, State Key Lab Vet Etiol Biol, Lanzhou 730046, Gansu, Peoples R China.	zhoudonghui@caas.cn; xingquanzhu1@hotmail.com	Elsheikha, Hany/G-7573-2011	Elsheikha, Hany/0000-0003-3303-930X	National Natural Science Foundation of China [31230073]; Science Fund for Creative Research Groups of Gansu Province [1210RJIA006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Fund for Creative Research Groups of Gansu Province(Science Fund for Creative Research Groups)	Project support was provided by the National Natural Science Foundation of China (Grant No. 31230073) and the Science Fund for Creative Research Groups of Gansu Province (Grant No. 1210RJIA006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atmaca HT, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-135; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; BergCandolfi M, 1996, INT J PARASITOL, V26, P1321, DOI 10.1016/S0020-7519(96)00111-7; BergCandolfi M, 1996, XENOBIOTICA, V26, P381, DOI 10.3109/00498259609046717; Blader IJ, 2009, APMIS, V117, P458, DOI 10.1111/j.1600-0463.2009.02453.x; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Butcher BA, 2005, J IMMUNOL, V174, P3148, DOI 10.4049/jimmunol.174.6.3148; Davis AP, 2015, NUCLEIC ACIDS RES, V43, pD914, DOI 10.1093/nar/gku935; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Giannini EG, 2005, CAN MED ASSOC J, V172, P367, DOI 10.1503/cmaj.1040752; He J., 2015, 2015 IEEE International Magnetics Conference (INTERMAG), DOI 10.1109/INTMAG.2015.7157342; Iaccheri B, 2008, CLIN THER, V30, P2069, DOI 10.1016/j.clinthera.2008.10.021; Jiang HH, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-227; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim SK, 2007, J IMMUNOL, V178, P5154, DOI 10.4049/jimmunol.178.8.5154; Kyriakides M, 2016, ARCH TOXICOL, P1; Lang C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002483; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Luder CGK, 2005, CURR TOP MICROBIOL, V289, P219; Luder CGK, 2001, EUR J IMMUNOL, V31, P1475, DOI 10.1002/1521-4141(200105)31:5&lt;1475::AID-IMMU1475&gt;3.0.CO;2-C; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mahmoud ME, 2015, CELL MICROBIOL, V17, P1069, DOI 10.1111/cmi.12423; Melo MB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003779; Melzer T, 2008, INFECT IMMUN, V76, P4883, DOI 10.1128/IAI.01288-07; Menendez MT, 2015, MBIO, V6, DOI 10.1128/mBio.00462-15; Mordue DG, 2001, J IMMUNOL, V167, P4574, DOI 10.4049/jimmunol.167.8.4574; Nelson MM, 2008, INFECT IMMUN, V76, P828, DOI 10.1128/IAI.01115-07; PERITI P, 1993, DRUG SAFETY, V9, P346, DOI 10.2165/00002018-199309050-00004; Pessayre D, 2012, DRUG METAB REV, V44, P34, DOI 10.3109/03602532.2011.604086; PRYER NK, 1992, ANNU REV BIOCHEM, V61, P471; SCOTT JP, 1988, MED TOXICOL ADV DRUG, V3, P107, DOI 10.1007/BF03259936; Shapira S, 2002, J INFECT DIS, V185, pS66, DOI 10.1086/338000; Shapira Y, 2012, EXP MOL PATHOL, V93, P386, DOI 10.1016/j.yexmp.2012.09.012; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; Sturge CR, 2013, P NATL ACAD SCI USA, V110, P10711, DOI 10.1073/pnas.1307868110; Stutz A, 2012, IMMUNOBIOLOGY, V217, P28, DOI 10.1016/j.imbio.2011.08.008; Talalay P, 2000, BIOFACTORS, V12, P5, DOI 10.1002/biof.5520120102; Tanaka S, 2013, INFECT IMMUN, V81, P3609, DOI 10.1128/IAI.00439-13; TIWARI I, 1982, POSTGRAD MED J, V58, P299, DOI 10.1136/pgmj.58.679.299; Tymoshenko S, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004261; Ustun S, 2004, WORLD J GASTROENTERO, V10, P452; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; WEITBERG AB, 1979, NEW ENGL J MED, V300, P1093, DOI 10.1056/NEJM197905103001907; Wendum D, 2002, J CLIN PATHOL, V55, P637, DOI 10.1136/jcp.55.8.637; Whitmarsh RJ, 2011, CELL HOST MICROBE, V10, P224, DOI 10.1016/j.chom.2011.07.009; Xu CJ, 2005, ARCH PHARM RES, V28, P249, DOI 10.1007/BF02977789; Yap GS, 1999, J EXP MED, V189, P1083, DOI 10.1084/jem.189.7.1083; Yarovinsky F, 2014, NAT REV IMMUNOL, V14, P109, DOI 10.1038/nri3598; Zambelli F, 2009, NUCLEIC ACIDS RES, V37, pW247, DOI 10.1093/nar/gkp464; Zeng J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006787; Zhou CX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139635; Zhou DH, 2011, PARASITOL RES, V109, P1637, DOI 10.1007/s00436-011-2435-z; Zhou DH, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-96	57	36	40	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152022	10.1371/journal.pone.0152022	http://dx.doi.org/10.1371/journal.pone.0152022			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003162	Green Published, Green Submitted, gold			2022-12-26	WOS:000372697400067
J	Steward, T; Pico-Perez, M; Mata, F; Martinez-Zalacain, I; Cano, M; Contreras-Rodriguez, O; Fernandez-Aranda, F; Yucel, M; Soriano-Mas, C; Verdejo-Garcia, A				Steward, Trevor; Pico-Perez, Maria; Mata, Fernanda; Martinez-Zalacain, Ignacio; Cano, Marta; Contreras-Rodriguez, Oren; Fernandez-Aranda, Fernando; Yucel, Murat; Soriano-Mas, Carles; Verdejo-Garcia, Antonio			Emotion Regulation and Excess Weight: Impaired Affective Processing Characterized by Dysfunctional Insula Activation and Connectivity	PLOS ONE			English	Article							DECISION-MAKING; COGNITIVE REAPPRAISAL; ANTERIOR INSULA; NEGATIVE AFFECT; NEURAL BASES; SUPPRESSION; ADOLESCENTS; OBESITY; FMRI; METAANALYSIS	Emotion-regulation strategies are understood to influence food intake. This study examined the neurophysiological underpinnings of negative emotion processing and emotion regulation in individuals with excess weight compared to normal-weight controls. Fifteen participants with excess-weight (body mass index >25) and sixteen normal-weight controls (body mass index 18-25) performed an emotion-regulation task during functional magnetic resonance imaging. Participants were exposed to 24 negative affective or neutral pictures that they were instructed to Observe (neutral pictures), Maintain (sustain the emotion elicited by negative pictures) or Regulate (down-regulate the emotion provoked by negative pictures through previously trained reappraisal techniques). When instructed to regulate negative emotions by means of cognitive reappraisal, participants with excess weight displayed persistently heightened activation in the right anterior insula. Decreased responsivity was also found in right anterior insula, the orbitofrontal cortex and cerebellum during negative emotion experience in participants with excess weight. Psycho-physiological interaction analyses showed that excess-weight participants had decreased negative functional coupling between the right anterior insula and the right dlPFC, and the bilateral dmPFC during cognitive reappraisal. Our findings support contentions that excess weight is linked to an abnormal pattern of neural activation and connectivity during the experience and regulation of negative emotions, with the insula playing a key role in these alterations. We posit that ineffective regulation of emotional states contributes to the acquisition and preservation of excess weight.	[Steward, Trevor; Pico-Perez, Maria; Martinez-Zalacain, Ignacio; Cano, Marta; Contreras-Rodriguez, Oren; Fernandez-Aranda, Fernando; Soriano-Mas, Carles] Bellvitge Univ Hosp IDIBELL, Dept Psychiat, Barcelona, Spain; [Steward, Trevor; Pico-Perez, Maria; Cano, Marta; Fernandez-Aranda, Fernando] Univ Barcelona, Sch Med, Dept Clin Sci, Barcelona, Spain; [Mata, Fernanda; Yucel, Murat; Verdejo-Garcia, Antonio] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia; [Mata, Fernanda; Yucel, Murat; Verdejo-Garcia, Antonio] Monash Univ, Monash Inst Cognit & Clin Neurosci, Melbourne, Vic 3004, Australia; [Contreras-Rodriguez, Oren; Soriano-Mas, Carles] Inst Salud Carlos III, CIBER Salud Mental CIBERsam, Barcelona, Spain; [Soriano-Mas, Carles] Univ Autonoma Barcelona, Dept Psychobiol & Methodol Hlth Sci, E-08193 Barcelona, Spain; [Steward, Trevor; Fernandez-Aranda, Fernando] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr CIBERObn, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; University of Barcelona; Monash University; Monash University; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Instituto de Salud Carlos III; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III	Soriano-Mas, C (corresponding author), Bellvitge Univ Hosp IDIBELL, Dept Psychiat, Barcelona, Spain.; Soriano-Mas, C (corresponding author), Inst Salud Carlos III, CIBER Salud Mental CIBERsam, Barcelona, Spain.; Soriano-Mas, C (corresponding author), Univ Autonoma Barcelona, Dept Psychobiol & Methodol Hlth Sci, E-08193 Barcelona, Spain.	csoriano@idibell.cat	Verdejo-Garcia, Antonio/AAV-1147-2021; Yücel, Murat/AAY-8124-2020; Fernandez-Aranda, Fernando/L-9762-2014; Picó-Pérez, Maria/AAE-1174-2020; Yucel, Murat/I-3004-2014; FERNANDEZ-ARANDA, FERNANDO/AGY-1597-2022; Soriano-Mas, Carles/E-4028-2019; Steward, Trevor/K-7469-2015	Verdejo-Garcia, Antonio/0000-0001-8874-9339; Yücel, Murat/0000-0002-4705-452X; Fernandez-Aranda, Fernando/0000-0002-2968-9898; Picó-Pérez, Maria/0000-0002-1573-2445; Yucel, Murat/0000-0002-4705-452X; FERNANDEZ-ARANDA, FERNANDO/0000-0002-2968-9898; Soriano-Mas, Carles/0000-0003-4574-6597; Steward, Trevor/0000-0003-3116-8175; Cano, Marta/0000-0003-0675-9483; Martinez-Zalacain, Ignacio/0000-0002-4036-0284	Monash Biomedical Imaging (MBI), Monash University, Melbourne (Australia); Carlos III Health Institute (Spain) [PI13/01958, CIBER-CB06/03/0034]; FEDER funds; Agency of University and Research Funding Management of the Catalan Government (AGAUR) [2014SGR1672]; Carlos III Health Institute [FIS PI14/00290]; FI grant from the AGAUR [2015 FI_B 00839]; National Health and Medical Research Council Research Fellowship [APP1021973]; Spanish Ministry for Education, Culture and Sport [FPU13/02141]; Miguel Servet contract from the Carlos III Health Institute [CP10/00604]; Sara Borrell postdoctoral fellowship from the Carlos III Health Institute [CD14/00246]	Monash Biomedical Imaging (MBI), Monash University, Melbourne (Australia); Carlos III Health Institute (Spain)(Instituto de Salud Carlos III); FEDER funds(European Commission); Agency of University and Research Funding Management of the Catalan Government (AGAUR); Carlos III Health Institute(Instituto de Salud Carlos III); FI grant from the AGAUR; National Health and Medical Research Council Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Spanish Ministry for Education, Culture and Sport(Spanish Government); Miguel Servet contract from the Carlos III Health Institute; Sara Borrell postdoctoral fellowship from the Carlos III Health Institute	This study was supported in part by grants from the Monash Biomedical Imaging (MBI), Monash University, Melbourne (Australia) (MBI Platform Access Grant 2013), Carlos III Health Institute (Spain) (PI13/01958 and CIBER-CB06/03/0034), FEDER funds, and the Agency of University and Research Funding Management of the Catalan Government (AGAUR; 2014SGR1672). TS is supported by grants from the Carlos III Health Institute (FIS PI14/00290 and CIBERobn) and co-funded by FEDER funds -a way to build Europe. CIBER Fisiopatologia de la Obesidad y Nutricion (CIBERobn) and CIBER Salud Mental (CIBERsam) are both initiatives of ISCIII. MPP is supported by a FI grant from the AGAUR (2015 FI_B 00839). MY is supported by a National Health and Medical Research Council Research Fellowship (#APP1021973). MC is supported by a grant from the Spanish Ministry for Education, Culture and Sport (FPU13/02141). CSM is funded by a Miguel Servet contract from the Carlos III Health Institute (CP10/00604). OCR is currently funded by a Sara Borrell postdoctoral fellowship (Grant No. CD14/00246) from the Carlos III Health Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albein-Urios N, 2014, ADDICT BIOL, V19, P415, DOI 10.1111/j.1369-1600.2012.00497.x; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Block JP, 2009, AM J EPIDEMIOL, V170, P181, DOI 10.1093/aje/kwp104; Brett M., 2002, NEUROIMAGE, V16, P497; Buhle JT, 2014, CEREB CORTEX, V24, P2981, DOI 10.1093/cercor/bht154; Burger KS, 2014, OBESITY, V22, P441, DOI 10.1002/oby.20563; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; de Weijer BA, 2011, EJNMMI RES, V1, DOI 10.1186/2191-219X-1-37; Delgado-Rico E, 2013, OBESITY, V21, P1662, DOI 10.1002/oby.20375; Diekhof EK, 2011, NEUROIMAGE, V58, P275, DOI 10.1016/j.neuroimage.2011.05.073; Durso LE, 2008, OBESITY, V16, pS80, DOI 10.1038/oby.2008.448; Etkin A, 2015, NAT REV NEUROSCI, V16, P693, DOI 10.1038/nrn4044; Fellows LK, 2011, ANN NY ACAD SCI, V1239, P51, DOI 10.1111/j.1749-6632.2011.06229.x; Frank DW, 2014, NEUROSCI BIOBEHAV R, V45, P202, DOI 10.1016/j.neubiorev.2014.06.010; Friedman KE, 2005, OBES RES, V13, P907, DOI 10.1038/oby.2005.105; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Golkar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048107; Grabenhorst F, 2008, CEREB CORTEX, V18, P1549, DOI 10.1093/cercor/bhm185; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; Gross JJ, 1998, J PERS SOC PSYCHOL, V74, P224, DOI 10.1037/0022-3514.74.1.224; Gross JJ., 1998, REV GEN PSYCHOL, V2, P271, DOI 10.1037/1089-2680.2.3.271; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Hemmingsson E, 2014, OBES REV, V15, P769, DOI 10.1111/obr.12197; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Lang PJ., 2001, INT AFFECTIVE PICTUR; Lavender JM, 2015, EUR EAT DISORD REV, V23, P246, DOI 10.1002/erv.2351; Lawrence EJ, 2014, NEUROIMAGE, V88, P113, DOI 10.1016/j.neuroimage.2013.10.069; Leehr EJ, 2016, EUR EAT DISORD REV, V24, P169, DOI 10.1002/erv.2421; Leehr EJ, 2015, NEUROSCI BIOBEHAV R, V49, P125, DOI 10.1016/j.neubiorev.2014.12.008; Lowe MR, 2006, APPETITE, V47, P83, DOI 10.1016/j.appet.2006.03.160; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mark AL, 2006, CLIN EXP PHARMACOL P, V33, P857, DOI 10.1111/j.1440-1681.2006.04454.x; Mata F, 2015, APPETITE, V93, P24, DOI 10.1016/j.appet.2015.03.024; Mcrae K, 2012, SOC COGN AFFECT NEUR, V7, P11, DOI 10.1093/scan/nsr093; Meule A, 2015, EUR EAT DISORD REV, V23, P193, DOI 10.1002/erv.2355; Muller A, 2014, EUR EAT DISORD REV, V22, P260, DOI 10.1002/erv.2294; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Ochsner KN, 2012, ANN NY ACAD SCI, V1251, pE1, DOI 10.1111/j.1749-6632.2012.06751.x; Ochsner KN, 2009, PSYCHOL SCI, V20, P1322, DOI 10.1111/j.1467-9280.2009.02459.x; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Perlman G, 2012, J AFFECT DISORDERS, V29, P997; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Potegal M, 2012, BEHAV BRAIN RES, V231, P386, DOI 10.1016/j.bbr.2011.10.049; Raspopow K, 2013, APPETITE, V62, P143, DOI 10.1016/j.appet.2012.11.031; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Roberts C, 2007, OBESITY, V15, P3045, DOI 10.1038/oby.2007.363; Rudenga KJ, 2013, INT J OBESITY, V37, P309, DOI 10.1038/ijo.2012.39; Siep N, 2012, NEUROIMAGE, V60, P213, DOI 10.1016/j.neuroimage.2011.12.067; Singh M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00925; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Svaldi J, 2012, APPETITE, V59, P256, DOI 10.1016/j.appet.2012.04.016; Tchanturia K, 2014, EUR EAT DISORD REV, V22, P200, DOI 10.1002/erv.2287; Vandewalle J, 2014, INT J OBESITY, V38, P525, DOI 10.1038/ijo.2013.233; Verdejo-Garcia A, 2015, HUM BRAIN MAPP, V36, P226, DOI 10.1002/hbm.22625; Vink M, 2014, NEUROIMAGE, V91, P70, DOI 10.1016/j.neuroimage.2014.01.035; Volkow ND, 2013, OBES REV, V14, P2, DOI 10.1111/j.1467-789X.2012.01031.x; Volkow ND, 2008, NEUROIMAGE, V42, P1537, DOI 10.1016/j.neuroimage.2008.06.002; Wager TD, 2008, NEURON, V59, P1037, DOI 10.1016/j.neuron.2008.09.006; Wagner A, 2006, PSYCHIAT RES-NEUROIM, V147, P57, DOI 10.1016/j.pscychresns.2005.11.005; Yokum S, 2013, INT J OBESITY, V37, P1565, DOI 10.1038/ijo.2013.39; Yuan JJ, 2015, SCI CHINA LIFE SCI, V58, P480, DOI 10.1007/s11427-014-4739-6; Zaki J, 2012, NEUROIMAGE, V62, P493, DOI 10.1016/j.neuroimage.2012.05.012	65	37	37	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152150	10.1371/journal.pone.0152150	http://dx.doi.org/10.1371/journal.pone.0152150			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH3OX	27003840	Green Published, gold			2022-12-26	WOS:000372697400087
J	Fais, A; Lewis, TP; Zitterbart, DP; Alvarez, O; Tejedor, A; Soto, NA				Fais, Andrea; Lewis, Tim P.; Zitterbart, Daniel P.; Alvarez, Omar; Tejedor, Ana; Soto, Natacha Aguilar			Abundance and Distribution of Sperm Whales in the Canary Islands: Can Sperm Whales in the Archipelago Sustain the Current Level of Ship-Strike Mortalities?	PLOS ONE			English	Article							DETECTION PROBABILITIES; ECOLOGICAL TRAPS; ACOUSTIC SURVEYS; COLLISIONS; MITOCHONDRIAL; CETACEANS; HABITAT	Sperm whales are present in the Canary Islands year-round, suggesting that the archipelago is an important area for this species in the North Atlantic. However, the area experiences one of the highest reported rates of sperm whale ship-strike in the world. Here we investigate if the number of sperm whales found in the archipelago can sustain the current rate of ship-strike mortality. The results of this study may also have implications for offshore areas where concentrations of sperm whales may coincide with high densities of ship traffic, but where ship-strikes may be undocumented. The absolute abundance of sperm whales in an area of 52933 km(2), covering the territorial waters of the Canary Islands, was estimated from 2668 km of acoustic line-transect survey using Distance sampling analysis. Data on sperm whale diving and acoustic behaviour, obtained from bio-logging, were used to calculate g(0) = 0.92, this is less than one because of occasional extended periods when whales do not echolocate. This resulted in an absolute abundance estimate of 224 sperm whales (95% log-normal CI 120-418) within the survey area. The recruitment capability of this number of whales, some 2.5 whales per year, is likely to be exceeded by the current ship-strike mortality rate. Furthermore, we found areas of higher whale density within the archipelago, many coincident with those previously described, suggesting that these are important habitats for females and immature animals inhabiting the archipelago. Some of these areas are crossed by active shipping lanes increasing the risk of ship-strikes. Given the philopatry in female sperm whales, replacement of impacted whales might be limited. Therefore, the application of mitigation measures to reduce the ship-strike mortality rate seems essential for the conservation of sperm whales in the Canary Islands.	[Fais, Andrea; Lewis, Tim P.; Alvarez, Omar; Soto, Natacha Aguilar] Univ La Laguna, Dept Anim Biol Geol & Edaphol, Biodiversidad Ecol Marina & Conservac BIOECOMAC, Tenerife, Canary Islands, Spain; [Zitterbart, Daniel P.] Helmholtz Zentrum Polar & Meeresforsch, Alfred Wegener Inst, Ocean Acoust Lab, Bremerhaven, Germany; [Zitterbart, Daniel P.] Woods Hole Oceanog Inst, Appl Ocean Phys & Engn, Woods Hole, MA 02543 USA; [Alvarez, Omar] CIMA Canarias, Avda Majuelos 115, Tenerife 38107, Canary Islands, Spain; [Tejedor, Ana] KAI Marine Serv, Nalon 16, Madrid 28240, Spain; [Soto, Natacha Aguilar] Univ St Andrews, Scottish Oceans Inst, CREEM, St Andrews, Fife, Scotland; [Fais, Andrea] Univ Vet Med, Inst Terr & Aquat Wildlife Res, Hannover, Germany	Universidad de la Laguna; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Woods Hole Oceanographic Institution; University of St Andrews; University of Veterinary Medicine Hannover, Foundation	Fais, A (corresponding author), Univ La Laguna, Dept Anim Biol Geol & Edaphol, Biodiversidad Ecol Marina & Conservac BIOECOMAC, Tenerife, Canary Islands, Spain.; Fais, A (corresponding author), Univ Vet Med, Inst Terr & Aquat Wildlife Res, Hannover, Germany.	andrea.fais@tiho-hannover.de	De Soto, Natacha Aguilar/D-3002-2011	De Soto, Natacha Aguilar/0000-0001-9818-3527; Zitterbart, Daniel/0000-0001-9429-4350	Canary Islands Government; Spanish Ministry of the Environment; Spanish Ministry of the Defence; Fundacion Biodiversidad-MAGRAMA via the LIFE-INDEMARES project	Canary Islands Government; Spanish Ministry of the Environment(Spanish Government); Spanish Ministry of the Defence; Fundacion Biodiversidad-MAGRAMA via the LIFE-INDEMARES project	Funding was provided through an agreement between the Canary Islands Government and the Spanish Ministries of the Environment and Defence. Additional survey effort on the Amanay, Banquete and Concepcion seamounts was funded by the Fundacion Biodiversidad-MAGRAMA via the LIFE-INDEMARES project. The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section. One of the authors (OA) is employed by a commercial company, CIMA Canarias, nevertheless this commercial affiliation only provided financial support in the form of author's salaries and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar Soto N, 2000, J CETACEAN RES MANAG; Alexander A, MOL ECOL UNPUB; Andre M, 1997, THESIS U LAS PALMAS; Arbelo M, 2013, DIS AQUAT ORGAN, V103, P87, DOI 10.3354/dao02558; Barlow J, 2005, MAR MAMMAL SCI, V21, P429, DOI 10.1111/j.1748-7692.2005.tb01242.x; Barlow J, 2013, J ACOUST SOC AM, V134, P2486, DOI 10.1121/1.4816573; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Borchers DL, 2013, BIOMETRICS, V69, P703, DOI 10.1111/biom.12049; Buckland S.T., 2001, pi; Carrillo Manuel, 2010, Journal of Cetacean Research and Management, V11, P131; Conn PB, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00004.1; Constantine R, 2015, BIOL CONSERV, V186, P149, DOI 10.1016/j.biocon.2015.03.008; Cooney R., 2004, PRECAUTIONARY PRINCI; Cooney R., 2005, BIODIVERSITY PRECAUT; Delibes M, 2001, AM NAT, V158, P277, DOI 10.1086/321319; Diaz-Delgado J, 2015, THESIS U LAS PALMAS; Donovan TM, 2001, ECOL APPL, V11, P871; Douglas AB, 2008, J MAR BIOL ASSOC UK, V88, P1121, DOI 10.1017/S0025315408000295; Engelhaupt D, 2009, MOL ECOL, V18, P4193, DOI 10.1111/j.1365-294X.2009.04355.x; Faerber MM, 2010, MAR MAMMAL SCI, V26, P602, DOI 10.1111/j.1748-7692.2010.00370.x; Fujiwara M, 2001, NATURE, V414, P537, DOI 10.1038/35107054; Gaona P, 1998, ECOL MONOGR, V68, P349, DOI 10.1890/0012-9615(1998)068[0349:DAVOAM]2.0.CO;2; Gero Shane, 2007, Journal of Cetacean Research and Management, V9, P143; Gero S, 2015, ANIM BEHAV, V102, P15, DOI 10.1016/j.anbehav.2015.01.008; Gero S, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1113; Gillespie D, 1996, EUROPEAN RES CETATEC, V10, P87; Gillespie Douglas, 1997, Report of the International Whaling Commission, V47, P897; Gordon JCD, 1987, BEHAV ECOLOGY SPERM; Hildebrand JA, 2009, MAR ECOL PROG SER, V395, P5, DOI 10.3354/meps08353; Jensen A.S., 2003, LARGE WHALE SHIP STR; Johnson MP, 2003, IEEE J OCEANIC ENG, V28, P3, DOI 10.1109/JOE.2002.808212; Kokko H, 2001, EVOL ECOL RES, V3, P537; Kraus SD, 2005, SCIENCE, V309, P561, DOI 10.1126/science.1111200; Laist DW, 2001, MAR MAMMAL SCI, V17, P35, DOI 10.1111/j.1748-7692.2001.tb00980.x; Leaper R., 2003, IWC SCI COMM M UNPUB; Leaper Russell, 2000, Journal of Cetacean Research and Management, V2, P187; Lewis T, 2007, J MAR BIOL ASSOC UK, V87, P353, DOI 10.1017/S0025315407054896; Lyrholm T, 1999, P ROY SOC B-BIOL SCI, V266, P347, DOI 10.1098/rspb.1999.0644; Lyrholm T, 1998, P ROY SOC B-BIOL SCI, V265, P1679, DOI 10.1098/rspb.1998.0488; Ritter Fabian, 2012, Journal of Cetacean Research and Management, V12, P119; Ritter Fabian, 2010, Journal of Cetacean Research and Management, V11, P139; Rodriguez MC, 2005, J MARIT RES, V2, P81; Silber GK, 2012, MAR POLICY, V36, P1221, DOI 10.1016/j.marpol.2012.03.008; Silber GK, 2010, J EXP MAR BIOL ECOL, V391, P10, DOI 10.1016/j.jembe.2010.05.013; Spalding MD, 2007, BIOSCIENCE, V57, P573, DOI 10.1641/B570707; Tejedor A., 2012, MITIGACION IMPACTOS; Thomas L., 2006, DISTANCE 6 0 RELEASE; Van Waerebeek Koen, 2007, Latin American Journal of Aquatic Mammals, V6, P43; Vanderlaan ASM, 2007, MAR MAMMAL SCI, V23, P144, DOI 10.1111/j.1748-7692.2006.00098.x; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; Whitehead H, 2002, MAR ECOL PROG SER, V242, P295, DOI 10.3354/meps242295; Whitehead H., 2003, SPERM WHALES SOCIAL; Whitehead H, 2008, MAR ECOL PROG SER, V361, P291, DOI 10.3354/meps07412; Williams R., 2011, CONSERV LETT, V2011, P1, DOI [DOI 10.1111/J.1755-263X.2010.00151.X, 10.1111/j.1755-263X.2010.00151.x]; Williams R, 2006, BIOL LETTERS, V2, P497, DOI 10.1098/rsbl.2006.0510	55	23	26	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0150660	10.1371/journal.pone.0150660	http://dx.doi.org/10.1371/journal.pone.0150660			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999791	Green Published, gold, Green Submitted			2022-12-26	WOS:000372694700013
J	Norby, FL; Adamsson Eryd, S; Niemeijer, MN; Rose, LM; Smith, AV; Yin, XY; Agarwal, SK; Arking, DE; Chasman, DL; Chen, LY; Eijgelsheim, M; Engstrom, G; Franco, OH; Heeringa, J; Hindy, G; Hofman, A; Lutsey, PL; Magnani, JW; McManus, DD; Orho-Melander, M; Pankow, JS; Rukh, G; Schulz, CA; Uitterlinden, AG; Albert, CM; Benjamin, EJ; Gudnason, V; Smith, JG; Stricker, BHC; Alonso, A				Norby, Faye L.; Adamsson Eryd, Samuel; Niemeijer, Maartje N.; Rose, Lynda M.; Smith, Albert V.; Yin, Xiaoyan; Agarwal, Sunil K.; Arking, Dan E.; Chasman, Daniel L.; Chen, Lin Y.; Eijgelsheim, Mark; Engstrom, Gunnar; Franco, Oscar H.; Heeringa, Jan; Hindy, George; Hofman, Albert; Lutsey, Pamela L.; Magnani, Jared W.; McManus, David D.; Orho-Melander, Marju; Pankow, James S.; Rukh, Gull; Schulz, Christina-Alexandra; Uitterlinden, Andre G.; Albert, Christine M.; Benjamin, Emelia J.; Gudnason, Vilmundur; Smith, J. Gustav; Stricker, Bruno H. C.; Alonso, Alvaro			Association of Lipid-Related Genetic Variants with the Incidence of Atrial Fibrillation: The AFGen Consortium	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-HEART-DISEASE; ATHEROSCLEROSIS RISK; LOCI; DESIGN; PREVALENCE; WHITES; COHORT; TRENDS; IMPACT	Background Several studies have shown associations between blood lipid levels and the risk of atrial fibrillation (AF). To test the potential effect of blood lipids with AF risk, we assessed whether previously developed lipid gene scores, used as instrumental variables, are associated with the incidence of AF in 7 large cohorts. Methods We analyzed 64,901 individuals of European ancestry without previous AF at baseline and with lipid gene scores. Lipid-specific gene scores, based on loci significantly associated with lipid levels, were calculated. Additionally, non-pleiotropic gene scores for high-density lipoprotein cholesterol (HDLc) and low-density lipoprotein cholesterol (LDLc) were calculated using SNPs that were only associated with the specific lipid fraction. Cox models were used to estimate the hazard ratio (HR) and 95% confidence intervals (CI) of AF per 1-standard deviation (SD) increase of each lipid gene score. Results During a mean follow-up of 12.0 years, 5434 (8.4%) incident AF cases were identified. After meta-analysis, the HDLc, LDLc, total cholesterol, and triglyceride gene scores were not associated with incidence of AF. Multivariable-adjusted HR (95% CI) were 1.01 (0.981.03); 0.98 (0.96-1.01); 0.98 (0.95-1.02); 0.99 (0.97-1.02), respectively. Similarly, non-pleiotropic HDLc and LDLc gene scores showed no association with incident AF: HR (95% CI) = 1.00 (0.97-1.03); 1.01 (0.99-1.04). Conclusions In this large cohort study of individuals of European ancestry, gene scores for lipid fractions were not associated with incident AF.	[Norby, Faye L.; Lutsey, Pamela L.; Pankow, James S.; Alonso, Alvaro] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Adamsson Eryd, Samuel; Engstrom, Gunnar; Hindy, George; Orho-Melander, Marju; Rukh, Gull; Schulz, Christina-Alexandra; Smith, J. Gustav] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Niemeijer, Maartje N.; Eijgelsheim, Mark; Franco, Oscar H.; Heeringa, Jan; Hofman, Albert; Uitterlinden, Andre G.; Stricker, Bruno H. C.] Univ Med Ctr, Erasmus Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Rose, Lynda M.; Chasman, Daniel L.; Albert, Christine M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Prevent Med,Dept Med, Boston, MA 02115 USA; [Smith, Albert V.; Gudnason, Vilmundur] Iceland Heart Assoc, Res Inst, Kopavogur, Iceland; [Smith, Albert V.; Gudnason, Vilmundur] Univ Iceland, Reykjavik, Iceland; [Yin, Xiaoyan] Boston Univ, Sch Med, Dept Biostat, Cardiol Sect, Boston, MA 02118 USA; [Yin, Xiaoyan] Boston Univ, Sch Med, Dept Biostat, Prevent Med Sect, Boston, MA 02118 USA; [Agarwal, Sunil K.] Mt Sinai Heart Ctr, Icahn Sch Med, New York, NY USA; [Arking, Dan E.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD USA; [Chen, Lin Y.] Univ Minnesota, Sch Med, Cardiac Arrhythmia Ctr, Cardiovasc Div,Dept Med, Minneapolis, MN 55455 USA; [Eijgelsheim, Mark; Uitterlinden, Andre G.; Stricker, Bruno H. C.] Univ Med Ctr, Erasmus Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Magnani, Jared W.; Benjamin, Emelia J.] Boston Univ, Sch Med, Dept Med, Cardiol Sect, Boston, MA 02118 USA; [Magnani, Jared W.; Benjamin, Emelia J.] Boston Univ, Sch Med, Dept Med, Prevent Med Sect, Boston, MA 02118 USA; [Magnani, Jared W.; Benjamin, Emelia J.] NHLBI, Framingham, MA USA; [Magnani, Jared W.; Benjamin, Emelia J.] Boston Univ, Framingham Heart Study, Framingham, MA USA; [McManus, David D.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [McManus, David D.] Univ Massachusetts, Sch Med, Dept Quantitat Hlth Sci, Worcester, MA USA; [Albert, Christine M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med,Dept Med, Boston, MA 02115 USA; [Benjamin, Emelia J.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Smith, J. Gustav] Lund Univ, Dept Cardiol, Lund, Sweden; [Stricker, Bruno H. C.] Inspectorate Hlth Care, Utrecht, Netherlands	University of Minnesota System; University of Minnesota Twin Cities; Lund University; Erasmus University Rotterdam; Erasmus MC; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Icelandic Heart Association; University of Iceland; Boston University; Boston University; Icahn School of Medicine at Mount Sinai; Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities; Erasmus University Rotterdam; Erasmus MC; Boston University; Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Framingham Heart Study; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Boston University; Lund University	Norby, FL (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA.	flopez@umn.edu	Alonso, Alvaro/A-4917-2010; Gudnason, Vilmundur/AAE-7126-2019; Franco, Óscar H/ABE-2305-2020; Benjamin, Emelia/E-7103-2011; Norby, Faye/FNA-7255-2022; Smith, Albert Vernon/K-5150-2015	Alonso, Alvaro/0000-0002-2225-8323; Gudnason, Vilmundur/0000-0001-5696-0084; Franco, Óscar H/0000-0002-4606-4929; Benjamin, Emelia/0000-0003-4076-2336; Norby, Faye/0000-0002-1975-0405; Lutsey, Pamela/0000-0002-1572-1340; Smith, Albert Vernon/0000-0003-1942-5845; Albert, Christine/0000-0002-2081-1121; Hindy, George/0000-0002-7257-9299; Chen, Lin/0000-0002-0700-814X; Pankow, James/0000-0001-7076-483X	National Institutes of Health [N01-AG-12100]; NIA Intramural Research Program; Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); National Heart, Lung, and Blood Institute [HHSN268201 100005C, HHSN268201100006C, HSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN2682 01100010C, HHSN268201100011C, HHSN26820110 0012C, RC1HL 099452, RC1HL101056, HL 043851, HL 69757, HL099355]; American Heart Association [09SDG2280087]; National Heart, Lung and Blood Institute's Framingham Heart Study [N01-HC-25195]; Affymetrix, Inc [N02-HL-6-4278]; Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine; Boston Medical Center; Malmo city council; Swedish Cancer Society; Swedish Medical Research Council; Swedish Dairy association; Albert Pahlsson foundation; Gunnar Nilsson foundation; Swedish Heart-Lung foundation; Swedish Research Council; Crafoord foundation; Swedish National Health Service; Skane University Hospital; Netherlands Organisation of Scientific Research NWO Investments [175.010.2005.011, 911-03-012]; Research Institute for Diseases in the Elderly [014-93-015, RIDE2]; Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) [050-060-810]; Erasmus MC; Erasmus University Rotterdam; Netherlands Organisation for Scientific Research (NWO); Netherlands Organisation for Health Research and Development (ZonMw); Research Institute for Diseases in the Elderly (RIDE); Netherlands Genomics Initiative (NGI); Ministry of Education, Culture and Science; Ministry of Health Welfare and Sport; European Commission (DG XII); Municipality of Rotterdam; National Cancer Institute [CA 047988]; Donald W. Reynolds Foundation; Amgen; Harris Family Foundation; Watkin's Foundation;  [2R01 HL092577];  [1RO1 HL076784];  [1R01 AG028321];  [6R01-NS 17950];  [KL2RR031981];  [HL-093613]; NATIONAL CANCER INSTITUTE [R01CA047988, UM1CA182913] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001453] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR031981] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL101056, RC1HL099355, R21HL093613, RC1HL099452, U19HL069757, R01HL116690, U01HL069757, R01HL043851, R01HL076784, R01HL092577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028321, N01AG012100] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Hjartavernd (the Icelandic Heart Association); Althingi (the Icelandic Parliament); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); National Heart, Lung and Blood Institute's Framingham Heart Study(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Affymetrix, Inc; Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine; Boston Medical Center; Malmo city council; Swedish Cancer Society(Swedish Cancer Society); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Dairy association; Albert Pahlsson foundation; Gunnar Nilsson foundation; Swedish Heart-Lung foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord foundation; Swedish National Health Service; Skane University Hospital; Netherlands Organisation of Scientific Research NWO Investments(Netherlands Organization for Scientific Research (NWO)); Research Institute for Diseases in the Elderly; Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)Netherlands Government); Erasmus MC; Erasmus University Rotterdam; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Research Institute for Diseases in the Elderly (RIDE); Netherlands Genomics Initiative (NGI); Ministry of Education, Culture and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health Welfare and Sport; European Commission (DG XII)(European CommissionEuropean Commission Joint Research Centre); Municipality of Rotterdam; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Donald W. Reynolds Foundation; Amgen(Amgen); Harris Family Foundation; Watkin's Foundation; ; ; ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	AGES: The Age, Gene/Environment Susceptibility Reykjavik Study has been funded by National Institutes of Health contract N01-AG-12100, the NIA Intramural Research Program, Hjartavernd (the Icelandic Heart Association), and the Althingi (the Icelandic Parliament). ARIC: The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201 100005C, HHSN268201100006C, HSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN2682 01100010C, HHSN268201100011C, and HHSN26820110 0012C). This work was additionally funded by grants RC1HL 099452 and RC1HL101056 from National Heart, Lung, and Blood Institute and 09SDG2280087 from the American Heart Association. FHS: Framingham Heart Study research was conducted using data and resources from the National Heart Lung and Blood Institute of the National Institutes of Health and Boston University School of Medicine based on analyses by Framingham Heart Study investigators participating in the SNP Health Association Resource (SHARe) project. This work was supported by the National Heart, Lung and Blood Institute's Framingham Heart Study (Contract No. N01-HC-25195) and its contract with Affymetrix, Inc for genotyping services (Contract No. N02-HL-6-4278). A portion of this research utilized the Linux Cluster for Genetic Analysis (LinGA-II) funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center. Other support came from 2R01 HL092577, 1RO1 HL076784, 1R01 AG028321 (Benjamin), 6R01-NS 17950, And KL2RR031981 (McManus). MDCS: The Malmo Diet and Cancer study was made possible by grants from the Malmo city council, the Swedish Cancer Society, the Swedish Medical Research Council, the Swedish Dairy association, and the Albert Pahlsson and Gunnar Nilsson foundations. J. Gustav Smith was supported by the Swedish Heart-Lung foundation, the Swedish Research Council, the Crafoord foundation, governmental funding of clinical research within the Swedish National Health Service, and Skane University Hospital. RS: The generation and management of GWAS genotype data for the Rotterdam Study is supported by the Netherlands Organisation of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012). This study is funded by the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO) project nr. 050-060-810. The Rotterdam Study is supported by the Erasmus MC and Erasmus University Rotterdam; the Netherlands Organisation for Scientific Research (NWO); the Netherlands Organisation for Health Research and Development (ZonMw); the Research Institute for Diseases in the Elderly (RIDE); the Netherlands Genomics Initiative (NGI); the Ministry of Education, Culture and Science; the Ministry of Health Welfare and Sport; the European Commission (DG XII); and the Municipality of Rotterdam. WGHS: The Women's Genome Health Study is supported by HL 043851, HL 69757, HL099355 from the National Heart, Lung, and Blood Institute and CA 047988 from the National Cancer Institute, the Donald W. Reynolds Foundation with collaborative scientific support and funding for genotyping provided by Amgen. AF endpoint confirmation was supported by HL-093613 and a grant from the Harris Family Foundation and Watkin's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso A, 2014, J AM HEART ASS, P3; Alonso A, 2009, AM HEART J, V158, P111, DOI 10.1016/j.ahj.2009.05.010; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Balse E, 2009, P NATL ACAD SCI USA, V106, P14681, DOI 10.1073/pnas.0902809106; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Brion MJA, 2013, INT J EPIDEMIOL, V42, P1497, DOI 10.1093/ije/dyt179; Chamberlain AM, 2010, AM HEART J, V159, P850, DOI 10.1016/j.ahj.2010.02.005; Duntas LH, 2012, MED CLIN N AM, V96, P269, DOI 10.1016/j.mcna.2012.01.012; Ellinor PT, 2012, NAT GENET, V44, P670, DOI 10.1038/ng.2261; FEINLEIB M, 1975, PREV MED, V4, P518, DOI 10.1016/0091-7435(75)90037-7; Harris TB, 2007, AM J EPIDEMIOL, V165, P1076, DOI 10.1093/aje/kwk115; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Hofman A, 2013, EUR J EPIDEMIOL, V28, P889, DOI 10.1007/s10654-013-9866-z; Iguchi Y, 2010, AM J CARDIOL, V106, P1129, DOI 10.1016/j.amjcard.2010.06.030; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Lewis SJ, 2010, CIRC-CARDIOVASC GENE, V3, P109, DOI 10.1161/CIRCGENETICS.109.880955; Lopez FL, 2012, CIRC-ARRHYTHMIA ELEC, V5, P155, DOI 10.1161/CIRCEP.111.966804; Lubitz SA, 2014, J AM COLL CARDIOL, V63, P1200, DOI 10.1016/j.jacc.2013.12.015; Lutsey PL, 2012, CIRC-CARDIOVASC GENE, V5, P73, DOI 10.1161/CIRCGENETICS.111.959619; Miyasaka Y, 2007, J AM COLL CARDIOL, V49, P986, DOI 10.1016/j.jacc.2006.10.062; Mora S, 2014, CIRC-ARRHYTHMIA ELEC, V7, P612, DOI 10.1161/CIRCEP.113.001378; Psaty BM, 1997, CIRCULATION, V96, P2455; Rasmussen-Torvik LJ, 2010, GENET EPIDEMIOL, V34, P665, DOI 10.1002/gepi.20525; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Sanoski CA, 2010, AM J HEALTH-SYST PH, V67, pS11, DOI 10.2146/ajhp100148; Smith JG, 2010, EUR J EPIDEMIOL, V25, P95, DOI 10.1007/s10654-009-9404-1; Smith JG, 2014, JAMA; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Voight BF, 2012, LANCET, V380, P572, DOI 10.1016/S0140-6736(12)60312-2; Wang TJ, 2004, JAMA-J AM MED ASSOC, V292, P2471, DOI 10.1001/jama.292.20.2471; Watanabe H, 2011, CIRC J, V75, P2767, DOI 10.1253/circj.CJ-11-0780; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	34	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151932	10.1371/journal.pone.0151932	http://dx.doi.org/10.1371/journal.pone.0151932			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999784	Green Published, Green Submitted, gold			2022-12-26	WOS:000372694700087
J	Rizk, SM; Shahin, NN; Shaker, OG				Rizk, Sherine M.; Shahin, Nancy N.; Shaker, Olfat G.			Association between SIRT1 Gene Polymorphisms and Breast Cancer in Egyptians	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; PROGNOSTIC VALUE; POOR-PROGNOSIS; EXPRESSION; SIRTUINS; DEACETYLASE; METASTASIS; PROMOTER; DBC1	Background Breast cancer is reported to cause the highest mortality among female cancer patients. Previous studies have explored the association of silent mating-type information regulator 2 homolog 1 (SIRT1) gene expression with prognosis in breast cancer. However, no studies exist, so far, on the role of SIRT1 gene polymorphism in breast cancer risk or prognosis. The present study aimed to assess the association between SIRT1 gene polymorphisms and breast cancer in Egyptians. Methods The study comprised 980 Egyptian females divided into a breast cancer group (541 patients) and a healthy control group (439 subjects). SIRT1 gene single nucleotide polymorphisms (SNPs) rs3758391, rs3740051 and rs12778366 were genotyped using real-time polymerase chain reaction (RT-PCR). Allelic and genotypic frequencies were determined in both groups and association with breast cancer and clinicopathological characteristics was assessed. Results Breast cancer patients exhibited elevated serum SIRT1 levels which varied among different tumor grades. SIRT1 rs3758391 and rs12778366 TT genotypes were more frequent, exhibited higher SIRT1 levels than CC and CT genotypes and were associated with histologic grade and lymph node status. SIRT1 rs12778366 TT genotype also correlated with negative estrogen receptor (ER) and progesterone receptor (PR) statuses. The T allele frequency for both SNPs was higher in breast cancer patients than in normal subjects. Combined GG and AG genotypes of rs3740051 were more frequent, showed higher serum SIRT1 levels than the AA genotype, and were associated with ER and PR expression. Furthermore, inheritance of the G allele was associated with breast cancer. Conclusions Our findings reveal that rs3758391 and rs12778366 polymorphisms of SIRT1 gene are associated with breast cancer risk and prognosis in the Egyptian population.	[Rizk, Sherine M.; Shahin, Nancy N.] Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt; [Shaker, Olfat G.] Cairo Univ, Fac Med, Dept Med Biochem & Mol Biol, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Shahin, NN (corresponding author), Cairo Univ, Fac Pharm, Dept Biochem, Cairo, Egypt.	nancy.shahin@pharma.cu.edu.eg	O, Shaker/Y-6125-2019; Shaker, Olfat G/S-2010-2017; Issa, Randa @M.T/E-7144-2019; Shahin, Nancy Nabil/I-5318-2019	O, Shaker/0000-0002-3031-3599; Issa, Randa @M.T/0000-0003-0619-1234; Shahin, Nancy Nabil/0000-0002-9746-5335				BABSON AL, 1966, CLIN CHEM, V12, P482; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Bradbury C, 2005, LEUKEMIA, V19, P1751, DOI 10.1038/sj.leu.2403910; Byler S, 2014, ANTICANCER RES, V34, P1071; Cao YW, 2015, INT J CLIN EXP MED, V8, P616; Cao YW, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0097-2; Cha EJ, 2009, CLIN CANCER RES, V15, P4453, DOI 10.1158/1078-0432.CCR-08-3329; Chen HC, 2012, ANN SURG ONCOL, V19, P2011, DOI 10.1245/s10434-011-2159-4; Chen WY, 2013, CURR OPIN HEMATOL, V20, P308, DOI 10.1097/MOH.0b013e328360ab64; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Choi HN, 2011, ONCOL REP, V26, P503, DOI 10.3892/or.2011.1301; Chong ZZ, 2012, FUTUR CARDIOL, V8, P89, DOI [10.2217/FCA.11.76, 10.2217/fca.11.76]; Clark-Knowles KV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082106; Consiglio CR, 2014, MOL BIOL REP, V41, P4233, DOI 10.1007/s11033-014-3294-3; Cruz M, 2010, DIABETES-METAB RES, V26, P261, DOI 10.1002/dmrr.1082; Dali-Youcef N, 2007, ANN MED, V39, P335, DOI 10.1080/07853890701408194; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Figarska SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058636; Gabay O, 2012, JOINT BONE SPINE, V79, P570, DOI 10.1016/j.jbspin.2012.04.005; Genestie C, 1998, ANTICANCER RES, V18, P571; Hamdy SI, 2002, BRIT J CLIN PHARMACO, V53, P596, DOI 10.1046/j.1365-2125.2002.01604.x; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, P907, DOI [10.1043/1543-2165-134.6.907, 10.1200/JCO.2009.25.6529, 10.1200/JOP.777003]; Hu YY, 2015, J ATHEROSCLER THROMB, V22, P165, DOI 10.5551/jat.24844; Huffman DM, 2007, CANCER RES, V67, P6612, DOI 10.1158/0008-5472.CAN-07-0085; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jendrassik L, 1938, BIOCHEM Z, V297, P81; Kilic U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090428; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Lee H, 2011, HUM PATHOL, V42, P204, DOI 10.1016/j.humpath.2010.05.023; Li Kai, 2011, N Am J Med Sci (Boston), V4, P104; Lim CS, 2007, CELL BIOL INT, V31, P636, DOI 10.1016/j.cellbi.2006.11.003; Lim CS, 2006, MED HYPOTHESES, V67, P341, DOI 10.1016/j.mehy.2006.01.050; Maeda S, 2011, CLIN EXP NEPHROL, V15, P381, DOI 10.1007/s10157-011-0418-0; McBurney Michael W, 2013, Genes Cancer, V4, P125, DOI 10.1177/1947601912474893; Naqvi A, 2010, HUM MOL GENET, V19, P4123, DOI 10.1093/hmg/ddq331; Ozcelik T, 2010, NAT GENET, V42, P641, DOI 10.1038/ng0810-641; Rai E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048621; REITMAN S, 1957, AM J CLIN PATHOL, V28, P56, DOI 10.1093/ajcp/28.1.56; Rizk SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114560; Roth M, 2014, ONCOGENE, V33, P1609, DOI 10.1038/onc.2013.120; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Shahin MHA, 2011, PHARMACOGENET GENOM, V21, P130, DOI 10.1097/FPC.0b013e3283436b86; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Stuenkel Walter, 2007, Biotechnology Journal, V2, P1360, DOI 10.1002/biot.200700087; Sung JY, 2010, CANCER SCI, V101, P1738, DOI 10.1111/j.1349-7006.2010.01573.x; Suzuki K, 2012, ONCOL REP, V27, P1726, DOI 10.3892/or.2012.1750; Teo YY, 2010, CURR OPIN LIPIDOL, V21, P104, DOI 10.1097/MOL.0b013e3283369e5b; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wu MQ, 2012, MED ONCOL, V29, P3240, DOI 10.1007/s12032-012-0260-6; Zhang T, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-351	51	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151901	10.1371/journal.pone.0151901	http://dx.doi.org/10.1371/journal.pone.0151901			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999517	Green Published, gold, Green Submitted			2022-12-26	WOS:000372694700083
J	Wang, AJ; Li, Y; Zhang, M; Chen, Q				Wang, Aijun; Li, You; Zhang, Ming; Chen, Qi			The Role of Parieto-Occipital Junction in the Interaction between Dorsal and Ventral Streams in Disparity-Defined Near and Far Space Processing	PLOS ONE			English	Article							AREA V6; SOMATOSENSORY CELLS; STEREOSCOPIC DEPTH; FMRI REVEALS; MACAQUE; CORTEX; BRAIN; SENSITIVITY; NEURONS; SIZE	Neuropsychological and functional MRI data suggest that two functionally and anatomically dissociable streams of visual processing exist: a ventral perception-related stream and a dorsal action-related stream. However, relatively little is known about how the two streams interact in the intact brain during the production of adaptive behavior. Using functional MRI and a virtual three-dimensional paradigm, we aimed at examining whether the parieto-occipital junction (POJ) acts as an interface for the integration and processing of information between the dorsal and ventral streams in the near and far space processing. Virtual reality three-dimensional near and far space was defined by manipulating binocular disparity, with -68.76 arcmin crossed disparity for near space and +68.76 arcmin uncrossed disparity for near space. Our results showed that the POJ and bilateral superior occipital gyrus (SOG) showed relative increased activity when responded to targets presented in the near space than in the far space, which was independent of the retinotopic and perceived sizes of target. Furthermore, the POJ showed the enhanced functional connectivity with both the dorsal and ventral streams during the far space processing irrespective of target sizes, supporting that the POJ acts as an interface between the dorsal and ventral streams in disparity-defined near and far space processing. In contrast, the bilateral SOG showed the enhanced functional connectivity only with the ventral stream if retinotopic sizes of targets in the near and far spaces were matched, which suggested there was a functional dissociation between the POJ and bilateral SOG.	[Wang, Aijun; Li, You; Chen, Qi] S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou 510631, Guangdong, Peoples R China; [Wang, Aijun; Li, You; Chen, Qi] S China Normal Univ, Sch Psychol, Guangzhou 510631, Guangdong, Peoples R China; [Chen, Qi] S China Normal Univ, Guangdong Key Lab Mental Hlth & Cognit Sci, Guangzhou 510631, Guangdong, Peoples R China; [Chen, Qi] Guangdong 999 Brain Hosp, Epilepsy Ctr, Guangzhou 510510, Guangdong, Peoples R China; [Wang, Aijun; Zhang, Ming] Soochow Univ, Dept Psychol, Suzhou 215123, Peoples R China	South China Normal University; South China Normal University; South China Normal University; Soochow University - China	Chen, Q (corresponding author), S China Normal Univ, Ctr Studies Psychol Applicat, Guangzhou 510631, Guangdong, Peoples R China.; Chen, Q (corresponding author), S China Normal Univ, Sch Psychol, Guangzhou 510631, Guangdong, Peoples R China.; Chen, Q (corresponding author), S China Normal Univ, Guangdong Key Lab Mental Hlth & Cognit Sci, Guangzhou 510631, Guangdong, Peoples R China.; Chen, Q (corresponding author), Guangdong 999 Brain Hosp, Epilepsy Ctr, Guangzhou 510510, Guangdong, Peoples R China.	qi.chen27@gmail.com			Natural Science Foundation of China [31371127, 31371025]; Program for New Century Excellent Talents in the University of China [NCET-12-0645]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Fundamental Research Funds for the Central Universities [14ZZ1202]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in the University of China(Program for New Century Excellent Talents in University (NCET)); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The work was supported by grants from Natural Science Foundation of China (31371127, 31371025). QC is supported by the Program for New Century Excellent Talents in the University of China (NCET-12-0645) and by the Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (2014). AW is supported by the Fundamental Research Funds for the Central Universities (14ZZ1202).	Astafiev SV, 2003, J NEUROSCI, V23, P4689; Berti A, 2000, J COGNITIVE NEUROSCI, V12, P415, DOI 10.1162/089892900562237; Blanke O, 2003, EUR J NEUROSCI, V18, P709, DOI 10.1046/j.1460-9568.2003.02771.x; Bremmer F, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00008; Breveglieri R, 2006, J NEUROSCI, V26, P3679, DOI 10.1523/JNEUROSCI.4637-05.2006; Breveglieri R, 2002, NEUROREPORT, V13, P2113, DOI 10.1097/00001756-200211150-00024; Cacola P., 2013, J IMAGERY RES SPORT, V8, P55, DOI [10.1515/jirspa-2013-0003, DOI 10.1515/JIRSPA-2013-0003]; Cardin V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047685; Cardin V, 2011, J NEUROPHYSIOL, V106, P1240, DOI 10.1152/jn.01120.2010; Cavina-Pratesi C, 2010, J NEUROSCI, V30, P10306, DOI 10.1523/JNEUROSCI.2023-10.2010; Chen Q, 2012, J COGNITIVE NEUROSCI, V24, P2223, DOI 10.1162/jocn_a_00260; Chen Q, 2012, J NEUROSCI, V32, P13352, DOI 10.1523/JNEUROSCI.1772-12.2012; Connolly JD, 2003, EXP BRAIN RES, V153, P140, DOI 10.1007/s00221-003-1587-1; de Jong BM, 2001, NEUROIMAGE, V14, P1128, DOI 10.1006/nimg.2001.0911; Fang F, 2008, CURR BIOL, V18, P1707, DOI 10.1016/j.cub.2008.09.025; Farne A, 2005, NEUROPSYCHOLOGIA, V43, P238, DOI 10.1016/j.neuropsychologia.2004.11.010; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Galletti C, 2005, EUR J NEUROSCI, V21, P959, DOI 10.1111/j.1460-9568.2005.03911.x; Galletti C, 2003, EXP BRAIN RES, V153, P158, DOI 10.1007/s00221-003-1589-z; Galletti C, 1997, EUR J NEUROSCI, V9, P410, DOI 10.1111/j.1460-9568.1997.tb01410.x; Galletti C, 1996, EUR J NEUROSCI, V8, P30, DOI 10.1111/j.1460-9568.1996.tb01165.x; Galletti C, 2001, EUR J NEUROSCI, V13, P1572, DOI 10.1046/j.0953-816x.2001.01538.x; Galletti C, 1999, EUR J NEUROSCI, V11, P3922, DOI 10.1046/j.1460-9568.1999.00817.x; Gallivan JP, 2009, J NEUROSCI, V29, P4381, DOI 10.1523/JNEUROSCI.0377-09.2009; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Hari R, 1997, TRENDS NEUROSCI, V20, P44, DOI 10.1016/S0166-2236(96)10065-5; Haxby JV, 1999, NEURON, V22, P189, DOI 10.1016/S0896-6273(00)80690-X; Iriki A, 1996, NEUROREPORT, V7, P2325; Legrand D, 2007, CONSCIOUS COGN, V16, P687, DOI 10.1016/j.concog.2007.06.003; Liu Q, 2009, NEUROREPORT, V20, P809, DOI 10.1097/WNR.0b013e32832be7c0; Luppino G, 2005, EUR J NEUROSCI, V21, P3056, DOI 10.1111/j.1460-9568.2005.04149.x; Maravita A, 2001, NEUROPSYCHOLOGIA, V39, P580, DOI 10.1016/S0028-3932(00)00150-0; MENNEMEIER M, 1992, BRAIN, V115, P37, DOI 10.1093/brain/115.1.37; Milner A. D., 1995, VISUAL BRAIN ACTION; Murray SO, 2006, NAT NEUROSCI, V9, P429, DOI 10.1038/nn1641; Nichols T, 2005, NEUROIMAGE, V25, P653, DOI 10.1016/j.neuroimage.2004.12.005; Patten ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140696; Pellijeff A, 2006, NEUROPSYCHOLOGIA, V44, P2685, DOI 10.1016/j.neuropsychologia.2006.01.009; Pitzalis S, 2013, NEUROIMAGE, V82, P517, DOI 10.1016/j.neuroimage.2013.06.026; Pitzalis S, 2006, J NEUROSCI, V26, P7962, DOI 10.1523/JNEUROSCI.0178-06.2006; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; Prado J, 2005, NEURON, V48, P849, DOI 10.1016/j.neuron.2005.10.010; PREVIC FH, 1990, BEHAV BRAIN SCI, V13, P519, DOI 10.1017/S0140525X00080018; Previc FH, 1998, PSYCHOL BULL, V124, P123, DOI 10.1037/0033-2909.124.2.123; Quinlan DJ, 2007, NEUROIMAGE, V36, P167, DOI 10.1016/j.neuroimage.2007.02.029; Rossit S, 2013, CORTEX, V49, P2525, DOI 10.1016/j.cortex.2012.12.014; ROY JP, 1990, NATURE, V348, P160, DOI 10.1038/348160a0; ROY JP, 1992, J NEUROSCI, V12, P2478; Shmuelof L, 2005, NEURON, V47, P457, DOI 10.1016/j.neuron.2005.06.034; Smith AT, 2008, J VISION, V8, DOI 10.1167/8.10.1; Stiers P, 2006, NEUROIMAGE, V29, P74, DOI 10.1016/j.neuroimage.2005.07.033; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Vuilleumier P, 1998, ANN NEUROL, V43, P406, DOI 10.1002/ana.410430324; Weiss PH, 2003, NEUROIMAGE, V18, P837, DOI 10.1016/S1053-8119(03)00018-1; Weiss PH, 2000, BRAIN, V123, P2531, DOI 10.1093/brain/123.12.2531; ZEKI S, 1986, J PHYSIOL-LONDON, V381, pP62	58	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151838	10.1371/journal.pone.0151838	http://dx.doi.org/10.1371/journal.pone.0151838			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999674	Green Published, Green Submitted, gold			2022-12-26	WOS:000372694700070
J	Ilczyszyn, WM; Sabat, AJ; Akkerboom, V; Szkarlat, A; Klepacka, J; Sowa-Sierant, I; Wasik, B; Kosecka-Strojek, M; Buda, A; Miedzobrodzki, J; Friedrich, AW				Ilczyszyn, Weronika M.; Sabat, Artur J.; Akkerboom, Viktoria; Szkarlat, Anna; Klepacka, Joanna; Sowa-Sierant, Iwona; Wasik, Barbara; Kosecka-Strojek, Maja; Buda, Aneta; Miedzobrodzki, Jacek; Friedrich, Alexander W.			Clonal Structure and Characterization of Staphylococcus aureus Strains from Invasive Infections in Paediatric Patients from South Poland: Association between Age, spa Types, Clonal Complexes, and Genetic Markers	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; NEONATOLOGY SURVEILLANCE NETWORK; LOW-LEVEL RESISTANCE; INTENSIVE-CARE-UNIT; METHICILLIN-RESISTANT; MOLECULAR CHARACTERIZATION; NASAL CARRIAGE; CHILDREN; COMMUNITY; EPIDEMIOLOGY	The aim of current study was to examine clonal structure and genetic profile of invasive Staphylococcus aureus isolates recovered from infants and children treated at the Jagiellonian University Children's Hospital of Krakow, Poland. The 107 invasive S. aureus isolates, collected between February 2012 and August 2014, were analysed retrospectively. Antimicrobial susceptibility testing, spa typing and DNA microarray analysis were performed to determine clonal distribution, diversity and gene content in regard to patients characteristics. In total, 107 isolates were recovered from 88 patients with clinical symptoms of invasive bacterial infection. The final set of 92 non-duplicate samples included 38 MRSA isolates. Additionally, a set of 54 S. aureus isolates collected during epidemiological screening was genotyped and analysed. There were 72 healthcare-associated (HCA) and 20 community-onset (CO) infection events caused by 33 and 5 MRSA isolates, respectively. The majority of isolates were affiliated with the major European clonal complexes CC5 (t003, spa-CC 002), CC45 (spa-CC 015), CC7 or CC15 (t084, t091, spa-CC 084). Two epidemic clones (CC5-MRSA-II or CC45-MRSA-IV) dominated among MRSA isolates, while MSSA population contained 15 different CCs. The epidemiological screening isolates belonged to similar genetic lineages as those collected from invasive infection cases. The HCA infection events, spa types t003, t2642 or CC5 were significantly associated with infections occurring in neonates and children under 5 years of age. Moreover, carriage of several genetic markers, including erm(A), sea (N315), egc-cluster, chp was significantly higher in isolates obtained from children in this age group. The spa types t091 and t008 were underrepresented among patients aged 5 years or younger, whereas spa type t008, CC8 and presence of splE was associated with infection in children aged 10 years or older. The HCA-MRSA strains were most frequently found in children under 5 years, although the majority of invasive infections was associated with MSSA strains. Moreover, an association between age group of children from the study population and a specific strain genotype (spa type, clonal complex or genetic content) was observed among the patients.	[Ilczyszyn, Weronika M.; Kosecka-Strojek, Maja; Buda, Aneta; Miedzobrodzki, Jacek] Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Sabat, Artur J.; Akkerboom, Viktoria; Friedrich, Alexander W.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [Szkarlat, Anna; Klepacka, Joanna; Sowa-Sierant, Iwona; Wasik, Barbara] Jagiellonian Univ, Childrens Univ Hosp, Dept Clin Microbiol, Krakow, Poland	Jagiellonian University; University of Groningen; Jagiellonian University	Miedzobrodzki, J (corresponding author), Jagiellonian Univ, Dept Microbiol, Fac Biochem Biophys & Biotechnol, Krakow, Poland.	jacek.miedzobrodzki@uj.edu.pl	Kosecka-Strojek, Maja/W-2624-2018; Międzobrodzki, Jacek/U-4353-2018; Friedrich, Alex/ABG-9823-2020	Kosecka-Strojek, Maja/0000-0001-8337-6975; Międzobrodzki, Jacek/0000-0003-4252-880X; 	Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University in Krakow, Leading National Research Center (KNOW) - Ministry of Science and Higher Education in Poland	Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University in Krakow, Leading National Research Center (KNOW) - Ministry of Science and Higher Education in Poland	This work was funded by the Faculty of Biochemistry, Biophysics and Biotechnology of the Jagiellonian University in Krakow, which is a part of the Leading National Research Center (KNOW) supported by the Ministry of Science and Higher Education in Poland.	Aires-de-Sousa M, 2006, J CLIN MICROBIOL, V44, P619, DOI 10.1128/JCM.44.2.619-621.2006; Albrich WC, 2008, LANCET INFECT DIS, V8, P289, DOI 10.1016/S1473-3099(08)70097-5; Anantha Ram Venkatesh, 2014, CMAJ Open, V2, pE352, DOI 10.9778/cmajo.20140018; Argudin MA, 2012, APPL ENVIRON MICROB, V78, P2930, DOI 10.1128/AEM.07487-11; Ascher SB, 2012, EARLY HUM DEV, V88, pS92, DOI 10.1016/S0378-3782(12)70025-7; Barrado L, 2014, J INFECTION, V68, P195, DOI 10.1016/j.jinf.2013.10.001; Becker K, 2003, J CLIN MICROBIOL, V41, P1434, DOI 10.1128/JCM.41.4.1434-1439.2003; Blomfeldt A, 2013, J CLIN MICROBIOL, V51, P345, DOI 10.1128/JCM.02571-12; Bonnal C, 2015, MED MALADIES INFECT, V45, P84, DOI 10.1016/j.medmal.2015.01.002; Britton PN, 2013, J PAEDIATR CHILD H, V49, P754, DOI 10.1111/jpc.12255; Calderwood MS, 2014, J INFECT DIS, V209, P571, DOI 10.1093/infdis/jit501; Cassat JE, 2005, J BACTERIOL, V187, P576, DOI 10.1128/JB.187.2.576-592.2005; Chen X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072811; Chung JW, 2014, DIAGN MICR INFEC DIS, V79, P119, DOI 10.1016/j.diagmicrobio.2014.03.009; de Sousa MA, 2005, J CLIN MICROBIOL, V43, P5150, DOI 10.1128/JCM.43.10.5150-5157.2005; Deurenberg RH, 2009, DIAGN MICR INFEC DIS, V65, P116, DOI 10.1016/j.diagmicrobio.2009.07.007; Dramowski A, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0354-3; Garcia C, 2016, EUR J CLIN MICROBIOL, V35, P89, DOI 10.1007/s10096-015-2512-9; Ghasemian Abdolmajid, 2015, Iran J Pathol, V10, P258; Gomes RT, 2013, BRAZ J INFECT DIS, V17, P573, DOI 10.1016/j.bjid.2013.02.010; Gradel KO, 2014, CLIN EPIDEMIOL, V6, P301, DOI 10.2147/CLEP.S66998; Grundmann H, 2014, EURO SURVEILL B EUR, V19; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Hamer DH, 2015, PEDIATR INFECT DIS J, V34, pE1, DOI 10.1097/INF.0000000000000549; Helbin WM, 2012, POSTEP MIKROBIOL, V51, P291; Hudson LO, 2012, J CLIN MICROBIOL, V50, P573, DOI 10.1128/JCM.05336-11; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Kinnevey PM, 2014, ANTIMICROB AGENTS CH, V58, P1907, DOI 10.1128/AAC.02653-13; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Kupferschmidt K, 2012, SCIENCE, V338, P1019, DOI 10.1126/science.338.6110.1019; Laupland KB, 2013, CLIN MICROBIOL INFEC, V19, P465, DOI 10.1111/j.1469-0691.2012.03903.x; Leclercq R, 2013, Clin Microbiol Infect, V19, P141, DOI 10.1111/j.1469-0691.2011.03703.x; Li HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053341; Li SP, 2015, APMIS, V123, P28, DOI 10.1111/apm.12304; Li T, 2013, EPIDEMIOL INFECT, V141, P2158, DOI 10.1017/S0950268812002919; Lindsay JA, 1998, MOL MICROBIOL, V29, P527, DOI 10.1046/j.1365-2958.1998.00947.x; Luedicke C, 2010, EUR J CLIN MICROBIOL, V29, P457, DOI 10.1007/s10096-010-0884-4; Luthander J, 2013, ACTA PAEDIATR, V102, P182, DOI 10.1111/apa.12077; Luxner J, 2014, DIAGN MICR INFEC DIS, V78, P153, DOI 10.1016/j.diagmicrobio.2013.10.010; McNeil JC, 2014, INFECT DRUG RESIST, V7, P117, DOI 10.2147/IDR.S39639; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2009, EUR J CLIN MICROBIOL, V28, P1159, DOI 10.1007/s10096-009-0752-2; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Monecke S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097833; Nakao A, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-14; Netsvyetayeva I, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-128; Nowrouzian FL, 2015, EUR J CLIN MICROBIOL, V34, P1443, DOI 10.1007/s10096-015-2371-4; Park DA, 2013, INFECT CHEMOTHER, V45, P202, DOI 10.3947/ic.2013.45.2.202; Peacock SJ, 2002, INFECT IMMUN, V70, P4987, DOI 10.1128/IAI.70.9.4987-4996.2002; Peton V, 2014, INFECT GENET EVOL, V21, P602, DOI 10.1016/j.meegid.2013.08.011; Polin RA, 2012, PEDIATRICS, V129, P1104, DOI 10.1542/peds.2012-0147; Post V, 2014, INT J MED MICROBIOL, V304, P565, DOI 10.1016/j.ijmm.2014.03.003; Powers ME, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003871; Qiao YH, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0582-4; Rasmussen G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114276; Rasmussen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077477; Regev-Yochay G, 2005, EMERG INFECT DIS, V11, P453, DOI 10.3201/eid1103.040470; Rello J, 2010, INFECT DIS CRITICAL; Rijnders MIA, 2009, J CLIN MICROBIOL, V47, P4090, DOI 10.1128/JCM.00820-09; Rojo A, 2014, EUR J CLIN MICROBIOL, V33, P651, DOI 10.1007/s10096-013-2000-z; Rolo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034768; Romaniszyn D, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0890-3; Rooijakkers SHM, 2006, CELL MICROBIOL, V8, P1282, DOI 10.1111/j.1462-5822.2006.00709.x; Ruffing U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052487; Sa-Leao R, 1999, J CLIN MICROBIOL, V37, P1913; Sangvik M, 2011, J CLIN MICROBIOL, V49, P4213, DOI 10.1128/JCM.05290-11; Satta Giovanni, 2013, BMC Res Notes, V6, P398, DOI 10.1186/1756-0500-6-398; Schaumburg F, 2012, J CLIN MICROBIOL, V50, P3186, DOI 10.1128/JCM.01174-12; Schulte B, 2013, J CLIN MICROBIOL, V51, P212, DOI 10.1128/JCM.01967-12; Shane AL, 2014, J INFECTION, V68, pS24, DOI 10.1016/j.jinf.2013.09.011; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vanderkooi OG, 2011, PAED CHILD HEALT-CAN, V16, P276, DOI 10.1093/pch/16.5.276; Vergnano S, 2011, PEDIATR INFECT DIS J, V30, P850, DOI 10.1097/INF.0b013e318224546d; Verkaik NJ, 2010, CLIN MICROBIOL INFEC, V16, P1312, DOI 10.1111/j.1469-0691.2009.03073.x; Wannet WJB, 2004, J CLIN MICROBIOL, V42, P3077, DOI 10.1128/JCM.42.7.3077-3082.2004; Wehrhahn MC, 2012, J INFECT DIS, V205, P1840, DOI 10.1093/infdis/jis279; Wisniewska K, 2012, FOLIA MICROBIOL, V57, P243, DOI 10.1007/s12223-012-0148-z; Witte Wolfgang, 1997, Clin Microbiol Infect, V3, P414, DOI 10.1111/j.1469-0691.1997.tb00277.x; Wojkowska-Mach J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-339; Yu FY, 2012, DIAGN MICR INFEC DIS, V74, P363, DOI 10.1016/j.diagmicrobio.2012.08.015	81	23	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151937	10.1371/journal.pone.0151937	http://dx.doi.org/10.1371/journal.pone.0151937			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992009	gold, Green Published, Green Submitted			2022-12-26	WOS:000372582800119
J	Park, SH; Lee, SI; Ricke, SC				Park, Si Hong; Lee, Sang In; Ricke, Steven C.			Microbial Populations in Naked Neck Chicken Ceca Raised on Pasture Flock Fed with Commercial Yeast Cell Wall Prebiotics via an Illumina MiSeq Platform	PLOS ONE			English	Article							INTESTINAL BACTERIAL COMMUNITY; SACCHAROMYCES-CEREVISIAE; POULTRY PRODUCTION; BROILER-CHICKENS; GASTROINTESTINAL-TRACT; MUCOSA DEVELOPMENT; FED DIETS; PERFORMANCE; IDENTIFICATION; MICROFLORA	Prebiotics are non-digestible carbohydrate dietary supplements that selectively stimulate the growth of one or more beneficial bacteria in the gastrointestinal tract of the host. These bacteria can inhibit colonization of pathogenic bacteria by producing antimicrobial substances such as short chain fatty acids (SCFAs) and competing for niches with pathogens within the gut. Pasture flock chickens are generally raised outdoors with fresh grass, sunlight and air, which represents different environmental growth conditions compared to conventionally raised chickens. The purpose of this study was to evaluate the difference in microbial populations from naked neck chicken ceca fed with commercial prebiotics derived from brewer's yeast cell wall via an Illumina MiSeq platform. A total of 147 day-of-hatch naked neck chickens were distributed into 3 groups consisted of 1) C: control (no prebiotic), 2) T1: Biolex (R) MB40 with 0.2%, and 3) T2: Leiber (R) ExCel with 0.2%, consistently supplemented prebiotics during the experimental period. At 8 weeks, a total of 15 birds from each group were randomly selected and ceca removed for DNA extraction. The Illumina Miseq platform based on V4 region of 16S rRNA gene was applied for microbiome analysis. Both treatments exhibited limited impact on the microbial populations at the phylum level, with no significant differences in the OTU number of Bacteroidetes among groups and an increase of Proteobacteria OTUs for the T1 (Biolex (R) MB40) group. In addition there was a significant increase of genus Faecalibacterium OTU, phylum Firmicutes. According to the development of next generation sequencing (NGS), microbiome analysis based on 16S rRNA gene proved to be informative on the prebiotic impact on poultry gut microbiota in pasture-raised naked neck birds.	[Park, Si Hong; Lee, Sang In; Ricke, Steven C.] Univ Arkansas, Dept Food Sci, Ctr Food Safety, Fayetteville, AR 72704 USA; [Lee, Sang In; Ricke, Steven C.] Univ Arkansas, Cellular & Mol Biol Grad Program, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Ricke, SC (corresponding author), Univ Arkansas, Dept Food Sci, Ctr Food Safety, Fayetteville, AR 72704 USA.; Ricke, SC (corresponding author), Univ Arkansas, Cellular & Mol Biol Grad Program, Fayetteville, AR 72701 USA.	sricke@uark.edu			Leiber GmbH, Hafenstrasse, Germany	Leiber GmbH, Hafenstrasse, Germany	Research funding was awarded to author SCR and from Leiber GmbH (http://www.leibergmbh.de/), Hafenstrasse, Germany. Leiber GmbH played a role in initial phases of the project and the editing of the publication but had no additional role in final study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMS/USDA, 2008, NAT ORG PROGR; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chon JW, 2012, POULTRY SCI, V91, P2382, DOI 10.3382/ps.2011-01980; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; Deusch S, 2015, COMPUT STRUCT BIOTEC, V13, P55, DOI 10.1016/j.csbj.2014.12.005; Diaz-Sanchez S, 2013, POULTRY SCI, V92, P562, DOI 10.3382/ps.2012-02741; Ding GZ, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-24; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Fanatico AC, 2009, J APPL POULTRY RES, V18, P355, DOI 10.3382/japr.2008-00123; Fanatico AC, 2005, POULTRY SCI, V84, P1785, DOI 10.1093/ps/84.11.1785; Gabriel I, 2006, WORLD POULTRY SCI J, V62, P499, DOI 10.1017/S0043933906001115; Gao J, 2008, POULTRY SCI, V87, P1377, DOI 10.3382/ps.2007-00418; Hanning I, 2012, POULTRY SCI, V91, P3295, DOI 10.3382/ps.2012-02557; Hooge D. M., 2004, International Journal of Poultry Science, V3, P163; Jones FT, 2003, POULTRY SCI, V82, P613, DOI 10.1093/ps/82.4.613; Jozefiak D, 2008, J ANIM FEED SCI, V17, P392, DOI 10.22358/jafs/66633/2008; Kohl KD, 2012, J COMP PHYSIOL B, V182, P591, DOI 10.1007/s00360-012-0645-z; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Line J. E., 2005, International Journal of Poultry Science, V4, P81; Lu JR, 2003, APPL ENVIRON MICROB, V69, P6816, DOI 10.1128/AEM.69.11.6816-6824.2003; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Meng H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089862; Morales-Lopez R, 2009, POULTRY SCI, V88, P601, DOI 10.3382/ps.2008-00298; Newman K., 1994, Biotechnology in the feed industry. Proceedings of Alltech's 10th Annual Symposium, P167; Oakley BB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057190; Oakley BB, 2012, FEMS MICROBIOL ECOL, V79, P327, DOI 10.1111/j.1574-6941.2011.01219.x; Park S., 2014, J PROB HLTH, V2, P122; Park SH, 2013, POULTRY SCI, V92, P546, DOI 10.3382/ps.2012-02734; Park SH, 2013, FOOD BIOSCI, V1, P66, DOI DOI 10.1016/J.FBIO.2013.02.003; Park SH, 2011, FEMS MICROBIOL LETT, V316, P7, DOI 10.1111/j.1574-6968.2010.02188.x; Pelícia K, 2004, Rev. Bras. Cienc. Avic., V6, P163, DOI 10.1590/S1516-635X2004000300006; Qu A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002945; Rastall RA, 2015, CURR OPIN BIOTECH, V32, P42, DOI 10.1016/j.copbio.2014.11.002; Ricke SC, 2015, POULTRY SCI, V94, P1411, DOI 10.3382/ps/pev049; Ricke SC, 1999, CRIT REV MICROBIOL, V25, P19, DOI 10.1080/10408419991299176; Roberfroid MB, 2005, BRIT J NUTR, V93, pS13, DOI 10.1079/BJN20041350; Saengkerdsub S, 2007, APPL ENVIRON MICROB, V73, P353, DOI 10.1128/AEM.01931-06; SALANITRO JP, 1974, APPL MICROBIOL, V27, P678, DOI 10.1128/AEM.27.4.678-687.1974; Santin E, 2001, J APPL POULTRY RES, V10, P236, DOI 10.1093/japr/10.3.236; Sergeant MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091941; Shakouri MD, 2009, J ANIM PHYSIOL AN N, V93, P647, DOI 10.1111/j.1439-0396.2008.00852.x; Shaufi MAM, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0051-7; Sirri F, 2011, ANIMAL, V5, P312, DOI 10.1017/S175173111000176X; Stanley D, 2014, APPL MICROBIOL BIOT, V98, P4301, DOI 10.1007/s00253-014-5646-2; Stanley VG, 2004, POULTRY SCI, V83, P39, DOI 10.1093/ps/83.1.39; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Tillman GE, 2011, FEMS MICROBIOL ECOL, V77, P395, DOI 10.1111/j.1574-6941.2011.01119.x; Van Loo EJ, 2012, ANNU REV FOOD SCI T, V3, P203, DOI 10.1146/annurev-food-022811-101158; Wise MG, 2007, J APPL MICROBIOL, V102, P1138, DOI 10.1111/j.1365-2672.2006.03153.x; Yeoman Carl J., 2012, Animal Health Research Reviews, V13, P89, DOI 10.1017/S1466252312000138; Yu H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-182; Zhang AW, 2005, POULTRY SCI, V84, P1015, DOI 10.1093/ps/84.7.1015; Zhao LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01163; Zhu XY, 2002, APPL ENVIRON MICROB, V68, P124, DOI 10.1128/AEM.68.1.124-137.2002; Zoetendal EG, 2004, J NUTR, V134, P465, DOI 10.1093/jn/134.2.465	57	48	51	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151944	10.1371/journal.pone.0151944	http://dx.doi.org/10.1371/journal.pone.0151944			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992104	Green Published, Green Submitted, gold			2022-12-26	WOS:000372582800120
J	Roser-Renouf, C; Maibach, EW; Li, J				Roser-Renouf, Connie; Maibach, Edward W.; Li, Jennifer			Adapting to the Changing Climate: An Assessment of Local Health Department Preparations for Climate Change-Related Health Threats, 2008-2012	PLOS ONE			English	Article							PUBLIC-HEALTH; PREPAREDNESS; METAANALYSIS; MITIGATION; PERCEPTION; BEHAVIOR; BARRIERS	Background Climate change poses a major public health threat. A survey of U.S. local health department directors in 2008 found widespread recognition of the threat, but limited adaptive capacity, due to perceived lack of expertise and other resources. Methods We assessed changes between 2008 and 2012 in local public health departments' preparedness for the public health threats of climate change, in light of increasing national polarization on the issue, and widespread funding cutbacks for public health. A geographically representative online survey of directors of local public health departments was conducted in 2011-2012 (N = 174; response rate = 50%), and compared to the 2008 telephone survey results (N = 133; response rate = 61%). Results Significant polarization had occurred: more respondents in 2012 were certain that the threat of local climate change impacts does/does not exist, and fewer were unsure. Roughly 10% said it is not a threat, compared to 1% in 2008. Adaptation capacity decreased in several areas: perceived departmental expertise in climate change risk assessment; departmental prioritization of adaptation; and the number of adaptation-related programs and services departments provided. In 2008, directors' perceptions of local impacts predicted the number of adaptation-related programs and services their departments offered, but in 2012, funding predicted programming and directors' impact perceptions did not. This suggests that budgets were constraining directors' ability to respond to local climate change-related health threats. Results also suggest that departmental expertise may mitigate funding constraints. Strategies for overcoming these obstacles to local public health departments' preparations for climate change are discussed.	[Roser-Renouf, Connie; Maibach, Edward W.] George Mason Univ, Ctr Climate Change Commun, Fairfax, VA 22030 USA; [Li, Jennifer] Natl Assoc Cty & City Hlth Officials, Washington, DC USA	George Mason University	Roser-Renouf, C (corresponding author), George Mason Univ, Ctr Climate Change Commun, Fairfax, VA 22030 USA.	croserre@gmu.edu	Maibach, Edward/A-7102-2009	Maibach, Edward/0000-0003-3409-9187	Centers for Disease Control and Prevention to the National Association for City & County Health Officials; NACCHO [2011-101305]	Centers for Disease Control and Prevention to the National Association for City & County Health Officials(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NACCHO	This research was funded by a grant from the Centers for Disease Control and Prevention to the National Association for City & County Health Officials, and was sub-contracted to Edward Maibach & Connie Roser-Renouf at the Center for Climate Change Communication at George Mason University. The sub-contract number was NACCHO contract #2011-101305.	American Public Health Association (APHA), 2011, CLIM CHANG MAST PUBL; American Public Health Association (APHA), 2014, CLIM HLTH INF; Association of State and Territorial Health Officials (ASTHO), 2009, TAK PULS CHANG NAT F; Balbus J, 2008, PREPARING PUBLIC HLT; Bedsworth L, 2009, ENVIRON HEALTH PERSP, V117, P617, DOI 10.1289/ehp.0800114; Bell E, 2011, AM J PUBLIC HEALTH, V101, P804, DOI 10.2105/AJPH.2010.202820; Bierbaum R, CLIMATE CHANGE IMPAC, P670; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Brulle RJ, 2012, CLIMATIC CHANGE, V114, P169, DOI 10.1007/s10584-012-0403-y; Carr JL, 2012, J PUBLIC HEALTH MAN, V18, pE24, DOI 10.1097/PHH.0b013e31823dea74; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Ebi KL, 2009, ENVIRON HEALTH PERSP, V117, P857, DOI 10.1289/ehp.0800088; Frumkin H, 2015, CLIMATE CHANGE PUBLI, P231; Frumkin H, 2008, AM J PUBLIC HEALTH, V98, P435, DOI 10.2105/AJPH.2007.119362; Hess JJ, 2014, RESPIR MED SER, V7, P341, DOI 10.1007/978-1-4614-8417-2_20; Huang CR, 2011, AM J PREV MED, V40, P183, DOI 10.1016/j.amepre.2010.10.025; Johnson TD, 2012, NATIONS HLTH, V42, pE17; Kahan DM, 2011, J RISK RES, V14, P147, DOI 10.1080/13669877.2010.511246; Kintisch E., 2012, SCI INSIDER; Leiserowitz A, 2015, CLIMATE CHANGE AM CA; Luber G, CLIMATE CHANGE IMPAC, P220; Luber G, 2008, AM J PREV MED, V35, P429, DOI 10.1016/j.amepre.2008.08.021; Maibach EW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002838; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; McCright AM, 2011, SOCIOL QUART, V52, P155, DOI 10.1111/j.1533-8525.2011.01198.x; Media Matters for America, 2015, STUD BROADC NETW COV; Milwaukee Metropolitan Area HeatTask Force, 2014, EXC HEAT EVENT COORD; NACCHO, 2014, 2 NACCHO; National Association of County and City Health Officials (NACCHO), 2014, LOC HLTH DEP BUDG CU; National Association of County and City Health Officials (NACCHO), 2012, LOC HLTH DEP JOB LOS; Polivka BJ, 2012, ENVIRON HEALTH PERSP, V120, P321, DOI 10.1289/ehp.1104025; Sarfaty M, 2016, J ALLER CL IMM-PRACT, V4, P333, DOI 10.1016/j.jaip.2015.09.018; Sarfaty M, 2015, ANN AM THORAC SOC, V12, P274, DOI 10.1513/AnnalsATS.201410-460BC; Sarfaty M, 2014, INT J ENV RES PUB HE, V11, P12473, DOI 10.3390/ijerph111212473; Schmidt CW, 2009, ENVIRON HEALTH PERSP, V117, pA306, DOI 10.1289/ehp.117-a306; Semenza JC, 2008, AM J PREV MED, V35, P479, DOI 10.1016/j.amepre.2008.08.020; Spence A, 2012, RISK ANAL, V32, P957, DOI 10.1111/j.1539-6924.2011.01695.x; Syal SS, 2011, MITIG ADAPT STRAT GL, V16, P911, DOI 10.1007/s11027-011-9302-1; United States Global Research Change Program (USGCRP), 2014, NAT CLIM ASS; van der Linden SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118489; Vynn S, 2009, CLIMATE LEADERSHIP I; Weed DL, 2004, J MED PHILOS, V29, P313, DOI 10.1080/03605310490500527; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506	43	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151558	10.1371/journal.pone.0151558	http://dx.doi.org/10.1371/journal.pone.0151558			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DH1ZE	26991658	Green Published, Green Submitted, gold			2022-12-26	WOS:000372582800076
J	Xue, BH; Li, Y; He, YL; Wei, RY; Sun, RZ; Yin, Z; Bou, G; Liu, ZH				Xue, Binghua; Li, Yan; He, Yilong; Wei, Renyue; Sun, Ruizhen; Yin, Zhi; Bou, Gerelchimeg; Liu, Zhonghua			Porcine Pluripotent Stem Cells Derived from IVF Embryos Contribute to Chimeric Development In Vivo	PLOS ONE			English	Article							CULTURE-CONDITIONS; VITRO DIFFERENTIATION; SELF-RENEWAL; BLASTOCYSTS; PIG; LINES; MASS; ESTABLISHMENT; EXPRESSION; NAIVE	Although the pig is considered an important model of human disease and an ideal animal for the preclinical testing of cell transplantation, the utility of this model has been hampered by a lack of genuine porcine embryonic stem cells. Here, we derived a porcine pluripotent stem cell (pPSC) line from day 5.5 blastocysts in a newly developed culture system based on MXV medium and a 5% oxygen atmosphere. The pPSCs had been passaged more than 75 times over two years, and the morphology of the colony was similar to that of human embryonic stemcells. Characterization and assessment showed that the pPSCs were alkaline phosphatase (AKP) positive, possessed normal karyotypes and expressed classic pluripotent markers, including OCT4, SOX2 and NANOG. In vitro differentiation through embryonic body formation and in vivo differentiation via teratoma formation in nude mice demonstrated that the pPSCs could differentiate into cells of the three germ layers. The pPSCs transfected with fuw-DsRed (pPSC-FDs) could be passaged with a stable expression of both DsRed and pluripotent markers. Notably, when pPSC-FDs were used as donor cells for somatic nuclear transfer, 11.52% of the reconstructed embryos developed into blastocysts, which was not significantly different from that of the reconstructed embryos derived from porcine embryonic fibroblasts. When pPSC-FDs were injected into day 4.5 blastocysts, they became involved in the in vitro embryonic development and contributed to the viscera of foetuses at day 50 of pregnancy as well as the developed placenta after the chimeric blastocysts were transferred into recipients. These findings indicated that the pPSCs were porcine pluripotent cells; that this would be a useful cell line for porcine genetic engineering and a valuable cell line for clarifying the molecular mechanism of pluripotency regulation in pigs.	[Xue, Binghua; Li, Yan; He, Yilong; Wei, Renyue; Yin, Zhi; Bou, Gerelchimeg; Liu, Zhonghua] Northeast Agr Univ, Coll Life Sci, Harbin 150030, Peoples R China; [Sun, Ruizhen] Harbin Med Univ, Dept Histol & Embryol, Harbin 150081, Peoples R China	Northeast Agricultural University - China; Harbin Medical University	Liu, ZH (corresponding author), Northeast Agr Univ, Coll Life Sci, Harbin 150030, Peoples R China.	liuzhonghua@neau.edu.cn			National Natural Science Foundation of China [31371457]; High Technology Research and Development Program of China (863 Program) [2012AA020601]; National Basic Research Program of China (Program 973) [2011CBA01000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Basic Research Program of China (Program 973)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (grant number 31371457), the High Technology Research and Development Program of China (863 Program) (grant number 2012AA020601) and the National Basic Research Program of China (Program 973) (grant number 2011CBA01000).	ANDERSON GB, 1994, THERIOGENOLOGY, V42, P204, DOI 10.1016/0093-691X(94)90676-A; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Blomberg LA, 2008, MOL REPROD DEV, V75, P450, DOI 10.1002/mrd.20780; Brevini TAL, 2008, REPROD DOMEST ANIM, V43, P193, DOI 10.1111/j.1439-0531.2008.01161.x; Brevini TAL, 2007, THERIOGENOLOGY, V68, pS206, DOI 10.1016/j.theriogenology.2007.05.043; Brevini TAL, 2010, STEM CELL REV REP, V6, P484, DOI 10.1007/s12015-010-9153-2; Chen LR, 1999, THERIOGENOLOGY, V52, P195, DOI 10.1016/S0093-691X(99)00122-3; Cheng D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051778; Choi KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072184; De Los Angeles A, 2015, NATURE, V525, P469, DOI 10.1038/nature15515; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Dodsworth BT, 2015, STEM CELLS, V33, P3181, DOI 10.1002/stem.2085; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; EVANS MJ, 1990, THERIOGENOLOGY, V33, P125, DOI 10.1016/0093-691X(90)90603-Q; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Fang RG, 2014, CELL STEM CELL, V15, P488, DOI 10.1016/j.stem.2014.09.004; Hall V, 2008, STEM CELL REV, V4, P275, DOI 10.1007/s12015-008-9040-2; Hall VJ, 2009, DEV DYNAM, V238, P2014, DOI 10.1002/dvdy.22027; Hall VJ, 2014, STEM CELLS DEV, V23, P2030, DOI 10.1089/scd.2013.0502; Haraguchi S, 2012, J REPROD DEVELOP, V58, P707, DOI 10.1262/jrd.2012-008; HOCHEREAUDEREVIERS MT, 1993, REPROD NUTR DEV, V33, P475, DOI 10.1051/rnd:19930508; Jung SK, 2014, J VET SCI, V15, P519, DOI 10.4142/jvs.2014.15.4.519; KASHIWAZAKI N, 1992, VET REC, V130, P186, DOI 10.1136/vr.130.9.186; Kim HS, 2007, ZYGOTE, V15, P55, DOI 10.1017/S0967199406003972; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Li M, 2004, J REPROD DEVELOP, V50, P237, DOI 10.1262/jrd.50.237; Li M, 2004, ZYGOTE, V12, P43, DOI 10.1017/S0967199404002679; Li M, 2003, MOL REPROD DEV, V65, P429, DOI 10.1002/mrd.10301; Liu SC, 2015, DEV DYNAM, V244, P619, DOI 10.1002/dvdy.24248; Moore K, 1997, IN VITRO CELL DEV-AN, V33, P62; Moore K, 1996, MOL REPROD DEV, V45, P139, DOI 10.1002/(SICI)1098-2795(199610)45:2&lt;139::AID-MRD5&gt;3.0.CO;2-U; MUMMERY CL, 1993, BIOCHEM BIOPH RES CO, V191, P188, DOI 10.1006/bbrc.1993.1201; Nagashima H, 2004, BIOL REPROD, V70, P702, DOI 10.1095/biolreprod.103.022681; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; NOTARIANNI E, 1990, J REPROD FERTIL, P51; ONISHI A, 1994, BIOL REPROD, V51, P1069, DOI 10.1095/biolreprod51.6.1069; Park Ji-Yeun, 2013, Evid Based Complement Alternat Med, V2013, P982095, DOI 10.1155/2013/982095; PIEDRAHITA JA, 1990, THERIOGENOLOGY, V34, P879, DOI 10.1016/0093-691X(90)90559-C; PIEDRAHITA JA, 1990, THERIOGENOLOGY, V34, P865, DOI 10.1016/0093-691X(90)90558-B; Rui R, 2006, THERIOGENOLOGY, V65, P713, DOI 10.1016/j.theriogenology.2005.04.033; Samuelson Linda C, 2006, CSH Protoc, V2006, DOI 10.1101/pdb.prot4483; Son HY, 2009, ASIAN AUSTRAL J ANIM, V22, P26, DOI 10.5713/ajas.2009.80343; Stroband H W, 1990, J Reprod Fertil Suppl, V40, P261; STROJEK RM, 1990, THERIOGENOLOGY, V33, P901, DOI 10.1016/0093-691X(90)90825-E; TALBOT NC, 1993, IN VITRO CELL DEV-AN, V29A, P543; Tan GY, 2012, ZYGOTE, V20, P347, DOI 10.1017/S096719941100030X; Telugu Bhanu Prakash V L, 2011, J Biol Chem, V286, P28948, DOI 10.1074/jbc.M111.229468; Vassiliev I, 2010, J REPROD DEVELOP, V56, P546, DOI 10.1262/jrd.09-197A; Vassiliev I, 2010, CELL REPROGRAM, V12, P223, DOI 10.1089/cell.2009.0053; Wang JY, 2013, STEM CELL REV REP, V9, P700, DOI 10.1007/s12015-013-9439-2; Westfall SD, 2008, STEM CELLS DEV, V17, P869, DOI 10.1089/scd.2007.0240; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Yang JR, 2009, CLONING STEM CELLS, V11, P235, DOI 10.1089/clo.2008.0050; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001	56	36	39	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151737	10.1371/journal.pone.0151737	http://dx.doi.org/10.1371/journal.pone.0151737			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991423	Green Published, gold, Green Submitted			2022-12-26	WOS:000372582800094
J	Black, KE; Berdyshev, E; Bain, G; Castelino, FV; Shea, BS; Probst, CK; Fontaine, BA; Bronova, I; Goulet, L; Lagares, D; Ahluwalia, N; Knipe, RS; Natarajan, V; Tager, AM				Black, Katharine E.; Berdyshev, Evgeny; Bain, Gretchen; Castelino, Flavia V.; Shea, Barry S.; Probst, Clemens K.; Fontaine, Benjamin A.; Bronova, Irina; Goulet, Lance; Lagares, David; Ahluwalia, Neil; Knipe, Rachel S.; Natarajan, Viswanathan; Tager, Andrew M.			Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis	FASEB JOURNAL			English	Article						ectonucleotide pyrophosphatase; phosphodiesterase 2; lysophospholipase D; lysophosphatidylcholine; bleomycin; mouse model	LYSOPHOSPHOLIPASE-D; SPHINGOSINE 1-PHOSPHATE; LIPID MEDIATORS; VASCULAR LEAK; HAIR-GROWTH; LPA; ENZYME; EXPRESSION; IDENTIFICATION; INFLAMMATION	Lysophosphatidic acid (LPA) is an important mediator of pulmonary fibrosis. In blood and multiple tumor types, autotaxin produces LPA from lysophosphatidylcholine (LPC) via lysophospholipase D activity, but alternative enzymatic pathways also exist for LPA production. We examined the role of autotaxin (ATX) in pulmonary LPA production during fibrogenesis in a bleomycin mouse model. We found that bleomycin injury increases the bronchoalveolar lavage (BAL) fluid levels of ATX protein 17-fold. However, the LPA and LPC species that increase in BAL of bleomycin-injured mice were discordant, inconsistent with a substrate-product relationship between LPC and LPA in pulmonary fibrosis. LPA species with longer chain polyunsaturated acyl groups predominated in BAL fluid after bleomycin injury, with 22:5 and 22:6 species accounting for 55 and 16% of the total, whereas the predominant BAL LPC species contained shorter chain, saturated acyl groups, with 16:0 and 18:0 species accounting for 56 and 14% of the total. Further, administration of the potent ATX inhibitor PAT-048 to bleomycin-challenged mice markedly decreased ATX activity systemically and in the lung, without effect on pulmonary LPA or fibrosis. Therefore, alternative ATX-independent pathways are likely responsible for local generation of LPA in the injured lung. These pathways will require identification to therapeutically target LPA production in pulmonary fibrosis.Black, K. E., Berdyshev, E., Bain, G., Castelino, F. V., Shea, B. S., Probst, C. K., Fontaine, B. A., Bronova, I., Goulet, L., Lagares, D., Ahluwalia, N., Knipe, R. S., Natarajan, V., Tager, A. M. Autotaxin activity increases locally following lung injury, but is not required for pulmonary lysophosphatidic acid production or fibrosis.	[Black, Katharine E.; Shea, Barry S.; Probst, Clemens K.; Fontaine, Benjamin A.; Lagares, David; Ahluwalia, Neil; Knipe, Rachel S.; Tager, Andrew M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Pulm & Crit Care Med, Boston, MA USA; [Black, Katharine E.; Castelino, Flavia V.; Shea, Barry S.; Probst, Clemens K.; Fontaine, Benjamin A.; Lagares, David; Ahluwalia, Neil; Knipe, Rachel S.; Tager, Andrew M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis, Boston, MA USA; [Castelino, Flavia V.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Rheumatol Allergy & Immunol, Boston, MA USA; [Berdyshev, Evgeny; Bronova, Irina; Natarajan, Viswanathan] Univ Illinois, Dept Med, Chicago, IL USA; [Natarajan, Viswanathan] Univ Illinois, Dept Pharmacol, Chicago, IL USA; [Berdyshev, Evgeny; Bronova, Irina] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Bain, Gretchen; Goulet, Lance] PharmAkea Inc, San Diego, CA USA; [Shea, Barry S.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Jewish Health; Brown University	Tager, AM (corresponding author), Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Div Pulm & Crit Care Med, CNY149-8301,149 Thirteenth St, Charlestown, MA 02129 USA.	amtager@partners.org		Lagares, David/0000-0002-7317-8796; Bain, Gretchen/0000-0001-7513-9486	U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute [R01HL108975]; Office of the Director [P01HL098050, S10OD010660]; National Center for Research Resources; National Center for Advancing Translational Sciences, NIH National Center for Advancing Translational Sciences [UL1TR001102]; Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001102] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108975, P01HL098050] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010660] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Office of the Director(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences, NIH National Center for Advancing Translational Sciences; Harvard University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors acknowledge the support of U.S. National Institutes of Health (NIH), National Heart, Lung, and Blood Institute Grant R01HL108975 (to A. M. T.); Grant P01HL098050 and Grant S10OD010660 from the Office of the Director (for ESI-LC/MS/MS equipment) (to V. N. and E. B.). The authors also gratefully acknowledge assistance with the analyses performed by the Harvard Clinical and Translational Science Center (Harvard Catalyst), which is supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, NIH National Center for Advancing Translational Sciences Grant UL1TR001102, and financial contributions from Harvard University and its affiliated academic healthcare centers. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University, and its affiliated academic healthcare centers, or the NIH. K. E. B. and A. M. T. conceived the project, designed the studies, and wrote the manuscript. K. E. B. performed and analyzed experiments investigating ATX or phospholipase activity, concentration, and expression. G. B. and L. G. designed and analyzed PAT-048 pharmacodynamic and pharmacokinetic analyses. E. B., I. B., and V. N. performed the LC/MS analysis of LPA and LPC. F. V. C. and B. S. S assisted with experimental design and data acquisition. R. S. K., C. K. P., and B. A. F. performed the animal experiments and assisted with data acquisition; D. L. and N. A. performed the FTY720 animal experiments and assisted with the experimental design. E. B., G. B., B. S. S., N. A., and V. N. also reviewed and intellectually contributed to the manuscript. G. B. and L. G. receive income and own equity in PharmAkea, Inc., and A. M. T. is a member of the PharmAkea scientific advisory board.	Ahluwalia N, 2014, AM J RESP CRIT CARE, V190, P867, DOI 10.1164/rccm.201403-0509PP; Aikawa S, 2015, J BIOCHEM, V157, P81, DOI 10.1093/jb/mvu077; Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; BEHR J, 1993, THORAX, V48, P736, DOI 10.1136/thx.48.7.736; Benesch MGK, 2015, J LIPID RES, V56, P1134, DOI 10.1194/jlr.M057661; Funke M, 2012, AM J RESP CELL MOL, V46, P355, DOI 10.1165/rcmb.2010-0155OC; Georas SN, 2007, CLIN EXP ALLERGY, V37, P311, DOI 10.1111/j.1365-2222.2006.02626.x; Grisanti L, 2013, J INVEST DERMATOL, V133, P2332, DOI 10.1038/jid.2013.140; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; Huang LS, 2013, AM J RESP CELL MOL, V49, P912, DOI 10.1165/rcmb.2013-0070OC; Inoue M, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-6; Kazantseva A, 2006, SCIENCE, V314, P982, DOI 10.1126/science.1133276; Keller UAD, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003512; Khalil MB, 2010, MASS SPECTROM REV, V29, P877, DOI 10.1002/mas.20294; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Liu F, 2010, J CELL BIOL, V190, P693, DOI 10.1083/jcb.201004082; Montesi SB, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-5; Moolenaar WH, 2013, BBA-MOL CELL BIOL L, V1831, P13, DOI 10.1016/j.bbalip.2012.09.013; Nakagawa H, 2011, CLIN CHIM ACTA, V412, P1201, DOI 10.1016/j.cca.2011.03.014; Nakamura K, 2007, CLIN BIOCHEM, V40, P274, DOI 10.1016/j.clinbiochem.2006.10.009; Nakanaga K, 2014, J BIOCHEM, V155, P235, DOI 10.1093/jb/mvt114; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Nikitopoulou I, 2012, J EXP MED, V209, P923, DOI 10.1084/jem.20112012; Nishimasu H, 2012, TRENDS PHARMACOL SCI, V33, P138, DOI 10.1016/j.tips.2011.12.004; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; North EJ, 2009, BIOORGAN MED CHEM, V17, P3433, DOI 10.1016/j.bmc.2009.03.030; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; Park GY, 2013, AM J RESP CRIT CARE, V188, P928, DOI 10.1164/rccm.201306-1014OC; Pasternack SM, 2009, J INVEST DERMATOL, V129, P2772, DOI 10.1038/jid.2009.154; Perrakis A, 2014, J LIPID RES, V55, P1010, DOI 10.1194/jlr.R046391; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Selman M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000482; Shea Barry S, 2012, Proc Am Thorac Soc, V9, P102, DOI 10.1513/pats.201201-005AW; Shea BS, 2010, AM J RESP CELL MOL, V43, P662, DOI 10.1165/rcmb.2009-0345OC; Shimizu Y, 2014, AM J PATHOL, V184, P1593, DOI 10.1016/j.ajpath.2014.01.029; Sonoda H, 2002, J BIOL CHEM, V277, P34254, DOI 10.1074/jbc.M201659200; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Vancheri C, 2010, EUR RESPIR J, V35, P496, DOI 10.1183/09031936.00077309; Yuelling LM, 2008, BBA-MOL CELL BIOL L, V1781, P525, DOI 10.1016/j.bbalip.2008.04.009	46	35	36	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2435	2450		10.1096/fj.201500197R	http://dx.doi.org/10.1096/fj.201500197R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	27006447	Green Published			2022-12-26	WOS:000376878300031
J	Happonen, KE; Tran, S; Morgelin, M; Prince, R; Calzavarini, S; Angelillo-Scherrer, A; Dahlback, B				Happonen, Kaisa E.; Sinh Tran; Morgelin, Matthias; Prince, Raja; Calzavarini, Sara; Angelillo-Scherrer, Anne; Dahlback, Bjorn			The Gas6-Axl Protein Interaction Mediates Endothelial Uptake of Platelet Microparticles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE RECEPTOR; APOPTOTIC CELLS; DENDRITIC CELLS; TAM RECEPTOR; ACTIVATED PLATELETS; AXL; MER; PHAGOCYTOSIS; CLEARANCE; GROWTH	Upon activation, platelets release plasma membrane-derived microparticles (PMPs) exposing phosphatidylserine on their surface. The functions and clearance mechanism of these microparticles are incompletely understood. As they are pro-coagulant and potentially pro-inflammatory, rapid clearance from the circulation is essential for prevention of thrombotic diseases. The tyrosine kinase receptors Tyro3, Axl, and Mer (TAMs) and their ligands protein S and Gas6 are involved in the uptake of phosphatidylserine-exposing apoptotic cells in macrophages and dendritic cells. Both TAMs and their ligands are expressed in the vasculature, the functional significance of which is poorly understood. In this study, we investigated how vascular TAMs and their ligands may mediate endothelial uptake of PMPs. PMPs, generated from purified human platelets, were isolated by ultracentrifugation and labeled with biotin or PKH67. The uptake of labeled microparticles in the presence of protein S and Gas6 in human aortic endothelial cells and human umbilical vein endothelial cells was monitored by flow cytometry, Western blotting, and confocal/electron microscopy. We found that both endothelial cell types can phagocytose PMPs, and by using TAM-blocking antibodies or siRNA knockdown of individual TAMs, we show that the uptake is mediated by endothelial Axl and Gas6. As circulatingPMPlevels were not altered in Gas6(-/-) mice compared with Gas6(+/+) mice, we hypothesize that the Gas6-mediated uptake is not a means to clear the bulk of circulating PMPs but may serve to locally phagocytose PMPs generated at sites of platelet activation and as a way to effect endothelial responses.	[Happonen, Kaisa E.; Sinh Tran; Dahlback, Bjorn] Lund Univ, Dept Translat Med, Div Clin Chem, Inga Marie Nilssons Gata 53, SE-20502 Malmo, Sweden; [Morgelin, Matthias] Lund Univ, Dept Clin Sci, Div Infect Med, SE-22185 Lund, Sweden; [Prince, Raja; Calzavarini, Sara; Angelillo-Scherrer, Anne] Univ Hosp Bern, Univ Clin Hematol, CH-3010 Bern, Switzerland; [Prince, Raja; Calzavarini, Sara; Angelillo-Scherrer, Anne] Univ Hosp Bern, Cent Hematol Lab, CH-3010 Bern, Switzerland; [Prince, Raja; Calzavarini, Sara; Angelillo-Scherrer, Anne] Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland	Lund University; Lund University; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern	Happonen, KE (corresponding author), Lund Univ, Dept Translat Med Clin Chem, Wallenberg Lab, Inga Marie Nilssons Gata 53, SE-20502 Malmo, Sweden.	kaisa.happonen@med.lu.se	Calzavarini, Sara/AAU-9368-2020	Calzavarini, Sara/0000-0002-7494-2995; Dahlback, Bjorn/0000-0003-1546-0328; Happonen, Kaisa/0000-0002-8346-6302; Angelillo-Scherrer, Anne/0000-0003-2872-4863	Swedish Research Council; Heart-Lung Foundation; Soderberg's Foundation; Skane University Hospital Research Funds; Foundation of Greta; Foundation of Johan Kock; Royal Physiographic Society in Lund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Heart-Lung Foundation(Swedish Heart-Lung Foundation); Soderberg's Foundation; Skane University Hospital Research Funds; Foundation of Greta; Foundation of Johan Kock; Royal Physiographic Society in Lund	This work was supported by grants from Swedish Research Council (to B. D.), the Heart-Lung Foundation (to B. D.), the Soderberg's Foundation (to B. D.), Skane University Hospital Research Funds (to B. D.) and grants from the Foundations of Greta and Johan Kock (to K. E. H.), Alfred Osterlund (to K. E. H.), Tore Nilsson (to K. E. H.), Prof. Nanna Svartz (to K. E. H.), Apotekare Hedberg (to K. E. H.), and the Royal Physiographic Society in Lund (to K. E. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Aatonen MT, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.24692; Abdel-Monem H, 2010, THROMB HAEMOSTASIS, V104, P335, DOI 10.1160/TH09-12-0849; Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; Arraud N, 2014, J THROMB HAEMOST, V12, P614, DOI 10.1111/jth.12554; Barry OP, 1998, J CLIN INVEST, V102, P136, DOI 10.1172/JCI2592; Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639; Bertin FR, 2015, J THROMB HAEMOST, V13, P2260, DOI 10.1111/jth.13156; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Burkhart JM, 2012, BLOOD, V120, pE73, DOI 10.1182/blood-2012-04-416594; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Cosemans JMEM, 2010, J THROMB HAEMOST, V8, P1797, DOI 10.1111/j.1538-7836.2010.03935.x; DAHLBACK B, 1983, BIOCHEM J, V209, P837, DOI 10.1042/bj2090837; DAHLBACK B, 1992, BIOCHEMISTRY-US, V31, P12769, DOI 10.1021/bi00166a009; DAHLBACK B, 1990, J BIOL CHEM, V265, P8127; Dasgupta SK, 2009, BLOOD, V113, P1332, DOI 10.1182/blood-2008-07-167148; Dasgupta SK, 2012, CIRCULATION, V125, P1664, DOI 10.1161/CIRCULATIONAHA.111.068833; Dransfield I, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.18; Duchez AC, 2015, P NATL ACAD SCI USA, V112, pE3564, DOI 10.1073/pnas.1507905112; Ekman C, 2010, J THROMB HAEMOST, V8, P838, DOI 10.1111/j.1538-7836.2010.03752.x; Faille D, 2012, J CELL MOL MED, V16, P1731, DOI 10.1111/j.1582-4934.2011.01434.x; Fens MHAM, 2008, BLOOD, V111, P4542, DOI 10.1182/blood-2007-06-094763; Flaumenhaft R, 2009, BLOOD, V113, P1112, DOI 10.1182/blood-2008-06-163832; Fraineau S, 2012, BLOOD, V120, P5073, DOI 10.1182/blood-2012-05-429183; Gallicchio M, 2005, BLOOD, V105, P1970, DOI 10.1182/blood-2004-04-1469; Gould WR, 2005, J THROMB HAEMOST, V3, P733, DOI 10.1111/j.1538-7836.2005.01186.x; Grommes C, 2008, J NEUROIMMUNE PHARM, V3, P130, DOI 10.1007/s11481-007-9090-2; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Hasanbasic I, 2004, AM J PHYSIOL-HEART C, V287, pH1207, DOI 10.1152/ajpheart.00020.2004; Healy AM, 2001, AM J PHYSIOL-LUNG C, V280, pL1273, DOI 10.1152/ajplung.2001.280.6.L1273; Horstman LL, 1999, CRIT REV ONCOL HEMAT, V30, P111, DOI 10.1016/S1040-8428(98)00044-4; Italiano JE, 2010, CURR OPIN HEMATOL, V17, P578, DOI 10.1097/MOH.0b013e32833e77ee; Koshiar RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104200; Laffont B, 2013, BLOOD, V122, P253, DOI 10.1182/blood-2013-03-492801; Laurance S, 2014, J THROMB HAEMOST, V12, P395, DOI 10.1111/jth.12481; Lew ED, 2014, ELIFE, V3, DOI 10.7554/eLife.03385; Lu QX, 1999, NATURE, V398, P723, DOI 10.1038/19554; LUNDBLAD RL, 1975, BIOCHEM BIOPH RES CO, V66, P482, DOI 10.1016/0006-291X(75)90536-7; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; Mause SF, 2005, ARTERIOSCL THROM VAS, V25, P1512, DOI 10.1161/01.ATV.0000170133.43608.37; Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974; NAKANO T, 1995, J BIOL CHEM, V270, P5702, DOI 10.1074/jbc.270.11.5702; Nomura S, 2001, ATHEROSCLEROSIS, V158, P277, DOI 10.1016/S0021-9150(01)00433-6; Piccin A, 2007, BLOOD REV, V21, P157, DOI 10.1016/j.blre.2006.09.001; Rand ML, 2006, J THROMB HAEMOST, V4, P1621, DOI 10.1111/j.1538-7836.2006.02011.x; Rank A, 2011, PLATELETS, V22, P111, DOI 10.3109/09537104.2010.520373; Robins RS, 2013, BLOOD, V121, P692, DOI 10.1182/blood-2012-05-433730; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Ruan GX, 2012, EMBO J, V31, P1692, DOI 10.1038/emboj.2012.21; Sadallah S, 2014, THROMB HAEMOSTASIS, V112, P1219, DOI 10.1160/TH14-03-0281; Sadallah S, 2011, J IMMUNOL, V186, P6543, DOI 10.4049/jimmunol.1002788; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Seitz HM, 2007, J IMMUNOL, V178, P5635, DOI 10.4049/jimmunol.178.9.5635; Sen P, 2007, BLOOD, V109, P653, DOI 10.1182/blood-2006-04-017368; Sinauridze EI, 2007, THROMB HAEMOSTASIS, V97, P425, DOI 10.1160/TH06-06-0313; Somajo S, 2014, THROMB RES, V134, P144, DOI 10.1016/j.thromres.2014.04.031; Stenhoff J, 2004, BIOCHEM BIOPH RES CO, V319, P871, DOI 10.1016/j.bbrc.2004.05.070; Subramanian M, 2014, J CLIN INVEST, V124, P1296, DOI 10.1172/JCI72051; Tsou WI, 2014, J BIOL CHEM, V289, P25750, DOI 10.1074/jbc.M114.569020; Vollrath D, 2001, P NATL ACAD SCI USA, V98, P12584, DOI 10.1073/pnas.221364198; Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878; Xiong W, 2008, REPRODUCTION, V135, P77, DOI 10.1530/REP-07-0287; Zagorska A, 2014, NAT IMMUNOL, V15, P920, DOI 10.1038/ni.2986; Zhu DH, 2010, BLOOD, V115, P4963, DOI 10.1182/blood-2010-01-262386	64	37	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10586	10601		10.1074/jbc.M115.699058	http://dx.doi.org/10.1074/jbc.M115.699058			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27006397	Green Published, hybrid			2022-12-26	WOS:000377042600013
J	Sakakini, N; Turchi, L; Bergon, A; Holota, H; Rekim, S; Lopez, F; Paquis, P; Almairac, F; Fontaine, D; Baeza-Kallee, N; Van Obberghen-Schilling, E; Junier, MP; Chneiweiss, H; Figarella-Branger, D; Burel-Vandenbos, F; Imbert, J; Virolle, T				Sakakini, Nathalie; Turchi, Laurent; Bergon, Aurelie; Holota, Helene; Rekim, Samah; Lopez, Fabrice; Paquis, Philipe; Almairac, Fabien; Fontaine, Denys; Baeza-Kallee, Nathalie; Van Obberghen-Schilling, Ellen; Junier, Marie-Pierre; Chneiweiss, Herve; Figarella-Branger, Dominique; Burel-Vandenbos, Fanny; Imbert, Jean; Virolle, Thierry			A Positive Feed-forward Loop Associating EGR1 and PDGFA Promotes Proliferation and Self-renewal in Glioblastoma Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FINGER TRANSCRIPTION FACTOR; GLIOMA-INITIATING CELLS; PROSTATE-CANCER CELLS; MALIGNANT GLIOMA; TUMOR-GROWTH; IN-VIVO; EXPRESSION; INHIBITION; DEATH; P53	Glioblastomas are the most common primary brain tumors, highly vascularized, infiltrating, and resistant to current therapies. This cancer leads to a fatal outcome in less than 18 months. The aggressive behavior of glioblastomas, including resistance to current treatments and tumor recurrence, has been attributed to glioma stemlike/progenitor cells. The transcription factor EGR1 (early growth response 1), a member of a zinc finger transcription factor family, has been described as tumor suppressor in gliomas when ectopically overexpressed. Although EGR1 expression in human glioblastomas has been associated with patient survival, its precise location in tumor territories as well as its contribution to glioblastoma progression remain elusive. In the present study, we show that EGR1-expressing cells are more frequent in high grade gliomas where the nuclear expression of EGR1 is restricted to proliferating/progenitor cells. We show in primary cultures of glioma stemlike cells that EGR1 contributes to stemness marker expression and proliferation by orchestrating a PDGFA-dependent growth-stimulatory loop. In addition, we demonstrate that EGR1 acts as a positive regulator of several important genes, including SHH, GLI1, GLI2, and PDGFA, previously linked to the maintenance and proliferation of glioma stemlike cells.	[Sakakini, Nathalie; Turchi, Laurent; Rekim, Samah; Paquis, Philipe; Almairac, Fabien; Van Obberghen-Schilling, Ellen; Burel-Vandenbos, Fanny; Virolle, Thierry] Univ Nice Sophia Antipolis, CNRS, INSERM, iBV, F-06108 Nice, France; [Sakakini, Nathalie; Bergon, Aurelie; Holota, Helene; Lopez, Fabrice; Imbert, Jean] INSERM, TGML TAGC, U1090, F-13009 Marseille, France; [Sakakini, Nathalie; Bergon, Aurelie; Holota, Helene; Lopez, Fabrice; Imbert, Jean] Aix Marseille Univ, TGML TAGC, UMR S 1090, F-13009 Marseille, France; [Burel-Vandenbos, Fanny] CHU Nice, Hop Pasteur, Serv Anatomopathol, F-06107 Nice, France; [Paquis, Philipe; Almairac, Fabien; Fontaine, Denys] CHU Nice, Hop Pasteur, Serv Neurchirurg, F-06107 Nice, France; [Baeza-Kallee, Nathalie; Figarella-Branger, Dominique] Aix Marseille Univ, Fac Med Timone, F-13284 Marseille, France; [Baeza-Kallee, Nathalie; Figarella-Branger, Dominique] INSERM UMR 911, CRO2, F-13284 Marseille, France; [Figarella-Branger, Dominique] CHU Timone, Dept Pathol, F-13385 Marseille 5, France; [Junier, Marie-Pierre; Chneiweiss, Herve] CNRS, Team Glial Plast, Neurosci Paris Seine IBPS UMR8246, 7 Quai St Bernard, F-75005 Paris, France; [Junier, Marie-Pierre; Chneiweiss, Herve] INSERM U1130, Team Glial Plast, Neurosci Paris Seine IBPS, 7 Quai St Bernard, F-75005 Paris, France; [Junier, Marie-Pierre; Chneiweiss, Herve] Univ Paris 06, Team Glial Plast, Neurosci Paris Seine IBPS, UMCR18, 7 Quai St Bernard, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; CHU Nice; CHU Nice; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Imbert, J (corresponding author), INSERM U1090, TAGC, Parc Sci Luminy,Case 928,163 Ave de Luminy, F-13288 Marseille 09, France.; Virolle, T (corresponding author), Univ Nice Sophia Antipolis, UFR Sci, iBV, Batiment Sci Nat,Parc Valrose,28 Ave Valrose, F-06108 Nice 2, France.	jean.imbert@inserm.fr; virolle@unice.fr	Van Obberghen-Schilling, Ellen/Q-4372-2019; Lopez, Fabrice/M-5021-2016; herve, chneiweiss/Q-6818-2019; Inserm U1090, TAGC/ABE-9980-2021; Virolle, Thierry/E-5838-2016; Imbert, Jean/G-3248-2013; Imbert, Jean/AAG-1165-2020; Van Obberghen-Schilling, Ellen/O-1581-2016; Bergon, Aurélie/M-4977-2016	Van Obberghen-Schilling, Ellen/0000-0003-2961-0059; Lopez, Fabrice/0000-0002-2401-0292; herve, chneiweiss/0000-0001-7675-5061; Imbert, Jean/0000-0002-0478-9593; Imbert, Jean/0000-0002-0478-9593; Van Obberghen-Schilling, Ellen/0000-0003-2961-0059; Bergon, Aurélie/0000-0003-1518-4562; Turchi, Laurent/0000-0003-2020-5831; Fontaine, Denys/0000-0001-5012-6769	INSERM; GIS IBiSA; Aix-Marseille-Universite;  [ANR-10-INBS-0009-10]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); GIS IBiSA; Aix-Marseille-Universite; 	We thank A. Borderie, S. Bestree, C. Hagnere, and F. Frassinetti for technical assistance and C Colin for statistical analyses. High throughput sequencing was performed at the TGML Platform, supported by grants from INSERM, GIS IBiSA, Aix-Marseille-Universite, and ANR-10-INBS-0009-10.	Baron V, 2003, ONCOGENE, V22, P4194, DOI 10.1038/sj.onc.1206560; Ben-Chetrit N, 2013, CELL ADHES MIGR, V7, P33, DOI 10.4161/cam.22263; Calogero A, 2004, CANCER CELL INT, V4, DOI 10.1186/1475-2867-4-1; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Choi BH, 2008, CANCER RES, V68, P1369, DOI 10.1158/0008-5472.CAN-07-5222; Cibelli G, 2002, J NEUROSCI RES, V67, P450, DOI 10.1002/jnr.10141; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Eid MA, 1998, CANCER RES, V58, P2461; Fareh M, 2012, CELL DEATH DIFFER, V19, P232, DOI 10.1038/cdd.2011.89; Gregg Jennifer, 2011, Genes Cancer, V2, P900, DOI 10.1177/1947601911431885; Huang RP, 1997, INT J CANCER, V72, P102, DOI 10.1002/(SICI)1097-0215(19970703)72:1<102::AID-IJC15>3.0.CO;2-L; KHACHIGIAN LM, 1995, J BIOL CHEM, V270, P27679, DOI 10.1074/jbc.270.46.27679; Kim Jin Wook, 2014, Genes Cancer, V5, P165; LEVIN WJ, 1995, ONCOGENE, V11, P1261; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Mahony S, 2007, NUCLEIC ACIDS RES, V35, pW253, DOI 10.1093/nar/gkm272; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mehta S, 2011, CANCER CELL, V19, P359, DOI 10.1016/j.ccr.2011.01.035; Min IM, 2008, CELL STEM CELL, V2, P380, DOI 10.1016/j.stem.2008.01.015; Mitchell A, 2004, NUCLEIC ACIDS RES, V32, P3065, DOI 10.1093/nar/gkh626; Mittelbronn M, 2009, BRAIN PATHOL, V19, P195, DOI 10.1111/j.1750-3639.2008.00175.x; Nair P, 1997, J BIOL CHEM, V272, P20131, DOI 10.1074/jbc.272.32.20131; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P896, DOI 10.1093/neuonc/nou087; Pagel JI, 2011, INDIAN J BIOCHEM BIO, V48, P226; Patru C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-66; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; RUPPRECHT HD, 1993, AM J PHYSIOL, V265, pF351, DOI 10.1152/ajprenal.1993.265.3.F351; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seto M, 2009, MOL CARCINOGEN, V48, P703, DOI 10.1002/mc.20516; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Thomas-Chollier M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1104; Thomas-Chollier M, 2011, NAT PROTOC, V6, P1860, DOI 10.1038/nprot.2011.409; Thyss R, 2005, EMBO J, V24, P128, DOI 10.1038/sj.emboj.7600501; Turchi L, 2013, STEM CELLS, V31, P1252, DOI 10.1002/stem.1373; Virolle T, 2003, J BIOL CHEM, V278, P11802, DOI 10.1074/jbc.M210279200; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang W, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/867517; Worden B, 2005, CANCER RES, V65, P7071, DOI 10.1158/0008-5472.CAN-04-0989; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137	41	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 13	2016	291	20					10684	10699		10.1074/jbc.M116.720698	http://dx.doi.org/10.1074/jbc.M116.720698			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DN4MY	27002148	Green Published, hybrid			2022-12-26	WOS:000377042600021
J	Gan, L; Di, R; Chao, YH; Han, LB; Chen, XW; Wu, C; Yin, SX				Gan, Lu; Di, Rong; Chao, Yuehui; Han, Liebao; Chen, Xingwu; Wu, Chao; Yin, Shuxia			De Novo Transcriptome Analysis for Kentucky Bluegrass Dwarf Mutants Induced by Space Mutation	PLOS ONE			English	Article							RNA-SEQ DATA; ISOPENTENYL DIPHOSPHATE; KEY ENZYMES; GIBBERELLIN; PATHWAY; BIOSYNTHESIS; ARABIDOPSIS; EXPRESSION; AUXIN; RICE	Kentucky bluegrass (Poa pratensis L.) is a major cool-season turfgrass requiring frequent mowing. Utilization of cultivars with slow growth is a promising method to decrease mowing frequency. In this study, two dwarf mutant selections of Kentucky bluegrass (A12 and A16) induced by space mutation were analyzed for the differentially expressed genes compared with the wild type (WT) by the high-throughput RNA-Seq technology. 253,909 unigenes were obtained by de novo assembly. 24.20% of the unigenes had a significant level of amino acid sequence identity to Brachypodium distachyon proteins, followed by Hordeum vulgare with 18.72% among the non-redundant (NR) Blastx top hits. Assembled unigenes were associated with 32 pathways using KEGG orthology terms and their respective KEGG maps. Between WT and A16 libraries, 4,203 differentially expressed genes (DEGs) were identified, whereas there were 883 DEGs between WT and A12 libraries. Further investigation revealed that the DEG pathways were mainly involved in terpenoid biosynthesis and plant hormone metabolism, which might account for the differences of plant height and leaf blade color between dwarf mutant and WT plants. Our study presents the first comprehensive transcriptomic data and gene function analysis of Poa pratensis L., providing a valuable resource for future studies in plant dwarfing breeding and comparative genome analysis for Pooideae plants.	[Gan, Lu; Chao, Yuehui; Han, Liebao; Chen, Xingwu; Wu, Chao; Yin, Shuxia] Beijing Forestry Univ, Inst Turfgrass Sci, Beijing 100083, Peoples R China; [Di, Rong] Rutgers State Univ, Dept Plant Biol & Pathol, New Brunswick, NJ 08901 USA	Beijing Forestry University; Rutgers State University New Brunswick	Yin, SX (corresponding author), Beijing Forestry Univ, Inst Turfgrass Sci, Beijing 100083, Peoples R China.	yinsx369@bjfu.edu.cn		Gan, Lu/0000-0002-0433-5831	National Natural Science Foundation of China [31302016]; National High Technology Research and Development Program of China (863 Program) [2013AA102607]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This study was supported by the National Natural Science Foundation of China (No. 31302016) and the National High Technology Research and Development Program of China (863 Program) (No. 2013AA102607). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EM, 2004, CROP SCI, V44, P1746, DOI 10.2135/cropsci2004.1746; [Anonymous], 1991, TURFGRASS MANAGEMENT; Aoki T, 2002, J PLANT RES, V115, P195, DOI 10.1007/s102650200025; Ashikari M, 1999, P NATL ACAD SCI USA, V96, P10284, DOI 10.1073/pnas.96.18.10284; Avram B.-C., 2004, FUNDAMENTALS MICROSY; Ayele BT, 2014, J PLANT GROWTH REGUL, V33, P340, DOI 10.1007/s00344-013-9385-x; [白丽君 Bai Lijun], 2014, [生物技术通报, Biotechnology Bulletin], P34; Bajguz A, 2009, PLANT PHYSIOL BIOCH, V47, P1, DOI 10.1016/j.plaphy.2008.10.002; BRIAN PW, 1959, BIOL REV, V34, P37, DOI 10.1111/j.1469-185X.1959.tb01301.x; Burden CJ, 2014, PEERJ, V2, DOI 10.7717/peerj.576; Chen JG, 1998, PLANT GROWTH REGUL, V26, P19, DOI 10.1023/A:1006091601256; Chen ML, 2012, J CHROMATOGR B, V905, P67, DOI 10.1016/j.jchromb.2012.08.005; Davidson RM, 2012, PLANT J, V71, P492, DOI 10.1111/j.1365-313X.2012.05005.x; De Paolo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102155; Desgagne-Penix I, 2005, PLANT J, V41, P231, DOI 10.1111/j.1365-313X.2004.02287.x; do Nascimento LC, 2012, GENET MOL BIOL, V35, P203, DOI 10.1590/S1415-47572012000200002; Filippi CV, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-014-0360-x; Fridborg I, 1999, PLANT CELL, V11, P1019, DOI 10.1105/tpc.11.6.1019; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; He JX, 2002, P NATL ACAD SCI USA, V99, P10185, DOI 10.1073/pnas.152342599; He XinHua, 2006, Floriculture, ornamental and plant biotechnology, P266; Hoeffler JF, 2002, BIOCHEM J, V366, P573, DOI 10.1042/BJ20020337; Kuzuyama T, 2000, J BACTERIOL, V182, P891, DOI 10.1128/JB.182.4.891-897.2000; Lally D, 2001, PLANT CELL, V13, P1317, DOI 10.1105/tpc.13.6.1317; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li J G, 1999, Space Med Med Eng (Beijing), V12, P464; Lichtenthaler HK, 2007, PHOTOSYNTH RES, V92, P163, DOI 10.1007/s11120-007-9204-y; Liu L.J., 2007, RAILWAY ENG, V2007, P4; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MITSUNAGA S, 1994, THEOR APPL GENET, V87, P705, DOI 10.1007/BF00222896; Miyawaki K, 2004, PLANT J, V37, P128, DOI 10.1046/j.1365-313X.2003.01945.x; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; O'Neill DP, 2002, PLANT PHYSIOL, V130, P1974, DOI 10.1104/pp.010587; Orshinsky AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041150; Otomo K, 2004, PLANT J, V39, P886, DOI 10.1111/j.1365-313X.2004.02175.x; Pakniyat H, 1997, EUPHYTICA, V94, P7, DOI 10.1023/A:1002956802041; Paran I, 2007, J EXP BOT, V58, P3841, DOI 10.1093/jxb/erm257; Porceddu A, 2002, THEOR APPL GENET, V104, P273, DOI 10.1007/s001220100659; Rasbery JM, 2007, J BIOL CHEM, V282, P17002, DOI 10.1074/jbc.M611831200; Saville RJ, 2012, J EXP BOT, V63, P1271, DOI 10.1093/jxb/err350; Strickler SR, 2012, AM J BOT, V99, P257, DOI 10.3732/ajb.1100292; Studer B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-140; Swain SM, 2004, PLANT PHYSIOL, V134, P694, DOI 10.1104/pp.103.031666; Toledo-Silva G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070781; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Tritsch D, 2010, FEBS LETT, V584, P129, DOI 10.1016/j.febslet.2009.11.010; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vranova E, 2012, MOL PLANT, V5, P318, DOI 10.1093/mp/sss015; Vukosavljev M, 2015, MOL ECOL RESOUR, V15, P17, DOI 10.1111/1755-0998.12289; Wachholtz M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-613; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Yilmaz A, 2009, PLANT PHYSIOL, V149, P171, DOI 10.1104/pp.108.128579; Zhao CL, 2010, NAT PROD COMMUN, V5, P1147; ZWAR JA, 1995, PLANTA, V197, P39, DOI 10.1007/BF00239937	56	15	15	6	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151768	10.1371/journal.pone.0151768	http://dx.doi.org/10.1371/journal.pone.0151768			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010560	Green Published, gold			2022-12-26	WOS:000372708000043
J	Hatten, J; Goni, M				Hatten, Jeff; Goni, Miguel			Cupric Oxide (CuO) Oxidation Detects Pyrogenic Carbon in Burnt Organic Matter and Soils	PLOS ONE			English	Article							BENZENE POLYCARBOXYLIC ACIDS; PONDEROSA PINE FOREST; STATE C-13 NMR; BLACK CARBON; TROPICAL ESTUARY; MANGROVE LEAVES; CLIMATE-CHANGE; FIRE SEVERITY; PLANT BIOMASS; SEDIMENTS	Wildfire greatly impacts the composition and quantity of organic carbon stocks within watersheds. Most methods used to measure the contributions of fire altered organic carbon-i.e. pyrogenic organic carbon (Py-OC) in natural samples are designed to quantify specific fractions such as black carbon or polyaromatic hydrocarbons. In contrast, the CuO oxidation procedure yields a variety of products derived from a variety of precursors, including both unaltered and thermally altered sources. Here, we test whether or not the benzene carboxylic acid and hydroxy benzoic acid (BCA) products obtained by CuO oxidation provide a robust indicator of Py-OC and compare them to non-Py-OC biomarkers of lignin. O and A horizons from microcosms were burned in the laboratory at varying levels of fire severity and subsequently incubated for 6 months. All soils were analyzed for total OC and N and were analyzed by CuO oxidation. All BCAs appeared to be preserved or created to some degree during burning while lignin phenols appeared to be altered or destroyed to varying extents dependent on fire severity. We found two specific CuO oxidation products, o-hydroxybenzoic acid (oBd) and 1,2,4-benzenetricarboxylic acid (BTC2) that responded strongly to burn severity and withstood degradation during post-burning microbial incubations. Interestingly, we found that benzene di- and tricarboxylic acids (BDC and BTC, respectively) were much more reactive than vanillyl phenols during the incubation as a possible result of physical protection of vanillyl phenols in the interior of char particles or CuO oxidation derived BCAs originating from biologically available classes of Py-OC. We found that the ability of these compounds to predict relative Py-OC content in burned samples improved when normalized by their respective BCA class (i.e. benzene monocarboxylic acids (BA) and BTC, respectively) and when BTC was normalized to total lignin yields (BTC:Lig). The major trends in BCAs imparted by burning persisted through a 6 month incubation suggesting that fire severity had first order control on BCA and lignin composition. Using original and published BCA data from soils, sediments, char, and interfering compounds we found that BTC:Lig and BTC2:BTC were able to distinguish Py-OC from compounds such as humic materials, tannins, etc. The BCAs released by the CuO oxidation procedure increase the functionality of this method in order to examine the relative contribution of Py-OC in geochemical samples.	[Hatten, Jeff] Oregon State Univ, Dept Forest Engn Resources & Management, Corvallis, OR 97331 USA; [Goni, Miguel] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Hatten, J (corresponding author), Oregon State Univ, Dept Forest Engn Resources & Management, Corvallis, OR 97331 USA.	jeff.hatten@oregonstate.edu	Goni, Miguel/AAE-3737-2020; Hatten, Jeff A/E-7742-2010	Hatten, Jeff A/0000-0002-1685-6351	NSF [0903748, 0628487]	NSF(National Science Foundation (NSF))	This research was supported by NSF grant numbers #0903748 and #0628487.	Baldock JA, 2002, ORG GEOCHEM, V33, P1093, DOI 10.1016/S0146-6380(02)00062-1; BENNER R, 1990, GEOCHIM COSMOCHIM AC, V54, P2003, DOI 10.1016/0016-7037(90)90268-P; Brodowski S, 2005, ORG GEOCHEM, V36, P1299, DOI 10.1016/j.orggeochem.2005.03.011; Cao XY, 2012, ENERG FUEL, V26, P5983, DOI 10.1021/ef300947s; Certini G, 2011, GEODERMA, V167-68, P148, DOI 10.1016/j.geoderma.2011.09.005; Dale VH, 2001, BIOSCIENCE, V51, P723, DOI 10.1641/0006-3568(2001)051[0723:CCAFD]2.0.CO;2; DeBano LF, 1998, FIRES EFFECTS ECOSYS; Dickens AF, 2007, ORG GEOCHEM, V38, P1256, DOI 10.1016/j.orggeochem.2007.04.004; Fried JS, 2004, CLIMATIC CHANGE, V64, P169, DOI 10.1023/B:CLIM.0000024667.89579.ed; Glaser B, 1998, ORG GEOCHEM, V29, P811, DOI 10.1016/S0146-6380(98)00194-6; Goldberg E.D., 1985, BLACK CARBON ENV PRO; Goni MA, 2009, DEEP-SEA RES PT I, V56, P614, DOI 10.1016/j.dsr.2008.11.010; GONI MA, 1995, GEOCHIM COSMOCHIM AC, V59, P2965, DOI 10.1016/0016-7037(95)00188-3; Goni MA, 2000, ANAL CHEM, V72, P3116, DOI 10.1021/ac991316w; Goni MA, 2003, ESTUAR COAST SHELF S, V57, P1023, DOI 10.1016/S0272-7714(03)00008-8; GONI MA, 1990, GEOCHIM COSMOCHIM AC, V54, P3073, DOI 10.1016/0016-7037(90)90123-3; GONI MA, 1993, GEOCHIM COSMOCHIM AC, V57, P3985, DOI 10.1016/0016-7037(93)90348-Z; GONI MA, 1992, GEOCHIM COSMOCHIM AC, V56, P4025, DOI 10.1016/0016-7037(92)90014-A; Hatten J, 2005, FOREST ECOL MANAG, V220, P227, DOI 10.1016/j.foreco.2005.08.014; Hatten JA, 2008, FOREST ECOL MANAG, V255, P2555, DOI 10.1016/j.foreco.2008.01.016; Hatten JA, 2009, SOIL SCI SOC AM J, V73, P262, DOI 10.2136/sssaj2007.0304; Hatten JA, 2012, BIOGEOCHEMISTRY, V107, P43, DOI 10.1007/s10533-010-9529-z; Hatten JA, 2010, INT J WILDLAND FIRE, V19, P613, DOI 10.1071/WF08048; Haumaier L, 2010, J PLANT NUTR SOIL SC, V173, P727, DOI 10.1002/jpln.201000065; Hedges J.I., 1993, ORG GEOCHEM, P237, DOI DOI 10.1007/978-1-4615-2890-6_11; HEDGES JI, 1984, LIMNOL OCEANOGR, V29, P657, DOI 10.4319/lo.1984.29.3.0657; HEDGES JI, 1989, GEOCHIM COSMOCHIM AC, V53, P2659, DOI 10.1016/0016-7037(89)90137-3; Hernes PJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031017; Hernes PJ, 2001, GEOCHIM COSMOCHIM AC, V65, P3109, DOI 10.1016/S0016-7037(01)00641-X; Houel S, 2006, LIMNOL OCEANOGR, V51, P1497, DOI 10.4319/lo.2006.51.3.1497; Keiluweit M, 2010, ENVIRON SCI TECHNOL, V44, P1247, DOI 10.1021/es9031419; Killops S., 2005, INTRO ORGANIC GEOCHE, V2; Knicker H, 1996, SOIL BIOL BIOCHEM, V28, P1053, DOI 10.1016/0038-0717(96)00078-8; Knicker H, 2008, ORG GEOCHEM, V39, P935, DOI 10.1016/j.orggeochem.2008.03.021; Knicker H, 2007, BIOGEOCHEMISTRY, V85, P91, DOI 10.1007/s10533-007-9104-4; Knicker H, 2010, ORG GEOCHEM, V41, P947, DOI 10.1016/j.orggeochem.2010.04.007; Kuo LJ, 2008, ORG GEOCHEM, V39, P1522, DOI 10.1016/j.orggeochem.2008.07.011; Mao JD, 2012, ENVIRON SCI TECHNOL, V46, P9571, DOI 10.1021/es301107c; Masiello CA, 2001, GLOBAL BIOGEOCHEM CY, V15, P407, DOI 10.1029/2000GB001290; Otto A, 2006, BIOGEOCHEMISTRY, V80, P121, DOI 10.1007/s10533-006-9014-x; PRAHL FG, 1994, GEOCHIM COSMOCHIM AC, V58, P3035, DOI 10.1016/0016-7037(94)90177-5; Sanchez-Garcia L, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003956; Schmidt MWI, 2011, NATURE, V478, P49, DOI 10.1038/nature10386; Schmidt MWI, 2001, GLOBAL BIOGEOCHEM CY, V15, P163, DOI 10.1029/2000GB001284; Schneider MPW, 2010, ORGANIC GEOCHEMISTRY; Skjemstad JO, 1999, COMMUN SOIL SCI PLAN, V30, P2283, DOI 10.1080/00103629909370372; Skjemstad JO, 2002, SOIL SCI SOC AM J, V66, P1249, DOI 10.2136/sssaj2002.1249; Song JZ, 2002, ENVIRON SCI TECHNOL, V36, P3960, DOI 10.1021/es025502m; Zabowski D, 2009, SOILS	49	4	5	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151957	10.1371/journal.pone.0151957	http://dx.doi.org/10.1371/journal.pone.0151957			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27011012	Green Submitted, Green Published, gold			2022-12-26	WOS:000372708000060
J	Sugimoto, M; Wakabayashi, M; Shimizu, Y; Yoshioka, T; Higashino, K; Numata, Y; Okuda, T; Zhao, S; Sakai, S; Igarashi, Y; Kuge, Y				Sugimoto, Masayuki; Wakabayashi, Masato; Shimizu, Yoichi; Yoshioka, Takeshi; Higashino, Kenichi; Numata, Yoshito; Okuda, Tomohiko; Zhao, Songji; Sakai, Shota; Igarashi, Yasuyuki; Kuge, Yuji			Imaging Mass Spectrometry Reveals Acyl-Chain- and Region-Specific Sphingolipid Metabolism in the Kidneys of Sphingomyelin Synthase 2-Deficient Mice	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; HIGH-FAT DIET; MEMBRANE SPHINGOMYELIN; INSULIN-RESISTANCE; CERAMIDE SYNTHASE; ANIMAL-MODELS; MOUSE-BRAIN; EXPRESSION; TISSUE; OBESITY	Obesity was reported to cause kidney injury by excessive accumulation of sphingolipids such as sphingomyelin and ceramide. Sphingomyelin synthase 2 (SMS2) is an important enzyme for hepatic sphingolipid homeostasis and its dysfunction is considered to result in fatty liver disease. The expression of SMS2 is also high in the kidneys. However, the contribution of SMS2 on renal sphingolipid metabolism remains unclear. Imaging mass spectrometry is a powerful tool to visualize the distribution and provide quantitative data on lipids in tissue sections. Thus, in this study, we analyzed the effects of SMS2 deficiency on the distribution and concentration of sphingomyelins in the liver and kidneys of mice fed with a normal-diet or a high-fat-diet using imaging mass spectrometry and liquid chromatography/electrospray ionization-tandem mass spectrometry. Our study revealed that high-fat-diet increased C18-C22 sphingomyelins, but decreased C24-sphingomyelins, in the liver and kidneys of wild-type mice. By contrast, SMS2 deficiency decreased C18-C24 sphingomyelins in the liver. Although a similar trend was observed in the whole-kidneys, the effects were minor. Interestingly, imaging mass spectrometry revealed that sphingomyelin localization was specific to each acyl-chain length in the kidneys. Further, SMS2 deficiency mainly decreased C22-sphingomyelin in the renal medulla and C24-sphingomyelins in the renal cortex. Thus, imaging mass spectrometry can provide visual assessment of the contribution of SMS2 on acyl-chain- and region-specific sphingomyelin metabolism in the kidneys.	[Sugimoto, Masayuki; Kuge, Yuji] Hokkaido Univ, Grad Sch Med, Dept Integrated Mol Imaging, Sapporo, Hokkaido, Japan; [Sugimoto, Masayuki; Wakabayashi, Masato; Yoshioka, Takeshi; Higashino, Kenichi; Numata, Yoshito] Shionogi & Co Ltd, Shionogi Innovat Ctr Drug Discovery, Discovery Res Lab Innovat Frontier Med, Sapporo, Hokkaido, Japan; [Shimizu, Yoichi; Kuge, Yuji] Hokkaido Univ, Cent Inst Isotope Sci, Sapporo, Hokkaido, Japan; [Shimizu, Yoichi] Hokkaido Univ, Fac Pharmaceut Sci, Lab Bioanal & Mol Imaging, Kita 12, Sapporo, Hokkaido 060, Japan; [Okuda, Tomohiko] Shionogi & Co Ltd, Drug Discovery Technol, Discovery Res Lab Core Therapeut Areas, Toyonaka, Osaka, Japan; [Zhao, Songji] Hokkaido Univ, Grad Sch Med, Dept Tracer Kinet & Bioanal, Sapporo, Hokkaido, Japan; [Sakai, Shota; Igarashi, Yasuyuki] Hokkaido Univ, Fac Adv Life Sci, Dept Biomembrane & Biofunct Chem, Sapporo, Hokkaido, Japan	Hokkaido University; Shionogi & Company Limited; Hokkaido University; Hokkaido University; Shionogi & Company Limited; Hokkaido University; Hokkaido University	Kuge, Y (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Integrated Mol Imaging, Sapporo, Hokkaido, Japan.; Kuge, Y (corresponding author), Hokkaido Univ, Cent Inst Isotope Sci, Sapporo, Hokkaido, Japan.	kuge@ric.hokudai.ac.jp		Yoshioka, Takeshi/0000-0002-8658-8081	Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program, Ministry of Education, Culture, Sports, Science and Technology, Japan; Shionogi Co., Ltd.	Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program, Ministry of Education, Culture, Sports, Science and Technology, Japan; Shionogi Co., Ltd.	This study was supported by the Creation of Innovation Centers for Advanced Interdisciplinary Research Areas Program, Ministry of Education, Culture, Sports, Science and Technology, Japan (URL: http://www.jst.go.jp/shincho/sentanyugo/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also funded by Shionogi & Co., Ltd. (http://www.shionogi.co.jp/index.html). The funder provided support in the form of salaries for authors [MS MW TY KH YN TO], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Berry KAZ, 2014, J LIPID RES, V55, P504, DOI 10.1194/jlr.M044990; Bickert A, 2015, J LIPID RES, V56, P821, DOI 10.1194/jlr.M055269; Boini KM, 2010, J PHARMACOL EXP THER, V334, P839, DOI 10.1124/jpet.110.168815; Colsch B, 2004, J LIPID RES, V45, P281, DOI 10.1194/jlr.M300331-JLR200; Cornett DS, 2008, ANAL CHEM, V80, P5648, DOI 10.1021/ac800617s; Ebel P, 2013, J BIOL CHEM, V288, P21433, DOI 10.1074/jbc.M113.479907; Goto-Inoue N, 2011, BBA-MOL CELL BIOL L, V1811, P961, DOI 10.1016/j.bbalip.2011.03.004; Goto-Inoue N, 2010, J AM SOC MASS SPECTR, V21, P1940, DOI 10.1016/j.jasms.2010.08.002; Guebre-Egziabher F, 2013, BIOCHIMIE, V95, P1971, DOI 10.1016/j.biochi.2013.07.017; Hussain MM, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-71; Imgrund S, 2009, J BIOL CHEM, V284, P33549, DOI 10.1074/jbc.M109.031971; Irie M, 2014, METABOLOMICS, V10, P473, DOI 10.1007/s11306-013-0588-8; Jadoul L, 2015, ANAL BIOANAL CHEM, V407, P2095, DOI 10.1007/s00216-014-8232-7; Jones EE, 2014, ANAL CHEM, V86, P8303, DOI 10.1021/ac501937d; Kozawa S, 2011, MOL MED REP, V4, P1157, DOI 10.3892/mmr.2011.560; Kuchar L, 2015, ANAL BIOANAL CHEM, V407, P2283, DOI 10.1007/s00216-014-8402-7; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Li Y, 2013, ARTERIOSCL THROM VAS, V33, P1513, DOI 10.1161/ATVBAHA.113.301498; Li ZQ, 2011, MOL CELL BIOL, V31, P4205, DOI 10.1128/MCB.05893-11; Liu J, 2009, ARTERIOSCL THROM VAS, V29, P850, DOI 10.1161/ATVBAHA.109.185223; Masaki Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep16802; Mitsutake S, 2011, J BIOL CHEM, V286, P28544, DOI 10.1074/jbc.M111.255646; Miura D, 2010, ANAL CHEM, V82, P5887, DOI 10.1021/ac902931x; Miyaji M, 2005, J EXP MED, V202, P249, DOI 10.1084/jem.20041685; Muller L, 2015, KIDNEY INT, V88, P186, DOI 10.1038/ki.2015.3; Ogiso H, 2015, J LIPID RES, V56, P1594, DOI 10.1194/jlr.M059972; Ortiz A, 2015, EUR J PHARMACOL, V759, P205, DOI 10.1016/j.ejphar.2015.03.026; Park JW, 2013, HEPATOLOGY, V57, P525, DOI 10.1002/hep.26015; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; Roux A, 2015, ACS CHEM NEUROSCI, V6, P247, DOI 10.1021/cn500174c; Stettner P, 2013, P NATL ACAD SCI USA, V110, P9998, DOI 10.1073/pnas.1217775110; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Sugimoto M, 2015, BBA-MOL CELL BIOL L, V1851, P1554, DOI 10.1016/j.bbalip.2015.09.004; Sugiura Y, 2009, J LIPID RES, V50, P1776, DOI 10.1194/jlr.M900047-JLR200; Taniguchi M, 2014, BBA-MOL CELL BIOL L, V1841, P692, DOI 10.1016/j.bbalip.2013.12.003; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; Uceyler N, 2012, SCHMERZ, V26, P609, DOI 10.1007/s00482-012-1238-1; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; Zager RA, 1998, KIDNEY INT, V53, P573, DOI 10.1046/j.1523-1755.1998.00772.x; Zager RA, 1997, KIDNEY INT, V52, P60, DOI 10.1038/ki.1997.304	41	21	21	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152191	10.1371/journal.pone.0152191	http://dx.doi.org/10.1371/journal.pone.0152191			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010944	gold, Green Published, Green Submitted			2022-12-26	WOS:000372708000107
J	Tian, TT; Zhao, JH; Yang, J; Qiang, CX; Li, ZR; Chen, J; Xu, KY; Ciu, QQ; Li, RX				Tian, Tian-tian; Zhao, Jian-hong; Yang, Jing; Qiang, Cui-xin; Li, Zhi-rong; Chen, Jing; Xu, Kai-yue; Ciu, Qing-qing; Li, Ru-xin			Molecular Characterization of Clostridium difficile Isolates from Human Subjects and the Environment	PLOS ONE			English	Article							COLONIZATION; COMMUNITY; EPIDEMIOLOGY; INFECTION; CARRIAGE; INFANTS; PREVALENCE; DIARRHEA; STRAINS; TOXIN	Clostridium difficile is a spore-forming, gram-positive, anaerobic bacillus that can cause C. difficile infection (CDI). However, only a few studies on the prevalence and antibiotic resistance of C. difficile in healthy individuals in China have been reported. We employed a spore enrichment culture to screen for C. difficile in the stool samples of 3699 healthy Chinese individuals who were divided into 4 groups: infants younger than 2 years of age and living at home with their parents; children aged 1 to 8 years of age and attending three different kindergarten schools; community-dwelling healthy adult aged 23-60 years old; and healthcare workers aged 28-80 years old. The C. difficile isolates were analyzed for the presence of toxin genes and typed by PCR ribotyping and multilocus sequence typing (MLST). The minimum inhibitory concentration of 8 antimicrobial agents was determined for all of the isolates using the agar dilution method. The intestinal carriage rate in the healthy children was 13.6% and ranged from 0% to 21% depending on age. The carriage rates in the 1654 community-dwelling healthy adults and 348 healthcare workers were 5.5% and 6.3%, respectively. Among the isolates, 226 were toxigenic (225 tcdA+/tcdB+ and 1 tcdA +/tcdB+ ctdA+/ctdB+). Twenty-four ribotypes were found, with the dominant type accounting for 29.7% of the isolates. The toxigenic isolates were typed into 27 MLST genotypes. All of the strains were susceptible to vancomycin, metronidazole, fidaxomicin, and rifaximin. High resistance to levofloxacin and ciprofloxacin at rates of 39.8% and 98.3%, respectively, were observed. ST37 isolates were more resistant to levofloxacin than the other STs. The PCR ribotypes and sequence types from the healthy populations were similar to those from the adult patients.	[Tian, Tian-tian; Zhao, Jian-hong; Yang, Jing; Qiang, Cui-xin; Li, Zhi-rong; Xu, Kai-yue; Ciu, Qing-qing; Li, Ru-xin] Hebei Med Univ, Dept Clin Microbiol, Hosp 2, Hebei Prov Ctr Clin Labs, Shijiazhuang, Hebei Province, Peoples R China; [Chen, Jing] Maternal & Child Hlth Care Ctr Cangzhou, Hlth Care Dept, Cangzhou City, Hebei Province, Peoples R China	Hebei Medical University	Zhao, JH (corresponding author), Hebei Med Univ, Dept Clin Microbiol, Hosp 2, Hebei Prov Ctr Clin Labs, Shijiazhuang, Hebei Province, Peoples R China.	zhaojh_2002@yahoo.com						Bauer MP, 2008, NETH J MED, V66, P207; Bidet P, 1999, FEMS MICROBIOL LETT, V175, P261, DOI 10.1016/S0378-1097(99)00204-9; Bouttier S, 2010, EMERG INFECT DIS, V16, P733, DOI 10.3201/eid1604.091138; Carmeli Y, 1998, INFECT CONT HOSP EP, V19, P38; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P1201; Cheng VCC, 2009, INT J ANTIMICROB AG, V34, P492, DOI 10.1016/j.ijantimicag.2009.04.004; Clinical and Laboratory Standards Institute, 2010, M11A7 CLSI; COLLIGNON A, 1993, EUR J PEDIATR, V152, P319, DOI 10.1007/BF01956743; European Committee on Antimicrobial Susceptibility Testing, 2011, CLIN BREAKP TABL VER; Fallani M, 2011, MICROBIOL-SGM, V157, P1385, DOI 10.1099/mic.0.042143-0; Galdys AL, 2014, J CLIN MICROBIOL, V52, P2406, DOI 10.1128/JCM.00222-14; Geric B, 2004, J MED MICROBIOL, V53, P887, DOI 10.1099/jmm.0.45610-0; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; Hell M, 2012, AM J INFECT CONTROL, V40, P1023, DOI 10.1016/j.ajic.2012.01.018; HOLST E, 1981, SCAND J INFECT DIS, V13, P41, DOI 10.1080/00365548.1981.11690365; Jangi S, 2010, J PEDIATR GASTR NUTR, V51, P2, DOI 10.1097/MPG.0b013e3181d29767; JOHNSON S, 1990, AM J MED, V88, P137, DOI 10.1016/0002-9343(90)90462-M; Kato H, 2001, J MED MICROBIOL, V50, P720, DOI 10.1099/0022-1317-50-8-720; Khanna S, 2012, AM J GASTROENTEROL, V107, P89, DOI 10.1038/ajg.2011.398; Khanna S, 2010, EXPERT REV GASTROENT, V4, P409, DOI 10.1586/EGH.10.48; LARSON HE, 1982, J INFECT DIS, V146, P727, DOI 10.1093/infdis/146.6.727; Matsuki S, 2005, INT MICROBIOL, V8, P43; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; McFarland LV, 2000, J PEDIATR GASTR NUTR, V31, P220, DOI 10.1097/00005176-200009000-00004; O'Connor JR, 2008, ANTIMICROB AGENTS CH, V52, P2813, DOI 10.1128/AAC.00342-08; Penders J, 2008, GUT, V57, P1025, DOI 10.1136/gut.2007.143214; Persson S, 2008, CLIN MICROBIOL INFEC, V14, P1057, DOI 10.1111/j.1469-0691.2008.02092.x; Rexach CE, 2006, DIAGN MICR INFEC DIS, V56, P109, DOI 10.1016/j.diagmicrobio.2006.03.002; Rousseau C, 2012, CLIN INFECT DIS, V55, P1209, DOI 10.1093/cid/cis637; Rousseau C, 2011, J MED MICROBIOL, V60, P1112, DOI 10.1099/jmm.0.029736-0; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Sandora TJ, 2011, PEDIATR INFECT DIS J, V30, P580, DOI 10.1097/INF.0b013e31820bfb29; van Nood E, 2009, INFECT CONT HOSP EP, V30, P924, DOI 10.1086/605642; Wang P, 2014, INFECT CONT HOSP EP, V35, P95, DOI 10.1086/674405; Weaver L, 2008, J HOSP INFECT, V68, P145, DOI 10.1016/j.jhin.2007.11.011; Wilcox MH, 2008, J ANTIMICROB CHEMOTH, V62, P388, DOI 10.1093/jac/dkn163; YAMAMOTOOSAKI T, 1994, J MED MICROBIOL, V40, P179, DOI 10.1099/00222615-40-3-179; [杨靖 Yang Jing], 2013, [中华检验医学杂志, Chinese Journal of Laboratory Medicine], V36, P920	38	33	37	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151964	10.1371/journal.pone.0151964	http://dx.doi.org/10.1371/journal.pone.0151964			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27011211	Green Submitted, Green Published, gold			2022-12-26	WOS:000372708000061
J	Van Effelterre, T; Dos Santos, G; Shinde, V				Van Effelterre, Thierry; Dos Santos, Gael; Shinde, Vivek			Twin Peaks: A/H1N1 Pandemic Influenza Virus Infection and Vaccination in Norway, 2009-2010	PLOS ONE			English	Article							SOCIAL CONTACTS; NARCOLEPSY; DISEASE	Background Vaccination campaigns against A/H1N1 2009 pandemic influenza virus (A/H1N1p) began in autumn 2009 in Europe, after the declaration of the pandemic at a global level. This study aimed to estimate the proportion of individuals vaccinated against A/H1N1p in Norway who were already infected (asymptomatically or symptomatically) by A/H1N1p before vaccination, using a mathematical model. Methods A dynamic, mechanistic, mathematical model of A/H1N1p transmission was developed for the Norwegian population. The model parameters were estimated by calibrating the model-projected number of symptomatic A/H1N1p cases to the number of laboratory-confirmed A/H1N1p cases reported to the surveillance system, accounting for potential under-reporting. It was assumed in the base case that the likelihood of vaccination was independent of infection/disease state. A sensitivity analysis explored the effects of four scenarios in which current or previous symptomatic A/H1N1p infection would influence the likelihood of being vaccinated. Results The number of model-projected symptomatic A/H1N1p cases by week during the epidemic, accounting for under-reporting and timing, closely matched that of the laboratory-confirmed A/H1N1p cases reported to the surveillance system. The model-projected incidence of symptomatic A/H1N1p infection was 27% overall, 55% in people <10 years old and 41% in people 10-20 years old. The model-projected percentage of individuals vaccinated against A/H1N1p who were already infected with A/H1N1p before being vaccinated was 56% overall, 62% in people <10 years old and 66% in people 10-20 years old. The results were sensitive to assumptions about the independence of vaccination and infection; however, even when current or previous symptomatic A/H1N1p infection was assumed to reduce the likelihood of vaccination, the estimated percentage of individuals who were infected before vaccination remained at least 32% in all age groups. Conclusion This analysis suggests that over half the people vaccinated against A/H1N1p in Norway during the 2009 pandemic may already have been infected by A/H1N1p before being vaccinated.	[Van Effelterre, Thierry] GSK Vaccines, Global Epidemiol, Wavre, Belgium; [Dos Santos, Gael] GSK Vaccines, Business & Decis Life Sci, Brussels, Belgium; [Shinde, Vivek] GSK Vaccines, King Of Prussia, PA USA; [Shinde, Vivek] Novavax, Rockville, MD USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Van Effelterre, T (corresponding author), GSK Vaccines, Global Epidemiol, Wavre, Belgium.	THIERRY.VAN-EFFELTERRE@GSK.COM			GlaxoSmithKline Biologicals SA	GlaxoSmithKline Biologicals SA(GlaxoSmithKline)	The study was funded by GlaxoSmithKline Biologicals SA. GlaxoSmithKline Biologicals SA was involved in all stages of the study design, conduct and analysis. GlaxoSmithKline Biologicals SA also funded all costs associated with the development and publishing of the present manuscript. All authors had full access to the data and approved the submission of the publication.	Ahmed SS, 2014, J AUTOIMMUN, V50, P1, DOI 10.1016/j.jaut.2014.01.033; Amato-Gauci A, 2011, EURO SURVEILL, V16, P19903; de Blasio BF, 2012, PLOS ONE, V7, P327, DOI 10.1371/journal.pone.0030018; European Centre for Disease Prevention and Control, 2010, 2009 H1N1 PAND EUR; Goeyvaerts N, 2010, J R STAT SOC C-APPL, V59, P255, DOI 10.1111/j.1467-9876.2009.00693.x; Han F, 2013, ANN NEUROL, V73, P560, DOI 10.1002/ana.23799; Han F, 2011, ANN NEUROL, V70, P410, DOI 10.1002/ana.22587; Hardelid P, 2010, HEALTH TECHNOL ASSES, V14, P115, DOI 10.3310/hta14550-03; Hayward AC, 2014, LANCET RESP MED, V2, P445, DOI 10.1016/S2213-2600(14)70034-7; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Oberle D, 2015, SLEEP, V38, P1619, DOI 10.5665/sleep.5060; Partinen M, 2014, LANCET NEUROL, V13, P600, DOI 10.1016/S1474-4422(14)70075-4; Silber MH, 2002, SLEEP, V25, P197, DOI 10.1093/sleep/25.2.197; Sturkenboom MCJM, 2015, VACCINE, V33, pB6, DOI 10.1016/j.vaccine.2015.03.026; Tesoriero C, 2016, P NATL ACAD SCI USA, V113, pE368, DOI 10.1073/pnas.1521463112; United States Census Bureau, 2015, INT DAT BAS; Vaarala O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114361; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Verstraeten T, 2015, HUM VACC IMMUNOTHER, V17, P1; Wichmann O, 2010, EURO SURVEILL, V15; World Health Organization, 2013, EV PAND H1N1 2009; World Health Organization, 2009, WORLD NOW START 2009; [No title captured]	24	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151575	10.1371/journal.pone.0151575	http://dx.doi.org/10.1371/journal.pone.0151575			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010830	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708000034
J	Gillett, AK; Ploeg, R; O'Donoghue, PJ; Chapman, PA; Webb, RI; Flint, M; Mills, PC				Gillett, Amber K.; Ploeg, Richard; O'Donoghue, Peter J.; Chapman, Phoebe A.; Webb, Richard I.; Flint, Mark; Mills, Paul C.			Ultrastructural and Molecular Characterisation of an Heterosporis-Like Microsporidian in Australian Sea Snakes (Hydrophiinae)	PLOS ONE			English	Article							N. SP MICROSPORIDIA; INTESTINAL MICROSPORIDIOSIS; ENTEROCYTOZOON-SALMONIS; PLISTOPHORA-ANGUILLARUM; TETRAMICRA-BREVIFILUM; EASTERN AUSTRALIA; FISH; PARASITE; INFECTION; MUSCLE	Four sea snakes (two Hydrophis major, one Hydrophis platurus, one Hydrophis elegans) were found washed ashore on different beaches in the Sunshine Coast region and Fraser Island in Queensland, Australia between 2007-2013. Each snake had multiple granulomas and locally extensive regions of pallor evident in the hypaxial and intercostal musculature along the body. Lesions in two individuals were also associated with vertebral and rib fractures. Histological examination revealed granulomas scattered throughout skeletal muscle, subcutaneous adipose tissue and fractured bone. These were composed of dense aggregates of microsporidian spores surrounded by a mantle of macrophages. Sequences (ssrRNA) were obtained from lesions in three sea snakes and all revealed 99% similarity with Heterosporis anguillarum from the Japanese eel (Anguillarum japonica). However, ultrastructural characteristics of the organism were not consistent with those of previous descriptions. Electron microscopic examination of skeletal muscle revealed large cysts (not xenomas) bound by walls of fibrillar material (Heterosporis-like sporophorocyst walls were not detected). The cysts contained numerous mature microsporidian spores arranged in small clusters, sometimes apparently within sporophorous vesicles. The microspores were monomorphic, oval and measured 2.5-3.0 mu m by 1.6-1.8 mu m. They contained isofilar polar filaments with 11 (infrequently 9-12) coils arranged in two ranks. This is the first published report of a microsporidian infection in hydrophiid sea snakes. This discovery shows microsporidia with molecular affinities to Heterosporis anguillarum but ultrastructural characters most consistent with the genus Pleistophora (but no hitherto described species). Further studies are required to determine whether the microsporidian presented here belongs to the genus Heterosporis, or to a polymorphic species group as suggested by the recognition of a robust Pleistophora/Heterosporis clade by molecular studies. The gross and histological pathology associated with these infections are described.	[Gillett, Amber K.; Chapman, Phoebe A.; Flint, Mark; Mills, Paul C.] Univ Queensland, Sch Vet Sci, Vet MARTI, Gatton, Qld, Australia; [Gillett, Amber K.] Australia Zoo Wildlife Hosp, Beerwah, Qld, Australia; [Ploeg, Richard] Univ Melbourne, Fac Vet & Agr Sci, Werribee, Vic, Australia; [O'Donoghue, Peter J.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Webb, Richard I.] Univ Queensland, Ctr Microscopy & Microanal, St Lucia, Qld, Australia; [Flint, Mark] Univ Florida, Sch Forest Resources & Conservat, Florida Aquariums Ctr Conservat, Apollo Beach, FL USA	University of Queensland; University of Melbourne; University of Queensland; University of Queensland; State University System of Florida; University of Florida	Gillett, AK (corresponding author), Univ Queensland, Sch Vet Sci, Vet MARTI, Gatton, Qld, Australia.; Gillett, AK (corresponding author), Australia Zoo Wildlife Hosp, Beerwah, Qld, Australia.	amber.gillett@uqconnect.edu.au	O'Donoghue, Peter/G-1043-2011; Chapman, Phoebe/E-5044-2016	O'Donoghue, Peter/0000-0001-8715-1394; Chapman, Phoebe/0000-0002-3303-9134	University of Queensland, The School of Veterinary Science Donor/Bequest Research fund [BEQPMI2014]	University of Queensland, The School of Veterinary Science Donor/Bequest Research fund	This work was supported by The University of Queensland, The School of Veterinary Science Donor/Bequest Research fund BEQPMI2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Ghaffar F, 2009, PARASITOL RES, V106, P39, DOI 10.1007/s00436-009-1633-4; Adl SM, 2012, J EUKARYOT MICROBIOL, V59, P429, DOI 10.1111/j.1550-7408.2012.00644.x; Al-Quraishy S, 2012, PARASITOLOGY, V139, P454, DOI 10.1017/S0031182011001971; Baquero E, 2005, J EUKARYOT MICROBIOL, V52, P476, DOI 10.1111/j.1550-7408.2005.00054.x; Canning E. U., 1981, Parasitological topics -- a presentation volume to P.C.C. Garnham, F.R.S. on the occasion of his 80th birthday, 1981., P57; CANNING EU, 1980, J FISH DIS, V3, P317, DOI 10.1111/j.1365-2761.1980.tb00402.x; CANNING EU, 1979, PROTISTOLOGICA, V15, P317; Casal G, 2010, J PARASITOL, V96, P1155, DOI 10.1645/GE-2182.1; Chen YP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-451; CHILMONCZYK S, 1991, J PROTOZOOL, V38, P264, DOI 10.1111/j.1550-7408.1991.tb04440.x; CHUPP GL, 1993, CLIN INFECT DIS, V16, P15, DOI 10.1093/clinids/16.1.15; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DesportesLivage I, 1996, J EUKARYOT MICROBIOL, V43, P49, DOI 10.1111/j.1550-7408.1996.tb02472.x; Diamant A, 2010, DIS AQUAT ORGAN, V91, P137, DOI 10.3354/dao02256; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FETCHO JR, 1986, J COMP NEUROL, V249, P551, DOI 10.1002/cne.902490409; FIGUERAS A, 1992, DIS AQUAT ORGAN, V14, P127, DOI 10.3354/dao014127; Gardiner CH, 1988, ATLAS PROTOZOAN PARA, V651; Garg P, 2013, CORNEA, V32, pS33, DOI 10.1097/ICO.0b013e3182a2c91f; Ghosh Kaya, 2009, Interdiscip Perspect Infect Dis, V2009, P926521, DOI 10.1155/2009/926521; Gill EE, 2006, GENE, V375, P103, DOI 10.1016/j.gene.2006.02.023; Gillett AK, 2014, J ZOO WILDLIFE MED, V45, P755, DOI 10.1638/2013-0265.1; Guyenot E., 1922, Revue Suisse de Zoologie, V30, P1; Hall T., 2005, BIOEDIT BIOL SEQUENC; HASHIMOTO K, 1976, B JPN SOC SCI FISH, V42, P411; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; Hoshina T, 1951, J TOKYO U FISH, V38, P35; Huelsenbeck JP, 2004, SYST BIOL, V53, P904, DOI 10.1080/10635150490522629; Jacobson ER, 1998, J ZOO WILDLIFE MED, V29, P315; Joh SJ, 2007, J VET SCI, V8, P147, DOI 10.4142/jvs.2007.8.2.147; Karpov SA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00112; Koudela B, 1998, FOLIA PARASIT, V45, P149; Ladds PW, 2009, PATHOLOGY AUSTR NATI, P261; Limpus CJ, 1975, BIOL SEA SNAKES, P173; LIU SK, 1971, J AM VET MED ASSOC, V159, P1578; Lom J, 2002, SYST PARASITOL, V53, P81, DOI 10.1023/A:1020422209539; Lom J, 2000, DIS AQUAT ORGAN, V43, P225, DOI 10.3354/dao043225; LOM J, 1967, J PROTOZOOL, V14, P141, DOI 10.1111/j.1550-7408.1967.tb01459.x; LOM JII, 1963, ACTA PROTOZOOLOGICA, V1, P81; Maillo PA, 1998, PARASITOL RES, V84, P208, DOI 10.1007/s004360050384; MAURAND J, 1988, J FISH DIS, V11, P251, DOI 10.1111/j.1365-2761.1988.tb00546.x; McCosker J., 1975, BIOL SEA SNAKES, V75, P217; McGourty KR, 2007, J PARASITOL, V93, P655, DOI 10.1645/GE-994R.1; Nagpal A, 2013, TRANSPL INFECT DIS, V15, P526, DOI 10.1111/tid.12119; NARASIMHAMURTI CC, 1982, ACTA PROTOZOOL, V21, P127; O'donoghue P., 2010, MICROSPORIDIA 2010 A; ORENSTEIN JM, 1990, HUM PATHOL, V21, P475; Pekkarinen M, 2002, DIS AQUAT ORGAN, V48, P133, DOI 10.3354/dao048133; Pfaller JB, 2012, INTEGR COMP BIOL, V52, P296, DOI 10.1093/icb/ics038; Phelps NBD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132027; PUTZ RE, 1965, J PROTOZOOL, V12, P228, DOI 10.1111/j.1550-7408.1965.tb01842.x; Rambaut A, 2014, TRACER VERSION V1 6; Rasmussen AR, 2014, ZOOTAXA, V3869, P351, DOI 10.11646/zootaxa.3869.4.1; Reece R, TARONGA ZOO, P227; Richter B, 2014, J COMP PATHOL, V150, P332, DOI 10.1016/j.jcpa.2013.07.009; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sanders JL, 2010, DIS AQUAT ORGAN, V91, P47, DOI 10.3354/dao02245; Schottelius J, 2000, MEM I OSWALDO CRUZ, V95, P133, DOI 10.1590/S0074-02762000000700022; Shaw RW, 1997, J PARASITOL, V83, P296, DOI 10.2307/3284459; SHIELDS JD, 1992, J CRUSTACEAN BIOL, V12, P94, DOI 10.2307/1548723; Small HJ, 2014, DIS AQUAT ORGAN, V110, P213, DOI 10.3354/dao02754; Stentiford GD, 2013, INT J PARASITOL, V43, P339, DOI 10.1016/j.ijpara.2012.11.010; Stentiford GD, 2013, TRENDS PARASITOL, V29, P567, DOI 10.1016/j.pt.2013.08.005; TSUI WH, 1988, B I ZOOL ACAD SINICA, V27, P159; Vagelli A, 2005, J PARASITOL, V91, P152, DOI 10.1645/GE-388R; Vavra J, 2013, ADV PARASIT, V82, P253, DOI 10.1016/B978-0-12-407706-5.00004-6; Videira M, 2015, PARASITOL RES, V114, P2435, DOI 10.1007/s00436-015-4438-7; Vossbrinck CR, 2005, FOLIA PARASIT, V52, P131, DOI 10.14411/fp.2005.017; Wassenberg TJ, 2001, BIOL CONSERV, V100, P271, DOI 10.1016/S0006-3207(01)00031-3; Xiang H, 2014, CAN J MICROBIOL, V60, P557, DOI 10.1139/cjm-2014-0209	70	4	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0150724	10.1371/journal.pone.0150724	http://dx.doi.org/10.1371/journal.pone.0150724			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007116	Green Published, gold			2022-12-26	WOS:000372701200027
J	Vila, S; Badosa, E; Montesinos, E; Planas, M; Feliu, L				Vila, Slvia; Badosa, Esther; Montesinos, Emilio; Planas, Marta; Feliu, Lidia			Synthetic Cyclolipopeptides Selective against Microbial, Plant and Animal Cell Targets by Incorporation of D-Amino Acids or Histidine	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; ANTIMICROBIAL PEPTIDES; ANTIFUNGAL ACTIVITY; CATHEPSIN-G; LIPOPEPTIDES; ANTIBACTERIAL; BACILLUS; BACTERIAL; MODES; BIOSYNTHESIS	Cyclolipopeptides derived from the antimicrobial peptide c(Lys-Lys-Leu-Lys-Lys-Phe-Lys-Lys-Leu-Gln) (BPC194) were prepared on solid-phase and screened against four plant pathogens. The incorporation at Lys(5) of fatty acids of 4 to 9 carbon atoms led to active cyclolipopeptides. The influence on the antimicrobial activity of the Lys residue that is derivatized was also evaluated. In general, acylation of Lys(1), Lys(2) or Lys(5) rendered the sequences with the highest activity. Incorporation of a D-amino acid maintained the antimicrobial activity while significantly reduced the hemolysis. Replacement of Phe with a His also yielded cyclolipopeptides with low hemolytic activity. Derivatives exhibiting low phytotoxicity in tobacco leaves were also found. Interestingly, sequences with or without significant activity against phytopathogenic bacteria and fungi, but with differential hemolysis and phytotoxicity were identified. Therefore, this study represents an approach to the development of bioactive peptides with selective activity against microbial, plant and animal cell targets. These selective cyclolipopeptides are candidates useful not only to combat plant pathogens but also to be applied in other fields.	[Vila, Slvia; Planas, Marta; Feliu, Lidia] Univ Girona, Dept Chem, LIPPSO, Campus Montilivi, Girona, Spain; [Badosa, Esther; Montesinos, Emilio] Univ Girona, Inst Food & Agr Technol CIDSAV XaRTA, Plant Pathol Lab, Campus Montilivi, Girona, Spain	Universitat de Girona; Universitat de Girona	Planas, M; Feliu, L (corresponding author), Univ Girona, Dept Chem, LIPPSO, Campus Montilivi, Girona, Spain.; Montesinos, E (corresponding author), Univ Girona, Inst Food & Agr Technol CIDSAV XaRTA, Plant Pathol Lab, Campus Montilivi, Girona, Spain.	emilio.montesinos@udg.edu; marta.planas@udg.edu; lidia.feliu@udg.edu	Romañó, Esther Badosa/H-3342-2015; Planas, Marta/E-4145-2015; Feliu, Lidia/H-8285-2015; MONTESINOS, EMILIO/H-5246-2015	Romañó, Esther Badosa/0000-0001-7776-8286; Planas, Marta/0000-0003-4988-4970; Feliu, Lidia/0000-0001-9792-6106; MONTESINOS, EMILIO/0000-0003-4455-8332; FCCN, Bogus/0000-0001-6282-8004	Ministerio de Economia y Competitividad of Spain [AGL2009-13255-C02-02/AGR, AGL2012-39880-C02-02]	Ministerio de Economia y Competitividad of Spain(Spanish Government)	Funding provided by grant numbers: AGL2009-13255-C02-02/AGR (SV, MP, LF) and AGL2012-39880-C02-02 (SV, MP, LF). These grants were obtained from the Ministerio de Economia y Competitividad of Spain http://www.mineco.gob.es/portal/site/mineco/idi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajesh K, 2009, PEPTIDES, V30, P999, DOI 10.1016/j.peptides.2009.01.026; Avrahami D, 2003, BIOCHEMISTRY-US, V42, P14946, DOI 10.1021/bi035142v; Badosa E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085515; Baltzer SA, 2011, J MOL MICROB BIOTECH, V20, P228, DOI 10.1159/000331009; Bisht GS, 2007, BIOORG MED CHEM LETT, V17, P4343, DOI 10.1016/j.bmcl.2007.05.015; Chu-Kung AF, 2004, BIOCONJUGATE CHEM, V15, P530, DOI 10.1021/bc0341573; Eisenstein BI, 2004, EXPERT OPIN INV DRUG, V13, P1159, DOI 10.1517/13543784.13.9.1159; Guell I, 2011, APPL ENVIRON MICROB, V77, P2667, DOI 10.1128/AEM.02759-10; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Jerala R, 2007, EXPERT OPIN INV DRUG, V16, P1159, DOI 10.1517/13543784.16.8.1159; Laverty G, 2010, CHEM BIOL DRUG DES, V75, P563, DOI 10.1111/j.1747-0285.2010.00973.x; Lockwood NA, 2004, BIOCHEM J, V378, P93, DOI 10.1042/BJ20031393; Majerle A, 2003, J ANTIMICROB CHEMOTH, V51, P1159, DOI 10.1093/jac/dkg219; Mak P, 2003, INT J ANTIMICROB AG, V21, P13, DOI 10.1016/S0924-8579(02)00245-5; Makovitzki A, 2007, APPL ENVIRON MICROB, V73, P6629, DOI 10.1128/AEM.01334-07; Makovitzki A, 2006, P NATL ACAD SCI USA, V103, P15997, DOI 10.1073/pnas.0606129103; Malina A, 2005, BIOCHEM J, V390, P695, DOI 10.1042/BJ20050520; Mandal SM, 2013, BIOTECHNOL ADV, V31, P338, DOI 10.1016/j.biotechadv.2013.01.004; Mangoni ML, 2011, CELL MOL LIFE SCI, V68, P2267, DOI 10.1007/s00018-011-0718-2; Marcos JF, 2008, ANNU REV PHYTOPATHOL, V46, P273, DOI 10.1146/annurev.phyto.121307.094843; Monroc S, 2006, PEPTIDES, V27, P2567, DOI 10.1016/j.peptides.2006.04.019; Monroc S, 2006, PEPTIDES, V27, P2575, DOI 10.1016/j.peptides.2006.05.001; Montesinos E, 2007, FEMS MICROBIOL LETT, V270, P1, DOI 10.1111/j.1574-6968.2007.00683.x; Ng-Choi I, 2014, PROTEIN PEPTIDE LETT, V21, P357, DOI 10.2174/09298665113206660103; Ng-Choi I, 2012, EUR J ORG CHEM, V2012, P4321, DOI 10.1002/ejoc.201200291; Nicolas P, 2009, FEBS J, V276, P6483, DOI 10.1111/j.1742-4658.2009.07359.x; Niu B, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-137; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Pirri G, 2009, CENT EUR J BIOL, V4, P258, DOI 10.2478/s11535-009-0031-3; Raaijmakers JM, 2006, MOL PLANT MICROBE IN, V19, P699, DOI 10.1094/MPMI-19-0699; Raaijmakers JM, 2010, FEMS MICROBIOL REV, V34, P1037, DOI 10.1111/j.1574-6976.2010.00221.x; Rahnamaeian M, 2011, PLANT SIGNAL BEHAV, V6, P1325, DOI 10.4161/psb.6.9.16319; Romero D, 2007, MOL PLANT MICROBE IN, V20, P430, DOI 10.1094/MPMI-20-4-0430; Schneider T, 2010, INT J MED MICROBIOL, V300, P161, DOI 10.1016/j.ijmm.2009.10.005; Schneider T, 2010, CURR OPIN INVEST DR, V11, P157; Shafer WM, 2002, CURR PHARM DESIGN, V8, P695, DOI 10.2174/1381612023395376; Shai Y, 2006, CURR PROTEIN PEPT SC, V7, P479, DOI 10.2174/138920306779025620; Straus SK, 2006, BBA-BIOMEMBRANES, V1758, P1215, DOI 10.1016/j.bbamem.2006.02.009; Strieker M, 2009, CHEMBIOCHEM, V10, P607, DOI 10.1002/cbic.200800546; Teixeira V, 2012, PROG LIPID RES, V51, P149, DOI 10.1016/j.plipres.2011.12.005; Thennarasu S, 2005, BBA-BIOMEMBRANES, V1711, P49, DOI 10.1016/j.bbamem.2005.02.010; Vallon-Eberhard A, 2008, ANTIMICROB AGENTS CH, V52, P3118, DOI 10.1128/AAC.00526-08; Vila S, 2013, ORG BIOMOL CHEM, V11, P3365, DOI 10.1039/c3ob40319j; Xu ZH, 2013, APPL ENVIRON MICROB, V79, P808, DOI 10.1128/AEM.02645-12; Yao JZ, 2012, EUR J MED CHEM, V50, P196, DOI 10.1016/j.ejmech.2012.01.054	46	14	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151639	10.1371/journal.pone.0151639	http://dx.doi.org/10.1371/journal.pone.0151639			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008420	Green Published, gold, Green Submitted			2022-12-26	WOS:000372701200060
J	Wang, XM; Zhou, MR; Fu, Y; Sun, T; Chen, J; Qin, XM; Yu, Y; Jia, JH; Chen, CY				Wang, Xiaoming; Zhou, Minran; Fu, Yue; Sun, Ting; Chen, Jin; Qin, Xuemei; Yu, Yuan; Jia, Jihui; Chen, Chunyan			RBP2 Promotes Adult Acute Lymphoblastic Leukemia by Upregulating BCL2	PLOS ONE			English	Article							HISTONE DEMETHYLASE RBP2; ACUTE LYMPHOCYTIC-LEUKEMIA; CHRONIC MYELOID-LEUKEMIA; GASTRIC-CANCER; THERAPEUTIC TARGET; TUMOR-SUPPRESSOR; CELLS; INHIBITION; EPIGENETICS; PROGRESSION	Despite recent increases in the cure rate of acute lymphoblastic leukemia (ALL), adult ALL remains a high-risk disease that exhibits a high relapse rate. In this study, we found that the histone demethylase retinoblastoma binding protein-2 (RBP2) was overexpressed in both on-going and relapse cases of adult ALL, which revealed that RBP2 overexpression was not only involved in the pathogenesis of ALL but that its overexpression might also be related to relapse of the disease. RBP2 knockdown induced apoptosis and attenuated leukemic cell viability. Our results demonstrated that BCL2 is a novel target of RBP2 and supported the notion of RBP2 being a regulator of BCL2 expression via directly binding to its promoter. As the role of RBP2 in regulating apoptosis was confirmed, RBP2 overexpression and activation of BCL2 might play important roles in ALL development and progression.	[Wang, Xiaoming; Zhou, Minran; Fu, Yue; Sun, Ting; Qin, Xuemei; Yu, Yuan; Chen, Chunyan] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan, Shandong, Peoples R China; [Chen, Jin] Anhui Med Coll, Hefei, Anhui, Peoples R China; [Jia, Jihui] Shandong Univ, Sch Med, Chinese Minist Educ, Dept Microbiol,Key Lab Expt Teratol, Jinan, Shandong, Peoples R China	Shandong University; Anhui Medical College; Shandong University	Chen, CY (corresponding author), Shandong Univ, Qilu Hosp, Dept Hematol, Jinan, Shandong, Peoples R China.	chency@sdu.edu.cn			National Natural Science Foundation of China [81470318, 81170514, 30971151]; cross training program of Shandong University [2015JC052]; National Basic Research Program of China [2012CB911202]; project of Shandong province science and technology development plans [2014GSF118114]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); cross training program of Shandong University; National Basic Research Program of China(National Basic Research Program of China); project of Shandong province science and technology development plans	The authors thank the grant support from the National Natural Science Foundation of China (nos. 81470318, 81170514, 30971151), the cross training program of Shandong University (nos. 2015JC052), the National Basic Research Program of China (no. 973 Program 2012CB911202) and the project of Shandong province science and technology development plans (nos. 2014GSF118114).	Alford SE, 2015, CANCER RES, V75, P1366, DOI 10.1158/0008-5472.CAN-14-1849; Benton CB, 2014, BRIT J HAEMATOL, V167, P356, DOI 10.1111/bjh.13050; Bodet L, 2011, BLOOD, V118, P3901, DOI 10.1182/blood-2010-11-317438; Cao J, 2014, CELL REP, V6, P868, DOI 10.1016/j.celrep.2014.02.004; Chao MP, 2011, CANCER RES, V71, P1374, DOI 10.1158/0008-5472.CAN-10-2238; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Crazzolara R, 2009, CURR CANCER DRUG TAR, V9, P19, DOI 10.2174/156800909787314057; DiTacchio L, 2011, SCIENCE, V333, P1881, DOI 10.1126/science.1206022; Gandhi L, 2011, J CLIN ONCOL, V29, P909, DOI 10.1200/JCO.2010.31.6208; Garcia-Manero G, 2009, SEMIN HEMATOL, V46, P24, DOI 10.1053/j.seminhematol.2008.09.008; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Ko TK, 2014, ONCOTARGET, V5, P9033, DOI 10.18632/oncotarget.1925; Li LP, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-81; Liang XM, 2015, ONCOTARGET, V6, P17661, DOI 10.18632/oncotarget.3756; Liang XM, 2014, ONCOTARGET, V5, P5798, DOI 10.18632/oncotarget.2185; Mets E, 2015, LEUKEMIA, V29, P798, DOI 10.1038/leu.2014.276; Ntziachristos P, 2014, NATURE, V514, P513, DOI 10.1038/nature13605; Peirs S, 2015, IMMUNOL REV, V263, P50, DOI 10.1111/imr.12237; Peirs S, 2014, BLOOD, V124, P3738, DOI 10.1182/blood-2014-05-574566; Pillai K, 2013, AM J CANCER RES, V3, P312; Qi L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106032; Ribera JM, 2011, CURR OPIN ONCOL, V23, P692, DOI 10.1097/CCO.0b013e32834bb854; Roberts AW, 2012, J CLIN ONCOL, V30, P488, DOI 10.1200/JCO.2011.34.7898; Rudin CM, 2012, CLIN CANCER RES, V18, P3163, DOI 10.1158/1078-0432.CCR-11-3090; Sanda T, 2013, CANCER DISCOV, V3, P564, DOI 10.1158/2159-8290.CD-12-0504; Scherr M, 2014, LEUKEMIA, V28, P554, DOI 10.1038/leu.2013.361; Stevenson WS, 2014, LEUKEMIA, V28, P787, DOI 10.1038/leu.2013.270; Tu SJ, 2008, NAT STRUCT MOL BIOL, V15, P419, DOI 10.1038/nsmb.1400; Van der Meulen J, 2015, BLOOD, V125, P13, DOI 10.1182/blood-2014-05-577270; Wang HJ, 2016, J BIOL CHEM, V291, P4004, DOI 10.1074/jbc.M115.679332; Yang Y, 2013, CANCER LETT, V333, P9, DOI 10.1016/j.canlet.2012.11.056; Zeng JP, 2010, GASTROENTEROLOGY, V138, P981, DOI 10.1053/j.gastro.2009.10.004; Zhou MR, 2015, ONCOTARGET, V6, P1249, DOI 10.18632/oncotarget.2859	34	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152142	10.1371/journal.pone.0152142	http://dx.doi.org/10.1371/journal.pone.0152142			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27008505	gold, Green Published, Green Submitted			2022-12-26	WOS:000372701200097
J	Arunrut, N; Kampeera, J; Sirithammajak, S; Sanguanrut, P; Proespraiwong, P; Suebsing, R; Kiatpathomchai, W				Arunrut, Narong; Kampeera, Jantana; Sirithammajak, Sarawut; Sanguanrut, Piyachat; Proespraiwong, Porranee; Suebsing, Rungkarn; Kiatpathomchai, Wansika			Sensitive Visual Detection of AHPND Bacteria Using Loop-Mediated Isothermal Amplification Combined with DNA-Functionalized Gold Nanoparticles as Probes	PLOS ONE			English	Article							NECROSIS DISEASE AHPND; SPOT SYNDROME VIRUS; VIBRIO-PARAHAEMOLYTICUS; SHRIMP; NANOGOLD; PLASMID; AGENT	Acute hepatopancreatic necrosis disease (AHPND) is a component cause of early mortality syndrome (EMS) of shrimp. In 2013, the causative agent was found to be unique isolates of Vibrio parahaemolyticus (VPAHPND) that contained a 69 kbp plasmid (pAP1) carrying binary Pir-like toxin genes Pir(vp)A and Pir(vp)B. In Thailand, AHPND was first recognized in 2012, prior to knowledge of the causative agent, and it subsequently led to a precipitous drop in shrimp production. After VPAHPND was characterized, a major focus of the AHPND control strategy was to monitor broodstock shrimp and post larvae for freedom from VPAHPND by nucleic acid amplification methods, most of which required use of expensive and sophisticated equipment not readily available in a shrimp farm setting. Here, we describe a simpler but equally sensitive approach for detection of VPAHPND based on loop-mediated isothermal amplification (LAMP) combined with unaided visual reading of positive amplification products using a DNA-functionalized, ssDNA-labled nanogold probe (AuNP). The target for the special set of six LAMP primers used was the VPAHPND Pir(vp)A gene. The LAMP reaction was carried out at 65 degrees C for 45 min followed by addition of the red AuNP solution and further incubation at 65 degrees C for 5 min, allowing any Pir(vp)A gene amplicons present to hybridize with the probe. Hybridization protected the AuNP against aggregation, so that the solution color remained red upon subsequent salt addition (positive test result) while unprotected AuNP aggregated and underwent a color change from red to blue and eventually precipitated (negative result). The total assay time was approximately 50 min. The detection limit (100 CFU) was comparable to that of other commonly-used methods for nested PCR detection of VPAHPND and 100-times more sensitive than 1-step PCR detection methods (104 CFU) that used amplicon detection by electrophoresis or spectrophotometry. There was no cross reaction with DNA templates derived from non-AHPND bacteria commonly found in shrimp ponds (including other Vibrio species). The new method significantly reduced the time, difficulty and cost for molecular detection of VPAHPND in shrimp hatchery and farm settings.	[Arunrut, Narong; Kampeera, Jantana; Sirithammajak, Sarawut; Suebsing, Rungkarn; Kiatpathomchai, Wansika] NSTDA, BIOTEC, Bioengn & Sensing Technol Lab, 113 Thailand Sci Pk,Phahonyothin Rd, Khlong Luang 12120, Pathum Thani, Thailand; [Sanguanrut, Piyachat] Mahidol Univ, Fac Sci, Ctr Excellence Shrimp Mol Biol & Biotechnol CENTE, Rama 6 Rd, Bangkok 10400, Thailand; [Proespraiwong, Porranee] Charoen Pokphand Foods Pul CO LTD, Aquat Anim Hlth Res Ctr, Samutsakorn 74000, Thailand	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Mahidol University	Kiatpathomchai, W (corresponding author), NSTDA, BIOTEC, Bioengn & Sensing Technol Lab, 113 Thailand Sci Pk,Phahonyothin Rd, Khlong Luang 12120, Pathum Thani, Thailand.	wansika@biotec.or.th	Suebsing, Rungkarn/AAL-7161-2021; Kiatpathomchai, Wansika/F-1625-2011		National Research Council of Thailand	National Research Council of Thailand(National Research Council of Thailand (NRCT))	This work was supported by grants from National Research Council of Thailand.	Arunrut N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108047; Arunrut N, 2013, J VIROL METHODS, V193, P542, DOI 10.1016/j.jviromet.2013.07.017; Arunrut N, 2011, J VIROL METHODS, V171, P21, DOI 10.1016/j.jviromet.2010.09.022; Dangtip S, 2015, AQUACULT REP, V2, P158, DOI 10.1016/j.aqrep.2015.10.002; Flegel TW, 2012, J INVERTEBR PATHOL, V110, P166, DOI 10.1016/j.jip.2012.03.004; Goto M, 2009, BIOTECHNIQUES, V46, P167, DOI 10.2144/000113072; Han JE, 2015, DIS AQUAT ORGAN, V113, P33, DOI 10.3354/dao02830; He YQ, 2011, BIOSENS BIOELECTRON, V26, P2018, DOI 10.1016/j.bios.2010.08.079; Iwamoto T, 2003, J CLIN MICROBIOL, V41, P2616, DOI 10.1128/JCM.41.6.2616-2622.2003; Jaroenram W, 2012, J VIROL METHODS, V186, P36, DOI 10.1016/j.jviromet.2012.08.013; Jaroenrama W, 2009, MOL CELL PROBE, V23, P65, DOI 10.1016/j.mcp.2008.12.003; Jiang Y, 2013, J AM CHEM SOC, V135, P7430, DOI 10.1021/ja4023978; Joshi J, 2014, AQUACULTURE, V428, P297, DOI 10.1016/j.aquaculture.2014.03.030; Kaewphinit T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/926230; Kiatpathomchai W, 2008, J VIROL METHODS, V153, P214, DOI 10.1016/j.jviromet.2008.06.025; Koiwai K, 2016, J FISH DIS, V39, P603, DOI 10.1111/jfd.12387; Leano E.M., 2012, GLOB AQUACULT, P38; Lee CT, 2015, P NATL ACAD SCI USA, V112, P10798, DOI 10.1073/pnas.1503129112; Tran L, 2013, DIS AQUAT ORGAN, V105, P45, DOI 10.3354/dao02621; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Nimitphak T, 2010, MOL CELL PROBE, V24, P1, DOI 10.1016/j.mcp.2009.09.004; Prompamorn P, 2011, LETT APPL MICROBIOL, V52, P344, DOI 10.1111/j.1472-765X.2011.03007.x; Seetang-Nun Y, 2013, MOL CELL PROBE, V27, P71, DOI 10.1016/j.mcp.2012.11.005; Sirikharin R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126987; Suebsing R, 2013, J APPL MICROBIOL, V114, P1254, DOI 10.1111/jam.12160; Thitamadee S, 2016, AQUACULTURE, V452, P69, DOI 10.1016/j.aquaculture.2015.10.028; Tinwongger S, 2014, FISH PATHOL, V49, P159, DOI 10.3147/jsfp.49.159; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Yamazaki W, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-94; Yang YT, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00816-14; Yongkiettrakul S, 2014, PARASITOL INT, V63, P777, DOI 10.1016/j.parint.2014.06.004	31	52	54	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151769	10.1371/journal.pone.0151769	http://dx.doi.org/10.1371/journal.pone.0151769			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003504	Green Published, gold, Green Submitted			2022-12-26	WOS:000372697400042
J	Imanaka, M; Ando, M; Kitamura, T; Kawamura, T				Imanaka, Mie; Ando, Masahiko; Kitamura, Tetsuhisa; Kawamura, Takashi			Impact of Registered Dietitian Expertise in Health Guidance for Weight Loss	PLOS ONE			English	Article							OBESE ADULTS; STUDENTS; PROGRAM; SUPPORT; MAINTENANCE; OVERWEIGHT; EDUCATION; SKILLS; RISK; OSCE	Background & Objectives Expertise of registered dietitians (RDs) is important for health guidance but has been poorly evaluated. We evaluated the kind of RD expertise that would improve their skills. Design, Setting, Participants, Measurements This study was a post-hoc analysis of our randomized controlled trial, which compared the weight change between participants using the web-based self-disclosure health support and those using the email health support. Healthy men and women aged 35-64 years with a body mass index (BMI) of > = 24.5 kg/m(2) were recruited for this study. We evaluated the relationship of RD expertise indicators including the duration of working as an RD, the experience of health counseling, and membership in the Japan Dietetic Association (JDA) with the weight loss of study participants. The primary endpoint was the change in body weight. Comparison of changes in body weight by the RD expertise indicators was evaluated using analysis of covariance. Results A total of 175 participants were eligible for analyses. Changes in body weight were significantly greater when they were supported by the RDs in the routine counseling group than when supported by the RDs in the non-routine counseling group (-1.8 kg versus -0.4 kg, fully adjusted P = 0.0089). Duration of working as an RD and JDA membership did not significantly affect changes in body weight. Conclusions Among some indices of RD experience, the experience of providing routine experience of health counseling was associated with weight loss.	[Imanaka, Mie] Kyoto Koka Womens Univ, Dept Hlth & Nutr, Kyoto, Japan; [Ando, Masahiko] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan; [Kitamura, Tetsuhisa] Osaka Univ, Grad Sch Med, Div Environm Med & Populat Sci, Dept Social & Environm Med, Suita, Osaka, Japan; [Kawamura, Takashi] Kyoto Univ Hlth Serv, Kyoto, Japan	Nagoya University; Osaka University; Kyoto University	Ando, M (corresponding author), Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan.	mando@med.nagoya-u.ac.jp	Kitamura, Tetsuhisa/AAA-2555-2020	Kitamura, Tetsuhisa/0000-0003-0107-0580				Anderson JW, 2011, POSTGRAD MED, V123, P205, DOI 10.3810/pgm.2011.09.2476; BENNER P, 1982, AM J NURS, V82, P402, DOI 10.2307/3462928; Brady J, 2012, CAN J DIET PRACT RES, V73, P117, DOI 10.3148/73.3.2012.117; Byham-Gray LD, 2005, J AM DIET ASSOC, V105, P1574, DOI 10.1016/j.jada.2005.07.007; Cant RP, 2008, J HUM NUTR DIET, V21, P502, DOI 10.1111/j.1365-277X.2008.00883.x; Chan M, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0343-0; Collins CE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-669; Dalle Grave R, 2010, DIABET METAB SYND OB, V3, P373, DOI 10.2147/DMSOTT.S13860; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Goodpaster BH, 2010, JAMA-J AM MED ASSOC, V304, P1795, DOI 10.1001/jama.2010.1505; Harvey-Berino J, 2004, OBES RES, V12, P320, DOI 10.1038/oby.2004.40; Imafuku Yuji, 2007, Rinsho Byori, V55, P1097; Imanaka M, 2013, J MED INTERNET RES, V15, P289, DOI 10.2196/jmir.2405; Jahangiri L, 2013, EUR J DENT EDUC, V17, P10, DOI 10.1111/eje.12012; Japan Diabetes Society, 2001, FOOD EXCH LIST DIAB; Ministry of Health Labour and Welfare Health Service Bureau, PROGR STAND SPEC HLT, P69; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Patricio MF, 2013, MED TEACH, V35, P503, DOI 10.3109/0142159X.2013.774330; Schulz AJ, 2003, EVAL PROGRAM PLANN, V26, P249, DOI 10.1016/S0149-7189(03)00029-6; Tabak N, 1996, WESTERN J NURS RES, V18, P534, DOI 10.1177/019394599601800505; Tate DF, 2006, ARCH INTERN MED, V166, P1620, DOI 10.1001/archinte.166.15.1620; Tate DF, 2001, JAMA-J AM MED ASSOC, V285, P1172, DOI 10.1001/jama.285.9.1172; Tate DF, 2003, JAMA-J AM MED ASSOC, V289, P1833, DOI 10.1001/jama.289.14.1833; Templeton C L, 1991, Diabetes Educ, V17, P355, DOI 10.1177/014572179101700505; Van Wieren A, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25139; Zakowski LJ, 2002, ACAD MED, V77, P1030, DOI 10.1097/00001888-200210000-00019	26	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151456	10.1371/journal.pone.0151456	http://dx.doi.org/10.1371/journal.pone.0151456			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003943	Green Published, gold			2022-12-26	WOS:000372697400032
J	Keinath, AT				Keinath, Alexander Thomas			The Preferred Directions of Conjunctive Grid X Head Direction Cells in the Medial Entorhinal Cortex Are Periodically Organized	PLOS ONE			English	Article							REPRESENTATION; MODEL; MAP	The discovery of speed-modulated grid, head direction, and conjunctive grid x head direction cells in the medial entorhinal cortex has led to the hypothesis that path integration, the updating of one's spatial representation based on movement, may be carried out within this region. This hypothesis has been formalized by many computational models, including a class known as attractor network models. While many of these models propose specific mechanisms by which path integration might occur, predictions of these specific mechanisms have not been tested. Here I derive and test a key prediction of one attractor network path integration mechanism. Specifically, I first demonstrate that this mechanism predicts a periodic distribution of conjunctive cell preferred directions in order to minimize drift. Next, I test whether conjunctive cell preferred directions are in fact periodically organized. Results indicate that conjunctive cells are preferentially tuned to increments of 36 degrees, consistent with drift minimization in this path integration mechanism. By contrast, no periodicity was observed in the preferred directions of either pure grid or pure head direction cells. These results provide the first neural evidence of a nonuniform structure in the directional preferences of any head direction representation found in the brain.	[Keinath, Alexander Thomas] Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA	University of Pennsylvania	Keinath, AT (corresponding author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	akeinath@sas.upenn.edu			National Science Foundation Integrative Graduate Education and Research Traineeship [0966142]	National Science Foundation Integrative Graduate Education and Research Traineeship(National Science Foundation (NSF))	This work was supported by a National Science Foundation Integrative Graduate Education and Research Traineeship #0966142 (ATK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry C, 2012, FRONT NEURAL CIRCUIT, V6, DOI [10.3389/fncir.2012.00030, 10.3389/fncir.2012.00005]; Blair HT, 1998, NEURON, V21, P1387, DOI 10.1016/S0896-6273(00)80657-1; Bonnevie T, 2013, NAT NEUROSCI, V16, P309, DOI 10.1038/nn.3311; Brun VH, 2008, HIPPOCAMPUS, V18, P1200, DOI 10.1002/hipo.20504; Burak Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000291; Burgess CP, 2014, J NEUROSCI, V34, P6224, DOI 10.1523/JNEUROSCI.2540-12.2014; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; CHEN LL, 1994, EXP BRAIN RES, V101, P8, DOI 10.1007/BF00243212; Cho JW, 2001, BEHAV NEUROSCI, V115, P3, DOI 10.1037//0735-7044.115.1.3; Couey JJ, 2013, NAT NEUROSCI, V16, P318, DOI 10.1038/nn.3310; Derdikman D, 2009, NAT NEUROSCI, V12, P1325, DOI 10.1038/nn.2396; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Giocomo LM, 2014, CURR BIOL, V24, P252, DOI 10.1016/j.cub.2013.12.002; Grossberg S, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2012.0524; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mhatre H, 2012, HIPPOCAMPUS, V22, P320, DOI 10.1002/hipo.20901; Pilly PK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060599; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Si BL, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003558; Stackman RW, 1998, J NEUROSCI, V18, P9020; Stensola H, 2012, NATURE, V492, P72, DOI 10.1038/nature11649; TAUBE JS, 1990, J NEUROSCI, V10, P420; TAUBE JS, 1995, J NEUROSCI, V15, P70; Widloski J, 2014, NEURON, V83, P481, DOI 10.1016/j.neuron.2014.06.018; Yoon KJ, 2013, NAT NEUROSCI, V16, P1077, DOI 10.1038/nn.3450	26	6	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152041	10.1371/journal.pone.0152041	http://dx.doi.org/10.1371/journal.pone.0152041			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003407	Green Submitted, Green Published, gold			2022-12-26	WOS:000372697400069
J	Khatri-Chhetri, N; Khatri-Chhetri, R; Chung, CS; Chern, RS; Chien, CH				Khatri-Chhetri, Nabin; Khatri-Chhetri, Rupak; Chung, Cheng-Shu; Chern, Rey-Shyong; Chien, Chi-Hsien			The Spatial Relationship and Surface Projection of Canine Sciatic Nerve and Sacrotuberous Ligament: A Perineal Hernia Repair Perspective	PLOS ONE			English	Article							BRACHIAL-PLEXUS; DOG; TRANSPOSITION; HERNIORRHAPHY; MUSCLE	Sciatic nerve entrapment can occur as post-operative complication of perineal hernia repair when sacrotuberous ligament is incorporated during hernia deficit closure. This results in sciatic sensory loss and paralysis of the hind leg. This study investigated the spatial relationship of sciatic nerve and sacrotuberous ligament and their surface topographic projection of 68 cadavers (29 Beagles and 39 Taiwanese mongrels) with various heights (25-56 cm). By gross dissection, the sacrotuberous ligament and sciatic nerve were exposed and their distance in between was measured along four parts (A, B, C, D) of sacrotuberous ligament. The present study revealed that the C was the section of sacrotuberous ligament where the sciatic nerve and the sacrotuberous ligament are closest to each other. Furthermore, a positive correlation was observed between C and height of the dogs. From the present study, we found that the C in smaller dogs has the shortest distance between the sciatic nerve and the sacrotuberous ligament, and thus the most vulnerable to sciatic nerve entrapment, and needs to be avoided or approached cautiously during perineal hernia repair.	[Khatri-Chhetri, Nabin; Khatri-Chhetri, Rupak; Chung, Cheng-Shu; Chern, Rey-Shyong; Chien, Chi-Hsien] Natl Pingtung Univ Sci & Technol, Coll Vet Med, Dept Vet Med, Pingtung 91201, Taiwan; [Khatri-Chhetri, Nabin; Chung, Cheng-Shu; Chien, Chi-Hsien] Natl Pingtung Univ Sci & Technol, Anim Hosp, Dept Small Anim Surg & Acupuncture, Pingtung 91201, Taiwan; [Chern, Rey-Shyong] Natl Pingtung Univ Sci & Technol, Coll Vet Med, Dept Vet Anat, Pingtung 91201, Taiwan; [Chien, Chi-Hsien] Asia Univ, Lab Small Anim Surg & Acupuncture, Dept Vet Med Postbaccalaureate, Taichung, Taiwan	National Pingtung University Science & Technology; National Pingtung University Science & Technology; National Pingtung University Science & Technology; Asia University Taiwan	Chien, CH (corresponding author), Natl Pingtung Univ Sci & Technol, Coll Vet Med, Dept Vet Med, Pingtung 91201, Taiwan.; Chien, CH (corresponding author), Natl Pingtung Univ Sci & Technol, Anim Hosp, Dept Small Anim Surg & Acupuncture, Pingtung 91201, Taiwan.; Chien, CH (corresponding author), Asia Univ, Lab Small Anim Surg & Acupuncture, Dept Vet Med Postbaccalaureate, Taichung, Taiwan.	chdvmm@gmail.com						Andrews CM, 2008, VET SURG, V37, P254, DOI 10.1111/j.1532-950X.2008.00374.x; BELLENGER CR, 1980, AUST VET J, V56, P434, DOI 10.1111/j.1751-0813.1980.tb02637.x; Bongartz A, 2005, VET SURG, V34, P405, DOI 10.1111/j.1532-950X.2005.00062.x; Brissot HN, 2004, VET SURG, V33, P412, DOI 10.1111/j.1532-950X.2004.04060.x; Budras KD, 2007, ANATOMY DOG ILLUSTRA, V5, P72; BURROWS CF, 1973, J SMALL ANIM PRACT, V14, P315, DOI 10.1111/j.1748-5827.1973.tb06466.x; Campoy L, 2008, VET ANAESTH ANALG, V35, P348, DOI 10.1111/j.1467-2995.2007.00390.x; Carrier DR, 2005, GENOME RES, V15, P1825, DOI 10.1101/gr.3800005; de Lahunta A., 2009, VET NEUROANATOMY CLI, P77; DESAI R, 1982, J AM ANIM HOSP ASSOC, V18, P195; DORN AS, 1982, J AM ANIM HOSP ASSOC, V18, P624; Evans HE, 2013, MILLERS ANATOMY DOG, P327; Evans HE, 2013, MILLERS ANATOMY DOG, P650; Forterre F, 2007, VET SURG, V36, P464, DOI 10.1111/j.1532-950X.2007.00293.x; HAYES HM, 1978, J AM ANIM HOSP ASSOC, V14, P703; HOSGOOD G, 1995, J AM ANIM HOSP ASSOC, V31, P331, DOI 10.5326/15473317-31-4-331; 윤헌영, 2010, [Journal of Veterinary Clinics, 한국임상수의학회지], V27, P584; Jeusette I, 2010, RES VET SCI, V88, P227, DOI 10.1016/j.rvsc.2009.07.009; Lorenz MD, 2011, HDB VET NEUROLOGY, P94, DOI [10.1016/B978-1- 4377- 0651-2.10005- 0, DOI 10.1016/B978-1-4377-0651-2.10005-0]; Mahler SP, 2008, VET ANAESTH ANALG, V35, P80, DOI 10.1111/j.1467-2995.2007.00356.x; Pratummintra K, 2013, J VET MED SCI, V75, P337, DOI 10.1292/jvms.11-0478; Radlinsky MG, 2013, SMALL ANIMAL SURG, P568; SJOLLEMA BE, 1989, VET QUART, V11, P18, DOI 10.1080/01652176.1989.9694191; SPREULL JSA, 1980, J SMALL ANIM PRACT, V21, P265, DOI 10.1111/j.1748-5827.1980.tb01247.x; Stoll MR, 2002, VET SURG, V31, P379, DOI 10.1053/jvet.2002.33596; Sutter NB, 2008, MAMM GENOME, V19, P713, DOI 10.1007/s00335-008-9153-6; Szabo S, 2007, J AM ANIM HOSP ASSOC, V43, P136, DOI 10.5326/0430136; Vnuk D, 2006, VET MED-CZECH, V51, P111, DOI 10.17221/5528-VETMED; WEAVER AD, 1981, J SMALL ANIM PRACT, V22, P749, DOI 10.1111/j.1748-5827.1981.tb00582.x; Zink MC, 2013, CANINE SPORTS MEDICINE AND REHABILITATION, P1	30	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0152078	10.1371/journal.pone.0152078	http://dx.doi.org/10.1371/journal.pone.0152078			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003911	Green Submitted, Green Published, gold			2022-12-26	WOS:000372697400074
J	Chandler, JF; Burn, D; Berggren, P; Sweet, MJ				Chandler, Josie F.; Burn, Deborah; Berggren, Per; Sweet, Michael J.			Influence of Resource Availability on the Foraging Strategies of the Triangle Butterflyfish Chaetodon triangulum in the Maldives	PLOS ONE			English	Article							GREAT-BARRIER-REEF; CORAL-FEEDING BUTTERFLYFISHES; TERRITORY SIZE; CORALLIVOROUS BUTTERFLYFISHES; SPECIALIZATION; FISH; CONSUMPTION; SELECTIVITY; AUSTRIACUS	Obligate coral feeders such as many members of the Chaetodontidae family (also known as butterflyfish) often show strong preferences for particular coral species. This is thought to have evolved through natural selection as an energy-maximising strategy. Although some species remain as highly specialised feeders throughout their lifetime, many corallivores show a degree of dietary versatility when food abundance is limited; a strategy described by the optimal foraging theory. This study aimed to examine if, within-reef differences in the feeding regime and territory size of the Triangle Butterflyfish Chaetodon triangulum occurred, as a function of resource availability. Results showed that the dietary specialisation of C. triangulum was significant in both areas of low and high coral cover (chi L2(2) = 2.52 x 102, P<0.001 and chi L2(2) = 3.78 x 102, P<0.001 respectively). Resource selection functions (RSFs), calculated for the two main sites of contrasting coral assemblage, showed that in the resource-rich environments, only two Genera (Acropora and Pocillopora) were preferentially selected for, with the majority of other corals being actively 'avoided'. Conversely, in territories of lower coral coverage, C. triangulum was being less selective in its prey choice and consuming corals in a more even distribution with respect to their availability. Interestingly, coral cover appeared to show no significant effect on feeding rate, however it was a primary determinant of territory size. The findings of the study agree with the predictions of the optimal foraging theory, in that where food supply is scarce, dietary specialisation is minimised and territory size increased. This results in maximising energy intake. This study represents the first scientific evidence that C. triangulum is an obligate corallivore and, as with many other butterflyfish, is therefore dependent on healthy scleractinian corals for survival.	[Chandler, Josie F.; Burn, Deborah; Berggren, Per] Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Sweet, Michael J.] Univ Derby, Environm Sustainabil Res Ctr, Derby DE22 1GB, England	Newcastle University - UK; University of Derby	Chandler, JF (corresponding author), Newcastle Univ, Sch Marine Sci & Technol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	j.f.chandler@outlook.com	Sweet, Michael/E-9661-2012	Sweet, Michael/0000-0003-4983-8333; Burn, Deborah/0000-0002-9581-2954				Allen G.R., 1998, GUIDE ANGELFISHES BU; Alwany M, 2003, MAR ECOL-P S Z N I, V24, P165, DOI 10.1046/j.1439-0485.2003.03833.x; Berumen M.L., 2001, INQUIRY U ARKANSAS U, V2; Berumen M.L., 2006, P 10 INT COR REEF S, P644; Berumen ML, 2008, BEHAV ECOL SOCIOBIOL, V62, P989, DOI 10.1007/s00265-007-0526-8; Brooker RM, 2013, CORAL REEFS, V32, P613, DOI 10.1007/s00338-013-1057-6; Brooker RM, 2013, OECOLOGIA, V172, P409, DOI 10.1007/s00442-012-2521-7; CHARNOV EL, 1976, AM NAT, V110, P141, DOI 10.1086/283054; Cole AJ, 2011, CORAL REEFS, V30, P85, DOI 10.1007/s00338-010-0674-6; Cole AJ, 2009, J EXP MAR BIOL ECOL, V373, P11, DOI 10.1016/j.jembe.2009.02.016; Cole AJ, 2008, FISH FISH, V9, P286, DOI 10.1111/j.1467-2979.2008.00290.x; Couce E, 2013, GLOBAL CHANGE BIOL, V19, P3592, DOI [10.1111/gcb.12335, 10]; Gassner P, 2012, BIODIV SCI, V6; Gregson MA, 2008, CORAL REEFS, V27, P583, DOI 10.1007/s00338-008-0366-7; HARMELINVIVIEN ML, 1989, ENVIRON BIOL FISH, V25, P101, DOI 10.1007/BF00002204; Hughes R.N., 1980, Oceanography and Marine Biology an Annual Review, V18, P423; IRONS D K, 1989, Environmental Biology of Fishes, V25, P187, DOI 10.1007/BF00002211; JONES GP, 1986, OECOLOGIA, V68, P549, DOI 10.1007/BF00378770; Lawton RJ, 2012, OIKOS, V121, P191, DOI 10.1111/j.1600-0706.2011.19409.x; MacArthur RH, 1966, AM NAT, V4, P100; Manly B., 1993, RESOURCE SELECTION A; Manly B.F.J., 2002, RESOURCE SELECTION A; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Michael SW, 2004, ANGELFISHES BUTTERFL; Pisapia C, 2012, P 12 INT COR REEF S; Pratchett M.S., 2007, RAFFLES B ZOOL, V14, P155; Pratchett MS, 2005, MAR BIOL, V148, P373, DOI 10.1007/s00227-005-0084-4; REESE E S, 1975, Zeitschrift fuer Tierpsychologie, V37, P37; Righton D, 1998, J EXP MAR BIOL ECOL, V226, P183, DOI 10.1016/S0022-0981(97)00235-9; ROBERTS CM, 1992, ENVIRON BIOL FISH, V34, P79, DOI 10.1007/BF00004786; STARCK WALTER A., 1966, ICHTHYOL AQUARIUM J, V38, P313; TRICAS TC, 1989, ANIM BEHAV, V37, P830, DOI 10.1016/0003-3472(89)90067-5; Veron J. E., 2000, CORALS WORLD, V1; Whiteman EA, 2004, BIOL REV, V79, P351, DOI 10.1017/S1464793103006304	34	4	4	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151923	10.1371/journal.pone.0151923	http://dx.doi.org/10.1371/journal.pone.0151923			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999662	gold, Green Published, Green Submitted			2022-12-26	WOS:000372694700085
J	Stern, WM; Desikan, M; Hoad, D; Jaffer, F; Strigaro, G; Sander, JW; Rothwell, JC; Sisodiya, SM				Stern, William M.; Desikan, Mahalekshmi; Hoad, Damon; Jaffer, Fatima; Strigaro, Gionata; Sander, Josemir W.; Rothwell, John C.; Sisodiya, Sanjay M.			Spontaneously Fluctuating Motor Cortex Excitability in Alternating Hemiplegia of Childhood: A Transcranial Magnetic Stimulation Study	PLOS ONE			English	Article							DE-NOVO MUTATIONS; CLINICAL-MANIFESTATIONS; ATP1A3; ATPASE; MECHANISMS; POTASSIUM; ALPHA	Background Alternating hemiplegia of childhood is a very rare and serious neurodevelopmental syndrome; its genetic basis has recently been established. Its characteristic features include typically-unprovoked episodes of hemiplegia and other transient or more persistent neurological abnormalities. Methods We used transcranial magnetic stimulation to assess the effect of the condition on motor cortex neurophysiology both during and between attacks of hemiplegia. Nine people with alternating hemiplegia of childhood were recruited; eight were successfully tested using transcranial magnetic stimulation to study motor cortex excitability, using single and paired pulse paradigms. For comparison, data from ten people with epilepsy but not alternating hemiplegia, and ten healthy controls, were used. Results YOne person with alternating hemiplegia tested during the onset of a hemiplegic attack showed progressively diminishing motor cortex excitability until no response could be evoked; a second person tested during a prolonged bilateral hemiplegic attack showed unusually low excitability. Three people tested between attacks showed asymptomatic variation in cortical excitability, not seen in controls. Paired pulse paradigms, which probe intracortical inhibitory and excitatory circuits, gave results similar to controls. Conclusions We report symptomatic and asymptomatic fluctuations in motor cortex excitability in people with alternating hemiplegia of childhood, not seen in controls. We propose that such fluctuations underlie hemiplegic attacks, and speculate that the asymptomatic fluctuation we detected may be useful as a biomarker for disease activity.	[Stern, William M.; Sander, Josemir W.; Sisodiya, Sanjay M.] UCL Inst Neurol, Dept Clin & Expt Epilepsy, NIHR Univ Coll London Hosp Biomed Res Ctr, London WC1N 3BG, England; [Stern, William M.; Sander, Josemir W.; Sisodiya, Sanjay M.] Epilepsy Soc, Gerrards Cross SL9 0RJ, Bucks, England; [Desikan, Mahalekshmi; Hoad, Damon; Rothwell, John C.] UCL Inst Neurol, Sobell Dept Motor Neurosci & Movement Disorders, London, England; [Jaffer, Fatima] UCL Inst Neurol, MRC Ctr Neuromuscular Dis, London WC1N 3BG, England; [Strigaro, Gionata] Univ Piemonte Orientale, Neurol Sect, Dept Translat Med, Novara, Italy; [Sander, Josemir W.] Stichting Epilepsie Instellingen Nederland, Heemstede, Netherlands	University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; University of London; University College London; University of Eastern Piedmont Amedeo Avogadro	Sisodiya, SM (corresponding author), UCL Inst Neurol, Dept Clin & Expt Epilepsy, NIHR Univ Coll London Hosp Biomed Res Ctr, London WC1N 3BG, England.; Sisodiya, SM (corresponding author), Epilepsy Soc, Gerrards Cross SL9 0RJ, Bucks, England.	s.sisodiya@ucl.ac.uk	Sander, Josemir W/C-1576-2008	Sander, Josemir W/0000-0001-6041-9661; Jaffer, Fatima/0000-0001-6336-2752	Epilepsy Society (UK); Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme; Marvin Weil Epilepsy Research Fund	Epilepsy Society (UK); Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme(National Institute for Health Research (NIHR)); Marvin Weil Epilepsy Research Fund	The study was funded by Epilepsy Society (UK) and undertaken at University College London Hospitals/University College London, which received a proportion of funding from the Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. JWS is supported by the Marvin Weil Epilepsy Research Fund.	Abbruzzese G, 1996, EXP BRAIN RES, V111, P465; AMINIAN A, 1993, ANN NEUROL, V33, P43, DOI 10.1002/ana.410330108; Bauer PR, 2014, INT J NEURAL SYST, V24, DOI 10.1142/S0129065714300010; Boroojerdi B, 2001, CLIN NEUROPHYSIOL, V112, P931, DOI 10.1016/S1388-2457(01)00523-5; Bottger P, 2011, J COMP NEUROL, V519, P376, DOI 10.1002/cne.22524; BOURGEOIS M, 1993, J PEDIATR-US, V122, P673, DOI 10.1016/S0022-3476(06)80003-X; Cantello R, 2002, BRAIN RES REV, V38, P309, DOI 10.1016/S0165-0173(01)00158-8; Dobretsov M, 2005, FRONT BIOSCI-LANDMRK, V10, P2373, DOI 10.2741/1704; Edwards IJ, 2013, J NEUROSCI, V33, P9913, DOI 10.1523/JNEUROSCI.5584-12.2013; Heinzen EL, 2014, LANCET NEUROL, V13, P503, DOI 10.1016/S1474-4422(14)70011-0; Heinzen EL, 2012, NAT GENET, V44, P1030, DOI 10.1038/ng.2358; Hoei-Hansen CE, 2014, EUR J PAEDIATR NEURO, V18, P50, DOI 10.1016/j.ejpn.2013.08.007; Hunanyan AS, 2015, EPILEPSIA, V56, P82, DOI 10.1111/epi.12878; Ishii A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056120; Jaffer F, 2015, BRAIN; Kale N, 2014, NEUROLOGY S, V82, pP4191; Kirshenbaum GS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060141; Koenderink JB, 2003, J BIOL CHEM, V278, P51213, DOI 10.1074/jbc.M306384200; Li M, 2015, NEUROBIOL DIS; Malcolm MP, 2006, CLIN NEUROPHYSIOL, V117, P1037, DOI 10.1016/j.clinph.2006.02.005; Mikati MA, 2000, PEDIATR NEUROL, V23, P134, DOI 10.1016/S0887-8994(00)00157-0; Neville BGR, 2007, DEV MED CHILD NEUROL, V49, P777, DOI 10.1111/j.1469-8749.2007.00777.x; Ogawa H, 2009, P NATL ACAD SCI USA, V106, P13742, DOI 10.1073/pnas.0907054106; Panagiotakaki E, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0335-5; Panagiotakaki E, 2010, BRAIN, V133, P3598, DOI 10.1093/brain/awq295; Rosewich H, 2012, LANCET NEUROL, V11, P764, DOI 10.1016/S1474-4422(12)70182-5; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rothwell JC, 2009, J PHYSIOL-LONDON, V587, P11, DOI 10.1113/jphysiol.2008.162461; Sasaki M, 2014, NEUROLOGY, V82, P482, DOI 10.1212/WNL.0000000000000102; Terao Y, 2002, J CLIN NEUROPHYSIOL, V19, P322, DOI 10.1097/00004691-200208000-00006; Viollet L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127045; Vollono C, 2014, EUR J NEUROL OF 0717; Wassermann EM, 2002, CLIN NEUROPHYSIOL, V113, P1165, DOI 10.1016/S1388-2457(02)00144-X; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Ziemann U, 2004, CLIN NEUROPHYSIOL, V115, P1717, DOI 10.1016/j.clinph.2004.03.006; ZUPANC ML, 1991, PEDIATR NEUROL, V7, P35, DOI 10.1016/0887-8994(91)90103-R	36	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151667	10.1371/journal.pone.0151667	http://dx.doi.org/10.1371/journal.pone.0151667			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999520	Green Published, gold, Green Submitted			2022-12-26	WOS:000372694700053
J	Li, R; Pu, X; Chang, JY; Ye, YQ; Komaki, R; Minna, JD; Roth, JA; Han, BH; Wu, XF				Li, Rong; Pu, Xia; Chang, Joe Y.; Ye, Yuanqing; Komaki, Ritsuko; Minna, John D.; Roth, Jack A.; Han, Baohui; Wu, Xifeng			MiRNA-Related Genetic Variations Associated with Radiotherapy-Induced Toxicities in Patients with Locally Advanced Non-Small Cell Lung Cancer	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; STEM-CELLS; LARGE-SCALE; MICRORNA; RISK; SURVIVAL; DATABASE; MODIFY; SITES	Severe radiation-induced toxicities limit treatment efficacy and compromise outcomes of lung cancer. We aimed to identify microRNA-related genetic variations as biomarkers for the prediction of radiotherapy-induced acute toxicities. We genotyped 233 SNPs (161 in microRNA binding site and 72 in processing gene) and analyzed their associations with pneumonitis and esophagitis in 167 stage III NSCLC patients received definitive radiation therapy. Sixteen and 11 SNPs were associated with esophagitis and pneumonitis, respectively. After multiple comparison correction, RPS6KB2:rs10274, SMO:rs1061280, SMO:rs1061285 remained significantly associated with esophagitis, while processing gene DGCR8:rs720014, DGCR8:rs3757, DGCR8:rs1633445 remained significantly associated with pneumonitis. Patients with the AA genotype of RPS6KB2: rs10274 had an 81% reduced risk of developing esophagitis (OR: 0.19, 95% CI: 0.07-0.51, p = 0.001, q = 0.06). Patients with the AG+GG genotype of SMO: rs1061280 had an 81% reduced risk of developing esophagitis (OR: 0.19, 95% CI: 0.07-0.53, p = 0.001, q = 0.06). Patients with the GG+GA genotype of DGCR8: rs720014 had a 3.54-fold increased risk of pneumonitis (OR: 3.54, 95% CI: 1.65-7.61, p < 0.05, q < 0.1). Significantly cumulative effects of the top SNPs were observed for both toxicities (P-trend < 0.001). Using bioinformatics tools, we found that the genotype of rs10274 was associated with altered expression of the RPS6KB2 gene. Gene-based analysis showed DGCR8 (p = 0.010) and GEMIN4 (p = 0.039) were the top genes associated with the risk of developing pneumonitis. Our results provide strong evidence that microRNA-related genetic variations contribute to the development of radiotherapy-induced acute esophagitis and pneumonitis and could thus serve as biomarkers to help accurately predict radiotherapy-induced toxicity in NSCLC patients.	[Li, Rong; Pu, Xia; Ye, Yuanqing; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Li, Rong; Han, Baohui] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pulm Med, W Huaihai Rd 241, Shanghai 200030, Peoples R China; [Chang, Joe Y.; Komaki, Ritsuko] Univ Texas MD Anderson Canc Ctr, Radiat Dept, Houston, TX 77030 USA; [Minna, John D.] Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; [Roth, Jack A.] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Shanghai Jiao Tong University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center	Wu, XF (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	xwu@mdanderson.org		Li, Rong/0000-0003-3971-1670	U.S. NIH [R01-CA111646, P50CA070907, R01-CA127615, CPRIT RP130502]; Center for Translational and Public Health Genomics of the Duncan Family Institute for Cancer Prevention and Risk Assessment, The University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE [R01CA111646, P50CA070907] Funding Source: NIH RePORTER	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Translational and Public Health Genomics of the Duncan Family Institute for Cancer Prevention and Risk Assessment, The University of Texas MD Anderson Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research was supported by U.S. NIH grants R01-CA111646 (X. Wu), P50CA070907 (J.D. Minna, J.A. Roth, and X. Wu), R01-CA127615 (X. Wu), and CPRIT RP130502 (X. Wu). Additional support was provided by the Center for Translational and Public Health Genomics of the Duncan Family Institute for Cancer Prevention and Risk Assessment, The University of Texas MD Anderson Cancer Center (X. Wu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen CN, 2009, RADIOTHER ONCOL, V92, P299, DOI 10.1016/j.radonc.2009.06.015; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Burdett S, 2014, LANCET, V383, P1561, DOI 10.1016/S0140-6736(13)62159-5; Cellini F, 2014, MOLECULES, V19, P5379, DOI 10.3390/molecules19045379; Chen Y, 2013, CANCER-AM CANCER SOC, V119, P4205, DOI 10.1002/cncr.28338; Eramo A, 2010, ONCOGENE, V29, P4625, DOI 10.1038/onc.2010.207; Fachal L, 2012, RADIOTHER ONCOL, V105, P321, DOI 10.1016/j.radonc.2012.09.013; Gomez-Cabello D, 2013, AGING CELL, V12, P923, DOI 10.1111/acel.12117; Gong M, 2012, PROTEIN SCI, V21, P797, DOI 10.1002/pro.2062; Grundberg E, 2012, NAT GENET, V44, P1084, DOI 10.1038/ng.2394; Hildebrandt MAT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012402; Horikawa Y, 2008, CLIN CANCER RES, V14, P7956, DOI 10.1158/1078-0432.CCR-08-1199; Jacob NK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057603; Ke HL, 2013, CARCINOGENESIS, V34, P1006, DOI 10.1093/carcin/bgt006; Lalaoui N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019679; Li J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5051; Liang D, 2010, CANCER RES, V70, P9765, DOI 10.1158/0008-5472.CAN-10-0130; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Madani I, 2007, J THORAC ONCOL, V2, P864, DOI 10.1097/JTO.0b013e318145b2c6; Marks LB, 2010, INT J RADIAT ONCOL, V76, pS70, DOI 10.1016/j.ijrobp.2009.06.091; Masson-Cote L, 2011, INT J RADIAT ONCOL, V80, P686, DOI 10.1016/j.ijrobp.2010.02.010; Osuka S, 2013, STEM CELLS, V31, P627, DOI 10.1002/stem.1328; Pelczar P, 2013, GASTROENTEROLOGY, V144, P134, DOI 10.1053/j.gastro.2012.09.061; Price A, 2012, NAT REV CLIN ONCOL, V9, P591, DOI 10.1038/nrclinonc.2012.135; Pu X, 2013, CANCER RES, V73, P1867, DOI 10.1158/0008-5472.CAN-12-0873; Pu X, 2012, CLIN CANCER RES, V18, P5983, DOI 10.1158/1078-0432.CCR-12-0774; Ramnath N, 2013, CHEST, V143, pE314, DOI 10.1378/chest.12-2360; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sridharan S, 2011, CANCER RES, V71, P2590, DOI 10.1158/0008-5472.CAN-10-3253; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tanaka T, 2013, NAT CELL BIOL, V15, P511, DOI 10.1038/ncb2719; Topkan E, 2009, LUNG CANCER, V63, P393, DOI 10.1016/j.lungcan.2008.06.015; Uyterlinde W, 2013, CLIN LUNG CANCER, V14, P541, DOI 10.1016/j.cllc.2013.04.001; Werner-Wasik M, 2010, INT J RADIAT ONCOL, V76, pS86, DOI 10.1016/j.ijrobp.2009.05.070; Wilker EH, 2010, ENVIRON HEALTH PERSP, V118, P943, DOI 10.1289/ehp.0901440; Wu XF, 2009, CANCER PREV RES, V2, P617, DOI 10.1158/1940-6207.CAPR-09-0025; Xue JX, 2013, MOL THER, V21, P456, DOI 10.1038/mt.2012.183; Yanaihara N, 2013, CLIN CHEM, V59, P1811, DOI 10.1373/clinchem.2012.198176; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Yazbeck VY, 2013, CANCER J, V19, P231, DOI 10.1097/PPO.0b013e31829453fb; Yu T, 2015, ONCOGENE, V34, P413, DOI 10.1038/onc.2013.574	42	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150467	10.1371/journal.pone.0150467	http://dx.doi.org/10.1371/journal.pone.0150467			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991123	gold, Green Published, Green Submitted			2022-12-26	WOS:000372582800032
J	Ma, DX; Duan, W; Li, YK; Wang, ZM; Li, SL; Gong, NQ; Chen, G; Chen, ZS; Wan, CD; Yang, J				Ma, Dongxia; Duan, Wu; Li, Yakun; Wang, Zhimin; Li, Shanglin; Gong, Nianqiao; Chen, Gang; Chen, Zhishui; Wan, Chidan; Yang, Jun			PD-L1 Deficiency within Islets Reduces Allograft Survival in Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; ALLOIMMUNE RESPONSES; PROGRAMMED DEATH-1; PANCREATIC-ISLETS; CO-TRANSPLANTATION; TISSUE EXPRESSION; GRAFT-SURVIVAL; AUTOIMMUNE; REJECTION; STIMULATION	Background Islet transplantation may potentially cure type 1 diabetes mellitus (T1DM). However, immune rejection, especially that induced by the alloreactive T-cell response, remains a restraining factor for the long-term survival of grafted islets. Programmed death ligand-1 (PD-L1) is a negative costimulatory molecule. PD-L1 deficiency within the donor heart accelerates allograft rejection. Here, we investigate whether PD-L1 deficiency in donor islets reduces allograft survival time. Methods Glucose Stimulation Assays were performed to evaluate whether PD-L1 deficiency has detrimental effects on islet function. Islets isolated from PDL1-deficient mice or wild-type (WT) mice (C57BL/6j) were implanted beneath the renal capsule of streptozotocin (STZ)-induced diabetic BALB/c mice. Blood glucose levels and graft survival time after transplantation were monitored. Moreover, we analyzed the residual islets, infiltrating immune cells and alloreactive cells from the recipients. Results PD-L1 deficiency within islets does not affect islet function. However, islet PD-L1 deficiency increased allograft rejection and was associated with enhanced inflammatory cell infiltration and recipient T-cell alloreactivity. Conclusions This is the first report to demonstrate that PD-L1 deficiency accelerated islet allograft rejection and regulated recipient alloimmune responses.	[Ma, Dongxia; Li, Yakun; Wang, Zhimin; Li, Shanglin; Gong, Nianqiao; Chen, Gang; Chen, Zhishui; Yang, Jun] Huazhong Univ Sci & Technol, Tongji Med Coll, Key Lab Organ Transplantat,Minist Hlth, Inst Organ Transplantat,Tongji Hosp,Minist Educ, Wuhan 430074, Hubei Province, Peoples R China; [Duan, Wu] Huazhong Univ Sci & Technol, Dept Endocrinol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China; [Wan, Chidan] Huazhong Univ Sci & Technol, Dept Hepatobiliary Surg, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Yang, J (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Key Lab Organ Transplantat,Minist Hlth, Inst Organ Transplantat,Tongji Hosp,Minist Educ, Wuhan 430074, Hubei Province, Peoples R China.; Wan, CD (corresponding author), Huazhong Univ Sci & Technol, Dept Hepatobiliary Surg, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei Province, Peoples R China.	chidanwan@163.com; jy@tjh.tjmu.edu.cn	Gong, Nianqiao/ABD-9276-2021		National Natural Science Foundation of China [81373169, 81172827]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (No. 81373169 & No. 81172827). JY obtained the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansaria MJI, 2008, CLIN IMMUNOL, V126, P140, DOI 10.1016/j.clim.2007.07.019; Aramaki O, 2004, TRANSPLANTATION, V77, P6, DOI 10.1097/01.TP.0000108637.65091.4B; Bassi R, 2011, CURR DIABETES REP, V11, P355, DOI 10.1007/s11892-011-0211-1; Ben Nasr M, 2015, ACTA DIABETOL, V52, P917, DOI 10.1007/s00592-015-0735-y; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; DiNorcia J, 2015, JAMA SURG, V150, P1066, DOI 10.1001/jamasurg.2015.1853; Dudler J, 2006, TRANSPLANTATION, V82, P1733, DOI 10.1097/01.tp.0000250757.69384.79; El Khatib MM, 2015, GENE THER, V22, P430, DOI 10.1038/gt.2015.18; Fiorina P, 2007, DIABETES, V56, P912, DOI 10.2337/db06-1445; Fiorina P, 2011, J IMMUNOL, V186, P121, DOI 10.4049/jimmunol.1000799; Gao WD, 2003, TRANSPLANTATION, V76, P994, DOI 10.1097/01.TP.0000085010.39567.FB; GOTOH M, 1985, TRANSPLANTATION, V40, P437, DOI 10.1097/00007890-198510000-00018; Grapensparr L, 2015, J CLIN ENDOCR METAB, V100, pE583, DOI 10.1210/jc.2014-4070; Guleria I, 2007, CLIN IMMUNOL, V125, P16, DOI 10.1016/j.clim.2007.05.013; Huang SH, 2010, DIABETOLOGIA, V53, P2389, DOI 10.1007/s00125-010-1858-x; Jeffery LE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131539; Keir ME, 2006, J EXP MED, V203, P883, DOI 10.1084/jem.20051776; Krogstrup NV, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007941; LACY PE, 1967, DIABETES, V16, P35, DOI 10.2337/diab.16.1.35; Lee G, 2015, J SURG RES, V197, P419, DOI 10.1016/j.jss.2015.02.061; Li T, 2015, TRANSPL P, V47, P165, DOI 10.1016/j.transproceed.2014.10.043; Liang SC, 2003, EUR J IMMUNOL, V33, P2706, DOI 10.1002/eji.200324228; Linn T, 2006, CLIN EXP IMMUNOL, V144, P179, DOI 10.1111/j.1365-2249.2006.03066.x; Luan Xi-Ying, 2009, Zhonghua Xue Ye Xue Za Zhi, V30, P689; Nishimura H, 1996, INT IMMUNOL, V8, P773, DOI 10.1093/intimm/8.5.773; Ozkaynak E, 2002, J IMMUNOL, V169, P6546, DOI 10.4049/jimmunol.169.11.6546; Plege-Fleck A, 2014, XENOTRANSPLANTATION, V21, P533, DOI 10.1111/xen.12121; Sakata N, 2008, PANCREAS, V36, P417, DOI 10.1097/MPA.0b013e31815ccad2; Sandner SE, 2005, J IMMUNOL, V174, P3408, DOI 10.4049/jimmunol.174.6.3408; Schreiner B, 2004, J NEUROIMMUNOL, V155, P172, DOI 10.1016/j.jneuroim.2004.06.013; Sho M, 2002, J IMMUNOL, V169, P3744, DOI 10.4049/jimmunol.169.7.3744; Shoji K, 2015, PEDIATR INFECT DIS J, V34, P1063, DOI 10.1097/INF.0000000000000811; Takemoto N, 2015, TRANSPLANTATION, V99, P942, DOI 10.1097/TP.0000000000000579; Tezza S, 2015, PHARMACOL RES, V98, P69, DOI 10.1016/j.phrs.2014.06.016; Vergani A, 2013, DIABETES, V62, P1665, DOI 10.2337/db12-0242; Wang XJ, 2009, TRANSPLANTATION, V87, P482, DOI 10.1097/TP.0b013e318195e5fa; Xu DM, 2012, DIABETOLOGIA, V55, P1091, DOI 10.1007/s00125-011-2433-9; Yamada A, 2001, J IMMUNOL, V167, P140, DOI 10.4049/jimmunol.167.1.140; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Yang J, 2008, CIRCULATION, V117, P660, DOI 10.1161/CIRCULATIONAHA.107.741025	40	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0152087	10.1371/journal.pone.0152087	http://dx.doi.org/10.1371/journal.pone.0152087			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990974	Green Submitted, Green Published, gold			2022-12-26	WOS:000372582800131
J	Hixson, SM; Shukla, K; Campbell, LG; Hallett, RH; Smith, SM; Packer, L; Arts, MT				Hixson, Stefanie M.; Shukla, Kruti; Campbell, Lesley G.; Hallett, Rebecca H.; Smith, Sandy M.; Packer, Laurence; Arts, Michael T.			Long-Chain Omega-3 Polyunsaturated Fatty Acids Have Developmental Effects on the Crop Pest, the Cabbage White Butterfly Pieris rapae	PLOS ONE			English	Article							CAMELINA-SATIVA; FISH-OIL; INSECTS; OILSEED; PLANT; ENVIRONMENT; METABOLISM	Nutritional enhancement of crops using genetic engineering can potentially affect herbivorous pests. Recently, oilseed crops have been genetically engineered to produce the longchain omega-3 polyunsaturated fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) at levels similar to that found in fish oil; to provide a more sustainable source of these compounds than is currently available from wild fish capture. We examined some of the growth and development impacts of adding EPA and DHA to an artificial diet of Pieris rapae, a common pest of Brassicaceae plants. We replaced 1% canola oil with EPA: DHA (11: 7 ratio) in larval diets, and examined morphological traits and growth of larvae and ensuing adults across 5 dietary treatments. Diets containing increasing amounts of EPA and DHA did not affect developmental phenology, larval or pupal weight, food consumption, nor larval mortality. However, the addition of EPA and DHA in larval diets resulted in progressively heavier adults (F (4), (108) = 6.78; p = 0.011), with smaller wings (p < 0.05) and a higher frequency of wing deformities (R = 0.988; p = 0.001). We conclude that the presence of EPA and DHA in diets of larval P. rapae may alter adult mass and wing morphology; therefore, further research on the environmental impacts of EPA and DHA production on terrestrial biota is advisable.	[Hixson, Stefanie M.; Shukla, Kruti; Campbell, Lesley G.; Arts, Michael T.] Ryerson Univ, Dept Biol & Chem, Toronto, ON, Canada; [Hallett, Rebecca H.] Univ Guelph, Sch Environm Sci, Guelph, ON N1G 2W1, Canada; [Smith, Sandy M.] Univ Toronto, Dept Forestry, Toronto, ON, Canada; [Packer, Laurence] York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada	Toronto Metropolitan University; University of Guelph; University of Toronto; York University - Canada	Hixson, SM (corresponding author), Ryerson Univ, Dept Biol & Chem, Toronto, ON, Canada.	shixson@ryerson.ca	Campbell, Lesley G/G-5866-2012; Arts, Michael/H-4973-2012	Campbell, Lesley G/0000-0002-6263-5170; Arts, Michael/0000-0002-2335-4317; packer, laurence/0000-0002-1711-8203	Ryerson University; Natural Sciences and Engineering Research Council [04537-2014, 402325-2011]	Ryerson University; Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding for this work was provided by Ryerson University and Natural Sciences and Engineering Research Council (#04537-2014 to MTA, #402325-2011 to LGC).	Arts MT, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P1, DOI 10.1007/978-0-387-89366-2; Betancor MB, 2015, SCI REP-UK, V5, DOI 10.1038/srep08104; BOLLER E, 1972, Entomophaga, V17, P9, DOI 10.1007/BF02371070; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; Canola Council of Canada, 2014, CAN GROW MAN; Chai S, 1990, AM NAT, V135, P748; Christie W.W., 2003, LIPID ANAL ISOLATION, V3rd ed., P205; DADD RH, 1983, J INSECT PHYSIOL, V29, P779, DOI 10.1016/0022-1910(83)90007-0; FAO, 2014, STAT WORLD FISH AQ, P3; FOLCH J, 1957, J BIOL CHEM, V226, P497; GRAU PA, 1971, J INSECT PHYSIOL, V17, P1637, DOI 10.1016/0022-1910(71)90059-X; Hixson S. M., 2014, Journal of Aquaculture Research and Development, V5, P234; Hixson SM, 2015, ENVIRON REV, V23, P414, DOI 10.1139/er-2015-0029; Kitessa SM, 2014, NUTRIENTS, V6, P2035, DOI 10.3390/nu6052035; Mansour MP, 2014, NUTRIENTS, V6, P776, DOI 10.3390/nu6020776; McMeans BC, 2012, MAR BIOL, V159, P1095, DOI 10.1007/s00227-012-1889-6; Morton AC, 1979, REARING BUTTERFLIES, V81, P221; MYERS JH, 1985, J ANIM ECOL, V54, P193, DOI 10.2307/4630; Napier JA, 2015, EUR J LIPID SCI TECH, V117, P1317, DOI 10.1002/ejlt.201400452; Parnanen S, 1986, EXPERIENTIA, V43, P215; Parrish CC, 2009, LIPIDS IN AQUATIC ECOSYSTEMS, P309, DOI 10.1007/978-0-387-89366-2_13; Peiretti PG, 2007, ANIM FEED SCI TECH, V133, P341, DOI 10.1016/j.anifeedsci.2006.05.001; Petrie JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085061; ROOT RB, 1984, ECOLOGY, V65, P147, DOI 10.2307/1939467; Rotem K, 2003, ECOL ENTOMOL, V28, P211, DOI 10.1046/j.1365-2311.2003.00507.x; Ruiz-Lopez N, 2014, PLANT J, V77, P198, DOI 10.1111/tpj.12378; Snow AA, 2005, ECOL APPL, V15, P377, DOI 10.1890/04-0539; Stanley D, 2014, CRIT REV PLANT SCI, V33, P20, DOI 10.1080/07352689.2014.847631; Stanley DW, 2006, ENTOMOL EXP APPL, V119, P1, DOI 10.1111/j.1570-7458.2006.00406.x; Stanley-Samuelson DW, 1984, INSECT BIOCHEM, V3, P321; STANLEYSAMUELSON DW, 1988, ARCH INSECT BIOCHEM, V9, P1, DOI 10.1002/arch.940090102; STANLEYSAMUELSON DW, 1994, ADV INSECT PHYSIOL, V24, P115, DOI 10.1016/S0065-2806(08)60083-1; Tacon AGJ, 2015, REV FISH SCI AQUAC, V23, P1, DOI 10.1080/23308249.2014.987209; TURUNEN S, 1974, J INSECT PHYSIOL, V20, P1257, DOI 10.1016/0022-1910(74)90231-5; Twining CW, 2016, OIKOS, V125, P749, DOI 10.1111/oik.02910; Webb S., 1988, NEW YORK FOOD LIFE, V12, P1	37	28	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152264	10.1371/journal.pone.0152264	http://dx.doi.org/10.1371/journal.pone.0152264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27011315	Green Published, gold, Green Submitted			2022-12-26	WOS:000372708000122
J	Jaouen, K; Szpak, P; Richards, MP				Jaouen, Klervia; Szpak, Paul; Richards, Michael P.			Zinc Isotope Ratios as Indicators of Diet and Trophic Level in Arctic Marine Mammals	PLOS ONE			English	Article							PHOCA-HISPIDA; RINGED SEAL; NITROGEN ISOTOPES; STABLE-ISOTOPES; BONE-COLLAGEN; FOOD-WEB; CARBON; COPPER; ZN; ECOLOGY	Carbon and nitrogen stable isotope ratios of bone collagen are an established method for dietary reconstruction, but this method is limited by the protein preservation. Zinc (Zn) is found in bioapatite and the isotopic compositions of this element constitute a very promising dietary indicator. The extent of fractionation of Zn isotopes in marine environments, however, remains unknown. We report here on the measurement of zinc, carbon and nitrogen isotopes in 47 marine mammals from the archaeological site of Arvik in the Canadian Arctic. We undertook this study to test and demonstrate the utility of Zn isotopes in recent mammal bone minerals as a dietary indicator by comparing them to other isotopic dietary tracers. We found a correlation between delta Zn-66 values and trophic level for most species, with the exception of walruses, which may be caused by their large seasonal movements. delta Zn-6 values can therefore be used as a dietary indicator in marine ecosystems for both modern and recent mammals.	[Jaouen, Klervia; Richards, Michael P.] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Deutsch Pl 6, D-04103 Leipzig, Germany; [Szpak, Paul; Richards, Michael P.] Univ British Columbia, Dept Anthropol, Vancouver Campus,6303 NW Marine Dr, Vancouver, BC V6T 1Z1, Canada	Max Planck Society; University of British Columbia	Jaouen, K (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, Deutsch Pl 6, D-04103 Leipzig, Germany.	Klervia_jaouen@eva.mpg.de	Richards, Michael/O-3717-2016	Richards, Michael/0000-0001-5274-8887	Max Planck Society; Social Sciences and Humanities Research Council of Canada; Natural Sciences and Engineering Council of Canada	Max Planck Society(Max Planck SocietyFoundation CELLEX); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Natural Sciences and Engineering Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	The funders were the Max Planck Society (http://www.mpg.de/en), the Social Sciences and Humanities Research Council of Canada (http://www.sshrc-crsh.gc.ca/) and the Natural Sciences and Engineering Council of Canada (http://www.nserccrsng.gc.ca/index_eng.asp). The fundings had no associated grant numbers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are thankful to the Max Planck Society, the Social Sciences and Humanities Research Council of Canada and the Natural Sciences and Engineering Council of Canada for funding. We would like to thank Annabell Reiner and Reba Macdonald for their help during sample preparation. Access to the samples was provided by the Prince of Wales Northern Heritage Centre (Yellowknife, YT) and the Department of Culture and Heritage, Government of Nunavut. We thank Joanne Bird, Susan Irving, Pat Freeman, and Sylvie Leblanc for their assistance with sample permits and access.	Auguie B, 2017, GRIDEXTRA MISCELLANE; Balter V, 2013, METALLOMICS, V5, P1470, DOI 10.1039/c3mt00151b; Balter V, 2010, RAPID COMMUN MASS SP, V24, P605, DOI 10.1002/rcm.4425; BARANOWSKA I, 1995, SCI TOTAL ENVIRON, V159, P155, DOI 10.1016/0048-9697(95)04218-P; Bellof G, 2007, J ANIM PHYSIOL AN N, V91, P100, DOI 10.1111/j.1439-0396.2006.00648.x; Bocherens H, 2003, INT J OSTEOARCHAEOL, V13, P46, DOI 10.1002/oa.662; Burns J. J., 1979, NATURAL HIST ECOLOGY, V19, P311; Chu NC, 2006, APPL GEOCHEM, V21, P1656, DOI 10.1016/j.apgeochem.2006.07.003; Copeland SR, 2008, RAPID COMMUN MASS SP, V22, P3187, DOI 10.1002/rcm.3717; Costas-Rodriguez M, 2014, METALLOMICS, V6, P139, DOI 10.1039/c3mt00244f; Darwent CM, 2001, HIGH ARCTIC PALEOESK; Dehn LA, 2007, POLAR BIOL, V30, P167, DOI 10.1007/s00300-006-0171-0; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Derocher AE, 2002, POLAR BIOL, V25, P448, DOI 10.1007/s00300-002-0364-0; Dyke AS, 1999, ARCTIC, V52, P160; FAY F. H., 1960, ARCTIC, V13, P111; Fisher KI, 1997, CAN J ZOOL, V75, P1166, DOI 10.1139/z97-139; Gelabert A, 2006, GEOCHIM COSMOCHIM AC, V70, P839, DOI 10.1016/j.gca.2005.10.026; Gorlova EN, 2012, BIOL BULL+, V39, P464, DOI 10.1134/S1062359012050056; Hedges REM, 2007, J ARCHAEOL SCI, V34, P1240, DOI 10.1016/j.jas.2006.10.015; HESSLEIN RH, 1991, CAN J FISH AQUAT SCI, V48, P2258, DOI 10.1139/f91-265; Hobson KA, 2002, DEEP-SEA RES PT II, V49, P5131, DOI 10.1016/S0967-0645(02)00182-0; Jaouen K., ZINC ISOTOPE RATIOS; Jaouen K, 2013, EARTH PLANET SC LETT, V374, P164, DOI 10.1016/j.epsl.2013.05.037; Jaouen K, 2013, METALLOMICS, V5, P1016, DOI 10.1039/c3mt00085k; Jaouen K, 2012, AM J PHYS ANTHROPOL, V148, P334, DOI 10.1002/ajpa.22053; Knudson KJ, 2010, J ARCHAEOL SCI, V37, P2352, DOI 10.1016/j.jas.2010.04.009; Lemoine G., 2003, ETUDESINUITSTUDIES, V27, P255, DOI [10.7202/010804ar, DOI 10.7202/010804AR]; Little SH, 2014, GEOCHIM COSMOCHIM AC, V125, P673, DOI 10.1016/j.gca.2013.07.046; Lonnerdal B, 2000, J NUTR, V130, p1378S, DOI 10.1093/jn/130.5.1378S; LOWRY LF, 1984, POLAR BIOL, V3, P11, DOI 10.1007/BF00265562; Mallory ML, 2004, POLAR RES, V23, P111, DOI 10.1111/j.1751-8369.2004.tb00133.x; Marechal CN, 2000, GEOCHEM GEOPHY GEOSY, V1, DOI 10.1029/1999GC000029; Marechal CN, 1999, CHEM GEOL, V156, P251, DOI 10.1016/S0009-2541(98)00191-0; Martin JE, 2015, P NATL ACAD SCI USA, V112, P430, DOI 10.1073/pnas.1417792112; Martin JE, 2014, GEOCHIM COSMOCHIM AC, V130, P12, DOI 10.1016/j.gca.2013.12.029; MCCONNAUGHEY T, 1979, MAR BIOL, V53, P257, DOI 10.1007/BF00952434; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Melin AD, 2014, AM J PHYS ANTHROPOL, V154, P633, DOI 10.1002/ajpa.22530; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; Montoya JP, 2002, LIMNOL OCEANOGR, V47, P1617, DOI 10.4319/lo.2002.47.6.1617; Moynier F, 2006, GEOCHIM COSMOCHIM AC, V70, P6103, DOI 10.1016/j.gca.2006.02.030; Moynier F, 2013, METALLOMICS, V5, P693, DOI 10.1039/c3mt00008g; Puceat E, 2004, CHEM GEOL, V205, P83, DOI 10.1016/j.chemgeo.2003.12.014; RAU GH, 1989, NATURE, V341, P516, DOI 10.1038/341516a0; Reynard B, 2014, PALAEOGEOGR PALAEOCL, V416, P4, DOI 10.1016/j.palaeo.2014.07.038; Reynard LM, 2013, ARCHAEOMETRY, V55, P946, DOI 10.1111/j.1475-4754.2012.00715.x; Reynard LM, 2011, J ARCHAEOL SCI, V38, P657, DOI 10.1016/j.jas.2010.10.017; SAUPE SM, 1989, MAR BIOL, V103, P427, DOI 10.1007/BF00399574; SCHOENINGER MJ, 1984, GEOCHIM COSMOCHIM AC, V48, P625, DOI 10.1016/0016-7037(84)90091-7; SMITH TG, 1981, CAN J ZOOL, V59, P966, DOI 10.1139/z81-135; Stirling I, 1995, CAN J FISH AQUAT SCI, V52, P2594, DOI 10.1139/f95-849; STIRLING I, 1975, CAN J ZOOL, V53, P1021, DOI 10.1139/z75-117; Tamelander T, 2006, MAR ECOL PROG SER, V310, P33, DOI 10.3354/meps310033; Thiemann GW, 2008, ECOL MONOGR, V78, P591, DOI 10.1890/07-1050.1; Toutain JP, 2008, CHEM GEOL, V253, P74, DOI 10.1016/j.chemgeo.2008.04.007; Van Heghe L, 2012, J ANAL ATOM SPECTROM, V27, P1327, DOI 10.1039/c2ja30070b; von Blanckenburg F, 2013, J AGR FOOD CHEM, V61, P11893, DOI 10.1021/jf402358n; Walczyk T, 2002, SCIENCE, V295, P2065, DOI 10.1126/science.1069389; Wiig O, 1996, J ZOOL, V238, P769, DOI 10.1111/j.1469-7998.1996.tb05429.x; Zhao Y, 2014, GEOCHIM COSMOCHIM AC, V125, P653, DOI 10.1016/j.gca.2013.07.045	61	39	39	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152299	10.1371/journal.pone.0152299	http://dx.doi.org/10.1371/journal.pone.0152299			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010907	gold, Green Published, Green Submitted			2022-12-26	WOS:000372708000130
J	Luo, H; Yang, HL; Huang, B; Yuan, D; Zhu, JQ; Zhao, JC				Luo, Han; Yang, Hongliu; Huang, Bin; Yuan, Ding; Zhu, Jingqiang; Zhao, Jichun			Geriatric Nutritional Risk Index (GNRI) Independently Predicts Amputation Inchronic Criticallimb Ischemia (CLI)	PLOS ONE			English	Article							CRITICAL LIMB ISCHEMIA; MORTALITY; SURVIVAL; OUTCOMES; THERAPY; DISEASE; SURGERY; BYPASS	Objective General malnutrition usually occurs in critical limb ischemia (CLI) patients because of shortness of appetite and sleeplessness leaded by chronic pain. And amputation frequently is end-point of CLI patients. So the aim of this study was to assess the predictive ability of Geriatric nutritional risk index (GNRI) for predicting amputation in patients with CLI. Methods A retrospective study was designed. Demographics, history, comorbidity, and risk factors for peripheral vascular disease of admitted patients, and laboratory study were documented. Patients' height, weight and BMI were recorded. Amputation was identified as end-point during follow-up. Patients' amputation-free survival (AFS) was recorded. Result 172 patients were identified, with mean age 71.98 +/- 3.12. Geriatric nutritional risk index (GNRI) = 90 was taken as cutoff value of high risk of amputation for CLI patients via using receiver operating characteristic (ROC) curve. Span of follow-up was 12-48 months. During follow-up, 60 patients (36.04%) received amputation surgery. And analyzed by Cox proportional hazards model, it is found that GNRI was the independent predictive factor for amputation in long term. Conclusion This study revealed that GNRI was a reliable and effective predictive marker for AFS. GNRI could identify patients with high risk for amputation in early time.	[Yang, Hongliu; Huang, Bin] Sichuan Univ, West China Hosp, Dept Nephrol, Ctr Biostat, Chengdu 610064, Peoples R China; [Luo, Han; Yuan, Ding; Zhao, Jichun] Sichuan Univ, West China Hosp, Dept Vasc Surg, Chengdu 610064, Peoples R China; [Luo, Han; Zhu, Jingqiang] Sichuan Univ, West China Hosp, Dept Thyroid & Parathyroid Surg, Chengdu 610064, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Zhu, JQ; Zhao, JC (corresponding author), Sichuan Univ, West China Hosp, Dept Vasc Surg, Chengdu 610064, Peoples R China.; Zhu, JQ (corresponding author), Sichuan Univ, West China Hosp, Dept Thyroid & Parathyroid Surg, Chengdu 610064, Peoples R China.	zjq-wkys@163.com; hxzhao9@163.com	luo, han/AAS-3459-2021	luo, han/0000-0002-9674-0139				Baumeister SE, 2011, NUTRITION, V27, P534, DOI 10.1016/j.nut.2010.06.005; Bouillanne O, 2005, AM J CLIN NUTR, V82, P777, DOI 10.1093/ajcn/82.4.777; Brass EP, 2006, J VASC SURG, V43, P752, DOI 10.1016/j.jvs.2005.11.041; Cheng SWK, 2000, ANN VASC SURG, V14, P158, DOI 10.1007/s100169910028; Chung J, 2013, J VASC SURG, V58, P972, DOI 10.1016/j.jvs.2013.03.050; Claudina Paula, 2010, Rev Port Cir Cardiotorac Vasc, V17, P239; Doumit JH, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-629; GonzalezFajardo JA, 1996, ANN VASC SURG, V10, P16, DOI 10.1007/BF02002336; Ignatovich I N, 2012, Khirurgiia (Mosk), P38; Kang SH, 2013, PERITON DIALYSIS INT, V33, P405, DOI 10.3747/pdi.2012.00018; Kim SY, 2012, J VASC SURG, V55, P90, DOI 10.1016/j.jvs.2011.06.107; Kinugasa Y, 2013, CIRC J, V77, P705, DOI 10.1253/circj.CJ-12-1091; Kitagawa Y, 2014, J GERIATR ONCOL S1, V5, pS12; Koch M, 2007, MED KLIN, V102, P107, DOI 10.1007/s00063-007-1021-8; Kumar BN, 2011, ANN VASC SURG, V25, P873, DOI 10.1016/j.avsg.2011.05.020; Lantis JC, 2011, ANN VASC SURG, V25, P79, DOI 10.1016/j.avsg.2010.09.006; Lee JS, 2013, CLIN NUTR, V32, P843, DOI 10.1016/j.clnu.2013.01.007; Murata N, 2015, EUR J VASC ENDOVASC, V49, P297, DOI 10.1016/j.ejvs.2014.10.014; Nehler MR, 2014, J VASC SURG, V60, P686, DOI 10.1016/j.jvs.2014.03.290; Norgren L, 2007, J VASC SURG, V45, pS5, DOI 10.1016/j.jvs.2006.12.037; Panichi V, 2014, J NEPHROL, V27, P193, DOI 10.1007/s40620-013-0033-0; Santilli JD, 1999, AM FAM PHYSICIAN, V59, P1899; Zhang JQ, 2014, J VASC SURG, V59, P1331, DOI 10.1016/j.jvs.2013.12.032	23	21	23	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152111	10.1371/journal.pone.0152111	http://dx.doi.org/10.1371/journal.pone.0152111			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27010532	gold, Green Published, Green Submitted			2022-12-26	WOS:000372708000091
J	Nair, HB; Santhamma, B; Krishnegowda, NK; Dileep, KV; Nickisch, KJ				Nair, Hareesh B.; Santhamma, Bindu; Krishnegowda, Naveen K.; Dileep, Kalarikkal V.; Nickisch, Klaus J.			Effects of Combination of Estradiol with Selective Progesterone Receptor Modulators (SPRMs) on Human Breast Cancer Cells In Vitro and In Vivo	PLOS ONE			English	Article							ESTROGEN-INDUCED APOPTOSIS; POSTMENOPAUSAL WOMEN; MAMMARY-GLAND; BAZEDOXIFENE/CONJUGATED ESTROGENS; BIOLOGICAL EVALUATION; CONJUGATED ESTROGENS; CONTROLLED TRIAL; EQUINE ESTROGEN; HORMONE-THERAPY; CERVICAL-CANCER	Use of estrogen or estrogen / progestin combination was an approved regimen for menopausal hormonal therapy (MHT). However, more recent patient-centered studies revealed an increase in the incidence of breast cancer in women receiving menopausal hormone therapy with estrogen plus progestin rather than estrogen alone. Tissue selective estrogen complex (TSEC) has been proposed to eliminate the progesterone component of MHT with supporting evidences. Based on our previous studies it is evident that SPRMs have a safer profile on endometrium in preventing unopposed estrogenicity. We hypothesized that a combination of estradiol (E2) with selective progesterone receptor modulator (SPRM) to exert a safer profile on endometrium will also reduce mammary gland proliferation and could be used to prevent breast cancer when used in MHT. In order to test our hypothesis, we compared the estradiol alone or in combination with our novel SPRMs, EC312 and EC313. The compounds were effectively controlled E2 mediated cell proliferation and induced apoptosis in T47D breast cancer cells. The observed effects were found comparable that of BZD in vitro. The effects of SPRMs were confirmed by receptor binding studies as well as gene and protein expression studies. Proliferation markers were found downregulated with EC312/313 treatment in vitro and reduced E2 induced mammary gland proliferation, evidenced as reduced ductal branching and terminal end bud growth in vivo. These data supporting our hypothesis that E2+EC312/EC313 blocked the estrogen action may provide basic rationale to further test the clinical efficacy of SPRMs to prevent breast cancer incidence in postmenopausal women undergoing MHT.	[Nair, Hareesh B.; Santhamma, Bindu; Nickisch, Klaus J.] Evestra Inc, 14508 Omicron Dr, San Antonio, TX 78245 USA; [Krishnegowda, Naveen K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Dileep, Kalarikkal V.] Indian Inst Sci Educ & Res, Sch Chem, Thiruvananthapuram 695016, Kerala, India	University of Texas System; University of Texas Health San Antonio; Indian Institute of Science Education & Research (IISER) - Thiruvananthapuram	Nair, HB (corresponding author), Evestra Inc, 14508 Omicron Dr, San Antonio, TX 78245 USA.	hnair@evestra.com	Vijayan, Dileep K/C-6179-2017	Vijayan, Dileep K/0000-0002-7456-4226	Evestra, Inc.; Indian Institute of Science Education and Research-Thiruvananthapuram (IISER-TVM)	Evestra, Inc.; Indian Institute of Science Education and Research-Thiruvananthapuram (IISER-TVM)	This work was supported by Evestra, Inc. which provided support in the form of salaries for authors [H.B.N., B.S. and K.J.N], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; The authors are gratefully acknowledges the Bioinformatics Infra Structure Facility, Department of Biotechnology and Microbiology, Kannur University, Thalassery Campus for providing the computational facility. The authors also acknowledge Prof. C. Sadasivan for the useful discussions in connection with molecular modeling studies. Dr. Dileep K V acknowledges Indian Institute of Science Education and Research-Thiruvananthapuram (IISER-TVM) for his postdoctoral fellowship. The authors acknowledge Carolyne Packenius for proof reading assistance.	Anderson E, 2004, MATURITAS, V48, pS13, DOI 10.1016/j.maturitas.2004.02.010; Anderson GL, 2012, LANCET ONCOL, V13, P476, DOI 10.1016/S1470-2045(12)70075-X; Archer DE, 2009, FERTIL STERIL, V92, P1039, DOI 10.1016/j.fertnstert.2009.05.093; Beatson G., 1896, LANCET, V2, P104, DOI DOI 10.1016/S0140-6736(01)72307-0; Beleut M, 2010, P NATL ACAD SCI USA, V107, P2989, DOI 10.1073/pnas.0915148107; Berrodin TJ, 2009, MOL ENDOCRINOL, V23, P74, DOI 10.1210/me.2008-0366; Bhaskaran S, 2013, MOL CANCER THER, V12, P361, DOI 10.1158/1535-7163.MCT-12-0965; Butt AJ, 2005, ENDOCR-RELAT CANCER, V12, pS47, DOI 10.1677/erc.1.00993; Chwalisz K, 2005, ENDOCR REV, V26, P423, DOI 10.1210/er.2005-0001; Chwalisz K, 2004, SEMIN REPROD MED, V22, P113; Donnez J, 2014, FERTIL STERIL, V101, P1565, DOI 10.1016/j.fertnstert.2014.02.008; Fan P, 2009, ENDOCRINOLOGY, V150, P2036, DOI 10.1210/en.2008-1195; Gregoraszczuk EL, 2008, ENVIRON TOXICOL PHAR, V25, P227, DOI 10.1016/j.etap.2007.10.004; Hagan CR, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-32; Hovey RC, 2011, TOXICOL SCI, V119, P380, DOI 10.1093/toxsci/kfq337; Jordan VC, 2015, ENDOCR-RELAT CANCER, V22, pR1, DOI 10.1530/ERC-14-0448; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Kirma N, 2007, CANCER RES, V67, P1918, DOI 10.1158/0008-5472.CAN-06-1991; Kramer EA, 2006, EUR J OBSTET GYN R B, V129, P77, DOI 10.1016/j.ejogrb.2005.12.004; Lanari C, 2012, ENDOCR-RELAT CANCER, V19, pR35, DOI 10.1530/ERC-11-0378; Lobo RA, 2009, FERTIL STERIL, V92, P1025, DOI 10.1016/j.fertnstert.2009.03.113; Marino M, 2003, MOL BIOL CELL, V14, P2583, DOI 10.1091/mbc.E02-09-0621; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Nair HB, 2005, CANCER RES, V65, P11164, DOI 10.1158/0008-5472.CAN-05-1087; Nickisch K, 2014, STEROIDS, V92, P45, DOI 10.1016/j.steroids.2014.08.017; Nickisch K, 2013, STEROIDS, V78, P909, DOI 10.1016/j.steroids.2013.04.003; Nickisch K, 2013, STEROIDS, V78, P255, DOI 10.1016/j.steroids.2012.09.010; Obr AE, 2013, MOL ENDOCRINOL, V27, P1808, DOI 10.1210/me.2013-1077; Ohara Noriyuki, 2007, Reprod Sci, V14, P20, DOI 10.1177/1933719107311464; Pinkerton JV, 2009, MENOPAUSE, V16, P1116, DOI 10.1097/gme.0b013e3181a7df0d; Robertson JFR, 1999, EUR J CANCER, V35, P214, DOI 10.1016/S0959-8049(98)00388-8; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Santen RJ, 2010, J CLIN ENDOCR METAB, V95, pS7, DOI 10.1210/jc.2009-2509; Santen RJ, 2014, J STEROID BIOCHEM, V142, P52, DOI 10.1016/j.jsbmb.2013.06.010; Santen RJ, 2013, J STEROID BIOCHEM, V137, P150, DOI 10.1016/j.jsbmb.2013.05.008; Santen RJ, 2008, WOMENS HEALTH, V4, P207, DOI 10.2217/17455057.4.3.207; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Schubert G, 2005, SEMIN REPROD MED, V23, P58, DOI 10.1055/s-2005-864034; Sciacca L, 2013, NUTR METAB CARDIOVAS, V23, P808, DOI 10.1016/j.numecd.2013.05.006; Sflomos G, 2013, ONCOTARGET, V4, P1126, DOI 10.18632/oncotarget.1178; SHAPIRO S, 1985, NEW ENGL J MED, V313, P969, DOI 10.1056/NEJM198510173131601; Song Y, 2013, ENDOCRINOLOGY, V154, P656, DOI 10.1210/en.2012-2038; Song Y, 2012, ENDOCRINOLOGY, V153, P5706, DOI 10.1210/en.2012-1583; Sweeney EE, 2014, CANCER RES, V74, P7060, DOI 10.1158/0008-5472.CAN-14-1784; Tanos T, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005654; von Holst T, 2002, MATURITAS, V43, P265, DOI 10.1016/S0378-5122(02)00203-7; Wagenfeld A, 2013, HUM REPROD, V28, P2253, DOI 10.1093/humrep/det247; Yue W, 1998, CANCER RES, V58, P927	48	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0151182	10.1371/journal.pone.0151182	http://dx.doi.org/10.1371/journal.pone.0151182			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27011208	Green Published, Green Submitted, gold			2022-12-26	WOS:000372708000025
J	Roberts, TE; Bridge, TC; Caley, MJ; Baird, AH				Roberts, T. Edward; Bridge, Thomas C.; Caley, M. Julian; Baird, Andrew H.			The Point Count Transect Method for Estimates of Biodiversity on Coral Reefs: Improving the Sampling of Rare Species	PLOS ONE			English	Article							ASSEMBLY RULES; DIVERSITY; GRADIENTS; SCALE	Understanding patterns in species richness and diversity over environmental gradients (such as altitude and depth) is an enduring component of ecology. As most biological communities feature few common and many rare species, quantifying the presence and abundance of rare species is a crucial requirement for analysis of these patterns. Coral reefs present specific challenges for data collection, with limitations on time and site accessibility making efficiency crucial. Many commonly used methods, such as line intercept transects (LIT), are poorly suited to questions requiring the detection of rare events or species. Here, an alternative method for surveying reef-building corals is presented; the point count transect (PCT). The PCT consists of a count of coral colonies at a series of sample stations, located at regular intervals along a transect. In contrast the LIT records the proportion of each species occurring under a transect tape of a given length. The same site was surveyed using PCT and LIT to compare species richness estimates between the methods. The total number of species increased faster per individual sampled and unit of time invested using PCT. Furthermore, 41 of the 44 additional species recorded by the PCT occurred <= 3 times, demonstrating the increased capacity of PCT to detect rare species. PCT provides a more accurate estimate of local-scale species richness than the LIT, and is an efficient alternative method for surveying reef corals to address questions associated with alpha-diversity, and rare or incidental events.	[Roberts, T. Edward; Bridge, Thomas C.; Baird, Andrew H.] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; [Roberts, T. Edward; Bridge, Thomas C.; Caley, M. Julian] Australian Inst Marine Sci, PMB 3, Townsville, Qld 4810, Australia	James Cook University; Australian Institute of Marine Science	Roberts, TE (corresponding author), James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	thomas.roberts@my.jcu.edu.au	Roberts, Thomas Edward/O-5900-2019; Baird, Andrew Hamilton/C-8449-2009; Roberts, Thomas Edward/X-9507-2019; Bridge, Tom/J-2693-2014	Roberts, Thomas Edward/0000-0002-4555-8281; Baird, Andrew Hamilton/0000-0001-8504-4077; Bridge, Tom/0000-0003-3951-284X	Australian Research Council Centre of Excellence in Coral Reef Studies [CE140100020]	Australian Research Council Centre of Excellence in Coral Reef Studies(Australian Research Council)	This work was funded by the Australian Research Council Centre of Excellence in Coral Reef Studies (CE140100020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellwood DR, 2001, SCIENCE, V292, P1532, DOI 10.1126/science.1058635; Bridge TCL, 2013, NAT CLIM CHANGE, V3, P528, DOI 10.1038/nclimate1879; Buckland ST, 2006, AUK, V123, P345, DOI 10.1642/0004-8038(2006)123[345:PSFSRM]2.0.CO;2; Caley MJ, 2014, TRENDS ECOL EVOL, V29, P187, DOI 10.1016/j.tree.2014.02.002; Chao A, 2009, ECOLOGY, V90, P1125, DOI 10.1890/07-2147.1; Colwell RK, 2013, USERS GUIDE APPL; Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Dornelas M, 2006, NATURE, V440, P80, DOI 10.1038/nature04534; Dornelas M, 2008, ECOL LETT, V11, P1008, DOI 10.1111/j.1461-0248.2008.01208.x; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Gotelli Nicholas J., 2011, P39; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gray JS, 2006, J ANIM ECOL, V75, P752, DOI 10.1111/j.1365-2656.2006.01095.x; Hill JJ, 2004, METHODS ECOLOGICAL M; Hughes TP, 2012, CURR BIOL, V22, P736, DOI 10.1016/j.cub.2012.02.068; Hughes TP, 1999, NATURE, V397, P59, DOI 10.1038/16237; Lee DC, 2008, IBIS, V150, P315, DOI 10.1111/j.1474-919X.2007.00790.x; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; LOYA Y, 1972, MAR BIOL, V13, P100, DOI 10.1007/BF00366561; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Marsden SJ, 1999, IBIS, V141, P377; Perry JJ, 2012, EMU, V112, P261, DOI 10.1071/MU12007; Presley SJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P968, DOI 10.1111/j.1466-8238.2011.00738.x; PRESTON FW, 1948, ECOLOGY, V29, P254, DOI 10.2307/1930989; Richards ZT, 2013, CORAL REEFS, V32, P287, DOI 10.1007/s00338-012-0963-3; Slattery M, 2011, J EXP MAR BIOL ECOL, V408, P32, DOI 10.1016/j.jembe.2011.07.024; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032	28	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2016	11	3							e0152335	10.1371/journal.pone.0152335	http://dx.doi.org/10.1371/journal.pone.0152335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3SV	27011368	Green Accepted, Green Published, gold			2022-12-26	WOS:000372708000134
J	Gisladottir, A; Luque-Fernandez, MA; Harlow, BL; Gudmundsdottir, B; Jonsdottir, E; Bjarnadottir, RI; Hauksdottir, A; Aspelund, T; Cnattingius, S; Valdimarsdottir, UA				Gisladottir, Agnes; Luque-Fernandez, Miguel Angel; Harlow, Bernard L.; Gudmundsdottir, Berglind; Jonsdottir, Eyrun; Bjarnadottir, Ragnheidur I.; Hauksdottir, Arna; Aspelund, Thor; Cnattingius, Sven; Valdimarsdottir, Unnur A.			Obstetric Outcomes of Mothers Previously Exposed to Sexual Violence	PLOS ONE			English	Article							CHILDHOOD ABUSE; LIFETIME DIAGNOSIS; PRIMIPAROUS WOMEN; NULLIPAROUS WOMEN; FEAR; CHILDBIRTH; BIRTH; RISK; PREGNANCY; HEALTH	Background There is a scarcity of data on the association of sexual violence and women's subsequent obstetric outcomes. Our aim was to investigate whether women exposed to sexual violence as teenagers (12-19 years of age) or adults present with different obstetric outcomes than women with no record of such violence. Methods We linked detailed prospectively collected information on women attending a Rape Trauma Service (RTS) to the Icelandic Medical Birth Registry (IBR). Women who attended the RTS in 1993-2010 and delivered (on average 5.8 years later) at least one singleton infant in Iceland through 2012 formed our exposed cohort (n = 1068). For each exposed woman's delivery, nine deliveries by women with no RTS attendance were randomly selected from the IBR (n = 9126) matched on age, parity, and year and season of delivery. Information on smoking and Body mass index (BMI) was available for a sub-sample (n = 792 exposed and n = 1416 non-exposed women). Poisson regression models were used to estimate Relative Risks (RR) with 95% confidence intervals (CI). Results Compared with non-exposed women, exposed women presented with increased risks of maternal distress during labor and delivery (RR 1.68, 95% CI 1.01-2.79), prolonged first stage of labor (RR 1.40, 95% CI 1.03-1.88), antepartum bleeding (RR 1.95, 95% CI 1.22-3.07) and emergency instrumental delivery (RR 1.16, 95% CI 1.00-1.34). Slightly higher risks were seen for women assaulted as teenagers. Overall, we did not observe differences between the groups regarding the risk of elective cesarean section (RR 0.86, 95% CI 0.61-1.21), except for a reduced risk among those assaulted as teenagers (RR 0.56, 95% CI 0.34-0.93). Adjusting for maternal smoking and BMI in a sub-sample did not substantially affect point estimates. Conclusion Our prospective data suggest that women with a history of sexual assault, particularly as teenagers, are at increased risks of some adverse obstetric outcomes.	[Gisladottir, Agnes; Hauksdottir, Arna; Aspelund, Thor; Valdimarsdottir, Unnur A.] Univ Iceland, Ctr Publ Hlth Sci, Reykjavik, Iceland; [Luque-Fernandez, Miguel Angel] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1, England; [Luque-Fernandez, Miguel Angel; Valdimarsdottir, Unnur A.] Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA; [Harlow, Bernard L.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Gudmundsdottir, Berglind; Jonsdottir, Eyrun] Natl Univ Hosp Iceland, Landspitali, Rape Trauma Serv, Reykjavik, Iceland; [Gudmundsdottir, Berglind; Jonsdottir, Eyrun] Natl Univ Hosp Iceland, Landspitali, Ctr Trauma, Reykjavik, Iceland; [Gudmundsdottir, Berglind] Univ Iceland, Dept Psychol, Reykjavik, Iceland; [Bjarnadottir, Ragnheidur I.] Natl Univ Hosp Iceland, Landspitali, Dept Obstet & Gynecol, Reykjavik, Iceland; [Aspelund, Thor] Iceland Heart Assoc, Kopavogur, Iceland; [Cnattingius, Sven] Karolinska Inst, Clin Epidemiol Unit, Stockholm, Sweden; [Valdimarsdottir, Unnur A.] Karolinska Inst, Dept Med Epidemiol, Stockholm, Sweden	University of Iceland; University of London; London School of Hygiene & Tropical Medicine; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Landspitali National University Hospital; Landspitali National University Hospital; University of Iceland; Landspitali National University Hospital; Icelandic Heart Association; Karolinska Institutet; Karolinska Institutet	Gisladottir, A (corresponding author), Univ Iceland, Ctr Publ Hlth Sci, Reykjavik, Iceland.	agnesg@hi.is	Aspelund, Thor/K-7022-2019; FERNANDEZ, MIGUEL ANGEL LUQUE/AAK-7183-2021; FERNANDEZ, MIGUEL ANGEL LUQUE/L-4053-2015; FERNANDEZ, MIGUEL ANGEL LUQUE/AAZ-5017-2020; Aspelund, Thor/C-5983-2008	Aspelund, Thor/0000-0002-7998-5433; FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; Aspelund, Thor/0000-0002-7998-5433; Valdimarsdottir, Unnur/0000-0001-5382-946X; Hauksdottir, Arna/0000-0002-4253-1059; Harlow, Bernard/0000-0002-6735-8862; Gudmundsdottir, Berglind/0000-0002-4145-7723	Icelandic Research Fund for Graduate Students [RAN090310-0736]; Landspitali University Hospital Research Fund	Icelandic Research Fund for Graduate Students; Landspitali University Hospital Research Fund	This work was supported by The Icelandic Research Fund for Graduate Students, RAN090310-0736, www.rannis.is (AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. It was also supported by the Landspitali University Hospital Research Fund, http://www.landspitali.is/visindi-og-menntun/visindastarfsemi/visindasjodur-lsh/ (AG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SS, 2012, BJOG-INT J OBSTET GY, V119, P1238, DOI 10.1111/j.1471-0528.2012.03433.x; Alehagen S, 2001, INT J BEHAV MED, V8, P50, DOI 10.1207/S15327558IJBM0801_04; Chen LP, 2010, MAYO CLIN PROC, V85, P618, DOI 10.4065/mcp.2009.0583; Eberhard-Gran M, 2008, J PSYCHOSOM OBST GYN, V29, P258, DOI 10.1080/01674820802075998; Elvander C, 2013, BIRTH-ISS PERINAT C, V40, P289, DOI 10.1111/birt.12065; Felitti VJ, 1998, AM J PREV MED, V14, P245, DOI 10.1016/S0749-3797(98)00017-8; Finnbogadottir H, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-14; Garcia-Moreno C, 2015, LANCET, V385, P1685, DOI 10.1016/S0140-6736(14)61830-4; Gisladottir A, 2014, ACTA OBSTET GYN SCAN, V93, P351, DOI 10.1111/aogs.12331; Gisladottir A, 2012, ACTA OBSTET GYN SCAN, V91, P134, DOI 10.1111/j.1600-0412.2011.01283.x; Halvorsen L, 2013, BIRTH-ISS PERINAT C, V40, P182, DOI 10.1111/birt.12054; Heimstad R, 2006, ACTA OBSTET GYN SCAN, V85, P435, DOI 10.1080/00016340500432507; Henriksen L, 2014, BJOG-INT J OBSTET GY, V121, P1237, DOI 10.1111/1471-0528.12923; Henriksen L, 2013, BIRTH-ISS PERINAT C, V40, P281, DOI 10.1111/birt.12063; Hodnett ED, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000012.pub4; Jonas S, 2011, PSYCHOL MED, V41, P709, DOI 10.1017/S003329171000111X; Karlsdottir E, 2010, RANNSOKN OFBELDI GEG; Laursen M, 2009, BJOG-INT J OBSTET GY, V116, P1350, DOI 10.1111/j.1471-0528.2009.02250.x; Leeners B, 2013, J PERINAT MED, V41, P365, DOI 10.1515/jpm-2011-0086; Leeners B, 2010, J PSYCHOSOM RES, V69, P503, DOI 10.1016/j.jpsychores.2010.04.017; Lindert J, 2014, INT J PUBLIC HEALTH, V59, P359, DOI 10.1007/s00038-013-0519-5; Lukasse M, 2010, BJOG-INT J OBSTET GY, V117, P1153, DOI 10.1111/j.1471-0528.2010.02627.x; Lukasse M, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-83; Lukasse M, 2009, BIRTH-ISS PERINAT C, V36, P190, DOI 10.1111/j.1523-536X.2009.00323.x; Masho SW, 2007, J WOMENS HEALTH, V16, P262, DOI 10.1089/jwh.2006.M076; Nelson EC, 2006, PSYCHOL MED, V36, P1473, DOI 10.1017/S0033291706008397; Nerum H, 2013, BJOG-INT J OBSTET GY, V120, P487, DOI 10.1111/1471-0528.12053; Nerum H, 2010, BJOG-INT J OBSTET GY, V117, P288, DOI 10.1111/j.1471-0528.2009.02454.x; Noll JG, 2007, PEDIATRICS, V120, pE61, DOI 10.1542/peds.2006-3058; Norman SM, 2012, OBSTET GYNECOL, V120, P130, DOI 10.1097/AOG.0b013e318259589c; Paras ML, 2009, JAMA-J AM MED ASSOC, V302, P550, DOI 10.1001/jama.2009.1091; Riley EH, 2010, J EPIDEMIOL COMMUN H, V64, P413, DOI 10.1136/jech.2009.095109; Rouhe H, 2013, BJOG-INT J OBSTET GY, V120, P75, DOI 10.1111/1471-0528.12011; Schei B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087579; Scott KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080573; Suglia SF, 2015, AM J PREV MED, V48, P205, DOI 10.1016/j.amepre.2014.09.013; Van der Hulst LAM, 2006, J PSYCHOSOM OBST GYN, V27, P59, DOI 10.1080/01674820500305788; Walsh K, 2012, CLIN PSYCHOL-SCI PR, V19, P260, DOI 10.1111/cpsp.12004	38	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0150726	10.1371/journal.pone.0150726	http://dx.doi.org/10.1371/journal.pone.0150726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007230	Green Published, Green Accepted, gold			2022-12-26	WOS:000372701200028
J	Jordan, CA; Schank, CJ; Urquhart, GR; Dans, AJ				Jordan, Christopher A.; Schank, Cody J.; Urquhart, Gerald R.; Dans, Armando J.			Terrestrial Mammal Occupancy in the Context of Widespread Forest Loss and a Proposed Interoceanic Canal in Nicaragua's Decreasingly Remote South Caribbean Region	PLOS ONE			English	Article								Central America is experiencing rapid forest loss and habitat degradation both inside and outside of protected areas. Despite increasing deforestation, the Caribbean region of Nicaragua plays an important role in the survival or extinction of large mammal populations in Central America given that it still retains core areas of habitat for large mammal species. The proposed interoceanic canal project that would bisect the southern half of this Caribbean region represents a new threat that, combined with an advancing agricultural frontier, could affect populations of large mammal species such as jaguars, white-lipped peccaries, and Baird's tapirs. We used occupancy models to examine the relative occupancy probabilities for an assemblage of terrestrial mammals in the south Caribbean region of Nicaragua to identify current core areas for our study species and conduct a preliminary evaluation of the potential impacts of the proposed interoceanic canal. We modeled a community level distribution of eight species with varying levels of sensitivity to human encroachment and a range of habitat associations. Our model results reveal three priority areas for terrestrial mammal conservation in our study area. The mapped predictions show that the only remaining area of suitable habitat for large mammals in the path of the proposed interoceanic canal is a relatively thin strip of forest that runs along the Caribbean Coast. In light of these findings, we propose five recommendations that will help ensure the conservation of this area of the proposed canal route as suitable habitat for our study species.	[Jordan, Christopher A.; Schank, Cody J.; Dans, Armando J.] Global Wildlife Conservat, Austin, TX USA; [Jordan, Christopher A.] Panthera, New York, NY USA; [Schank, Cody J.] Univ Texas Austin, Dept Geog & Environm, Austin, TX 78712 USA; [Jordan, Christopher A.; Urquhart, Gerald R.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Urquhart, Gerald R.] Michigan State Univ, Lyman Briggs Coll, E Lansing, MI 48824 USA	University of Texas System; University of Texas Austin; Michigan State University; Michigan State University	Jordan, CA (corresponding author), Global Wildlife Conservat, Austin, TX USA.; Jordan, CA (corresponding author), Panthera, New York, NY USA.; Jordan, CA (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	cjordan@globalwildlife.org			National Science Foundation Coupled Natural and Human System Program [CNH-0815966]; National Science Foundation Graduate Research Fellowship [2010081992]; Disney Worldwide Conservation Fund; Global Forest Watch Small Grants Program [00530]; Liz Claiborne and Art Ortenberg Jaguar Research Grant; Tapir Specialist Group Conservation Fund; Donald. D. Harrington Fellowship from the Graduate School at the University of Texas at Austin; Department of Geography and the Environment at the University of Texas at Austin; Tinker Field Research Grant from the Teresa Lozano Long Institue of Latin American Studies at the University of Texas at Austin	National Science Foundation Coupled Natural and Human System Program; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Disney Worldwide Conservation Fund; Global Forest Watch Small Grants Program; Liz Claiborne and Art Ortenberg Jaguar Research Grant; Tapir Specialist Group Conservation Fund; Donald. D. Harrington Fellowship from the Graduate School at the University of Texas at Austin; Department of Geography and the Environment at the University of Texas at Austin; Tinker Field Research Grant from the Teresa Lozano Long Institue of Latin American Studies at the University of Texas at Austin	This work was supported by the National Science Foundation Coupled Natural and Human System Program (CNH-0815966), www.nsf.gov, to GRU; the National Science Foundation Graduate Research Fellowship (2010081992) 2010-2012, http://www.nsf.gov/, to CAJ; the Disney Worldwide Conservation Fund, 2012, 2013, https://thewaltdisneycompany.com/content/conservation-funding, to GRU; the Global Forest Watch Small Grants Program (00530), 2015, https://gfw.fluidreview.com/, to CAJ; the Liz Claiborne and Art Ortenberg Jaguar Research Grant, 2013, http://www.panthera.org/node/785, to CAJ; the Tapir Specialist Group Conservation Fund. 2012. http://www.tapirs.org/tsgcf/index.html, to CAJ; the Donald. D. Harrington Fellowship from the Graduate School at the University of Texas at Austin, http://www.utexas.edu/ogs/funding/fellowships/harrington/CJS; the Robert E. Veselka Fellowship from the Department of Geography and the Environment at the University of Texas at Austin, http://www.utexas.edu/cola/depts/geography/events/16493, to CJS; and The Tinker Field Research Grant from the Teresa Lozano Long Institue of Latin American Studies at the University of Texas at Austin, http://www.utexas.edu/cola/insts/llilas/student-programs/funding-opportunities/graduate-funding/field-research.php, to CJS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambientalistas Jovenes, 2013, LIST ROJ ESP ALT RIE; [Anonymous], ESTUD AMBIENT; [Anonymous], NATURAL RESERVES NO; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Christie, 2000, TAKING CARE WHAT WE; Condit R, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002208; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Holland M.B., 2012, CLIMATE CONSERVATION, P56, DOI DOI 10.5822/978-1-61091-203-7_5; Hong Kong Nicaraguan Canal Development Group (HKND), ENV SOC IMP ASS; Hong Kong Nicaraguan Canal Development Group (HKND), 2014, NIC CAN PROJ OV; Huete-Perez JA, 2015, ENVIRON SCI TECHNOL, V49, P3989, DOI 10.1021/acs.est.5b00215; IUCN, 2013, IUCN RED LIST THREAT; Jordan C.A., 2015, THESIS MICHIGAN STAT; Jordan Christopher A., 2013, Tapir Conservation, V22, P14; Kilpatrick K, 2015, CANAL WILL DESTROY W; Linden DW, 2012, FOREST ECOL MANAG, V284, P174, DOI 10.1016/j.foreco.2012.08.002; Link WA, 2012, METHODS ECOL EVOL, V3, P112, DOI 10.1111/j.2041-210X.2011.00131.x; NASA, 2015, THIS DAT SET WAS PRO; Petracca LS, 2014, J NAT CONSERV, V22, P436, DOI 10.1016/j.jnc.2014.04.002; Rabinowitz A, 2010, BIOL CONSERV, V143, P939, DOI 10.1016/j.biocon.2010.01.002; Royle J. A., 2008, HIERARCHICAL MODELIN; Schank Cody, 2015, Tapir Conservation, V23, P15; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Spiegelhalter DJ, 2003, WINBUGS VERSION 1 4; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; UNEP-WCMC IUCN, 2021, PROT PLAN INS NAM CO; Vreugdenhil D, 2002, MAP ECOSYSTEMAS CENT; Zipkin E, HIERARCHICAL APPROAC	28	13	13	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151372	10.1371/journal.pone.0151372	http://dx.doi.org/10.1371/journal.pone.0151372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007122	Green Published, gold, Green Submitted			2022-12-26	WOS:000372701200051
J	Le Clef, N; Verhulst, A; D'Haese, PC; Vervaet, BA				Le Clef, Nathalie; Verhulst, Anja; D'Haese, Patrick C.; Vervaet, Benjamin A.			Unilateral Renal Ischemia-Reperfusion as a Robust Model for Acute to Chronic Kidney Injury in Mice	PLOS ONE			English	Article							GELATINASE-ASSOCIATED LIPOCALIN; ISCHEMIA/REPERFUSION-INJURY; COLD ISCHEMIA; POSTISCHEMIC ACUTE; MOLECULE-1 KIM-1; ANGIOTENSIN-II; MOUSE MODEL; RAT MODEL; FAILURE; DISEASE	Acute kidney injury (AKI) is an underestimated, yet important risk factor for development of chronic kidney disease (CKD). Even after initial total recovery of renal function, some patients develop progressive and persistent deterioration of renal function and these patients are more likely to progress to end-stage renal disease (ESRD). Animal models are indispensable for unravelling the mechanisms underlying this progression towards CKD and ESRD and for the development of new therapeutic strategies in its prevention or treatment. Ischemia (i.e. hypoperfusion after surgery, bleeding, dehydration, shock, or sepsis) is a major aetiology in human AKI, yet unilateral ischemia-reperfusion is a rarely used animal model for research on CKD and fibrosis. Here, we demonstrate in C57Bl/6J mice, by both histology and gene expression, that unilateral ischemia-reperfusion without contralateral nephrectomy is a very robust model to study the progression from acute renal injury to longterm tubulo-interstitial fibrosis, i.e. the histopathological hallmark of CKD. Furthermore, we report that the extent of renal fibrosis, in terms of Col I, TGF beta, CCN2 and CCN3 expression and collagen I immunostaining, increases with increasing body temperature during ischemia and ischemia-time. Thus, varying these two main determinants of ischemic injury allows tuning the extent of the long-term fibrotic outcome in this model. Finally, in order to cover the whole practical finesse of ischemia-reperfusion and allow model and data transfer, we provide a referenced overview on crucial technical issues (incl. anaesthesia, analgesia, and pre- and post-operative care) with the specific aim of putting starters in the right direction of implementing ischemia in their research and stimulate them, as well as the community, to have a critical view on ischemic literature data.	[Le Clef, Nathalie; Verhulst, Anja; D'Haese, Patrick C.; Vervaet, Benjamin A.] Univ Antwerp, Lab Pathophysiol, Dept Biomed Sci, B-2020 Antwerp, Belgium	University of Antwerp	D'Haese, PC (corresponding author), Univ Antwerp, Lab Pathophysiol, Dept Biomed Sci, B-2020 Antwerp, Belgium.	Patrick.Dhaese@uantwerpen.be	Vervaet, Benjamin/AAU-4679-2020	Vervaet, Benjamin/0000-0002-8589-5469	Agency for Innovation by Science and Technology in Flanders [111389]	Agency for Innovation by Science and Technology in Flanders	NLC was funded by a PhD grant of the Agency for Innovation by Science and Technology in Flanders (http://www.iwt.be/), grant number 111389. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi T, 2013, ACTA HISTOCHEM CYTOC, V46, P161, DOI 10.1267/ahc.13022; Alpers CE, 2014, DRUG DISCOV TODAY, V11, P1, DOI DOI 10.1016/J.DDM0D.2014.12.003; Ascon M, 2009, KIDNEY INT, V75, P526, DOI 10.1038/ki.2008.602; Basile DP, 2012, COMPR PHYSIOL, V2, P1303, DOI 10.1002/cphy.c110041; Basile DP, 2011, AM J PHYSIOL-RENAL, V300, pF721, DOI 10.1152/ajprenal.00546.2010; Basile DP, 1998, AM J PHYSIOL-RENAL, V275, pF894, DOI 10.1152/ajprenal.1998.275.6.F894; Basile DP, 2001, AM J PHYSIOL-RENAL, V281, pF887, DOI 10.1152/ajprenal.0050.2001; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Braun H, 2012, J AM SOC NEPHROL, V23, P1467, DOI 10.1681/ASN.2011100967; Burne MJ, 2000, TRANSPLANTATION, V69, P1023; Campbell D, 2015, J CLIN HYPERTENS, V17, P514, DOI 10.1111/jch.12560; Carattino MD, 1999, IMMUNOPHARMACOLOGY, V43, P241, DOI 10.1016/S0162-3109(99)00095-8; Celie JWAM, 2012, KIDNEY INT, V81, P651, DOI 10.1038/ki.2011.425; Chawla LS, 2012, KIDNEY INT, V82, P516, DOI 10.1038/ki.2012.208; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; CRADDOCK GN, 1976, ARCH SURG-CHICAGO, V111, P582; del Moral RMG, 2013, SCI WORLD J, DOI 10.1155/2013/486574; Delbridge MS, 2007, TRANSPL P, V39, P2983, DOI 10.1016/j.transproceed.2007.04.028; Dhaun N, 2013, KIDNEY INT, V84, P637, DOI 10.1038/ki.2013.158; Downey P, 2001, J ENDOUROL, V15, P209, DOI 10.1089/089277901750134647; Ertugrul A., 1999, International Urology and Nephrology, V31, P611, DOI 10.1023/A:1007100303378; Feitoza CQ, 2008, MOL MED, V14, P724, DOI 10.2119/2008-00064.Feitoza; Fish R, 2011, ANESTHESIA ANALGESIA; Gargiulo S, 2012, ILAR J, V53, pE55, DOI 10.1093/ilar.53.1.55; Gottmann U, 2006, KIDNEY INT, V70, P321, DOI 10.1038/sj.ki.5001501; Guarnieri M, 2012, LAB ANIMAL, V41, P337, DOI 10.1038/laban.152; Gueler F, 2004, KIDNEY INT, V66, P523, DOI 10.1111/j.1523-1755.2004.761_11.x; Haisch C, 1997, TRANSPLANT P, V29, P3424, DOI 10.1016/S0041-1345(97)00963-9; Hankenson FC, 2013, CRITICAL CARE MANAGE; Heung M, 2012, CURR OPIN NEPHROL HY, V21, P628, DOI 10.1097/MNH.0b013e3283588f24; Horbelt M, 2007, AM J PHYSIOL-RENAL, V293, pF688, DOI 10.1152/ajprenal.00452.2006; Holderied A., 2014, DRUG DISCOV TODAY, V11, P19, DOI [10.1016/j.ddmod.2014.06.004, DOI 10.1016/J.DDMOD.2014.06.004]; Hosgood SA, 2013, J SURG RES, V182, P153, DOI 10.1016/j.jss.2012.08.001; Hosgood SA, 2012, J SURG RES, V174, pE85, DOI 10.1016/j.jss.2011.10.024; Humphreys BD, 2014, KIDNEY INT, V86, P481, DOI 10.1038/ki.2013.368; Humphreys BD, 2013, J CLIN INVEST, V123, P4023, DOI 10.1172/JCI45361; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Jani A, 2004, AM J TRANSPLANT, V4, P1246, DOI 10.1111/j.1600-6143.2004.00498.x; Jones J, 2012, AM J KIDNEY DIS, V60, P402, DOI 10.1053/j.ajkd.2012.03.014; Karipineni F, 2014, INT J SURG, V12, P551, DOI 10.1016/j.ijsu.2014.04.002; Kashiwagi E, 2014, EXP TOXICOL PATHOL, V66, P301, DOI 10.1016/j.etp.2014.04.007; Kassab S, 2001, FUND CLIN PHARMACOL, V15, P379, DOI 10.1046/j.1472-8206.2001.xs052.x; Kennedy SE, 2008, NEPHROLOGY, V13, P390, DOI 10.1111/j.1440-1797.2008.00979.x; Kim J, 2014, KIDNEY INT; Kimura M, 1999, AM J PATHOL, V155, P1371, DOI 10.1016/S0002-9440(10)65239-X; Ko GJ, 2010, AM J PHYSIOL-RENAL, V298, pF1472, DOI 10.1152/ajprenal.00619.2009; Kohn D. F., 1997, ANESTHESIA ANALGESIA; Kosieradzki M, 2008, TRANSPL P, V40, P3279, DOI 10.1016/j.transproceed.2008.10.004; Kwak W, 2011, BIOCHEM BIOPH RES CO, V406, P7, DOI 10.1016/j.bbrc.2011.01.085; Lameire NH, 2013, LANCET, V382, P170, DOI 10.1016/S0140-6736(13)60647-9; Lech M, 2013, KIDNEY INT, V83, P647, DOI 10.1038/ki.2012.463; Lech M, 2009, J IMMUNOL, V183, P4109, DOI 10.4049/jimmunol.0900118; Lee HT, 2004, ANESTHESIOLOGY, V101, P1313; Lieberthal W, 2000, AM J PHYSIOL-RENAL, V278, pF1, DOI 10.1152/ajprenal.2000.278.1.F1; Lim Beom Jin, 2014, Drug Discov Today Dis Models, V11, P45; Ling H, 2015, INFLAMMATION; MALIS CD, 1983, AM J PHYSIOL, V245, pF735, DOI 10.1152/ajprenal.1983.245.6.F735; MANGINO MJ, 1991, AM J PHYSIOL, V261, pF841, DOI 10.1152/ajprenal.1991.261.5.F841; Massberg S, 1998, TRANSPL P, V30, P4217, DOI 10.1016/S0041-1345(98)01397-9; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Nakagawa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136994; Nguan CYC, 2014, AM J PHYSIOL-RENAL, V306, pF724, DOI 10.1152/ajprenal.00410.2013; Oxburgh Leif, 2012, Methods Mol Biol, V886, P363, DOI 10.1007/978-1-61779-851-1_32; Pang P, 2015, KIDNEY INT, V87, P771, DOI 10.1038/ki.2014.364; Park KM, 2004, J BIOL CHEM, V279, P52282, DOI 10.1074/jbc.M407629200; PELKEY TJ, 1992, J VASC SURG, V15, P619, DOI 10.1016/0741-5214(92)90006-T; Salahudeen AK, 2004, KIDNEY INT, V65, P713, DOI 10.1111/j.1523-1755.2004.00416.x; Singh AP, 2012, PHARMACOL REP, V64, P31, DOI 10.1016/S1734-1140(12)70728-4; Singh P, 2013, CLIN EXP PHARMACOL P, V40, P138, DOI 10.1111/1440-1681.12036; Skrypnyk NI, 2013, JOVE-J VIS EXP, DOI 10.3791/50495; Spurgeon-Pechman KR, 2007, AM J PHYSIOL-RENAL, V293, pF269, DOI 10.1152/ajprenal.00279.2006; Stokman G, 2005, J AM SOC NEPHROL, V16, P1684, DOI 10.1681/ASN.2004080678; Stubenitsky BM, 2001, TRANSPLANT INT, V14, P256, DOI 10.1111/j.1432-2277.2001.tb00054.x; Tilney NL, 2003, TRANSPLANT REV, V17, P140, DOI [10.1016/S0955-470X(03)00040-5, DOI 10.1016/S0955-470X(03)00040-5]; Tokuyama H, 2002, HYPERTENSION, V40, P34, DOI 10.1161/01.HYP.0000022060.13995.ED; Tsuji Y., 1993, International Urology and Nephrology, V25, P83, DOI 10.1007/BF02552259; van Timmeren MM, 2007, J PATHOL, V212, P209, DOI 10.1002/path.2175; van Zutphen LFM, 1993, PRINCIPLES LAB ANIMA; Wang YL, 2013, TRANSPL P, V45, P3198, DOI 10.1016/j.transproceed.2013.07.061; Wei QQ, 2012, AM J PHYSIOL-RENAL, V303, pF1487, DOI 10.1152/ajprenal.00352.2012; Yang Hai-Chun, 2010, Drug Discov Today Dis Models, V7, P13, DOI 10.1016/j.ddmod.2010.08.002; Yunos NM, 2012, JAMA-J AM MED ASSOC, V308, P1566, DOI 10.1001/jama.2012.13356; ZAGER RA, 1989, CIRC RES, V65, P1263, DOI 10.1161/01.RES.65.5.1263; Zager RA, 2013, KIDNEY INT, V84, P703, DOI 10.1038/ki.2013.157; Zager RA, 2011, AM J PHYSIOL-RENAL, V301, pF1334, DOI 10.1152/ajprenal.00431.2011; Zager RA, 2009, AM J PHYSIOL-RENAL, V297, pF961, DOI 10.1152/ajprenal.00381.2009; Zager RA, 2009, AM J PHYSIOL-RENAL, V296, pF362, DOI 10.1152/ajprenal.90645.2008	87	92	93	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0152153	10.1371/journal.pone.0152153	http://dx.doi.org/10.1371/journal.pone.0152153			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007127	gold, Green Published, Green Submitted			2022-12-26	WOS:000372701200099
J	Zhang, L; Butler, CA; Khan, HSG; Dashper, SG; Seers, CA; Veith, PD; Zhang, JG; Reynolds, EC				Zhang, Lianyi; Butler, Catherine A.; Khan, Hasnah S. G.; Dashper, Stuart G.; Seers, Christine A.; Veith, Paul D.; Zhang, Jian-Guo; Reynolds, Eric C.			Characterisation of the Porphyromonas gingivalis Manganese Transport Regulator Orthologue	PLOS ONE			English	Article							METALLOREGULATORY PROTEIN MNTR; SECONDARY STRUCTURE ANALYSES; METAL-ION-ACTIVATION; BACILLUS-SUBTILIS; RESPONSE REGULATOR; DIPHTHERIA; IRON; PATHOGENESIS; MECHANISM; REPRESSOR	PgMntR is a predicted member of the DtxR family of transcriptional repressors responsive to manganese in the anaerobic periodontal pathogen Porphyromonas gingivalis. Our bioinformatic analyses predicted that PgMntR had divalent metal binding site(s) with elements of both manganous and ferrous ion specificity and that PgMntR has unusual twin C-terminal FeoA domains. We produced recombinant PgMntR and four variants to probe the specificity of metal binding and its impact on protein structure and DNA binding. PgMntR dimerised in the absence of a divalent transition metal cation. PgMntR bound three Mn(II) per monomer with an overall dissociation constant K-d 2.0 x 10(-11) M at pH 7.5. PgMntR also bound two Fe (II) with distinct binding affinities, K-d1 2.5 x 10(-10) M and K-d2 <= 6.0 x 10(-8) M at pH 6.8. Two of the metal binding sites may form a binuclear centre with two bound Mn2+ being bridged by Cys108 but this centre provided only one site for Fe2+. Binding of Fe2+ or Mn2+ did not have a marked effect on the PgMntR secondary structure. Apo-PgMntR had a distinct affinity for the promoter region of the gene encoding the only known P. gingivalis manganese transporter, FB2. Mn2+ increased the DNA binding affinity of PgMntR whilst Fe2+ destabilised the protein-DNA complex in vitro. PgMntR did not bind the promoter DNA of the gene encoding the characterised iron transporter FB1. The C-terminal FeoA domain was shown to be essential for PgMntR structure/function, as its removal caused the introduction of an intramolecular disulfide bond and abolished the binding of Mn2+ and DNA. These data indicate that PgMntR is a novel member of the DtxR family that may function as a transcriptional repressor switch to specifically regulate manganese transport and homeostasis in an iron-dependent manner.	[Zhang, Lianyi; Butler, Catherine A.; Khan, Hasnah S. G.; Dashper, Stuart G.; Seers, Christine A.; Veith, Paul D.; Reynolds, Eric C.] Univ Melbourne, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, Inst Bio21, Melbourne, Vic, Australia; [Zhang, Jian-Guo] Univ Melbourne, Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Zhang, Jian-Guo] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne	Reynolds, EC (corresponding author), Univ Melbourne, Melbourne Dent Sch, Oral Hlth Cooperat Res Ctr, Inst Bio21, Melbourne, Vic, Australia.	e.reynolds@unimelb.edu.au	Zhang, Lianyi/H-7491-2014	Khan, Hasnah/0000-0001-9807-438X; Butler, Catherine/0000-0001-6371-3954; Dashper, Stuart/0000-0003-0106-8691; Veith, Paul/0000-0002-7344-1662	Australian Government, Department of Industry, Innovation and Science	Australian Government, Department of Industry, Innovation and Science(Australian GovernmentDepartment of Industry, Innovation and Science)	Funding provided by Australian Government, Department of Industry, Innovation and Science.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ARCHIBALD F, 1986, CRC CR REV MICROBIOL, V13, P63, DOI 10.3109/10408418609108735; Briggs HL, 2008, INFECT IMMUN, V76, P2189, DOI 10.1128/IAI.01609-07; Butler CA, 2015, J ORAL BIOSCI, V57, P91, DOI 10.1016/j.job.2014.12.003; Butler CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111168; Chen YY, 2011, MOL MICROBIOL, V79, P1380, DOI 10.1111/j.1365-2958.2010.07530.x; Cornelis P, 2011, METALLOMICS, V3, P540, DOI 10.1039/c1mt00022e; Cugini C, 2013, J ORAL MICROBIOL, P5, DOI [10.3402/jom.v5i0.19804, DOI 10.3402/JOM.V5I0.19804]; D'Aquino JA, 2005, P NATL ACAD SCI USA, V102, P18408, DOI 10.1073/pnas.0500908102; Dashper SG, 2005, J BIOL CHEM, V280, P28095, DOI 10.1074/jbc.M503896200; Dashper SG, 2009, J BACTERIOL, V191, P1044, DOI 10.1128/JB.01270-08; Desai KK, 2013, BIOCHEMISTRY-US, V52, P2518, DOI 10.1021/bi4002375; DeWitt MA, 2007, J MOL BIOL, V365, P1257, DOI 10.1016/j.jmb.2006.10.080; Diaz PI, 2006, J BACTERIOL, V188, P2454, DOI 10.1128/JB.188.7.2454-2462.2006; Ding X, 1996, NAT STRUCT BIOL, V3, P382, DOI 10.1038/nsb0496-382; Duran-Pinedo AE, 2007, MOL MICROBIOL, V64, P1061, DOI 10.1111/j.1365-2958.2007.05717.x; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Golynskiy M, 2007, J BIOL INORG CHEM, V12, P699, DOI 10.1007/s00775-007-0216-z; Golynskiy MV, 2006, BIOCHEMISTRY-US, V45, P15359, DOI 10.1021/bi0607406; Golynskiy MV, 2005, BIOCHEMISTRY-US, V44, P3380, DOI 10.1021/bi0480741; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Guedon E, 2003, MOL MICROBIOL, V48, P495, DOI 10.1046/j.1365-2958.2003.03445.x; Guerra AJ, 2012, ARCH BIOCHEM BIOPHYS, V519, P210, DOI 10.1016/j.abb.2011.11.021; Hansen RE, 2009, ANAL BIOCHEM, V394, P147, DOI 10.1016/j.ab.2009.07.051; Harding MM, 2004, ACTA CRYSTALLOGR D, V60, P849, DOI 10.1107/S0907444904004081; He J, 2006, INFECT IMMUN, V74, P4214, DOI 10.1128/IAI.00014-06; Henry LG, 2012, FUTURE MICROBIOL, V7, P497, DOI [10.2217/FMB.12.17, 10.2217/fmb.12.17]; Jakubovics NS, 2001, MICROBIOL-SGM, V147, P1709, DOI 10.1099/00221287-147-7-1709; Jakubovics NS, 2000, MOL MICROBIOL, V38, P140, DOI 10.1046/j.1365-2958.2000.02122.x; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kliegman JI, 2006, BIOCHEMISTRY-US, V45, P3493, DOI 10.1021/bi0524215; Krezel A, 2001, J INORG BIOCHEM, V84, P77, DOI 10.1016/S0162-0134(00)00212-9; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Lewis JP, 2009, MICROBIOL-SGM, V155, P3758, DOI 10.1099/mic.0.027953-0; Lewis JP, 2010, PERIODONTOL, V52, P94, DOI [http://dx.doi.org/10.1111/j.1600-0757.2009.00329.x, DOI 10.1111/J.1600-0757.2009.00329.X]; Lieser SA, 2003, BIOCHEMISTRY-US, V42, P12634, DOI 10.1021/bi0350248; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; O'Brien-Simpson NM, 2005, J IMMUNOL, V175, P3980, DOI 10.4049/jimmunol.175.6.3980; Ong CLY, 2013, INFECT IMMUN, V81, P421, DOI 10.1128/IAI.00805-12; Parker D, 2005, J BACTERIOL, V187, P366, DOI 10.1128/JB.187.1.366-375.2005; PEARSON RG, 1963, J AM CHEM SOC, V85, P3533, DOI 10.1021/ja00905a001; Pennella MA, 2005, BIOMETALS, V18, P413, DOI 10.1007/s10534-005-3716-8; Posey JE, 1999, P NATL ACAD SCI USA, V96, P10887, DOI 10.1073/pnas.96.19.10887; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Que Q, 2000, MOL MICROBIOL, V35, P1454, DOI 10.1046/j.1365-2958.2000.01811.x; Schmitt MP, 2002, J BACTERIOL, V184, P6882, DOI 10.1128/JB.184.24.6882-6892.2002; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Silver S, 1996, ANNU REV MICROBIOL, V50, P753, DOI 10.1146/annurev.micro.50.1.753; Stoll KE, 2009, BIOCHEMISTRY-US, V48, P10308, DOI 10.1021/bi900980g; Van Holde K.E., 2006, PRINCIPLES PHYS BIOC; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Xiao ZG, 2010, NAT PROD REP, V27, P768, DOI 10.1039/b906690j; Zaharik ML, 2004, FRONT BIOSCI-LANDMRK, V9, P1035, DOI 10.2741/1317; Zhang L, 2006, J AM CHEM SOC, V128, P5834, DOI 10.1021/ja058528x	59	1	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 23	2016	11	3							e0151407	10.1371/journal.pone.0151407	http://dx.doi.org/10.1371/journal.pone.0151407			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3QJ	27007570	Green Submitted, Green Published, gold			2022-12-26	WOS:000372701200054
J	Doboro, FA; Njiro, S; Sibeko-Matjila, K; Van Vuuren, M				Doboro, Fulufhelo Amanda; Njiro, Stephen; Sibeko-Matjila, Kgomotso; Van Vuuren, Moritz			Molecular Analysis of South African Ovine Herpesvirus 2 Strains Based on Selected Glycoprotein and Tegument Genes	PLOS ONE			English	Article							MALIGNANT CATARRHAL FEVER; KAPOSIS-SARCOMA; SHEEP; OUTBREAK; PHYLOGENIES; DIVERSITY; INFECTION; GENOTYPES; VIRUS; PCR	Ovine herpesvirus 2 (OvHV-2), is the causative agent of sheep-associated malignant catarrhal fever (SA-MCF), a generally fatal disease of cattle and other captive wild ruminants. Information on the OvHV-2 strains circulating in South Africa (SA) and other African countries with regard to genetic structure and diversity, and pattern of distribution is not available. This study aimed to characterize the OvHV-2 strains circulating in SA using selected genes encoding glycoproteins and tegument proteins. To establish the genetic diversity of OvHV-2 strains, four genes, Ov 7, Ov 8 ex2, ORF 27 and ORF 73 were selected for analysis by PCR and DNA sequencing. Nucleotide and amino acid multiple sequence analyses revealed two genotypes for ORF 27 and ORF 73, and three genotypes for Ov 7 and Ov 8 ex2, randomly distributed throughout the regions. Ov 7 and ORF 27 nucleotide sequence analysis revealed variations that distinguished SA genotypes from those of reference OvHV-2 strains. Epitope mapping analysis showed that mutations identified from the investigated genes are not likely to affect the functions of the gene products, particularly those responsible for antibody binding activities associated with B-cell epitopes. Knowledge of the extent of genetic diversity existing among OvHV-2 strains has provided an understanding on the distribution patterns of OvHV-2 strains or genotypes across the regions of South Africa. This can facilitate the management of SA-MCF in SA, in terms of introduction of control measures or safe practices to monitor and control OvHV-2 infection. The products encoded by the Ov 7, Ov 8 ex2 and ORF 27 genes are recommended for evaluation of their coded proteins as possible antigens in the development of an OvHV-2 specific serodiagnostic assay.	[Doboro, Fulufhelo Amanda] Agr Res Council, Mol Epidemiol & Diagnost Programme, Onderstepoort Vet Inst, Onderstepoort, South Africa; [Njiro, Stephen] Agr Res Council, Food Feed & Vet Publ Hlth Programme, Onderstepoort Vet Inst, Onderstepoort, South Africa; [Sibeko-Matjila, Kgomotso; Van Vuuren, Moritz] Univ Pretoria, Fac Vet Sci, ZA-0002 Pretoria, South Africa	Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; University of Pretoria	Doboro, FA (corresponding author), Agr Res Council, Mol Epidemiol & Diagnost Programme, Onderstepoort Vet Inst, Onderstepoort, South Africa.	DoboroA@arc.agric.za	Sibeko-Matjila, Kgomotso/X-6565-2019; Sibeko-Matjila, Kgomotso/O-6028-2014; Sibeko-Matjila, Kgomotso/O-3691-2019	Sibeko-Matjila, Kgomotso/0000-0003-1139-7333; Sibeko-Matjila, Kgomotso/0000-0003-1139-7333; 	Department of Science and Technology (DST); Meat Industry Trust (MIT)	Department of Science and Technology (DST)(Department of Science & Technology (India)); Meat Industry Trust (MIT)	This work was supported by Department of Science and Technology (DST) for research funding; Meat Industry Trust (MIT) for payment of the University tuitions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0; Bastawecy IM, 2012, LIFE SCI J, V9, P798; BAXTER SIF, 1993, ARCH VIROL, V132, P145, DOI 10.1007/BF01309849; Bell SA, 2006, VET MICROBIOL, V116, P249, DOI 10.1016/j.vetmic.2006.05.002; Brault SA, 2010, VET IMMUNOL IMMUNOP, V137, P136, DOI 10.1016/j.vetimm.2010.05.010; Collery P, 1996, VET REC, V139, P16, DOI 10.1136/vr.139.1.16; Coulter LJ, 2001, J COMP PATHOL, V124, P2, DOI 10.1053/jcpa.2000.0524; de KOCK GILLES, 1950, S AFRICAN JOUR SCI, V46, P176; Dunowska M, 2001, J GEN VIROL, V82, P2785, DOI 10.1099/0022-1317-82-11-2785; Egyed L, 1996, J CLIN MICROBIOL, V34, P1091, DOI 10.1128/JCM.34.5.1091-1095.1996; El-Manzalawy Y, 2008, J MOL RECOGNIT, V21, P243, DOI 10.1002/jmr.893; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FOSTER PD, 1983, VET REC, V113, P477, DOI 10.1136/vr.113.20.477; Gao SJ, 1999, J INFECT DIS, V180, P1466, DOI 10.1086/315098; Garcia S, 2001, J CLIN MICROBIOL, V39, P4456, DOI 10.1128/JCM.39.12.4456-4461.2001; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Greenblatt RJ, 2005, J VIROL, V79, P1125, DOI 10.1128/JVI.79.2.1125-1132.2005; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hart J, 2007, J GEN VIROL, V88, P28, DOI 10.1099/vir.0.82284-0; Honiball EJ, 2008, REV MALIGNANT CATARR; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Li H, 2004, J CLIN MICROBIOL, V42, P5558, DOI 10.1128/JCM.42.12.5558-5564.2004; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; LI H, 1995, J CLIN MICROBIOL, V33, P2048, DOI 10.1128/JCM.33.8.2048-2053.1995; Li H, 2011, VET MICROBIOL, V150, P270, DOI 10.1016/j.vetmic.2011.02.016; Liang L, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006916; Liu Y, 2013, ECOL EVOL, V3, P4683, DOI 10.1002/ece3.856; Loken T, 1998, VET REC, V143, P464, DOI 10.1136/vr.143.17.464; Muller-Doblies UU, 1998, J CLIN MICROBIOL, V36, P2970; National Research Council, 1981, WAT BUFF NEW PROSP U, P111; NEI M, 1986, MOL BIOL EVOL, V3, P418; O'Toole D, 2002, J VET DIAGN INVEST, V14, P183, DOI 10.1177/104063870201400301; Pier G, 2004, IMMUNOLOGY INFECT IM, V1; Pier G, 2004, INFECT IMMUNITY, V1; PIERCY S. E., 1952, BRIT VET JOUR, V108, P35; Plowright W., 1990, Virus infections of ruminants., P123; Plowright W, 1964, THESIS U PRETORIA S, P336; Reid H W, 2004, INFECT DIS LIVESTOCK; ROSSITER PB, 1981, J COMP PATHOL, V91, P303, DOI 10.1016/0021-9975(81)90036-0; Russell GC, 2009, VET J, V179, P324, DOI 10.1016/j.tvjl.2007.11.007; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taus NS, 2007, J GEN VIROL, V88, P40, DOI 10.1099/vir.0.82285-0; Thorsteinsdottir L, 2013, RES VET SCI, V94, P170, DOI 10.1016/j.rvsc.2012.07.011; Tustin RC, 2001, COMMUNICATION; Wright H, 2003, RES VET SCI, V75, P163, DOI 10.1016/S0034-5288(03)00043-2; Zhang YJ, 2001, J INFECT DIS, V183, P125, DOI 10.1086/317650; ZUCKERKANDL EMILE, 1965, P97	52	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0147019	10.1371/journal.pone.0147019	http://dx.doi.org/10.1371/journal.pone.0147019			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27002629	gold, Green Published, Green Submitted			2022-12-26	WOS:000372697400007
J	Allegri, M; Bianchi, MG; Chiu, M; Varet, J; Costa, AL; Ortelli, S; Blosi, M; Bussolati, O; Poland, CA; Bergamaschi, E				Allegri, Manfredi; Bianchi, Massimiliano G.; Chiu, Martina; Varet, Julia; Costa, Anna L.; Ortelli, Simona; Blosi, Magda; Bussolati, Ovidio; Poland, Craig A.; Bergamaschi, Enrico			Shape-Related Toxicity of Titanium Dioxide Nanofibres	PLOS ONE			English	Article							CARBON NANOTUBES; OXIDATIVE STRESS; IN-VITRO; NANOPARTICLES; ASBESTOS; PERMEABILITY; EXPOSURE; TIO2; INHALATION; DEPOSITION	Titanium dioxide (TiO2) nanofibres are a novel fibrous nanomaterial with increasing applications in a variety of fields. While the biological effects of TiO2 nanoparticles have been extensively studied, the toxicological characterization of TiO2 nanofibres is far from being complete. In this study, we evaluated the toxicity of commercially available anatase TiO2 nanofibres using TiO2 nanoparticles (NP) and crocidolite asbestos as non-fibrous or fibrous benchmark materials. The evaluated endpoints were cell viability, haemolysis, macrophage activation, trans-epithelial electrical resistance (an indicator of the epithelial barrier competence), ROS production and oxidative stress as well as the morphology of exposed cells. The results showed that TiO2 nanofibres caused a cell-specific, dose-dependent decrease of cell viability, with larger effects on alveolar epithelial cells than on macrophages. The observed effects were comparable to those of crocidolite, while TiO2 NP did not decrease cell viability. TiO2 nanofibres were also found endowed with a marked haemolytic activity, at levels significantly higher than those observed with TiO2 nanoparticles or crocidolite. Moreover, TiO2 nanofibres and crocidolite, but not TiO2 nanoparticles, caused a significant decrease of the trans-epithelial electrical resistance of airway cell monolayers. SEM images demonstrated that the interaction with nanofibres and crocidolite caused cell shape perturbation with the longest fibres incompletely or not phagocytosed. The expression of several pro-inflammatory markers, such as NO production and the induction of Nos2 and Ptgs2, was significantly increased by TiO2 nanofibres, as well as by TiO2 nanoparticles and crocidolite. This study indicates that TiO2 nanofibres had significant toxic effects and, for most endpoints with the exception of pro-inflammatory changes, are more bio-active than TiO2 nanoparticles, showing the relevance of shape in determining the toxicity of nanomaterials. Given that several toxic effects of TiO2 nanofibres appear comparable to those observed with crocidolite, the possibility that they exert length dependent toxicity in vivo seems worthy of further investigation.	[Allegri, Manfredi; Chiu, Martina; Bussolati, Ovidio] Univ Parma, Dept Biomed Biotechnol & Translat Sci SBiBiT, I-43100 Parma, Italy; [Bianchi, Massimiliano G.; Bergamaschi, Enrico] Univ Parma, Dept Clin & Expt Med, I-43100 Parma, Italy; [Varet, Julia; Poland, Craig A.] Inst Occupat Med, Edinburgh EH8 9SV, Midlothian, Scotland; [Costa, Anna L.; Ortelli, Simona; Blosi, Magda] Inst Sci & Technol Ceram ISTEC CNR, Faenza, Italy; [Poland, Craig A.] Univ Edinburgh, Ctr Inflammat Res, Queens Med Res Inst, ELEGI,Colt Labs,MRC, Edinburgh, Midlothian, Scotland	University of Parma; University of Parma; University Hospital of Parma; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienza e Tecnologia dei Materiali Ceramici (ISTEC-CNR); University of Edinburgh	Bussolati, O (corresponding author), Univ Parma, Dept Biomed Biotechnol & Translat Sci SBiBiT, I-43100 Parma, Italy.; Poland, CA (corresponding author), Inst Occupat Med, Edinburgh EH8 9SV, Midlothian, Scotland.; Poland, CA (corresponding author), Univ Edinburgh, Ctr Inflammat Res, Queens Med Res Inst, ELEGI,Colt Labs,MRC, Edinburgh, Midlothian, Scotland.	ovidio.bussolati@unipr.it; craig.poland@iom-world.org	Chiu, Martina/ABF-5811-2020; Chiu, Martina/I-7792-2016; Costa, Anna Luisa/AFF-8479-2022; Ortelli, Simona/G-6374-2018; Costa, Anna Luisa/AAF-1024-2022; Poland, Craig/AAM-8237-2020; Costa, Anna/A-8534-2012	Chiu, Martina/0000-0002-5655-9984; Chiu, Martina/0000-0002-5655-9984; Ortelli, Simona/0000-0002-0868-3315; Costa, Anna Luisa/0000-0003-1407-6498; Costa, Anna/0000-0003-1407-6498; BLOSI, MAGDA/0000-0001-8841-247X; BIANCHI, Massimiliano/0000-0002-4179-6573; Poland, Craig/0000-0002-5345-1249	EU [280716]	EU(European Commission)	This work was supported by EU FP7 SANOWORK (Grant n. 280716, http://sanowork.eu/) to EB and ALC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANJILVEL S, 1995, FUND APPL TOXICOL, V28, P41, DOI 10.1006/faat.1995.1144; Baisch BL, 2014, PART FIBRE TOXICOL, V11, DOI 10.1186/1743-8977-11-5; Banga A, 2012, CELL PHYSIOL BIOCHEM, V29, P197, DOI 10.1159/000337601; Belade E, 2015, ARCH TOXICOL, V89, P1543, DOI 10.1007/s00204-014-1324-5; Bergstrand H, 1990, Agents Actions Suppl, V30, P199; Bianchi MG, 2015, TOXICOL RES-UK, V4, P385, DOI 10.1039/c4tx00193a; Bonner JC, 2013, ENVIRON HEALTH PERSP, V121, P676, DOI 10.1289/ehp.1205693; Brown DM, 2007, CARBON, V45, P1743, DOI 10.1016/j.carbon.2007.05.011; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Chen SL, 2010, BIOMATERIALS, V31, P3479, DOI 10.1016/j.biomaterials.2010.01.074; Cho WS, 2012, TOXICOL SCI, V126, P469, DOI 10.1093/toxsci/kfs006; Cho WS, 2012, NANOTOXICOLOGY, V6, P22, DOI 10.3109/17435390.2011.552810; Clouter A, 2001, TOXICOL SCI, V63, P90, DOI 10.1093/toxsci/63.1.90; Dikalov S, 1997, BIOCHEM BIOPH RES CO, V230, P54, DOI 10.1006/bbrc.1996.5880; Dobrovoiskaia MA, 2008, NANO LETT, V8, P2180, DOI 10.1021/nl0805615; Donaldson K, 2004, MUTAT RES-FUND MOL M, V553, P5, DOI 10.1016/j.mrfmmm.2004.06.011; Donaldson K, 2013, CURR OPIN BIOTECH, V24, P724, DOI 10.1016/j.copbio.2013.05.003; Donaldson K, 2013, ACCOUNTS CHEM RES, V46, P723, DOI 10.1021/ar300092y; Donaldson K, 2011, NANOMEDICINE-UK, V6, P143, DOI 10.2217/NNM.10.139; Donaldson K, 2009, CRIT REV TOXICOL, V39, P487, DOI 10.1080/10408440902911861; Farcal L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127174; FINKBEINER WE, 1993, AM J RESP CELL MOL, V9, P547, DOI 10.1165/ajrcmb/9.5.547; Fubini B, 1997, ENVIRON HEALTH PERSP, V105, P1013, DOI 10.2307/3433502; Gardner SY, 1997, EXP LUNG RES, V23, P1, DOI 10.3109/01902149709046044; GROSS TJ, 1994, AM J PHYSIOL, V266, pL287, DOI 10.1152/ajplung.1994.266.3.L287; Hamilton RF, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-35; Hurbankova M, 2013, CENT EUR J PUBL HEAL, V21, P165, DOI 10.21101/cejph.a3881; Jensen H, 2006, J EXP NANOSCI, V1, P355, DOI 10.1080/17458080600752482; JONES AD, 1993, ANN OCCUP HYG, V37, P211, DOI 10.1093/annhyg/37.2.211; Kim D, 2005, COLLOID SURFACE B, V40, P83, DOI 10.1016/j.colsurfb.2004.05.007; Kohyama N, 1996, AM J IND MED, V30, P515, DOI 10.1002/(SICI)1097-0274(199611)30:5<515::AID-AJIM1>3.0.CO;2-S; Li Y, 2014, REDOX BIOL, V2, P485, DOI 10.1016/j.redox.2014.01.023; Lim SJ, 2004, J CONTROL RELEASE, V100, P53, DOI 10.1016/j.jconrel.2004.07.032; Liu CH, 2012, J MATER RES, V27, P2265, DOI 10.1557/jmr.2012.154; Lu SL, 2009, ENVIRON HEALTH PERSP, V117, P241, DOI 10.1289/ehp.11811; MISKO TP, 1993, ANAL BIOCHEM, V214, P11, DOI 10.1006/abio.1993.1449; Murphy FA, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-8; Naito Y, 2014, ARCH BIOCHEM BIOPHYS, V564, P83, DOI 10.1016/j.abb.2014.09.005; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Pavan C, 2013, CHEM RES TOXICOL, V26, P1188, DOI 10.1021/tx400105f; Peterson MW, 1998, AM J PHYSIOL-LUNG C, V275, pL262, DOI 10.1152/ajplung.1998.275.2.L262; PETERSON MW, 1993, AM J PHYSIOL, V265, pL308, DOI 10.1152/ajplung.1993.265.3.L308; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Pollastri S, 2014, J HAZARD MATER, V276, P469, DOI 10.1016/j.jhazmat.2014.05.060; Ramkumar KM, 2012, EUR J PHARM BIOPHARM, V81, P324, DOI 10.1016/j.ejpb.2012.02.013; RIVM, 2002, 650010030 RIVA; Rotoli BM, 2009, HUM EXP TOXICOL, V28, P361, DOI 10.1177/0960327109105159; Rotoli BM, 2008, TOXICOL LETT, V178, P95, DOI 10.1016/j.toxlet.2008.02.007; Rotoli BM, 2012, J NANOPART RES, P14; Rushton EK, 2010, J TOXICOL ENV HEAL A, V73, P445, DOI 10.1080/15287390903489422; Salem LB, 2009, J CONTROL RELEASE, V136, P110, DOI 10.1016/j.jconrel.2009.01.019; Schinwald A, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-47; Shi HB, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-15; Silva RM, 2013, J TOXICOL ENV HEAL A, V76, P953, DOI 10.1080/15287394.2013.826567; Singh DP, 2010, SCI ADV MATER, V2, P295, DOI 10.1166/sam.2010.1095; Siu MT, 2013, TOXICOL APPL PHARM, V273, P508, DOI 10.1016/j.taap.2013.09.020; Sweeney S, 2015, INT J NANOMED, V10, P3115, DOI 10.2147/IJN.S77867; Taylor EL, 2004, BRIT J PHARMACOL, V143, P179, DOI 10.1038/sj.bjp.0705909; Wei MD, 2004, CHEM PHYS LETT, V400, P231, DOI 10.1016/j.cplett.2004.10.114; WHO, 1997, DET AIRB FIBR NUMB C	60	37	37	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151365	10.1371/journal.pone.0151365	http://dx.doi.org/10.1371/journal.pone.0151365			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26999274	gold, Green Submitted, Green Published			2022-12-26	WOS:000372694700035
J	Chow, LN; Schreiner, P; Ng, BYY; Lo, B; Hughes, MR; Scott, RW; Gusti, V; Lecour, S; Simonson, E; Manisali, I; Barta, I; McNagny, KM; Crawford, J; Webb, M; Underhill, TM				Chow, Leola N.; Schreiner, Petra; Ng, Betina Y. Y.; Lo, Bernard; Hughes, Michael R.; Scott, R. Wilder; Gusti, Vionarica; Lecour, Samantha; Simonson, Eric; Manisali, Irina; Barta, Ingrid; McNagny, Kelly M.; Crawford, Jason; Webb, Murray; Underhill, T. Michael			Impact of a CXCL12/CXCR4 Antagonist in Bleomycin (BLM) Induced Pulmonary Fibrosis and Carbon Tetrachloride (CCl4) Induced Hepatic Fibrosis in Mice	PLOS ONE			English	Article							STEM-CELL MIGRATION; CHEMOKINE RECEPTOR; LIVER FIBROSIS; STELLATE CELLS; LUNG INJURY; CIRCULATING FIBROCYTES; CXCR4; PIRFENIDONE; PHARMACOKINETICS; HEMATOPOIESIS	Modulation of chemokine CXCL12 and its receptor CXCR4 has been implicated in attenuation of bleomycin (BLM)-induced pulmonary fibrosis and carbon tetrachloride (CCl4)-induced hepatic injury. In pulmonary fibrosis, published reports suggest that collagen production in the injured lung is derived from fibrocytes recruited from the circulation in response to release of pulmonary CXCL12. Conversely, in hepatic fibrosis, resident hepatic stellate cells (HSC), the key cell type in progression of fibrosis, upregulate CXCR4 expression in response to activation. Further, CXCL12 induces HSC proliferation and subsequent production of collagen I. In the current study, we evaluated AMD070, an orally bioavailable inhibitor of CXCL12/CXCR4 in alleviating BLM-induced pulmonary and CCl4-induced hepatic fibrosis in mice. Similar to other CXCR4 antagonists, treatment with AMD070 significantly increased leukocyte mobilization. However, in these two models of fibrosis, AMD070 had a negligible impact on extracellular matrix deposition. Interestingly, our results indicated that CXCL12/CXCR4 signaling has a role in improving mortality associated with BLM induced pulmonary injury, likely through dampening an early inflammatory response and/or vascular leakage. Together, these findings indicate that the CXCL12-CXCR4 signaling axis is not an effective target for reducing fibrosis.	[Chow, Leola N.; Gusti, Vionarica; Lecour, Samantha; Simonson, Eric; Manisali, Irina] Ctr Drug Res & Dev, Vancouver, BC, Canada; [Schreiner, Petra; Ng, Betina Y. Y.; Lo, Bernard; Hughes, Michael R.; Scott, R. Wilder; Barta, Ingrid; McNagny, Kelly M.; Crawford, Jason; Webb, Murray; Underhill, T. Michael] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada	University of British Columbia	Chow, LN (corresponding author), Ctr Drug Res & Dev, Vancouver, BC, Canada.; Underhill, TM (corresponding author), Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada.	lchow@cdrd.ca; tunderhi@brc.ubc.ca	McNagny, Kelly/P-5239-2014; Hughes, Michael/N-6039-2015	McNagny, Kelly/0000-0003-4737-3499; Hughes, Michael/0000-0002-7925-6070; Gusti, Vionarica/0000-0001-9663-8428; Crawford, Jason/0000-0002-5512-9018	Centre for Drug Research and Development; Canadian Institutes of Health Research [MOP-106484]	Centre for Drug Research and Development; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Innovation Funds from The Centre for Drug Research and Development and Canadian Institutes of Health Research grant (MOP-106484) to MU. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjoraker JA, 1998, AM J RESP CRIT CARE, V157, P199, DOI 10.1164/ajrccm.157.1.9704130; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Cao YJ, 2008, ANTIMICROB AGENTS CH, V52, P1630, DOI 10.1128/AAC.01460-07; Chaudhary NI, 2006, AM J RESP CRIT CARE, V173, P769, DOI 10.1164/rccm.200505-717OC; Crawford JB, 2008, ORG PROCESS RES DEV, V12, P823, DOI 10.1021/op8000993; Dar A, 2006, EXP HEMATOL, V34, P967, DOI 10.1016/j.exphem.2006.04.002; Debnath B, 2013, THERANOSTICS, V3, P47, DOI 10.7150/thno.5376; Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Dranse HJ, 2011, J CELL SCI, V124, P2723, DOI 10.1242/jcs.084699; Egan JJ, 1999, LANCET, V354, P1839, DOI 10.1016/S0140-6736(99)00347-5; Eng FJ, 2000, AM J PHYSIOL-GASTR L, V279, pG7, DOI 10.1152/ajpgi.2000.279.1.G7; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Hamada N, 2005, J IMMUNOL, V175, P1224, DOI 10.4049/jimmunol.175.2.1224; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Henderson NC, 2007, CLIN SCI, V112, P265, DOI 10.1042/CS20060242; Hendrix CW, 2000, ANTIMICROB AGENTS CH, V44, P1667, DOI 10.1128/AAC.44.6.1667-1673.2000; Hong F, 2009, HEPATOLOGY, V49, P2055, DOI 10.1002/hep.22890; Hung C, 2013, AM J RESP CRIT CARE, V188, P820, DOI 10.1164/rccm.201212-2297OC; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kleaveland KR, 2014, J IMMUNOL, V193, P5229, DOI 10.4049/jimmunol.1400753; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; Lapidot T, 2001, ANN NY ACAD SCI, V938, P83, DOI 10.1111/j.1749-6632.2001.tb03577.x; Li F, 2012, EUR RESP SOC ANN C 2; Lim YS, 2008, CLIN LIVER DIS, V12, P733, DOI 10.1016/j.cld.2008.07.007; Makino H, 2013, J MED INVESTIG, V60, P127, DOI 10.2152/jmi.60.127; Mark AL, 2010, ANN SURG, V252, P591, DOI 10.1097/SLA.0b013e3181f4e479; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Moeller A, 2009, AM J RESP CRIT CARE, V179, P588, DOI 10.1164/rccm.200810-1534OC; Mosi RM, 2012, BIOCHEM PHARMACOL, V83, P472, DOI 10.1016/j.bcp.2011.11.020; Nagasawa T, 1998, SEMIN IMMUNOL, V10, P179, DOI 10.1006/smim.1998.0128; Nicod LP, 1999, LANCET, V354, P268, DOI 10.1016/S0140-6736(99)00178-6; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Raghu G, 1999, AM J RESP CRIT CARE, V159, P1061, DOI 10.1164/ajrccm.159.4.9805017; Raghu G, 2006, AM J RESP CRIT CARE, V174, P810, DOI 10.1164/rccm.200602-163OC; Raghu G, 2014, LANCET RESP MED, V2, P566, DOI 10.1016/S2213-2600(14)70101-8; Ramachandran P, 2012, QJM-INT J MED, V105, P813, DOI 10.1093/qjmed/hcs069; Saiman Y, 2015, HEPATOL RES, V45, P794, DOI 10.1111/hepr.12411; Schols D, 1997, J EXP MED, V186, P1383, DOI 10.1084/jem.186.8.1383; Skerlj RT, 2010, J MED CHEM, V53, P3376, DOI 10.1021/jm100073m; Song JS, 2010, EXP MOL MED, V42, P465, DOI 10.3858/emm.2010.42.6.048; Spagnolo P, 2015, DRUG DISCOV TODAY, V20, P514, DOI 10.1016/j.drudis.2015.01.001; Stone ND, 2007, ANTIMICROB AGENTS CH, V51, P2351, DOI 10.1128/AAC.00013-07; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Wald O, 2004, EUR J IMMUNOL, V34, P1164, DOI 10.1002/eji.200324441; Wang XD, 1999, NUTR REV, V57, P51, DOI 10.1111/j.1753-4887.1999.tb01778.x; Watanabe M, 2008, J IMMUNOL, V181, P6670, DOI 10.4049/jimmunol.181.9.6670; Weiler-Normann C, 2007, Z GASTROENTEROL, V45, P43, DOI 10.1055/s-2006-927387; Wu J, 2000, J GASTROENTEROL, V35, P665, DOI 10.1007/s005350070045; Xu JG, 2007, AM J RESP CELL MOL, V37, P291, DOI 10.1165/rcmb.2006-0187OC; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	53	35	38	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 21	2016	11	3							e0151765	10.1371/journal.pone.0151765	http://dx.doi.org/10.1371/journal.pone.0151765			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3NW	26998906	Green Submitted, Green Published, gold			2022-12-26	WOS:000372694700062
J	Barsotti, NS; Almeida, RR; Costa, PR; Barros, MT; Kalil, J; Kokron, CM				Barsotti, Nathalia Silveira; Almeida, Rafael Ribeiro; Costa, Priscilla Ramos; Barros, Myrthes Toledo; Kalil, Jorge; Kokron, Cristina Maria			IL-10-Producing Regulatory B Cells Are Decreased in Patients with Common Variable Immunodeficiency	PLOS ONE			English	Article							T-CELLS; B10 CELLS; IN-VITRO; AUTOIMMUNITY; DISEASE; FREQUENCY; INFLAMMATION; COMPARTMENT; ACTIVATION; EXPRESSION	Common variable immunodeficiency (CVID) is the most prevalent symptomatic primary immunodeficiency in adults. CVID patients often present changes in the frequency and function of B lymphocytes, reduced number of Treg cells, chronic immune activation, recurrent infections, high incidence of autoimmunity and increased risk for malignancies. We hypothesized that the frequency of B10 cells would be diminished in CVID patients because these cells play an important role in the development of Treg cells and in the control of T cell activation and autoimmunity. Therefore, we evaluated the frequency of B10 cells in CVID patients and correlated it with different clinical and immunological characteristics of this disease. Forty-two CVID patients and 17 healthy controls were recruited for this study. Cryo-preserved PBMCs were used for analysis of T cell activation, frequency of Treg cells and characterization of B10 cells by flow cytometry. IL-10 production by sorted B cells culture and plasma sCD14 were determined by ELISA. We found that CVID patients presented decreased frequency of IL-10-producing CD24(hi)CD38(hi) B cells in different cell culture conditions and decreased frequency of IL-10-producing CD24(hi)CD27(+) B cells stimulated with CpG+PIB. Moreover, we found that CVID patients presented lower secretion of IL-10 by sorting-purified B cells when compared to healthy controls. The frequency of B10 cells had no correlation with autoimmunity, immune activation and Treg cells in CVID patients. This work suggests that CVID patients have a compromised regulatory B cell compartment which is not correlated with clinical and immunological characteristics presented by these individuals.	[Barsotti, Nathalia Silveira; Almeida, Rafael Ribeiro; Costa, Priscilla Ramos; Kalil, Jorge; Kokron, Cristina Maria] Univ Sao Paulo, Sch Med, Dept Med, Lab Clin Immunol & Allergy LIM60,Div Clin Immunol, Sao Paulo, Brazil; [Barros, Myrthes Toledo; Kalil, Jorge; Kokron, Cristina Maria] Inst Invest Immunol INCT, Sao Paulo, Brazil; [Kalil, Jorge] Univ Sao Paulo, Sch Med, InCor, Inst Heart, Sao Paulo, Brazil; [Barros, Myrthes Toledo; Kokron, Cristina Maria] HC FMUSP, Clin Immunol & Allergy Div, Primary Immunodeficiency Outpatient Clin, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Barsotti, NS (corresponding author), Univ Sao Paulo, Sch Med, Dept Med, Lab Clin Immunol & Allergy LIM60,Div Clin Immunol, Sao Paulo, Brazil.	nathalia.btt@usp.br	Kokron, Cristina M/D-3140-2012; Almeida, Rafael Ribeiro/F-8014-2014; KALIL, JORGE/C-8029-2012	Kokron, Cristina M/0000-0002-9080-0305; Almeida, Rafael Ribeiro/0000-0003-3984-7527; Silveira Barsotti, Nathalia/0000-0003-3513-5258; KALIL, JORGE/0000-0001-8415-4274				Agarwal S, 2009, CURR ALLERGY ASTHM R, V9, P347, DOI 10.1007/s11882-009-0051-0; Arumugakani G, 2010, J CLIN IMMUNOL, V30, P292, DOI 10.1007/s10875-009-9351-3; Audo R, 2014, ARTHRITIS RHEUMATOL, V66, pS168, DOI 10.1002/art.38666; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Bouaziz JD, 2008, IMMUNOL REV, V224, P201, DOI 10.1111/j.1600-065X.2008.00661.x; Bouaziz JD, 2010, EUR J IMMUNOL, V40, P2686, DOI 10.1002/eji.201040673; Brouet JC, 2000, EUR J IMMUNOL, V30, P2516, DOI 10.1002/1521-4141(200009)30:9<2516::AID-IMMU2516>3.0.CO;2-Z; Carter NA, 2011, J IMMUNOL, V186, P5569, DOI 10.4049/jimmunol.1100284; Chapel H, 2008, BLOOD, V112, P277, DOI 10.1182/blood-2007-11-124545; Conley ME, 1999, CLIN IMMUNOL, V93, P190, DOI 10.1006/clim.1999.4799; Cunningham-Rundles C, 1999, CLIN IMMUNOL, V92, P34, DOI 10.1006/clim.1999.4725; Fevang B, 2007, CLIN EXP IMMUNOL, V147, P521, DOI 10.1111/j.1365-2249.2006.03314.x; Genre J, 2009, CLIN IMMUNOL, V132, P215, DOI 10.1016/j.clim.2009.03.519; Goode I, 2014, TRANSPL P, V46, P3, DOI 10.1016/j.transproceed.2013.08.075; Hel Z, 2014, J CLIN IMMUNOL, V34, P971, DOI 10.1007/s10875-014-0099-z; Iwata Y, 2011, BLOOD, V117, P530, DOI 10.1182/blood-2010-07-294249; Kalampokis I, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar3907; Kofod-Olsen E, 2016, CLIN IMMUNOL, V162, P49, DOI 10.1016/j.clim.2015.11.003; Kokron CM, 2004, AN ACAD BRAS CIENC, V76, P707, DOI 10.1590/S0001-37652004000400007; Kondratenko I, 1997, CLIN EXP IMMUNOL, V108, P9, DOI 10.1046/j.1365-2249.1997.d01-993.x; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Li XJ, 2012, BLOOD, V120, P3318, DOI 10.1182/blood-2012-05-432575; Litzman J, 2012, CLIN EXP IMMUNOL, V170, P321, DOI 10.1111/j.1365-2249.2012.04655.x; Lopes-da-Silva S, 2008, J CLIN IMMUNOL, V28, pS46, DOI 10.1007/s10875-008-9172-9; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Mauri C, 2010, CURR OPIN IMMUNOL, V22, P761, DOI 10.1016/j.coi.2010.10.009; Melo KM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006269; Mouillot G, 2010, J CLIN IMMUNOL, V30, P746, DOI 10.1007/s10875-010-9424-3; Rakhmanov M, 2009, P NATL ACAD SCI USA, V106, P13451, DOI 10.1073/pnas.0901984106; Siewe B, 2013, J LEUKOCYTE BIOL, V93, P811, DOI 10.1189/jlb.0912436; Vlkova M, 2015, CLIN IMMUNOL, V160, P292, DOI 10.1016/j.clim.2015.06.013; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; Yanaba K, 2009, J IMMUNOL, V182, P7459, DOI 10.4049/jimmunol.0900270; Yang M, 2013, CELL MOL IMMUNOL, V10, P122, DOI 10.1038/cmi.2012.60; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501; Zha BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049835	37	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151761	10.1371/journal.pone.0151761	http://dx.doi.org/10.1371/journal.pone.0151761			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26991898	Green Submitted, Green Published, gold			2022-12-26	WOS:000372582800098
J	Samad, MS; Bakken, LR; Nadeem, S; Clough, TJ; de Klein, CAM; Richards, KG; Lanigan, GJ; Morales, SE				Samad, Md Sainur; Bakken, Lars R.; Nadeem, Shahid; Clough, Timothy J.; de Klein, Cecile A. M.; Richards, Karl G.; Lanigan, Gary J.; Morales, Sergio E.			High-Resolution Denitrification Kinetics in Pasture Soils Link N2O Emissions to pH, and Denitrification to C Mineralization	PLOS ONE			English	Article							NITROUS-OXIDE; PRODUCT RATIO; NO; ACIDIFICATION; COMMUNITIES	Denitrification in pasture soils is mediated by microbial and physicochemical processes leading to nitrogen loss through the emission of N2O and N-2. It is known that N2O reduction to N-2 is impaired by low soil pH yet controversy remains as inconsistent use of soil pH measurement methods by researchers, and differences in analytical methods between studies, undermine direct comparison of results. In addition, the link between denitrification and N2O emissions in response to carbon (C) mineralization and pH in different pasture soils is still not well described. We hypothesized that potential denitrification rate and aerobic respiration rate would be positively associated with soils. This relationship was predicted to be more robust when a high resolution analysis is performed as opposed to a single time point comparison. We tested this by characterizing 13 different temperate pasture soils from northern and southern hemispheres sites (Ireland and New Zealand) using a fully automated-high-resolution GC detection system that allowed us to detect a wide range of gas emissions simultaneously. We also compared the impact of using different extractants for determining pH on our conclusions. In all pH measurements, soil pH was strongly and negatively associated with both N2O production index (IN2O) and N2O/(N2O+N-2) product ratio. Furthermore, emission kinetics across all soils revealed that the denitrification rates under anoxic conditions (NO+N2O+N-2 mu mol N/h/vial) were significantly associated with C mineralization (CO2 mu mol/h/vial) measured both under oxic (r(2) = 0.62, p = 0.0015) and anoxic (r(2) = 0.89, p<0.0001) conditions.	[Samad, Md Sainur; Morales, Sergio E.] Univ Otago, Otago Sch Med Sci, Dept Microbiol & Immunol, Dunedin, New Zealand; [Bakken, Lars R.; Nadeem, Shahid] Norwegian Univ Life Sci, Dept Environm Sci, As, Norway; [Clough, Timothy J.] Lincoln Univ, Dept Soil & Phys Sci, Lincoln, New Zealand; [de Klein, Cecile A. M.] AgRes Invermay, Mosgiel, New Zealand; [Richards, Karl G.; Lanigan, Gary J.] TEAGASC, Environm Res Ctr, Johnstown Castle, Wexford, Ireland	University of Otago; Norwegian University of Life Sciences; Lincoln University - New Zealand; AgResearch - New Zealand; Teagasc	Morales, SE (corresponding author), Univ Otago, Otago Sch Med Sci, Dept Microbiol & Immunol, Dunedin, New Zealand.	sergio.morales@otago.ac.nz	Bakken, Lars/AAO-2099-2020; Morales, Sergio/O-5680-2019; Clough, Timothy/Q-4982-2018; Lanigan, Gary J/C-6864-2012; Richards, Karl G./A-5606-2010; Richards, Karl/ABF-1109-2020	Morales, Sergio/0000-0002-5862-0726; Clough, Timothy/0000-0002-5978-5274; Lanigan, Gary J/0000-0003-0813-3097; Richards, Karl G./0000-0002-3703-3450; Richards, Karl/0000-0002-3703-3450; Samad, Md Sainur/0000-0003-1409-7985	New Zealand Government through the New Zealand Fund for Global Partnerships in Livestock Emissions Research [16084]; University of Otago	New Zealand Government through the New Zealand Fund for Global Partnerships in Livestock Emissions Research; University of Otago	This work was funded by the New Zealand Government through the New Zealand Fund for Global Partnerships in Livestock Emissions Research to support the objectives of the Livestock Research Group of the Global Research Alliance on Agricultural Greenhouse Gases (Agreement number: 16084) awarded to SEM and the University of Otago. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakken LR, 2012, PHILOS T R SOC B, V367, P1226, DOI 10.1098/rstb.2011.0321; Bergaust L, 2010, APPL ENVIRON MICROB, V76, P6387, DOI 10.1128/AEM.00608-10; Ciais P, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P465; Cole CV, 1997, NUTR CYCL AGROECOSYS, V49, P221, DOI 10.1023/A:1009731711346; Cuhel J, 2011, AGR ECOSYST ENVIRON, V141, P230, DOI 10.1016/j.agee.2011.02.016; FIRESTONE MK, 1980, SCIENCE, V208, P749, DOI 10.1126/science.208.4445.749; Gawlik BM, 2003, SCI TOTAL ENVIRON, V312, P33, DOI 10.1016/S0048-9697(03)00194-3; ISO, 2005, 10390 ISO, P7; Jahangir MMR, 2012, AGR ECOSYST ENVIRON, V147, P13, DOI 10.1016/j.agee.2011.04.015; Lampe C, 2006, SOIL BIOL BIOCHEM, V38, P2602, DOI 10.1016/j.soilbio.2006.03.016; Lesschen JP, 2011, ENVIRON POLLUT, V159, P3215, DOI 10.1016/j.envpol.2011.04.001; Liu BB, 2014, MBIO, V5, DOI 10.1128/mBio.01383-14; Liu BB, 2010, FEMS MICROBIOL ECOL, V72, P407, DOI 10.1111/j.1574-6941.2010.00856.x; Molstad L, 2007, J MICROBIOL METH, V71, P202, DOI 10.1016/j.mimet.2007.08.011; Morales SE, 2015, SOIL BIOL BIOCHEM, V82, P87, DOI 10.1016/j.soilbio.2014.12.018; Morkved PT, 2007, SOIL BIOL BIOCHEM, V39, P2048, DOI 10.1016/j.soilbio.2007.03.006; Mosier AR, 1998, BIOL FERT SOILS, V27, P221, DOI 10.1007/s003740050424; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Ostrom NE, 2010, SOIL BIOL BIOCHEM, V42, P499, DOI 10.1016/j.soilbio.2009.12.003; Pachauri Rajendra, 2007, AR4 CLIMATE CHANGE 2; PAUSTIAN K, 2004, R141 CAST; Qu Z, 2014, GLOBAL CHANGE BIOL, V20, P1685, DOI 10.1111/gcb.12461; Raut N, 2012, SOIL BIOL BIOCHEM, V55, P104, DOI 10.1016/j.soilbio.2012.06.011; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Regaert D., 2015, Journal of Soil Science and Environmental Management, V6, P178; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Saggar S, 2013, SCI TOTAL ENVIRON, V465, P173, DOI 10.1016/j.scitotenv.2012.11.050; Senbayram M, 2012, AGR ECOSYST ENVIRON, V147, P4, DOI 10.1016/j.agee.2011.06.022; Simek M, 2002, EUR J SOIL SCI, V53, P345, DOI 10.1046/j.1365-2389.2002.00461.x; Zhu X, 2013, P NATL ACAD SCI USA, V110, P6328, DOI 10.1073/pnas.1219993110	30	54	54	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151713	10.1371/journal.pone.0151713	http://dx.doi.org/10.1371/journal.pone.0151713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26990862	Green Published, Green Submitted, gold			2022-12-26	WOS:000372582800090
J	Schwarz, R; Tanzler, D; Ihling, CH; Sinz, A				Schwarz, Rico; Taenzler, Dirk; Ihling, Christian H.; Sinz, Andrea			Monitoring Solution Structures of Peroxisome Proliferator-Activated Receptor beta/delta upon Ligand Binding	PLOS ONE			English	Article							CHEMICAL CROSS-LINKING; MASS-SPECTROMETRY; PPAR-GAMMA; PROTEIN STRUCTURES; ALPHA; IDENTIFICATION; HETERODIMER; CONSTRAINTS; SELECTIVITY; SIMULATION	Peroxisome proliferator-activated receptors (PPARs) have been intensively studied as drug targets to treat type 2 diabetes, lipid disorders, and metabolic syndrome. This study is part of our ongoing efforts to map conformational changes in PPARs in solution by a combination of chemical cross-linking and mass spectrometry (MS). To our best knowledge, we performed the first studies addressing solution structures of full-length PPAR-beta/delta. We monitored the conformations of the ligand-binding domain (LBD) as well as full-length PPAR-beta/delta upon binding of two agonists. (Photo-) cross-linking relied on (i) a variety of externally introduced amine-and carboxyl-reactive linkers and (ii) the incorporation of the photo-reactive amino acid p-benzoylphenylalanine (Bpa) into PPAR-beta/delta by genetic engineering. The distances derived from cross-linking experiments allowed us to monitor conformational changes in PPAR-beta/delta upon ligand binding. The cross-linking/MS approach proved highly advantageous to study nuclear receptors, such as PPARs, and revealed the interplay between DBD (DNA-binding domain) and LDB in PPAR-beta/delta. Our results indicate the stabilization of a specific conformation through ligand binding in PPAR-beta/delta LBD as well as fulllength PPAR-beta/delta. Moreover, our results suggest a close distance between the N-and C-terminal regions of full-length PPAR-beta/delta in the presence of GW1516. Chemical cross-linking/MS allowed us gaining detailed insights into conformational changes that are induced in PPARs when activating ligands are present. Thus, cross-linking/MS should be added to the arsenal of structural methods available for studying nuclear receptors.	[Schwarz, Rico; Taenzler, Dirk; Ihling, Christian H.; Sinz, Andrea] Univ Halle Wittenberg, Inst Pharm, Dept Pharmaceut Chem & Bioanalyt, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg	Sinz, A (corresponding author), Univ Halle Wittenberg, Inst Pharm, Dept Pharmaceut Chem & Bioanalyt, D-06120 Halle, Germany.	andrea.sinz@pharmazie.uni-halle.de			DFG [Si 867/14-1, Si 867/15-1, Si 867/16-1]; EU (COST Action) [1403]	DFG(German Research Foundation (DFG)); EU (COST Action)(European Cooperation in Science and Technology (COST)European Commission)	This study was supported by the DFG (projects Si 867/14-1, 15-1, and 16-1) and the EU (COST Action 1403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AS acknowledges financial support by the DFG (projects Si 867/14-1, 15-1, and 16-1) and the EU (COST Action 1403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary T, 2015, NUCLEIC ACIDS RES, V43, P5033, DOI 10.1093/nar/gkv331; Arlt C M., 2015, INTEGRATED WOR UNPUB; Batista FAH, 2012, PLOS ONE, V7; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chandra V, 2013, NATURE, V495, P394, DOI 10.1038/nature11966; Chon SH, 2015, EXP DERMATOL, V24, P290, DOI 10.1111/exd.12658; Cronet P, 2001, STRUCTURE, V9, P699, DOI 10.1016/S0969-2126(01)00634-7; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Fabris D, 2010, J MASS SPECTROM, V45, P841, DOI 10.1002/jms.1762; Giordano Attianese Greta M P, 2015, Nucl Recept Signal, V13, pe001, DOI 10.1621/nrs.13001; Gotze M, 2015, J AM SOC MASS SPECTR, V26, P83, DOI 10.1007/s13361-014-1001-1; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; ISSEMANN I, 1993, J MOL ENDOCRINOL, V11, P37, DOI 10.1677/jme.0.0110037; Kalkhof S, 2008, ANAL BIOANAL CHEM, V392, P305, DOI 10.1007/s00216-008-2231-5; Kalkhof S, 2010, PROTEINS, V78, P3409, DOI 10.1002/prot.22848; Krauth F, 2009, RAPID COMMUN MASS SP, V23, P2811, DOI 10.1002/rcm.4188; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Leitner A, 2014, P NATL ACAD SCI USA, V111, P9455, DOI 10.1073/pnas.1320298111; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; Li JE, 2015, AM J CHINESE MED, V43, P879, DOI 10.1142/S0192415X15500512; Lou XH, 2014, NAT STRUCT MOL BIOL, V21, P277, DOI 10.1038/nsmb.2778; Merkley ED, 2014, PROTEIN SCI, V23, P747, DOI 10.1002/pro.2458; Michalik L, 1999, CURR OPIN BIOTECH, V10, P564, DOI 10.1016/S0958-1669(99)00030-0; Michalik L, 2007, J BIOL CHEM, V282, P9666, DOI 10.1074/jbc.M610523200; Montagner A, 2015, EUR J DERMATOL, V25, P4, DOI 10.1684/ejd.2014.2505; Muller MQ, 2010, ANAL CHEM, V82, P6958, DOI 10.1021/ac101241t; Muller MQ, 2009, J MED CHEM, V52, P2875, DOI 10.1021/jm9000665; Qi C, 2000, CELL BIOCHEM BIOPHYS, V32, P187, DOI 10.1385/CBB:32:1-3:187; Rappsilber J, 2011, J STRUCT BIOL, V173, P530, DOI 10.1016/j.jsb.2010.10.014; Rastinejad F, 2015, TRENDS BIOCHEM SCI, V40, P16, DOI 10.1016/j.tibs.2014.10.011; Rau O, 2008, ARCH PHARM, V341, P191, DOI 10.1002/ardp.200700209; Schwarz R, 2013, J MED CHEM, V56, P4252, DOI 10.1021/jm400446b; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sinz A, 2007, ANGEW CHEM INT EDIT, V46, P660, DOI 10.1002/anie.200602549; Sinz A, 2006, MASS SPECTROM REV, V25, P663, DOI 10.1002/mas.20082; Sinz A, 2014, EXPERT REV PROTEOMIC, V11, P733, DOI 10.1586/14789450.2014.960852; Souza-Mello V, 2015, WORLD J HEPATOL, V7, P1012, DOI 10.4254/wjh.v7.i8.1012; Sznaidman ML, 2003, BIOORG MED CHEM LETT, V13, P1517, DOI 10.1016/S0960-894X(03)00207-5; Toral M, 2015, J HYPERTENS, V33, P1831, DOI 10.1097/HJH.0000000000000634; Wittelsberger A, 2006, FEBS LETT, V580, P1872, DOI 10.1016/j.febslet.2006.02.050; Xie JM, 2006, NAT REV MOL CELL BIO, V7, P775, DOI 10.1038/nrm2005; Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198; Young MM, 2000, P NATL ACAD SCI USA, V97, P5802, DOI 10.1073/pnas.090099097; Vincent ZA, 2007, BBA-MOL CELL BIOL L, V1771, P915, DOI 10.1016/j.bbalip.2007.01.007	44	10	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0151412	10.1371/journal.pone.0151412	http://dx.doi.org/10.1371/journal.pone.0151412			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	26992147	gold, Green Published, Green Submitted			2022-12-26	WOS:000372582800061
J	Wang, TH; Hsia, SM; Wu, CH; Ko, SY; Chen, MY; Shih, YH; Shieh, TM; Chuang, LC; Wu, CY				Wang, Tong-Hong; Hsia, Shih-Min; Wu, Chi-Hao; Ko, Shun-Yao; Chen, Michael Yuanchien; Shih, Yin-Hua; Shieh, Tzong-Ming; Chuang, Li-Chuan; Wu, Ching-Yi			Evaluation of the Antibacterial Potential of Liquid and Vapor Phase Phenolic Essential Oil Compounds against Oral Microorganisms	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; IN-VITRO; BETA-THUJAPLICIN; ANTIMICROBIAL ACTIVITY; CARVACROL; THYMOL; HINOKITIOL; BACTERIAL; COMPONENTS; MECHANISM	The aim of the present study was to determine the antibacterial activities of the phenolic essential oil ( EO) compounds hinokitiol, carvacrol, thymol, and menthol against oral pathogens. Aggregatibacter actinomycetemcomitans, Streptococcus mutans, Methicillin-resistant Staphylococcus aureus (MRSA), and Escherichia. coli were used in this study. The minimum inhibitory concentrations (MICs), minimum bactericidal concentrations (MBCs), bacterial growth curves, temperature and pH stabilities, and synergistic effects of the liquid and vapor EO compounds were tested. The MIC/MBC of the EO compounds, ranging from the strongest to weakest, were hinokitiol (40-60 mu g/mL/40-100 mu g/mL), thymol (100-200 mu g/mL/200-400 mu g/mL), carvacrol (200-400 mu g/mL/200-600 mu g/mL), and menthol (500-more than 2500 mu g/mL/1000-more than 2500 mu g/mL). The antibacterial activities of the four EO phenolic compound based on the agar diffusion test and bacterial growth curves showed that the four EO phenolic compounds were stable under different temperatures for 24 h, but the thymol activity decreased when the temperature was higher than 80 degrees C. The combination of liquid carvacrol with thymol did not show any synergistic effects. The activities of the vaporous carvacrol and thymol were inhibited by the presence of water. Continual violent shaking during culture enhanced the activity of menthol. Both liquid and vaporous hinokitiol were stable at different temperatures and pH conditions. The combination of vaporous hinokitiol with zinc oxide did not show synergistic effects. These results showed that the liquid and vapor phases of hinokitiol have strong anti-oral bacteria abilities. Hinokitiol has the potential to be applied in oral health care products, dental materials, and infection controls to exert antimicrobial activity.	[Wang, Tong-Hong] Chang Gung Mem Hosp, Tissue Bank, Taoyuan, Taiwan; [Wang, Tong-Hong] Chang Gung Univ Sci & Technol, Res Ctr Ind Human Ecol, Taoyuan, Taiwan; [Wang, Tong-Hong] Chang Gung Univ Sci & Technol, Grad Inst Hlth Ind Technol, Taoyuan, Taiwan; [Hsia, Shih-Min; Wu, Chi-Hao] Taipei Med Univ, Sch Nutr & Hlth Sci, Taipei, Taiwan; [Ko, Shun-Yao] Chang Jung Christian Univ, Grad Inst Med Sci, Coll Hlth Sci, Tainan, Taiwan; [Ko, Shun-Yao] Chang Jung Christian Univ, Innovate Res Ctr Med, Tainan, Taiwan; [Chen, Michael Yuanchien] China Med Univ Hosp, Dept Oral & Maxillofacial Surg, Taichung, Taiwan; [Chen, Michael Yuanchien] China Med Univ, Sch Dent, Coll Med, Taichung, Taiwan; [Shih, Yin-Hua] China Med Univ Hosp, Mind Body Interface Lab, Taichung, Taiwan; [Shieh, Tzong-Ming] China Med Univ, Dept Dent Hyg, Coll Hlth Care, Taichung, Taiwan; [Chuang, Li-Chuan] Chang Gung Mem Hosp Linkou, Dept Pediat Dent, Taoyuan, Taiwan; [Chuang, Li-Chuan] Chang Gung Univ, Grad Inst Craniofacial & Dent Sci, Coll Med, Taoyuan, Taiwan; [Wu, Ching-Yi] Natl Yang Ming Univ, Inst Oral Biol, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University of Science & Technology; Chang Gung University of Science & Technology; Taipei Medical University; Chang Jung Christian University; Chang Jung Christian University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Chang Gung Memorial Hospital; Chang Gung University; National Yang Ming Chiao Tung University	Shieh, TM (corresponding author), China Med Univ, Dept Dent Hyg, Coll Hlth Care, Taichung, Taiwan.	tmshieh@mail.cmu.edu.tw	Hsia, Shih-Min/AAL-2026-2020; hao, yingbin/I-8600-2017; Abbas, Aqleem/M-9403-2016	hao, yingbin/0000-0001-9211-0554; Abbas, Aqleem/0000-0001-9174-9700; Wu, Ching-Yi/0000-0002-2004-4874; Kang, Zhensheng/0000-0001-5575-0122	China Medical University [CMU103-S-38]; Taipei Medical University [03C0720007A, 104-6202-015-111]; National Science Council, Taiwan [MOST104-2320-B-182A-009-, NSC 102-2314-B-039-015-MY3]	China Medical University(China Medical University); Taipei Medical University; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants from China Medical University (CMU103-S-38), Taipei Medical University (03C0720007A, 104-6202-015-111), and the National Science Council, Taiwan (MOST104-2320-B-182A-009- and NSC 102-2314-B-039-015-MY3).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants from China Medical University (CMU103-S-38), Taipei Medical University (03C0720007A, 104-6202-015-111), and the National Science Council, Taiwan (MOST 104-2320-B-182A-009- and NSC 102-2314-B-039-015-MY3).	Abdullah GZ, 2011, INT J NANOMED, V6, P387, DOI 10.2147/IJN.S14667; Aguiar GP, 2013, NAT PROD RES, V27, P1668, DOI 10.1080/14786419.2012.751595; Akiyama H, 1998, J DERMATOL SCI, V17, P67, DOI 10.1016/S0923-1811(97)00070-4; Alam M, 2013, NANOMED-NANOTECHNOL, V9, P247, DOI 10.1016/j.nano.2012.07.004; Arima Y, 2003, J ANTIMICROB CHEMOTH, V51, P113, DOI 10.1093/jac/dkg037; Bardaji DKR, 2016, NAT PROD RES, V30, P1178, DOI 10.1080/14786419.2015.1043630; Barret MC, 2001, INORG CHEM, V40, P4384, DOI 10.1021/ic0100368; Bebermeyer Richard D, 2005, Tex Dent J, V122, P1022; Botelho MA, 2007, BRAZ J MED BIOL RES, V40, P349, DOI 10.1590/S0100-879X2007000300010; Burt SA, 2005, J FOOD PROTECT, V68, P919, DOI 10.4315/0362-028X-68.5.919; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Chami N, 2005, ORAL MICROBIOL IMMUN, V20, P106, DOI 10.1111/j.1399-302X.2004.00202.x; Ciandrini E, 2014, CLIN ORAL INVEST, V18, P2001, DOI 10.1007/s00784-013-1179-9; Duarte MCT, 2007, J ETHNOPHARMACOL, V111, P197, DOI 10.1016/j.jep.2006.11.034; Du WX, 2008, J AGR FOOD CHEM, V56, P3082, DOI 10.1021/jf703629s; Ebihara S, 2011, J PHARMACOL SCI, V115, P99, DOI 10.1254/jphs.10R05CP; Ema M, 2004, FOOD CHEM TOXICOL, V42, P465, DOI 10.1016/j.fct.2003.10.009; Farazuddin M, 2014, INT J NANOMED, V9, P1139, DOI 10.2147/IJN.S34668; Flamee S, 2015, EUR ARCH PAEDIATR DE, V16, P449, DOI 10.1007/s40368-015-0192-x; Freires IA, 2015, MOLECULES, V20, P7329, DOI 10.3390/molecules20047329; Guarda A, 2011, INT J FOOD MICROBIOL, V146, P144, DOI 10.1016/j.ijfoodmicro.2011.02.011; Holowachuk SA, 2003, J MICROBIOL METH, V55, P441, DOI 10.1016/S0167-7012(03)00190-8; Iha K, 2013, OR SURG OR MED OR PA, V116, P433, DOI 10.1016/j.oooo.2013.05.021; Imai Norio, 2006, Journal of Toxicological Sciences, V31, P357, DOI 10.2131/jts.31.357; Inouye S, 2001, J ANTIMICROB CHEMOTH, V47, P565, DOI 10.1093/jac/47.5.565; Jung SY, 2012, DRUG DEV IND PHARM, V38, P635, DOI 10.3109/03639045.2011.621432; Kavoosi G, 2013, J FOOD SCI, V78, pE244, DOI 10.1111/1750-3841.12015; Labib GS, 2015, DRUG DES DEV THER, V9, P3349, DOI 10.2147/DDDT.S85356; Langeveld WT, 2014, CRIT REV MICROBIOL, V40, P76, DOI 10.3109/1040841X.2013.763219; Li H, 2014, INT J CLIN EXP PATHO, V7, P7389; Lindenmuller IH, 2011, CURR PROBL DERMATOL, V40, P107, DOI 10.1159/000321060; Lopez P, 2005, J AGR FOOD CHEM, V53, P6939, DOI 10.1021/jf050709v; Lopez P, 2007, J AGR FOOD CHEM, V55, P4348, DOI 10.1021/jf063295u; Low SB, 2014, AM J VET RES, V75, P653, DOI 10.2460/ajvr.75.7.653; Maisanaba S, 2015, MUTAT RES-GEN TOX EN, V784, P37, DOI 10.1016/j.mrgentox.2015.05.005; Marcos-Arias C, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-119; Maroof A, 2010, BIOSCIENCE REP, V30, P223, DOI 10.1042/BSR20090068; Miyake M, 2007, J ORAL MAXIL SURG, V65, P2159, DOI 10.1016/j.joms.2007.04.026; Morita Yasilihiro, 2007, Biocontrol Science, V12, P101; Nafisi S, 2004, BIOPOLYMERS, V74, P345, DOI 10.1002/bip.20080; Bitu VDN, 2014, NAT PROD RES, V28, P399, DOI 10.1080/14786419.2013.867343; Nunez L, 2012, BRAZ J MICROBIOL, V43, P1255, DOI 10.1590/S1517-83822012000400003; Okuyama Yusuke, 2012, Nihon Rinsho, V70, P1362; Rahim ZHA, 2014, JCPSP-J COLL PHYSICI, V24, P796, DOI 11.2014/JCPSP.796801; Rodrigues Celia Regina Martins Delgado, 2008, J Clin Dent, V19, P18; Rodriguez-Garcia I, 2016, CRIT REV FOOD SCI, V56, P1717, DOI 10.1080/10408398.2013.800832; Sarrami N, 2002, BRIT DENT J, V193, P257, DOI 10.1038/sj.bdj.4801539; Seo HS, 2015, INT J FOOD MICROBIOL, V215, P95, DOI 10.1016/j.ijfoodmicro.2015.08.021; Shen Q, 2011, AAPS PHARMSCITECH, V12, P1044, DOI 10.1208/s12249-011-9672-4; Shih MF, 2012, INT J IMMUNOPATH PH, V25, P39, DOI 10.1177/039463201202500106; Shih YH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094941; Shih YH, 2013, MICROBIOL RES, V168, P254, DOI 10.1016/j.micres.2012.12.007; Tan CQ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/525218; TRAUB WH, 1995, J ANTIMICROB CHEMOTH, V35, P149, DOI 10.1093/jac/35.1.149; Ursino MG, 2011, REGUL TOXICOL PHARM, V60, P93, DOI 10.1016/j.yrtph.2011.02.010; Wang CM, 2016, J NAT MED-TOKYO, V70, P563, DOI 10.1007/s11418-016-0978-0; Williams C, 2001, BEST PRACT RES CL GA, V15, P511, DOI 10.1053/bega.2001.0191; Xu J, 2008, LETT APPL MICROBIOL, V47, P174, DOI 10.1111/j.1472-765X.2008.02407.x; Zhou SY, 2013, J FOOD SCI, V78, pM725, DOI 10.1111/1750-3841.12098	59	383	395	16	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2016	11	9							e0163147	10.1371/journal.pone.0163147	http://dx.doi.org/10.1371/journal.pone.0163147			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX2BH	27681039	Green Submitted, Green Published, gold			2022-12-26	WOS:000384171400032
J	Hao, YB; Wang, T; Wang, K; Wang, XJ; Fu, YP; Huang, LL; Kang, ZS				Hao, Yingbin; Wang, Ting; Wang, Kang; Wang, Xiaojie; Fu, Yanping; Huang, Lili; Kang, Zhensheng			Transcriptome Analysis Provides Insights into the Mechanisms Underlying Wheat Plant Resistance to Stripe Rust at the Adult Plant Stage	PLOS ONE			English	Article							F-SP TRITICI; PUCCINIA-STRIIFORMIS; GENE-EXPRESSION; DISEASE RESISTANCE; SALICYLIC-ACID; DEFENSE RESPONSES; BROAD-SPECTRUM; BIOSYNTHESIS; METABOLISM; ANNOTATION	Stripe rust (or yellow rust), which is caused by Puccinia striiformis f. sp. tritici (Pst), is one of the most devastating wheat diseases worldwide. The wheat cultivar Xingzi 9104 (XZ) is an elite wheat germplasm that possesses adult plant resistance (APR), which is non-race-specific and durable. Thus, to better understand the mechanism underlying APR, we performed transcriptome sequencing of wheat seedlings and adult plants without Pst infection, and a total of 157,689 unigenes were obtained as a reference. In total, 2,666, 783 and 2,587 differentially expressed genes (DEGs) were found to be up-or down-regulated after Pst infection at 24, 48 and 120 hours post-inoculation (hpi), respectively, based on a comparison of Pst- and mock-infected plants. Among these unigenes, the temporal pattern of the up-regulated unigenes exhibited transient expression patterns during Pst infection, as determined through a Gene Ontology (GO) enrichment analysis. In addition, a Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis showed that many biological processes, including phenylpropanoid biosynthesis, reactive oxygen species, photosynthesis and thiamine metabolism, which mainly control the mechanisms of lignification, reactive oxygen species and sugar, respectively, are involved in APR. In particular, the continuous accumulation of reactive oxygen species may potentially contribute to the ability of the adult plant to inhibit fungal growth and development. To validate the bioinformatics results, 6 candidate genes were selected for further functional identification using the virus-induced gene silencing (VIGS) system, and 4 candidate genes likely contribute to plant resistance against Pst infection. Our study provides new information concerning the transcriptional changes that occur during the Pst-wheat interaction at the adult stage and will help further our understanding of the detailed mechanisms underlying APR to Pst.	[Hao, Yingbin; Wang, Ting; Wang, Kang; Wang, Xiaojie; Fu, Yanping; Huang, Lili; Kang, Zhensheng] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Peoples R China; [Hao, Yingbin; Wang, Ting; Wang, Kang; Wang, Xiaojie; Huang, Lili; Kang, Zhensheng] Northwest A&F Univ, Coll Plant Protect, Yangling, Peoples R China; [Fu, Yanping] Northwest A&F Univ, Coll Life Sci, Yangling, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Wang, XJ; Kang, ZS (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Peoples R China.; Wang, XJ; Kang, ZS (corresponding author), Northwest A&F Univ, Coll Plant Protect, Yangling, Peoples R China.	wangxiaojie@nwsuaf.edu.cn; kangzs@nwsuaf.edu.cn	Hsia, Shih-Min/AAL-2026-2020; hao, yingbin/I-8600-2017; Abbas, Aqleem/M-9403-2016	hao, yingbin/0000-0001-9211-0554; Abbas, Aqleem/0000-0001-9174-9700; Wu, Ching-Yi/0000-0002-2004-4874; Kang, Zhensheng/0000-0001-5575-0122				Ahn IP, 2005, PLANT PHYSIOL, V138, P1505, DOI 10.1104/pp.104.058693; Asensi-Fabado MA, 2010, TRENDS PLANT SCI, V15, P582, DOI 10.1016/j.tplants.2010.07.003; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Chen XM, 2007, AUST J AGR RES, V58, P648, DOI 10.1071/AR07045; Chen X. M., 2013, American Journal of Plant Sciences, V4, P608; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; Cheng YL, 2015, ENVIRON MICROBIOL, V17, P2601, DOI 10.1111/1462-2920.12719; Christianson JA, 2010, PLANT CELL PHYSIOL, V51, P21, DOI 10.1093/pcp/pcp163; Coram TE, 2008, MOL PLANT PATHOL, V9, P479, DOI [10.1111/j.1364-3703.2008.00476.x, 10.1111/J.1364-3703.2008.00476.X]; Coram TE, 2008, MOL PLANT PATHOL, V9, P157, DOI 10.1111/J.1364-3703.2007.00453.X; Coura Jose Rodrigues, 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P415, DOI 10.1590/S0036-46651995000500006; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Croft MT, 2006, EUKARYOT CELL, V5, P1175, DOI 10.1128/EC.00097-06; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; Duan XY, 2013, MOL PLANT PATHOL, V14, P728, DOI 10.1111/mpp.12044; Emrich SJ, 2007, GENOME RES, V17, P69, DOI 10.1101/gr.5145806; Eveland AL, 2010, PLANT PHYSIOL, V154, P1024, DOI 10.1104/pp.110.159673; Feng H, 2013, BIOCHIM BIOPHYS ACTA, V1839, P1; FUKUDA H, 1982, PLANTA, V155, P423, DOI 10.1007/BF00394471; Gomez-Ariza J, 2007, MOL PLANT MICROBE IN, V20, P832, DOI 10.1094/MPMI-20-7-0832; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; hang XZ, 1986, LIAONING AGR SCI, V3, P26; Holzberg S, 2002, PLANT J, V30, P315, DOI 10.1046/j.1365-313X.2002.01291.x; Hua J, 2013, CURR OPIN PLANT BIOL, V16, P406, DOI 10.1016/j.pbi.2013.06.017; Huang XL, 2013, PHYSIOL MOL PLANT P, V81, P26, DOI 10.1016/j.pmpp.2012.10.004; Hulbert SH, 2007, PHYTOPATHOLOGY, V97, P1083, DOI 10.1094/PHYTO-97-9-1083; LINE RF, 1995, PLANT DIS, V79, P1254; Liu GQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-700; Liu HongMei, 2006, Acta Agronomica Sinica, V32, P1742; Loake G, 2007, CURR OPIN PLANT BIOL, V10, P466, DOI 10.1016/j.pbi.2007.08.008; MARES DJ, 1977, PHYSIOL PLANT PATHOL, V10, P257, DOI 10.1016/0048-4059(77)90030-3; Metraux JP, 2002, TRENDS PLANT SCI, V7, P332, DOI 10.1016/S1360-1385(02)02313-0; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mutz KO, 2013, CURR OPIN BIOTECH, V24, P22, DOI 10.1016/j.copbio.2012.09.004; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Pandelova I, 2009, MOL PLANT, V2, P1067, DOI 10.1093/mp/ssp045; PETTY ITD, 1990, EMBO J, V9, P3453, DOI 10.1002/j.1460-2075.1990.tb07553.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pont C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r119; Rapala-Kozik M, 2008, J EXP BOT, V59, P4133, DOI 10.1093/jxb/ern253; Roje S, 2007, PHYTOCHEMISTRY, V68, P1904, DOI 10.1016/j.phytochem.2007.03.038; Scofield SR, 2005, PLANT PHYSIOL, V138, P2165, DOI 10.1104/pp.105.061861; Shalitin D, 2000, PLANT PHYSIOL, V123, P597, DOI 10.1104/pp.123.2.597; Singh Ravi Prakash, 2005, Turkish Journal of Agriculture and Forestry, V29, P121; Sticher L, 1997, ANNU REV PHYTOPATHOL, V35, P235, DOI 10.1146/annurev.phyto.35.1.235; Swarbrick PJ, 2006, PLANT CELL ENVIRON, V29, P1061, DOI 10.1111/j.1365-3040.2005.01472.x; Tamas L, 2010, PLANTA, V231, P221, DOI 10.1007/s00425-009-1042-z; Thrall PH, 2003, SCIENCE, V299, P1735, DOI 10.1126/science.1080070; Tsuda K, 2008, PLANT J, V53, P763, DOI 10.1111/j.1365-313X.2007.03369.x; Tunc-Ozdemir M, 2009, PLANT PHYSIOL, V151, P421, DOI 10.1104/pp.109.140046; van de Mortel M, 2007, MOL PLANT MICROBE IN, V20, P887, DOI 10.1094/MPMI-20-8-0887; Voegele RT, 2006, FEMS MICROBIOL LETT, V259, P165, DOI 10.1111/j.1574-6968.2006.00248.x; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang CF, 2007, PHYSIOL MOL PLANT P, V71, P230, DOI 10.1016/j.pmpp.2008.02.006; Wang GN, 2006, PLANT MOL BIOL, V60, P437, DOI 10.1007/s11103-005-4770-x; Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375; Weisshaar B, 1998, CURR OPIN PLANT BIOL, V1, P251, DOI 10.1016/S1369-5266(98)80113-1; Wellings CR, 2011, EUPHYTICA, V179, P129, DOI 10.1007/s10681-011-0360-y; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Wu JA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-234; Zaninotto F, 2006, PLANT PHYSIOL, V141, P379, DOI 10.1104/pp.106.078857; Zhang HC, 2012, PLANT CELL REP, V31, P2121, DOI 10.1007/s00299-012-1322-0; Zhang SJ, 2014, J BIOTECHNOL, V189, P48, DOI 10.1016/j.jbiotec.2014.08.032; Zhang YD, 2013, SCI WORLD J, DOI 10.1155/2013/130134	68	383	395	16	112	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 18	2016	11	3							e0150717	10.1371/journal.pone.0150717	http://dx.doi.org/10.1371/journal.pone.0150717			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH1ZE	27681039	Green Submitted, Green Published, gold			2022-12-26	WOS:000372582800038
J	Ramu, R; Shirahatti, PS; Swamy, SN; Zameer, F; Dhananjaya, BL; Prasad, MNN				Ramu, Ramith; Shirahatti, Prithvi S.; Swamy, Nanjunda S.; Zameer, Farhan; Dhananjaya, Bhadrapura Lakkappa; Prasad, Nagendra M. N.			Assessment of In Vivo Antidiabetic Properties of Umbelliferone and Lupeol Constituents of Banana (Musa sp var. Nanjangud Rasa Bale) Flower in Hyperglycaemic Rodent Model	PLOS ONE			English	Article							ANTIOXIDANT; GLYCOGEN	Banana is an extensively cultivated plant worldwide, mainly for its fruit, while its ancillary product, the banana flower is consumed as a vegetable and is highly recommended for diabetics in the traditional Indian medicine system. This study is based on an investigation of the in vivo antihyperglycaemic activity of Umbelliferone (C1) and Lupeol (C2) isolated from the ethanol extract of banana flower (EF) in alloxan induced diabetic rat model. Diabetic rats which were administered with C1, C2 and EF (100 and 200 mg/kg b. wt.) for 4 weeks showed deterioration in fasting hyperglycaemia and reversal of abnormalities in serum/urine protein, urea and creatinine, when compared to the diabetic control group of rats. The diabetic group of rats fed with EF, C1 and C2 (100 mg/kg b. wt.) once daily, for a period of 28 days resulted in a significant reduction of diabetic symptoms viz., polyphagia, polydipsia, polyuria and urine sugar together with an improved body weight. HbA1c extent was reduced whereas levels of insulin and Hb were increased. Both the extract and compounds wielded positive impacts in diabetic rats by reversal of altered activities of hepatic marker enzymes viz., aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP); glycolytic enzyme (hexokinase); shunt enzyme (glucose-6-phosphate dehydrogenase); gluconeogenic enzymes (glucose-6-phosphatase, fructose-1,6-bisphosphatase, lactate dehydrogenase) and pyruvate kinase. The characteristic diabetic complications such as hypercholesterolemia and hypertriacylglycerolemia also significantly reverted to normal in the serum/liver of diabetic rats. Besides these, the treatment increased the activities of enzymatic and nonenzymatic antioxidants in the serum and liver. The histological observations revealed a marked regeneration of the beta-cells in the drug treated diabetic rats. In conclusion, the present study illustrates that EF, C1 and C2 enhances the glycolytic activities, besides increasing the hepatic glucose utilization in diabetic rats by stimulating insulin secretion from the remnant beta-cells along with potential enzymatic and non-enzymatic antioxidant activities.	[Ramu, Ramith] Sri Dharmasthala Manjunatheshwara Coll Post Grad, Dept Biotechnol, Dakshina Kannada 574240, Karnataka, India; [Ramu, Ramith; Shirahatti, Prithvi S.; Swamy, Nanjunda S.; Prasad, Nagendra M. N.] Sri Jayachamarajendra Coll Engn, Dept Biotechnol, JSS Tech Inst Campus, Mysore 570006, Karnataka, India; [Zameer, Farhan] Pooja Bhagavat Mem Mahajana PG Ctr, Dept Studies Biotechnol Microbiol & Biochem, Mahajana Life Sci Res Ctr, Mysore 570016, Karnataka, India; [Dhananjaya, Bhadrapura Lakkappa] Jain Univ, Ctr Emerging Technol, Toxinol Toxicol & Drug Discovery Unit, Jain Global Campus, Kanakapura Taluk 562112, Karnataka, India	Sri Jayachamarajendra College of Engineering; Jain University	Prasad, MNN (corresponding author), Sri Jayachamarajendra Coll Engn, Dept Biotechnol, JSS Tech Inst Campus, Mysore 570006, Karnataka, India.; Dhananjaya, BL (corresponding author), Jain Univ, Ctr Emerging Technol, Toxinol Toxicol & Drug Discovery Unit, Jain Global Campus, Kanakapura Taluk 562112, Karnataka, India.	chandu_greeshma@rediffmail.com; npmicro8@yahoo.com	Zameer, Farhan/AAU-8054-2021; RAMU, RAMITH/AAY-3039-2020	RAMU, Dr. RAMITH/0000-0003-2776-5815; Zameer, Dr. Farhan/0000-0002-4868-1111; SHIVANANJU, NANJUNDA SWAMY/0000-0002-5494-9428				BAKER H, 1980, NUTR REP INT, V21, P531; Bhaskar JJ, 2012, J AGR FOOD CHEM, V60, P427, DOI 10.1021/jf204539v; CORNBLATH M, 1963, J BIOL CHEM, V238, P1592; David LD, 1932, J BIOL CHEM, V98, P719; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fugen A, 2002, CELL BIOCHEM FUNCT, V20, P297; Indradevi S., 2012, Journal of King Saud University Science, V24, P171, DOI 10.1016/j.jksus.2010.12.007; Kavishankar GB, 2014, PHYTOMEDICINE, V21, P1026, DOI 10.1016/j.phymed.2014.04.033; KEMP A, 1954, BIOCHEM J, V56, P646, DOI 10.1042/bj0560646; King A, 2016, BIOCHEM PHARMACOL, V99, P1, DOI 10.1016/j.bcp.2015.08.108; King J., 1965, PRACTICAL CLIN ENZYM, P363; LELOIR LF, 1962, METHOD ENZYMOL, V5, P145, DOI 10.1016/S0076-6879(62)05196-4; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luna GL, 1968, MANUAL HISTOLOGICAL; Mahboob M., 2005, SMJ Singapore Medical Journal, V46, P322; Mahendran G, 2014, PHYTOMEDICINE, V21, P1237, DOI 10.1016/j.phymed.2014.06.011; Maithili V, 2011, INDIAN J PHARMACOL, V43, P455, DOI 10.4103/0253-7613.83121; Makni M, 2011, J DIABETES COMPLICAT, V25, P339, DOI 10.1016/j.jdiacomp.2010.09.001; Makni M, 2010, FOOD CHEM TOXICOL, V48, P2407, DOI 10.1016/j.fct.2010.05.079; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Murali R, 2013, BIOCHIMIE, V95, P1848, DOI 10.1016/j.biochi.2013.06.013; Muruganandan S, 2005, J ETHNOPHARMACOL, V97, P497, DOI 10.1016/j.jep.2004.12.010; NAYAK SS, 1981, CLIN CHIM ACTA, V109, P267; OECD Guidelines for the Testing of Chemicals, 2001, 423 OECD, V423; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Oi K, 1997, BIOCHEM MOL MED, V62, P70, DOI 10.1006/bmme.1997.2622; Omaye S T, 1979, Methods Enzymol, V62, P3, DOI 10.1016/0076-6879(79)62181-X; POGSON CI, 1967, NATURE, V216, P156, DOI 10.1038/216156a0; Prabakaran D, 2012, J FUNCT FOODS, V4, P776, DOI 10.1016/j.jff.2012.05.005; Rahimi R, 2005, BIOMED PHARMACOTHER, V59, P365, DOI 10.1016/j.biopha.2005.07.002; Ramachandran V, 2014, PHYTOMEDICINE, V21, P225, DOI 10.1016/j.phymed.2013.08.027; Ramesh B, 2006, J MED FOOD, V9, P562, DOI 10.1089/jmf.2006.9.562; Ramith R., 2014, S AFRICAN J BOT, V95, P54; Rangachari B, 2011, EUR J PHARMACOL, V667, P410; Rao USM, 2011, AFR J TRADIT COMPLEM, V8, P210; Rohilla A., 2012, INT J RES PHARM BIOM, V3, P819; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Shao JH, 2005, DIABETES, V54, P976, DOI 10.2337/diabetes.54.4.976; Shobana S, 2010, BRIT J NUTR, V104, P1787, DOI 10.1017/S0007114510002977; SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7; Stadler K, 2003, FREE RADICAL BIO MED, V35, P1240, DOI 10.1016/S0891-5849(03)00499-4; Sundaram R, 2014, PHYTOMEDICINE, V21, P793, DOI 10.1016/j.phymed.2014.01.007; Sundaram R, 2013, PHYTOMEDICINE, V20, P577, DOI 10.1016/j.phymed.2013.01.006; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Tabatabaei-Malazy O, 2013, J MED HYPOTHESES IDE, V7, P25, DOI 10.1016/j.jmhi.2012.12.002; Vessal M, 2003, COMP BIOCHEM PHYS C, V135, P357, DOI 10.1016/S1532-0456(03)00140-6	48	35	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2016	11	3							e0151135	10.1371/journal.pone.0151135	http://dx.doi.org/10.1371/journal.pone.0151135			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH3OX	27003006	Green Submitted, Green Published, gold			2022-12-26	WOS:000372697400024
